VARIABLE,TYPE,NGENES,BETA,BETA_STD,SE,P,FULL_NAME,P_FDR
HP_COLDNESS,SET,2,2.7654,0.028861,0.63951,7.6929e-06,HP_COLDNESS,0.08762604375
HP_HAND_APRAXIA,SET,2,2.7654,0.028861,0.63951,7.6929e-06,HP_HAND_APRAXIA,0.08762604375
GROSS_HIF1A_TARGETS_UP,SET,7,1.6375,0.031967,0.38238,9.2911e-06,GROSS_HIF1A_TARGETS_UP,0.08762604375
BAUS_TFF2_TARGETS_UP,SET,30,0.64278,0.025961,0.15074,1.0085e-05,BAUS_TFF2_TARGETS_UP,0.08762604375
SCHERER_PBMC_APSV_WETVAX_AGE...5,SET,171,0.26109,0.025079,0.063352,1.8931e-05,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN,0.131589381
HP_OPEN_BITE,SET,54,0.48175,0.026087,0.11984,2.9243e-05,HP_OPEN_BITE,0.150126705
REACTOME_MUSCARINIC_ACETYLCH...,SET,5,1.515,0.024997,0.37762,3.0237e-05,REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS,0.150126705
GOCC_GINS_COMPLEX,SET,5,1.5022,0.024785,0.38349,4.4988e-05,GOCC_GINS_COMPLEX,0.1954447425
HP_ACNE_INVERSA,SET,11,0.81927,0.020047,0.21147,5.3672e-05,HP_ACNE_INVERSA,0.2050602925
FAN_OVARY_CL5_HEALTHY_SELECT...,SET,281,0.20076,0.024645,0.052514,6.6165e-05,FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL,0.2050602925
GOCC_JUXTAPARANODE_REGION_OF...,SET,12,0.98783,0.025245,0.25866,6.722e-05,GOCC_JUXTAPARANODE_REGION_OF_AXON,0.2050602925
GSE21546_SAP1A_KO_VS_SAP1A_K...2,SET,178,0.23936,0.023453,0.062887,7.0802e-05,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.2050602925
KEGG_SELENOAMINO_ACID_METABO...,SET,23,0.65342,0.023112,0.17351,8.3217e-05,KEGG_SELENOAMINO_ACID_METABOLISM,0.2190558
HP_EXCESSIVE_BLEEDING_FROM_S...,SET,5,1.48,0.02442,0.39454,8.824e-05,HP_EXCESSIVE_BLEEDING_FROM_SUPERFICIAL_CUTS,0.2190558
GSE13522_CTRL_VS_T_CRUZI_Y_S...5,SET,183,0.23551,0.023395,0.063393,0.00010186,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_DN,0.220180480434783
BENNETT_SYSTEMIC_LUPUS_ERYTH...,SET,25,0.67128,0.024753,0.18164,0.00010997,BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,0.220180480434783
WP_MAMMARY_GLAND_DEVELOPMENT...4,SET,12,0.96379,0.024631,0.26174,0.00011596,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,0.220180480434783
ABBUD_LIF_SIGNALING_1_UP,SET,38,0.52825,0.024007,0.14351,0.00011654,ABBUD_LIF_SIGNALING_1_UP,0.220180480434783
KEGG_LEISHMANIA_INFECTION,SET,63,0.43509,0.025442,0.11932,0.00013335,KEGG_LEISHMANIA_INFECTION,0.220180480434783
REACTOME_DEFECTIVE_CHST6_CAU...,SET,8,1.0472,0.021854,0.28845,0.00014194,REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1,0.220180480434783
GSE22601_IMMATURE_CD4_SINGLE...1,SET,180,0.22193,0.021865,0.061156,0.00014272,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.220180480434783
HP_MINICORE_MYOPATHY,SET,8,1.0525,0.021965,0.29009,0.00014312,HP_MINICORE_MYOPATHY,0.220180480434783
HP_EPISODIC_HYPERTENSION,SET,5,1.2935,0.021343,0.35697,0.00014571,HP_EPISODIC_HYPERTENSION,0.220180480434783
HP_SUDDEN_UNEXPECTED_DEATH_I...,SET,9,1.0185,0.022543,0.28293,0.00015974,HP_SUDDEN_UNEXPECTED_DEATH_IN_EPILEPSY,0.230953926
GSE12845_PRE_GC_VS_DARKZONE_...2,SET,173,0.22865,0.022089,0.063699,0.00016613,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.230953926
GSE9988_LPS_VS_CTRL_TREATED_...2,SET,163,0.24918,0.023374,0.070339,0.00019859,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP,0.257804866666667
GOBP_MIDBRAIN_HINDBRAIN_BOUN...,SET,5,1.386,0.022869,0.39149,0.00020028,GOBP_MIDBRAIN_HINDBRAIN_BOUNDARY_DEVELOPMENT,0.257804866666667
GROSS_HYPOXIA_VIA_ELK3_DN,SET,137,0.27049,0.023278,0.078057,0.00026545,GROSS_HYPOXIA_VIA_ELK3_DN,0.3294898125
GOMF_PHOSPHATIDYLINOSITOL_5_...,SET,18,0.6545,0.020483,0.1911,0.00030824,GOMF_PHOSPHATIDYLINOSITOL_5_PHOSPHATE_BINDING,0.358502280769231
GOBP_DNA_UNWINDING_INVOLVED_...,SET,20,0.6633,0.02188,0.19394,0.00031367,GOBP_DNA_UNWINDING_INVOLVED_IN_DNA_REPLICATION,0.358502280769231
JOHANSSON_GLIOMAGENESIS_BY_P...2,SET,55,0.40007,0.021864,0.1176,0.00033537,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,0.358502280769231
GSE32986_CURDLAN_HIGHDOSE_VS...1,SET,185,0.22024,0.021995,0.064801,0.00033939,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.358502280769231
GSE3982_MEMORY_CD4_TCELL_VS_...5,SET,186,0.20151,0.020178,0.059512,0.00035543,GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN,0.358502280769231
GOBP_ROSTROCAUDAL_NEURAL_TUB...,SET,8,1.0915,0.022779,0.32281,0.00036151,GOBP_ROSTROCAUDAL_NEURAL_TUBE_PATTERNING,0.358502280769231
GOBP_B_CELL_MEDIATED_IMMUNITY,SET,117,0.27323,0.021742,0.080962,0.00037006,GOBP_B_CELL_MEDIATED_IMMUNITY,0.358502280769231
GOBP_POSITIVE_REGULATION_OF_...27,SET,4,1.3587,0.020052,0.40356,0.00038102,GOBP_POSITIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.358502280769231
KEGG_MEDICUS_REFERENCE_TLR5_...,SET,15,0.72677,0.020764,0.21625,0.00038933,KEGG_MEDICUS_REFERENCE_TLR5_NFKB_SIGNALING_PATHWAY,0.358502280769231
GOMF_G_PROTEIN_COUPLED_ACETY...,SET,7,1.114,0.021748,0.33181,0.00039404,GOMF_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_ACTIVITY,0.358502280769231
BIDUS_METASTASIS_DN,SET,131,0.2442,0.020553,0.072856,0.00040229,BIDUS_METASTASIS_DN,0.358502280769231
REACTOME_DRUG_ADME,SET,101,0.31869,0.023571,0.095592,0.0004292,REACTOME_DRUG_ADME,0.37292115
HP_HEAT_INTOLERANCE,SET,19,0.6208,0.01996,0.18694,0.00044975,HP_HEAT_INTOLERANCE,0.381245396341463
HP_PERIAURICULAR_SKIN_PITS,SET,48,0.42219,0.021558,0.12767,0.00047259,HP_PERIAURICULAR_SKIN_PITS,0.385672373333333
HP_SKIN_PIT,SET,62,0.35273,0.020462,0.10699,0.00048983,HP_SKIN_PIT,0.385672373333333
MARIADASON_RESPONSE_TO_BUTYR...2,SET,7,1.0805,0.021093,0.32781,0.00049109,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2,0.385672373333333
HALLMARK_UNFOLDED_PROTEIN_RE...,SET,104,0.26565,0.019936,0.080708,0.00049936,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.385672373333333
HP_SINUS_TACHYCARDIA,SET,27,0.4792,0.018362,0.14613,0.00052143,HP_SINUS_TACHYCARDIA,0.393963035869565
VILIMAS_NOTCH1_TARGETS_DN,SET,24,0.622,0.022473,0.19046,0.00054682,VILIMAS_NOTCH1_TARGETS_DN,0.404355938297872
GOBP_REGULATION_OF_BONE_RESO...,SET,42,0.45513,0.021743,0.14016,0.00058396,GOBP_REGULATION_OF_BONE_RESORPTION,0.414485292857143
GOBP_ADENYLATE_CYCLASE_INHIB...2,SET,8,0.98724,0.020603,0.30405,0.00058437,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.414485292857143
WP_TH17_CELL_DIFFERENTIATION...,SET,67,0.35676,0.021512,0.11011,0.00059878,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,0.415697058823529
GOCC_INTERMEDIATE_FILAMENT_C...,SET,208,0.22887,0.024222,0.070756,0.00061,GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON,0.415697058823529
HP_HYPERPIGMENTED_PAPULE,SET,5,1.0139,0.01673,0.31568,0.00066057,HP_HYPERPIGMENTED_PAPULE,0.437821194339623
YAGUE_PRETUMOR_DRUG_RESISTAN...2,SET,7,1.1543,0.022535,0.35974,0.00066766,YAGUE_PRETUMOR_DRUG_RESISTANCE_UP,0.437821194339623
MIR668_3P,SET,54,0.35776,0.019373,0.11176,0.00068574,MIR668_3P,0.441349883333333
KEGG_MEDICUS_REFERENCE_SKELE...,SET,21,0.63789,0.02156,0.20035,0.00072782,KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING,0.45623385
GSE14769_UNSTIM_VS_240MIN_LP...2,SET,181,0.18979,0.018751,0.059664,0.00073512,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP,0.45623385
MIR217_5P,SET,170,0.20261,0.019406,0.063895,0.00076072,MIR217_5P,0.461067020689655
GSE3982_BCELL_VS_NKCELL_UP,SET,177,0.1986,0.019405,0.062694,0.00076944,GSE3982_BCELL_VS_NKCELL_UP,0.461067020689655
SONG_TARGETS_OF_IE86_CMV_PRO...,SET,51,0.38048,0.020024,0.12039,0.00078891,SONG_TARGETS_OF_IE86_CMV_PROTEIN,0.464721475423729
PASQUALUCCI_LYMPHOMA_BY_GC_S...2,SET,262,0.16859,0.019994,0.053543,0.00082165,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,0.46756878984375
MIR6807_3P,SET,128,0.2315,0.019262,0.073661,0.000838,MIR6807_3P,0.46756878984375
GOCC_PODOSOME,SET,33,0.46145,0.019545,0.14693,0.00084425,GOCC_PODOSOME,0.46756878984375
GSE29618_BCELL_VS_MDC_DAY7_F...2,SET,169,0.21307,0.020348,0.067952,0.00085881,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP,0.46756878984375
REACTOME_ATF6_ATF6_ALPHA_ACT...1,SET,11,0.71905,0.017594,0.22937,0.00086101,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES,0.46756878984375
GOBP_REGULATION_OF_VOLTAGE_G...2,SET,6,1.1843,0.021405,0.38068,0.00093396,GOBP_REGULATION_OF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,0.491169926470588
GSE27859_MACROPHAGE_VS_CD11C...4,SET,153,0.21161,0.019236,0.068108,0.00094632,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP,0.491169926470588
GOCC_ESC_E_Z_COMPLEX,SET,14,0.65804,0.018164,0.21198,0.00095514,GOCC_ESC_E_Z_COMPLEX,0.491169926470588
GOBP_AXON_CHOICE_POINT_RECOG...,SET,7,1.2237,0.023888,0.39442,0.000961,GOBP_AXON_CHOICE_POINT_RECOGNITION,0.491169926470588
GSE24210_CTRL_VS_IL35_TREATE...1,SET,180,0.18335,0.018065,0.05927,0.00099052,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_DN,0.498920617391304
HP_CHEST_PAIN,SET,127,0.23802,0.019727,0.077091,0.0010107,HP_CHEST_PAIN,0.50181255
MIR2467_3P,SET,139,0.21035,0.018233,0.068689,0.0010994,MIR2467_3P,0.535227
GOCC_CMG_COMPLEX,SET,11,0.73077,0.017881,0.23946,0.0011393,GOCC_CMG_COMPLEX,0.535227
REACTOME_AZATHIOPRINE_ADME,SET,21,0.59296,0.020042,0.19465,0.00116,REACTOME_AZATHIOPRINE_ADME,0.535227
HP_HEMANGIOBLASTOMA,SET,18,0.51059,0.015979,0.16765,0.0011629,HP_HEMANGIOBLASTOMA,0.535227
GOBP_EARLY_ENDOSOME_TO_RECYC...,SET,7,1.006,0.019639,0.33126,0.0011966,GOBP_EARLY_ENDOSOME_TO_RECYCLING_ENDOSOME_TRANSPORT,0.535227
HP_HEMATURIA,SET,164,0.20498,0.019286,0.067507,0.0011989,HP_HEMATURIA,0.535227
MIR6752_5P,SET,112,0.24742,0.019265,0.081571,0.0012116,MIR6752_5P,0.535227
KEGG_PPAR_SIGNALING_PATHWAY,SET,67,0.32187,0.019408,0.10616,0.0012163,KEGG_PPAR_SIGNALING_PATHWAY,0.535227
GSE25087_FETAL_VS_ADULT_TCON...2,SET,174,0.19071,0.018477,0.062985,0.0012329,GSE25087_FETAL_VS_ADULT_TCONV_UP,0.535227
GOMF_MHC_CLASS_I_RECEPTOR_AC...,SET,10,1.0726,0.025025,0.35444,0.0012402,GOMF_MHC_CLASS_I_RECEPTOR_ACTIVITY,0.535227
RODRIGUES_DCC_TARGETS_UP,SET,5,1.1007,0.018161,0.36487,0.0012797,RODRIGUES_DCC_TARGETS_UP,0.535227
GOBP_ADAPTIVE_IMMUNE_RESPONS...,SET,281,0.16399,0.020131,0.054394,0.0012876,GOBP_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS,0.535227
KEGG_MEDICUS_VARIANT_AMPLIFI...12,SET,11,0.74908,0.018329,0.24918,0.0013248,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_CELL_CYCLE_G1_S,0.535227
KEGG_MEDICUS_VARIANT_MUTATIO...22,SET,5,1.1759,0.019401,0.39239,0.0013669,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_USP8_TO_EGFR_ERK_ACTH_SIGNALING_PATHWAY,0.535227
KEGG_MEDICUS_REFERENCE_TLR1_...,SET,18,0.58102,0.018183,0.19401,0.0013753,KEGG_MEDICUS_REFERENCE_TLR1_2_4_NFKB_SIGNALING_PATHWAY,0.535227
HP_HIP_CONTRACTURE,SET,51,0.36316,0.019113,0.12129,0.0013782,HP_HIP_CONTRACTURE,0.535227
GAUTAM_EYE_IRIS_CILIARY_BODY...7,SET,88,0.29607,0.020448,0.099196,0.0014211,GAUTAM_EYE_IRIS_CILIARY_BODY_FIBROBLASTS,0.535227
WP_GLIAL_CELL_DIFFERENTIATION,SET,5,1.0859,0.017917,0.36412,0.0014325,WP_GLIAL_CELL_DIFFERENTIATION,0.535227
GOBP_TRNA_5_LEADER_REMOVAL,SET,11,0.67127,0.016425,0.22526,0.0014434,GOBP_TRNA_5_LEADER_REMOVAL,0.535227
HP_NEONATAL_SEIZURE,SET,8,0.88756,0.018522,0.29809,0.0014551,HP_NEONATAL_SEIZURE,0.535227
KEGG_MEDICUS_REFERENCE_EGF_E...6,SET,14,0.68885,0.019014,0.23141,0.0014588,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY,0.535227
MIR3126_3P,SET,43,0.38232,0.01848,0.12847,0.0014627,MIR3126_3P,0.535227
REACTOME_UNWINDING_OF_DNA,SET,12,0.68463,0.017497,0.23054,0.0014927,REACTOME_UNWINDING_OF_DNA,0.535227
GAVISH_3CA_METAPROGRAM_MACRO...2,SET,47,0.38344,0.019375,0.12912,0.0014928,GAVISH_3CA_METAPROGRAM_MACROPHAGES_INTERFERON,0.535227
REACTOME_DEFECTIVE_B4GALT1_C...,SET,8,0.87794,0.018322,0.29569,0.0014953,REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D,0.535227
GOBP_MYD88_INDEPENDENT_TOLL_...,SET,16,0.57786,0.017051,0.19488,0.0015143,GOBP_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.535227
ZHANG_ANTIVIRAL_RESPONSE_TO_...2,SET,24,0.53696,0.019401,0.18126,0.0015285,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,0.535227
GOBP_REGULATION_OF_B_CELL_ME...,SET,52,0.34461,0.018313,0.11641,0.001539,GOBP_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.535227
SASAI_TARGETS_OF_CXCR6_AND_P...1,SET,8,0.87119,0.018181,0.2943,0.0015392,SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN,0.535227
GOBP_STRESS_ACTIVATED_PROTEI...,SET,52,0.3437,0.018265,0.11613,0.0015417,GOBP_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.535227
GSE34156_UNTREATED_VS_24H_NO...4,SET,150,0.20387,0.018352,0.068968,0.0015599,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_UP,0.535227
GOBP_INTRACELLULAR_MAGNESIUM...,SET,3,1.4189,0.018136,0.48083,0.0015861,GOBP_INTRACELLULAR_MAGNESIUM_ION_HOMEOSTASIS,0.535227
GOMF_RETINOIC_ACID_RESPONSIV...,SET,6,0.97287,0.017584,0.33003,0.0016021,GOMF_RETINOIC_ACID_RESPONSIVE_ELEMENT_BINDING,0.535227
HP_ELEVATED_URINARY_NOREPINE...,SET,18,0.49941,0.015629,0.1697,0.0016277,HP_ELEVATED_URINARY_NOREPINEPHRINE_LEVEL,0.535227
MODULE_484,SET,39,0.37717,0.017364,0.12825,0.0016391,MODULE_484,0.535227
REACTOME_SLC15A4_TASL_DEPEND...,SET,4,1.0466,0.015446,0.35629,0.0016563,REACTOME_SLC15A4_TASL_DEPENDENT_IRF5_ACTIVATION,0.535227
ATXN7L3_TARGET_GENES,SET,514,0.1113,0.018359,0.037902,0.0016623,ATXN7L3_TARGET_GENES,0.535227
GSE11864_CSF1_IFNG_VS_CSF1_P...1,SET,161,0.1944,0.018124,0.066206,0.0016632,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN,0.535227
KEGG_MEDICUS_REFERENCE_ORIGI...,SET,29,0.41666,0.016546,0.14232,0.0017098,KEGG_MEDICUS_REFERENCE_ORIGIN_UNWINDING_AND_ELONGATION,0.545175220183486
GSE10325_LUPUS_BCELL_VS_LUPU...2,SET,161,0.19275,0.01797,0.065971,0.0017429,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP,0.54717403125
GOBP_ERBB2_EGFR_SIGNALING_PA...,SET,8,0.97962,0.020444,0.33547,0.0017515,GOBP_ERBB2_EGFR_SIGNALING_PATHWAY,0.54717403125
GOBP_MYELOID_LEUKOCYTE_DIFFE...,SET,218,0.17995,0.019491,0.061666,0.0017633,GOBP_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.54717403125
MYLLYKANGAS_AMPLIFICATION_HO...15,SET,6,1.0114,0.01828,0.34803,0.0018324,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5,0.552784711111111
KEGG_MEDICUS_VARIANT_ERBB2_O...1,SET,7,1.0005,0.019531,0.34553,0.0018957,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY,0.552784711111111
HP_ABNORMAL_PERIAURICULAR_RE...,SET,95,0.25101,0.018008,0.086732,0.001904,HP_ABNORMAL_PERIAURICULAR_REGION_MORPHOLOGY,0.552784711111111
AIZARANI_LIVER_C22_RESIDENT_...,SET,26,0.47123,0.01772,0.16293,0.0019151,AIZARANI_LIVER_C22_RESIDENT_B_CELLS_2,0.552784711111111
GSE1925_CTRL_VS_IFNG_PRIMED_...6,SET,189,0.18248,0.018419,0.063107,0.0019186,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP,0.552784711111111
HP_MITRAL_VALVE_PROLAPSE,SET,103,0.24202,0.018076,0.083765,0.001933,HP_MITRAL_VALVE_PROLAPSE,0.552784711111111
HP_PENILE_FRECKLING,SET,5,0.90786,0.014979,0.31425,0.0019351,HP_PENILE_FRECKLING,0.552784711111111
GAVISH_3CA_METAPROGRAM_MACRO...9,SET,46,0.33461,0.016727,0.11606,0.0019716,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MYC_MITOCHONDRIA,0.552784711111111
GOBP_GDP_METABOLIC_PROCESS,SET,9,0.80998,0.017928,0.28133,0.0019965,GOBP_GDP_METABOLIC_PROCESS,0.552784711111111
GSE35685_CD34POS_CD10NEG_CD6...1,SET,190,0.17961,0.018176,0.062386,0.001997,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN,0.552784711111111
GSE3982_MAC_VS_TH2_UP,SET,181,0.18336,0.018116,0.063711,0.0020031,GSE3982_MAC_VS_TH2_UP,0.552784711111111
HP_DISTAL_MUSCLE_WEAKNESS,SET,205,0.16354,0.017183,0.05687,0.0020184,HP_DISTAL_MUSCLE_WEAKNESS,0.552784711111111
HP_CHRONIC_ORAL_CANDIDIASIS,SET,26,0.4632,0.017418,0.16114,0.0020263,HP_CHRONIC_ORAL_CANDIDIASIS,0.552784711111111
DESERT_EXTRACELLULAR_MATRIX_...,SET,19,0.59768,0.019216,0.20812,0.0020427,DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.552784711111111
GSE15624_3H_VS_6H_HALOFUGINO...2,SET,159,0.18806,0.017424,0.06549,0.0020446,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.552784711111111
WP_PHOTODYNAMIC_THERAPYINDUC...3,SET,23,0.57134,0.020209,0.19916,0.0020631,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,0.552784711111111
GSE28726_NAIVE_CD4_TCELL_VS_...2,SET,188,0.17038,0.017152,0.059433,0.0020762,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP,0.552784711111111
GOBP_AMINOGLYCAN_BIOSYNTHETI...,SET,74,0.28089,0.017796,0.098014,0.0020822,GOBP_AMINOGLYCAN_BIOSYNTHETIC_PROCESS,0.552784711111111
GOMF_DIACYLGLYCEROL_DEPENDEN...,SET,16,0.61,0.017999,0.21316,0.0021093,GOMF_DIACYLGLYCEROL_DEPENDENT_SERINE_THREONINE_KINASE_ACTIVITY,0.552784711111111
HP_ABNORMAL_FETAL_GASTROINTE...,SET,17,0.60345,0.018353,0.21093,0.0021147,HP_ABNORMAL_FETAL_GASTROINTESTINAL_SYSTEM_MORPHOLOGY,0.552784711111111
BIOCARTA_ION_PATHWAY,SET,5,1.0342,0.017064,0.36187,0.0021342,BIOCARTA_ION_PATHWAY,0.552784711111111
ZNF774_TARGET_GENES,SET,19,0.54604,0.017556,0.19113,0.0021411,ZNF774_TARGET_GENES,0.552784711111111
HP_IMPAIRED_COLLAGEN_INDUCED...,SET,16,0.55378,0.01634,0.1939,0.0021472,HP_IMPAIRED_COLLAGEN_INDUCED_PLATELET_AGGREGATION,0.552784711111111
GSE16385_ROSIGLITAZONE_IFNG_...1,SET,174,0.181,0.017536,0.063466,0.002176,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,0.55608
WP_PPAR_SIGNALING,SET,66,0.30254,0.018106,0.10618,0.002194,WP_PPAR_SIGNALING,0.556587372262774
HP_PARAGANGLIOMA,SET,19,0.46884,0.015074,0.16484,0.0022287,HP_PARAGANGLIOMA,0.56129325
HP_ABNORMAL_PEER_RELATIONSHI...,SET,6,0.94682,0.017113,0.33353,0.0022672,HP_ABNORMAL_PEER_RELATIONSHIPS,0.562439806701031
GSE17721_PAM3CSK4_VS_GADIQUI...18,SET,168,0.17736,0.016887,0.062489,0.0022708,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_UP,0.562439806701031
PAX7_TARGET_GENES,SET,514,0.10566,0.01743,0.037316,0.0023186,PAX7_TARGET_GENES,0.562439806701031
RICKMAN_METASTASIS_UP,SET,273,0.14408,0.017438,0.050928,0.0023362,RICKMAN_METASTASIS_UP,0.562439806701031
GSE45739_NRAS_KO_VS_WT_UNSTI...2,SET,177,0.17808,0.017401,0.062969,0.0023437,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_UP,0.562439806701031
REACTOME_TAK1_DEPENDENT_IKK_...,SET,40,0.36458,0.016998,0.12896,0.0023506,REACTOME_TAK1_DEPENDENT_IKK_AND_NF_KAPPA_B_ACTIVATION,0.562439806701031
HP_EVERSION_OF_LATERAL_THIRD...,SET,4,0.90416,0.013344,0.31998,0.0023615,HP_EVERSION_OF_LATERAL_THIRD_OF_LOWER_EYELIDS,0.562439806701031
WAMUNYOKOLI_OVARIAN_CANCER_L...2,SET,254,0.15062,0.017592,0.053387,0.0023944,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,0.562439806701031
GOBP_POSITIVE_REGULATION_OF_...195,SET,23,0.51327,0.018155,0.182,0.0024025,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,0.562439806701031
HP_UNUSUAL_FUNGAL_INFECTION,SET,103,0.23705,0.017705,0.084094,0.0024125,HP_UNUSUAL_FUNGAL_INFECTION,0.562439806701031
GOBP_HEPARIN_METABOLIC_PROCE...,SET,17,0.60453,0.018386,0.2148,0.002446,GOBP_HEPARIN_METABOLIC_PROCESS,0.562439806701031
MIR1237_5P_MIR4488,SET,12,0.74162,0.018953,0.26365,0.0024573,MIR1237_5P_MIR4488,0.562439806701031
ZHONG_PFC_C6_PLXNA4_POS_EXCI...,SET,6,1.0432,0.018855,0.37159,0.0024995,ZHONG_PFC_C6_PLXNA4_POS_EXCITATORY_NEURON,0.562439806701031
LI_CISPLATIN_RESISTANCE_DN,SET,28,0.49895,0.01947,0.17785,0.0025147,LI_CISPLATIN_RESISTANCE_DN,0.562439806701031
GOBP_TONIC_SMOOTH_MUSCLE_CON...,SET,11,0.81511,0.019945,0.29126,0.0025697,GOBP_TONIC_SMOOTH_MUSCLE_CONTRACTION,0.562439806701031
COLIN_PILOCYTIC_ASTROCYTOMA_...1,SET,26,0.51653,0.019423,0.18462,0.002575,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,0.562439806701031
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...4,SET,7,0.954,0.018624,0.34114,0.0025854,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_DN,0.562439806701031
HP_PREMATURE_SKIN_WRINKLING,SET,61,0.29718,0.017101,0.10629,0.0025903,HP_PREMATURE_SKIN_WRINKLING,0.562439806701031
GSE3982_MAC_VS_BCELL_UP,SET,178,0.17445,0.017093,0.06248,0.0026219,GSE3982_MAC_VS_BCELL_UP,0.562439806701031
GAVISH_3CA_METAPROGRAM_CD8_T...9,SET,40,0.37617,0.017539,0.13476,0.0026262,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_2,0.562439806701031
HP_INGUINAL_FRECKLING,SET,6,0.80073,0.014472,0.2871,0.0026462,HP_INGUINAL_FRECKLING,0.562439806701031
GOBP_POSITIVE_REGULATION_OF_...59,SET,5,1.2137,0.020025,0.43555,0.0026669,GOBP_POSITIVE_REGULATION_OF_BLOOD_BRAIN_BARRIER_PERMEABILITY,0.562439806701031
GOMF_PROTEIN_PHOSPHATASE_2B_...,SET,6,0.83837,0.015153,0.30128,0.0026984,GOMF_PROTEIN_PHOSPHATASE_2B_BINDING,0.562439806701031
GSE46242_CTRL_VS_EGR2_DELETE...3,SET,161,0.18717,0.01745,0.067276,0.0027028,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN,0.562439806701031
GOMF_INHIBITORY_MHC_CLASS_I_...,SET,8,1.1898,0.024829,0.42805,0.0027248,GOMF_INHIBITORY_MHC_CLASS_I_RECEPTOR_ACTIVITY,0.562439806701031
GOMF_GUANYLATE_KINASE_ACTIVI...,SET,7,0.86411,0.016869,0.31089,0.0027251,GOMF_GUANYLATE_KINASE_ACTIVITY,0.562439806701031
HP_SEMANTIC_DEMENTIA,SET,6,0.95742,0.017304,0.34452,0.0027293,HP_SEMANTIC_DEMENTIA,0.562439806701031
GSE15659_NONSUPPRESSIVE_TCEL...1,SET,170,0.17514,0.016774,0.063095,0.0027557,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN,0.562439806701031
MIR4666B,SET,111,0.23534,0.018243,0.084814,0.0027648,MIR4666B,0.562439806701031
KEGG_MEDICUS_REFERENCE_P15_C...,SET,13,0.62202,0.016545,0.22433,0.0027815,KEGG_MEDICUS_REFERENCE_P15_CELL_CYCLE_G1_S,0.562439806701031
MIR328_5P,SET,53,0.31342,0.016815,0.11308,0.002791,MIR328_5P,0.562439806701031
GSE2585_THYMIC_MACROPHAGE_VS...2,SET,173,0.17531,0.016936,0.063259,0.002795,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_UP,0.562439806701031
GOBP_REGULATION_OF_ERYTHROCY...,SET,42,0.36597,0.017483,0.13206,0.0027955,GOBP_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,0.562439806701031
KEGG_PROSTATE_CANCER,SET,86,0.24957,0.01704,0.090117,0.0028111,KEGG_PROSTATE_CANCER,0.562439806701031
MIR6761_5P,SET,108,0.22471,0.017183,0.081186,0.0028246,MIR6761_5P,0.562439806701031
FRANCO_BLOOD_SANOFI_PASTEUR_...3,SET,24,0.48862,0.017654,0.17695,0.0028808,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_NEGATIVE,0.562439806701031
GSE23568_ID3_KO_VS_WT_CD8_TC...1,SET,185,0.17372,0.017349,0.062924,0.0028864,GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN,0.562439806701031
GOBP_METAPHASE_ANAPHASE_TRAN...,SET,6,0.94286,0.017041,0.34164,0.0028952,GOBP_METAPHASE_ANAPHASE_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.562439806701031
GOBP_REGULATION_OF_BONE_REMO...,SET,50,0.35757,0.018634,0.12963,0.0029064,GOBP_REGULATION_OF_BONE_REMODELING,0.562439806701031
KEGG_MEDICUS_VARIANT_MUTATIO...83,SET,8,0.84672,0.01767,0.30699,0.0029099,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,0.562439806701031
REACTOME_GLYCOSAMINOGLYCAN_M...,SET,120,0.21503,0.017327,0.078044,0.0029348,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,0.562439806701031
GOBP_NEGATIVE_REGULATION_OF_...19,SET,5,1.0067,0.01661,0.36598,0.0029768,GOBP_NEGATIVE_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.562439806701031
MIR4329,SET,70,0.27531,0.016967,0.10011,0.0029818,MIR4329,0.562439806701031
AIZARANI_LIVER_C18_NK_NKT_CE...,SET,110,0.23661,0.018259,0.086075,0.0029932,AIZARANI_LIVER_C18_NK_NKT_CELLS_5,0.562439806701031
GOBP_POSITIVE_REGULATION_OF_...67,SET,19,0.55523,0.017852,0.202,0.0029945,GOBP_POSITIVE_REGULATION_OF_BONE_RESORPTION,0.562439806701031
GOMF_MYOSIN_II_BINDING,SET,11,0.68586,0.016782,0.24954,0.0029964,GOMF_MYOSIN_II_BINDING,0.562439806701031
GSE3982_EFF_MEMORY_CD4_TCELL...2,SET,179,0.17105,0.016807,0.06231,0.0030269,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP,0.562439806701031
GSE7852_TREG_VS_TCONV_FAT_DN,SET,183,0.16903,0.016791,0.061692,0.0030757,GSE7852_TREG_VS_TCONV_FAT_DN,0.562439806701031
GOBP_POSITIVE_REGULATION_OF_...186,SET,76,0.27473,0.017638,0.1003,0.003084,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.562439806701031
HP_BIFID_NASAL_TIP,SET,13,0.61746,0.016424,0.22563,0.0031072,HP_BIFID_NASAL_TIP,0.562439806701031
E2F_Q3,SET,196,0.15879,0.016319,0.058028,0.0031079,E2F_Q3,0.562439806701031
GAUSSMANN_MLL_AF4_FUSION_TAR...14,SET,219,0.1597,0.017337,0.058371,0.0031129,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,0.562439806701031
PEDRIOLI_MIR31_TARGETS_DN,SET,367,0.12339,0.017269,0.045113,0.0031217,PEDRIOLI_MIR31_TARGETS_DN,0.562439806701031
REACTOME_EGFR_INTERACTS_WITH...,SET,9,0.84303,0.01866,0.30843,0.0031386,REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA,0.562439806701031
REACTOME_ATF6_ATF6_ALPHA_ACT...2,SET,10,0.65097,0.015188,0.23817,0.0031388,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES,0.562439806701031
HASLINGER_B_CLL_WITH_17P13_D...,SET,20,0.49428,0.016305,0.18085,0.0031395,HASLINGER_B_CLL_WITH_17P13_DELETION,0.562439806701031
GOBP_REGULATION_OF_TRANSCRIP...2,SET,39,0.32002,0.014733,0.11727,0.0031808,GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.566916430769231
REACTOME_CYTOSOLIC_SENSORS_O...,SET,57,0.29439,0.016377,0.10797,0.0032021,REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,0.567800946428571
GOBP_AXON_MIDLINE_CHOICE_POI...,SET,5,1.3035,0.021507,0.47884,0.0032464,GOBP_AXON_MIDLINE_CHOICE_POINT_RECOGNITION,0.570017106060606
HP_HAIR_FOLLICLE_NEOPLASM,SET,5,1.2394,0.020451,0.45534,0.0032474,HP_HAIR_FOLLICLE_NEOPLASM,0.570017106060606
HP_ABNORMALITY_OF_FACIAL_ADI...,SET,10,0.73872,0.017235,0.27179,0.0032872,HP_ABNORMALITY_OF_FACIAL_ADIPOSE_TISSUE,0.574103698492462
KEGG_MEDICUS_VARIANT_MUTATIO...4,SET,13,0.64441,0.017141,0.23777,0.0033649,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY,0.575749532327586
GOBP_CORTICAL_ACTIN_CYTOSKEL...,SET,42,0.33539,0.016022,0.12378,0.0033716,GOBP_CORTICAL_ACTIN_CYTOSKELETON_ORGANIZATION,0.575749532327586
chr2q13,SET,14,0.90162,0.024887,0.33283,0.0033779,chr2q13,0.575749532327586
MIR224_5P,SET,164,0.17657,0.016613,0.065225,0.0033969,MIR224_5P,0.575749532327586
GAVISH_3CA_MALIGNANT_METAPRO...38,SET,46,0.30073,0.015034,0.11135,0.0034625,GAVISH_3CA_MALIGNANT_METAPROGRAM_8_PROTEASOMAL_DEGRADATION,0.575749532327586
SHEPARD_BMYB_MORPHOLINO_DN,SET,187,0.16727,0.016794,0.061974,0.003481,SHEPARD_BMYB_MORPHOLINO_DN,0.575749532327586
HP_CONGENITAL_HIP_DISLOCATION,SET,68,0.27489,0.016698,0.10191,0.0034972,HP_CONGENITAL_HIP_DISLOCATION,0.575749532327586
GSE6269_FLU_VS_STREP_PNEUMO_...1,SET,146,0.18563,0.016487,0.06889,0.0035277,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN,0.575749532327586
HP_ANTERIOR_OPEN_BITE_MALOCC...,SET,14,0.64363,0.017766,0.23909,0.0035542,HP_ANTERIOR_OPEN_BITE_MALOCCLUSION,0.575749532327586
UROSEVIC_RESPONSE_TO_IMIQUIM...,SET,18,0.55642,0.017413,0.20693,0.0035874,UROSEVIC_RESPONSE_TO_IMIQUIMOD,0.575749532327586
GOMF_ISOPRENOID_BINDING,SET,42,0.41396,0.019776,0.15399,0.0035944,GOMF_ISOPRENOID_BINDING,0.575749532327586
GSE40225_WT_VS_RIP_B7X_DIABE...2,SET,167,0.16815,0.015964,0.062554,0.0035957,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP,0.575749532327586
KEGG_MEDICUS_REFERENCE_CARDI...,SET,21,0.53301,0.018015,0.19832,0.0036023,KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING,0.575749532327586
HP_GENERALIZED_MYOCLONIC_ATO...,SET,9,0.72886,0.016133,0.27123,0.0036061,HP_GENERALIZED_MYOCLONIC_ATONIC_SEIZURE,0.575749532327586
PUJANA_BREAST_CANCER_LIT_INT...,SET,91,0.21897,0.015377,0.081518,0.0036173,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,0.575749532327586
GSE13229_IMM_VS_MATURE_NKCEL...2,SET,181,0.16621,0.016421,0.061898,0.0036277,GSE13229_IMM_VS_MATURE_NKCELL_UP,0.575749532327586
GOBP_REGULATION_OF_MYELOID_C...2,SET,186,0.17474,0.017498,0.065106,0.0036412,GOBP_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.575749532327586
GOBP_CENTRAL_NERVOUS_SYSTEM_...4,SET,4,1.27,0.018743,0.4739,0.0036856,GOBP_CENTRAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE,0.575749532327586
GSE16266_CTRL_VS_HEATSHOCK_A...1,SET,186,0.16033,0.016055,0.059832,0.0036888,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,0.575749532327586
HP_DECREASED_FACIAL_EXPRESSI...,SET,126,0.2045,0.016883,0.07635,0.0037015,HP_DECREASED_FACIAL_EXPRESSION,0.575749532327586
REACTOME_RHO_GTPASE_EFFECTORS,SET,244,0.14277,0.016348,0.053337,0.0037214,REACTOME_RHO_GTPASE_EFFECTORS,0.575749532327586
GOBP_PURINE_NUCLEOSIDE_TRANS...,SET,5,0.98168,0.016197,0.36687,0.0037312,GOBP_PURINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT,0.575749532327586
HP_RECURRENT_CUTANEOUS_FUNGA...,SET,53,0.31098,0.016684,0.11623,0.0037337,HP_RECURRENT_CUTANEOUS_FUNGAL_INFECTIONS,0.575749532327586
PYEON_HPV_POSITIVE_TUMORS_DN,SET,8,0.88729,0.018517,0.33179,0.0037482,PYEON_HPV_POSITIVE_TUMORS_DN,0.575749532327586
GOBP_NEGATIVE_REGULATION_OF_...449,SET,3,1.399,0.017881,0.52326,0.0037552,GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,0.575749532327586
MIR6729_3P,SET,63,0.27472,0.016065,0.10277,0.0037599,MIR6729_3P,0.575749532327586
NAKAMURA_METASTASIS_MODEL_UP,SET,39,0.33277,0.01532,0.12459,0.0037846,NAKAMURA_METASTASIS_MODEL_UP,0.575749532327586
RUBENSTEIN_SKELETAL_MUSCLE_F...1,SET,154,0.19126,0.017442,0.071687,0.003819,RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS,0.575749532327586
GSE22886_DAY0_VS_DAY7_MONOCY...2,SET,176,0.169,0.016467,0.063352,0.0038219,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP,0.575749532327586
GSE29618_BCELL_VS_MONOCYTE_UP,SET,160,0.18684,0.017365,0.070067,0.0038353,GSE29618_BCELL_VS_MONOCYTE_UP,0.575749532327586
GSE22935_UNSTIM_VS_48H_MBOVI...4,SET,179,0.16483,0.016195,0.061826,0.0038408,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.575749532327586
HP_PILL_ROLLING_TREMOR,SET,4,1.2118,0.017884,0.45453,0.003841,HP_PILL_ROLLING_TREMOR,0.575749532327586
HP_HEPATIC_ENCEPHALOPATHY,SET,19,0.57953,0.018633,0.21739,0.0038433,HP_HEPATIC_ENCEPHALOPATHY,0.575749532327586
HOWARD_NEUTROPHIL_INACT_MONO...2,SET,358,0.12739,0.017614,0.047848,0.0038821,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.579066032188841
HP_CAVERNOUS_HEMANGIOMA,SET,33,0.36816,0.015594,0.1384,0.0039085,HP_CAVERNOUS_HEMANGIOMA,0.580512467948718
KAMIKUBO_MYELOID_CEBPA_NETWO...,SET,27,0.46451,0.0178,0.17472,0.0039275,KAMIKUBO_MYELOID_CEBPA_NETWORK,0.580852180851064
GOMF_MRNA_CDS_BINDING,SET,3,1.2245,0.015651,0.46131,0.0039757,GOMF_MRNA_CDS_BINDING,0.583124647058823
GOBP_MUCOPOLYSACCHARIDE_META...,SET,86,0.24406,0.016664,0.091984,0.0039893,GOBP_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS,0.583124647058823
GOBP_LYMPHOCYTE_MEDIATED_IMM...,SET,267,0.14933,0.017876,0.056287,0.0039932,GOBP_LYMPHOCYTE_MEDIATED_IMMUNITY,0.583124647058823
MIR145_3P,SET,64,0.28499,0.016796,0.10757,0.0040375,MIR145_3P,0.587126830543933
MIR7515,SET,142,0.18339,0.016066,0.069295,0.0040693,MIR7515,0.58928550625
HP_INAPPROPRIATE_CRYING,SET,14,0.58123,0.016044,0.21989,0.0041092,HP_INAPPROPRIATE_CRYING,0.5893455
RUBENSTEIN_SKELETAL_MUSCLE_M...,SET,306,0.12602,0.016133,0.047692,0.0041197,RUBENSTEIN_SKELETAL_MUSCLE_MYELOID_CELLS,0.5893455
REACTOME_CIPROFLOXACIN_ADME,SET,5,1.0118,0.016694,0.38322,0.0041461,REACTOME_CIPROFLOXACIN_ADME,0.5893455
HP_ACCELERATED_ATHEROSCLEROS...,SET,7,0.77933,0.015214,0.29518,0.0041464,HP_ACCELERATED_ATHEROSCLEROSIS,0.5893455
GOBP_NEGATIVE_REGULATION_OF_...152,SET,8,0.92355,0.019274,0.34989,0.0041545,GOBP_NEGATIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.5893455
AIZARANI_LIVER_C21_STELLATE_...,SET,176,0.18549,0.018074,0.070328,0.0041793,AIZARANI_LIVER_C21_STELLATE_CELLS_1,0.589619189045936
GOMF_CONNEXIN_BINDING,SET,5,1.1199,0.018478,0.42499,0.0042087,GOMF_CONNEXIN_BINDING,0.589619189045936
chr8p21,SET,79,0.51576,0.033758,0.19579,0.0042208,chr8p21,0.589619189045936
GOMF_TRNA_SPECIFIC_RIBONUCLE...,SET,13,0.61712,0.016415,0.23444,0.0042442,GOMF_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY,0.589619189045936
GSE9988_LPS_VS_VEHICLE_TREAT...2,SET,162,0.1876,0.017543,0.0713,0.0042594,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,0.589619189045936
GOMF_DNA_INSERTION_OR_DELETI...,SET,6,0.65599,0.011856,0.24972,0.0043127,GOMF_DNA_INSERTION_OR_DELETION_BINDING,0.589619189045936
HP_ABNORMAL_SYSTEMIC_BLOOD_P...,SET,487,0.10342,0.016618,0.039383,0.0043229,HP_ABNORMAL_SYSTEMIC_BLOOD_PRESSURE,0.589619189045936
HP_ABNORMALITY_OF_FACIAL_SOF...,SET,458,0.10464,0.01632,0.039874,0.0043444,HP_ABNORMALITY_OF_FACIAL_SOFT_TISSUE,0.589619189045936
DOANE_BREAST_CANCER_ESR1_DN,SET,42,0.37469,0.0179,0.14281,0.0043528,DOANE_BREAST_CANCER_ESR1_DN,0.589619189045936
MIR4697_5P,SET,14,0.64968,0.017933,0.24793,0.0043941,MIR4697_5P,0.589619189045936
GOCC_RDNA_HETEROCHROMATIN,SET,3,1.0528,0.013457,0.40197,0.0044103,GOCC_RDNA_HETEROCHROMATIN,0.589619189045936
GOBP_T_HELPER_17_TYPE_IMMUNE...,SET,45,0.35306,0.017457,0.13486,0.0044261,GOBP_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.589619189045936
HP_WEAK_VOICE,SET,24,0.41022,0.014821,0.15674,0.0044361,HP_WEAK_VOICE,0.589619189045936
VERRECCHIA_RESPONSE_TO_TGFB1...2,SET,19,0.57524,0.018495,0.21991,0.0044553,VERRECCHIA_RESPONSE_TO_TGFB1_C2,0.589619189045936
GSE17721_LPS_VS_PAM3CSK4_16H...2,SET,190,0.15561,0.015747,0.059498,0.0044604,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_UP,0.589619189045936
REACTOME_RNA_POLYMERASE_III_...5,SET,21,0.43769,0.014794,0.16736,0.0044608,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION,0.589619189045936
HP_PSEUDOBULBAR_SIGNS,SET,28,0.39842,0.015547,0.15256,0.0045105,HP_PSEUDOBULBAR_SIGNS,0.589619189045936
AIZARANI_LIVER_C34_MHC_II_PO...,SET,118,0.21121,0.016877,0.080881,0.0045133,AIZARANI_LIVER_C34_MHC_II_POS_B_CELLS,0.589619189045936
WAMUNYOKOLI_OVARIAN_CANCER_G...2,SET,125,0.20004,0.016449,0.076606,0.0045134,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,0.589619189045936
GOBP_REGULATION_OF_ADAPTIVE_...,SET,191,0.17038,0.017287,0.065261,0.004521,GOBP_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,0.589619189045936
GSE3920_UNTREATED_VS_IFNG_TR...3,SET,166,0.17274,0.01635,0.066274,0.0045781,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN,0.589619189045936
GOBP_TRIF_DEPENDENT_TOLL_LIK...,SET,11,0.60602,0.014829,0.23264,0.0045985,GOBP_TRIF_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.589619189045936
KEGG_MEDICUS_REFERENCE_IL12_...,SET,10,0.79488,0.018545,0.30537,0.0046244,KEGG_MEDICUS_REFERENCE_IL12_23_TO_JAK_STAT_SIGNALING_PATHWAY,0.589619189045936
GAVISH_3CA_METAPROGRAM_EPITH...9,SET,49,0.33464,0.017264,0.12857,0.0046266,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI4,0.589619189045936
GOBP_POSITIVE_REGULATION_OF_...592,SET,97,0.22653,0.016421,0.087131,0.004667,GOBP_POSITIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY,0.589619189045936
GSE26351_UNSTIM_VS_BMP_PATHW...1,SET,176,0.16197,0.015782,0.062303,0.0046689,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,0.589619189045936
WP_EXERCISEINDUCED_CIRCADIAN...,SET,46,0.3289,0.016442,0.12656,0.0046822,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,0.589619189045936
HP_RETINAL_HAMARTOMA,SET,22,0.40747,0.014096,0.15688,0.0047009,HP_RETINAL_HAMARTOMA,0.589619189045936
HP_ABNORMAL_ENDOCARDIUM_MORP...,SET,54,0.31272,0.016934,0.1204,0.0047013,HP_ABNORMAL_ENDOCARDIUM_MORPHOLOGY,0.589619189045936
GOBP_POSITIVE_REGULATION_OF_...257,SET,29,0.43463,0.017259,0.16746,0.0047275,GOBP_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,0.589619189045936
GOBP_CELLULAR_RESPONSE_TO_AC...1,SET,14,0.59004,0.016287,0.22737,0.0047332,GOBP_CELLULAR_RESPONSE_TO_ACIDIC_PH,0.589619189045936
GOBP_CILIARY_BASAL_BODY_ORGA...,SET,5,0.95664,0.015784,0.36876,0.0047443,GOBP_CILIARY_BASAL_BODY_ORGANIZATION,0.589619189045936
MIR493_3P,SET,61,0.27091,0.015589,0.10445,0.0047503,MIR493_3P,0.589619189045936
GSE24634_TEFF_VS_TCONV_DAY10...1,SET,185,0.16659,0.016638,0.064238,0.0047556,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN,0.589619189045936
GSE34205_HEALTHY_VS_RSV_INF_...2,SET,168,0.16233,0.015457,0.062652,0.0047883,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP,0.589619189045936
GSE32034_LY6C_HIGH_VS_LOW_RO...2,SET,183,0.15493,0.01539,0.059814,0.0047995,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_UP,0.589619189045936
GSE15659_NAIVE_VS_PTPRC_NEG_...1,SET,170,0.1693,0.016215,0.065364,0.0048004,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN,0.589619189045936
GSE360_L_DONOVANI_VS_M_TUBER...1,SET,183,0.1579,0.015685,0.060961,0.0048011,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN,0.589619189045936
WP_OSTEOPONTIN_SIGNALING,SET,13,0.56075,0.014915,0.21689,0.0048667,WP_OSTEOPONTIN_SIGNALING,0.593343092783505
HP_RECURRENT_PAROXYSMAL_HEAD...,SET,18,0.4391,0.013742,0.16995,0.0048923,HP_RECURRENT_PAROXYSMAL_HEADACHE,0.593343092783505
HP_SECOND_TRIMESTER_ONSET,SET,41,0.33121,0.015634,0.12827,0.0049147,HP_SECOND_TRIMESTER_ONSET,0.593343092783505
HP_ABNORMAL_PLATELET_AGGREGA...,SET,39,0.33499,0.015423,0.12977,0.0049247,HP_ABNORMAL_PLATELET_AGGREGATION,0.593343092783505
GOBP_REGULATION_OF_MRNA_3_EN...,SET,9,0.65029,0.014394,0.25215,0.0049587,GOBP_REGULATION_OF_MRNA_3_END_PROCESSING,0.593343092783505
HP_VERTIGO,SET,136,0.19126,0.0164,0.074177,0.0049657,HP_VERTIGO,0.593343092783505
GOMF_PROTEIN_DISULFIDE_ISOME...,SET,21,0.48266,0.016314,0.18719,0.0049665,GOMF_PROTEIN_DISULFIDE_ISOMERASE_ACTIVITY,0.593343092783505
ZIRN_TRETINOIN_RESPONSE_WT1_...1,SET,5,1.015,0.016747,0.39365,0.004968,ZIRN_TRETINOIN_RESPONSE_WT1_DN,0.593343092783505
GSE46606_IRF4HIGH_VS_WT_CD40...2,SET,177,0.1555,0.015194,0.060382,0.0050128,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.596643369863014
GOCC_DNA_REPLICATION_PREINIT...,SET,13,0.58763,0.015631,0.2283,0.005031,GOCC_DNA_REPLICATION_PREINITIATION_COMPLEX,0.596765887372014
SOBOLEV_PBMC_PANDEMRIX_AGE_1...4,SET,18,0.58126,0.01819,0.22598,0.0050567,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP,0.596890616949153
SREBP1_02,SET,79,0.22798,0.014922,0.088654,0.0050664,SREBP1_02,0.596890616949153
STK33_SKM_UP,SET,229,0.14256,0.015821,0.055519,0.0051217,STK33_SKM_UP,0.59972448019802
GOBP_REGULATION_OF_T_HELPER_...3,SET,31,0.40417,0.016593,0.15757,0.0051632,GOBP_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.59972448019802
GOBP_REGULATION_OF_MYELOID_L...1,SET,116,0.2166,0.017162,0.084479,0.0051789,GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.59972448019802
GOBP_REGULATION_OF_MONOCYTE_...2,SET,18,0.54959,0.017199,0.2145,0.0052049,GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.59972448019802
WP_NRF2_PATHWAY,SET,133,0.20319,0.017231,0.079323,0.0052142,WP_NRF2_PATHWAY,0.59972448019802
GOBP_OSTEOCLAST_DIFFERENTIAT...,SET,100,0.24109,0.017743,0.094128,0.0052188,GOBP_OSTEOCLAST_DIFFERENTIATION,0.59972448019802
HP_ABNORMAL_MUSCLE_FIBER_MOR...,SET,233,0.13589,0.01521,0.053063,0.0052252,HP_ABNORMAL_MUSCLE_FIBER_MORPHOLOGY,0.59972448019802
HP_ELEVATED_URINARY_CATECHOL...,SET,27,0.38813,0.014873,0.15158,0.0052285,HP_ELEVATED_URINARY_CATECHOLAMINE_LEVEL,0.59972448019802
GSE40274_CTRL_VS_SATB1_TRANS...1,SET,151,0.17094,0.015438,0.066833,0.005272,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.602724868421053
HAY_BONE_MARROW_IMMATURE_NEU...,SET,173,0.17034,0.016457,0.066639,0.0052953,HAY_BONE_MARROW_IMMATURE_NEUTROPHIL,0.603403775409836
GSE15930_STIM_VS_STIM_AND_TR...1,SET,177,0.15404,0.015051,0.060321,0.005335,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN,0.604984446601942
HP_ABNORMAL_MONOCYTE_COUNT,SET,20,0.42525,0.014027,0.16662,0.0053571,HP_ABNORMAL_MONOCYTE_COUNT,0.604984446601942
LEE_BMP2_TARGETS_DN,SET,824,0.074015,0.015324,0.029006,0.0053638,LEE_BMP2_TARGETS_DN,0.604984446601942
GSE29618_BCELL_VS_MDC_DN,SET,183,0.16315,0.016207,0.063962,0.0053788,GSE29618_BCELL_VS_MDC_DN,0.604984446601942
GOCC_CBM_COMPLEX,SET,5,0.91555,0.015106,0.35924,0.0054128,GOCC_CBM_COMPLEX,0.605580891373802
WP_METAPATHWAY_BIOTRANSFORMA...,SET,173,0.18353,0.017731,0.072029,0.0054204,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,0.605580891373802
TRAVAGLINI_LUNG_CD4_NAIVE_T_...,SET,118,0.19952,0.015943,0.078341,0.0054405,TRAVAGLINI_LUNG_CD4_NAIVE_T_CELL,0.605580891373802
AR_01,SET,142,0.17975,0.015747,0.070605,0.0054538,AR_01,0.605580891373802
GOBP_FUCOSYLATION,SET,16,0.53941,0.015916,0.21225,0.005526,GOBP_FUCOSYLATION,0.608737103773585
GOBP_REGULATION_OF_CELLULAR_...19,SET,24,0.46536,0.016814,0.18319,0.0055406,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.608737103773585
GSE15330_HSC_VS_PRO_BCELL_UP,SET,176,0.15539,0.015141,0.061174,0.0055436,GSE15330_HSC_VS_PRO_BCELL_UP,0.608737103773585
MIR4303,SET,212,0.14823,0.015835,0.05837,0.0055555,MIR4303,0.608737103773585
PETROVA_PROX1_TARGETS_DN,SET,55,0.28854,0.015768,0.11366,0.0055698,PETROVA_PROX1_TARGETS_DN,0.608737103773585
GOCC_EXTERNAL_SIDE_OF_APICAL...,SET,6,0.89784,0.016228,0.35397,0.0056025,GOCC_EXTERNAL_SIDE_OF_APICAL_PLASMA_MEMBRANE,0.6093094546875
GSE29618_BCELL_VS_PDC_DAY7_F...2,SET,165,0.17613,0.016622,0.069453,0.0056101,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP,0.6093094546875
REACTOME_RECRUITMENT_OF_NUMA...,SET,87,0.21853,0.015007,0.086268,0.0056567,REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,0.611126739130435
GAVISH_3CA_MALIGNANT_METAPRO...39,SET,41,0.32385,0.015286,0.12786,0.005662,GAVISH_3CA_MALIGNANT_METAPROGRAM_9_UNFOLDED_PROTEIN_RESPONSE,0.611126739130435
WP_LNCRNA_IN_CANONICAL_WNT_S...,SET,89,0.23332,0.016205,0.092303,0.0057446,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,0.612536772493573
WP_GLYCOSAMINOGLYCAN_SYNTHES...,SET,39,0.33818,0.01557,0.1338,0.0057487,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,0.612536772493573
GSE17721_LPS_VS_CPG_24H_BMDC...2,SET,180,0.15559,0.01533,0.061622,0.0057901,GSE17721_LPS_VS_CPG_24H_BMDC_UP,0.612536772493573
GOBP_POSITIVE_REGULATION_OF_...517,SET,5,1.0606,0.017499,0.42006,0.0057916,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.612536772493573
GOBP_INNER_EAR_RECEPTOR_CELL...2,SET,4,1.129,0.016662,0.44719,0.0057958,GOBP_INNER_EAR_RECEPTOR_CELL_FATE_COMMITMENT,0.612536772493573
HP_HYPERTENSION,SET,355,0.11601,0.015975,0.045956,0.0057982,HP_HYPERTENSION,0.612536772493573
GOBP_MUCOCILIARY_CLEARANCE,SET,7,0.85573,0.016705,0.33908,0.0058116,GOBP_MUCOCILIARY_CLEARANCE,0.612536772493573
WP_MAMMARY_GLAND_DEVELOPMENT...3,SET,32,0.40896,0.017058,0.16249,0.0059239,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,0.612536772493573
GOBP_REGULATION_OF_TRANSCRIP...4,SET,11,0.535,0.013091,0.2126,0.0059311,GOBP_REGULATION_OF_TRANSCRIPTION_OF_NUCLEOLAR_LARGE_RRNA_BY_RNA_POLYMERASE_I,0.612536772493573
GOBP_POSITIVE_REGULATION_OF_...680,SET,10,0.76088,0.017752,0.30249,0.0059495,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,0.612536772493573
HP_PREMATURE_THELARCHE,SET,10,0.65654,0.015318,0.26127,0.005992,HP_PREMATURE_THELARCHE,0.612536772493573
GSE36078_UNTREATED_VS_AD5_T4...2,SET,177,0.15756,0.015396,0.06273,0.0060106,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_UP,0.612536772493573
GOMF_MOLECULAR_TAG_ACTIVITY,SET,11,0.65651,0.016064,0.26143,0.0060205,GOMF_MOLECULAR_TAG_ACTIVITY,0.612536772493573
MIR12115,SET,63,0.25262,0.014772,0.10067,0.0060516,MIR12115,0.612536772493573
EPPERT_LSC_R,SET,36,0.32504,0.014379,0.12954,0.0060534,EPPERT_LSC_R,0.612536772493573
GOBP_DETECTION_OF_MUSCLE_STR...,SET,7,0.85707,0.016732,0.34156,0.0060534,GOBP_DETECTION_OF_MUSCLE_STRETCH,0.612536772493573
HP_BRANCHIAL_CYST,SET,4,0.80692,0.011909,0.32159,0.0060551,HP_BRANCHIAL_CYST,0.612536772493573
HP_HYPOPLASTIC_PELVIS,SET,14,0.5813,0.016045,0.23168,0.0060573,HP_HYPOPLASTIC_PELVIS,0.612536772493573
GSE7219_UNSTIM_VS_LPS_AND_AN...3,SET,185,0.16029,0.016008,0.063886,0.0060585,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN,0.612536772493573
HP_ABNORMAL_LOWER_LIP_MORPHO...,SET,208,0.14876,0.015743,0.05929,0.0060586,HP_ABNORMAL_LOWER_LIP_MORPHOLOGY,0.612536772493573
HP_EPISODIC_HYPERHIDROSIS,SET,25,0.37532,0.01384,0.1496,0.0060605,HP_EPISODIC_HYPERHIDROSIS,0.612536772493573
HP_ABNORMAL_MESENTERY_MORPHO...,SET,4,0.86719,0.012798,0.34578,0.0060767,HP_ABNORMAL_MESENTERY_MORPHOLOGY,0.612536772493573
REACTOME_KERATAN_SULFATE_BIO...,SET,28,0.40471,0.015792,0.16149,0.0061085,REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,0.612536772493573
ACGCACA_MIR210,SET,8,0.71639,0.01495,0.28603,0.0061342,ACGCACA_MIR210,0.612536772493573
HP_SHOULDER_GIRDLE_MUSCLE_WE...,SET,50,0.28815,0.015016,0.11511,0.006156,HP_SHOULDER_GIRDLE_MUSCLE_WEAKNESS,0.612536772493573
GOBP_PULMONARY_ARTERY_MORPHO...,SET,6,0.96862,0.017507,0.38746,0.0062152,GOBP_PULMONARY_ARTERY_MORPHOGENESIS,0.612536772493573
CASORELLI_ACUTE_PROMYELOCYTI...2,SET,143,0.17946,0.015776,0.071791,0.0062173,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,0.612536772493573
HP_CORNEAL_DYSTROPHY,SET,29,0.42202,0.016759,0.16883,0.0062193,HP_CORNEAL_DYSTROPHY,0.612536772493573
GOLDRATH_NAIVE_VS_EFF_CD8_TC...2,SET,181,0.14851,0.014673,0.059444,0.0062426,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP,0.612536772493573
NAKAYA_PBMC_FLUMIST_AGE_18_5...6,SET,31,0.37306,0.015316,0.14957,0.0063152,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_UP,0.612536772493573
HP_NARROW_FACE,SET,83,0.24342,0.016329,0.097592,0.0063155,HP_NARROW_FACE,0.612536772493573
HP_MULTIPLE_IMPACTED_TEETH,SET,4,1.1931,0.017607,0.47842,0.0063244,HP_MULTIPLE_IMPACTED_TEETH,0.612536772493573
KEGG_MEDICUS_REFERENCE_NOD_N...,SET,8,0.64593,0.01348,0.2592,0.0063554,KEGG_MEDICUS_REFERENCE_NOD_NFKB_SIGNALING_PATHWAY,0.612536772493573
GOBP_NEGATIVE_REGULATION_OF_...386,SET,7,0.80698,0.015754,0.32385,0.0063582,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.612536772493573
HP_ARACHNOID_HEMANGIOMATOSIS,SET,16,0.4356,0.012853,0.17482,0.0063618,HP_ARACHNOID_HEMANGIOMATOSIS,0.612536772493573
HP_NEOPLASM_OF_THE_PERIPHERA...,SET,68,0.23826,0.014473,0.095634,0.006366,HP_NEOPLASM_OF_THE_PERIPHERAL_NERVOUS_SYSTEM,0.612536772493573
HP_ESOPHORIA,SET,5,0.86073,0.014202,0.3457,0.006395,HP_ESOPHORIA,0.612536772493573
KEGG_MEDICUS_ENV_FACTOR_BENZ...,SET,11,0.72481,0.017735,0.29119,0.0064077,KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM,0.612536772493573
REACTOME_NOD1_2_SIGNALING_PA...,SET,32,0.35404,0.014767,0.14231,0.0064311,REACTOME_NOD1_2_SIGNALING_PATHWAY,0.612536772493573
GOBP_IRES_DEPENDENT_VIRAL_TR...,SET,10,0.63767,0.014878,0.25638,0.0064412,GOBP_IRES_DEPENDENT_VIRAL_TRANSLATIONAL_INITIATION,0.612536772493573
BOWIE_RESPONSE_TO_EXTRACELLU...,SET,17,0.48521,0.014757,0.19512,0.0064503,BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,0.612536772493573
GOBP_POSITIVE_REGULATION_OF_...762,SET,3,1.5024,0.019203,0.6042,0.0064532,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.612536772493573
GOMF_CATALYTIC_ACTIVITY_ACTI...4,SET,109,0.18306,0.014063,0.073628,0.006458,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_TRNA,0.612536772493573
GSE3982_EOSINOPHIL_VS_TH2_UP,SET,174,0.15599,0.015113,0.062793,0.0064982,GSE3982_EOSINOPHIL_VS_TH2_UP,0.612536772493573
GOMF_TRANSFERASE_ACTIVITY_TR...5,SET,67,0.27279,0.016448,0.10982,0.0065026,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_SULPHUR_CONTAINING_GROUPS,0.612536772493573
LAKE_ADULT_KIDNEY_C15_CONNEC...,SET,156,0.18213,0.016716,0.073329,0.0065054,LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE,0.612536772493573
PID_ERBB_NETWORK_PATHWAY,SET,15,0.53327,0.015236,0.21479,0.0065232,PID_ERBB_NETWORK_PATHWAY,0.612536772493573
GOBP_POSITIVE_REGULATION_OF_...168,SET,27,0.40599,0.015557,0.16355,0.0065297,GOBP_POSITIVE_REGULATION_OF_CILIUM_ASSEMBLY,0.612536772493573
GOBP_AMINOGLYCAN_METABOLIC_P...,SET,116,0.19581,0.015514,0.079005,0.0066033,GOBP_AMINOGLYCAN_METABOLIC_PROCESS,0.612536772493573
HP_INFANTILE_SENSORINEURAL_H...,SET,5,0.93111,0.015363,0.37571,0.0066059,HP_INFANTILE_SENSORINEURAL_HEARING_IMPAIRMENT,0.612536772493573
GSE3982_MAC_VS_EFF_MEMORY_CD...2,SET,180,0.15406,0.015178,0.0622,0.0066335,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP,0.612536772493573
HP_FLUSHING,SET,45,0.29088,0.014383,0.1175,0.0066559,HP_FLUSHING,0.612536772493573
ZNF197_TARGET_GENES,SET,504,0.092864,0.015173,0.037515,0.0066589,ZNF197_TARGET_GENES,0.612536772493573
GNF2_CD48,SET,30,0.37618,0.015193,0.15205,0.0066829,GNF2_CD48,0.612536772493573
HP_TOTAL_OPHTHALMOPLEGIA,SET,5,0.86314,0.014242,0.34894,0.0066926,HP_TOTAL_OPHTHALMOPLEGIA,0.612536772493573
HP_RECURRENT_STAPHYLOCOCCAL_...,SET,32,0.38481,0.016051,0.15562,0.006707,HP_RECURRENT_STAPHYLOCOCCAL_INFECTIONS,0.612536772493573
GSE7219_WT_VS_NIK_NFKB2_KO_D...2,SET,175,0.1606,0.015604,0.064967,0.006723,GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP,0.612536772493573
GOBP_PURINE_NUCLEOSIDE_TRIPH...,SET,5,0.92271,0.015224,0.3734,0.0067399,GOBP_PURINE_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS,0.612536772493573
GSE2770_IL12_AND_TGFB_ACT_VS...3,SET,181,0.14902,0.014722,0.060336,0.0067644,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN,0.612536772493573
GOBP_IMMUNE_EFFECTOR_PROCESS,SET,580,0.092765,0.016225,0.037563,0.0067677,GOBP_IMMUNE_EFFECTOR_PROCESS,0.612536772493573
GOBP_RETINOIC_ACID_RECEPTOR_...,SET,31,0.36658,0.01505,0.1485,0.0067867,GOBP_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.612536772493573
KEGG_PRION_DISEASES,SET,33,0.39488,0.016726,0.15999,0.0067943,KEGG_PRION_DISEASES,0.612536772493573
MIR4447,SET,255,0.12703,0.014866,0.051482,0.0068093,MIR4447,0.612536772493573
REACTOME_EGFR_DOWNREGULATION,SET,29,0.40604,0.016124,0.16466,0.0068396,REACTOME_EGFR_DOWNREGULATION,0.612536772493573
GOBP_LEUKOCYTE_MEDIATED_IMMU...,SET,363,0.11681,0.016261,0.047375,0.0068444,GOBP_LEUKOCYTE_MEDIATED_IMMUNITY,0.612536772493573
KEGG_MEDICUS_VARIANT_MUTATIO...1,SET,5,0.98229,0.016208,0.39846,0.0068511,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY,0.612536772493573
GOBP_REGULATION_OF_LONG_TERM...1,SET,23,0.41827,0.014794,0.16968,0.0068559,GOBP_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,0.612536772493573
HP_FACIAL_EDEMA,SET,122,0.19748,0.016044,0.080173,0.006891,HP_FACIAL_EDEMA,0.614094115384615
HP_ACNE,SET,60,0.26965,0.015389,0.10954,0.0069221,HP_ACNE,0.615287942455243
HP_MICROLISSENCEPHALY,SET,5,0.9849,0.016251,0.40073,0.0069951,HP_MICROLISSENCEPHALY,0.619599565326633
HP_OVARIAN_CYST,SET,106,0.20524,0.015549,0.083575,0.0070351,HP_OVARIAN_CYST,0.619599565326633
GOBP_PHOTORECEPTOR_CELL_MORP...,SET,4,1.0233,0.015102,0.41676,0.0070419,GOBP_PHOTORECEPTOR_CELL_MORPHOGENESIS,0.619599565326633
GOBP_ANTIGEN_PROCESSING_AND_...11,SET,36,0.36328,0.01607,0.14799,0.0070543,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,0.619599565326633
YAO_TEMPORAL_RESPONSE_TO_PRO...14,SET,27,0.39736,0.015227,0.16197,0.0070825,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,0.619599565326633
GSE12845_IGD_POS_BLOOD_VS_DA...2,SET,166,0.15658,0.01482,0.063824,0.007083,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.619599565326633
GOBP_POSITIVE_REGULATION_OF_...350,SET,666,0.083038,0.015525,0.033857,0.0070954,GOBP_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE,0.619599565326633
WP_ALTERED_GLYCOSYLATION_OF_...,SET,8,0.64779,0.013519,0.2643,0.0071281,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,0.62089502631579
GOBP_NUCLEOLUS_ORGANIZATION,SET,14,0.48676,0.013436,0.19887,0.0071935,GOBP_NUCLEOLUS_ORGANIZATION,0.62502523125
REACTOME_RHO_GTPASES_ACTIVAT...5,SET,21,0.47156,0.015939,0.19281,0.0072321,REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES,0.626812058603491
REACTOME_UNFOLDED_PROTEIN_RE...,SET,87,0.20515,0.014088,0.084076,0.0073483,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,0.635298921641791
GOBP_MALE_SEX_DIFFERENTIATION,SET,158,0.17135,0.015827,0.070272,0.0073806,GOBP_MALE_SEX_DIFFERENTIATION,0.636403622524752
GOBP_REGULATION_OF_CELL_DEVE...,SET,764,0.078376,0.015651,0.032153,0.0073977,GOBP_REGULATION_OF_CELL_DEVELOPMENT,0.636403622524752
HOEK_NK_CELL_2011_2012_TIV_A...1,SET,7,0.6551,0.012789,0.26889,0.0074244,HOEK_NK_CELL_2011_2012_TIV_ADULT_1DY_UP,0.637123511111111
GSE9037_CTRL_VS_LPS_4H_STIM_...3,SET,183,0.15226,0.015125,0.062542,0.0074606,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN,0.638653086206897
MIR758_5P,SET,31,0.35408,0.014537,0.14557,0.0075055,MIR758_5P,0.640314252439024
GSE2197_CPG_DNA_VS_UNTREATED...1,SET,175,0.15057,0.014629,0.061943,0.0075394,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN,0.640314252439024
ATGCAGT_MIR217,SET,97,0.20849,0.015114,0.085772,0.0075395,ATGCAGT_MIR217,0.640314252439024
FARMER_BREAST_CANCER_CLUSTER...5,SET,19,0.45107,0.014503,0.18562,0.0075537,FARMER_BREAST_CANCER_CLUSTER_5,0.640314252439024
MIR1285_3P,SET,151,0.16273,0.014696,0.067008,0.0075852,MIR1285_3P,0.64142001459854
GSE40274_CTRL_VS_FOXP3_AND_X...2,SET,148,0.15573,0.013925,0.064212,0.0076537,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.645433169491525
HP_PHEOCHROMOCYTOMA,SET,28,0.3447,0.013451,0.14217,0.0076698,HP_PHEOCHROMOCYTOMA,0.645433169491525
HP_TISSUE_ISCHEMIA,SET,108,0.20884,0.015969,0.086361,0.0078044,HP_TISSUE_ISCHEMIA,0.649467239179955
HARALAMBIEVA_PBMC_M_M_R_II_A...3,SET,10,0.6752,0.015753,0.27928,0.0078157,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_HIGH_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_DN,0.649467239179955
REACTOME_PARACETAMOL_ADME,SET,25,0.46003,0.016963,0.1903,0.0078203,REACTOME_PARACETAMOL_ADME,0.649467239179955
GOMF_ATPASE_COUPLED_INTRAMEM...,SET,26,0.40365,0.015179,0.16698,0.0078235,GOMF_ATPASE_COUPLED_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY,0.649467239179955
GOBP_POSITIVE_REGULATION_OF_...141,SET,9,0.7664,0.016964,0.3171,0.0078314,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.649467239179955
HP_LINGUAL_DYSTONIA,SET,5,0.8914,0.014708,0.36909,0.0078696,HP_LINGUAL_DYSTONIA,0.649467239179955
WP_ACQUIRED_PARTIAL_LIPODYST...,SET,10,0.62617,0.014609,0.25944,0.0079043,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,0.649467239179955
PID_VEGFR1_PATHWAY,SET,26,0.37722,0.014185,0.15636,0.0079266,PID_VEGFR1_PATHWAY,0.649467239179955
ZNF394_TARGET_GENES,SET,828,0.071704,0.014879,0.029725,0.0079329,ZNF394_TARGET_GENES,0.649467239179955
PID_INTEGRIN2_PATHWAY,SET,26,0.43013,0.016175,0.17854,0.0080001,PID_INTEGRIN2_PATHWAY,0.649467239179955
HP_GAIT_IMBALANCE,SET,63,0.26016,0.015213,0.10804,0.0080235,HP_GAIT_IMBALANCE,0.649467239179955
GOBP_POSITIVE_REGULATION_OF_...505,SET,97,0.21919,0.01589,0.091036,0.0080302,GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.649467239179955
GOBP_REGULATION_OF_TOLL_LIKE...4,SET,4,1.2496,0.018442,0.51903,0.0080346,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.649467239179955
GOBP_DOUBLE_STRAND_BREAK_REP...5,SET,9,0.65145,0.014419,0.27061,0.0080404,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_CLASSICAL_NONHOMOLOGOUS_END_JOINING,0.649467239179955
MIR3179,SET,117,0.18045,0.014359,0.074995,0.0080643,MIR3179,0.649467239179955
SHIN_B_CELL_LYMPHOMA_CLUSTER...5,SET,10,0.75449,0.017603,0.31364,0.0080784,SHIN_B_CELL_LYMPHOMA_CLUSTER_6,0.649467239179955
LAKE_ADULT_KIDNEY_C22_ENDOTH...,SET,135,0.18756,0.016023,0.077982,0.0080882,LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES,0.649467239179955
GOBP_REGULATION_OF_TISSUE_RE...,SET,72,0.25336,0.015835,0.10534,0.0080888,GOBP_REGULATION_OF_TISSUE_REMODELING,0.649467239179955
HP_IMPAIRED_ADP_INDUCED_PLAT...,SET,18,0.47136,0.014751,0.19598,0.0080895,HP_IMPAIRED_ADP_INDUCED_PLATELET_AGGREGATION,0.649467239179955
HP_CEREBRAL_HEMORRHAGE,SET,63,0.23777,0.013904,0.098881,0.008101,HP_CEREBRAL_HEMORRHAGE,0.649467239179955
HE_LIM_SUN_FETAL_LUNG_C1_LAT...4,SET,28,0.42667,0.016649,0.17759,0.0081465,HE_LIM_SUN_FETAL_LUNG_C1_LATE_TIP_CELL,0.649467239179955
GOBP_POSITIVE_REGULATION_OF_...832,SET,15,0.58282,0.016652,0.2426,0.0081498,GOBP_POSITIVE_REGULATION_OF_VASCULAR_PERMEABILITY,0.649467239179955
MIR4782_5P,SET,150,0.1678,0.015105,0.069865,0.0081626,MIR4782_5P,0.649467239179955
GAUCHER_PBMC_YF_VAX_STAMARIL...5,SET,12,0.59555,0.01522,0.24809,0.0081916,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_DN,0.649467239179955
HP_OVERFRIENDLINESS,SET,23,0.50271,0.017781,0.20943,0.0081951,HP_OVERFRIENDLINESS,0.649467239179955
GAVISH_3CA_METAPROGRAM_B_CEL...8,SET,44,0.32983,0.016127,0.13743,0.0082036,GAVISH_3CA_METAPROGRAM_B_CELLS_MHC_II,0.649467239179955
GSE22432_MULTIPOTENT_VS_COMM...1,SET,187,0.14595,0.014654,0.06087,0.0082532,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN,0.650805027088036
HP_ABNORMAL_CEREBRAL_VASCULA...,SET,307,0.11529,0.014782,0.048104,0.0082777,HP_ABNORMAL_CEREBRAL_VASCULAR_MORPHOLOGY,0.650805027088036
GSE24142_EARLY_THYMIC_PROGEN...9,SET,186,0.14753,0.014774,0.06157,0.0082879,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN,0.650805027088036
HP_LARYNGEAL_STRIDOR,SET,4,1.0613,0.015662,0.44295,0.0082954,HP_LARYNGEAL_STRIDOR,0.650805027088036
ZNF419_TARGET_GENES,SET,5,0.88937,0.014674,0.3722,0.0084408,ZNF419_TARGET_GENES,0.651389360068259
HP_ABNORMAL_PULSE,SET,5,0.76737,0.012661,0.32116,0.0084436,HP_ABNORMAL_PULSE,0.651389360068259
GOMF_PHOSPHATIDYLINOSITOL_4_...4,SET,27,0.37262,0.014278,0.15599,0.0084599,GOMF_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING,0.651389360068259
GOCC_CYTOPLASMIC_STRESS_GRAN...,SET,83,0.20663,0.013861,0.086529,0.0084754,GOCC_CYTOPLASMIC_STRESS_GRANULE,0.651389360068259
MIR425_5P,SET,78,0.22534,0.014656,0.094365,0.0084769,MIR425_5P,0.651389360068259
GSE11864_UNTREATED_VS_CSF1_P...2,SET,164,0.15113,0.014219,0.063291,0.0084779,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP,0.651389360068259
GOMF_PHOSPHATIDYLINOSITOL_3_...7,SET,26,0.3597,0.013526,0.15064,0.0084803,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING,0.651389360068259
MYAATNNNNNNNGGC_UNKNOWN,SET,103,0.20064,0.014986,0.084044,0.00849,MYAATNNNNNNNGGC_UNKNOWN,0.651389360068259
HP_ABNORMAL_RENAL_PHYSIOLOGY,SET,624,0.079891,0.014476,0.033506,0.008559,HP_ABNORMAL_RENAL_PHYSIOLOGY,0.651389360068259
REACTOME_SYNTHESIS_OF_BILE_A...3,SET,14,0.64301,0.017749,0.26971,0.0085654,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL,0.651389360068259
GOBP_FEMALE_MEIOSIS_CHROMOSO...,SET,6,0.722,0.01305,0.30288,0.0085734,GOBP_FEMALE_MEIOSIS_CHROMOSOME_SEGREGATION,0.651389360068259
GOCC_MULTIMERIC_RIBONUCLEASE...,SET,9,0.65885,0.014583,0.27644,0.0085841,GOCC_MULTIMERIC_RIBONUCLEASE_P_COMPLEX,0.651389360068259
GOMF_RIBONUCLEASE_P_ACTIVITY,SET,9,0.65885,0.014583,0.27644,0.0085841,GOMF_RIBONUCLEASE_P_ACTIVITY,0.651389360068259
GOMF_RIBONUCLEASE_P_RNA_BIND...,SET,9,0.65885,0.014583,0.27644,0.0085841,GOMF_RIBONUCLEASE_P_RNA_BINDING,0.651389360068259
MIR6799_3P,SET,106,0.20955,0.015876,0.088073,0.0086777,MIR6799_3P,0.651389360068259
WP_VITAMIN_A1_AND_A5X_PATHWA...,SET,6,0.7815,0.014125,0.32861,0.008704,WP_VITAMIN_A1_AND_A5X_PATHWAYS,0.651389360068259
GSE16385_UNTREATED_VS_12H_IF...2,SET,159,0.15881,0.014715,0.066789,0.0087127,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,0.651389360068259
GSE17974_CTRL_VS_ACT_IL4_AND...10,SET,167,0.15752,0.014954,0.066248,0.0087158,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP,0.651389360068259
RBM34_TARGET_GENES,SET,811,0.071519,0.014695,0.030086,0.0087291,RBM34_TARGET_GENES,0.651389360068259
GOBP_POSITIVE_REGULATION_OF_...351,SET,975,0.067673,0.015175,0.028469,0.0087308,GOBP_POSITIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,0.651389360068259
KEGG_MEDICUS_REFERENCE_PRE_I...,SET,27,0.37221,0.014263,0.1566,0.0087344,KEGG_MEDICUS_REFERENCE_PRE_IC_FORMATION,0.651389360068259
GOBP_T_CELL_DIFFERENTIATION_...2,SET,81,0.22866,0.015154,0.096201,0.0087358,GOBP_T_CELL_DIFFERENTIATION_IN_THYMUS,0.651389360068259
GARCIA_PINERES_PBMC_HPV_16_L...1,SET,20,0.46202,0.01524,0.1944,0.0087419,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE,0.651389360068259
HP_DEPOSITS_IMMUNOREACTIVE_T...,SET,8,0.72256,0.015079,0.3041,0.0087545,HP_DEPOSITS_IMMUNOREACTIVE_TO_BETA_AMYLOID_PROTEIN,0.651389360068259
GOBP_NEGATIVE_REGULATION_OF_...215,SET,7,0.86492,0.016885,0.36464,0.0088516,GOBP_NEGATIVE_REGULATION_OF_ERAD_PATHWAY,0.651389360068259
GOBP_POSITIVE_REGULATION_OF_...811,SET,18,0.49006,0.015336,0.20667,0.0088714,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.651389360068259
GOCC_NLRP1_INFLAMMASOME_COMP...,SET,5,1.0836,0.017879,0.45716,0.0088938,GOCC_NLRP1_INFLAMMASOME_COMPLEX,0.651389360068259
HP_RIGHT_AORTIC_ARCH_WITH_MI...,SET,5,0.7997,0.013195,0.33777,0.0089586,HP_RIGHT_AORTIC_ARCH_WITH_MIRROR_IMAGE_BRANCHING,0.651389360068259
HP_ABNORMAL_CSF_HOMOVANILLIC...,SET,9,0.69725,0.015433,0.29461,0.0089797,HP_ABNORMAL_CSF_HOMOVANILLIC_ACID_CONCENTRATION,0.651389360068259
KEGG_MEDICUS_PATHOGEN_SHIGEL...8,SET,6,0.93841,0.016961,0.3969,0.0090365,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.651389360068259
REACTOME_DNA_STRAND_ELONGATI...,SET,31,0.32679,0.013416,0.13822,0.0090392,REACTOME_DNA_STRAND_ELONGATION,0.651389360068259
SHEPARD_BMYB_MORPHOLINO_UP,SET,198,0.13816,0.01427,0.05846,0.0090595,SHEPARD_BMYB_MORPHOLINO_UP,0.651389360068259
GOBP_POSITIVE_REGULATION_OF_...724,SET,43,0.28845,0.013943,0.12208,0.0090747,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.651389360068259
REACTOME_IRAK1_RECRUITS_IKK_...,SET,11,0.60587,0.014825,0.25646,0.0090825,REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,0.651389360068259
HP_WOOLLY_HAIR,SET,22,0.44781,0.015492,0.1896,0.0090957,HP_WOOLLY_HAIR,0.651389360068259
GOBP_PROTEIN_SULFATION,SET,6,0.861,0.015562,0.36469,0.0091209,GOBP_PROTEIN_SULFATION,0.651389360068259
HP_THICK_LOWER_LIP_VERMILION,SET,115,0.18491,0.014588,0.078392,0.0091714,HP_THICK_LOWER_LIP_VERMILION,0.651389360068259
HP_IMPACTED_TOOTH,SET,6,0.88545,0.016004,0.37546,0.0091847,HP_IMPACTED_TOOTH,0.651389360068259
GSE29618_BCELL_VS_PDC_UP,SET,169,0.16531,0.015786,0.070164,0.0092419,GSE29618_BCELL_VS_PDC_UP,0.651389360068259
GOCC_ENDOPLASMIC_RETICULUM_G...2,SET,72,0.23456,0.014659,0.099614,0.009275,GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE,0.651389360068259
GSE15735_2H_VS_12H_HDAC_INHI...2,SET,188,0.1508,0.015181,0.064051,0.0092811,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP,0.651389360068259
GSE5099_CLASSICAL_M1_VS_ALTE...1,SET,146,0.16495,0.014651,0.07011,0.0093224,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN,0.651389360068259
TRAVAGLINI_LUNG_B_CELL,SET,142,0.1693,0.014831,0.071966,0.0093277,TRAVAGLINI_LUNG_B_CELL,0.651389360068259
GOBP_G_PROTEIN_COUPLED_ACETY...,SET,20,0.4527,0.014933,0.19245,0.0093354,GOBP_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.651389360068259
GSE41867_DAY15_EFFECTOR_VS_D...1,SET,182,0.13913,0.013783,0.05924,0.009429,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.651389360068259
RGAGGAARY_PU1_Q6,SET,462,0.095409,0.014943,0.040644,0.0094567,RGAGGAARY_PU1_Q6,0.651389360068259
MIR5189_5P,SET,139,0.16484,0.014288,0.07023,0.0094663,MIR5189_5P,0.651389360068259
GOBP_HEPARIN_BIOSYNTHETIC_PR...,SET,11,0.59349,0.014522,0.25286,0.0094663,GOBP_HEPARIN_BIOSYNTHETIC_PROCESS,0.651389360068259
HP_ATROPHY_DEGENERATION_INVO...2,SET,34,0.33717,0.014496,0.14374,0.0095011,HP_ATROPHY_DEGENERATION_INVOLVING_THE_CORTICOSPINAL_TRACTS,0.651389360068259
GSE10463_CD40L_AND_VA347_VS_...2,SET,167,0.15423,0.014641,0.065759,0.0095108,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP,0.651389360068259
RUAN_RESPONSE_TO_TNF_TROGLIT...2,SET,17,0.50507,0.015361,0.21545,0.0095365,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,0.651389360068259
HP_BLUE_SCLERAE,SET,97,0.19293,0.013986,0.082299,0.0095371,HP_BLUE_SCLERAE,0.651389360068259
EBAUER_MYOGENIC_TARGETS_OF_P...,SET,43,0.30977,0.014973,0.13216,0.0095486,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,0.651389360068259
KEGG_MEDICUS_PATHOGEN_SALMON...7,SET,8,0.6057,0.01264,0.25858,0.0095855,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_E2_TO_NOD_NFKB_SIGNALING_PATHWAY,0.651389360068259
GSE22601_DOUBLE_NEGATIVE_VS_...6,SET,167,0.15002,0.014242,0.064115,0.0096534,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,0.651389360068259
REACTOME_CREB3_FACTORS_ACTIV...,SET,8,0.61317,0.012796,0.26225,0.0096959,REACTOME_CREB3_FACTORS_ACTIVATE_GENES,0.651389360068259
KEGG_MEDICUS_PATHOGEN_KSHV_V...2,SET,5,0.78158,0.012896,0.33432,0.0097032,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_NFKB_SIGNALING_PATHWAY,0.651389360068259
KEGG_MEDICUS_PATHOGEN_EBV_LM...1,SET,10,0.60139,0.014031,0.25725,0.0097049,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY,0.651389360068259
REACTOME_ALTERNATIVE_COMPLEM...,SET,4,1.0761,0.015882,0.46045,0.0097208,REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION,0.651389360068259
GOBP_L_SERINE_BIOSYNTHETIC_P...,SET,6,0.71237,0.012875,0.30482,0.0097242,GOBP_L_SERINE_BIOSYNTHETIC_PROCESS,0.651389360068259
GOMF_RETINOL_BINDING,SET,14,0.56272,0.015533,0.24087,0.0097453,GOMF_RETINOL_BINDING,0.651389360068259
GSE14308_TH1_VS_INDUCED_TREG...1,SET,176,0.14189,0.013825,0.060746,0.0097557,GSE14308_TH1_VS_INDUCED_TREG_DN,0.651389360068259
GOBP_POSITIVE_REGULATION_OF_...347,SET,5,0.79368,0.013096,0.3398,0.0097591,GOBP_POSITIVE_REGULATION_OF_HYPERSENSITIVITY,0.651389360068259
GOBP_POSITIVE_REGULATION_OF_...362,SET,33,0.32226,0.01365,0.13812,0.0098258,GOBP_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,0.651389360068259
HP_HIPPOCAMPAL_ATROPHY,SET,5,0.88433,0.014591,0.37905,0.0098297,HP_HIPPOCAMPAL_ATROPHY,0.651389360068259
GSE15659_CD45RA_NEG_CD4_TCEL...5,SET,172,0.14851,0.014306,0.063689,0.0098605,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN,0.651389360068259
HUANG_AML_LSC47,SET,41,0.34457,0.016264,0.14779,0.0098705,HUANG_AML_LSC47,0.651389360068259
GSE1448_CTRL_VS_ANTI_VALPHA2...2,SET,178,0.14388,0.014097,0.061716,0.009875,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP,0.651389360068259
MIR217_3P,SET,83,0.20855,0.01399,0.089534,0.0099275,MIR217_3P,0.651389360068259
REACTOME_PRC2_METHYLATES_HIS...,SET,12,0.55167,0.014099,0.23686,0.0099325,REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA,0.651389360068259
GOMF_LYSOPHOSPHATIDIC_ACID_P...,SET,2,1.6805,0.017538,0.72248,0.010015,GOMF_LYSOPHOSPHATIDIC_ACID_PHOSPHATASE_ACTIVITY,0.651389360068259
YAN_ESCAPE_FROM_ANOIKIS,SET,23,0.411,0.014537,0.1767,0.010016,YAN_ESCAPE_FROM_ANOIKIS,0.651389360068259
GOMF_HISTONE_DEACETYLASE_BIN...,SET,102,0.19209,0.014277,0.082599,0.010027,GOMF_HISTONE_DEACETYLASE_BINDING,0.651389360068259
GSE18791_UNSTIM_VS_NEWCATSLE...2,SET,186,0.13677,0.013696,0.058819,0.010035,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP,0.651389360068259
GOCC_CHROMATOID_BODY,SET,12,0.64157,0.016396,0.27595,0.010043,GOCC_CHROMATOID_BODY,0.651389360068259
GOMF_UREA_TRANSMEMBRANE_TRAN...,SET,7,0.87959,0.017171,0.37835,0.010047,GOMF_UREA_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.651389360068259
GOBP_REGULATION_OF_PROTEIN_K...4,SET,3,1.2843,0.016415,0.55247,0.01005,GOBP_REGULATION_OF_PROTEIN_KINASE_C_ACTIVITY,0.651389360068259
RBM15_TARGET_GENES,SET,141,0.16551,0.014448,0.071207,0.010059,RBM15_TARGET_GENES,0.651389360068259
GOBP_UTERUS_MORPHOGENESIS,SET,6,0.74836,0.013526,0.32198,0.010062,GOBP_UTERUS_MORPHOGENESIS,0.651389360068259
GSE3565_DUSP1_VS_WT_SPLENOCY...1,SET,164,0.15315,0.014409,0.0659,0.010069,GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN,0.651389360068259
GOCC_INHIBITORY_SYNAPSE,SET,13,0.56547,0.015041,0.24337,0.010082,GOCC_INHIBITORY_SYNAPSE,0.651389360068259
GOMF_SMALL_RIBOSOMAL_SUBUNIT...,SET,7,0.70594,0.013781,0.30398,0.010112,GOMF_SMALL_RIBOSOMAL_SUBUNIT_RRNA_BINDING,0.651389360068259
GOBP_POSITIVE_REGULATION_OF_...303,SET,7,0.83362,0.016274,0.35902,0.010124,GOBP_POSITIVE_REGULATION_OF_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION,0.651389360068259
WORSCHECH_TUMOR_EVASION_AND_...2,SET,29,0.39732,0.015778,0.17113,0.01013,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,0.651389360068259
HP_RENOVASCULAR_HYPERTENSION,SET,25,0.39232,0.014467,0.16899,0.010134,HP_RENOVASCULAR_HYPERTENSION,0.651389360068259
GOBP_TOLL_LIKE_RECEPTOR_7_SI...,SET,8,0.7637,0.015938,0.32899,0.01014,GOBP_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.651389360068259
GSE10239_NAIVE_VS_KLRG1HIGH_...1,SET,180,0.14501,0.014288,0.062486,0.010156,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.651389360068259
GOBP_POSITIVE_REGULATION_OF_...71,SET,34,0.32117,0.013808,0.13841,0.010164,GOBP_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.651389360068259
HP_NARROW_NARIS,SET,8,0.68829,0.014364,0.2967,0.010181,HP_NARROW_NARIS,0.651389360068259
GOBP_BONE_REMODELING,SET,89,0.21793,0.015136,0.093947,0.010184,GOBP_BONE_REMODELING,0.651389360068259
HU_FETAL_RETINA_MULLER,SET,36,0.35055,0.015507,0.15121,0.01022,HU_FETAL_RETINA_MULLER,0.651389360068259
FLECHNER_PBL_KIDNEY_TRANSPLA...4,SET,57,0.2543,0.014147,0.10972,0.010239,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,0.651389360068259
BOQUEST_STEM_CELL_CULTURED_V...1,SET,29,0.39338,0.015621,0.16974,0.010244,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,0.651389360068259
GOBP_MYD88_DEPENDENT_TOLL_LI...,SET,18,0.42722,0.01337,0.18438,0.010257,GOBP_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.651389360068259
GSE2770_TGFB_AND_IL4_VS_IL4_...2,SET,184,0.14222,0.014166,0.061395,0.01027,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.651389360068259
GSE3720_LPS_VS_PMA_STIM_VD1_...1,SET,157,0.15423,0.014201,0.06659,0.010281,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,0.651389360068259
SMID_BREAST_CANCER_RELAPSE_I...8,SET,21,0.45434,0.015356,0.1963,0.010325,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP,0.651389360068259
WP_DOPAMINERGIC_NEUROGENESIS,SET,28,0.40865,0.015946,0.17659,0.010335,WP_DOPAMINERGIC_NEUROGENESIS,0.651389360068259
KEGG_MEDICUS_REFERENCE_NOTCH...2,SET,6,0.82107,0.01484,0.35482,0.010338,KEGG_MEDICUS_REFERENCE_NOTCH_MESP2_SIGNALING,0.651389360068259
FOURATI_BLOOD_TWINRIX_AGE_65...3,SET,4,0.91275,0.013471,0.39466,0.010374,FOURATI_BLOOD_TWINRIX_AGE_65_83YO_POOR_RESPONDERS_VS_RESPONDERS_0DY_NETWORK_INFERENCE_UP,0.651389360068259
GOMF_O_PALMITOYLTRANSFERASE_...,SET,5,0.83357,0.013754,0.36048,0.010383,GOMF_O_PALMITOYLTRANSFERASE_ACTIVITY,0.651389360068259
HP_RECURRENT_SKIN_INFECTIONS,SET,122,0.1759,0.014291,0.076079,0.010392,HP_RECURRENT_SKIN_INFECTIONS,0.651389360068259
GOBP_CORTICAL_CYTOSKELETON_O...,SET,51,0.26206,0.013792,0.11336,0.010401,GOBP_CORTICAL_CYTOSKELETON_ORGANIZATION,0.651389360068259
GSE21546_WT_VS_ELK1_KO_ANTI_...1,SET,177,0.14105,0.013782,0.061023,0.01041,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.651389360068259
KAECH_NAIVE_VS_MEMORY_CD8_TC...2,SET,184,0.14544,0.014486,0.062943,0.010431,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.651389360068259
CONCANNON_APOPTOSIS_BY_EPOXO...2,SET,216,0.13574,0.014636,0.058777,0.010465,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,0.651389360068259
GOMF_HISTONE_H3K9_TRIMETHYLT...,SET,4,1.1032,0.016282,0.47777,0.010474,GOMF_HISTONE_H3K9_TRIMETHYLTRANSFERASE_ACTIVITY,0.651389360068259
GOBP_CARDIAC_NEURAL_CREST_CE...2,SET,15,0.58953,0.016843,0.25531,0.010476,GOBP_CARDIAC_NEURAL_CREST_CELL_DIFFERENTIATION_INVOLVED_IN_HEART_DEVELOPMENT,0.651389360068259
GOCC_NUCLEAR_STRESS_GRANULE,SET,6,0.82117,0.014842,0.35576,0.010498,GOCC_NUCLEAR_STRESS_GRANULE,0.651389360068259
HP_CONGESTIVE_HEART_FAILURE,SET,220,0.13016,0.014162,0.056388,0.010498,HP_CONGESTIVE_HEART_FAILURE,0.651389360068259
GSE7460_FOXP3_MUT_VS_HET_ACT...2,SET,183,0.14697,0.014599,0.063675,0.010502,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP,0.651389360068259
GSE3982_MAST_CELL_VS_MAC_DN,SET,171,0.15032,0.014439,0.06513,0.010504,GSE3982_MAST_CELL_VS_MAC_DN,0.651389360068259
FAN_OVARY_CL11_MURAL_GRANULO...,SET,387,0.10295,0.014788,0.044608,0.010509,FAN_OVARY_CL11_MURAL_GRANULOSA_CELL,0.651389360068259
KEGG_MEDICUS_REFERENCE_EGF_E...7,SET,15,0.49759,0.014216,0.21568,0.010532,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.651389360068259
GOBP_REGULATION_OF_BLOOD_BRA...,SET,9,0.7538,0.016685,0.32691,0.010565,GOBP_REGULATION_OF_BLOOD_BRAIN_BARRIER_PERMEABILITY,0.651389360068259
GOBP_OVIDUCT_DEVELOPMENT,SET,6,0.81743,0.014774,0.35453,0.01057,GOBP_OVIDUCT_DEVELOPMENT,0.651389360068259
WP_ANTIVIRAL_AND_ANTIINFLAMM...,SET,26,0.39449,0.014834,0.1711,0.010572,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,0.651389360068259
GOMF_MRNA_5_UTR_BINDING,SET,22,0.37431,0.012949,0.16237,0.010581,GOMF_MRNA_5_UTR_BINDING,0.651389360068259
REACTOME_RECRUITMENT_OF_MITO...,SET,74,0.21006,0.013309,0.091137,0.010593,REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,0.651389360068259
PID_S1P_S1P1_PATHWAY,SET,21,0.42006,0.014198,0.18226,0.010598,PID_S1P_S1P1_PATHWAY,0.651389360068259
YU_MYC_TARGETS_DN,SET,50,0.2783,0.014503,0.12076,0.0106,YU_MYC_TARGETS_DN,0.651389360068259
GOCC_SMOOTH_ENDOPLASMIC_RETI...1,SET,28,0.36807,0.014363,0.15981,0.010638,GOCC_SMOOTH_ENDOPLASMIC_RETICULUM,0.651389360068259
BENPORATH_MYC_MAX_TARGETS,SET,687,0.070088,0.013301,0.03044,0.010659,BENPORATH_MYC_MAX_TARGETS,0.651389360068259
HP_SMALL_FACE,SET,112,0.19196,0.014947,0.083373,0.01066,HP_SMALL_FACE,0.651389360068259
GOBP_RESPONSE_TO_MECHANICAL_...,SET,209,0.13919,0.014765,0.060476,0.010686,GOBP_RESPONSE_TO_MECHANICAL_STIMULUS,0.651389360068259
GOBP_PROTEIN_O_LINKED_FUCOSY...,SET,4,0.82087,0.012115,0.35676,0.010704,GOBP_PROTEIN_O_LINKED_FUCOSYLATION,0.651389360068259
GSE15930_NAIVE_VS_24H_IN_VIT...3,SET,188,0.13396,0.013485,0.058253,0.010742,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.651389360068259
HOLLEMAN_VINCRISTINE_RESISTA...4,SET,36,0.32533,0.014392,0.1415,0.010753,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,0.651389360068259
PID_S1P_S1P4_PATHWAY,SET,14,0.50231,0.013865,0.21851,0.010762,PID_S1P_S1P4_PATHWAY,0.651389360068259
GSE8921_3H_VS_24H_TLR1_2_STI...2,SET,175,0.14746,0.014328,0.064161,0.010777,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP,0.651389360068259
GSE44732_UNSTIM_VS_IL27_STIM...1,SET,182,0.14159,0.014027,0.061624,0.010796,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN,0.651389360068259
RUBENSTEIN_SKELETAL_MUSCLE_N...,SET,198,0.13675,0.014124,0.059532,0.010813,RUBENSTEIN_SKELETAL_MUSCLE_NK_CELLS,0.651389360068259
GOBP_RESPONSE_TO_AUDITORY_ST...,SET,32,0.34395,0.014346,0.14976,0.010826,GOBP_RESPONSE_TO_AUDITORY_STIMULUS,0.651389360068259
BIOCARTA_CIRCADIAN_PATHWAY,SET,5,0.99943,0.01649,0.43525,0.010837,BIOCARTA_CIRCADIAN_PATHWAY,0.651389360068259
DANG_REGULATED_BY_MYC_DN,SET,225,0.1303,0.014335,0.056759,0.010853,DANG_REGULATED_BY_MYC_DN,0.651389360068259
GSE21033_3H_VS_24H_POLYIC_ST...2,SET,148,0.15966,0.014277,0.06956,0.010862,GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP,0.651389360068259
BERENJENO_TRANSFORMED_BY_RHO...3,SET,20,0.45031,0.014854,0.19627,0.01089,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,0.651389360068259
HP_ABNORMAL_CARPAL_MORPHOLOGY,SET,79,0.2213,0.014485,0.096486,0.010911,HP_ABNORMAL_CARPAL_MORPHOLOGY,0.651389360068259
GSE6269_HEALTHY_VS_STAPH_AUR...2,SET,154,0.15146,0.013813,0.066064,0.010941,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP,0.651389360068259
MIR5706,SET,150,0.16072,0.014467,0.07013,0.010966,MIR5706,0.651389360068259
GOMF_HISTONE_UBIQUITIN_LIGAS...,SET,10,0.59198,0.013811,0.25832,0.010969,GOMF_HISTONE_UBIQUITIN_LIGASE_ACTIVITY,0.651389360068259
HP_KERATOACANTHOMA,SET,4,0.76599,0.011305,0.33429,0.010976,HP_KERATOACANTHOMA,0.651389360068259
GOBP_RESPONSE_TO_VIRUS,SET,368,0.10421,0.014604,0.045483,0.010983,GOBP_RESPONSE_TO_VIRUS,0.651389360068259
GOBP_REGULATION_OF_DEVELOPME...2,SET,13,0.56143,0.014934,0.24519,0.011023,GOBP_REGULATION_OF_DEVELOPMENT_HETEROCHRONIC,0.652647981260647
GAVISH_3CA_MALIGNANT_METAPRO...18,SET,45,0.30275,0.014969,0.13234,0.011083,GAVISH_3CA_MALIGNANT_METAPROGRAM_27_OLIGO_PROGENITOR,0.654111166666667
GSE24210_RESTING_TREG_VS_TCO...1,SET,178,0.13745,0.013468,0.060093,0.011095,GSE24210_RESTING_TREG_VS_TCONV_DN,0.654111166666667
GOCC_SPERM_PLASMA_MEMBRANE,SET,14,0.50406,0.013913,0.22061,0.011167,GOCC_SPERM_PLASMA_MEMBRANE,0.654111166666667
WP_TCA_CYCLE_NUTRIENT_USE_AN...,SET,5,0.9406,0.01552,0.41173,0.011177,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,0.654111166666667
GOCC_AXON_CYTOPLASM,SET,61,0.25061,0.014421,0.1097,0.011177,GOCC_AXON_CYTOPLASM,0.654111166666667
GOMF_TRANSMEMBRANE_RECEPTOR_...5,SET,16,0.5673,0.016739,0.24847,0.011215,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,0.654111166666667
E2F_Q4_01,SET,211,0.1299,0.013845,0.05694,0.011269,E2F_Q4_01,0.654111166666667
MIR151A_5P_MIR151B,SET,10,0.58111,0.013558,0.25481,0.011293,MIR151A_5P_MIR151B,0.654111166666667
MIR6885_5P,SET,46,0.28006,0.014,0.12285,0.011319,MIR6885_5P,0.654111166666667
GARGALOVIC_RESPONSE_TO_OXIDI...24,SET,27,0.36697,0.014062,0.16109,0.011368,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,0.654111166666667
MIR7847_3P,SET,65,0.24499,0.014551,0.10759,0.011396,MIR7847_3P,0.654111166666667
BIOCARTA_SLRP_PATHWAY,SET,5,1.2031,0.01985,0.52873,0.011448,BIOCARTA_SLRP_PATHWAY,0.654111166666667
GOBP_POSITIVE_REGULATION_OF_...459,SET,6,0.89489,0.016174,0.3934,0.011465,GOBP_POSITIVE_REGULATION_OF_MHC_CLASS_I_BIOSYNTHETIC_PROCESS,0.654111166666667
WP_EXTRACELLULAR_VESICLES_IN...,SET,19,0.49625,0.015955,0.21819,0.011479,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,0.654111166666667
GNF2_CD53,SET,52,0.27621,0.014678,0.12146,0.011487,GNF2_CD53,0.654111166666667
HP_APLASIA_OF_THE_ULNA,SET,5,1.0898,0.017982,0.47958,0.011535,HP_APLASIA_OF_THE_ULNA,0.654111166666667
GOMF_SOLUTE_PROTON_SYMPORTER...,SET,24,0.42481,0.015349,0.18695,0.011538,GOMF_SOLUTE_PROTON_SYMPORTER_ACTIVITY,0.654111166666667
GAVISH_3CA_METAPROGRAM_ENDOT...15,SET,49,0.28328,0.014615,0.12467,0.01154,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_STRESS,0.654111166666667
GSE3982_CENT_MEMORY_CD4_TCEL...4,SET,169,0.14525,0.013871,0.063931,0.011549,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP,0.654111166666667
GAUTAM_EYE_CHOROID_SCLERA_MO...,SET,120,0.17513,0.014112,0.077089,0.011554,GAUTAM_EYE_CHOROID_SCLERA_MONOCYTES,0.654111166666667
GSE17974_CTRL_VS_ACT_IL4_AND...13,SET,178,0.13305,0.013036,0.058597,0.011594,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN,0.654111166666667
KEGG_MEDICUS_REFERENCE_REGUL...7,SET,10,0.58156,0.013568,0.25618,0.011607,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS,0.654111166666667
COLLIS_PRKDC_REGULATORS,SET,13,0.57488,0.015291,0.25327,0.011614,COLLIS_PRKDC_REGULATORS,0.654111166666667
GSE45365_NK_CELL_VS_CD8A_DC_...4,SET,181,0.13836,0.013669,0.060981,0.011645,GSE45365_NK_CELL_VS_CD8A_DC_UP,0.654111166666667
GOMF_HISTONE_H3K4_MONOMETHYL...,SET,8,0.64296,0.013418,0.2834,0.011649,GOMF_HISTONE_H3K4_MONOMETHYLTRANSFERASE_ACTIVITY,0.654111166666667
GOBP_POSITIVE_REGULATION_OF_...831,SET,7,0.79911,0.0156,0.35235,0.011672,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY,0.654111166666667
WP_NODLIKE_RECEPTOR_NLR_SIGN...,SET,7,0.67614,0.0132,0.29822,0.011693,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,0.654111166666667
GSE6269_FLU_VS_E_COLI_INF_PB...1,SET,120,0.17959,0.014471,0.079219,0.011699,GSE6269_FLU_VS_E_COLI_INF_PBMC_DN,0.654111166666667
WP_MIRNA_ROLE_IN_IMMUNE_RESP...,SET,32,0.34647,0.014452,0.15285,0.011711,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.654111166666667
GOMF_D1_DOPAMINE_RECEPTOR_BI...,SET,6,0.67583,0.012215,0.29817,0.011715,GOMF_D1_DOPAMINE_RECEPTOR_BINDING,0.654111166666667
TRAVAGLINI_LUNG_TREM2_DENDRI...,SET,516,0.086552,0.014304,0.038188,0.011717,TRAVAGLINI_LUNG_TREM2_DENDRITIC_CELL,0.654111166666667
KEGG_MEDICUS_REFERENCE_DNA_R...2,SET,17,0.418,0.012713,0.18445,0.011724,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_TERMINATION,0.654111166666667
GOBP_ANTIGEN_PROCESSING_AND_...7,SET,8,0.59359,0.012388,0.26199,0.011742,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,0.654111166666667
GOBP_EMBRYONIC_CAMERA_TYPE_E...1,SET,37,0.33497,0.015022,0.14785,0.011744,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,0.654111166666667
WP_STRIATED_MUSCLE_CONTRACTI...,SET,37,0.30468,0.013663,0.13449,0.011747,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,0.654111166666667
MIR4700_5P,SET,200,0.14003,0.014535,0.061838,0.011778,MIR4700_5P,0.654111166666667
GSE7548_NAIVE_VS_DAY7_PCC_IM...1,SET,184,0.14319,0.014262,0.063257,0.011804,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN,0.654111166666667
HP_BRANCHIAL_ANOMALY,SET,16,0.43461,0.012824,0.192,0.011806,HP_BRANCHIAL_ANOMALY,0.654111166666667
GSE13547_WT_VS_ZFX_KO_BCELL_...5,SET,164,0.14875,0.013995,0.065728,0.011821,GSE13547_WT_VS_ZFX_KO_BCELL_DN,0.654111166666667
WP_TYROBP_CAUSAL_NETWORK_IN_...,SET,56,0.26545,0.014638,0.11731,0.011828,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,0.654111166666667
GSE40274_CTRL_VS_IRF4_TRANSD...2,SET,150,0.15523,0.013973,0.068598,0.011828,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.654111166666667
GSE34205_HEALTHY_VS_FLU_INF_...2,SET,173,0.14261,0.013777,0.063043,0.011852,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP,0.654111166666667
HP_ABNORMAL_CORTICOSPINAL_TR...,SET,44,0.28704,0.014035,0.1269,0.011857,HP_ABNORMAL_CORTICOSPINAL_TRACT_MORPHOLOGY,0.654111166666667
REACTOME_ROBO_RECEPTORS_BIND...,SET,9,0.60795,0.013457,0.26896,0.011905,REACTOME_ROBO_RECEPTORS_BIND_AKAP5,0.65509607771261
GSE22601_DOUBLE_NEGATIVE_VS_...2,SET,182,0.14455,0.01432,0.063976,0.011932,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.65509607771261
WANG_METASTASIS_OF_BREAST_CA...3,SET,19,0.39643,0.012746,0.17546,0.011937,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP,0.65509607771261
LIU_IL13_PRIMING_MODEL,SET,15,0.50919,0.014548,0.22545,0.011961,LIU_IL13_PRIMING_MODEL,0.65509607771261
TONKS_TARGETS_OF_RUNX1_RUNX1...5,SET,177,0.15173,0.014825,0.067188,0.011973,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,0.65509607771261
KEGG_GLYCOSAMINOGLYCAN_BIOSY...2,SET,25,0.38441,0.014175,0.17034,0.01202,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,0.65509607771261
GOBP_NEGATIVE_REGULATION_OF_...389,SET,2,1.6306,0.017017,0.72261,0.012025,GOBP_NEGATIVE_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.65509607771261
KEGG_THYROID_CANCER,SET,29,0.33669,0.01337,0.14922,0.012032,KEGG_THYROID_CANCER,0.65509607771261
HP_INTRACRANIAL_HEMORRHAGE,SET,141,0.16071,0.014029,0.071251,0.012054,HP_INTRACRANIAL_HEMORRHAGE,0.65509607771261
KEGG_MEDICUS_VARIANT_AMPLIFI...11,SET,6,0.66941,0.012099,0.29716,0.012146,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_REPRESSION,0.65509607771261
KEGG_MEDICUS_REFERENCE_TRAIP...,SET,14,0.47911,0.013225,0.21283,0.012194,KEGG_MEDICUS_REFERENCE_TRAIP_DEPENDENT_REPLISOME_DISASSEMBLY,0.65509607771261
chr14q23,SET,53,0.5101,0.027367,0.22664,0.012208,chr14q23,0.65509607771261
BUSSLINGER_ESOPHAGEAL_DENDRI...,SET,194,0.14232,0.014552,0.063244,0.01222,BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS,0.65509607771261
GOMF_COMPLEMENT_COMPONENT_C3...,SET,7,0.89508,0.017473,0.39776,0.012221,GOMF_COMPLEMENT_COMPONENT_C3B_BINDING,0.65509607771261
HP_HOARSE_VOICE,SET,91,0.19795,0.013901,0.088059,0.012296,HP_HOARSE_VOICE,0.65509607771261
GOCC_CORTICAL_GRANULE,SET,6,0.74146,0.013401,0.33007,0.012346,GOCC_CORTICAL_GRANULE,0.65509607771261
HP_PREAURICULAR_SKIN_TAG,SET,59,0.23684,0.013404,0.10543,0.012346,HP_PREAURICULAR_SKIN_TAG,0.65509607771261
HP_HYPOPLASTIC_FIFTH_FINGERN...,SET,14,0.47905,0.013223,0.21328,0.012354,HP_HYPOPLASTIC_FIFTH_FINGERNAIL,0.65509607771261
CDPCR1_01,SET,117,0.18605,0.014804,0.082847,0.012367,CDPCR1_01,0.65509607771261
HP_ABNORMAL_CIRCULATING_BRAN...,SET,8,0.6557,0.013684,0.29199,0.012369,HP_ABNORMAL_CIRCULATING_BRANCHED_CHAIN_AMINO_ACID_CONCENTRATION,0.65509607771261
GSE45365_HEALTHY_VS_MCMV_INF...11,SET,157,0.15325,0.01411,0.068252,0.012379,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN,0.65509607771261
GSE411_UNSTIM_VS_400MIN_IL6_...1,SET,180,0.13659,0.013458,0.060856,0.012405,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN,0.65509607771261
GSE34156_UNTREATED_VS_24H_NO...3,SET,176,0.14628,0.014253,0.065201,0.012436,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN,0.65509607771261
MIR8066,SET,142,0.16179,0.014173,0.072113,0.012438,MIR8066,0.65509607771261
KEGG_MEDICUS_PATHOGEN_HCV_CO...3,SET,5,0.89421,0.014754,0.39858,0.01244,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_PPARA_MEDIATED_TRANSCRIPTION,0.65509607771261
GSE3982_EFF_MEMORY_CD4_TCELL...5,SET,184,0.13357,0.013305,0.059543,0.012444,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN,0.65509607771261
HP_AGAMMAGLOBULINEMIA,SET,19,0.45913,0.014762,0.20467,0.012445,HP_AGAMMAGLOBULINEMIA,0.65509607771261
GOBP_NEGATIVE_REGULATION_OF_...408,SET,7,0.75003,0.014642,0.33455,0.012491,GOBP_NEGATIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,0.65509607771261
HP_ABNORMAL_ALVEOLAR_RIDGE_M...,SET,38,0.29377,0.01335,0.13108,0.012513,HP_ABNORMAL_ALVEOLAR_RIDGE_MORPHOLOGY,0.65509607771261
GOMF_MAP_KINASE_KINASE_KINAS...2,SET,6,0.77558,0.014018,0.3461,0.012523,GOMF_MAP_KINASE_KINASE_KINASE_KINASE_ACTIVITY,0.65509607771261
REACTOME_RETINOID_CYCLE_DISE...,SET,11,0.56771,0.013891,0.25336,0.012529,REACTOME_RETINOID_CYCLE_DISEASE_EVENTS,0.65509607771261
GOBP_GRANULOCYTE_DIFFERENTIA...,SET,38,0.31343,0.014244,0.13994,0.012558,GOBP_GRANULOCYTE_DIFFERENTIATION,0.65509607771261
GOBP_POSITIVE_REGULATION_OF_...768,SET,31,0.30815,0.012651,0.13763,0.012585,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.65509607771261
GOMF_G_PROTEIN_COUPLED_NEURO...,SET,12,0.58351,0.014912,0.26075,0.012625,GOMF_G_PROTEIN_COUPLED_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.65509607771261
GOBP_IMMUNOGLOBULIN_PRODUCTI...2,SET,47,0.26415,0.013348,0.11806,0.012635,GOBP_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE,0.65509607771261
REACTOME_GRB2_SOS_PROVIDES_L...,SET,15,0.52105,0.014887,0.23297,0.012664,REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,0.65509607771261
GOBP_REGULATION_OF_OSTEOCLAS...2,SET,65,0.25965,0.015421,0.11611,0.012673,GOBP_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.65509607771261
MIR506_5P,SET,118,0.17343,0.013858,0.077562,0.012684,MIR506_5P,0.65509607771261
GSE16522_ANTI_CD3CD28_STIM_V...3,SET,179,0.13684,0.013445,0.061205,0.012689,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN,0.65509607771261
GOBP_REGULATION_OF_MYOSIN_LI...,SET,7,0.63436,0.012384,0.28408,0.012778,GOBP_REGULATION_OF_MYOSIN_LIGHT_CHAIN_PHOSPHATASE_ACTIVITY,0.65509607771261
KEGG_GLYCOSPHINGOLIPID_BIOSY...1,SET,15,0.5416,0.015474,0.24254,0.012781,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,0.65509607771261
NKX22_01,SET,169,0.15702,0.014995,0.07033,0.012793,NKX22_01,0.65509607771261
MIR4711_3P,SET,73,0.2276,0.014323,0.10195,0.012798,MIR4711_3P,0.65509607771261
GSE24634_IL4_VS_CTRL_TREATED...3,SET,176,0.1442,0.01405,0.064593,0.012799,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN,0.65509607771261
HP_HYPOPLASTIC_SPLEEN,SET,8,0.6964,0.014533,0.31195,0.012801,HP_HYPOPLASTIC_SPLEEN,0.65509607771261
HP_RECURRENT_TONSILLITIS,SET,12,0.58716,0.015006,0.26303,0.012806,HP_RECURRENT_TONSILLITIS,0.65509607771261
GSE30971_2H_VS_4H_LPS_STIM_M...4,SET,184,0.13575,0.013521,0.060818,0.012812,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP,0.65509607771261
MIR7106_3P,SET,37,0.30289,0.013583,0.13572,0.012821,MIR7106_3P,0.65509607771261
GSE5589_WT_VS_IL10_KO_LPS_ST...3,SET,185,0.13793,0.013775,0.061807,0.012826,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,0.65509607771261
MIR197_5P,SET,57,0.24729,0.013757,0.11082,0.012831,MIR197_5P,0.65509607771261
E2F1DP1RB_01,SET,208,0.12991,0.013748,0.058234,0.012855,E2F1DP1RB_01,0.65509607771261
HP_URINARY_TRACT_NEOPLASM,SET,133,0.16204,0.013741,0.072639,0.012855,HP_URINARY_TRACT_NEOPLASM,0.65509607771261
WP_TRANSSULFURATION_ONECARBO...,SET,63,0.23904,0.013978,0.10722,0.012902,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.656528565153734
MYLLYKANGAS_AMPLIFICATION_HO...10,SET,14,0.46116,0.012729,0.20698,0.012943,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24,0.656945605839416
GOBP_POSITIVE_REGULATION_OF_...773,SET,9,0.54026,0.011958,0.24249,0.012948,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NUCLEOLAR_LARGE_RRNA_BY_RNA_POLYMERASE_I,0.656945605839416
KEGG_MEDICUS_VARIANT_EML4_AL...3,SET,13,0.52634,0.014,0.23673,0.013102,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY,0.660345
HP_PAPILLARY_THYROID_CARCINO...,SET,24,0.37752,0.01364,0.1698,0.013104,HP_PAPILLARY_THYROID_CARCINOMA,0.660345
GALIE_TUMOR_ANGIOGENESIS,SET,7,0.76725,0.014978,0.34514,0.013114,GALIE_TUMOR_ANGIOGENESIS,0.660345
GSE6269_HEALTHY_VS_E_COLI_IN...2,SET,157,0.14397,0.013256,0.064774,0.013127,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP,0.660345
MIR6804_3P,SET,85,0.20849,0.014153,0.093827,0.013145,MIR6804_3P,0.660345
GOMF_IMMUNOGLOBULIN_RECEPTOR...1,SET,12,0.66079,0.016887,0.29751,0.01318,GOMF_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY,0.660345
GSE43863_TH1_VS_LY6C_INT_CXC...1,SET,189,0.13477,0.013603,0.060688,0.013189,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,0.660345
HP_DIAPHYSEAL_DYSPLASIA,SET,5,0.86762,0.014316,0.39071,0.013194,HP_DIAPHYSEAL_DYSPLASIA,0.660345
HP_DISTAL_LOWER_LIMB_AMYOTRO...,SET,46,0.2865,0.014322,0.12905,0.013216,HP_DISTAL_LOWER_LIMB_AMYOTROPHY,0.660345
GOCC_RIBONUCLEASE_MRP_COMPLEX,SET,8,0.62181,0.012977,0.28013,0.013226,GOCC_RIBONUCLEASE_MRP_COMPLEX,0.660345
MIR1277_3P,SET,14,0.49611,0.013694,0.22351,0.013229,MIR1277_3P,0.660345
PLASARI_TGFB1_TARGETS_10HR_UP,SET,186,0.14831,0.014852,0.066832,0.013243,PLASARI_TGFB1_TARGETS_10HR_UP,0.660345
REACTOME_DEFECTIVE_ST3GAL3_C...,SET,8,0.61885,0.012915,0.27907,0.0133,REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15,0.661849755586592
HP_APLASIA_HYPOPLASIA_OF_THE...67,SET,83,0.19413,0.013023,0.087561,0.013313,HP_APLASIA_HYPOPLASIA_OF_THE_SPLEEN,0.661849755586592
GOBP_INTERFERON_BETA_PRODUCT...,SET,49,0.25265,0.013035,0.11399,0.013338,GOBP_INTERFERON_BETA_PRODUCTION,0.661849755586592
HP_BROAD_PHILTRUM,SET,42,0.2749,0.013133,0.12406,0.013358,HP_BROAD_PHILTRUM,0.661849755586592
GSE35685_CD34POS_CD38NEG_VS_...1,SET,188,0.13464,0.013554,0.060786,0.013386,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN,0.661849755586592
HP_SEVERE_POSTNATAL_GROWTH_R...,SET,32,0.33525,0.013984,0.15144,0.013427,HP_SEVERE_POSTNATAL_GROWTH_RETARDATION,0.661849755586592
MIR23A_5P,SET,30,0.34506,0.013937,0.15588,0.013433,MIR23A_5P,0.661849755586592
WEINBERGER_BLOOD_TWINRIX_AGE...3,SET,6,0.88401,0.015978,0.39944,0.013451,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_HIGH_ANTI_HBS_CONC_AT_WEEK_4_POST_BOOSTER_VACC_1DY_POSITIVE,0.661849755586592
HP_ANTENATAL_ONSET,SET,215,0.12478,0.013423,0.056396,0.013469,HP_ANTENATAL_ONSET,0.661849755586592
GOBP_REGULATION_OF_INTRINSIC...4,SET,15,0.458,0.013085,0.207,0.013472,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,0.661849755586592
GOBP_NUCLEOSIDE_TRIPHOSPHATE...2,SET,12,0.57874,0.014791,0.26169,0.013506,GOBP_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS,0.661849755586592
GSE18893_TCONV_VS_TREG_24H_T...1,SET,169,0.13779,0.013158,0.062332,0.01354,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN,0.661849755586592
WP_TCELL_ACTIVATION_SARSCOV2,SET,86,0.20957,0.014309,0.094823,0.013554,WP_TCELL_ACTIVATION_SARSCOV2,0.661849755586592
GSE36527_CD62L_HIGH_VS_CD62L...2,SET,180,0.13878,0.013674,0.062804,0.013566,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP,0.661849755586592
KEGG_MEDICUS_PATHOGEN_HCV_CO...2,SET,6,0.74636,0.01349,0.3379,0.013601,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_LXRA_MEDIATED_TRANSCRIPTION,0.661849755586592
RUIZ_TNC_TARGETS_DN,SET,136,0.15876,0.013613,0.071882,0.013608,RUIZ_TNC_TARGETS_DN,0.661849755586592
MORF_CCNI,SET,82,0.1968,0.013123,0.089114,0.013613,MORF_CCNI,0.661849755586592
GOMF_N_METHYLTRANSFERASE_ACT...,SET,82,0.19552,0.013037,0.088542,0.013621,GOMF_N_METHYLTRANSFERASE_ACTIVITY,0.661849755586592
REACTOME_MITOTIC_PROMETAPHASE,SET,185,0.13213,0.013196,0.059846,0.013635,REACTOME_MITOTIC_PROMETAPHASE,0.661849755586592
GOBP_NEGATIVE_REGULATION_OF_...430,SET,5,0.68945,0.011376,0.3124,0.013665,GOBP_NEGATIVE_REGULATION_OF_MYOSIN_LIGHT_CHAIN_PHOSPHATASE_ACTIVITY,0.662380857740586
GSE339_CD8POS_VS_CD4CD8DN_DC...1,SET,182,0.13142,0.01302,0.059575,0.013698,GSE339_CD8POS_VS_CD4CD8DN_DC_DN,0.662566358189081
DESCARTES_FETAL_EYE_SKELETAL...,SET,132,0.16615,0.014037,0.075331,0.013711,DESCARTES_FETAL_EYE_SKELETAL_MUSCLE_CELLS,0.662566358189081
HP_ADENOMATOUS_COLONIC_POLYP...,SET,17,0.39615,0.012049,0.1797,0.013749,HP_ADENOMATOUS_COLONIC_POLYPOSIS,0.662566358189081
GOMF_RETINOIC_ACID_BINDING,SET,26,0.47263,0.017773,0.21444,0.013767,GOMF_RETINOIC_ACID_BINDING,0.662566358189081
GSE27786_ERYTHROBLAST_VS_MON...2,SET,173,0.13866,0.013396,0.062952,0.013818,GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP,0.662566358189081
GSE9988_LOW_LPS_VS_CTRL_TREA...2,SET,165,0.15452,0.014582,0.07019,0.013858,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP,0.662566358189081
GSE36888_UNTREATED_VS_IL2_TR...2,SET,168,0.1486,0.014149,0.067524,0.013884,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP,0.662566358189081
REACTOME_AGGREPHAGY,SET,38,0.32276,0.014668,0.14668,0.013898,REACTOME_AGGREPHAGY,0.662566358189081
GSE17721_LPS_VS_GARDIQUIMOD_...16,SET,187,0.13345,0.013399,0.060718,0.013984,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP,0.662566358189081
MIR3173_5P,SET,93,0.19325,0.013719,0.087947,0.014004,MIR3173_5P,0.662566358189081
GSE42088_UNINF_VS_LEISHMANIA...5,SET,178,0.13997,0.013715,0.063704,0.014009,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN,0.662566358189081
GOBP_CELLULAR_RESPONSE_TO_IN...8,SET,78,0.21602,0.01405,0.098364,0.014047,GOBP_CELLULAR_RESPONSE_TO_INTERLEUKIN_1,0.662566358189081
GSE15767_MED_VS_SCS_MAC_LN_UP,SET,176,0.14517,0.014145,0.066111,0.014057,GSE15767_MED_VS_SCS_MAC_LN_UP,0.662566358189081
WANG_CLASSIC_ADIPOGENIC_TARG...,SET,27,0.36974,0.014168,0.16842,0.014077,WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,0.662566358189081
HP_LIMB_MUSCLE_WEAKNESS,SET,306,0.10517,0.013464,0.047912,0.014084,HP_LIMB_MUSCLE_WEAKNESS,0.662566358189081
GSE32533_WT_VS_MIR17_OVEREXP...1,SET,174,0.14703,0.014245,0.066981,0.014084,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,0.662566358189081
GOBP_REGULATION_OF_INTRINSIC...2,SET,28,0.34942,0.013635,0.15922,0.014104,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.662566358189081
GSE17721_0.5H_VS_8H_PAM3CSK4...2,SET,181,0.13345,0.013184,0.060812,0.014108,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_UP,0.662566358189081
GSE43955_TH0_VS_TGFB_IL6_TH1...11,SET,190,0.13416,0.013576,0.061141,0.014117,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN,0.662566358189081
GSE17721_POLYIC_VS_GARDIQUIM...15,SET,184,0.13003,0.012951,0.059271,0.014132,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_DN,0.662566358189081
GSE18148_CBFB_KO_VS_WT_TREG_...2,SET,173,0.1415,0.01367,0.064516,0.014151,GSE18148_CBFB_KO_VS_WT_TREG_UP,0.662566358189081
MODULE_121,SET,94,0.21403,0.015275,0.097615,0.014173,MODULE_121,0.662566358189081
GSE18281_CORTICAL_VS_MEDULLA...2,SET,182,0.14048,0.013917,0.064081,0.014188,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP,0.662566358189081
LI_INDUCED_T_TO_NATURAL_KILL...1,SET,127,0.16479,0.013658,0.075193,0.014212,LI_INDUCED_T_TO_NATURAL_KILLER_DN,0.662566358189081
HP_BCGITIS,SET,10,0.62931,0.014682,0.28718,0.01422,HP_BCGITIS,0.662566358189081
GOBP_POSITIVE_REGULATION_OF_...296,SET,1056,0.059437,0.013838,0.027124,0.014221,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION,0.662566358189081
HP_SLOWED_SLURRED_SPEECH,SET,6,0.71118,0.012854,0.32465,0.014247,HP_SLOWED_SLURRED_SPEECH,0.662566358189081
GOMF_VOLTAGE_GATED_CALCIUM_C...1,SET,41,0.31287,0.014768,0.14283,0.014251,GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.662566358189081
GOBP_REGULATION_OF_HEMOPOIES...,SET,384,0.098572,0.014105,0.045006,0.014261,GOBP_REGULATION_OF_HEMOPOIESIS,0.662566358189081
GSE17721_POLYIC_VS_CPG_12H_B...1,SET,183,0.13384,0.013295,0.061114,0.014268,GSE17721_POLYIC_VS_CPG_12H_BMDC_DN,0.662566358189081
GSE40666_WT_VS_STAT1_KO_CD8_...4,SET,178,0.13882,0.013602,0.063391,0.014274,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.662566358189081
HP_MYALGIA,SET,157,0.14812,0.013638,0.067657,0.014296,HP_MYALGIA,0.662566358189081
GOBP_POSITIVE_REGULATION_OF_...256,SET,176,0.14469,0.014098,0.066109,0.014317,GOBP_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,0.662566358189081
GOMF_SIGNAL_SEQUENCE_BINDING,SET,43,0.25887,0.012513,0.11828,0.014317,GOMF_SIGNAL_SEQUENCE_BINDING,0.662566358189081
HP_NORMAL_PRESSURE_HYDROCEPH...,SET,5,0.8844,0.014592,0.40429,0.014359,HP_NORMAL_PRESSURE_HYDROCEPHALUS,0.662883545816733
MODULE_404,SET,25,0.40629,0.014982,0.18574,0.014362,MODULE_404,0.662883545816733
MIR873_5P,SET,101,0.18553,0.013722,0.084946,0.014484,MIR873_5P,0.667157900662252
GSE15930_STIM_VS_STIM_AND_IL...6,SET,181,0.1294,0.012784,0.059251,0.014493,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP,0.667157900662252
MIR3922_5P,SET,92,0.19449,0.013733,0.089104,0.014535,MIR3922_5P,0.66820625
GSE24972_MARGINAL_ZONE_BCELL...3,SET,184,0.14028,0.013973,0.064299,0.014572,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP,0.66855231530343
BIOCARTA_FOSB_PATHWAY,SET,5,0.83254,0.013737,0.38165,0.014581,BIOCARTA_FOSB_PATHWAY,0.66855231530343
MIR7850_5P,SET,110,0.17599,0.013581,0.08071,0.014616,MIR7850_5P,0.668622177631579
HU_FETAL_RETINA_MICROGLIA,SET,338,0.10444,0.01404,0.047901,0.014621,HU_FETAL_RETINA_MICROGLIA,0.668622177631579
ZHENG_CORD_BLOOD_C2_PUTATIVE...,SET,86,0.20159,0.013764,0.092516,0.014675,ZHENG_CORD_BLOOD_C2_PUTATIVE_BASOPHIL_EOSINOPHIL_MAST_CELL_PROGENITOR,0.670209756898817
GSE27896_HDAC6_KO_VS_WT_TREG...2,SET,164,0.14022,0.013193,0.064374,0.014699,GSE27896_HDAC6_KO_VS_WT_TREG_UP,0.670320550458716
GOBP_NERVE_GROWTH_FACTOR_SIG...,SET,14,0.54537,0.015054,0.25042,0.014716,GOBP_NERVE_GROWTH_FACTOR_SIGNALING_PATHWAY,0.670320550458716
GOMF_NUCLEAR_LOCALIZATION_SE...,SET,23,0.36188,0.0128,0.16624,0.014754,GOMF_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING,0.670677567567568
MODULE_430,SET,52,0.24365,0.012948,0.11201,0.014813,MODULE_430,0.670677567567568
GOBP_INORGANIC_ION_IMPORT_AC...,SET,113,0.17997,0.014075,0.082735,0.014813,GOBP_INORGANIC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.670677567567568
JIANG_HYPOXIA_CANCER,SET,53,0.25001,0.013413,0.11498,0.014846,JIANG_HYPOXIA_CANCER,0.670677567567568
HP_NEOPLASM_OF_THE_ADRENAL_G...,SET,45,0.26622,0.013164,0.12244,0.014847,HP_NEOPLASM_OF_THE_ADRENAL_GLAND,0.670677567567568
GAVISH_3CA_METAPROGRAM_MACRO...13,SET,42,0.27799,0.01328,0.12787,0.014859,GAVISH_3CA_METAPROGRAM_MACROPHAGES_UNFOLDED_PROTEIN_RESPONSE,0.670677567567568
LAKE_ADULT_KIDNEY_C16_COLLEC...,SET,124,0.1796,0.01471,0.082642,0.014887,LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX,0.670677567567568
MIR3187_5P,SET,109,0.17002,0.013061,0.078237,0.01489,MIR3187_5P,0.670677567567568
WP_IL17_SIGNALING,SET,30,0.34603,0.013976,0.15925,0.014898,WP_IL17_SIGNALING,0.670677567567568
GOBP_MUCUS_SECRETION,SET,19,0.4676,0.015034,0.21527,0.01493,GOBP_MUCUS_SECRETION,0.670677567567568
GOBP_POSITIVE_REGULATION_OF_...198,SET,11,0.55904,0.013679,0.25745,0.014955,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.670677567567568
WNT_SIGNALING,SET,82,0.21328,0.014221,0.098245,0.014975,WNT_SIGNALING,0.670677567567568
MODULE_156,SET,16,0.45787,0.01351,0.21093,0.014982,MODULE_156,0.670677567567568
GOBP_MEIOTIC_CELL_CYCLE_CHEC...,SET,9,0.67416,0.014922,0.31061,0.014994,GOBP_MEIOTIC_CELL_CYCLE_CHECKPOINT_SIGNALING,0.670677567567568
GOBP_SEX_DIFFERENTIATION,SET,260,0.11903,0.014063,0.054881,0.015053,GOBP_SEX_DIFFERENTIATION,0.671632567394095
GSE22443_NAIVE_VS_ACT_AND_IL...3,SET,185,0.13705,0.013688,0.063192,0.015054,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN,0.671632567394095
GOBP_LOCALIZATION_OF_CELL,SET,5,0.78348,0.012927,0.3614,0.015089,GOBP_LOCALIZATION_OF_CELL,0.672331019230769
GSE21360_PRIMARY_VS_TERTIARY...1,SET,180,0.14009,0.013802,0.064653,0.015133,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.67342818822023
WP_SEROTONIN_RECEPTOR_467_AN...,SET,18,0.47512,0.014869,0.2194,0.015179,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,0.673728649144254
SEITZ_NEOPLASTIC_TRANSFORMAT...2,SET,67,0.24797,0.014952,0.11453,0.015196,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,0.673728649144254
HP_ABNORMAL_ATRIOVENTRICULAR...3,SET,150,0.15505,0.013957,0.071623,0.01521,HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_MORPHOLOGY,0.673728649144254
GOBP_FOREBRAIN_NEURON_FATE_C...,SET,7,0.82735,0.016151,0.3823,0.015234,GOBP_FOREBRAIN_NEURON_FATE_COMMITMENT,0.673728649144254
HP_CYTOCHROME_C_OXIDASE_NEGA...,SET,26,0.32801,0.012335,0.15164,0.01527,HP_CYTOCHROME_C_OXIDASE_NEGATIVE_MUSCLE_FIBERS,0.673728649144254
MIR6794_5P,SET,78,0.20533,0.013355,0.094954,0.015299,MIR6794_5P,0.673728649144254
GOMF_COMPLEMENT_BINDING,SET,20,0.43633,0.014393,0.2019,0.015352,GOMF_COMPLEMENT_BINDING,0.673728649144254
AP4_Q6_01,SET,233,0.11964,0.013392,0.05538,0.015377,AP4_Q6_01,0.673728649144254
HERNANDEZ_ABERRANT_MITOSIS_B...1,SET,18,0.45594,0.014269,0.21112,0.015406,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,0.673728649144254
MIR5196_3P,SET,60,0.23113,0.013191,0.10702,0.015407,MIR5196_3P,0.673728649144254
GAVISH_3CA_METAPROGRAM_ENDOT...12,SET,47,0.28021,0.014159,0.12975,0.015407,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_INTERFERON,0.673728649144254
MODULE_313,SET,13,0.49112,0.013063,0.22745,0.015422,MODULE_313,0.673728649144254
GSE1460_INTRATHYMIC_T_PROGEN...1,SET,186,0.14233,0.014253,0.06598,0.015501,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN,0.673728649144254
QI_PBMC_ZOSTAVAX_AGE_50_75YO...1,SET,6,0.7043,0.01273,0.32653,0.015511,QI_PBMC_ZOSTAVAX_AGE_50_75YO_1DY_UP,0.673728649144254
HP_GASTRIC_ULCER,SET,5,0.76964,0.012699,0.35695,0.015542,HP_GASTRIC_ULCER,0.673728649144254
GOBP_RENAL_SYSTEM_VASCULATUR...1,SET,31,0.36767,0.015095,0.17053,0.015549,GOBP_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT,0.673728649144254
GSE37301_LYMPHOID_PRIMED_MPP...10,SET,185,0.12837,0.01282,0.059544,0.015556,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP,0.673728649144254
GOBP_REGULATION_OF_CALCIUM_I...8,SET,223,0.12692,0.013902,0.058892,0.015585,GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT,0.673728649144254
REACTOME_DEFECTIVE_C1GALT1C1...,SET,14,0.50886,0.014046,0.23615,0.015596,REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS,0.673728649144254
GOBP_BLEB_ASSEMBLY,SET,11,0.58871,0.014405,0.27321,0.015596,GOBP_BLEB_ASSEMBLY,0.673728649144254
MIR593_3P,SET,127,0.16883,0.013993,0.078365,0.015611,MIR593_3P,0.673728649144254
GOBP_REGULATION_OF_RRNA_PROC...,SET,15,0.47012,0.013432,0.21833,0.015657,GOBP_REGULATION_OF_RRNA_PROCESSING,0.673728649144254
MIR181A_2_3P,SET,99,0.18448,0.01351,0.085701,0.015683,MIR181A_2_3P,0.673728649144254
GOBP_CHONDROITIN_SULFATE_BIO...,SET,18,0.40197,0.01258,0.18674,0.015684,GOBP_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS,0.673728649144254
NIKOLSKY_OVERCONNECTED_IN_BR...,SET,21,0.38868,0.013137,0.18058,0.015689,NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,0.673728649144254
HP_ATROPHY_DEGENERATION_INVO...3,SET,19,0.39152,0.012588,0.18194,0.015711,HP_ATROPHY_DEGENERATION_INVOLVING_THE_SPINAL_CORD,0.673728649144254
BROWNE_HCMV_INFECTION_4HR_UP,SET,47,0.27119,0.013703,0.12603,0.015714,BROWNE_HCMV_INFECTION_4HR_UP,0.673728649144254
WP_IMATINIB_AND_CHRONIC_MYEL...,SET,19,0.45051,0.014485,0.20944,0.015741,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,0.673728649144254
HP_SKIN_ULCER,SET,122,0.16712,0.013577,0.077727,0.015781,HP_SKIN_ULCER,0.673728649144254
KEGG_GLYCOSAMINOGLYCAN_BIOSY...1,SET,21,0.36646,0.012386,0.17045,0.015783,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,0.673728649144254
GOCC_COPII_COATED_ER_TO_GOLG...,SET,84,0.19913,0.013438,0.092622,0.015787,GOCC_COPII_COATED_ER_TO_GOLGI_TRANSPORT_VESICLE,0.673728649144254
HP_ABNORMAL_CHEEK_MORPHOLOGY,SET,231,0.11611,0.012941,0.054011,0.015798,HP_ABNORMAL_CHEEK_MORPHOLOGY,0.673728649144254
GSE3982_MAC_VS_NKCELL_UP,SET,180,0.13785,0.013581,0.064127,0.015801,GSE3982_MAC_VS_NKCELL_UP,0.673728649144254
HAY_BONE_MARROW_CD34_POS_MEP,SET,8,0.65881,0.013749,0.30658,0.015827,HAY_BONE_MARROW_CD34_POS_MEP,0.673728649144254
GOBP_REGULATION_OF_GRANULOCY...2,SET,15,0.45184,0.012909,0.21029,0.015836,GOBP_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,0.673728649144254
WP_PROSTAGLANDIN_SYNTHESIS_A...,SET,45,0.30778,0.015219,0.14325,0.015839,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,0.673728649144254
GAUCHER_PBMC_YF_VAX_STAMARIL...7,SET,91,0.18873,0.013254,0.087858,0.015857,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_DN,0.673728649144254
RODRIGUES_THYROID_CARCINOMA_...6,SET,14,0.53956,0.014893,0.25131,0.015902,RODRIGUES_THYROID_CARCINOMA_UP,0.674031526980482
MIR4722_5P,SET,127,0.16419,0.013608,0.076476,0.015903,MIR4722_5P,0.674031526980482
GOBP_PODOCYTE_CELL_MIGRATION,SET,7,0.72474,0.014148,0.33775,0.015952,GOBP_PODOCYTE_CELL_MIGRATION,0.674031526980482
KEGG_MEDICUS_VARIANT_AMPLIFI...13,SET,15,0.42999,0.012285,0.20048,0.015991,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_P27_CELL_CYCLE_G1_S,0.674031526980482
GSE9988_ANTI_TREM1_AND_LPS_V...2,SET,165,0.15016,0.014171,0.070032,0.016015,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP,0.674031526980482
GOBP_MYELOID_DENDRITIC_CELL_...2,SET,6,0.72756,0.01315,0.33933,0.016019,GOBP_MYELOID_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.674031526980482
HP_ABNORMAL_SWEAT_GLAND_MORP...,SET,18,0.46186,0.014454,0.21546,0.01604,HP_ABNORMAL_SWEAT_GLAND_MORPHOLOGY,0.674031526980482
GSE17721_CTRL_VS_PAM3CSK4_0....1,SET,181,0.13155,0.012997,0.0614,0.016081,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_DN,0.674031526980482
GSE2706_R848_VS_R848_AND_LPS...4,SET,156,0.14806,0.013589,0.069124,0.016108,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP,0.674031526980482
CUI_GLUCOSE_DEPRIVATION,SET,52,0.26348,0.014002,0.12302,0.016111,CUI_GLUCOSE_DEPRIVATION,0.674031526980482
GOBP_GAMMA_AMINOBUTYRIC_ACID...3,SET,8,0.68922,0.014383,0.32182,0.016118,GOBP_GAMMA_AMINOBUTYRIC_ACID_METABOLIC_PROCESS,0.674031526980482
HP_NEUROENDOCRINE_NEOPLASM,SET,37,0.27458,0.012314,0.12828,0.016167,HP_NEUROENDOCRINE_NEOPLASM,0.674031526980482
KORKOLA_YOLK_SAC_TUMOR_UP,SET,13,0.57817,0.015379,0.27014,0.016172,KORKOLA_YOLK_SAC_TUMOR_UP,0.674031526980482
GSE37301_HEMATOPOIETIC_STEM_...8,SET,165,0.14078,0.013285,0.065776,0.016175,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP,0.674031526980482
NAKAYA_PBMC_FLUAD_MALE_AGE_1...1,SET,36,0.31548,0.013955,0.1474,0.016176,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_ATIV_UP,0.674031526980482
GSE20500_CTRL_VS_RETINOIC_AC...1,SET,174,0.1379,0.013361,0.064435,0.016177,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN,0.674031526980482
GOBP_EPIGENETIC_PROGRAMMING_...2,SET,28,0.3277,0.012787,0.15321,0.016226,GOBP_EPIGENETIC_PROGRAMMING_OF_GENE_EXPRESSION,0.674031526980482
GSE3982_DC_VS_BCELL_UP,SET,183,0.13509,0.01342,0.063204,0.016289,GSE3982_DC_VS_BCELL_UP,0.674031526980482
GOCC_ER_TO_GOLGI_TRANSPORT_V...,SET,56,0.24855,0.013706,0.11641,0.016383,GOCC_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE,0.674031526980482
HP_FETAL_ONSET,SET,170,0.13238,0.012679,0.062005,0.016388,HP_FETAL_ONSET,0.674031526980482
GOBP_CORNEA_DEVELOPMENT_IN_C...,SET,12,0.59996,0.015333,0.28124,0.016457,GOBP_CORNEA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.674031526980482
GSE3720_UNSTIM_VS_PMA_STIM_V...4,SET,148,0.14166,0.012667,0.066408,0.016461,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,0.674031526980482
GOBP_REGULATION_OF_CHOLESTER...1,SET,16,0.43587,0.012861,0.20446,0.01652,GOBP_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS,0.674031526980482
GOCC_ANNULATE_LAMELLAE,SET,5,0.73909,0.012195,0.34673,0.016526,GOCC_ANNULATE_LAMELLAE,0.674031526980482
KEGG_NOD_LIKE_RECEPTOR_SIGNA...,SET,57,0.23589,0.013122,0.11069,0.01655,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.674031526980482
MATSUMIYA_BLOOD_MODIFIED_VAC...1,SET,9,0.59909,0.01326,0.28114,0.016553,MATSUMIYA_BLOOD_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_DN,0.674031526980482
GOBP_DNA_TEMPLATED_DNA_REPLI...2,SET,54,0.24134,0.013069,0.11326,0.016556,GOBP_DNA_TEMPLATED_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY,0.674031526980482
HP_ABNORMAL_PROPORTION_OF_NA...,SET,4,1.0154,0.014986,0.47664,0.016578,HP_ABNORMAL_PROPORTION_OF_NAIVE_T_CELLS,0.674031526980482
TERAMOTO_OPN_TARGETS_CLUSTER...6,SET,17,0.45911,0.013963,0.21553,0.016587,TERAMOTO_OPN_TARGETS_CLUSTER_7,0.674031526980482
KEGG_MEDICUS_REFERENCE_PRNP_...,SET,27,0.34837,0.013349,0.16357,0.016604,KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY,0.674031526980482
HP_ABNORMAL_CALCIFICATION_OF...,SET,5,0.90244,0.01489,0.42374,0.016605,HP_ABNORMAL_CALCIFICATION_OF_THE_CARPAL_BONES,0.674031526980482
HP_ARTERIAL_STENOSIS,SET,94,0.19237,0.013729,0.090343,0.01662,HP_ARTERIAL_STENOSIS,0.674031526980482
HP_RENAL_CELL_CARCINOMA,SET,70,0.21065,0.012982,0.098931,0.016621,HP_RENAL_CELL_CARCINOMA,0.674031526980482
HP_ADDUCTED_THUMB,SET,97,0.18298,0.013265,0.085939,0.016625,HP_ADDUCTED_THUMB,0.674031526980482
HARALAMBIEVA_PBMC_TIV_AGE_50...2,SET,13,0.41651,0.011079,0.19566,0.016646,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_3DY_NEGATIVE,0.674031526980482
GOBP_INTERMEDIATE_FILAMENT_B...1,SET,92,0.22556,0.015927,0.10602,0.016691,GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS,0.674031526980482
HP_ABNORMAL_OVARIAN_MORPHOLO...,SET,158,0.14319,0.013226,0.067305,0.016696,HP_ABNORMAL_OVARIAN_MORPHOLOGY,0.674031526980482
GOBP_TRNA_5_END_PROCESSING,SET,13,0.43946,0.011689,0.20657,0.016701,GOBP_TRNA_5_END_PROCESSING,0.674031526980482
KAPOSI_LIVER_CANCER_MET_DN,SET,5,0.84619,0.013962,0.39777,0.016703,KAPOSI_LIVER_CANCER_MET_DN,0.674031526980482
HP_APLASIA_HYPOPLASIA_OF_THE...7,SET,58,0.23548,0.013214,0.1107,0.016709,HP_APLASIA_HYPOPLASIA_OF_THE_5TH_FINGER,0.674031526980482
WP_GANGLIO_SPHINGOLIPID_META...,SET,13,0.54093,0.014388,0.25439,0.016742,WP_GANGLIO_SPHINGOLIPID_METABOLISM,0.674031526980482
KEGG_ABC_TRANSPORTERS,SET,42,0.29649,0.014164,0.13945,0.016755,KEGG_ABC_TRANSPORTERS,0.674031526980482
LAKE_ADULT_KIDNEY_C17_COLLEC...,SET,225,0.12662,0.01393,0.059566,0.016773,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.674031526980482
REACTOME_TRANSLESION_SYNTHES...2,SET,16,0.39761,0.011732,0.18707,0.016781,REACTOME_TRANSLESION_SYNTHESIS_BY_POLK,0.674031526980482
MUNSHI_MULTIPLE_MYELOMA_DN,SET,9,0.66612,0.014744,0.31341,0.016784,MUNSHI_MULTIPLE_MYELOMA_DN,0.674031526980482
MARKS_HDAC_TARGETS_DN,SET,14,0.50465,0.01393,0.2375,0.016805,MARKS_HDAC_TARGETS_DN,0.674031526980482
GSE22601_IMMATURE_CD4_SINGLE...2,SET,179,0.1251,0.012292,0.058888,0.016825,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.674031526980482
HP_TONGUE_NODULES,SET,12,0.42767,0.01093,0.20132,0.016829,HP_TONGUE_NODULES,0.674031526980482
GSE19888_ADENOSINE_A3R_ACT_V...6,SET,178,0.13602,0.013328,0.064066,0.016876,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP,0.674031526980482
GSE8921_UNSTIM_VS_TLR1_2_STI...1,SET,179,0.13165,0.012935,0.062012,0.016883,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN,0.674031526980482
PID_GMCSF_PATHWAY,SET,35,0.30954,0.013502,0.14581,0.016889,PID_GMCSF_PATHWAY,0.674031526980482
GOBP_MEIOTIC_CHROMOSOME_SEPA...,SET,9,0.52542,0.01163,0.2475,0.016889,GOBP_MEIOTIC_CHROMOSOME_SEPARATION,0.674031526980482
GSE42088_2H_VS_24H_LEISHMANI...1,SET,173,0.13302,0.012851,0.062664,0.016892,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN,0.674031526980482
GSE9946_LISTERIA_INF_MATURE_...1,SET,100,0.18126,0.01334,0.085454,0.016963,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,0.674381433447099
HP_PANCREATIC_CYSTS,SET,33,0.28065,0.011887,0.13233,0.016977,HP_PANCREATIC_CYSTS,0.674381433447099
KEGG_MEDICUS_PATHOGEN_ESCHER...8,SET,4,0.85571,0.012629,0.40352,0.016984,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_TIR_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.674381433447099
GOCC_MULTIVESICULAR_BODY_MEM...,SET,27,0.3354,0.012852,0.15817,0.016989,GOCC_MULTIVESICULAR_BODY_MEMBRANE,0.674381433447099
GENTILE_UV_RESPONSE_CLUSTER_...8,SET,24,0.37962,0.013716,0.17907,0.017012,GENTILE_UV_RESPONSE_CLUSTER_D9,0.674381433447099
GOBP_NEGATIVE_REGULATION_OF_...113,SET,581,0.078051,0.013663,0.036833,0.017051,GOBP_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION,0.674381433447099
GSE41867_LCMV_ARMSTRONG_VS_C...4,SET,181,0.12769,0.012615,0.060258,0.017053,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_UP,0.674381433447099
WP_TLR4_SIGNALING_AND_TOLERA...,SET,26,0.33054,0.01243,0.156,0.017056,WP_TLR4_SIGNALING_AND_TOLERANCE,0.674381433447099
GOBP_TISSUE_HOMEOSTASIS,SET,247,0.12077,0.013913,0.057042,0.01713,GOBP_TISSUE_HOMEOSTASIS,0.675791666666667
POU2AF1_TARGET_GENES,SET,664,0.069994,0.013068,0.033064,0.017139,POU2AF1_TARGET_GENES,0.675791666666667
GOBP_NEGATIVE_REGULATION_OF_...55,SET,29,0.36169,0.014363,0.17087,0.01715,GOBP_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION,0.675791666666667
DESCARTES_MAIN_FETAL_URETERI...,SET,27,0.35742,0.013696,0.16895,0.0172,DESCARTES_MAIN_FETAL_URETERIC_BUD_CELLS,0.676328372881356
GOBP_CELL_PROJECTION_ASSEMBLY,SET,537,0.077842,0.013116,0.036799,0.017206,GOBP_CELL_PROJECTION_ASSEMBLY,0.676328372881356
HP_TIBIALIS_ANTERIOR_MUSCLE_...,SET,4,0.94069,0.013883,0.44477,0.017222,HP_TIBIALIS_ANTERIOR_MUSCLE_ATROPHY,0.676328372881356
GSE42021_TREG_PLN_VS_CD24INT...1,SET,184,0.13588,0.013534,0.06426,0.017243,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN,0.676388786681716
GOBP_REGULATION_OF_NOTCH_SIG...,SET,86,0.19461,0.013288,0.092096,0.017302,GOBP_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.676550983146067
WP_QUERCETIN_AND_NFKB_AP1_IN...,SET,15,0.48813,0.013946,0.23102,0.017309,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.676550983146067
HP_ABNORMAL_ARTERIAL_PHYSIOL...,SET,154,0.14833,0.013527,0.0702,0.017311,HP_ABNORMAL_ARTERIAL_PHYSIOLOGY,0.676550983146067
MADAN_DPPA4_TARGETS,SET,49,0.25663,0.01324,0.12148,0.017325,MADAN_DPPA4_TARGETS,0.676550983146067
REACTOME_SIGNALING_BY_NOTCH2,SET,30,0.34293,0.013851,0.1624,0.017364,REACTOME_SIGNALING_BY_NOTCH2,0.676826350896861
GOBP_SULFATION,SET,20,0.4514,0.01489,0.21378,0.017371,GOBP_SULFATION,0.676826350896861
GOBP_UREA_TRANSMEMBRANE_TRAN...,SET,8,0.74902,0.015631,0.35533,0.017524,GOBP_UREA_TRANSMEMBRANE_TRANSPORT,0.682023090705487
SCHERER_PBMC_YF_VAX_OR_APSV_...,SET,21,0.40179,0.01358,0.19068,0.01756,SCHERER_PBMC_YF_VAX_OR_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_DN,0.682595966480447
GOBP_POSITIVE_REGULATION_OF_...646,SET,13,0.49167,0.013078,0.23338,0.017578,GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,0.682595966480447
GOCC_ROUGH_ENDOPLASMIC_RETIC...1,SET,52,0.23786,0.012641,0.11295,0.017612,GOCC_ROUGH_ENDOPLASMIC_RETICULUM,0.682623846153846
GAVISH_3CA_METAPROGRAM_CD8_T...11,SET,40,0.28125,0.013113,0.13356,0.017618,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1,0.682623846153846
GSE21033_3H_VS_12H_POLYIC_ST...1,SET,122,0.16777,0.01363,0.079727,0.017684,GSE21033_3H_VS_12H_POLYIC_STIM_DC_DN,0.683540687361419
MARTINEZ_RB1_TARGETS_DN,SET,496,0.080734,0.013089,0.038377,0.017708,MARTINEZ_RB1_TARGETS_DN,0.683540687361419
HP_MENORRHAGIA,SET,34,0.30082,0.012933,0.14302,0.017726,HP_MENORRHAGIA,0.683540687361419
HP_RAGGED_RED_MUSCLE_FIBERS,SET,40,0.26664,0.012432,0.12678,0.017734,HP_RAGGED_RED_MUSCLE_FIBERS,0.683540687361419
KEGG_CYTOSOLIC_DNA_SENSING_P...,SET,45,0.26292,0.013,0.12502,0.01774,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,0.683540687361419
MIR4717_3P,SET,71,0.21948,0.013622,0.10442,0.017791,MIR4717_3P,0.68414294800885
GOBP_BONE_RESORPTION,SET,65,0.23018,0.013671,0.10952,0.017795,GOBP_BONE_RESORPTION,0.68414294800885
KEGG_MEDICUS_VARIANT_PAX8_PP...,SET,5,0.79148,0.013059,0.37678,0.017845,KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION,0.684589105960265
HP_FETAL_PERICARDIAL_EFFUSION,SET,6,0.64475,0.011653,0.30694,0.017846,HP_FETAL_PERICARDIAL_EFFUSION,0.684589105960265
HP_HYPOREFLEXIA_OF_UPPER_LIM...,SET,7,0.75729,0.014784,0.36069,0.01789,HP_HYPOREFLEXIA_OF_UPPER_LIMBS,0.685520341786108
PID_ERBB4_PATHWAY,SET,38,0.27431,0.012466,0.13079,0.017987,PID_ERBB4_PATHWAY,0.688217821782178
GOBP_REGULATION_OF_CELL_PROJ...1,SET,202,0.12765,0.013315,0.06087,0.018,GOBP_REGULATION_OF_CELL_PROJECTION_ASSEMBLY,0.688217821782178
GOMF_DNA_BINDING_TRANSCRIPTI...4,SET,263,0.11162,0.013263,0.053245,0.018034,GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY,0.688760076923077
GOBP_NEGATIVE_REGULATION_OF_...44,SET,4,0.69495,0.010256,0.33192,0.018149,GOBP_NEGATIVE_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,0.690015753275109
HP_PANCREATIC_FIBROSIS,SET,21,0.327,0.011052,0.1562,0.01816,HP_PANCREATIC_FIBROSIS,0.690015753275109
GOBP_ERK1_AND_ERK2_CASCADE,SET,280,0.11015,0.013498,0.052616,0.018164,GOBP_ERK1_AND_ERK2_CASCADE,0.690015753275109
GSE16522_MEMORY_VS_NAIVE_ANT...1,SET,183,0.12885,0.012799,0.061561,0.018181,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN,0.690015753275109
REACTOME_TERMINATION_OF_O_GL...,SET,21,0.39678,0.013411,0.18958,0.018185,REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS,0.690015753275109
GESERICK_TERT_TARGETS_DN,SET,21,0.41445,0.014008,0.19802,0.018186,GESERICK_TERT_TARGETS_DN,0.690015753275109
GOBP_REGULATION_OF_RIBOSOME_...,SET,6,0.68948,0.012462,0.32971,0.018264,GOBP_REGULATION_OF_RIBOSOME_BIOGENESIS,0.690849659090909
HP_APLASIA_HYPOPLASIA_OF_THE...74,SET,37,0.26596,0.011927,0.12718,0.018265,HP_APLASIA_HYPOPLASIA_OF_THE_TONGUE,0.690849659090909
GOBP_COMPLEMENT_DEPENDENT_CY...,SET,13,0.54165,0.014407,0.25914,0.018307,GOBP_COMPLEMENT_DEPENDENT_CYTOTOXICITY,0.690849659090909
GSE411_WT_VS_SOCS3_KO_MACROP...1,SET,185,0.1263,0.012614,0.060429,0.018312,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN,0.690849659090909
CHESLER_BRAIN_QTL_CIS,SET,68,0.21319,0.01295,0.10203,0.01834,CHESLER_BRAIN_QTL_CIS,0.690849659090909
TAL1BETAITF2_01,SET,237,0.11796,0.013315,0.056456,0.01834,TAL1BETAITF2_01,0.690849659090909
KEGG_MEDICUS_VARIANT_AML1_ET...,SET,5,0.67853,0.011196,0.32481,0.018362,KEGG_MEDICUS_VARIANT_AML1_ETO_FUSION_TO_PU.1_MEDIATED_TRANSCRIPTION,0.690849659090909
MAINA_VHL_TARGETS_DN,SET,14,0.53598,0.014795,0.25659,0.018367,MAINA_VHL_TARGETS_DN,0.690849659090909
KEGG_MEDICUS_PATHOGEN_SARS_C...2,SET,12,0.57729,0.014753,0.27663,0.018457,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,0.692718501070664
GSE17721_POLYIC_VS_GARDIQUIM...17,SET,180,0.12419,0.012236,0.059541,0.018504,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN,0.692718501070664
MIR6845_5P,SET,56,0.23168,0.012775,0.1111,0.018529,MIR6845_5P,0.692718501070664
GSE3920_UNTREATED_VS_IFNA_TR...3,SET,179,0.12711,0.012489,0.060955,0.01853,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN,0.692718501070664
KALMA_E2F1_TARGETS,SET,11,0.44993,0.011009,0.21582,0.018554,KALMA_E2F1_TARGETS,0.692718501070664
GOBP_ESTABLISHMENT_OF_LYMPHO...,SET,15,0.45679,0.013051,0.21915,0.018573,GOBP_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY,0.692718501070664
HP_BROAD_DISTAL_PHALANX_OF_T...,SET,5,0.85518,0.01411,0.41031,0.018578,HP_BROAD_DISTAL_PHALANX_OF_THE_TOES,0.692718501070664
GSE20727_H2O2_VS_ROS_INHIBIT...1,SET,174,0.13377,0.01296,0.064183,0.01858,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN,0.692718501070664
chr4p12,SET,15,0.82126,0.023464,0.39417,0.018609,chr4p12,0.692718501070664
HP_ABNORMAL_TALUS_MORPHOLOGY,SET,61,0.22084,0.012708,0.106,0.018616,HP_ABNORMAL_TALUS_MORPHOLOGY,0.692718501070664
HP_PRIMARY_GONADAL_INSUFFICI...,SET,15,0.475,0.013571,0.22807,0.018647,HP_PRIMARY_GONADAL_INSUFFICIENCY,0.693129930481283
GOCC_SPERM_ANNULUS,SET,2,1.4039,0.014652,0.67427,0.018673,GOCC_SPERM_ANNULUS,0.693354823717949
HOWLIN_CITED1_TARGETS_2_UP,SET,16,0.41825,0.012341,0.20098,0.018723,HOWLIN_CITED1_TARGETS_2_UP,0.693584090425532
GSE40666_STAT1_KO_VS_STAT4_K...3,SET,145,0.1524,0.01349,0.073251,0.018746,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.693584090425532
REACTOME_SHC1_EVENTS_IN_EGFR...,SET,14,0.46029,0.012705,0.22124,0.018748,REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,0.693584090425532
HP_HEMOPTYSIS,SET,81,0.21115,0.013993,0.1015,0.018759,HP_HEMOPTYSIS,0.693584090425532
WP_CONSTITUTIVE_ANDROSTANE_R...,SET,29,0.33437,0.013278,0.16087,0.018838,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,0.69477212264151
PEDERSEN_METASTASIS_BY_ERBB2...1,SET,44,0.26419,0.012917,0.1271,0.018839,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,0.69477212264151
TOMLINS_METASTASIS_DN,SET,18,0.4156,0.013006,0.20013,0.018922,TOMLINS_METASTASIS_DN,0.69477212264151
MIR12119,SET,173,0.13031,0.012589,0.062754,0.01893,MIR12119,0.69477212264151
MIR624_3P,SET,90,0.1833,0.012802,0.088273,0.018931,MIR624_3P,0.69477212264151
HP_SPARSE_EYEBROW,SET,121,0.15391,0.012453,0.074154,0.018978,HP_SPARSE_EYEBROW,0.69477212264151
WP_GASTRIC_ACID_PRODUCTION,SET,8,0.67934,0.014177,0.3274,0.019003,WP_GASTRIC_ACID_PRODUCTION,0.69477212264151
KAZMIN_PBMC_P_FALCIPARUM_RTS...2,SET,6,0.85661,0.015482,0.41283,0.019003,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_POSITIVE,0.69477212264151
GOBP_RESPONSE_TO_TUMOR_CELL,SET,38,0.30743,0.013971,0.14818,0.019013,GOBP_RESPONSE_TO_TUMOR_CELL,0.69477212264151
GOCC_SNO_S_RNA_CONTAINING_RI...,SET,19,0.37569,0.012079,0.18112,0.019033,GOCC_SNO_S_RNA_CONTAINING_RIBONUCLEOPROTEIN_COMPLEX,0.69477212264151
HP_TYPE_1_MUSCLE_FIBER_ATROP...,SET,14,0.46392,0.012805,0.2237,0.019054,HP_TYPE_1_MUSCLE_FIBER_ATROPHY,0.69477212264151
GSE25123_CTRL_VS_IL4_STIM_MA...1,SET,174,0.13414,0.012996,0.064688,0.019066,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN,0.69477212264151
MIR5584_5P,SET,229,0.1156,0.01283,0.055751,0.019069,MIR5584_5P,0.69477212264151
GSE15930_NAIVE_VS_24H_IN_VIT...1,SET,189,0.11978,0.01209,0.057767,0.019071,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN,0.69477212264151
KERLEY_RESPONSE_TO_CISPLATIN...2,SET,44,0.26678,0.013044,0.12869,0.019094,KERLEY_RESPONSE_TO_CISPLATIN_UP,0.694881643979057
MIR134_3P,SET,81,0.19419,0.01287,0.093757,0.019175,MIR134_3P,0.697024780564263
HP_PERIORBITAL_EDEMA,SET,99,0.18493,0.013543,0.089303,0.019193,HP_PERIORBITAL_EDEMA,0.697024780564263
MIR4661_3P,SET,29,0.32142,0.012764,0.15527,0.019229,MIR4661_3P,0.69705700729927
REACTOME_NR1H2_NR1H3_REGULAT...1,SET,5,0.71006,0.011716,0.34303,0.019234,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS,0.69705700729927
BONOME_OVARIAN_CANCER_SURVIV...1,SET,215,0.1189,0.012791,0.057461,0.01927,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,0.69763421875
HP_DELAYED_ABILITY_TO_CRAWL,SET,8,0.50806,0.010603,0.246,0.019455,HP_DELAYED_ABILITY_TO_CRAWL,0.698497637474542
SASAKI_ADULT_T_CELL_LEUKEMIA,SET,154,0.1411,0.012868,0.06838,0.01954,SASAKI_ADULT_T_CELL_LEUKEMIA,0.698497637474542
GOBP_PHOSPHOLIPASE_C_ACTIVAT...2,SET,8,0.69383,0.01448,0.33632,0.019565,GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.698497637474542
GOMF_HISTONE_H3K4_TRIMETHYLT...,SET,10,0.54276,0.012663,0.2631,0.019567,GOMF_HISTONE_H3K4_TRIMETHYLTRANSFERASE_ACTIVITY,0.698497637474542
GOBP_ASTROCYTE_DIFFERENTIATI...,SET,79,0.20575,0.013467,0.099741,0.019571,GOBP_ASTROCYTE_DIFFERENTIATION,0.698497637474542
OSMAN_BLADDER_CANCER_UP,SET,363,0.088751,0.012355,0.043027,0.019578,OSMAN_BLADDER_CANCER_UP,0.698497637474542
GOBP_POSITIVE_REGULATION_OF_...12,SET,116,0.17026,0.01349,0.082549,0.019587,GOBP_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,0.698497637474542
GOBP_POSITIVE_REGULATION_OF_...723,SET,21,0.36784,0.012433,0.17837,0.019601,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,0.698497637474542
GOCC_SITE_OF_DNA_DAMAGE,SET,110,0.15095,0.011649,0.073199,0.019603,GOCC_SITE_OF_DNA_DAMAGE,0.698497637474542
KEGG_MEDICUS_REFERENCE_WNT_S...2,SET,13,0.56855,0.015123,0.27572,0.019608,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4,0.698497637474542
KORKOLA_YOLK_SAC_TUMOR,SET,53,0.25785,0.013833,0.12505,0.019613,KORKOLA_YOLK_SAC_TUMOR,0.698497637474542
KEGG_NATURAL_KILLER_CELL_MED...,SET,121,0.16929,0.013698,0.082113,0.019625,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.698497637474542
ZHAN_MULTIPLE_MYELOMA_DN,SET,35,0.31709,0.013831,0.1538,0.019627,ZHAN_MULTIPLE_MYELOMA_DN,0.698497637474542
MIR612,SET,97,0.16927,0.012271,0.082105,0.019628,MIR612,0.698497637474542
MEISSNER_NPC_HCP_WITH_H3K4ME...1,SET,329,0.10732,0.014236,0.05206,0.019637,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,0.698497637474542
GOBP_NEGATIVE_REGULATION_OF_...314,SET,43,0.27572,0.013327,0.13375,0.019637,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,0.698497637474542
GSE14308_TH2_VS_INDUCED_TREG...1,SET,180,0.12363,0.012181,0.059975,0.019642,GSE14308_TH2_VS_INDUCED_TREG_DN,0.698497637474542
GSE13484_12H_VS_3H_YF17D_VAC...1,SET,178,0.12751,0.012494,0.061866,0.019656,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,0.698497637474542
GSE3982_NEUTROPHIL_VS_TH2_UP,SET,181,0.13219,0.013059,0.064155,0.019687,GSE3982_NEUTROPHIL_VS_TH2_UP,0.698497637474542
GSE37605_C57BL6_VS_NOD_FOXP3...6,SET,123,0.16184,0.013202,0.078584,0.019733,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP,0.698497637474542
GSE16385_MONOCYTE_VS_12H_ROS...5,SET,169,0.12757,0.012183,0.061947,0.019735,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,0.698497637474542
REACTOME_SIGNALING_BY_EGFR_I...,SET,24,0.34407,0.012432,0.16708,0.019736,REACTOME_SIGNALING_BY_EGFR_IN_CANCER,0.698497637474542
AP4_01,SET,235,0.11533,0.012964,0.056035,0.019791,AP4_01,0.699070995955511
GOBP_LEUKOCYTE_DIFFERENTIATI...,SET,579,0.077302,0.013509,0.037562,0.019804,GOBP_LEUKOCYTE_DIFFERENTIATION,0.699070995955511
LEIN_OLIGODENDROCYTE_MARKERS,SET,72,0.2155,0.013468,0.10473,0.019813,LEIN_OLIGODENDROCYTE_MARKERS,0.699070995955511
AZARE_NEOPLASTIC_TRANSFORMAT...2,SET,116,0.17098,0.013547,0.083121,0.019849,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,0.699070995955511
GOBP_NEGATIVE_REGULATION_OF_...504,SET,26,0.37695,0.014175,0.18326,0.019857,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,0.699070995955511
GSE14000_TRANSLATED_RNA_VS_M...1,SET,162,0.13033,0.012188,0.063379,0.019884,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN,0.699070995955511
HP_INFECTION_FOLLOWING_LIVE_...,SET,20,0.40984,0.013519,0.19933,0.019893,HP_INFECTION_FOLLOWING_LIVE_VACCINATION,0.699070995955511
HP_FURROWED_TONGUE,SET,38,0.24543,0.011154,0.11952,0.020023,HP_FURROWED_TONGUE,0.702928651515151
HP_APLASIA_HYPOPLASIA_OF_THE...30,SET,182,0.12631,0.012513,0.061564,0.020108,HP_APLASIA_HYPOPLASIA_OF_THE_EYEBROW,0.70377238700565
MODULE_75,SET,368,0.10063,0.014103,0.049071,0.020157,MODULE_75,0.70377238700565
HP_ABNORMAL_MORPHOLOGY_OF_TH...5,SET,43,0.27219,0.013157,0.13274,0.020165,HP_ABNORMAL_MORPHOLOGY_OF_THE_LIMBIC_SYSTEM,0.70377238700565
GOBP_INTERLEUKIN_1_MEDIATED_...,SET,29,0.31551,0.012529,0.15389,0.020178,GOBP_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,0.70377238700565
GOBP_NEGATIVE_REGULATION_OF_...338,SET,51,0.246,0.012947,0.12001,0.020197,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.70377238700565
GOBP_POSITIVE_REGULATION_OF_...383,SET,5,0.84747,0.013983,0.41348,0.020209,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.70377238700565
HP_ABNORMALITY_OF_THE_DORSAL...,SET,5,0.6475,0.010684,0.31592,0.020211,HP_ABNORMALITY_OF_THE_DORSAL_COLUMN_OF_THE_SPINAL_CORD,0.70377238700565
MIR4716_3P,SET,77,0.19548,0.012632,0.095509,0.02035,MIR4716_3P,0.70377238700565
WP_ANDROGEN_RECEPTOR_NETWORK...,SET,106,0.16892,0.012797,0.082537,0.020358,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,0.70377238700565
WP_GASTRIN_SIGNALING,SET,113,0.16713,0.013071,0.081663,0.020358,WP_GASTRIN_SIGNALING,0.70377238700565
IBRAHIM_NRF2_UP,SET,476,0.078013,0.012397,0.03812,0.02036,IBRAHIM_NRF2_UP,0.70377238700565
MIR3139,SET,54,0.23402,0.012672,0.11435,0.020364,MIR3139,0.70377238700565
GOBP_NEGATIVE_REGULATION_OF_...119,SET,29,0.32299,0.012826,0.15789,0.020402,GOBP_NEGATIVE_REGULATION_OF_CELL_KILLING,0.70377238700565
REACTOME_NRCAM_INTERACTIONS,SET,6,0.71663,0.012952,0.3505,0.020456,REACTOME_NRCAM_INTERACTIONS,0.70377238700565
WP_DEVELOPMENT_AND_HETEROGEN...,SET,32,0.33084,0.0138,0.16185,0.020477,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,0.70377238700565
GSE411_UNSTIM_VS_100MIN_IL6_...4,SET,177,0.1231,0.012028,0.060236,0.020506,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.70377238700565
GOBP_NEGATIVE_REGULATION_OF_...181,SET,14,0.5084,0.014033,0.24879,0.020507,GOBP_NEGATIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,0.70377238700565
GSE14000_TRANSLATED_RNA_VS_M...3,SET,152,0.13649,0.012367,0.066793,0.020512,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN,0.70377238700565
GOBP_DNA_PROTECTION,SET,5,0.7496,0.012368,0.36687,0.020522,GOBP_DNA_PROTECTION,0.70377238700565
GOBP_ECTOPIC_GERM_CELL_PROGR...,SET,17,0.41683,0.012678,0.20404,0.020537,GOBP_ECTOPIC_GERM_CELL_PROGRAMMED_CELL_DEATH,0.70377238700565
HP_INTERHEMISPHERIC_CYST,SET,5,0.78609,0.01297,0.3853,0.020672,HP_INTERHEMISPHERIC_CYST,0.70377238700565
HP_PANCREATIC_CALCIFICATION,SET,8,0.67368,0.014059,0.33023,0.020682,HP_PANCREATIC_CALCIFICATION,0.70377238700565
REACTOME_NUCLEOTIDE_BINDING_...,SET,50,0.23593,0.012295,0.11566,0.020687,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,0.70377238700565
KEGG_MEDICUS_REFERENCE_PROK_...,SET,9,0.59836,0.013244,0.29341,0.020715,KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,0.70377238700565
GOBP_REGULATION_OF_CYTOSOLIC...,SET,52,0.25377,0.013486,0.12447,0.020743,GOBP_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.70377238700565
GOMF_MHC_CLASS_IB_PROTEIN_BI...,SET,6,0.73281,0.013245,0.35945,0.020749,GOMF_MHC_CLASS_IB_PROTEIN_BINDING,0.70377238700565
KEGG_MEDICUS_VARIANT_MUTATIO...5,SET,14,0.4501,0.012424,0.2208,0.020755,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY,0.70377238700565
ZWANG_CLASS_3_TRANSIENTLY_IN...,SET,205,0.12932,0.013588,0.063439,0.020756,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,0.70377238700565
SCHERER_PBMC_APSV_WETVAX_AGE...6,SET,263,0.11178,0.013282,0.054837,0.020761,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP,0.70377238700565
GSE9509_LPS_VS_LPS_AND_IL10_...4,SET,168,0.13732,0.013075,0.067368,0.020762,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP,0.70377238700565
GOCC_SARCOPLASMIC_RETICULUM_...1,SET,9,0.57143,0.012648,0.28034,0.020766,GOCC_SARCOPLASMIC_RETICULUM_LUMEN,0.70377238700565
GOBP_ERBB2_SIGNALING_PATHWAY,SET,23,0.36465,0.012898,0.17891,0.020773,GOBP_ERBB2_SIGNALING_PATHWAY,0.70377238700565
HP_OPPORTUNISTIC_FUNGAL_INFE...,SET,13,0.45594,0.012128,0.22377,0.020807,HP_OPPORTUNISTIC_FUNGAL_INFECTION,0.70377238700565
HP_ABNORMAL_BRAINSTEM_MRI_SI...,SET,31,0.26249,0.010776,0.12885,0.020824,HP_ABNORMAL_BRAINSTEM_MRI_SIGNAL_INTENSITY,0.70377238700565
GOBP_T_CELL_DIFFERENTIATION,SET,295,0.10474,0.013169,0.05142,0.020833,GOBP_T_CELL_DIFFERENTIATION,0.70377238700565
SCHERER_PBMC_APSV_WETVAX_AGE...7,SET,20,0.42046,0.013869,0.20652,0.020885,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_DN,0.70377238700565
GOBP_PROTEOGLYCAN_BIOSYNTHET...,SET,63,0.21838,0.01277,0.10727,0.020897,GOBP_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.70377238700565
GOBP_NEGATIVE_REGULATION_OF_...381,SET,4,0.90542,0.013362,0.44485,0.020915,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CHROMOSOME_SEPARATION,0.70377238700565
MIR4726_3P,SET,65,0.21986,0.013058,0.10804,0.020933,MIR4726_3P,0.70377238700565
MIR6803_5P,SET,52,0.24132,0.012824,0.11863,0.020977,MIR6803_5P,0.70377238700565
HP_ABNORMAL_VESTIBULAR_FUNCT...,SET,193,0.12625,0.012876,0.062082,0.021003,HP_ABNORMAL_VESTIBULAR_FUNCTION,0.70377238700565
KEGG_MEDICUS_REFERENCE_WNT_S...5,SET,44,0.27836,0.01361,0.13689,0.02101,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY,0.70377238700565
REACTOME_RNA_POLYMERASE_III_...3,SET,26,0.28676,0.010783,0.14103,0.021015,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER,0.70377238700565
GSE17721_PAM3CSK4_VS_CPG_16H...1,SET,176,0.12785,0.012457,0.06288,0.021024,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_DN,0.70377238700565
HP_LARGE_FACE,SET,225,0.111,0.012212,0.05461,0.021051,HP_LARGE_FACE,0.70377238700565
GOBP_REGULATION_OF_SYNAPTIC_...7,SET,6,0.81317,0.014697,0.40017,0.02108,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CLUSTERING,0.70377238700565
HP_BRUISING_SUSCEPTIBILITY,SET,162,0.13547,0.012669,0.066672,0.021091,HP_BRUISING_SUSCEPTIBILITY,0.70377238700565
GSE14415_ACT_VS_CTRL_NATURAL...1,SET,157,0.13594,0.012516,0.066934,0.02114,GSE14415_ACT_VS_CTRL_NATURAL_TREG_DN,0.70377238700565
NAKAMURA_METASTASIS,SET,42,0.24999,0.011943,0.12315,0.021182,NAKAMURA_METASTASIS,0.70377238700565
TIEN_INTESTINE_PROBIOTICS_2H...2,SET,28,0.3305,0.012897,0.16281,0.021189,TIEN_INTESTINE_PROBIOTICS_2HR_UP,0.70377238700565
PICCALUGA_ANGIOIMMUNOBLASTIC...2,SET,189,0.13808,0.013937,0.06803,0.021203,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,0.70377238700565
REACTOME_THE_FATTY_ACID_CYCL...,SET,4,0.79377,0.011715,0.39115,0.02122,REACTOME_THE_FATTY_ACID_CYCLING_MODEL,0.70377238700565
HOLLEMAN_ASPARAGINASE_RESIST...1,SET,22,0.32114,0.01111,0.15828,0.021237,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN,0.70377238700565
HP_ABNORMAL_THIRD_TOE_MORPHO...,SET,7,0.71938,0.014044,0.35456,0.021241,HP_ABNORMAL_THIRD_TOE_MORPHOLOGY,0.70377238700565
GNF2_CASP4,SET,21,0.38426,0.012988,0.1894,0.021246,GNF2_CASP4,0.70377238700565
MIR6818_3P,SET,108,0.17443,0.013339,0.085994,0.021265,MIR6818_3P,0.70377238700565
GOMF_PHOSPHATIDYLINOSITOL_3_...14,SET,41,0.26515,0.012516,0.13072,0.021266,GOMF_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING,0.70377238700565
GOBP_MICROTUBULE_NUCLEATION,SET,41,0.23678,0.011176,0.11678,0.02131,GOBP_MICROTUBULE_NUCLEATION,0.70377238700565
GOBP_EMBRYONIC_CAMERA_TYPE_E...3,SET,26,0.36093,0.013572,0.17802,0.021312,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS,0.70377238700565
GOBP_DEDIFFERENTIATION,SET,8,0.71736,0.014971,0.35386,0.021327,GOBP_DEDIFFERENTIATION,0.70377238700565
HP_DISPROPORTIONATE_SHORT_ST...,SET,119,0.16139,0.012951,0.07964,0.021365,HP_DISPROPORTIONATE_SHORT_STATURE,0.70377238700565
GSE25123_CTRL_VS_IL4_AND_ROS...3,SET,185,0.12657,0.01264,0.062468,0.021384,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,0.70377238700565
HP_ANDROGEN_INSUFFICIENCY,SET,3,0.95956,0.012265,0.47375,0.021418,HP_ANDROGEN_INSUFFICIENCY,0.70377238700565
UNTERMAN_IPF_VS_CTRL_DC_DN,SET,6,0.8147,0.014725,0.40226,0.021425,UNTERMAN_IPF_VS_CTRL_DC_DN,0.70377238700565
GOCC_MITOCHONDRIAL_PERMEABIL...,SET,6,0.70513,0.012745,0.34818,0.02143,GOCC_MITOCHONDRIAL_PERMEABILITY_TRANSITION_PORE_COMPLEX,0.70377238700565
GSE11818_WT_VS_DICER_KO_TREG...1,SET,143,0.13827,0.012155,0.068277,0.021435,GSE11818_WT_VS_DICER_KO_TREG_DN,0.70377238700565
GSE24972_WT_VS_IRF8_KO_SPLEE...1,SET,176,0.12816,0.012487,0.063284,0.021435,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN,0.70377238700565
HP_ABNORMAL_SEX_DETERMINATION,SET,18,0.44209,0.013835,0.21834,0.021455,HP_ABNORMAL_SEX_DETERMINATION,0.70377238700565
GSE15930_STIM_VS_STIM_AND_IL...1,SET,174,0.13068,0.012661,0.064545,0.021461,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN,0.70377238700565
HP_RECURRENT_GRAM_NEGATIVE_B...,SET,32,0.32311,0.013477,0.15964,0.021496,HP_RECURRENT_GRAM_NEGATIVE_BACTERIAL_INFECTIONS,0.70377238700565
HP_ABNORMAL_RELATIONSHIP,SET,11,0.55211,0.01351,0.2728,0.021501,HP_ABNORMAL_RELATIONSHIP,0.70377238700565
GSE9037_CTRL_VS_LPS_4H_STIM_...4,SET,173,0.12985,0.012545,0.064165,0.021505,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP,0.70377238700565
GSE1460_CD4_THYMOCYTE_VS_NAI...4,SET,191,0.12097,0.012273,0.059788,0.021533,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,0.704025790216369
DESCARTES_MAIN_FETAL_SATB2_L...,SET,77,0.20019,0.012937,0.09897,0.021559,DESCARTES_MAIN_FETAL_SATB2_LRRC7_POSITIVE_CELLS,0.704213388157895
HP_BROAD_CLAVICLES,SET,10,0.57385,0.013388,0.28378,0.021587,HP_BROAD_CLAVICLES,0.704309424157303
SMID_BREAST_CANCER_LUMINAL_B...1,SET,494,0.08537,0.013813,0.042235,0.021631,SMID_BREAST_CANCER_LUMINAL_B_DN,0.704309424157303
HP_ELFIN_FACIES,SET,18,0.43983,0.013765,0.21762,0.021641,HP_ELFIN_FACIES,0.704309424157303
HP_CENTRALLY_NUCLEATED_SKELE...,SET,47,0.23843,0.012048,0.11797,0.021643,HP_CENTRALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS,0.704309424157303
GOBP_S_ADENOSYLMETHIONINE_ME...,SET,16,0.43387,0.012802,0.21477,0.021692,GOBP_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS,0.705243648269411
GOBP_ISOTYPE_SWITCHING_TO_IG...2,SET,15,0.44076,0.012593,0.21825,0.021727,GOBP_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES,0.705721387850467
HP_ENCEPHALOMALACIA,SET,12,0.54223,0.013857,0.26867,0.021793,HP_ENCEPHALOMALACIA,0.705732074861368
GOBP_DNA_DAMAGE_RESPONSE,SET,793,0.057877,0.011765,0.028685,0.021819,GOBP_DNA_DAMAGE_RESPONSE,0.705732074861368
MODULE_363,SET,41,0.25837,0.012195,0.12806,0.021826,MODULE_363,0.705732074861368
GOBP_POSITIVE_REGULATION_OF_...454,SET,6,0.73464,0.013278,0.36421,0.02185,GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_STEM_CELL_PROLIFERATION,0.705732074861368
DEBIASI_APOPTOSIS_BY_REOVIRU...2,SET,272,0.10429,0.012599,0.051711,0.021866,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,0.705732074861368
HP_NEOPLASM_OF_THE_GENITOURI...,SET,213,0.11535,0.012351,0.057206,0.021889,HP_NEOPLASM_OF_THE_GENITOURINARY_TRACT,0.705732074861368
SUZUKI_RESPONSE_TO_TSA_AND_D...1,SET,20,0.41822,0.013795,0.20743,0.021896,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,0.705732074861368
KUWANO_RNA_STABILIZED_BY_NO,SET,7,0.77366,0.015103,0.38377,0.02191,KUWANO_RNA_STABILIZED_BY_NO,0.705732074861368
KEGG_MEDICUS_VARIANT_MUTATIO...80,SET,18,0.37633,0.011777,0.18668,0.021911,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.705732074861368
HOFMANN_CELL_LYMPHOMA_UP,SET,44,0.25026,0.012236,0.12421,0.021966,HOFMANN_CELL_LYMPHOMA_UP,0.705732074861368
GOMF_RRNA_BINDING,SET,56,0.21114,0.011643,0.10479,0.021967,GOMF_RRNA_BINDING,0.705732074861368
LIU_VAV3_PROSTATE_CARCINOGEN...2,SET,82,0.19755,0.013172,0.098049,0.021971,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,0.705732074861368
GSE32986_CURDLAN_HIGHDOSE_VS...2,SET,177,0.12413,0.012129,0.061657,0.02205,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.707615650969529
REACTOME_PASSIVE_TRANSPORT_B...,SET,12,0.5941,0.015183,0.29523,0.022098,REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS,0.708413149171271
MIR6860,SET,102,0.16137,0.011994,0.080206,0.022118,MIR6860,0.708413149171271
MIR887_5P,SET,92,0.17846,0.012601,0.088713,0.022136,MIR887_5P,0.708413149171271
MIR6751_5P,SET,66,0.21282,0.012737,0.10586,0.022204,MIR6751_5P,0.709193311926606
TRAVAGLINI_LUNG_EREG_DENDRIT...,SET,525,0.078521,0.013086,0.039066,0.022225,TRAVAGLINI_LUNG_EREG_DENDRITIC_CELL,0.709193311926606
DESCARTES_MAIN_FETAL_ACINAR_...,SET,50,0.26265,0.013687,0.13068,0.022228,DESCARTES_MAIN_FETAL_ACINAR_CELLS,0.709193311926606
GSE40273_GATA1_KO_VS_WT_TREG...2,SET,174,0.12495,0.012106,0.062177,0.022242,GSE40273_GATA1_KO_VS_WT_TREG_UP,0.709193311926606
MIR4510,SET,166,0.13314,0.012602,0.066268,0.022269,MIR4510,0.7094033868011
HP_DELIRIUM,SET,8,0.60418,0.012609,0.30087,0.022324,HP_DELIRIUM,0.710504230769231
TARTE_PLASMA_CELL_VS_B_LYMPH...1,SET,34,0.31921,0.013723,0.15907,0.022398,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,0.712207218664227
HP_IMPAIRED_TEMPERATURE_SENS...,SET,34,0.30612,0.013161,0.15263,0.022453,HP_IMPAIRED_TEMPERATURE_SENSATION,0.712461745240254
TITF1_Q3,SET,214,0.1181,0.012675,0.058885,0.022457,TITF1_Q3,0.712461745240254
HP_LONG_NECK,SET,3,0.83385,0.010658,0.4159,0.022493,HP_LONG_NECK,0.712461745240254
HP_RESTING_TREMOR,SET,45,0.24145,0.011939,0.12046,0.022524,HP_RESTING_TREMOR,0.712461745240254
PITX2_Q2,SET,236,0.11735,0.013219,0.05855,0.022525,PITX2_Q2,0.712461745240254
WP_SUPPRESSION_OF_HMGB1MEDIA...,SET,8,0.57573,0.012015,0.28733,0.022558,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,0.712461745240254
GOBP_L_LEUCINE_TRANSPORT,SET,10,0.55015,0.012836,0.27457,0.02256,GOBP_L_LEUCINE_TRANSPORT,0.712461745240254
REACTOME_KERATAN_SULFATE_KER...,SET,36,0.28697,0.012694,0.14325,0.022582,REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,0.712461745240254
REACTOME_SIGNALING_BY_ERBB2_...2,SET,25,0.31126,0.011477,0.15542,0.022609,REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,0.712461745240254
KEGG_MEDICUS_ENV_FACTOR_META...3,SET,14,0.40311,0.011127,0.20128,0.022611,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY,0.712461745240254
MIR7976,SET,91,0.16831,0.01182,0.084067,0.022646,MIR7976,0.712918233695652
MIR3132,SET,62,0.21325,0.012371,0.10658,0.022711,MIR3132,0.713229042365402
HP_SLENDER_BUILD,SET,23,0.32866,0.011625,0.16426,0.022714,HP_SLENDER_BUILD,0.713229042365402
HP_MONOCYTOPENIA,SET,5,0.90774,0.014977,0.45395,0.022778,HP_MONOCYTOPENIA,0.713229042365402
REACTOME_DRUG_MEDIATED_INHIB...,SET,5,0.79842,0.013174,0.39939,0.022807,REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY,0.713229042365402
LEIN_LOCALIZED_TO_DISTAL_AND...,SET,16,0.4489,0.013245,0.22457,0.022815,LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES,0.713229042365402
ICHIBA_GRAFT_VERSUS_HOST_DIS...4,SET,108,0.1668,0.012755,0.083458,0.022835,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,0.713229042365402
GSE17974_1H_VS_72H_UNTREATED...2,SET,179,0.12104,0.011892,0.060587,0.022881,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.713229042365402
REACTOME_ACTIVATED_TAK1_MEDI...,SET,19,0.41122,0.013221,0.20586,0.022889,REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,0.713229042365402
ACEVEDO_LIVER_TUMOR_VS_NORMA...1,SET,241,0.10984,0.012501,0.054994,0.022906,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,0.713229042365402
GSE20198_IL12_IL18_VS_IFNA_T...1,SET,178,0.1234,0.012091,0.061782,0.022906,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,0.713229042365402
MIR6130,SET,164,0.13286,0.0125,0.066544,0.022946,MIR6130,0.713229042365402
SEITZ_NEOPLASTIC_TRANSFORMAT...1,SET,30,0.30385,0.012272,0.15221,0.022956,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,0.713229042365402
HP_ABNORMAL_CIRCULATING_GABA...,SET,6,0.58687,0.010607,0.29405,0.022984,HP_ABNORMAL_CIRCULATING_GABA_CONCENTRATION,0.713229042365402
GOBP_REGULATION_OF_PHOSPHATI...4,SET,5,0.50208,0.0082841,0.25157,0.022988,GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,0.713229042365402
GSE17721_LPS_VS_PAM3CSK4_12H...2,SET,188,0.12143,0.012224,0.06085,0.022998,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP,0.713229042365402
HP_ABSENT_NIPPLE,SET,9,0.50853,0.011256,0.25491,0.02303,HP_ABSENT_NIPPLE,0.713229042365402
GOCC_CHROMOSOMAL_REGION,SET,340,0.088079,0.011874,0.044184,0.023114,GOCC_CHROMOSOMAL_REGION,0.713229042365402
HALLMARK_APOPTOSIS,SET,149,0.13967,0.012531,0.070068,0.023116,HALLMARK_APOPTOSIS,0.713229042365402
GSE11961_GERMINAL_CENTER_BCE...6,SET,179,0.12606,0.012386,0.063248,0.023131,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,0.713229042365402
GOBP_MONOCYTE_DIFFERENTIATION,SET,32,0.32175,0.01342,0.16148,0.023165,GOBP_MONOCYTE_DIFFERENTIATION,0.713229042365402
WP_HEMATOPOIETIC_STEM_CELL_D...,SET,52,0.24607,0.013077,0.12351,0.023175,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,0.713229042365402
WP_HEPATITIS_C_AND_HEPATOCEL...,SET,49,0.25112,0.012956,0.12605,0.023181,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,0.713229042365402
GOBP_VENOUS_BLOOD_VESSEL_MOR...,SET,9,0.60864,0.013472,0.30562,0.023219,GOBP_VENOUS_BLOOD_VESSEL_MORPHOGENESIS,0.713229042365402
BIOCARTA_BIOPEPTIDES_PATHWAY,SET,28,0.32758,0.012783,0.16449,0.023221,BIOCARTA_BIOPEPTIDES_PATHWAY,0.713229042365402
STAEGE_EWING_FAMILY_TUMOR,SET,24,0.38316,0.013844,0.1924,0.023222,STAEGE_EWING_FAMILY_TUMOR,0.713229042365402
REACTOME_GROWTH_HORMONE_RECE...,SET,22,0.40336,0.013954,0.20257,0.023235,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,0.713229042365402
BIOCARTA_EEA1_PATHWAY,SET,7,0.59292,0.011575,0.29777,0.023237,BIOCARTA_EEA1_PATHWAY,0.713229042365402
GSE17721_LPS_VS_POLYIC_16H_B...2,SET,176,0.11872,0.011567,0.05962,0.023237,GSE17721_LPS_VS_POLYIC_16H_BMDC_UP,0.713229042365402
BUCASAS_PBMC_FLUARIX_FLUVIRI...1,SET,6,0.68615,0.012401,0.34463,0.023251,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_3DY_POSITIVE_PREDICTIVE_OF_TITER,0.713229042365402
GOBP_NEGATIVE_REGULATION_OF_...406,SET,7,0.73732,0.014394,0.37046,0.023287,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.713239671052632
GSE3982_BCELL_VS_BASOPHIL_UP,SET,164,0.12653,0.011905,0.0636,0.023329,GSE3982_BCELL_VS_BASOPHIL_UP,0.713239671052632
HP_HYPOPLASTIC_FIFTH_TOENAIL,SET,16,0.41986,0.012389,0.21105,0.023339,HP_HYPOPLASTIC_FIFTH_TOENAIL,0.713239671052632
REACTOME_RHO_GTPASES_ACTIVAT...2,SET,129,0.14609,0.012202,0.073464,0.023379,REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,0.713239671052632
MIR5006_5P,SET,109,0.15628,0.012006,0.07859,0.02338,MIR5006_5P,0.713239671052632
E2F1_Q6_01,SET,214,0.11103,0.011916,0.055839,0.023395,E2F1_Q6_01,0.713239671052632
GOBP_RESPONSE_TO_ACIDIC_PH,SET,25,0.34014,0.012543,0.17107,0.023395,GOBP_RESPONSE_TO_ACIDIC_PH,0.713239671052632
GOBP_NEGATIVE_REGULATION_OF_...702,SET,14,0.43196,0.011923,0.21735,0.023446,GOBP_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION,0.714168036809816
GOBP_INTRINSIC_APOPTOTIC_SIG...2,SET,74,0.18769,0.011891,0.094477,0.023491,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.714912176007005
GOBERT_CORE_OLIGODENDROCYTE_...,SET,40,0.27565,0.012852,0.13883,0.023553,GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,0.715771094369548
PETRETTO_HEART_MASS_QTL_CIS_...2,SET,30,0.30712,0.012404,0.1548,0.023633,PETRETTO_HEART_MASS_QTL_CIS_UP,0.715771094369548
GOBP_NEGATIVE_REGULATION_OF_...644,SET,8,0.62429,0.013028,0.31478,0.023677,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,0.715771094369548
HP_IMPAIRED_OXIDATIVE_BURST,SET,5,0.84482,0.013939,0.42599,0.02368,HP_IMPAIRED_OXIDATIVE_BURST,0.715771094369548
GSE15930_NAIVE_VS_24H_IN_VIT...5,SET,189,0.11369,0.011475,0.057344,0.023719,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN,0.715771094369548
THUM_SYSTOLIC_HEART_FAILURE_...1,SET,190,0.12127,0.012272,0.061172,0.023726,THUM_SYSTOLIC_HEART_FAILURE_DN,0.715771094369548
MODULE_130,SET,18,0.44687,0.013985,0.22543,0.023732,MODULE_130,0.715771094369548
TSUTSUMI_FBXW8_TARGETS,SET,9,0.54755,0.01212,0.27639,0.0238,TSUTSUMI_FBXW8_TARGETS,0.715771094369548
GOBP_CHROMOSOME_MOVEMENT_TOW...,SET,7,0.6086,0.011881,0.30725,0.023816,GOBP_CHROMOSOME_MOVEMENT_TOWARDS_SPINDLE_POLE,0.715771094369548
GOBP_TOLL_LIKE_RECEPTOR_SIGN...,SET,68,0.19901,0.012088,0.10047,0.023817,GOBP_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.715771094369548
MURARO_PANCREAS_ACINAR_CELL,SET,659,0.068186,0.012684,0.03443,0.023836,MURARO_PANCREAS_ACINAR_CELL,0.715771094369548
GOBP_CELLULAR_RESPONSE_TO_TE...1,SET,5,0.71329,0.011769,0.36018,0.023837,GOBP_CELLULAR_RESPONSE_TO_TEMPERATURE_STIMULUS,0.715771094369548
REACTOME_TRAF6_MEDIATED_IRF7...2,SET,10,0.53305,0.012437,0.26921,0.023854,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,0.715771094369548
SALL4_TARGET_GENES,SET,1442,0.045186,0.012156,0.022824,0.023871,SALL4_TARGET_GENES,0.715771094369548
WP_COMPLEMENT_SYSTEM,SET,89,0.19456,0.013513,0.098303,0.023904,WP_COMPLEMENT_SYSTEM,0.715771094369548
YAMASHITA_LIVER_CANCER_WITH_...2,SET,49,0.22801,0.011763,0.1153,0.024001,YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,0.715771094369548
GOBP_HEPARAN_SULFATE_PROTEOG...1,SET,32,0.29875,0.012461,0.15116,0.024067,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.715771094369548
GOBP_DEFENSE_RESPONSE_TO_GRA...1,SET,77,0.21953,0.014187,0.11109,0.024073,GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM,0.715771094369548
GOCC_SUPRAMOLECULAR_COMPLEX,SET,1253,0.049172,0.012399,0.024889,0.024105,GOCC_SUPRAMOLECULAR_COMPLEX,0.715771094369548
REACTOME_KERATAN_SULFATE_DEG...,SET,15,0.43248,0.012356,0.21893,0.024116,REACTOME_KERATAN_SULFATE_DEGRADATION,0.715771094369548
KEGG_MEDICUS_PATHOGEN_EBV_EB...3,SET,9,0.56382,0.01248,0.28547,0.024139,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00483,0.715771094369548
MIR3605_5P,SET,75,0.20332,0.012968,0.10299,0.02419,MIR3605_5P,0.715771094369548
MIR6853_5P,SET,6,0.6861,0.012401,0.34754,0.02419,MIR6853_5P,0.715771094369548
GOMF_L_LACTATE_DEHYDROGENASE...,SET,5,1.0164,0.01677,0.51484,0.02419,GOMF_L_LACTATE_DEHYDROGENASE_ACTIVITY,0.715771094369548
GOBP_REGULATORY_NCRNA_MEDIAT...2,SET,16,0.40706,0.012011,0.20624,0.024215,GOBP_REGULATORY_NCRNA_MEDIATED_HETEROCHROMATIN_FORMATION,0.715771094369548
WEINMANN_ADAPTATION_TO_HYPOX...2,SET,25,0.36271,0.013375,0.18386,0.024267,WEINMANN_ADAPTATION_TO_HYPOXIA_UP,0.715771094369548
MIR524_3P_MIR525_3P,SET,11,0.50158,0.012273,0.25429,0.024286,MIR524_3P_MIR525_3P,0.715771094369548
GOBP_REGULATION_OF_T_CELL_CO...,SET,4,0.88159,0.013011,0.44695,0.024286,GOBP_REGULATION_OF_T_CELL_COSTIMULATION,0.715771094369548
HP_DIFFICULTY_CLIMBING_STAIRS,SET,58,0.21503,0.012066,0.10911,0.024382,HP_DIFFICULTY_CLIMBING_STAIRS,0.715771094369548
GOBP_BERGMANN_GLIAL_CELL_DIF...,SET,10,0.52405,0.012227,0.26593,0.024392,GOBP_BERGMANN_GLIAL_CELL_DIFFERENTIATION,0.715771094369548
GOBP_REGULATION_OF_ISOTYPE_S...1,SET,30,0.27717,0.011194,0.1407,0.024431,GOBP_REGULATION_OF_ISOTYPE_SWITCHING,0.715771094369548
GOBP_AMYLOID_BETA_CLEARANCE,SET,35,0.28269,0.012331,0.1435,0.024432,GOBP_AMYLOID_BETA_CLEARANCE,0.715771094369548
MIR3974,SET,86,0.18987,0.012964,0.096398,0.024448,MIR3974,0.715771094369548
GOBP_POSITIVE_REGULATION_OF_...544,SET,57,0.21555,0.011991,0.10944,0.024452,GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.715771094369548
HP_ABNORMAL_ALPHA_GRANULES,SET,4,0.67087,0.0099009,0.34068,0.024472,HP_ABNORMAL_ALPHA_GRANULES,0.715771094369548
NGO_MALIGNANT_GLIOMA_1P_LOH,SET,13,0.39718,0.010565,0.20172,0.024488,NGO_MALIGNANT_GLIOMA_1P_LOH,0.715771094369548
WU_HBX_TARGETS_2_UP,SET,21,0.37574,0.0127,0.19086,0.0245,WU_HBX_TARGETS_2_UP,0.715771094369548
GSE40666_WT_VS_STAT4_KO_CD8_...3,SET,187,0.11903,0.011952,0.060469,0.024512,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.715771094369548
GOBP_RESPONSE_TO_MOLECULE_OF...2,SET,4,0.86255,0.01273,0.43829,0.024542,GOBP_RESPONSE_TO_MOLECULE_OF_FUNGAL_ORIGIN,0.715771094369548
GOBP_T_CELL_MEDIATED_CYTOTOX...,SET,56,0.25332,0.013969,0.12873,0.024547,GOBP_T_CELL_MEDIATED_CYTOTOXICITY,0.715771094369548
GSE2770_TGFB_AND_IL4_VS_IL12...1,SET,182,0.12547,0.01243,0.063762,0.024556,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.715771094369548
HP_HIGH_OUTPUT_CONGESTIVE_HE...,SET,6,0.69534,0.012568,0.35339,0.024561,HP_HIGH_OUTPUT_CONGESTIVE_HEART_FAILURE,0.715771094369548
LI_PBMC_MENACTRA_AGE_18_45YO...3,SET,25,0.33888,0.012496,0.17228,0.024596,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP,0.715771094369548
MIR4471,SET,68,0.19428,0.011801,0.098783,0.024614,MIR4471,0.715771094369548
MIR330_3P,SET,307,0.10043,0.012877,0.051071,0.024629,MIR330_3P,0.715771094369548
REACTOME_MITOCHONDRIAL_CALCI...,SET,19,0.38605,0.012412,0.1964,0.02468,REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT,0.715771094369548
KEGG_MEDICUS_REFERENCE_TLR3_...3,SET,9,0.54934,0.012159,0.27949,0.024685,KEGG_MEDICUS_REFERENCE_TLR3_NFKB_SIGNALING_PATHWAY,0.715771094369548
GSE17721_CTRL_VS_PAM3CSK4_2H...1,SET,183,0.12673,0.012589,0.06448,0.024689,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_DN,0.715771094369548
MIR6835_3P,SET,414,0.086035,0.012772,0.043785,0.024718,MIR6835_3P,0.715771094369548
REACTOME_TYSND1_CLEAVES_PERO...,SET,7,0.60122,0.011737,0.30599,0.024726,REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS,0.715771094369548
MIR4462,SET,13,0.37721,0.010034,0.19202,0.024749,MIR4462,0.715771094369548
BIOCARTA_GH_PATHWAY,SET,26,0.33492,0.012594,0.17051,0.024759,BIOCARTA_GH_PATHWAY,0.715771094369548
REACTOME_RESPONSE_TO_ELEVATE...,SET,120,0.15414,0.01242,0.078474,0.024762,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,0.715771094369548
GOMF_PROTEIN_ARGININE_DEIMIN...,SET,5,0.8926,0.014728,0.45444,0.024763,GOMF_PROTEIN_ARGININE_DEIMINASE_ACTIVITY,0.715771094369548
CUI_DEVELOPING_HEART_TRABECU...1,SET,161,0.13277,0.012378,0.067634,0.024824,CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE,0.715771094369548
CGCTGCT_MIR503,SET,21,0.33899,0.011458,0.17272,0.024847,CGCTGCT_MIR503,0.715771094369548
GSE21379_TFH_VS_NON_TFH_SAP_...2,SET,179,0.1201,0.011801,0.061195,0.024851,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP,0.715771094369548
MIR23B_5P,SET,43,0.26112,0.012622,0.13305,0.024857,MIR23B_5P,0.715771094369548
GOBP_MAGNESIUM_ION_HOMEOSTAS...,SET,10,0.51704,0.012063,0.26355,0.024897,GOBP_MAGNESIUM_ION_HOMEOSTASIS,0.715771094369548
HP_ABNORMAL_RENAL_VASCULAR_M...,SET,24,0.31702,0.011454,0.16164,0.024928,HP_ABNORMAL_RENAL_VASCULAR_MORPHOLOGY,0.715771094369548
GOCC_EARLY_ENDOSOME_MEMBRANE,SET,175,0.12044,0.011702,0.061413,0.02494,GOCC_EARLY_ENDOSOME_MEMBRANE,0.715771094369548
GOBP_REGULATION_OF_CELL_ADHE...2,SET,46,0.2367,0.011833,0.12075,0.024989,GOBP_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.715771094369548
BILD_CTNNB1_ONCOGENIC_SIGNAT...,SET,72,0.19157,0.011973,0.097728,0.02499,BILD_CTNNB1_ONCOGENIC_SIGNATURE,0.715771094369548
GOMF_INTERLEUKIN_12_RECEPTOR...,SET,5,0.92387,0.015244,0.47134,0.025001,GOMF_INTERLEUKIN_12_RECEPTOR_BINDING,0.715771094369548
GSE11864_CSF1_VS_CSF1_PAM3CY...1,SET,166,0.12937,0.012245,0.066018,0.025032,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN,0.715771094369548
GSE10239_KLRG1INT_VS_KLRG1HI...2,SET,183,0.11801,0.011723,0.06024,0.025062,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.715771094369548
HP_SPARSE_LATERAL_EYEBROW,SET,30,0.28982,0.011705,0.14797,0.025088,HP_SPARSE_LATERAL_EYEBROW,0.715771094369548
GTTTGTT_MIR495,SET,228,0.11125,0.01232,0.056806,0.025093,GTTTGTT_MIR495,0.715771094369548
GSE6269_E_COLI_VS_STAPH_AURE...2,SET,126,0.14891,0.012293,0.076051,0.025122,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP,0.715771094369548
WP_IL9_SIGNALING,SET,15,0.49467,0.014133,0.25267,0.025134,WP_IL9_SIGNALING,0.715771094369548
BOHN_PRIMARY_IMMUNODEFICIENC...1,SET,36,0.27679,0.012244,0.14138,0.025139,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,0.715771094369548
WP_BRAINDERIVED_NEUROTROPHIC...,SET,135,0.15248,0.013027,0.077908,0.02517,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,0.715771094369548
GOCC_PLATELET_DENSE_GRANULE_...2,SET,5,0.82872,0.013674,0.42357,0.025209,GOCC_PLATELET_DENSE_GRANULE_MEMBRANE,0.715771094369548
HP_GENERALIZED_ABNORMALITY_O...,SET,944,0.054259,0.011982,0.027732,0.025211,HP_GENERALIZED_ABNORMALITY_OF_SKIN,0.715771094369548
HP_PROGRESSIVE_FLEXION_CONTR...,SET,6,0.80509,0.014551,0.41153,0.025222,HP_PROGRESSIVE_FLEXION_CONTRACTURES,0.715771094369548
GOBP_ANTIGEN_RECEPTOR_MEDIAT...,SET,171,0.12922,0.012412,0.066053,0.025224,GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.715771094369548
OSAWA_TNF_TARGETS,SET,10,0.50295,0.011734,0.25716,0.025254,OSAWA_TNF_TARGETS,0.715771094369548
HP_ELBOW_CONTRACTURE,SET,98,0.17164,0.012506,0.087758,0.025254,HP_ELBOW_CONTRACTURE,0.715771094369548
HP_IMMUNODEFICIENCY,SET,194,0.12057,0.012328,0.061653,0.025259,HP_IMMUNODEFICIENCY,0.715771094369548
GOCC_GOLGI_LUMEN,SET,88,0.18442,0.012737,0.094305,0.025268,GOCC_GOLGI_LUMEN,0.715771094369548
NAGASHIMA_EGF_SIGNALING_UP,SET,53,0.24487,0.013137,0.12524,0.025284,NAGASHIMA_EGF_SIGNALING_UP,0.715771094369548
GOMF_CATALYTIC_ACTIVITY_ACTI...2,SET,541,0.066138,0.011184,0.033832,0.025305,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_NUCLEIC_ACID,0.715771094369548
HP_MONOCYTOSIS,SET,15,0.35008,0.010002,0.17913,0.025342,HP_MONOCYTOSIS,0.715771094369548
HP_ECTOPIC_KIDNEY,SET,72,0.20061,0.012538,0.10266,0.025348,HP_ECTOPIC_KIDNEY,0.715771094369548
GSE2585_CD80_HIGH_VS_LOW_MTE...1,SET,171,0.12671,0.012171,0.064857,0.025376,GSE2585_CD80_HIGH_VS_LOW_MTEC_DN,0.715771094369548
MIR4786_5P,SET,85,0.17967,0.012196,0.091994,0.025414,MIR4786_5P,0.715771094369548
GOMF_WNT_PROTEIN_BINDING,SET,30,0.34389,0.013889,0.17609,0.02542,GOMF_WNT_PROTEIN_BINDING,0.715771094369548
MIR3162_3P,SET,20,0.37388,0.012333,0.19147,0.025438,MIR3162_3P,0.715771094369548
REACTOME_FGFR2_ALTERNATIVE_S...,SET,27,0.30228,0.011583,0.15482,0.025453,REACTOME_FGFR2_ALTERNATIVE_SPLICING,0.715771094369548
GOBP_REGULATION_OF_ANION_CHA...,SET,5,0.83286,0.013742,0.42692,0.025544,GOBP_REGULATION_OF_ANION_CHANNEL_ACTIVITY,0.715771094369548
KEGG_MEDICUS_PATHOGEN_HBV_LH...,SET,11,0.53039,0.012978,0.27191,0.02556,KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY,0.715771094369548
BIOCARTA_SPPA_PATHWAY,SET,16,0.44503,0.013131,0.22821,0.025592,BIOCARTA_SPPA_PATHWAY,0.715771094369548
GOCC_ALPHA_DNA_POLYMERASE_PR...,SET,4,0.68047,0.010043,0.34896,0.025596,GOCC_ALPHA_DNA_POLYMERASE_PRIMASE_COMPLEX,0.715771094369548
GOMF_DNA_DEMETHYLASE_ACTIVITY,SET,5,0.62414,0.010298,0.32009,0.025603,GOMF_DNA_DEMETHYLASE_ACTIVITY,0.715771094369548
GSE17721_0.5H_VS_12H_POLYIC_...2,SET,180,0.1182,0.011645,0.060639,0.025644,GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP,0.715771094369548
LAKE_ADULT_KIDNEY_C6_PROXIMA...,SET,171,0.12896,0.012388,0.066174,0.025665,LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3,0.715771094369548
HP_GOWERS_SIGN,SET,68,0.21022,0.01277,0.10788,0.025673,HP_GOWERS_SIGN,0.715771094369548
GOBP_DEOXYRIBONUCLEOSIDE_TRI...,SET,9,0.52317,0.01158,0.26848,0.025677,GOBP_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.715771094369548
RAO_BOUND_BY_SALL4_ISOFORM_A,SET,166,0.13038,0.012341,0.066954,0.025755,RAO_BOUND_BY_SALL4_ISOFORM_A,0.715771094369548
GOBP_VASCULAR_ASSOCIATED_SMO...2,SET,11,0.56058,0.013717,0.2879,0.025769,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEVELOPMENT,0.715771094369548
KEGG_MEDICUS_REFERENCE_BRANC...,SET,30,0.29997,0.012115,0.15408,0.025786,KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION,0.715771094369548
GOBP_REGULATION_OF_METALLOEN...,SET,4,0.92263,0.013616,0.47397,0.0258,GOBP_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.715771094369548
HP_BENIGN_NEOPLASM_OF_THE_CE...,SET,100,0.15178,0.011171,0.077984,0.025818,HP_BENIGN_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM,0.715771094369548
GOBP_REGULATION_OF_BINDING_O...,SET,5,0.6514,0.010748,0.33474,0.025834,GOBP_REGULATION_OF_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,0.715771094369548
HP_MACROTHROMBOCYTOPENIA,SET,12,0.49402,0.012625,0.25389,0.025848,HP_MACROTHROMBOCYTOPENIA,0.715771094369548
GOBP_ACTIVATION_OF_IMMUNE_RE...,SET,485,0.075973,0.012183,0.039046,0.025851,GOBP_ACTIVATION_OF_IMMUNE_RESPONSE,0.715771094369548
GOBP_AROMATIC_AMINO_ACID_TRA...,SET,9,0.55805,0.012352,0.28683,0.025859,GOBP_AROMATIC_AMINO_ACID_TRANSPORT,0.715771094369548
GSE27291_6H_VS_7D_STIM_GAMMA...1,SET,156,0.13225,0.012139,0.06798,0.025866,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN,0.715771094369548
KEGG_MEDICUS_REFERENCE_BREAK...,SET,8,0.56961,0.011887,0.29284,0.025887,KEGG_MEDICUS_REFERENCE_BREAK_INDUCED_REPLICATION,0.715771094369548
HP_ABNORMAL_OLFACTORY_LOBE_M...,SET,6,0.65185,0.011782,0.33518,0.025909,HP_ABNORMAL_OLFACTORY_LOBE_MORPHOLOGY,0.715771094369548
BIOCARTA_ALTERNATIVE_PATHWAY,SET,8,0.59497,0.012416,0.30595,0.025915,BIOCARTA_ALTERNATIVE_PATHWAY,0.715771094369548
GOBP_NEGATIVE_REGULATION_OF_...68,SET,4,0.79868,0.011787,0.41072,0.025921,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL,0.715771094369548
GSE9006_TYPE_1_DIABETES_AT_D...4,SET,184,0.12016,0.011968,0.061795,0.025926,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP,0.715771094369548
GSE12198_NK_VS_NK_ACT_EXPANS...1,SET,184,0.11695,0.011649,0.06015,0.025937,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN,0.715771094369548
E2F_Q3_01,SET,209,0.11142,0.011819,0.057305,0.025938,E2F_Q3_01,0.715771094369548
FAN_EMBRYONIC_CTX_MICROGLIA_2,SET,8,0.61803,0.012898,0.31789,0.025945,FAN_EMBRYONIC_CTX_MICROGLIA_2,0.715771094369548
GSE14413_UNSTIM_VS_IFNB_STIM...1,SET,104,0.16278,0.012216,0.083735,0.025956,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_DN,0.715771094369548
TIMOFEEVA_GROWTH_STRESS_VIA_...,SET,16,0.4103,0.012107,0.21108,0.025969,TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN,0.715771094369548
MODULE_415,SET,11,0.49742,0.012171,0.2559,0.02597,MODULE_415,0.715771094369548
SAMOLS_TARGETS_OF_KHSV_MIRNA...1,SET,47,0.26033,0.013154,0.13397,0.026008,SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,0.715870577075099
CAO_BLOOD_FLUZONE_AGE_05_14Y...7,SET,6,0.64749,0.011703,0.33334,0.026052,CAO_BLOOD_FLUZONE_AGE_05_14YO_CORRELATED_WITH_H3N1_HI_TITER_1DY_POSITIVE,0.715870577075099
KEGG_MEDICUS_REFERENCE_DOUBL...1,SET,4,0.74871,0.01105,0.38546,0.026054,KEGG_MEDICUS_REFERENCE_DOUBLE_HOLLIDAY_JUNCTION_RESOLUTION,0.715870577075099
GSE26343_UNSTIM_VS_LPS_STIM_...4,SET,184,0.11838,0.011791,0.060947,0.026056,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP,0.715870577075099
REACTOME_INNATE_IMMUNE_SYSTEM,SET,961,0.054941,0.012236,0.028305,0.026136,REACTOME_INNATE_IMMUNE_SYSTEM,0.717356356466877
HP_ENAMEL_HYPOMINERALIZATION,SET,8,0.57996,0.012103,0.29884,0.026153,HP_ENAMEL_HYPOMINERALIZATION,0.717356356466877
MIR6515_3P,SET,199,0.11397,0.011801,0.058736,0.026172,MIR6515_3P,0.717356356466877
BERENJENO_ROCK_SIGNALING_NOT...1,SET,48,0.24679,0.012602,0.12727,0.026252,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,0.718982080378251
GOBP_MEMBRANE_PROTEIN_INTRAC...,SET,12,0.42229,0.010792,0.21784,0.026287,GOBP_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS,0.719161153846154
GOBP_MECHANOSENSORY_BEHAVIOR,SET,14,0.47784,0.01319,0.24654,0.026308,GOBP_MECHANOSENSORY_BEHAVIOR,0.719161153846154
GOBP_OOCYTE_DIFFERENTIATION,SET,60,0.20852,0.0119,0.1076,0.026329,GOBP_OOCYTE_DIFFERENTIATION,0.719161153846154
GOBP_REGULATION_OF_TRANSLATI...10,SET,4,0.76792,0.011333,0.39637,0.026358,GOBP_REGULATION_OF_TRANSLATION_AT_SYNAPSE_MODULATING_SYNAPTIC_TRANSMISSION,0.719161153846154
HP_AORTIC_DISSECTION,SET,37,0.28822,0.012925,0.14877,0.026362,HP_AORTIC_DISSECTION,0.719161153846154
REACTOME_METABOLISM_OF_CARBO...,SET,267,0.09879,0.011826,0.051017,0.026418,REACTOME_METABOLISM_OF_CARBOHYDRATES,0.7201236
MIR28_5P,SET,42,0.24681,0.011791,0.12749,0.026445,MIR28_5P,0.720265545596259
GOBP_NEGATIVE_REGULATION_OF_...439,SET,146,0.14333,0.01273,0.074049,0.026466,GOBP_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.720265545596259
GOBP_PHOSPHATIDYLSERINE_EXPO...,SET,8,0.56311,0.011752,0.29107,0.026527,GOBP_PHOSPHATIDYLSERINE_EXPOSURE_ON_APOPTOTIC_CELL_SURFACE,0.720265545596259
REACTOME_ANTIVIRAL_MECHANISM...,SET,135,0.13758,0.011753,0.071126,0.02655,REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,0.720265545596259
GOMF_FUCOSYLTRANSFERASE_ACTI...,SET,13,0.49748,0.013233,0.25727,0.026584,GOMF_FUCOSYLTRANSFERASE_ACTIVITY,0.720265545596259
GOMF_EPOXIDE_HYDROLASE_ACTIV...,SET,8,0.64291,0.013417,0.33249,0.026587,GOMF_EPOXIDE_HYDROLASE_ACTIVITY,0.720265545596259
REACTOME_RNA_POLYMERASE_III_...1,SET,16,0.37645,0.011108,0.19469,0.026589,REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION,0.720265545596259
GOCC_RNA_POLYMERASE_III_COMP...,SET,16,0.37645,0.011108,0.19469,0.026589,GOCC_RNA_POLYMERASE_III_COMPLEX,0.720265545596259
HP_DISPROPORTIONATE_SHORT_TR...,SET,24,0.32313,0.011675,0.16722,0.026663,HP_DISPROPORTIONATE_SHORT_TRUNK_SHORT_STATURE,0.721173011673152
GSE13229_MATURE_VS_INTMATURE...2,SET,173,0.12778,0.012345,0.066127,0.026664,GSE13229_MATURE_VS_INTMATURE_NKCELL_UP,0.721173011673152
GOBP_POSITIVE_REGULATION_OF_...603,SET,121,0.14792,0.011968,0.076596,0.026741,GOBP_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.722693199844479
GOBP_SYNAPTIC_VESICLE_CLUSTE...,SET,15,0.45258,0.01293,0.23444,0.026782,GOBP_SYNAPTIC_VESICLE_CLUSTERING,0.723028125
REACTOME_P130CAS_LINKAGE_TO_...,SET,15,0.46663,0.013332,0.24174,0.026795,REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,0.723028125
MIR378G,SET,79,0.17638,0.011544,0.091418,0.026853,MIR378G,0.72400861627907
GOBP_REGULATION_OF_DEFENSE_R...5,SET,34,0.30185,0.012977,0.15648,0.026873,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,0.72400861627907
GSE21774_CD56_BRIGHT_VS_DIM_...1,SET,178,0.12138,0.011893,0.06298,0.02698,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN,0.726328350116189
GSE22601_IMMATURE_CD4_SINGLE...3,SET,184,0.12163,0.012115,0.063151,0.02706,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.727918188854489
GSE22196_HEALTHY_VS_OBESE_MO...1,SET,182,0.11951,0.011839,0.062073,0.027107,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN,0.728271567567568
GSE3565_CTRL_VS_LPS_INJECTED...1,SET,155,0.13323,0.012189,0.069207,0.027118,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN,0.728271567567568
REACTOME_PROCESSING_OF_SMDT1,SET,12,0.46305,0.011834,0.24057,0.027136,REACTOME_PROCESSING_OF_SMDT1,0.728271567567568
BRUNEAU_HEART_GREAT_VESSELS_...,SET,8,0.58965,0.012306,0.30649,0.027191,BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS,0.729184571759259
GOBP_UREA_TRANSPORT,SET,10,0.62614,0.014608,0.32558,0.027237,GOBP_UREA_TRANSPORT,0.729640958429561
ABDULRAHMAN_KIDNEY_CANCER_VH...,SET,13,0.46137,0.012272,0.23993,0.027255,ABDULRAHMAN_KIDNEY_CANCER_VHL_DN,0.729640958429561
HP_HAMARTOMA_OF_THE_ORBITAL_...,SET,29,0.26741,0.010619,0.13908,0.027271,HP_HAMARTOMA_OF_THE_ORBITAL_REGION,0.729640958429561
HP_MESOMELIC_ARM_SHORTENING,SET,3,1.1505,0.014705,0.59852,0.027295,HP_MESOMELIC_ARM_SHORTENING,0.72966814516129
GOBP_NEGATIVE_REGULATION_OF_...305,SET,13,0.49823,0.013252,0.25926,0.027328,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,0.72966814516129
CTGRYYYNATT_UNKNOWN,SET,63,0.21356,0.012488,0.11113,0.027335,CTGRYYYNATT_UNKNOWN,0.72966814516129
GSE24142_ADULT_VS_FETAL_DN3_...1,SET,181,0.12421,0.012272,0.064655,0.027364,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN,0.729828367816092
GOBP_OPTIC_CUP_MORPHOGENESIS...,SET,7,0.72054,0.014066,0.37516,0.027397,GOBP_OPTIC_CUP_MORPHOGENESIS_INVOLVED_IN_CAMERA_TYPE_EYE_DEVELOPMENT,0.729828367816092
MIR7158_3P,SET,57,0.22327,0.012421,0.11626,0.027404,MIR7158_3P,0.729828367816092
GOBP_CHONDROITIN_SULFATE_MET...,SET,24,0.31875,0.011517,0.1661,0.027497,GOBP_CHONDROITIN_SULFATE_METABOLIC_PROCESS,0.731635263761468
IZADPANAH_STEM_CELL_ADIPOSE_...2,SET,118,0.15145,0.012102,0.078945,0.027535,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,0.731635263761468
GOBP_POSITIVE_REGULATION_OF_...736,SET,41,0.25263,0.011925,0.13169,0.027535,GOBP_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.731635263761468
HP_ELEVATED_CIRCULATING_CALC...,SET,22,0.29563,0.010227,0.15416,0.02758,HP_ELEVATED_CIRCULATING_CALCITONIN_CONCENTRATION,0.7320271875
GOBP_PURINE_CONTAINING_COMPO...4,SET,37,0.28597,0.012825,0.14917,0.027623,GOBP_PURINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT,0.7320271875
GOMF_RACEMASE_AND_EPIMERASE_...2,SET,9,0.50965,0.011281,0.26585,0.027624,GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY_ACTING_ON_CARBOHYDRATES_AND_DERIVATIVES,0.7320271875
HP_PAIN,SET,754,0.060842,0.012074,0.03174,0.027634,HP_PAIN,0.7320271875
GSE23505_UNTREATED_VS_4DAY_I...3,SET,184,0.11349,0.011304,0.059243,0.027715,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,0.733126366716867
T3R_Q6,SET,229,0.10638,0.011806,0.055548,0.027746,T3R_Q6,0.733126366716867
UZONYI_RESPONSE_TO_LEUKOTRIE...,SET,34,0.32643,0.014034,0.17046,0.027753,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,0.733126366716867
MIR4781_5P,SET,5,0.76063,0.01255,0.39727,0.027778,MIR4781_5P,0.733126366716867
GSE11961_MARGINAL_ZONE_BCELL...3,SET,182,0.11608,0.0115,0.060634,0.027787,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.733126366716867
GNF2_SMC1L1,SET,23,0.33258,0.011764,0.17378,0.027832,GNF2_SMC1L1,0.733126366716867
WP_EXTRAFOLLICULAR_AND_FOLLI...,SET,65,0.2238,0.013292,0.11694,0.027834,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,0.733126366716867
GOMF_ASPARTIC_ENDOPEPTIDASE_...,SET,8,0.48837,0.010192,0.25524,0.027858,GOMF_ASPARTIC_ENDOPEPTIDASE_ACTIVITY_INTRAMEMBRANE_CLEAVING,0.733126366716867
KOBAYASHI_EGFR_SIGNALING_6HR...1,SET,17,0.40986,0.012466,0.21426,0.027889,KOBAYASHI_EGFR_SIGNALING_6HR_DN,0.733126366716867
GOMF_UDP_XYLOSYLTRANSFERASE_...,SET,6,0.53023,0.0095834,0.27724,0.027913,GOMF_UDP_XYLOSYLTRANSFERASE_ACTIVITY,0.733126366716867
GSE14769_UNSTIM_VS_120MIN_LP...2,SET,184,0.11248,0.011203,0.058819,0.027927,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP,0.733126366716867
GOBP_POSITIVE_REGULATION_OF_...382,SET,52,0.21754,0.01156,0.11381,0.027988,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.733126366716867
KEGG_MEDICUS_VARIANT_MUTATIO...84,SET,8,0.59017,0.012316,0.30878,0.027991,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,0.733126366716867
GSE19401_PLN_VS_PEYERS_PATCH...1,SET,186,0.11398,0.011414,0.059636,0.027993,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN,0.733126366716867
GOBP_NUCLEOSIDE_TRANSMEMBRAN...,SET,8,0.58361,0.012179,0.30537,0.028002,GOBP_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT,0.733126366716867
GSE360_L_DONOVANI_VS_M_TUBER...3,SET,188,0.1177,0.011849,0.061592,0.028013,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN,0.733126366716867
HP_MICROANGIOPATHIC_HEMOLYTI...,SET,9,0.55672,0.012323,0.29138,0.028035,HP_MICROANGIOPATHIC_HEMOLYTIC_ANEMIA,0.733150056433409
HP_PROMINENT_EYELASHES,SET,14,0.39534,0.010912,0.20703,0.028102,HP_PROMINENT_EYELASHES,0.733991261227545
GOBP_POSITIVE_REGULATION_OF_...813,SET,18,0.40441,0.012656,0.21183,0.028132,GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.733991261227545
HP_OPPORTUNISTIC_INFECTION,SET,43,0.25119,0.012142,0.13161,0.028164,HP_OPPORTUNISTIC_INFECTION,0.733991261227545
GOBP_ACTIN_POLYMERIZATION_DE...,SET,7,0.61377,0.011982,0.32159,0.028168,GOBP_ACTIN_POLYMERIZATION_DEPENDENT_CELL_MOTILITY,0.733991261227545
GOBP_REGULATION_OF_DNA_DIREC...,SET,9,0.48848,0.010812,0.25601,0.028202,GOBP_REGULATION_OF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,0.733991261227545
GOBP_XENOPHAGY,SET,14,0.41484,0.011451,0.21742,0.028205,GOBP_XENOPHAGY,0.733991261227545
HP_INTERMITTENT_THROMBOCYTOP...,SET,4,0.85243,0.01258,0.4468,0.028215,HP_INTERMITTENT_THROMBOCYTOPENIA,0.733991261227545
SAKAI_CHRONIC_HEPATITIS_VS_L...1,SET,33,0.29735,0.012595,0.15593,0.028267,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,0.734794005235602
GOMF_MONOCARBOXYLIC_ACID_BIN...,SET,82,0.19375,0.012919,0.10164,0.028313,GOMF_MONOCARBOXYLIC_ACID_BINDING,0.735439697309417
REACTOME_IRAK2_MEDIATED_ACTI...,SET,8,0.65951,0.013763,0.34626,0.028419,REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX,0.737246921641791
HP_ALVEOLAR_RIDGE_OVERGROWTH,SET,11,0.47723,0.011677,0.25057,0.028425,HP_ALVEOLAR_RIDGE_OVERGROWTH,0.737246921641791
GSE26912_TUMORICIDAL_VS_CTRL...1,SET,184,0.11682,0.011636,0.061361,0.028476,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_DN,0.737644467609829
WP_INHIBITION_OF_EXOSOME_BIO...,SET,17,0.3475,0.010569,0.18255,0.02849,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,0.737644467609829
BREUHAHN_GROWTH_FACTOR_SIGNA...,SET,15,0.47016,0.013433,0.24701,0.028504,BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,0.737644467609829
GOCC_NUCLEOLAR_RIBONUCLEASE_...,SET,7,0.58966,0.011511,0.30994,0.028559,GOCC_NUCLEOLAR_RIBONUCLEASE_P_COMPLEX,0.737782031946508
DESCARTES_FETAL_KIDNEY_MYELO...,SET,151,0.13942,0.012592,0.073285,0.028562,DESCARTES_FETAL_KIDNEY_MYELOID_CELLS,0.737782031946508
MIR6891_3P,SET,62,0.20589,0.011944,0.10823,0.028573,MIR6891_3P,0.737782031946508
GOBP_POSITIVE_REGULATION_OF_...614,SET,178,0.11734,0.011497,0.061719,0.028644,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.738638124547429
HP_RENAL_INSUFFICIENCY,SET,364,0.083844,0.011688,0.044105,0.02866,HP_RENAL_INSUFFICIENCY,0.738638124547429
KEGG_MEDICUS_VARIANT_LMO2_RE...2,SET,5,0.72598,0.011978,0.38196,0.02868,KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_REPRESSION,0.738638124547429
PID_NFAT_3PATHWAY,SET,53,0.22547,0.012096,0.11866,0.028715,PID_NFAT_3PATHWAY,0.738638124547429
GOBP_POSTREPLICATION_REPAIR,SET,32,0.23387,0.009755,0.12312,0.028752,GOBP_POSTREPLICATION_REPAIR,0.738638124547429
GSE29617_CTRL_VS_DAY3_TIV_FL...2,SET,165,0.12141,0.011458,0.063926,0.028772,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP,0.738638124547429
HAHTOLA_MYCOSIS_FUNGOIDES_CD...2,SET,57,0.23038,0.012816,0.12132,0.02879,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,0.738638124547429
ZHOU_CELL_CYCLE_GENES_IN_IR_...3,SET,79,0.17907,0.011721,0.094305,0.028799,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR,0.738638124547429
DESCARTES_FETAL_CEREBELLUM_V...,SET,506,0.077257,0.012647,0.040709,0.028872,DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS,0.738638124547429
GOMF_SINGLE_STRANDED_DNA_HEL...,SET,23,0.33115,0.011713,0.17452,0.028888,GOMF_SINGLE_STRANDED_DNA_HELICASE_ACTIVITY,0.738638124547429
GSE17721_POLYIC_VS_PAM3CSK4_...4,SET,188,0.11408,0.011484,0.060125,0.028901,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP,0.738638124547429
GOBP_NEGATIVE_REGULATION_OF_...609,SET,22,0.33913,0.011732,0.17882,0.028955,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.738638124547429
GOMF_NUCLEOCYTOPLASMIC_CARRI...,SET,30,0.25684,0.010373,0.13548,0.029002,GOMF_NUCLEOCYTOPLASMIC_CARRIER_ACTIVITY,0.738638124547429
CERIBELLI_GENES_INACTIVE_AND...,SET,29,0.32594,0.012943,0.17194,0.029009,CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,0.738638124547429
GSE40666_NAIVE_VS_EFFECTOR_C...4,SET,187,0.12018,0.012066,0.063416,0.029049,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.738638124547429
KEGG_MEDICUS_REFERENCE_CA2_E...3,SET,24,0.35641,0.012877,0.18807,0.029051,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL,0.738638124547429
GSE3982_MEMORY_CD4_TCELL_VS_...6,SET,172,0.12122,0.011677,0.063972,0.029064,GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP,0.738638124547429
HP_PUNCTATE_OPACIFICATION_OF...,SET,5,0.72419,0.011949,0.38226,0.029087,HP_PUNCTATE_OPACIFICATION_OF_THE_CORNEA,0.738638124547429
GUTIERREZ_CHRONIC_LYMPHOCYTI...1,SET,50,0.22883,0.011925,0.1208,0.029098,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,0.738638124547429
MIR6133,SET,169,0.12395,0.011837,0.065445,0.02912,MIR6133,0.738638124547429
GSE7831_1H_VS_4H_INFLUENZA_S...1,SET,186,0.11862,0.011879,0.062645,0.029148,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN,0.738638124547429
GSE41978_ID2_KO_VS_BIM_KO_KL...2,SET,186,0.12181,0.012198,0.064351,0.02919,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.738638124547429
KEGG_ANTIGEN_PROCESSING_AND_...,SET,72,0.2193,0.013706,0.11586,0.029199,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,0.738638124547429
GOMF_PHOSPHATIDYLINOSITOL_3_...1,SET,4,0.76498,0.01129,0.40416,0.029202,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_3_PHOSPHATASE_ACTIVITY,0.738638124547429
GSE3982_BASOPHIL_VS_TH2_DN,SET,179,0.11777,0.011571,0.062226,0.029217,GSE3982_BASOPHIL_VS_TH2_DN,0.738638124547429
MIR7110_5P,SET,154,0.13228,0.012064,0.069904,0.029233,MIR7110_5P,0.738638124547429
MARSHALL_VIRAL_INFECTION_RES...1,SET,26,0.30986,0.011652,0.16377,0.029247,MARSHALL_VIRAL_INFECTION_RESPONSE_DN,0.738638124547429
REACTOME_CELL_CYCLE_MITOTIC,SET,469,0.071311,0.011251,0.03769,0.029251,REACTOME_CELL_CYCLE_MITOTIC,0.738638124547429
MIR6127,SET,185,0.11854,0.011839,0.062655,0.029259,MIR6127,0.738638124547429
GOMF_PHOSPHATASE_BINDING,SET,176,0.11751,0.01145,0.062128,0.029289,GOMF_PHOSPHATASE_BINDING,0.738638124547429
REACTOME_SIGNALING_BY_RNF43_...,SET,8,0.59798,0.012479,0.31623,0.029324,REACTOME_SIGNALING_BY_RNF43_MUTANTS,0.738638124547429
GNF2_VAV1,SET,33,0.28823,0.012208,0.15243,0.029327,GNF2_VAV1,0.738638124547429
GOBP_REGULATION_OF_MEMBRANE_...5,SET,58,0.21349,0.01198,0.11291,0.029327,GOBP_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION,0.738638124547429
HP_DEGENERATION_OF_THE_LATER...,SET,19,0.32726,0.010522,0.1731,0.029347,HP_DEGENERATION_OF_THE_LATERAL_CORTICOSPINAL_TRACTS,0.738638124547429
MIR4430,SET,128,0.13898,0.011563,0.073512,0.02935,MIR4430,0.738638124547429
HP_APLASIA_HYPOPLASIA_OF_THE...69,SET,6,0.66776,0.012069,0.35338,0.02941,HP_APLASIA_HYPOPLASIA_OF_THE_SWEAT_GLANDS,0.739126341023792
GOBP_THELARCHE,SET,4,0.94038,0.013878,0.49779,0.029448,GOBP_THELARCHE,0.739126341023792
REACTOME_RNA_POLYMERASE_III_...2,SET,39,0.22048,0.010151,0.11671,0.029449,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION,0.739126341023792
BUSSLINGER_GASTRIC_IMMATURE_...,SET,156,0.13285,0.012194,0.070336,0.029464,BUSSLINGER_GASTRIC_IMMATURE_PIT_CELLS,0.739126341023792
GOBP_ANTEROGRADE_AXONAL_TRAN...1,SET,48,0.22711,0.011597,0.12027,0.029494,GOBP_ANTEROGRADE_AXONAL_TRANSPORT,0.739126341023792
GOMF_ABC_TYPE_TRANSPORTER_AC...,SET,46,0.24921,0.012458,0.13197,0.029497,GOMF_ABC_TYPE_TRANSPORTER_ACTIVITY,0.739126341023792
GOBP_NEGATIVE_REGULATION_OF_...572,SET,8,0.54399,0.011353,0.28815,0.029531,GOBP_NEGATIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.739381370503597
REACTOME_SIGNALING_BY_ERBB2_...1,SET,15,0.36171,0.010334,0.19163,0.029553,REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS,0.739381370503597
CAO_BLOOD_FLUZONE_AGE_05_14Y...2,SET,5,0.72617,0.011982,0.38478,0.029571,CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_UP,0.739381370503597
HP_INTERMITTENT_CLAUDICATION,SET,8,0.5173,0.010796,0.27423,0.029632,HP_INTERMITTENT_CLAUDICATION,0.740369735543018
PRC2_EZH2_UP.V1_DN,SET,169,0.11832,0.011299,0.062743,0.029666,PRC2_EZH2_UP.V1_DN,0.740369735543018
REACTOME_RIBAVIRIN_ADME,SET,11,0.54065,0.013229,0.28674,0.02969,REACTOME_RIBAVIRIN_ADME,0.740369735543018
MIR7156_3P,SET,89,0.16205,0.011255,0.085986,0.029747,MIR7156_3P,0.740369735543018
GOCC_ENDOSOME_MEMBRANE,SET,518,0.069417,0.011494,0.036838,0.029766,GOCC_ENDOSOME_MEMBRANE,0.740369735543018
GSE30971_CTRL_VS_LPS_STIM_MA...6,SET,168,0.13751,0.013093,0.072993,0.029801,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_UP,0.740369735543018
GOBP_REGULATION_OF_TRANSCRIP...1,SET,8,0.4803,0.010023,0.25499,0.029818,GOBP_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE,0.740369735543018
WP_SPINA_BIFIDA,SET,12,0.43291,0.011064,0.22985,0.029829,WP_SPINA_BIFIDA,0.740369735543018
GOBP_REGULATION_OF_LEUKOCYTE...6,SET,308,0.094753,0.012169,0.05031,0.029832,GOBP_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION,0.740369735543018
GSE18281_MEDULLARY_THYMOCYTE...2,SET,163,0.12217,0.01146,0.064867,0.029832,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_UP,0.740369735543018
GOMF_SINGLE_STRANDED_DNA_BIN...,SET,107,0.14522,0.011053,0.077112,0.029846,GOMF_SINGLE_STRANDED_DNA_BINDING,0.740369735543018
GSE17721_LPS_VS_POLYIC_12H_B...2,SET,185,0.11342,0.011327,0.060247,0.029887,GSE17721_LPS_VS_POLYIC_12H_BMDC_UP,0.740369735543018
ABE_VEGFA_TARGETS_2HR,SET,27,0.31453,0.012052,0.16718,0.02997,ABE_VEGFA_TARGETS_2HR,0.740369735543018
HP_ENLARGED_VESTIBULAR_AQUED...,SET,7,0.61348,0.011976,0.32613,0.029988,HP_ENLARGED_VESTIBULAR_AQUEDUCT,0.740369735543018
GOBP_SUBSTRATE_ADHESION_DEPE...,SET,97,0.16262,0.011789,0.086454,0.029992,GOBP_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.740369735543018
E2F1_Q4,SET,222,0.10773,0.011774,0.057274,0.029998,E2F1_Q4,0.740369735543018
ACEVEDO_LIVER_CANCER_WITH_H3...4,SET,111,0.1643,0.012736,0.087364,0.030018,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP,0.740369735543018
MIR6856_3P,SET,65,0.1894,0.011249,0.10072,0.030025,MIR6856_3P,0.740369735543018
GOBP_POSITIVE_REGULATION_OF_...335,SET,10,0.47045,0.010976,0.25028,0.030085,GOBP_POSITIVE_REGULATION_OF_HEPATOCYTE_PROLIFERATION,0.740369735543018
HP_ISOMERISM,SET,4,0.78552,0.011593,0.4179,0.030085,HP_ISOMERISM,0.740369735543018
GSE3039_NKT_CELL_VS_ALPHABET...1,SET,174,0.12074,0.011698,0.064239,0.030093,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN,0.740369735543018
HP_FIBER_TYPE_GROUPING,SET,10,0.42942,0.010019,0.22848,0.030096,HP_FIBER_TYPE_GROUPING,0.740369735543018
REACTOME_PKR_MEDIATED_SIGNAL...,SET,65,0.19321,0.011475,0.10283,0.030135,REACTOME_PKR_MEDIATED_SIGNALING,0.740369735543018
JOHNSTONE_PARVB_TARGETS_3_DN,SET,758,0.056973,0.011334,0.030326,0.030154,JOHNSTONE_PARVB_TARGETS_3_DN,0.740369735543018
GSE32986_UNSTIM_VS_CURDLAN_L...2,SET,190,0.10902,0.011033,0.058032,0.030156,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP,0.740369735543018
GOBP_NEGATIVE_REGULATION_OF_...502,SET,21,0.3846,0.012999,0.20478,0.03019,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,0.740369735543018
HP_ABNORMAL_SPUTUM,SET,119,0.15035,0.012065,0.080059,0.030199,HP_ABNORMAL_SPUTUM,0.740369735543018
GOBP_NUCLEOBASE_TRANSPORT,SET,12,0.42183,0.01078,0.22463,0.030207,GOBP_NUCLEOBASE_TRANSPORT,0.740369735543018
GOBP_REGULATION_OF_ODONTOGEN...2,SET,12,0.51611,0.01319,0.2749,0.030234,GOBP_REGULATION_OF_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,0.740509281183932
MIR1286,SET,80,0.17161,0.011303,0.091454,0.030305,MIR1286,0.741301403940887
REACTOME_INTERLEUKIN_12_FAMI...,SET,53,0.20959,0.011244,0.1117,0.030309,REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,0.741301403940887
GOCC_SIN3_TYPE_COMPLEX,SET,19,0.34529,0.011102,0.18412,0.03038,GOCC_SIN3_TYPE_COMPLEX,0.74227795997191
EHLERS_ANEUPLOIDY_DN,SET,10,0.53473,0.012476,0.28519,0.030405,EHLERS_ANEUPLOIDY_DN,0.74227795997191
BIOCARTA_EGF_PATHWAY,SET,26,0.31281,0.011763,0.16684,0.030413,BIOCARTA_EGF_PATHWAY,0.74227795997191
GSE20727_CTRL_VS_ROS_INH_AND...1,SET,170,0.11687,0.011193,0.062382,0.030512,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,0.742768661971831
HE_LIM_SUN_FETAL_LUNG_C2_HSC...2,SET,350,0.084175,0.01151,0.044952,0.030575,HE_LIM_SUN_FETAL_LUNG_C2_HSC_ELP_CELL,0.742768661971831
KEGG_MEDICUS_REFERENCE_P16_C...,SET,10,0.51494,0.012014,0.275,0.030579,KEGG_MEDICUS_REFERENCE_P16_CELL_CYCLE_G1_S,0.742768661971831
HP_LOCALIZED_SKIN_LESION,SET,790,0.058167,0.011803,0.031064,0.030579,HP_LOCALIZED_SKIN_LESION,0.742768661971831
GOBP_POSITIVE_REGULATION_OF_...711,SET,15,0.378,0.0108,0.20189,0.030589,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.742768661971831
GSE19198_6H_VS_24H_IL21_TREA...1,SET,177,0.11916,0.011643,0.063658,0.030621,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN,0.742768661971831
SANSOM_WNT_PATHWAY_REQUIRE_M...,SET,60,0.22825,0.013027,0.12196,0.030641,SANSOM_WNT_PATHWAY_REQUIRE_MYC,0.742768661971831
GOMF_PROTEIN_METHYLTRANSFERA...,SET,80,0.16773,0.011047,0.08962,0.030642,GOMF_PROTEIN_METHYLTRANSFERASE_ACTIVITY,0.742768661971831
REACTOME_STRIATED_MUSCLE_CON...,SET,35,0.26031,0.011354,0.13911,0.030666,REACTOME_STRIATED_MUSCLE_CONTRACTION,0.742768661971831
GSE7764_IL15_NK_CELL_24H_VS_...2,SET,171,0.11454,0.011002,0.06122,0.030681,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP,0.742768661971831
LIU_VAV3_PROSTATE_CARCINOGEN...1,SET,14,0.44687,0.012335,0.23897,0.030751,LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,0.742768661971831
GOBP_RUFFLE_ORGANIZATION,SET,53,0.21918,0.011759,0.11722,0.030766,GOBP_RUFFLE_ORGANIZATION,0.742768661971831
GSE21927_BALBC_VS_C57BL6_MON...3,SET,160,0.12088,0.011235,0.064663,0.030797,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_DN,0.742768661971831
GOMF_NUCLEOSIDE_TRIPHOSPHATE...,SET,9,0.57804,0.012795,0.30931,0.030831,GOMF_NUCLEOSIDE_TRIPHOSPHATE_DIPHOSPHATASE_ACTIVITY,0.742768661971831
HP_IMPAIRED_ARACHIDONIC_ACID...,SET,7,0.5652,0.011034,0.30245,0.030836,HP_IMPAIRED_ARACHIDONIC_ACID_INDUCED_PLATELET_AGGREGATION,0.742768661971831
HP_PERINEAL_FISTULA,SET,12,0.43118,0.011019,0.23078,0.030864,HP_PERINEAL_FISTULA,0.742768661971831
GOBP_POSITIVE_REGULATION_OF_...317,SET,8,0.53978,0.011265,0.28891,0.030865,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,0.742768661971831
HP_ENLARGED_NARIS,SET,5,0.68708,0.011337,0.36778,0.030878,HP_ENLARGED_NARIS,0.742768661971831
GOMF_SULFOTRANSFERASE_ACTIVI...,SET,49,0.24477,0.012628,0.13108,0.030931,GOMF_SULFOTRANSFERASE_ACTIVITY,0.742768661971831
JI_CARCINOGENESIS_BY_KRAS_AN...1,SET,16,0.44702,0.01319,0.23942,0.03095,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,0.742768661971831
REACTOME_ADVANCED_GLYCOSYLAT...,SET,13,0.42127,0.011205,0.22562,0.030951,REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING,0.742768661971831
REACTOME_MAP2K_AND_MAPK_ACTI...,SET,38,0.25165,0.011437,0.1348,0.030973,REACTOME_MAP2K_AND_MAPK_ACTIVATION,0.742768661971831
GOBP_NEGATIVE_REGULATION_OF_...468,SET,35,0.28253,0.012324,0.15135,0.030981,GOBP_NEGATIVE_REGULATION_OF_OSSIFICATION,0.742768661971831
GSE15930_NAIVE_VS_72H_IN_VIT...7,SET,188,0.11002,0.011076,0.058947,0.030999,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN,0.742768661971831
GOCC_POSTSYNAPTIC_ACTIN_CYTO...,SET,8,0.51018,0.010647,0.27335,0.031003,GOCC_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.742768661971831
GOBP_REGULATION_OF_LEUKOCYTE...3,SET,83,0.17623,0.011822,0.09448,0.031079,GOBP_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.742768661971831
REACTOME_INHIBITION_OF_REPLI...,SET,11,0.43745,0.010704,0.23455,0.031094,REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1,0.742768661971831
KANG_DOXORUBICIN_RESISTANCE_...2,SET,49,0.2222,0.011463,0.11915,0.03111,KANG_DOXORUBICIN_RESISTANCE_UP,0.742768661971831
E2F1_Q3,SET,221,0.10183,0.011104,0.054633,0.031176,E2F1_Q3,0.742768661971831
GARCIA_TARGETS_OF_FLI1_AND_D...1,SET,148,0.12272,0.010973,0.06584,0.031179,GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,0.742768661971831
HP_ABNORMALITY_OF_VON_WILLEB...,SET,12,0.43525,0.011123,0.23353,0.031185,HP_ABNORMALITY_OF_VON_WILLEBRAND_FACTOR,0.742768661971831
RAY_TUMORIGENESIS_BY_ERBB2_C...1,SET,243,0.10609,0.012123,0.056922,0.031189,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,0.742768661971831
MIR3921,SET,135,0.13951,0.011918,0.074856,0.031191,MIR3921,0.742768661971831
KEGG_DNA_REPLICATION,SET,34,0.2441,0.010495,0.13107,0.031285,KEGG_DNA_REPLICATION,0.742768661971831
GSE21063_3H_VS_16H_ANTI_IGM_...3,SET,182,0.11299,0.011194,0.060681,0.031307,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN,0.742768661971831
GOBP_REGULATION_OF_PLASMA_CE...,SET,6,0.59484,0.010751,0.31947,0.031312,GOBP_REGULATION_OF_PLASMA_CELL_DIFFERENTIATION,0.742768661971831
GOBP_NEGATIVE_REGULATION_OF_...477,SET,4,0.7192,0.010614,0.38627,0.031317,GOBP_NEGATIVE_REGULATION_OF_PANCREATIC_JUICE_SECRETION,0.742768661971831
HP_ANKYLOGLOSSIA,SET,23,0.30923,0.010938,0.16613,0.031354,HP_ANKYLOGLOSSIA,0.742768661971831
GOBP_DEVELOPMENTAL_PROCESS_I...,SET,868,0.054199,0.011502,0.029118,0.031358,GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION,0.742768661971831
HP_PROLONGED_BLEEDING_FOLLOW...2,SET,29,0.31227,0.0124,0.16779,0.031378,HP_PROLONGED_BLEEDING_FOLLOWING_PROCEDURE,0.742768661971831
GOBP_DEVELOPMENT_OF_PRIMARY_...2,SET,213,0.11212,0.012006,0.060256,0.031397,GOBP_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS,0.742768661971831
REACTOME_IKBA_VARIANT_LEADS_...,SET,6,0.58061,0.010494,0.31206,0.03141,REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID,0.742768661971831
DESCARTES_FETAL_SPLEEN_ERYTH...,SET,53,0.21631,0.011605,0.11626,0.031411,DESCARTES_FETAL_SPLEEN_ERYTHROBLASTS,0.742768661971831
HP_RECURRENT_ASPERGILLUS_INF...,SET,22,0.34828,0.012049,0.18725,0.031449,HP_RECURRENT_ASPERGILLUS_INFECTIONS,0.742768661971831
HP_FOCAL_T2_HYPERINTENSE_BRA...,SET,26,0.26288,0.0098852,0.14137,0.031489,HP_FOCAL_T2_HYPERINTENSE_BRAINSTEM_LESION,0.742768661971831
HOLLEMAN_ASPARAGINASE_RESIST...4,SET,24,0.29105,0.010516,0.15653,0.031498,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP,0.742768661971831
GSE22886_UNSTIM_VS_IL2_STIM_...1,SET,185,0.10656,0.010642,0.057312,0.0315,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN,0.742768661971831
MODULE_240,SET,14,0.41231,0.011381,0.22179,0.031523,MODULE_240,0.742768661971831
HP_BUTTERFLY_VERTEBRAE,SET,16,0.38984,0.011503,0.2098,0.031581,HP_BUTTERFLY_VERTEBRAE,0.742768661971831
MIR3158_3P,SET,35,0.25269,0.011022,0.136,0.031587,MIR3158_3P,0.742768661971831
HP_FETAL_ASCITES,SET,8,0.62462,0.013035,0.33617,0.031589,HP_FETAL_ASCITES,0.742768661971831
GSE13411_PLASMA_CELL_VS_MEMO...2,SET,161,0.12438,0.011596,0.066957,0.031615,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP,0.742768661971831
CREBP1_Q2,SET,231,0.10243,0.011416,0.055147,0.031638,CREBP1_Q2,0.742768661971831
HP_ABNORMAL_MITOCHONDRIAL_SH...,SET,10,0.47162,0.011003,0.25396,0.03166,HP_ABNORMAL_MITOCHONDRIAL_SHAPE,0.742768661971831
PID_HIF2PATHWAY,SET,30,0.26999,0.010904,0.1454,0.031675,PID_HIF2PATHWAY,0.742768661971831
ZHONG_PFC_MAJOR_TYPES_MICROG...,SET,389,0.083947,0.012089,0.045213,0.031686,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,0.742768661971831
MIR4682,SET,117,0.1404,0.011172,0.075628,0.031699,MIR4682,0.742768661971831
KEGG_MEDICUS_VARIANT_TEL_AML...,SET,10,0.53719,0.012533,0.2894,0.031719,KEGG_MEDICUS_VARIANT_TEL_AML1_FUSION_TO_TRANSCRIPTIONAL_REPRESSION,0.742768661971831
HP_JOINT_HYPERMOBILITY,SET,476,0.072023,0.011445,0.038802,0.031721,HP_JOINT_HYPERMOBILITY,0.742768661971831
MIR24_3P,SET,246,0.098526,0.011328,0.053101,0.031774,MIR24_3P,0.742768661971831
MAP2K1_TARGET_GENES,SET,5,0.63093,0.01041,0.3401,0.031797,MAP2K1_TARGET_GENES,0.742768661971831
CUI_DEVELOPING_HEART_C9_B_T_...,SET,133,0.1413,0.011982,0.076167,0.031799,CUI_DEVELOPING_HEART_C9_B_T_CELL,0.742768661971831
GOBP_POSITIVE_REGULATION_OF_...616,SET,6,0.58829,0.010633,0.31714,0.031809,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION,0.742768661971831
REACTOME_PREDNISONE_ADME,SET,9,0.51916,0.011491,0.27988,0.031813,REACTOME_PREDNISONE_ADME,0.742768661971831
HP_MICROGLOSSIA,SET,17,0.37987,0.011553,0.20483,0.031839,HP_MICROGLOSSIA,0.742768661971831
GSE43863_DAY6_EFF_VS_DAY150_...3,SET,181,0.12121,0.011975,0.065362,0.031844,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN,0.742768661971831
HP_FEMALE_EXTERNAL_GENITALIA...,SET,14,0.45833,0.012651,0.24718,0.031865,HP_FEMALE_EXTERNAL_GENITALIA_IN_INDIVIDUAL_WITH_46_XY_KARYOTYPE,0.742768661971831
REACTOME_REGULATION_OF_FZD_B...,SET,20,0.3777,0.012459,0.20375,0.031894,REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION,0.742946360589812
GOBP_RESPONSE_TO_INTERLEUKIN...1,SET,100,0.16198,0.011922,0.087417,0.031949,GOBP_RESPONSE_TO_INTERLEUKIN_1,0.743511234156104
HP_WADDLING_GAIT,SET,116,0.14476,0.01147,0.07813,0.031964,HP_WADDLING_GAIT,0.743511234156104
GOBP_CELL_KILLING,SET,204,0.1217,0.012757,0.065695,0.031983,GOBP_CELL_KILLING,0.743511234156104
GSE23568_CTRL_TRANSDUCED_VS_...2,SET,185,0.11884,0.011869,0.06417,0.032024,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP,0.743511234156104
MIR3908,SET,106,0.16217,0.012286,0.087591,0.032061,MIR3908,0.743511234156104
REACTOME_C_TYPE_LECTIN_RECEP...,SET,125,0.13281,0.010921,0.071735,0.032063,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,0.743511234156104
HP_ABNORMAL_ORAL_FRENULUM_MO...,SET,58,0.1963,0.011015,0.10603,0.032068,HP_ABNORMAL_ORAL_FRENULUM_MORPHOLOGY,0.743511234156104
MODULE_3,SET,361,0.081629,0.011333,0.044102,0.0321,MODULE_3,0.743757
GSE7219_WT_VS_NIK_NFKB2_KO_D...1,SET,158,0.12588,0.011627,0.068021,0.032123,GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN,0.743794047301799
chr12p11,SET,31,0.48708,0.019997,0.26331,0.03218,chr12p11,0.744385987450462
GSE14350_IL2RB_KO_VS_WT_TREG...2,SET,183,0.11286,0.011211,0.061028,0.032213,GSE14350_IL2RB_KO_VS_WT_TREG_UP,0.744385987450462
BILD_HRAS_ONCOGENIC_SIGNATURE,SET,229,0.10745,0.011925,0.058112,0.032232,BILD_HRAS_ONCOGENIC_SIGNATURE,0.744385987450462
GOBP_OLFACTORY_BEHAVIOR,SET,11,0.53166,0.013009,0.28754,0.032238,GOBP_OLFACTORY_BEHAVIOR,0.744385987450462
HP_CHRONIC_FURUNCULOSIS,SET,4,0.78459,0.011579,0.42451,0.032292,HP_CHRONIC_FURUNCULOSIS,0.744385987450462
GOMF_HISTONE_H2A_UBIQUITIN_L...,SET,6,0.5919,0.010698,0.32032,0.032322,GOMF_HISTONE_H2A_UBIQUITIN_LIGASE_ACTIVITY,0.744385987450462
MIR8057,SET,79,0.16988,0.011119,0.091949,0.032343,MIR8057,0.744385987450462
GOBP_LYMPHOCYTE_AGGREGATION,SET,4,0.8386,0.012376,0.45394,0.032355,GOBP_LYMPHOCYTE_AGGREGATION,0.744385987450462
KEGG_MEDICUS_VARIANT_MUTATIO...18,SET,17,0.35661,0.010846,0.19305,0.032369,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.744385987450462
WP_LDL_INFLUENCE_ON_CD14_AND...,SET,22,0.34499,0.011935,0.18681,0.032398,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,0.744385987450462
GOBP_NEGATIVE_REGULATION_OF_...403,SET,103,0.1593,0.011898,0.086262,0.032402,GOBP_NEGATIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,0.744385987450462
GOCC_GEMINI_OF_COILED_BODIES,SET,8,0.43025,0.008979,0.23299,0.032406,GOCC_GEMINI_OF_COILED_BODIES,0.744385987450462
GOBP_NEGATIVE_REGULATION_OF_...293,SET,16,0.38382,0.011325,0.20788,0.032427,GOBP_NEGATIVE_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.744385987450462
GOBP_POSITIVE_REGULATION_OF_...297,SET,49,0.21205,0.01094,0.11492,0.032511,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,0.745573686635945
HP_DUPLICATED_COLLECTING_SYS...,SET,19,0.32261,0.010372,0.17488,0.032542,HP_DUPLICATED_COLLECTING_SYSTEM,0.745573686635945
GSE43863_NAIVE_VS_TFH_CD4_EF...2,SET,173,0.11508,0.011118,0.062387,0.032551,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP,0.745573686635945
DESCARTES_FETAL_LUNG_MYELOID...,SET,143,0.14058,0.012358,0.07622,0.032575,DESCARTES_FETAL_LUNG_MYELOID_CELLS,0.745573686635945
GOCC_PTW_PP1_PHOSPHATASE_COM...,SET,7,0.49482,0.0096598,0.26831,0.032586,GOCC_PTW_PP1_PHOSPHATASE_COMPLEX,0.745573686635945
PID_NFAT_TFPATHWAY,SET,42,0.25125,0.012003,0.13631,0.032658,PID_NFAT_TFPATHWAY,0.746661622864652
GOBP_PURINE_NUCLEOBASE_TRANS...,SET,8,0.57371,0.011973,0.31133,0.032687,GOBP_PURINE_NUCLEOBASE_TRANSMEMBRANE_TRANSPORT,0.746661622864652
GSE46606_UNSTIM_VS_CD40L_IL2...1,SET,185,0.11459,0.011445,0.06219,0.032698,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,0.746661622864652
WHITESIDE_CISPLATIN_RESISTAN...1,SET,12,0.40448,0.010337,0.21956,0.032728,WHITESIDE_CISPLATIN_RESISTANCE_DN,0.746663781818182
GOCC_PROTEIN_PHOSPHATASE_TYP...1,SET,18,0.34126,0.01068,0.18533,0.032793,GOCC_PROTEIN_PHOSPHATASE_TYPE_1_COMPLEX,0.746663781818182
BUSSLINGER_DUODENAL_IMMUNE_C...,SET,822,0.054925,0.011358,0.029843,0.032859,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.746663781818182
NAKAYA_PBMC_IMUVAC_MALE_AGE_...,SET,38,0.25414,0.01155,0.13809,0.03286,NAKAYA_PBMC_IMUVAC_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0DY_PREIMM_TIV_UP,0.746663781818182
GOBP_RESPONSE_TO_UV_B,SET,19,0.33173,0.010666,0.18028,0.032887,GOBP_RESPONSE_TO_UV_B,0.746663781818182
GOBP_POSITIVE_REGULATION_OF_...506,SET,32,0.28236,0.011777,0.15347,0.032905,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.746663781818182
VALK_AML_CLUSTER_11,SET,37,0.27109,0.012157,0.14735,0.032908,VALK_AML_CLUSTER_11,0.746663781818182
GSE23321_CD8_STEM_CELL_MEMOR...5,SET,178,0.11222,0.010995,0.060996,0.032909,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.746663781818182
HP_LATERAL_VENTRICLE_DILATAT...,SET,75,0.17224,0.010986,0.093624,0.032912,HP_LATERAL_VENTRICLE_DILATATION,0.746663781818182
KLF14_TARGET_GENES,SET,203,0.10975,0.011476,0.059657,0.03292,KLF14_TARGET_GENES,0.746663781818182
chr5q13,SET,51,0.40991,0.021574,0.22291,0.032972,chr5q13,0.746663781818182
WP_NAD_METABOLISM_SIRTUINS_A...,SET,11,0.50378,0.012327,0.27401,0.033001,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,0.746663781818182
ZHENG_GLIOBLASTOMA_PLASTICIT...1,SET,57,0.22345,0.012431,0.12156,0.033027,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,0.746663781818182
MIR7706,SET,10,0.53608,0.012507,0.29179,0.033098,MIR7706,0.746663781818182
MCBRYAN_TERMINAL_END_BUD_DN,SET,6,0.68532,0.012387,0.37317,0.03315,MCBRYAN_TERMINAL_END_BUD_DN,0.746663781818182
GSE10325_BCELL_VS_MYELOID_UP,SET,170,0.12008,0.011501,0.065393,0.033169,GSE10325_BCELL_VS_MYELOID_UP,0.746663781818182
GSE9650_GP33_VS_GP276_LCMV_S...1,SET,185,0.1078,0.010766,0.05873,0.033228,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN,0.746663781818182
HP_REDUCED_CIRCULATING_GROWT...,SET,10,0.50684,0.011825,0.27621,0.033262,HP_REDUCED_CIRCULATING_GROWTH_HORMONE_CONCENTRATION,0.746663781818182
HP_DIFFICULTY_RUNNING,SET,47,0.22861,0.011551,0.12462,0.033302,HP_DIFFICULTY_RUNNING,0.746663781818182
GOBP_PROTEOGLYCAN_METABOLIC_...,SET,83,0.17228,0.011557,0.093938,0.03334,GOBP_PROTEOGLYCAN_METABOLIC_PROCESS,0.746663781818182
GOBP_PROTEIN_LOCALIZATION_TO...8,SET,4,0.74605,0.01101,0.40685,0.033356,GOBP_PROTEIN_LOCALIZATION_TO_CELL_LEADING_EDGE,0.746663781818182
GOBP_ISOPRENOID_TRANSPORT,SET,5,0.75495,0.012457,0.41173,0.033363,GOBP_ISOPRENOID_TRANSPORT,0.746663781818182
GOBP_INNATE_IMMUNE_RESPONSE,SET,845,0.055945,0.011722,0.030519,0.033399,GOBP_INNATE_IMMUNE_RESPONSE,0.746663781818182
HP_4_5_TOE_SYNDACTYLY,SET,8,0.60459,0.012617,0.32991,0.033438,HP_4_5_TOE_SYNDACTYLY,0.746663781818182
HP_RIDGED_FINGERNAIL,SET,7,0.62918,0.012283,0.34335,0.033449,HP_RIDGED_FINGERNAIL,0.746663781818182
GOBP_POSITIVE_REGULATION_OF_...682,SET,70,0.19125,0.011786,0.10438,0.033469,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,0.746663781818182
HP_ABNORMAL_INTERVERTEBRAL_D...,SET,39,0.23747,0.010933,0.12962,0.03348,HP_ABNORMAL_INTERVERTEBRAL_DISK_MORPHOLOGY,0.746663781818182
TCGATGG_MIR213,SET,5,0.63951,0.010552,0.34918,0.033525,TCGATGG_MIR213,0.746663781818182
PTEN_DN.V2_DN,SET,119,0.14523,0.011654,0.079301,0.033528,PTEN_DN.V2_DN,0.746663781818182
GOBP_REGULATION_OF_CHROMATIN...1,SET,10,0.44453,0.010371,0.24274,0.033536,GOBP_REGULATION_OF_CHROMATIN_BINDING,0.746663781818182
JIANG_MELANOMA_TRM1_CD8,SET,152,0.13159,0.011923,0.071862,0.033552,JIANG_MELANOMA_TRM1_CD8,0.746663781818182
REACTOME_INTERLEUKIN_4_AND_I...,SET,101,0.1717,0.0127,0.093817,0.03362,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,0.746663781818182
GOBP_CALCIUM_ION_IMPORT,SET,73,0.187,0.011768,0.10218,0.033623,GOBP_CALCIUM_ION_IMPORT,0.746663781818182
KEGG_MEDICUS_REFERENCE_II_BL...,SET,7,0.65915,0.012868,0.36021,0.033641,KEGG_MEDICUS_REFERENCE_II_BLOOD_GROUP_ANTIGEN_BIOSYNTHESIS,0.746663781818182
GOCC_OUTER_DYNEIN_ARM,SET,10,0.47974,0.011193,0.26217,0.033641,GOCC_OUTER_DYNEIN_ARM,0.746663781818182
MIR4668_3P,SET,277,0.093155,0.011355,0.050909,0.033646,MIR4668_3P,0.746663781818182
REACTOME_ALPHA_PROTEIN_KINAS...,SET,9,0.56317,0.012465,0.30778,0.033649,REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY,0.746663781818182
MODULE_58,SET,17,0.42151,0.01282,0.23037,0.033656,MODULE_58,0.746663781818182
GOCC_SPECIFIC_GRANULE_MEMBRA...,SET,84,0.16356,0.011037,0.089413,0.033689,GOCC_SPECIFIC_GRANULE_MEMBRANE,0.746663781818182
HP_MITOCHONDRIAL_MYOPATHY,SET,37,0.22705,0.010182,0.12415,0.033723,HP_MITOCHONDRIAL_MYOPATHY,0.746663781818182
HP_BIFID_TONGUE,SET,22,0.3187,0.011025,0.17428,0.033732,HP_BIFID_TONGUE,0.746663781818182
LEE_DIFFERENTIATING_T_LYMPHO...,SET,170,0.11652,0.01116,0.063723,0.033741,LEE_DIFFERENTIATING_T_LYMPHOCYTE,0.746663781818182
HP_GANGRENE,SET,52,0.22988,0.012216,0.12575,0.033774,HP_GANGRENE,0.746663781818182
GSE24814_STAT5_KO_VS_WT_PRE_...1,SET,183,0.10997,0.010923,0.060153,0.033776,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN,0.746663781818182
GOCC_NUCLEAR_ENVELOPE_LUMEN,SET,10,0.51363,0.011984,0.28101,0.0338,GOCC_NUCLEAR_ENVELOPE_LUMEN,0.746663781818182
GSE9988_ANTI_TREM1_VS_ANTI_T...1,SET,161,0.13067,0.012183,0.071507,0.033827,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,0.746663781818182
LMO2COM_02,SET,220,0.10567,0.011497,0.057852,0.033892,LMO2COM_02,0.746663781818182
WP_AGERAGE_PATHWAY,SET,63,0.19596,0.011459,0.1073,0.03391,WP_AGERAGE_PATHWAY,0.746663781818182
GOBP_NEGATIVE_REGULATION_OF_...336,SET,6,0.73437,0.013273,0.40211,0.033911,GOBP_NEGATIVE_REGULATION_OF_LENS_FIBER_CELL_DIFFERENTIATION,0.746663781818182
BHAT_ESR1_TARGETS_NOT_VIA_AK...1,SET,84,0.17967,0.012125,0.098382,0.033915,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,0.746663781818182
GSE13522_WT_VS_IFNAR_KO_SKIN...4,SET,177,0.11558,0.011293,0.063301,0.033946,GSE13522_WT_VS_IFNAR_KO_SKIN_UP,0.746663781818182
GOBP_L_LEUCINE_IMPORT_ACROSS...,SET,5,0.68989,0.011383,0.37788,0.033958,GOBP_L_LEUCINE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.746663781818182
MIR5693,SET,78,0.17669,0.011492,0.096801,0.033988,MIR5693,0.746663781818182
HP_ANIRIDIA,SET,41,0.23462,0.011074,0.12855,0.034002,HP_ANIRIDIA,0.746663781818182
REACTOME_ALK_MUTANTS_BIND_TK...,SET,12,0.42082,0.010755,0.23062,0.034032,REACTOME_ALK_MUTANTS_BIND_TKIS,0.746663781818182
KEGG_MEDICUS_REFERENCE_EGF_E...12,SET,15,0.38558,0.011016,0.21138,0.034074,KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY,0.746663781818182
GSE40666_WT_VS_STAT4_KO_CD8_...2,SET,147,0.13164,0.011732,0.072182,0.034101,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_UP,0.746663781818182
GOBP_MEMBRANE_DEPOLARIZATION...2,SET,5,0.78301,0.012919,0.42944,0.034134,GOBP_MEMBRANE_DEPOLARIZATION_DURING_AV_NODE_CELL_ACTION_POTENTIAL,0.746663781818182
PID_ALPHA_SYNUCLEIN_PATHWAY,SET,30,0.28022,0.011318,0.15376,0.034198,PID_ALPHA_SYNUCLEIN_PATHWAY,0.746663781818182
GOBP_SODIUM_INDEPENDENT_ORGA...,SET,15,0.48939,0.013982,0.26855,0.034209,GOBP_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT,0.746663781818182
GOBP_NADPH_OXIDATION,SET,6,0.62883,0.011366,0.34507,0.034212,GOBP_NADPH_OXIDATION,0.746663781818182
GOBP_ENGULFMENT_OF_APOPTOTIC...,SET,15,0.38211,0.010917,0.20969,0.034215,GOBP_ENGULFMENT_OF_APOPTOTIC_CELL,0.746663781818182
GSE17721_POLYIC_VS_PAM3CSK4_...14,SET,180,0.11307,0.01114,0.062063,0.034248,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP,0.746663781818182
GOBP_REGULATION_OF_DEPHOSPHO...,SET,92,0.15404,0.010877,0.084562,0.034262,GOBP_REGULATION_OF_DEPHOSPHORYLATION,0.746663781818182
GOBP_SULFUR_AMINO_ACID_BIOSY...,SET,15,0.39544,0.011298,0.21712,0.034287,GOBP_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.746663781818182
REACTOME_TRANSCRIPTION_OF_E2...1,SET,19,0.31379,0.010089,0.1723,0.034297,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX,0.746663781818182
HP_ANKYLOSIS,SET,16,0.41334,0.012196,0.22704,0.034347,HP_ANKYLOSIS,0.746663781818182
HP_SMALL_THENAR_EMINENCE,SET,10,0.50413,0.011762,0.27693,0.034355,HP_SMALL_THENAR_EMINENCE,0.746663781818182
GSE3720_UNSTIM_VS_PMA_STIM_V...2,SET,158,0.11763,0.010865,0.064623,0.03437,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,0.746663781818182
FAN_EMBRYONIC_CTX_BIG_GROUPS...7,SET,333,0.089703,0.01197,0.049283,0.034376,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,0.746663781818182
GOBP_CELLULAR_RESPONSE_TO_ST...2,SET,193,0.11274,0.011498,0.06195,0.034399,GOBP_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS,0.746663781818182
HP_ABNORMALITY_OF_THE_SHOULD...,SET,128,0.13338,0.011098,0.073296,0.034406,HP_ABNORMALITY_OF_THE_SHOULDER_GIRDLE_MUSCULATURE,0.746663781818182
KEGG_MEDICUS_VARIANT_HRAS_OV...,SET,9,0.53524,0.011847,0.29415,0.034415,KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY,0.746663781818182
HP_EXERCISE_INDUCED_MYALGIA,SET,31,0.25647,0.010529,0.14096,0.034428,HP_EXERCISE_INDUCED_MYALGIA,0.746663781818182
GOBP_POSITIVE_REGULATION_OF_...624,SET,7,0.60474,0.011805,0.3324,0.034443,GOBP_POSITIVE_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.746663781818182
HP_BRUXISM,SET,29,0.28262,0.011223,0.15535,0.034448,HP_BRUXISM,0.746663781818182
SCHLOSSER_MYC_TARGETS_REPRES...,SET,140,0.12191,0.010604,0.067022,0.034469,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,0.746663781818182
GSE34515_CD16_POS_MONOCYTE_V...1,SET,182,0.1109,0.010987,0.060973,0.034472,GSE34515_CD16_POS_MONOCYTE_VS_DC_DN,0.746663781818182
SMID_BREAST_CANCER_BASAL_UP,SET,588,0.067112,0.011816,0.036899,0.034478,SMID_BREAST_CANCER_BASAL_UP,0.746663781818182
GOBP_ASTRAL_MICROTUBULE_ORGA...,SET,10,0.46326,0.010808,0.25471,0.03448,GOBP_ASTRAL_MICROTUBULE_ORGANIZATION,0.746663781818182
GOCC_EARLY_ENDOSOME,SET,399,0.07626,0.011119,0.04193,0.034484,GOCC_EARLY_ENDOSOME,0.746663781818182
GOBP_SECRETION_OF_LYSOSOMAL_...,SET,6,0.54138,0.0097849,0.29774,0.034521,GOBP_SECRETION_OF_LYSOSOMAL_ENZYMES,0.746663781818182
GOBP_NEGATIVE_REGULATION_OF_...418,SET,19,0.38027,0.012226,0.20915,0.034527,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION,0.746663781818182
DESCARTES_MAIN_FETAL_ANTIGEN...,SET,91,0.16967,0.011915,0.093331,0.034543,DESCARTES_MAIN_FETAL_ANTIGEN_PRESENTING_CELLS,0.746663781818182
GOBP_REGULATION_OF_NEURONAL_...2,SET,52,0.21303,0.011321,0.11721,0.034573,GOBP_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY,0.746663781818182
BASSO_CD40_SIGNALING_UP,SET,95,0.16509,0.011844,0.09087,0.034638,BASSO_CD40_SIGNALING_UP,0.746663781818182
GOBP_ENSHEATHMENT_OF_NEURONS,SET,148,0.12641,0.011303,0.06959,0.034659,GOBP_ENSHEATHMENT_OF_NEURONS,0.746663781818182
E2F1_Q4_01,SET,202,0.10696,0.011157,0.058886,0.034662,E2F1_Q4_01,0.746663781818182
DELPUECH_FOXO3_TARGETS_DN,SET,34,0.28847,0.012402,0.15882,0.034669,DELPUECH_FOXO3_TARGETS_DN,0.746663781818182
FAN_EMBRYONIC_CTX_BIG_GROUPS...2,SET,131,0.13924,0.011719,0.076666,0.03468,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,0.746663781818182
GOMF_CARBOXY_LYASE_ACTIVITY,SET,32,0.26661,0.011121,0.14685,0.034729,GOMF_CARBOXY_LYASE_ACTIVITY,0.746663781818182
HP_DISPROPORTIONATE_TALL_STA...,SET,32,0.28029,0.011691,0.15442,0.034766,HP_DISPROPORTIONATE_TALL_STATURE,0.746663781818182
KEGG_MEDICUS_REFERENCE_LEWIS...,SET,5,0.82112,0.013548,0.45244,0.034779,KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS,0.746663781818182
GOCC_MCM_COMPLEX,SET,11,0.51329,0.01256,0.28289,0.034812,GOCC_MCM_COMPLEX,0.746663781818182
GSE3720_VD1_VS_VD2_GAMMADELT...1,SET,184,0.11223,0.011178,0.06187,0.034853,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN,0.746663781818182
HP_ANKLE_CONTRACTURE,SET,52,0.21046,0.011184,0.11604,0.034872,HP_ANKLE_CONTRACTURE,0.746663781818182
REACTOME_DEX_H_BOX_HELICASES...,SET,7,0.57837,0.011291,0.31893,0.034888,REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION,0.746663781818182
GSE6259_FLT3L_INDUCED_DEC205...5,SET,161,0.12284,0.011452,0.067744,0.034902,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN,0.746663781818182
REN_ALVEOLAR_RHABDOMYOSARCOM...1,SET,369,0.080319,0.011271,0.044297,0.03491,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,0.746663781818182
HE_LIM_SUN_FETAL_LUNG_C7_PCP...,SET,48,0.23475,0.011987,0.12948,0.034926,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,0.746663781818182
HOWARD_DENDRITIC_CELL_INACT_...2,SET,140,0.13816,0.012018,0.076239,0.034987,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.746663781818182
GOMF_LONG_CHAIN_FATTY_ACYL_C...,SET,12,0.44449,0.011359,0.24535,0.03503,GOMF_LONG_CHAIN_FATTY_ACYL_COA_HYDROLASE_ACTIVITY,0.746663781818182
REACTOME_PROTON_COUPLED_MONO...,SET,6,0.6878,0.012431,0.37966,0.035031,REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT,0.746663781818182
GOMF_MISFOLDED_PROTEIN_BINDI...,SET,15,0.34356,0.0098157,0.18968,0.035056,GOMF_MISFOLDED_PROTEIN_BINDING,0.746663781818182
HP_ACUTE_CORONARY_SYNDROME,SET,101,0.16518,0.012217,0.091204,0.03507,HP_ACUTE_CORONARY_SYNDROME,0.746663781818182
HP_RECURRENT_BACTERIAL_INFEC...,SET,184,0.11428,0.011383,0.063104,0.035075,HP_RECURRENT_BACTERIAL_INFECTIONS,0.746663781818182
MODULE_411,SET,72,0.18089,0.011305,0.099905,0.03511,MODULE_411,0.746663781818182
KEGG_MEDICUS_PATHOGEN_KSHV_K...,SET,7,0.51647,0.010082,0.2853,0.035137,KEGG_MEDICUS_PATHOGEN_KSHV_K15_TO_TNF_NFKB_SIGNALING_PATHWAY,0.746663781818182
FOROUTAN_INTEGRATED_TGFB_EMT...1,SET,70,0.2043,0.012591,0.11287,0.035145,FOROUTAN_INTEGRATED_TGFB_EMT_DN,0.746663781818182
KEGG_MEDICUS_VARIANT_FZD7_OV...,SET,36,0.26599,0.011766,0.14696,0.035159,KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,0.746663781818182
WP_FARNESOID_X_RECEPTOR_PATH...,SET,19,0.36937,0.011876,0.20408,0.035164,WP_FARNESOID_X_RECEPTOR_PATHWAY,0.746663781818182
MIR7106_5P,SET,325,0.08491,0.011196,0.046924,0.035192,MIR7106_5P,0.746663781818182
CAIRO_PML_TARGETS_BOUND_BY_M...1,SET,12,0.46062,0.011772,0.25461,0.035225,CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,0.746663781818182
BIOCARTA_NPC_PATHWAY,SET,11,0.44119,0.010795,0.24387,0.035225,BIOCARTA_NPC_PATHWAY,0.746663781818182
GOBP_NEGATIVE_REGULATION_OF_...315,SET,15,0.39185,0.011195,0.21662,0.035239,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,0.746663781818182
GOBP_NEGATIVE_REGULATION_OF_...390,SET,4,0.83578,0.012335,0.46205,0.035247,GOBP_NEGATIVE_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.746663781818182
GOBP_NEGATIVE_REGULATION_OF_...472,SET,31,0.29755,0.012216,0.1645,0.035247,GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.746663781818182
HP_CYSTATHIONINEMIA,SET,5,0.6689,0.011037,0.36997,0.035311,HP_CYSTATHIONINEMIA,0.746663781818182
GOBP_CYTOKINE_PRODUCTION_INV...1,SET,115,0.15078,0.011895,0.083405,0.035326,GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.746663781818182
GSE369_SOCS3_KO_VS_WT_LIVER_...4,SET,178,0.10821,0.010602,0.059856,0.035328,GSE369_SOCS3_KO_VS_WT_LIVER_UP,0.746663781818182
HP_GLOMERULAR_SCLEROSIS,SET,78,0.16422,0.010681,0.09085,0.035342,HP_GLOMERULAR_SCLEROSIS,0.746663781818182
GOBP_POSITIVE_REGULATION_OF_...11,SET,7,0.51311,0.010017,0.28393,0.035378,GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.746663781818182
GOMF_CIS_REGULATORY_REGION_S...,SET,1111,0.050998,0.012159,0.028221,0.035384,GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.746663781818182
TURASHVILI_BREAST_DUCTAL_CAR...3,SET,60,0.20953,0.011958,0.11596,0.035393,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,0.746663781818182
GOBP_L_ALANINE_TRANSMEMBRANE...,SET,4,0.79635,0.011753,0.4408,0.03542,GOBP_L_ALANINE_TRANSMEMBRANE_TRANSPORT,0.746663781818182
HP_MUSCLE_WEAKNESS,SET,912,0.05048,0.010967,0.027946,0.035442,HP_MUSCLE_WEAKNESS,0.746663781818182
GSE2770_UNTREATED_VS_TGFB_AN...3,SET,175,0.1103,0.010717,0.061066,0.035444,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.746663781818182
GOBP_POSITIVE_REGULATION_OF_...543,SET,9,0.60764,0.01345,0.33641,0.035448,GOBP_POSITIVE_REGULATION_OF_NK_T_CELL_ACTIVATION,0.746663781818182
GSE18281_SUBCAPSULAR_VS_PERI...1,SET,184,0.11196,0.011152,0.062012,0.035507,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_DN,0.747453534221684
GSE3920_IFNA_VS_IFNB_TREATED...2,SET,159,0.12225,0.011327,0.067731,0.03555,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,0.747473417721519
GOBP_REGULATION_OF_OSSIFICAT...,SET,111,0.1516,0.011752,0.084003,0.035566,GOBP_REGULATION_OF_OSSIFICATION,0.747473417721519
MIR6815_3P,SET,187,0.11076,0.011121,0.061394,0.035614,MIR6815_3P,0.747473417721519
REACTOME_ANCHORING_OF_THE_BA...,SET,91,0.1443,0.010133,0.079989,0.035628,REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,0.747473417721519
GOBP_INTERKINETIC_NUCLEAR_MI...,SET,5,0.73312,0.012096,0.40646,0.035649,GOBP_INTERKINETIC_NUCLEAR_MIGRATION,0.747473417721519
KEGG_MEDICUS_VARIANT_LRP6_OV...,SET,43,0.25002,0.012085,0.13862,0.035655,KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,0.747473417721519
GSE37416_0H_VS_12H_F_TULAREN...1,SET,178,0.11339,0.01111,0.062876,0.035675,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.747473417721519
GAVISH_3CA_MALIGNANT_METAPRO...11,SET,46,0.20342,0.010169,0.1128,0.03568,GAVISH_3CA_MALIGNANT_METAPROGRAM_20_MYC,0.747473417721519
FAN_EMBRYONIC_CTX_BRAIN_NAIV...,SET,139,0.13531,0.011728,0.075088,0.035781,FAN_EMBRYONIC_CTX_BRAIN_NAIVE_LIKE_T_CELL,0.748937817579771
GSE360_CTRL_VS_L_MAJOR_MAC_DN,SET,171,0.11289,0.010844,0.062653,0.035793,GSE360_CTRL_VS_L_MAJOR_MAC_DN,0.748937817579771
MIR5586_5P,SET,74,0.1821,0.011537,0.10113,0.035889,MIR5586_5P,0.750494702166065
CHEN_ETV5_TARGETS_TESTIS,SET,21,0.33927,0.011467,0.1885,0.035951,CHEN_ETV5_TARGETS_TESTIS,0.751096487379808
ROZANOV_MMP14_TARGETS_SUBSET,SET,32,0.31041,0.012947,0.17248,0.035961,ROZANOV_MMP14_TARGETS_SUBSET,0.751096487379808
JIANG_MELANOMA_TRM5_CD8,SET,180,0.11525,0.011355,0.064065,0.036023,JIANG_MELANOMA_TRM5_CD8,0.751613382352941
GOMF_OXIDATIVE_PHOSPHORYLATI...,SET,4,0.71408,0.010539,0.39696,0.036029,GOMF_OXIDATIVE_PHOSPHORYLATION_UNCOUPLER_ACTIVITY,0.751613382352941
GOBP_NEGATIVE_REGULATION_OF_...154,SET,11,0.56607,0.013851,0.31478,0.036073,GOBP_NEGATIVE_REGULATION_OF_COMPLEMENT_ACTIVATION,0.752079853029394
CAO_BLOOD_FLUZONE_AGE_05_14Y...6,SET,5,0.60963,0.010059,0.33921,0.036162,CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_UP,0.752655920353982
GSE27786_ERYTHROBLAST_VS_NEU...2,SET,178,0.11202,0.010976,0.062339,0.036183,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP,0.752655920353982
GOMF_CALCIUM_DEPENDENT_PROTE...4,SET,5,0.63816,0.01053,0.35516,0.03619,GOMF_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_REGULATOR_ACTIVITY,0.752655920353982
CGTCTTA_MIR208,SET,8,0.55856,0.011657,0.3109,0.036208,CGTCTTA_MIR208,0.752655920353982
REACTOME_BUTYROPHILIN_BTN_FA...,SET,12,0.53163,0.013586,0.29604,0.036274,REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS,0.752655920353982
GSE2585_CTEC_VS_THYMIC_DC_DN,SET,187,0.11383,0.011429,0.063393,0.036285,GSE2585_CTEC_VS_THYMIC_DC_DN,0.752655920353982
MIR637,SET,78,0.16799,0.010926,0.093557,0.036287,MIR637,0.752655920353982
HP_INTERVERTEBRAL_SPACE_NARR...,SET,6,0.6186,0.011181,0.3445,0.036287,HP_INTERVERTEBRAL_SPACE_NARROWING,0.752655920353982
HP_ABNORMAL_PLATELET_FUNCTION,SET,58,0.1893,0.010623,0.10544,0.036304,HP_ABNORMAL_PLATELET_FUNCTION,0.752655920353982
GOBP_DITERPENOID_BIOSYNTHETI...,SET,10,0.51862,0.0121,0.28893,0.036337,GOBP_DITERPENOID_BIOSYNTHETIC_PROCESS,0.752655920353982
HP_2_3_TOE_SYNDACTYLY,SET,81,0.16986,0.011257,0.094635,0.036347,HP_2_3_TOE_SYNDACTYLY,0.752655920353982
GSE1432_CTRL_VS_IFNG_1H_MICR...1,SET,185,0.10941,0.010927,0.060969,0.036374,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,0.752655920353982
GOMF_ENDONUCLEASE_ACTIVITY,SET,111,0.1395,0.010814,0.077753,0.036403,GOMF_ENDONUCLEASE_ACTIVITY,0.752655920353982
MIR4649_3P,SET,186,0.11485,0.011501,0.064013,0.036405,MIR4649_3P,0.752655920353982
GOMF_SUPEROXIDE_DISMUTASE_AC...,SET,5,0.69676,0.011496,0.38841,0.036426,GOMF_SUPEROXIDE_DISMUTASE_ACTIVITY,0.752655920353982
GOBP_SKELETAL_MUSCLE_SATELLI...3,SET,4,0.83637,0.012343,0.46634,0.036456,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_MAINTENANCE_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.752655920353982
GOBP_REGULATION_OF_GLUCOCORT...3,SET,5,0.78184,0.0129,0.43598,0.036472,GOBP_REGULATION_OF_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY,0.752655920353982
HP_HEMOLYTIC_UREMIC_SYNDROME,SET,14,0.4386,0.012107,0.2447,0.036541,HP_HEMOLYTIC_UREMIC_SYNDROME,0.752655920353982
KEGG_MEDICUS_PATHOGEN_HTLV_1...8,SET,5,0.71762,0.011841,0.4005,0.03659,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SRF_MEDIATED_TRANSCRIPTION,0.752655920353982
GOBP_TYPE_II_HYPERSENSITIVITY,SET,8,0.65302,0.013628,0.36451,0.036614,GOBP_TYPE_II_HYPERSENSITIVITY,0.752655920353982
HP_STEROETYPIC_MOVEMENTS_OF_...,SET,50,0.20756,0.010817,0.11586,0.036618,HP_STEROETYPIC_MOVEMENTS_OF_FACE_AND_HEAD,0.752655920353982
GOBP_REGULATION_OF_ENDOTHELI...2,SET,18,0.35556,0.011127,0.19851,0.036643,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT,0.752655920353982
LIU_SOX4_TARGETS_UP,SET,126,0.13919,0.011491,0.077711,0.036645,LIU_SOX4_TARGETS_UP,0.752655920353982
GSE2770_IL12_VS_IL4_TREATED_...3,SET,176,0.1117,0.010884,0.062373,0.036668,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.752655920353982
FAN_EMBRYONIC_CTX_EX_2_EXCIT...,SET,15,0.42987,0.012282,0.24004,0.03667,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,0.752655920353982
HP_OSTEOMYELITIS,SET,58,0.20815,0.011681,0.11626,0.036699,HP_OSTEOMYELITIS,0.752655920353982
GOBP_HEPARAN_SULFATE_PROTEOG...3,SET,8,0.56086,0.011705,0.31326,0.036702,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_POLYSACCHARIDE_CHAIN_BIOSYNTHETIC_PROCESS,0.752655920353982
GOBP_CHONDROITIN_SULFATE_PRO...1,SET,23,0.29897,0.010575,0.16699,0.036707,GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.752655920353982
chr14q24,SET,107,0.31568,0.024028,0.17642,0.036792,chr14q24,0.752848956750438
GOBP_POSITIVE_REGULATION_OF_...349,SET,233,0.10467,0.011716,0.058503,0.036809,GOBP_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,0.752848956750438
GOMF_ATP_DEPENDENT_ACTIVITY_...1,SET,109,0.13509,0.010378,0.075513,0.036819,GOMF_ATP_DEPENDENT_ACTIVITY_ACTING_ON_DNA,0.752848956750438
GOBP_NEGATIVE_REGULATION_OF_...368,SET,6,0.54509,0.009852,0.30484,0.036889,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS,0.752848956750438
HP_METATARSAL_SYNOSTOSIS,SET,7,0.61645,0.012034,0.34479,0.036907,HP_METATARSAL_SYNOSTOSIS,0.752848956750438
HP_OPEN_MOUTH,SET,98,0.15119,0.011016,0.084583,0.036936,HP_OPEN_MOUTH,0.752848956750438
HP_THIRD_DEGREE_ATRIOVENTRIC...,SET,9,0.45233,0.010012,0.25306,0.03694,HP_THIRD_DEGREE_ATRIOVENTRICULAR_BLOCK,0.752848956750438
GSE40274_CTRL_VS_EOS_TRANSDU...1,SET,133,0.13556,0.011495,0.075844,0.036952,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.752848956750438
GSE45365_CD8A_DC_VS_CD11B_DC...3,SET,142,0.13089,0.011466,0.073236,0.036954,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN,0.752848956750438
LBP1_Q6,SET,211,0.10653,0.011354,0.059608,0.036961,LBP1_Q6,0.752848956750438
GOBP_ISOTYPE_SWITCHING_TO_IG...1,SET,6,0.503,0.0090913,0.28146,0.036965,GOBP_ISOTYPE_SWITCHING_TO_IGA_ISOTYPES,0.752848956750438
GSE25085_FETAL_LIVER_VS_ADUL...2,SET,166,0.10831,0.010252,0.060615,0.03699,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,0.752848956750438
HP_LIVEDO_RETICULARIS,SET,4,0.68459,0.010103,0.3832,0.037017,HP_LIVEDO_RETICULARIS,0.752848956750438
GSE7509_UNSTIM_VS_IFNA_STIM_...1,SET,163,0.12172,0.011418,0.068148,0.037045,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN,0.752848956750438
FLECHNER_BIOPSY_KIDNEY_TRANS...4,SET,80,0.16822,0.01108,0.094189,0.037056,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,0.752848956750438
NEMETH_INFLAMMATORY_RESPONSE...2,SET,76,0.18505,0.011881,0.10361,0.037063,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,0.752848956750438
GSE6259_33D1_POS_DC_VS_CD4_T...2,SET,161,0.11592,0.010807,0.064921,0.037089,GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP,0.752882977232925
PROVENZANI_METASTASIS_DN,SET,134,0.13096,0.011146,0.073349,0.037108,PROVENZANI_METASTASIS_DN,0.752882977232925
GOCC_SMN_COMPLEX,SET,6,0.51643,0.0093341,0.28932,0.037141,GOCC_SMN_COMPLEX,0.75311286756126
HP_ABNORMAL_PULMONARY_ALVEOL...,SET,5,0.80652,0.013307,0.45202,0.037201,HP_ABNORMAL_PULMONARY_ALVEOLAR_SYSTEM_MORPHOLOGY,0.753355614443797
GSE1925_CTRL_VS_IFNG_PRIMED_...1,SET,183,0.11416,0.011341,0.063988,0.037207,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN,0.753355614443797
GOBP_FC_RECEPTOR_SIGNALING_P...,SET,53,0.21812,0.011702,0.12226,0.037218,GOBP_FC_RECEPTOR_SIGNALING_PATHWAY,0.753355614443797
GOCC_RIBONUCLEOPROTEIN_GRANU...,SET,246,0.092772,0.010666,0.052011,0.037246,GOCC_RIBONUCLEOPROTEIN_GRANULE,0.753483544819558
GAVISH_3CA_MALIGNANT_METAPRO...7,SET,45,0.24622,0.012175,0.13814,0.037349,GAVISH_3CA_MALIGNANT_METAPROGRAM_16_MES_GLIOMA,0.754855981987217
GOBP_FIBROBLAST_MIGRATION,SET,49,0.21433,0.011057,0.12026,0.03737,GOBP_FIBROBLAST_MIGRATION,0.754855981987217
GOCC_AXON_INITIAL_SEGMENT,SET,21,0.34568,0.011684,0.19398,0.037379,GOCC_AXON_INITIAL_SEGMENT,0.754855981987217
HP_SHORT_THORAX,SET,45,0.22229,0.010991,0.12477,0.037418,HP_SHORT_THORAX,0.755129529889727
GSE34156_TLR1_TLR2_LIGAND_VS...2,SET,174,0.11562,0.011202,0.064904,0.037436,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,0.755129529889727
HOEK_MYELOID_DENDRITIC_CELL_...2,SET,16,0.38774,0.011441,0.21777,0.037509,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_UP,0.755810501158749
GOBP_POSITIVE_REGULATION_OF_...176,SET,4,0.84918,0.012532,0.47697,0.037516,GOBP_POSITIVE_REGULATION_OF_COMPLEMENT_ACTIVATION,0.755810501158749
MIR6512_5P,SET,106,0.1446,0.010955,0.081228,0.037535,MIR6512_5P,0.755810501158749
SCHAEFFER_PROSTATE_DEVELOPME...7,SET,9,0.47137,0.010434,0.26488,0.037579,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN,0.756258335263463
MIR4635,SET,120,0.13629,0.010982,0.076627,0.037658,MIR4635,0.757112246963563
GOMF_MISMATCH_REPAIR_COMPLEX...,SET,11,0.40151,0.0098245,0.22575,0.037665,GOMF_MISMATCH_REPAIR_COMPLEX_BINDING,0.757112246963563
SABATES_COLORECTAL_ADENOMA_S...1,SET,11,0.41664,0.010195,0.23435,0.037724,SABATES_COLORECTAL_ADENOMA_SIZE_DN,0.757562625649913
HP_LIMB_PAIN,SET,52,0.21604,0.011481,0.12153,0.037731,HP_LIMB_PAIN,0.757562625649913
HP_GASTROINTESTINAL_INFARCTI...,SET,13,0.44273,0.011776,0.24918,0.037811,HP_GASTROINTESTINAL_INFARCTIONS,0.758730545612009
GOMF_N_ACETYLLACTOSAMINE_SYN...,SET,5,0.72548,0.01197,0.40841,0.037845,GOMF_N_ACETYLLACTOSAMINE_SYNTHASE_ACTIVITY,0.758941028818444
GOBP_INTERLEUKIN_6_PRODUCTION,SET,136,0.13366,0.011461,0.07526,0.037874,GOBP_INTERLEUKIN_6_PRODUCTION,0.758941028818444
REACTOME_INTERLEUKIN_17_SIGN...,SET,65,0.19149,0.011373,0.10783,0.037887,REACTOME_INTERLEUKIN_17_SIGNALING,0.758941028818444
GSE31082_DP_VS_CD4_SP_THYMOC...2,SET,171,0.10992,0.010559,0.061937,0.037978,GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP,0.759693536515239
NAB2_TARGET_GENES,SET,1207,0.044198,0.010953,0.024905,0.037986,NAB2_TARGET_GENES,0.759693536515239
GOBP_CELL_CYCLE,SET,1476,0.039414,0.010716,0.022212,0.038005,GOBP_CELL_CYCLE,0.759693536515239
GOMF_NUCLEOBASE_TRANSMEMBRAN...,SET,10,0.45854,0.010698,0.25843,0.038012,GOMF_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.759693536515239
GOBP_POSITIVE_REGULATION_OF_...25,SET,7,0.56904,0.011109,0.3208,0.038055,GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.760115818965517
ZNF837_TARGET_GENES,SET,5,0.67622,0.011158,0.38151,0.038166,ZNF837_TARGET_GENES,0.761307578706354
GSE25502_WT_VS_KLF13_KO_THYM...2,SET,158,0.11831,0.010928,0.066765,0.038199,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_UP,0.761307578706354
KEGG_MEDICUS_REFERENCE_EGF_J...,SET,7,0.72199,0.014094,0.40752,0.038236,KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY,0.761307578706354
GSE41867_NAIVE_VS_DAY30_LCMV...4,SET,170,0.11915,0.011412,0.067258,0.038246,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP,0.761307578706354
MIR6887_3P,SET,176,0.11413,0.01112,0.064427,0.038253,MIR6887_3P,0.761307578706354
GOBP_T_CELL_SELECTION,SET,57,0.21695,0.012069,0.12247,0.038258,GOBP_T_CELL_SELECTION,0.761307578706354
BOWIE_RESPONSE_TO_TAMOXIFEN,SET,18,0.33622,0.010522,0.18982,0.038268,BOWIE_RESPONSE_TO_TAMOXIFEN,0.761307578706354
HP_HEAD_BANGING,SET,9,0.48246,0.010679,0.27244,0.038299,HP_HEAD_BANGING,0.761351097770154
NIKOLSKY_BREAST_CANCER_19P13...,SET,5,1.0038,0.016562,0.56689,0.038314,NIKOLSKY_BREAST_CANCER_19P13_AMPLICON,0.761351097770154
MIR6072,SET,72,0.17456,0.010909,0.098597,0.038339,MIR6072,0.76141254
HP_RECTAL_PROLAPSE,SET,49,0.23053,0.011893,0.13024,0.038361,HP_RECTAL_PROLAPSE,0.761414366076528
MIR7162_3P,SET,201,0.10773,0.01121,0.060882,0.038411,MIR7162_3P,0.761736867160775
MIR5588_3P,SET,41,0.22899,0.010809,0.12943,0.03844,MIR5588_3P,0.761736867160775
GSE17974_CTRL_VS_ACT_IL4_AND...18,SET,172,0.11434,0.011014,0.064628,0.038443,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP,0.761736867160775
GOBP_REGULATION_OF_ACTIVATIO...,SET,8,0.5569,0.011622,0.31486,0.038479,GOBP_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY,0.76179951594533
GOBP_CALCINEURIN_MEDIATED_SI...,SET,47,0.21368,0.010797,0.12082,0.03849,GOBP_CALCINEURIN_MEDIATED_SIGNALING,0.76179951594533
GOMF_INTRAMEMBRANE_LIPID_TRA...,SET,41,0.24232,0.011438,0.13708,0.038555,GOMF_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY,0.762651693227092
GOMF_SODIUM_INDEPENDENT_ORGA...,SET,16,0.44166,0.013032,0.24996,0.038632,GOMF_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.763740136518771
GOBP_REGULATION_OF_METALLOPE...,SET,9,0.56512,0.012509,0.31993,0.038674,GOBP_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.764096573863636
DESCARTES_FETAL_CEREBELLUM_U...,SET,19,0.38033,0.012228,0.21534,0.038694,DESCARTES_FETAL_CEREBELLUM_UNIPOLAR_BRUSH_CELLS,0.764096573863636
BLANCO_MELO_COVID19_SARS_COV...5,SET,69,0.19144,0.011714,0.10841,0.038716,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN,0.764096865417376
HP_ALZHEIMER_DISEASE,SET,8,0.49414,0.010312,0.2799,0.038757,HP_ALZHEIMER_DISEASE,0.764471926787741
GOBERT_OLIGODENDROCYTE_DIFFE...2,SET,525,0.06426,0.01071,0.036405,0.03878,GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP,0.764491718661373
MENON_FETAL_KIDNEY_8_CONNECT...,SET,223,0.099675,0.010918,0.056489,0.038833,MENON_FETAL_KIDNEY_8_CONNECTING_TUBULE_CELLS,0.764963840497738
GSE29618_BCELL_VS_MDC_UP,SET,160,0.12303,0.011435,0.069738,0.038861,GSE29618_BCELL_VS_MDC_UP,0.764963840497738
GOBP_CORTICOSPINAL_TRACT_MOR...,SET,8,0.5909,0.012331,0.335,0.038883,GOBP_CORTICOSPINAL_TRACT_MORPHOGENESIS,0.764963840497738
ELF1_Q6,SET,227,0.096793,0.010696,0.05488,0.038897,ELF1_Q6,0.764963840497738
HP_SHORT_UMBILICAL_CORD,SET,6,0.64667,0.011688,0.36669,0.038914,HP_SHORT_UMBILICAL_CORD,0.764963840497738
GOBP_NUCLEOTIDE_BINDING_OLIG...1,SET,7,0.57338,0.011193,0.32528,0.038985,GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_1_SIGNALING_PATHWAY,0.765610849802371
REACTOME_DOWNREGULATION_OF_E...2,SET,27,0.27464,0.010524,0.15583,0.039006,REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,0.765610849802371
HP_ABNORMAL_ELECTROPHYSIOLOG...,SET,78,0.16836,0.01095,0.095531,0.039013,HP_ABNORMAL_ELECTROPHYSIOLOGY_OF_SINOATRIAL_NODE_ORIGIN,0.765610849802371
TSUNODA_CISPLATIN_RESISTANCE...2,SET,11,0.45169,0.011052,0.25642,0.039083,TSUNODA_CISPLATIN_RESISTANCE_UP,0.766214679054054
GSE15659_NAIVE_CD4_TCELL_VS_...1,SET,168,0.11568,0.011015,0.06568,0.039103,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN,0.766214679054054
GSE13547_WT_VS_ZFX_KO_BCELL_...3,SET,148,0.11821,0.01057,0.067122,0.039116,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_DN,0.766214679054054
GOBP_RESPONSE_TO_PURINE_CONT...,SET,136,0.12839,0.011009,0.072916,0.039139,GOBP_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,0.766214679054054
HP_ABNORMAL_NEPHRON_MORPHOLO...,SET,219,0.1004,0.010899,0.05702,0.039154,HP_ABNORMAL_NEPHRON_MORPHOLOGY,0.766214679054054
GOBP_OXIDATIVE_DEMETHYLATION,SET,10,0.43778,0.010214,0.2487,0.039192,GOBP_OXIDATIVE_DEMETHYLATION,0.766526707934721
MIR196B_3P,SET,6,0.67906,0.012273,0.38593,0.039251,MIR196B_3P,0.766756574957889
GOBP_RRNA_METABOLIC_PROCESS,SET,228,0.08987,0.0099523,0.051078,0.039257,GOBP_RRNA_METABOLIC_PROCESS,0.766756574957889
GOBP_TRNA_METABOLIC_PROCESS,SET,167,0.10414,0.0098867,0.059201,0.039287,GOBP_TRNA_METABOLIC_PROCESS,0.766756574957889
ATGTTAA_MIR302C,SET,217,0.1029,0.01112,0.058498,0.039292,ATGTTAA_MIR302C,0.766756574957889
LANDIS_BREAST_CANCER_PROGRES...1,SET,68,0.19246,0.01169,0.10944,0.039331,LANDIS_BREAST_CANCER_PROGRESSION_DN,0.766791928251121
GOBP_POSITIVE_REGULATION_OF_...74,SET,20,0.30962,0.010213,0.17608,0.039346,GOBP_POSITIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,0.766791928251121
GOBP_RENAL_ALBUMIN_ABSORPTION,SET,7,0.64104,0.012514,0.36459,0.03936,GOBP_RENAL_ALBUMIN_ABSORPTION,0.766791928251121
HP_MICRORETROGNATHIA,SET,71,0.17497,0.010859,0.099531,0.039391,HP_MICRORETROGNATHIA,0.766965941176471
MIR664B_5P,SET,53,0.20023,0.010742,0.11393,0.039425,MIR664B_5P,0.767198138297872
GOBP_POSITIVE_REGULATION_OF_...558,SET,8,0.60047,0.012531,0.34174,0.039459,GOBP_POSITIVE_REGULATION_OF_ODONTOGENESIS,0.767430075545607
GSE28783_ANTI_MIR33_VS_UNTRE...2,SET,177,0.11079,0.010826,0.063065,0.039482,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,0.767447936241611
GOBP_REGULATION_OF_TRANSLATI...2,SET,10,0.41949,0.0097871,0.23881,0.039506,GOBP_REGULATION_OF_TRANSLATIONAL_ELONGATION,0.767466046640755
REACTOME_FASTK_FAMILY_PROTEI...,SET,4,0.81047,0.011961,0.46157,0.039561,REACTOME_FASTK_FAMILY_PROTEINS_REGULATE_PROCESSING_AND_STABILITY_OF_MITOCHONDRIAL_RNAS,0.767466046640755
HP_RESTRICTIVE_CARDIOMYOPATHY,SET,22,0.32309,0.011177,0.18405,0.039601,HP_RESTRICTIVE_CARDIOMYOPATHY,0.767466046640755
KEGG_MEDICUS_REFERENCE_ACTIV...2,SET,23,0.29306,0.010366,0.16699,0.039645,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES,0.767466046640755
AIZARANI_LIVER_C2_KUPFFER_CE...,SET,178,0.11919,0.011679,0.067931,0.039674,AIZARANI_LIVER_C2_KUPFFER_CELLS_1,0.767466046640755
GOBP_MONONUCLEAR_CELL_DIFFER...,SET,487,0.071688,0.011519,0.040859,0.039679,GOBP_MONONUCLEAR_CELL_DIFFERENTIATION,0.767466046640755
GOMF_METALLOENDOPEPTIDASE_AC...,SET,102,0.15436,0.011473,0.08798,0.039681,GOMF_METALLOENDOPEPTIDASE_ACTIVITY,0.767466046640755
REACTOME_PHASE_2_PLATEAU_PHA...,SET,14,0.40234,0.011106,0.22935,0.039699,REACTOME_PHASE_2_PLATEAU_PHASE,0.767466046640755
GSE22935_WT_VS_MYD88_KO_MACR...4,SET,180,0.10457,0.010303,0.059612,0.039711,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_UP,0.767466046640755
GSE3982_MEMORY_CD4_TCELL_VS_...4,SET,168,0.11327,0.010785,0.06459,0.039757,GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP,0.767466046640755
CAGCAGG_MIR370,SET,138,0.12197,0.010534,0.069556,0.039765,CAGCAGG_MIR370,0.767466046640755
BURTON_ADIPOGENESIS_PEAK_AT_...4,SET,40,0.24433,0.011392,0.13934,0.039766,BURTON_ADIPOGENESIS_PEAK_AT_2HR,0.767466046640755
HP_ECHOGENIC_FETAL_BOWEL,SET,5,0.60422,0.0099694,0.34458,0.03977,HP_ECHOGENIC_FETAL_BOWEL,0.767466046640755
GOBP_SYNAPTIC_VESICLE_UNCOAT...,SET,7,0.52694,0.010287,0.30063,0.039827,GOBP_SYNAPTIC_VESICLE_UNCOATING,0.767692483370288
HP_BROAD_TOE,SET,72,0.17204,0.010752,0.098164,0.039842,HP_BROAD_TOE,0.767692483370288
REACTOME_MUSCLE_CONTRACTION,SET,194,0.10944,0.011189,0.062444,0.039848,REACTOME_MUSCLE_CONTRACTION,0.767692483370288
BIOCARTA_EIF4_PATHWAY,SET,24,0.32372,0.011696,0.18477,0.039895,BIOCARTA_EIF4_PATHWAY,0.767824885057471
HP_LIP_PIT,SET,9,0.50398,0.011155,0.2877,0.039915,HP_LIP_PIT,0.767824885057471
DAZARD_UV_RESPONSE_CLUSTER_G4,SET,17,0.36365,0.01106,0.20762,0.039935,DAZARD_UV_RESPONSE_CLUSTER_G4,0.767824885057471
HOXA3_01,SET,14,0.39659,0.010947,0.22644,0.039946,HOXA3_01,0.767824885057471
GOBP_REGULATION_OF_CALCIUM_I...6,SET,153,0.1244,0.011308,0.071053,0.040005,GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.767824885057471
MIR4718,SET,97,0.16487,0.011952,0.094198,0.040043,MIR4718,0.767824885057471
HP_CONGENITAL_BLINDNESS,SET,8,0.52717,0.011002,0.30119,0.040044,HP_CONGENITAL_BLINDNESS,0.767824885057471
HP_POSTAXIAL_POLYDACTYLY,SET,123,0.13042,0.010639,0.07456,0.040138,HP_POSTAXIAL_POLYDACTYLY,0.767824885057471
SCHERER_PBMC_APSV_WETVAX_AGE...1,SET,31,0.25325,0.010397,0.14478,0.040139,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_DN,0.767824885057471
GOBP_AXONAL_TRANSPORT,SET,62,0.18852,0.010936,0.1078,0.040176,GOBP_AXONAL_TRANSPORT,0.767824885057471
HP_CONSTITUTIONAL_SYMPTOM,SET,1128,0.046219,0.011098,0.026431,0.040184,HP_CONSTITUTIONAL_SYMPTOM,0.767824885057471
WACKER_HYPOXIA_TARGETS_OF_VHL,SET,11,0.46901,0.011476,0.26827,0.040217,WACKER_HYPOXIA_TARGETS_OF_VHL,0.767824885057471
GSE17721_POLYIC_VS_PAM3CSK4_...3,SET,182,0.10832,0.010731,0.061961,0.040225,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN,0.767824885057471
GOBP_REGULATION_OF_VIRAL_TRA...,SET,18,0.32723,0.010241,0.1872,0.040244,GOBP_REGULATION_OF_VIRAL_TRANSCRIPTION,0.767824885057471
GOMF_LIGAND_GATED_SODIUM_CHA...,SET,16,0.36771,0.01085,0.21036,0.040245,GOMF_LIGAND_GATED_SODIUM_CHANNEL_ACTIVITY,0.767824885057471
REACTOME_RESPONSE_OF_MTB_TO_...,SET,21,0.30653,0.010361,0.17537,0.040246,REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS,0.767824885057471
GOBP_REGULATION_OF_GOLGI_ORG...,SET,15,0.38179,0.010908,0.21844,0.040257,GOBP_REGULATION_OF_GOLGI_ORGANIZATION,0.767824885057471
HALLMARK_BILE_ACID_METABOLISM,SET,110,0.14654,0.011308,0.083857,0.040286,HALLMARK_BILE_ACID_METABOLISM,0.767824885057471
GOBP_ORGAN_OR_TISSUE_SPECIFI...,SET,26,0.32313,0.012151,0.18492,0.040294,GOBP_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE,0.767824885057471
TERAMOTO_OPN_TARGETS_CLUSTER...4,SET,6,0.49139,0.0088815,0.28123,0.040303,TERAMOTO_OPN_TARGETS_CLUSTER_5,0.767824885057471
GOMF_N_ACYLSPHINGOSINE_AMIDO...,SET,7,0.62542,0.012209,0.35803,0.04034,GOMF_N_ACYLSPHINGOSINE_AMIDOHYDROLASE_ACTIVITY,0.767824885057471
ZHENG_CORD_BLOOD_C4_PUTATIVE...,SET,86,0.16264,0.011105,0.093111,0.04035,ZHENG_CORD_BLOOD_C4_PUTATIVE_EARLY_ERYTHROID_COMMITMENT,0.767824885057471
GOBP_SERINE_FAMILY_AMINO_ACI...1,SET,15,0.36465,0.010418,0.20878,0.040363,GOBP_SERINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.767824885057471
GSE41867_DAY8_VS_DAY15_LCMV_...4,SET,182,0.10605,0.010506,0.060735,0.040404,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.768184365426696
GSE5679_PPARG_LIGAND_ROSIGLI...3,SET,181,0.1071,0.010581,0.061349,0.040441,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,0.76826941898527
CRX_NRL_DN.V1_DN,SET,112,0.14566,0.011341,0.083453,0.040466,CRX_NRL_DN.V1_DN,0.76826941898527
MIR6842_5P,SET,143,0.12644,0.011115,0.072465,0.040511,MIR6842_5P,0.76826941898527
HP_SUBCUTANEOUS_HEMORRHAGE,SET,233,0.097802,0.010947,0.056051,0.040512,HP_SUBCUTANEOUS_HEMORRHAGE,0.76826941898527
FAN_EMBRYONIC_CTX_BRAIN_B_CE...,SET,84,0.17137,0.011564,0.098215,0.040519,FAN_EMBRYONIC_CTX_BRAIN_B_CELL,0.76826941898527
KARLSSON_TGFB1_TARGETS_UP,SET,113,0.1361,0.010644,0.078027,0.040561,KARLSSON_TGFB1_TARGETS_UP,0.768312163043478
KAUFFMANN_MELANOMA_RELAPSE_UP,SET,59,0.18361,0.010391,0.10529,0.040598,KAUFFMANN_MELANOMA_RELAPSE_UP,0.768312163043478
GOBP_REGULATION_OF_VASCULAR_...2,SET,14,0.40909,0.011292,0.23461,0.040616,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.768312163043478
BUCASAS_PBMC_FLUARIX_FLUVIRI...2,SET,18,0.3085,0.0096546,0.17695,0.04064,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_TOP_FUNCTIONAL_NETWORK_POSITIVE,0.768312163043478
GOBP_PURINE_DEOXYRIBONUCLEOS...4,SET,7,0.52918,0.01033,0.30355,0.040651,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.768312163043478
HP_SCHWANNOMA,SET,11,0.38039,0.0093077,0.21822,0.040665,HP_SCHWANNOMA,0.768312163043478
MIR325,SET,28,0.26942,0.010513,0.15457,0.040676,MIR325,0.768312163043478
GSE27241_WT_VS_RORGT_KO_TH17...3,SET,166,0.1093,0.010345,0.062731,0.040736,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP,0.768794170281996
GOBP_B_CELL_ACTIVATION_INVOL...,SET,75,0.16845,0.010744,0.096691,0.040754,GOBP_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.768794170281996
PRC1_BMI_UP.V1_DN,SET,155,0.11645,0.010654,0.066856,0.040778,PRC1_BMI_UP.V1_DN,0.768794170281996
GOBP_DOPAMINERGIC_NEURON_DIF...,SET,37,0.26896,0.012062,0.15443,0.04079,GOBP_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.768794170281996
GSE43956_WT_VS_SGK1_KO_TH17_...2,SET,183,0.10891,0.010819,0.062544,0.040822,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_UP,0.768895888529887
GSE17301_CTRL_VS_48H_ACD3_AC...2,SET,178,0.10775,0.010557,0.061892,0.040859,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP,0.768895888529887
GSE7509_DC_VS_MONOCYTE_WITH_...1,SET,185,0.10908,0.010894,0.06266,0.040862,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN,0.768895888529887
GOBP_COMPLEMENT_ACTIVATION_A...,SET,14,0.42951,0.011856,0.24687,0.040953,GOBP_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY,0.768895888529887
MENON_FETAL_KIDNEY_2_NEPHRON...,SET,35,0.2501,0.010909,0.14375,0.040959,MENON_FETAL_KIDNEY_2_NEPHRON_PROGENITOR_CELLS,0.768895888529887
BROWNE_INTERFERON_RESPONSIVE...,SET,65,0.19009,0.01129,0.10926,0.040965,BROWNE_INTERFERON_RESPONSIVE_GENES,0.768895888529887
HP_ABNORMAL_PYRAMIDAL_TRACT_...,SET,61,0.19281,0.011095,0.11085,0.040993,HP_ABNORMAL_PYRAMIDAL_TRACT_MORPHOLOGY,0.768895888529887
GSE29618_MONOCYTE_VS_MDC_DAY...1,SET,171,0.11673,0.011212,0.067119,0.041015,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN,0.768895888529887
GSE30971_WBP7_HET_VS_KO_MACR...2,SET,178,0.11104,0.01088,0.063852,0.041029,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_UP,0.768895888529887
GSE37532_TREG_VS_TCONV_PPARG...1,SET,180,0.1031,0.010158,0.059298,0.041053,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN,0.768895888529887
GSE22601_CD4_SINGLE_POSITIVE...1,SET,180,0.10199,0.010048,0.05866,0.041061,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.768895888529887
REACTOME_INTERLEUKIN_23_SIGN...,SET,9,0.50516,0.011181,0.29056,0.041065,REACTOME_INTERLEUKIN_23_SIGNALING,0.768895888529887
MODULE_93,SET,173,0.11079,0.010704,0.063735,0.041083,MODULE_93,0.768895888529887
MIR708_5P,SET,43,0.21883,0.010578,0.1259,0.041107,MIR708_5P,0.768930993003229
GOBP_NEGATIVE_REGULATION_OF_...364,SET,57,0.21158,0.01177,0.12181,0.041201,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,0.768989316353888
WP_NUCLEAR_RECEPTORS_METAPAT...,SET,300,0.090059,0.011417,0.051849,0.041207,WP_NUCLEAR_RECEPTORS_METAPATHWAY,0.768989316353888
KEGG_MEDICUS_REFERENCE_METHI...,SET,10,0.51612,0.012042,0.29715,0.041211,KEGG_MEDICUS_REFERENCE_METHIONINE_DEGRADATION,0.768989316353888
KEGG_MEDICUS_REFERENCE_MICRO...3,SET,26,0.3122,0.01174,0.17976,0.041224,KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION,0.768989316353888
GOBP_NEGATIVE_REGULATION_OF_...112,SET,242,0.097786,0.011152,0.056313,0.04125,GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT,0.768989316353888
MIR4486,SET,34,0.23123,0.0099412,0.13317,0.041256,MIR4486,0.768989316353888
WP_EGFR_TYROSINE_KINASE_INHI...,SET,83,0.17171,0.011519,0.098894,0.041265,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,0.768989316353888
HP_ANORECTAL_ANOMALY,SET,149,0.12136,0.010888,0.069915,0.041302,HP_ANORECTAL_ANOMALY,0.769266350482315
GOBP_REGULATION_OF_DNA_TEMPL...1,SET,47,0.20379,0.010297,0.11744,0.041361,GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.769952627209427
REACTOME_NOTCH2_INTRACELLULA...,SET,11,0.4813,0.011777,0.27748,0.041422,REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.770092740641711
MODULE_132,SET,13,0.43814,0.011654,0.25262,0.041432,MODULE_132,0.770092740641711
GSE24142_DN2_VS_DN3_THYMOCYT...1,SET,180,0.10961,0.010799,0.063197,0.041435,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN,0.770092740641711
BIOCARTA_MYOSIN_PATHWAY,SET,11,0.51381,0.012572,0.29634,0.04148,BIOCARTA_MYOSIN_PATHWAY,0.770232405232248
WP_RETT_SYNDROME,SET,41,0.22617,0.010676,0.13046,0.041503,WP_RETT_SYNDROME,0.770232405232248
MIR6790_3P,SET,4,0.83485,0.012321,0.48159,0.041509,MIR6790_3P,0.770232405232248
PID_WNT_NONCANONICAL_PATHWAY,SET,31,0.27469,0.011277,0.15852,0.041575,PID_WNT_NONCANONICAL_PATHWAY,0.770647167370644
GSE28726_ACT_CD4_TCELL_VS_AC...2,SET,188,0.10136,0.010204,0.058495,0.041576,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP,0.770647167370644
HP_PANIC_ATTACK,SET,49,0.19276,0.0099448,0.11128,0.041618,HP_PANIC_ATTACK,0.770647167370644
GOMF_CYCLIN_DEPENDENT_PROTEI...1,SET,26,0.26114,0.0098198,0.15079,0.041666,GOMF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.770647167370644
GSE37416_CTRL_VS_12H_F_TULAR...2,SET,169,0.11541,0.011022,0.066646,0.041668,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.770647167370644
REACTOME_RUNX3_REGULATES_WNT...,SET,8,0.52721,0.011002,0.30449,0.041696,REACTOME_RUNX3_REGULATES_WNT_SIGNALING,0.770647167370644
GSE10239_NAIVE_VS_MEMORY_CD8...2,SET,184,0.10341,0.0103,0.059746,0.041749,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.770647167370644
GSE2770_UNTREATED_VS_TGFB_AN...10,SET,131,0.13172,0.011086,0.076124,0.04179,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.770647167370644
chr5q33,SET,63,0.32717,0.019132,0.18911,0.041815,chr5q33,0.770647167370644
GOBP_REGULATION_OF_OLIGODEND...,SET,46,0.24896,0.012446,0.14391,0.041824,GOBP_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.770647167370644
REACTOME_CELL_CYCLE,SET,591,0.058183,0.010269,0.033633,0.041829,REACTOME_CELL_CYCLE,0.770647167370644
GOBP_MYOSIN_FILAMENT_ORGANIZ...,SET,6,0.58441,0.010563,0.33786,0.041848,GOBP_MYOSIN_FILAMENT_ORGANIZATION,0.770647167370644
GSE37301_RAG2_KO_VS_RAG2_AND...1,SET,182,0.10553,0.010455,0.061015,0.041859,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_DN,0.770647167370644
BUSSLINGER_GASTRIC_IMMUNE_CE...,SET,1342,0.040977,0.010666,0.023702,0.041929,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.770647167370644
TIEN_INTESTINE_PROBIOTICS_6H...2,SET,46,0.21338,0.010667,0.12343,0.041939,TIEN_INTESTINE_PROBIOTICS_6HR_UP,0.770647167370644
GSE17721_PAM3CSK4_VS_CPG_16H...2,SET,177,0.10629,0.010385,0.061489,0.041949,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP,0.770647167370644
HP_ABNORMAL_PARANASAL_SINUS_...,SET,158,0.11844,0.010939,0.068517,0.041953,HP_ABNORMAL_PARANASAL_SINUS_MORPHOLOGY,0.770647167370644
HP_CUTIS_LAXA,SET,110,0.1377,0.010626,0.07967,0.041965,HP_CUTIS_LAXA,0.770647167370644
DESCARTES_MAIN_FETAL_PAEP_ME...,SET,109,0.14268,0.01096,0.082558,0.041984,DESCARTES_MAIN_FETAL_PAEP_MECOM_POSITIVE_CELLS,0.770647167370644
GOBP_RETROGRADE_AXONAL_TRANS...,SET,21,0.31812,0.010752,0.18409,0.041992,GOBP_RETROGRADE_AXONAL_TRANSPORT,0.770647167370644
GSE360_L_DONOVANI_VS_B_MALAY...6,SET,177,0.11409,0.011148,0.066023,0.041997,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP,0.770647167370644
GOBP_NEGATIVE_REGULATION_OF_...625,SET,4,0.7701,0.011365,0.44588,0.04208,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,0.771762744063325
MODULE_180,SET,109,0.1477,0.011347,0.08559,0.042209,MODULE_180,0.773697232472325
GOMF_ACTIN_FILAMENT_BINDING,SET,197,0.10479,0.010796,0.060732,0.04223,GOMF_ACTIN_FILAMENT_BINDING,0.773697232472325
GSE43863_DAY6_EFF_VS_DAY150_...6,SET,179,0.11214,0.011018,0.065001,0.042255,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP,0.77374737881981
MODULE_419,SET,30,0.26245,0.0106,0.15222,0.042351,MODULE_419,0.774091951731375
GOBP_REGULATION_OF_COLLAGEN_...2,SET,32,0.27833,0.011609,0.16146,0.042383,GOBP_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.774091951731375
GOBP_POSITIVE_REGULATION_OF_...508,SET,19,0.3061,0.0098416,0.17758,0.042384,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.774091951731375
GOBP_LACTATE_TRANSMEMBRANE_T...,SET,8,0.56865,0.011867,0.32993,0.042401,GOBP_LACTATE_TRANSMEMBRANE_TRANSPORT,0.774091951731375
GOCC_SMALL_RIBOSOMAL_SUBUNIT,SET,66,0.16867,0.010095,0.097863,0.042402,GOCC_SMALL_RIBOSOMAL_SUBUNIT,0.774091951731375
GSE6269_HEALTHY_VS_STAPH_PNE...2,SET,165,0.10874,0.010262,0.063104,0.04243,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP,0.774091951731375
MODULE_547,SET,11,0.43851,0.01073,0.25447,0.042435,MODULE_547,0.774091951731375
GOBP_NEGATIVE_REGULATION_OF_...180,SET,796,0.054548,0.011109,0.031659,0.042452,GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS,0.774091951731375
HP_EEG_WITH_FOCAL_SPIKE_WAVES,SET,13,0.41851,0.011132,0.24298,0.042503,HP_EEG_WITH_FOCAL_SPIKE_WAVES,0.774615503408495
MIR7109_3P,SET,60,0.18074,0.010315,0.10499,0.042583,MIR7109_3P,0.775382230366492
REACTOME_SHC1_EVENTS_IN_ERBB...1,SET,22,0.2957,0.010229,0.17177,0.042594,REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,0.775382230366492
REACTOME_AURKA_ACTIVATION_BY...,SET,67,0.163,0.0098284,0.094699,0.042612,REACTOME_AURKA_ACTIVATION_BY_TPX2,0.775382230366492
HP_ABNORMAL_STERNUM_MORPHOLO...,SET,402,0.071845,0.010514,0.041747,0.042638,HP_ABNORMAL_STERNUM_MORPHOLOGY,0.775449340659341
RUBENSTEIN_SKELETAL_MUSCLE_T...,SET,157,0.11349,0.010449,0.065961,0.042674,RUBENSTEIN_SKELETAL_MUSCLE_T_CELLS,0.77569815376569
HP_OLIGODONTIA,SET,52,0.19643,0.010439,0.11419,0.042707,HP_OLIGODONTIA,0.775873348492102
GSE32423_CTRL_VS_IL7_MEMORY_...2,SET,179,0.11232,0.011036,0.065308,0.04274,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP,0.775873348492102
REACTOME_SEALING_OF_THE_NUCL...,SET,29,0.26025,0.010335,0.15135,0.042766,REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III,0.775873348492102
HP_PERIPHERAL_PULMONARY_ARTE...,SET,30,0.27153,0.010967,0.15802,0.042875,HP_PERIPHERAL_PULMONARY_ARTERY_STENOSIS,0.775873348492102
GOCC_CENTRIOLAR_SATELLITE,SET,112,0.13413,0.010444,0.07806,0.042879,GOCC_CENTRIOLAR_SATELLITE,0.775873348492102
GOBP_G_QUADRUPLEX_DNA_UNWIND...,SET,7,0.56099,0.010951,0.32648,0.042881,GOBP_G_QUADRUPLEX_DNA_UNWINDING,0.775873348492102
HP_AGITATION,SET,95,0.14725,0.010565,0.085703,0.04289,HP_AGITATION,0.775873348492102
HP_ABNORMALITY_OF_THE_VOICE,SET,386,0.073972,0.010612,0.043059,0.042915,HP_ABNORMALITY_OF_THE_VOICE,0.775873348492102
EGR_Q6,SET,248,0.09153,0.010565,0.053291,0.042948,EGR_Q6,0.775873348492102
GOBP_POSITIVE_REGULATION_OF_...569,SET,8,0.50583,0.010556,0.29451,0.04295,GOBP_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.775873348492102
MODULE_83,SET,281,0.081639,0.010022,0.047548,0.043001,MODULE_83,0.775873348492102
HP_ABNORMAL_SOCIAL_BEHAVIOR,SET,152,0.11594,0.010505,0.067531,0.043017,HP_ABNORMAL_SOCIAL_BEHAVIOR,0.775873348492102
WP_INFLAMMATORY_BOWEL_DISEAS...,SET,41,0.2471,0.011664,0.14396,0.043042,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,0.775873348492102
GOBP_REPRODUCTIVE_SYSTEM_DEV...,SET,284,0.089966,0.011102,0.052425,0.043082,GOBP_REPRODUCTIVE_SYSTEM_DEVELOPMENT,0.775873348492102
MIR4299,SET,67,0.17673,0.010656,0.10299,0.043089,MIR4299,0.775873348492102
HP_INCREASED_ENDOMYSIAL_CONN...,SET,27,0.28777,0.011027,0.16777,0.043156,HP_INCREASED_ENDOMYSIAL_CONNECTIVE_TISSUE,0.775873348492102
GOBP_REGULATION_OF_PROTEIN_L...1,SET,10,0.47462,0.011073,0.27672,0.04317,GOBP_REGULATION_OF_PROTEIN_LIPIDATION,0.775873348492102
SUNG_METASTASIS_STROMA_DN,SET,51,0.2033,0.0107,0.11855,0.043198,SUNG_METASTASIS_STROMA_DN,0.775873348492102
FEVR_CTNNB1_TARGETS_DN,SET,504,0.063217,0.010329,0.03687,0.043221,FEVR_CTNNB1_TARGETS_DN,0.775873348492102
HWANG_PROSTATE_CANCER_MARKERS,SET,25,0.28552,0.010529,0.16654,0.043228,HWANG_PROSTATE_CANCER_MARKERS,0.775873348492102
GSE10239_MEMORY_VS_KLRG1HIGH...2,SET,180,0.10621,0.010465,0.061973,0.043286,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.775873348492102
WANG_ESOPHAGUS_CANCER_VS_NOR...2,SET,114,0.14252,0.011195,0.083179,0.043326,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,0.775873348492102
HE_LIM_SUN_FETAL_LUNG_C5_CD5...3,SET,587,0.059553,0.010477,0.034763,0.043353,HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_POS_MATURE_B_CELL,0.775873348492102
GAVISH_3CA_MALIGNANT_METAPRO...2,SET,38,0.23172,0.010531,0.13531,0.043415,GAVISH_3CA_MALIGNANT_METAPROGRAM_11_TRANSLATION_INITIATION,0.775873348492102
GSE24634_NAIVE_CD4_TCELL_VS_...1,SET,187,0.10503,0.010546,0.061336,0.043416,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN,0.775873348492102
MIR8071,SET,31,0.23807,0.0097739,0.13904,0.04343,MIR8071,0.775873348492102
GOBP_INTERMEDIATE_FILAMENT_O...,SET,71,0.23125,0.014352,0.13506,0.043439,GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION,0.775873348492102
GOBP_IMMUNE_RESPONSE_REGULAT...3,SET,478,0.067793,0.010795,0.039598,0.043452,GOBP_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY,0.775873348492102
GOBP_CEREBROSPINAL_FLUID_CIR...,SET,9,0.52293,0.011575,0.30544,0.043454,GOBP_CEREBROSPINAL_FLUID_CIRCULATION,0.775873348492102
GOBP_MESENCHYMAL_STEM_CELL_P...,SET,7,0.59068,0.011531,0.34515,0.043515,GOBP_MESENCHYMAL_STEM_CELL_PROLIFERATION,0.775873348492102
GOBP_REGULATION_OF_T_HELPER_...2,SET,10,0.4957,0.011565,0.28981,0.0436,GOBP_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT,0.775873348492102
MIR4679,SET,141,0.12308,0.010744,0.071979,0.043653,MIR4679,0.775873348492102
DESCARTES_MAIN_FETAL_SKELETA...,SET,134,0.12506,0.010645,0.073163,0.043699,DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS,0.775873348492102
GSE8921_UNSTIM_VS_TLR1_2_STI...7,SET,178,0.10347,0.010138,0.060539,0.043718,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN,0.775873348492102
REACTOME_TRNA_MODIFICATION_I...2,SET,38,0.21193,0.0096315,0.124,0.043723,REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,0.775873348492102
HP_SKIN_TAGS,SET,72,0.16617,0.010385,0.09723,0.043733,HP_SKIN_TAGS,0.775873348492102
GOBP_NUCLEOLAR_CHROMATIN_ORG...,SET,8,0.47363,0.0098842,0.27715,0.043742,GOBP_NUCLEOLAR_CHROMATIN_ORGANIZATION,0.775873348492102
GSE10239_NAIVE_VS_KLRG1HIGH_...2,SET,187,0.10419,0.010461,0.060999,0.043818,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.775873348492102
MIR640,SET,46,0.1914,0.0095679,0.11206,0.043832,MIR640,0.775873348492102
MIR4653_5P,SET,137,0.12699,0.010928,0.074365,0.043857,MIR4653_5P,0.775873348492102
GOBP_PROTEIN_UNFOLDING,SET,5,0.55765,0.0092011,0.32661,0.043882,GOBP_PROTEIN_UNFOLDING,0.775873348492102
GOBP_RESPONSE_TO_TRANSFORMIN...,SET,255,0.092968,0.01088,0.054461,0.043915,GOBP_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA,0.775873348492102
REACTOME_GAP_JUNCTION_ASSEMB...,SET,33,0.26968,0.011423,0.15802,0.043955,REACTOME_GAP_JUNCTION_ASSEMBLY,0.775873348492102
ZWANG_EGF_PERSISTENTLY_UP,SET,27,0.2697,0.010335,0.15807,0.043992,ZWANG_EGF_PERSISTENTLY_UP,0.775873348492102
GOBP_ESTABLISHMENT_OF_ENDOTH...1,SET,50,0.21851,0.011387,0.12809,0.044019,GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER,0.775873348492102
GOBP_NEGATIVE_REGULATION_OF_...58,SET,13,0.48567,0.012918,0.28474,0.044041,GOBP_NEGATIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.775873348492102
GOBP_NEGATIVE_REGULATION_OF_...447,SET,65,0.17308,0.01028,0.10154,0.044144,GOBP_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,0.775873348492102
GOBP_DNA_TEMPLATED_DNA_REPLI...1,SET,154,0.11086,0.010111,0.065046,0.044162,GOBP_DNA_TEMPLATED_DNA_REPLICATION,0.775873348492102
GSE32423_CTRL_VS_IL4_MEMORY_...1,SET,178,0.10422,0.010211,0.061161,0.044203,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN,0.775873348492102
GOBP_NUCLEOLAR_LARGE_RRNA_TR...,SET,19,0.30322,0.0097491,0.17797,0.044222,GOBP_NUCLEOLAR_LARGE_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.775873348492102
HP_ABNORMALITY_OF_SKELETAL_M...2,SET,106,0.13632,0.010328,0.08001,0.044222,HP_ABNORMALITY_OF_SKELETAL_MUSCLE_FIBER_SIZE,0.775873348492102
GOBP_NEGATIVE_REGULATION_OF_...354,SET,5,0.68668,0.01133,0.40306,0.044232,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS,0.775873348492102
HP_SWOLLEN_LIP,SET,6,0.68694,0.012416,0.4034,0.044305,HP_SWOLLEN_LIP,0.775873348492102
HP_ABNORMAL_CIRCLE_OF_WILLIS...,SET,6,0.59138,0.010689,0.34729,0.044308,HP_ABNORMAL_CIRCLE_OF_WILLIS_MORPHOLOGY,0.775873348492102
HP_PSYCHIC_EPILEPTIC_AURA,SET,10,0.43784,0.010215,0.25712,0.044308,HP_PSYCHIC_EPILEPTIC_AURA,0.775873348492102
MIR6129,SET,170,0.11149,0.010678,0.065474,0.044314,MIR6129,0.775873348492102
GOCC_KERATIN_FILAMENT,SET,81,0.2159,0.014308,0.1268,0.044319,GOCC_KERATIN_FILAMENT,0.775873348492102
GOBP_POSITIVE_REGULATION_OF_...338,SET,12,0.54202,0.013852,0.31833,0.044323,GOBP_POSITIVE_REGULATION_OF_HIPPO_SIGNALING,0.775873348492102
BLANCO_MELO_RESPIRATORY_SYNC...2,SET,272,0.093589,0.011306,0.054969,0.044333,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,0.775873348492102
BIOCARTA_ERBB4_PATHWAY,SET,7,0.49115,0.009588,0.28855,0.044374,BIOCARTA_ERBB4_PATHWAY,0.775873348492102
WP_WNT_SIGNALING_AND_PLURIPO...,SET,95,0.15393,0.011044,0.090444,0.044388,WP_WNT_SIGNALING_AND_PLURIPOTENCY,0.775873348492102
GOBP_TRNA_PROCESSING,SET,119,0.12014,0.0096403,0.070594,0.044406,GOBP_TRNA_PROCESSING,0.775873348492102
GOBP_IMMUNE_RESPONSE_REGULAT...1,SET,307,0.08593,0.011018,0.050499,0.044424,GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.775873348492102
HOFFMANN_SMALL_PRE_BII_TO_IM...1,SET,35,0.24243,0.010575,0.14248,0.044429,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,0.775873348492102
REACTOME_ROLE_OF_SECOND_MESS...,SET,9,0.49383,0.010931,0.29033,0.044483,REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING,0.775873348492102
HP_OPTIC_DISC_DRUSEN,SET,12,0.4234,0.010821,0.24894,0.044495,HP_OPTIC_DISC_DRUSEN,0.775873348492102
GOCC_ENDODEOXYRIBONUCLEASE_C...,SET,5,0.61165,0.010092,0.35964,0.044506,GOCC_ENDODEOXYRIBONUCLEASE_COMPLEX,0.775873348492102
MCGARVEY_SILENCED_BY_METHYLA...,SET,41,0.2435,0.011494,0.14318,0.044512,MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER,0.775873348492102
MODULE_44,SET,290,0.088355,0.011016,0.051962,0.044538,MODULE_44,0.775873348492102
GOBP_FUCOSE_METABOLIC_PROCESS,SET,15,0.37268,0.010648,0.2192,0.04456,GOBP_FUCOSE_METABOLIC_PROCESS,0.775873348492102
GOMF_SUPEROXIDE_GENERATING_N...1,SET,7,0.57365,0.011199,0.33743,0.044569,GOMF_SUPEROXIDE_GENERATING_NADPH_OXIDASE_ACTIVATOR_ACTIVITY,0.775873348492102
GOBP_REGULATION_OF_LEUKOCYTE...7,SET,226,0.10237,0.011287,0.060217,0.044571,GOBP_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,0.775873348492102
LI_PBMC_MENACTRA_AGE_18_45YO...4,SET,14,0.40255,0.011111,0.23681,0.044588,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN,0.775873348492102
GOBP_MAMMARY_GLAND_ALVEOLUS_...,SET,18,0.37062,0.011599,0.21807,0.044613,GOBP_MAMMARY_GLAND_ALVEOLUS_DEVELOPMENT,0.775873348492102
HP_ACHROMATOPSIA,SET,5,0.73401,0.012111,0.43189,0.044616,HP_ACHROMATOPSIA,0.775873348492102
HOFMANN_MYELODYSPLASTIC_SYND...6,SET,19,0.30354,0.0097594,0.1786,0.044617,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,0.775873348492102
GOBP_REGULATION_OF_ESTABLISH...1,SET,13,0.4305,0.011451,0.25342,0.044691,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY,0.775873348492102
GSE26488_WT_VS_HDAC7_DELTAP_...1,SET,184,0.10821,0.010778,0.063705,0.044699,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN,0.775873348492102
GOBP_PEROXISOME_PROLIFERATOR...,SET,22,0.32719,0.011319,0.19264,0.044714,GOBP_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.775873348492102
HP_VENTILATOR_DEPENDENCE_WIT...,SET,4,0.70823,0.010452,0.417,0.044724,HP_VENTILATOR_DEPENDENCE_WITH_INABILITY_TO_WEAN,0.775873348492102
GSE39820_CTRL_VS_TGFBETA3_IL...4,SET,173,0.10299,0.0099502,0.060649,0.044743,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP,0.775873348492102
RIZKI_TUMOR_INVASIVENESS_3D_...1,SET,243,0.091376,0.010442,0.053822,0.044786,RIZKI_TUMOR_INVASIVENESS_3D_DN,0.775873348492102
GOBP_PURKINJE_MYOCYTE_TO_VEN...,SET,6,0.62784,0.011348,0.36981,0.044786,GOBP_PURKINJE_MYOCYTE_TO_VENTRICULAR_CARDIAC_MUSCLE_CELL_COMMUNICATION,0.775873348492102
GOBP_REGULATION_OF_ASYMMETRI...,SET,5,0.67209,0.011089,0.3959,0.0448,GOBP_REGULATION_OF_ASYMMETRIC_CELL_DIVISION,0.775873348492102
GOBP_ADENINE_TRANSPORT,SET,5,0.60689,0.010013,0.35752,0.04481,GOBP_ADENINE_TRANSPORT,0.775873348492102
GOMF_FLOPPASE_ACTIVITY,SET,15,0.37874,0.010821,0.22312,0.044813,GOMF_FLOPPASE_ACTIVITY,0.775873348492102
REACTOME_ATORVASTATIN_ADME,SET,9,0.5168,0.011439,0.30447,0.044825,REACTOME_ATORVASTATIN_ADME,0.775873348492102
KEGG_MEDICUS_VARIANT_MUTATIO...12,SET,9,0.45651,0.010105,0.26897,0.044834,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY,0.775873348492102
GOMF_NUCLEOSIDE_DIPHOSPHATE_...2,SET,17,0.3152,0.0095866,0.18572,0.044842,GOMF_NUCLEOSIDE_DIPHOSPHATE_PHOSPHATASE_ACTIVITY,0.775873348492102
ZHANG_TARGETS_OF_EWSR1_FLI1_...,SET,83,0.17003,0.011406,0.1002,0.044876,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,0.775873348492102
HP_ABNORMAL_CARDIAC_BIOMARKE...,SET,6,0.67057,0.01212,0.3952,0.044876,HP_ABNORMAL_CARDIAC_BIOMARKER_TEST,0.775873348492102
chr15q24,SET,57,0.37928,0.0211,0.22354,0.044885,chr15q24,0.775873348492102
HP_DYSGENESIS_OF_THE_HIPPOCA...,SET,15,0.38551,0.011014,0.22723,0.0449,HP_DYSGENESIS_OF_THE_HIPPOCAMPUS,0.775873348492102
AIZARANI_LIVER_C25_KUPFFER_C...,SET,158,0.12365,0.01142,0.072887,0.044914,AIZARANI_LIVER_C25_KUPFFER_CELLS_4,0.775873348492102
GSE22432_UNTREATED_VS_TGFB1_...2,SET,186,0.10504,0.010519,0.061924,0.044924,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_UP,0.775873348492102
KEGG_MEDICUS_VARIANT_MUTATIO...47,SET,44,0.21211,0.010371,0.12505,0.044932,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT,0.775873348492102
REACTOME_TRANSLESION_SYNTHES...3,SET,36,0.20617,0.0091201,0.12156,0.044946,REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE,0.775873348492102
PID_ERBB1_RECEPTOR_PROXIMAL_...,SET,34,0.22888,0.0098399,0.13495,0.044947,PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,0.775873348492102
GSE1460_NAIVE_CD4_TCELL_CORD...2,SET,162,0.10652,0.0099617,0.06281,0.044953,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP,0.775873348492102
GSE34205_RSV_VS_FLU_INF_INFA...2,SET,154,0.11755,0.010721,0.069324,0.044977,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP,0.775873348492102
GOMF_BUBBLE_DNA_BINDING,SET,8,0.519,0.010831,0.30618,0.045041,GOMF_BUBBLE_DNA_BINDING,0.775873348492102
GOCC_TROPONIN_COMPLEX,SET,8,0.55632,0.01161,0.32823,0.045054,GOCC_TROPONIN_COMPLEX,0.775873348492102
KEGG_MEDICUS_REFERENCE_MODIF...1,SET,6,0.58291,0.010536,0.34403,0.045107,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_II_SUBUNITS,0.775873348492102
GSE9650_NAIVE_VS_EFF_CD8_TCE...2,SET,182,0.10414,0.010317,0.061466,0.045115,GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP,0.775873348492102
GOMF_STRUCTURAL_CONSTITUENT_...9,SET,147,0.11191,0.0099733,0.066054,0.045118,GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME,0.775873348492102
GOMF_ASPARTIC_TYPE_ENDOPEPTI...,SET,7,0.56704,0.01107,0.33474,0.045143,GOMF_ASPARTIC_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.775873348492102
MIR185_5P,SET,266,0.090663,0.010833,0.053524,0.045153,MIR185_5P,0.775873348492102
GSE21033_CTRL_VS_POLYIC_STIM...9,SET,147,0.11202,0.0099833,0.06614,0.045168,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN,0.775873348492102
GOBP_SOMATOSTATIN_RECEPTOR_S...,SET,6,0.73168,0.013224,0.43202,0.045177,GOBP_SOMATOSTATIN_RECEPTOR_SIGNALING_PATHWAY,0.775873348492102
HP_SPINA_BIFIDA_OCCULTA,SET,68,0.18047,0.010962,0.10657,0.045194,HP_SPINA_BIFIDA_OCCULTA,0.775873348492102
GOMF_KETOSTEROID_MONOOXYGENA...,SET,5,0.92159,0.015206,0.54427,0.045211,GOMF_KETOSTEROID_MONOOXYGENASE_ACTIVITY,0.775873348492102
GSE9006_HEALTHY_VS_TYPE_1_DI...6,SET,169,0.10753,0.010268,0.063509,0.045228,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP,0.775873348492102
HP_IMPAIRED_RISTOCETIN_INDUC...,SET,8,0.51812,0.010813,0.30604,0.045236,HP_IMPAIRED_RISTOCETIN_INDUCED_PLATELET_AGGREGATION,0.775873348492102
GOBP_NEGATIVE_REGULATION_OF_...121,SET,8,0.50221,0.010481,0.29672,0.045281,GOBP_NEGATIVE_REGULATION_OF_CELL_MATURATION,0.775873348492102
REACTOME_ESTROGEN_DEPENDENT_...2,SET,23,0.33339,0.011792,0.19699,0.045298,REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING,0.775873348492102
GOMF_ADENINE_TRANSMEMBRANE_T...,SET,4,0.72962,0.010768,0.4312,0.045327,GOMF_ADENINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.775873348492102
GOMF_PROTEIN_PHOSPHATASE_1_B...,SET,23,0.28027,0.0099132,0.16567,0.045358,GOMF_PROTEIN_PHOSPHATASE_1_BINDING,0.775873348492102
GOBP_PRODUCTION_OF_MOLECULAR...2,SET,205,0.1,0.010507,0.059115,0.045367,GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.775873348492102
GOBP_POSITIVE_REGULATION_OF_...848,SET,5,0.63449,0.010469,0.37527,0.045451,GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,0.775873348492102
HP_CAPILLARY_MALFORMATION,SET,58,0.20543,0.011528,0.12151,0.045463,HP_CAPILLARY_MALFORMATION,0.775873348492102
GOBP_POSITIVE_REGULATION_OF_...426,SET,129,0.12955,0.010821,0.076635,0.045476,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,0.775873348492102
GOBP_3_UTR_MEDIATED_MRNA_DES...,SET,19,0.33636,0.010815,0.19898,0.045485,GOBP_3_UTR_MEDIATED_MRNA_DESTABILIZATION,0.775873348492102
WP_FATTY_ACID_BIOSYNTHESIS,SET,21,0.29233,0.0098805,0.17298,0.045531,WP_FATTY_ACID_BIOSYNTHESIS,0.775873348492102
HP_PARESIS_OF_EXTENSOR_MUSCL...,SET,6,0.66825,0.012078,0.39544,0.045531,HP_PARESIS_OF_EXTENSOR_MUSCLES_OF_THE_BIG_TOE,0.775873348492102
MIR495_5P,SET,62,0.18043,0.010467,0.10678,0.045551,MIR495_5P,0.775873348492102
GOBP_POSTSYNAPTIC_MODULATION...,SET,26,0.28049,0.010547,0.16601,0.045568,GOBP_POSTSYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION,0.775873348492102
HP_RENAL_ARTERY_STENOSIS,SET,21,0.29536,0.0099831,0.17483,0.045577,HP_RENAL_ARTERY_STENOSIS,0.775873348492102
BIOCARTA_RECK_PATHWAY,SET,8,0.51843,0.010819,0.30693,0.04561,BIOCARTA_RECK_PATHWAY,0.775873348492102
GOBP_REGULATION_OF_LYMPHOCYT...5,SET,170,0.11897,0.011394,0.070432,0.04561,GOBP_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,0.775873348492102
GOBP_REGULATION_OF_CALCIUM_I...4,SET,40,0.22344,0.010417,0.1323,0.045628,GOBP_REGULATION_OF_CALCIUM_ION_IMPORT,0.775873348492102
GOMF_STRUCTURAL_CONSTITUENT_...4,SET,40,0.21513,0.01003,0.1274,0.045655,GOMF_STRUCTURAL_CONSTITUENT_OF_MUSCLE,0.775873348492102
DESCARTES_MAIN_FETAL_LIMBIC_...,SET,6,0.59118,0.010685,0.35015,0.045682,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,0.775873348492102
GOCC_CONDENSED_CHROMOSOME_CE...,SET,164,0.10631,0.010002,0.062966,0.045683,GOCC_CONDENSED_CHROMOSOME_CENTROMERIC_REGION,0.775873348492102
HP_ELEVATED_CREATINE_KINASE_...,SET,10,0.43338,0.010111,0.25676,0.045727,HP_ELEVATED_CREATINE_KINASE_AFTER_EXERCISE,0.775873348492102
MENON_FETAL_KIDNEY_4_PODOCYT...,SET,181,0.10723,0.010594,0.063546,0.045766,MENON_FETAL_KIDNEY_4_PODOCYTES,0.775873348492102
GSE2770_IL12_ACT_VS_ACT_CD4_...5,SET,158,0.11138,0.010288,0.066005,0.045768,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN,0.775873348492102
GSE2770_IL12_VS_TGFB_AND_IL1...4,SET,179,0.10963,0.010772,0.064975,0.045783,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.775873348492102
GSE20484_MCSG_VS_CXCL4_MONOC...1,SET,174,0.10718,0.010385,0.063536,0.045814,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN,0.775873348492102
GOBP_REGULATION_OF_MONOATOMI...3,SET,302,0.086774,0.011037,0.051443,0.045832,GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.775873348492102
GOMF_INTRACELLULARLY_GATED_C...,SET,18,0.32425,0.010147,0.19224,0.045839,GOMF_INTRACELLULARLY_GATED_CALCIUM_CHANNEL_ACTIVITY,0.775873348492102
GOBP_REGULATION_OF_FAS_SIGNA...,SET,4,0.64992,0.0095917,0.38541,0.045875,GOBP_REGULATION_OF_FAS_SIGNALING_PATHWAY,0.775873348492102
GAVISH_3CA_METAPROGRAM_MACRO...11,SET,41,0.20454,0.0096545,0.1213,0.045893,GAVISH_3CA_METAPROGRAM_MACROPHAGES_RESPIRATION,0.775873348492102
GSE4984_UNTREATED_VS_GALECTI...1,SET,154,0.11782,0.010745,0.069887,0.045914,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN,0.775873348492102
DUTERTRE_ESTRADIOL_RESPONSE_...2,SET,297,0.080169,0.010113,0.047596,0.046067,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,0.775873348492102
HAY_BONE_MARROW_NAIVE_T_CELL,SET,324,0.081872,0.010779,0.048614,0.046088,HAY_BONE_MARROW_NAIVE_T_CELL,0.775873348492102
DACH1_TARGET_GENES,SET,742,0.051825,0.010206,0.030777,0.046113,DACH1_TARGET_GENES,0.775873348492102
GOCC_HISTONE_METHYLTRANSFERA...,SET,63,0.1621,0.0094791,0.096278,0.046129,GOCC_HISTONE_METHYLTRANSFERASE_COMPLEX,0.775873348492102
GSE14415_TCONV_VS_FOXP3_KO_I...1,SET,159,0.11017,0.010207,0.065432,0.046131,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN,0.775873348492102
GOBP_REGULATION_OF_ANTIGEN_R...,SET,61,0.18203,0.010474,0.10813,0.046164,GOBP_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.775873348492102
GOMF_GLUCURONOSYL_N_ACETYLGA...,SET,6,0.59056,0.010674,0.35085,0.046176,GOMF_GLUCURONOSYL_N_ACETYLGALACTOSAMINYL_PROTEOGLYCAN_4_BETA_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,0.775873348492102
E2F3_UP.V1_UP,SET,175,0.10726,0.010421,0.063727,0.046185,E2F3_UP.V1_UP,0.775873348492102
GOBP_REGULATION_OF_PHOSPHOLI...1,SET,7,0.47886,0.0093482,0.28455,0.046209,GOBP_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY,0.775873348492102
GOBP_POSITIVE_REGULATION_OF_...404,SET,134,0.13113,0.011161,0.077925,0.046217,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,0.775873348492102
GSE16385_UNTREATED_VS_12H_IF...1,SET,171,0.1044,0.010028,0.062045,0.046228,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,0.775873348492102
MIR1224_5P,SET,55,0.19047,0.010409,0.11321,0.046257,MIR1224_5P,0.775873348492102
GOBP_NEGATIVE_REGULATION_OF_...425,SET,49,0.22087,0.011395,0.1313,0.046269,GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.775873348492102
GOCC_CONTRACTILE_MUSCLE_FIBER,SET,237,0.094368,0.010652,0.056102,0.046284,GOCC_CONTRACTILE_MUSCLE_FIBER,0.775873348492102
GOMF_CARGO_RECEPTOR_ACTIVITY,SET,71,0.17082,0.010602,0.10156,0.046307,GOMF_CARGO_RECEPTOR_ACTIVITY,0.775873348492102
GOBP_POSITIVE_REGULATION_OF_...719,SET,5,0.55998,0.0092396,0.33308,0.046366,GOBP_POSITIVE_REGULATION_OF_SODIUM_PROTON_ANTIPORTER_ACTIVITY,0.775873348492102
WP_BIOGENIC_AMINE_SYNTHESIS,SET,13,0.40262,0.010709,0.23951,0.046393,WP_BIOGENIC_AMINE_SYNTHESIS,0.775873348492102
HP_HAND_MUSCLE_WEAKNESS,SET,43,0.2058,0.0099478,0.12244,0.046404,HP_HAND_MUSCLE_WEAKNESS,0.775873348492102
MIR30B_5P_MIR30C_5P,SET,713,0.054824,0.010592,0.032617,0.046405,MIR30B_5P_MIR30C_5P,0.775873348492102
GOBP_SEXUAL_REPRODUCTION,SET,922,0.046729,0.010205,0.027803,0.046416,GOBP_SEXUAL_REPRODUCTION,0.775873348492102
HP_ABNORMAL_MEGAKARYOCYTE_MO...,SET,23,0.29102,0.010293,0.17319,0.046451,HP_ABNORMAL_MEGAKARYOCYTE_MORPHOLOGY,0.775873348492102
GOBP_POSITIVE_REGULATION_OF_...33,SET,25,0.2869,0.010579,0.17077,0.046482,GOBP_POSITIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.775873348492102
KRIGE_RESPONSE_TO_TOSEDOSTAT...1,SET,910,0.046413,0.010073,0.027628,0.046494,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN,0.775873348492102
WP_NIPBL_ROLE_IN_DNA_DAMAGE_...,SET,7,0.47471,0.0092672,0.28259,0.046503,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,0.775873348492102
GSE5099_UNSTIM_VS_MCSF_TREAT...4,SET,175,0.10142,0.0098541,0.060392,0.046549,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP,0.775873348492102
REACTOME_DISEASES_ASSOCIATED...1,SET,38,0.22937,0.010424,0.13659,0.046557,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,0.775873348492102
GINESTIER_BREAST_CANCER_ZNF2...2,SET,63,0.16997,0.0099393,0.10122,0.046559,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,0.775873348492102
GOBP_EMBRYONIC_EYE_MORPHOGEN...,SET,34,0.26383,0.011343,0.15712,0.046566,GOBP_EMBRYONIC_EYE_MORPHOGENESIS,0.775873348492102
WP_MRNA_VACCINE_ACTIVATION_O...,SET,7,0.47174,0.0092092,0.28097,0.046588,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,0.775873348492102
GSE25088_WT_VS_STAT6_KO_MACR...3,SET,176,0.10484,0.010215,0.062446,0.046591,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP,0.775873348492102
HP_LIMITED_ELBOW_MOVEMENT,SET,145,0.12008,0.010629,0.071526,0.046604,HP_LIMITED_ELBOW_MOVEMENT,0.775873348492102
LIANG_SILENCED_BY_METHYLATIO...1,SET,45,0.21897,0.010827,0.13044,0.046616,LIANG_SILENCED_BY_METHYLATION_2,0.775873348492102
GSE3039_ALPHABETA_CD8_TCELL_...2,SET,178,0.10236,0.01003,0.060979,0.046619,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP,0.775873348492102
GOBP_MEMBRANE_PROTEIN_PROTEO...,SET,56,0.18028,0.0099411,0.10741,0.046635,GOBP_MEMBRANE_PROTEIN_PROTEOLYSIS,0.775873348492102
GSE17721_LPS_VS_POLYIC_0.5H_...2,SET,181,0.10054,0.0099329,0.059911,0.046668,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_UP,0.776050880382775
MIR3652,SET,135,0.11863,0.010134,0.070701,0.046695,MIR3652,0.776128515064562
GOBP_POSITIVE_REGULATION_OF_...689,SET,40,0.20667,0.0096356,0.12321,0.046751,GOBP_POSITIVE_REGULATION_OF_RNA_SPLICING,0.776687860898662
HP_MICRODONTIA,SET,157,0.11468,0.010559,0.068422,0.046867,HP_MICRODONTIA,0.77794159351145
KEGG_MEDICUS_REFERENCE_MICRO...2,SET,19,0.34825,0.011197,0.20778,0.046873,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS,0.77794159351145
GOMF_RIBOSOMAL_SMALL_SUBUNIT...,SET,15,0.33522,0.0095774,0.20005,0.046913,GOMF_RIBOSOMAL_SMALL_SUBUNIT_BINDING,0.77794159351145
GOBP_REGULATION_OF_STRESS_AC...,SET,36,0.23355,0.010331,0.13938,0.046916,GOBP_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.77794159351145
HP_MASK_LIKE_FACIES,SET,44,0.20381,0.009965,0.12166,0.046955,HP_MASK_LIKE_FACIES,0.778216988555079
WINTER_HYPOXIA_DN,SET,42,0.23262,0.011113,0.13889,0.046994,WINTER_HYPOXIA_DN,0.778492121067684
GSE12484_HEALTHY_VS_PERIDONT...2,SET,120,0.13355,0.010761,0.079754,0.04702,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP,0.778551738923297
GOBP_REGULATION_OF_CELLULAR_...7,SET,904,0.047476,0.010272,0.028369,0.047121,GOBP_REGULATION_OF_CELLULAR_LOCALIZATION,0.779658386406844
BRUINS_UVC_RESPONSE_VIA_TP53...2,SET,493,0.063546,0.010272,0.037985,0.047179,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B,0.779658386406844
GOBP_REGULATION_OF_B_CELL_RE...,SET,21,0.30943,0.010459,0.18497,0.047184,GOBP_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.779658386406844
HP_DECREASED_LYMPHOCYTE_PROL...2,SET,27,0.28683,0.010991,0.17148,0.047199,HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_MITOGEN,0.779658386406844
GSE14413_UNSTIM_VS_IFNB_STIM...6,SET,123,0.12767,0.010415,0.076326,0.047199,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_UP,0.779658386406844
GSE40274_FOXP3_VS_FOXP3_AND_...5,SET,119,0.12828,0.010294,0.076702,0.047226,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.779733790973872
GSE43955_1H_VS_60H_ACT_CD4_T...3,SET,185,0.10636,0.010622,0.063602,0.047249,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.779743112535613
GSE37319_WT_VS_RC3H1_KO_CD44...1,SET,122,0.13104,0.010646,0.078386,0.047303,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN,0.78005849857685
GOCC_RNA_CAP_BINDING_COMPLEX,SET,15,0.32863,0.0093892,0.1966,0.047313,GOCC_RNA_CAP_BINDING_COMPLEX,0.78005849857685
MIR432_5P,SET,87,0.15385,0.010565,0.092064,0.047356,MIR432_5P,0.780109741706161
BHAT_ESR1_TARGETS_NOT_VIA_AK...2,SET,201,0.10436,0.010859,0.062448,0.047361,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,0.780109741706161
HP_APLASIA_HYPOPLASIA_AFFECT...2,SET,127,0.1233,0.010219,0.073872,0.047559,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_ANTERIOR_SEGMENT_OF_THE_EYE,0.783000021316911
GCGNNANTTCC_UNKNOWN,SET,115,0.12457,0.009828,0.074695,0.047689,GCGNNANTTCC_UNKNOWN,0.783810766016713
GSE24142_EARLY_THYMIC_PROGEN...8,SET,186,0.10504,0.010519,0.062988,0.047698,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP,0.783810766016713
GOBP_POSITIVE_REGULATION_OF_...847,SET,60,0.18837,0.01075,0.11297,0.047721,GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING,0.783810766016713
MIR374A_3P,SET,128,0.12599,0.010483,0.075566,0.047738,MIR374A_3P,0.783810766016713
PID_REG_GR_PATHWAY,SET,80,0.15681,0.010328,0.094058,0.047752,PID_REG_GR_PATHWAY,0.783810766016713
HP_THORACIC_AORTIC_ANEURYSM,SET,108,0.13915,0.010641,0.083478,0.047771,HP_THORACIC_AORTIC_ANEURYSM,0.783810766016713
GOBP_MUSCLE_CELL_DEVELOPMENT,SET,185,0.10505,0.010491,0.063056,0.047867,GOBP_MUSCLE_CELL_DEVELOPMENT,0.783810766016713
HEY2_TARGET_GENES,SET,54,0.19137,0.010363,0.11487,0.047879,HEY2_TARGET_GENES,0.783810766016713
GOBP_POSITIVE_REGULATION_OF_...233,SET,7,0.51811,0.010114,0.31108,0.047912,GOBP_POSITIVE_REGULATION_OF_ENDOCYTIC_RECYCLING,0.783810766016713
MIR382_5P,SET,52,0.18778,0.0099792,0.11279,0.047975,MIR382_5P,0.783810766016713
GSE19941_LPS_VS_LPS_AND_IL10...2,SET,161,0.10777,0.010048,0.064734,0.047981,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.783810766016713
WP_PHOTODYNAMIC_THERAPYINDUC...5,SET,25,0.28807,0.010622,0.17307,0.048017,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,0.783810766016713
GOBP_PROTEIN_LOCALIZATION_TO...36,SET,12,0.40788,0.010424,0.24508,0.048034,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_ENVELOPE,0.783810766016713
GOCC_POSTSYNAPTIC_CYTOSKELET...,SET,13,0.3626,0.0096448,0.2179,0.048059,GOCC_POSTSYNAPTIC_CYTOSKELETON,0.783810766016713
GOBP_SEBACEOUS_GLAND_DEVELOP...,SET,10,0.46394,0.010824,0.27895,0.04815,GOBP_SEBACEOUS_GLAND_DEVELOPMENT,0.783810766016713
HP_PALPITATIONS,SET,102,0.14099,0.010479,0.084783,0.04817,HP_PALPITATIONS,0.783810766016713
KEGG_MEDICUS_VARIANT_EGF_OVE...2,SET,14,0.36897,0.010184,0.22189,0.048179,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,0.783810766016713
SHEN_SMARCA2_TARGETS_UP,SET,389,0.069273,0.0099756,0.041667,0.048211,SHEN_SMARCA2_TARGETS_UP,0.783810766016713
GOMF_GTPASE_INHIBITOR_ACTIVI...,SET,12,0.41075,0.010497,0.24708,0.048227,GOMF_GTPASE_INHIBITOR_ACTIVITY,0.783810766016713
BALLIF_DEVELOPMENTAL_DISABIL...,SET,13,0.41367,0.011003,0.24885,0.04823,BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION,0.783810766016713
WP_ACUTE_MYELOID_LEUKEMIA,SET,65,0.17661,0.010489,0.10625,0.04824,WP_ACUTE_MYELOID_LEUKEMIA,0.783810766016713
ONDER_CDH1_TARGETS_1_UP,SET,122,0.12671,0.010294,0.076233,0.048256,ONDER_CDH1_TARGETS_1_UP,0.783810766016713
MIR3927_5P,SET,35,0.22111,0.0096444,0.13304,0.04827,MIR3927_5P,0.783810766016713
GSE21033_CTRL_VS_POLYIC_STIM...4,SET,174,0.10657,0.010325,0.064126,0.048274,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP,0.783810766016713
GOBP_EMBRYONIC_APPENDAGE_MOR...,SET,116,0.14244,0.011286,0.085729,0.048315,GOBP_EMBRYONIC_APPENDAGE_MORPHOGENESIS,0.783810766016713
SCHERER_PBMC_APSV_WETVAX_AGE...8,SET,23,0.29792,0.010538,0.17932,0.048324,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_UP,0.783810766016713
MODULE_218,SET,18,0.37168,0.011632,0.22372,0.048332,MODULE_218,0.783810766016713
GOCC_CHOLINERGIC_SYNAPSE,SET,10,0.50342,0.011745,0.30304,0.048342,GOCC_CHOLINERGIC_SYNAPSE,0.783810766016713
TESAR_JAK_TARGETS_MOUSE_ES_D...,SET,7,0.6031,0.011773,0.36311,0.048374,TESAR_JAK_TARGETS_MOUSE_ES_D3_DN,0.783810766016713
DESCARTES_FETAL_PLACENTA_MEG...,SET,156,0.11421,0.010482,0.068767,0.048386,DESCARTES_FETAL_PLACENTA_MEGAKARYOCYTES,0.783810766016713
FRANCO_BLOOD_SANOFI_PASTEUR_...5,SET,19,0.31293,0.010061,0.18842,0.048388,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_NEGATIVE,0.783810766016713
HALMOS_CEBPA_TARGETS_UP,SET,46,0.22991,0.011493,0.13844,0.048391,HALMOS_CEBPA_TARGETS_UP,0.783810766016713
GOMF_SODIUM_CHANNEL_ACTIVITY,SET,47,0.21776,0.011003,0.13115,0.048424,GOMF_SODIUM_CHANNEL_ACTIVITY,0.783810766016713
GSE4590_PRE_BCELL_VS_LARGE_P...1,SET,147,0.10954,0.0097622,0.065981,0.048446,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN,0.783810766016713
REACTOME_SUPPRESSION_OF_APOP...,SET,7,0.50534,0.0098651,0.30441,0.048457,REACTOME_SUPPRESSION_OF_APOPTOSIS,0.783810766016713
GSE1432_1H_VS_24H_IFNG_MICRO...1,SET,181,0.10592,0.010464,0.063809,0.048477,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.783810766016713
REACTOME_CONSTITUTIVE_SIGNAL...5,SET,10,0.36627,0.0085453,0.2207,0.048507,REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2,0.783810766016713
GOBP_RIBOSOMAL_SMALL_SUBUNIT...1,SET,16,0.32892,0.0097053,0.19819,0.048509,GOBP_RIBOSOMAL_SMALL_SUBUNIT_ASSEMBLY,0.783810766016713
SMID_BREAST_CANCER_RELAPSE_I...1,SET,275,0.091137,0.01107,0.054921,0.048526,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,0.783810766016713
HAMAI_APOPTOSIS_VIA_TRAIL_UP,SET,596,0.05732,0.010158,0.034544,0.048531,HAMAI_APOPTOSIS_VIA_TRAIL_UP,0.783810766016713
ZNF175_TARGET_GENES,SET,627,0.056136,0.010195,0.033833,0.048549,ZNF175_TARGET_GENES,0.783810766016713
GOBP_LEARNED_VOCALIZATION_BE...,SET,10,0.4921,0.011481,0.29661,0.048559,GOBP_LEARNED_VOCALIZATION_BEHAVIOR_OR_VOCAL_LEARNING,0.783810766016713
GOCC_RIBONUCLEASE_P_COMPLEX,SET,10,0.42868,0.010002,0.25841,0.048578,GOCC_RIBONUCLEASE_P_COMPLEX,0.783810766016713
KEGG_MEDICUS_REFERENCE_RETRO...,SET,42,0.21225,0.01014,0.12797,0.048611,KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT,0.783979259860789
WP_CHRONIC_HYPERGLYCEMIA_IMP...,SET,43,0.23864,0.011535,0.14392,0.048655,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.784324918831169
HELLER_SILENCED_BY_METHYLATI...2,SET,237,0.094681,0.010687,0.05711,0.048682,HELLER_SILENCED_BY_METHYLATION_UP,0.784354962928638
GOBP_POSITIVE_REGULATION_OF_...577,SET,26,0.28606,0.010757,0.17257,0.048702,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,0.784354962928638
GSE12963_UNINF_VS_ENV_AND_NE...4,SET,127,0.1253,0.010385,0.075624,0.048782,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.785279485873089
FAN_OVARY_CL18_B_LYMPHOCYTE,SET,382,0.070234,0.010025,0.042396,0.048808,FAN_OVARY_CL18_B_LYMPHOCYTE,0.785334277777778
REACTOME_DISEASES_OF_DNA_REP...,SET,49,0.19307,0.0099605,0.11659,0.048872,REACTOME_DISEASES_OF_DNA_REPAIR,0.785523945546839
MIR4703_5P,SET,225,0.098021,0.010784,0.059213,0.04893,MIR4703_5P,0.785523945546839
GSE24081_CONTROLLER_VS_PROGR...2,SET,178,0.10759,0.010542,0.064992,0.048931,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP,0.785523945546839
GSE38696_LIGHT_ZONE_VS_DARK_...1,SET,122,0.12635,0.010265,0.076334,0.048944,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,0.785523945546839
LEE_AGING_NEOCORTEX_DN,SET,62,0.16874,0.0097886,0.10194,0.048951,LEE_AGING_NEOCORTEX_DN,0.785523945546839
GOMF_THIOLESTER_HYDROLASE_AC...,SET,40,0.21781,0.010155,0.13161,0.048975,GOMF_THIOLESTER_HYDROLASE_ACTIVITY,0.785523945546839
GSE41867_LCMV_ARMSTRONG_VS_C...6,SET,174,0.1041,0.010086,0.062902,0.048978,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP,0.785523945546839
LI_PBMC_ZOSTAVAX_AGE_25_40_A...2,SET,7,0.56904,0.011109,0.34397,0.049039,LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_79YO_3DY_UP,0.786139504151292
GOBP_SODIUM_ION_IMPORT_ACROS...,SET,22,0.29889,0.01034,0.18069,0.049063,GOBP_SODIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.786161625172891
GSE19825_NAIVE_VS_IL2RALOW_D...2,SET,180,0.10817,0.010657,0.065439,0.049178,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP,0.78760398480663
GOBP_SERINE_FAMILY_AMINO_ACI...3,SET,29,0.24787,0.0098432,0.14999,0.049217,GOBP_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.78760398480663
GSE11961_FOLLICULAR_BCELL_VS...3,SET,182,0.1039,0.010293,0.06287,0.049221,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.78760398480663
REACTOME_AMYLOID_FIBER_FORMA...,SET,47,0.21553,0.010891,0.13048,0.049291,REACTOME_AMYLOID_FIBER_FORMATION,0.788222297608096
GOBP_REGULATION_OF_B_CELL_AC...,SET,116,0.13064,0.010351,0.079095,0.049305,GOBP_REGULATION_OF_B_CELL_ACTIVATION,0.788222297608096
GOBP_INTERLEUKIN_8_PRODUCTION,SET,77,0.16671,0.010773,0.10096,0.049343,GOBP_INTERLEUKIN_8_PRODUCTION,0.788467110344828
RHEIN_ALL_GLUCOCORTICOID_THE...2,SET,67,0.17296,0.010429,0.10476,0.049374,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,0.788498078512397
BIOCARTA_PPARA_PATHWAY,SET,52,0.20263,0.010768,0.12275,0.049407,BIOCARTA_PPARA_PATHWAY,0.788498078512397
BROWN_MYELOID_CELL_DEVELOPME...1,SET,119,0.12769,0.010247,0.077358,0.049413,BROWN_MYELOID_CELL_DEVELOPMENT_DN,0.788498078512397
LOPEZ_MESOTELIOMA_SURVIVAL_T...1,SET,7,0.5133,0.01002,0.31105,0.049458,LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN,0.788509886058981
DANG_MYC_TARGETS_DN,SET,27,0.27768,0.01064,0.16833,0.049514,DANG_MYC_TARGETS_DN,0.788509886058981
TRAVAGLINI_LUNG_GOBLET_CELL,SET,138,0.12264,0.010592,0.074368,0.049579,TRAVAGLINI_LUNG_GOBLET_CELL,0.788509886058981
DESCARTES_MAIN_FETAL_LYMPHOI...,SET,116,0.13795,0.010931,0.083661,0.049586,DESCARTES_MAIN_FETAL_LYMPHOID_CELLS,0.788509886058981
GOMF_HISTONE_ACETYLTRANSFERA...,SET,23,0.29528,0.010444,0.17909,0.049607,GOMF_HISTONE_ACETYLTRANSFERASE_BINDING,0.788509886058981
GOCC_HEMOGLOBIN_COMPLEX,SET,8,0.56737,0.01184,0.34413,0.049611,GOCC_HEMOGLOBIN_COMPLEX,0.788509886058981
GOBP_REGULATION_OF_MATRIX_ME...,SET,5,0.73877,0.01219,0.44828,0.049684,GOBP_REGULATION_OF_MATRIX_METALLOPEPTIDASE_SECRETION,0.788509886058981
AIZARANI_LIVER_C38_RESIDENT_...,SET,19,0.32804,0.010547,0.19908,0.049705,AIZARANI_LIVER_C38_RESIDENT_B_CELLS_3,0.788509886058981
HP_ABNORMAL_RENAL_CORPUSCLE_...,SET,164,0.10744,0.010108,0.065214,0.049742,HP_ABNORMAL_RENAL_CORPUSCLE_MORPHOLOGY,0.788509886058981
REACTOME_DNA_DAMAGE_BYPASS,SET,44,0.18366,0.0089801,0.1115,0.049772,REACTOME_DNA_DAMAGE_BYPASS,0.788509886058981
WP_NCRNAS_INVOLVED_IN_WNT_SI...,SET,82,0.15891,0.010596,0.096474,0.049773,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,0.788509886058981
GOBP_HEMIDESMOSOME_ASSEMBLY,SET,6,0.63333,0.011447,0.38459,0.049812,GOBP_HEMIDESMOSOME_ASSEMBLY,0.788509886058981
GSE22886_NAIVE_CD4_TCELL_VS_...4,SET,176,0.099525,0.0096973,0.060442,0.049827,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP,0.788509886058981
GOBP_NEGATIVE_REGULATION_OF_...424,SET,76,0.17055,0.01095,0.10362,0.049895,GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.788509886058981
HP_WRIST_FLEXION_CONTRACTURE,SET,33,0.26602,0.011268,0.16163,0.049906,HP_WRIST_FLEXION_CONTRACTURE,0.788509886058981
XU_RESPONSE_TO_TRETINOIN_AND...2,SET,14,0.40938,0.0113,0.24877,0.04993,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP,0.788509886058981
GSE360_L_MAJOR_VS_B_MALAYI_H...4,SET,181,0.10503,0.010377,0.063826,0.049931,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.788509886058981
KEGG_MEDICUS_PATHOGEN_KSHV_L...,SET,7,0.51804,0.010113,0.31487,0.049967,KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY,0.788509886058981
HP_APLASIA_HYPOPLASIA_OF_FAC...,SET,50,0.19701,0.010267,0.11975,0.049976,HP_APLASIA_HYPOPLASIA_OF_FACIAL_BONES,0.788509886058981
OSWALD_HEMATOPOIETIC_STEM_CE...2,SET,208,0.10025,0.010609,0.060937,0.049982,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,0.788509886058981
GSE15330_HSC_VS_GRANULOCYTE_...1,SET,174,0.10462,0.010137,0.063597,0.049982,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.788509886058981
REACTOME_SARS_COV_1_HOST_INT...,SET,85,0.14627,0.0099291,0.08892,0.049998,REACTOME_SARS_COV_1_HOST_INTERACTIONS,0.788509886058981
GOBP_POSITIVE_REGULATION_OF_...615,SET,32,0.24159,0.010077,0.14689,0.050028,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.788509886058981
WP_TOLLLIKE_RECEPTOR_SIGNALI...2,SET,26,0.25451,0.0095706,0.15476,0.05004,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,0.788509886058981
HOX13_01,SET,42,0.22468,0.010734,0.13664,0.050066,HOX13_01,0.788509886058981
GOMF_OXIDATIVE_RNA_DEMETHYLA...,SET,5,0.57062,0.0094151,0.34716,0.05013,GOMF_OXIDATIVE_RNA_DEMETHYLASE_ACTIVITY,0.788509886058981
IIZUKA_LIVER_CANCER_PROGRESS...3,SET,8,0.52795,0.011018,0.32137,0.050219,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN,0.788509886058981
GOBP_ANTIGEN_PROCESSING_AND_...9,SET,7,0.7396,0.014438,0.45022,0.050226,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_LIPID_ANTIGEN_VIA_MHC_CLASS_IB,0.788509886058981
GOBP_REGULATION_OF_SHORT_TER...,SET,14,0.38898,0.010737,0.23682,0.050249,GOBP_REGULATION_OF_SHORT_TERM_NEURONAL_SYNAPTIC_PLASTICITY,0.788509886058981
BARIS_THYROID_CANCER_DN,SET,52,0.18908,0.010048,0.11512,0.050251,BARIS_THYROID_CANCER_DN,0.788509886058981
HP_SEVERE_VARICELLA_ZOSTER_I...,SET,13,0.39974,0.010633,0.24346,0.050315,HP_SEVERE_VARICELLA_ZOSTER_INFECTION,0.788509886058981
AMIT_DELAYED_EARLY_GENES,SET,18,0.34371,0.010757,0.20934,0.050317,AMIT_DELAYED_EARLY_GENES,0.788509886058981
GOBP_RESPONSE_TO_ORGANOPHOSP...,SET,123,0.12595,0.010274,0.076722,0.050344,GOBP_RESPONSE_TO_ORGANOPHOSPHORUS,0.788509886058981
HP_MESOMELIA,SET,32,0.23797,0.0099261,0.14497,0.050348,HP_MESOMELIA,0.788509886058981
AMIT_EGF_RESPONSE_40_MCF10A,SET,15,0.37923,0.010835,0.23105,0.050373,AMIT_EGF_RESPONSE_40_MCF10A,0.788509886058981
NUNODA_RESPONSE_TO_DASATINIB...1,SET,13,0.3561,0.0094719,0.21696,0.050376,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,0.788509886058981
MODULE_46,SET,367,0.08073,0.011299,0.049192,0.050395,MODULE_46,0.788509886058981
MIKKELSEN_ES_LCP_WITH_H3K4ME...,SET,7,0.53681,0.010479,0.32712,0.050406,MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3,0.788509886058981
WP_GLYCINE_METABOLISM_INCLUD...,SET,15,0.33233,0.0094948,0.20253,0.050416,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,0.788509886058981
GOBP_REGULATION_OF_LYMPHOCYT...4,SET,205,0.09964,0.010469,0.060724,0.05042,GOBP_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,0.788509886058981
GOMF_GAMMA_AMINOBUTYRIC_ACID...1,SET,5,0.75996,0.012539,0.46323,0.050453,GOMF_GAMMA_AMINOBUTYRIC_ACID_SODIUM_CHLORIDE_SYMPORTER_ACTIVITY,0.788509886058981
REACTOME_FCGAMMA_RECEPTOR_FC...,SET,81,0.14628,0.0096944,0.089172,0.050467,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,0.788509886058981
SNAI1_TARGET_GENES,SET,370,0.07142,0.010036,0.04354,0.050478,SNAI1_TARGET_GENES,0.788509886058981
NRL_DN.V1_DN,SET,120,0.12875,0.010374,0.078491,0.050481,NRL_DN.V1_DN,0.788509886058981
GSE42021_CD24INT_VS_CD24LOW_...2,SET,181,0.10508,0.010382,0.064064,0.050482,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP,0.788509886058981
GOMF_MELANOCORTIN_RECEPTOR_B...,SET,5,0.6104,0.010071,0.37213,0.050483,GOMF_MELANOCORTIN_RECEPTOR_BINDING,0.788509886058981
GSE37532_WT_VS_PPARG_KO_VISC...3,SET,180,0.10695,0.010537,0.065224,0.05054,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN,0.788509886058981
MIR433_3P,SET,127,0.12603,0.010445,0.076873,0.050567,MIR433_3P,0.788509886058981
MIR215_5P,SET,34,0.23962,0.010302,0.14619,0.050605,MIR215_5P,0.788509886058981
GSE24574_NAIVE_VS_TCONV_CD4_...1,SET,185,0.095601,0.0095477,0.058334,0.05063,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN,0.788509886058981
GOBP_POSITIVE_REGULATION_OF_...825,SET,6,0.59485,0.010751,0.36298,0.050635,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.788509886058981
GOBP_POSITIVE_REGULATION_OF_...396,SET,23,0.29575,0.010461,0.18047,0.050639,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.788509886058981
GOBP_PROTEIN_TARGETING_TO_MI...,SET,96,0.13324,0.0096091,0.081312,0.050654,GOBP_PROTEIN_TARGETING_TO_MITOCHONDRION,0.788509886058981
HP_LOBULATED_TONGUE,SET,15,0.31384,0.0089667,0.19153,0.050656,HP_LOBULATED_TONGUE,0.788509886058981
GOBP_POSITIVE_REGULATION_OF_...639,SET,5,0.74195,0.012242,0.45289,0.050692,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE,0.788509886058981
GOBP_MEIOTIC_CELL_CYCLE_PROC...1,SET,189,0.09581,0.0096705,0.058486,0.050702,GOBP_MEIOTIC_CELL_CYCLE_PROCESS,0.788509886058981
GSE360_HIGH_DOSE_B_MALAYI_VS...2,SET,175,0.10335,0.010041,0.063105,0.050751,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,0.788509886058981
RUBENSTEIN_SKELETAL_MUSCLE_B...,SET,154,0.11027,0.010057,0.067337,0.050758,RUBENSTEIN_SKELETAL_MUSCLE_B_CELLS,0.788509886058981
KIM_GLIS2_TARGETS_UP,SET,81,0.16962,0.011241,0.10359,0.050769,KIM_GLIS2_TARGETS_UP,0.788509886058981
MIR4699_5P,SET,95,0.14404,0.010334,0.087967,0.050775,MIR4699_5P,0.788509886058981
GGCGGCA_MIR371,SET,5,0.56286,0.009287,0.34379,0.050804,GGCGGCA_MIR371,0.788607869584636
MIR1284,SET,214,0.096882,0.010398,0.059195,0.050858,MIR1284,0.788839288581624
HP_ABNORMALITY_OF_COMPLEMENT...,SET,49,0.20834,0.010749,0.12731,0.050873,HP_ABNORMALITY_OF_COMPLEMENT_SYSTEM,0.788839288581624
MIR6762_5P,SET,54,0.18848,0.010206,0.11518,0.050887,MIR6762_5P,0.788839288581624
PETRETTO_BLOOD_PRESSURE_UP,SET,11,0.38943,0.009529,0.23813,0.050997,PETRETTO_BLOOD_PRESSURE_UP,0.789909376606684
GOBP_ISOLEUCINE_TRANSPORT,SET,5,0.61719,0.010184,0.37765,0.051107,GOBP_ISOLEUCINE_TRANSPORT,0.789909376606684
WP_LIVER_X_RECEPTOR_PATHWAY,SET,10,0.4509,0.01052,0.27591,0.051114,WP_LIVER_X_RECEPTOR_PATHWAY,0.789909376606684
GSE15930_NAIVE_VS_48H_IN_VIT...3,SET,181,0.096026,0.009487,0.05876,0.051118,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,0.789909376606684
GSE17721_PAM3CSK4_VS_CPG_12H...2,SET,174,0.098492,0.0095425,0.060301,0.051207,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_UP,0.789909376606684
GOBP_L_HISTIDINE_TRANSMEMBRA...,SET,4,0.7506,0.011077,0.45956,0.051214,GOBP_L_HISTIDINE_TRANSMEMBRANE_TRANSPORT,0.789909376606684
GSE7460_WT_VS_FOXP3_HET_ACT_...1,SET,183,0.10085,0.010018,0.061758,0.051246,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN,0.789909376606684
MIR9903,SET,44,0.20591,0.010068,0.12611,0.051271,MIR9903,0.789909376606684
GSE3203_INFLUENZA_INF_VS_IFN...1,SET,172,0.10574,0.010186,0.064765,0.051273,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_DN,0.789909376606684
GOBP_POSITIVE_REGULATION_OF_...126,SET,428,0.070178,0.010589,0.042987,0.051292,GOBP_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT,0.789909376606684
MIR6805_5P,SET,40,0.20237,0.0094355,0.12398,0.051313,MIR6805_5P,0.789909376606684
SA_PTEN_PATHWAY,SET,17,0.30881,0.0093922,0.18919,0.051322,SA_PTEN_PATHWAY,0.789909376606684
HP_NEVUS_FLAMMEUS_OF_THE_FOR...,SET,6,0.58727,0.010614,0.35984,0.051347,HP_NEVUS_FLAMMEUS_OF_THE_FOREHEAD,0.789909376606684
TAKADA_GASTRIC_CANCER_COPY_N...1,SET,28,0.31503,0.012293,0.19304,0.051358,TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,0.789909376606684
HP_NORMAL_INTERICTAL_EEG,SET,6,0.56849,0.010275,0.34837,0.051365,HP_NORMAL_INTERICTAL_EEG,0.789909376606684
REACTOME_SERINE_BIOSYNTHESIS,SET,9,0.42232,0.0093477,0.25889,0.051425,REACTOME_SERINE_BIOSYNTHESIS,0.789909376606684
GOMF_ANTIOXIDANT_ACTIVITY,SET,72,0.16703,0.010439,0.1024,0.051432,GOMF_ANTIOXIDANT_ACTIVITY,0.789909376606684
GOBP_GALACTOSE_TRANSMEMBRANE...,SET,4,0.79255,0.011697,0.48591,0.051448,GOBP_GALACTOSE_TRANSMEMBRANE_TRANSPORT,0.789909376606684
GOBP_CHONDROITIN_SULFATE_PRO...2,SET,29,0.24749,0.0098278,0.15174,0.051455,GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,0.789909376606684
GAVISH_3CA_MALIGNANT_METAPRO...13,SET,48,0.2058,0.010508,0.12618,0.051456,GAVISH_3CA_MALIGNANT_METAPROGRAM_22_SECRETED_1,0.789909376606684
GSE6259_33D1_POS_DC_VS_CD4_T...1,SET,163,0.10749,0.010083,0.065936,0.05153,GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN,0.789909376606684
GSE4748_CYANOBACTERIUM_LPSLI...2,SET,166,0.11117,0.010522,0.068198,0.051556,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.789909376606684
WEINMANN_ADAPTATION_TO_HYPOX...1,SET,37,0.2462,0.011041,0.15109,0.051605,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,0.789909376606684
IRF7_01,SET,224,0.097041,0.010653,0.059559,0.051631,IRF7_01,0.789909376606684
GOCC_CYTOPLASMIC_SIDE_OF_END...1,SET,18,0.28299,0.0088562,0.17369,0.051638,GOCC_CYTOPLASMIC_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,0.789909376606684
HP_ABNORMAL_MORPHOLOGY_OF_TH...2,SET,24,0.27994,0.010114,0.17187,0.051685,HP_ABNORMAL_MORPHOLOGY_OF_THE_CHOROIDAL_VASCULATURE,0.789909376606684
HP_LOSS_OF_SUBCUTANEOUS_ADIP...,SET,9,0.46993,0.010401,0.28859,0.051732,HP_LOSS_OF_SUBCUTANEOUS_ADIPOSE_TISSUE_IN_LIMBS,0.789909376606684
GOBP_RESPONSE_TO_INTERLEUKIN...2,SET,12,0.40476,0.010344,0.24859,0.051749,GOBP_RESPONSE_TO_INTERLEUKIN_12,0.789909376606684
MODULE_453,SET,40,0.20036,0.0093414,0.12305,0.051751,MODULE_453,0.789909376606684
GOBP_PANTOTHENATE_METABOLIC_...,SET,7,0.52856,0.010318,0.32465,0.051758,GOBP_PANTOTHENATE_METABOLIC_PROCESS,0.789909376606684
GSE360_L_MAJOR_VS_B_MALAYI_L...4,SET,178,0.10085,0.0098812,0.061941,0.051758,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.789909376606684
GOBP_NEGATIVE_REGULATION_OF_...234,SET,48,0.21659,0.01106,0.1331,0.051846,GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.789909376606684
ZNF768_TARGET_GENES,SET,1013,0.044547,0.010171,0.027379,0.051872,ZNF768_TARGET_GENES,0.789909376606684
SA_REG_CASCADE_OF_CYCLIN_EXPR,SET,13,0.37752,0.010042,0.23203,0.051875,SA_REG_CASCADE_OF_CYCLIN_EXPR,0.789909376606684
GSE36888_UNTREATED_VS_IL2_TR...5,SET,178,0.10045,0.0098424,0.061759,0.05193,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_DN,0.789909376606684
NKX25_01,SET,109,0.13567,0.010422,0.083414,0.051938,NKX25_01,0.789909376606684
GOBP_GLOMERULAR_MESANGIAL_CE...1,SET,4,0.68187,0.010063,0.41928,0.051952,GOBP_GLOMERULAR_MESANGIAL_CELL_DEVELOPMENT,0.789909376606684
FAN_OVARY_CL10_PUTATIVE_EARL...,SET,225,0.084346,0.0092796,0.051871,0.051977,FAN_OVARY_CL10_PUTATIVE_EARLY_ATRESIA_GRANULOSA_CELL,0.789909376606684
GOBP_PRESYNAPTIC_MEMBRANE_OR...,SET,6,0.5958,0.010769,0.36643,0.051986,GOBP_PRESYNAPTIC_MEMBRANE_ORGANIZATION,0.789909376606684
HP_ABNORMAL_PLATELET_VOLUME,SET,25,0.27574,0.010168,0.16962,0.052027,HP_ABNORMAL_PLATELET_VOLUME,0.789909376606684
GSE43955_1H_VS_20H_ACT_CD4_T...3,SET,187,0.10658,0.010701,0.065585,0.052086,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.789909376606684
GOMF_CATALYTIC_ACTIVITY_ACTI...6,SET,341,0.069032,0.0093199,0.042491,0.052128,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_RNA,0.789909376606684
KOYAMA_SEMA3B_TARGETS_DN,SET,319,0.077652,0.010146,0.047799,0.052137,KOYAMA_SEMA3B_TARGETS_DN,0.789909376606684
ATGAAGG_MIR205,SET,139,0.11317,0.0098098,0.069666,0.05214,ATGAAGG_MIR205,0.789909376606684
GSE411_WT_VS_SOCS3_KO_MACROP...4,SET,182,0.099123,0.0098197,0.061018,0.052145,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_DN,0.789909376606684
GSE1432_CTRL_VS_IFNG_24H_MIC...1,SET,182,0.10709,0.010609,0.065925,0.052146,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.789909376606684
GAVISH_3CA_METAPROGRAM_EPITH...23,SET,45,0.22191,0.010972,0.13661,0.052151,GAVISH_3CA_METAPROGRAM_EPITHELIAL_STRESS,0.789909376606684
GOMF_MONOATOMIC_ANION_MONOAT...,SET,24,0.28117,0.010159,0.17309,0.052151,GOMF_MONOATOMIC_ANION_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.789909376606684
GSE13738_RESTING_VS_BYSTANDE...1,SET,173,0.10592,0.010233,0.065208,0.052161,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,0.789909376606684
GOCC_CYTOPLASMIC_SIDE_OF_END...2,SET,6,0.45311,0.0081896,0.27899,0.052184,GOCC_CYTOPLASMIC_SIDE_OF_ENDOSOME_MEMBRANE,0.789909376606684
MARKS_ACETYLATED_NON_HISTONE...,SET,11,0.39074,0.009561,0.24067,0.052245,MARKS_ACETYLATED_NON_HISTONE_PROTEINS,0.789909376606684
HARALAMBIEVA_PBMC_M_M_R_II_A...4,SET,11,0.46565,0.011394,0.28682,0.052252,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_LOW_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_DN,0.789909376606684
NAKAYA_PBMC_FLUAD_IMUVAC_MAL...,SET,17,0.32063,0.0097516,0.1975,0.052256,NAKAYA_PBMC_FLUAD_IMUVAC_MALE_AGE_14_27YO_CORRELATED_WITH_HAI_RESPONSE_MF59_ADJUVANTED_AND_NON_1DY_GENES_IN_BTM_M75_POSITIVE,0.789909376606684
MORF_PRKAR1A,SET,125,0.11494,0.0094514,0.070836,0.052342,MORF_PRKAR1A,0.789909376606684
WP_CYTOSOLIC_DNASENSING_PATH...,SET,62,0.17507,0.010156,0.1079,0.052357,WP_CYTOSOLIC_DNASENSING_PATHWAY,0.789909376606684
GSE25123_CTRL_VS_ROSIGLITAZO...2,SET,183,0.098907,0.0098249,0.06096,0.052358,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.789909376606684
MIR874_3P,SET,49,0.18179,0.0093787,0.11205,0.052366,MIR874_3P,0.789909376606684
IGARASHI_ATF4_TARGETS_DN,SET,88,0.14612,0.010092,0.090069,0.052372,IGARASHI_ATF4_TARGETS_DN,0.789909376606684
REACTOME_ERKS_ARE_INACTIVATED,SET,13,0.36623,0.0097413,0.22578,0.052403,REACTOME_ERKS_ARE_INACTIVATED,0.789909376606684
HP_MALE_PSEUDOHERMAPHRODITISM,SET,36,0.21583,0.0095475,0.13309,0.052444,HP_MALE_PSEUDOHERMAPHRODITISM,0.789909376606684
GRANDVAUX_IRF3_TARGETS_DN,SET,17,0.35887,0.010915,0.22131,0.052457,GRANDVAUX_IRF3_TARGETS_DN,0.789909376606684
GOBP_ERBB4_SIGNALING_PATHWAY,SET,9,0.4381,0.0096971,0.27017,0.052457,GOBP_ERBB4_SIGNALING_PATHWAY,0.789909376606684
HAY_BONE_MARROW_CD34_POS_LYM...,SET,7,0.60718,0.011853,0.37445,0.052461,HAY_BONE_MARROW_CD34_POS_LYMPHOID_UNK,0.789909376606684
HP_PELVIC_GIRDLE_MUSCLE_WEAK...,SET,42,0.20767,0.0099211,0.12809,0.052478,HP_PELVIC_GIRDLE_MUSCLE_WEAKNESS,0.789909376606684
GOBP_PHOSPHOLIPID_DEPHOSPHOR...,SET,27,0.22146,0.0084863,0.1366,0.052493,GOBP_PHOSPHOLIPID_DEPHOSPHORYLATION,0.789909376606684
REACTOME_NEGATIVE_FEEDBACK_R...,SET,6,0.56895,0.010283,0.35094,0.052495,REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY,0.789909376606684
GSE22886_NAIVE_BCELL_VS_BLOO...2,SET,174,0.10252,0.0099322,0.063238,0.052507,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP,0.789909376606684
GOMF_ALCOHOL_TRANSMEMBRANE_T...,SET,6,0.57548,0.010401,0.355,0.052509,GOMF_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.789909376606684
GOCC_CHROMOSOME_CENTROMERIC_...2,SET,219,0.089703,0.0097381,0.055352,0.052564,GOCC_CHROMOSOME_CENTROMERIC_REGION,0.789909376606684
MIR193A_3P_MIR193B_3P,SET,79,0.1542,0.010093,0.095205,0.052658,MIR193A_3P_MIR193B_3P,0.789909376606684
MIR1273C,SET,6,0.51901,0.0093807,0.32049,0.052686,MIR1273C,0.789909376606684
GSE15930_STIM_VS_STIM_AND_TR...6,SET,180,0.095168,0.0093765,0.058779,0.052723,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP,0.789909376606684
GOBP_SENSORY_PERCEPTION_OF_T...3,SET,5,0.60098,0.009916,0.37124,0.052748,GOBP_SENSORY_PERCEPTION_OF_TOUCH,0.789909376606684
REACTOME_DEFECTIVE_GALNT3_CA...,SET,14,0.38255,0.010559,0.23631,0.052754,REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC,0.789909376606684
GOBP_REGULATION_OF_MRNA_PROC...,SET,117,0.11467,0.0091241,0.070834,0.052756,GOBP_REGULATION_OF_MRNA_PROCESSING,0.789909376606684
TCGA_GLIOBLASTOMA_COPY_NUMBE...1,SET,28,0.35921,0.014017,0.22191,0.05276,TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,0.789909376606684
REACTOME_FORMATION_OF_TUBULI...,SET,24,0.26268,0.0094909,0.16228,0.052767,REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC,0.789909376606684
HP_ABNORMALITY_OF_HAIR_PIGME...,SET,109,0.13397,0.010292,0.082779,0.052792,HP_ABNORMALITY_OF_HAIR_PIGMENTATION,0.789909376606684
HP_MULTIPLE_RENAL_CYSTS,SET,67,0.17467,0.010532,0.10793,0.052799,HP_MULTIPLE_RENAL_CYSTS,0.789909376606684
HP_NEOPLASM_OF_THE_EAR,SET,22,0.28083,0.0097151,0.17353,0.052804,HP_NEOPLASM_OF_THE_EAR,0.789909376606684
HOFFMANN_PRE_BI_TO_LARGE_PRE...1,SET,73,0.16421,0.010333,0.10148,0.052827,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,0.789909376606684
REACTOME_INFECTION_WITH_MYCO...,SET,25,0.2658,0.0098011,0.16427,0.052837,REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS,0.789909376606684
GOMF_MONOATOMIC_ANION_SODIUM...,SET,17,0.37005,0.011255,0.22872,0.052844,GOMF_MONOATOMIC_ANION_SODIUM_SYMPORTER_ACTIVITY,0.789909376606684
GSE21927_SPLEEN_VS_C26GM_TUM...2,SET,137,0.12297,0.010582,0.076024,0.052896,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_UP,0.789909376606684
BURTON_ADIPOGENESIS_PEAK_AT_...2,SET,39,0.19878,0.0091514,0.12291,0.052922,BURTON_ADIPOGENESIS_PEAK_AT_16HR,0.789909376606684
PID_PI3K_PLC_TRK_PATHWAY,SET,36,0.23392,0.010348,0.14465,0.052929,PID_PI3K_PLC_TRK_PATHWAY,0.789909376606684
BIOCARTA_RACCYCD_PATHWAY,SET,25,0.25949,0.0095687,0.16051,0.052982,BIOCARTA_RACCYCD_PATHWAY,0.789909376606684
HP_FOCAL_MOTOR_STATUS_EPILEP...,SET,13,0.38855,0.010335,0.24034,0.052984,HP_FOCAL_MOTOR_STATUS_EPILEPTICUS,0.789909376606684
GOBP_NEGATIVE_REGULATION_OF_...281,SET,14,0.44772,0.012358,0.27697,0.053001,GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.789909376606684
MODULE_567,SET,90,0.13735,0.0095923,0.084966,0.053005,MODULE_567,0.789909376606684
GSE360_L_DONOVANI_VS_B_MALAY...2,SET,173,0.10692,0.01033,0.066155,0.05303,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP,0.789909376606684
MIR6878_3P,SET,59,0.17863,0.010109,0.11053,0.053047,MIR6878_3P,0.789909376606684
GOBP_RRNA_PROCESSING,SET,194,0.08956,0.0091572,0.055431,0.053089,GOBP_RRNA_PROCESSING,0.790196229122056
HP_NEUROPATHIC_ARTHROPATHY,SET,5,0.53928,0.008898,0.33386,0.053135,HP_NEUROPATHIC_ARTHROPATHY,0.790204075738126
HP_TROPHIC_CHANGES_RELATED_T...,SET,5,0.53928,0.008898,0.33386,0.053135,HP_TROPHIC_CHANGES_RELATED_TO_PAIN,0.790204075738126
GSE12707_AT16L1_HYPOMORPH_VS...2,SET,111,0.13653,0.010583,0.084586,0.053267,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_UP,0.791828308383234
GOBP_REGULATION_OF_CILIUM_DE...,SET,27,0.2651,0.010158,0.16433,0.053353,GOBP_REGULATION_OF_CILIUM_DEPENDENT_CELL_MOTILITY,0.792227017506405
REACTOME_FCERI_MEDIATED_CA_2...,SET,30,0.24028,0.0097045,0.14894,0.053355,REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION,0.792227017506405
GOUYER_TATI_TARGETS_DN,SET,17,0.32811,0.0099792,0.2034,0.05337,GOUYER_TATI_TARGETS_DN,0.792227017506405
MIR6089,SET,16,0.33802,0.0099739,0.20956,0.053385,MIR6089,0.792227017506405
HE_LIM_SUN_FETAL_LUNG_C5_PRO...,SET,407,0.065845,0.009694,0.040833,0.05343,HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL,0.792250970149254
DANG_BOUND_BY_MYC,SET,941,0.043239,0.0095345,0.026816,0.053441,DANG_BOUND_BY_MYC,0.792250970149254
GOMF_SOMATOSTATIN_RECEPTOR_A...,SET,5,0.76103,0.012557,0.47201,0.053455,GOMF_SOMATOSTATIN_RECEPTOR_ACTIVITY,0.792250970149254
HOWARD_B_CELL_INACT_MONOV_IN...,SET,14,0.35214,0.0097201,0.21857,0.053588,HOWARD_B_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.792904797958316
KEGG_GLYCOSAMINOGLYCAN_BIOSY...3,SET,15,0.38513,0.011003,0.23908,0.053607,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,0.792904797958316
GSE20198_UNTREATED_VS_IFNA_T...2,SET,186,0.097115,0.0097249,0.060288,0.053616,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.792904797958316
HP_SMALL_PLACENTA,SET,9,0.48413,0.010716,0.30057,0.05363,HP_SMALL_PLACENTA,0.792904797958316
HP_PROGRESSIVE_SPASTIC_PARAP...1,SET,5,0.54674,0.0090211,0.33945,0.053634,HP_PROGRESSIVE_SPASTIC_PARAPARESIS,0.792904797958316
ZNF584_TARGET_GENES,SET,284,0.079735,0.0098395,0.049504,0.053636,ZNF584_TARGET_GENES,0.792904797958316
GSE33424_CD161_HIGH_VS_INT_C...2,SET,183,0.10466,0.010397,0.065012,0.053718,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP,0.7932839660946
GOBP_REGULATION_OF_NON_CANON...1,SET,87,0.14428,0.0099081,0.089631,0.053737,GOBP_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.7932839660946
HP_LOWER_LIMB_AMYOTROPHY,SET,69,0.16812,0.010287,0.10447,0.05379,HP_LOWER_LIMB_AMYOTROPHY,0.7932839660946
GOBP_REGULATION_OF_PROTEIN_O...,SET,5,0.60482,0.0099794,0.37596,0.053846,GOBP_REGULATION_OF_PROTEIN_OLIGOMERIZATION,0.7932839660946
GSE23308_CTRL_VS_CORTICOSTER...3,SET,185,0.096553,0.0096428,0.060023,0.05386,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_UP,0.7932839660946
KEGG_MEDICUS_REFERENCE_LIGHT...,SET,9,0.41266,0.0091339,0.25655,0.05387,KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY,0.7932839660946
GNF2_PRDX2,SET,27,0.26794,0.010267,0.16658,0.05388,GNF2_PRDX2,0.7932839660946
TRAVAGLINI_LUNG_OLR1_CLASSIC...,SET,652,0.055718,0.010311,0.034648,0.053911,TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL,0.7932839660946
HP_PECTUS_EXCAVATUM,SET,263,0.082154,0.0097617,0.051093,0.053935,HP_PECTUS_EXCAVATUM,0.7932839660946
GSE3039_NKT_CELL_VS_B1_BCELL...1,SET,173,0.10487,0.010132,0.065258,0.054034,GSE3039_NKT_CELL_VS_B1_BCELL_DN,0.7932839660946
GSE18281_CORTICAL_THYMOCYTE_...1,SET,177,0.094589,0.0092422,0.058861,0.054037,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN,0.7932839660946
MYLLYKANGAS_AMPLIFICATION_HO...7,SET,6,0.53921,0.0097457,0.33559,0.054065,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21,0.7932839660946
HP_HYPOPLASTIC_FRONTAL_SINUS...,SET,6,0.5628,0.010172,0.35028,0.054066,HP_HYPOPLASTIC_FRONTAL_SINUSES,0.7932839660946
HP_ATLANTOAXIAL_DISLOCATION,SET,6,0.50546,0.0091357,0.3146,0.054073,HP_ATLANTOAXIAL_DISLOCATION,0.7932839660946
chr1p34,SET,154,0.23271,0.021223,0.14484,0.054075,chr1p34,0.7932839660946
HP_ABNORMALITY_OF_MOUTH_SHAPE,SET,240,0.08777,0.0099688,0.054645,0.054125,HP_ABNORMALITY_OF_MOUTH_SHAPE,0.7932839660946
HP_MUSCLE_ABNORMALITY_RELATE...,SET,63,0.15311,0.0089534,0.095331,0.054132,HP_MUSCLE_ABNORMALITY_RELATED_TO_MITOCHONDRIAL_DYSFUNCTION,0.7932839660946
GOMF_CARD_DOMAIN_BINDING,SET,15,0.33052,0.0094432,0.20581,0.054148,GOMF_CARD_DOMAIN_BINDING,0.7932839660946
SF1_Q6,SET,233,0.08924,0.0099889,0.055574,0.05417,SF1_Q6,0.7932839660946
KEGG_B_CELL_RECEPTOR_SIGNALI...,SET,72,0.16112,0.01007,0.10034,0.054182,KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.7932839660946
BIOCARTA_TRKA_PATHWAY,SET,14,0.33501,0.0092471,0.20864,0.054185,BIOCARTA_TRKA_PATHWAY,0.7932839660946
NABA_MATRISOME_POORLY_METAST...2,SET,12,0.39142,0.010003,0.24382,0.054214,NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED,0.7932839660946
HP_ABNORMALITY_OF_MUSCLE_SIZE,SET,635,0.053877,0.0098447,0.033566,0.054244,HP_ABNORMALITY_OF_MUSCLE_SIZE,0.7932839660946
HP_ABNORMAL_RECTUM_MORPHOLOGY,SET,124,0.12161,0.0099598,0.075779,0.054281,HP_ABNORMAL_RECTUM_MORPHOLOGY,0.7932839660946
HTF_01,SET,65,0.15553,0.0092376,0.096934,0.054308,HTF_01,0.7932839660946
GOCC_DYNEIN_AXONEMAL_PARTICLE,SET,14,0.34025,0.0093919,0.21207,0.054315,GOCC_DYNEIN_AXONEMAL_PARTICLE,0.7932839660946
GOCC_T_TUBULE,SET,52,0.19754,0.010498,0.12314,0.054348,GOCC_T_TUBULE,0.7932839660946
GOMF_4_GALACTOSYL_N_ACETYLGL...,SET,6,0.68995,0.01247,0.43013,0.054359,GOMF_4_GALACTOSYL_N_ACETYLGLUCOSAMINIDE_3_ALPHA_L_FUCOSYLTRANSFERASE_ACTIVITY,0.7932839660946
ZHU_CMV_ALL_DN,SET,108,0.13726,0.010496,0.085576,0.054367,ZHU_CMV_ALL_DN,0.7932839660946
MANNO_MIDBRAIN_NEUROTYPES_HR...1,SET,316,0.08145,0.010593,0.050786,0.05439,MANNO_MIDBRAIN_NEUROTYPES_HRGL1,0.7932839660946
GOBP_POSITIVE_REGULATION_OF_...398,SET,30,0.24896,0.010055,0.15524,0.054395,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.7932839660946
GOBP_NUCLEOTIDE_BINDING_DOMA...,SET,26,0.26495,0.0099632,0.16521,0.0544,GOBP_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.7932839660946
GSE1448_ANTI_VALPHA2_VS_VBET...1,SET,178,0.10378,0.010169,0.064733,0.054455,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN,0.7932839660946
GOCC_SECRETORY_GRANULE_MEMBR...,SET,291,0.081681,0.010201,0.050953,0.05447,GOCC_SECRETORY_GRANULE_MEMBRANE,0.7932839660946
GUTIERREZ_WALDENSTROEMS_MACR...1,SET,8,0.52461,0.010948,0.32732,0.054504,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN,0.7932839660946
MODULE_424,SET,17,0.33977,0.010334,0.21201,0.054516,MODULE_424,0.7932839660946
GSE30971_CTRL_VS_LPS_STIM_MA...8,SET,173,0.11337,0.010952,0.070738,0.054519,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_UP,0.7932839660946
MEBARKI_HCC_PROGENITOR_WNT_U...2,SET,72,0.17463,0.010914,0.10897,0.054529,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,0.7932839660946
GSE28783_CTRL_ANTI_MIR_VS_UN...2,SET,171,0.1013,0.0097304,0.063225,0.054563,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,0.793446470711297
GOBP_CELLULAR_RESPONSE_TO_PO...,SET,12,0.43092,0.011013,0.26904,0.054619,GOBP_CELLULAR_RESPONSE_TO_POTASSIUM_ION,0.793814661371237
GOCC_ACTIN_FILAMENT_BUNDLE,SET,85,0.15007,0.010187,0.093705,0.054634,GOCC_ACTIN_FILAMENT_BUNDLE,0.793814661371237
HP_THICKENED_CORTEX_OF_LONG_...,SET,14,0.36053,0.0099516,0.22514,0.054657,HP_THICKENED_CORTEX_OF_LONG_BONES,0.793816980777267
MODULE_329,SET,50,0.19546,0.010186,0.1221,0.054715,MODULE_329,0.794327412280702
GSE19941_IL10_KO_VS_IL10_KO_...1,SET,150,0.1035,0.0093164,0.064666,0.054753,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN,0.794505682387312
HP_LIMITATION_OF_MOVEMENT_AT...,SET,5,0.67911,0.011205,0.42436,0.054773,HP_LIMITATION_OF_MOVEMENT_AT_ANKLES,0.794505682387312
MIR885_3P,SET,26,0.25727,0.0096743,0.16079,0.054803,MIR885_3P,0.794609205256571
HP_SPONDYLOEPIMETAPHYSEAL_DY...,SET,15,0.34206,0.0097728,0.21381,0.054826,HP_SPONDYLOEPIMETAPHYSEAL_DYSPLASIA,0.794611188490409
GNF2_MCM5,SET,54,0.17967,0.0097295,0.11235,0.054891,GNF2_MCM5,0.794617128279883
CUI_DEVELOPING_HEART_TRABECU...2,SET,99,0.13742,0.010064,0.08593,0.054892,CUI_DEVELOPING_HEART_TRABECULAR_VENTRICULAR_CARDIOMYOCYTE,0.794617128279883
GSE28130_ACTIVATED_VS_INDUCE...2,SET,175,0.10393,0.010098,0.064986,0.054895,GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP,0.794617128279883
NRSF_01,SET,93,0.14509,0.0103,0.090747,0.054942,NRSF_01,0.794827981765437
GOBP_REGULATION_OF_CALCINEUR...,SET,40,0.20528,0.0095708,0.12841,0.054958,GOBP_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,0.794827981765437
MURARO_PANCREAS_PANCREATIC_P...,SET,134,0.12741,0.010845,0.079714,0.05499,MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL,0.794827981765437
NIKOLSKY_BREAST_CANCER_14Q22...,SET,12,0.56929,0.014549,0.35621,0.055007,NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON,0.794827981765437
REACTOME_NR1H2_NR1H3_REGULAT...3,SET,5,0.48894,0.0080675,0.306,0.055049,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE,0.794827981765437
GOBP_PROTEIN_LOCALIZATION_TO...32,SET,116,0.11933,0.0094547,0.074691,0.055071,GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.794827981765437
HP_ABNORMAL_RENAL_COLLECTING...,SET,24,0.25654,0.009269,0.16058,0.055078,HP_ABNORMAL_RENAL_COLLECTING_SYSTEM_MORPHOLOGY,0.794827981765437
KEGG_BIOSYNTHESIS_OF_UNSATUR...,SET,22,0.30923,0.010698,0.1936,0.055112,KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS,0.794827981765437
GSE27786_LIN_NEG_VS_CD8_TCEL...1,SET,185,0.097815,0.0097689,0.061248,0.055139,GSE27786_LIN_NEG_VS_CD8_TCELL_DN,0.794827981765437
HP_NEOPLASM_OF_THE_INNER_EAR,SET,8,0.4418,0.0092199,0.27667,0.055157,HP_NEOPLASM_OF_THE_INNER_EAR,0.794827981765437
GSE17974_IL4_AND_ANTI_IL12_V...10,SET,155,0.11011,0.010074,0.068959,0.055178,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP,0.794827981765437
GSE19888_ADENOSINE_A3R_ACT_V...4,SET,164,0.10022,0.0094293,0.06277,0.055184,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP,0.794827981765437
PID_SHP2_PATHWAY,SET,55,0.19213,0.0105,0.12037,0.055224,PID_SHP2_PATHWAY,0.795074614747307
WP_NONSMALL_CELL_LUNG_CANCER,SET,71,0.15861,0.0098439,0.099405,0.055299,WP_NONSMALL_CELL_LUNG_CANCER,0.7954681836988
GSE21063_CTRL_VS_ANTI_IGM_ST...8,SET,181,0.10244,0.010121,0.064208,0.055307,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_UP,0.7954681836988
REACTOME_DECTIN_2_FAMILY,SET,19,0.32358,0.010404,0.20282,0.05532,REACTOME_DECTIN_2_FAMILY,0.7954681836988
GOBP_RENAL_PROTEIN_ABSORPTION,SET,9,0.50267,0.011126,0.31521,0.055396,GOBP_RENAL_PROTEIN_ABSORPTION,0.79564125
DIAZ_CHRONIC_MYELOGENOUS_LEU...1,SET,106,0.13833,0.01048,0.086751,0.055418,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,0.79564125
GSE22886_UNSTIM_VS_IL15_STIM...1,SET,183,0.095392,0.0094758,0.059837,0.055455,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN,0.79564125
KEGG_MEDICUS_PATHOGEN_HCV_CO...1,SET,12,0.41946,0.01072,0.26315,0.055473,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY,0.79564125
GOBP_NEGATIVE_REGULATION_OF_...264,SET,8,0.47147,0.0098391,0.29584,0.055512,GOBP_NEGATIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,0.79564125
MIR4765,SET,44,0.20463,0.010005,0.12841,0.055529,MIR4765,0.79564125
HP_PROXIMAL_MUSCLE_WEAKNESS,SET,219,0.091122,0.0098921,0.057192,0.055559,HP_PROXIMAL_MUSCLE_WEAKNESS,0.79564125
KEGG_MEDICUS_REFERENCE_AREG_...2,SET,14,0.35459,0.0097877,0.22258,0.055576,KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.79564125
GSE17301_IFNA2_VS_IFNA5_STIM...1,SET,174,0.10375,0.010052,0.065131,0.055595,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN,0.79564125
GOBP_ACTIVATION_OF_JANUS_KIN...,SET,13,0.37788,0.010051,0.23724,0.055609,GOBP_ACTIVATION_OF_JANUS_KINASE_ACTIVITY,0.79564125
GOBP_REGULATION_OF_RUFFLE_AS...,SET,29,0.26283,0.010437,0.16506,0.055658,GOBP_REGULATION_OF_RUFFLE_ASSEMBLY,0.79564125
GSE42021_TREG_VS_TCONV_PLN_DN,SET,179,0.10052,0.0098763,0.063178,0.055809,GSE42021_TREG_VS_TCONV_PLN_DN,0.79564125
GOCC_LAMELLIPODIUM,SET,187,0.094466,0.0094847,0.059375,0.055813,GOCC_LAMELLIPODIUM,0.79564125
GSE36078_WT_VS_IL1R_KO_LUNG_...6,SET,183,0.098726,0.0098069,0.062062,0.055841,GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP,0.79564125
KEGG_MEDICUS_VARIANT_AMPLIFI...3,SET,8,0.47342,0.0098799,0.29763,0.055856,KEGG_MEDICUS_VARIANT_AMPLIFIED_CDK4_TO_CELL_CYCLE_G1_S,0.79564125
REACTOME_TERMINATION_OF_TRAN...,SET,30,0.21748,0.0087838,0.13674,0.055871,REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS,0.79564125
WP_HDAC6_INTERACTIONS_IN_THE...,SET,105,0.12459,0.0093946,0.078334,0.055873,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,0.79564125
GOBP_MEIOTIC_CELL_CYCLE_PHAS...,SET,13,0.3467,0.0092219,0.21798,0.055874,GOBP_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.79564125
KANG_DOXORUBICIN_RESISTANCE_...1,SET,16,0.34904,0.010299,0.21947,0.055881,KANG_DOXORUBICIN_RESISTANCE_DN,0.79564125
GOCC_CTF18_RFC_LIKE_COMPLEX,SET,8,0.44421,0.0092701,0.27932,0.05589,GOCC_CTF18_RFC_LIKE_COMPLEX,0.79564125
WP_RAC1PAK1P38MMP2_PATHWAY,SET,66,0.16471,0.0098572,0.10358,0.055904,WP_RAC1PAK1P38MMP2_PATHWAY,0.79564125
GOBP_REGULATION_OF_TORC2_SIG...,SET,4,0.65445,0.0096585,0.41161,0.05593,GOBP_REGULATION_OF_TORC2_SIGNALING,0.79564125
GOBP_GAMETE_GENERATION,SET,675,0.050872,0.009573,0.031996,0.055932,GOBP_GAMETE_GENERATION,0.79564125
HP_NEONATAL_HYPOTONIA,SET,169,0.10135,0.0096788,0.063749,0.055941,HP_NEONATAL_HYPOTONIA,0.79564125
GOMF_CARBOHYDRATE_PROTON_SYM...,SET,7,0.58476,0.011416,0.36788,0.055979,GOMF_CARBOHYDRATE_PROTON_SYMPORTER_ACTIVITY,0.79564125
HOLLEMAN_DAUNORUBICIN_B_ALL_...1,SET,12,0.3758,0.0096042,0.23643,0.055982,HOLLEMAN_DAUNORUBICIN_B_ALL_DN,0.79564125
MARTINEZ_RB1_AND_TP53_TARGET...1,SET,549,0.057697,0.0098265,0.036308,0.056027,MARTINEZ_RB1_AND_TP53_TARGETS_DN,0.79564125
GSE37416_0H_VS_48H_F_TULAREN...1,SET,168,0.099069,0.009433,0.062343,0.056027,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.79564125
GOCC_RIBOSOMAL_SUBUNIT,SET,166,0.099299,0.0093989,0.062503,0.056072,GOCC_RIBOSOMAL_SUBUNIT,0.79564125
TAYLOR_METHYLATED_IN_ACUTE_L...,SET,66,0.17625,0.010548,0.11095,0.056086,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,0.79564125
GSE22443_IL2_VS_IL12_TREATED...2,SET,185,0.099788,0.0099659,0.062816,0.056086,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_UP,0.79564125
HEB_Q6,SET,239,0.085893,0.0097356,0.054092,0.056163,HEB_Q6,0.79564125
MODULE_524,SET,27,0.26444,0.010133,0.16656,0.056198,MODULE_524,0.79564125
GSE35543_IN_VITRO_ITREG_VS_C...1,SET,178,0.099846,0.0097831,0.062899,0.056219,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_DN,0.79564125
GSE10273_HIGH_IL7_VS_HIGH_IL...2,SET,182,0.096949,0.0096044,0.061077,0.056228,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,0.79564125
GOBP_CENTRIOLE_ELONGATION,SET,7,0.46842,0.0091443,0.29513,0.05625,GOBP_CENTRIOLE_ELONGATION,0.79564125
GOBP_EOSINOPHIL_DIFFERENTIAT...,SET,6,0.57351,0.010366,0.36136,0.056253,GOBP_EOSINOPHIL_DIFFERENTIATION,0.79564125
GOCC_PROTEIN_DNA_COMPLEX,SET,1227,0.039617,0.0098931,0.024962,0.056256,GOCC_PROTEIN_DNA_COMPLEX,0.79564125
MIR4254,SET,92,0.13746,0.0097056,0.086619,0.056274,MIR4254,0.79564125
TFIII_Q6,SET,201,0.096735,0.010066,0.060959,0.056278,TFIII_Q6,0.79564125
MIR1973,SET,6,0.59055,0.010674,0.37228,0.056345,MIR1973,0.79564125
GSE22589_HEALTHY_VS_HIV_INFE...2,SET,188,0.09099,0.0091598,0.057366,0.056363,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP,0.79564125
LU_IL4_SIGNALING,SET,86,0.13835,0.009446,0.087226,0.056371,LU_IL4_SIGNALING,0.79564125
GOBP_RRNA_TRANSCRIPTION,SET,33,0.20546,0.0087023,0.12954,0.056371,GOBP_RRNA_TRANSCRIPTION,0.79564125
GOBP_CYTOPLASMIC_MICROTUBULE...,SET,58,0.17039,0.0095612,0.10743,0.056379,GOBP_CYTOPLASMIC_MICROTUBULE_ORGANIZATION,0.79564125
GSE17721_POLYIC_VS_GARDIQUIM...18,SET,185,0.098614,0.0098487,0.062187,0.056405,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP,0.79564125
GSE5589_WT_VS_IL10_KO_LPS_AN...4,SET,176,0.097598,0.0095095,0.061548,0.056408,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.79564125
GOBP_GENOMIC_IMPRINTING,SET,17,0.30277,0.0092084,0.19099,0.056461,GOBP_GENOMIC_IMPRINTING,0.796065742393509
GSE22601_DOUBLE_POSITIVE_VS_...1,SET,183,0.093101,0.0092482,0.058759,0.056553,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.796675289708266
WP_H19_RBE2F1_AND_CDKBETACAT...,SET,13,0.36829,0.0097962,0.23244,0.056554,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,0.796675289708266
GOMF_PEPTIDASE_REGULATOR_ACT...,SET,208,0.10017,0.010601,0.063224,0.056573,GOMF_PEPTIDASE_REGULATOR_ACTIVITY,0.796675289708266
RICHERT_PBMC_HIV_LIPO_5_AGE_...2,SET,5,0.62008,0.010231,0.39144,0.056596,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_INTERFERON_SUBSET_UP,0.796676379100851
GOBP_FEMALE_MEIOTIC_NUCLEAR_...,SET,32,0.24497,0.010218,0.15472,0.056688,GOBP_FEMALE_MEIOTIC_NUCLEAR_DIVISION,0.79762725
REACTOME_DISEASES_OF_MISMATC...,SET,5,0.44033,0.0072654,0.27819,0.056734,REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR,0.79762725
NAKAYA_PBMC_FLUARIX_FLUVIRIN...4,SET,488,0.057668,0.0092758,0.036444,0.05679,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.79762725
MODULE_18,SET,415,0.066093,0.0098235,0.04178,0.056843,MODULE_18,0.79762725
HEDENFALK_BREAST_CANCER_BRAC...1,SET,18,0.29161,0.0091258,0.18436,0.056861,HEDENFALK_BREAST_CANCER_BRACX_DN,0.79762725
GOBP_MITOCHONDRIAL_CALCIUM_I...2,SET,20,0.32209,0.010625,0.20364,0.056873,GOBP_MITOCHONDRIAL_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.79762725
GSE15330_LYMPHOID_MULTIPOTEN...1,SET,181,0.095431,0.0094283,0.060338,0.056878,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.79762725
GOBP_REGULATION_OF_NK_T_CELL...2,SET,6,0.61923,0.011192,0.39158,0.056907,GOBP_REGULATION_OF_NK_T_CELL_DIFFERENTIATION,0.79762725
HP_CEREBRAL_AMYLOID_ANGIOPAT...,SET,4,0.76205,0.011247,0.4819,0.056908,HP_CEREBRAL_AMYLOID_ANGIOPATHY,0.79762725
MIR7153_3P,SET,43,0.19821,0.0095809,0.12535,0.056915,MIR7153_3P,0.79762725
GOBP_REGULATION_OF_NEUTROPHI...2,SET,29,0.27245,0.010819,0.1723,0.056916,GOBP_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS,0.79762725
GOBP_ANTIGEN_PROCESSING_AND_...1,SET,104,0.14398,0.010805,0.091076,0.056962,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION,0.797684661563255
KEGG_SULFUR_METABOLISM,SET,11,0.39115,0.009571,0.24743,0.056966,KEGG_SULFUR_METABOLISM,0.797684661563255
REACTOME_SIGNALING_BY_ERBB4,SET,54,0.17251,0.0093419,0.10919,0.057064,REACTOME_SIGNALING_BY_ERBB4,0.797870912012857
HP_ABNORMAL_RENAL_TUBULAR_LU...,SET,5,0.6387,0.010538,0.40428,0.057082,HP_ABNORMAL_RENAL_TUBULAR_LUMEN_MORPHOLOGY,0.797870912012857
WP_PROTEOGLYCAN_BIOSYNTHESIS,SET,17,0.32301,0.009824,0.20447,0.05709,WP_PROTEOGLYCAN_BIOSYNTHESIS,0.797870912012857
GOBP_EPOXIDE_METABOLIC_PROCE...,SET,5,0.66782,0.011019,0.4228,0.057115,GOBP_EPOXIDE_METABOLIC_PROCESS,0.797870912012857
MIR873_3P,SET,55,0.17486,0.0095559,0.1107,0.057118,MIR873_3P,0.797870912012857
DAUER_STAT3_TARGETS_UP,SET,41,0.22769,0.010748,0.14417,0.057136,DAUER_STAT3_TARGETS_UP,0.797870912012857
BIOCARTA_FXR_PATHWAY,SET,7,0.51491,0.010052,0.32603,0.05714,BIOCARTA_FXR_PATHWAY,0.797870912012857
DESCARTES_FETAL_PANCREAS_ACI...,SET,68,0.17806,0.010816,0.11286,0.057318,DESCARTES_FETAL_PANCREAS_ACINAR_CELLS,0.798685161676647
GOBP_REGULATION_OF_PEPTIDYL_...5,SET,39,0.22047,0.01015,0.13976,0.057354,GOBP_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,0.798685161676647
GNF2_UBE2I,SET,36,0.22242,0.009839,0.14104,0.057401,GNF2_UBE2I,0.798685161676647
GSE3920_IFNA_VS_IFNG_TREATED...2,SET,153,0.10551,0.0095915,0.066911,0.057417,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.798685161676647
GOBP_VITAMIN_A_METABOLIC_PRO...,SET,8,0.52362,0.010927,0.3321,0.057443,GOBP_VITAMIN_A_METABOLIC_PROCESS,0.798685161676647
GSE15330_WT_VS_IKAROS_KO_HSC...2,SET,178,0.097845,0.009587,0.062065,0.057467,GSE15330_WT_VS_IKAROS_KO_HSC_UP,0.798685161676647
HP_THICKENED_CALVARIA,SET,32,0.23442,0.009778,0.14871,0.057471,HP_THICKENED_CALVARIA,0.798685161676647
PID_ERB_GENOMIC_PATHWAY,SET,14,0.33427,0.0092267,0.21205,0.05748,PID_ERB_GENOMIC_PATHWAY,0.798685161676647
GSE8868_SPLEEN_VS_INTESTINE_...2,SET,175,0.097003,0.0094249,0.061544,0.057503,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP,0.798685161676647
GAVISH_3CA_METAPROGRAM_B_CEL...5,SET,50,0.19506,0.010165,0.12376,0.057506,GAVISH_3CA_METAPROGRAM_B_CELLS_INTERFERON,0.798685161676647
HP_NEOPLASM_OF_THE_NERVOUS_S...,SET,184,0.094732,0.0094356,0.060109,0.057521,HP_NEOPLASM_OF_THE_NERVOUS_SYSTEM,0.798685161676647
MIR606,SET,87,0.14448,0.0099216,0.091675,0.057523,MIR606,0.798685161676647
HP_ABNORMAL_FEMALE_MEIOSIS,SET,6,0.53647,0.0096962,0.34041,0.057525,HP_ABNORMAL_FEMALE_MEIOSIS,0.798685161676647
GOBP_REGULATION_OF_FERTILIZA...,SET,16,0.33217,0.0098013,0.21078,0.057529,GOBP_REGULATION_OF_FERTILIZATION,0.798685161676647
WP_COMPLEMENT_AND_COAGULATIO...,SET,52,0.19222,0.010215,0.12199,0.05756,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.798685161676647
GOBP_SPINAL_CORD_ASSOCIATION...,SET,11,0.47166,0.011541,0.29935,0.057566,GOBP_SPINAL_CORD_ASSOCIATION_NEURON_DIFFERENTIATION,0.798685161676647
ATF3_Q6,SET,229,0.089116,0.0098901,0.056621,0.057763,ATF3_Q6,0.800029372759857
GOMF_RNA_POLYMERASE_II_SPECI...,SET,318,0.073734,0.0096193,0.046851,0.057774,GOMF_RNA_POLYMERASE_II_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING,0.800029372759857
GOBP_ESTABLISHMENT_OF_PLANAR...2,SET,15,0.36962,0.01056,0.23488,0.057792,GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_OF_EMBRYONIC_EPITHELIUM,0.800029372759857
REACTOME_DNA_METHYLATION,SET,5,0.64562,0.010653,0.41027,0.057794,REACTOME_DNA_METHYLATION,0.800029372759857
MARTORIATI_MDM4_TARGETS_FETA...2,SET,211,0.091152,0.0097152,0.057926,0.057798,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,0.800029372759857
KEGG_MEDICUS_VARIANT_AMPLIFI...1,SET,6,0.52178,0.0094307,0.33159,0.057801,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCND1_TO_CELL_CYCLE_G1_S,0.800029372759857
GOMF_HYDROLASE_ACTIVITY_ACTI...6,SET,11,0.40942,0.010018,0.26023,0.057829,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDINES,0.800098286226115
REACTOME_EXTRA_NUCLEAR_ESTRO...,SET,74,0.16291,0.010322,0.10358,0.057893,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,0.800650174950298
GSE2706_2H_VS_8H_LPS_STIM_DC...2,SET,178,0.099624,0.0097613,0.063356,0.057934,GSE2706_2H_VS_8H_LPS_STIM_DC_UP,0.800650174950298
GSE26928_NAIVE_VS_EFF_MEMORY...1,SET,168,0.098292,0.009359,0.062511,0.057938,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,0.800650174950298
E2F1_Q3_01,SET,220,0.088359,0.0096139,0.056222,0.058029,E2F1_Q3_01,0.801410219194313
HP_2_3_TOE_CUTANEOUS_SYNDACT...,SET,13,0.37305,0.009923,0.2374,0.058055,HP_2_3_TOE_CUTANEOUS_SYNDACTYLY,0.801410219194313
GOBP_DNA_STRAND_RESECTION_IN...,SET,9,0.46055,0.010194,0.29313,0.058084,GOBP_DNA_STRAND_RESECTION_INVOLVED_IN_REPLICATION_FORK_PROCESSING,0.801410219194313
FOXF2_TARGET_GENES,SET,7,0.46577,0.0090927,0.29651,0.058117,FOXF2_TARGET_GENES,0.801410219194313
GOMF_NEUROTROPHIN_RECEPTOR_A...,SET,5,0.64074,0.010572,0.4079,0.058122,GOMF_NEUROTROPHIN_RECEPTOR_ACTIVITY,0.801410219194313
FIGUEROA_AML_METHYLATION_CLU...9,SET,42,0.23214,0.01109,0.14784,0.058198,FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,0.801410219194313
PARK_APL_PATHOGENESIS_DN,SET,47,0.20246,0.01023,0.12898,0.05825,PARK_APL_PATHOGENESIS_DN,0.801410219194313
KEGG_CIRCADIAN_RHYTHM_MAMMAL,SET,12,0.43821,0.011199,0.27923,0.058291,KEGG_CIRCADIAN_RHYTHM_MAMMAL,0.801410219194313
FAN_OVARY_CL8_MATURE_CUMULUS...,SET,540,0.055844,0.009435,0.035587,0.058306,FAN_OVARY_CL8_MATURE_CUMULUS_GRANULOSA_CELL_2,0.801410219194313
GSE7218_IGM_VS_IGG_SIGNAL_TH...1,SET,161,0.10719,0.009993,0.06831,0.058317,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_DN,0.801410219194313
GAVISH_3CA_METAPROGRAM_FIBRO...12,SET,41,0.22545,0.010642,0.14368,0.05832,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_COMPLEMENT,0.801410219194313
GOBP_POSITIVE_REGULATION_OF_...809,SET,11,0.41004,0.010033,0.26133,0.058326,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION,0.801410219194313
GSE17721_CTRL_VS_GARDIQUIMOD...9,SET,187,0.096709,0.00971,0.061643,0.05835,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN,0.801410219194313
HP_HAMARTOMA_OF_TONGUE,SET,21,0.26278,0.008882,0.1675,0.058353,HP_HAMARTOMA_OF_TONGUE,0.801410219194313
GOBP_POSITIVE_REGULATION_OF_...547,SET,41,0.21738,0.010261,0.13857,0.058359,GOBP_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.801410219194313
KEGG_MEDICUS_REFERENCE_GLYCO...5,SET,5,0.47622,0.0078576,0.3036,0.058379,KEGG_MEDICUS_REFERENCE_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_LINKAGE_TETRASACCHARIDE,0.801410219194313
GOBP_FC_EPSILON_RECEPTOR_SIG...,SET,24,0.27657,0.0099927,0.17632,0.058385,GOBP_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY,0.801410219194313
BIOCARTA_AGPCR_PATHWAY,SET,11,0.42724,0.010454,0.27244,0.058424,BIOCARTA_AGPCR_PATHWAY,0.801586906077348
GOBP_REGULATION_OF_MEIOTIC_C...2,SET,10,0.3894,0.0090852,0.24834,0.058444,GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.801586906077348
GOMF_TRANSFERRIN_RECEPTOR_BI...,SET,9,0.39511,0.0087455,0.25208,0.058522,GOMF_TRANSFERRIN_RECEPTOR_BINDING,0.801946489444879
PID_IL27_PATHWAY,SET,26,0.26495,0.0099632,0.16905,0.058532,PID_IL27_PATHWAY,0.801946489444879
GSE45365_NK_CELL_VS_CD11B_DC...1,SET,184,0.099727,0.0099331,0.063652,0.058596,GSE45365_NK_CELL_VS_CD11B_DC_DN,0.801946489444879
GOMF_IRON_ION_BINDING,SET,139,0.11801,0.010229,0.075328,0.058607,GOMF_IRON_ION_BINDING,0.801946489444879
REACTOME_ERBB2_ACTIVATES_PTK...,SET,13,0.36459,0.0096978,0.23274,0.058621,REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,0.801946489444879
GOBP_URATE_METABOLIC_PROCESS,SET,10,0.43989,0.010263,0.28081,0.058624,GOBP_URATE_METABOLIC_PROCESS,0.801946489444879
GOBP_CALCIUM_IMPORT_INTO_THE...,SET,14,0.36393,0.010046,0.23236,0.058658,GOBP_CALCIUM_IMPORT_INTO_THE_MITOCHONDRION,0.801946489444879
HP_AV_NODAL_TACHYCARDIA,SET,2,1.0897,0.011372,0.69582,0.05868,HP_AV_NODAL_TACHYCARDIA,0.801946489444879
GOBP_FC_RECEPTOR_MEDIATED_IN...,SET,5,0.68962,0.011379,0.44054,0.058754,GOBP_FC_RECEPTOR_MEDIATED_INHIBITORY_SIGNALING_PATHWAY,0.801946489444879
GOCC_ACTIN_CYTOSKELETON,SET,481,0.061315,0.0097933,0.039176,0.058787,GOCC_ACTIN_CYTOSKELETON,0.801946489444879
REACTOME_GDP_FUCOSE_BIOSYNTH...,SET,4,0.58405,0.0086196,0.37319,0.058798,REACTOME_GDP_FUCOSE_BIOSYNTHESIS,0.801946489444879
HP_RECURRENT_PROTOZOAN_INFEC...,SET,5,0.66987,0.011053,0.42803,0.058802,HP_RECURRENT_PROTOZOAN_INFECTIONS,0.801946489444879
HP_DENTAL_MALOCCLUSION,SET,127,0.12126,0.01005,0.077489,0.058811,HP_DENTAL_MALOCCLUSION,0.801946489444879
GOBP_MITOTIC_METAPHASE_CHROM...,SET,62,0.15576,0.0090357,0.099572,0.058887,GOBP_MITOTIC_METAPHASE_CHROMOSOME_ALIGNMENT,0.801946489444879
GOBP_POSITIVE_REGULATION_OF_...316,SET,24,0.29118,0.01052,0.18615,0.058893,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,0.801946489444879
GSE18791_CTRL_VS_NEWCASTLE_V...15,SET,167,0.10446,0.0099169,0.066786,0.058906,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN,0.801946489444879
MORF_RAGE,SET,136,0.11379,0.0097566,0.07275,0.058909,MORF_RAGE,0.801946489444879
GSE2770_UNTREATED_VS_ACT_CD4...5,SET,179,0.096153,0.0094475,0.06148,0.05892,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN,0.801946489444879
HP_LAMELLAR_CATARACT,SET,6,0.52993,0.009578,0.33894,0.058976,HP_LAMELLAR_CATARACT,0.801946489444879
GOBP_RECEPTOR_DIFFUSION_TRAP...,SET,10,0.4504,0.010508,0.28809,0.05899,GOBP_RECEPTOR_DIFFUSION_TRAPPING,0.801946489444879
DESCARTES_FETAL_INTESTINE_CH...,SET,86,0.1531,0.010453,0.097929,0.058995,DESCARTES_FETAL_INTESTINE_CHROMAFFIN_CELLS,0.801946489444879
GOCC_CHROMATIN_SILENCING_COM...,SET,12,0.34476,0.0088108,0.22055,0.059013,GOCC_CHROMATIN_SILENCING_COMPLEX,0.801946489444879
MARIADASON_REGULATED_BY_HIST...2,SET,55,0.17756,0.0097034,0.11359,0.059018,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,0.801946489444879
MIR12114,SET,37,0.21384,0.0095898,0.13681,0.059024,MIR12114,0.801946489444879
MIR744_5P,SET,10,0.4113,0.0095959,0.26321,0.059082,MIR744_5P,0.801982134217714
GOBP_RETROTRANSPOSON_SILENCI...,SET,15,0.31626,0.0090357,0.20241,0.059099,GOBP_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.801982134217714
HP_BROAD_PHALANX_OF_THE_TOES,SET,38,0.22466,0.01021,0.1438,0.059112,HP_BROAD_PHALANX_OF_THE_TOES,0.801982134217714
GOMF_VOLTAGE_GATED_MONOATOMI...3,SET,11,0.46633,0.011411,0.29851,0.059132,GOMF_VOLTAGE_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY_INVOLVED_IN_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.801982134217714
GOMF_PEPTIDE_TRANSMEMBRANE_T...,SET,9,0.46827,0.010365,0.29977,0.059142,GOMF_PEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.801982134217714
GOMF_ORGANIC_HYDROXY_COMPOUN...,SET,52,0.19716,0.010478,0.12626,0.059199,GOMF_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.802441983229329
MISIAK_ANAPLASTIC_THYROID_CA...1,SET,17,0.34632,0.010533,0.22182,0.059243,MISIAK_ANAPLASTIC_THYROID_CARCINOMA_DN,0.802484038461538
MANNO_MIDBRAIN_NEUROTYPES_HR...2,SET,513,0.062363,0.010277,0.039953,0.059281,MANNO_MIDBRAIN_NEUROTYPES_HRGL2A,0.802484038461538
GOBP_REGULATION_OF_AMYLOID_B...,SET,16,0.32276,0.0095237,0.20681,0.059309,GOBP_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.802484038461538
GSE20727_H2O2_VS_ROS_INHIBIT...2,SET,173,0.096763,0.0093482,0.062004,0.059319,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP,0.802484038461538
GOMF_SULFURTRANSFERASE_ACTIV...,SET,11,0.3956,0.00968,0.2535,0.05932,GOMF_SULFURTRANSFERASE_ACTIVITY,0.802484038461538
MIR6773_5P,SET,33,0.20969,0.0088815,0.13438,0.059349,MIR6773_5P,0.802484038461538
REACTOME_SPRY_REGULATION_OF_...,SET,15,0.3389,0.0096827,0.21723,0.059373,REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING,0.802484038461538
GSE3982_NKCELL_VS_TH2_DN,SET,179,0.093784,0.0092147,0.060127,0.059418,GSE3982_NKCELL_VS_TH2_DN,0.802484038461538
CARD_MIR302A_TARGETS,SET,74,0.16257,0.0103,0.10423,0.059433,CARD_MIR302A_TARGETS,0.802484038461538
REACTOME_ACTIVATION_OF_THE_M...,SET,52,0.17157,0.0091175,0.11001,0.059433,REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,0.802484038461538
MYLLYKANGAS_AMPLIFICATION_HO...14,SET,5,0.47167,0.0077825,0.30249,0.05947,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30,0.802615273573923
GOBP_REGULATION_OF_FIBROBLAS...3,SET,35,0.22268,0.0097132,0.14282,0.05949,GOBP_REGULATION_OF_FIBROBLAST_MIGRATION,0.802615273573923
HP_CRANIAL_NERVE_COMPRESSION,SET,49,0.17524,0.009041,0.11241,0.059512,HP_CRANIAL_NERVE_COMPRESSION,0.802615273573923
MIR5187_3P,SET,91,0.13351,0.0093759,0.085658,0.059548,MIR5187_3P,0.802647269611577
GOMF_CARBON_CARBON_LYASE_ACT...,SET,50,0.18216,0.0094927,0.11688,0.059562,GOMF_CARBON_CARBON_LYASE_ACTIVITY,0.802647269611577
GOBP_NEGATIVE_REGULATION_OF_...380,SET,6,0.56407,0.010195,0.36206,0.05963,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.802647269611577
GSE7509_DC_VS_MONOCYTE_DN,SET,186,0.096351,0.0096484,0.06185,0.059646,GSE7509_DC_VS_MONOCYTE_DN,0.802647269611577
GSE6674_UNSTIM_VS_ANTI_IGM_S...1,SET,117,0.12221,0.0097247,0.078452,0.059648,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_DN,0.802647269611577
GOBP_DEFENSE_RESPONSE_TO_TUM...,SET,12,0.38792,0.0099139,0.24908,0.059695,GOBP_DEFENSE_RESPONSE_TO_TUMOR_CELL,0.802647269611577
WANG_TUMOR_INVASIVENESS_UP,SET,362,0.06574,0.0091393,0.042213,0.059706,WANG_TUMOR_INVASIVENESS_UP,0.802647269611577
LOPEZ_MESOTHELIOMA_SURVIVAL_...6,SET,12,0.40347,0.010311,0.25913,0.059747,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP,0.802647269611577
CHARAFE_BREAST_CANCER_LUMINA...3,SET,425,0.06769,0.010179,0.043482,0.059775,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,0.802647269611577
HP_POSTERIOR_EMBRYOTOXON,SET,46,0.21173,0.010584,0.13602,0.059794,HP_POSTERIOR_EMBRYOTOXON,0.802647269611577
GOBP_GLOMERULAR_MESANGIUM_DE...,SET,16,0.36443,0.010753,0.23416,0.059822,GOBP_GLOMERULAR_MESANGIUM_DEVELOPMENT,0.802647269611577
HP_APLASIA_HYPOPLASIA_OF_THE...58,SET,26,0.26342,0.0099055,0.1693,0.05987,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES,0.802647269611577
GOBP_VASCULAR_ASSOCIATED_SMO...3,SET,28,0.27269,0.01064,0.17526,0.059875,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.802647269611577
KEGG_MEDICUS_VARIANT_EML4_AL...4,SET,11,0.38231,0.0093548,0.24584,0.05997,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.802647269611577
HP_AIRWAY_OBSTRUCTION,SET,115,0.12449,0.0098217,0.080074,0.060012,HP_AIRWAY_OBSTRUCTION,0.802647269611577
GOMF_TAURINE_TRANSMEMBRANE_T...,SET,5,0.65867,0.010868,0.42366,0.060016,GOMF_TAURINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.802647269611577
HP_HYPOMIMIC_FACE,SET,35,0.21469,0.0093643,0.13811,0.060049,HP_HYPOMIMIC_FACE,0.802647269611577
GOBP_REGULATION_OF_PANCREATI...,SET,7,0.45333,0.0088497,0.29165,0.060062,GOBP_REGULATION_OF_PANCREATIC_JUICE_SECRETION,0.802647269611577
GOBP_CELLULAR_RESPONSE_TO_CO...2,SET,13,0.35443,0.0094275,0.22807,0.060096,GOBP_CELLULAR_RESPONSE_TO_COLD,0.802647269611577
RAY_TARGETS_OF_P210_BCR_ABL_...1,SET,15,0.34563,0.0098749,0.22253,0.060196,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN,0.802647269611577
PBX1_02,SET,113,0.13251,0.010363,0.085319,0.060205,PBX1_02,0.802647269611577
MIR6765_3P,SET,88,0.13831,0.0095523,0.08906,0.060219,MIR6765_3P,0.802647269611577
LEE_LIVER_CANCER_CIPROFIBRAT...1,SET,63,0.17617,0.010301,0.11347,0.060274,LEE_LIVER_CANCER_CIPROFIBRATE_DN,0.802647269611577
HP_BULIMIA,SET,5,0.72125,0.0119,0.46456,0.060276,HP_BULIMIA,0.802647269611577
GOBP_AXO_DENDRITIC_TRANSPORT,SET,74,0.153,0.0096933,0.098547,0.060279,GOBP_AXO_DENDRITIC_TRANSPORT,0.802647269611577
DESCARTES_FETAL_CEREBELLUM_S...,SET,33,0.25278,0.010707,0.16285,0.06031,DESCARTES_FETAL_CEREBELLUM_SLC24A4_PEX5L_POSITIVE_CELLS,0.802647269611577
GSE3400_UNTREATED_VS_IFNB_TR...1,SET,154,0.10522,0.0095958,0.0678,0.060351,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN,0.802647269611577
GOBP_REGULATION_OF_GOLGI_TO_...,SET,8,0.44115,0.0092064,0.28427,0.060357,GOBP_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.802647269611577
REACTOME_RESOLUTION_OF_SISTE...,SET,113,0.12204,0.0095445,0.078645,0.060365,REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION,0.802647269611577
GSE46606_UNSTIM_VS_CD40L_IL2...5,SET,163,0.099763,0.0093579,0.064294,0.060379,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN,0.802647269611577
MIKKELSEN_IPS_LCP_WITH_H3K4M...2,SET,5,0.6964,0.01149,0.44884,0.060394,MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3,0.802647269611577
GSE9960_HEALTHY_VS_GRAM_NEG_...3,SET,175,0.10273,0.0099809,0.06621,0.060398,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN,0.802647269611577
GUILLAUMOND_KLF10_TARGETS_DN,SET,27,0.2571,0.0098518,0.16574,0.060439,GUILLAUMOND_KLF10_TARGETS_DN,0.802647269611577
HP_ABNORMAL_HYPOTHALAMUS_MOR...,SET,19,0.26833,0.0086271,0.17299,0.060443,HP_ABNORMAL_HYPOTHALAMUS_MORPHOLOGY,0.802647269611577
BUSSLINGER_GASTRIC_MATURE_PI...,SET,208,0.095076,0.010062,0.061308,0.060483,BUSSLINGER_GASTRIC_MATURE_PIT_CELLS,0.802647269611577
REACTOME_MYD88_INDEPENDENT_T...,SET,103,0.12738,0.0095136,0.082143,0.060497,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,0.802647269611577
GOLDRATH_NAIVE_VS_MEMORY_CD8...2,SET,190,0.095018,0.0096156,0.061279,0.060509,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.802647269611577
GSE45365_NK_CELL_VS_CD11B_DC...3,SET,186,0.097507,0.0097641,0.062886,0.060515,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_UP,0.802647269611577
WIERENGA_PML_INTERACTOME,SET,38,0.20218,0.0091883,0.1304,0.06052,WIERENGA_PML_INTERACTOME,0.802647269611577
REACTOME_INTERLEUKIN_12_SIGN...,SET,43,0.18853,0.0091127,0.1216,0.060532,REACTOME_INTERLEUKIN_12_SIGNALING,0.802647269611577
GSE3994_WT_VS_PAC1_KO_ACTIVA...1,SET,189,0.096744,0.0097647,0.062402,0.06054,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN,0.802647269611577
MODULE_5,SET,398,0.070165,0.010218,0.045262,0.060556,MODULE_5,0.802647269611577
MIR4725_3P,SET,260,0.080092,0.009463,0.051674,0.060585,MIR4725_3P,0.802647269611577
CAFFAREL_RESPONSE_TO_THC_24H...4,SET,29,0.21796,0.0086552,0.14063,0.060595,CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,0.802647269611577
REACTOME_BBSOME_MEDIATED_CAR...,SET,23,0.25868,0.0091496,0.16691,0.060605,REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM,0.802647269611577
GOBP_NUCLEOTIDE_BINDING_OLIG...2,SET,16,0.34224,0.010099,0.22084,0.060615,GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY,0.802647269611577
BEGUM_TARGETS_OF_PAX3_FOXO1_...1,SET,7,0.58275,0.011376,0.37605,0.060622,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3,0.802647269611577
RODRIGUES_THYROID_CARCINOMA_...1,SET,468,0.061042,0.0096205,0.039394,0.060636,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN,0.802647269611577
GSE25123_ROSIGLITAZONE_VS_IL...4,SET,178,0.095161,0.0093241,0.061416,0.060646,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,0.802647269611577
GOBP_RENAL_ABSORPTION,SET,33,0.2506,0.010615,0.16177,0.060688,GOBP_RENAL_ABSORPTION,0.802897388656262
GOBP_POSITIVE_REGULATION_OF_...583,SET,5,0.50783,0.0083791,0.32803,0.060807,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY,0.804025831154277
GOBP_SMOOTH_MUSCLE_CELL_CHEM...,SET,8,0.4699,0.0098064,0.30379,0.060969,GOBP_SMOOTH_MUSCLE_CELL_CHEMOTAXIS,0.804025831154277
GOCC_NEURONAL_DENSE_CORE_VES...2,SET,5,0.65985,0.010887,0.42667,0.060997,GOCC_NEURONAL_DENSE_CORE_VESICLE_MEMBRANE,0.804025831154277
GOBP_RIBOSOME_BIOGENESIS,SET,272,0.073215,0.0088449,0.047361,0.061075,GOBP_RIBOSOME_BIOGENESIS,0.804025831154277
GOBP_POSITIVE_REGULATION_OF_...679,SET,576,0.055825,0.0097313,0.036115,0.061093,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,0.804025831154277
GSE17974_IL4_AND_ANTI_IL12_V...1,SET,135,0.11535,0.0098544,0.074627,0.0611,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN,0.804025831154277
GOMF_MAGNESIUM_ION_BINDING,SET,209,0.087931,0.0093278,0.05689,0.061107,GOMF_MAGNESIUM_ION_BINDING,0.804025831154277
GAVISH_3CA_METAPROGRAM_EPITH...8,SET,49,0.18906,0.0097535,0.12234,0.061146,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3,0.804025831154277
HP_PSYCHOTIC_EPISODES,SET,15,0.30758,0.0087877,0.19905,0.061154,HP_PSYCHOTIC_EPISODES,0.804025831154277
DESCARTES_FETAL_ADRENAL_SYMP...,SET,90,0.15372,0.010736,0.099479,0.061156,DESCARTES_FETAL_ADRENAL_SYMPATHOBLASTS,0.804025831154277
AIZARANI_LIVER_C8_RESIDENT_B...,SET,30,0.23465,0.0094771,0.15188,0.061187,AIZARANI_LIVER_C8_RESIDENT_B_CELLS_1,0.804025831154277
MCBRYAN_PUBERTAL_TGFB1_TARGE...1,SET,57,0.18663,0.010382,0.1208,0.061192,MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,0.804025831154277
GOBP_POSITIVE_REGULATION_OF_...139,SET,319,0.074405,0.0097217,0.048161,0.061192,GOBP_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.804025831154277
CHEOK_RESPONSE_TO_MERCAPTOPU...5,SET,19,0.30409,0.0097771,0.19684,0.061196,CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,0.804025831154277
GSE37534_UNTREATED_VS_GW1929...1,SET,186,0.091698,0.0091824,0.059377,0.061265,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.804025831154277
GSE22935_UNSTIM_VS_24H_MBOVI...3,SET,181,0.095743,0.0094591,0.062007,0.061294,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.804025831154277
GOBP_REGULATION_OF_ATPASE_CO...,SET,5,0.48103,0.0079368,0.3116,0.061336,GOBP_REGULATION_OF_ATPASE_COUPLED_CALCIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.804025831154277
GSE339_CD8POS_VS_CD4CD8DN_DC...2,SET,182,0.094742,0.0093857,0.061382,0.061368,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,0.804025831154277
TTGCWCAAY_CEBPB_02,SET,60,0.17326,0.0098883,0.11228,0.06141,TTGCWCAAY_CEBPB_02,0.804025831154277
MIR6892_5P,SET,84,0.13569,0.0091567,0.087939,0.061427,MIR6892_5P,0.804025831154277
MIKKELSEN_NPC_WITH_LCP_H3K27...,SET,7,0.47367,0.0092468,0.30699,0.061429,MIKKELSEN_NPC_WITH_LCP_H3K27ME3,0.804025831154277
SCHEIDEREIT_IKK_INTERACTING_...,SET,52,0.1808,0.0096078,0.1172,0.061477,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,0.804025831154277
GOCC_BETA_CATENIN_DESTRUCTIO...,SET,12,0.36071,0.0092184,0.23387,0.061508,GOCC_BETA_CATENIN_DESTRUCTION_COMPLEX,0.804025831154277
GOBP_NEGATIVE_REGULATION_OF_...642,SET,7,0.36307,0.0070877,0.2355,0.061584,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.804025831154277
GOBP_IP_10_PRODUCTION,SET,4,0.72393,0.010684,0.46959,0.061592,GOBP_IP_10_PRODUCTION,0.804025831154277
GOMF_WATER_TRANSMEMBRANE_TRA...,SET,17,0.37676,0.011459,0.2444,0.061599,GOMF_WATER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.804025831154277
BIOCARTA_PAR1_PATHWAY,SET,19,0.33763,0.010855,0.21903,0.06161,BIOCARTA_PAR1_PATHWAY,0.804025831154277
FOURATI_BLOOD_TWINRIX_AGE_65...1,SET,4,0.72937,0.010764,0.47321,0.061627,FOURATI_BLOOD_TWINRIX_AGE_65_81Y0_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_UP,0.804025831154277
BIOCARTA_NEUTROPHIL_PATHWAY,SET,8,0.54411,0.011355,0.35304,0.061641,BIOCARTA_NEUTROPHIL_PATHWAY,0.804025831154277
HP_HYPOPLASTIC_HIPPOCAMPUS,SET,16,0.31734,0.0093636,0.20591,0.061646,HP_HYPOPLASTIC_HIPPOCAMPUS,0.804025831154277
KEGG_MEDICUS_REFERENCE_WNT_S...1,SET,18,0.34199,0.010703,0.22191,0.061652,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO,0.804025831154277
GSE557_WT_VS_I_AB_KO_DC_UP,SET,178,0.092785,0.0090913,0.060206,0.061653,GSE557_WT_VS_I_AB_KO_DC_UP,0.804025831154277
HP_GINGIVAL_OVERGROWTH,SET,110,0.13126,0.010129,0.085177,0.061668,HP_GINGIVAL_OVERGROWTH,0.804025831154277
REACTOME_TOLL_LIKE_RECEPTOR_...1,SET,101,0.12789,0.0094594,0.082997,0.061675,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,0.804025831154277
GSE22886_DC_VS_MONOCYTE_DN,SET,180,0.097327,0.0095892,0.063169,0.061699,GSE22886_DC_VS_MONOCYTE_DN,0.804025831154277
HE_LIM_SUN_FETAL_LUNG_C5_CD5...2,SET,142,0.1128,0.0098817,0.073223,0.061724,HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_NEG_MATURE_B_CELL,0.804025831154277
GOBP_REGULATION_OF_INTRINSIC...3,SET,35,0.21368,0.0093206,0.13872,0.061747,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.804025831154277
MIR9899,SET,4,0.60816,0.0089754,0.39482,0.061748,MIR9899,0.804025831154277
MIR6791_5P,SET,152,0.10514,0.0095263,0.06826,0.06176,MIR6791_5P,0.804025831154277
HP_EPIPHORA,SET,22,0.27434,0.0094906,0.17813,0.061772,HP_EPIPHORA,0.804025831154277
HP_PREMATURE_ATRIAL_CONTRACT...,SET,6,0.64002,0.011568,0.41559,0.061783,HP_PREMATURE_ATRIAL_CONTRACTIONS,0.804025831154277
REACTOME_PECAM1_INTERACTIONS,SET,11,0.37348,0.0091388,0.24252,0.06179,REACTOME_PECAM1_INTERACTIONS,0.804025831154277
GOBP_NEGATIVE_REGULATION_OF_...156,SET,20,0.29961,0.009883,0.19459,0.061828,GOBP_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.804025831154277
WP_TYPE_II_INTERFERON_SIGNAL...,SET,35,0.23123,0.010086,0.15018,0.061832,WP_TYPE_II_INTERFERON_SIGNALING,0.804025831154277
ETS1_B,SET,241,0.084397,0.0096055,0.054819,0.061844,ETS1_B,0.804025831154277
BYSTRYKH_HEMATOPOIESIS_STEM_...2,SET,142,0.1068,0.0093558,0.069386,0.061886,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,0.804025831154277
HP_FINGERNAIL_DYSPLASIA,SET,16,0.34228,0.0101,0.22239,0.061902,HP_FINGERNAIL_DYSPLASIA,0.804025831154277
GSE9946_IMMATURE_VS_MATURE_S...1,SET,124,0.11857,0.0097112,0.077044,0.061909,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN,0.804025831154277
HALLMARK_ALLOGRAFT_REJECTION,SET,183,0.10108,0.01004,0.065679,0.061918,HALLMARK_ALLOGRAFT_REJECTION,0.804025831154277
HP_ATLANTOAXIAL_ABNORMALITY,SET,12,0.34975,0.0089385,0.22728,0.06193,HP_ATLANTOAXIAL_ABNORMALITY,0.804025831154277
HP_SPASTIC_HYPERACTIVE_BLADD...,SET,9,0.43372,0.0096002,0.28191,0.06197,HP_SPASTIC_HYPERACTIVE_BLADDER,0.804244716206124
GOBP_NUCLEOSIDE_TRANSPORT,SET,10,0.42177,0.0098404,0.27419,0.062003,GOBP_NUCLEOSIDE_TRANSPORT,0.804372625979843
HP_CHRONIC_INFECTION,SET,21,0.28739,0.0097136,0.18687,0.062048,HP_CHRONIC_INFECTION,0.804656059701493
GSE39820_CTRL_VS_TGFBETA1_IL...4,SET,172,0.096617,0.0093074,0.062848,0.062116,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP,0.805237441253264
GOBP_POSITIVE_REGULATION_OF_...7,SET,7,0.54435,0.010627,0.3542,0.062175,GOBP_POSITIVE_REGULATION_OF_ACTION_POTENTIAL,0.805701761744967
CHOI_ATL_CHRONIC_VS_ACUTE_DN,SET,17,0.33829,0.010289,0.22019,0.062234,CHOI_ATL_CHRONIC_VS_ACUTE_DN,0.805904223174367
GOCC_HETEROCHROMATIN,SET,69,0.15186,0.0092916,0.098843,0.062237,GOCC_HETEROCHROMATIN,0.805904223174367
MIR9898,SET,52,0.17534,0.0093177,0.11416,0.062292,MIR9898,0.806052551020408
GOBP_NEGATIVE_REGULATION_OF_...25,SET,18,0.32179,0.01007,0.2096,0.062373,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.806052551020408
GSE42021_CD24HI_VS_CD24INT_T...3,SET,182,0.09991,0.0098976,0.065082,0.062384,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN,0.806052551020408
GOMF_HISTONE_DEUBIQUITINASE_...,SET,7,0.37628,0.0073455,0.24515,0.062413,GOMF_HISTONE_DEUBIQUITINASE_ACTIVITY,0.806052551020408
GOBP_NEGATIVE_REGULATION_OF_...76,SET,6,0.58007,0.010484,0.37796,0.062436,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,0.806052551020408
PID_MYC_REPRESS_PATHWAY,SET,60,0.16307,0.0093067,0.10628,0.062485,PID_MYC_REPRESS_PATHWAY,0.806052551020408
MIR4497,SET,8,0.51169,0.010679,0.33352,0.062495,MIR4497,0.806052551020408
MIR642B_5P,SET,70,0.16083,0.0099116,0.10483,0.062499,MIR642B_5P,0.806052551020408
HP_HYPERCALCEMIA,SET,63,0.164,0.0095898,0.1069,0.062509,HP_HYPERCALCEMIA,0.806052551020408
ZHU_SKIL_TARGETS_UP,SET,19,0.31188,0.010027,0.20331,0.062522,ZHU_SKIL_TARGETS_UP,0.806052551020408
GOBP_KERATINOCYTE_DEVELOPMENT,SET,13,0.38476,0.010234,0.25084,0.062541,GOBP_KERATINOCYTE_DEVELOPMENT,0.806052551020408
GSE3982_NEUTROPHIL_VS_TH2_DN,SET,182,0.090287,0.0089444,0.058864,0.062545,GSE3982_NEUTROPHIL_VS_TH2_DN,0.806052551020408
WP_MALE_STEROID_HORMONES_IN_...,SET,13,0.36583,0.0097309,0.23856,0.062583,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.806052551020408
GOBP_NEGATIVE_REGULATION_OF_...584,SET,6,0.55223,0.009981,0.36016,0.062613,GOBP_NEGATIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.806052551020408
GOBP_REGULATION_OF_PRODUCTIO...,SET,171,0.10039,0.0096426,0.065482,0.062642,GOBP_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.806052551020408
WANG_METHYLATED_IN_BREAST_CA...,SET,34,0.2308,0.0099224,0.15056,0.062661,WANG_METHYLATED_IN_BREAST_CANCER,0.806052551020408
GOBP_OLFACTORY_NERVE_DEVELOP...,SET,6,0.56072,0.010134,0.36597,0.062752,GOBP_OLFACTORY_NERVE_DEVELOPMENT,0.806052551020408
GOCC_AZUROPHIL_GRANULE,SET,139,0.10748,0.0093161,0.070154,0.062762,GOCC_AZUROPHIL_GRANULE,0.806052551020408
REACTOME_SIGNALING_BY_ERBB2,SET,48,0.17519,0.0089456,0.11435,0.062763,REACTOME_SIGNALING_BY_ERBB2,0.806052551020408
GOCC_CATION_CHANNEL_COMPLEX,SET,195,0.10037,0.010288,0.06556,0.062904,GOCC_CATION_CHANNEL_COMPLEX,0.806052551020408
GAO_LARGE_INTESTINE_ADULT_CE...,SET,287,0.077798,0.0096503,0.050827,0.062936,GAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL,0.806052551020408
GOBP_POSITIVE_REGULATION_OF_...69,SET,74,0.14754,0.0093478,0.096403,0.062958,GOBP_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION,0.806052551020408
GOCC_ENDOPLASMIC_RETICULUM_G...1,SET,121,0.11584,0.0093726,0.075693,0.062973,GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT,0.806052551020408
DESCARTES_FETAL_LIVER_ERYTHR...,SET,55,0.17712,0.0096793,0.11574,0.062981,DESCARTES_FETAL_LIVER_ERYTHROBLASTS,0.806052551020408
BLUM_RESPONSE_TO_SALIRASIB_UP,SET,219,0.084541,0.0091778,0.055247,0.062988,BLUM_RESPONSE_TO_SALIRASIB_UP,0.806052551020408
GOBP_REGULATION_OF_LYMPHANGI...,SET,6,0.59063,0.010675,0.3861,0.063053,GOBP_REGULATION_OF_LYMPHANGIOGENESIS,0.806052551020408
GOBP_REGULATION_OF_GLIAL_CEL...2,SET,74,0.16771,0.010626,0.10966,0.063092,GOBP_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.806052551020408
HP_POSITIONAL_FOOT_DEFORMITY,SET,414,0.064626,0.0095941,0.042261,0.063116,HP_POSITIONAL_FOOT_DEFORMITY,0.806052551020408
ZHAN_MULTIPLE_MYELOMA_CD1_VS...1,SET,48,0.19963,0.010193,0.13059,0.063181,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,0.806052551020408
MIR6824_3P,SET,99,0.12481,0.00914,0.081651,0.063194,MIR6824_3P,0.806052551020408
HP_HYPOPLASIA_OF_OLFACTORY_T...,SET,8,0.36756,0.0076706,0.24047,0.063201,HP_HYPOPLASIA_OF_OLFACTORY_TRACT,0.806052551020408
GOBP_PROTEIN_DE_ADP_RIBOSYLA...,SET,4,0.77586,0.01145,0.50762,0.063212,GOBP_PROTEIN_DE_ADP_RIBOSYLATION,0.806052551020408
PID_FRA_PATHWAY,SET,35,0.22004,0.0095979,0.14401,0.063264,PID_FRA_PATHWAY,0.806052551020408
MIR30A_5P,SET,709,0.049958,0.0096257,0.032695,0.063265,MIR30A_5P,0.806052551020408
MIR30D_5P,SET,709,0.049958,0.0096257,0.032695,0.063265,MIR30D_5P,0.806052551020408
MIR30E_5P,SET,709,0.049958,0.0096257,0.032695,0.063265,MIR30E_5P,0.806052551020408
GOBP_POSITIVE_REGULATION_OF_...691,SET,13,0.35262,0.0093796,0.23079,0.063281,GOBP_POSITIVE_REGULATION_OF_RUFFLE_ASSEMBLY,0.806052551020408
GOBP_POSITIVE_REGULATION_OF_...298,SET,11,0.45269,0.011077,0.29629,0.063285,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_VIA_CHROMOSOMAL_CPG_ISLAND_DEMETHYLATION,0.806052551020408
MODULE_223,SET,132,0.12322,0.01041,0.08066,0.063312,MODULE_223,0.806052551020408
GSE9988_ANTI_TREM1_VS_CTRL_T...2,SET,172,0.1064,0.010249,0.069653,0.063324,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP,0.806052551020408
GSE33424_CD161_INT_VS_NEG_CD...2,SET,181,0.095022,0.0093878,0.06221,0.063336,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP,0.806052551020408
GSE15930_NAIVE_VS_72H_IN_VIT...3,SET,183,0.092463,0.0091848,0.060548,0.063377,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,0.806052551020408
HP_INCREASED_MEAN_PLATELET_V...,SET,21,0.304,0.010275,0.19908,0.063388,HP_INCREASED_MEAN_PLATELET_VOLUME,0.806052551020408
HP_GENERALIZED_OSTEOSCLEROSIS,SET,8,0.41641,0.00869,0.27274,0.06342,HP_GENERALIZED_OSTEOSCLEROSIS,0.806052551020408
WP_TYPE_II_DIABETES_MELLITUS,SET,20,0.29477,0.0097233,0.19309,0.063442,WP_TYPE_II_DIABETES_MELLITUS,0.806052551020408
HP_EMG_ABNORMALITY,SET,250,0.081293,0.009421,0.05326,0.063472,HP_EMG_ABNORMALITY,0.806052551020408
GOBP_POSITIVE_REGULATION_OF_...539,SET,127,0.11424,0.0094684,0.074857,0.063496,GOBP_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,0.806052551020408
GOMF_L_LEUCINE_TRANSMEMBRANE...,SET,6,0.54001,0.0097603,0.35386,0.063506,GOMF_L_LEUCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.806052551020408
HP_STROKE,SET,148,0.10704,0.009571,0.070139,0.063506,HP_STROKE,0.806052551020408
GOBP_GAMMA_AMINOBUTYRIC_ACID...1,SET,6,0.57977,0.010479,0.37992,0.063511,GOBP_GAMMA_AMINOBUTYRIC_ACID_BIOSYNTHETIC_PROCESS,0.806052551020408
GOBP_NEUROTRANSMITTER_RECEPT...5,SET,7,0.54566,0.010652,0.35758,0.063515,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_POSTSYNAPTIC_ENDOSOME_TO_LYSOSOME,0.806052551020408
GSE5589_WT_VS_IL10_KO_LPS_ST...2,SET,140,0.1057,0.0091943,0.069268,0.063524,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,0.806052551020408
GOMF_DNA_BINDING_TRANSCRIPTI...3,SET,440,0.061659,0.0094299,0.040412,0.063543,GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING,0.806052551020408
GNF2_PTPN6,SET,41,0.19993,0.0094369,0.13106,0.063585,GNF2_PTPN6,0.806052551020408
GOBP_GLANDULAR_EPITHELIAL_CE...3,SET,8,0.52088,0.01087,0.34147,0.063587,GOBP_GLANDULAR_EPITHELIAL_CELL_MATURATION,0.806052551020408
REACTOME_BMAL1_CLOCK_NPAS2_A...,SET,23,0.28743,0.010167,0.18843,0.06359,REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION,0.806052551020408
GOMF_DNA_HELICASE_ACTIVITY,SET,55,0.16791,0.009176,0.11008,0.063606,GOMF_DNA_HELICASE_ACTIVITY,0.806052551020408
GSE43863_TH1_VS_LY6C_INT_CXC...2,SET,179,0.091987,0.0090381,0.060311,0.063612,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,0.806052551020408
GOBP_GALACTOSYLCERAMIDE_BIOS...,SET,6,0.56661,0.010241,0.37154,0.063635,GOBP_GALACTOSYLCERAMIDE_BIOSYNTHETIC_PROCESS,0.806052551020408
RUBENSTEIN_SKELETAL_MUSCLE_F...2,SET,256,0.083036,0.0097361,0.05445,0.06364,RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS,0.806052551020408
HADDAD_B_LYMPHOCYTE_PROGENIT...,SET,248,0.085681,0.0098903,0.05621,0.063724,HADDAD_B_LYMPHOCYTE_PROGENITOR,0.806488066982162
HP_TYPE_A_BRACHYDACTYLY,SET,20,0.31103,0.01026,0.20406,0.063736,HP_TYPE_A_BRACHYDACTYLY,0.806488066982162
GOBP_MRNA_CIS_SPLICING_VIA_S...,SET,26,0.21937,0.0082491,0.14393,0.063744,GOBP_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,0.806488066982162
LEIN_CHOROID_PLEXUS_MARKERS,SET,98,0.13288,0.0096816,0.087218,0.063827,LEIN_CHOROID_PLEXUS_MARKERS,0.806573815268275
KEGG_MEDICUS_VARIANT_MUTATIO...25,SET,16,0.3188,0.0094068,0.20929,0.063859,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY,0.806573815268275
GILMORE_CORE_NFKB_PATHWAY,SET,10,0.39259,0.0091596,0.25774,0.063861,GILMORE_CORE_NFKB_PATHWAY,0.806573815268275
LEIN_PONS_MARKERS,SET,79,0.14608,0.0095613,0.095905,0.063867,LEIN_PONS_MARKERS,0.806573815268275
MODULE_341,SET,74,0.15004,0.009506,0.098508,0.063873,MODULE_341,0.806573815268275
GOMF_RNA_POLYMERASE_III_TYPE...,SET,6,0.43496,0.0078616,0.28578,0.064013,GOMF_RNA_POLYMERASE_III_TYPE_3_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.806573815268275
MITSIADES_RESPONSE_TO_APLIDI...2,SET,385,0.064883,0.0092963,0.042634,0.06403,MITSIADES_RESPONSE_TO_APLIDIN_UP,0.806573815268275
MYCMAX_02,SET,240,0.083757,0.0095131,0.055041,0.064049,MYCMAX_02,0.806573815268275
REACTOME_VITAMIN_C_ASCORBATE...,SET,7,0.46469,0.0090716,0.30538,0.064055,REACTOME_VITAMIN_C_ASCORBATE_METABOLISM,0.806573815268275
MIR3619_3P,SET,49,0.21438,0.01106,0.14093,0.064119,MIR3619_3P,0.806573815268275
GOBP_METHIONINE_BIOSYNTHETIC...,SET,12,0.36657,0.0093683,0.24099,0.064127,GOBP_METHIONINE_BIOSYNTHETIC_PROCESS,0.806573815268275
HP_NATAL_TOOTH,SET,31,0.22597,0.0092773,0.14856,0.064133,HP_NATAL_TOOTH,0.806573815268275
MIR6764_3P,SET,98,0.12452,0.0090731,0.081871,0.064141,MIR6764_3P,0.806573815268275
JEPSEN_SMRT_TARGETS,SET,29,0.23891,0.0094875,0.1571,0.064167,JEPSEN_SMRT_TARGETS,0.806573815268275
GSE22886_NAIVE_CD4_TCELL_VS_...6,SET,179,0.092917,0.0091295,0.061102,0.064178,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP,0.806573815268275
GSE2405_0H_VS_12H_A_PHAGOCYT...2,SET,184,0.09687,0.0096486,0.063711,0.064207,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.806573815268275
WP_SELENIUM_MICRONUTRIENT_NE...,SET,70,0.16291,0.010039,0.10715,0.064211,WP_SELENIUM_MICRONUTRIENT_NETWORK,0.806573815268275
GOBP_REGULATION_OF_ESTABLISH...6,SET,22,0.27189,0.0094059,0.17883,0.064211,GOBP_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,0.806573815268275
DELASERNA_TARGETS_OF_MYOD_AN...,SET,10,0.43678,0.010191,0.2873,0.064226,DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4,0.806573815268275
GOBP_POSITIVE_REGULATION_OF_...797,SET,63,0.1539,0.0089993,0.10128,0.064322,GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,0.806573815268275
GOCC_CHROMAFFIN_GRANULE_MEMB...,SET,9,0.48235,0.010677,0.31743,0.064323,GOCC_CHROMAFFIN_GRANULE_MEMBRANE,0.806573815268275
GOBP_G_PROTEIN_COUPLED_SEROT...,SET,22,0.27434,0.0094906,0.18055,0.064329,GOBP_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,0.806573815268275
HP_PERIORBITAL_WRINKLES,SET,4,0.70056,0.010339,0.46115,0.064372,HP_PERIORBITAL_WRINKLES,0.806573815268275
chr1p36,SET,326,0.15685,0.020713,0.10325,0.064382,chr1p36,0.806573815268275
REACTOME_SCAVENGING_BY_CLASS...3,SET,6,0.50252,0.0090825,0.33082,0.064388,REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS,0.806573815268275
KRIGE_RESPONSE_TO_TOSEDOSTAT...3,SET,822,0.043563,0.0090087,0.028681,0.064401,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN,0.806573815268275
GOBP_T_HELPER_17_CELL_LINEAG...,SET,19,0.32834,0.010557,0.21621,0.064437,GOBP_T_HELPER_17_CELL_LINEAGE_COMMITMENT,0.806573815268275
HP_CHILDHOOD_ONSET_SENSORINE...,SET,18,0.32142,0.010059,0.21165,0.064437,HP_CHILDHOOD_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT,0.806573815268275
KEGG_REGULATION_OF_ACTIN_CYT...,SET,196,0.093056,0.009563,0.061279,0.064446,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,0.806573815268275
HP_MULTIPLE_ENCHONDROMATOSIS,SET,10,0.3982,0.0092903,0.26222,0.064447,HP_MULTIPLE_ENCHONDROMATOSIS,0.806573815268275
GSE8835_CD4_VS_CD8_TCELL_DN,SET,178,0.097911,0.0095935,0.064491,0.064491,GSE8835_CD4_VS_CD8_TCELL_DN,0.806833947084233
HP_UROGENITAL_SINUS_ANOMALY,SET,15,0.3575,0.010214,0.23553,0.064537,HP_UROGENITAL_SINUS_ANOMALY,0.807118904282116
GOBP_REGULATION_OF_CILIUM_BE...2,SET,9,0.41922,0.0092791,0.27628,0.064594,GOBP_REGULATION_OF_CILIUM_BEAT_FREQUENCY_INVOLVED_IN_CILIARY_MOTILITY,0.807201667859699
MIR924,SET,44,0.18234,0.0089155,0.12019,0.064629,MIR924,0.807201667859699
REACTOME_VITAMIN_B5_PANTOTHE...,SET,19,0.272,0.0087452,0.1793,0.064641,REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM,0.807201667859699
GSE5542_IFNA_VS_IFNA_AND_IFN...2,SET,183,0.093935,0.0093311,0.061929,0.064666,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.807201667859699
BIOCARTA_ECM_PATHWAY,SET,19,0.28977,0.0093165,0.19108,0.064711,BIOCARTA_ECM_PATHWAY,0.807201667859699
HP_PROXIMAL_MUSCLE_WEAKNESS_...1,SET,62,0.16219,0.0094086,0.10697,0.064742,HP_PROXIMAL_MUSCLE_WEAKNESS_IN_LOWER_LIMBS,0.807201667859699
MEISSNER_BRAIN_HCP_WITH_H3K4...3,SET,1021,0.044913,0.010292,0.029626,0.064767,MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.807201667859699
GSE20198_UNTREATED_VS_IL12_T...2,SET,178,0.090195,0.0088375,0.059499,0.06478,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP,0.807201667859699
GOBP_REGULATION_OF_TAU_PROTE...,SET,4,0.54843,0.0080939,0.36182,0.064798,GOBP_REGULATION_OF_TAU_PROTEIN_KINASE_ACTIVITY,0.807201667859699
GOBP_VIRAL_TRANSLATION,SET,18,0.28979,0.0090691,0.19119,0.064806,GOBP_VIRAL_TRANSLATION,0.807201667859699
MIR200A_5P,SET,96,0.12589,0.0090793,0.083063,0.064814,MIR200A_5P,0.807201667859699
GSE30962_PRIMARY_VS_SECONDAR...4,SET,180,0.091383,0.0090035,0.060299,0.064832,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP,0.807201667859699
DAIRKEE_CANCER_PRONE_RESPONS...3,SET,27,0.26274,0.010068,0.1734,0.064862,DAIRKEE_CANCER_PRONE_RESPONSE_E2,0.807201667859699
GSE25088_IL4_VS_IL4_AND_ROSI...1,SET,185,0.09352,0.0093399,0.061724,0.064879,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.807201667859699
GSE37533_PPARG1_FOXP3_VS_FOX...1,SET,189,0.096395,0.0097295,0.063626,0.064892,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,0.807201667859699
MIR4766_5P,SET,293,0.074846,0.0093791,0.049423,0.064972,MIR4766_5P,0.807513420300214
KEGG_HISTIDINE_METABOLISM,SET,26,0.24367,0.009163,0.16091,0.06498,KEGG_HISTIDINE_METABOLISM,0.807513420300214
HP_SEVERE_LACTIC_ACIDOSIS,SET,11,0.37909,0.009276,0.25035,0.064991,HP_SEVERE_LACTIC_ACIDOSIS,0.807513420300214
GOMF_RNA_ENDONUCLEASE_ACTIVI...1,SET,63,0.16137,0.009436,0.10658,0.06501,GOMF_RNA_ENDONUCLEASE_ACTIVITY,0.807513420300214
WP_MICRORNA_FOR_TARGETING_CA...,SET,7,0.46516,0.0090807,0.30732,0.065071,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,0.80755690376569
GSE8621_UNSTIM_VS_LPS_STIM_M...1,SET,175,0.091911,0.0089302,0.06077,0.06522,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.80755690376569
KEGG_MEDICUS_VARIANT_MUTATIO...76,SET,20,0.27115,0.0089443,0.17932,0.065263,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.80755690376569
SREBP1_Q6,SET,233,0.082576,0.009243,0.054627,0.065322,SREBP1_Q6,0.80755690376569
GSE36527_CD62L_HIGH_CD69_NEG...2,SET,180,0.092767,0.0091399,0.061372,0.065332,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_UP,0.80755690376569
REACTOME_RIP_MEDIATED_NFKB_A...,SET,16,0.32242,0.0095137,0.21332,0.065343,REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,0.80755690376569
GSE25085_FETAL_LIVER_VS_FETA...1,SET,183,0.097008,0.0096363,0.064187,0.065362,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN,0.80755690376569
GOBP_REGULATION_OF_PROTEIN_D...2,SET,69,0.15184,0.0092907,0.10047,0.065365,GOBP_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.80755690376569
GSE31082_CD4_VS_CD8_SP_THYMO...1,SET,179,0.092925,0.0091303,0.06149,0.065374,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN,0.80755690376569
GSE27786_LIN_NEG_VS_MONO_MAC...2,SET,181,0.088535,0.0087469,0.058586,0.065378,GSE27786_LIN_NEG_VS_MONO_MAC_UP,0.80755690376569
GOBP_DEFENSE_RESPONSE_TO_OTH...,SET,1091,0.041337,0.0097723,0.027357,0.065406,GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM,0.80755690376569
GOBP_UDP_N_ACETYLGLUCOSAMINE...1,SET,9,0.44362,0.0098191,0.29362,0.065424,GOBP_UDP_N_ACETYLGLUCOSAMINE_BIOSYNTHETIC_PROCESS,0.80755690376569
GOBP_MYELOID_CELL_DIFFERENTI...,SET,392,0.06717,0.0097093,0.044461,0.065433,GOBP_MYELOID_CELL_DIFFERENTIATION,0.80755690376569
HP_LIMB_GIRDLE_MUSCLE_WEAKNE...,SET,86,0.13509,0.0092238,0.089424,0.065442,HP_LIMB_GIRDLE_MUSCLE_WEAKNESS,0.80755690376569
HP_DECREASED_URINE_OUTPUT,SET,24,0.2795,0.010098,0.18501,0.065445,HP_DECREASED_URINE_OUTPUT,0.80755690376569
MANNO_MIDBRAIN_NEUROTYPES_HDA,SET,435,0.066665,0.010139,0.044136,0.065473,MANNO_MIDBRAIN_NEUROTYPES_HDA,0.80755690376569
KEGG_MEDICUS_REFERENCE_PDGF_...3,SET,16,0.32215,0.0095056,0.21328,0.065475,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY,0.80755690376569
GSE19941_LPS_VS_LPS_AND_IL10...3,SET,178,0.093533,0.0091645,0.061931,0.065496,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.80755690376569
HP_CHOANAL_STENOSIS,SET,25,0.25324,0.0093381,0.16771,0.065526,HP_CHOANAL_STENOSIS,0.80755690376569
HP_FLAT_CORNEA,SET,19,0.33545,0.010785,0.22215,0.065527,HP_FLAT_CORNEA,0.80755690376569
MIR5700,SET,269,0.078595,0.0094432,0.052051,0.065535,MIR5700,0.80755690376569
LU_TUMOR_ENDOTHELIAL_MARKERS...1,SET,4,0.53551,0.0079032,0.35472,0.065572,LU_TUMOR_ENDOTHELIAL_MARKERS_DN,0.80755690376569
HP_PHONOPHOBIA,SET,22,0.30834,0.010667,0.20425,0.065581,HP_PHONOPHOBIA,0.80755690376569
GSE1460_DP_VS_CD4_THYMOCYTE_...1,SET,189,0.10002,0.010096,0.066311,0.065733,GSE1460_DP_VS_CD4_THYMOCYTE_DN,0.80755690376569
GOBP_REGULATION_OF_ALPHA_BET...1,SET,107,0.13347,0.010159,0.088493,0.065753,GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.80755690376569
GOBP_PROTEIN_TARGETING,SET,295,0.072146,0.009071,0.047849,0.065815,GOBP_PROTEIN_TARGETING,0.80755690376569
GOBP_MICROTUBULE_NUCLEATION_...,SET,5,0.55482,0.0091543,0.36799,0.065827,GOBP_MICROTUBULE_NUCLEATION_BY_MICROTUBULE_ORGANIZING_CENTER,0.80755690376569
GSE17580_UNINFECTED_VS_S_MAN...3,SET,175,0.096498,0.0093758,0.064005,0.065829,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN,0.80755690376569
MIR4255,SET,155,0.10292,0.0094158,0.068269,0.065849,MIR4255,0.80755690376569
GSE9006_TYPE_1_VS_TYPE_2_DIA...1,SET,180,0.092066,0.0090708,0.061079,0.065873,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,0.80755690376569
PID_EPHB_FWD_PATHWAY,SET,39,0.19539,0.0089954,0.12964,0.065889,PID_EPHB_FWD_PATHWAY,0.80755690376569
PID_TCR_RAS_PATHWAY,SET,13,0.35081,0.0093313,0.23277,0.065902,PID_TCR_RAS_PATHWAY,0.80755690376569
GOCC_CYTOSOLIC_SMALL_RIBOSOM...,SET,35,0.20763,0.0090566,0.13779,0.065926,GOCC_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT,0.80755690376569
PAPASPYRIDONOS_UNSTABLE_ATER...1,SET,39,0.20431,0.0094061,0.13562,0.065979,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,0.80755690376569
HP_DYSPHONIA,SET,111,0.11763,0.0091184,0.078101,0.066023,HP_DYSPHONIA,0.80755690376569
HP_HYPERTENSIVE_CRISIS,SET,14,0.37657,0.010394,0.25003,0.066029,HP_HYPERTENSIVE_CRISIS,0.80755690376569
GOBP_POSITIVE_REGULATION_OF_...645,SET,81,0.13712,0.0090871,0.091045,0.066038,GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,0.80755690376569
GOBP_CHROMOSOME_LOCALIZATION,SET,112,0.11546,0.00899,0.076672,0.06606,GOBP_CHROMOSOME_LOCALIZATION,0.80755690376569
MILICIC_FAMILIAL_ADENOMATOUS...2,SET,9,0.443,0.0098056,0.2942,0.066071,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP,0.80755690376569
MANALO_HYPOXIA_DN,SET,263,0.073889,0.0087796,0.049071,0.066077,MANALO_HYPOXIA_DN,0.80755690376569
HP_DELAYED_GROSS_MOTOR_DEVEL...,SET,410,0.062885,0.0092915,0.041765,0.066085,HP_DELAYED_GROSS_MOTOR_DEVELOPMENT,0.80755690376569
QIU_PBMC_HEPTATITIS_B_SURFAC...5,SET,12,0.3955,0.010108,0.26269,0.066099,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_35DY_UP,0.80755690376569
GOBP_REGULATION_OF_LYMPHOCYT...6,SET,63,0.16411,0.0095967,0.10901,0.066104,GOBP_REGULATION_OF_LYMPHOCYTE_MIGRATION,0.80755690376569
FIGUEROA_AML_METHYLATION_CLU...11,SET,29,0.23729,0.0094228,0.15763,0.066127,FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,0.80755690376569
HP_ABNORMAL_URINE_PROTEIN_LE...,SET,212,0.085796,0.0091657,0.056996,0.066132,HP_ABNORMAL_URINE_PROTEIN_LEVEL,0.80755690376569
REACTOME_CONSTITUTIVE_SIGNAL...4,SET,18,0.2752,0.0086122,0.1829,0.06622,REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS,0.80755690376569
HOWLIN_CITED1_TARGETS_2_DN,SET,15,0.3599,0.010283,0.23921,0.066232,HOWLIN_CITED1_TARGETS_2_DN,0.80755690376569
GOBP_CALCIUM_ION_TRANSPORT,SET,396,0.066709,0.0096906,0.044341,0.06624,GOBP_CALCIUM_ION_TRANSPORT,0.80755690376569
WP_GENE_REGULATORY_NETWORK_M...,SET,11,0.3867,0.0094621,0.25705,0.066252,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,0.80755690376569
GSE37416_CTRL_VS_24H_F_TULAR...2,SET,166,0.1006,0.0095219,0.066879,0.066275,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.80755690376569
WANG_TARGETS_OF_MLL_CBP_FUSI...2,SET,43,0.19123,0.0092435,0.12714,0.066286,WANG_TARGETS_OF_MLL_CBP_FUSION_UP,0.80755690376569
HP_GOUT,SET,15,0.30529,0.0087223,0.203,0.066319,HP_GOUT,0.80755690376569
LAMB_CCND1_TARGETS,SET,18,0.30897,0.0096693,0.20551,0.06637,LAMB_CCND1_TARGETS,0.80755690376569
GOBP_PROTEIN_POLYMERIZATION,SET,253,0.078573,0.0091596,0.052263,0.066375,GOBP_PROTEIN_POLYMERIZATION,0.80755690376569
GOMF_HISTONE_BINDING,SET,204,0.084643,0.0088722,0.056305,0.066389,GOMF_HISTONE_BINDING,0.80755690376569
HP_HYPEREXTENSIBILITY_AT_ELB...,SET,6,0.5175,0.0093533,0.34428,0.06641,HP_HYPEREXTENSIBILITY_AT_ELBOW,0.80755690376569
GSE17974_CTRL_VS_ACT_IL4_AND...7,SET,176,0.090056,0.0087747,0.059916,0.066423,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN,0.80755690376569
KEGG_MEDICUS_VARIANT_MUTATIO...63,SET,27,0.22758,0.0087207,0.15144,0.066456,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT,0.80755690376569
GSE22443_NAIVE_VS_ACT_AND_IL...4,SET,188,0.097216,0.0097866,0.064693,0.066463,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_UP,0.80755690376569
CLIMENT_BREAST_CANCER_COPY_N...2,SET,23,0.28655,0.010135,0.19069,0.066469,CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,0.80755690376569
GOBP_SIGNAL_PEPTIDE_PROCESSI...,SET,13,0.3368,0.0089587,0.2242,0.066529,GOBP_SIGNAL_PEPTIDE_PROCESSING,0.80755690376569
LIANG_SILENCED_BY_METHYLATIO...3,SET,26,0.28112,0.010571,0.18714,0.066532,LIANG_SILENCED_BY_METHYLATION_UP,0.80755690376569
GOBP_REGULATION_OF_RETINOIC_...,SET,15,0.3121,0.008917,0.20778,0.06655,GOBP_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.80755690376569
QUINTENS_EMBRYONIC_BRAIN_RES...,SET,73,0.14658,0.0092238,0.097584,0.066551,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,0.80755690376569
GOMF_PROTEIN_ARGININE_N_METH...,SET,12,0.33096,0.0084581,0.22039,0.066597,GOMF_PROTEIN_ARGININE_N_METHYLTRANSFERASE_ACTIVITY,0.80755690376569
MIR27B_5P,SET,43,0.1902,0.0091936,0.12666,0.066607,MIR27B_5P,0.80755690376569
BILD_E2F3_ONCOGENIC_SIGNATURE,SET,223,0.085709,0.0093881,0.057081,0.066617,BILD_E2F3_ONCOGENIC_SIGNATURE,0.80755690376569
GOBP_POSITIVE_REGULATION_OF_...494,SET,6,0.60379,0.010913,0.40212,0.066618,GOBP_POSITIVE_REGULATION_OF_MUCUS_SECRETION,0.80755690376569
GSE17721_LPS_VS_PAM3CSK4_0.5...2,SET,180,0.091876,0.0090521,0.061195,0.066638,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_UP,0.80755690376569
GOBP_POSITIVE_REGULATION_OF_...197,SET,7,0.46632,0.0091034,0.3106,0.06664,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,0.80755690376569
KAMMINGA_EZH2_TARGETS,SET,40,0.19373,0.0090326,0.12911,0.066754,KAMMINGA_EZH2_TARGETS,0.808628963414634
MIR1245A,SET,34,0.23226,0.0099852,0.1548,0.066775,MIR1245A,0.808628963414634
HP_LATE_FIRST_TRIMESTER_ONSET,SET,7,0.44119,0.0086127,0.2941,0.066799,HP_LATE_FIRST_TRIMESTER_ONSET,0.808637842215256
GOBP_EMBRYONIC_FORELIMB_MORP...,SET,32,0.24455,0.0102,0.16309,0.06688,GOBP_EMBRYONIC_FORELIMB_MORPHOGENESIS,0.809144754782609
MAPK3_TARGET_GENES,SET,69,0.1459,0.0089272,0.097316,0.066913,MAPK3_TARGET_GENES,0.809144754782609
GSE25085_FETAL_BM_VS_ADULT_B...1,SET,179,0.096251,0.0094571,0.064206,0.066931,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,0.809144754782609
MODULE_387,SET,48,0.18768,0.0095834,0.12519,0.066934,MODULE_387,0.809144754782609
NAKAMURA_ADIPOGENESIS_EARLY_...2,SET,57,0.18121,0.010081,0.12091,0.066984,NAKAMURA_ADIPOGENESIS_EARLY_UP,0.809319160583942
MIR5685,SET,58,0.16623,0.009328,0.11092,0.066995,MIR5685,0.809319160583942
HP_PROGRESSIVE_MUSCLE_WEAKNE...,SET,64,0.1543,0.0090937,0.10298,0.067041,HP_PROGRESSIVE_MUSCLE_WEAKNESS,0.809593452050035
BENPORATH_ES_1,SET,337,0.067394,0.0090462,0.044987,0.067065,BENPORATH_ES_1,0.809601971170545
GOBP_REGULATION_OF_NEUTROPHI...3,SET,8,0.42443,0.0088574,0.28338,0.067112,GOBP_REGULATION_OF_NEUTROPHIL_DEGRANULATION,0.809742312737314
GSE6269_FLU_VS_STAPH_AUREUS_...1,SET,146,0.10573,0.0093907,0.070613,0.067162,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_DN,0.809742312737314
HP_HYPODONTIA,SET,206,0.087275,0.0091924,0.058313,0.067249,HP_HYPODONTIA,0.809742312737314
WP_WNT_SIGNALING_IN_KIDNEY_D...,SET,34,0.24209,0.010408,0.16176,0.067256,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,0.809742312737314
HP_FOCAL_HEAD_NODDING_AUTOMA...,SET,5,0.55882,0.0092203,0.37349,0.067308,HP_FOCAL_HEAD_NODDING_AUTOMATISM_SEIZURE,0.809742312737314
TRAVAGLINI_LUNG_ALVEOLAR_FIB...,SET,149,0.11374,0.010204,0.076026,0.067333,TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL,0.809742312737314
HP_NECK_FLEXOR_WEAKNESS,SET,43,0.1819,0.0087922,0.12159,0.06734,HP_NECK_FLEXOR_WEAKNESS,0.809742312737314
HP_ABNORMAL_HEART_VALVE_MORP...,SET,307,0.073919,0.009478,0.049417,0.067356,HP_ABNORMAL_HEART_VALVE_MORPHOLOGY,0.809742312737314
GOBP_REGULATION_OF_CATECHOLA...1,SET,15,0.32745,0.0093553,0.21892,0.067375,GOBP_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,0.809742312737314
GOBP_REGULATION_OF_CHOLESTER...2,SET,35,0.2087,0.0091032,0.13954,0.067381,GOBP_REGULATION_OF_CHOLESTEROL_EFFLUX,0.809742312737314
GOBP_REGULATION_OF_RNA_POLYM...1,SET,6,0.50481,0.0091241,0.33754,0.06739,GOBP_REGULATION_OF_RNA_POLYMERASE_II_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.809742312737314
HP_SHORT_PROXIMAL_PHALANX_OF...,SET,7,0.48165,0.0094027,0.32213,0.06744,HP_SHORT_PROXIMAL_PHALANX_OF_FINGER,0.809742312737314
GSE18804_SPLEEN_MACROPHAGE_V...1,SET,170,0.095796,0.0091749,0.064071,0.067445,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN,0.809742312737314
GOCC_ORIGIN_RECOGNITION_COMP...,SET,8,0.41213,0.0086008,0.27567,0.067464,GOCC_ORIGIN_RECOGNITION_COMPLEX,0.809742312737314
HP_ABNORMAL_NASAL_MUCOSA_MOR...,SET,69,0.14996,0.0091755,0.10032,0.067482,HP_ABNORMAL_NASAL_MUCOSA_MORPHOLOGY,0.809742312737314
GNF2_ICAM3,SET,34,0.21053,0.0090511,0.14084,0.067486,GNF2_ICAM3,0.809742312737314
WP_PROGERIAASSOCIATED_LIPODY...,SET,21,0.27086,0.0091549,0.1812,0.067491,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,0.809742312737314
HP_ABNORMALITY_OF_THE_OVARY,SET,216,0.085198,0.0091862,0.056997,0.067496,HP_ABNORMALITY_OF_THE_OVARY,0.809742312737314
ZSCAN4_TARGET_GENES,SET,1097,0.039688,0.0094067,0.026555,0.067522,ZSCAN4_TARGET_GENES,0.809774710144928
MIR646,SET,225,0.083754,0.0092145,0.056057,0.067585,MIR646,0.809859788004136
GOBP_NEGATIVE_REGULATION_OF_...402,SET,79,0.14605,0.0095591,0.09775,0.067587,GOBP_NEGATIVE_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.809859788004136
HP_ASCENDING_TUBULAR_AORTA_A...,SET,26,0.25384,0.0095453,0.16991,0.067599,HP_ASCENDING_TUBULAR_AORTA_ANEURYSM,0.809859788004136
KEGG_MEDICUS_REFERENCE_WNT5A...,SET,15,0.36293,0.010369,0.24297,0.067632,KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY,0.809975933838732
REACTOME_DOWNREGULATION_OF_T...,SET,25,0.22715,0.0083762,0.1521,0.067672,REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,0.810175804340338
GOBP_REGULATION_OF_TRANSLATI...7,SET,8,0.4287,0.0089466,0.28713,0.067718,GOBP_REGULATION_OF_TRANSLATIONAL_TERMINATION,0.810447345041322
HP_ABNORMALITY_OF_THE_TARSAL...,SET,113,0.1223,0.0095652,0.081935,0.067767,HP_ABNORMALITY_OF_THE_TARSAL_BONES,0.810754590361446
NAKAYA_B_CELL_FLUARIX_FLUVIR...1,SET,261,0.073153,0.0086595,0.049017,0.067805,NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.810930067102546
REACTOME_P75NTR_SIGNALS_VIA_...,SET,14,0.35228,0.009724,0.23611,0.067855,REACTOME_P75NTR_SIGNALS_VIA_NF_KB,0.811184080479452
GOBP_POSITIVE_REGULATION_OF_...717,SET,11,0.37739,0.0092343,0.25296,0.067875,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.811184080479452
HP_TEMPORAL_CORTICAL_ATROPHY,SET,17,0.29773,0.0090551,0.19963,0.067939,HP_TEMPORAL_CORTICAL_ATROPHY,0.811184080479452
HP_FIRST_DORSAL_INTEROSSEI_M...,SET,7,0.51734,0.010099,0.3469,0.067945,HP_FIRST_DORSAL_INTEROSSEI_MUSCLE_WEAKNESS,0.811184080479452
GOBP_ANTIBACTERIAL_HUMORAL_R...,SET,48,0.22246,0.01136,0.1492,0.067989,GOBP_ANTIBACTERIAL_HUMORAL_RESPONSE,0.811184080479452
GOCC_PHOSPHATASE_COMPLEX,SET,49,0.16925,0.0087319,0.11354,0.068022,GOCC_PHOSPHATASE_COMPLEX,0.811184080479452
HP_ABNORMAL_MIDFACE_MORPHOLO...,SET,533,0.054244,0.0091069,0.036388,0.068029,HP_ABNORMAL_MIDFACE_MORPHOLOGY,0.811184080479452
GSE21670_IL6_VS_TGFB_AND_IL6...1,SET,188,0.091213,0.0091823,0.061191,0.06804,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,0.811184080479452
REACTOME_DNA_REPLICATION_INI...,SET,7,0.3904,0.0076212,0.26191,0.068048,REACTOME_DNA_REPLICATION_INITIATION,0.811184080479452
GSE7460_CD8_TCELL_VS_CD4_TCE...2,SET,173,0.096501,0.0093229,0.064749,0.068071,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP,0.811184080479452
GSE24026_PD1_LIGATION_VS_CTR...2,SET,180,0.094393,0.0093001,0.063339,0.068086,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP,0.811184080479452
GOMF_POLYSACCHARIDE_BINDING,SET,21,0.29986,0.010135,0.20126,0.068132,GOMF_POLYSACCHARIDE_BINDING,0.811184080479452
chr10p12,SET,46,0.33645,0.016819,0.22583,0.068142,chr10p12,0.811184080479452
GSE40274_GATA1_VS_FOXP3_AND_...1,SET,181,0.095687,0.0094535,0.06423,0.068153,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.811184080479452
WP_ERK_PATHWAY_IN_HUNTINGTON...,SET,16,0.34884,0.010293,0.23422,0.068204,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,0.811513187264635
GOBP_REGULATION_OF_T_HELPER_...1,SET,22,0.27866,0.0096401,0.18714,0.068249,GOBP_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION,0.811551232565683
GOBP_CELLULAR_RESPONSE_TO_DE...,SET,27,0.26634,0.010206,0.17888,0.068266,GOBP_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS,0.811551232565683
GSE21670_STAT3_KO_VS_WT_CD4_...7,SET,180,0.089443,0.0088124,0.060078,0.068283,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP,0.811551232565683
GSE15930_STIM_VS_STIM_AND_IF...6,SET,171,0.094881,0.0091137,0.06375,0.068342,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP,0.811551232565683
GSE360_DC_VS_MAC_T_GONDII_UP,SET,182,0.098414,0.0097495,0.066127,0.068351,GSE360_DC_VS_MAC_T_GONDII_UP,0.811551232565683
GSE2706_UNSTIM_VS_2H_R848_DC...1,SET,172,0.10218,0.0098431,0.068662,0.068365,GSE2706_UNSTIM_VS_2H_R848_DC_DN,0.811551232565683
GOCC_I_BAND,SET,137,0.10989,0.0094568,0.073853,0.068389,GOCC_I_BAND,0.811551232565683
HP_GENERALIZED_CLONIC_SEIZURE,SET,28,0.25087,0.0097891,0.16866,0.068457,HP_GENERALIZED_CLONIC_SEIZURE,0.811551232565683
BCAT.100_UP.V1_UP,SET,45,0.21239,0.010501,0.14279,0.068469,BCAT.100_UP.V1_UP,0.811551232565683
GOBP_INNATE_IMMUNE_RESPONSE_...2,SET,12,0.42269,0.010802,0.2843,0.068547,GOBP_INNATE_IMMUNE_RESPONSE_IN_MUCOSA,0.811551232565683
MIR34C_3P,SET,58,0.15417,0.0086515,0.10371,0.068563,MIR34C_3P,0.811551232565683
GOBP_PROTEIN_NEDDYLATION,SET,27,0.22335,0.0085586,0.15026,0.068587,GOBP_PROTEIN_NEDDYLATION,0.811551232565683
KEGG_MEDICUS_VARIANT_MUTATIO...37,SET,17,0.32029,0.0097415,0.21551,0.068616,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT,0.811551232565683
E2F_03,SET,218,0.083543,0.0090489,0.056225,0.068668,E2F_03,0.811551232565683
GOMF_LIPOPEPTIDE_BINDING,SET,10,0.57155,0.013335,0.3847,0.068689,GOMF_LIPOPEPTIDE_BINDING,0.811551232565683
HP_NEOPLASM_OF_THE_ENDOCRINE...,SET,150,0.10017,0.0090166,0.067452,0.068777,HP_NEOPLASM_OF_THE_ENDOCRINE_SYSTEM,0.811551232565683
HP_UNDERFOLDED_HELIX,SET,4,0.71446,0.010544,0.48118,0.068806,HP_UNDERFOLDED_HELIX,0.811551232565683
GOBP_INTERLEUKIN_17_PRODUCTI...,SET,37,0.22664,0.010164,0.15266,0.068829,GOBP_INTERLEUKIN_17_PRODUCTION,0.811551232565683
GSE43955_TH0_VS_TGFB_IL6_TH1...2,SET,184,0.092752,0.0092384,0.062483,0.068856,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_UP,0.811551232565683
MORF_JUND,SET,57,0.15699,0.0087334,0.10576,0.068865,MORF_JUND,0.811551232565683
GOBP_LEUKOCYTE_MEDIATED_CYTO...,SET,133,0.12121,0.010279,0.081691,0.068942,GOBP_LEUKOCYTE_MEDIATED_CYTOTOXICITY,0.811551232565683
KEGG_MEDICUS_REFERENCE_P4_PR...2,SET,15,0.31823,0.0090921,0.2145,0.068969,KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY,0.811551232565683
GOBP_REGULATION_OF_MONOATOMI...4,SET,410,0.065188,0.0096318,0.043951,0.069021,GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,0.811551232565683
GSE39864_WT_VS_GATA3_KO_TREG...2,SET,188,0.094389,0.009502,0.063652,0.069061,GSE39864_WT_VS_GATA3_KO_TREG_UP,0.811551232565683
GOBP_FEVER_GENERATION,SET,11,0.43425,0.010626,0.29287,0.06908,GOBP_FEVER_GENERATION,0.811551232565683
HP_ABNORMAL_PERIPHERAL_NERVO...1,SET,360,0.064433,0.0089332,0.04346,0.069103,HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_MORPHOLOGY,0.811551232565683
HP_ABNORMAL_SARCOMERE_MORPHO...,SET,12,0.36706,0.0093807,0.24759,0.069112,HP_ABNORMAL_SARCOMERE_MORPHOLOGY,0.811551232565683
GOBP_RESPIRATORY_SYSTEM_PROC...,SET,40,0.21056,0.0098173,0.14204,0.069123,GOBP_RESPIRATORY_SYSTEM_PROCESS,0.811551232565683
MIR6747_3P,SET,105,0.12398,0.0093491,0.083637,0.069124,MIR6747_3P,0.811551232565683
GOBP_ADENYLATE_CYCLASE_INHIB...4,SET,77,0.15536,0.01004,0.1048,0.06913,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.811551232565683
HP_HYPERTELORISM,SET,721,0.046645,0.00906,0.031469,0.069147,HP_HYPERTELORISM,0.811551232565683
GOBP_POSITIVE_REGULATION_OF_...204,SET,49,0.18243,0.0094117,0.12309,0.069161,GOBP_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION,0.811551232565683
GOCC_CHROMOSOME_TELOMERIC_RE...1,SET,134,0.10129,0.0086212,0.068344,0.069176,GOCC_CHROMOSOME_TELOMERIC_REGION,0.811551232565683
HP_SEVERE_HEARING_IMPAIRMENT,SET,14,0.31426,0.0086743,0.21206,0.069187,HP_SEVERE_HEARING_IMPAIRMENT,0.811551232565683
GSE34156_NOD2_LIGAND_VS_TLR1...2,SET,152,0.10097,0.009149,0.068147,0.069219,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,0.811551232565683
MANNE_COVID19_NONICU_VS_HEAL...2,SET,129,0.10763,0.0089898,0.072641,0.069222,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,0.811551232565683
GOCC_AZUROPHIL_GRANULE_LUMEN,SET,81,0.13975,0.0092613,0.094324,0.06924,GOCC_AZUROPHIL_GRANULE_LUMEN,0.811551232565683
NIKOLSKY_BREAST_CANCER_1Q21_...,SET,34,0.30219,0.012992,0.20397,0.069242,NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON,0.811551232565683
KRAS.600_UP.V1_UP,SET,249,0.086498,0.010004,0.058404,0.069307,KRAS.600_UP.V1_UP,0.811551232565683
GOMF_SEROTONIN_RECEPTOR_ACTI...,SET,6,0.62592,0.011313,0.42264,0.069315,GOMF_SEROTONIN_RECEPTOR_ACTIVITY,0.811551232565683
REACTOME_NOTCH2_ACTIVATION_A...,SET,20,0.28628,0.0094433,0.19333,0.069335,REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,0.811551232565683
GENTILE_UV_LOW_DOSE_UP,SET,23,0.26163,0.009254,0.17668,0.069342,GENTILE_UV_LOW_DOSE_UP,0.811551232565683
GSE5455_HEALTHY_VS_TUMOR_BEA...1,SET,179,0.095073,0.0093413,0.064216,0.069376,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN,0.811551232565683
GOBP_REGULATION_OF_RNA_BINDI...,SET,6,0.46978,0.0084909,0.31734,0.069394,GOBP_REGULATION_OF_RNA_BINDING,0.811551232565683
GOBP_SODIUM_ION_TRANSMEMBRAN...,SET,177,0.10001,0.0097719,0.067558,0.069397,GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,0.811551232565683
GOBP_TRANSMEMBRANE_TRANSPORT,SET,1409,0.035585,0.0094718,0.02404,0.069415,GOBP_TRANSMEMBRANE_TRANSPORT,0.811551232565683
GOBP_REGULATION_OF_SYNAPTIC_...9,SET,17,0.28907,0.0087918,0.19535,0.069475,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS,0.811551232565683
GSE45365_WT_VS_IFNAR_KO_BCEL...4,SET,161,0.093426,0.0087101,0.063138,0.069483,GSE45365_WT_VS_IFNAR_KO_BCELL_UP,0.811551232565683
chr11p13,SET,36,0.44104,0.01951,0.29806,0.069484,chr11p13,0.811551232565683
UDAYAKUMAR_MED1_TARGETS_DN,SET,212,0.085294,0.009112,0.057643,0.069488,UDAYAKUMAR_MED1_TARGETS_DN,0.811551232565683
GOBP_INTERLEUKIN_12_MEDIATED...,SET,9,0.4068,0.0090044,0.27494,0.069496,GOBP_INTERLEUKIN_12_MEDIATED_SIGNALING_PATHWAY,0.811551232565683
MANNO_MIDBRAIN_NEUROTYPES_HO...2,SET,324,0.074994,0.0098738,0.050687,0.069505,MANNO_MIDBRAIN_NEUROTYPES_HOPC,0.811551232565683
MUELLER_METHYLATED_IN_GLIOBL...,SET,35,0.21004,0.0091615,0.14197,0.069517,MUELLER_METHYLATED_IN_GLIOBLASTOMA,0.811551232565683
GSE24142_EARLY_THYMIC_PROGEN...10,SET,187,0.089964,0.0090328,0.060809,0.069519,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN,0.811551232565683
REACTOME_OAS_ANTIVIRAL_RESPO...,SET,7,0.61474,0.012001,0.41552,0.06952,REACTOME_OAS_ANTIVIRAL_RESPONSE,0.811551232565683
FORTSCHEGGER_PHF8_TARGETS_DN,SET,684,0.047868,0.0090652,0.032362,0.069561,FORTSCHEGGER_PHF8_TARGETS_DN,0.811551232565683
HP_BROAD_NAIL,SET,8,0.46885,0.0097845,0.31702,0.069586,HP_BROAD_NAIL,0.811551232565683
GSE42021_TREG_VS_TCONV_PLN_UP,SET,186,0.095451,0.0095583,0.064543,0.069595,GSE42021_TREG_VS_TCONV_PLN_UP,0.811551232565683
HP_ABNORMAL_LOWER_LIMB_MOTOR...,SET,5,0.53999,0.0089098,0.36519,0.069623,HP_ABNORMAL_LOWER_LIMB_MOTOR_EVOKED_POTENTIALS,0.811551232565683
GOBP_REGULATION_OF_CELL_PROJ...2,SET,613,0.05213,0.0093647,0.035256,0.06963,GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.811551232565683
HP_BROAD_EYEBROW,SET,23,0.25814,0.0091307,0.17461,0.069654,HP_BROAD_EYEBROW,0.811551232565683
HP_CUTANEOUS_ABSCESS,SET,23,0.25681,0.0090835,0.17372,0.069675,HP_CUTANEOUS_ABSCESS,0.811551232565683
MIR6828_3P,SET,107,0.12165,0.0092594,0.082305,0.069709,MIR6828_3P,0.811551232565683
GOBP_POSITIVE_REGULATION_OF_...421,SET,5,0.54152,0.0089349,0.3664,0.069719,GOBP_POSITIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY,0.811551232565683
GOBP_POSITIVE_REGULATION_OF_...512,SET,13,0.36797,0.0097877,0.24899,0.069731,GOBP_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.811551232565683
GNF2_TTN,SET,26,0.23109,0.0086899,0.15645,0.069833,GNF2_TTN,0.811551232565683
GOBP_RESPONSE_TO_FUNGUS,SET,54,0.17989,0.0097413,0.12183,0.06991,GOBP_RESPONSE_TO_FUNGUS,0.811551232565683
HP_TALIPES_EQUINOVARUS,SET,347,0.068217,0.0092889,0.046203,0.069919,HP_TALIPES_EQUINOVARUS,0.811551232565683
GSE40274_FOXP3_VS_FOXP3_AND_...16,SET,134,0.1065,0.009065,0.072151,0.06997,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.811551232565683
GOBP_NEGATIVE_REGULATION_OF_...525,SET,29,0.21749,0.0086366,0.14735,0.069983,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,0.811551232565683
BIOCARTA_RNAPOL3_PATHWAY,SET,7,0.3411,0.0066588,0.23113,0.070009,BIOCARTA_RNAPOL3_PATHWAY,0.811551232565683
NABA_MATRISOME_POORLY_METAST...1,SET,25,0.26065,0.0096114,0.17663,0.070025,NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER,0.811551232565683
HP_NARROW_VERTEBRAL_INTERPED...,SET,13,0.33117,0.0088087,0.22446,0.070062,HP_NARROW_VERTEBRAL_INTERPEDICULAR_DISTANCE,0.811551232565683
HP_ABNORMALITY_OF_PAIN_SENSA...,SET,90,0.13212,0.0092272,0.089559,0.070087,HP_ABNORMALITY_OF_PAIN_SENSATION,0.811551232565683
GSE9946_MATURE_STIMULATORY_V...3,SET,117,0.11774,0.0093684,0.079829,0.070136,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,0.811551232565683
GOBP_REGULATION_OF_T_CELL_ME...1,SET,47,0.20888,0.010554,0.14165,0.070168,GOBP_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,0.811551232565683
GOBP_REGULATION_OF_CILIUM_AS...,SET,89,0.13026,0.0090471,0.088339,0.070173,GOBP_REGULATION_OF_CILIUM_ASSEMBLY,0.811551232565683
HP_COMPLETE_DUPLICATION_OF_P...,SET,11,0.35629,0.0087181,0.24162,0.070173,HP_COMPLETE_DUPLICATION_OF_PHALANX_OF_HAND,0.811551232565683
GOBP_FILOPODIUM_ASSEMBLY,SET,60,0.17379,0.0099183,0.11786,0.070182,GOBP_FILOPODIUM_ASSEMBLY,0.811551232565683
TTGCACT_MIR130A_MIR301_MIR13...,SET,352,0.066519,0.0091216,0.045122,0.070223,TTGCACT_MIR130A_MIR301_MIR130B,0.811551232565683
GOBP_PHOSPHATIDYLINOSITOL_DE...,SET,24,0.2079,0.0075113,0.14104,0.070254,GOBP_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,0.811551232565683
GOCC_ENDONUCLEASE_COMPLEX,SET,35,0.20726,0.0090404,0.14065,0.070304,GOCC_ENDONUCLEASE_COMPLEX,0.811551232565683
HP_SEVERELY_REDUCED_LEFT_VEN...,SET,13,0.29137,0.0077503,0.19777,0.070344,HP_SEVERELY_REDUCED_LEFT_VENTRICULAR_EJECTION_FRACTION,0.811551232565683
GOMF_NITRIC_OXIDE_SYNTHASE_B...,SET,10,0.39321,0.009174,0.2669,0.070351,GOMF_NITRIC_OXIDE_SYNTHASE_BINDING,0.811551232565683
GSE29618_BCELL_VS_MONOCYTE_D...2,SET,169,0.1005,0.0095977,0.068222,0.070361,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP,0.811551232565683
HP_SOMATIC_SENSORY_DYSFUNCTI...,SET,379,0.063379,0.0090113,0.043024,0.07037,HP_SOMATIC_SENSORY_DYSFUNCTION,0.811551232565683
AKT_UP.V1_DN,SET,178,0.095945,0.0094008,0.065135,0.070382,AKT_UP.V1_DN,0.811551232565683
MIR216A_5P,SET,118,0.1151,0.0091977,0.078147,0.070397,MIR216A_5P,0.811551232565683
HP_ADVANCED_ERUPTION_OF_TEETH,SET,37,0.19476,0.0087339,0.13223,0.07041,HP_ADVANCED_ERUPTION_OF_TEETH,0.811551232565683
ZNF589_TARGET_GENES,SET,509,0.055577,0.0091243,0.037736,0.070413,ZNF589_TARGET_GENES,0.811551232565683
HOLLEMAN_DAUNORUBICIN_ALL_DN,SET,8,0.43459,0.0090695,0.29509,0.070418,HOLLEMAN_DAUNORUBICIN_ALL_DN,0.811551232565683
GSE22935_24H_VS_48H_MBOVIS_B...1,SET,181,0.089472,0.0088395,0.060755,0.070429,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.811551232565683
GOBP_REGULATION_OF_IMMUNE_EF...,SET,356,0.06976,0.009619,0.047377,0.070459,GOBP_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,0.811551232565683
GOBP_POST_EMBRYONIC_CAMERA_T...,SET,8,0.48805,0.010185,0.33152,0.070497,GOBP_POST_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,0.811551232565683
HP_ABNORMAL_CSF_PROTEIN_CONC...,SET,45,0.19161,0.009474,0.13018,0.070541,HP_ABNORMAL_CSF_PROTEIN_CONCENTRATION,0.811551232565683
GOCC_TERTIARY_GRANULE_MEMBRA...,SET,63,0.1515,0.0088589,0.10294,0.070554,GOCC_TERTIARY_GRANULE_MEMBRANE,0.811551232565683
GSE15659_NAIVE_CD4_TCELL_VS_...3,SET,175,0.095295,0.009259,0.064758,0.070578,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,0.811551232565683
HP_DECREASED_PATELLAR_REFLEX,SET,9,0.3981,0.0088116,0.27054,0.070587,HP_DECREASED_PATELLAR_REFLEX,0.811551232565683
GOBP_NEUROENDOCRINE_CELL_DIF...,SET,16,0.37073,0.010939,0.25195,0.070596,GOBP_NEUROENDOCRINE_CELL_DIFFERENTIATION,0.811551232565683
MIR6870_5P,SET,199,0.086681,0.0089751,0.058919,0.070627,MIR6870_5P,0.811551232565683
HP_EMG_DECREMENTAL_RESPONSE_...,SET,28,0.23278,0.0090833,0.15824,0.070648,HP_EMG_DECREMENTAL_RESPONSE_OF_COMPOUND_MUSCLE_ACTION_POTENTIAL_TO_REPETITIVE_NERVE_STIMULATION,0.811551232565683
MIR4292,SET,143,0.10318,0.0090706,0.070149,0.070664,MIR4292,0.811551232565683
MIR6727_3P,SET,102,0.1243,0.0092385,0.084533,0.070737,MIR6727_3P,0.811551232565683
MIR4690_3P,SET,57,0.16408,0.0091279,0.11159,0.070739,MIR4690_3P,0.811551232565683
HP_ABNORMALITY_OF_THE_MUSCUL...5,SET,243,0.078808,0.009006,0.053609,0.070783,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_LIMBS,0.811551232565683
GOCC_MYOFILAMENT,SET,25,0.2465,0.0090897,0.1677,0.070807,GOCC_MYOFILAMENT,0.811551232565683
GOBP_CELL_CELL_ADHESION_INVO...,SET,11,0.38105,0.0093239,0.25925,0.070817,GOBP_CELL_CELL_ADHESION_INVOLVED_IN_GASTRULATION,0.811551232565683
HP_CYSTIC_LIVER_DISEASE,SET,40,0.17773,0.0082865,0.12094,0.070847,HP_CYSTIC_LIVER_DISEASE,0.811551232565683
GOMF_PHOSPHOTRANSFERASE_ACTI...1,SET,21,0.25976,0.00878,0.17679,0.070875,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS,0.811551232565683
MIR4433A_3P,SET,53,0.16294,0.0087417,0.11097,0.071011,MIR4433A_3P,0.811551232565683
GAO_STOMACH_24W_C4_PARIETAL_...,SET,8,0.4674,0.0097543,0.31832,0.071016,GAO_STOMACH_24W_C4_PARIETAL_PROGENITOR,0.811551232565683
WP_CARDIOMYOCYTE_SIGNALING_C...,SET,31,0.22677,0.0093102,0.15444,0.071017,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,0.811551232565683
GOMF_N_ACETYLGLUCOSAMINE_6_O...,SET,6,0.56303,0.010176,0.38347,0.071028,GOMF_N_ACETYLGLUCOSAMINE_6_O_SULFOTRANSFERASE_ACTIVITY,0.811551232565683
GOBP_POSITIVE_REGULATION_OF_...13,SET,6,0.47256,0.0085412,0.32187,0.071038,GOBP_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.811551232565683
GOMF_INOSITOL_TETRAKISPHOSPH...2,SET,7,0.45266,0.0088368,0.30837,0.071073,GOMF_INOSITOL_TETRAKISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.811551232565683
GSE2770_IL4_ACT_VS_ACT_CD4_T...1,SET,176,0.091322,0.008898,0.062218,0.071092,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,0.811551232565683
LEE_LIVER_CANCER_HEPATOBLAST,SET,15,0.35412,0.010117,0.24127,0.071099,LEE_LIVER_CANCER_HEPATOBLAST,0.811551232565683
GOBP_NEGATIVE_REGULATION_OF_...585,SET,2,1.0408,0.010862,0.70913,0.071105,GOBP_NEGATIVE_REGULATION_OF_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.811551232565683
BARX1_TARGET_GENES,SET,1024,0.038865,0.0089186,0.026483,0.071124,BARX1_TARGET_GENES,0.811551232565683
GSE13547_CTRL_VS_ANTI_IGM_ST...7,SET,149,0.09868,0.0088533,0.067242,0.071125,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_DN,0.811551232565683
WEBER_METHYLATED_IN_COLON_CA...,SET,18,0.3154,0.0098704,0.21492,0.071127,WEBER_METHYLATED_IN_COLON_CANCER,0.811551232565683
GSE1925_CTRL_VS_24H_IFNG_STI...4,SET,176,0.092194,0.0089829,0.062825,0.071134,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP,0.811551232565683
GOMF_3_PHOSPHOADENOSINE_5_PH...,SET,9,0.42253,0.0093525,0.28795,0.071147,GOMF_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_BINDING,0.811551232565683
FOURNIER_ACINAR_DEVELOPMENT_...2,SET,18,0.32865,0.010285,0.22399,0.071161,FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,0.811551232565683
GOBP_COENZYME_A_BIOSYNTHETIC...,SET,10,0.36146,0.0084332,0.24638,0.071189,GOBP_COENZYME_A_BIOSYNTHETIC_PROCESS,0.811551232565683
WP_MAMMALIAN_DISORDER_OF_SEX...,SET,24,0.26895,0.0097174,0.18335,0.071215,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,0.811551232565683
chr16p11,SET,88,0.28176,0.01946,0.19209,0.071216,chr16p11,0.811551232565683
HP_ABNORMAL_RENAL_CORTEX_MOR...,SET,200,0.08681,0.0090107,0.059187,0.071237,HP_ABNORMAL_RENAL_CORTEX_MORPHOLOGY,0.811551232565683
GOMF_NUCLEAR_EXPORT_SIGNAL_R...,SET,11,0.34614,0.0084698,0.236,0.071238,GOMF_NUCLEAR_EXPORT_SIGNAL_RECEPTOR_ACTIVITY,0.811551232565683
GOMF_INOSITOL_PHOSPHATE_PHOS...,SET,18,0.26146,0.0081824,0.17829,0.071262,GOMF_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.811551232565683
ALONSO_METASTASIS_NEURAL_UP,SET,15,0.34578,0.0098792,0.23581,0.071285,ALONSO_METASTASIS_NEURAL_UP,0.811551232565683
HP_URETHRAL_OBSTRUCTION,SET,60,0.16478,0.0094042,0.11238,0.07129,HP_URETHRAL_OBSTRUCTION,0.811551232565683
BIOCARTA_ERK_PATHWAY,SET,26,0.25393,0.0095487,0.17322,0.07134,BIOCARTA_ERK_PATHWAY,0.811551232565683
GOBP_NEGATIVE_REGULATION_OF_...677,SET,5,0.60105,0.0099171,0.41017,0.071419,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MIGRATION,0.811551232565683
ZNF502_TARGET_GENES,SET,25,0.23324,0.0086008,0.15923,0.07149,ZNF502_TARGET_GENES,0.811551232565683
REACTOME_PARASITE_INFECTION,SET,56,0.15535,0.0085664,0.10606,0.071495,REACTOME_PARASITE_INFECTION,0.811551232565683
LAKE_ADULT_KIDNEY_C9_THIN_AS...,SET,246,0.079995,0.0091972,0.054613,0.0715,LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB,0.811551232565683
GOBP_LYMPHOCYTE_MIGRATION_IN...,SET,9,0.45129,0.0099889,0.3081,0.071504,GOBP_LYMPHOCYTE_MIGRATION_INTO_LYMPHOID_ORGANS,0.811551232565683
MIR6780B_5P,SET,258,0.075998,0.0089452,0.051888,0.071517,MIR6780B_5P,0.811551232565683
ERWIN_COHEN_PBMC_TC_83_AGE_1...2,SET,14,0.34606,0.0095521,0.23633,0.071564,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_DN,0.811551232565683
MIR6884_5P,SET,132,0.10592,0.0089488,0.07234,0.071572,MIR6884_5P,0.811551232565683
SHEPARD_BMYB_TARGETS,SET,71,0.14747,0.0091527,0.10073,0.071601,SHEPARD_BMYB_TARGETS,0.811551232565683
GOMF_KERATIN_FILAMENT_BINDING,SET,6,0.47265,0.0085428,0.32286,0.071611,GOMF_KERATIN_FILAMENT_BINDING,0.811551232565683
GSE17186_NAIVE_VS_CD21LOW_TR...1,SET,186,0.092357,0.0092484,0.063103,0.071661,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.811551232565683
GOBP_INTRINSIC_APOPTOTIC_SIG...4,SET,40,0.17931,0.00836,0.12251,0.071663,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,0.811551232565683
GSE27786_LSK_VS_CD8_TCELL_UP,SET,168,0.093742,0.0089258,0.064056,0.071682,GSE27786_LSK_VS_CD8_TCELL_UP,0.811551232565683
GSE37301_LYMPHOID_PRIMED_MPP...3,SET,189,0.091315,0.0092167,0.062405,0.071707,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN,0.811551232565683
GSE3920_IFNA_VS_IFNG_TREATED...3,SET,172,0.096321,0.0092788,0.06584,0.07175,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN,0.811551232565683
KEGG_MEDICUS_PATHOGEN_ESCHER...3,SET,16,0.333,0.0098259,0.22763,0.071756,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY,0.811551232565683
HP_ABSENT_OUTER_DYNEIN_ARMS,SET,9,0.39271,0.0086924,0.26849,0.07179,HP_ABSENT_OUTER_DYNEIN_ARMS,0.811551232565683
HP_SIMPLE_FEBRILE_SEIZURE,SET,25,0.26627,0.0098185,0.18206,0.071808,HP_SIMPLE_FEBRILE_SEIZURE,0.811551232565683
DIRMEIER_LMP1_RESPONSE_EARLY,SET,59,0.16763,0.0094873,0.11463,0.071823,DIRMEIER_LMP1_RESPONSE_EARLY,0.811551232565683
GOMF_RACEMASE_AND_EPIMERASE_...1,SET,15,0.29898,0.0085419,0.2045,0.07188,GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY,0.811551232565683
GOBP_CENTRAL_NERVOUS_SYSTEM_...5,SET,35,0.2271,0.0099057,0.15534,0.071882,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS,0.811551232565683
DESCARTES_FETAL_STOMACH_SQUA...,SET,60,0.17235,0.0098364,0.11789,0.071888,DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS,0.811551232565683
GSE40274_CTRL_VS_FOXP3_AND_P...1,SET,148,0.098452,0.0088034,0.067346,0.071895,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.811551232565683
GSE17721_0.5H_VS_12H_PAM3CSK...2,SET,182,0.09097,0.009012,0.062234,0.071914,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP,0.811551232565683
GOBP_POSITIVE_REGULATION_OF_...32,SET,8,0.42558,0.0088815,0.29118,0.071941,GOBP_POSITIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,0.811551232565683
REACTOME_BH3_ONLY_PROTEINS_A...,SET,9,0.47692,0.010556,0.32634,0.071957,REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS,0.811551232565683
GSE15330_LYMPHOID_MULTIPOTEN...2,SET,187,0.088374,0.0088731,0.060479,0.071982,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.811551232565683
KEGG_ACUTE_MYELOID_LEUKEMIA,SET,54,0.16983,0.0091967,0.11623,0.071986,KEGG_ACUTE_MYELOID_LEUKEMIA,0.811551232565683
HP_AORTIC_REGURGITATION,SET,89,0.13458,0.0093473,0.092105,0.07199,HP_AORTIC_REGURGITATION,0.811551232565683
HP_VASCULAR_DILATATION,SET,196,0.088511,0.0090959,0.060585,0.072025,HP_VASCULAR_DILATATION,0.81168251459144
GOBP_REGULATION_OF_RELEASE_O...2,SET,77,0.15107,0.0097624,0.10351,0.072224,GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,0.813275989330747
HP_TUBULOINTERSTITIAL_NEPHRI...,SET,19,0.25933,0.008338,0.1777,0.072243,HP_TUBULOINTERSTITIAL_NEPHRITIS,0.813275989330747
BIOCARTA_HSWI_SNF_PATHWAY,SET,12,0.31414,0.0080282,0.21529,0.072271,BIOCARTA_HSWI_SNF_PATHWAY,0.813275989330747
GOMF_GROWTH_FACTOR_ACTIVITY,SET,145,0.10713,0.0094822,0.073428,0.072303,GOMF_GROWTH_FACTOR_ACTIVITY,0.813275989330747
GSE10239_NAIVE_VS_DAY4.5_EFF...1,SET,186,0.088794,0.0088917,0.060873,0.072337,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN,0.813275989330747
MIR7109_5P,SET,71,0.13927,0.0086438,0.095479,0.072338,MIR7109_5P,0.813275989330747
DURANTE_ADULT_OLFACTORY_NEUR...14,SET,105,0.13017,0.0098153,0.089239,0.072341,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_ENSHEATHING_GLIA,0.813275989330747
KEGG_HEMATOPOIETIC_CELL_LINE...,SET,80,0.15101,0.0099462,0.10354,0.072367,KEGG_HEMATOPOIETIC_CELL_LINEAGE,0.813275989330747
GOCC_EUKARYOTIC_TRANSLATION_...5,SET,13,0.3291,0.0087537,0.22566,0.072377,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_4F_COMPLEX,0.813275989330747
GOMF_G_PROTEIN_COUPLED_SEROT...,SET,21,0.28018,0.0094701,0.19215,0.072407,GOMF_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_ACTIVITY,0.813350124434389
HP_ABNORMAL_FACIAL_SHAPE,SET,937,0.040625,0.00894,0.027865,0.072441,HP_ABNORMAL_FACIAL_SHAPE,0.813469129240711
GOMF_RNA_POLYMERASE_III_ACTI...,SET,10,0.35889,0.0083733,0.24625,0.07251,GOMF_RNA_POLYMERASE_III_ACTIVITY,0.813980959302326
GSE21774_CD62L_POS_CD56_DIM_...2,SET,183,0.092465,0.009185,0.063458,0.072551,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,0.813992789236223
GOBP_REGULATION_OF_DNA_TEMPL...2,SET,15,0.3044,0.008697,0.20897,0.072615,GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION_INITIATION,0.813992789236223
GOBP_NEGATIVE_REGULATION_OF_...14,SET,13,0.36182,0.0096241,0.24842,0.072642,GOBP_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.813992789236223
GAUCHER_PBMC_YF_VAX_STAMARIL...11,SET,171,0.095106,0.0091354,0.065304,0.072656,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_DN,0.813992789236223
BOYLAN_MULTIPLE_MYELOMA_D_DN,SET,72,0.15262,0.0095384,0.1048,0.072662,BOYLAN_MULTIPLE_MYELOMA_D_DN,0.813992789236223
HP_ABNORMALITY_OF_THE_ELBOW,SET,246,0.078807,0.0090606,0.054114,0.072662,HP_ABNORMALITY_OF_THE_ELBOW,0.813992789236223
HP_ABNORMALITY_OF_THE_PHALAN...2,SET,3,0.72697,0.0092917,0.49922,0.072675,HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_3RD_TOE,0.813992789236223
GSE15930_STIM_VS_STIM_AND_IF...1,SET,178,0.09258,0.0090712,0.06361,0.072783,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN,0.814891211779852
GOMF_INITIATOR_METHIONYL_AMI...,SET,4,0.63799,0.0094156,0.43842,0.072814,GOMF_INITIATOR_METHIONYL_AMINOPEPTIDASE_ACTIVITY,0.814891211779852
NUP214_TARGET_GENES,SET,7,0.54225,0.010586,0.37268,0.072848,NUP214_TARGET_GENES,0.814891211779852
GOMF_MOLECULAR_CARRIER_ACTIV...,SET,84,0.12561,0.0084769,0.086335,0.072849,GOMF_MOLECULAR_CARRIER_ACTIVITY,0.814891211779852
HP_VERTEBRAL_COMPRESSION_FRA...,SET,32,0.20937,0.008733,0.14394,0.072909,HP_VERTEBRAL_COMPRESSION_FRACTURE,0.81489734548336
REACTOME_NR1H2_NR1H3_REGULAT...5,SET,5,0.45443,0.007498,0.31246,0.072931,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE,0.81489734548336
TRAVAGLINI_LUNG_BASOPHIL_MAS...1,SET,248,0.080714,0.0093169,0.055507,0.072965,TRAVAGLINI_LUNG_BASOPHIL_MAST_1_CELL,0.81489734548336
HP_ABNORMAL_RENAL_INSTERSTIT...,SET,52,0.17223,0.0091524,0.11853,0.073123,HP_ABNORMAL_RENAL_INSTERSTITIAL_MORPHOLOGY,0.81489734548336
HP_OVERFOLDING_OF_THE_SUPERI...,SET,4,0.63373,0.0093527,0.43618,0.073136,HP_OVERFOLDING_OF_THE_SUPERIOR_HELICES,0.81489734548336
MIR210_3P,SET,10,0.36887,0.008606,0.2539,0.073152,MIR210_3P,0.81489734548336
GSE9239_CTRL_VS_TNF_INHIBITO...1,SET,177,0.086919,0.0084927,0.059829,0.073152,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN,0.81489734548336
CHEN_HOXA5_TARGETS_9HR_DN,SET,37,0.21139,0.0094798,0.14551,0.073159,CHEN_HOXA5_TARGETS_9HR_DN,0.81489734548336
WANG_RESPONSE_TO_GSK3_INHIBI...1,SET,313,0.066944,0.0086657,0.046088,0.073185,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,0.81489734548336
HP_MYOPATHIC_FACIES,SET,46,0.18998,0.0094974,0.1308,0.073186,HP_MYOPATHIC_FACIES,0.81489734548336
KEGG_MEDICUS_REFERENCE_NON_C...,SET,6,0.57978,0.010479,0.39918,0.073199,KEGG_MEDICUS_REFERENCE_NON_CANONICAL_INFLAMMASOME_SIGNALING_PATHWAY,0.81489734548336
GOMF_DNA_TRANSLOCASE_ACTIVITY,SET,2,0.61401,0.0064079,0.42274,0.0732,GOMF_DNA_TRANSLOCASE_ACTIVITY,0.81489734548336
chr11p15,SET,274,0.16029,0.019434,0.11037,0.073228,chr11p15,0.81489734548336
GOBP_BONE_MATURATION,SET,24,0.25976,0.0093852,0.17891,0.073272,GOBP_BONE_MATURATION,0.81489734548336
GOCC_CHROMOCENTER,SET,13,0.3336,0.0088735,0.22979,0.073294,GOCC_CHROMOCENTER,0.81489734548336
MIR3160_5P,SET,188,0.091962,0.0092577,0.063349,0.073305,MIR3160_5P,0.81489734548336
GSE14769_UNSTIM_VS_240MIN_LP...1,SET,181,0.089865,0.0088783,0.061906,0.073311,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN,0.81489734548336
GOBP_POSITIVE_REGULATION_OF_...355,SET,11,0.35374,0.0086556,0.24369,0.073316,GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.81489734548336
GOBP_PROGRAMMED_CELL_DEATH_I...1,SET,24,0.25243,0.0091205,0.17399,0.073422,GOBP_PROGRAMMED_CELL_DEATH_INVOLVED_IN_CELL_DEVELOPMENT,0.81489734548336
HP_EVERTED_LOWER_LIP_VERMILI...,SET,117,0.11648,0.0092682,0.080285,0.073427,HP_EVERTED_LOWER_LIP_VERMILION,0.81489734548336
KEGG_MEDICUS_VARIANT_MUTATIO...62,SET,6,0.52711,0.009527,0.36335,0.073442,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_PERK_ATF4_SIGNALING_PATHWAY,0.81489734548336
HP_ABNORMALITY_OF_THE_TONSILS,SET,29,0.23809,0.0094546,0.16415,0.073475,HP_ABNORMALITY_OF_THE_TONSILS,0.81489734548336
GSE13484_3H_UNSTIM_VS_YF17D_...1,SET,184,0.093072,0.0092702,0.064184,0.073528,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,0.81489734548336
GOMF_RETINAL_BINDING,SET,17,0.31054,0.0094448,0.21416,0.073537,GOMF_RETINAL_BINDING,0.81489734548336
GSE17721_POLYIC_VS_PAM3CSK4_...18,SET,185,0.08991,0.0089794,0.062009,0.073545,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP,0.81489734548336
GSE37534_GW1929_VS_PIOGLITAZ...2,SET,179,0.090461,0.0088882,0.062397,0.073571,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,0.81489734548336
BIOCARTA_CARDIACEGF_PATHWAY,SET,17,0.32596,0.0099137,0.22484,0.073574,BIOCARTA_CARDIACEGF_PATHWAY,0.81489734548336
GRAESSMANN_RESPONSE_TO_MC_AN...1,SET,696,0.045314,0.0086536,0.031257,0.073576,GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN,0.81489734548336
HP_PECTUS_EXCAVATUM_OF_INFER...,SET,5,0.47631,0.0078589,0.32856,0.07358,HP_PECTUS_EXCAVATUM_OF_INFERIOR_STERNUM,0.81489734548336
REACTOME_DETOXIFICATION_OF_R...,SET,33,0.20613,0.0087311,0.1422,0.073595,REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES,0.81489734548336
MIR6753_5P,SET,20,0.27912,0.0092072,0.1926,0.07364,MIR6753_5P,0.81489734548336
WP_NOTCH1_REGULATION_OF_ENDO...,SET,16,0.33411,0.0098585,0.23057,0.073668,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,0.81489734548336
JOHNSTONE_PARVB_TARGETS_3_UP,SET,384,0.063976,0.0091548,0.044157,0.073699,JOHNSTONE_PARVB_TARGETS_3_UP,0.81489734548336
FRIDMAN_SENESCENCE_UP,SET,75,0.14762,0.0094156,0.1019,0.073724,FRIDMAN_SENESCENCE_UP,0.81489734548336
GSE43955_TGFB_IL6_VS_TGFB_IL...4,SET,183,0.08833,0.0087743,0.060974,0.073726,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,0.81489734548336
GAVISH_3CA_METAPROGRAM_FIBRO...14,SET,47,0.18999,0.0096,0.13116,0.073742,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_INTERFERON,0.81489734548336
GOCC_SERINE_PROTEASE_INHIBIT...,SET,6,0.45826,0.0082826,0.31636,0.073743,GOCC_SERINE_PROTEASE_INHIBITOR_COMPLEX,0.81489734548336
MEDINA_SMARCA4_TARGETS,SET,35,0.21301,0.0092911,0.14708,0.07378,MEDINA_SMARCA4_TARGETS,0.81489734548336
GOMF_LACTATE_DEHYDROGENASE_A...,SET,6,0.65718,0.011878,0.45389,0.073832,GOMF_LACTATE_DEHYDROGENASE_ACTIVITY,0.81489734548336
GOBP_ECTODERMAL_CELL_DIFFERE...,SET,5,0.62443,0.010303,0.43129,0.073845,GOBP_ECTODERMAL_CELL_DIFFERENTIATION,0.81489734548336
KEGG_MEDICUS_REFERENCE_HEPAR...1,SET,11,0.3788,0.0092688,0.26169,0.073886,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS,0.81489734548336
GOBP_HEAT_ACCLIMATION,SET,5,0.57759,0.0095302,0.39903,0.073886,GOBP_HEAT_ACCLIMATION,0.81489734548336
GOBP_SIGNAL_TRANSDUCTION_IN_...2,SET,170,0.089562,0.0085778,0.061873,0.073886,GOBP_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE,0.81489734548336
HP_MYELIN_OUTFOLDINGS,SET,7,0.4656,0.0090894,0.32169,0.073905,HP_MYELIN_OUTFOLDINGS,0.81489734548336
MORF_THRA,SET,46,0.19218,0.009607,0.13278,0.073917,MORF_THRA,0.81489734548336
KEGG_MEDICUS_ENV_FACTOR_NICO...2,SET,5,0.65825,0.010861,0.45486,0.073936,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_TO_JAK_STAT_SIGNALING_PATHWAY,0.81489734548336
GSE8678_IL7R_LOW_VS_HIGH_EFF...1,SET,171,0.093778,0.0090078,0.064808,0.073956,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN,0.81489734548336
GOMF_CALCIUM_DEPENDENT_PHOSP...2,SET,52,0.1812,0.0096292,0.12523,0.073975,GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING,0.81489734548336
MIR323B_3P,SET,56,0.15985,0.0088142,0.1105,0.074017,MIR323B_3P,0.814927761075949
KEGG_PANTOTHENATE_AND_COA_BI...,SET,16,0.30351,0.0089557,0.20983,0.074028,KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS,0.814927761075949
GOCC_SITE_OF_DOUBLE_STRAND_B...,SET,85,0.12071,0.008194,0.083472,0.074082,GOCC_SITE_OF_DOUBLE_STRAND_BREAK,0.814927761075949
REACTOME_INTERFERON_SIGNALING,SET,246,0.080221,0.0092232,0.055475,0.074085,REACTOME_INTERFERON_SIGNALING,0.814927761075949
GOBP_NEGATIVE_REGULATION_OF_...396,SET,8,0.44899,0.0093699,0.3105,0.074095,GOBP_NEGATIVE_REGULATION_OF_MIRNA_PROCESSING,0.814927761075949
GOBP_MHC_CLASS_I_BIOSYNTHETI...,SET,8,0.50428,0.010524,0.34881,0.074133,GOBP_MHC_CLASS_I_BIOSYNTHETIC_PROCESS,0.815087761784246
GOBP_KERATINOCYTE_MIGRATION,SET,20,0.30237,0.009974,0.20921,0.074195,GOBP_KERATINOCYTE_MIGRATION,0.815511456356736
DESCARTES_FETAL_PLACENTA_MYE...,SET,125,0.11545,0.0094933,0.079904,0.07426,DESCARTES_FETAL_PLACENTA_MYELOID_CELLS,0.815775862831858
GGTGAAG_MIR412,SET,54,0.16436,0.0089004,0.11376,0.074266,GGTGAAG_MIR412,0.815775862831858
NAKAYA_MYELOID_DENDRITIC_CEL...3,SET,247,0.073782,0.0084998,0.051074,0.074293,NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN,0.815787451042325
GOBP_DRINKING_BEHAVIOR,SET,8,0.50613,0.010562,0.35039,0.074314,GOBP_DRINKING_BEHAVIOR,0.815787451042325
GOBP_REGULATION_OF_LYMPHOCYT...3,SET,25,0.25363,0.0093524,0.17566,0.074405,GOBP_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS,0.815820428571429
KEGG_MEDICUS_VARIANT_MUTATIO...74,SET,7,0.4681,0.0091381,0.32424,0.07442,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_OPTN_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,0.815820428571429
WP_TYPE_I_COLLAGEN_SYNTHESIS...,SET,31,0.21932,0.0090042,0.15191,0.074421,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,0.815820428571429
GSE9988_LOW_LPS_VS_VEHICLE_T...2,SET,164,0.10296,0.0096875,0.071323,0.074429,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,0.815820428571429
XU_HGF_SIGNALING_NOT_VIA_AKT...2,SET,32,0.21235,0.0088571,0.14712,0.074475,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,0.815820428571429
WP_DENGUE2_INTERACTIONS_WITH...,SET,53,0.17482,0.0093789,0.12114,0.0745,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.815820428571429
GOBP_INTRACELLULAR_RECEPTOR_...,SET,335,0.0655,0.0087663,0.045396,0.074539,GOBP_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY,0.815820428571429
GOCC_VESICLE_LUMEN,SET,301,0.071173,0.0090378,0.049329,0.074544,GOCC_VESICLE_LUMEN,0.815820428571429
GOBP_POSITIVE_REGULATION_OF_...559,SET,28,0.2655,0.01036,0.18402,0.074551,GOBP_POSITIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.815820428571429
MIR6779_3P,SET,64,0.15524,0.0091493,0.1076,0.074561,MIR6779_3P,0.815820428571429
REACTOME_E2F_MEDIATED_REGULA...,SET,20,0.25728,0.0084865,0.17837,0.074609,REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION,0.815820428571429
BOYLAN_MULTIPLE_MYELOMA_C_CL...1,SET,27,0.26978,0.010338,0.18705,0.074621,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,0.815820428571429
REACTOME_O_LINKED_GLYCOSYLAT...2,SET,56,0.17746,0.0097853,0.12306,0.074648,REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,0.815820428571429
GOBP_RESPONSE_TO_CAMP,SET,83,0.13247,0.0088864,0.091863,0.074653,GOBP_RESPONSE_TO_CAMP,0.815820428571429
GSE17721_CTRL_VS_POLYIC_12H_...2,SET,178,0.086491,0.0084745,0.059987,0.074687,GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP,0.815820428571429
HP_ABNORMAL_NASAL_SKELETON_M...,SET,11,0.43107,0.010548,0.29902,0.074712,HP_ABNORMAL_NASAL_SKELETON_MORPHOLOGY,0.815820428571429
GOBP_VESICLE_TRANSPORT_ALONG...2,SET,43,0.18175,0.0087852,0.12608,0.074719,GOBP_VESICLE_TRANSPORT_ALONG_MICROTUBULE,0.815820428571429
GSE23695_CD57_POS_VS_NEG_NK_...1,SET,184,0.08534,0.0085002,0.059209,0.074754,GSE23695_CD57_POS_VS_NEG_NK_CELL_DN,0.815820428571429
GOBP_REGULATION_OF_MESENCHYM...2,SET,10,0.41452,0.0096712,0.28761,0.074763,GOBP_REGULATION_OF_MESENCHYMAL_STEM_CELL_DIFFERENTIATION,0.815820428571429
HP_URETHRAL_VALVE,SET,11,0.3535,0.0086498,0.24531,0.074801,HP_URETHRAL_VALVE,0.815978893596987
HP_TONGUE_THRUSTING,SET,13,0.30935,0.0082286,0.21484,0.074952,HP_TONGUE_THRUSTING,0.816086438377535
GSE17721_CTRL_VS_GARDIQUIMOD...5,SET,183,0.091144,0.0090538,0.063305,0.074976,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN,0.816086438377535
GOBP_INDOLE_CONTAINING_COMPO...1,SET,5,0.51867,0.0085579,0.36026,0.074984,GOBP_INDOLE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.816086438377535
EVI1_02,SET,112,0.11588,0.0090228,0.080507,0.075031,EVI1_02,0.816086438377535
MIR6830_5P,SET,163,0.097622,0.009157,0.067831,0.075057,MIR6830_5P,0.816086438377535
GSE24210_TCONV_VS_TREG_UP,SET,184,0.089385,0.008903,0.062113,0.075076,GSE24210_TCONV_VS_TREG_UP,0.816086438377535
GSE3039_CD4_TCELL_VS_B1_BCEL...1,SET,175,0.093934,0.0091267,0.065275,0.075077,GSE3039_CD4_TCELL_VS_B1_BCELL_DN,0.816086438377535
GSE18791_CTRL_VS_NEWCASTLE_V...18,SET,177,0.085732,0.0083768,0.059581,0.075098,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP,0.816086438377535
GOMF_PROTEIN_TRANSMEMBRANE_T...,SET,24,0.24488,0.0088476,0.17019,0.0751,GOMF_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.816086438377535
CALVET_IRINOTECAN_SENSITIVE_...1,SET,4,0.59868,0.0088355,0.41612,0.075125,CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP,0.816086438377535
HP_PROLONGED_BLEEDING_AFTER_...2,SET,16,0.34114,0.010066,0.23715,0.075151,HP_PROLONGED_BLEEDING_AFTER_SURGERY,0.816086438377535
ELLWOOD_MYC_TARGETS_DN,SET,40,0.19188,0.0089462,0.13339,0.075159,ELLWOOD_MYC_TARGETS_DN,0.816086438377535
GOBP_RESPONSE_TO_GRAVITY,SET,8,0.41315,0.0086219,0.28725,0.075186,GOBP_RESPONSE_TO_GRAVITY,0.816086438377535
GSE17721_LPS_VS_PAM3CSK4_24H...2,SET,187,0.08587,0.0086217,0.059708,0.075203,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_UP,0.816086438377535
HP_NUCLEAR_CATARACT,SET,25,0.24541,0.0090494,0.17066,0.075226,HP_NUCLEAR_CATARACT,0.816086438377535
REACTOME_SARS_COV_2_HOST_INT...,SET,178,0.088089,0.0086311,0.061259,0.07523,REACTOME_SARS_COV_2_HOST_INTERACTIONS,0.816086438377535
MIR1278,SET,56,0.16323,0.0090006,0.11351,0.075234,MIR1278,0.816086438377535
GOMF_PYRUVATE_DEHYDROGENASE_...1,SET,4,0.56419,0.0083264,0.39238,0.075244,GOMF_PYRUVATE_DEHYDROGENASE_ACETYL_TRANSFERRING_KINASE_ACTIVITY,0.816086438377535
PALOMERO_GSI_SENSITIVITY_UP,SET,6,0.48011,0.0086775,0.33392,0.075257,PALOMERO_GSI_SENSITIVITY_UP,0.816086438377535
WP_UROTENSINIIMEDIATED_SIGNA...,SET,66,0.15064,0.0090156,0.1048,0.075303,WP_UROTENSINIIMEDIATED_SIGNALING,0.81609246882793
HP_IRIS_TRANSILLUMINATION_DE...,SET,12,0.38316,0.0097923,0.26659,0.075326,HP_IRIS_TRANSILLUMINATION_DEFECT,0.81609246882793
STEIN_ESRRA_TARGETS_RESPONSI...1,SET,39,0.19528,0.0089905,0.13587,0.075328,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,0.81609246882793
MIR1207_5P,SET,305,0.070168,0.0089682,0.048828,0.07536,MIR1207_5P,0.816184730445622
GOMF_NAD_BINDING,SET,55,0.16526,0.0090313,0.11503,0.075412,GOMF_NAD_BINDING,0.81643952988792
GSE17186_CD21LOW_VS_CD21HIGH...2,SET,184,0.088033,0.0087684,0.061283,0.07544,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,0.81643952988792
REACTOME_METABOLISM_OF_INGES...,SET,7,0.52175,0.010185,0.36324,0.075454,REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE,0.81643952988792
GOMF_SODIUM_PROTON_ANTIPORTE...,SET,13,0.32957,0.0087664,0.22948,0.075482,GOMF_SODIUM_PROTON_ANTIPORTER_ACTIVITY,0.816488300653595
GSE3920_UNTREATED_VS_IFNG_TR...2,SET,136,0.1035,0.0088743,0.072106,0.075604,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.817130824022346
GSE360_CTRL_VS_B_MALAYI_HIGH...4,SET,178,0.086765,0.0085014,0.060456,0.075626,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.817130824022346
MIR92A_1_5P,SET,40,0.19113,0.0089114,0.13321,0.075681,MIR92A_1_5P,0.817130824022346
GOBP_POSITIVE_REGULATION_OF_...333,SET,184,0.093493,0.0093122,0.065175,0.075724,GOBP_POSITIVE_REGULATION_OF_HEMOPOIESIS,0.817130824022346
KEGG_MEDICUS_VARIANT_MUTATIO...66,SET,12,0.35118,0.008975,0.24483,0.075738,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY,0.817130824022346
GOBP_REGULATION_OF_ISOMERASE...,SET,7,0.49834,0.0097285,0.34742,0.075738,GOBP_REGULATION_OF_ISOMERASE_ACTIVITY,0.817130824022346
REACTOME_COOPERATION_OF_PREF...,SET,30,0.20144,0.0081357,0.14044,0.075749,REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING,0.817130824022346
GSE21670_UNTREATED_VS_IL6_TR...1,SET,183,0.087089,0.0086509,0.060718,0.075752,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN,0.817130824022346
HP_SLENDER_TOE,SET,4,0.59609,0.0087973,0.4156,0.075753,HP_SLENDER_TOE,0.817130824022346
GOBP_NATURAL_KILLER_CELL_CYT...,SET,8,0.46727,0.0097514,0.3259,0.075828,GOBP_NATURAL_KILLER_CELL_CYTOKINE_PRODUCTION,0.817307928416486
GOBP_MICROTUBULE_BASED_MOVEM...,SET,367,0.06161,0.0086228,0.042971,0.07583,GOBP_MICROTUBULE_BASED_MOVEMENT,0.817307928416486
GOBP_TRANSCRIPTION_BY_RNA_PO...1,SET,58,0.14217,0.0079779,0.099179,0.07587,GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.817307928416486
GOBP_REGULATION_OF_ERAD_PATH...,SET,22,0.23119,0.007998,0.16129,0.075877,GOBP_REGULATION_OF_ERAD_PATHWAY,0.817307928416486
REACTOME_ERBB2_REGULATES_CEL...,SET,15,0.29341,0.0083828,0.2047,0.075887,REACTOME_ERBB2_REGULATES_CELL_MOTILITY,0.817307928416486
LIU_NASOPHARYNGEAL_CARCINOMA,SET,62,0.14941,0.0086677,0.10426,0.075927,LIU_NASOPHARYNGEAL_CARCINOMA,0.817323543343653
GSE17721_CTRL_VS_GARDIQUIMOD...6,SET,188,0.084229,0.0084792,0.058777,0.075936,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_UP,0.817323543343653
LAKE_ADULT_KIDNEY_C2_PODOCYT...,SET,192,0.092475,0.0094069,0.064539,0.075959,LAKE_ADULT_KIDNEY_C2_PODOCYTES,0.817323543343653
HP_PREMATURELY_AGED_APPEARAN...,SET,156,0.095087,0.0087274,0.066384,0.076026,HP_PREMATURELY_AGED_APPEARANCE,0.817774826732673
GOBP_REGULATION_OF_ALPHA_BET...2,SET,70,0.15408,0.0094957,0.10758,0.076048,GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.817774826732673
FULLER_PBMC_F_TULARENSIS_VAC...10,SET,16,0.31077,0.0091699,0.21705,0.076112,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_DN,0.81797684990735
GNF2_MYL2,SET,32,0.22153,0.0092402,0.15473,0.076126,GNF2_MYL2,0.81797684990735
GOCC_SMOOTH_ENDOPLASMIC_RETI...2,SET,7,0.52776,0.010303,0.36866,0.076143,GOCC_SMOOTH_ENDOPLASMIC_RETICULUM_MEMBRANE,0.81797684990735
GSE45739_NRAS_KO_VS_WT_ACD3_...2,SET,180,0.087078,0.0085795,0.060844,0.076199,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP,0.81797684990735
REACTOME_GRB2_EVENTS_IN_ERBB...,SET,16,0.28363,0.008369,0.19818,0.0762,REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,0.81797684990735
REACTOME_SYNTHESIS_OF_BILE_A...2,SET,13,0.39549,0.01052,0.27635,0.076208,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL,0.81797684990735
GOBP_LYMPHOCYTE_MIGRATION,SET,96,0.12921,0.0093183,0.09031,0.076265,GOBP_LYMPHOCYTE_MIGRATION,0.818076757631822
REACTOME_GLYCINE_DEGRADATION,SET,7,0.37202,0.0072624,0.26004,0.076277,REACTOME_GLYCINE_DEGRADATION,0.818076757631822
REACTOME_NF_KB_IS_ACTIVATED_...,SET,11,0.36955,0.0090427,0.25833,0.076289,REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,0.818076757631822
GOBP_POSITIVE_REGULATION_OF_...236,SET,13,0.36154,0.0096167,0.25276,0.076315,GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.818076757631822
GOBP_VESICLE_UNCOATING,SET,9,0.34602,0.0076589,0.24193,0.076335,GOBP_VESICLE_UNCOATING,0.818076757631822
MIR194_5P,SET,179,0.091121,0.008953,0.06372,0.076363,MIR194_5P,0.818124557644883
GOBP_AMINO_ACID_SALVAGE,SET,7,0.52662,0.01028,0.36836,0.076423,GOBP_AMINO_ACID_SALVAGE,0.818515058551618
GOMF_TESTOSTERONE_DEHYDROGEN...2,SET,10,0.35193,0.0082108,0.24621,0.076454,GOMF_TESTOSTERONE_DEHYDROGENASE_NAD_P_ACTIVITY,0.818594815157116
GOCC_GOLGI_APPARATUS,SET,1465,0.032723,0.0088668,0.022897,0.07649,GOCC_GOLGI_APPARATUS,0.81864483394834
GOMF_POLYOL_TRANSMEMBRANE_TR...,SET,11,0.44354,0.010853,0.31043,0.076537,GOMF_POLYOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.81864483394834
MARSON_FOXP3_TARGETS_UP,SET,61,0.16522,0.0095074,0.11567,0.076593,MARSON_FOXP3_TARGETS_UP,0.81864483394834
GOBP_NEUROTRANSMITTER_RECEPT...2,SET,22,0.26501,0.0091677,0.18552,0.076594,GOBP_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,0.81864483394834
FOROUTAN_TGFB_EMT_DN,SET,102,0.1294,0.0096176,0.090588,0.076595,FOROUTAN_TGFB_EMT_DN,0.81864483394834
HP_RECURRENT_PANCREATITIS,SET,11,0.4441,0.010867,0.31091,0.0766,HP_RECURRENT_PANCREATITIS,0.81864483394834
REACTOME_DARPP_32_EVENTS,SET,24,0.23785,0.0085937,0.16658,0.076673,REACTOME_DARPP_32_EVENTS,0.818968741935484
AZARE_STAT3_TARGETS,SET,23,0.25662,0.0090768,0.17973,0.076684,AZARE_STAT3_TARGETS,0.818968741935484
RIZ_ERYTHROID_DIFFERENTIATIO...6,SET,25,0.26435,0.0097477,0.18516,0.076701,RIZ_ERYTHROID_DIFFERENTIATION_HEMGN,0.818968741935484
HP_BICONVEX_VERTEBRAL_BODIES,SET,3,0.69157,0.0088391,0.48449,0.07674,HP_BICONVEX_VERTEBRAL_BODIES,0.818972025782689
REACTOME_P75NTR_RECRUITS_SIG...,SET,11,0.3775,0.009237,0.2645,0.076765,REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,0.818972025782689
GSE339_CD4POS_VS_CD8POS_DC_DN,SET,185,0.087371,0.0087258,0.061219,0.076772,GSE339_CD4POS_VS_CD8POS_DC_DN,0.818972025782689
GSE12003_4D_VS_8D_CULTURE_BM...2,SET,153,0.095761,0.008705,0.067116,0.076829,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP,0.819098590490797
HP_DISTAL_AMYOTROPHY,SET,199,0.081796,0.0084693,0.05733,0.076831,HP_DISTAL_AMYOTROPHY,0.819098590490797
MIR374A_5P,SET,396,0.063165,0.0091757,0.044286,0.076903,MIR374A_5P,0.819392607343796
MIR8079,SET,30,0.23884,0.0096463,0.16748,0.076939,MIR8079,0.819392607343796
LEE_CALORIE_RESTRICTION_NEOC...2,SET,65,0.1488,0.0088376,0.10437,0.076985,LEE_CALORIE_RESTRICTION_NEOCORTEX_UP,0.819392607343796
MIR3934_5P,SET,55,0.16076,0.0087855,0.11276,0.076987,MIR3934_5P,0.819392607343796
CSHL1_TARGET_GENES,SET,177,0.089771,0.0087715,0.062973,0.077006,CSHL1_TARGET_GENES,0.819392607343796
GOBP_POSITIVE_REGULATION_OF_...644,SET,5,0.49287,0.0081322,0.34576,0.077023,GOBP_POSITIVE_REGULATION_OF_PROTEIN_NEDDYLATION,0.819392607343796
HP_HYPERKALEMIA,SET,35,0.21481,0.0093697,0.15075,0.077088,HP_HYPERKALEMIA,0.819392607343796
MIR192_5P,SET,32,0.21351,0.0089057,0.14984,0.077101,MIR192_5P,0.819392607343796
WP_PHOTODYNAMIC_THERAPYINDUC...4,SET,33,0.21922,0.0092854,0.15388,0.077136,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,0.819392607343796
FAELT_B_CLL_WITH_VH3_21_UP,SET,38,0.17824,0.0081005,0.12512,0.07714,FAELT_B_CLL_WITH_VH3_21_UP,0.819392607343796
GSE41978_ID2_KO_VS_ID2_KO_AN...1,SET,188,0.085227,0.0085797,0.059829,0.07716,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.819392607343796
GOBP_CARDIAC_NEURAL_CREST_CE...1,SET,12,0.41234,0.010538,0.28952,0.077202,GOBP_CARDIAC_NEURAL_CREST_CELL_DEVELOPMENT_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS,0.819392607343796
HP_RECURRENT_HAEMOPHILUS_INF...,SET,22,0.27584,0.0095425,0.1937,0.077225,HP_RECURRENT_HAEMOPHILUS_INFLUENZAE_INFECTIONS,0.819392607343796
GSE17721_PAM3CSK4_VS_GADIQUI...5,SET,180,0.087604,0.0086312,0.061521,0.077239,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_DN,0.819392607343796
LET_7A_2_3P,SET,265,0.074194,0.0088489,0.05211,0.077262,LET_7A_2_3P,0.819392607343796
LET_7G_3P,SET,265,0.074194,0.0088489,0.05211,0.077262,LET_7G_3P,0.819392607343796
HOEK_PBMC_INACTIVATED_INFLUE...3,SET,10,0.40758,0.0095093,0.28629,0.077283,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_DN,0.819392607343796
HP_VOCAL_CORD_PARALYSIS,SET,53,0.15747,0.008448,0.11067,0.07739,HP_VOCAL_CORD_PARALYSIS,0.819392607343796
HP_CONGENITAL_DIAPHRAGMATIC_...,SET,79,0.1342,0.0087836,0.094327,0.077423,HP_CONGENITAL_DIAPHRAGMATIC_HERNIA,0.819392607343796
WANG_RESPONSE_TO_ANDROGEN_UP,SET,28,0.2223,0.0086742,0.15627,0.077449,WANG_RESPONSE_TO_ANDROGEN_UP,0.819392607343796
HP_NIGHT_SWEATS,SET,10,0.39762,0.009277,0.27953,0.077452,HP_NIGHT_SWEATS,0.819392607343796
GSE2706_UNSTIM_VS_8H_LPS_AND...2,SET,176,0.090446,0.0088127,0.063585,0.077458,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP,0.819392607343796
SCIAN_CELL_CYCLE_TARGETS_OF_...2,SET,8,0.39745,0.0082944,0.27942,0.077462,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP,0.819392607343796
FAELT_B_CLL_WITH_VH_REARRANG...1,SET,43,0.18196,0.0087952,0.12794,0.077497,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,0.819392607343796
KEGG_TAURINE_AND_HYPOTAURINE...,SET,10,0.41007,0.0095674,0.28842,0.077554,KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM,0.819392607343796
REACTOME_SARS_COV_2_ACTIVATE...,SET,111,0.11151,0.0086435,0.078432,0.077569,REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,0.819392607343796
GOBP_REGULATION_OF_COLLAGEN_...1,SET,8,0.40859,0.0085269,0.28741,0.077577,GOBP_REGULATION_OF_COLLAGEN_FIBRIL_ORGANIZATION,0.819392607343796
GOBP_HYDROGEN_SULFIDE_METABO...,SET,4,0.5251,0.0077495,0.36945,0.077623,GOBP_HYDROGEN_SULFIDE_METABOLIC_PROCESS,0.819392607343796
GOBP_CELLULAR_RESPONSE_TO_HI...,SET,6,0.50909,0.0092014,0.35825,0.07766,GOBP_CELLULAR_RESPONSE_TO_HISTAMINE,0.819392607343796
GOMF_PROLINE_RICH_REGION_BIN...,SET,16,0.31447,0.009279,0.22132,0.077685,GOMF_PROLINE_RICH_REGION_BINDING,0.819392607343796
GOBP_SECRETION_BY_TISSUE,SET,46,0.18813,0.0094048,0.13242,0.077699,GOBP_SECRETION_BY_TISSUE,0.819392607343796
GTF2A2_TARGET_GENES,SET,384,0.061991,0.0088707,0.043634,0.07771,GTF2A2_TARGET_GENES,0.819392607343796
MCDOWELL_ACUTE_LUNG_INJURY_DN,SET,41,0.19515,0.0092114,0.13739,0.077748,MCDOWELL_ACUTE_LUNG_INJURY_DN,0.819392607343796
GSE22432_CDC_VS_COMMON_DC_PR...2,SET,175,0.090679,0.0088104,0.063851,0.077789,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP,0.819392607343796
HP_ABNORMAL_SCROTAL_RUGATION,SET,4,0.69105,0.010199,0.48669,0.077826,HP_ABNORMAL_SCROTAL_RUGATION,0.819392607343796
HP_ARTERIA_LUSORIA,SET,6,0.56302,0.010176,0.39652,0.077828,HP_ARTERIA_LUSORIA,0.819392607343796
GSE37605_FOXP3_FUSION_GFP_VS...4,SET,171,0.089776,0.0086234,0.063234,0.07785,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_UP,0.819392607343796
ZNF423_TARGET_GENES,SET,844,0.042148,0.0088264,0.029687,0.077851,ZNF423_TARGET_GENES,0.819392607343796
GSE21927_SPLEEN_C57BL6_VS_4T...1,SET,185,0.087863,0.008775,0.061892,0.07787,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN,0.819392607343796
GSE42021_TREG_PLN_VS_CD24INT...2,SET,182,0.091532,0.0090677,0.064486,0.0779,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_UP,0.819392607343796
GOBP_ESTABLISHMENT_OF_BLOOD_...1,SET,14,0.35614,0.0098304,0.25093,0.07792,GOBP_ESTABLISHMENT_OF_BLOOD_BRAIN_BARRIER,0.819392607343796
HP_GENERALIZED_MUSCLE_WEAKNE...,SET,120,0.10598,0.00854,0.074681,0.077936,HP_GENERALIZED_MUSCLE_WEAKNESS,0.819392607343796
GOMF_ALDO_KETO_REDUCTASE_NAD...,SET,29,0.24364,0.0096753,0.17173,0.077993,GOMF_ALDO_KETO_REDUCTASE_NADPH_ACTIVITY,0.819392607343796
MIR3686,SET,294,0.070563,0.0088572,0.049736,0.077995,MIR3686,0.819392607343796
HP_ABNORMALITY_OF_THE_WRIST,SET,147,0.10214,0.0091023,0.071997,0.078011,HP_ABNORMALITY_OF_THE_WRIST,0.819392607343796
CACBINDINGPROTEIN_Q6,SET,231,0.078238,0.0087202,0.055154,0.078024,CACBINDINGPROTEIN_Q6,0.819392607343796
GOBP_REGULATION_OF_MYELINATI...,SET,44,0.17932,0.0087678,0.12643,0.078049,GOBP_REGULATION_OF_MYELINATION,0.819392607343796
MIR1231,SET,48,0.17364,0.0088663,0.12245,0.078107,MIR1231,0.819392607343796
GSE3203_UNTREATED_VS_IFNB_TR...1,SET,186,0.090166,0.009029,0.06362,0.078211,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN,0.819392607343796
ANDERSON_BLOOD_CN54GP140_ADJ...8,SET,28,0.2216,0.0086469,0.15636,0.078224,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_UP,0.819392607343796
HP_SYNDACTYLY,SET,346,0.06466,0.0087921,0.045636,0.07827,HP_SYNDACTYLY,0.819392607343796
GOBP_EPITHELIAL_CELL_MORPHOG...,SET,30,0.23241,0.0093867,0.16404,0.078282,GOBP_EPITHELIAL_CELL_MORPHOGENESIS,0.819392607343796
MIR6813_3P,SET,30,0.22366,0.0090334,0.1579,0.078321,MIR6813_3P,0.819392607343796
DESCARTES_MAIN_FETAL_CSH1_CS...,SET,70,0.13068,0.0080533,0.09227,0.078359,DESCARTES_MAIN_FETAL_CSH1_CSH2_POSITIVE_CELLS,0.819392607343796
MIR5687,SET,16,0.30256,0.0089277,0.21366,0.078381,MIR5687,0.819392607343796
GSE3982_BASOPHIL_VS_NKCELL_UP,SET,177,0.088967,0.0086929,0.062826,0.078383,GSE3982_BASOPHIL_VS_NKCELL_UP,0.819392607343796
BIOCARTA_SPRY_PATHWAY,SET,16,0.29528,0.0087126,0.20852,0.07839,BIOCARTA_SPRY_PATHWAY,0.819392607343796
chr16q24,SET,72,0.29578,0.018486,0.20891,0.078421,chr16q24,0.819392607343796
GOBP_POSITIVE_REGULATION_OF_...30,SET,4,0.44574,0.0065783,0.31483,0.078428,GOBP_POSITIVE_REGULATION_OF_ANOIKIS,0.819392607343796
GSE9650_NAIVE_VS_MEMORY_CD8_...2,SET,184,0.088184,0.0087835,0.062292,0.078445,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.819392607343796
BUYTAERT_PHOTODYNAMIC_THERAP...2,SET,758,0.043831,0.0087199,0.030962,0.078449,BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP,0.819392607343796
GOMF_UNMETHYLATED_CPG_BINDING,SET,9,0.35819,0.0079284,0.25303,0.078449,GOMF_UNMETHYLATED_CPG_BINDING,0.819392607343796
GSE3982_BASOPHIL_VS_CENT_MEM...1,SET,172,0.090237,0.0086928,0.063755,0.078487,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.819392607343796
HP_ABNORMAL_HALLUX_MORPHOLOGY,SET,177,0.09209,0.008998,0.065071,0.078512,HP_ABNORMAL_HALLUX_MORPHOLOGY,0.819392607343796
MIR101_5P,SET,37,0.19466,0.0087294,0.13755,0.078522,MIR101_5P,0.819392607343796
MIR100_5P_MIR99A_5P_MIR99B_5P,SET,17,0.31343,0.0095326,0.22149,0.078529,MIR100_5P_MIR99A_5P_MIR99B_5P,0.819392607343796
CEBPB_02,SET,237,0.078746,0.0088886,0.055673,0.078625,CEBPB_02,0.819392607343796
GOBP_MAINTENANCE_OF_BLOOD_BR...,SET,37,0.21827,0.0097882,0.15432,0.078627,GOBP_MAINTENANCE_OF_BLOOD_BRAIN_BARRIER,0.819392607343796
KEGG_MEDICUS_REFERENCE_RAC_C...,SET,9,0.38123,0.0084382,0.26956,0.078648,KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY,0.819392607343796
HOXA4_Q2,SET,243,0.080012,0.0091436,0.056574,0.07865,HOXA4_Q2,0.819392607343796
GOBP_WOUND_HEALING_INVOLVED_...,SET,7,0.50804,0.0099178,0.35927,0.07868,GOBP_WOUND_HEALING_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.819392607343796
OLSSON_E2F3_TARGETS_UP,SET,22,0.2818,0.0097485,0.19931,0.078714,OLSSON_E2F3_TARGETS_UP,0.819392607343796
KEGG_MEDICUS_REFERENCE_EREG_...2,SET,14,0.31456,0.0086827,0.2225,0.078728,KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.819392607343796
HP_OSTEOLYSIS_INVOLVING_BONE...2,SET,20,0.27661,0.0091241,0.19566,0.078733,HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.819392607343796
KEGG_MEDICUS_REFERENCE_BETA_...3,SET,5,0.49886,0.0082311,0.35299,0.0788,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_PEROXISOME_VLCFA,0.819392607343796
GOBP_DEFENSE_RESPONSE_TO_GRA...2,SET,92,0.1325,0.0093559,0.09376,0.078803,GOBP_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,0.819392607343796
GSE12366_PLASMA_CELL_VS_MEMO...1,SET,175,0.087263,0.0084786,0.061752,0.078818,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.819392607343796
CDPCR3_01,SET,50,0.18295,0.0095339,0.12948,0.078842,CDPCR3_01,0.819392607343796
GAVISH_3CA_METAPROGRAM_CD4_T...10,SET,46,0.16928,0.0084623,0.11981,0.078848,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_UNASSIGNED,0.819392607343796
GSE41978_KLRG1_HIGH_VS_LOW_E...1,SET,179,0.086505,0.0084995,0.061226,0.078854,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_DN,0.819392607343796
MIR5572,SET,70,0.14664,0.0090371,0.10381,0.078888,MIR5572,0.819392607343796
WP_IL11_SIGNALING,SET,41,0.18847,0.0088961,0.13343,0.078904,WP_IL11_SIGNALING,0.819392607343796
GSE4590_LARGE_PRE_BCELL_VS_V...1,SET,172,0.09382,0.0090379,0.06644,0.078968,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.819392607343796
MODULE_136,SET,447,0.05538,0.0085351,0.039219,0.078975,MODULE_136,0.819392607343796
ESC_V6.5_UP_LATE.V1_DN,SET,161,0.091944,0.0085719,0.065119,0.078993,ESC_V6.5_UP_LATE.V1_DN,0.819392607343796
MIR6501_5P,SET,65,0.15336,0.0091087,0.10864,0.079034,MIR6501_5P,0.819392607343796
DESCARTES_MAIN_FETAL_VASCULA...,SET,40,0.19349,0.0090212,0.13707,0.07904,DESCARTES_MAIN_FETAL_VASCULAR_ENDOTHELIAL_CELLS,0.819392607343796
GOBP_TRANSLESION_SYNTHESIS,SET,24,0.1983,0.0071648,0.14049,0.079061,GOBP_TRANSLESION_SYNTHESIS,0.819392607343796
MIR200B_5P,SET,95,0.11764,0.0084397,0.083346,0.079071,MIR200B_5P,0.819392607343796
MIR6826_5P,SET,34,0.19758,0.0084944,0.13999,0.079075,MIR6826_5P,0.819392607343796
MIR6864_3P,SET,39,0.18279,0.0084154,0.12952,0.079083,MIR6864_3P,0.819392607343796
GOBP_OBSERVATIONAL_LEARNING,SET,7,0.4379,0.0085485,0.31036,0.079138,GOBP_OBSERVATIONAL_LEARNING,0.819392607343796
MIR3928_3P,SET,84,0.12322,0.008315,0.087351,0.079194,MIR3928_3P,0.819392607343796
LEI_HOXC8_TARGETS_UP,SET,11,0.35504,0.0086876,0.25174,0.079225,LEI_HOXC8_TARGETS_UP,0.819392607343796
GOMF_NUCLEOSIDE_TRANSMEMBRAN...,SET,10,0.39809,0.0092879,0.28231,0.079261,GOMF_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.819392607343796
GSE41867_NAIVE_VS_DAY15_LCMV...2,SET,179,0.082872,0.0081425,0.058771,0.079266,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.819392607343796
CRX_DN.V1_UP,SET,120,0.10972,0.0088412,0.077816,0.079276,CRX_DN.V1_UP,0.819392607343796
MIR4757_5P,SET,55,0.16732,0.0091441,0.11868,0.07929,MIR4757_5P,0.819392607343796
GSE23505_IL6_IL1_VS_IL6_IL1_...1,SET,184,0.087835,0.0087487,0.062314,0.079342,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,0.819392607343796
GRYDER_PAX3FOXO1_ENHANCERS_I...,SET,942,0.041504,0.0091566,0.029448,0.079368,GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS,0.819392607343796
GOMF_PHOSPHATIDYLINOSITOL_MO...,SET,11,0.29771,0.0072847,0.21123,0.079369,GOMF_PHOSPHATIDYLINOSITOL_MONOPHOSPHATE_PHOSPHATASE_ACTIVITY,0.819392607343796
MORF_FEN1,SET,56,0.14549,0.0080226,0.10324,0.079386,MORF_FEN1,0.819392607343796
BIOCARTA_AKT_PATHWAY,SET,20,0.25957,0.008562,0.18419,0.079392,BIOCARTA_AKT_PATHWAY,0.819392607343796
GSE19888_ADENOSINE_A3R_ACT_V...1,SET,183,0.086896,0.0086318,0.061664,0.079399,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN,0.819392607343796
GOMF_ASPARTIC_TYPE_PEPTIDASE...,SET,25,0.22795,0.0084055,0.16177,0.079411,GOMF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,0.819392607343796
GOBP_NEGATIVE_REGULATION_OF_...222,SET,8,0.42087,0.0087832,0.29868,0.079414,GOBP_NEGATIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,0.819392607343796
GOBP_DERMATAN_SULFATE_BIOSYN...,SET,5,0.53557,0.0088368,0.38019,0.079472,GOBP_DERMATAN_SULFATE_BIOSYNTHETIC_PROCESS,0.819392607343796
WP_B_CELL_RECEPTOR_SIGNALING,SET,93,0.12253,0.0086983,0.087001,0.079517,WP_B_CELL_RECEPTOR_SIGNALING,0.819392607343796
WP_SOMITOGENESIS_IN_THE_CONT...,SET,9,0.40131,0.0088827,0.28496,0.079533,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,0.819392607343796
ZHENG_FOXP3_TARGETS_IN_THYMU...1,SET,12,0.33515,0.0085652,0.23801,0.079556,ZHENG_FOXP3_TARGETS_IN_THYMUS_DN,0.819392607343796
GOBP_CYTOKINE_PRODUCTION,SET,720,0.046512,0.0090282,0.033032,0.079558,GOBP_CYTOKINE_PRODUCTION,0.819392607343796
WEBER_METHYLATED_ICP_IN_SPER...1,SET,8,0.44396,0.009265,0.31529,0.079562,WEBER_METHYLATED_ICP_IN_SPERM_DN,0.819392607343796
REACTOME_PROLONGED_ERK_ACTIV...,SET,14,0.33295,0.0091903,0.23646,0.079567,REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS,0.819392607343796
GOBP_ERAD_PATHWAY,SET,104,0.10947,0.0082154,0.07775,0.079577,GOBP_ERAD_PATHWAY,0.819392607343796
GSE360_L_MAJOR_VS_B_MALAYI_L...2,SET,177,0.08853,0.0086502,0.062884,0.079598,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP,0.819392607343796
DESCARTES_FETAL_INTESTINE_MY...,SET,187,0.095514,0.00959,0.067849,0.079612,DESCARTES_FETAL_INTESTINE_MYELOID_CELLS,0.819392607343796
KEGG_MEDICUS_REFERENCE_PROMO...,SET,21,0.26111,0.0088254,0.18548,0.079617,KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH,0.819392607343796
ZNF669_TARGET_GENES,SET,95,0.12276,0.0088077,0.087231,0.079671,ZNF669_TARGET_GENES,0.819705626110124
REACTOME_TGFBR3_PTM_REGULATI...,SET,9,0.39158,0.0086674,0.27827,0.079695,REACTOME_TGFBR3_PTM_REGULATION,0.819709891979876
MIER1_TARGET_GENES,SET,297,0.069596,0.0087795,0.049473,0.079761,MIER1_TARGET_GENES,0.819735461335677
GOCC_VACUOLAR_LUMEN,SET,160,0.095273,0.0088548,0.067739,0.079802,GOCC_VACUOLAR_LUMEN,0.819735461335677
GSE22229_RENAL_TRANSPLANT_IM...2,SET,185,0.084285,0.0084176,0.059939,0.079843,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP,0.819735461335677
GSE20198_IL12_VS_IFNA_TREATE...2,SET,181,0.086537,0.0085495,0.061544,0.079858,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.819735461335677
HP_ABNORMAL_NONVERBAL_COMMUN...,SET,89,0.11668,0.0081038,0.082991,0.079882,HP_ABNORMAL_NONVERBAL_COMMUNICATIVE_BEHAVIOR,0.819735461335677
GOBP_SUPEROXIDE_ANION_GENERA...,SET,36,0.21254,0.0094021,0.15118,0.079892,GOBP_SUPEROXIDE_ANION_GENERATION,0.819735461335677
GSE46468_LUNG_INNATE_LYMPHOI...1,SET,178,0.084334,0.0082632,0.059998,0.079931,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN,0.819735461335677
GOBP_LIPID_DROPLET_FORMATION,SET,12,0.34474,0.0088103,0.24527,0.079939,GOBP_LIPID_DROPLET_FORMATION,0.819735461335677
GOBP_TRNA_MODIFICATION,SET,83,0.11801,0.0079164,0.083967,0.079953,GOBP_TRNA_MODIFICATION,0.819735461335677
HP_LACK_OF_T_CELL_FUNCTION,SET,7,0.50517,0.0098617,0.3595,0.07999,HP_LACK_OF_T_CELL_FUNCTION,0.819735461335677
GSE29618_MONOCYTE_VS_MDC_DN,SET,170,0.094237,0.0090256,0.067088,0.080068,GSE29618_MONOCYTE_VS_MDC_DN,0.819735461335677
GSE20366_CD103_KLRG1_DP_VS_D...2,SET,180,0.087566,0.0086275,0.062344,0.080085,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP,0.819735461335677
EGUCHI_CELL_CYCLE_RB1_TARGETS,SET,22,0.24804,0.0085809,0.17663,0.080118,EGUCHI_CELL_CYCLE_RB1_TARGETS,0.819735461335677
VDR_Q3,SET,212,0.082204,0.008782,0.05854,0.080131,VDR_Q3,0.819735461335677
GARCIA_PINERES_PBMC_HPV_16_L...5,SET,12,0.34879,0.0089139,0.24839,0.080136,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE,0.819735461335677
SHAFFER_IRF4_MULTIPLE_MYELOM...,SET,33,0.21076,0.0089272,0.1501,0.080139,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,0.819735461335677
MIR3672,SET,41,0.17869,0.0084345,0.12726,0.080144,MIR3672,0.819735461335677
VARELA_ZMPSTE24_TARGETS_UP,SET,40,0.18791,0.0087612,0.13384,0.080167,VARELA_ZMPSTE24_TARGETS_UP,0.819735461335677
GAUCHER_PBMC_YF_VAX_STAMARIL...9,SET,31,0.19855,0.0081516,0.14145,0.080217,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_DN,0.819735461335677
GOMF_PEPTIDE_BINDING,SET,233,0.082601,0.0092458,0.058848,0.08022,GOMF_PEPTIDE_BINDING,0.819735461335677
CHARAFE_BREAST_CANCER_LUMINA...1,SET,414,0.061958,0.009198,0.044145,0.08024,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,0.819735461335677
GALINDO_IMMUNE_RESPONSE_TO_E...,SET,72,0.14656,0.0091597,0.10447,0.080324,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,0.819735461335677
HP_SKIN_NODULE,SET,120,0.11077,0.0089254,0.078957,0.080336,HP_SKIN_NODULE,0.819735461335677
DESCARTES_FETAL_STOMACH_GOBL...,SET,16,0.32843,0.009691,0.23411,0.080336,DESCARTES_FETAL_STOMACH_GOBLET_CELLS,0.819735461335677
GSE17301_ACD3_ACD28_VS_ACD3_...1,SET,183,0.085525,0.0084956,0.060967,0.080345,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN,0.819735461335677
GSE46606_UNSTIM_VS_CD40L_IL2...2,SET,171,0.08974,0.00862,0.063979,0.08037,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,0.819735461335677
MIR2467_5P,SET,102,0.11432,0.0084968,0.081504,0.080377,MIR2467_5P,0.819735461335677
GOBP_LEUKOCYTE_CHEMOTAXIS,SET,219,0.087712,0.009522,0.062536,0.08038,GOBP_LEUKOCYTE_CHEMOTAXIS,0.819735461335677
REACTOME_CARGO_RECOGNITION_F...,SET,95,0.12349,0.0088595,0.088075,0.080454,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,0.819735461335677
GSE2706_UNSTIM_VS_2H_LPS_DC_...1,SET,168,0.096926,0.0092289,0.06913,0.080454,GSE2706_UNSTIM_VS_2H_LPS_DC_DN,0.819735461335677
GOBP_POSITIVE_REGULATION_OF_...35,SET,6,0.46212,0.0083524,0.3296,0.080458,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE,0.819735461335677
CHANDRAN_METASTASIS_TOP50_UP,SET,29,0.19358,0.0076874,0.13809,0.080482,CHANDRAN_METASTASIS_TOP50_UP,0.819735461335677
MIR490_5P,SET,39,0.189,0.0087012,0.13482,0.080492,MIR490_5P,0.819735461335677
OCONNOR_PBMC_MENVEO_ACWYVAX_...1,SET,221,0.079364,0.0086545,0.05662,0.080512,OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN,0.819735461335677
CTGTTAC_MIR194,SET,92,0.1223,0.0086354,0.087257,0.080523,CTGTTAC_MIR194,0.819735461335677
GOMF_CERAMIDE_BINDING,SET,17,0.29363,0.0089305,0.20957,0.080596,GOMF_CERAMIDE_BINDING,0.820161024590164
HP_OSTEOLYSIS_INVOLVING_BONE...1,SET,11,0.38268,0.0093638,0.27314,0.080612,HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_LOWER_LIMBS,0.820161024590164
GSE33424_CD161_HIGH_VS_NEG_C...1,SET,182,0.087463,0.0086646,0.062438,0.080648,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN,0.820287164179105
GSE15330_MEGAKARYOCYTE_ERYTH...1,SET,174,0.085473,0.0082811,0.061037,0.080714,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_DN,0.820718276770041
HP_VASCULAR_NEOPLASM,SET,143,0.095142,0.0083637,0.067967,0.080791,HP_VASCULAR_NEOPLASM,0.820979808640186
GOMF_RNA_POLYMERASE_III_TRAN...,SET,8,0.3542,0.0073919,0.25312,0.08086,GOMF_RNA_POLYMERASE_III_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.820979808640186
ROYLANCE_BREAST_CANCER_16Q_C...2,SET,59,0.23443,0.013267,0.16754,0.080878,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP,0.820979808640186
GOMF_EPIDERMAL_GROWTH_FACTOR...,SET,33,0.21137,0.0089529,0.15111,0.080948,GOMF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING,0.820979808640186
HP_PATCHY_ALOPECIA,SET,19,0.30198,0.0097092,0.21589,0.08095,HP_PATCHY_ALOPECIA,0.820979808640186
ROVERSI_GLIOMA_LOH_REGIONS,SET,45,0.22772,0.01126,0.16283,0.080988,ROVERSI_GLIOMA_LOH_REGIONS,0.820979808640186
GOMF_NEUROTRANSMITTER_TRANSM...,SET,20,0.27602,0.009105,0.19737,0.080991,GOMF_NEUROTRANSMITTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.820979808640186
GOBP_NEGATIVE_REGULATION_OF_...188,SET,31,0.19062,0.0078259,0.13631,0.080992,GOBP_NEGATIVE_REGULATION_OF_DNA_RECOMBINATION,0.820979808640186
CAGNWMCNNNGAC_UNKNOWN,SET,79,0.13999,0.0091626,0.1001,0.080993,CAGNWMCNNNGAC_UNKNOWN,0.820979808640186
HP_WEAKNESS_OF_MUSCLES_OF_RE...,SET,99,0.11791,0.0086344,0.084333,0.081051,HP_WEAKNESS_OF_MUSCLES_OF_RESPIRATION,0.820979808640186
WP_FERROPTOSIS,SET,56,0.16603,0.0091553,0.11877,0.081077,WP_FERROPTOSIS,0.820979808640186
GAVISH_3CA_METAPROGRAM_FIBRO...4,SET,38,0.21147,0.0096105,0.1513,0.081106,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_3,0.820979808640186
GOBP_PLANAR_CELL_POLARITY_PA...2,SET,10,0.40651,0.0094842,0.29086,0.081124,GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_NEURAL_TUBE_CLOSURE,0.820979808640186
GOBP_REGULATION_OF_AMIDE_MET...,SET,63,0.14709,0.0086014,0.10529,0.081204,GOBP_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.820979808640186
HOXC6_TARGET_GENES,SET,948,0.038679,0.0085591,0.027687,0.081213,HOXC6_TARGET_GENES,0.820979808640186
HP_PAROXYSMAL_INVOLUNTARY_EY...,SET,30,0.19678,0.0079478,0.14087,0.081221,HP_PAROXYSMAL_INVOLUNTARY_EYE_MOVEMENTS,0.820979808640186
CAR_WBSCR22,SET,32,0.18852,0.0078634,0.13498,0.08126,CAR_WBSCR22,0.820979808640186
HP_PENETRATING_FOOT_ULCERS,SET,6,0.45698,0.0082595,0.32725,0.081301,HP_PENETRATING_FOOT_ULCERS,0.820979808640186
GSE6259_DEC205_POS_DC_VS_BCE...1,SET,165,0.091339,0.0086197,0.065414,0.081318,GSE6259_DEC205_POS_DC_VS_BCELL_DN,0.820979808640186
PUIFFE_INVASION_INHIBITED_BY...1,SET,134,0.098999,0.0084265,0.070901,0.081319,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,0.820979808640186
KEGG_MEDICUS_REFERENCE_SIALY...,SET,6,0.51507,0.0093095,0.3689,0.081327,KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS,0.820979808640186
HP_SEVERE_TEMPER_TANTRUMS,SET,6,0.49829,0.0090062,0.35688,0.081329,HP_SEVERE_TEMPER_TANTRUMS,0.820979808640186
GOBP_LAMELLIPODIUM_ASSEMBLY,SET,61,0.16034,0.0092264,0.11484,0.081334,GOBP_LAMELLIPODIUM_ASSEMBLY,0.820979808640186
MORF_ATOX1,SET,68,0.13307,0.0080834,0.095314,0.081342,MORF_ATOX1,0.820979808640186
MIR4763_3P,SET,228,0.077973,0.0086348,0.055857,0.081375,MIR4763_3P,0.820979808640186
GOBP_MEMBRANE_PROTEIN_ECTODO...,SET,45,0.1669,0.0082523,0.11958,0.08141,GOBP_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.820979808640186
GOBP_ESTABLISHMENT_OF_PLANAR...1,SET,12,0.36152,0.0092391,0.25902,0.081413,GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_INVOLVED_IN_NEURAL_TUBE_CLOSURE,0.820979808640186
GSE5589_WT_VS_IL10_KO_LPS_AN...5,SET,182,0.086892,0.008608,0.06226,0.081423,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.820979808640186
MARSON_FOXP3_TARGETS_STIMULA...2,SET,29,0.23506,0.0093345,0.16844,0.081436,MARSON_FOXP3_TARGETS_STIMULATED_UP,0.820979808640186
GAVISH_3CA_MALIGNANT_METAPRO...14,SET,49,0.18726,0.0096609,0.13421,0.081468,GAVISH_3CA_MALIGNANT_METAPROGRAM_23_SECRETED_2,0.820979808640186
REACTOME_HEME_DEGRADATION,SET,15,0.30968,0.0088478,0.22195,0.081472,REACTOME_HEME_DEGRADATION,0.820979808640186
GOBP_REGULATION_OF_PROTEIN_T...1,SET,72,0.13312,0.0083198,0.095437,0.081537,GOBP_REGULATION_OF_PROTEIN_TARGETING,0.821008892588303
REACTOME_GOLGI_CISTERNAE_PER...,SET,14,0.28504,0.007868,0.20438,0.081562,REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION,0.821008892588303
HP_COARSE_FACIAL_FEATURES,SET,191,0.082494,0.0083699,0.059152,0.081574,HP_COARSE_FACIAL_FEATURES,0.821008892588303
REACTOME_TRANSPORT_OF_BILE_S...,SET,82,0.13794,0.0091979,0.09892,0.081592,REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,0.821008892588303
KEGG_MEDICUS_REFERENCE_ANTIG...2,SET,12,0.34177,0.0087345,0.24509,0.081593,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.821008892588303
PID_TELOMERASE_PATHWAY,SET,64,0.15086,0.0088909,0.1082,0.081626,PID_TELOMERASE_PATHWAY,0.821103221418235
HP_ELEVATED_CIRCULATING_FOLL...,SET,46,0.17092,0.0085442,0.12263,0.081709,HP_ELEVATED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_LEVEL,0.821700316840278
GOBP_TRANSFORMING_GROWTH_FAC...4,SET,196,0.085337,0.0087698,0.061252,0.081787,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,0.822033050259965
HP_ABNORMAL_FACIAL_EXPRESSION,SET,165,0.093028,0.008779,0.066778,0.081805,HP_ABNORMAL_FACIAL_EXPRESSION,0.822033050259965
GOBP_POSITIVE_REGULATION_OF_...503,SET,17,0.29422,0.0089485,0.21123,0.081835,GOBP_POSITIVE_REGULATION_OF_MYELINATION,0.822033050259965
MIR675_3P,SET,56,0.16523,0.0091111,0.11863,0.081848,MIR675_3P,0.822033050259965
KANG_FLUOROURACIL_RESISTANCE...2,SET,19,0.25543,0.0082126,0.18341,0.081868,KANG_FLUOROURACIL_RESISTANCE_UP,0.822033050259965
JIANG_MELANOMA_TRM8_CD4,SET,364,0.062431,0.0087027,0.044831,0.081884,JIANG_MELANOMA_TRM8_CD4,0.822033050259965
GSE2405_HEAT_KILLED_VS_LIVE_...1,SET,173,0.087041,0.008409,0.062534,0.081985,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,0.822121011527378
GOMF_HISTONE_METHYLTRANSFERA...1,SET,58,0.14745,0.0082743,0.10594,0.081991,GOMF_HISTONE_METHYLTRANSFERASE_ACTIVITY,0.822121011527378
HP_NYSTAGMUS_INDUCED_HEAD_NO...,SET,15,0.35903,0.010258,0.25798,0.082017,HP_NYSTAGMUS_INDUCED_HEAD_NODDING,0.822121011527378
CUI_DEVELOPING_HEART_C2_CARD...,SET,85,0.13193,0.008956,0.094805,0.082024,CUI_DEVELOPING_HEART_C2_CARDIOMYOCYTE,0.822121011527378
GOBP_LAMELLIPODIUM_ORGANIZAT...,SET,79,0.13503,0.0088384,0.097044,0.082048,GOBP_LAMELLIPODIUM_ORGANIZATION,0.822121011527378
HP_ESOPHAGEAL_NEOPLASM,SET,27,0.22844,0.0087536,0.16417,0.08205,HP_ESOPHAGEAL_NEOPLASM,0.822121011527378
KONDO_HYPOXIA,SET,6,0.46364,0.0083799,0.33322,0.082062,KONDO_HYPOXIA,0.822121011527378
GAUTAM_EYE_CORNEA_ELF3_HIGH_...,SET,134,0.10111,0.0086065,0.072679,0.082082,GAUTAM_EYE_CORNEA_ELF3_HIGH_EPITHELIAL_CELLS,0.822121011527378
BOGNI_TREATMENT_RELATED_MYEL...1,SET,31,0.20044,0.0082291,0.1441,0.082128,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,0.82212208249497
REACTOME_LATE_ENDOSOMAL_MICR...,SET,32,0.21081,0.0087931,0.15157,0.082138,REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY,0.82212208249497
GOBP_NEGATIVE_REGULATION_OF_...115,SET,10,0.46856,0.010932,0.33696,0.082186,GOBP_NEGATIVE_REGULATION_OF_CELL_FATE_COMMITMENT,0.82212208249497
HP_RELATIVE_MACROCEPHALY,SET,52,0.15539,0.0082575,0.11175,0.082194,HP_RELATIVE_MACROCEPHALY,0.82212208249497
GSE14308_TH2_VS_TH17_UP,SET,184,0.084827,0.0084491,0.061007,0.082205,GSE14308_TH2_VS_TH17_UP,0.82212208249497
MORI_PRE_BI_LYMPHOCYTE_UP,SET,73,0.1377,0.0086653,0.099052,0.082245,MORI_PRE_BI_LYMPHOCYTE_UP,0.82212208249497
GOBP_ZINC_ION_IMPORT_ACROSS_...,SET,10,0.36682,0.0085583,0.26388,0.082255,GOBP_ZINC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.82212208249497
GOBP_PANCREATIC_JUICE_SECRET...,SET,11,0.34399,0.0084172,0.24748,0.082277,GOBP_PANCREATIC_JUICE_SECRETION,0.82212208249497
HP_LEFT_SUPERIOR_VENA_CAVA_D...,SET,3,0.70926,0.0090653,0.51031,0.082295,HP_LEFT_SUPERIOR_VENA_CAVA_DRAINING_TO_CORONARY_SINUS,0.82212208249497
HP_HYPOPIGMENTATION_OF_HAIR,SET,88,0.13045,0.0090092,0.093898,0.082387,HP_HYPOPIGMENTATION_OF_HAIR,0.82246849598163
AIZARANI_LIVER_C23_KUPFFER_C...,SET,196,0.087534,0.0089955,0.063012,0.082401,AIZARANI_LIVER_C23_KUPFFER_CELLS_3,0.82246849598163
HP_MALROTATION_OF_SMALL_BOWEL,SET,8,0.40338,0.0084182,0.29041,0.082424,HP_MALROTATION_OF_SMALL_BOWEL,0.82246849598163
HP_PROGRESSIVE_PERIPHERAL_NE...,SET,4,0.65398,0.0096516,0.47086,0.08244,HP_PROGRESSIVE_PERIPHERAL_NEUROPATHY,0.82246849598163
HP_IMPAIRED_EPINEPHRINE_INDU...,SET,9,0.34769,0.0076959,0.25035,0.082448,HP_IMPAIRED_EPINEPHRINE_INDUCED_PLATELET_AGGREGATION,0.82246849598163
MIR4535,SET,26,0.22966,0.0086361,0.16542,0.082523,MIR4535,0.822847299971322
REACTOME_TICAM1_DEPENDENT_AC...,SET,12,0.33451,0.0085489,0.24097,0.08255,REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7,0.822847299971322
GOBP_DEMETHYLATION,SET,37,0.19151,0.0085883,0.13796,0.082557,GOBP_DEMETHYLATION,0.822847299971322
GSE2124_CTRL_VS_LYMPHOTOXIN_...2,SET,182,0.088811,0.0087982,0.063995,0.082608,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP,0.822993220120378
HP_BILIARY_TRACT_NEOPLASM,SET,15,0.31156,0.0089015,0.22451,0.082619,HP_BILIARY_TRACT_NEOPLASM,0.822993220120378
GSE41176_UNSTIM_VS_ANTI_IGM_...1,SET,177,0.087787,0.0085776,0.063274,0.082666,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN,0.823022684707904
MIR345_5P,SET,40,0.18945,0.0088328,0.13656,0.082688,MIR345_5P,0.823022684707904
MODULE_345,SET,110,0.11476,0.0088562,0.082728,0.082693,MODULE_345,0.823022684707904
WANG_THOC1_TARGETS_DN,SET,16,0.31439,0.0092766,0.22672,0.082783,WANG_THOC1_TARGETS_DN,0.823130629820051
TAL1BETAE47_01,SET,225,0.080224,0.0088261,0.057863,0.082814,TAL1BETAE47_01,0.823130629820051
GSE16450_CTRL_VS_IFNA_12H_ST...2,SET,172,0.09152,0.0088163,0.066017,0.082836,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.823130629820051
GOBP_MESENCHYMAL_STEM_CELL_D...,SET,11,0.38442,0.0094064,0.27732,0.082854,GOBP_MESENCHYMAL_STEM_CELL_DIFFERENTIATION,0.823130629820051
HP_THICK_NASAL_ALAE,SET,34,0.19226,0.0082655,0.13871,0.082872,HP_THICK_NASAL_ALAE,0.823130629820051
GOMF_FAD_BINDING,SET,36,0.19304,0.0085392,0.13929,0.082899,GOMF_FAD_BINDING,0.823130629820051
GSE23308_WT_VS_MINERALCORTIC...4,SET,187,0.082189,0.008252,0.059304,0.082899,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP,0.823130629820051
REACTOME_CHONDROITIN_SULFATE...2,SET,45,0.16895,0.0083537,0.12192,0.082915,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,0.823130629820051
GOBP_MACROPHAGE_PROLIFERATION,SET,10,0.41042,0.0095755,0.29617,0.082917,GOBP_MACROPHAGE_PROLIFERATION,0.823130629820051
GOBP_ATF6_MEDIATED_UNFOLDED_...,SET,8,0.37423,0.0078097,0.27015,0.082993,GOBP_ATF6_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.823420814550642
GSE21546_WT_VS_SAP1A_KO_DP_T...2,SET,176,0.091281,0.008894,0.065895,0.083,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP,0.823420814550642
GOMF_ALPHA_1_3_FUCOSYLTRANSF...,SET,8,0.49297,0.010288,0.35594,0.083035,GOMF_ALPHA_1_3_FUCOSYLTRANSFERASE_ACTIVITY,0.823420814550642
REACTOME_CILIUM_ASSEMBLY,SET,182,0.081275,0.0080516,0.058684,0.083041,REACTOME_CILIUM_ASSEMBLY,0.823420814550642
REN_BOUND_BY_E2F,SET,53,0.14731,0.007903,0.10638,0.08307,REN_BOUND_BY_E2F,0.823473431260696
GOBP_SNRNA_MODIFICATION,SET,6,0.40509,0.0073217,0.29259,0.083109,GOBP_SNRNA_MODIFICATION,0.823625119760479
YYCATTCAWW_UNKNOWN,SET,177,0.088568,0.0086539,0.063978,0.083136,YYCATTCAWW_UNKNOWN,0.823657833523375
MIR1224_3P,SET,63,0.14389,0.0084138,0.10396,0.083178,MIR1224_3P,0.82383909660872
GOMF_GLUCURONOSYLTRANSFERASE...,SET,31,0.26951,0.011065,0.19479,0.083257,GOMF_GLUCURONOSYLTRANSFERASE_ACTIVITY,0.82438661965812
GAUTAM_EYE_IRIS_CILIARY_BODY...5,SET,76,0.13635,0.0087544,0.098571,0.083295,GAUTAM_EYE_IRIS_CILIARY_BODY_CRYAA_HIGH_CILIARY_BODY_CELLS,0.824527976360011
LI_WILMS_TUMOR_VS_FETAL_KIDN...2,SET,169,0.093336,0.0089133,0.067507,0.083398,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,0.824727557544757
GSE3565_CTRL_VS_LPS_INJECTED...3,SET,155,0.093802,0.008582,0.067846,0.083408,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_DN,0.824727557544757
URS_ADIPOCYTE_DIFFERENTIATIO...1,SET,31,0.22454,0.0092186,0.16243,0.083432,URS_ADIPOCYTE_DIFFERENTIATION_DN,0.824727557544757
GOBP_VASCULAR_TRANSPORT,SET,81,0.14183,0.0093997,0.10261,0.083463,GOBP_VASCULAR_TRANSPORT,0.824727557544757
GOMF_OPSONIN_BINDING,SET,16,0.31699,0.0093534,0.22936,0.083484,GOMF_OPSONIN_BINDING,0.824727557544757
GOBP_REGULATION_OF_SUPEROXID...1,SET,20,0.27536,0.009083,0.19924,0.083486,GOBP_REGULATION_OF_SUPEROXIDE_ANION_GENERATION,0.824727557544757
GSE6259_BCELL_VS_CD8_TCELL_UP,SET,174,0.093764,0.0090844,0.067844,0.083487,GSE6259_BCELL_VS_CD8_TCELL_UP,0.824727557544757
GSE15624_CTRL_VS_3H_HALOFUGI...2,SET,147,0.092914,0.0082803,0.067235,0.083505,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.824727557544757
MIR6813_5P,SET,36,0.18884,0.0083537,0.13668,0.083555,MIR6813_5P,0.824986938920454
MIR551A_MIR551B_3P,SET,5,0.57479,0.0094839,0.41616,0.083623,MIR551A_MIR551B_3P,0.825095929341657
HP_CONE_SHAPED_METACARPAL_EP...,SET,4,0.57455,0.0084793,0.41599,0.083623,HP_CONE_SHAPED_METACARPAL_EPIPHYSES,0.825095929341657
HP_WIDE_NASAL_BRIDGE,SET,433,0.056687,0.008602,0.041048,0.083648,HP_WIDE_NASAL_BRIDGE,0.825095929341657
HP_ABNORMAL_NUMBER_OF_GRANUL...,SET,9,0.39048,0.0086429,0.28277,0.083661,HP_ABNORMAL_NUMBER_OF_GRANULOCYTE_PRECURSORS,0.825095929341657
GSE36392_TYPE_2_MYELOID_VS_N...1,SET,180,0.08384,0.0082604,0.060732,0.083727,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,0.825193638285875
CHANG_POU5F1_TARGETS_DN,SET,7,0.50579,0.0098739,0.36644,0.083761,CHANG_POU5F1_TARGETS_DN,0.825193638285875
GARGALOVIC_RESPONSE_TO_OXIDI...21,SET,48,0.16208,0.0082763,0.11744,0.083787,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,0.825193638285875
GOMF_MUTLALPHA_COMPLEX_BINDI...,SET,7,0.38844,0.007583,0.28146,0.083787,GOMF_MUTLALPHA_COMPLEX_BINDING,0.825193638285875
GOBP_VIRAL_RNA_GENOME_REPLIC...,SET,24,0.25274,0.0091315,0.18318,0.083848,GOBP_VIRAL_RNA_GENOME_REPLICATION,0.825193638285875
GOMF_STRUCTURAL_MOLECULE_ACT...2,SET,12,0.3609,0.0092234,0.26166,0.083914,GOMF_STRUCTURAL_MOLECULE_ACTIVITY_CONFERRING_ELASTICITY,0.825193638285875
KASLER_HDAC7_TARGETS_2_DN,SET,31,0.21399,0.0087852,0.15515,0.083929,KASLER_HDAC7_TARGETS_2_DN,0.825193638285875
REACTOME_CALNEXIN_CALRETICUL...,SET,24,0.22476,0.0081207,0.16297,0.083931,REACTOME_CALNEXIN_CALRETICULIN_CYCLE,0.825193638285875
MIR12118,SET,90,0.12151,0.0084862,0.088105,0.083934,MIR12118,0.825193638285875
PID_TCR_CALCIUM_PATHWAY,SET,27,0.22113,0.0084737,0.16035,0.083943,PID_TCR_CALCIUM_PATHWAY,0.825193638285875
HP_ABNORMAL_ELASTICITY_OF_SK...,SET,204,0.081517,0.0085446,0.059115,0.083961,HP_ABNORMAL_ELASTICITY_OF_SKIN,0.825193638285875
GSE17721_CTRL_VS_POLYIC_12H_...1,SET,188,0.08311,0.0083666,0.060286,0.084018,GSE17721_CTRL_VS_POLYIC_12H_BMDC_DN,0.825193638285875
GOCC_DNA_POLYMERASE_COMPLEX,SET,19,0.23456,0.0075415,0.17015,0.084019,GOCC_DNA_POLYMERASE_COMPLEX,0.825193638285875
ZNF236_TARGET_GENES,SET,212,0.078008,0.0083337,0.056589,0.084031,ZNF236_TARGET_GENES,0.825193638285875
KEGG_TIGHT_JUNCTION,SET,125,0.10661,0.0087664,0.077338,0.084034,KEGG_TIGHT_JUNCTION,0.825193638285875
UNTERMAN_PROGRESSIVE_VS_STAB...3,SET,5,0.55898,0.0092231,0.40566,0.084116,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_CD8T_UP,0.825193638285875
DURANTE_ADULT_OLFACTORY_NEUR...2,SET,29,0.22637,0.0089895,0.16429,0.084129,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_B_CELLS,0.825193638285875
UNTERMAN_IPF_VS_CTRL_TREG_CE...2,SET,13,0.36386,0.0096784,0.2641,0.084153,UNTERMAN_IPF_VS_CTRL_TREG_CELL_UP,0.825193638285875
MIR486_5P,SET,85,0.12289,0.0083417,0.0892,0.084167,MIR486_5P,0.825193638285875
RAF_UP.V1_UP,SET,176,0.094715,0.0092286,0.06876,0.084192,RAF_UP.V1_UP,0.825193638285875
MIR450B_3P,SET,42,0.17534,0.0083765,0.12729,0.084196,MIR450B_3P,0.825193638285875
GOMF_2_OXOGLUTARATE_DEPENDEN...,SET,52,0.13868,0.0073696,0.10068,0.084205,GOMF_2_OXOGLUTARATE_DEPENDENT_DIOXYGENASE_ACTIVITY,0.825193638285875
HP_GENERALIZED_DYSTONIA,SET,27,0.20933,0.0080214,0.15199,0.084217,HP_GENERALIZED_DYSTONIA,0.825193638285875
MIR4455,SET,100,0.12288,0.009044,0.089264,0.084322,MIR4455,0.82598960259301
GOBP_MEIOTIC_CHROMOSOME_SEGR...,SET,79,0.12526,0.0081987,0.091007,0.08436,GOBP_MEIOTIC_CHROMOSOME_SEGREGATION,0.82612899408284
MIR4636,SET,3,0.97935,0.012517,0.71171,0.084414,MIR4636,0.826193592519685
GSE22935_WT_VS_MYD88_KO_MACR...5,SET,175,0.087669,0.008518,0.063716,0.084428,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_DN,0.826193592519685
GOBP_ADENOHYPOPHYSIS_DEVELOP...,SET,16,0.31791,0.0093805,0.23114,0.084512,GOBP_ADENOHYPOPHYSIS_DEVELOPMENT,0.826193592519685
GSE2128_C57BL6_VS_NOD_THYMOC...4,SET,179,0.083897,0.0082432,0.061,0.084521,GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP,0.826193592519685
GSE17721_LPS_VS_POLYIC_6H_BM...1,SET,178,0.085878,0.0084145,0.062442,0.084524,GSE17721_LPS_VS_POLYIC_6H_BMDC_DN,0.826193592519685
GOBP_SUPRAMOLECULAR_FIBER_OR...,SET,775,0.043132,0.0086723,0.031361,0.084525,GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.826193592519685
GOBP_SOMATIC_DIVERSIFICATION...3,SET,55,0.14172,0.0077451,0.10305,0.084533,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS,0.826193592519685
HP_SPONTANEOUS_PAIN_SENSATION,SET,5,0.54499,0.0089922,0.39644,0.084619,HP_SPONTANEOUS_PAIN_SENSATION,0.826588773187184
WP_INFLUENCE_OF_LAMINOPATHIE...,SET,33,0.20136,0.0085287,0.14647,0.084621,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,0.826588773187184
GOBP_RESPONSE_TO_MANGANESE_I...,SET,16,0.29459,0.0086924,0.21438,0.084712,GOBP_RESPONSE_TO_MANGANESE_ION,0.82694647430497
LFA1_Q6,SET,237,0.075345,0.0085048,0.054836,0.084727,LFA1_Q6,0.82694647430497
GOBP_REGULATION_OF_LAMELLIPO...1,SET,32,0.21536,0.0089828,0.15674,0.084729,GOBP_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.82694647430497
GOBP_LYMPHOCYTE_DIFFERENTIAT...,SET,402,0.061445,0.0089918,0.044736,0.084808,GOBP_LYMPHOCYTE_DIFFERENTIATION,0.827272396856581
NAKAYA_PBMC_FLUMIST_AGE_18_5...3,SET,502,0.050509,0.0082366,0.036774,0.08481,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP,0.827272396856581
KEGG_MEDICUS_REFERENCE_TLR2_...,SET,25,0.25206,0.0092947,0.18355,0.08484,KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY,0.827301103968698
GOBP_RESPONSE_TO_CORTICOSTER...2,SET,15,0.31132,0.0088947,0.22678,0.084914,GOBP_RESPONSE_TO_CORTICOSTERONE,0.827301103968698
GSE29617_DAY3_VS_DAY7_TIV_FL...2,SET,168,0.09277,0.0088332,0.06758,0.084922,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,0.827301103968698
GOBP_CYTOCHROME_METABOLIC_PR...,SET,5,0.57945,0.0095608,0.42211,0.084927,GOBP_CYTOCHROME_METABOLIC_PROCESS,0.827301103968698
GSE39152_SPLEEN_CD103_NEG_VS...2,SET,187,0.083454,0.0083791,0.060797,0.084936,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_UP,0.827301103968698
GSE17721_LPS_VS_GARDIQUIMOD_...6,SET,187,0.08543,0.0085775,0.062268,0.085044,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_UP,0.827301103968698
GOMF_ADENOSINE_3_5_BISPHOSPH...,SET,5,0.51787,0.0085447,0.37746,0.085045,GOMF_ADENOSINE_3_5_BISPHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.827301103968698
KEGG_PYRUVATE_METABOLISM,SET,38,0.17919,0.0081434,0.13062,0.085069,KEGG_PYRUVATE_METABOLISM,0.827301103968698
BIOCARTA_IRES_PATHWAY,SET,7,0.40886,0.0079816,0.29804,0.08507,BIOCARTA_IRES_PATHWAY,0.827301103968698
KEGG_MEDICUS_PATHOGEN_HPV_E5...2,SET,13,0.31204,0.0082999,0.22747,0.085072,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.827301103968698
GOBP_AV_NODE_CELL_TO_BUNDLE_...2,SET,10,0.40918,0.0095466,0.29831,0.085095,GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_SIGNALING,0.827301103968698
XBP1_01,SET,113,0.10735,0.0083958,0.078278,0.085131,XBP1_01,0.827301103968698
HP_TOE_SYNDACTYLY,SET,199,0.0824,0.0085318,0.060092,0.085161,HP_TOE_SYNDACTYLY,0.827301103968698
MIR6783_3P,SET,185,0.08418,0.0084071,0.061392,0.085168,MIR6783_3P,0.827301103968698
GSE3982_MAST_CELL_VS_TH2_UP,SET,181,0.087143,0.0086094,0.063554,0.08517,GSE3982_MAST_CELL_VS_TH2_UP,0.827301103968698
GSE43955_1H_VS_42H_ACT_CD4_T...4,SET,180,0.084968,0.0083715,0.061977,0.085201,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.827370984911987
REACTOME_REGULATION_OF_ENDOG...2,SET,47,0.16433,0.0083035,0.11994,0.085336,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS,0.828048801257518
HALLMARK_INTERFERON_GAMMA_RE...,SET,190,0.08785,0.0088902,0.064124,0.085353,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.828048801257518
WP_PREGNANE_X_RECEPTOR_PATHW...,SET,31,0.2228,0.009147,0.16263,0.085358,WP_PREGNANE_X_RECEPTOR_PATHWAY,0.828048801257518
GOBP_OOCYTE_MATURATION,SET,30,0.20588,0.0083152,0.15033,0.085419,GOBP_OOCYTE_MATURATION,0.828048801257518
REACTOME_MITOCHONDRIAL_UNCOU...,SET,6,0.46025,0.0083185,0.33607,0.085429,REACTOME_MITOCHONDRIAL_UNCOUPLING,0.828048801257518
TAKEDA_TARGETS_OF_NUP98_HOXA...6,SET,168,0.097511,0.0092846,0.071213,0.085464,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,0.828048801257518
GSE27786_NKCELL_VS_MONO_MAC_...2,SET,178,0.08291,0.0081237,0.060557,0.085487,GSE27786_NKCELL_VS_MONO_MAC_UP,0.828048801257518
GSE2770_IL12_VS_IL4_TREATED_...6,SET,182,0.083177,0.00824,0.06077,0.085553,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.828048801257518
GSE32986_CURDLAN_LOWDOSE_VS_...4,SET,179,0.082435,0.0080996,0.06024,0.085596,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.828048801257518
GSE360_DC_VS_MAC_M_TUBERCULO...2,SET,179,0.087365,0.008584,0.063843,0.085597,GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP,0.828048801257518
MIR5681B,SET,48,0.166,0.0084763,0.12131,0.085599,MIR5681B,0.828048801257518
MODULE_200,SET,27,0.25342,0.009711,0.18525,0.085659,MODULE_200,0.828048801257518
REACTOME_SUMO_IS_CONJUGATED_...,SET,5,0.42043,0.006937,0.30737,0.085688,REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1,0.828048801257518
GOBP_NEGATIVE_REGULATION_OF_...217,SET,59,0.15413,0.0087233,0.11268,0.085689,GOBP_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,0.828048801257518
GOBP_EPITHELIAL_FLUID_TRANSP...,SET,12,0.35575,0.0090917,0.26013,0.085727,GOBP_EPITHELIAL_FLUID_TRANSPORT,0.828048801257518
WATANABE_COLON_CANCER_MSI_VS...2,SET,28,0.22531,0.0087917,0.16476,0.085741,WATANABE_COLON_CANCER_MSI_VS_MSS_UP,0.828048801257518
HP_LIVEDO,SET,6,0.40234,0.007272,0.29422,0.085746,HP_LIVEDO,0.828048801257518
GOBP_DEOXYRIBONUCLEOTIDE_CAT...,SET,28,0.22538,0.0087947,0.16485,0.085792,GOBP_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS,0.828048801257518
REACTOME_MITOTIC_G2_G2_M_PHA...,SET,187,0.079191,0.0079511,0.057932,0.085826,REACTOME_MITOTIC_G2_G2_M_PHASES,0.828048801257518
GOMF_HISTONE_H3_METHYLTRANSF...,SET,40,0.1762,0.008215,0.1289,0.08584,GOMF_HISTONE_H3_METHYLTRANSFERASE_ACTIVITY,0.828048801257518
GOBP_ADAPTIVE_IMMUNE_RESPONSE,SET,425,0.061255,0.009211,0.044816,0.085848,GOBP_ADAPTIVE_IMMUNE_RESPONSE,0.828048801257518
GOBP_CYSTEINE_METABOLIC_PROC...,SET,10,0.39038,0.0091079,0.28561,0.085848,GOBP_CYSTEINE_METABOLIC_PROCESS,0.828048801257518
GSE13484_UNSTIM_VS_12H_YF17D...2,SET,185,0.08357,0.0083462,0.061147,0.085868,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP,0.828048801257518
chr9q21,SET,57,0.23384,0.013009,0.17113,0.085912,chr9q21,0.828048801257518
GOCC_MHC_CLASS_I_PEPTIDE_LOA...,SET,8,0.37771,0.0078824,0.27647,0.085946,GOCC_MHC_CLASS_I_PEPTIDE_LOADING_COMPLEX,0.828048801257518
MIR4477B,SET,242,0.074216,0.008464,0.054332,0.085981,MIR4477B,0.828048801257518
HP_TORTUOUS_CEREBRAL_ARTERIES,SET,5,0.47268,0.0077991,0.34611,0.086026,HP_TORTUOUS_CEREBRAL_ARTERIES,0.828048801257518
MODULE_207,SET,207,0.0812,0.008573,0.059461,0.086039,MODULE_207,0.828048801257518
HP_EMG_AXONAL_ABNORMALITY,SET,14,0.32305,0.0089171,0.23657,0.086044,HP_EMG_AXONAL_ABNORMALITY,0.828048801257518
NIKOLSKY_MUTATED_AND_AMPLIFI...,SET,87,0.12145,0.0083402,0.088951,0.086081,NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,0.828048801257518
GSE28737_BCL6_HET_VS_BCL6_KO...1,SET,184,0.083189,0.0082859,0.060934,0.086099,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN,0.828048801257518
TBK1.DF_UP,SET,261,0.0727,0.008606,0.053258,0.086125,TBK1.DF_UP,0.828048801257518
MIR6724_5P,SET,18,0.24277,0.0075974,0.17787,0.086156,MIR6724_5P,0.828048801257518
MODULE_512,SET,36,0.193,0.0085376,0.14141,0.086168,MODULE_512,0.828048801257518
GSE45739_UNSTIM_VS_ACD3_ACD2...4,SET,181,0.088387,0.0087323,0.064776,0.086214,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP,0.828048801257518
GSE29949_CD8_NEG_DC_SPLEEN_V...3,SET,179,0.086571,0.008506,0.063446,0.086215,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN,0.828048801257518
GOBP_B_CELL_RECEPTOR_SIGNALI...,SET,58,0.1592,0.0089333,0.11668,0.086231,GOBP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.828048801257518
FREAC2_01,SET,235,0.079465,0.0089324,0.058247,0.08625,FREAC2_01,0.828048801257518
GOBP_EPITHELIAL_CELL_DEVELOP...,SET,205,0.084807,0.0089109,0.062164,0.086254,GOBP_EPITHELIAL_CELL_DEVELOPMENT,0.828048801257518
GOMF_PROTEIN_ANTIGEN_BINDING,SET,7,0.45814,0.0089437,0.33584,0.086269,GOMF_PROTEIN_ANTIGEN_BINDING,0.828048801257518
GOBP_PLASMA_MEMBRANE_REPAIR,SET,27,0.21497,0.0082374,0.1576,0.086286,GOBP_PLASMA_MEMBRANE_REPAIR,0.828048801257518
GSE42724_B1_BCELL_VS_PLASMAB...1,SET,181,0.080516,0.0079546,0.059029,0.086291,GSE42724_B1_BCELL_VS_PLASMABLAST_DN,0.828048801257518
XPO1_TARGET_GENES,SET,19,0.28536,0.0091749,0.20925,0.086329,XPO1_TARGET_GENES,0.828048801257518
BIOCARTA_PDGF_PATHWAY,SET,27,0.22542,0.0086378,0.1653,0.086338,BIOCARTA_PDGF_PATHWAY,0.828048801257518
GOBP_FACE_DEVELOPMENT,SET,49,0.16805,0.0086697,0.12324,0.086363,GOBP_FACE_DEVELOPMENT,0.828048801257518
HP_BROAD_FOREHEAD,SET,167,0.08881,0.0084312,0.065139,0.08639,HP_BROAD_FOREHEAD,0.828048801257518
GOMF_CHLORIDE_CHANNEL_INHIBI...,SET,7,0.39996,0.007808,0.29345,0.086457,GOMF_CHLORIDE_CHANNEL_INHIBITOR_ACTIVITY,0.828048801257518
GSE369_PRE_VS_POST_IL6_INJEC...5,SET,184,0.08068,0.008036,0.059198,0.086469,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN,0.828048801257518
HP_SKELETAL_MUSCLE_HYPERTROP...,SET,184,0.085197,0.0084859,0.062533,0.086538,HP_SKELETAL_MUSCLE_HYPERTROPHY,0.828048801257518
HP_ABNORMAL_NOSTRIL_MORPHOLO...,SET,434,0.054026,0.0082074,0.039655,0.086543,HP_ABNORMAL_NOSTRIL_MORPHOLOGY,0.828048801257518
RRAGTTGT_UNKNOWN,SET,228,0.078566,0.0087005,0.057673,0.086564,RRAGTTGT_UNKNOWN,0.828048801257518
HP_ABNORMAL_MITOCHONDRIA_IN_...,SET,25,0.20107,0.0074144,0.1476,0.086567,HP_ABNORMAL_MITOCHONDRIA_IN_MUSCLE_TISSUE,0.828048801257518
GOMF_NEUROTROPHIN_RECEPTOR_B...,SET,11,0.32535,0.0079609,0.23884,0.086573,GOMF_NEUROTROPHIN_RECEPTOR_BINDING,0.828048801257518
GSE17721_LPS_VS_PAM3CSK4_1H_...1,SET,189,0.086352,0.0087158,0.063398,0.086599,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN,0.828048801257518
MIR508_3P,SET,94,0.11695,0.0083463,0.085878,0.08664,MIR508_3P,0.828048801257518
HP_CHEILITIS,SET,48,0.17842,0.0091106,0.13106,0.086716,HP_CHEILITIS,0.828048801257518
MARTIN_NFKB_TARGETS_UP,SET,41,0.19419,0.0091661,0.14266,0.086738,MARTIN_NFKB_TARGETS_UP,0.828048801257518
GOBP_POST_TRANSLATIONAL_PROT...2,SET,14,0.29275,0.0080805,0.2151,0.08677,GOBP_POST_TRANSLATIONAL_PROTEIN_TARGETING_TO_ENDOPLASMIC_RETICULUM_MEMBRANE,0.828048801257518
GOBP_AMYLOID_PRECURSOR_PROTE...2,SET,53,0.15877,0.0085177,0.11666,0.08678,GOBP_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.828048801257518
GAVISH_3CA_METAPROGRAM_FIBRO...22,SET,48,0.17084,0.0087234,0.12556,0.08683,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS,0.828048801257518
GSE22432_UNTREATED_VS_TGFB1_...1,SET,174,0.084236,0.0081613,0.061912,0.08683,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_DN,0.828048801257518
EINAV_INTERFERON_SIGNATURE_I...,SET,27,0.21917,0.0083982,0.16108,0.086832,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.828048801257518
KOYAMA_SEMA3B_TARGETS_UP,SET,221,0.076482,0.0083402,0.056213,0.086835,KOYAMA_SEMA3B_TARGETS_UP,0.828048801257518
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...2,SET,727,0.043442,0.0084715,0.031939,0.086899,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN,0.828048801257518
HE_LIM_SUN_FETAL_LUNG_C0_MYL...,SET,110,0.11735,0.0090556,0.086279,0.086909,HE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL,0.828048801257518
GOBP_REGULATION_OF_NEURONAL_...1,SET,3,0.76158,0.0097341,0.55998,0.08692,GOBP_REGULATION_OF_NEURONAL_ACTION_POTENTIAL,0.828048801257518
GOBP_REGULATION_OF_RESPONSE_...4,SET,74,0.12488,0.007912,0.091828,0.086935,GOBP_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.828048801257518
GSE13522_WT_VS_IFNG_KO_SKIN_...2,SET,119,0.11042,0.0088606,0.0812,0.086945,GSE13522_WT_VS_IFNG_KO_SKIN_UP,0.828048801257518
GOBP_CHEMOSENSORY_BEHAVIOR,SET,19,0.28107,0.0090369,0.2067,0.08696,GOBP_CHEMOSENSORY_BEHAVIOR,0.828048801257518
REACTOME_ONCOGENIC_MAPK_SIGN...,SET,77,0.1308,0.0084526,0.096216,0.087012,REACTOME_ONCOGENIC_MAPK_SIGNALING,0.828048801257518
GOCC_GAMMA_TUBULIN_RING_COMP...,SET,8,0.46115,0.0096238,0.33925,0.087028,GOCC_GAMMA_TUBULIN_RING_COMPLEX,0.828048801257518
HP_GONADOBLASTOMA,SET,14,0.34743,0.0095899,0.25558,0.087028,HP_GONADOBLASTOMA,0.828048801257518
GOMF_NEUROTROPHIN_TRK_RECEPT...,SET,6,0.39465,0.0071329,0.29033,0.087035,GOMF_NEUROTROPHIN_TRK_RECEPTOR_BINDING,0.828048801257518
HP_LEUKODYSTROPHY,SET,83,0.11482,0.0077026,0.084492,0.087084,HP_LEUKODYSTROPHY,0.828048801257518
GSE45365_NK_CELL_VS_CD8A_DC_...3,SET,154,0.091663,0.0083595,0.067458,0.087109,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP,0.828048801257518
GSE6269_HEALTHY_VS_E_COLI_IN...1,SET,145,0.099358,0.0087947,0.073128,0.08713,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN,0.828048801257518
HP_REDUCED_BRAIN_N_ACETYL_AS...,SET,16,0.25553,0.0075398,0.18808,0.087142,HP_REDUCED_BRAIN_N_ACETYL_ASPARTATE_LEVEL_BY_MRS,0.828048801257518
GOMF_ATP_DEPENDENT_PROTEIN_F...,SET,31,0.19029,0.0078122,0.14006,0.087146,GOMF_ATP_DEPENDENT_PROTEIN_FOLDING_CHAPERONE,0.828048801257518
BIOCARTA_IGF1MTOR_PATHWAY,SET,18,0.29481,0.009226,0.217,0.087153,BIOCARTA_IGF1MTOR_PATHWAY,0.828048801257518
GOBP_RETINA_HOMEOSTASIS,SET,53,0.16493,0.0088486,0.12143,0.087202,GOBP_RETINA_HOMEOSTASIS,0.82827707562568
GOBP_MEDIUM_CHAIN_FATTY_ACID...1,SET,6,0.45091,0.0081498,0.33203,0.087232,GOBP_MEDIUM_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.82827707562568
REACTOME_TRAFFICKING_OF_MYRI...,SET,4,0.54323,0.0080171,0.4001,0.087281,REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM,0.82827707562568
REACTOME_INFLUENZA_INFECTION,SET,145,0.089794,0.007948,0.066145,0.087316,REACTOME_INFLUENZA_INFECTION,0.82827707562568
GOBP_MYELOID_PROGENITOR_CELL...,SET,9,0.35343,0.0078229,0.26038,0.087342,GOBP_MYELOID_PROGENITOR_CELL_DIFFERENTIATION,0.82827707562568
GOMF_CO_SMAD_BINDING,SET,9,0.42151,0.0093298,0.31062,0.087401,GOMF_CO_SMAD_BINDING,0.82827707562568
GOBP_POSITIVE_REGULATION_OF_...259,SET,32,0.18937,0.0078989,0.13956,0.087406,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.82827707562568
MIR662,SET,4,0.46751,0.0068997,0.34454,0.087412,MIR662,0.82827707562568
GOBP_REGULATION_OF_MICROTUBU...6,SET,16,0.24649,0.0072732,0.18168,0.087435,GOBP_REGULATION_OF_MICROTUBULE_NUCLEATION,0.82827707562568
REACTOME_DISEASES_OF_IMMUNE_...,SET,29,0.22212,0.0088206,0.16373,0.087454,REACTOME_DISEASES_OF_IMMUNE_SYSTEM,0.82827707562568
GOBP_T_CELL_RECEPTOR_SIGNALI...,SET,127,0.10363,0.0085892,0.076395,0.087468,GOBP_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.82827707562568
ZBTB44_TARGET_GENES,SET,621,0.046992,0.0084947,0.034645,0.087497,ZBTB44_TARGET_GENES,0.82827707562568
GOBP_CELL_ACTIVATION,SET,1021,0.038328,0.0087833,0.02826,0.087515,GOBP_CELL_ACTIVATION,0.82827707562568
GCNP_SHH_UP_LATE.V1_UP,SET,163,0.087168,0.0081765,0.064271,0.087517,GCNP_SHH_UP_LATE.V1_UP,0.82827707562568
GOBP_VASCULAR_ENDOTHELIAL_GR...1,SET,34,0.20262,0.0087111,0.14942,0.087549,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,0.82827707562568
HP_ABSCESS,SET,61,0.15254,0.0087778,0.1125,0.087562,HP_ABSCESS,0.82827707562568
GSE22886_NAIVE_TCELL_VS_NEUT...1,SET,173,0.092653,0.0089511,0.068338,0.087589,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN,0.82827707562568
TESAR_ALK_AND_JAK_TARGETS_MO...2,SET,4,0.57072,0.0084228,0.42098,0.087606,TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP,0.82827707562568
GOBP_STEM_CELL_DEVELOPMENT,SET,82,0.13474,0.0089846,0.09941,0.087646,GOBP_STEM_CELL_DEVELOPMENT,0.82836529771615
GOBP_POSITIVE_REGULATION_OF_...143,SET,10,0.35272,0.0082293,0.26024,0.087663,GOBP_POSITIVE_REGULATION_OF_CELL_SIZE,0.82836529771615
GOBP_ORGANELLE_INHERITANCE,SET,15,0.28202,0.0080576,0.20818,0.087764,GOBP_ORGANELLE_INHERITANCE,0.828713666666667
GOBP_NEGATIVE_REGULATION_OF_...434,SET,124,0.10512,0.0086093,0.077614,0.087817,GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.828713666666667
GALE_APL_WITH_FLT3_MUTATED_UP,SET,55,0.14873,0.0081277,0.10982,0.087839,GALE_APL_WITH_FLT3_MUTATED_UP,0.828713666666667
GOBP_POSITIVE_REGULATION_OF_...73,SET,8,0.39116,0.0081632,0.28885,0.087845,GOBP_POSITIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.828713666666667
GOBP_REGULATION_OF_MACROPHAG...2,SET,9,0.34976,0.0077417,0.25828,0.087848,GOBP_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS,0.828713666666667
KEGG_NON_SMALL_CELL_LUNG_CAN...,SET,53,0.1549,0.0083104,0.11441,0.087882,KEGG_NON_SMALL_CELL_LUNG_CANCER,0.828713666666667
AACWWCAANK_UNKNOWN,SET,132,0.099688,0.008422,0.073636,0.087908,AACWWCAANK_UNKNOWN,0.828713666666667
JOSEPH_RESPONSE_TO_SODIUM_BU...2,SET,26,0.22513,0.0084659,0.16631,0.087926,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,0.828713666666667
GOBP_TELOMERE_ORGANIZATION,SET,147,0.08785,0.007829,0.064904,0.087949,GOBP_TELOMERE_ORGANIZATION,0.828713666666667
GOMF_CARNITINE_O_ACYLTRANSFE...,SET,6,0.41284,0.0074617,0.30505,0.087984,GOMF_CARNITINE_O_ACYLTRANSFERASE_ACTIVITY,0.828713666666667
CHNG_MULTIPLE_MYELOMA_HYPERP...2,SET,50,0.15127,0.0078832,0.11178,0.087985,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,0.828713666666667
GOBP_NEGATIVE_REGULATION_OF_...564,SET,39,0.17656,0.0081284,0.13046,0.087986,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.828713666666667
ZHANG_BREAST_CANCER_PROGENIT...2,SET,397,0.055989,0.0081434,0.041387,0.088064,ZHANG_BREAST_CANCER_PROGENITORS_UP,0.829223603359523
HP_TRIANGULAR_SHAPED_PHALANG...,SET,7,0.48503,0.0094687,0.35873,0.088183,HP_TRIANGULAR_SHAPED_PHALANGES_OF_THE_HAND,0.830119221289274
BIOCARTA_TERC_PATHWAY,SET,6,0.41507,0.007502,0.30706,0.088238,BIOCARTA_TERC_PATHWAY,0.830187246886843
GOMF_ATP_DEPENDENT_ACTIVITY,SET,533,0.048627,0.0081639,0.035974,0.088238,GOMF_ATP_DEPENDENT_ACTIVITY,0.830187246886843
HOWARD_T_CELL_INACT_MONOV_IN...,SET,40,0.18915,0.0088189,0.13998,0.088315,HOWARD_T_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.830269810861929
GOBP_SNRNA_TRANSCRIPTION,SET,20,0.23367,0.0077079,0.17293,0.088316,GOBP_SNRNA_TRANSCRIPTION,0.830269810861929
GSE26030_TH1_VS_TH17_RESTIMU...3,SET,180,0.083125,0.0081899,0.061533,0.088374,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN,0.830269810861929
GOBP_UBIQUITIN_DEPENDENT_GLY...,SET,7,0.45706,0.0089225,0.33837,0.088392,GOBP_UBIQUITIN_DEPENDENT_GLYCOPROTEIN_ERAD_PATHWAY,0.830269810861929
GOMF_MANNOSYL_OLIGOSACCHARID...1,SET,7,0.45706,0.0089225,0.33837,0.088392,GOMF_MANNOSYL_OLIGOSACCHARIDE_1_2_ALPHA_MANNOSIDASE_ACTIVITY,0.830269810861929
HP_POLYARTICULAR_ARTHROPATHY,SET,18,0.28244,0.0088391,0.20911,0.088402,HP_POLYARTICULAR_ARTHROPATHY,0.830269810861929
GSE5589_WT_VS_IL10_KO_LPS_AN...2,SET,140,0.092035,0.0080058,0.068141,0.088414,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.830269810861929
BIOCARTA_PYK2_PATHWAY,SET,27,0.21747,0.008333,0.16104,0.08845,BIOCARTA_PYK2_PATHWAY,0.830383508914101
GOBP_RESPONSE_TO_SORBITOL,SET,6,0.49415,0.0089313,0.3662,0.088612,GOBP_RESPONSE_TO_SORBITOL,0.831679735349716
GSE369_SOCS3_KO_VS_IFNG_KO_L...1,SET,181,0.085223,0.0084197,0.063184,0.088708,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN,0.831959676202861
MIR3160_3P,SET,66,0.14261,0.008535,0.10575,0.088731,MIR3160_3P,0.831959676202861
MIR548AT_3P,SET,56,0.14889,0.0082102,0.1104,0.08874,MIR548AT_3P,0.831959676202861
KEGG_CHRONIC_MYELOID_LEUKEMIA,SET,70,0.13713,0.0084506,0.10168,0.088744,KEGG_CHRONIC_MYELOID_LEUKEMIA,0.831959676202861
GSE3982_NEUTROPHIL_VS_CENT_M...1,SET,183,0.077328,0.0076814,0.057362,0.088827,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.831959676202861
KEGG_MEDICUS_PATHOGEN_EBV_EB...4,SET,5,0.49743,0.0082074,0.36899,0.088828,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00484,0.831959676202861
GOBP_NEURON_REMODELING,SET,15,0.32765,0.0093613,0.24307,0.088837,GOBP_NEURON_REMODELING,0.831959676202861
GOMF_EXTRACELLULAR_MATRIX_ST...2,SET,19,0.27798,0.0089376,0.20622,0.088839,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_COMPRESSION_RESISTANCE,0.831959676202861
GSE37301_HEMATOPOIETIC_STEM_...2,SET,167,0.089339,0.0084814,0.066297,0.08891,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP,0.831959676202861
BIOCARTA_TPO_PATHWAY,SET,24,0.2404,0.0086858,0.17842,0.088932,BIOCARTA_TPO_PATHWAY,0.831959676202861
HP_MENOMETRORRHAGIA,SET,5,0.63272,0.01044,0.46961,0.088946,HP_MENOMETRORRHAGIA,0.831959676202861
GOBP_CELLULAR_RESPONSE_TO_IN...5,SET,196,0.080116,0.0082332,0.059466,0.088957,GOBP_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.831959676202861
GOBP_REGULATION_OF_AMYLOID_P...,SET,41,0.18526,0.0087445,0.13753,0.088987,GOBP_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.831959676202861
LY_AGING_PREMATURE_DN,SET,29,0.20739,0.0082358,0.15398,0.089015,LY_AGING_PREMATURE_DN,0.831959676202861
GSE17721_POLYIC_VS_CPG_0.5H_...1,SET,178,0.083855,0.0082163,0.062261,0.089025,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN,0.831959676202861
MIR1301_3P_MIR5047,SET,105,0.11165,0.0084194,0.082929,0.089096,MIR1301_3P_MIR5047,0.831959676202861
HP_CHOROIDAL_NEOVASCULARIZAT...,SET,19,0.26767,0.0086061,0.19882,0.089108,HP_CHOROIDAL_NEOVASCULARIZATION,0.831959676202861
GSE3982_DC_VS_EFF_MEMORY_CD4...2,SET,187,0.083653,0.0083991,0.062139,0.089123,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP,0.831959676202861
HP_ABNORMAL_5TH_METACARPAL_M...,SET,17,0.2738,0.0083273,0.20339,0.089135,HP_ABNORMAL_5TH_METACARPAL_MORPHOLOGY,0.831959676202861
GOCC_SPERM_MITOCHONDRIAL_SHE...,SET,6,0.45809,0.0082796,0.34033,0.089153,GOCC_SPERM_MITOCHONDRIAL_SHEATH,0.831959676202861
REACTOME_SIGNALING_BY_ALK_IN...,SET,86,0.12206,0.0083338,0.090687,0.089174,REACTOME_SIGNALING_BY_ALK_IN_CANCER,0.831959676202861
KEGG_MEDICUS_REFERENCE_REGUL...6,SET,7,0.35474,0.0069251,0.26363,0.089229,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE,0.831959676202861
ZHAN_MULTIPLE_MYELOMA_MS_UP,SET,41,0.2054,0.0096953,0.15267,0.08926,ZHAN_MULTIPLE_MYELOMA_MS_UP,0.831959676202861
GOBP_FAT_PAD_DEVELOPMENT,SET,8,0.39251,0.0081913,0.29179,0.089292,GOBP_FAT_PAD_DEVELOPMENT,0.831959676202861
HP_PSEUDOBULBAR_PARALYSIS,SET,20,0.25146,0.0082948,0.18694,0.0893,HP_PSEUDOBULBAR_PARALYSIS,0.831959676202861
GOCC_NUCLEAR_PORE_OUTER_RING,SET,10,0.31527,0.0073557,0.23445,0.089364,GOCC_NUCLEAR_PORE_OUTER_RING,0.831959676202861
GOCC_CCAAT_BINDING_FACTOR_CO...,SET,5,0.47368,0.0078157,0.35226,0.089368,GOCC_CCAAT_BINDING_FACTOR_COMPLEX,0.831959676202861
GSE11924_TFH_VS_TH2_CD4_TCEL...1,SET,176,0.083104,0.0080972,0.06181,0.089401,GSE11924_TFH_VS_TH2_CD4_TCELL_DN,0.831959676202861
KANNAN_BLOOD_2012_2013_TIV_A...1,SET,297,0.063087,0.0079584,0.046923,0.089408,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN,0.831959676202861
GSE1925_3H_VS_24H_IFNG_STIM_...3,SET,181,0.081351,0.0080372,0.060528,0.089478,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN,0.831959676202861
VERRECCHIA_EARLY_RESPONSE_TO...,SET,52,0.16464,0.0087495,0.1225,0.08948,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,0.831959676202861
MIR488_3P,SET,168,0.083623,0.0079622,0.062237,0.089543,MIR488_3P,0.831959676202861
GOBP_OUTER_DYNEIN_ARM_ASSEMB...,SET,15,0.26377,0.007536,0.19631,0.089545,GOBP_OUTER_DYNEIN_ARM_ASSEMBLY,0.831959676202861
HP_ABNORMAL_BLEEDING,SET,497,0.050676,0.0082239,0.037722,0.089579,HP_ABNORMAL_BLEEDING,0.831959676202861
GOBP_MACROMOLECULE_DEPALMITO...,SET,14,0.3006,0.0082973,0.22384,0.089659,GOBP_MACROMOLECULE_DEPALMITOYLATION,0.831959676202861
GOMF_PALMITOYL_HYDROLASE_ACT...,SET,14,0.3006,0.0082973,0.22384,0.089659,GOMF_PALMITOYL_HYDROLASE_ACTIVITY,0.831959676202861
GOBP_T_CELL_MEDIATED_IMMUNITY,SET,121,0.11555,0.0093497,0.086067,0.089708,GOBP_T_CELL_MEDIATED_IMMUNITY,0.831959676202861
MIR3620_3P,SET,58,0.15271,0.0085692,0.11379,0.089802,MIR3620_3P,0.831959676202861
HOFFMANN_IMMATURE_TO_MATURE_...2,SET,35,0.19982,0.008716,0.1489,0.08981,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,0.831959676202861
HP_AXONAL_LOSS,SET,17,0.25452,0.007741,0.1897,0.089851,HP_AXONAL_LOSS,0.831959676202861
TIEN_INTESTINE_PROBIOTICS_2H...1,SET,83,0.12971,0.0087011,0.096682,0.089871,TIEN_INTESTINE_PROBIOTICS_2HR_DN,0.831959676202861
CAFFAREL_RESPONSE_TO_THC_8HR...1,SET,9,0.30063,0.0066542,0.22411,0.089895,CAFFAREL_RESPONSE_TO_THC_8HR_3_DN,0.831959676202861
HP_UPPER_LIMB_MUSCLE_WEAKNESS,SET,131,0.099631,0.0083855,0.074274,0.089903,HP_UPPER_LIMB_MUSCLE_WEAKNESS,0.831959676202861
CAO_BLOOD_FLUMIST_AGE_05_14Y...7,SET,9,0.38208,0.008457,0.28484,0.089908,CAO_BLOOD_FLUMIST_AGE_05_14YO_CORRELATED_WITH_H3N2_VN_TITER_7DY_POSITIVE,0.831959676202861
WP_CYTOSINE_METHYLATION,SET,7,0.45672,0.008916,0.34052,0.089926,WP_CYTOSINE_METHYLATION,0.831959676202861
HP_CHOLESTEATOMA,SET,10,0.35601,0.0083061,0.26545,0.089946,HP_CHOLESTEATOMA,0.831959676202861
WP_VITAMIN_A_AND_CAROTENOID_...,SET,42,0.18111,0.0086519,0.13509,0.090027,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,0.831959676202861
chr8p23,SET,42,0.31665,0.015127,0.2362,0.090035,chr8p23,0.831959676202861
GSE21927_C26GM_VS_4T1_TUMOR_...1,SET,176,0.082322,0.0080211,0.061414,0.09006,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,0.831959676202861
MIR556_5P,SET,39,0.18329,0.0084383,0.13674,0.090067,MIR556_5P,0.831959676202861
GOBP_POSITIVE_REGULATION_OF_...157,SET,25,0.22251,0.008205,0.16605,0.090124,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_EFFLUX,0.831959676202861
HP_FATIGUE,SET,445,0.055871,0.008592,0.041699,0.090154,HP_FATIGUE,0.831959676202861
GOMF_DNA_CLAMP_LOADER_ACTIVI...,SET,9,0.35581,0.0078757,0.26559,0.090177,GOMF_DNA_CLAMP_LOADER_ACTIVITY,0.831959676202861
GOBP_CARBOHYDRATE_DERIVATIVE...4,SET,88,0.12334,0.0085184,0.092078,0.090207,GOBP_CARBOHYDRATE_DERIVATIVE_TRANSPORT,0.831959676202861
GOBP_L_SERINE_METABOLIC_PROC...,SET,11,0.31473,0.0077013,0.23498,0.090225,GOBP_L_SERINE_METABOLIC_PROCESS,0.831959676202861
HP_PROXIMAL_FEMORAL_EPIPHYSI...,SET,7,0.38665,0.0075481,0.28869,0.090239,HP_PROXIMAL_FEMORAL_EPIPHYSIOLYSIS,0.831959676202861
HP_SHUFFLING_GAIT,SET,30,0.20356,0.0082216,0.152,0.09025,HP_SHUFFLING_GAIT,0.831959676202861
HP_HAMARTOMA,SET,61,0.13496,0.0077661,0.10078,0.090261,HP_HAMARTOMA,0.831959676202861
HP_ANKLE_WEAKNESS,SET,17,0.25432,0.0077349,0.18992,0.090275,HP_ANKLE_WEAKNESS,0.831959676202861
HELLER_HDAC_TARGETS_DN,SET,266,0.072164,0.0086227,0.053896,0.090303,HELLER_HDAC_TARGETS_DN,0.831959676202861
GSE46606_DAY1_VS_DAY3_CD40L_...4,SET,186,0.079588,0.0079698,0.059446,0.090321,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_UP,0.831959676202861
KEGG_MEDICUS_REFERENCE_BLOOD...2,SET,7,0.47293,0.0092324,0.35325,0.090324,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_2_BIOSYNTHESIS,0.831959676202861
KEGG_MEDICUS_VARIANT_TRK_FUS...,SET,10,0.33455,0.0078054,0.24989,0.090327,KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.831959676202861
GOBP_GLYCOPROTEIN_BIOSYNTHET...,SET,289,0.067757,0.0084336,0.050614,0.09034,GOBP_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS,0.831959676202861
HP_HYPOPLASIA_OF_THE_MUSCULA...,SET,20,0.28201,0.0093023,0.21067,0.090356,HP_HYPOPLASIA_OF_THE_MUSCULATURE,0.831959676202861
GOBP_GLYCOPROTEIN_METABOLIC_...,SET,344,0.062365,0.008456,0.046604,0.090426,GOBP_GLYCOPROTEIN_METABOLIC_PROCESS,0.831959676202861
GOMF_ATP_HYDROLYSIS_ACTIVITY,SET,381,0.056525,0.0080575,0.04224,0.090429,GOMF_ATP_HYDROLYSIS_ACTIVITY,0.831959676202861
FISCHER_G1_S_CELL_CYCLE,SET,172,0.084901,0.0081787,0.063449,0.090442,FISCHER_G1_S_CELL_CYCLE,0.831959676202861
GOBP_REGULATION_OF_STEM_CELL...3,SET,67,0.13008,0.0078434,0.097216,0.090451,GOBP_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.831959676202861
MIR509_3P,SET,53,0.15031,0.008064,0.11235,0.090485,MIR509_3P,0.831959676202861
GSE30971_2H_VS_4H_LPS_STIM_M...3,SET,176,0.085515,0.0083322,0.063928,0.09051,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN,0.831959676202861
GSE26669_CTRL_VS_COSTIM_BLOC...4,SET,184,0.081585,0.0081261,0.060993,0.090522,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP,0.831959676202861
HP_ABNORMAL_CIRCULATING_SERI...1,SET,5,0.50386,0.0083136,0.3767,0.090527,HP_ABNORMAL_CIRCULATING_SERINE_CONCENTRATION,0.831959676202861
GCM_TPT1,SET,60,0.13675,0.0078044,0.10228,0.090616,GCM_TPT1,0.831959676202861
WANG_RESPONSE_TO_FORSKOLIN_UP,SET,22,0.24296,0.0084049,0.18172,0.090623,WANG_RESPONSE_TO_FORSKOLIN_UP,0.831959676202861
CCAGGTT_MIR490,SET,58,0.14561,0.008171,0.10891,0.09063,CCAGGTT_MIR490,0.831959676202861
BROWNE_HCMV_INFECTION_6HR_UP,SET,57,0.15116,0.008409,0.11307,0.090636,BROWNE_HCMV_INFECTION_6HR_UP,0.831959676202861
WP_CALCIUM_REGULATION_IN_CAR...,SET,149,0.097313,0.0087306,0.072794,0.090648,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,0.831959676202861
GSE22886_IGM_MEMORY_BCELL_VS...3,SET,178,0.083284,0.0081604,0.062308,0.090674,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,0.831959676202861
GOBP_PROTEIN_DEPHOSPHORYLATI...,SET,187,0.079471,0.0079791,0.05946,0.090697,GOBP_PROTEIN_DEPHOSPHORYLATION,0.831959676202861
MODULE_151,SET,274,0.064322,0.0077987,0.048136,0.090744,MODULE_151,0.831959676202861
MIR3194_5P,SET,71,0.12879,0.007993,0.096384,0.090752,MIR3194_5P,0.831959676202861
GOMF_STRUCTURAL_CONSTITUENT_...2,SET,100,0.11363,0.0083626,0.085058,0.090807,GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON,0.831959676202861
REACTOME_ACTIVATION_OF_IRF3_...,SET,17,0.25733,0.0078265,0.19265,0.090826,REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_IKBKE,0.831959676202861
GSE21379_WT_VS_SAP_KO_CD4_TC...1,SET,183,0.08664,0.0086064,0.064864,0.090827,GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN,0.831959676202861
GOBP_TYPE_I_INTERFERON_PRODU...,SET,106,0.10424,0.0078976,0.078047,0.090842,GOBP_TYPE_I_INTERFERON_PRODUCTION,0.831959676202861
MORF_AP3D1,SET,119,0.090994,0.0073017,0.068129,0.090845,MORF_AP3D1,0.831959676202861
REACTOME_DEADENYLATION_OF_MR...,SET,22,0.23529,0.0081397,0.17618,0.090869,REACTOME_DEADENYLATION_OF_MRNA,0.831959676202861
GOMF_CALCIUM_MONOATOMIC_CATI...,SET,13,0.35467,0.0094339,0.26558,0.090878,GOMF_CALCIUM_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,0.831959676202861
GOMF_INTRONIC_TRANSCRIPTION_...,SET,11,0.36449,0.0089188,0.27295,0.090889,GOMF_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.831959676202861
HOEK_MONOCYTE_2011_2012_TIV_...6,SET,5,0.50183,0.0082801,0.37582,0.0909,HOEK_MONOCYTE_2011_2012_TIV_ADULT_7DY_UP,0.831959676202861
MODULE_310,SET,19,0.28007,0.0090048,0.20977,0.09092,MODULE_310,0.831959676202861
KEGG_MEDICUS_REFERENCE_REGUL...2,SET,9,0.3932,0.0087031,0.29451,0.090934,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION,0.831959676202861
CETS1P54_01,SET,250,0.068442,0.0079317,0.051271,0.09096,CETS1P54_01,0.831959676202861
GSE3720_VD1_VS_VD2_GAMMADELT...4,SET,172,0.084942,0.0081827,0.063631,0.090961,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP,0.831959676202861
GSE30083_SP1_VS_SP4_THYMOCYT...1,SET,189,0.082104,0.0082871,0.061534,0.091065,GSE30083_SP1_VS_SP4_THYMOCYTE_DN,0.831959676202861
REACTOME_NEUTROPHIL_DEGRANUL...,SET,439,0.054637,0.0083468,0.040956,0.091101,REACTOME_NEUTROPHIL_DEGRANULATION,0.831959676202861
E2F_Q4,SET,212,0.075974,0.0081164,0.05695,0.091101,E2F_Q4,0.831959676202861
GOBP_NEGATIVE_REGULATION_OF_...512,SET,9,0.3798,0.0084065,0.28473,0.09113,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.831959676202861
FAN_OVARY_CL13_MONOCYTE_MACR...,SET,411,0.056209,0.008315,0.042145,0.091157,FAN_OVARY_CL13_MONOCYTE_MACROPHAGE,0.831959676202861
GAVISH_3CA_MALIGNANT_METAPRO...29,SET,42,0.1773,0.0084703,0.13296,0.091188,GAVISH_3CA_MALIGNANT_METAPROGRAM_37_HEMATO_RELATED_2,0.831959676202861
TENEDINI_MEGAKARYOCYTE_MARKE...,SET,60,0.15129,0.0086342,0.11345,0.091193,TENEDINI_MEGAKARYOCYTE_MARKERS,0.831959676202861
MANNO_MIDBRAIN_NEUROTYPES_HD...2,SET,450,0.057546,0.0088979,0.043156,0.091202,MANNO_MIDBRAIN_NEUROTYPES_HDA2,0.831959676202861
GOBP_NEGATIVE_REGULATION_OF_...201,SET,33,0.2171,0.0091956,0.16284,0.091246,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.831959676202861
HP_SUBCUTANEOUS_NODULE,SET,87,0.12033,0.008263,0.090276,0.091297,HP_SUBCUTANEOUS_NODULE,0.831959676202861
HP_ASYMMETRY_OF_THE_EARS,SET,4,0.48549,0.007165,0.3643,0.091329,HP_ASYMMETRY_OF_THE_EARS,0.831959676202861
MIR4644,SET,273,0.070113,0.0084855,0.052611,0.091331,MIR4644,0.831959676202861
MIR6807_5P,SET,53,0.14974,0.0080334,0.11237,0.091344,MIR6807_5P,0.831959676202861
KEGG_MEDICUS_REFERENCE_TGFA_...3,SET,14,0.29573,0.008163,0.22194,0.09136,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.831959676202861
TGACATY_UNKNOWN,SET,613,0.048028,0.0086278,0.036045,0.091365,TGACATY_UNKNOWN,0.831959676202861
REACTOME_FOXO_MEDIATED_TRANS...3,SET,15,0.30228,0.0086362,0.22689,0.091395,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES,0.831959676202861
HP_PULMONARY_LYMPHANGIECTASIA,SET,5,0.59467,0.0098119,0.44637,0.091401,HP_PULMONARY_LYMPHANGIECTASIA,0.831959676202861
MIR511_5P,SET,291,0.065633,0.008197,0.049268,0.091409,MIR511_5P,0.831959676202861
GOBP_DNA_SYNTHESIS_INVOLVED_...,SET,38,0.15338,0.0069704,0.11516,0.091464,GOBP_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR,0.831959676202861
GSE17721_PAM3CSK4_VS_GADIQUI...3,SET,194,0.079784,0.0081576,0.059906,0.09147,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN,0.831959676202861
GOCC_MAIN_AXON,SET,67,0.15058,0.0090793,0.11308,0.091514,GOCC_MAIN_AXON,0.831959676202861
GSE1740_UNSTIM_VS_IFNA_STIMU...4,SET,164,0.091458,0.0086049,0.068687,0.091518,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP,0.831959676202861
GSE25123_WT_VS_PPARG_KO_MACR...8,SET,173,0.092198,0.0089072,0.069264,0.091585,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP,0.831959676202861
GOBP_REGULATION_OF_IMMUNE_RE...,SET,833,0.040718,0.0084739,0.030593,0.091608,GOBP_REGULATION_OF_IMMUNE_RESPONSE,0.831959676202861
MIR5705,SET,5,0.44985,0.0074223,0.338,0.091619,MIR5705,0.831959676202861
GAVISH_3CA_MALIGNANT_METAPRO...19,SET,45,0.1811,0.0089545,0.13608,0.091624,GAVISH_3CA_MALIGNANT_METAPROGRAM_28_OLIGO_NORMAL,0.831959676202861
MIR6740_5P,SET,58,0.14714,0.0082567,0.1106,0.091699,MIR6740_5P,0.831959676202861
HP_POSITIVE_ROMBERG_SIGN,SET,26,0.20483,0.0077024,0.15396,0.091701,HP_POSITIVE_ROMBERG_SIGN,0.831959676202861
KEGG_RIG_I_LIKE_RECEPTOR_SIG...,SET,61,0.15374,0.0088466,0.11556,0.091705,KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.831959676202861
GSE36009_UNSTIM_VS_LPS_STIM_...2,SET,174,0.08702,0.008431,0.065411,0.091709,GSE36009_UNSTIM_VS_LPS_STIM_DC_UP,0.831959676202861
GOMF_UBIQUITIN_LIGASE_ACTIVA...,SET,9,0.36239,0.0080213,0.27241,0.091712,GOMF_UBIQUITIN_LIGASE_ACTIVATOR_ACTIVITY,0.831959676202861
IRITANI_MAD1_TARGETS_DN,SET,41,0.16877,0.0079663,0.12688,0.091736,IRITANI_MAD1_TARGETS_DN,0.831959676202861
SHAFFER_IRF4_TARGETS_IN_ACTI...2,SET,58,0.15214,0.0085374,0.11439,0.09176,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,0.831959676202861
GOBP_TRANSCRIPTION_BY_RNA_PO...2,SET,56,0.13317,0.0073434,0.10013,0.091773,GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.831959676202861
WP_OPIOID_RECEPTOR_PATHWAYS,SET,41,0.18593,0.008776,0.13981,0.091797,WP_OPIOID_RECEPTOR_PATHWAYS,0.831959676202861
REACTOME_TRANSPORT_OF_CONNEX...,SET,18,0.28995,0.0090741,0.21806,0.091813,REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE,0.831959676202861
GOBP_POSITIVE_REGULATION_OF_...402,SET,89,0.12531,0.0087035,0.094277,0.091898,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,0.831959676202861
LAKE_ADULT_KIDNEY_C29_UNKNOW...,SET,77,0.14117,0.0091225,0.10621,0.09191,LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2,0.831959676202861
WP_PPARALPHA_PATHWAY,SET,26,0.23392,0.0087962,0.176,0.091926,WP_PPARALPHA_PATHWAY,0.831959676202861
MODULE_563,SET,13,0.30333,0.0080684,0.22824,0.091934,MODULE_563,0.831959676202861
GSE360_DC_VS_MAC_DN,SET,171,0.086294,0.0082889,0.06494,0.091962,GSE360_DC_VS_MAC_DN,0.831959676202861
GOBP_PROTEIN_LOCALIZATION_TO...20,SET,59,0.13457,0.0076163,0.10128,0.091978,GOBP_PROTEIN_LOCALIZATION_TO_CYTOSKELETON,0.831959676202861
KEGG_PRIMARY_BILE_ACID_BIOSY...,SET,16,0.30175,0.0089038,0.22712,0.091999,KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,0.831959676202861
HP_ABNORMAL_ENDOCRINE_MORPHO...,SET,101,0.10981,0.0081218,0.08265,0.092,HP_ABNORMAL_ENDOCRINE_MORPHOLOGY,0.831959676202861
ZHONG_PFC_C7_SST_LHX6_POS_PU...,SET,13,0.32231,0.0085731,0.24261,0.092019,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.831959676202861
GOBP_RESPONSE_TO_INTERLEUKIN...10,SET,32,0.21475,0.0089575,0.16166,0.092022,GOBP_RESPONSE_TO_INTERLEUKIN_6,0.831959676202861
DESCARTES_FETAL_EYE_HORIZONT...,SET,13,0.31705,0.0084332,0.23868,0.092041,DESCARTES_FETAL_EYE_HORIZONTAL_CELLS,0.831959676202861
BIOCARTA_HBX_PATHWAY,SET,7,0.39659,0.0077421,0.29861,0.092078,BIOCARTA_HBX_PATHWAY,0.83204480529595
PID_TGFBR_PATHWAY,SET,52,0.15799,0.0083961,0.11898,0.092106,PID_TGFBR_PATHWAY,0.83204480529595
REACTOME_SARS_COV_1_ACTIVATE...,SET,34,0.18498,0.0079526,0.13932,0.092151,REACTOME_SARS_COV_1_ACTIVATES_MODULATES_INNATE_IMMUNE_RESPONSES,0.83204480529595
SRSF9_TARGET_GENES,SET,613,0.045997,0.0082629,0.034648,0.092173,SRSF9_TARGET_GENES,0.83204480529595
REACTOME_REGULATION_OF_PYRUV...2,SET,29,0.21056,0.0083613,0.15861,0.092185,REACTOME_REGULATION_OF_PYRUVATE_METABOLISM,0.83204480529595
HP_HYPOPLASIA_OF_THE_VAGINA,SET,13,0.3388,0.0090119,0.25524,0.092201,HP_HYPOPLASIA_OF_THE_VAGINA,0.83204480529595
GOBP_MEIOTIC_CELL_CYCLE,SET,249,0.067501,0.0078072,0.050857,0.092218,GOBP_MEIOTIC_CELL_CYCLE,0.83204480529595
GSE22611_NOD2_TRANSD_VS_CTRL...1,SET,114,0.10439,0.0081997,0.078659,0.092251,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN,0.832126526083571
MIR4749_5P,SET,4,0.58988,0.0087055,0.44462,0.092314,MIR4749_5P,0.832165143856921
MIR6884_3P,SET,60,0.1497,0.0085434,0.11285,0.092337,MIR6884_3P,0.832165143856921
GSE13229_IMM_VS_INTMATURE_NK...1,SET,177,0.081747,0.0079874,0.061626,0.092345,GSE13229_IMM_VS_INTMATURE_NKCELL_DN,0.832165143856921
GAVISH_3CA_METAPROGRAM_B_CEL...7,SET,48,0.15252,0.0077881,0.11499,0.09237,GAVISH_3CA_METAPROGRAM_B_CELLS_METABOLISM_MYC,0.832165143856921
TGCACTG_MIR148A_MIR152_MIR14...,SET,270,0.069458,0.0083606,0.052369,0.092375,TGCACTG_MIR148A_MIR152_MIR148B,0.832165143856921
GOBP_SEMI_LUNAR_VALVE_DEVELO...,SET,48,0.17933,0.0091571,0.13528,0.092485,GOBP_SEMI_LUNAR_VALVE_DEVELOPMENT,0.832339756756757
MIKKELSEN_PLURIPOTENT_STATE_...2,SET,8,0.37247,0.0077731,0.28099,0.092505,MIKKELSEN_PLURIPOTENT_STATE_UP,0.832339756756757
HESSON_TUMOR_SUPPRESSOR_CLUS...,SET,8,0.42207,0.0088082,0.31845,0.092531,HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3,0.832339756756757
GOBP_REGULATION_OF_MITOPHAGY,SET,33,0.18936,0.0080206,0.1429,0.092569,GOBP_REGULATION_OF_MITOPHAGY,0.832339756756757
HP_CYANOTIC_EPISODE,SET,7,0.49126,0.0095902,0.37076,0.092593,HP_CYANOTIC_EPISODE,0.832339756756757
ABE_VEGFA_TARGETS,SET,15,0.30812,0.0088031,0.2326,0.092652,ABE_VEGFA_TARGETS,0.832339756756757
HP_OVERRIDING_AORTA,SET,21,0.28795,0.0097328,0.21739,0.092661,HP_OVERRIDING_AORTA,0.832339756756757
GOMF_HYALURONONGLUCOSAMINIDA...,SET,6,0.46577,0.0084185,0.35168,0.09269,GOMF_HYALURONONGLUCOSAMINIDASE_ACTIVITY,0.832339756756757
GOBP_POSITIVE_REGULATION_OF_...99,SET,41,0.18976,0.0089571,0.14329,0.092709,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.832339756756757
GOBP_INTERLEUKIN_10_MEDIATED...,SET,11,0.43343,0.010606,0.32731,0.09272,GOBP_INTERLEUKIN_10_MEDIATED_SIGNALING_PATHWAY,0.832339756756757
REACTOME_TICAM1_TRAF6_DEPEND...,SET,9,0.44175,0.0097779,0.3336,0.092728,REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX,0.832339756756757
PID_TOLL_ENDOGENOUS_PATHWAY,SET,21,0.23082,0.0078016,0.17433,0.092754,PID_TOLL_ENDOGENOUS_PATHWAY,0.832339756756757
TTANWNANTGGM_UNKNOWN,SET,55,0.16007,0.0087479,0.1209,0.092757,TTANWNANTGGM_UNKNOWN,0.832339756756757
GOBP_INTESTINAL_HEXOSE_ABSOR...,SET,5,0.4582,0.0075603,0.34612,0.092786,GOBP_INTESTINAL_HEXOSE_ABSORPTION,0.832339756756757
KEGG_MEDICUS_PATHOGEN_KSHV_V...3,SET,6,0.39157,0.0070773,0.29582,0.092816,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_TNF_NFKB_SIGNALING_PATHWAY,0.832339756756757
WP_AUTOSOMAL_RECESSIVE_OSTEO...,SET,11,0.31911,0.0078084,0.24111,0.092844,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,0.832339756756757
GSE21670_IL6_VS_TGFB_AND_IL6...2,SET,173,0.085254,0.0082363,0.064433,0.092903,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,0.832339756756757
HP_ELBOW_ANKYLOSIS,SET,7,0.45091,0.0088025,0.34079,0.092904,HP_ELBOW_ANKYLOSIS,0.832339756756757
GSE2770_UNTREATED_VS_ACT_CD4...1,SET,181,0.078888,0.0077938,0.059622,0.092906,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN,0.832339756756757
GOBP_CELL_ACTIVATION_INVOLVE...,SET,278,0.069671,0.0085077,0.05266,0.09292,GOBP_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.832339756756757
REACTOME_SUPPRESSION_OF_PHAG...,SET,12,0.29793,0.007614,0.22524,0.092976,REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION,0.832339756756757
GOBP_CENTRAL_NERVOUS_SYSTEM_...6,SET,76,0.14125,0.0090685,0.10679,0.09299,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT,0.832339756756757
GSE37532_TREG_VS_TCONV_PPARG...4,SET,186,0.080634,0.0080745,0.060968,0.093,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,0.832339756756757
MIR4505,SET,237,0.072577,0.0081923,0.054877,0.093001,MIR4505,0.832339756756757
MORF_SART1,SET,58,0.13166,0.0073882,0.099564,0.093028,MORF_SART1,0.832339756756757
HP_ABNORMAL_CSF_GLYCINE_CONC...,SET,8,0.35396,0.0073869,0.26767,0.093031,HP_ABNORMAL_CSF_GLYCINE_CONCENTRATION,0.832339756756757
GOBP_REGULATION_OF_CALCIUM_I...1,SET,5,0.49781,0.0082137,0.37647,0.093041,GOBP_REGULATION_OF_CALCIUM_IMPORT_INTO_THE_MITOCHONDRION,0.832339756756757
HALLMARK_SPERMATOGENESIS,SET,126,0.10022,0.008274,0.075828,0.093137,HALLMARK_SPERMATOGENESIS,0.832984157231086
GOBP_MESANGIAL_CELL_DEVELOPM...,SET,5,0.51538,0.0085036,0.39014,0.093259,GOBP_MESANGIAL_CELL_DEVELOPMENT,0.833166220825853
HP_AGENESIS_OF_CENTRAL_INCIS...,SET,13,0.32699,0.0086976,0.24755,0.093275,HP_AGENESIS_OF_CENTRAL_INCISOR,0.833166220825853
MIR6895_3P,SET,85,0.12516,0.0084963,0.094757,0.093277,MIR6895_3P,0.833166220825853
GARGALOVIC_RESPONSE_TO_OXIDI...11,SET,8,0.47286,0.0098682,0.35802,0.093299,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN,0.833166220825853
GOBP_POSITIVE_REGULATION_OF_...299,SET,45,0.18813,0.0093019,0.14244,0.093307,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.833166220825853
GSE4748_CTRL_VS_CYANOBACTERI...3,SET,178,0.078566,0.007698,0.059491,0.09332,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,0.833166220825853
REACTOME_SMOOTH_MUSCLE_CONTR...,SET,40,0.18026,0.0084043,0.13651,0.093348,REACTOME_SMOOTH_MUSCLE_CONTRACTION,0.833166220825853
KEGG_MEDICUS_REFERENCE_ACTH_...,SET,32,0.19772,0.0082472,0.14976,0.093384,KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY,0.833166220825853
WP_DOPAMINE_METABOLISM,SET,11,0.33906,0.0082964,0.25683,0.093399,WP_DOPAMINE_METABOLISM,0.833166220825853
GSE22935_24H_VS_48H_MBOVIS_B...3,SET,178,0.085223,0.0083504,0.064574,0.093464,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.833166220825853
KEGG_PANCREATIC_CANCER,SET,66,0.14119,0.0084499,0.10698,0.093466,KEGG_PANCREATIC_CANCER,0.833166220825853
GSE17721_POLYIC_VS_PAM3CSK4_...8,SET,184,0.076841,0.0076536,0.058223,0.093466,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_UP,0.833166220825853
MIR4687_5P,SET,40,0.17632,0.0082209,0.1336,0.093469,MIR4687_5P,0.833166220825853
REACTOME_ACTIVATION_OF_C3_AN...,SET,4,0.57902,0.0085452,0.43887,0.09354,REACTOME_ACTIVATION_OF_C3_AND_C5,0.833398350422969
LAKE_ADULT_KIDNEY_C7_PROXIMA...,SET,129,0.10235,0.008549,0.077581,0.093543,LAKE_ADULT_KIDNEY_C7_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S3,0.833398350422969
GAGCCTG_MIR484,SET,96,0.1125,0.0081136,0.085316,0.093651,GAGCCTG_MIR484,0.834146720912353
GOMF_THREONINE_TYPE_ENDOPEPT...,SET,9,0.35798,0.0079236,0.27159,0.093743,GOMF_THREONINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.834752232897771
GOMF_PHOSPHATIDYLINOSITOL_TR...2,SET,8,0.34085,0.0071132,0.25869,0.093832,GOMF_PHOSPHATIDYLINOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.835291816091954
HP_SPARSE_OR_ABSENT_EYELASHES,SET,80,0.12825,0.0084468,0.097351,0.093867,HP_SPARSE_OR_ABSENT_EYELASHES,0.835291816091954
WP_CANONICAL_NFKB_PATHWAY,SET,7,0.39287,0.0076695,0.29825,0.093888,WP_CANONICAL_NFKB_PATHWAY,0.835291816091954
HP_STOOPED_POSTURE,SET,8,0.33655,0.0070236,0.25562,0.093988,HP_STOOPED_POSTURE,0.835291816091954
GOMF_NADPLUS_PROTEIN_ASPARTA...,SET,5,0.48468,0.0079971,0.36813,0.093994,GOMF_NADPLUS_PROTEIN_ASPARTATE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.835291816091954
MODULE_255,SET,405,0.055431,0.0081412,0.042103,0.094002,MODULE_255,0.835291816091954
GOBP_CONNECTIVE_TISSUE_REPLA...2,SET,5,0.54849,0.00905,0.41673,0.094064,GOBP_CONNECTIVE_TISSUE_REPLACEMENT_INVOLVED_IN_INFLAMMATORY_RESPONSE_WOUND_HEALING,0.835291816091954
GOBP_POSTSYNAPTIC_SIGNAL_TRA...,SET,46,0.15825,0.0079112,0.12024,0.094071,GOBP_POSTSYNAPTIC_SIGNAL_TRANSDUCTION,0.835291816091954
GSE20151_CTRL_VS_FUSOBACT_NU...2,SET,178,0.080537,0.0078912,0.061193,0.094076,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP,0.835291816091954
REACTOME_NECTIN_NECL_TRANS_H...,SET,3,0.68479,0.0087526,0.52033,0.094084,REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION,0.835291816091954
GOMF_GLYCOGEN_BINDING,SET,7,0.45506,0.0088835,0.34578,0.094089,GOMF_GLYCOGEN_BINDING,0.835291816091954
REACTOME_POLYMERASE_SWITCHING,SET,13,0.27615,0.0073453,0.20984,0.094092,REACTOME_POLYMERASE_SWITCHING,0.835291816091954
HP_SKELETAL_MUSCLE_ATROPHY,SET,497,0.049243,0.0079913,0.037443,0.09424,HP_SKELETAL_MUSCLE_ATROPHY,0.836392032686415
LOPEZ_MBD_TARGETS,SET,861,0.036823,0.0077848,0.028008,0.094306,LOPEZ_MBD_TARGETS,0.83676411284146
GOBP_IRIS_MORPHOGENESIS,SET,9,0.42561,0.0094205,0.32377,0.09434,GOBP_IRIS_MORPHOGENESIS,0.836840495920449
NICK_RESPONSE_TO_PROC_TREATM...2,SET,4,0.57014,0.0084143,0.43376,0.094363,NICK_RESPONSE_TO_PROC_TREATMENT_UP,0.836840495920449
HP_GINGIVAL_BLEEDING,SET,52,0.16452,0.0087428,0.1252,0.09442,HP_GINGIVAL_BLEEDING,0.836840495920449
CHUNG_BLISTER_CYTOTOXICITY_UP,SET,120,0.099871,0.0080474,0.076003,0.094425,CHUNG_BLISTER_CYTOTOXICITY_UP,0.836840495920449
ZHU_CMV_8_HR_UP,SET,39,0.18643,0.0085831,0.14188,0.094435,ZHU_CMV_8_HR_UP,0.836840495920449
GSE23502_WT_VS_HDC_KO_MYELOI...2,SET,179,0.079538,0.0078149,0.060551,0.094503,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP,0.836997802547771
GSE3691_IFN_PRODUCING_KILLER...2,SET,173,0.08051,0.0077781,0.061295,0.094517,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_UP,0.836997802547771
REACTOME_IRE1ALPHA_ACTIVATES...,SET,47,0.15025,0.0075922,0.1144,0.094525,REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,0.836997802547771
GOMF_DIPHOSPHOTRANSFERASE_AC...,SET,4,0.50577,0.0074643,0.38512,0.09455,GOMF_DIPHOSPHOTRANSFERASE_ACTIVITY,0.837005187165775
CHYLA_CBFA2T3_TARGETS_UP,SET,346,0.061572,0.0083722,0.046888,0.094574,CHYLA_CBFA2T3_TARGETS_UP,0.837005187165775
GAUTAM_EYE_IRIS_CILIARY_BODY...6,SET,68,0.12596,0.0076513,0.095945,0.094626,GAUTAM_EYE_IRIS_CILIARY_BODY_CYTOTOXIC_T_CELLS,0.837020671755725
GOMF_AROMATIC_AMINO_ACID_TRA...,SET,8,0.39358,0.0082136,0.29979,0.094627,GOMF_AROMATIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.837020671755725
HP_PELVIC_KIDNEY,SET,30,0.21987,0.0088804,0.1675,0.094648,HP_PELVIC_KIDNEY,0.837020671755725
PER1_TARGET_GENES,SET,21,0.24467,0.0082699,0.18646,0.094738,PER1_TARGET_GENES,0.83740560609911
GOBP_REGULATION_OF_CHEMOTAXIS,SET,193,0.084568,0.0086247,0.064451,0.094746,GOBP_REGULATION_OF_CHEMOTAXIS,0.83740560609911
KEGG_MEDICUS_REFERENCE_TLR4_...,SET,9,0.33575,0.0074316,0.25591,0.094771,KEGG_MEDICUS_REFERENCE_TLR4_IRF3_7_SIGNALING_PATHWAY,0.83740560609911
GSE46606_UNSTIM_VS_CD40L_IL2...13,SET,179,0.080014,0.0078617,0.060995,0.094801,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.83740560609911
REACTOME_PP2A_MEDIATED_DEPHO...,SET,6,0.45708,0.0082613,0.34845,0.094812,REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS,0.83740560609911
HP_INTELLECTUAL_DISABILITY_P...1,SET,87,0.11481,0.0078841,0.087545,0.094868,HP_INTELLECTUAL_DISABILITY_PROFOUND,0.837687332317073
GOBP_POSITIVE_REGULATION_OF_...664,SET,6,0.41759,0.0075476,0.31849,0.094908,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS,0.837827670815342
HP_TRUE_HERMAPHRODITISM,SET,20,0.21774,0.0071822,0.16608,0.094935,HP_TRUE_HERMAPHRODITISM,0.837853205942103
ZFP28_TARGET_GENES,SET,69,0.13367,0.0081787,0.10197,0.09497,ZFP28_TARGET_GENES,0.837940678544352
HP_HYPERHIDROSIS,SET,149,0.090494,0.0081189,0.069054,0.095025,HP_HYPERHIDROSIS,0.837940678544352
HASINA_NOL7_TARGETS_DN,SET,13,0.33111,0.0088074,0.25271,0.095062,HASINA_NOL7_TARGETS_DN,0.837940678544352
MIR548Q,SET,43,0.16144,0.0078036,0.12322,0.095074,MIR548Q,0.837940678544352
GOBP_REGULATION_OF_TRANSMEMB...2,SET,420,0.057134,0.0085417,0.043609,0.095082,GOBP_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,0.837940678544352
REACTOME_HYALURONAN_METABOLI...,SET,17,0.25814,0.0078511,0.19708,0.095136,REACTOME_HYALURONAN_METABOLISM,0.837940678544352
GOMF_UDP_GLYCOSYLTRANSFERASE...,SET,132,0.10485,0.0088585,0.080066,0.095173,GOMF_UDP_GLYCOSYLTRANSFERASE_ACTIVITY,0.837940678544352
HP_SYNOSTOSIS_OF_METACARPALS...,SET,15,0.30268,0.0086479,0.23114,0.095184,HP_SYNOSTOSIS_OF_METACARPALS_METATARSALS,0.837940678544352
MIR4723_5P,SET,194,0.077311,0.0079048,0.05905,0.095235,MIR4723_5P,0.837940678544352
GOMF_INTRAMOLECULAR_OXIDORED...1,SET,51,0.15156,0.0079766,0.11578,0.095261,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY,0.837940678544352
MIR1913,SET,138,0.089223,0.007706,0.06816,0.095273,MIR1913,0.837940678544352
GOCC_PARANODE_REGION_OF_AXON,SET,12,0.32949,0.0084206,0.25172,0.095281,GOCC_PARANODE_REGION_OF_AXON,0.837940678544352
HP_ABNORMAL_RESPONSE_TO_SOCI...,SET,61,0.14817,0.008526,0.11319,0.095282,HP_ABNORMAL_RESPONSE_TO_SOCIAL_NORMS,0.837940678544352
SMIRNOV_CIRCULATING_ENDOTHEL...2,SET,145,0.095024,0.008411,0.072608,0.095322,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,0.837940678544352
REACTOME_TOLL_LIKE_RECEPTOR_...3,SET,108,0.10763,0.0082302,0.082247,0.095345,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,0.837940678544352
KEGG_MEDICUS_REFERENCE_ASSEM...,SET,17,0.23575,0.0071702,0.18016,0.095346,KEGG_MEDICUS_REFERENCE_ASSEMBLY_AND_TRAFFICKING_OF_TELOMERASE,0.837940678544352
BACOLOD_RESISTANCE_TO_ALKYLA...1,SET,44,0.17273,0.0084455,0.13203,0.095398,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN,0.837940678544352
GOMF_PHOSPHATIDYLINOSITOL_BI...2,SET,98,0.1104,0.0080439,0.084386,0.095402,GOMF_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING,0.837940678544352
GOBP_RESPONSE_TO_ACETYLCHOLI...,SET,44,0.17434,0.0085242,0.13326,0.095403,GOBP_RESPONSE_TO_ACETYLCHOLINE,0.837940678544352
GSE5589_LPS_AND_IL10_VS_LPS_...4,SET,181,0.080407,0.0079439,0.061471,0.095435,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,0.837994299194766
WP_LACTO_SERIES_SPHINGOLIPID...,SET,6,0.47795,0.0086385,0.36557,0.095543,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,0.837994299194766
CUI_DEVELOPING_HEART_CARDIAC...,SET,100,0.11355,0.0083569,0.086854,0.095557,CUI_DEVELOPING_HEART_CARDIAC_FIBROBLASTS,0.837994299194766
GSE19888_ADENOSINE_A3R_INH_P...4,SET,186,0.08293,0.0083044,0.063435,0.09556,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,0.837994299194766
GOBP_RESPONSE_TO_ENDOPLASMIC...,SET,244,0.067268,0.0077029,0.051471,0.095629,GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.837994299194766
HESS_TARGETS_OF_HOXA9_AND_ME...1,SET,79,0.12965,0.0084861,0.09921,0.095642,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,0.837994299194766
GSE3982_BCELL_VS_TH1_UP,SET,163,0.086674,0.0081302,0.066324,0.095643,GSE3982_BCELL_VS_TH1_UP,0.837994299194766
GSE9988_LOW_LPS_VS_ANTI_TREM...2,SET,176,0.084732,0.0082559,0.064843,0.09566,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,0.837994299194766
GOBP_NEGATIVE_REGULATION_OF_...109,SET,71,0.1316,0.0081678,0.10071,0.095668,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,0.837994299194766
chr5q23,SET,35,0.29588,0.012906,0.22644,0.095673,chr5q23,0.837994299194766
COULOUARN_TEMPORAL_TGFB1_SIG...2,SET,101,0.1127,0.0083357,0.08627,0.09572,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,0.837994299194766
GOMF_OXIDOREDUCTASE_ACTIVITY...19,SET,164,0.087117,0.0081965,0.066689,0.09573,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN,0.837994299194766
GOCC_CHAPERONIN_CONTAINING_T...,SET,10,0.28694,0.0066947,0.21966,0.095737,GOCC_CHAPERONIN_CONTAINING_T_COMPLEX,0.837994299194766
GOBP_CELLULAR_RESPONSE_TO_SA...1,SET,6,0.45884,0.0082932,0.35128,0.095752,GOBP_CELLULAR_RESPONSE_TO_SALT,0.837994299194766
HP_ABNORMAL_U_WAVE,SET,5,0.55545,0.0091647,0.42528,0.095774,HP_ABNORMAL_U_WAVE,0.837994299194766
GSE7831_UNSTIM_VS_CPG_STIM_P...4,SET,185,0.07976,0.0079657,0.061081,0.095817,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_UP,0.837994299194766
MOHANKUMAR_HOXA1_TARGETS_UP,SET,364,0.05595,0.0077993,0.042848,0.095819,MOHANKUMAR_HOXA1_TARGETS_UP,0.837994299194766
MIR5088_5P,SET,33,0.19349,0.0081956,0.14823,0.095898,MIR5088_5P,0.838474211320755
HP_HITCHHIKER_THUMB,SET,6,0.38009,0.0068697,0.29131,0.096001,HP_HITCHHIKER_THUMB,0.839163670774648
WINTER_HYPOXIA_METAGENE,SET,216,0.078477,0.0084616,0.060171,0.096087,WINTER_HYPOXIA_METAGENE,0.839371634036145
HP_LIMBAL_STEM_CELL_DEFICIEN...,SET,8,0.46585,0.0097218,0.3572,0.096095,HP_LIMBAL_STEM_CELL_DEFICIENCY,0.839371634036145
GSE45365_NK_CELL_VS_BCELL_UP,SET,186,0.080694,0.0080805,0.061878,0.096111,GSE45365_NK_CELL_VS_BCELL_UP,0.839371634036145
HP_CHRONIC_HEPATITIS_DUE_TO_...,SET,5,0.55706,0.0091914,0.4272,0.096128,HP_CHRONIC_HEPATITIS_DUE_TO_CRYPTOSPORIDIUM_INFECTION,0.839371634036145
DESCARTES_FETAL_STOMACH_NEUR...,SET,40,0.18703,0.0087199,0.14346,0.096181,DESCARTES_FETAL_STOMACH_NEUROENDOCRINE_CELLS,0.839371634036145
HP_ABSENT_TOE,SET,61,0.14351,0.0082578,0.11008,0.096195,HP_ABSENT_TOE,0.839371634036145
GOCC_PORE_COMPLEX,SET,22,0.24312,0.0084104,0.18651,0.09621,GOCC_PORE_COMPLEX,0.839371634036145
GOBP_RESPONSE_TO_HUMAN_CHORI...,SET,5,0.57962,0.0095636,0.44468,0.096218,GOBP_RESPONSE_TO_HUMAN_CHORIONIC_GONADOTROPIN,0.839371634036145
GSE45365_CD8A_DC_VS_CD11B_DC...6,SET,166,0.084955,0.0080413,0.065186,0.096251,GSE45365_CD8A_DC_VS_CD11B_DC_UP,0.839448809284818
GOBP_NEGATIVE_REGULATION_OF_...528,SET,32,0.18445,0.0076937,0.14155,0.096276,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.839456191670848
HP_SPARSE_AXILLARY_HAIR,SET,42,0.18218,0.0087034,0.13986,0.096359,HP_SPARSE_AXILLARY_HAIR,0.839969161023326
HP_SPASTIC_GAIT,SET,69,0.13406,0.0082025,0.10293,0.096391,HP_SPASTIC_GAIT,0.840037413490471
REACTOME_REGULATION_OF_IFNG_...,SET,13,0.3098,0.0082406,0.23803,0.096548,REACTOME_REGULATION_OF_IFNG_SIGNALING,0.840902100450902
BUSSLINGER_GASTRIC_PREZYMOGE...,SET,57,0.15445,0.0085924,0.11868,0.096561,BUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS,0.840902100450902
GOCC_NUCLEOLUS,SET,908,0.035559,0.0077095,0.027323,0.09657,GOCC_NUCLEOLUS,0.840902100450902
KEGG_MEDICUS_REFERENCE_REGUL...5,SET,6,0.40834,0.0073804,0.3138,0.096587,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_PAI,0.840902100450902
HP_EPISODIC_PAIN,SET,38,0.16875,0.007669,0.12973,0.096669,HP_EPISODIC_PAIN,0.841405232907588
PELLICCIOTTA_HDAC_IN_ANTIGEN...1,SET,49,0.1481,0.0076406,0.11387,0.096705,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,0.841507830495744
chr3p26,SET,14,0.51326,0.014167,0.39488,0.096843,chr3p26,0.841906781179985
MODULE_229,SET,27,0.20649,0.0079126,0.15887,0.096855,MODULE_229,0.841906781179985
ERWIN_COHEN_BLOOD_VACCINE_TC...1,SET,6,0.43712,0.0079005,0.33632,0.096863,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_DN,0.841906781179985
GAVISH_3CA_METAPROGRAM_B_CEL...9,SET,36,0.17054,0.007544,0.13127,0.096951,GAVISH_3CA_METAPROGRAM_B_CELLS_PLASMA,0.841906781179985
HP_NARROW_PELVIS_BONE,SET,7,0.391,0.007633,0.30105,0.097016,HP_NARROW_PELVIS_BONE,0.841906781179985
GOBP_REGULATION_OF_NON_CANON...2,SET,26,0.22691,0.0085327,0.17471,0.097019,GOBP_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.841906781179985
HP_ABNORMALITY_OF_THE_MUSCUL...2,SET,564,0.046317,0.0079921,0.035666,0.097044,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LIMBS,0.841906781179985
GOBP_REGULATION_OF_CELL_CYCLE,SET,997,0.035054,0.0079435,0.026996,0.097068,GOBP_REGULATION_OF_CELL_CYCLE,0.841906781179985
DESCARTES_MAIN_FETAL_SLC24A4...,SET,16,0.31458,0.0092822,0.24227,0.097073,DESCARTES_MAIN_FETAL_SLC24A4_PEX5L_POSITIVE_CELLS,0.841906781179985
BIOCARTA_AMAN_PATHWAY,SET,15,0.30582,0.0087374,0.23554,0.097087,BIOCARTA_AMAN_PATHWAY,0.841906781179985
GOMF_PROTEIN_KINASE_A_REGULA...,SET,24,0.21083,0.0076174,0.16238,0.097089,GOMF_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING,0.841906781179985
REACTOME_SARS_COV_2_MODULATE...2,SET,42,0.1551,0.0074094,0.11947,0.097118,REACTOME_SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,0.841906781179985
ZHU_CMV_24_HR_DN,SET,78,0.12909,0.0083957,0.099437,0.097121,ZHU_CMV_24_HR_DN,0.841906781179985
KEGG_DRUG_METABOLISM_OTHER_E...,SET,48,0.18956,0.0096793,0.14602,0.097125,KEGG_DRUG_METABOLISM_OTHER_ENZYMES,0.841906781179985
GSE24210_IL35_TREATED_VS_RES...1,SET,181,0.084743,0.0083723,0.065279,0.097125,GSE24210_IL35_TREATED_VS_RESTING_TREG_DN,0.841906781179985
GOBP_IMPORT_ACROSS_PLASMA_ME...,SET,184,0.084834,0.0084498,0.065367,0.097182,GOBP_IMPORT_ACROSS_PLASMA_MEMBRANE,0.841906781179985
GOMF_TRANSCRIPTION_COREGULAT...2,SET,105,0.10998,0.0082928,0.08476,0.097235,GOMF_TRANSCRIPTION_COREGULATOR_BINDING,0.841906781179985
HP_URETHROVESICAL_OCCLUSION,SET,10,0.32484,0.0075788,0.25037,0.097248,HP_URETHROVESICAL_OCCLUSION,0.841906781179985
KEGG_MEDICUS_REFERENCE_MICRO...1,SET,22,0.23751,0.0082164,0.18309,0.097288,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION,0.841906781179985
HP_INFERTILITY,SET,248,0.068486,0.0079054,0.052796,0.097291,HP_INFERTILITY,0.841906781179985
GOBP_SULFUR_COMPOUND_BIOSYNT...,SET,155,0.091337,0.0083565,0.070413,0.097295,GOBP_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS,0.841906781179985
GOBP_NEUTROPHIL_MEDIATED_IMM...,SET,37,0.17842,0.0080012,0.13755,0.0973,GOBP_NEUTROPHIL_MEDIATED_IMMUNITY,0.841906781179985
WP_ASPIRIN_AND_MIRNAS,SET,9,0.41273,0.0091356,0.3182,0.097308,WP_ASPIRIN_AND_MIRNAS,0.841906781179985
GOBP_DNA_CONFORMATION_CHANGE,SET,83,0.1134,0.0076069,0.087447,0.097367,GOBP_DNA_CONFORMATION_CHANGE,0.842127745707888
GOBP_SMOOTH_MUSCLE_CELL_APOP...,SET,29,0.19829,0.0078742,0.15292,0.097382,GOBP_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.842127745707888
MIR5196_5P,SET,267,0.066363,0.0079442,0.051193,0.097439,MIR5196_5P,0.842244769957722
GAUCHER_PBMC_YF_VAX_STAMARIL...3,SET,12,0.32237,0.0082388,0.24869,0.097444,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_DN,0.842244769957722
GSE46242_TH1_VS_ANERGIC_TH1_...1,SET,158,0.085329,0.0078814,0.065837,0.097483,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN,0.842372368224764
GERHOLD_ADIPOGENESIS_UP,SET,46,0.17113,0.0085546,0.13207,0.097541,GERHOLD_ADIPOGENESIS_UP,0.842429855054509
GOMF_HISTONE_H3K9_METHYLTRAN...,SET,12,0.3172,0.0081065,0.24484,0.09758,GOMF_HISTONE_H3K9_METHYLTRANSFERASE_ACTIVITY,0.842429855054509
MIR3200_3P,SET,24,0.23703,0.0085639,0.18299,0.097618,MIR3200_3P,0.842429855054509
GSE8621_UNSTIM_VS_LPS_PRIMED...4,SET,176,0.080895,0.0078821,0.062461,0.097646,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_UP,0.842429855054509
GSE27786_NKCELL_VS_ERYTHROBL...2,SET,181,0.078323,0.0077381,0.060485,0.097682,GSE27786_NKCELL_VS_ERYTHROBLAST_UP,0.842429855054509
MIR374C_3P,SET,47,0.16943,0.0085612,0.13086,0.097713,MIR374C_3P,0.842429855054509
REACTOME_FOLDING_OF_ACTIN_BY...,SET,10,0.28394,0.0066246,0.2193,0.097714,REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC,0.842429855054509
MIR7114_5P,SET,136,0.095489,0.0081877,0.07376,0.097738,MIR7114_5P,0.842429855054509
RAMJAUN_APOPTOSIS_BY_TGFB1_V...2,SET,6,0.44331,0.0080125,0.34245,0.097748,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP,0.842429855054509
HARALAMBIEVA_PBMC_FLUARIX_AG...9,SET,317,0.060542,0.007886,0.046777,0.097792,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE,0.842429855054509
TRAVAGLINI_LUNG_NEUTROPHIL_C...,SET,293,0.064214,0.0080468,0.049618,0.097811,TRAVAGLINI_LUNG_NEUTROPHIL_CELL,0.842429855054509
GOBP_CHAPERONE_MEDIATED_AUTO...,SET,14,0.25634,0.0070758,0.19808,0.097818,GOBP_CHAPERONE_MEDIATED_AUTOPHAGY,0.842429855054509
WP_EFFECT_OF_PROGERIN_ON_GEN...,SET,20,0.23178,0.0076454,0.1791,0.097819,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,0.842429855054509
HP_INTESTINAL_HYPOPLASIA,SET,19,0.24621,0.007916,0.19026,0.097829,HP_INTESTINAL_HYPOPLASIA,0.842429855054509
GSE3982_MAST_CELL_VS_TH1_UP,SET,180,0.082427,0.0081212,0.063722,0.097918,GSE3982_MAST_CELL_VS_TH1_UP,0.84289912332838
GSE45365_HEALTHY_VS_MCMV_INF...4,SET,160,0.0869,0.0080766,0.067183,0.097932,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN,0.84289912332838
MIR6760_5P,SET,105,0.10503,0.0079197,0.081213,0.097973,MIR6760_5P,0.843043232235702
KEGG_MEDICUS_PATHOGEN_HCMV_G...1,SET,14,0.28799,0.0079494,0.22272,0.098005,KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY,0.84310984529703
GOBP_POSITIVE_REGULATION_OF_...676,SET,350,0.058117,0.0079471,0.044951,0.098031,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,0.84312482182628
GOBP_NEGATIVE_REGULATION_OF_...383,SET,6,0.46563,0.0084159,0.36027,0.098112,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.843354212802768
GOBP_GLYCOPHAGY,SET,11,0.34429,0.0084245,0.26641,0.098125,GOBP_GLYCOPHAGY,0.843354212802768
WP_GABA_METABOLISM_AKA_GHB,SET,10,0.37019,0.0086369,0.28645,0.098132,WP_GABA_METABOLISM_AKA_GHB,0.843354212802768
GOBP_REGULATION_OF_LAMELLIPO...3,SET,43,0.17015,0.0082244,0.13169,0.098178,GOBP_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.843354212802768
FAN_OVARY_CL14_MATURE_SMOOTH...,SET,267,0.066782,0.0079944,0.051687,0.098179,FAN_OVARY_CL14_MATURE_SMOOTH_MUSCLE_CELL,0.843354212802768
GOBP_NEGATIVE_REGULATION_OF_...433,SET,21,0.23735,0.0080225,0.18375,0.098234,GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.843618154188288
GOBP_NEGATIVE_REGULATION_OF_...359,SET,6,0.43241,0.0078154,0.33488,0.098319,GOBP_NEGATIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY,0.8441395368083
TAKAO_RESPONSE_TO_UVB_RADIAT...2,SET,71,0.12122,0.0075232,0.093901,0.098379,TAKAO_RESPONSE_TO_UVB_RADIATION_UP,0.844446071869597
GSE9946_IMMATURE_VS_PROSTAGL...2,SET,139,0.092488,0.0080166,0.071678,0.098479,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.84463310880829
GOBP_NEGATIVE_REGULATION_OF_...209,SET,59,0.15555,0.0088034,0.12055,0.09848,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.84463310880829
GOBP_REGULATION_OF_ESTABLISH...4,SET,43,0.15675,0.0075768,0.12149,0.098492,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.84463310880829
GOBP_POSITIVE_REGULATION_OF_...193,SET,450,0.052424,0.0081059,0.040632,0.098498,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE,0.84463310880829
GOBP_LEUKOCYTE_AGGREGATION,SET,12,0.3501,0.0089473,0.27141,0.098546,GOBP_LEUKOCYTE_AGGREGATION,0.844836267883572
GOMF_ROUNDABOUT_BINDING,SET,8,0.42497,0.0088687,0.32952,0.09859,GOMF_ROUNDABOUT_BINDING,0.845005043156597
HP_ANTEVERTED_EARS,SET,10,0.37498,0.0087487,0.29083,0.098649,HP_ANTEVERTED_EARS,0.845017034457478
GOBP_DETECTION_OF_MECHANICAL...3,SET,14,0.30412,0.0083945,0.23592,0.098694,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.845017034457478
YAO_TEMPORAL_RESPONSE_TO_PRO...7,SET,132,0.092692,0.0078309,0.071917,0.09873,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,0.845017034457478
GKCGCNNNNNNNTGAYG_UNKNOWN,SET,54,0.12998,0.0070384,0.10087,0.098785,GKCGCNNNNNNNTGAYG_UNKNOWN,0.845017034457478
GOMF_TRANSFORMING_GROWTH_FAC...1,SET,23,0.24537,0.0086788,0.19046,0.098828,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING,0.845017034457478
MODULE_286,SET,35,0.19069,0.0083175,0.14803,0.098851,MODULE_286,0.845017034457478
GOBP_PEPTIDYL_TYROSINE_AUTOP...,SET,16,0.27346,0.0080688,0.21232,0.098895,GOBP_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION,0.845017034457478
CAMPS_COLON_CANCER_COPY_NUMB...1,SET,35,0.20864,0.0091007,0.162,0.098903,CAMPS_COLON_CANCER_COPY_NUMBER_DN,0.845017034457478
HP_QUADRICEPS_MUSCLE_WEAKNESS,SET,19,0.2624,0.0084367,0.20375,0.098908,HP_QUADRICEPS_MUSCLE_WEAKNESS,0.845017034457478
GOBP_ALPHA_BETA_T_CELL_ACTIV...,SET,166,0.091294,0.0086412,0.070897,0.098935,GOBP_ALPHA_BETA_T_CELL_ACTIVATION,0.845017034457478
GOBP_DEPHOSPHORYLATION,SET,243,0.067014,0.0076583,0.052043,0.098939,GOBP_DEPHOSPHORYLATION,0.845017034457478
REACTOME_M_PHASE,SET,329,0.057697,0.0076537,0.044816,0.098985,REACTOME_M_PHASE,0.845017034457478
GOBP_POSITIVE_REGULATION_OF_...386,SET,22,0.21159,0.0073198,0.16437,0.099005,GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING,0.845017034457478
TOOKER_GEMCITABINE_RESISTANC...1,SET,115,0.10332,0.0081508,0.080275,0.099053,TOOKER_GEMCITABINE_RESISTANCE_DN,0.845017034457478
CHICAS_RB1_TARGETS_SENESCENT,SET,506,0.049207,0.0080554,0.038237,0.099074,CHICAS_RB1_TARGETS_SENESCENT,0.845017034457478
WWTAAGGC_UNKNOWN,SET,130,0.10026,0.0084063,0.077914,0.099093,WWTAAGGC_UNKNOWN,0.845017034457478
GOBP_IMMUNE_RESPONSE_INHIBIT...1,SET,8,0.41873,0.0087384,0.32543,0.099111,GOBP_IMMUNE_RESPONSE_INHIBITING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.845017034457478
GOMF_NUCLEAR_IMPORT_SIGNAL_R...,SET,19,0.21277,0.0068409,0.1654,0.099162,GOMF_NUCLEAR_IMPORT_SIGNAL_RECEPTOR_ACTIVITY,0.845017034457478
REACTOME_SARS_COV_1_MODULATE...,SET,32,0.18129,0.0075616,0.14094,0.099183,REACTOME_SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,0.845017034457478
GOBP_POSITIVE_REGULATION_OF_...179,SET,13,0.30538,0.0081229,0.23743,0.099198,GOBP_POSITIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY,0.845017034457478
GOBP_FORELIMB_MORPHOGENESIS,SET,38,0.19126,0.0086922,0.14873,0.099227,GOBP_FORELIMB_MORPHOGENESIS,0.845017034457478
GOBP_POSITIVE_REGULATION_OF_...80,SET,107,0.11006,0.0083775,0.085595,0.099256,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,0.845017034457478
WANG_METASTASIS_OF_BREAST_CA...1,SET,13,0.28919,0.0076922,0.22491,0.09926,WANG_METASTASIS_OF_BREAST_CANCER,0.845017034457478
GSE4142_PLASMA_CELL_VS_GC_BC...1,SET,177,0.079338,0.0077521,0.061711,0.099291,GSE4142_PLASMA_CELL_VS_GC_BCELL_DN,0.845017034457478
GOBP_PROTEIN_LOCALIZATION_TO...30,SET,17,0.22179,0.0067456,0.17254,0.099328,GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE,0.845017034457478
WP_SOMATROPH_AXIS_GH_AND_ITS...,SET,6,0.45562,0.008235,0.35456,0.099396,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,0.845017034457478
GOMF_ACYL_COA_HYDROLASE_ACTI...,SET,22,0.24185,0.0083665,0.18821,0.099408,GOMF_ACYL_COA_HYDROLASE_ACTIVITY,0.845017034457478
SHETH_LIVER_CANCER_VS_TXNIP_...2,SET,152,0.089235,0.0080855,0.069447,0.099415,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,0.845017034457478
HP_SEROSITIS,SET,88,0.11764,0.0081245,0.091556,0.099426,HP_SEROSITIS,0.845017034457478
GOBP_CELL_CYCLE_DNA_REPLICAT...2,SET,4,0.51119,0.0075442,0.39789,0.09945,GOBP_CELL_CYCLE_DNA_REPLICATION_INITIATION,0.845017034457478
HP_DELAYED_ERUPTION_OF_PERMA...,SET,32,0.19099,0.0079664,0.14866,0.099452,HP_DELAYED_ERUPTION_OF_PERMANENT_TEETH,0.845017034457478
WENG_POR_TARGETS_GLOBAL_DN,SET,23,0.23217,0.0082119,0.18071,0.099453,WENG_POR_TARGETS_GLOBAL_DN,0.845017034457478
HERNANDEZ_ABERRANT_MITOSIS_B...3,SET,5,0.59226,0.0097722,0.46101,0.099454,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN,0.845017034457478
REACTOME_REGULATION_OF_CHOLE...,SET,53,0.13841,0.0074254,0.10774,0.099463,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,0.845017034457478
GOBP_SARCOMERE_ORGANIZATION,SET,50,0.15363,0.0080063,0.11959,0.099465,GOBP_SARCOMERE_ORGANIZATION,0.845017034457478
GSE20366_TREG_VS_NAIVE_CD4_T...3,SET,179,0.08274,0.0081296,0.064412,0.099482,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN,0.845017034457478
DR3_Q4,SET,133,0.096349,0.0081704,0.075008,0.099491,DR3_Q4,0.845017034457478
GOMF_AMINE_TRANSMEMBRANE_TRA...,SET,6,0.51394,0.009289,0.40021,0.099548,GOMF_AMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.845294585878329
GSE40274_FOXP3_VS_FOXP3_AND_...11,SET,182,0.080247,0.0079498,0.062507,0.099612,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.845631426477772
HOFFMANN_PRE_BI_TO_LARGE_PRE...2,SET,26,0.2114,0.0079495,0.16469,0.099642,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,0.845679538461538
GOBP_MINERALOCORTICOID_SECRE...,SET,7,0.45456,0.0088737,0.35419,0.099692,GOBP_MINERALOCORTICOID_SECRETION,0.845897329101563
GSE43955_TH0_VS_TGFB_IL6_TH1...12,SET,176,0.082047,0.0079943,0.063956,0.099778,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP,0.846001616678859
REACTOME_SIGNALING_BY_CSF3_G...,SET,27,0.22092,0.0084654,0.17221,0.099784,REACTOME_SIGNALING_BY_CSF3_G_CSF,0.846001616678859
GOCC_PLATELET_ALPHA_GRANULE_...1,SET,59,0.14314,0.0081011,0.11159,0.099798,GOCC_PLATELET_ALPHA_GRANULE_LUMEN,0.846001616678859
OSMAN_BLOOD_CHAD63_KH_AGE_18...1,SET,1467,0.029684,0.0080484,0.023143,0.099818,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN,0.846001616678859
HP_ABNORMALITY_OF_THE_UPPER_...4,SET,1280,0.031138,0.0079296,0.024277,0.099826,HP_ABNORMALITY_OF_THE_UPPER_URINARY_TRACT,0.846001616678859
HP_SUDDEN_EPISODIC_APNEA,SET,16,0.27132,0.0080059,0.21158,0.099868,HP_SUDDEN_EPISODIC_APNEA,0.846151228668942
HP_EPISTAXIS,SET,96,0.11636,0.0083919,0.090768,0.099936,HP_EPISTAXIS,0.84634014254386
GSE19772_CTRL_VS_HCMV_INF_MO...3,SET,144,0.090042,0.0079427,0.070238,0.099939,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN,0.84634014254386
MIR573,SET,86,0.11826,0.0080742,0.092275,0.10001,MIR573,0.84673509135201
WP_SULFATASE_AND_AROMATASE_P...,SET,14,0.30046,0.0082934,0.23455,0.10011,WP_SULFATASE_AND_AROMATASE_PATHWAY,0.846979096868172
GSE22589_HEALTHY_VS_SIV_INFE...1,SET,186,0.081499,0.0081612,0.063629,0.10013,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN,0.846979096868172
GOBP_TACHYKININ_RECEPTOR_SIG...,SET,7,0.39402,0.007692,0.30763,0.10014,GOBP_TACHYKININ_RECEPTOR_SIGNALING_PATHWAY,0.846979096868172
HP_CHRONIC_LYMPHOCYTIC_MENIN...,SET,5,0.5414,0.008933,0.42271,0.10015,HP_CHRONIC_LYMPHOCYTIC_MENINGITIS,0.846979096868172
HP_PULMONIC_STENOSIS,SET,115,0.10574,0.0083424,0.082613,0.10028,HP_PULMONIC_STENOSIS,0.846979096868172
SHEDDEN_LUNG_CANCER_GOOD_SUR...2,SET,182,0.082652,0.008188,0.064587,0.10034,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,0.846979096868172
GOCC_PARASPECKLES,SET,7,0.36005,0.0070288,0.28137,0.10034,GOCC_PARASPECKLES,0.846979096868172
PACHER_TARGETS_OF_IGF1_AND_I...,SET,35,0.19751,0.0086151,0.15435,0.10035,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,0.846979096868172
ZSCAN5C_TARGET_GENES,SET,111,0.10507,0.0081449,0.082113,0.10035,ZSCAN5C_TARGET_GENES,0.846979096868172
GOBP_PURINE_DEOXYRIBONUCLEOT...2,SET,10,0.34801,0.0081194,0.27197,0.10035,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS,0.846979096868172
GOBP_TRANS_SYNAPTIC_SIGNALIN...4,SET,9,0.41232,0.0091264,0.32223,0.10035,GOBP_TRANS_SYNAPTIC_SIGNALING_MODULATING_SYNAPTIC_TRANSMISSION,0.846979096868172
GSE35825_UNTREATED_VS_IFNA_S...2,SET,161,0.082515,0.0076928,0.064484,0.10035,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_UP,0.846979096868172
GOBP_PLASMA_CELL_DIFFERENTIA...,SET,9,0.34721,0.0076852,0.27135,0.10036,GOBP_PLASMA_CELL_DIFFERENTIATION,0.846979096868172
GOMF_L_HISTIDINE_TRANSMEMBRA...,SET,3,0.66136,0.0084531,0.51692,0.10038,GOMF_L_HISTIDINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.846979096868172
GOBP_RESPONSE_TO_INTERLEUKIN...12,SET,5,0.55269,0.0091193,0.43215,0.10046,GOBP_RESPONSE_TO_INTERLEUKIN_9,0.847448373786408
GOMF_E_BOX_BINDING,SET,52,0.17173,0.009126,0.13435,0.10059,GOMF_E_BOX_BINDING,0.847532770429854
GOCC_STRIATED_MUSCLE_THIN_FI...,SET,21,0.23603,0.0079778,0.18468,0.10062,GOCC_STRIATED_MUSCLE_THIN_FILAMENT,0.847532770429854
GOBP_CELL_RECOGNITION,SET,152,0.093423,0.0084649,0.073099,0.10063,GOBP_CELL_RECOGNITION,0.847532770429854
GOMF_INTRACELLULARLY_LIGAND_...,SET,30,0.19454,0.007857,0.15221,0.10063,GOMF_INTRACELLULARLY_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.847532770429854
HP_ABNORMAL_SUBARACHNOID_SPA...,SET,70,0.13007,0.0080159,0.10179,0.10066,HP_ABNORMAL_SUBARACHNOID_SPACE_MORPHOLOGY,0.847532770429854
LY_AGING_OLD_DN,SET,53,0.13855,0.0074333,0.10844,0.10069,LY_AGING_OLD_DN,0.847532770429854
WP_8Q1123_RB1CC1_COPY_NUMBER...,SET,16,0.25961,0.0076602,0.2032,0.1007,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,0.847532770429854
KEGG_MEDICUS_REFERENCE_WNT_S...4,SET,27,0.22379,0.0085753,0.17517,0.10071,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR,0.847532770429854
HP_AGENESIS_OF_CEREBELLAR_VE...,SET,16,0.23325,0.0068825,0.18261,0.10076,HP_AGENESIS_OF_CEREBELLAR_VERMIS,0.847532770429854
MCBRYAN_PUBERTAL_BREAST_4_5W...1,SET,170,0.08497,0.0081381,0.066526,0.10077,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,0.847532770429854
HP_MOON_FACIES,SET,12,0.29977,0.007661,0.23471,0.10077,HP_MOON_FACIES,0.847532770429854
GRAHAM_CML_QUIESCENT_VS_NORM...3,SET,37,0.1911,0.0085697,0.14967,0.10085,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,0.847532770429854
GOCC_TRANSPORT_VESICLE_MEMBR...,SET,221,0.073546,0.0080201,0.057607,0.10086,GOCC_TRANSPORT_VESICLE_MEMBRANE,0.847532770429854
GOBP_T_HELPER_1_CELL_CYTOKIN...,SET,8,0.36939,0.0077087,0.28934,0.10087,GOBP_T_HELPER_1_CELL_CYTOKINE_PRODUCTION,0.847532770429854
GOCC_VESICLE_MEMBRANE,SET,1141,0.033096,0.0079899,0.025924,0.10087,GOCC_VESICLE_MEMBRANE,0.847532770429854
SENESE_HDAC3_TARGETS_DN,SET,466,0.050832,0.0079947,0.039823,0.1009,SENESE_HDAC3_TARGETS_DN,0.847532770429854
REACTOME_NA_CL_DEPENDENT_NEU...,SET,18,0.29978,0.0093815,0.23485,0.1009,REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS,0.847532770429854
GOBP_DERMATAN_SULFATE_PROTEO...1,SET,8,0.35807,0.0074726,0.28062,0.10098,GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.847532770429854
HP_ABNORMAL_FINGER_PHALANX_M...,SET,578,0.045412,0.0079294,0.035596,0.10103,HP_ABNORMAL_FINGER_PHALANX_MORPHOLOGY,0.847532770429854
GOBP_MITOTIC_NUCLEAR_MEMBRAN...1,SET,8,0.40155,0.00838,0.31483,0.10108,GOBP_MITOTIC_NUCLEAR_MEMBRANE_DISASSEMBLY,0.847532770429854
ACOSTA_PROLIFERATION_INDEPEN...2,SET,77,0.11591,0.0074907,0.090902,0.10113,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,0.847532770429854
GOBP_REGULATION_OF_MITOCHOND...11,SET,7,0.42431,0.0082832,0.33274,0.10113,GOBP_REGULATION_OF_MITOCHONDRIAL_MRNA_STABILITY,0.847532770429854
HP_PERCUSSION_MYOTONIA,SET,9,0.36084,0.007987,0.28298,0.10113,HP_PERCUSSION_MYOTONIA,0.847532770429854
GOBP_LEARNING,SET,143,0.091618,0.0080538,0.071851,0.10114,GOBP_LEARNING,0.847532770429854
PID_TRKR_PATHWAY,SET,60,0.13885,0.0079244,0.10892,0.1012,PID_TRKR_PATHWAY,0.847532770429854
GOBP_REGULATION_OF_AXONOGENE...,SET,125,0.097971,0.0080561,0.076862,0.10123,GOBP_REGULATION_OF_AXONOGENESIS,0.847532770429854
HP_LARGE_INTESTINAL_POLYPOSIS,SET,31,0.17433,0.007157,0.13681,0.10131,HP_LARGE_INTESTINAL_POLYPOSIS,0.847532770429854
VECCHI_GASTRIC_CANCER_EARLY_...2,SET,386,0.054547,0.0078253,0.04283,0.10141,VECCHI_GASTRIC_CANCER_EARLY_UP,0.847532770429854
CASTELLANO_HRAS_AND_NRAS_TAR...1,SET,7,0.41175,0.008038,0.32333,0.10143,CASTELLANO_HRAS_AND_NRAS_TARGETS_DN,0.847532770429854
WU_HBX_TARGETS_1_DN,SET,22,0.24207,0.0083743,0.1901,0.10144,WU_HBX_TARGETS_1_DN,0.847532770429854
BIOCARTA_CALCINEURIN_PATHWAY,SET,18,0.25142,0.0078681,0.19748,0.1015,BIOCARTA_CALCINEURIN_PATHWAY,0.847532770429854
MANNO_MIDBRAIN_NEUROTYPES_HR...5,SET,502,0.051162,0.0083431,0.04019,0.10152,MANNO_MIDBRAIN_NEUROTYPES_HRGL3,0.847532770429854
GOBP_CELL_ADHESION_INVOLVED_...,SET,7,0.48675,0.0095022,0.38239,0.10153,GOBP_CELL_ADHESION_INVOLVED_IN_HEART_MORPHOGENESIS,0.847532770429854
GSE21546_UNSTIM_VS_ANTI_CD3_...6,SET,147,0.091115,0.00812,0.071581,0.10154,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.847532770429854
GOBP_MYELOID_LEUKOCYTE_MEDIA...,SET,107,0.10543,0.0080246,0.082843,0.10159,GOBP_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.847532770429854
GSE14699_NAIVE_VS_ACT_CD8_TC...1,SET,158,0.08613,0.0079554,0.067682,0.10159,GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN,0.847532770429854
MCBRYAN_PUBERTAL_BREAST_3_4W...2,SET,192,0.081761,0.008317,0.064272,0.10167,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,0.847532770429854
E2F_Q6,SET,209,0.072863,0.0077294,0.057313,0.10182,E2F_Q6,0.847532770429854
GSE41867_DAY6_EFFECTOR_VS_DA...1,SET,181,0.076182,0.0075265,0.059924,0.10182,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.847532770429854
HP_POLYDACTYLY,SET,228,0.07133,0.0078991,0.056112,0.10183,HP_POLYDACTYLY,0.847532770429854
DESCARTES_FETAL_PLACENTA_PAE...,SET,132,0.098089,0.0082869,0.077166,0.10185,DESCARTES_FETAL_PLACENTA_PAEP_MECOM_POSITIVE_CELLS,0.847532770429854
HP_ABNORMALITY_OF_FACIAL_MUS...,SET,291,0.062694,0.0078299,0.049326,0.10187,HP_ABNORMALITY_OF_FACIAL_MUSCULATURE,0.847532770429854
GOBP_REGULATION_OF_AMINE_MET...,SET,27,0.20945,0.0080261,0.16482,0.1019,GOBP_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.847532770429854
MARTIN_VIRAL_GPCR_SIGNALING_...2,SET,82,0.11897,0.0079328,0.093621,0.10191,MARTIN_VIRAL_GPCR_SIGNALING_UP,0.847532770429854
GOBP_KERATINIZATION,SET,72,0.15588,0.0097423,0.12267,0.10191,GOBP_KERATINIZATION,0.847532770429854
FINETTI_BREAST_CANCERS_KINOM...1,SET,20,0.22667,0.0074769,0.17841,0.10196,FINETTI_BREAST_CANCERS_KINOME_BLUE,0.847532770429854
WAKABAYASHI_ADIPOGENESIS_PPA...4,SET,780,0.039245,0.0079151,0.030891,0.10197,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D,0.847532770429854
GOBP_CELL_CYCLE_PROCESS,SET,1143,0.031686,0.0076557,0.024942,0.10198,GOBP_CELL_CYCLE_PROCESS,0.847532770429854
GAVISH_3CA_METAPROGRAM_MACRO...10,SET,48,0.15021,0.00767,0.11824,0.10199,GAVISH_3CA_METAPROGRAM_MACROPHAGES_PROTEASOMAL_DEGRADATION,0.847532770429854
GOMF_UBIQUITIN_LIKE_MODIFIER...,SET,9,0.2905,0.0064301,0.22869,0.102,GOMF_UBIQUITIN_LIKE_MODIFIER_ACTIVATING_ENZYME_ACTIVITY,0.847532770429854
HP_KERATOSIS_PILARIS,SET,34,0.19388,0.0083352,0.15263,0.10201,HP_KERATOSIS_PILARIS,0.847532770429854
GOBP_GLYCOLIPID_BIOSYNTHETIC...,SET,74,0.12163,0.0077058,0.095764,0.10204,GOBP_GLYCOLIPID_BIOSYNTHETIC_PROCESS,0.847532770429854
SCHERER_PBMC_APSV_WETVAX_AGE...9,SET,55,0.15939,0.0087104,0.12551,0.10206,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,0.847532770429854
SCHERER_PBMC_YF_VAX_AGE_18_4...5,SET,55,0.15939,0.0087104,0.12551,0.10206,SCHERER_PBMC_YF_VAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,0.847532770429854
STEGMEIER_PREMITOTIC_CELL_CY...,SET,11,0.30736,0.0075208,0.24203,0.10207,STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS,0.847532770429854
GOBP_NEGATIVE_REGULATION_OF_...647,SET,9,0.38785,0.0085848,0.30542,0.10207,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.847532770429854
GOBP_ANATOMICAL_STRUCTURE_MA...,SET,247,0.070388,0.0081089,0.05543,0.10208,GOBP_ANATOMICAL_STRUCTURE_MATURATION,0.847532770429854
HP_APLASIA_HYPOPLASIA_OF_THE...60,SET,20,0.24414,0.0080534,0.19227,0.10208,HP_APLASIA_HYPOPLASIA_OF_THE_PUBIC_BONE,0.847532770429854
GOCC_SPECIFIC_GRANULE,SET,148,0.087511,0.0078251,0.068918,0.10209,GOCC_SPECIFIC_GRANULE,0.847532770429854
GSE22886_TH1_VS_TH2_48H_ACT_...1,SET,182,0.079845,0.0079099,0.062885,0.1021,GSE22886_TH1_VS_TH2_48H_ACT_DN,0.847532770429854
FULLER_PBMC_F_TULARENSIS_VAC...7,SET,42,0.17554,0.0083859,0.13829,0.10218,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_UP,0.847532770429854
EBAUER_TARGETS_OF_PAX3_FOXO1...1,SET,46,0.1549,0.0077434,0.12207,0.10224,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,0.847532770429854
ZHAN_EARLY_DIFFERENTIATION_G...1,SET,41,0.17651,0.0083316,0.1391,0.10224,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,0.847532770429854
REACTOME_ASSEMBLY_OF_THE_ORC...,SET,9,0.3029,0.0067045,0.23872,0.10225,REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION,0.847532770429854
WP_IL18_SIGNALING,SET,259,0.069157,0.0081555,0.054513,0.10229,WP_IL18_SIGNALING,0.847532770429854
GOBP_POSITIVE_REGULATION_OF_...458,SET,14,0.29062,0.0080218,0.22907,0.10229,GOBP_POSITIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.847532770429854
GOBP_POSITIVE_T_CELL_SELECTI...,SET,44,0.1762,0.008615,0.1389,0.10231,GOBP_POSITIVE_T_CELL_SELECTION,0.847532770429854
FEKIR_HEPARG_SPHERE_VS_HEPAR...2,SET,95,0.11223,0.008052,0.088488,0.10235,FEKIR_HEPARG_SPHERE_VS_HEPARG_UP,0.847532770429854
chr21q11,SET,4,0.68461,0.010104,0.53981,0.10236,chr21q11,0.847532770429854
GOCC_UNIPLEX_COMPLEX,SET,5,0.57133,0.0094268,0.45061,0.10243,GOCC_UNIPLEX_COMPLEX,0.847532770429854
GOBP_MEDIUM_CHAIN_FATTY_ACID...3,SET,15,0.26956,0.0077016,0.21263,0.10245,GOBP_MEDIUM_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.847532770429854
KEGG_MEDICUS_VARIANT_MUTATIO...86,SET,27,0.20115,0.007708,0.15871,0.1025,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.847532770429854
HP_SUBRETINAL_DEPOSITS,SET,6,0.45177,0.0081653,0.35643,0.1025,HP_SUBRETINAL_DEPOSITS,0.847532770429854
GOCC_COMPACT_MYELIN,SET,13,0.31889,0.0084823,0.25162,0.10252,GOCC_COMPACT_MYELIN,0.847532770429854
HP_FACIAL_HYPOTONIA,SET,41,0.16637,0.0078529,0.13127,0.10252,HP_FACIAL_HYPOTONIA,0.847532770429854
GOBP_POSITIVE_REGULATION_OF_...76,SET,23,0.21483,0.0075989,0.16954,0.10255,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT,0.847532770429854
GOBP_HEPARAN_SULFATE_PROTEOG...2,SET,11,0.36232,0.0088656,0.28597,0.10259,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_ENZYMATIC_MODIFICATION,0.847532770429854
GSE17974_0H_VS_0.5H_IN_VITRO...2,SET,162,0.081515,0.0076229,0.064355,0.10265,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP,0.847532770429854
GOBP_POSITIVE_REGULATION_OF_...210,SET,199,0.076485,0.0079194,0.060389,0.10267,GOBP_POSITIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.847532770429854
HP_ABNORMALITY_OF_THE_THENAR...,SET,30,0.18745,0.0075707,0.148,0.10267,HP_ABNORMALITY_OF_THE_THENAR_EMINENCE,0.847532770429854
GOBP_ACUTE_PHASE_RESPONSE,SET,44,0.18111,0.0088552,0.143,0.10268,GOBP_ACUTE_PHASE_RESPONSE,0.847532770429854
HP_SUDDEN_DEATH,SET,123,0.10201,0.0083214,0.08055,0.10268,HP_SUDDEN_DEATH,0.847532770429854
WP_PDGF_PATHWAY,SET,38,0.16914,0.0076866,0.13358,0.10273,WP_PDGF_PATHWAY,0.847532770429854
ZHONG_PFC_MAJOR_TYPES_EXCITA...,SET,8,0.3695,0.0077112,0.29182,0.10273,ZHONG_PFC_MAJOR_TYPES_EXCITATORY_NEURON,0.847532770429854
MIR450A_1_3P,SET,168,0.081651,0.0077745,0.064492,0.10275,MIR450A_1_3P,0.847532770429854
TFAM_TARGET_GENES,SET,2,0.78332,0.0081749,0.61871,0.10275,TFAM_TARGET_GENES,0.847532770429854
GSE19923_WT_VS_HEB_AND_E2A_K...1,SET,185,0.079823,0.0079719,0.063047,0.10275,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.847532770429854
FAN_OVARY_CL7_ANGEIOGENIC_EN...,SET,223,0.077086,0.0084436,0.0609,0.1028,FAN_OVARY_CL7_ANGEIOGENIC_ENDOTHELIAL_CELL,0.847532770429854
MYLLYKANGAS_AMPLIFICATION_HO...12,SET,10,0.3553,0.0082896,0.28074,0.10283,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27,0.847532770429854
GOMF_PROTEIN_TYROSINE_KINASE...4,SET,5,0.50689,0.0083635,0.40049,0.10283,GOMF_PROTEIN_TYROSINE_KINASE_INHIBITOR_ACTIVITY,0.847532770429854
HP_ABNORMAL_FOOT_MORPHOLOGY,SET,1315,0.030688,0.0079132,0.024251,0.10286,HP_ABNORMAL_FOOT_MORPHOLOGY,0.847532770429854
GSE40274_FOXP3_VS_FOXP3_AND_...10,SET,185,0.077245,0.0077145,0.061041,0.10286,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.847532770429854
GSE41867_DAY6_VS_DAY8_LCMV_A...1,SET,187,0.074113,0.0074412,0.058568,0.10287,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.847532770429854
GOMF_MUTSALPHA_COMPLEX_BINDI...,SET,7,0.37798,0.0073788,0.29872,0.10288,GOMF_MUTSALPHA_COMPLEX_BINDING,0.847532770429854
TSAI_DNAJB4_TARGETS_UP,SET,12,0.30764,0.0078621,0.24313,0.10289,TSAI_DNAJB4_TARGETS_UP,0.847532770429854
REACTOME_SIGNALING_BY_MRAS_C...,SET,7,0.34979,0.0068286,0.27645,0.10289,REACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS,0.847532770429854
LINDVALL_IMMORTALIZED_BY_TER...2,SET,59,0.15117,0.0085554,0.11948,0.1029,LINDVALL_IMMORTALIZED_BY_TERT_UP,0.847532770429854
GOBP_NEGATIVE_REGULATION_OF_...178,SET,29,0.18252,0.0072481,0.14427,0.10291,GOBP_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION,0.847532770429854
GOBP_DOUBLE_STRAND_BREAK_REP...4,SET,12,0.29599,0.0075644,0.23397,0.10293,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_BREAK_INDUCED_REPLICATION,0.847532770429854
GOCC_FHF_COMPLEX,SET,4,0.43046,0.0063529,0.34027,0.10293,GOCC_FHF_COMPLEX,0.847532770429854
GOBP_ELASTIC_FIBER_ASSEMBLY,SET,8,0.36928,0.0077065,0.29191,0.10294,GOBP_ELASTIC_FIBER_ASSEMBLY,0.847532770429854
GSE17974_0H_VS_2H_IN_VITRO_A...2,SET,166,0.08141,0.0077057,0.064364,0.10297,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP,0.847532770429854
LEE_EARLY_T_LYMPHOCYTE_UP,SET,95,0.11147,0.0079972,0.08814,0.103,LEE_EARLY_T_LYMPHOCYTE_UP,0.847532770429854
HP_BILIARY_TRACT_ABNORMALITY,SET,93,0.11178,0.0079351,0.088402,0.10304,HP_BILIARY_TRACT_ABNORMALITY,0.847532770429854
KEGG_MEDICUS_REFERENCE_RIG_I...2,SET,17,0.31383,0.009545,0.24821,0.10305,KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY,0.847532770429854
BIOCARTA_ERK5_PATHWAY,SET,14,0.2786,0.0076901,0.22036,0.10307,BIOCARTA_ERK5_PATHWAY,0.847532770429854
E2F5_TARGET_GENES,SET,1007,0.034715,0.0079039,0.027463,0.10311,E2F5_TARGET_GENES,0.847532770429854
HEDENFALK_BREAST_CANCER_BRAC...2,SET,15,0.27975,0.0079925,0.22132,0.10312,HEDENFALK_BREAST_CANCER_BRACX_UP,0.847532770429854
GOBP_COPI_COATED_VESICLE_BUD...,SET,6,0.35239,0.0063691,0.27884,0.10317,GOBP_COPI_COATED_VESICLE_BUDDING,0.847532770429854
HP_POSTURAL_INSTABILITY,SET,74,0.12338,0.0078167,0.097638,0.10319,HP_POSTURAL_INSTABILITY,0.847532770429854
GOBP_ERBB2_ERBB4_SIGNALING_P...,SET,5,0.49741,0.0082071,0.39368,0.10321,GOBP_ERBB2_ERBB4_SIGNALING_PATHWAY,0.847532770429854
GOMF_TRANSLATION_INITIATION_...2,SET,28,0.1813,0.0070747,0.14351,0.10323,GOMF_TRANSLATION_INITIATION_FACTOR_BINDING,0.847532770429854
GNF2_STAT6,SET,73,0.11906,0.007492,0.094237,0.10324,GNF2_STAT6,0.847532770429854
GOMF_SEQUENCE_SPECIFIC_DNA_B...,SET,1523,0.030691,0.0084647,0.024295,0.10325,GOMF_SEQUENCE_SPECIFIC_DNA_BINDING,0.847532770429854
GSE16385_IFNG_TNF_VS_IL4_STI...4,SET,184,0.077126,0.007682,0.061069,0.10332,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,0.847871033994334
GOMF_ANNEALING_ACTIVITY,SET,8,0.38417,0.0080172,0.30422,0.10334,GOMF_ANNEALING_ACTIVITY,0.847871033994334
GSE6259_CD4_TCELL_VS_CD8_TCE...2,SET,173,0.084005,0.0081157,0.066534,0.10338,GSE6259_CD4_TCELL_VS_CD8_TCELL_UP,0.847999032334199
ACAACTT_MIR382,SET,62,0.13384,0.0077643,0.10604,0.10345,ACAACTT_MIR382,0.848182622023108
REACTOME_ABERRANT_REGULATION...2,SET,17,0.2589,0.0078742,0.20514,0.10347,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,0.848182622023108
GNF2_MSN,SET,20,0.21527,0.0071009,0.17058,0.10348,GNF2_MSN,0.848182622023108
MIR8074,SET,17,0.23927,0.0072771,0.18961,0.1035,MIR8074,0.848182622023108
STAT5A_04,SET,188,0.080188,0.0080724,0.063568,0.10358,STAT5A_04,0.848638118811881
REACTOME_RMTS_METHYLATE_HIST...,SET,29,0.19087,0.0075797,0.15134,0.10363,REACTOME_RMTS_METHYLATE_HISTONE_ARGININES,0.848847666745227
GOBP_REGULATION_OF_MRNA_SPLI...,SET,97,0.097445,0.0070639,0.07728,0.10368,GOBP_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME,0.848938975265018
GOBP_DEOXYRIBONUCLEOSIDE_MET...,SET,10,0.36741,0.008572,0.2914,0.10369,GOBP_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,0.848938975265018
HP_PROGRESSIVE_GAIT_ATAXIA,SET,26,0.20122,0.0075667,0.15965,0.10378,HP_PROGRESSIVE_GAIT_ATAXIA,0.849357534730398
GOBP_POSITIVE_REGULATION_OF_...261,SET,31,0.20113,0.0082574,0.15959,0.10379,GOBP_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,0.849357534730398
GOBP_REGULATION_OF_LIPOPROTE...2,SET,15,0.29354,0.0083867,0.23294,0.10382,GOBP_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS,0.849403036723164
HP_LACTICACIDURIA,SET,20,0.24268,0.0080049,0.19268,0.10394,HP_LACTICACIDURIA,0.849974876673714
GOCC_SPERM_HEAD_PLASMA_MEMBR...,SET,6,0.43231,0.0078136,0.34331,0.10398,GOCC_SPERM_HEAD_PLASMA_MEMBRANE,0.849974876673714
HP_ABNORMAL_CARDIAC_ATRIUM_M...,SET,518,0.046727,0.0077369,0.037112,0.10401,HP_ABNORMAL_CARDIAC_ATRIUM_MORPHOLOGY,0.849974876673714
ACAACCT_MIR453,SET,36,0.17424,0.0077075,0.1384,0.10403,ACAACCT_MIR453,0.849974876673714
MODULE_470,SET,15,0.31311,0.0089458,0.24872,0.10404,MODULE_470,0.849974876673714
REACTOME_HDR_THROUGH_HOMOLOG...,SET,64,0.12364,0.0072871,0.098232,0.10408,REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,0.849974876673714
GOMF_SINGLE_STRANDED_DNA_3_5...,SET,6,0.3546,0.0064091,0.28174,0.10409,GOMF_SINGLE_STRANDED_DNA_3_5_DNA_EXONUCLEASE_ACTIVITY,0.849974876673714
GSE5142_HTERT_TRANSDUCED_VS_...2,SET,176,0.074527,0.0072616,0.059213,0.10409,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP,0.849974876673714
GOBP_AMMONIUM_TRANSMEMBRANE_...,SET,13,0.30134,0.0080155,0.23944,0.10411,GOBP_AMMONIUM_TRANSMEMBRANE_TRANSPORT,0.849974876673714
GSE43863_TH1_VS_LY6C_INT_CXC...3,SET,177,0.081412,0.0079547,0.064706,0.10417,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,0.849982872539831
GSE23502_WT_VS_HDC_KO_MYELOI...1,SET,185,0.079115,0.0079013,0.062883,0.10418,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_DN,0.849982872539831
KEGG_MEDICUS_VARIANT_MUTATIO...6,SET,15,0.27318,0.0078048,0.21713,0.10419,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY,0.849982872539831
BIOCARTA_P27_PATHWAY,SET,13,0.28074,0.0074674,0.22323,0.10427,BIOCARTA_P27_PATHWAY,0.849982872539831
TIEN_INTESTINE_PROBIOTICS_24...1,SET,192,0.077736,0.0079076,0.061829,0.10434,TIEN_INTESTINE_PROBIOTICS_24HR_DN,0.849982872539831
GOBP_SERINE_FAMILY_AMINO_ACI...2,SET,11,0.30585,0.007484,0.24329,0.10435,GOBP_SERINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,0.849982872539831
HP_AMELOGENESIS_IMPERFECTA,SET,31,0.19405,0.0079669,0.15435,0.10435,HP_AMELOGENESIS_IMPERFECTA,0.849982872539831
GOBP_POSITIVE_REGULATION_OF_...752,SET,17,0.25091,0.0076312,0.19959,0.10436,GOBP_POSITIVE_REGULATION_OF_TELOMERE_CAPPING,0.849982872539831
KEGG_MEDICUS_VARIANT_MUTATIO...52,SET,11,0.30999,0.0075851,0.2466,0.10438,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.849982872539831
MIR6796_5P,SET,67,0.12515,0.0075463,0.099561,0.10438,MIR6796_5P,0.849982872539831
GOBP_LEYDIG_CELL_DIFFERENTIA...,SET,9,0.36491,0.008077,0.29029,0.10438,GOBP_LEYDIG_CELL_DIFFERENTIATION,0.849982872539831
GSE9006_HEALTHY_VS_TYPE_2_DI...1,SET,179,0.079156,0.0077775,0.062996,0.10447,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,0.850370992277089
GOBP_VESICLE_FUSION_WITH_GOL...,SET,8,0.35285,0.0073636,0.28082,0.10448,GOBP_VESICLE_FUSION_WITH_GOLGI_APPARATUS,0.850370992277089
HP_ABNORMAL_CEREBRAL_ARTERY_...,SET,74,0.12606,0.0079866,0.10035,0.10452,HP_ABNORMAL_CEREBRAL_ARTERY_MORPHOLOGY,0.850370992277089
KEGG_MEDICUS_REFERENCE_GLUTA...,SET,11,0.30848,0.0075483,0.24558,0.10454,KEGG_MEDICUS_REFERENCE_GLUTATHIONE_BIOSYNTHESIS,0.850370992277089
GSE24142_EARLY_THYMIC_PROGEN...11,SET,180,0.081701,0.0080497,0.065045,0.10455,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP,0.850370992277089
KEGG_GLIOMA,SET,64,0.13431,0.0079155,0.10695,0.1046,KEGG_GLIOMA,0.850460947368421
KIM_WT1_TARGETS_UP,SET,211,0.076097,0.0081106,0.060598,0.10461,KIM_WT1_TARGETS_UP,0.850460947368421
HP_DISTAL_LOWER_LIMB_MUSCLE_...,SET,84,0.11697,0.0078938,0.093177,0.10468,HP_DISTAL_LOWER_LIMB_MUSCLE_WEAKNESS,0.850831010289991
GOMF_PYRIMIDINE_NUCLEOBASE_T...,SET,7,0.4136,0.0080741,0.32954,0.10473,GOMF_PYRIMIDINE_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.850892676944639
MIR4313,SET,26,0.20553,0.0077287,0.1638,0.10479,MIR4313,0.850892676944639
GOMF_CARDIOLIPIN_BINDING,SET,10,0.34627,0.0080789,0.27598,0.1048,GOMF_CARDIOLIPIN_BINDING,0.850892676944639
HOFMANN_MYELODYSPLASTIC_SYND...3,SET,24,0.20449,0.0073882,0.16298,0.10481,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN,0.850892676944639
GOBP_ESTABLISHMENT_OF_BLOOD_...2,SET,4,0.58838,0.0086835,0.46897,0.10481,GOBP_ESTABLISHMENT_OF_BLOOD_RETINAL_BARRIER,0.850892676944639
REACTOME_TRANSCRIPTIONAL_REG...1,SET,31,0.17994,0.0073873,0.14347,0.10489,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6,0.850945513563645
HP_BIFID_SCROTUM,SET,30,0.2096,0.0084652,0.16714,0.10493,HP_BIFID_SCROTUM,0.850945513563645
HP_ABNORMAL_SCROTUM_MORPHOLO...,SET,110,0.10467,0.008077,0.083482,0.10497,HP_ABNORMAL_SCROTUM_MORPHOLOGY,0.850945513563645
GOBP_POSITIVE_REGULATION_OF_...380,SET,9,0.3429,0.0075898,0.27355,0.10502,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.850945513563645
HP_POLYNEUROPATHY,SET,45,0.15532,0.0076801,0.12391,0.10502,HP_POLYNEUROPATHY,0.850945513563645
HP_ABNORMAL_PIGMENTATION_OF_...,SET,35,0.18078,0.0078853,0.14423,0.10504,HP_ABNORMAL_PIGMENTATION_OF_THE_ORAL_MUCOSA,0.850945513563645
GSE21033_1H_VS_12H_POLYIC_ST...1,SET,124,0.095239,0.0078002,0.075985,0.10504,GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN,0.850945513563645
MIR335_5P,SET,105,0.10344,0.0078,0.082542,0.10508,MIR335_5P,0.850945513563645
HP_LEG_MUSCLE_STIFFNESS,SET,14,0.25839,0.0071322,0.2062,0.1051,HP_LEG_MUSCLE_STIFFNESS,0.850945513563645
GOBP_APPENDAGE_MORPHOGENESIS,SET,139,0.097539,0.0084545,0.077855,0.10514,GOBP_APPENDAGE_MORPHOGENESIS,0.850945513563645
chr13q12,SET,65,0.24924,0.014803,0.19898,0.10518,chr13q12,0.850945513563645
TESAR_ALK_TARGETS_HUMAN_ES_5...2,SET,4,0.55791,0.0082338,0.44541,0.10519,TESAR_ALK_TARGETS_HUMAN_ES_5D_UP,0.850945513563645
GOBP_REGULATION_OF_ASPARTIC_...1,SET,6,0.46796,0.008458,0.3736,0.10519,GOBP_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.850945513563645
WP_DYRK1A_INVOLVEMENT_REGARD...,SET,59,0.1345,0.0076118,0.10739,0.10521,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,0.850945513563645
SHAFFER_IRF4_TARGETS_IN_ACTI...1,SET,74,0.12143,0.0076934,0.097001,0.10532,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,0.850945513563645
MODULE_500,SET,28,0.19683,0.0076803,0.15723,0.10532,MODULE_500,0.850945513563645
WP_NONGENOMIC_ACTIONS_OF_125...,SET,69,0.13154,0.0080483,0.10508,0.10534,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,0.850945513563645
MIR3128,SET,114,0.097521,0.0076604,0.077914,0.10535,MIR3128,0.850945513563645
MODULE_60,SET,378,0.054886,0.0077937,0.043858,0.10539,MODULE_60,0.850945513563645
GOBP_T_HELPER_17_CELL_DIFFER...,SET,33,0.19857,0.0084108,0.1587,0.10543,GOBP_T_HELPER_17_CELL_DIFFERENTIATION,0.850945513563645
GOBP_EYELID_DEVELOPMENT_IN_C...,SET,13,0.33377,0.008878,0.26675,0.10544,GOBP_EYELID_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.850945513563645
GAVISH_3CA_METAPROGRAM_MACRO...12,SET,48,0.16916,0.0086376,0.1352,0.10545,GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP,0.850945513563645
GROSS_HYPOXIA_VIA_HIF1A_DN,SET,98,0.11032,0.0080378,0.088188,0.10549,GROSS_HYPOXIA_VIA_HIF1A_DN,0.850945513563645
TRAVAGLINI_LUNG_CAPILLARY_IN...2,SET,353,0.055697,0.0076482,0.044529,0.10551,TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_2_CELL,0.850945513563645
GOCC_RNA_POLYMERASE_II_TRANS...2,SET,14,0.27908,0.0077033,0.22313,0.10552,GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REPRESSOR_COMPLEX,0.850945513563645
BIOCARTA_PTEN_PATHWAY,SET,18,0.25501,0.0079805,0.2039,0.10553,BIOCARTA_PTEN_PATHWAY,0.850945513563645
GSE19888_ADENOSINE_A3R_INH_P...1,SET,181,0.077141,0.0076213,0.061679,0.10553,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN,0.850945513563645
GSE3337_CTRL_VS_16H_IFNG_IN_...1,SET,179,0.077403,0.0076052,0.061887,0.10553,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN,0.850945513563645
GOMF_ACTIVIN_BINDING,SET,11,0.3451,0.0084444,0.27595,0.10555,GOMF_ACTIVIN_BINDING,0.850945513563645
KRIGE_AMINO_ACID_DEPRIVATION,SET,24,0.2418,0.0087363,0.19337,0.10558,KRIGE_AMINO_ACID_DEPRIVATION,0.850945513563645
GAVISH_3CA_METAPROGRAM_B_CEL...12,SET,44,0.1783,0.0087179,0.14259,0.10558,GAVISH_3CA_METAPROGRAM_B_CELLS_STRESS,0.850945513563645
GOMF_SECONDARY_ACTIVE_TRANSM...,SET,274,0.066168,0.0080226,0.052921,0.1056,GOMF_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.850945513563645
GSE13522_CTRL_VS_T_CRUZI_Y_S...3,SET,117,0.10012,0.0079666,0.080094,0.10566,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_DN,0.851231641168289
GSE27786_LIN_NEG_VS_NKCELL_UP,SET,174,0.077238,0.0074833,0.061829,0.1058,GSE27786_LIN_NEG_VS_NKCELL_UP,0.852103783416402
HP_NEOPLASM_OF_HEAD_AND_NECK,SET,35,0.18558,0.0080946,0.14858,0.10584,HP_NEOPLASM_OF_HEAD_AND_NECK,0.852103783416402
MODULE_259,SET,41,0.17532,0.0082752,0.14047,0.10601,MODULE_259,0.852103783416402
HP_ERYTHEMATOUS_PAPULE,SET,10,0.26553,0.006195,0.21276,0.10602,HP_ERYTHEMATOUS_PAPULE,0.852103783416402
RIZKI_TUMOR_INVASIVENESS_2D_...1,SET,52,0.14366,0.0076343,0.11512,0.10604,RIZKI_TUMOR_INVASIVENESS_2D_DN,0.852103783416402
GOBP_CARDIAC_MUSCLE_CONTRACT...,SET,131,0.096512,0.0081229,0.077342,0.10605,GOBP_CARDIAC_MUSCLE_CONTRACTION,0.852103783416402
GOBP_POSITIVE_REGULATION_OF_...273,SET,17,0.24853,0.0075587,0.19918,0.10607,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.852103783416402
WP_NAD_BIOSYNTHETIC_PATHWAYS,SET,22,0.23116,0.0079967,0.18535,0.10618,WP_NAD_BIOSYNTHETIC_PATHWAYS,0.852103783416402
GOBP_PROTEIN_INSERTION_INTO_...7,SET,13,0.26504,0.0070498,0.21256,0.10623,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_OUTER_MEMBRANE,0.852103783416402
GSE18791_UNSTIM_VS_NEWCATSLE...5,SET,159,0.08302,0.0076921,0.066584,0.10624,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN,0.852103783416402
MYLLYKANGAS_AMPLIFICATION_HO...4,SET,18,0.22629,0.0070818,0.18155,0.1063,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17,0.852103783416402
GOBP_TELOMERE_MAINTENANCE,SET,142,0.082379,0.0072165,0.066089,0.1063,GOBP_TELOMERE_MAINTENANCE,0.852103783416402
MIR7111_5P,SET,189,0.07431,0.0075004,0.059628,0.10635,MIR7111_5P,0.852103783416402
GOBP_INTRACELLULAR_WATER_HOM...,SET,6,0.48906,0.0088392,0.39244,0.10636,GOBP_INTRACELLULAR_WATER_HOMEOSTASIS,0.852103783416402
REACTOME_UPTAKE_AND_FUNCTION...2,SET,6,0.40551,0.0073292,0.32544,0.10638,REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN,0.852103783416402
GOBP_NEGATIVE_REGULATION_OF_...586,SET,3,0.72533,0.0092707,0.5821,0.10638,GOBP_NEGATIVE_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY,0.852103783416402
HP_RECURRENT_RESPIRATORY_INF...,SET,544,0.046112,0.0078188,0.037018,0.10645,HP_RECURRENT_RESPIRATORY_INFECTIONS,0.852103783416402
GAUTAM_EYE_IRIS_CILIARY_BODY...1,SET,104,0.097659,0.007329,0.078403,0.10646,GAUTAM_EYE_IRIS_CILIARY_BODY_ACTIVATED_T_CELLS,0.852103783416402
HP_ABNORMALITY_OF_THE_GINGIVA,SET,211,0.074345,0.0079238,0.059695,0.1065,HP_ABNORMALITY_OF_THE_GINGIVA,0.852103783416402
HP_HEPATOBLASTOMA,SET,21,0.23127,0.0078169,0.18571,0.10651,HP_HEPATOBLASTOMA,0.852103783416402
GOBP_MAGNESIUM_ION_TRANSPORT,SET,14,0.27714,0.0076497,0.22256,0.10653,GOBP_MAGNESIUM_ION_TRANSPORT,0.852103783416402
GSE27786_LIN_NEG_VS_NEUTROPH...1,SET,185,0.074332,0.0074236,0.059699,0.10655,GSE27786_LIN_NEG_VS_NEUTROPHIL_DN,0.852103783416402
MIR6891_5P,SET,109,0.099625,0.0076532,0.080017,0.10656,MIR6891_5P,0.852103783416402
ZA_UNIPROT_Q9UM89_UNREVIEWED...,SET,60,0.14166,0.0080848,0.11379,0.10658,ZA_UNIPROT_Q9UM89_UNREVIEWED_GENES_TARGET_GENES,0.852103783416402
HP_ABNORMAL_EXPERIENCE_OF_RE...,SET,532,0.04575,0.0076739,0.036748,0.10658,HP_ABNORMAL_EXPERIENCE_OF_REALITY,0.852103783416402
GOBP_AV_NODE_CELL_TO_BUNDLE_...1,SET,13,0.30676,0.0081596,0.24642,0.10659,GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_COMMUNICATION,0.852103783416402
MIR4797_3P,SET,94,0.10015,0.0071472,0.080456,0.10662,MIR4797_3P,0.852103783416402
GOBP_TRANSLATIONAL_TERMINATI...,SET,13,0.29048,0.0077265,0.23342,0.10667,GOBP_TRANSLATIONAL_TERMINATION,0.852103783416402
HP_SEX_REVERSAL,SET,11,0.3531,0.0086402,0.28387,0.10677,HP_SEX_REVERSAL,0.852103783416402
MODULE_361,SET,127,0.094325,0.0078176,0.075837,0.1068,MODULE_361,0.852103783416402
GOBP_POSITIVE_REGULATION_OF_...418,SET,8,0.3657,0.0076318,0.29408,0.10684,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,0.852103783416402
GSE18791_CTRL_VS_NEWCASTLE_V...20,SET,180,0.073623,0.0072538,0.059207,0.10685,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP,0.852103783416402
KEGG_MEDICUS_VARIANT_AMPLIFI...10,SET,6,0.42709,0.0077193,0.34351,0.10688,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_ACTIVATION,0.852103783416402
GOMF_HELICASE_ACTIVITY,SET,142,0.083937,0.007353,0.067508,0.10688,GOMF_HELICASE_ACTIVITY,0.852103783416402
GOBP_POSITIVE_REGULATION_OF_...313,SET,4,0.51794,0.0076439,0.41659,0.10689,GOBP_POSITIVE_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.852103783416402
MIR8059,SET,55,0.14033,0.0076688,0.11289,0.10693,MIR8059,0.852103783416402
GOMF_SPHINGOSINE_1_PHOSPHATE...2,SET,8,0.39392,0.0082208,0.3169,0.10693,GOMF_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_ACTIVITY,0.852103783416402
REACTOME_SODIUM_PROTON_EXCHA...,SET,7,0.39322,0.0076764,0.3164,0.10698,REACTOME_SODIUM_PROTON_EXCHANGERS,0.852103783416402
FAN_EMBRYONIC_CTX_IN_4_INTER...,SET,8,0.40608,0.0084745,0.32677,0.10699,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,0.852103783416402
HP_MANDIBULAR_PROGNATHIA,SET,174,0.076856,0.0074462,0.061859,0.10705,HP_MANDIBULAR_PROGNATHIA,0.852103783416402
HP_MICROSCOPIC_HEMATURIA,SET,18,0.25634,0.0080221,0.20633,0.10705,HP_MICROSCOPIC_HEMATURIA,0.852103783416402
GOCC_CILIARY_ROOTLET,SET,12,0.30588,0.0078172,0.24621,0.10706,GOCC_CILIARY_ROOTLET,0.852103783416402
GOCC_SPERM_HEAD,SET,17,0.23354,0.0071029,0.18798,0.10706,GOCC_SPERM_HEAD,0.852103783416402
MIR4691_3P,SET,90,0.11039,0.0077094,0.088859,0.10708,MIR4691_3P,0.852103783416402
MYC_UP.V1_DN,SET,145,0.085258,0.0075465,0.068633,0.10708,MYC_UP.V1_DN,0.852103783416402
PID_S1P_S1P3_PATHWAY,SET,29,0.20685,0.0082141,0.16654,0.10712,PID_S1P_S1P3_PATHWAY,0.852103783416402
MODULE_292,SET,120,0.099765,0.0080389,0.080328,0.10713,MODULE_292,0.852103783416402
GOMF_ACETYLCHOLINE_RECEPTOR_...2,SET,11,0.3424,0.0083782,0.2757,0.10714,GOMF_ACETYLCHOLINE_RECEPTOR_BINDING,0.852103783416402
HP_UNUSUAL_INFECTION,SET,917,0.035486,0.0077298,0.028578,0.10718,HP_UNUSUAL_INFECTION,0.852103783416402
HP_KYPHOSCOLIOSIS,SET,164,0.080858,0.0076076,0.065125,0.10721,HP_KYPHOSCOLIOSIS,0.852103783416402
VETTER_TARGETS_OF_PRKCA_AND_...1,SET,16,0.27671,0.0081649,0.22291,0.10725,VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,0.852103783416402
REACTOME_GABA_SYNTHESIS_RELE...,SET,19,0.26234,0.0084346,0.21134,0.10726,REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION,0.852103783416402
GOBP_TERPENOID_BIOSYNTHETIC_...,SET,16,0.26144,0.0077142,0.21064,0.10728,GOBP_TERPENOID_BIOSYNTHETIC_PROCESS,0.852103783416402
HARALAMBIEVA_PBMC_FLUARIX_AG...1,SET,376,0.055431,0.0078507,0.044669,0.10732,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE,0.852103783416402
GSE17721_CTRL_VS_CPG_0.5H_BM...2,SET,184,0.07561,0.0075311,0.060933,0.10733,GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP,0.852103783416402
GOBP_REGULATION_OF_PHOSPHATA...,SET,50,0.1464,0.0076295,0.118,0.10737,GOBP_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.852103783416402
HP_AUDITORY_HYPERSENSITIVITY,SET,30,0.20751,0.0083808,0.16727,0.1074,HP_AUDITORY_HYPERSENSITIVITY,0.852103783416402
GOBP_RETINAL_PIGMENT_EPITHEL...,SET,6,0.49034,0.0088624,0.39529,0.10741,GOBP_RETINAL_PIGMENT_EPITHELIUM_DEVELOPMENT,0.852103783416402
BIOCARTA_CYTOKINE_PATHWAY,SET,19,0.25449,0.0081823,0.20518,0.10743,BIOCARTA_CYTOKINE_PATHWAY,0.852103783416402
GOMF_RDNA_BINDING,SET,8,0.32283,0.0067371,0.26027,0.10743,GOMF_RDNA_BINDING,0.852103783416402
GOBP_REGULATION_OF_T_CELL_DI...,SET,24,0.22129,0.0079954,0.17843,0.10745,GOBP_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,0.852103783416402
GSE2770_IL12_ACT_VS_ACT_CD4_...3,SET,178,0.074672,0.0073165,0.060208,0.10745,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN,0.852103783416402
HP_QUADRICEPS_MUSCLE_ATROPHY,SET,3,0.65335,0.0083506,0.52685,0.10748,HP_QUADRICEPS_MUSCLE_ATROPHY,0.852103783416402
BIOCARTA_PLCD_PATHWAY,SET,5,0.54874,0.0090541,0.44254,0.1075,BIOCARTA_PLCD_PATHWAY,0.852103783416402
KEGG_MEDICUS_REFERENCE_ALTER...,SET,5,0.55649,0.009182,0.44883,0.10752,KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN,0.852103783416402
AGCTCCT_MIR28,SET,79,0.11672,0.0076396,0.094155,0.10756,AGCTCCT_MIR28,0.852103783416402
HP_RIB_SEGMENTATION_ABNORMAL...,SET,11,0.34483,0.0084376,0.27818,0.10758,HP_RIB_SEGMENTATION_ABNORMALITIES,0.852103783416402
WOOD_EBV_EBNA1_TARGETS_UP,SET,103,0.10761,0.0080375,0.086842,0.10764,WOOD_EBV_EBNA1_TARGETS_UP,0.852103783416402
HP_DISTAL_SENSORY_IMPAIRMENT,SET,117,0.092581,0.0073668,0.074713,0.10765,HP_DISTAL_SENSORY_IMPAIRMENT,0.852103783416402
HP_DEATH_IN_ADULTHOOD,SET,42,0.15962,0.0076256,0.12884,0.10769,HP_DEATH_IN_ADULTHOOD,0.852103783416402
GOBP_MUSCLE_CELL_CELLULAR_HO...,SET,21,0.21472,0.0072574,0.17337,0.10777,GOBP_MUSCLE_CELL_CELLULAR_HOMEOSTASIS,0.852103783416402
HP_FRONTAL_POLYMICROGYRIA,SET,5,0.50654,0.0083579,0.40901,0.10778,HP_FRONTAL_POLYMICROGYRIA,0.852103783416402
GSE15330_LYMPHOID_MULTIPOTEN...4,SET,180,0.077022,0.0075886,0.062194,0.10779,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.852103783416402
MODULE_114,SET,290,0.057935,0.0072233,0.046784,0.1078,MODULE_114,0.852103783416402
GOBP_VASCULAR_ASSOCIATED_SMO...6,SET,24,0.22693,0.0081991,0.18327,0.10782,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION,0.852103783416402
GSE360_DC_VS_MAC_L_DONOVANI_...1,SET,174,0.07636,0.0073982,0.061668,0.10782,GSE360_DC_VS_MAC_L_DONOVANI_DN,0.852103783416402
GSE17721_POLYIC_VS_CPG_12H_B...2,SET,178,0.079428,0.0077825,0.064155,0.10785,GSE17721_POLYIC_VS_CPG_12H_BMDC_UP,0.852103783416402
BIOCARTA_BARRESTIN_PATHWAY,SET,11,0.34593,0.0084646,0.27944,0.10788,BIOCARTA_BARRESTIN_PATHWAY,0.852103783416402
OHM_EMBRYONIC_CARCINOMA_DN,SET,8,0.42328,0.0088334,0.34199,0.10792,OHM_EMBRYONIC_CARCINOMA_DN,0.852103783416402
GOBP_REGULATION_OF_CYTOKINES...,SET,87,0.11029,0.007574,0.089109,0.10792,GOBP_REGULATION_OF_CYTOKINESIS,0.852103783416402
GOBP_DNA_REPLICATION_SYNTHES...,SET,6,0.37559,0.0067884,0.30351,0.10796,GOBP_DNA_REPLICATION_SYNTHESIS_OF_PRIMER,0.852103783416402
REACTOME_G0_AND_EARLY_G1,SET,27,0.18506,0.0070913,0.14955,0.10797,REACTOME_G0_AND_EARLY_G1,0.852103783416402
YAGI_AML_WITH_11Q23_REARRANG...,SET,305,0.059888,0.0076543,0.048401,0.10799,YAGI_AML_WITH_11Q23_REARRANGED,0.852103783416402
LEE_LIVER_CANCER_DENA_DN,SET,71,0.12492,0.0077531,0.10097,0.10801,LEE_LIVER_CANCER_DENA_DN,0.852103783416402
WP_IL3_SIGNALING,SET,46,0.16203,0.0080999,0.13097,0.10803,WP_IL3_SIGNALING,0.852103783416402
GOBP_NEGATIVE_REGULATION_OF_...398,SET,11,0.33052,0.0080876,0.26718,0.10803,GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.852103783416402
STK33_SKM_DN,SET,239,0.068787,0.0077968,0.055602,0.10803,STK33_SKM_DN,0.852103783416402
WP_EICOSANOID_METABOLISM_VIA...3,SET,28,0.19849,0.0077454,0.16045,0.10804,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.852103783416402
GOMF_POTASSIUM_CHANNEL_INHIB...,SET,5,0.47719,0.0078736,0.38575,0.10804,GOMF_POTASSIUM_CHANNEL_INHIBITOR_ACTIVITY,0.852103783416402
MODULE_532,SET,366,0.054616,0.0076337,0.044153,0.10806,MODULE_532,0.852103783416402
WP_15Q25_COPY_NUMBER_VARIATI...,SET,42,0.17699,0.0084553,0.14309,0.10807,WP_15Q25_COPY_NUMBER_VARIATION,0.852103783416402
MODULE_378,SET,393,0.052962,0.0076651,0.042822,0.10809,MODULE_378,0.852103783416402
GSE17721_4H_VS_24H_POLYIC_BM...1,SET,179,0.075324,0.0074009,0.060917,0.10815,GSE17721_4H_VS_24H_POLYIC_BMDC_DN,0.852103783416402
WP_GLUCOCORTICOID_BIOSYNTHES...,SET,14,0.31779,0.0087719,0.25703,0.10816,WP_GLUCOCORTICOID_BIOSYNTHESIS,0.852103783416402
HP_ABNORMALITY_OF_LYSOSOMAL_...,SET,8,0.39073,0.0081542,0.31603,0.10817,HP_ABNORMALITY_OF_LYSOSOMAL_METABOLISM,0.852103783416402
HP_ABNORMALITY_OF_THE_PROXIM...1,SET,4,0.5125,0.0075636,0.41455,0.10818,HP_ABNORMALITY_OF_THE_PROXIMAL_PHALANX_OF_THE_5TH_FINGER,0.852103783416402
REACTOME_JNK_C_JUN_KINASES_P...,SET,18,0.26079,0.0081615,0.21095,0.10819,REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,0.852103783416402
GSE43863_NAIVE_VS_MEMORY_TFH...2,SET,178,0.078025,0.0076451,0.06312,0.10821,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP,0.852103783416402
MIR1255B_2_3P,SET,78,0.11215,0.0072944,0.090733,0.10822,MIR1255B_2_3P,0.852103783416402
GSE30083_SP1_VS_SP3_THYMOCYT...2,SET,178,0.081926,0.0080273,0.066279,0.10822,GSE30083_SP1_VS_SP3_THYMOCYTE_UP,0.852103783416402
PID_AR_PATHWAY,SET,57,0.1366,0.007599,0.11053,0.10826,PID_AR_PATHWAY,0.852225662514156
MCM5_TARGET_GENES,SET,7,0.39014,0.0076162,0.3158,0.10835,MCM5_TARGET_GENES,0.852577457627119
GAVISH_3CA_METAPROGRAM_CD8_T...8,SET,44,0.17242,0.0084302,0.13958,0.10838,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_MEMORY_NAIVE_1,0.852577457627119
GOMF_UBIQUITIN_CONJUGATING_E...,SET,28,0.19515,0.0076151,0.15801,0.10841,GOMF_UBIQUITIN_CONJUGATING_ENZYME_BINDING,0.852577457627119
BURTON_ADIPOGENESIS_PEAK_AT_...5,SET,38,0.17771,0.0080764,0.14391,0.10844,BURTON_ADIPOGENESIS_PEAK_AT_8HR,0.852577457627119
REACTOME_N_GLYCAN_TRIMMING_I...,SET,33,0.1745,0.0073912,0.14131,0.10844,REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,0.852577457627119
OKAWA_NEUROBLASTOMA_1P36_31_...,SET,22,0.38084,0.013175,0.30849,0.10851,OKAWA_NEUROBLASTOMA_1P36_31_DELETION,0.852577457627119
BIOCARTA_STAT3_PATHWAY,SET,8,0.42829,0.008938,0.34692,0.10851,BIOCARTA_STAT3_PATHWAY,0.852577457627119
HP_ABNORMAL_CIRCULATING_INHI...,SET,6,0.50885,0.0091971,0.4122,0.10852,HP_ABNORMAL_CIRCULATING_INHIBIN_B_CONCENTRATION,0.852577457627119
MIR4537,SET,6,0.43365,0.0078378,0.35132,0.10854,MIR4537,0.852577457627119
HP_MINIMAL_CHANGE_GLOMERULON...,SET,34,0.17374,0.0074693,0.14076,0.10855,HP_MINIMAL_CHANGE_GLOMERULONEPHRITIS,0.852577457627119
HP_Y_SHAPED_METACARPALS,SET,12,0.25665,0.0065589,0.20795,0.10858,HP_Y_SHAPED_METACARPALS,0.852620402169001
HP_MUSCLE_FIBER_INCLUSION_BO...,SET,36,0.17104,0.0075662,0.13861,0.10861,HP_MUSCLE_FIBER_INCLUSION_BODIES,0.852663327309691
REACTOME_GABA_B_RECEPTOR_ACT...,SET,43,0.16898,0.0081681,0.13697,0.10866,REACTOME_GABA_B_RECEPTOR_ACTIVATION,0.852863211382114
MODULE_1,SET,334,0.061478,0.0082159,0.049836,0.10869,MODULE_1,0.85290606231655
GOMF_DNA_POLYMERASE_BINDING,SET,19,0.19074,0.0061326,0.15467,0.10876,GOMF_DNA_POLYMERASE_BINDING,0.85292047146402
GOBP_REGULATION_OF_SUBSTRATE...,SET,58,0.13731,0.0077052,0.11135,0.10877,GOBP_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.85292047146402
GSE24574_BCL6_HIGH_VS_LOW_TF...2,SET,183,0.077635,0.0077119,0.062962,0.10879,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP,0.85292047146402
GSE9006_HEALTHY_VS_TYPE_1_DI...5,SET,178,0.082252,0.0080592,0.066707,0.10879,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN,0.85292047146402
REACTOME_NR1H2_NR1H3_REGULAT...2,SET,9,0.31187,0.0069031,0.25299,0.10884,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS,0.853084379217274
GSE22886_DAY0_VS_DAY7_MONOCY...1,SET,182,0.076881,0.0076163,0.062376,0.10888,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN,0.853084379217274
GSE22611_UNSTIM_VS_2H_MDP_ST...2,SET,177,0.0752,0.0073477,0.061016,0.1089,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.853084379217274
WEBER_METHYLATED_HCP_IN_SPER...2,SET,16,0.24183,0.0071358,0.19626,0.10894,WEBER_METHYLATED_HCP_IN_SPERM_UP,0.853084379217274
GOBP_REGULATION_OF_MONOATOMI...1,SET,6,0.47599,0.0086032,0.38631,0.10895,GOBP_REGULATION_OF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORT,0.853084379217274
GOBP_PHOTORECEPTOR_CELL_OUTE...,SET,12,0.28621,0.0073145,0.23232,0.10899,GOBP_PHOTORECEPTOR_CELL_OUTER_SEGMENT_ORGANIZATION,0.853084379217274
HP_ABNORMAL_SPINAL_CORD_MORP...,SET,274,0.06383,0.007739,0.051821,0.10903,HP_ABNORMAL_SPINAL_CORD_MORPHOLOGY,0.853084379217274
GOBP_N_ACETYLNEURAMINATE_CAT...,SET,6,0.45263,0.0081808,0.36748,0.10904,GOBP_N_ACETYLNEURAMINATE_CATABOLIC_PROCESS,0.853084379217274
STEGER_ADIPOGENESIS_UP,SET,21,0.2421,0.008183,0.19659,0.10907,STEGER_ADIPOGENESIS_UP,0.853084379217274
KOINUMA_COLON_CANCER_MSI_DN,SET,8,0.39097,0.0081592,0.31749,0.10909,KOINUMA_COLON_CANCER_MSI_DN,0.853084379217274
HP_ABNORMAL_ORAL_MUCOSA_MORP...,SET,336,0.059367,0.0079571,0.048209,0.10909,HP_ABNORMAL_ORAL_MUCOSA_MORPHOLOGY,0.853084379217274
GOBP_CHROMOSOME_ORGANIZATION,SET,543,0.04282,0.007254,0.034777,0.10912,GOBP_CHROMOSOME_ORGANIZATION,0.853084379217274
HP_THENAR_MUSCLE_WEAKNESS,SET,4,0.58786,0.0086757,0.47746,0.10913,HP_THENAR_MUSCLE_WEAKNESS,0.853084379217274
BYSTRYKH_HEMATOPOIESIS_STEM_...3,SET,7,0.3738,0.0072972,0.30365,0.10917,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3,0.85320516078255
WAKABAYASHI_ADIPOGENESIS_PPA...1,SET,28,0.19136,0.0074672,0.15552,0.10927,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,0.853346834306242
GSE40441_NRP1_POS_INDUCED_TR...2,SET,184,0.079344,0.007903,0.064485,0.10928,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_UP,0.853346834306242
BIOCARTA_FLUMAZENIL_PATHWAY,SET,8,0.39106,0.008161,0.31784,0.10929,BIOCARTA_FLUMAZENIL_PATHWAY,0.853346834306242
GOBP_STEROID_HORMONE_MEDIATE...,SET,122,0.092812,0.0075403,0.075442,0.10931,GOBP_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.853346834306242
WP_WNT_SIGNALING_WP363,SET,51,0.14884,0.0078335,0.12099,0.10932,WP_WNT_SIGNALING_WP363,0.853346834306242
REACTOME_SARS_COV_1_INFECTION,SET,129,0.087615,0.007318,0.071227,0.10934,REACTOME_SARS_COV_1_INFECTION,0.853346834306242
GOMF_DNA_DNA_ANNEALING_ACTIV...,SET,7,0.40147,0.0078374,0.3264,0.10936,GOMF_DNA_DNA_ANNEALING_ACTIVITY,0.853346834306242
GGGTGGRR_PAX4_03,SET,1156,0.031902,0.0077487,0.025944,0.10942,GGGTGGRR_PAX4_03,0.853565971755212
HP_POOR_WOUND_HEALING,SET,40,0.16157,0.0075329,0.13142,0.10947,HP_POOR_WOUND_HEALING,0.853565971755212
WP_LNCRNAMEDIATED_MECHANISMS...,SET,6,0.41911,0.007575,0.34094,0.1095,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,0.853565971755212
MIR133A_3P_MIR133B,SET,222,0.066704,0.0072901,0.054268,0.10951,MIR133A_3P_MIR133B,0.853565971755212
GOBP_DEFENSE_RESPONSE_TO_BAC...,SET,273,0.069761,0.0084429,0.056757,0.10952,GOBP_DEFENSE_RESPONSE_TO_BACTERIUM,0.853565971755212
MODULE_429,SET,14,0.27006,0.0074544,0.21976,0.10956,MODULE_429,0.853565971755212
GOMF_UDP_GALACTOSE_BETA_N_AC...,SET,12,0.3266,0.0083469,0.26577,0.10956,GOMF_UDP_GALACTOSE_BETA_N_ACETYLGLUCOSAMINE_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,0.853565971755212
GOBP_KERATINOCYTE_PROLIFERAT...,SET,56,0.15038,0.0082921,0.12241,0.10964,GOBP_KERATINOCYTE_PROLIFERATION,0.853725384615385
HP_EMG_SLOW_MOTOR_CONDUCTION,SET,5,0.42419,0.006999,0.34529,0.10964,HP_EMG_SLOW_MOTOR_CONDUCTION,0.853725384615385
FLETCHER_PBMC_BCG_10W_INFANT...1,SET,233,0.070919,0.0079381,0.057738,0.10968,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN,0.853725384615385
RADAEVA_RESPONSE_TO_IFNA1_UP,SET,46,0.15431,0.0077141,0.12568,0.10977,RADAEVA_RESPONSE_TO_IFNA1_UP,0.853725384615385
GOBP_REGULATION_OF_NATURAL_K...4,SET,8,0.37739,0.0078758,0.30737,0.10977,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.853725384615385
KEGG_MEDICUS_VARIANT_MUTATIO...11,SET,13,0.27953,0.0074352,0.22768,0.10978,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY,0.853725384615385
GOMF_NUCLEASE_ACTIVITY,SET,197,0.070238,0.0072362,0.057212,0.10979,GOMF_NUCLEASE_ACTIVITY,0.853725384615385
GSE13522_CTRL_VS_T_CRUZI_BRA...2,SET,130,0.094504,0.0079238,0.076983,0.10981,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP,0.853725384615385
MIR4776_5P,SET,44,0.15291,0.0074762,0.12457,0.10983,MIR4776_5P,0.853725384615385
GOCC_MIDBODY,SET,185,0.071934,0.0071841,0.058602,0.10983,GOCC_MIDBODY,0.853725384615385
GOBP_RESPONSE_TO_LIGHT_STIMU...,SET,288,0.060159,0.007475,0.049025,0.1099,GOBP_RESPONSE_TO_LIGHT_STIMULUS,0.853725384615385
CAIRO_HEPATOBLASTOMA_CLASSES...2,SET,559,0.041934,0.0072047,0.034177,0.10992,CAIRO_HEPATOBLASTOMA_CLASSES_UP,0.853725384615385
GOBP_SPHINGOID_BIOSYNTHETIC_...,SET,13,0.30161,0.0080226,0.24581,0.10992,GOBP_SPHINGOID_BIOSYNTHETIC_PROCESS,0.853725384615385
GSE33292_DN3_THYMOCYTE_VS_TC...1,SET,183,0.077999,0.007748,0.063589,0.10999,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN,0.853725384615385
GOBP_LEUKOCYTE_MIGRATION_INV...,SET,19,0.24563,0.0078973,0.20026,0.11001,GOBP_LEUKOCYTE_MIGRATION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.853725384615385
GSE32255_WT_UNSTIM_VS_JMJD2D...2,SET,159,0.082134,0.00761,0.066984,0.11007,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,0.853725384615385
REACTOME_SYNTHESIS_OF_PIPS_A...2,SET,5,0.48003,0.0079204,0.39149,0.11008,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE,0.853725384615385
MIR574_3P,SET,5,0.50787,0.0083798,0.41425,0.1101,MIR574_3P,0.853725384615385
KEGG_MEDICUS_VARIANT_MUTATIO...53,SET,5,0.46517,0.0076753,0.37944,0.11012,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_PERK_ATF4_SIGNALING_PATHWAY,0.853725384615385
RUAN_RESPONSE_TO_TROGLITAZON...2,SET,24,0.23832,0.0086107,0.19442,0.11014,RUAN_RESPONSE_TO_TROGLITAZONE_UP,0.853725384615385
GSE20366_TREG_VS_TCONV_DN,SET,179,0.078953,0.0077575,0.064407,0.11014,GSE20366_TREG_VS_TCONV_DN,0.853725384615385
KEGG_MEDICUS_PATHOGEN_HIV_GP...4,SET,13,0.27174,0.0072281,0.22169,0.11015,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY,0.853725384615385
GOBP_ANTIGEN_PROCESSING_AND_...2,SET,5,0.7594,0.01253,0.61958,0.11017,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_ENDOGENOUS_LIPID_ANTIGEN_VIA_MHC_CLASS_IB,0.853725384615385
GOMF_LIPID_ANTIGEN_BINDING,SET,5,0.7594,0.01253,0.61958,0.11017,GOMF_LIPID_ANTIGEN_BINDING,0.853725384615385
MIR6840_3P,SET,154,0.08153,0.0074353,0.066543,0.11025,MIR6840_3P,0.85376581054036
REACTOME_WNT5A_DEPENDENT_INT...1,SET,13,0.27515,0.0073189,0.22459,0.11027,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2,0.85376581054036
PID_ANGIOPOIETIN_RECEPTOR_PA...,SET,47,0.14929,0.0075436,0.12186,0.11028,PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,0.85376581054036
GSE3720_UNSTIM_VS_LPS_STIM_V...4,SET,143,0.087259,0.0076707,0.071231,0.11029,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP,0.85376581054036
REACTOME_INSERTION_OF_TAIL_A...,SET,18,0.23052,0.007214,0.18822,0.11035,REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE,0.85376581054036
GOBP_REGULATION_OF_NK_T_CELL...1,SET,11,0.35969,0.0088013,0.29369,0.11035,GOBP_REGULATION_OF_NK_T_CELL_ACTIVATION,0.85376581054036
GSE13411_IGM_MEMORY_BCELL_VS...2,SET,178,0.078624,0.0077038,0.064199,0.11035,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP,0.85376581054036
MIR5589_5P,SET,67,0.12745,0.0076848,0.10409,0.11041,MIR5589_5P,0.85376581054036
CHAUHAN_RESPONSE_TO_METHOXYE...1,SET,83,0.11047,0.0074108,0.09023,0.11042,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,0.85376581054036
HP_CORTICAL_CATARACT,SET,10,0.33122,0.0077278,0.27056,0.11044,HP_CORTICAL_CATARACT,0.85376581054036
HES4_TARGET_GENES,SET,489,0.047246,0.0076069,0.038597,0.11047,HES4_TARGET_GENES,0.85376581054036
HP_ABNORMAL_URINE_OSMOLALITY,SET,6,0.48135,0.0087,0.39324,0.11047,HP_ABNORMAL_URINE_OSMOLALITY,0.85376581054036
GOMF_FLIPPASE_ACTIVITY,SET,15,0.26706,0.0076301,0.21824,0.11054,GOMF_FLIPPASE_ACTIVITY,0.854116874166296
GSE32901_TH1_VS_TH17_NEG_CD4...1,SET,104,0.10032,0.0075288,0.081993,0.11058,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN,0.854220206391478
KEGG_MEDICUS_VARIANT_LMO2_RE...1,SET,5,0.47818,0.0078898,0.39087,0.11061,KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_ACTIVATION,0.854220206391478
WILCOX_RESPONSE_TO_PROGESTER...1,SET,57,0.13966,0.0077695,0.11419,0.11067,WILCOX_RESPONSE_TO_PROGESTERONE_DN,0.854220206391478
GSE25088_CTRL_VS_IL4_STIM_MA...1,SET,174,0.077087,0.0074686,0.063037,0.11069,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN,0.854220206391478
ZHONG_PFC_HES1_POS_C1_NPC,SET,6,0.43998,0.0079522,0.3598,0.1107,ZHONG_PFC_HES1_POS_C1_NPC,0.854220206391478
GSE15735_CTRL_VS_HDAC_INHIBI...3,SET,178,0.078447,0.0076864,0.064154,0.11071,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN,0.854220206391478
GSE24634_NAIVE_CD4_TCELL_VS_...7,SET,178,0.0734,0.0071919,0.060035,0.11074,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN,0.854220206391478
GOBP_NEGATIVE_REGULATION_OF_...680,SET,10,0.33066,0.0077146,0.27046,0.11075,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.854220206391478
chr3p22,SET,78,0.23132,0.015045,0.18924,0.1108,chr3p22,0.854345575515635
KEGG_MEDICUS_VARIANT_IGF2_OV...,SET,14,0.27318,0.0075405,0.22352,0.11082,KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,0.854345575515635
REACTOME_MAP3K8_TPL2_DEPENDE...,SET,14,0.26358,0.0072756,0.21568,0.11084,REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION,0.854345575515635
HP_CALF_MUSCLE_HYPERTROPHY,SET,42,0.16797,0.0080244,0.13751,0.11095,HP_CALF_MUSCLE_HYPERTROPHY,0.854891332298825
UNTERMAN_PROGRESSIVE_VS_STAB...2,SET,12,0.36405,0.0093038,0.29804,0.11096,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_CD8T_DN,0.854891332298825
HP_DECREASED_CIRCULATING_COM...1,SET,33,0.18614,0.0078843,0.15241,0.11099,HP_DECREASED_CIRCULATING_COMPLEMENT_C3_CONCENTRATION,0.854932945478723
GOBP_MYELOID_LEUKOCYTE_CYTOK...,SET,47,0.15647,0.0079065,0.12816,0.11107,GOBP_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION,0.855330093002657
GOBP_NEGATIVE_REGULATION_OF_...603,SET,11,0.33342,0.0081586,0.27315,0.11111,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,0.855330093002657
NIKOLSKY_BREAST_CANCER_5P15_...,SET,25,0.3962,0.01461,0.32461,0.11114,NIKOLSKY_BREAST_CANCER_5P15_AMPLICON,0.855330093002657
GOMF_DELTA_CATENIN_BINDING,SET,9,0.36865,0.0081597,0.30203,0.11114,GOMF_DELTA_CATENIN_BINDING,0.855330093002657
GOBP_MALE_SEX_DETERMINATION,SET,11,0.33744,0.0082568,0.27658,0.11124,GOBP_MALE_SEX_DETERMINATION,0.855519500883392
HP_ABNORMAL_MATERNAL_SERUM_S...,SET,6,0.46262,0.0083615,0.37925,0.11127,HP_ABNORMAL_MATERNAL_SERUM_SCREENING,0.855519500883392
MIR6744_3P,SET,56,0.14236,0.00785,0.11671,0.11128,MIR6744_3P,0.855519500883392
GOBP_POSITIVE_REGULATION_OF_...211,SET,68,0.11845,0.0071953,0.097118,0.1113,GOBP_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.855519500883392
MULLIGHAN_MLL_SIGNATURE_1_DN,SET,216,0.071994,0.0077626,0.059031,0.11132,MULLIGHAN_MLL_SIGNATURE_1_DN,0.855519500883392
HP_DIMPLE_CHIN,SET,14,0.29921,0.0082589,0.24539,0.11137,HP_DIMPLE_CHIN,0.855519500883392
HP_GLOMERULOPATHY,SET,30,0.20521,0.008288,0.1683,0.11137,HP_GLOMERULOPATHY,0.855519500883392
GSE20715_0H_VS_48H_OZONE_LUN...2,SET,180,0.077476,0.0076334,0.063548,0.11139,GSE20715_0H_VS_48H_OZONE_LUNG_UP,0.855519500883392
REACTOME_ACTIVATED_NTRK3_SIG...2,SET,8,0.31449,0.0065631,0.25798,0.11142,REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS,0.855519500883392
GSE13522_CTRL_VS_T_CRUZI_Y_S...8,SET,146,0.084763,0.0075284,0.069537,0.11144,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_UP,0.855519500883392
GSE3982_MEMORY_CD4_TCELL_VS_...1,SET,174,0.077309,0.0074901,0.063422,0.11144,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN,0.855519500883392
GSE29618_LAIV_VS_TIV_FLU_VAC...5,SET,173,0.075551,0.0072989,0.061985,0.11146,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN,0.855519500883392
KEGG_MEDICUS_REFERENCE_GLUCO...,SET,5,0.40957,0.0067578,0.33615,0.11154,KEGG_MEDICUS_REFERENCE_GLUCONEOGENESIS,0.855737502755125
DESCARTES_MAIN_FETAL_HORIZON...,SET,26,0.21144,0.0079509,0.17355,0.11156,DESCARTES_MAIN_FETAL_HORIZONTAL_CELLS,0.855737502755125
HP_NONPROGRESSIVE,SET,18,0.23133,0.0072395,0.18989,0.11157,HP_NONPROGRESSIVE,0.855737502755125
REACTOME_REGULATION_OF_LIPID...,SET,114,0.093114,0.0073142,0.076446,0.11161,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,0.855737502755125
GOBP_NUCLEAR_MRNA_SURVEILLAN...,SET,10,0.26787,0.0062498,0.21998,0.11167,GOBP_NUCLEAR_MRNA_SURVEILLANCE,0.855737502755125
HP_ARACHNODACTYLY,SET,109,0.098887,0.0075965,0.081205,0.11167,HP_ARACHNODACTYLY,0.855737502755125
KEGG_MEDICUS_PATHOGEN_HIV_NE...,SET,12,0.27628,0.0070608,0.2269,0.11169,KEGG_MEDICUS_PATHOGEN_HIV_NEF_TO_TNF_NFKB_SIGNALING_PATHWAY,0.855737502755125
GOBP_RESPONSE_TO_LEUKEMIA_IN...,SET,92,0.1118,0.0078938,0.091818,0.1117,GOBP_RESPONSE_TO_LEUKEMIA_INHIBITORY_FACTOR,0.855737502755125
GOMF_ALL_TRANS_RETINOL_DEHYD...,SET,13,0.29691,0.0078977,0.24386,0.11171,GOMF_ALL_TRANS_RETINOL_DEHYDROGENASE_NADPPLUS_ACTIVITY,0.855737502755125
GOBP_MEDIUM_CHAIN_FATTY_ACYL...,SET,6,0.41784,0.0075522,0.34327,0.11176,GOBP_MEDIUM_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS,0.855790224570674
MIR500A_3P,SET,71,0.12867,0.0079856,0.10571,0.11178,MIR500A_3P,0.855790224570674
GOBP_LACTONE_METABOLIC_PROCE...,SET,12,0.32741,0.0083676,0.26904,0.11181,GOBP_LACTONE_METABOLIC_PROCESS,0.855790224570674
GOBP_INTRACILIARY_TRANSPORT_...,SET,6,0.42135,0.0076155,0.34625,0.11183,GOBP_INTRACILIARY_TRANSPORT_INVOLVED_IN_CILIUM_ASSEMBLY,0.855790224570674
HP_ONYCHOMYCOSIS,SET,20,0.24555,0.0080996,0.20179,0.11184,HP_ONYCHOMYCOSIS,0.855790224570674
REACTOME_TRANSCRIPTIONAL_REG...12,SET,30,0.19789,0.0079925,0.16267,0.1119,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,0.855913564356436
GOBP_CELLULAR_RESPONSE_TO_ATP,SET,16,0.27074,0.0079888,0.22257,0.11192,GOBP_CELLULAR_RESPONSE_TO_ATP,0.855913564356436
REACTOME_NUCLEAR_SIGNALING_B...,SET,30,0.17666,0.0071349,0.14523,0.11193,REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,0.855913564356436
HP_MUSCLE_FIBER_NECROSIS,SET,10,0.32121,0.007494,0.26415,0.112,HP_MUSCLE_FIBER_NECROSIS,0.855987289433384
GSE22443_NAIVE_VS_ACT_AND_IL...2,SET,186,0.075041,0.0075144,0.061731,0.11207,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_UP,0.855987289433384
GOBP_RESPONSE_TO_POTASSIUM_I...,SET,18,0.25948,0.0081203,0.21346,0.11209,GOBP_RESPONSE_TO_POTASSIUM_ION,0.855987289433384
PRC2_SUZ12_UP.V1_DN,SET,168,0.080972,0.0077099,0.066624,0.11212,PRC2_SUZ12_UP.V1_DN,0.855987289433384
MIR7852_3P,SET,66,0.12462,0.0074583,0.10255,0.11214,MIR7852_3P,0.855987289433384
TURJANSKI_MAPK7_TARGETS,SET,7,0.43121,0.008418,0.35486,0.11216,TURJANSKI_MAPK7_TARGETS,0.855987289433384
REACTOME_PI3K_EVENTS_IN_ERBB...1,SET,16,0.2572,0.0075891,0.21166,0.11216,REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,0.855987289433384
HP_ANTIMITOCHONDRIAL_ANTIBOD...,SET,11,0.36472,0.0089243,0.30031,0.11229,HP_ANTIMITOCHONDRIAL_ANTIBODY_POSITIVITY,0.855987289433384
TRAVAGLINI_LUNG_CAPILLARY_AE...,SET,41,0.16794,0.0079272,0.13829,0.1123,TRAVAGLINI_LUNG_CAPILLARY_AEROCYTE_CELL,0.855987289433384
WP_METABOLISM_OF_SPHINGOLIPI...,SET,21,0.23588,0.0079728,0.19425,0.11232,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,0.855987289433384
GAL_LEUKEMIC_STEM_CELL_UP,SET,110,0.097919,0.0075563,0.080649,0.11235,GAL_LEUKEMIC_STEM_CELL_UP,0.855987289433384
GOBP_RESPONSE_TO_FATTY_ACID,SET,54,0.15288,0.0082786,0.12591,0.11235,GOBP_RESPONSE_TO_FATTY_ACID,0.855987289433384
GARCIA_TARGETS_OF_FLI1_AND_D...2,SET,46,0.1342,0.0067089,0.11057,0.11244,GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,0.855987289433384
GOBP_RESPONSE_TO_BLUE_LIGHT,SET,6,0.41089,0.0074265,0.33856,0.11245,GOBP_RESPONSE_TO_BLUE_LIGHT,0.855987289433384
HP_FOLLICULAR_THYROID_CARCIN...,SET,16,0.23931,0.0070614,0.19718,0.11245,HP_FOLLICULAR_THYROID_CARCINOMA,0.855987289433384
REACTOME_CONSTITUTIVE_SIGNAL...3,SET,15,0.23165,0.0066184,0.19088,0.11246,REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII,0.855987289433384
BARHL1_TARGET_GENES,SET,1039,0.032084,0.0074131,0.026437,0.11246,BARHL1_TARGET_GENES,0.855987289433384
MIR16_1_3P,SET,173,0.077012,0.0074401,0.063461,0.11247,MIR16_1_3P,0.855987289433384
CREB_Q3,SET,238,0.066777,0.0075533,0.055028,0.11247,CREB_Q3,0.855987289433384
HP_ABNORMAL_SCLERA_MORPHOLOGY,SET,127,0.087625,0.0072623,0.072206,0.11247,HP_ABNORMAL_SCLERA_MORPHOLOGY,0.855987289433384
GOBP_RESPONSE_TO_LECTIN,SET,20,0.24929,0.0082231,0.20543,0.11248,GOBP_RESPONSE_TO_LECTIN,0.855987289433384
RAMASWAMY_METASTASIS_UP,SET,60,0.12715,0.0072568,0.10481,0.11254,RAMASWAMY_METASTASIS_UP,0.855987289433384
GSE17721_0.5H_VS_4H_POLYIC_B...2,SET,182,0.071186,0.0070521,0.058678,0.11254,GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP,0.855987289433384
GSE12963_UNINF_VS_ENV_AND_NE...1,SET,121,0.091523,0.0074052,0.075443,0.11255,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.855987289433384
HELLER_HDAC_TARGETS_SILENCED...1,SET,257,0.065919,0.0077441,0.054346,0.11258,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,0.855987289433384
MIR3125,SET,220,0.067998,0.0073985,0.05606,0.11258,MIR3125,0.855987289433384
MIR6887_5P,SET,120,0.093165,0.0075071,0.076828,0.11264,MIR6887_5P,0.855998557377049
GOBP_GLYCEROL_TRANSMEMBRANE_...,SET,7,0.47263,0.0092266,0.38981,0.11267,GOBP_GLYCEROL_TRANSMEMBRANE_TRANSPORT,0.855998557377049
GOMF_GLYCEROL_TRANSMEMBRANE_...,SET,7,0.47263,0.0092266,0.38981,0.11267,GOMF_GLYCEROL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.855998557377049
GOBP_NON_MOTILE_CILIUM_ASSEM...,SET,60,0.12752,0.0072777,0.10518,0.11268,GOBP_NON_MOTILE_CILIUM_ASSEMBLY,0.855998557377049
GOBP_BUNDLE_OF_HIS_CELL_TO_P...2,SET,7,0.45633,0.0089083,0.37642,0.11271,GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_SIGNALING,0.856039346590909
KEGG_MEDICUS_REFERENCE_P300_...,SET,15,0.25431,0.0072659,0.20983,0.11276,KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S,0.856085706486132
GOBP_BRANCHED_CHAIN_AMINO_AC...4,SET,13,0.29054,0.0077281,0.23972,0.11277,GOBP_BRANCHED_CHAIN_AMINO_ACID_TRANSPORT,0.856085706486132
CHEBOTAEV_GR_TARGETS_DN,SET,109,0.104,0.0079891,0.085815,0.11279,CHEBOTAEV_GR_TARGETS_DN,0.856085706486132
JOHNSTONE_PARVB_TARGETS_2_DN,SET,306,0.061006,0.0078097,0.050351,0.11284,JOHNSTONE_PARVB_TARGETS_2_DN,0.856167157825802
GOBP_REGULATION_OF_PROTEIN_S...1,SET,245,0.067716,0.0077698,0.055892,0.11285,GOBP_REGULATION_OF_PROTEIN_SECRETION,0.856167157825802
HP_ABNORMAL_FOURTH_TOE_MORPH...,SET,8,0.40428,0.008437,0.33373,0.11288,HP_ABNORMAL_FOURTH_TOE_MORPHOLOGY,0.856207856831078
GSE37532_WT_VS_PPARG_KO_VISC...2,SET,172,0.076051,0.0073262,0.062808,0.11299,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP,0.856855214924722
GSE40685_NAIVE_CD4_TCELL_VS_...1,SET,171,0.079881,0.007673,0.06599,0.11305,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN,0.85712320026178
PID_LPA4_PATHWAY,SET,14,0.29745,0.0082103,0.24578,0.1131,PID_LPA4_PATHWAY,0.857315267175572
GSE24634_TEFF_VS_TCONV_DAY7_...1,SET,183,0.078983,0.0078458,0.065285,0.11318,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN,0.857734605320541
GOMF_LACTATE_TRANSMEMBRANE_T...,SET,6,0.47041,0.0085023,0.38901,0.11329,GOMF_LACTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.858087399259421
HP_ABNORMAL_RESPONSE_TO_INSU...,SET,8,0.3685,0.0076902,0.30474,0.1133,HP_ABNORMAL_RESPONSE_TO_INSULIN_TOLERANCE_TEST,0.858087399259421
DIDO1_TARGET_GENES,SET,1307,0.028678,0.007374,0.023719,0.11333,DIDO1_TARGET_GENES,0.858087399259421
GOBP_NOTCH_SIGNALING_PATHWAY,SET,164,0.081961,0.0077114,0.067795,0.11335,GOBP_NOTCH_SIGNALING_PATHWAY,0.858087399259421
GSE17721_LPS_VS_POLYIC_12H_B...1,SET,187,0.073223,0.0073519,0.060567,0.11335,GSE17721_LPS_VS_POLYIC_12H_BMDC_DN,0.858087399259421
GOBP_POSITIVE_REGULATION_OF_...162,SET,9,0.31135,0.0068915,0.25762,0.11342,GOBP_POSITIVE_REGULATION_OF_CHROMATIN_BINDING,0.858323699673558
GSE13738_RESTING_VS_TCR_ACTI...1,SET,178,0.075476,0.0073952,0.062457,0.11345,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN,0.858323699673558
GSE17721_LPS_VS_CPG_8H_BMDC_...1,SET,167,0.076736,0.0072849,0.063507,0.11347,GSE17721_LPS_VS_CPG_8H_BMDC_DN,0.858323699673558
DESCARTES_MAIN_FETAL_INHIBIT...1,SET,25,0.23124,0.0085267,0.19138,0.11348,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.858323699673558
GOBP_POSITIVE_REGULATION_OF_...18,SET,67,0.13562,0.0081773,0.11229,0.11358,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.858746313614615
GOBP_C_TERMINAL_PROTEIN_AMIN...,SET,16,0.26381,0.0077842,0.21845,0.1136,GOBP_C_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,0.858746313614615
GOBP_VACUOLE_FUSION,SET,12,0.27503,0.0070287,0.22775,0.11361,GOBP_VACUOLE_FUSION,0.858746313614615
GOMF_CYCLIN_BINDING,SET,33,0.16725,0.0070842,0.13855,0.11369,GOMF_CYCLIN_BINDING,0.859128489130435
GOCC_LATE_ENDOSOME_LUMEN,SET,7,0.39911,0.0077912,0.33064,0.11371,GOCC_LATE_ENDOSOME_LUMEN,0.859128489130435
MIR298,SET,170,0.077637,0.0074358,0.064334,0.11377,MIR298,0.859179076557093
GOCC_CATALYTIC_STEP_1_SPLICE...,SET,10,0.276,0.0064393,0.22874,0.1138,GOCC_CATALYTIC_STEP_1_SPLICEOSOME,0.859179076557093
GSE14000_TRANSLATED_RNA_VS_M...5,SET,161,0.078444,0.0073133,0.065014,0.11381,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN,0.859179076557093
HP_URETERAL_OBSTRUCTION,SET,34,0.16647,0.007157,0.13798,0.11383,HP_URETERAL_OBSTRUCTION,0.859179076557093
GOBP_NK_T_CELL_ACTIVATION,SET,13,0.32945,0.0087633,0.2731,0.11385,GOBP_NK_T_CELL_ACTIVATION,0.859179076557093
NABA_ECM_AFFILIATED,SET,151,0.093285,0.0084248,0.077341,0.11389,NABA_ECM_AFFILIATED,0.859179076557093
GOMF_INOSITOL_TRISPHOSPHATE_...,SET,12,0.25735,0.0065769,0.21341,0.11394,GOMF_INOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.859179076557093
GCTGAGT_MIR5125P,SET,42,0.15153,0.0072391,0.12568,0.11397,GCTGAGT_MIR5125P,0.859179076557093
OUYANG_PROSTATE_CANCER_PROGR...2,SET,18,0.24717,0.0077351,0.205,0.11398,OUYANG_PROSTATE_CANCER_PROGRESSION_UP,0.859179076557093
BROWNE_HCMV_INFECTION_2HR_UP,SET,33,0.20662,0.0087518,0.1714,0.11401,BROWNE_HCMV_INFECTION_2HR_UP,0.859179076557093
WP_MELANOMA,SET,66,0.12152,0.0072726,0.10081,0.11403,WP_MELANOMA,0.859179076557093
GOBP_NEGATIVE_REGULATION_OF_...69,SET,56,0.13463,0.0074237,0.11169,0.11404,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,0.859179076557093
SPIELMAN_LYMPHOBLAST_EUROPEA...3,SET,545,0.042291,0.0071772,0.035089,0.11406,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN,0.859179076557093
GOBP_CELLULAR_RESPONSE_TO_FR...,SET,5,0.40654,0.0067079,0.33732,0.11407,GOBP_CELLULAR_RESPONSE_TO_FRUCTOSE_STIMULUS,0.859179076557093
GSE2585_THYMIC_DC_VS_THYMIC_...1,SET,177,0.075283,0.0073559,0.062497,0.11419,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_DN,0.859179076557093
WP_PHYSIOLOGICAL_AND_PATHOLO...,SET,24,0.22163,0.0080075,0.18401,0.11422,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,0.859179076557093
GOMF_SNAP_RECEPTOR_ACTIVITY,SET,35,0.15843,0.0069105,0.13154,0.11423,GOMF_SNAP_RECEPTOR_ACTIVITY,0.859179076557093
GOBP_POSITIVE_REGULATION_OF_...754,SET,37,0.15183,0.006809,0.12607,0.11424,GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.859179076557093
GOBP_POSITIVE_REGULATION_OF_...144,SET,119,0.098738,0.0079231,0.081989,0.11425,GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,0.859179076557093
GOBP_HOMOSERINE_METABOLIC_PR...,SET,3,0.62386,0.0079738,0.51807,0.11426,GOBP_HOMOSERINE_METABOLIC_PROCESS,0.859179076557093
GOBP_NEURON_RECOGNITION,SET,46,0.1762,0.0088082,0.14633,0.11427,GOBP_NEURON_RECOGNITION,0.859179076557093
REACTOME_SENSORY_PERCEPTION_...1,SET,6,0.47982,0.0086722,0.39848,0.11428,REACTOME_SENSORY_PERCEPTION_OF_SALTY_TASTE,0.859179076557093
GOBP_HYDROCARBON_METABOLIC_P...,SET,7,0.40064,0.0078212,0.33273,0.11429,GOBP_HYDROCARBON_METABOLIC_PROCESS,0.859179076557093
BIOCARTA_CDMAC_PATHWAY,SET,16,0.27468,0.008105,0.22815,0.11431,BIOCARTA_CDMAC_PATHWAY,0.859179076557093
GSE4535_BM_DERIVED_DC_VS_FOL...1,SET,177,0.073636,0.0071949,0.061176,0.11437,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN,0.859444183783784
YIH_RESPONSE_TO_ARSENITE_C5,SET,10,0.35454,0.0082719,0.29462,0.11442,YIH_RESPONSE_TO_ARSENITE_C5,0.859543541082597
GSE12963_ENV_NEF_VS_ENV_NEF_...1,SET,132,0.087499,0.0073923,0.072732,0.11449,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.859543541082597
GOCC_DENSE_CORE_GRANULE_MEMB...,SET,7,0.40107,0.0078295,0.33346,0.11454,GOCC_DENSE_CORE_GRANULE_MEMBRANE,0.859543541082597
GSE37301_COMMON_LYMPHOID_PRO...8,SET,166,0.078126,0.0073949,0.064969,0.11459,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.859543541082597
GOBP_REGULATION_OF_MEIOSIS_I,SET,5,0.40658,0.0067084,0.33811,0.1146,GOBP_REGULATION_OF_MEIOSIS_I,0.859543541082597
GOBP_TELOMERASE_RNA_LOCALIZA...,SET,18,0.21283,0.0066605,0.17703,0.11465,GOBP_TELOMERASE_RNA_LOCALIZATION,0.859543541082597
HP_MOLAR_TOOTH_SIGN_ON_MRI,SET,37,0.14709,0.0065965,0.12235,0.11465,HP_MOLAR_TOOTH_SIGN_ON_MRI,0.859543541082597
KEGG_MEDICUS_REFERENCE_ACH_C...2,SET,20,0.21008,0.0069297,0.17476,0.11466,KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY,0.859543541082597
GOBP_INFLAMMATORY_CELL_APOPT...,SET,21,0.21785,0.0073633,0.18122,0.11466,GOBP_INFLAMMATORY_CELL_APOPTOTIC_PROCESS,0.859543541082597
MANNO_MIDBRAIN_NEUROTYPES_HD...1,SET,516,0.048745,0.008056,0.040549,0.11467,MANNO_MIDBRAIN_NEUROTYPES_HDA1,0.859543541082597
GOBP_ADENOSINE_TRANSPORT,SET,5,0.45071,0.0074365,0.37495,0.11468,GOBP_ADENOSINE_TRANSPORT,0.859543541082597
GSE32255_WT_UNSTIM_VS_JMJD2D...1,SET,155,0.080976,0.0074085,0.067365,0.11468,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,0.859543541082597
HP_SILVER_GRAY_HAIR,SET,6,0.4113,0.0074338,0.34231,0.11478,HP_SILVER_GRAY_HAIR,0.859744702842377
GSE30971_WBP7_HET_VS_KO_MACR...5,SET,179,0.082427,0.0080988,0.068611,0.11481,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN,0.859744702842377
GSE18281_CORTICAL_THYMOCYTE_...2,SET,173,0.081451,0.007869,0.0678,0.11482,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP,0.859744702842377
GSE25123_CTRL_VS_IL4_STIM_PP...1,SET,175,0.078424,0.0076198,0.065283,0.11482,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN,0.859744702842377
GOMF_CARBOHYDRATE_MONOATOMIC...,SET,16,0.25829,0.0076213,0.21503,0.11485,GOMF_CARBOHYDRATE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.859744702842377
REACTOME_TRNA_PROCESSING,SET,96,0.095338,0.0068757,0.07938,0.11488,REACTOME_TRNA_PROCESSING,0.859744702842377
GOMF_LBD_DOMAIN_BINDING,SET,6,0.50074,0.0090504,0.41692,0.11488,GOMF_LBD_DOMAIN_BINDING,0.859744702842377
GOBP_STRESS_GRANULE_DISASSEM...,SET,7,0.33718,0.0065823,0.28078,0.11491,GOBP_STRESS_GRANULE_DISASSEMBLY,0.859784079655544
GOBP_POSITIVE_REGULATION_OF_...675,SET,7,0.41341,0.0080704,0.34431,0.11495,GOBP_POSITIVE_REGULATION_OF_RESPIRATORY_BURST,0.859862782440284
KRAS.50_UP.V1_DN,SET,44,0.15556,0.0076058,0.12957,0.11497,KRAS.50_UP.V1_DN,0.859862782440284
TAGAACC_MIR182,SET,34,0.17484,0.0075166,0.14566,0.11502,TAGAACC_MIR182,0.859941417509142
GOBP_REGULATION_OF_STEROID_H...2,SET,22,0.23072,0.0079815,0.19223,0.11503,GOBP_REGULATION_OF_STEROID_HORMONE_SECRETION,0.859941417509142
WCTCNATGGY_UNKNOWN,SET,69,0.12062,0.0073803,0.10052,0.11509,WCTCNATGGY_UNKNOWN,0.860033946130825
HOWARD_MONOCYTE_INACT_MONOV_...2,SET,203,0.076967,0.0080481,0.064158,0.11515,HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.860033946130825
GOBP_NEGATIVE_REGULATION_OF_...141,SET,5,0.46139,0.0076129,0.38464,0.11517,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.860033946130825
PATEL_SKIN_OF_BODY_ZOSTAVAX_...6,SET,259,0.065861,0.0077668,0.054915,0.11521,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP,0.860033946130825
HP_ABNORMAL_ARACHNOID_MATER_...,SET,48,0.1433,0.0073171,0.11952,0.11528,HP_ABNORMAL_ARACHNOID_MATER_MORPHOLOGY,0.860033946130825
GSE14308_TH2_VS_NATURAL_TREG...2,SET,168,0.07381,0.0070279,0.061566,0.11529,GSE14308_TH2_VS_NATURAL_TREG_UP,0.860033946130825
GOBP_ADRENAL_GLAND_DEVELOPME...,SET,26,0.21915,0.0082408,0.18282,0.11533,GOBP_ADRENAL_GLAND_DEVELOPMENT,0.860033946130825
GSE4590_SMALL_VS_VPREB_POS_L...2,SET,149,0.081167,0.0072821,0.067727,0.11538,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,0.860033946130825
MIR6510_5P,SET,78,0.11123,0.0072342,0.092827,0.11542,MIR6510_5P,0.860033946130825
GOMF_LOW_DENSITY_LIPOPROTEIN...2,SET,15,0.27466,0.0078471,0.22923,0.11543,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,0.860033946130825
GOBP_AMYGDALA_DEVELOPMENT,SET,5,0.44446,0.0073334,0.37096,0.11544,GOBP_AMYGDALA_DEVELOPMENT,0.860033946130825
LIM_MAMMARY_LUMINAL_PROGENIT...2,SET,57,0.13701,0.0076221,0.11438,0.11549,LIM_MAMMARY_LUMINAL_PROGENITOR_UP,0.860033946130825
MIR3678_3P,SET,115,0.099429,0.0078443,0.083007,0.1155,MIR3678_3P,0.860033946130825
HP_REDUCED_FORCED_EXPIRATORY...,SET,27,0.19253,0.0073775,0.16073,0.1155,HP_REDUCED_FORCED_EXPIRATORY_VOLUME_IN_ONE_SECOND,0.860033946130825
GOCC_GOLGI_MEMBRANE,SET,624,0.041358,0.0074938,0.03453,0.11552,GOCC_GOLGI_MEMBRANE,0.860033946130825
GSE19374_UNINF_VS_LISTERIA_I...1,SET,182,0.072484,0.0071807,0.060519,0.11552,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN,0.860033946130825
GSE9650_NAIVE_VS_EXHAUSTED_C...2,SET,182,0.070175,0.0069519,0.058594,0.11554,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP,0.860033946130825
KENNEDY_PBMC_DRYVAX_AGE_18_4...,SET,31,0.18053,0.0074116,0.15074,0.11554,KENNEDY_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_DN,0.860033946130825
CONRAD_GERMLINE_STEM_CELL,SET,8,0.3346,0.0069827,0.27939,0.11555,CONRAD_GERMLINE_STEM_CELL,0.860033946130825
HP_GRANULOMATOSIS,SET,8,0.43537,0.0090857,0.36362,0.1156,HP_GRANULOMATOSIS,0.860033946130825
ADNP_TARGET_GENES,SET,507,0.044396,0.0072748,0.037084,0.11563,ADNP_TARGET_GENES,0.860033946130825
KLF7_TARGET_GENES,SET,735,0.037642,0.007379,0.031447,0.11566,KLF7_TARGET_GENES,0.860033946130825
DESCARTES_MAIN_FETAL_STELLAT...,SET,44,0.16478,0.0080566,0.13767,0.11569,DESCARTES_MAIN_FETAL_STELLATE_CELLS,0.860033946130825
GOMF_U2_SNRNA_BINDING,SET,5,0.4284,0.0070685,0.35795,0.1157,GOMF_U2_SNRNA_BINDING,0.860033946130825
MODULE_317,SET,396,0.051041,0.0074146,0.042651,0.11572,MODULE_317,0.860033946130825
MODULE_51,SET,36,0.19024,0.0084155,0.15897,0.11572,MODULE_51,0.860033946130825
DACOSTA_UV_RESPONSE_VIA_ERCC...7,SET,79,0.11581,0.00758,0.096778,0.11573,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,0.860033946130825
MIR3972,SET,62,0.12475,0.0072372,0.10427,0.11576,MIR3972,0.860033946130825
GSE21670_STAT3_KO_VS_WT_CD4_...6,SET,174,0.081233,0.0078703,0.067893,0.11576,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN,0.860033946130825
REACTOME_BINDING_OF_TCF_LEF_...,SET,8,0.36779,0.0076755,0.30751,0.11585,REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS,0.860303139013453
GSE21927_BALBC_VS_C57BL6_MON...4,SET,181,0.070318,0.0069472,0.058794,0.11586,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP,0.860303139013453
HU_GENOTOXIC_DAMAGE_4HR,SET,34,0.16203,0.0069661,0.13551,0.1159,HU_GENOTOXIC_DAMAGE_4HR,0.860303139013453
HP_SCLEROSIS_OF_SKULL_BASE,SET,13,0.31114,0.0082761,0.26022,0.11592,HP_SCLEROSIS_OF_SKULL_BASE,0.860303139013453
LAKE_ADULT_KIDNEY_C4_PROXIMA...,SET,159,0.087707,0.0081264,0.073353,0.11592,LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2,0.860303139013453
HP_FOCAL_CLONIC_SEIZURE,SET,39,0.15835,0.0072903,0.13246,0.11597,HP_FOCAL_CLONIC_SEIZURE,0.860490467549103
GCGSCMNTTT_UNKNOWN,SET,62,0.12497,0.0072495,0.10458,0.11606,GCGSCMNTTT_UNKNOWN,0.860974450373533
HP_FIBULAR_APLASIA,SET,6,0.46065,0.0083258,0.38554,0.11609,HP_FIBULAR_APLASIA,0.861013220230474
GOBP_POSITIVE_REGULATION_OF_...129,SET,13,0.28874,0.0076802,0.24171,0.11614,GOBP_POSITIVE_REGULATION_OF_CELL_FATE_COMMITMENT,0.861090710324232
GOCC_PLATELET_DENSE_TUBULAR_...1,SET,10,0.30256,0.007059,0.25329,0.11615,GOCC_PLATELET_DENSE_TUBULAR_NETWORK,0.861090710324232
GSE41867_DAY15_EFFECTOR_VS_D...2,SET,189,0.072101,0.0072774,0.060383,0.11623,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,0.861500031989763
MIR6085,SET,35,0.16505,0.0071994,0.13826,0.11629,MIR6085,0.861506317920307
MIR3173_3P,SET,90,0.10431,0.0072853,0.087385,0.1163,MIR3173_3P,0.861506317920307
MODULE_368,SET,17,0.25434,0.0077356,0.21309,0.11633,MODULE_368,0.861506317920307
GSE21063_CTRL_VS_ANTI_IGM_ST...12,SET,173,0.076619,0.0074021,0.064192,0.11633,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP,0.861506317920307
GSE17721_ALL_VS_24H_PAM3CSK4...2,SET,178,0.074052,0.0072558,0.06208,0.11647,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP,0.862142975734355
FERRARI_RESPONSE_TO_FENRETIN...2,SET,20,0.2595,0.0085598,0.21756,0.11649,FERRARI_RESPONSE_TO_FENRETINIDE_UP,0.862142975734355
GOMF_PHOSPHATIDYLINOSITOL_PH...3,SET,162,0.078336,0.0073256,0.065684,0.11652,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING,0.862142975734355
HP_VARIABLE_EXPRESSIVITY,SET,63,0.12259,0.0071685,0.10279,0.11652,HP_VARIABLE_EXPRESSIVITY,0.862142975734355
GOBP_MHC_CLASS_II_BIOSYNTHET...,SET,19,0.23884,0.0076791,0.20028,0.11654,GOBP_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.862142975734355
HP_PREAXIAL_FOOT_POLYDACTYLY,SET,16,0.24977,0.0073701,0.20949,0.11658,HP_PREAXIAL_FOOT_POLYDACTYLY,0.862219787234043
ACTGCAG_MIR173P,SET,95,0.10209,0.0073243,0.085631,0.1166,ACTGCAG_MIR173P,0.862219787234043
MODULE_459,SET,389,0.051293,0.0073865,0.043034,0.11665,MODULE_459,0.862395254237288
ZHAN_LATE_DIFFERENTIATION_GE...1,SET,14,0.25127,0.0069357,0.21084,0.11669,ZHAN_LATE_DIFFERENTIATION_GENES_DN,0.862395254237288
WP_VITAMIN_D_RECEPTOR_PATHWAY,SET,168,0.083348,0.0079361,0.06995,0.11673,WP_VITAMIN_D_RECEPTOR_PATHWAY,0.862395254237288
DELASERNA_MYOD_TARGETS_DN,SET,49,0.15327,0.0079072,0.12864,0.11675,DELASERNA_MYOD_TARGETS_DN,0.862395254237288
HP_3_4_TOE_SYNDACTYLY,SET,6,0.44378,0.008021,0.37252,0.11677,HP_3_4_TOE_SYNDACTYLY,0.862395254237288
BIOCARTA_EIF_PATHWAY,SET,13,0.2582,0.006868,0.21676,0.1168,BIOCARTA_EIF_PATHWAY,0.862395254237288
KEGG_MEDICUS_VARIANT_BCR_ABL...2,SET,13,0.26726,0.0071089,0.2244,0.11684,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.862395254237288
GOCC_TRANSPORT_VESICLE,SET,397,0.051681,0.0075168,0.043408,0.11692,GOCC_TRANSPORT_VESICLE,0.862395254237288
DESCARTES_MAIN_FETAL_GRANULE...,SET,14,0.28585,0.0078903,0.24011,0.11693,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,0.862395254237288
GOMF_METAL_ION_TRANSMEMBRANE...,SET,426,0.051028,0.0076818,0.042866,0.11695,GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.862395254237288
HP_URETERAL_STENOSIS,SET,29,0.17394,0.0069075,0.14613,0.11697,HP_URETERAL_STENOSIS,0.862395254237288
AIZARANI_LIVER_C30_HEPATOCYT...,SET,369,0.052201,0.0073255,0.043856,0.11697,AIZARANI_LIVER_C30_HEPATOCYTES_4,0.862395254237288
BROWNE_HCMV_INFECTION_14HR_UP,SET,137,0.081781,0.0070378,0.068715,0.117,BROWNE_HCMV_INFECTION_14HR_UP,0.862395254237288
GREENBAUM_E2A_TARGETS_DN,SET,17,0.23207,0.0070581,0.19498,0.117,GREENBAUM_E2A_TARGETS_DN,0.862395254237288
HP_SPARSE_HAIR,SET,332,0.054645,0.0072813,0.045916,0.11701,HP_SPARSE_HAIR,0.862395254237288
REACTOME_GLYCOSPHINGOLIPID_B...,SET,19,0.24786,0.0079691,0.20834,0.11709,REACTOME_GLYCOSPHINGOLIPID_BIOSYNTHESIS,0.862395254237288
GOMF_SIGNALING_RECEPTOR_BIND...,SET,1324,0.029862,0.0077245,0.025102,0.1171,GOMF_SIGNALING_RECEPTOR_BINDING,0.862395254237288
GR_Q6_01,SET,247,0.06573,0.0075722,0.055255,0.11711,GR_Q6_01,0.862395254237288
HP_ABNORMALITY_OF_DERMAL_MEL...,SET,5,0.47366,0.0078152,0.39817,0.11711,HP_ABNORMALITY_OF_DERMAL_MELANOSOMES,0.862395254237288
WP_OXYSTEROLS_DERIVED_FROM_C...,SET,49,0.15217,0.0078508,0.12793,0.11712,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,0.862395254237288
GSE21670_TGFB_VS_TGFB_AND_IL...1,SET,175,0.07238,0.0070325,0.06087,0.11721,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,0.862632026627219
MORF_TPT1,SET,90,0.1031,0.0072005,0.086716,0.11724,MORF_TPT1,0.862632026627219
GOBP_INNER_CELL_MASS_CELL_DI...,SET,8,0.42121,0.0087903,0.3543,0.11725,GOBP_INNER_CELL_MASS_CELL_DIFFERENTIATION,0.862632026627219
GOBP_SIRNA_MEDIATED_RETROTRA...,SET,10,0.28386,0.0066227,0.23878,0.11727,GOBP_SIRNA_MEDIATED_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.862632026627219
FU_INTERACT_WITH_ALKBH8,SET,13,0.22475,0.0059781,0.18909,0.11732,FU_INTERACT_WITH_ALKBH8,0.862632026627219
GOBP_NADH_OXIDATION,SET,6,0.3892,0.0070345,0.32747,0.11732,GOBP_NADH_OXIDATION,0.862632026627219
GOCC_NUCLEAR_CHROMOSOME,SET,211,0.06551,0.0069822,0.055122,0.11734,GOCC_NUCLEAR_CHROMOSOME,0.862632026627219
GOBP_PURINE_DEOXYRIBONUCLEOT...3,SET,16,0.25348,0.0074795,0.21333,0.11738,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,0.862632026627219
GOBP_INTERSTRAND_CROSS_LINK_...,SET,34,0.14713,0.0063256,0.12384,0.11741,GOBP_INTERSTRAND_CROSS_LINK_REPAIR,0.862632026627219
KEGG_MEDICUS_REFERENCE_CHOND...,SET,7,0.39253,0.0076628,0.33043,0.11744,KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS,0.862632026627219
HP_SHALLOW_ORBITS,SET,32,0.17284,0.0072093,0.1455,0.11744,HP_SHALLOW_ORBITS,0.862632026627219
MIR127_3P,SET,5,0.52133,0.0086018,0.43887,0.11745,MIR127_3P,0.862632026627219
GOCC_HEMIDESMOSOME,SET,7,0.42826,0.0083605,0.36064,0.11752,GOCC_HEMIDESMOSOME,0.862963786182126
GOBP_CENTRAL_NERVOUS_SYSTEM_...8,SET,27,0.21612,0.0082814,0.18207,0.11762,GOBP_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS,0.863297761824324
GSE2405_HEAT_KILLED_VS_LIVE_...3,SET,183,0.074244,0.007375,0.062547,0.11762,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,0.863297761824324
KEGG_MEDICUS_VARIANT_MUTATIO...70,SET,10,0.30977,0.0072273,0.261,0.11764,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY,0.863297761824324
MODULE_162,SET,17,0.27337,0.0083142,0.23036,0.11768,MODULE_162,0.863408993033566
FOXO3_01,SET,228,0.06965,0.007713,0.058718,0.11778,FOXO3_01,0.863742405063291
GOBP_COLUMNAR_CUBOIDAL_EPITH...3,SET,14,0.27778,0.0076674,0.2342,0.1178,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_MATURATION,0.863742405063291
GOBP_METAPHASE_CHROMOSOME_AL...,SET,96,0.098976,0.0071381,0.083449,0.1178,GOBP_METAPHASE_CHROMOSOME_ALIGNMENT,0.863742405063291
GOMF_NEUROPEPTIDE_RECEPTOR_A...,SET,42,0.17913,0.0085575,0.1511,0.11791,GOMF_NEUROPEPTIDE_RECEPTOR_ACTIVITY,0.864267329545454
GOBP_TRYPTOPHAN_TRANSPORT,SET,5,0.43516,0.0071801,0.36713,0.11796,GOBP_TRYPTOPHAN_TRANSPORT,0.864267329545454
HP_WIDE_FEMORAL_METAPHYSIS,SET,6,0.36714,0.0066357,0.3098,0.118,HP_WIDE_FEMORAL_METAPHYSIS,0.864267329545454
GOCC_CELL_SUBSTRATE_JUNCTION,SET,411,0.049125,0.0072671,0.041459,0.11803,GOCC_CELL_SUBSTRATE_JUNCTION,0.864267329545454
GOBP_ANTIGEN_PROCESSING_AND_...3,SET,30,0.21277,0.0085935,0.1796,0.11808,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN,0.864267329545454
GOBP_POSITIVE_REGULATION_OF_...669,SET,51,0.14566,0.0076659,0.12295,0.11808,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.864267329545454
MIR5008_5P,SET,78,0.10674,0.0069421,0.090117,0.11813,MIR5008_5P,0.864267329545454
MIR708_3P,SET,102,0.10305,0.0076591,0.087003,0.11813,MIR708_3P,0.864267329545454
ZHONG_PFC_C5_BCL11B_CALB2_PO...,SET,22,0.22388,0.007745,0.18903,0.11814,ZHONG_PFC_C5_BCL11B_CALB2_POS_INP,0.864267329545454
ANDERSEN_LIVER_CANCER_KRT19_...1,SET,70,0.11978,0.0073819,0.10114,0.11815,ANDERSEN_LIVER_CANCER_KRT19_DN,0.864267329545454
GOCC_EKC_KEOPS_COMPLEX,SET,3,0.55581,0.007104,0.46933,0.11816,GOCC_EKC_KEOPS_COMPLEX,0.864267329545454
WP_GLP1_IN_PANCREATIC_ISLET_...,SET,7,0.43653,0.0085218,0.36862,0.11817,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,0.864267329545454
GSE360_L_DONOVANI_VS_T_GONDI...1,SET,169,0.074956,0.007158,0.063312,0.11823,GSE360_L_DONOVANI_VS_T_GONDII_DC_DN,0.864310621979407
GOCC_KATANIN_COMPLEX,SET,5,0.46733,0.0077108,0.39476,0.11824,GOCC_KATANIN_COMPLEX,0.864310621979407
WP_FBXL10_ENHANCEMENT_OF_MAP...,SET,10,0.28395,0.0066247,0.23991,0.1183,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,0.864310621979407
GSE40273_EOS_KO_VS_WT_TREG_DN,SET,187,0.072605,0.0072898,0.061343,0.1183,GSE40273_EOS_KO_VS_WT_TREG_DN,0.864310621979407
HP_DECREASED_FERTILITY,SET,312,0.055636,0.0071906,0.047012,0.11832,HP_DECREASED_FERTILITY,0.864310621979407
GOBP_ENUCLEATE_ERYTHROCYTE_M...,SET,3,0.71622,0.0091542,0.60525,0.11835,GOBP_ENUCLEATE_ERYTHROCYTE_MATURATION,0.864310621979407
GSE14308_TH2_VS_TH1_UP,SET,174,0.07333,0.0071046,0.06197,0.11835,GSE14308_TH2_VS_TH1_UP,0.864310621979407
GOMF_EPHRIN_RECEPTOR_BINDING,SET,26,0.19626,0.00738,0.16589,0.11841,GOMF_EPHRIN_RECEPTOR_BINDING,0.864498980228928
WP_INTERACTOME_OF_POLYCOMB_R...,SET,15,0.23876,0.0068216,0.20186,0.11845,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,0.864498980228928
WP_GANGLIO_SERIES_SPHINGOLIP...,SET,13,0.29731,0.0079082,0.2514,0.11849,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,0.864498980228928
KEGG_MEDICUS_REFERENCE_NUCLE...3,SET,5,0.51686,0.008528,0.43707,0.1185,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,0.864498980228928
GOBP_POSITIVE_REGULATION_OF_...751,SET,14,0.23225,0.0064107,0.1964,0.11851,GOBP_POSITIVE_REGULATION_OF_TELOMERASE_RNA_LOCALIZATION_TO_CAJAL_BODY,0.864498980228928
GOMF_MAGNESIUM_ION_TRANSMEMB...,SET,13,0.26898,0.0071548,0.2275,0.11854,GOMF_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.864498980228928
TOX4_TARGET_GENES,SET,163,0.074761,0.0070127,0.06324,0.11857,TOX4_TARGET_GENES,0.864498980228928
MODULE_436,SET,118,0.096034,0.0076739,0.081235,0.11858,MODULE_436,0.864498980228928
MIR6730_5P,SET,120,0.089043,0.0071749,0.075338,0.11863,MIR6730_5P,0.864498980228928
GSE14769_UNSTIM_VS_20MIN_LPS...2,SET,174,0.074686,0.0072359,0.063195,0.11865,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP,0.864498980228928
MIR3622A_5P,SET,37,0.17505,0.0078501,0.14815,0.11869,MIR3622A_5P,0.864498980228928
AP1_Q2_01,SET,247,0.064429,0.0074224,0.054553,0.1188,AP1_Q2_01,0.864498980228928
GOBP_MEMBRANE_DISASSEMBLY,SET,12,0.30143,0.0077034,0.25524,0.11881,GOBP_MEMBRANE_DISASSEMBLY,0.864498980228928
HP_HYPEROXALURIA,SET,6,0.38436,0.0069469,0.32549,0.11883,HP_HYPEROXALURIA,0.864498980228928
KYNG_RESPONSE_TO_H2O2,SET,64,0.12477,0.0073537,0.10567,0.11885,KYNG_RESPONSE_TO_H2O2,0.864498980228928
GOBP_REGULATION_OF_ENDOCYTIC...,SET,18,0.2355,0.0073701,0.19947,0.11888,GOBP_REGULATION_OF_ENDOCYTIC_RECYCLING,0.864498980228928
GSE360_L_DONOVANI_VS_B_MALAY...7,SET,179,0.074084,0.0072791,0.06277,0.11896,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.864498980228928
GSE37301_MULTIPOTENT_PROGENI...4,SET,153,0.076668,0.0069694,0.064962,0.11897,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.864498980228928
GOBP_ALANINE_TRANSPORT,SET,16,0.2719,0.0080228,0.23042,0.11901,GOBP_ALANINE_TRANSPORT,0.864498980228928
HP_SHOULDER_CONTRACTURE,SET,8,0.36233,0.0075615,0.30711,0.11904,HP_SHOULDER_CONTRACTURE,0.864498980228928
GOBP_MITOPHAGY,SET,57,0.12495,0.0069512,0.10594,0.11911,GOBP_MITOPHAGY,0.864498980228928
HP_SUBMUCOUS_CLEFT_SOFT_PALA...,SET,9,0.31641,0.0070036,0.26827,0.11912,HP_SUBMUCOUS_CLEFT_SOFT_PALATE,0.864498980228928
HAN_JNK_SINGALING_DN,SET,36,0.17549,0.0077628,0.14882,0.11917,HAN_JNK_SINGALING_DN,0.864498980228928
MATZUK_SPERMATOZOA,SET,105,0.097779,0.0073731,0.082922,0.11917,MATZUK_SPERMATOZOA,0.864498980228928
GOMF_CENTROMERIC_DNA_BINDING,SET,6,0.36185,0.0065401,0.30687,0.11918,GOMF_CENTROMERIC_DNA_BINDING,0.864498980228928
HP_SPASTIC_PARAPARESIS,SET,49,0.12636,0.006519,0.10718,0.11922,HP_SPASTIC_PARAPARESIS,0.864498980228928
GOBP_REGULATION_OF_STEM_CELL...1,SET,80,0.10884,0.0071684,0.092325,0.11924,GOBP_REGULATION_OF_STEM_CELL_DIFFERENTIATION,0.864498980228928
HP_DECREASED_CIRCULATING_REN...,SET,11,0.29732,0.0072752,0.25222,0.11925,HP_DECREASED_CIRCULATING_RENIN_LEVEL,0.864498980228928
REACTOME_SIGNAL_TRANSDUCTION...,SET,20,0.232,0.0076526,0.19685,0.1193,REACTOME_SIGNAL_TRANSDUCTION_BY_L1,0.864498980228928
WP_AMINO_ACID_METABOLISM_PAT...,SET,6,0.41847,0.0075635,0.35508,0.1193,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,0.864498980228928
TGACCTY_ERR1_Q2,SET,933,0.033556,0.0073695,0.028474,0.11931,TGACCTY_ERR1_Q2,0.864498980228928
MIR4737,SET,4,0.49724,0.0073383,0.42195,0.11932,MIR4737,0.864498980228928
HP_CERVICAL_LYMPHADENOPATHY,SET,9,0.29567,0.0065444,0.2509,0.11932,HP_CERVICAL_LYMPHADENOPATHY,0.864498980228928
GSE9006_HEALTHY_VS_TYPE_1_DI...1,SET,170,0.072729,0.0069657,0.061732,0.11938,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN,0.864498980228928
GOBP_RUFFLE_ASSEMBLY,SET,42,0.15483,0.0073966,0.13142,0.11939,GOBP_RUFFLE_ASSEMBLY,0.864498980228928
GOCC_TRANS_GOLGI_NETWORK_TRA...1,SET,35,0.16935,0.0073867,0.14377,0.11942,GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE,0.864498980228928
GOCC_CELL_SURFACE,SET,815,0.038992,0.0080307,0.033105,0.11944,GOCC_CELL_SURFACE,0.864498980228928
GSE30971_CTRL_VS_LPS_STIM_MA...7,SET,169,0.078047,0.0074532,0.066264,0.11944,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN,0.864498980228928
HE_LIM_SUN_FETAL_LUNG_C3_DEF...1,SET,23,0.20488,0.0072466,0.17397,0.11948,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROBLAST,0.864498980228928
GOBP_RESPONSE_TO_CELL_CYCLE_...,SET,7,0.36725,0.0071694,0.31187,0.11949,GOBP_RESPONSE_TO_CELL_CYCLE_CHECKPOINT_SIGNALING,0.864498980228928
GOMF_NAADP_SENSITIVE_CALCIUM...,SET,5,0.43279,0.0071409,0.36752,0.11949,GOMF_NAADP_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.864498980228928
GSE24210_CTRL_VS_IL35_TREATE...2,SET,187,0.073046,0.0073341,0.062033,0.1195,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP,0.864498980228928
GOMF_UBIQUITIN_LIKE_PROTEIN_...3,SET,34,0.15943,0.0068542,0.1354,0.11951,GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING,0.864498980228928
DUAN_PRDM5_TARGETS,SET,65,0.13119,0.0077917,0.11142,0.11952,DUAN_PRDM5_TARGETS,0.864498980228928
FARMER_BREAST_CANCER_APOCRIN...2,SET,290,0.060075,0.0074901,0.051022,0.11952,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,0.864498980228928
HP_MEGALOCORNEA,SET,42,0.16498,0.0078818,0.14013,0.11952,HP_MEGALOCORNEA,0.864498980228928
GAUTAM_EYE_IRIS_CILIARY_BODY...2,SET,93,0.10718,0.0076088,0.091042,0.11955,GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_CELLS,0.864536048689139
GOBP_L_ALANINE_TRANSPORT,SET,10,0.32584,0.0076021,0.27681,0.11958,GOBP_L_ALANINE_TRANSPORT,0.864573101726649
PRMT5_TARGET_GENES,SET,64,0.12157,0.0071651,0.10333,0.11968,PRMT5_TARGET_GENES,0.865051805728518
GOBP_CELL_SUBSTRATE_ADHESION,SET,332,0.055676,0.0074187,0.047323,0.1197,GOBP_CELL_SUBSTRATE_ADHESION,0.865051805728518
GOBP_NEGATIVE_REGULATION_OF_...486,SET,19,0.20275,0.0065187,0.17238,0.11977,GOBP_NEGATIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.865051805728518
GOBP_URATE_TRANSPORT,SET,11,0.30153,0.0073781,0.2564,0.1198,GOBP_URATE_TRANSPORT,0.865051805728518
GOBP_ATTACHMENT_OF_MITOTIC_S...,SET,25,0.18861,0.0069549,0.16038,0.11981,GOBP_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.865051805728518
GSE37416_CTRL_VS_48H_F_TULAR...2,SET,167,0.076976,0.0073077,0.065462,0.11983,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.865051805728518
WP_MAPK_AND_NFKB_SIGNALING_I...,SET,11,0.29513,0.0072215,0.25103,0.11988,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,0.865051805728518
GOMF_PHOSPHATIDYLINOSITOL_3_...4,SET,25,0.19436,0.0071668,0.16533,0.1199,GOMF_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING,0.865051805728518
GSE20715_0H_VS_48H_OZONE_TLR...1,SET,190,0.071498,0.0072354,0.060821,0.1199,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN,0.865051805728518
GOBP_FUNGIFORM_PAPILLA_DEVEL...,SET,5,0.46174,0.0076186,0.39281,0.11991,GOBP_FUNGIFORM_PAPILLA_DEVELOPMENT,0.865051805728518
REACTOME_FORMATION_OF_THE_PO...,SET,9,0.36325,0.0080403,0.30904,0.11992,REACTOME_FORMATION_OF_THE_POSTERIOR_NEURAL_PLATE,0.865051805728518
GOBP_REGULATION_OF_MACROPHAG...8,SET,6,0.44291,0.0080052,0.37688,0.11996,GOBP_REGULATION_OF_MACROPHAGE_PROLIFERATION,0.865160780244864
GOCC_NEUROMUSCULAR_JUNCTION,SET,70,0.11744,0.0072372,0.099945,0.12001,GOCC_NEUROMUSCULAR_JUNCTION,0.865307982583454
GOBP_POSITIVE_REGULATION_OF_...283,SET,9,0.37769,0.0083599,0.3215,0.12005,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,0.865307982583454
REACTOME_SYNTHESIS_OF_15_EIC...,SET,6,0.4131,0.0074664,0.35166,0.12006,REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES,0.865307982583454
GOMF_DNA_REPLICATION_ORIGIN_...,SET,15,0.2689,0.0076826,0.22892,0.12008,GOMF_DNA_REPLICATION_ORIGIN_BINDING,0.865307982583454
HP_CONCAVE_NASAL_RIDGE,SET,21,0.23213,0.0078458,0.19764,0.12011,HP_CONCAVE_NASAL_RIDGE,0.865344745024876
HP_SHORT_LINGUAL_FRENULUM,SET,11,0.29926,0.0073227,0.25489,0.12019,HP_SHORT_LINGUAL_FRENULUM,0.865359320809249
GSE7348_UNSTIM_VS_LPS_STIM_M...2,SET,141,0.078696,0.0068698,0.067037,0.12022,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,0.865359320809249
chr3q13,SET,80,0.21156,0.013934,0.18024,0.12025,chr3q13,0.865359320809249
GSE24634_TREG_VS_TCONV_POST_...1,SET,188,0.074858,0.0075359,0.063781,0.12027,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN,0.865359320809249
FAN_OVARY_CL1_GPRC5A_TNFRS12...,SET,342,0.052427,0.0070882,0.044675,0.1203,FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL,0.865359320809249
GSE5589_UNSTIM_VS_45MIN_LPS_...3,SET,178,0.070789,0.006936,0.060329,0.12033,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN,0.865359320809249
GOBP_POSITIVE_REGULATION_OF_...833,SET,4,0.40571,0.0059875,0.34578,0.12034,GOBP_POSITIVE_REGULATION_OF_VASCULAR_WOUND_HEALING,0.865359320809249
SCHAEFFER_PROSTATE_DEVELOPME...10,SET,6,0.43052,0.0077812,0.36698,0.12038,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP,0.865359320809249
HP_LACRIMATION_ABNORMALITY,SET,76,0.11867,0.0076189,0.10116,0.12038,HP_LACRIMATION_ABNORMALITY,0.865359320809249
GSE3920_IFNA_VS_IFNG_TREATED...4,SET,161,0.076607,0.007142,0.065302,0.12038,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP,0.865359320809249
HP_FOCAL_TONIC_SEIZURE,SET,28,0.19674,0.0076768,0.16775,0.12045,HP_FOCAL_TONIC_SEIZURE,0.865359320809249
GOBP_PULMONARY_VALVE_DEVELOP...,SET,24,0.23643,0.0085424,0.20161,0.12047,GOBP_PULMONARY_VALVE_DEVELOPMENT,0.865359320809249
MIR6894_5P,SET,37,0.15195,0.0068142,0.12958,0.12048,MIR6894_5P,0.865359320809249
HP_CONGENITAL_POSTERIOR_URET...,SET,8,0.31852,0.0066472,0.27164,0.12049,HP_CONGENITAL_POSTERIOR_URETHRAL_VALVE,0.865359320809249
GOMF_PHOSPHATIDYLCHOLINE_FLO...,SET,8,0.36775,0.0076746,0.31365,0.12051,GOMF_PHOSPHATIDYLCHOLINE_FLOPPASE_ACTIVITY,0.865359320809249
HP_PALPEBRAL_EDEMA,SET,37,0.16246,0.0072856,0.13858,0.12054,HP_PALPEBRAL_EDEMA,0.865359320809249
STTTCRNTTT_IRF_Q6,SET,174,0.078792,0.0076338,0.067214,0.12055,STTTCRNTTT_IRF_Q6,0.865359320809249
GERHOLD_RESPONSE_TO_TZD_UP,SET,6,0.45053,0.0081429,0.38435,0.12057,GERHOLD_RESPONSE_TO_TZD_UP,0.865359320809249
GOCC_CHROMAFFIN_GRANULE,SET,14,0.30493,0.0084168,0.26017,0.1206,GOCC_CHROMAFFIN_GRANULE,0.865359320809249
GSE11961_FOLLICULAR_BCELL_VS...4,SET,177,0.072852,0.0071183,0.062162,0.12061,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,0.865359320809249
BIOCARTA_SRCRPTP_PATHWAY,SET,11,0.26597,0.0065081,0.227,0.12067,BIOCARTA_SRCRPTP_PATHWAY,0.865419247159091
HE_LIM_SUN_FETAL_LUNG_C2_PDC...,SET,132,0.088074,0.0074408,0.075177,0.12069,HE_LIM_SUN_FETAL_LUNG_C2_PDC_CELL,0.865419247159091
MIR485_5P,SET,127,0.085871,0.0071169,0.073322,0.12078,MIR485_5P,0.865419247159091
HP_APLASIA_HYPOPLASIA_OF_THE...4,SET,6,0.46789,0.0084567,0.39954,0.12079,HP_APLASIA_HYPOPLASIA_OF_THE_3RD_FINGER,0.865419247159091
HP_ABNORMAL_AUTONOMIC_NERVOU...,SET,121,0.091886,0.0074346,0.078484,0.12086,HP_ABNORMAL_AUTONOMIC_NERVOUS_SYSTEM_PHYSIOLOGY,0.865419247159091
GOMF_FATTY_ACID_BINDING,SET,44,0.15114,0.0073901,0.12911,0.12088,GOMF_FATTY_ACID_BINDING,0.865419247159091
GOMF_ESTRADIOL_17_BETA_DEHYD...,SET,18,0.24247,0.0075881,0.20718,0.12094,GOMF_ESTRADIOL_17_BETA_DEHYDROGENASE_NAD_P_ACTIVITY,0.865419247159091
GSE29164_CD8_TCELL_VS_CD8_TC...4,SET,174,0.073678,0.0071384,0.062957,0.12095,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,0.865419247159091
GAVISH_3CA_METAPROGRAM_MACRO...8,SET,46,0.16246,0.0081213,0.13884,0.12098,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MONOCYTE_SECRETED,0.865419247159091
REACTOME_PEPTIDE_HORMONE_BIO...,SET,13,0.28523,0.0075869,0.24377,0.12099,REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS,0.865419247159091
GOBP_GLOMERULAR_MESANGIAL_CE...2,SET,12,0.33075,0.0084529,0.28267,0.12099,GOBP_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION,0.865419247159091
MIR12125,SET,101,0.099415,0.007353,0.084976,0.12103,MIR12125,0.865419247159091
GSE16450_CTRL_VS_IFNA_12H_ST...1,SET,155,0.081745,0.0074789,0.069882,0.12106,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.865419247159091
PETRETTO_LEFT_VENTRICLE_MASS...2,SET,5,0.52288,0.0086274,0.44713,0.12113,PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP,0.865419247159091
GOMF_NUCLEAR_STEROID_RECEPTO...,SET,25,0.20867,0.0076945,0.17847,0.12117,GOMF_NUCLEAR_STEROID_RECEPTOR_ACTIVITY,0.865419247159091
VANDESLUIS_COMMD1_TARGETS_GR...1,SET,15,0.25905,0.0074012,0.22158,0.12119,VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP,0.865419247159091
GOBP_REGULATION_OF_CALCIUM_I...5,SET,11,0.26322,0.0064407,0.22516,0.12121,GOBP_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.865419247159091
GSE2770_IL12_AND_TGFB_VS_IL4...4,SET,182,0.072074,0.0071401,0.06166,0.12123,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.865419247159091
WHITE_NEUROBLASTOMA_WITH_1P3...,SET,19,0.33571,0.010794,0.28722,0.12124,WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION,0.865419247159091
TGACCTTG_SF1_Q6,SET,214,0.068765,0.0073804,0.058832,0.12124,TGACCTTG_SF1_Q6,0.865419247159091
HP_CYSTIC_RENAL_DYSPLASIA,SET,8,0.3302,0.0068909,0.28254,0.12127,HP_CYSTIC_RENAL_DYSPLASIA,0.865419247159091
HP_ABNORMAL_LACRIMAL_DUCT_MO...,SET,41,0.15098,0.0071266,0.12922,0.12133,HP_ABNORMAL_LACRIMAL_DUCT_MORPHOLOGY,0.865419247159091
GSE32423_IL7_VS_IL7_IL4_MEMO...1,SET,180,0.069505,0.0068481,0.059492,0.12135,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,0.865419247159091
GOMF_NATURAL_KILLER_CELL_LEC...,SET,8,0.42282,0.0088238,0.36202,0.12143,GOMF_NATURAL_KILLER_CELL_LECTIN_LIKE_RECEPTOR_BINDING,0.865419247159091
GSE9316_IL6_KO_VS_IFNG_KO_IN...1,SET,188,0.074701,0.0075201,0.063962,0.12143,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN,0.865419247159091
GOBP_TRNA_WOBBLE_BASE_MODIFI...,SET,18,0.21543,0.0067419,0.18448,0.12146,GOBP_TRNA_WOBBLE_BASE_MODIFICATION,0.865419247159091
GOCC_WASH_COMPLEX,SET,7,0.32468,0.0063382,0.27803,0.12146,GOCC_WASH_COMPLEX,0.865419247159091
KEGG_MEDICUS_PATHOGEN_HCMV_U...4,SET,8,0.36848,0.0076898,0.31558,0.12148,KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,0.865419247159091
GOMF_EFFLUX_TRANSMEMBRANE_TR...,SET,15,0.25342,0.0072405,0.21703,0.12148,GOMF_EFFLUX_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.865419247159091
HP_FASCICULATIONS,SET,123,0.086751,0.0070765,0.074302,0.1215,HP_FASCICULATIONS,0.865419247159091
GSE17721_POLYIC_VS_CPG_6H_BM...2,SET,185,0.068935,0.0068846,0.059053,0.12154,GSE17721_POLYIC_VS_CPG_6H_BMDC_UP,0.865419247159091
GSE6259_DEC205_POS_DC_VS_CD8...1,SET,140,0.082611,0.007186,0.070775,0.12157,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN,0.865419247159091
KEGG_MEDICUS_REFERENCE_GHRHR...,SET,28,0.18253,0.0071224,0.15641,0.12162,KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY,0.865419247159091
REACTOME_REGULATION_OF_MITF_...2,SET,17,0.2365,0.007193,0.20268,0.12164,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION,0.865419247159091
WP_LET7_INHIBITION_OF_ES_CEL...,SET,6,0.42184,0.0076243,0.36155,0.12167,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,0.865419247159091
REACTOME_ANTIGEN_PROCESSING_...1,SET,97,0.094393,0.0068427,0.080907,0.12168,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.865419247159091
MIR27A_5P,SET,34,0.17238,0.0074108,0.14777,0.12171,MIR27A_5P,0.865419247159091
MODULE_119,SET,130,0.082991,0.0069585,0.071157,0.12175,MODULE_119,0.865419247159091
GOMF_AMINO_ACID_MONOATOMIC_C...2,SET,27,0.21858,0.0083756,0.18745,0.1218,GOMF_AMINO_ACID_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.865419247159091
LENAOUR_DENDRITIC_CELL_MATUR...1,SET,115,0.093643,0.0073877,0.080315,0.12182,LENAOUR_DENDRITIC_CELL_MATURATION_DN,0.865419247159091
FIGUEROA_AML_METHYLATION_CLU...3,SET,8,0.36694,0.0076578,0.31478,0.12187,FIGUEROA_AML_METHYLATION_CLUSTER_2_DN,0.865419247159091
MIR6795_3P,SET,12,0.29574,0.007558,0.25372,0.1219,MIR6795_3P,0.865419247159091
SOBOLEV_PBMC_PANDEMRIX_AGE_1...8,SET,32,0.19579,0.0081665,0.16797,0.1219,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_1DY_UP,0.865419247159091
LEE_RECENT_THYMIC_EMIGRANT,SET,197,0.070479,0.0072611,0.060472,0.12192,LEE_RECENT_THYMIC_EMIGRANT,0.865419247159091
GOBP_DICHOTOMOUS_SUBDIVISION...,SET,8,0.39532,0.0082498,0.3392,0.12193,GOBP_DICHOTOMOUS_SUBDIVISION_OF_AN_EPITHELIAL_TERMINAL_UNIT,0.865419247159091
GOBP_NUCLEAR_TRANSCRIBED_MRN...3,SET,6,0.37813,0.0068344,0.32445,0.12193,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_INDEPENDENT_DECAY,0.865419247159091
GOBP_MONOATOMIC_CATION_TRANS...1,SET,750,0.037665,0.0074554,0.032327,0.12199,GOBP_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORT,0.865419247159091
HP_REDUCED_LEFT_VENTRICULAR_...,SET,55,0.13134,0.0071778,0.11273,0.12199,HP_REDUCED_LEFT_VENTRICULAR_EJECTION_FRACTION,0.865419247159091
GOBP_NEGATIVE_REGULATION_OF_...182,SET,28,0.1863,0.0072698,0.15991,0.122,GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING,0.865419247159091
GOBP_UBIQUINONE_METABOLIC_PR...,SET,16,0.21358,0.0063021,0.18332,0.122,GOBP_UBIQUINONE_METABOLIC_PROCESS,0.865419247159091
HP_SOFT_SKIN,SET,40,0.16076,0.0074952,0.13798,0.122,HP_SOFT_SKIN,0.865419247159091
GOBP_LYMPHANGIOGENESIS,SET,17,0.24159,0.0073476,0.20736,0.12201,GOBP_LYMPHANGIOGENESIS,0.865419247159091
BIOCARTA_PS1_PATHWAY,SET,13,0.24936,0.0066328,0.21411,0.1221,BIOCARTA_PS1_PATHWAY,0.865419247159091
ZNF391_TARGET_GENES,SET,752,0.036392,0.0072126,0.031254,0.12213,ZNF391_TARGET_GENES,0.865419247159091
GOBP_MIDBRAIN_DOPAMINERGIC_N...,SET,15,0.29369,0.0083909,0.25221,0.12213,GOBP_MIDBRAIN_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.865419247159091
HP_BLUE_IRIDES,SET,50,0.14665,0.0076426,0.12596,0.12216,HP_BLUE_IRIDES,0.865419247159091
GOBP_COENZYME_A_METABOLIC_PR...,SET,18,0.21063,0.0065916,0.18094,0.12221,GOBP_COENZYME_A_METABOLIC_PROCESS,0.865419247159091
LI_ESTROGENE_BIDIRECTIONAL_E...,SET,85,0.11688,0.0079339,0.10042,0.12224,LI_ESTROGENE_BIDIRECTIONAL_E2_RESPONSE,0.865419247159091
GOBP_PLATELET_DEGRANULATION,SET,7,0.41491,0.0080999,0.35654,0.12227,GOBP_PLATELET_DEGRANULATION,0.865419247159091
HP_OVERLAPPING_FINGERS,SET,29,0.18332,0.0072799,0.15753,0.12228,HP_OVERLAPPING_FINGERS,0.865419247159091
KEGG_MEDICUS_REFERENCE_ORGAN...2,SET,16,0.25553,0.0075398,0.21963,0.12233,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_OUTER_KINETOCHORE,0.865419247159091
FOXO4_02,SET,239,0.066279,0.0075124,0.056978,0.12237,FOXO4_02,0.865419247159091
GALE_APL_WITH_FLT3_MUTATED_DN,SET,13,0.26973,0.0071747,0.23188,0.12238,GALE_APL_WITH_FLT3_MUTATED_DN,0.865419247159091
GOBP_REGULATION_OF_CELL_CYCL...5,SET,665,0.037624,0.0070294,0.032349,0.12241,GOBP_REGULATION_OF_CELL_CYCLE_PROCESS,0.865419247159091
JIANG_MELANOMA_TRM3_CD8,SET,363,0.05103,0.0071038,0.043883,0.12245,JIANG_MELANOMA_TRM3_CD8,0.865419247159091
TRAVAGLINI_LUNG_BASOPHIL_MAS...2,SET,423,0.049048,0.0073583,0.042179,0.12245,TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL,0.865419247159091
GOCC_DENDRITIC_SPINE_MEMBRANE,SET,14,0.2645,0.007301,0.22748,0.12247,GOCC_DENDRITIC_SPINE_MEMBRANE,0.865419247159091
MODULE_392,SET,14,0.26012,0.00718,0.22378,0.12254,MODULE_392,0.865419247159091
GOBP_IMMUNE_RESPONSE_REGULAT...2,SET,21,0.22031,0.0074463,0.18952,0.12254,GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_PHAGOCYTOSIS,0.865419247159091
HP_ABNORMAL_LIGHT_ADAPTED_EL...,SET,9,0.37142,0.0082212,0.31952,0.12254,HP_ABNORMAL_LIGHT_ADAPTED_ELECTRORETINOGRAM,0.865419247159091
HP_MULTIPLE_BLADDER_DIVERTIC...,SET,4,0.51426,0.0075895,0.44241,0.12255,HP_MULTIPLE_BLADDER_DIVERTICULA,0.865419247159091
KEGG_MEDICUS_PATHOGEN_SALMON...2,SET,24,0.19872,0.00718,0.17098,0.12257,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,0.865419247159091
VERNELL_RETINOBLASTOMA_PATHW...1,SET,19,0.22619,0.0072724,0.19462,0.12258,VERNELL_RETINOBLASTOMA_PATHWAY_DN,0.865419247159091
MODULE_85,SET,47,0.15824,0.0079957,0.13616,0.1226,MODULE_85,0.865419247159091
BIOCARTA_MAL_PATHWAY,SET,19,0.22194,0.0071359,0.19099,0.12261,BIOCARTA_MAL_PATHWAY,0.865419247159091
KEGG_MEDICUS_REFERENCE_TGFA_...2,SET,7,0.38058,0.0074295,0.32752,0.12263,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY,0.865419247159091
AGARWAL_AKT_PATHWAY_TARGETS,SET,10,0.30761,0.0071768,0.26476,0.12266,AGARWAL_AKT_PATHWAY_TARGETS,0.865419247159091
GSE17721_PAM3CSK4_VS_CPG_2H_...2,SET,180,0.074331,0.0073235,0.063981,0.12267,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_UP,0.865419247159091
GSE360_CTRL_VS_L_DONOVANI_DC...1,SET,180,0.07513,0.0074022,0.064671,0.12268,GSE360_CTRL_VS_L_DONOVANI_DC_DN,0.865419247159091
MIR6793_3P,SET,70,0.10926,0.0067335,0.094057,0.12269,MIR6793_3P,0.865419247159091
MIZUKAMI_HYPOXIA_DN,SET,6,0.44271,0.0080015,0.38111,0.1227,MIZUKAMI_HYPOXIA_DN,0.865419247159091
HP_CENTRAL_Y_SHAPED_METACARP...,SET,8,0.27589,0.0057576,0.23751,0.1227,HP_CENTRAL_Y_SHAPED_METACARPAL,0.865419247159091
GOBP_PROTEIN_LOCALIZATION_TO...27,SET,5,0.42762,0.0070557,0.36813,0.12271,GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_MEMBRANE,0.865419247159091
HP_NODULAR_CHANGES_AFFECTING...,SET,26,0.21405,0.008049,0.18427,0.12271,HP_NODULAR_CHANGES_AFFECTING_THE_EYELIDS,0.865419247159091
GOBP_TISSUE_REMODELING,SET,166,0.079757,0.0075493,0.068684,0.12278,GOBP_TISSUE_REMODELING,0.865562986618005
GSE19941_IL10_KO_VS_IL10_KO_...5,SET,179,0.075354,0.0074039,0.064897,0.1228,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN,0.865562986618005
ZBTB1_TARGET_GENES,SET,90,0.10098,0.0070522,0.086967,0.12281,ZBTB1_TARGET_GENES,0.865562986618005
HP_RETICULATED_SKIN_PIGMENTA...,SET,5,0.4163,0.0068688,0.35858,0.12283,HP_RETICULATED_SKIN_PIGMENTATION,0.865562986618005
GOMF_RNA_POLYMERASE_II_INTRO...,SET,8,0.36834,0.0076868,0.31731,0.12287,GOMF_RNA_POLYMERASE_II_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.86556432914471
GOMF_SPHINGOLIPID_TRANSPORTE...,SET,18,0.23111,0.0072326,0.1991,0.12288,GOMF_SPHINGOLIPID_TRANSPORTER_ACTIVITY,0.86556432914471
GSE36476_YOUNG_VS_OLD_DONOR_...5,SET,173,0.074829,0.0072292,0.064495,0.12299,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN,0.866163617021277
GOBP_PROTEIN_DEGLYCOSYLATION,SET,14,0.26315,0.0072635,0.2269,0.12308,GOBP_PROTEIN_DEGLYCOSYLATION,0.866555188106796
GRADE_COLON_VS_RECTAL_CANCER...1,SET,46,0.13682,0.0068398,0.118,0.12314,GRADE_COLON_VS_RECTAL_CANCER_DN,0.866555188106796
GOCC_RIBOSE_PHOSPHATE_DIPHOS...,SET,3,0.47949,0.0061285,0.41362,0.12319,GOCC_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_COMPLEX,0.866555188106796
GOMF_RIBOSE_PHOSPHATE_DIPHOS...,SET,3,0.47949,0.0061285,0.41362,0.12319,GOMF_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_ACTIVITY,0.866555188106796
GOBP_VESICLE_TETHERING_TO_GO...,SET,5,0.46594,0.0076879,0.40195,0.1232,GOBP_VESICLE_TETHERING_TO_GOLGI,0.866555188106796
HP_CERVICAL_SPINAL_CORD_ATRO...,SET,5,0.44122,0.00728,0.38063,0.1232,HP_CERVICAL_SPINAL_CORD_ATROPHY,0.866555188106796
REACTOME_INTEGRIN_SIGNALING,SET,27,0.19002,0.0072815,0.16395,0.12323,REACTOME_INTEGRIN_SIGNALING,0.866555188106796
GOMF_CATALYTIC_ACTIVITY_ACTI...5,SET,225,0.059539,0.0065503,0.051374,0.12325,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_DNA,0.866555188106796
MIKKELSEN_NPC_HCP_WITH_H3K27...,SET,330,0.06074,0.0080695,0.052416,0.12327,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,0.866555188106796
WP_AFLATOXIN_B1_METABOLISM,SET,6,0.42694,0.0077166,0.3686,0.12338,WP_AFLATOXIN_B1_METABOLISM,0.866758754242364
GSE6259_33D1_POS_VS_DEC205_P...3,SET,179,0.076677,0.0075338,0.066203,0.1234,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN,0.866758754242364
GOBP_REGULATION_OF_PROTEIN_N...,SET,18,0.22196,0.0069463,0.19167,0.12344,GOBP_REGULATION_OF_PROTEIN_NEDDYLATION,0.866758754242364
GOBP_DERMATAN_SULFATE_METABO...,SET,8,0.34323,0.007163,0.29645,0.12348,GOBP_DERMATAN_SULFATE_METABOLIC_PROCESS,0.866758754242364
GOBP_CONSTITUTIVE_HETEROCHRO...,SET,8,0.33169,0.0069221,0.28653,0.12351,GOBP_CONSTITUTIVE_HETEROCHROMATIN_FORMATION,0.866758754242364
DIRMEIER_LMP1_RESPONSE_LATE_...1,SET,25,0.19985,0.0073693,0.17264,0.12352,DIRMEIER_LMP1_RESPONSE_LATE_DN,0.866758754242364
GOMF_MALATE_DEHYDROGENASE_AC...,SET,8,0.33747,0.0070426,0.29153,0.12352,GOMF_MALATE_DEHYDROGENASE_ACTIVITY,0.866758754242364
GSE17301_CTRL_VS_48H_IFNA2_S...1,SET,163,0.075311,0.0070643,0.065074,0.12358,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN,0.866758754242364
GOBP_LEUKOTRIENE_BIOSYNTHETI...,SET,16,0.26658,0.0078659,0.23036,0.12359,GOBP_LEUKOTRIENE_BIOSYNTHETIC_PROCESS,0.866758754242364
GOBP_SENSORY_PERCEPTION_OF_S...2,SET,9,0.33528,0.0074212,0.28973,0.1236,GOBP_SENSORY_PERCEPTION_OF_SOUR_TASTE,0.866758754242364
GOCC_RETROMER_COMPLEX,SET,19,0.20132,0.0064727,0.17396,0.1236,GOCC_RETROMER_COMPLEX,0.866758754242364
GSE4590_LARGE_PRE_BCELL_VS_V...2,SET,160,0.081311,0.0075572,0.070275,0.12364,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,0.866758754242364
GOBP_POSITIVE_REGULATION_OF_...376,SET,58,0.13512,0.0075825,0.1168,0.12368,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,0.866758754242364
HP_HYPERKERATOTIC_PAPULE,SET,12,0.24759,0.0063275,0.21405,0.12371,HP_HYPERKERATOTIC_PAPULE,0.866758754242364
HP_MULTIPLE_MYELOMA,SET,7,0.41026,0.008009,0.35478,0.12377,HP_MULTIPLE_MYELOMA,0.866758754242364
GSE1460_INTRATHYMIC_T_PROGEN...3,SET,174,0.073574,0.0071283,0.063625,0.12377,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN,0.866758754242364
GSE19923_HEB_KO_VS_HEB_AND_E...1,SET,190,0.071154,0.0072006,0.061538,0.1238,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.866758754242364
GSE37301_COMMON_LYMPHOID_PRO...1,SET,181,0.070377,0.0069529,0.060873,0.12382,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN,0.866758754242364
GOCC_DNA_DEPENDENT_PROTEIN_K...2,SET,6,0.33329,0.0060239,0.28829,0.12383,GOCC_DNA_DEPENDENT_PROTEIN_KINASE_DNA_LIGASE_4_COMPLEX,0.866758754242364
GOMF_FOUR_WAY_JUNCTION_HELIC...,SET,6,0.44594,0.00806,0.38576,0.12385,GOMF_FOUR_WAY_JUNCTION_HELICASE_ACTIVITY,0.866758754242364
REACTOME_RNA_POLYMERASE_III_...4,SET,26,0.16932,0.0063672,0.14648,0.12386,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER,0.866758754242364
MIR4480,SET,49,0.13944,0.0071936,0.12064,0.12389,MIR4480,0.866758754242364
HP_PYODERMA_GANGRENOSUM,SET,11,0.28898,0.0070711,0.2501,0.12396,HP_PYODERMA_GANGRENOSUM,0.866758754242364
HP_SPINAL_DYSRAPHISM,SET,129,0.08719,0.0072826,0.075461,0.12396,HP_SPINAL_DYSRAPHISM,0.866758754242364
GOBP_POSITIVE_REGULATION_OF_...650,SET,27,0.17736,0.0067961,0.15351,0.12398,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.866758754242364
GSE37534_UNTREATED_VS_PIOGLI...1,SET,185,0.071521,0.0071428,0.06191,0.124,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.866758754242364
BIOCARTA_TH1TH2_PATHWAY,SET,18,0.23353,0.0073085,0.20218,0.12403,BIOCARTA_TH1TH2_PATHWAY,0.866758754242364
GOBP_ADHESION_OF_SYMBIONT_TO...2,SET,8,0.39297,0.008201,0.34022,0.12404,GOBP_ADHESION_OF_SYMBIONT_TO_HOST_CELL,0.866758754242364
MIR5698,SET,187,0.069366,0.0069646,0.060073,0.12411,MIR5698,0.866758754242364
DESCARTES_FETAL_THYMUS_STROM...,SET,116,0.096721,0.0076635,0.08377,0.12413,DESCARTES_FETAL_THYMUS_STROMAL_CELLS,0.866758754242364
GOBP_REGULATION_OF_KERATINOC...3,SET,44,0.16038,0.0078417,0.13893,0.12417,GOBP_REGULATION_OF_KERATINOCYTE_PROLIFERATION,0.866758754242364
GOMF_OXIDOREDUCTASE_ACTIVITY...21,SET,38,0.16139,0.0073343,0.13981,0.12418,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.866758754242364
GOBP_REGULATION_OF_NUCLEAR_C...,SET,12,0.25432,0.0064994,0.22032,0.12419,GOBP_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION,0.866758754242364
GSE17974_IL4_AND_ANTI_IL12_V...12,SET,158,0.081704,0.0075465,0.07079,0.12422,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP,0.866758754242364
HP_HYPERREFLEXIA_IN_UPPER_LI...,SET,25,0.18864,0.0069559,0.16345,0.12424,HP_HYPERREFLEXIA_IN_UPPER_LIMBS,0.866758754242364
GOBP_PRODUCTION_OF_MOLECULAR...1,SET,84,0.10371,0.0069987,0.089866,0.12425,GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.866758754242364
GSE37301_COMMON_LYMPHOID_PRO...7,SET,177,0.073388,0.0071707,0.063601,0.12428,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,0.866758754242364
HP_APLASIA_OF_THE_NASAL_BONE,SET,5,0.55957,0.0092327,0.485,0.12431,HP_APLASIA_OF_THE_NASAL_BONE,0.866758754242364
GAUTAM_EYE_CORNEA_MELANOCYTES,SET,235,0.061336,0.0068945,0.053169,0.12434,GAUTAM_EYE_CORNEA_MELANOCYTES,0.866758754242364
HP_ABNORMAL_LOCALIZATION_OF_...,SET,202,0.067544,0.0070456,0.058557,0.12436,HP_ABNORMAL_LOCALIZATION_OF_KIDNEY,0.866758754242364
GOBP_EPIGENETIC_PROGRAMMING_...1,SET,12,0.28664,0.0073254,0.2485,0.12437,GOBP_EPIGENETIC_PROGRAMMING_IN_THE_ZYGOTIC_PRONUCLEI,0.866758754242364
REACTOME_CLEC7A_DECTIN_1_IND...,SET,11,0.26883,0.0065781,0.23308,0.12438,REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION,0.866758754242364
HP_DECREASED_BODY_MASS_INDEX,SET,20,0.23202,0.0076536,0.20121,0.12443,HP_DECREASED_BODY_MASS_INDEX,0.866758754242364
GOBP_ACTIVATION_OF_INNATE_IM...,SET,266,0.05841,0.0069793,0.050659,0.12446,GOBP_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE,0.866758754242364
REACTOME_NETRIN_1_SIGNALING,SET,42,0.15085,0.0072065,0.13085,0.1245,REACTOME_NETRIN_1_SIGNALING,0.866758754242364
MIR361_5P,SET,152,0.079799,0.0072305,0.069222,0.1245,MIR361_5P,0.866758754242364
chr2q36,SET,34,0.28143,0.012099,0.24414,0.12452,chr2q36,0.866758754242364
GSE7460_FOXP3_MUT_VS_WT_ACT_...1,SET,184,0.070675,0.0070394,0.06131,0.12452,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN,0.866758754242364
HP_RECURRENT_CUTANEOUS_ABSCE...,SET,6,0.43016,0.0077747,0.37321,0.12455,HP_RECURRENT_CUTANEOUS_ABSCESS_FORMATION,0.866758754242364
GSE15750_WT_VS_TRAF6KO_DAY10...1,SET,180,0.076513,0.0075385,0.066393,0.12458,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN,0.866758754242364
GSE25088_CTRL_VS_IL4_STIM_ST...1,SET,155,0.078296,0.0071634,0.067941,0.12458,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_DN,0.866758754242364
GOCC_MITOCHONDRIAL_CRISTA_JU...,SET,4,0.48597,0.0071721,0.42173,0.1246,GOCC_MITOCHONDRIAL_CRISTA_JUNCTION,0.866758754242364
REACTOME_ACTIVATION_OF_THE_P...2,SET,31,0.16145,0.0066284,0.14017,0.12471,REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,0.866758754242364
GSE18893_TCONV_VS_TREG_2H_CU...1,SET,187,0.070428,0.0070713,0.061163,0.12477,GSE18893_TCONV_VS_TREG_2H_CULTURE_DN,0.866758754242364
GSE10239_MEMORY_VS_DAY4.5_EF...2,SET,187,0.069456,0.0069737,0.060319,0.12478,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP,0.866758754242364
GOCC_NUCLEAR_ENVELOPE,SET,450,0.04563,0.0070554,0.039633,0.1248,GOCC_NUCLEAR_ENVELOPE,0.866758754242364
GOBP_REGULATION_OF_FEVER_GEN...,SET,9,0.37114,0.0082148,0.32237,0.12482,GOBP_REGULATION_OF_FEVER_GENERATION,0.866758754242364
GOBP_TRANSDIFFERENTIATION,SET,7,0.42975,0.0083895,0.3733,0.12483,GOBP_TRANSDIFFERENTIATION,0.866758754242364
GOBP_CELL_ADHESION_MEDIATED_...,SET,82,0.10798,0.0071997,0.093799,0.12485,GOBP_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.866758754242364
KEGG_LEUKOCYTE_TRANSENDOTHEL...,SET,108,0.098804,0.0075554,0.085841,0.12487,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,0.866758754242364
GOBP_INTRINSIC_APOPTOTIC_SIG...3,SET,97,0.094102,0.0068216,0.081763,0.12489,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.866758754242364
FOURNIER_ACINAR_DEVELOPMENT_...1,SET,6,0.44356,0.0080169,0.3854,0.1249,FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN,0.866758754242364
REACTOME_TICAM1_RIP1_MEDIATE...,SET,17,0.25004,0.0076046,0.21726,0.1249,REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,0.866758754242364
NIKOLSKY_BREAST_CANCER_17Q21...,SET,305,0.094619,0.012093,0.08222,0.12491,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,0.866758754242364
GOBP_MESANGIAL_CELL_DIFFEREN...,SET,6,0.41887,0.0075706,0.36399,0.12492,GOBP_MESANGIAL_CELL_DIFFERENTIATION,0.866758754242364
REACTOME_SYNTHESIS_OF_PIPS_A...5,SET,48,0.13168,0.0067241,0.11446,0.12498,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,0.867001976047904
HP_NEPHROPATHY,SET,82,0.10803,0.0072032,0.093909,0.12501,HP_NEPHROPATHY,0.867037028537218
GOBP_NEGATIVE_REGULATION_OF_...100,SET,14,0.275,0.0075906,0.23913,0.12508,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.867178451882845
GOBP_RESPONSE_TO_THYROXINE,SET,4,0.54999,0.0081169,0.47836,0.12513,GOBP_RESPONSE_TO_THYROXINE,0.867178451882845
HP_ABNORMAL_CAROTID_ARTERY_M...,SET,83,0.1081,0.0072516,0.094026,0.12514,HP_ABNORMAL_CAROTID_ARTERY_MORPHOLOGY,0.867178451882845
CASTELLANO_HRAS_AND_NRAS_TAR...2,SET,5,0.40155,0.0066255,0.34929,0.12515,CASTELLANO_HRAS_AND_NRAS_TARGETS_UP,0.867178451882845
MODULE_17,SET,316,0.052759,0.0068615,0.0459,0.1252,MODULE_17,0.867178451882845
REACTOME_REGULATION_OF_GLYCO...,SET,11,0.27619,0.0067581,0.2403,0.12521,REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM,0.867178451882845
GOMF_MACROMOLECULE_TRANSMEMB...,SET,29,0.17532,0.006962,0.15254,0.12522,GOMF_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.867178451882845
GOBP_NEGATIVE_REGULATION_OF_...324,SET,28,0.18394,0.0071774,0.16005,0.12523,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.867178451882845
BOYAULT_LIVER_CANCER_SUBCLAS...12,SET,15,0.26678,0.0076221,0.23216,0.12526,BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN,0.867213406374502
HP_ABNORMALITY_OF_FRONTAL_SI...,SET,13,0.26157,0.0069575,0.22765,0.12529,HP_ABNORMALITY_OF_FRONTAL_SINUS,0.86724834694284
GOCC_SPERMATOPROTEASOME_COMP...,SET,5,0.36407,0.006007,0.31694,0.12535,GOCC_SPERMATOPROTEASOME_COMPLEX,0.867490890083632
PID_ATR_PATHWAY,SET,38,0.14827,0.006738,0.1291,0.1254,PID_ATR_PATHWAY,0.867560619028662
GSE15930_NAIVE_VS_48H_IN_VIT...2,SET,181,0.072865,0.0071988,0.06345,0.12541,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP,0.867560619028662
GOMF_G_PROTEIN_ALPHA_SUBUNIT...,SET,29,0.18401,0.0073073,0.16027,0.12546,GOMF_G_PROTEIN_ALPHA_SUBUNIT_BINDING,0.867733791044776
GOCC_RECYCLING_ENDOSOME_MEMB...,SET,97,0.097449,0.0070643,0.084888,0.1255,GOCC_RECYCLING_ENDOSOME_MEMBRANE,0.86783774373259
HP_OROPHARYNGEAL_SQUAMOUS_CE...,SET,6,0.381,0.0068862,0.33196,0.12555,HP_OROPHARYNGEAL_SQUAMOUS_CELL_CARCINOMA,0.867907279236277
GOBP_RESPONSE_TO_OXYGEN_RADI...,SET,25,0.19287,0.0071121,0.16806,0.12556,GOBP_RESPONSE_TO_OXYGEN_RADICAL,0.867907279236277
HP_PERSISTENCE_OF_HEMOGLOBIN...,SET,32,0.16302,0.0067998,0.14209,0.12563,HP_PERSISTENCE_OF_HEMOGLOBIN_F,0.868011478831246
HP_HYPOMELANOTIC_MACULE,SET,8,0.3303,0.0068929,0.28789,0.12564,HP_HYPOMELANOTIC_MACULE,0.868011478831246
BIOCARTA_ERAD_PATHWAY,SET,19,0.20193,0.0064922,0.17601,0.12565,BIOCARTA_ERAD_PATHWAY,0.868011478831246
HP_CEREBELLAR_CALCIFICATIONS,SET,8,0.37512,0.0078285,0.32713,0.12576,HP_CEREBELLAR_CALCIFICATIONS,0.868357298907646
MODULE_126,SET,166,0.076097,0.0072028,0.066365,0.12577,MODULE_126,0.868357298907646
GOBP_POSITIVE_REGULATION_OF_...584,SET,37,0.15983,0.0071675,0.13941,0.1258,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,0.868357298907646
GSE8921_UNSTIM_0H_VS_TLR1_2_...7,SET,172,0.073539,0.0070842,0.064143,0.1258,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN,0.868357298907646
MIR3190_5P,SET,110,0.089941,0.0069407,0.078465,0.12585,MIR3190_5P,0.868392865636147
GNF2_MYD88,SET,54,0.12762,0.0069108,0.11135,0.12588,GNF2_MYD88,0.868392865636147
GOBP_DERMATAN_SULFATE_PROTEO...2,SET,11,0.27667,0.0067699,0.24141,0.12589,GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,0.868392865636147
HP_ARTHRITIS,SET,206,0.069694,0.0073406,0.060827,0.12595,HP_ARTHRITIS,0.868392865636147
GOMF_CHLORIDE_CHANNEL_REGULA...,SET,13,0.24773,0.0065894,0.21624,0.12599,GOMF_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY,0.868392865636147
GSE22140_GERMFREE_VS_SPF_MOU...1,SET,187,0.071636,0.0071925,0.062537,0.12601,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN,0.868392865636147
GOBP_POSITIVE_REGULATION_OF_...432,SET,22,0.21033,0.0072763,0.18363,0.12602,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION,0.868392865636147
GSE29949_CD8_NEG_DC_SPLEEN_V...2,SET,176,0.075991,0.0074042,0.066341,0.12602,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP,0.868392865636147
BIOCARTA_MTOR_PATHWAY,SET,21,0.22221,0.0075105,0.19402,0.12606,BIOCARTA_MTOR_PATHWAY,0.868392865636147
GOMF_GLYCEROPHOSPHOLIPID_FLI...,SET,12,0.29111,0.0074396,0.2542,0.12607,GOMF_GLYCEROPHOSPHOLIPID_FLIPPASE_ACTIVITY,0.868392865636147
E2F_01,SET,59,0.11975,0.0067771,0.10457,0.12608,E2F_01,0.868392865636147
GSE14308_TH17_VS_INDUCED_TRE...2,SET,178,0.069224,0.0067827,0.060469,0.12616,GSE14308_TH17_VS_INDUCED_TREG_UP,0.868599603803486
GSE360_T_GONDII_VS_B_MALAYI_...4,SET,179,0.072165,0.0070905,0.063038,0.12616,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.868599603803486
GSE25088_WT_VS_STAT6_KO_MACR...4,SET,168,0.0759,0.0072269,0.066324,0.12624,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN,0.86897825311943
REACTOME_ACTIVATED_NOTCH1_TR...,SET,29,0.17053,0.0067717,0.14905,0.1263,REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS,0.869184636705603
LIANG_SILENCED_BY_METHYLATIO...2,SET,9,0.32413,0.0071744,0.28333,0.12632,LIANG_SILENCED_BY_METHYLATION_DN,0.869184636705603
GOCC_CCR4_NOT_CORE_COMPLEX,SET,5,0.35092,0.0057901,0.30684,0.12639,GOCC_CCR4_NOT_CORE_COMPLEX,0.869321192968596
LEE_LIVER_CANCER_MYC_E2F1_DN,SET,58,0.13833,0.0077621,0.12098,0.12645,LEE_LIVER_CANCER_MYC_E2F1_DN,0.869321192968596
GSE13493_DP_VS_CD4INTCD8POS_...2,SET,177,0.070786,0.0069165,0.061914,0.12646,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP,0.869321192968596
WP_HIPPOYAP_SIGNALING,SET,22,0.20193,0.0069857,0.17664,0.12648,WP_HIPPOYAP_SIGNALING,0.869321192968596
TRAVAGLINI_LUNG_ADVENTITIAL_...,SET,279,0.062582,0.0076556,0.054751,0.12652,TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL,0.869321192968596
MODULE_113,SET,96,0.10072,0.0072635,0.08813,0.12657,MODULE_113,0.869321192968596
GSE360_CTRL_VS_T_GONDII_DC_DN,SET,175,0.075519,0.0073375,0.066085,0.12658,GSE360_CTRL_VS_T_GONDII_DC_DN,0.869321192968596
GSE29615_CTRL_VS_DAY3_LAIV_I...1,SET,153,0.073957,0.0067229,0.064721,0.12659,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN,0.869321192968596
HP_DIMINISHED_MOVEMENT,SET,72,0.10684,0.0066772,0.093503,0.1266,HP_DIMINISHED_MOVEMENT,0.869321192968596
REACTOME_CHAPERONE_MEDIATED_...,SET,19,0.22741,0.0073116,0.19904,0.12663,REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY,0.869321192968596
WP_MITOCHONDRIAL_COMPLEX_IV_...,SET,28,0.15939,0.0062197,0.13951,0.12663,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,0.869321192968596
HP_PERIODONTITIS,SET,33,0.16685,0.0070672,0.14605,0.12664,HP_PERIODONTITIS,0.869321192968596
GSE3982_DC_VS_TH2_UP,SET,181,0.0737,0.0072813,0.064521,0.12668,GSE3982_DC_VS_TH2_UP,0.869424052132701
HP_LEUKOCYTOSIS,SET,140,0.081495,0.007089,0.071355,0.12671,HP_LEUKOCYTOSIS,0.8694527772345
GOBP_EXOCRINE_PANCREAS_DEVEL...,SET,7,0.42319,0.0082614,0.3708,0.12688,GOBP_EXOCRINE_PANCREAS_DEVELOPMENT,0.8694527772345
GOCC_BBSOME,SET,8,0.33583,0.0070083,0.29426,0.12689,GOCC_BBSOME,0.8694527772345
HP_NEUROMA,SET,6,0.34847,0.0062984,0.30535,0.12689,HP_NEUROMA,0.8694527772345
MULLIGHAN_NPM1_SIGNATURE_3_UP,SET,290,0.056088,0.006993,0.04915,0.12691,MULLIGHAN_NPM1_SIGNATURE_3_UP,0.8694527772345
WP_MONOAMINE_TRANSPORT,SET,30,0.18048,0.0072891,0.15818,0.12695,WP_MONOAMINE_TRANSPORT,0.8694527772345
GSE3203_WT_VS_IFNAR1_KO_INFL...1,SET,186,0.071269,0.0071367,0.062465,0.12695,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN,0.8694527772345
GSE36009_UNSTIM_VS_LPS_STIM_...3,SET,169,0.069088,0.0065976,0.060557,0.12697,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN,0.8694527772345
GTCTACC_MIR379,SET,22,0.22826,0.0078966,0.20008,0.12698,GTCTACC_MIR379,0.8694527772345
GOMF_STRUCTURAL_MOLECULE_ACT...1,SET,650,0.039157,0.0072359,0.03433,0.12703,GOMF_STRUCTURAL_MOLECULE_ACTIVITY,0.8694527772345
GSE10240_IL22_VS_IL22_AND_IL...1,SET,187,0.067172,0.0067443,0.058895,0.12704,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.8694527772345
WP_5Q35_COPY_NUMBER_VARIATION,SET,97,0.10597,0.0076818,0.092914,0.12705,WP_5Q35_COPY_NUMBER_VARIATION,0.8694527772345
HP_APLASIA_HYPOPLASIA_OF_THE...22,SET,13,0.26636,0.0070849,0.2336,0.1271,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,0.8694527772345
RUTELLA_RESPONSE_TO_CSF2RB_A...1,SET,295,0.057919,0.0072822,0.050807,0.12716,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,0.8694527772345
HP_ABSENT_VAS_DEFERENS,SET,19,0.23474,0.0075473,0.20594,0.12718,HP_ABSENT_VAS_DEFERENS,0.8694527772345
BROWNE_HCMV_INFECTION_1HR_DN,SET,186,0.068567,0.0068661,0.060159,0.1272,BROWNE_HCMV_INFECTION_1HR_DN,0.8694527772345
GOTTWEIN_TARGETS_OF_KSHV_MIR...,SET,59,0.12576,0.0071173,0.11037,0.12727,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,0.8694527772345
GOBP_NEGATIVE_REGULATION_OF_...214,SET,35,0.16128,0.0070348,0.14159,0.12735,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.8694527772345
GOBP_MONOTERPENOID_METABOLIC...,SET,6,0.34974,0.0063211,0.30705,0.12736,GOBP_MONOTERPENOID_METABOLIC_PROCESS,0.8694527772345
REACTOME_STAT5_ACTIVATION,SET,7,0.32462,0.0063372,0.28502,0.12737,REACTOME_STAT5_ACTIVATION,0.8694527772345
GOMF_VOLTAGE_GATED_SODIUM_CH...1,SET,23,0.21471,0.0075946,0.18858,0.12744,GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,0.8694527772345
SNIJDERS_AMPLIFIED_IN_HEAD_A...,SET,37,0.17505,0.00785,0.15375,0.12746,SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,0.8694527772345
FAN_OVARY_CL6_PUTATIVE_EARLY...,SET,259,0.061929,0.0073031,0.054398,0.12748,FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2,0.8694527772345
GOBP_NUCLEOBASE_CONTAINING_C...,SET,207,0.063836,0.0067397,0.056078,0.12749,GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.8694527772345
GOBP_SUBSTRATE_DEPENDENT_CEL...2,SET,7,0.35107,0.0068536,0.3084,0.12749,GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION_CELL_EXTENSION,0.8694527772345
HP_HYPOVENTILATION,SET,46,0.13464,0.0067308,0.11829,0.12751,HP_HYPOVENTILATION,0.8694527772345
MORF_RPA2,SET,174,0.066366,0.0064299,0.058317,0.12756,MORF_RPA2,0.8694527772345
GOBP_REGULATION_OF_CELL_KILL...,SET,106,0.10369,0.0078556,0.091115,0.12757,GOBP_REGULATION_OF_CELL_KILLING,0.8694527772345
GSE16385_UNTREATED_VS_12H_IL...2,SET,179,0.072371,0.0071108,0.063596,0.12757,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP,0.8694527772345
GSE17721_CTRL_VS_GARDIQUIMOD...7,SET,181,0.066275,0.0065477,0.058239,0.12757,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN,0.8694527772345
GSE41867_NAIVE_VS_DAY8_LCMV_...1,SET,180,0.068887,0.0067871,0.060538,0.12758,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.8694527772345
MIR4747_5P,SET,256,0.059481,0.0069743,0.052277,0.12761,MIR4747_5P,0.8694527772345
MIR875_5P,SET,49,0.13823,0.0071316,0.1215,0.12762,MIR875_5P,0.8694527772345
GSE5503_LIVER_DC_VS_MLN_DC_A...2,SET,179,0.072231,0.007097,0.063487,0.12763,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.8694527772345
HP_OSTEOPOROSIS,SET,281,0.058094,0.0071316,0.051071,0.12767,HP_OSTEOPOROSIS,0.8694527772345
CASTELLANO_HRAS_TARGETS_UP,SET,5,0.3462,0.0057122,0.30439,0.1277,CASTELLANO_HRAS_TARGETS_UP,0.8694527772345
GOBP_REGULATION_OF_CELL_SHAPE,SET,125,0.087658,0.007208,0.077087,0.12775,GOBP_REGULATION_OF_CELL_SHAPE,0.8694527772345
GSE19888_NO_PRETREAT_VS_ADEN...1,SET,179,0.068815,0.0067614,0.060517,0.12775,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN,0.8694527772345
GOCC_RADIAL_SPOKE_HEAD,SET,5,0.42522,0.0070161,0.37398,0.12777,GOCC_RADIAL_SPOKE_HEAD,0.8694527772345
GSE17721_LPS_VS_PAM3CSK4_12H...1,SET,179,0.069674,0.0068458,0.061279,0.12778,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_DN,0.8694527772345
GOBP_POSITIVE_REGULATION_OF_...728,SET,33,0.1688,0.0071498,0.14848,0.12781,GOBP_POSITIVE_REGULATION_OF_STEROL_TRANSPORT,0.8694527772345
GOBP_SKELETAL_MYOFIBRIL_ASSE...,SET,10,0.31413,0.0073289,0.27634,0.12783,GOBP_SKELETAL_MYOFIBRIL_ASSEMBLY,0.8694527772345
GOBP_POSITIVE_REGULATION_OF_...617,SET,39,0.15813,0.0072801,0.13911,0.12784,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.8694527772345
HP_ABNORMAL_NASAL_BONE_MORPH...,SET,9,0.37501,0.0083006,0.32991,0.12784,HP_ABNORMAL_NASAL_BONE_MORPHOLOGY,0.8694527772345
KEGG_MEDICUS_VARIANT_AMPLIFI...16,SET,13,0.25935,0.0068985,0.22816,0.12785,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY,0.8694527772345
HP_REDUNDANT_SKIN,SET,79,0.10935,0.0071575,0.096212,0.12786,HP_REDUNDANT_SKIN,0.8694527772345
BIOCARTA_IL6_PATHWAY,SET,20,0.21984,0.0072515,0.19343,0.12788,BIOCARTA_IL6_PATHWAY,0.8694527772345
GOBP_INTERLEUKIN_27_MEDIATED...,SET,7,0.37937,0.0074059,0.33382,0.12789,GOBP_INTERLEUKIN_27_MEDIATED_SIGNALING_PATHWAY,0.8694527772345
GOCC_POLE_PLASM,SET,23,0.1934,0.0068406,0.17019,0.12791,GOCC_POLE_PLASM,0.8694527772345
HP_ABNORMAL_PLATELET_GRANULES,SET,12,0.25316,0.0064699,0.22281,0.12794,HP_ABNORMAL_PLATELET_GRANULES,0.86948664450528
GSE42021_CD24HI_VS_CD24LOW_T...4,SET,171,0.072131,0.0069285,0.063495,0.12798,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_UP,0.869588445747801
MIR3940_5P,SET,33,0.14946,0.0063306,0.13158,0.12801,MIR3940_5P,0.86962227326036
HP_ENLARGED_INTERPHALANGEAL_...,SET,5,0.43816,0.0072296,0.38579,0.12804,HP_ENLARGED_INTERPHALANGEAL_JOINTS,0.8696560875513
GSE3982_MEMORY_CD4_TCELL_VS_...3,SET,185,0.068086,0.0067998,0.05996,0.12809,GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN,0.869825703399766
GOBP_REGULATION_OF_CYCLIN_DE...,SET,73,0.10864,0.0068368,0.095702,0.12815,GOBP_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.869890832034295
WP_ALTERNATIVE_PATHWAY_OF_FE...,SET,11,0.29043,0.0071067,0.25589,0.1282,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,0.869890832034295
GOBP_ALPHA_BETA_T_CELL_DIFFE...,SET,118,0.094843,0.0075788,0.083573,0.12823,GOBP_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.869890832034295
REACTOME_TERMINAL_PATHWAY_OF...,SET,8,0.36341,0.007584,0.32036,0.12832,REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT,0.869890832034295
WP_GLYCOSPHINGOLIPID_METABOL...,SET,19,0.23065,0.0074158,0.20333,0.12833,WP_GLYCOSPHINGOLIPID_METABOLISM,0.869890832034295
REACTOME_SIGNALING_BY_INTERL...,SET,430,0.047016,0.0071102,0.04145,0.12835,REACTOME_SIGNALING_BY_INTERLEUKINS,0.869890832034295
MODULE_273,SET,40,0.14602,0.0068081,0.12874,0.12835,MODULE_273,0.869890832034295
ZHAN_MULTIPLE_MYELOMA_LB_UP,SET,45,0.15539,0.0076833,0.13701,0.12838,ZHAN_MULTIPLE_MYELOMA_LB_UP,0.869890832034295
HP_ABSENT_FRONTAL_SINUSES,SET,6,0.34669,0.0062662,0.30569,0.12838,HP_ABSENT_FRONTAL_SINUSES,0.869890832034295
PID_S1P_S1P2_PATHWAY,SET,23,0.20772,0.0073472,0.18317,0.1284,PID_S1P_S1P2_PATHWAY,0.869890832034295
HP_LOWER_LIMB_PAIN,SET,37,0.16483,0.0073919,0.14535,0.1284,HP_LOWER_LIMB_PAIN,0.869890832034295
HP_INCOMPLETE_PARTITION_OF_T...,SET,7,0.34651,0.0067646,0.30558,0.12841,HP_INCOMPLETE_PARTITION_OF_THE_COCHLEA_TYPE_II,0.869890832034295
HP_RENAL_FIBROSIS,SET,15,0.23863,0.0068179,0.21046,0.12843,HP_RENAL_FIBROSIS,0.869890832034295
GOBP_POSITIVE_REGULATION_OF_...688,SET,1682,0.024152,0.0069673,0.021302,0.12845,GOBP_POSITIVE_REGULATION_OF_RNA_METABOLIC_PROCESS,0.869890832034295
GSE27786_CD4_VS_CD8_TCELL_DN,SET,175,0.071299,0.0069275,0.062905,0.12852,GSE27786_CD4_VS_CD8_TCELL_DN,0.870194296281877
GOBP_TONGUE_DEVELOPMENT,SET,19,0.24316,0.0078181,0.21456,0.12855,GOBP_TONGUE_DEVELOPMENT,0.870194296281877
CHEMNITZ_RESPONSE_TO_PROSTAG...1,SET,348,0.05192,0.0070798,0.045821,0.12859,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,0.870194296281877
GSE43955_1H_VS_42H_ACT_CD4_T...3,SET,181,0.069903,0.0069061,0.061696,0.12861,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.870194296281877
MURAKAMI_UV_RESPONSE_1HR_DN,SET,10,0.30416,0.0070963,0.26845,0.12862,MURAKAMI_UV_RESPONSE_1HR_DN,0.870194296281877
GOMF_CUPRIC_ION_BINDING,SET,5,0.40963,0.0067588,0.36162,0.12866,GOMF_CUPRIC_ION_BINDING,0.870295504087193
PID_S1P_META_PATHWAY,SET,21,0.21402,0.0072339,0.18903,0.12877,PID_S1P_META_PATHWAY,0.870835885214008
GOMF_AMINE_BINDING,SET,12,0.26751,0.0068367,0.23628,0.12879,GOMF_AMINE_BINDING,0.870835885214008
GOCC_MITOTIC_SPINDLE_MIDZONE,SET,13,0.25802,0.0068632,0.22794,0.12883,GOCC_MITOTIC_SPINDLE_MIDZONE,0.870936909161642
CCCNNNNNNAAGWT_UNKNOWN,SET,93,0.098131,0.0069662,0.086719,0.12891,CCCNNNNNNAAGWT_UNKNOWN,0.871104617029549
HP_ABSENT_PUBIC_HAIR,SET,8,0.36194,0.0075534,0.31986,0.12892,HP_ABSENT_PUBIC_HAIR,0.871104617029549
GSE17721_POLYIC_VS_CPG_1H_BM...2,SET,188,0.067287,0.0067738,0.059469,0.12893,GSE17721_POLYIC_VS_CPG_1H_BMDC_UP,0.871104617029549
GOBP_POSITIVE_REGULATION_OF_...285,SET,14,0.25558,0.0070546,0.22591,0.12896,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_MIGRATION,0.871137079852341
HP_SKIN_VESICLE,SET,24,0.17371,0.0062762,0.15356,0.12899,HP_SKIN_VESICLE,0.871137079852341
GOBP_RESPONSE_TO_MUSCLE_STRE...,SET,24,0.19548,0.0070629,0.17282,0.12901,GOBP_RESPONSE_TO_MUSCLE_STRETCH,0.871137079852341
GOBP_TOLL_LIKE_RECEPTOR_3_SI...,SET,28,0.17043,0.0066505,0.1507,0.12904,GOBP_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.871170396270396
HP_REACTIVE_HYPOGLYCEMIA,SET,7,0.3412,0.0066609,0.30174,0.12908,HP_REACTIVE_HYPOGLYCEMIA,0.87127119829093
RUTELLA_RESPONSE_TO_HGF_DN,SET,217,0.065609,0.0070903,0.05803,0.12912,RUTELLA_RESPONSE_TO_HGF_DN,0.871371961165049
OSMAN_BLADDER_CANCER_DN,SET,353,0.048142,0.0066107,0.04259,0.12917,OSMAN_BLADDER_CANCER_DN,0.871540157251019
GOBP_MAINTENANCE_OF_PRESYNAP...,SET,5,0.46693,0.0077042,0.41331,0.1293,GOBP_MAINTENANCE_OF_PRESYNAPTIC_ACTIVE_ZONE_STRUCTURE,0.871625878378378
HP_HYPOKINESIA,SET,46,0.12922,0.0064597,0.1144,0.12934,HP_HYPOKINESIA,0.871625878378378
HP_UPPER_LIMB_POSTURAL_TREMOR,SET,10,0.34144,0.0079662,0.30227,0.12934,HP_UPPER_LIMB_POSTURAL_TREMOR,0.871625878378378
GOMF_MRNA_BINDING,SET,304,0.050896,0.0064945,0.045073,0.12942,GOMF_MRNA_BINDING,0.871625878378378
GOBP_POSITIVE_REGULATION_OF_...807,SET,17,0.23891,0.0072664,0.21162,0.12946,GOBP_POSITIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.871625878378378
GAVISH_3CA_MALIGNANT_METAPRO...36,SET,48,0.14784,0.007549,0.13096,0.12948,GAVISH_3CA_MALIGNANT_METAPROGRAM_5_STRESS,0.871625878378378
GSE2128_CTRL_VS_MIMETOPE_NEG...4,SET,178,0.073643,0.0072157,0.065236,0.12948,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP,0.871625878378378
GSE36888_UNTREATED_VS_IL2_TR...4,SET,182,0.071974,0.0071302,0.063756,0.12948,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP,0.871625878378378
GOMF_IMPORTIN_ALPHA_FAMILY_P...,SET,9,0.34112,0.0075504,0.30218,0.12949,GOMF_IMPORTIN_ALPHA_FAMILY_PROTEIN_BINDING,0.871625878378378
HP_AMYLOIDOSIS,SET,34,0.17217,0.0074021,0.15252,0.12949,HP_AMYLOIDOSIS,0.871625878378378
GGATTA_PITX2_Q2,SET,522,0.044485,0.0073933,0.039415,0.12953,GGATTA_PITX2_Q2,0.871625878378378
HP_DECREASED_CIRCULATING_DEH...,SET,7,0.37036,0.00723,0.32818,0.12956,HP_DECREASED_CIRCULATING_DEHYDROEPIANDROSTERONE_CONCENTRATION,0.871625878378378
GAVISH_3CA_METAPROGRAM_EPITH...16,SET,47,0.13432,0.0067869,0.11903,0.12957,GAVISH_3CA_METAPROGRAM_EPITHELIAL_MYC,0.871625878378378
HP_DECREASED_ACTIVITY_OF_MIT...2,SET,86,0.090909,0.0062071,0.080564,0.12958,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_I,0.871625878378378
GOBP_REGULATION_BY_VIRUS_OF_...,SET,7,0.3265,0.0063739,0.2894,0.12963,GOBP_REGULATION_BY_VIRUS_OF_VIRAL_PROTEIN_LEVELS_IN_HOST_CELL,0.871625878378378
MIR4710,SET,72,0.11361,0.0071003,0.1007,0.12964,MIR4710,0.871625878378378
GOBP_SYNAPTIC_VESICLE_CYTOSK...,SET,18,0.2243,0.0070195,0.19884,0.12966,GOBP_SYNAPTIC_VESICLE_CYTOSKELETAL_TRANSPORT,0.871625878378378
GOBP_REGULATION_OF_NEURON_PR...1,SET,14,0.24469,0.0067542,0.21693,0.12967,GOBP_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION,0.871625878378378
MIR665,SET,122,0.084107,0.0068331,0.074566,0.12968,MIR665,0.871625878378378
GOMF_OXIDOREDUCTASE_ACTIVITY,SET,653,0.037827,0.0070057,0.03354,0.1297,GOMF_OXIDOREDUCTASE_ACTIVITY,0.871625878378378
GSE17721_CTRL_VS_PAM3CSK4_0....2,SET,179,0.068752,0.0067552,0.060979,0.12978,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_UP,0.871625878378378
GOBP_ERROR_PRONE_TRANSLESION...,SET,12,0.2281,0.0058295,0.20233,0.1298,GOBP_ERROR_PRONE_TRANSLESION_SYNTHESIS,0.871625878378378
VANDESLUIS_NORMAL_EMBRYOS_DN,SET,19,0.24474,0.0078688,0.21711,0.12982,VANDESLUIS_NORMAL_EMBRYOS_DN,0.871625878378378
MIR1324,SET,107,0.092109,0.0070109,0.081709,0.12982,MIR1324,0.871625878378378
GOMF_OPSONIN_RECEPTOR_ACTIVI...,SET,4,0.53228,0.0078554,0.47226,0.12986,GOMF_OPSONIN_RECEPTOR_ACTIVITY,0.871625878378378
GSE21360_SECONDARY_VS_QUATER...1,SET,147,0.081531,0.0072659,0.07234,0.12987,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.871625878378378
GSE33292_DN3_THYMOCYTE_VS_TC...3,SET,137,0.084497,0.0072716,0.074975,0.12988,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_DN,0.871625878378378
chr2q33,SET,74,0.21511,0.013628,0.19089,0.12991,chr2q33,0.871625878378378
UNTERMAN_IPF_VS_CTRL_MONOCYT...1,SET,19,0.24839,0.0079862,0.22042,0.12991,UNTERMAN_IPF_VS_CTRL_MONOCYTE_DN,0.871625878378378
GOMF_TRANSCRIPTION_FACTOR_BI...,SET,553,0.040933,0.0069959,0.036333,0.12996,GOMF_TRANSCRIPTION_FACTOR_BINDING,0.871655668016194
RORIE_TARGETS_OF_EWSR1_FLI1_...2,SET,24,0.22386,0.0080883,0.19876,0.13003,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,0.871655668016194
GOMF_THIOL_OXIDASE_ACTIVITY,SET,4,0.38221,0.0056408,0.33939,0.13005,GOMF_THIOL_OXIDASE_ACTIVITY,0.871655668016194
HP_SPASTIC_DYSARTHRIA,SET,22,0.18579,0.0064271,0.16497,0.13006,HP_SPASTIC_DYSARTHRIA,0.871655668016194
GOBP_RRNA_PSEUDOURIDINE_SYNT...,SET,7,0.34029,0.0066431,0.3022,0.13007,GOBP_RRNA_PSEUDOURIDINE_SYNTHESIS,0.871655668016194
KEGG_MEDICUS_REFERENCE_EGF_E...2,SET,13,0.25071,0.0066687,0.22265,0.13008,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY,0.871655668016194
REACTOME_INTERLEUKIN_35_SIGN...,SET,12,0.29182,0.0074578,0.25916,0.13009,REACTOME_INTERLEUKIN_35_SIGNALLING,0.871655668016194
GOMF_PHOSPHATIDYLINOSITOL_PH...4,SET,23,0.16553,0.0058549,0.14706,0.13018,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.871853235124206
GOBP_NEURON_GLIAL_CELL_SIGNA...,SET,5,0.50859,0.0083915,0.45197,0.13024,GOBP_NEURON_GLIAL_CELL_SIGNALING,0.871853235124206
KEGG_MEDICUS_VARIANT_MUTATIO...34,SET,11,0.29783,0.0072877,0.26469,0.13025,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004,0.871853235124206
GSE19401_PAM2CSK4_VS_RETINOI...4,SET,179,0.069768,0.006855,0.062003,0.13025,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,0.871853235124206
REACTOME_MAPK1_ERK2_ACTIVATI...,SET,9,0.34065,0.0075401,0.30276,0.13027,REACTOME_MAPK1_ERK2_ACTIVATION,0.871853235124206
GOBP_POSITIVE_REGULATION_OF_...19,SET,50,0.14273,0.007438,0.12685,0.13027,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.871853235124206
GOBP_HUMORAL_IMMUNE_RESPONSE...,SET,41,0.16625,0.0078474,0.14781,0.13035,GOBP_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.871950663716814
GOMF_SALT_TRANSMEMBRANE_TRAN...,SET,9,0.27852,0.0061648,0.24762,0.13035,GOMF_SALT_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.871950663716814
HOELZEL_NF1_TARGETS_UP,SET,115,0.097075,0.0076585,0.086315,0.13037,HOELZEL_NF1_TARGETS_UP,0.871950663716814
HP_GENERALIZED_AMYOTROPHY,SET,78,0.098763,0.0064235,0.087827,0.1304,HP_GENERALIZED_AMYOTROPHY,0.871950663716814
GOBP_POSITIVE_REGULATION_OF_...546,SET,6,0.37734,0.0068201,0.33556,0.13041,GOBP_POSITIVE_REGULATION_OF_NON_MOTILE_CILIUM_ASSEMBLY,0.871950663716814
GOBP_PROTEIN_LOCALIZATION_TO...47,SET,11,0.29168,0.0071372,0.25954,0.13055,GOBP_PROTEIN_LOCALIZATION_TO_PRESYNAPSE,0.872313775216138
REACTOME_TRANSLATION_OF_REPL...,SET,14,0.25063,0.006918,0.22303,0.13057,REACTOME_TRANSLATION_OF_REPLICASE_AND_ASSEMBLY_OF_THE_REPLICATION_TRANSCRIPTION_COMPLEX,0.872313775216138
GOCC_H3_HISTONE_ACETYLTRANSF...,SET,8,0.33485,0.0069879,0.29803,0.13061,GOCC_H3_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.872313775216138
HP_SPARSE_MEDIAL_EYEBROW,SET,5,0.38991,0.0064334,0.34704,0.13061,HP_SPARSE_MEDIAL_EYEBROW,0.872313775216138
HP_UNILATERAL_CRYPTORCHIDISM,SET,11,0.30477,0.0074574,0.27127,0.13062,HP_UNILATERAL_CRYPTORCHIDISM,0.872313775216138
HP_THICK_VERMILION_BORDER,SET,226,0.060657,0.006688,0.053992,0.13063,HP_THICK_VERMILION_BORDER,0.872313775216138
MODULE_478,SET,18,0.22152,0.0069324,0.19718,0.13064,MODULE_478,0.872313775216138
REACTOME_WNT5A_DEPENDENT_INT...2,SET,15,0.23217,0.0066333,0.20678,0.13078,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4,0.872778181992705
MIR4697_3P,SET,99,0.093046,0.0068138,0.082875,0.13079,MIR4697_3P,0.872778181992705
BUSSLINGER_ESOPHAGEAL_PROLIF...,SET,67,0.1216,0.0073319,0.10831,0.13079,BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS,0.872778181992705
HP_SEVERE_VIRAL_INFECTION,SET,29,0.17227,0.006841,0.15346,0.13081,HP_SEVERE_VIRAL_INFECTION,0.872778181992705
MIR4507,SET,34,0.14466,0.0062192,0.12892,0.13091,MIR4507,0.872925544516622
MIR223_3P,SET,112,0.088411,0.006884,0.078809,0.13097,MIR223_3P,0.872925544516622
HP_ABNORMAL_CIRCULATING_LEUC...,SET,4,0.4469,0.0065955,0.39836,0.13097,HP_ABNORMAL_CIRCULATING_LEUCINE_CONCENTRATION,0.872925544516622
GOBP_PROTEIN_DEPALMITOYLATION,SET,8,0.3151,0.0065759,0.28095,0.13103,GOBP_PROTEIN_DEPALMITOYLATION,0.872925544516622
SHARMA_PILOCYTIC_ASTROCYTOMA...2,SET,26,0.20572,0.0077359,0.18344,0.13106,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP,0.872925544516622
HP_IRREGULAR_MENSTRUATION,SET,58,0.12296,0.0068998,0.10966,0.1311,HP_IRREGULAR_MENSTRUATION,0.872925544516622
GOMF_OXIDIZED_DNA_BINDING,SET,11,0.26173,0.0064043,0.23344,0.13111,GOMF_OXIDIZED_DNA_BINDING,0.872925544516622
MODULE_69,SET,479,0.042284,0.0067399,0.037717,0.13113,MODULE_69,0.872925544516622
REACTOME_ARMS_MEDIATED_ACTIV...,SET,7,0.37797,0.0073785,0.33715,0.13114,REACTOME_ARMS_MEDIATED_ACTIVATION,0.872925544516622
GSE27786_NKCELL_VS_NEUTROPHI...2,SET,184,0.068348,0.0068077,0.060968,0.13114,GSE27786_NKCELL_VS_NEUTROPHIL_UP,0.872925544516622
BROCKE_APOPTOSIS_REVERSED_BY...,SET,136,0.081457,0.0069845,0.072673,0.13118,BROCKE_APOPTOSIS_REVERSED_BY_IL6,0.872925544516622
HP_LIMB_TREMOR,SET,20,0.22043,0.007271,0.19666,0.13118,HP_LIMB_TREMOR,0.872925544516622
HP_EYE_POKING,SET,5,0.44692,0.0073741,0.39877,0.13121,HP_EYE_POKING,0.872925544516622
GOMF_PROTEIN_DISULFIDE_REDUC...,SET,7,0.33914,0.0066207,0.30262,0.13122,GOMF_PROTEIN_DISULFIDE_REDUCTASE_NAD_P_H_ACTIVITY,0.872925544516622
GOBP_DEVELOPMENTAL_MATURATION,SET,310,0.055646,0.0071692,0.049658,0.13124,GOBP_DEVELOPMENTAL_MATURATION,0.872925544516622
GOMF_CALCIUM_ION_TRANSMEMBRA...,SET,135,0.083886,0.0071664,0.074873,0.13129,GOMF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.872925544516622
KEGG_MEDICUS_REFERENCE_HOMOL...1,SET,31,0.15224,0.0062501,0.13589,0.1313,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION,0.872925544516622
GOBP_PROTEIN_IMPORT_INTO_MIT...,SET,17,0.20974,0.0063792,0.18727,0.13136,GOBP_PROTEIN_IMPORT_INTO_MITOCHONDRIAL_MATRIX,0.872925544516622
GOBP_POSTSYNAPTIC_MEMBRANE_A...,SET,7,0.36098,0.007047,0.32231,0.13137,GOBP_POSTSYNAPTIC_MEMBRANE_ASSEMBLY,0.872925544516622
HP_ABNORMAL_CIRCULATING_BETA...,SET,8,0.34731,0.0072481,0.31014,0.1314,HP_ABNORMAL_CIRCULATING_BETA_GLOBULIN_LEVEL,0.872925544516622
HP_ABNORMALITY_OF_THE_URETHRA,SET,375,0.048197,0.0068173,0.043047,0.13144,HP_ABNORMALITY_OF_THE_URETHRA,0.872925544516622
REACTOME_ONCOGENE_INDUCED_SE...,SET,32,0.17021,0.0070995,0.15202,0.13145,REACTOME_ONCOGENE_INDUCED_SENESCENCE,0.872925544516622
HP_TOOTH_MALPOSITION,SET,349,0.051093,0.0069769,0.045636,0.13145,HP_TOOTH_MALPOSITION,0.872925544516622
HP_TRACHEAL_CALCIFICATION,SET,3,0.58422,0.0074671,0.52181,0.13145,HP_TRACHEAL_CALCIFICATION,0.872925544516622
BLANCO_MELO_COVID19_BRONCHIA...2,SET,135,0.088085,0.0075252,0.078677,0.13146,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,0.872925544516622
GSE42021_TCONV_PLN_VS_CD24HI...2,SET,186,0.070168,0.0070264,0.062686,0.1315,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP,0.87302435530086
HILLION_HMGA1_TARGETS,SET,75,0.11117,0.0070904,0.099336,0.13155,HILLION_HMGA1_TARGETS,0.873121506300115
MARTIN_VIRAL_GPCR_SIGNALING_...1,SET,47,0.13442,0.006792,0.12012,0.13157,MARTIN_VIRAL_GPCR_SIGNALING_DN,0.873121506300115
BASSO_HAIRY_CELL_LEUKEMIA_UP,SET,74,0.11528,0.0073039,0.10303,0.13159,BASSO_HAIRY_CELL_LEUKEMIA_UP,0.873121506300115
GSE15330_HSC_VS_GRANULOCYTE_...4,SET,185,0.065571,0.0065487,0.058621,0.13167,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.873283177570093
GSE25087_TREG_VS_TCONV_ADULT...1,SET,164,0.074129,0.0069745,0.066281,0.13171,GSE25087_TREG_VS_TCONV_ADULT_DN,0.873283177570093
GOBP_LYMPHOCYTE_CHEMOTAXIS,SET,42,0.15549,0.0074282,0.13904,0.13172,GOBP_LYMPHOCYTE_CHEMOTAXIS,0.873283177570093
GSE11386_NAIVE_VS_MEMORY_BCE...2,SET,159,0.072802,0.0067454,0.065101,0.13173,GSE11386_NAIVE_VS_MEMORY_BCELL_UP,0.873283177570093
GSE2706_UNSTIM_VS_2H_LPS_AND...1,SET,169,0.077534,0.0074042,0.069336,0.13174,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN,0.873283177570093
GOBP_HYALURONAN_CATABOLIC_PR...,SET,15,0.23479,0.0067081,0.21001,0.13179,GOBP_HYALURONAN_CATABOLIC_PROCESS,0.873448026315789
GOBP_SISTER_CHROMATID_COHESI...,SET,42,0.1476,0.007051,0.13208,0.1319,GOBP_SISTER_CHROMATID_COHESION,0.873908117378049
MIR4489,SET,49,0.13313,0.0068683,0.11915,0.13193,MIR4489,0.873908117378049
MIR4280,SET,43,0.1459,0.0070521,0.13059,0.13196,MIR4280,0.873908117378049
HP_ABNORMAL_PLACENTAL_SIZE,SET,14,0.27033,0.0074618,0.24197,0.13196,HP_ABNORMAL_PLACENTAL_SIZE,0.873908117378049
GAVISH_3CA_METAPROGRAM_CD8_T...5,SET,48,0.12691,0.0064802,0.11361,0.132,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_GLYCOLYSIS_MYC,0.873990883190883
GOBP_REGULATION_OF_GERMINAL_...,SET,8,0.36786,0.0076769,0.32941,0.13206,GOBP_REGULATION_OF_GERMINAL_CENTER_FORMATION,0.873990883190883
GOMF_MONOATOMIC_CATION_TRANS...,SET,580,0.04039,0.0070643,0.036173,0.13209,GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.873990883190883
REACTOME_REGULATION_OF_PLK1_...,SET,81,0.096466,0.006393,0.0864,0.13211,REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,0.873990883190883
GSE33425_CD8_ALPHAALPHA_VS_A...2,SET,186,0.068323,0.0068417,0.061203,0.13215,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,0.873990883190883
MIR4277,SET,116,0.086278,0.0068361,0.077293,0.13217,MIR4277,0.873990883190883
GOMF_NEUTRAL_L_AMINO_ACID_SO...,SET,8,0.38387,0.0080111,0.34393,0.13219,GOMF_NEUTRAL_L_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY,0.873990883190883
DER_IFN_GAMMA_RESPONSE_UP,SET,67,0.11709,0.0070604,0.10492,0.13221,DER_IFN_GAMMA_RESPONSE_UP,0.873990883190883
HP_MONOCHROMACY,SET,8,0.3391,0.0070767,0.3039,0.13226,HP_MONOCHROMACY,0.873990883190883
HP_ABNORMALITY_OF_GLOBE_LOCA...,SET,965,0.030388,0.006781,0.027235,0.13227,HP_ABNORMALITY_OF_GLOBE_LOCATION,0.873990883190883
HP_ATHETOSIS,SET,139,0.079543,0.0068947,0.071294,0.13228,HP_ATHETOSIS,0.873990883190883
HP_ABSENT_THUMBNAIL,SET,16,0.24432,0.007209,0.21901,0.13231,HP_ABSENT_THUMBNAIL,0.873990883190883
HP_ABNORMAL_T_WAVE,SET,35,0.16232,0.0070802,0.14551,0.13233,HP_ABNORMAL_T_WAVE,0.873990883190883
HP_ANGINA_PECTORIS,SET,36,0.16289,0.0072057,0.14604,0.13235,HP_ANGINA_PECTORIS,0.873990883190883
LI_ESTROGENE_NON_MCF7_T47D_E...1,SET,6,0.41824,0.0075593,0.37498,0.13236,LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_DN,0.873990883190883
GOMF_ORGANIC_CATION_TRANSMEM...,SET,75,0.11546,0.0073643,0.10353,0.13238,GOMF_ORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.873990883190883
MIR512_5P,SET,49,0.13085,0.0067504,0.11733,0.1324,MIR512_5P,0.873990883190883
GNF2_EIF3S6,SET,106,0.086395,0.0065454,0.077482,0.13243,GNF2_EIF3S6,0.874022911127991
GOCC_JUNCTIONAL_SARCOPLASMIC...,SET,9,0.34557,0.0076491,0.31011,0.13257,GOCC_JUNCTIONAL_SARCOPLASMIC_RETICULUM_MEMBRANE,0.874270513063234
REACTOME_SHC1_EVENTS_IN_ERBB...2,SET,14,0.22731,0.0062742,0.20403,0.13263,REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING,0.874270513063234
HP_EXERCISE_INDUCED_MUSCLE_S...,SET,7,0.31075,0.0060665,0.27896,0.13265,HP_EXERCISE_INDUCED_MUSCLE_STIFFNESS,0.874270513063234
KORKOLA_EMBRYONIC_CARCINOMA_...2,SET,16,0.23191,0.0068429,0.20819,0.13266,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,0.874270513063234
WEIGEL_OXIDATIVE_STRESS_BY_H...2,SET,59,0.12765,0.0072246,0.1146,0.13266,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,0.874270513063234
KEGG_PROXIMAL_TUBULE_BICARBO...,SET,21,0.2106,0.0071182,0.18906,0.13266,KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION,0.874270513063234
GOMF_PHOSPHATIDYLGLYCEROL_BI...,SET,14,0.26074,0.007197,0.23412,0.13272,GOMF_PHOSPHATIDYLGLYCEROL_BINDING,0.874270513063234
GOBP_REGULATION_OF_PROTON_TR...,SET,12,0.25968,0.0066364,0.23319,0.13273,GOBP_REGULATION_OF_PROTON_TRANSPORT,0.874270513063234
GOBP_EXTRACELLULAR_MATRIX_CE...,SET,4,0.54683,0.0080703,0.49109,0.13275,GOBP_EXTRACELLULAR_MATRIX_CELL_SIGNALING,0.874270513063234
BURTON_ADIPOGENESIS_7,SET,41,0.15558,0.0073436,0.13973,0.13276,BURTON_ADIPOGENESIS_7,0.874270513063234
GOBP_GLYCOLIPID_TRANSPORT,SET,8,0.32172,0.0067139,0.28896,0.13278,GOBP_GLYCOLIPID_TRANSPORT,0.874270513063234
GOMF_MRNA_3_UTR_BINDING,SET,98,0.090426,0.0065887,0.081217,0.13278,GOMF_MRNA_3_UTR_BINDING,0.874270513063234
BIOCARTA_PDZS_PATHWAY,SET,15,0.24959,0.007131,0.22419,0.1328,BIOCARTA_PDZS_PATHWAY,0.874270513063234
WP_SELECTIVE_EXPRESSION_OF_C...,SET,27,0.19614,0.007516,0.1762,0.13282,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.874270513063234
GOBP_POSITIVE_REGULATION_OF_...405,SET,141,0.083107,0.0072548,0.07467,0.13286,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,0.874270513063234
HP_HOMOCYSTINURIA,SET,9,0.3043,0.0067354,0.27341,0.13287,HP_HOMOCYSTINURIA,0.874270513063234
GOBP_REGULATION_OF_HEPATIC_S...,SET,7,0.39885,0.0077862,0.3585,0.13296,GOBP_REGULATION_OF_HEPATIC_STELLATE_CELL_ACTIVATION,0.874455232338497
HP_NECK_MUSCLE_WEAKNESS,SET,84,0.099742,0.0067309,0.08968,0.13303,HP_NECK_MUSCLE_WEAKNESS,0.874455232338497
GOBP_EPIGENETIC_REGULATION_O...,SET,210,0.062596,0.006656,0.056282,0.13304,GOBP_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,0.874455232338497
HP_HEPATIC_CALCIFICATION,SET,5,0.43605,0.0071948,0.39207,0.13304,HP_HEPATIC_CALCIFICATION,0.874455232338497
GOBP_NEGATIVE_REGULATION_OF_...688,SET,3,0.59457,0.0075994,0.53463,0.13305,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.874455232338497
GSE43955_10H_VS_30H_ACT_CD4_...4,SET,183,0.068156,0.0067703,0.061296,0.13309,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.874455232338497
GOBP_NEUTROPHIL_APOPTOTIC_PR...,SET,7,0.41319,0.0080662,0.37161,0.1331,GOBP_NEUTROPHIL_APOPTOTIC_PROCESS,0.874455232338497
MIR1202,SET,67,0.10969,0.0066138,0.098669,0.13315,MIR1202,0.874455232338497
GOBP_NEGATIVE_REGULATION_OF_...518,SET,25,0.17223,0.006351,0.15495,0.13317,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.874455232338497
ANDERSEN_LIVER_CANCER_KRT19_...2,SET,33,0.16043,0.0067954,0.14434,0.13318,ANDERSEN_LIVER_CANCER_KRT19_UP,0.874455232338497
HP_IMPAIRED_NEUTROPHIL_BACTE...,SET,8,0.33716,0.0070362,0.30335,0.13319,HP_IMPAIRED_NEUTROPHIL_BACTERICIDAL_ACTIVITY,0.874455232338497
GSE17721_CTRL_VS_PAM3CSK4_1H...1,SET,184,0.069982,0.0069704,0.062966,0.1332,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN,0.874455232338497
HP_METHEMOGLOBINEMIA,SET,5,0.41783,0.0068941,0.37599,0.13323,HP_METHEMOGLOBINEMIA,0.874484853603604
GOBP_REGULATION_OF_OSTEOCLAS...1,SET,11,0.29856,0.0073056,0.26875,0.1333,GOBP_REGULATION_OF_OSTEOCLAST_DEVELOPMENT,0.874484853603604
GSE32533_MIR17_KO_VS_MIR17_O...1,SET,175,0.070097,0.0068107,0.063102,0.13332,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,0.874484853603604
GOBP_REGULATION_OF_NON_MOTIL...,SET,9,0.2806,0.006211,0.25261,0.13333,GOBP_REGULATION_OF_NON_MOTILE_CILIUM_ASSEMBLY,0.874484853603604
GSE26351_UNSTIM_VS_WNT_PATHW...1,SET,175,0.068338,0.0066398,0.061535,0.13339,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,0.874484853603604
HE_LIM_SUN_FETAL_LUNG_C4_ILC...2,SET,68,0.12057,0.0073238,0.10858,0.13341,HE_LIM_SUN_FETAL_LUNG_C4_ILC3_CELL,0.874484853603604
HP_CORTICAL_SCLEROSIS,SET,5,0.3884,0.0064085,0.34985,0.13347,HP_CORTICAL_SCLEROSIS,0.874484853603604
GSE3982_CTRL_VS_LPS_1H_NEUTR...1,SET,174,0.069071,0.006692,0.062223,0.13349,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN,0.874484853603604
chr3p25,SET,79,0.24679,0.016153,0.22236,0.13354,chr3p25,0.874484853603604
KEGG_MEDICUS_VARIANT_CDH1_RE...,SET,8,0.31474,0.0065684,0.28363,0.13357,KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY,0.874484853603604
GOBP_REGULATION_OF_SMOOTH_MU...1,SET,6,0.37437,0.0067664,0.33735,0.13357,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_CHEMOTAXIS,0.874484853603604
KEGG_MEDICUS_REFERENCE_IGF_I...2,SET,15,0.24093,0.0068836,0.21713,0.13359,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY,0.874484853603604
GSE34179_THPOK_KO_VS_WT_VA14...1,SET,183,0.070662,0.0070192,0.063681,0.13359,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN,0.874484853603604
HP_IMMOTILE_SPERM,SET,14,0.25454,0.0070259,0.22943,0.13362,HP_IMMOTILE_SPERM,0.874484853603604
NOUSHMEHR_GBM_SILENCED_BY_ME...,SET,45,0.14367,0.0071039,0.12954,0.13371,NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,0.874484853603604
GOBP_PEPTIDYL_ARGININE_METHY...1,SET,10,0.26791,0.0062506,0.24159,0.13374,GOBP_PEPTIDYL_ARGININE_METHYLATION,0.874484853603604
HAY_BONE_MARROW_CD34_POS_ERP...,SET,10,0.26921,0.0062809,0.24277,0.13374,HAY_BONE_MARROW_CD34_POS_ERP_EARLY,0.874484853603604
GOBP_RESPONSE_TO_HEPATOCYTE_...,SET,17,0.2427,0.0073815,0.21887,0.13375,GOBP_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR,0.874484853603604
GOBP_PLASMA_MEMBRANE_PHOSPHO...,SET,24,0.19891,0.0071868,0.1794,0.13378,GOBP_PLASMA_MEMBRANE_PHOSPHOLIPID_SCRAMBLING,0.874484853603604
DESCARTES_MAIN_FETAL_SLC26A4...,SET,195,0.06234,0.0063903,0.056227,0.13378,DESCARTES_MAIN_FETAL_SLC26A4_PAEP_POSITIVE_CELLS,0.874484853603604
SENESE_HDAC2_TARGETS_DN,SET,110,0.094943,0.0073267,0.085635,0.13379,SENESE_HDAC2_TARGETS_DN,0.874484853603604
MIR4782_3P,SET,140,0.077464,0.0067383,0.069868,0.13379,MIR4782_3P,0.874484853603604
HP_ABNORMAL_SPERMATOGENESIS,SET,134,0.079775,0.0067902,0.071972,0.13385,HP_ABNORMAL_SPERMATOGENESIS,0.874484853603604
GSE22886_NAIVE_BCELL_VS_BM_P...2,SET,178,0.067326,0.0065968,0.060744,0.13386,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP,0.874484853603604
KRIGE_RESPONSE_TO_TOSEDOSTAT...4,SET,793,0.033547,0.0068195,0.030269,0.13388,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP,0.874484853603604
chr17q24,SET,32,0.26366,0.010997,0.23792,0.1339,chr17q24,0.874484853603604
BIOCARTA_GPCR_PATHWAY,SET,28,0.18673,0.0072863,0.16852,0.13393,BIOCARTA_GPCR_PATHWAY,0.874484853603604
GSE3982_BCELL_VS_CENT_MEMORY...2,SET,177,0.069722,0.0068125,0.062925,0.13393,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP,0.874484853603604
GOBP_MONOUBIQUITINATED_PROTE...,SET,8,0.31502,0.0065742,0.28438,0.13399,GOBP_MONOUBIQUITINATED_PROTEIN_DEUBIQUITINATION,0.874484853603604
KEGG_MEDICUS_REFERENCE_AGE_R...,SET,15,0.23691,0.0067686,0.21387,0.134,KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY,0.874484853603604
GOBP_MEMBRANE_TO_MEMBRANE_DO...,SET,4,0.49896,0.0073637,0.45045,0.13401,GOBP_MEMBRANE_TO_MEMBRANE_DOCKING,0.874484853603604
WP_7OXOC_AND_7BETAHC_PATHWAYS,SET,25,0.19373,0.0071438,0.17491,0.13402,WP_7OXOC_AND_7BETAHC_PATHWAYS,0.874484853603604
REACTOME_SIGNALING_BY_RETINO...,SET,40,0.15633,0.0072889,0.14117,0.13406,REACTOME_SIGNALING_BY_RETINOIC_ACID,0.874484853603604
GSE23695_CD57_POS_VS_NEG_NK_...2,SET,185,0.065623,0.0065538,0.059257,0.13406,GSE23695_CD57_POS_VS_NEG_NK_CELL_UP,0.874484853603604
HP_LIMB_MYOCLONUS,SET,25,0.18867,0.0069571,0.17041,0.13412,HP_LIMB_MYOCLONUS,0.874579487900957
WP_PANCREATIC_ADENOCARCINOMA...,SET,83,0.10518,0.0070555,0.095005,0.13414,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,0.874579487900957
ZHU_CMV_24_HR_UP,SET,79,0.10354,0.006777,0.093532,0.13415,ZHU_CMV_24_HR_UP,0.874579487900957
GOBP_CELLULAR_RESPONSE_TO_CO...4,SET,62,0.1293,0.007501,0.11684,0.13423,GOBP_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS,0.874900937207123
HP_HYPOPLASIA_OF_THE_FOVEA,SET,25,0.19837,0.0073149,0.17928,0.13426,HP_HYPOPLASIA_OF_THE_FOVEA,0.874900937207123
WP_NUCLEOTIDEBINDING_OLIGOME...,SET,37,0.14089,0.0063181,0.12734,0.13429,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,0.874900937207123
GOBP_COBALT_ION_TRANSPORT,SET,6,0.40325,0.0072884,0.3645,0.1343,GOBP_COBALT_ION_TRANSPORT,0.874900937207123
HP_ABNORMALITY_OF_INTRACRANI...,SET,82,0.097306,0.0064883,0.08802,0.13448,HP_ABNORMALITY_OF_INTRACRANIAL_PRESSURE,0.875677580071174
HP_ABNORMAL_PHAGOCYTOSIS,SET,3,0.56253,0.0071899,0.50885,0.13448,HP_ABNORMAL_PHAGOCYTOSIS,0.875677580071174
GOBP_RESPONSE_TO_INTERLEUKIN...9,SET,35,0.15664,0.0068323,0.14171,0.13451,GOBP_RESPONSE_TO_INTERLEUKIN_4,0.875677580071174
REACTOME_MITOTIC_SPINDLE_CHE...,SET,104,0.087618,0.0065755,0.07927,0.13452,REACTOME_MITOTIC_SPINDLE_CHECKPOINT,0.875677580071174
GOBP_REGULATION_OF_TOOTH_MIN...,SET,10,0.31803,0.0074199,0.28779,0.13457,GOBP_REGULATION_OF_TOOTH_MINERALIZATION,0.875839016853933
GSE22935_WT_VS_MYD88_KO_MACR...8,SET,181,0.07123,0.0070373,0.064465,0.1346,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP,0.875870249017038
GSE9650_EFFECTOR_VS_MEMORY_C...2,SET,183,0.067115,0.0066668,0.060759,0.13467,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP,0.875898839820359
KEGG_DORSO_VENTRAL_AXIS_FORM...,SET,24,0.19691,0.0071146,0.17827,0.13468,KEGG_DORSO_VENTRAL_AXIS_FORMATION,0.875898839820359
GSE32986_GMCSF_VS_GMCSF_AND_...1,SET,167,0.074022,0.0070273,0.067014,0.13468,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.875898839820359
HP_OVOTESTIS,SET,3,0.567,0.007247,0.51354,0.13478,HP_OVOTESTIS,0.876385201122545
GOBP_REGULATION_OF_RECEPTOR_...2,SET,10,0.27994,0.0065312,0.25368,0.13491,GOBP_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS,0.876843971893491
GOCC_NURD_COMPLEX,SET,14,0.23472,0.0064788,0.2127,0.13491,GOCC_NURD_COMPLEX,0.876843971893491
ASTON_MAJOR_DEPRESSIVE_DISOR...1,SET,146,0.076568,0.0068005,0.069393,0.13493,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,0.876843971893491
GSE15271_CXCR4_POS_VS_NEG_GC...2,SET,158,0.070583,0.0065194,0.064003,0.13506,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_UP,0.876843971893491
HP_OLIGURIA,SET,13,0.26807,0.0071304,0.24309,0.13507,HP_OLIGURIA,0.876843971893491
REACTOME_TRAF6_MEDIATED_NF_K...,SET,23,0.18651,0.0065971,0.16915,0.1351,REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION,0.876843971893491
KORKOLA_CORRELATED_WITH_POU5...,SET,25,0.19247,0.0070971,0.17456,0.13511,KORKOLA_CORRELATED_WITH_POU5F1,0.876843971893491
GSE43863_DAY6_EFF_VS_DAY150_...1,SET,174,0.069989,0.0067809,0.063478,0.13511,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_DN,0.876843971893491
GSE9946_IMMATURE_VS_MATURE_S...2,SET,124,0.078996,0.0064699,0.071675,0.13521,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP,0.876843971893491
REACTOME_DOWNSTREAM_SIGNALIN...1,SET,77,0.096278,0.0062218,0.08736,0.13522,REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,0.876843971893491
REACTOME_INTERACTION_WITH_CU...,SET,11,0.26752,0.0065459,0.24273,0.13522,REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA,0.876843971893491
HP_ABNORMALITY_OF_THE_BILIAR...,SET,355,0.049593,0.0068288,0.04501,0.13528,HP_ABNORMALITY_OF_THE_BILIARY_SYSTEM,0.876843971893491
MIR6795_5P,SET,120,0.085261,0.0068702,0.077386,0.13529,MIR6795_5P,0.876843971893491
KEGG_CYSTEINE_AND_METHIONINE...,SET,32,0.18268,0.0076199,0.16581,0.1353,KEGG_CYSTEINE_AND_METHIONINE_METABOLISM,0.876843971893491
BOYLAN_MULTIPLE_MYELOMA_C_D_...2,SET,125,0.081413,0.0066945,0.073944,0.13546,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,0.876843971893491
HP_APLASIA_HYPOPLASIA_INVOLV...12,SET,64,0.11822,0.0069672,0.10737,0.13546,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_PELVIS,0.876843971893491
REACTOME_LOSS_OF_FUNCTION_OF...2,SET,7,0.34341,0.0067039,0.31194,0.13549,REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER,0.876843971893491
GOBP_SYNAPTIC_VESICLE_MEMBRA...,SET,27,0.16566,0.006348,0.15049,0.13549,GOBP_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION,0.876843971893491
ZNF486_TARGET_GENES,SET,160,0.074252,0.0069011,0.067452,0.1355,ZNF486_TARGET_GENES,0.876843971893491
GSE22886_DAY1_VS_DAY7_MONOCY...2,SET,181,0.070091,0.0069247,0.063676,0.13551,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP,0.876843971893491
HP_HIGH_FREQUENCY_SENSORINEU...,SET,6,0.35879,0.0064848,0.32603,0.13557,HP_HIGH_FREQUENCY_SENSORINEURAL_HEARING_IMPAIRMENT,0.876843971893491
HP_PHOCOMELIA,SET,7,0.36165,0.0070601,0.32865,0.13558,HP_PHOCOMELIA,0.876843971893491
GOBP_PLASMINOGEN_ACTIVATION,SET,24,0.19308,0.0069762,0.17548,0.1356,GOBP_PLASMINOGEN_ACTIVATION,0.876843971893491
IKEDA_MIR1_TARGETS_DN,SET,6,0.41577,0.0075146,0.37789,0.13562,IKEDA_MIR1_TARGETS_DN,0.876843971893491
VANTVEER_BREAST_CANCER_METAS...2,SET,41,0.14539,0.0068629,0.13215,0.13563,VANTVEER_BREAST_CANCER_METASTASIS_UP,0.876843971893491
GOBP_REGULATION_OF_ASPARTIC_...2,SET,7,0.38174,0.0074522,0.34699,0.13564,GOBP_REGULATION_OF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,0.876843971893491
GSE15659_CD45RA_NEG_CD4_TCEL...1,SET,164,0.072029,0.006777,0.065471,0.13564,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN,0.876843971893491
REACTOME_BIOSYNTHESIS_OF_MAR...1,SET,8,0.3221,0.006722,0.29279,0.13565,REACTOME_BIOSYNTHESIS_OF_MARESINS,0.876843971893491
GOCC_MITOCHONDRIAL_CRISTA,SET,6,0.4241,0.0076652,0.38556,0.13569,GOCC_MITOCHONDRIAL_CRISTA,0.876843971893491
PLASARI_TGFB1_SIGNALING_VIA_...1,SET,29,0.20016,0.0079486,0.18203,0.13576,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN,0.876843971893491
WP_OMEGA3_OMEGA6_FATTY_ACID_...,SET,14,0.27108,0.0074825,0.24657,0.13581,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,0.876843971893491
KEGG_MEDICUS_REFERENCE_RAB7_...,SET,40,0.15175,0.0070751,0.13804,0.13582,KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT,0.876843971893491
NERF_Q2,SET,228,0.061321,0.0067907,0.055792,0.13587,NERF_Q2,0.876843971893491
GOMF_NUCLEOSIDE_BINDING,SET,8,0.30414,0.006347,0.27672,0.13588,GOMF_NUCLEOSIDE_BINDING,0.876843971893491
MIR1253,SET,158,0.075286,0.0069538,0.068519,0.13594,MIR1253,0.876843971893491
MIR5787,SET,230,0.061807,0.0068741,0.05625,0.13594,MIR5787,0.876843971893491
GOMF_GABA_RECEPTOR_BINDING,SET,16,0.22441,0.0066216,0.20424,0.13595,GOMF_GABA_RECEPTOR_BINDING,0.876843971893491
REACTOME_PHASE_0_RAPID_DEPOL...,SET,31,0.18798,0.0077175,0.17109,0.13596,REACTOME_PHASE_0_RAPID_DEPOLARISATION,0.876843971893491
GOBP_NEGATIVE_REGULATION_OF_...503,SET,17,0.24808,0.0075451,0.22588,0.13604,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.876843971893491
GOBP_TROPHECTODERMAL_CELL_DI...,SET,19,0.20885,0.0067148,0.19015,0.13604,GOBP_TROPHECTODERMAL_CELL_DIFFERENTIATION,0.876843971893491
PID_FOXO_PATHWAY,SET,47,0.13859,0.007003,0.1262,0.13606,PID_FOXO_PATHWAY,0.876843971893491
MATZUK_CUMULUS_EXPANSION,SET,8,0.39028,0.0081449,0.3554,0.13608,MATZUK_CUMULUS_EXPANSION,0.876843971893491
GOMF_PHOSPHATIDYLINOSITOL_4_...1,SET,9,0.24719,0.0054714,0.22511,0.13609,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.876843971893491
GOMF_PHOSPHATIDYLINOSITOL_4_...3,SET,9,0.24719,0.0054714,0.22511,0.13609,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.876843971893491
MIR644A,SET,56,0.12868,0.0070955,0.1172,0.13612,MIR644A,0.876843971893491
GOBP_POSITIVE_REGULATION_OF_...816,SET,25,0.19475,0.0071815,0.17738,0.13612,GOBP_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,0.876843971893491
HALLMARK_PEROXISOME,SET,98,0.09196,0.0067004,0.083755,0.13612,HALLMARK_PEROXISOME,0.876843971893491
HP_ABNORMAL_FIFTH_TOE_MORPHO...,SET,83,0.099758,0.006692,0.090865,0.13614,HP_ABNORMAL_FIFTH_TOE_MORPHOLOGY,0.876843971893491
HP_ABNORMAL_VASCULAR_PHYSIOL...,SET,285,0.055293,0.0068351,0.050367,0.13615,HP_ABNORMAL_VASCULAR_PHYSIOLOGY,0.876843971893491
HP_PROLONGED_BLEEDING_AFTER_...1,SET,21,0.22968,0.0077632,0.20923,0.13617,HP_PROLONGED_BLEEDING_AFTER_DENTAL_EXTRACTION,0.876843971893491
GOMF_ALANINE_TRANSMEMBRANE_T...,SET,14,0.27072,0.0074725,0.24662,0.13618,GOMF_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.876843971893491
HP_RENAL_DUPLICATION,SET,31,0.18467,0.0075816,0.16825,0.1362,HP_RENAL_DUPLICATION,0.876843971893491
GOBP_NEURAL_TUBE_PATTERNING,SET,29,0.18395,0.0073048,0.16761,0.13622,GOBP_NEURAL_TUBE_PATTERNING,0.876843971893491
GOBP_POSITIVE_REGULATION_OF_...387,SET,11,0.2668,0.0065284,0.24313,0.13625,GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES,0.876843971893491
GOBP_MRNA_5_SPLICE_SITE_RECO...,SET,6,0.3062,0.0055344,0.27904,0.13626,GOBP_MRNA_5_SPLICE_SITE_RECOGNITION,0.876843971893491
GSE24142_ADULT_VS_FETAL_EARL...1,SET,177,0.07085,0.0069227,0.064575,0.13629,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN,0.876843971893491
ERWIN_COHEN_BLOOD_VACCINE_TC...3,SET,5,0.40005,0.0066008,0.36464,0.1363,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_DN,0.876843971893491
HP_ABNORMAL_GLOMERULAR_FILTR...,SET,26,0.17682,0.0066489,0.16118,0.13632,HP_ABNORMAL_GLOMERULAR_FILTRATION_RATE,0.876843971893491
GOBP_REGULATION_OF_GLUCOKINA...,SET,4,0.49849,0.0073568,0.45444,0.13634,GOBP_REGULATION_OF_GLUCOKINASE_ACTIVITY,0.876843971893491
GSE14350_IL2RB_KO_VS_WT_TEFF...1,SET,184,0.066739,0.0066474,0.060855,0.1364,GSE14350_IL2RB_KO_VS_WT_TEFF_DN,0.876843971893491
DORN_ADENOVIRUS_INFECTION_12...1,SET,30,0.15933,0.0064349,0.14529,0.13642,DORN_ADENOVIRUS_INFECTION_12HR_DN,0.876843971893491
HP_ACQUIRED_ABNORMAL_HAIR_PA...,SET,34,0.16569,0.0071233,0.1511,0.13642,HP_ACQUIRED_ABNORMAL_HAIR_PATTERN,0.876843971893491
GOCC_DYNEIN_COMPLEX,SET,43,0.13464,0.0065081,0.12279,0.13644,GOCC_DYNEIN_COMPLEX,0.876843971893491
GOBP_TONGUE_MORPHOGENESIS,SET,9,0.33952,0.0075151,0.30972,0.1365,GOBP_TONGUE_MORPHOGENESIS,0.876871668822768
HP_HYPOPLASIA_OF_THE_ZYGOMAT...,SET,37,0.15664,0.0070247,0.1429,0.13651,HP_HYPOPLASIA_OF_THE_ZYGOMATIC_BONE,0.876871668822768
GOCC_PERINUCLEOLAR_COMPARTME...,SET,5,0.39647,0.0065416,0.3617,0.13652,GOCC_PERINUCLEOLAR_COMPARTMENT,0.876871668822768
HP_ABNORMAL_FACTOR_VIII_ACTI...,SET,4,0.44711,0.0065985,0.408,0.13658,HP_ABNORMAL_FACTOR_VIII_ACTIVITY,0.876921912899669
HP_MIXED_HYPO_AND_HYPERPIGME...,SET,10,0.25816,0.006023,0.23559,0.13659,HP_MIXED_HYPO_AND_HYPERPIGMENTATION_OF_THE_SKIN,0.876921912899669
ATGTACA_MIR493,SET,294,0.055474,0.0069632,0.050635,0.13664,ATGTACA_MIR493,0.876921912899669
GOBP_CELL_MATURATION,SET,188,0.069322,0.0069786,0.063279,0.13666,GOBP_CELL_MATURATION,0.876921912899669
HP_OVARIAN_GONADOBLASTOMA,SET,9,0.33993,0.0075242,0.31031,0.13666,HP_OVARIAN_GONADOBLASTOMA,0.876921912899669
GSE29164_UNTREATED_VS_CD8_TC...7,SET,178,0.069392,0.0067992,0.063369,0.13675,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN,0.876921912899669
KEGG_MEDICUS_VARIANT_MUTATIO...7,SET,29,0.17187,0.0068251,0.157,0.13683,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.876921912899669
GOBP_REGULATION_OF_PLASMINOG...,SET,17,0.21183,0.0064426,0.19354,0.13688,GOBP_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.876921912899669
HP_LONG_EAR,SET,6,0.32331,0.0058435,0.29544,0.13691,HP_LONG_EAR,0.876921912899669
GOBP_ANIMAL_ORGAN_MATURATION,SET,28,0.18284,0.0071346,0.16708,0.13692,GOBP_ANIMAL_ORGAN_MATURATION,0.876921912899669
GSE6566_STRONG_VS_WEAK_DC_ST...1,SET,156,0.073258,0.0067239,0.066947,0.13692,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN,0.876921912899669
GOBP_CALCIUM_ION_TRANSMEMBRA...2,SET,311,0.054454,0.0070267,0.049764,0.13693,GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.876921912899669
GSE28737_FOLLICULAR_VS_MARGI...1,SET,184,0.068444,0.0068172,0.062556,0.13696,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_DN,0.876921912899669
GSE30971_WBP7_HET_VS_KO_MACR...1,SET,184,0.073687,0.0073395,0.067349,0.13696,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN,0.876921912899669
HAY_BONE_MARROW_PRE_DENDRITIC,SET,5,0.43768,0.0072216,0.40012,0.13701,HAY_BONE_MARROW_PRE_DENDRITIC,0.876921912899669
GOBP_POSITIVE_REGULATION_OF_...318,SET,14,0.25978,0.0071705,0.23749,0.13702,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,0.876921912899669
HP_FULMINANT_HEPATIC_FAILURE,SET,5,0.35543,0.0058644,0.32493,0.13702,HP_FULMINANT_HEPATIC_FAILURE,0.876921912899669
WP_DNA_REPLICATION,SET,40,0.13719,0.0063963,0.12544,0.13707,WP_DNA_REPLICATION,0.876921912899669
GOBP_MITOTIC_DNA_REPLICATION,SET,15,0.22528,0.0064364,0.20606,0.13714,GOBP_MITOTIC_DNA_REPLICATION,0.876921912899669
GOMF_SCAFFOLD_PROTEIN_BINDING,SET,65,0.11736,0.0069706,0.10736,0.13716,GOMF_SCAFFOLD_PROTEIN_BINDING,0.876921912899669
GSE21546_UNSTIM_VS_ANTI_CD3_...4,SET,160,0.074227,0.0068988,0.067911,0.1372,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP,0.876921912899669
GOBP_CELLULAR_RESPONSE_TO_AL...3,SET,7,0.38313,0.0074793,0.35054,0.13721,GOBP_CELLULAR_RESPONSE_TO_ALDOSTERONE,0.876921912899669
GOBP_HEMOPOIESIS,SET,878,0.032965,0.0070341,0.030161,0.13721,GOBP_HEMOPOIESIS,0.876921912899669
GAVISH_3CA_MALIGNANT_METAPRO...37,SET,37,0.15567,0.006981,0.14244,0.13722,GAVISH_3CA_MALIGNANT_METAPROGRAM_7_STRESS_IN_VITRO,0.876921912899669
SANCHEZ_MDM2_TARGETS,SET,9,0.30399,0.0067287,0.27815,0.13723,SANCHEZ_MDM2_TARGETS,0.876921912899669
CHEN_HOXA5_TARGETS_9HR_UP,SET,205,0.064908,0.00682,0.059397,0.13726,CHEN_HOXA5_TARGETS_9HR_UP,0.876921912899669
DESCARTES_FETAL_MUSCLE_LYMPH...2,SET,96,0.093616,0.0067515,0.085671,0.13726,DESCARTES_FETAL_MUSCLE_LYMPHOID_CELLS,0.876921912899669
GOBP_REGULATION_OF_NEUROTRAN...1,SET,40,0.15371,0.0071663,0.14067,0.13728,GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.876921912899669
HP_DELAYED_FINE_MOTOR_DEVELO...,SET,45,0.13584,0.0067167,0.12432,0.13728,HP_DELAYED_FINE_MOTOR_DEVELOPMENT,0.876921912899669
REACTOME_METAL_ION_SLC_TRANS...,SET,23,0.18656,0.0065988,0.17076,0.13731,REACTOME_METAL_ION_SLC_TRANSPORTERS,0.876921912899669
GSE18893_TCONV_VS_TREG_24H_T...2,SET,175,0.064814,0.0062974,0.059326,0.13731,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP,0.876921912899669
HP_ABNORMALITY_OF_THE_MUSCUL...1,SET,111,0.083534,0.0064753,0.076475,0.13736,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_HAND,0.876962000732869
GSE36078_UNTREATED_VS_AD5_T4...3,SET,181,0.068698,0.0067871,0.062913,0.13743,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN,0.876962000732869
GOBP_RESPONSE_TO_NITRIC_OXIDE,SET,17,0.22025,0.0066988,0.20173,0.13746,GOBP_RESPONSE_TO_NITRIC_OXIDE,0.876962000732869
GOMF_OXIDOREDUCTASE_ACTIVITY...32,SET,31,0.15388,0.0063176,0.14095,0.13748,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,0.876962000732869
HP_THORACIC_KYPHOSCOLIOSIS,SET,24,0.17185,0.0062089,0.15745,0.13754,HP_THORACIC_KYPHOSCOLIOSIS,0.876962000732869
REACTOME_TRANSCRIPTIONAL_REG...14,SET,12,0.28554,0.0072975,0.26164,0.13757,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_TESTIS_DIFFERENTIATION,0.876962000732869
GOBP_POSITIVE_REGULATION_OF_...640,SET,24,0.18746,0.0067732,0.17179,0.13759,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MATURATION,0.876962000732869
WP_OXIDATIVE_STRESS_RESPONSE,SET,29,0.18319,0.0072748,0.16789,0.13761,WP_OXIDATIVE_STRESS_RESPONSE,0.876962000732869
REACTOME_TRANSLATION,SET,256,0.054347,0.0063723,0.049815,0.13765,REACTOME_TRANSLATION,0.876962000732869
GOBP_POSITIVE_REGULATION_OF_...804,SET,63,0.13056,0.0076346,0.11967,0.13765,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,0.876962000732869
MIR578,SET,168,0.072451,0.0068985,0.066412,0.13766,MIR578,0.876962000732869
GSE27786_NKTCELL_VS_ERYTHROB...2,SET,185,0.065611,0.0065526,0.060142,0.13766,GSE27786_NKTCELL_VS_ERYTHROBLAST_UP,0.876962000732869
GOMF_DOPAMINE_RECEPTOR_BINDI...,SET,13,0.2514,0.0066871,0.23048,0.13769,GOMF_DOPAMINE_RECEPTOR_BINDING,0.876962000732869
GOCC_EUCHROMATIN,SET,49,0.12447,0.0064213,0.11411,0.1377,GOCC_EUCHROMATIN,0.876962000732869
HP_DECREASED_PROPORTION_OF_C...2,SET,8,0.30418,0.006348,0.27889,0.13771,HP_DECREASED_PROPORTION_OF_CD8_POSITIVE_T_CELLS,0.876962000732869
GOBP_URIDINE_TRANSMEMBRANE_T...,SET,6,0.37844,0.00684,0.34699,0.13772,GOBP_URIDINE_TRANSMEMBRANE_TRANSPORT,0.876962000732869
GOMF_BETA_2_MICROGLOBULIN_BI...,SET,8,0.34608,0.0072224,0.31739,0.13777,GOMF_BETA_2_MICROGLOBULIN_BINDING,0.876986408566722
GOCC_DYSTROGLYCAN_COMPLEX,SET,7,0.36966,0.0072163,0.33903,0.13779,GOCC_DYSTROGLYCAN_COMPLEX,0.876986408566722
GOBP_MONOCYTE_ACTIVATION,SET,12,0.27261,0.0069669,0.25004,0.1378,GOBP_MONOCYTE_ACTIVATION,0.876986408566722
HP_AMBIGUOUS_GENITALIA_MALE,SET,11,0.2818,0.0068954,0.25849,0.13783,HP_AMBIGUOUS_GENITALIA_MALE,0.876986408566722
GOBP_STEM_CELL_DIVISION,SET,30,0.17218,0.006954,0.15796,0.13785,GOBP_STEM_CELL_DIVISION,0.876986408566722
GOBP_NEGATIVE_REGULATION_OF_...451,SET,26,0.18297,0.0068802,0.16792,0.13794,GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.87727375524348
BOSCO_EPITHELIAL_DIFFERENTIA...,SET,60,0.12697,0.0072464,0.11656,0.13802,BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE,0.87727375524348
MIR4999_3P,SET,35,0.1479,0.0064513,0.13579,0.13805,MIR4999_3P,0.87727375524348
HP_TALIPES_EQUINOVALGUS,SET,13,0.23459,0.0062398,0.21545,0.13812,HP_TALIPES_EQUINOVALGUS,0.87727375524348
GSE23321_CENTRAL_VS_EFFECTOR...1,SET,178,0.067449,0.0066087,0.06195,0.13814,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,0.87727375524348
HP_RETINAL_ARTERIOLAR_TORTUO...,SET,27,0.20619,0.007901,0.1894,0.13817,HP_RETINAL_ARTERIOLAR_TORTUOSITY,0.87727375524348
GOBP_POSITIVE_REGULATION_OF_...332,SET,6,0.37882,0.0068468,0.34801,0.13819,GOBP_POSITIVE_REGULATION_OF_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.87727375524348
GSE27670_CTRL_VS_BLIMP1_TRAN...2,SET,186,0.068014,0.0068108,0.062482,0.13819,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP,0.87727375524348
ACTTTAT_MIR1425P,SET,268,0.054831,0.0065758,0.050374,0.1382,ACTTTAT_MIR1425P,0.87727375524348
SHIN_B_CELL_LYMPHOMA_CLUSTER...3,SET,27,0.19544,0.0074891,0.17957,0.13821,SHIN_B_CELL_LYMPHOMA_CLUSTER_3,0.87727375524348
GOBP_RELAXATION_OF_VASCULAR_...,SET,4,0.46621,0.0068804,0.42836,0.13822,GOBP_RELAXATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE,0.87727375524348
GSE27786_NKCELL_VS_NKTCELL_DN,SET,182,0.067912,0.0067278,0.06242,0.13831,GSE27786_NKCELL_VS_NKTCELL_DN,0.87727375524348
GOBP_AMYLOID_BETA_CLEARANCE_...1,SET,8,0.34088,0.0071139,0.31333,0.13832,GOBP_AMYLOID_BETA_CLEARANCE_BY_CELLULAR_CATABOLIC_PROCESS,0.87727375524348
MIR203A_5P,SET,51,0.12514,0.0065861,0.11503,0.13833,MIR203A_5P,0.87727375524348
HP_HYPOTHALAMIC_HAMARTOMA,SET,14,0.21101,0.0058243,0.19396,0.13833,HP_HYPOTHALAMIC_HAMARTOMA,0.87727375524348
BLANCO_MELO_INFLUENZA_A_INFE...1,SET,101,0.08562,0.0063327,0.078717,0.13837,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN,0.87727375524348
THAKAR_PBMC_INACTIVATED_INFL...4,SET,115,0.085667,0.0067585,0.078759,0.13837,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP,0.87727375524348
GOBP_REGULATION_OF_MAST_CELL...2,SET,4,0.47152,0.0069589,0.43353,0.13839,GOBP_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.87727375524348
GOMF_ARYL_SULFOTRANSFERASE_A...,SET,7,0.43461,0.0084844,0.39962,0.1384,GOMF_ARYL_SULFOTRANSFERASE_ACTIVITY,0.87727375524348
HP_REDUCED_FEV1_FVC_RATIO,SET,7,0.35173,0.0068663,0.3234,0.1384,HP_REDUCED_FEV1_FVC_RATIO,0.87727375524348
MIR219B_3P,SET,54,0.12305,0.0066631,0.11318,0.1385,MIR219B_3P,0.877714238833181
REACTOME_TRAF6_MEDIATED_INDU...,SET,14,0.26382,0.007282,0.24269,0.13852,REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX,0.877714238833181
GOBP_GERM_CELL_PROLIFERATION,SET,10,0.25399,0.0059258,0.23374,0.13861,GOBP_GERM_CELL_PROLIFERATION,0.878087702678083
REACTOME_ANDROGEN_BIOSYNTHES...,SET,11,0.28587,0.006995,0.26311,0.13864,REACTOME_ANDROGEN_BIOSYNTHESIS,0.878087702678083
HP_PNEUMONIA,SET,274,0.055176,0.0066898,0.050788,0.13866,HP_PNEUMONIA,0.878087702678083
MODULE_103,SET,10,0.25134,0.005864,0.23137,0.13868,MODULE_103,0.878087702678083
RUTELLA_RESPONSE_TO_HGF_VS_C...2,SET,371,0.049796,0.0070066,0.045859,0.13878,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,0.878167442706439
GOBP_REGULATION_OF_PROTEIN_P...2,SET,22,0.19684,0.0068096,0.18128,0.13879,GOBP_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,0.878167442706439
MANNO_MIDBRAIN_NEUROTYPES_HP...1,SET,701,0.03692,0.0070749,0.034003,0.13879,MANNO_MIDBRAIN_NEUROTYPES_HPERIC,0.878167442706439
GOBP_ALTERNATIVE_MRNA_SPLICI...,SET,67,0.10391,0.0062656,0.095712,0.13882,GOBP_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,0.878167442706439
NAGASHIMA_NRG1_SIGNALING_UP,SET,166,0.075045,0.0071033,0.069132,0.13885,NAGASHIMA_NRG1_SIGNALING_UP,0.878167442706439
NAKAYA_PBMC_FLUMIST_AGE_18_5...4,SET,764,0.033198,0.0066296,0.030588,0.13889,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN,0.878167442706439
HP_ABNORMAL_MALE_INTERNAL_GE...,SET,69,0.11654,0.0071308,0.10738,0.1389,HP_ABNORMAL_MALE_INTERNAL_GENITALIA_MORPHOLOGY,0.878167442706439
GSE27291_0H_VS_7D_STIM_GAMMA...2,SET,154,0.069985,0.0063825,0.064486,0.13891,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP,0.878167442706439
HP_SPINAL_CORD_TUMOR,SET,9,0.28711,0.006355,0.26457,0.13892,HP_SPINAL_CORD_TUMOR,0.878167442706439
GSE15930_NAIVE_VS_48H_IN_VIT...1,SET,183,0.062846,0.0062428,0.057922,0.13897,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN,0.878223854961832
GOBP_MAINTENANCE_OF_CELL_NUM...,SET,170,0.069064,0.0066147,0.063665,0.13901,GOBP_MAINTENANCE_OF_CELL_NUMBER,0.878223854961832
GSE9946_IMMATURE_VS_LISTERIA...1,SET,112,0.085252,0.006638,0.078586,0.13901,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_DN,0.878223854961832
BIOCARTA_HES_PATHWAY,SET,11,0.28652,0.0070108,0.26414,0.13903,BIOCARTA_HES_PATHWAY,0.878223854961832
GSE43955_1H_VS_10H_ACT_CD4_T...3,SET,179,0.069257,0.0068048,0.063861,0.13908,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.878283602834302
BOQUEST_STEM_CELL_UP,SET,232,0.065738,0.0073427,0.06062,0.13909,BOQUEST_STEM_CELL_UP,0.878283602834302
KEGG_MEDICUS_REFERENCE_CA2_P...2,SET,14,0.23673,0.0065344,0.21834,0.13913,KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY,0.87837659400545
MA_MYELOID_DIFFERENTIATION_DN,SET,40,0.14844,0.0069208,0.13693,0.13918,MA_MYELOID_DIFFERENTIATION_DN,0.878532673447149
GOMF_TRNA_BINDING,SET,62,0.10102,0.0058602,0.093198,0.13921,GOMF_TRNA_BINDING,0.878562475031778
WP_HYPERTROPHY_MODEL,SET,19,0.2199,0.0070701,0.20296,0.13931,WP_HYPERTROPHY_MODEL,0.8789374841169
GOBP_HYDROGEN_PEROXIDE_BIOSY...,SET,14,0.25963,0.0071665,0.23964,0.13932,GOBP_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS,0.8789374841169
GOBP_CILIUM_ORGANIZATION,SET,369,0.046109,0.0064706,0.042573,0.1394,GOBP_CILIUM_ORGANIZATION,0.879186091453457
GOBP_POSITIVE_REGULATION_OF_...155,SET,136,0.082703,0.0070913,0.076365,0.13941,GOBP_POSITIVE_REGULATION_OF_CHEMOTAXIS,0.879186091453457
GOMF_POTASSIUM_CHANNEL_REGUL...,SET,46,0.13776,0.0068864,0.12721,0.13944,GOMF_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY,0.879215747460087
AMBROSINI_FLAVOPIRIDOL_TREAT...,SET,99,0.089299,0.0065394,0.08249,0.13951,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,0.87949756031199
GOMF_UDP_GLUCOSYLTRANSFERASE...,SET,8,0.27676,0.0057757,0.25573,0.13958,GOMF_UDP_GLUCOSYLTRANSFERASE_ACTIVITY,0.879779270946681
HP_BILATERAL_CRYPTORCHIDISM,SET,43,0.12935,0.0062524,0.11959,0.13972,HP_BILATERAL_CRYPTORCHIDISM,0.880502012692656
MIR1293,SET,55,0.12801,0.0069957,0.11838,0.13977,MIR1293,0.880581682361463
GSE5589_WT_VS_IL10_KO_LPS_AN...3,SET,183,0.065657,0.0065221,0.060726,0.13981,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.880581682361463
OUILLETTE_CLL_13Q14_DELETION...2,SET,70,0.097212,0.0059909,0.089922,0.13984,OUILLETTE_CLL_13Q14_DELETION_UP,0.880581682361463
GOBP_CARDIAC_MUSCLE_TISSUE_R...,SET,6,0.35141,0.0063514,0.32506,0.13984,GOBP_CARDIAC_MUSCLE_TISSUE_REGENERATION,0.880581682361463
GOMF_MITOCHONDRION_TARGETING...,SET,5,0.35295,0.0058236,0.32652,0.13986,GOMF_MITOCHONDRION_TARGETING_SEQUENCE_BINDING,0.880581682361463
GSE3720_VD1_VS_VD2_GAMMADELT...6,SET,177,0.069138,0.0067554,0.063966,0.13989,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP,0.880581682361463
GOBP_REGULATION_OF_ENAMEL_MI...,SET,7,0.36101,0.0070475,0.33403,0.13991,GOBP_REGULATION_OF_ENAMEL_MINERALIZATION,0.880581682361463
DESCARTES_MAIN_FETAL_INTESTI...,SET,69,0.11201,0.0068535,0.10366,0.13995,DESCARTES_MAIN_FETAL_INTESTINAL_EPITHELIAL_CELLS,0.880673954372624
REACTOME_BIOSYNTHESIS_OF_EPA...,SET,6,0.44296,0.008006,0.41001,0.14,REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS,0.880811822125813
GSE12507_PDC_CELL_LINE_VS_IM...2,SET,136,0.078879,0.0067635,0.073025,0.14004,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP,0.880811822125813
REACTOME_RRNA_PROCESSING,SET,177,0.063815,0.0062353,0.059081,0.14005,REACTOME_RRNA_PROCESSING,0.880811822125813
GOBP_POSITIVE_REGULATION_OF_...810,SET,8,0.33094,0.0069064,0.30643,0.14008,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT,0.880811822125813
GOMF_3_5_DNA_EXONUCLEASE_ACT...,SET,13,0.23466,0.0062418,0.21731,0.14011,GOMF_3_5_DNA_EXONUCLEASE_ACTIVITY,0.880811822125813
HP_ABNORMAL_BRONCHUS_MORPHOL...,SET,186,0.066624,0.0066716,0.061704,0.14014,HP_ABNORMAL_BRONCHUS_MORPHOLOGY,0.880811822125813
chr19q12,SET,9,0.41644,0.0092175,0.38572,0.14016,chr19q12,0.880811822125813
GCCATNTTG_YY1_Q6,SET,385,0.045102,0.0064622,0.041783,0.1402,GCCATNTTG_YY1_Q6,0.880811822125813
GOBP_NEGATIVE_REGULATION_OF_...64,SET,14,0.22034,0.006082,0.20413,0.1402,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT,0.880811822125813
KONDO_COLON_CANCER_HCP_WITH_...2,SET,4,0.51197,0.0075558,0.47443,0.14027,KONDO_COLON_CANCER_HCP_WITH_H3K27ME3,0.88095796460177
MIR146A_3P,SET,197,0.066269,0.0068273,0.061417,0.1403,MIR146A_3P,0.88095796460177
MIR643,SET,58,0.11641,0.0065322,0.10789,0.14032,MIR643,0.88095796460177
YAMANAKA_GLIOBLASTOMA_SURVIV...2,SET,9,0.32034,0.0070905,0.29695,0.14035,YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP,0.88095796460177
GOMF_ACETYLCHOLINE_RECEPTOR_...1,SET,22,0.20469,0.007081,0.18974,0.14035,GOMF_ACETYLCHOLINE_RECEPTOR_ACTIVITY,0.88095796460177
EPC1_TARGET_GENES,SET,308,0.051313,0.00659,0.047577,0.14041,EPC1_TARGET_GENES,0.881074688684353
GOMF_MACROLIDE_BINDING,SET,12,0.23086,0.0059,0.21406,0.14042,GOMF_MACROLIDE_BINDING,0.881074688684353
GOCC_EUKARYOTIC_TRANSLATION_...2,SET,3,0.51222,0.0065468,0.47501,0.14045,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2_COMPLEX,0.881074688684353
GOBP_REGULATION_OF_HEXOKINAS...,SET,5,0.44514,0.0073446,0.41283,0.14047,GOBP_REGULATION_OF_HEXOKINASE_ACTIVITY,0.881074688684353
HP_PAIN_INSENSITIVITY,SET,26,0.17781,0.0066862,0.16493,0.1405,HP_PAIN_INSENSITIVITY,0.881103843377842
WP_ENDOPLASMIC_RETICULUM_STR...,SET,44,0.13492,0.0065969,0.12523,0.14066,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.881808695260407
HP_DERMATOLOGICAL_MANIFESTAT...,SET,301,0.052045,0.0066088,0.048312,0.14069,HP_DERMATOLOGICAL_MANIFESTATIONS_OF_SYSTEMIC_DISORDERS,0.881808695260407
HP_SEVERE_EXPRESSIVE_LANGUAG...,SET,9,0.30359,0.0067197,0.28182,0.14069,HP_SEVERE_EXPRESSIVE_LANGUAGE_DELAY,0.881808695260407
GOMF_ATP_DEPENDENT_CHROMATIN...,SET,33,0.14348,0.0060771,0.13321,0.14073,GOMF_ATP_DEPENDENT_CHROMATIN_REMODELER_ACTIVITY,0.881808695260407
HP_NEOPLASM_OF_THE_EYE,SET,47,0.11545,0.0058336,0.10719,0.14074,HP_NEOPLASM_OF_THE_EYE,0.881808695260407
HP_SCAPULAR_WINGING,SET,88,0.095175,0.0065731,0.088382,0.14078,HP_SCAPULAR_WINGING,0.881808695260407
GOBP_NEGATIVE_REGULATION_OF_...533,SET,360,0.048473,0.0067205,0.045015,0.14079,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.881808695260407
HP_SHORT_COLUMELLA,SET,24,0.18104,0.006541,0.16828,0.14102,HP_SHORT_COLUMELLA,0.882733204320432
HP_LIMITED_WRIST_MOVEMENT,SET,12,0.26504,0.0067735,0.24639,0.14103,HP_LIMITED_WRIST_MOVEMENT,0.882733204320432
MIR542_3P,SET,125,0.082941,0.0068201,0.077114,0.14107,MIR542_3P,0.882733204320432
HP_ABNORMAL_CIRCULATING_CREA...2,SET,49,0.12834,0.0066213,0.11933,0.14107,HP_ABNORMAL_CIRCULATING_CREATININE_CONCENTRATION,0.882733204320432
HP_ABNORMAL_MUSCLE_FIBER_TYP...,SET,76,0.09749,0.0062592,0.09064,0.14107,HP_ABNORMAL_MUSCLE_FIBER_TYPE_DISTRIBUTION,0.882733204320432
GOBP_POSITIVE_REGULATION_OF_...364,SET,42,0.15315,0.0073162,0.1424,0.14109,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,0.882733204320432
PAX3_01,SET,18,0.19343,0.0060533,0.1799,0.14115,PAX3_01,0.882785752833243
HP_OPPORTUNISTIC_BACTERIAL_I...,SET,22,0.20346,0.0070385,0.18923,0.14116,HP_OPPORTUNISTIC_BACTERIAL_INFECTION,0.882785752833243
HP_DYSGENESIS_OF_THE_CEREBEL...,SET,7,0.28017,0.0054695,0.26062,0.14119,HP_DYSGENESIS_OF_THE_CEREBELLAR_VERMIS,0.882785752833243
GOBP_RESOLUTION_OF_MEIOTIC_R...,SET,13,0.2421,0.0064396,0.22521,0.1412,GOBP_RESOLUTION_OF_MEIOTIC_RECOMBINATION_INTERMEDIATES,0.882785752833243
HP_BRADYKINESIA,SET,95,0.089954,0.0064537,0.083696,0.14125,HP_BRADYKINESIA,0.882939523381295
GOBP_POSITIVE_REGULATION_OF_...274,SET,33,0.16105,0.0068217,0.1499,0.14132,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,0.883020566037736
GOBP_LUNG_VASCULATURE_DEVELO...,SET,9,0.31812,0.0070414,0.29611,0.14135,GOBP_LUNG_VASCULATURE_DEVELOPMENT,0.883020566037736
GOBP_SERTOLI_CELL_DIFFERENTI...,SET,17,0.21099,0.0064171,0.1964,0.14136,GOBP_SERTOLI_CELL_DIFFERENTIATION,0.883020566037736
MIR1204,SET,6,0.3874,0.0070019,0.36063,0.14137,MIR1204,0.883020566037736
REACTOME_SYNTHESIS_OF_BILE_A...4,SET,23,0.20515,0.0072564,0.191,0.14139,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL,0.883020566037736
HP_ATROPHIC_SCARS,SET,33,0.1595,0.0067558,0.14853,0.14145,HP_ATROPHIC_SCARS,0.883236570247934
CHIANG_LIVER_CANCER_SUBCLASS...10,SET,80,0.1045,0.0068828,0.097339,0.14152,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,0.883322445681451
GSE2770_UNTREATED_VS_TGFB_AN...9,SET,184,0.066565,0.0066301,0.062005,0.14152,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.883322445681451
GOBP_GLYCOSPHINGOLIPID_BIOSY...,SET,38,0.15677,0.0071245,0.14604,0.14154,GOBP_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS,0.883322445681451
GOMF_NUCLEAR_ANDROGEN_RECEPT...,SET,25,0.16144,0.0059532,0.15044,0.14161,GOMF_NUCLEAR_ANDROGEN_RECEPTOR_BINDING,0.883600637342909
chr8q23,SET,16,0.38993,0.011506,0.3634,0.14165,chr8q23,0.883691572428648
WP_SEROTONIN_HTR1_GROUP_AND_...,SET,36,0.16599,0.0073429,0.15478,0.14176,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,0.88411732735426
GOMF_METAL_CATION_PROTON_ANT...,SET,23,0.18581,0.0065723,0.17326,0.14177,GOMF_METAL_CATION_PROTON_ANTIPORTER_ACTIVITY,0.88411732735426
GSE2826_WT_VS_BTK_KO_BCELL_UP,SET,181,0.065115,0.0064331,0.060726,0.14181,GSE2826_WT_VS_BTK_KO_BCELL_UP,0.88411732735426
GSE17580_UNINFECTED_VS_S_MAN...1,SET,175,0.067393,0.0065479,0.062853,0.14182,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN,0.88411732735426
HP_REDUCED_FACTOR_XII_ACTIVI...,SET,6,0.34827,0.0062946,0.32489,0.14188,HP_REDUCED_FACTOR_XII_ACTIVITY,0.88433274748924
HP_PALMAR_PITS,SET,8,0.24029,0.0050146,0.22424,0.14197,HP_PALMAR_PITS,0.884378973717146
HP_APLASIA_HYPOPLASIA_OF_THE...79,SET,43,0.14152,0.0068406,0.13208,0.14198,HP_APLASIA_HYPOPLASIA_OF_THE_VAGINA,0.884378973717146
GOBP_LIPID_DROPLET_ORGANIZAT...,SET,33,0.16193,0.0068589,0.15116,0.14203,GOBP_LIPID_DROPLET_ORGANIZATION,0.884378973717146
MIR12129,SET,131,0.082133,0.0069127,0.076674,0.14205,MIR12129,0.884378973717146
MODULE_462,SET,15,0.26725,0.0076355,0.24952,0.14208,MODULE_462,0.884378973717146
MIR367_5P,SET,67,0.1066,0.0064278,0.099539,0.1421,MIR367_5P,0.884378973717146
WP_MINERALOCORTICOID_BIOSYNT...,SET,14,0.28407,0.0078411,0.26529,0.14214,WP_MINERALOCORTICOID_BIOSYNTHESIS,0.884378973717146
GOBP_NEGATIVE_REGULATION_OF_...357,SET,12,0.27708,0.0070811,0.25876,0.14214,GOBP_NEGATIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,0.884378973717146
GSE360_L_DONOVANI_VS_B_MALAY...1,SET,177,0.066632,0.0065105,0.06223,0.14215,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.884378973717146
GSE15659_NAIVE_CD4_TCELL_VS_...2,SET,160,0.071318,0.0066284,0.066616,0.14219,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP,0.884378973717146
WP_16P112_PROXIMAL_DELETION_...,SET,68,0.12045,0.0073168,0.11252,0.1422,WP_16P112_PROXIMAL_DELETION_SYNDROME,0.884378973717146
TERAO_AOX4_TARGETS_SKIN_UP,SET,24,0.17644,0.006375,0.16484,0.14223,TERAO_AOX4_TARGETS_SKIN_UP,0.884378973717146
HP_MUSCLE_FIBER_CYTOPLASMATI...,SET,29,0.16601,0.0065924,0.1551,0.14224,HP_MUSCLE_FIBER_CYTOPLASMATIC_INCLUSION_BODIES,0.884378973717146
HE_LIM_SUN_FETAL_LUNG_C3_DEF...3,SET,102,0.088824,0.0066019,0.082995,0.14226,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_RETICULOCYTE,0.884378973717146
HP_UTERINE_LEIOMYOMA,SET,8,0.29809,0.0062208,0.27855,0.14228,HP_UTERINE_LEIOMYOMA,0.884378973717146
GOMF_PLATELET_DERIVED_GROWTH...2,SET,13,0.28476,0.0075745,0.26611,0.1423,GOMF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BINDING,0.884378973717146
GSE3982_BCELL_VS_TH1_DN,SET,176,0.068745,0.0066982,0.064249,0.14232,GSE3982_BCELL_VS_TH1_DN,0.884378973717146
HP_RENAL_HYPOPLASIA,SET,116,0.085398,0.0067663,0.079826,0.14236,HP_RENAL_HYPOPLASIA,0.884469395781194
MIR619_3P,SET,53,0.12184,0.0065368,0.11391,0.1424,MIR619_3P,0.884486506519021
GOMF_DNA_DAMAGE_SENSOR_ACTIV...,SET,20,0.16687,0.0055045,0.15605,0.14246,GOMF_DNA_DAMAGE_SENSOR_ACTIVITY,0.884486506519021
BLANCO_MELO_BRONCHIAL_EPITHE...3,SET,69,0.11009,0.0067363,0.10296,0.14247,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN,0.884486506519021
GSE25846_IL10_POS_VS_NEG_CD8...1,SET,176,0.063881,0.0062243,0.05974,0.14247,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN,0.884486506519021
MARTINEZ_TP53_TARGETS_DN,SET,552,0.038868,0.0066372,0.03635,0.14249,MARTINEZ_TP53_TARGETS_DN,0.884486506519021
REACTOME_SIGNALING_BY_EGFR,SET,51,0.12307,0.0064772,0.11512,0.14253,REACTOME_SIGNALING_BY_EGFR,0.8845768125
MIR4774_5P,SET,87,0.094711,0.006504,0.088615,0.14259,MIR4774_5P,0.88479118907338
HP_PROLONGED_PR_INTERVAL,SET,10,0.31972,0.0074595,0.29932,0.14273,HP_PROLONGED_PR_INTERVAL,0.884953276505061
GOCC_NADPH_OXIDASE_COMPLEX,SET,13,0.26039,0.0069262,0.24379,0.14275,GOCC_NADPH_OXIDASE_COMPLEX,0.884953276505061
GSE11057_NAIVE_VS_MEMORY_CD4...2,SET,158,0.075057,0.0069325,0.070286,0.1428,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP,0.884953276505061
WEBER_METHYLATED_LCP_IN_FIBR...2,SET,11,0.26807,0.0065595,0.25105,0.14281,WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP,0.884953276505061
BEGUM_TARGETS_OF_PAX3_FOXO1_...3,SET,54,0.13474,0.0072961,0.12619,0.14283,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,0.884953276505061
HALLMARK_PROTEIN_SECRETION,SET,85,0.093607,0.0063542,0.08767,0.14283,HALLMARK_PROTEIN_SECRETION,0.884953276505061
GOCC_MEDIATOR_COMPLEX,SET,34,0.15013,0.0064544,0.14063,0.14287,GOCC_MEDIATOR_COMPLEX,0.884953276505061
MOOTHA_PGC,SET,377,0.044855,0.006361,0.042021,0.14289,MOOTHA_PGC,0.884953276505061
KEGG_MEDICUS_REFERENCE_KITLG...2,SET,14,0.23722,0.0065478,0.22222,0.14289,KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY,0.884953276505061
GOBP_REGULATION_OF_NITRIC_OX...2,SET,54,0.13251,0.0071758,0.12414,0.14289,GOBP_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,0.884953276505061
GSE46606_IRF4HIGH_VS_IRF4MID...2,SET,185,0.064797,0.0064714,0.060723,0.14297,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.884953276505061
REACTOME_ENDOGENOUS_STEROLS,SET,24,0.19321,0.0069807,0.18109,0.14301,REACTOME_ENDOGENOUS_STEROLS,0.884953276505061
ATF1_Q6,SET,219,0.06447,0.0069988,0.060442,0.14307,ATF1_Q6,0.884953276505061
REACTOME_EICOSANOIDS,SET,12,0.31593,0.008074,0.29623,0.14311,REACTOME_EICOSANOIDS,0.884953276505061
GSE17721_CTRL_VS_CPG_0.5H_BM...1,SET,181,0.066432,0.0065632,0.062302,0.14315,GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN,0.884953276505061
PARK_OSTEOBLAST_DIFFERENTIAT...1,SET,6,0.45265,0.0081812,0.42455,0.14318,PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN,0.884953276505061
GSE9037_WT_VS_IRAK4_KO_LPS_1...2,SET,180,0.067215,0.0066224,0.063045,0.14319,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP,0.884953276505061
HP_LOW_BACK_PAIN,SET,13,0.24085,0.0064064,0.22592,0.1432,HP_LOW_BACK_PAIN,0.884953276505061
GOMF_PHOSPHATIDYLINOSITOL_3_...5,SET,8,0.24595,0.0051327,0.23072,0.14321,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_3_PHOSPHATASE_ACTIVITY,0.884953276505061
GSE15330_HSC_VS_MEGAKARYOCYT...4,SET,149,0.072751,0.006527,0.068245,0.14321,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,0.884953276505061
chr3q27,SET,60,0.25028,0.014284,0.23479,0.14323,chr3q27,0.884953276505061
GOBP_PROPIONATE_METABOLIC_PR...,SET,4,0.41417,0.0061125,0.38857,0.14324,GOBP_PROPIONATE_METABOLIC_PROCESS,0.884953276505061
HP_ELEVATED_MATERNAL_CIRCULA...,SET,4,0.5048,0.00745,0.47359,0.14324,HP_ELEVATED_MATERNAL_CIRCULATING_ALPHA_FETOPROTEIN_CONCENTRATION,0.884953276505061
KEGG_MEDICUS_PATHOGEN_HPV_E7...2,SET,7,0.32603,0.0063647,0.30596,0.14331,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_P27_CELL_CYCLE_G1_S,0.884953276505061
HP_ELEVATED_BRAIN_CHOLINE_LE...,SET,8,0.28024,0.0058483,0.263,0.14332,HP_ELEVATED_BRAIN_CHOLINE_LEVEL_BY_MRS,0.884953276505061
GOCC_PHAGOPHORE_ASSEMBLY_SIT...,SET,20,0.19277,0.0063586,0.18092,0.14333,GOCC_PHAGOPHORE_ASSEMBLY_SITE_MEMBRANE,0.884953276505061
BIOCARTA_CXCR4_PATHWAY,SET,19,0.21512,0.0069166,0.20192,0.14335,BIOCARTA_CXCR4_PATHWAY,0.884953276505061
GOBP_POSITIVE_REGULATION_OF_...788,SET,7,0.35397,0.0069101,0.33225,0.14336,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,0.884953276505061
HAY_BONE_MARROW_PLATELET,SET,217,0.061845,0.0066835,0.058053,0.14337,HAY_BONE_MARROW_PLATELET,0.884953276505061
HP_CARPAL_SYNOSTOSIS,SET,33,0.17167,0.0072711,0.16114,0.14338,HP_CARPAL_SYNOSTOSIS,0.884953276505061
GOBP_PROTEIN_LOCALIZATION_TO...19,SET,7,0.35525,0.0069352,0.33362,0.14348,GOBP_PROTEIN_LOCALIZATION_TO_CYTOPLASMIC_STRESS_GRANULE,0.885222310969116
MIR4722_3P,SET,79,0.10079,0.0065971,0.094657,0.14349,MIR4722_3P,0.885222310969116
GSE369_SOCS3_KO_VS_WT_LIVER_...2,SET,182,0.067153,0.0066526,0.063068,0.1435,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN,0.885222310969116
HP_EASY_FATIGABILITY,SET,85,0.091211,0.0061916,0.085683,0.14355,HP_EASY_FATIGABILITY,0.885373602484472
GOBP_NEGATIVE_REGULATION_OF_...459,SET,1305,0.025573,0.006571,0.02403,0.14362,GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.885479276723985
chr16q21,SET,37,0.27903,0.012513,0.26223,0.14365,chr16q21,0.885479276723985
GOBP_ENUCLEATE_ERYTHROCYTE_D...1,SET,5,0.45671,0.0075357,0.42923,0.14367,GOBP_ENUCLEATE_ERYTHROCYTE_DEVELOPMENT,0.885479276723985
GOMF_HISTONE_H3K4_METHYLTRAN...,SET,18,0.20277,0.0063458,0.1906,0.1437,GOMF_HISTONE_H3K4_METHYLTRANSFERASE_ACTIVITY,0.885479276723985
MIR519D_5P,SET,220,0.05981,0.0065076,0.056224,0.14372,MIR519D_5P,0.885479276723985
GOBP_AMELOGENESIS,SET,23,0.19174,0.0067821,0.18025,0.14372,GOBP_AMELOGENESIS,0.885479276723985
GOBP_NEGATIVE_REGULATION_OF_...65,SET,5,0.32666,0.0053898,0.30711,0.14375,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.885507133995037
GSE2405_0H_VS_3H_A_PHAGOCYTO...2,SET,188,0.070046,0.0070515,0.065871,0.14381,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.885719750132908
MIR4651,SET,188,0.06867,0.0069129,0.064584,0.14384,MIR4651,0.885747554925585
TRAVAGLINI_LUNG_MESOTHELIAL_...,SET,579,0.038392,0.0067092,0.036118,0.14391,TRAVAGLINI_LUNG_MESOTHELIAL_CELL,0.885926248671626
CHIARADONNA_NEOPLASTIC_TRANS...4,SET,53,0.12823,0.0068796,0.12064,0.14392,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,0.885926248671626
WP_BREAST_CANCER_PATHWAY,SET,149,0.077485,0.0069518,0.07291,0.14395,WP_BREAST_CANCER_PATHWAY,0.885949029811254
GOBP_REGULATION_OF_NUCLEOTID...2,SET,9,0.3294,0.0072911,0.31008,0.14405,GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY,0.885949029811254
GOBP_CELL_JUNCTION_MAINTENAN...,SET,41,0.14696,0.006937,0.13838,0.14412,GOBP_CELL_JUNCTION_MAINTENANCE,0.885949029811254
DESCARTES_FETAL_EYE_BIPOLAR_...,SET,19,0.23287,0.0074872,0.21927,0.14412,DESCARTES_FETAL_EYE_BIPOLAR_CELLS,0.885949029811254
ICHIBA_GRAFT_VERSUS_HOST_DIS...2,SET,130,0.080626,0.0067601,0.075919,0.14413,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,0.885949029811254
KEGG_MEDICUS_VARIANT_CYP11B1...,SET,31,0.16007,0.0065715,0.15073,0.14414,KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.885949029811254
MODULE_311,SET,16,0.23473,0.006926,0.22104,0.14415,MODULE_311,0.885949029811254
GOBP_RIBOSOMAL_SMALL_SUBUNIT...2,SET,93,0.088612,0.0062905,0.08345,0.14416,GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS,0.885949029811254
GSE2770_UNTREATED_VS_TGFB_AN...7,SET,181,0.0649,0.0064119,0.061126,0.14418,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.885949029811254
HP_HYPERMOBILITY_OF_INTERPHA...,SET,5,0.43044,0.0071021,0.4055,0.14424,HP_HYPERMOBILITY_OF_INTERPHALANGEAL_JOINTS,0.885949029811254
GSE22229_RENAL_TRANSPLANT_IM...1,SET,183,0.067178,0.0066731,0.06329,0.14426,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN,0.885949029811254
HP_THROMBOEMBOLISM,SET,91,0.098665,0.0069288,0.09299,0.14435,HP_THROMBOEMBOLISM,0.885949029811254
GOMF_INOSITOL_1_4_5_TRISPHOS...1,SET,6,0.31367,0.0056693,0.29566,0.14437,GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.885949029811254
PID_SYNDECAN_3_PATHWAY,SET,15,0.22985,0.0065669,0.21666,0.14438,PID_SYNDECAN_3_PATHWAY,0.885949029811254
ACCTGTTG_UNKNOWN,SET,144,0.075338,0.0066456,0.071016,0.14438,ACCTGTTG_UNKNOWN,0.885949029811254
HP_HIP_DYSPLASIA,SET,207,0.062026,0.0065486,0.058474,0.14441,HP_HIP_DYSPLASIA,0.885949029811254
HALLMARK_REACTIVE_OXYGEN_SPE...,SET,45,0.13704,0.0067762,0.12922,0.14445,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.885949029811254
GSE45365_WT_VS_IFNAR_KO_CD8A...1,SET,183,0.064945,0.0064513,0.061241,0.14447,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_DN,0.885949029811254
REACTOME_PKA_MEDIATED_PHOSPH...2,SET,4,0.44508,0.0065686,0.41971,0.14448,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS,0.885949029811254
GOBP_ENDOTHELIAL_CELL_DEVELO...,SET,64,0.11905,0.0070161,0.11227,0.14449,GOBP_ENDOTHELIAL_CELL_DEVELOPMENT,0.885949029811254
GOLDRATH_EFF_VS_MEMORY_CD8_T...1,SET,186,0.063984,0.0064072,0.060342,0.1445,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN,0.885949029811254
GSE25088_CTRL_VS_IL4_AND_ROS...4,SET,172,0.063285,0.0060964,0.059684,0.1445,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,0.885949029811254
KEGG_MEDICUS_ENV_FACTOR_NNK_...5,SET,5,0.45711,0.0075422,0.4311,0.14451,KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS,0.885949029811254
GOCC_BLOOD_MICROPARTICLE,SET,97,0.097711,0.0070832,0.092203,0.14464,GOCC_BLOOD_MICROPARTICLE,0.886433292188326
GOMF_CULLIN_FAMILY_PROTEIN_B...,SET,21,0.17333,0.0058584,0.16356,0.14464,GOMF_CULLIN_FAMILY_PROTEIN_BINDING,0.886433292188326
GOBP_PEPTIDE_MODIFICATION,SET,5,0.41247,0.0068056,0.3894,0.14475,GOBP_PEPTIDE_MODIFICATION,0.886441584766585
GOCC_GRANULAR_COMPONENT,SET,7,0.33832,0.0066045,0.31941,0.14476,GOCC_GRANULAR_COMPONENT,0.886441584766585
GSE7768_OVA_WITH_LPS_VS_OVA_...2,SET,156,0.070091,0.0064331,0.066178,0.14478,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,0.886441584766585
VANHARANTA_UTERINE_FIBROID_DN,SET,59,0.12606,0.0071344,0.11903,0.14479,VANHARANTA_UTERINE_FIBROID_DN,0.886441584766585
GSE29618_PRE_VS_DAY7_POST_TI...8,SET,176,0.067172,0.0065449,0.063431,0.14481,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP,0.886441584766585
MIR1185_5P,SET,53,0.12346,0.0066234,0.1166,0.14484,MIR1185_5P,0.886441584766585
REACTOME_RELEASE_OF_HH_NP_FR...,SET,8,0.29426,0.006141,0.27792,0.14485,REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL,0.886441584766585
GSE20366_EX_VIVO_VS_DEC205_C...3,SET,181,0.064953,0.0064171,0.061357,0.14489,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP,0.886441584766585
SCHAEFFER_PROSTATE_DEVELOPME...13,SET,10,0.29603,0.0069067,0.27966,0.14491,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP,0.886441584766585
REACTOME_RESOLUTION_OF_D_LOO...1,SET,32,0.15188,0.0063349,0.1435,0.14495,REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES,0.886441584766585
MIR892A,SET,117,0.086642,0.0068943,0.081875,0.14498,MIR892A,0.886441584766585
GOBP_NEGATIVE_REGULATION_OF_...79,SET,6,0.38601,0.0069768,0.36477,0.14499,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,0.886441584766585
HP_ATROPHY_OF_ALVEOLAR_RIDGES,SET,3,0.61838,0.0079037,0.58453,0.14505,HP_ATROPHY_OF_ALVEOLAR_RIDGES,0.886441584766585
ABRAMSON_INTERACT_WITH_AIRE,SET,39,0.12596,0.0057991,0.11908,0.14508,ABRAMSON_INTERACT_WITH_AIRE,0.886441584766585
SOTIRIOU_BREAST_CANCER_GRADE...1,SET,48,0.121,0.0061785,0.11438,0.14508,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN,0.886441584766585
GSE24142_EARLY_THYMIC_PROGEN...3,SET,183,0.065404,0.0064969,0.061836,0.14511,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN,0.886441584766585
GSE11961_UNSTIM_VS_ANTI_IGM_...1,SET,177,0.067538,0.0065991,0.06386,0.14513,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN,0.886441584766585
HP_APLASIA_OF_THE_UTERUS,SET,18,0.22327,0.0069874,0.21112,0.14514,HP_APLASIA_OF_THE_UTERUS,0.886441584766585
GOBP_DEOXYRIBONUCLEOSIDE_CAT...,SET,6,0.43141,0.0077973,0.40797,0.14516,GOBP_DEOXYRIBONUCLEOSIDE_CATABOLIC_PROCESS,0.886441584766585
GSE22196_HEALTHY_VS_OBESE_MO...2,SET,180,0.067572,0.0066576,0.063905,0.14517,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP,0.886441584766585
HOFT_CD4_POSITIVE_ALPHA_BETA...6,SET,39,0.13683,0.0062996,0.12941,0.14519,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP,0.886441584766585
SMARCA1_TARGET_GENES,SET,98,0.090393,0.0065862,0.085533,0.1453,SMARCA1_TARGET_GENES,0.886441584766585
FOXE1_TARGET_GENES,SET,566,0.038385,0.0066347,0.036322,0.14531,FOXE1_TARGET_GENES,0.886441584766585
GOCC_METHYLTRANSFERASE_COMPL...,SET,92,0.083835,0.0059195,0.079329,0.14531,GOCC_METHYLTRANSFERASE_COMPLEX,0.886441584766585
GSE2405_HEAT_KILLED_VS_LIVE_...2,SET,174,0.067566,0.0065462,0.063935,0.14531,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,0.886441584766585
GOBP_SEROTONIN_RECEPTOR_SIGN...,SET,8,0.33942,0.0070834,0.32119,0.14532,GOBP_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,0.886441584766585
GGATCCG_MIR127,SET,9,0.33,0.0073042,0.31229,0.14533,GGATCCG_MIR127,0.886441584766585
GOBP_SEX_DETERMINATION,SET,18,0.22929,0.0071757,0.21704,0.14539,GOBP_SEX_DETERMINATION,0.886456654392425
GOBP_REGULATION_OF_ODONTOGEN...1,SET,19,0.23096,0.0074258,0.21864,0.14541,GOBP_REGULATION_OF_ODONTOGENESIS,0.886456654392425
GOBP_ATTACHMENT_OF_SPINDLE_M...,SET,49,0.12183,0.0062855,0.11535,0.14543,GOBP_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.886456654392425
HP_EMBRYONAL_NEOPLASM,SET,73,0.109,0.0068595,0.10321,0.14546,HP_EMBRYONAL_NEOPLASM,0.886456654392425
HP_RESTLESSNESS,SET,127,0.079937,0.0066251,0.075689,0.14546,HP_RESTLESSNESS,0.886456654392425
GOMF_OXYGEN_SENSOR_ACTIVITY,SET,5,0.31292,0.0051631,0.2964,0.14555,GOMF_OXYGEN_SENSOR_ACTIVITY,0.886660594111462
HP_APPENDICULAR_HYPOTONIA,SET,16,0.23882,0.0070467,0.22621,0.14555,HP_APPENDICULAR_HYPOTONIA,0.886660594111462
GOCC_AMPA_GLUTAMATE_RECEPTOR...,SET,23,0.20066,0.0070974,0.19008,0.14557,GOCC_AMPA_GLUTAMATE_RECEPTOR_COMPLEX,0.886660594111462
GOBP_PROTEIN_O_LINKED_GLYCOS...1,SET,87,0.097152,0.0066716,0.092058,0.14564,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION,0.886820471140473
GOBP_DENDRITIC_CELL_DIFFEREN...,SET,45,0.14341,0.0070909,0.13595,0.14576,GOBP_DENDRITIC_CELL_DIFFERENTIATION,0.886820471140473
GOMF_HAPTOGLOBIN_BINDING,SET,6,0.4798,0.0086719,0.4549,0.14578,GOMF_HAPTOGLOBIN_BINDING,0.886820471140473
KEGG_MEDICUS_ENV_FACTOR_IRON...,SET,18,0.22958,0.0071846,0.21772,0.14585,KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.886820471140473
GOBP_DIENCEPHALON_DEVELOPMENT,SET,71,0.11603,0.0072014,0.11004,0.14585,GOBP_DIENCEPHALON_DEVELOPMENT,0.886820471140473
REACTOME_HS_GAG_BIOSYNTHESIS,SET,28,0.18741,0.0073131,0.17776,0.14588,REACTOME_HS_GAG_BIOSYNTHESIS,0.886820471140473
GOBP_VISUAL_BEHAVIOR,SET,53,0.12581,0.0067495,0.11934,0.14591,GOBP_VISUAL_BEHAVIOR,0.886820471140473
GOBP_SYNAPTIC_ASSEMBLY_AT_NE...,SET,8,0.32983,0.0068833,0.3129,0.14592,GOBP_SYNAPTIC_ASSEMBLY_AT_NEUROMUSCULAR_JUNCTION,0.886820471140473
GOMF_GLUCOSYLTRANSFERASE_ACT...,SET,16,0.20365,0.0060092,0.1932,0.14592,GOMF_GLUCOSYLTRANSFERASE_ACTIVITY,0.886820471140473
KEGG_COMPLEMENT_AND_COAGULAT...,SET,61,0.12354,0.0071088,0.11722,0.14598,KEGG_COMPLEMENT_AND_COAGULATION_CASCADES,0.886820471140473
MIR548S,SET,119,0.079206,0.0063558,0.075161,0.14599,MIR548S,0.886820471140473
GOBP_ESTABLISHMENT_OF_PIGMEN...,SET,21,0.20262,0.0068485,0.19227,0.14599,GOBP_ESTABLISHMENT_OF_PIGMENT_GRANULE_LOCALIZATION,0.886820471140473
REACTOME_S_PHASE,SET,155,0.064874,0.0059353,0.061562,0.146,REACTOME_S_PHASE,0.886820471140473
GOMF_RETINAL_DEHYDROGENASE_A...,SET,9,0.36078,0.0079856,0.3424,0.14602,GOMF_RETINAL_DEHYDROGENASE_ACTIVITY,0.886820471140473
MIR1273H_5P,SET,176,0.065846,0.0064157,0.062494,0.14603,MIR1273H_5P,0.886820471140473
KEGG_MEDICUS_REFERENCE_NON_H...,SET,13,0.19932,0.0053018,0.18921,0.14607,KEGG_MEDICUS_REFERENCE_NON_HOMOLOGOUS_END_JOINING,0.886820471140473
GSE31622_WT_VS_KLF3_KO_BCELL...2,SET,178,0.065655,0.006433,0.062332,0.1461,GSE31622_WT_VS_KLF3_KO_BCELL_UP,0.886820471140473
GOBP_NON_PROTEINOGENIC_AMINO...1,SET,16,0.22022,0.0064981,0.20913,0.14616,GOBP_NON_PROTEINOGENIC_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.886820471140473
LAKE_ADULT_KIDNEY_C1_EPITHEL...,SET,27,0.1756,0.0067288,0.16675,0.14617,LAKE_ADULT_KIDNEY_C1_EPITHELIAL_CELLS_UNASSIGNED,0.886820471140473
GOBP_POSITIVE_REGULATION_OF_...100,SET,33,0.16411,0.006951,0.15585,0.14618,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.886820471140473
HP_ABNORMAL_PALATE_MORPHOLOGY,SET,991,0.028567,0.0064552,0.02713,0.14618,HP_ABNORMAL_PALATE_MORPHOLOGY,0.886820471140473
LAKE_ADULT_KIDNEY_C3_PROXIMA...,SET,194,0.06717,0.0068679,0.063807,0.14624,LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2,0.886820471140473
MIR6888_3P,SET,87,0.095548,0.0065615,0.09077,0.14626,MIR6888_3P,0.886820471140473
GOCC_SODIUM_CHANNEL_COMPLEX,SET,24,0.207,0.007479,0.19665,0.14626,GOCC_SODIUM_CHANNEL_COMPLEX,0.886820471140473
AKL_HTLV1_INFECTION_UP,SET,24,0.16922,0.0061138,0.16078,0.1463,AKL_HTLV1_INFECTION_UP,0.886820471140473
GHANDHI_BYSTANDER_IRRADIATIO...1,SET,11,0.33031,0.0080823,0.31386,0.14632,GHANDHI_BYSTANDER_IRRADIATION_DN,0.886820471140473
GOBP_REGULATION_OF_ADENYLATE...1,SET,19,0.20677,0.0066481,0.19653,0.14637,GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.886820471140473
LAKE_ADULT_KIDNEY_C14_DISTAL...,SET,179,0.071395,0.0070148,0.067857,0.14638,LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE,0.886820471140473
YTATTTTNR_MEF2_02,SET,627,0.037062,0.0067308,0.03523,0.14641,YTATTTTNR_MEF2_02,0.886820471140473
GOMF_EXTRACELLULAR_MATRIX_CO...,SET,10,0.30611,0.0071418,0.29103,0.14645,GOMF_EXTRACELLULAR_MATRIX_CONSTITUENT_CONFERRING_ELASTICITY,0.886820471140473
OCT1_07,SET,143,0.078821,0.0069289,0.074943,0.14646,OCT1_07,0.886820471140473
HP_ABNORMAL_EXTEROCEPTIVE_SE...,SET,219,0.059802,0.0064921,0.056866,0.14649,HP_ABNORMAL_EXTEROCEPTIVE_SENSATION,0.886820471140473
GOBP_EMBRYONIC_NEUROCRANIUM_...,SET,8,0.34793,0.0072609,0.33086,0.1465,GOBP_EMBRYONIC_NEUROCRANIUM_MORPHOGENESIS,0.886820471140473
REACTOME_TANDEM_PORE_DOMAIN_...,SET,12,0.27861,0.0071202,0.26495,0.14651,REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS,0.886820471140473
SRF_Q6,SET,228,0.060652,0.0067167,0.057697,0.14659,SRF_Q6,0.886820471140473
REACTOME_MAPK3_ERK1_ACTIVATI...,SET,10,0.30691,0.0071605,0.292,0.14662,REACTOME_MAPK3_ERK1_ACTIVATION,0.886820471140473
MORF_BMI1,SET,74,0.094007,0.0059559,0.08945,0.14665,MORF_BMI1,0.886820471140473
GOBP_NEGATIVE_REGULATION_OF_...66,SET,40,0.13694,0.0063848,0.13031,0.14665,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.886820471140473
GOBP_ALKANESULFONATE_TRANSME...,SET,8,0.36158,0.0075459,0.34408,0.14667,GOBP_ALKANESULFONATE_TRANSMEMBRANE_TRANSPORT,0.886820471140473
REACTOME_FANCONI_ANEMIA_PATH...,SET,30,0.1411,0.0056987,0.13428,0.14668,REACTOME_FANCONI_ANEMIA_PATHWAY,0.886820471140473
LINDSTEDT_DENDRITIC_CELL_MAT...1,SET,61,0.12351,0.0071074,0.11756,0.14671,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,0.886820471140473
HP_HYPOPLASIA_OF_THE_EAR_CAR...,SET,10,0.25077,0.0058507,0.23867,0.14671,HP_HYPOPLASIA_OF_THE_EAR_CARTILAGE,0.886820471140473
GOBP_PROTEIN_DEMETHYLATION,SET,8,0.25275,0.0052746,0.2406,0.14675,GOBP_PROTEIN_DEMETHYLATION,0.886820471140473
ABE_INNER_EAR,SET,39,0.14954,0.0068845,0.14236,0.14676,ABE_INNER_EAR,0.886820471140473
HP_SPASTIC_ATAXIA,SET,18,0.19522,0.0061095,0.18585,0.14676,HP_SPASTIC_ATAXIA,0.886820471140473
REACTOME_BUDDING_AND_MATURAT...,SET,27,0.16099,0.0061689,0.15326,0.14677,REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION,0.886820471140473
MIR4639_5P,SET,86,0.098452,0.0067221,0.093783,0.14692,MIR4639_5P,0.887178214471629
ZNF766_TARGET_GENES,SET,933,0.029369,0.0064499,0.027976,0.14692,ZNF766_TARGET_GENES,0.887178214471629
ABBUD_LIF_SIGNALING_2_DN,SET,7,0.39365,0.0076847,0.37503,0.14695,ABBUD_LIF_SIGNALING_2_DN,0.887178214471629
GOBP_POSITIVE_REGULATION_OF_...268,SET,28,0.15957,0.0062267,0.15204,0.14696,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,0.887178214471629
HP_SPARSE_EYELASHES,SET,61,0.11522,0.00663,0.1098,0.14701,HP_SPARSE_EYELASHES,0.887178214471629
GSE3982_MAST_CELL_VS_DC_DN,SET,179,0.068648,0.0067449,0.065428,0.14705,GSE3982_MAST_CELL_VS_DC_DN,0.887178214471629
GOMF_STRUCTURAL_CONSTITUENT_...10,SET,36,0.18543,0.0082025,0.17674,0.14706,GOMF_STRUCTURAL_CONSTITUENT_OF_SKIN_EPIDERMIS,0.887178214471629
GOMF_ACTIN_MONOMER_BINDING,SET,21,0.18909,0.0063912,0.18026,0.14709,GOMF_ACTIN_MONOMER_BINDING,0.887178214471629
GAVISH_3CA_METAPROGRAM_EPITH...12,SET,46,0.13503,0.0067504,0.12873,0.1471,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_2,0.887178214471629
HP_APLASIA_OF_THE_DISTAL_PHA...,SET,5,0.35647,0.0058816,0.33984,0.14711,HP_APLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,0.887178214471629
GSE25088_WT_VS_STAT6_KO_MACR...5,SET,183,0.062402,0.0061987,0.059492,0.14711,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_UP,0.887178214471629
GOMF_HYDROLASE_ACTIVITY_ACTI...8,SET,10,0.31588,0.0073697,0.30126,0.14721,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ETHER_BONDS,0.887378264989662
GOBP_MEMBRANE_DEPOLARIZATION...1,SET,27,0.19129,0.0073302,0.18248,0.14726,GOBP_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,0.887378264989662
GSE37336_LY6C_POS_VS_NEG_NAI...1,SET,140,0.076573,0.0066609,0.073057,0.1473,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN,0.887378264989662
GOBP_INTRACELLULAR_MRNA_LOCA...,SET,15,0.22153,0.0063292,0.21138,0.14733,GOBP_INTRACELLULAR_MRNA_LOCALIZATION,0.887378264989662
GSE24574_NAIVE_VS_TCONV_CD4_...2,SET,181,0.068067,0.0067247,0.06495,0.14733,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP,0.887378264989662
MIR374B_5P,SET,343,0.049652,0.0067226,0.047381,0.14734,MIR374B_5P,0.887378264989662
GSE15330_GRANULOCYTE_MONOCYT...1,SET,184,0.063725,0.0063472,0.060825,0.1474,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN,0.887378264989662
KEGG_MEDICUS_REFERENCE_FLT3L...1,SET,14,0.21639,0.005973,0.2066,0.14746,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY,0.887378264989662
HP_APLASIA_HYPOPLASIA_OF_THE...76,SET,55,0.11681,0.0063836,0.11153,0.14747,HP_APLASIA_HYPOPLASIA_OF_THE_ULNA,0.887378264989662
GSE28737_WT_VS_BCL6_HET_MARG...2,SET,173,0.067072,0.0064798,0.06405,0.14752,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_UP,0.887378264989662
HP_HYPERACUSIS,SET,23,0.20227,0.0071545,0.19319,0.14755,HP_HYPERACUSIS,0.887378264989662
GOBP_NEGATIVE_REGULATION_OF_...18,SET,22,0.18232,0.0063073,0.17419,0.14762,GOBP_NEGATIVE_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.887378264989662
GOCC_CONDENSED_CHROMOSOME,SET,250,0.053618,0.0062138,0.051228,0.14764,GOCC_CONDENSED_CHROMOSOME,0.887378264989662
GAVISH_3CA_METAPROGRAM_CD4_T...4,SET,46,0.1193,0.0059641,0.11402,0.1477,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_GLYCOLYSIS_MYC,0.887378264989662
GOBP_CALCIUM_ION_IMPORT_ACRO...,SET,36,0.14999,0.0066349,0.14334,0.14771,GOBP_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.887378264989662
REACTOME_SIGNAL_ATTENUATION,SET,10,0.27969,0.0065255,0.26732,0.14773,REACTOME_SIGNAL_ATTENUATION,0.887378264989662
WP_JOUBERT_SYNDROME,SET,69,0.099486,0.0060873,0.095089,0.14773,WP_JOUBERT_SYNDROME,0.887378264989662
GSE34156_NOD2_LIGAND_VS_TLR1...4,SET,186,0.06601,0.00661,0.063104,0.14778,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,0.887378264989662
GOBP_INTERLEUKIN_6_MEDIATED_...,SET,18,0.23045,0.0072119,0.22035,0.14782,GOBP_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY,0.887378264989662
AGTCAGC_MIR345,SET,55,0.10973,0.0059967,0.10492,0.14783,AGTCAGC_MIR345,0.887378264989662
KEGG_MEDICUS_PATHOGEN_KSHV_V...1,SET,6,0.35065,0.0063378,0.33534,0.14786,KEGG_MEDICUS_PATHOGEN_KSHV_VCYCLIN_TO_CELL_CYCLE_G1_S,0.887378264989662
KYNG_RESPONSE_TO_H2O2_VIA_ER...2,SET,39,0.13653,0.0062858,0.13057,0.14787,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,0.887378264989662
GOBP_MYOTUBE_CELL_DEVELOPMENT,SET,37,0.14992,0.0067233,0.1434,0.1479,GOBP_MYOTUBE_CELL_DEVELOPMENT,0.887378264989662
TESAR_ALK_TARGETS_EPISC_4D_UP,SET,5,0.40511,0.0066842,0.38748,0.14791,TESAR_ALK_TARGETS_EPISC_4D_UP,0.887378264989662
GOBP_LEUKOTRIENE_SIGNALING_P...,SET,4,0.38276,0.0056488,0.36613,0.14792,GOBP_LEUKOTRIENE_SIGNALING_PATHWAY,0.887378264989662
GOMF_PHOSPHATIDYLINOSITOL_PH...2,SET,12,0.21214,0.0054216,0.20293,0.14792,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.887378264989662
WP_PRIMARY_OVARIAN_INSUFFICI...,SET,159,0.067687,0.0062715,0.064749,0.14793,WP_PRIMARY_OVARIAN_INSUFFICIENCY,0.887378264989662
KEGG_MEDICUS_REFERENCE_RECRU...,SET,9,0.33113,0.0073292,0.31677,0.14795,KEGG_MEDICUS_REFERENCE_RECRUITMENT_AND_FORMATION_OF_THE_MCC,0.887378264989662
KEGG_MEDICUS_VARIANT_MUTATIO...16,SET,14,0.23003,0.0063494,0.22007,0.14796,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY,0.887378264989662
REACTOME_PHOSPHATE_BOND_HYDR...2,SET,7,0.35056,0.0068436,0.3355,0.14804,REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS,0.887378264989662
GOBP_FUNGIFORM_PAPILLA_MORPH...,SET,4,0.4822,0.0071164,0.4615,0.14805,GOBP_FUNGIFORM_PAPILLA_MORPHOGENESIS,0.887378264989662
KEGG_MEDICUS_REFERENCE_N_GLY...3,SET,5,0.33574,0.0055396,0.32134,0.14806,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG7_TO_ALG11,0.887378264989662
GSE9006_HEALTHY_VS_TYPE_1_DI...2,SET,179,0.062589,0.0061496,0.059903,0.14806,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP,0.887378264989662
HP_ABNORMAL_MITOCHONDRIAL_MO...,SET,23,0.16471,0.0058259,0.15768,0.14811,HP_ABNORMAL_MITOCHONDRIAL_MORPHOLOGY,0.887378264989662
chr2q22,SET,11,0.40722,0.0099644,0.38984,0.14812,chr2q22,0.887378264989662
KEGG_MEDICUS_REFERENCE_DNA_E...,SET,13,0.22339,0.0059421,0.21386,0.14812,KEGG_MEDICUS_REFERENCE_DNA_END_RESECTION_AND_RPA_LOADING,0.887378264989662
GSE22886_NAIVE_TCELL_VS_NKCE...2,SET,173,0.066788,0.0064523,0.063942,0.14813,GSE22886_NAIVE_TCELL_VS_NKCELL_UP,0.887378264989662
HP_ABNORMAL_AORTIC_MORPHOLOGY,SET,350,0.047294,0.0064672,0.045284,0.14816,HP_ABNORMAL_AORTIC_MORPHOLOGY,0.887378264989662
GOBP_PSEUDOURIDINE_SYNTHESIS,SET,17,0.19356,0.005887,0.18534,0.14817,GOBP_PSEUDOURIDINE_SYNTHESIS,0.887378264989662
HP_ABNORMAL_FACIAL_SKELETON_...,SET,1162,0.026432,0.0064356,0.02531,0.14817,HP_ABNORMAL_FACIAL_SKELETON_MORPHOLOGY,0.887378264989662
GSE11973_MIR223_KOVS_WT_BONE...2,SET,179,0.067061,0.006589,0.064218,0.14819,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_UP,0.887378264989662
GOBP_REGULATION_OF_WNT_SIGNA...2,SET,15,0.24461,0.0069886,0.23427,0.14822,GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,0.887405012919897
GOBP_PEPTIDYL_ARGININE_METHY...2,SET,8,0.2759,0.0057578,0.26434,0.14831,GOBP_PEPTIDYL_ARGININE_METHYLATION_TO_ASYMMETRICAL_DIMETHYL_ARGININE,0.887790914571133
GSE39820_CTRL_VS_IL1B_IL6_CD...2,SET,171,0.067243,0.006459,0.064433,0.14834,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP,0.887811636301134
GOBP_MUSCULAR_SEPTUM_MORPHOG...,SET,5,0.47754,0.0078793,0.45775,0.14842,GOBP_MUSCULAR_SEPTUM_MORPHOGENESIS,0.887811636301134
GSE27786_LIN_NEG_VS_CD8_TCEL...2,SET,179,0.062937,0.0061838,0.060327,0.14842,GSE27786_LIN_NEG_VS_CD8_TCELL_UP,0.887811636301134
GSE32533_MIR17_KO_VS_MIR17_O...2,SET,180,0.063792,0.0062852,0.061164,0.14849,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,0.887811636301134
KEGG_MEDICUS_VARIANT_AMPLIFI...8,SET,12,0.25128,0.0064218,0.24094,0.1485,KEGG_MEDICUS_VARIANT_AMPLIFIED_MDM2_TO_P21_CELL_CYCLE_G1_S,0.887811636301134
GOMF_PHOSPHATIDYLSERINE_FLOP...,SET,8,0.31237,0.0065188,0.29957,0.14854,GOMF_PHOSPHATIDYLSERINE_FLOPPASE_ACTIVITY,0.887811636301134
THAKAR_PBMC_INACTIVATED_INFL...9,SET,15,0.21405,0.0061154,0.20528,0.14855,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP,0.887811636301134
GOBP_REGULATION_OF_COMPLEMEN...4,SET,11,0.30136,0.0073739,0.28906,0.14859,GOBP_REGULATION_OF_COMPLEMENT_DEPENDENT_CYTOTOXICITY,0.887811636301134
GAUCHER_PBMC_YF_VAX_STAMARIL...10,SET,44,0.13529,0.0066149,0.12977,0.14859,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_UP,0.887811636301134
HP_ABNORMALITY_OF_THE_DISTAL...1,SET,22,0.19324,0.0066849,0.18537,0.14861,HP_ABNORMALITY_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,0.887811636301134
GOBP_NEGATIVE_REGULATION_OF_...614,SET,7,0.38433,0.0075027,0.3687,0.14862,GOBP_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.887811636301134
HP_LOSS_OF_VOICE,SET,6,0.29479,0.0053281,0.2828,0.14862,HP_LOSS_OF_VOICE,0.887811636301134
WP_EMBRYONIC_STEM_CELL_PLURI...,SET,108,0.09114,0.0069694,0.087492,0.14878,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,0.88791479816825
GOBP_NEGATIVE_REGULATION_OF_...12,SET,14,0.24674,0.0068107,0.23688,0.1488,GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.88791479816825
GOBP_POSITIVE_REGULATION_OF_...493,SET,29,0.14459,0.0057418,0.13885,0.14887,GOBP_POSITIVE_REGULATION_OF_MRNA_PROCESSING,0.88791479816825
MIR608,SET,195,0.065328,0.0066965,0.062738,0.14888,MIR608,0.88791479816825
MODULE_323,SET,52,0.10988,0.0058393,0.10553,0.1489,MODULE_323,0.88791479816825
AR_02,SET,34,0.14709,0.0063236,0.14129,0.14893,AR_02,0.88791479816825
MODULE_48,SET,293,0.051765,0.0064867,0.049727,0.14895,MODULE_48,0.88791479816825
HP_EMG_MYOPATHIC_ABNORMALITI...,SET,116,0.079425,0.006293,0.076302,0.14896,HP_EMG_MYOPATHIC_ABNORMALITIES,0.88791479816825
HP_NEGATIVISM,SET,10,0.27773,0.0064798,0.26684,0.14899,HP_NEGATIVISM,0.88791479816825
MIR4673,SET,129,0.076808,0.0064154,0.073798,0.149,MIR4673,0.88791479816825
HP_HIGH_PALATE,SET,672,0.033744,0.0063363,0.032422,0.149,HP_HIGH_PALATE,0.88791479816825
GSE43955_1H_VS_42H_ACT_CD4_T...1,SET,186,0.064834,0.0064923,0.062308,0.14905,GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN,0.88791479816825
HP_DISPROPORTIONATE_SHORT_LI...,SET,96,0.093244,0.0067246,0.089621,0.14908,HP_DISPROPORTIONATE_SHORT_LIMB_SHORT_STATURE,0.88791479816825
AGCATTA_MIR155,SET,124,0.081066,0.0066395,0.077921,0.14909,AGCATTA_MIR155,0.88791479816825
LIEN_BREAST_CARCINOMA_METAPL...1,SET,32,0.17069,0.0071195,0.16409,0.14913,LIEN_BREAST_CARCINOMA_METAPLASTIC,0.88791479816825
GOBP_PEPTIDYL_TYROSINE_MODIF...,SET,247,0.058318,0.0067183,0.056067,0.14914,GOBP_PEPTIDYL_TYROSINE_MODIFICATION,0.88791479816825
GOBP_REGULATION_OF_MULTICELL...1,SET,1270,0.026354,0.006687,0.025339,0.14917,GOBP_REGULATION_OF_MULTICELLULAR_ORGANISMAL_DEVELOPMENT,0.88791479816825
HP_ANTERIOR_SYNECHIAE_OF_THE...,SET,13,0.27362,0.007278,0.26316,0.14924,HP_ANTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER,0.88791479816825
HP_THORACIC_SCOLIOSIS,SET,54,0.11434,0.0061914,0.10997,0.14925,HP_THORACIC_SCOLIOSIS,0.88791479816825
GOBP_TRNA_THIO_MODIFICATION,SET,5,0.39074,0.0064471,0.37586,0.14927,GOBP_TRNA_THIO_MODIFICATION,0.88791479816825
GOBP_CELLULAR_RESPONSE_TO_SA...2,SET,14,0.24239,0.0066906,0.23318,0.1493,GOBP_CELLULAR_RESPONSE_TO_SALT_STRESS,0.88791479816825
HP_LEFT_VENTRICULAR_SYSTOLIC...,SET,81,0.09721,0.0064424,0.093522,0.14931,HP_LEFT_VENTRICULAR_SYSTOLIC_DYSFUNCTION,0.88791479816825
GOBP_LYMPHOCYTE_ACTIVATION_I...,SET,192,0.066058,0.0067196,0.063556,0.14933,GOBP_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.88791479816825
MORF_ACTG1,SET,126,0.076434,0.00631,0.073545,0.14935,MORF_ACTG1,0.88791479816825
GSE18791_UNSTIM_VS_NEWCATSLE...1,SET,171,0.06833,0.0065634,0.065755,0.14937,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN,0.88791479816825
GOMF_DNA_EXONUCLEASE_ACTIVITY,SET,23,0.16454,0.0058197,0.15835,0.1494,GOMF_DNA_EXONUCLEASE_ACTIVITY,0.88791479816825
GSE5589_LPS_VS_LPS_AND_IL6_S...5,SET,173,0.065238,0.0063026,0.062794,0.14943,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.88791479816825
REACTOME_PYROPTOSIS,SET,26,0.1853,0.006968,0.1784,0.14948,REACTOME_PYROPTOSIS,0.88791479816825
ZHU_CMV_8_HR_DN,SET,44,0.14686,0.0071804,0.1414,0.14951,ZHU_CMV_8_HR_DN,0.88791479816825
GOBP_EPIGENETIC_PROGRAMING_O...,SET,4,0.45376,0.0066967,0.43695,0.14953,GOBP_EPIGENETIC_PROGRAMING_OF_MALE_PRONUCLEUS,0.88791479816825
HP_CHRONIC_SINUSITIS,SET,57,0.11108,0.0061796,0.10699,0.14958,HP_CHRONIC_SINUSITIS,0.88791479816825
REACTOME_ACTIVATION_OF_GENE_...,SET,41,0.12423,0.0058637,0.11968,0.14965,REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,0.88791479816825
KEGG_MEDICUS_PATHOGEN_HBV_HB...1,SET,13,0.22286,0.005928,0.21473,0.14967,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION,0.88791479816825
GNF2_DENR,SET,46,0.11424,0.0057111,0.11011,0.14974,GNF2_DENR,0.88791479816825
GSE17721_0.5H_VS_4H_CPG_BMDC...1,SET,188,0.065381,0.0065818,0.063021,0.14977,GSE17721_0.5H_VS_4H_CPG_BMDC_DN,0.88791479816825
EHRLICH_ICF_SYNDROM_UP,SET,9,0.28881,0.0063926,0.27839,0.14978,EHRLICH_ICF_SYNDROM_UP,0.88791479816825
GSE22935_WT_VS_MYD88_KO_MACR...7,SET,180,0.06809,0.0067086,0.065638,0.14979,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_DN,0.88791479816825
HP_ANURIA,SET,11,0.29654,0.007256,0.28589,0.14982,HP_ANURIA,0.88791479816825
HP_LOSS_OF_SPEECH,SET,45,0.12841,0.0063492,0.1238,0.14983,HP_LOSS_OF_SPEECH,0.88791479816825
HP_TINNITUS,SET,65,0.10246,0.0060856,0.098786,0.14983,HP_TINNITUS,0.88791479816825
GOCC_GROWTH_CONE_MEMBRANE,SET,7,0.35634,0.0069564,0.34361,0.14986,GOCC_GROWTH_CONE_MEMBRANE,0.88791479816825
STK33_UP,SET,253,0.055593,0.0064807,0.05361,0.14988,STK33_UP,0.88791479816825
MIR4482_3P,SET,427,0.043352,0.0065339,0.041822,0.14997,MIR4482_3P,0.88791479816825
LEE_NAIVE_T_LYMPHOCYTE,SET,16,0.23219,0.0068511,0.224,0.14998,LEE_NAIVE_T_LYMPHOCYTE,0.88791479816825
GOCC_ACTIVIN_RECEPTOR_COMPLEX,SET,6,0.37233,0.0067295,0.35921,0.14998,GOCC_ACTIVIN_RECEPTOR_COMPLEX,0.88791479816825
HU_FETAL_RETINA_RGC,SET,393,0.04517,0.0065373,0.043592,0.15006,HU_FETAL_RETINA_RGC,0.88791479816825
GOBP_NEGATIVE_REGULATION_OF_...5,SET,6,0.39951,0.0072208,0.38558,0.15008,GOBP_NEGATIVE_REGULATION_OF_ACTION_POTENTIAL,0.88791479816825
HP_PROMINENT_OCCIPUT,SET,50,0.11431,0.0059568,0.11032,0.15008,HP_PROMINENT_OCCIPUT,0.88791479816825
GNF2_PECAM1,SET,48,0.13261,0.0067715,0.12799,0.15009,GNF2_PECAM1,0.88791479816825
GOMF_IMMUNOGLOBULIN_BINDING,SET,25,0.18802,0.0069332,0.18148,0.1501,GOMF_IMMUNOGLOBULIN_BINDING,0.88791479816825
GOBP_GOLGI_VESICLE_BUDDING,SET,10,0.25538,0.0059583,0.24653,0.15013,GOBP_GOLGI_VESICLE_BUDDING,0.88791479816825
GNF2_LYN,SET,23,0.18984,0.0067149,0.1833,0.15018,GNF2_LYN,0.88791479816825
HP_ACROMESOMELIA,SET,5,0.33794,0.0055759,0.32629,0.15018,HP_ACROMESOMELIA,0.88791479816825
HP_ABNORMAL_CIRCULATING_RENIN,SET,29,0.17602,0.0069898,0.16996,0.15019,HP_ABNORMAL_CIRCULATING_RENIN,0.88791479816825
HP_RIGHT_AORTIC_ARCH,SET,20,0.18662,0.0061559,0.18022,0.15022,HP_RIGHT_AORTIC_ARCH,0.88791479816825
FULCHER_INFLAMMATORY_RESPONS...1,SET,404,0.0449,0.0065865,0.043364,0.15024,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,0.88791479816825
GOBP_DEFENSE_RESPONSE_TO_VIR...,SET,280,0.054557,0.0066857,0.052696,0.15027,GOBP_DEFENSE_RESPONSE_TO_VIRUS,0.88791479816825
GOBP_RESPONSE_TO_GLYCOPROTEIN,SET,11,0.29164,0.0071362,0.28169,0.15027,GOBP_RESPONSE_TO_GLYCOPROTEIN,0.88791479816825
DESCARTES_MAIN_FETAL_ERYTHRO...,SET,194,0.062403,0.0063804,0.060275,0.15027,DESCARTES_MAIN_FETAL_ERYTHROBLASTS,0.88791479816825
VANGURP_PANCREATIC_BETA_CELL,SET,107,0.088276,0.0067192,0.085275,0.1503,VANGURP_PANCREATIC_BETA_CELL,0.88791479816825
GOBP_CALCIUM_ION_TRANSMEMBRA...3,SET,17,0.22707,0.0069062,0.21937,0.15031,GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL,0.88791479816825
RIZ_ERYTHROID_DIFFERENTIATION,SET,74,0.099113,0.0062794,0.095753,0.15032,RIZ_ERYTHROID_DIFFERENTIATION,0.88791479816825
HP_APLASIA_HYPOPLASIA_INVOLV...14,SET,13,0.23666,0.0062949,0.22864,0.15033,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SINUSES,0.88791479816825
GSE9988_ANTI_TREM1_VS_VEHICL...2,SET,166,0.073675,0.0069735,0.071179,0.15033,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP,0.88791479816825
GOBP_CELL_CELL_JUNCTION_MAIN...,SET,15,0.24853,0.0071007,0.24014,0.15036,GOBP_CELL_CELL_JUNCTION_MAINTENANCE,0.88791479816825
GSE22935_24H_VS_48H_MBOVIS_B...2,SET,178,0.063928,0.0062638,0.06177,0.15036,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.88791479816825
HP_SAGITTAL_CRANIOSYNOSTOSIS,SET,23,0.16279,0.0057578,0.15731,0.15038,HP_SAGITTAL_CRANIOSYNOSTOSIS,0.88791479816825
TIEN_INTESTINE_PROBIOTICS_6H...1,SET,159,0.067363,0.0062414,0.065106,0.15042,TIEN_INTESTINE_PROBIOTICS_6HR_DN,0.88791479816825
GOBP_NEGATIVE_REGULATION_OF_...462,SET,26,0.16442,0.0061829,0.15895,0.15047,GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,0.88791479816825
GSE42724_NAIVE_BCELL_VS_PLAS...2,SET,181,0.066235,0.0065438,0.064029,0.15047,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP,0.88791479816825
GSE24142_EARLY_THYMIC_PROGEN...4,SET,179,0.066378,0.0065219,0.064171,0.15048,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN,0.88791479816825
REACTOME_CYTOKINE_SIGNALING_...,SET,714,0.033836,0.0065414,0.032715,0.15051,REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,0.88791479816825
GSE369_SOCS3_KO_VS_WT_LIVER_...3,SET,187,0.061373,0.0061621,0.059349,0.15055,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_UP,0.88791479816825
YAO_TEMPORAL_RESPONSE_TO_PRO...12,SET,13,0.26242,0.0069803,0.25378,0.15057,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3,0.88791479816825
MIR4721,SET,63,0.1034,0.0060466,0.1,0.15057,MIR4721,0.88791479816825
KEGG_MEDICUS_REFERENCE_TNF_P...,SET,24,0.17063,0.006165,0.16504,0.1506,KEGG_MEDICUS_REFERENCE_TNF_P38_SIGNALING_PATHWAY,0.88791479816825
DMRT1_TARGET_GENES,SET,328,0.047906,0.0063455,0.046339,0.15062,DMRT1_TARGET_GENES,0.88791479816825
GOMF_PROTEIN_RNA_ADAPTOR_ACT...,SET,18,0.2094,0.0065532,0.20256,0.15063,GOMF_PROTEIN_RNA_ADAPTOR_ACTIVITY,0.88791479816825
HP_MALABSORPTION,SET,212,0.061247,0.0065431,0.059261,0.15069,HP_MALABSORPTION,0.888117848058335
MIR1207_3P,SET,124,0.079903,0.0065442,0.077333,0.15075,MIR1207_3P,0.888124466463415
MIR3677_3P,SET,5,0.41049,0.006773,0.39736,0.1508,MIR3677_3P,0.888124466463415
GOBP_PRESYNAPSE_ORGANIZATION,SET,46,0.14233,0.0071152,0.13779,0.15082,GOBP_PRESYNAPSE_ORGANIZATION,0.888124466463415
GOBP_MITOTIC_CELL_CYCLE,SET,838,0.029922,0.0062448,0.028968,0.15083,GOBP_MITOTIC_CELL_CYCLE,0.888124466463415
KEGG_MEDICUS_REFERENCE_TNF_N...,SET,14,0.22004,0.0060736,0.21305,0.15085,KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY,0.888124466463415
GSE17974_0H_VS_24H_IN_VITRO_...2,SET,162,0.068622,0.0064173,0.066443,0.15086,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP,0.888124466463415
MIR6822_3P,SET,49,0.12052,0.0062177,0.1167,0.15087,MIR6822_3P,0.888124466463415
GOBP_ROUNDABOUT_SIGNALING_PA...,SET,5,0.44294,0.0073084,0.42898,0.15091,GOBP_ROUNDABOUT_SIGNALING_PATHWAY,0.888196403790828
YAATNRNNNYNATT_UNKNOWN,SET,97,0.094742,0.006868,0.091777,0.15097,YAATNRNNNYNATT_UNKNOWN,0.888196403790828
GOBP_REGULATION_OF_CELLULAR_...18,SET,137,0.075755,0.0065193,0.073394,0.151,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,0.888196403790828
SALVADOR_MARTIN_PEDIATRIC_TB...2,SET,19,0.2147,0.0069031,0.20802,0.15101,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP,0.888196403790828
GSE360_CTRL_VS_M_TUBERCULOSI...3,SET,177,0.063973,0.0062508,0.06198,0.15101,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN,0.888196403790828
GSE24142_ADULT_VS_FETAL_DN2_...1,SET,169,0.067354,0.006432,0.06528,0.1511,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN,0.888542649297919
HP_DOLICHOCEPHALY,SET,196,0.060813,0.0062495,0.058947,0.15112,HP_DOLICHOCEPHALY,0.888542649297919
GOBP_POSITIVE_REGULATION_OF_...507,SET,58,0.1229,0.0068963,0.11917,0.15121,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.888607477188239
KEGG_MEDICUS_REFERENCE_GENE_...,SET,26,0.16442,0.006183,0.15945,0.15123,KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119,0.888607477188239
WEINBERGER_BLOOD_TWINRIX_AGE...1,SET,32,0.15992,0.0066703,0.15511,0.15127,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_ANTI_HBS_CONC_PRIMARY_VACC_1DY_SIGNIFICANT,0.888607477188239
MIR548AY_3P,SET,54,0.11643,0.006305,0.11295,0.15131,MIR548AY_3P,0.888607477188239
HP_DECREASED_MINIATURE_ENDPL...,SET,13,0.22431,0.0059665,0.2176,0.15131,HP_DECREASED_MINIATURE_ENDPLATE_POTENTIALS,0.888607477188239
GSE13485_CTRL_VS_DAY3_YF17D_...1,SET,179,0.064175,0.0063055,0.062254,0.15131,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN,0.888607477188239
GSE25088_ROSIGLITAZONE_VS_IL...3,SET,178,0.065203,0.0063888,0.063253,0.15131,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,0.888607477188239
GSE12001_MIR223_KO_VS_WT_NEU...2,SET,150,0.071015,0.0063924,0.068902,0.15136,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_UP,0.888750937658388
GOMF_MISMATCHED_DNA_BINDING,SET,14,0.17463,0.0048202,0.16948,0.15143,GOMF_MISMATCHED_DNA_BINDING,0.889011765202703
HP_ABNORMAL_LATERAL_VENTRICL...,SET,104,0.081838,0.0061418,0.079463,0.15154,HP_ABNORMAL_LATERAL_VENTRICLE_MORPHOLOGY,0.889313957597173
HP_ABNORMAL_PROPORTION_OF_CD...2,SET,39,0.13483,0.0062076,0.13094,0.15156,HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_T_CELLS,0.889313957597173
HP_ABNORMAL_SUBCLAVIAN_ARTER...,SET,10,0.28766,0.0067113,0.27935,0.15157,HP_ABNORMAL_SUBCLAVIAN_ARTERY_MORPHOLOGY,0.889313957597173
HP_DECREASED_CORNEAL_REFLEX,SET,9,0.26336,0.0058294,0.25585,0.15166,HP_DECREASED_CORNEAL_REFLEX,0.889313957597173
REACTOME_AUTOPHAGY,SET,144,0.070028,0.0061772,0.068035,0.15168,REACTOME_AUTOPHAGY,0.889313957597173
GOMF_TRAIL_BINDING,SET,5,0.49,0.0080848,0.4763,0.1518,GOMF_TRAIL_BINDING,0.889313957597173
SHAFFER_IRF4_TARGETS_IN_MYEL...,SET,94,0.090236,0.00644,0.08773,0.15185,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,0.889313957597173
JIANG_MELANOMA_TRM4,SET,185,0.067311,0.0067224,0.065448,0.15187,JIANG_MELANOMA_TRM4,0.889313957597173
GSE16385_MONOCYTE_VS_12H_ROS...2,SET,186,0.063355,0.0063443,0.061608,0.1519,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,0.889313957597173
TRAVAGLINI_LUNG_SEROUS_CELL,SET,86,0.095048,0.0064897,0.092429,0.1519,TRAVAGLINI_LUNG_SEROUS_CELL,0.889313957597173
GOBP_SHORT_TERM_MEMORY,SET,10,0.26733,0.0062371,0.25997,0.15191,GOBP_SHORT_TERM_MEMORY,0.889313957597173
GOCC_EXTRINSIC_COMPONENT_OF_...3,SET,6,0.31942,0.0057733,0.31063,0.15191,GOCC_EXTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE,0.889313957597173
TAGGTCA_MIR192_MIR215,SET,36,0.14184,0.0062744,0.13794,0.15192,TAGGTCA_MIR192_MIR215,0.889313957597173
GSE360_CTRL_VS_B_MALAYI_LOW_...1,SET,177,0.065459,0.0063959,0.063659,0.15192,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN,0.889313957597173
GSE17186_MEMORY_VS_CD21HIGH_...2,SET,182,0.065149,0.006454,0.063363,0.15194,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,0.889313957597173
MIR1228_3P,SET,70,0.10595,0.0065294,0.10306,0.15197,MIR1228_3P,0.889313957597173
GOBP_METANEPHRIC_GLOMERULUS_...2,SET,9,0.35617,0.0078836,0.34646,0.15197,GOBP_METANEPHRIC_GLOMERULUS_VASCULATURE_DEVELOPMENT,0.889313957597173
MIR5571_3P,SET,39,0.1392,0.0064086,0.13543,0.15202,MIR5571_3P,0.889313957597173
HOEK_T_CELL_2011_2012_TIV_AD...5,SET,2,0.46785,0.0048826,0.45522,0.15204,HOEK_T_CELL_2011_2012_TIV_ADULT_7DY_UP,0.889313957597173
DACOSTA_UV_RESPONSE_VIA_ERCC...5,SET,49,0.12708,0.0065562,0.12365,0.15205,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,0.889313957597173
GSE41867_NAIVE_VS_DAY30_LCMV...2,SET,182,0.059774,0.0059216,0.058161,0.15205,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP,0.889313957597173
GSE3337_CTRL_VS_4H_IFNG_IN_C...2,SET,185,0.063289,0.0063207,0.061584,0.15206,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP,0.889313957597173
GOBP_OLFACTORY_BULB_INTERNEU...2,SET,12,0.29082,0.0074324,0.283,0.15207,GOBP_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION,0.889313957597173
MIR19A_5P,SET,161,0.070847,0.006605,0.068966,0.15215,MIR19A_5P,0.889632108008075
MIR139_3P,SET,14,0.24973,0.0068931,0.24316,0.15222,MIR139_3P,0.889800479313824
GOBP_MIDBRAIN_DEVELOPMENT,SET,81,0.097333,0.0064505,0.094781,0.15223,GOBP_MIDBRAIN_DEVELOPMENT,0.889800479313824
GOBP_POSITIVE_REGULATION_OF_...829,SET,28,0.16811,0.0065597,0.16377,0.15235,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,0.889947480685254
GOBP_NEUROMUSCULAR_PROCESS,SET,153,0.070935,0.0064482,0.069112,0.15236,GOBP_NEUROMUSCULAR_PROCESS,0.889947480685254
GSE6269_HEALTHY_VS_FLU_INF_P...2,SET,153,0.067693,0.0061535,0.065959,0.15239,GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP,0.889947480685254
GOBP_POSITIVE_REGULATION_OF_...671,SET,20,0.20592,0.0067926,0.20066,0.1524,GOBP_POSITIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION,0.889947480685254
TRAVAGLINI_LUNG_PROLIFERATIN...2,SET,872,0.029437,0.0062609,0.028685,0.1524,TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL,0.889947480685254
MIR6766_3P,SET,139,0.071747,0.0062189,0.06992,0.15242,MIR6766_3P,0.889947480685254
GOBP_TRNA_AMINOACYLATION_FOR...,SET,7,0.28067,0.0054792,0.27354,0.15244,GOBP_TRNA_AMINOACYLATION_FOR_MITOCHONDRIAL_PROTEIN_TRANSLATION,0.889947480685254
GOBP_NEGATIVE_REGULATION_OF_...376,SET,9,0.31948,0.0070714,0.3114,0.15246,GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION,0.889947480685254
GOBP_HORMONE_MEDIATED_SIGNAL...,SET,178,0.065247,0.006393,0.063603,0.15249,GOBP_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.889973123425693
ZNF92_TARGET_GENES,SET,1104,0.027242,0.0064759,0.02656,0.15253,ZNF92_TARGET_GENES,0.890050116686114
WP_BENZENE_METABOLISM,SET,5,0.38051,0.0062784,0.37107,0.15258,WP_BENZENE_METABOLISM,0.890050116686114
MIR4490,SET,95,0.087271,0.0062612,0.085116,0.15261,MIR4490,0.890050116686114
GOBP_POSITIVE_REGULATION_OF_...361,SET,20,0.17653,0.005823,0.1722,0.15266,GOBP_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,0.890050116686114
GSE24671_CTRL_VS_SENDAI_VIRU...1,SET,177,0.060338,0.0058956,0.058869,0.1527,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,0.890050116686114
PUJANA_BREAST_CANCER_WITH_BR...2,SET,52,0.11299,0.0060045,0.11027,0.15276,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP,0.890050116686114
GOBP_REGULATION_OF_RIBONUCLE...,SET,9,0.32109,0.0071072,0.31335,0.15276,GOBP_REGULATION_OF_RIBONUCLEASE_ACTIVITY,0.890050116686114
GOCC_LATERAL_ELEMENT,SET,13,0.2297,0.0061098,0.22418,0.15278,GOCC_LATERAL_ELEMENT,0.890050116686114
GSE9601_UNTREATED_VS_NFKB_IN...1,SET,162,0.066498,0.0062187,0.064905,0.1528,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,0.890050116686114
GOMF_CDP_ALCOHOL_PHOSPHATIDY...,SET,7,0.29658,0.0057897,0.28949,0.15281,GOMF_CDP_ALCOHOL_PHOSPHATIDYLTRANSFERASE_ACTIVITY,0.890050116686114
CUI_DEVELOPING_HEART_C7_MAST...,SET,135,0.077042,0.0065818,0.07523,0.1529,CUI_DEVELOPING_HEART_C7_MAST_CELL,0.890050116686114
GOCC_DNA_DEPENDENT_PROTEIN_K...1,SET,5,0.35644,0.0058812,0.34808,0.15292,GOCC_DNA_DEPENDENT_PROTEIN_KINASE_COMPLEX,0.890050116686114
HP_MIXED_HEARING_IMPAIRMENT,SET,32,0.15765,0.0065756,0.15396,0.15294,HP_MIXED_HEARING_IMPAIRMENT,0.890050116686114
GOMF_HEPARAN_SULFATE_SULFOTR...,SET,14,0.2563,0.0070745,0.25038,0.15301,GOMF_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY,0.890050116686114
MEBARKI_HCC_PROGENITOR_WNT_U...3,SET,39,0.15726,0.00724,0.15367,0.15307,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,0.890050116686114
GSE9988_ANTI_TREM1_AND_LPS_V...4,SET,162,0.072739,0.0068023,0.071088,0.15311,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP,0.890050116686114
GSE9509_LPS_VS_LPS_AND_IL10_...5,SET,169,0.066733,0.0063728,0.065223,0.15313,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN,0.890050116686114
GOMF_O_ACYLTRANSFERASE_ACTIV...,SET,47,0.12843,0.0064896,0.12556,0.15319,GOMF_O_ACYLTRANSFERASE_ACTIVITY,0.890050116686114
REACTOME_SIGNALING_BY_THE_B_...,SET,103,0.078841,0.0058885,0.077084,0.15321,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,0.890050116686114
OSADA_ASCL1_TARGETS_UP,SET,43,0.13977,0.0067562,0.13666,0.15322,OSADA_ASCL1_TARGETS_UP,0.890050116686114
GOCC_GAMMA_SECRETASE_COMPLEX,SET,6,0.35045,0.0063341,0.34266,0.15323,GOCC_GAMMA_SECRETASE_COMPLEX,0.890050116686114
MIR6079,SET,135,0.075582,0.006457,0.073907,0.15324,MIR6079,0.890050116686114
MIR4423_5P,SET,26,0.15975,0.0060071,0.15622,0.15326,MIR4423_5P,0.890050116686114
GOMF_ENDOPEPTIDASE_REGULATOR...,SET,168,0.073355,0.0069846,0.071749,0.15331,GOMF_ENDOPEPTIDASE_REGULATOR_ACTIVITY,0.890050116686114
YBX1_TARGET_GENES,SET,57,0.10879,0.0060523,0.10643,0.15334,YBX1_TARGET_GENES,0.890050116686114
GOBP_POSITIVE_REGULATION_OF_...486,SET,9,0.324,0.0071715,0.31696,0.15335,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.890050116686114
KYNG_ENVIRONMENTAL_STRESS_RE...1,SET,16,0.21617,0.0063784,0.21152,0.1534,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN,0.890050116686114
GOBP_NEGATIVE_REGULATION_OF_...70,SET,21,0.18929,0.006398,0.18522,0.15341,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,0.890050116686114
ZWANG_EGF_INTERVAL_DN,SET,185,0.062957,0.0062876,0.061609,0.15343,ZWANG_EGF_INTERVAL_DN,0.890050116686114
GSE17301_IFNA2_VS_IFNA5_STIM...2,SET,176,0.063334,0.006171,0.061978,0.15343,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP,0.890050116686114
ACTGTGA_MIR27A_MIR27B,SET,435,0.042719,0.006497,0.041815,0.15348,ACTGTGA_MIR27A_MIR27B,0.890050116686114
GOBP_POSITIVE_REGULATION_OF_...84,SET,193,0.062568,0.006381,0.061243,0.15348,GOBP_POSITIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.890050116686114
GOBP_DEFENSE_RESPONSE,SET,1629,0.023383,0.0066488,0.022889,0.15349,GOBP_DEFENSE_RESPONSE,0.890050116686114
HP_AORTIC_ANEURYSM,SET,152,0.070306,0.0063703,0.06882,0.1535,HP_AORTIC_ANEURYSM,0.890050116686114
HP_MYELODYSPLASIA,SET,100,0.082561,0.0060763,0.08082,0.1535,HP_MYELODYSPLASIA,0.890050116686114
POMEROY_MEDULLOBLASTOMA_PROG...1,SET,40,0.13448,0.0062701,0.13166,0.15353,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,0.890050116686114
GOBP_KINETOCHORE_ORGANIZATION,SET,20,0.19104,0.0063016,0.18704,0.15354,GOBP_KINETOCHORE_ORGANIZATION,0.890050116686114
HP_DIGENIC_INHERITANCE,SET,13,0.25874,0.0068822,0.25333,0.15355,HP_DIGENIC_INHERITANCE,0.890050116686114
BIOCARTA_MONOCYTE_PATHWAY,SET,11,0.29901,0.0073165,0.29279,0.15358,BIOCARTA_MONOCYTE_PATHWAY,0.890050116686114
GSE24142_EARLY_THYMIC_PROGEN...2,SET,183,0.0674,0.0066952,0.065999,0.15358,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP,0.890050116686114
GOBP_PIGMENT_ACCUMULATION,SET,11,0.26776,0.0065517,0.26223,0.15362,GOBP_PIGMENT_ACCUMULATION,0.890050116686114
HP_FUSED_CERVICAL_VERTEBRAE,SET,30,0.15481,0.0062526,0.15162,0.15362,HP_FUSED_CERVICAL_VERTEBRAE,0.890050116686114
GNF2_INPP5D,SET,39,0.14491,0.0066713,0.14192,0.15363,GNF2_INPP5D,0.890050116686114
GOMF_MHC_PROTEIN_COMPLEX_BIN...,SET,30,0.15965,0.0064481,0.15637,0.15363,GOMF_MHC_PROTEIN_COMPLEX_BINDING,0.890050116686114
GOBP_NEGATIVE_REGULATION_OF_...706,SET,10,0.29723,0.0069348,0.29119,0.1537,GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.890068485504832
GOBP_EMBRYONIC_CAMERA_TYPE_E...2,SET,11,0.2823,0.0069077,0.27658,0.15371,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_FORMATION,0.890068485504832
GOBP_REGULATION_OF_HUMORAL_I...2,SET,17,0.24938,0.0075847,0.24433,0.15371,GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.890068485504832
BREDEMEYER_RAG_SIGNALING_NOT...2,SET,59,0.11629,0.0065813,0.11396,0.15377,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,0.89017719853431
GSE17721_0.5H_VS_4H_POLYIC_B...1,SET,178,0.06492,0.006361,0.063622,0.15378,GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN,0.89017719853431
GOBP_ACTIN_NUCLEATION,SET,45,0.11543,0.0057073,0.11313,0.15381,GOBP_ACTIN_NUCLEATION,0.890182404181185
MODULE_533,SET,41,0.14011,0.0066134,0.13734,0.15384,MODULE_533,0.890182404181185
HP_ABNORMAL_MORPHOLOGY_OF_TH...7,SET,496,0.037711,0.0061138,0.036979,0.15392,HP_ABNORMAL_MORPHOLOGY_OF_THE_NASAL_ALAE,0.890182404181185
GOBP_SEMICIRCULAR_CANAL_MORP...,SET,7,0.36302,0.0070868,0.35599,0.15393,GOBP_SEMICIRCULAR_CANAL_MORPHOGENESIS,0.890182404181185
HP_LEFT_ANTERIOR_FASCICULAR_...,SET,7,0.35812,0.0069911,0.3512,0.15394,HP_LEFT_ANTERIOR_FASCICULAR_BLOCK,0.890182404181185
GOBP_INHIBITION_OF_NEUROEPIT...,SET,6,0.34108,0.0061646,0.3345,0.15395,GOBP_INHIBITION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.890182404181185
GSE36476_YOUNG_VS_OLD_DONOR_...7,SET,166,0.07054,0.0066768,0.06919,0.15399,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN,0.890182404181185
ZNF488_TARGET_GENES,SET,25,0.1663,0.0061322,0.16315,0.15404,ZNF488_TARGET_GENES,0.890182404181185
BIOCARTA_ACETAMINOPHEN_PATHW...,SET,5,0.41962,0.0069235,0.41173,0.15407,BIOCARTA_ACETAMINOPHEN_PATHWAY,0.890182404181185
GRYDER_PAX3FOXO1_ENHANCERS_K...,SET,412,0.045277,0.0067059,0.04443,0.15409,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,0.890182404181185
REACTOME_EGFR_TRANSACTIVATIO...,SET,9,0.27186,0.0060174,0.26678,0.1541,REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN,0.890182404181185
HP1SITEFACTOR_Q6,SET,204,0.061579,0.0064546,0.060447,0.15417,HP1SITEFACTOR_Q6,0.890182404181185
GSE15139_GMCSF_TREATED_VS_UN...2,SET,180,0.061635,0.0060726,0.060511,0.15421,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP,0.890182404181185
PID_PS1_PATHWAY,SET,42,0.14016,0.0066957,0.13761,0.15422,PID_PS1_PATHWAY,0.890182404181185
GOCC_ARP2_3_PROTEIN_COMPLEX,SET,9,0.23423,0.0051845,0.22997,0.15422,GOCC_ARP2_3_PROTEIN_COMPLEX,0.890182404181185
REACTOME_RHO_GTPASES_ACTIVAT...7,SET,33,0.15328,0.0064923,0.15056,0.15433,REACTOME_RHO_GTPASES_ACTIVATE_PKNS,0.890182404181185
GOBP_AGGRESOME_ASSEMBLY,SET,4,0.41302,0.0060954,0.4057,0.15433,GOBP_AGGRESOME_ASSEMBLY,0.890182404181185
GOBP_CORTICOSTEROID_HORMONE_...,SET,18,0.2103,0.0065813,0.20658,0.15434,GOBP_CORTICOSTEROID_HORMONE_SECRETION,0.890182404181185
FULCHER_INFLAMMATORY_RESPONS...2,SET,525,0.039347,0.0065576,0.038654,0.15436,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP,0.890182404181185
REACTOME_SYNTHESIS_OF_PG,SET,8,0.29795,0.0062179,0.2927,0.15436,REACTOME_SYNTHESIS_OF_PG,0.890182404181185
GOBP_PSYCHOMOTOR_BEHAVIOR,SET,3,0.59873,0.0076526,0.58817,0.15436,GOBP_PSYCHOMOTOR_BEHAVIOR,0.890182404181185
GOMF_AMINO_ACID_PROTON_SYMPO...,SET,6,0.39263,0.0070965,0.38573,0.15437,GOMF_AMINO_ACID_PROTON_SYMPORTER_ACTIVITY,0.890182404181185
HP_CENTRAL_HYPOVENTILATION,SET,11,0.28614,0.0070017,0.28111,0.15437,HP_CENTRAL_HYPOVENTILATION,0.890182404181185
HP_ABNORMAL_SYSTEMIC_ARTERIA...,SET,470,0.039806,0.0062866,0.039119,0.15445,HP_ABNORMAL_SYSTEMIC_ARTERIAL_MORPHOLOGY,0.890449254102437
HOLLEMAN_ASPARAGINASE_RESIST...3,SET,12,0.22053,0.0056359,0.21675,0.15449,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN,0.890449254102437
HP_AREFLEXIA,SET,271,0.050666,0.0061098,0.049806,0.15452,HP_AREFLEXIA,0.890449254102437
chr1q41,SET,31,0.26641,0.010937,0.2619,0.15453,chr1q41,0.890449254102437
HP_TESTICULAR_DYSGENESIS,SET,10,0.29309,0.0068381,0.28816,0.15456,HP_TESTICULAR_DYSGENESIS,0.890449254102437
MODULE_511,SET,34,0.14418,0.0061984,0.14175,0.15457,MODULE_511,0.890449254102437
TERAO_AOX4_TARGETS_HG_DN,SET,6,0.3904,0.0070561,0.38392,0.15462,TERAO_AOX4_TARGETS_HG_DN,0.89046599902296
GOBP_REGULATION_OF_XENOPHAGY,SET,9,0.25493,0.0056426,0.25076,0.15468,GOBP_REGULATION_OF_XENOPHAGY,0.89046599902296
GOBP_AORTA_MORPHOGENESIS,SET,33,0.16267,0.0068899,0.16003,0.1547,GOBP_AORTA_MORPHOGENESIS,0.89046599902296
HP_PERONEAL_MUSCLE_WEAKNESS,SET,8,0.32146,0.0067085,0.31625,0.15471,HP_PERONEAL_MUSCLE_WEAKNESS,0.89046599902296
GOBP_LACTATE_METABOLIC_PROCE...,SET,16,0.20899,0.0061667,0.20562,0.15473,GOBP_LACTATE_METABOLIC_PROCESS,0.89046599902296
GOBP_RESPIRATORY_GASEOUS_EXC...,SET,72,0.10689,0.0066804,0.10518,0.15475,GOBP_RESPIRATORY_GASEOUS_EXCHANGE_BY_RESPIRATORY_SYSTEM,0.89046599902296
HP_SMALL_FOREHEAD,SET,11,0.25181,0.0061616,0.24783,0.15481,HP_SMALL_FOREHEAD,0.89046599902296
GSE15930_STIM_VS_STIM_AND_IF...4,SET,180,0.062587,0.0061664,0.061598,0.15481,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP,0.89046599902296
JINESH_BLEBBISHIELD_TO_IMMUN...2,SET,341,0.048857,0.0065961,0.048092,0.15484,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,0.89046599902296
GAO_LARGE_INTESTINE_ADULT_CH...,SET,92,0.084258,0.0059493,0.08296,0.15491,GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS,0.89046599902296
MIR6870_3P,SET,42,0.1301,0.0062153,0.12812,0.15494,MIR6870_3P,0.89046599902296
GSE27786_CD4_TCELL_VS_NEUTRO...1,SET,180,0.064841,0.0063885,0.063878,0.15504,GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN,0.89046599902296
LU_TUMOR_ANGIOGENESIS_UP,SET,25,0.17956,0.0066213,0.1769,0.15505,LU_TUMOR_ANGIOGENESIS_UP,0.89046599902296
GSE1460_CORD_VS_ADULT_BLOOD_...2,SET,165,0.06498,0.0061322,0.064017,0.15505,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP,0.89046599902296
GOCC_UBIQUITIN_CONJUGATING_E...,SET,7,0.25459,0.00497,0.25089,0.15512,GOCC_UBIQUITIN_CONJUGATING_ENZYME_COMPLEX,0.89046599902296
GOBP_POSITIVE_REGULATION_OF_...538,SET,27,0.18162,0.0069594,0.17899,0.15513,GOBP_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,0.89046599902296
HP_RECURRENT_HAND_FLAPPING,SET,24,0.16604,0.0059992,0.16366,0.15516,HP_RECURRENT_HAND_FLAPPING,0.89046599902296
CHARAFE_BREAST_CANCER_BASAL_...1,SET,50,0.12983,0.0067658,0.12798,0.1552,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,0.89046599902296
HP_TRANSIENT_ISCHEMIC_ATTACK,SET,53,0.12127,0.0065062,0.11955,0.1552,HP_TRANSIENT_ISCHEMIC_ATTACK,0.89046599902296
GOBP_TAXIS,SET,423,0.044578,0.0066878,0.043989,0.15544,GOBP_TAXIS,0.89046599902296
GSE28726_NAIVE_VS_ACTIVATED_...6,SET,180,0.060929,0.0060031,0.060129,0.15546,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP,0.89046599902296
HP_ABNORMAL_SWEAT_HOMEOSTASIS,SET,28,0.17406,0.0067919,0.17179,0.15549,HP_ABNORMAL_SWEAT_HOMEOSTASIS,0.89046599902296
FAN_OVARY_CL17_PUTATIVE_APOP...,SET,209,0.057913,0.0061435,0.057158,0.15549,FAN_OVARY_CL17_PUTATIVE_APOPTOTIC_SMOOTH_MUSCLE_CELL,0.89046599902296
GOBP_RNA_LOCALIZATION,SET,180,0.058403,0.0057542,0.057645,0.1555,GOBP_RNA_LOCALIZATION,0.89046599902296
BHATTACHARYA_EMBRYONIC_STEM_...,SET,76,0.095139,0.0061083,0.093938,0.15559,BHATTACHARYA_EMBRYONIC_STEM_CELL,0.89046599902296
GOCC_ACTOMYOSIN,SET,86,0.095068,0.0064911,0.093879,0.15562,GOCC_ACTOMYOSIN,0.89046599902296
MIR4690_5P,SET,68,0.10752,0.006531,0.10618,0.15563,MIR4690_5P,0.89046599902296
BIOCARTA_CLASSIC_PATHWAY,SET,10,0.28923,0.006748,0.28566,0.15566,BIOCARTA_CLASSIC_PATHWAY,0.89046599902296
GOBP_MINERALOCORTICOID_METAB...,SET,14,0.26578,0.0073361,0.2625,0.15566,GOBP_MINERALOCORTICOID_METABOLIC_PROCESS,0.89046599902296
GSE20715_WT_VS_TLR4_KO_48H_O...1,SET,176,0.060491,0.005894,0.059749,0.15567,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN,0.89046599902296
WP_COMPLEMENT_ACTIVATION,SET,17,0.23215,0.0070606,0.22932,0.1557,WP_COMPLEMENT_ACTIVATION,0.89046599902296
GSE23925_LIGHT_ZONE_VS_DARK_...2,SET,179,0.063723,0.0062611,0.062948,0.1557,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,0.89046599902296
IWANAGA_E2F1_TARGETS_INDUCED...,SET,22,0.17428,0.0060291,0.17217,0.15571,IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM,0.89046599902296
YTCCCRNNAGGY_UNKNOWN,SET,59,0.10788,0.0061054,0.10658,0.15574,YTCCCRNNAGGY_UNKNOWN,0.89046599902296
GOBP_POSITIVE_REGULATION_OF_...286,SET,53,0.12534,0.0067245,0.12385,0.15577,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,0.89046599902296
HP_HIP_FLEXOR_WEAKNESS,SET,15,0.20615,0.0058898,0.20371,0.15579,HP_HIP_FLEXOR_WEAKNESS,0.89046599902296
HP_METACARPOPHALANGEAL_JOINT...,SET,3,0.60228,0.007698,0.59527,0.15583,HP_METACARPOPHALANGEAL_JOINT_CONTRACTURE,0.89046599902296
GOMF_NUCLEAR_THYROID_HORMONE...,SET,27,0.1574,0.0060312,0.15558,0.15585,GOMF_NUCLEAR_THYROID_HORMONE_RECEPTOR_BINDING,0.89046599902296
KEGG_CARDIAC_MUSCLE_CONTRACT...,SET,68,0.1034,0.0062807,0.10222,0.15589,KEGG_CARDIAC_MUSCLE_CONTRACTION,0.89046599902296
MIR4650_5P,SET,64,0.10309,0.006076,0.10192,0.15589,MIR4650_5P,0.89046599902296
GOBP_NEGATIVE_REGULATION_OF_...238,SET,7,0.30877,0.0060278,0.30525,0.15589,GOBP_NEGATIVE_REGULATION_OF_FERTILIZATION,0.89046599902296
GSE13306_RA_VS_UNTREATED_MEM...1,SET,170,0.066442,0.0063635,0.065685,0.15589,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN,0.89046599902296
GOMF_TRANSFERASE_ACTIVITY_TR...3,SET,178,0.060162,0.0058948,0.059487,0.15593,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS,0.89046599902296
HP_PHIMOSIS,SET,9,0.28286,0.0062608,0.27971,0.15596,HP_PHIMOSIS,0.89046599902296
GOBP_MITOCHONDRIAL_TRANSLATI...1,SET,122,0.071547,0.0058127,0.070756,0.15597,GOBP_MITOCHONDRIAL_TRANSLATION,0.89046599902296
HP_REDUCED_FACTOR_XIII_ACTIV...,SET,6,0.33281,0.0060153,0.32921,0.15603,HP_REDUCED_FACTOR_XIII_ACTIVITY,0.89046599902296
GSE37533_UNTREATED_VS_PIOGLI...2,SET,149,0.068741,0.0061672,0.068011,0.15608,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_UP,0.89046599902296
REACTOME_SIRT1_NEGATIVELY_RE...,SET,7,0.28114,0.0054884,0.27818,0.1561,REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION,0.89046599902296
GOBP_REGULATION_OF_RESPIRATO...1,SET,16,0.22236,0.0065611,0.22002,0.1561,GOBP_REGULATION_OF_RESPIRATORY_BURST,0.89046599902296
HOLLEMAN_VINCRISTINE_RESISTA...2,SET,25,0.17653,0.0065095,0.17468,0.15611,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,0.89046599902296
GSE25123_ROSIGLITAZONE_VS_IL...3,SET,175,0.064534,0.0062701,0.063857,0.15611,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,0.89046599902296
GOBP_ORGANELLE_DISASSEMBLY,SET,153,0.064456,0.0058593,0.063785,0.15613,GOBP_ORGANELLE_DISASSEMBLY,0.89046599902296
GSE16385_UNTREATED_VS_12H_RO...1,SET,173,0.063414,0.0061264,0.062755,0.15614,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,0.89046599902296
HP_CHRONIC_PANCREATITIS,SET,4,0.42679,0.0062986,0.42241,0.15617,HP_CHRONIC_PANCREATITIS,0.89046599902296
GOBP_REGULATION_OF_VITAMIN_M...,SET,12,0.24564,0.0062777,0.24314,0.15619,GOBP_REGULATION_OF_VITAMIN_METABOLIC_PROCESS,0.89046599902296
GOBP_MAST_CELL_CHEMOTAXIS,SET,11,0.2788,0.006822,0.27601,0.15622,GOBP_MAST_CELL_CHEMOTAXIS,0.89046599902296
GOBP_NEGATIVE_REGULATION_OF_...648,SET,89,0.090145,0.0062609,0.089247,0.15624,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,0.89046599902296
BILANGES_SERUM_AND_RAPAMYCIN...,SET,60,0.10605,0.0060522,0.10501,0.15629,BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,0.89046599902296
GOBP_NEGATIVE_REGULATION_OF_...578,SET,7,0.34484,0.0067318,0.34148,0.1563,GOBP_NEGATIVE_REGULATION_OF_RUFFLE_ASSEMBLY,0.89046599902296
HP_MITRAL_STENOSIS,SET,21,0.19258,0.0065091,0.19073,0.15632,HP_MITRAL_STENOSIS,0.89046599902296
MIR6787_3P,SET,90,0.091553,0.0063941,0.090676,0.15633,MIR6787_3P,0.89046599902296
HP_ABNORMAL_KNEE_PHYSIOLOGY,SET,78,0.095249,0.0061949,0.094337,0.15633,HP_ABNORMAL_KNEE_PHYSIOLOGY,0.89046599902296
GSE17301_CTRL_VS_48H_ACD3_AC...3,SET,186,0.06138,0.0061464,0.060791,0.15633,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN,0.89046599902296
GOBP_PROLINE_TRANSPORT,SET,11,0.27458,0.0067188,0.27198,0.15636,GOBP_PROLINE_TRANSPORT,0.89046599902296
REACTOME_TFAP2_AP_2_FAMILY_R...2,SET,14,0.25531,0.0070472,0.2529,0.15637,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS,0.89046599902296
GAUTAM_EYE_CHOROID_SCLERA_FI...,SET,185,0.063818,0.0063736,0.063229,0.15642,GAUTAM_EYE_CHOROID_SCLERA_FIBROBLASTS,0.89046599902296
GSE29618_BCELL_VS_PDC_DN,SET,177,0.066131,0.0064616,0.065529,0.15645,GSE29618_BCELL_VS_PDC_DN,0.89046599902296
GOBP_LYMPHOCYTE_ACTIVATION,SET,725,0.033524,0.0065288,0.033221,0.15647,GOBP_LYMPHOCYTE_ACTIVATION,0.89046599902296
ZHONG_PFC_MAJOR_TYPES_OPC,SET,86,0.10075,0.0068792,0.099842,0.15647,ZHONG_PFC_MAJOR_TYPES_OPC,0.89046599902296
GOMF_TAU_PROTEIN_KINASE_ACTI...,SET,22,0.16155,0.0055888,0.16013,0.15652,GOMF_TAU_PROTEIN_KINASE_ACTIVITY,0.89046599902296
MULLIGAN_NTF3_SIGNALING_VIA_...1,SET,7,0.37316,0.0072847,0.3699,0.15654,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN,0.89046599902296
GSE15330_MEGAKARYOCYTE_ERYTH...6,SET,165,0.067674,0.0063864,0.067099,0.1566,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.89046599902296
HP_URETEROPELVIC_JUNCTION_OB...,SET,20,0.16672,0.0054994,0.16532,0.15663,HP_URETEROPELVIC_JUNCTION_OBSTRUCTION,0.89046599902296
MODULE_37,SET,427,0.040229,0.0060631,0.039894,0.15664,MODULE_37,0.89046599902296
GSE26343_UNSTIM_VS_LPS_STIM_...2,SET,191,0.061885,0.0062789,0.061377,0.15667,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,0.89046599902296
GSE27786_BCELL_VS_ERYTHROBLA...2,SET,179,0.060267,0.0059215,0.059789,0.15674,GSE27786_BCELL_VS_ERYTHROBLAST_UP,0.89046599902296
GOCC_PARALLEL_FIBER_TO_PURKI...,SET,17,0.20072,0.0061048,0.19915,0.15675,GOCC_PARALLEL_FIBER_TO_PURKINJE_CELL_SYNAPSE,0.89046599902296
GSE28737_FOLLICULAR_VS_MARGI...2,SET,175,0.063063,0.0061272,0.062574,0.15678,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP,0.89046599902296
GOBP_NEGATIVE_REGULATION_OF_...13,SET,4,0.451,0.0066559,0.44757,0.15682,GOBP_NEGATIVE_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.89046599902296
GOMF_LARGE_RIBOSOMAL_SUBUNIT...,SET,5,0.37384,0.0061682,0.37102,0.15683,GOMF_LARGE_RIBOSOMAL_SUBUNIT_RRNA_BINDING,0.89046599902296
GSE18893_CTRL_VS_TNF_TREATED...4,SET,182,0.060058,0.0059497,0.059612,0.15686,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP,0.89046599902296
MIR3616_5P,SET,84,0.094041,0.0063462,0.093362,0.15691,MIR3616_5P,0.89046599902296
chr6q23,SET,45,0.23542,0.01164,0.23374,0.15693,chr6q23,0.89046599902296
GOBP_RESPONSE_TO_MURAMYL_DIP...,SET,18,0.18486,0.0057853,0.18355,0.15694,GOBP_RESPONSE_TO_MURAMYL_DIPEPTIDE,0.89046599902296
YAGI_AML_FAB_MARKERS,SET,179,0.06437,0.0063246,0.063915,0.15695,YAGI_AML_FAB_MARKERS,0.89046599902296
KEGG_GAP_JUNCTION,SET,84,0.098121,0.0066215,0.097441,0.15698,KEGG_GAP_JUNCTION,0.89046599902296
MIR1251_3P,SET,140,0.074587,0.0064881,0.074073,0.15699,MIR1251_3P,0.89046599902296
HP_PREAXIAL_POLYDACTYLY,SET,73,0.093675,0.0058948,0.093028,0.15699,HP_PREAXIAL_POLYDACTYLY,0.89046599902296
WP_OSTEOARTHRITIC_CHONDROCYT...,SET,47,0.12694,0.0064144,0.12608,0.15701,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,0.89046599902296
GAVISH_3CA_METAPROGRAM_CD4_T...7,SET,38,0.13465,0.0061195,0.13376,0.15704,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_2,0.89046599902296
REACTOME_OREXIN_AND_NEUROPEP...,SET,6,0.41888,0.0075709,0.4161,0.15705,REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS,0.89046599902296
GOMF_TRANSCRIPTION_REGULATOR...1,SET,5,0.44595,0.0073581,0.443,0.15706,GOMF_TRANSCRIPTION_REGULATOR_ACTIVATOR_ACTIVITY,0.89046599902296
GOBP_NEGATIVE_REGULATION_OF_...47,SET,20,0.18513,0.0061068,0.18393,0.15708,GOBP_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION,0.89046599902296
GOBP_NEGATIVE_REGULATION_OF_...53,SET,18,0.2272,0.0071101,0.22572,0.15709,GOBP_NEGATIVE_REGULATION_OF_BONE_REMODELING,0.89046599902296
GSE360_L_DONOVANI_VS_L_MAJOR...1,SET,177,0.0625,0.0061069,0.062097,0.15709,GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN,0.89046599902296
HP_APLASIA_HYPOPLASIA_OF_THE...43,SET,21,0.2059,0.0069594,0.20461,0.15714,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANX_OF_THE_5TH_FINGER,0.89046599902296
chr4p14,SET,29,0.29542,0.011731,0.2936,0.15716,chr4p14,0.89046599902296
MIR3613_5P,SET,64,0.10971,0.006466,0.10904,0.15718,MIR3613_5P,0.89046599902296
HP_TEMPORAL_PATTERN,SET,18,0.19459,0.0060898,0.19346,0.15725,HP_TEMPORAL_PATTERN,0.89046599902296
GOBP_LOCOMOTION_INVOLVED_IN_...,SET,11,0.2627,0.006428,0.26118,0.15726,GOBP_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR,0.89046599902296
MIR1297,SET,579,0.036149,0.0063173,0.035941,0.15727,MIR1297,0.89046599902296
GOBP_MEIOSIS_I_CELL_CYCLE_PR...,SET,120,0.07213,0.0058121,0.071716,0.15727,GOBP_MEIOSIS_I_CELL_CYCLE_PROCESS,0.89046599902296
HP_POSTERIOR_RIB_CUPPING,SET,4,0.4423,0.0065275,0.43975,0.15727,HP_POSTERIOR_RIB_CUPPING,0.89046599902296
PEPPER_CHRONIC_LYMPHOCYTIC_L...2,SET,29,0.1667,0.0066199,0.16575,0.15728,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,0.89046599902296
GOBP_ABSCISSION,SET,5,0.33044,0.0054522,0.32855,0.15728,GOBP_ABSCISSION,0.89046599902296
GOMF_HISTONE_CHAPERONE_ACTIV...,SET,12,0.23751,0.0060699,0.23616,0.15729,GOMF_HISTONE_CHAPERONE_ACTIVITY,0.89046599902296
GOMF_TYPE_II_TRANSFORMING_GR...,SET,11,0.28447,0.0069608,0.28291,0.15733,GOMF_TYPE_II_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.89046599902296
REACTOME_PEXOPHAGY,SET,9,0.29737,0.006582,0.29575,0.15734,REACTOME_PEXOPHAGY,0.89046599902296
HP_HYPOMETRIC_SACCADES,SET,13,0.23616,0.0062816,0.23497,0.15744,HP_HYPOMETRIC_SACCADES,0.890779876013352
REACTOME_SCAVENGING_OF_HEME_...,SET,10,0.28847,0.0067303,0.28709,0.1575,REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA,0.890779876013352
GOBP_CELLULAR_RESPONSE_TO_HO...,SET,568,0.037206,0.006442,0.037037,0.15756,GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS,0.890779876013352
GAUCHER_PBMC_YF_VAX_STAMARIL...1,SET,96,0.086468,0.006236,0.086081,0.15757,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_DN,0.890779876013352
GOBP_CYTOPLASMIC_PATTERN_REC...,SET,148,0.06698,0.0059892,0.06668,0.15758,GOBP_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.890779876013352
HP_WORMIAN_BONES,SET,53,0.11146,0.0059798,0.11099,0.15762,HP_WORMIAN_BONES,0.890779876013352
GSE37532_TREG_VS_TCONV_CD4_T...1,SET,173,0.063085,0.0060946,0.062835,0.1577,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN,0.890779876013352
GSE16450_IMMATURE_VS_MATURE_...3,SET,177,0.063573,0.0062116,0.063324,0.15771,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.890779876013352
GOMF_HYDROLASE_ACTIVITY_ACTI...1,SET,716,0.032028,0.0062002,0.031905,0.15773,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES,0.890779876013352
MIR769_3P,SET,27,0.16457,0.0063063,0.16397,0.15777,MIR769_3P,0.890779876013352
GOMF_LIPOPROTEIN_PARTICLE_RE...1,SET,18,0.20867,0.0065305,0.20792,0.15779,GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,0.890779876013352
GOCC_ENDOPLASMIC_RETICULUM_Q...,SET,15,0.2083,0.0059514,0.20757,0.15781,GOCC_ENDOPLASMIC_RETICULUM_QUALITY_CONTROL_COMPARTMENT,0.890779876013352
chr13q32,SET,29,0.29958,0.011897,0.29858,0.15785,chr13q32,0.890779876013352
GSE13887_HEALTHY_VS_LUPUS_RE...2,SET,104,0.085982,0.0064527,0.085727,0.15795,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP,0.890779876013352
GSE9988_ANTI_TREM1_VS_LOW_LP...1,SET,174,0.067263,0.0065168,0.067084,0.15802,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN,0.890779876013352
HP_HORIZONTAL_NYSTAGMUS,SET,102,0.081378,0.0060485,0.081191,0.15811,HP_HORIZONTAL_NYSTAGMUS,0.890779876013352
CAHOY_ASTROGLIAL,SET,89,0.093551,0.0064974,0.093339,0.15811,CAHOY_ASTROGLIAL,0.890779876013352
MIR933,SET,6,0.39071,0.0070617,0.38988,0.15815,MIR933,0.890779876013352
RUBENSTEIN_SKELETAL_MUSCLE_P...1,SET,202,0.063472,0.0066207,0.063349,0.15819,RUBENSTEIN_SKELETAL_MUSCLE_PCV_ENDOTHELIAL_CELLS,0.890779876013352
MODULE_335,SET,14,0.24521,0.0067685,0.24479,0.15824,MODULE_335,0.890779876013352
HP_ABNORMAL_CORNEAL_REFLEX,SET,11,0.24204,0.0059224,0.24162,0.15825,HP_ABNORMAL_CORNEAL_REFLEX,0.890779876013352
BIOCARTA_CREB_PATHWAY,SET,22,0.18779,0.0064963,0.18749,0.15828,BIOCARTA_CREB_PATHWAY,0.890779876013352
GSE24634_IL4_VS_CTRL_TREATED...1,SET,180,0.063781,0.006284,0.06368,0.15828,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN,0.890779876013352
HP_BABINSKI_SIGN,SET,254,0.051449,0.0060092,0.05137,0.15829,HP_BABINSKI_SIGN,0.890779876013352
GOBP_ACTIN_MEDIATED_CELL_CON...,SET,106,0.085629,0.0064874,0.085507,0.15832,GOBP_ACTIN_MEDIATED_CELL_CONTRACTION,0.890779876013352
GOBP_FORMATION_OF_TRANSLATIO...,SET,5,0.29793,0.0049157,0.29751,0.15832,GOBP_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX,0.890779876013352
LEE_LIVER_CANCER_MYC_TGFA_DN,SET,57,0.11758,0.0065412,0.11743,0.15834,LEE_LIVER_CANCER_MYC_TGFA_DN,0.890779876013352
KEGG_SNARE_INTERACTIONS_IN_V...,SET,36,0.13052,0.0057738,0.13037,0.15837,KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT,0.890779876013352
GOBP_GLYCOSYLCERAMIDE_BIOSYN...,SET,8,0.30607,0.0063873,0.30573,0.1584,GOBP_GLYCOSYLCERAMIDE_BIOSYNTHETIC_PROCESS,0.890779876013352
MIR4272,SET,180,0.061916,0.0061003,0.061863,0.15845,MIR4272,0.890779876013352
GOBP_NEGATIVE_REGULATION_OF_...269,SET,10,0.25684,0.0059924,0.25663,0.15846,GOBP_NEGATIVE_REGULATION_OF_HEART_RATE,0.890779876013352
GOBP_CELLULAR_RESPONSE_TO_LA...,SET,7,0.3249,0.0063426,0.32464,0.15847,GOBP_CELLULAR_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS,0.890779876013352
GSE19888_ADENOSINE_A3R_INH_V...4,SET,184,0.063963,0.006371,0.063912,0.15847,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP,0.890779876013352
PETRETTO_LEFT_VENTRICLE_MASS...1,SET,9,0.23555,0.0052138,0.23542,0.15853,PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN,0.890779876013352
GOBP_POSITIVE_REGULATION_OF_...175,SET,9,0.28328,0.0062703,0.28314,0.15854,GOBP_POSITIVE_REGULATION_OF_COLLATERAL_SPROUTING,0.890779876013352
GOBP_POSITIVE_REGULATION_OF_...452,SET,8,0.36279,0.007571,0.36262,0.15855,GOBP_POSITIVE_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION,0.890779876013352
GNF2_ANK1,SET,61,0.10975,0.0063156,0.10972,0.15859,GNF2_ANK1,0.890779876013352
GNF2_SPTB,SET,61,0.10975,0.0063156,0.10972,0.15859,GNF2_SPTB,0.890779876013352
GOBP_REGULATION_OF_ANAPHASE_...,SET,5,0.35267,0.0058189,0.35256,0.15859,GOBP_REGULATION_OF_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,0.890779876013352
MIR8053,SET,5,0.25633,0.0042293,0.25629,0.15862,MIR8053,0.890779876013352
GOBP_FOREBRAIN_MORPHOGENESIS,SET,13,0.23641,0.0062883,0.23641,0.15866,GOBP_FOREBRAIN_MORPHOGENESIS,0.890779876013352
GSE21546_ELK1_KO_VS_SAP1A_KO...3,SET,180,0.058409,0.0057548,0.058408,0.15866,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.890779876013352
GSE24142_EARLY_THYMIC_PROGEN...12,SET,185,0.064452,0.0064369,0.06446,0.15869,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP,0.890779876013352
BACH2_01,SET,242,0.054434,0.0062079,0.054444,0.15871,BACH2_01,0.890779876013352
GSE27241_WT_VS_RORGT_KO_TH17...2,SET,164,0.065678,0.0061794,0.065692,0.15871,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_DN,0.890779876013352
GSE29618_LAIV_VS_TIV_FLU_VAC...3,SET,170,0.064268,0.0061553,0.06428,0.15871,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN,0.890779876013352
KEGG_MEDICUS_VARIANT_MUTATIO...87,SET,5,0.4154,0.006854,0.41554,0.15874,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RUNX1_TO_TRANSCRIPTION,0.890779876013352
HP_CLUMSINESS,SET,84,0.092478,0.0062407,0.092539,0.15882,HP_CLUMSINESS,0.890779876013352
GOBP_PROTEIN_DENEDDYLATION,SET,11,0.22487,0.0055023,0.22503,0.15883,GOBP_PROTEIN_DENEDDYLATION,0.890779876013352
MIR7155_5P,SET,86,0.086582,0.0059117,0.086646,0.15884,MIR7155_5P,0.890779876013352
GOBP_CALCIUM_ION_IMPORT_INTO...,SET,5,0.29572,0.0048793,0.29594,0.15884,GOBP_CALCIUM_ION_IMPORT_INTO_SARCOPLASMIC_RETICULUM,0.890779876013352
GOMF_DIPEPTIDE_TRANSMEMBRANE...,SET,5,0.40059,0.0066096,0.40088,0.15884,GOMF_DIPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.890779876013352
GSE13306_RA_VS_UNTREATED_TCO...2,SET,183,0.061094,0.0060688,0.061141,0.15885,GSE13306_RA_VS_UNTREATED_TCONV_UP,0.890779876013352
GSE17721_POLYIC_VS_PAM3CSK4_...2,SET,180,0.063459,0.0062523,0.063527,0.15892,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_UP,0.890779876013352
REACTOME_ABC_TRANSPORTERS_IN...,SET,17,0.21054,0.0064033,0.21077,0.15893,REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS,0.890779876013352
GOBP_MALATE_METABOLIC_PROCESS,SET,9,0.28067,0.0062124,0.28105,0.15899,GOBP_MALATE_METABOLIC_PROCESS,0.890779876013352
GSE16385_ROSIGLITAZONE_IFNG_...2,SET,185,0.062737,0.0062656,0.062828,0.15901,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,0.890779876013352
GSE360_L_MAJOR_VS_T_GONDII_M...2,SET,178,0.064373,0.0063074,0.064465,0.15901,GSE360_L_MAJOR_VS_T_GONDII_MAC_UP,0.890779876013352
MORF_CCNF,SET,72,0.091217,0.0057009,0.09135,0.15902,MORF_CCNF,0.890779876013352
MIR219A_5P,SET,141,0.069478,0.006065,0.069584,0.15903,MIR219A_5P,0.890779876013352
MIR6503_5P,SET,52,0.11657,0.0061949,0.11678,0.15909,MIR6503_5P,0.890779876013352
GSE41176_UNSTIM_VS_ANTI_IGM_...2,SET,183,0.065775,0.0065338,0.065891,0.15909,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_UP,0.890779876013352
HP_ABNORMAL_SELLA_TURCICA_MO...,SET,37,0.13095,0.0058725,0.13119,0.15911,HP_ABNORMAL_SELLA_TURCICA_MORPHOLOGY,0.890779876013352
GOBP_NON_LYTIC_VIRAL_RELEASE,SET,14,0.21299,0.0058791,0.2134,0.15913,GOBP_NON_LYTIC_VIRAL_RELEASE,0.890779876013352
ITO_PTTG1_TARGETS_UP,SET,11,0.29565,0.0072344,0.29624,0.15914,ITO_PTTG1_TARGETS_UP,0.890779876013352
HP_DECREASED_LYMPHOCYTE_PROL...1,SET,9,0.31658,0.0070072,0.31725,0.15918,HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_ANTI_CD3,0.890779876013352
HP_RADIAL_DEVIATION_OF_FINGER,SET,43,0.1267,0.0061243,0.12698,0.15919,HP_RADIAL_DEVIATION_OF_FINGER,0.890779876013352
GSE21927_SPLEEN_VS_BONE_MARR...1,SET,164,0.066235,0.0062318,0.06638,0.15919,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN,0.890779876013352
GSE10240_CTRL_VS_IL22_STIM_P...1,SET,174,0.060445,0.0058563,0.06058,0.1592,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.890779876013352
HP_DECREASED_CIRCULATING_BET...,SET,5,0.40669,0.0067103,0.40761,0.15921,HP_DECREASED_CIRCULATING_BETA_2_MICROGLOBULIN_LEVEL,0.890779876013352
GOBP_REGULATION_OF_LEUKOCYTE...1,SET,4,0.46404,0.0068484,0.46522,0.15928,GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_ARTERIAL_ENDOTHELIAL_CELL,0.890779876013352
GOBP_RESPONSE_TO_INTERLEUKIN...3,SET,5,0.39101,0.0064516,0.39205,0.15931,GOBP_RESPONSE_TO_INTERLEUKIN_13,0.890779876013352
GOMF_PROMOTER_ENHANCER_LOOP_...,SET,4,0.41892,0.0061826,0.42005,0.15931,GOMF_PROMOTER_ENHANCER_LOOP_ANCHORING_ACTIVITY,0.890779876013352
GOBP_PROTEIN_TRANSMEMBRANE_T...,SET,68,0.10225,0.0062109,0.10255,0.15937,GOBP_PROTEIN_TRANSMEMBRANE_TRANSPORT,0.890779876013352
GOMF_NAD_DEPENDENT_HISTONE_D...,SET,5,0.35844,0.0059141,0.3595,0.15938,GOMF_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY,0.890779876013352
GOMF_PEPTIDE_ALPHA_N_ACETYLT...,SET,6,0.33782,0.0061059,0.33883,0.15938,GOMF_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE_ACTIVITY,0.890779876013352
DESCARTES_FETAL_PANCREAS_SMO...,SET,30,0.16387,0.0066186,0.16436,0.15938,DESCARTES_FETAL_PANCREAS_SMOOTH_MUSCLE_CELLS,0.890779876013352
MIR655_3P,SET,382,0.044687,0.0063783,0.044837,0.15947,MIR655_3P,0.890779876013352
BUSSLINGER_GASTRIC_PPP1R1B_P...,SET,114,0.078018,0.0061284,0.078281,0.15947,BUSSLINGER_GASTRIC_PPP1R1B_POSITIVE_CELLS,0.890779876013352
KANG_CISPLATIN_RESISTANCE_UP,SET,18,0.19317,0.0060452,0.19383,0.15949,KANG_CISPLATIN_RESISTANCE_UP,0.890779876013352
KEGG_MEDICUS_ENV_FACTOR_META...2,SET,9,0.32649,0.0072266,0.32763,0.15951,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY,0.890779876013352
GSE13547_WT_VS_ZFX_KO_BCELL_...2,SET,123,0.080978,0.0066056,0.08126,0.15951,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP,0.890779876013352
BROWNE_HCMV_INFECTION_8HR_DN,SET,40,0.13522,0.0063047,0.13577,0.15964,BROWNE_HCMV_INFECTION_8HR_DN,0.890779876013352
MIR6846_5P,SET,70,0.098653,0.0060797,0.099053,0.15964,MIR6846_5P,0.890779876013352
GOMF_TRANSMEMBRANE_RECEPTOR_...1,SET,80,0.10228,0.0067364,0.10269,0.15964,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY,0.890779876013352
HP_GOITER,SET,54,0.11341,0.0061415,0.11388,0.15965,HP_GOITER,0.890779876013352
GOBP_SULFUR_AMINO_ACID_METAB...,SET,30,0.16147,0.0065216,0.16216,0.15969,GOBP_SULFUR_AMINO_ACID_METABOLIC_PROCESS,0.890779876013352
GSE339_CD4POS_VS_CD4CD8DN_DC...2,SET,189,0.060129,0.006069,0.060385,0.15969,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,0.890779876013352
GSE23321_CENTRAL_MEMORY_VS_N...2,SET,182,0.062078,0.0061498,0.062344,0.1597,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.890779876013352
GSE18893_TCONV_VS_TREG_24H_C...2,SET,189,0.061847,0.0062425,0.06212,0.15973,GSE18893_TCONV_VS_TREG_24H_CULTURE_UP,0.890779876013352
GSE19888_CTRL_VS_TCELL_MEMBR...2,SET,171,0.063556,0.0061048,0.063849,0.15978,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP,0.890779876013352
GSE27786_NKCELL_VS_NEUTROPHI...1,SET,180,0.063076,0.0062146,0.063385,0.15984,GSE27786_NKCELL_VS_NEUTROPHIL_DN,0.890779876013352
AIZARANI_LIVER_C20_LSECS_3,SET,271,0.053449,0.0064453,0.05371,0.15984,AIZARANI_LIVER_C20_LSECS_3,0.890779876013352
GOBP_CENTROMERE_COMPLEX_ASSE...,SET,26,0.15904,0.0059804,0.15982,0.15986,GOBP_CENTROMERE_COMPLEX_ASSEMBLY,0.890779876013352
GAZDA_DIAMOND_BLACKFAN_ANEMI...1,SET,403,0.040557,0.0059423,0.040771,0.15994,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,0.890779876013352
PID_BCR_5PATHWAY,SET,59,0.11036,0.0062456,0.11095,0.15997,PID_BCR_5PATHWAY,0.890779876013352
GCM_ATM,SET,23,0.1725,0.0061013,0.17343,0.15997,GCM_ATM,0.890779876013352
GOBP_INTEGRIN_ACTIVATION,SET,26,0.1713,0.0064414,0.17228,0.16004,GOBP_INTEGRIN_ACTIVATION,0.890779876013352
REACTOME_NONHOMOLOGOUS_END_J...,SET,29,0.13418,0.0053285,0.13498,0.16009,REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ,0.890779876013352
HP_OROMANDIBULAR_DYSTONIA,SET,18,0.17574,0.0054997,0.17678,0.16009,HP_OROMANDIBULAR_DYSTONIA,0.890779876013352
GOBP_REGULATION_OF_BILE_ACID...1,SET,11,0.27897,0.0068262,0.28064,0.16011,GOBP_REGULATION_OF_BILE_ACID_BIOSYNTHETIC_PROCESS,0.890779876013352
HP_CONGENITAL_HYPOTHYROIDISM,SET,30,0.15525,0.0062704,0.15618,0.16011,HP_CONGENITAL_HYPOTHYROIDISM,0.890779876013352
GAVISH_3CA_MALIGNANT_METAPRO...16,SET,46,0.13938,0.0069677,0.14022,0.16012,GAVISH_3CA_MALIGNANT_METAPROGRAM_25_ASTROCYTES,0.890779876013352
REACTOME_EXTRINSIC_PATHWAY_O...,SET,4,0.49635,0.0073252,0.49941,0.16015,REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,0.890779876013352
GOMF_DYNEIN_INTERMEDIATE_CHA...,SET,31,0.15111,0.0062038,0.15207,0.16019,GOMF_DYNEIN_INTERMEDIATE_CHAIN_BINDING,0.890779876013352
HP_ABNORMALITY_OF_SALIVATION,SET,178,0.063958,0.0062667,0.064363,0.16019,HP_ABNORMALITY_OF_SALIVATION,0.890779876013352
GSE5503_MLN_DC_VS_PLN_DC_ACT...1,SET,183,0.061304,0.0060897,0.061703,0.16023,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.890779876013352
GOMF_KINASE_INHIBITOR_ACTIVI...,SET,73,0.0996,0.0062677,0.10027,0.16028,GOMF_KINASE_INHIBITOR_ACTIVITY,0.890779876013352
REACTOME_GABA_RECEPTOR_ACTIV...,SET,57,0.12119,0.0067418,0.12201,0.1603,REACTOME_GABA_RECEPTOR_ACTIVATION,0.890779876013352
CHEN_LVAD_SUPPORT_OF_FAILING...2,SET,88,0.094073,0.006497,0.094735,0.16036,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,0.890779876013352
GOBP_COLLATERAL_SPROUTING_IN...,SET,4,0.43351,0.0063978,0.43659,0.16037,GOBP_COLLATERAL_SPROUTING_IN_ABSENCE_OF_INJURY,0.890779876013352
GSE8621_UNSTIM_VS_LPS_PRIMED...1,SET,188,0.060417,0.0060822,0.060849,0.16038,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.890779876013352
BIOCARTA_GRANULOCYTES_PATHWAY,SET,15,0.22439,0.006411,0.226,0.16039,BIOCARTA_GRANULOCYTES_PATHWAY,0.890779876013352
HP_NEUROINFLAMMATION,SET,18,0.2025,0.0063373,0.20397,0.16041,HP_NEUROINFLAMMATION,0.890779876013352
HP_ABNORMAL_TRAGUS_MORPHOLOGY,SET,11,0.24109,0.0058992,0.24286,0.16044,HP_ABNORMAL_TRAGUS_MORPHOLOGY,0.890779876013352
KEGG_MEDICUS_VARIANT_MUTATIO...39,SET,25,0.16838,0.0062088,0.16966,0.16049,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.890779876013352
HP_ANARTHRIA,SET,15,0.19095,0.0054556,0.19244,0.16054,HP_ANARTHRIA,0.890779876013352
HP_MORNING_GLORY_ANOMALY,SET,6,0.39959,0.0072223,0.40273,0.16055,HP_MORNING_GLORY_ANOMALY,0.890779876013352
GOMF_UBIQUITIN_PROTEIN_TRANS...1,SET,15,0.21599,0.0061709,0.21772,0.16059,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVATOR_ACTIVITY,0.890779876013352
MORF_CD8A,SET,111,0.084545,0.0065537,0.085236,0.16063,MORF_CD8A,0.890779876013352
ZNF622_TARGET_GENES,SET,55,0.11103,0.0060676,0.11195,0.16066,ZNF622_TARGET_GENES,0.890779876013352
KEGG_MEDICUS_PATHOGEN_HPV_E6...3,SET,13,0.22684,0.0060337,0.22873,0.16067,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382,0.890779876013352
HP_CEREBRAL_BERRY_ANEURYSM,SET,6,0.33304,0.0060194,0.33584,0.16068,HP_CEREBRAL_BERRY_ANEURYSM,0.890779876013352
HP_ABSENT_SPEECH,SET,364,0.042956,0.005988,0.043321,0.16071,HP_ABSENT_SPEECH,0.890779876013352
GOBP_POSITIVE_REGULATION_OF_...802,SET,37,0.1693,0.0075924,0.17075,0.16072,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,0.890779876013352
MODULE_53,SET,360,0.044036,0.0061053,0.044416,0.16074,MODULE_53,0.890779876013352
chr9q31,SET,55,0.20152,0.011013,0.20328,0.16077,chr9q31,0.890779876013352
GOBP_REGULATION_OF_INFLAMMAS...,SET,35,0.13859,0.0060449,0.13981,0.16079,GOBP_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.890779876013352
SHIPP_DLBCL_VS_FOLLICULAR_LY...2,SET,44,0.12665,0.0061926,0.1278,0.16083,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,0.890779876013352
GOBP_TOLL_LIKE_RECEPTOR_8_SI...,SET,2,0.70228,0.0073292,0.70862,0.16084,GOBP_TOLL_LIKE_RECEPTOR_8_SIGNALING_PATHWAY,0.890779876013352
GNF2_FGR,SET,30,0.14935,0.0060322,0.15072,0.16086,GNF2_FGR,0.890779876013352
KEGG_CHEMOKINE_SIGNALING_PAT...,SET,176,0.06643,0.0064726,0.067038,0.16087,KEGG_CHEMOKINE_SIGNALING_PATHWAY,0.890779876013352
SIMBULAN_UV_RESPONSE_IMMORTA...,SET,31,0.15237,0.0062557,0.15379,0.16089,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,0.890779876013352
REACTOME_DNA_REPLICATION,SET,122,0.06794,0.0055197,0.068573,0.1609,REACTOME_DNA_REPLICATION,0.890779876013352
HP_ESOPHAGEAL_CARCINOMA,SET,13,0.23409,0.0062267,0.23627,0.1609,HP_ESOPHAGEAL_CARCINOMA,0.890779876013352
GOCC_NEUROFIBRILLARY_TANGLE,SET,5,0.4706,0.0077648,0.47505,0.16094,GOCC_NEUROFIBRILLARY_TANGLE,0.890779876013352
GSE45365_NK_CELL_VS_BCELL_MC...2,SET,181,0.062158,0.006141,0.062748,0.16095,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_UP,0.890779876013352
PID_EPHA2_FWD_PATHWAY,SET,19,0.18491,0.0059451,0.18671,0.16101,PID_EPHA2_FWD_PATHWAY,0.890779876013352
DESCARTES_MAIN_FETAL_RETINAL...1,SET,106,0.084815,0.0064257,0.085653,0.16104,DESCARTES_MAIN_FETAL_RETINAL_PIGMENT_CELLS,0.890779876013352
HP_LIMB_JOINT_CONTRACTURE,SET,399,0.042708,0.006227,0.043131,0.16105,HP_LIMB_JOINT_CONTRACTURE,0.890779876013352
HP_ABDOMINAL_PAIN,SET,308,0.048797,0.0062668,0.049285,0.16107,HP_ABDOMINAL_PAIN,0.890779876013352
HP_TACTILE_HYPERSENSITIVITY,SET,5,0.34013,0.0056121,0.34353,0.16107,HP_TACTILE_HYPERSENSITIVITY,0.890779876013352
GOBP_MITOTIC_CHROMOSOME_COND...,SET,17,0.18256,0.0055524,0.18439,0.16108,GOBP_MITOTIC_CHROMOSOME_CONDENSATION,0.890779876013352
GOMF_AMMONIUM_TRANSMEMBRANE_...,SET,12,0.24454,0.0062495,0.24702,0.1611,GOMF_AMMONIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.890779876013352
GOMF_THREONINE_TYPE_PEPTIDAS...,SET,16,0.20848,0.0061515,0.21062,0.16113,GOMF_THREONINE_TYPE_PEPTIDASE_ACTIVITY,0.890779876013352
GSE11864_CSF1_IFNG_VS_CSF1_P...2,SET,174,0.061264,0.0059356,0.061896,0.16115,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP,0.890779876013352
KEGG_MEDICUS_REFERENCE_MDM2_...1,SET,13,0.2321,0.0061736,0.23455,0.1612,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00066,0.890779876013352
WP_BENZOAPYRENE_METABOLISM,SET,9,0.31893,0.0070593,0.3223,0.16121,WP_BENZOAPYRENE_METABOLISM,0.890779876013352
GOMF_AMIDE_TRANSMEMBRANE_TRA...,SET,34,0.15034,0.0064635,0.15195,0.16124,GOMF_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.890779876013352
QI_PBMC_ZOSTAVAX_AGE_50_75YO...2,SET,35,0.13178,0.0057482,0.13319,0.16124,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_28D_PEAK_T_CELL_RESPONSE_14DY_NEGATIVE,0.890779876013352
GOBP_RESPONSE_TO_PHENYLPROPA...,SET,4,0.47572,0.0070208,0.48092,0.16129,GOBP_RESPONSE_TO_PHENYLPROPANOID,0.890914486649714
GOBP_SUBTELOMERIC_HETEROCHRO...,SET,6,0.31037,0.0056097,0.31383,0.16135,GOBP_SUBTELOMERIC_HETEROCHROMATIN_FORMATION,0.891104282536151
MIR6134,SET,122,0.074139,0.0060233,0.074982,0.1614,MIR6134,0.891238798856053
KEGG_MEDICUS_REFERENCE_WNT_S...3,SET,17,0.21573,0.0065613,0.21821,0.16143,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION,0.891255740828966
RUVBL2_TARGET_GENES,SET,28,0.1521,0.0059351,0.15387,0.16147,RUVBL2_TARGET_GENES,0.891255740828966
HP_ABNORMAL_MOTOR_EVOKED_POT...,SET,10,0.23981,0.0055951,0.24262,0.16148,HP_ABNORMAL_MOTOR_EVOKED_POTENTIALS,0.891255740828966
GSE6269_FLU_VS_STREP_PNEUMO_...2,SET,162,0.064154,0.0059995,0.064936,0.16159,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP,0.891482934177997
MODULE_179,SET,420,0.040876,0.0061111,0.041376,0.16161,MODULE_179,0.891482934177997
GOBP_RESPONSE_TO_COLD,SET,42,0.12972,0.0061972,0.13134,0.16166,GOBP_RESPONSE_TO_COLD,0.891482934177997
GOBP_TRANSPOSITION,SET,35,0.13951,0.0060852,0.1413,0.16176,GOBP_TRANSPOSITION,0.891482934177997
REACTOME_SIGNALING_BY_NTRKS,SET,132,0.073109,0.0061765,0.074103,0.16193,REACTOME_SIGNALING_BY_NTRKS,0.891482934177997
GSE4984_LPS_VS_VEHICLE_CTRL_...2,SET,168,0.062482,0.0059493,0.06334,0.16196,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP,0.891482934177997
GOBP_POSITIVE_REGULATION_OF_...216,SET,5,0.35395,0.0058401,0.35882,0.16197,GOBP_POSITIVE_REGULATION_OF_DNA_LIGATION,0.891482934177997
WP_OREXIN_RECEPTOR_PATHWAY,SET,189,0.066284,0.0066902,0.067208,0.16201,WP_OREXIN_RECEPTOR_PATHWAY,0.891482934177997
GRESHOCK_CANCER_COPY_NUMBER_...,SET,309,0.047205,0.006072,0.047872,0.16206,GRESHOCK_CANCER_COPY_NUMBER_UP,0.891482934177997
GOBP_OOCYTE_CONSTRUCTION,SET,8,0.29519,0.0061604,0.29939,0.16208,GOBP_OOCYTE_CONSTRUCTION,0.891482934177997
GSE6269_HEALTHY_VS_STAPH_AUR...1,SET,145,0.068184,0.0060353,0.06916,0.1621,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN,0.891482934177997
MIR6719_3P,SET,110,0.084344,0.0065088,0.085558,0.16212,MIR6719_3P,0.891482934177997
GOCC_SEROTONIN_RECEPTOR_COMP...,SET,5,0.46682,0.0077024,0.47358,0.16214,GOCC_SEROTONIN_RECEPTOR_COMPLEX,0.891482934177997
GOMF_SEROTONIN_GATED_MONOATO...,SET,5,0.46682,0.0077024,0.47358,0.16214,GOMF_SEROTONIN_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.891482934177997
MIR6778_3P,SET,204,0.055689,0.0058373,0.056497,0.16215,MIR6778_3P,0.891482934177997
CAGGTA_AREB6_01,SET,684,0.033069,0.0062626,0.033549,0.16215,CAGGTA_AREB6_01,0.891482934177997
DESCARTES_FETAL_HEART_SCHWAN...,SET,47,0.12717,0.0064258,0.12904,0.1622,DESCARTES_FETAL_HEART_SCHWANN_CELLS,0.891482934177997
ABE_VEGFA_TARGETS_30MIN,SET,25,0.17031,0.0062799,0.17284,0.16223,ABE_VEGFA_TARGETS_30MIN,0.891482934177997
BIOCARTA_FCER1_PATHWAY,SET,37,0.13928,0.0062461,0.14135,0.16223,BIOCARTA_FCER1_PATHWAY,0.891482934177997
MODULE_534,SET,9,0.29232,0.0064703,0.29669,0.16225,MODULE_534,0.891482934177997
GOBP_SECRETORY_GRANULE_ORGAN...,SET,61,0.10759,0.0061911,0.1092,0.16225,GOBP_SECRETORY_GRANULE_ORGANIZATION,0.891482934177997
GSE42088_UNINF_VS_LEISHMANIA...1,SET,184,0.060488,0.0060248,0.061391,0.16225,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN,0.891482934177997
MIR6772_3P,SET,66,0.10089,0.0060381,0.10243,0.16233,MIR6772_3P,0.891482934177997
GOBP_MITOTIC_DNA_INTEGRITY_C...,SET,79,0.084701,0.0055439,0.086021,0.1624,GOBP_MITOTIC_DNA_INTEGRITY_CHECKPOINT_SIGNALING,0.891482934177997
REACTOME_SIGNALING_BY_FGFR2,SET,71,0.097633,0.0060595,0.099166,0.16243,REACTOME_SIGNALING_BY_FGFR2,0.891482934177997
REACTOME_VEGFR2_MEDIATED_CEL...,SET,19,0.18522,0.0059551,0.18816,0.16248,REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION,0.891482934177997
GOBP_DENDRITIC_CELL_CYTOKINE...,SET,17,0.2113,0.0064264,0.21466,0.16249,GOBP_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.891482934177997
HP_ABNORMALLY_LAX_OR_HYPEREX...,SET,150,0.067099,0.00604,0.068177,0.16252,HP_ABNORMALLY_LAX_OR_HYPEREXTENSIBLE_SKIN,0.891482934177997
HP_POLYCYSTIC_LIVER_DISEASE,SET,11,0.24174,0.0059152,0.24565,0.16254,HP_POLYCYSTIC_LIVER_DISEASE,0.891482934177997
WHN_B,SET,228,0.054905,0.0060802,0.055803,0.16259,WHN_B,0.891482934177997
MIR3683,SET,5,0.37233,0.0061434,0.37846,0.16261,MIR3683,0.891482934177997
GSE42724_MEMORY_VS_B1_BCELL_...2,SET,185,0.058041,0.0057966,0.059003,0.16264,GSE42724_MEMORY_VS_B1_BCELL_UP,0.891482934177997
GSE6269_HEALTHY_VS_FLU_INF_P...1,SET,143,0.067739,0.0059547,0.068874,0.16268,GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN,0.891482934177997
HP_SCLEROSIS_OF_FINGER_PHALA...,SET,8,0.31064,0.0064828,0.31591,0.16273,HP_SCLEROSIS_OF_FINGER_PHALANX,0.891482934177997
DESCARTES_FETAL_SPLEEN_VASCU...,SET,41,0.1405,0.006632,0.14289,0.16273,DESCARTES_FETAL_SPLEEN_VASCULAR_ENDOTHELIAL_CELLS,0.891482934177997
GOMF_LIGAND_GATED_MONOATOMIC...2,SET,132,0.075899,0.0064122,0.077213,0.16281,GOMF_LIGAND_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.891482934177997
GOBP_CELL_MIGRATION_INVOLVED...4,SET,5,0.4581,0.0075586,0.46614,0.16287,GOBP_CELL_MIGRATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,0.891482934177997
MIR297,SET,130,0.074961,0.0062852,0.076294,0.16293,MIR297,0.891482934177997
GOBP_POSITIVE_REGULATION_OF_...282,SET,7,0.35488,0.006928,0.3612,0.16293,GOBP_POSITIVE_REGULATION_OF_FEVER_GENERATION,0.891482934177997
GOBP_REGULATION_OF_CARDIAC_M...5,SET,7,0.28388,0.0055419,0.28896,0.16295,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_POTENTIAL,0.891482934177997
REACTOME_NEGATIVE_EPIGENETIC...,SET,44,0.11347,0.005548,0.11558,0.16313,REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,0.891482934177997
HP_SHORT_PHILTRUM,SET,213,0.056268,0.0060251,0.057319,0.16314,HP_SHORT_PHILTRUM,0.891482934177997
REACTOME_BASIGIN_INTERACTIONS,SET,24,0.17542,0.0063379,0.1787,0.16315,REACTOME_BASIGIN_INTERACTIONS,0.891482934177997
MIR129_1_3P_MIR129_2_3P,SET,120,0.074685,0.006018,0.076086,0.16316,MIR129_1_3P_MIR129_2_3P,0.891482934177997
GSE1448_CTRL_VS_ANTI_VBETA5_...2,SET,187,0.061459,0.0061707,0.062617,0.16318,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP,0.891482934177997
GSE3039_CD4_TCELL_VS_ALPHABE...1,SET,183,0.05975,0.0059352,0.060878,0.16319,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_DN,0.891482934177997
GSE5542_UNTREATED_VS_IFNA_TR...3,SET,171,0.06192,0.0059477,0.063089,0.16319,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,0.891482934177997
CREIGHTON_ENDOCRINE_THERAPY_...4,SET,266,0.052288,0.0062478,0.05328,0.16321,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,0.891482934177997
GOMF_DNA_DNA_TETHERING_ACTIV...,SET,5,0.34708,0.0057267,0.35375,0.16326,GOMF_DNA_DNA_TETHERING_ACTIVITY,0.891482934177997
HP_HEMOTHORAX,SET,6,0.33536,0.0060614,0.3418,0.16326,HP_HEMOTHORAX,0.891482934177997
GSE32164_RESTING_DIFFERENTIA...2,SET,186,0.059938,0.0060021,0.061089,0.16326,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP,0.891482934177997
MAGRANGEAS_MULTIPLE_MYELOMA_...3,SET,22,0.1707,0.0059051,0.17398,0.16328,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,0.891482934177997
GOCC_GAMMA_TUBULIN_COMPLEX,SET,17,0.20042,0.0060956,0.2043,0.1633,GOCC_GAMMA_TUBULIN_COMPLEX,0.891482934177997
QIU_PBMC_HEPTATITIS_B_SURFAC...1,SET,15,0.23031,0.00658,0.23482,0.16335,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0DY_UP,0.891482934177997
GOMF_THIOREDOXIN_DISULFIDE_R...,SET,6,0.33435,0.0060431,0.34093,0.16337,GOMF_THIOREDOXIN_DISULFIDE_REDUCTASE_NADPH_ACTIVITY,0.891482934177997
WP_FIBRIN_COMPLEMENT_RECEPTO...,SET,41,0.13265,0.0062613,0.13526,0.16338,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.891482934177997
GSE5099_DAY3_VS_DAY7_MCSF_TR...1,SET,144,0.068449,0.0060379,0.069802,0.1634,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN,0.891482934177997
GSE3039_B2_VS_B1_BCELL_UP,SET,186,0.059413,0.0059495,0.060597,0.16344,GSE3039_B2_VS_B1_BCELL_UP,0.891482934177997
KORKOLA_EMBRYONAL_CARCINOMA,SET,8,0.277,0.0057807,0.28253,0.16345,KORKOLA_EMBRYONAL_CARCINOMA,0.891482934177997
ZBED5_TARGET_GENES,SET,1305,0.02376,0.0061051,0.024239,0.16349,ZBED5_TARGET_GENES,0.891482934177997
GSE2197_IMMUNOSUPPRESSIVE_DN...1,SET,178,0.059392,0.0058193,0.060588,0.16349,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN,0.891482934177997
KEGG_AMINOACYL_TRNA_BIOSYNTH...,SET,22,0.16258,0.0056242,0.16589,0.16354,KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,0.891482934177997
SANSOM_APC_TARGETS_UP,SET,120,0.077558,0.0062495,0.079145,0.16356,SANSOM_APC_TARGETS_UP,0.891482934177997
HP_ENCHONDROMA,SET,21,0.17135,0.0057916,0.17486,0.16356,HP_ENCHONDROMA,0.891482934177997
GOCC_SUPRAMOLECULAR_POLYMER,SET,924,0.028539,0.006239,0.029127,0.16359,GOCC_SUPRAMOLECULAR_POLYMER,0.891482934177997
FIGUEROA_AML_METHYLATION_CLU...2,SET,105,0.081569,0.0061507,0.083256,0.16362,FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,0.891482934177997
GOBP_REGULATION_OF_FIBROBLAS...4,SET,87,0.091696,0.006297,0.093601,0.16364,GOBP_REGULATION_OF_FIBROBLAST_PROLIFERATION,0.891482934177997
GOBP_COMMON_BILE_DUCT_DEVELO...,SET,5,0.38764,0.0063959,0.39573,0.16366,GOBP_COMMON_BILE_DUCT_DEVELOPMENT,0.891482934177997
GSE34156_NOD2_LIGAND_VS_NOD2...2,SET,155,0.067398,0.0061663,0.068816,0.1637,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,0.891482934177997
MODULE_139,SET,73,0.10242,0.0064454,0.1046,0.16374,MODULE_139,0.891482934177997
GOBP_MISMATCH_REPAIR,SET,31,0.12918,0.0053035,0.13192,0.16374,GOBP_MISMATCH_REPAIR,0.891482934177997
GOBP_NEGATIVE_REGULATION_OF_...261,SET,14,0.22828,0.0063012,0.23313,0.16375,GOBP_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,0.891482934177997
GOBP_ENAMEL_MINERALIZATION,SET,18,0.19711,0.0061686,0.20133,0.16378,GOBP_ENAMEL_MINERALIZATION,0.891482934177997
HP_PRIMARY_HYPERALDOSTERONISM,SET,10,0.29921,0.0069809,0.30562,0.16379,HP_PRIMARY_HYPERALDOSTERONISM,0.891482934177997
GOBP_LUTEOLYSIS,SET,6,0.3921,0.0070869,0.40056,0.16383,GOBP_LUTEOLYSIS,0.891482934177997
GSE17974_IL4_AND_ANTI_IL12_V...2,SET,149,0.064231,0.0057626,0.065618,0.16383,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP,0.891482934177997
chr12q24,SET,200,0.13194,0.013695,0.1348,0.16385,chr12q24,0.891482934177997
MIR548AD_3P,SET,23,0.17017,0.0060189,0.17387,0.16387,MIR548AD_3P,0.891482934177997
HP_SUNKEN_CHEEKS,SET,5,0.378,0.0062369,0.38622,0.16387,HP_SUNKEN_CHEEKS,0.891482934177997
GOCC_XY_BODY,SET,14,0.19545,0.0053949,0.19972,0.16389,GOCC_XY_BODY,0.891482934177997
HP_LACRIMAL_DUCT_APLASIA,SET,9,0.26124,0.0057825,0.26698,0.16391,HP_LACRIMAL_DUCT_APLASIA,0.891482934177997
HP_THROMBOEMBOLIC_STROKE,SET,69,0.10392,0.0063588,0.1062,0.16391,HP_THROMBOEMBOLIC_STROKE,0.891482934177997
EGFR_UP.V1_UP,SET,169,0.068514,0.0065428,0.070021,0.16393,EGFR_UP.V1_UP,0.891482934177997
HP_ABNORMAL_CRANIAL_NERVE_MO...,SET,71,0.095084,0.0059013,0.097181,0.16394,HP_ABNORMAL_CRANIAL_NERVE_MORPHOLOGY,0.891482934177997
GOBP_NEGATIVE_REGULATION_OF_...559,SET,68,0.099764,0.00606,0.10198,0.16397,GOBP_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,0.891482934177997
GSE7460_FOXP3_MUT_VS_WT_ACT_...4,SET,180,0.061519,0.0060612,0.062883,0.16397,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP,0.891482934177997
REACTOME_Z_DECAY_DEGRADATION...,SET,10,0.24794,0.0057848,0.25351,0.16403,REACTOME_Z_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_ZYGOTICALLY_EXPRESSED_FACTORS,0.891482934177997
GSE15330_LYMPHOID_MULTIPOTEN...6,SET,164,0.066625,0.0062685,0.068147,0.16412,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,0.891482934177997
GOBP_PULMONARY_VALVE_MORPHOG...,SET,20,0.21665,0.0071465,0.22161,0.16414,GOBP_PULMONARY_VALVE_MORPHOGENESIS,0.891482934177997
GOBP_MACROPHAGE_APOPTOTIC_PR...,SET,12,0.21344,0.0054547,0.21834,0.16415,GOBP_MACROPHAGE_APOPTOTIC_PROCESS,0.891482934177997
REACTOME_RESPIRATORY_SYNCYTI...2,SET,21,0.18609,0.0062897,0.19037,0.16416,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY,0.891482934177997
MODULE_331,SET,69,0.095447,0.0058401,0.097655,0.16419,MODULE_331,0.891482934177997
KEGG_MEDICUS_VARIANT_MUTATIO...82,SET,4,0.36675,0.0054126,0.37527,0.16422,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY,0.891482934177997
CROONQUIST_STROMAL_STIMULATI...2,SET,49,0.12845,0.0066269,0.13146,0.16426,CROONQUIST_STROMAL_STIMULATION_UP,0.891482934177997
GSE19401_NAIVE_VS_IMMUNIZED_...2,SET,185,0.06291,0.0062829,0.064395,0.16431,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP,0.891482934177997
GOBP_PROTEIN_LOCALIZATION_TO...35,SET,11,0.19163,0.0046891,0.19617,0.16432,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_BODY,0.891482934177997
SAKAI_TUMOR_INFILTRATING_MON...1,SET,75,0.088989,0.0056758,0.091121,0.16439,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,0.891482934177997
HP_MOYAMOYA_PHENOMENON,SET,12,0.217,0.0055458,0.22223,0.16443,HP_MOYAMOYA_PHENOMENON,0.891482934177997
HOEK_PBMC_INACTIVATED_INFLUE...6,SET,14,0.2233,0.0061637,0.2287,0.16444,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP,0.891482934177997
GSE6269_STAPH_AUREUS_VS_STRE...1,SET,158,0.064865,0.0059912,0.066437,0.16445,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN,0.891482934177997
GSE14769_UNSTIM_VS_60MIN_LPS...2,SET,180,0.058482,0.005762,0.059909,0.1645,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP,0.891482934177997
GSE19888_ADENOSINE_A3R_INH_V...1,SET,179,0.061788,0.006071,0.063303,0.16452,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN,0.891482934177997
GSE5589_LPS_VS_LPS_AND_IL10_...9,SET,176,0.061537,0.0059959,0.063051,0.16454,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.891482934177997
MIR3138,SET,65,0.10565,0.006275,0.10826,0.16457,MIR3138,0.891482934177997
ER_Q6,SET,245,0.053756,0.0061681,0.055086,0.16457,ER_Q6,0.891482934177997
HP_CYANOSIS,SET,100,0.082502,0.006072,0.084548,0.16459,HP_CYANOSIS,0.891482934177997
REACTOME_HYALURONAN_UPTAKE_A...,SET,12,0.22045,0.0056338,0.22592,0.1646,REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION,0.891482934177997
GSE45739_UNSTIM_VS_ACD3_ACD2...2,SET,171,0.060452,0.0058067,0.061953,0.1646,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP,0.891482934177997
GOBP_T_CELL_MIGRATION,SET,63,0.10876,0.0063598,0.11148,0.16463,GOBP_T_CELL_MIGRATION,0.891482934177997
CTTGTAT_MIR381,SET,185,0.061018,0.0060939,0.062563,0.16471,CTTGTAT_MIR381,0.891482934177997
NEWMAN_ERCC6_TARGETS_DN,SET,33,0.15963,0.0067614,0.16368,0.16472,NEWMAN_ERCC6_TARGETS_DN,0.891482934177997
REACTOME_SUMO_IS_TRANSFERRED...,SET,7,0.26918,0.0052549,0.27602,0.16473,REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9,0.891482934177997
MIR4260,SET,64,0.10393,0.0061251,0.10657,0.16474,MIR4260,0.891482934177997
BCAT_BILD_ET_AL_DN,SET,42,0.12254,0.0058541,0.12566,0.16475,BCAT_BILD_ET_AL_DN,0.891482934177997
GOBP_POSITIVE_REGULATION_OF_...185,SET,454,0.040012,0.0062135,0.041034,0.16476,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION,0.891482934177997
KEGG_MEDICUS_REFERENCE_BETA_...2,SET,10,0.25731,0.0060034,0.26391,0.16478,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS,0.891482934177997
KARAKAS_TGFB1_SIGNALING,SET,18,0.20403,0.0063851,0.20928,0.1648,KARAKAS_TGFB1_SIGNALING,0.891482934177997
GSE16385_UNTREATED_VS_12H_RO...4,SET,186,0.056562,0.005664,0.058017,0.1648,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,0.891482934177997
HLF_01,SET,228,0.055148,0.0061071,0.056567,0.16481,HLF_01,0.891482934177997
MIR6894_3P,SET,62,0.10224,0.0059312,0.10488,0.16482,MIR6894_3P,0.891482934177997
GSE17721_POLYIC_VS_PAM3CSK4_...1,SET,185,0.059611,0.0059534,0.061153,0.16484,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN,0.891482934177997
IRF1_Q6,SET,247,0.052659,0.0060664,0.05403,0.16488,IRF1_Q6,0.891482934177997
BOYAULT_LIVER_CANCER_SUBCLAS...9,SET,46,0.11349,0.0056732,0.11645,0.16489,BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,0.891482934177997
MIR5591_3P,SET,41,0.12878,0.0060786,0.13214,0.16489,MIR5591_3P,0.891482934177997
HP_LIMITED_ELBOW_EXTENSION,SET,45,0.12055,0.0059606,0.1237,0.16491,HP_LIMITED_ELBOW_EXTENSION,0.891482934177997
GOBP_POSITIVE_REGULATION_OF_...408,SET,47,0.12073,0.0061003,0.12389,0.16492,GOBP_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY,0.891482934177997
MSX1_01,SET,158,0.070058,0.0064709,0.071905,0.16496,MSX1_01,0.891482934177997
GOBP_NEGATIVE_REGULATION_OF_...323,SET,19,0.19129,0.0061502,0.19634,0.16496,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.891482934177997
GOBP_MITOTIC_INTRA_S_DNA_DAM...,SET,16,0.17492,0.0051615,0.17956,0.16498,GOBP_MITOTIC_INTRA_S_DNA_DAMAGE_CHECKPOINT_SIGNALING,0.891482934177997
GOBP_POSITIVE_REGULATION_OF_...481,SET,1055,0.02643,0.0061506,0.02713,0.16499,GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION,0.891482934177997
HELLER_HDAC_TARGETS_SILENCED...2,SET,370,0.043994,0.006182,0.045168,0.16503,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,0.891482934177997
JECHLINGER_EPITHELIAL_TO_MES...2,SET,65,0.10725,0.00637,0.11013,0.16507,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,0.891482934177997
LEF1_Q2,SET,212,0.059437,0.0063498,0.061035,0.16508,LEF1_Q2,0.891482934177997
GOBP_CELLULAR_RESPONSE_TO_GL...2,SET,53,0.12258,0.0065765,0.12588,0.16508,GOBP_CELLULAR_RESPONSE_TO_GLUCOCORTICOID_STIMULUS,0.891482934177997
GSE25088_IL4_VS_IL4_AND_ROSI...4,SET,177,0.063,0.0061557,0.064701,0.16511,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,0.891482934177997
HP_DECREASED_CORNEAL_SENSATI...,SET,5,0.42029,0.0069346,0.43166,0.16512,HP_DECREASED_CORNEAL_SENSATION,0.891482934177997
REACTOME_PERK_REGULATES_GENE...,SET,30,0.14491,0.0058526,0.14885,0.16516,REACTOME_PERK_REGULATES_GENE_EXPRESSION,0.891482934177997
GOBP_REGULATION_OF_CD4_POSIT...1,SET,71,0.10415,0.0064642,0.10699,0.16516,GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.891482934177997
REACTOME_NUCLEAR_EVENTS_KINA...,SET,59,0.11025,0.0062395,0.11325,0.16517,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,0.891482934177997
HP_DIAPHRAGMATIC_PARALYSIS,SET,6,0.35025,0.0063304,0.35986,0.16521,HP_DIAPHRAGMATIC_PARALYSIS,0.891482934177997
GOBP_SINGLE_STRANDED_VIRAL_R...,SET,17,0.21768,0.0066205,0.22368,0.16524,GOBP_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE,0.891482934177997
DACOSTA_LOW_DOSE_UV_RESPONSE...2,SET,11,0.25718,0.006293,0.26431,0.16527,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP,0.891482934177997
SWEET_KRAS_TARGETS_DN,SET,56,0.11787,0.0064994,0.12114,0.16528,SWEET_KRAS_TARGETS_DN,0.891482934177997
GOMF_K63_LINKED_DEUBIQUITINA...,SET,11,0.2243,0.0054883,0.23056,0.16533,GOMF_K63_LINKED_DEUBIQUITINASE_ACTIVITY,0.891482934177997
BASSO_B_LYMPHOCYTE_NETWORK,SET,129,0.068582,0.0057283,0.070518,0.16539,BASSO_B_LYMPHOCYTE_NETWORK,0.891482934177997
HP_LYMPHEDEMA,SET,68,0.096087,0.0058367,0.098797,0.16539,HP_LYMPHEDEMA,0.891482934177997
GSE2405_0H_VS_9H_A_PHAGOCYTO...1,SET,182,0.057712,0.0057173,0.059353,0.16545,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.891482934177997
HP_PAPILLEDEMA,SET,26,0.15789,0.0059373,0.1624,0.16547,HP_PAPILLEDEMA,0.891482934177997
GOBP_GLUCOSAMINE_CONTAINING_...1,SET,9,0.29208,0.0064651,0.30044,0.16548,GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.891482934177997
ZNF667_TARGET_GENES,SET,120,0.073581,0.005929,0.075692,0.1655,ZNF667_TARGET_GENES,0.891482934177997
GOCC_SYNAPTONEMAL_STRUCTURE,SET,34,0.13052,0.0056114,0.13429,0.16554,GOCC_SYNAPTONEMAL_STRUCTURE,0.891482934177997
HP_LYMPHANGIOMA,SET,11,0.27484,0.0067252,0.28279,0.16556,HP_LYMPHANGIOMA,0.891482934177997
KEGG_MEDICUS_PATHOGEN_SALMON...1,SET,6,0.33241,0.006008,0.34206,0.16558,KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY,0.891482934177997
GOBP_PROTEIN_MATURATION,SET,489,0.03639,0.0058591,0.03745,0.16561,GOBP_PROTEIN_MATURATION,0.891482934177997
HOEK_NEUTROPHIL_2011_2012_TI...4,SET,7,0.29921,0.005841,0.30794,0.16562,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_3DY_UP,0.891482934177997
GSE24972_MARGINAL_ZONE_BCELL...1,SET,178,0.061318,0.006008,0.063109,0.16563,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN,0.891482934177997
GSE1432_CTRL_VS_IFNG_6H_MICR...1,SET,183,0.062831,0.0062414,0.064671,0.16564,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,0.891482934177997
VALK_AML_CLUSTER_1,SET,26,0.17764,0.0066799,0.18287,0.16568,VALK_AML_CLUSTER_1,0.891482934177997
FAN_OVARY_CL15_SMALL_ANTRAL_...,SET,552,0.035245,0.0060185,0.036283,0.16568,FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL,0.891482934177997
GNF2_HLA_C,SET,40,0.12932,0.0060293,0.13314,0.16571,GNF2_HLA_C,0.891482934177997
HP_HYPERALDOSTERONISM,SET,30,0.16513,0.0066695,0.17002,0.16572,HP_HYPERALDOSTERONISM,0.891482934177997
GSE24634_IL4_VS_CTRL_TREATED...7,SET,176,0.06253,0.0060927,0.064389,0.16575,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN,0.891482934177997
GSE11367_CTRL_VS_IL17_TREATE...2,SET,119,0.077065,0.006184,0.079363,0.16577,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP,0.891482934177997
SMID_BREAST_CANCER_ERBB2_UP,SET,127,0.072744,0.006029,0.074929,0.16582,SMID_BREAST_CANCER_ERBB2_UP,0.891482934177997
GOMF_GANGLIOSIDE_BINDING,SET,5,0.41354,0.0068234,0.42597,0.16583,GOMF_GANGLIOSIDE_BINDING,0.891482934177997
ZHENG_CORD_BLOOD_C10_MULTILY...,SET,81,0.093276,0.0061816,0.096103,0.16589,ZHENG_CORD_BLOOD_C10_MULTILYMPHOID_PROGENITOR,0.891482934177997
GSE13547_CTRL_VS_ANTI_IGM_ST...8,SET,139,0.06579,0.0057026,0.06779,0.1659,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_UP,0.891482934177997
SHIRAISHI_PLZF_TARGETS_DN,SET,9,0.29011,0.0064214,0.29895,0.16592,SHIRAISHI_PLZF_TARGETS_DN,0.891482934177997
ZNF322_TARGET_GENES,SET,714,0.03023,0.0058443,0.031152,0.16592,ZNF322_TARGET_GENES,0.891482934177997
GOCC_CAJAL_BODY,SET,56,0.099263,0.0054736,0.1023,0.16594,GOCC_CAJAL_BODY,0.891482934177997
GOBP_POSITIVE_REGULATION_OF_...370,SET,66,0.10579,0.0063314,0.10903,0.16596,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,0.891482934177997
HP_RECURRENT_PATELLAR_DISLOC...,SET,3,0.53501,0.0068381,0.55143,0.16597,HP_RECURRENT_PATELLAR_DISLOCATION,0.891482934177997
HP_HORIZONTAL_RIBS,SET,15,0.1991,0.0056883,0.20522,0.16599,HP_HORIZONTAL_RIBS,0.891482934177997
WP_GABA_RECEPTOR_SIGNALING,SET,28,0.17525,0.0068384,0.18065,0.166,WP_GABA_RECEPTOR_SIGNALING,0.891482934177997
GOBP_POSITIVE_REGULATION_OF_...652,SET,19,0.18858,0.0060633,0.1944,0.16601,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.891482934177997
GOMF_MANNOSYL_OLIGOSACCHARID...2,SET,9,0.28394,0.0062848,0.29277,0.16607,GOMF_MANNOSYL_OLIGOSACCHARIDE_MANNOSIDASE_ACTIVITY,0.891522637430513
REACTOME_SEROTONIN_AND_MELAT...,SET,4,0.40822,0.0060246,0.42093,0.16608,REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS,0.891522637430513
GOBP_POSITIVE_REGULATION_OF_...686,SET,4,0.34958,0.0051592,0.36052,0.16612,GOBP_POSITIVE_REGULATION_OF_RNA_BINDING,0.891522637430513
GSE22886_IL2_VS_IL15_STIM_NK...2,SET,177,0.065636,0.0064132,0.067691,0.16612,GSE22886_IL2_VS_IL15_STIM_NKCELL_UP,0.891522637430513
MIR450B_5P,SET,421,0.040797,0.0061064,0.042079,0.16615,MIR450B_5P,0.891545970356647
GOCC_NUCLEOSOME,SET,37,0.12863,0.0057683,0.13269,0.16618,GOCC_NUCLEOSOME,0.891569296079037
HP_ABNORMALITY_ON_PULMONARY_...,SET,167,0.06234,0.0059182,0.064333,0.16628,HP_ABNORMALITY_ON_PULMONARY_FUNCTION_TESTING,0.891706361538462
GOCC_NUCLEAR_REPLICATION_FORK,SET,39,0.12231,0.0056309,0.12625,0.16633,GOCC_NUCLEAR_REPLICATION_FORK,0.891706361538462
ETF_Q6,SET,111,0.078601,0.0060929,0.081135,0.16634,ETF_Q6,0.891706361538462
MIR128_3P,SET,409,0.042018,0.006201,0.043376,0.16636,MIR128_3P,0.891706361538462
LAKE_ADULT_KIDNEY_C19_COLLEC...,SET,288,0.047287,0.0058757,0.048817,0.16636,LAKE_ADULT_KIDNEY_C19_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_MEDULLA,0.891706361538462
HP_ABNORMALITY_OF_PATTERN_VI...,SET,5,0.45366,0.0074853,0.46834,0.16637,HP_ABNORMALITY_OF_PATTERN_VISUAL_EVOKED_POTENTIALS,0.891706361538462
MULLIGHAN_MLL_SIGNATURE_2_DN,SET,255,0.052923,0.0061935,0.054652,0.16644,MULLIGHAN_MLL_SIGNATURE_2_DN,0.891706361538462
HP_SCLEROSIS_OF_HAND_BONE,SET,11,0.26406,0.0064614,0.27274,0.16648,HP_SCLEROSIS_OF_HAND_BONE,0.891706361538462
RAO_BOUND_BY_SALL4_ISOFORM_B,SET,463,0.03883,0.0060879,0.040108,0.1665,RAO_BOUND_BY_SALL4_ISOFORM_B,0.891706361538462
GOBP_DIAPHRAGM_DEVELOPMENT,SET,9,0.2893,0.0064035,0.29882,0.1665,GOBP_DIAPHRAGM_DEVELOPMENT,0.891706361538462
GSE36888_STAT5_AB_KNOCKIN_VS...1,SET,177,0.062169,0.0060745,0.064232,0.16656,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN,0.891706361538462
COUP_01,SET,235,0.052421,0.0058925,0.054165,0.16658,COUP_01,0.891706361538462
HP_POSTAXIAL_FOOT_POLYDACTYLY,SET,63,0.09946,0.005816,0.10279,0.16662,HP_POSTAXIAL_FOOT_POLYDACTYLY,0.891706361538462
GSE37416_0H_VS_6H_F_TULARENS...1,SET,182,0.060379,0.0059815,0.062398,0.16662,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.891706361538462
JINESH_BLEBBISHIELD_VS_LIVE_...1,SET,241,0.055395,0.0063047,0.057252,0.16663,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,0.891706361538462
MARKEY_RB1_ACUTE_LOF_DN,SET,211,0.058366,0.0062207,0.060332,0.16667,MARKEY_RB1_ACUTE_LOF_DN,0.891706361538462
ZHONG_PFC_C7_ORG_UNDERGOING_...,SET,61,0.11164,0.0064243,0.11542,0.16671,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,0.891706361538462
HP_ABNORMAL_LARGE_INTESTINE_...1,SET,295,0.04799,0.0060339,0.049615,0.16672,HP_ABNORMAL_LARGE_INTESTINE_MORPHOLOGY,0.891706361538462
KEGG_MEDICUS_REFERENCE_EGF_E...4,SET,16,0.19758,0.00583,0.2043,0.16675,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,0.891706361538462
MIR577,SET,300,0.046949,0.0059519,0.048548,0.16676,MIR577,0.891706361538462
GSE1460_DP_THYMOCYTE_VS_NAIV...2,SET,170,0.06006,0.0057523,0.062106,0.16676,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.891706361538462
HP_LOBAR_HOLOPROSENCEPHALY,SET,23,0.14747,0.0052162,0.1525,0.16677,HP_LOBAR_HOLOPROSENCEPHALY,0.891706361538462
ZNF426_TARGET_GENES,SET,121,0.070978,0.0057429,0.073414,0.16682,ZNF426_TARGET_GENES,0.891836502076604
BUSSLINGER_GASTRIC_LYZ_POSIT...,SET,101,0.083233,0.0061562,0.086111,0.16688,BUSSLINGER_GASTRIC_LYZ_POSITIVE_CELLS,0.891907994163723
MODULE_307,SET,21,0.1666,0.005631,0.17239,0.16692,MODULE_307,0.891907994163723
NABA_PROTEOGLYCANS,SET,33,0.15586,0.0066016,0.16131,0.16697,NABA_PROTEOGLYCANS,0.891907994163723
GNF2_FBL,SET,129,0.066855,0.005584,0.069197,0.16699,GNF2_FBL,0.891907994163723
GOBP_MATURE_CONVENTIONAL_DEN...,SET,5,0.42123,0.0069502,0.43598,0.16699,GOBP_MATURE_CONVENTIONAL_DENDRITIC_CELL_DIFFERENTIATION,0.891907994163723
GSE7460_FOXP3_MUT_VS_WT_ACT_...2,SET,182,0.062302,0.006172,0.064489,0.16701,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP,0.891907994163723
GOBP_HETEROTYPIC_CELL_CELL_A...,SET,62,0.11217,0.0065073,0.11612,0.16702,GOBP_HETEROTYPIC_CELL_CELL_ADHESION,0.891907994163723
HP_POLYCYTHEMIA,SET,22,0.17658,0.0061086,0.18282,0.16706,HP_POLYCYTHEMIA,0.891907994163723
GOBP_REGULATION_OF_PHOSPHATI...3,SET,4,0.3879,0.0057247,0.40164,0.16708,GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,0.891907994163723
GOMF_INTEGRIN_BINDING,SET,145,0.070593,0.0062485,0.073096,0.16709,GOMF_INTEGRIN_BINDING,0.891907994163723
GSE6259_FLT3L_INDUCED_VS_WT_...1,SET,145,0.071569,0.0063349,0.074115,0.16712,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN,0.891931142506142
HP_ORTHOPNEA,SET,68,0.10158,0.00617,0.1052,0.16715,HP_ORTHOPNEA,0.891954283740212
GSE11961_PLASMA_CELL_DAY7_VS...3,SET,177,0.060521,0.0059134,0.062709,0.16725,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,0.892267275518035
KONG_E2F1_TARGETS,SET,8,0.26329,0.0054945,0.27281,0.16726,KONG_E2F1_TARGETS,0.892267275518035
GSE16451_CTRL_VS_WEST_EQUINE...4,SET,181,0.05851,0.0057806,0.060636,0.16729,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.89229035451197
HP_ABNORMAL_SHOULDER_PHYSIOL...,SET,12,0.25026,0.0063959,0.25941,0.16734,HP_ABNORMAL_SHOULDER_PHYSIOLOGY,0.892420085929108
COULOUARN_TEMPORAL_TGFB1_SIG...1,SET,124,0.072299,0.0059214,0.074949,0.16737,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,0.892435904907976
GOMF_INTERFERON_RECEPTOR_ACT...,SET,5,0.39292,0.006483,0.40739,0.16741,GOMF_INTERFERON_RECEPTOR_ACTIVITY,0.892435904907976
GOBP_QUINONE_METABOLIC_PROCE...,SET,21,0.15919,0.0053806,0.16506,0.16742,GOBP_QUINONE_METABOLIC_PROCESS,0.892435904907976
HE_LIM_SUN_FETAL_LUNG_C7_TM4...2,SET,107,0.082214,0.0062578,0.085275,0.16751,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,0.892642969826926
REACTOME_INTESTINAL_ABSORPTI...,SET,5,0.39518,0.0065204,0.40998,0.16755,REACTOME_INTESTINAL_ABSORPTION,0.892642969826926
HP_ECLABION,SET,147,0.068879,0.0061383,0.071462,0.16757,HP_ECLABION,0.892642969826926
MIR6868_5P,SET,111,0.075629,0.0058625,0.078484,0.16763,MIR6868_5P,0.892642969826926
MODULE_87,SET,41,0.12478,0.0058899,0.12949,0.16763,MODULE_87,0.892642969826926
BROWN_MYELOID_CELL_DEVELOPME...2,SET,147,0.069508,0.0061944,0.072141,0.16765,BROWN_MYELOID_CELL_DEVELOPMENT_UP,0.892642969826926
VERHAAK_AML_WITH_NPM1_MUTATE...1,SET,224,0.058414,0.0064125,0.06063,0.16767,VERHAAK_AML_WITH_NPM1_MUTATED_DN,0.892642969826926
MODULE_247,SET,35,0.14984,0.0065356,0.15554,0.16769,MODULE_247,0.892642969826926
GSE43863_NAIVE_VS_LY6C_LOW_C...1,SET,172,0.059919,0.0057721,0.062197,0.16769,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_DN,0.892642969826926
GSE4590_SMALL_VS_LARGE_PRE_B...1,SET,139,0.071172,0.0061691,0.073892,0.16773,GSE4590_SMALL_VS_LARGE_PRE_BCELL_DN,0.892711864666259
GOBP_POSITIVE_REGULATION_OF_...26,SET,19,0.18511,0.0059517,0.19221,0.16776,GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_FORMATION,0.892711864666259
GSE29618_PRE_VS_DAY7_POST_TI...2,SET,168,0.067025,0.0063819,0.0696,0.16778,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP,0.892711864666259
GSE17721_CPG_VS_GARDIQUIMOD_...17,SET,183,0.058872,0.005848,0.06115,0.16785,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN,0.892780696250956
GOCC_PROTEASOME_CORE_COMPLEX...2,SET,11,0.22167,0.0054241,0.23026,0.16786,GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX,0.892780696250956
GOMF_SUPEROXIDE_GENERATING_N...2,SET,7,0.34135,0.0066637,0.3546,0.16787,GOMF_SUPEROXIDE_GENERATING_NAD_P_H_OXIDASE_ACTIVITY,0.892780696250956
ENGELMANN_CANCER_PROGENITORS...2,SET,46,0.12711,0.0063541,0.1321,0.16797,ENGELMANN_CANCER_PROGENITORS_UP,0.893175849143207
GSE16755_CTRL_VS_IFNA_TREATE...1,SET,174,0.064909,0.0062888,0.067468,0.16801,GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN,0.893187133525748
BLANCO_MELO_BRONCHIAL_EPITHE...1,SET,159,0.062592,0.0057994,0.065072,0.16806,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN,0.893187133525748
GOBP_NEURON_NEURON_SYNAPTIC_...,SET,8,0.30992,0.0064678,0.32223,0.16808,GOBP_NEURON_NEURON_SYNAPTIC_TRANSMISSION,0.893187133525748
GOBP_NEGATIVE_REGULATION_OF_...301,SET,12,0.23351,0.0059678,0.24291,0.1682,GOBP_NEGATIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,0.893187133525748
HP_STATUS_EPILEPTICUS_WITH_P...,SET,24,0.16838,0.0060838,0.17517,0.16822,HP_STATUS_EPILEPTICUS_WITH_PROMINENT_MOTOR_SYMPTOMS,0.893187133525748
GOBP_NEGATIVE_REGULATION_OF_...226,SET,13,0.24035,0.0063932,0.25006,0.16823,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,0.893187133525748
GOBP_POSITIVE_REGULATION_OF_...803,SET,4,0.47234,0.0069709,0.49143,0.16824,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.893187133525748
HP_APLASIA_OF_THE_PHALANGES_...,SET,8,0.27451,0.0057288,0.2856,0.16824,HP_APLASIA_OF_THE_PHALANGES_OF_THE_TOES,0.893187133525748
REACTOME_RHO_GTPASES_ACTIVAT...10,SET,33,0.12449,0.0052731,0.12954,0.16826,REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,0.893187133525748
MIR4741,SET,41,0.12192,0.005755,0.12686,0.16826,MIR4741,0.893187133525748
GOBP_POSITIVE_REGULATION_OF_...174,SET,22,0.18454,0.0063841,0.19205,0.1683,GOBP_POSITIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.893187133525748
GSE5542_IFNG_VS_IFNA_AND_IFN...3,SET,174,0.060491,0.0058607,0.062955,0.16832,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.893187133525748
GOBP_GLOMERULUS_DEVELOPMENT,SET,68,0.10926,0.0066371,0.11374,0.16837,GOBP_GLOMERULUS_DEVELOPMENT,0.893187133525748
TURASHVILI_BREAST_NORMAL_DUC...2,SET,57,0.10168,0.0056568,0.10588,0.16844,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,0.893187133525748
NPM1_TARGET_GENES,SET,280,0.047436,0.005813,0.049395,0.16845,NPM1_TARGET_GENES,0.893187133525748
PID_IL3_PATHWAY,SET,25,0.17174,0.0063329,0.17884,0.16846,PID_IL3_PATHWAY,0.893187133525748
GSE33424_CD161_HIGH_VS_NEG_C...2,SET,189,0.060758,0.0061325,0.06327,0.16846,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP,0.893187133525748
HP_HYPOPLASTIC_TOENAILS,SET,75,0.092354,0.0058904,0.096193,0.16851,HP_HYPOPLASTIC_TOENAILS,0.893187133525748
HP_ABNORMAL_MENINGEAL_MORPHO...,SET,177,0.060354,0.0058971,0.062867,0.16853,HP_ABNORMAL_MENINGEAL_MORPHOLOGY,0.893187133525748
MIR597_3P,SET,100,0.081223,0.0059779,0.084614,0.16855,MIR597_3P,0.893187133525748
HP_GENERALIZED_LIMB_MUSCLE_A...,SET,18,0.1793,0.0056112,0.18685,0.16863,HP_GENERALIZED_LIMB_MUSCLE_ATROPHY,0.893187133525748
HP_APLASIA_HYPOPLASIA_INVOLV...6,SET,15,0.19663,0.0056179,0.20493,0.16866,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CARPAL_BONES,0.893187133525748
GOBP_LATE_ENDOSOME_TO_VACUOL...2,SET,26,0.14367,0.0054024,0.14975,0.16869,GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.893187133525748
MODULE_29,SET,24,0.15051,0.0054379,0.1569,0.16872,MODULE_29,0.893187133525748
GSE12392_IFNAR_KO_VS_IFNB_KO...2,SET,177,0.05954,0.0058176,0.062069,0.16872,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP,0.893187133525748
HP_SEMILOBAR_HOLOPROSENCEPHA...,SET,7,0.2977,0.0058117,0.31035,0.16873,HP_SEMILOBAR_HOLOPROSENCEPHALY,0.893187133525748
TRAVAGLINI_LUNG_CAPILLARY_IN...1,SET,150,0.070811,0.0063741,0.073827,0.16875,TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_1_CELL,0.893187133525748
ZHENG_CORD_BLOOD_C8_PUTATIVE...,SET,74,0.096553,0.0061173,0.10068,0.16877,ZHENG_CORD_BLOOD_C8_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_2,0.893187133525748
BIOCARTA_TFF_PATHWAY,SET,24,0.16763,0.0060566,0.1748,0.16879,BIOCARTA_TFF_PATHWAY,0.893187133525748
GOBP_REGULATION_OF_EPITHELIA...7,SET,100,0.084523,0.0062207,0.088157,0.16884,GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.893187133525748
HALLMARK_MYOGENESIS,SET,191,0.061017,0.0061908,0.063646,0.16886,HALLMARK_MYOGENESIS,0.893187133525748
MIR7108_3P,SET,12,0.23259,0.0059442,0.24263,0.16888,MIR7108_3P,0.893187133525748
HP_APLASIA_HYPOPLASIA_OF_THE...55,SET,6,0.30934,0.0055911,0.32269,0.16888,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HALLUX,0.893187133525748
GOBP_ETHER_BIOSYNTHETIC_PROC...,SET,11,0.2494,0.0061026,0.26018,0.16889,GOBP_ETHER_BIOSYNTHETIC_PROCESS,0.893187133525748
KEGG_MEDICUS_PATHOGEN_HCMV_U...1,SET,26,0.15549,0.0058471,0.16222,0.1689,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY,0.893187133525748
REACTOME_SIGNALING_BY_NOTCH1...1,SET,14,0.21853,0.0060321,0.22805,0.16897,REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER,0.893187133525748
GOBP_REGULATION_OF_MEMBRANE_...2,SET,5,0.41453,0.0068396,0.43267,0.16902,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,0.893187133525748
REACTOME_LEUKOTRIENE_RECEPTO...,SET,4,0.34563,0.0051009,0.3608,0.16905,REACTOME_LEUKOTRIENE_RECEPTORS,0.893187133525748
GOBP_REGULATION_OF_IMMUNE_SY...,SET,1404,0.023054,0.0061266,0.024067,0.16905,GOBP_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,0.893187133525748
MIR450A_2_3P,SET,114,0.075829,0.0059564,0.079161,0.16906,MIR450A_2_3P,0.893187133525748
GOCC_PI_BODY,SET,9,0.26924,0.0059594,0.28109,0.16908,GOCC_PI_BODY,0.893187133525748
HUMMERICH_BENIGN_SKIN_TUMOR_...1,SET,19,0.20088,0.0064585,0.20973,0.16909,HUMMERICH_BENIGN_SKIN_TUMOR_DN,0.893187133525748
GOCC_CHROMOSOME_CENTROMERIC_...1,SET,2,0.61532,0.0064217,0.64248,0.1691,GOCC_CHROMOSOME_CENTROMERIC_CORE_DOMAIN,0.893187133525748
TESAR_ALK_TARGETS_EPISC_3D_UP,SET,5,0.37164,0.006132,0.38815,0.16917,TESAR_ALK_TARGETS_EPISC_3D_UP,0.893187133525748
MODULE_71,SET,19,0.20462,0.006579,0.21371,0.16917,MODULE_71,0.893187133525748
MODULE_81,SET,18,0.18083,0.0056589,0.18886,0.16918,MODULE_81,0.893187133525748
GOCC_RAGULATOR_COMPLEX,SET,6,0.26257,0.0047457,0.27424,0.16918,GOCC_RAGULATOR_COMPLEX,0.893187133525748
GSE21927_UNTREATED_VS_GMCSF_...4,SET,154,0.064632,0.0058942,0.06753,0.16927,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_UP,0.893307986638324
ZHENG_RESPONSE_TO_ARSENITE_UP,SET,14,0.25704,0.0070949,0.26857,0.16928,ZHENG_RESPONSE_TO_ARSENITE_UP,0.893307986638324
GOBP_CELL_PROLIFERATION_INVO...2,SET,21,0.20115,0.0067987,0.21018,0.16928,GOBP_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.893307986638324
GSE9037_CTRL_VS_LPS_1H_STIM_...3,SET,174,0.062998,0.0061036,0.065876,0.16946,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN,0.89409189435337
GSE1740_UNSTIM_VS_IFNA_STIMU...1,SET,159,0.064202,0.0059485,0.06714,0.16948,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN,0.89409189435337
HP_PSYCHOMOTOR_DETERIORATION,SET,19,0.19263,0.0061935,0.20153,0.16958,HP_PSYCHOMOTOR_DETERIORATION,0.894483669752618
BRUNEAU_SEPTATION_VENTRICULAR,SET,10,0.23351,0.005448,0.24436,0.16965,BRUNEAU_SEPTATION_VENTRICULAR,0.894686822940373
GSE3720_VD1_VS_VD2_GAMMADELT...5,SET,179,0.057557,0.0056553,0.060237,0.16967,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN,0.894686822940373
SHAFFER_IRF4_TARGETS_IN_PLAS...,SET,65,0.10642,0.0063208,0.11143,0.16978,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,0.894995282875777
GSE42021_CD24HI_VS_CD24INT_T...1,SET,187,0.061469,0.0061718,0.064363,0.16978,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN,0.894995282875777
GSE40225_WT_VS_RIP_B7X_DIABE...1,SET,168,0.059076,0.005625,0.061903,0.16996,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN,0.895163163064833
GUO_HEX_TARGETS_UP,SET,72,0.097721,0.0061074,0.10241,0.16998,GUO_HEX_TARGETS_UP,0.895163163064833
GOBP_SERTOLI_CELL_DEVELOPMENT,SET,12,0.22009,0.0056246,0.23068,0.17002,GOBP_SERTOLI_CELL_DEVELOPMENT,0.895163163064833
MODULE_188,SET,118,0.075435,0.0060279,0.079071,0.17004,MODULE_188,0.895163163064833
GOBP_POSITIVE_REGULATION_OF_...288,SET,26,0.16091,0.0060507,0.16868,0.17007,GOBP_POSITIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY,0.895163163064833
REACTOME_EPH_EPHRIN_SIGNALING,SET,89,0.085569,0.005943,0.089711,0.17009,REACTOME_EPH_EPHRIN_SIGNALING,0.895163163064833
GARCIA_PINERES_PBMC_HPV_16_L...7,SET,122,0.073556,0.0059759,0.077125,0.17012,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN,0.895163163064833
GOMF_SERINE_TYPE_ENDOPEPTIDA...,SET,92,0.096416,0.0068078,0.1011,0.17014,GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.895163163064833
HP_RECURRENT_BACTERIAL_SKIN_...,SET,23,0.16968,0.0060018,0.17796,0.17018,HP_RECURRENT_BACTERIAL_SKIN_INFECTIONS,0.895163163064833
INSM2_TARGET_GENES,SET,747,0.029843,0.0058957,0.0313,0.17019,INSM2_TARGET_GENES,0.895163163064833
GSE2770_UNTREATED_VS_TGFB_AN...5,SET,178,0.058211,0.0057037,0.061058,0.17021,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.895163163064833
REACTOME_DISEASES_OF_BASE_EX...,SET,5,0.38302,0.0063197,0.40178,0.17023,REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR,0.895163163064833
GOBP_POSITIVE_REGULATION_OF_...477,SET,13,0.21387,0.0056889,0.22437,0.17024,GOBP_POSITIVE_REGULATION_OF_MITOTIC_CYTOKINESIS,0.895163163064833
SENESE_HDAC1_AND_HDAC2_TARGE...1,SET,203,0.058348,0.0061011,0.061213,0.17025,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,0.895163163064833
GOBP_POSITIVE_REGULATION_OF_...77,SET,9,0.23108,0.0051147,0.24242,0.17025,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.895163163064833
HP_HBS_HEMOGLOBIN,SET,5,0.38274,0.0063151,0.40153,0.17025,HP_HBS_HEMOGLOBIN,0.895163163064833
MODULE_163,SET,489,0.037594,0.0060529,0.039449,0.1703,MODULE_163,0.895163163064833
GOBP_AXON_ENSHEATHMENT_IN_CE...,SET,23,0.17446,0.0061707,0.18307,0.17032,GOBP_AXON_ENSHEATHMENT_IN_CENTRAL_NERVOUS_SYSTEM,0.895163163064833
GTCGATC_MIR3695P,SET,4,0.36416,0.0053743,0.38224,0.17038,GTCGATC_MIR3695P,0.895163163064833
HP_RETICULAR_HYPERPIGMENTATI...,SET,9,0.23903,0.0052908,0.2509,0.17038,HP_RETICULAR_HYPERPIGMENTATION,0.895163163064833
GOBP_POSITIVE_REGULATION_OF_...6,SET,13,0.2209,0.0058757,0.23187,0.17039,GOBP_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION,0.895163163064833
MIR4660,SET,124,0.073032,0.0059814,0.076663,0.1704,MIR4660,0.895163163064833
GSE29949_MICROGLIA_VS_DC_BRA...1,SET,176,0.061933,0.0060345,0.065018,0.17042,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.895163163064833
HP_NEMALINE_BODIES,SET,19,0.18166,0.0058407,0.19072,0.17043,HP_NEMALINE_BODIES,0.895163163064833
GSE7852_TREG_VS_TCONV_LN_UP,SET,177,0.062298,0.0060871,0.065476,0.17069,GSE7852_TREG_VS_TCONV_LN_UP,0.896048614040374
GAUTAM_EYE_IRIS_CILIARY_BODY...13,SET,256,0.05106,0.0059869,0.053667,0.1707,GAUTAM_EYE_IRIS_CILIARY_BODY_PUTATIVE_STEM_CELLS,0.896048614040374
DESCARTES_FETAL_STOMACH_MYEL...,SET,65,0.10719,0.0063667,0.11268,0.17072,DESCARTES_FETAL_STOMACH_MYELOID_CELLS,0.896048614040374
GOBP_ACTIVATION_OF_GTPASE_AC...,SET,81,0.08953,0.0059334,0.094128,0.17077,GOBP_ACTIVATION_OF_GTPASE_ACTIVITY,0.896048614040374
HP_CLEFT_SOFT_PALATE,SET,49,0.11159,0.0057568,0.11732,0.17077,HP_CLEFT_SOFT_PALATE,0.896048614040374
GOMF_CHROMATIN_DNA_BINDING,SET,95,0.078884,0.0056595,0.082945,0.1708,GOMF_CHROMATIN_DNA_BINDING,0.896048614040374
NAKAYA_PBMC_FLUMIST_AGE_18_5...2,SET,30,0.14187,0.0057298,0.14918,0.17082,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_IFN_SUBSET_UP,0.896048614040374
CCACACA_MIR147,SET,56,0.10427,0.0057497,0.10966,0.17084,CCACACA_MIR147,0.896048614040374
PXR_Q2,SET,241,0.052497,0.0059749,0.055214,0.17086,PXR_Q2,0.896048614040374
HP_ABNORMAL_CIRCULATING_GLOB...,SET,10,0.27164,0.0063377,0.28574,0.17089,HP_ABNORMAL_CIRCULATING_GLOBULIN_CONCENTRATION,0.896048614040374
GOBP_MONONUCLEAR_CELL_MIGRAT...,SET,203,0.05944,0.0062153,0.062535,0.17093,GOBP_MONONUCLEAR_CELL_MIGRATION,0.896048614040374
GOBP_REGULATION_OF_STEROID_B...,SET,68,0.10361,0.0062935,0.10901,0.17096,GOBP_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS,0.896048614040374
GOMF_LAMININ_BINDING,SET,27,0.15593,0.005975,0.16407,0.17096,GOMF_LAMININ_BINDING,0.896048614040374
GSE19512_NAUTRAL_VS_INDUCED_...2,SET,179,0.061353,0.0060282,0.064567,0.17101,GSE19512_NAUTRAL_VS_INDUCED_TREG_UP,0.896048614040374
HP_AORTIC_ROOT_ANEURYSM,SET,64,0.09965,0.005873,0.10489,0.17105,HP_AORTIC_ROOT_ANEURYSM,0.896048614040374
HP_APLASIA_CUTIS_CONGENITA_O...3,SET,7,0.2701,0.0052728,0.28431,0.17106,HP_APLASIA_CUTIS_CONGENITA_OVER_THE_SCALP_VERTEX,0.896048614040374
JIANG_MELANOMA_TRM7_CD8,SET,78,0.089098,0.0057949,0.093797,0.17109,JIANG_MELANOMA_TRM7_CD8,0.896048614040374
PID_ENDOTHELIN_PATHWAY,SET,62,0.10893,0.0063189,0.11467,0.17109,PID_ENDOTHELIN_PATHWAY,0.896048614040374
GOCC_POTASSIUM_CHANNEL_COMPL...,SET,99,0.087462,0.006405,0.092084,0.17111,GOCC_POTASSIUM_CHANNEL_COMPLEX,0.896048614040374
GSE14769_20MIN_VS_360MIN_LPS...1,SET,178,0.060077,0.0058865,0.063253,0.17112,GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN,0.896048614040374
GOBP_POSITIVE_REGULATION_OF_...281,SET,5,0.38507,0.0063536,0.40547,0.17114,GOBP_POSITIVE_REGULATION_OF_FERTILIZATION,0.896048614040374
GSE3982_MAST_CELL_VS_CENT_ME...2,SET,185,0.057021,0.0056947,0.060051,0.17118,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP,0.896084575429088
BIOCARTA_BARR_MAPK_PATHWAY,SET,13,0.24894,0.0066217,0.26222,0.17122,BIOCARTA_BARR_MAPK_PATHWAY,0.896084575429088
HP_ACUTE_MYELOID_LEUKEMIA,SET,68,0.096739,0.0058763,0.1019,0.17123,HP_ACUTE_MYELOID_LEUKEMIA,0.896084575429088
DESCARTES_FETAL_ADRENAL_SCHW...,SET,108,0.085018,0.0065012,0.089562,0.17125,DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS,0.896084575429088
BLANCO_MELO_COVID19_BRONCHIA...1,SET,49,0.12404,0.0063995,0.13071,0.17131,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,0.896101577287066
REACTOME_RECOGNITION_OF_DNA_...,SET,28,0.14349,0.0055993,0.15121,0.17133,REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX,0.896101577287066
GOCC_NODE_OF_RANVIER,SET,16,0.2214,0.0065329,0.23333,0.17134,GOCC_NODE_OF_RANVIER,0.896101577287066
KAUFFMANN_DNA_REPAIR_GENES,SET,208,0.049738,0.0052638,0.052435,0.17143,KAUFFMANN_DNA_REPAIR_GENES,0.896101577287066
GOBP_NEGATIVE_REGULATION_OF_...633,SET,9,0.26742,0.0059192,0.28194,0.17144,GOBP_NEGATIVE_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS,0.896101577287066
GOCC_NUCLEAR_PORE,SET,87,0.081692,0.0056099,0.086148,0.1715,GOCC_NUCLEAR_PORE,0.896101577287066
GOBP_COMMISSURAL_NEURON_AXON...,SET,13,0.23876,0.0063508,0.25179,0.17151,GOBP_COMMISSURAL_NEURON_AXON_GUIDANCE,0.896101577287066
WP_CHROMOSOMAL_AND_MICROSATE...,SET,72,0.09349,0.0058429,0.098596,0.17152,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,0.896101577287066
REACTOME_ACTIVATED_NTRK2_SIG...3,SET,7,0.30836,0.0060198,0.32522,0.17153,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN,0.896101577287066
GSE12198_LOW_IL2_STIM_NK_CEL...1,SET,189,0.05758,0.0058118,0.060727,0.17153,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN,0.896101577287066
GSE7831_UNSTIM_VS_CPG_STIM_P...2,SET,180,0.05981,0.0058928,0.063082,0.17154,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP,0.896101577287066
GSE36392_MAC_VS_NEUTROPHIL_I...1,SET,186,0.061991,0.0062076,0.065397,0.17159,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,0.896101577287066
HP_ABNORMAL_CIRCULATING_SERI...2,SET,30,0.14696,0.0059354,0.15504,0.1716,HP_ABNORMAL_CIRCULATING_SERINE_FAMILY_AMINO_ACID_CONCENTRATION,0.896101577287066
PID_AVB3_OPN_PATHWAY,SET,31,0.14407,0.0059149,0.15201,0.17163,PID_AVB3_OPN_PATHWAY,0.896101577287066
HP_STEROETYPIC_UPPER_EXTREMI...,SET,43,0.12037,0.0058184,0.12701,0.17164,HP_STEROETYPIC_UPPER_EXTREMITY_MOVEMENTS,0.896101577287066
GSE411_100MIN_VS_400MIN_IL6_...3,SET,183,0.05695,0.0056571,0.060117,0.17174,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,0.896112869356532
HP_URETHRAL_ATRESIA,SET,22,0.15244,0.0052736,0.16093,0.17175,HP_URETHRAL_ATRESIA,0.896112869356532
MODULE_177,SET,95,0.079188,0.0056813,0.083601,0.17177,MODULE_177,0.896112869356532
GOBP_BLASTOCYST_FORMATION,SET,45,0.11793,0.0058312,0.12451,0.17178,GOBP_BLASTOCYST_FORMATION,0.896112869356532
GSE37416_12H_VS_24H_F_TULARE...2,SET,181,0.059241,0.0058528,0.062545,0.17178,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.896112869356532
GOMF_PIRNA_BINDING,SET,5,0.39053,0.0064437,0.4124,0.17184,GOMF_PIRNA_BINDING,0.896112869356532
GOBP_METHYLATION,SET,180,0.055546,0.0054727,0.058661,0.17185,GOBP_METHYLATION,0.896112869356532
GOBP_CYTOLYSIS_BY_HOST_OF_SY...,SET,6,0.32447,0.0058645,0.34271,0.17188,GOBP_CYTOLYSIS_BY_HOST_OF_SYMBIONT_CELLS,0.896112869356532
MEISSNER_ES_ICP_WITH_H3K4ME3...,SET,11,0.24839,0.0060779,0.26237,0.17189,MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,0.896112869356532
GOBP_REGULATION_OF_COMPLEMEN...3,SET,9,0.34177,0.0075649,0.36101,0.1719,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY,0.896112869356532
GSE557_WT_VS_I_AB_KO_DC_DN,SET,181,0.05821,0.0057509,0.061496,0.17193,GSE557_WT_VS_I_AB_KO_DC_DN,0.896127728085868
HE_LIM_SUN_FETAL_LUNG_C0_LAT...1,SET,103,0.085162,0.0063605,0.089985,0.17198,HE_LIM_SUN_FETAL_LUNG_C0_LATE_AIRWAY_SMC_CELL,0.896127728085868
GOBP_POSITIVE_REGULATION_OF_...495,SET,1503,0.022197,0.0060852,0.023462,0.17206,GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS,0.896127728085868
RAO_BOUND_BY_SALL4,SET,205,0.056015,0.0058856,0.059216,0.1721,RAO_BOUND_BY_SALL4,0.896127728085868
STEIN_ESRRA_TARGETS_UP,SET,345,0.042251,0.0057369,0.044666,0.1721,STEIN_ESRRA_TARGETS_UP,0.896127728085868
REACTOME_REGULATION_OF_NF_KA...,SET,16,0.18199,0.0053699,0.1924,0.17211,REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING,0.896127728085868
HP_DECREASED_NASAL_NITRIC_OX...,SET,24,0.15745,0.0056889,0.16654,0.17222,HP_DECREASED_NASAL_NITRIC_OXIDE,0.896127728085868
GNF2_MBD4,SET,22,0.15392,0.0053246,0.16282,0.17225,GNF2_MBD4,0.896127728085868
GSE32423_IL7_VS_IL7_IL4_NAIV...1,SET,173,0.059855,0.0057826,0.063336,0.17233,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN,0.896127728085868
HP_EPILEPTIC_AURA,SET,20,0.18023,0.005945,0.19072,0.17234,HP_EPILEPTIC_AURA,0.896127728085868
MIR584_5P,SET,79,0.090251,0.0059072,0.095513,0.17236,MIR584_5P,0.896127728085868
MODULE_289,SET,117,0.080913,0.0064384,0.085635,0.17237,MODULE_289,0.896127728085868
GOBP_REGULATION_OF_ENDOSOME_...1,SET,4,0.33673,0.0049695,0.3564,0.17238,GOBP_REGULATION_OF_ENDOSOME_ORGANIZATION,0.896127728085868
KEGG_VASOPRESSIN_REGULATED_W...,SET,42,0.12277,0.005865,0.12995,0.1724,KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,0.896127728085868
BERTUCCI_MEDULLARY_VS_DUCTAL...2,SET,171,0.061832,0.0059393,0.065457,0.17243,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,0.896127728085868
GOBP_POSITIVE_REGULATION_OF_...374,SET,10,0.2505,0.0058445,0.2652,0.17244,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,0.896127728085868
CHASSOT_SKIN_WOUND,SET,9,0.3035,0.0067178,0.32132,0.17245,CHASSOT_SKIN_WOUND,0.896127728085868
LEI_HOXC8_TARGETS_DN,SET,17,0.18715,0.0056921,0.19817,0.17249,LEI_HOXC8_TARGETS_DN,0.896127728085868
MODULE_433,SET,59,0.11985,0.0067828,0.12691,0.1725,MODULE_433,0.896127728085868
GOBP_CORONARY_ARTERY_MORPHOG...,SET,8,0.30469,0.0063585,0.32265,0.17251,GOBP_CORONARY_ARTERY_MORPHOGENESIS,0.896127728085868
GSE18791_CTRL_VS_NEWCASTLE_V...19,SET,178,0.061658,0.0060414,0.065294,0.17251,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN,0.896127728085868
GSE22611_UNSTIM_VS_6H_MDP_ST...1,SET,174,0.060499,0.0058615,0.06407,0.17252,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.896127728085868
FUNG_IL2_SIGNALING_2,SET,12,0.22936,0.0058615,0.24291,0.17254,FUNG_IL2_SIGNALING_2,0.896127728085868
BYSTROEM_CORRELATED_WITH_IL5...2,SET,38,0.12185,0.0055377,0.12906,0.17255,BYSTROEM_CORRELATED_WITH_IL5_UP,0.896127728085868
MODULE_26,SET,187,0.058586,0.0058823,0.062054,0.17256,MODULE_26,0.896127728085868
GSE3337_4H_VS_16H_IFNG_IN_CD...1,SET,183,0.05913,0.0058737,0.062639,0.1726,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN,0.896127728085868
REACTOME_ANTIGEN_PRESENTATIO...,SET,28,0.14962,0.0058385,0.15851,0.17262,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,0.896127728085868
GOCC_A_BAND,SET,39,0.12013,0.0055307,0.12729,0.17266,GOCC_A_BAND,0.896127728085868
GOBP_CELLULAR_RESPONSE_TO_ST...5,SET,1635,0.019925,0.0056749,0.021117,0.17271,GOBP_CELLULAR_RESPONSE_TO_STRESS,0.896127728085868
GOMF_TRANSCRIPTION_ELONGATIO...,SET,7,0.31191,0.006089,0.33064,0.17276,GOMF_TRANSCRIPTION_ELONGATION_FACTOR_ACTIVITY,0.896127728085868
GOBP_POSITIVE_REGULATION_OF_...767,SET,6,0.28431,0.0051387,0.30141,0.17278,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE,0.896127728085868
HP_ABNORMAL_PENIS_MORPHOLOGY,SET,559,0.033616,0.0057755,0.035642,0.17281,HP_ABNORMAL_PENIS_MORPHOLOGY,0.896127728085868
GOMF_ABC_TYPE_XENOBIOTIC_TRA...,SET,14,0.23596,0.0065131,0.2502,0.17282,GOMF_ABC_TYPE_XENOBIOTIC_TRANSPORTER_ACTIVITY,0.896127728085868
GSE13493_CD4INTCD8POS_VS_CD8...2,SET,168,0.059246,0.0056412,0.062824,0.17283,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP,0.896127728085868
GSE43955_1H_VS_10H_ACT_CD4_T...1,SET,185,0.057727,0.0057652,0.061226,0.17289,GSE43955_1H_VS_10H_ACT_CD4_TCELL_DN,0.896127728085868
OUYANG_PROSTATE_CANCER_PROGR...1,SET,20,0.18132,0.005981,0.19232,0.1729,OUYANG_PROSTATE_CANCER_PROGRESSION_DN,0.896127728085868
HADDAD_T_LYMPHOCYTE_AND_NK_P...1,SET,59,0.10843,0.0061364,0.11502,0.17293,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,0.896127728085868
GOBP_T_HELPER_CELL_LINEAGE_C...,SET,23,0.18648,0.0065959,0.19782,0.17293,GOBP_T_HELPER_CELL_LINEAGE_COMMITMENT,0.896127728085868
OCT1_03,SET,206,0.056189,0.0059181,0.059608,0.17294,OCT1_03,0.896127728085868
KEGG_MEDICUS_PATHOGEN_SHIGEL...9,SET,7,0.28028,0.0054715,0.29736,0.17296,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPG_TO_TNF_NFKB_SIGNALING_PATHWAY,0.896127728085868
GSE42021_CD24HI_TREG_VS_CD24...1,SET,186,0.060159,0.0060242,0.063827,0.17296,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_DN,0.896127728085868
GOBP_ACTIN_FILAMENT_BASED_PR...,SET,755,0.029768,0.0059109,0.031585,0.17299,GOBP_ACTIN_FILAMENT_BASED_PROCESS,0.89614956774482
P300_01,SET,223,0.053686,0.0058805,0.05698,0.17305,P300_01,0.89619322753688
HP_LOWER_LIMB_MUSCLE_WEAKNESS,SET,196,0.05629,0.0057847,0.059742,0.17305,HP_LOWER_LIMB_MUSCLE_WEAKNESS,0.89619322753688
GOBP_ESTABLISHMENT_OF_PROTEI...6,SET,30,0.12943,0.0052276,0.13742,0.17313,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRIAL_MEMBRANE,0.896294097945817
HP_ABNORMAL_PANCREAS_MORPHOL...,SET,99,0.078686,0.0057622,0.083543,0.17314,HP_ABNORMAL_PANCREAS_MORPHOLOGY,0.896294097945817
POS_RESPONSE_TO_HISTAMINE_UP,SET,11,0.22557,0.0055196,0.23955,0.17319,POS_RESPONSE_TO_HISTAMINE_UP,0.896294097945817
MIR5739,SET,6,0.37601,0.006796,0.39933,0.1732,MIR5739,0.896294097945817
MIR590_5P,SET,118,0.073753,0.0058935,0.078332,0.17322,MIR590_5P,0.896294097945817
HP_ABSENT_DISTAL_INTERPHALAN...,SET,7,0.29862,0.0058295,0.3172,0.17325,HP_ABSENT_DISTAL_INTERPHALANGEAL_CREASES,0.896294097945817
TRAVAGLINI_LUNG_BRONCHIAL_VE...1,SET,207,0.055688,0.0058794,0.059152,0.17325,TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_1_CELL,0.896294097945817
GOBP_NUCLEAR_PORE_LOCALIZATI...,SET,5,0.36932,0.0060937,0.39242,0.17332,GOBP_NUCLEAR_PORE_LOCALIZATION,0.8964928125
HP_APLASIA_HYPOPLASIA_OF_THE...77,SET,70,0.096115,0.0059233,0.10213,0.17334,HP_APLASIA_HYPOPLASIA_OF_THE_UTERUS,0.8964928125
GOBP_GRANULOCYTE_CHEMOTAXIS,SET,118,0.081923,0.0065463,0.087069,0.17338,GOBP_GRANULOCYTE_CHEMOTAXIS,0.896536298720619
AIZARANI_LIVER_C9_LSECS_1,SET,280,0.050515,0.0061904,0.053692,0.1734,AIZARANI_LIVER_C9_LSECS_1,0.896536298720619
GOBP_SPERMINE_METABOLIC_PROC...,SET,4,0.3476,0.00513,0.36954,0.17345,GOBP_SPERMINE_METABOLIC_PROCESS,0.896549799256505
GOCC_ORGANELLAR_RIBOSOME,SET,85,0.081474,0.0055306,0.086619,0.17346,GOCC_ORGANELLAR_RIBOSOME,0.896549799256505
GOBP_MYELOID_CELL_HOMEOSTASIS,SET,163,0.062309,0.0058447,0.066248,0.17348,GOBP_MYELOID_CELL_HOMEOSTASIS,0.896549799256505
REACTOME_DDX58_IFIH1_MEDIATE...,SET,74,0.093568,0.0059281,0.099497,0.17351,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,0.896571520963426
HP_HYDROCELE_TESTIS,SET,35,0.12936,0.0056424,0.13758,0.17355,HP_HYDROCELE_TESTIS,0.896644901144641
HP_EXCESSIVE_WRINKLED_SKIN,SET,36,0.12941,0.0057244,0.13765,0.17359,HP_EXCESSIVE_WRINKLED_SKIN,0.896718259512485
MODULE_454,SET,10,0.27554,0.0064287,0.29316,0.17364,MODULE_454,0.896843245653143
FAN_OVARY_CL9_PUTATIVE_APOPT...,SET,328,0.043838,0.0058066,0.046648,0.17368,FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL,0.896916552748886
HP_ABNORMAL_CURVATURE_OF_THE...,SET,1027,0.0249,0.0057219,0.026504,0.17375,HP_ABNORMAL_CURVATURE_OF_THE_VERTEBRAL_COLUMN,0.896951507276507
GSE3982_CTRL_VS_LPS_48H_DC_DN,SET,180,0.061741,0.006083,0.065721,0.17376,GSE3982_CTRL_VS_LPS_48H_DC_DN,0.896951507276507
GOBP_LYMPHOCYTE_COSTIMULATION,SET,44,0.12595,0.0061582,0.13408,0.17377,GOBP_LYMPHOCYTE_COSTIMULATION,0.896951507276507
SAUL_SEN_MAYO,SET,123,0.079784,0.0065082,0.084937,0.17379,SAUL_SEN_MAYO,0.896951507276507
GOMF_PROTEIN_CONTAINING_COMP...1,SET,1561,0.020915,0.0058333,0.022274,0.17388,GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING,0.897022742078768
MIR1295B_3P,SET,18,0.21254,0.0066516,0.22637,0.17389,MIR1295B_3P,0.897022742078768
HP_KERATAN_SULFATE_EXCRETION...,SET,5,0.34552,0.005701,0.36811,0.17396,HP_KERATAN_SULFATE_EXCRETION_IN_URINE,0.897022742078768
GSE22103_UNSTIM_VS_GMCSF_AND...1,SET,188,0.054607,0.0054972,0.058176,0.17396,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,0.897022742078768
DESCARTES_FETAL_KIDNEY_LYMPH...,SET,150,0.069863,0.0062887,0.074439,0.17399,DESCARTES_FETAL_KIDNEY_LYMPHOID_CELLS,0.897022742078768
REACTOME_HYALURONAN_BIOSYNTH...,SET,5,0.37847,0.0062446,0.40329,0.17401,REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT,0.897022742078768
GSE39820_CTRL_VS_TGFBETA1_IL...1,SET,183,0.057661,0.0057278,0.061452,0.17405,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN,0.897022742078768
ARID3B_TARGET_GENES,SET,114,0.074936,0.0058863,0.079866,0.17406,ARID3B_TARGET_GENES,0.897022742078768
GOMF_LIM_DOMAIN_BINDING,SET,5,0.38062,0.0062802,0.40571,0.17409,GOMF_LIM_DOMAIN_BINDING,0.897022742078768
REACTOME_CELL_CYCLE_CHECKPOI...,SET,241,0.048325,0.0055,0.051515,0.17411,REACTOME_CELL_CYCLE_CHECKPOINTS,0.897022742078768
MIR4776_3P,SET,152,0.068152,0.0061752,0.072655,0.17412,MIR4776_3P,0.897022742078768
GOMF_PHOSPHATIDYLINOSITOL_3_...2,SET,6,0.2626,0.0047462,0.27998,0.17415,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.897022742078768
HP_STEROID_RESISTANT_NEPHROT...,SET,14,0.19625,0.0054169,0.20925,0.17416,HP_STEROID_RESISTANT_NEPHROTIC_SYNDROME,0.897022742078768
GSE22919_RESTING_VS_IL2_IL12...2,SET,181,0.054772,0.0054113,0.058409,0.1742,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP,0.897022742078768
LEE_LIVER_CANCER_MYC_DN,SET,56,0.12099,0.0066716,0.12903,0.17421,LEE_LIVER_CANCER_MYC_DN,0.897022742078768
KEGG_MEDICUS_ENV_FACTOR_ZN_T...,SET,18,0.20497,0.0064145,0.21864,0.17427,KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.897022742078768
GNF2_PCAF,SET,31,0.14306,0.0058734,0.15262,0.17429,GNF2_PCAF,0.897022742078768
MIZUKAMI_HYPOXIA_UP,SET,11,0.23521,0.0057554,0.25094,0.1743,MIZUKAMI_HYPOXIA_UP,0.897022742078768
XU_HGF_TARGETS_INDUCED_BY_AK...3,SET,15,0.20118,0.005748,0.21465,0.17432,XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,0.897022742078768
GOBP_EMBRYONIC_DIGIT_MORPHOG...,SET,53,0.11828,0.0063456,0.1262,0.17432,GOBP_EMBRYONIC_DIGIT_MORPHOGENESIS,0.897022742078768
GGCACTT_MIR519E,SET,109,0.074496,0.0057227,0.079509,0.1744,GGCACTT_MIR519E,0.897168738898757
GSE21927_EL4_VS_MCA203_TUMOR...2,SET,149,0.068081,0.006108,0.072663,0.1744,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_UP,0.897168738898757
TSENG_IRS1_TARGETS_DN,SET,112,0.079134,0.0061616,0.0845,0.17451,TSENG_IRS1_TARGETS_DN,0.89725114526378
GOBP_NEGATIVE_REGULATION_OF_...634,SET,21,0.19369,0.0065468,0.20682,0.17451,GOBP_NEGATIVE_REGULATION_OF_TISSUE_REMODELING,0.89725114526378
HP_DECREASED_CIRCULATING_COM...2,SET,27,0.1585,0.0060734,0.16924,0.17451,HP_DECREASED_CIRCULATING_COMPLEMENT_C4_CONCENTRATION,0.89725114526378
HP_MYOPATHY,SET,280,0.046571,0.005707,0.049734,0.17454,HP_MYOPATHY,0.89725114526378
GSE37416_0H_VS_24H_F_TULAREN...1,SET,177,0.058647,0.0057304,0.062634,0.17455,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.89725114526378
HP_STREAK_OVARY,SET,31,0.14078,0.0057799,0.1504,0.17462,HP_STREAK_OVARY,0.89725114526378
GOCC_AZUROPHIL_GRANULE_MEMBR...,SET,51,0.10573,0.0055648,0.11296,0.17463,GOCC_AZUROPHIL_GRANULE_MEMBRANE,0.89725114526378
GOMF_ADP_PHOSPHATASE_ACTIVITY,SET,6,0.24926,0.0045052,0.26635,0.17468,GOMF_ADP_PHOSPHATASE_ACTIVITY,0.89725114526378
DORN_ADENOVIRUS_INFECTION_32...2,SET,9,0.25263,0.0055917,0.26995,0.17469,DORN_ADENOVIRUS_INFECTION_32HR_UP,0.89725114526378
PID_AMB2_NEUTROPHILS_PATHWAY,SET,40,0.1245,0.0058049,0.13305,0.1747,PID_AMB2_NEUTROPHILS_PATHWAY,0.89725114526378
GOBP_REGULATION_OF_SERINE_TY...,SET,5,0.3774,0.006227,0.40331,0.1747,GOBP_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY,0.89725114526378
GSE29949_MICROGLIA_BRAIN_VS_...6,SET,182,0.060069,0.0059508,0.0642,0.17473,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.897272628546099
HP_AMBIGUOUS_GENITALIA,SET,109,0.07416,0.0056969,0.079284,0.17481,HP_AMBIGUOUS_GENITALIA,0.897437958614617
GOBP_EMBRYONIC_HEART_TUBE_DE...,SET,82,0.089469,0.0059657,0.095679,0.17488,GOBP_EMBRYONIC_HEART_TUBE_DEVELOPMENT,0.897437958614617
MODULE_280,SET,44,0.12298,0.0060129,0.13152,0.17489,MODULE_280,0.897437958614617
REACTOME_DNA_DAMAGE_RECOGNIT...,SET,35,0.13447,0.0058655,0.14387,0.17499,REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER,0.897437958614617
NAKAYA_MYELOID_DENDRITIC_CEL...2,SET,355,0.040343,0.0055552,0.043163,0.17499,NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.897437958614617
HP_HYPERCONVEX_FINGERNAILS,SET,6,0.34424,0.0062218,0.36833,0.17501,HP_HYPERCONVEX_FINGERNAILS,0.897437958614617
HP_ABNORMAL_ANTERIOR_HORN_CE...,SET,18,0.1834,0.0057394,0.19629,0.17508,HP_ABNORMAL_ANTERIOR_HORN_CELL_MORPHOLOGY,0.897437958614617
GOBP_AMPA_GLUTAMATE_RECEPTOR...,SET,9,0.27517,0.0060907,0.29455,0.17511,GOBP_AMPA_GLUTAMATE_RECEPTOR_CLUSTERING,0.897437958614617
MIR6773_3P,SET,96,0.081289,0.0058624,0.087018,0.17512,MIR6773_3P,0.897437958614617
PLASARI_TGFB1_SIGNALING_VIA_...4,SET,27,0.1544,0.0059164,0.16531,0.17515,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP,0.897437958614617
GOBP_POSITIVE_REGULATION_OF_...681,SET,6,0.31374,0.0056706,0.33593,0.17518,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,0.897437958614617
GOCC_L_TYPE_VOLTAGE_GATED_CA...,SET,12,0.25631,0.0065504,0.27448,0.17521,GOCC_L_TYPE_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,0.897437958614617
HALLMARK_P53_PATHWAY,SET,187,0.056274,0.0056501,0.060262,0.17521,HALLMARK_P53_PATHWAY,0.897437958614617
GSE12845_IGD_NEG_BLOOD_VS_DA...2,SET,162,0.06233,0.0058288,0.066754,0.17523,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.897437958614617
GSE5542_UNTREATED_VS_IFNA_AN...4,SET,163,0.0604,0.0056656,0.064688,0.17523,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.897437958614617
NIKOLSKY_BREAST_CANCER_17Q11...,SET,119,0.12382,0.0099362,0.13262,0.17524,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,0.897437958614617
HP_HYPOAMYLASEMIA,SET,4,0.33582,0.0049561,0.35967,0.17524,HP_HYPOAMYLASEMIA,0.897437958614617
GSE15659_RESTING_TREG_VS_NON...1,SET,172,0.059675,0.0057487,0.063925,0.17528,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN,0.897437958614617
REACTOME_PYRUVATE_METABOLISM,SET,44,0.12459,0.0060915,0.13346,0.17529,REACTOME_PYRUVATE_METABOLISM,0.897437958614617
MILI_PSEUDOPODIA_CHEMOTAXIS_...1,SET,419,0.036891,0.0055089,0.039521,0.1753,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,0.897437958614617
GSE13411_NAIVE_VS_SWITCHED_M...1,SET,178,0.057618,0.0056455,0.061732,0.17532,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN,0.897437958614617
HP_NEUTROPHILIA,SET,21,0.17109,0.0057828,0.18335,0.17538,HP_NEUTROPHILIA,0.897437958614617
GOBP_COLLAGEN_BIOSYNTHETIC_P...,SET,39,0.13687,0.0063013,0.14669,0.1754,GOBP_COLLAGEN_BIOSYNTHETIC_PROCESS,0.897437958614617
HP_ABNORMAL_ZYGOMATIC_BONE_M...,SET,206,0.055845,0.005882,0.059862,0.17544,HP_ABNORMAL_ZYGOMATIC_BONE_MORPHOLOGY,0.897437958614617
GSE17721_CPG_VS_GARDIQUIMOD_...12,SET,182,0.058692,0.0058144,0.062914,0.17544,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_UP,0.897437958614617
GOBP_NEGATIVE_REGULATION_OF_...104,SET,11,0.20234,0.0049511,0.21693,0.17548,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.897437958614617
KEGG_MEDICUS_REFERENCE_ARL8_...,SET,30,0.14531,0.0058689,0.15582,0.17553,KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,0.897437958614617
GOBP_POSITIVE_REGULATION_OF_...366,SET,26,0.16797,0.0063164,0.18016,0.17558,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,0.897437958614617
GSE2128_C57BL6_VS_NOD_CD4CD8...1,SET,187,0.056567,0.0056796,0.06067,0.17558,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN,0.897437958614617
HP_ABNORMALLY_SHAPED_CARPAL_...,SET,7,0.31616,0.006172,0.33911,0.17559,HP_ABNORMALLY_SHAPED_CARPAL_BONES,0.897437958614617
REACTOME_CD209_DC_SIGN_SIGNA...,SET,19,0.17589,0.0056552,0.18868,0.17563,REACTOME_CD209_DC_SIGN_SIGNALING,0.897437958614617
HP_APLASIA_HYPOPLASIA_OF_THE...32,SET,4,0.40858,0.00603,0.43835,0.17565,HP_APLASIA_HYPOPLASIA_OF_THE_FALLOPIAN_TUBE,0.897437958614617
GOBP_KINETOCHORE_ASSEMBLY,SET,16,0.18505,0.0054601,0.19857,0.1757,GOBP_KINETOCHORE_ASSEMBLY,0.897437958614617
MIR19B_1_5P_MIR19B_2_5P,SET,160,0.064475,0.0059925,0.069189,0.17571,MIR19B_1_5P_MIR19B_2_5P,0.897437958614617
HE_LIM_SUN_FETAL_LUNG_C5_LAR...,SET,1181,0.022425,0.0055014,0.024069,0.17575,HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL,0.897437958614617
HP_NEONATAL_OMPHALITIS,SET,10,0.23795,0.0055515,0.25541,0.17577,HP_NEONATAL_OMPHALITIS,0.897437958614617
GOBP_FEMALE_GAMETE_GENERATION,SET,145,0.064665,0.0057238,0.069412,0.17578,GOBP_FEMALE_GAMETE_GENERATION,0.897437958614617
GOCC_KINETOCHORE_MICROTUBULE,SET,19,0.16325,0.0052487,0.17525,0.1758,GOCC_KINETOCHORE_MICROTUBULE,0.897437958614617
HP_THIN_EYEBROW,SET,22,0.16404,0.0056747,0.17609,0.1758,HP_THIN_EYEBROW,0.897437958614617
BACH1_01,SET,238,0.052227,0.0059075,0.056076,0.17584,BACH1_01,0.897437958614617
GOBP_NEGATIVE_REGULATION_OF_...177,SET,6,0.33639,0.00608,0.3612,0.17585,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,0.897437958614617
REACTOME_SULFUR_AMINO_ACID_M...,SET,26,0.16247,0.0061096,0.17446,0.17586,REACTOME_SULFUR_AMINO_ACID_METABOLISM,0.897437958614617
GSE10239_KLRG1INT_VS_KLRG1HI...1,SET,179,0.059823,0.0058778,0.064243,0.17588,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.897437958614617
HP_COMPLETE_OR_NEAR_COMPLETE...1,SET,7,0.35241,0.0068797,0.3785,0.17591,HP_COMPLETE_OR_NEAR_COMPLETE_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_TETANUS_VACCINE,0.897437958614617
HP_ABNORMAL_SECOND_TOE_MORPH...,SET,12,0.24289,0.0062073,0.26089,0.17594,HP_ABNORMAL_SECOND_TOE_MORPHOLOGY,0.897437958614617
MIR520G_5P,SET,53,0.10828,0.0058094,0.11632,0.17595,MIR520G_5P,0.897437958614617
WATANABE_ULCERATIVE_COLITIS_...1,SET,14,0.21513,0.0059383,0.23122,0.17608,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN,0.897969244314013
MIR3664_3P,SET,141,0.063417,0.005536,0.068173,0.17613,MIR3664_3P,0.897973394428152
BIOCARTA_COMP_PATHWAY,SET,15,0.22474,0.0064209,0.2416,0.17614,BIOCARTA_COMP_PATHWAY,0.897973394428152
GOBP_RESPONSE_TO_SODIUM_ARSE...,SET,6,0.32577,0.0058879,0.35028,0.17618,GOBP_RESPONSE_TO_SODIUM_ARSENITE,0.897973394428152
REACTOME_PROLACTIN_RECEPTOR_...,SET,14,0.2083,0.0057497,0.22399,0.1762,REACTOME_PROLACTIN_RECEPTOR_SIGNALING,0.897973394428152
POOLA_INVASIVE_BREAST_CANCER...2,SET,256,0.052341,0.0061372,0.056286,0.17621,POOLA_INVASIVE_BREAST_CANCER_UP,0.897973394428152
MODULE_431,SET,15,0.22286,0.0063673,0.23973,0.17628,MODULE_431,0.898083448023426
HP_PROGRESSIVE_HEARING_IMPAI...,SET,35,0.12885,0.0056201,0.13864,0.17636,HP_PROGRESSIVE_HEARING_IMPAIRMENT,0.898083448023426
GOBP_REGULATION_OF_COMPLEMEN...1,SET,17,0.21956,0.0066778,0.23627,0.17638,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION,0.898083448023426
REACTOME_CLEC7A_DECTIN_1_SIG...,SET,93,0.075962,0.0053925,0.081757,0.17642,REACTOME_CLEC7A_DECTIN_1_SIGNALING,0.898083448023426
GSE17721_CPG_VS_GARDIQUIMOD_...13,SET,177,0.05765,0.0056329,0.062049,0.17642,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_DN,0.898083448023426
GSE19888_CTRL_VS_T_CELL_MEMB...2,SET,184,0.055908,0.0055686,0.060175,0.17643,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP,0.898083448023426
MYOCD_TARGET_GENES,SET,1134,0.023978,0.005772,0.02581,0.17644,MYOCD_TARGET_GENES,0.898083448023426
GOCC_CALCINEURIN_COMPLEX,SET,6,0.26936,0.0048684,0.28993,0.17644,GOCC_CALCINEURIN_COMPLEX,0.898083448023426
GOCC_RUFFLE,SET,172,0.058873,0.0056714,0.063378,0.17647,GOCC_RUFFLE,0.898083448023426
GSE20500_CTRL_VS_RETINOIC_AC...2,SET,174,0.056406,0.005465,0.060726,0.17649,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_UP,0.898083448023426
MIR7114_3P,SET,42,0.11735,0.005606,0.12637,0.17656,MIR7114_3P,0.898143161775336
JOHNSTONE_PARVB_TARGETS_2_UP,SET,125,0.071552,0.0058836,0.077068,0.1766,JOHNSTONE_PARVB_TARGETS_2_UP,0.898143161775336
HP_CHORIOCAPILLARIS_ATROPHY,SET,8,0.28714,0.0059924,0.3094,0.17669,HP_CHORIOCAPILLARIS_ATROPHY,0.898143161775336
GSE29618_LAIV_VS_TIV_FLU_VAC...6,SET,167,0.060776,0.0057698,0.0655,0.17674,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP,0.898143161775336
GSE25123_CTRL_VS_IL4_AND_ROS...2,SET,186,0.056242,0.0056319,0.060622,0.17678,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.898143161775336
GOBP_NEGATIVE_REGULATION_OF_...342,SET,67,0.10456,0.0063048,0.11272,0.1768,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,0.898143161775336
GOMF_ATPASE_COUPLED_INORGANI...,SET,10,0.26371,0.0061526,0.28433,0.17685,GOMF_ATPASE_COUPLED_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.898143161775336
chr6q15,SET,23,0.26018,0.0092027,0.28064,0.17695,chr6q15,0.898143161775336
HP_PENDULAR_NYSTAGMUS,SET,37,0.12664,0.0056791,0.13663,0.177,HP_PENDULAR_NYSTAGMUS,0.898143161775336
BIOCARTA_BARD1_PATHWAY,SET,8,0.23331,0.0048689,0.25175,0.17703,BIOCARTA_BARD1_PATHWAY,0.898143161775336
GSE14026_TH1_VS_TH17_DN,SET,179,0.056538,0.0055551,0.061005,0.17703,GSE14026_TH1_VS_TH17_DN,0.898143161775336
chr9q33,SET,74,0.19067,0.01208,0.20575,0.17705,chr9q33,0.898143161775336
GOBP_BRANCH_ELONGATION_INVOL...,SET,5,0.41309,0.0068159,0.44582,0.17708,GOBP_BRANCH_ELONGATION_INVOLVED_IN_MAMMARY_GLAND_DUCT_BRANCHING,0.898143161775336
REACTOME_NETRIN_MEDIATED_REP...,SET,8,0.28082,0.0058604,0.30308,0.17709,REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS,0.898143161775336
GOMF_PROTEIN_KINASE_B_BINDING,SET,10,0.21699,0.0050626,0.23425,0.17714,GOMF_PROTEIN_KINASE_B_BINDING,0.898143161775336
MIKKELSEN_ES_LCP_WITH_H3K27M...,SET,12,0.23066,0.005895,0.24904,0.17718,MIKKELSEN_ES_LCP_WITH_H3K27ME3,0.898143161775336
WP_NUCLEAR_RECEPTORS,SET,36,0.13239,0.0058566,0.14296,0.17721,WP_NUCLEAR_RECEPTORS,0.898143161775336
GSE45365_CD8A_DC_VS_CD11B_DC...2,SET,167,0.061113,0.0058018,0.065993,0.17722,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN,0.898143161775336
GNF2_RBBP6,SET,65,0.08672,0.0051506,0.09367,0.17728,GNF2_RBBP6,0.898143161775336
HP_SUBARACHNOID_HEMORRHAGE,SET,36,0.13841,0.0061228,0.1495,0.17728,HP_SUBARACHNOID_HEMORRHAGE,0.898143161775336
HP_RECURRENT_CORNEAL_EROSIONS,SET,11,0.2485,0.0060805,0.26842,0.17729,HP_RECURRENT_CORNEAL_EROSIONS,0.898143161775336
GSE3039_CD4_TCELL_VS_B2_BCEL...2,SET,182,0.058438,0.0057892,0.063124,0.17729,GSE3039_CD4_TCELL_VS_B2_BCELL_UP,0.898143161775336
AHR_Q5,SET,195,0.056631,0.005805,0.061175,0.1773,AHR_Q5,0.898143161775336
GSE22886_NAIVE_CD8_TCELL_VS_...10,SET,175,0.058139,0.0056488,0.062803,0.1773,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP,0.898143161775336
GOCC_MITOCHONDRIAL_SMALL_RIB...,SET,31,0.12836,0.0052697,0.13868,0.17734,GOCC_MITOCHONDRIAL_SMALL_RIBOSOMAL_SUBUNIT,0.898143161775336
GOBP_INTRACELLULAR_TRIGLYCER...,SET,9,0.24225,0.005362,0.26178,0.17739,GOBP_INTRACELLULAR_TRIGLYCERIDE_HOMEOSTASIS,0.898143161775336
GOCC_LUMENAL_SIDE_OF_ENDOPLA...,SET,29,0.14543,0.0057752,0.15716,0.17739,GOCC_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,0.898143161775336
BANDRES_RESPONSE_TO_CARMUSTI...5,SET,9,0.27848,0.0061639,0.30095,0.1774,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN,0.898143161775336
WP_TOLLLIKE_RECEPTOR_SIGNALI...1,SET,95,0.085798,0.0061555,0.092721,0.1774,WP_TOLLLIKE_RECEPTOR_SIGNALING,0.898143161775336
MCCLUNG_DELTA_FOSB_TARGETS_8...,SET,45,0.11316,0.0055953,0.1223,0.17742,MCCLUNG_DELTA_FOSB_TARGETS_8WK,0.898143161775336
GOBP_PROTEIN_PROCESSING,SET,217,0.052422,0.0056652,0.056655,0.17742,GOBP_PROTEIN_PROCESSING,0.898143161775336
GRANDVAUX_IFN_RESPONSE_NOT_V...,SET,14,0.19854,0.0054801,0.21459,0.17744,GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,0.898143161775336
HP_NARROW_NOSE,SET,21,0.17417,0.0058869,0.18825,0.17744,HP_NARROW_NOSE,0.898143161775336
REACTOME_DISPLACEMENT_OF_DNA...,SET,9,0.24649,0.0054559,0.26644,0.17745,REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1,0.898143161775336
HP_CHOROIDAL_HEMANGIOMA,SET,5,0.31637,0.0052201,0.34199,0.17746,HP_CHOROIDAL_HEMANGIOMA,0.898143161775336
BIOCARTA_NTHI_PATHWAY,SET,23,0.17215,0.0060889,0.1861,0.17749,BIOCARTA_NTHI_PATHWAY,0.898143161775336
BUSSLINGER_GASTRIC_NECK_CELLS,SET,34,0.14368,0.0061772,0.15535,0.17751,BUSSLINGER_GASTRIC_NECK_CELLS,0.898143161775336
GOMF_ARMADILLO_REPEAT_DOMAIN...,SET,8,0.23642,0.0049339,0.25563,0.17752,GOMF_ARMADILLO_REPEAT_DOMAIN_BINDING,0.898143161775336
BIOCARTA_BCR_PATHWAY,SET,31,0.13984,0.0057411,0.15123,0.17758,BIOCARTA_BCR_PATHWAY,0.898143161775336
JISON_SICKLE_CELL_DISEASE_UP,SET,165,0.061972,0.0058483,0.067025,0.17759,JISON_SICKLE_CELL_DISEASE_UP,0.898143161775336
GOBP_PROTEIN_LOCALIZATION_TO...48,SET,11,0.21873,0.0053522,0.23658,0.17761,GOBP_PROTEIN_LOCALIZATION_TO_SITE_OF_DOUBLE_STRAND_BREAK,0.898143161775336
chr22q12,SET,107,0.16086,0.012244,0.17404,0.17768,chr22q12,0.898143161775336
GOBP_L_ASCORBIC_ACID_METABOL...,SET,9,0.26874,0.0059485,0.2908,0.17771,GOBP_L_ASCORBIC_ACID_METABOLIC_PROCESS,0.898143161775336
GOMF_PEPTIDASE_ACTIVATOR_ACT...2,SET,21,0.16496,0.0055756,0.17852,0.17774,GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.898143161775336
REACTOME_SIGNALING_BY_ACTIVIN,SET,16,0.21073,0.006218,0.22806,0.17775,REACTOME_SIGNALING_BY_ACTIVIN,0.898143161775336
REACTOME_CA2_ACTIVATED_K_CHA...,SET,9,0.28258,0.0062548,0.30584,0.17776,REACTOME_CA2_ACTIVATED_K_CHANNELS,0.898143161775336
REACTOME_SEPARATION_OF_SISTE...,SET,174,0.056568,0.0054806,0.061241,0.17783,REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,0.898143161775336
GOBP_FC_GAMMA_RECEPTOR_SIGNA...,SET,31,0.15153,0.0062212,0.16405,0.17783,GOBP_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY,0.898143161775336
GOBP_MAINTENANCE_OF_DNA_REPE...,SET,7,0.26426,0.0051589,0.28616,0.17788,GOBP_MAINTENANCE_OF_DNA_REPEAT_ELEMENTS,0.898143161775336
GSE16385_IL4_VS_ROSIGLITAZON...2,SET,174,0.056424,0.0054666,0.061109,0.17793,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.898143161775336
FLORIO_HUMAN_NEOCORTEX,SET,28,0.15816,0.0061716,0.17133,0.17797,FLORIO_HUMAN_NEOCORTEX,0.898143161775336
GOBP_NEGATIVE_REGULATION_OF_...420,SET,9,0.27512,0.0060896,0.29806,0.178,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT,0.898143161775336
GOBP_PRIMITIVE_ERYTHROCYTE_D...,SET,4,0.45158,0.0066646,0.48925,0.17801,GOBP_PRIMITIVE_ERYTHROCYTE_DIFFERENTIATION,0.898143161775336
GSE37533_UNTREATED_VS_PIOGLI...1,SET,150,0.062537,0.0056293,0.067753,0.17801,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN,0.898143161775336
GOBP_STEROID_HORMONE_SECRETI...,SET,26,0.16372,0.0061564,0.17739,0.17802,GOBP_STEROID_HORMONE_SECRETION,0.898143161775336
GOBP_POSITIVE_REGULATION_OF_...843,SET,6,0.3482,0.0062934,0.37728,0.17803,GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.898143161775336
GOBP_AMP_CATABOLIC_PROCESS,SET,5,0.37319,0.0061576,0.40438,0.17804,GOBP_AMP_CATABOLIC_PROCESS,0.898143161775336
REACTOME_GENE_AND_PROTEIN_EX...,SET,35,0.12313,0.0053708,0.13346,0.17811,REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,0.898143161775336
POMEROY_MEDULLOBLASTOMA_PROG...2,SET,42,0.1138,0.0054365,0.12335,0.17813,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,0.898143161775336
TRAVAGLINI_LUNG_FIBROMYOCYTE...,SET,21,0.19027,0.0064311,0.20624,0.17813,TRAVAGLINI_LUNG_FIBROMYOCYTE_CELL,0.898143161775336
MODULE_516,SET,15,0.22386,0.0063959,0.24269,0.17816,MODULE_516,0.898143161775336
MYLLYKANGAS_AMPLIFICATION_HO...19,SET,7,0.30278,0.0059107,0.32826,0.17818,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9,0.898143161775336
GOBP_REGULATION_OF_LYMPHOCYT...2,SET,55,0.10724,0.0058607,0.11628,0.1782,GOBP_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.898143161775336
MODULE_24,SET,407,0.040444,0.0059543,0.043861,0.17825,MODULE_24,0.898143161775336
HP_GENERALIZED_LIPODYSTROPHY,SET,8,0.32183,0.0067162,0.34903,0.17825,HP_GENERALIZED_LIPODYSTROPHY,0.898143161775336
HP_PERIPHERAL_HYPERMYELINATI...,SET,9,0.26652,0.0058992,0.28908,0.17828,HP_PERIPHERAL_HYPERMYELINATION,0.898143161775336
DEBIASI_APOPTOSIS_BY_REOVIRU...1,SET,246,0.048622,0.0055901,0.052743,0.17831,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,0.898143161775336
GSE12366_PLASMA_CELL_VS_NAIV...1,SET,170,0.057536,0.0055105,0.062426,0.17836,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN,0.898143161775336
LI_PBMC_MENOMUNE_A_C_Y_W_135...1,SET,16,0.20919,0.0061725,0.22699,0.17839,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_DN,0.898143161775336
GSE24292_WT_VS_PPARG_KO_MACR...2,SET,185,0.057978,0.0057903,0.062929,0.17845,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_UP,0.898143161775336
GSE3982_DC_VS_MAC_LPS_STIM_UP,SET,173,0.056955,0.0055024,0.061822,0.17846,GSE3982_DC_VS_MAC_LPS_STIM_UP,0.898143161775336
CHANDRAN_METASTASIS_TOP50_DN,SET,35,0.13279,0.0057922,0.14414,0.17847,CHANDRAN_METASTASIS_TOP50_DN,0.898143161775336
GSE19772_CTRL_VS_HCMV_INF_MO...4,SET,182,0.05718,0.0056645,0.062078,0.17851,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP,0.898143161775336
GOBP_REGULATION_OF_CORTICOST...,SET,16,0.20371,0.0060108,0.22118,0.17853,GOBP_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION,0.898143161775336
GOBP_PROTEIN_LOCALIZATION_TO...45,SET,5,0.37235,0.0061436,0.4043,0.17854,GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE_RAFT,0.898143161775336
MIR6508_3P,SET,46,0.11681,0.0058393,0.12684,0.17856,MIR6508_3P,0.898143161775336
GOBP_REGULATION_OF_LIPID_TRA...1,SET,122,0.072784,0.0059132,0.07904,0.17857,GOBP_REGULATION_OF_LIPID_TRANSPORT,0.898143161775336
FULLER_PBMC_F_TULARENSIS_VAC...1,SET,19,0.18851,0.0060609,0.20472,0.17858,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_DN,0.898143161775336
GSE21670_IL6_VS_TGFB_AND_IL6...4,SET,187,0.051582,0.005179,0.056025,0.17861,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.898143161775336
HP_EDEMA_OF_THE_DORSUM_OF_FE...,SET,4,0.36752,0.005424,0.39919,0.17862,HP_EDEMA_OF_THE_DORSUM_OF_FEET,0.898143161775336
SHIN_B_CELL_LYMPHOMA_CLUSTER...4,SET,17,0.1949,0.0059278,0.21171,0.17864,SHIN_B_CELL_LYMPHOMA_CLUSTER_5,0.898143161775336
ZHENG_IL22_SIGNALING_UP,SET,53,0.11303,0.0060642,0.12281,0.1787,ZHENG_IL22_SIGNALING_UP,0.898143161775336
HP_FOOT_JOINT_CONTRACTURE,SET,123,0.069694,0.0056851,0.075727,0.1787,HP_FOOT_JOINT_CONTRACTURE,0.898143161775336
GOBP_MIDGUT_DEVELOPMENT,SET,11,0.27498,0.0067284,0.2988,0.17872,GOBP_MIDGUT_DEVELOPMENT,0.898143161775336
GOCC_BOX_H_ACA_RNP_COMPLEX,SET,3,0.37718,0.0048208,0.4099,0.17875,GOCC_BOX_H_ACA_RNP_COMPLEX,0.898143161775336
GOCC_BOX_H_ACA_TELOMERASE_RN...,SET,3,0.37718,0.0048208,0.4099,0.17875,GOCC_BOX_H_ACA_TELOMERASE_RNP_COMPLEX,0.898143161775336
HP_OSTEOPETROSIS,SET,17,0.19545,0.0059443,0.2124,0.17875,HP_OSTEOPETROSIS,0.898143161775336
HP_ENLARGED_OVARIES,SET,16,0.18333,0.0054096,0.19935,0.17888,HP_ENLARGED_OVARIES,0.898456929190751
GSE22140_GERMFREE_VS_SPF_ART...1,SET,175,0.057485,0.0055853,0.062508,0.17888,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN,0.898456929190751
MIR6808_3P,SET,37,0.12569,0.0056366,0.13668,0.17889,MIR6808_3P,0.898456929190751
HSIAO_HOUSEKEEPING_GENES,SET,344,0.040473,0.0054877,0.044019,0.17894,HSIAO_HOUSEKEEPING_GENES,0.898578196792371
VANHARANTA_UTERINE_FIBROID_W...1,SET,35,0.13848,0.0060403,0.15067,0.17903,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,0.898870829120324
GOBP_OUTER_EAR_MORPHOGENESIS,SET,8,0.28124,0.0058692,0.30602,0.17905,GOBP_OUTER_EAR_MORPHOGENESIS,0.898870829120324
GSE3337_CTRL_VS_16H_IFNG_IN_...2,SET,179,0.058928,0.0057899,0.064129,0.17908,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP,0.898891594454073
HP_ANGULATED_MUSCLE_FIBERS,SET,5,0.33149,0.0054694,0.36086,0.17916,HP_ANGULATED_MUSCLE_FIBERS,0.89910437418796
GOBP_NEGATIVE_REGULATION_BY_...1,SET,8,0.26983,0.0056312,0.2938,0.1792,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,0.89910437418796
GOMF_TAU_PROTEIN_BINDING,SET,41,0.1121,0.0052912,0.12205,0.1792,GOMF_TAU_PROTEIN_BINDING,0.89910437418796
GOCC_TUBULAR_ENDOSOME,SET,5,0.33621,0.0055475,0.36624,0.17931,GOCC_TUBULAR_ENDOSOME,0.899287505410475
WP_ENDODERM_DIFFERENTIATION,SET,130,0.070834,0.0059391,0.077164,0.17932,WP_ENDODERM_DIFFERENTIATION,0.899287505410475
GOBP_REGULATION_OF_NUCLEOTID...1,SET,13,0.23758,0.0063195,0.25883,0.17934,GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.899287505410475
HP_ENDOCARDITIS,SET,14,0.21745,0.0060023,0.2369,0.17934,HP_ENDOCARDITIS,0.899287505410475
SCHOEN_NFKB_SIGNALING,SET,32,0.16164,0.0067421,0.17621,0.1795,SCHOEN_NFKB_SIGNALING,0.899309323858743
LEI_MYB_TARGETS,SET,297,0.045924,0.0057934,0.050069,0.17952,LEI_MYB_TARGETS,0.899309323858743
WP_CHEMOKINE_SIGNALING,SET,157,0.063698,0.0058649,0.069445,0.17952,WP_CHEMOKINE_SIGNALING,0.899309323858743
GOCC_ACTIN_FILAMENT,SET,105,0.075383,0.0056842,0.082215,0.1796,GOCC_ACTIN_FILAMENT,0.899309323858743
TEL2_Q6,SET,221,0.051571,0.0056237,0.056254,0.17964,TEL2_Q6,0.899309323858743
GOBP_LEUKOTRIENE_TRANSPORT,SET,7,0.31207,0.0060922,0.3404,0.17964,GOBP_LEUKOTRIENE_TRANSPORT,0.899309323858743
WP_INCLUSION_BODY_MYOSITIS,SET,10,0.24317,0.0056734,0.26526,0.17965,WP_INCLUSION_BODY_MYOSITIS,0.899309323858743
GAVISH_3CA_METAPROGRAM_EPITH...15,SET,47,0.11437,0.005779,0.12476,0.17965,GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_2,0.899309323858743
GSE27786_CD4_TCELL_VS_NKCELL...1,SET,180,0.056995,0.0056154,0.062174,0.17966,GSE27786_CD4_TCELL_VS_NKCELL_DN,0.899309323858743
GOBP_TRNA_PSEUDOURIDINE_SYNT...,SET,6,0.27337,0.0049409,0.29824,0.17968,GOBP_TRNA_PSEUDOURIDINE_SYNTHESIS,0.899309323858743
GOMF_DEACETYLASE_ACTIVITY,SET,35,0.12734,0.0055545,0.13894,0.1797,GOMF_DEACETYLASE_ACTIVITY,0.899309323858743
LUI_THYROID_CANCER_CLUSTER_2,SET,43,0.12078,0.005838,0.1318,0.17974,LUI_THYROID_CANCER_CLUSTER_2,0.899309323858743
GSE3982_BASOPHIL_VS_TH1_DN,SET,174,0.057536,0.0055744,0.062791,0.17976,GSE3982_BASOPHIL_VS_TH1_DN,0.899309323858743
KEGG_MEDICUS_REFERENCE_DOUBL...2,SET,11,0.22333,0.0054648,0.24374,0.17977,KEGG_MEDICUS_REFERENCE_DOUBLE_STRAND_BREAK_SIGNALING,0.899309323858743
GOMF_WNT_RECEPTOR_ACTIVITY,SET,16,0.22192,0.0065482,0.24222,0.17979,GOMF_WNT_RECEPTOR_ACTIVITY,0.899309323858743
GSE17974_0H_VS_1H_IN_VITRO_A...2,SET,159,0.059921,0.0055519,0.065404,0.17979,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP,0.899309323858743
GSE22886_NAIVE_TCELL_VS_DC_DN,SET,189,0.055565,0.0056084,0.060649,0.17979,GSE22886_NAIVE_TCELL_VS_DC_DN,0.899309323858743
GOCC_AUTOPHAGOSOME_MEMBRANE,SET,49,0.10441,0.0053868,0.114,0.17986,GOCC_AUTOPHAGOSOME_MEMBRANE,0.899309323858743
HP_PNEUMOTHORAX,SET,72,0.096688,0.0060428,0.10557,0.17987,HP_PNEUMOTHORAX,0.899309323858743
HANN_RESISTANCE_TO_BCL2_INHI...1,SET,40,0.13542,0.0063139,0.14788,0.1799,HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,0.899309323858743
VILIMAS_NOTCH1_TARGETS_UP,SET,49,0.11464,0.0059142,0.12519,0.17991,VILIMAS_NOTCH1_TARGETS_UP,0.899309323858743
KOINUMA_TARGETS_OF_SMAD2_OR_...,SET,773,0.028867,0.0057971,0.031533,0.17998,KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3,0.899309323858743
GSE35825_UNTREATED_VS_IFNA_S...1,SET,159,0.063665,0.0058988,0.069543,0.17998,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_DN,0.899309323858743
GOBP_CELLULAR_OXIDANT_DETOXI...,SET,83,0.086084,0.0057747,0.094049,0.18002,GOBP_CELLULAR_OXIDANT_DETOXIFICATION,0.899309323858743
MIR5697,SET,139,0.06455,0.0055951,0.070528,0.18004,MIR5697,0.899309323858743
GSE2706_LPS_VS_R848_AND_LPS_...3,SET,159,0.063904,0.0059209,0.069826,0.18005,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN,0.899309323858743
GOBP_CYTOKINE_PRODUCTION_INV...2,SET,57,0.098309,0.005469,0.10743,0.18007,GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.899309323858743
BURTON_ADIPOGENESIS_1,SET,28,0.15269,0.0059582,0.16686,0.18008,BURTON_ADIPOGENESIS_1,0.899309323858743
GOBP_CONSTITUTIVE_SECRETORY_...,SET,7,0.30185,0.0058927,0.32996,0.18015,GOBP_CONSTITUTIVE_SECRETORY_PATHWAY,0.899309323858743
GSE33162_HDAC3_KO_VS_HDAC3_K...2,SET,181,0.054493,0.0053837,0.059569,0.18016,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP,0.899309323858743
HALLMARK_APICAL_SURFACE,SET,39,0.12676,0.0058357,0.13857,0.18017,HALLMARK_APICAL_SURFACE,0.899309323858743
FAN_EMBRYONIC_CTX_IN_3_INTER...,SET,5,0.37009,0.0061065,0.40469,0.18023,FAN_EMBRYONIC_CTX_IN_3_INTERNEURON,0.899309323858743
GOBP_RESPIRATORY_BURST,SET,30,0.14635,0.005911,0.16004,0.18024,GOBP_RESPIRATORY_BURST,0.899309323858743
HP_VERTEBRAL_SEGMENTATION_DE...,SET,131,0.067727,0.0057003,0.074061,0.18024,HP_VERTEBRAL_SEGMENTATION_DEFECT,0.899309323858743
GOBP_UDP_N_ACETYLGLUCOSAMINE...2,SET,14,0.21085,0.00582,0.23058,0.18025,GOBP_UDP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,0.899309323858743
GSE27859_MACROPHAGE_VS_DC_DN,SET,170,0.058954,0.0056464,0.064492,0.18033,GSE27859_MACROPHAGE_VS_DC_DN,0.899579323955792
HP_NON_MEDULLARY_THYROID_CAR...,SET,6,0.3386,0.0061199,0.37056,0.18043,HP_NON_MEDULLARY_THYROID_CARCINOMA,0.899931174698795
WP_VASOPRESSINREGULATED_WATE...,SET,43,0.11771,0.0056898,0.12885,0.18048,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,0.899931174698795
GOBP_C21_STEROID_HORMONE_MET...,SET,35,0.1455,0.0063465,0.15928,0.18051,GOBP_C21_STEROID_HORMONE_METABOLIC_PROCESS,0.899931174698795
GOBP_POSITIVE_REGULATION_OF_...189,SET,15,0.19269,0.0055054,0.21096,0.18052,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION,0.899931174698795
GSE43955_TH0_VS_TGFB_IL6_TH1...15,SET,189,0.056721,0.005725,0.0621,0.18053,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN,0.899931174698795
GSE13738_TCR_VS_BYSTANDER_AC...2,SET,178,0.057924,0.0056755,0.063427,0.18056,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,0.899951642047899
BIOCARTA_MPR_PATHWAY,SET,21,0.1709,0.0057764,0.18718,0.18062,BIOCARTA_MPR_PATHWAY,0.900121608832808
GOBP_POSITIVE_REGULATION_OF_...110,SET,24,0.15722,0.0056805,0.17223,0.18066,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.900191870967742
GOBP_MORPHOGENESIS_OF_AN_EPI...2,SET,22,0.18181,0.0062895,0.19919,0.1807,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_FOLD,0.900262112958715
GSE36527_CD62L_HIGH_VS_CD62L...1,SET,188,0.056415,0.0056792,0.061822,0.18075,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_DN,0.900382148487889
REACTOME_THE_RETINOID_CYCLE_...,SET,3,0.58257,0.0074461,0.63849,0.18078,REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION,0.900402536543422
MIR1265,SET,40,0.121,0.0056415,0.13264,0.18082,MIR1265,0.900472718154463
GTACAGG_MIR486,SET,53,0.10515,0.0056411,0.11529,0.18088,GTACAGG_MIR486,0.900490774617693
BAE_BRCA1_TARGETS_DN,SET,29,0.14668,0.0058248,0.16091,0.18101,BAE_BRCA1_TARGETS_DN,0.900490774617693
SALVADOR_MARTIN_PEDIATRIC_TB...1,SET,21,0.17219,0.0058199,0.18889,0.18101,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP,0.900490774617693
ZHONG_PFC_C6_DLX5_GAD1_GAD2_...,SET,13,0.22322,0.0059375,0.24491,0.18103,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.900490774617693
GOBP_REGULATION_OF_BIOMINERA...,SET,89,0.085832,0.0059613,0.094173,0.18104,GOBP_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.900490774617693
MORF_RFC1,SET,100,0.073308,0.0053953,0.080445,0.18108,MORF_RFC1,0.900490774617693
MORF_MSH2,SET,58,0.086915,0.0048773,0.095381,0.18109,MORF_MSH2,0.900490774617693
GOBP_MALE_GENITALIA_DEVELOPM...,SET,23,0.1735,0.0061367,0.19044,0.18114,GOBP_MALE_GENITALIA_DEVELOPMENT,0.900490774617693
HP_FOCAL_T2_HYPERINTENSE_BAS...,SET,23,0.15084,0.0053353,0.16559,0.18118,HP_FOCAL_T2_HYPERINTENSE_BASAL_GANGLIA_LESION,0.900490774617693
REACTOME_IKK_COMPLEX_RECRUIT...,SET,21,0.17202,0.0058143,0.18887,0.1812,REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,0.900490774617693
MIR381_5P,SET,7,0.27587,0.0053854,0.30293,0.18124,MIR381_5P,0.900490774617693
HP_ABNORMAL_LABIA_MINORA_MOR...,SET,34,0.14606,0.0062796,0.16039,0.18124,HP_ABNORMAL_LABIA_MINORA_MORPHOLOGY,0.900490774617693
GSE17721_CTRL_VS_LPS_1H_BMDC...2,SET,177,0.056472,0.0055179,0.062011,0.18124,GSE17721_CTRL_VS_LPS_1H_BMDC_UP,0.900490774617693
GOBP_LIVER_REGENERATION,SET,30,0.13839,0.0055893,0.15197,0.18126,GOBP_LIVER_REGENERATION,0.900490774617693
MODULE_148,SET,13,0.2424,0.0064475,0.26621,0.18128,MODULE_148,0.900490774617693
GOMF_METAL_CATION_MONOATOMIC...,SET,39,0.12307,0.0056659,0.13516,0.18128,GOMF_METAL_CATION_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,0.900490774617693
WP_MICROTUBULE_CYTOSKELETON_...,SET,48,0.10464,0.0053434,0.11493,0.18129,WP_MICROTUBULE_CYTOSKELETON_REGULATION,0.900490774617693
GOBP_APOLIPOPROTEIN_A_I_MEDI...,SET,5,0.36589,0.0060372,0.40186,0.18129,GOBP_APOLIPOPROTEIN_A_I_MEDIATED_SIGNALING_PATHWAY,0.900490774617693
HEBERT_MATRISOME_TNBC_BONE_B...1,SET,13,0.23032,0.0061263,0.25302,0.18135,HEBERT_MATRISOME_TNBC_BONE_BRAIN_LIVER_LUNG_METASTASTASES,0.900660081451843
GSE40274_FOXP3_VS_FOXP3_AND_...15,SET,151,0.062862,0.0056772,0.069081,0.18142,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.9008496
GARGALOVIC_RESPONSE_TO_OXIDI...18,SET,16,0.19252,0.0056807,0.21158,0.18144,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP,0.9008496
GSE9006_TYPE_1_DIABETES_AT_D...3,SET,172,0.055936,0.0053884,0.061493,0.18151,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN,0.90095997429673
GSE14769_UNSTIM_VS_360MIN_LP...2,SET,175,0.054386,0.0052842,0.059796,0.18154,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP,0.90095997429673
GSE24492_LYVE_NEG_VS_POS_MAC...1,SET,177,0.058825,0.0057478,0.064677,0.18154,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_DN,0.90095997429673
GOBP_STEM_CELL_FATE_SPECIFIC...,SET,6,0.37336,0.0067482,0.41067,0.18164,GOBP_STEM_CELL_FATE_SPECIFICATION,0.901031680696248
HP_ABNORMAL_SCAPULA_MORPHOLO...,SET,159,0.05992,0.0055518,0.065911,0.18165,HP_ABNORMAL_SCAPULA_MORPHOLOGY,0.901031680696248
HP_NONTUBERCULOUS_MYCOBACTER...,SET,19,0.18075,0.0058115,0.19883,0.18166,HP_NONTUBERCULOUS_MYCOBACTERIAL_PULMONARY_INFECTION,0.901031680696248
REACTOME_PRE_NOTCH_PROCESSIN...2,SET,6,0.25937,0.0046879,0.28536,0.1817,REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM,0.901031680696248
GOBP_EPITHELIAL_CELL_MATURAT...,SET,26,0.16059,0.0060386,0.17668,0.18171,GOBP_EPITHELIAL_CELL_MATURATION,0.901031680696248
HP_INTERNALLY_NUCLEATED_SKEL...,SET,6,0.34109,0.0061649,0.37528,0.18171,HP_INTERNALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS,0.901031680696248
GOBP_AUDITORY_RECEPTOR_CELL_...2,SET,19,0.18098,0.0058188,0.19916,0.18176,GOBP_AUDITORY_RECEPTOR_CELL_MORPHOGENESIS,0.901151041369472
HP_SMALL_PITUITARY_GLAND,SET,12,0.24003,0.0061344,0.26419,0.1818,HP_SMALL_PITUITARY_GLAND,0.901220795892169
MIR194_3P,SET,81,0.089292,0.0059176,0.09829,0.18183,MIR194_3P,0.901240965487735
HP_DIFFICULTY_WALKING,SET,277,0.04504,0.0054902,0.049594,0.1819,HP_DIFFICULTY_WALKING,0.901323230309073
MIR663B,SET,28,0.14673,0.0057256,0.16158,0.18192,MIR663B,0.901323230309073
GSE4748_LPS_VS_LPS_AND_CYANO...1,SET,142,0.061103,0.0053527,0.067304,0.18198,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,0.901323230309073
HAY_BONE_MARROW_CD34_POS_PRE...1,SET,80,0.091599,0.0060331,0.1009,0.18198,HAY_BONE_MARROW_CD34_POS_PRE_B,0.901323230309073
MIR4686,SET,74,0.086094,0.0054546,0.094837,0.18199,MIR4686,0.901323230309073
chr13q34,SET,34,0.21183,0.0091069,0.23336,0.18202,chr13q34,0.901323230309073
HE_LIM_SUN_FETAL_LUNG_C5_CD5...1,SET,46,0.11803,0.0059005,0.13004,0.18204,HE_LIM_SUN_FETAL_LUNG_C5_CD5_NEG_MATURE_B_CELL,0.901323230309073
REACTOME_NEGATIVE_REGULATORS...,SET,32,0.13222,0.0055151,0.14569,0.18206,REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,0.901323230309073
MIR660_5P,SET,68,0.095081,0.0057755,0.10477,0.18208,MIR660_5P,0.901323230309073
GOBP_REGULATION_OF_CHOLESTER...3,SET,32,0.13714,0.0057202,0.15114,0.18211,GOBP_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.901343356593563
HP_FOCAL_AUTONOMIC_SEIZURE,SET,11,0.2227,0.0054493,0.24547,0.18215,HP_FOCAL_AUTONOMIC_SEIZURE,0.901412964545066
GSE5589_LPS_VS_LPS_AND_IL10_...6,SET,184,0.05397,0.0053756,0.05951,0.18223,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP,0.901671135781383
MORF_RAD23A,SET,303,0.040409,0.005148,0.044563,0.18227,MORF_RAD23A,0.901671135781383
GOMF_POTASSIUM_PROTON_ANTIPO...,SET,12,0.22076,0.0056419,0.24347,0.18228,GOMF_POTASSIUM_PROTON_ANTIPORTER_ACTIVITY,0.901671135781383
HALLMARK_ANDROGEN_RESPONSE,SET,94,0.082308,0.0058741,0.090805,0.18236,HALLMARK_ANDROGEN_RESPONSE,0.901938494378825
MIR922,SET,180,0.055154,0.0054341,0.060868,0.18244,MIR922,0.902061882803632
TGTGTGA_MIR377,SET,182,0.056625,0.0056096,0.062492,0.18244,TGTGTGA_MIR377,0.902061882803632
HP_BREECH_PRESENTATION,SET,49,0.10443,0.0053874,0.1153,0.18256,HP_BREECH_PRESENTATION,0.902061882803632
HOLLEMAN_ASPARAGINASE_RESIST...2,SET,21,0.1735,0.0058643,0.19158,0.18257,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,0.902061882803632
REACTOME_SIGNALING_BY_NOTCH1...3,SET,7,0.25486,0.0049754,0.28141,0.18257,REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT,0.902061882803632
REACTOME_ACTIVATION_OF_SMO,SET,17,0.18862,0.0057367,0.20829,0.18259,REACTOME_ACTIVATION_OF_SMO,0.902061882803632
GOMF_IONOTROPIC_GLUTAMATE_RE...,SET,23,0.1579,0.0055851,0.17438,0.1826,GOMF_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING,0.902061882803632
REACTOME_SEMA3A_PAK_DEPENDEN...,SET,14,0.20091,0.0055457,0.22189,0.18262,REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION,0.902061882803632
GOBP_IMPORT_INTO_CELL,SET,844,0.027404,0.0057387,0.030269,0.18265,GOBP_IMPORT_INTO_CELL,0.902061882803632
GOBP_REGULATION_OF_PHOSPHOLI...2,SET,45,0.11564,0.0057179,0.12775,0.18268,GOBP_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,0.902061882803632
MIR4711_5P,SET,94,0.077901,0.0055596,0.086076,0.18273,MIR4711_5P,0.902061882803632
TORCHIA_TARGETS_OF_EWSR1_FLI...1,SET,291,0.046855,0.0058517,0.051773,0.18274,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,0.902061882803632
REACTOME_STAT3_NUCLEAR_EVENT...,SET,10,0.27191,0.006344,0.30053,0.1828,REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING,0.902061882803632
HP_ABNORMAL_BRAIN_LACTATE_LE...,SET,23,0.1548,0.0054753,0.17109,0.1828,HP_ABNORMAL_BRAIN_LACTATE_LEVEL_BY_MRS,0.902061882803632
GOBP_POSITIVE_REGULATION_OF_...65,SET,32,0.14863,0.0061993,0.1643,0.18284,GOBP_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.902061882803632
DIERICK_SEROTONIN_FUNCTION_G...,SET,7,0.26667,0.0052059,0.29482,0.18287,DIERICK_SEROTONIN_FUNCTION_GENES,0.902061882803632
MIKKELSEN_MCV6_LCP_WITH_H3K4...,SET,146,0.064899,0.0057641,0.071758,0.18289,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,0.902061882803632
REACTOME_GASTRIN_CREB_SIGNAL...,SET,17,0.18876,0.0057408,0.2087,0.18289,REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK,0.902061882803632
HP_RIGHT_VENTRICULAR_HYPERTR...,SET,25,0.14076,0.0051905,0.15565,0.18291,HP_RIGHT_VENTRICULAR_HYPERTROPHY,0.902061882803632
RB_P107_DN.V1_UP,SET,121,0.066262,0.0053613,0.073273,0.18292,RB_P107_DN.V1_UP,0.902061882803632
MIR4527,SET,64,0.095445,0.0056252,0.10555,0.18293,MIR4527,0.902061882803632
GSE5099_UNSTIM_VS_MCSF_TREAT...2,SET,177,0.055327,0.0054059,0.061191,0.18296,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP,0.902081827209533
GOBP_DNA_STRAND_INVASION,SET,6,0.30959,0.0055955,0.34248,0.18302,GOBP_DNA_STRAND_INVASION,0.902249659574468
GOBP_RESPONSE_TO_FOLLICLE_ST...,SET,15,0.21663,0.0061893,0.23969,0.18305,GOBP_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE,0.902269571691959
GOBP_REGULATION_OF_NEURON_AP...,SET,219,0.053775,0.0058378,0.059508,0.18309,GOBP_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.902338762053318
HP_APLASIA_HYPOPLASIA_OF_THE...2,SET,15,0.19342,0.0055262,0.21411,0.18317,HP_APLASIA_HYPOPLASIA_OF_THE_2ND_FINGER,0.902605040408337
GOMF_FUCOSE_BINDING,SET,8,0.28122,0.0058689,0.31135,0.18321,GOMF_FUCOSE_BINDING,0.902674163595123
GSE28737_BCL6_HET_VS_BCL6_KO...2,SET,179,0.054193,0.0053246,0.060009,0.18325,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP,0.902743267186393
GSE17721_LPS_VS_GARDIQUIMOD_...4,SET,184,0.055646,0.0055425,0.061641,0.18334,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP,0.902844021201414
HP_MICROPHALLUS,SET,14,0.21254,0.0058666,0.23548,0.18338,HP_MICROPHALLUS,0.902844021201414
GOBP_POSITIVE_REGULATION_OF_...38,SET,123,0.071589,0.0058397,0.079337,0.18344,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.902844021201414
HP_ABNORMALITY_OF_THE_MALE_G...,SET,1026,0.024102,0.005536,0.026711,0.18345,HP_ABNORMALITY_OF_THE_MALE_GENITALIA,0.902844021201414
HP_ERLENMEYER_FLASK_DEFORMIT...,SET,8,0.27539,0.0057471,0.3052,0.18345,HP_ERLENMEYER_FLASK_DEFORMITY_OF_THE_FEMURS,0.902844021201414
BIOCARTA_CBL_PATHWAY,SET,11,0.23035,0.0056366,0.25531,0.18346,BIOCARTA_CBL_PATHWAY,0.902844021201414
GOBP_RESPONSE_TO_MINERALOCOR...,SET,36,0.13397,0.0059264,0.14851,0.18351,GOBP_RESPONSE_TO_MINERALOCORTICOID,0.902844021201414
GGCNKCCATNK_UNKNOWN,SET,111,0.069574,0.0053932,0.077137,0.18355,GGCNKCCATNK_UNKNOWN,0.902844021201414
GOMF_LYSOPHOSPHATIDIC_ACID_B...,SET,7,0.2646,0.0051654,0.29346,0.18363,GOMF_LYSOPHOSPHATIDIC_ACID_BINDING,0.902844021201414
HP_SPLENIC_INFARCTION,SET,6,0.33433,0.0060428,0.37083,0.18365,HP_SPLENIC_INFARCTION,0.902844021201414
HALLMARK_TNFA_SIGNALING_VIA_...,SET,188,0.05982,0.0060221,0.06636,0.18368,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.902844021201414
GSE5099_MONOCYTE_VS_ALTERNAT...1,SET,166,0.054019,0.0051131,0.059929,0.1837,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN,0.902844021201414
HP_DOWNTURNED_CORNERS_OF_MOU...,SET,150,0.062827,0.0056554,0.069704,0.18371,HP_DOWNTURNED_CORNERS_OF_MOUTH,0.902844021201414
GOBP_DEOXYRIBONUCLEOTIDE_MET...,SET,42,0.11925,0.005697,0.13232,0.18374,GOBP_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,0.902844021201414
HP_MODERATELY_SHORT_STATURE,SET,4,0.3454,0.0050975,0.38326,0.18374,HP_MODERATELY_SHORT_STATURE,0.902844021201414
DURANTE_ADULT_OLFACTORY_NEUR...11,SET,163,0.05945,0.0055765,0.065973,0.18376,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.902844021201414
DEMAGALHAES_AGING_DN,SET,13,0.20098,0.0053459,0.22305,0.18378,DEMAGALHAES_AGING_DN,0.902844021201414
HP_ABNORMALITY_OF_THE_HUMERUS,SET,54,0.10891,0.0058975,0.12086,0.18378,HP_ABNORMALITY_OF_THE_HUMERUS,0.902844021201414
GOMF_C3HC4_TYPE_RING_FINGER_...,SET,6,0.29163,0.0052709,0.32366,0.18379,GOMF_C3HC4_TYPE_RING_FINGER_DOMAIN_BINDING,0.902844021201414
GSE3982_NEUTROPHIL_VS_NKCELL...2,SET,179,0.055831,0.0054856,0.061964,0.18379,GSE3982_NEUTROPHIL_VS_NKCELL_UP,0.902844021201414
GOMF_S_ADENOSYLMETHIONINE_DE...,SET,133,0.06115,0.0051856,0.067876,0.18383,GOMF_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY,0.902912895703788
GOBP_CARNITINE_METABOLIC_PRO...,SET,11,0.21185,0.0051838,0.23519,0.18386,GOBP_CARNITINE_METABOLIC_PROCESS,0.902932640949555
GOBP_TETRAPYRROLE_CATABOLIC_...,SET,13,0.20875,0.0055526,0.23179,0.18391,GOBP_TETRAPYRROLE_CATABOLIC_PROCESS,0.90305058632382
GOBP_ANTIGEN_PROCESSING_AND_...5,SET,45,0.12604,0.006232,0.14001,0.18401,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_ANTIGEN,0.903306058466318
NIKOLSKY_BREAST_CANCER_20Q11...,SET,31,0.24601,0.0101,0.2733,0.18403,NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON,0.903306058466318
GOMF_TROPOMYOSIN_BINDING,SET,14,0.18587,0.0051306,0.2065,0.18404,GOMF_TROPOMYOSIN_BINDING,0.903306058466318
GOCC_WEIBEL_PALADE_BODY,SET,5,0.32111,0.0052982,0.35681,0.18408,GOCC_WEIBEL_PALADE_BODY,0.90336506916996
MIR10A_3P,SET,20,0.16667,0.0054978,0.18524,0.18413,MIR10A_3P,0.90336506916996
DESCARTES_MAIN_FETAL_UNIPOLA...,SET,22,0.1797,0.0062164,0.19972,0.18413,DESCARTES_MAIN_FETAL_UNIPOLAR_BRUSH_CELLS,0.90336506916996
HP_NOCTURIA,SET,14,0.20569,0.0056776,0.22864,0.18416,HP_NOCTURIA,0.903384728299224
GOBP_POSITIVE_REGULATION_OF_...846,SET,8,0.30345,0.0063328,0.33735,0.18419,GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,0.903404381879763
NOJIMA_SFRP2_TARGETS_DN,SET,23,0.17603,0.0062262,0.19576,0.18428,NOJIMA_SFRP2_TARGETS_DN,0.903571192893401
MAINA_HYPOXIA_VHL_TARGETS_UP,SET,6,0.37786,0.0068294,0.42028,0.18432,MAINA_HYPOXIA_VHL_TARGETS_UP,0.903571192893401
GOBP_ANTIGEN_PROCESSING_AND_...10,SET,64,0.10495,0.0061852,0.11674,0.18434,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,0.903571192893401
GOCC_SIGNAL_PEPTIDASE_COMPLEX,SET,5,0.31801,0.0052471,0.35377,0.18435,GOCC_SIGNAL_PEPTIDASE_COMPLEX,0.903571192893401
DESCARTES_FETAL_HEART_ELF3_A...,SET,34,0.12931,0.0055594,0.14386,0.18437,DESCARTES_FETAL_HEART_ELF3_AGBL2_POSITIVE_CELLS,0.903571192893401
MORF_CUL1,SET,68,0.081399,0.0049445,0.090563,0.18438,MORF_CUL1,0.903571192893401
HP_INCREASED_CIRCULATING_CRE...,SET,3,0.56706,0.0072478,0.63105,0.18444,HP_INCREASED_CIRCULATING_CREATINE_KINASE_MB_ISOFORM,0.903737797828845
GSE5542_IFNG_VS_IFNA_TREATED...4,SET,175,0.054445,0.00529,0.06061,0.18452,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,0.903805259840314
SCHERER_PBMC_YF_VAX_AGE_18_4...2,SET,317,0.042979,0.0055983,0.04785,0.18454,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP,0.903805259840314
HP_APLASIA_HYPOPLASIA_OF_THE...42,SET,5,0.28841,0.0047587,0.3211,0.18455,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES,0.903805259840314
KEGG_MEDICUS_VARIANT_LOSS_OF...4,SET,12,0.23581,0.0060264,0.26257,0.18458,KEGG_MEDICUS_VARIANT_LOSS_OF_VHL_TO_HIF_1_SIGNALING_PATHWAY,0.903805259840314
GSE34156_UNTREATED_VS_6H_TLR...2,SET,172,0.059297,0.0057122,0.066047,0.18465,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.903805259840314
KEGG_MEDICUS_REFERENCE_RIG_I...1,SET,20,0.18795,0.0061998,0.20941,0.18473,KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY,0.903805259840314
GOMF_ISOMERASE_ACTIVITY,SET,158,0.05636,0.0052057,0.062799,0.18474,GOMF_ISOMERASE_ACTIVITY,0.903805259840314
GOBP_CELLULAR_RESPONSE_TO_OX...5,SET,21,0.1612,0.0054485,0.17963,0.18476,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_RADICAL,0.903805259840314
GOBP_NEGATIVE_REGULATION_OF_...413,SET,998,0.025363,0.0057501,0.028268,0.18481,GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS,0.903805259840314
WP_ARYLAMINE_METABOLISM,SET,6,0.40278,0.0072799,0.44899,0.18484,WP_ARYLAMINE_METABOLISM,0.903805259840314
GOBP_NEGATIVE_REGULATION_OF_...689,SET,8,0.27577,0.0057551,0.30748,0.1849,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.903805259840314
NUTT_GBM_VS_AO_GLIOMA_UP,SET,41,0.12164,0.0057416,0.13568,0.185,NUTT_GBM_VS_AO_GLIOMA_UP,0.903805259840314
GOBP_POSITIVE_REGULATION_OF_...474,SET,12,0.2121,0.0054206,0.23661,0.18502,GOBP_POSITIVE_REGULATION_OF_MITOPHAGY,0.903805259840314
GOBP_REGULATION_OF_NEUROMUSC...,SET,7,0.28537,0.0055709,0.31836,0.18503,GOBP_REGULATION_OF_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,0.903805259840314
HP_ABNORMALITY_OF_THE_VERTEB...1,SET,1337,0.021057,0.0054714,0.023496,0.18509,HP_ABNORMALITY_OF_THE_VERTEBRAL_COLUMN,0.903805259840314
GOBP_LYSOSOMAL_MEMBRANE_ORGA...,SET,15,0.19554,0.0055868,0.21821,0.1851,GOBP_LYSOSOMAL_MEMBRANE_ORGANIZATION,0.903805259840314
MIR1909_5P,SET,34,0.12589,0.0054122,0.14049,0.18511,MIR1909_5P,0.903805259840314
GOMF_K48_LINKED_DEUBIQUITINA...,SET,10,0.21538,0.005025,0.24036,0.18512,GOMF_K48_LINKED_DEUBIQUITINASE_ACTIVITY,0.903805259840314
GOBP_REGULATION_OF_RNA_SPLIC...,SET,161,0.055016,0.0051291,0.061401,0.18513,GOBP_REGULATION_OF_RNA_SPLICING,0.903805259840314
GOCC_NPBAF_COMPLEX,SET,14,0.18377,0.0050726,0.2051,0.18513,GOCC_NPBAF_COMPLEX,0.903805259840314
REACTOME_RAS_PROCESSING,SET,21,0.15619,0.0052791,0.17434,0.18516,REACTOME_RAS_PROCESSING,0.903805259840314
GOBP_REGULATION_OF_DNA_BIOSY...,SET,111,0.068772,0.005331,0.076765,0.18516,GOBP_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.903805259840314
GSE11924_TH1_VS_TH17_CD4_TCE...1,SET,186,0.053343,0.0053417,0.059546,0.18518,GSE11924_TH1_VS_TH17_CD4_TCELL_DN,0.903805259840314
MCCABE_HOXC6_TARGETS_UP,SET,7,0.27431,0.0053549,0.30628,0.18524,MCCABE_HOXC6_TARGETS_UP,0.903805259840314
KEGG_MISMATCH_REPAIR,SET,22,0.14188,0.0049083,0.15843,0.18525,KEGG_MISMATCH_REPAIR,0.903805259840314
KEGG_MEDICUS_REFERENCE_DYNEI...,SET,29,0.13927,0.0055303,0.1555,0.18525,KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE,0.903805259840314
GOMF_ACTIVE_TRANSMEMBRANE_TR...,SET,421,0.03724,0.005574,0.041584,0.18526,GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.903805259840314
GSE32986_CURDLAN_LOWDOSE_VS_...3,SET,180,0.053518,0.0052729,0.059779,0.18533,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.903805259840314
MIR181A_3P,SET,7,0.31248,0.0061002,0.34912,0.18538,MIR181A_3P,0.903805259840314
GOMF_OXYGEN_BINDING,SET,28,0.16017,0.0062499,0.17895,0.18539,GOMF_OXYGEN_BINDING,0.903805259840314
GOBP_COMPLEMENT_ACTIVATION_C...,SET,29,0.1611,0.0063972,0.18,0.1854,GOBP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY,0.903805259840314
ANDERSON_BLOOD_CN54GP140_ADJ...2,SET,63,0.09649,0.0056423,0.10781,0.18541,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_UP,0.903805259840314
KEGG_AXON_GUIDANCE,SET,122,0.071006,0.0057687,0.079351,0.18545,KEGG_AXON_GUIDANCE,0.903805259840314
REACTOME_SRP_DEPENDENT_COTRA...,SET,102,0.071733,0.0053317,0.080178,0.18549,REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.903805259840314
HP_ABNORMAL_PLATELET_MEMBRAN...,SET,6,0.31744,0.0057375,0.35485,0.18551,HP_ABNORMAL_PLATELET_MEMBRANE_PROTEIN_EXPRESSION,0.903805259840314
FEKIR_HEPARG_SIDE_POP_VS_HEP...1,SET,77,0.085211,0.0055065,0.095254,0.18552,FEKIR_HEPARG_SIDE_POP_VS_HEPARG_DN,0.903805259840314
GSE6269_E_COLI_VS_STREP_PNEU...2,SET,145,0.064347,0.0056957,0.071933,0.18552,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP,0.903805259840314
CAMP_UP.V1_DN,SET,178,0.056963,0.0055814,0.063683,0.18554,CAMP_UP.V1_DN,0.903805259840314
MARKEY_RB1_CHRONIC_LOF_DN,SET,107,0.076842,0.0058489,0.085922,0.18558,MARKEY_RB1_CHRONIC_LOF_DN,0.903805259840314
GOBP_POSITIVE_REGULATION_OF_...461,SET,6,0.2683,0.0048493,0.3,0.18558,GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_NUCLEATION,0.903805259840314
MIR3189_3P,SET,69,0.086724,0.0053064,0.096976,0.18559,MIR3189_3P,0.903805259840314
HUMMEL_BURKITTS_LYMPHOMA_DN,SET,14,0.22026,0.0060797,0.24631,0.1856,HUMMEL_BURKITTS_LYMPHOMA_DN,0.903805259840314
HALLMARK_COAGULATION,SET,127,0.070724,0.0058615,0.079086,0.1856,HALLMARK_COAGULATION,0.903805259840314
HP_ABNORMAL_BLOOD_UREA_NITRO...,SET,17,0.18077,0.005498,0.20216,0.18561,HP_ABNORMAL_BLOOD_UREA_NITROGEN_CONCENTRATION,0.903805259840314
KEGG_PATHWAYS_IN_CANCER,SET,310,0.044245,0.0057004,0.049487,0.18565,KEGG_PATHWAYS_IN_CANCER,0.903805259840314
REACTOME_NUCLEAR_ENVELOPE_NE...,SET,71,0.086921,0.0053947,0.097219,0.18565,REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY,0.903805259840314
REACTOME_METABOLISM_OF_PORPH...,SET,26,0.14975,0.005631,0.16757,0.18576,REACTOME_METABOLISM_OF_PORPHYRINS,0.904087494748635
GOCC_DOPAMINERGIC_SYNAPSE,SET,13,0.19736,0.0052495,0.22084,0.18576,GOCC_DOPAMINERGIC_SYNAPSE,0.904087494748635
GSE2770_UNTREATED_VS_IL12_TR...6,SET,177,0.056886,0.0055583,0.06367,0.18581,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.904184445843829
GOBP_REGULATION_OF_STEROL_TR...,SET,53,0.10482,0.0056233,0.11733,0.18584,GOBP_REGULATION_OF_STEROL_TRANSPORT,0.904184445843829
GSE40274_IRF4_VS_FOXP3_AND_I...1,SET,102,0.077408,0.0057535,0.086667,0.18589,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.904184445843829
MIR21_5P,SET,133,0.066323,0.0056243,0.074259,0.1859,MIR21_5P,0.904184445843829
GSE37301_LYMPHOID_PRIMED_MPP...6,SET,180,0.055391,0.0054574,0.062022,0.18591,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP,0.904184445843829
HP_SUPRAVENTRICULAR_ARRHYTHM...,SET,111,0.076332,0.0059171,0.085498,0.18599,HP_SUPRAVENTRICULAR_ARRHYTHMIA,0.904417676273083
HP_ABNORMAL_VERTEBRAL_MORPHO...,SET,421,0.036358,0.0054419,0.040726,0.18601,HP_ABNORMAL_VERTEBRAL_MORPHOLOGY,0.904417676273083
GAZDA_DIAMOND_BLACKFAN_ANEMI...3,SET,30,0.14042,0.0056713,0.15742,0.1862,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,0.90476489673458
HP_INAPPROPRIATE_LAUGHTER,SET,27,0.14679,0.0056247,0.16457,0.18622,HP_INAPPROPRIATE_LAUGHTER,0.90476489673458
HP_RESTRICTIVE_BEHAVIOR,SET,12,0.21448,0.0054813,0.24048,0.18623,HP_RESTRICTIVE_BEHAVIOR,0.90476489673458
GOBP_REGULATION_OF_PROTEIN_U...,SET,165,0.058019,0.0054752,0.065064,0.18628,GOBP_REGULATION_OF_PROTEIN_UBIQUITINATION,0.90476489673458
MIR152_3P,SET,314,0.043212,0.0056024,0.048464,0.1863,MIR152_3P,0.90476489673458
GOBP_REGULATION_OF_T_CELL_MI...,SET,44,0.11622,0.0056824,0.13039,0.18638,GOBP_REGULATION_OF_T_CELL_MIGRATION,0.90476489673458
KEGG_MEDICUS_PATHOGEN_YERSIN...1,SET,5,0.33806,0.0055779,0.37931,0.1864,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPH_TO_TCR_NFAT_SIGNALING_PATHWAY,0.90476489673458
GOBP_NEGATIVE_REGULATION_OF_...452,SET,7,0.27569,0.0053819,0.30933,0.18641,GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.90476489673458
GSE9988_LPS_VS_LOW_LPS_MONOC...2,SET,137,0.06476,0.0055731,0.072663,0.18641,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP,0.90476489673458
HP_PROTEIN_LOSING_ENTEROPATHY,SET,20,0.16463,0.0054306,0.18475,0.18644,HP_PROTEIN_LOSING_ENTEROPATHY,0.90476489673458
GOBP_CELL_SUBSTRATE_JUNCTION...2,SET,100,0.074994,0.0055194,0.084161,0.18645,GOBP_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.90476489673458
GSE22935_WT_VS_MYD88_KO_MACR...1,SET,186,0.055827,0.0055903,0.062652,0.18645,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN,0.90476489673458
KEGG_MEDICUS_REFERENCE_DEPHO...,SET,12,0.20856,0.0053301,0.23412,0.18651,KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE,0.90476489673458
GOBP_DETECTION_OF_OTHER_ORGA...,SET,17,0.1903,0.0057878,0.21361,0.18651,GOBP_DETECTION_OF_OTHER_ORGANISM,0.90476489673458
FRANCO_BLOOD_SANOFI_PASTEUR_...6,SET,119,0.070652,0.0056694,0.079308,0.18651,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE,0.90476489673458
GOBP_POSITIVE_REGULATION_OF_...554,SET,7,0.31237,0.006098,0.35065,0.18652,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.90476489673458
GOMF_DIOXYGENASE_ACTIVITY,SET,82,0.077383,0.0051598,0.08687,0.18653,GOMF_DIOXYGENASE_ACTIVITY,0.90476489673458
GOMF_TRNA_PSEUDOURIDINE_SYNT...,SET,8,0.23139,0.0048289,0.25978,0.18655,GOMF_TRNA_PSEUDOURIDINE_SYNTHASE_ACTIVITY,0.90476489673458
GSE40274_XBP1_VS_FOXP3_AND_X...1,SET,180,0.052697,0.005192,0.059185,0.18664,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.905075094181666
TTCNRGNNNNTTC_HSF_Q6,SET,137,0.064393,0.0055415,0.072345,0.18671,TTCNRGNNNNTTC_HSF_Q6,0.905103367731139
GOBP_GOLGI_RIBBON_FORMATION,SET,11,0.24091,0.0058949,0.27067,0.18673,GOBP_GOLGI_RIBBON_FORMATION,0.905103367731139
HP_NAUSEA,SET,91,0.076297,0.005358,0.085731,0.18675,HP_NAUSEA,0.905103367731139
GSE3920_UNTREATED_VS_IFNA_TR...4,SET,158,0.060222,0.0055623,0.067668,0.18675,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP,0.905103367731139
GSE17721_CTRL_VS_CPG_2H_BMDC...1,SET,189,0.056096,0.005662,0.063048,0.18681,GSE17721_CTRL_VS_CPG_2H_BMDC_DN,0.905180048780488
GOBP_REGULATION_OF_MITOTIC_C...1,SET,472,0.034267,0.005423,0.038519,0.18685,GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE,0.905180048780488
GOMF_PEPTIDOGLYCAN_BINDING,SET,18,0.19548,0.0061177,0.21976,0.18686,GOMF_PEPTIDOGLYCAN_BINDING,0.905180048780488
GSE27786_LSK_VS_CD8_TCELL_DN,SET,182,0.05384,0.0053337,0.060528,0.18687,GSE27786_LSK_VS_CD8_TCELL_DN,0.905180048780488
GSE17721_LPS_VS_POLYIC_1H_BM...2,SET,177,0.056928,0.0055624,0.064014,0.18693,GSE17721_LPS_VS_POLYIC_1H_BMDC_UP,0.90526678277832
GOBP_REGULATION_OF_SEQUESTER...,SET,14,0.21402,0.0059075,0.24067,0.18694,GOBP_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.90526678277832
GOBP_PROTEIN_TRANSMEMBRANE_I...,SET,33,0.12396,0.0052504,0.13944,0.18701,GOBP_PROTEIN_TRANSMEMBRANE_IMPORT_INTO_INTRACELLULAR_ORGANELLE,0.905474458182828
GOMF_INTRAMOLECULAR_OXIDORED...3,SET,15,0.18932,0.0054091,0.21305,0.1871,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_C_C_BONDS,0.905474458182828
GOMF_ANTIGEN_BINDING,SET,63,0.1084,0.0063386,0.12202,0.18717,GOMF_ANTIGEN_BINDING,0.905474458182828
BIOCARTA_NOTCH_PATHWAY,SET,6,0.25898,0.0046809,0.29153,0.18718,BIOCARTA_NOTCH_PATHWAY,0.905474458182828
GOBP_INTERFERON_ALPHA_PRODUC...,SET,26,0.13569,0.0051026,0.15276,0.1872,GOBP_INTERFERON_ALPHA_PRODUCTION,0.905474458182828
HP_ABNORMAL_CIRCULATING_C_RE...,SET,59,0.096575,0.0054657,0.10874,0.18724,HP_ABNORMAL_CIRCULATING_C_REACTIVE_PROTEIN_CONCENTRATION,0.905474458182828
DESCARTES_FETAL_STOMACH_LYMP...2,SET,68,0.093395,0.0056732,0.10517,0.18726,DESCARTES_FETAL_STOMACH_LYMPHOID_CELLS,0.905474458182828
GOBP_MEIOTIC_METAPHASE_CHROM...,SET,3,0.4026,0.0051458,0.45341,0.18729,GOBP_MEIOTIC_METAPHASE_CHROMOSOME_ALIGNMENT,0.905474458182828
BUSSLINGER_GASTRIC_ISTHMUS_C...,SET,428,0.036628,0.0055267,0.041249,0.18729,BUSSLINGER_GASTRIC_ISTHMUS_CELLS,0.905474458182828
HP_PETECHIAE,SET,54,0.10471,0.0056702,0.11793,0.18731,HP_PETECHIAE,0.905474458182828
SEIDEN_ONCOGENESIS_BY_MET,SET,79,0.082339,0.0053893,0.092749,0.18734,SEIDEN_ONCOGENESIS_BY_MET,0.905474458182828
LIN_MELANOMA_COPY_NUMBER_UP,SET,65,0.09841,0.0058449,0.11088,0.18739,LIN_MELANOMA_COPY_NUMBER_UP,0.905474458182828
PID_EPHA_FWDPATHWAY,SET,34,0.13557,0.0058284,0.15274,0.18739,PID_EPHA_FWDPATHWAY,0.905474458182828
GOBP_METHIONINE_METABOLIC_PR...,SET,15,0.19638,0.0056107,0.22126,0.18739,GOBP_METHIONINE_METABOLIC_PROCESS,0.905474458182828
BLANCO_MELO_INFLUENZA_A_INFE...2,SET,37,0.12695,0.0056932,0.14305,0.18742,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,0.905474458182828
BIOCARTA_NDKDYNAMIN_PATHWAY,SET,17,0.18487,0.0056226,0.20832,0.18744,BIOCARTA_NDKDYNAMIN_PATHWAY,0.905474458182828
GOBP_NEGATIVE_REGULATION_OF_...195,SET,17,0.16982,0.0051649,0.19139,0.18746,GOBP_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,0.905474458182828
GOBP_MITOTIC_CELL_CYCLE_CHEC...,SET,134,0.06108,0.0051989,0.068843,0.18748,GOBP_MITOTIC_CELL_CYCLE_CHECKPOINT_SIGNALING,0.905474458182828
GOBP_REGULATION_OF_T_HELPER_...7,SET,42,0.12103,0.0057819,0.13642,0.1875,GOBP_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,0.905474458182828
GOBP_REGULATION_OF_GRANULOCY...1,SET,47,0.11563,0.0058425,0.13034,0.18751,GOBP_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,0.905474458182828
GSE26669_CTRL_VS_COSTIM_BLOC...2,SET,186,0.053223,0.0053296,0.06,0.18753,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP,0.905474458182828
GOBP_HYDROGEN_PEROXIDE_METAB...,SET,46,0.11589,0.0057934,0.1307,0.18763,GOBP_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,0.905654563106796
WP_PHYSICOCHEMICAL_FEATURES_...,SET,62,0.096359,0.0055899,0.10868,0.18764,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,0.905654563106796
GOBP_NEGATIVE_REGULATION_OF_...617,SET,7,0.30233,0.0059021,0.34106,0.18769,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,0.905654563106796
HP_CEREBRAL_CAVERNOUS_MALFOR...,SET,5,0.29065,0.0047956,0.3279,0.18771,HP_CEREBRAL_CAVERNOUS_MALFORMATION,0.905654563106796
ATM_TARGET_GENES,SET,11,0.24437,0.0059795,0.27573,0.18775,ATM_TARGET_GENES,0.905654563106796
MODULE_95,SET,485,0.035072,0.0056244,0.039578,0.18777,MODULE_95,0.905654563106796
GNF2_PAK2,SET,25,0.13522,0.004986,0.15262,0.18783,GNF2_PAK2,0.905654563106796
GSE22432_MULTIPOTENT_VS_COMM...2,SET,174,0.053891,0.0052213,0.060828,0.18783,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN,0.905654563106796
GOBP_POSITIVE_REGULATION_OF_...334,SET,5,0.34411,0.0056777,0.38844,0.18785,GOBP_POSITIVE_REGULATION_OF_HEPATIC_STELLATE_CELL_ACTIVATION,0.905654563106796
HP_IMPAIRED_PAIN_SENSATION,SET,65,0.093468,0.0055514,0.10551,0.18786,HP_IMPAIRED_PAIN_SENSATION,0.905654563106796
PSMB5_TARGET_GENES,SET,196,0.054655,0.0056167,0.061704,0.18788,PSMB5_TARGET_GENES,0.905654563106796
GAVISH_3CA_METAPROGRAM_MACRO...5,SET,47,0.11783,0.0059538,0.13303,0.18788,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_2,0.905654563106796
MODULE_186,SET,19,0.18175,0.0058435,0.20526,0.18796,MODULE_186,0.905914547219526
GSE13306_RA_VS_UNTREATED_MEM...2,SET,189,0.053693,0.0054195,0.060653,0.18802,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP,0.905980579710145
HP_ST_SEGMENT_DEPRESSION,SET,13,0.23327,0.0062047,0.26352,0.18804,HP_ST_SEGMENT_DEPRESSION,0.905980579710145
GOBP_POSITIVE_REGULATION_OF_...101,SET,10,0.28257,0.0065927,0.31926,0.18806,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.905980579710145
GOBP_HYALURONAN_METABOLIC_PR...,SET,32,0.13237,0.0055212,0.14958,0.18811,GOBP_HYALURONAN_METABOLIC_PROCESS,0.905980579710145
GSE44649_NAIVE_VS_ACTIVATED_...4,SET,186,0.054717,0.0054793,0.061836,0.18812,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,0.905980579710145
GOBP_REGULATION_OF_EPITHELIA...2,SET,144,0.067739,0.0059754,0.076562,0.18815,GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,0.905980579710145
GOCC_PLATELET_ALPHA_GRANULE,SET,81,0.086554,0.0057362,0.097831,0.18816,GOCC_PLATELET_ALPHA_GRANULE,0.905980579710145
FISCHER_DREAM_TARGETS,SET,860,0.024791,0.0052381,0.028026,0.18821,FISCHER_DREAM_TARGETS,0.905980579710145
REACTOME_INTERLEUKIN_9_SIGNA...,SET,7,0.35953,0.0070186,0.40657,0.18827,REACTOME_INTERLEUKIN_9_SIGNALING,0.905980579710145
GOCC_FAR_SIN_STRIPAK_COMPLEX,SET,16,0.18938,0.0055881,0.21417,0.18828,GOCC_FAR_SIN_STRIPAK_COMPLEX,0.905980579710145
MIR6732_5P,SET,25,0.1503,0.0055421,0.17001,0.18833,MIR6732_5P,0.905980579710145
GOBP_INNATE_IMMUNE_RESPONSE_...1,SET,88,0.080827,0.0055822,0.091426,0.18833,GOBP_INNATE_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.905980579710145
GOBP_MYELIN_MAINTENANCE,SET,15,0.18981,0.005423,0.21472,0.18835,GOBP_MYELIN_MAINTENANCE,0.905980579710145
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...2,SET,6,0.27478,0.0049665,0.31086,0.18837,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_I_PROTEIN_COMPLEX,0.905980579710145
PID_INTEGRIN3_PATHWAY,SET,39,0.1314,0.0060495,0.14866,0.18838,PID_INTEGRIN3_PATHWAY,0.905980579710145
GSE21927_GMCSF_IL6_VS_GMCSF_...2,SET,144,0.059364,0.0052366,0.067181,0.18845,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,0.905980579710145
WP_GLP1_SECRETION_FROM_INTES...,SET,5,0.38419,0.006339,0.4349,0.18852,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,0.905980579710145
HP_ESOPHAGEAL_STRICTURE,SET,19,0.16888,0.0054299,0.19119,0.18854,HP_ESOPHAGEAL_STRICTURE,0.905980579710145
GOBP_IMMUNE_RESPONSE_TO_TUMO...,SET,24,0.17027,0.006152,0.19277,0.18855,GOBP_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.905980579710145
GSE23321_CD8_STEM_CELL_MEMOR...6,SET,167,0.057684,0.0054763,0.065308,0.18855,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.905980579710145
GOMF_MHC_CLASS_II_PROTEIN_CO...,SET,23,0.16479,0.0058288,0.18659,0.18857,GOMF_MHC_CLASS_II_PROTEIN_COMPLEX_BINDING,0.905980579710145
HP_ABNORMAL_AFFECT,SET,37,0.13398,0.0060082,0.15173,0.18863,HP_ABNORMAL_AFFECT,0.905980579710145
MIR6857_3P,SET,68,0.094085,0.005715,0.10656,0.18865,MIR6857_3P,0.905980579710145
GOBP_CELLULAR_RESPONSE_TO_UV...2,SET,10,0.22868,0.0053353,0.25902,0.18866,GOBP_CELLULAR_RESPONSE_TO_UV_B,0.905980579710145
HP_PERITONITIS,SET,41,0.11428,0.005394,0.12944,0.18866,HP_PERITONITIS,0.905980579710145
GOBP_REGULATION_OF_SNRNA_TRA...,SET,5,0.27784,0.0045843,0.31476,0.1887,GOBP_REGULATION_OF_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.905980579710145
GSE33162_UNTREATED_VS_4H_LPS...2,SET,183,0.054413,0.0054051,0.061642,0.1887,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP,0.905980579710145
MIR5010_3P,SET,269,0.045958,0.0055219,0.052074,0.18874,MIR5010_3P,0.905980579710145
DESCARTES_FETAL_HEART_SMOOTH...,SET,36,0.13389,0.0059227,0.1517,0.18874,DESCARTES_FETAL_HEART_SMOOTH_MUSCLE_CELLS,0.905980579710145
GOBP_REGULATION_OF_PROTEIN_K...2,SET,12,0.21943,0.0056077,0.24869,0.1888,GOBP_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.905980579710145
HP_GRANULOCYTOPENIA,SET,6,0.2928,0.005292,0.33185,0.18881,HP_GRANULOCYTOPENIA,0.905980579710145
HOLLEMAN_PREDNISOLONE_RESIST...4,SET,16,0.16011,0.0047245,0.18148,0.18882,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP,0.905980579710145
MODULE_301,SET,136,0.064635,0.0055421,0.073267,0.18884,MODULE_301,0.905980579710145
GSE2706_LPS_VS_R848_AND_LPS_...4,SET,166,0.056616,0.0053588,0.064181,0.18886,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP,0.905980579710145
GSE21546_ELK1_KO_VS_SAP1A_KO...4,SET,172,0.055376,0.0053345,0.062795,0.18893,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.906133050496689
BAKER_HEMATOPOESIS_STAT5_TAR...,SET,7,0.33025,0.006447,0.37451,0.18895,BAKER_HEMATOPOESIS_STAT5_TARGETS,0.906133050496689
GSE12963_UNINF_VS_ENV_AND_NE...3,SET,129,0.066653,0.0055672,0.075595,0.18897,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.906133050496689
GSE32423_MEMORY_VS_NAIVE_CD8...6,SET,184,0.055705,0.0055484,0.063186,0.189,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.906151883018347
QUEREC_MODEL_PBMC_YF_17D_VAC...1,SET,46,0.10563,0.0052803,0.11984,0.18906,QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_PREDICTIVE,0.906314524137931
GSE27786_BCELL_VS_ERYTHROBLA...1,SET,178,0.056716,0.0055572,0.064363,0.18911,GSE27786_BCELL_VS_ERYTHROBLAST_DN,0.906350248036379
GOBP_REGULATION_OF_FLAGELLAT...,SET,18,0.17953,0.0056183,0.20375,0.18913,GOBP_REGULATION_OF_FLAGELLATED_SPERM_MOTILITY,0.906350248036379
WP_MFAP5MEDIATED_OVARIAN_CAN...,SET,12,0.22257,0.0056882,0.25265,0.18917,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,0.906350248036379
ROSS_AML_WITH_PML_RARA_FUSION,SET,69,0.084993,0.0052005,0.096483,0.18919,ROSS_AML_WITH_PML_RARA_FUSION,0.906350248036379
GOBP_SUCKLING_BEHAVIOR,SET,11,0.22592,0.0055279,0.25652,0.18924,GOBP_SUCKLING_BEHAVIOR,0.906350248036379
WP_PREIMPLANTATION_EMBRYO,SET,54,0.10365,0.0056127,0.11769,0.18925,WP_PREIMPLANTATION_EMBRYO,0.906350248036379
GOBP_NEGATIVE_REGULATION_OF_...17,SET,13,0.21161,0.0056287,0.24028,0.18925,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,0.906350248036379
MIR7977,SET,207,0.051427,0.0054296,0.058417,0.18934,MIR7977,0.906550185950413
GOBP_CARDIAC_NEURAL_CREST_CE...3,SET,10,0.27715,0.0064662,0.31485,0.18936,GOBP_CARDIAC_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS,0.906550185950413
GOBP_MULTICELLULAR_ORGANISMA...6,SET,819,0.026161,0.0054005,0.029719,0.18937,GOBP_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_PROCESS,0.906550185950413
GOBP_IMMUNE_COMPLEX_CLEARANCE,SET,5,0.38699,0.0063852,0.43969,0.1894,GOBP_IMMUNE_COMPLEX_CLEARANCE,0.906568929899463
GSE22886_DAY1_VS_DAY7_MONOCY...1,SET,176,0.053848,0.0052467,0.061193,0.18944,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN,0.906635527402919
CEBP_01,SET,238,0.050702,0.005735,0.057642,0.18954,CEBP_01,0.906989219330855
WP_PILOCYTIC_ASTROCYTOMA,SET,6,0.24914,0.0045031,0.28329,0.18958,WP_PILOCYTIC_ASTROCYTOMA,0.907055740638766
WP_TCA_CYCLE_IN_SENESCENCE,SET,9,0.26469,0.0058587,0.30113,0.18971,WP_TCA_CYCLE_IN_SENESCENCE,0.907462463907603
MIR384,SET,109,0.070362,0.0054052,0.080057,0.18973,MIR384,0.907462463907603
MIR568,SET,239,0.048539,0.0055017,0.055235,0.18977,MIR568,0.907462463907603
GOCC_MYOSIN_II_COMPLEX,SET,25,0.15893,0.0058606,0.18086,0.18977,GOCC_MYOSIN_II_COMPLEX,0.907462463907603
MIR3691_5P,SET,40,0.11699,0.0054547,0.13317,0.18983,MIR3691_5P,0.907462463907603
MODULE_50,SET,13,0.17395,0.0046268,0.19801,0.18985,MODULE_50,0.907462463907603
HP_ABNORMAL_DELIVERY,SET,87,0.076704,0.0052674,0.087319,0.18986,HP_ABNORMAL_DELIVERY,0.907462463907603
REACTOME_NGF_STIMULATED_TRAN...,SET,38,0.1246,0.0056624,0.14186,0.18989,REACTOME_NGF_STIMULATED_TRANSCRIPTION,0.907462463907603
KEGG_MEDICUS_REFERENCE_ANTER...,SET,23,0.15472,0.0054726,0.17616,0.1899,KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT,0.907462463907603
GSE12366_PLASMA_CELL_VS_MEMO...2,SET,168,0.057036,0.0054307,0.064949,0.18993,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP,0.907481048941435
GOBP_POSITIVE_REGULATION_OF_...3,SET,57,0.099303,0.0055243,0.11313,0.19004,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.90788181443299
GSE22140_GERMFREE_VS_SPF_MOU...2,SET,184,0.055251,0.0055032,0.062953,0.19007,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP,0.907900336723474
XU_GH1_AUTOCRINE_TARGETS_DN,SET,117,0.070472,0.0056075,0.080323,0.19015,XU_GH1_AUTOCRINE_TARGETS_DN,0.908146860832532
BREDEMEYER_RAG_SIGNALING_VIA...2,SET,46,0.11601,0.0057995,0.13225,0.19019,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,0.908146860832532
PUJANA_ATM_PCC_NETWORK,SET,1242,0.020782,0.0052192,0.023692,0.1902,PUJANA_ATM_PCC_NETWORK,0.908146860832532
BIOCARTA_PLATELETAPP_PATHWAY,SET,11,0.22068,0.0053998,0.25164,0.19026,BIOCARTA_PLATELETAPP_PATHWAY,0.908183807169345
HP_SYNOSTOSIS_OF_CARPAL_BONES,SET,23,0.16783,0.0059364,0.19138,0.19026,HP_SYNOSTOSIS_OF_CARPAL_BONES,0.908183807169345
CHANDRAN_METASTASIS_UP,SET,176,0.054997,0.0053587,0.06272,0.19029,CHANDRAN_METASTASIS_UP,0.908202272727273
ZWANG_CLASS_2_TRANSIENTLY_IN...,SET,47,0.10976,0.0055463,0.1252,0.19032,ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,0.908220733214335
GOCC_TIM22_MITOCHONDRIAL_IMP...,SET,6,0.29897,0.0054036,0.34106,0.19036,GOCC_TIM22_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_INSERTION_COMPLEX,0.908286902800659
GSE10147_IL3_VS_IL3_AND_HIVP...1,SET,131,0.066322,0.005582,0.075736,0.1906,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN,0.908518677730921
REACTOME_DEGRADATION_OF_CYST...,SET,14,0.19852,0.0054797,0.22673,0.19063,REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE,0.908518677730921
ZNF138_TARGET_GENES,SET,3,0.36514,0.004667,0.41705,0.19065,ZNF138_TARGET_GENES,0.908518677730921
HALLMARK_ESTROGEN_RESPONSE_E...,SET,187,0.058024,0.0058259,0.066273,0.19065,HALLMARK_ESTROGEN_RESPONSE_EARLY,0.908518677730921
GOBP_THYROID_HORMONE_TRANSPO...,SET,10,0.23493,0.0054812,0.26837,0.19068,GOBP_THYROID_HORMONE_TRANSPORT,0.908518677730921
GOCC_EXTRINSIC_COMPONENT_OF_...4,SET,22,0.1538,0.0053205,0.17569,0.19068,GOCC_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE,0.908518677730921
GOBP_KERATINOCYTE_DIFFERENTI...,SET,161,0.067454,0.0062887,0.077058,0.19069,GOBP_KERATINOCYTE_DIFFERENTIATION,0.908518677730921
HP_APLASIA_HYPOPLASIA_OF_THE...56,SET,200,0.053107,0.0055124,0.060679,0.19074,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HAND,0.908518677730921
GSE40274_CTRL_VS_IRF4_TRANSD...1,SET,151,0.060019,0.0054205,0.068585,0.19076,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.908518677730921
REACTOME_RHOC_GTPASE_CYCLE,SET,68,0.092605,0.0056251,0.10583,0.19079,REACTOME_RHOC_GTPASE_CYCLE,0.908518677730921
MURARO_PANCREAS_MESENCHYMAL_...,SET,620,0.0314,0.0056718,0.035889,0.19081,MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL,0.908518677730921
HP_CEREBELLAR_HEMISPHERE_HYP...,SET,8,0.23222,0.0048461,0.26548,0.19087,HP_CEREBELLAR_HEMISPHERE_HYPOPLASIA,0.908518677730921
GOBP_URINARY_BLADDER_SMOOTH_...,SET,7,0.29753,0.0058082,0.34015,0.19088,GOBP_URINARY_BLADDER_SMOOTH_MUSCLE_CONTRACTION,0.908518677730921
GSE3982_EOSINOPHIL_VS_TH1_DN,SET,178,0.052883,0.0051815,0.060464,0.1909,GSE3982_EOSINOPHIL_VS_TH1_DN,0.908518677730921
HP_SKIN_PICKING,SET,12,0.22582,0.0057713,0.25825,0.19094,HP_SKIN_PICKING,0.908518677730921
LINDGREN_BLADDER_CANCER_WITH...,SET,103,0.076874,0.0057415,0.087924,0.19098,LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,0.908518677730921
MIR661,SET,146,0.06149,0.0054613,0.070341,0.19102,MIR661,0.908518677730921
HP_FOCAL_AUTOMATISM_SEIZURE,SET,12,0.20531,0.0052469,0.23486,0.19102,HP_FOCAL_AUTOMATISM_SEIZURE,0.908518677730921
GSE360_CTRL_VS_B_MALAYI_HIGH...1,SET,177,0.054812,0.0053556,0.062715,0.19107,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.908518677730921
GSE41867_DAY8_EFFECTOR_VS_DA...2,SET,174,0.055282,0.005356,0.063254,0.19107,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,0.908518677730921
GOCC_BLEB,SET,9,0.24684,0.0054636,0.28254,0.19116,GOCC_BLEB,0.908518677730921
GSE36078_UNTREATED_VS_AD5_IN...2,SET,182,0.052654,0.0052163,0.060273,0.19117,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP,0.908518677730921
LEE_LIVER_CANCER_E2F1_DN,SET,59,0.10364,0.0058658,0.11865,0.1912,LEE_LIVER_CANCER_E2F1_DN,0.908518677730921
MODULE_199,SET,52,0.11089,0.0058929,0.12695,0.19121,MODULE_199,0.908518677730921
GOMF_NFAT_PROTEIN_BINDING,SET,5,0.3283,0.0054169,0.37588,0.19122,GOMF_NFAT_PROTEIN_BINDING,0.908518677730921
PHONG_TNF_RESPONSE_VIA_P38_C...,SET,213,0.049815,0.0053341,0.057034,0.19123,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,0.908518677730921
HP_ABNORMAL_LARYNX_PHYSIOLOGY,SET,43,0.10781,0.005211,0.12343,0.19123,HP_ABNORMAL_LARYNX_PHYSIOLOGY,0.908518677730921
GOBP_PURINE_NUCLEOTIDE_TRANS...,SET,38,0.13068,0.0059387,0.14963,0.19124,GOBP_PURINE_NUCLEOTIDE_TRANSPORT,0.908518677730921
HP_ABNORMALITY_OF_ABDOMINAL_...,SET,15,0.19683,0.0056234,0.2254,0.19128,HP_ABNORMALITY_OF_ABDOMINAL_SITUS,0.908518677730921
GOBP_NEGATIVE_REGULATION_OF_...448,SET,11,0.25691,0.0062863,0.29422,0.19129,GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,0.908518677730921
HP_FUNCTIONAL_MOTOR_DEFICIT,SET,450,0.034439,0.005325,0.039441,0.19129,HP_FUNCTIONAL_MOTOR_DEFICIT,0.908518677730921
GOBP_POSITIVE_REGULATION_OF_...302,SET,68,0.097679,0.0059334,0.11187,0.1913,GOBP_POSITIVE_REGULATION_OF_GLIOGENESIS,0.908518677730921
GOMF_MHC_CLASS_IB_RECEPTOR_A...,SET,6,0.3567,0.006447,0.40853,0.1913,GOMF_MHC_CLASS_IB_RECEPTOR_ACTIVITY,0.908518677730921
GOBP_ERBB4_ERBB4_SIGNALING_P...,SET,6,0.28711,0.0051892,0.32892,0.19137,GOBP_ERBB4_ERBB4_SIGNALING_PATHWAY,0.908518677730921
GSE45365_NK_CELL_VS_CD11B_DC...2,SET,178,0.055433,0.0054315,0.063508,0.19138,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN,0.908518677730921
GOMF_CALCIUM_SODIUM_ANTIPORT...,SET,10,0.26047,0.0060769,0.29847,0.19142,GOMF_CALCIUM_SODIUM_ANTIPORTER_ACTIVITY,0.908518677730921
HP_TALL_STATURE,SET,147,0.060006,0.0053476,0.068765,0.19144,HP_TALL_STATURE,0.908518677730921
HP_TESTICULAR_ADRENAL_REST_T...,SET,8,0.27647,0.0057697,0.31686,0.19146,HP_TESTICULAR_ADRENAL_REST_TUMOR,0.908518677730921
GSE4590_PRE_BCELL_VS_SMALL_P...1,SET,109,0.069043,0.0053038,0.079149,0.19152,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN,0.908518677730921
KEGG_MEDICUS_VARIANT_MUTATIO...29,SET,15,0.17367,0.004962,0.19912,0.19156,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.908518677730921
WP_BDNFTRKB_SIGNALING,SET,33,0.13196,0.0055892,0.15131,0.19157,WP_BDNFTRKB_SIGNALING,0.908518677730921
REACTOME_NONSENSE_MEDIATED_D...,SET,103,0.069333,0.0051784,0.079521,0.19164,REACTOME_NONSENSE_MEDIATED_DECAY_NMD,0.908518677730921
WP_EICOSANOID_SYNTHESIS,SET,22,0.17348,0.0060013,0.19897,0.19164,WP_EICOSANOID_SYNTHESIS,0.908518677730921
LEE_LIVER_CANCER_SURVIVAL_DN,SET,165,0.05704,0.0053829,0.065441,0.19171,LEE_LIVER_CANCER_SURVIVAL_DN,0.908518677730921
HP_HAIR_PULLING,SET,7,0.31835,0.0062146,0.36524,0.19172,HP_HAIR_PULLING,0.908518677730921
HP_DECREASED_PROPORTION_OF_N...,SET,3,0.49236,0.0062931,0.56491,0.19173,HP_DECREASED_PROPORTION_OF_NAIVE_T_CELLS,0.908518677730921
GSE15330_HSC_VS_GRANULOCYTE_...2,SET,173,0.05407,0.0052237,0.062049,0.19177,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.908518677730921
GSE19923_WT_VS_HEB_AND_E2A_K...2,SET,182,0.052009,0.0051523,0.059685,0.19177,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.908518677730921
PETROVA_ENDOTHELIUM_LYMPHATI...1,SET,154,0.061664,0.0056236,0.070769,0.19179,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,0.908518677730921
CAGTATT_MIR200B_MIR200C_MIR4...,SET,423,0.036432,0.0054657,0.041821,0.19184,CAGTATT_MIR200B_MIR200C_MIR429,0.908518677730921
HALLMARK_MYC_TARGETS_V1,SET,182,0.049149,0.004869,0.056419,0.19184,HALLMARK_MYC_TARGETS_V1,0.908518677730921
GOBP_AXONEMAL_CENTRAL_APPARA...,SET,5,0.32024,0.0052839,0.36762,0.19185,GOBP_AXONEMAL_CENTRAL_APPARATUS_ASSEMBLY,0.908518677730921
GOMF_CERAMIDE_1_PHOSPHATE_BI...,SET,5,0.30112,0.0049684,0.34569,0.19187,GOMF_CERAMIDE_1_PHOSPHATE_BINDING,0.908518677730921
GSE25890_CTRL_VS_IL33_IL7_TR...1,SET,185,0.053298,0.0053229,0.061189,0.19187,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN,0.908518677730921
MANNE_COVID19_NONICU_VS_HEAL...1,SET,179,0.059252,0.0058218,0.068035,0.19191,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,0.908518677730921
MIR592,SET,70,0.086229,0.0053141,0.099014,0.19192,MIR592,0.908518677730921
KIM_RESPONSE_TO_TSA_AND_DECI...1,SET,8,0.23179,0.0048372,0.26623,0.19198,KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN,0.908518677730921
PID_WNT_CANONICAL_PATHWAY,SET,20,0.15491,0.0051098,0.17793,0.19198,PID_WNT_CANONICAL_PATHWAY,0.908518677730921
STEINER_ERYTHROCYTE_MEMBRANE...,SET,14,0.19221,0.0053055,0.22078,0.192,STEINER_ERYTHROCYTE_MEMBRANE_GENES,0.908518677730921
GOCC_PCG_PROTEIN_COMPLEX,SET,44,0.10541,0.0051538,0.1211,0.19203,GOCC_PCG_PROTEIN_COMPLEX,0.908518677730921
LIEN_BREAST_CARCINOMA_METAPL...3,SET,73,0.094308,0.0059347,0.10836,0.19206,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,0.908518677730921
GOCC_BOX_C_D_RNP_COMPLEX,SET,4,0.33399,0.0049291,0.38374,0.19206,GOCC_BOX_C_D_RNP_COMPLEX,0.908518677730921
GOBP_POSITIVE_REGULATION_OF_...444,SET,10,0.23912,0.0055789,0.27479,0.1921,GOBP_POSITIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,0.908518677730921
ATTACAT_MIR3803P,SET,87,0.081023,0.005564,0.093117,0.19212,ATTACAT_MIR3803P,0.908518677730921
MIR8089,SET,155,0.063133,0.0057761,0.072558,0.19213,MIR8089,0.908518677730921
GOBP_NEGATIVE_REGULATION_OF_...40,SET,44,0.10929,0.0053434,0.12561,0.19215,GOBP_NEGATIVE_REGULATION_OF_AXONOGENESIS,0.908518677730921
MIR136_5P,SET,102,0.072114,0.0053599,0.082891,0.19216,MIR136_5P,0.908518677730921
DESCARTES_MAIN_FETAL_OLIGODE...,SET,40,0.12628,0.0058877,0.14522,0.19228,DESCARTES_MAIN_FETAL_OLIGODENDROCYTES,0.908904215392983
DEURIG_T_CELL_PROLYMPHOCYTIC...1,SET,282,0.044091,0.0054221,0.050709,0.1923,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,0.908904215392983
GSE6092_CTRL_VS_BORRELIA_BIR...1,SET,140,0.062114,0.0054031,0.071444,0.19232,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN,0.908904215392983
MATTHEWS_AP1_TARGETS,SET,16,0.19776,0.0058353,0.22755,0.1924,MATTHEWS_AP1_TARGETS,0.90895875356803
BOUDOUKHA_BOUND_BY_IGF2BP2,SET,92,0.076311,0.0053882,0.087807,0.19241,BOUDOUKHA_BOUND_BY_IGF2BP2,0.90895875356803
GOMF_PYRUVATE_DEHYDROGENASE_...2,SET,5,0.31657,0.0052233,0.36426,0.19241,GOMF_PYRUVATE_DEHYDROGENASE_ACETYL_TRANSFERRING_PHOSPHATASE_ACTIVITY,0.90895875356803
HP_NEUROFIBRILLARY_TANGLES,SET,21,0.16094,0.0054399,0.18522,0.19245,HP_NEUROFIBRILLARY_TANGLES,0.909024157379723
LAKE_ADULT_KIDNEY_C30_IMMUNE...,SET,9,0.26462,0.0058571,0.3046,0.19251,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.909093050088231
GOBP_GLANDULAR_EPITHELIAL_CE...1,SET,33,0.1366,0.005786,0.15725,0.19252,GOBP_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT,0.909093050088231
GSE13485_DAY1_VS_DAY7_YF17D_...1,SET,180,0.053526,0.0052737,0.06163,0.19257,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN,0.909093050088231
ZHONG_PFC_C4_UNKNOWN_INP,SET,81,0.083209,0.0055145,0.095837,0.19264,ZHONG_PFC_C4_UNKNOWN_INP,0.909093050088231
AMUNDSON_DNA_DAMAGE_RESPONSE...,SET,16,0.18529,0.0054672,0.21343,0.19266,AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,0.909093050088231
GSE18203_CTRL_VS_INTRATUMORA...1,SET,176,0.05533,0.0053911,0.063739,0.19268,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_DN,0.909093050088231
KEGG_MEDICUS_VARIANT_RET_FUS...,SET,10,0.22053,0.0051452,0.25405,0.19269,KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.909093050088231
GOBP_NEGATIVE_REGULATION_OF_...282,SET,10,0.30263,0.0070607,0.34865,0.1927,GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.909093050088231
GOMF_ALCOHOL_DEHYDROGENASE_N...2,SET,23,0.17174,0.0060745,0.19785,0.1927,GOMF_ALCOHOL_DEHYDROGENASE_NADPPLUS_ACTIVITY,0.909093050088231
GARGALOVIC_RESPONSE_TO_OXIDI...12,SET,11,0.21404,0.0052374,0.24667,0.19278,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP,0.909347027687296
HP_CHRONIC_PULMONARY_OBSTRUC...,SET,30,0.14573,0.0058856,0.16798,0.19284,HP_CHRONIC_PULMONARY_OBSTRUCTION,0.909430359565807
MIR1260A_MIR1260B,SET,97,0.072983,0.0052907,0.084133,0.19285,MIR1260A_MIR1260B,0.909430359565807
REACTOME_ADENYLATE_CYCLASE_I...,SET,14,0.20119,0.0055534,0.23196,0.19289,REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY,0.909437427098874
MURARO_PANCREAS_DUCTAL_CELL,SET,1166,0.02297,0.0056018,0.026487,0.19291,MURARO_PANCREAS_DUCTAL_CELL,0.909437427098874
ZSCAN2_TARGET_GENES,SET,674,0.029268,0.0055037,0.033751,0.19293,ZSCAN2_TARGET_GENES,0.909437427098874
GSE14415_INDUCED_TREG_VS_FOX...4,SET,149,0.058264,0.0052272,0.0672,0.19297,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP,0.909502624084622
HONRADO_BREAST_CANCER_BRCA1_...,SET,17,0.18678,0.0056807,0.21545,0.193,HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2,0.909520677966102
GOBP_POSITIVE_REGULATION_OF_...87,SET,9,0.28927,0.0064028,0.33372,0.19303,GOBP_POSITIVE_REGULATION_OF_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.909538726952278
GOBP_G_PROTEIN_COUPLED_RECEP...4,SET,9,0.23849,0.0052788,0.27517,0.19306,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_PROCESS,0.909544744318182
BIOCARTA_P53_PATHWAY,SET,16,0.17763,0.0052412,0.20502,0.19315,BIOCARTA_P53_PATHWAY,0.909544744318182
GOMF_SODIUM_ION_TRANSMEMBRAN...,SET,156,0.061861,0.0056778,0.071409,0.19317,GOMF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.909544744318182
HP_ABNORMAL_LYMPHOCYTE_PROLI...,SET,39,0.11595,0.0053381,0.13384,0.19317,HP_ABNORMAL_LYMPHOCYTE_PROLIFERATION,0.909544744318182
BIOCARTA_KERATINOCYTE_PATHWAY,SET,46,0.11275,0.0056365,0.13017,0.1932,BIOCARTA_KERATINOCYTE_PATHWAY,0.909544744318182
REACTOME_SIGNALLING_TO_ERKS,SET,34,0.12429,0.0053434,0.14351,0.19323,REACTOME_SIGNALLING_TO_ERKS,0.909544744318182
MIR3202,SET,229,0.047086,0.0052256,0.05438,0.19328,MIR3202,0.909544744318182
MIR4720_3P,SET,106,0.072722,0.0055095,0.083997,0.19332,MIR4720_3P,0.909544744318182
KLEIN_PRIMARY_EFFUSION_LYMPH...1,SET,50,0.11176,0.0058244,0.12912,0.19336,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,0.909544744318182
BIOCARTA_TERT_PATHWAY,SET,8,0.24105,0.0050304,0.27848,0.19336,BIOCARTA_TERT_PATHWAY,0.909544744318182
HP_RADIAL_DEVIATION_OF_THE_2...,SET,6,0.3236,0.0058488,0.37385,0.19337,HP_RADIAL_DEVIATION_OF_THE_2ND_FINGER,0.909544744318182
GOMF_PROTEIN_FOLDING_CHAPERO...1,SET,62,0.089924,0.0052166,0.1039,0.1934,GOMF_PROTEIN_FOLDING_CHAPERONE,0.909544744318182
HEBERT_MATRISOME_TNBC_BONE_M...2,SET,4,0.40231,0.0059374,0.46488,0.19341,HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED,0.909544744318182
DESCARTES_MAIN_FETAL_LYMPHAT...,SET,64,0.095672,0.0056386,0.11056,0.19342,DESCARTES_MAIN_FETAL_LYMPHATIC_ENDOTHELIAL_CELLS,0.909544744318182
GOBP_POSITIVE_REGULATION_OF_...581,SET,24,0.15647,0.0056533,0.18082,0.19344,GOBP_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.909544744318182
GSE10325_CD4_TCELL_VS_MYELOI...1,SET,179,0.057281,0.0056281,0.066198,0.19345,GSE10325_CD4_TCELL_VS_MYELOID_DN,0.909544744318182
MIR631,SET,48,0.10847,0.0055389,0.12539,0.1935,MIR631,0.90965676991749
LU_EZH2_TARGETS_DN,SET,343,0.039536,0.005353,0.045712,0.19355,LU_EZH2_TARGETS_DN,0.909692738336714
MIR190B_3P,SET,124,0.064542,0.0052861,0.074627,0.19356,MIR190B_3P,0.909692738336714
HP_DELAYED_ABILITY_TO_ROLL_O...,SET,14,0.17336,0.0047852,0.20058,0.19372,HP_DELAYED_ABILITY_TO_ROLL_OVER,0.910232187542042
HP_ENLARGED_THORAX,SET,57,0.09339,0.0051953,0.10807,0.19376,HP_ENLARGED_THORAX,0.910232187542042
HP_DELAYED_ERUPTION_OF_TEETH,SET,153,0.060172,0.0054698,0.069637,0.19378,HP_DELAYED_ERUPTION_OF_TEETH,0.910232187542042
DESCARTES_FETAL_MUSCLE_SMOOT...,SET,67,0.093051,0.0056107,0.10772,0.19385,DESCARTES_FETAL_MUSCLE_SMOOTH_MUSCLE_CELLS,0.910232187542042
GOBP_REGULATION_OF_MUCUS_SEC...,SET,9,0.27713,0.0061341,0.32096,0.19395,GOBP_REGULATION_OF_MUCUS_SECRETION,0.910232187542042
GSE9988_ANTI_TREM1_VS_LPS_MO...2,SET,173,0.055706,0.0053817,0.064516,0.19395,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP,0.910232187542042
GOBP_TRACHEA_FORMATION,SET,7,0.32851,0.006413,0.38047,0.19396,GOBP_TRACHEA_FORMATION,0.910232187542042
GOBP_SEQUESTERING_OF_CALCIUM...,SET,126,0.067765,0.0055943,0.078499,0.194,GOBP_SEQUESTERING_OF_CALCIUM_ION,0.910232187542042
HP_FUNCTIONAL_ABNORMALITY_OF...1,SET,228,0.048046,0.0053206,0.055667,0.19405,HP_FUNCTIONAL_ABNORMALITY_OF_MALE_INTERNAL_GENITALIA,0.910232187542042
GOBP_ONE_CARBON_COMPOUND_TRA...,SET,22,0.18842,0.0065182,0.21833,0.19407,GOBP_ONE_CARBON_COMPOUND_TRANSPORT,0.910232187542042
GSE15930_STIM_VS_STIM_AND_IF...2,SET,176,0.052168,0.005083,0.060448,0.19407,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP,0.910232187542042
BLANCO_MELO_COVID19_SARS_COV...10,SET,132,0.06619,0.005592,0.076704,0.19409,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,0.910232187542042
REACTOME_TOXICITY_OF_BOTULIN...,SET,5,0.28995,0.0047842,0.33604,0.19412,REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BOTD,0.910232187542042
MIR10396A_5P,SET,8,0.25929,0.0054112,0.30055,0.19415,MIR10396A_5P,0.910232187542042
NIKOLSKY_BREAST_CANCER_16Q24...,SET,50,0.19551,0.010189,0.22665,0.19418,NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON,0.910232187542042
GSE39022_LN_VS_SPLEEN_DC_UP,SET,180,0.053366,0.0052579,0.061872,0.1942,GSE39022_LN_VS_SPLEEN_DC_UP,0.910232187542042
KEGG_GLYCOSPHINGOLIPID_BIOSY...3,SET,26,0.15269,0.0057417,0.17709,0.19429,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES,0.910232187542042
HP_HYPERAUTOFLUORESCENT_RETI...,SET,14,0.21979,0.0060667,0.25491,0.19429,HP_HYPERAUTOFLUORESCENT_RETINAL_LESION,0.910232187542042
GOBP_CELLULAR_RESPONSE_TO_PH,SET,25,0.14607,0.0053862,0.16944,0.19433,GOBP_CELLULAR_RESPONSE_TO_PH,0.910232187542042
PHF21A_TARGET_GENES,SET,224,0.049306,0.0054127,0.057199,0.19435,PHF21A_TARGET_GENES,0.910232187542042
GOBP_MITOCHONDRIAL_RIBOSOME_...,SET,11,0.20672,0.0050582,0.23983,0.19437,GOBP_MITOCHONDRIAL_RIBOSOME_ASSEMBLY,0.910232187542042
STAMBOLSKY_TARGETS_OF_MUTATE...1,SET,47,0.107,0.0054066,0.12414,0.19438,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,0.910232187542042
ZNF331_TARGET_GENES,SET,270,0.044424,0.0053473,0.051542,0.19438,ZNF331_TARGET_GENES,0.910232187542042
MIR1304_5P,SET,121,0.065256,0.0052799,0.075726,0.19442,MIR1304_5P,0.910232187542042
MIR7973,SET,43,0.10868,0.0052532,0.12612,0.19442,MIR7973,0.910232187542042
GOBP_REGULATION_OF_LENS_FIBE...,SET,8,0.28526,0.005953,0.33103,0.19442,GOBP_REGULATION_OF_LENS_FIBER_CELL_DIFFERENTIATION,0.910232187542042
HP_ANGIOEDEMA,SET,12,0.24219,0.0061894,0.28115,0.19451,HP_ANGIOEDEMA,0.910232187542042
WP_CLASSICAL_PATHWAY_OF_STER...,SET,16,0.19612,0.0057869,0.22768,0.19452,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,0.910232187542042
GOBP_NEURONAL_SIGNAL_TRANSDU...,SET,6,0.34672,0.0062666,0.40252,0.19452,GOBP_NEURONAL_SIGNAL_TRANSDUCTION,0.910232187542042
GOBP_MULTIVESICULAR_BODY_SOR...,SET,45,0.10151,0.0050193,0.11787,0.19457,GOBP_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.910232187542042
GSE15750_DAY6_VS_DAY10_EFF_C...1,SET,180,0.052883,0.0052103,0.061406,0.19457,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN,0.910232187542042
GOBP_NEGATIVE_REGULATION_OF_...438,SET,12,0.22559,0.0057652,0.26198,0.1946,GOBP_NEGATIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,0.910232187542042
MIR4701_5P,SET,107,0.072592,0.0055254,0.084306,0.19461,MIR4701_5P,0.910232187542042
GOBP_MULTICELLULAR_ORGANISMA...5,SET,58,0.093702,0.0052581,0.10882,0.19461,GOBP_MULTICELLULAR_ORGANISMAL_MOVEMENT,0.910232187542042
GOCC_GLYCOPROTEIN_IB_IX_V_CO...,SET,4,0.42539,0.0062779,0.49405,0.19462,GOCC_GLYCOPROTEIN_IB_IX_V_COMPLEX,0.910232187542042
GOBP_RESPONSE_TO_CALCIUM_ION,SET,124,0.067658,0.0055413,0.078588,0.19465,GOBP_RESPONSE_TO_CALCIUM_ION,0.910232187542042
GSE6875_WT_VS_FOXP3_KO_TREG_...1,SET,179,0.055086,0.0054125,0.063988,0.19466,GSE6875_WT_VS_FOXP3_KO_TREG_DN,0.910232187542042
JOHNSTONE_PARVB_TARGETS_1_DN,SET,56,0.10049,0.0055413,0.11674,0.19467,JOHNSTONE_PARVB_TARGETS_1_DN,0.910232187542042
GOBP_GROWTH_INVOLVED_IN_HEAR...,SET,4,0.43252,0.0063832,0.50257,0.19473,GOBP_GROWTH_INVOLVED_IN_HEART_MORPHOGENESIS,0.910305417894455
GOBP_PROTEIN_RETENTION_IN_GO...,SET,5,0.35304,0.005825,0.41024,0.19475,GOBP_PROTEIN_RETENTION_IN_GOLGI_APPARATUS,0.910305417894455
KEGG_MEDICUS_REFERENCE_E2_ER...,SET,22,0.14573,0.0050414,0.16942,0.19485,KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY,0.910305417894455
GOBP_NUCLEUS_ORGANIZATION,SET,132,0.059903,0.0050608,0.069639,0.19485,GOBP_NUCLEUS_ORGANIZATION,0.910305417894455
HP_BREATHING_DYSREGULATION,SET,19,0.15972,0.0051353,0.18573,0.19491,HP_BREATHING_DYSREGULATION,0.910305417894455
TRAVAGLINI_LUNG_NONCLASSICAL...,SET,171,0.058697,0.0056381,0.068255,0.19491,TRAVAGLINI_LUNG_NONCLASSICAL_MONOCYTE_CELL,0.910305417894455
GOMF_ALL_TRANS_RETINAL_BINDI...,SET,5,0.33659,0.0055537,0.39146,0.19494,GOMF_ALL_TRANS_RETINAL_BINDING,0.910305417894455
HP_BILIARY_CIRRHOSIS,SET,19,0.17896,0.0057539,0.20818,0.195,HP_BILIARY_CIRRHOSIS,0.910305417894455
WILCOX_RESPONSE_TO_PROGESTER...2,SET,136,0.062809,0.0053855,0.073074,0.19503,WILCOX_RESPONSE_TO_PROGESTERONE_UP,0.910305417894455
HP_CEREBELLAR_DENTATE_NUCLEU...,SET,5,0.35434,0.0058465,0.41227,0.19504,HP_CEREBELLAR_DENTATE_NUCLEUS_CALCIFICATION,0.910305417894455
GOBP_IMMUNOGLOBULIN_PRODUCTI...1,SET,91,0.070703,0.0049651,0.082268,0.19506,GOBP_IMMUNOGLOBULIN_PRODUCTION,0.910305417894455
YAGI_AML_WITH_T_9_11_TRANSLO...,SET,115,0.068347,0.0053921,0.079551,0.19513,YAGI_AML_WITH_T_9_11_TRANSLOCATION,0.910305417894455
HP_ONYCHOGRYPOSIS,SET,27,0.14472,0.0055455,0.16847,0.19517,HP_ONYCHOGRYPOSIS,0.910305417894455
GSE22342_CD11C_HIGH_VS_LOW_D...1,SET,154,0.058308,0.0053176,0.067877,0.19517,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_DN,0.910305417894455
GOBP_POSITIVE_REGULATION_OF_...678,SET,35,0.11199,0.0048849,0.13038,0.19518,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.910305417894455
GOBP_GRANULOCYTE_MACROPHAGE_...,SET,17,0.1873,0.0056967,0.21809,0.19522,GOBP_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,0.910305417894455
SA_B_CELL_RECEPTOR_COMPLEXES,SET,22,0.15236,0.0052709,0.17742,0.19524,SA_B_CELL_RECEPTOR_COMPLEXES,0.910305417894455
GABP_B,SET,239,0.045447,0.0051512,0.05292,0.19524,GABP_B,0.910305417894455
HP_ABNORMAL_5TH_FINGER_PHALA...,SET,54,0.099463,0.005386,0.11583,0.19527,HP_ABNORMAL_5TH_FINGER_PHALANX_MORPHOLOGY,0.910305417894455
HP_APLASIA_HYPOPLASIA_OF_THE...53,SET,27,0.14497,0.0055549,0.16886,0.19531,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_5TH_FINGER,0.910305417894455
HP_PYELONEPHRITIS,SET,20,0.15999,0.0052775,0.18637,0.19532,HP_PYELONEPHRITIS,0.910305417894455
BIOCARTA_HER2_PATHWAY,SET,23,0.14982,0.0052992,0.17456,0.19537,BIOCARTA_HER2_PATHWAY,0.910305417894455
HP_ACUTE_OTITIS_MEDIA,SET,5,0.36588,0.0060369,0.42635,0.1954,HP_ACUTE_OTITIS_MEDIA,0.910305417894455
GOMF_HEPARAN_SULFATE_GLUCOSA...,SET,7,0.32604,0.0063648,0.37997,0.19544,GOMF_HEPARAN_SULFATE_GLUCOSAMINE_3_SULFOTRANSFERASE_1_ACTIVITY,0.910305417894455
GOMF_MYOSIN_HEAVY_CHAIN_BIND...,SET,13,0.18775,0.0049941,0.21883,0.19546,GOMF_MYOSIN_HEAVY_CHAIN_BINDING,0.910305417894455
GOCC_ENDOCYTIC_VESICLE_LUMEN,SET,20,0.16094,0.0053087,0.18759,0.19548,GOCC_ENDOCYTIC_VESICLE_LUMEN,0.910305417894455
GSE38304_MYC_NEG_VS_POS_GC_B...2,SET,184,0.054776,0.0054558,0.063848,0.19548,GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP,0.910305417894455
ZAMORA_NOS2_TARGETS_DN,SET,76,0.082859,0.0053198,0.096588,0.19549,ZAMORA_NOS2_TARGETS_DN,0.910305417894455
HP_ABNORMAL_BLOOD_INORGANIC_...,SET,160,0.058857,0.0054703,0.06862,0.19553,HP_ABNORMAL_BLOOD_INORGANIC_CATION_CONCENTRATION,0.910305417894455
KEGG_HOMOLOGOUS_RECOMBINATION,SET,25,0.13154,0.0048505,0.15337,0.19554,KEGG_HOMOLOGOUS_RECOMBINATION,0.910305417894455
AAAGGGA_MIR204_MIR211,SET,211,0.050435,0.0053755,0.058804,0.19554,AAAGGGA_MIR204_MIR211,0.910305417894455
GOCC_CELL_LEADING_EDGE,SET,399,0.03594,0.0052402,0.041904,0.19554,GOCC_CELL_LEADING_EDGE,0.910305417894455
GOBP_VASCULAR_PROCESS_IN_CIR...,SET,253,0.049308,0.005748,0.057491,0.19555,GOBP_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM,0.910305417894455
KAUFFMANN_DNA_REPLICATION_GE...,SET,135,0.060071,0.0051319,0.070054,0.19559,KAUFFMANN_DNA_REPLICATION_GENES,0.910347470218177
HP_ABNORMAL_TONGUE_MORPHOLOGY,SET,333,0.039336,0.0052491,0.045877,0.19562,HP_ABNORMAL_TONGUE_MORPHOLOGY,0.910347470218177
GSE44649_WT_VS_MIR155_KO_NAI...1,SET,188,0.055455,0.0055826,0.064688,0.19565,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_DN,0.910347470218177
SPIELMAN_LYMPHOBLAST_EUROPEA...2,SET,12,0.20159,0.0051519,0.23517,0.19567,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP,0.910347470218177
GOBP_NEGATIVE_REGULATION_OF_...362,SET,34,0.12412,0.0053363,0.14481,0.19569,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.910347470218177
GSE45881_CXCR6HI_VS_CXCR1LO_...1,SET,184,0.052721,0.0052512,0.061518,0.19573,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_DN,0.910411690310492
HP_ABNORMAL_NEUTROPHIL_MORPH...,SET,18,0.19192,0.0060061,0.22403,0.19582,HP_ABNORMAL_NEUTROPHIL_MORPHOLOGY,0.910708430349257
HP_PAPULE,SET,92,0.072483,0.0051179,0.084638,0.1959,HP_PAPULE,0.910883217391304
HAY_BONE_MARROW_EOSINOPHIL,SET,41,0.11465,0.0054117,0.13389,0.19591,HAY_BONE_MARROW_EOSINOPHIL,0.910883217391304
HP_APLASIA_HYPOPLASIA_OF_THE...37,SET,25,0.15307,0.0056443,0.1788,0.19598,HP_APLASIA_HYPOPLASIA_OF_THE_HUMERUS,0.911081813928619
GSE1460_NAIVE_CD4_TCELL_CORD...1,SET,173,0.054642,0.0052789,0.063837,0.19602,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN,0.911081813928619
GOBP_ACTIN_FILAMENT_SEVERING,SET,16,0.18113,0.0053445,0.21163,0.19604,GOBP_ACTIN_FILAMENT_SEVERING,0.911081813928619
LMTK3_TARGET_GENES,SET,426,0.035617,0.0053618,0.041625,0.1961,LMTK3_TARGET_GENES,0.911081813928619
GOBP_REGULATION_OF_T_HELPER_...5,SET,31,0.14596,0.0059924,0.17059,0.19611,GOBP_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.911081813928619
HP_BILATERAL_TONIC_CLONIC_SE...2,SET,47,0.097713,0.0049374,0.1142,0.19611,HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_FOCAL_ONSET,0.911081813928619
GOMF_N6_METHYLADENOSINE_CONT...,SET,11,0.22399,0.0054809,0.26187,0.19618,GOMF_N6_METHYLADENOSINE_CONTAINING_RNA_READER_ACTIVITY,0.911256314312442
GSE24634_TREG_VS_TCONV_POST_...5,SET,177,0.055774,0.0054496,0.065211,0.1962,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN,0.911256314312442
GOBP_REACTIVE_NITROGEN_SPECI...,SET,73,0.089976,0.0056621,0.10522,0.19624,GOBP_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS,0.911291422845691
HP_NEOPLASM_OF_THE_LARGE_INT...,SET,108,0.067612,0.0051702,0.079072,0.19626,HP_NEOPLASM_OF_THE_LARGE_INTESTINE,0.911291422845691
GOMF_PRIMARY_MIRNA_BINDING,SET,9,0.22055,0.0048817,0.25801,0.19633,GOMF_PRIMARY_MIRNA_BINDING,0.911396635963156
HP_MYELOFIBROSIS,SET,11,0.20301,0.0049674,0.2375,0.19635,HP_MYELOFIBROSIS,0.911396635963156
GOBP_NEGATIVE_REGULATION_OF_...196,SET,5,0.30997,0.0051144,0.36273,0.19641,GOBP_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.911396635963156
HP_UNBALANCED_ATRIOVENTRICUL...,SET,5,0.30867,0.005093,0.36124,0.19643,HP_UNBALANCED_ATRIOVENTRICULAR_CANAL_DEFECT,0.911396635963156
KEGG_MEDICUS_PATHOGEN_HTLV_1...6,SET,8,0.23395,0.0048822,0.2738,0.19644,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00498,0.911396635963156
GSE43260_BTLA_POS_VS_NEG_INT...2,SET,182,0.053029,0.0052534,0.062063,0.19644,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP,0.911396635963156
GOMF_PRE_MRNA_5_SPLICE_SITE_...,SET,2,0.39054,0.0040757,0.45724,0.19653,GOMF_PRE_MRNA_5_SPLICE_SITE_BINDING,0.911541933546837
WP_FGFR3_SIGNALING_IN_CHONDR...,SET,27,0.14651,0.0056142,0.17155,0.19654,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,0.911541933546837
GSE17974_IL4_AND_ANTI_IL12_V...6,SET,151,0.060337,0.0054491,0.070649,0.19655,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP,0.911541933546837
WONG_ADULT_TISSUE_STEM_MODULE,SET,658,0.029986,0.0055739,0.035116,0.19658,WONG_ADULT_TISSUE_STEM_MODULE,0.91155942628419
HP_HAND_POLYDACTYLY,SET,149,0.058293,0.0052299,0.068301,0.19671,HP_HAND_POLYDACTYLY,0.912040561632871
HP_UPPER_LIMB_JOINT_CONTRACT...,SET,300,0.042689,0.0054119,0.050028,0.19675,HP_UPPER_LIMB_JOINT_CONTRACTURE,0.912046466195493
MIR6809_3P,SET,504,0.033763,0.0055165,0.039572,0.19678,MIR6809_3P,0.912046466195493
GSE15324_ELF4_KO_VS_WT_ACTIV...2,SET,180,0.050447,0.0049703,0.059131,0.19679,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP,0.912046466195493
MIR22_5P,SET,127,0.064207,0.0053214,0.075268,0.19682,MIR22_5P,0.912052366035724
YEMELYANOV_GR_TARGETS_DN,SET,10,0.23142,0.0053993,0.27134,0.19686,YEMELYANOV_GR_TARGETS_DN,0.912052366035724
HP_FOOT_DORSIFLEXOR_WEAKNESS,SET,128,0.062531,0.0052028,0.073318,0.19687,HP_FOOT_DORSIFLEXOR_WEAKNESS,0.912052366035724
MYC_Q2,SET,180,0.054508,0.0053704,0.063921,0.19691,MYC_Q2,0.912116093562575
HOFFMANN_LARGE_TO_SMALL_PRE_...2,SET,142,0.058734,0.0051452,0.068896,0.19697,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,0.912197188540973
HP_URINARY_URGENCY,SET,43,0.10638,0.0051418,0.12478,0.19698,HP_URINARY_URGENCY,0.912197188540973
GOBP_N_ACETYLGLUCOSAMINE_MET...,SET,14,0.2054,0.0056696,0.24107,0.1971,GOBP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,0.912544386735917
BIOCARTA_MCM_PATHWAY,SET,18,0.17412,0.0054491,0.2044,0.19716,BIOCARTA_MCM_PATHWAY,0.912544386735917
MIR5580_3P,SET,222,0.049711,0.005433,0.058358,0.19716,MIR5580_3P,0.912544386735917
GOBP_PYRIMIDINE_DEOXYRIBONUC...1,SET,4,0.35509,0.0052405,0.41685,0.19716,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,0.912544386735917
chr4q13,SET,70,0.17692,0.010903,0.20779,0.19726,chr4q13,0.912699734254584
SGCGSSAAA_E2F1DP2_01,SET,147,0.057888,0.0051588,0.067988,0.19727,SGCGSSAAA_E2F1DP2_01,0.912699734254584
GSE43955_TH0_VS_TGFB_IL6_TH1...8,SET,191,0.054941,0.0055743,0.064537,0.1973,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP,0.912699734254584
REACTOME_POU5F1_OCT4_SOX2_NA...1,SET,10,0.23159,0.0054032,0.27206,0.19732,REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION,0.912699734254584
BIOCARTA_PGC1A_PATHWAY,SET,15,0.18897,0.0053991,0.22204,0.19737,BIOCARTA_PGC1A_PATHWAY,0.912699734254584
GOBP_NEGATIVE_REGULATION_OF_...626,SET,4,0.35083,0.0051776,0.41224,0.19738,GOBP_NEGATIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,0.912699734254584
GOMF_PROTEIN_CONTAINING_COMP...2,SET,15,0.17752,0.0050719,0.20863,0.19742,GOMF_PROTEIN_CONTAINING_COMPLEX_DESTABILIZING_ACTIVITY,0.912699734254584
GOMF_L_ALANINE_TRANSMEMBRANE...,SET,9,0.24495,0.0054219,0.28793,0.19746,GOMF_L_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.912699734254584
GAVISH_3CA_METAPROGRAM_B_CEL...6,SET,43,0.10952,0.0052936,0.12875,0.1975,GAVISH_3CA_METAPROGRAM_B_CELLS_MEMORY,0.912699734254584
MIR4274,SET,51,0.10251,0.0053949,0.12052,0.19751,MIR4274,0.912699734254584
HAY_BONE_MARROW_ERYTHROBLAST,SET,1134,0.021033,0.005063,0.024728,0.19752,HAY_BONE_MARROW_ERYTHROBLAST,0.912699734254584
MIR5087,SET,85,0.078087,0.0053007,0.091831,0.19758,MIR5087,0.912699734254584
MODULE_202,SET,26,0.14275,0.0053678,0.16788,0.19759,MODULE_202,0.912699734254584
GOBP_POSITIVE_REGULATION_OF_...4,SET,9,0.24843,0.0054987,0.29219,0.19761,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,0.912699734254584
GAVISH_3CA_METAPROGRAM_FIBRO...18,SET,42,0.11904,0.0056867,0.14001,0.19762,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II_CYTOKINE,0.912699734254584
GOBP_REGULATION_OF_T_CELL_AP...,SET,38,0.1203,0.0054672,0.14151,0.19764,GOBP_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.912699734254584
GAUTAM_EYE_CORNEA_FIBROBLASTS,SET,147,0.059647,0.0053156,0.070166,0.19764,GAUTAM_EYE_CORNEA_FIBROBLASTS,0.912699734254584
MTHFD1_TARGET_GENES,SET,16,0.16729,0.0049362,0.19687,0.19774,MTHFD1_TARGET_GENES,0.912878309653433
GOBP_GOLGI_ORGANIZATION,SET,136,0.059775,0.0051253,0.070356,0.19778,GOBP_GOLGI_ORGANIZATION,0.912878309653433
GOBP_NEUTROPHIL_ACTIVATION_I...,SET,20,0.15833,0.0052226,0.18636,0.19779,GOBP_NEUTROPHIL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.912878309653433
GOBP_PRIMARY_AMINO_COMPOUND_...1,SET,6,0.2492,0.0045041,0.29334,0.1978,GOBP_PRIMARY_AMINO_COMPOUND_BIOSYNTHETIC_PROCESS,0.912878309653433
HP_UNCONJUGATED_HYPERBILIRUB...,SET,11,0.19558,0.0047858,0.23024,0.19781,HP_UNCONJUGATED_HYPERBILIRUBINEMIA,0.912878309653433
MIR6513_5P,SET,88,0.076963,0.0053153,0.090627,0.19788,MIR6513_5P,0.913073842377604
GSE369_IFNG_KO_VS_WT_LIVER_DN,SET,170,0.051446,0.0049273,0.060588,0.19792,GSE369_IFNG_KO_VS_WT_LIVER_DN,0.913073842377604
GNF2_RAB3A,SET,34,0.13043,0.0056074,0.15365,0.19798,GNF2_RAB3A,0.913073842377604
HOOI_ST7_TARGETS_DN,SET,95,0.077763,0.005579,0.091609,0.19799,HOOI_ST7_TARGETS_DN,0.913073842377604
RASHI_RESPONSE_TO_IONIZING_R...5,SET,126,0.063116,0.0052106,0.07436,0.198,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,0.913073842377604
HP_ABNORMAL_THIRD_VENTRICLE_...,SET,14,0.19975,0.0055135,0.23534,0.19801,HP_ABNORMAL_THIRD_VENTRICLE_MORPHOLOGY,0.913073842377604
OCT_C,SET,220,0.050615,0.0055071,0.059652,0.19809,OCT_C,0.913321564075352
HP_RECURRENT_MYCOBACTERIAL_I...,SET,48,0.10091,0.0051525,0.11896,0.19816,HP_RECURRENT_MYCOBACTERIAL_INFECTIONS,0.91340729152857
GOBP_TRNA_TRANSCRIPTION,SET,13,0.16305,0.004337,0.19226,0.19821,GOBP_TRNA_TRANSCRIPTION,0.91340729152857
HP_ABNORMALITY_OF_THE_PULMON...2,SET,185,0.053233,0.0053164,0.062775,0.19823,HP_ABNORMALITY_OF_THE_PULMONARY_VASCULATURE,0.91340729152857
GOCC_POSTSYNAPTIC_ENDOSOME_M...,SET,4,0.33228,0.0049038,0.39186,0.19824,GOCC_POSTSYNAPTIC_ENDOSOME_MEMBRANE,0.91340729152857
GSE32901_NAIVE_VS_TH17_NEG_C...2,SET,157,0.056078,0.0051633,0.066135,0.19824,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP,0.91340729152857
GOBP_REGULATION_OF_TRANSCRIP...3,SET,27,0.12875,0.0049336,0.15188,0.1983,GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.913417936150484
RUBENSTEIN_SKELETAL_MUSCLE_S...2,SET,376,0.035286,0.0049976,0.041633,0.19835,RUBENSTEIN_SKELETAL_MUSCLE_SMOOTH_MUSCLE_CELLS,0.913417936150484
FIGUEROA_AML_METHYLATION_CLU...7,SET,14,0.19537,0.0053927,0.23052,0.19836,FIGUEROA_AML_METHYLATION_CLUSTER_4_DN,0.913417936150484
GSE3982_CENT_MEMORY_CD4_TCEL...6,SET,175,0.053951,0.0052419,0.063658,0.19836,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP,0.913417936150484
GOBP_POSITIVE_REGULATION_OF_...48,SET,7,0.24737,0.004829,0.29192,0.1984,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION,0.913417936150484
DESCARTES_FETAL_ADRENAL_ERYT...,SET,84,0.079573,0.0053699,0.093908,0.1984,DESCARTES_FETAL_ADRENAL_ERYTHROBLASTS,0.913417936150484
GOBP_GEPHYRIN_CLUSTERING_INV...,SET,5,0.32343,0.0053366,0.38193,0.19855,GOBP_GEPHYRIN_CLUSTERING_INVOLVED_IN_POSTSYNAPTIC_DENSITY_ASSEMBLY,0.913825536139793
REACTOME_MITOCHONDRIAL_TRANS...,SET,90,0.071371,0.0049846,0.084285,0.19856,REACTOME_MITOCHONDRIAL_TRANSLATION,0.913825536139793
DESCARTES_FETAL_PANCREAS_MYE...,SET,185,0.056172,0.0056099,0.066345,0.1986,DESCARTES_FETAL_PANCREAS_MYELOID_CELLS,0.913825536139793
GOBP_POSITIVE_REGULATION_OF_...632,SET,7,0.28558,0.005575,0.33731,0.19861,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CENTROSOME,0.913825536139793
HASINA_NOL7_TARGETS_UP,SET,10,0.2439,0.0056905,0.2881,0.19862,HASINA_NOL7_TARGETS_UP,0.913825536139793
HP_EXERTIONAL_DYSPNEA,SET,134,0.062896,0.0053535,0.07432,0.1987,HP_EXERTIONAL_DYSPNEA,0.914014648670107
GSE32128_INOS_DEPENDENT_VS_I...1,SET,181,0.051168,0.0050552,0.060466,0.19872,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN,0.914014648670107
KEGG_MEDICUS_ENV_FACTOR_PHIP...,SET,3,0.45612,0.0058299,0.53906,0.19874,KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS,0.914014648670107
RUAN_RESPONSE_TO_TNF_DN,SET,75,0.0863,0.0055043,0.10204,0.19886,RUAN_RESPONSE_TO_TNF_DN,0.914028049907579
GNF2_CBFB,SET,28,0.12815,0.0050004,0.15153,0.19887,GNF2_CBFB,0.914028049907579
GSE2770_IL12_AND_TGFB_VS_IL4...5,SET,175,0.056941,0.0055324,0.067331,0.19887,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.914028049907579
BIOCARTA_STRESS_PATHWAY,SET,23,0.14987,0.0053009,0.17723,0.19889,BIOCARTA_STRESS_PATHWAY,0.914028049907579
BIOCARTA_RAB_PATHWAY,SET,12,0.20515,0.0052429,0.24264,0.19892,BIOCARTA_RAB_PATHWAY,0.914028049907579
GOBP_REGULATION_OF_INNATE_IM...,SET,395,0.035701,0.0051797,0.042228,0.19894,GOBP_REGULATION_OF_INNATE_IMMUNE_RESPONSE,0.914028049907579
REACTOME_PURINE_CATABOLISM,SET,17,0.18542,0.0056395,0.21933,0.19895,REACTOME_PURINE_CATABOLISM,0.914028049907579
GSE17721_12H_VS_24H_LPS_BMDC...2,SET,190,0.052784,0.0053416,0.062448,0.19899,GSE17721_12H_VS_24H_LPS_BMDC_UP,0.914028049907579
GOBP_POSITIVE_REGULATION_OF_...513,SET,21,0.16897,0.0057112,0.19994,0.19903,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,0.914028049907579
HOLLERN_PAPILLARY_BREAST_TUM...,SET,15,0.19238,0.0054965,0.22771,0.1991,HOLLERN_PAPILLARY_BREAST_TUMOR,0.914028049907579
HP_ABNORMAL_ISCHIUM_MORPHOLO...,SET,24,0.14448,0.00522,0.17101,0.19911,HP_ABNORMAL_ISCHIUM_MORPHOLOGY,0.914028049907579
GOMF_ABC_TYPE_GLUTATHIONE_S_...,SET,8,0.27195,0.0056753,0.32194,0.19914,GOMF_ABC_TYPE_GLUTATHIONE_S_CONJUGATE_TRANSPORTER_ACTIVITY,0.914028049907579
FAN_EMBRYONIC_CTX_BRAIN_EFFE...,SET,116,0.069556,0.0055111,0.082347,0.19915,FAN_EMBRYONIC_CTX_BRAIN_EFFECTOR_T_CELL,0.914028049907579
REACTOME_LYSOSPHINGOLIPID_AN...,SET,9,0.25791,0.0057086,0.30536,0.19917,REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS,0.914028049907579
BIOCARTA_NUCLEARRS_PATHWAY,SET,34,0.12556,0.0053981,0.14867,0.19918,BIOCARTA_NUCLEARRS_PATHWAY,0.914028049907579
KEGG_FC_GAMMA_R_MEDIATED_PHA...,SET,90,0.075576,0.0052782,0.089482,0.19918,KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,0.914028049907579
REACTOME_MECP2_REGULATES_TRA...1,SET,4,0.42089,0.0062116,0.49837,0.19919,REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS,0.914028049907579
GSE5589_LPS_VS_LPS_AND_IL6_S...6,SET,176,0.051961,0.0050629,0.061552,0.19929,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.914366198019802
GSE42021_CD24HI_VS_CD24LOW_T...1,SET,183,0.054142,0.0053782,0.064148,0.19933,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN,0.914429006071806
HP_HERNIA,SET,500,0.032271,0.0052524,0.038243,0.19938,HP_HERNIA,0.914537666622674
GOBP_DORSAL_AORTA_DEVELOPMENT,SET,10,0.25525,0.0059553,0.30262,0.19948,GOBP_DORSAL_AORTA_DEVELOPMENT,0.914846615648503
HP_FOCAL_NON_MOTOR_SEIZURE,SET,37,0.11861,0.0053191,0.14063,0.1995,HP_FOCAL_NON_MOTOR_SEIZURE,0.914846615648503
HP_ABNORMAL_CARDIOVASCULAR_S...,SET,1282,0.020461,0.0052144,0.024263,0.19953,HP_ABNORMAL_CARDIOVASCULAR_SYSTEM_PHYSIOLOGY,0.914863476253298
SU_KIDNEY,SET,12,0.22059,0.0056375,0.26175,0.19969,SU_KIDNEY,0.915108296052632
HARALAMBIEVA_PBMC_FLUARIX_AG...5,SET,11,0.20225,0.0049489,0.24,0.1997,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_SIG_DIAB_OF_THE_YNG_NEGATIVE,0.915108296052632
HP_INCREASED_SERUM_PYRUVATE,SET,41,0.098079,0.0046295,0.11639,0.19971,HP_INCREASED_SERUM_PYRUVATE,0.915108296052632
HP_STEATORRHEA,SET,61,0.09493,0.0054626,0.11266,0.19973,HP_STEATORRHEA,0.915108296052632
GSE7219_UNSTIM_VS_LPS_AND_AN...4,SET,168,0.054754,0.0052134,0.064987,0.19975,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP,0.915108296052632
GOBP_CELLULAR_RESPONSE_TO_VA...,SET,61,0.098923,0.0056923,0.11744,0.1998,GOBP_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.915108296052632
REACTOME_DEFECTIVE_F9_ACTIVA...,SET,5,0.37679,0.0062169,0.44735,0.19982,REACTOME_DEFECTIVE_F9_ACTIVATION,0.915108296052632
GSE31082_DP_VS_CD8_SP_THYMOC...1,SET,179,0.052833,0.0051911,0.062734,0.19985,GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN,0.915108296052632
GSE33513_TCF7_KO_VS_HET_EARL...1,SET,181,0.051648,0.0051027,0.061346,0.19992,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN,0.915108296052632
BIOCARTA_LAIR_PATHWAY,SET,17,0.18757,0.0057047,0.2228,0.19993,BIOCARTA_LAIR_PATHWAY,0.915108296052632
WP_CELLS_AND_MOLECULES_INVOL...,SET,17,0.18757,0.0057047,0.2228,0.19993,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,0.915108296052632
GOBP_VOLUNTARY_SKELETAL_MUSC...,SET,5,0.28503,0.0047029,0.33862,0.19997,GOBP_VOLUNTARY_SKELETAL_MUSCLE_CONTRACTION,0.915108296052632
HP_CONGENITAL_HYPOPLASTIC_AN...,SET,4,0.32908,0.0048566,0.39095,0.19997,HP_CONGENITAL_HYPOPLASTIC_ANEMIA,0.915108296052632
AP1_Q4_01,SET,241,0.045248,0.0051498,0.053761,0.2,AP1_Q4_01,0.915108296052632
GOBP_CELLULAR_RESPONSE_TO_SO...,SET,5,0.31308,0.0051658,0.37204,0.20004,GOBP_CELLULAR_RESPONSE_TO_SODIUM_ARSENITE,0.915108296052632
HP_CLEFT_PALATE,SET,510,0.031508,0.0051777,0.037442,0.20004,HP_CLEFT_PALATE,0.915108296052632
HP_ACUTE_KIDNEY_INJURY,SET,34,0.12,0.0051592,0.14261,0.20005,HP_ACUTE_KIDNEY_INJURY,0.915108296052632
MIR3674,SET,123,0.063116,0.0051485,0.075011,0.20006,MIR3674,0.915108296052632
HP_ABNORMALITY_OF_THE_DIAPHR...,SET,101,0.068633,0.0050763,0.081583,0.2001,HP_ABNORMALITY_OF_THE_DIAPHRAGM,0.915108296052632
MIR588,SET,108,0.070675,0.0054044,0.084011,0.20011,MIR588,0.915108296052632
GSE40274_FOXP3_VS_FOXP3_AND_...13,SET,164,0.053032,0.0049896,0.063058,0.20018,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.915278753930818
CEBP_Q2,SET,205,0.050111,0.0052653,0.059598,0.20023,CEBP_Q2,0.915278753930818
GSE15330_HSC_VS_LYMPHOID_PRI...3,SET,181,0.052574,0.0051941,0.062527,0.20023,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_UP,0.915278753930818
WU_HBX_TARGETS_1_UP,SET,13,0.21173,0.0056318,0.25188,0.2003,WU_HBX_TARGETS_1_UP,0.915278753930818
GOBP_POSITIVE_REGULATION_OF_...352,SET,44,0.10025,0.0049016,0.11926,0.2003,GOBP_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.915278753930818
HP_MITOCHONDRIAL_INHERITANCE,SET,4,0.31116,0.0045922,0.37021,0.20032,HP_MITOCHONDRIAL_INHERITANCE,0.915278753930818
GOBP_PROTECTION_FROM_NATURAL...,SET,6,0.31259,0.0056498,0.37196,0.20035,GOBP_PROTECTION_FROM_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.915278753930818
REACTOME_ACTIVATION_OF_MATRI...,SET,30,0.14812,0.0059824,0.17628,0.20039,REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES,0.915278753930818
MIR3679_5P,SET,70,0.083694,0.0051578,0.099619,0.20042,MIR3679_5P,0.915278753930818
GOCC_TRANSCRIPTION_REGULATOR...,SET,477,0.032498,0.0051696,0.038686,0.20044,GOCC_TRANSCRIPTION_REGULATOR_COMPLEX,0.915278753930818
chr7p14,SET,54,0.15484,0.0083847,0.18437,0.20051,chr7p14,0.915278753930818
GOBP_ESTABLISHMENT_OF_SERTOL...,SET,4,0.2901,0.0042814,0.34545,0.20052,GOBP_ESTABLISHMENT_OF_SERTOLI_CELL_BARRIER,0.915278753930818
GSE22886_NAIVE_BCELL_VS_DC_UP,SET,153,0.057962,0.0052689,0.069026,0.20054,GSE22886_NAIVE_BCELL_VS_DC_UP,0.915278753930818
GOMF_INOSITOL_1_4_5_TRISPHOS...2,SET,11,0.22958,0.0056175,0.27345,0.20058,GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_BINDING,0.915278753930818
chr2p12,SET,13,0.29967,0.0079709,0.35695,0.2006,chr2p12,0.915278753930818
GOBP_INTRACELLULAR_ESTROGEN_...,SET,45,0.097654,0.0048286,0.11633,0.2006,GOBP_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.915278753930818
ZNF211_TARGET_GENES,SET,2,0.3402,0.0035504,0.40535,0.20067,ZNF211_TARGET_GENES,0.915278753930818
REACTOME_ABC_FAMILY_PROTEINS...,SET,97,0.067804,0.0049152,0.080793,0.20068,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,0.915278753930818
GOMF_GTPASE_ACTIVATOR_ACTIVI...,SET,240,0.045672,0.0051874,0.054424,0.20069,GOMF_GTPASE_ACTIVATOR_ACTIVITY,0.915278753930818
GOBP_RNA_MODIFICATION,SET,145,0.054678,0.0048398,0.06516,0.2007,GOBP_RNA_MODIFICATION,0.915278753930818
GAUTAM_EYE_CORNEA_TGFBI_HIGH...,SET,102,0.071949,0.0053477,0.085743,0.20071,GAUTAM_EYE_CORNEA_TGFBI_HIGH_EPITHELIAL_CELLS,0.915278753930818
GOBP_NEGATIVE_REGULATION_OF_...61,SET,15,0.1811,0.005174,0.21584,0.20073,GOBP_NEGATIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,0.915278753930818
GOBP_MYOBLAST_MIGRATION,SET,12,0.20012,0.0051143,0.23854,0.20076,GOBP_MYOBLAST_MIGRATION,0.915278753930818
GOBP_REGULATION_OF_INSULIN_S...1,SET,157,0.058549,0.0053908,0.069803,0.20081,GOBP_REGULATION_OF_INSULIN_SECRETION,0.915278753930818
MIR576_5P,SET,313,0.040954,0.0053014,0.048835,0.20085,MIR576_5P,0.915278753930818
IVANOVA_HEMATOPOIESIS_STEM_C...2,SET,514,0.031741,0.0052359,0.037853,0.20087,IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR,0.915278753930818
MIR381_3P,SET,407,0.035672,0.0052518,0.042547,0.20091,MIR381_3P,0.915278753930818
GOCC_INNER_ACROSOMAL_MEMBRANE,SET,5,0.36108,0.0059577,0.43067,0.20091,GOCC_INNER_ACROSOMAL_MEMBRANE,0.915278753930818
HP_PROGRESSIVE_SPASTIC_QUADR...,SET,11,0.22117,0.0054118,0.26382,0.20093,HP_PROGRESSIVE_SPASTIC_QUADRIPLEGIA,0.915278753930818
COLE_BLOOD_FLUZONE_FLUARIX_A...,SET,7,0.31564,0.0061618,0.37658,0.20097,COLE_BLOOD_FLUZONE_FLUARIX_AGE_03_17YO_7DY_DN,0.915278753930818
MIR4687_3P,SET,76,0.08392,0.0053879,0.10013,0.20098,MIR4687_3P,0.915278753930818
GSE43863_TFH_VS_LY6C_LOW_CXC...1,SET,174,0.055567,0.0053837,0.066302,0.20099,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,0.915278753930818
MIR152_5P,SET,74,0.083983,0.0053209,0.10023,0.20105,MIR152_5P,0.915432038516966
NAKAMURA_METASTASIS_MODEL_DN,SET,43,0.11608,0.0056107,0.13857,0.20111,NAKAMURA_METASTASIS_MODEL_DN,0.91552753404924
HP_BOWEL_DIVERTICULOSIS,SET,32,0.12184,0.0050821,0.14546,0.20113,HP_BOWEL_DIVERTICULOSIS,0.91552753404924
GOBP_CHORIONIC_TROPHOBLAST_C...1,SET,7,0.31885,0.0062245,0.3807,0.20115,GOBP_CHORIONIC_TROPHOBLAST_CELL_DIFFERENTIATION,0.91552753404924
FOXD3_TARGET_GENES,SET,29,0.13507,0.0053639,0.16132,0.20122,FOXD3_TARGET_GENES,0.915535127737226
GSE46242_TH1_VS_ANERGIC_TH1_...2,SET,168,0.05373,0.0051159,0.064176,0.20124,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_UP,0.915535127737226
ZNF8_TARGET_GENES,SET,785,0.025662,0.0051914,0.030655,0.20127,ZNF8_TARGET_GENES,0.915535127737226
WP_NANOPARTICLEMEDIATED_ACTI...,SET,28,0.14006,0.0054654,0.16738,0.20135,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,0.915535127737226
TRAVAGLINI_LUNG_LIPOFIBROBLA...,SET,138,0.064052,0.0055321,0.076553,0.20138,TRAVAGLINI_LUNG_LIPOFIBROBLAST_CELL,0.915535127737226
GOBP_REGULATION_OF_CELL_FATE...1,SET,38,0.12043,0.0054733,0.14395,0.2014,GOBP_REGULATION_OF_CELL_FATE_COMMITMENT,0.915535127737226
GSE7219_WT_VS_NIK_NFKB2_KO_L...2,SET,180,0.056079,0.0055252,0.067044,0.20146,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP,0.915535127737226
HP_RENAL_POTASSIUM_WASTING,SET,6,0.31897,0.0057651,0.38153,0.20158,HP_RENAL_POTASSIUM_WASTING,0.915535127737226
GOBP_REGULATION_OF_AUTOPHAGY...1,SET,39,0.10881,0.0050092,0.13015,0.20159,GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.915535127737226
HP_APLASIA_HYPOPLASIA_OF_THE...54,SET,3,0.43509,0.0055611,0.52047,0.2016,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_5TH_TOE,0.915535127737226
chr6p25,SET,31,0.20626,0.008468,0.24675,0.20161,chr6p25,0.915535127737226
GOMF_COLLAGEN_BINDING,SET,67,0.091145,0.0054958,0.10904,0.20161,GOMF_COLLAGEN_BINDING,0.915535127737226
GSE8921_UNSTIM_0H_VS_TLR1_2_...5,SET,186,0.052187,0.0052259,0.062444,0.20166,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN,0.915535127737226
GSE9650_EFFECTOR_VS_MEMORY_C...1,SET,184,0.051494,0.005129,0.061616,0.20166,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN,0.915535127737226
BUSSLINGER_GASTRIC_METALLOTH...,SET,91,0.077458,0.0054395,0.092687,0.20167,BUSSLINGER_GASTRIC_METALLOTHIONEIN_CELLS,0.915535127737226
GOBP_B_CELL_ACTIVATION,SET,244,0.047311,0.0054175,0.056617,0.20169,GOBP_B_CELL_ACTIVATION,0.915535127737226
HP_DISTAL_UPPER_LIMB_MUSCLE_...,SET,37,0.12444,0.0055805,0.14892,0.20169,HP_DISTAL_UPPER_LIMB_MUSCLE_WEAKNESS,0.915535127737226
HP_CLINODACTYLY,SET,492,0.031505,0.0050876,0.037705,0.20171,HP_CLINODACTYLY,0.915535127737226
GSE17721_12H_VS_24H_GARDIQUI...1,SET,175,0.049398,0.0047996,0.059122,0.20172,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_DN,0.915535127737226
HP_DECREASED_ACTIVITY_OF_MIT...3,SET,13,0.16966,0.0045128,0.20314,0.20181,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_II,0.915535127737226
THILLAINADESAN_ZNF217_TARGET...1,SET,6,0.31944,0.0057736,0.38249,0.20182,THILLAINADESAN_ZNF217_TARGETS_DN,0.915535127737226
GOBP_GLIAL_CELL_DIFFERENTIAT...,SET,247,0.046838,0.0053958,0.056093,0.20186,GOBP_GLIAL_CELL_DIFFERENTIATION,0.915535127737226
NADLER_OBESITY_DN,SET,46,0.10093,0.0050454,0.12088,0.20187,NADLER_OBESITY_DN,0.915535127737226
chr13q33,SET,18,0.25308,0.0079201,0.30314,0.20191,chr13q33,0.915535127737226
BREDEMEYER_RAG_SIGNALING_NOT...1,SET,57,0.094742,0.0052705,0.11352,0.20198,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,0.915535127737226
GOMF_PHOSPHATIDYLINOSITOL_3_...8,SET,11,0.16134,0.003948,0.19332,0.20198,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.915535127737226
HP_ABNORMALITY_OF_THE_TONGUE,SET,409,0.034546,0.0050982,0.041396,0.202,HP_ABNORMALITY_OF_THE_TONGUE,0.915535127737226
BIOCARTA_PKC_PATHWAY,SET,7,0.29426,0.0057444,0.35263,0.20202,BIOCARTA_PKC_PATHWAY,0.915535127737226
MIR8088,SET,5,0.28536,0.0047084,0.342,0.20203,MIR8088,0.915535127737226
MIR6739_3P,SET,174,0.054649,0.0052947,0.065502,0.20206,MIR6739_3P,0.915535127737226
GOBP_DORSAL_AORTA_MORPHOGENE...,SET,8,0.27747,0.0057904,0.33257,0.20206,GOBP_DORSAL_AORTA_MORPHOGENESIS,0.915535127737226
HP_RESPIRATORY_TRACT_INFECTI...,SET,680,0.027603,0.0052128,0.033085,0.20206,HP_RESPIRATORY_TRACT_INFECTION,0.915535127737226
GOBP_ESTABLISHMENT_OF_RNA_LO...,SET,143,0.054269,0.0047706,0.065056,0.20209,GOBP_ESTABLISHMENT_OF_RNA_LOCALIZATION,0.915535127737226
GOBP_INFLAMMASOME_MEDIATED_S...,SET,39,0.11233,0.0051714,0.13465,0.20209,GOBP_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.915535127737226
FERRANDO_TAL1_NEIGHBORS,SET,17,0.17187,0.0052274,0.20604,0.2021,FERRANDO_TAL1_NEIGHBORS,0.915535127737226
GOBP_ARTICULAR_CARTILAGE_DEV...,SET,5,0.29123,0.0048053,0.34913,0.2021,GOBP_ARTICULAR_CARTILAGE_DEVELOPMENT,0.915535127737226
ZFP82_TARGET_GENES,SET,25,0.13076,0.0048218,0.15679,0.20215,ZFP82_TARGET_GENES,0.915642284634432
MIR30B_3P,SET,154,0.055274,0.0050408,0.066286,0.20218,MIR30B_3P,0.915658835027365
GOMF_BRANCHED_CHAIN_AMINO_AC...,SET,9,0.23997,0.0053116,0.28787,0.20226,GOMF_BRANCHED_CHAIN_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.915692747495772
HP_GAZE_EVOKED_NYSTAGMUS,SET,53,0.089796,0.0048175,0.10774,0.20231,HP_GAZE_EVOKED_NYSTAGMUS,0.915692747495772
GOBP_NEUTROPHIL_DIFFERENTIAT...,SET,11,0.21959,0.0053732,0.2635,0.20232,GOBP_NEUTROPHIL_DIFFERENTIATION,0.915692747495772
MODULE_244,SET,172,0.050534,0.004868,0.060639,0.20233,MODULE_244,0.915692747495772
SOBOLEV_PBMC_PANDEMRIX_AGE_1...1,SET,15,0.19027,0.0054363,0.22837,0.20238,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP,0.915692747495772
GOBP_IMMUNOLOGICAL_MEMORY_PR...,SET,18,0.19257,0.0060264,0.23114,0.20239,GOBP_IMMUNOLOGICAL_MEMORY_PROCESS,0.915692747495772
AFFAR_YY1_TARGETS_DN,SET,236,0.046351,0.005221,0.055636,0.2024,AFFAR_YY1_TARGETS_DN,0.915692747495772
VALK_AML_CLUSTER_12,SET,24,0.1385,0.0050042,0.16627,0.20243,VALK_AML_CLUSTER_12,0.915692747495772
MIR216A_3P,SET,409,0.036185,0.0053401,0.043446,0.20246,MIR216A_3P,0.915692747495772
HP_AZOOSPERMIA,SET,105,0.067818,0.0051138,0.081429,0.20247,HP_AZOOSPERMIA,0.915692747495772
GSE5589_LPS_VS_LPS_AND_IL6_S...2,SET,180,0.052874,0.0052095,0.063488,0.20248,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,0.915692747495772
REACTOME_NERVOUS_SYSTEM_DEVE...,SET,533,0.030875,0.0051835,0.037081,0.20253,REACTOME_NERVOUS_SYSTEM_DEVELOPMENT,0.915692747495772
GSE36476_CTRL_VS_TSST_ACT_16...3,SET,185,0.049851,0.0049786,0.059871,0.20253,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN,0.915692747495772
GSE38697_LIGHT_ZONE_VS_DARK_...1,SET,113,0.067636,0.0052897,0.081241,0.20256,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,0.915709261186264
MIR624_5P,SET,97,0.070528,0.0051127,0.084731,0.20261,MIR624_5P,0.915787470741222
HP_NASOGASTRIC_TUBE_FEEDING_...,SET,34,0.12292,0.0052844,0.14769,0.20263,HP_NASOGASTRIC_TUBE_FEEDING_IN_INFANCY,0.915787470741222
HP_LEUKEMIA,SET,162,0.054169,0.0050657,0.0651,0.20268,HP_LEUKEMIA,0.915825369841682
GOBP_PROTEIN_LOCALIZATION_TO...38,SET,12,0.15958,0.0040784,0.19181,0.20272,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOPLASM,0.915825369841682
GSE20198_UNTREATED_VS_IL12_I...1,SET,176,0.050023,0.004874,0.060141,0.20278,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,0.915825369841682
GSE17721_0.5H_VS_12H_CPG_BMD...1,SET,186,0.049818,0.0049886,0.059897,0.20279,GSE17721_0.5H_VS_12H_CPG_BMDC_DN,0.915825369841682
MIR6165,SET,111,0.063822,0.0049473,0.076739,0.2028,MIR6165,0.915825369841682
GOBP_SNRNA_TRANSCRIPTION_BY_...1,SET,16,0.15417,0.0045491,0.1854,0.20283,GOBP_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.915825369841682
ZNF250_TARGET_GENES,SET,444,0.033127,0.0050887,0.039843,0.20287,ZNF250_TARGET_GENES,0.915825369841682
XU_HGF_SIGNALING_NOT_VIA_AKT...3,SET,23,0.14696,0.0051981,0.17681,0.20294,XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,0.915825369841682
GOCC_BASOLATERAL_PLASMA_MEMB...,SET,246,0.047369,0.0054461,0.056992,0.20295,GOCC_BASOLATERAL_PLASMA_MEMBRANE,0.915825369841682
GOBP_ACTIN_POLYMERIZATION_OR...,SET,171,0.05348,0.005137,0.064354,0.20298,GOBP_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION,0.915825369841682
GOBP_KILLING_BY_HOST_OF_SYMB...,SET,23,0.16486,0.0058312,0.19838,0.20299,GOBP_KILLING_BY_HOST_OF_SYMBIONT_CELLS,0.915825369841682
MIR4457,SET,112,0.066737,0.0051964,0.080314,0.203,MIR4457,0.915825369841682
GOBP_RETINAL_GANGLION_CELL_A...,SET,22,0.16317,0.0056446,0.19637,0.20302,GOBP_RETINAL_GANGLION_CELL_AXON_GUIDANCE,0.915825369841682
GSE36888_UNTREATED_VS_IL2_TR...7,SET,179,0.055397,0.005443,0.066675,0.20304,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN,0.915825369841682
HP_INGUINAL_HERNIA,SET,265,0.043635,0.0052041,0.052521,0.20305,HP_INGUINAL_HERNIA,0.915825369841682
MIR374C_5P,SET,381,0.037293,0.0053161,0.04489,0.20306,MIR374C_5P,0.915825369841682
GOBP_POSITIVE_REGULATION_OF_...411,SET,102,0.072958,0.0054227,0.087846,0.20313,GOBP_POSITIVE_REGULATION_OF_LIPID_LOCALIZATION,0.915891167315175
GOMF_EUKARYOTIC_INITIATION_F...,SET,9,0.19631,0.0043453,0.2364,0.20315,GOMF_EUKARYOTIC_INITIATION_FACTOR_4E_BINDING,0.915891167315175
PALOMERO_GSI_SENSITIVITY_DN,SET,3,0.42731,0.0054616,0.51457,0.20316,PALOMERO_GSI_SENSITIVITY_DN,0.915891167315175
MODULE_181,SET,270,0.043139,0.0051926,0.051954,0.20318,MODULE_181,0.915891167315175
MORF_LMO1,SET,48,0.10262,0.00524,0.1236,0.20321,MORF_LMO1,0.915907606017378
MIR6886_5P,SET,8,0.26508,0.005532,0.31948,0.20335,MIR6886_5P,0.916419767894191
MIR6780A_5P,SET,203,0.047439,0.0049605,0.057184,0.20339,MIR6780A_5P,0.916452495462795
GOBP_CD4_POSITIVE_ALPHA_BETA...4,SET,19,0.17538,0.0056389,0.21143,0.20341,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.916452495462795
WP_STING_PATHWAY_IN_KAWASAKI...,SET,18,0.1593,0.0049854,0.19209,0.20347,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,0.916485206065319
COLE_BLOOD_FLUMIST_QUADRIVAL...,SET,5,0.37167,0.0061325,0.44818,0.20347,COLE_BLOOD_FLUMIST_QUADRIVALENT_AGE_03_17YO_7DY_UP,0.916485206065319
GOMF_AMINOACYL_TRNA_HYDROLAS...,SET,4,0.26939,0.0039757,0.32488,0.2035,GOMF_AMINOACYL_TRNA_HYDROLASE_ACTIVITY,0.916501555008423
AP1_Q6,SET,233,0.046117,0.005162,0.055623,0.20353,AP1_Q6,0.916517899714952
GOBP_REGULATION_OF_GERM_CELL...,SET,7,0.22616,0.0044149,0.27285,0.2036,GOBP_REGULATION_OF_GERM_CELL_PROLIFERATION,0.916640615284974
FIRESTEIN_PROLIFERATION,SET,150,0.054563,0.0049115,0.065832,0.20361,FIRESTEIN_PROLIFERATION,0.916640615284974
WP_INTERFERON_TYPE_I_SIGNALI...,SET,51,0.10061,0.0052954,0.12143,0.20368,WP_INTERFERON_TYPE_I_SIGNALING,0.916836990027199
REACTOME_THE_ROLE_OF_GTSE1_I...,SET,73,0.075293,0.0047381,0.090891,0.20373,REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,0.916869571410074
MODULE_457,SET,10,0.21411,0.0049954,0.25848,0.20374,MODULE_457,0.916869571410074
GSE14308_TH1_VS_NATURAL_TREG...1,SET,181,0.049659,0.0049061,0.05996,0.20379,GSE14308_TH1_VS_NATURAL_TREG_DN,0.916975848006214
HP_ABNORMAL_MASTOID_MORPHOLO...,SET,10,0.21932,0.0051169,0.26493,0.20388,HP_ABNORMAL_MASTOID_MORPHOLOGY,0.917233303132281
HP_ALBINISM,SET,18,0.17525,0.0054846,0.21171,0.2039,HP_ALBINISM,0.917233303132281
GOBP_REGULATION_OF_RECEPTOR_...8,SET,100,0.073761,0.0054286,0.089119,0.20394,GOBP_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.917294512747509
REACTOME_MODULATION_BY_MTB_O...,SET,6,0.33757,0.0061012,0.40794,0.20399,REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM,0.917343163001294
MODULE_19,SET,281,0.044703,0.0054878,0.054033,0.20403,MODULE_19,0.917343163001294
GOBP_REGULATION_OF_PROTEIN_L...4,SET,38,0.1095,0.0049764,0.13236,0.20403,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,0.917343163001294
GOMF_OXIDOREDUCTASE_ACTIVITY...2,SET,51,0.097548,0.005134,0.11796,0.20413,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS,0.917672061482821
GOBP_ENDOCRINE_SYSTEM_DEVELO...,SET,130,0.066288,0.005558,0.080177,0.20419,GOBP_ENDOCRINE_SYSTEM_DEVELOPMENT,0.917672061482821
REACTOME_TIE2_SIGNALING,SET,18,0.15391,0.0048165,0.18618,0.20422,REACTOME_TIE2_SIGNALING,0.917672061482821
ARHGAP35_TARGET_GENES,SET,87,0.072444,0.0049749,0.087644,0.20424,ARHGAP35_TARGET_GENES,0.917672061482821
GSE26488_HDAC7_KO_VS_VP16_TR...2,SET,157,0.056417,0.0051946,0.068254,0.20424,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,0.917672061482821
SAGIV_CD24_TARGETS_UP,SET,21,0.16072,0.0054323,0.19448,0.20429,SAGIV_CD24_TARGETS_UP,0.917672061482821
GSE14769_UNSTIM_VS_80MIN_LPS...1,SET,188,0.054165,0.0054527,0.065547,0.20431,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN,0.917672061482821
LINDGREN_BLADDER_CANCER_HIGH...,SET,47,0.10391,0.0052503,0.12575,0.20433,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,0.917672061482821
GOBP_REGULATION_OF_NODAL_SIG...,SET,7,0.31013,0.0060543,0.37539,0.20436,GOBP_REGULATION_OF_NODAL_SIGNALING_PATHWAY,0.917672061482821
CUI_DEVELOPING_HEART_C8_MACR...,SET,248,0.046758,0.0053973,0.056601,0.20438,CUI_DEVELOPING_HEART_C8_MACROPHAGE,0.917672061482821
GSE46606_IRF4HIGH_VS_WT_CD40...1,SET,185,0.051135,0.0051069,0.061909,0.20441,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.917672061482821
HP_HIGH_PITCHED_VOICE,SET,41,0.11351,0.0053579,0.13743,0.20442,HP_HIGH_PITCHED_VOICE,0.917672061482821
PID_MTOR_4PATHWAY,SET,67,0.08558,0.0051602,0.10364,0.20447,PID_MTOR_4PATHWAY,0.917747117988395
GOBP_POSITIVE_REGULATION_OF_...70,SET,15,0.1698,0.0048512,0.20565,0.2045,GOBP_POSITIVE_REGULATION_OF_B_CELL_DIFFERENTIATION,0.917747117988395
MIR629_5P,SET,102,0.072153,0.0053629,0.087415,0.20458,MIR629_5P,0.917747117988395
REACTOME_BILE_ACID_AND_BILE_...,SET,44,0.11023,0.0053895,0.13355,0.20459,REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,0.917747117988395
GOBP_HARD_PALATE_DEVELOPMENT,SET,8,0.30551,0.0063756,0.3702,0.20462,GOBP_HARD_PALATE_DEVELOPMENT,0.917747117988395
REACTOME_PROTEIN_LIPOYLATION,SET,10,0.20311,0.0047387,0.24613,0.20464,REACTOME_PROTEIN_LIPOYLATION,0.917747117988395
REACTOME_NEF_MEDIATED_CD8_DO...,SET,7,0.25708,0.0050186,0.31157,0.20466,REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION,0.917747117988395
HP_APLASIA_HYPOPLASIA_OF_THE...72,SET,23,0.14205,0.0050245,0.17217,0.20467,HP_APLASIA_HYPOPLASIA_OF_THE_THYROID_GLAND,0.917747117988395
GOMF_LIPOPOLYSACCHARIDE_BIND...,SET,36,0.12552,0.0055525,0.15215,0.2047,GOMF_LIPOPOLYSACCHARIDE_BINDING,0.917747117988395
GOBP_INTERLEUKIN_18_MEDIATED...,SET,10,0.24413,0.0056957,0.29597,0.20474,GOBP_INTERLEUKIN_18_MEDIATED_SIGNALING_PATHWAY,0.917747117988395
GOBP_RESPONSE_TO_LIPOTEICHOI...,SET,10,0.2203,0.0051398,0.26708,0.20474,GOBP_RESPONSE_TO_LIPOTEICHOIC_ACID,0.917747117988395
GOBP_AMINO_SUGAR_METABOLIC_P...,SET,38,0.11689,0.0053122,0.14173,0.20476,GOBP_AMINO_SUGAR_METABOLIC_PROCESS,0.917747117988395
GOMF_DISULFIDE_OXIDOREDUCTAS...,SET,37,0.11123,0.004988,0.13488,0.20478,GOMF_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,0.917747117988395
HP_PEPTIC_ULCER,SET,34,0.13218,0.0056829,0.1603,0.20481,HP_PEPTIC_ULCER,0.917763222021661
HP_BULBOUS_NOSE,SET,176,0.051786,0.0050457,0.062814,0.20485,HP_BULBOUS_NOSE,0.917798898337843
chr11q13,SET,240,0.091424,0.010384,0.11091,0.20489,chr11q13,0.917798898337843
GOBP_REGULATION_OF_APOPTOTIC...1,SET,8,0.24858,0.0051875,0.30161,0.20493,GOBP_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE,0.917798898337843
GSE6269_HEALTHY_VS_STAPH_PNE...1,SET,151,0.056486,0.0051014,0.068542,0.20494,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN,0.917798898337843
GSE23505_UNTREATED_VS_4DAY_I...6,SET,171,0.048657,0.0046738,0.059044,0.20495,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_UP,0.917798898337843
YANG_BREAST_CANCER_ESR1_BULK...1,SET,22,0.1531,0.0052962,0.18581,0.20499,YANG_BREAST_CANCER_ESR1_BULK_DN,0.91784714064915
GOBP_REGULATION_OF_AMYLOID_F...,SET,14,0.16875,0.0046579,0.20484,0.20503,GOBP_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.91784714064915
TAKEDA_TARGETS_OF_NUP98_HOXA...10,SET,144,0.063552,0.005606,0.077147,0.20504,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,0.91784714064915
LI_PBMC_MENACTRA_AGE_18_45YO...1,SET,8,0.26033,0.0054328,0.3161,0.2051,LI_PBMC_MENACTRA_AGE_18_45YO_7DY_UP,0.917924034251867
GSE43955_TH0_VS_TGFB_IL6_IL2...1,SET,187,0.050778,0.0050983,0.061659,0.20511,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,0.917924034251867
GSE13306_TREG_VS_TCONV_SPLEE...1,SET,177,0.053224,0.0052005,0.064663,0.20523,GSE13306_TREG_VS_TCONV_SPLEEN_DN,0.917953760123409
CUI_DEVELOPING_HEART_C6_EPIC...,SET,178,0.055009,0.0053899,0.066839,0.20526,CUI_DEVELOPING_HEART_C6_EPICARDIAL_CELL,0.917953760123409
TTTGCAG_MIR518A2,SET,188,0.051109,0.0051451,0.062109,0.20529,TTTGCAG_MIR518A2,0.917953760123409
GOMF_INORGANIC_MOLECULAR_ENT...,SET,659,0.028205,0.0052466,0.034275,0.20529,GOMF_INORGANIC_MOLECULAR_ENTITY_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.917953760123409
VALK_AML_CLUSTER_2,SET,26,0.15396,0.0057895,0.18711,0.2053,VALK_AML_CLUSTER_2,0.917953760123409
ZNF354A_TARGET_GENES,SET,15,0.16825,0.0048071,0.2045,0.20533,ZNF354A_TARGET_GENES,0.917953760123409
GOMF_K63_LINKED_POLYUBIQUITI...,SET,22,0.12679,0.0043861,0.1541,0.20533,GOMF_K63_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.917953760123409
GOBP_CARDIAC_CELL_DEVELOPMENT,SET,82,0.080543,0.0053705,0.097898,0.20534,GOBP_CARDIAC_CELL_DEVELOPMENT,0.917953760123409
GOBP_CELL_MIGRATION_INVOLVED...3,SET,6,0.34601,0.0062537,0.42067,0.2054,GOBP_CELL_MIGRATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.917953760123409
NKX61_01,SET,215,0.05032,0.0054132,0.061188,0.20544,NKX61_01,0.917953760123409
MIR3129_3P,SET,94,0.073142,0.0052199,0.088945,0.20545,MIR3129_3P,0.917953760123409
MIR3689A_3P_MIR3689B_3P_MIR3...,SET,153,0.054614,0.0049646,0.066416,0.20546,MIR3689A_3P_MIR3689B_3P_MIR3689C,0.917953760123409
DESCARTES_FETAL_STOMACH_MESO...,SET,29,0.14167,0.0056257,0.17228,0.20546,DESCARTES_FETAL_STOMACH_MESOTHELIAL_CELLS,0.917953760123409
REACTOME_INTERFERON_GAMMA_SI...,SET,90,0.078992,0.0055168,0.096103,0.20556,REACTOME_INTERFERON_GAMMA_SIGNALING,0.918017846588719
GOBP_ASTROCYTE_DEVELOPMENT,SET,40,0.11352,0.0052926,0.13811,0.20556,GOBP_ASTROCYTE_DEVELOPMENT,0.918017846588719
HP_MEDIAN_CLEFT_PALATE,SET,24,0.15099,0.0054553,0.1837,0.20556,HP_MEDIAN_CLEFT_PALATE,0.918017846588719
HP_HEADACHE,SET,298,0.040199,0.0050795,0.048911,0.20558,HP_HEADACHE,0.918017846588719
WP_16P112_DISTAL_DELETION_SY...,SET,31,0.13767,0.0056521,0.16753,0.20561,WP_16P112_DISTAL_DELETION_SYNDROME,0.918033857913669
DESCARTES_FETAL_LUNG_MESOTHE...,SET,83,0.083107,0.005575,0.10117,0.2057,DESCARTES_FETAL_LUNG_MESOTHELIAL_CELLS,0.918260395531013
GSE26030_TH1_VS_TH17_DAY5_PO...2,SET,183,0.050748,0.005041,0.061785,0.20573,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP,0.918260395531013
YGCANTGCR_UNKNOWN,SET,109,0.065991,0.0050694,0.080348,0.20574,YGCANTGCR_UNKNOWN,0.918260395531013
KEGG_RNA_POLYMERASE,SET,24,0.13151,0.0047515,0.16014,0.20577,KEGG_RNA_POLYMERASE,0.918276367488444
GSE17721_POLYIC_VS_GARDIQUIM...3,SET,182,0.04909,0.0048632,0.059797,0.20584,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_DN,0.918470817820003
chr3q23,SET,27,0.24044,0.0092136,0.29305,0.20598,chr3q23,0.918830852156057
REACTOME_GAB1_SIGNALOSOME,SET,17,0.17412,0.0052957,0.21224,0.206,REACTOME_GAB1_SIGNALOSOME,0.918830852156057
MIR6879_5P,SET,99,0.070436,0.0051581,0.085855,0.206,MIR6879_5P,0.918830852156057
RUAN_RESPONSE_TO_TNF_UP,SET,13,0.19996,0.0053189,0.24379,0.20605,RUAN_RESPONSE_TO_TNF_UP,0.918894381734223
GOBP_HEPATIC_STELLATE_CELL_A...,SET,9,0.25565,0.0056586,0.31171,0.20607,GOBP_HEPATIC_STELLATE_CELL_ACTIVATION,0.918894381734223
GOBP_CELLULAR_COMPONENT_ASSE...,SET,130,0.059528,0.0049911,0.072592,0.2061,GOBP_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS,0.918894381734223
UBN1_TARGET_GENES,SET,1414,0.01911,0.005095,0.023306,0.20612,UBN1_TARGET_GENES,0.918894381734223
GSE8835_CD4_VS_CD8_TCELL_CLL...1,SET,185,0.051903,0.0051836,0.063325,0.20622,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN,0.91920936658546
DER_IFN_BETA_RESPONSE_UP,SET,98,0.070069,0.0051054,0.085503,0.20626,DER_IFN_BETA_RESPONSE_UP,0.91920936658546
REACTOME_ZBP1_DAI_MEDIATED_I...,SET,20,0.14681,0.0048428,0.17916,0.20627,REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,0.91920936658546
HP_ULNAR_CLAW,SET,9,0.25579,0.0056618,0.31224,0.20634,HP_ULNAR_CLAW,0.919403423076923
HP_SEVERE_SHORT_LIMB_DWARFISM,SET,5,0.34375,0.0056719,0.41969,0.20638,HP_SEVERE_SHORT_LIMB_DWARFISM,0.919435016662394
chr7q32,SET,43,0.20769,0.010039,0.2536,0.2064,chr7q32,0.919435016662394
FRASOR_RESPONSE_TO_SERM_OR_F...2,SET,21,0.15938,0.0053871,0.19466,0.20647,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,0.919628969627067
GOBP_NEGATIVE_REGULATION_OF_...10,SET,60,0.097535,0.0055664,0.11916,0.20653,GOBP_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,0.919689911775988
JINESH_BLEBBISHIELD_TO_IMMUN...1,SET,342,0.039741,0.0053731,0.048554,0.20654,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,0.919689911775988
chr19p13,SET,517,0.070246,0.01162,0.085844,0.2066,chr19p13,0.919689911775988
RAFFEL_VEGFA_TARGETS_DN,SET,5,0.30831,0.0050871,0.37689,0.20667,RAFFEL_VEGFA_TARGETS_DN,0.919689911775988
BIOCARTA_NKT_PATHWAY,SET,24,0.1488,0.0053762,0.18189,0.20667,BIOCARTA_NKT_PATHWAY,0.919689911775988
REACTOME_APOPTOSIS_INDUCED_D...,SET,7,0.2361,0.004609,0.28865,0.2067,REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION,0.919689911775988
GSE43955_TH0_VS_TGFB_IL6_TH1...1,SET,180,0.052083,0.0051315,0.063687,0.20674,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_DN,0.919689911775988
DURAND_STROMA_NS_UP,SET,161,0.056542,0.0052714,0.069148,0.20677,DURAND_STROMA_NS_UP,0.919689911775988
GOBP_GLIAL_CELL_DEVELOPMENT,SET,126,0.062643,0.0051715,0.076613,0.20678,GOBP_GLIAL_CELL_DEVELOPMENT,0.919689911775988
GOBP_SNO_S_RNA_METABOLIC_PRO...,SET,11,0.18915,0.0046284,0.23136,0.2068,GOBP_SNO_S_RNA_METABOLIC_PROCESS,0.919689911775988
GOBP_CELLULAR_GLUCURONIDATION,SET,19,0.26422,0.008495,0.3232,0.20683,GOBP_CELLULAR_GLUCURONIDATION,0.919689911775988
HP_RESPIRATORY_INSUFFICIENCY...,SET,5,0.27869,0.0045982,0.34096,0.20687,HP_RESPIRATORY_INSUFFICIENCY_DUE_TO_DEFECTIVE_CILIARY_CLEARANCE,0.919689911775988
HP_SEESAW_NYSTAGMUS,SET,6,0.28157,0.0050892,0.3445,0.20687,HP_SEESAW_NYSTAGMUS,0.919689911775988
RICKMAN_TUMOR_DIFFERENTIATED...5,SET,356,0.037391,0.0051558,0.045748,0.20688,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,0.919689911775988
WP_4P163_COPY_NUMBER_VARIATI...,SET,27,0.13053,0.0050016,0.15972,0.20691,WP_4P163_COPY_NUMBER_VARIATION,0.919689911775988
BIOCARTA_RHO_PATHWAY,SET,18,0.15303,0.0047892,0.18731,0.20696,BIOCARTA_RHO_PATHWAY,0.919689911775988
GOBP_POSITIVE_REGULATION_OF_...64,SET,2,0.37581,0.003922,0.45997,0.20696,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_REMODELING,0.919689911775988
HP_HYPOPLASTIC_ILIAC_WING,SET,27,0.13858,0.0053104,0.16962,0.20696,HP_HYPOPLASTIC_ILIAC_WING,0.919689911775988
GOBP_RNA_STABILIZATION,SET,60,0.090491,0.0051645,0.11082,0.20709,GOBP_RNA_STABILIZATION,0.920149955254411
GSE45365_WT_VS_IFNAR_KO_CD8A...4,SET,174,0.052746,0.0051103,0.064613,0.20716,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_UP,0.920228210042162
BIOCARTA_IL10_PATHWAY,SET,13,0.20104,0.0053475,0.24632,0.2072,BIOCARTA_IL10_PATHWAY,0.920228210042162
LAKE_ADULT_KIDNEY_C10_THIN_A...,SET,317,0.039103,0.0050934,0.04791,0.2072,LAKE_ADULT_KIDNEY_C10_THIN_ASCENDING_LIMB,0.920228210042162
GOMF_PHOSPHATIDYLSERINE_BIND...,SET,65,0.091554,0.0054377,0.11218,0.20722,GOMF_PHOSPHATIDYLSERINE_BINDING,0.920228210042162
GOBP_SKELETAL_MUSCLE_ACETYLC...,SET,11,0.19269,0.004715,0.23613,0.20724,GOBP_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING,0.920228210042162
TET1_TARGET_GENES,SET,1072,0.021392,0.0050157,0.026218,0.20728,TET1_TARGET_GENES,0.920288247317322
MARIADASON_RESPONSE_TO_BUTYR...5,SET,40,0.11484,0.0053541,0.14078,0.20734,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,0.920408275862069
GSE360_CTRL_VS_L_DONOVANI_MA...1,SET,175,0.051121,0.004967,0.062676,0.20736,GSE360_CTRL_VS_L_DONOVANI_MAC_DN,0.920408275862069
HP_ABNORMAL_NATURAL_KILLER_C...,SET,38,0.1062,0.0048261,0.13022,0.2074,HP_ABNORMAL_NATURAL_KILLER_CELL_MORPHOLOGY,0.920468267143404
GOMF_FOUR_WAY_JUNCTION_DNA_B...,SET,16,0.16431,0.0048482,0.20159,0.20753,GOMF_FOUR_WAY_JUNCTION_DNA_BINDING,0.920854423592493
MIR767_5P,SET,174,0.053178,0.0051522,0.065249,0.20754,MIR767_5P,0.920854423592493
UNTERMAN_IPF_VS_CTRL_TREG_CE...1,SET,16,0.19743,0.0058255,0.24228,0.20757,UNTERMAN_IPF_VS_CTRL_TREG_CELL_DN,0.920869970640796
STEGER_ADIPOGENESIS_DN,SET,22,0.14811,0.0051237,0.18177,0.2076,STEGER_ADIPOGENESIS_DN,0.920885513720485
HP_MENTAL_DETERIORATION,SET,333,0.036993,0.0049365,0.045424,0.20772,HP_MENTAL_DETERIORATION,0.92119816917581
GOBP_POSITIVE_REGULATION_OF_...593,SET,7,0.26997,0.0052703,0.33154,0.20774,GOBP_POSITIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.92119816917581
MIR589_5P,SET,77,0.076608,0.0049506,0.094082,0.20775,MIR589_5P,0.92119816917581
RBL1_TARGET_GENES,SET,36,0.11531,0.0051009,0.14168,0.20786,RBL1_TARGET_GENES,0.921470338983051
GOBP_RESPIRATORY_CHAIN_COMPL...2,SET,23,0.1266,0.0044779,0.15557,0.20789,GOBP_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY,0.921470338983051
GSE14000_UNSTIM_VS_16H_LPS_D...1,SET,174,0.05174,0.0050128,0.063603,0.20798,GSE14000_UNSTIM_VS_16H_LPS_DC_DN,0.921470338983051
GSE16385_UNTREATED_VS_12H_IL...1,SET,171,0.052545,0.0050472,0.064601,0.20801,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN,0.921470338983051
WHITFIELD_CELL_CYCLE_G1_S,SET,117,0.059766,0.0047556,0.073483,0.20802,WHITFIELD_CELL_CYCLE_G1_S,0.921470338983051
GSE2585_AIRE_KO_VS_WT_CD80_L...1,SET,192,0.049223,0.0050071,0.06052,0.20802,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN,0.921470338983051
MIR524_5P,SET,853,0.024455,0.0051472,0.030072,0.20805,MIR524_5P,0.921470338983051
HP_AXONAL_REGENERATION,SET,6,0.31484,0.0056904,0.38714,0.20805,HP_AXONAL_REGENERATION,0.921470338983051
GSE2770_UNTREATED_VS_ACT_CD4...4,SET,171,0.050975,0.0048964,0.062683,0.20805,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP,0.921470338983051
GOBP_TELOMERE_TETHERING_AT_N...,SET,3,0.31347,0.0040066,0.38576,0.20823,GOBP_TELOMERE_TETHERING_AT_NUCLEAR_PERIPHERY,0.922003662420382
GSE19198_CTRL_VS_IL21_TREATE...5,SET,176,0.051747,0.005042,0.063682,0.20823,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN,0.922003662420382
GSE13306_LAMINA_PROPRIA_VS_S...1,SET,186,0.051019,0.0051089,0.06279,0.20825,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN,0.922003662420382
GOMF_HISTONE_MODIFYING_ACTIV...,SET,182,0.047638,0.0047193,0.058647,0.20832,GOMF_HISTONE_MODIFYING_ACTIVITY,0.92210433402515
REACTOME_ABACAVIR_TRANSMEMBR...,SET,5,0.3518,0.0058047,0.43322,0.20838,REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT,0.92210433402515
REACTOME_RHOT1_GTPASE_CYCLE,SET,5,0.30182,0.00498,0.37166,0.20838,REACTOME_RHOT1_GTPASE_CYCLE,0.92210433402515
GSE17721_POLYIC_VS_GARDIQUIM...9,SET,176,0.049808,0.0048531,0.06136,0.20847,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_DN,0.92210433402515
HP_FOCAL_EMOTIONAL_SEIZURE,SET,17,0.16818,0.0051151,0.2072,0.20849,HP_FOCAL_EMOTIONAL_SEIZURE,0.92210433402515
MARSON_BOUND_BY_E2F4_UNSTIMU...,SET,613,0.028331,0.0050895,0.034907,0.20851,MARSON_BOUND_BY_E2F4_UNSTIMULATED,0.92210433402515
GOMF_ARP2_3_COMPLEX_BINDING,SET,13,0.18427,0.0049015,0.22705,0.20852,GOMF_ARP2_3_COMPLEX_BINDING,0.92210433402515
HP_ANAL_FISSURE,SET,4,0.26967,0.0039799,0.33236,0.20858,HP_ANAL_FISSURE,0.92210433402515
REACTOME_HEME_BIOSYNTHESIS,SET,13,0.18671,0.0049664,0.23016,0.20862,REACTOME_HEME_BIOSYNTHESIS,0.92210433402515
HP_DECREASED_CIRCULATING_COM...3,SET,3,0.41939,0.0053604,0.51704,0.20865,HP_DECREASED_CIRCULATING_COMPLEMENT_FACTOR_B_CONCENTRATION,0.92210433402515
GOBP_TRANS_SYNAPTIC_SIGNALIN...1,SET,4,0.38247,0.0056445,0.47157,0.20867,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_BDNF,0.92210433402515
MIR135A_2_3P,SET,48,0.092903,0.0047439,0.11458,0.20874,MIR135A_2_3P,0.92210433402515
MIR135B_3P,SET,48,0.092903,0.0047439,0.11458,0.20874,MIR135B_3P,0.92210433402515
GOMF_WD40_REPEAT_DOMAIN_BIND...,SET,4,0.30119,0.004445,0.37148,0.20876,GOMF_WD40_REPEAT_DOMAIN_BINDING,0.92210433402515
GSE13946_CTRL_VS_DSS_COLITIS...2,SET,163,0.055314,0.0051885,0.068234,0.20879,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_UP,0.92210433402515
DELYS_THYROID_CANCER_DN,SET,213,0.050788,0.0054384,0.062653,0.2088,DELYS_THYROID_CANCER_DN,0.92210433402515
HP_CHRONIC_KIDNEY_DISEASE,SET,178,0.049881,0.0048874,0.061536,0.2088,HP_CHRONIC_KIDNEY_DISEASE,0.92210433402515
GSE13946_CTRL_VS_DSS_COLITIS...1,SET,157,0.054373,0.0050064,0.06708,0.20881,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN,0.92210433402515
GOBP_REGULATION_OF_CELL_DIFF...,SET,1405,0.019489,0.0051809,0.024048,0.20885,GOBP_REGULATION_OF_CELL_DIFFERENTIATION,0.92210433402515
MIR4312,SET,42,0.10874,0.0051948,0.1342,0.20889,MIR4312,0.92210433402515
GOCC_GOLGI_CIS_CISTERNA,SET,15,0.16597,0.0047419,0.20487,0.20894,GOCC_GOLGI_CIS_CISTERNA,0.92210433402515
GOBP_REGULATION_OF_TETRAPYRR...,SET,7,0.27546,0.0053774,0.34003,0.20895,GOBP_REGULATION_OF_TETRAPYRROLE_METABOLIC_PROCESS,0.92210433402515
GSE32901_NAIVE_VS_TH1_CD4_TC...2,SET,113,0.064942,0.005079,0.080173,0.20897,GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP,0.92210433402515
KEGG_MEDICUS_VARIANT_DUPLICA...2,SET,13,0.18395,0.0048928,0.2271,0.20898,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY,0.92210433402515
HP_PROLONGED_BLEEDING_FOLLOW...1,SET,11,0.24027,0.0058793,0.29666,0.20899,HP_PROLONGED_BLEEDING_FOLLOWING_CIRCUMCISION,0.92210433402515
GOBP_NEGATIVE_REGULATION_OF_...52,SET,15,0.17819,0.0050909,0.22003,0.20902,GOBP_NEGATIVE_REGULATION_OF_BONE_MINERALIZATION,0.92210433402515
REACTOME_ATF4_ACTIVATES_GENE...,SET,26,0.12978,0.0048801,0.16032,0.20912,REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.92210433402515
ZSCAN30_TARGET_GENES,SET,1380,0.019246,0.0050742,0.023783,0.20919,ZSCAN30_TARGET_GENES,0.92210433402515
GOBP_NEGATIVE_REGULATION_OF_...99,SET,4,0.36342,0.0053634,0.44907,0.20919,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,0.92210433402515
GOBP_ISG15_PROTEIN_CONJUGATI...,SET,6,0.25766,0.004657,0.31842,0.20921,GOBP_ISG15_PROTEIN_CONJUGATION,0.92210433402515
REACTOME_EGR2_AND_SOX10_MEDI...,SET,27,0.13953,0.0053467,0.17246,0.20924,REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,0.92210433402515
HP_MESOMELIC_LEG_SHORTENING,SET,5,0.3005,0.0049581,0.37146,0.20927,HP_MESOMELIC_LEG_SHORTENING,0.92210433402515
GSE5589_UNSTIM_VS_180MIN_LPS...1,SET,184,0.048168,0.0047977,0.059542,0.20927,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,0.92210433402515
WP_NUCLEAR_RECEPTORS_IN_LIPI...,SET,33,0.12161,0.005151,0.15033,0.20928,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,0.92210433402515
GSE21063_WT_VS_NFATC1_KO_16H...2,SET,175,0.049762,0.004835,0.061519,0.2093,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_UP,0.92210433402515
GSE7548_DAY7_VS_DAY28_PCC_IM...2,SET,187,0.050404,0.0050608,0.062323,0.20933,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,0.92210433402515
GOBP_DNA_REPLICATION_INITIAT...,SET,35,0.10889,0.0047494,0.1347,0.20944,GOBP_DNA_REPLICATION_INITIATION,0.92210433402515
GOBP_CYTOSKELETON_ORGANIZATI...,SET,1360,0.019069,0.0049938,0.023591,0.20946,GOBP_CYTOSKELETON_ORGANIZATION,0.92210433402515
GSE18791_CTRL_VS_NEWCASTLE_V...6,SET,176,0.049413,0.0048145,0.061141,0.2095,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP,0.92210433402515
KEGG_MEDICUS_VARIANT_MUTATIO...41,SET,13,0.17328,0.0046091,0.21442,0.20951,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION,0.92210433402515
REACTOME_SARS_COV_2_INFECTION,SET,268,0.040605,0.0048698,0.050247,0.20952,REACTOME_SARS_COV_2_INFECTION,0.92210433402515
GOBP_LIPID_STORAGE,SET,85,0.078904,0.0053562,0.097668,0.20958,GOBP_LIPID_STORAGE,0.92210433402515
GOMF_HISTONE_H3K27ME2_H3K27M...,SET,2,0.40022,0.0041768,0.49547,0.20962,GOMF_HISTONE_H3K27ME2_H3K27ME3_DEMETHYLASE_ACTIVITY,0.92210433402515
GSE2706_R848_VS_R848_AND_LPS...1,SET,164,0.056114,0.0052795,0.069472,0.20963,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN,0.92210433402515
REACTOME_SLC_MEDIATED_TRANSM...,SET,235,0.046038,0.0051749,0.056998,0.20964,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,0.92210433402515
HP_ACUTE_LEUKEMIA,SET,110,0.06445,0.0049736,0.079821,0.20971,HP_ACUTE_LEUKEMIA,0.92210433402515
MODULE_377,SET,10,0.2253,0.0052564,0.27907,0.20975,MODULE_377,0.92210433402515
GOMF_METALLOENDOPEPTIDASE_IN...,SET,13,0.18474,0.0049141,0.22887,0.20978,GOMF_METALLOENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.92210433402515
GSE11961_FOLLICULAR_BCELL_VS...6,SET,180,0.051388,0.005063,0.063675,0.20983,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_UP,0.92210433402515
GOBP_POSITIVE_REGULATION_OF_...578,SET,147,0.058473,0.005211,0.072463,0.20986,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,0.92210433402515
GOBP_NEUROTRANSMITTER_GATED_...,SET,15,0.19337,0.0055246,0.23965,0.20987,GOBP_NEUROTRANSMITTER_GATED_ION_CHANNEL_CLUSTERING,0.92210433402515
GOBP_VASCULOGENESIS_INVOLVED...,SET,4,0.3982,0.0058768,0.49351,0.20987,GOBP_VASCULOGENESIS_INVOLVED_IN_CORONARY_VASCULAR_MORPHOGENESIS,0.92210433402515
GOBP_REPRODUCTIVE_PROCESS,SET,1328,0.019433,0.0050338,0.024087,0.2099,GOBP_REPRODUCTIVE_PROCESS,0.92210433402515
GOBP_SUCCINATE_METABOLIC_PRO...,SET,7,0.28385,0.0055413,0.35187,0.20993,GOBP_SUCCINATE_METABOLIC_PROCESS,0.92210433402515
GOBP_POSITIVE_REGULATION_OF_...425,SET,19,0.15585,0.0050107,0.19323,0.20997,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS,0.92210433402515
HP_REDUCED_SUBCUTANEOUS_ADIP...,SET,30,0.13288,0.0053669,0.16478,0.21,HP_REDUCED_SUBCUTANEOUS_ADIPOSE_TISSUE,0.92210433402515
GOBP_POSITIVE_REGULATION_OF_...28,SET,24,0.14177,0.0051222,0.17582,0.21002,GOBP_POSITIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.92210433402515
WP_MYD88_DISTINCT_INPUTOUTPU...,SET,15,0.19887,0.0056817,0.24662,0.21003,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,0.92210433402515
GOBP_MESENCHYME_MIGRATION,SET,5,0.31235,0.0051536,0.38736,0.21003,GOBP_MESENCHYME_MIGRATION,0.92210433402515
GOBP_POSITIVE_REGULATION_OF_...764,SET,6,0.28995,0.0052405,0.35961,0.21004,GOBP_POSITIVE_REGULATION_OF_TOOTH_MINERALIZATION,0.92210433402515
GOBP_VIRAL_TRANSCRIPTION,SET,50,0.086045,0.0044841,0.10673,0.21006,GOBP_VIRAL_TRANSCRIPTION,0.92210433402515
HALLMARK_E2F_TARGETS,SET,188,0.047037,0.0047352,0.058341,0.21006,HALLMARK_E2F_TARGETS,0.92210433402515
WENG_POR_TARGETS_GLOBAL_UP,SET,18,0.14398,0.004506,0.17864,0.21013,WENG_POR_TARGETS_GLOBAL_UP,0.92210433402515
GOBP_REGULATION_OF_DNA_LIGAT...,SET,6,0.26366,0.0047655,0.32713,0.21013,GOBP_REGULATION_OF_DNA_LIGATION,0.92210433402515
PID_BARD1_PATHWAY,SET,28,0.11782,0.0045975,0.14619,0.21014,PID_BARD1_PATHWAY,0.92210433402515
PURWIN_A375_MEWO_COMMON_SOX1...,SET,25,0.13356,0.004925,0.16576,0.21019,PURWIN_A375_MEWO_COMMON_SOX10_TARGETS,0.92210433402515
REACTOME_NFE2L2_REGULATING_A...,SET,19,0.16485,0.0053003,0.20459,0.21019,REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES,0.92210433402515
GOBP_SEMINIFEROUS_TUBULE_DEV...,SET,13,0.19635,0.0052227,0.24368,0.2102,GOBP_SEMINIFEROUS_TUBULE_DEVELOPMENT,0.92210433402515
HP_HALLUCINATIONS,SET,145,0.055062,0.0048738,0.068338,0.2102,HP_HALLUCINATIONS,0.92210433402515
GSE17721_PAM3CSK4_VS_CPG_24H...2,SET,176,0.049268,0.0048005,0.061149,0.21021,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_UP,0.92210433402515
GSE1460_CD4_THYMOCYTE_VS_NAI...2,SET,182,0.050678,0.0050204,0.062914,0.21027,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.92210433402515
HP_HORSESHOE_KIDNEY,SET,122,0.05879,0.0047763,0.072993,0.21029,HP_HORSESHOE_KIDNEY,0.92210433402515
HP_PROXIMAL_SYMPHALANGISM_OF...,SET,5,0.34602,0.0057092,0.4296,0.21029,HP_PROXIMAL_SYMPHALANGISM_OF_HANDS,0.92210433402515
HP_INTELLECTUAL_DISABILITY_M...1,SET,289,0.040157,0.0049983,0.049861,0.2103,HP_INTELLECTUAL_DISABILITY_MILD,0.92210433402515
GSE9037_WT_VS_IRAK4_KO_BMDM_...2,SET,179,0.050695,0.004981,0.062954,0.21034,GSE9037_WT_VS_IRAK4_KO_BMDM_UP,0.92210433402515
GSE46242_CTRL_VS_EGR2_DELETE...2,SET,169,0.051289,0.0048979,0.063697,0.21036,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP,0.92210433402515
DURANTE_ADULT_OLFACTORY_NEUR...10,SET,66,0.092343,0.0055264,0.11468,0.21036,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MAST_CELLS,0.92210433402515
GOBP_NEGATIVE_REGULATION_OF_...371,SET,13,0.19192,0.005105,0.23838,0.21038,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,0.92210433402515
FOROUTAN_PRODRANK_TGFB_EMT_DN,SET,76,0.083276,0.0053466,0.10344,0.21039,FOROUTAN_PRODRANK_TGFB_EMT_DN,0.92210433402515
BIOCARTA_TOLL_PATHWAY,SET,22,0.1507,0.0052132,0.18724,0.21046,BIOCARTA_TOLL_PATHWAY,0.92210433402515
PID_ARF_3PATHWAY,SET,19,0.14556,0.00468,0.18087,0.21047,PID_ARF_3PATHWAY,0.92210433402515
FLETCHER_PBMC_BCG_10W_INFANT...2,SET,119,0.069806,0.0056015,0.08674,0.21048,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_UP,0.92210433402515
GSE17721_LPS_VS_POLYIC_24H_B...1,SET,178,0.0507,0.0049677,0.063012,0.21052,GSE17721_LPS_VS_POLYIC_24H_BMDC_DN,0.92210433402515
GOBP_IMMUNOLOGICAL_MEMORY_FO...,SET,13,0.21831,0.0058069,0.27138,0.21057,GOBP_IMMUNOLOGICAL_MEMORY_FORMATION_PROCESS,0.92210433402515
GOBP_THALAMUS_DEVELOPMENT,SET,10,0.22677,0.0052907,0.28189,0.21057,GOBP_THALAMUS_DEVELOPMENT,0.92210433402515
HP_SMALL_FORAMEN_MAGNUM,SET,11,0.17859,0.00437,0.222,0.21057,HP_SMALL_FORAMEN_MAGNUM,0.92210433402515
MIR1252_5P,SET,294,0.03925,0.0049267,0.048801,0.21062,MIR1252_5P,0.92210433402515
ZBED4_TARGET_GENES,SET,248,0.042298,0.0048826,0.052601,0.21067,ZBED4_TARGET_GENES,0.92210433402515
MIR4450,SET,66,0.080229,0.0048015,0.099819,0.21078,MIR4450,0.92210433402515
MODULE_305,SET,19,0.1462,0.0047006,0.1819,0.21078,MODULE_305,0.92210433402515
HP_ABNORMAL_CARTILAGE_MORPHO...,SET,41,0.10875,0.005133,0.1353,0.21078,HP_ABNORMAL_CARTILAGE_MORPHOLOGY,0.92210433402515
CHIARADONNA_NEOPLASTIC_TRANS...6,SET,113,0.06527,0.0051046,0.081222,0.21082,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,0.92210433402515
HP_WRIST_DROP,SET,7,0.27027,0.0052761,0.33637,0.21086,HP_WRIST_DROP,0.92210433402515
MIR6779_5P,SET,158,0.052885,0.0048846,0.065831,0.2109,MIR6779_5P,0.92210433402515
IM_SREBF1A_TARGETS,SET,5,0.2902,0.0047882,0.36126,0.21091,IM_SREBF1A_TARGETS,0.92210433402515
HP_POSTNATAL_MACROCEPHALY,SET,5,0.25073,0.004137,0.31218,0.21095,HP_POSTNATAL_MACROCEPHALY,0.92210433402515
GOBP_DETECTION_OF_MECHANICAL...1,SET,51,0.097881,0.0051515,0.1219,0.21099,GOBP_DETECTION_OF_MECHANICAL_STIMULUS,0.92210433402515
GOBP_ENDOCRINE_HORMONE_SECRE...,SET,54,0.098904,0.0053558,0.12317,0.211,GOBP_ENDOCRINE_HORMONE_SECRETION,0.92210433402515
GSE10239_NAIVE_VS_KLRG1INT_E...1,SET,184,0.048728,0.0048535,0.060708,0.21109,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN,0.92210433402515
HP_MICROVESICULAR_HEPATIC_ST...,SET,19,0.14623,0.0047014,0.18219,0.2111,HP_MICROVESICULAR_HEPATIC_STEATOSIS,0.92210433402515
REACTOME_ENDOSOMAL_SORTING_C...,SET,30,0.11452,0.0046253,0.14269,0.21112,REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT,0.92210433402515
GSE23505_IL6_IL1_IL23_VS_IL6...2,SET,180,0.049534,0.0048804,0.061723,0.21113,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,0.92210433402515
GSE23114_WT_VS_SLE2C1_MOUSE_...1,SET,167,0.052948,0.0050266,0.06599,0.21118,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_DN,0.92210433402515
GOBP_CYTOKINESIS,SET,164,0.051386,0.0048347,0.064056,0.21122,GOBP_CYTOKINESIS,0.92210433402515
HOLLERN_MICROACINAR_BREAST_T...2,SET,40,0.1111,0.0051799,0.13851,0.21125,HOLLERN_MICROACINAR_BREAST_TUMOR_UP,0.92210433402515
GOBP_SKELETAL_MUSCLE_SATELLI...1,SET,9,0.20763,0.0045957,0.25885,0.21125,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_ACTIVATION,0.92210433402515
GSE12839_CTRL_VS_IL12_TREATE...2,SET,135,0.057279,0.0048934,0.071415,0.21126,GSE12839_CTRL_VS_IL12_TREATED_PBMC_UP,0.92210433402515
HP_DECREASED_EOSINOPHIL_COUNT,SET,8,0.24818,0.0051793,0.30946,0.21128,HP_DECREASED_EOSINOPHIL_COUNT,0.92210433402515
HP_MENINGIOMA,SET,42,0.095874,0.0045801,0.11957,0.21134,HP_MENINGIOMA,0.92210433402515
BUSSLINGER_DUODENAL_STEM_CEL...,SET,281,0.041174,0.0050546,0.051357,0.21136,BUSSLINGER_DUODENAL_STEM_CELLS,0.92210433402515
ROPERO_HDAC2_TARGETS,SET,98,0.068222,0.0049708,0.085095,0.21137,ROPERO_HDAC2_TARGETS,0.92210433402515
HP_HYPERURICOSURIA,SET,8,0.2175,0.004539,0.27134,0.2114,HP_HYPERURICOSURIA,0.92210433402515
GOBP_REGULATION_OF_POST_TRAN...,SET,211,0.045067,0.0048033,0.056225,0.21141,GOBP_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.92210433402515
HP_OLIGOSACCHARIDURIA,SET,9,0.21413,0.0047397,0.26715,0.21141,HP_OLIGOSACCHARIDURIA,0.92210433402515
MODULE_226,SET,27,0.12731,0.0048783,0.15884,0.21143,MODULE_226,0.92210433402515
MODULE_152,SET,102,0.060091,0.0044663,0.074995,0.21149,MODULE_152,0.92210433402515
GOBP_NEGATIVE_REGULATION_OF_...136,SET,4,0.36044,0.0053194,0.44984,0.2115,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,0.92210433402515
MIR5583_5P,SET,93,0.071561,0.00508,0.089318,0.21152,MIR5583_5P,0.92210433402515
GOBP_POSITIVE_REGULATION_OF_...690,SET,9,0.23694,0.0052445,0.29575,0.21153,GOBP_POSITIVE_REGULATION_OF_RRNA_PROCESSING,0.92210433402515
HP_MECHANICAL_ILEUS,SET,21,0.15881,0.0053679,0.19825,0.21155,HP_MECHANICAL_ILEUS,0.92210433402515
GSE22282_HYPOXIA_VS_NORMOXIA...2,SET,174,0.05035,0.0048782,0.062853,0.21155,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP,0.92210433402515
CREB_Q2,SET,237,0.044516,0.0050249,0.055572,0.21156,CREB_Q2,0.92210433402515
HP_ABNORMALITY_OF_THE_HYPOTH...2,SET,7,0.25448,0.0049679,0.31775,0.2116,HP_ABNORMALITY_OF_THE_HYPOTHENAR_EMINENCE,0.92210433402515
GOBP_POSITIVE_REGULATION_OF_...359,SET,11,0.21866,0.0053504,0.27303,0.21161,GOBP_POSITIVE_REGULATION_OF_INTEGRIN_ACTIVATION,0.92210433402515
GSE40068_CXCR5POS_BCL6POS_TF...1,SET,183,0.052405,0.0052056,0.065439,0.21162,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN,0.92210433402515
HP_ABSENT_FINGERNAIL,SET,35,0.115,0.0050162,0.14361,0.21163,HP_ABSENT_FINGERNAIL,0.92210433402515
BANG_VERTEPORFIN_ENDOMETRIAL...2,SET,16,0.16905,0.0049881,0.21117,0.21171,BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP,0.92210433402515
WP_NEPHROGENESIS,SET,18,0.17157,0.0053692,0.21435,0.21174,WP_NEPHROGENESIS,0.92210433402515
GSE17580_UNINFECTED_VS_S_MAN...4,SET,186,0.047406,0.0047472,0.059229,0.21175,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP,0.92210433402515
GSE7460_CTRL_VS_TGFB_TREATED...3,SET,182,0.050114,0.0049646,0.062615,0.21176,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN,0.92210433402515
GOBP_REGULATION_OF_LIGASE_AC...,SET,5,0.24164,0.0039869,0.30201,0.21183,GOBP_REGULATION_OF_LIGASE_ACTIVITY,0.92210433402515
GOBP_DORSAL_SPINAL_CORD_DEVE...,SET,19,0.1814,0.0058324,0.22678,0.21189,GOBP_DORSAL_SPINAL_CORD_DEVELOPMENT,0.92210433402515
COBLL1_TARGET_GENES,SET,115,0.059553,0.0046983,0.074464,0.21193,COBLL1_TARGET_GENES,0.92210433402515
GOBP_SPECIFICATION_OF_SYMMET...,SET,131,0.059686,0.0050235,0.074632,0.21194,GOBP_SPECIFICATION_OF_SYMMETRY,0.92210433402515
GOBP_REGULATION_OF_SYNAPTIC_...4,SET,8,0.19826,0.0041375,0.24792,0.21196,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,0.92210433402515
HP_LONG_PALM,SET,3,0.46927,0.0059979,0.58688,0.21198,HP_LONG_PALM,0.92210433402515
HP_CERVICAL_KYPHOSIS,SET,8,0.23382,0.0048795,0.29245,0.212,HP_CERVICAL_KYPHOSIS,0.92210433402515
REACTOME_ORGANELLE_BIOGENESI...,SET,250,0.040803,0.0047287,0.051038,0.21202,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,0.92210433402515
XU_CREBBP_TARGETS_UP,SET,20,0.14363,0.0047377,0.17966,0.21203,XU_CREBBP_TARGETS_UP,0.92210433402515
GOBP_NUCLEAR_BODY_ORGANIZATI...,SET,15,0.15479,0.0044224,0.19364,0.21205,GOBP_NUCLEAR_BODY_ORGANIZATION,0.92210433402515
GOCC_MITOCHONDRIAL_LARGE_RIB...,SET,53,0.089171,0.0047839,0.11157,0.21208,GOCC_MITOCHONDRIAL_LARGE_RIBOSOMAL_SUBUNIT,0.92210433402515
RAMJAUN_APOPTOSIS_BY_TGFB1_V...1,SET,8,0.26165,0.0054604,0.32741,0.21211,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN,0.92210433402515
GOBP_GLYCINE_IMPORT_ACROSS_P...,SET,5,0.35374,0.0058367,0.44266,0.21211,GOBP_GLYCINE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.92210433402515
GSE3720_LPS_VS_PMA_STIM_VD2_...1,SET,138,0.059975,0.00518,0.07506,0.21214,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,0.92210433402515
GOBP_REGULATION_OF_ADIPONECT...,SET,7,0.27043,0.0052792,0.3385,0.21218,GOBP_REGULATION_OF_ADIPONECTIN_SECRETION,0.92210433402515
HP_CHONDROSARCOMA,SET,7,0.29328,0.0057253,0.36711,0.21218,HP_CHONDROSARCOMA,0.92210433402515
KEGG_MEDICUS_PATHOGEN_KSHV_M...2,SET,6,0.3137,0.0056699,0.39274,0.21222,KEGG_MEDICUS_PATHOGEN_KSHV_MIR2_TO_CELL_SURFACE_MOLECULE_ENDOCYTOSIS,0.92210433402515
HP_PITUITARY_DWARFISM,SET,9,0.23034,0.0050984,0.28837,0.21222,HP_PITUITARY_DWARFISM,0.92210433402515
GSE19825_IL2RALOW_VS_IL2RAHI...2,SET,173,0.04927,0.00476,0.06169,0.21224,GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,0.92210433402515
GNF2_TAL1,SET,61,0.085893,0.0049426,0.10756,0.21227,GNF2_TAL1,0.92210433402515
GSE41176_UNSTIM_VS_ANTI_IGM_...7,SET,175,0.050177,0.0048752,0.062843,0.21231,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN,0.92210433402515
WP_UNFOLDED_PROTEIN_RESPONSE,SET,22,0.14592,0.0050479,0.18276,0.21232,WP_UNFOLDED_PROTEIN_RESPONSE,0.92210433402515
GOBP_REGULATION_OF_CD40_SIGN...,SET,6,0.21954,0.003968,0.27504,0.21238,GOBP_REGULATION_OF_CD40_SIGNALING_PATHWAY,0.92210433402515
HP_SCLEROCORNEA,SET,43,0.097352,0.0047057,0.12196,0.21238,HP_SCLEROCORNEA,0.92210433402515
MODULE_138,SET,80,0.077195,0.0050844,0.096731,0.21243,MODULE_138,0.92210433402515
GSE22886_IGA_VS_IGM_MEMORY_B...1,SET,186,0.048528,0.0048594,0.06081,0.21243,GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN,0.92210433402515
HP_PREAXIAL_HAND_POLYDACTYLY,SET,53,0.084362,0.0045259,0.10572,0.21245,HP_PREAXIAL_HAND_POLYDACTYLY,0.92210433402515
GOCC_BRUSH_BORDER,SET,100,0.066484,0.0048931,0.083342,0.21252,GOCC_BRUSH_BORDER,0.92210433402515
GOBP_B_CELL_CHEMOTAXIS,SET,8,0.2748,0.0057348,0.3445,0.21253,GOBP_B_CELL_CHEMOTAXIS,0.92210433402515
WP_SMITHMAGENIS_AND_POTOCKIL...,SET,144,0.060651,0.0053501,0.076042,0.21256,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,0.92210433402515
GSE43955_1H_VS_60H_ACT_CD4_T...4,SET,185,0.047494,0.0047432,0.059572,0.21266,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.92210433402515
GOBP_RESPONSE_TO_FOLIC_ACID,SET,9,0.22122,0.0048965,0.27748,0.21267,GOBP_RESPONSE_TO_FOLIC_ACID,0.92210433402515
GAVISH_3CA_METAPROGRAM_EPITH...17,SET,38,0.12569,0.0057121,0.15768,0.2127,GAVISH_3CA_METAPROGRAM_EPITHELIAL_NEUROENDOCRINE,0.92210433402515
GOBP_MAST_CELL_DIFFERENTIATI...,SET,6,0.30891,0.0055833,0.38759,0.21273,GOBP_MAST_CELL_DIFFERENTIATION,0.92210433402515
HP_ATYPICAL_NEVI_IN_NON_SUN_...,SET,5,0.27471,0.0045326,0.34477,0.21279,HP_ATYPICAL_NEVI_IN_NON_SUN_EXPOSED_AREAS,0.92210433402515
GOMF_SNARE_BINDING,SET,102,0.065238,0.0048489,0.081878,0.2128,GOMF_SNARE_BINDING,0.92210433402515
CORRE_MULTIPLE_MYELOMA_UP,SET,64,0.088727,0.0052293,0.11141,0.2129,CORRE_MULTIPLE_MYELOMA_UP,0.92210433402515
MIR4738_3P,SET,163,0.052986,0.0049702,0.066529,0.2129,MIR4738_3P,0.92210433402515
GOBP_RESPONSE_TO_NERVE_GROWT...,SET,51,0.09769,0.0051414,0.12268,0.21294,GOBP_RESPONSE_TO_NERVE_GROWTH_FACTOR,0.92210433402515
REACTOME_CYCLIN_D_ASSOCIATED...,SET,45,0.097933,0.0048423,0.12299,0.21295,REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,0.92210433402515
HP_SINGLE_VENTRICLE,SET,8,0.23032,0.0048066,0.28937,0.21304,HP_SINGLE_VENTRICLE,0.92210433402515
GOBP_NEURONAL_ACTION_POTENTI...1,SET,33,0.12334,0.005224,0.15498,0.21308,GOBP_NEURONAL_ACTION_POTENTIAL,0.92210433402515
GOBP_POSITIVE_REGULATION_OF_...731,SET,49,0.097717,0.0050413,0.12284,0.21317,GOBP_POSITIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY,0.92210433402515
HP_LIVER_ABSCESS,SET,7,0.26974,0.0052657,0.33912,0.21319,HP_LIVER_ABSCESS,0.92210433402515
HP_RETICULOCYTOPENIA,SET,32,0.11016,0.0045948,0.13851,0.21322,HP_RETICULOCYTOPENIA,0.92210433402515
GOBP_THYMUS_DEVELOPMENT,SET,47,0.10014,0.00506,0.12594,0.21327,GOBP_THYMUS_DEVELOPMENT,0.92210433402515
HP_NEOPLASM_OF_THE_COLON,SET,77,0.073645,0.0047591,0.092627,0.21329,HP_NEOPLASM_OF_THE_COLON,0.92210433402515
ZNF512_TARGET_GENES,SET,327,0.037774,0.0049959,0.047516,0.21332,ZNF512_TARGET_GENES,0.92210433402515
GSE2585_CTEC_VS_THYMIC_MACRO...1,SET,187,0.046696,0.0046885,0.05874,0.21332,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN,0.92210433402515
GSE5589_WT_VS_IL6_KO_LPS_STI...2,SET,119,0.059034,0.0047371,0.074271,0.21336,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_UP,0.92210433402515
GOMF_PHOSPHOTRANSFERASE_ACTI...3,SET,34,0.10957,0.0047108,0.13788,0.21339,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR,0.92210433402515
HP_SHORT_MANDIBULAR_RAMI,SET,6,0.27811,0.0050265,0.3501,0.2135,HP_SHORT_MANDIBULAR_RAMI,0.92210433402515
HP_ABSENT_PATELLAR_REFLEXES,SET,11,0.21209,0.0051897,0.26701,0.21351,HP_ABSENT_PATELLAR_REFLEXES,0.92210433402515
GSE41176_UNSTIM_VS_ANTI_IGM_...14,SET,179,0.04865,0.00478,0.061247,0.21351,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP,0.92210433402515
GOBP_VOLUNTARY_MUSCULOSKELET...,SET,7,0.23211,0.0045311,0.29223,0.21353,GOBP_VOLUNTARY_MUSCULOSKELETAL_MOVEMENT,0.92210433402515
CASORELLI_APL_SECONDARY_VS_D...,SET,34,0.11917,0.0051235,0.1501,0.21362,CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,0.92210433402515
REACTOME_COENZYME_A_BIOSYNTH...,SET,7,0.22281,0.0043496,0.28064,0.21362,REACTOME_COENZYME_A_BIOSYNTHESIS,0.92210433402515
GOBP_REGULATION_OF_HEAT_GENE...,SET,13,0.20897,0.0055584,0.26321,0.21363,GOBP_REGULATION_OF_HEAT_GENERATION,0.92210433402515
HP_ABNORMAL_LEFT_ATRIUM_MORP...,SET,22,0.14601,0.0050512,0.18393,0.21365,HP_ABNORMAL_LEFT_ATRIUM_MORPHOLOGY,0.92210433402515
BIOCARTA_IL3_PATHWAY,SET,13,0.19384,0.005156,0.24421,0.21368,BIOCARTA_IL3_PATHWAY,0.92210433402515
BENPORATH_ES_2,SET,32,0.10769,0.0044918,0.13569,0.2137,BENPORATH_ES_2,0.92210433402515
GOBP_PROTEIN_HYDROXYLATION,SET,23,0.12535,0.0044335,0.15794,0.21371,GOBP_PROTEIN_HYDROXYLATION,0.92210433402515
HP_GLUCOCORTOCOID_INSENSITIV...,SET,5,0.32227,0.0053174,0.40612,0.21374,HP_GLUCOCORTOCOID_INSENSITIVE_PRIMARY_HYPERALDOSTERONISM,0.92210433402515
HP_FETAL_PLEURAL_EFFUSION,SET,5,0.2836,0.0046794,0.35744,0.21377,HP_FETAL_PLEURAL_EFFUSION,0.92210433402515
HAY_BONE_MARROW_PRO_B,SET,255,0.041123,0.0048125,0.051831,0.21378,HAY_BONE_MARROW_PRO_B,0.92210433402515
MIR148B_3P,SET,313,0.038492,0.0049827,0.048518,0.21379,MIR148B_3P,0.92210433402515
CHEN_METABOLIC_SYNDROM_NETWO...,SET,1122,0.021036,0.0050386,0.026519,0.21382,CHEN_METABOLIC_SYNDROM_NETWORK,0.92210433402515
GOBP_PROTEIN_DESTABILIZATION,SET,45,0.1044,0.0051621,0.13161,0.21382,GOBP_PROTEIN_DESTABILIZATION,0.92210433402515
KEGG_OOCYTE_MEIOSIS,SET,105,0.063788,0.00481,0.080435,0.21388,KEGG_OOCYTE_MEIOSIS,0.92210433402515
KEGG_MEDICUS_REFERENCE_FE_TF...,SET,7,0.26655,0.0052036,0.33611,0.21388,KEGG_MEDICUS_REFERENCE_FE_TF_TRANSPORT,0.92210433402515
HP_CONGENITAL_MALFORMATION_O...2,SET,76,0.077185,0.0049555,0.097326,0.21388,HP_CONGENITAL_MALFORMATION_OF_THE_RIGHT_HEART,0.92210433402515
CUI_DEVELOPING_HEART_RIGHT_A...,SET,36,0.11512,0.0050923,0.14518,0.21392,CUI_DEVELOPING_HEART_RIGHT_ATRIAL_CARDIOMYOCYTE,0.92210433402515
GSE17186_BLOOD_VS_CORD_BLOOD...5,SET,175,0.048211,0.0046843,0.060805,0.21393,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN,0.92210433402515
GSE36009_WT_VS_NLRP10_KO_DC_...3,SET,186,0.0479,0.0047966,0.060416,0.21394,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP,0.92210433402515
BUCASAS_PBMC_FLUARIX_FLUVIRI...3,SET,5,0.28158,0.0046459,0.35515,0.21394,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_LOW_RESPONDERS_1DY_POSITIVE_PREDICTIVE_OF_TITER,0.92210433402515
MCBRYAN_PUBERTAL_BREAST_5_6W...1,SET,119,0.058378,0.0046845,0.07364,0.21397,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,0.92210433402515
HP_STEREOTYPICAL_HAND_WRINGI...,SET,20,0.1567,0.005169,0.19767,0.21397,HP_STEREOTYPICAL_HAND_WRINGING,0.92210433402515
MIR141_5P,SET,91,0.070845,0.0049751,0.089371,0.21398,MIR141_5P,0.92210433402515
PID_IL12_2PATHWAY,SET,60,0.092917,0.0053029,0.11723,0.21401,PID_IL12_2PATHWAY,0.92210433402515
HP_MEMBRANOPROLIFERATIVE_GLO...,SET,9,0.23297,0.0051567,0.29396,0.21404,HP_MEMBRANOPROLIFERATIVE_GLOMERULONEPHRITIS,0.92210433402515
MODULE_203,SET,3,0.39795,0.0050864,0.50221,0.21407,MODULE_203,0.92210433402515
HP_SHORT_TERM_MEMORY_IMPAIRM...,SET,6,0.30733,0.0055548,0.38791,0.2141,HP_SHORT_TERM_MEMORY_IMPAIRMENT,0.92210433402515
HP_ETHYLMALONIC_ACIDURIA,SET,9,0.18841,0.0041703,0.23785,0.21415,HP_ETHYLMALONIC_ACIDURIA,0.92210433402515
MODULE_33,SET,346,0.037744,0.0051323,0.047656,0.21418,MODULE_33,0.92210433402515
GOCC_MICROBODY_MEMBRANE,SET,57,0.085745,0.0047701,0.10826,0.21419,GOCC_MICROBODY_MEMBRANE,0.92210433402515
SREBP_Q3,SET,229,0.043743,0.0048546,0.055242,0.21423,SREBP_Q3,0.92210433402515
GOBP_REGULATION_OF_PEPTIDE_T...,SET,187,0.050841,0.0051046,0.064211,0.21425,GOBP_REGULATION_OF_PEPTIDE_TRANSPORT,0.92210433402515
GOBP_REGULATION_OF_GLIOGENES...,SET,101,0.070753,0.0052331,0.089375,0.21429,GOBP_REGULATION_OF_GLIOGENESIS,0.92210433402515
GOBP_PHOSPHATIDYLINOSITOL_3_...1,SET,275,0.042013,0.0051031,0.053073,0.2143,GOBP_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,0.92210433402515
HP_CORPUS_CALLOSUM_ATROPHY,SET,37,0.10526,0.0047204,0.13301,0.21436,HP_CORPUS_CALLOSUM_ATROPHY,0.92210433402515
GOMF_PHOTORECEPTOR_ACTIVITY,SET,13,0.19098,0.0050799,0.24135,0.21439,GOMF_PHOTORECEPTOR_ACTIVITY,0.92210433402515
MYLLYKANGAS_AMPLIFICATION_HO...17,SET,7,0.26162,0.0051073,0.33063,0.2144,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7,0.92210433402515
GOBP_HOMOLOGOUS_RECOMBINATION,SET,58,0.082198,0.0046125,0.10388,0.2144,GOBP_HOMOLOGOUS_RECOMBINATION,0.92210433402515
MIR3145_5P,SET,93,0.066478,0.0047192,0.084031,0.21445,MIR3145_5P,0.92210433402515
MIR6864_5P,SET,77,0.077612,0.0050155,0.09811,0.21446,MIR6864_5P,0.92210433402515
HP_REDUCED_SYSTOLIC_FUNCTION,SET,21,0.14974,0.0050611,0.18937,0.21456,HP_REDUCED_SYSTOLIC_FUNCTION,0.92210433402515
GOBP_OLIGOPEPTIDE_IMPORT_ACR...,SET,5,0.31861,0.005257,0.40296,0.21457,GOBP_OLIGOPEPTIDE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.92210433402515
HP_FEMUR_FRACTURE,SET,5,0.24244,0.0040002,0.30665,0.21459,HP_FEMUR_FRACTURE,0.92210433402515
GOBP_REGULATION_OF_CARDIAC_M...10,SET,18,0.15933,0.0049861,0.20153,0.2146,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION,0.92210433402515
GSE10239_NAIVE_VS_KLRG1INT_E...2,SET,181,0.04876,0.0048173,0.061676,0.2146,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP,0.92210433402515
WP_GALANIN_RECEPTOR_PATHWAY,SET,21,0.15412,0.0052094,0.19496,0.21461,WP_GALANIN_RECEPTOR_PATHWAY,0.92210433402515
DESCARTES_FETAL_EYE_PDE11A_F...,SET,16,0.18868,0.0055674,0.23868,0.21462,DESCARTES_FETAL_EYE_PDE11A_FAM19A2_POSITIVE_CELLS,0.92210433402515
MIR6516_5P,SET,172,0.049836,0.0048008,0.063051,0.21465,MIR6516_5P,0.92210433402515
MIR5192,SET,45,0.093464,0.0046213,0.11826,0.21467,MIR5192,0.92210433402515
GSE17974_IL4_AND_ANTI_IL12_V...4,SET,167,0.052067,0.004943,0.065879,0.21467,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP,0.92210433402515
WP_EGFEGFR_SIGNALING,SET,154,0.054886,0.0050054,0.069449,0.21468,WP_EGFEGFR_SIGNALING,0.92210433402515
GNF2_NPM1,SET,65,0.07269,0.0043173,0.091985,0.2147,GNF2_NPM1,0.92210433402515
MORF_PAX7,SET,242,0.043794,0.0049945,0.055445,0.21481,MORF_PAX7,0.92210433402515
GOBP_CITRULLINE_METABOLIC_PR...,SET,7,0.23948,0.0046751,0.30324,0.21484,GOBP_CITRULLINE_METABOLIC_PROCESS,0.92210433402515
ACOSTA_PROLIFERATION_INDEPEN...1,SET,105,0.066727,0.0050316,0.084503,0.21487,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,0.92210433402515
HP_SLENDER_LONG_BONE,SET,46,0.091351,0.0045667,0.11569,0.21487,HP_SLENDER_LONG_BONE,0.92210433402515
SAKAI_CHRONIC_HEPATITIS_VS_L...2,SET,79,0.066826,0.0043739,0.084634,0.21489,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,0.92210433402515
GSE14308_TH1_VS_TH17_UP,SET,177,0.049443,0.004831,0.062634,0.21494,GSE14308_TH1_VS_TH17_UP,0.92210433402515
STAMBOLSKY_TARGETS_OF_MUTATE...2,SET,45,0.099888,0.004939,0.12654,0.21495,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP,0.92210433402515
GOBP_REGULATION_OF_LIPID_LOC...,SET,150,0.057164,0.0051456,0.072415,0.21495,GOBP_REGULATION_OF_LIPID_LOCALIZATION,0.92210433402515
HP_HEMIVERTEBRAE,SET,47,0.094665,0.0047833,0.11994,0.21499,HP_HEMIVERTEBRAE,0.92210433402515
ZHAN_MULTIPLE_MYELOMA_CD1_DN,SET,40,0.10687,0.0049827,0.13542,0.21501,ZHAN_MULTIPLE_MYELOMA_CD1_DN,0.92210433402515
GOBP_MEIOTIC_DNA_DOUBLE_STRA...,SET,5,0.35218,0.0058109,0.44629,0.21503,GOBP_MEIOTIC_DNA_DOUBLE_STRAND_BREAK_FORMATION,0.92210433402515
GOCC_NBAF_COMPLEX,SET,16,0.15945,0.0047049,0.20207,0.21503,GOCC_NBAF_COMPLEX,0.92210433402515
HP_CALCINOSIS,SET,11,0.21729,0.0053169,0.27538,0.21504,HP_CALCINOSIS,0.92210433402515
GOBP_EPITHELIAL_TO_MESENCHYM...1,SET,164,0.053867,0.0050681,0.068273,0.21506,GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.92210433402515
GOBP_NEGATIVE_REGULATION_OF_...210,SET,46,0.10884,0.005441,0.13795,0.21506,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,0.92210433402515
ZHU_CMV_ALL_UP,SET,102,0.065994,0.0049051,0.083666,0.21512,ZHU_CMV_ALL_UP,0.92210433402515
GOBP_CELL_CELL_RECOGNITION,SET,71,0.079443,0.0049306,0.10074,0.21518,GOBP_CELL_CELL_RECOGNITION,0.92210433402515
HP_ABNORMAL_FORM_OF_THE_VERT...,SET,307,0.037441,0.0048007,0.047493,0.21525,HP_ABNORMAL_FORM_OF_THE_VERTEBRAL_BODIES,0.92210433402515
HP_RECURRENT_KLEBSIELLA_INFE...,SET,4,0.38408,0.0056684,0.48722,0.21526,HP_RECURRENT_KLEBSIELLA_INFECTIONS,0.92210433402515
HP_CUTANEOUS_FINGER_SYNDACTY...,SET,30,0.12855,0.0051919,0.16309,0.21529,HP_CUTANEOUS_FINGER_SYNDACTYLY,0.92210433402515
GSE13522_CTRL_VS_T_CRUZI_Y_S...6,SET,184,0.049921,0.0049723,0.063374,0.21544,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP,0.92210433402515
GOBP_CELLULAR_LIPID_BIOSYNTH...,SET,11,0.20538,0.0050254,0.26074,0.21545,GOBP_CELLULAR_LIPID_BIOSYNTHETIC_PROCESS,0.92210433402515
MUNSHI_MULTIPLE_MYELOMA_UP,SET,70,0.080062,0.004934,0.10165,0.21547,MUNSHI_MULTIPLE_MYELOMA_UP,0.92210433402515
GOBP_NEGATIVE_REGULATION_OF_...148,SET,19,0.14232,0.004576,0.18074,0.21551,GOBP_NEGATIVE_REGULATION_OF_CILIUM_ASSEMBLY,0.92210433402515
CP2_02,SET,220,0.045639,0.0049657,0.057961,0.21553,CP2_02,0.92210433402515
MAYBURD_RESPONSE_TO_L663536_...1,SET,51,0.086383,0.0045463,0.10972,0.21556,MAYBURD_RESPONSE_TO_L663536_DN,0.92210433402515
GOBP_REGULATION_OF_LEUKOCYTE...4,SET,115,0.065479,0.0051658,0.083168,0.21556,GOBP_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,0.92210433402515
GAO_LARGE_INTESTINE_24W_C6_S...,SET,12,0.1958,0.005004,0.24872,0.21557,GAO_LARGE_INTESTINE_24W_C6_SECRETORY_PROGENITOR,0.92210433402515
GSE26928_EFF_MEMORY_VS_CXCR5...2,SET,163,0.052009,0.0048785,0.066073,0.21561,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,0.92210433402515
HP_APLASIA_OF_THE_MIDDLE_PHA...,SET,7,0.24336,0.0047508,0.30922,0.21564,HP_APLASIA_OF_THE_MIDDLE_PHALANX_OF_THE_HAND,0.92210433402515
GOBP_NEGATIVE_REGULATION_OF_...501,SET,75,0.076261,0.004864,0.096902,0.21565,GOBP_NEGATIVE_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.92210433402515
MIR4263,SET,240,0.043584,0.0049503,0.055384,0.21566,MIR4263,0.92210433402515
JACKSON_DNMT1_TARGETS_UP,SET,80,0.075793,0.004992,0.096325,0.21569,JACKSON_DNMT1_TARGETS_UP,0.92210433402515
HIF1_Q3,SET,211,0.046024,0.0049053,0.058499,0.21572,HIF1_Q3,0.92210433402515
GOBP_FOREBRAIN_DORSAL_VENTRA...,SET,7,0.2917,0.0056945,0.37083,0.21576,GOBP_FOREBRAIN_DORSAL_VENTRAL_PATTERN_FORMATION,0.92210433402515
GOBP_BIOMINERAL_TISSUE_DEVEL...,SET,161,0.055539,0.0051779,0.070614,0.21579,GOBP_BIOMINERAL_TISSUE_DEVELOPMENT,0.92210433402515
GOBP_NEGATIVE_REGULATION_OF_...140,SET,5,0.29296,0.0048338,0.37248,0.21579,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_EFFLUX,0.92210433402515
TCGA_GLIOBLASTOMA_MUTATED,SET,8,0.22727,0.0047429,0.289,0.21582,TCGA_GLIOBLASTOMA_MUTATED,0.92210433402515
REACTOME_SELENOAMINO_ACID_ME...,SET,99,0.065069,0.0047651,0.082745,0.21583,REACTOME_SELENOAMINO_ACID_METABOLISM,0.92210433402515
GOBP_POSITIVE_REGULATION_OF_...427,SET,39,0.11036,0.0050807,0.14038,0.2159,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,0.92210433402515
HP_ANTERIOR_CREASES_OF_EARLO...,SET,3,0.34243,0.0043767,0.43561,0.21591,HP_ANTERIOR_CREASES_OF_EARLOBE,0.92210433402515
ICHIBA_GRAFT_VERSUS_HOST_DIS...3,SET,41,0.10841,0.0051172,0.13791,0.21592,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN,0.92210433402515
REACTOME_SIGNALING_BY_RHO_GT...,SET,608,0.026775,0.004791,0.034062,0.21592,REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,0.92210433402515
HP_NAEVUS_FLAMMEUS_OF_THE_EY...,SET,7,0.2707,0.0052846,0.34438,0.21592,HP_NAEVUS_FLAMMEUS_OF_THE_EYELID,0.92210433402515
ZF5_B,SET,214,0.045791,0.0049147,0.05826,0.21595,ZF5_B,0.92210433402515
GOBP_MRNA_TRANSPORT,SET,112,0.058455,0.0045515,0.074376,0.21596,GOBP_MRNA_TRANSPORT,0.92210433402515
GOCC_PROTEIN_FOLDING_CHAPERO...,SET,40,0.091182,0.0042512,0.11603,0.21597,GOCC_PROTEIN_FOLDING_CHAPERONE_COMPLEX,0.92210433402515
GOBP_POSITIVE_REGULATION_OF_...700,SET,28,0.1283,0.0050064,0.16328,0.216,GOBP_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.92210433402515
GOBP_MALE_GAMETE_GENERATION,SET,529,0.028164,0.0047111,0.035845,0.21602,GOBP_MALE_GAMETE_GENERATION,0.92210433402515
LHX3_01,SET,211,0.049283,0.0052527,0.062729,0.21604,LHX3_01,0.92210433402515
GOBP_ATRIOVENTRICULAR_CANAL_...,SET,13,0.19661,0.0052296,0.25037,0.21615,GOBP_ATRIOVENTRICULAR_CANAL_DEVELOPMENT,0.92210433402515
MIR7160_5P,SET,171,0.051074,0.0049059,0.065042,0.21616,MIR7160_5P,0.92210433402515
MIR6834_5P,SET,53,0.09119,0.0048923,0.11615,0.2162,MIR6834_5P,0.92210433402515
HP_ABNORMAL_ATRIOVENTRICULAR...4,SET,183,0.048923,0.0048598,0.062319,0.21622,HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_PHYSIOLOGY,0.92210433402515
MAGRANGEAS_MULTIPLE_MYELOMA_...1,SET,24,0.1432,0.0051738,0.18242,0.21623,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,0.92210433402515
GSE15324_NAIVE_VS_ACTIVATED_...4,SET,183,0.047204,0.004689,0.060137,0.21625,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP,0.92210433402515
GOCC_VACUOLAR_MEMBRANE,SET,438,0.031078,0.0047425,0.039595,0.21626,GOCC_VACUOLAR_MEMBRANE,0.92210433402515
GOMF_HISTONE_H3K14_ACETYLTRA...,SET,9,0.21551,0.0047702,0.27465,0.21633,GOMF_HISTONE_H3K14_ACETYLTRANSFERASE_ACTIVITY,0.92210433402515
GOBP_CHAPERONE_MEDIATED_PROT...1,SET,22,0.12514,0.0043292,0.15956,0.21644,GOBP_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY,0.92210433402515
GOBP_NUCLEUS_LOCALIZATION,SET,31,0.11544,0.0047392,0.14719,0.21644,GOBP_NUCLEUS_LOCALIZATION,0.92210433402515
GOBP_POSITIVE_REGULATION_OF_...414,SET,81,0.076195,0.0050496,0.097154,0.21645,GOBP_POSITIVE_REGULATION_OF_LIPID_TRANSPORT,0.92210433402515
GOBP_CELLULAR_METABOLIC_COMP...,SET,30,0.13152,0.005312,0.16771,0.21646,GOBP_CELLULAR_METABOLIC_COMPOUND_SALVAGE,0.92210433402515
GSE17974_CTRL_VS_ACT_IL4_AND...16,SET,161,0.05258,0.004902,0.06705,0.21647,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP,0.92210433402515
NAKAYA_PBMC_FLUMIST_AGE_18_5...7,SET,1366,0.017683,0.0046404,0.02255,0.21647,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP,0.92210433402515
KAZMIN_PBMC_P_FALCIPARUM_RTS...3,SET,9,0.23491,0.0051997,0.2996,0.2165,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_UNKN_AGE_IMM_WITH_ARR_VS_IMM_BY_RRR_PRIMARY_IMMUNIZ_WITH_RECOMB_ADENOVIRUS_35_1DY_UP,0.92210433402515
HP_LIPOATROPHY,SET,71,0.08145,0.0050551,0.10388,0.21651,HP_LIPOATROPHY,0.92210433402515
GOBP_NATURAL_KILLER_CELL_MED...1,SET,9,0.23009,0.0050929,0.29349,0.21653,GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.92210433402515
GSE37532_VISCERAL_ADIPOSE_TI...1,SET,89,0.072224,0.0050162,0.092127,0.21654,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_DN,0.92210433402515
MIR144_5P,SET,47,0.09355,0.004727,0.11934,0.21655,MIR144_5P,0.92210433402515
GOBP_CELLULAR_RESPONSE_TO_MA...3,SET,9,0.21047,0.0046587,0.26858,0.21662,GOBP_CELLULAR_RESPONSE_TO_MANGANESE_ION,0.92210433402515
HP_ABNORMAL_FINGER_FLEXION_C...,SET,19,0.15935,0.0051233,0.20335,0.21664,HP_ABNORMAL_FINGER_FLEXION_CREASE,0.92210433402515
GOBP_NEUTROPHIL_CHEMOTAXIS,SET,78,0.082171,0.0053443,0.10487,0.21666,GOBP_NEUTROPHIL_CHEMOTAXIS,0.92210433402515
GOCC_TRANSCRIPTION_PREINITIA...,SET,13,0.17391,0.0046259,0.22197,0.21668,GOCC_TRANSCRIPTION_PREINITIATION_COMPLEX,0.92210433402515
GSE10240_CTRL_VS_IL22_STIM_P...2,SET,182,0.0496,0.0049137,0.063328,0.21675,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.92210433402515
GOBP_POSITIVE_REGULATION_OF_...666,SET,25,0.14146,0.0052162,0.18061,0.21676,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,0.92210433402515
KEGG_MEDICUS_REFERENCE_TIGHT...,SET,34,0.11472,0.0049319,0.14649,0.21678,KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY,0.92210433402515
GOBP_PIGMENT_GRANULE_MATURAT...,SET,10,0.21279,0.0049645,0.27171,0.21678,GOBP_PIGMENT_GRANULE_MATURATION,0.92210433402515
GOCC_VCP_NPL4_UFD1_AAA_ATPAS...,SET,7,0.25939,0.0050638,0.33129,0.21683,GOCC_VCP_NPL4_UFD1_AAA_ATPASE_COMPLEX,0.92210433402515
GOMF_ADP_RIBOSE_DIPHOSPHATAS...,SET,6,0.27958,0.0050531,0.35707,0.21683,GOMF_ADP_RIBOSE_DIPHOSPHATASE_ACTIVITY,0.92210433402515
GOBP_MUSCLE_ORGAN_DEVELOPMENT,SET,328,0.038215,0.0050618,0.048809,0.21684,GOBP_MUSCLE_ORGAN_DEVELOPMENT,0.92210433402515
GSE14350_TREG_VS_TEFF_DN,SET,185,0.04989,0.0049826,0.063728,0.21686,GSE14350_TREG_VS_TEFF_DN,0.92210433402515
MODULE_573,SET,24,0.13866,0.0050099,0.17715,0.2169,MODULE_573,0.92210433402515
GOBP_SYNAPTIC_VESICLE_LOCALI...,SET,53,0.090691,0.0048655,0.11587,0.2169,GOBP_SYNAPTIC_VESICLE_LOCALIZATION,0.92210433402515
FXR_IR1_Q6,SET,105,0.065111,0.0049097,0.083198,0.21694,FXR_IR1_Q6,0.92210433402515
GSE22886_NAIVE_CD4_TCELL_VS_...10,SET,171,0.048665,0.0046745,0.062186,0.21694,GSE22886_NAIVE_CD4_TCELL_VS_DC_UP,0.92210433402515
GOMF_LIGASE_ACTIVITY_FORMING...3,SET,22,0.12806,0.0044302,0.16369,0.21701,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS,0.92210433402515
KEGG_MEDICUS_VARIANT_MUTATIO...73,SET,14,0.17061,0.0047094,0.21811,0.21704,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY,0.92210433402515
HP_ABNORMAL_TRICUSPID_VALVE_...2,SET,72,0.077296,0.0048308,0.098824,0.21707,HP_ABNORMAL_TRICUSPID_VALVE_PHYSIOLOGY,0.92210433402515
GOBP_REGULATION_OF_LYSOSOME_...1,SET,12,0.19853,0.0050738,0.25384,0.21708,GOBP_REGULATION_OF_LYSOSOME_ORGANIZATION,0.92210433402515
HP_HYPEREXTENSIBLE_SKIN,SET,60,0.082525,0.0047098,0.10552,0.2171,HP_HYPEREXTENSIBLE_SKIN,0.92210433402515
GSE28726_NAIVE_VS_ACTIVATED_...4,SET,177,0.048706,0.0047591,0.062285,0.21711,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP,0.92210433402515
GOBP_THYROID_HORMONE_MEDIATE...,SET,7,0.28108,0.0054872,0.35945,0.21712,GOBP_THYROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.92210433402515
GOBP_MIDBODY_ABSCISSION,SET,17,0.15632,0.0047545,0.19992,0.21713,GOBP_MIDBODY_ABSCISSION,0.92210433402515
WANG_RESPONSE_TO_GSK3_INHIBI...2,SET,310,0.037142,0.0047853,0.047504,0.21715,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,0.92210433402515
MODULE_198,SET,289,0.037127,0.0046211,0.047484,0.21715,MODULE_198,0.92210433402515
GOBP_NOTCH_RECEPTOR_PROCESSI...,SET,8,0.2079,0.0043387,0.2659,0.21715,GOBP_NOTCH_RECEPTOR_PROCESSING,0.92210433402515
GOBP_POSITIVE_REGULATION_OF_...44,SET,37,0.10346,0.0046395,0.13232,0.21715,GOBP_POSITIVE_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.92210433402515
VISALA_AGING_LYMPHOCYTE_UP,SET,6,0.32219,0.0058232,0.41218,0.21721,VISALA_AGING_LYMPHOCYTE_UP,0.92210433402515
REACTOME_SYNTHESIS_OF_DNA,SET,116,0.055574,0.0044033,0.071096,0.21721,REACTOME_SYNTHESIS_OF_DNA,0.92210433402515
HP_LARGE_SELLA_TURCICA,SET,14,0.17775,0.0049064,0.22743,0.21724,HP_LARGE_SELLA_TURCICA,0.92210433402515
HP_VERY_LOW_VISUAL_ACUITY,SET,5,0.31112,0.0051334,0.39814,0.21728,HP_VERY_LOW_VISUAL_ACUITY,0.92210433402515
GOBP_EMBRYONIC_CRANIAL_SKELE...,SET,42,0.10705,0.0051142,0.137,0.21729,GOBP_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS,0.92210433402515
GOBP_REGULATION_OF_NEUROGENE...,SET,346,0.036965,0.0050264,0.047309,0.2173,GOBP_REGULATION_OF_NEUROGENESIS,0.92210433402515
GOMF_RNA_NUCLEASE_ACTIVITY,SET,117,0.059308,0.0047192,0.075909,0.21732,GOMF_RNA_NUCLEASE_ACTIVITY,0.92210433402515
GOBP_SYNAPSE_PRUNING,SET,14,0.20664,0.0057038,0.26454,0.21737,GOBP_SYNAPSE_PRUNING,0.922203900146484
MIR4473,SET,79,0.072862,0.004769,0.093309,0.21745,MIR4473,0.922334447426202
PASTURAL_RIZ1_TARGETS_UP,SET,8,0.22337,0.0046614,0.28607,0.21746,PASTURAL_RIZ1_TARGETS_UP,0.922334447426202
REACTOME_SIGNALING_BY_BRAF_A...,SET,62,0.084221,0.0048858,0.10788,0.21749,REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,0.922334447426202
HP_HYPOPLASIA_OF_THE_COCHLEA,SET,8,0.23723,0.0049507,0.3039,0.21752,HP_HYPOPLASIA_OF_THE_COCHLEA,0.922334447426202
HP_LEFT_BUNDLE_BRANCH_BLOCK,SET,18,0.16054,0.005024,0.20567,0.21754,HP_LEFT_BUNDLE_BRANCH_BLOCK,0.922334447426202
GOMF_ATP_DEPENDENT_PROTEIN_D...,SET,6,0.25659,0.0046376,0.32876,0.21756,GOMF_ATP_DEPENDENT_PROTEIN_DISAGGREGASE_ACTIVITY,0.922334447426202
KEGG_MEDICUS_PATHOGEN_EBV_EB...5,SET,11,0.19424,0.004753,0.24896,0.21764,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00264,0.92244856097561
GOMF_PHOSPHATIDYLETHANOLAMIN...2,SET,5,0.29873,0.0049289,0.38288,0.21764,GOMF_PHOSPHATIDYLETHANOLAMINE_FLIPPASE_ACTIVITY,0.92244856097561
MIR4756_3P,SET,106,0.06357,0.0048161,0.081495,0.21769,MIR4756_3P,0.922477871250914
GOBP_REGULATION_OF_RESPONSE_...12,SET,20,0.16403,0.0054106,0.21029,0.2177,GOBP_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,0.922477871250914
GOBP_NEGATIVE_REGULATION_OF_...576,SET,72,0.077755,0.0048595,0.099726,0.21779,GOBP_NEGATIVE_REGULATION_OF_RNA_CATABOLIC_PROCESS,0.922494095783573
ZHAN_MULTIPLE_MYELOMA_HP_DN,SET,38,0.10335,0.0046967,0.13256,0.2178,ZHAN_MULTIPLE_MYELOMA_HP_DN,0.922494095783573
GOBP_NEGATIVE_REGULATION_OF_...436,SET,24,0.13639,0.0049279,0.17494,0.2178,GOBP_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.922494095783573
GOBP_POSITIVE_REGULATION_OF_...519,SET,10,0.23648,0.0055173,0.30332,0.21781,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION,0.922494095783573
HP_DILATATION_OF_THE_CEREBRA...,SET,49,0.096923,0.0050003,0.12438,0.21792,HP_DILATATION_OF_THE_CEREBRAL_ARTERY,0.922615705946735
GOMF_ALPHA_ACTININ_BINDING,SET,28,0.12965,0.0050589,0.16642,0.21799,GOMF_ALPHA_ACTININ_BINDING,0.922615705946735
HP_POSTPRANDIAL_HYPERGLYCEMIA,SET,7,0.26452,0.005164,0.33955,0.21799,HP_POSTPRANDIAL_HYPERGLYCEMIA,0.922615705946735
HP_SIMPLIFIED_GYRAL_PATTERN,SET,78,0.072057,0.0046865,0.092498,0.21799,HP_SIMPLIFIED_GYRAL_PATTERN,0.922615705946735
KEGG_MEDICUS_REFERENCE_TESTO...,SET,11,0.19075,0.0046675,0.24487,0.218,KEGG_MEDICUS_REFERENCE_TESTOSTERONE_BIOSYNTHESIS,0.922615705946735
GOMF_NOTCH_BINDING,SET,22,0.13049,0.0045141,0.16753,0.21803,GOMF_NOTCH_BINDING,0.922615705946735
KEGG_MEDICUS_VARIANT_MUTATIO...31,SET,19,0.15081,0.0048489,0.1937,0.21811,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY,0.922615705946735
HP_INTERSTITIAL_CARDIAC_FIBR...,SET,9,0.23333,0.0051647,0.29969,0.21812,HP_INTERSTITIAL_CARDIAC_FIBROSIS,0.922615705946735
GOBP_NEGATIVE_REGULATION_OF_...248,SET,128,0.05617,0.0046735,0.072165,0.21818,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,0.922615705946735
REACTOME_DEPOSITION_OF_NEW_C...,SET,23,0.13672,0.0048358,0.17567,0.21821,REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,0.922615705946735
GOBP_RESPONSE_TO_PH,SET,38,0.10847,0.0049294,0.13937,0.21821,GOBP_RESPONSE_TO_PH,0.922615705946735
MIR6836_5P,SET,115,0.061917,0.0048848,0.079562,0.21822,MIR6836_5P,0.922615705946735
GOMF_AMINOPEPTIDASE_ACTIVITY,SET,36,0.11355,0.005023,0.14591,0.21822,GOMF_AMINOPEPTIDASE_ACTIVITY,0.922615705946735
HP_PERIPHERAL_AXONAL_NEUROPA...,SET,152,0.051625,0.0046777,0.066343,0.21824,HP_PERIPHERAL_AXONAL_NEUROPATHY,0.922615705946735
WP_SEROTONIN_RECEPTOR_2_AND_...,SET,18,0.15047,0.0047089,0.19338,0.21826,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,0.922615705946735
GSE15324_ELF4_KO_VS_WT_NAIVE...1,SET,175,0.050313,0.0048884,0.064666,0.21828,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN,0.922615705946735
WP_IL4_SIGNALING,SET,50,0.097374,0.0050744,0.12516,0.21829,WP_IL4_SIGNALING,0.922615705946735
HP_BROAD_NASAL_TIP,SET,133,0.054415,0.0046145,0.069954,0.21833,HP_BROAD_NASAL_TIP,0.922672562013619
chr13q14,SET,81,0.14966,0.0099183,0.19246,0.2184,chr13q14,0.922856170212766
HP_SANDWICH_APPEARANCE_OF_VE...,SET,5,0.26717,0.0044082,0.34366,0.21846,HP_SANDWICH_APPEARANCE_OF_VERTEBRAL_BODIES,0.92295663507109
ACTACCT_MIR196A_MIR196B,SET,133,0.058965,0.0050003,0.075868,0.21852,ACTACCT_MIR196A_MIR196B,0.92295663507109
HP_DEMENTIA,SET,186,0.047535,0.0047601,0.06116,0.21852,HP_DEMENTIA,0.92295663507109
GOBP_PROTEIN_MATURATION_BY_P...,SET,6,0.25127,0.0045415,0.32332,0.21853,GOBP_PROTEIN_MATURATION_BY_PROTEIN_FOLDING,0.92295663507109
GOBP_ALPHA_BETA_T_CELL_PROLI...,SET,42,0.11015,0.0052623,0.14182,0.21868,GOBP_ALPHA_BETA_T_CELL_PROLIFERATION,0.923477934386391
MIR4695_5P,SET,79,0.072169,0.0047237,0.092945,0.21874,MIR4695_5P,0.923506887755102
GOBP_PHAGOCYTOSIS_ENGULFMENT,SET,49,0.099045,0.0051098,0.12756,0.21874,GOBP_PHAGOCYTOSIS_ENGULFMENT,0.923506887755102
GSE41867_MEMORY_VS_EXHAUSTED...1,SET,180,0.048261,0.0047549,0.062167,0.21879,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_DN,0.923535827058538
REACTOME_REGULATION_OF_TLR_B...,SET,20,0.16863,0.0055625,0.21723,0.2188,REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND,0.923535827058538
MAHADEVAN_GIST_MORPHOLOGICAL...,SET,14,0.19933,0.0055019,0.25682,0.21884,MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH,0.923592495446266
STAT6_01,SET,238,0.044311,0.0050121,0.057134,0.21901,STAT6_01,0.923808963636364
KEGG_MEDICUS_PATHOGEN_HSV_GD...,SET,11,0.18666,0.0045673,0.24074,0.21907,KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY,0.923808963636364
GOBP_CARDIAC_MYOFIBRIL_ASSEM...,SET,19,0.15113,0.004859,0.19496,0.21912,GOBP_CARDIAC_MYOFIBRIL_ASSEMBLY,0.923808963636364
GOBP_CD4_POSITIVE_ALPHA_BETA...1,SET,110,0.067532,0.0052114,0.087121,0.21913,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.923808963636364
GOCC_CENTRAL_ELEMENT,SET,7,0.22542,0.0044006,0.29083,0.21915,GOCC_CENTRAL_ELEMENT,0.923808963636364
REACTOME_TRANSLESION_SYNTHES...1,SET,17,0.13675,0.004159,0.17644,0.21917,REACTOME_TRANSLESION_SYNTHESIS_BY_POLH,0.923808963636364
HP_INCREASED_CIRCULATING_REN...,SET,18,0.17282,0.0054085,0.22299,0.21917,HP_INCREASED_CIRCULATING_RENIN_LEVEL,0.923808963636364
GSE37533_UNTREATED_VS_PIOGLI...4,SET,181,0.050158,0.0049555,0.064719,0.21917,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.923808963636364
GOBP_POSITIVE_REGULATION_OF_...120,SET,300,0.038557,0.004888,0.049751,0.21918,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE,0.923808963636364
WP_TAMOXIFEN_METABOLISM,SET,21,0.15183,0.005132,0.19593,0.21919,WP_TAMOXIFEN_METABOLISM,0.923808963636364
GOMF_S_METHYLTRANSFERASE_ACT...,SET,8,0.27346,0.0057068,0.35287,0.21919,GOMF_S_METHYLTRANSFERASE_ACTIVITY,0.923808963636364
GOBP_STRIATED_MUSCLE_CELL_DE...,SET,77,0.074374,0.0048063,0.09599,0.21923,GOBP_STRIATED_MUSCLE_CELL_DEVELOPMENT,0.923808963636364
HP_APLASIA_HYPOPLASIA_OF_THE...59,SET,15,0.16204,0.0046295,0.20914,0.21924,HP_APLASIA_HYPOPLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,0.923808963636364
GSE15330_GRANULOCYTE_MONOCYT...2,SET,177,0.047049,0.0045971,0.060735,0.21928,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_UP,0.923808963636364
HAY_BONE_MARROW_CD34_POS_HSC,SET,96,0.071359,0.0051463,0.092121,0.21929,HAY_BONE_MARROW_CD34_POS_HSC,0.923808963636364
GOMF_CCR1_CHEMOKINE_RECEPTOR...,SET,5,0.30022,0.0049536,0.38765,0.21933,GOMF_CCR1_CHEMOKINE_RECEPTOR_BINDING,0.923865489031632
PURBEY_TARGETS_OF_CTBP1_NOT_...2,SET,262,0.039511,0.0046859,0.051022,0.21936,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,0.923879883664566
HP_DECREASED_URINARY_POTASSI...,SET,4,0.36113,0.0053296,0.46649,0.21943,HP_DECREASED_URINARY_POTASSIUM,0.924062722646311
HP_KNEE_DISLOCATION,SET,13,0.17001,0.0045222,0.21968,0.2195,HP_KNEE_DISLOCATION,0.924092437636231
chr9p13,SET,78,0.15659,0.010184,0.20234,0.21951,chr9p13,0.924092437636231
GSE15659_NAIVE_CD4_TCELL_VS_...6,SET,156,0.051626,0.0047384,0.066713,0.21952,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP,0.924092437636231
HP_3_4_FINGER_SYNDACTYLY,SET,10,0.22617,0.0052768,0.29231,0.21955,HP_3_4_FINGER_SYNDACTYLY,0.924092437636231
GOMF_FLAP_ENDONUCLEASE_ACTIV...,SET,6,0.23733,0.0042896,0.30677,0.21957,GOMF_FLAP_ENDONUCLEASE_ACTIVITY,0.924092437636231
PID_NFKAPPAB_ATYPICAL_PATHWAY,SET,15,0.16016,0.0045758,0.2071,0.21966,PID_NFKAPPAB_ATYPICAL_PATHWAY,0.924331525423729
GOMF_TRANSMEMBRANE_RECEPTOR_...3,SET,18,0.16333,0.0051115,0.21122,0.21968,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.924331525423729
KEGG_MEDICUS_REFERENCE_KINET...1,SET,22,0.13939,0.0048221,0.18029,0.21972,KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION,0.924387919138119
VECCHI_GASTRIC_CANCER_ADVANC...2,SET,154,0.05624,0.0051289,0.072757,0.21977,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,0.92440444818466
HALMOS_CEBPA_TARGETS_DN,SET,40,0.11017,0.0051366,0.14257,0.21983,HALMOS_CEBPA_TARGETS_DN,0.92440444818466
FIGUEROA_AML_METHYLATION_CLU...12,SET,127,0.059052,0.0048942,0.076425,0.21986,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,0.92440444818466
DESCARTES_FETAL_LIVER_HEMATO...,SET,23,0.14681,0.0051926,0.18999,0.21986,DESCARTES_FETAL_LIVER_HEMATOPOIETIC_STEM_CELLS,0.92440444818466
GOBP_PENETRATION_OF_ZONA_PEL...,SET,9,0.22505,0.0049813,0.29127,0.21987,GOBP_PENETRATION_OF_ZONA_PELLUCIDA,0.92440444818466
GSE9946_IMMATURE_VS_PROSTAGL...1,SET,124,0.057667,0.004723,0.074649,0.21991,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,0.92440444818466
HP_ABNORMALITY_OF_MASSETER_M...,SET,5,0.29972,0.0049453,0.38802,0.21993,HP_ABNORMALITY_OF_MASSETER_MUSCLE,0.92440444818466
HP_MACROSCOPIC_HEMATURIA,SET,8,0.25752,0.0053741,0.33351,0.22002,HP_MACROSCOPIC_HEMATURIA,0.92440444818466
GOBP_INTERLEUKIN_1_PRODUCTION,SET,104,0.067398,0.005058,0.08732,0.22011,GOBP_INTERLEUKIN_1_PRODUCTION,0.92440444818466
HP_MINIMAL_SUBCUTANEOUS_FAT,SET,4,0.33121,0.0048881,0.42916,0.22013,HP_MINIMAL_SUBCUTANEOUS_FAT,0.92440444818466
GSE5542_UNTREATED_VS_IFNA_TR...1,SET,168,0.048428,0.0046111,0.062753,0.22014,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,0.92440444818466
WP_MFAP5_EFFECT_ON_PERMEABIL...,SET,17,0.16657,0.005066,0.21586,0.22016,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,0.92440444818466
WP_MIRNAS_INVOLVED_IN_DNA_DA...,SET,14,0.17365,0.0047931,0.22507,0.2202,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,0.92440444818466
HP_PANCREATIC_PSEUDOCYST,SET,4,0.35968,0.0053083,0.46619,0.2202,HP_PANCREATIC_PSEUDOCYST,0.92440444818466
HP_ABNORMAL_LIVER_ENZYME_ACT...,SET,11,0.18102,0.0044295,0.23468,0.22025,HP_ABNORMAL_LIVER_ENZYME_ACTIVITY_OR_CONCENTRATION,0.92440444818466
HP_HYPEREOSINOPHILIA,SET,5,0.29082,0.0047985,0.37703,0.22025,HP_HYPEREOSINOPHILIA,0.92440444818466
GOBP_POSITIVE_REGULATION_OF_...730,SET,20,0.13184,0.0043489,0.17093,0.22027,GOBP_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.92440444818466
GSE17974_CTRL_VS_ACT_IL4_AND...9,SET,173,0.047252,0.0045649,0.061262,0.22027,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN,0.92440444818466
WP_BLOOD_CLOTTING_CASCADE,SET,20,0.15228,0.0050231,0.19745,0.22029,WP_BLOOD_CLOTTING_CASCADE,0.92440444818466
GSE41867_DAY6_VS_DAY15_LCMV_...1,SET,169,0.048711,0.0046518,0.063172,0.22033,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.92440444818466
GSE37605_TREG_VS_TCONV_NOD_F...2,SET,133,0.059249,0.0050244,0.07685,0.22037,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP,0.92440444818466
GSE41176_UNSTIM_VS_ANTI_IGM_...16,SET,161,0.049638,0.0046277,0.064386,0.22038,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_UP,0.92440444818466
REACTOME_CHREBP_ACTIVATES_ME...,SET,8,0.19697,0.0041106,0.25551,0.22039,REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION,0.92440444818466
MODULE_59,SET,22,0.15247,0.0052744,0.19782,0.22044,MODULE_59,0.92440444818466
EHRLICH_ICF_SYNDROM_DN,SET,12,0.19277,0.0049264,0.25013,0.22046,EHRLICH_ICF_SYNDROM_DN,0.92440444818466
KEGG_MEDICUS_PATHOGEN_HBV_HB...3,SET,13,0.17412,0.0046314,0.22599,0.22052,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY,0.92440444818466
GOCC_SECRETORY_GRANULE,SET,826,0.023674,0.004907,0.030731,0.22055,GOCC_SECRETORY_GRANULE,0.92440444818466
HP_MUSCULAR_DYSTROPHY,SET,69,0.0787,0.0048154,0.10217,0.22058,HP_MUSCULAR_DYSTROPHY,0.92440444818466
MIR6797_5P,SET,181,0.048781,0.0048194,0.063342,0.22062,MIR6797_5P,0.92440444818466
HP_PULMONARY_HEMORRHAGE,SET,29,0.12875,0.0051127,0.1672,0.22065,HP_PULMONARY_HEMORRHAGE,0.92440444818466
GSE11818_WT_VS_DICER_KO_TREG...2,SET,129,0.062202,0.0051954,0.08078,0.22065,GSE11818_WT_VS_DICER_KO_TREG_UP,0.92440444818466
BIOCARTA_BARRESTIN_SRC_PATHW...,SET,16,0.17897,0.0052807,0.23244,0.22067,BIOCARTA_BARRESTIN_SRC_PATHWAY,0.92440444818466
GSE37416_CTRL_VS_6H_F_TULARE...2,SET,164,0.049232,0.004632,0.063953,0.22071,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.92440444818466
CTCTGGA_MIR520A_MIR525,SET,141,0.053694,0.0046872,0.069753,0.22072,CTCTGGA_MIR520A_MIR525,0.92440444818466
GOBP_XENOBIOTIC_TRANSPORT_AC...,SET,6,0.30221,0.0054622,0.3927,0.22078,GOBP_XENOBIOTIC_TRANSPORT_ACROSS_BLOOD_BRAIN_BARRIER,0.92440444818466
WP_STEROID_HORMONE_PRECURSOR...,SET,9,0.22964,0.005083,0.29841,0.22079,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,0.92440444818466
GOBP_INTERLEUKIN_17A_MEDIATE...,SET,6,0.28952,0.0052328,0.37625,0.22081,GOBP_INTERLEUKIN_17A_MEDIATED_SIGNALING_PATHWAY,0.92440444818466
FXR1_TARGET_GENES,SET,979,0.020647,0.0046388,0.026834,0.22082,FXR1_TARGET_GENES,0.92440444818466
GSE19198_CTRL_VS_IL21_TREATE...6,SET,172,0.051256,0.0049376,0.066618,0.22083,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP,0.92440444818466
MIR29A_3P,SET,396,0.034017,0.0049415,0.044213,0.22084,MIR29A_3P,0.92440444818466
GSE15271_CXCR4_POS_VS_NEG_GC...1,SET,164,0.050275,0.0047302,0.065349,0.22085,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN,0.92440444818466
GOBP_POSITIVE_REGULATION_OF_...229,SET,10,0.17901,0.0041766,0.2327,0.22087,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.92440444818466
HP_FOLLICULAR_HYPERKERATOSIS,SET,26,0.13103,0.0049273,0.17034,0.22088,HP_FOLLICULAR_HYPERKERATOSIS,0.92440444818466
HP_ABNORMAL_NASAL_BASE_NORPH...,SET,24,0.12476,0.0045076,0.16227,0.22101,HP_ABNORMAL_NASAL_BASE_NORPHOLOGY,0.92440444818466
GSE46606_IRF4_KO_VS_WT_CD40L...1,SET,168,0.048811,0.0046476,0.063494,0.22102,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_DN,0.92440444818466
GSE25088_ROSIGLITAZONE_VS_IL...1,SET,181,0.046713,0.0046151,0.060773,0.22106,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.92440444818466
WP_TROP2_REGULATORY_SIGNALING,SET,48,0.095267,0.0048646,0.12395,0.22107,WP_TROP2_REGULATORY_SIGNALING,0.92440444818466
GOBP_POSITIVE_REGULATION_OF_...369,SET,56,0.088688,0.0048905,0.11541,0.22111,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,0.92440444818466
HP_ASTHENIA,SET,8,0.21246,0.0044338,0.27648,0.22112,HP_ASTHENIA,0.92440444818466
GOCC_SPECIFIC_GRANULE_LUMEN,SET,57,0.090359,0.0050267,0.11759,0.22113,GOCC_SPECIFIC_GRANULE_LUMEN,0.92440444818466
GOMF_N_ACETYLLACTOSAMINIDE_B...,SET,6,0.32256,0.0058299,0.41981,0.22115,GOMF_N_ACETYLLACTOSAMINIDE_BETA_1_3_N_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,0.92440444818466
PASQUALUCCI_LYMPHOMA_BY_GC_S...1,SET,156,0.052962,0.004861,0.068934,0.22116,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,0.92440444818466
GOBP_CHOLESTEROL_EFFLUX,SET,53,0.09138,0.0049025,0.11894,0.22116,GOBP_CHOLESTEROL_EFFLUX,0.92440444818466
GSE28408_LY6G_POS_VS_NEG_DC_...2,SET,175,0.047432,0.0046086,0.061743,0.22118,GSE28408_LY6G_POS_VS_NEG_DC_UP,0.92440444818466
HP_ABNORMAL_ANTIHELIX_MORPHO...,SET,36,0.10602,0.00469,0.13801,0.22119,HP_ABNORMAL_ANTIHELIX_MORPHOLOGY,0.92440444818466
HP_ABNORMAL_CIRCULATING_FOLL...,SET,77,0.072538,0.0046876,0.094443,0.22123,HP_ABNORMAL_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_CONCENTRATION,0.92440444818466
REACTOME_METABOLISM_OF_STERO...2,SET,33,0.11698,0.0049549,0.15231,0.22124,REACTOME_METABOLISM_OF_STEROID_HORMONES,0.92440444818466
GSE31082_DN_VS_CD4_SP_THYMOC...1,SET,180,0.047023,0.004633,0.061253,0.22134,GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN,0.924670864864865
GOMF_AMINO_ACID_SODIUM_SYMPO...,SET,21,0.16449,0.0055599,0.21431,0.22138,GOMF_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY,0.924670864864865
HP_MODERATE_MYOPIA,SET,3,0.39846,0.0050928,0.51918,0.2214,HP_MODERATE_MYOPIA,0.924670864864865
KEGG_MEDICUS_REFERENCE_REGUL...13,SET,4,0.34075,0.0050288,0.44411,0.22147,KEGG_MEDICUS_REFERENCE_REGULATION_OF_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY_NLRP3_INHIBITION,0.924670864864865
MIR6873_3P,SET,340,0.036354,0.004901,0.047385,0.22148,MIR6873_3P,0.924670864864865
GOBP_POSITIVE_REGULATION_OF_...82,SET,56,0.090831,0.0050086,0.11839,0.22149,GOBP_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,0.924670864864865
GOBP_REGULATION_OF_TOLL_LIKE...6,SET,29,0.11162,0.0044323,0.14549,0.22149,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.924670864864865
RIZ_ERYTHROID_DIFFERENTIATIO...2,SET,38,0.10625,0.0048287,0.13851,0.22152,RIZ_ERYTHROID_DIFFERENTIATION_6HR,0.924685034830651
HP_URETERAL_DUPLICATION,SET,41,0.092854,0.0043829,0.12109,0.22159,HP_URETERAL_DUPLICATION,0.92482512605042
GOBP_RECEPTOR_CLUSTERING,SET,54,0.087971,0.0047637,0.11473,0.22162,GOBP_RECEPTOR_CLUSTERING,0.92482512605042
GOBP_REGULATION_OF_PATTERN_R...,SET,149,0.050627,0.0045421,0.066033,0.22164,GOBP_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.92482512605042
GOBP_POSITIVE_REGULATION_OF_...135,SET,9,0.22606,0.0050036,0.29488,0.22166,GOBP_POSITIVE_REGULATION_OF_CELL_MATURATION,0.92482512605042
HP_SYNOSTOSIS_INVOLVING_BONE...1,SET,26,0.14279,0.0053693,0.18634,0.22176,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_FEET,0.924854109178164
ZHAN_MULTIPLE_MYELOMA_HP_UP,SET,39,0.10406,0.0047908,0.13581,0.22177,ZHAN_MULTIPLE_MYELOMA_HP_UP,0.924854109178164
MODULE_521,SET,35,0.12138,0.0052944,0.15841,0.22178,MODULE_521,0.924854109178164
GSE32423_CTRL_VS_IL7_IL4_MEM...2,SET,182,0.048022,0.0047573,0.062676,0.22178,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,0.924854109178164
GRYDER_PAX3FOXO1_TOP_ENHANCE...,SET,415,0.033274,0.0049455,0.04343,0.2218,GRYDER_PAX3FOXO1_TOP_ENHANCERS,0.924854109178164
WP_SUDDEN_INFANT_DEATH_SYNDR...,SET,148,0.058334,0.0052161,0.076178,0.22192,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,0.925008719884933
GSE16386_IL4_VS_IL4_AND_ROSI...2,SET,181,0.045203,0.0044659,0.059031,0.22192,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP,0.925008719884933
HP_NASAL_DYSARTHRIA,SET,29,0.11973,0.0047545,0.1564,0.22198,HP_NASAL_DYSARTHRIA,0.925008719884933
HP_BILATERAL_TONIC_CLONIC_SE...1,SET,322,0.035511,0.0046612,0.046389,0.22199,HP_BILATERAL_TONIC_CLONIC_SEIZURE,0.925008719884933
CROMER_METASTASIS_UP,SET,59,0.085305,0.0048279,0.11145,0.22201,CROMER_METASTASIS_UP,0.925008719884933
GOMF_SIGNALING_RECEPTOR_REGU...,SET,489,0.032108,0.0051696,0.041947,0.22201,GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY,0.925008719884933
DESCARTES_FETAL_MUSCLE_MEGAK...,SET,195,0.04576,0.0046907,0.059788,0.22203,DESCARTES_FETAL_MUSCLE_MEGAKARYOCYTES,0.925008719884933
GOBP_URINARY_TRACT_SMOOTH_MU...,SET,9,0.2315,0.0051241,0.30249,0.22205,GOBP_URINARY_TRACT_SMOOTH_MUSCLE_CONTRACTION,0.925008719884933
GOBP_DIACYLGLYCEROL_BIOSYNTH...,SET,9,0.20076,0.0044438,0.26244,0.22215,GOBP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.925231646100395
GOBP_CD8_POSITIVE_ALPHA_BETA...1,SET,26,0.13523,0.0050852,0.1768,0.22218,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.925231646100395
BIOCARTA_IFNG_PATHWAY,SET,6,0.29235,0.005284,0.38227,0.22221,BIOCARTA_IFNG_PATHWAY,0.925231646100395
REACTOME_AFLATOXIN_ACTIVATIO...,SET,18,0.15371,0.0048104,0.20099,0.22221,REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION,0.925231646100395
CASTELLANO_NRAS_TARGETS_UP,SET,67,0.084494,0.0050948,0.1105,0.22225,CASTELLANO_NRAS_TARGETS_UP,0.925287344274078
HP_FEW_CAFE_AU_LAIT_SPOTS,SET,6,0.26545,0.0047977,0.34723,0.2223,HP_FEW_CAFE_AU_LAIT_SPOTS,0.925287887678122
GOBP_ACTIN_FILAMENT_BASED_MO...,SET,130,0.058434,0.0048994,0.076441,0.22231,GOBP_ACTIN_FILAMENT_BASED_MOVEMENT,0.925287887678122
GAVISH_3CA_MALIGNANT_METAPRO...9,SET,41,0.1082,0.0051074,0.14156,0.22233,GAVISH_3CA_MALIGNANT_METAPROGRAM_18_INTERFERON_MHC_II_2,0.925287887678122
GOBP_POSITIVE_REGULATION_OF_...21,SET,28,0.11956,0.0046655,0.15647,0.2224,GOBP_POSITIVE_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.925388022969647
EIF4E_DN,SET,90,0.067404,0.0047075,0.088231,0.22245,EIF4E_DN,0.925388022969647
HP_NEOPLASM_OF_THE_SMALL_INT...,SET,18,0.1357,0.0042467,0.17766,0.2225,HP_NEOPLASM_OF_THE_SMALL_INTESTINE,0.925388022969647
KEGG_MEDICUS_PATHOGEN_ESCHER...1,SET,14,0.14981,0.0041351,0.19621,0.22258,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TCCP_TO_ACTIN_SIGNALING_PATHWAY,0.925388022969647
GOBP_NEGATIVE_REGULATION_OF_...311,SET,26,0.13502,0.0050774,0.17684,0.22258,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,0.925388022969647
GSE3203_WT_VS_IFNAR1_KO_INFL...2,SET,178,0.048705,0.0047722,0.063814,0.22267,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_UP,0.925388022969647
GOBP_CELLULAR_COMPONENT_MAIN...,SET,64,0.082651,0.0048712,0.1083,0.22269,GOBP_CELLULAR_COMPONENT_MAINTENANCE,0.925388022969647
GOBP_MYELOID_DENDRITIC_CELL_...3,SET,19,0.15996,0.0051431,0.2096,0.22269,GOBP_MYELOID_DENDRITIC_CELL_DIFFERENTIATION,0.925388022969647
CROONQUIST_IL6_DEPRIVATION_UP,SET,17,0.17334,0.0052721,0.22718,0.22273,CROONQUIST_IL6_DEPRIVATION_UP,0.925388022969647
ZNF26_TARGET_GENES,SET,20,0.1385,0.0045685,0.1816,0.22283,ZNF26_TARGET_GENES,0.925388022969647
REACTOME_HCMV_LATE_EVENTS,SET,51,0.0826,0.0043472,0.10832,0.22287,REACTOME_HCMV_LATE_EVENTS,0.925388022969647
GOMF_GLYCEROL_CHANNEL_ACTIVI...,SET,5,0.3518,0.0058046,0.46134,0.22287,GOMF_GLYCEROL_CHANNEL_ACTIVITY,0.925388022969647
MIR6781_3P,SET,72,0.07583,0.0047392,0.099453,0.2229,MIR6781_3P,0.925388022969647
GOBP_DOUBLE_STRAND_BREAK_REP...1,SET,272,0.037019,0.0044723,0.048565,0.22295,GOBP_DOUBLE_STRAND_BREAK_REPAIR,0.925388022969647
GOBP_STEM_CELL_DIFFERENTIATI...,SET,229,0.04358,0.0048365,0.05717,0.22295,GOBP_STEM_CELL_DIFFERENTIATION,0.925388022969647
HP_MULTIPLE_LENTIGINES,SET,15,0.15327,0.0043791,0.2011,0.22298,HP_MULTIPLE_LENTIGINES,0.925388022969647
YIH_RESPONSE_TO_ARSENITE_C4,SET,16,0.15415,0.0045484,0.20228,0.22301,YIH_RESPONSE_TO_ARSENITE_C4,0.925388022969647
HP_DECREASED_PALMAR_CREASES,SET,5,0.29159,0.0048112,0.38263,0.22301,HP_DECREASED_PALMAR_CREASES,0.925388022969647
MORF_MYC,SET,75,0.073326,0.0046768,0.096233,0.22305,MORF_MYC,0.925388022969647
GOBP_NUCLEAR_MEMBRANE_ORGANI...,SET,44,0.095006,0.0046453,0.12471,0.22308,GOBP_NUCLEAR_MEMBRANE_ORGANIZATION,0.925388022969647
GOMF_ATP_DEPENDENT_DNA_DAMAG...,SET,16,0.13218,0.0039002,0.17352,0.2231,GOMF_ATP_DEPENDENT_DNA_DAMAGE_SENSOR_ACTIVITY,0.925388022969647
TACGGGT_MIR99A_MIR100_MIR99B,SET,23,0.13862,0.0049033,0.18198,0.22311,TACGGGT_MIR99A_MIR100_MIR99B,0.925388022969647
GOBP_APOPTOTIC_CELL_CLEARANCE,SET,46,0.096566,0.0048274,0.12678,0.22313,GOBP_APOPTOTIC_CELL_CLEARANCE,0.925388022969647
MALTA_CURATED_STEMNESS_MARKE...,SET,20,0.15735,0.0051904,0.20661,0.22316,MALTA_CURATED_STEMNESS_MARKERS,0.925388022969647
GSE20715_0H_VS_48H_OZONE_LUN...1,SET,189,0.045488,0.0045913,0.059745,0.22322,GSE20715_0H_VS_48H_OZONE_LUNG_DN,0.925388022969647
WP_7Q1123_DISTAL_COPY_NUMBER...,SET,21,0.15286,0.0051666,0.20078,0.22324,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,0.925388022969647
MIR6848_5P,SET,70,0.076711,0.0047275,0.10076,0.22324,MIR6848_5P,0.925388022969647
GOMF_THYROID_HORMONE_TRANSME...,SET,7,0.24668,0.0048156,0.32403,0.22325,GOMF_THYROID_HORMONE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.925388022969647
HP_HYPOPLASIA_OF_THE_RADIUS,SET,38,0.099229,0.0045095,0.13034,0.22325,HP_HYPOPLASIA_OF_THE_RADIUS,0.925388022969647
HP_LONG_HALLUX,SET,20,0.14394,0.004748,0.18909,0.22327,HP_LONG_HALLUX,0.925388022969647
BIOCARTA_SUMO_PATHWAY,SET,6,0.2221,0.0040143,0.29183,0.22331,BIOCARTA_SUMO_PATHWAY,0.925388022969647
HAY_BONE_MARROW_MONOCYTE,SET,195,0.047242,0.0048426,0.062076,0.22333,HAY_BONE_MARROW_MONOCYTE,0.925388022969647
MIR4726_5P,SET,89,0.063076,0.0043808,0.082887,0.22334,MIR4726_5P,0.925388022969647
HP_DEFICIT_IN_PHONOLOGIC_SHO...,SET,5,0.32675,0.0053913,0.42938,0.22334,HP_DEFICIT_IN_PHONOLOGIC_SHORT_TERM_MEMORY,0.925388022969647
MIR29B_3P_MIR29C_3P,SET,396,0.03364,0.0048867,0.044218,0.2234,MIR29B_3P_MIR29C_3P,0.925388022969647
DESCARTES_MAIN_FETAL_ASTROCY...,SET,33,0.11915,0.0050468,0.15663,0.22341,DESCARTES_MAIN_FETAL_ASTROCYTES,0.925388022969647
HP_ABNORMAL_METABOLIC_BRAIN_...,SET,46,0.088557,0.004427,0.11645,0.22349,HP_ABNORMAL_METABOLIC_BRAIN_IMAGING_BY_MRS,0.925388022969647
GOBP_ERYTHROCYTE_HOMEOSTASIS,SET,133,0.055413,0.0046991,0.072875,0.22352,GOBP_ERYTHROCYTE_HOMEOSTASIS,0.925388022969647
GOBP_NEGATIVE_REGULATION_OF_...160,SET,7,0.2283,0.0044569,0.3003,0.22355,GOBP_NEGATIVE_REGULATION_OF_CYTOKINESIS,0.925388022969647
GSE10325_MYELOID_VS_LUPUS_MY...1,SET,185,0.047542,0.0047481,0.062552,0.22362,GSE10325_MYELOID_VS_LUPUS_MYELOID_DN,0.925388022969647
MIR6717_5P,SET,4,0.32124,0.004741,0.4227,0.22363,MIR6717_5P,0.925388022969647
GOBP_REGULATION_OF_PROTEIN_P...1,SET,179,0.046428,0.0045617,0.061089,0.22363,GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION,0.925388022969647
GOMF_GPI_ANCHOR_BINDING,SET,8,0.21994,0.0045899,0.28946,0.22369,GOMF_GPI_ANCHOR_BINDING,0.925388022969647
HP_CEREBELLAR_HEMORRHAGE,SET,5,0.33665,0.0055547,0.4431,0.2237,HP_CEREBELLAR_HEMORRHAGE,0.925388022969647
GOMF_BETA_1_3_GALACTOSYLTRAN...,SET,14,0.1876,0.0051782,0.24694,0.22372,GOMF_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,0.925388022969647
BIOCARTA_AT1R_PATHWAY,SET,26,0.12527,0.0047107,0.16492,0.22375,BIOCARTA_AT1R_PATHWAY,0.925388022969647
GOBP_FATTY_ACYL_COA_CATABOLI...,SET,5,0.26376,0.004352,0.34723,0.22375,GOBP_FATTY_ACYL_COA_CATABOLIC_PROCESS,0.925388022969647
HP_ANAL_FISTULA,SET,7,0.22264,0.0043463,0.29311,0.22375,HP_ANAL_FISTULA,0.925388022969647
MIR4744,SET,155,0.049809,0.0045571,0.065576,0.22376,MIR4744,0.925388022969647
GOBP_ANTIGEN_PROCESSING_AND_...14,SET,24,0.16331,0.0059003,0.21502,0.22378,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_VIA_MHC_CLASS_IB,0.925388022969647
HP_LYMPHADENITIS,SET,13,0.16849,0.0044816,0.22183,0.22378,HP_LYMPHADENITIS,0.925388022969647
GSE18804_SPLEEN_MACROPHAGE_V...2,SET,170,0.051256,0.0049091,0.067493,0.2238,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP,0.925388022969647
chr4q25,SET,28,0.20624,0.0080479,0.27158,0.22381,chr4q25,0.925388022969647
KEGG_MEDICUS_VARIANT_AMPLIFI...7,SET,14,0.16526,0.0045615,0.21764,0.22384,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY,0.925388022969647
HP_MEDIAL_FLARING_OF_THE_EYE...,SET,35,0.10634,0.0046385,0.14009,0.2239,HP_MEDIAL_FLARING_OF_THE_EYEBROW,0.925388022969647
GOBP_REGULATION_OF_SYNAPTIC_...13,SET,22,0.13052,0.0045152,0.17195,0.22392,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING,0.925388022969647
GOBP_RESPONSE_TO_INTERLEUKIN...6,SET,12,0.2086,0.005331,0.27486,0.22395,GOBP_RESPONSE_TO_INTERLEUKIN_18,0.925388022969647
GOBP_CELLULAR_RESPONSE_TO_FO...,SET,9,0.25197,0.0055773,0.33205,0.22398,GOBP_CELLULAR_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE_STIMULUS,0.925388022969647
GCM_SIRT2,SET,40,0.098109,0.0045742,0.12932,0.22404,GCM_SIRT2,0.925388022969647
HEBERT_MATRISOME_TNBC_LIVER_...,SET,13,0.19221,0.0051126,0.25338,0.22405,HEBERT_MATRISOME_TNBC_LIVER_METASTASIS,0.925388022969647
REACTOME_FCERI_MEDIATED_NF_K...,SET,76,0.06858,0.004403,0.090428,0.22411,REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,0.925388022969647
HP_ATTACHED_EARLOBE,SET,6,0.27358,0.0049447,0.36087,0.22419,HP_ATTACHED_EARLOBE,0.925388022969647
HP_PROLONGED_BLEEDING_TIME,SET,46,0.094001,0.0046991,0.12399,0.22419,HP_PROLONGED_BLEEDING_TIME,0.925388022969647
WONG_ENDMETRIUM_CANCER_DN,SET,69,0.085224,0.0052146,0.11242,0.2242,WONG_ENDMETRIUM_CANCER_DN,0.925388022969647
GOBP_NEGATIVE_REGULATION_OF_...251,SET,24,0.1439,0.0051992,0.18984,0.22423,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.925388022969647
HUANG_GATA2_TARGETS_DN,SET,66,0.078812,0.0047166,0.10398,0.22424,HUANG_GATA2_TARGETS_DN,0.925388022969647
KEGG_MEDICUS_REFERENCE_EARLY...,SET,8,0.20356,0.004248,0.26861,0.22429,KEGG_MEDICUS_REFERENCE_EARLY_ENDOSOMAL_FUSION,0.925388022969647
GOBP_ARTERIAL_ENDOTHELIAL_CE...,SET,6,0.28472,0.0051461,0.37577,0.22432,GOBP_ARTERIAL_ENDOTHELIAL_CELL_DIFFERENTIATION,0.925388022969647
GSE17721_PAM3CSK4_VS_CPG_4H_...1,SET,181,0.04876,0.0048173,0.064352,0.22432,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_DN,0.925388022969647
FULLER_PBMC_F_TULARENSIS_VAC...9,SET,43,0.10062,0.0048637,0.1328,0.22432,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_UP,0.925388022969647
HP_BELL_SHAPED_THORAX,SET,32,0.11725,0.0048906,0.15477,0.22436,HP_BELL_SHAPED_THORAX,0.925388022969647
GSE22611_UNSTIM_VS_2H_MDP_ST...1,SET,171,0.045771,0.0043965,0.06043,0.2244,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.925388022969647
GOMF_NUCLEOSIDE_MONOPHOSPHAT...,SET,19,0.14238,0.0045778,0.18799,0.22442,GOMF_NUCLEOSIDE_MONOPHOSPHATE_KINASE_ACTIVITY,0.925388022969647
GSE1448_CTRL_VS_ANTI_VBETA5_...1,SET,185,0.0467,0.004664,0.061664,0.22443,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN,0.925388022969647
GOBP_REGULATION_OF_CD8_POSIT...1,SET,19,0.15763,0.0050679,0.20817,0.22447,GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.925388022969647
GOBP_POSITIVE_REGULATION_OF_...329,SET,6,0.21172,0.0038266,0.27967,0.22452,GOBP_POSITIVE_REGULATION_OF_HELICASE_ACTIVITY,0.925388022969647
HP_DENTAL_CROWDING,SET,119,0.059179,0.0047488,0.078189,0.22457,HP_DENTAL_CROWDING,0.925388022969647
GOMF_ACYLTRANSFERASE_ACTIVIT...1,SET,5,0.28379,0.0046824,0.37497,0.22459,GOMF_ACYLTRANSFERASE_ACTIVITY_ACYL_GROUPS_CONVERTED_INTO_ALKYL_ON_TRANSFER,0.925388022969647
GOBP_ZINC_ION_IMPORT_INTO_OR...,SET,11,0.18039,0.0044139,0.23837,0.22461,GOBP_ZINC_ION_IMPORT_INTO_ORGANELLE,0.925388022969647
HP_GLOMUS_JUGULAR_TUMOR,SET,5,0.20497,0.0033819,0.27092,0.22466,HP_GLOMUS_JUGULAR_TUMOR,0.925388022969647
HP_URETHRAL_STENOSIS,SET,49,0.095658,0.004935,0.12644,0.22467,HP_URETHRAL_STENOSIS,0.925388022969647
HP_ABNORMAL_CRY,SET,54,0.085123,0.0046095,0.11253,0.22469,HP_ABNORMAL_CRY,0.925388022969647
GSE36527_CD69_NEG_VS_POS_TRE...2,SET,187,0.048988,0.0049186,0.064759,0.22469,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP,0.925388022969647
GSE17186_MEMORY_VS_NAIVE_BCE...2,SET,169,0.049072,0.0046862,0.064891,0.22476,GSE17186_MEMORY_VS_NAIVE_BCELL_UP,0.925388022969647
HP_ABNORMAL_MIDDLE_EAR_MORPH...,SET,322,0.036997,0.0048563,0.048929,0.22479,HP_ABNORMAL_MIDDLE_EAR_MORPHOLOGY,0.925388022969647
HP_JAW_HYPERREFLEXIA,SET,39,0.094848,0.0043667,0.12544,0.22479,HP_JAW_HYPERREFLEXIA,0.925388022969647
GOBP_POSITIVE_REGULATION_OF_...41,SET,5,0.30159,0.0049762,0.3989,0.22481,GOBP_POSITIVE_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.925388022969647
GOBP_MITOTIC_G1_S_TRANSITION...,SET,30,0.11143,0.0045006,0.14739,0.22482,GOBP_MITOTIC_G1_S_TRANSITION_CHECKPOINT_SIGNALING,0.925388022969647
STONER_ESOPHAGEAL_CARCINOGEN...2,SET,31,0.11121,0.0045659,0.14712,0.22484,STONER_ESOPHAGEAL_CARCINOGENESIS_UP,0.925388022969647
GOCC_REPLISOME,SET,22,0.12058,0.0041715,0.15954,0.22488,GOCC_REPLISOME,0.925388022969647
MIR4704_5P,SET,55,0.085415,0.0046678,0.11301,0.22489,MIR4704_5P,0.925388022969647
HP_COCHLEAR_MALFORMATION,SET,8,0.20234,0.0042227,0.26773,0.22489,HP_COCHLEAR_MALFORMATION,0.925388022969647
GSE17721_PAM3CSK4_VS_GADIQUI...8,SET,181,0.049184,0.0048592,0.065076,0.22489,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP,0.925388022969647
GSE36888_STAT5_AB_KNOCKIN_VS...6,SET,175,0.045912,0.0044608,0.060755,0.22492,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP,0.925388022969647
MIR520D_5P,SET,852,0.022709,0.0047771,0.030057,0.22497,MIR520D_5P,0.925388022969647
GOBP_POSITIVE_REGULATION_OF_...224,SET,66,0.073906,0.0044231,0.097847,0.22503,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.925388022969647
REACTOME_RRNA_MODIFICATION_I...1,SET,4,0.33078,0.0048817,0.43802,0.22508,REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION,0.925388022969647
GOMF_PROTEASOME_BINDING,SET,16,0.13653,0.0040287,0.18081,0.22509,GOMF_PROTEASOME_BINDING,0.925388022969647
MIR645,SET,35,0.098683,0.0043044,0.13071,0.22513,MIR645,0.925388022969647
GOBP_REGULATION_OF_MITOTIC_C...4,SET,16,0.15121,0.0044619,0.20032,0.22518,GOBP_REGULATION_OF_MITOTIC_CYTOKINESIS,0.925388022969647
GOBP_REGULATION_OF_PROTEIN_L...5,SET,12,0.1977,0.0050524,0.26196,0.22523,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CENTROSOME,0.925388022969647
GOMF_STRUCTURAL_CONSTITUENT_...1,SET,3,0.37513,0.0047946,0.49722,0.2253,GOMF_STRUCTURAL_CONSTITUENT_OF_CHROMATIN,0.925388022969647
GSE26343_UNSTIM_VS_LPS_STIM_...3,SET,186,0.048046,0.0048112,0.063688,0.22531,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN,0.925388022969647
HP_ABNORMALLY_FOLDED_HELIX,SET,71,0.076445,0.0047445,0.10134,0.22533,HP_ABNORMALLY_FOLDED_HELIX,0.925388022969647
GSE40274_CTRL_VS_GATA1_TRANS...1,SET,147,0.05144,0.0045842,0.068193,0.22533,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.925388022969647
DASU_IL6_SIGNALING_SCAR_DN,SET,13,0.19328,0.005141,0.25626,0.22536,DASU_IL6_SIGNALING_SCAR_DN,0.925388022969647
GOBP_RESPONSE_TO_HISTAMINE,SET,10,0.21457,0.0050061,0.28449,0.22536,GOBP_RESPONSE_TO_HISTAMINE,0.925388022969647
HP_HYPEROPIC_ASTIGMATISM,SET,5,0.24171,0.0039882,0.32051,0.22538,HP_HYPEROPIC_ASTIGMATISM,0.925388022969647
GOCC_AGGRESOME,SET,30,0.11257,0.0045465,0.14928,0.2254,GOCC_AGGRESOME,0.925388022969647
HP_DISTAL_SENSORY_IMPAIRMENT...,SET,10,0.19023,0.0044382,0.25226,0.2254,HP_DISTAL_SENSORY_IMPAIRMENT_OF_ALL_MODALITIES,0.925388022969647
HP_FOAMY_URINE,SET,29,0.11754,0.0046677,0.15587,0.2254,HP_FOAMY_URINE,0.925388022969647
FAELT_B_CLL_WITH_VH_REARRANG...2,SET,45,0.095748,0.0047343,0.12698,0.22541,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,0.925388022969647
HP_APLASIA_HYPOPLASIA_INVOLV...4,SET,479,0.029453,0.0046947,0.039074,0.2255,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.925388022969647
WP_SOMATIC_SEX_DETERMINATION,SET,13,0.18405,0.0048955,0.24421,0.22554,WP_SOMATIC_SEX_DETERMINATION,0.925388022969647
KEGG_GLYCINE_SERINE_AND_THRE...,SET,27,0.12122,0.0046452,0.16086,0.22555,KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM,0.925388022969647
DESCARTES_FETAL_LUNG_LYMPHOI...,SET,118,0.062541,0.0049976,0.082999,0.22557,DESCARTES_FETAL_LUNG_LYMPHOID_CELLS,0.925388022969647
GSE2405_0H_VS_24H_A_PHAGOCYT...2,SET,187,0.045446,0.004563,0.060316,0.22559,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.925388022969647
GOBP_MEMBRANE_RAFT_LOCALIZAT...,SET,6,0.25656,0.0046372,0.34053,0.2256,GOBP_MEMBRANE_RAFT_LOCALIZATION,0.925388022969647
GOBP_POSITIVE_REGULATION_OF_...346,SET,412,0.033043,0.0048939,0.043858,0.22561,GOBP_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY,0.925388022969647
GOBP_FOCAL_ADHESION_ASSEMBLY,SET,82,0.068324,0.0045558,0.090712,0.22567,GOBP_FOCAL_ADHESION_ASSEMBLY,0.925388022969647
GSE2770_IL4_ACT_VS_ACT_CD4_T...5,SET,173,0.046205,0.0044639,0.061351,0.22569,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,0.925388022969647
GOBP_RETINAL_METABOLIC_PROCE...,SET,18,0.16374,0.0051242,0.21744,0.22572,GOBP_RETINAL_METABOLIC_PROCESS,0.925388022969647
GOMF_N_ACETYLGALACTOSAMINE_4...,SET,5,0.25384,0.0041883,0.33717,0.22577,GOMF_N_ACETYLGALACTOSAMINE_4_O_SULFOTRANSFERASE_ACTIVITY,0.925388022969647
HP_APLASIA_HYPOPLASIA_OF_THE...66,SET,178,0.046775,0.0045831,0.062128,0.22577,HP_APLASIA_HYPOPLASIA_OF_THE_SKIN,0.925388022969647
KEGG_BLADDER_CANCER,SET,40,0.098945,0.0046132,0.13146,0.22582,KEGG_BLADDER_CANCER,0.925388022969647
GOBP_NEGATIVE_REGULATION_OF_...133,SET,11,0.17511,0.0042848,0.23268,0.22586,GOBP_NEGATIVE_REGULATION_OF_CGAS_STING_SIGNALING_PATHWAY,0.925388022969647
GSE1460_DP_THYMOCYTE_VS_THYM...1,SET,174,0.046368,0.0044924,0.061628,0.22592,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,0.925388022969647
REACTOME_SYNTHESIS_SECRETION...3,SET,12,0.17989,0.0045973,0.23911,0.22593,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP,0.925388022969647
WANG_NFKB_TARGETS,SET,24,0.12644,0.0045684,0.16809,0.22596,WANG_NFKB_TARGETS,0.925388022969647
REACTOME_DOPAMINE_CLEARANCE_...,SET,3,0.48835,0.0062418,0.64922,0.22597,REACTOME_DOPAMINE_CLEARANCE_FROM_THE_SYNAPTIC_CLEFT,0.925388022969647
HP_THROMBOCYTOSIS,SET,55,0.082832,0.0045267,0.11013,0.22599,HP_THROMBOCYTOSIS,0.925388022969647
CHOI_ATL_STAGE_PREDICTOR,SET,39,0.10309,0.0047462,0.13708,0.22601,CHOI_ATL_STAGE_PREDICTOR,0.925388022969647
GSE37301_HEMATOPOIETIC_STEM_...9,SET,151,0.051035,0.0046091,0.067859,0.22601,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_DN,0.925388022969647
REACTOME_MITOCHONDRIAL_PROTE...1,SET,78,0.066585,0.0043306,0.088538,0.22602,REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION,0.925388022969647
GSE17721_CTRL_VS_GARDIQUIMOD...11,SET,179,0.047016,0.0046195,0.062524,0.22604,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_DN,0.925388022969647
GSE40274_FOXP3_VS_FOXP3_AND_...8,SET,176,0.048494,0.004725,0.064502,0.22608,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.925388022969647
MIR6090,SET,9,0.2213,0.0048984,0.29437,0.2261,MIR6090,0.925388022969647
REICHERT_G1S_REGULATORS_AS_P...,SET,8,0.18702,0.0039029,0.24878,0.22611,REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS,0.925388022969647
GOMF_CARBOHYDRATE_TRANSMEMBR...,SET,36,0.11445,0.0050627,0.15225,0.22613,GOMF_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.925388022969647
HP_ABNORMALITY_OF_THE_CHIN,SET,336,0.034507,0.0046251,0.045924,0.22621,HP_ABNORMALITY_OF_THE_CHIN,0.925388022969647
REACTOME_ACETYLCHOLINE_INHIB...,SET,5,0.33297,0.0054939,0.44325,0.22627,REACTOME_ACETYLCHOLINE_INHIBITS_CONTRACTION_OF_OUTER_HAIR_CELLS,0.925388022969647
HP_APLASIA_HYPOPLASIA_OF_THE...27,SET,47,0.095327,0.0048168,0.1269,0.22627,HP_APLASIA_HYPOPLASIA_OF_THE_EARLOBES,0.925388022969647
GOBP_L_METHIONINE_SALVAGE_FR...,SET,5,0.32583,0.0053761,0.43383,0.22631,GOBP_L_METHIONINE_SALVAGE_FROM_METHYLTHIOADENOSINE,0.925388022969647
BURTON_ADIPOGENESIS_3,SET,95,0.062958,0.0045169,0.08383,0.22632,BURTON_ADIPOGENESIS_3,0.925388022969647
GOBP_NEGATIVE_REGULATION_OF_...461,SET,18,0.13845,0.0043327,0.18435,0.22633,GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,0.925388022969647
GOBP_REGULATION_OF_POTASSIUM...4,SET,87,0.072738,0.0049951,0.096867,0.22636,GOBP_REGULATION_OF_POTASSIUM_ION_TRANSPORT,0.925388022969647
HP_ABNORMAL_EPIGLOTTIS_MORPH...,SET,20,0.13944,0.0045997,0.18571,0.22637,HP_ABNORMAL_EPIGLOTTIS_MORPHOLOGY,0.925388022969647
HP_NASOLACRIMAL_DUCT_OBSTRUC...,SET,29,0.11733,0.0046593,0.15626,0.22637,HP_NASOLACRIMAL_DUCT_OBSTRUCTION,0.925388022969647
HP_EMG_IMPAIRED_NEUROMUSCULA...,SET,34,0.108,0.0046433,0.14384,0.22638,HP_EMG_IMPAIRED_NEUROMUSCULAR_TRANSMISSION,0.925388022969647
REACTOME_DOWNREGULATION_OF_S...,SET,28,0.11975,0.0046726,0.1595,0.2264,REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,0.925388022969647
GSE37301_COMMON_LYMPHOID_PRO...5,SET,177,0.046016,0.0044962,0.061295,0.22641,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_DN,0.925388022969647
GOBP_CELL_SURFACE_RECEPTOR_S...1,SET,7,0.26461,0.0051657,0.35252,0.22644,GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT,0.925388022969647
HP_CORONARY_ARTERY_ATHEROSCL...,SET,50,0.094499,0.0049246,0.12592,0.22649,HP_CORONARY_ARTERY_ATHEROSCLEROSIS,0.925388022969647
GOBP_COMPLEMENT_RECEPTOR_MED...,SET,13,0.2029,0.0053969,0.27037,0.2265,GOBP_COMPLEMENT_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.925388022969647
chr11q11,SET,10,0.31016,0.0072364,0.41338,0.22654,chr11q11,0.925388022969647
GSE9037_WT_VS_IRAK4_KO_LPS_1...1,SET,172,0.04924,0.0047434,0.06563,0.22655,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN,0.925388022969647
GOMF_PROTEIN_DIMERIZATION_AC...,SET,893,0.021886,0.0047078,0.029175,0.22658,GOMF_PROTEIN_DIMERIZATION_ACTIVITY,0.925388022969647
GOBP_POSITIVE_REGULATION_OF_...685,SET,9,0.1982,0.0043871,0.26423,0.2266,GOBP_POSITIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.925388022969647
GSE17721_POLYIC_VS_PAM3CSK4_...7,SET,175,0.049151,0.0047755,0.065527,0.22661,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN,0.925388022969647
MIR455_3P,SET,84,0.069454,0.004687,0.092619,0.22667,MIR455_3P,0.925388022969647
GOMF_NF_KAPPAB_BINDING,SET,28,0.10943,0.0042702,0.14594,0.22668,GOMF_NF_KAPPAB_BINDING,0.925388022969647
GOCC_DNA_REPLICATION_FACTOR_...2,SET,5,0.2735,0.0045127,0.36477,0.2267,GOCC_DNA_REPLICATION_FACTOR_C_COMPLEX,0.925388022969647
GOBP_GALACTOLIPID_METABOLIC_...,SET,9,0.22903,0.0050695,0.30552,0.22673,GOBP_GALACTOLIPID_METABOLIC_PROCESS,0.925388022969647
FOURNIER_ACINAR_DEVELOPMENT_...3,SET,264,0.03783,0.0045034,0.050464,0.22674,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,0.925388022969647
KEGG_MEDICUS_VARIANT_LOSS_OF...1,SET,8,0.21858,0.0045616,0.29166,0.2268,KEGG_MEDICUS_VARIANT_LOSS_OF_CDKN1B_TO_P27_CELL_CYCLE_G1_S,0.925388022969647
GOBP_POSITIVE_REGULATION_OF_...799,SET,14,0.17672,0.004878,0.23584,0.22683,GOBP_POSITIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.925388022969647
GOMF_LIGAND_ACTIVATED_TRANSC...,SET,52,0.090557,0.0048124,0.12085,0.22683,GOMF_LIGAND_ACTIVATED_TRANSCRIPTION_FACTOR_ACTIVITY,0.925388022969647
GOBP_NEUROTROPHIN_SIGNALING_...,SET,38,0.10052,0.004568,0.13414,0.22684,GOBP_NEUROTROPHIN_SIGNALING_PATHWAY,0.925388022969647
GOBP_INSULIN_RECEPTOR_SIGNAL...,SET,119,0.056255,0.0045141,0.075106,0.22693,GOBP_INSULIN_RECEPTOR_SIGNALING_PATHWAY,0.925388022969647
PATEL_SKIN_OF_BODY_ZOSTAVAX_...5,SET,28,0.13366,0.0052154,0.17844,0.22693,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_TOP_30_DEG_UP,0.925388022969647
HP_MISCARRIAGE,SET,32,0.11931,0.0049765,0.15938,0.22706,HP_MISCARRIAGE,0.925388022969647
KEGG_MEDICUS_ENV_FACTOR_META...4,SET,11,0.18718,0.0045802,0.25008,0.22708,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY,0.925388022969647
GOCC_MYELIN_SHEATH,SET,41,0.095927,0.0045279,0.12816,0.22708,GOCC_MYELIN_SHEATH,0.925388022969647
GOBP_PROTEIN_LOCALIZATION_TO...13,SET,21,0.15113,0.0051081,0.20191,0.22709,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_CENTROMERIC_REGION,0.925388022969647
GSE30971_CTRL_VS_LPS_STIM_MA...2,SET,167,0.052968,0.0050286,0.070767,0.22709,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_UP,0.925388022969647
HP_NEOPLASM_OF_THE_RECTUM,SET,46,0.087299,0.0043641,0.11664,0.2271,HP_NEOPLASM_OF_THE_RECTUM,0.925388022969647
GOMF_DYNEIN_HEAVY_CHAIN_BIND...,SET,12,0.16335,0.0041746,0.21828,0.22713,GOMF_DYNEIN_HEAVY_CHAIN_BINDING,0.925388022969647
HP_FACIAL_ERYTHEMA,SET,11,0.19783,0.0048408,0.26435,0.22713,HP_FACIAL_ERYTHEMA,0.925388022969647
DESCARTES_FETAL_EYE_MICROGLIA,SET,127,0.057516,0.0047669,0.076858,0.22713,DESCARTES_FETAL_EYE_MICROGLIA,0.925388022969647
KEGG_MEDICUS_REFERENCE_NOTCH...1,SET,9,0.22344,0.0049456,0.29861,0.22716,KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION,0.925388022969647
HP_ABNORMAL_BRAIN_N_ACETYL_A...,SET,19,0.13012,0.0041835,0.17393,0.2272,HP_ABNORMAL_BRAIN_N_ACETYL_ASPARTATE_LEVEL_BY_MRS,0.925388022969647
HP_HYPEREXTENSIBILITY_OF_THE...2,SET,38,0.097675,0.0044389,0.13056,0.2272,HP_HYPEREXTENSIBILITY_OF_THE_KNEE,0.925388022969647
MIR4271,SET,198,0.043585,0.0045016,0.05828,0.22728,MIR4271,0.925390500701919
KEGG_MEDICUS_REFERENCE_DRD1_...,SET,16,0.15234,0.0044951,0.20372,0.22729,KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY,0.925390500701919
GOBP_MESENCHYMAL_CELL_DIFFER...1,SET,237,0.043309,0.0048886,0.057918,0.22731,GOBP_MESENCHYMAL_CELL_DIFFERENTIATION,0.925390500701919
GOBP_NEGATIVE_REGULATION_OF_...463,SET,14,0.19957,0.0055085,0.26691,0.22733,GOBP_NEGATIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.925390500701919
JIANG_VHL_TARGETS,SET,77,0.069099,0.0044653,0.092425,0.22735,JIANG_VHL_TARGETS,0.925390500701919
HP_BRISK_REFLEXES,SET,99,0.059308,0.0043432,0.079347,0.2274,HP_BRISK_REFLEXES,0.925390500701919
CGTSACG_PAX3_B,SET,140,0.054231,0.0047174,0.072557,0.22741,CGTSACG_PAX3_B,0.925390500701919
VERHAAK_GLIOBLASTOMA_MESENCH...,SET,203,0.046538,0.0048662,0.062277,0.22745,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,0.925390500701919
HP_PREMATURE_VENTRICULAR_CON...,SET,27,0.13131,0.0050315,0.17574,0.22749,HP_PREMATURE_VENTRICULAR_CONTRACTION,0.925390500701919
GOMF_DNA_METHYLTRANSFERASE_A...,SET,7,0.2681,0.0052338,0.35887,0.22752,GOMF_DNA_METHYLTRANSFERASE_ACTIVITY,0.925390500701919
GSE40274_CTRL_VS_LEF1_TRANSD...1,SET,156,0.047494,0.0043592,0.063579,0.22753,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.925390500701919
SILIGAN_TARGETS_OF_EWS_FLI1_...2,SET,15,0.17321,0.0049486,0.23187,0.22754,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP,0.925390500701919
GOBP_DOUBLE_STRAND_BREAK_REP...3,SET,8,0.19719,0.0041152,0.26402,0.22757,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_ALTERNATIVE_NONHOMOLOGOUS_END_JOINING,0.925390500701919
HP_CRANIOFACIAL_OSTEOSCLEROS...,SET,13,0.16827,0.0044759,0.2253,0.22758,HP_CRANIOFACIAL_OSTEOSCLEROSIS,0.925390500701919
GOBP_POSITIVE_REGULATION_OF_...201,SET,4,0.34494,0.0050907,0.4619,0.2276,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE,0.925390500701919
REACTOME_REGULATION_OF_COMMI...,SET,10,0.23044,0.0053764,0.30874,0.22772,REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO,0.925757526002103
GOCC_ORGANELLE_ENVELOPE,SET,1108,0.018991,0.0045221,0.025447,0.22775,GOCC_ORGANELLE_ENVELOPE,0.925757526002103
GOMF_PROLINE_SODIUM_SYMPORTE...,SET,5,0.34448,0.0056838,0.46171,0.22781,GOMF_PROLINE_SODIUM_SYMPORTER_ACTIVITY,0.925757526002103
GSE22886_NAIVE_TCELL_VS_DC_UP,SET,178,0.04506,0.0044151,0.0604,0.22783,GSE22886_NAIVE_TCELL_VS_DC_UP,0.925757526002103
PRAMOONJAGO_SOX4_TARGETS_DN,SET,46,0.089109,0.0044546,0.11945,0.22785,PRAMOONJAGO_SOX4_TARGETS_DN,0.925757526002103
VECCHI_GASTRIC_CANCER_ADVANC...1,SET,132,0.05399,0.0045613,0.072391,0.22789,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,0.925757526002103
HP_ABNORMALITY_OF_THE_DENTIT...,SET,875,0.021757,0.0046351,0.029172,0.22789,HP_ABNORMALITY_OF_THE_DENTITION,0.925757526002103
GOBP_ALDITOL_BIOSYNTHETIC_PR...,SET,5,0.26406,0.004357,0.35409,0.22792,GOBP_ALDITOL_BIOSYNTHETIC_PROCESS,0.925757526002103
REACTOME_SIGNALING_BY_MODERA...,SET,42,0.099404,0.0047488,0.13331,0.22793,REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS,0.925757526002103
MONNIER_POSTRADIATION_TUMOR_...1,SET,335,0.034279,0.0045878,0.045981,0.22799,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,0.925893018228558
MODULE_94,SET,342,0.035358,0.0047805,0.047441,0.22805,MODULE_94,0.926028478794252
GSE21360_SECONDARY_VS_TERTIA...2,SET,179,0.044261,0.0043488,0.059416,0.22816,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,0.926083457813047
GOCC_MITOCHONDRIAL_PROTEIN_C...,SET,228,0.038983,0.004317,0.052334,0.22817,GOCC_MITOCHONDRIAL_PROTEIN_CONTAINING_COMPLEX,0.926083457813047
GSE9601_UNTREATED_VS_NFKB_IN...2,SET,145,0.054146,0.0047927,0.072702,0.22821,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,0.926083457813047
GOBP_REGULATION_OF_RESTING_M...,SET,10,0.1973,0.0046032,0.26494,0.22823,GOBP_REGULATION_OF_RESTING_MEMBRANE_POTENTIAL,0.926083457813047
GOCC_MISMATCH_REPAIR_COMPLEX,SET,7,0.18285,0.0035696,0.2456,0.22829,GOCC_MISMATCH_REPAIR_COMPLEX,0.926083457813047
HP_RECURRENT_URINARY_TRACT_I...,SET,143,0.053111,0.0046689,0.071339,0.22829,HP_RECURRENT_URINARY_TRACT_INFECTIONS,0.926083457813047
RIZ_ERYTHROID_DIFFERENTIATIO...5,SET,36,0.11556,0.0051121,0.15523,0.2283,RIZ_ERYTHROID_DIFFERENTIATION_HBZ,0.926083457813047
HP_ORAL_AVERSION,SET,16,0.14997,0.0044252,0.20145,0.2283,HP_ORAL_AVERSION,0.926083457813047
REACTOME_SHC_RELATED_EVENTS_...,SET,9,0.18972,0.0041993,0.25487,0.22833,REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R,0.926083457813047
HP_PEDAL_EDEMA,SET,48,0.092604,0.0047286,0.1244,0.22833,HP_PEDAL_EDEMA,0.926083457813047
LI_PBMC_MENACTRA_AGE_18_45YO...5,SET,30,0.12119,0.0048945,0.16283,0.22837,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP,0.926137613768961
GSE15330_HSC_VS_LYMPHOID_PRI...4,SET,181,0.046811,0.0046248,0.062918,0.22844,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,0.926300005832264
GSE40274_FOXP3_VS_FOXP3_AND_...3,SET,182,0.044945,0.0044525,0.060417,0.22847,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.926300005832264
REACTOME_STAT5_ACTIVATION_DO...,SET,10,0.19751,0.0046081,0.26552,0.22849,REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,0.926300005832264
SOTIRIOU_BREAST_CANCER_GRADE...2,SET,137,0.05122,0.0044078,0.068876,0.22855,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP,0.926300355519291
WP_MAPK_PATHWAY_IN_CONGENITA...,SET,14,0.1696,0.0046813,0.2281,0.22859,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,0.926300355519291
GSE27241_WT_CTRL_VS_DIGOXIN_...2,SET,161,0.050793,0.0047354,0.068316,0.22859,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,0.926300355519291
HP_PARANOIA,SET,20,0.13266,0.004376,0.17846,0.22863,HP_PARANOIA,0.926300355519291
CREB_Q2_01,SET,205,0.043534,0.0045742,0.058566,0.22864,CREB_Q2_01,0.926300355519291
GSE17721_POLYIC_VS_CPG_1H_BM...1,SET,183,0.04569,0.0045386,0.061467,0.22865,GSE17721_POLYIC_VS_CPG_1H_BMDC_DN,0.926300355519291
SRY_02,SET,229,0.043484,0.0048258,0.058507,0.22868,SRY_02,0.926313916083916
MIR300,SET,406,0.03172,0.0046644,0.042687,0.22872,MIR300,0.926367975760401
REACTOME_DEFECTS_OF_CONTACT_...,SET,14,0.18203,0.0050245,0.24507,0.22882,REACTOME_DEFECTS_OF_CONTACT_ACTIVATION_SYSTEM_CAS_AND_KALLIKREIN_KININ_SYSTEM_KKS,0.926611055452004
FONTAINE_THYROID_TUMOR_UNCER...1,SET,26,0.12778,0.0048051,0.17207,0.22886,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,0.926611055452004
KEGG_STEROID_HORMONE_BIOSYNT...,SET,52,0.10289,0.0054678,0.13855,0.22886,KEGG_STEROID_HORMONE_BIOSYNTHESIS,0.926611055452004
MODULE_115,SET,25,0.11794,0.0043491,0.15886,0.22891,MODULE_115,0.926705538730344
chr12p13,SET,133,0.12403,0.010518,0.16708,0.22894,chr12p13,0.926719042627533
GOBP_TRICARBOXYLIC_ACID_META...,SET,15,0.16181,0.0046231,0.218,0.22897,GOBP_TRICARBOXYLIC_ACID_METABOLIC_PROCESS,0.926719070904646
REACTOME_SIGNALLING_TO_RAS,SET,20,0.13793,0.0045498,0.18585,0.229,REACTOME_SIGNALLING_TO_RAS,0.926719070904646
GOBP_BIOLOGICAL_PROCESS_INVO...3,SET,1525,0.017234,0.0047561,0.023224,0.22902,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS,0.926719070904646
HP_INCREASED_DENSITY_OF_LONG...,SET,11,0.20715,0.0050687,0.27918,0.22905,HP_INCREASED_DENSITY_OF_LONG_BONES,0.9267325669383
GOBP_MEMBRANE_INVAGINATION,SET,65,0.080135,0.0047595,0.10804,0.22914,GOBP_MEMBRANE_INVAGINATION,0.926773045602606
GSE22601_DOUBLE_NEGATIVE_VS_...5,SET,184,0.043662,0.0043489,0.058874,0.22916,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,0.926773045602606
ADDYA_ERYTHROID_DIFFERENTIAT...,SET,68,0.083796,0.0050901,0.11301,0.2292,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,0.926773045602606
HANSON_HRAS_SIGNALING_VIA_NF...,SET,21,0.13404,0.0045304,0.18077,0.22921,HANSON_HRAS_SIGNALING_VIA_NFKB,0.926773045602606
GOCC_CONNEXIN_COMPLEX,SET,18,0.15285,0.0047835,0.20615,0.22921,GOCC_CONNEXIN_COMPLEX,0.926773045602606
GSE22935_24H_VS_48H_MBOVIS_B...4,SET,183,0.045755,0.0045451,0.061711,0.22922,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.926773045602606
REACTOME_NEGATIVE_REGULATION...7,SET,40,0.10093,0.0047059,0.13615,0.22925,REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,0.926786524368966
HP_VASCULAR_TORTUOSITY,SET,21,0.13244,0.0044764,0.17875,0.22937,HP_VASCULAR_TORTUOSITY,0.927123152022315
GSE18893_TCONV_VS_TREG_24H_C...1,SET,177,0.049146,0.004802,0.066336,0.22939,GSE18893_TCONV_VS_TREG_24H_CULTURE_DN,0.927123152022315
GSE15659_RESTING_VS_ACTIVATE...1,SET,167,0.048111,0.0045675,0.064962,0.22947,GSE15659_RESTING_VS_ACTIVATED_TREG_DN,0.927123152022315
GOCC_MON1_CCZ1_COMPLEX,SET,4,0.31821,0.0046962,0.42971,0.2295,GOCC_MON1_CCZ1_COMPLEX,0.927123152022315
PODAR_RESPONSE_TO_ADAPHOSTIN...1,SET,17,0.1695,0.0051551,0.22891,0.22952,PODAR_RESPONSE_TO_ADAPHOSTIN_DN,0.927123152022315
HP_ABNORMAL_CARDIAC_TEST,SET,24,0.13269,0.0047941,0.1792,0.22952,HP_ABNORMAL_CARDIAC_TEST,0.927123152022315
HP_CAFE_AU_LAIT_SPOT,SET,120,0.053344,0.0042984,0.072042,0.22952,HP_CAFE_AU_LAIT_SPOT,0.927123152022315
MULLIGAN_NTF3_SIGNALING_VIA_...2,SET,20,0.12899,0.0042548,0.17422,0.22955,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,0.92713657757118
GSE1460_DP_THYMOCYTE_VS_NAIV...3,SET,173,0.048946,0.0047286,0.066125,0.2296,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,0.927216920130021
GOBP_REGULATION_OF_DEFENSE_R...4,SET,52,0.089275,0.0047442,0.12064,0.22965,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,0.927216920130021
HP_HYPOREFLEXIA_OF_LOWER_LIM...,SET,33,0.1104,0.0046761,0.14923,0.22971,HP_HYPOREFLEXIA_OF_LOWER_LIMBS,0.927216920130021
PID_NFKAPPAB_CANONICAL_PATHW...,SET,21,0.14124,0.004774,0.19097,0.22977,PID_NFKAPPAB_CANONICAL_PATHWAY,0.927216920130021
HP_LOW_SET_EARS,SET,768,0.02266,0.0045364,0.030639,0.22978,HP_LOW_SET_EARS,0.927216920130021
HP_CEREBRAL_PALSY,SET,157,0.049398,0.0045483,0.066795,0.22979,HP_CEREBRAL_PALSY,0.927216920130021
GSE22886_NAIVE_CD8_TCELL_VS_...9,SET,184,0.045839,0.0045657,0.061983,0.2298,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN,0.927216920130021
GOBP_NEGATIVE_REGULATION_OF_...163,SET,23,0.11882,0.0042026,0.16067,0.22981,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.927216920130021
HP_DEPRESSED_NASAL_TIP,SET,22,0.13586,0.0047,0.18372,0.22981,HP_DEPRESSED_NASAL_TIP,0.927216920130021
SASSON_RESPONSE_TO_GONADOTRO...2,SET,76,0.069993,0.0044938,0.094691,0.22991,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,0.927512716192687
GOBP_AMINO_SUGAR_BIOSYNTHETI...,SET,11,0.18772,0.0045933,0.25403,0.22996,GOBP_AMINO_SUGAR_BIOSYNTHETIC_PROCESS,0.927551749710313
HP_LATE_YOUNG_ADULT_ONSET,SET,42,0.093676,0.0044752,0.12678,0.23,HP_LATE_YOUNG_ADULT_ONSET,0.927551749710313
BROWNE_HCMV_INFECTION_10HR_UP,SET,90,0.063176,0.0044122,0.085512,0.23002,BROWNE_HCMV_INFECTION_10HR_UP,0.927551749710313
GOBP_CELLULAR_RESPONSE_TO_AN...2,SET,11,0.19675,0.0048143,0.26641,0.2301,GOBP_CELLULAR_RESPONSE_TO_ANTIBIOTIC,0.927551749710313
GOBP_REGULATION_OF_MAST_CELL...3,SET,7,0.24465,0.004776,0.33126,0.2301,GOBP_REGULATION_OF_MAST_CELL_CHEMOTAXIS,0.927551749710313
GOBP_NEGATIVE_REGULATION_OF_...62,SET,7,0.25062,0.0048925,0.33937,0.23011,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.927551749710313
GOBP_MONOATOMIC_ION_TRANSMEM...,SET,904,0.022033,0.004767,0.029839,0.23014,GOBP_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.927551749710313
GOMF_OXIDOREDUCTASE_ACTIVITY...5,SET,9,0.18752,0.0041507,0.25397,0.23015,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,0.927551749710313
BLALOCK_ALZHEIMERS_DISEASE_I...2,SET,348,0.032547,0.0044382,0.044084,0.23017,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,0.927551749710313
MZF1_02,SET,220,0.042164,0.0045876,0.057122,0.23022,MZF1_02,0.927551749710313
CUI_DEVELOPING_HEART_LEFT_AT...,SET,16,0.1695,0.0050015,0.22964,0.23022,CUI_DEVELOPING_HEART_LEFT_ATRIAL_CARDIOMYOCYTE,0.927551749710313
GOBP_HYPOXIA_INDUCIBLE_FACTO...,SET,3,0.3876,0.004954,0.52518,0.23025,GOBP_HYPOXIA_INDUCIBLE_FACTOR_1ALPHA_SIGNALING_PATHWAY,0.927551749710313
GOCC_LYSOSOMAL_LUMEN,SET,89,0.066927,0.0046483,0.090696,0.23028,GOCC_LYSOSOMAL_LUMEN,0.927551749710313
GOMF_DNA_SECONDARY_STRUCTURE...,SET,34,0.10726,0.0046115,0.14537,0.23031,GOMF_DNA_SECONDARY_STRUCTURE_BINDING,0.927551749710313
WP_IRON_METABOLISM_IN_PLACEN...,SET,12,0.19388,0.004955,0.26279,0.23032,WP_IRON_METABOLISM_IN_PLACENTA,0.927551749710313
HP_POSTERIOR_PITUITARY_DYSGE...,SET,22,0.13174,0.0045574,0.17863,0.23041,HP_POSTERIOR_PITUITARY_DYSGENESIS,0.927629123860095
GOBP_NEUTROPHIL_MEDIATED_KIL...2,SET,13,0.20027,0.0053269,0.2716,0.23046,GOBP_NEUTROPHIL_MEDIATED_KILLING_OF_SYMBIONT_CELL,0.927629123860095
GOBP_HORMONE_BIOSYNTHETIC_PR...,SET,64,0.080056,0.0047182,0.10858,0.23048,GOBP_HORMONE_BIOSYNTHETIC_PROCESS,0.927629123860095
HP_HYPERCAPNIA,SET,12,0.19156,0.0048956,0.25986,0.23052,HP_HYPERCAPNIA,0.927629123860095
BOYLAN_MULTIPLE_MYELOMA_C_UP,SET,44,0.098438,0.0048131,0.13355,0.23055,BOYLAN_MULTIPLE_MYELOMA_C_UP,0.927629123860095
SENGUPTA_NASOPHARYNGEAL_CARC...2,SET,285,0.038057,0.0047044,0.051645,0.2306,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,0.927629123860095
DAZARD_UV_RESPONSE_CLUSTER_G...2,SET,17,0.17118,0.0052064,0.23232,0.23062,DAZARD_UV_RESPONSE_CLUSTER_G28,0.927629123860095
HP_SHORT_UPPER_LIP,SET,9,0.20342,0.0045025,0.27607,0.23062,HP_SHORT_UPPER_LIP,0.927629123860095
GOBP_ANATOMICAL_STRUCTURE_RE...,SET,15,0.16415,0.00469,0.22282,0.23065,GOBP_ANATOMICAL_STRUCTURE_REGRESSION,0.927629123860095
GRATIAS_RETINOBLASTOMA_16Q24,SET,17,0.18026,0.0054826,0.24473,0.23069,GRATIAS_RETINOBLASTOMA_16Q24,0.927629123860095
CHENG_TAF7L_TARGETS,SET,4,0.29053,0.0042877,0.3946,0.23079,CHENG_TAF7L_TARGETS,0.927629123860095
GOBP_RRNA_MODIFICATION,SET,25,0.10763,0.0039687,0.1462,0.23081,GOBP_RRNA_MODIFICATION,0.927629123860095
CRX_DN.V1_DN,SET,121,0.058091,0.0047002,0.078919,0.23084,CRX_DN.V1_DN,0.927629123860095
HP_CONGENITAL_ADRENAL_HYPERP...,SET,5,0.2941,0.0048525,0.39964,0.2309,HP_CONGENITAL_ADRENAL_HYPERPLASIA,0.927629123860095
HP_ABNORMAL_CSF_LACTATE_CONC...,SET,82,0.062913,0.0041949,0.085497,0.23092,HP_ABNORMAL_CSF_LACTATE_CONCENTRATION,0.927629123860095
GOBP_ERK5_CASCADE,SET,3,0.35388,0.0045231,0.48095,0.23093,GOBP_ERK5_CASCADE,0.927629123860095
GOBP_POSITIVE_REGULATION_OF_...483,SET,184,0.048407,0.0048215,0.065788,0.23093,GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,0.927629123860095
HP_LOP_EAR,SET,3,0.40688,0.0052005,0.55305,0.23096,HP_LOP_EAR,0.927629123860095
GSE17721_CTRL_VS_GARDIQUIMOD...1,SET,176,0.0446,0.0043456,0.060624,0.23097,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN,0.927629123860095
GSE24574_BCL6_HIGH_TFH_VS_NA...1,SET,187,0.044305,0.0044484,0.060229,0.23099,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN,0.927629123860095
REACTOME_EUKARYOTIC_TRANSLAT...1,SET,85,0.064358,0.0043688,0.087492,0.231,REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION,0.927629123860095
ESC_V6.5_UP_EARLY.V1_DN,SET,148,0.052817,0.0047228,0.071823,0.23106,ESC_V6.5_UP_EARLY.V1_DN,0.927629123860095
KREPPEL_CD99_TARGETS_DN,SET,7,0.24636,0.0048093,0.33504,0.23108,KREPPEL_CD99_TARGETS_DN,0.927629123860095
GSE45365_NK_CELL_VS_CD8_TCEL...3,SET,183,0.045496,0.0045193,0.061877,0.23109,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_UP,0.927629123860095
WP_MACROPHAGESTIMULATING_PRO...,SET,104,0.065213,0.0048941,0.0887,0.23111,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,0.927629123860095
WP_HISTONE_MODIFICATIONS,SET,35,0.096613,0.0042141,0.13141,0.23112,WP_HISTONE_MODIFICATIONS,0.927629123860095
HP_LOSS_OF_AMBULATION,SET,114,0.056076,0.0044048,0.07628,0.23113,HP_LOSS_OF_AMBULATION,0.927629123860095
IK3_01,SET,199,0.04539,0.0046997,0.061746,0.23114,IK3_01,0.927629123860095
GAO_LARGE_INTESTINE_ADULT_CI...,SET,307,0.036951,0.0047379,0.050264,0.23114,GAO_LARGE_INTESTINE_ADULT_CI_MESENCHYMAL_CELLS,0.927629123860095
BRUECKNER_TARGETS_OF_MIRLET7...2,SET,104,0.062568,0.0046956,0.085131,0.23118,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,0.927629123860095
GSE21379_WT_VS_SAP_KO_CD4_TC...2,SET,185,0.044887,0.0044829,0.061078,0.2312,GSE21379_WT_VS_SAP_KO_CD4_TCELL_UP,0.927629123860095
HP_PORPHYRINURIA,SET,7,0.21684,0.0042331,0.29507,0.23121,HP_PORPHYRINURIA,0.927629123860095
REACTOME_FC_EPSILON_RECEPTOR...,SET,125,0.052649,0.0043293,0.071646,0.23122,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,0.927629123860095
REACTOME_REGULATION_OF_INNAT...,SET,13,0.17361,0.0046178,0.23643,0.23139,REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA,0.928096878245817
GOBP_RENAL_VESICLE_FORMATION,SET,8,0.23724,0.004951,0.32309,0.23139,GOBP_RENAL_VESICLE_FORMATION,0.928096878245817
HP_ABNORMAL_PULMONARY_VALVE_...3,SET,137,0.054994,0.0047326,0.074945,0.23154,HP_ABNORMAL_PULMONARY_VALVE_PHYSIOLOGY,0.928334348727398
GSE9988_LPS_VS_LPS_AND_ANTI_...1,SET,170,0.048985,0.0046916,0.066755,0.23154,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN,0.928334348727398
HP_DECREASED_FERTILITY_IN_MA...,SET,183,0.044766,0.0044468,0.061009,0.23156,HP_DECREASED_FERTILITY_IN_MALES,0.928334348727398
REACTOME_TRANSPORT_AND_SYNTH...,SET,6,0.25902,0.0046815,0.35307,0.2316,REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS,0.928334348727398
MORF_PDCD1,SET,64,0.080271,0.0047309,0.10944,0.23163,MORF_PDCD1,0.928334348727398
GOBP_REGULATION_OF_DNA_DAMAG...1,SET,18,0.14417,0.0045118,0.19658,0.23166,GOBP_REGULATION_OF_DNA_DAMAGE_CHECKPOINT,0.928334348727398
GOBP_BRANCHING_INVOLVED_IN_L...,SET,12,0.19186,0.0049032,0.2616,0.23167,GOBP_BRANCHING_INVOLVED_IN_LABYRINTHINE_LAYER_MORPHOGENESIS,0.928334348727398
SENESE_HDAC1_AND_HDAC2_TARGE...2,SET,212,0.04392,0.004692,0.059933,0.23184,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,0.928334348727398
GSE45739_NRAS_KO_VS_WT_UNSTI...1,SET,169,0.04788,0.0045724,0.065338,0.23185,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN,0.928334348727398
REACTOME_NTRK2_ACTIVATES_RAC1,SET,5,0.27272,0.0044999,0.3722,0.23187,REACTOME_NTRK2_ACTIVATES_RAC1,0.928334348727398
HP_ABNORMAL_TOE_PHALANX_MORP...,SET,113,0.058306,0.00456,0.079574,0.23187,HP_ABNORMAL_TOE_PHALANX_MORPHOLOGY,0.928334348727398
HP_DOUBLE_AORTIC_ARCH,SET,5,0.2675,0.0044138,0.36508,0.23187,HP_DOUBLE_AORTIC_ARCH,0.928334348727398
REACTOME_HOMOLOGY_DIRECTED_R...,SET,96,0.057377,0.0041379,0.078311,0.23188,REACTOME_HOMOLOGY_DIRECTED_REPAIR,0.928334348727398
GOBP_PROLINE_TRANSMEMBRANE_T...,SET,9,0.23036,0.0050989,0.31443,0.23189,GOBP_PROLINE_TRANSMEMBRANE_TRANSPORT,0.928334348727398
GOBP_REGULATION_OF_SYNAPTIC_...1,SET,5,0.28239,0.0046594,0.38544,0.23189,GOBP_REGULATION_OF_SYNAPTIC_ASSEMBLY_AT_NEUROMUSCULAR_JUNCTION,0.928334348727398
MORI_PLASMA_CELL_DN,SET,34,0.10941,0.0047039,0.14936,0.23192,MORI_PLASMA_CELL_DN,0.928334348727398
GOBP_REGULATION_OF_ENDOPLASM...3,SET,27,0.12162,0.0046603,0.16602,0.23192,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.928334348727398
GOBP_CHOLINE_TRANSPORT,SET,9,0.21729,0.0048095,0.29663,0.23193,GOBP_CHOLINE_TRANSPORT,0.928334348727398
GOBP_NEGATIVE_REGULATION_BY_...3,SET,14,0.15957,0.0044046,0.21794,0.23204,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION,0.92866768770152
LEE_DOUBLE_POLAR_THYMOCYTE,SET,24,0.1441,0.0052065,0.19687,0.23211,LEE_DOUBLE_POLAR_THYMOCYTE,0.928718178682304
GOMF_TYPE_I_TRANSFORMING_GRO...,SET,11,0.20713,0.0050682,0.28299,0.23212,GOMF_TYPE_I_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.928718178682304
GOBP_EXTRACELLULAR_MATRIX_DI...,SET,58,0.084411,0.0047367,0.11535,0.23215,GOBP_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.928718178682304
MURARO_PANCREAS_ALPHA_CELL,SET,470,0.029622,0.0046782,0.040483,0.23218,MURARO_PANCREAS_ALPHA_CELL,0.928718178682304
MIR148A_3P,SET,315,0.035375,0.0045935,0.048353,0.23221,MIR148A_3P,0.928718178682304
WP_RIBOFLAVIN_AND_COQ_DISORD...,SET,13,0.15143,0.0040279,0.20703,0.23227,WP_RIBOFLAVIN_AND_COQ_DISORDERS,0.928718178682304
SCHERER_PBMC_YF_VAX_AGE_18_4...4,SET,10,0.19804,0.0046204,0.27079,0.23229,SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_UP,0.928718178682304
GOBP_HYPERSENSITIVITY,SET,15,0.18177,0.0051933,0.24856,0.2323,GOBP_HYPERSENSITIVITY,0.928718178682304
HP_SUPRANUCLEAR_GAZE_PALSY,SET,49,0.086847,0.0044805,0.11877,0.23233,HP_SUPRANUCLEAR_GAZE_PALSY,0.928718178682304
HDAC4_TARGET_GENES,SET,516,0.027861,0.0046045,0.038103,0.23234,HDAC4_TARGET_GENES,0.928718178682304
WENG_POR_TARGETS_LIVER_UP,SET,41,0.0973,0.0045927,0.1331,0.23238,WENG_POR_TARGETS_LIVER_UP,0.928718178682304
REACTOME_LAGGING_STRAND_SYNT...,SET,19,0.12651,0.0040674,0.17305,0.23238,REACTOME_LAGGING_STRAND_SYNTHESIS,0.928718178682304
GOBP_POSITIVE_REGULATION_OF_...801,SET,10,0.20759,0.0048434,0.28399,0.2324,GOBP_POSITIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,0.928718178682304
GOBP_NON_MEMBRANE_BOUNDED_OR...,SET,385,0.030009,0.0042996,0.04107,0.2325,GOBP_NON_MEMBRANE_BOUNDED_ORGANELLE_ASSEMBLY,0.928849029516481
GOMF_DNA_N_GLYCOSYLASE_ACTIV...,SET,14,0.15627,0.0043134,0.21391,0.23254,GOMF_DNA_N_GLYCOSYLASE_ACTIVITY,0.928849029516481
GSE27786_CD8_TCELL_VS_MONO_M...1,SET,179,0.044622,0.0043843,0.061107,0.23263,GSE27786_CD8_TCELL_VS_MONO_MAC_DN,0.928849029516481
MODULE_208,SET,108,0.06263,0.0047892,0.085772,0.23264,MODULE_208,0.928849029516481
GOBP_CILIUM_MOVEMENT,SET,172,0.045376,0.0043712,0.06215,0.23267,GOBP_CILIUM_MOVEMENT,0.928849029516481
REACTOME_EPH_EPHRIN_MEDIATED...,SET,49,0.091298,0.0047101,0.12506,0.23268,REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,0.928849029516481
IBRAHIM_NRF1_UP,SET,390,0.030423,0.0043866,0.041673,0.23269,IBRAHIM_NRF1_UP,0.928849029516481
MIR4763_5P,SET,54,0.079171,0.0042872,0.10846,0.2327,MIR4763_5P,0.928849029516481
MORF_JAG1,SET,91,0.066103,0.0046421,0.090552,0.2327,MORF_JAG1,0.928849029516481
GSE32533_WT_VS_MIR17_KO_ACT_...1,SET,179,0.044652,0.0043872,0.061168,0.2327,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN,0.928849029516481
YAO_TEMPORAL_RESPONSE_TO_PRO...10,SET,169,0.04447,0.0042468,0.06094,0.23278,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,0.928994884602136
MIR3123,SET,229,0.041614,0.0046184,0.057029,0.23279,MIR3123,0.928994884602136
HP_ABNORMALITY_OF_UPPER_LIMB...,SET,489,0.028483,0.0045859,0.039041,0.23283,HP_ABNORMALITY_OF_UPPER_LIMB_JOINT,0.929047835820896
HP_PATENT_FORAMEN_OVALE,SET,112,0.055007,0.0042831,0.075425,0.23291,HP_PATENT_FORAMEN_OVALE,0.929151272789818
GOBP_HYALURONAN_BIOSYNTHETIC...,SET,14,0.16729,0.0046178,0.22947,0.23299,GOBP_HYALURONAN_BIOSYNTHETIC_PROCESS,0.929151272789818
HAY_BONE_MARROW_CD34_POS_CLP,SET,7,0.27394,0.0053477,0.37574,0.23299,HAY_BONE_MARROW_CD34_POS_CLP,0.929151272789818
GOBP_POSITIVE_REGULATION_OF_...758,SET,10,0.19856,0.0046326,0.27237,0.233,GOBP_POSITIVE_REGULATION_OF_TOLERANCE_INDUCTION,0.929151272789818
GOBP_CELL_REDOX_HOMEOSTASIS,SET,34,0.10527,0.0045259,0.14441,0.23301,GOBP_CELL_REDOX_HOMEOSTASIS,0.929151272789818
GSE2405_0H_VS_1.5H_A_PHAGOCY...1,SET,181,0.042712,0.0042198,0.058605,0.23306,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.929151272789818
HP_APLASIA_INVOLVING_BONES_O...2,SET,13,0.17244,0.0045867,0.23661,0.23307,HP_APLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS,0.929151272789818
GOMF_ATPASE_BINDING,SET,78,0.073004,0.0047481,0.10018,0.23308,GOMF_ATPASE_BINDING,0.929151272789818
WP_DNA_MISMATCH_REPAIR,SET,23,0.11209,0.0039647,0.15384,0.23312,WP_DNA_MISMATCH_REPAIR,0.929151272789818
KEGG_MEDICUS_REFERENCE_GF_RT...2,SET,89,0.071053,0.0049349,0.097531,0.23315,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY,0.929151272789818
HP_DRY_HAIR,SET,16,0.15279,0.0045082,0.20972,0.23315,HP_DRY_HAIR,0.929151272789818
GSE8835_HEALTHY_VS_CLL_CD4_T...2,SET,176,0.046189,0.0045004,0.06342,0.23322,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP,0.929203306590258
WP_SPINAL_CORD_INJURY,SET,116,0.061137,0.004844,0.083948,0.23323,WP_SPINAL_CORD_INJURY,0.929203306590258
MODULE_326,SET,13,0.19003,0.0050545,0.26098,0.23327,MODULE_326,0.929203306590258
GSE22432_PDC_VS_TGFB1_TREATE...1,SET,176,0.047806,0.004658,0.065654,0.23327,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN,0.929203306590258
GOBP_CELLULAR_PROCESS_INVOLV...,SET,356,0.032246,0.0044463,0.044314,0.23341,GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM,0.929312441502112
KEGG_WNT_SIGNALING_PATHWAY,SET,144,0.053344,0.0047055,0.073312,0.23343,KEGG_WNT_SIGNALING_PATHWAY,0.929312441502112
GOMF_STRUCTURAL_CONSTITUENT_...12,SET,4,0.34174,0.0050434,0.46976,0.23348,GOMF_STRUCTURAL_CONSTITUENT_OF_TOOTH_ENAMEL,0.929312441502112
GOBP_SULFUR_COMPOUND_METABOL...,SET,291,0.037173,0.0046425,0.051105,0.2335,GOBP_SULFUR_COMPOUND_METABOLIC_PROCESS,0.929312441502112
GOBP_CILIUM_OR_FLAGELLUM_DEP...,SET,149,0.048583,0.0043588,0.066797,0.23352,GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY,0.929312441502112
KYNG_DNA_DAMAGE_BY_GAMMA_AND...,SET,74,0.070006,0.0044353,0.096259,0.23354,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,0.929312441502112
MIR4715_5P,SET,39,0.10191,0.004692,0.14015,0.23356,MIR4715_5P,0.929312441502112
BLANCO_MELO_SARS_COV_1_INFEC...1,SET,9,0.20729,0.0045883,0.28507,0.23357,BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_DN,0.929312441502112
MORF_ACP1,SET,198,0.040108,0.0041425,0.05517,0.23362,MORF_ACP1,0.929312441502112
GSE17721_0.5H_VS_24H_CPG_BMD...2,SET,182,0.044305,0.0043892,0.060942,0.23362,GSE17721_0.5H_VS_24H_CPG_BMDC_UP,0.929312441502112
IKEDA_MIR133_TARGETS_DN,SET,6,0.30765,0.0055606,0.4232,0.23363,IKEDA_MIR133_TARGETS_DN,0.929312441502112
GOBP_PLATELET_DENSE_GRANULE_...,SET,24,0.12659,0.0045736,0.17417,0.23368,GOBP_PLATELET_DENSE_GRANULE_ORGANIZATION,0.929312441502112
MIR2909,SET,47,0.083612,0.0042248,0.11506,0.23371,MIR2909,0.929312441502112
HP_ELEVATED_LACTATE_PYRUVATE...,SET,18,0.12811,0.0040092,0.17631,0.23373,HP_ELEVATED_LACTATE_PYRUVATE_RATIO,0.929312441502112
HP_DELAYED_ABILITY_TO_SIT,SET,76,0.069683,0.0044739,0.095917,0.23377,HP_DELAYED_ABILITY_TO_SIT,0.929312441502112
GOBP_REGULATION_OF_ATP_BIOSY...,SET,11,0.16999,0.0041595,0.23399,0.23378,GOBP_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS,0.929312441502112
HP_HYPOMETHIONINEMIA,SET,8,0.2069,0.0043178,0.28482,0.2338,HP_HYPOMETHIONINEMIA,0.929312441502112
WP_OVERVIEW_OF_NANOPARTICLE_...,SET,19,0.15219,0.0048933,0.20953,0.23381,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,0.929312441502112
KEGG_TYPE_II_DIABETES_MELLIT...,SET,46,0.096351,0.0048166,0.13265,0.23382,KEGG_TYPE_II_DIABETES_MELLITUS,0.929312441502112
GAURNIER_PSMD4_TARGETS,SET,63,0.08615,0.0050377,0.11864,0.23388,GAURNIER_PSMD4_TARGETS,0.929312441502112
GSE3039_ALPHAALPHA_CD8_TCELL...3,SET,181,0.046368,0.004581,0.063864,0.23391,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_DN,0.929312441502112
GOMF_LIGAND_GATED_CALCIUM_CH...,SET,30,0.11298,0.0045631,0.15563,0.23394,GOMF_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY,0.929312441502112
GOMF_DNA_BINDING_TRANSCRIPTI...2,SET,1329,0.019546,0.0050648,0.026926,0.23395,GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.929312441502112
GOBP_MEIOTIC_CHROMOSOME_COND...,SET,6,0.21452,0.0038772,0.29564,0.23404,GOBP_MEIOTIC_CHROMOSOME_CONDENSATION,0.929312441502112
MCLACHLAN_DENTAL_CARIES_UP,SET,211,0.04612,0.0049156,0.063564,0.23405,MCLACHLAN_DENTAL_CARIES_UP,0.929312441502112
MODULE_204,SET,79,0.066258,0.0043368,0.091331,0.23409,MODULE_204,0.929312441502112
GOBP_RECOMBINATIONAL_REPAIR,SET,165,0.045094,0.0042555,0.062157,0.23409,GOBP_RECOMBINATIONAL_REPAIR,0.929312441502112
GOBP_REGULATION_OF_HELICASE_...,SET,9,0.16443,0.0036395,0.22666,0.2341,GOBP_REGULATION_OF_HELICASE_ACTIVITY,0.929312441502112
GSE7548_DAY7_VS_DAY28_PCC_IM...1,SET,174,0.045394,0.004398,0.062577,0.23411,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,0.929312441502112
GSE17186_BLOOD_VS_CORD_BLOOD...3,SET,182,0.045378,0.0044954,0.062564,0.23413,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN,0.929312441502112
MATZUK_SPERMATOCYTE,SET,67,0.069044,0.0041631,0.095196,0.23415,MATZUK_SPERMATOCYTE,0.929312441502112
GOMF_GTPASE_ACTIVATING_PROTE...,SET,11,0.18588,0.0045483,0.25635,0.23419,GOMF_GTPASE_ACTIVATING_PROTEIN_BINDING,0.929312441502112
HP_CHIARI_MALFORMATION,SET,91,0.065771,0.0046188,0.090709,0.23421,HP_CHIARI_MALFORMATION,0.929312441502112
REACTOME_METABOLISM_OF_STERO...1,SET,146,0.050387,0.0044752,0.069495,0.23422,REACTOME_METABOLISM_OF_STEROIDS,0.929312441502112
GOBP_PREASSEMBLY_OF_GPI_ANCH...,SET,7,0.20665,0.0040341,0.28507,0.23426,GOBP_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE,0.929312441502112
ALK_DN.V1_UP,SET,122,0.057751,0.0046918,0.079666,0.23426,ALK_DN.V1_UP,0.929312441502112
GOMF_TRANSCRIPTION_REGULATOR...2,SET,1780,0.016192,0.004791,0.022345,0.23434,GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY,0.929523704633645
BIOCARTA_AGR_PATHWAY,SET,29,0.12036,0.0047794,0.16613,0.2344,BIOCARTA_AGR_PATHWAY,0.929655597398151
GSE3982_CENT_MEMORY_CD4_TCEL...2,SET,176,0.045769,0.0044595,0.063186,0.23443,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP,0.929668490415336
GOCC_POSTSYNAPTIC_ENDOCYTIC_...,SET,5,0.29984,0.0049473,0.41421,0.23457,GOCC_POSTSYNAPTIC_ENDOCYTIC_ZONE,0.92977152872777
SCHWAB_TARGETS_OF_BMYB_POLYM...2,SET,12,0.16276,0.0041596,0.22488,0.23461,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP,0.92977152872777
KEGG_MEDICUS_PATHOGEN_KSHV_V...4,SET,31,0.11373,0.0046691,0.15714,0.23462,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY,0.92977152872777
MORF_GSPT1,SET,43,0.084569,0.0040878,0.11685,0.23462,MORF_GSPT1,0.92977152872777
GOBP_REGULATION_OF_SODIUM_DE...,SET,5,0.29357,0.0048438,0.40562,0.23462,GOBP_REGULATION_OF_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT,0.92977152872777
GOBP_POSTSYNAPTIC_MEMBRANE_O...,SET,35,0.10408,0.0045399,0.14383,0.23465,GOBP_POSTSYNAPTIC_MEMBRANE_ORGANIZATION,0.92977152872777
HP_ABNORMAL_MYELOID_LEUKOCYT...,SET,300,0.035176,0.0044595,0.048615,0.23467,HP_ABNORMAL_MYELOID_LEUKOCYTE_MORPHOLOGY,0.92977152872777
GSE40274_FOXP3_VS_FOXP3_AND_...4,SET,183,0.046778,0.0046467,0.06465,0.23467,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.92977152872777
MARSON_BOUND_BY_FOXP3_STIMUL...,SET,880,0.021197,0.004528,0.029312,0.2348,MARSON_BOUND_BY_FOXP3_STIMULATED,0.929970548489666
GOMF_SINGLE_STRANDED_RNA_BIN...,SET,75,0.069778,0.0044505,0.096501,0.23482,GOMF_SINGLE_STRANDED_RNA_BINDING,0.929970548489666
GSE34006_WT_VS_A2AR_KO_TREG_...1,SET,182,0.046466,0.0046032,0.064293,0.23493,GSE34006_WT_VS_A2AR_KO_TREG_DN,0.929970548489666
GSE17974_1H_VS_72H_UNTREATED...1,SET,178,0.041845,0.0041,0.057902,0.23494,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,0.929970548489666
GOBP_MAINTENANCE_OF_SYNAPSE_...,SET,24,0.12589,0.0045485,0.17425,0.23501,GOBP_MAINTENANCE_OF_SYNAPSE_STRUCTURE,0.929970548489666
HP_ABNORMALITY_OF_THE_UMBILI...,SET,62,0.076266,0.0044243,0.10557,0.23502,HP_ABNORMALITY_OF_THE_UMBILICAL_CORD,0.929970548489666
GSE3039_NKT_CELL_VS_B1_BCELL...2,SET,176,0.04412,0.0042989,0.061077,0.23504,GSE3039_NKT_CELL_VS_B1_BCELL_UP,0.929970548489666
HP_ABSENT_HAND,SET,17,0.15474,0.0047062,0.21423,0.23506,HP_ABSENT_HAND,0.929970548489666
GOBP_LIPID_EXPORT_FROM_CELL,SET,49,0.093991,0.004849,0.13014,0.23508,GOBP_LIPID_EXPORT_FROM_CELL,0.929970548489666
HP_PES_PLANUS,SET,310,0.034788,0.0044819,0.048167,0.23508,HP_PES_PLANUS,0.929970548489666
GSE15659_NAIVE_CD4_TCELL_VS_...5,SET,171,0.045305,0.0043517,0.062734,0.2351,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN,0.929970548489666
GOBP_BIOLOGICAL_PROCESS_INVO...2,SET,106,0.05829,0.0044162,0.080728,0.23513,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_SYMBIONT,0.929970548489666
HP_PULMONARY_ARTERY_ATRESIA,SET,29,0.11378,0.0045183,0.1576,0.23517,HP_PULMONARY_ARTERY_ATRESIA,0.929970548489666
GOBP_RECEPTOR_LOCALIZATION_T...1,SET,4,0.28864,0.0042598,0.39988,0.2352,GOBP_RECEPTOR_LOCALIZATION_TO_NON_MOTILE_CILIUM,0.929970548489666
HP_APLASIA_HYPOPLASIA_OF_THE...51,SET,17,0.14488,0.0044062,0.20073,0.23523,HP_APLASIA_HYPOPLASIA_OF_THE_PALMAR_CREASES,0.929970548489666
GOMF_INTERLEUKIN_17_RECEPTOR...,SET,8,0.22523,0.0047003,0.3121,0.23525,GOMF_INTERLEUKIN_17_RECEPTOR_ACTIVITY,0.929970548489666
GSE17721_PAM3CSK4_VS_GADIQUI...13,SET,181,0.044692,0.0044154,0.061933,0.23527,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN,0.929970548489666
HP_ABNORMALITY_OF_THE_ADRENA...,SET,199,0.042928,0.0044448,0.059495,0.23529,HP_ABNORMALITY_OF_THE_ADRENAL_GLANDS,0.929970548489666
GOBP_NEGATIVE_REGULATION_OF_...56,SET,14,0.16079,0.0044383,0.22286,0.23531,GOBP_NEGATIVE_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,0.929970548489666
GSE45365_HEALTHY_VS_MCMV_INF...3,SET,162,0.049744,0.0046519,0.068965,0.23537,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN,0.929970548489666
CROONQUIST_NRAS_SIGNALING_DN,SET,68,0.071259,0.0043285,0.098812,0.23541,CROONQUIST_NRAS_SIGNALING_DN,0.929970548489666
GNF2_TYK2,SET,28,0.10358,0.0040418,0.14367,0.23547,GNF2_TYK2,0.929970548489666
GOBP_REGULATION_OF_IMMUNOGLO...,SET,62,0.072133,0.0041845,0.10007,0.23551,GOBP_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.929970548489666
GSE32034_UNTREATED_VS_ROSIGL...3,SET,166,0.049186,0.0046556,0.068234,0.23551,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN,0.929970548489666
AML_Q6,SET,238,0.039995,0.0045239,0.055488,0.23553,AML_Q6,0.929970548489666
MIR6132,SET,119,0.056224,0.0045116,0.07801,0.23554,MIR6132,0.929970548489666
HP_FETAL_DISTRESS,SET,52,0.079192,0.0042084,0.10987,0.23554,HP_FETAL_DISTRESS,0.929970548489666
HP_ABNORMAL_THUMB_MORPHOLOGY,SET,344,0.032309,0.0043808,0.044832,0.23556,HP_ABNORMAL_THUMB_MORPHOLOGY,0.929970548489666
GSE8921_UNSTIM_0H_VS_TLR1_2_...2,SET,188,0.043227,0.0043517,0.059983,0.23556,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP,0.929970548489666
MIR1229_5P,SET,30,0.11999,0.0048461,0.16652,0.2356,MIR1229_5P,0.929970548489666
GSE41867_NAIVE_VS_DAY30_LCMV...1,SET,175,0.04366,0.0042421,0.060594,0.2356,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_DN,0.929970548489666
MIR6801_5P,SET,97,0.066201,0.004799,0.091888,0.23563,MIR6801_5P,0.929970548489666
GOBP_MITOCHONDRIAL_CALCIUM_I...1,SET,21,0.13694,0.0046284,0.19008,0.23563,GOBP_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS,0.929970548489666
HP_DISCOID_LUPUS_RASH,SET,28,0.12363,0.0048242,0.1716,0.23563,HP_DISCOID_LUPUS_RASH,0.929970548489666
HP_VESTIBULAR_SCHWANNOMA,SET,6,0.21915,0.003961,0.30428,0.2357,HP_VESTIBULAR_SCHWANNOMA,0.930020611596505
REACTOME_BLOOD_GROUP_SYSTEMS...,SET,21,0.14226,0.0048084,0.19758,0.23576,REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS,0.930020611596505
GSE22886_DAY0_VS_DAY1_MONOCY...1,SET,185,0.04561,0.0045551,0.063353,0.23579,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN,0.930020611596505
GINESTIER_BREAST_CANCER_20Q1...1,SET,157,0.044925,0.0041364,0.062407,0.23581,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,0.930020611596505
GSE5589_UNSTIM_VS_45MIN_LPS_...1,SET,181,0.043863,0.0043335,0.060934,0.23581,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,0.930020611596505
GGAANCGGAANY_UNKNOWN,SET,102,0.057301,0.004259,0.079609,0.23583,GGAANCGGAANY_UNKNOWN,0.930020611596505
HP_ABNORMAL_GRANULOCYTOPOIET...,SET,14,0.16178,0.0044656,0.22476,0.23583,HP_ABNORMAL_GRANULOCYTOPOIETIC_CELL_MORPHOLOGY,0.930020611596505
GOBP_DNA_BIOSYNTHETIC_PROCESS,SET,177,0.041635,0.0040681,0.057852,0.23587,GOBP_DNA_BIOSYNTHETIC_PROCESS,0.930057300135501
BLALOCK_ALZHEIMERS_DISEASE_UP,SET,1508,0.015927,0.004373,0.022142,0.23598,BLALOCK_ALZHEIMERS_DISEASE_UP,0.930057300135501
HP_BRONCHIECTASIS,SET,154,0.049195,0.0044865,0.068394,0.23599,HP_BRONCHIECTASIS,0.930057300135501
REACTOME_PIWI_INTERACTING_RN...,SET,29,0.099762,0.0039616,0.13871,0.23602,REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS,0.930057300135501
MIR6852_3P,SET,134,0.052676,0.0044836,0.073259,0.23606,MIR6852_3P,0.930057300135501
GOMF_WIDE_PORE_CHANNEL_ACTIV...,SET,30,0.11309,0.0045674,0.15728,0.23608,GOMF_WIDE_PORE_CHANNEL_ACTIVITY,0.930057300135501
HP_DEFICIENT_EXCISION_OF_UV_...,SET,5,0.21547,0.0035552,0.29969,0.23608,HP_DEFICIENT_EXCISION_OF_UV_INDUCED_PYRIMIDINE_DIMERS_IN_DNA,0.930057300135501
GOBP_AMYLOID_BETA_METABOLIC_...,SET,51,0.086644,0.0045601,0.12053,0.23612,GOBP_AMYLOID_BETA_METABOLIC_PROCESS,0.930057300135501
GOBP_PEPTIDYL_ARGININE_MODIF...,SET,13,0.1474,0.0039208,0.20506,0.23613,GOBP_PEPTIDYL_ARGININE_MODIFICATION,0.930057300135501
GOCC_MULTIVESICULAR_BODY,SET,60,0.080378,0.0045873,0.11188,0.23626,GOCC_MULTIVESICULAR_BODY,0.930057300135501
MIR526B_3P,SET,565,0.026115,0.00451,0.036354,0.23628,MIR526B_3P,0.930057300135501
HP_SYNOSTOSIS_INVOLVING_BONE...2,SET,43,0.099021,0.0047864,0.13785,0.23628,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_HAND,0.930057300135501
KEGG_MEDICUS_VARIANT_AMPLIFI...2,SET,6,0.25229,0.0045599,0.35124,0.2363,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCNE_TO_CELL_CYCLE_G1_S,0.930057300135501
WP_MAPK_SIGNALING,SET,234,0.041345,0.0046376,0.057562,0.2363,WP_MAPK_SIGNALING,0.930057300135501
GOBP_B_CELL_APOPTOTIC_PROCESS,SET,24,0.12988,0.0046928,0.18084,0.23631,GOBP_B_CELL_APOPTOTIC_PROCESS,0.930057300135501
BLANCO_MELO_HUMAN_PARAINFLUE...1,SET,100,0.06165,0.0045373,0.085862,0.23638,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN,0.930057300135501
GOBP_NEGATIVE_REGULATION_OF_...263,SET,4,0.35635,0.0052591,0.49632,0.23639,GOBP_NEGATIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,0.930057300135501
HP_ABNORMALITY_OF_CYTOKINE_S...,SET,6,0.27789,0.0050227,0.38712,0.23643,HP_ABNORMALITY_OF_CYTOKINE_SECRETION,0.930057300135501
GSE46606_DAY1_VS_DAY3_CD40L_...1,SET,175,0.045082,0.0043802,0.0628,0.23643,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_DN,0.930057300135501
GOMF_UBIQUITIN_LIKE_PROTEIN_...5,SET,291,0.03452,0.0043112,0.048099,0.23648,GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING,0.930057300135501
HP_HYPERSEGMENTATION_OF_NEUT...,SET,6,0.27594,0.0049874,0.38449,0.23648,HP_HYPERSEGMENTATION_OF_NEUTROPHIL_NUCLEI,0.930057300135501
GOBP_HEART_VALVE_DEVELOPMENT,SET,72,0.07841,0.0049004,0.10926,0.23649,GOBP_HEART_VALVE_DEVELOPMENT,0.930057300135501
HP_JOINT_CONTRACTURE_OF_THE_...2,SET,14,0.16136,0.004454,0.22484,0.23649,HP_JOINT_CONTRACTURE_OF_THE_5TH_FINGER,0.930057300135501
HE_LIM_SUN_FETAL_LUNG_C7_PRO...,SET,909,0.020225,0.0043873,0.028183,0.2365,HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL,0.930057300135501
GOCC_FANCONI_ANAEMIA_NUCLEAR...,SET,7,0.19681,0.0038421,0.27428,0.23652,GOCC_FANCONI_ANAEMIA_NUCLEAR_COMPLEX,0.930057300135501
NADELLA_PRKAR1A_TARGETS_DN,SET,7,0.22485,0.0043894,0.31358,0.23668,NADELLA_PRKAR1A_TARGETS_DN,0.930057300135501
GOBP_REGULATION_OF_ENDOPLASM...1,SET,29,0.10342,0.0041068,0.14425,0.23672,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.930057300135501
GSE22935_UNSTIM_VS_48H_MBOVI...1,SET,180,0.044688,0.0044029,0.062338,0.23673,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.930057300135501
ATF_01,SET,240,0.0397,0.0045091,0.055381,0.23674,ATF_01,0.930057300135501
HALLMARK_ANGIOGENESIS,SET,35,0.10946,0.0047745,0.1527,0.23674,HALLMARK_ANGIOGENESIS,0.930057300135501
GOBP_POSITIVE_REGULATION_OF_...184,SET,46,0.091621,0.0045802,0.12782,0.23675,GOBP_POSITIVE_REGULATION_OF_CYTOKINESIS,0.930057300135501
GOBP_REGULATION_OF_MYELOID_L...2,SET,52,0.084801,0.0045065,0.11834,0.23682,GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.930057300135501
HP_VACUOLATED_LYMPHOCYTES,SET,11,0.19427,0.0047536,0.27113,0.23684,HP_VACUOLATED_LYMPHOCYTES,0.930057300135501
MIR3668,SET,95,0.062285,0.0044686,0.08694,0.23687,MIR3668,0.930057300135501
MODULE_159,SET,69,0.06708,0.0041044,0.093632,0.23687,MODULE_159,0.930057300135501
BROWNE_HCMV_INFECTION_20HR_DN,SET,90,0.06585,0.004599,0.091922,0.23689,BROWNE_HCMV_INFECTION_20HR_DN,0.930057300135501
MIR6728_3P,SET,134,0.051548,0.0043876,0.071971,0.23693,MIR6728_3P,0.930057300135501
HP_EEG_WITH_IRREGULAR_GENERA...,SET,11,0.18877,0.004619,0.26355,0.23693,HP_EEG_WITH_IRREGULAR_GENERALIZED_SPIKE_AND_WAVE_COMPLEXES,0.930057300135501
HP_AKINESIA,SET,37,0.095291,0.0042734,0.13306,0.23695,HP_AKINESIA,0.930057300135501
HP_CONGENITAL_HEPATIC_FIBROS...,SET,42,0.086994,0.0041559,0.12147,0.23695,HP_CONGENITAL_HEPATIC_FIBROSIS,0.930057300135501
GOMF_HISTONE_H2A_DEUBIQUITIN...,SET,5,0.21828,0.0036015,0.30481,0.23696,GOMF_HISTONE_H2A_DEUBIQUITINASE_ACTIVITY,0.930057300135501
KIM_WT1_TARGETS_8HR_UP,SET,159,0.048094,0.004456,0.067161,0.23697,KIM_WT1_TARGETS_8HR_UP,0.930057300135501
WP_GAMMAGLUTAMYL_CYCLE_FOR_T...,SET,6,0.21123,0.0038179,0.29501,0.23699,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,0.930057300135501
HP_AXONAL_DEGENERATION_REGEN...,SET,9,0.19185,0.0042465,0.26801,0.23705,HP_AXONAL_DEGENERATION_REGENERATION,0.930187732866659
GSE14308_NAIVE_CD4_TCELL_VS_...2,SET,178,0.044334,0.004344,0.061947,0.2371,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP,0.930278900428991
ZHAN_VARIABLE_EARLY_DIFFEREN...2,SET,17,0.1509,0.0045896,0.21093,0.23718,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP,0.930368221672662
REACTOME_IFNG_SIGNALING_ACTI...,SET,8,0.22489,0.0046933,0.31435,0.23718,REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS,0.930368221672662
BENPORATH_ES_CORE_NINE,SET,8,0.20739,0.0043279,0.28993,0.23722,BENPORATH_ES_CORE_NINE,0.930368221672662
MIR4762_5P,SET,128,0.053041,0.0044131,0.074175,0.23729,MIR4762_5P,0.930368221672662
CHO_NR4A1_TARGETS,SET,29,0.12277,0.0048752,0.1717,0.2373,CHO_NR4A1_TARGETS,0.930368221672662
AMIT_EGF_RESPONSE_120_MCF10A,SET,38,0.10522,0.0047819,0.14722,0.2374,AMIT_EGF_RESPONSE_120_MCF10A,0.930368221672662
HP_UNDETECTABLE_LIGHT_ADAPTE...,SET,6,0.28191,0.0050953,0.39452,0.23745,HP_UNDETECTABLE_LIGHT_ADAPTED_ELECTRORETINOGRAM,0.930368221672662
HP_SHORT_FACE,SET,17,0.15358,0.004671,0.21498,0.2375,HP_SHORT_FACE,0.930368221672662
GOMF_FRIZZLED_BINDING,SET,35,0.10661,0.0046502,0.14925,0.23752,GOMF_FRIZZLED_BINDING,0.930368221672662
INAMURA_LUNG_CANCER_SCC_UP,SET,11,0.18327,0.0044843,0.25661,0.23756,INAMURA_LUNG_CANCER_SCC_UP,0.930368221672662
KOKKINAKIS_METHIONINE_DEPRIV...1,SET,57,0.081148,0.0045143,0.11364,0.23759,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,0.930368221672662
GSE12392_WT_VS_IFNAR_KO_CD8A...2,SET,174,0.044725,0.0043332,0.062644,0.23763,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP,0.930368221672662
GOMF_RNA_STEM_LOOP_BINDING,SET,13,0.1571,0.0041787,0.22005,0.23764,GOMF_RNA_STEM_LOOP_BINDING,0.930368221672662
GOBP_GANGLION_DEVELOPMENT,SET,16,0.16558,0.0048857,0.23194,0.23766,GOBP_GANGLION_DEVELOPMENT,0.930368221672662
AHRARNT_01,SET,129,0.054901,0.0045856,0.076919,0.2377,AHRARNT_01,0.930368221672662
GOCC_BRCA1_C_COMPLEX,SET,5,0.26282,0.0043365,0.36832,0.23775,GOCC_BRCA1_C_COMPLEX,0.930368221672662
GOCC_SPHERICAL_HIGH_DENSITY_...,SET,7,0.23738,0.004634,0.33266,0.23775,GOCC_SPHERICAL_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,0.930368221672662
HP_PAROXYSMAL_ATRIAL_FIBRILL...,SET,23,0.13044,0.0046136,0.18279,0.23775,HP_PAROXYSMAL_ATRIAL_FIBRILLATION,0.930368221672662
HP_HYPOCHROMIC_MICROCYTIC_AN...,SET,15,0.1585,0.0045285,0.22216,0.23779,HP_HYPOCHROMIC_MICROCYTIC_ANEMIA,0.930368221672662
MIR4705,SET,111,0.059545,0.0046158,0.083464,0.2378,MIR4705,0.930368221672662
chr7p11,SET,14,0.23751,0.0065559,0.33299,0.23784,chr7p11,0.930368221672662
ATACTGT_MIR144,SET,181,0.045823,0.0045272,0.064244,0.23784,ATACTGT_MIR144,0.930368221672662
MEBARKI_HCC_PROGENITOR_WNT_D...1,SET,54,0.084077,0.0045529,0.11788,0.23785,MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD,0.930368221672662
HP_ABNORMAL_CSF_METABOLITE_C...,SET,128,0.048858,0.0040651,0.068501,0.23785,HP_ABNORMAL_CSF_METABOLITE_CONCENTRATION,0.930368221672662
GOBP_ASTROCYTE_ACTIVATION,SET,23,0.13803,0.0048821,0.19353,0.23786,GOBP_ASTROCYTE_ACTIVATION,0.930368221672662
GOBP_REGULATION_OF_CALCIUM_M...,SET,92,0.065873,0.0046512,0.092379,0.2379,GOBP_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,0.930368221672662
HP_PROGRESSIVE_SPASTIC_PARAP...2,SET,26,0.11351,0.0042684,0.15919,0.23792,HP_PROGRESSIVE_SPASTIC_PARAPLEGIA,0.930368221672662
GOBP_POSITIVE_REGULATION_OF_...567,SET,11,0.18876,0.0046188,0.2648,0.23798,GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION,0.930368221672662
MIR191_5P,SET,19,0.1375,0.0044208,0.1929,0.23799,MIR191_5P,0.930368221672662
BIOCARTA_GATA3_PATHWAY,SET,14,0.17393,0.0048009,0.24407,0.23804,BIOCARTA_GATA3_PATHWAY,0.930368221672662
GOBP_REGULATION_OF_PROTEIN_K...1,SET,6,0.23633,0.0042715,0.33162,0.23804,GOBP_REGULATION_OF_PROTEIN_K48_LINKED_UBIQUITINATION,0.930368221672662
CAGCTG_AP4_Q5,SET,1354,0.017199,0.0044951,0.024139,0.23808,CAGCTG_AP4_Q5,0.930368221672662
WINNEPENNINCKX_MELANOMA_META...1,SET,38,0.10265,0.0046651,0.14408,0.23809,WINNEPENNINCKX_MELANOMA_METASTASIS_DN,0.930368221672662
GOBP_IMMUNOLOGICAL_SYNAPSE_F...,SET,16,0.16043,0.0047339,0.2252,0.23811,GOBP_IMMUNOLOGICAL_SYNAPSE_FORMATION,0.930368221672662
GOBP_REGULATION_OF_MEMBRANE_...10,SET,33,0.10935,0.0046317,0.15349,0.23811,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION,0.930368221672662
GSE28726_NAIVE_VS_ACTIVATED_...5,SET,177,0.045678,0.0044632,0.064118,0.23811,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_DN,0.930368221672662
GSE6092_UNSTIM_VS_IFNG_STIM_...4,SET,179,0.042024,0.0041291,0.058994,0.23813,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP,0.930368221672662
GOBP_POSITIVE_REGULATION_OF_...456,SET,5,0.31591,0.0052125,0.44349,0.23814,GOBP_POSITIVE_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.930368221672662
GOBP_CELLULAR_RESPONSE_TO_NI...1,SET,9,0.21087,0.0046675,0.29617,0.23824,GOBP_CELLULAR_RESPONSE_TO_NICOTINE,0.930523238566131
HP_REDUCED_SOCIAL_RECIPROCITY,SET,52,0.077681,0.0041281,0.1091,0.23824,HP_REDUCED_SOCIAL_RECIPROCITY,0.930523238566131
DAVICIONI_TARGETS_OF_PAX_FOX...2,SET,233,0.043122,0.0048268,0.060572,0.23826,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,0.930523238566131
MIR6879_3P,SET,41,0.096259,0.0045436,0.13526,0.23835,MIR6879_3P,0.930686798698384
MIR516B_5P,SET,114,0.053617,0.0042117,0.075348,0.23836,MIR516B_5P,0.930686798698384
SANDERSON_PPARA_TARGETS,SET,15,0.1442,0.00412,0.20273,0.23846,SANDERSON_PPARA_TARGETS,0.930686798698384
AGGGCCA_MIR328,SET,68,0.071401,0.0043372,0.10038,0.23846,AGGGCCA_MIR328,0.930686798698384
HP_VERY_LONG_CHAIN_FATTY_ACI...,SET,15,0.15162,0.004332,0.21317,0.23846,HP_VERY_LONG_CHAIN_FATTY_ACID_ACCUMULATION,0.930686798698384
HP_ABNORMAL_THALAMUS_MORPHOL...,SET,53,0.075323,0.004041,0.10592,0.2385,HP_ABNORMAL_THALAMUS_MORPHOLOGY,0.930686798698384
HP_EMG_MYOTONIC_DISCHARGES,SET,8,0.21352,0.0044559,0.30024,0.2385,HP_EMG_MYOTONIC_DISCHARGES,0.930686798698384
UNTERMAN_PROGRESSIVE_VS_STAB...4,SET,26,0.14032,0.0052766,0.19736,0.23855,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_MONOCYTE_DN,0.930686798698384
HP_APLASIA_HYPOPLASIA_OF_THE...48,SET,43,0.087284,0.004219,0.12277,0.23857,HP_APLASIA_HYPOPLASIA_OF_THE_NIPPLES,0.930686798698384
GROSS_ELK3_TARGETS_UP,SET,25,0.13112,0.004835,0.18444,0.23858,GROSS_ELK3_TARGETS_UP,0.930686798698384
HP_PACE_OF_PROGRESSION,SET,400,0.029425,0.0042956,0.041396,0.2386,HP_PACE_OF_PROGRESSION,0.930686798698384
YRTCANNRCGC_UNKNOWN,SET,61,0.075921,0.0043688,0.10682,0.23863,YRTCANNRCGC_UNKNOWN,0.930686798698384
GOBP_CHORION_DEVELOPMENT,SET,10,0.21437,0.0050014,0.30164,0.23865,GOBP_CHORION_DEVELOPMENT,0.930686798698384
GOBP_DNA_INTEGRITY_CHECKPOIN...,SET,125,0.04912,0.0040391,0.06914,0.23872,GOBP_DNA_INTEGRITY_CHECKPOINT_SIGNALING,0.930855334904073
GOBP_NEGATIVE_REGULATION_OF_...419,SET,27,0.12298,0.0047125,0.17316,0.23879,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,0.931023833295939
GOMF_SELENIUM_BINDING,SET,6,0.28154,0.0050886,0.39657,0.23887,GOMF_SELENIUM_BINDING,0.93123127874369
MIR4528,SET,203,0.044435,0.0046463,0.062615,0.23897,MIR4528,0.93134364634693
REACTOME_MISCELLANEOUS_SUBST...,SET,12,0.18894,0.0048287,0.26627,0.23898,REACTOME_MISCELLANEOUS_SUBSTRATES,0.93134364634693
GOMF_OXIDOREDUCTASE_ACTIVITY...18,SET,2,0.38262,0.0039931,0.53926,0.239,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_OTHER_NITROGENOUS_COMPOUNDS_AS_DONORS_CYTOCHROME_AS_ACCEPTOR,0.93134364634693
GOBP_REGULATION_OF_ADIPOSE_T...,SET,14,0.16076,0.0044373,0.22663,0.23906,GOBP_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.93134364634693
WP_CHOLESTEROL_METABOLISM_WI...,SET,44,0.084061,0.0041101,0.11851,0.23907,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,0.93134364634693
GOBP_AMINO_SUGAR_CATABOLIC_P...,SET,14,0.17065,0.0047104,0.24062,0.2391,GOBP_AMINO_SUGAR_CATABOLIC_PROCESS,0.93134364634693
MODULE_98,SET,368,0.029475,0.0041307,0.041562,0.23912,MODULE_98,0.93134364634693
GOBP_FARNESYL_DIPHOSPHATE_ME...,SET,5,0.23269,0.0038393,0.32812,0.23912,GOBP_FARNESYL_DIPHOSPHATE_METABOLIC_PROCESS,0.93134364634693
HP_LOCALIZED_OSTEOPOROSIS,SET,19,0.12375,0.0039787,0.17451,0.23914,HP_LOCALIZED_OSTEOPOROSIS,0.93134364634693
GOBP_CELL_PROLIFERATION_INVO...1,SET,17,0.16316,0.0049623,0.23017,0.23921,GOBP_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS,0.931446459780417
GSE45365_NK_CELL_VS_BCELL_DN,SET,127,0.055082,0.0045652,0.077707,0.23922,GSE45365_NK_CELL_VS_BCELL_DN,0.931446459780417
HP_INCREASED_CIRCULATING_INT...3,SET,11,0.1893,0.004632,0.26709,0.23925,HP_INCREASED_CIRCULATING_INTERLEUKIN_6_CONCENTRATION,0.931458916769351
MENON_FETAL_KIDNEY_10_IMMUNE...,SET,71,0.072281,0.0044861,0.10202,0.23932,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.931618986917142
VETTER_TARGETS_OF_PRKCA_AND_...2,SET,16,0.15478,0.004567,0.2185,0.23937,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,0.931618986917142
MIR3942_5P,SET,197,0.044797,0.0046152,0.063244,0.23938,MIR3942_5P,0.931618986917142
GOBP_REGULATION_OF_NATURAL_K...1,SET,38,0.10287,0.0046748,0.14524,0.2394,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,0.931618986917142
PID_IL23_PATHWAY,SET,37,0.11034,0.0049483,0.15585,0.23948,PID_IL23_PATHWAY,0.931618986917142
HP_ABSENCE_OF_STOMACH_BUBBLE...,SET,5,0.27648,0.0045619,0.39054,0.23949,HP_ABSENCE_OF_STOMACH_BUBBLE_ON_FETAL_SONOGRAPHY,0.931618986917142
GOCC_HOST_CELLULAR_COMPONENT,SET,9,0.18168,0.0040214,0.25665,0.23951,GOCC_HOST_CELLULAR_COMPONENT,0.931618986917142
GERY_CEBP_TARGETS,SET,118,0.059197,0.0047303,0.083627,0.23952,GERY_CEBP_TARGETS,0.931618986917142
MIR6082,SET,15,0.1652,0.0047199,0.2335,0.23964,MIR6082,0.931618986917142
GOBP_POSITIVE_REGULATION_OF_...105,SET,459,0.027976,0.0043677,0.039544,0.23964,GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,0.931618986917142
HP_ABNORMAL_DIAPHYSIS_MORPHO...,SET,296,0.034873,0.004392,0.049294,0.23965,HP_ABNORMAL_DIAPHYSIS_MORPHOLOGY,0.931618986917142
GNF2_CDC27,SET,56,0.080023,0.0044126,0.11313,0.23967,GNF2_CDC27,0.931618986917142
GOMF_TRANSMEMBRANE_RECEPTOR_...6,SET,62,0.082881,0.004808,0.11717,0.23967,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.931618986917142
GOBP_POSITIVE_REGULATION_OF_...830,SET,14,0.16899,0.0046647,0.23892,0.23969,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.931618986917142
REACTOME_EPIGENETIC_REGULATI...,SET,182,0.041305,0.004092,0.058406,0.23972,REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,0.931618986917142
WP_NOVEL_INTRACELLULAR_COMPO...,SET,54,0.080333,0.0043501,0.11359,0.23972,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,0.931618986917142
GOBP_ANTERIOR_POSTERIOR_AXON...,SET,7,0.25854,0.0050472,0.3657,0.23979,GOBP_ANTERIOR_POSTERIOR_AXON_GUIDANCE,0.931624927422957
GSE21546_ELK1_KO_VS_SAP1A_KO...2,SET,176,0.042335,0.004125,0.059902,0.23987,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.931624927422957
MODULE_505,SET,16,0.15184,0.0044804,0.21487,0.23989,MODULE_505,0.931624927422957
GOBP_SODIUM_ION_TRANSPORT,SET,232,0.041868,0.0046765,0.059247,0.23989,GOBP_SODIUM_ION_TRANSPORT,0.931624927422957
GSE17721_PAM3CSK4_VS_CPG_6H_...1,SET,186,0.043811,0.0043871,0.062003,0.23991,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN,0.931624927422957
GSE46606_DAY1_VS_DAY3_CD40L_...3,SET,177,0.044662,0.0043639,0.063219,0.23995,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN,0.931624927422957
KEGG_MEDICUS_PATHOGEN_ESCHER...5,SET,14,0.14076,0.0038854,0.19928,0.23999,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPT_TO_RAC_SIGNALING_PATHWAY,0.931624927422957
GOBP_RESPONSE_TO_ODORANT,SET,5,0.28438,0.0046922,0.40264,0.24001,GOBP_RESPONSE_TO_ODORANT,0.931624927422957
GSE360_CTRL_VS_L_DONOVANI_DC...2,SET,178,0.043551,0.0042672,0.061666,0.24002,GSE360_CTRL_VS_L_DONOVANI_DC_UP,0.931624927422957
GRADE_COLON_AND_RECTAL_CANCE...2,SET,256,0.03589,0.0042082,0.050821,0.24004,GRADE_COLON_AND_RECTAL_CANCER_UP,0.931624927422957
NABA_MATRISOME_ASSOCIATED,SET,698,0.025777,0.0049295,0.036503,0.24005,NABA_MATRISOME_ASSOCIATED,0.931624927422957
GOBP_HEPARAN_SULFATE_PROTEOG...5,SET,15,0.17286,0.0049387,0.24479,0.24005,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,0.931624927422957
DESCARTES_MAIN_FETAL_THYMOCY...,SET,70,0.074516,0.0045922,0.10553,0.24007,DESCARTES_MAIN_FETAL_THYMOCYTES,0.931624927422957
ZHAN_LATE_DIFFERENTIATION_GE...2,SET,29,0.11319,0.004495,0.16038,0.24016,ZHAN_LATE_DIFFERENTIATION_GENES_UP,0.931843703951775
GOBP_POSITIVE_REGULATION_OF_...315,SET,8,0.24428,0.0050978,0.34613,0.24018,GOBP_POSITIVE_REGULATION_OF_GONAD_DEVELOPMENT,0.931843703951775
HP_ABNORMAL_ERYTHROCYTE_ADEN...,SET,22,0.1178,0.0040753,0.16705,0.24035,HP_ABNORMAL_ERYTHROCYTE_ADENOSINE_DEAMINASE_ACTIVITY,0.932081757886523
HP_ABNORMALITY_OF_URINARY_UR...,SET,11,0.17246,0.0042199,0.24456,0.24036,HP_ABNORMALITY_OF_URINARY_URIC_ACID_LEVEL,0.932081757886523
HOWARD_NEUTROPHIL_INACT_MONO...4,SET,113,0.057825,0.0045224,0.082009,0.24038,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.932081757886523
GOMF_INOSITOL_BISPHOSPHATE_P...,SET,7,0.20499,0.0040017,0.29078,0.24042,GOMF_INOSITOL_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.932081757886523
GOBP_POSITIVE_REGULATION_OF_...113,SET,343,0.033859,0.0045844,0.048032,0.24043,GOBP_POSITIVE_REGULATION_OF_CELL_ACTIVATION,0.932081757886523
GOBP_INTERLEUKIN_5_PRODUCTION,SET,19,0.1418,0.0045591,0.20118,0.24046,GOBP_INTERLEUKIN_5_PRODUCTION,0.932081757886523
MANNE_COVID19_COMBINED_COHOR...2,SET,161,0.046276,0.0043143,0.065656,0.24047,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,0.932081757886523
GSE10325_LUPUS_CD4_TCELL_VS_...3,SET,183,0.046235,0.0045928,0.065623,0.24055,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN,0.932081757886523
PDGF_ERK_DN.V1_UP,SET,125,0.050395,0.0041439,0.071532,0.24056,PDGF_ERK_DN.V1_UP,0.932081757886523
ZNF318_TARGET_GENES,SET,824,0.020843,0.0043152,0.029585,0.24057,ZNF318_TARGET_GENES,0.932081757886523
HP_PARIETAL_BOSSING,SET,8,0.17509,0.003654,0.24856,0.24058,HP_PARIETAL_BOSSING,0.932081757886523
HP_OOCYTE_ARREST_AT_METAPHAS...,SET,5,0.26285,0.0043369,0.37315,0.24059,HP_OOCYTE_ARREST_AT_METAPHASE_I,0.932081757886523
GSE16385_ROSIGLITAZONE_IL4_V...1,SET,169,0.047213,0.0045086,0.067023,0.24059,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN,0.932081757886523
HP_APLASIA_CUTIS_CONGENITA_O...1,SET,19,0.13035,0.0041911,0.18515,0.24071,HP_APLASIA_CUTIS_CONGENITA_OF_SCALP,0.932155658906093
HP_HYPERESTHESIA,SET,9,0.19417,0.0042979,0.27581,0.24071,HP_HYPERESTHESIA,0.932155658906093
MIR6829_3P,SET,77,0.069165,0.0044696,0.098257,0.24075,MIR6829_3P,0.932155658906093
GSE28737_WT_VS_BCL6_HET_FOLL...2,SET,183,0.043867,0.0043575,0.062318,0.24075,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP,0.932155658906093
WP_VITAMIN_D_IN_INFLAMMATORY...,SET,20,0.13155,0.0043393,0.18689,0.24076,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,0.932155658906093
GSE12507_PDC_CELL_LINE_VS_IM...1,SET,119,0.056509,0.0045345,0.080289,0.24077,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN,0.932155658906093
GOBP_RENAL_SODIUM_ION_TRANSP...,SET,14,0.17406,0.0048045,0.24736,0.24082,GOBP_RENAL_SODIUM_ION_TRANSPORT,0.932245388728002
ANDERSON_BLOOD_CN54GP140_ADJ...6,SET,31,0.10725,0.0044031,0.15244,0.24086,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_UP,0.93228226812159
GSE2585_CTEC_VS_THYMIC_MACRO...2,SET,183,0.044729,0.0044432,0.063589,0.2409,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP,0.93228226812159
GOBP_ACROSOMAL_VESICLE_EXOCY...,SET,9,0.20198,0.0044706,0.28714,0.24091,GOBP_ACROSOMAL_VESICLE_EXOCYTOSIS,0.93228226812159
CYCLIN_D1_UP.V1_DN,SET,175,0.044508,0.0043245,0.0633,0.24099,CYCLIN_D1_UP.V1_DN,0.932422909941
GOCC_IMMUNOLOGICAL_SYNAPSE,SET,43,0.091894,0.0044419,0.1307,0.241,GOCC_IMMUNOLOGICAL_SYNAPSE,0.932422909941
GOCC_PLASMA_MEMBRANE_REGION,SET,1187,0.018212,0.0044785,0.025908,0.24104,GOCC_PLASMA_MEMBRANE_REGION,0.932470077864294
GOBP_RESPONSE_TO_SALT_STRESS,SET,24,0.12218,0.0044145,0.17387,0.24111,GOBP_RESPONSE_TO_SALT_STRESS,0.932470077864294
GOBP_MANGANESE_ION_TRANSPORT,SET,11,0.1786,0.0043703,0.25417,0.24113,GOBP_MANGANESE_ION_TRANSPORT,0.932470077864294
GOMF_PROTEIN_PHOSPHATASE_BIN...,SET,136,0.049992,0.0042865,0.071147,0.24114,GOMF_PROTEIN_PHOSPHATASE_BINDING,0.932470077864294
GSE19888_ADENOSINE_A3R_INH_V...6,SET,176,0.04397,0.0042842,0.062584,0.24116,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP,0.932470077864294
HP_ABNORMAL_CARDIOMYOCYTE_MO...,SET,15,0.15249,0.0043567,0.21706,0.24118,HP_ABNORMAL_CARDIOMYOCYTE_MORPHOLOGY,0.932470077864294
UBE2I_TARGET_GENES,SET,70,0.070696,0.0043568,0.10064,0.2412,UBE2I_TARGET_GENES,0.932470077864294
MIR101_3P,SET,418,0.029861,0.004454,0.042516,0.24123,MIR101_3P,0.932482332332332
GOMF_CAMP_DEPENDENT_PROTEIN_...2,SET,10,0.19139,0.0044653,0.27257,0.2413,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_INHIBITOR_ACTIVITY,0.932519079386258
GOBP_AMINO_ACID_NEUROTRANSMI...,SET,10,0.21942,0.0051192,0.31252,0.24132,GOBP_AMINO_ACID_NEUROTRANSMITTER_REUPTAKE,0.932519079386258
HP_ABNORMAL_DENSE_GRANULES,SET,9,0.19062,0.0042192,0.27151,0.24132,HP_ABNORMAL_DENSE_GRANULES,0.932519079386258
GOBP_EGG_ACTIVATION,SET,11,0.16015,0.0039186,0.22813,0.24135,GOBP_EGG_ACTIVATION,0.932531322957199
REACTOME_ER_QUALITY_CONTROL_...,SET,19,0.12926,0.004156,0.18418,0.2414,REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC,0.932620831480658
GOBP_CARBON_CATABOLITE_REGUL...,SET,7,0.19893,0.0038834,0.28353,0.24147,GOBP_CARBON_CATABOLITE_REGULATION_OF_TRANSCRIPTION,0.932681952005333
DESCARTES_FETAL_PLACENTA_VAS...,SET,85,0.070073,0.0047567,0.099891,0.2415,DESCARTES_FETAL_PLACENTA_VASCULAR_ENDOTHELIAL_CELLS,0.932681952005333
GOBP_REGULATION_OF_NEUTROPHI...6,SET,37,0.10694,0.0047958,0.15245,0.24151,GOBP_REGULATION_OF_NEUTROPHIL_MIGRATION,0.932681952005333
REACTOME_FORMATION_OF_INCISI...,SET,38,0.082744,0.0037604,0.11798,0.24154,REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER,0.932681952005333
GOBP_NOREPINEPHRINE_METABOLI...,SET,10,0.21632,0.0050471,0.30844,0.24155,GOBP_NOREPINEPHRINE_METABOLIC_PROCESS,0.932681952005333
IGF1R_TARGET_GENES,SET,2,0.47962,0.0050054,0.68412,0.24163,IGF1R_TARGET_GENES,0.932730799555802
HP_PNEUMOCYSTIS_JIROVECII_PN...,SET,3,0.29706,0.0037969,0.42374,0.24164,HP_PNEUMOCYSTIS_JIROVECII_PNEUMONIA,0.932730799555802
HP_CRANIOFACIAL_ASYMMETRY,SET,5,0.28267,0.004664,0.40323,0.24165,HP_CRANIOFACIAL_ASYMMETRY,0.932730799555802
MIR5011_3P,SET,46,0.090525,0.0045254,0.12914,0.24167,MIR5011_3P,0.932730799555802
KIM_MYCN_AMPLIFICATION_TARGE...1,SET,98,0.061133,0.0044543,0.087237,0.24173,KIM_MYCN_AMPLIFICATION_TARGETS_DN,0.932793793715999
GOMF_ACTININ_BINDING,SET,36,0.10208,0.0045156,0.14567,0.24174,GOMF_ACTININ_BINDING,0.932793793715999
GSE40274_FOXP3_VS_FOXP3_AND_...6,SET,138,0.051235,0.0044251,0.073141,0.24181,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.932960318605684
HP_FOCAL_HEMICLONIC_SEIZURE,SET,23,0.12886,0.0045579,0.18403,0.24191,HP_FOCAL_HEMICLONIC_SEIZURE,0.932982429140833
JONES_OVARY_MAST_CELL,SET,39,0.099428,0.0045775,0.14201,0.24193,JONES_OVARY_MAST_CELL,0.932982429140833
RYCACNNRNNRNCAG_UNKNOWN,SET,63,0.073634,0.0043058,0.10518,0.24195,RYCACNNRNNRNCAG_UNKNOWN,0.932982429140833
OCT1_B,SET,225,0.042034,0.0046245,0.060062,0.24202,OCT1_B,0.932982429140833
HP_SKIN_APPENDAGE_NEOPLASM,SET,16,0.14581,0.0043024,0.20837,0.24204,HP_SKIN_APPENDAGE_NEOPLASM,0.932982429140833
HAY_BONE_MARROW_EARLY_ERYTHR...,SET,81,0.06478,0.0042932,0.092589,0.24208,HAY_BONE_MARROW_EARLY_ERYTHROBLAST,0.932982429140833
HP_ABNORMAL_MITRAL_VALVE_PHY...,SET,151,0.048144,0.004348,0.068819,0.2421,HP_ABNORMAL_MITRAL_VALVE_PHYSIOLOGY,0.932982429140833
REACTOME_FLT3_SIGNALING_THRO...,SET,6,0.21802,0.0039405,0.31167,0.24212,REACTOME_FLT3_SIGNALING_THROUGH_SRC_FAMILY_KINASES,0.932982429140833
MIR3140_3P,SET,207,0.042435,0.0044802,0.060667,0.24213,MIR3140_3P,0.932982429140833
HOLLEMAN_PREDNISOLONE_RESIST...2,SET,16,0.11978,0.0035342,0.17124,0.24214,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP,0.932982429140833
GSE41867_DAY8_VS_DAY15_LCMV_...2,SET,147,0.049114,0.0043769,0.070228,0.24217,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.932982429140833
HP_ECCHYMOSIS,SET,54,0.083949,0.004546,0.12004,0.24218,HP_ECCHYMOSIS,0.932982429140833
GSE3982_EOSINOPHIL_VS_TH1_UP,SET,178,0.043565,0.0042686,0.062298,0.24219,GSE3982_EOSINOPHIL_VS_TH1_UP,0.932982429140833
GSE40666_UNTREATED_VS_IFNA_S...4,SET,185,0.044904,0.0044846,0.064245,0.2423,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP,0.932982429140833
GOBP_RESPONSE_TO_2_3_7_8_TET...,SET,5,0.31668,0.0052251,0.45313,0.24232,GOBP_RESPONSE_TO_2_3_7_8_TETRACHLORODIBENZODIOXINE,0.932982429140833
REACTOME_DUAL_INCISION_IN_GG...,SET,38,0.084497,0.00384,0.12091,0.24233,REACTOME_DUAL_INCISION_IN_GG_NER,0.932982429140833
GSE4142_NAIVE_VS_GC_BCELL_UP,SET,181,0.043193,0.0042673,0.061809,0.24234,GSE4142_NAIVE_VS_GC_BCELL_UP,0.932982429140833
HP_PROMINENT_ANTIHELIX,SET,13,0.15819,0.0042078,0.22642,0.24238,HP_PROMINENT_ANTIHELIX,0.932982429140833
MIR7154_5P,SET,239,0.038744,0.0043915,0.055456,0.24239,MIR7154_5P,0.932982429140833
GOBP_MESENCHYME_DEVELOPMENT,SET,293,0.036522,0.0045766,0.052277,0.2424,GOBP_MESENCHYME_DEVELOPMENT,0.932982429140833
HP_HYPOKALEMIC_ALKALOSIS,SET,12,0.17947,0.0045866,0.25692,0.24242,HP_HYPOKALEMIC_ALKALOSIS,0.932982429140833
OCONNOR_PBMC_MENVEO_ACWYVAX_...2,SET,124,0.049619,0.0040639,0.071035,0.24243,OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP,0.932982429140833
GOBP_OLIGODENDROCYTE_DIFFERE...,SET,104,0.061572,0.0046208,0.088152,0.24244,GOBP_OLIGODENDROCYTE_DIFFERENTIATION,0.932982429140833
GOBP_PROTEIN_UFMYLATION,SET,6,0.22633,0.0040907,0.32406,0.24246,GOBP_PROTEIN_UFMYLATION,0.932982429140833
LAKE_ADULT_KIDNEY_C13_THICK_...,SET,113,0.057916,0.0045295,0.082941,0.2425,LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB,0.933033045499834
HP_HALITOSIS,SET,6,0.25525,0.0046134,0.36558,0.24253,HP_HALITOSIS,0.933045179322559
GSE18893_CTRL_VS_TNF_TREATED...6,SET,182,0.042412,0.0042016,0.06077,0.24262,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP,0.933178474295191
GOMF_POU_DOMAIN_BINDING,SET,2,0.5041,0.0052609,0.72239,0.24265,GOMF_POU_DOMAIN_BINDING,0.933178474295191
GOBP_KETONE_BIOSYNTHETIC_PRO...,SET,42,0.087391,0.0041749,0.12526,0.24269,GOBP_KETONE_BIOSYNTHETIC_PROCESS,0.933178474295191
HP_EPIDERMOID_CYST,SET,15,0.13963,0.0039893,0.20014,0.2427,HP_EPIDERMOID_CYST,0.933178474295191
GSE360_T_GONDII_VS_M_TUBERCU...3,SET,176,0.043167,0.004206,0.061901,0.24279,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN,0.933178474295191
LCORL_TARGET_GENES,SET,359,0.030328,0.0041991,0.043492,0.2428,LCORL_TARGET_GENES,0.933178474295191
FRASOR_RESPONSE_TO_SERM_OR_F...1,SET,48,0.081772,0.0041755,0.11727,0.24281,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,0.933178474295191
HP_ABNORMAL_CIRCULATING_THYR...1,SET,20,0.1329,0.004384,0.1906,0.24282,HP_ABNORMAL_CIRCULATING_THYROGLOBULIN_CONCENTRATION,0.933178474295191
GOMF_STEROID_DEHYDROGENASE_A...1,SET,36,0.10138,0.0044847,0.1454,0.24283,GOMF_STEROID_DEHYDROGENASE_ACTIVITY,0.933178474295191
KEGG_MEDICUS_REFERENCE_GH_JA...,SET,7,0.25672,0.0050117,0.36823,0.24285,KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY,0.933178474295191
GOMF_PHOSPHATE_ION_BINDING,SET,8,0.2281,0.0047603,0.32719,0.24286,GOMF_PHOSPHATE_ION_BINDING,0.933178474295191
MIR1296_5P,SET,26,0.11854,0.0044576,0.17014,0.24299,MIR1296_5P,0.933515018697756
RODRIGUES_THYROID_CARCINOMA_...4,SET,706,0.022077,0.0042451,0.031699,0.24307,RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN,0.933515018697756
HAMAI_APOPTOSIS_VIA_TRAIL_DN,SET,176,0.043832,0.0042708,0.062945,0.24311,HAMAI_APOPTOSIS_VIA_TRAIL_DN,0.933515018697756
GOCC_COHESIN_COMPLEX,SET,8,0.21691,0.0045266,0.31152,0.24313,GOCC_COHESIN_COMPLEX,0.933515018697756
GOBP_NEGATIVE_REGULATION_OF_...360,SET,17,0.14259,0.0043368,0.20486,0.2432,GOBP_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY,0.933515018697756
MIR5699_5P,SET,98,0.057169,0.0041655,0.082142,0.24322,MIR5699_5P,0.933515018697756
LXR_Q3,SET,73,0.067698,0.0042601,0.097283,0.24325,LXR_Q3,0.933515018697756
GOMF_G_PROTEIN_COUPLED_RECEP...3,SET,4,0.25714,0.0037949,0.36954,0.24327,GOMF_G_PROTEIN_COUPLED_RECEPTOR_KINASE_ACTIVITY,0.933515018697756
GOBP_PEPTIDYL_TYROSINE_DEPHO...2,SET,7,0.2302,0.0044939,0.33089,0.24331,GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION_INVOLVED_IN_INACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,0.933515018697756
MODULE_306,SET,22,0.11459,0.0039643,0.16479,0.24341,MODULE_306,0.933515018697756
GOBP_RESPONSE_TO_GRAM_POSITI...,SET,6,0.23176,0.0041889,0.33341,0.24349,GOBP_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,0.933515018697756
MIR6858_5P,SET,56,0.080105,0.0044172,0.11524,0.2435,MIR6858_5P,0.933515018697756
GOMF_GLYCOLIPID_MANNOSYLTRAN...,SET,5,0.21504,0.0035481,0.30936,0.2435,GOMF_GLYCOLIPID_MANNOSYLTRANSFERASE_ACTIVITY,0.933515018697756
GOBP_RESPONSE_TO_LAMINAR_FLU...,SET,14,0.16579,0.0045761,0.23853,0.24352,GOBP_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS,0.933515018697756
GSE15659_NAIVE_VS_PTPRC_NEG_...2,SET,156,0.045454,0.0041719,0.065406,0.24354,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP,0.933515018697756
HP_BILATERAL_SUPERIOR_VENA_C...,SET,8,0.20769,0.0043343,0.29886,0.24356,HP_BILATERAL_SUPERIOR_VENA_CAVA,0.933515018697756
GOBP_MITOTIC_SISTER_CHROMATI...1,SET,21,0.1299,0.0043905,0.18697,0.2436,GOBP_MITOTIC_SISTER_CHROMATID_COHESION,0.933515018697756
REACTOME_REGULATION_OF_FOXO_...,SET,8,0.20522,0.0042826,0.29539,0.24361,REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION,0.933515018697756
GOBP_GLYCOSYLCERAMIDE_METABO...,SET,16,0.15049,0.0044404,0.21661,0.24362,GOBP_GLYCOSYLCERAMIDE_METABOLIC_PROCESS,0.933515018697756
ROSS_AML_WITH_AML1_ETO_FUSION,SET,67,0.075975,0.004581,0.10937,0.24364,ROSS_AML_WITH_AML1_ETO_FUSION,0.933515018697756
HP_DEVIATION_OF_TOES,SET,103,0.05974,0.0044618,0.086007,0.24366,HP_DEVIATION_OF_TOES,0.933515018697756
REACTOME_COMPLEMENT_CASCADE,SET,49,0.097706,0.0050407,0.14068,0.24368,REACTOME_COMPLEMENT_CASCADE,0.933515018697756
GSE6269_FLU_VS_E_COLI_INF_PB...2,SET,147,0.045058,0.0040155,0.064876,0.24368,GSE6269_FLU_VS_E_COLI_INF_PBMC_UP,0.933515018697756
GSE11057_CD4_CENT_MEM_VS_PBM...2,SET,178,0.043703,0.0042821,0.06293,0.2437,GSE11057_CD4_CENT_MEM_VS_PBMC_UP,0.933515018697756
HEIDENBLAD_AMPLICON_8Q24_DN,SET,38,0.098924,0.0044957,0.14246,0.24372,HEIDENBLAD_AMPLICON_8Q24_DN,0.933515018697756
REACTOME_MALATE_ASPARTATE_SH...,SET,9,0.17574,0.0038899,0.25315,0.24378,REACTOME_MALATE_ASPARTATE_SHUTTLE,0.933515018697756
BLANCO_MELO_BETA_INTERFERON_...1,SET,183,0.044295,0.0044,0.063818,0.24382,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,0.933515018697756
SHI_SPARC_TARGETS_DN,SET,12,0.18301,0.0046772,0.26368,0.24382,SHI_SPARC_TARGETS_DN,0.933515018697756
REACTOME_GLYOXYLATE_METABOLI...,SET,19,0.12889,0.0041441,0.18571,0.24382,REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION,0.933515018697756
HP_APLASIA_HYPOPLASIA_OF_FIN...,SET,314,0.033176,0.0043013,0.0478,0.24382,HP_APLASIA_HYPOPLASIA_OF_FINGERS,0.933515018697756
BUYTAERT_PHOTODYNAMIC_THERAP...1,SET,578,0.023898,0.0041728,0.034439,0.24387,BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN,0.933515018697756
MIR1292_5P,SET,15,0.14578,0.0041649,0.21008,0.24387,MIR1292_5P,0.933515018697756
PID_IL2_1PATHWAY,SET,54,0.084682,0.0045856,0.12204,0.24388,PID_IL2_1PATHWAY,0.933515018697756
MORF_RFC5,SET,72,0.065264,0.0040788,0.094057,0.24388,MORF_RFC5,0.933515018697756
GSE43955_TH0_VS_TGFB_IL6_TH1...4,SET,188,0.043578,0.004387,0.062818,0.24393,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP,0.933515018697756
GOBP_SOMITE_DEVELOPMENT,SET,74,0.070674,0.0044777,0.1019,0.24398,GOBP_SOMITE_DEVELOPMENT,0.933515018697756
GOBP_NEGATIVE_REGULATION_OF_...668,SET,38,0.089417,0.0040636,0.12898,0.24408,GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,0.933515018697756
GHANDHI_BYSTANDER_IRRADIATIO...2,SET,71,0.077243,0.004794,0.11144,0.24412,GHANDHI_BYSTANDER_IRRADIATION_UP,0.933515018697756
GOBP_MICROTUBULE_BUNDLE_FORM...,SET,99,0.055979,0.0040994,0.080765,0.24412,GOBP_MICROTUBULE_BUNDLE_FORMATION,0.933515018697756
HP_TRANSIENT_NEUTROPENIA,SET,7,0.19029,0.0037148,0.27454,0.24412,HP_TRANSIENT_NEUTROPENIA,0.933515018697756
MIR409_3P,SET,88,0.063135,0.0043603,0.0911,0.24415,MIR409_3P,0.933515018697756
BIOCARTA_CD40_PATHWAY,SET,12,0.16863,0.0043095,0.24333,0.24416,BIOCARTA_CD40_PATHWAY,0.933515018697756
HP_IMPAIRED_VIBRATION_SENSAT...2,SET,46,0.08295,0.0041467,0.1197,0.24416,HP_IMPAIRED_VIBRATION_SENSATION_IN_THE_LOWER_LIMBS,0.933515018697756
GOBP_REGULATION_OF_ODONTOBLA...,SET,10,0.21586,0.0050363,0.31155,0.2442,GOBP_REGULATION_OF_ODONTOBLAST_DIFFERENTIATION,0.933515018697756
HP_ABNORMALITY_OF_THE_ABDOMI...1,SET,1200,0.017205,0.0042523,0.024832,0.2442,HP_ABNORMALITY_OF_THE_ABDOMINAL_ORGANS,0.933515018697756
MIR155_5P,SET,215,0.041246,0.0044371,0.059533,0.24421,MIR155_5P,0.933515018697756
GOBP_NEGATIVE_REGULATION_OF_...298,SET,7,0.23301,0.0045487,0.33632,0.24421,GOBP_NEGATIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.933515018697756
HP_IMPAIRED_DISTAL_VIBRATION...,SET,47,0.081865,0.0041366,0.11821,0.24431,HP_IMPAIRED_DISTAL_VIBRATION_SENSATION,0.933633883537179
GOBP_LAMELLIPODIUM_MORPHOGEN...,SET,18,0.12678,0.0039674,0.18314,0.2444,GOBP_LAMELLIPODIUM_MORPHOGENESIS,0.933633883537179
HP_SPINAL_MUSCULAR_ATROPHY,SET,51,0.076015,0.0040006,0.10982,0.24441,HP_SPINAL_MUSCULAR_ATROPHY,0.933633883537179
MIR494_3P,SET,346,0.031865,0.0043328,0.046041,0.24444,MIR494_3P,0.933633883537179
HP_HYPERMAGNESEMIA,SET,7,0.23112,0.0045118,0.33406,0.24453,HP_HYPERMAGNESEMIA,0.933633883537179
GSE2770_IL12_ACT_VS_ACT_CD4_...4,SET,181,0.041785,0.0041282,0.060402,0.24454,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP,0.933633883537179
HP_FATIGUABLE_WEAKNESS_OF_PR...,SET,21,0.12687,0.0042881,0.1834,0.24455,HP_FATIGUABLE_WEAKNESS_OF_PROXIMAL_LIMB_MUSCLES,0.933633883537179
HP_PROGRESSIVE_LEUKOENCEPHAL...,SET,4,0.29305,0.0043249,0.4237,0.24458,HP_PROGRESSIVE_LEUKOENCEPHALOPATHY,0.933633883537179
HP_EPISODIC_TACHYPNEA,SET,48,0.074031,0.0037802,0.10705,0.24461,HP_EPISODIC_TACHYPNEA,0.933633883537179
HP_DUPLICATION_OF_BONES_INVO...,SET,193,0.04156,0.0042385,0.060101,0.24463,HP_DUPLICATION_OF_BONES_INVOLVING_THE_UPPER_EXTREMITIES,0.933633883537179
HP_LUPUS_ANTICOAGULANT,SET,4,0.30629,0.0045203,0.44295,0.24463,HP_LUPUS_ANTICOAGULANT,0.933633883537179
GSE10094_LCMV_VS_LISTERIA_IN...2,SET,175,0.041188,0.0040019,0.059565,0.24463,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP,0.933633883537179
GSE37301_PRO_BCELL_VS_GRANUL...1,SET,161,0.046193,0.0043066,0.066805,0.24464,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.933633883537179
GOBP_NEGATIVE_REGULATION_OF_...199,SET,17,0.13118,0.0039897,0.18973,0.24466,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.933633883537179
MORF_TERF1,SET,61,0.067872,0.0039056,0.098175,0.24468,MORF_TERF1,0.933633883537179
GOBP_REGULATION_OF_DNA_BINDI...2,SET,319,0.032705,0.0042733,0.047309,0.24469,GOBP_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.933633883537179
GSE37416_12H_VS_48H_F_TULARE...2,SET,182,0.042922,0.0042522,0.0621,0.24473,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.933633883537179
BRUINS_UVC_RESPONSE_EARLY_LA...,SET,286,0.033488,0.0041468,0.048456,0.24475,BRUINS_UVC_RESPONSE_EARLY_LATE,0.933633883537179
GSE22611_MUTANT_NOD2_TRANSDU...1,SET,184,0.042371,0.0042203,0.061315,0.24478,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN,0.933633883537179
GAUTAM_EYE_IRIS_CILIARY_BODY...11,SET,111,0.059118,0.0045827,0.085569,0.24482,GAUTAM_EYE_IRIS_CILIARY_BODY_MONOCYTES,0.933633883537179
CUX1_TARGET_GENES,SET,662,0.022717,0.0042351,0.032882,0.24483,CUX1_TARGET_GENES,0.933633883537179
GSE17301_IFNA2_VS_IFNA2_AND_...2,SET,183,0.041702,0.0041425,0.060382,0.2449,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP,0.933633883537179
WP_POLYCYSTIC_KIDNEY_DISEASE...,SET,82,0.066765,0.0044518,0.096678,0.24491,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,0.933633883537179
GSE18804_SPLEEN_MACROPHAGE_V...4,SET,182,0.043177,0.0042774,0.062522,0.24492,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP,0.933633883537179
PEDERSEN_METASTASIS_BY_ERBB2...4,SET,11,0.19827,0.0048515,0.28715,0.24495,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5,0.933633883537179
KEGG_MEDICUS_VARIANT_CDX2_OV...,SET,5,0.30842,0.0050889,0.44668,0.24495,KEGG_MEDICUS_VARIANT_CDX2_OVEREXPRESSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.933633883537179
GSE7460_TREG_VS_TCONV_ACT_DN,SET,173,0.045462,0.0043921,0.065863,0.24502,GSE7460_TREG_VS_TCONV_ACT_DN,0.933633883537179
GNATENKO_PLATELET_SIGNATURE,SET,34,0.10138,0.0043585,0.14689,0.24505,GNATENKO_PLATELET_SIGNATURE,0.933633883537179
GOBP_PERICYTE_CELL_DIFFERENT...,SET,10,0.19052,0.004445,0.27611,0.24509,GOBP_PERICYTE_CELL_DIFFERENTIATION,0.933633883537179
GOBP_NUCLEOTIDE_TRANSMEMBRAN...,SET,28,0.11928,0.0046545,0.17289,0.24513,GOBP_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT,0.933633883537179
GSE27786_NKCELL_VS_ERYTHROBL...1,SET,185,0.042725,0.004267,0.061934,0.24515,GSE27786_NKCELL_VS_ERYTHROBLAST_DN,0.933633883537179
GOBP_REGULATION_OF_CELL_PROL...1,SET,15,0.16685,0.0047669,0.2419,0.24519,GOBP_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.933633883537179
GSE19825_NAIVE_VS_IL2RALOW_D...1,SET,177,0.040347,0.0039422,0.058497,0.24519,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN,0.933633883537179
GOBP_POSITIVE_REGULATION_OF_...683,SET,5,0.28774,0.0047476,0.41724,0.24522,GOBP_POSITIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.933633883537179
GOBP_NEURAL_CREST_CELL_DIFFE...,SET,87,0.067562,0.0046396,0.098004,0.2453,GOBP_NEURAL_CREST_CELL_DIFFERENTIATION,0.933633883537179
WP_FOXA2_PATHWAY,SET,21,0.13425,0.0045375,0.19478,0.24535,WP_FOXA2_PATHWAY,0.933633883537179
MIR3675_5P,SET,30,0.10072,0.0040678,0.14615,0.24537,MIR3675_5P,0.933633883537179
GSE17721_LPS_VS_CPG_1H_BMDC_...1,SET,192,0.041923,0.0042646,0.060841,0.2454,GSE17721_LPS_VS_CPG_1H_BMDC_DN,0.933633883537179
GOBP_POSITIVE_REGULATION_OF_...786,SET,75,0.069313,0.0044209,0.10061,0.24545,GOBP_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,0.933633883537179
GOMF_NUCLEOSIDE_KINASE_ACTIV...,SET,9,0.17622,0.0039005,0.2558,0.24546,GOMF_NUCLEOSIDE_KINASE_ACTIVITY,0.933633883537179
AGGCACT_MIR5153P,SET,80,0.064685,0.0042604,0.093924,0.24551,AGGCACT_MIR5153P,0.933633883537179
GSE45365_WT_VS_IFNAR_KO_CD11...1,SET,154,0.045217,0.0041237,0.065669,0.24555,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN,0.933633883537179
HP_TRUNCUS_ARTERIOSUS,SET,24,0.13387,0.0048369,0.19444,0.24557,HP_TRUNCUS_ARTERIOSUS,0.933633883537179
WP_THIAMINE_METABOLIC_PATHWA...,SET,8,0.193,0.0040276,0.2804,0.24564,WP_THIAMINE_METABOLIC_PATHWAYS,0.933633883537179
GOBP_REGULATION_OF_TELOMERE_...4,SET,57,0.070775,0.0039373,0.10283,0.24564,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.933633883537179
HP_DECREASED_THYROID_STIMULA...,SET,11,0.17391,0.0042553,0.25271,0.24568,HP_DECREASED_THYROID_STIMULATING_HORMONE_LEVEL,0.933633883537179
GSE17974_CTRL_VS_ACT_IL4_AND...5,SET,176,0.041972,0.0040896,0.060995,0.24569,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN,0.933633883537179
RICKMAN_TUMOR_DIFFERENTIATED...3,SET,101,0.057886,0.0042814,0.084122,0.2457,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,0.933633883537179
GOBP_POSITIVE_REGULATION_OF_...526,SET,226,0.040471,0.0044623,0.05883,0.24575,GOBP_POSITIVE_REGULATION_OF_NEUROGENESIS,0.933633883537179
IRITANI_MAD1_TARGETS_UP,SET,12,0.18136,0.004635,0.26365,0.24577,IRITANI_MAD1_TARGETS_UP,0.933633883537179
MIR6088,SET,152,0.046911,0.0042505,0.068197,0.24577,MIR6088,0.933633883537179
GSE17721_12H_VS_24H_GARDIQUI...2,SET,177,0.043837,0.0042833,0.063727,0.24577,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_UP,0.933633883537179
GOBP_REGULATION_OF_MRNA_CIS_...,SET,3,0.28858,0.0036884,0.41966,0.24584,GOBP_REGULATION_OF_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,0.933633883537179
MIR7161_5P,SET,177,0.045317,0.0044278,0.065902,0.24585,MIR7161_5P,0.933633883537179
GOMF_RNA_7_METHYLGUANOSINE_C...,SET,11,0.14464,0.0035392,0.2104,0.24591,GOMF_RNA_7_METHYLGUANOSINE_CAP_BINDING,0.933633883537179
GOBP_VASCULAR_ENDOTHELIAL_GR...4,SET,40,0.099066,0.0046188,0.14417,0.24599,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY,0.933633883537179
MIR4642,SET,90,0.063482,0.0044336,0.09239,0.24601,MIR4642,0.933633883537179
chr3p21,SET,185,0.098913,0.0098785,0.14398,0.24604,chr3p21,0.933633883537179
REACTOME_SUMO_IS_PROTEOLYTIC...,SET,6,0.20907,0.0037787,0.30431,0.24604,REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED,0.933633883537179
GOBP_POSITIVE_REGULATION_OF_...312,SET,24,0.11519,0.0041619,0.16766,0.24604,GOBP_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,0.933633883537179
GOMF_SINGLE_STRANDED_DNA_EXO...,SET,10,0.14933,0.0034841,0.21738,0.24606,GOMF_SINGLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY,0.933633883537179
GOBP_3_PHOSPHOADENOSINE_5_PH...,SET,15,0.16589,0.0047396,0.24151,0.24608,GOBP_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_METABOLIC_PROCESS,0.933633883537179
GOBP_NEGATIVE_REGULATION_OF_...142,SET,10,0.17482,0.0040788,0.25461,0.24616,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_STORAGE,0.933633883537179
GOMF_DEMETHYLASE_ACTIVITY,SET,33,0.088421,0.0037452,0.12877,0.24616,GOMF_DEMETHYLASE_ACTIVITY,0.933633883537179
WP_LDLRAD4_AND_WHAT_WE_KNOW_...,SET,7,0.26502,0.0051736,0.38598,0.24617,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,0.933633883537179
GOBP_INDUCTION_OF_POSITIVE_C...,SET,13,0.17949,0.0047742,0.26143,0.24618,GOBP_INDUCTION_OF_POSITIVE_CHEMOTAXIS,0.933633883537179
KEGG_MEDICUS_REFERENCE_BILE_...,SET,14,0.15893,0.004387,0.23155,0.24624,KEGG_MEDICUS_REFERENCE_BILE_ACID_BIOSYNTHESIS,0.933633883537179
GOMF_NUCLEAR_RECEPTOR_BINDING,SET,126,0.050617,0.0041787,0.073755,0.24627,GOMF_NUCLEAR_RECEPTOR_BINDING,0.933633883537179
GOBP_REGULATION_OF_CARDIAC_E...,SET,11,0.2015,0.0049305,0.29369,0.24633,GOBP_REGULATION_OF_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.933633883537179
HP_ABNORMAL_ORAL_PHYSIOLOGY,SET,286,0.03491,0.0043229,0.050889,0.24636,HP_ABNORMAL_ORAL_PHYSIOLOGY,0.933633883537179
GOCC_TIGHT_JUNCTION,SET,116,0.055353,0.0043858,0.080703,0.2464,GOCC_TIGHT_JUNCTION,0.933633883537179
GOMF_OXIDOREDUCTASE_ACTIVITY...27,SET,51,0.085549,0.0045025,0.12473,0.2464,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR,0.933633883537179
HUMMEL_BURKITTS_LYMPHOMA_UP,SET,38,0.098255,0.0044653,0.14326,0.24641,HUMMEL_BURKITTS_LYMPHOMA_UP,0.933633883537179
GOBP_EMBRYONIC_HEART_TUBE_LE...,SET,5,0.23852,0.0039356,0.34792,0.2465,GOBP_EMBRYONIC_HEART_TUBE_LEFT_RIGHT_PATTERN_FORMATION,0.933633883537179
GOCC_COPII_VESICLE_COAT,SET,16,0.13541,0.0039956,0.19755,0.24653,GOCC_COPII_VESICLE_COAT,0.933633883537179
GSE6259_33D1_POS_DC_VS_CD8_T...2,SET,122,0.052259,0.0042456,0.07624,0.24653,GSE6259_33D1_POS_DC_VS_CD8_TCELL_UP,0.933633883537179
GOBP_RESPONSE_TO_ATP,SET,31,0.11122,0.0045662,0.16227,0.24655,GOBP_RESPONSE_TO_ATP,0.933633883537179
WP_RUBINSTEINTAYBI_SYNDROME_1,SET,14,0.15972,0.0044086,0.23306,0.24658,WP_RUBINSTEINTAYBI_SYNDROME_1,0.933633883537179
KEGG_MEDICUS_REFERENCE_MITOC...,SET,52,0.067927,0.0036098,0.099127,0.2466,KEGG_MEDICUS_REFERENCE_MITOCHONDRIAL_COMPLEX_UCP1_IN_THERMOGENESIS,0.933633883537179
HP_DEVELOPMENTAL_STAGNATION,SET,16,0.15381,0.0045385,0.22448,0.24661,HP_DEVELOPMENTAL_STAGNATION,0.933633883537179
GSE32423_MEMORY_VS_NAIVE_CD8...3,SET,178,0.043031,0.0042162,0.062802,0.24662,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN,0.933633883537179
SWEET_LUNG_CANCER_KRAS_DN,SET,387,0.031824,0.0045713,0.04645,0.24664,SWEET_LUNG_CANCER_KRAS_DN,0.933633883537179
ACEVEDO_NORMAL_TISSUE_ADJACE...2,SET,154,0.044076,0.0040196,0.06434,0.24666,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,0.933633883537179
GSE22589_SIV_VS_HIV_AND_SIV_...1,SET,181,0.041676,0.0041174,0.060835,0.24666,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN,0.933633883537179
GSE3691_CONVENTIONAL_VS_PLAS...2,SET,188,0.042148,0.004243,0.061531,0.24668,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP,0.933633883537179
HP_ABNORMAL_JAW_MORPHOLOGY,SET,987,0.018687,0.0042146,0.027285,0.24671,HP_ABNORMAL_JAW_MORPHOLOGY,0.933633883537179
GSE369_PRE_VS_POST_IL6_INJEC...2,SET,176,0.043211,0.0042102,0.063099,0.24674,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP,0.933633883537179
VANGURP_PANCREATIC_GAMMA_CELL,SET,41,0.1018,0.004805,0.14869,0.24679,VANGURP_PANCREATIC_GAMMA_CELL,0.933633883537179
REACTOME_TOLL_LIKE_RECEPTOR_...2,SET,159,0.046636,0.004321,0.068134,0.24684,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,0.933633883537179
GOBP_POSITIVE_REGULATION_OF_...328,SET,10,0.2007,0.0046825,0.29322,0.24685,GOBP_POSITIVE_REGULATION_OF_HEAT_GENERATION,0.933633883537179
GSE17721_PAM3CSK4_VS_CPG_4H_...2,SET,177,0.041898,0.0040938,0.061214,0.24685,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP,0.933633883537179
PICCALUGA_ANGIOIMMUNOBLASTIC...1,SET,117,0.056362,0.0044848,0.08235,0.24686,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,0.933633883537179
WP_METABOLISM_OF_ALPHALINOLE...,SET,6,0.25619,0.0046303,0.37437,0.24689,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,0.933633883537179
HP_WEAK_CRY,SET,44,0.085554,0.0041831,0.12502,0.24689,HP_WEAK_CRY,0.933633883537179
GSE39820_TGFBETA3_IL6_VS_TGF...1,SET,179,0.041941,0.0041209,0.061291,0.2469,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN,0.933633883537179
HP_RECURRENT_ASPIRATION_PNEU...,SET,23,0.11562,0.0040896,0.16905,0.24701,HP_RECURRENT_ASPIRATION_PNEUMONIA,0.933633883537179
GNF2_DNM1,SET,68,0.074081,0.0045,0.10832,0.24702,GNF2_DNM1,0.933633883537179
ZHONG_PFC_MAJOR_TYPES_ASTROC...,SET,298,0.035513,0.0044874,0.051928,0.24703,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,0.933633883537179
MIR4257,SET,120,0.049841,0.0040161,0.072882,0.24704,MIR4257,0.933633883537179
HP_INTESTINAL_FISTULA,SET,29,0.10407,0.0041326,0.15219,0.24705,HP_INTESTINAL_FISTULA,0.933633883537179
GOBP_REGULATION_OF_BONE_MINE...1,SET,70,0.072305,0.004456,0.10575,0.24707,GOBP_REGULATION_OF_BONE_MINERALIZATION,0.933633883537179
GOMF_FATTY_ACID_OMEGA_HYDROX...,SET,7,0.25346,0.004948,0.3708,0.24714,GOMF_FATTY_ACID_OMEGA_HYDROXYLASE_ACTIVITY,0.933633883537179
GARY_CD5_TARGETS_DN,SET,396,0.027436,0.0039856,0.040141,0.24715,GARY_CD5_TARGETS_DN,0.933633883537179
ATF4_Q2,SET,226,0.03767,0.0041534,0.055122,0.24719,ATF4_Q2,0.933633883537179
GSE46606_IRF4_KO_VS_WT_CD40L...2,SET,170,0.045757,0.0043824,0.066975,0.24725,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_UP,0.933633883537179
GOBP_COLUMNAR_CUBOIDAL_EPITH...1,SET,49,0.08789,0.0045343,0.12865,0.24726,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT,0.933633883537179
MIR4645_5P,SET,103,0.056183,0.0041962,0.08225,0.24728,MIR4645_5P,0.933633883537179
HARRIS_HYPOXIA,SET,74,0.07301,0.0046256,0.10692,0.24735,HARRIS_HYPOXIA,0.933633883537179
GOBP_REGULATION_OF_ALTERNATI...,SET,50,0.07529,0.0039236,0.11026,0.24735,GOBP_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,0.933633883537179
WP_AFFECTED_PATHWAYS_IN_DUCH...,SET,67,0.073212,0.0044145,0.10722,0.24737,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,0.933633883537179
chr3q12,SET,22,0.19991,0.0069156,0.29278,0.24738,chr3q12,0.933633883537179
HP_ABNORMALITY_OF_BODY_MASS_...,SET,25,0.12285,0.0045302,0.17996,0.24741,HP_ABNORMALITY_OF_BODY_MASS_INDEX,0.933633883537179
GSE7568_CTRL_VS_24H_TGFB_TRE...1,SET,180,0.044521,0.0043864,0.06524,0.24749,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,0.933633883537179
GOBP_ASSOCIATIVE_LEARNING,SET,82,0.066159,0.0044114,0.096955,0.24751,GOBP_ASSOCIATIVE_LEARNING,0.933633883537179
TURASHVILI_BREAST_CARCINOMA_...2,SET,21,0.134,0.0045292,0.1964,0.24753,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP,0.933633883537179
HP_BROAD_FEMORAL_NECK,SET,16,0.13792,0.0040696,0.20214,0.24753,HP_BROAD_FEMORAL_NECK,0.933633883537179
KEGG_MELANOGENESIS,SET,98,0.060521,0.0044097,0.088708,0.24754,KEGG_MELANOGENESIS,0.933633883537179
GSE32423_CTRL_VS_IL4_MEMORY_...2,SET,176,0.043362,0.004225,0.063569,0.24758,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP,0.933633883537179
SNF5_DN.V1_UP,SET,147,0.048826,0.0043512,0.071581,0.24759,SNF5_DN.V1_UP,0.933633883537179
GSE23321_CD8_STEM_CELL_MEMOR...3,SET,180,0.041729,0.0041114,0.061177,0.24759,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,0.933633883537179
HP_DECREASED_COMPOUND_MUSCLE...,SET,13,0.15574,0.0041426,0.22836,0.24763,HP_DECREASED_COMPOUND_MUSCLE_ACTION_POTENTIAL_AMPLITUDE,0.933633883537179
GSE21670_UNTREATED_VS_TGFB_T...3,SET,180,0.043692,0.0043048,0.064073,0.24765,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN,0.933633883537179
GSE37301_MULTIPOTENT_PROGENI...2,SET,148,0.049421,0.0044192,0.072476,0.24766,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_UP,0.933633883537179
PURWIN_MEWO_SOX10_TARGETS,SET,82,0.06384,0.0042568,0.093629,0.24767,PURWIN_MEWO_SOX10_TARGETS,0.933633883537179
GOCC_CEREBELLAR_MOSSY_FIBER,SET,7,0.22359,0.0043649,0.32797,0.2477,GOCC_CEREBELLAR_MOSSY_FIBER,0.933633883537179
HP_ORCHITIS,SET,14,0.16555,0.0045695,0.24284,0.24771,HP_ORCHITIS,0.933633883537179
MIR4671_3P,SET,191,0.041946,0.0042559,0.061544,0.24776,MIR4671_3P,0.933633883537179
KEGG_MEDICUS_REFERENCE_CITRA...2,SET,10,0.15469,0.003609,0.22699,0.2478,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_SECOND_CARBON_OXIDATION_2,0.933633883537179
HP_APLASIA_HYPOPLASIA_INVOLV...11,SET,98,0.058535,0.004265,0.085921,0.24786,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_NOSE,0.933633883537179
GOBP_PROSTANOID_METABOLIC_PR...,SET,45,0.087001,0.0043018,0.12771,0.24787,GOBP_PROSTANOID_METABOLIC_PROCESS,0.933633883537179
GSE22313_HEALTHY_VS_SLE_MOUS...1,SET,179,0.043075,0.0042323,0.063238,0.24789,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN,0.933633883537179
REACTOME_GAP_JUNCTION_TRAFFI...,SET,46,0.089382,0.0044682,0.13124,0.24791,REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION,0.933633883537179
GSE6259_FLT3L_INDUCED_DEC205...2,SET,138,0.049333,0.0042608,0.072432,0.24791,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP,0.933633883537179
GOBP_POSITIVE_REGULATION_OF_...618,SET,15,0.15253,0.0043579,0.22398,0.24794,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,0.933633883537179
GOBP_MESENCHYMAL_CELL_MIGRAT...,SET,57,0.081261,0.0045206,0.11934,0.24796,GOBP_MESENCHYMAL_CELL_MIGRATION,0.933633883537179
ACACTGG_MIR199A_MIR199B,SET,139,0.048058,0.0041655,0.070591,0.24801,ACACTGG_MIR199A_MIR199B,0.933633883537179
GOBP_AXO_DENDRITIC_PROTEIN_T...,SET,9,0.19348,0.0042826,0.28424,0.24803,GOBP_AXO_DENDRITIC_PROTEIN_TRANSPORT,0.933633883537179
WP_CORTICOTROPINRELEASING_HO...,SET,89,0.062761,0.0043589,0.092206,0.24805,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,0.933633883537179
GSE13484_UNSTIM_VS_12H_YF17D...1,SET,177,0.042107,0.0041142,0.061873,0.24809,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN,0.933633883537179
GOBP_REGULATION_OF_CORE_PROM...,SET,5,0.25529,0.0042123,0.37522,0.24814,GOBP_REGULATION_OF_CORE_PROMOTER_BINDING,0.933633883537179
GOBP_NEGATIVE_REGULATION_OF_...90,SET,7,0.22709,0.0044332,0.33379,0.24815,GOBP_NEGATIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.933633883537179
GOBP_POSITIVE_REGULATION_OF_...214,SET,16,0.13989,0.0041277,0.20562,0.24816,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.933633883537179
HP_LONG_THUMB,SET,7,0.22629,0.0044176,0.33264,0.24816,HP_LONG_THUMB,0.933633883537179
GAUSSMANN_MLL_AF4_FUSION_TAR...2,SET,165,0.046371,0.004376,0.068164,0.24817,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,0.933633883537179
KEGG_MEDICUS_REFERENCE_EGF_E...10,SET,11,0.17323,0.0042387,0.25464,0.24817,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY,0.933633883537179
GSE2935_UV_INACTIVATED_VS_LI...2,SET,163,0.047399,0.0044461,0.069677,0.24817,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP,0.933633883537179
REACTOME_BETA_OXIDATION_OF_D...,SET,6,0.20294,0.003668,0.29835,0.24819,REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA,0.933633883537179
GSE17721_4_VS_24H_CPG_BMDC_UP,SET,177,0.043908,0.0042902,0.064575,0.24827,GSE17721_4_VS_24H_CPG_BMDC_UP,0.93383375
GOBP_LYMPH_VESSEL_MORPHOGENE...,SET,21,0.12753,0.0043106,0.18764,0.24836,GOBP_LYMPH_VESSEL_MORPHOGENESIS,0.934045325687081
HP_CEREBRAL_CORTICAL_ATROPHY,SET,276,0.033906,0.0041257,0.049892,0.24838,HP_CEREBRAL_CORTICAL_ATROPHY,0.934045325687081
GSE3982_EOSINOPHIL_VS_MAC_UP,SET,173,0.043478,0.0042004,0.063994,0.24844,GSE3982_EOSINOPHIL_VS_MAC_UP,0.934127521894259
HP_HETEROPHORIA,SET,11,0.15879,0.0038855,0.23374,0.24846,HP_HETEROPHORIA,0.934127521894259
HP_SEVERE_MUSCULAR_HYPOTONIA,SET,58,0.069212,0.0038838,0.10189,0.24849,HP_SEVERE_MUSCULAR_HYPOTONIA,0.934127521894259
MIR3681_3P,SET,357,0.031384,0.0043334,0.046212,0.24853,MIR3681_3P,0.934127521894259
GOMF_PROTEIN_HOMODIMERIZATIO...,SET,640,0.023051,0.0042279,0.033943,0.24854,GOMF_PROTEIN_HOMODIMERIZATION_ACTIVITY,0.934127521894259
HP_INCREASED_MUSCLE_FATIGUAB...,SET,16,0.14355,0.0042356,0.21141,0.24858,HP_INCREASED_MUSCLE_FATIGUABILITY,0.934127521894259
PID_P73PATHWAY,SET,76,0.062056,0.0039842,0.091402,0.24859,PID_P73PATHWAY,0.934127521894259
MARTORIATI_MDM4_TARGETS_NEUR...1,SET,147,0.049498,0.0044111,0.072928,0.24866,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,0.934289545945946
GOMF_RNA_CAP_BINDING,SET,17,0.11738,0.00357,0.17313,0.24889,GOMF_RNA_CAP_BINDING,0.934723614262561
HP_RETINAL_VASCULAR_TORTUOSI...,SET,38,0.10033,0.0045595,0.14798,0.24889,HP_RETINAL_VASCULAR_TORTUOSITY,0.934723614262561
GSE43863_NAIVE_VS_LY6C_INT_C...1,SET,146,0.048722,0.0043273,0.071864,0.2489,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_DN,0.934723614262561
GOBP_CELLULAR_RESPONSE_TO_BR...,SET,10,0.19001,0.0044332,0.28028,0.24891,GOBP_CELLULAR_RESPONSE_TO_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_STIMULUS,0.934723614262561
GOMF_DYNEIN_LIGHT_INTERMEDIA...,SET,28,0.10211,0.0039843,0.15062,0.24891,GOMF_DYNEIN_LIGHT_INTERMEDIATE_CHAIN_BINDING,0.934723614262561
GSE20715_0H_VS_6H_OZONE_LUNG...2,SET,182,0.042781,0.0042382,0.06313,0.24899,GSE20715_0H_VS_6H_OZONE_LUNG_UP,0.934848761659698
HP_EXPRESSIVE_LANGUAGE_DELAY,SET,50,0.076069,0.0039642,0.11225,0.249,HP_EXPRESSIVE_LANGUAGE_DELAY,0.934848761659698
GSE43955_TGFB_IL6_VS_TGFB_IL...3,SET,180,0.042961,0.0042328,0.063409,0.24904,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,0.934848761659698
GOBP_REGULATION_OF_INTRINSIC...1,SET,160,0.043671,0.0040589,0.064479,0.24912,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.934848761659698
SOBOLEV_PBMC_PANDEMRIX_AGE_1...9,SET,18,0.13557,0.0042428,0.20019,0.24913,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_RESPONDERS_VS_NONRESPONDERS_7DY_UP,0.934848761659698
MODULE_80,SET,32,0.11363,0.0047398,0.16788,0.24925,MODULE_80,0.934848761659698
HP_GASTROINTESTINAL_ULCER,SET,46,0.08986,0.0044921,0.13276,0.24926,HP_GASTROINTESTINAL_ULCER,0.934848761659698
GSE32533_WT_VS_MIR17_OVEREXP...2,SET,170,0.043556,0.0041716,0.064351,0.24926,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,0.934848761659698
MIR1252_3P,SET,270,0.036283,0.0043673,0.053614,0.24929,MIR1252_3P,0.934848761659698
GOBP_CELL_SURFACE_RECEPTOR_P...1,SET,333,0.032431,0.0043277,0.047924,0.24929,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.934848761659698
GOCC_IMMUNOGLOBULIN_COMPLEX,SET,10,0.2047,0.0047759,0.30249,0.2493,GOCC_IMMUNOGLOBULIN_COMPLEX,0.934848761659698
GSE557_CIITA_KO_VS_I_AB_KO_D...1,SET,183,0.040712,0.0040442,0.060184,0.24938,GSE557_CIITA_KO_VS_I_AB_KO_DC_DN,0.934848761659698
MIR136_3P,SET,8,0.18941,0.0039529,0.28003,0.2494,MIR136_3P,0.934848761659698
MORF_JAK3,SET,90,0.059435,0.004151,0.08787,0.2494,MORF_JAK3,0.934848761659698
GSE29949_DC_BRAIN_VS_MONOCYT...1,SET,178,0.043782,0.0042899,0.064743,0.24945,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.934848761659698
GSE3982_DC_VS_CENT_MEMORY_CD...1,SET,165,0.044388,0.0041888,0.065643,0.24946,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN,0.934848761659698
GOBP_REGULATION_OF_AXON_EXTE...2,SET,15,0.15319,0.0043767,0.22659,0.24951,GOBP_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.934848761659698
GOMF_TAT_PROTEIN_BINDING,SET,10,0.15974,0.0037268,0.23628,0.24951,GOMF_TAT_PROTEIN_BINDING,0.934848761659698
HP_LARYNGOTRACHEOMALACIA,SET,7,0.21672,0.0042308,0.32058,0.24952,HP_LARYNGOTRACHEOMALACIA,0.934848761659698
GOBP_REGULATION_OF_PROTEIN_A...2,SET,5,0.214,0.0035309,0.31662,0.24957,GOBP_REGULATION_OF_PROTEIN_ADP_RIBOSYLATION,0.934848761659698
GSE15330_HSC_VS_MEGAKARYOCYT...1,SET,150,0.04574,0.0041173,0.067682,0.24958,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.934848761659698
MIR124_5P,SET,102,0.056206,0.0041776,0.083172,0.24959,MIR124_5P,0.934848761659698
MCBRYAN_PUBERTAL_BREAST_5_6W...2,SET,115,0.055606,0.0043869,0.082303,0.24964,MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,0.934848761659698
HP_LIMITATION_OF_KNEE_MOBILI...,SET,30,0.11049,0.0044627,0.16354,0.24964,HP_LIMITATION_OF_KNEE_MOBILITY,0.934848761659698
HP_EEG_WITH_FOCAL_EPILEPTIFO...,SET,108,0.056738,0.0043387,0.083994,0.24968,HP_EEG_WITH_FOCAL_EPILEPTIFORM_DISCHARGES,0.934848761659698
GOBP_CENTRAL_NERVOUS_SYSTEM_...7,SET,163,0.049531,0.0046461,0.073327,0.24969,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,0.934848761659698
MYB_Q5_01,SET,246,0.036656,0.0042144,0.054274,0.24972,MYB_Q5_01,0.934848761659698
GSE45382_UNTREATED_VS_TGFB_T...2,SET,179,0.042716,0.004197,0.063255,0.24975,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP,0.934848761659698
MIR1911_3P,SET,42,0.091193,0.0043565,0.13505,0.24976,MIR1911_3P,0.934848761659698
GSE3039_ALPHABETA_CD8_TCELL_...4,SET,180,0.042152,0.0041531,0.062427,0.24977,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP,0.934848761659698
MANNO_MIDBRAIN_NEUROTYPES_HP...3,SET,284,0.034529,0.004261,0.051143,0.2498,MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL,0.934848761659698
GSE20366_EX_VIVO_VS_HOMEOSTA...4,SET,187,0.039437,0.0039596,0.058418,0.24982,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP,0.934848761659698
GSE13411_NAIVE_BCELL_VS_PLAS...2,SET,169,0.043818,0.0041844,0.06492,0.24986,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP,0.934848761659698
HP_ABDOMINAL_SITUS_AMBIGUUS,SET,4,0.29003,0.0042804,0.42975,0.24988,HP_ABDOMINAL_SITUS_AMBIGUUS,0.934848761659698
GOCC_LARGE_RIBOSOMAL_SUBUNIT,SET,103,0.053669,0.0040084,0.079532,0.2499,GOCC_LARGE_RIBOSOMAL_SUBUNIT,0.934848761659698
chr7p22,SET,67,0.14538,0.0087661,0.21551,0.24997,chr7p22,0.934848761659698
JONES_OVARY_ENDOTHELIAL,SET,144,0.051642,0.0045554,0.076584,0.25006,JONES_OVARY_ENDOTHELIAL,0.934848761659698
KEGG_TOLL_LIKE_RECEPTOR_SIGN...,SET,95,0.062122,0.0044569,0.092129,0.25007,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.934848761659698
NRF1_Q6,SET,231,0.03622,0.004037,0.053723,0.2501,NRF1_Q6,0.934848761659698
ZHAN_MULTIPLE_MYELOMA_CD1_AN...1,SET,51,0.082684,0.0043517,0.12265,0.25011,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,0.934848761659698
MIR6076,SET,49,0.084416,0.0043551,0.12522,0.25012,MIR6076,0.934848761659698
BHAT_ESR1_TARGETS_VIA_AKT1_UP,SET,263,0.037082,0.0044062,0.055013,0.25014,BHAT_ESR1_TARGETS_VIA_AKT1_UP,0.934848761659698
MEBARKI_HCC_PROGENITOR_WNT_DN,SET,72,0.069942,0.0043712,0.10378,0.25018,MEBARKI_HCC_PROGENITOR_WNT_DN,0.934848761659698
REACTOME_SYNTHESIS_OF_GLYCOS...,SET,17,0.1308,0.003978,0.1941,0.25021,REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI,0.934848761659698
KRIEG_KDM3A_TARGETS_NOT_HYPO...,SET,176,0.041004,0.0039953,0.060862,0.25025,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,0.934848761659698
BLALOCK_ALZHEIMERS_DISEASE_DN,SET,1103,0.017346,0.0041218,0.025751,0.25028,BLALOCK_ALZHEIMERS_DISEASE_DN,0.934848761659698
GOBP_BASE_EXCISION_REPAIR_AP...,SET,12,0.15736,0.0040216,0.23371,0.25038,GOBP_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,0.934848761659698
chr2p23,SET,84,0.11164,0.0075341,0.16582,0.25039,chr2p23,0.934848761659698
HP_CEREBRAL_INCLUSION_BODIES,SET,43,0.085304,0.0041233,0.12671,0.25041,HP_CEREBRAL_INCLUSION_BODIES,0.934848761659698
SMID_BREAST_CANCER_RELAPSE_I...6,SET,6,0.24421,0.0044138,0.36276,0.25042,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP,0.934848761659698
KOBAYASHI_EGFR_SIGNALING_24H...1,SET,240,0.035413,0.0040222,0.052623,0.25049,KOBAYASHI_EGFR_SIGNALING_24HR_DN,0.934848761659698
GOBP_CHROMOSOME_ATTACHMENT_T...,SET,4,0.23498,0.0034679,0.34918,0.25049,GOBP_CHROMOSOME_ATTACHMENT_TO_THE_NUCLEAR_ENVELOPE,0.934848761659698
MORI_MATURE_B_LYMPHOCYTE_UP,SET,79,0.069299,0.0045358,0.103,0.25053,MORI_MATURE_B_LYMPHOCYTE_UP,0.934848761659698
ZNF85_TARGET_GENES,SET,252,0.035486,0.0041287,0.052742,0.25053,ZNF85_TARGET_GENES,0.934848761659698
GSE14308_TH17_VS_NAIVE_CD4_T...2,SET,179,0.041167,0.0040449,0.06119,0.25055,GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP,0.934848761659698
GOMF_ENDOPEPTIDASE_ACTIVITY,SET,362,0.031185,0.0043354,0.046362,0.25059,GOMF_ENDOPEPTIDASE_ACTIVITY,0.934848761659698
HP_METOPIC_SYNOSTOSIS,SET,23,0.10222,0.0036157,0.15197,0.25059,HP_METOPIC_SYNOSTOSIS,0.934848761659698
GOCC_TIM23_MITOCHONDRIAL_IMP...,SET,14,0.14013,0.003868,0.20836,0.25063,GOCC_TIM23_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_TRANSLOCASE_COMPLEX,0.934848761659698
BIOCARTA_NO1_PATHWAY,SET,28,0.11466,0.0044743,0.17053,0.25067,BIOCARTA_NO1_PATHWAY,0.934848761659698
HP_SUPRAVALVULAR_AORTIC_STEN...,SET,26,0.13041,0.004904,0.19395,0.25067,HP_SUPRAVALVULAR_AORTIC_STENOSIS,0.934848761659698
ZHENG_CORD_BLOOD_C6_HSC_MULT...,SET,81,0.06787,0.0044979,0.10094,0.25068,ZHENG_CORD_BLOOD_C6_HSC_MULTIPOTENT_PROGENITOR,0.934848761659698
MIR451B,SET,150,0.047486,0.0042745,0.070632,0.2507,MIR451B,0.934848761659698
STAT1_02,SET,233,0.036822,0.0041216,0.054775,0.25072,STAT1_02,0.934848761659698
DESCARTES_FETAL_EYE_CORNEAL_...,SET,222,0.040973,0.004478,0.06095,0.25072,DESCARTES_FETAL_EYE_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS,0.934848761659698
LIU_CMYB_TARGETS_UP,SET,147,0.048976,0.0043646,0.072862,0.25074,LIU_CMYB_TARGETS_UP,0.934848761659698
HP_CANDIDA_ESOPHAGITIS,SET,5,0.2488,0.0041052,0.37014,0.25074,HP_CANDIDA_ESOPHAGITIS,0.934848761659698
GSE40274_CTRL_VS_FOXP3_TRANS...1,SET,182,0.043217,0.0042813,0.064303,0.25077,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.934848761659698
MIR6847_5P,SET,136,0.048522,0.0041605,0.072217,0.25083,MIR6847_5P,0.934848761659698
HP_ABNORMAL_DENTIN_MORPHOLOGY,SET,21,0.1208,0.0040831,0.17979,0.25083,HP_ABNORMAL_DENTIN_MORPHOLOGY,0.934848761659698
GAZIN_EPIGENETIC_SILENCING_B...,SET,25,0.117,0.0043142,0.17416,0.25086,GAZIN_EPIGENETIC_SILENCING_BY_KRAS,0.934848761659698
GOBP_NEGATIVE_REGULATION_OF_...491,SET,330,0.031423,0.0041746,0.046778,0.25088,GOBP_NEGATIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,0.934848761659698
HE_LIM_SUN_FETAL_LUNG_C2_CXC...,SET,118,0.055405,0.0044273,0.082478,0.25088,HE_LIM_SUN_FETAL_LUNG_C2_CXCL9_POS_MACROPHAGE_CELL,0.934848761659698
UEDA_PERIFERAL_CLOCK,SET,157,0.04674,0.0043035,0.069592,0.25092,UEDA_PERIFERAL_CLOCK,0.934897577186964
GSE26030_UNSTIM_VS_RESTIM_TH...2,SET,163,0.046088,0.0043231,0.068632,0.25095,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP,0.934909127452031
GOBP_ALDEHYDE_BIOSYNTHETIC_P...,SET,17,0.1509,0.0045896,0.22486,0.25109,GOBP_ALDEHYDE_BIOSYNTHETIC_PROCESS,0.935115781015642
HP_ABNORMALITY_OF_CIRCULATIN...1,SET,41,0.096157,0.0045388,0.14329,0.25109,HP_ABNORMALITY_OF_CIRCULATING_FIBRINOGEN,0.935115781015642
GOBP_NEGATIVE_REGULATION_OF_...653,SET,108,0.055699,0.0042592,0.083007,0.25111,GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,0.935115781015642
TIAN_TNF_SIGNALING_NOT_VIA_N...,SET,21,0.13489,0.0045594,0.20104,0.25112,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,0.935115781015642
ZHAN_MULTIPLE_MYELOMA_SPIKED,SET,20,0.13617,0.0044918,0.20296,0.25114,ZHAN_MULTIPLE_MYELOMA_SPIKED,0.935115781015642
HASEGAWA_TUMORIGENESIS_BY_RE...,SET,9,0.17641,0.0039048,0.26302,0.25121,HASEGAWA_TUMORIGENESIS_BY_RET_C634R,0.935276223888591
HP_AORTIC_ARCH_ANEURYSM,SET,37,0.10225,0.0045855,0.15249,0.25125,HP_AORTIC_ARCH_ANEURYSM,0.935299223519332
GOBP_MYELIN_ASSEMBLY,SET,23,0.11906,0.0042113,0.17757,0.25127,GOBP_MYELIN_ASSEMBLY,0.935299223519332
GOMF_HEMOGLOBIN_BINDING,SET,8,0.23468,0.0048974,0.35007,0.25132,GOMF_HEMOGLOBIN_BINDING,0.935359428204305
HP_COLORECTAL_POLYPOSIS,SET,23,0.10875,0.0038467,0.16225,0.25134,HP_COLORECTAL_POLYPOSIS,0.935359428204305
HP_HEART_BLOCK,SET,116,0.052898,0.0041912,0.07895,0.25143,HP_HEART_BLOCK,0.935542928915019
MIR10397_3P,SET,42,0.090898,0.0043425,0.1357,0.25148,MIR10397_3P,0.935542928915019
WAKABAYASHI_ADIPOGENESIS_PPA...3,SET,143,0.048719,0.0042827,0.072738,0.2515,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,0.935542928915019
HP_ATRIAL_STANDSTILL,SET,6,0.2456,0.004439,0.36677,0.25155,HP_ATRIAL_STANDSTILL,0.935542928915019
JIANG_TIP30_TARGETS_UP,SET,42,0.090119,0.0043052,0.13459,0.25157,JIANG_TIP30_TARGETS_UP,0.935542928915019
LEF1_UP.V1_UP,SET,173,0.045218,0.0043685,0.067536,0.25158,LEF1_UP.V1_UP,0.935542928915019
MIR6782_5P,SET,37,0.092045,0.0041278,0.13749,0.25161,MIR6782_5P,0.935542928915019
GNF2_CD33,SET,43,0.087689,0.0042386,0.13099,0.25161,GNF2_CD33,0.935542928915019
HP_PALLOR,SET,140,0.046401,0.0040363,0.069331,0.25167,HP_PALLOR,0.935542928915019
GOBP_TRANSCRIPTION_INITIATIO...1,SET,8,0.15874,0.0033127,0.23723,0.25171,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_III_PROMOTER,0.935542928915019
HP_HYPERCONVEX_NAIL,SET,16,0.14643,0.0043206,0.21887,0.25175,HP_HYPERCONVEX_NAIL,0.935542928915019
MIR651_5P,SET,107,0.054841,0.0041743,0.081983,0.25177,MIR651_5P,0.935542928915019
UNTERMAN_PROGRESSIVE_VS_STAB...6,SET,8,0.22512,0.0046981,0.33658,0.25179,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_UP,0.935542928915019
REACTOME_METABOLISM_OF_AMINE...,SET,17,0.14623,0.0044474,0.21863,0.25181,REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES,0.935542928915019
HP_PUNCTATE_KERATITIS,SET,5,0.29041,0.0047917,0.43422,0.25181,HP_PUNCTATE_KERATITIS,0.935542928915019
KEGG_GLYOXYLATE_AND_DICARBOX...,SET,16,0.1284,0.0037885,0.19198,0.25182,KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM,0.935542928915019
GOMF_ACYL_COA_OXIDASE_ACTIVI...,SET,7,0.19758,0.0038571,0.2955,0.25187,GOMF_ACYL_COA_OXIDASE_ACTIVITY,0.935551570680628
GOMF_IMMUNE_RECEPTOR_ACTIVITY,SET,131,0.057481,0.0048379,0.085973,0.25188,GOMF_IMMUNE_RECEPTOR_ACTIVITY,0.935551570680628
GSE17721_CPG_VS_GARDIQUIMOD_...1,SET,186,0.041097,0.0041154,0.061478,0.25192,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN,0.935551570680628
REACTOME_YAP1_AND_WWTR1_TAZ_...,SET,14,0.16071,0.004436,0.24043,0.25193,REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,0.935551570680628
GOBP_RESPONSE_TO_L_PHENYLALA...,SET,5,0.28748,0.0047433,0.43026,0.25202,GOBP_RESPONSE_TO_L_PHENYLALANINE_DERIVATIVE,0.93567156360141
REN_ALVEOLAR_RHABDOMYOSARCOM...2,SET,93,0.063299,0.0044935,0.094743,0.25203,REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,0.93567156360141
MEK_UP.V1_UP,SET,175,0.044945,0.0043669,0.067276,0.25205,MEK_UP.V1_UP,0.93567156360141
LOPEZ_TRANSLATION_VIA_FN1_SI...,SET,34,0.10069,0.0043288,0.15073,0.25207,LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,0.93567156360141
MARKEY_RB1_CHRONIC_LOF_UP,SET,106,0.053433,0.0040482,0.080005,0.25211,MARKEY_RB1_CHRONIC_LOF_UP,0.93572010358821
GOBP_SUGAR_MEDIATED_SIGNALIN...,SET,9,0.17503,0.0038742,0.26216,0.25218,GOBP_SUGAR_MEDIATED_SIGNALING_PATHWAY,0.93587996796583
GSE13411_IGM_VS_SWITCHED_MEM...1,SET,176,0.041483,0.0040419,0.062156,0.25227,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN,0.936114013452915
GOBP_REGULATION_OF_CELL_MATU...,SET,22,0.12442,0.0043041,0.18649,0.25234,GOBP_REGULATION_OF_CELL_MATURATION,0.93627380164407
HP_GRANULOCYTIC_HYPERPLASIA,SET,6,0.26123,0.0047215,0.39163,0.25238,HP_GRANULOCYTIC_HYPERPLASIA,0.936322256618275
CAO_BLOOD_FLUMIST_AGE_05_14Y...3,SET,7,0.24175,0.0047194,0.3626,0.25248,CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_DN,0.93646755949205
GOBP_LIMB_JOINT_MORPHOGENESIS,SET,7,0.22017,0.0042981,0.33024,0.25249,GOBP_LIMB_JOINT_MORPHOGENESIS,0.93646755949205
GSE14769_40MIN_VS_360MIN_LPS...1,SET,189,0.038806,0.0039168,0.058211,0.2525,GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN,0.93646755949205
GOBP_RIBONUCLEOPROTEIN_COMPL...1,SET,397,0.025782,0.0037499,0.038691,0.2526,GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS,0.936493169253668
BUSSLINGER_ESOPHAGEAL_QUIESC...,SET,70,0.069056,0.0042557,0.10364,0.25261,BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS,0.936493169253668
chr10q22,SET,85,0.12154,0.0082506,0.18242,0.25262,chr10q22,0.936493169253668
ANDERSON_BLOOD_CN54GP140_ADJ...4,SET,25,0.10999,0.0040559,0.1651,0.25264,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_UP,0.936493169253668
MEBARKI_HCC_PROGENITOR_WNT_D...2,SET,25,0.1252,0.0046166,0.18798,0.2527,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT,0.936493169253668
GSE11864_UNTREATED_VS_CSF1_I...4,SET,169,0.040731,0.0038896,0.061185,0.25281,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.936493169253668
GOBP_ENDOPLASMIC_RETICULUM_T...1,SET,25,0.099588,0.0036723,0.14961,0.25282,GOBP_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT,0.936493169253668
CREIGHTON_AKT1_SIGNALING_VIA...2,SET,32,0.097659,0.0040734,0.14674,0.25287,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP,0.936493169253668
MIR3675_3P,SET,78,0.067522,0.0043916,0.10146,0.25288,MIR3675_3P,0.936493169253668
GOBP_PIGMENT_CATABOLIC_PROCE...,SET,11,0.17601,0.0043068,0.26453,0.25291,GOBP_PIGMENT_CATABOLIC_PROCESS,0.936493169253668
MIR5190,SET,121,0.053135,0.0042992,0.079867,0.25294,MIR5190,0.936493169253668
GOBP_POST_EMBRYONIC_DEVELOPM...,SET,80,0.063197,0.0041624,0.094999,0.25295,GOBP_POST_EMBRYONIC_DEVELOPMENT,0.936493169253668
HP_MESOAXIAL_POLYDACTYLY,SET,18,0.1245,0.0038963,0.18716,0.25296,HP_MESOAXIAL_POLYDACTYLY,0.936493169253668
GOBP_POSITIVE_REGULATION_OF_...375,SET,88,0.061641,0.0042571,0.09268,0.253,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,0.936493169253668
MIR3117_5P,SET,54,0.073516,0.003981,0.11054,0.25301,MIR3117_5P,0.936493169253668
GNF2_CD14,SET,32,0.10736,0.0044783,0.16145,0.25303,GNF2_CD14,0.936493169253668
GOBP_REGULATION_OF_REPRODUCT...,SET,187,0.041414,0.0041581,0.062279,0.25304,GOBP_REGULATION_OF_REPRODUCTIVE_PROCESS,0.936493169253668
GOBP_NUCLEOSIDE_MONOPHOSPHAT...1,SET,36,0.092228,0.0040798,0.13872,0.25308,GOBP_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.936493169253668
GOBP_RESPONSE_TO_NITROSATIVE...,SET,10,0.16909,0.003945,0.25444,0.25317,GOBP_RESPONSE_TO_NITROSATIVE_STRESS,0.936493169253668
HP_NEOPLASM_OF_THE_HEART,SET,15,0.13345,0.0038127,0.20081,0.25318,HP_NEOPLASM_OF_THE_HEART,0.936493169253668
GOBP_REGULATION_OF_MITOCHOND...15,SET,23,0.10676,0.0037763,0.16067,0.25319,GOBP_REGULATION_OF_MITOCHONDRIAL_TRANSLATION,0.936493169253668
GOMF_PHOSPHATIDIC_ACID_TRANS...,SET,5,0.25388,0.004189,0.38209,0.2532,GOMF_PHOSPHATIDIC_ACID_TRANSFER_ACTIVITY,0.936493169253668
GOBP_PROPRIOCEPTION,SET,4,0.31265,0.0046142,0.47055,0.25321,GOBP_PROPRIOCEPTION,0.936493169253668
SCHWAB_TARGETS_OF_BMYB_POLYM...1,SET,13,0.16451,0.0043758,0.24763,0.25324,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN,0.936493169253668
MIR7152_3P,SET,87,0.05823,0.0039988,0.087651,0.25324,MIR7152_3P,0.936493169253668
GOBP_REGULATION_OF_TYPE_B_PA...1,SET,8,0.20974,0.004377,0.31571,0.25325,GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_DEVELOPMENT,0.936493169253668
GOBP_HETEROCHROMATIN_FORMATI...,SET,95,0.055838,0.0040061,0.084067,0.25328,GOBP_HETEROCHROMATIN_FORMATION,0.936493169253668
GOMF_FMN_BINDING,SET,15,0.14392,0.004112,0.21673,0.25333,GOMF_FMN_BINDING,0.936493169253668
POOLA_INVASIVE_BREAST_CANCER...1,SET,123,0.051783,0.004224,0.077993,0.25337,POOLA_INVASIVE_BREAST_CANCER_DN,0.936493169253668
GSE3982_EOSINOPHIL_VS_EFF_ME...1,SET,171,0.042028,0.004037,0.063308,0.25339,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.936493169253668
GOBP_CELL_CHEMOTAXIS,SET,290,0.035665,0.0044467,0.053728,0.25341,GOBP_CELL_CHEMOTAXIS,0.936493169253668
GSE41867_DAY8_VS_DAY15_LCMV_...3,SET,178,0.038749,0.0037967,0.058373,0.25341,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.936493169253668
GSE1925_CTRL_VS_IFNG_PRIMED_...2,SET,179,0.041598,0.0040872,0.062672,0.25343,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP,0.936493169253668
GOBP_PHOTORECEPTOR_CELL_MAIN...,SET,43,0.088692,0.0042871,0.13363,0.25345,GOBP_PHOTORECEPTOR_CELL_MAINTENANCE,0.936493169253668
GSE1791_CTRL_VS_NEUROMEDINU_...2,SET,170,0.041729,0.0039967,0.062875,0.25345,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_UP,0.936493169253668
GOMF_HEXOSAMINIDASE_ACTIVITY,SET,12,0.15849,0.0040503,0.23884,0.25349,GOMF_HEXOSAMINIDASE_ACTIVITY,0.936512848459442
GATA1_04,SET,222,0.039335,0.004299,0.059283,0.25351,GATA1_04,0.936512848459442
CEBP_C,SET,184,0.041744,0.0041579,0.062948,0.25362,CEBP_C,0.936512848459442
MIR921,SET,57,0.078381,0.0043604,0.11821,0.25365,MIR921,0.936512848459442
HP_ABSENT_EARLOBE,SET,20,0.12434,0.0041014,0.18752,0.25365,HP_ABSENT_EARLOBE,0.936512848459442
GSE9006_HEALTHY_VS_TYPE_1_DI...3,SET,176,0.038758,0.0037764,0.058452,0.25365,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN,0.936512848459442
WP_BLADDER_CANCER,SET,39,0.0892,0.0041066,0.13457,0.25372,WP_BLADDER_CANCER,0.936512848459442
HP_ABNORMAL_MUSCLE_FIBER_PRO...,SET,25,0.11407,0.0042064,0.17215,0.25378,HP_ABNORMAL_MUSCLE_FIBER_PROTEIN_EXPRESSION,0.936512848459442
HP_ABNORMAL_FINGERNAIL_MORPH...,SET,173,0.042461,0.0041021,0.064091,0.25383,HP_ABNORMAL_FINGERNAIL_MORPHOLOGY,0.936512848459442
VANLOO_SP3_TARGETS_DN,SET,83,0.057554,0.0038609,0.086891,0.25387,VANLOO_SP3_TARGETS_DN,0.936512848459442
GSE9509_LPS_VS_LPS_AND_IL10_...6,SET,168,0.042387,0.0040359,0.063991,0.25387,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_UP,0.936512848459442
GOBP_INNER_EAR_RECEPTOR_CELL...3,SET,32,0.10336,0.0043111,0.15606,0.2539,GOBP_INNER_EAR_RECEPTOR_CELL_STEREOCILIUM_ORGANIZATION,0.936512848459442
HP_ELEVATED_MEAN_ARTERIAL_PR...,SET,10,0.17986,0.0041962,0.27157,0.2539,HP_ELEVATED_MEAN_ARTERIAL_PRESSURE,0.936512848459442
HP_SUPERNUMERARY_CUSP,SET,4,0.27204,0.0040149,0.41081,0.25392,HP_SUPERNUMERARY_CUSP,0.936512848459442
HP_KYPHOSIS,SET,380,0.028265,0.004024,0.042697,0.25399,HP_KYPHOSIS,0.936512848459442
WP_LINOLEIC_ACID_METABOLISM_...,SET,5,0.26116,0.0043091,0.39455,0.25402,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,0.936512848459442
GOMF_PROTEIN_CARRIER_CHAPERO...,SET,31,0.095092,0.003904,0.1437,0.25407,GOMF_PROTEIN_CARRIER_CHAPERONE,0.936512848459442
GOBP_TERMINAL_BUTTON_ORGANIZ...,SET,6,0.24023,0.0043419,0.3631,0.25412,GOBP_TERMINAL_BUTTON_ORGANIZATION,0.936512848459442
GOMF_VASCULAR_ENDOTHELIAL_GR...2,SET,9,0.19915,0.0044081,0.30106,0.25415,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_BINDING,0.936512848459442
MILI_PSEUDOPODIA_CHEMOTAXIS_...2,SET,73,0.061292,0.003857,0.092663,0.25417,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,0.936512848459442
GOBP_REGULATION_OF_T_CELL_ME...3,SET,94,0.064155,0.0045786,0.096992,0.25417,GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,0.936512848459442
REACTOME_MITOTIC_G1_PHASE_AN...,SET,143,0.043265,0.0038033,0.065416,0.25419,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,0.936512848459442
GOBP_NEGATIVE_REGULATION_OF_...621,SET,11,0.18811,0.0046028,0.28442,0.25419,GOBP_NEGATIVE_REGULATION_OF_SYNAPSE_ORGANIZATION,0.936512848459442
GSE7852_LN_VS_FAT_TCONV_UP,SET,180,0.040599,0.0040001,0.061403,0.25425,GSE7852_LN_VS_FAT_TCONV_UP,0.936512848459442
GOBP_DETECTION_OF_BACTERIUM,SET,15,0.14795,0.0042271,0.22378,0.25426,GOBP_DETECTION_OF_BACTERIUM,0.936512848459442
GOMF_RNA_POLYMERASE_II_CORE_...,SET,15,0.14543,0.0041549,0.21996,0.25426,GOMF_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.936512848459442
KEGG_MEDICUS_REFERENCE_CA2_C...2,SET,12,0.15466,0.0039525,0.23397,0.2543,KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY,0.936512848459442
GOMF_PROTEIN_TYROSINE_KINASE...1,SET,29,0.11546,0.0045849,0.17468,0.25433,GOMF_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,0.936512848459442
ABRAHAM_ALPC_VS_MULTIPLE_MYE...2,SET,24,0.12096,0.0043703,0.18302,0.25434,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,0.936512848459442
MIR4472,SET,93,0.057873,0.0041083,0.087568,0.25434,MIR4472,0.936512848459442
GOBP_RESPONSE_TO_ACTINOMYCIN...,SET,5,0.23533,0.0038829,0.35609,0.25435,GOBP_RESPONSE_TO_ACTINOMYCIN_D,0.936512848459442
HOEK_MONOCYTE_2011_2012_TIV_...2,SET,7,0.26105,0.0050961,0.39505,0.25437,HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_UP,0.936512848459442
BIOCARTA_EPO_PATHWAY,SET,17,0.13903,0.0042284,0.2104,0.25438,BIOCARTA_EPO_PATHWAY,0.936512848459442
GOBP_REGULATION_OF_ER_TO_GOL...,SET,10,0.16759,0.00391,0.25368,0.25442,GOBP_REGULATION_OF_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.936512848459442
GOMF_POTASSIUM_CHLORIDE_SYMP...,SET,9,0.16544,0.003662,0.25054,0.25452,GOMF_POTASSIUM_CHLORIDE_SYMPORTER_ACTIVITY,0.936512848459442
GSE9946_MATURE_STIMULATORY_V...1,SET,114,0.053582,0.0042089,0.08114,0.25452,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN,0.936512848459442
GSE5589_WT_VS_IL10_KO_LPS_ST...1,SET,134,0.051175,0.0043559,0.077504,0.25454,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,0.936512848459442
GOBP_REGULATION_OF_PRE_MIRNA...,SET,5,0.24305,0.0040102,0.36811,0.25455,GOBP_REGULATION_OF_PRE_MIRNA_PROCESSING,0.936512848459442
GOBP_MICROTUBULE_POLYMERIZAT...1,SET,87,0.056351,0.0038697,0.085365,0.25459,GOBP_MICROTUBULE_POLYMERIZATION,0.936512848459442
GSE22601_DOUBLE_POSITIVE_VS_...3,SET,184,0.039654,0.0039497,0.060075,0.25461,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.936512848459442
GOBP_HYALOID_VASCULAR_PLEXUS...,SET,7,0.23745,0.0046355,0.35979,0.25464,GOBP_HYALOID_VASCULAR_PLEXUS_REGRESSION,0.936512848459442
MIR33A_5P_MIR33B_5P,SET,106,0.056142,0.0042534,0.085074,0.25465,MIR33A_5P_MIR33B_5P,0.936512848459442
GOBP_LEUKOCYTE_ADHESION_TO_A...,SET,5,0.27928,0.004608,0.42332,0.25472,GOBP_LEUKOCYTE_ADHESION_TO_ARTERIAL_ENDOTHELIAL_CELL,0.936512848459442
GSE36527_CD62L_HIGH_CD69_NEG...1,SET,178,0.04225,0.0041397,0.06404,0.25472,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN,0.936512848459442
BIOCARTA_PROTEASOME_PATHWAY,SET,17,0.12381,0.0037655,0.18768,0.25473,BIOCARTA_PROTEASOME_PATHWAY,0.936512848459442
WP_LEPTIN_SIGNALING,SET,74,0.066291,0.0042,0.10049,0.25474,WP_LEPTIN_SIGNALING,0.936512848459442
GSE3720_UNSTIM_VS_PMA_STIM_V...1,SET,112,0.053873,0.0041947,0.081678,0.25477,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,0.936512848459442
JONES_OVARY_T_CELL,SET,83,0.066422,0.0044557,0.10073,0.25483,JONES_OVARY_T_CELL,0.936512848459442
WP_CANNABINOID_RECEPTOR_SIGN...,SET,29,0.1064,0.0042254,0.16139,0.25485,WP_CANNABINOID_RECEPTOR_SIGNALING,0.936512848459442
HP_DECREASED_ACTIVITY_OF_NAD...,SET,3,0.33356,0.0042634,0.50599,0.25488,HP_DECREASED_ACTIVITY_OF_NADPH_OXIDASE,0.936512848459442
REACTOME_EUKARYOTIC_TRANSLAT...2,SET,108,0.051185,0.0039141,0.077661,0.25492,REACTOME_EUKARYOTIC_TRANSLATION_INITIATION,0.936512848459442
GSE22886_IL2_VS_IL15_STIM_NK...1,SET,166,0.041205,0.0039002,0.06252,0.25493,GSE22886_IL2_VS_IL15_STIM_NKCELL_DN,0.936512848459442
ZNF781_TARGET_GENES,SET,121,0.048201,0.0039,0.073143,0.25495,ZNF781_TARGET_GENES,0.936512848459442
MODULE_395,SET,12,0.15431,0.0039435,0.23416,0.25496,MODULE_395,0.936512848459442
DESCARTES_FETAL_KIDNEY_ERYTH...,SET,129,0.050029,0.0041787,0.075935,0.255,DESCARTES_FETAL_KIDNEY_ERYTHROBLASTS,0.936512848459442
HOWARD_NEUTROPHIL_INACT_MONO...1,SET,102,0.054989,0.0040871,0.083468,0.25502,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.936512848459442
HP_BULBAR_SIGNS,SET,32,0.09213,0.0038428,0.13989,0.25509,HP_BULBAR_SIGNS,0.936512848459442
HP_LARYNGEAL_DYSTONIA,SET,13,0.1486,0.0039526,0.22569,0.25514,HP_LARYNGEAL_DYSTONIA,0.936512848459442
REACTOME_SULFIDE_OXIDATION_T...,SET,5,0.20569,0.0033938,0.31242,0.25515,REACTOME_SULFIDE_OXIDATION_TO_SULFATE,0.936512848459442
REACTOME_TRAF3_DEPENDENT_IRF...,SET,14,0.1353,0.0037346,0.20553,0.25518,REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY,0.936512848459442
GOMF_ATP_DEPENDENT_ACTIVITY_...2,SET,71,0.061419,0.0038119,0.093303,0.25518,GOMF_ATP_DEPENDENT_ACTIVITY_ACTING_ON_RNA,0.936512848459442
IVANOVA_HEMATOPOIESIS_STEM_C...3,SET,201,0.039458,0.0041057,0.059948,0.25521,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,0.936512848459442
HP_KNEE_CLONUS,SET,5,0.25548,0.0042153,0.38819,0.25523,HP_KNEE_CLONUS,0.936512848459442
GSE27786_LSK_VS_CD4_TCELL_UP,SET,172,0.041846,0.0040312,0.063589,0.25525,GSE27786_LSK_VS_CD4_TCELL_UP,0.936512848459442
GOBP_MITOCHONDRIAL_RNA_MODIF...,SET,8,0.18062,0.0037693,0.2745,0.25528,GOBP_MITOCHONDRIAL_RNA_MODIFICATION,0.936512848459442
GSE6674_ANTI_IGM_VS_PL2_3_ST...2,SET,178,0.038662,0.0037882,0.058792,0.2554,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_UP,0.936512848459442
GOBP_POSITIVE_REGULATION_OF_...725,SET,44,0.084239,0.0041188,0.12812,0.25543,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,0.936512848459442
GSE3982_MAST_CELL_VS_NKCELL_...2,SET,176,0.041576,0.004051,0.063237,0.25544,GSE3982_MAST_CELL_VS_NKCELL_UP,0.936512848459442
PID_CIRCADIAN_PATHWAY,SET,13,0.15796,0.0042017,0.24026,0.25545,PID_CIRCADIAN_PATHWAY,0.936512848459442
GOBP_RENAL_SODIUM_ION_ABSORP...,SET,12,0.17484,0.0044682,0.26593,0.25545,GOBP_RENAL_SODIUM_ION_ABSORPTION,0.936512848459442
MIR4470,SET,227,0.037346,0.0041268,0.056827,0.25553,MIR4470,0.936512848459442
HP_REFLEX_SEIZURE,SET,19,0.12917,0.0041531,0.19655,0.25553,HP_REFLEX_SEIZURE,0.936512848459442
GSE10240_CTRL_VS_IL17_STIM_P...1,SET,181,0.040565,0.0040077,0.061724,0.25553,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.936512848459442
GOBP_ALLANTOIN_METABOLIC_PRO...,SET,9,0.20562,0.0045514,0.3129,0.25554,GOBP_ALLANTOIN_METABOLIC_PROCESS,0.936512848459442
MIR7845_5P,SET,54,0.074139,0.0040147,0.11282,0.25555,MIR7845_5P,0.936512848459442
GOMF_OXIDOREDUCTASE_ACTIVITY...10,SET,15,0.15168,0.0043335,0.23082,0.25556,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS,0.936512848459442
REACTOME_IRAK4_DEFICIENCY_TL...,SET,17,0.14045,0.0042716,0.21382,0.25564,REACTOME_IRAK4_DEFICIENCY_TLR2_4,0.936512848459442
DLX2_TARGET_GENES,SET,217,0.039079,0.0042232,0.059505,0.25568,DLX2_TARGET_GENES,0.936512848459442
MIR6867_5P,SET,773,0.021032,0.0042236,0.032034,0.25574,MIR6867_5P,0.936512848459442
POS_HISTAMINE_RESPONSE_NETWO...,SET,27,0.10888,0.0041722,0.16591,0.25583,POS_HISTAMINE_RESPONSE_NETWORK,0.936512848459442
MONNIER_POSTRADIATION_TUMOR_...2,SET,374,0.027054,0.0038216,0.041237,0.2559,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,0.936512848459442
MORF_RUNX1,SET,139,0.04543,0.0039378,0.06925,0.25591,MORF_RUNX1,0.936512848459442
HAY_BONE_MARROW_NEUTROPHIL,SET,397,0.028516,0.0041476,0.043479,0.25596,HAY_BONE_MARROW_NEUTROPHIL,0.936512848459442
HP_BLADDER_DIVERTICULUM,SET,29,0.11085,0.0044019,0.16903,0.25598,HP_BLADDER_DIVERTICULUM,0.936512848459442
HP_FRONTOTEMPORAL_DEMENTIA,SET,50,0.075452,0.003932,0.11505,0.25598,HP_FRONTOTEMPORAL_DEMENTIA,0.936512848459442
GOMF_CHEMOREPELLENT_ACTIVITY,SET,28,0.10963,0.0042778,0.16717,0.25599,GOMF_CHEMOREPELLENT_ACTIVITY,0.936512848459442
GOBP_POSITIVE_REGULATION_OF_...330,SET,6,0.20302,0.0036693,0.30963,0.25602,GOBP_POSITIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,0.936512848459442
GOBP_DNA_INTEGRATION,SET,7,0.18281,0.0035687,0.27882,0.25603,GOBP_DNA_INTEGRATION,0.936512848459442
MCCABE_HOXC6_TARGETS_DN,SET,18,0.13201,0.0041314,0.20137,0.25605,MCCABE_HOXC6_TARGETS_DN,0.936512848459442
HP_ABNORMAL_INTRAHEPATIC_BIL...,SET,28,0.10729,0.0041866,0.16372,0.25613,HP_ABNORMAL_INTRAHEPATIC_BILE_DUCT_MORPHOLOGY,0.936512848459442
MORF_UBE2A,SET,39,0.079363,0.0036537,0.12112,0.25616,MORF_UBE2A,0.936512848459442
GOMF_11_CIS_RETINAL_BINDING,SET,7,0.21733,0.0042427,0.33167,0.25616,GOMF_11_CIS_RETINAL_BINDING,0.936512848459442
HP_AMEGAKARYOCYTIC_THROMBOCY...,SET,6,0.20821,0.0037633,0.31778,0.25617,HP_AMEGAKARYOCYTIC_THROMBOCYTOPENIA,0.936512848459442
GOBP_POSITIVE_REGULATION_OF_...778,SET,111,0.049748,0.0038563,0.075948,0.25623,GOBP_POSITIVE_REGULATION_OF_TRANSLATION,0.936512848459442
GOBP_CHONDROCYTE_PROLIFERATI...,SET,23,0.11617,0.0041092,0.17738,0.25626,GOBP_CHONDROCYTE_PROLIFERATION,0.936512848459442
GOBP_CELLULAR_RESPONSE_TO_EX...2,SET,72,0.070198,0.0043872,0.10719,0.25628,GOBP_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS,0.936512848459442
GOBP_POSITIVE_REGULATION_OF_...579,SET,9,0.21786,0.0048222,0.33268,0.25628,GOBP_POSITIVE_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.936512848459442
REACTOME_G2_M_DNA_DAMAGE_CHE...,SET,55,0.0704,0.0038473,0.10751,0.2563,REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,0.936512848459442
MIR6074,SET,249,0.036306,0.0041992,0.055445,0.2563,MIR6074,0.936512848459442
GOBP_SERINE_TRANSPORT,SET,9,0.1745,0.0038625,0.26651,0.25631,GOBP_SERINE_TRANSPORT,0.936512848459442
HP_ABNORMAL_PLEURA_MORPHOLOGY,SET,168,0.044779,0.0042636,0.068407,0.25637,HP_ABNORMAL_PLEURA_MORPHOLOGY,0.936512848459442
MIR6769A_3P,SET,17,0.13905,0.0042291,0.21244,0.25639,MIR6769A_3P,0.936512848459442
NPAT_TARGET_GENES,SET,190,0.039814,0.0040291,0.060827,0.25639,NPAT_TARGET_GENES,0.936512848459442
LEIN_MEDULLA_MARKERS,SET,76,0.064052,0.0041124,0.097867,0.2564,LEIN_MEDULLA_MARKERS,0.936512848459442
REACTOME_ACETYLCHOLINE_NEURO...,SET,16,0.15237,0.004496,0.23282,0.25641,REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE,0.936512848459442
GOBP_CELL_DIVISION,SET,578,0.022793,0.0039799,0.034827,0.25641,GOBP_CELL_DIVISION,0.936512848459442
ZNF19_TARGET_GENES,SET,10,0.16216,0.0037834,0.24779,0.25642,ZNF19_TARGET_GENES,0.936512848459442
GOBP_CARNITINE_TRANSPORT,SET,7,0.26674,0.0052072,0.40762,0.25643,GOBP_CARNITINE_TRANSPORT,0.936512848459442
VANGURP_PANCREATIC_ALPHA_CELL,SET,38,0.096701,0.0043947,0.14785,0.25654,VANGURP_PANCREATIC_ALPHA_CELL,0.936512848459442
HP_MALIGNANT_GENITOURINARY_T...,SET,33,0.086814,0.0036771,0.13273,0.25655,HP_MALIGNANT_GENITOURINARY_TRACT_TUMOR,0.936512848459442
RAMPON_ENRICHED_LEARNING_ENV...3,SET,21,0.11339,0.0038324,0.17339,0.25659,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP,0.936512848459442
HUMMERICH_MALIGNANT_SKIN_TUM...2,SET,16,0.13322,0.0039309,0.20374,0.2566,HUMMERICH_MALIGNANT_SKIN_TUMOR_UP,0.936512848459442
KEGG_MEDICUS_VARIANT_SCRAPIE...2,SET,17,0.12998,0.0039532,0.19879,0.25661,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.936512848459442
HP_INCREASED_MUSCLE_LIPID_CO...,SET,33,0.095583,0.0040485,0.14621,0.25664,HP_INCREASED_MUSCLE_LIPID_CONTENT,0.936512848459442
GSE46606_DAY1_VS_DAY3_CD40L_...5,SET,180,0.039957,0.0039367,0.061126,0.25666,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN,0.936512848459442
YAMASHITA_SILENCED_BY_METHYL...,SET,7,0.22957,0.0044816,0.35129,0.25672,YAMASHITA_SILENCED_BY_METHYLATION,0.936512848459442
GSE17721_POLYIC_VS_PAM3CSK4_...12,SET,182,0.039631,0.0039261,0.060644,0.25672,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP,0.936512848459442
MAFG_TARGET_GENES,SET,1313,0.015487,0.0039907,0.0237,0.25673,MAFG_TARGET_GENES,0.936512848459442
GOBP_RESPONSE_TO_STEROID_HOR...,SET,310,0.032252,0.0041552,0.04936,0.25676,GOBP_RESPONSE_TO_STEROID_HORMONE,0.936512848459442
GOBP_DIAPEDESIS,SET,6,0.24649,0.004455,0.37731,0.25679,GOBP_DIAPEDESIS,0.936512848459442
GSE37301_MULTIPOTENT_PROGENI...8,SET,146,0.044397,0.0039432,0.067961,0.25679,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP,0.936512848459442
MODULE_552,SET,7,0.21112,0.0041214,0.3232,0.25682,MODULE_552,0.936512848459442
GSE2770_TGFB_AND_IL4_VS_TGFB...1,SET,166,0.0419,0.003966,0.064148,0.25682,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.936512848459442
DURANTE_ADULT_OLFACTORY_NEUR...24,SET,46,0.090967,0.0045475,0.1393,0.25687,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_SUSTENTACULAR_CELLS,0.936512848459442
GSE26495_PD1HIGH_VS_PD1LOW_C...2,SET,166,0.042885,0.0040592,0.065681,0.2569,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP,0.936512848459442
GOBP_EPIDERMAL_CELL_FATE_SPE...,SET,5,0.26834,0.0044275,0.41116,0.257,GOBP_EPIDERMAL_CELL_FATE_SPECIFICATION,0.936512848459442
GOBP_INTERLEUKIN_11_MEDIATED...,SET,6,0.23021,0.0041608,0.35273,0.257,GOBP_INTERLEUKIN_11_MEDIATED_SIGNALING_PATHWAY,0.936512848459442
REACTOME_A_TETRASACCHARIDE_L...,SET,23,0.11023,0.0038989,0.16891,0.25701,REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS,0.936512848459442
DAWSON_METHYLATED_IN_LYMPHOM...,SET,55,0.087823,0.0047994,0.1346,0.25704,DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,0.936512848459442
PID_IL6_7_PATHWAY,SET,43,0.088804,0.0042925,0.1361,0.25705,PID_IL6_7_PATHWAY,0.936512848459442
HP_FOLLICULITIS,SET,7,0.24981,0.0048768,0.38287,0.25705,HP_FOLLICULITIS,0.936512848459442
GOBP_NETRIN_ACTIVATED_SIGNAL...,SET,8,0.19734,0.0041183,0.30249,0.25708,GOBP_NETRIN_ACTIVATED_SIGNALING_PATHWAY,0.936512848459442
HP_PHOTOSENSITIVE_MYOCLONIC_...,SET,7,0.22232,0.00434,0.34077,0.25708,HP_PHOTOSENSITIVE_MYOCLONIC_SEIZURE,0.936512848459442
GOBP_MITOTIC_SPINDLE_ASSEMBLY,SET,68,0.062953,0.003824,0.096501,0.25709,GOBP_MITOTIC_SPINDLE_ASSEMBLY,0.936512848459442
GSE7400_CTRL_VS_CSF3_IN_VIVO...2,SET,176,0.039401,0.003839,0.060405,0.25711,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP,0.936512848459442
GSE17301_CTRL_VS_48H_ACD3_AC...5,SET,177,0.042471,0.0041498,0.065112,0.25712,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN,0.936512848459442
CDP_01,SET,87,0.065334,0.0044866,0.10021,0.25721,CDP_01,0.93666654619736
GOBP_RESPONSE_TO_PROSTAGLAND...2,SET,5,0.30905,0.0050993,0.47408,0.25724,GOBP_RESPONSE_TO_PROSTAGLANDIN_D,0.93666654619736
GSE40274_HELIOS_VS_FOXP3_AND...1,SET,179,0.03998,0.0039282,0.061335,0.25726,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.93666654619736
GOMF_CLATHRIN_BINDING,SET,53,0.074398,0.0039914,0.11414,0.25727,GOMF_CLATHRIN_BINDING,0.93666654619736
GSE18281_PERIMEDULLARY_CORTI...3,SET,156,0.04404,0.0040421,0.06758,0.25731,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,0.936714051534513
GOCC_MEIOTIC_COHESIN_COMPLEX,SET,6,0.21712,0.0039243,0.33332,0.2574,GOCC_MEIOTIC_COHESIN_COMPLEX,0.936783722513089
KEGG_PEROXISOME,SET,74,0.062676,0.0039709,0.096222,0.25741,KEGG_PEROXISOME,0.936783722513089
REACTOME_SIGNALING_BY_TGF_BE...2,SET,8,0.19449,0.0040588,0.2986,0.25741,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER,0.936783722513089
GSE17721_LPS_VS_CPG_2H_BMDC_...1,SET,181,0.040486,0.0039999,0.062188,0.25752,GSE17721_LPS_VS_CPG_2H_BMDC_DN,0.937079460081616
HP_RETROBULBAR_OPTIC_NEURITIS,SET,15,0.15288,0.0043679,0.23489,0.25757,HP_RETROBULBAR_OPTIC_NEURITIS,0.937079460081616
GSE5099_CLASSICAL_M1_VS_ALTE...2,SET,178,0.041617,0.0040777,0.063957,0.25762,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP,0.937079460081616
GOBP_REGULATION_OF_T_CELL_RE...,SET,43,0.084591,0.0040888,0.13,0.25763,GOBP_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.937079460081616
GOBP_REGULATION_OF_HETEROTYP...,SET,24,0.11771,0.0042528,0.18091,0.25765,GOBP_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,0.937079460081616
GOBP_ESTROGEN_METABOLIC_PROC...,SET,37,0.094917,0.0042566,0.1459,0.25767,GOBP_ESTROGEN_METABOLIC_PROCESS,0.937079460081616
HP_INCREASED_T_CELL_COUNT,SET,4,0.30133,0.0044471,0.46321,0.25768,HP_INCREASED_T_CELL_COUNT,0.937079460081616
MIR4681,SET,5,0.2107,0.0034764,0.32395,0.25772,MIR4681,0.937126867545512
GOBP_CARBOHYDRATE_MEDIATED_S...,SET,11,0.15869,0.0038829,0.24412,0.25784,GOBP_CARBOHYDRATE_MEDIATED_SIGNALING,0.937382969928697
FAN_EMBRYONIC_CTX_BIG_GROUPS...4,SET,43,0.088855,0.004295,0.13671,0.25787,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,0.937382969928697
GSE339_CD4POS_VS_CD8POS_DC_I...2,SET,183,0.039542,0.0039279,0.060846,0.25789,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP,0.937382969928697
LAKE_ADULT_KIDNEY_C20_COLLEC...,SET,139,0.04877,0.0042273,0.075057,0.25792,LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX,0.937382969928697
WP_PLEURAL_MESOTHELIOMA,SET,419,0.028282,0.0042233,0.043532,0.25796,WP_PLEURAL_MESOTHELIOMA,0.937382969928697
GSE17974_IL4_AND_ANTI_IL12_V...15,SET,173,0.042284,0.0040851,0.065089,0.25797,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN,0.937382969928697
GOBP_REGULATION_OF_RAB_PROTE...,SET,7,0.20448,0.0039918,0.31505,0.25816,GOBP_REGULATION_OF_RAB_PROTEIN_SIGNAL_TRANSDUCTION,0.937382969928697
GSE14415_INDUCED_TREG_VS_FOX...1,SET,160,0.044018,0.0040911,0.067835,0.25821,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN,0.937382969928697
SA_G1_AND_S_PHASES,SET,15,0.14427,0.004122,0.22238,0.25824,SA_G1_AND_S_PHASES,0.937382969928697
ZNF704_TARGET_GENES,SET,61,0.068189,0.0039238,0.1051,0.25824,ZNF704_TARGET_GENES,0.937382969928697
KRASNOSELSKAYA_ILF3_TARGETS_...2,SET,36,0.093872,0.0041525,0.14472,0.25829,KRASNOSELSKAYA_ILF3_TARGETS_UP,0.937382969928697
HP_IMPAIRED_CORTISOL_RESPONS...,SET,5,0.26425,0.0043601,0.4074,0.25829,HP_IMPAIRED_CORTISOL_RESPONSE_TO_INSULIN_STIMULATION_TEST,0.937382969928697
GOBP_SNRNA_CATABOLIC_PROCESS,SET,4,0.22071,0.0032573,0.34028,0.2583,GOBP_SNRNA_CATABOLIC_PROCESS,0.937382969928697
GOBP_MAST_CELL_CYTOKINE_PROD...,SET,6,0.24679,0.0044606,0.38052,0.25831,GOBP_MAST_CELL_CYTOKINE_PRODUCTION,0.937382969928697
HP_RADIAL_DEVIATION_OF_THE_H...2,SET,51,0.07704,0.0040546,0.1188,0.25833,HP_RADIAL_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,0.937382969928697
HP_PHYSICAL_URTICARIA,SET,14,0.15263,0.0042131,0.23543,0.25839,HP_PHYSICAL_URTICARIA,0.937382969928697
HP_ABNORMAL_CIRCULATING_GLYC...,SET,27,0.10725,0.0041097,0.16545,0.25842,HP_ABNORMAL_CIRCULATING_GLYCINE_CONCENTRATION,0.937382969928697
TONKS_TARGETS_OF_RUNX1_RUNX1...1,SET,16,0.1358,0.0040072,0.20952,0.25844,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN,0.937382969928697
MONTERO_THYROID_CANCER_POOR_...1,SET,9,0.16387,0.0036273,0.25284,0.25845,MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN,0.937382969928697
HP_APLASIA_HYPOPLASIA_OF_THE...50,SET,85,0.058815,0.0039925,0.090757,0.25848,HP_APLASIA_HYPOPLASIA_OF_THE_OVARY,0.937382969928697
GOBP_NEGATIVE_REGULATION_OF_...575,SET,1109,0.016918,0.0040303,0.026107,0.25849,GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS,0.937382969928697
KEGG_MEDICUS_REFERENCE_P27_C...,SET,14,0.13505,0.0037278,0.20843,0.25851,KEGG_MEDICUS_REFERENCE_P27_CELL_CYCLE_G1_S,0.937382969928697
WP_SULFATION_BIOTRANSFORMATI...,SET,14,0.16898,0.0046643,0.26078,0.25851,WP_SULFATION_BIOTRANSFORMATION_REACTION,0.937382969928697
MIR6885_3P,SET,364,0.029442,0.0041041,0.045439,0.25852,MIR6885_3P,0.937382969928697
WP_EFFECTS_OF_NITRIC_OXIDE,SET,6,0.24906,0.0045016,0.38475,0.25871,WP_EFFECTS_OF_NITRIC_OXIDE,0.937382969928697
KUNINGER_IGF1_VS_PDGFB_TARGE...2,SET,75,0.06311,0.0040253,0.097496,0.25872,KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,0.937382969928697
HP_PREMATURE_PUBARCHE,SET,13,0.16452,0.0043762,0.25419,0.25874,HP_PREMATURE_PUBARCHE,0.937382969928697
GOBP_MODULATION_OF_EXCITATOR...,SET,46,0.084202,0.0042093,0.1301,0.25876,GOBP_MODULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,0.937382969928697
SCHAEFFER_PROSTATE_DEVELOPME...1,SET,52,0.078393,0.004166,0.12116,0.25881,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,0.937382969928697
GOMF_UBIQUITIN_MODIFIED_HIST...,SET,7,0.17098,0.0033379,0.2643,0.25885,GOMF_UBIQUITIN_MODIFIED_HISTONE_READER_ACTIVITY,0.937382969928697
TONKS_TARGETS_OF_RUNX1_RUNX1...8,SET,191,0.040646,0.004124,0.062837,0.25887,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,0.937382969928697
REACTOME_PREVENTION_OF_PHAGO...,SET,8,0.1917,0.0040006,0.29651,0.25897,REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION,0.937382969928697
GOBP_REGULATION_OF_CD4_POSIT...2,SET,53,0.079316,0.0042552,0.12268,0.25897,GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.937382969928697
ZNF112_TARGET_GENES,SET,3,0.32973,0.0042144,0.51001,0.25898,ZNF112_TARGET_GENES,0.937382969928697
KOKKINAKIS_METHIONINE_DEPRIV...3,SET,69,0.064109,0.0039226,0.099174,0.25901,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,0.937382969928697
HP_ACUTE_HEPATIC_FAILURE,SET,31,0.09084,0.0037294,0.14054,0.25902,HP_ACUTE_HEPATIC_FAILURE,0.937382969928697
GOMF_OXYGEN_CARRIER_ACTIVITY,SET,10,0.21121,0.0049276,0.32676,0.25903,GOMF_OXYGEN_CARRIER_ACTIVITY,0.937382969928697
HP_PARAPARESIS,SET,67,0.061257,0.0036936,0.094775,0.25903,HP_PARAPARESIS,0.937382969928697
FUNG_IL2_TARGETS_WITH_STAT5_...1,SET,6,0.23658,0.0042759,0.36603,0.25904,FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES,0.937382969928697
GSE17721_LPS_VS_POLYIC_16H_B...1,SET,190,0.039885,0.0040362,0.061727,0.2591,GSE17721_LPS_VS_POLYIC_16H_BMDC_DN,0.937382969928697
HP_ABNORMAL_GLYCOSPHINGOLIPI...,SET,6,0.24367,0.0044041,0.37715,0.25912,HP_ABNORMAL_GLYCOSPHINGOLIPID_METABOLISM,0.937382969928697
HP_EPILEPSIA_PARTIALIS_CONTI...,SET,8,0.197,0.0041111,0.30494,0.25914,HP_EPILEPSIA_PARTIALIS_CONTINUA,0.937382969928697
HP_SPLENIC_RUPTURE,SET,4,0.37417,0.0055221,0.5792,0.25914,HP_SPLENIC_RUPTURE,0.937382969928697
REACTOME_SIGNALING_BY_CYTOSO...,SET,17,0.15257,0.0046402,0.23622,0.25919,REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS,0.937382969928697
GOBP_NK_T_CELL_PROLIFERATION,SET,8,0.21928,0.0045761,0.33953,0.2592,GOBP_NK_T_CELL_PROLIFERATION,0.937382969928697
GOBP_POSITIVE_REGULATION_OF_...10,SET,26,0.11169,0.0041999,0.17294,0.2592,GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,0.937382969928697
PEA3_Q6,SET,242,0.03637,0.0041479,0.056321,0.25922,PEA3_Q6,0.937382969928697
ZNF524_TARGET_GENES,SET,277,0.031906,0.0038892,0.049412,0.25924,ZNF524_TARGET_GENES,0.937382969928697
MODULE_545,SET,18,0.13253,0.0041474,0.20526,0.25926,MODULE_545,0.937382969928697
GSE13411_NAIVE_BCELL_VS_PLAS...1,SET,166,0.042084,0.0039834,0.065186,0.25927,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN,0.937382969928697
HP_FINGER_APLASIA,SET,77,0.060687,0.0039218,0.094026,0.25933,HP_FINGER_APLASIA,0.937382969928697
MIR8058,SET,41,0.088907,0.0041966,0.13776,0.25934,MIR8058,0.937382969928697
GSE33162_UNTREATED_VS_4H_LPS...4,SET,185,0.038854,0.0038804,0.060209,0.25936,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_UP,0.937382969928697
GOBP_DETECTION_OF_MECHANICAL...2,SET,33,0.10026,0.0042467,0.15538,0.25938,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,0.937382969928697
RODRIGUES_NTN1_AND_DCC_TARGE...,SET,28,0.10673,0.0041648,0.16542,0.2594,RODRIGUES_NTN1_AND_DCC_TARGETS,0.937382969928697
GOCC_AXONEMAL_DYNEIN_COMPLEX,SET,18,0.12085,0.003782,0.18734,0.25944,GOCC_AXONEMAL_DYNEIN_COMPLEX,0.937382969928697
MIR4638_5P,SET,5,0.22815,0.0037645,0.35378,0.2595,MIR4638_5P,0.937382969928697
HP_SINUS_BRADYCARDIA,SET,30,0.10326,0.0041705,0.16014,0.25953,HP_SINUS_BRADYCARDIA,0.937382969928697
GSE14769_UNSTIM_VS_20MIN_LPS...1,SET,183,0.039989,0.0039723,0.062015,0.25953,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN,0.937382969928697
GOBP_HOMOLOGOUS_CHROMOSOME_S...,SET,56,0.06798,0.0037485,0.10543,0.25954,GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION,0.937382969928697
GSE22886_NAIVE_CD4_TCELL_VS_...2,SET,178,0.039418,0.0038622,0.061141,0.25956,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP,0.937382969928697
GOBP_POSITIVE_REGULATION_OF_...745,SET,6,0.21492,0.0038845,0.33355,0.25968,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS,0.937382969928697
REACTOME_EARLY_SARS_COV_2_IN...,SET,34,0.092535,0.0039783,0.14362,0.25969,REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS,0.937382969928697
HP_APLASIA_HYPOPLASIA_OF_THE...47,SET,4,0.31567,0.0046587,0.48998,0.25971,HP_APLASIA_HYPOPLASIA_OF_THE_NASAL_SEPTUM,0.937382969928697
GSE23502_BM_VS_COLON_TUMOR_H...1,SET,187,0.039608,0.0039768,0.061487,0.25974,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,0.937382969928697
GOBP_ENDOCARDIUM_MORPHOGENES...,SET,6,0.26106,0.0047184,0.4053,0.25976,GOBP_ENDOCARDIUM_MORPHOGENESIS,0.937382969928697
GSE18893_CTRL_VS_TNF_TREATED...5,SET,171,0.040267,0.0038678,0.062519,0.25977,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN,0.937382969928697
GOCC_SMN_SM_PROTEIN_COMPLEX,SET,13,0.1318,0.0035057,0.20465,0.25979,GOCC_SMN_SM_PROTEIN_COMPLEX,0.937382969928697
HP_PSORIASIFORM_DERMATITIS,SET,28,0.11373,0.0044378,0.17664,0.25984,HP_PSORIASIFORM_DERMATITIS,0.937382969928697
MIR1912_3P,SET,80,0.05989,0.0039446,0.093033,0.25987,MIR1912_3P,0.937382969928697
REACTOME_SYNTHESIS_OF_PROSTA...,SET,14,0.13836,0.003819,0.21495,0.25989,REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX,0.937382969928697
MORF_BUB1B,SET,56,0.071992,0.0039698,0.11184,0.25989,MORF_BUB1B,0.937382969928697
FINETTI_BREAST_CANCERS_KINOM...2,SET,15,0.13655,0.0039013,0.21223,0.25998,FINETTI_BREAST_CANCERS_KINOME_GRAY,0.937382969928697
FAN_EMBRYONIC_CTX_IN_2_INTER...,SET,7,0.19887,0.0038823,0.30909,0.25998,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,0.937382969928697
REACTOME_G_ALPHA_Q_SIGNALLIN...,SET,203,0.040945,0.0042814,0.063648,0.26002,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,0.937382969928697
PANAPASA_BLOOD_FLUENZ_AGE_03...2,SET,9,0.19722,0.0043654,0.30659,0.26003,PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_6DY_7DY_UP,0.937382969928697
PLASARI_NFIC_TARGETS_BASAL_UP,SET,28,0.11659,0.0045493,0.18126,0.26005,PLASARI_NFIC_TARGETS_BASAL_UP,0.937382969928697
MIR10393_3P,SET,96,0.059277,0.004275,0.092161,0.26006,MIR10393_3P,0.937382969928697
MIR4714_5P,SET,93,0.056635,0.0040205,0.088056,0.26006,MIR4714_5P,0.937382969928697
HP_COMPENSATED_HYPOTHYROIDISM,SET,9,0.18182,0.0040244,0.28273,0.26009,HP_COMPENSATED_HYPOTHYROIDISM,0.937382969928697
REACTOME_BIOSYNTHESIS_OF_MAR...2,SET,6,0.20763,0.0037528,0.32289,0.2601,REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS,0.937382969928697
HP_COR_PULMONALE,SET,10,0.17295,0.004035,0.26897,0.26012,HP_COR_PULMONALE,0.937382969928697
KEGG_MEDICUS_PATHOGEN_HPV_E6...1,SET,12,0.16449,0.0042038,0.25586,0.26016,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380,0.937382969928697
REACTOME_INTERLEUKIN_18_SIGN...,SET,8,0.20769,0.0043343,0.32307,0.26016,REACTOME_INTERLEUKIN_18_SIGNALING,0.937382969928697
GOCC_9PLUS2_MOTILE_CILIUM,SET,158,0.043179,0.0039882,0.067182,0.26021,GOCC_9PLUS2_MOTILE_CILIUM,0.937382969928697
GOBP_FOREBRAIN_NEURON_DEVELO...,SET,21,0.12747,0.0043086,0.1984,0.26028,GOBP_FOREBRAIN_NEURON_DEVELOPMENT,0.937382969928697
MIR7153_5P,SET,103,0.052035,0.0038864,0.080999,0.2603,MIR7153_5P,0.937382969928697
HP_RIEGER_ANOMALY,SET,11,0.1824,0.0044631,0.28392,0.2603,HP_RIEGER_ANOMALY,0.937382969928697
WP_PHOTODYNAMIC_THERAPYINDUC...2,SET,34,0.093331,0.0040125,0.14528,0.26031,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,0.937382969928697
MIR1270,SET,72,0.064942,0.0040587,0.10109,0.26031,MIR1270,0.937382969928697
HP_ABNORMAL_ASCENDING_AORTA_...,SET,26,0.11574,0.0043524,0.18017,0.26031,HP_ABNORMAL_ASCENDING_AORTA_MORPHOLOGY,0.937382969928697
BRACHAT_RESPONSE_TO_METHOTRE...2,SET,18,0.11603,0.003631,0.18062,0.26032,BRACHAT_RESPONSE_TO_METHOTREXATE_UP,0.937382969928697
HP_ABNORMAL_BLOOD_POTASSIUM_...,SET,105,0.054972,0.0041452,0.08559,0.26035,HP_ABNORMAL_BLOOD_POTASSIUM_CONCENTRATION,0.937382969928697
GSE360_L_DONOVANI_VS_T_GONDI...4,SET,175,0.040924,0.0039762,0.063717,0.26035,GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP,0.937382969928697
GOMF_MONOATOMIC_CATION_CHANN...,SET,302,0.033499,0.0042607,0.052184,0.26046,GOMF_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.937382969928697
PTEN_DN.V1_DN,SET,151,0.046514,0.0042008,0.072462,0.26047,PTEN_DN.V1_DN,0.937382969928697
GOBP_SPLICEOSOMAL_SNRNP_ASSE...,SET,36,0.076481,0.0033832,0.11916,0.26049,GOBP_SPLICEOSOMAL_SNRNP_ASSEMBLY,0.937382969928697
GHANDHI_DIRECT_IRRADIATION_DN,SET,32,0.10561,0.0044049,0.16459,0.26056,GHANDHI_DIRECT_IRRADIATION_DN,0.937382969928697
GOMF_PHOSPHATIDYLSERINE_FLIP...,SET,4,0.25183,0.0037166,0.39249,0.26056,GOMF_PHOSPHATIDYLSERINE_FLIPPASE_ACTIVITY,0.937382969928697
MIR7704,SET,5,0.2571,0.0042421,0.40074,0.26058,MIR7704,0.937382969928697
GOMF_NUCLEAR_ESTROGEN_RECEPT...,SET,35,0.089808,0.0039173,0.14009,0.26073,GOMF_NUCLEAR_ESTROGEN_RECEPTOR_BINDING,0.937382969928697
GSE24026_PD1_LIGATION_VS_CTR...1,SET,182,0.039765,0.0039393,0.06204,0.26078,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN,0.937382969928697
GOBP_PITUITARY_GLAND_DEVELOP...,SET,39,0.096197,0.0044288,0.15011,0.26081,GOBP_PITUITARY_GLAND_DEVELOPMENT,0.937382969928697
HP_HEPATIC_BRIDGING_FIBROSIS,SET,9,0.18049,0.0039949,0.28165,0.26083,HP_HEPATIC_BRIDGING_FIBROSIS,0.937382969928697
GOBP_NEGATIVE_REGULATION_OF_...350,SET,21,0.12114,0.0040944,0.18908,0.26087,GOBP_NEGATIVE_REGULATION_OF_LIPID_STORAGE,0.937382969928697
HP_CORNEAL_STROMAL_EDEMA,SET,11,0.17942,0.0043903,0.28009,0.2609,HP_CORNEAL_STROMAL_EDEMA,0.937382969928697
REACTOME_PROCESSING_AND_ACTI...,SET,10,0.14819,0.0034574,0.23135,0.26092,REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO,0.937382969928697
GSE9509_10MIN_VS_30MIN_LPS_A...2,SET,162,0.041066,0.0038403,0.064112,0.26092,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.937382969928697
GOMF_STORE_OPERATED_CALCIUM_...,SET,9,0.19253,0.0042616,0.30059,0.26093,GOMF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,0.937382969928697
E2F1DP1_01,SET,209,0.036824,0.0039063,0.057496,0.26094,E2F1DP1_01,0.937382969928697
E2F1DP2_01,SET,209,0.036824,0.0039063,0.057496,0.26094,E2F1DP2_01,0.937382969928697
E2F4DP2_01,SET,209,0.036824,0.0039063,0.057496,0.26094,E2F4DP2_01,0.937382969928697
E2F_02,SET,209,0.036824,0.0039063,0.057496,0.26094,E2F_02,0.937382969928697
HP_SHOULDER_PAIN,SET,6,0.26302,0.0047539,0.4107,0.26095,HP_SHOULDER_PAIN,0.937382969928697
GOBP_REGULATION_OF_NERVOUS_S...1,SET,417,0.027706,0.0041277,0.043263,0.26096,GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.937382969928697
GSE41867_LCMV_ARMSTRONG_VS_C...5,SET,178,0.0389,0.0038115,0.060743,0.26096,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN,0.937382969928697
HP_DELAYED_PUBERTY,SET,177,0.040196,0.0039275,0.06277,0.26097,HP_DELAYED_PUBERTY,0.937382969928697
HP_PENOSCROTAL_HYPOSPADIAS,SET,8,0.19667,0.0041042,0.30716,0.261,HP_PENOSCROTAL_HYPOSPADIAS,0.937382969928697
GSE360_CTRL_VS_L_MAJOR_DC_DN,SET,181,0.041898,0.0041394,0.065436,0.261,GSE360_CTRL_VS_L_MAJOR_DC_DN,0.937382969928697
GOBP_CELLULAR_RESPONSE_TO_LI...1,SET,106,0.050205,0.0038036,0.078431,0.26105,GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS,0.937440629197231
WP_FTO_OBESITY_VARIANT_MECHA...,SET,8,0.20125,0.0041999,0.31442,0.26107,WP_FTO_OBESITY_VARIANT_MECHANISM,0.937440629197231
GAVISH_3CA_MALIGNANT_METAPRO...25,SET,42,0.085131,0.0040669,0.13306,0.26116,GAVISH_3CA_MALIGNANT_METAPROGRAM_33_RBCS,0.937616814707705
E2F_Q6_01,SET,206,0.036901,0.0038867,0.057688,0.2612,E2F_Q6_01,0.937616814707705
GNF2_MSH2,SET,26,0.09701,0.0036479,0.15166,0.2612,GNF2_MSH2,0.937616814707705
HP_ASTROCYTOMA,SET,22,0.10679,0.0036944,0.16699,0.26124,HP_ASTROCYTOMA,0.937638506815366
GOBP_REGULATION_OF_VASCULAR_...6,SET,9,0.17085,0.0037817,0.26717,0.26126,GOBP_REGULATION_OF_VASCULAR_WOUND_HEALING,0.937638506815366
GOBP_REGULATION_OF_MEIOTIC_C...1,SET,63,0.065326,0.00382,0.10221,0.26137,GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.937683312731768
MIR4463,SET,75,0.061279,0.0039085,0.095885,0.26139,MIR4463,0.937683312731768
KEGG_MEDICUS_REFERENCE_CYTOK...,SET,42,0.091723,0.0043819,0.14356,0.26145,KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY,0.937683312731768
MIR4717_5P,SET,94,0.054349,0.0038787,0.085084,0.26149,MIR4717_5P,0.937683312731768
HIF1_Q5,SET,227,0.036126,0.0039919,0.056556,0.26149,HIF1_Q5,0.937683312731768
GOCC_INTERCELLULAR_BRIDGE,SET,83,0.056806,0.0038107,0.088928,0.26149,GOCC_INTERCELLULAR_BRIDGE,0.937683312731768
GOBP_REGULATION_OF_3_UTR_MED...,SET,5,0.26645,0.0043964,0.41724,0.26155,GOBP_REGULATION_OF_3_UTR_MEDIATED_MRNA_STABILIZATION,0.937683312731768
MIR4322,SET,35,0.09952,0.0043409,0.1559,0.26162,MIR4322,0.937683312731768
GOBP_LEUKOCYTE_MIGRATION,SET,369,0.030471,0.0042761,0.047738,0.26164,GOBP_LEUKOCYTE_MIGRATION,0.937683312731768
GOMF_INOSITOL_TETRAKISPHOSPH...1,SET,5,0.25958,0.004283,0.40667,0.26164,GOMF_INOSITOL_TETRAKISPHOSPHATE_KINASE_ACTIVITY,0.937683312731768
MIR5691_MIR6805_3P,SET,144,0.046371,0.0040904,0.072681,0.26174,MIR5691_MIR6805_3P,0.937683312731768
GOBP_NEGATIVE_REGULATION_OF_...302,SET,17,0.14772,0.0044928,0.23154,0.26174,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,0.937683312731768
PBRM1_TARGET_GENES,SET,5,0.28481,0.0046993,0.44648,0.26177,PBRM1_TARGET_GENES,0.937683312731768
GSE29614_CTRL_VS_DAY7_TIV_FL...1,SET,159,0.04265,0.0039517,0.066863,0.26178,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,0.937683312731768
REACTOME_REGULATION_OF_BACH1...,SET,10,0.1698,0.0039617,0.26627,0.26183,REACTOME_REGULATION_OF_BACH1_ACTIVITY,0.937683312731768
GOBP_PEPTIDYL_SERINE_MODIFIC...,SET,256,0.033704,0.0039519,0.052851,0.26183,GOBP_PEPTIDYL_SERINE_MODIFICATION,0.937683312731768
GOBP_CALCIUM_ION_TRANSMEMBRA...1,SET,172,0.043226,0.004164,0.067786,0.26185,GOBP_CALCIUM_ION_TRANSMEMBRANE_IMPORT_INTO_CYTOSOL,0.937683312731768
HP_REDUCED_FORCED_VITAL_CAPA...,SET,34,0.086545,0.0037207,0.13573,0.26187,HP_REDUCED_FORCED_VITAL_CAPACITY,0.937683312731768
GSE8685_IL2_ACT_IL2_STARVED_...1,SET,181,0.039412,0.0038937,0.061814,0.26188,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,0.937683312731768
GSE360_L_MAJOR_VS_M_TUBERCUL...4,SET,172,0.042526,0.0040966,0.066704,0.26189,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP,0.937683312731768
GSE28726_ACT_CD4_TCELL_VS_AC...4,SET,183,0.038332,0.0038077,0.060127,0.2619,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP,0.937683312731768
GOMF_SOLUTE_MONOATOMIC_CATIO...,SET,114,0.052218,0.0041018,0.081912,0.26191,GOMF_SOLUTE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.937683312731768
GSE32255_WT_VS_JMJD2D_KNOCKD...2,SET,129,0.047886,0.0039996,0.075116,0.26191,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,0.937683312731768
KRIEG_HYPOXIA_NOT_VIA_KDM3A,SET,663,0.021585,0.004027,0.033862,0.26192,KRIEG_HYPOXIA_NOT_VIA_KDM3A,0.937683312731768
MODULE_52,SET,392,0.028271,0.0040865,0.044365,0.26199,MODULE_52,0.937751529193698
MIR938,SET,69,0.059544,0.0036433,0.093444,0.262,MIR938,0.937751529193698
GOBP_NUCLEAR_CHROMOSOME_SEGR...,SET,293,0.030145,0.0037775,0.047312,0.26202,GOBP_NUCLEAR_CHROMOSOME_SEGREGATION,0.937751529193698
WP_STEROID_BIOSYNTHESIS,SET,10,0.17644,0.0041166,0.27702,0.26209,WP_STEROID_BIOSYNTHESIS,0.937756208881579
GSE22432_MULTIPOTENT_PROGENI...2,SET,183,0.039832,0.0039567,0.062539,0.2621,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP,0.937756208881579
SERVITJA_ISLET_HNF1A_TARGETS...1,SET,100,0.05588,0.0041127,0.087749,0.26212,SERVITJA_ISLET_HNF1A_TARGETS_DN,0.937756208881579
HP_EXCESSIVE_SALIVATION,SET,106,0.053022,0.004017,0.083267,0.26214,HP_EXCESSIVE_SALIVATION,0.937756208881579
GOBP_REGULATION_OF_CENTROMER...2,SET,4,0.27974,0.0041285,0.43943,0.2622,GOBP_REGULATION_OF_CENTROMERIC_SISTER_CHROMATID_COHESION,0.937756208881579
PID_UPA_UPAR_PATHWAY,SET,42,0.090067,0.0043027,0.14149,0.26222,PID_UPA_UPAR_PATHWAY,0.937756208881579
HP_ABNORMALITY_OF_THE_PULMON...1,SET,119,0.050458,0.004049,0.079298,0.26229,HP_ABNORMALITY_OF_THE_PULMONARY_ARTERY,0.937756208881579
GSE14308_INDUCED_VS_NATURAL_...2,SET,177,0.038389,0.0037509,0.060336,0.26231,GSE14308_INDUCED_VS_NATURAL_TREG_UP,0.937756208881579
MIR5590_5P,SET,106,0.051847,0.003928,0.081505,0.26235,MIR5590_5P,0.937756208881579
MIR4485_5P,SET,7,0.20998,0.0040992,0.33011,0.26236,MIR4485_5P,0.937756208881579
PID_HIF1A_PATHWAY,SET,15,0.12119,0.0034625,0.19054,0.26238,PID_HIF1A_PATHWAY,0.937756208881579
GOBP_REGULATION_OF_CELL_MORP...,SET,222,0.036257,0.0039626,0.057005,0.26238,GOBP_REGULATION_OF_CELL_MORPHOGENESIS,0.937756208881579
SHI_SPARC_TARGETS_UP,SET,24,0.11266,0.0040705,0.17715,0.2624,SHI_SPARC_TARGETS_UP,0.937756208881579
WP_HYPOTHESIZED_PATHWAYS_IN_...,SET,23,0.11647,0.0041195,0.18315,0.26242,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,0.937756208881579
DESCARTES_FETAL_PANCREAS_ERY...,SET,107,0.05215,0.0039695,0.082026,0.26247,DESCARTES_FETAL_PANCREAS_ERYTHROBLASTS,0.937756208881579
GOCC_TRANS_GOLGI_NETWORK_MEM...,SET,95,0.05481,0.0039323,0.086217,0.26248,GOCC_TRANS_GOLGI_NETWORK_MEMBRANE,0.937756208881579
GOMF_VOLTAGE_GATED_CALCIUM_C...2,SET,5,0.26788,0.0044199,0.42137,0.26248,GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.937756208881579
RBM17_TARGET_GENES,SET,5,0.21919,0.0036165,0.34491,0.26256,RBM17_TARGET_GENES,0.937757498974148
REACTOME_ISG15_ANTIVIRAL_MEC...,SET,70,0.060385,0.0037213,0.095034,0.26259,REACTOME_ISG15_ANTIVIRAL_MECHANISM,0.937757498974148
BAELDE_DIABETIC_NEPHROPATHY_...2,SET,82,0.061726,0.0041158,0.097157,0.26261,BAELDE_DIABETIC_NEPHROPATHY_UP,0.937757498974148
HP_ABNORMAL_SERUM_BICARBONAT...,SET,5,0.24125,0.0039806,0.37983,0.26267,HP_ABNORMAL_SERUM_BICARBONATE_CONCENTRATION,0.937757498974148
GOBP_NEGATIVE_REGULATION_OF_...161,SET,263,0.034137,0.0040562,0.05375,0.26268,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION,0.937757498974148
GOBP_POSITIVE_REGULATION_OF_...254,SET,15,0.11709,0.0033453,0.18437,0.2627,GOBP_POSITIVE_REGULATION_OF_ERAD_PATHWAY,0.937757498974148
HP_RIGHT_BUNDLE_BRANCH_BLOCK,SET,50,0.075982,0.0039596,0.11965,0.26271,HP_RIGHT_BUNDLE_BRANCH_BLOCK,0.937757498974148
MIR4667_5P,SET,157,0.046038,0.0042389,0.072509,0.26274,MIR4667_5P,0.937757498974148
GOMF_LONG_CHAIN_FATTY_ACID_B...,SET,16,0.12423,0.0036657,0.19567,0.26274,GOMF_LONG_CHAIN_FATTY_ACID_BINDING,0.937757498974148
GOBP_CYCLIC_NUCLEOTIDE_TRANS...,SET,11,0.17888,0.004377,0.28176,0.26276,GOBP_CYCLIC_NUCLEOTIDE_TRANSPORT,0.937757498974148
GOBP_EMBRYONIC_VISCEROCRANIU...,SET,9,0.18541,0.004104,0.29207,0.26278,GOBP_EMBRYONIC_VISCEROCRANIUM_MORPHOGENESIS,0.937757498974148
KEGG_MEDICUS_REFERENCE_PLASM...,SET,8,0.19977,0.0041689,0.31482,0.26287,KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA,0.937757498974148
GSE21063_CTRL_VS_ANTI_IGM_ST...5,SET,178,0.040117,0.0039307,0.063227,0.26288,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_DN,0.937757498974148
MIR548AS_3P,SET,241,0.034185,0.0038907,0.053879,0.26289,MIR548AS_3P,0.937757498974148
GOBP_REELIN_MEDIATED_SIGNALI...,SET,8,0.18827,0.003929,0.29673,0.26289,GOBP_REELIN_MEDIATED_SIGNALING_PATHWAY,0.937757498974148
SATO_SILENCED_BY_METHYLATION...2,SET,41,0.089272,0.0042138,0.14075,0.26296,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,0.937757498974148
SYATTGTG_UNKNOWN,SET,204,0.038751,0.0040619,0.061103,0.26298,SYATTGTG_UNKNOWN,0.937757498974148
GOBP_BONE_MINERALIZATION,SET,113,0.053224,0.0041625,0.083935,0.26301,GOBP_BONE_MINERALIZATION,0.937757498974148
HP_OPTIC_DISC_COLOBOMA,SET,24,0.10159,0.0036704,0.16021,0.26302,HP_OPTIC_DISC_COLOBOMA,0.937757498974148
GSE37301_CD4_TCELL_VS_GRANUL...2,SET,148,0.045447,0.0040637,0.071673,0.26302,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.937757498974148
GOCC_ROUGH_ENDOPLASMIC_RETIC...2,SET,20,0.11994,0.0039564,0.1892,0.26306,GOCC_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,0.937803908093138
GOBP_RESPONSE_TO_KETONE,SET,201,0.039612,0.0041218,0.06251,0.26314,GOBP_RESPONSE_TO_KETONE,0.93794785254116
GOBP_NEUTROPHIL_MEDIATED_CYT...,SET,15,0.15497,0.0044276,0.24458,0.26317,GOBP_NEUTROPHIL_MEDIATED_CYTOTOXICITY,0.93794785254116
REACTOME_NUCLEOTIDE_CATABOLI...,SET,35,0.093001,0.0040566,0.14681,0.26321,REACTOME_NUCLEOTIDE_CATABOLISM,0.93794785254116
KEGG_AMYOTROPHIC_LATERAL_SCL...,SET,52,0.072085,0.0038307,0.11382,0.26326,KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,0.93794785254116
GOBP_REGULATION_OF_ALCOHOL_B...,SET,44,0.083186,0.0040673,0.13135,0.26328,GOBP_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.93794785254116
GOBP_RETINOIC_ACID_METABOLIC...,SET,33,0.10806,0.0045772,0.17064,0.26328,GOBP_RETINOIC_ACID_METABOLIC_PROCESS,0.93794785254116
KASLER_HDAC7_TARGETS_1_DN,SET,16,0.13987,0.0041271,0.22092,0.26333,KASLER_HDAC7_TARGETS_1_DN,0.93794785254116
HP_APLASIA_HYPOPLASIA_OF_THE...5,SET,3,0.36801,0.0047036,0.58148,0.26341,HP_APLASIA_HYPOPLASIA_OF_THE_3RD_METACARPAL,0.93794785254116
GSE10325_LUPUS_CD4_TCELL_VS_...4,SET,172,0.041472,0.0039951,0.06554,0.26344,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP,0.93794785254116
GSE2770_UNTREATED_VS_IL4_TRE...1,SET,179,0.037167,0.0036518,0.058755,0.26351,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.93794785254116
HP_MYELOPROLIFERATIVE_DISORD...,SET,15,0.14462,0.004132,0.22864,0.26352,HP_MYELOPROLIFERATIVE_DISORDER,0.93794785254116
DESCARTES_FETAL_PANCREAS_MES...,SET,63,0.07069,0.0041337,0.11178,0.26356,DESCARTES_FETAL_PANCREAS_MESOTHELIAL_CELLS,0.93794785254116
HOEK_T_CELL_2011_2012_TIV_AD...3,SET,8,0.22031,0.0045976,0.34838,0.26358,HOEK_T_CELL_2011_2012_TIV_ADULT_3DY_DN,0.93794785254116
GSE15659_CD45RA_NEG_CD4_TCEL...3,SET,172,0.039891,0.0038428,0.063087,0.26359,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,0.93794785254116
HP_ABNORMAL_ACTIVITY_OF_MITO...,SET,125,0.042532,0.0034973,0.067269,0.26361,HP_ABNORMAL_ACTIVITY_OF_MITOCHONDRIAL_RESPIRATORY_CHAIN,0.93794785254116
MIR4793_5P,SET,58,0.070122,0.0039349,0.11091,0.26362,MIR4793_5P,0.93794785254116
GOBP_REGULATION_OF_ESTABLISH...2,SET,488,0.024172,0.0038879,0.038238,0.26365,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.93794785254116
REACTOME_THYROXINE_BIOSYNTHE...,SET,10,0.18658,0.0043531,0.29524,0.26371,REACTOME_THYROXINE_BIOSYNTHESIS,0.93794785254116
REACTOME_REGULATION_OF_PYRUV...1,SET,12,0.1645,0.004204,0.26032,0.26373,REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX,0.93794785254116
HP_WEAKNESS_OF_FACIAL_MUSCUL...,SET,210,0.036315,0.0038615,0.057472,0.26374,HP_WEAKNESS_OF_FACIAL_MUSCULATURE,0.93794785254116
GOMF_PEROXISOME_PROLIFERATOR...,SET,10,0.20294,0.0047348,0.32122,0.26377,GOMF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING,0.93794785254116
FUJIWARA_PARK2_HEPATOCYTE_PR...1,SET,7,0.22594,0.0044108,0.35771,0.26382,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN,0.93794785254116
GENTLES_LEUKEMIC_STEM_CELL_UP,SET,28,0.11241,0.0043862,0.17797,0.26383,GENTLES_LEUKEMIC_STEM_CELL_UP,0.93794785254116
GOBP_REGULATION_OF_AMPA_RECE...,SET,19,0.12893,0.0041453,0.20413,0.26383,GOBP_REGULATION_OF_AMPA_RECEPTOR_ACTIVITY,0.93794785254116
GOBP_NEGATIVE_REGULATION_OF_...367,SET,14,0.14948,0.004126,0.23668,0.26384,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_ACTIVATION,0.93794785254116
GOBP_REGULATION_OF_STEM_CELL...2,SET,10,0.17173,0.0040066,0.27195,0.26387,GOBP_REGULATION_OF_STEM_CELL_DIVISION,0.93794785254116
GSE24671_BAKIMULC_VS_SENDAI_...1,SET,173,0.037929,0.0036643,0.060067,0.26387,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,0.93794785254116
GOBP_NEURAL_PLATE_MORPHOGENE...,SET,4,0.26354,0.0038894,0.4174,0.2639,GOBP_NEURAL_PLATE_MORPHOGENESIS,0.93794785254116
HUNSBERGER_EXERCISE_REGULATE...,SET,28,0.10681,0.0041679,0.16918,0.26391,HUNSBERGER_EXERCISE_REGULATED_GENES,0.93794785254116
LU_AGING_BRAIN_DN,SET,139,0.045686,0.00396,0.072365,0.26391,LU_AGING_BRAIN_DN,0.93794785254116
GOBP_REGULATION_OF_ISOTYPE_S...2,SET,6,0.21109,0.0038153,0.33444,0.26396,GOBP_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGE_ISOTYPES,0.937967111245832
REACTOME_HORMONE_LIGAND_BIND...,SET,12,0.15701,0.0040126,0.24878,0.26399,REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS,0.937967111245832
BIOCARTA_IGF1R_PATHWAY,SET,23,0.1138,0.0040253,0.1804,0.26408,BIOCARTA_IGF1R_PATHWAY,0.937967111245832
HP_CUBITUS_VALGUS,SET,45,0.075973,0.0037565,0.12046,0.26413,HP_CUBITUS_VALGUS,0.937967111245832
chr6q24,SET,32,0.17351,0.0072371,0.27518,0.26418,chr6q24,0.937967111245832
FARMER_BREAST_CANCER_CLUSTER...3,SET,13,0.17227,0.0045822,0.27324,0.2642,FARMER_BREAST_CANCER_CLUSTER_3,0.937967111245832
LI_ESTROGENE_T47D_E2_RESPONS...1,SET,33,0.10293,0.0043599,0.16331,0.26425,LI_ESTROGENE_T47D_E2_RESPONSE_DN,0.937967111245832
GOBP_CALCIUM_MEDIATED_SIGNAL...,SET,214,0.038187,0.0040986,0.060586,0.26425,GOBP_CALCIUM_MEDIATED_SIGNALING,0.937967111245832
GSE21546_WT_VS_ELK1_KO_DP_TH...2,SET,183,0.038516,0.003826,0.061118,0.26429,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP,0.937967111245832
GOMF_GALACTOSYLTRANSFERASE_A...,SET,32,0.10176,0.0042444,0.16154,0.26437,GOMF_GALACTOSYLTRANSFERASE_ACTIVITY,0.937967111245832
REACTOME_O_LINKED_GLYCOSYLAT...1,SET,100,0.057762,0.0042512,0.09171,0.26441,REACTOME_O_LINKED_GLYCOSYLATION,0.937967111245832
MIR876_3P,SET,80,0.06173,0.0040658,0.09805,0.26449,MIR876_3P,0.937967111245832
KAAB_FAILED_HEART_VENTRICLE_...,SET,37,0.087455,0.0039219,0.13892,0.2645,KAAB_FAILED_HEART_VENTRICLE_DN,0.937967111245832
WP_PRION_DISEASE_PATHWAY,SET,31,0.097781,0.0040144,0.15535,0.26454,WP_PRION_DISEASE_PATHWAY,0.937967111245832
HP_IMPAIRED_DISTAL_PROPRIOCE...,SET,16,0.12093,0.0035683,0.19215,0.26456,HP_IMPAIRED_DISTAL_PROPRIOCEPTION,0.937967111245832
MIKHAYLOVA_OXIDATIVE_STRESS_...2,SET,6,0.20257,0.0036613,0.3219,0.26458,MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP,0.937967111245832
GOBP_GLIAL_CELL_FATE_COMMITM...,SET,13,0.17063,0.0045386,0.27116,0.2646,GOBP_GLIAL_CELL_FATE_COMMITMENT,0.937967111245832
MIR6895_5P,SET,38,0.088368,0.0040159,0.14046,0.26464,MIR6895_5P,0.937967111245832
HP_BROAD_FOOT,SET,26,0.10673,0.0040133,0.16967,0.26467,HP_BROAD_FOOT,0.937967111245832
HP_ABNORMAL_RENAL_MEDULLA_MO...,SET,57,0.068061,0.0037863,0.1082,0.26468,HP_ABNORMAL_RENAL_MEDULLA_MORPHOLOGY,0.937967111245832
HP_ABNORMALITY_OF_THE_ABDOMI...2,SET,467,0.024796,0.003904,0.039438,0.26476,HP_ABNORMALITY_OF_THE_ABDOMINAL_WALL,0.937967111245832
GSE10147_IL3_VS_IL3_AND_CPG_...1,SET,147,0.042186,0.0037596,0.067103,0.26478,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN,0.937967111245832
TIEN_INTESTINE_PROBIOTICS_24...2,SET,514,0.02248,0.0037082,0.035763,0.26482,TIEN_INTESTINE_PROBIOTICS_24HR_UP,0.937967111245832
GOBP_RESPONSE_TO_ALDOSTERONE,SET,17,0.13284,0.0040401,0.21133,0.26482,GOBP_RESPONSE_TO_ALDOSTERONE,0.937967111245832
HP_ABNORMAL_NASOLABIAL_REGIO...,SET,17,0.12621,0.0038386,0.2008,0.26482,HP_ABNORMAL_NASOLABIAL_REGION_MORPHOLOGY,0.937967111245832
WP_ATM_SIGNALING_IN_DEVELOPM...,SET,43,0.073956,0.0035748,0.11769,0.26488,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,0.937967111245832
GOBP_CD4_POSITIVE_OR_CD8_POS...,SET,29,0.11003,0.0043693,0.17513,0.26492,GOBP_CD4_POSITIVE_OR_CD8_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT,0.937967111245832
GSE36888_UNTREATED_VS_IL2_TR...12,SET,167,0.042568,0.0040412,0.06779,0.26503,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_UP,0.937967111245832
KEGG_MEDICUS_VARIANT_MUTATIO...56,SET,24,0.10897,0.0039371,0.17355,0.26504,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.937967111245832
GOBP_NEGATIVE_REGULATION_OF_...151,SET,44,0.076375,0.0037343,0.12164,0.26505,GOBP_NEGATIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS,0.937967111245832
MIR4511,SET,139,0.04548,0.0039421,0.072444,0.26507,MIR4511,0.937967111245832
MIR563,SET,30,0.1008,0.0040711,0.16056,0.26507,MIR563,0.937967111245832
GOMF_PROTEIN_TYROSINE_KINASE...2,SET,140,0.047913,0.0041678,0.076317,0.26507,GOMF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.937967111245832
GOBP_ALKALOID_METABOLIC_PROC...,SET,7,0.18456,0.003603,0.29402,0.26509,GOBP_ALKALOID_METABOLIC_PROCESS,0.937967111245832
HP_ABNORMAL_TOE_MORPHOLOGY,SET,627,0.021603,0.0039234,0.034414,0.26509,HP_ABNORMAL_TOE_MORPHOLOGY,0.937967111245832
GSE36888_UNTREATED_VS_IL2_TR...9,SET,162,0.042783,0.0040009,0.068161,0.26511,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_DN,0.937967111245832
MIR1343_3P,SET,144,0.044331,0.0039105,0.07063,0.26512,MIR1343_3P,0.937967111245832
WP_ESTROGEN_SIGNALING,SET,21,0.11431,0.0038637,0.18213,0.26513,WP_ESTROGEN_SIGNALING,0.937967111245832
HP_ABSENT_TOENAIL,SET,17,0.12688,0.0038588,0.20217,0.26515,HP_ABSENT_TOENAIL,0.937967111245832
GOBP_REGULATION_OF_LIPID_STO...,SET,49,0.079504,0.0041016,0.12671,0.26518,GOBP_REGULATION_OF_LIPID_STORAGE,0.937967111245832
GOBP_DNA_CYTOSINE_DEAMINATION,SET,8,0.26935,0.0056211,0.42928,0.26519,GOBP_DNA_CYTOSINE_DEAMINATION,0.937967111245832
HONMA_DOCETAXEL_RESISTANCE,SET,32,0.1012,0.0042212,0.16136,0.26527,HONMA_DOCETAXEL_RESISTANCE,0.937967111245832
GOMF_MOLECULAR_SEQUESTERING_...,SET,41,0.083159,0.0039252,0.13261,0.2653,GOMF_MOLECULAR_SEQUESTERING_ACTIVITY,0.937967111245832
HP_GENERALIZED_HYPOPIGMENTAT...2,SET,45,0.079629,0.0039373,0.12699,0.26531,HP_GENERALIZED_HYPOPIGMENTATION_OF_HAIR,0.937967111245832
GOBP_MRNA_PSEUDOURIDINE_SYNT...,SET,8,0.1575,0.0032869,0.2512,0.26534,GOBP_MRNA_PSEUDOURIDINE_SYNTHESIS,0.937967111245832
KHETCHOUMIAN_TRIM24_TARGETS_...2,SET,44,0.083305,0.0040731,0.13287,0.26535,KHETCHOUMIAN_TRIM24_TARGETS_UP,0.937967111245832
BIOCARTA_RANMS_PATHWAY,SET,10,0.15806,0.0036878,0.25211,0.26535,BIOCARTA_RANMS_PATHWAY,0.937967111245832
REACTOME_ENOS_ACTIVATION,SET,10,0.17173,0.0040067,0.27396,0.26538,REACTOME_ENOS_ACTIVATION,0.937967111245832
HP_RECTAL_ABSCESS,SET,7,0.23756,0.0046375,0.37897,0.26538,HP_RECTAL_ABSCESS,0.937967111245832
DAVICIONI_RHABDOMYOSARCOMA_P...2,SET,56,0.074808,0.0041251,0.11936,0.26542,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,0.937967111245832
KEGG_PATHOGENIC_ESCHERICHIA_...,SET,53,0.069451,0.003726,0.11082,0.26544,KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,0.937967111245832
WP_PATHOGENIC_ESCHERICHIA_CO...,SET,53,0.069451,0.003726,0.11082,0.26544,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,0.937967111245832
MODULE_439,SET,20,0.11493,0.0037911,0.18342,0.26547,MODULE_439,0.937967111245832
GSE21927_SPLEEN_C57BL6_VS_4T...2,SET,182,0.036897,0.0036552,0.058902,0.26553,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP,0.937967111245832
GOMF_ACETYLATION_DEPENDENT_P...,SET,25,0.10328,0.0038082,0.16488,0.26554,GOMF_ACETYLATION_DEPENDENT_PROTEIN_BINDING,0.937967111245832
MIR188_3P,SET,139,0.044096,0.0038221,0.070405,0.26556,MIR188_3P,0.937967111245832
ZHANG_GATA6_TARGETS_DN,SET,61,0.069378,0.0039922,0.11081,0.26564,ZHANG_GATA6_TARGETS_DN,0.937967111245832
REACTOME_REGULATION_OF_PTEN_...2,SET,7,0.23559,0.0045992,0.37639,0.26568,REACTOME_REGULATION_OF_PTEN_LOCALIZATION,0.937967111245832
MIR6821_3P,SET,47,0.073024,0.0036899,0.11666,0.26568,MIR6821_3P,0.937967111245832
GSE339_EX_VIVO_VS_IN_CULTURE...1,SET,180,0.038627,0.0038057,0.06171,0.26568,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN,0.937967111245832
GOBP_CERAMIDE_CATABOLIC_PROC...,SET,20,0.12722,0.0041964,0.20325,0.26569,GOBP_CERAMIDE_CATABOLIC_PROCESS,0.937967111245832
HP_ABNORMALITY_OF_THE_AXILLA...,SET,51,0.07834,0.004123,0.12516,0.26569,HP_ABNORMALITY_OF_THE_AXILLARY_HAIR,0.937967111245832
HP_NARROW_JAW,SET,13,0.13843,0.0036821,0.2212,0.26572,HP_NARROW_JAW,0.937967111245832
KEGG_RIBOFLAVIN_METABOLISM,SET,13,0.14405,0.0038317,0.23021,0.26574,KEGG_RIBOFLAVIN_METABOLISM,0.937967111245832
MULLIGHAN_MLL_SIGNATURE_1_UP,SET,353,0.027725,0.0038071,0.04432,0.2658,MULLIGHAN_MLL_SIGNATURE_1_UP,0.937967111245832
WEST_ADRENOCORTICAL_TUMOR_DN,SET,479,0.024491,0.0039038,0.039155,0.26583,WEST_ADRENOCORTICAL_TUMOR_DN,0.937967111245832
HP_DYSDIADOCHOKINESIS,SET,49,0.070392,0.0036315,0.11255,0.26584,HP_DYSDIADOCHOKINESIS,0.937967111245832
P53_DECAMER_Q2,SET,233,0.034284,0.0038375,0.054822,0.26586,P53_DECAMER_Q2,0.937967111245832
GOBP_DEVELOPMENT_OF_PRIMARY_...1,SET,101,0.055144,0.0040786,0.088179,0.26587,GOBP_DEVELOPMENT_OF_PRIMARY_FEMALE_SEXUAL_CHARACTERISTICS,0.937967111245832
CAR_MLANA,SET,40,0.079394,0.0037017,0.12698,0.26591,CAR_MLANA,0.937967111245832
REACTOME_MET_RECEPTOR_ACTIVA...,SET,6,0.22584,0.0040818,0.36122,0.26592,REACTOME_MET_RECEPTOR_ACTIVATION,0.937967111245832
DELACROIX_RARG_BOUND_MEF,SET,345,0.029558,0.0040134,0.047281,0.26594,DELACROIX_RARG_BOUND_MEF,0.937967111245832
GOBP_RELAXATION_OF_SMOOTH_MU...,SET,6,0.22645,0.0040928,0.36227,0.26597,GOBP_RELAXATION_OF_SMOOTH_MUSCLE,0.937967111245832
GGCCAGT_MIR193A_MIR193B,SET,84,0.053693,0.0036234,0.085946,0.26608,GGCCAGT_MIR193A_MIR193B,0.937967111245832
REACTOME_RECYCLING_OF_BILE_A...,SET,18,0.12806,0.0040076,0.20504,0.26614,REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS,0.937967111245832
HP_ABNORMALITY_OF_CORNEAL_SI...,SET,145,0.044463,0.0039356,0.071193,0.26614,HP_ABNORMALITY_OF_CORNEAL_SIZE,0.937967111245832
HP_BROAD_HALLUX_PHALANX,SET,19,0.12932,0.0041578,0.20707,0.26615,HP_BROAD_HALLUX_PHALANX,0.937967111245832
MODULE_171,SET,122,0.04949,0.0040207,0.079263,0.26619,MODULE_171,0.937967111245832
GSE3982_NEUTROPHIL_VS_NKCELL...1,SET,176,0.037318,0.003636,0.059765,0.26619,GSE3982_NEUTROPHIL_VS_NKCELL_DN,0.937967111245832
GOMF_SYNTAXIN_BINDING,SET,59,0.065547,0.0037096,0.10502,0.26626,GOMF_SYNTAXIN_BINDING,0.937967111245832
GSE1432_CTRL_VS_IFNG_24H_MIC...2,SET,186,0.038679,0.0038732,0.061968,0.26626,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.937967111245832
GOBP_GLYOXYLATE_METABOLIC_PR...,SET,8,0.20169,0.0042091,0.32317,0.26629,GOBP_GLYOXYLATE_METABOLIC_PROCESS,0.937967111245832
GOBP_REGULATION_OF_POSITIVE_...,SET,25,0.11714,0.0043196,0.1877,0.26629,GOBP_REGULATION_OF_POSITIVE_CHEMOTAXIS,0.937967111245832
GOBP_NEURON_PROJECTION_GUIDA...,SET,217,0.038863,0.0041998,0.062276,0.26631,GOBP_NEURON_PROJECTION_GUIDANCE,0.937967111245832
HP_SPHEROCYTOSIS,SET,8,0.19592,0.0040886,0.31397,0.26632,HP_SPHEROCYTOSIS,0.937967111245832
BRUNEAU_SEPTATION_ATRIAL,SET,5,0.2629,0.0043377,0.42141,0.26637,BRUNEAU_SEPTATION_ATRIAL,0.937967111245832
TONKS_TARGETS_OF_RUNX1_RUNX1...13,SET,21,0.1243,0.0042013,0.19929,0.26641,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,0.937967111245832
MIR3915,SET,197,0.036638,0.0037746,0.058751,0.26645,MIR3915,0.937967111245832
GOBP_NEGATIVE_REGULATION_OF_...174,SET,9,0.192,0.0042499,0.30791,0.26646,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_APOPTOTIC_PROCESS,0.937967111245832
MIR877_3P,SET,174,0.040297,0.0039042,0.064627,0.26647,MIR877_3P,0.937967111245832
GOBP_REGULATION_OF_GLUCOCORT...4,SET,10,0.16793,0.003918,0.26933,0.26647,GOBP_REGULATION_OF_GLUCOCORTICOID_SECRETION,0.937967111245832
GOCC_DNA_REPLICATION_FACTOR_...1,SET,12,0.13675,0.0034949,0.21935,0.2665,GOCC_DNA_REPLICATION_FACTOR_A_COMPLEX,0.937967111245832
GSE17721_LPS_VS_GARDIQUIMOD_...12,SET,183,0.041063,0.004079,0.065869,0.26651,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_UP,0.937967111245832
REACTOME_RHOBTB3_ATPASE_CYCLE,SET,8,0.1795,0.0037459,0.28797,0.26654,REACTOME_RHOBTB3_ATPASE_CYCLE,0.937967111245832
GOBP_LEUKOCYTE_APOPTOTIC_PRO...,SET,111,0.050736,0.0039329,0.081397,0.26654,GOBP_LEUKOCYTE_APOPTOTIC_PROCESS,0.937967111245832
HP_MICROGRAPHIA,SET,13,0.15114,0.0040201,0.24247,0.26654,HP_MICROGRAPHIA,0.937967111245832
HP_PAINLESS_FRACTURES_DUE_TO...,SET,7,0.18512,0.0036138,0.2971,0.26662,HP_PAINLESS_FRACTURES_DUE_TO_INJURY,0.937967111245832
HP_SPORADIC,SET,86,0.058423,0.003989,0.093778,0.26665,HP_SPORADIC,0.937967111245832
MIR3916,SET,202,0.036246,0.0037808,0.058185,0.26667,MIR3916,0.937967111245832
KEGG_MEDICUS_PATHOGEN_EBV_EB...6,SET,9,0.1682,0.0037231,0.27004,0.26669,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482,0.937967111245832
GOBP_BLOOD_COAGULATION_INTRI...,SET,6,0.25446,0.0045991,0.40852,0.26669,GOBP_BLOOD_COAGULATION_INTRINSIC_PATHWAY,0.937967111245832
GOBP_REGULATION_OF_COMPLEMEN...2,SET,3,0.34663,0.0044304,0.55655,0.2667,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY,0.937967111245832
BANP_TARGET_GENES,SET,612,0.020965,0.0037633,0.033668,0.26674,BANP_TARGET_GENES,0.937967111245832
KEGG_MEDICUS_VARIANT_TMPRSS2...,SET,7,0.17996,0.0035131,0.28905,0.26678,KEGG_MEDICUS_VARIANT_TMPRSS2_ERG_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.937967111245832
MODULE_238,SET,141,0.044687,0.0039009,0.071776,0.26678,MODULE_238,0.937967111245832
HP_EARLY_ONSET_OF_SEXUAL_MAT...,SET,150,0.044491,0.0040049,0.071482,0.26684,HP_EARLY_ONSET_OF_SEXUAL_MATURATION,0.937967111245832
GOCC_SARCOLEMMA,SET,136,0.047031,0.0040327,0.075565,0.26685,GOCC_SARCOLEMMA,0.937967111245832
GOBP_THYMIC_T_CELL_SELECTION,SET,24,0.11335,0.0040953,0.18215,0.26689,GOBP_THYMIC_T_CELL_SELECTION,0.937967111245832
GSE6674_ANTI_IGM_VS_PL2_3_ST...1,SET,176,0.038331,0.0037348,0.061603,0.2669,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN,0.937967111245832
GOBP_NEUROMUSCULAR_PROCESS_C...1,SET,50,0.079629,0.0041497,0.12799,0.26692,GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE,0.937967111245832
BIOCARTA_FREE_PATHWAY,SET,9,0.16007,0.0035431,0.2573,0.26694,BIOCARTA_FREE_PATHWAY,0.937967111245832
NFXL1_TARGET_GENES,SET,340,0.028897,0.0038957,0.046454,0.26696,NFXL1_TARGET_GENES,0.937967111245832
HP_BROAD_THUMB,SET,75,0.060949,0.0038874,0.097998,0.26699,HP_BROAD_THUMB,0.937967111245832
KEGG_MEDICUS_REFERENCE_DNA_R...1,SET,24,0.10139,0.0036634,0.16303,0.267,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_LICENSING,0.937967111245832
GSE37301_LYMPHOID_PRIMED_MPP...2,SET,167,0.039854,0.0037835,0.064101,0.26706,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP,0.937967111245832
CHAF1A_TARGET_GENES,SET,79,0.060419,0.0039546,0.097184,0.26707,CHAF1A_TARGET_GENES,0.937967111245832
GOBP_CHOLESTEROL_CATABOLIC_P...,SET,8,0.19568,0.0040836,0.31475,0.26708,GOBP_CHOLESTEROL_CATABOLIC_PROCESS,0.937967111245832
GOBP_NEGATIVE_REGULATION_OF_...591,SET,13,0.1677,0.0044607,0.26979,0.2671,GOBP_NEGATIVE_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE,0.937967111245832
MIR1295B_5P,SET,69,0.061059,0.003736,0.098267,0.26719,MIR1295B_5P,0.938188366336634
TCTCTCC_MIR185,SET,115,0.05027,0.0039659,0.080954,0.26731,TCTCTCC_MIR185,0.93831129960618
HP_GASTROINTESTINAL_HEMORRHA...,SET,154,0.04231,0.0038586,0.068139,0.26732,HP_GASTROINTESTINAL_HEMORRHAGE,0.93831129960618
GSE8621_UNSTIM_VS_LPS_PRIMED...2,SET,179,0.038721,0.0038045,0.062363,0.26733,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,0.93831129960618
REACTOME_REGULATION_OF_EXPRE...,SET,154,0.039728,0.0036231,0.063988,0.26735,REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,0.93831129960618
HP_ABNORMAL_PHALANGEAL_JOINT...,SET,194,0.038289,0.0039149,0.061674,0.26736,HP_ABNORMAL_PHALANGEAL_JOINT_MORPHOLOGY_OF_THE_HAND,0.93831129960618
REACTOME_TRANSCRIPTION_OF_E2...2,SET,16,0.12286,0.0036253,0.198,0.26747,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1,0.938402526475038
MIR6791_3P,SET,76,0.061338,0.0039381,0.098862,0.26749,MIR6791_3P,0.938402526475038
WP_MITOCHONDRIAL_FATTY_ACID_...3,SET,5,0.22188,0.003661,0.35771,0.26754,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,0.938402526475038
GOBP_REGULATION_OF_SEROTONIN...,SET,6,0.22421,0.0040524,0.36147,0.26754,GOBP_REGULATION_OF_SEROTONIN_SECRETION,0.938402526475038
LEE_INTRATHYMIC_T_PROGENITOR,SET,17,0.13313,0.0040492,0.21466,0.26756,LEE_INTRATHYMIC_T_PROGENITOR,0.938402526475038
MIR663A,SET,17,0.13168,0.0040051,0.21233,0.26757,MIR663A,0.938402526475038
KEGG_MEDICUS_REFERENCE_IL1_I...2,SET,15,0.15014,0.0042896,0.24209,0.26758,KEGG_MEDICUS_REFERENCE_IL1_IL1R_P38_SIGNALING_PATHWAY,0.938402526475038
HP_DYSESTHESIA,SET,16,0.14146,0.0041742,0.22817,0.26763,HP_DYSESTHESIA,0.938402526475038
GSE26669_CD4_VS_CD8_TCELL_IN...3,SET,179,0.038185,0.0037518,0.061598,0.26766,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN,0.938402526475038
WP_PDGFRBETA_PATHWAY,SET,28,0.10193,0.0039775,0.16445,0.26769,WP_PDGFRBETA_PATHWAY,0.938402526475038
KAECH_DAY15_EFF_VS_MEMORY_CD...1,SET,182,0.038364,0.0038006,0.061894,0.26769,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN,0.938402526475038
HP_CONVULSIVE_STATUS_EPILEPT...,SET,6,0.20158,0.0036434,0.32525,0.26771,HP_CONVULSIVE_STATUS_EPILEPTICUS,0.938402526475038
GSE15330_MEGAKARYOCYTE_ERYTH...3,SET,180,0.039055,0.0038479,0.063027,0.26774,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.93840601693207
PRDM12_TARGET_GENES,SET,93,0.052211,0.0037064,0.08428,0.2678,PRDM12_TARGET_GENES,0.93840601693207
HP_ABNORMAL_CALF_MUSCULATURE...,SET,60,0.068491,0.0039089,0.11058,0.26783,HP_ABNORMAL_CALF_MUSCULATURE_MORPHOLOGY,0.93840601693207
HP_SOFT_DOUGHY_SKIN,SET,12,0.15453,0.0039492,0.24953,0.26787,HP_SOFT_DOUGHY_SKIN,0.93840601693207
GOMF_HISTONE_H4K5_ACETYLTRAN...,SET,11,0.14982,0.0036661,0.24194,0.26788,GOMF_HISTONE_H4K5_ACETYLTRANSFERASE_ACTIVITY,0.93840601693207
GSE4142_GC_BCELL_VS_MEMORY_B...1,SET,180,0.037439,0.0036887,0.060461,0.26789,GSE4142_GC_BCELL_VS_MEMORY_BCELL_DN,0.93840601693207
GOBP_NEGATIVE_REGULATION_OF_...542,SET,63,0.066678,0.0038991,0.10769,0.2679,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_UBIQUITINATION,0.93840601693207
BIOCARTA_S1P_PATHWAY,SET,7,0.18322,0.0035767,0.29594,0.26793,BIOCARTA_S1P_PATHWAY,0.938416522221103
HP_ABNORMAL_STERNAL_OSSIFICA...,SET,11,0.1488,0.003641,0.24057,0.26811,HP_ABNORMAL_STERNAL_OSSIFICATION,0.938860904148208
GOMF_VOLTAGE_GATED_MONOATOMI...2,SET,139,0.048695,0.0042208,0.078726,0.26812,GOMF_VOLTAGE_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.938860904148208
GSE45382_UNTREATED_VS_TGFB_T...1,SET,166,0.040071,0.0037929,0.0648,0.26816,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN,0.938860904148208
GSE30083_SP3_VS_SP4_THYMOCYT...1,SET,181,0.040648,0.0040159,0.065744,0.2682,GSE30083_SP3_VS_SP4_THYMOCYTE_DN,0.938860904148208
REACTOME_NEUROTRANSMITTER_CL...,SET,9,0.17975,0.0039787,0.29077,0.26823,REACTOME_NEUROTRANSMITTER_CLEARANCE,0.938860904148208
GOBP_POSITIVE_REGULATION_OF_...455,SET,2,0.38814,0.0040507,0.62796,0.26826,GOBP_POSITIVE_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.938860904148208
HP_DECREASED_AMPLITUDE_OF_SE...,SET,24,0.10675,0.0038569,0.17273,0.26829,HP_DECREASED_AMPLITUDE_OF_SENSORY_ACTION_POTENTIALS,0.938860904148208
DURANTE_ADULT_OLFACTORY_NEUR...9,SET,71,0.068661,0.0042614,0.1111,0.26829,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MACROPHAGES,0.938860904148208
GOBP_NEGATIVE_REGULATION_OF_...657,SET,3,0.30226,0.0038632,0.48911,0.2683,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.938860904148208
HP_SHORT_5TH_TOE,SET,5,0.25267,0.004169,0.40907,0.2684,HP_SHORT_5TH_TOE,0.939028481585832
HP_ABNORMAL_PULMONARY_VALVE_...2,SET,52,0.071833,0.0038173,0.11631,0.26842,HP_ABNORMAL_PULMONARY_VALVE_MORPHOLOGY,0.939028481585832
ZNF697_TARGET_GENES,SET,121,0.045276,0.0036633,0.073321,0.26845,ZNF697_TARGET_GENES,0.939028481585832
HU_FETAL_RETINA_FIBROBLAST,SET,337,0.030746,0.004127,0.0498,0.26849,HU_FETAL_RETINA_FIBROBLAST,0.939028481585832
GOBP_REGULATION_OF_SPHINGOLI...,SET,12,0.12607,0.0032219,0.20422,0.26851,GOBP_REGULATION_OF_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,0.939028481585832
GOMF_D_LOOP_DNA_BINDING,SET,5,0.27072,0.0044669,0.43853,0.26851,GOMF_D_LOOP_DNA_BINDING,0.939028481585832
GOBP_REGULATION_OF_PROTEIN_L...7,SET,11,0.12236,0.002994,0.19832,0.26863,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION,0.939353622094778
ZFHX3_TARGET_GENES,SET,1384,0.014293,0.0037733,0.023169,0.26866,ZFHX3_TARGET_GENES,0.939364014084507
GOBP_POSITIVE_REGULATION_OF_...747,SET,8,0.18046,0.0037659,0.29269,0.26877,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING,0.939654094155517
HP_MYOCLONIC_ABSENCE_SEIZURE,SET,14,0.14089,0.0038889,0.22854,0.2688,HP_MYOCLONIC_ABSENCE_SEIZURE,0.939664453832227
HP_ELEVATED_CIRCULATING_CATE...,SET,12,0.1488,0.0038029,0.24161,0.26899,HP_ELEVATED_CIRCULATING_CATECHOLAMINE_LEVEL,0.940135503166784
MIR339_5P,SET,65,0.063573,0.0037758,0.10325,0.26905,MIR339_5P,0.940135503166784
KEGG_MEDICUS_VARIANT_FUS_DDI...,SET,5,0.27175,0.0044838,0.4414,0.26907,KEGG_MEDICUS_VARIANT_FUS_DDIT3_FUSION_TO_NFKB_MEDIATED_TRANSCRIPTION,0.940135503166784
REACTOME_SARS_COV_2_TARGETS_...2,SET,3,0.34627,0.0044258,0.56245,0.26907,REACTOME_SARS_COV_2_TARGETS_PDZ_PROTEINS_IN_CELL_CELL_JUNCTION,0.940135503166784
ANDERSON_BLOOD_CN54GP140_ADJ...10,SET,5,0.2325,0.0038363,0.37766,0.26907,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_LOW_IGM_RESPONDERS_6HY_1DY_UP,0.940135503166784
HP_SCAPHOCEPHALY,SET,38,0.082603,0.0037539,0.13421,0.26912,HP_SCAPHOCEPHALY,0.940166412060302
HP_COLOR_VISION_TEST_ABNORMA...,SET,9,0.19808,0.0043843,0.32186,0.26914,HP_COLOR_VISION_TEST_ABNORMALITY,0.940166412060302
GOBP_NEURON_PROJECTION_MAINT...,SET,10,0.14256,0.003326,0.23166,0.26916,GOBP_NEURON_PROJECTION_MAINTENANCE,0.940166412060302
MIR620,SET,69,0.063792,0.0039033,0.1037,0.26923,MIR620,0.940316415435635
HP_ABNORMAL_SUBSTANTIA_NIGRA...,SET,18,0.11794,0.0036911,0.19179,0.26929,HP_ABNORMAL_SUBSTANTIA_NIGRA_MORPHOLOGY,0.940322621798091
HE_LIM_SUN_FETAL_LUNG_C4_ILC...1,SET,135,0.047946,0.0040961,0.077971,0.26931,HE_LIM_SUN_FETAL_LUNG_C4_ILC2_CELL,0.940322621798091
GSE40274_CTRL_VS_FOXP3_TRANS...2,SET,181,0.037488,0.0037037,0.060967,0.26932,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.940322621798091
HP_CARCINOMA,SET,6,0.19671,0.0035553,0.31994,0.26934,HP_CARCINOMA,0.940322621798091
SOBOLEV_PBMC_PANDEMRIX_AGE_1...6,SET,5,0.26467,0.004367,0.43064,0.26942,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_LOW_VS_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_0DY_DN,0.940404787714544
HP_MACROCEPHALY,SET,375,0.026214,0.0037079,0.042657,0.26943,HP_MACROCEPHALY,0.940404787714544
HP_CRANIOFACIAL_DISPROPORTION,SET,6,0.20234,0.0036571,0.32936,0.2695,HP_CRANIOFACIAL_DISPROPORTION,0.940404787714544
SHEPARD_CRASH_AND_BURN_MUTAN...1,SET,179,0.039784,0.0039089,0.064763,0.26951,SHEPARD_CRASH_AND_BURN_MUTANT_DN,0.940404787714544
GOBP_NEGATIVE_REGULATION_OF_...45,SET,97,0.051039,0.0036999,0.083084,0.26951,GOBP_NEGATIVE_REGULATION_OF_BINDING,0.940404787714544
HE_LIM_SUN_FETAL_LUNG_C3_DEF...2,SET,23,0.10757,0.0038048,0.17514,0.26955,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROCYTE,0.940404787714544
GOBP_NEGATIVE_REGULATION_OF_...411,SET,83,0.054899,0.0036827,0.089389,0.26956,GOBP_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,0.940404787714544
MA_RAT_AGING_UP,SET,96,0.054565,0.0039351,0.088855,0.26958,MA_RAT_AGING_UP,0.940404787714544
HP_SCLEROSING_CHOLANGITIS,SET,10,0.18518,0.0043204,0.30163,0.26963,HP_SCLEROSING_CHOLANGITIS,0.940421207865169
REACTOME_CHONDROITIN_SULFATE...1,SET,18,0.11494,0.0035969,0.18722,0.26965,REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS,0.940421207865169
HP_IVORY_EPIPHYSES_OF_THE_PH...,SET,6,0.21954,0.0039679,0.35768,0.26969,HP_IVORY_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.940421207865169
REACTOME_REGULATION_OF_ENDOG...1,SET,80,0.055466,0.0036532,0.090375,0.2697,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS,0.940421207865169
GSE15330_WT_VS_IKAROS_KO_LYM...2,SET,188,0.036408,0.0036652,0.059329,0.26972,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_UP,0.940421207865169
HP_CRANIAL_NERVE_PARALYSIS,SET,258,0.032278,0.0037993,0.052618,0.26979,HP_CRANIAL_NERVE_PARALYSIS,0.940511434302909
HP_MALAR_FLATTENING,SET,175,0.039745,0.0038616,0.064791,0.2698,HP_MALAR_FLATTENING,0.940511434302909
GOMF_IGG_RECEPTOR_ACTIVITY,SET,6,0.28278,0.0051111,0.46108,0.26984,GOMF_IGG_RECEPTOR_ACTIVITY,0.940556533948451
F10_TARGET_GENES,SET,211,0.036307,0.0038697,0.059223,0.26993,F10_TARGET_GENES,0.940775887484958
MIR424_3P,SET,34,0.084334,0.0036257,0.13759,0.26997,MIR424_3P,0.940781896551724
GOBP_NEGATIVE_REGULATION_OF_...46,SET,24,0.10962,0.0039604,0.17889,0.27002,GOBP_NEGATIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.940781896551724
GSE41176_WT_VS_TAK1_KO_UNSTI...2,SET,178,0.038697,0.0037917,0.063156,0.27003,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_UP,0.940781896551724
MYOD_01,SET,232,0.034441,0.0038469,0.056212,0.27004,MYOD_01,0.940781896551724
MORF_CDC16,SET,63,0.061676,0.0036065,0.10069,0.2701,MORF_CDC16,0.940871978352375
SASAKI_TARGETS_OF_TP73_AND_T...,SET,11,0.16489,0.0040348,0.26923,0.27012,SASAKI_TARGETS_OF_TP73_AND_TP63,0.940871978352375
BIOCARTA_INSULIN_PATHWAY,SET,20,0.11336,0.0037393,0.18514,0.27018,BIOCARTA_INSULIN_PATHWAY,0.940986661990179
GSE20715_WT_VS_TLR4_KO_LUNG_...1,SET,175,0.037982,0.0036904,0.062052,0.27024,GSE20715_WT_VS_TLR4_KO_LUNG_DN,0.94110132264529
HP_NECK_PAIN,SET,5,0.2514,0.0041481,0.41079,0.27027,HP_NECK_PAIN,0.941111496844004
GNF2_MYL3,SET,31,0.097848,0.0040171,0.15991,0.2703,GNF2_MYL3,0.941121669004207
MIR518D_5P_MIR518F_5P_MIR520...,SET,85,0.05386,0.0036561,0.088046,0.27036,MIR518D_5P_MIR518F_5P_MIR520C_5P_MIR526A_5P,0.941176817908654
WP_SMALL_CELL_LUNG_CANCER,SET,93,0.052376,0.0037181,0.085624,0.27037,WP_SMALL_CELL_LUNG_CANCER,0.941176817908654
GOBP_COLLAGEN_FIBRIL_ORGANIZ...,SET,63,0.068655,0.0040146,0.11228,0.27046,GOBP_COLLAGEN_FIBRIL_ORGANIZATION,0.941387058352517
GOBP_NEGATIVE_REGULATION_OF_...155,SET,15,0.13633,0.0038951,0.22304,0.27052,GOBP_NEGATIVE_REGULATION_OF_CYCLASE_ACTIVITY,0.941387058352517
GOBP_POSITIVE_REGULATION_OF_...482,SET,132,0.047488,0.0040119,0.077693,0.27053,GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.941387058352517
HP_BICONCAVE_VERTEBRAL_BODIES,SET,21,0.11138,0.0037646,0.18224,0.27055,HP_BICONCAVE_VERTEBRAL_BODIES,0.941387058352517
GOBP_COCHLEA_MORPHOGENESIS,SET,22,0.11954,0.0041354,0.19562,0.27058,GOBP_COCHLEA_MORPHOGENESIS,0.941387058352517
GOBP_POSITIVE_REGULATION_OF_...826,SET,14,0.16166,0.0044623,0.26462,0.27062,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,0.941387058352517
HP_2_4_TOE_CUTANEOUS_SYNDACT...,SET,4,0.30271,0.0044675,0.49549,0.27062,HP_2_4_TOE_CUTANEOUS_SYNDACTYLY,0.941387058352517
ACEVEDO_LIVER_CANCER_WITH_H3...2,SET,229,0.038357,0.0042569,0.062791,0.27065,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,0.941397192754203
chr18q22,SET,23,0.18202,0.0064382,0.29841,0.27094,chr18q22,0.942212673802141
LI_ESTROGENE_MID_E2_RESPONSE...1,SET,40,0.084861,0.0039565,0.13912,0.27094,LI_ESTROGENE_MID_E2_RESPONSE_DN,0.942212673802141
GOBP_METANEPHRIC_GLOMERULAR_...,SET,5,0.27969,0.0046148,0.45865,0.271,GOBP_METANEPHRIC_GLOMERULAR_MESANGIUM_DEVELOPMENT,0.942212673802141
GOBP_PROTEIN_LOCALIZATION_TO...25,SET,349,0.028387,0.0038763,0.046552,0.271,GOBP_PROTEIN_LOCALIZATION_TO_EXTRACELLULAR_REGION,0.942212673802141
MIR4465,SET,395,0.026228,0.0038054,0.043015,0.27102,MIR4465,0.942212673802141
GOBP_INNER_CELL_MASS_CELL_PR...,SET,14,0.12508,0.0034526,0.20529,0.27117,GOBP_INNER_CELL_MASS_CELL_PROLIFERATION,0.942639862972595
GOBP_REGULATION_OF_MICROTUBU...1,SET,47,0.076504,0.0038657,0.12558,0.27121,GOBP_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT,0.942684623462346
WP_HAIR_FOLLICLE_DEVELOPMENT...1,SET,86,0.06124,0.0041813,0.10055,0.27125,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,0.942697815703055
GOMF_HEXOSYLTRANSFERASE_ACTI...,SET,184,0.040548,0.0040387,0.066607,0.27134,GOMF_HEXOSYLTRANSFERASE_ACTIVITY,0.942697815703055
GOMF_PROTEIN_TYROSINE_SERINE...,SET,22,0.10597,0.0036658,0.17406,0.27134,GOMF_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.942697815703055
GSE21670_STAT3_KO_VS_WT_CD4_...4,SET,175,0.040665,0.0039511,0.0668,0.27134,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_DN,0.942697815703055
DESCARTES_FETAL_STOMACH_ERYT...,SET,86,0.054383,0.0037132,0.089357,0.2714,DESCARTES_FETAL_STOMACH_ERYTHROBLASTS,0.942697815703055
GOBP_NEGATIVE_REGULATION_OF_...481,SET,23,0.09886,0.0034967,0.16246,0.27142,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,0.942697815703055
HE_LIM_SUN_FETAL_LUNG_C7_MID...,SET,237,0.035826,0.0040439,0.058874,0.27142,HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL,0.942697815703055
GOCC_MRNA_CLEAVAGE_AND_POLYA...,SET,17,0.10492,0.003191,0.17244,0.27146,GOCC_MRNA_CLEAVAGE_AND_POLYADENYLATION_SPECIFICITY_FACTOR_COMPLEX,0.942697815703055
GOBP_REGULATION_OF_PHOSPHOPR...,SET,38,0.081882,0.0037212,0.13459,0.27148,GOBP_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.942697815703055
MARKEY_RB1_ACUTE_LOF_UP,SET,215,0.034591,0.0037212,0.056871,0.27152,MARKEY_RB1_ACUTE_LOF_UP,0.942697815703055
GOBP_ESTROGEN_BIOSYNTHETIC_P...,SET,11,0.14822,0.0036269,0.24375,0.27157,GOBP_ESTROGEN_BIOSYNTHETIC_PROCESS,0.942697815703055
GOBP_POSITIVE_REGULATION_OF_...172,SET,7,0.21428,0.0041831,0.35243,0.27159,GOBP_POSITIVE_REGULATION_OF_COA_TRANSFERASE_ACTIVITY,0.942697815703055
GOBP_REGULATION_OF_COA_TRANS...,SET,7,0.21428,0.0041831,0.35243,0.27159,GOBP_REGULATION_OF_COA_TRANSFERASE_ACTIVITY,0.942697815703055
GOCC_PROTEASOME_CORE_COMPLEX,SET,20,0.10279,0.0033906,0.16908,0.27162,GOCC_PROTEASOME_CORE_COMPLEX,0.942697815703055
GOMF_FERROUS_IRON_BINDING,SET,23,0.10008,0.0035401,0.16464,0.27163,GOMF_FERROUS_IRON_BINDING,0.942697815703055
GOBP_DNA_REPAIR_DEPENDENT_CH...,SET,18,0.10659,0.0033358,0.17537,0.27166,GOBP_DNA_REPAIR_DEPENDENT_CHROMATIN_REMODELING,0.942697815703055
GOBP_VIRAL_BUDDING,SET,25,0.096802,0.0035695,0.15933,0.27174,GOBP_VIRAL_BUDDING,0.942697815703055
GSE26030_TH1_VS_TH17_RESTIMU...1,SET,181,0.037105,0.0036658,0.061077,0.27176,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_DN,0.942697815703055
GOCC_ENDOSOME_LUMEN,SET,37,0.089049,0.0039934,0.14659,0.27177,GOCC_ENDOSOME_LUMEN,0.942697815703055
BANDRES_RESPONSE_TO_CARMUSTI...2,SET,8,0.16556,0.003455,0.2727,0.27189,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP,0.942697815703055
GOCC_IGG_IMMUNOGLOBULIN_COMP...,SET,2,0.42883,0.0044753,0.7065,0.27194,GOCC_IGG_IMMUNOGLOBULIN_COMPLEX,0.942697815703055
GSE29618_BCELL_VS_PDC_DAY7_F...1,SET,181,0.039067,0.0038596,0.064365,0.27194,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN,0.942697815703055
HP_DECREASED_SPECIFIC_ANTIBO...2,SET,3,0.36208,0.0046279,0.5966,0.27196,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_PROTEIN_CONJUGATED_POLYSACCHARIDE_VACCINE,0.942697815703055
REACTOME_FORMYL_PEPTIDE_RECE...,SET,8,0.21545,0.0044962,0.35507,0.272,REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS,0.942697815703055
MIR518E_5P_MIR519A_5P_MIR519...,SET,82,0.054483,0.0036329,0.089796,0.27201,MIR518E_5P_MIR519A_5P_MIR519B_5P_MIR519C_5P_MIR522_5P_MIR523_5P,0.942697815703055
GSE17721_POLYIC_VS_CPG_16H_B...2,SET,184,0.03707,0.0036923,0.06111,0.27206,GSE17721_POLYIC_VS_CPG_16H_BMDC_UP,0.942697815703055
HP_APLASIA_CUTIS_CONGENITA,SET,37,0.081876,0.0036717,0.135,0.2721,HP_APLASIA_CUTIS_CONGENITA,0.942697815703055
GOBP_REGULATION_OF_EXTRACELL...4,SET,61,0.066593,0.003832,0.10981,0.27212,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,0.942697815703055
REACTOME_PTK6_REGULATES_CELL...,SET,6,0.21444,0.0038758,0.35363,0.27213,REACTOME_PTK6_REGULATES_CELL_CYCLE,0.942697815703055
REACTOME_CYTOPROTECTION_BY_H...,SET,51,0.068864,0.0036243,0.11358,0.27217,REACTOME_CYTOPROTECTION_BY_HMOX1,0.942697815703055
HP_ABNORMAL_CARDIAC_VENTRICU...,SET,142,0.043995,0.003854,0.072567,0.27217,HP_ABNORMAL_CARDIAC_VENTRICULAR_FUNCTION,0.942697815703055
GOBP_TRANSMISSION_OF_NERVE_I...,SET,71,0.064751,0.0040187,0.10683,0.27222,GOBP_TRANSMISSION_OF_NERVE_IMPULSE,0.942697815703055
REACTOME_PINK1_PRKN_MEDIATED...,SET,28,0.091624,0.0035753,0.15118,0.27224,REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY,0.942697815703055
HP_ABNORMAL_JUDGMENT,SET,438,0.024377,0.0037199,0.040224,0.27225,HP_ABNORMAL_JUDGMENT,0.942697815703055
GNF2_PCNA,SET,64,0.062467,0.0036816,0.10308,0.27227,GNF2_PCNA,0.942697815703055
MIR4656,SET,98,0.051698,0.0037669,0.08532,0.27228,MIR4656,0.942697815703055
NR0B1_TARGET_GENES,SET,276,0.031575,0.0038421,0.052109,0.27228,NR0B1_TARGET_GENES,0.942697815703055
MIR3192_3P,SET,75,0.060034,0.003829,0.099112,0.27235,MIR3192_3P,0.942697815703055
GSE14769_UNSTIM_VS_60MIN_LPS...1,SET,188,0.03909,0.0039351,0.064544,0.27238,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN,0.942697815703055
MIR548AT_5P,SET,313,0.029346,0.0037987,0.048464,0.27242,MIR548AT_5P,0.942697815703055
BIOCARTA_PRC2_PATHWAY,SET,12,0.16197,0.0041394,0.2675,0.27243,BIOCARTA_PRC2_PATHWAY,0.942697815703055
GOCC_CENTRIOLE,SET,144,0.041109,0.0036262,0.067895,0.27244,GOCC_CENTRIOLE,0.942697815703055
GSE41176_UNSTIM_VS_ANTI_IGM_...3,SET,180,0.037932,0.0037372,0.062654,0.27245,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN,0.942697815703055
WANG_HCP_PROSTATE_CANCER,SET,100,0.051105,0.0037612,0.084429,0.27249,WANG_HCP_PROSTATE_CANCER,0.942697815703055
GSE22025_UNTREATED_VS_TGFB1_...4,SET,184,0.038873,0.0038719,0.064222,0.2725,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP,0.942697815703055
MORF_ZNF10,SET,46,0.081641,0.0040813,0.1349,0.27252,MORF_ZNF10,0.942697815703055
GOBP_REGULATION_OF_GLUCOSE_T...,SET,70,0.063522,0.0039147,0.10496,0.27252,GOBP_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,0.942697815703055
GSE3920_IFNB_VS_IFNG_TREATED...2,SET,144,0.043618,0.0038476,0.072071,0.27252,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.942697815703055
LI_WILMS_TUMOR_VS_FETAL_KIDN...3,SET,45,0.085647,0.0042348,0.14154,0.27257,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,0.942697815703055
WP_VITAMIN_DSENSITIVE_CALCIU...,SET,34,0.090026,0.0038704,0.14879,0.27257,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,0.942697815703055
GOBP_REGULATION_OF_HEART_MOR...,SET,8,0.22968,0.0047931,0.37979,0.27268,GOBP_REGULATION_OF_HEART_MORPHOGENESIS,0.942831732776618
GOCC_SPINDLE_MIDZONE,SET,35,0.086723,0.0037827,0.14343,0.27272,GOCC_SPINDLE_MIDZONE,0.942831732776618
HP_SYNOSTOSIS_INVOLVING_BONE...3,SET,106,0.051725,0.0039187,0.085554,0.27273,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.942831732776618
HP_BILATERAL_CONDUCTIVE_HEAR...,SET,6,0.16858,0.0030469,0.27888,0.27277,HP_BILATERAL_CONDUCTIVE_HEARING_IMPAIRMENT,0.942831732776618
SIRNA_EIF4GI_UP,SET,84,0.052477,0.0035413,0.086818,0.27277,SIRNA_EIF4GI_UP,0.942831732776618
HP_ABNORMAL_COAGULATION_FACT...,SET,5,0.26141,0.0043132,0.43255,0.27281,HP_ABNORMAL_COAGULATION_FACTOR_V_ACTIVITY,0.942831732776618
GOMF_TAP_BINDING,SET,7,0.19935,0.0038916,0.32988,0.27282,GOMF_TAP_BINDING,0.942831732776618
GOCC_UBIQUINONE_BIOSYNTHESIS...,SET,6,0.17118,0.003094,0.28333,0.27286,GOCC_UBIQUINONE_BIOSYNTHESIS_COMPLEX,0.942831732776618
HP_WIDE_NASAL_RIDGE,SET,8,0.14402,0.0030056,0.23837,0.27286,HP_WIDE_NASAL_RIDGE,0.942831732776618
HP_ABNORMALITY_OF_THE_UPPER_...1,SET,65,0.066623,0.0039569,0.11028,0.27288,HP_ABNORMALITY_OF_THE_UPPER_ARM,0.942831732776618
ZNF30_TARGET_GENES,SET,1184,0.014973,0.0036777,0.024791,0.27293,ZNF30_TARGET_GENES,0.942910750497018
BYSTRYKH_HEMATOPOIESIS_STEM_...6,SET,121,0.044603,0.0036089,0.073892,0.27305,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS,0.943231562468939
ZHU_SKIL_TARGETS_DN,SET,9,0.17011,0.0037653,0.282,0.27318,ZHU_SKIL_TARGETS_DN,0.943586851520572
ESC_J1_UP_EARLY.V1_UP,SET,154,0.041394,0.003775,0.068631,0.27322,ESC_J1_UP_EARLY.V1_UP,0.943631233230647
UNTERMAN_IPF_VS_CTRL_CD4T_DN,SET,9,0.19813,0.0043855,0.32858,0.27326,UNTERMAN_IPF_VS_CTRL_CD4T_DN,0.943650909090909
REACTOME_BACTERIAL_INFECTION...,SET,67,0.061294,0.0036958,0.10166,0.27328,REACTOME_BACTERIAL_INFECTION_PATHWAYS,0.943650909090909
GOBP_MITOCHONDRIAL_ELECTRON_...3,SET,5,0.17038,0.0028113,0.28268,0.27335,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_SUCCINATE_TO_UBIQUINONE,0.943709889782544
GSE24634_TREG_VS_TCONV_POST_...3,SET,180,0.038341,0.0037775,0.063622,0.27338,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN,0.943709889782544
PUJANA_XPRSS_INT_NETWORK,SET,155,0.038219,0.0034967,0.063424,0.27339,PUJANA_XPRSS_INT_NETWORK,0.943709889782544
GOBP_GASTRO_INTESTINAL_SYSTE...,SET,12,0.14156,0.0036176,0.23494,0.27342,GOBP_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION,0.943709889782544
HP_CHOREA,SET,202,0.035445,0.0036973,0.058838,0.27345,HP_CHOREA,0.943709889782544
GOBP_ENDODERMAL_CELL_FATE_SP...,SET,7,0.20208,0.0039449,0.33546,0.27346,GOBP_ENDODERMAL_CELL_FATE_SPECIFICATION,0.943709889782544
REACTOME_COPII_MEDIATED_VESI...,SET,66,0.06145,0.0036776,0.10206,0.27355,REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,0.943926752382844
GSE3982_CTRL_VS_LPS_1H_NEUTR...2,SET,170,0.038248,0.0036632,0.063535,0.27359,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP,0.94397105628909
ONDER_CDH1_TARGETS_2_DN,SET,443,0.026092,0.0040036,0.043355,0.27365,ONDER_CDH1_TARGETS_2_DN,0.943979539375929
REACTOME_WNT_LIGAND_BIOGENES...,SET,24,0.11104,0.0040119,0.18453,0.27368,REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING,0.943979539375929
HP_ABNORMAL_RESPIRATORY_EPIT...,SET,23,0.094977,0.0033594,0.15786,0.27371,HP_ABNORMAL_RESPIRATORY_EPITHELIUM_MORPHOLOGY,0.943979539375929
GSE2770_IL12_ACT_VS_ACT_CD4_...6,SET,169,0.037673,0.0035976,0.062625,0.27374,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP,0.943979539375929
GOBP_NEGATIVE_REGULATION_OF_...6,SET,13,0.14764,0.0039272,0.24544,0.27375,GOBP_NEGATIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,0.943979539375929
GOBP_ORGANELLE_ASSEMBLY,SET,914,0.016529,0.0035949,0.027489,0.27382,GOBP_ORGANELLE_ASSEMBLY,0.943979539375929
GOBP_RESPONSE_TO_PEPTIDOGLYC...,SET,11,0.14968,0.0036626,0.24896,0.27384,GOBP_RESPONSE_TO_PEPTIDOGLYCAN,0.943979539375929
HP_MULTIPLE_EPIPHYSEAL_DYSPL...,SET,8,0.17481,0.0036482,0.29076,0.27385,HP_MULTIPLE_EPIPHYSEAL_DYSPLASIA,0.943979539375929
GOBP_FAS_SIGNALING_PATHWAY,SET,6,0.18678,0.0033759,0.31067,0.27386,GOBP_FAS_SIGNALING_PATHWAY,0.943979539375929
GOMF_AMYLOID_BETA_BINDING,SET,80,0.060597,0.0039912,0.1008,0.27387,GOMF_AMYLOID_BETA_BINDING,0.943979539375929
REACTOME_RHO_GTPASES_ACTIVAT...1,SET,19,0.11521,0.0037043,0.19169,0.27391,REACTOME_RHO_GTPASES_ACTIVATE_CIT,0.943979539375929
SWEET_LUNG_CANCER_KRAS_UP,SET,426,0.024705,0.0037192,0.041112,0.27395,SWEET_LUNG_CANCER_KRAS_UP,0.943979539375929
HUI_MAPK14_TARGETS_UP,SET,18,0.12296,0.0038479,0.20466,0.274,HUI_MAPK14_TARGETS_UP,0.943979539375929
KEGG_MEDICUS_PATHOGEN_HBV_HB...2,SET,5,0.25865,0.0042677,0.43053,0.274,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_ERK_SIGNALING_PATHWAY,0.943979539375929
HP_ATYPICAL_SCARRING_OF_SKIN,SET,64,0.065054,0.003834,0.10829,0.27402,HP_ATYPICAL_SCARRING_OF_SKIN,0.943979539375929
GSE2585_CD80_HIGH_VS_LOW_MTE...2,SET,179,0.039037,0.0038355,0.064998,0.27406,GSE2585_CD80_HIGH_VS_LOW_MTEC_UP,0.943979539375929
GOCC_B_CELL_RECEPTOR_COMPLEX,SET,5,0.24366,0.0040204,0.40574,0.27408,GOCC_B_CELL_RECEPTOR_COMPLEX,0.943979539375929
GSE22025_PROGESTERONE_VS_TGF...2,SET,177,0.037644,0.0036781,0.062709,0.27416,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.943979539375929
GOBP_COPPER_ION_TRANSPORT,SET,15,0.12771,0.0036488,0.21277,0.27418,GOBP_COPPER_ION_TRANSPORT,0.943979539375929
GOBP_GMP_METABOLIC_PROCESS,SET,25,0.10121,0.0037322,0.16862,0.27418,GOBP_GMP_METABOLIC_PROCESS,0.943979539375929
GOBP_REGULATION_OF_PEPTIDYL_...6,SET,199,0.037365,0.0038688,0.06225,0.27418,GOBP_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,0.943979539375929
GSE13484_UNSTIM_VS_YF17D_VAC...1,SET,188,0.037981,0.0038235,0.06328,0.27419,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,0.943979539375929
NOTCH_DN.V1_UP,SET,157,0.041275,0.0038004,0.06878,0.27422,NOTCH_DN.V1_UP,0.943989312599049
REACTOME_POSTMITOTIC_NUCLEAR...,SET,26,0.094249,0.0035441,0.1571,0.27428,REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION,0.944102347231851
MODULE_104,SET,314,0.028725,0.0037241,0.047903,0.27438,MODULE_104,0.944156959219858
HP_PROXIMAL_TUBULOPATHY,SET,35,0.075356,0.0032869,0.12568,0.2744,HP_PROXIMAL_TUBULOPATHY,0.944156959219858
YAGI_AML_WITH_T_8_21_TRANSLO...,SET,325,0.028607,0.0037722,0.047715,0.27441,YAGI_AML_WITH_T_8_21_TRANSLOCATION,0.944156959219858
GSE3920_UNTREATED_VS_IFNA_TR...1,SET,146,0.042235,0.0037512,0.070464,0.27446,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN,0.944156959219858
GSE9960_HEALTHY_VS_GRAM_NEG_...4,SET,186,0.036689,0.0036739,0.061212,0.27447,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP,0.944156959219858
MIR10395_5P,SET,66,0.06439,0.0038535,0.10749,0.27459,MIR10395_5P,0.944156959219858
IVANOVA_HEMATOPOIESIS_EARLY_...,SET,404,0.024782,0.0036354,0.041379,0.27462,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,0.944156959219858
HALLMARK_OXIDATIVE_PHOSPHORY...,SET,169,0.03609,0.0034464,0.060278,0.27468,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.944156959219858
GOBP_POSITIVE_REGULATION_OF_...106,SET,1023,0.016329,0.0037455,0.02729,0.2748,GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION,0.944156959219858
MULLIGHAN_NPM1_MUTATED_SIGNA...2,SET,234,0.032908,0.0036913,0.055004,0.27483,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,0.944156959219858
KEGG_MEDICUS_VARIANT_MUTATIO...89,SET,9,0.16258,0.0035986,0.27177,0.27485,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_TP53_TO_TRANSCRIPTION,0.944156959219858
IL21_UP.V1_DN,SET,157,0.042341,0.0038985,0.070804,0.27492,IL21_UP.V1_DN,0.944156959219858
REACTOME_ERYTHROCYTES_TAKE_U...2,SET,7,0.20231,0.0039495,0.33833,0.27493,REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE,0.944156959219858
TCF1P_Q6,SET,238,0.033312,0.0037679,0.055713,0.27495,TCF1P_Q6,0.944156959219858
SCHLESINGER_METHYLATED_DE_NO...,SET,80,0.062561,0.0041205,0.10464,0.27497,SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,0.944156959219858
HP_THYMUS_HYPERPLASIA,SET,6,0.19301,0.0034885,0.32284,0.27498,HP_THYMUS_HYPERPLASIA,0.944156959219858
GOBP_POSITIVE_REGULATION_OF_...568,SET,28,0.10714,0.0041806,0.17923,0.27501,GOBP_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.944156959219858
HP_HYPERPLASTIC_CALLUS_FORMA...,SET,5,0.24612,0.0040609,0.41178,0.27503,HP_HYPERPLASTIC_CALLUS_FORMATION,0.944156959219858
GSE21546_SAP1A_KO_VS_SAP1A_K...1,SET,190,0.037106,0.003755,0.0621,0.27509,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.944156959219858
GOBP_RNA_GUANINE_N7_METHYLAT...,SET,4,0.20933,0.0030894,0.35036,0.2751,GOBP_RNA_GUANINE_N7_METHYLATION,0.944156959219858
WIERENGA_STAT5A_TARGETS_GROU...2,SET,50,0.075796,0.0039499,0.12687,0.27511,WIERENGA_STAT5A_TARGETS_GROUP2,0.944156959219858
GOBP_INTERLEUKIN_12_PRODUCTI...,SET,61,0.068552,0.0039447,0.11474,0.27511,GOBP_INTERLEUKIN_12_PRODUCTION,0.944156959219858
GOBP_REGULATION_OF_NEURAL_PR...,SET,96,0.055006,0.0039669,0.092071,0.27512,GOBP_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.944156959219858
HP_FATIGABLE_WEAKNESS_OF_SKE...,SET,42,0.074514,0.0035597,0.12473,0.27512,HP_FATIGABLE_WEAKNESS_OF_SKELETAL_MUSCLES,0.944156959219858
AAAGACA_MIR511,SET,185,0.037312,0.0037264,0.062473,0.27517,AAAGACA_MIR511,0.944156959219858
GSE43863_NAIVE_VS_TH1_EFF_CD...1,SET,147,0.043181,0.0038482,0.072297,0.27517,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_DN,0.944156959219858
GOBP_NEGATIVE_CHEMOTAXIS,SET,46,0.080571,0.0040278,0.13492,0.27519,GOBP_NEGATIVE_CHEMOTAXIS,0.944156959219858
GOBP_OOCYTE_ANTERIOR_POSTERI...,SET,6,0.21119,0.003817,0.35377,0.27527,GOBP_OOCYTE_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,0.944156959219858
GOBP_POSITIVE_REGULATION_OF_...39,SET,7,0.17857,0.003486,0.29917,0.2753,GOBP_POSITIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.944156959219858
GOBP_REGULATION_OF_CARDIAC_M...8,SET,68,0.062659,0.0038061,0.10499,0.27533,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,0.944156959219858
KEGG_EPITHELIAL_CELL_SIGNALI...,SET,65,0.060921,0.0036183,0.10211,0.2754,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,0.944156959219858
HP_CARDIORESPIRATORY_ARREST,SET,10,0.16978,0.0039612,0.28459,0.2754,HP_CARDIORESPIRATORY_ARREST,0.944156959219858
KEGG_MEDICUS_REFERENCE_AHR_S...,SET,8,0.18484,0.0038574,0.30995,0.27547,KEGG_MEDICUS_REFERENCE_AHR_SIGNALING_PATHWAY,0.944156959219858
MIR5692B_MIR5692C,SET,373,0.027325,0.0038549,0.045826,0.2755,MIR5692B_MIR5692C,0.944156959219858
GSE1791_CTRL_VS_NEUROMEDINU_...5,SET,168,0.037898,0.0036085,0.063569,0.27554,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN,0.944156959219858
GSE18281_SUBCAPSULAR_CORTICA...4,SET,187,0.034073,0.0034211,0.057156,0.27554,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,0.944156959219858
GSE43863_TFH_VS_LY6C_INT_CXC...1,SET,181,0.039241,0.0038768,0.065839,0.27559,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,0.944156959219858
AIZARANI_LIVER_C28_NK_NKT_CE...,SET,85,0.056409,0.0038292,0.094651,0.2756,AIZARANI_LIVER_C28_NK_NKT_CELLS_6,0.944156959219858
GOBP_LYMPH_NODE_DEVELOPMENT,SET,19,0.1125,0.0036172,0.18878,0.27561,GOBP_LYMPH_NODE_DEVELOPMENT,0.944156959219858
WP_BMP2WNT4FOXO1_PATHWAY_IN_...,SET,13,0.16586,0.0044118,0.27833,0.27562,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,0.944156959219858
HP_ABNORMALITY_OF_THE_MIDDLE...3,SET,10,0.15125,0.0035289,0.25382,0.27562,HP_ABNORMALITY_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES,0.944156959219858
GSE16450_IMMATURE_VS_MATURE_...5,SET,183,0.035646,0.0035409,0.059816,0.27562,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,0.944156959219858
BIOCARTA_SAM68_PATHWAY,SET,6,0.20965,0.0037893,0.35183,0.27563,BIOCARTA_SAM68_PATHWAY,0.944156959219858
GSE15330_HSC_VS_GRANULOCYTE_...3,SET,173,0.038724,0.0037411,0.064994,0.27565,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,0.944156959219858
GSE17974_0H_VS_1H_IN_VITRO_A...1,SET,183,0.035877,0.0035639,0.060215,0.27565,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN,0.944156959219858
GNF2_HCK,SET,86,0.056569,0.0038624,0.094946,0.27566,GNF2_HCK,0.944156959219858
GOBP_RESPONSE_TO_SODIUM_PHOS...,SET,9,0.18449,0.0040836,0.30971,0.27569,GOBP_RESPONSE_TO_SODIUM_PHOSPHATE,0.944156959219858
WP_SCFA_AND_SKELETAL_MUSCLE_...,SET,6,0.20568,0.0037174,0.34529,0.2757,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,0.944156959219858
MIR615_5P,SET,37,0.088323,0.0039609,0.14828,0.2757,MIR615_5P,0.944156959219858
GOBP_POSITIVE_REGULATION_OF_...792,SET,12,0.13194,0.0033719,0.2215,0.2757,GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.944156959219858
LUI_THYROID_CANCER_CLUSTER_1,SET,47,0.072233,0.0036499,0.12127,0.27571,LUI_THYROID_CANCER_CLUSTER_1,0.944156959219858
MIR4296,SET,65,0.064176,0.0038117,0.10774,0.27571,MIR4296,0.944156959219858
MIR324_3P,SET,71,0.058494,0.0036303,0.09822,0.27575,MIR324_3P,0.944156959219858
REACTOME_THROMBIN_SIGNALLING...,SET,32,0.094863,0.0039568,0.15931,0.27577,REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS,0.944156959219858
REACTOME_SYNTHESIS_OF_UDP_N_...,SET,7,0.20033,0.0039108,0.33646,0.27579,REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE,0.944156959219858
GOBP_AMINO_ACID_BIOSYNTHETIC...,SET,71,0.059476,0.0036913,0.099906,0.27582,GOBP_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.944166660100463
GOBP_PROTEIN_LOCALIZATION_TO...7,SET,98,0.052033,0.0037913,0.087431,0.27588,GOBP_PROTEIN_LOCALIZATION_TO_CELL_JUNCTION,0.944279042741777
SFMBT1_TARGET_GENES,SET,1309,0.014351,0.0036928,0.024124,0.27596,SFMBT1_TARGET_GENES,0.944356484943909
HP_ABNORMALITY_THIGH_MUSCULA...,SET,15,0.13906,0.0039731,0.23377,0.27597,HP_ABNORMALITY_THIGH_MUSCULATURE_MORPHOLOGY,0.944356484943909
GNF2_ST13,SET,57,0.061293,0.0034098,0.10305,0.276,GNF2_ST13,0.944356484943909
REACTOME_ERK_MAPK_TARGETS,SET,20,0.11435,0.0037718,0.1923,0.27605,REACTOME_ERK_MAPK_TARGETS,0.944356484943909
GOBP_APPENDAGE_DEVELOPMENT,SET,173,0.040681,0.0039301,0.068412,0.27605,GOBP_APPENDAGE_DEVELOPMENT,0.944356484943909
KRAS.300_UP.V1_UP,SET,127,0.04977,0.0041249,0.08371,0.27607,KRAS.300_UP.V1_UP,0.944356484943909
ATF5_TARGET_GENES,SET,349,0.02632,0.003594,0.044273,0.2761,ATF5_TARGET_GENES,0.944356484943909
GOBP_PROTEIN_KINASE_C_ACTIVA...,SET,24,0.10116,0.003655,0.17018,0.27612,GOBP_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.944356484943909
HP_PERIPHERAL_AXONAL_DEGENER...,SET,179,0.035937,0.003531,0.060484,0.27621,HP_PERIPHERAL_AXONAL_DEGENERATION,0.944414486624705
HP_NODULAR_GOITER,SET,11,0.16565,0.0040532,0.2788,0.27622,HP_NODULAR_GOITER,0.944414486624705
GSE5099_DAY3_VS_DAY7_MCSF_TR...2,SET,169,0.037963,0.0036254,0.063904,0.27624,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP,0.944414486624705
GOMF_HYDROLASE_ACTIVITY_ACTI...2,SET,128,0.04461,0.0037117,0.075108,0.27628,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS,0.944414486624705
PPARA_01,SET,31,0.091337,0.0037498,0.15379,0.27629,PPARA_01,0.944414486624705
MUELLER_PLURINET,SET,276,0.029318,0.0035674,0.049367,0.2763,MUELLER_PLURINET,0.944414486624705
GOBP_RESPONSE_TO_YEAST,SET,6,0.23435,0.0042357,0.39489,0.27644,GOBP_RESPONSE_TO_YEAST,0.944700987229863
GOBP_SEROTONIN_METABOLIC_PRO...,SET,10,0.17071,0.0039828,0.28768,0.27646,GOBP_SEROTONIN_METABOLIC_PROCESS,0.944700987229863
EGFR_TARGET_GENES,SET,20,0.11493,0.0037911,0.19373,0.2765,EGFR_TARGET_GENES,0.944700987229863
GOMF_RNA_POLYMERASE_ACTIVITY,SET,28,0.084284,0.0032889,0.14207,0.2765,GOMF_RNA_POLYMERASE_ACTIVITY,0.944700987229863
GSE7219_UNSTIM_VS_LPS_AND_AN...2,SET,159,0.041341,0.0038304,0.069699,0.27655,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP,0.944700987229863
HP_AXIAL_MUSCLE_WEAKNESS,SET,39,0.07891,0.0036329,0.1331,0.27664,HP_AXIAL_MUSCLE_WEAKNESS,0.944700987229863
GSE7831_UNSTIM_VS_CPG_STIM_P...1,SET,175,0.037953,0.0036876,0.064019,0.27665,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_DN,0.944700987229863
GOBP_RESPONSE_TO_CGMP,SET,8,0.17372,0.0036253,0.29305,0.27666,GOBP_RESPONSE_TO_CGMP,0.944700987229863
MIR10523_5P,SET,216,0.035072,0.0037815,0.059166,0.27667,MIR10523_5P,0.944700987229863
HP_ABNORMAL_SPERM_MOTILITY,SET,93,0.050909,0.003614,0.085889,0.27668,HP_ABNORMAL_SPERM_MOTILITY,0.944700987229863
HP_MACROCYTIC_ANEMIA,SET,63,0.063804,0.003731,0.10766,0.27671,HP_MACROCYTIC_ANEMIA,0.944700987229863
JONES_OVARY_STROMAL,SET,134,0.045925,0.003909,0.077492,0.27671,JONES_OVARY_STROMAL,0.944700987229863
MORF_KDR,SET,82,0.057472,0.0038321,0.096988,0.27674,MORF_KDR,0.944710607995285
HP_FIFTH_FINGER_DISTAL_PHALA...,SET,27,0.095133,0.0036454,0.16058,0.27678,HP_FIFTH_FINGER_DISTAL_PHALANX_CLINODACTYLY,0.944729843857409
GOMF_TRNA_METHYLTRANSFERASE_...,SET,30,0.081187,0.003279,0.13705,0.2768,GOMF_TRNA_METHYLTRANSFERASE_ACTIVITY,0.944729843857409
GOCC_GOLGI_STACK,SET,125,0.04457,0.003665,0.075289,0.27693,GOCC_GOLGI_STACK,0.94502206185567
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SET,49,0.072294,0.0037297,0.12213,0.27694,SMIRNOV_RESPONSE_TO_IR_2HR_UP,0.94502206185567
GOBP_NEGATIVE_REGULATION_OF_...24,SET,6,0.21018,0.0037988,0.3552,0.27702,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS,0.945050809776207
GOBP_NEURON_MATURATION,SET,46,0.076059,0.0038022,0.12854,0.27702,GOBP_NEURON_MATURATION,0.945050809776207
HE_LIM_SUN_FETAL_LUNG_C1_LAT...3,SET,6,0.22612,0.0040869,0.38216,0.27703,HE_LIM_SUN_FETAL_LUNG_C1_LATE_STALK_CELL,0.945050809776207
GOBP_HUMORAL_IMMUNE_RESPONSE,SET,231,0.038251,0.0042633,0.06466,0.27707,GOBP_HUMORAL_IMMUNE_RESPONSE,0.945094498969477
GSE27786_ERYTHROBLAST_VS_MON...1,SET,184,0.034729,0.0034591,0.058719,0.27712,GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN,0.945172286555446
HP_COARCTATION_OF_AORTA,SET,128,0.042911,0.0035703,0.072572,0.27717,HP_COARCTATION_OF_AORTA,0.945210535609182
REACTOME_REGULATION_OF_HMOX1...,SET,5,0.21002,0.0034654,0.35529,0.27722,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,0.945210535609182
chr3p14,SET,47,0.15447,0.0078054,0.26134,0.27724,chr3p14,0.945210535609182
BILANGES_RAPAMYCIN_SENSITIVE...1,SET,35,0.081689,0.0035632,0.1382,0.27724,BILANGES_RAPAMYCIN_SENSITIVE_GENES,0.945210535609182
PARK_HSC_AND_MULTIPOTENT_PRO...,SET,42,0.072664,0.0034713,0.12298,0.27731,PARK_HSC_AND_MULTIPOTENT_PROGENITORS,0.9452598022903
GOMF_PYRIMIDINE_NUCLEOSIDE_T...,SET,8,0.18562,0.0038738,0.31419,0.27733,GOMF_PYRIMIDINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.9452598022903
GSE36826_NORMAL_VS_STAPH_AUR...3,SET,185,0.036067,0.0036021,0.06108,0.27743,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_DN,0.9452598022903
BERENJENO_TRANSFORMED_BY_RHO...2,SET,27,0.097814,0.0037481,0.16565,0.27744,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,0.9452598022903
MIR122_5P,SET,82,0.053686,0.0035797,0.09093,0.27746,MIR122_5P,0.9452598022903
HP_TACHYCARDIA,SET,134,0.044229,0.0037646,0.07491,0.27746,HP_TACHYCARDIA,0.9452598022903
KIM_WT1_TARGETS_8HR_DN,SET,113,0.044882,0.0035102,0.076043,0.27752,KIM_WT1_TARGETS_8HR_DN,0.9452598022903
GOBP_POSITIVE_REGULATION_OF_...148,SET,6,0.18566,0.0033556,0.31457,0.27753,GOBP_POSITIVE_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS,0.9452598022903
GOBP_GLUCOSAMINE_CONTAINING_...2,SET,21,0.112,0.0037855,0.18978,0.27755,GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.9452598022903
GOMF_2_IRON_2_SULFUR_CLUSTER...,SET,23,0.091574,0.003239,0.15519,0.27757,GOMF_2_IRON_2_SULFUR_CLUSTER_BINDING,0.9452598022903
ALONSO_METASTASIS_EMT_DN,SET,5,0.26838,0.0044282,0.45486,0.27759,ALONSO_METASTASIS_EMT_DN,0.9452598022903
GOMF_BIOACTIVE_LIPID_RECEPTO...,SET,13,0.14175,0.0037704,0.24026,0.27761,GOMF_BIOACTIVE_LIPID_RECEPTOR_ACTIVITY,0.9452598022903
HP_HYPOPLASTIC_PUBIC_RAMUS,SET,6,0.21351,0.003859,0.36193,0.27763,HP_HYPOPLASTIC_PUBIC_RAMUS,0.9452598022903
MIR4708_5P,SET,80,0.053076,0.0034958,0.08998,0.27764,MIR4708_5P,0.9452598022903
GOMF_NITRITE_REDUCTASE_ACTIV...,SET,5,0.23759,0.0039202,0.40294,0.27771,GOMF_NITRITE_REDUCTASE_ACTIVITY,0.9452598022903
BIOCARTA_LYMPHOCYTE_PATHWAY,SET,9,0.19377,0.0042891,0.32863,0.27772,BIOCARTA_LYMPHOCYTE_PATHWAY,0.9452598022903
GOCC_ANCHORING_JUNCTION,SET,837,0.017705,0.0036929,0.030028,0.27773,GOCC_ANCHORING_JUNCTION,0.9452598022903
HP_IMPAIRED_TANDEM_GAIT,SET,9,0.19394,0.0042926,0.32898,0.27777,HP_IMPAIRED_TANDEM_GAIT,0.9452598022903
NABA_MATRISOME,SET,950,0.018422,0.0040805,0.031256,0.2778,NABA_MATRISOME,0.9452598022903
MODULE_189,SET,10,0.14608,0.0034083,0.24785,0.2778,MODULE_189,0.9452598022903
GSE26559_TCF1_KO_VS_WT_LIN_N...1,SET,174,0.037266,0.0036105,0.063242,0.27785,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN,0.9452598022903
GSE26495_NAIVE_VS_PD1LOW_CD8...2,SET,153,0.040624,0.0036928,0.068945,0.27786,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP,0.9452598022903
GOMF_CCR5_CHEMOKINE_RECEPTOR...,SET,7,0.20575,0.0040166,0.34922,0.27788,GOMF_CCR5_CHEMOKINE_RECEPTOR_BINDING,0.9452598022903
HP_ECTRODACTYLY,SET,66,0.063997,0.00383,0.10866,0.27795,HP_ECTRODACTYLY,0.94540538755138
HP_FOCAL_WHITE_MATTER_LESIONS,SET,13,0.13085,0.0034806,0.2223,0.27806,HP_FOCAL_WHITE_MATTER_LESIONS,0.945486946101927
HP_CROSSED_FUSED_RENAL_ECTOP...,SET,9,0.15748,0.0034858,0.26755,0.27807,HP_CROSSED_FUSED_RENAL_ECTOPIA,0.945486946101927
GOBP_PROTEIN_IMPORT,SET,8,0.18854,0.0039346,0.32037,0.2781,GOBP_PROTEIN_IMPORT,0.945486946101927
KEGG_MEDICUS_REFERENCE_KINET...2,SET,19,0.12422,0.0039938,0.21108,0.27811,KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT,0.945486946101927
GOMF_MONOOXYGENASE_ACTIVITY,SET,100,0.055264,0.0040673,0.093911,0.27811,GOMF_MONOOXYGENASE_ACTIVITY,0.945486946101927
NEBEN_AML_WITH_FLT3_OR_NRAS_...2,SET,7,0.18899,0.0036894,0.32129,0.2782,NEBEN_AML_WITH_FLT3_OR_NRAS_UP,0.945681349245007
GOMF_IGE_BINDING,SET,5,0.21793,0.0035957,0.37057,0.27824,GOMF_IGE_BINDING,0.945681349245007
MODULE_67,SET,199,0.034432,0.0035651,0.058561,0.27828,MODULE_67,0.945681349245007
ZHANG_PROLIFERATING_VS_QUIES...,SET,45,0.075317,0.0037241,0.1281,0.27829,ZHANG_PROLIFERATING_VS_QUIESCENT,0.945681349245007
GSE13485_DAY3_VS_DAY7_YF17D_...2,SET,151,0.03945,0.0035628,0.067105,0.27831,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP,0.945681349245007
GSE42021_TREG_PLN_VS_TREG_PR...1,SET,188,0.037997,0.0038251,0.064653,0.27837,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN,0.945681349245007
MARTINELLI_IMMATURE_NEUTROPH...2,SET,8,0.20408,0.0042589,0.34735,0.27843,MARTINELLI_IMMATURE_NEUTROPHIL_UP,0.945681349245007
GOBP_CHROMOSOME_ORGANIZATION...,SET,55,0.060515,0.0033071,0.10301,0.27844,GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE,0.945681349245007
HP_GENERALIZED_JOINT_HYPERMO...,SET,46,0.076344,0.0038164,0.12999,0.2785,HP_GENERALIZED_JOINT_HYPERMOBILITY,0.945681349245007
PEART_HDAC_PROLIFERATION_CLU...2,SET,51,0.070981,0.0037357,0.12088,0.27854,PEART_HDAC_PROLIFERATION_CLUSTER_UP,0.945681349245007
HOXD1_TARGET_GENES,SET,56,0.06303,0.0034756,0.10737,0.2786,HOXD1_TARGET_GENES,0.945681349245007
SCHLINGEMANN_SKIN_CARCINOGEN...2,SET,36,0.085041,0.0037619,0.14494,0.27869,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP,0.945681349245007
GOBP_NEGATIVE_REGULATION_OF_...599,SET,12,0.13885,0.0035484,0.23663,0.27869,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.945681349245007
GSE7460_CTRL_VS_TGFB_TREATED...4,SET,192,0.033945,0.003453,0.057853,0.27869,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP,0.945681349245007
HUANG_GATA2_TARGETS_UP,SET,141,0.042494,0.0037095,0.072435,0.27872,HUANG_GATA2_TARGETS_UP,0.945681349245007
HP_INSIDIOUS_ONSET,SET,15,0.1228,0.0035084,0.20936,0.27876,HP_INSIDIOUS_ONSET,0.945681349245007
LIU_CMYB_TARGETS_DN,SET,6,0.20071,0.0036277,0.34227,0.2788,LIU_CMYB_TARGETS_DN,0.945681349245007
HP_PROGRESSIVE_SPASTICITY,SET,26,0.09398,0.003534,0.16028,0.27882,HP_PROGRESSIVE_SPASTICITY,0.945681349245007
GOMF_CLATHRIN_HEAVY_CHAIN_BI...,SET,11,0.15401,0.0037685,0.26272,0.27886,GOMF_CLATHRIN_HEAVY_CHAIN_BINDING,0.945681349245007
GOBP_REGULATION_OF_POTASSIUM...3,SET,45,0.077132,0.0038138,0.13157,0.27887,GOBP_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.945681349245007
GOBP_LYTIC_VACUOLE_ORGANIZAT...,SET,98,0.049937,0.0036385,0.085189,0.27888,GOBP_LYTIC_VACUOLE_ORGANIZATION,0.945681349245007
HP_ECTODERMAL_DYSPLASIA,SET,23,0.1051,0.0037176,0.1793,0.27888,HP_ECTODERMAL_DYSPLASIA,0.945681349245007
WEI_MYCN_TARGETS_WITH_E_BOX,SET,722,0.01804,0.0035062,0.030776,0.27889,WEI_MYCN_TARGETS_WITH_E_BOX,0.945681349245007
GSE42021_TREG_PLN_VS_CD24LO_...1,SET,180,0.037527,0.0036974,0.064036,0.27893,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN,0.945681349245007
YGCGYRCGC_UNKNOWN,SET,287,0.02825,0.0035042,0.048211,0.27895,YGCGYRCGC_UNKNOWN,0.945681349245007
GSE23984_CTRL_VS_HYPOCALEMIC...2,SET,176,0.036092,0.0035167,0.061601,0.27897,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP,0.945681349245007
GNF2_GLTSCR2,SET,30,0.086281,0.0034847,0.14727,0.27899,GNF2_GLTSCR2,0.945681349245007
HP_LIMITED_ELBOW_FLEXION,SET,10,0.17474,0.0040769,0.29828,0.279,HP_LIMITED_ELBOW_FLEXION,0.945681349245007
MIR34A_3P,SET,64,0.061657,0.0036338,0.10526,0.27902,MIR34A_3P,0.945681349245007
GOBP_T_CELL_ACTIVATION,SET,525,0.023033,0.0038387,0.039336,0.27909,GOBP_T_CELL_ACTIVATION,0.945681349245007
HINATA_NFKB_MATRIX,SET,10,0.16762,0.0039108,0.28628,0.27911,HINATA_NFKB_MATRIX,0.945681349245007
GOBP_REGULATION_OF_NADP_META...,SET,8,0.18249,0.0038085,0.31173,0.27914,GOBP_REGULATION_OF_NADP_METABOLIC_PROCESS,0.945681349245007
WP_PURINE_METABOLISM,SET,10,0.17504,0.0040838,0.29902,0.27915,WP_PURINE_METABOLISM,0.945681349245007
MIR582_3P,SET,83,0.053811,0.0036098,0.09195,0.2792,MIR582_3P,0.945681349245007
GOBP_ACTIN_MYOSIN_FILAMENT_S...,SET,15,0.12871,0.0036772,0.21992,0.2792,GOBP_ACTIN_MYOSIN_FILAMENT_SLIDING,0.945681349245007
GOBP_POSITIVE_REGULATION_OF_...5,SET,45,0.074234,0.0036705,0.12684,0.2792,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,0.945681349245007
HP_MYOCARDITIS,SET,6,0.23523,0.0042516,0.40199,0.27922,HP_MYOCARDITIS,0.945681349245007
GSE22886_TCELL_VS_BCELL_NAIV...2,SET,182,0.03501,0.0034683,0.059837,0.27925,GSE22886_TCELL_VS_BCELL_NAIVE_UP,0.945681349245007
PID_FCER1_PATHWAY,SET,56,0.064955,0.0035817,0.11102,0.27926,PID_FCER1_PATHWAY,0.945681349245007
MIR3685,SET,166,0.03794,0.0035911,0.06485,0.27926,MIR3685,0.945681349245007
REACTOME_GLOBAL_GENOME_NUCLE...,SET,79,0.050066,0.003277,0.085595,0.27931,REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,0.945681349245007
HP_ACETABULAR_SPURS,SET,5,0.2263,0.0037339,0.3869,0.27931,HP_ACETABULAR_SPURS,0.945681349245007
GSE17974_2.5H_VS_72H_IL4_AND...2,SET,178,0.035065,0.0034358,0.059959,0.27934,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,0.945690794856809
GOBP_RESPONSE_TO_ELECTRICAL_...,SET,41,0.07861,0.0037106,0.13448,0.27943,GOBP_RESPONSE_TO_ELECTRICAL_STIMULUS,0.945693120560475
WP_CELL_DIFFERENTIATION_EXPA...,SET,18,0.12733,0.0039848,0.21786,0.27946,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,0.945693120560475
BIOCARTA_NOS1_PATHWAY,SET,21,0.11094,0.0037498,0.18984,0.27948,BIOCARTA_NOS1_PATHWAY,0.945693120560475
REACTOME_FORMATION_OF_FIBRIN...,SET,36,0.088801,0.0039282,0.15199,0.27953,REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE,0.945693120560475
GSE37416_CTRL_VS_6H_F_TULARE...1,SET,169,0.037245,0.0035567,0.063749,0.27953,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.945693120560475
REACTOME_HYDROLYSIS_OF_LPC,SET,9,0.17075,0.0037795,0.2923,0.27956,REACTOME_HYDROLYSIS_OF_LPC,0.945693120560475
HP_ABNORMAL_SPERM_HEAD_MORPH...,SET,26,0.10234,0.0038485,0.17521,0.27958,HP_ABNORMAL_SPERM_HEAD_MORPHOLOGY,0.945693120560475
HP_TOOTH_ABSCESS,SET,6,0.22271,0.0040254,0.38131,0.27959,HP_TOOTH_ABSCESS,0.945693120560475
GOBP_POSITIVE_REGULATION_OF_...130,SET,137,0.042875,0.0036897,0.073411,0.2796,GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH,0.945693120560475
HP_STARING_GAZE,SET,20,0.10402,0.0034314,0.17814,0.27963,HP_STARING_GAZE,0.945693120560475
PATEL_SKIN_OF_BODY_ZOSTAVAX_...2,SET,33,0.086448,0.0036616,0.14805,0.27964,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_DN,0.945693120560475
MARZEC_IL2_SIGNALING_UP,SET,109,0.047745,0.0036677,0.081794,0.27971,MARZEC_IL2_SIGNALING_UP,0.945744166828699
GSE15624_3H_VS_6H_HALOFUGINO...1,SET,135,0.042932,0.0036677,0.073548,0.27971,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,0.945744166828699
GSE22589_HEALTHY_VS_HIV_AND_...1,SET,171,0.035991,0.0034571,0.061681,0.27978,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN,0.945744166828699
GOMF_KINASE_ACTIVITY,SET,682,0.018771,0.0035499,0.032179,0.27984,GOMF_KINASE_ACTIVITY,0.945744166828699
GOMF_TRANSCRIPTION_COACTIVAT...2,SET,40,0.083067,0.0038729,0.14242,0.27987,GOMF_TRANSCRIPTION_COACTIVATOR_BINDING,0.945744166828699
HP_ABNORMALLY_LOW_T_CELL_REC...,SET,6,0.2223,0.0040178,0.38115,0.27987,HP_ABNORMALLY_LOW_T_CELL_RECEPTOR_EXCISION_CIRCLE_LEVEL,0.945744166828699
GSE16755_CTRL_VS_IFNA_TREATE...2,SET,180,0.034242,0.0033737,0.058712,0.27988,GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP,0.945744166828699
GSE3982_DC_VS_MAC_UP,SET,174,0.036488,0.0035352,0.062565,0.27988,GSE3982_DC_VS_MAC_UP,0.945744166828699
GOBP_PROTEIN_DNA_COMPLEX_DIS...,SET,21,0.10592,0.0035802,0.18165,0.2799,GOBP_PROTEIN_DNA_COMPLEX_DISASSEMBLY,0.945744166828699
GOBP_CORONARY_VASCULATURE_MO...,SET,17,0.12676,0.0038552,0.21741,0.27994,GOBP_CORONARY_VASCULATURE_MORPHOGENESIS,0.945787372411782
GOBP_ENDOSOME_TO_LYSOSOME_TR...2,SET,17,0.11083,0.0033708,0.19015,0.28001,GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.945931915824261
HP_GENITAL_NEOPLASM,SET,146,0.040689,0.0036139,0.069858,0.28013,HP_GENITAL_NEOPLASM,0.946007065850816
REACTOME_TRANSCRIPTIONAL_REG...4,SET,171,0.036565,0.0035122,0.062782,0.28015,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,0.946007065850816
GOBP_ATP_TRANSPORT,SET,19,0.12326,0.0039631,0.21165,0.28016,GOBP_ATP_TRANSPORT,0.946007065850816
REACTOME_MITOCHONDRIAL_IRON_...,SET,12,0.14349,0.0036672,0.24643,0.28019,REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS,0.946007065850816
STEIN_ESRRA_TARGETS,SET,473,0.022356,0.0035417,0.038401,0.28023,STEIN_ESRRA_TARGETS,0.946007065850816
GOMF_ARYLSULFATASE_ACTIVITY,SET,9,0.17171,0.0038006,0.29494,0.28023,GOMF_ARYLSULFATASE_ACTIVITY,0.946007065850816
GOMF_TRIPEPTIDE_TRANSMEMBRAN...,SET,9,0.16955,0.003753,0.29127,0.28025,GOMF_TRIPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.946007065850816
HP_GAIT_ATAXIA,SET,217,0.032794,0.003544,0.056337,0.28025,HP_GAIT_ATAXIA,0.946007065850816
KEGG_NON_HOMOLOGOUS_END_JOIN...,SET,12,0.11762,0.003006,0.20209,0.28028,KEGG_NON_HOMOLOGOUS_END_JOINING,0.94601645139361
GOMF_OLIGOPEPTIDE_TRANSMEMBR...,SET,14,0.13737,0.0037918,0.23607,0.28032,GOMF_OLIGOPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.946059584385318
GOBP_DENSE_CORE_GRANULE_EXOC...,SET,10,0.17259,0.0040266,0.29671,0.2804,GOBP_DENSE_CORE_GRANULE_EXOCYTOSIS,0.946097087944089
GOCC_F_ACTIN_CAPPING_PROTEIN...,SET,8,0.16405,0.0034237,0.28204,0.2804,GOCC_F_ACTIN_CAPPING_PROTEIN_COMPLEX,0.946097087944089
MIR4665_5P,SET,137,0.043217,0.0037191,0.074307,0.28042,MIR4665_5P,0.946097087944089
REACTOME_INTERLEUKIN_6_SIGNA...,SET,11,0.15359,0.0037582,0.26411,0.28044,REACTOME_INTERLEUKIN_6_SIGNALING,0.946097087944089
MODULE_99,SET,325,0.029312,0.0038651,0.050413,0.28047,MODULE_99,0.946106459283704
KINSEY_TARGETS_OF_EWSR1_FLII...2,SET,1155,0.014411,0.0034989,0.024792,0.28053,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP,0.946192649199418
SIMBULAN_PARP1_TARGETS_UP,SET,27,0.1027,0.0039353,0.17669,0.28055,SIMBULAN_PARP1_TARGETS_UP,0.946192649199418
GOBP_COLLAGEN_METABOLIC_PROC...,SET,90,0.056189,0.0039243,0.096694,0.28059,GOBP_COLLAGEN_METABOLIC_PROCESS,0.946235731612653
REACTOME_UPTAKE_OF_DIETARY_C...,SET,9,0.17972,0.0039781,0.30939,0.28066,REACTOME_UPTAKE_OF_DIETARY_COBALAMINS_INTO_ENTEROCYTES,0.946263788922301
HP_CHRONIC_AXONAL_NEUROPATHY,SET,7,0.21441,0.0041857,0.36913,0.28067,HP_CHRONIC_AXONAL_NEUROPATHY,0.946263788922301
HP_INTESTINAL_POLYP,SET,63,0.059819,0.003498,0.10299,0.28068,HP_INTESTINAL_POLYP,0.946263788922301
MIR494_5P,SET,38,0.077583,0.0035258,0.1336,0.28073,MIR494_5P,0.946276817917394
GCM_PTPRU,SET,50,0.065444,0.0034105,0.11271,0.28074,GCM_PTPRU,0.946276817917394
GTTRYCATRR_UNKNOWN,SET,156,0.037993,0.0034871,0.065452,0.2808,GTTRYCATRR_UNKNOWN,0.946276817917394
GSE7764_IL15_NK_CELL_24H_VS_...1,SET,176,0.035561,0.0034649,0.061265,0.28081,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN,0.946276817917394
MEISSNER_BRAIN_HCP_WITH_H3_U...,SET,31,0.086851,0.0035657,0.14963,0.28082,MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED,0.946276817917394
HP_UNUSUAL_SKIN_INFECTION,SET,7,0.16099,0.0031429,0.27747,0.28088,HP_UNUSUAL_SKIN_INFECTION,0.946338528642047
MIR4675,SET,38,0.076127,0.0034597,0.13121,0.2809,MIR4675,0.946338528642047
PID_HDAC_CLASSIII_PATHWAY,SET,23,0.10188,0.0036035,0.17562,0.28092,PID_HDAC_CLASSIII_PATHWAY,0.946338528642047
HP_SHORT_STEPPED_SHUFFLING_G...,SET,14,0.12668,0.0034968,0.21848,0.28101,HP_SHORT_STEPPED_SHUFFLING_GAIT,0.94645823723229
GSE8835_CD4_VS_CD8_TCELL_CLL...2,SET,189,0.036952,0.0037297,0.063725,0.28101,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP,0.94645823723229
HP_DYSGYRIA,SET,7,0.17886,0.0034917,0.3085,0.28104,HP_DYSGYRIA,0.946467558139535
MIKKELSEN_IPS_WITH_HCP_H3K27...,SET,97,0.057621,0.004177,0.099403,0.28107,MIKKELSEN_IPS_WITH_HCP_H3K27ME3,0.946474757939582
GOBP_CALCIUM_ION_REGULATED_E...1,SET,62,0.062144,0.0036051,0.10725,0.28115,GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS,0.946474757939582
HP_ABNORMAL_NASAL_TIP_MORPHO...,SET,324,0.026582,0.0034998,0.045875,0.28115,HP_ABNORMAL_NASAL_TIP_MORPHOLOGY,0.946474757939582
SABATES_COLORECTAL_ADENOMA_S...2,SET,15,0.11963,0.0034178,0.20653,0.28122,SABATES_COLORECTAL_ADENOMA_SIZE_UP,0.946474757939582
HAHTOLA_MYCOSIS_FUNGOIDES_SK...1,SET,26,0.099901,0.0037567,0.17249,0.28124,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,0.946474757939582
GOBP_DNA_METABOLIC_PROCESS,SET,870,0.016069,0.0034139,0.027744,0.28124,GOBP_DNA_METABOLIC_PROCESS,0.946474757939582
GSE12845_IGD_NEG_BLOOD_VS_NA...1,SET,182,0.03568,0.0035347,0.061605,0.28124,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,0.946474757939582
GSE42021_CD24INT_VS_CD24LOW_...4,SET,172,0.037062,0.0035702,0.063996,0.28126,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP,0.946474757939582
REACTOME_PI3K_EVENTS_IN_ERBB...2,SET,10,0.1552,0.0036209,0.26805,0.28131,REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING,0.946502686090407
REACTOME_NEGATIVE_REGULATION...11,SET,5,0.22317,0.0036822,0.38553,0.28135,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS,0.946502686090407
GSE6269_FLU_VS_STAPH_AUREUS_...2,SET,172,0.03561,0.0034304,0.061518,0.28135,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP,0.946502686090407
HP_MOTOR_REGRESSION,SET,19,0.11444,0.0036793,0.19778,0.28143,HP_MOTOR_REGRESSION,0.946635026117237
ZHENG_FOXP3_TARGETS_UP,SET,24,0.10738,0.0038795,0.18562,0.28148,ZHENG_FOXP3_TARGETS_UP,0.946635026117237
GSE27859_MACROPHAGE_VS_CD11C...3,SET,178,0.036743,0.0036001,0.063531,0.28152,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_DN,0.946635026117237
WP_IL1_AND_MEGAKARYOCYTES_IN...,SET,22,0.11213,0.0038789,0.1939,0.28155,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,0.946635026117237
GOBP_CONNECTIVE_TISSUE_DEVEL...,SET,260,0.031418,0.0037122,0.054334,0.28155,GOBP_CONNECTIVE_TISSUE_DEVELOPMENT,0.946635026117237
HP_APLASIA_HYPOPLASIA_OF_THE...46,SET,7,0.23268,0.0045424,0.40244,0.28157,HP_APLASIA_HYPOPLASIA_OF_THE_NASAL_BONE,0.946635026117237
GOCC_TETRASPANIN_ENRICHED_MI...,SET,10,0.15806,0.0036877,0.27338,0.28158,GOCC_TETRASPANIN_ENRICHED_MICRODOMAIN,0.946635026117237
BRN2_01,SET,210,0.034538,0.0036725,0.05975,0.28162,BRN2_01,0.946677928232905
MIR4638_3P,SET,56,0.063816,0.0035189,0.11042,0.28165,MIR4638_3P,0.946687209864604
HP_POLLAKISURIA,SET,7,0.17568,0.0034295,0.30402,0.28169,HP_POLLAKISURIA,0.946730098636495
HP_UNILATERAL_PRIMARY_PULMON...,SET,3,0.24925,0.0031857,0.43146,0.28175,HP_UNILATERAL_PRIMARY_PULMONARY_DYSGENESIS,0.946755612984253
GOMF_COMPLEMENT_COMPONENT_C1...,SET,7,0.18561,0.0036235,0.32139,0.28179,GOMF_COMPLEMENT_COMPONENT_C1Q_COMPLEX_BINDING,0.946755612984253
HP_ABNORMAL_FUNDUS_AUTOFLUOR...,SET,26,0.10614,0.0039912,0.18378,0.28179,HP_ABNORMAL_FUNDUS_AUTOFLUORESCENCE_IMAGING,0.946755612984253
GSE25088_CTRL_VS_IL4_AND_ROS...2,SET,160,0.039873,0.0037058,0.069051,0.28183,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.946755612984253
GOBP_POSITIVE_REGULATION_OF_...344,SET,7,0.19747,0.0038549,0.34204,0.28186,GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.946755612984253
HP_BRANCHIAL_FISTULA,SET,9,0.1717,0.0038004,0.29745,0.2819,HP_BRANCHIAL_FISTULA,0.946755612984253
GSE11386_NAIVE_VS_MEMORY_BCE...1,SET,144,0.040926,0.0036101,0.070906,0.28191,GSE11386_NAIVE_VS_MEMORY_BCELL_DN,0.946755612984253
GOBP_NUCLEIC_ACID_CATABOLIC_...,SET,606,0.018866,0.0033704,0.032688,0.28192,GOBP_NUCLEIC_ACID_CATABOLIC_PROCESS,0.946755612984253
MIR6852_5P,SET,175,0.036631,0.0035591,0.063477,0.28195,MIR6852_5P,0.946755612984253
WP_NPHP1_DELETION_SYNDROME,SET,10,0.16782,0.0039154,0.29084,0.28197,WP_NPHP1_DELETION_SYNDROME,0.946755612984253
HP_DYNEIN_ARM_DEFECT_OF_RESP...,SET,14,0.11619,0.0032073,0.20142,0.28202,HP_DYNEIN_ARM_DEFECT_OF_RESPIRATORY_MOTILE_CILIA,0.946807707910751
TFCP2_TARGET_GENES,SET,76,0.055433,0.003559,0.096103,0.28204,TFCP2_TARGET_GENES,0.946807707910751
GOBP_PEROXISOME_FISSION,SET,8,0.17414,0.0036341,0.30211,0.28218,GOBP_PEROXISOME_FISSION,0.946994959482925
HP_PAROXYSMAL_DYSKINESIA,SET,15,0.12313,0.0035178,0.21363,0.28219,HP_PAROXYSMAL_DYSKINESIA,0.946994959482925
KIM_MYCL1_AMPLIFICATION_TARG...1,SET,18,0.11661,0.0036492,0.20234,0.28221,KIM_MYCL1_AMPLIFICATION_TARGETS_DN,0.946994959482925
GOBP_POSITIVE_REGULATION_OF_...323,SET,29,0.089989,0.0035735,0.15615,0.28221,GOBP_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.946994959482925
DESCARTES_FETAL_STOMACH_LYMP...1,SET,19,0.12589,0.0040477,0.21851,0.28226,DESCARTES_FETAL_STOMACH_LYMPHATIC_ENDOTHELIAL_CELLS,0.946994959482925
GOBP_POSITIVE_REGULATION_OF_...488,SET,87,0.053949,0.0037048,0.093642,0.28227,GOBP_POSITIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,0.946994959482925
GOBP_CRANIAL_GANGLION_DEVELO...,SET,4,0.26048,0.0038442,0.45228,0.28234,GOBP_CRANIAL_GANGLION_DEVELOPMENT,0.946994959482925
UNTERMAN_IPF_VS_CTRL_CD8T_UP,SET,2,0.3436,0.0035859,0.59664,0.28235,UNTERMAN_IPF_VS_CTRL_CD8T_UP,0.946994959482925
GOBP_NEGATIVE_REGULATION_OF_...537,SET,80,0.054491,0.003589,0.09465,0.28241,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.946994959482925
REACTOME_LEISHMANIA_INFECTION,SET,152,0.038532,0.0034913,0.066934,0.28242,REACTOME_LEISHMANIA_INFECTION,0.946994959482925
HP_AORTOPULMONARY_COLLATERAL...,SET,14,0.14284,0.0039429,0.24817,0.28245,HP_AORTOPULMONARY_COLLATERAL_ARTERIES,0.946994959482925
HP_UNDERDEVELOPED_SUPRAORBIT...,SET,55,0.068832,0.0037616,0.11958,0.28245,HP_UNDERDEVELOPED_SUPRAORBITAL_RIDGES,0.946994959482925
GSE22886_IGM_MEMORY_BCELL_VS...1,SET,174,0.036166,0.0035039,0.062833,0.28245,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,0.946994959482925
WP_ULCERATIVE_COLITIS_SIGNAL...,SET,16,0.1272,0.0037533,0.22107,0.28252,WP_ULCERATIVE_COLITIS_SIGNALING,0.947138284942606
HP_PECTUS_CARINATUM,SET,158,0.03754,0.0034673,0.065287,0.28265,HP_PECTUS_CARINATUM,0.947170328669988
GSE22282_HYPOXIA_VS_NORMOXIA...1,SET,178,0.036969,0.0036223,0.064295,0.28265,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN,0.947170328669988
ROETH_TERT_TARGETS_UP,SET,14,0.14394,0.0039731,0.25047,0.28276,ROETH_TERT_TARGETS_UP,0.947170328669988
GOCC_NONHOMOLOGOUS_END_JOINI...,SET,7,0.15751,0.0030749,0.2741,0.28277,GOCC_NONHOMOLOGOUS_END_JOINING_COMPLEX,0.947170328669988
GOBP_REGULATION_OF_GONAD_DEV...,SET,12,0.15545,0.0039726,0.27052,0.28278,GOBP_REGULATION_OF_GONAD_DEVELOPMENT,0.947170328669988
GSE7218_UNSTIM_VS_ANTIGEN_ST...2,SET,176,0.034918,0.0034022,0.060817,0.28294,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP,0.947170328669988
MIR9851_3P,SET,161,0.038101,0.0035522,0.066366,0.28295,MIR9851_3P,0.947170328669988
GOBP_REGULATION_OF_TRIGLYCER...2,SET,12,0.14236,0.0036381,0.248,0.28298,GOBP_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,0.947170328669988
GAVISH_3CA_MALIGNANT_METAPRO...27,SET,46,0.078434,0.0039209,0.13665,0.28299,GAVISH_3CA_MALIGNANT_METAPROGRAM_35_HEMATO_RELATED_1,0.947170328669988
HP_APLASTIC_HYPOPLASTIC_TOEN...,SET,105,0.046263,0.0034885,0.080615,0.28303,HP_APLASTIC_HYPOPLASTIC_TOENAIL,0.947170328669988
GOBP_SHORT_CHAIN_FATTY_ACID_...1,SET,7,0.19984,0.0039012,0.34824,0.28304,GOBP_SHORT_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.947170328669988
HP_ABNORMAL_PYRAMIDAL_SIGN,SET,382,0.023932,0.0034158,0.041704,0.28304,HP_ABNORMAL_PYRAMIDAL_SIGN,0.947170328669988
GOCC_SMALL_SUBUNIT_PROCESSOME,SET,63,0.056581,0.0033086,0.098643,0.28313,GOCC_SMALL_SUBUNIT_PROCESSOME,0.947170328669988
CAFFAREL_RESPONSE_TO_THC_24H...1,SET,12,0.14192,0.0036269,0.24743,0.28314,CAFFAREL_RESPONSE_TO_THC_24HR_3_DN,0.947170328669988
GOMF_ISOCITRATE_DEHYDROGENAS...,SET,4,0.24238,0.0035771,0.42263,0.28316,GOMF_ISOCITRATE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.947170328669988
PID_PDGFRB_PATHWAY,SET,124,0.04286,0.0035103,0.074741,0.28317,PID_PDGFRB_PATHWAY,0.947170328669988
MIR6847_3P,SET,55,0.063523,0.0034714,0.11077,0.28317,MIR6847_3P,0.947170328669988
GSE41176_UNSTIM_VS_ANTI_IGM_...10,SET,170,0.035447,0.003395,0.061813,0.28317,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP,0.947170328669988
GSE20366_TREG_VS_NAIVE_CD4_T...4,SET,184,0.037066,0.0036919,0.064657,0.28324,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN,0.947170328669988
GOBP_CELLULAR_RESPONSE_TO_CG...,SET,7,0.1759,0.0034338,0.30696,0.28332,GOBP_CELLULAR_RESPONSE_TO_CGMP,0.947170328669988
REACTOME_SIGNALING_BY_CSF1_M...,SET,29,0.088728,0.0035234,0.1549,0.28339,REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS,0.947170328669988
MODULE_530,SET,15,0.12374,0.0035352,0.21608,0.28345,MODULE_530,0.947170328669988
ACCAATC_MIR509,SET,45,0.081393,0.0040245,0.14217,0.28349,ACCAATC_MIR509,0.947170328669988
HP_TRICEPS_WEAKNESS,SET,17,0.11113,0.0033799,0.19412,0.2835,HP_TRICEPS_WEAKNESS,0.947170328669988
DESCARTES_FETAL_PLACENTA_EXT...,SET,60,0.065759,0.003753,0.11489,0.28353,DESCARTES_FETAL_PLACENTA_EXTRAVILLOUS_TROPHOBLASTS,0.947170328669988
GSE22886_NAIVE_VS_IGM_MEMORY...1,SET,176,0.037036,0.0036086,0.064705,0.28354,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN,0.947170328669988
GOMF_GAP_JUNCTION_CHANNEL_AC...1,SET,21,0.11051,0.0037352,0.19309,0.28356,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY,0.947170328669988
KEGG_MEDICUS_PATHOGEN_SHIGEL...4,SET,13,0.11831,0.003147,0.20677,0.2836,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY,0.947170328669988
GOBP_COLLATERAL_SPROUTING,SET,25,0.10179,0.0037533,0.17791,0.28362,GOBP_COLLATERAL_SPROUTING,0.947170328669988
GOBP_NEUROFILAMENT_CYTOSKELE...,SET,10,0.14396,0.0033587,0.25162,0.28362,GOBP_NEUROFILAMENT_CYTOSKELETON_ORGANIZATION,0.947170328669988
HP_ABNORMAL_MORPHOLOGY_OF_TH...10,SET,28,0.086734,0.0033845,0.1516,0.28362,HP_ABNORMAL_MORPHOLOGY_OF_THE_VESTIBULE_OF_THE_INNER_EAR,0.947170328669988
MORF_MTA1,SET,93,0.046796,0.003322,0.081815,0.28367,MORF_MTA1,0.947170328669988
GNF2_SPI1,SET,34,0.085253,0.0036652,0.14907,0.28369,GNF2_SPI1,0.947170328669988
GOBP_ACTIN_CROSSLINK_FORMATI...,SET,13,0.14769,0.0039285,0.25828,0.28372,GOBP_ACTIN_CROSSLINK_FORMATION,0.947170328669988
SARTIPY_NORMAL_AT_INSULIN_RE...2,SET,27,0.096819,0.00371,0.16932,0.28373,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,0.947170328669988
KEGG_MEDICUS_REFERENCE_TRANS...3,SET,72,0.054743,0.0034213,0.095735,0.28373,KEGG_MEDICUS_REFERENCE_TRANSLATION_INITIATION,0.947170328669988
GOBP_POSITIVE_REGULATION_OF_...301,SET,19,0.11553,0.0037144,0.20204,0.28373,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION,0.947170328669988
GARY_CD5_TARGETS_UP,SET,415,0.02305,0.003426,0.040317,0.28375,GARY_CD5_TARGETS_UP,0.947170328669988
HP_RENAL_SALT_WASTING,SET,20,0.1177,0.0038825,0.2059,0.28378,HP_RENAL_SALT_WASTING,0.947170328669988
GSE557_WT_VS_CIITA_KO_DC_DN,SET,186,0.0359,0.003595,0.062804,0.28379,GSE557_WT_VS_CIITA_KO_DC_DN,0.947170328669988
REACTOME_PLATELET_ACTIVATION...,SET,246,0.03175,0.0036504,0.055556,0.28383,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,0.947170328669988
GOBP_TESTOSTERONE_BIOSYNTHET...,SET,10,0.14677,0.0034242,0.25681,0.28384,GOBP_TESTOSTERONE_BIOSYNTHETIC_PROCESS,0.947170328669988
chr7q21,SET,73,0.10007,0.0062971,0.17515,0.2839,chr7q21,0.947170328669988
JAZAG_TGFB1_SIGNALING_VIA_SM...2,SET,98,0.048438,0.0035293,0.08479,0.28391,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,0.947170328669988
GSE2585_CTEC_VS_MTEC_THYMUS_...1,SET,187,0.036159,0.0036305,0.063299,0.28392,GSE2585_CTEC_VS_MTEC_THYMUS_DN,0.947170328669988
SRF_01,SET,45,0.075319,0.0037242,0.13186,0.28393,SRF_01,0.947170328669988
MIR593_5P,SET,146,0.040082,0.0035599,0.070188,0.28398,MIR593_5P,0.947170328669988
HP_ABNORMAL_REPRODUCTIVE_SYS...,SET,1236,0.013987,0.0035047,0.024496,0.28401,HP_ABNORMAL_REPRODUCTIVE_SYSTEM_MORPHOLOGY,0.947170328669988
GSE22935_WT_VS_MYD88_KO_MACR...3,SET,182,0.035362,0.0035031,0.061933,0.28401,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_DN,0.947170328669988
FOXN3_TARGET_GENES,SET,1155,0.01507,0.0036589,0.026395,0.28403,FOXN3_TARGET_GENES,0.947170328669988
GOCC_MOTILE_CILIUM,SET,229,0.031559,0.0035025,0.055278,0.28403,GOCC_MOTILE_CILIUM,0.947170328669988
REACTOME_FOXO_MEDIATED_TRANS...2,SET,16,0.12498,0.0036877,0.21892,0.28404,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,0.947170328669988
GOBP_NEGATIVE_REGULATION_BY_...2,SET,13,0.13511,0.0035937,0.23674,0.2841,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS,0.947170328669988
GOCC_M_BAND,SET,27,0.08607,0.0032981,0.15082,0.28411,GOCC_M_BAND,0.947170328669988
REACTOME_SIGNALLING_TO_P38_V...,SET,5,0.18652,0.0030776,0.32687,0.28413,REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN,0.947170328669988
HP_PAPILLARY_CYSTADENOMA_OF_...,SET,5,0.22535,0.0037183,0.39496,0.28415,HP_PAPILLARY_CYSTADENOMA_OF_THE_EPIDIDYMIS,0.947170328669988
GOCC_PHAGOLYSOSOME,SET,7,0.17176,0.003353,0.30104,0.28416,GOCC_PHAGOLYSOSOME,0.947170328669988
GOBP_VESICLE_CYTOSKELETAL_TR...,SET,55,0.063078,0.0034471,0.11057,0.28418,GOBP_VESICLE_CYTOSKELETAL_TRAFFICKING,0.947170328669988
HP_POSTTERM_PREGNANCY,SET,5,0.25823,0.0042608,0.45272,0.2842,HP_POSTTERM_PREGNANCY,0.947170328669988
MIR3167,SET,96,0.050283,0.0036264,0.08817,0.28424,MIR3167,0.947170328669988
GOBP_CELLULAR_COMPONENT_DISA...1,SET,481,0.021611,0.0034518,0.037895,0.28424,GOBP_CELLULAR_COMPONENT_DISASSEMBLY,0.947170328669988
GOCC_CYTOSOLIC_RIBOSOME,SET,102,0.044881,0.0033358,0.078708,0.28427,GOCC_CYTOSOLIC_RIBOSOME,0.947170328669988
HP_ECTOPIC_ANTERIOR_PITUITAR...,SET,8,0.16562,0.0034564,0.29046,0.28427,HP_ECTOPIC_ANTERIOR_PITUITARY_GLAND,0.947170328669988
CTACCTC_LET7A_LET7B_LET7C_LE...,SET,352,0.025861,0.0035462,0.045359,0.28429,CTACCTC_LET7A_LET7B_LET7C_LET7D_LET7E_LET7F_MIR98_LET7G_LET7I,0.947170328669988
GOBP_VENOUS_BLOOD_VESSEL_DEV...,SET,16,0.12539,0.0037,0.22002,0.28437,GOBP_VENOUS_BLOOD_VESSEL_DEVELOPMENT,0.947170328669988
GOMF_DYNACTIN_BINDING,SET,11,0.13247,0.0032415,0.23244,0.28437,GOMF_DYNACTIN_BINDING,0.947170328669988
REACTOME_SIGNALING_BY_NTRK3_...,SET,17,0.10363,0.0031517,0.18184,0.28438,REACTOME_SIGNALING_BY_NTRK3_TRKC,0.947170328669988
VANASSE_BCL2_TARGETS_UP,SET,29,0.095624,0.0037973,0.16782,0.28441,VANASSE_BCL2_TARGETS_UP,0.947170328669988
GOBP_ENDOSOME_ORGANIZATION,SET,86,0.048982,0.0033444,0.085965,0.28441,GOBP_ENDOSOME_ORGANIZATION,0.947170328669988
MIR4755_3P,SET,133,0.04228,0.0035854,0.074241,0.28451,MIR4755_3P,0.94720691091954
GOCC_MUSCLE_MYOSIN_COMPLEX,SET,14,0.15349,0.0042366,0.2695,0.28451,GOCC_MUSCLE_MYOSIN_COMPLEX,0.94720691091954
GSE20754_WT_VS_TCF1_KO_MEMOR...2,SET,187,0.033064,0.0033198,0.058062,0.28453,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP,0.94720691091954
GSE32986_GMCSF_VS_GMCSF_AND_...4,SET,170,0.036474,0.0034933,0.064053,0.28453,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.94720691091954
GSE35435_RESTING_VS_IL4_TREA...1,SET,170,0.036764,0.0035212,0.064605,0.28466,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN,0.947285064377682
KESHELAVA_MULTIPLE_DRUG_RESI...,SET,66,0.057423,0.0034366,0.10092,0.28468,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,0.947285064377682
HMX1_01,SET,39,0.081601,0.0037568,0.14342,0.28469,HMX1_01,0.947285064377682
GOMF_TRANSPORTER_ACTIVITY,SET,1107,0.015266,0.0036338,0.026837,0.28473,GOMF_TRANSPORTER_ACTIVITY,0.947285064377682
GOBP_ESTABLISHMENT_OR_MAINTE...2,SET,211,0.033941,0.0036175,0.059669,0.28474,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,0.947285064377682
GOBP_REGULATION_OF_DENDRITIC...5,SET,11,0.14805,0.0036226,0.2603,0.28476,GOBP_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE,0.947285064377682
HP_NEOPLASM_OF_THE_ORAL_CAVI...,SET,63,0.055823,0.0032643,0.098158,0.28478,HP_NEOPLASM_OF_THE_ORAL_CAVITY,0.947285064377682
HP_ONYCHOGRYPOSIS_OF_FINGERN...,SET,9,0.15879,0.0035148,0.27927,0.28482,HP_ONYCHOGRYPOSIS_OF_FINGERNAIL,0.947285064377682
REACTOME_INTERLEUKIN_2_FAMIL...,SET,39,0.08677,0.0039948,0.15262,0.28484,REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,0.947285064377682
HP_ESOPHAGEAL_STENOSIS,SET,29,0.085706,0.0034034,0.15078,0.28488,HP_ESOPHAGEAL_STENOSIS,0.947285064377682
KEGG_MEDICUS_VARIANT_NOTCH_O...,SET,16,0.12569,0.0037087,0.22113,0.28489,KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY,0.947285064377682
KRIGE_RESPONSE_TO_TOSEDOSTAT...2,SET,644,0.019271,0.0035452,0.033913,0.28494,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP,0.947285064377682
GOBP_POSTSYNAPSE_ASSEMBLY,SET,41,0.078791,0.0037191,0.13869,0.28498,GOBP_POSTSYNAPSE_ASSEMBLY,0.947285064377682
ZNF563_TARGET_GENES,SET,472,0.022094,0.0034965,0.038892,0.285,ZNF563_TARGET_GENES,0.947285064377682
FOXJ2_TARGET_GENES,SET,439,0.022849,0.0034906,0.040236,0.28507,FOXJ2_TARGET_GENES,0.947285064377682
GOBP_ADHESION_OF_SYMBIONT_TO...1,SET,12,0.16335,0.0041746,0.28769,0.28509,GOBP_ADHESION_OF_SYMBIONT_TO_HOST,0.947285064377682
GSE17186_CD21LOW_VS_CD21HIGH...4,SET,183,0.037009,0.0036763,0.065197,0.28514,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,0.947285064377682
GSE22886_NAIVE_VS_IGG_IGA_ME...2,SET,169,0.036548,0.0034902,0.064387,0.28515,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP,0.947285064377682
HP_ABNORMALITY_OF_THE_SPINOC...,SET,10,0.15458,0.0036066,0.27239,0.28518,HP_ABNORMALITY_OF_THE_SPINOCEREBELLAR_TRACTS,0.947285064377682
GOBP_REGULATION_OF_ASTROCYTE...2,SET,27,0.099964,0.0038305,0.17614,0.28519,GOBP_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,0.947285064377682
HP_THENAR_MUSCLE_ATROPHY,SET,13,0.11151,0.002966,0.1965,0.2852,HP_THENAR_MUSCLE_ATROPHY,0.947285064377682
GSE360_HIGH_DOSE_B_MALAYI_VS...4,SET,187,0.033913,0.003405,0.059771,0.28523,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,0.947285064377682
KEGG_MEDICUS_REFERENCE_LOADI...,SET,7,0.19061,0.003721,0.33596,0.28524,KEGG_MEDICUS_REFERENCE_LOADING_OF_THE_SMC5_SMC6_COMPLEX,0.947285064377682
REACTOME_2_LTR_CIRCLE_FORMAT...,SET,7,0.18208,0.0035545,0.32096,0.28526,REACTOME_2_LTR_CIRCLE_FORMATION,0.947285064377682
GOCC_ENDOPLASMIC_RETICULUM_L...,SET,284,0.029297,0.0036154,0.051657,0.28531,GOCC_ENDOPLASMIC_RETICULUM_LUMEN,0.947285064377682
GSE22886_CD4_TCELL_VS_BCELL_...2,SET,183,0.034319,0.0034091,0.060511,0.28531,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP,0.947285064377682
PID_RAS_PATHWAY,SET,29,0.084442,0.0033532,0.14889,0.28532,PID_RAS_PATHWAY,0.947285064377682
HP_HOARSE_CRY,SET,14,0.13693,0.0037797,0.24149,0.28535,HP_HOARSE_CRY,0.947285064377682
GNF2_RAP1B,SET,32,0.082651,0.0034474,0.14578,0.28537,GNF2_RAP1B,0.947285064377682
REACTOME_AMINO_ACID_TRANSPOR...,SET,30,0.093164,0.0037627,0.16433,0.28538,REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE,0.947285064377682
GSE19888_CTRL_VS_A3R_INHIBIT...2,SET,179,0.033306,0.0032724,0.058769,0.28546,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_UP,0.947285064377682
ZHONG_PFC_C2_ASCL1_POS_ASTRO...,SET,4,0.27943,0.0041239,0.49313,0.28548,ZHONG_PFC_C2_ASCL1_POS_ASTROCYTE,0.947285064377682
GOBP_SMOOTHENED_SIGNALING_PA...2,SET,5,0.21468,0.0035421,0.3789,0.2855,GOBP_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,0.947285064377682
HP_PULMONARY_ARTERY_STENOSIS,SET,66,0.059939,0.0035872,0.10584,0.2856,HP_PULMONARY_ARTERY_STENOSIS,0.947285064377682
HP_URINARY_BLADDER_SPHINCTER...,SET,28,0.085462,0.0033348,0.15091,0.2856,HP_URINARY_BLADDER_SPHINCTER_DYSFUNCTION,0.947285064377682
GSE17974_CTRL_VS_ACT_IL4_AND...3,SET,178,0.033702,0.0033022,0.059513,0.2856,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN,0.947285064377682
GOBP_NEURONAL_ACTION_POTENTI...2,SET,10,0.15341,0.0035793,0.27096,0.28564,GOBP_NEURONAL_ACTION_POTENTIAL_PROPAGATION,0.947285064377682
PID_HNF3B_PATHWAY,SET,43,0.078218,0.0037808,0.13817,0.28566,PID_HNF3B_PATHWAY,0.947285064377682
AR_03,SET,54,0.063369,0.0034315,0.11194,0.28567,AR_03,0.947285064377682
YAO_TEMPORAL_RESPONSE_TO_PRO...5,SET,70,0.057009,0.0035133,0.10071,0.28568,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,0.947285064377682
HOEK_MONOCYTE_2011_2012_TIV_...1,SET,13,0.12843,0.0034161,0.22693,0.28572,HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_DN,0.947285064377682
TSHZ1_TARGET_GENES,SET,180,0.034101,0.0033598,0.06026,0.28573,TSHZ1_TARGET_GENES,0.947285064377682
GSE36888_UNTREATED_VS_IL2_TR...1,SET,181,0.034864,0.0034444,0.06161,0.28574,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_DN,0.947285064377682
KEGG_MEDICUS_VARIANT_MUTATIO...8,SET,24,0.09592,0.0034656,0.16954,0.28578,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.947285064377682
HP_DIGITAL_FLEXOR_TENOSYNOVI...,SET,7,0.18456,0.0036029,0.32621,0.28578,HP_DIGITAL_FLEXOR_TENOSYNOVITIS,0.947285064377682
HP_CEREBRAL_HAMARTOMA,SET,18,0.10038,0.0031415,0.17752,0.28587,HP_CEREBRAL_HAMARTOMA,0.947493024032043
GOBP_BODY_FLUID_SECRETION,SET,87,0.053679,0.0036863,0.094939,0.2859,GOBP_BODY_FLUID_SECRETION,0.947502097835415
GOBP_PYRAMIDAL_NEURON_DIFFER...,SET,12,0.13732,0.0035094,0.24291,0.28593,GOBP_PYRAMIDAL_NEURON_DIFFERENTIATION,0.947511169908467
GOBP_NEGATIVE_REGULATION_OF_...529,SET,5,0.16287,0.0026873,0.2883,0.28607,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MICROTUBULE,0.947788358905937
GLI1_UP.V1_DN,SET,16,0.11128,0.0032834,0.19704,0.28613,GLI1_UP.V1_DN,0.947788358905937
YAGI_AML_WITH_INV_16_TRANSLO...,SET,371,0.024691,0.0034741,0.043723,0.28614,YAGI_AML_WITH_INV_16_TRANSLOCATION,0.947788358905937
GOBP_INTERLEUKIN_3_MEDIATED_...,SET,6,0.22858,0.0041314,0.40479,0.28615,GOBP_INTERLEUKIN_3_MEDIATED_SIGNALING_PATHWAY,0.947788358905937
GOBP_NEGATIVE_REGULATION_OF_...474,SET,9,0.16279,0.0036032,0.28828,0.28615,GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.947788358905937
HP_CHRONIC_OTITIS_MEDIA,SET,136,0.041994,0.0036008,0.074387,0.2862,HP_CHRONIC_OTITIS_MEDIA,0.947863636363636
WP_G1_TO_S_CELL_CYCLE_CONTROL,SET,64,0.056497,0.0033297,0.10011,0.28626,WP_G1_TO_S_CELL_CYCLE_CONTROL,0.947914810403963
HP_FATIGABLE_WEAKNESS_OF_RES...,SET,57,0.061064,0.0033971,0.10821,0.28627,HP_FATIGABLE_WEAKNESS_OF_RESPIRATORY_MUSCLES,0.947914810403963
GSE12366_GC_BCELL_VS_PLASMA_...2,SET,171,0.034779,0.0033407,0.061645,0.28632,GSE12366_GC_BCELL_VS_PLASMA_CELL_UP,0.947990054301229
MODULE_6,SET,381,0.026057,0.0037143,0.0462,0.28638,MODULE_6,0.9480502
GOBP_VASCULAR_ASSOCIATED_SMO...1,SET,11,0.14291,0.0034969,0.25342,0.28641,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.9480502
GSE3982_NKCELL_VS_TH1_DN,SET,180,0.035458,0.0034935,0.062883,0.28642,GSE3982_NKCELL_VS_TH1_DN,0.9480502
BIOCARTA_TID_PATHWAY,SET,19,0.1092,0.0035109,0.19369,0.28646,BIOCARTA_TID_PATHWAY,0.948092305494715
GOBP_POSITIVE_REGULATION_OF_...289,SET,5,0.2168,0.0035772,0.38476,0.28656,GOBP_POSITIVE_REGULATION_OF_G0_TO_G1_TRANSITION,0.948179380413058
UNTERMAN_IPF_VS_CTRL_MONOCYT...2,SET,11,0.14445,0.0035345,0.25638,0.28658,UNTERMAN_IPF_VS_CTRL_MONOCYTE_UP,0.948179380413058
GSE17721_PAM3CSK4_VS_GADIQUI...2,SET,186,0.034588,0.0034636,0.061404,0.28662,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP,0.948179380413058
NOJIMA_SFRP2_TARGETS_UP,SET,29,0.095425,0.0037894,0.16941,0.28663,NOJIMA_SFRP2_TARGETS_UP,0.948179380413058
GSE3982_NEUTROPHIL_VS_TH1_UP,SET,171,0.036692,0.0035245,0.065144,0.28663,GSE3982_NEUTROPHIL_VS_TH1_UP,0.948179380413058
GOBP_NATURAL_KILLER_CELL_MED...2,SET,75,0.059468,0.003793,0.10559,0.28665,GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.948179380413058
HP_ABNORMAL_TRACHEOBRONCHIAL...,SET,330,0.02633,0.003498,0.04676,0.28669,HP_ABNORMAL_TRACHEOBRONCHIAL_MORPHOLOGY,0.948221445565284
MCCABE_BOUND_BY_HOXC6,SET,356,0.025591,0.0035286,0.045461,0.28675,MCCABE_BOUND_BY_HOXC6,0.948272483349191
TRAVAGLINI_LUNG_ALVEOLAR_EPI...1,SET,363,0.026272,0.0036574,0.046676,0.28676,TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL,0.948272483349191
PID_ERBB2_ERBB3_PATHWAY,SET,44,0.070662,0.003455,0.1256,0.28686,PID_ERBB2_ERBB3_PATHWAY,0.948365533149434
MORF_IL4,SET,162,0.038535,0.0036036,0.068497,0.28687,MORF_IL4,0.948365533149434
GSE29618_PRE_VS_DAY7_POST_LA...7,SET,177,0.033348,0.0032584,0.059278,0.28687,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN,0.948365533149434
GSE4984_UNTREATED_VS_GALECTI...2,SET,169,0.036427,0.0034786,0.064769,0.28692,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP,0.948440612516644
HP_PHARYNGITIS,SET,15,0.1237,0.0035342,0.22001,0.28698,HP_PHARYNGITIS,0.948461307034221
SCHUETZ_BREAST_CANCER_DUCTAL...2,SET,321,0.02828,0.0037065,0.05031,0.28702,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,0.948461307034221
GOBP_ORGANELLE_FISSION,SET,450,0.02175,0.003363,0.038698,0.28705,GOBP_ORGANELLE_FISSION,0.948461307034221
HP_EPIDERMAL_HYPERKERATOSIS,SET,11,0.14992,0.0036684,0.26678,0.28708,HP_EPIDERMAL_HYPERKERATOSIS,0.948461307034221
REACTOME_LIPID_PARTICLE_ORGA...,SET,6,0.20939,0.0037846,0.37264,0.28709,REACTOME_LIPID_PARTICLE_ORGANIZATION,0.948461307034221
HP_HEMIPARESIS,SET,79,0.055003,0.0036001,0.097883,0.28709,HP_HEMIPARESIS,0.948461307034221
GAUTAM_EYE_IRIS_CILIARY_BODY...17,SET,104,0.047932,0.0035972,0.085342,0.28718,GAUTAM_EYE_IRIS_CILIARY_BODY_WIF1_HIGH_FIBROBLASTS,0.948668463073852
MIR1269A_MIR1269B,SET,48,0.085222,0.0043517,0.15176,0.28721,MIR1269A_MIR1269B,0.948677394981943
GSE17721_LPS_VS_CPG_0.5H_BMD...2,SET,177,0.033969,0.0033191,0.060504,0.28725,GSE17721_LPS_VS_CPG_0.5H_BMDC_UP,0.948683378441437
MIR182_5P,SET,506,0.021469,0.0035146,0.038247,0.28729,MIR182_5P,0.948683378441437
REACTOME_CELL_SURFACE_INTERA...,SET,131,0.045239,0.0038076,0.080626,0.28737,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,0.948683378441437
GSE1791_CTRL_VS_NEUROMEDINU_...4,SET,173,0.035649,0.003444,0.063535,0.28737,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP,0.948683378441437
HP_ELEVATED_CIRCULATING_LUTE...,SET,35,0.07866,0.0034311,0.14026,0.28746,HP_ELEVATED_CIRCULATING_LUTEINIZING_HORMONE_LEVEL,0.948683378441437
GSE20727_CTRL_VS_DNFB_ALLERG...1,SET,165,0.036347,0.0034301,0.064808,0.28746,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_DN,0.948683378441437
GOBP_PROTEIN_LOCALIZATION_TO...6,SET,11,0.15402,0.0037688,0.27465,0.28748,GOBP_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,0.948683378441437
GOCC_ANKYRIN_1_COMPLEX,SET,8,0.18322,0.0038236,0.32679,0.28751,GOCC_ANKYRIN_1_COMPLEX,0.948683378441437
GSE19941_UNSTIM_VS_LPS_STIM_...2,SET,178,0.035677,0.0034957,0.063629,0.28751,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP,0.948683378441437
NRF2_Q4,SET,227,0.031309,0.0034597,0.055851,0.28755,NRF2_Q4,0.948683378441437
BIOCARTA_VOBESITY_PATHWAY,SET,8,0.1893,0.0039506,0.3378,0.28761,BIOCARTA_VOBESITY_PATHWAY,0.948683378441437
GOBP_NEGATIVE_REGULATION_OF_...663,SET,56,0.066958,0.0036922,0.11951,0.28766,GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.948683378441437
GSE17721_LPS_VS_CPG_8H_BMDC_...2,SET,186,0.035074,0.0035122,0.062604,0.28766,GSE17721_LPS_VS_CPG_8H_BMDC_UP,0.948683378441437
MIR766_5P,SET,195,0.03423,0.0035088,0.061108,0.28769,MIR766_5P,0.948683378441437
GOMF_SOLUTE_POTASSIUM_ANTIPO...,SET,17,0.12079,0.0036738,0.21566,0.28771,GOMF_SOLUTE_POTASSIUM_ANTIPORTER_ACTIVITY,0.948683378441437
GOBP_PROTEIN_POLYUFMYLATION,SET,5,0.19302,0.0031848,0.34466,0.28773,GOBP_PROTEIN_POLYUFMYLATION,0.948683378441437
GSE2706_UNSTIM_VS_8H_LPS_DC_...2,SET,178,0.034326,0.0033634,0.061295,0.28773,GSE2706_UNSTIM_VS_8H_LPS_DC_UP,0.948683378441437
GOBP_REGULATION_OF_FEMALE_GO...,SET,7,0.19655,0.003837,0.35104,0.28777,GOBP_REGULATION_OF_FEMALE_GONAD_DEVELOPMENT,0.948683378441437
VALK_AML_WITH_EVI1,SET,22,0.11161,0.0038611,0.19934,0.28778,VALK_AML_WITH_EVI1,0.948683378441437
GSE21927_SPLENIC_C26GM_TUMOR...3,SET,162,0.036527,0.0034158,0.065249,0.28781,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_DN,0.948683378441437
MEBARKI_HCC_PROGENITOR_FZD8C...2,SET,477,0.02152,0.0034233,0.038449,0.28785,MEBARKI_HCC_PROGENITOR_FZD8CRD_UP,0.948683378441437
NABA_MATRISOME_PRIMARY_METAS...,SET,54,0.070728,0.00383,0.12647,0.288,NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR,0.948683378441437
GSE4590_SMALL_VS_VPREB_POS_L...1,SET,139,0.040322,0.003495,0.0721,0.288,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.948683378441437
KEGG_MEDICUS_REFERENCE_IGG_F...,SET,9,0.16721,0.0037011,0.29904,0.28803,KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY,0.948683378441437
MODULE_32,SET,210,0.030428,0.0032354,0.054417,0.28803,MODULE_32,0.948683378441437
MIR4755_5P,SET,333,0.026647,0.0035559,0.047659,0.28804,MIR4755_5P,0.948683378441437
GSE29164_UNTREATED_VS_CD8_TC...3,SET,181,0.035195,0.0034772,0.062958,0.28807,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,0.948683378441437
HP_PREMATURE_CORONARY_ARTERY...,SET,18,0.11991,0.0037526,0.21455,0.28813,HP_PREMATURE_CORONARY_ARTERY_ATHEROSCLEROSIS,0.948683378441437
GOBP_TRIPEPTIDE_TRANSMEMBRAN...,SET,10,0.15631,0.0036469,0.27983,0.28822,GOBP_TRIPEPTIDE_TRANSMEMBRANE_TRANSPORT,0.948683378441437
GSE27786_LSK_VS_LIN_NEG_CELL...1,SET,179,0.03408,0.0033485,0.061009,0.28822,GSE27786_LSK_VS_LIN_NEG_CELL_DN,0.948683378441437
HP_ABNORMALITY_OF_SECONDARY_...,SET,70,0.056927,0.0035083,0.102,0.28838,HP_ABNORMALITY_OF_SECONDARY_SEXUAL_HAIR,0.948683378441437
MODULE_285,SET,41,0.069809,0.0032951,0.12511,0.28843,MODULE_285,0.948683378441437
HP_ABNORMALITY_OF_THE_NECK,SET,611,0.019049,0.0034167,0.034142,0.28845,HP_ABNORMALITY_OF_THE_NECK,0.948683378441437
GSE46606_UNSTIM_VS_CD40L_IL2...6,SET,180,0.035106,0.0034589,0.062924,0.28845,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP,0.948683378441437
SANA_RESPONSE_TO_IFNG_UP,SET,68,0.058115,0.0035301,0.10417,0.28846,SANA_RESPONSE_TO_IFNG_UP,0.948683378441437
GSE16385_ROSIGLITAZONE_VS_UN...1,SET,188,0.031892,0.0032105,0.057171,0.28848,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN,0.948683378441437
MIR548L,SET,334,0.026149,0.0034945,0.046925,0.28868,MIR548L,0.948683378441437
GSE29949_CD8_NEG_DC_SPLEEN_V...1,SET,175,0.0358,0.0034783,0.064266,0.28875,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_DN,0.948683378441437
HP_POLYCYSTIC_KIDNEY_DYSPLAS...,SET,48,0.068558,0.0035007,0.12311,0.2888,HP_POLYCYSTIC_KIDNEY_DYSPLASIA,0.948683378441437
KRAS.DF.V1_UP,SET,174,0.03695,0.0035799,0.066347,0.2888,KRAS.DF.V1_UP,0.948683378441437
chr20q12,SET,7,0.29335,0.0057267,0.5268,0.28882,chr20q12,0.948683378441437
SOX5_01,SET,236,0.031642,0.0035643,0.056831,0.28884,SOX5_01,0.948683378441437
GOBP_MALE_MEIOTIC_NUCLEAR_DI...,SET,49,0.060342,0.0031131,0.10844,0.28895,GOBP_MALE_MEIOTIC_NUCLEAR_DIVISION,0.948683378441437
E47_02,SET,222,0.032963,0.0036026,0.059252,0.289,E47_02,0.948683378441437
GOBP_BRAIN_MORPHOGENESIS,SET,37,0.075937,0.0034054,0.13651,0.28901,GOBP_BRAIN_MORPHOGENESIS,0.948683378441437
MIR11181_5P,SET,65,0.056759,0.0033711,0.10204,0.28902,MIR11181_5P,0.948683378441437
GOMF_UNFOLDED_PROTEIN_BINDING,SET,107,0.040926,0.0031151,0.073618,0.28913,GOMF_UNFOLDED_PROTEIN_BINDING,0.948683378441437
HALLMARK_HEME_METABOLISM,SET,178,0.034927,0.0034222,0.062837,0.28917,HALLMARK_HEME_METABOLISM,0.948683378441437
BIOCARTA_EGFR_SMRTE_PATHWAY,SET,11,0.15222,0.0037246,0.27387,0.28918,BIOCARTA_EGFR_SMRTE_PATHWAY,0.948683378441437
GOBP_POSITIVE_REGULATION_OF_...78,SET,77,0.056179,0.0036305,0.10108,0.28919,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.948683378441437
ZNF610_TARGET_GENES,SET,708,0.01777,0.0034215,0.031976,0.2892,ZNF610_TARGET_GENES,0.948683378441437
HP_LIMB_GIRDLE_MUSCULAR_DYST...,SET,13,0.12711,0.0033811,0.22873,0.2892,HP_LIMB_GIRDLE_MUSCULAR_DYSTROPHY,0.948683378441437
DACOSTA_UV_RESPONSE_VIA_ERCC...4,SET,78,0.053574,0.0034844,0.096414,0.28922,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,0.948683378441437
HP_RED_HAIR,SET,8,0.1749,0.0036499,0.31477,0.28924,HP_RED_HAIR,0.948683378441437
REACTOME_POTASSIUM_CHANNELS,SET,102,0.051512,0.0038287,0.092718,0.28925,REACTOME_POTASSIUM_CHANNELS,0.948683378441437
GOBP_CELLULAR_RESPONSE_TO_GR...,SET,24,0.10487,0.003789,0.1888,0.2893,GOBP_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS,0.948683378441437
GOBP_EPITHELIAL_STRUCTURE_MA...,SET,32,0.090014,0.0037546,0.16207,0.28931,GOBP_EPITHELIAL_STRUCTURE_MAINTENANCE,0.948683378441437
GOMF_SEROTONIN_BINDING,SET,10,0.15341,0.0035793,0.27628,0.28935,GOMF_SEROTONIN_BINDING,0.948683378441437
GOBP_REGULATION_OF_TRANSLATI...1,SET,333,0.025208,0.0033638,0.045406,0.28939,GOBP_REGULATION_OF_TRANSLATION,0.948683378441437
RODRIGUES_THYROID_CARCINOMA_...3,SET,73,0.059661,0.0037544,0.10747,0.2894,RODRIGUES_THYROID_CARCINOMA_DN,0.948683378441437
GOBP_GOLGI_TO_PLASMA_MEMBRAN...2,SET,61,0.058748,0.0033806,0.10584,0.28943,GOBP_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT,0.948683378441437
GOBP_SYNAPTIC_TRANSMISSION_C...,SET,31,0.088301,0.0036252,0.15911,0.28947,GOBP_SYNAPTIC_TRANSMISSION_CHOLINERGIC,0.948683378441437
GSE16385_IFNG_TNF_VS_IL4_STI...2,SET,174,0.034675,0.0033596,0.062491,0.28949,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,0.948683378441437
PODAR_RESPONSE_TO_ADAPHOSTIN...2,SET,127,0.044322,0.0036734,0.079894,0.28953,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,0.948683378441437
GOCC_CDC73_PAF1_COMPLEX,SET,6,0.20491,0.0037036,0.36944,0.28957,GOCC_CDC73_PAF1_COMPLEX,0.948683378441437
MIR4790_3P,SET,77,0.052703,0.0034058,0.09507,0.28967,MIR4790_3P,0.948683378441437
MIR1287_3P,SET,31,0.075372,0.0030944,0.13597,0.28968,MIR1287_3P,0.948683378441437
REACTOME_TRANSPORT_OF_MATURE...1,SET,40,0.065507,0.0030542,0.11818,0.2897,REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS,0.948683378441437
MIR567,SET,95,0.047706,0.0034226,0.086071,0.2897,MIR567,0.948683378441437
GSE19941_UNSTIM_VS_LPS_STIM_...3,SET,174,0.035418,0.0034315,0.063905,0.28971,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.948683378441437
HP_FLAT_FACE,SET,94,0.047582,0.0033958,0.085861,0.28973,HP_FLAT_FACE,0.948683378441437
GOBP_CERAMIDE_TRANSPORT,SET,15,0.12226,0.0034932,0.22063,0.28974,GOBP_CERAMIDE_TRANSPORT,0.948683378441437
GOBP_DEFENSE_RESPONSE_TO_FUN...,SET,44,0.074344,0.003635,0.13418,0.28978,GOBP_DEFENSE_RESPONSE_TO_FUNGUS,0.948683378441437
MATSUMIYA_PBMC_MODIFIED_VACC...4,SET,81,0.051301,0.0033999,0.092595,0.28978,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_MVA85A_6HR_UP,0.948683378441437
GOMF_MONOATOMIC_ION_TRANSMEM...,SET,687,0.018604,0.0035307,0.03359,0.28984,GOMF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.948683378441437
HP_CELLULAR_IMMUNODEFICIENCY,SET,33,0.075324,0.0031905,0.136,0.28984,HP_CELLULAR_IMMUNODEFICIENCY,0.948683378441437
GOCC_NEURON_PROJECTION_CYTOP...,SET,83,0.051037,0.0034237,0.092161,0.28987,GOCC_NEURON_PROJECTION_CYTOPLASM,0.948683378441437
MIR5702,SET,68,0.05776,0.0035086,0.10433,0.28991,MIR5702,0.948683378441437
HP_HYPOGLYCEMIC_SEIZURES,SET,23,0.10452,0.0036969,0.18878,0.28991,HP_HYPOGLYCEMIC_SEIZURES,0.948683378441437
HP_ABNORMALITY_OF_TEMPERATUR...,SET,490,0.021693,0.0034962,0.039183,0.28992,HP_ABNORMALITY_OF_TEMPERATURE_REGULATION,0.948683378441437
HP_HYPOTENSION,SET,103,0.047726,0.0035646,0.086221,0.28995,HP_HYPOTENSION,0.948683378441437
GSE13485_PRE_VS_POST_YF17D_V...1,SET,179,0.034566,0.0033963,0.062446,0.28995,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN,0.948683378441437
KEGG_MEDICUS_PATHOGEN_HTLV_1...5,SET,9,0.14449,0.0031982,0.26104,0.28996,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00497,0.948683378441437
GOMF_4_IRON_4_SULFUR_CLUSTER...,SET,44,0.068395,0.0033441,0.12358,0.28997,GOMF_4_IRON_4_SULFUR_CLUSTER_BINDING,0.948683378441437
HP_PULMONARY_INFILTRATES,SET,51,0.070162,0.0036926,0.12677,0.28998,HP_PULMONARY_INFILTRATES,0.948683378441437
GSE21927_SPLENIC_VS_TUMOR_MO...1,SET,178,0.032989,0.0032323,0.059613,0.29,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN,0.948683378441437
KEGG_TASTE_TRANSDUCTION,SET,48,0.077466,0.0039556,0.13999,0.29001,KEGG_TASTE_TRANSDUCTION,0.948683378441437
MIR581,SET,73,0.053365,0.0033582,0.096438,0.29001,MIR581,0.948683378441437
REACTOME_SNRNP_ASSEMBLY,SET,48,0.060348,0.0030816,0.10908,0.29005,REACTOME_SNRNP_ASSEMBLY,0.948683378441437
NAKAYA_MONOCYTE_FLUMIST_AGE_...1,SET,237,0.029671,0.0033492,0.053635,0.29006,NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN,0.948683378441437
GOBP_STOMACH_DEVELOPMENT,SET,5,0.22634,0.0037346,0.40918,0.29008,GOBP_STOMACH_DEVELOPMENT,0.948683378441437
REACTOME_DEFECTIVE_FACTOR_VI...,SET,5,0.2165,0.0035722,0.39147,0.29012,REACTOME_DEFECTIVE_FACTOR_VIII_CAUSES_HEMOPHILIA_A,0.948683378441437
CAR_MYST2,SET,25,0.088641,0.0032686,0.16028,0.29012,CAR_MYST2,0.948683378441437
GOBP_MONOSACCHARIDE_TRANSMEM...,SET,110,0.046155,0.0035617,0.083458,0.29012,GOBP_MONOSACCHARIDE_TRANSMEMBRANE_TRANSPORT,0.948683378441437
HP_ABNORMAL_NASAL_MORPHOLOGY,SET,1289,0.013201,0.0033726,0.02387,0.29013,HP_ABNORMAL_NASAL_MORPHOLOGY,0.948683378441437
KEGG_MEDICUS_REFERENCE_NUCLE...1,SET,27,0.082273,0.0031526,0.14878,0.29014,KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA,0.948683378441437
GSE360_DC_VS_MAC_M_TUBERCULO...1,SET,180,0.034734,0.0034222,0.062838,0.29022,GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN,0.948683378441437
CAVARD_LIVER_CANCER_MALIGNAN...,SET,28,0.094583,0.0036907,0.17112,0.29023,CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,0.948683378441437
GSE17186_CD21LOW_VS_CD21HIGH...3,SET,184,0.035505,0.0035365,0.064244,0.29025,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,0.948683378441437
MIR301A_5P,SET,75,0.05394,0.0034403,0.097638,0.29033,MIR301A_5P,0.948683378441437
MIR301B_5P,SET,75,0.05394,0.0034403,0.097638,0.29033,MIR301B_5P,0.948683378441437
GSE15930_STIM_VS_STIM_AND_TR...2,SET,177,0.035042,0.0034239,0.063433,0.29033,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP,0.948683378441437
GSE7852_THYMUS_VS_FAT_TCONV_...1,SET,178,0.036451,0.0035715,0.065981,0.29033,GSE7852_THYMUS_VS_FAT_TCONV_DN,0.948683378441437
GOBP_PEPTIDYL_METHIONINE_MOD...,SET,11,0.1335,0.0032665,0.24168,0.29035,GOBP_PEPTIDYL_METHIONINE_MODIFICATION,0.948683378441437
WENG_POR_DOSAGE,SET,22,0.10596,0.0036655,0.19183,0.29036,WENG_POR_DOSAGE,0.948683378441437
GOMF_ANGIOTENSIN_RECEPTOR_BI...,SET,9,0.16595,0.0036731,0.30046,0.29037,GOMF_ANGIOTENSIN_RECEPTOR_BINDING,0.948683378441437
GSE23502_BM_VS_COLON_TUMOR_M...2,SET,184,0.036763,0.0036618,0.066565,0.29038,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,0.948683378441437
REACTOME_MIRO_GTPASE_CYCLE,SET,8,0.15603,0.0032562,0.28257,0.29042,REACTOME_MIRO_GTPASE_CYCLE,0.948683378441437
YUAN_ZNF143_PARTNERS,SET,20,0.10224,0.0033724,0.18527,0.29054,YUAN_ZNF143_PARTNERS,0.948683378441437
MIR4696,SET,91,0.04819,0.0033842,0.087331,0.29054,MIR4696,0.948683378441437
GLASS_IGF2BP1_CLIP_TARGETS_K...,SET,105,0.043799,0.0033026,0.079374,0.29055,GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,0.948683378441437
GOMF_PEPTIDE_ANTIGEN_BINDING,SET,32,0.0916,0.0038207,0.16601,0.29055,GOMF_PEPTIDE_ANTIGEN_BINDING,0.948683378441437
GSE43260_BTLA_POS_VS_NEG_INT...1,SET,173,0.034631,0.0033456,0.062786,0.29063,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN,0.948683378441437
BIOCARTA_CREM_PATHWAY,SET,6,0.21474,0.0038813,0.38942,0.29067,BIOCARTA_CREM_PATHWAY,0.948683378441437
PU1_Q6,SET,221,0.032293,0.0035215,0.058563,0.29068,PU1_Q6,0.948683378441437
DESCARTES_FETAL_PLACENTA_STR...,SET,56,0.070743,0.0039009,0.1283,0.29069,DESCARTES_FETAL_PLACENTA_STROMAL_CELLS,0.948683378441437
PID_SMAD2_3PATHWAY,SET,16,0.1202,0.0035468,0.21809,0.29077,PID_SMAD2_3PATHWAY,0.948683378441437
HP_PROFOUND_GLOBAL_DEVELOPME...,SET,59,0.05977,0.0033827,0.10846,0.29079,HP_PROFOUND_GLOBAL_DEVELOPMENTAL_DELAY,0.948683378441437
FOXF1_TARGET_GENES,SET,5,0.20197,0.0033325,0.36653,0.29081,FOXF1_TARGET_GENES,0.948683378441437
GSE27786_BCELL_VS_CD8_TCELL_...2,SET,184,0.032959,0.0032828,0.059815,0.29081,GSE27786_BCELL_VS_CD8_TCELL_UP,0.948683378441437
GSE7831_UNSTIM_VS_INFLUENZA_...1,SET,182,0.035365,0.0035035,0.064204,0.29088,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN,0.948683378441437
GOMF_FK506_BINDING,SET,10,0.1278,0.0029818,0.23205,0.2909,GOMF_FK506_BINDING,0.948683378441437
GOBP_NEUROEPITHELIAL_CELL_DI...,SET,42,0.079721,0.0038085,0.14478,0.29095,GOBP_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.948683378441437
HP_CONJUGATED_HYPERBILIRUBIN...,SET,34,0.087549,0.0037639,0.159,0.29095,HP_CONJUGATED_HYPERBILIRUBINEMIA,0.948683378441437
BIOCARTA_FMLP_PATHWAY,SET,32,0.084903,0.0035414,0.1542,0.29096,BIOCARTA_FMLP_PATHWAY,0.948683378441437
GOBP_REGULATION_OF_MITOTIC_S...2,SET,22,0.088021,0.003045,0.1599,0.291,GOBP_REGULATION_OF_MITOTIC_SPINDLE_ASSEMBLY,0.948683378441437
ZNF784_TARGET_GENES,SET,432,0.022152,0.0033577,0.040246,0.29102,ZNF784_TARGET_GENES,0.948683378441437
GOMF_PSEUDOURIDINE_SYNTHASE_...,SET,12,0.11963,0.0030572,0.21733,0.29102,GOMF_PSEUDOURIDINE_SYNTHASE_ACTIVITY,0.948683378441437
MIR382_3P,SET,91,0.048785,0.0034259,0.088657,0.29107,MIR382_3P,0.948683378441437
GOMF_OXIDOREDUCTASE_ACTIVITY...11,SET,6,0.21481,0.0038824,0.39039,0.29108,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS_NAD_OR_NADP_AS_ACCEPTOR,0.948683378441437
HP_RECURRENT_EAR_INFECTIONS,SET,16,0.11865,0.0035011,0.21566,0.2911,HP_RECURRENT_EAR_INFECTIONS,0.948683378441437
GSE20727_DNFB_ALLERGEN_VS_RO...1,SET,188,0.034284,0.0034513,0.06232,0.29112,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,0.948683378441437
KDM1B_TARGET_GENES,SET,110,0.042821,0.0033044,0.077841,0.29113,KDM1B_TARGET_GENES,0.948683378441437
MIR4796_5P,SET,89,0.051479,0.0035754,0.093587,0.29114,MIR4796_5P,0.948683378441437
PID_P38_GAMMA_DELTA_PATHWAY,SET,10,0.14894,0.003475,0.27084,0.29119,PID_P38_GAMMA_DELTA_PATHWAY,0.948683378441437
MIR1256,SET,64,0.058847,0.0034682,0.10702,0.29121,MIR1256,0.948683378441437
MIR26B_5P,SET,455,0.022193,0.0034501,0.040362,0.29122,MIR26B_5P,0.948683378441437
WP_COMMON_PATHWAYS_UNDERLYIN...,SET,38,0.081007,0.0036814,0.14735,0.29125,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,0.948683378441437
WP_PARKINSONS_DISEASE_PATHWAY,SET,33,0.077499,0.0032826,0.14097,0.29125,WP_PARKINSONS_DISEASE_PATHWAY,0.948683378441437
GOBP_MICROTUBULE_BASED_TRANS...,SET,187,0.03303,0.0033164,0.060083,0.29125,GOBP_MICROTUBULE_BASED_TRANSPORT,0.948683378441437
GOBP_REGULATION_OF_PROTEIN_T...2,SET,31,0.080741,0.0033148,0.14688,0.29126,GOBP_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.948683378441437
KEGG_MEDICUS_REFERENCE_ESTAB...,SET,5,0.196,0.003234,0.35658,0.29127,KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION,0.948683378441437
GOMF_NETRIN_RECEPTOR_ACTIVITY,SET,5,0.2058,0.0033957,0.37439,0.29127,GOMF_NETRIN_RECEPTOR_ACTIVITY,0.948683378441437
GOBP_NEGATIVE_REGULATION_OF_...440,SET,68,0.061816,0.0037549,0.11247,0.29129,GOBP_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION,0.948683378441437
GOBP_REGULATION_OF_CAMP_DEPE...,SET,13,0.12816,0.0034089,0.23323,0.29134,GOBP_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.948683378441437
GSE40274_CTRL_VS_EOS_TRANSDU...2,SET,158,0.036427,0.0033645,0.0663,0.29136,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.948683378441437
HP_EYELID_APRAXIA,SET,5,0.19389,0.0031991,0.3529,0.29137,HP_EYELID_APRAXIA,0.948683378441437
GOBP_NEGATIVE_REGULATION_OF_...326,SET,50,0.069378,0.0036155,0.12629,0.29139,GOBP_NEGATIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.948683378441437
PEDERSEN_METASTASIS_BY_ERBB2...2,SET,17,0.12581,0.0038265,0.22903,0.2914,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,0.948683378441437
GOBP_ENDOPLASMIC_RETICULUM_T...2,SET,126,0.039064,0.0032249,0.071115,0.2914,GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.948683378441437
HP_GIANT_PLATELETS,SET,10,0.15945,0.0037201,0.29029,0.29141,HP_GIANT_PLATELETS,0.948683378441437
MIR146B_5P,SET,102,0.044549,0.0033112,0.081117,0.29144,MIR146B_5P,0.948683378441437
BIOCARTA_EICOSANOID_PATHWAY,SET,21,0.11094,0.0037496,0.20208,0.29152,BIOCARTA_EICOSANOID_PATHWAY,0.948683378441437
GOMF_HISTONE_H3K9_MONOMETHYL...,SET,6,0.18502,0.003344,0.33709,0.29155,GOMF_HISTONE_H3K9_MONOMETHYLTRANSFERASE_ACTIVITY,0.948683378441437
MODULE_145,SET,95,0.047724,0.0034239,0.086954,0.29156,MODULE_145,0.948683378441437
HP_CLITORAL_HYPERTROPHY,SET,60,0.061665,0.0035193,0.11238,0.2916,HP_CLITORAL_HYPERTROPHY,0.948683378441437
HP_HYPERLORDOSIS,SET,184,0.034379,0.0034243,0.062652,0.2916,HP_HYPERLORDOSIS,0.948683378441437
chr5q11,SET,34,0.13364,0.0057453,0.24354,0.29161,chr5q11,0.948683378441437
MIR429,SET,457,0.022745,0.0035435,0.041459,0.29164,MIR429,0.948683378441437
GOBP_REGULATION_OF_PROTEIN_L...11,SET,166,0.035579,0.0033677,0.064898,0.29177,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.948683378441437
HP_PSEUDOHYPOALDOSTERONISM,SET,6,0.19892,0.0035954,0.36288,0.29179,HP_PSEUDOHYPOALDOSTERONISM,0.948683378441437
GOCC_MITOTIC_SPINDLE_POLE,SET,36,0.078689,0.0034809,0.14356,0.2918,GOCC_MITOTIC_SPINDLE_POLE,0.948683378441437
REACTOME_SIGNALING_BY_FGFR,SET,86,0.050392,0.0034407,0.091955,0.29185,REACTOME_SIGNALING_BY_FGFR,0.948683378441437
MIR891A_3P,SET,119,0.043858,0.0035193,0.080031,0.29185,MIR891A_3P,0.948683378441437
HOXA10_TARGET_GENES,SET,205,0.030795,0.0032357,0.056194,0.29185,HOXA10_TARGET_GENES,0.948683378441437
GSE2770_IL12_VS_TGFB_AND_IL1...1,SET,145,0.039812,0.0035239,0.072653,0.29186,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.948683378441437
GCM_MAP1B,SET,62,0.058944,0.0034194,0.10757,0.29187,GCM_MAP1B,0.948683378441437
HP_MYOCARDIAL_FIBROSIS,SET,17,0.11733,0.0035686,0.21414,0.29187,HP_MYOCARDIAL_FIBROSIS,0.948683378441437
GOBP_HEART_VALVE_FORMATION,SET,15,0.13311,0.003803,0.243,0.29193,GOBP_HEART_VALVE_FORMATION,0.948683378441437
GOCC_RIBOSOME,SET,210,0.029996,0.0031895,0.054774,0.29198,GOCC_RIBOSOME,0.948683378441437
BIOCARTA_MET_PATHWAY,SET,32,0.084928,0.0035424,0.15511,0.29201,BIOCARTA_MET_PATHWAY,0.948683378441437
HP_ABNORMAL_CIRCULATING_LEPT...,SET,12,0.14081,0.0035985,0.25718,0.29202,HP_ABNORMAL_CIRCULATING_LEPTIN_CONCENTRATION,0.948683378441437
GOBP_REGULATION_OF_PERK_MEDI...,SET,12,0.14179,0.0036237,0.25902,0.29205,GOBP_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.948683378441437
AMUNDSON_RESPONSE_TO_ARSENITE,SET,193,0.032819,0.0033471,0.059956,0.29206,AMUNDSON_RESPONSE_TO_ARSENITE,0.948683378441437
MIKKELSEN_MCV6_HCP_WITH_H3K2...,SET,412,0.02505,0.0037101,0.045768,0.29208,MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,0.948683378441437
HP_NEPHROTIC_SYNDROME,SET,118,0.041983,0.0033548,0.076715,0.2921,HP_NEPHROTIC_SYNDROME,0.948683378441437
GSE8621_UNSTIM_VS_LPS_PRIMED...3,SET,179,0.032439,0.0031872,0.059283,0.29213,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_DN,0.948683378441437
HP_RETROGNATHIA,SET,308,0.025896,0.0033258,0.04733,0.29214,HP_RETROGNATHIA,0.948683378441437
HP_SMALL_EARLOBE,SET,23,0.099642,0.0035244,0.18211,0.29214,HP_SMALL_EARLOBE,0.948683378441437
GSE339_EX_VIVO_VS_IN_CULTURE...6,SET,182,0.032438,0.0032135,0.059295,0.29217,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP,0.948683378441437
BURTON_ADIPOGENESIS_2,SET,70,0.056154,0.0034606,0.10266,0.2922,BURTON_ADIPOGENESIS_2,0.948683378441437
GOBP_IMMUNE_SYSTEM_DEVELOPME...,SET,181,0.033949,0.003354,0.062081,0.29224,GOBP_IMMUNE_SYSTEM_DEVELOPMENT,0.948683378441437
GOBP_CELLULAR_ALDEHYDE_METAB...,SET,74,0.05481,0.0034725,0.10025,0.29229,GOBP_CELLULAR_ALDEHYDE_METABOLIC_PROCESS,0.948683378441437
BOYLAN_MULTIPLE_MYELOMA_D_CL...1,SET,35,0.078848,0.0034392,0.14423,0.29231,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,0.948683378441437
GSE24142_DN2_VS_DN3_THYMOCYT...3,SET,185,0.034496,0.0034452,0.063114,0.29234,GSE24142_DN2_VS_DN3_THYMOCYTE_DN,0.948683378441437
HP_ABNORMAL_POSTERIOR_SEGMEN...,SET,41,0.077837,0.0036741,0.14242,0.29235,HP_ABNORMAL_POSTERIOR_SEGMENT_IMAGING,0.948683378441437
MIR603,SET,150,0.038288,0.0034465,0.070068,0.29239,MIR603,0.948683378441437
HP_PROPTOSIS,SET,257,0.028451,0.0033424,0.052072,0.2924,HP_PROPTOSIS,0.948683378441437
GOBP_RESPONSE_TO_ISOQUINOLIN...,SET,13,0.13486,0.0035871,0.24682,0.29241,GOBP_RESPONSE_TO_ISOQUINOLINE_ALKALOID,0.948683378441437
GSE3982_EOSINOPHIL_VS_MAC_DN,SET,177,0.034149,0.0033367,0.062508,0.29243,GSE3982_EOSINOPHIL_VS_MAC_DN,0.948683378441437
THAKAR_PBMC_INACTIVATED_INFL...10,SET,125,0.040955,0.0033677,0.074971,0.29244,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_DN,0.948683378441437
GSE41867_NAIVE_VS_DAY6_LCMV_...4,SET,185,0.032472,0.003243,0.059449,0.29246,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP,0.948683378441437
GSE8921_UNSTIM_VS_TLR1_2_STI...8,SET,189,0.033544,0.0033857,0.061417,0.29248,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP,0.948683378441437
LAKE_ADULT_KIDNEY_C12_THICK_...,SET,328,0.02528,0.0033485,0.046307,0.29256,LAKE_ADULT_KIDNEY_C12_THICK_ASCENDING_LIMB,0.948830633572828
HP_APLASIA_HYPOPLASIA_INVOLV...5,SET,90,0.047835,0.0033408,0.087629,0.29258,HP_APLASIA_HYPOPLASIA_INVOLVING_FOREARM_BONES,0.948830633572828
CHIANG_LIVER_CANCER_SUBCLASS...9,SET,163,0.03487,0.0032709,0.063904,0.29265,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,0.948969094047397
POS_RESPONSE_TO_HISTAMINE_DN,SET,11,0.11938,0.0029211,0.21887,0.29273,POS_RESPONSE_TO_HISTAMINE_DN,0.948980364636762
GOBP_DOPAMINE_BIOSYNTHETIC_P...,SET,12,0.14051,0.003591,0.25762,0.29273,GOBP_DOPAMINE_BIOSYNTHETIC_PROCESS,0.948980364636762
GOBP_LEUKOCYTE_CHEMOTAXIS_IN...,SET,8,0.18015,0.0037596,0.33031,0.29275,GOBP_LEUKOCYTE_CHEMOTAXIS_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.948980364636762
HP_ABNORMALITY_OF_HAIR_GROWTH,SET,29,0.082622,0.003281,0.15152,0.29278,HP_ABNORMALITY_OF_HAIR_GROWTH,0.948980364636762
INAMURA_LUNG_CANCER_SCC_DN,SET,13,0.12611,0.0033544,0.23129,0.29279,INAMURA_LUNG_CANCER_SCC_DN,0.948980364636762
MIR4640_5P,SET,118,0.039643,0.0031678,0.072725,0.29284,MIR4640_5P,0.949053916449086
GSE42021_TCONV_PLN_VS_CD24HI...1,SET,181,0.034774,0.0034356,0.063833,0.29296,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN,0.949212133072407
LAKE_ADULT_KIDNEY_C23_ENDOTH...,SET,115,0.044067,0.0034766,0.080894,0.29296,LAKE_ADULT_KIDNEY_C23_ENDOTHELIAL_CELLS_AVR,0.949212133072407
GOBP_POSITIVE_REGULATION_OF_...540,SET,36,0.08181,0.003619,0.15019,0.29298,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,0.949212133072407
REACTOME_VLDLR_INTERNALISATI...,SET,15,0.11293,0.0032265,0.20738,0.29303,REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION,0.949212133072407
WP_SMALL_LIGAND_GPCRS,SET,18,0.12143,0.0038002,0.22302,0.29306,WP_SMALL_LIGAND_GPCRS,0.949212133072407
HP_LEG_DYSTONIA,SET,7,0.1612,0.0031469,0.29609,0.29308,HP_LEG_DYSTONIA,0.949212133072407
HP_SYMPHALANGISM_AFFECTING_T...,SET,16,0.11329,0.0033428,0.20809,0.29308,HP_SYMPHALANGISM_AFFECTING_THE_PHALANGES_OF_THE_HAND,0.949212133072407
GOBP_NEGATIVE_REGULATION_OF_...652,SET,137,0.04044,0.0034802,0.074326,0.29319,GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.949379654082202
MODULE_206,SET,144,0.037861,0.0033398,0.069605,0.29324,MODULE_206,0.949379654082202
GOBP_NEGATIVE_REGULATION_OF_...545,SET,4,0.23223,0.0034273,0.42694,0.29325,GOBP_NEGATIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.949379654082202
GOBP_NAD_TRANSPORT,SET,5,0.22127,0.0036509,0.40683,0.29326,GOBP_NAD_TRANSPORT,0.949379654082202
GSE32901_NAIVE_VS_TH1_CD4_TC...1,SET,152,0.037133,0.0033645,0.068313,0.29337,GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN,0.949379654082202
MAZ_Q6,SET,179,0.033427,0.0032843,0.061503,0.2934,MAZ_Q6,0.949379654082202
GSE18791_CTRL_VS_NEWCASTLE_V...2,SET,178,0.032103,0.0031456,0.059069,0.2934,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP,0.949379654082202
MIR6502_3P,SET,50,0.065456,0.0034111,0.12045,0.29342,MIR6502_3P,0.949379654082202
MIR7843_5P,SET,86,0.048605,0.0033187,0.089501,0.29355,MIR7843_5P,0.949379654082202
GOBP_OXALOACETATE_METABOLIC_...,SET,9,0.13631,0.0030172,0.25102,0.29355,GOBP_OXALOACETATE_METABOLIC_PROCESS,0.949379654082202
GOMF_ALPHA_N_ACETYLGALACTOSA...,SET,6,0.22848,0.0041295,0.42074,0.29355,GOMF_ALPHA_N_ACETYLGALACTOSAMINIDE_ALPHA_2_6_SIALYLTRANSFERASE_ACTIVITY,0.949379654082202
HP_ABNORMALITY_OF_RENIN_ANGI...,SET,35,0.08229,0.0035894,0.15153,0.29355,HP_ABNORMALITY_OF_RENIN_ANGIOTENSIN_SYSTEM,0.949379654082202
MORF_PCNA,SET,71,0.049101,0.0030474,0.090423,0.29356,MORF_PCNA,0.949379654082202
CHNG_MULTIPLE_MYELOMA_HYPERP...1,SET,28,0.076552,0.0029872,0.14101,0.29361,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,0.949379654082202
GSE21063_WT_VS_NFATC1_KO_8H_...1,SET,180,0.033163,0.0032674,0.061087,0.29361,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN,0.949379654082202
GOCC_PROXIMAL_DENDRITE,SET,6,0.17831,0.0032228,0.32847,0.29362,GOCC_PROXIMAL_DENDRITE,0.949379654082202
HP_ENLARGED_CEREBELLUM,SET,6,0.1884,0.0034052,0.34709,0.29364,HP_ENLARGED_CEREBELLUM,0.949379654082202
DACOSTA_ERCC3_ALLELE_XPCS_VS...2,SET,26,0.095076,0.0035752,0.17518,0.29366,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,0.949379654082202
HP_ABNORMAL_PERIFOLLICULAR_M...,SET,5,0.27989,0.0046181,0.51579,0.29369,HP_ABNORMAL_PERIFOLLICULAR_MORPHOLOGY,0.949379654082202
HP_APLASIA_HYPOPLASIA_OF_THE...24,SET,4,0.2104,0.0031051,0.38776,0.2937,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_HALLUX,0.949379654082202
HP_JAUNDICE,SET,200,0.031956,0.0033169,0.0589,0.29373,HP_JAUNDICE,0.949379654082202
GOMF_UBIQUINONE_BINDING,SET,5,0.16165,0.0026672,0.298,0.29375,GOMF_UBIQUINONE_BINDING,0.949379654082202
GOBP_DUCTUS_ARTERIOSUS_CLOSU...,SET,5,0.23165,0.0038222,0.42704,0.29376,GOBP_DUCTUS_ARTERIOSUS_CLOSURE,0.949379654082202
SARRIO_EPITHELIAL_MESENCHYMA...2,SET,159,0.035052,0.0032477,0.064644,0.29383,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,0.949429309222759
GOBP_POSITIVE_REGULATION_OF_...716,SET,15,0.12076,0.0034502,0.22271,0.29383,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,0.949429309222759
ZHAN_MULTIPLE_MYELOMA_MF_DN,SET,40,0.074879,0.0034912,0.13815,0.29391,ZHAN_MULTIPLE_MYELOMA_MF_DN,0.949599521241982
HP_CARDIOGENIC_SHOCK,SET,6,0.17762,0.0032103,0.32779,0.29395,HP_CARDIOGENIC_SHOCK,0.949640476854434
HP_ABNORMALITY_OF_THE_VESTIB...,SET,9,0.1472,0.0032581,0.27178,0.29405,HP_ABNORMALITY_OF_THE_VESTIBULOCOCHLEAR_NERVE,0.949875243981783
REACTOME_MITOTIC_PROPHASE,SET,77,0.050222,0.0032455,0.092746,0.29409,REACTOME_MITOTIC_PROPHASE,0.949916166356877
HP_POSTURAL_TREMOR,SET,53,0.060751,0.0032592,0.11222,0.29414,HP_POSTURAL_TREMOR,0.949989378310566
GOCC_HAPTOGLOBIN_HEMOGLOBIN_...,SET,7,0.21044,0.0041082,0.38882,0.29417,GOCC_HAPTOGLOBIN_HEMOGLOBIN_COMPLEX,0.949997988292139
REACTOME_SARS_COV_INFECTIONS,SET,378,0.022923,0.0032551,0.042372,0.29426,REACTOME_SARS_COV_INFECTIONS,0.950176644370123
OVSYANNIKOVA_PBMC_FLUARIX_AG...3,SET,17,0.10625,0.0032314,0.19641,0.29428,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN,0.950176644370123
GOMF_GROWTH_HORMONE_RECEPTOR...,SET,8,0.17796,0.0037138,0.32917,0.29439,GOMF_GROWTH_HORMONE_RECEPTOR_BINDING,0.950443516024152
GSE37605_C57BL6_VS_NOD_FOXP3...5,SET,148,0.037859,0.0033853,0.070058,0.29447,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_DN,0.950501481240713
MIR9500,SET,145,0.036982,0.0032734,0.06844,0.29448,MIR9500,0.950501481240713
GSE15735_CTRL_VS_HDAC_INHIBI...2,SET,178,0.033138,0.0032469,0.061329,0.29449,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_UP,0.950501481240713
GOMF_RS_DOMAIN_BINDING,SET,4,0.18727,0.0027638,0.34675,0.29457,GOMF_RS_DOMAIN_BINDING,0.950671404030086
GOMF_GLYCOSYLTRANSFERASE_ACT...,SET,254,0.030061,0.0035111,0.05567,0.29461,GOMF_GLYCOSYLTRANSFERASE_ACTIVITY,0.950688482963513
GOMF_PHOSPHATIDYLINOSITOL_BI...1,SET,253,0.028264,0.0032948,0.052348,0.29463,GOMF_PHOSPHATIDYLINOSITOL_BINDING,0.950688482963513
HANN_RESISTANCE_TO_BCL2_INHI...2,SET,30,0.091814,0.0037082,0.17008,0.29466,HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP,0.950697020051987
MIR20A_5P,SET,623,0.018627,0.0033725,0.034515,0.29471,MIR20A_5P,0.95077007797271
MIR6716_5P,SET,118,0.04174,0.0033354,0.07737,0.29478,MIR6716_5P,0.950883897911833
REACTOME_DNA_DOUBLE_STRAND_B...1,SET,126,0.037413,0.0030886,0.069359,0.2948,REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,0.950883897911833
GNF2_SELL,SET,44,0.066782,0.0032653,0.1239,0.29495,GNF2_SELL,0.950955957446808
MANNO_MIDBRAIN_NEUROTYPES_HM...,SET,521,0.02081,0.0034554,0.038618,0.29499,MANNO_MIDBRAIN_NEUROTYPES_HMGL,0.950955957446808
MIR331_3P,SET,59,0.063286,0.0035817,0.11746,0.29502,MIR331_3P,0.950955957446808
GSE1460_DP_VS_CD4_THYMOCYTE_...2,SET,176,0.03374,0.0032874,0.062624,0.29503,GSE1460_DP_VS_CD4_THYMOCYTE_UP,0.950955957446808
HP_FOCAL_MOTOR_SEIZURE,SET,100,0.045353,0.0033379,0.08419,0.29505,HP_FOCAL_MOTOR_SEIZURE,0.950955957446808
MIR3165,SET,33,0.078195,0.0033121,0.14519,0.2951,MIR3165,0.950955957446808
GSE29617_CTRL_VS_TIV_FLU_VAC...2,SET,162,0.036294,0.0033941,0.067399,0.29512,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP,0.950955957446808
GOBP_RESPONSE_TO_AMYLOID_BETA,SET,50,0.070066,0.0036513,0.13013,0.29515,GOBP_RESPONSE_TO_AMYLOID_BETA,0.950955957446808
GOMF_GLUTATHIONE_PEROXIDASE_...,SET,21,0.10496,0.0035476,0.19496,0.29516,GOMF_GLUTATHIONE_PEROXIDASE_ACTIVITY,0.950955957446808
BROWNE_HCMV_INFECTION_16HR_DN,SET,77,0.053705,0.0034706,0.099758,0.29517,BROWNE_HCMV_INFECTION_16HR_DN,0.950955957446808
GOBP_PURINE_DEOXYRIBONUCLEOS...1,SET,5,0.23955,0.0039525,0.44501,0.29519,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,0.950955957446808
MIR6829_5P,SET,89,0.047839,0.0033226,0.088904,0.29526,MIR6829_5P,0.950955957446808
GOBP_REGULATION_OF_TRANSLATI...9,SET,7,0.16602,0.003241,0.3086,0.2953,GOBP_REGULATION_OF_TRANSLATION_AT_SYNAPSE,0.950955957446808
XU_AKT1_TARGETS_6HR,SET,25,0.083146,0.003066,0.15456,0.29531,XU_AKT1_TARGETS_6HR,0.950955957446808
GSE29618_PRE_VS_DAY7_FLU_VAC...2,SET,177,0.034532,0.0033741,0.064195,0.29532,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP,0.950955957446808
GOMF_INOSITOL_PHOSPHATE_KINA...,SET,11,0.1185,0.0028996,0.22033,0.29535,GOMF_INOSITOL_PHOSPHATE_KINASE_ACTIVITY,0.950955957446808
GOMF_ANAPHASE_PROMOTING_COMP...,SET,9,0.14,0.0030988,0.26033,0.29537,GOMF_ANAPHASE_PROMOTING_COMPLEX_BINDING,0.950955957446808
MURATA_VIRULENCE_OF_H_PILORI,SET,20,0.1072,0.003536,0.19935,0.29539,MURATA_VIRULENCE_OF_H_PILORI,0.950955957446808
HP_PARALYSIS,SET,146,0.036865,0.0032743,0.06856,0.29539,HP_PARALYSIS,0.950955957446808
GOBP_PROTEIN_FOLDING_IN_ENDO...,SET,10,0.13255,0.0030926,0.24653,0.29541,GOBP_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM,0.950955957446808
HP_ABNORMALITY_OF_THE_URETER,SET,328,0.025009,0.0033126,0.046521,0.29544,HP_ABNORMALITY_OF_THE_URETER,0.950955957446808
GOMF_METHYLATION_DEPENDENT_P...,SET,66,0.050979,0.0030509,0.094847,0.29547,GOMF_METHYLATION_DEPENDENT_PROTEIN_BINDING,0.950955957446808
REACTOME_SIGNALING_BY_ROBO_R...,SET,198,0.030674,0.0031681,0.057073,0.29548,REACTOME_SIGNALING_BY_ROBO_RECEPTORS,0.950955957446808
GSE21360_PRIMARY_VS_QUATERNA...1,SET,180,0.032244,0.0031769,0.060011,0.29553,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.950955957446808
GSE3920_UNTREATED_VS_IFNG_TR...1,SET,174,0.032863,0.003184,0.061173,0.29556,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.950955957446808
E47_01,SET,233,0.029867,0.0033431,0.055599,0.29558,E47_01,0.950955957446808
HP_ABNORMAL_CIRCULATING_CARB...1,SET,55,0.055718,0.0030449,0.10373,0.29559,HP_ABNORMAL_CIRCULATING_CARBOHYDRATE_CONCENTRATION,0.950955957446808
GOBP_RESPONSE_TO_OXIDATIVE_S...,SET,356,0.024353,0.003358,0.045348,0.29563,GOBP_RESPONSE_TO_OXIDATIVE_STRESS,0.950955957446808
HP_EMPHYSEMA,SET,63,0.05801,0.0033922,0.10802,0.29563,HP_EMPHYSEMA,0.950955957446808
MIR4731_5P,SET,238,0.029136,0.0032957,0.054275,0.2957,MIR4731_5P,0.950955957446808
chr15q26,SET,67,0.10826,0.0065275,0.20168,0.29571,chr15q26,0.950955957446808
REACTOME_MULTIFUNCTIONAL_ANI...,SET,9,0.15037,0.0033283,0.28015,0.29573,REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS,0.950955957446808
GSE35825_UNTREATED_VS_IFNG_S...2,SET,186,0.035492,0.0035541,0.06614,0.29577,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP,0.950955957446808
GSE44649_WT_VS_MIR155_KO_NAI...2,SET,184,0.033921,0.0033786,0.063213,0.29577,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP,0.950955957446808
HINATA_NFKB_IMMU_INF,SET,15,0.13379,0.0038226,0.24935,0.29578,HINATA_NFKB_IMMU_INF,0.950955957446808
SUMI_HNF4A_TARGETS,SET,28,0.091845,0.0035839,0.1713,0.29592,SUMI_HNF4A_TARGETS,0.95103398318396
CROONQUIST_NRAS_VS_STROMAL_S...1,SET,86,0.049832,0.0034024,0.092952,0.29595,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,0.95103398318396
GOBP_AORTIC_VALVE_MORPHOGENE...,SET,39,0.0804,0.0037015,0.15,0.29598,GOBP_AORTIC_VALVE_MORPHOGENESIS,0.95103398318396
chr10p14,SET,15,0.18636,0.0053244,0.34771,0.29599,chr10p14,0.95103398318396
GOBP_CHRONIC_INFLAMMATORY_RE...,SET,18,0.10971,0.0034335,0.2047,0.29599,GOBP_CHRONIC_INFLAMMATORY_RESPONSE,0.95103398318396
HP_INTERPHALANGEAL_JOINT_ERO...,SET,7,0.17444,0.0034054,0.32545,0.29599,HP_INTERPHALANGEAL_JOINT_EROSIONS,0.95103398318396
GSE21927_GMCSF_IL6_VS_GMCSF_...1,SET,181,0.031472,0.0031093,0.058729,0.29602,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,0.95103398318396
GOBP_PRESYNAPTIC_ACTIVE_ZONE...,SET,7,0.18905,0.0036905,0.35284,0.29606,GOBP_PRESYNAPTIC_ACTIVE_ZONE_ORGANIZATION,0.95103398318396
HP_RENAL_MALROTATION,SET,6,0.18956,0.0034261,0.35381,0.29607,HP_RENAL_MALROTATION,0.95103398318396
HP_LIPODYSTROPHY,SET,114,0.042918,0.0033712,0.080124,0.29611,HP_LIPODYSTROPHY,0.95103398318396
GOBP_OPTIC_NERVE_DEVELOPMENT,SET,20,0.10317,0.0034032,0.19263,0.29612,GOBP_OPTIC_NERVE_DEVELOPMENT,0.95103398318396
HP_RESPIRATORY_PARALYSIS,SET,7,0.18807,0.0036715,0.3512,0.29615,HP_RESPIRATORY_PARALYSIS,0.95103398318396
HP_ELEVATED_CIRCULATING_LONG...,SET,3,0.21674,0.0027703,0.40476,0.29616,HP_ELEVATED_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION,0.95103398318396
HP_ABNORMAL_FINGER_MORPHOLOGY,SET,1056,0.01414,0.0032921,0.026418,0.29625,HP_ABNORMAL_FINGER_MORPHOLOGY,0.951157382271468
HAN_SATB1_TARGETS_UP,SET,387,0.024176,0.0034727,0.045171,0.29626,HAN_SATB1_TARGETS_UP,0.951157382271468
DURANTE_ADULT_OLFACTORY_NEUR...17,SET,70,0.059645,0.0036758,0.11147,0.2963,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PERICYTES,0.951157382271468
GOCC_BBAF_COMPLEX,SET,10,0.14266,0.0033284,0.26664,0.29631,GOCC_BBAF_COMPLEX,0.951157382271468
HP_ABNORMAL_DENTAL_ROOT_MORP...,SET,47,0.065475,0.0033084,0.1224,0.29635,HP_ABNORMAL_DENTAL_ROOT_MORPHOLOGY,0.951157382271468
GSE31082_DN_VS_CD8_SP_THYMOC...2,SET,176,0.032521,0.0031687,0.060806,0.29638,GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP,0.951157382271468
HP_ABNORMAL_THROMBOSIS,SET,185,0.035062,0.0035016,0.065559,0.29639,HP_ABNORMAL_THROMBOSIS,0.951157382271468
GOBP_MICROTUBULE_BASED_PROCE...,SET,831,0.015413,0.0032039,0.028845,0.29656,GOBP_MICROTUBULE_BASED_PROCESS,0.951336337209302
GOBP_NEGATIVE_REGULATION_OF_...643,SET,809,0.016337,0.0033528,0.030575,0.29656,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.951336337209302
HP_DOWN_SLOPING_SHOULDERS,SET,34,0.080502,0.003461,0.15069,0.29659,HP_DOWN_SLOPING_SHOULDERS,0.951336337209302
GSE39820_CTRL_VS_TGFBETA3_IL...1,SET,182,0.033003,0.0032695,0.061779,0.2966,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN,0.951336337209302
GOMF_ACETYLGALACTOSAMINYLTRA...,SET,32,0.087361,0.0036439,0.16354,0.29661,GOMF_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,0.951336337209302
IL15_UP.V1_DN,SET,157,0.036436,0.0033548,0.068211,0.29661,IL15_UP.V1_DN,0.951336337209302
LI_PBMC_MENACTRA_AGE_18_45YO...2,SET,15,0.123,0.0035143,0.23035,0.29668,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_DN,0.951473046045954
LA_MEN1_TARGETS,SET,21,0.10681,0.0036103,0.20014,0.29678,LA_MEN1_TARGETS,0.951668991750687
GOBP_REGULATION_OF_EPITHELIA...1,SET,97,0.049055,0.003556,0.091947,0.29684,GOBP_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.951668991750687
REACTOME_NR1H2_NR1H3_REGULAT...4,SET,9,0.12697,0.0028104,0.23801,0.29686,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS,0.951668991750687
HP_ABNORMAL_NUMBER_OF_DENSE_...,SET,7,0.16413,0.0032041,0.3077,0.29688,HP_ABNORMAL_NUMBER_OF_DENSE_GRANULES,0.951668991750687
TCF4_Q5,SET,219,0.032455,0.0035233,0.060864,0.29694,TCF4_Q5,0.951668991750687
GSE26928_NAIVE_VS_CXCR5_POS_...1,SET,166,0.032947,0.0031185,0.061801,0.29698,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN,0.951668991750687
GOBP_CELL_MIGRATION_INVOLVED...1,SET,13,0.12492,0.0033228,0.23437,0.29701,GOBP_CELL_MIGRATION_INVOLVED_IN_GASTRULATION,0.951668991750687
GOBP_PORE_COMPLEX_ASSEMBLY,SET,18,0.10359,0.0032417,0.19434,0.29701,GOBP_PORE_COMPLEX_ASSEMBLY,0.951668991750687
CCAATNNSNNNGCG_UNKNOWN,SET,53,0.064985,0.0034864,0.12193,0.29704,CCAATNNSNNNGCG_UNKNOWN,0.951668991750687
GSE6259_33D1_POS_DC_VS_BCELL...2,SET,136,0.038704,0.0033186,0.072623,0.29704,GSE6259_33D1_POS_DC_VS_BCELL_UP,0.951668991750687
GSE4748_CTRL_VS_CYANOBACTERI...1,SET,176,0.033867,0.0032999,0.063551,0.29705,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN,0.951668991750687
HP_ADENOMA_SEBACEUM,SET,26,0.078886,0.0029664,0.14805,0.29708,HP_ADENOMA_SEBACEUM,0.951668991750687
HP_HYPOPLASTIC_ANEMIA,SET,6,0.15577,0.0028153,0.29239,0.29711,HP_HYPOPLASTIC_ANEMIA,0.951668991750687
HP_VENOUS_MALFORMATION,SET,11,0.13425,0.0032851,0.25204,0.29714,HP_VENOUS_MALFORMATION,0.951668991750687
GOBP_SENSORY_ORGAN_DEVELOPME...,SET,554,0.020551,0.0035155,0.03859,0.29717,GOBP_SENSORY_ORGAN_DEVELOPMENT,0.951668991750687
GOMF_HYDROXYMETHYL_FORMYL_AN...,SET,8,0.13728,0.0028648,0.25787,0.29725,GOMF_HYDROXYMETHYL_FORMYL_AND_RELATED_TRANSFERASE_ACTIVITY,0.951668991750687
CHEOK_RESPONSE_TO_HD_MTX_DN,SET,19,0.096123,0.0030905,0.1806,0.29728,CHEOK_RESPONSE_TO_HD_MTX_DN,0.951668991750687
GSE25123_ROSIGLITAZONE_VS_IL...2,SET,177,0.033801,0.0033027,0.063522,0.29733,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,0.951668991750687
HP_ABNORMAL_PR_INTERVAL,SET,17,0.11624,0.0035353,0.21847,0.29734,HP_ABNORMAL_PR_INTERVAL,0.951668991750687
HP_POSTAXIAL_HAND_POLYDACTYLY,SET,78,0.048647,0.0031639,0.091431,0.29735,HP_POSTAXIAL_HAND_POLYDACTYLY,0.951668991750687
GSE45365_HEALTHY_VS_MCMV_INF...9,SET,172,0.034,0.0032753,0.063927,0.29741,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP,0.951668991750687
WP_WNT_SIGNALING_WP428,SET,109,0.044126,0.0033897,0.082969,0.29742,WP_WNT_SIGNALING_WP428,0.951668991750687
DESCARTES_FETAL_KIDNEY_VASCU...,SET,79,0.052961,0.0034664,0.099586,0.29743,DESCARTES_FETAL_KIDNEY_VASCULAR_ENDOTHELIAL_CELLS,0.951668991750687
GSE33425_CD161_HIGH_VS_INT_C...2,SET,186,0.032549,0.0032594,0.061206,0.29744,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP,0.951668991750687
GOMF_PYRIMIDINE_NUCLEOTIDE_B...,SET,5,0.17465,0.0028817,0.32848,0.29748,GOMF_PYRIMIDINE_NUCLEOTIDE_BINDING,0.951668991750687
GOMF_FIBRINOGEN_BINDING,SET,6,0.19257,0.0034806,0.36224,0.2975,GOMF_FIBRINOGEN_BINDING,0.951668991750687
GOBP_NERVOUS_SYSTEM_PROCESS,SET,1292,0.014252,0.0036452,0.026836,0.29769,GOBP_NERVOUS_SYSTEM_PROCESS,0.951668991750687
GOMF_MONOATOMIC_ION_GATED_CH...,SET,30,0.087771,0.0035449,0.16529,0.29771,GOMF_MONOATOMIC_ION_GATED_CHANNEL_ACTIVITY,0.951668991750687
GOBP_MICROGLIA_DIFFERENTIATI...,SET,11,0.14341,0.0035091,0.27013,0.29775,GOBP_MICROGLIA_DIFFERENTIATION,0.951668991750687
WP_ENDOMETRIAL_CANCER,SET,61,0.057316,0.0032981,0.10798,0.29778,WP_ENDOMETRIAL_CANCER,0.951668991750687
GOBP_PML_BODY_ORGANIZATION,SET,6,0.17968,0.0032475,0.33858,0.29782,GOBP_PML_BODY_ORGANIZATION,0.951668991750687
HP_REFRACTORY_ANEMIA,SET,6,0.20011,0.0036168,0.37708,0.29782,HP_REFRACTORY_ANEMIA,0.951668991750687
GOBP_NEGATIVE_REGULATION_OF_...484,SET,7,0.16829,0.0032852,0.31716,0.29785,GOBP_NEGATIVE_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.951668991750687
GOMF_MICROTUBULE_MOTOR_ACTIV...,SET,68,0.053205,0.0032319,0.10028,0.29786,GOMF_MICROTUBULE_MOTOR_ACTIVITY,0.951668991750687
GSE5589_UNSTIM_VS_45MIN_LPS_...4,SET,182,0.032051,0.0031752,0.060408,0.29786,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP,0.951668991750687
STAT5A_01,SET,227,0.030864,0.0034105,0.058178,0.29788,STAT5A_01,0.951668991750687
HP_ABNORMALITY_OF_THE_DIENCE...,SET,122,0.039411,0.0032018,0.074293,0.29789,HP_ABNORMALITY_OF_THE_DIENCEPHALON,0.951668991750687
MIR155_3P,SET,85,0.048267,0.0032764,0.091014,0.29795,MIR155_3P,0.951668991750687
GOBP_OLIGODENDROCYTE_DEVELOP...,SET,44,0.06976,0.0034108,0.13156,0.29798,GOBP_OLIGODENDROCYTE_DEVELOPMENT,0.951668991750687
HP_ORAL_ULCER,SET,57,0.060491,0.0033652,0.11411,0.29803,HP_ORAL_ULCER,0.951668991750687
HP_EXCESSIVE_SHYNESS,SET,8,0.13623,0.002843,0.25701,0.29804,HP_EXCESSIVE_SHYNESS,0.951668991750687
GSE6269_STAPH_AUREUS_VS_STRE...2,SET,145,0.03677,0.0032546,0.069378,0.29806,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP,0.951668991750687
WP_TYPE_I_INTERFERON_INDUCTI...,SET,28,0.08336,0.0032528,0.15729,0.29807,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,0.951668991750687
GSE17974_IL4_AND_ANTI_IL12_V...17,SET,173,0.034467,0.0033298,0.065034,0.29807,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN,0.951668991750687
GSE23308_CTRL_VS_CORTICOSTER...4,SET,188,0.031506,0.0031717,0.05946,0.2981,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP,0.951668991750687
MIR6800_5P,SET,42,0.066619,0.0031826,0.12575,0.29814,MIR6800_5P,0.951668991750687
ZNF20_TARGET_GENES,SET,5,0.17906,0.0029545,0.33801,0.29814,ZNF20_TARGET_GENES,0.951668991750687
MIR374B_3P,SET,128,0.040578,0.0033762,0.076633,0.29823,MIR374B_3P,0.951668991750687
MIR551B_5P,SET,451,0.022105,0.0034216,0.04176,0.29829,MIR551B_5P,0.951668991750687
HP_APLASIA_HYPOPLASIA_OF_THE...21,SET,108,0.043844,0.0033527,0.082847,0.29833,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,0.951668991750687
GSE30153_LUPUS_VS_HEALTHY_DO...1,SET,180,0.034363,0.0033857,0.064947,0.29837,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_DN,0.951668991750687
HP_ERYTHROID_HYPOPLASIA,SET,26,0.082685,0.0031093,0.15634,0.29844,HP_ERYTHROID_HYPOPLASIA,0.951668991750687
WP_WNTBETACATENIN_SIGNALING_...1,SET,4,0.25626,0.0037819,0.48454,0.29845,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,0.951668991750687
HP_PHTHISIS_BULBI,SET,13,0.13207,0.0035129,0.24971,0.29845,HP_PHTHISIS_BULBI,0.951668991750687
REACTOME_MITOTIC_METAPHASE_A...,SET,217,0.029198,0.0031553,0.055211,0.29846,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,0.951668991750687
MIR623,SET,107,0.042533,0.0032374,0.080428,0.29846,MIR623,0.951668991750687
GACAATC_MIR219,SET,134,0.038867,0.0033082,0.073518,0.29852,GACAATC_MIR219,0.951668991750687
GOBP_ENDOCARDIAL_CUSHION_TO_...,SET,6,0.1975,0.0035696,0.37361,0.29853,GOBP_ENDOCARDIAL_CUSHION_TO_MESENCHYMAL_TRANSITION,0.951668991750687
GOBP_ENDOCYTOSIS,SET,643,0.018029,0.0033142,0.034103,0.29853,GOBP_ENDOCYTOSIS,0.951668991750687
GOCC_TRNA_METHYLTRANSFERASE_...,SET,6,0.14656,0.0026489,0.27732,0.29859,GOCC_TRNA_METHYLTRANSFERASE_COMPLEX,0.951668991750687
GSE27786_LIN_NEG_VS_ERYTHROB...1,SET,181,0.032264,0.0031876,0.061051,0.29859,GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN,0.951668991750687
GSE22919_RESTING_VS_IL2_IL12...1,SET,181,0.031761,0.0031379,0.060102,0.2986,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN,0.951668991750687
GOBP_POSITIVE_REGULATION_OF_...594,SET,12,0.14729,0.0037643,0.27875,0.29861,GOBP_POSITIVE_REGULATION_OF_PLATELET_ACTIVATION,0.951668991750687
GOMF_STEROID_DEHYDROGENASE_A...2,SET,30,0.084376,0.0034078,0.15967,0.29861,GOMF_STEROID_DEHYDROGENASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,0.951668991750687
GSE36392_EOSINOPHIL_VS_MAC_I...1,SET,177,0.032197,0.0031459,0.060946,0.29865,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN,0.951668991750687
GOBP_GANGLIOSIDE_BIOSYNTHETI...1,SET,17,0.11671,0.0035497,0.22093,0.29866,GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS,0.951668991750687
MIR1468_5P,SET,14,0.11001,0.0030366,0.20827,0.29868,MIR1468_5P,0.951668991750687
MORF_TNFRSF25,SET,244,0.028627,0.0032781,0.054196,0.29868,MORF_TNFRSF25,0.951668991750687
GOBP_CELLULAR_RESPONSE_TO_FA...,SET,32,0.084436,0.0035219,0.15986,0.29869,GOBP_CELLULAR_RESPONSE_TO_FATTY_ACID,0.951668991750687
MODULE_15,SET,319,0.02513,0.0032834,0.047584,0.29872,MODULE_15,0.951668991750687
ESC_V6.5_UP_LATE.V1_UP,SET,161,0.03676,0.0034271,0.069613,0.29873,ESC_V6.5_UP_LATE.V1_UP,0.951668991750687
DELACROIX_RAR_TARGETS_UP,SET,44,0.075513,0.0036922,0.143,0.29874,DELACROIX_RAR_TARGETS_UP,0.951668991750687
HE_LIM_SUN_FETAL_LUNG_C6_MUC...,SET,49,0.066773,0.0034449,0.12646,0.29874,HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL,0.951668991750687
HP_FOCAL_SEGMENTAL_GLOMERULO...,SET,51,0.061309,0.0032267,0.11616,0.29883,HP_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS,0.951831154973438
DURANTE_ADULT_OLFACTORY_NEUR...19,SET,119,0.039781,0.0031922,0.075404,0.2989,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_CILIATED_CELLS,0.951831154973438
GOBP_CELLULAR_RESPONSE_TO_LE...1,SET,4,0.26475,0.0039073,0.50188,0.29892,GOBP_CELLULAR_RESPONSE_TO_LEAD_ION,0.951831154973438
WP_DISORDERS_OF_BILE_ACID_SY...,SET,29,0.086277,0.0034261,0.16357,0.29894,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,0.951831154973438
MODULE_220,SET,309,0.027497,0.0035369,0.05213,0.29894,MODULE_220,0.951831154973438
GOMF_ENONE_REDUCTASE_ACTIVITY,SET,5,0.19896,0.0032828,0.37731,0.29899,GOMF_ENONE_REDUCTASE_ACTIVITY,0.951831154973438
MORF_RAB5A,SET,85,0.042517,0.0028861,0.080639,0.29901,MORF_RAB5A,0.951831154973438
GSE28408_LY6G_POS_VS_NEG_DC_...1,SET,176,0.031618,0.0030807,0.059967,0.29901,GSE28408_LY6G_POS_VS_NEG_DC_DN,0.951831154973438
GOBP_NAD_TRANSMEMBRANE_TRANS...,SET,4,0.2361,0.0034844,0.44794,0.29908,GOBP_NAD_TRANSMEMBRANE_TRANSPORT,0.951879615384615
GOMF_NAD_TRANSMEMBRANE_TRANS...,SET,4,0.2361,0.0034844,0.44794,0.29908,GOMF_NAD_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.951879615384615
MIR4731_3P,SET,203,0.032938,0.0034441,0.062518,0.29915,MIR4731_3P,0.951984782608696
MIR1199_5P,SET,72,0.051314,0.003207,0.097434,0.29922,MIR1199_5P,0.951984782608696
HP_PROPORTIONATE_SHORT_STATU...,SET,130,0.038527,0.0032303,0.073156,0.29923,HP_PROPORTIONATE_SHORT_STATURE,0.951984782608696
GOMF_LYSINE_N_METHYLTRANSFER...,SET,49,0.062266,0.0032123,0.11824,0.29924,GOMF_LYSINE_N_METHYLTRANSFERASE_ACTIVITY,0.951984782608696
GSE3982_DC_VS_BASOPHIL_DN,SET,172,0.032751,0.003155,0.062196,0.29925,GSE3982_DC_VS_BASOPHIL_DN,0.951984782608696
MANNO_MIDBRAIN_NEUROTYPES_HR...3,SET,385,0.024221,0.0034704,0.046018,0.29933,MANNO_MIDBRAIN_NEUROTYPES_HRGL2B,0.951986165248422
MIR6873_5P,SET,93,0.046659,0.0033123,0.088652,0.29934,MIR6873_5P,0.951986165248422
KEGG_MEDICUS_REFERENCE_MYOST...,SET,8,0.15655,0.0032671,0.29746,0.29935,KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY,0.951986165248422
GOBP_POSITIVE_REGULATION_OF_...667,SET,50,0.065173,0.0033964,0.12385,0.29936,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.951986165248422
HE_LIM_SUN_FETAL_LUNG_C7_LAT...,SET,90,0.048515,0.0033883,0.092211,0.2994,HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL,0.952002753636447
HP_MOTTLED_PIGMENTATION,SET,8,0.16497,0.0034428,0.31359,0.29942,HP_MOTTLED_PIGMENTATION,0.952002753636447
CAMPS_COLON_CANCER_COPY_NUMB...2,SET,81,0.055326,0.0036666,0.10521,0.29949,CAMPS_COLON_CANCER_COPY_NUMBER_UP,0.952138213501647
GOBP_POSITIVE_REGULATION_OF_...368,SET,6,0.22222,0.0040164,0.42264,0.29952,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION,0.952146492271106
SUZUKI_AMPLIFIED_IN_ORAL_CAN...,SET,17,0.12099,0.0036798,0.23022,0.29961,SUZUKI_AMPLIFIED_IN_ORAL_CANCER,0.952338479473347
GOCC_MICROTUBULE_ASSOCIATED_...,SET,139,0.035256,0.0030559,0.067096,0.29964,GOCC_MICROTUBULE_ASSOCIATED_COMPLEX,0.952338479473347
CERVERA_SDHB_TARGETS_2,SET,102,0.047574,0.003536,0.090554,0.29967,CERVERA_SDHB_TARGETS_2,0.952338479473347
TCTGATC_MIR383,SET,46,0.067003,0.0033495,0.12755,0.29969,TCTGATC_MIR383,0.952338479473347
HP_REDUCED_CIRCULATING_CH50_...,SET,4,0.23011,0.003396,0.43819,0.29975,HP_REDUCED_CIRCULATING_CH50_ACTIVITY,0.952364487390351
HP_INCREASED_NUCHAL_TRANSLUC...,SET,46,0.070401,0.0035194,0.13407,0.29976,HP_INCREASED_NUCHAL_TRANSLUCENCY,0.952364487390351
GOBP_REGULATION_OF_PEPTIDYL_...3,SET,7,0.15881,0.0031003,0.30254,0.29982,GOBP_REGULATION_OF_PEPTIDYL_SERINE_DEPHOSPHORYLATION,0.952364487390351
HP_CHYLOTHORAX,SET,16,0.10741,0.0031692,0.20463,0.29984,HP_CHYLOTHORAX,0.952364487390351
GOBP_PROTEIN_LOCALIZATION_TO...18,SET,14,0.1322,0.003649,0.25188,0.29985,GOBP_PROTEIN_LOCALIZATION_TO_CONDENSED_CHROMOSOME,0.952364487390351
REACTOME_DEFECTIVE_EXT2_CAUS...,SET,12,0.1444,0.0036904,0.27517,0.29987,REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,0.952364487390351
GOBP_CANONICAL_NF_KAPPAB_SIG...,SET,279,0.026733,0.0032702,0.050947,0.29989,GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.952364487390351
ATM_DN.V1_UP,SET,138,0.039041,0.0033719,0.07442,0.29993,ATM_DN.V1_UP,0.952384686986676
chr9p24,SET,33,0.12702,0.0053802,0.2422,0.29998,chr9p24,0.952384686986676
chr3q29,SET,43,0.13111,0.0063372,0.25002,0.30001,chr3q29,0.952384686986676
GOBP_NEURON_FATE_DETERMINATI...,SET,8,0.18946,0.0039538,0.36135,0.30004,GOBP_NEURON_FATE_DETERMINATION,0.952384686986676
LEIN_NEURON_MARKERS,SET,57,0.061225,0.003406,0.11678,0.30005,LEIN_NEURON_MARKERS,0.952384686986676
MORF_NPM1,SET,147,0.03473,0.003095,0.066266,0.30011,MORF_NPM1,0.952384686986676
WP_VEGFAVEGFR2_SIGNALING,SET,404,0.021985,0.0032251,0.04195,0.30012,WP_VEGFAVEGFR2_SIGNALING,0.952384686986676
GOBP_GLYCOSYLATION,SET,223,0.030085,0.0032954,0.05742,0.30016,GOBP_GLYCOSYLATION,0.952384686986676
GNF2_BNIP2,SET,32,0.070999,0.0029614,0.13553,0.30019,GNF2_BNIP2,0.952384686986676
GNF2_FEN1,SET,54,0.056799,0.0030757,0.10843,0.3002,GNF2_FEN1,0.952384686986676
HP_REDUCED_VITAL_CAPACITY,SET,26,0.081963,0.0030821,0.15647,0.30021,HP_REDUCED_VITAL_CAPACITY,0.952384686986676
HP_ABNORMAL_ST_SEGMENT,SET,38,0.074117,0.0033683,0.14152,0.30023,HP_ABNORMAL_ST_SEGMENT,0.952384686986676
GOBP_TOLL_LIKE_RECEPTOR_4_SI...,SET,56,0.057325,0.003161,0.10948,0.30027,GOBP_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.952384686986676
GOMF_FRUCTOSE_BINDING,SET,6,0.14483,0.0026177,0.2766,0.30028,GOMF_FRUCTOSE_BINDING,0.952384686986676
GSE17721_POLYIC_VS_GARDIQUIM...11,SET,184,0.031647,0.0031522,0.060471,0.30037,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_DN,0.952559712591241
HP_SMALL_BOWEL_DIVERTICULA,SET,5,0.17897,0.002953,0.34201,0.30039,HP_SMALL_BOWEL_DIVERTICULA,0.952559712591241
RODRIGUES_DCC_TARGETS_DN,SET,110,0.041074,0.0031696,0.078511,0.30043,RODRIGUES_DCC_TARGETS_DN,0.95259963963142
HP_MEGACYSTIS,SET,9,0.15858,0.00351,0.30323,0.3005,HP_MEGACYSTIS,0.952711173948737
QIU_PBMC_HEPTATITIS_B_SURFAC...7,SET,28,0.091147,0.0035567,0.17431,0.30052,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_7DY_UP,0.952711173948737
GOBP_POSITIVE_REGULATION_OF_...260,SET,9,0.11609,0.0025697,0.22208,0.30058,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE,0.952728685386088
REACTOME_RHOB_GTPASE_CYCLE,SET,65,0.05385,0.0031983,0.10303,0.3006,REACTOME_RHOB_GTPASE_CYCLE,0.952728685386088
ZID_01,SET,232,0.02824,0.0031543,0.054039,0.30063,ZID_01,0.952728685386088
GOBP_RESPONSE_TO_UV,SET,141,0.035252,0.0030773,0.067459,0.30064,GOBP_RESPONSE_TO_UV,0.952728685386088
chr2p11,SET,44,0.1511,0.0073877,0.2892,0.30068,chr2p11,0.952728685386088
HP_ABNORMAL_MUSCLE_FIBER_MER...,SET,4,0.20412,0.0030124,0.39072,0.30069,HP_ABNORMAL_MUSCLE_FIBER_MEROSIN_EXPRESSION,0.952728685386088
GSE14000_4H_VS_16H_LPS_DC_TR...2,SET,170,0.034019,0.0032582,0.06513,0.30073,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP,0.952768564266181
GOMF_DNA_BINDING_BENDING,SET,17,0.11431,0.0034768,0.21908,0.30091,GOMF_DNA_BINDING_BENDING,0.952863880556313
GOBP_REGULATION_OF_INTEGRIN_...1,SET,17,0.11351,0.0034523,0.21757,0.30094,GOBP_REGULATION_OF_INTEGRIN_ACTIVATION,0.952863880556313
HP_HYPERAUTOFLUORESCENT_MACU...,SET,11,0.15169,0.0037116,0.29075,0.30094,HP_HYPERAUTOFLUORESCENT_MACULAR_LESION,0.952863880556313
REACTOME_ACTIVATION_OF_ATR_I...,SET,37,0.066703,0.0029913,0.12792,0.30103,REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,0.952863880556313
GSE24210_TCONV_VS_TREG_DN,SET,176,0.031675,0.0030862,0.060755,0.30106,GSE24210_TCONV_VS_TREG_DN,0.952863880556313
REACTOME_SYNTHESIS_OF_BILE_A...1,SET,33,0.081281,0.0034428,0.15592,0.30108,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,0.952863880556313
DESCARTES_MAIN_FETAL_MYELOID...,SET,78,0.051972,0.0033802,0.099699,0.30109,DESCARTES_MAIN_FETAL_MYELOID_CELLS,0.952863880556313
HP_ABNORMAL_PERIPHERAL_ACTIO...,SET,37,0.072618,0.0032566,0.13932,0.30111,HP_ABNORMAL_PERIPHERAL_ACTION_POTENTIAL_AMPLITUDE,0.952863880556313
GOMF_DEOXYNUCLEOSIDE_KINASE_...,SET,5,0.1928,0.0031811,0.36993,0.30113,GOMF_DEOXYNUCLEOSIDE_KINASE_ACTIVITY,0.952863880556313
HP_BCGOSIS,SET,7,0.19896,0.003884,0.38181,0.30115,HP_BCGOSIS,0.952863880556313
GOMF_CARBOXYLESTERASE_ACTIVI...,SET,6,0.19055,0.003444,0.36568,0.30116,GOMF_CARBOXYLESTERASE_ACTIVITY,0.952863880556313
MORF_TERF2IP,SET,109,0.037916,0.0029127,0.072788,0.30122,MORF_TERF2IP,0.952863880556313
MACLACHLAN_BRCA1_TARGETS_DN,SET,16,0.105,0.0030983,0.2016,0.30124,MACLACHLAN_BRCA1_TARGETS_DN,0.952863880556313
MIR4328,SET,518,0.019918,0.003298,0.038241,0.30124,MIR4328,0.952863880556313
HP_PULVERULENT_CATARACT,SET,11,0.14248,0.0034863,0.27358,0.30126,HP_PULVERULENT_CATARACT,0.952863880556313
GOBP_POSITIVE_REGULATION_OF_...628,SET,451,0.020565,0.0031833,0.039497,0.3013,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION,0.952863880556313
LEE_EARLY_T_LYMPHOCYTE_DN,SET,54,0.064482,0.0034918,0.12388,0.30136,LEE_EARLY_T_LYMPHOCYTE_DN,0.952863880556313
DORSAM_HOXA9_TARGETS_UP,SET,35,0.071009,0.0030973,0.13643,0.30137,DORSAM_HOXA9_TARGETS_UP,0.952863880556313
JOHANSSON_BRAIN_CANCER_EARLY...1,SET,41,0.067208,0.0031724,0.12914,0.30138,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,0.952863880556313
GSE41867_NAIVE_VS_DAY30_LCMV...3,SET,180,0.031084,0.0030626,0.059733,0.3014,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_DN,0.952863880556313
GSE24142_EARLY_THYMIC_PROGEN...1,SET,183,0.032294,0.0032079,0.062061,0.30141,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN,0.952863880556313
REACTOME_INTERFERON_ALPHA_BE...,SET,72,0.055537,0.0034709,0.10673,0.30142,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,0.952863880556313
KEGG_MEDICUS_VARIANT_MUTATIO...42,SET,5,0.15621,0.0025774,0.30024,0.30144,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,0.952863880556313
HP_ABDOMINAL_SITUS_INVERSUS,SET,12,0.12558,0.0032095,0.24143,0.30148,HP_ABDOMINAL_SITUS_INVERSUS,0.952863880556313
WAESCH_ANAPHASE_PROMOTING_CO...,SET,12,0.12126,0.0030989,0.23313,0.3015,WAESCH_ANAPHASE_PROMOTING_COMPLEX,0.952863880556313
YAO_TEMPORAL_RESPONSE_TO_PRO...16,SET,69,0.050655,0.0030994,0.0974,0.30151,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,0.952863880556313
GOMF_OXIDOREDUCTASE_ACTIVITY...24,SET,9,0.1745,0.0038626,0.33559,0.30154,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_IRON_SULFUR_PROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.952863880556313
GOBP_POSITIVE_REGULATION_OF_...654,SET,5,0.19814,0.0032692,0.3811,0.30157,GOBP_POSITIVE_REGULATION_OF_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.952863880556313
HP_PATELLAR_SUBLUXATION,SET,5,0.23174,0.0038237,0.44578,0.30158,HP_PATELLAR_SUBLUXATION,0.952863880556313
GOMF_MRF_BINDING,SET,5,0.19918,0.0032865,0.38317,0.30159,GOMF_MRF_BINDING,0.952863880556313
GOBP_NEGATIVE_REGULATION_OF_...365,SET,14,0.11672,0.0032218,0.22455,0.30161,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,0.952863880556313
HP_VENTRICULAR_ARRHYTHMIA,SET,188,0.032154,0.0032369,0.061874,0.30165,HP_VENTRICULAR_ARRHYTHMIA,0.952903631157971
HP_MOVEMENT_ABNORMALITY_OF_T...,SET,15,0.113,0.0032285,0.21751,0.3017,HP_MOVEMENT_ABNORMALITY_OF_THE_TONGUE,0.952904670179902
DAUER_STAT3_TARGETS_DN,SET,46,0.067272,0.003363,0.12952,0.30174,DAUER_STAT3_TARGETS_DN,0.952904670179902
GOMF_MINUS_END_DIRECTED_MICR...,SET,17,0.10411,0.0031663,0.20043,0.30174,GOMF_MINUS_END_DIRECTED_MICROTUBULE_MOTOR_ACTIVITY,0.952904670179902
HP_RECURRENT_ACUTE_RESPIRATO...,SET,11,0.12371,0.0030271,0.2382,0.30176,HP_RECURRENT_ACUTE_RESPIRATORY_TRACT_INFECTION,0.952904670179902
ZHONG_PFC_C1_NEUROD1_POS_EXC...,SET,25,0.097279,0.0035871,0.18738,0.30183,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,0.952913858868404
GOBP_INTRACILIARY_TRANSPORT,SET,40,0.069686,0.003249,0.13423,0.30184,GOBP_INTRACILIARY_TRANSPORT,0.952913858868404
GOBP_INTEGRIN_MEDIATED_SIGNA...,SET,102,0.045517,0.0033831,0.087699,0.30188,GOBP_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.952913858868404
chr8q22,SET,62,0.10366,0.0060135,0.19975,0.3019,chr8q22,0.952913858868404
KEGG_CALCIUM_SIGNALING_PATHW...,SET,167,0.034693,0.0032936,0.066851,0.3019,KEGG_CALCIUM_SIGNALING_PATHWAY,0.952913858868404
HP_HETEROTAXY,SET,21,0.094388,0.0031903,0.18191,0.30193,HP_HETEROTAXY,0.952922007809662
TORCHIA_TARGETS_OF_EWSR1_FLI...4,SET,240,0.028738,0.0032641,0.05541,0.30201,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,0.953064522426003
GOBP_TRANSPORT_OF_VIRUS,SET,20,0.094681,0.0031232,0.18258,0.30203,GOBP_TRANSPORT_OF_VIRUS,0.953064522426003
PEREZ_TP63_TARGETS,SET,309,0.026414,0.0033977,0.050977,0.30218,PEREZ_TP63_TARGETS,0.953175162425555
MIR130B_5P,SET,175,0.033667,0.0032711,0.064997,0.30224,MIR130B_5P,0.953175162425555
GOCC_DENSE_CORE_GRANULE,SET,38,0.0785,0.0035675,0.15156,0.30225,GOCC_DENSE_CORE_GRANULE,0.953175162425555
GSE25502_WT_VS_KLF13_KO_THYM...1,SET,154,0.036773,0.0033536,0.071027,0.30232,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_DN,0.953175162425555
GOBP_CELLULAR_RESPONSE_TO_AM...2,SET,40,0.073602,0.0034316,0.14217,0.30234,GOBP_CELLULAR_RESPONSE_TO_AMYLOID_BETA,0.953175162425555
LI_CYTIDINE_ANALOGS_CYCTOTOX...,SET,14,0.11056,0.0030518,0.2137,0.30245,LI_CYTIDINE_ANALOGS_CYCTOTOXICITY,0.953175162425555
GOBP_RIBOSOME_ASSEMBLY,SET,51,0.057611,0.003032,0.11136,0.30247,GOBP_RIBOSOME_ASSEMBLY,0.953175162425555
GOBP_AMINOPHOSPHOLIPID_TRANS...1,SET,6,0.15984,0.0028889,0.30906,0.30252,GOBP_AMINOPHOSPHOLIPID_TRANSLOCATION,0.953175162425555
GOMF_AMINOPHOSPHOLIPID_FLIPP...,SET,6,0.15984,0.0028889,0.30906,0.30252,GOMF_AMINOPHOSPHOLIPID_FLIPPASE_ACTIVITY,0.953175162425555
ROSTY_CERVICAL_CANCER_PROLIF...,SET,130,0.036087,0.0030258,0.069788,0.30255,ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER,0.953175162425555
GSE22501_PERIPHERAL_BLOOD_VS...2,SET,178,0.033586,0.0032908,0.06496,0.30257,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP,0.953175162425555
GOBP_FLUID_TRANSPORT,SET,35,0.08278,0.0036107,0.16013,0.3026,GOBP_FLUID_TRANSPORT,0.953175162425555
GSE6259_DEC205_POS_DC_VS_CD8...2,SET,168,0.032179,0.003064,0.06226,0.30263,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_UP,0.953175162425555
HP_HYPOPLASIA_OF_THE_PHALANG...,SET,6,0.16437,0.0029709,0.31819,0.30272,HP_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES,0.953175162425555
GOBP_RESPONSE_TO_METHIONINE,SET,5,0.21858,0.0036065,0.42316,0.30274,GOBP_RESPONSE_TO_METHIONINE,0.953175162425555
GOMF_L_SERINE_TRANSMEMBRANE_...,SET,8,0.15198,0.0031717,0.29425,0.30275,GOMF_L_SERINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.953175162425555
GOBP_NEUTROPHIL_MEDIATED_KIL...1,SET,7,0.20083,0.0039206,0.38891,0.30279,GOBP_NEUTROPHIL_MEDIATED_KILLING_OF_GRAM_NEGATIVE_BACTERIUM,0.953175162425555
REACTOME_RAF_INDEPENDENT_MAP...,SET,22,0.10198,0.0035279,0.19756,0.30286,REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,0.953175162425555
WP_CHOLESTEROL_BIOSYNTHESIS_...2,SET,106,0.041903,0.0031746,0.081217,0.30295,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,0.953175162425555
KEGG_MEDICUS_VARIANT_SCRAPIE...5,SET,5,0.21423,0.0035347,0.41529,0.30299,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY,0.953175162425555
MIR206,SET,340,0.023612,0.0031832,0.045798,0.30308,MIR206,0.953175162425555
GOCC_BLOC_COMPLEX,SET,19,0.10118,0.0032531,0.19624,0.30308,GOCC_BLOC_COMPLEX,0.953175162425555
GOMF_ZINC_ION_TRANSMEMBRANE_...,SET,24,0.080445,0.0029065,0.15605,0.3031,GOMF_ZINC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.953175162425555
HP_PREDOMINANTLY_LOWER_LIMB_...,SET,8,0.15988,0.0033365,0.31013,0.3031,HP_PREDOMINANTLY_LOWER_LIMB_LYMPHEDEMA,0.953175162425555
GOCC_OUTER_MITOCHONDRIAL_MEM...,SET,17,0.097296,0.0029592,0.18878,0.30314,GOCC_OUTER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,0.953175162425555
MODULE_360,SET,12,0.11862,0.0030314,0.23016,0.30315,MODULE_360,0.953175162425555
LINDGREN_BLADDER_CANCER_CLUS...3,SET,118,0.042158,0.0033688,0.081805,0.30316,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,0.953175162425555
BIOCARTA_PARKIN_PATHWAY,SET,7,0.16433,0.0032079,0.31889,0.30317,BIOCARTA_PARKIN_PATHWAY,0.953175162425555
WP_RANKLRANK_SIGNALING,SET,53,0.05978,0.0032072,0.11604,0.30322,WP_RANKLRANK_SIGNALING,0.953175162425555
GSE27786_NKCELL_VS_MONO_MAC_...1,SET,177,0.033377,0.0032612,0.064814,0.30329,GSE27786_NKCELL_VS_MONO_MAC_DN,0.953175162425555
GSE3982_NKCELL_VS_TH2_UP,SET,171,0.033611,0.0032285,0.065269,0.30329,GSE3982_NKCELL_VS_TH2_UP,0.953175162425555
ZHOU_PANCREATIC_BETA_CELL,SET,11,0.15142,0.0037052,0.29406,0.3033,ZHOU_PANCREATIC_BETA_CELL,0.953175162425555
GOBP_TRICARBOXYLIC_ACID_CYCLE,SET,28,0.074075,0.0028905,0.14385,0.3033,GOBP_TRICARBOXYLIC_ACID_CYCLE,0.953175162425555
GOBP_ENDOSOME_TO_LYSOSOME_TR...1,SET,68,0.052117,0.0031658,0.10123,0.30333,GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT,0.953175162425555
GSE17721_0.5H_VS_24H_PAM3CSK...2,SET,186,0.030934,0.0030976,0.060082,0.30333,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_UP,0.953175162425555
GSE17721_POLYIC_VS_GARDIQUIM...8,SET,181,0.031166,0.0030791,0.060536,0.30334,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP,0.953175162425555
GOMF_GPI_LINKED_EPHRIN_RECEP...,SET,6,0.2001,0.0036165,0.38883,0.30341,GOMF_GPI_LINKED_EPHRIN_RECEPTOR_ACTIVITY,0.953175162425555
GSE17580_UNINFECTED_VS_S_MAN...2,SET,186,0.031624,0.0031667,0.061449,0.30341,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP,0.953175162425555
GSE3982_MAC_VS_CENT_MEMORY_C...2,SET,179,0.031425,0.0030877,0.061068,0.30342,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP,0.953175162425555
GOBP_S_ADENOSYLMETHIONINE_CY...,SET,7,0.17359,0.0033887,0.33736,0.30344,GOBP_S_ADENOSYLMETHIONINE_CYCLE,0.953175162425555
GOBP_HYPOTHALAMUS_DEVELOPMENT,SET,25,0.095305,0.0035143,0.18525,0.30346,GOBP_HYPOTHALAMUS_DEVELOPMENT,0.953175162425555
GOBP_NEGATIVE_REGULATION_OF_...495,SET,34,0.074201,0.0031901,0.14425,0.30349,GOBP_NEGATIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY,0.953175162425555
KEGG_FC_EPSILON_RI_SIGNALING...,SET,78,0.051833,0.0033712,0.1008,0.30356,KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,0.953175162425555
ONGUSAHA_BRCA1_TARGETS_UP,SET,10,0.15132,0.0035304,0.29436,0.30361,ONGUSAHA_BRCA1_TARGETS_UP,0.953175162425555
GOCC_TRANSCRIPTION_REPRESSOR...,SET,72,0.052038,0.0032522,0.10123,0.30361,GOCC_TRANSCRIPTION_REPRESSOR_COMPLEX,0.953175162425555
MIR1180_5P,SET,34,0.072324,0.0031093,0.14071,0.30363,MIR1180_5P,0.953175162425555
ZNF260_TARGET_GENES,SET,667,0.017144,0.0032076,0.033355,0.30364,ZNF260_TARGET_GENES,0.953175162425555
KEGG_MEDICUS_REFERENCE_ATR_S...,SET,11,0.11741,0.002873,0.22845,0.30365,KEGG_MEDICUS_REFERENCE_ATR_SIGNALING,0.953175162425555
HP_RECURRENT_CANDIDA_INFECTI...,SET,17,0.1122,0.0034125,0.21832,0.30366,HP_RECURRENT_CANDIDA_INFECTIONS,0.953175162425555
MIR4522,SET,52,0.062947,0.0033451,0.1225,0.30367,MIR4522,0.953175162425555
GOBP_NEGATIVE_REGULATION_OF_...701,SET,85,0.050623,0.0034364,0.09851,0.30367,GOBP_NEGATIVE_REGULATION_OF_VIRAL_PROCESS,0.953175162425555
GOBP_ENDOSOME_TRANSPORT_VIA_...,SET,39,0.063737,0.0029344,0.12404,0.30368,GOBP_ENDOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.953175162425555
GOBP_POSITIVE_REGULATION_OF_...771,SET,48,0.057296,0.0029257,0.1115,0.30368,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_BY_RNA_POLYMERASE_II,0.953175162425555
ZNF202_TARGET_GENES,SET,64,0.054467,0.0032101,0.10601,0.3037,ZNF202_TARGET_GENES,0.953175162425555
REACTOME_MISMATCH_REPAIR,SET,15,0.093867,0.0026818,0.1827,0.30371,REACTOME_MISMATCH_REPAIR,0.953175162425555
GOBP_REGULATION_OF_ACYL_COA_...,SET,4,0.24106,0.0035577,0.46923,0.30372,GOBP_REGULATION_OF_ACYL_COA_BIOSYNTHETIC_PROCESS,0.953175162425555
GOBP_REGULATION_OF_INTRACELL...1,SET,29,0.07597,0.0030168,0.14787,0.30372,GOBP_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.953175162425555
GOCC_SYMMETRIC_SYNAPSE,SET,7,0.16987,0.0033161,0.33067,0.30373,GOCC_SYMMETRIC_SYNAPSE,0.953175162425555
REACTOME_MITOTIC_TELOPHASE_C...,SET,10,0.14424,0.0033652,0.28092,0.30382,REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS,0.953175162425555
FAN_EMBRYONIC_CTX_ASTROCYTE_2,SET,138,0.041369,0.0035729,0.080572,0.30382,FAN_EMBRYONIC_CTX_ASTROCYTE_2,0.953175162425555
KOBAYASHI_EGFR_SIGNALING_24H...2,SET,83,0.04734,0.0031756,0.092207,0.30384,KOBAYASHI_EGFR_SIGNALING_24HR_UP,0.953175162425555
BLANCO_MELO_BETA_INTERFERON_...2,SET,337,0.025545,0.0034289,0.049764,0.30386,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,0.953175162425555
GOBP_NUCLEOSIDE_BISPHOSPHATE...2,SET,11,0.13087,0.0032022,0.25494,0.30386,GOBP_NUCLEOSIDE_BISPHOSPHATE_CATABOLIC_PROCESS,0.953175162425555
GOBP_MICROTUBULE_SEVERING,SET,9,0.12357,0.0027351,0.24074,0.30388,GOBP_MICROTUBULE_SEVERING,0.953175162425555
MIR6838_3P,SET,58,0.056707,0.0031821,0.11048,0.30389,MIR6838_3P,0.953175162425555
KEGG_MEDICUS_VARIANT_SCRAPIE...3,SET,6,0.20186,0.0036485,0.39331,0.3039,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_PERK_ATF4_SIGNALING_PATHWAY,0.953175162425555
CBX7_TARGET_GENES,SET,726,0.016437,0.0032032,0.032029,0.30391,CBX7_TARGET_GENES,0.953175162425555
LXR_DR4_Q3,SET,79,0.050315,0.0032932,0.098055,0.30393,LXR_DR4_Q3,0.953175162425555
GOMF_OLFACTORY_RECEPTOR_BIND...,SET,6,0.19389,0.0035044,0.37791,0.30396,GOMF_OLFACTORY_RECEPTOR_BINDING,0.953183235586033
GOBP_REGULATION_OF_RELEASE_O...3,SET,27,0.087648,0.0033586,0.17087,0.304,GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM,0.953222663298448
HP_CARDIAC_CONDUCTION_ABNORM...,SET,127,0.038536,0.0031938,0.075167,0.3041,HP_CARDIAC_CONDUCTION_ABNORMALITY,0.953367654476671
TERT_TARGET_GENES,SET,71,0.053586,0.0033258,0.10457,0.30417,TERT_TARGET_GENES,0.953367654476671
GOBP_URETERIC_BUD_ELONGATION,SET,7,0.14763,0.0028819,0.28815,0.30422,GOBP_URETERIC_BUD_ELONGATION,0.953367654476671
GOCC_PHAGOCYTIC_VESICLE_LUMEN,SET,5,0.19177,0.0031641,0.37436,0.30424,GOCC_PHAGOCYTIC_VESICLE_LUMEN,0.953367654476671
BIOCARTA_HIF_PATHWAY,SET,15,0.10655,0.0030441,0.20802,0.30426,BIOCARTA_HIF_PATHWAY,0.953367654476671
GSE17721_POLYIC_VS_CPG_24H_B...1,SET,181,0.032194,0.0031806,0.062862,0.30428,GSE17721_POLYIC_VS_CPG_24H_BMDC_DN,0.953367654476671
FUKUSHIMA_TNFSF11_TARGETS,SET,16,0.11747,0.0034661,0.2294,0.3043,FUKUSHIMA_TNFSF11_TARGETS,0.953367654476671
RHODES_UNDIFFERENTIATED_CANC...,SET,64,0.051082,0.0030106,0.099782,0.30435,RHODES_UNDIFFERENTIATED_CANCER,0.953367654476671
GOBP_POSITIVE_REGULATION_OF_...424,SET,17,0.11334,0.003447,0.22145,0.3044,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.953367654476671
GSE19198_CTRL_VS_IL21_TREATE...2,SET,148,0.03608,0.0032262,0.070503,0.30442,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_UP,0.953367654476671
GOBP_C_TERMINAL_PROTEIN_LIPI...,SET,8,0.14882,0.0031056,0.29083,0.30444,GOBP_C_TERMINAL_PROTEIN_LIPIDATION,0.953367654476671
HP_EDEMA_OF_THE_DORSUM_OF_HA...,SET,14,0.11387,0.0031432,0.22256,0.30445,HP_EDEMA_OF_THE_DORSUM_OF_HANDS,0.953367654476671
GOMF_PHOSPHATIDYLINOSITOL_3_...6,SET,5,0.14704,0.0024262,0.28745,0.30449,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.953367654476671
GOMF_OXIDOREDUCTASE_ACTIVITY...4,SET,10,0.13306,0.0031045,0.26015,0.30451,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_NAD_P_AS_ACCEPTOR,0.953367654476671
GOMF_PROTON_TRANSMEMBRANE_TR...,SET,143,0.034336,0.0030183,0.067135,0.30452,GOMF_PROTON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.953367654476671
GSE30971_WBP7_HET_VS_KO_MACR...6,SET,184,0.031828,0.0031702,0.062235,0.30453,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP,0.953367654476671
NIKOLSKY_BREAST_CANCER_8P12_...,SET,50,0.11534,0.0060106,0.22554,0.30454,NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,0.953367654476671
HP_MATERNAL_AUTOIMMUNE_DISEA...,SET,14,0.11278,0.0031131,0.22054,0.30454,HP_MATERNAL_AUTOIMMUNE_DISEASE,0.953367654476671
GOBP_MOTOR_LEARNING,SET,8,0.16133,0.0033669,0.31559,0.3046,GOBP_MOTOR_LEARNING,0.953415035122478
GOBP_POSITIVE_REGULATION_OF_...305,SET,17,0.10364,0.0031521,0.20273,0.30461,GOBP_POSITIVE_REGULATION_OF_GLUCONEOGENESIS,0.953415035122478
GSE36392_MAC_VS_NEUTROPHIL_I...2,SET,186,0.030561,0.0030603,0.059801,0.30466,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,0.953462398703404
BROWNE_HCMV_INFECTION_16HR_UP,SET,199,0.029085,0.0030115,0.056919,0.30468,BROWNE_HCMV_INFECTION_16HR_UP,0.953462398703404
WP_MICRORNAS_IN_CARDIOMYOCYT...,SET,81,0.049072,0.0032522,0.096053,0.30472,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,0.953501719636265
MODULE_444,SET,17,0.11911,0.0036225,0.23322,0.30478,MODULE_444,0.953603610010803
GOBP_REGULATION_OF_KILLING_O...,SET,9,0.16399,0.0036297,0.32121,0.30484,GOBP_REGULATION_OF_KILLING_OF_CELLS_OF_ANOTHER_ORGANISM,0.953705482041588
BIOCARTA_FIBRINOLYSIS_PATHWAY,SET,12,0.12753,0.0032591,0.24989,0.30492,BIOCARTA_FIBRINOLYSIS_PATHWAY,0.953815331653316
GOBP_CELLULAR_RESPONSE_TO_TH...,SET,12,0.14413,0.0036835,0.28245,0.30493,GOBP_CELLULAR_RESPONSE_TO_THYROID_HORMONE_STIMULUS,0.953815331653316
GSE5589_LPS_VS_LPS_AND_IL10_...2,SET,181,0.032195,0.0031808,0.063112,0.30498,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_UP,0.95383131917574
GOBP_SKELETAL_MUSCLE_ORGAN_D...,SET,169,0.033903,0.0032376,0.066462,0.30499,GOBP_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT,0.95383131917574
GOBP_REGULATION_OF_G2_MI_TRA...,SET,4,0.18185,0.0026839,0.35678,0.30513,GOBP_REGULATION_OF_G2_MI_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.953966335610282
MIR12131,SET,154,0.034968,0.003189,0.068638,0.30522,MIR12131,0.953966335610282
GOBP_GLYCOSYL_COMPOUND_METAB...,SET,75,0.0539,0.0034378,0.1058,0.30522,GOBP_GLYCOSYL_COMPOUND_METABOLIC_PROCESS,0.953966335610282
GOBP_POLAR_BODY_EXTRUSION_AF...,SET,4,0.27376,0.0040402,0.5375,0.30527,GOBP_POLAR_BODY_EXTRUSION_AFTER_MEIOTIC_DIVISIONS,0.953966335610282
STAT3_02,SET,136,0.037205,0.0031901,0.073056,0.30529,STAT3_02,0.953966335610282
BOYLAN_MULTIPLE_MYELOMA_C_DN,SET,52,0.064874,0.0034476,0.1274,0.3053,BOYLAN_MULTIPLE_MYELOMA_C_DN,0.953966335610282
CHEN_HOXA5_TARGETS_6HR_UP,SET,9,0.15236,0.0033724,0.2992,0.3053,CHEN_HOXA5_TARGETS_6HR_UP,0.953966335610282
THEILGAARD_NEUTROPHIL_AT_SKI...2,SET,73,0.051437,0.0032369,0.10101,0.3053,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,0.953966335610282
GSE22886_NAIVE_CD8_TCELL_VS_...1,SET,185,0.031285,0.0031244,0.06144,0.30531,GSE22886_NAIVE_CD8_TCELL_VS_DC_DN,0.953966335610282
GOBP_RAB_PROTEIN_SIGNAL_TRAN...,SET,17,0.10193,0.0031002,0.20022,0.30534,GOBP_RAB_PROTEIN_SIGNAL_TRANSDUCTION,0.953966335610282
GOBP_POSITIVE_REGULATION_OF_...164,SET,8,0.13176,0.0027498,0.25886,0.30537,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_CONDENSATION,0.953966335610282
GOCC_CONDENSIN_COMPLEX,SET,8,0.13176,0.0027498,0.25886,0.30537,GOCC_CONDENSIN_COMPLEX,0.953966335610282
GCM_AQP4,SET,41,0.071047,0.0033535,0.13959,0.30539,GCM_AQP4,0.953966335610282
GOBP_TRNA_3_END_PROCESSING,SET,6,0.14401,0.0026028,0.28304,0.30545,GOBP_TRNA_3_END_PROCESSING,0.954068010245349
GSE28237_FOLLICULAR_VS_LATE_...1,SET,177,0.031776,0.0031048,0.062468,0.30549,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN,0.954107202552121
AREB6_01,SET,247,0.027919,0.0032163,0.054904,0.30556,AREB6_01,0.954154339622642
TRAVAGLINI_LUNG_PLASMACYTOID...,SET,101,0.04534,0.0033535,0.089167,0.30556,TRAVAGLINI_LUNG_PLASMACYTOID_DENDRITIC_CELL,0.954154339622642
RODRIGUES_NTN1_TARGETS_DN,SET,148,0.035975,0.0032168,0.070767,0.30561,RODRIGUES_NTN1_TARGETS_DN,0.954224737220375
WP_EICOSANOID_METABOLISM_VIA...1,SET,30,0.08158,0.0032949,0.16052,0.30565,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.954263901365433
HP_SYNOSTOSIS_OF_CARPALS_TAR...,SET,42,0.0729,0.0034826,0.14348,0.3057,HP_SYNOSTOSIS_OF_CARPALS_TARSALS,0.954334276475344
GSE1925_CTRL_VS_24H_IFNG_STI...1,SET,185,0.031342,0.0031301,0.061706,0.30576,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,0.954381351594073
GOBP_RESPONSE_TO_PHORBOL_13_...,SET,8,0.15455,0.0032254,0.30431,0.30577,GOBP_RESPONSE_TO_PHORBOL_13_ACETATE_12_MYRISTATE,0.954381351594073
GOCC_MYELIN_SHEATH_ADAXONAL_...,SET,5,0.16254,0.0026819,0.32019,0.30585,GOCC_MYELIN_SHEATH_ADAXONAL_REGION,0.954545325969828
HP_UNUSUAL_VIRUS_REACTIVATION,SET,21,0.099489,0.0033627,0.19606,0.30592,HP_UNUSUAL_VIRUS_REACTIVATION,0.95456948308355
GOBP_NUCLEOTIDE_TRANSPORT,SET,44,0.069902,0.0034178,0.13777,0.30594,GOBP_NUCLEOTIDE_TRANSPORT,0.95456948308355
GOMF_HISTONE_H3K36_DEMETHYLA...,SET,7,0.14652,0.0028603,0.28879,0.30596,GOMF_HISTONE_H3K36_DEMETHYLASE_ACTIVITY,0.95456948308355
LEONARD_HYPOXIA,SET,38,0.067412,0.0030636,0.13289,0.30598,LEONARD_HYPOXIA,0.95456948308355
GAUCHER_PBMC_YF_VAX_STAMARIL...12,SET,274,0.026921,0.003264,0.053074,0.306,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP,0.95456948308355
GOBP_POSITIVE_REGULATION_OF_...72,SET,43,0.067897,0.0032819,0.13389,0.30604,GOBP_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION,0.95456948308355
GSE2585_AIRE_KO_VS_WT_CD80_L...2,SET,165,0.034114,0.0032193,0.067275,0.30605,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP,0.95456948308355
IVANOV_MUTATED_IN_COLON_CANC...,SET,13,0.09913,0.0026368,0.19553,0.30609,IVANOV_MUTATED_IN_COLON_CANCER,0.954569911186866
MIR3144_3P,SET,56,0.054496,0.003005,0.1075,0.30611,MIR3144_3P,0.954569911186866
GOBP_ANTIVIRAL_INNATE_IMMUNE...,SET,49,0.059,0.0030439,0.11643,0.30616,GOBP_ANTIVIRAL_INNATE_IMMUNE_RESPONSE,0.954569911186866
FRANCO_BLOOD_SANOFI_PASTEUR_...2,SET,19,0.10074,0.0032389,0.19878,0.30616,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_0DY_POSITIVE,0.954569911186866
HP_PULMONARY_VENOUS_HYPERTEN...,SET,9,0.14798,0.0032755,0.29216,0.30625,HP_PULMONARY_VENOUS_HYPERTENSION,0.954671731527977
HP_INTELLECTUAL_DISABILITY_M...2,SET,132,0.034765,0.0029371,0.068638,0.30626,HP_INTELLECTUAL_DISABILITY_MODERATE,0.954671731527977
GOBP_RESPONSE_TO_NITROGEN_CO...,SET,991,0.014024,0.0031688,0.027694,0.3063,GOBP_RESPONSE_TO_NITROGEN_COMPOUND,0.954671731527977
MIR1225_3P,SET,56,0.057825,0.0031886,0.1142,0.30631,MIR1225_3P,0.954671731527977
GOMF_MHC_PROTEIN_BINDING,SET,26,0.086158,0.0032399,0.17017,0.30633,GOMF_MHC_PROTEIN_BINDING,0.954671731527977
HP_LIPOMA,SET,22,0.084727,0.002931,0.16744,0.30642,HP_LIPOMA,0.95482001792918
IKEDA_MIR133_TARGETS_UP,SET,40,0.063769,0.0029731,0.12604,0.30646,IKEDA_MIR133_TARGETS_UP,0.95482001792918
GSE10240_IL17_VS_IL17_AND_IL...2,SET,180,0.030759,0.0030305,0.060799,0.30646,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.95482001792918
GOBP_NEURON_PROJECTION_ARBOR...,SET,32,0.072914,0.0030413,0.14419,0.30655,GOBP_NEURON_PROJECTION_ARBORIZATION,0.955014812656866
GOBP_NEGATIVE_REGULATION_OF_...60,SET,7,0.16817,0.003283,0.33271,0.30662,GOBP_NEGATIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.955147270771713
BURTON_ADIPOGENESIS_9,SET,73,0.053384,0.0033594,0.10565,0.30668,BURTON_ADIPOGENESIS_9,0.955155330585916
PID_TXA2PATHWAY,SET,52,0.061716,0.0032797,0.12216,0.30671,PID_TXA2PATHWAY,0.955155330585916
GOBP_N_ACETYLNEURAMINATE_MET...,SET,11,0.13393,0.0032772,0.26515,0.30674,GOBP_N_ACETYLNEURAMINATE_METABOLIC_PROCESS,0.955155330585916
GOBP_EMBRYONIC_HEART_TUBE_MO...,SET,70,0.05165,0.003183,0.10226,0.30675,GOBP_EMBRYONIC_HEART_TUBE_MORPHOGENESIS,0.955155330585916
GAVISH_3CA_MALIGNANT_METAPRO...1,SET,41,0.070866,0.003345,0.14031,0.30676,GAVISH_3CA_MALIGNANT_METAPROGRAM_10_PROTEIN_MATURATION,0.955155330585916
REACTOME_HCMV_INFECTION,SET,91,0.043587,0.0030609,0.086323,0.30681,REACTOME_HCMV_INFECTION,0.955155548092423
SINGH_NFE2L2_TARGETS,SET,13,0.12509,0.0033272,0.24776,0.30683,SINGH_NFE2L2_TARGETS,0.955155548092423
HP_COXA_VARA,SET,58,0.0561,0.0031481,0.11114,0.30686,HP_COXA_VARA,0.955155548092423
GOBP_RESPONSE_TO_RADIATION,SET,390,0.021054,0.0030357,0.041711,0.30687,GOBP_RESPONSE_TO_RADIATION,0.955155548092423
HP_MILD_POSTNATAL_GROWTH_RET...,SET,16,0.1112,0.0032813,0.22038,0.30692,HP_MILD_POSTNATAL_GROWTH_RETARDATION,0.955225629085699
GSE360_T_GONDII_VS_B_MALAYI_...7,SET,184,0.030144,0.0030025,0.059794,0.30709,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.955560616621984
GOBP_CELLULAR_RESPONSE_TO_PE...2,SET,293,0.025359,0.0031778,0.050326,0.30717,GOBP_CELLULAR_RESPONSE_TO_PEPTIDE_HORMONE_STIMULUS,0.955560616621984
HP_LONG_TOE,SET,38,0.068948,0.0031334,0.13685,0.3072,HP_LONG_TOE,0.955560616621984
HOEK_NEUTROPHIL_2011_2012_TI...5,SET,37,0.077069,0.0034562,0.15297,0.3072,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_DN,0.955560616621984
NMYC_01,SET,257,0.026273,0.0030865,0.052155,0.30722,NMYC_01,0.955560616621984
WP_NITRIC_OXIDE_METABOLISM_I...,SET,13,0.12049,0.0032051,0.23921,0.30723,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,0.955560616621984
BROWNE_HCMV_INFECTION_8HR_UP,SET,91,0.04443,0.0031201,0.088211,0.30725,BROWNE_HCMV_INFECTION_8HR_UP,0.955560616621984
GOMF_VOLTAGE_GATED_CHANNEL_A...,SET,165,0.035793,0.0033778,0.071071,0.30727,GOMF_VOLTAGE_GATED_CHANNEL_ACTIVITY,0.955560616621984
GOBP_PURINE_NUCLEOTIDE_SALVA...,SET,10,0.14159,0.0033034,0.28121,0.30731,GOBP_PURINE_NUCLEOTIDE_SALVAGE,0.955560616621984
GSE3982_EOSINOPHIL_VS_BASOPH...1,SET,177,0.031164,0.003045,0.061908,0.30735,GSE3982_EOSINOPHIL_VS_BASOPHIL_DN,0.955560616621984
GOBP_PROTEIN_LIPOYLATION,SET,5,0.1892,0.0031218,0.37598,0.30741,GOBP_PROTEIN_LIPOYLATION,0.955560616621984
UNTERMAN_PROGRESSIVE_VS_STAB...5,SET,8,0.16695,0.0034842,0.33181,0.30743,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_DN,0.955560616621984
GOBP_POSITIVE_REGULATION_OF_...377,SET,4,0.20294,0.0029951,0.40335,0.30743,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,0.955560616621984
HP_HYPOPLASTIC_ISCHIA,SET,16,0.10604,0.003129,0.21081,0.30748,HP_HYPOPLASTIC_ISCHIA,0.955560616621984
GOMF_MYOSIN_PHOSPHATASE_ACTI...,SET,69,0.04866,0.0029773,0.096741,0.30749,GOMF_MYOSIN_PHOSPHATASE_ACTIVITY,0.955560616621984
GSE20715_0H_VS_6H_OZONE_LUNG...1,SET,185,0.030741,0.0030701,0.061116,0.30749,GSE20715_0H_VS_6H_OZONE_LUNG_DN,0.955560616621984
HP_ABNORMAL_MIDBRAIN_MORPHOL...,SET,72,0.045998,0.0028748,0.091471,0.30753,HP_ABNORMAL_MIDBRAIN_MORPHOLOGY,0.955560616621984
BIOCARTA_SET_PATHWAY,SET,10,0.1558,0.0036349,0.30983,0.30754,BIOCARTA_SET_PATHWAY,0.955560616621984
REACTOME_ELEVATION_OF_CYTOSO...,SET,16,0.11124,0.0032824,0.22128,0.30758,REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS,0.955560616621984
PAX_Q6,SET,227,0.029898,0.0033037,0.059477,0.3076,PAX_Q6,0.955560616621984
GSE37532_WT_VS_PPARG_KO_LN_T...1,SET,166,0.032114,0.0030397,0.063902,0.30764,GSE37532_WT_VS_PPARG_KO_LN_TCONV_DN,0.955560616621984
DAZARD_RESPONSE_TO_UV_SCC_DN,SET,110,0.040485,0.0031242,0.080561,0.30765,DAZARD_RESPONSE_TO_UV_SCC_DN,0.955560616621984
RHODES_CANCER_META_SIGNATURE,SET,58,0.053733,0.0030152,0.10693,0.30766,RHODES_CANCER_META_SIGNATURE,0.955560616621984
KEGG_MEDICUS_REFERENCE_MISMA...,SET,26,0.072126,0.0027122,0.14357,0.3077,KEGG_MEDICUS_REFERENCE_MISMATCH_REPAIR,0.955599454919131
MODULE_464,SET,14,0.1087,0.0030005,0.21648,0.30778,MODULE_464,0.955708161350844
GOMF_CYTOSKELETAL_MOTOR_ACTI...,SET,112,0.040327,0.00314,0.080312,0.30779,GOMF_CYTOSKELETAL_MOTOR_ACTIVITY,0.955708161350844
GOMF_GLUTAMATE_RECEPTOR_BIND...,SET,42,0.064711,0.0030914,0.1289,0.30783,GOMF_GLUTAMATE_RECEPTOR_BINDING,0.955746976058603
GOMF_HYALURONIC_ACID_BINDING,SET,24,0.086053,0.0031091,0.17146,0.30788,GOMF_HYALURONIC_ACID_BINDING,0.955770259891042
GACTGTT_MIR212_MIR132,SET,144,0.034674,0.0030586,0.069098,0.3079,GACTGTT_MIR212_MIR132,0.955770259891042
TCF11_01,SET,225,0.02906,0.0031971,0.057916,0.30792,TCF11_01,0.955770259891042
MIR5006_3P,SET,334,0.023876,0.0031908,0.047609,0.30801,MIR5006_3P,0.955793498037817
GOBP_REGULATION_OF_PROTEIN_S...2,SET,237,0.02749,0.003103,0.054827,0.30805,GOBP_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.955793498037817
GOBP_SKELETAL_MUSCLE_FIBER_D...,SET,11,0.13343,0.003265,0.26612,0.30805,GOBP_SKELETAL_MUSCLE_FIBER_DIFFERENTIATION,0.955793498037817
GOBP_POSITIVE_REGULATION_OF_...599,SET,111,0.038077,0.0029516,0.075948,0.30806,GOBP_POSITIVE_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.955793498037817
BURTON_ADIPOGENESIS_PEAK_AT_...1,SET,59,0.056128,0.0031766,0.11202,0.30817,BURTON_ADIPOGENESIS_PEAK_AT_0HR,0.955793498037817
CUI_DEVELOPING_HEART_C5_VALV...,SET,183,0.033273,0.0033052,0.066414,0.30819,CUI_DEVELOPING_HEART_C5_VALVAR_CELL,0.955793498037817
HP_INCISOR_MACRODONTIA,SET,15,0.12188,0.0034823,0.24332,0.30822,HP_INCISOR_MACRODONTIA,0.955793498037817
GSE28737_BCL6_HET_VS_BCL6_KO...3,SET,186,0.029964,0.0030005,0.059822,0.30823,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,0.955793498037817
GSE45739_UNSTIM_VS_ACD3_ACD2...3,SET,178,0.033177,0.0032508,0.066247,0.30825,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN,0.955793498037817
VALK_AML_WITH_CEBPA,SET,31,0.084407,0.0034653,0.16856,0.30828,VALK_AML_WITH_CEBPA,0.955793498037817
chr17q12,SET,86,0.091206,0.0062274,0.18216,0.30829,chr17q12,0.955793498037817
HOEK_B_CELL_2011_2012_TIV_AD...4,SET,6,0.18961,0.003427,0.37867,0.30829,HOEK_B_CELL_2011_2012_TIV_ADULT_7DY_DN,0.955793498037817
GOMF_3_KETO_STEROL_REDUCTASE...,SET,5,0.19445,0.0032084,0.38844,0.30833,GOMF_3_KETO_STEROL_REDUCTASE_ACTIVITY,0.955793498037817
WP_CANCER_PATHWAYS,SET,483,0.020127,0.0032211,0.040207,0.30834,WP_CANCER_PATHWAYS,0.955793498037817
GOBP_INTESTINE_SMOOTH_MUSCLE...,SET,8,0.14515,0.0030292,0.28998,0.30834,GOBP_INTESTINE_SMOOTH_MUSCLE_CONTRACTION,0.955793498037817
GAVISH_3CA_MALIGNANT_METAPRO...8,SET,44,0.066946,0.0032733,0.13384,0.30847,GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1,0.956056614110101
GOBP_REGULATION_OF_NUCLEOTID...5,SET,28,0.076248,0.0029753,0.15245,0.30848,GOBP_REGULATION_OF_NUCLEOTIDE_EXCISION_REPAIR,0.956056614110101
GOBP_IRON_IMPORT_INTO_CELL,SET,9,0.13453,0.0029777,0.26902,0.30852,GOBP_IRON_IMPORT_INTO_CELL,0.956056614110101
REACTOME_PROCESSING_OF_DNA_D...,SET,57,0.051307,0.0028542,0.10263,0.30857,REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,0.956056614110101
GOBP_MYELOID_DENDRITIC_CELL_...1,SET,26,0.090427,0.0034004,0.18093,0.30861,GOBP_MYELOID_DENDRITIC_CELL_ACTIVATION,0.956056614110101
GSE2770_UNTREATED_VS_IL4_TRE...5,SET,185,0.030102,0.0030063,0.060238,0.30864,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.956056614110101
GSE5960_TH1_VS_ANERGIC_TH1_DN,SET,184,0.029762,0.0029644,0.059572,0.30868,GSE5960_TH1_VS_ANERGIC_TH1_DN,0.956056614110101
KEGG_MEDICUS_REFERENCE_MDA5_...,SET,21,0.10041,0.0033939,0.201,0.30869,KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY,0.956056614110101
GOBP_THYMOCYTE_MIGRATION,SET,7,0.17425,0.0034017,0.34881,0.3087,GOBP_THYMOCYTE_MIGRATION,0.956056614110101
MIR3135B,SET,97,0.04251,0.0030816,0.085102,0.30871,MIR3135B,0.956056614110101
HP_RIMMED_VACUOLES,SET,38,0.065466,0.0029751,0.13109,0.30875,HP_RIMMED_VACUOLES,0.956056614110101
GSE37605_TREG_VS_TCONV_C57BL...2,SET,122,0.040102,0.003258,0.080313,0.30878,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP,0.956056614110101
REACTOME_SYNTHESIS_OF_DIPHTH...,SET,8,0.14054,0.0029329,0.28151,0.30881,REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2,0.956056614110101
HP_SHOCK,SET,12,0.12493,0.0031928,0.25025,0.30881,HP_SHOCK,0.956056614110101
GOBP_GLYCERALDEHYDE_3_PHOSPH...,SET,11,0.11507,0.0028157,0.23055,0.30885,GOBP_GLYCERALDEHYDE_3_PHOSPHATE_METABOLIC_PROCESS,0.956095283691102
GOMF_AMINO_ACID_BINDING,SET,43,0.067448,0.0032602,0.13521,0.30895,GOMF_AMINO_ACID_BINDING,0.956233330372213
YAO_TEMPORAL_RESPONSE_TO_PRO...4,SET,86,0.041506,0.0028339,0.08322,0.30898,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,0.956233330372213
GOBP_MAINTENANCE_OF_ORGANELL...,SET,11,0.11614,0.0028418,0.23286,0.30898,GOBP_MAINTENANCE_OF_ORGANELLE_LOCATION,0.956233330372213
GOBP_DETECTION_OF_VIRUS,SET,5,0.17289,0.0028526,0.34686,0.30909,GOBP_DETECTION_OF_VIRUS,0.956233330372213
WP_DEREGULATION_OF_RAB_AND_R...,SET,14,0.10754,0.0029685,0.21582,0.30914,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,0.956233330372213
HP_ABNORMALITY_OF_THE_MUSCUL...3,SET,89,0.04494,0.0031212,0.090198,0.30916,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LOWER_LIMBS,0.956233330372213
GSE21360_TERTIARY_VS_QUATERN...2,SET,172,0.032829,0.0031625,0.06592,0.30924,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.956233330372213
REACTOME_GAP_FILLING_DNA_REP...,SET,24,0.076718,0.0027719,0.15408,0.30927,REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER,0.956233330372213
DBP_TARGET_GENES,SET,1181,0.012494,0.003065,0.025095,0.3093,DBP_TARGET_GENES,0.956233330372213
GSE13485_CTRL_VS_DAY1_YF17D_...1,SET,132,0.03809,0.0032179,0.07652,0.30932,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN,0.956233330372213
HP_ABNORMAL_OCCIPITAL_BONE_M...,SET,103,0.038992,0.0029122,0.078356,0.30938,HP_ABNORMAL_OCCIPITAL_BONE_MORPHOLOGY,0.956233330372213
HP_EQUINOVARUS_DEFORMITY,SET,13,0.12658,0.0033669,0.25437,0.30938,HP_EQUINOVARUS_DEFORMITY,0.956233330372213
GOBP_SUPEROXIDE_METABOLIC_PR...,SET,62,0.056008,0.0032491,0.11256,0.3094,GOBP_SUPEROXIDE_METABOLIC_PROCESS,0.956233330372213
REACTOME_TNFR1_INDUCED_NF_KA...,SET,27,0.079118,0.0030317,0.15905,0.30944,REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY,0.956233330372213
WP_17P133_YWHAE_COPY_NUMBER_...,SET,21,0.09587,0.0032404,0.19275,0.30947,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,0.956233330372213
GOBP_SPHINGOID_METABOLIC_PRO...,SET,18,0.1051,0.0032891,0.21134,0.30949,GOBP_SPHINGOID_METABOLIC_PROCESS,0.956233330372213
GOBP_NEGATIVE_REGULATION_OF_...422,SET,9,0.13252,0.0029331,0.26648,0.3095,GOBP_NEGATIVE_REGULATION_OF_MYELINATION,0.956233330372213
HP_PARTIAL_ALBINISM,SET,9,0.15117,0.0033461,0.304,0.3095,HP_PARTIAL_ALBINISM,0.956233330372213
HP_JUVENILE_ONSET,SET,597,0.017119,0.0030362,0.03443,0.30953,HP_JUVENILE_ONSET,0.956233330372213
GOBP_NEGATIVE_REGULATION_OF_...80,SET,18,0.10277,0.0032162,0.20676,0.30958,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH,0.956233330372213
TGCTTTG_MIR330,SET,297,0.024344,0.003071,0.048991,0.30963,TGCTTTG_MIR330,0.956233330372213
GOBP_AMYLOID_FIBRIL_FORMATION,SET,34,0.071335,0.0030669,0.14355,0.30963,GOBP_AMYLOID_FIBRIL_FORMATION,0.956233330372213
GOBP_XENOBIOTIC_TRANSPORT,SET,47,0.063953,0.0032315,0.12871,0.30963,GOBP_XENOBIOTIC_TRANSPORT,0.956233330372213
GOBP_ANDROGEN_BIOSYNTHETIC_P...,SET,10,0.13386,0.003123,0.2694,0.30965,GOBP_ANDROGEN_BIOSYNTHETIC_PROCESS,0.956233330372213
PID_WNT_SIGNALING_PATHWAY,SET,25,0.093616,0.003452,0.18844,0.30967,PID_WNT_SIGNALING_PATHWAY,0.956233330372213
GSE15930_STIM_VS_STIM_AND_IF...3,SET,190,0.030201,0.0030563,0.060796,0.30968,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN,0.956233330372213
GOBP_POSITIVE_REGULATION_OF_...562,SET,472,0.019179,0.0030353,0.038612,0.3097,GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,0.956233330372213
GSE2770_IL12_VS_IL4_TREATED_...2,SET,128,0.034813,0.0028965,0.070089,0.3097,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.956233330372213
GTCNYYATGR_UNKNOWN,SET,103,0.041247,0.0030807,0.083049,0.30972,GTCNYYATGR_UNKNOWN,0.956233330372213
GAVISH_3CA_METAPROGRAM_EPITH...18,SET,47,0.068948,0.0034839,0.13882,0.30972,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_1,0.956233330372213
CEBPDELTA_Q6,SET,217,0.02916,0.0031513,0.058743,0.30981,CEBPDELTA_Q6,0.956417876475286
GOBP_RESPONSE_TO_THYROGLOBUL...,SET,5,0.21115,0.003484,0.42544,0.30984,GOBP_RESPONSE_TO_THYROGLOBULIN_TRIIODOTHYRONINE,0.956417876475286
GOCC_CEREBELLAR_CLIMBING_FIB...,SET,7,0.18516,0.0036146,0.37318,0.30989,GOCC_CEREBELLAR_CLIMBING_FIBER_TO_PURKINJE_CELL_SYNAPSE,0.956417876475286
HP_HYPERTHYROIDISM,SET,30,0.078697,0.0031784,0.15863,0.30991,HP_HYPERTHYROIDISM,0.956417876475286
HP_RHIZOMELIC_ARM_SHORTENING,SET,9,0.15027,0.0033261,0.303,0.30997,HP_RHIZOMELIC_ARM_SHORTENING,0.956417876475286
GOBP_SKELETAL_MUSCLE_CONTRAC...,SET,43,0.062389,0.0030157,0.12581,0.30998,GOBP_SKELETAL_MUSCLE_CONTRACTION,0.956417876475286
GOBP_PROTEIN_C_LINKED_GLYCOS...,SET,4,0.23785,0.0035102,0.47967,0.31,GOBP_PROTEIN_C_LINKED_GLYCOSYLATION,0.956417876475286
WP_GENES_RELATED_TO_PRIMARY_...,SET,88,0.04154,0.0028689,0.083798,0.31005,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,0.956417876475286
GOBP_REGULATION_OF_LEUKOCYTE...8,SET,213,0.030248,0.0032389,0.061022,0.31006,GOBP_REGULATION_OF_LEUKOCYTE_MIGRATION,0.956417876475286
LU_EZH2_TARGETS_UP,SET,253,0.024673,0.0028762,0.049782,0.31008,LU_EZH2_TARGETS_UP,0.956417876475286
REACTOME_NGF_INDEPENDANT_TRK...,SET,5,0.1999,0.0032984,0.4034,0.31011,REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION,0.956417876475286
WP_NICOTINE_EFFECT_ON_DOPAMI...,SET,21,0.091879,0.0031055,0.18541,0.31011,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,0.956417876475286
PID_NCADHERIN_PATHWAY,SET,33,0.074922,0.0031734,0.15123,0.31015,PID_NCADHERIN_PATHWAY,0.956456366459627
GOBP_POSITIVE_REGULATION_OF_...43,SET,8,0.1459,0.0030448,0.29455,0.31018,GOBP_POSITIVE_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS,0.95646401384083
GOMF_POTASSIUM_ION_LEAK_CHAN...,SET,16,0.10856,0.0032033,0.21925,0.31025,GOMF_POTASSIUM_ION_LEAK_CHANNEL_ACTIVITY,0.956514307787392
BIOCARTA_SARS_PATHWAY,SET,7,0.16536,0.0032281,0.334,0.31027,BIOCARTA_SARS_PATHWAY,0.956514307787392
HP_ACRAL_ULCERATION,SET,8,0.1467,0.0030614,0.29633,0.31029,HP_ACRAL_ULCERATION,0.956514307787392
GOBP_LATE_ENDOSOME_TO_VACUOL...1,SET,36,0.063996,0.0028309,0.12935,0.31039,GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT,0.956514307787392
HP_APLASIA_HYPOPLASIA_OF_THE...71,SET,36,0.074384,0.0032904,0.15038,0.31043,HP_APLASIA_HYPOPLASIA_OF_THE_THYMUS,0.956514307787392
GSE34156_UNTREATED_VS_24H_TL...2,SET,148,0.035582,0.0031816,0.071974,0.31053,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.956514307787392
HP_ABNORMAL_BRANCHING_PATTER...,SET,26,0.079705,0.0029972,0.16127,0.31057,HP_ABNORMAL_BRANCHING_PATTERN_OF_THE_AORTIC_ARCH,0.956514307787392
GOCC_CONE_PHOTORECEPTOR_OUTE...,SET,7,0.18751,0.0036604,0.37943,0.31059,GOCC_CONE_PHOTORECEPTOR_OUTER_SEGMENT,0.956514307787392
GOBP_THREONINE_METABOLIC_PRO...,SET,4,0.21689,0.0032009,0.43893,0.31061,GOBP_THREONINE_METABOLIC_PROCESS,0.956514307787392
GSE16385_MONOCYTE_VS_12H_ROS...1,SET,175,0.031602,0.0030705,0.063953,0.31061,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,0.956514307787392
HP_DYSGRAPHIA,SET,51,0.057795,0.0030417,0.11698,0.31064,HP_DYSGRAPHIA,0.956514307787392
MIR659_3P,SET,204,0.029886,0.0031326,0.060515,0.3107,MIR659_3P,0.956514307787392
GOBP_NEGATIVE_REGULATION_OF_...273,SET,107,0.043212,0.0032891,0.0875,0.31071,GOBP_NEGATIVE_REGULATION_OF_HEMOPOIESIS,0.956514307787392
RODWELL_AGING_KIDNEY_UP,SET,422,0.020879,0.0031288,0.04228,0.31072,RODWELL_AGING_KIDNEY_UP,0.956514307787392
NAKAYA_PBMC_FLUARIX_FLUVIRIN...2,SET,564,0.017222,0.0029717,0.034876,0.31072,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP,0.956514307787392
CREIGHTON_ENDOCRINE_THERAPY_...1,SET,445,0.020168,0.0031014,0.040859,0.3108,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1,0.956514307787392
HP_HYPERTROPHIC_CARDIOMYOPAT...,SET,243,0.026225,0.0029969,0.053148,0.31085,HP_HYPERTROPHIC_CARDIOMYOPATHY,0.956514307787392
GOBP_POSITIVE_REGULATION_OF_...91,SET,6,0.16464,0.0029757,0.33367,0.31086,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,0.956514307787392
HP_ABNORMAL_SACRUM_MORPHOLOGY,SET,139,0.037039,0.0032105,0.075075,0.31088,HP_ABNORMAL_SACRUM_MORPHOLOGY,0.956514307787392
BIOCARTA_ETC_PATHWAY,SET,7,0.13128,0.0025628,0.26618,0.31094,BIOCARTA_ETC_PATHWAY,0.956514307787392
GSE41867_NAIVE_VS_EFFECTOR_C...2,SET,187,0.028528,0.0028643,0.057849,0.31096,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,0.956514307787392
HP_SEVERE_DEMYELINATION_OF_T...,SET,6,0.16813,0.0030388,0.34099,0.31099,HP_SEVERE_DEMYELINATION_OF_THE_WHITE_MATTER,0.956514307787392
HP_REDUCED_TENDON_REFLEXES,SET,521,0.017834,0.0029611,0.036174,0.31101,HP_REDUCED_TENDON_REFLEXES,0.956514307787392
GOBP_NEUTROPHIL_EXTRAVASATION,SET,9,0.15625,0.0034585,0.31701,0.31105,GOBP_NEUTROPHIL_EXTRAVASATION,0.956514307787392
GOBP_REGULATION_OF_PEROXISOM...,SET,14,0.12711,0.0035086,0.25789,0.31105,GOBP_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.956514307787392
RB_DN.V1_DN,SET,109,0.041129,0.0031595,0.083447,0.31105,RB_DN.V1_DN,0.956514307787392
GOMF_HYDROLASE_ACTIVITY_ACTI...5,SET,69,0.04861,0.0029743,0.098643,0.31108,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES,0.956514307787392
FIGUEROA_AML_METHYLATION_CLU...5,SET,35,0.074837,0.0032643,0.15188,0.31111,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,0.956514307787392
YATTNATC_UNKNOWN,SET,340,0.02373,0.0031991,0.048165,0.31112,YATTNATC_UNKNOWN,0.956514307787392
HP_ABNORMALITY_OF_CONNECTIVE...,SET,1351,0.011718,0.0030594,0.023785,0.31113,HP_ABNORMALITY_OF_CONNECTIVE_TISSUE,0.956514307787392
HP_MILDLY_ELEVATED_CREATINE_...,SET,53,0.054816,0.0029408,0.11127,0.31114,HP_MILDLY_ELEVATED_CREATINE_KINASE,0.956514307787392
KONDO_EZH2_TARGETS,SET,203,0.030362,0.0031748,0.061662,0.31122,KONDO_EZH2_TARGETS,0.956514307787392
GOBP_NEGATIVE_REGULATION_OF_...279,SET,12,0.12987,0.003319,0.26375,0.31122,GOBP_NEGATIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS,0.956514307787392
GOBP_MITOCHONDRIAL_RNA_PROCE...,SET,20,0.085968,0.0028357,0.17459,0.31123,GOBP_MITOCHONDRIAL_RNA_PROCESSING,0.956514307787392
GAVISH_3CA_METAPROGRAM_FIBRO...7,SET,48,0.065179,0.0033282,0.1324,0.31126,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_6,0.956514307787392
MORF_DEK,SET,237,0.024737,0.0027922,0.050255,0.31128,MORF_DEK,0.956514307787392
GSE3203_HEALTHY_VS_INFLUENZA...2,SET,177,0.031294,0.0030577,0.063578,0.31129,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_UP,0.956514307787392
PID_TCPTP_PATHWAY,SET,42,0.0684,0.0032676,0.13904,0.31139,PID_TCPTP_PATHWAY,0.956514307787392
MIR211_3P,SET,75,0.048754,0.0031096,0.099145,0.31145,MIR211_3P,0.956514307787392
WEBER_METHYLATED_LCP_IN_SPER...2,SET,14,0.11345,0.0031315,0.23072,0.31146,WEBER_METHYLATED_LCP_IN_SPERM_UP,0.956514307787392
MORF_FANCG,SET,156,0.031452,0.0028868,0.063962,0.31146,MORF_FANCG,0.956514307787392
GOBP_VITAMIN_B6_METABOLIC_PR...,SET,5,0.19461,0.003211,0.39582,0.31148,GOBP_VITAMIN_B6_METABOLIC_PROCESS,0.956514307787392
GOMF_TRANSLATION_ELONGATION_...,SET,18,0.084936,0.0026581,0.17276,0.31149,GOMF_TRANSLATION_ELONGATION_FACTOR_ACTIVITY,0.956514307787392
GOBP_POSITIVE_REGULATION_OF_...114,SET,453,0.020831,0.0032313,0.042371,0.3115,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION,0.956514307787392
GSE46606_IRF4_KO_VS_WT_CD40L...4,SET,176,0.032913,0.0032069,0.066954,0.31151,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_UP,0.956514307787392
KEGG_CITRATE_CYCLE_TCA_CYCLE,SET,27,0.071791,0.002751,0.14606,0.31153,KEGG_CITRATE_CYCLE_TCA_CYCLE,0.956514307787392
MIR7110_3P,SET,366,0.022671,0.0031688,0.046124,0.31153,MIR7110_3P,0.956514307787392
TGGAAA_NFAT_Q4_01,SET,1694,0.010864,0.0031439,0.022103,0.31154,TGGAAA_NFAT_Q4_01,0.956514307787392
HP_ABNORMAL_OPTICAL_COHERENC...,SET,18,0.10206,0.003194,0.20766,0.31155,HP_ABNORMAL_OPTICAL_COHERENCE_TOMOGRAPHY,0.956514307787392
MORI_IMMATURE_B_LYMPHOCYTE_DN,SET,86,0.04327,0.0029544,0.088072,0.31161,MORI_IMMATURE_B_LYMPHOCYTE_DN,0.956514307787392
GSE18791_CTRL_VS_NEWCASTLE_V...14,SET,165,0.031657,0.0029875,0.064457,0.31167,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP,0.956514307787392
GSE42021_CD24HI_TREG_VS_CD24...2,SET,179,0.029229,0.0028718,0.05952,0.31169,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_UP,0.956514307787392
HUMMERICH_BENIGN_SKIN_TUMOR_...2,SET,15,0.10552,0.0030148,0.2149,0.31171,HUMMERICH_BENIGN_SKIN_TUMOR_UP,0.956514307787392
MIR363_3P,SET,384,0.021523,0.0030798,0.043834,0.31171,MIR363_3P,0.956514307787392
GOBP_REGULATION_OF_PROTEIN_C...4,SET,374,0.020866,0.0029475,0.042495,0.31171,GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.956514307787392
WP_FOCAL_ADHESION,SET,190,0.031262,0.0031636,0.063696,0.31179,WP_FOCAL_ADHESION,0.956552316653429
HP_TRACHEOESOPHAGEAL_FISTULA,SET,82,0.04549,0.0030332,0.092702,0.31182,HP_TRACHEOESOPHAGEAL_FISTULA,0.956552316653429
KRAS.50_UP.V1_UP,SET,44,0.068744,0.0033612,0.14009,0.31182,KRAS.50_UP.V1_UP,0.956552316653429
GOCC_CENTROSOME,SET,666,0.015705,0.0029363,0.032009,0.31184,GOCC_CENTROSOME,0.956552316653429
GSE13173_UNTREATED_VS_IL12_T...1,SET,117,0.037887,0.0030147,0.077227,0.31186,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN,0.956552316653429
GOBP_EMBRYONIC_HINDLIMB_MORP...,SET,27,0.091246,0.0034965,0.18627,0.31212,GOBP_EMBRYONIC_HINDLIMB_MORPHOGENESIS,0.956909580179546
REACTOME_KINESINS,SET,57,0.053284,0.0029642,0.10878,0.31213,REACTOME_KINESINS,0.956909580179546
HP_LETHAL_SKELETAL_DYSPLASIA,SET,8,0.13738,0.002867,0.28047,0.31214,HP_LETHAL_SKELETAL_DYSPLASIA,0.956909580179546
GSE29618_MONOCYTE_VS_PDC_DAY...2,SET,186,0.031169,0.0031212,0.063661,0.31221,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP,0.956909580179546
MIR2682_3P,SET,59,0.053201,0.0030109,0.10869,0.31225,MIR2682_3P,0.956909580179546
HP_ABNORMAL_ESOPHAGUS_MORPHO...,SET,207,0.029184,0.0030812,0.059621,0.31225,HP_ABNORMAL_ESOPHAGUS_MORPHOLOGY,0.956909580179546
GSE5679_CTRL_VS_RARA_AGONIST...2,SET,179,0.02958,0.0029064,0.060431,0.31225,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP,0.956909580179546
GOBP_TRNA_SURVEILLANCE,SET,8,0.13208,0.0027564,0.26991,0.3123,GOBP_TRNA_SURVEILLANCE,0.956909580179546
GOBP_LIPOPROTEIN_METABOLIC_P...,SET,125,0.036727,0.0030201,0.075058,0.31231,GOBP_LIPOPROTEIN_METABOLIC_PROCESS,0.956909580179546
GOMF_BETA_TUBULIN_BINDING,SET,35,0.065459,0.0028552,0.13379,0.31233,GOMF_BETA_TUBULIN_BINDING,0.956909580179546
AMIT_SERUM_RESPONSE_60_MCF10A,SET,54,0.062956,0.0034092,0.1287,0.31237,AMIT_SERUM_RESPONSE_60_MCF10A,0.956909580179546
GSE17186_BLOOD_VS_CORD_BLOOD...6,SET,186,0.030802,0.0030844,0.062973,0.31238,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP,0.956909580179546
GOBP_RESPONSE_TO_INSULIN,SET,251,0.025991,0.0030181,0.053181,0.31252,GOBP_RESPONSE_TO_INSULIN,0.956909580179546
HARALAMBIEVA_PBMC_TIV_AGE_50...3,SET,13,0.11068,0.0029441,0.22649,0.31253,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_3DY_POSITIVE,0.956909580179546
GOBP_REGULATION_OF_SODIUM_IO...2,SET,42,0.068353,0.0032654,0.13987,0.31254,GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.956909580179546
HP_ATRIAL_FIBRILLATION,SET,79,0.050499,0.0033053,0.10336,0.31258,HP_ATRIAL_FIBRILLATION,0.956909580179546
HP_FAILURE_TO_THRIVE_IN_INFA...,SET,108,0.039638,0.0030311,0.081135,0.31258,HP_FAILURE_TO_THRIVE_IN_INFANCY,0.956909580179546
GOBP_NEGATIVE_REGULATION_OF_...496,SET,8,0.12748,0.0026603,0.26094,0.31259,GOBP_NEGATIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.956909580179546
GOBP_POSITIVE_REGULATION_OF_...522,SET,28,0.0829,0.0032348,0.16971,0.31261,GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,0.956909580179546
HP_HYPOSEGMENTATION_OF_NEUTR...,SET,6,0.17733,0.0032051,0.36314,0.31266,HP_HYPOSEGMENTATION_OF_NEUTROPHIL_NUCLEI,0.956909580179546
HP_ABNORMAL_PERICARDIUM_MORP...,SET,71,0.050478,0.0031329,0.10338,0.31267,HP_ABNORMAL_PERICARDIUM_MORPHOLOGY,0.956909580179546
KEGG_MEDICUS_REFERENCE_PDL_P...,SET,8,0.15731,0.003283,0.32217,0.31268,KEGG_MEDICUS_REFERENCE_PDL_PD1_SHP_PI3K_SIGNALING_PATHWAY,0.956909580179546
MIR6787_5P,SET,24,0.088068,0.0031819,0.18041,0.31272,MIR6787_5P,0.956909580179546
GAVISH_3CA_METAPROGRAM_ENDOT...14,SET,46,0.068253,0.003412,0.13982,0.31273,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING,0.956909580179546
VANTVEER_BREAST_CANCER_ESR1_...1,SET,207,0.029351,0.0030989,0.060135,0.31275,VANTVEER_BREAST_CANCER_ESR1_DN,0.956909580179546
GNF2_SPTA1,SET,69,0.049778,0.0030458,0.10199,0.31276,GNF2_SPTA1,0.956909580179546
HP_UROGENITAL_FISTULA,SET,46,0.059477,0.0029733,0.12188,0.31278,HP_UROGENITAL_FISTULA,0.956909580179546
GSE360_CTRL_VS_M_TUBERCULOSI...1,SET,183,0.030919,0.0030714,0.063361,0.31278,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN,0.956909580179546
GSE22313_HEALTHY_VS_SLE_MOUS...2,SET,164,0.032436,0.0030517,0.066478,0.31281,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_UP,0.956909580179546
chr6q12,SET,5,0.28759,0.0047451,0.58948,0.31283,chr6q12,0.956909580179546
GOBP_PHOSPHOLIPID_EFFLUX,SET,11,0.12815,0.0031356,0.26267,0.31283,GOBP_PHOSPHOLIPID_EFFLUX,0.956909580179546
GSE36078_WT_VS_IL1R_KO_LUNG_...5,SET,176,0.030067,0.0029296,0.061645,0.31287,GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN,0.956947711871865
GOBP_CARDIAC_CHAMBER_FORMATI...,SET,11,0.14582,0.003568,0.29904,0.31292,GOBP_CARDIAC_CHAMBER_FORMATION,0.956970332570825
GSE22935_UNSTIM_VS_48H_MBOVI...3,SET,177,0.031256,0.003054,0.064108,0.31294,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.956970332570825
GOMF_CALMODULIN_DEPENDENT_PR...2,SET,5,0.15309,0.0025259,0.31403,0.31296,GOMF_CALMODULIN_DEPENDENT_PROTEIN_PHOSPHATASE_ACTIVITY,0.956970332570825
SCHERER_PBMC_APSV_WETVAX_AGE...3,SET,130,0.035208,0.002952,0.072245,0.31301,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_DN,0.957039020849828
GOBP_POSITIVE_REGULATION_OF_...761,SET,13,0.10988,0.0029227,0.22552,0.31305,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.957077124384236
GSE21546_WT_VS_SAP1A_KO_AND_...1,SET,181,0.030845,0.0030473,0.063315,0.31308,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.957084651244613
GOMF_NADP_BINDING,SET,50,0.057775,0.0030108,0.11864,0.31314,GOMF_NADP_BINDING,0.957160830182042
GOMF_HISTONE_H3K27_METHYLTRA...,SET,5,0.17378,0.0028673,0.35688,0.31316,GOMF_HISTONE_H3K27_METHYLTRANSFERASE_ACTIVITY,0.957160830182042
HP_DYSMENORRHEA,SET,12,0.11769,0.0030077,0.24176,0.31321,HP_DYSMENORRHEA,0.957229471508969
GSE20366_CD103_POS_VS_NEG_TR...2,SET,179,0.031526,0.0030976,0.064799,0.3133,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP,0.957366717953227
MIR4446_5P,SET,271,0.024957,0.0030096,0.051298,0.31331,MIR4446_5P,0.957366717953227
MIR1178_5P,SET,32,0.074266,0.0030977,0.15275,0.31341,MIR1178_5P,0.957396125461255
MIR3191_3P,SET,21,0.08533,0.0028841,0.17553,0.31344,MIR3191_3P,0.957396125461255
GSE34156_UNTREATED_VS_6H_NOD...1,SET,146,0.033661,0.0029896,0.069242,0.31344,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.957396125461255
MARTINEZ_TP53_TARGETS_UP,SET,569,0.01748,0.0030291,0.035964,0.31347,MARTINEZ_TP53_TARGETS_UP,0.957396125461255
WP_AMINO_ACID_METABOLISM_IN_...,SET,7,0.15373,0.003001,0.31634,0.3135,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.957396125461255
HP_MASTOIDITIS,SET,7,0.15739,0.0030725,0.32391,0.31352,HP_MASTOIDITIS,0.957396125461255
GOBP_L_PROLINE_TRANSMEMBRANE...,SET,3,0.24407,0.0031195,0.50232,0.31353,GOBP_L_PROLINE_TRANSMEMBRANE_TRANSPORT,0.957396125461255
GOBP_DNA_REPLICATION,SET,260,0.024574,0.0029035,0.05058,0.31354,GOBP_DNA_REPLICATION,0.957396125461255
MIR1178_3P,SET,83,0.046997,0.0031526,0.096753,0.31358,MIR1178_3P,0.957434147412809
GSE17974_CTRL_VS_ACT_IL4_AND...11,SET,177,0.029115,0.0028448,0.059983,0.3137,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN,0.957609221851397
GENTILE_UV_RESPONSE_CLUSTER_...7,SET,36,0.068725,0.0030401,0.1416,0.31372,GENTILE_UV_RESPONSE_CLUSTER_D8,0.957609221851397
REACTOME_HSP90_CHAPERONE_CYC...,SET,53,0.056062,0.0030077,0.11551,0.31372,REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,0.957609221851397
GOCC_ESCRT_COMPLEX,SET,29,0.072898,0.0028948,0.15027,0.3138,GOCC_ESCRT_COMPLEX,0.957715028089888
GSE37533_PPARG2_FOXP3_VS_FOX...1,SET,182,0.031208,0.0030917,0.06435,0.31385,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,0.957715028089888
BIOCARTA_EXTRINSIC_PATHWAY,SET,13,0.12441,0.0033092,0.25659,0.31389,BIOCARTA_EXTRINSIC_PATHWAY,0.957715028089888
GOBP_SMALL_NUCLEOLAR_RIBONUC...,SET,10,0.12536,0.0029247,0.25853,0.31389,GOBP_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX_ASSEMBLY,0.957715028089888
METHYLCYTOSINE_DIOXYGENASE_T...,SET,117,0.035998,0.0028644,0.074254,0.31391,METHYLCYTOSINE_DIOXYGENASE_TET_UNIPROT_A0A023HHK9_UNREVIEWED_TARGET_GENES,0.957715028089888
MIR1587,SET,55,0.051383,0.002808,0.10599,0.31392,MIR1587,0.957715028089888
GOBP_SKELETAL_MUSCLE_THIN_FI...,SET,7,0.16331,0.003188,0.33701,0.31399,GOBP_SKELETAL_MUSCLE_THIN_FILAMENT_ASSEMBLY,0.95774484029484
HP_ABNORMALITY_OF_RENAL_EXCR...,SET,62,0.05413,0.0031402,0.1117,0.31399,HP_ABNORMALITY_OF_RENAL_EXCRETION,0.95774484029484
KAYO_CALORIE_RESTRICTION_MUS...2,SET,89,0.042033,0.0029193,0.086757,0.31402,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,0.95774484029484
HP_ABNORMAL_SPEECH_DISCRIMIN...,SET,4,0.18362,0.00271,0.37906,0.31404,HP_ABNORMAL_SPEECH_DISCRIMINATION,0.95774484029484
CHEOK_RESPONSE_TO_MERCAPTOPU...2,SET,4,0.22016,0.0032492,0.45463,0.3141,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP,0.957805118421053
REACTOME_MECP2_REGULATES_NEU...,SET,16,0.11301,0.0033347,0.23344,0.31415,REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,0.957805118421053
GSE33162_UNTREATED_VS_4H_LPS...3,SET,186,0.030576,0.0030618,0.063155,0.31415,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN,0.957805118421053
MIR4477A,SET,329,0.022291,0.002957,0.046049,0.31417,MIR4477A,0.957805118421053
MATSUMIYA_PBMC_MODIFIED_VACC...7,SET,9,0.13199,0.0029215,0.27273,0.31422,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_28DY_UP,0.957873528637839
GOBP_REGULATION_OF_CELL_CELL...3,SET,11,0.11987,0.0029332,0.24777,0.31426,GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.957888397790055
GOBP_SPLICEOSOMAL_CONFORMATI...,SET,4,0.17128,0.0025278,0.35405,0.31428,GOBP_SPLICEOSOMAL_CONFORMATIONAL_CHANGES_TO_GENERATE_CATALYTIC_CONFORMATION,0.957888397790055
GOBP_NEGATIVE_REGULATION_OF_...620,SET,8,0.16052,0.0033498,0.33199,0.31438,GOBP_NEGATIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,0.957952941176471
HE_LIM_SUN_FETAL_LUNG_C4_CYC...1,SET,594,0.01604,0.0028379,0.033175,0.31438,HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL,0.957952941176471
GSE2706_2H_VS_8H_R848_AND_LP...2,SET,174,0.029935,0.0029003,0.061924,0.3144,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP,0.957952941176471
GSE2770_TGFB_AND_IL4_VS_IL4_...3,SET,174,0.031209,0.0030237,0.06457,0.31443,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.957952941176471
NAKAYA_PLASMACYTOID_DENDRITI...4,SET,1082,0.012183,0.0028691,0.025213,0.31448,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP,0.957952941176471
GSE40274_CTRL_VS_XBP1_TRANSD...1,SET,148,0.031794,0.002843,0.065807,0.3145,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.957952941176471
BRACHAT_RESPONSE_TO_CAMPTOTH...1,SET,39,0.0642,0.0029557,0.13295,0.31458,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,0.957952941176471
GSE20715_WT_VS_TLR4_KO_6H_OZ...1,SET,177,0.030886,0.0030178,0.06396,0.31459,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN,0.957952941176471
GSE360_T_GONDII_VS_B_MALAYI_...3,SET,180,0.029555,0.002912,0.061217,0.31462,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.957952941176471
WP_GLUTATHIONE_METABOLISM,SET,16,0.098659,0.0029111,0.20437,0.31464,WP_GLUTATHIONE_METABOLISM,0.957952941176471
HE_LIM_SUN_FETAL_LUNG_C3_PRI...,SET,100,0.040792,0.0030022,0.084541,0.31472,HE_LIM_SUN_FETAL_LUNG_C3_PRIMITIVE_ERYTHROCYTE,0.957952941176471
MORF_CDC10,SET,140,0.031666,0.0027545,0.065639,0.31475,MORF_CDC10,0.957952941176471
GOBP_POSITIVE_REGULATION_OF_...223,SET,57,0.049847,0.002773,0.10332,0.31475,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.957952941176471
HP_DEVIATION_OF_THE_2ND_TOE,SET,5,0.21353,0.0035231,0.44266,0.31477,HP_DEVIATION_OF_THE_2ND_TOE,0.957952941176471
GOBP_L_AMINO_ACID_BIOSYNTHET...,SET,55,0.053877,0.0029443,0.1117,0.31479,GOBP_L_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.957952941176471
BIOCARTA_IGF1_PATHWAY,SET,20,0.089819,0.0029628,0.18626,0.31482,BIOCARTA_IGF1_PATHWAY,0.957952941176471
GOBP_INTRACELLULAR_CORTICOST...,SET,12,0.12333,0.0031518,0.25575,0.31483,GOBP_INTRACELLULAR_CORTICOSTEROID_RECEPTOR_SIGNALING_PATHWAY,0.957952941176471
HP_MACROGLOSSIA,SET,134,0.034579,0.0029432,0.071709,0.31483,HP_MACROGLOSSIA,0.957952941176471
GOBP_POSITIVE_REGULATION_OF_...258,SET,307,0.02267,0.0029068,0.047016,0.31484,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.957952941176471
REACTOME_NUCLEAR_EVENTS_STIM...,SET,32,0.073717,0.0030748,0.15292,0.31488,REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,0.957952941176471
GSE1460_CD4_THYMOCYTE_VS_THY...2,SET,177,0.029675,0.0028996,0.061557,0.31488,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,0.957952941176471
HP_BICARBONATURIA,SET,5,0.16482,0.0027194,0.34197,0.31492,HP_BICARBONATURIA,0.957990774617068
GSE17721_PAM3CSK4_VS_CPG_0.5...1,SET,181,0.028541,0.0028197,0.059244,0.31499,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN,0.957996619730628
LEE_METASTASIS_AND_ALTERNATI...1,SET,44,0.06167,0.0030153,0.12803,0.31502,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN,0.957996619730628
GSE29618_PRE_VS_DAY7_POST_TI...6,SET,166,0.03113,0.0029466,0.064634,0.31503,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP,0.957996619730628
GOMF_MRNA_METHYLTRANSFERASE_...,SET,12,0.10001,0.0025559,0.20765,0.31504,GOMF_MRNA_METHYLTRANSFERASE_ACTIVITY,0.957996619730628
GOBP_GLIAL_CELL_FATE_SPECIFI...,SET,7,0.18018,0.0035174,0.37419,0.31508,GOBP_GLIAL_CELL_FATE_SPECIFICATION,0.957996619730628
MIR29B_2_5P,SET,199,0.028706,0.0029723,0.059631,0.31512,MIR29B_2_5P,0.957996619730628
DARWICHE_SKIN_TUMOR_PROMOTER...2,SET,128,0.035963,0.0029922,0.074715,0.31514,DARWICHE_SKIN_TUMOR_PROMOTER_UP,0.957996619730628
FAN_OVARY_CL4_T_LYMPHOCYTE_N...,SET,212,0.027823,0.0029724,0.057805,0.31515,FAN_OVARY_CL4_T_LYMPHOCYTE_NK_CELL_1,0.957996619730628
GOBP_NEGATIVE_REGULATION_OF_...670,SET,22,0.08842,0.0030588,0.18373,0.31517,GOBP_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.957996619730628
GOBP_INSULIN_METABOLIC_PROCE...,SET,15,0.10865,0.0031043,0.22592,0.31528,GOBP_INSULIN_METABOLIC_PROCESS,0.958193769674711
HP_INTRAVENTRICULAR_HEMORRHA...,SET,7,0.16953,0.0033096,0.35253,0.31529,HP_INTRAVENTRICULAR_HEMORRHAGE,0.958193769674711
NAKAJIMA_EOSINOPHIL,SET,22,0.099028,0.0034258,0.20599,0.31535,NAKAJIMA_EOSINOPHIL,0.958223299825175
GOBP_CELL_CYCLE_DNA_REPLICAT...1,SET,41,0.059667,0.0028164,0.12414,0.31538,GOBP_CELL_CYCLE_DNA_REPLICATION,0.958223299825175
GSE36476_YOUNG_VS_OLD_DONOR_...8,SET,167,0.031629,0.0030027,0.065811,0.3154,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP,0.958223299825175
GOCC_CORE_MEDIATOR_COMPLEX,SET,25,0.077801,0.0028689,0.16189,0.31541,GOCC_CORE_MEDIATOR_COMPLEX,0.958223299825175
JAATINEN_HEMATOPOIETIC_STEM_...2,SET,274,0.025842,0.0031332,0.053793,0.31548,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,0.958352189493925
GOBP_BLOOD_COAGULATION_FIBRI...,SET,14,0.13166,0.003634,0.27416,0.31554,GOBP_BLOOD_COAGULATION_FIBRIN_CLOT_FORMATION,0.958450681699004
GOMF_ARYLESTERASE_ACTIVITY,SET,6,0.21217,0.0038347,0.44219,0.31569,GOMF_ARYLESTERASE_ACTIVITY,0.958799462600489
VERRECCHIA_RESPONSE_TO_TGFB1...1,SET,19,0.0897,0.002884,0.18697,0.31571,VERRECCHIA_RESPONSE_TO_TGFB1_C1,0.958799462600489
HP_DIAPHRAGMATIC_WEAKNESS,SET,16,0.10741,0.0031694,0.22404,0.31582,HP_DIAPHRAGMATIC_WEAKNESS,0.959045555458819
GOMF_NADH_DEHYDROGENASE_ACTI...,SET,8,0.13079,0.0027294,0.27296,0.31592,GOMF_NADH_DEHYDROGENASE_ACTIVITY,0.959045555458819
MODULE_89,SET,2,0.3187,0.003326,0.66526,0.31595,MODULE_89,0.959045555458819
GOBP_NEGATIVE_REGULATION_OF_...139,SET,42,0.064446,0.0030787,0.13453,0.31596,GOBP_NEGATIVE_REGULATION_OF_CHEMOTAXIS,0.959045555458819
GSE360_CTRL_VS_L_MAJOR_MAC_UP,SET,182,0.029129,0.0028857,0.060814,0.31598,GSE360_CTRL_VS_L_MAJOR_MAC_UP,0.959045555458819
HP_SPRENGEL_ANOMALY,SET,43,0.05892,0.002848,0.12301,0.31599,HP_SPRENGEL_ANOMALY,0.959045555458819
GOBP_VASOCONSTRICTION,SET,83,0.047225,0.0031679,0.098648,0.31607,GOBP_VASOCONSTRICTION,0.959045555458819
GSE360_LOW_DOSE_B_MALAYI_VS_...2,SET,183,0.028575,0.0028385,0.059711,0.31613,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,0.959045555458819
WAGNER_APO2_SENSITIVITY,SET,25,0.090132,0.0033236,0.18835,0.31614,WAGNER_APO2_SENSITIVITY,0.959045555458819
REACTOME_HEMOSTASIS,SET,570,0.017937,0.003111,0.037495,0.31619,REACTOME_HEMOSTASIS,0.959045555458819
GOBP_PROTEIN_STABILIZATION,SET,186,0.02827,0.0028309,0.059095,0.31619,GOBP_PROTEIN_STABILIZATION,0.959045555458819
HP_HYPERTONIC_DEHYDRATION,SET,4,0.22731,0.0033547,0.47518,0.3162,HP_HYPERTONIC_DEHYDRATION,0.959045555458819
WELCH_GATA1_TARGETS,SET,21,0.088993,0.003008,0.18626,0.3164,WELCH_GATA1_TARGETS,0.959045555458819
GOBP_MACROPHAGE_ACTIVATION,SET,103,0.043071,0.0032169,0.090149,0.31641,GOBP_MACROPHAGE_ACTIVATION,0.959045555458819
PID_ERBB1_DOWNSTREAM_PATHWAY,SET,102,0.039945,0.002969,0.083632,0.31646,PID_ERBB1_DOWNSTREAM_PATHWAY,0.959045555458819
GOBP_RESPONSE_TO_CYCLOHEXIMI...,SET,5,0.19652,0.0032425,0.41156,0.31651,GOBP_RESPONSE_TO_CYCLOHEXIMIDE,0.959045555458819
HAHTOLA_CTCL_PATHOGENESIS,SET,15,0.11022,0.003149,0.23088,0.31654,HAHTOLA_CTCL_PATHOGENESIS,0.959045555458819
HP_HEMANGIOMATOSIS,SET,19,0.095197,0.0030607,0.19941,0.31654,HP_HEMANGIOMATOSIS,0.959045555458819
HP_CEPHALOHEMATOMA,SET,9,0.14117,0.0031247,0.29575,0.31657,HP_CEPHALOHEMATOMA,0.959045555458819
XIE_LT_HSC_S1PR3_OE_UP,SET,26,0.083579,0.0031429,0.17511,0.31658,XIE_LT_HSC_S1PR3_OE_UP,0.959045555458819
REACTOME_CARGO_TRAFFICKING_T...,SET,49,0.053843,0.0027778,0.11285,0.31664,REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,0.959045555458819
REACTOME_PLATELET_CALCIUM_HO...,SET,27,0.078376,0.0030033,0.16427,0.31665,REACTOME_PLATELET_CALCIUM_HOMEOSTASIS,0.959045555458819
GSE12845_IGD_NEG_BLOOD_VS_PR...2,SET,169,0.029949,0.00286,0.062774,0.31665,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,0.959045555458819
GOBP_DNA_ALKYLATION_REPAIR,SET,11,0.10433,0.002553,0.21871,0.31667,GOBP_DNA_ALKYLATION_REPAIR,0.959045555458819
GOBP_RNA_POLYMERASE_I_PREINI...,SET,9,0.11598,0.0025672,0.24324,0.31674,GOBP_RNA_POLYMERASE_I_PREINITIATION_COMPLEX_ASSEMBLY,0.959045555458819
GOBP_TRANSCRIPTION_INITIATIO...3,SET,9,0.11598,0.0025672,0.24324,0.31674,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_I_PROMOTER,0.959045555458819
GSE27786_NEUTROPHIL_VS_MONO_...2,SET,176,0.030173,0.0029399,0.063275,0.31674,GSE27786_NEUTROPHIL_VS_MONO_MAC_UP,0.959045555458819
WP_MECP2_AND_ASSOCIATED_RETT...,SET,67,0.053605,0.0032322,0.11242,0.31675,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,0.959045555458819
HP_CHOLESTASIS,SET,257,0.024971,0.0029336,0.052371,0.31675,HP_CHOLESTASIS,0.959045555458819
GSE20727_CTRL_VS_H2O2_TREATE...2,SET,178,0.029128,0.002854,0.061097,0.31677,GSE20727_CTRL_VS_H2O2_TREATED_DC_UP,0.959045555458819
HP_FAILURE_OF_ERUPTION_OF_PE...,SET,5,0.20283,0.0033466,0.42545,0.31678,HP_FAILURE_OF_ERUPTION_OF_PERMANENT_TEETH,0.959045555458819
HP_ABNORMAL_GAMMA_GLUTAMYLTR...,SET,41,0.062931,0.0029705,0.13202,0.3168,HP_ABNORMAL_GAMMA_GLUTAMYLTRANSFERASE_LEVEL,0.959045555458819
WP_IRONSULFUR_CLUSTER_BIOGEN...,SET,13,0.11375,0.0030257,0.23866,0.31682,WP_IRONSULFUR_CLUSTER_BIOGENESIS,0.959045555458819
GOBP_AUTOPHAGY_OF_MITOCHONDR...,SET,91,0.040368,0.0028348,0.084702,0.31683,GOBP_AUTOPHAGY_OF_MITOCHONDRION,0.959045555458819
GSE15324_NAIVE_VS_ACTIVATED_...3,SET,185,0.027956,0.002792,0.05866,0.31683,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN,0.959045555458819
MIR6081,SET,97,0.041746,0.0030262,0.087599,0.31684,MIR6081,0.959045555458819
VECCHI_GASTRIC_CANCER_EARLY_...1,SET,306,0.02527,0.0032349,0.053032,0.31686,VECCHI_GASTRIC_CANCER_EARLY_DN,0.959045555458819
HP_APLASIA_HYPOPLASIA_OF_THE...40,SET,142,0.034118,0.0029888,0.071601,0.31686,HP_APLASIA_HYPOPLASIA_OF_THE_LUNGS,0.959045555458819
HP_LUPUS_NEPHRITIS,SET,25,0.085677,0.0031593,0.17986,0.31691,HP_LUPUS_NEPHRITIS,0.959045555458819
GSE22589_HEALTHY_VS_SIV_INFE...2,SET,177,0.029491,0.0028816,0.061913,0.31692,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP,0.959045555458819
KAPOSI_LIVER_CANCER_MET_UP,SET,18,0.087602,0.0027415,0.18393,0.31694,KAPOSI_LIVER_CANCER_MET_UP,0.959045555458819
GOBP_REGULATION_OF_CILIUM_MO...,SET,36,0.068523,0.0030312,0.14388,0.31695,GOBP_REGULATION_OF_CILIUM_MOVEMENT,0.959045555458819
NAKAMURA_ALVEOLAR_EPITHELIUM,SET,5,0.1889,0.0031168,0.39673,0.31699,NAKAMURA_ALVEOLAR_EPITHELIUM,0.959051688277783
MIR1910_5P,SET,76,0.046162,0.0029638,0.096968,0.31702,MIR1910_5P,0.959051688277783
KEGG_MEDICUS_PATHOGEN_HCMV_U...3,SET,33,0.070807,0.0029991,0.14877,0.31705,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY,0.959051688277783
GOMF_PROTEIN_SERINE_THREONIN...4,SET,36,0.067826,0.0030003,0.14253,0.31709,GOMF_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,0.959051688277783
HP_INCREASED_VERTEBRAL_HEIGHT,SET,10,0.11706,0.0027312,0.246,0.31709,HP_INCREASED_VERTEBRAL_HEIGHT,0.959051688277783
GOBP_SOMATIC_DIVERSIFICATION...1,SET,66,0.045342,0.0027136,0.0953,0.31712,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS,0.9590589627567
GOBP_PROTEIN_LOCALIZATION_TO...31,SET,37,0.062949,0.002823,0.13243,0.31728,GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE_ORGANIZING_CENTER,0.959190878671997
HP_ABNORMALITY_OF_THE_GLABEL...,SET,22,0.085536,0.002959,0.17996,0.31729,HP_ABNORMALITY_OF_THE_GLABELLA,0.959190878671997
REACTOME_FOXO_MEDIATED_TRANS...1,SET,63,0.05212,0.0030478,0.10971,0.31737,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,0.959190878671997
GSE33162_HDAC3_KO_VS_HDAC3_K...1,SET,184,0.029746,0.0029628,0.062621,0.31739,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_DN,0.959190878671997
GOBP_PEPTIDYL_SERINE_DEPHOSP...,SET,14,0.0985,0.0027189,0.20738,0.31741,GOBP_PEPTIDYL_SERINE_DEPHOSPHORYLATION,0.959190878671997
GOBP_HOMOLOGOUS_CHROMOSOME_P...,SET,44,0.05536,0.0027068,0.11657,0.31743,GOBP_HOMOLOGOUS_CHROMOSOME_PAIRING_AT_MEIOSIS,0.959190878671997
GOBP_CARDIOBLAST_PROLIFERATI...,SET,9,0.14801,0.0032761,0.31168,0.31744,GOBP_CARDIOBLAST_PROLIFERATION,0.959190878671997
MIR6747_5P,SET,40,0.059867,0.0027912,0.12608,0.31745,MIR6747_5P,0.959190878671997
DESCARTES_MAIN_FETAL_PDE11A_...,SET,37,0.074328,0.0033333,0.15659,0.31751,DESCARTES_MAIN_FETAL_PDE11A_FAM19A2_POSITIVE_CELLS,0.959190878671997
GSE17721_LPS_VS_GARDIQUIMOD_...13,SET,176,0.028587,0.0027854,0.060228,0.31752,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_DN,0.959190878671997
KEGG_MEDICUS_REFERENCE_HGF_M...2,SET,14,0.10529,0.0029063,0.22184,0.31753,KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY,0.959190878671997
HP_FINE_HAIR,SET,69,0.046986,0.002875,0.098995,0.31753,HP_FINE_HAIR,0.959190878671997
GOBP_NEGATIVE_REGULATION_OF_...42,SET,8,0.14539,0.0030341,0.30636,0.31755,GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.959190878671997
GOBP_NEGATIVE_REGULATION_OF_...671,SET,10,0.13808,0.0032214,0.29095,0.31755,GOBP_NEGATIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,0.959190878671997
MIR3176,SET,67,0.046829,0.0028237,0.098696,0.31758,MIR3176,0.959198131572086
GOBP_POSITIVE_REGULATION_OF_...308,SET,40,0.0657,0.0030632,0.13849,0.31761,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,0.959205383211679
MIR1908_5P,SET,16,0.10305,0.0030406,0.21726,0.31765,MIR1908_5P,0.959242831696933
E2F4DP1_01,SET,209,0.027264,0.0028922,0.057509,0.31772,E2F4DP1_01,0.959370860121633
HP_SPONTANEOUS_RECURRENT_EPI...,SET,13,0.12012,0.003195,0.25343,0.31776,HP_SPONTANEOUS_RECURRENT_EPISTAXIS,0.959408287724785
GOBP_SEQUESTERING_OF_TRIGLYC...,SET,17,0.1033,0.0031419,0.218,0.3178,GOBP_SEQUESTERING_OF_TRIGLYCERIDE,0.95942274819769
ATF2_UP.V1_DN,SET,166,0.032711,0.0030962,0.069037,0.31782,ATF2_UP.V1_DN,0.95942274819769
PID_PRL_SIGNALING_EVENTS_PAT...,SET,23,0.083865,0.0029664,0.17705,0.31786,PID_PRL_SIGNALING_EVENTS_PATHWAY,0.95946016154247
MIR339_3P,SET,6,0.15527,0.0028063,0.32786,0.3179,MIR339_3P,0.959494975266858
REACTOME_TGF_BETA_RECEPTOR_S...1,SET,46,0.056387,0.0028188,0.11909,0.31794,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,0.959494975266858
NAKAYA_MONOCYTE_FLUMIST_AGE_...2,SET,436,0.018973,0.0028888,0.040082,0.31798,NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP,0.959494975266858
HP_DORSOCERVICAL_FAT_PAD,SET,14,0.10165,0.0028059,0.2148,0.31802,HP_DORSOCERVICAL_FAT_PAD,0.959494975266858
GSE41867_DAY6_VS_DAY8_LCMV_C...2,SET,179,0.02992,0.0029398,0.063234,0.31805,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.959494975266858
HP_TEMPORAL_OPTIC_DISC_PALLOR,SET,7,0.15832,0.0030907,0.33466,0.31808,HP_TEMPORAL_OPTIC_DISC_PALLOR,0.959494975266858
HP_EPICANTHUS,SET,527,0.017155,0.0028644,0.036265,0.31809,HP_EPICANTHUS,0.959494975266858
HP_DISPLACEMENT_OF_THE_URETH...,SET,315,0.022096,0.0028692,0.046711,0.3181,HP_DISPLACEMENT_OF_THE_URETHRAL_MEATUS,0.959494975266858
KEGG_MEDICUS_REFERENCE_ORGAN...1,SET,14,0.10555,0.0029134,0.22316,0.31812,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_INNER_KINETOCHORE,0.959494975266858
WP_SREBF_AND_MIR33_IN_CHOLES...,SET,16,0.095513,0.0028183,0.20201,0.31818,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,0.959542177635562
GOBP_CLATHRIN_COATED_VESICLE...,SET,7,0.14458,0.0028224,0.30593,0.31825,GOBP_CLATHRIN_COATED_VESICLE_CARGO_LOADING,0.959542177635562
MIR7111_3P,SET,112,0.037825,0.0029452,0.08005,0.31828,MIR7111_3P,0.959542177635562
GSE11961_GERMINAL_CENTER_BCE...1,SET,177,0.029743,0.0029061,0.062946,0.31828,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.959542177635562
LUDWICZEK_TREATING_IRON_OVER...,SET,7,0.17317,0.0033805,0.36663,0.31835,LUDWICZEK_TREATING_IRON_OVERLOAD,0.959542177635562
REACTOME_ACTIVATION_OF_TRKA_...,SET,6,0.17719,0.0032025,0.37517,0.31836,REACTOME_ACTIVATION_OF_TRKA_RECEPTORS,0.959542177635562
REACTOME_SIGNALING_BY_LTK_IN...,SET,7,0.15488,0.0030235,0.32795,0.31837,REACTOME_SIGNALING_BY_LTK_IN_CANCER,0.959542177635562
GOBP_GANGLIOSIDE_METABOLIC_P...,SET,28,0.078803,0.003075,0.16686,0.31837,GOBP_GANGLIOSIDE_METABOLIC_PROCESS,0.959542177635562
REACTOME_ADP_SIGNALLING_THRO...2,SET,22,0.08714,0.0030145,0.18459,0.31844,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12,0.959542177635562
MIR203B_5P,SET,64,0.049286,0.0029048,0.10443,0.31848,MIR203B_5P,0.959542177635562
HP_HYPEREXTENSIBILITY_OF_THE...1,SET,21,0.091741,0.0031008,0.1944,0.3185,HP_HYPEREXTENSIBILITY_OF_THE_FINGER_JOINTS,0.959542177635562
GOBP_RESPONSE_TO_TOPOLOGICAL...,SET,144,0.032391,0.0028572,0.068654,0.31854,GOBP_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,0.959542177635562
GSE21927_SPLEEN_VS_BONE_MARR...2,SET,168,0.030564,0.0029102,0.06478,0.31854,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP,0.959542177635562
IVANOVA_HEMATOPOIESIS_STEM_C...1,SET,179,0.030649,0.0030114,0.064971,0.31856,IVANOVA_HEMATOPOIESIS_STEM_CELL,0.959542177635562
HP_C1_C2_VERTEBRAL_ABNORMALI...,SET,7,0.1461,0.0028521,0.30971,0.31856,HP_C1_C2_VERTEBRAL_ABNORMALITY,0.959542177635562
WP_FOLATEALCOHOL_AND_CANCER_...,SET,8,0.14697,0.0030672,0.31184,0.31871,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,0.959542177635562
GSE17721_POLYIC_VS_CPG_8H_BM...1,SET,181,0.028608,0.0028264,0.060707,0.31873,GSE17721_POLYIC_VS_CPG_8H_BMDC_DN,0.959542177635562
GSE11961_GERMINAL_CENTER_BCE...5,SET,183,0.029351,0.0029156,0.062296,0.31877,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,0.959542177635562
GSE46606_IRF4MID_VS_WT_CD40L...4,SET,190,0.028574,0.0028916,0.060646,0.31877,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.959542177635562
GOBP_CYTOSOL_TO_ENDOPLASMIC_...,SET,4,0.17744,0.0026187,0.37675,0.31883,GOBP_CYTOSOL_TO_ENDOPLASMIC_RETICULUM_TRANSPORT,0.959542177635562
HP_CONJUNCTIVAL_ICTERUS,SET,6,0.16307,0.0029473,0.34628,0.31886,HP_CONJUNCTIVAL_ICTERUS,0.959542177635562
HP_ELEVATED_SERUM_ACID_PHOSP...,SET,5,0.18383,0.0030331,0.39037,0.31886,HP_ELEVATED_SERUM_ACID_PHOSPHATASE,0.959542177635562
MARTENS_TRETINOIN_RESPONSE_DN,SET,683,0.015022,0.0028429,0.031902,0.31887,MARTENS_TRETINOIN_RESPONSE_DN,0.959542177635562
GOBP_POSITIVE_REGULATION_OF_...753,SET,66,0.045459,0.0027206,0.096548,0.31888,GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE,0.959542177635562
HP_RESPIRATORY_INSUFFICIENCY,SET,561,0.016628,0.0028618,0.035321,0.3189,HP_RESPIRATORY_INSUFFICIENCY,0.959542177635562
KEGG_MEDICUS_REFERENCE_THYRO...,SET,8,0.13103,0.0027344,0.27851,0.31902,KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY,0.959542177635562
GOBP_REGULATION_OF_GASTRIC_A...,SET,6,0.15586,0.0028171,0.33132,0.31903,GOBP_REGULATION_OF_GASTRIC_ACID_SECRETION,0.959542177635562
HP_EMBRYONAL_RENAL_NEOPLASM,SET,41,0.069622,0.0032863,0.148,0.31903,HP_EMBRYONAL_RENAL_NEOPLASM,0.959542177635562
GOBP_STEM_CELL_FATE_COMMITME...,SET,10,0.14743,0.0034398,0.31344,0.31905,GOBP_STEM_CELL_FATE_COMMITMENT,0.959542177635562
HP_CRANIAL_ASYMMETRY,SET,15,0.10113,0.0028893,0.21505,0.31909,HP_CRANIAL_ASYMMETRY,0.959542177635562
HP_HYPOPLASTIC_LABIA_MINORA,SET,28,0.082705,0.0032272,0.17588,0.31909,HP_HYPOPLASTIC_LABIA_MINORA,0.959542177635562
GOBP_EMBRYONIC_AXIS_SPECIFIC...,SET,35,0.07094,0.0030943,0.15088,0.31912,GOBP_EMBRYONIC_AXIS_SPECIFICATION,0.959542177635562
GOMF_PHOSPHATIDYLINOSITOL_3_...9,SET,6,0.18689,0.0033778,0.39757,0.31915,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVATOR_ACTIVITY,0.959542177635562
DESCARTES_MAIN_FETAL_AFP_ALB...,SET,77,0.046657,0.0030151,0.099254,0.31915,DESCARTES_MAIN_FETAL_AFP_ALB_POSITIVE_CELLS,0.959542177635562
HP_DESCENDING_AORTIC_DISSECT...,SET,20,0.094727,0.0031247,0.20152,0.31916,HP_DESCENDING_AORTIC_DISSECTION,0.959542177635562
MIR146A_5P,SET,103,0.037949,0.0028343,0.080744,0.31918,MIR146A_5P,0.959542177635562
MORF_FDXR,SET,210,0.026366,0.0028036,0.056098,0.31918,MORF_FDXR,0.959542177635562
POMEROY_MEDULLOBLASTOMA_DESM...2,SET,56,0.0518,0.0028563,0.11025,0.31924,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,0.959542177635562
GOBP_PEPTIDE_CATABOLIC_PROCE...,SET,19,0.09583,0.0030811,0.20397,0.31924,GOBP_PEPTIDE_CATABOLIC_PROCESS,0.959542177635562
HP_MULTIPLE_PRENATAL_FRACTUR...,SET,16,0.093168,0.0027491,0.1983,0.31924,HP_MULTIPLE_PRENATAL_FRACTURES,0.959542177635562
KEGG_MEDICUS_REFERENCE_UCHL1...,SET,4,0.25738,0.0037985,0.54802,0.3193,KEGG_MEDICUS_REFERENCE_UCHL1_MEDIATED_HYDROLYSIS,0.959593783503372
GOCC_GAP_JUNCTION,SET,27,0.079071,0.0030299,0.16838,0.31933,GOCC_GAP_JUNCTION,0.959593783503372
YTAATTAA_LHX3_01,SET,179,0.032355,0.003179,0.068905,0.31934,YTAATTAA_LHX3_01,0.959593783503372
GOBP_RESPONSE_TO_UV_A,SET,13,0.1267,0.0033701,0.26991,0.31939,GOBP_RESPONSE_TO_UV_A,0.959615321116778
GOBP_POSITIVE_REGULATION_OF_...145,SET,31,0.072794,0.0029886,0.15509,0.31941,GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.959615321116778
MODULE_194,SET,15,0.097818,0.0027947,0.20844,0.31943,MODULE_194,0.959615321116778
MODULE_519,SET,15,0.10525,0.0030071,0.22439,0.31951,MODULE_519,0.959772692307692
HP_ONION_BULB_FORMATION,SET,27,0.075839,0.0029061,0.16177,0.3196,HP_ONION_BULB_FORMATION,0.959960072595281
KEGG_INSULIN_SIGNALING_PATHW...,SET,129,0.034796,0.0029064,0.074254,0.31968,KEGG_INSULIN_SIGNALING_PATHWAY,0.960117386795714
EPPERT_PROGENITOR,SET,124,0.034105,0.0027932,0.072813,0.31976,EPPERT_PROGENITOR,0.960191705546915
GSE6259_DEC205_POS_DC_VS_BCE...2,SET,139,0.035573,0.0030834,0.075949,0.31976,GSE6259_DEC205_POS_DC_VS_BCELL_UP,0.960191705546915
WP_COVID19_STRUCTURAL_COVERA...,SET,19,0.087793,0.0028227,0.18753,0.31984,WP_COVID19_STRUCTURAL_COVERAGE_MAP,0.960197296830469
GOBP_NEGATIVE_REGULATION_OF_...674,SET,10,0.11789,0.0027506,0.25183,0.31984,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,0.960197296830469
GOMF_CALCIUM_INDUCED_CALCIUM...,SET,6,0.14904,0.0026938,0.31839,0.31986,GOMF_CALCIUM_INDUCED_CALCIUM_RELEASE_ACTIVITY,0.960197296830469
KEGG_MEDICUS_REFERENCE_IL6_F...,SET,25,0.080286,0.0029605,0.17153,0.31988,KEGG_MEDICUS_REFERENCE_IL6_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.960197296830469
GSE17721_12H_VS_24H_LPS_BMDC...1,SET,181,0.02749,0.0027159,0.058741,0.3199,GSE17721_12H_VS_24H_LPS_BMDC_DN,0.960197296830469
GOBP_NEGATIVE_REGULATION_OF_...608,SET,26,0.077875,0.0029284,0.16647,0.31996,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,0.960248661716457
KEGG_ALDOSTERONE_REGULATED_S...,SET,39,0.068895,0.0031718,0.14731,0.32,KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,0.960248661716457
GOBP_NEGATIVE_REGULATION_OF_...91,SET,103,0.038178,0.0028515,0.081627,0.32,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.960248661716457
HP_ABNORMAL_MUSCLE_GLYCOGEN_...,SET,10,0.11096,0.0025889,0.23734,0.32006,HP_ABNORMAL_MUSCLE_GLYCOGEN_CONTENT,0.960345791245791
KEGG_MEDICUS_REFERENCE_IGF_I...3,SET,13,0.10307,0.0027415,0.22051,0.32011,KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY,0.960404198670924
HP_OCCIPITAL_CORTICAL_ATROPHY,SET,5,0.2306,0.0038049,0.49348,0.32015,HP_OCCIPITAL_CORTICAL_ATROPHY,0.960404198670924
BONOME_OVARIAN_CANCER_SURVIV...2,SET,453,0.0186,0.0028853,0.039813,0.32019,BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING,0.960404198670924
GOMF_ATPASE_COUPLED_TRANSMEM...,SET,91,0.042977,0.0030181,0.091992,0.32019,GOMF_ATPASE_COUPLED_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.960404198670924
GOCC_MITOCHONDRION,SET,1451,0.010421,0.0028115,0.022312,0.32022,GOCC_MITOCHONDRION,0.96041129616845
GSE32986_UNSTIM_VS_GMCSF_STI...2,SET,166,0.029454,0.0027879,0.063075,0.32027,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP,0.960423878730378
GOBP_REGULATION_OF_RESPONSE_...1,SET,474,0.018229,0.0028908,0.03906,0.32037,GOBP_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,0.960423878730378
HP_COGWHEEL_RIGIDITY,SET,25,0.084085,0.0031006,0.18019,0.32038,HP_COGWHEEL_RIGIDITY,0.960423878730378
GSE11057_CD4_EFF_MEM_VS_PBMC...2,SET,175,0.029402,0.0028567,0.063007,0.32038,GSE11057_CD4_EFF_MEM_VS_PBMC_UP,0.960423878730378
GAVISH_3CA_MALIGNANT_METAPRO...26,SET,43,0.06379,0.0030834,0.13671,0.32039,GAVISH_3CA_MALIGNANT_METAPROGRAM_34_PLATELET_ACTIVATION,0.960423878730378
GOMF_TRANSLATION_ACTIVATOR_A...,SET,9,0.12097,0.0026775,0.25924,0.32039,GOMF_TRANSLATION_ACTIVATOR_ACTIVITY,0.960423878730378
KEGG_MEDICUS_REFERENCE_CX3CR...,SET,17,0.10024,0.0030486,0.21491,0.32047,KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY,0.960527346570397
chr18p11,SET,63,0.10062,0.0058838,0.21583,0.32054,chr18p11,0.960527346570397
GOCC_CLOCK_BMAL_TRANSCRIPTIO...,SET,2,0.38356,0.004003,0.8231,0.32061,GOCC_CLOCK_BMAL_TRANSCRIPTION_COMPLEX,0.960527346570397
GSE1460_DP_THYMOCYTE_VS_THYM...2,SET,169,0.029492,0.0028164,0.063288,0.32061,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,0.960527346570397
HOLLEMAN_VINCRISTINE_RESISTA...3,SET,16,0.094088,0.0027762,0.20193,0.32063,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,0.960527346570397
GOBP_REGULATION_OF_TERMINATI...,SET,5,0.17615,0.0029064,0.37808,0.32065,GOBP_REGULATION_OF_TERMINATION_OF_DNA_TEMPLATED_TRANSCRIPTION,0.960527346570397
GOCC_PINOSOME,SET,7,0.14124,0.0027573,0.30335,0.32075,GOCC_PINOSOME,0.960527346570397
PURBEY_TARGETS_OF_CTBP1_AND_...2,SET,65,0.046105,0.0027384,0.099035,0.32077,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,0.960527346570397
PATEL_SKIN_OF_BODY_ZOSTAVAX_...4,SET,91,0.04185,0.0029389,0.089912,0.32081,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_DN,0.960527346570397
GSE26030_TH1_VS_TH17_RESTIMU...2,SET,175,0.029945,0.0029094,0.064341,0.32083,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP,0.960527346570397
GOBP_LIPID_DROPLET_DISASSEMB...,SET,6,0.14937,0.0026997,0.32106,0.32089,GOBP_LIPID_DROPLET_DISASSEMBLY,0.960527346570397
GSE14415_INDUCED_TREG_VS_FOX...2,SET,124,0.037149,0.0030425,0.07985,0.32089,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN,0.960527346570397
GSE17721_0.5H_VS_12H_POLYIC_...1,SET,186,0.028084,0.0028123,0.060368,0.32089,GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN,0.960527346570397
MIR4468,SET,107,0.037918,0.0028862,0.081517,0.32091,MIR4468,0.960527346570397
GSE14769_UNSTIM_VS_120MIN_LP...1,SET,194,0.028694,0.0029339,0.061686,0.32091,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN,0.960527346570397
GSE17721_LPS_VS_POLYIC_24H_B...2,SET,173,0.028324,0.0027364,0.060898,0.32093,GSE17721_LPS_VS_POLYIC_24H_BMDC_UP,0.960527346570397
HP_ABNORMAL_PUTAMEN_MORPHOLO...,SET,5,0.17901,0.0029537,0.38498,0.32097,HP_ABNORMAL_PUTAMEN_MORPHOLOGY,0.960527346570397
MARTINEZ_RESPONSE_TO_TRABECT...2,SET,254,0.023447,0.0027387,0.050432,0.32099,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,0.960527346570397
HP_POST_PARTUM_HEMORRHAGE,SET,13,0.11442,0.0030435,0.24619,0.32105,HP_POST_PARTUM_HEMORRHAGE,0.960527346570397
GOBP_CARBOHYDRATE_TRANSPORT,SET,126,0.036462,0.0030101,0.078459,0.32107,GOBP_CARBOHYDRATE_TRANSPORT,0.960527346570397
GOBP_SINOATRIAL_NODE_CELL_DE...,SET,5,0.20033,0.0033055,0.43121,0.32112,GOBP_SINOATRIAL_NODE_CELL_DEVELOPMENT,0.960527346570397
GOBP_NEUTROPHIL_DEGRANULATION,SET,13,0.10695,0.0028447,0.23025,0.32115,GOBP_NEUTROPHIL_DEGRANULATION,0.960527346570397
GOMF_STRUCTURAL_CONSTITUENT_...6,SET,22,0.076872,0.0026593,0.16551,0.32116,GOMF_STRUCTURAL_CONSTITUENT_OF_NUCLEAR_PORE,0.960527346570397
GOCC_PROTEASE_INHIBITOR_COMP...,SET,8,0.12559,0.0026209,0.27043,0.32118,GOCC_PROTEASE_INHIBITOR_COMPLEX,0.960527346570397
GOMF_GLUTATHIONE_DISULFIDE_O...,SET,5,0.19725,0.0032546,0.42475,0.32118,GOMF_GLUTATHIONE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,0.960527346570397
GOBP_MONOATOMIC_CATION_TRANS...2,SET,917,0.013725,0.0029897,0.029561,0.32122,GOBP_MONOATOMIC_CATION_TRANSPORT,0.960527346570397
GOMF_INSULIN_RECEPTOR_BINDING,SET,21,0.091243,0.003084,0.19652,0.32122,GOMF_INSULIN_RECEPTOR_BINDING,0.960527346570397
ONKEN_UVEAL_MELANOMA_DN,SET,474,0.018403,0.0029184,0.039645,0.32126,ONKEN_UVEAL_MELANOMA_DN,0.960527346570397
HP_DECREASED_ACTIVITY_OF_MIT...1,SET,8,0.1184,0.002471,0.25508,0.32126,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_ATP_SYNTHASE_COMPLEX,0.960527346570397
GOCC_MLL3_4_COMPLEX,SET,10,0.10757,0.0025096,0.23175,0.32128,GOCC_MLL3_4_COMPLEX,0.960527346570397
HFH1_01,SET,217,0.02779,0.0030032,0.059881,0.3213,HFH1_01,0.960527346570397
HP_ABNORMAL_CIRCULATING_AMYL...,SET,6,0.14975,0.0027067,0.32281,0.32136,HP_ABNORMAL_CIRCULATING_AMYLASE_CONCENTRATION,0.960527346570397
GOMF_ADP_TRANSMEMBRANE_TRANS...,SET,9,0.1396,0.0030899,0.30103,0.32142,GOMF_ADP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.960527346570397
RIZ_ERYTHROID_DIFFERENTIATIO...4,SET,39,0.06138,0.0028259,0.13237,0.32143,RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,0.960527346570397
BIOCARTA_CCR5_PATHWAY,SET,17,0.10366,0.0031527,0.22355,0.32143,BIOCARTA_CCR5_PATHWAY,0.960527346570397
FONTAINE_FOLLICULAR_THYROID_...1,SET,62,0.051144,0.0029669,0.11033,0.32148,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,0.960527346570397
HP_SEPTIC_ARTHRITIS,SET,7,0.13509,0.0026372,0.29141,0.32148,HP_SEPTIC_ARTHRITIS,0.960527346570397
GOBP_MYELOID_CELL_DEVELOPMENT,SET,80,0.045416,0.0029913,0.097982,0.3215,GOBP_MYELOID_CELL_DEVELOPMENT,0.960527346570397
KEGG_MEDICUS_REFERENCE_COMMO...,SET,7,0.15613,0.0030479,0.3369,0.32153,KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION,0.960527346570397
GOCC_MEMBRANE_ATTACK_COMPLEX,SET,7,0.15613,0.0030479,0.3369,0.32153,GOCC_MEMBRANE_ATTACK_COMPLEX,0.960527346570397
KEGG_MEDICUS_REFERENCE_ELECT...3,SET,14,0.094086,0.002597,0.20305,0.32156,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.960534404813064
GOBP_CARBOHYDRATE_DERIVATIVE...1,SET,569,0.016401,0.0028422,0.035417,0.32165,GOBP_CARBOHYDRATE_DERIVATIVE_BIOSYNTHETIC_PROCESS,0.960537029575654
HP_CATAPLEXY,SET,10,0.12447,0.002904,0.26878,0.32165,HP_CATAPLEXY,0.960537029575654
GOBP_O_GLYCAN_PROCESSING,SET,41,0.066211,0.0031253,0.14298,0.32166,GOBP_O_GLYCAN_PROCESSING,0.960537029575654
SASSON_RESPONSE_TO_FORSKOLIN...1,SET,84,0.041024,0.0027684,0.088652,0.32177,SASSON_RESPONSE_TO_FORSKOLIN_DN,0.960537029575654
GOBP_REGULATION_OF_NEURON_MA...,SET,8,0.14624,0.0030519,0.31605,0.32179,GOBP_REGULATION_OF_NEURON_MATURATION,0.960537029575654
XU_RESPONSE_TO_TRETINOIN_AND...1,SET,13,0.10921,0.0029049,0.23617,0.32189,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,0.960537029575654
GOMF_NUCLEAR_RECEPTOR_COACTI...,SET,51,0.052237,0.0027492,0.11298,0.32192,GOMF_NUCLEAR_RECEPTOR_COACTIVATOR_ACTIVITY,0.960537029575654
GOCC_POLYMERIC_CYTOSKELETAL_...,SET,687,0.015501,0.0029417,0.03353,0.32194,GOCC_POLYMERIC_CYTOSKELETAL_FIBER,0.960537029575654
PID_MAPK_TRK_PATHWAY,SET,33,0.070397,0.0029817,0.15229,0.32195,PID_MAPK_TRK_PATHWAY,0.960537029575654
GSE43863_NAIVE_VS_MEMORY_TFH...1,SET,183,0.028512,0.0028322,0.061684,0.32196,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_DN,0.960537029575654
GSE24726_WT_VS_E2_2_KO_PDC_DN,SET,180,0.027699,0.0027291,0.059927,0.32197,GSE24726_WT_VS_E2_2_KO_PDC_DN,0.960537029575654
GSE39820_TGFBETA1_VS_TGFBETA...1,SET,183,0.028253,0.0028065,0.061132,0.32199,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN,0.960537029575654
BROWNE_HCMV_INFECTION_48HR_UP,SET,168,0.029648,0.0028229,0.064179,0.32206,BROWNE_HCMV_INFECTION_48HR_UP,0.960537029575654
GOBP_POSITIVE_REGULATION_OF_...514,SET,5,0.1806,0.0029799,0.39098,0.32207,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS,0.960537029575654
GSE40274_CTRL_VS_FOXP3_AND_P...2,SET,152,0.031945,0.0028945,0.069155,0.32207,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.960537029575654
TGCACTT_MIR519C_MIR519B_MIR5...,SET,409,0.019366,0.002858,0.04194,0.32213,TGCACTT_MIR519C_MIR519B_MIR519A,0.960537029575654
REACTOME_IONOTROPIC_ACTIVITY...,SET,9,0.13666,0.003025,0.29599,0.32215,REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS,0.960537029575654
REACTOME_CELLULAR_RESPONSE_T...1,SET,191,0.027205,0.0027602,0.058926,0.32216,REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,0.960537029575654
GOBP_NEGATIVE_REGULATION_OF_...50,SET,7,0.15737,0.0030722,0.34091,0.32218,GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.960537029575654
GOBP_RESPONSE_TO_ESTROGEN,SET,64,0.048771,0.0028744,0.10566,0.32219,GOBP_RESPONSE_TO_ESTROGEN,0.960537029575654
GOBP_WATER_SOLUBLE_VITAMIN_B...,SET,11,0.11831,0.0028948,0.25631,0.3222,GOBP_WATER_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS,0.960537029575654
GSE27786_CD4_TCELL_VS_MONO_M...1,SET,180,0.028901,0.0028475,0.062615,0.3222,GSE27786_CD4_TCELL_VS_MONO_MAC_DN,0.960537029575654
GOCC_FEMALE_PRONUCLEUS,SET,8,0.12507,0.0026101,0.27109,0.32227,GOCC_FEMALE_PRONUCLEUS,0.960537029575654
GOBP_NEGATIVE_REGULATION_OF_...605,SET,14,0.11602,0.0032024,0.25151,0.3223,GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,0.960537029575654
GOBP_DEOXYRIBONUCLEOSIDE_DIP...,SET,5,0.17055,0.0028141,0.3698,0.32233,GOBP_DEOXYRIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.960537029575654
GOMF_ATP_DEPENDENT_DNA_DNA_A...,SET,4,0.18809,0.0027758,0.40781,0.32233,GOMF_ATP_DEPENDENT_DNA_DNA_ANNEALING_ACTIVITY,0.960537029575654
GSE2585_AIRE_KO_VS_WT_CD80_H...2,SET,182,0.028099,0.0027836,0.060927,0.32233,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP,0.960537029575654
GSE34156_NOD2_LIGAND_VS_TLR1...3,SET,169,0.030715,0.0029332,0.066612,0.32236,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,0.960537029575654
HE_LIM_SUN_FETAL_LUNG_C0_MID...1,SET,57,0.055694,0.0030983,0.12079,0.32238,HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_1_CELL,0.960537029575654
MIR2861,SET,82,0.049646,0.0033104,0.10769,0.32239,MIR2861,0.960537029575654
MODULE_281,SET,28,0.069519,0.0027127,0.15089,0.32251,MODULE_281,0.960812193553917
GOBP_REGULATION_OF_KERATINOC...2,SET,14,0.12029,0.0033204,0.26117,0.32255,GOBP_REGULATION_OF_KERATINOCYTE_MIGRATION,0.960840244215938
GOBP_ENDODERMAL_CELL_FATE_CO...,SET,14,0.11139,0.0030746,0.24188,0.32258,GOBP_ENDODERMAL_CELL_FATE_COMMITMENT,0.960840244215938
KEGG_MEDICUS_PATHOGEN_ESCHER...6,SET,13,0.090839,0.0024163,0.19732,0.32263,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_CDC42_SIGNALING_PATHWAY,0.960840244215938
GSE11864_CSF1_IFNG_VS_CSF1_I...1,SET,167,0.029235,0.0027755,0.063506,0.32263,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.960840244215938
GOMF_MICROTUBULE_SEVERING_AT...,SET,9,0.1242,0.002749,0.26994,0.32273,GOMF_MICROTUBULE_SEVERING_ATPASE_ACTIVITY,0.960905049250535
BIOCARTA_NGF_PATHWAY,SET,19,0.088668,0.0028508,0.19273,0.32274,BIOCARTA_NGF_PATHWAY,0.960905049250535
GOBP_REGULATION_OF_HORMONE_M...,SET,38,0.064689,0.0029399,0.14063,0.32277,GOBP_REGULATION_OF_HORMONE_METABOLIC_PROCESS,0.960905049250535
REACTOME_RELEASE_OF_APOPTOTI...,SET,5,0.16119,0.0026596,0.35045,0.32278,REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA,0.960905049250535
BENPORATH_PRC2_TARGETS,SET,575,0.018782,0.0032713,0.040838,0.32279,BENPORATH_PRC2_TARGETS,0.960905049250535
GSE17721_CTRL_VS_PAM3CSK4_12...1,SET,185,0.028536,0.0028499,0.06208,0.32288,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_DN,0.961090647482014
REACTOME_INTERLEUKIN_1_SIGNA...,SET,108,0.034859,0.0026656,0.07585,0.32291,REACTOME_INTERLEUKIN_1_SIGNALING,0.961097632097285
GOBP_CELLULAR_RESPONSE_TO_CA...3,SET,69,0.048958,0.0029956,0.10659,0.32301,GOBP_CELLULAR_RESPONSE_TO_CALCIUM_ION,0.961288256440983
NABA_ECM_GLYCOPROTEINS,SET,177,0.031388,0.0030669,0.068346,0.32303,NABA_ECM_GLYCOPROTEINS,0.961288256440983
MIR4256,SET,68,0.045571,0.0027681,0.099267,0.32309,MIR4256,0.961288256440983
GSE3039_ALPHAALPHA_CD8_TCELL...1,SET,184,0.028724,0.002861,0.062573,0.32311,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN,0.961288256440983
KEGG_MEDICUS_PATHOGEN_HCMV_U...5,SET,13,0.11395,0.003031,0.24826,0.32312,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY,0.961288256440983
GOBP_POSITIVE_REGULATION_OF_...270,SET,9,0.13398,0.0029656,0.29194,0.32314,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,0.961288256440983
GSE11961_MEMORY_BCELL_DAY7_V...6,SET,180,0.028901,0.0028475,0.062999,0.32321,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.961368624850248
KEGG_MEDICUS_REFERENCE_REGUL...14,SET,8,0.1129,0.0023561,0.24616,0.32325,KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA,0.961368624850248
REACTOME_DEADENYLATION_DEPEN...,SET,49,0.051275,0.0026453,0.1118,0.32325,REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY,0.961368624850248
GSE33374_CD8_ALPHAALPHA_VS_A...1,SET,189,0.027287,0.0027542,0.059515,0.3233,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,0.961410336127267
GSE7852_TREG_VS_TCONV_LN_DN,SET,182,0.029924,0.0029644,0.065293,0.32337,GSE7852_TREG_VS_TCONV_LN_DN,0.961410336127267
WANG_ESOPHAGUS_CANCER_VS_NOR...1,SET,95,0.03855,0.0027657,0.084133,0.32341,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,0.961410336127267
MIR4316,SET,131,0.032614,0.002745,0.071179,0.32341,MIR4316,0.961410336127267
HP_ABNORMAL_HAND_MORPHOLOGY,SET,920,0.012891,0.0028124,0.028136,0.32342,HP_ABNORMAL_HAND_MORPHOLOGY,0.961410336127267
ZHANG_INTERFERON_RESPONSE,SET,23,0.089316,0.0031592,0.19495,0.32343,ZHANG_INTERFERON_RESPONSE,0.961410336127267
GOBP_ACROSOME_ASSEMBLY,SET,25,0.073839,0.0027228,0.1612,0.32346,GOBP_ACROSOME_ASSEMBLY,0.961417283845036
HP_HYPOPLASTIC_FINGERNAIL,SET,46,0.058737,0.0029363,0.12828,0.32352,HP_HYPOPLASTIC_FINGERNAIL,0.961513391482812
GOMF_NEUROTROPHIN_BINDING,SET,9,0.14228,0.0031492,0.3109,0.32361,GOMF_NEUROTROPHIN_BINDING,0.961698636169303
HP_OSTEOPENIA,SET,288,0.022516,0.0027978,0.049217,0.32366,HP_OSTEOPENIA,0.961764988030096
chr1p22,SET,59,0.098152,0.0055549,0.21464,0.32373,chr1p22,0.961890754039497
GOMF_PROTEIN_ARGININE_OMEGA_...2,SET,5,0.16709,0.002757,0.36545,0.32376,GOMF_PROTEIN_ARGININE_OMEGA_N_MONOMETHYLTRANSFERASE_ACTIVITY,0.961897657719268
GOBP_CD4_POSITIVE_ALPHA_BETA...3,SET,88,0.044417,0.0030676,0.09717,0.3238,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.961909360047847
HP_C1_C2_SUBLUXATION,SET,5,0.16108,0.0026578,0.35251,0.32386,HP_C1_C2_SUBLUXATION,0.961909360047847
REACTOME_ORGANIC_ANION_TRANS...2,SET,12,0.11554,0.0029527,0.25287,0.32387,REACTOME_ORGANIC_ANION_TRANSPORTERS,0.961909360047847
GSE2405_0H_VS_9H_A_PHAGOCYTO...2,SET,176,0.028515,0.0027783,0.062411,0.32388,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.961909360047847
GOBP_DISRUPTION_OF_CELLULAR_...,SET,3,0.29013,0.0037082,0.63515,0.32392,GOBP_DISRUPTION_OF_CELLULAR_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM,0.961909360047847
GOMF_ANKYRIN_REPEAT_BINDING,SET,6,0.13446,0.0024302,0.29439,0.32393,GOMF_ANKYRIN_REPEAT_BINDING,0.961909360047847
GOBP_SINOATRIAL_NODE_CELL_DI...,SET,6,0.1802,0.0032569,0.39459,0.32396,GOBP_SINOATRIAL_NODE_CELL_DIFFERENTIATION,0.961916258009398
SIPA1_TARGET_GENES,SET,102,0.037321,0.0027739,0.081828,0.32417,SIPA1_TARGET_GENES,0.962014839948784
GSE32533_WT_VS_MIR17_KO_ACT_...2,SET,178,0.0293,0.0028708,0.064242,0.32417,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP,0.962014839948784
MIR1288_5P,SET,46,0.061545,0.0030766,0.13499,0.32422,MIR1288_5P,0.962014839948784
GOMF_POTASSIUM_ION_TRANSMEMB...,SET,156,0.033395,0.0030651,0.073255,0.32424,GOMF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.962014839948784
GSE20715_0H_VS_24H_OZONE_TLR...2,SET,175,0.029736,0.0028892,0.06523,0.32424,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP,0.962014839948784
HOFFMANN_IMMATURE_TO_MATURE_...1,SET,43,0.062255,0.0030092,0.13656,0.32425,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN,0.962014839948784
GOBP_ANTIGEN_PROCESSING_AND_...4,SET,23,0.088767,0.0031398,0.19472,0.32425,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN,0.962014839948784
GOMF_HISTONE_H4_METHYLTRANSF...,SET,13,0.10588,0.0028163,0.23226,0.32425,GOMF_HISTONE_H4_METHYLTRANSFERASE_ACTIVITY,0.962014839948784
HP_VASCULITIS_BY_ANATOMICAL_...,SET,14,0.10169,0.0028068,0.22309,0.32427,HP_VASCULITIS_BY_ANATOMICAL_SITE,0.962014839948784
GSE15330_MEGAKARYOCYTE_ERYTH...2,SET,188,0.02827,0.0028459,0.062023,0.32427,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_UP,0.962014839948784
HP_RHINITIS,SET,97,0.037748,0.0027364,0.082861,0.32436,HP_RHINITIS,0.962092642040607
GAVISH_3CA_METAPROGRAM_FIBRO...20,SET,48,0.056875,0.0029042,0.12488,0.32441,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE,0.962092642040607
HP_NEPHRITIS,SET,113,0.036161,0.0028281,0.079417,0.32444,HP_NEPHRITIS,0.962092642040607
GOBP_REGULATION_OF_GLUTAMATE...2,SET,6,0.16642,0.0030079,0.36556,0.32447,GOBP_REGULATION_OF_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.962092642040607
GOCC_BRISC_COMPLEX,SET,3,0.21839,0.0027913,0.47975,0.32448,GOCC_BRISC_COMPLEX,0.962092642040607
GSE37416_0H_VS_12H_F_TULAREN...2,SET,168,0.030009,0.0028573,0.065924,0.32448,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.962092642040607
GOBP_POSITIVE_REGULATION_OF_...834,SET,156,0.032207,0.002956,0.070757,0.32449,GOBP_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,0.962092642040607
GSE5589_WT_VS_IL6_KO_LPS_AND...3,SET,178,0.028149,0.0027581,0.061865,0.32455,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.96218626247122
WP_AIRWAY_SMOOTH_MUSCLE_CELL...,SET,15,0.10087,0.002882,0.22176,0.32461,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,0.96218626247122
MODULE_416,SET,22,0.083424,0.002886,0.18343,0.32463,MODULE_416,0.96218626247122
HP_DECREASED_FERTILITY_IN_FE...,SET,87,0.039705,0.0027266,0.087306,0.32464,HP_DECREASED_FERTILITY_IN_FEMALES,0.96218626247122
GOBP_RIBONUCLEOSIDE_MONOPHOS...1,SET,29,0.070359,0.002794,0.15473,0.32466,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.96218626247122
GOCC_ATG1_ULK1_KINASE_COMPLEX,SET,9,0.13542,0.0029975,0.29797,0.32474,GOCC_ATG1_ULK1_KINASE_COMPLEX,0.962288877994714
GOBP_TRNA_TRANSPORT,SET,6,0.12775,0.002309,0.28111,0.32475,GOBP_TRNA_TRANSPORT,0.962288877994714
DURCHDEWALD_SKIN_CARCINOGENE...2,SET,74,0.044896,0.0028444,0.098813,0.32479,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,0.962325358056266
WP_CANONICAL_AND_NONCANONICA...1,SET,27,0.07467,0.0028613,0.16439,0.32483,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,0.962325491782338
KEGG_MEDICUS_REFERENCE_BLOOD...1,SET,6,0.16773,0.0030315,0.36943,0.32491,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_1_BIOSYNTHESIS,0.962325491782338
GOBP_TYPE_B_PANCREATIC_CELL_...2,SET,22,0.0859,0.0029716,0.18924,0.32494,GOBP_TYPE_B_PANCREATIC_CELL_DEVELOPMENT,0.962325491782338
MODULE_219,SET,21,0.081974,0.0027707,0.1806,0.32495,MODULE_219,0.962325491782338
GRADE_COLON_VS_RECTAL_CANCER...2,SET,34,0.066009,0.0028379,0.14552,0.32506,GRADE_COLON_VS_RECTAL_CANCER_UP,0.962325491782338
MIR4531,SET,302,0.022569,0.0028706,0.049756,0.32506,MIR4531,0.962325491782338
GSE4142_NAIVE_VS_GC_BCELL_DN,SET,179,0.027399,0.002692,0.060401,0.32506,GSE4142_NAIVE_VS_GC_BCELL_DN,0.962325491782338
IVANOVSKA_MIR106B_TARGETS,SET,82,0.039576,0.0026389,0.087253,0.32507,IVANOVSKA_MIR106B_TARGETS,0.962325491782338
GSE11057_NAIVE_CD4_VS_PBMC_C...2,SET,163,0.028968,0.0027172,0.063872,0.32509,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP,0.962325491782338
KEGG_MEDICUS_REFERENCE_TRANS...2,SET,28,0.062841,0.0024521,0.13859,0.32512,KEGG_MEDICUS_REFERENCE_TRANSCRIPTION_COUPLED_NER,0.962325491782338
GOBP_ANAPHASE_PROMOTING_COMP...,SET,22,0.074694,0.002584,0.16473,0.32512,GOBP_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,0.962325491782338
WONG_EMBRYONIC_STEM_CELL_CORE,SET,309,0.020862,0.0026835,0.046018,0.32515,WONG_EMBRYONIC_STEM_CELL_CORE,0.962325491782338
GOBP_TERPENOID_METABOLIC_PRO...,SET,96,0.043165,0.003113,0.095212,0.32515,GOBP_TERPENOID_METABOLIC_PROCESS,0.962325491782338
HP_ABNORMALITY_OF_TUMOR_NECR...,SET,5,0.18802,0.0031022,0.41487,0.32521,HP_ABNORMALITY_OF_TUMOR_NECROSIS_FACTOR_SECRETION,0.962421112908719
LEE_AGING_MUSCLE_DN,SET,38,0.060404,0.0027451,0.13339,0.32533,LEE_AGING_MUSCLE_DN,0.962648706052609
OUELLET_OVARIAN_CANCER_INVAS...1,SET,11,0.12854,0.0031454,0.28392,0.32537,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,0.962648706052609
GOCC_FIBRINOGEN_COMPLEX,SET,8,0.14278,0.0029797,0.31538,0.32537,GOCC_FIBRINOGEN_COMPLEX,0.962648706052609
GOBP_BONE_DEVELOPMENT,SET,196,0.028772,0.0029568,0.063587,0.32546,GOBP_BONE_DEVELOPMENT,0.962751068176015
HP_HYPERECHOGENIC_PANCREAS,SET,4,0.17563,0.002592,0.38815,0.32546,HP_HYPERECHOGENIC_PANCREAS,0.962751068176015
PHONG_TNF_TARGETS_UP,SET,61,0.054476,0.0031347,0.12042,0.3255,PHONG_TNF_TARGETS_UP,0.962787446808511
GOCC_ORGANELLE_INNER_MEMBRANE,SET,465,0.017056,0.0026797,0.037724,0.32559,GOCC_ORGANELLE_INNER_MEMBRANE,0.962971700280827
GOMF_TRNA_CYTIDINE_METHYLTRA...,SET,9,0.1182,0.0026163,0.26155,0.32567,GOMF_TRNA_CYTIDINE_METHYLTRANSFERASE_ACTIVITY,0.963126348706603
GAVISH_3CA_MALIGNANT_METAPRO...5,SET,46,0.058977,0.0029483,0.13057,0.32575,GAVISH_3CA_MALIGNANT_METAPROGRAM_14_EMT_3,0.963228586013272
GOBP_TRANSLATION,SET,578,0.015321,0.0026752,0.033922,0.32576,GOBP_TRANSLATION,0.963228586013272
GSE2585_AIRE_KO_VS_WT_CD80_H...1,SET,181,0.028094,0.0027755,0.062211,0.32579,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN,0.963235342407486
GSE8621_LPS_PRIMED_UNSTIM_VS...2,SET,175,0.027811,0.0027022,0.0616,0.32582,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,0.963242097652263
MEBARKI_HCC_PROGENITOR_WNT_D...3,SET,18,0.097472,0.0030504,0.21605,0.32594,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,0.963514901760653
chr4q35,SET,36,0.11283,0.0049914,0.25028,0.32606,chr4q35,0.963682857142857
MIR657,SET,68,0.044882,0.0027263,0.099552,0.32606,MIR657,0.963682857142857
HP_TYPE_2_MUSCLE_FIBER_PREDO...,SET,9,0.12282,0.0027186,0.27247,0.32608,HP_TYPE_2_MUSCLE_FIBER_PREDOMINANCE,0.963682857142857
MIR6788_3P,SET,3,0.2208,0.0028221,0.49001,0.32614,MIR6788_3P,0.963747235434007
MATTHEWS_SKIN_CARCINOGENESIS...,SET,17,0.093501,0.0028437,0.20754,0.32617,MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN,0.963747235434007
GOCC_SCHMIDT_LANTERMAN_INCIS...,SET,10,0.12873,0.0030034,0.28581,0.32621,GOCC_SCHMIDT_LANTERMAN_INCISURE,0.963747235434007
GOBP_DENDRITIC_CELL_APOPTOTI...,SET,12,0.12122,0.003098,0.26917,0.32623,GOBP_DENDRITIC_CELL_APOPTOTIC_PROCESS,0.963747235434007
GOBP_HISTAMINE_METABOLIC_PRO...,SET,6,0.18729,0.0033852,0.41592,0.32625,GOBP_HISTAMINE_METABOLIC_PROCESS,0.963747235434007
HP_DELAYED_OSSIFICATION_OF_C...,SET,15,0.090483,0.0025852,0.201,0.3263,HP_DELAYED_OSSIFICATION_OF_CARPAL_BONES,0.963747235434007
HP_HEPATIC_CYSTS,SET,23,0.076027,0.0026891,0.16892,0.32633,HP_HEPATIC_CYSTS,0.963747235434007
MIR3157_5P,SET,97,0.037795,0.0027398,0.084011,0.3264,MIR3157_5P,0.963747235434007
KEGG_ENDOMETRIAL_CANCER,SET,50,0.053449,0.0027854,0.11884,0.32644,KEGG_ENDOMETRIAL_CANCER,0.963747235434007
HUANG_FOXA2_TARGETS_UP,SET,45,0.060869,0.0030097,0.13536,0.32647,HUANG_FOXA2_TARGETS_UP,0.963747235434007
GOBP_DORSAL_ROOT_GANGLION_DE...,SET,7,0.16678,0.0032557,0.37087,0.32647,GOBP_DORSAL_ROOT_GANGLION_DEVELOPMENT,0.963747235434007
GOBP_RESPONSE_TO_HORMONE,SET,816,0.01392,0.0028686,0.030955,0.32647,GOBP_RESPONSE_TO_HORMONE,0.963747235434007
GOMF_L_PROLINE_TRANSMEMBRANE...,SET,7,0.15893,0.0031026,0.35344,0.32648,GOMF_L_PROLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.963747235434007
MODULE_312,SET,46,0.056215,0.0028102,0.12503,0.32649,MODULE_312,0.963747235434007
MIR378H,SET,39,0.056706,0.0026106,0.12614,0.32652,MIR378H,0.963753936305732
DESCARTES_FETAL_CEREBELLUM_I...,SET,24,0.089683,0.0032403,0.19954,0.32656,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,0.96377800644997
REACTOME_CLATHRIN_MEDIATED_E...,SET,134,0.032333,0.002752,0.071986,0.32666,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,0.96377800644997
GOMF_TPR_DOMAIN_BINDING,SET,7,0.1104,0.0021552,0.2458,0.32666,GOMF_TPR_DOMAIN_BINDING,0.96377800644997
TAVOR_CEBPA_TARGETS_DN,SET,29,0.074684,0.0029657,0.16632,0.3267,TAVOR_CEBPA_TARGETS_DN,0.96377800644997
KEGG_MEDICUS_REFERENCE_CENPE...,SET,12,0.10353,0.0026459,0.23055,0.3267,KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX,0.96377800644997
JINESH_BLEBBISHIELD_VS_LIVE_...2,SET,303,0.021257,0.002708,0.047346,0.32673,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,0.96377800644997
BIOCARTA_AMI_PATHWAY,SET,18,0.097569,0.0030534,0.21733,0.32674,BIOCARTA_AMI_PATHWAY,0.96377800644997
AACYNNNNTTCCS_UNKNOWN,SET,88,0.040617,0.0028051,0.090477,0.32675,AACYNNNNTTCCS_UNKNOWN,0.96377800644997
VICENT_METASTASIS_UP,SET,13,0.10632,0.002828,0.23691,0.3268,VICENT_METASTASIS_UP,0.963791391599491
GSE22033_UNTREATED_VS_MRL24_...2,SET,178,0.026264,0.0025734,0.058527,0.32681,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_UP,0.963791391599491
GOMF_L_AMINO_ACID_TRANSMEMBR...,SET,62,0.050105,0.0029067,0.1117,0.32687,GOMF_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.963886547598846
GOMF_KINETOCHORE_BINDING,SET,6,0.14765,0.0026687,0.32924,0.32691,GOMF_KINETOCHORE_BINDING,0.963899910926366
GOBP_CYTOSKELETON_DEPENDENT_...1,SET,103,0.035407,0.0026445,0.078963,0.32693,GOBP_CYTOSKELETON_DEPENDENT_CYTOKINESIS,0.963899910926366
GCGCCTT_MIR525_MIR524,SET,15,0.088666,0.0025333,0.19783,0.32701,GCGCCTT_MIR525_MIR524,0.963996117986099
BILANGES_SERUM_SENSITIVE_VIA...2,SET,24,0.074404,0.0026883,0.16602,0.32702,BILANGES_SERUM_SENSITIVE_VIA_TSC2,0.963996117986099
HP_ABNORMALITY_OF_THE_PHALAN...1,SET,16,0.094254,0.0027811,0.21039,0.32708,HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_2ND_FINGER,0.963996117986099
HP_CAVUM_SEPTUM_PELLUCIDUM,SET,30,0.067356,0.0027204,0.15035,0.32709,HP_CAVUM_SEPTUM_PELLUCIDUM,0.963996117986099
MIR4436B_3P,SET,97,0.038191,0.0027685,0.085271,0.32713,MIR4436B_3P,0.963996117986099
HP_FLAT_ACETABULAR_ROOF,SET,26,0.070593,0.0026546,0.15767,0.32718,HP_FLAT_ACETABULAR_ROOF,0.963996117986099
AACTGGA_MIR145,SET,216,0.024858,0.0026803,0.055524,0.32719,AACTGGA_MIR145,0.963996117986099
GSE27670_CTRL_VS_BLIMP1_TRAN...1,SET,180,0.028833,0.0028408,0.064402,0.32719,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN,0.963996117986099
LU_TUMOR_VASCULATURE_DN,SET,8,0.12909,0.0026939,0.28838,0.32722,LU_TUMOR_VASCULATURE_DN,0.963996117986099
GOMF_HYDROLASE_ACTIVITY_HYDR...1,SET,37,0.068492,0.0030715,0.15303,0.32724,GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS,0.963996117986099
ODONNELL_TFRC_TARGETS_UP,SET,329,0.020951,0.0027793,0.04685,0.32737,ODONNELL_TFRC_TARGETS_UP,0.964258362989324
GSE2706_UNSTIM_VS_8H_LPS_DC_...1,SET,171,0.029601,0.0028433,0.066209,0.32741,GSE2706_UNSTIM_VS_8H_LPS_DC_DN,0.964258362989324
GOBP_DENTATE_GYRUS_DEVELOPME...,SET,23,0.081555,0.0028847,0.18243,0.32742,GOBP_DENTATE_GYRUS_DEVELOPMENT,0.964258362989324
GOBP_POSITIVE_REGULATION_OF_...183,SET,6,0.14538,0.0026275,0.32522,0.32744,GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.964258362989324
GOBP_POSITIVE_REGULATION_OF_...660,SET,18,0.091451,0.0028619,0.20463,0.32747,GOBP_POSITIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.964265004659832
GOBP_MESODERMAL_CELL_MIGRATI...,SET,5,0.18603,0.0030694,0.41634,0.32751,GOBP_MESODERMAL_CELL_MIGRATION,0.964301088614029
HP_TERATOMA,SET,12,0.10453,0.0026715,0.23407,0.32758,HP_TERATOMA,0.964363692946058
MIR5688,SET,715,0.014623,0.0028288,0.032751,0.32763,MIR5688,0.964363692946058
GOBP_FIBROBLAST_ACTIVATION,SET,15,0.11009,0.0031453,0.24657,0.32763,GOBP_FIBROBLAST_ACTIVATION,0.964363692946058
GOCC_EXTRINSIC_COMPONENT_OF_...1,SET,47,0.056823,0.0028712,0.12729,0.32765,GOCC_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,0.964363692946058
SABATES_COLORECTAL_ADENOMA_UP,SET,127,0.037445,0.0031034,0.083891,0.32767,SABATES_COLORECTAL_ADENOMA_UP,0.964363692946058
REACTOME_CHROMOSOME_MAINTENA...,SET,83,0.038798,0.0026026,0.086948,0.32772,REACTOME_CHROMOSOME_MAINTENANCE,0.964368206039076
HINATA_NFKB_TARGETS_KERATINO...2,SET,84,0.041683,0.0028129,0.093421,0.32773,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,0.964368206039076
GOBP_NEURAL_FOLD_FORMATION,SET,7,0.14109,0.0027543,0.31627,0.32776,GOBP_NEURAL_FOLD_FORMATION,0.964368206039076
HP_PREMATURE_LOSS_OF_TEETH,SET,53,0.051793,0.0027787,0.11613,0.3278,HP_PREMATURE_LOSS_OF_TEETH,0.964368206039076
MIR6756_5P,SET,241,0.024759,0.0028179,0.055528,0.32784,MIR6756_5P,0.964368206039076
GOBP_SOMITE_ROSTRAL_CAUDAL_A...,SET,9,0.12589,0.0027865,0.28236,0.32786,GOBP_SOMITE_ROSTRAL_CAUDAL_AXIS_SPECIFICATION,0.964368206039076
REACTOME_REGULATION_OF_CDH11...2,SET,10,0.13369,0.0031191,0.29994,0.3279,REACTOME_REGULATION_OF_CDH11_GENE_TRANSCRIPTION,0.964368206039076
GSE14415_INDUCED_VS_NATURAL_...1,SET,162,0.029116,0.0027228,0.065331,0.32792,GSE14415_INDUCED_VS_NATURAL_TREG_DN,0.964368206039076
MIR4730,SET,6,0.16598,0.0029999,0.37254,0.32797,MIR4730,0.964368206039076
GSE40685_NAIVE_CD4_TCELL_VS_...3,SET,180,0.027837,0.0027427,0.06248,0.32797,GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN,0.964368206039076
GSE23321_EFFECTOR_MEMORY_VS_...1,SET,172,0.026243,0.002528,0.058924,0.32803,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.964368206039076
HP_NARROW_NASAL_RIDGE,SET,19,0.083091,0.0026715,0.18657,0.32804,HP_NARROW_NASAL_RIDGE,0.964368206039076
GAVISH_3CA_METAPROGRAM_ENDOT...13,SET,49,0.057446,0.0029637,0.129,0.32805,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NF_KB,0.964368206039076
GOBP_ACTIVATION_OF_PHOSPHOLI...,SET,21,0.081434,0.0027525,0.18289,0.32806,GOBP_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY,0.964368206039076
GOCC_SECRETORY_VESICLE,SET,986,0.012555,0.0028302,0.028209,0.32814,GOCC_SECRETORY_VESICLE,0.964469619450317
GOBP_NEGATIVE_REGULATION_OF_...287,SET,4,0.18226,0.0026899,0.40954,0.32815,GOBP_NEGATIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION,0.964469619450317
MIR4330,SET,82,0.040308,0.0026877,0.090613,0.32822,MIR4330,0.964593784880771
PID_RXR_VDR_PATHWAY,SET,26,0.071731,0.0026974,0.16132,0.32829,PID_RXR_VDR_PATHWAY,0.964710462666442
GSE20715_WT_VS_TLR4_KO_LUNG_...2,SET,179,0.028443,0.0027947,0.064,0.32837,GSE20715_WT_VS_TLR4_KO_LUNG_UP,0.964710462666442
DORMOY_ELAVL1_TARGETS,SET,17,0.097019,0.0029508,0.2184,0.32844,DORMOY_ELAVL1_TARGETS,0.964710462666442
GSE37416_CTRL_VS_12H_F_TULAR...1,SET,175,0.02681,0.0026049,0.060357,0.32845,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.964710462666442
MIR3922_3P,SET,89,0.037909,0.0026329,0.085353,0.32847,MIR3922_3P,0.964710462666442
GOMF_FATZ_BINDING,SET,5,0.16812,0.002774,0.37855,0.32848,GOMF_FATZ_BINDING,0.964710462666442
REACTOME_FORMATION_OF_AXIAL_...,SET,13,0.11109,0.0029549,0.25015,0.32849,REACTOME_FORMATION_OF_AXIAL_MESODERM,0.964710462666442
GOBP_POSITIVE_REGULATION_OF_...343,SET,20,0.091159,0.003007,0.20527,0.32849,GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.964710462666442
GOBP_PIRNA_PROCESSING,SET,21,0.075008,0.0025352,0.16895,0.32853,GOBP_PIRNA_PROCESSING,0.964710462666442
MIR1825,SET,149,0.030652,0.00275,0.069067,0.3286,MIR1825,0.964710462666442
TGCACGA_MIR517A_MIR517C,SET,17,0.086567,0.0026329,0.19517,0.32868,TGCACGA_MIR517A_MIR517C,0.964710462666442
FRANCO_BLOOD_SANOFI_PASTEUR_...1,SET,14,0.10601,0.0029262,0.23902,0.32869,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_0DY_NEGATIVE,0.964710462666442
GOBP_CELLULAR_RESPONSE_TO_RE...1,SET,14,0.10488,0.002895,0.23653,0.32874,GOBP_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES,0.964710462666442
HP_SPHEROPHAKIA,SET,5,0.17597,0.0029035,0.39695,0.32877,HP_SPHEROPHAKIA,0.964710462666442
HP_ARTHROPATHY,SET,41,0.060861,0.0028728,0.13732,0.32881,HP_ARTHROPATHY,0.964710462666442
GSE16450_IMMATURE_VS_MATURE_...4,SET,182,0.027424,0.0027168,0.061882,0.32882,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.964710462666442
GOBP_REGULATION_OF_CARDIAC_C...,SET,23,0.079921,0.0028269,0.18038,0.32886,GOBP_REGULATION_OF_CARDIAC_CONDUCTION,0.964710462666442
GOBP_REGULATION_OF_ESTABLISH...5,SET,5,0.17122,0.002825,0.38643,0.32886,GOBP_REGULATION_OF_ESTABLISHMENT_OF_T_CELL_POLARITY,0.964710462666442
GOBP_PROGESTERONE_METABOLIC_...,SET,15,0.10193,0.0029122,0.23024,0.32899,GOBP_PROGESTERONE_METABOLIC_PROCESS,0.964710462666442
GOCC_MALE_PRONUCLEUS,SET,6,0.1309,0.0023659,0.29567,0.32899,GOCC_MALE_PRONUCLEUS,0.964710462666442
BIOCARTA_NKCELLS_PATHWAY,SET,18,0.090956,0.0028465,0.2055,0.32903,BIOCARTA_NKCELLS_PATHWAY,0.964710462666442
BIOCARTA_LONGEVITY_PATHWAY,SET,15,0.099083,0.0028309,0.22387,0.32904,BIOCARTA_LONGEVITY_PATHWAY,0.964710462666442
FIRESTEIN_CTNNB1_PATHWAY,SET,26,0.079229,0.0029793,0.17905,0.32907,FIRESTEIN_CTNNB1_PATHWAY,0.964710462666442
REACTOME_RESPIRATORY_SYNCYTI...1,SET,106,0.036065,0.0027323,0.081503,0.32907,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,0.964710462666442
HP_PERICARDITIS,SET,33,0.068673,0.0029087,0.15522,0.32909,HP_PERICARDITIS,0.964710462666442
GOBP_MULTIVESICULAR_BODY_ORG...,SET,32,0.060805,0.0025362,0.13745,0.32911,GOBP_MULTIVESICULAR_BODY_ORGANIZATION,0.964710462666442
GOBP_REGULATION_OF_MEMBRANE_...6,SET,16,0.081653,0.0024093,0.18461,0.32914,GOBP_REGULATION_OF_MEMBRANE_LIPID_METABOLIC_PROCESS,0.964710462666442
VANTVEER_BREAST_CANCER_BRCA1...2,SET,31,0.062979,0.0025856,0.14242,0.32917,VANTVEER_BREAST_CANCER_BRCA1_UP,0.964710462666442
HP_INTESTINAL_MALROTATION,SET,126,0.033392,0.0027567,0.075518,0.32918,HP_INTESTINAL_MALROTATION,0.964710462666442
GOBP_VESICLE_ORGANIZATION,SET,336,0.019996,0.0026801,0.045223,0.32919,GOBP_VESICLE_ORGANIZATION,0.964710462666442
LIN_TUMOR_ESCAPE_FROM_IMMUNE...,SET,17,0.0903,0.0027464,0.20424,0.3292,LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,0.964710462666442
GOBP_ETHANOL_METABOLIC_PROCE...,SET,11,0.12558,0.0030727,0.28403,0.3292,GOBP_ETHANOL_METABOLIC_PROCESS,0.964710462666442
MODULE_562,SET,20,0.095164,0.0031391,0.21527,0.32922,MODULE_562,0.964710462666442
GOBP_CAMERA_TYPE_EYE_MORPHOG...,SET,127,0.035027,0.002903,0.079232,0.32922,GOBP_CAMERA_TYPE_EYE_MORPHOGENESIS,0.964710462666442
GCTTGAA_MIR498,SET,98,0.03849,0.0028045,0.087104,0.32929,GCTTGAA_MIR498,0.964710462666442
THILLAINADESAN_ZNF217_TARGET...2,SET,38,0.057909,0.0026317,0.13106,0.32931,THILLAINADESAN_ZNF217_TARGETS_UP,0.964710462666442
GOBP_POSITIVE_REGULATION_OF_...171,SET,30,0.064341,0.0025987,0.14563,0.32932,GOBP_POSITIVE_REGULATION_OF_COAGULATION,0.964710462666442
WP_METABOLIC_PATHWAYS_OF_FIB...,SET,32,0.063343,0.0026421,0.1434,0.32935,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,0.964710462666442
GSE13522_CTRL_VS_T_CRUZI_Y_S...2,SET,120,0.034019,0.0027412,0.077015,0.32935,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP,0.964710462666442
HP_ADULT_ONSET_SENSORINEURAL...,SET,5,0.2011,0.0033181,0.45532,0.32937,HP_ADULT_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT,0.964710462666442
CAHOY_ASTROCYTIC,SET,94,0.039908,0.0028481,0.090417,0.32947,CAHOY_ASTROCYTIC,0.964840735591507
GSE7460_FOXP3_MUT_VS_HET_ACT...1,SET,181,0.027413,0.0027083,0.062106,0.32947,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN,0.964840735591507
GOBP_AUTOSOME_GENOMIC_IMPRIN...,SET,5,0.1543,0.0025459,0.34991,0.32962,GOBP_AUTOSOME_GENOMIC_IMPRINTING,0.965065339903967
GOCC_MONOATOMIC_ION_CHANNEL_...,SET,319,0.022804,0.0029795,0.051713,0.32962,GOCC_MONOATOMIC_ION_CHANNEL_COMPLEX,0.965065339903967
REACTOME_RORA_ACTIVATES_GENE...,SET,17,0.089732,0.0027291,0.2035,0.32963,REACTOME_RORA_ACTIVATES_GENE_EXPRESSION,0.965065339903967
GOBP_ASPARTATE_FAMILY_AMINO_...3,SET,41,0.057315,0.0027054,0.13001,0.32966,GOBP_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.965071875
GSE7568_IL4_TGFB_DEXAMETHASO...1,SET,160,0.027855,0.0025889,0.063201,0.3297,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN,0.965107681293692
GOBP_QUINOLINATE_METABOLIC_P...,SET,5,0.17927,0.0029579,0.40704,0.32982,GOBP_QUINOLINATE_METABOLIC_PROCESS,0.965377640222334
EVI1_05,SET,161,0.030786,0.0028702,0.069933,0.32989,EVI1_05,0.965436120906801
BCAT_BILD_ET_AL_UP,SET,42,0.056701,0.0027087,0.12884,0.32994,BCAT_BILD_ET_AL_UP,0.965436120906801
DESCARTES_FETAL_SPLEEN_MYELO...,SET,110,0.03935,0.0030366,0.089421,0.32995,DESCARTES_FETAL_SPLEEN_MYELOID_CELLS,0.965436120906801
GOBP_REGULATION_OF_B_CELL_AP...,SET,18,0.09029,0.0028256,0.20523,0.32999,GOBP_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,0.965436120906801
GSE22611_NOD2_TRANSDUCED_VS_...1,SET,173,0.026195,0.0025307,0.059561,0.33004,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN,0.965436120906801
HP_MEGAKARYOCYTOPENIA,SET,6,0.14258,0.002577,0.32437,0.33014,HP_MEGAKARYOCYTOPENIA,0.965436120906801
GOBP_NUCLEOPHAGY,SET,21,0.082031,0.0027726,0.18664,0.33015,GOBP_NUCLEOPHAGY,0.965436120906801
LAKE_ADULT_KIDNEY_C18_COLLEC...,SET,295,0.021712,0.0027298,0.049399,0.33015,LAKE_ADULT_KIDNEY_C18_COLLECTING_DUCT_PRINCIPAL_CELLS_MEDULLA,0.965436120906801
WP_SPHINGOLIPID_METABOLISM_I...2,SET,27,0.075516,0.0028937,0.17185,0.33018,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.965436120906801
MIR208B_3P,SET,39,0.060655,0.0027925,0.13805,0.3302,MIR208B_3P,0.965436120906801
MIR548G_3P,SET,216,0.024989,0.0026944,0.056881,0.33021,MIR548G_3P,0.965436120906801
HP_APLASIA_INVOLVING_BONES_O...1,SET,22,0.080415,0.0027819,0.18307,0.33024,HP_APLASIA_INVOLVING_BONES_OF_THE_EXTREMITIES,0.965436120906801
HP_LONG_PHILTRUM,SET,371,0.019216,0.0027038,0.043755,0.33027,HP_LONG_PHILTRUM,0.965436120906801
GOCC_ACROSOMAL_MEMBRANE,SET,30,0.075543,0.0030511,0.17202,0.33028,GOCC_ACROSOMAL_MEMBRANE,0.965436120906801
MODULE_557,SET,9,0.14453,0.0031991,0.32918,0.33031,MODULE_557,0.965436120906801
HP_PES_VALGUS,SET,48,0.055631,0.0028407,0.12674,0.33036,HP_PES_VALGUS,0.965436120906801
GOBP_IMMUNE_RESPONSE_INHIBIT...2,SET,10,0.12848,0.0029976,0.29272,0.33037,GOBP_IMMUNE_RESPONSE_INHIBITING_SIGNAL_TRANSDUCTION,0.965436120906801
MIR4327,SET,74,0.050332,0.0031889,0.11473,0.33044,MIR4327,0.965436120906801
GOBP_BRAIN_DERIVED_NEUROTROP...,SET,6,0.17318,0.00313,0.39478,0.33045,GOBP_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.965436120906801
HP_ABNORMAL_METACARPAL_MORPH...,SET,196,0.026829,0.0027571,0.061163,0.33046,HP_ABNORMAL_METACARPAL_MORPHOLOGY,0.965436120906801
GOBP_TRIPEPTIDE_TRANSPORT,SET,11,0.11858,0.0029015,0.27044,0.33053,GOBP_TRIPEPTIDE_TRANSPORT,0.965436120906801
HP_INTERRUPTED_INFERIOR_VENA...,SET,5,0.12772,0.0021074,0.2914,0.33058,HP_INTERRUPTED_INFERIOR_VENA_CAVA_WITH_AZYGOUS_CONTINUATION,0.965436120906801
GOBP_NEURAL_PLATE_DEVELOPMENT,SET,7,0.14296,0.0027908,0.3262,0.3306,GOBP_NEURAL_PLATE_DEVELOPMENT,0.965436120906801
GOCC_CLATHRIN_SCULPTED_GAMMA...,SET,8,0.14612,0.0030493,0.33343,0.33062,GOCC_CLATHRIN_SCULPTED_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT_VESICLE,0.965436120906801
GOBP_MEMBRANE_LIPID_BIOSYNTH...,SET,143,0.031046,0.0027292,0.070865,0.33066,GOBP_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS,0.965436120906801
GOBP_POSITIVE_REGULATION_OF_...655,SET,303,0.021367,0.0027221,0.048775,0.33067,GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS,0.965436120906801
HP_CONGENITAL_MUSCULAR_TORTI...,SET,6,0.1557,0.0028141,0.35552,0.33072,HP_CONGENITAL_MUSCULAR_TORTICOLLIS,0.965436120906801
GOBP_RECEPTOR_CATABOLIC_PROC...,SET,26,0.070418,0.002648,0.16081,0.33073,GOBP_RECEPTOR_CATABOLIC_PROCESS,0.965436120906801
HP_DIAPHYSEAL_SCLEROSIS,SET,9,0.13377,0.0029608,0.30557,0.33078,HP_DIAPHYSEAL_SCLEROSIS,0.965436120906801
PRC2_EED_DN.V1_DN,SET,177,0.026022,0.0025426,0.059444,0.33078,PRC2_EED_DN.V1_DN,0.965436120906801
GSE26669_CTRL_VS_COSTIM_BLOC...3,SET,179,0.026474,0.0026012,0.060475,0.33078,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN,0.965436120906801
WP_NEOLACTO_SERIES_SPHINGOLI...,SET,11,0.11425,0.0027956,0.261,0.33079,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,0.965436120906801
MIR4684_5P,SET,156,0.02871,0.0026351,0.065584,0.33079,MIR4684_5P,0.965436120906801
GOBP_VIRION_ASSEMBLY,SET,33,0.060741,0.0025728,0.13877,0.3308,GOBP_VIRION_ASSEMBLY,0.965436120906801
WP_PAFAH1B1_COPY_NUMBER_VARI...,SET,10,0.10575,0.0024671,0.24163,0.33083,WP_PAFAH1B1_COPY_NUMBER_VARIATION,0.965436120906801
GSE18791_UNSTIM_VS_NEWCATSLE...3,SET,154,0.030228,0.0027567,0.069076,0.33084,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN,0.965436120906801
GSE17721_LPS_VS_GARDIQUIMOD_...17,SET,182,0.026638,0.0026389,0.060932,0.33099,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN,0.965789383130508
GAVISH_3CA_METAPROGRAM_CD4_T...6,SET,44,0.059813,0.0029245,0.13687,0.33106,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_1,0.965789383130508
GOBP_SOMITOGENESIS,SET,59,0.049923,0.0028254,0.11424,0.33106,GOBP_SOMITOGENESIS,0.965789383130508
MIR4689,SET,78,0.042078,0.0027367,0.096303,0.33108,MIR4689,0.965789383130508
GSE10325_BCELL_VS_LUPUS_BCEL...1,SET,186,0.026802,0.0026839,0.061348,0.3311,GSE10325_BCELL_VS_LUPUS_BCELL_DN,0.965789383130508
GSE7852_LN_VS_THYMUS_TCONV_UP,SET,177,0.02829,0.0027642,0.064786,0.33118,GSE7852_LN_VS_THYMUS_TCONV_UP,0.965834511826875
GOCC_MITOTIC_SPINDLE_ASTRAL_...,SET,7,0.13649,0.0026645,0.31258,0.33119,GOCC_MITOTIC_SPINDLE_ASTRAL_MICROTUBULE,0.965834511826875
BIOCARTA_PITX2_PATHWAY,SET,15,0.093827,0.0026807,0.21498,0.33126,BIOCARTA_PITX2_PATHWAY,0.965834511826875
HP_ERYSIPELAS,SET,11,0.1178,0.0028825,0.26994,0.33127,HP_ERYSIPELAS,0.965834511826875
GSE22229_UNTREATED_VS_IMMUNO...1,SET,180,0.028524,0.0028104,0.06536,0.33127,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN,0.965834511826875
GOBP_SISTER_CHROMATID_SEGREG...,SET,218,0.02386,0.0025844,0.054684,0.3313,GOBP_SISTER_CHROMATID_SEGREGATION,0.965834511826875
GOBP_SKELETAL_MUSCLE_ATROPHY,SET,5,0.16976,0.0028009,0.38908,0.33131,GOBP_SKELETAL_MUSCLE_ATROPHY,0.965834511826875
BCAT_GDS748_UP,SET,45,0.058004,0.002868,0.13302,0.3314,BCAT_GDS748_UP,0.965941270440252
AIZARANI_LIVER_C4_EPCAM_POS_...,SET,178,0.029463,0.0028868,0.067568,0.33141,AIZARANI_LIVER_C4_EPCAM_POS_BILE_DUCT_CELLS_1,0.965941270440252
HP_ABNORMAL_PELVIS_BONE_MORP...,SET,18,0.084606,0.0026477,0.19406,0.33143,HP_ABNORMAL_PELVIS_BONE_MORPHOLOGY,0.965941270440252
LET_7E_3P,SET,4,0.19683,0.0029048,0.45176,0.33153,LET_7E_3P,0.966047975352113
GOBP_POSITIVE_REGULATION_OF_...53,SET,7,0.14885,0.0029058,0.34163,0.33153,GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.966047975352113
MIR367_3P,SET,385,0.019081,0.0027338,0.043798,0.33155,MIR367_3P,0.966047975352113
GOBP_AMYLOID_PRECURSOR_PROTE...3,SET,70,0.04367,0.0026913,0.10031,0.33165,GOBP_AMYLOID_PRECURSOR_PROTEIN_METABOLIC_PROCESS,0.966212886597938
MED25_TARGET_GENES,SET,76,0.040814,0.0026204,0.093757,0.33167,MED25_TARGET_GENES,0.966212886597938
BASSO_CD40_SIGNALING_DN,SET,64,0.048421,0.0028538,0.11124,0.33169,BASSO_CD40_SIGNALING_DN,0.966212886597938
GSE37416_CTRL_VS_0H_F_TULARE...1,SET,133,0.03249,0.0027552,0.074692,0.33179,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.966423185551458
IZADPANAH_STEM_CELL_ADIPOSE_...1,SET,97,0.038407,0.0027842,0.088344,0.33188,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,0.966467878381774
MIR4266,SET,74,0.041479,0.002628,0.09541,0.33188,MIR4266,0.966467878381774
GOBP_ASYMMETRIC_CELL_DIVISION,SET,18,0.090952,0.0028464,0.20922,0.33189,GOBP_ASYMMETRIC_CELL_DIVISION,0.966467878381774
REACTOME_GLUCURONIDATION,SET,23,0.1096,0.0038767,0.25223,0.33195,REACTOME_GLUCURONIDATION,0.966467878381774
HP_EYELID_MYOCLONIA_SEIZURE,SET,7,0.12184,0.0023785,0.28043,0.33198,HP_EYELID_MYOCLONIA_SEIZURE,0.966467878381774
GOBP_RESPIRATORY_BURST_INVOL...1,SET,14,0.10199,0.0028152,0.23477,0.33199,GOBP_RESPIRATORY_BURST_INVOLVED_IN_DEFENSE_RESPONSE,0.966467878381774
MIR6814_3P_MIR6872_5P,SET,7,0.13875,0.0027087,0.31941,0.332,MIR6814_3P_MIR6872_5P,0.966467878381774
MIR3907,SET,49,0.054016,0.0027867,0.12443,0.33211,MIR3907,0.966479836820084
GSE4984_GALECTIN1_VS_LPS_STI...2,SET,144,0.029237,0.002579,0.067388,0.3322,GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP,0.966479836820084
GOBP_G_PROTEIN_COUPLED_RECEP...3,SET,54,0.05513,0.0029853,0.12708,0.33221,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER,0.966479836820084
SU_SALIVARY_GLAND,SET,10,0.11838,0.0027619,0.27288,0.33222,SU_SALIVARY_GLAND,0.966479836820084
GOBP_REGULATION_OF_NUCLEAR_T...2,SET,11,0.10179,0.0024908,0.23467,0.33223,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,0.966479836820084
GOBP_CELLULAR_RESPONSE_TO_CA...2,SET,10,0.10983,0.0025624,0.2532,0.33224,GOBP_CELLULAR_RESPONSE_TO_CAFFEINE,0.966479836820084
GSE7460_CTRL_VS_FOXP3_OVEREX...2,SET,171,0.027525,0.0026439,0.063464,0.33225,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP,0.966479836820084
HP_FRECKLING,SET,46,0.048229,0.002411,0.11122,0.33228,HP_FRECKLING,0.966479836820084
MORF_RAD21,SET,158,0.026056,0.0024067,0.060098,0.3323,MORF_RAD21,0.966479836820084
GOBP_CENTROMERIC_SISTER_CHRO...,SET,9,0.1468,0.0032494,0.33861,0.33231,GOBP_CENTROMERIC_SISTER_CHROMATID_COHESION,0.966479836820084
DESCARTES_FETAL_PANCREAS_ISL...,SET,117,0.037704,0.0030002,0.086966,0.33231,DESCARTES_FETAL_PANCREAS_ISLET_ENDOCRINE_CELLS,0.966479836820084
FLOTHO_PEDIATRIC_ALL_THERAPY...2,SET,50,0.0493,0.0025692,0.11376,0.33238,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,0.96660253535269
GSE25123_WT_VS_PPARG_KO_MACR...3,SET,161,0.028493,0.0026564,0.065785,0.33247,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_UP,0.966731565297415
KORKOLA_CHORIOCARCINOMA_DN,SET,8,0.15061,0.003143,0.34775,0.33248,KORKOLA_CHORIOCARCINOMA_DN,0.966731565297415
NABA_MATRISOME_METASTATIC_CO...,SET,26,0.082246,0.0030927,0.19,0.33255,NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS,0.96676597425395
HP_DELAYED_EARLY_CHILDHOOD_S...,SET,20,0.077007,0.0025401,0.17791,0.33257,HP_DELAYED_EARLY_CHILDHOOD_SOCIAL_MILESTONE_DEVELOPMENT,0.96676597425395
DROSHA_TARGET_GENES,SET,36,0.057713,0.002553,0.13339,0.33263,DROSHA_TARGET_GENES,0.96676597425395
GOBP_TYPE_II_INTERFERON_MEDI...,SET,26,0.069502,0.0026135,0.16066,0.33265,GOBP_TYPE_II_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.96676597425395
GOMF_GAP_JUNCTION_CHANNEL_AC...2,SET,5,0.16311,0.0026912,0.37709,0.33268,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_CONDUCTION_ELECTRICAL_COUPLING,0.96676597425395
WP_KREBS_CYCLE_DISORDERS,SET,13,0.10524,0.0027993,0.24338,0.33272,WP_KREBS_CYCLE_DISORDERS,0.96676597425395
YY1_Q6,SET,221,0.024234,0.0026426,0.05604,0.33272,YY1_Q6,0.96676597425395
HP_CEREBRAL_HYPOMYELINATION,SET,25,0.065714,0.0024232,0.152,0.33276,HP_CEREBRAL_HYPOMYELINATION,0.96676597425395
GOBP_REGULATION_OF_MYOTUBE_D...,SET,40,0.060805,0.002835,0.14066,0.33277,GOBP_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.96676597425395
GSE33425_CD8_ALPHAALPHA_VS_A...1,SET,182,0.026379,0.0026133,0.061022,0.33277,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,0.96676597425395
GOBP_REGULATION_OF_PROTEIN_G...,SET,11,0.10728,0.0026251,0.24826,0.33282,GOBP_REGULATION_OF_PROTEIN_GLYCOSYLATION,0.966791338681374
GOBP_CARDIAC_PACEMAKER_CELL_...1,SET,9,0.13221,0.0029265,0.30607,0.33288,GOBP_CARDIAC_PACEMAKER_CELL_DEVELOPMENT,0.966791338681374
HOEK_MYELOID_DENDRITIC_CELL_...5,SET,6,0.14544,0.0026287,0.33668,0.33288,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_DN,0.966791338681374
MODULE_448,SET,40,0.052805,0.002462,0.12224,0.33289,MODULE_448,0.966791338681374
HP_PROXIMAL_MUSCLE_WEAKNESS_...2,SET,54,0.049403,0.0026752,0.11439,0.33292,HP_PROXIMAL_MUSCLE_WEAKNESS_IN_UPPER_LIMBS,0.966797677139037
GOMF_GAMMA_AMINOBUTYRIC_ACID...2,SET,7,0.16873,0.003294,0.39082,0.33297,GOMF_GAMMA_AMINOBUTYRIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.966862089564709
AP1_01,SET,235,0.023983,0.0026958,0.055566,0.33301,AP1_01,0.966897456140351
REACTOME_ORGANIC_ANION_TRANS...1,SET,5,0.15356,0.0025336,0.35591,0.33307,REACTOME_ORGANIC_ANION_TRANSPORT,0.966990882131819
LIEN_BREAST_CARCINOMA_METAPL...2,SET,104,0.035132,0.0026365,0.081512,0.33324,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,0.967136942121388
GSE42724_NAIVE_VS_B1_BCELL_DN,SET,170,0.026614,0.002549,0.061765,0.33328,GSE42724_NAIVE_VS_B1_BCELL_DN,0.967136942121388
GOBP_NUCLEOSIDE_METABOLIC_PR...,SET,50,0.056059,0.0029214,0.13011,0.33329,GOBP_NUCLEOSIDE_METABOLIC_PROCESS,0.967136942121388
GOMF_VITAMIN_B6_BINDING,SET,48,0.054808,0.0027987,0.12723,0.33331,GOMF_VITAMIN_B6_BINDING,0.967136942121388
MENON_FETAL_KIDNEY_6_COLLECT...,SET,84,0.042007,0.0028348,0.097516,0.33332,MENON_FETAL_KIDNEY_6_COLLECTING_DUCT_CELLS,0.967136942121388
WP_INTEGRATED_CANCER_PATHWAY,SET,43,0.05379,0.0026001,0.12488,0.33333,WP_INTEGRATED_CANCER_PATHWAY,0.967136942121388
MODULE_264,SET,10,0.11041,0.0025761,0.25646,0.33341,MODULE_264,0.967136942121388
HP_ABNORMAL_VASCULAR_MORPHOL...,SET,1014,0.01173,0.0026793,0.027251,0.33344,HP_ABNORMAL_VASCULAR_MORPHOLOGY,0.967136942121388
REACTOME_DISEASES_OF_HEMOSTA...,SET,17,0.093945,0.0028572,0.21837,0.33353,REACTOME_DISEASES_OF_HEMOSTASIS,0.967136942121388
HP_HYPOPLASTIC_IRIS_STROMA,SET,8,0.1555,0.0032452,0.36148,0.33353,HP_HYPOPLASTIC_IRIS_STROMA,0.967136942121388
HP_PROSTATE_CANCER,SET,32,0.066779,0.0027854,0.15523,0.33353,HP_PROSTATE_CANCER,0.967136942121388
HP_POSTERIORLY_ROTATED_EARS,SET,397,0.018086,0.0026306,0.042053,0.33357,HP_POSTERIORLY_ROTATED_EARS,0.967136942121388
GOBP_REGULATION_OF_HORMONE_S...,SET,243,0.02467,0.0028192,0.057365,0.33358,GOBP_REGULATION_OF_HORMONE_SECRETION,0.967136942121388
MIR1_3P,SET,337,0.019726,0.0026477,0.045891,0.33366,MIR1_3P,0.967136942121388
HP_LAGOPHTHALMOS,SET,12,0.09494,0.0024263,0.22097,0.33372,HP_LAGOPHTHALMOS,0.967136942121388
HP_CONFUSION,SET,68,0.043153,0.0026212,0.10044,0.33373,HP_CONFUSION,0.967136942121388
BHAT_ESR1_TARGETS_VIA_AKT1_DN,SET,79,0.042942,0.0028107,0.10007,0.33391,BHAT_ESR1_TARGETS_VIA_AKT1_DN,0.967136942121388
KEGG_PROTEIN_EXPORT,SET,22,0.073211,0.0025327,0.17066,0.33397,KEGG_PROTEIN_EXPORT,0.967136942121388
GSE17721_LPS_VS_CPG_12H_BMDC...2,SET,178,0.027731,0.0027172,0.064656,0.334,GSE17721_LPS_VS_CPG_12H_BMDC_UP,0.967136942121388
FARMER_BREAST_CANCER_BASAL_V...,SET,292,0.021379,0.0026745,0.04986,0.33405,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,0.967136942121388
FOXD2_TARGET_GENES,SET,994,0.011442,0.0025893,0.026687,0.33405,FOXD2_TARGET_GENES,0.967136942121388
GOBP_SENSORY_PERCEPTION_OF_P...,SET,73,0.044752,0.0028162,0.10437,0.33405,GOBP_SENSORY_PERCEPTION_OF_PAIN,0.967136942121388
MIR4483,SET,85,0.040477,0.0027477,0.094423,0.33408,MIR4483,0.967136942121388
HP_ABDOMINAL_WALL_MUSCLE_WEA...,SET,14,0.092413,0.0025509,0.21557,0.33408,HP_ABDOMINAL_WALL_MUSCLE_WEAKNESS,0.967136942121388
GOBP_HOMOCYSTEINE_METABOLIC_...,SET,11,0.10407,0.0025466,0.24281,0.3341,GOBP_HOMOCYSTEINE_METABOLIC_PROCESS,0.967136942121388
GAVISH_3CA_METAPROGRAM_B_CEL...4,SET,45,0.05294,0.0026176,0.12352,0.33412,GAVISH_3CA_METAPROGRAM_B_CELLS_HSP_STRESS,0.967136942121388
GOBP_NEGATIVE_REGULATION_OF_...521,SET,15,0.092675,0.0026478,0.21628,0.33415,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,0.967136942121388
NAKAYA_PBMC_FLUARIX_FLUVIRIN...5,SET,315,0.019639,0.0025502,0.045836,0.33416,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE,0.967136942121388
KEGG_MEDICUS_REFERENCE_REGUL...8,SET,19,0.091391,0.0029384,0.21331,0.33417,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PTP,0.967136942121388
WP_ONECARBON_METABOLISM,SET,29,0.062809,0.0024942,0.14662,0.33419,WP_ONECARBON_METABOLISM,0.967136942121388
GCANCTGNY_MYOD_Q6,SET,845,0.012869,0.0026965,0.030044,0.3342,GCANCTGNY_MYOD_Q6,0.967136942121388
HE_LIM_SUN_FETAL_LUNG_C3_CYC...,SET,388,0.017815,0.0025623,0.041591,0.3342,HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST,0.967136942121388
GOBP_REGULATION_OF_THYMOCYTE...,SET,13,0.1013,0.0026945,0.23657,0.33426,GOBP_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS,0.967136942121388
GOMF_SCAVENGER_RECEPTOR_ACTI...,SET,25,0.072474,0.0026724,0.16927,0.33428,GOMF_SCAVENGER_RECEPTOR_ACTIVITY,0.967136942121388
GOBP_TELOMERE_MAINTENANCE_VI...3,SET,74,0.038197,0.00242,0.089227,0.3343,GOBP_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.967136942121388
GOCC_MRE11_COMPLEX,SET,3,0.18724,0.0023932,0.43739,0.3343,GOCC_MRE11_COMPLEX,0.967136942121388
GSE37605_FOXP3_FUSION_GFP_VS...1,SET,157,0.029406,0.0027075,0.068728,0.33438,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN,0.967136942121388
MODULE_243,SET,71,0.042842,0.0026589,0.10014,0.33439,MODULE_243,0.967136942121388
HP_ABNORMAL_CONNECTION_OF_TH...,SET,234,0.023782,0.0026676,0.055592,0.3344,HP_ABNORMAL_CONNECTION_OF_THE_CARDIAC_SEGMENTS,0.967136942121388
GSE36078_WT_VS_IL1R_KO_LUNG_...3,SET,180,0.027055,0.0026656,0.063246,0.33441,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN,0.967136942121388
KEGG_MEDICUS_REFERENCE_AUTOP...3,SET,5,0.15694,0.0025894,0.3669,0.33442,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TRANS_SNARE,0.967136942121388
WP_PROLACTIN_SIGNALING,SET,72,0.045174,0.0028232,0.10561,0.33443,WP_PROLACTIN_SIGNALING,0.967136942121388
MIR4649_5P,SET,8,0.11874,0.002478,0.27761,0.33443,MIR4649_5P,0.967136942121388
HP_BILATERAL_CHOANAL_ATRESIA,SET,9,0.10099,0.0022353,0.23614,0.33445,HP_BILATERAL_CHOANAL_ATRESIA,0.967136942121388
HU_FETAL_RETINA_RPE,SET,252,0.02454,0.0028552,0.057382,0.33445,HU_FETAL_RETINA_RPE,0.967136942121388
GSE12366_GC_VS_NAIVE_BCELL_DN,SET,171,0.028106,0.0026997,0.065725,0.33446,GSE12366_GC_VS_NAIVE_BCELL_DN,0.967136942121388
REACTOME_TGFBR3_REGULATES_TG...,SET,8,0.1324,0.002763,0.30968,0.3345,REACTOME_TGFBR3_REGULATES_TGF_BETA_SIGNALING,0.967136942121388
GOBP_REGULATION_OF_SECONDARY...1,SET,8,0.13975,0.0029164,0.3269,0.33451,GOBP_REGULATION_OF_SECONDARY_HEART_FIELD_CARDIOBLAST_PROLIFERATION,0.967136942121388
chr8p11,SET,50,0.095812,0.004993,0.22414,0.33452,chr8p11,0.967136942121388
GSE27241_CTRL_VS_DIGOXIN_TRE...1,SET,176,0.027583,0.0026875,0.06453,0.33453,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,0.967136942121388
WANG_PROSTATE_CANCER_ANDROGE...,SET,58,0.048707,0.0027332,0.114,0.3346,WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,0.967136942121388
GSE5589_LPS_VS_LPS_AND_IL10_...10,SET,180,0.026902,0.0026505,0.06297,0.33461,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.967136942121388
GSE19198_1H_VS_24H_IL21_TREA...1,SET,182,0.027309,0.0027054,0.063926,0.33462,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN,0.967136942121388
GSE7460_TCONV_VS_TREG_THYMUS...1,SET,184,0.027405,0.0027296,0.06418,0.33469,GSE7460_TCONV_VS_TREG_THYMUS_DN,0.967136942121388
REACTOME_CALCINEURIN_ACTIVAT...,SET,9,0.11003,0.0024355,0.25772,0.33471,REACTOME_CALCINEURIN_ACTIVATES_NFAT,0.967136942121388
MIR9851_5P,SET,103,0.034513,0.0025777,0.080838,0.33472,MIR9851_5P,0.967136942121388
WP_IMMUNE_RESPONSE_TO_TUBERC...,SET,22,0.075626,0.0026162,0.17717,0.33475,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.967136942121388
GSE45739_NRAS_KO_VS_WT_ACD3_...1,SET,166,0.027492,0.0026022,0.064411,0.33476,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN,0.967136942121388
MODULE_403,SET,43,0.053681,0.0025948,0.12582,0.33482,MODULE_403,0.967136942121388
HSF2_01,SET,229,0.023956,0.0026587,0.056155,0.33483,HSF2_01,0.967136942121388
GOMF_INOSITOL_POLYPHOSPHATE_...,SET,6,0.1328,0.0024002,0.31147,0.33492,GOMF_INOSITOL_POLYPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.967136942121388
REACTOME_PROCESSIVE_SYNTHESI...2,SET,14,0.083811,0.0023134,0.19658,0.33493,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND,0.967136942121388
WP_SELENIUM_METABOLISM_AND_S...,SET,34,0.063884,0.0027465,0.14985,0.33494,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,0.967136942121388
HP_ABSENCE_OF_SECONDARY_SEX_...,SET,40,0.060448,0.0028183,0.14183,0.33499,HP_ABSENCE_OF_SECONDARY_SEX_CHARACTERISTICS,0.967136942121388
MORF_PAPSS1,SET,97,0.034686,0.0025145,0.081415,0.33504,MORF_PAPSS1,0.967136942121388
KEGG_MELANOMA,SET,68,0.046428,0.0028202,0.10898,0.33505,KEGG_MELANOMA,0.967136942121388
MODY_HIPPOCAMPUS_PRENATAL,SET,42,0.051702,0.00247,0.12137,0.33506,MODY_HIPPOCAMPUS_PRENATAL,0.967136942121388
GOMF_L_LEUCINE_BINDING,SET,6,0.13073,0.0023628,0.30697,0.33511,GOMF_L_LEUCINE_BINDING,0.967136942121388
MIR10B_3P,SET,72,0.042003,0.0026251,0.098645,0.33513,MIR10B_3P,0.967136942121388
GOBP_NEGATIVE_REGULATION_OF_...399,SET,214,0.024087,0.0025852,0.056576,0.33515,GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,0.967136942121388
GOBP_XENOBIOTIC_TRANSMEMBRAN...,SET,17,0.089975,0.0027365,0.21137,0.33518,GOBP_XENOBIOTIC_TRANSMEMBRANE_TRANSPORT,0.967136942121388
GSE369_PRE_VS_POST_IL6_INJEC...4,SET,177,0.027761,0.0027125,0.065221,0.33518,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP,0.967136942121388
KEGG_MEDICUS_PATHOGEN_SARS_C...3,SET,3,0.30494,0.0038975,0.71699,0.33531,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE,0.967136942121388
GOBP_ATRIAL_CARDIAC_MUSCLE_C...1,SET,8,0.13571,0.0028322,0.31915,0.33534,GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.967136942121388
MIR598_3P,SET,10,0.12156,0.0028362,0.28594,0.33537,MIR598_3P,0.967136942121388
GOBP_TRANSLATIONAL_ELONGATION,SET,59,0.042398,0.0023995,0.099742,0.33539,GOBP_TRANSLATIONAL_ELONGATION,0.967136942121388
GOBP_POSITIVE_REGULATION_OF_...533,SET,9,0.1262,0.0027933,0.29691,0.33541,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION,0.967136942121388
GOBP_NEGATIVE_REGULATION_OF_...225,SET,4,0.17463,0.0025773,0.41095,0.33544,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.967136942121388
GOBP_OLFACTORY_BULB_INTERNEU...1,SET,7,0.15633,0.0030517,0.3679,0.33545,GOBP_OLFACTORY_BULB_INTERNEURON_DEVELOPMENT,0.967136942121388
GOBP_ASTROCYTE_CELL_MIGRATION,SET,9,0.1308,0.0028952,0.30787,0.33547,GOBP_ASTROCYTE_CELL_MIGRATION,0.967136942121388
HAY_BONE_MARROW_CD34_POS_GRAN,SET,24,0.076654,0.0027695,0.18045,0.3355,HAY_BONE_MARROW_CD34_POS_GRAN,0.967136942121388
DE_YY1_TARGETS_DN,SET,88,0.038508,0.0026595,0.09069,0.33556,DE_YY1_TARGETS_DN,0.967136942121388
GSE7460_CD8_TCELL_VS_CD4_TCE...1,SET,191,0.026156,0.0026538,0.061607,0.33558,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN,0.967136942121388
WP_ARYL_HYDROCARBON_RECEPTOR...2,SET,45,0.053585,0.0026495,0.12623,0.3356,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,0.967136942121388
HOQUE_METHYLATED_IN_CANCER,SET,55,0.04953,0.0027068,0.11669,0.33562,HOQUE_METHYLATED_IN_CANCER,0.967136942121388
GSE24634_IL4_VS_CTRL_TREATED...4,SET,184,0.027152,0.0027044,0.063982,0.33565,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP,0.967136942121388
GOBP_DETECTION_OF_EXTERNAL_B...,SET,23,0.077813,0.0027523,0.18337,0.33566,GOBP_DETECTION_OF_EXTERNAL_BIOTIC_STIMULUS,0.967136942121388
MIR4265,SET,36,0.06533,0.00289,0.15398,0.33568,MIR4265,0.967136942121388
GOBP_DIET_INDUCED_THERMOGENE...,SET,13,0.10253,0.0027273,0.24174,0.33573,GOBP_DIET_INDUCED_THERMOGENESIS,0.967136942121388
GOBP_IMPORT_INTO_THE_MITOCHO...,SET,45,0.050435,0.0024938,0.11892,0.33574,GOBP_IMPORT_INTO_THE_MITOCHONDRION,0.967136942121388
GOBP_TRANS_SYNAPTIC_SIGNALIN...2,SET,7,0.15118,0.0029513,0.35648,0.33575,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_LIPID,0.967136942121388
REACTOME_HDL_ASSEMBLY,SET,7,0.12551,0.0024501,0.29617,0.33587,REACTOME_HDL_ASSEMBLY,0.967136942121388
GOBP_NEGATIVE_REGULATION_OF_...89,SET,9,0.12202,0.0027008,0.28794,0.33587,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.967136942121388
HP_PROMINENT_FOREHEAD,SET,221,0.023225,0.0025326,0.054805,0.33587,HP_PROMINENT_FOREHEAD,0.967136942121388
WP_IL7_SIGNALING,SET,24,0.081179,0.002933,0.19158,0.33588,WP_IL7_SIGNALING,0.967136942121388
HP_TORSADE_DE_POINTES,SET,24,0.074205,0.0026811,0.17512,0.33588,HP_TORSADE_DE_POINTES,0.967136942121388
REACTOME_NOTCH3_ACTIVATION_A...,SET,23,0.074072,0.00262,0.17485,0.33591,REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,0.967136942121388
HOWARD_PBMC_INACT_MONOV_INFL...2,SET,333,0.021228,0.0028328,0.050112,0.33592,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP,0.967136942121388
GOBP_POSITIVE_REGULATION_OF_...251,SET,9,0.13851,0.0030658,0.32701,0.33594,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_WOUND_HEALING,0.967136942121388
GOCC_MKS_COMPLEX,SET,13,0.083631,0.0022245,0.19745,0.33595,GOCC_MKS_COMPLEX,0.967136942121388
RASHI_RESPONSE_TO_IONIZING_R...6,SET,72,0.040281,0.0025175,0.095119,0.33598,RASHI_RESPONSE_TO_IONIZING_RADIATION_6,0.967136942121388
BOYLAN_MULTIPLE_MYELOMA_PCA3...2,SET,75,0.045984,0.0029329,0.1086,0.336,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,0.967136942121388
GOBP_REGULATION_OF_TRANSLATI...8,SET,5,0.1691,0.0027901,0.39941,0.33601,GOBP_REGULATION_OF_TRANSLATION_AT_POSTSYNAPSE,0.967136942121388
GSE37301_PRO_BCELL_VS_CD4_TC...2,SET,155,0.028605,0.0026171,0.067583,0.33606,GSE37301_PRO_BCELL_VS_CD4_TCELL_UP,0.967136942121388
GOBP_POST_TRANSLATIONAL_PROT...3,SET,8,0.13595,0.0028371,0.32122,0.33607,GOBP_POST_TRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_TRANSLOCATION,0.967136942121388
GOMF_TRACE_AMINE_RECEPTOR_AC...,SET,6,0.2187,0.0039528,0.51675,0.33607,GOMF_TRACE_AMINE_RECEPTOR_ACTIVITY,0.967136942121388
HP_ABNORMALITY_OF_NEUTROPHIL...,SET,14,0.094251,0.0026016,0.22276,0.33611,HP_ABNORMALITY_OF_NEUTROPHIL_PHYSIOLOGY,0.96717196969697
MIR10401_3P,SET,6,0.14081,0.002545,0.33291,0.33616,MIR10401_3P,0.967235764550046
FINETTI_BREAST_CANCER_KINOME...1,SET,14,0.1028,0.0028375,0.24321,0.33627,FINETTI_BREAST_CANCER_KINOME_GREEN,0.967306792062836
ZNF7_TARGET_GENES,SET,679,0.014079,0.002657,0.03332,0.33632,ZNF7_TARGET_GENES,0.967306792062836
GOMF_CYCLASE_INHIBITOR_ACTIV...,SET,4,0.16353,0.0024134,0.387,0.33632,GOMF_CYCLASE_INHIBITOR_ACTIVITY,0.967306792062836
MIR124_3P,SET,691,0.013853,0.0026363,0.032793,0.33636,MIR124_3P,0.967306792062836
GOBP_REGULATION_OF_EXECUTION...,SET,22,0.079606,0.0027539,0.18849,0.33639,GOBP_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,0.967306792062836
APPIERTO_RESPONSE_TO_FENRETI...2,SET,37,0.054579,0.0024476,0.12927,0.33643,APPIERTO_RESPONSE_TO_FENRETINIDE_UP,0.967306792062836
HP_CHILDHOOD_ONSET_TRUNCAL_O...,SET,30,0.064666,0.0026117,0.15317,0.33645,HP_CHILDHOOD_ONSET_TRUNCAL_OBESITY,0.967306792062836
KYNG_ENVIRONMENTAL_STRESS_RE...4,SET,29,0.066525,0.0026418,0.15759,0.33647,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,0.967306792062836
AP1_C,SET,249,0.022194,0.002567,0.052583,0.33649,AP1_C,0.967306792062836
GSE25123_IL4_VS_IL4_AND_ROSI...2,SET,190,0.026959,0.0027282,0.06388,0.33651,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,0.967306792062836
BOYLAN_MULTIPLE_MYELOMA_C_CL...2,SET,35,0.059245,0.0025842,0.14042,0.33654,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP,0.967306792062836
GOBP_4FE_4S_CLUSTER_ASSEMBLY,SET,4,0.17775,0.0026233,0.42137,0.33657,GOBP_4FE_4S_CLUSTER_ASSEMBLY,0.967306792062836
HP_ENLARGED_CISTERNA_MAGNA,SET,52,0.045038,0.0023934,0.10677,0.33658,HP_ENLARGED_CISTERNA_MAGNA,0.967306792062836
HP_DECREASED_CIRCULATING_MET...,SET,8,0.13367,0.0027896,0.31694,0.33661,HP_DECREASED_CIRCULATING_METHYLCOBALAMIN_CONCENTRATION,0.967306792062836
GOBP_PROTEIN_KINASE_A_SIGNAL...,SET,37,0.061879,0.002775,0.14674,0.33663,GOBP_PROTEIN_KINASE_A_SIGNALING,0.967306792062836
GSE22103_UNSTIM_VS_LPS_STIM_...2,SET,188,0.025373,0.0025543,0.06017,0.33663,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP,0.967306792062836
NIKOLSKY_BREAST_CANCER_20P13...,SET,7,0.17887,0.0034918,0.42428,0.33667,NIKOLSKY_BREAST_CANCER_20P13_AMPLICON,0.967328414332784
MIR1179,SET,108,0.033477,0.0025599,0.07944,0.33673,MIR1179,0.967328414332784
GSE23114_WT_VS_SLE2C1_MOUSE_...4,SET,191,0.024847,0.002521,0.058965,0.33674,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP,0.967328414332784
GOBP_POSITIVE_REGULATION_OF_...95,SET,769,0.013359,0.002676,0.031729,0.33687,GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY,0.967328414332784
GOCC_CLATHRIN_SCULPTED_VESIC...,SET,12,0.11168,0.0028541,0.2653,0.3369,GOCC_CLATHRIN_SCULPTED_VESICLE,0.967328414332784
REACTOME_GPER1_SIGNALING,SET,45,0.053729,0.0026567,0.12766,0.33693,REACTOME_GPER1_SIGNALING,0.967328414332784
GOBP_MYELOID_LEUKOCYTE_MIGRA...,SET,217,0.026457,0.0028592,0.06292,0.33707,GOBP_MYELOID_LEUKOCYTE_MIGRATION,0.967328414332784
GOMF_SULFATE_TRANSMEMBRANE_T...,SET,15,0.09188,0.0026251,0.21857,0.33711,GOMF_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.967328414332784
GSE360_L_MAJOR_VS_T_GONDII_M...1,SET,177,0.025304,0.0024724,0.060204,0.33713,GSE360_L_MAJOR_VS_T_GONDII_MAC_DN,0.967328414332784
HP_LOW_SERUM_CALCITRIOL,SET,7,0.14217,0.0027754,0.33829,0.33715,HP_LOW_SERUM_CALCITRIOL,0.967328414332784
GOBP_POSITIVE_REGULATION_OF_...102,SET,8,0.12718,0.0026542,0.30269,0.33718,GOBP_POSITIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.967328414332784
GOMF_NUCLEOBASE_CONTAINING_C...1,SET,40,0.054997,0.0025642,0.13096,0.33726,GOMF_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY,0.967328414332784
HP_TALIPES_CALCANEOVALGUS,SET,13,0.091561,0.0024355,0.21803,0.33726,HP_TALIPES_CALCANEOVALGUS,0.967328414332784
GSE3982_CENT_MEMORY_CD4_TCEL...5,SET,184,0.024703,0.0024605,0.058824,0.33726,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN,0.967328414332784
MIR4633_3P_MIR6500_5P,SET,32,0.061501,0.0025652,0.14645,0.33727,MIR4633_3P_MIR6500_5P,0.967328414332784
REACTOME_MATURATION_OF_PROTE...,SET,9,0.12252,0.0027119,0.2918,0.33729,REACTOME_MATURATION_OF_PROTEIN_3A,0.967328414332784
GOBP_PEROXISOME_ORGANIZATION,SET,30,0.062574,0.0025273,0.14904,0.3373,GOBP_PEROXISOME_ORGANIZATION,0.967328414332784
GOBP_POSITIVE_REGULATION_OF_...118,SET,10,0.09863,0.0023011,0.23501,0.33736,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.967328414332784
GOBP_REGULATION_OF_KETONE_BI...,SET,19,0.081638,0.0026248,0.19453,0.33736,GOBP_REGULATION_OF_KETONE_BIOSYNTHETIC_PROCESS,0.967328414332784
GSE37301_CD4_TCELL_VS_GRANUL...1,SET,170,0.028191,0.0027,0.067183,0.33739,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.967328414332784
FLORIO_NEOCORTEX_BASAL_RADIA...2,SET,339,0.020553,0.0027668,0.048985,0.3374,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,0.967328414332784
GSE25085_FETAL_BM_VS_ADULT_B...2,SET,186,0.026743,0.002678,0.06374,0.3374,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,0.967328414332784
ZAIDI_OSTEOBLAST_TRANSCRIPTI...,SET,13,0.10906,0.0029009,0.26,0.33744,ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS,0.967328414332784
BIOCARTA_PTDINS_PATHWAY,SET,22,0.067635,0.0023398,0.16126,0.33746,BIOCARTA_PTDINS_PATHWAY,0.967328414332784
GOBP_NEGATIVE_REGULATION_OF_...71,SET,8,0.12186,0.002543,0.29059,0.33749,GOBP_NEGATIVE_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.967328414332784
GOBP_POSITIVE_REGULATION_OF_...521,SET,270,0.02291,0.0027577,0.054639,0.3375,GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.967328414332784
KEGG_MEDICUS_VARIANT_MUTATIO...35,SET,8,0.12554,0.0026199,0.29947,0.33754,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006,0.967328414332784
GOBP_PROTEIN_HOMOOLIGOMERIZA...,SET,190,0.026303,0.0026618,0.062746,0.33754,GOBP_PROTEIN_HOMOOLIGOMERIZATION,0.967328414332784
GOBP_REGULATION_OF_OOCYTE_MA...,SET,7,0.12399,0.0024205,0.29579,0.33754,GOBP_REGULATION_OF_OOCYTE_MATURATION,0.967328414332784
GSE26488_CTRL_VS_PEPTIDE_INJ...2,SET,188,0.027183,0.0027365,0.064848,0.33754,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP,0.967328414332784
HP_APLASIA_OF_THE_PECTORALIS...,SET,4,0.17912,0.0026435,0.42736,0.33756,HP_APLASIA_OF_THE_PECTORALIS_MAJOR_MUSCLE,0.967328414332784
chr22q13,SET,177,0.052271,0.0051074,0.12473,0.33758,chr22q13,0.967328414332784
GSE10240_IL22_VS_IL17_STIM_P...2,SET,171,0.02594,0.0024916,0.061905,0.3376,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.967328414332784
RUBENSTEIN_SKELETAL_MUSCLE_P...2,SET,116,0.033748,0.0026739,0.080553,0.33763,RUBENSTEIN_SKELETAL_MUSCLE_PERICYTES,0.967328414332784
chr19p12,SET,29,0.10694,0.0042468,0.25535,0.33768,chr19p12,0.967328414332784
GOMF_TELOMERASE_RNA_BINDING,SET,20,0.0749,0.0024706,0.17887,0.33771,GOMF_TELOMERASE_RNA_BINDING,0.967328414332784
GOBP_RESPONSE_TO_COCAINE,SET,54,0.050103,0.0027132,0.11967,0.33772,GOBP_RESPONSE_TO_COCAINE,0.967328414332784
GSE12963_UNINF_VS_ENV_AND_NE...2,SET,119,0.032052,0.002572,0.076559,0.33774,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.967328414332784
LANDIS_ERBB2_BREAST_TUMORS_3...1,SET,141,0.030859,0.0026938,0.073718,0.33775,LANDIS_ERBB2_BREAST_TUMORS_324_DN,0.967328414332784
HP_ABNORMAL_GLOMERULAR_MESAN...,SET,44,0.052723,0.0025778,0.12596,0.33777,HP_ABNORMAL_GLOMERULAR_MESANGIUM_MORPHOLOGY,0.967328414332784
MIR492,SET,23,0.072674,0.0025705,0.17367,0.3378,MIR492,0.967328414332784
HP_ULNAR_DEVIATION_OF_FINGER,SET,33,0.063358,0.0026836,0.15143,0.33783,HP_ULNAR_DEVIATION_OF_FINGER,0.967328414332784
MIR122B_5P,SET,195,0.024801,0.0025423,0.059281,0.33784,MIR122B_5P,0.967328414332784
HP_ABNORMAL_OSSIFICATION_INV...,SET,23,0.070272,0.0024856,0.16801,0.33788,HP_ABNORMAL_OSSIFICATION_INVOLVING_THE_FEMORAL_HEAD_AND_NECK,0.967328414332784
GOBP_NITRIC_OXIDE_TRANSPORT,SET,3,0.25016,0.0031973,0.59811,0.33789,GOBP_NITRIC_OXIDE_TRANSPORT,0.967328414332784
GSE30971_WBP7_HET_VS_KO_MACR...4,SET,178,0.02681,0.0026269,0.064127,0.33795,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_UP,0.967420496664196
HP_PROLONGED_QTC_INTERVAL,SET,28,0.070041,0.0027331,0.16767,0.33808,HP_PROLONGED_QTC_INTERVAL,0.96756961162657
MIR1249_5P,SET,177,0.026677,0.0026066,0.063888,0.33814,MIR1249_5P,0.96756961162657
GOBP_SYNOVIOCYTE_PROLIFERATI...,SET,2,0.24117,0.002517,0.57772,0.33817,GOBP_SYNOVIOCYTE_PROLIFERATION,0.96756961162657
MIR1250_5P,SET,6,0.13229,0.0023911,0.31697,0.3382,MIR1250_5P,0.96756961162657
KEGG_SMALL_CELL_LUNG_CANCER,SET,80,0.038913,0.002563,0.093254,0.33824,KEGG_SMALL_CELL_LUNG_CANCER,0.96756961162657
GSE20727_ROS_INH_VS_ROS_INH_...1,SET,149,0.029777,0.0026715,0.071365,0.33825,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,0.96756961162657
MODULE_149,SET,34,0.055648,0.0023924,0.13339,0.33827,MODULE_149,0.96756961162657
GSE14000_TRANSLATED_RNA_VS_M...6,SET,178,0.02566,0.0025142,0.061506,0.33827,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP,0.96756961162657
MIR601,SET,34,0.061072,0.0026256,0.14647,0.33836,MIR601,0.96756961162657
GSE21360_NAIVE_VS_TERTIARY_M...1,SET,178,0.025548,0.0025032,0.061321,0.33848,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.96756961162657
MODULE_160,SET,2,0.23646,0.0024678,0.56767,0.33851,MODULE_160,0.96756961162657
GSE13762_CTRL_VS_125_VITAMIN...4,SET,122,0.034034,0.002765,0.081709,0.33851,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP,0.96756961162657
GOBP_REGULATION_OF_RESPONSE_...13,SET,14,0.084884,0.002343,0.2038,0.33852,GOBP_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,0.96756961162657
MIR548AL,SET,10,0.1045,0.002438,0.25095,0.33856,MIR548AL,0.96756961162657
GOBP_EMBRYONIC_HEMOPOIESIS,SET,23,0.07626,0.0026974,0.18313,0.33856,GOBP_EMBRYONIC_HEMOPOIESIS,0.96756961162657
GSE37533_PPARG1_FOXP3_VS_PPA...1,SET,183,0.024872,0.0024707,0.059764,0.33864,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN,0.96756961162657
EMX1_TARGET_GENES,SET,183,0.025963,0.002579,0.062391,0.33866,EMX1_TARGET_GENES,0.96756961162657
GSE10273_LOW_IL7_VS_HIGH_IL7...2,SET,176,0.025944,0.0025279,0.062346,0.33866,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,0.96756961162657
GOMF_DNA_RNA_HYBRID_BINDING,SET,5,0.13975,0.0023058,0.33584,0.33867,GOMF_DNA_RNA_HYBRID_BINDING,0.96756961162657
REACTOME_THE_CANONICAL_RETIN...,SET,22,0.074672,0.0025832,0.17947,0.33869,REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION,0.96756961162657
GOBP_MITOTIC_G2_M_TRANSITION...,SET,46,0.047479,0.0023735,0.11412,0.33869,GOBP_MITOTIC_G2_M_TRANSITION_CHECKPOINT,0.96756961162657
GOMF_BH3_DOMAIN_BINDING,SET,5,0.16819,0.0027752,0.40427,0.33869,GOMF_BH3_DOMAIN_BINDING,0.96756961162657
FLORIO_NEOCORTEX_BASAL_RADIA...1,SET,170,0.027127,0.0025981,0.065215,0.33872,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,0.96756961162657
REACTOME_DISEASES_OF_SIGNAL_...,SET,439,0.016571,0.0025316,0.039847,0.33875,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,0.96756961162657
GOCC_MSL_COMPLEX,SET,3,0.14717,0.001881,0.35389,0.33876,GOCC_MSL_COMPLEX,0.96756961162657
KEGG_BASAL_CELL_CARCINOMA,SET,53,0.050394,0.0027036,0.12122,0.33881,KEGG_BASAL_CELL_CARCINOMA,0.96756961162657
GOBP_RELAXATION_OF_MUSCLE,SET,31,0.066147,0.0027157,0.15915,0.33885,GOBP_RELAXATION_OF_MUSCLE,0.96756961162657
GSE17301_IFNA2_VS_IFNA2_AND_...1,SET,182,0.026798,0.0026548,0.064478,0.33885,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN,0.96756961162657
GSE21546_WT_VS_SAP1A_KO_DP_T...1,SET,156,0.028536,0.0026191,0.068666,0.33886,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN,0.96756961162657
MODULE_274,SET,76,0.042706,0.0027419,0.10278,0.33889,MODULE_274,0.96756961162657
GOCC_LAMELLIPODIUM_MEMBRANE,SET,22,0.076155,0.0026345,0.18332,0.33892,GOCC_LAMELLIPODIUM_MEMBRANE,0.96756961162657
HP_GENERALIZED_HYPOPIGMENTAT...1,SET,28,0.072986,0.002848,0.17574,0.33896,HP_GENERALIZED_HYPOPIGMENTATION,0.96756961162657
GOMF_14_3_3_PROTEIN_BINDING,SET,29,0.065337,0.0025946,0.15734,0.33898,GOMF_14_3_3_PROTEIN_BINDING,0.96756961162657
GNF2_MCL1,SET,49,0.049064,0.0025312,0.11816,0.33899,GNF2_MCL1,0.96756961162657
MODULE_248,SET,117,0.033296,0.0026494,0.080194,0.339,MODULE_248,0.96756961162657
KOHN_EMT_MESENCHYMAL,SET,14,0.089847,0.00248,0.21645,0.33904,KOHN_EMT_MESENCHYMAL,0.96756961162657
CSR_EARLY_UP.V1_UP,SET,143,0.028812,0.0025328,0.069413,0.33904,CSR_EARLY_UP.V1_UP,0.96756961162657
WP_EBSTEINBARR_VIRUS_LMP1_SI...,SET,21,0.070485,0.0023824,0.16983,0.33906,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,0.96756961162657
GSE2197_IMMUNOSUPPRESSIVE_DN...2,SET,179,0.026287,0.0025828,0.063368,0.33913,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP,0.967673690691184
BEGUM_TARGETS_OF_PAX3_FOXO1_...2,SET,46,0.056708,0.0028349,0.13672,0.33916,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,0.967673690691184
GSE21063_WT_VS_NFATC1_KO_8H_...2,SET,179,0.024751,0.0024319,0.059681,0.33918,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP,0.967673690691184
chr2p14,SET,17,0.10555,0.0032101,0.25486,0.33939,chr2p14,0.967993855046323
GOBP_POSITIVE_REGULATION_OF_...365,SET,14,0.091153,0.002516,0.22013,0.33941,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,0.967993855046323
MIR1972,SET,88,0.035863,0.0024768,0.086619,0.33943,MIR1972,0.967993855046323
GOBP_NEGATIVE_REGULATION_OF_...373,SET,12,0.095062,0.0024294,0.22962,0.33944,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_MIGRATION,0.967993855046323
GOBP_PHASIC_SMOOTH_MUSCLE_CO...,SET,24,0.077896,0.0028144,0.18816,0.33944,GOBP_PHASIC_SMOOTH_MUSCLE_CONTRACTION,0.967993855046323
WP_PROSTAGLANDIN_SIGNALING,SET,32,0.06699,0.0027942,0.16186,0.33948,WP_PROSTAGLANDIN_SIGNALING,0.967993855046323
GOBP_POSITIVE_REGULATION_OF_...598,SET,11,0.10974,0.0026853,0.26526,0.33954,GOBP_POSITIVE_REGULATION_OF_POST_TRANSCRIPTIONAL_GENE_SILENCING,0.967993855046323
GOBP_CELL_SURFACE_PATTERN_RE...,SET,71,0.041517,0.0025767,0.10036,0.33955,GOBP_CELL_SURFACE_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.967993855046323
GOMF_TYPE_1_FIBROBLAST_GROWT...,SET,5,0.16669,0.0027504,0.40294,0.33956,GOMF_TYPE_1_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,0.967993855046323
GOMF_EXOGENOUS_PROTEIN_BINDI...,SET,78,0.042321,0.0027525,0.10236,0.33963,GOMF_EXOGENOUS_PROTEIN_BINDING,0.967993855046323
GSE45837_WT_VS_GFI1_KO_PDC_DN,SET,173,0.025014,0.0024166,0.060497,0.33963,GSE45837_WT_VS_GFI1_KO_PDC_DN,0.967993855046323
KAAB_FAILED_HEART_ATRIUM_DN,SET,133,0.02979,0.0025262,0.072065,0.33967,KAAB_FAILED_HEART_ATRIUM_DN,0.967993855046323
GOBP_GLUTAMATERGIC_NEURON_DI...,SET,15,0.10169,0.0029053,0.24602,0.33969,GOBP_GLUTAMATERGIC_NEURON_DIFFERENTIATION,0.967993855046323
GOCC_PHAGOCYTIC_CUP,SET,26,0.067352,0.0025327,0.16297,0.3397,GOCC_PHAGOCYTIC_CUP,0.967993855046323
GSE11961_FOLLICULAR_BCELL_VS...1,SET,180,0.026179,0.0025793,0.063348,0.33971,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.967993855046323
HE_LIM_SUN_FETAL_LUNG_C0_MID...2,SET,168,0.028991,0.0027604,0.070183,0.33978,HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL,0.968018330464716
GOBP_PROTOPORPHYRINOGEN_IX_B...,SET,8,0.11635,0.0024281,0.28173,0.33981,GOBP_PROTOPORPHYRINOGEN_IX_BIOSYNTHETIC_PROCESS,0.968018330464716
PID_PDGFRA_PATHWAY,SET,21,0.077585,0.0026223,0.18789,0.33983,PID_PDGFRA_PATHWAY,0.968018330464716
MIR4484,SET,31,0.061799,0.0025372,0.14966,0.33983,MIR4484,0.968018330464716
TCTATGA_MIR376A_MIR376B,SET,79,0.038576,0.0025249,0.093481,0.33993,TCTATGA_MIR376A_MIR376B,0.968053069744597
MODULE_525,SET,58,0.044442,0.0024938,0.1077,0.33993,MODULE_525,0.968053069744597
HP_LARGE_JOINT_HYPERMOBILTY,SET,6,0.14435,0.002609,0.34993,0.33998,HP_LARGE_JOINT_HYPERMOBILTY,0.968053069744597
SOBOLEV_PBMC_PANDEMRIX_AGE_1...5,SET,9,0.12214,0.0027035,0.29613,0.34,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_TRANSIENT_UP,0.968053069744597
MIR409_5P,SET,35,0.053791,0.0023463,0.13046,0.34005,MIR409_5P,0.968053069744597
HP_ABNORMALITY_OF_THE_AUTONO...,SET,269,0.020971,0.0025197,0.050876,0.3401,HP_ABNORMALITY_OF_THE_AUTONOMIC_NERVOUS_SYSTEM,0.968053069744597
GOBP_REGULATION_OF_SUPEROXID...2,SET,27,0.068785,0.0026358,0.16689,0.34011,GOBP_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS,0.968053069744597
HP_ABNORMAL_GRANULOCYTE_COUNT,SET,234,0.022473,0.0025208,0.054527,0.34012,HP_ABNORMAL_GRANULOCYTE_COUNT,0.968053069744597
GOBP_CELL_DIFFERENTIATION_IN...4,SET,3,0.22685,0.0028995,0.55047,0.34014,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_PHENOTYPIC_SWITCHING,0.968053069744597
HP_THIRD_TRIMESTER_ONSET,SET,41,0.050943,0.0024046,0.12364,0.34017,HP_THIRD_TRIMESTER_ONSET,0.968053069744597
DESCARTES_FETAL_KIDNEY_MESAN...,SET,42,0.058582,0.0027986,0.1422,0.34018,DESCARTES_FETAL_KIDNEY_MESANGIAL_CELLS,0.968053069744597
GOBP_POSITIVE_REGULATION_OF_...838,SET,3,0.18255,0.0023333,0.44313,0.34019,GOBP_POSITIVE_REGULATION_OF_VESICLE_TRANSPORT_ALONG_MICROTUBULE,0.968053069744597
ZNF140_TARGET_GENES,SET,551,0.014694,0.0025069,0.035672,0.34021,ZNF140_TARGET_GENES,0.968053069744597
REACTOME_SYNTHESIS_OF_PYROPH...,SET,8,0.10643,0.0022212,0.25848,0.34026,REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL,0.968053069744597
DESCARTES_MAIN_FETAL_GANGLIO...,SET,19,0.089522,0.0028783,0.21741,0.34026,DESCARTES_MAIN_FETAL_GANGLION_CELLS,0.968053069744597
HP_ABNORMALITY_OF_THE_PERIOR...,SET,229,0.023512,0.0026093,0.057145,0.34038,HP_ABNORMALITY_OF_THE_PERIORBITAL_REGION,0.968183120706575
MODULE_316,SET,63,0.046951,0.0027455,0.11414,0.34042,MODULE_316,0.968183120706575
GOBP_NEGATIVE_REGULATION_OF_...137,SET,6,0.13362,0.0024151,0.3249,0.34044,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,0.968183120706575
NIKOLSKY_BREAST_CANCER_8Q12_...,SET,124,0.05424,0.0044423,0.1319,0.34046,NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,0.968183120706575
GOBP_ANAGEN,SET,5,0.1743,0.0028758,0.42386,0.34046,GOBP_ANAGEN,0.968183120706575
SHETH_LIVER_CANCER_VS_TXNIP_...5,SET,96,0.036839,0.0026568,0.089605,0.34049,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,0.968183120706575
GOBP_REGULATION_OF_DNA_TEMPL...4,SET,79,0.037437,0.0024504,0.091087,0.34054,GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.968183120706575
GOBP_ALANINE_METABOLIC_PROCE...,SET,5,0.15806,0.002608,0.38469,0.34058,GOBP_ALANINE_METABOLIC_PROCESS,0.968183120706575
GOBP_POSITIVE_REGULATION_OF_...212,SET,5,0.15913,0.0026257,0.3873,0.34058,GOBP_POSITIVE_REGULATION_OF_DNA_CATABOLIC_PROCESS,0.968183120706575
GSE9006_TYPE_1_VS_TYPE_2_DIA...2,SET,180,0.023721,0.0023371,0.057737,0.3406,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,0.968183120706575
HP_RING_SCOTOMA,SET,5,0.14273,0.002355,0.34746,0.34062,HP_RING_SCOTOMA,0.968183120706575
MIR10400_3P_MIR4674,SET,33,0.060603,0.0025669,0.14755,0.34064,MIR10400_3P_MIR4674,0.968183120706575
HP_ABNORMALITY_OF_JAW_MUSCLES,SET,26,0.067686,0.0025453,0.16483,0.34067,HP_ABNORMALITY_OF_JAW_MUSCLES,0.968189210074413
DESCARTES_FETAL_CEREBRUM_OLI...,SET,48,0.056616,0.002891,0.13792,0.34072,DESCARTES_FETAL_CEREBRUM_OLIGODENDROCYTES,0.968201385822909
DONATO_CELL_CYCLE_TRETINOIN,SET,6,0.15885,0.0028712,0.387,0.34073,DONATO_CELL_CYCLE_TRETINOIN,0.968201385822909
GOBP_PROTEIN_POLYGLUTAMYLATI...,SET,11,0.11224,0.0027465,0.27356,0.34079,GOBP_PROTEIN_POLYGLUTAMYLATION,0.968241968446007
FARMER_BREAST_CANCER_CLUSTER...2,SET,32,0.06283,0.0026207,0.15314,0.3408,FARMER_BREAST_CANCER_CLUSTER_2,0.968241968446007
KEGG_MEDICUS_REFERENCE_V_D_J...,SET,12,0.083579,0.002136,0.20381,0.34087,KEGG_MEDICUS_REFERENCE_V_D_J_RECOMBINATION,0.968260211670481
GOBP_POSITIVE_REGULATION_OF_...63,SET,8,0.1437,0.0029989,0.35044,0.34088,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.968260211670481
GOBP_CELL_CYCLE_CHECKPOINT_S...,SET,180,0.024422,0.0024062,0.059559,0.34089,GOBP_CELL_CYCLE_CHECKPOINT_SIGNALING,0.968260211670481
GSE3982_CENT_MEMORY_CD4_TCEL...3,SET,182,0.024405,0.0024177,0.059529,0.34092,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN,0.968266290757539
HP_CONTRACTURE_OF_THE_PROXIM...1,SET,6,0.14623,0.0026429,0.35695,0.34103,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_3RD_FINGER,0.968448827518588
GSE17721_12H_VS_24H_POLYIC_B...2,SET,178,0.025764,0.0025244,0.062894,0.34104,GSE17721_12H_VS_24H_POLYIC_BMDC_UP,0.968448827518588
KEGG_RIBOSOME,SET,79,0.037496,0.0024543,0.091567,0.34109,KEGG_RIBOSOME,0.968511678921569
REACTOME_CARDIAC_CONDUCTION,SET,125,0.032439,0.0026674,0.079234,0.34112,REACTOME_CARDIAC_CONDUCTION,0.968517735479127
GOBP_ANTIMICROBIAL_HUMORAL_I...,SET,90,0.041984,0.0029322,0.10257,0.34115,GOBP_ANTIMICROBIAL_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_ANTIMICROBIAL_PEPTIDE,0.968523791047215
WP_MODULATORS_OF_TCR_SIGNALI...,SET,57,0.044246,0.0024614,0.10814,0.34122,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,0.968643396226415
HP_CENTRAL_SCOTOMA,SET,36,0.058696,0.0025965,0.14352,0.34128,HP_CENTRAL_SCOTOMA,0.968734596537079
GOBP_GRANULOCYTE_MIGRATION,SET,140,0.032591,0.002835,0.079721,0.34134,GOBP_GRANULOCYTE_MIGRATION,0.968746668299853
HP_PILI_TORTI,SET,12,0.10239,0.0026167,0.25045,0.34134,HP_PILI_TORTI,0.968746668299853
JIANG_TIP30_TARGETS_DN,SET,22,0.082359,0.0028491,0.20158,0.34143,JIANG_TIP30_TARGETS_DN,0.968896327130264
GAUSSMANN_MLL_AF4_FUSION_TAR...7,SET,10,0.11079,0.0025849,0.27122,0.34146,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN,0.968896327130264
GSE13547_2H_VS_12_H_ANTI_IGM...3,SET,154,0.028435,0.0025932,0.069632,0.34151,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN,0.968896327130264
GOMF_ALKANE_1_MONOOXYGENASE_...,SET,5,0.16748,0.0027634,0.41018,0.34153,GOMF_ALKANE_1_MONOOXYGENASE_ACTIVITY,0.968896327130264
MYLLYKANGAS_AMPLIFICATION_HO...1,SET,11,0.098957,0.0024214,0.24241,0.34156,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,0.968896327130264
HP_IMPAIRED_OROPHARYNGEAL_SW...,SET,12,0.10163,0.0025972,0.24896,0.34156,HP_IMPAIRED_OROPHARYNGEAL_SWALLOW_RESPONSE,0.968896327130264
MIR506_3P,SET,693,0.013366,0.0025473,0.03275,0.34159,MIR506_3P,0.968902346364156
GSE17721_0.5H_VS_12H_LPS_BMD...1,SET,184,0.024945,0.0024846,0.06114,0.34164,GSE17721_0.5H_VS_12H_LPS_BMDC_DN,0.968965088950547
MORF_IL13,SET,216,0.023157,0.0024969,0.056789,0.34172,MORF_IL13,0.969112900856793
GOMF_INSULIN_BINDING,SET,5,0.14386,0.0023737,0.35289,0.34176,GOMF_INSULIN_BINDING,0.96912490005711
CHESLER_BRAIN_D6MIT150_QTL_T...,SET,9,0.12309,0.0027244,0.30197,0.34178,CHESLER_BRAIN_D6MIT150_QTL_TRANS,0.96912490005711
KEGG_MAPK_SIGNALING_PATHWAY,SET,255,0.022449,0.0026271,0.055102,0.34186,KEGG_MAPK_SIGNALING_PATHWAY,0.9692339246391
MIR6751_3P,SET,73,0.039491,0.0024851,0.096966,0.34191,MIR6751_3P,0.9692339246391
SCHAEFFER_PROSTATE_DEVELOPME...15,SET,10,0.12793,0.0029848,0.31415,0.34192,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP,0.9692339246391
PEDRIOLI_MIR31_TARGETS_UP,SET,189,0.025423,0.0025661,0.062433,0.34193,PEDRIOLI_MIR31_TARGETS_UP,0.9692339246391
GOCC_GOLGI_CISTERNA_MEMBRANE,SET,74,0.04015,0.0025438,0.098634,0.34198,GOCC_GOLGI_CISTERNA_MEMBRANE,0.969296599249715
GSE22025_UNTREATED_VS_TGFB1_...2,SET,177,0.026355,0.0025751,0.064783,0.34207,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.969448802736602
MIR190A_5P,SET,105,0.034426,0.0025959,0.084638,0.3421,MIR190A_5P,0.969448802736602
GOCC_TOM_COMPLEX,SET,5,0.14067,0.0023211,0.34595,0.34214,GOCC_TOM_COMPLEX,0.969448802736602
GOBP_MEMBRANE_REPOLARIZATION...2,SET,5,0.16708,0.0027568,0.41103,0.34219,GOBP_MEMBRANE_REPOLARIZATION_DURING_ATRIAL_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.969448802736602
GAVISH_3CA_METAPROGRAM_CD4_T...5,SET,47,0.050356,0.0025444,0.12389,0.34221,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_INTERFERON,0.969448802736602
GSE360_CTRL_VS_M_TUBERCULOSI...4,SET,179,0.024827,0.0024394,0.061115,0.34228,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP,0.969448802736602
GOMF_T_CELL_RECEPTOR_BINDING,SET,10,0.113,0.0026365,0.27818,0.34229,GOMF_T_CELL_RECEPTOR_BINDING,0.969448802736602
GSE41978_WT_VS_ID2_KO_KLRG1_...2,SET,187,0.025513,0.0025616,0.062809,0.3423,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.969448802736602
HP_RETINAL_COLOBOMA,SET,37,0.055962,0.0025096,0.1378,0.34233,HP_RETINAL_COLOBOMA,0.969448802736602
GOBP_LIPOSACCHARIDE_METABOLI...,SET,103,0.033261,0.0024842,0.081908,0.34235,GOBP_LIPOSACCHARIDE_METABOLIC_PROCESS,0.969448802736602
chr1q44,SET,56,0.077952,0.0042984,0.192,0.34237,chr1q44,0.969448802736602
BIOCARTA_LIS1_PATHWAY,SET,18,0.078244,0.0024486,0.19273,0.34238,BIOCARTA_LIS1_PATHWAY,0.969448802736602
KEGG_MEDICUS_PATHOGEN_EBV_EB...1,SET,10,0.1045,0.0024381,0.25748,0.34243,KEGG_MEDICUS_PATHOGEN_EBV_EBNA1_TO_P53_MEDIATED_TRANSCRIPTION,0.969448802736602
GSE3982_MAC_VS_TH1_DN,SET,180,0.024443,0.0024083,0.060241,0.34246,GSE3982_MAC_VS_TH1_DN,0.969448802736602
GOBP_PHOTOPERIODISM,SET,26,0.06628,0.0024924,0.16337,0.34248,GOBP_PHOTOPERIODISM,0.969448802736602
GOCC_GOLGI_CISTERNA,SET,96,0.035421,0.0025545,0.087306,0.34248,GOCC_GOLGI_CISTERNA,0.969448802736602
GOBP_CELL_CELL_ADHESION_MEDI...2,SET,17,0.083799,0.0025487,0.20664,0.34255,GOBP_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.969462222222222
HP_PROMINENT_VEINS_ON_TRUNK,SET,5,0.16747,0.0027632,0.41305,0.34258,HP_PROMINENT_VEINS_ON_TRUNK,0.969462222222222
HP_TIP_TOE_GAIT,SET,75,0.03828,0.0024416,0.09443,0.3426,HP_TIP_TOE_GAIT,0.969462222222222
GOBP_REGULATION_OF_SPERM_CAP...,SET,4,0.19325,0.0028521,0.47686,0.34264,GOBP_REGULATION_OF_SPERM_CAPACITATION,0.969462222222222
ATGTAGC_MIR221_MIR222,SET,130,0.032524,0.002727,0.080269,0.34267,ATGTAGC_MIR221_MIR222,0.969462222222222
HAY_BONE_MARROW_STROMAL,SET,669,0.014709,0.0027561,0.036301,0.34267,HAY_BONE_MARROW_STROMAL,0.969462222222222
GSE6259_FLT3L_INDUCED_33D1_P...3,SET,149,0.027169,0.0024375,0.067054,0.34268,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN,0.969462222222222
GSE32901_NAIVE_VS_TH17_NEG_C...1,SET,112,0.033371,0.0025984,0.082419,0.34278,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN,0.969666197297737
GOMF_TASTE_RECEPTOR_ACTIVITY,SET,28,0.078793,0.0030746,0.19466,0.34282,GOMF_TASTE_RECEPTOR_ACTIVITY,0.969700423211524
GSE40685_NAIVE_CD4_TCELL_VS_...4,SET,164,0.025593,0.002408,0.063244,0.34286,GSE40685_NAIVE_CD4_TCELL_VS_TREG_UP,0.969714722357526
RASHI_RESPONSE_TO_IONIZING_R...1,SET,36,0.055798,0.0024683,0.13796,0.34294,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,0.969714722357526
GOMF_ATPASE_COUPLED_LIPID_TR...,SET,8,0.12788,0.0026687,0.3162,0.34296,GOMF_ATPASE_COUPLED_LIPID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.969714722357526
MODULE_70,SET,39,0.055077,0.0025357,0.13623,0.343,MODULE_70,0.969714722357526
MIR7159_5P,SET,323,0.019587,0.0025749,0.048458,0.34303,MIR7159_5P,0.969714722357526
GSE37605_TREG_VS_TCONV_C57BL...4,SET,114,0.032266,0.0025345,0.079833,0.34305,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP,0.969714722357526
GSE19923_E2A_KO_VS_HEB_AND_E...1,SET,163,0.028018,0.0026282,0.069329,0.34306,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.969714722357526
GOMF_ENDONUCLEASE_ACTIVITY_A...2,SET,33,0.05908,0.0025024,0.14624,0.34311,GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,0.969714722357526
GOBP_LOCOMOTORY_EXPLORATION_...,SET,14,0.095659,0.0026404,0.23679,0.34312,GOBP_LOCOMOTORY_EXPLORATION_BEHAVIOR,0.969714722357526
HOEK_PBMC_INACTIVATED_INFLUE...2,SET,2,0.22843,0.002384,0.56556,0.34314,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP,0.969714722357526
GNF2_NS,SET,37,0.05186,0.0023257,0.12842,0.34318,GNF2_NS,0.969714722357526
MORF_FLT1,SET,116,0.032392,0.0025665,0.080218,0.34318,MORF_FLT1,0.969714722357526
LIM_MAMMARY_LUMINAL_PROGENIT...1,SET,14,0.098927,0.0027307,0.24503,0.3432,LIM_MAMMARY_LUMINAL_PROGENITOR_DN,0.969714722357526
GOBP_REGULATION_OF_PROTEIN_L...15,SET,16,0.084762,0.0025011,0.21,0.34325,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE,0.969714722357526
AP2_Q6,SET,239,0.021768,0.0024673,0.053945,0.34329,AP2_Q6,0.969714722357526
GSE25087_TREG_VS_TCONV_FETUS...2,SET,175,0.025818,0.0025085,0.063997,0.34332,GSE25087_TREG_VS_TCONV_FETUS_UP,0.969714722357526
GOMF_AROMATASE_ACTIVITY,SET,25,0.080894,0.0029829,0.2006,0.34338,GOMF_AROMATASE_ACTIVITY,0.969714722357526
GOBP_POSITIVE_REGULATION_OF_...222,SET,13,0.090416,0.002405,0.22425,0.34341,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.969714722357526
MIR12126,SET,34,0.059377,0.0025527,0.14733,0.34347,MIR12126,0.969714722357526
GSE46143_CTRL_VS_LMP2A_TRANS...1,SET,181,0.024672,0.0024375,0.061233,0.34351,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN,0.969714722357526
GOMF_HIGH_DENSITY_LIPOPROTEI...,SET,11,0.11506,0.0028154,0.28561,0.34353,GOMF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,0.969714722357526
GOBP_NEGATIVE_REGULATION_OF_...485,SET,19,0.079821,0.0025664,0.19815,0.34354,GOBP_NEGATIVE_REGULATION_OF_PHAGOCYTOSIS,0.969714722357526
BIOCARTA_VITCB_PATHWAY,SET,8,0.10547,0.002201,0.26187,0.34356,BIOCARTA_VITCB_PATHWAY,0.969714722357526
ZC3H11A_TARGET_GENES,SET,745,0.012532,0.0024727,0.031114,0.34356,ZC3H11A_TARGET_GENES,0.969714722357526
GOBP_METALLO_SULFUR_CLUSTER_...,SET,21,0.07169,0.0024231,0.17803,0.34359,GOBP_METALLO_SULFUR_CLUSTER_ASSEMBLY,0.969714722357526
KEGG_MEDICUS_REFERENCE_PURIN...2,SET,10,0.10409,0.0024285,0.25854,0.34362,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_HYPOXANTHINE_GUANINE_TO_IMP_GMP,0.969714722357526
GOBP_REGULATION_OF_CELL_CYCL...3,SET,103,0.032358,0.0024167,0.080371,0.34362,GOBP_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.969714722357526
MORF_ESPL1,SET,54,0.042116,0.0022807,0.10462,0.34363,MORF_ESPL1,0.969714722357526
GOCC_FILOPODIUM_TIP,SET,16,0.088556,0.002613,0.22002,0.34366,GOCC_FILOPODIUM_TIP,0.969714722357526
GOCC_RNA_POLYMERASE_III_TRAN...,SET,9,0.091743,0.0020307,0.22798,0.34369,GOCC_RNA_POLYMERASE_III_TRANSCRIPTION_REGULATOR_COMPLEX,0.969714722357526
GSE42021_TCONV_PLN_VS_CD24IN...2,SET,177,0.025597,0.0025011,0.063609,0.34369,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP,0.969714722357526
HP_NEPHROGENIC_DIABETES_INSI...,SET,7,0.13294,0.0025951,0.33043,0.34373,HP_NEPHROGENIC_DIABETES_INSIPIDUS,0.969748855426577
MCCLUNG_COCAIN_REWARD_4WK,SET,68,0.042488,0.0025809,0.10571,0.34386,MCCLUNG_COCAIN_REWARD_4WK,0.969910253811223
RCGCANGCGY_NRF1_Q6,SET,852,0.011361,0.0023898,0.028263,0.34386,RCGCANGCGY_NRF1_Q6,0.969910253811223
RFX1_02,SET,252,0.021108,0.0024558,0.052528,0.3439,RFX1_02,0.969910253811223
GSE17721_LPS_VS_CPG_16H_BMDC...2,SET,183,0.024831,0.0024666,0.061794,0.34391,GSE17721_LPS_VS_CPG_16H_BMDC_UP,0.969910253811223
GSE39864_WT_VS_GATA3_KO_TREG...1,SET,178,0.02408,0.0023594,0.059934,0.34393,GSE39864_WT_VS_GATA3_KO_TREG_DN,0.969910253811223
chr10q11,SET,45,0.08693,0.0042983,0.21643,0.34397,chr10q11,0.969910253811223
WP_SPHINGOLIPID_PATHWAY,SET,27,0.06747,0.0025854,0.16802,0.34401,WP_SPHINGOLIPID_PATHWAY,0.969910253811223
GOBP_VASCULAR_WOUND_HEALING,SET,18,0.082498,0.0025818,0.20547,0.34403,GOBP_VASCULAR_WOUND_HEALING,0.969910253811223
GSE21670_TGFB_VS_IL6_TREATED...2,SET,177,0.025391,0.0024809,0.063256,0.34406,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP,0.969910253811223
HP_LINEAR_ARRAYS_OF_MACULAR_...,SET,5,0.16654,0.0027478,0.41493,0.34408,HP_LINEAR_ARRAYS_OF_MACULAR_HYPERKERATOSES_IN_FLEXURAL_AREAS,0.969910253811223
GOMF_FLAVIN_ADENINE_DINUCLEO...,SET,81,0.036827,0.0024406,0.091774,0.34411,GOMF_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING,0.969910253811223
ZHAN_MULTIPLE_MYELOMA_PR_DN,SET,45,0.05439,0.0026893,0.13557,0.34414,ZHAN_MULTIPLE_MYELOMA_PR_DN,0.969910253811223
MOREIRA_RESPONSE_TO_TSA_DN,SET,18,0.081169,0.0025402,0.20234,0.34415,MOREIRA_RESPONSE_TO_TSA_DN,0.969910253811223
GSE6259_BCELL_VS_CD4_TCELL_UP,SET,154,0.026492,0.002416,0.066111,0.34431,GSE6259_BCELL_VS_CD4_TCELL_UP,0.97016043675553
GSE360_L_DONOVANI_VS_B_MALAY...8,SET,185,0.02536,0.0025327,0.063288,0.34432,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.97016043675553
MARSHALL_VIRAL_INFECTION_RES...2,SET,9,0.1317,0.002915,0.32879,0.34438,MARSHALL_VIRAL_INFECTION_RESPONSE_UP,0.97016043675553
GOMF_TRANSLATION_TERMINATION...,SET,4,0.15543,0.0022939,0.38806,0.34438,GOMF_TRANSLATION_TERMINATION_FACTOR_ACTIVITY,0.97016043675553
GOMF_PROSTAGLANDIN_E_RECEPTO...,SET,5,0.17952,0.002962,0.44827,0.34441,GOMF_PROSTAGLANDIN_E_RECEPTOR_ACTIVITY,0.97016043675553
KEGG_MEDICUS_REFERENCE_HIF_1...,SET,9,0.11965,0.0026484,0.29887,0.34445,KEGG_MEDICUS_REFERENCE_HIF_1_SIGNALING_PATHWAY,0.97016043675553
GCM_DDX11,SET,44,0.045699,0.0022344,0.11417,0.34448,GCM_DDX11,0.97016043675553
HP_CRANIOFACIAL_DYSOSTOSIS,SET,8,0.11031,0.002302,0.27558,0.34448,HP_CRANIOFACIAL_DYSOSTOSIS,0.97016043675553
GSE31082_DN_VS_DP_THYMOCYTE_...1,SET,184,0.023697,0.0023603,0.059205,0.34449,GSE31082_DN_VS_DP_THYMOCYTE_DN,0.97016043675553
GOBP_IRON_ION_IMPORT_ACROSS_...,SET,4,0.15679,0.002314,0.39187,0.34454,GOBP_IRON_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.970222630043753
REACTOME_CYCLIN_A_CDK2_ASSOC...,SET,82,0.033302,0.0022205,0.083272,0.34461,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,0.970324690157959
GOBP_POSITIVE_REGULATION_OF_...51,SET,68,0.042461,0.0025792,0.1062,0.34465,GOBP_POSITIVE_REGULATION_OF_AXONOGENESIS,0.970324690157959
MIR582_5P,SET,326,0.018983,0.0025069,0.047483,0.34466,MIR582_5P,0.970324690157959
REACTOME_RESPONSE_OF_EIF2AK4...,SET,91,0.034335,0.0024112,0.085908,0.3447,REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,0.970358699173822
GOBP_ENDOCYTOSIS_INVOLVED_IN...,SET,11,0.10089,0.0024687,0.25262,0.34481,GOBP_ENDOCYTOSIS_INVOLVED_IN_VIRAL_ENTRY_INTO_HOST_CELL,0.970439490084986
GOBP_POSITIVE_REGULATION_OF_...653,SET,90,0.034383,0.0024013,0.086104,0.34483,GOBP_POSITIVE_REGULATION_OF_PROTEIN_UBIQUITINATION,0.970439490084986
PCGF6_TARGET_GENES,SET,64,0.039112,0.0023051,0.097974,0.34487,PCGF6_TARGET_GENES,0.970439490084986
GOMF_PEROXIREDOXIN_ACTIVITY,SET,6,0.11983,0.0021657,0.30014,0.34487,GOMF_PEROXIREDOXIN_ACTIVITY,0.970439490084986
HP_INCREASED_LAXITY_OF_FINGE...,SET,5,0.17473,0.0028831,0.43781,0.34491,HP_INCREASED_LAXITY_OF_FINGERS,0.970439490084986
GSE5142_CTRL_VS_HTERT_TRANSD...1,SET,176,0.024943,0.0024303,0.062501,0.34492,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN,0.970439490084986
GOBP_OOGENESIS,SET,100,0.033092,0.0024355,0.082938,0.34495,GOBP_OOGENESIS,0.970439490084986
HP_ABNORMAL_NASAL_SEPTUM_MOR...,SET,15,0.096291,0.0027511,0.24138,0.34498,HP_ABNORMAL_NASAL_SEPTUM_MORPHOLOGY,0.970439490084986
HP_SECUNDUM_ATRIAL_SEPTAL_DE...,SET,38,0.055079,0.0025031,0.13807,0.34498,HP_SECUNDUM_ATRIAL_SEPTAL_DEFECT,0.970439490084986
HP_INTRAALVEOLAR_PHOSPHOLIPI...,SET,7,0.117,0.0022841,0.29349,0.34508,HP_INTRAALVEOLAR_PHOSPHOLIPID_ACCUMULATION,0.970642230495306
GSE9006_HEALTHY_VS_TYPE_1_DI...4,SET,183,0.024633,0.0024469,0.061855,0.34523,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP,0.970881613190011
GOBP_PROTEIN_LOCALIZATION_TO...4,SET,4,0.18661,0.002754,0.46866,0.34525,GOBP_PROTEIN_LOCALIZATION_TO_BICELLULAR_TIGHT_JUNCTION,0.970881613190011
GOBP_MYELOID_LEUKOCYTE_ACTIV...,SET,223,0.02374,0.0026004,0.059633,0.34528,GOBP_MYELOID_LEUKOCYTE_ACTIVATION,0.970881613190011
GOMF_PATCHED_BINDING,SET,8,0.12184,0.0025427,0.30608,0.34529,GOMF_PATCHED_BINDING,0.970881613190011
GOBP_REGULATION_OF_RESPIRATO...2,SET,7,0.13693,0.002673,0.34417,0.34537,GOBP_REGULATION_OF_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.970881613190011
GOCC_EXCITATORY_SYNAPSE,SET,57,0.046006,0.0025593,0.11564,0.34537,GOCC_EXCITATORY_SYNAPSE,0.970881613190011
GOBP_RESPONSE_TO_REACTIVE_OX...,SET,179,0.025856,0.0025405,0.064991,0.34538,GOBP_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,0.970881613190011
HP_CARDIOMEGALY,SET,114,0.031228,0.002453,0.078522,0.34543,HP_CARDIOMEGALY,0.970881613190011
GSE25846_IL10_POS_VS_NEG_CD8...2,SET,175,0.025416,0.0024694,0.063932,0.34549,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP,0.970881613190011
HP_APLASIA_HYPOPLASIA_OF_TOE,SET,112,0.031913,0.0024848,0.080296,0.34552,HP_APLASIA_HYPOPLASIA_OF_TOE,0.970881613190011
ZNF404_TARGET_GENES,SET,17,0.072784,0.0022137,0.18315,0.34554,ZNF404_TARGET_GENES,0.970881613190011
GOBP_NEGATIVE_REGULATION_OF_...431,SET,15,0.087345,0.0024955,0.21981,0.34555,GOBP_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.970881613190011
PID_ERA_GENOMIC_PATHWAY,SET,61,0.042759,0.0024605,0.10761,0.34556,PID_ERA_GENOMIC_PATHWAY,0.970881613190011
GSE11057_CD4_EFF_MEM_VS_PBMC...1,SET,183,0.025777,0.0025606,0.064872,0.34556,GSE11057_CD4_EFF_MEM_VS_PBMC_DN,0.970881613190011
KAAB_HEART_ATRIUM_VS_VENTRIC...2,SET,233,0.022901,0.0025633,0.057653,0.34561,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,0.970881613190011
GOMF_POLY_PYRIMIDINE_TRACT_B...,SET,25,0.066651,0.0024577,0.16782,0.34563,GOMF_POLY_PYRIMIDINE_TRACT_BINDING,0.970881613190011
GOBP_NUCLEOSOME_ORGANIZATION,SET,64,0.038884,0.0022917,0.097913,0.34564,GOBP_NUCLEOSOME_ORGANIZATION,0.970881613190011
HP_SYNOSTOSIS_OF_JOINTS,SET,171,0.026172,0.0025139,0.065936,0.34571,HP_SYNOSTOSIS_OF_JOINTS,0.970999761596897
REACTOME_SIGNALING_BY_MST1,SET,5,0.13782,0.0022741,0.34728,0.34574,REACTOME_SIGNALING_BY_MST1,0.971005551515152
GOBP_REGULATION_OF_PROTEIN_L...3,SET,128,0.029062,0.002418,0.073257,0.34579,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,0.971067505656108
GSE29949_CD8_POS_DC_SPLEEN_V...1,SET,173,0.025716,0.0024844,0.064908,0.34598,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN,0.971090647655872
HP_CEREBELLAR_CORTICAL_ATROP...,SET,5,0.1482,0.0024453,0.37409,0.34599,HP_CEREBELLAR_CORTICAL_ATROPHY,0.971090647655872
GOMF_METAL_CLUSTER_BINDING,SET,69,0.038655,0.0023652,0.0976,0.34604,GOMF_METAL_CLUSTER_BINDING,0.971090647655872
GOBP_LUNG_SACCULE_DEVELOPMENT,SET,10,0.10701,0.0024967,0.27026,0.34607,GOBP_LUNG_SACCULE_DEVELOPMENT,0.971090647655872
SHARMA_PILOCYTIC_ASTROCYTOMA...1,SET,6,0.15617,0.0028225,0.39446,0.34609,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN,0.971090647655872
GOMF_INOSITOL_1_3_4_5_TETRAK...,SET,5,0.15331,0.0025296,0.38724,0.34609,GOMF_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE_BINDING,0.971090647655872
REACTOME_INTERLEUKIN_15_SIGN...,SET,13,0.10472,0.0027855,0.26452,0.3461,REACTOME_INTERLEUKIN_15_SIGNALING,0.971090647655872
QIU_PBMC_HEPTATITIS_B_SURFAC...2,SET,7,0.14461,0.002823,0.36529,0.3461,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0_TO_35DY_JOINTLY_UP,0.971090647655872
YIH_RESPONSE_TO_ARSENITE_C3,SET,26,0.067909,0.0025536,0.17157,0.34612,YIH_RESPONSE_TO_ARSENITE_C3,0.971090647655872
HP_CHOLANGITIS,SET,18,0.080918,0.0025323,0.20443,0.34612,HP_CHOLANGITIS,0.971090647655872
GOBP_CORTISOL_BIOSYNTHETIC_P...,SET,10,0.1212,0.0028277,0.30624,0.34614,GOBP_CORTISOL_BIOSYNTHETIC_PROCESS,0.971090647655872
HP_ABNORMALITY_OF_BONE_MINER...,SET,572,0.014066,0.0024437,0.035555,0.3462,HP_ABNORMALITY_OF_BONE_MINERAL_DENSITY,0.971090647655872
FAN_EMBRYONIC_CTX_IN_6_INTER...,SET,4,0.18853,0.0027824,0.47675,0.34626,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,0.971090647655872
MODULE_254,SET,59,0.043955,0.0024876,0.11119,0.34631,MODULE_254,0.971090647655872
GOCC_BLOC_1_COMPLEX,SET,14,0.091717,0.0025316,0.23201,0.34631,GOCC_BLOC_1_COMPLEX,0.971090647655872
HP_PREMATURE_LOSS_OF_PERMANE...,SET,7,0.13774,0.0026889,0.34848,0.34633,HP_PREMATURE_LOSS_OF_PERMANENT_TEETH,0.971090647655872
HP_COGNITIVE_DISTORTION,SET,29,0.061793,0.0024538,0.15636,0.34635,HP_COGNITIVE_DISTORTION,0.971090647655872
GSE19198_CTRL_VS_IL21_TREATE...3,SET,186,0.024318,0.0024351,0.061536,0.34636,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN,0.971090647655872
GOMF_ANKYRIN_BINDING,SET,19,0.081411,0.0026175,0.20609,0.34642,GOMF_ANKYRIN_BINDING,0.971090647655872
FOROUTAN_TGFB_EMT_UP,SET,185,0.025748,0.0025715,0.065197,0.34645,FOROUTAN_TGFB_EMT_UP,0.971090647655872
THUM_MIR21_TARGETS_HEART_DIS...1,SET,7,0.16324,0.0031867,0.41341,0.34647,THUM_MIR21_TARGETS_HEART_DISEASE_DN,0.971090647655872
GOMF_DOPAMINE_BINDING,SET,6,0.15738,0.0028446,0.39856,0.34647,GOMF_DOPAMINE_BINDING,0.971090647655872
GOBP_REGULATION_OF_PROTEIN_L...13,SET,137,0.027448,0.0023621,0.069577,0.34661,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.971090647655872
GOMF_STAT_FAMILY_PROTEIN_BIN...,SET,10,0.10132,0.0023638,0.25684,0.34662,GOMF_STAT_FAMILY_PROTEIN_BINDING,0.971090647655872
RICKMAN_HEAD_AND_NECK_CANCER...2,SET,33,0.06277,0.0026587,0.15917,0.34666,RICKMAN_HEAD_AND_NECK_CANCER_B,0.971090647655872
REACTOME_AEROBIC_RESPIRATION...,SET,209,0.02098,0.0022256,0.053208,0.34668,REACTOME_AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,0.971090647655872
WP_APOPTOSISRELATED_NETWORK_...,SET,50,0.050048,0.0026081,0.12692,0.34668,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,0.971090647655872
ELLWOOD_MYC_TARGETS_UP,SET,13,0.093087,0.0024761,0.23612,0.3467,ELLWOOD_MYC_TARGETS_UP,0.971090647655872
HP_ABNORMAL_2ND_FINGER_MORPH...,SET,37,0.054579,0.0024476,0.13844,0.3467,HP_ABNORMAL_2ND_FINGER_MORPHOLOGY,0.971090647655872
GSE39820_CTRL_VS_IL1B_IL6_IL...1,SET,185,0.024961,0.0024929,0.063328,0.34673,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN,0.971090647655872
GOMF_BITTER_TASTE_RECEPTOR_A...,SET,22,0.095762,0.0033128,0.24302,0.34677,GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY,0.971090647655872
MIR6759_5P,SET,56,0.045899,0.0025309,0.1165,0.3468,MIR6759_5P,0.971090647655872
AREB6_04,SET,226,0.023465,0.0025873,0.059558,0.3468,AREB6_04,0.971090647655872
GSE21380_TFH_VS_GERMINAL_CEN...2,SET,183,0.025312,0.0025144,0.064246,0.3468,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,0.971090647655872
CMYB_01,SET,232,0.021247,0.0023732,0.053933,0.34681,CMYB_01,0.971090647655872
MODULE_261,SET,89,0.035176,0.0024431,0.089308,0.34684,MODULE_261,0.971090647655872
chr2p21,SET,35,0.096401,0.0042049,0.24478,0.34686,chr2p21,0.971090647655872
GOBP_NEGATIVE_REGULATION_OF_...641,SET,11,0.10401,0.0025449,0.2641,0.34686,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_COMPETITIVE_PROMOTER_BINDING,0.971090647655872
GOBP_POSITIVE_REGULATION_OF_...712,SET,16,0.081785,0.0024132,0.20774,0.34691,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.971121083755733
GSE25123_ROSIGLITAZONE_VS_IL...1,SET,105,0.031383,0.0023665,0.079777,0.34702,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.971121083755733
MORI_IMMATURE_B_LYMPHOCYTE_UP,SET,46,0.052005,0.0025998,0.13225,0.34708,MORI_IMMATURE_B_LYMPHOCYTE_UP,0.971121083755733
HOWARD_DENDRITIC_CELL_INACT_...3,SET,9,0.12349,0.0027334,0.31405,0.34708,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.971121083755733
GOBP_POTASSIUM_ION_TRANSPORT,SET,227,0.023826,0.0026328,0.060595,0.34709,GOBP_POTASSIUM_ION_TRANSPORT,0.971121083755733
HP_DELAYED_SOMATOSENSORY_CEN...,SET,3,0.19132,0.0024453,0.48664,0.34711,HP_DELAYED_SOMATOSENSORY_CENTRAL_CONDUCTION_TIME,0.971121083755733
KEGG_MEDICUS_REFERENCE_GPI_A...,SET,23,0.063159,0.002234,0.16069,0.34714,KEGG_MEDICUS_REFERENCE_GPI_ANCHOR_BIOSYNTHESIS,0.971121083755733
GSE44649_WT_VS_MIR155_KO_ACT...1,SET,182,0.023986,0.0023762,0.061026,0.34714,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN,0.971121083755733
GOBP_POSITIVE_REGULATION_OF_...744,SET,33,0.062944,0.0026661,0.16018,0.34718,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,0.971121083755733
STK33_NOMO_DN,SET,233,0.022087,0.0024723,0.056207,0.34718,STK33_NOMO_DN,0.971121083755733
GSE17721_CPG_VS_GARDIQUIMOD_...15,SET,172,0.024044,0.0023162,0.061198,0.3472,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN,0.971121083755733
DER_IFN_ALPHA_RESPONSE_UP,SET,72,0.038846,0.0024278,0.098881,0.34722,DER_IFN_ALPHA_RESPONSE_UP,0.971121083755733
YANG_BCL3_TARGETS_UP,SET,308,0.019229,0.0024694,0.048958,0.34725,YANG_BCL3_TARGETS_UP,0.971121083755733
GOBP_MATURE_B_CELL_DIFFERENT...2,SET,29,0.064557,0.0025636,0.16439,0.34727,GOBP_MATURE_B_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,0.971121083755733
HP_PUSTULE,SET,25,0.068109,0.0025115,0.17346,0.34729,HP_PUSTULE,0.971121083755733
MIR6871_3P,SET,116,0.032222,0.0025531,0.08211,0.34737,MIR6871_3P,0.971266641190668
FUNG_IL2_SIGNALING_1,SET,9,0.10868,0.0024055,0.277,0.34741,FUNG_IL2_SIGNALING_1,0.971283763925101
HP_TAPERED_FINGER,SET,111,0.02961,0.0022953,0.075515,0.34749,HP_TAPERED_FINGER,0.971283763925101
GSE17721_12H_VS_24H_POLYIC_B...1,SET,180,0.023947,0.0023594,0.061073,0.34749,GSE17721_12H_VS_24H_POLYIC_BMDC_DN,0.971283763925101
MIR4683,SET,47,0.050714,0.0025626,0.12937,0.34753,MIR4683,0.971283763925101
GSE14350_IL2RB_KO_VS_WT_TEFF...2,SET,181,0.024456,0.0024161,0.062401,0.34756,GSE14350_IL2RB_KO_VS_WT_TEFF_UP,0.971283763925101
GOBP_P_BODY_ASSEMBLY,SET,21,0.069304,0.0023425,0.17686,0.34758,GOBP_P_BODY_ASSEMBLY,0.971283763925101
GOBP_REGULATION_OF_SYNAPSE_M...,SET,21,0.072825,0.0024615,0.18584,0.34758,GOBP_REGULATION_OF_SYNAPSE_MATURATION,0.971283763925101
GOBP_PROTEIN_LOCALIZATION_TO...41,SET,6,0.11652,0.0021061,0.29742,0.34761,GOBP_PROTEIN_LOCALIZATION_TO_PERINUCLEAR_REGION_OF_CYTOPLASM,0.971283763925101
MIR6758_5P,SET,99,0.033059,0.002421,0.084413,0.34767,MIR6758_5P,0.971283763925101
MODULE_131,SET,31,0.05912,0.0024272,0.15098,0.34769,MODULE_131,0.971283763925101
MORF_NME2,SET,137,0.026395,0.0022714,0.06743,0.34774,MORF_NME2,0.971283763925101
GSE1432_1H_VS_24H_IFNG_MICRO...2,SET,188,0.025115,0.0025283,0.064163,0.34774,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,0.971283763925101
GAJATE_RESPONSE_TO_TRABECTED...2,SET,59,0.044527,0.00252,0.11379,0.34779,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,0.971283763925101
HP_DIAPHRAGMATIC_EVENTRATION,SET,18,0.07313,0.0022886,0.1869,0.3478,HP_DIAPHRAGMATIC_EVENTRATION,0.971283763925101
GSE5542_UNTREATED_VS_IFNA_AN...1,SET,179,0.023608,0.0023196,0.060353,0.34784,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.971283763925101
chr7q35,SET,17,0.12619,0.003838,0.32268,0.34787,chr7q35,0.971283763925101
HP_MULTIFOCAL_EPILEPTIFORM_D...,SET,66,0.042611,0.0025501,0.10896,0.34787,HP_MULTIFOCAL_EPILEPTIFORM_DISCHARGES,0.971283763925101
WP_ANGIOGENESIS,SET,24,0.070732,0.0025556,0.18094,0.34794,WP_ANGIOGENESIS,0.971283763925101
PID_SYNDECAN_2_PATHWAY,SET,31,0.061227,0.0025137,0.15669,0.34799,PID_SYNDECAN_2_PATHWAY,0.971283763925101
GOBP_REGULATION_OF_EPITHELIA...8,SET,6,0.15179,0.0027435,0.38848,0.348,GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION,0.971283763925101
DOUGLAS_BMI1_TARGETS_UP,SET,513,0.014897,0.002455,0.038135,0.34804,DOUGLAS_BMI1_TARGETS_UP,0.971283763925101
KEGG_MEDICUS_REFERENCE_GLYCO...1,SET,5,0.13528,0.0022321,0.34652,0.34813,KEGG_MEDICUS_REFERENCE_GLYCOGEN_BIOSYNTHESIS,0.971283763925101
GOCC_NUCLEAR_EXOSOME_RNASE_C...,SET,14,0.077109,0.0021284,0.19762,0.3482,GOCC_NUCLEAR_EXOSOME_RNASE_COMPLEX,0.971283763925101
GSE12845_IGD_POS_BLOOD_VS_DA...1,SET,174,0.023533,0.0022801,0.060324,0.34823,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.971283763925101
HP_LOWER_LIMB_JOINT_CONTRACT...,SET,197,0.02377,0.0024489,0.06095,0.34827,HP_LOWER_LIMB_JOINT_CONTRACTURE,0.971283763925101
HP_XEROSTOMIA,SET,52,0.045324,0.0024086,0.11622,0.34827,HP_XEROSTOMIA,0.971283763925101
GOBP_POSITIVE_REGULATION_OF_...440,SET,76,0.039091,0.0025098,0.10025,0.3483,GOBP_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,0.971283763925101
HP_RESTRICTIVE_VENTILATORY_D...,SET,90,0.03512,0.0024528,0.090069,0.3483,HP_RESTRICTIVE_VENTILATORY_DEFECT,0.971283763925101
GOBP_AUTOCRINE_SIGNALING,SET,7,0.1387,0.0027076,0.35573,0.34831,GOBP_AUTOCRINE_SIGNALING,0.971283763925101
IWANAGA_CARCINOGENESIS_BY_KR...1,SET,115,0.030637,0.002417,0.078606,0.34836,IWANAGA_CARCINOGENESIS_BY_KRAS_DN,0.971283763925101
GOBP_MATURE_B_CELL_DIFFERENT...1,SET,34,0.059588,0.0025618,0.15291,0.34839,GOBP_MATURE_B_CELL_DIFFERENTIATION,0.971283763925101
HP_ABNORMAL_THYMUS_MORPHOLOGY,SET,51,0.04802,0.0025273,0.12323,0.34839,HP_ABNORMAL_THYMUS_MORPHOLOGY,0.971283763925101
IRF5_TARGET_GENES,SET,654,0.012618,0.0023385,0.032391,0.34844,IRF5_TARGET_GENES,0.971283763925101
MISSIAGLIA_REGULATED_BY_METH...2,SET,109,0.032783,0.0025184,0.084164,0.34845,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,0.971283763925101
GOBP_PEPTIDYL_THREONINE_DEPH...,SET,17,0.084044,0.0025561,0.21603,0.34862,GOBP_PEPTIDYL_THREONINE_DEPHOSPHORYLATION,0.971283763925101
GOMF_METALLOAMINOPEPTIDASE_A...,SET,23,0.074897,0.0026492,0.19253,0.34864,GOMF_METALLOAMINOPEPTIDASE_ACTIVITY,0.971283763925101
ACEVEDO_METHYLATED_IN_LIVER_...,SET,683,0.013853,0.0026217,0.035615,0.34865,ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN,0.971283763925101
GOMF_ATPASE_INHIBITOR_ACTIVI...,SET,4,0.15855,0.0023399,0.40765,0.34866,GOMF_ATPASE_INHIBITOR_ACTIVITY,0.971283763925101
HSF1_01,SET,246,0.020785,0.0023897,0.05347,0.34874,HSF1_01,0.971283763925101
GSE17721_0.5H_VS_12H_GARDIQU...2,SET,184,0.022527,0.0022438,0.057955,0.34875,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_UP,0.971283763925101
MOSERLE_IFNA_RESPONSE,SET,30,0.069666,0.0028137,0.17939,0.34888,MOSERLE_IFNA_RESPONSE,0.971283763925101
HP_HYPOPLASIA_OF_THE_UTERUS,SET,47,0.049129,0.0024824,0.12655,0.34893,HP_HYPOPLASIA_OF_THE_UTERUS,0.971283763925101
REACTOME_NADE_MODULATES_DEAT...,SET,5,0.17425,0.0028752,0.44888,0.34894,REACTOME_NADE_MODULATES_DEATH_SIGNALLING,0.971283763925101
WIERENGA_STAT5A_TARGETS_DN,SET,175,0.025754,0.0025023,0.06638,0.34902,WIERENGA_STAT5A_TARGETS_DN,0.971283763925101
REACTOME_CATION_COUPLED_CHLO...,SET,7,0.11088,0.0021646,0.28588,0.34906,REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS,0.971283763925101
SHEPARD_CRASH_AND_BURN_MUTAN...2,SET,187,0.024382,0.0024481,0.062873,0.34908,SHEPARD_CRASH_AND_BURN_MUTANT_UP,0.971283763925101
GSE2128_C57BL6_VS_NOD_THYMOC...3,SET,183,0.024546,0.0024382,0.063296,0.34909,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_UP,0.971283763925101
HE_LIM_SUN_FETAL_LUNG_C1_EAR...2,SET,497,0.0145,0.0023531,0.037399,0.34912,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL,0.971283763925101
HP_SPASTIC_PARAPLEGIA,SET,95,0.03367,0.0024156,0.086873,0.34917,HP_SPASTIC_PARAPLEGIA,0.971283763925101
IK1_01,SET,250,0.020879,0.0024196,0.053877,0.34919,IK1_01,0.971283763925101
AP4_Q6,SET,199,0.023347,0.0024174,0.06026,0.34922,AP4_Q6,0.971283763925101
TANG_SENESCENCE_TP53_TARGETS...2,SET,31,0.058639,0.0024074,0.1514,0.34927,TANG_SENESCENCE_TP53_TARGETS_UP,0.971283763925101
KEGG_MEDICUS_REFERENCE_PKA_H...,SET,7,0.12968,0.0025316,0.33488,0.34929,KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME,0.971283763925101
GOCC_CAMP_DEPENDENT_PROTEIN_...,SET,7,0.12968,0.0025316,0.33488,0.34929,GOCC_CAMP_DEPENDENT_PROTEIN_KINASE_COMPLEX,0.971283763925101
PAPASPYRIDONOS_UNSTABLE_ATER...2,SET,51,0.047137,0.0024808,0.12176,0.34934,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,0.971283763925101
GOBP_PYRIMIDINE_NUCLEOSIDE_B...,SET,4,0.14922,0.0022022,0.3855,0.34935,GOBP_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,0.971283763925101
GOBP_POSITIVE_THYMIC_T_CELL_...,SET,15,0.088941,0.0025411,0.22984,0.34939,GOBP_POSITIVE_THYMIC_T_CELL_SELECTION,0.971283763925101
GOBP_EPHRIN_RECEPTOR_SIGNALI...,SET,48,0.048169,0.0024596,0.12453,0.34945,GOBP_EPHRIN_RECEPTOR_SIGNALING_PATHWAY,0.971283763925101
GOBP_REGULATION_OF_HEPATOCYT...2,SET,16,0.078485,0.0023158,0.20292,0.34946,GOBP_REGULATION_OF_HEPATOCYTE_PROLIFERATION,0.971283763925101
GOCC_ENDOPLASMIC_RETICULUM_P...3,SET,111,0.029832,0.0023125,0.077168,0.34953,GOCC_ENDOPLASMIC_RETICULUM_PROTEIN_CONTAINING_COMPLEX,0.971283763925101
BOYAULT_LIVER_CANCER_SUBCLAS...8,SET,10,0.10627,0.0024795,0.27494,0.34955,BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN,0.971283763925101
GOMF_MAP_KINASE_ACTIVITY,SET,16,0.090945,0.0026835,0.23537,0.3496,GOMF_MAP_KINASE_ACTIVITY,0.971283763925101
REACTOME_P75_NTR_RECEPTOR_ME...,SET,87,0.035613,0.0024456,0.092194,0.34964,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,0.971283763925101
GOBP_MAST_CELL_PROLIFERATION,SET,7,0.13505,0.0026365,0.34961,0.34964,GOBP_MAST_CELL_PROLIFERATION,0.971283763925101
MORF_RAD54L,SET,91,0.031577,0.0022175,0.081758,0.34967,MORF_RAD54L,0.971283763925101
HP_BROAD_ISCHIA,SET,5,0.15643,0.002581,0.4051,0.3497,HP_BROAD_ISCHIA,0.971283763925101
GSE6259_FLT3L_INDUCED_33D1_P...2,SET,177,0.023547,0.0023007,0.060992,0.34973,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_UP,0.971283763925101
MIR5579_3P,SET,140,0.027788,0.0024172,0.07201,0.34979,MIR5579_3P,0.971283763925101
REACTOME_REGULATED_NECROSIS,SET,54,0.044415,0.0024052,0.11514,0.34984,REACTOME_REGULATED_NECROSIS,0.971283763925101
BRUINS_UVC_RESPONSE_VIA_TP53...1,SET,815,0.011734,0.0024166,0.03042,0.34985,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A,0.971283763925101
WP_DISORDERS_OF_GALACTOSE_ME...,SET,12,0.090325,0.0023084,0.23424,0.34989,WP_DISORDERS_OF_GALACTOSE_METABOLISM,0.971283763925101
MORI_EMU_MYC_LYMPHOMA_BY_ONS...2,SET,104,0.030617,0.0022977,0.079417,0.34993,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,0.971283763925101
WANG_IMMORTALIZED_BY_HOXA9_A...2,SET,30,0.065664,0.0026521,0.17036,0.34996,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP,0.971283763925101
GOBP_REGULATION_OF_IRON_ION_...1,SET,3,0.17173,0.0021949,0.44553,0.34996,GOBP_REGULATION_OF_IRON_ION_TRANSMEMBRANE_TRANSPORT,0.971283763925101
IIZUKA_LIVER_CANCER_PROGRESS...5,SET,15,0.080348,0.0022956,0.20848,0.34997,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN,0.971283763925101
OHASHI_AURKB_TARGETS,SET,7,0.12202,0.002382,0.3166,0.34997,OHASHI_AURKB_TARGETS,0.971283763925101
DESCARTES_FETAL_EYE_VASCULAR...,SET,81,0.038835,0.0025737,0.10077,0.34998,DESCARTES_FETAL_EYE_VASCULAR_ENDOTHELIAL_CELLS,0.971283763925101
MIR3065_3P,SET,234,0.021555,0.0024178,0.055951,0.35003,MIR3065_3P,0.971283763925101
GSE24634_NAIVE_CD4_TCELL_VS_...6,SET,184,0.023583,0.002349,0.061242,0.35009,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP,0.971283763925101
GSE13306_RA_VS_UNTREATED_TRE...1,SET,190,0.024083,0.0024371,0.062554,0.35012,GSE13306_RA_VS_UNTREATED_TREG_DN,0.971283763925101
HP_APLASIA_HYPOPLASIA_OF_THE...11,SET,80,0.035376,0.00233,0.0919,0.35014,HP_APLASIA_HYPOPLASIA_OF_THE_BRAINSTEM,0.971283763925101
GSE19941_UNSTIM_VS_LPS_STIM_...4,SET,182,0.023467,0.0023247,0.060974,0.35017,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.971283763925101
LEE_LIVER_CANCER_MYC_TGFA_UP,SET,58,0.045863,0.0025736,0.11918,0.35019,LEE_LIVER_CANCER_MYC_TGFA_UP,0.971283763925101
VALK_AML_CLUSTER_4,SET,25,0.068942,0.0025422,0.17925,0.35027,VALK_AML_CLUSTER_4,0.971283763925101
chr18q23,SET,15,0.12642,0.0036118,0.32872,0.35028,chr18q23,0.971283763925101
GOBP_ADHERENS_JUNCTION_MAINT...,SET,6,0.14439,0.0026097,0.37546,0.35028,GOBP_ADHERENS_JUNCTION_MAINTENANCE,0.971283763925101
HP_ABNORMAL_SYNAPTIC_TRANSMI...,SET,111,0.030483,0.002363,0.079271,0.35029,HP_ABNORMAL_SYNAPTIC_TRANSMISSION_AT_THE_NEUROMUSCULAR_JUNCTION,0.971283763925101
SCHLOSSER_SERUM_RESPONSE_UP,SET,116,0.030179,0.0023912,0.078503,0.35033,SCHLOSSER_SERUM_RESPONSE_UP,0.971283763925101
REACTOME_SIGNALING_BY_RECEPT...,SET,508,0.0149,0.0024438,0.038758,0.35033,REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,0.971283763925101
HP_SEVERE_COMBINED_IMMUNODEF...,SET,19,0.077396,0.0024884,0.20133,0.35034,HP_SEVERE_COMBINED_IMMUNODEFICIENCY,0.971283763925101
NUYTTEN_EZH2_TARGETS_DN,SET,908,0.010466,0.0022691,0.027233,0.35038,NUYTTEN_EZH2_TARGETS_DN,0.971283763925101
GOBP_REGULATION_OF_PHENOTYPI...,SET,3,0.21092,0.0026959,0.54886,0.35038,GOBP_REGULATION_OF_PHENOTYPIC_SWITCHING,0.971283763925101
HP_DERMAL_TRANSLUCENCY,SET,25,0.066201,0.0024411,0.17227,0.35038,HP_DERMAL_TRANSLUCENCY,0.971283763925101
HP_INCREASED_SULFUR_AMINO_AC...,SET,15,0.089479,0.0025565,0.23295,0.35045,HP_INCREASED_SULFUR_AMINO_ACID_LEVEL_IN_URINE,0.971283763925101
GOMF_CYTOSKELETAL_ANCHOR_ACT...,SET,23,0.066461,0.0023508,0.17307,0.35049,GOMF_CYTOSKELETAL_ANCHOR_ACTIVITY,0.971283763925101
REACTOME_SUMOYLATION_OF_RNA_...,SET,44,0.045948,0.0022466,0.11971,0.35056,REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS,0.971283763925101
MIR411_5P,SET,44,0.047547,0.0023248,0.12389,0.35058,MIR411_5P,0.971283763925101
SU_TESTIS,SET,68,0.037035,0.0022496,0.096516,0.3506,SU_TESTIS,0.971283763925101
GOBP_MYCOTOXIN_METABOLIC_PRO...,SET,7,0.12026,0.0023476,0.31347,0.35063,GOBP_MYCOTOXIN_METABOLIC_PROCESS,0.971283763925101
KRAS.LUNG_UP.V1_UP,SET,122,0.031277,0.0025411,0.081554,0.35067,KRAS.LUNG_UP.V1_UP,0.971283763925101
GOMF_IMMUNOGLOBULIN_RECEPTOR...2,SET,9,0.12237,0.0027085,0.31914,0.3507,GOMF_IMMUNOGLOBULIN_RECEPTOR_BINDING,0.971283763925101
BIOCARTA_BOTULIN_PATHWAY,SET,5,0.15672,0.0025859,0.40875,0.35071,BIOCARTA_BOTULIN_PATHWAY,0.971283763925101
REACTOME_DEFECTS_OF_PLATELET...,SET,8,0.1191,0.0024856,0.31065,0.35071,REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,0.971283763925101
SMID_BREAST_CANCER_RELAPSE_I...7,SET,37,0.055882,0.002506,0.14576,0.35072,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,0.971283763925101
GOBP_FEMALE_SEX_DIFFERENTIAT...,SET,116,0.031693,0.0025112,0.08268,0.35074,GOBP_FEMALE_SEX_DIFFERENTIATION,0.971283763925101
GOBP_REGULATION_OF_MAST_CELL...1,SET,16,0.085796,0.0025316,0.22386,0.35077,GOBP_REGULATION_OF_MAST_CELL_ACTIVATION,0.971283763925101
GOBP_INFLAMMATORY_RESPONSE,SET,778,0.012413,0.0025004,0.032393,0.35079,GOBP_INFLAMMATORY_RESPONSE,0.971283763925101
HP_CONGENITAL_FINGER_FLEXION...,SET,11,0.10847,0.0026541,0.28316,0.35084,HP_CONGENITAL_FINGER_FLEXION_CONTRACTURES,0.971283763925101
ZSCAN21_TARGET_GENES,SET,393,0.016037,0.0023209,0.041875,0.35088,ZSCAN21_TARGET_GENES,0.971283763925101
GOBP_ESTABLISHMENT_OR_MAINTE...1,SET,51,0.047177,0.0024829,0.12326,0.35096,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY,0.971283763925101
HP_NONCOMMUNICATING_HYDROCEP...,SET,6,0.13378,0.0024179,0.34959,0.35099,HP_NONCOMMUNICATING_HYDROCEPHALUS,0.971283763925101
REACTOME_DNA_DOUBLE_STRAND_B...2,SET,38,0.050535,0.0022966,0.13208,0.351,REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE,0.971283763925101
MIR6877_3P,SET,31,0.057841,0.0023747,0.15116,0.351,MIR6877_3P,0.971283763925101
GOBP_COLLAGEN_CATABOLIC_PROC...,SET,39,0.057939,0.0026674,0.15143,0.351,GOBP_COLLAGEN_CATABOLIC_PROCESS,0.971283763925101
GOBP_NEURON_PROJECTION_EXTEN...2,SET,19,0.078566,0.002526,0.20537,0.35103,GOBP_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE,0.971283763925101
HP_FACIAL_PARALYSIS,SET,10,0.11395,0.0026585,0.29787,0.35103,HP_FACIAL_PARALYSIS,0.971283763925101
GOBP_B_CELL_PROLIFERATION_IN...,SET,6,0.15021,0.0027149,0.39268,0.35104,GOBP_B_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE,0.971283763925101
TAF9B_TARGET_GENES,SET,397,0.015991,0.0023258,0.041814,0.35107,TAF9B_TARGET_GENES,0.971283763925101
HP_RETINAL_HOLE,SET,5,0.14395,0.0023752,0.37645,0.35108,HP_RETINAL_HOLE,0.971283763925101
GSE3203_UNTREATED_VS_IFNB_TR...2,SET,169,0.024139,0.0023052,0.063126,0.35109,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP,0.971283763925101
GSE14308_NAIVE_CD4_TCELL_VS_...3,SET,182,0.023813,0.0023591,0.062284,0.35111,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN,0.971283763925101
REACTOME_ACTIVATED_NTRK2_SIG...5,SET,9,0.096838,0.0021435,0.2533,0.35112,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS,0.971283763925101
GOBP_POSITIVE_REGULATION_OF_...169,SET,13,0.099013,0.0026337,0.25901,0.35113,GOBP_POSITIVE_REGULATION_OF_CILIUM_MOVEMENT,0.971283763925101
GOMF_DOUBLE_STRANDED_RNA_BIN...,SET,69,0.036688,0.0022449,0.095974,0.35113,GOMF_DOUBLE_STRANDED_RNA_BINDING,0.971283763925101
GOBP_POSITIVE_REGULATION_OF_...606,SET,6,0.15605,0.0028204,0.40825,0.35115,GOBP_POSITIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS,0.971283763925101
HP_DIFFUSE_MESANGIAL_SCLEROS...,SET,38,0.051468,0.002339,0.13467,0.35116,HP_DIFFUSE_MESANGIAL_SCLEROSIS,0.971283763925101
AHR_01,SET,54,0.042473,0.0023,0.11114,0.35118,AHR_01,0.971283763925101
GOBP_NEGATIVE_REGULATION_OF_...114,SET,14,0.089745,0.0024772,0.23488,0.3512,GOBP_NEGATIVE_REGULATION_OF_CELL_DIVISION,0.971283763925101
MORF_PPP2CA,SET,117,0.027213,0.0021654,0.071229,0.35121,MORF_PPP2CA,0.971283763925101
MIR4520_5P,SET,6,0.14264,0.0025781,0.37363,0.35132,MIR4520_5P,0.971283763925101
GSE25123_WT_VS_PPARG_KO_MACR...5,SET,178,0.024283,0.0023793,0.063605,0.35132,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP,0.971283763925101
GSE34006_A2AR_KO_VS_A2AR_AGO...1,SET,188,0.022558,0.0022709,0.059092,0.35133,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN,0.971283763925101
HP_SPINAL_RIGIDITY,SET,54,0.043009,0.002329,0.1127,0.35138,HP_SPINAL_RIGIDITY,0.971283763925101
HP_BROAD_PALM,SET,24,0.064474,0.0023295,0.169,0.35142,HP_BROAD_PALM,0.971283763925101
MIR4760_3P,SET,249,0.020905,0.0024179,0.054801,0.35143,MIR4760_3P,0.971283763925101
GOBP_REGULATION_OF_INSULIN_S...2,SET,51,0.044754,0.0023554,0.11739,0.35151,GOBP_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.971283763925101
GSE17974_0H_VS_4H_IN_VITRO_A...2,SET,168,0.0249,0.0023709,0.065315,0.35152,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP,0.971283763925101
HP_DEVIATION_OF_THE_HALLUX,SET,75,0.039238,0.0025027,0.10294,0.35154,HP_DEVIATION_OF_THE_HALLUX,0.971283763925101
GOBP_CELLULAR_RESPONSE_TO_GL...1,SET,12,0.0995,0.0025429,0.26117,0.35161,GOBP_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS,0.971283763925101
GOBP_T_TUBULE_ORGANIZATION,SET,6,0.11974,0.0021641,0.31435,0.35164,GOBP_T_TUBULE_ORGANIZATION,0.971283763925101
REACTOME_RHOG_GTPASE_CYCLE,SET,68,0.040939,0.0024868,0.10748,0.35165,REACTOME_RHOG_GTPASE_CYCLE,0.971283763925101
GOCC_VOLTAGE_GATED_SODIUM_CH...,SET,14,0.10145,0.0028004,0.26645,0.3517,GOCC_VOLTAGE_GATED_SODIUM_CHANNEL_COMPLEX,0.971283763925101
HP_ABNORMAL_ASTROCYTE_MORPHO...,SET,45,0.046875,0.0023177,0.12312,0.35171,HP_ABNORMAL_ASTROCYTE_MORPHOLOGY,0.971283763925101
GSE19401_UNSTIM_VS_PAM2CSK4_...1,SET,183,0.023473,0.0023317,0.061653,0.35171,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.971283763925101
HP_ABNORMAL_RENAL_TUBULE_MOR...,SET,74,0.037404,0.0023698,0.09827,0.35174,HP_ABNORMAL_RENAL_TUBULE_MORPHOLOGY,0.971283763925101
OCT1_06,SET,221,0.023016,0.0025098,0.060483,0.35178,OCT1_06,0.971283763925101
BASSO_HAIRY_CELL_LEUKEMIA_DN,SET,4,0.17028,0.0025131,0.44755,0.3518,BASSO_HAIRY_CELL_LEUKEMIA_DN,0.971283763925101
HP_MENINGITIS,SET,65,0.041603,0.0024709,0.10934,0.3518,HP_MENINGITIS,0.971283763925101
HP_IMPAIRED_HORIZONTAL_SMOOT...,SET,7,0.11525,0.0022499,0.30305,0.35186,HP_IMPAIRED_HORIZONTAL_SMOOTH_PURSUIT,0.971283763925101
MIR628_3P,SET,66,0.036954,0.0022116,0.097178,0.35187,MIR628_3P,0.971283763925101
HP_THINNING_OF_DESCEMET_MEMB...,SET,6,0.15384,0.0027805,0.40454,0.35187,HP_THINNING_OF_DESCEMET_MEMBRANE,0.971283763925101
STARK_HYPPOCAMPUS_22Q11_DELE...2,SET,46,0.047455,0.0023723,0.12485,0.35194,STARK_HYPPOCAMPUS_22Q11_DELETION_UP,0.971283763925101
GOBP_POSITIVE_REGULATION_OF_...523,SET,61,0.044308,0.0025496,0.11657,0.35194,GOBP_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.971283763925101
HP_INSULIN_RESISTANCE,SET,104,0.032638,0.0024494,0.085868,0.35194,HP_INSULIN_RESISTANCE,0.971283763925101
GSE17721_POLYIC_VS_PAM3CSK4_...6,SET,187,0.023013,0.0023106,0.060558,0.35197,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP,0.971283763925101
GOBP_CLEARANCE_OF_FOREIGN_IN...,SET,6,0.18098,0.003271,0.47653,0.35206,GOBP_CLEARANCE_OF_FOREIGN_INTRACELLULAR_NUCLEIC_ACIDS,0.971283763925101
GOMF_CD4_RECEPTOR_BINDING,SET,7,0.12913,0.0025208,0.3401,0.35209,GOMF_CD4_RECEPTOR_BINDING,0.971283763925101
WP_OXIDATION_BY_CYTOCHROME_P...,SET,61,0.045984,0.0026461,0.12112,0.3521,WP_OXIDATION_BY_CYTOCHROME_P450,0.971283763925101
HP_ABNORMAL_4TH_METACARPAL_M...,SET,14,0.092855,0.002563,0.24457,0.3521,HP_ABNORMAL_4TH_METACARPAL_MORPHOLOGY,0.971283763925101
GOBP_NEGATIVE_REGULATION_OF_...467,SET,26,0.065784,0.0024737,0.17336,0.35217,GOBP_NEGATIVE_REGULATION_OF_ORGAN_GROWTH,0.971283763925101
HP_DERMAL_ATROPHY,SET,90,0.033099,0.0023117,0.087224,0.35217,HP_DERMAL_ATROPHY,0.971283763925101
GSE10325_BCELL_VS_LUPUS_BCEL...2,SET,163,0.024905,0.0023361,0.065646,0.3522,GSE10325_BCELL_VS_LUPUS_BCELL_UP,0.971283763925101
HP_PROGRESSIVE_PSYCHOMOTOR_D...,SET,12,0.087421,0.0022342,0.23045,0.35221,HP_PROGRESSIVE_PSYCHOMOTOR_DETERIORATION,0.971283763925101
BIOCARTA_CDK5_PATHWAY,SET,13,0.093873,0.0024969,0.2475,0.35224,BIOCARTA_CDK5_PATHWAY,0.971283763925101
TRAVAGLINI_LUNG_CLUB_CELL,SET,102,0.033614,0.0024984,0.088624,0.35224,TRAVAGLINI_LUNG_CLUB_CELL,0.971283763925101
KEGG_MEDICUS_REFERENCE_MACHR...,SET,18,0.074804,0.002341,0.19731,0.3523,KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY,0.971283763925101
GSE10239_NAIVE_VS_DAY4.5_EFF...2,SET,187,0.023821,0.0023917,0.062838,0.35232,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP,0.971283763925101
MORF_PRDX3,SET,72,0.034956,0.0021847,0.092231,0.35235,MORF_PRDX3,0.971283763925101
REACTOME_METALLOPROTEASE_DUBS,SET,15,0.085444,0.0024412,0.22547,0.35236,REACTOME_METALLOPROTEASE_DUBS,0.971283763925101
DUTERTRE_ESTRADIOL_RESPONSE_...4,SET,209,0.021852,0.0023181,0.057671,0.35238,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,0.971283763925101
MORI_SMALL_PRE_BII_LYMPHOCYT...2,SET,73,0.03774,0.0023749,0.099602,0.35238,MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,0.971283763925101
IKEDA_MIR30_TARGETS_DN,SET,22,0.071652,0.0024787,0.18919,0.35245,IKEDA_MIR30_TARGETS_DN,0.971283763925101
GSE24634_TREG_VS_TCONV_POST_...2,SET,180,0.023133,0.0022791,0.061094,0.35248,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP,0.971283763925101
GOBP_REGULATION_OF_CELL_ACTI...,SET,578,0.014075,0.0024576,0.037174,0.35249,GOBP_REGULATION_OF_CELL_ACTIVATION,0.971283763925101
GOCC_EXORIBONUCLEASE_COMPLEX,SET,22,0.05917,0.0020469,0.15632,0.35252,GOCC_EXORIBONUCLEASE_COMPLEX,0.971283763925101
GOMF_MITOGEN_ACTIVATED_PROTE...3,SET,16,0.073636,0.0021728,0.19456,0.35254,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING,0.971283763925101
GSE17580_TREG_VS_TEFF_UP,SET,182,0.023298,0.002308,0.061559,0.35254,GSE17580_TREG_VS_TEFF_UP,0.971283763925101
MODULE_109,SET,35,0.055427,0.0024177,0.14646,0.35255,MODULE_109,0.971283763925101
KORKOLA_EMBRYONIC_CARCINOMA_...1,SET,19,0.074902,0.0024082,0.19797,0.35259,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN,0.971283763925101
GOBP_BILE_ACID_BIOSYNTHETIC_...,SET,36,0.054142,0.002395,0.14312,0.35261,GOBP_BILE_ACID_BIOSYNTHETIC_PROCESS,0.971283763925101
GOBP_POSITIVE_REGULATION_OF_...397,SET,7,0.11438,0.0022328,0.30245,0.35265,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS,0.971283763925101
HP_CAROTID_ARTERY_STENOSIS,SET,6,0.12981,0.0023462,0.34328,0.35266,HP_CAROTID_ARTERY_STENOSIS,0.971283763925101
GSE15330_WT_VS_IKAROS_KO_MEG...1,SET,184,0.023792,0.0023698,0.062916,0.35266,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.971283763925101
WP_KALLMANN_SYNDROME,SET,23,0.067065,0.0023721,0.17736,0.35267,WP_KALLMANN_SYNDROME,0.971283763925101
GSE15330_LYMPHOID_MULTIPOTEN...7,SET,149,0.026516,0.002379,0.070132,0.35268,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,0.971283763925101
GSE17974_0H_VS_12H_IN_VITRO_...1,SET,176,0.022873,0.0022287,0.060493,0.35268,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN,0.971283763925101
MIR6871_5P,SET,51,0.04968,0.0026146,0.13141,0.3527,MIR6871_5P,0.971283763925101
GSE9960_GRAM_NEG_VS_GRAM_NEG...2,SET,151,0.025659,0.0023173,0.067873,0.3527,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,0.971283763925101
HP_ABNORMAL_UVULA_MORPHOLOGY,SET,168,0.023989,0.0022841,0.063474,0.35274,HP_ABNORMAL_UVULA_MORPHOLOGY,0.971283763925101
GOBP_WATER_TRANSPORT,SET,25,0.072712,0.0026812,0.19245,0.35278,GOBP_WATER_TRANSPORT,0.971283763925101
HP_COUGH,SET,135,0.027731,0.0023691,0.073401,0.35279,HP_COUGH,0.971283763925101
HP_PROGRESSIVE_VISUAL_FIELD_...,SET,13,0.087214,0.0023198,0.23085,0.35279,HP_PROGRESSIVE_VISUAL_FIELD_DEFECTS,0.971283763925101
FLECHNER_BIOPSY_KIDNEY_TRANS...3,SET,504,0.014458,0.0023624,0.038276,0.35282,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,0.971283763925101
KEGG_MEDICUS_VARIANT_ESR1_PO...,SET,5,0.16215,0.0026755,0.42948,0.35288,KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,0.971283763925101
GSE40655_FOXO1_KO_VS_WT_NTRE...1,SET,169,0.023038,0.0022,0.061036,0.35292,GSE40655_FOXO1_KO_VS_WT_NTREG_DN,0.971283763925101
HP_KNEE_CONTRACTURE,SET,98,0.032878,0.0023956,0.087113,0.35293,HP_KNEE_CONTRACTURE,0.971283763925101
WP_COVID19_AND_ENDOTHELIAL_C...,SET,5,0.15749,0.0025985,0.41741,0.35298,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,0.971283763925101
GOBP_MULTI_CILIATED_EPITHELI...,SET,8,0.11198,0.0023369,0.29681,0.35299,GOBP_MULTI_CILIATED_EPITHELIAL_CELL_DIFFERENTIATION,0.971283763925101
GOBP_CENTRAL_NERVOUS_SYSTEM_...3,SET,8,0.12193,0.0025445,0.32332,0.35305,GOBP_CENTRAL_NERVOUS_SYSTEM_MYELIN_FORMATION,0.971283763925101
GSE4590_PRE_BCELL_VS_SMALL_P...2,SET,136,0.027135,0.0023267,0.071982,0.3531,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP,0.971283763925101
STAT1_03,SET,239,0.020705,0.0023469,0.054929,0.35311,STAT1_03,0.971283763925101
HP_BREAST_CARCINOMA,SET,68,0.036681,0.0022281,0.097314,0.35311,HP_BREAST_CARCINOMA,0.971283763925101
GSE8685_IL2_ACT_IL2_STARVED_...3,SET,127,0.027904,0.0023127,0.074043,0.35314,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,0.971283763925101
GOBP_REGULATION_OF_BEHAVIOR,SET,70,0.041594,0.0025633,0.11039,0.35316,GOBP_REGULATION_OF_BEHAVIOR,0.971283763925101
GSE6090_UNSTIM_VS_DC_SIGN_ST...1,SET,128,0.029534,0.0024573,0.078385,0.35317,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN,0.971283763925101
REACTOME_TACHYKININ_RECEPTOR...,SET,5,0.14627,0.0024134,0.38843,0.35325,REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS,0.971283763925101
DESCARTES_FETAL_SPLEEN_STROM...,SET,31,0.064737,0.0026578,0.17192,0.35325,DESCARTES_FETAL_SPLEEN_STROMAL_CELLS,0.971283763925101
MIR22_3P,SET,126,0.028527,0.0023551,0.075773,0.35328,MIR22_3P,0.971283763925101
GSE2770_UNTREATED_VS_TGFB_AN...11,SET,114,0.028782,0.0022609,0.076462,0.3533,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN,0.971283763925101
ACAWYAAAG_UNKNOWN,SET,91,0.034461,0.00242,0.091581,0.35336,ACAWYAAAG_UNKNOWN,0.971283763925101
GOBP_PROTEIN_EXIT_FROM_ENDOP...,SET,45,0.043388,0.0021454,0.11534,0.3534,GOBP_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,0.971283763925101
GOBP_IMMATURE_B_CELL_DIFFERE...,SET,12,0.095298,0.0024355,0.25337,0.35341,GOBP_IMMATURE_B_CELL_DIFFERENTIATION,0.971283763925101
GOBP_ASPARTATE_FAMILY_AMINO_...1,SET,21,0.072492,0.0024502,0.19276,0.35343,GOBP_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.971283763925101
MIR26A_5P,SET,455,0.015142,0.002354,0.040275,0.35347,MIR26A_5P,0.971283763925101
GOBP_TETRAHYDROFOLATE_INTERC...,SET,9,0.093809,0.0020764,0.24952,0.35348,GOBP_TETRAHYDROFOLATE_INTERCONVERSION,0.971283763925101
GSE17301_CTRL_VS_48H_ACD3_AC...1,SET,173,0.023551,0.0022752,0.062648,0.35349,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN,0.971283763925101
WP_RESOLVIN_E1_AND_RESOLVIN_...,SET,11,0.098916,0.0024204,0.26319,0.35352,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,0.971283763925101
GOBP_AXONAL_FASCICULATION,SET,20,0.079613,0.0026261,0.21201,0.35364,GOBP_AXONAL_FASCICULATION,0.971283763925101
GOBP_RADIAL_GLIA_GUIDED_PYRA...,SET,6,0.13935,0.0025186,0.3711,0.35364,GOBP_RADIAL_GLIA_GUIDED_PYRAMIDAL_NEURON_MIGRATION,0.971283763925101
HP_DEEP_PALMAR_CREASE,SET,28,0.057517,0.0022444,0.15319,0.35366,HP_DEEP_PALMAR_CREASE,0.971283763925101
PID_P75_NTR_PATHWAY,SET,59,0.040639,0.0023,0.10825,0.35368,PID_P75_NTR_PATHWAY,0.971283763925101
GOBP_NEGATIVE_REGULATION_OF_...78,SET,9,0.11902,0.0026344,0.31703,0.35368,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.971283763925101
BLANCO_MELO_BRONCHIAL_EPITHE...4,SET,124,0.02898,0.0023735,0.077199,0.35369,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,0.971283763925101
GOBP_LIPID_TRANSPORT_ACROSS_...,SET,5,0.14246,0.0023506,0.37951,0.35369,GOBP_LIPID_TRANSPORT_ACROSS_BLOOD_BRAIN_BARRIER,0.971283763925101
GOBP_REGULATION_OF_ANIMAL_OR...2,SET,82,0.037913,0.002528,0.101,0.35369,GOBP_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS,0.971283763925101
REACTOME_RAS_SIGNALING_DOWNS...,SET,7,0.11131,0.0021729,0.29656,0.35371,REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS,0.971283763925101
GSE17974_CTRL_VS_ACT_IL4_AND...2,SET,131,0.026232,0.0022078,0.069893,0.35372,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP,0.971283763925101
HP_AREFLEXIA_OF_LOWER_LIMBS,SET,76,0.034913,0.0022415,0.093059,0.35377,HP_AREFLEXIA_OF_LOWER_LIMBS,0.971344315847685
REACTOME_SELECTIVE_AUTOPHAGY,SET,80,0.035258,0.0023222,0.094002,0.3538,REACTOME_SELECTIVE_AUTOPHAGY,0.971349948653132
MODULE_575,SET,12,0.10468,0.0026753,0.27915,0.35383,MODULE_575,0.97135558056872
GOBP_ENDONUCLEOLYTIC_CLEAVAG...2,SET,9,0.10369,0.0022951,0.27664,0.3539,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_IN_ITS1_TO_SEPARATE_SSU_RRNA_FROM_5_8S_RRNA_AND_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.97139991708126
GSE20715_WT_VS_TLR4_KO_48H_O...2,SET,178,0.023758,0.0023278,0.063393,0.35392,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP,0.97139991708126
REACTOME_PREGNENOLONE_BIOSYN...,SET,10,0.10673,0.0024901,0.28483,0.35393,REACTOME_PREGNENOLONE_BIOSYNTHESIS,0.97139991708126
GSE5679_CTRL_VS_PPARG_LIGAND...2,SET,179,0.025296,0.0024854,0.067545,0.35402,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,0.971517241107343
HP_BROAD_METATARSAL,SET,12,0.093166,0.002381,0.24898,0.35413,HP_BROAD_METATARSAL,0.971517241107343
GOBP_NEGATIVE_REGULATION_OF_...379,SET,17,0.079173,0.002408,0.2116,0.35414,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.971517241107343
GOBP_7_METHYLGUANOSINE_RNA_C...,SET,5,0.10871,0.0017938,0.29059,0.35416,GOBP_7_METHYLGUANOSINE_RNA_CAPPING,0.971517241107343
GOBP_RESPONSE_TO_DIACYL_BACT...,SET,4,0.16518,0.0024378,0.44154,0.35417,GOBP_RESPONSE_TO_DIACYL_BACTERIAL_LIPOPEPTIDE,0.971517241107343
GSE14308_TH17_VS_NATURAL_TRE...1,SET,179,0.022178,0.0021791,0.059289,0.35418,GSE14308_TH17_VS_NATURAL_TREG_DN,0.971517241107343
MIR4760_5P,SET,181,0.023992,0.0023703,0.064142,0.35419,MIR4760_5P,0.971517241107343
MIR6859_5P,SET,189,0.0225,0.002271,0.060177,0.35424,MIR6859_5P,0.971517241107343
HP_TRISMUS,SET,13,0.077599,0.0020641,0.20753,0.35424,HP_TRISMUS,0.971517241107343
MOOTHA_GLUCONEOGENESIS,SET,27,0.056573,0.0021678,0.15134,0.35427,MOOTHA_GLUCONEOGENESIS,0.971517241107343
GOBP_SYNAPSE_MATURATION,SET,33,0.056683,0.0024009,0.15166,0.3543,GOBP_SYNAPSE_MATURATION,0.971517241107343
GOBP_NODAL_SIGNALING_PATHWAY,SET,16,0.086108,0.0025408,0.23041,0.35431,GOBP_NODAL_SIGNALING_PATHWAY,0.971517241107343
GOBP_PROTEIN_IMPORT_INTO_PER...4,SET,5,0.13497,0.0022269,0.36122,0.35434,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MEMBRANE,0.971517241107343
GSE24726_WT_VS_E2_2_KO_PDC_D...3,SET,177,0.022417,0.0021903,0.060012,0.35437,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_UP,0.971517241107343
MORF_PRKDC,SET,168,0.022638,0.0021555,0.060623,0.35442,MORF_PRKDC,0.971517241107343
GOBP_STEM_CELL_PROLIFERATION,SET,107,0.030931,0.0023543,0.082834,0.35442,GOBP_STEM_CELL_PROLIFERATION,0.971517241107343
MIR4766_3P,SET,151,0.027843,0.0025146,0.074616,0.35452,MIR4766_3P,0.971638088478827
HP_HIGH_FOREHEAD,SET,261,0.019481,0.0023061,0.052208,0.35452,HP_HIGH_FOREHEAD,0.971638088478827
HP_ABNORMAL_URINE_HORMONE_LE...,SET,16,0.080859,0.0023859,0.21681,0.35459,HP_ABNORMAL_URINE_HORMONE_LEVEL,0.97175330783788
KEGG_FOCAL_ADHESION,SET,190,0.023733,0.0024017,0.063665,0.35466,KEGG_FOCAL_ADHESION,0.971753854339087
REACTOME_TRANSCRIPTIONAL_REG...15,SET,79,0.034542,0.0022609,0.092662,0.35466,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,0.971753854339087
HP_ABNORMAL_NUMBER_OF_TEETH,SET,356,0.016822,0.0023196,0.045134,0.35468,HP_ABNORMAL_NUMBER_OF_TEETH,0.971753854339087
MIR4516,SET,271,0.019,0.0022912,0.050993,0.35472,MIR4516,0.971753854339087
GOCC_INNER_KINETOCHORE,SET,14,0.081347,0.0022454,0.21833,0.35473,GOCC_INNER_KINETOCHORE,0.971753854339087
GSE46606_UNSTIM_VS_CD40L_IL2...9,SET,189,0.023209,0.0023425,0.062326,0.35481,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,0.971798002364066
SHARMA_ASTROCYTOMA_WITH_NF1_...,SET,4,0.1596,0.0023554,0.42865,0.35483,SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM,0.971798002364066
REACTOME_METABOLISM_OF_VITAM...,SET,183,0.023016,0.0022863,0.061819,0.35483,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,0.971798002364066
GSE23321_CENTRAL_MEMORY_VS_N...1,SET,180,0.023695,0.0023346,0.063694,0.35494,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.972022669608384
GOBP_REGULATION_OF_LIPASE_AC...,SET,59,0.041891,0.0023708,0.11264,0.35498,GOBP_REGULATION_OF_LIPASE_ACTIVITY,0.972055617711945
TAKEDA_TARGETS_OF_NUP98_HOXA...4,SET,160,0.026707,0.0024822,0.071828,0.35502,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,0.972066740192217
GOBP_OSSIFICATION,SET,382,0.016895,0.0024114,0.045446,0.35504,GOBP_OSSIFICATION,0.972066740192217
BURTON_ADIPOGENESIS_6,SET,174,0.023045,0.0022327,0.062063,0.35521,BURTON_ADIPOGENESIS_6,0.972455576998818
HP_FATTY_REPLACEMENT_OF_SKEL...,SET,33,0.04983,0.0021106,0.13432,0.35533,HP_FATTY_REPLACEMENT_OF_SKELETAL_MUSCLE,0.972582082152974
GSE14308_NAIVE_CD4_TCELL_VS_...1,SET,182,0.02247,0.002226,0.060576,0.35534,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN,0.972582082152974
CHARAFE_BREAST_CANCER_BASAL_...2,SET,107,0.030268,0.0023039,0.08165,0.35543,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,0.972582082152974
MIR6883_5P,SET,372,0.016278,0.0022934,0.043922,0.35546,MIR6883_5P,0.972582082152974
chr1q31,SET,30,0.083087,0.0033557,0.22419,0.35547,chr1q31,0.972582082152974
GSE3982_MAC_VS_BASOPHIL_UP,SET,181,0.022987,0.002271,0.062029,0.35548,GSE3982_MAC_VS_BASOPHIL_UP,0.972582082152974
GOBP_FC_RECEPTOR_MEDIATED_ST...,SET,30,0.059371,0.0023979,0.16023,0.35549,GOBP_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.972582082152974
MORF_EPHA7,SET,125,0.028503,0.0023437,0.076926,0.3555,MORF_EPHA7,0.972582082152974
chr5q22,SET,26,0.1202,0.0045201,0.3246,0.35558,chr5q22,0.972582082152974
RIGGI_EWING_SARCOMA_PROGENIT...2,SET,389,0.017828,0.0025673,0.048143,0.35558,RIGGI_EWING_SARCOMA_PROGENITOR_UP,0.972582082152974
GOMF_RAGE_RECEPTOR_BINDING,SET,10,0.10756,0.0025094,0.29048,0.35559,GOMF_RAGE_RECEPTOR_BINDING,0.972582082152974
GOBP_REGULATION_OF_PROTEIN_M...3,SET,5,0.14184,0.0023403,0.38308,0.3556,GOBP_REGULATION_OF_PROTEIN_MONOUBIQUITINATION,0.972582082152974
MODULE_509,SET,12,0.085029,0.002173,0.22969,0.35562,MODULE_509,0.972582082152974
ROSS_AML_OF_FAB_M7_TYPE,SET,61,0.039627,0.0022803,0.10714,0.35574,ROSS_AML_OF_FAB_M7_TYPE,0.972599894042854
GSE11924_TH1_VS_TH2_CD4_TCEL...2,SET,192,0.021469,0.0021839,0.058052,0.35576,GSE11924_TH1_VS_TH2_CD4_TCELL_UP,0.972599894042854
GOBP_POSITIVE_REGULATION_OF_...718,SET,28,0.062306,0.0024312,0.16849,0.35577,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,0.972599894042854
KAECH_NAIVE_VS_DAY8_EFF_CD8_...2,SET,185,0.022361,0.0022332,0.060486,0.35581,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP,0.972599894042854
GOBP_REGULATION_OF_NEUROTRAN...2,SET,8,0.10766,0.0022468,0.29128,0.35584,GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,0.972599894042854
LI_ESTROGENE_META_E2_RESPONS...1,SET,22,0.070695,0.0024456,0.19134,0.35589,LI_ESTROGENE_META_E2_RESPONSE_DN,0.972599894042854
GOCC_CILIARY_BASAL_BODY,SET,144,0.025484,0.002248,0.069003,0.35595,GOCC_CILIARY_BASAL_BODY,0.972599894042854
HP_BRITTLE_HAIR,SET,41,0.045521,0.0021487,0.12327,0.35596,HP_BRITTLE_HAIR,0.972599894042854
BIOCARTA_TCR_PATHWAY,SET,43,0.046667,0.0022557,0.12639,0.35598,BIOCARTA_TCR_PATHWAY,0.972599894042854
HP_ABNORMAL_Z_DISK_MORPHOLOGY,SET,8,0.10728,0.0022388,0.29065,0.35603,HP_ABNORMAL_Z_DISK_MORPHOLOGY,0.972599894042854
GOCC_CALCIUM_CHANNEL_COMPLEX,SET,63,0.040776,0.0023844,0.11049,0.35605,GOCC_CALCIUM_CHANNEL_COMPLEX,0.972599894042854
PID_EPO_PATHWAY,SET,31,0.057715,0.0023695,0.15646,0.35611,PID_EPO_PATHWAY,0.972599894042854
HP_APLASIA_HYPOPLASIA_OF_THE...75,SET,8,0.1012,0.0021119,0.27439,0.35614,HP_APLASIA_HYPOPLASIA_OF_THE_TRAGUS,0.972599894042854
FAN_EMBRYONIC_CTX_IN_1_INTER...,SET,10,0.1127,0.0026294,0.30585,0.35626,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.972599894042854
VANDESLUIS_COMMD1_TARGETS_GR...5,SET,13,0.08882,0.0023626,0.24106,0.35627,VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,0.972599894042854
GAGACTG_MIR452,SET,88,0.033104,0.0022863,0.089859,0.35629,GAGACTG_MIR452,0.972599894042854
WANG_CISPLATIN_RESPONSE_AND_...2,SET,158,0.025282,0.0023351,0.068637,0.35631,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,0.972599894042854
GOBP_DNA_RECOMBINATION,SET,284,0.017634,0.002176,0.047873,0.35631,GOBP_DNA_RECOMBINATION,0.972599894042854
ZHENG_CORD_BLOOD_C9_GRANULOC...,SET,90,0.032957,0.0023017,0.089473,0.35631,ZHENG_CORD_BLOOD_C9_GRANULOCYTE_MACROPHAGE_PROGENITOR,0.972599894042854
GCM_PPM1D,SET,23,0.059254,0.0020958,0.16088,0.35632,GCM_PPM1D,0.972599894042854
HP_INCREASED_TOTAL_BILIRUBIN,SET,14,0.081401,0.0022469,0.221,0.35632,HP_INCREASED_TOTAL_BILIRUBIN,0.972599894042854
GSE19198_1H_VS_6H_IL21_TREAT...2,SET,145,0.027056,0.0023948,0.073457,0.35632,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_UP,0.972599894042854
HP_EPIDURAL_HEMORRHAGE,SET,5,0.17848,0.0029448,0.48464,0.35634,HP_EPIDURAL_HEMORRHAGE,0.972599894042854
HP_MICROTIA_FIRST_DEGREE,SET,4,0.18695,0.0027591,0.50766,0.35634,HP_MICROTIA_FIRST_DEGREE,0.972599894042854
MATZUK_MEIOTIC_AND_DNA_REPAIR,SET,35,0.044235,0.0019295,0.12012,0.35635,MATZUK_MEIOTIC_AND_DNA_REPAIR,0.972599894042854
TURASHVILI_BREAST_DUCTAL_CAR...1,SET,173,0.025195,0.002434,0.06844,0.35639,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,0.972599894042854
GSE11961_GERMINAL_CENTER_BCE...4,SET,176,0.023049,0.0022458,0.062637,0.35645,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.972599894042854
MIR1185_1_3P_MIR1185_2_3P,SET,376,0.016074,0.0022766,0.043687,0.35646,MIR1185_1_3P_MIR1185_2_3P,0.972599894042854
GOMF_THYROID_HORMONE_BINDING,SET,6,0.13934,0.0025185,0.37871,0.35646,GOMF_THYROID_HORMONE_BINDING,0.972599894042854
GSE37605_NOD_VS_C57BL6_IRES_...2,SET,140,0.026819,0.0023329,0.072898,0.35648,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP,0.972599894042854
OCT1_04,SET,201,0.023666,0.0024625,0.06434,0.35651,OCT1_04,0.972599894042854
DESCARTES_MAIN_FETAL_STROMAL...,SET,11,0.10735,0.0026268,0.29192,0.35653,DESCARTES_MAIN_FETAL_STROMAL_CELLS,0.972599894042854
HP_BARREL_SHAPED_CHEST,SET,20,0.070811,0.0023358,0.19257,0.35655,HP_BARREL_SHAPED_CHEST,0.972599894042854
REACTOME_TRANSCRIPTIONAL_REG...11,SET,30,0.057155,0.0023084,0.15548,0.35659,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION,0.972632667556114
GSE15930_NAIVE_VS_48H_IN_VIT...5,SET,178,0.021753,0.0021315,0.0592,0.35664,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.972692709722985
WP_WHITE_FAT_CELL_DIFFERENTI...,SET,31,0.061448,0.0025227,0.16733,0.35673,WP_WHITE_FAT_CELL_DIFFERENTIATION,0.972726282402694
GSE26351_UNSTIM_VS_WNT_PATHW...2,SET,178,0.021847,0.0021406,0.059502,0.35675,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,0.972726282402694
GOBP_WNT_SIGNALING_PATHWAY_P...,SET,48,0.046963,0.002398,0.12795,0.3568,GOBP_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,0.972726282402694
MIR597_5P,SET,72,0.035737,0.0022335,0.097412,0.35686,MIR597_5P,0.972726282402694
GOBP_ESTABLISHMENT_OR_MAINTE...3,SET,7,0.11175,0.0021815,0.30467,0.35689,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CYTOSKELETON_POLARITY,0.972726282402694
REACTOME_MITOCHONDRIAL_TRNA_...,SET,18,0.069627,0.002179,0.18988,0.35693,REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION,0.972726282402694
GOBP_REGULATION_OF_PHOSPHOLI...4,SET,32,0.055588,0.0023186,0.15162,0.35695,GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY,0.972726282402694
SCHLINGEMANN_SKIN_CARCINOGEN...1,SET,23,0.061515,0.0021758,0.16779,0.35696,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,0.972726282402694
HP_APLASIA_HYPOPLASIA_OF_THE...28,SET,12,0.089297,0.0022821,0.24373,0.35705,HP_APLASIA_HYPOPLASIA_OF_THE_EPIGLOTTIS,0.972726282402694
HP_ABNORMAL_THYROID_MORPHOLO...,SET,166,0.023807,0.0022534,0.064999,0.35708,HP_ABNORMAL_THYROID_MORPHOLOGY,0.972726282402694
GOBP_CYTOCHROME_COMPLEX_ASSE...,SET,32,0.050186,0.0020933,0.13702,0.35709,GOBP_CYTOCHROME_COMPLEX_ASSEMBLY,0.972726282402694
GOBP_POSITIVE_REGULATION_OF_...726,SET,11,0.10247,0.0025074,0.27981,0.3571,GOBP_POSITIVE_REGULATION_OF_STEROID_HORMONE_SECRETION,0.972726282402694
GOBP_REGULATION_OF_NK_T_CELL...3,SET,7,0.13119,0.002561,0.3583,0.35713,GOBP_REGULATION_OF_NK_T_CELL_PROLIFERATION,0.972726282402694
GOCC_NUCLEOLAR_EXOSOME_RNASE...,SET,9,0.085936,0.0019021,0.23474,0.35715,GOCC_NUCLEOLAR_EXOSOME_RNASE_COMPLEX,0.972726282402694
LIU_PROSTATE_CANCER_DN,SET,435,0.0156,0.0023726,0.042616,0.35716,LIU_PROSTATE_CANCER_DN,0.972726282402694
GSE10325_MYELOID_VS_LUPUS_MY...2,SET,170,0.023839,0.0022832,0.06512,0.35716,GSE10325_MYELOID_VS_LUPUS_MYELOID_UP,0.972726282402694
GSE34156_TLR1_TLR2_LIGAND_VS...1,SET,176,0.02284,0.0022254,0.062395,0.35716,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,0.972726282402694
MODULE_16,SET,461,0.014337,0.002243,0.039174,0.35719,MODULE_16,0.972726282402694
HP_IMPAIRED_PROPRIOCEPTION,SET,136,0.025575,0.0021929,0.069883,0.3572,HP_IMPAIRED_PROPRIOCEPTION,0.972726282402694
GOBP_SYNAPTIC_VESICLE_RECYCL...1,SET,74,0.035152,0.0022271,0.096112,0.35728,GOBP_SYNAPTIC_VESICLE_RECYCLING,0.972726282402694
MIR553,SET,10,0.089823,0.0020957,0.24561,0.35729,MIR553,0.972726282402694
REACTOME_CARGO_CONCENTRATION...,SET,31,0.055877,0.002294,0.1528,0.3573,REACTOME_CARGO_CONCENTRATION_IN_THE_ER,0.972726282402694
HP_LARGE_HANDS,SET,29,0.050951,0.0020233,0.13935,0.35732,HP_LARGE_HANDS,0.972726282402694
ONGUSAHA_TP53_TARGETS,SET,33,0.053218,0.0022541,0.14558,0.35735,ONGUSAHA_TP53_TARGETS,0.972726282402694
HP_WHITE_HAIR,SET,21,0.066616,0.0022516,0.18225,0.35736,HP_WHITE_HAIR,0.972726282402694
REACTOME_DAP12_INTERACTIONS,SET,36,0.048718,0.0021551,0.1333,0.35738,REACTOME_DAP12_INTERACTIONS,0.972726282402694
GOBP_PROTEIN_RNA_COMPLEX_DIS...,SET,10,0.088342,0.0020611,0.24204,0.35756,GOBP_PROTEIN_RNA_COMPLEX_DISASSEMBLY,0.973069249138741
HP_WHEEZING,SET,52,0.041692,0.0022156,0.11424,0.35758,HP_WHEEZING,0.973069249138741
MIR10392_3P,SET,5,0.13142,0.0021684,0.36014,0.35759,MIR10392_3P,0.973069249138741
MORF_PPP1CC,SET,146,0.023979,0.0021298,0.065749,0.35767,MORF_PPP1CC,0.973085674091442
HP_ABNORMAL_ANKLE_MORPHOLOGY,SET,87,0.033759,0.0023183,0.092581,0.35769,HP_ABNORMAL_ANKLE_MORPHOLOGY,0.973085674091442
GCATTTG_MIR105,SET,153,0.025373,0.0023065,0.069599,0.35772,GCATTTG_MIR105,0.973085674091442
GOBP_R_LOOP_PROCESSING,SET,8,0.089871,0.0018755,0.24652,0.35772,GOBP_R_LOOP_PROCESSING,0.973085674091442
REACTOME_PHASE_3_RAPID_REPOL...,SET,8,0.10651,0.0022227,0.29247,0.35787,REACTOME_PHASE_3_RAPID_REPOLARISATION,0.973085674091442
GSE34156_UNTREATED_VS_6H_NOD...2,SET,149,0.025285,0.0022685,0.069442,0.35789,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.973085674091442
VIETOR_IFRD1_TARGETS,SET,20,0.070567,0.0023277,0.19386,0.35793,VIETOR_IFRD1_TARGETS,0.973085674091442
REACTOME_RAC1_GTPASE_CYCLE,SET,167,0.024557,0.0023313,0.067462,0.35793,REACTOME_RAC1_GTPASE_CYCLE,0.973085674091442
WP_ESTROGEN_RECEPTOR_PATHWAY,SET,13,0.091571,0.0024357,0.25156,0.35793,WP_ESTROGEN_RECEPTOR_PATHWAY,0.973085674091442
MIR616_5P,SET,856,0.010698,0.0022554,0.0294,0.35798,MIR616_5P,0.973085674091442
chr11q23,SET,107,0.061206,0.0046587,0.16832,0.35807,chr11q23,0.973085674091442
REACTOME_ORC1_REMOVAL_FROM_C...,SET,68,0.034034,0.0020673,0.093598,0.35808,REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,0.973085674091442
AMIT_EGF_RESPONSE_20_MCF10A,SET,11,0.089864,0.0021989,0.24719,0.3581,AMIT_EGF_RESPONSE_20_MCF10A,0.973085674091442
ATGTCAC_MIR489,SET,77,0.036689,0.0023709,0.10092,0.3581,ATGTCAC_MIR489,0.973085674091442
HP_ABNORMAL_CORPUS_STRIATUM_...,SET,35,0.048328,0.002108,0.13295,0.35812,HP_ABNORMAL_CORPUS_STRIATUM_MORPHOLOGY,0.973085674091442
PID_ARF6_DOWNSTREAM_PATHWAY,SET,15,0.080163,0.0022903,0.22055,0.35813,PID_ARF6_DOWNSTREAM_PATHWAY,0.973085674091442
MIR4270,SET,164,0.023554,0.0022161,0.064802,0.35813,MIR4270,0.973085674091442
GNF2_APEX1,SET,77,0.032259,0.0020847,0.088774,0.35816,GNF2_APEX1,0.973085674091442
GSE22045_TREG_VS_TCONV_DN,SET,157,0.024671,0.0022716,0.0679,0.35818,GSE22045_TREG_VS_TCONV_DN,0.973085674091442
GSE43957_UNTREATED_VS_NACL_T...2,SET,181,0.0227,0.0022426,0.062486,0.3582,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,0.973085674091442
ZNF490_TARGET_GENES,SET,335,0.016623,0.0022248,0.04576,0.35821,ZNF490_TARGET_GENES,0.973085674091442
chr4p16,SET,93,0.06121,0.0043452,0.16853,0.35823,chr4p16,0.973085674091442
MORF_ESR1,SET,159,0.023742,0.0021997,0.065374,0.35824,MORF_ESR1,0.973085674091442
GOBP_MRNA_TRANSCRIPTION,SET,46,0.041132,0.0020562,0.11328,0.35827,GOBP_MRNA_TRANSCRIPTION,0.973091110503282
GSE360_CTRL_VS_T_GONDII_MAC_...2,SET,180,0.021755,0.0021434,0.059954,0.35836,GSE360_CTRL_VS_T_GONDII_MAC_UP,0.973259498319919
REACTOME_DEGRADATION_OF_DVL,SET,54,0.037653,0.002039,0.10379,0.35839,REACTOME_DEGRADATION_OF_DVL,0.973264871514489
BORCZUK_MALIGNANT_MESOTHELIO...1,SET,86,0.032144,0.0021947,0.088644,0.35845,BORCZUK_MALIGNANT_MESOTHELIOMA_DN,0.973264871514489
GOBP_SNRNA_METABOLIC_PROCESS,SET,50,0.0388,0.002022,0.10703,0.35849,GOBP_SNRNA_METABOLIC_PROCESS,0.973264871514489
GOBP_POSITIVE_REGULATION_OF_...393,SET,15,0.084673,0.0024192,0.23362,0.35851,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION,0.973264871514489
REACTOME_INTERLEUKIN_27_SIGN...,SET,11,0.096149,0.0023527,0.26528,0.35852,REACTOME_INTERLEUKIN_27_SIGNALING,0.973264871514489
GOBP_CELL_MATRIX_ADHESION,SET,224,0.020857,0.0022897,0.057553,0.35853,GOBP_CELL_MATRIX_ADHESION,0.973264871514489
MIR1275,SET,258,0.019408,0.0022844,0.053582,0.3586,MIR1275,0.973378865979381
GOBP_NEGATIVE_REGULATION_OF_...348,SET,41,0.047975,0.0022645,0.13252,0.35867,GOBP_NEGATIVE_REGULATION_OF_LIPID_LOCALIZATION,0.973492842639594
PIEPOLI_LGI1_TARGETS_UP,SET,12,0.10021,0.002561,0.27697,0.35875,PIEPOLI_LGI1_TARGETS_UP,0.973633941121349
CAIRO_LIVER_DEVELOPMENT_DN,SET,203,0.022207,0.0023221,0.061429,0.35886,CAIRO_LIVER_DEVELOPMENT_DN,0.973856430077301
GOBP_POSITIVE_REGULATION_OF_...573,SET,152,0.025194,0.0022828,0.069726,0.35893,GOBP_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,0.973931549801108
HP_CORNEAL_ULCERATION,SET,18,0.070106,0.002194,0.19405,0.35895,HP_CORNEAL_ULCERATION,0.973931549801108
GOMF_TRANSFORMING_GROWTH_FAC...2,SET,13,0.090622,0.0024105,0.25103,0.35905,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_ACTIVITY,0.973931549801108
GOMF_3_5_DNA_HELICASE_ACTIVI...,SET,14,0.0802,0.0022137,0.2222,0.35907,GOMF_3_5_DNA_HELICASE_ACTIVITY,0.973931549801108
GOMF_PENTOSYLTRANSFERASE_ACT...,SET,47,0.042936,0.0021695,0.11896,0.35908,GOMF_PENTOSYLTRANSFERASE_ACTIVITY,0.973931549801108
HP_ABNORMAL_HEART_VALVE_PHYS...,SET,336,0.016936,0.0022699,0.04693,0.3591,HP_ABNORMAL_HEART_VALVE_PHYSIOLOGY,0.973931549801108
GOBP_NUCLEAR_MEMBRANE_REASSE...,SET,25,0.058942,0.0021735,0.16334,0.35911,GOBP_NUCLEAR_MEMBRANE_REASSEMBLY,0.973931549801108
HP_RAYNAUD_PHENOMENON,SET,41,0.04855,0.0022916,0.13462,0.35918,HP_RAYNAUD_PHENOMENON,0.973931549801108
HP_PSYCHOSIS,SET,94,0.031754,0.0022662,0.08807,0.35922,HP_PSYCHOSIS,0.973931549801108
BIOCARTA_TGFB_PATHWAY,SET,19,0.070385,0.002263,0.19525,0.35924,BIOCARTA_TGFB_PATHWAY,0.973931549801108
REACTOME_NEUROTOXICITY_OF_CL...,SET,10,0.090588,0.0021135,0.2513,0.35925,REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS,0.973931549801108
GOMF_ALDEHYDE_LYASE_ACTIVITY,SET,9,0.092025,0.0020369,0.25531,0.35926,GOMF_ALDEHYDE_LYASE_ACTIVITY,0.973931549801108
GSE23925_LIGHT_ZONE_VS_NAIVE...1,SET,174,0.022489,0.0021788,0.062391,0.35926,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN,0.973931549801108
CHESLER_BRAIN_D6MIT150_QTL_C...,SET,3,0.17928,0.0022915,0.49746,0.35928,CHESLER_BRAIN_D6MIT150_QTL_CIS,0.973931549801108
GSE17721_PAM3CSK4_VS_CPG_8H_...2,SET,182,0.022114,0.0021907,0.061422,0.35942,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP,0.974235072531586
GSE36078_UNTREATED_VS_AD5_IN...4,SET,185,0.022816,0.0022786,0.063392,0.35946,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP,0.974267511502768
GOBP_NEGATIVE_REGULATION_OF_...83,SET,307,0.016944,0.0021726,0.047107,0.35954,GOBP_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS,0.974408351528384
REACTOME_LIGAND_RECEPTOR_INT...,SET,8,0.12104,0.002526,0.33666,0.3596,REACTOME_LIGAND_RECEPTOR_INTERACTIONS,0.974418992671137
MIR486_3P,SET,152,0.024656,0.0022341,0.068578,0.3596,MIR486_3P,0.974418992671137
GOBP_RESPONSE_TO_BACTERIAL_L...,SET,8,0.11208,0.0023389,0.31203,0.35973,GOBP_RESPONSE_TO_BACTERIAL_LIPOPROTEIN,0.974673468194574
BROWNE_HCMV_INFECTION_48HR_DN,SET,425,0.014647,0.0022025,0.040786,0.35975,BROWNE_HCMV_INFECTION_48HR_DN,0.974673468194574
GOBP_STORE_OPERATED_CALCIUM_...,SET,20,0.069852,0.0023042,0.1946,0.35982,GOBP_STORE_OPERATED_CALCIUM_ENTRY,0.974748827150873
GSE1740_MCSF_VS_MCSF_AND_IFN...3,SET,146,0.024889,0.0022105,0.069354,0.35985,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_DN,0.974748827150873
GOBP_CELLULAR_RESPONSE_TO_PU...,SET,13,0.08336,0.0022173,0.23232,0.35987,GOBP_CELLULAR_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,0.974748827150873
MIR4999_5P,SET,81,0.03349,0.0022195,0.093347,0.35989,MIR4999_5P,0.974748827150873
HP_STOMATOCYTOSIS,SET,12,0.09607,0.0024552,0.26795,0.35997,HP_STOMATOCYTOSIS,0.974889530896906
HSF2_TARGET_GENES,SET,196,0.020644,0.0021215,0.057588,0.36,HSF2_TARGET_GENES,0.974890038075997
MODULE_127,SET,12,0.083815,0.002142,0.23391,0.36005,MODULE_127,0.974890038075997
GOBP_GOLGI_TO_PLASMA_MEMBRAN...1,SET,40,0.049445,0.0023053,0.138,0.36006,GOBP_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.974890038075997
REACTOME_HEPARAN_SULFATE_HEP...,SET,52,0.04237,0.0022516,0.11829,0.3601,REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,0.974890038075997
BLUM_RESPONSE_TO_SALIRASIB_DN,SET,308,0.016801,0.0021577,0.046912,0.36012,BLUM_RESPONSE_TO_SALIRASIB_DN,0.974890038075997
HP_UNILATERAL_PTOSIS,SET,8,0.10591,0.0022101,0.2958,0.36016,HP_UNILATERAL_PTOSIS,0.974890038075997
HP_ABNORMAL_PROPORTION_OF_CD...3,SET,17,0.06942,0.0021114,0.19395,0.3602,HP_ABNORMAL_PROPORTION_OF_CD8_POSITIVE_T_CELLS,0.974890038075997
GSE3982_EOSINOPHIL_VS_MAST_C...2,SET,178,0.022683,0.0022225,0.063397,0.36025,GSE3982_EOSINOPHIL_VS_MAST_CELL_UP,0.974890038075997
GOBP_REGULATION_OF_MRNA_META...,SET,271,0.017483,0.0021082,0.048885,0.36031,GOBP_REGULATION_OF_MRNA_METABOLIC_PROCESS,0.974890038075997
KEGG_MEDICUS_REFERENCE_FE3_F...,SET,5,0.15037,0.002481,0.42048,0.36032,KEGG_MEDICUS_REFERENCE_FE3_FERRITIN_TRANSPORT,0.974890038075997
VERNELL_RETINOBLASTOMA_PATHW...2,SET,68,0.034687,0.002107,0.09701,0.36034,VERNELL_RETINOBLASTOMA_PATHWAY_UP,0.974890038075997
GOBP_MEGAKARYOCYTE_DEVELOPME...,SET,20,0.074094,0.0024441,0.20724,0.36035,GOBP_MEGAKARYOCYTE_DEVELOPMENT,0.974890038075997
HP_CALVARIAL_SKULL_DEFECT,SET,27,0.059074,0.0022637,0.16523,0.36035,HP_CALVARIAL_SKULL_DEFECT,0.974890038075997
GTF3A_TARGET_GENES,SET,12,0.087465,0.0022353,0.24481,0.36045,GTF3A_TARGET_GENES,0.974890038075997
HP_RENAL_CYST,SET,245,0.019359,0.0022212,0.054191,0.36046,HP_RENAL_CYST,0.974890038075997
GSE3982_MAST_CELL_VS_BASOPHI...1,SET,172,0.023044,0.0022198,0.064539,0.36053,GSE3982_MAST_CELL_VS_BASOPHIL_DN,0.974890038075997
KIM_HYPOXIA,SET,15,0.079251,0.0022642,0.22198,0.36054,KIM_HYPOXIA,0.974890038075997
HP_TYPE_I_DIABETES_MELLITUS,SET,51,0.042614,0.0022428,0.11941,0.36059,HP_TYPE_I_DIABETES_MELLITUS,0.974890038075997
GOBP_SNRNA_TRANSCRIPTION_BY_...2,SET,9,0.087831,0.0019441,0.24625,0.36067,GOBP_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.974890038075997
GSE24142_EARLY_THYMIC_PROGEN...7,SET,180,0.0221,0.0021774,0.061979,0.36071,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN,0.974890038075997
HP_ESOPHAGEAL_ULCERATION,SET,7,0.10612,0.0020716,0.29773,0.36076,HP_ESOPHAGEAL_ULCERATION,0.974890038075997
GOBP_POSITIVE_REGULATION_OF_...267,SET,6,0.11517,0.0020817,0.32322,0.3608,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.974890038075997
GOMF_CROSSOVER_JUNCTION_DNA_...,SET,7,0.10502,0.0020502,0.29476,0.36081,GOMF_CROSSOVER_JUNCTION_DNA_ENDONUCLEASE_ACTIVITY,0.974890038075997
GSE6674_ANTI_IGM_VS_CPG_STIM...1,SET,179,0.02195,0.0021567,0.061605,0.36081,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_DN,0.974890038075997
GOCC_IKAPPAB_KINASE_COMPLEX,SET,6,0.099892,0.0018054,0.28044,0.36085,GOCC_IKAPPAB_KINASE_COMPLEX,0.974890038075997
HP_MALE_REPRODUCTIVE_SYSTEM_...,SET,59,0.041794,0.0023653,0.11734,0.36085,HP_MALE_REPRODUCTIVE_SYSTEM_NEOPLASM,0.974890038075997
GOBP_REGULATION_OF_EATING_BE...,SET,7,0.13184,0.0025737,0.37016,0.36086,GOBP_REGULATION_OF_EATING_BEHAVIOR,0.974890038075997
GOBP_VALINE_METABOLIC_PROCESS,SET,7,0.11201,0.0021866,0.31452,0.36087,GOBP_VALINE_METABOLIC_PROCESS,0.974890038075997
GSE26495_NAIVE_VS_PD1HIGH_CD...2,SET,151,0.025133,0.0022698,0.070571,0.36087,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP,0.974890038075997
GSE7459_UNTREATED_VS_IL6_TRE...2,SET,117,0.027722,0.0022059,0.077846,0.36088,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_UP,0.974890038075997
COLINA_TARGETS_OF_4EBP1_AND_...,SET,320,0.017304,0.0022644,0.048597,0.3609,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,0.974890038075997
HP_VERTEBRAL_ARCH_ANOMALY,SET,16,0.069525,0.0020515,0.19526,0.3609,HP_VERTEBRAL_ARCH_ANOMALY,0.974890038075997
MULLIGHAN_NPM1_MUTATED_SIGNA...4,SET,114,0.028761,0.0022592,0.080798,0.36094,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,0.974890038075997
HP_PROGRESSIVE_DISTAL_MUSCUL...,SET,37,0.046158,0.00207,0.12967,0.36094,HP_PROGRESSIVE_DISTAL_MUSCULAR_ATROPHY,0.974890038075997
GOBP_LIPID_DROPLET_FUSION,SET,5,0.15425,0.002545,0.43342,0.36097,GOBP_LIPID_DROPLET_FUSION,0.974890038075997
MIR3651,SET,18,0.070545,0.0022077,0.19825,0.36098,MIR3651,0.974890038075997
GOMF_RNA_POLYMERASE_I_TRANSC...,SET,9,0.084099,0.0018615,0.23642,0.36103,GOMF_RNA_POLYMERASE_I_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.974900567166498
GOBP_BINDING_OF_SPERM_TO_ZON...,SET,38,0.045836,0.002083,0.12887,0.36104,GOBP_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,0.974900567166498
GOBP_PROTEIN_LOCALIZATION_TO...26,SET,29,0.052555,0.002087,0.14781,0.36109,GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS,0.974959831417029
GOBP_REGULATION_OF_ACTIN_FIL...1,SET,39,0.046893,0.0021589,0.13195,0.36116,GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT,0.974996622408572
HP_TETRALOGY_OF_FALLOT,SET,156,0.02439,0.0022385,0.06864,0.36118,HP_TETRALOGY_OF_FALLOT,0.974996622408572
GOCC_ENDOSOME,SET,961,0.0098319,0.0021897,0.027678,0.36121,GOCC_ENDOSOME,0.974996622408572
HP_VERTICAL_SUPRANUCLEAR_GAZ...,SET,26,0.058446,0.0021978,0.16458,0.36125,HP_VERTICAL_SUPRANUCLEAR_GAZE_PALSY,0.974996622408572
GOMF_NADPLUS_BINDING,SET,18,0.07061,0.0022097,0.19884,0.36126,GOMF_NADPLUS_BINDING,0.974996622408572
MIR549A_5P,SET,43,0.048764,0.0023571,0.13734,0.36128,MIR549A_5P,0.974996622408572
GOBP_REGULATION_OF_PRESYNAPS...,SET,28,0.06572,0.0025645,0.18513,0.3613,GOBP_REGULATION_OF_PRESYNAPSE_ORGANIZATION,0.974996622408572
MENON_FETAL_KIDNEY_1_EMBRYON...,SET,83,0.032528,0.0021821,0.091661,0.36134,MENON_FETAL_KIDNEY_1_EMBRYONIC_RED_BLOOD_CELLS,0.975028858695652
HP_EXAGGERATED_CUPID_S_BOW,SET,31,0.052008,0.0021352,0.14666,0.36144,HP_EXAGGERATED_CUPID_S_BOW,0.975222979582331
GOMF_AXON_GUIDANCE_RECEPTOR_...,SET,10,0.10215,0.0023833,0.28835,0.36158,GOMF_AXON_GUIDANCE_RECEPTOR_ACTIVITY,0.975330055874593
GOBP_DAMP_METABOLIC_PROCESS,SET,7,0.12122,0.0023665,0.34226,0.3616,GOBP_DAMP_METABOLIC_PROCESS,0.975330055874593
GSE26488_CTRL_VS_PEPTIDE_INJ...3,SET,172,0.023715,0.0022845,0.066955,0.3616,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN,0.975330055874593
GSE27859_DC_VS_CD11C_INT_F48...3,SET,183,0.020664,0.0020526,0.058345,0.36161,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN,0.975330055874593
GSE13411_IGM_MEMORY_BCELL_VS...1,SET,173,0.022241,0.0021487,0.062803,0.36162,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN,0.975330055874593
GOBP_CRANIAL_NERVE_DEVELOPME...,SET,61,0.040162,0.0023111,0.11346,0.36168,GOBP_CRANIAL_NERVE_DEVELOPMENT,0.975340502793296
GOMF_GLYCEROL_3_PHOSPHATE_O_...,SET,3,0.19807,0.0025316,0.55955,0.36168,GOMF_GLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY,0.975340502793296
WP_IRINOTECAN_PATHWAY,SET,12,0.088275,0.002256,0.24953,0.36176,WP_IRINOTECAN_PATHWAY,0.975388345485572
GSE13306_RA_VS_UNTREATED_TRE...2,SET,173,0.021961,0.0021216,0.062083,0.36177,GSE13306_RA_VS_UNTREATED_TREG_UP,0.975388345485572
GOBP_RNA_EXPORT_FROM_NUCLEUS,SET,80,0.030779,0.0020272,0.087034,0.36181,GOBP_RNA_EXPORT_FROM_NUCLEUS,0.975388345485572
HE_LIM_SUN_FETAL_LUNG_C2_GMP...,SET,33,0.056,0.002372,0.15836,0.36181,HE_LIM_SUN_FETAL_LUNG_C2_GMP_CELL,0.975388345485572
GOBP_NEGATIVE_REGULATION_OF_...532,SET,723,0.011219,0.002182,0.031737,0.36186,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS,0.975445535023968
HP_IRREGULAR_HYPERPIGMENTATI...,SET,211,0.019661,0.0020955,0.05563,0.36189,HP_IRREGULAR_HYPERPIGMENTATION,0.975445535023968
GSE15330_LYMPHOID_MULTIPOTEN...3,SET,176,0.02187,0.0021309,0.06191,0.36195,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,0.975445535023968
GSE2706_UNSTIM_VS_2H_LPS_DC_...2,SET,155,0.022444,0.0020534,0.063545,0.36197,GSE2706_UNSTIM_VS_2H_LPS_DC_UP,0.975445535023968
GOCC_SWI_SNF_COMPLEX,SET,28,0.052268,0.0020396,0.14801,0.36199,GOCC_SWI_SNF_COMPLEX,0.975445535023968
GSE17721_POLYIC_VS_GARDIQUIM...4,SET,181,0.021506,0.0021247,0.060901,0.362,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_UP,0.975445535023968
MATSUMIYA_PBMC_MODIFIED_VACC...2,SET,9,0.098184,0.0021732,0.27824,0.36209,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_HIGH_RESPONDERS_VS_LOW_RESPONDERS_0DY_UP,0.975445535023968
GOMF_PROTEIN_SERINE_THREONIN...5,SET,90,0.028997,0.0020251,0.082179,0.3621,GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.975445535023968
HOFFMANN_LARGE_TO_SMALL_PRE_...1,SET,60,0.037625,0.0021473,0.10667,0.36216,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,0.975445535023968
DESCARTES_FETAL_ADRENAL_MEGA...,SET,86,0.033091,0.0022594,0.093837,0.36218,DESCARTES_FETAL_ADRENAL_MEGAKARYOCYTES,0.975445535023968
GOLDRATH_HOMEOSTATIC_PROLIFE...,SET,134,0.025157,0.0021413,0.071358,0.36222,GOLDRATH_HOMEOSTATIC_PROLIFERATION,0.975445535023968
GSE40274_LEF1_VS_FOXP3_AND_L...2,SET,180,0.022844,0.0022508,0.064818,0.36226,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.975445535023968
MIR6514_5P,SET,47,0.04477,0.0022622,0.12704,0.36227,MIR6514_5P,0.975445535023968
CLASPER_LYMPHATIC_VESSELS_DU...1,SET,32,0.057361,0.0023926,0.16284,0.36233,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,0.975445535023968
GSE7831_CPG_VS_INFLUENZA_STI...1,SET,186,0.022299,0.002233,0.06332,0.36236,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN,0.975445535023968
GSE1460_NAIVE_CD4_TCELL_ADUL...1,SET,182,0.022185,0.0021978,0.063004,0.36238,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN,0.975445535023968
MIR548N,SET,554,0.012969,0.0022185,0.036855,0.36246,MIR548N,0.975445535023968
KEGG_MEDICUS_REFERENCE_CHOLE...,SET,11,0.082096,0.0020088,0.23337,0.3625,KEGG_MEDICUS_REFERENCE_CHOLESTEROL_BIOSYNTHESIS,0.975445535023968
GSE40274_CTRL_VS_SATB1_TRANS...2,SET,150,0.024839,0.0022359,0.070607,0.3625,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.975445535023968
REACTOME_SPECIFICATION_OF_TH...,SET,16,0.079914,0.002358,0.22719,0.36251,REACTOME_SPECIFICATION_OF_THE_NEURAL_PLATE_BORDER,0.975445535023968
GOBP_DENDRITIC_TRANSPORT,SET,12,0.084416,0.0021574,0.24003,0.36254,GOBP_DENDRITIC_TRANSPORT,0.975445535023968
GOBP_NON_CANONICAL_NF_KAPPAB...,SET,112,0.028094,0.0021875,0.079884,0.36254,GOBP_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.975445535023968
GSE40685_TREG_VS_FOXP3_KO_TR...1,SET,182,0.022117,0.002191,0.062895,0.36256,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN,0.975445535023968
GSE15330_HSC_VS_MEGAKARYOCYT...3,SET,188,0.021524,0.0021668,0.06125,0.36264,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,0.975445535023968
TAKEDA_TARGETS_OF_NUP98_HOXA...2,SET,171,0.024897,0.0023915,0.070876,0.36269,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,0.975445535023968
MIR1197,SET,84,0.032137,0.0021687,0.0915,0.36271,MIR1197,0.975445535023968
REACTOME_ELASTIC_FIBRE_FORMA...,SET,42,0.048506,0.0023173,0.13814,0.36275,REACTOME_ELASTIC_FIBRE_FORMATION,0.975445535023968
KEGG_MEDICUS_VARIANT_MET_OVE...,SET,13,0.079575,0.0021166,0.22667,0.36277,KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,0.975445535023968
REACTOME_SIGNALING_BY_TGFB_F...,SET,149,0.024056,0.0021583,0.068521,0.36277,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,0.975445535023968
GOBP_POSITIVE_REGULATION_OF_...800,SET,25,0.061723,0.002276,0.17586,0.3628,GOBP_POSITIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,0.975445535023968
DAVICIONI_PAX_FOXO1_SIGNATUR...2,SET,52,0.044319,0.0023552,0.12629,0.36282,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,0.975445535023968
SESTO_RESPONSE_TO_UV_C3,SET,19,0.068224,0.0021935,0.19443,0.36284,SESTO_RESPONSE_TO_UV_C3,0.975445535023968
GSE360_LOW_DOSE_B_MALAYI_VS_...4,SET,184,0.021281,0.0021196,0.060671,0.36289,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,0.975445535023968
REACTOME_BINDING_AND_UPTAKE_...,SET,38,0.050983,0.002317,0.14538,0.36291,REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,0.975445535023968
HP_SLOPING_FOREHEAD,SET,165,0.02167,0.002045,0.061792,0.36291,HP_SLOPING_FOREHEAD,0.975445535023968
LANDEMAINE_LUNG_METASTASIS,SET,20,0.068915,0.0022732,0.19652,0.36292,LANDEMAINE_LUNG_METASTASIS,0.975445535023968
GOBP_PROTEIN_GERANYLGERANYLA...,SET,6,0.10994,0.001987,0.31349,0.36292,GOBP_PROTEIN_GERANYLGERANYLATION,0.975445535023968
PUIFFE_INVASION_INHIBITED_BY...2,SET,64,0.036332,0.0021413,0.10362,0.36294,PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,0.975445535023968
HP_NEOPLASM_OF_THE_THYROID_G...,SET,87,0.030739,0.0021109,0.087685,0.36296,HP_NEOPLASM_OF_THE_THYROID_GLAND,0.975445535023968
MIR3660,SET,96,0.031032,0.002238,0.088527,0.36297,MIR3660,0.975445535023968
WP_PARKINUBIQUITIN_PROTEASOM...,SET,64,0.034248,0.0020185,0.097719,0.36299,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,0.975445535023968
REACTOME_P2Y_RECEPTORS,SET,9,0.10883,0.0024089,0.31057,0.36301,REACTOME_P2Y_RECEPTORS,0.975445535023968
MODULE_318,SET,27,0.054409,0.0020849,0.15533,0.36306,MODULE_318,0.975482792207792
WP_TCA_CYCLE_AKA_KREBS_OR_CI...,SET,17,0.061202,0.0018614,0.17474,0.36308,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,0.975482792207792
HP_RIGHT_VENTRICULAR_DILATAT...,SET,17,0.079589,0.0024206,0.22734,0.36314,HP_RIGHT_VENTRICULAR_DILATATION,0.975487076958739
DESCARTES_MAIN_FETAL_METANEP...,SET,25,0.069239,0.0025532,0.19778,0.36314,DESCARTES_MAIN_FETAL_METANEPHRIC_CELLS,0.975487076958739
KEGG_DILATED_CARDIOMYOPATHY,SET,85,0.033903,0.0023014,0.096891,0.36321,KEGG_DILATED_CARDIOMYOPATHY,0.975487076958739
GOBP_REGULATION_OF_CELLULAR_...4,SET,310,0.016665,0.0021471,0.04763,0.36321,GOBP_REGULATION_OF_CELLULAR_COMPONENT_SIZE,0.975487076958739
GOMF_SYMPORTER_ACTIVITY,SET,144,0.026164,0.002308,0.074791,0.36323,GOMF_SYMPORTER_ACTIVITY,0.975487076958739
HP_NON_MENDELIAN_INHERITANCE,SET,86,0.034129,0.0023303,0.097572,0.36325,HP_NON_MENDELIAN_INHERITANCE,0.975487076958739
MIR10525_3P,SET,55,0.041717,0.0022798,0.11936,0.36336,MIR10525_3P,0.975631705809642
GOBP_FOREBRAIN_NEUROBLAST_DI...,SET,6,0.13167,0.0023799,0.37674,0.36336,GOBP_FOREBRAIN_NEUROBLAST_DIVISION,0.975631705809642
AMIT_EGF_RESPONSE_240_MCF10A,SET,21,0.067367,0.002277,0.19281,0.3634,AMIT_EGF_RESPONSE_240_MCF10A,0.975663731170336
MIR378B,SET,37,0.045534,0.002042,0.13039,0.36347,MIR378B,0.975684783597362
GOMF_PHOSPHATIDYLINOSITOL_3_...10,SET,24,0.06378,0.0023044,0.18282,0.3636,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING,0.975684783597362
STEIN_ESRRA_TARGETS_RESPONSI...2,SET,26,0.058729,0.0022084,0.16836,0.36361,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,0.975684783597362
REACTOME_NEGATIVE_REGULATION...5,SET,29,0.056594,0.0022474,0.16223,0.36361,REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING,0.975684783597362
HP_ELEVATED_SYSTOLIC_BLOOD_P...,SET,13,0.08175,0.0021745,0.23437,0.36362,HP_ELEVATED_SYSTOLIC_BLOOD_PRESSURE,0.975684783597362
BIOCARTA_NO2IL12_PATHWAY,SET,14,0.084601,0.0023352,0.24256,0.36363,BIOCARTA_NO2IL12_PATHWAY,0.975684783597362
GOBP_SINGLE_STRAND_BREAK_REP...,SET,11,0.079414,0.0019432,0.22772,0.36365,GOBP_SINGLE_STRAND_BREAK_REPAIR,0.975684783597362
FERRANDO_T_ALL_WITH_MLL_ENL_...2,SET,77,0.033795,0.0021839,0.097046,0.36383,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,0.975684783597362
HP_XANTHOMATOSIS,SET,36,0.053518,0.0023674,0.1537,0.36385,HP_XANTHOMATOSIS,0.975684783597362
HOWARD_NK_CELL_INACT_MONOV_I...2,SET,56,0.041187,0.0022711,0.11834,0.3639,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_28DY_DN,0.975684783597362
GSE5589_WT_VS_IL6_KO_LPS_AND...6,SET,180,0.022649,0.0022315,0.065101,0.36396,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.975684783597362
REACTOME_MOLECULES_ASSOCIATE...,SET,35,0.05206,0.0022708,0.14965,0.36397,REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,0.975684783597362
HP_ABNORMALITY_OF_THE_PREMAX...,SET,11,0.086973,0.0021282,0.25003,0.36398,HP_ABNORMALITY_OF_THE_PREMAXILLA,0.975684783597362
MIR215_3P,SET,119,0.027103,0.0021749,0.077941,0.36402,MIR215_3P,0.975684783597362
MODULE_39,SET,9,0.094509,0.0020919,0.27179,0.36402,MODULE_39,0.975684783597362
GOBP_VIRAL_RELEASE_FROM_HOST...,SET,28,0.05248,0.0020478,0.15096,0.36405,GOBP_VIRAL_RELEASE_FROM_HOST_CELL,0.975684783597362
HOEK_NK_CELL_2011_2012_TIV_A...3,SET,13,0.085371,0.0022708,0.24556,0.36405,HOEK_NK_CELL_2011_2012_TIV_ADULT_7DY_UP,0.975684783597362
GOBP_NEGATIVE_REGULATION_OF_...704,SET,7,0.11921,0.0023271,0.34293,0.36407,GOBP_NEGATIVE_REGULATION_OF_VITAMIN_METABOLIC_PROCESS,0.975684783597362
HP_MODERATELY_REDUCED_VISUAL...,SET,7,0.12282,0.0023977,0.35353,0.36414,HP_MODERATELY_REDUCED_VISUAL_ACUITY,0.975684783597362
GSE19888_CTRL_VS_A3R_ACT_TRE...1,SET,178,0.021241,0.0020813,0.061146,0.36415,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN,0.975684783597362
FERNANDEZ_BOUND_BY_MYC,SET,169,0.022222,0.0021221,0.064011,0.36424,FERNANDEZ_BOUND_BY_MYC,0.975684783597362
BLANCO_MELO_HUMAN_PARAINFLUE...2,SET,188,0.023016,0.002317,0.066329,0.3643,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,0.975684783597362
GSE17721_POLYIC_VS_PAM3CSK4_...15,SET,178,0.020646,0.0020229,0.059503,0.36431,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN,0.975684783597362
SHEDDEN_LUNG_CANCER_GOOD_SUR...3,SET,64,0.035898,0.0021157,0.10349,0.36434,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5,0.975684783597362
GSE45365_HEALTHY_VS_MCMV_INF...10,SET,182,0.020896,0.0020701,0.06025,0.36437,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_UP,0.975684783597362
MIR8068,SET,353,0.01602,0.0021999,0.046204,0.3644,MIR8068,0.975684783597362
HP_ABNORMAL_CIRCULATING_ATRI...,SET,8,0.083424,0.001741,0.24069,0.36444,HP_ABNORMAL_CIRCULATING_ATRIAL_NATRIURETIC_PEPTIDE_PRO_HORMONE_CONCENTRATION,0.975684783597362
MIR3622B_5P,SET,46,0.043002,0.0021497,0.12409,0.36447,MIR3622B_5P,0.975684783597362
GOBP_REGULATION_OF_MALE_GONA...,SET,8,0.1177,0.0024563,0.33965,0.36447,GOBP_REGULATION_OF_MALE_GONAD_DEVELOPMENT,0.975684783597362
REACTOME_ACTIVATION_OF_BAD_A...,SET,15,0.074871,0.0021391,0.21609,0.36449,REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA,0.975684783597362
GOCC_APICAL_JUNCTION_COMPLEX,SET,130,0.02634,0.0022085,0.076024,0.3645,GOCC_APICAL_JUNCTION_COMPLEX,0.975684783597362
GSE360_L_MAJOR_VS_T_GONDII_D...1,SET,176,0.021517,0.0020965,0.062122,0.36454,GSE360_L_MAJOR_VS_T_GONDII_DC_DN,0.975684783597362
FOSTER_KDM1A_TARGETS_UP,SET,225,0.020684,0.0022756,0.059721,0.36455,FOSTER_KDM1A_TARGETS_UP,0.975684783597362
TESAR_ALK_AND_JAK_TARGETS_MO...1,SET,4,0.12178,0.0017973,0.35171,0.36458,TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN,0.975684783597362
HP_PERINEAL_HYPOSPADIAS,SET,4,0.13523,0.0019957,0.39081,0.36467,HP_PERINEAL_HYPOSPADIAS,0.975684783597362
GOBP_SKELETAL_MUSCLE_SATELLI...4,SET,16,0.06485,0.0019135,0.18743,0.36468,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_PROLIFERATION,0.975684783597362
ZBTB12_TARGET_GENES,SET,1036,0.0092023,0.0021233,0.026599,0.36469,ZBTB12_TARGET_GENES,0.975684783597362
HAN_SATB1_TARGETS_DN,SET,346,0.016073,0.0021856,0.046466,0.3647,HAN_SATB1_TARGETS_DN,0.975684783597362
KEGG_VEGF_SIGNALING_PATHWAY,SET,76,0.033818,0.0021712,0.09777,0.36471,KEGG_VEGF_SIGNALING_PATHWAY,0.975684783597362
BIOCARTA_INTEGRIN_PATHWAY,SET,34,0.051209,0.0022016,0.14806,0.36472,BIOCARTA_INTEGRIN_PATHWAY,0.975684783597362
MIR613,SET,289,0.017134,0.0021326,0.049536,0.36472,MIR613,0.975684783597362
GAO_LARGE_INTESTINE_ADULT_CG...,SET,42,0.048616,0.0023225,0.14058,0.36474,GAO_LARGE_INTESTINE_ADULT_CG_GOBLET_CELL_SUBTYPE_2,0.975684783597362
YAO_TEMPORAL_RESPONSE_TO_PRO...3,SET,63,0.036389,0.0021279,0.10524,0.36476,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,0.975684783597362
GOMF_SULFATIDE_BINDING,SET,6,0.10672,0.0019289,0.30868,0.36477,GOMF_SULFATIDE_BINDING,0.975684783597362
GSE17721_PAM3CSK4_VS_CPG_1H_...2,SET,179,0.020838,0.0020474,0.060296,0.36483,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP,0.975684783597362
GOBP_SYMPATHETIC_NEURON_PROJ...,SET,5,0.13511,0.0022293,0.39099,0.36484,GOBP_SYMPATHETIC_NEURON_PROJECTION_EXTENSION,0.975684783597362
GOBP_NATURAL_KILLER_CELL_ACT...1,SET,89,0.033539,0.0023294,0.097122,0.36493,GOBP_NATURAL_KILLER_CELL_ACTIVATION,0.975684783597362
MOOTHA_GLYCOLYSIS,SET,17,0.059099,0.0017974,0.17118,0.36496,MOOTHA_GLYCOLYSIS,0.975684783597362
HP_HYPERKINETIC_MOVEMENTS,SET,35,0.050178,0.0021887,0.14537,0.36499,HP_HYPERKINETIC_MOVEMENTS,0.975684783597362
GOMF_MOLECULAR_CONDENSATE_SC...,SET,33,0.045073,0.0019091,0.13067,0.36507,GOMF_MOLECULAR_CONDENSATE_SCAFFOLD_ACTIVITY,0.975684783597362
GAO_LARGE_INTESTINE_24W_C10_...,SET,55,0.037989,0.0020761,0.11013,0.36507,GAO_LARGE_INTESTINE_24W_C10_ENTEROCYTE,0.975684783597362
GOMF_ADENYL_NUCLEOTIDE_BINDI...,SET,1501,0.0076834,0.0021051,0.022277,0.36508,GOMF_ADENYL_NUCLEOTIDE_BINDING,0.975684783597362
GOMF_UBIQUITIN_LIKE_PROTEIN_...1,SET,112,0.026647,0.0020748,0.077304,0.36516,GOMF_UBIQUITIN_LIKE_PROTEIN_BINDING,0.975684783597362
WP_INTERLEUKIN1_IL1_STRUCTUR...,SET,46,0.043263,0.0021627,0.12552,0.36517,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,0.975684783597362
GOMF_PHOSPHOPROTEIN_PHOSPHAT...,SET,159,0.021886,0.0020278,0.063529,0.36524,GOMF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.975684783597362
MIR376A_2_5P,SET,59,0.038468,0.0021771,0.11171,0.3653,MIR376A_2_5P,0.975684783597362
KEGG_MEDICUS_REFERENCE_GLOBA...,SET,16,0.058523,0.0017268,0.16999,0.36532,KEGG_MEDICUS_REFERENCE_GLOBAL_GENOME_NER,0.975684783597362
HP_APLASIA_HYPOPLASIA_OF_THE...18,SET,10,0.093556,0.0021828,0.27175,0.36532,HP_APLASIA_HYPOPLASIA_OF_THE_COLON,0.975684783597362
GOBP_REGULATION_OF_HEART_RAT...2,SET,5,0.13795,0.0022761,0.40101,0.36542,GOBP_REGULATION_OF_HEART_RATE_BY_CHEMICAL_SIGNAL,0.975684783597362
GOBP_NEUTROPHIL_MIGRATION,SET,96,0.032479,0.0023423,0.094439,0.36546,GOBP_NEUTROPHIL_MIGRATION,0.975684783597362
THEILGAARD_NEUTROPHIL_AT_SKI...1,SET,213,0.018929,0.0020269,0.055046,0.36547,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,0.975684783597362
HP_STENOSIS_OF_THE_EXTERNAL_...,SET,32,0.052953,0.0022087,0.15399,0.36547,HP_STENOSIS_OF_THE_EXTERNAL_AUDITORY_CANAL,0.975684783597362
GOBP_RESCUE_OF_STALLED_RIBOS...,SET,25,0.052276,0.0019276,0.15205,0.36549,GOBP_RESCUE_OF_STALLED_RIBOSOME,0.975684783597362
MODULE_568,SET,62,0.036262,0.0021036,0.10551,0.36555,MODULE_568,0.975684783597362
HP_APLASIA_HYPOPLASIA_OF_THE...39,SET,14,0.079223,0.0021868,0.23053,0.36555,HP_APLASIA_HYPOPLASIA_OF_THE_LENS,0.975684783597362
GOBP_MATURATION_OF_SSU_RRNA,SET,47,0.041447,0.0020943,0.12062,0.36557,GOBP_MATURATION_OF_SSU_RRNA,0.975684783597362
GOBP_PURINE_DEOXYRIBONUCLEOT...1,SET,5,0.12475,0.0020584,0.36309,0.36558,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.975684783597362
HP_ABNORMAL_2ND_METACARPAL_M...,SET,6,0.12919,0.0023351,0.37616,0.36563,HP_ABNORMAL_2ND_METACARPAL_MORPHOLOGY,0.975684783597362
HP_SPASTIC_TETRAPLEGIA,SET,109,0.027369,0.0021025,0.079714,0.36567,HP_SPASTIC_TETRAPLEGIA,0.975684783597362
GOBP_REGULATION_OF_ARACHIDON...,SET,7,0.12339,0.0024088,0.35942,0.36569,GOBP_REGULATION_OF_ARACHIDONIC_ACID_SECRETION,0.975684783597362
MIR7703,SET,101,0.029071,0.0021502,0.084693,0.36571,MIR7703,0.975684783597362
GOBP_POSITIVE_REGULATION_OF_...249,SET,189,0.022027,0.0022233,0.064178,0.36572,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,0.975684783597362
GOBP_NEGATIVE_REGULATION_OF_...291,SET,10,0.089911,0.0020977,0.26199,0.36573,GOBP_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.975684783597362
GOBP_GLYCOSPHINGOLIPID_METAB...,SET,62,0.039048,0.0022652,0.1138,0.36575,GOBP_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,0.975684783597362
GSE5589_LPS_AND_IL10_VS_LPS_...2,SET,178,0.022024,0.002158,0.064186,0.36575,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,0.975684783597362
SHIN_B_CELL_LYMPHOMA_CLUSTER...2,SET,31,0.053046,0.0021778,0.15469,0.36583,SHIN_B_CELL_LYMPHOMA_CLUSTER_2,0.975684783597362
MIR8073,SET,76,0.03327,0.002136,0.097045,0.36587,MIR8073,0.975684783597362
TERAMOTO_OPN_TARGETS_CLUSTER...5,SET,25,0.055602,0.0020503,0.16238,0.36602,TERAMOTO_OPN_TARGETS_CLUSTER_6,0.975684783597362
MORF_PSMC2,SET,101,0.025743,0.001904,0.075188,0.36603,MORF_PSMC2,0.975684783597362
GOBP_POSITIVE_REGULATION_OF_...20,SET,24,0.068049,0.0024586,0.19875,0.36603,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,0.975684783597362
GOCC_SNARE_COMPLEX,SET,48,0.039496,0.0020168,0.11536,0.36604,GOCC_SNARE_COMPLEX,0.975684783597362
GOBP_NEGATIVE_REGULATION_OF_...221,SET,9,0.096467,0.0021352,0.28188,0.36609,GOBP_NEGATIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,0.975684783597362
HOLLERN_EMT_BREAST_TUMOR_DN,SET,115,0.027298,0.0021536,0.079779,0.36611,HOLLERN_EMT_BREAST_TUMOR_DN,0.975684783597362
MODULE_455,SET,36,0.046283,0.0020474,0.13528,0.36613,MODULE_455,0.975684783597362
REACTOME_INACTIVATION_OF_CSF...,SET,22,0.071871,0.0024863,0.21008,0.36614,REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,0.975684783597362
GOBP_REGULATION_OF_ANATOMICA...2,SET,444,0.014,0.0021506,0.040924,0.36614,GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE,0.975684783597362
MIR6810_3P,SET,69,0.035119,0.0021488,0.10267,0.36615,MIR6810_3P,0.975684783597362
KEGG_MEDICUS_REFERENCE_TLR3_...2,SET,16,0.08853,0.0026122,0.25885,0.36617,KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY,0.975684783597362
GOBP_POLY_N_ACETYLLACTOSAMIN...,SET,9,0.10301,0.00228,0.30123,0.36619,GOBP_POLY_N_ACETYLLACTOSAMINE_METABOLIC_PROCESS,0.975684783597362
HP_LONG_FINGERS,SET,246,0.017882,0.002056,0.052293,0.36619,HP_LONG_FINGERS,0.975684783597362
GSE19888_ADENOSINE_A3R_INH_V...8,SET,183,0.021251,0.002111,0.062147,0.36619,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,0.975684783597362
VANHARANTA_UTERINE_FIBROID_UP,SET,39,0.047874,0.002204,0.14011,0.3663,VANHARANTA_UTERINE_FIBROID_UP,0.975684783597362
GAVISH_3CA_METAPROGRAM_FIBRO...5,SET,43,0.038722,0.0018717,0.11334,0.36631,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4,0.975684783597362
chr8q13,SET,31,0.11489,0.0047167,0.33638,0.36635,chr8q13,0.975684783597362
GOBP_METANEPHRIC_NEPHRON_TUB...1,SET,6,0.13816,0.0024972,0.40454,0.36636,GOBP_METANEPHRIC_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION,0.975684783597362
MIR3661,SET,62,0.037469,0.0021736,0.10974,0.3664,MIR3661,0.975684783597362
DBP_Q6,SET,224,0.019657,0.0021579,0.057576,0.3664,DBP_Q6,0.975684783597362
GOBP_CONNECTIVE_TISSUE_REPLA...1,SET,11,0.085844,0.0021005,0.25159,0.36647,GOBP_CONNECTIVE_TISSUE_REPLACEMENT,0.975684783597362
GSE360_L_DONOVANI_VS_B_MALAY...5,SET,181,0.020819,0.0020569,0.061019,0.36648,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN,0.975684783597362
HP_RECURRENT_ABSCESS_FORMATI...,SET,16,0.083103,0.0024521,0.24358,0.36649,HP_RECURRENT_ABSCESS_FORMATION,0.975684783597362
HSD17B8_TARGET_GENES,SET,518,0.013322,0.0022059,0.039059,0.36652,HSD17B8_TARGET_GENES,0.975684783597362
GAVISH_3CA_METAPROGRAM_MACRO...6,SET,43,0.047743,0.0023078,0.13999,0.36653,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_3,0.975684783597362
CROMER_TUMORIGENESIS_UP,SET,53,0.044304,0.0023769,0.12992,0.36655,CROMER_TUMORIGENESIS_UP,0.975684783597362
HP_DIGESTIVE_SYSTEM_NEOPLASM,SET,343,0.015649,0.0021188,0.045903,0.36659,HP_DIGESTIVE_SYSTEM_NEOPLASM,0.975684783597362
PID_IL2_STAT5_PATHWAY,SET,28,0.055268,0.0021566,0.16214,0.36661,PID_IL2_STAT5_PATHWAY,0.975684783597362
GSE7831_CPG_VS_INFLUENZA_STI...2,SET,181,0.02035,0.0020105,0.059702,0.36661,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP,0.975684783597362
GSE33425_CD161_HIGH_VS_NEG_C...2,SET,184,0.021497,0.0021412,0.06308,0.36663,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP,0.975684783597362
MIR200B_3P,SET,448,0.014272,0.002202,0.041885,0.36665,MIR200B_3P,0.975684783597362
MIR200C_3P,SET,448,0.014272,0.002202,0.041885,0.36665,MIR200C_3P,0.975684783597362
WP_INTRACELLULAR_TRAFFICKING...,SET,27,0.056718,0.0021734,0.16654,0.36672,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,0.975684783597362
HEIDENBLAD_AMPLIFIED_IN_SOFT...,SET,13,0.077307,0.0020563,0.22708,0.36677,HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER,0.975684783597362
GOMF_PHOSPHATIDYLINOSITOL_PH...1,SET,6,0.10252,0.0018529,0.3013,0.36684,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_4_PHOSPHATASE_ACTIVITY,0.975684783597362
HP_ABNORMAL_FORAMEN_MAGNUM_M...,SET,16,0.064292,0.001897,0.18897,0.36684,HP_ABNORMAL_FORAMEN_MAGNUM_MORPHOLOGY,0.975684783597362
GSE13306_TREG_VS_TCONV_LAMIN...2,SET,182,0.022012,0.0021807,0.064699,0.36685,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP,0.975684783597362
HP_BUNDLE_BRANCH_BLOCK,SET,68,0.034609,0.0021023,0.10174,0.36686,HP_BUNDLE_BRANCH_BLOCK,0.975684783597362
GOMF_MONOAMINE_TRANSMEMBRANE...,SET,12,0.089581,0.0022894,0.26341,0.3669,GOMF_MONOAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.975684783597362
HP_ABNORMAL_GLOBUS_PALLIDUS_...,SET,21,0.059014,0.0019947,0.17355,0.36691,HP_ABNORMAL_GLOBUS_PALLIDUS_MORPHOLOGY,0.975684783597362
GOBP_ANTERIOR_POSTERIOR_PATT...,SET,200,0.022794,0.0023659,0.067042,0.36693,GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION,0.975684783597362
GSE22501_PERIPHERAL_BLOOD_VS...1,SET,175,0.021949,0.0021326,0.064584,0.36698,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN,0.975684783597362
HP_SMALL_ANTERIOR_FONTANELLE,SET,6,0.11224,0.0020286,0.33036,0.36703,HP_SMALL_ANTERIOR_FONTANELLE,0.975684783597362
DESCARTES_FETAL_ADRENAL_SLC2...,SET,32,0.052168,0.002176,0.15358,0.36705,DESCARTES_FETAL_ADRENAL_SLC26A4_PAEP_POSITIVE_CELLS,0.975684783597362
GNF2_CKS2,SET,49,0.039882,0.0020575,0.11742,0.36706,GNF2_CKS2,0.975684783597362
HP_APLASIA_HYPOPLASIA_OF_THE...61,SET,74,0.032338,0.0020488,0.095223,0.36708,HP_APLASIA_HYPOPLASIA_OF_THE_RADIUS,0.975684783597362
LOPEZ_MESOTHELIOMA_SURVIVAL_...3,SET,7,0.11084,0.0021637,0.32668,0.3672,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP,0.975684783597362
MALONEY_RESPONSE_TO_17AAG_DN,SET,66,0.034223,0.0020481,0.10089,0.36722,MALONEY_RESPONSE_TO_17AAG_DN,0.975684783597362
GOCC_HAUS_COMPLEX,SET,7,0.087374,0.0017057,0.25759,0.36723,GOCC_HAUS_COMPLEX,0.975684783597362
GOMF_CARBON_SULFUR_LYASE_ACT...,SET,10,0.09676,0.0022575,0.28525,0.36723,GOMF_CARBON_SULFUR_LYASE_ACTIVITY,0.975684783597362
HP_RESPIRATORY_FAILURE,SET,228,0.018554,0.0020547,0.05471,0.36726,HP_RESPIRATORY_FAILURE,0.975684783597362
HP_EXTRAMEDULLARY_HEMATOPOIE...,SET,19,0.067021,0.0021548,0.19767,0.36729,HP_EXTRAMEDULLARY_HEMATOPOIESIS,0.975684783597362
GOBP_REGULATION_OF_HIPPO_SIG...,SET,36,0.051449,0.0022759,0.15175,0.3673,GOBP_REGULATION_OF_HIPPO_SIGNALING,0.975684783597362
GOBP_DEOXYRIBONUCLEOSIDE_MON...3,SET,24,0.059995,0.0021677,0.17699,0.36731,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.975684783597362
HP_WHITE_FORELOCK,SET,14,0.087335,0.0024107,0.25776,0.36737,HP_WHITE_FORELOCK,0.975684783597362
HP_EVERTED_UPPER_LIP_VERMILI...,SET,19,0.06534,0.0021008,0.19291,0.36742,HP_EVERTED_UPPER_LIP_VERMILION,0.975684783597362
KUNINGER_IGF1_VS_PDGFB_TARGE...1,SET,41,0.04677,0.0022076,0.13811,0.36744,KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,0.975684783597362
REACTOME_NS1_MEDIATED_EFFECT...,SET,39,0.041111,0.0018927,0.12142,0.36747,REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS,0.975684783597362
MIR6735_5P,SET,92,0.029762,0.0021014,0.087958,0.36755,MIR6735_5P,0.975684783597362
GOBP_CD8_POSITIVE_ALPHA_BETA...3,SET,7,0.10998,0.002147,0.32509,0.36756,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.975684783597362
GSE5589_IL6_KO_VS_IL10_KO_LP...2,SET,179,0.02071,0.0020348,0.061213,0.36756,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.975684783597362
REACTOME_NUCLEAR_RECEPTOR_TR...,SET,50,0.041279,0.0021512,0.12202,0.36757,REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,0.975684783597362
GOMF_ER_RETENTION_SEQUENCE_B...,SET,5,0.11829,0.0019518,0.34971,0.36759,GOMF_ER_RETENTION_SEQUENCE_BINDING,0.975684783597362
GSE14699_DELETIONAL_TOLERANC...1,SET,167,0.022036,0.002092,0.065212,0.36771,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.975684783597362
GSE10239_MEMORY_VS_KLRG1INT_...2,SET,179,0.021497,0.0021122,0.063622,0.36773,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP,0.975684783597362
ARNT2_TARGET_GENES,SET,552,0.011966,0.0020433,0.035426,0.36778,ARNT2_TARGET_GENES,0.975684783597362
HP_ABNORMAL_PROSTATE_MORPHOL...,SET,38,0.049262,0.0022388,0.1459,0.36782,HP_ABNORMAL_PROSTATE_MORPHOLOGY,0.975684783597362
GSE9988_ANTI_TREM1_VS_LPS_MO...1,SET,176,0.022613,0.0022033,0.067009,0.36789,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN,0.975684783597362
GOBP_MODULATION_BY_HOST_OF_S...,SET,78,0.030768,0.0020011,0.09121,0.36794,GOBP_MODULATION_BY_HOST_OF_SYMBIONT_PROCESS,0.975684783597362
HP_LOW_1_MINUTE_APGAR_SCORE,SET,6,0.14191,0.0025649,0.42069,0.36794,HP_LOW_1_MINUTE_APGAR_SCORE,0.975684783597362
GOBP_AXONOGENESIS_INVOLVED_I...,SET,9,0.099185,0.0021954,0.29407,0.36795,GOBP_AXONOGENESIS_INVOLVED_IN_INNERVATION,0.975684783597362
GSE29618_BCELL_VS_MDC_DAY7_F...1,SET,183,0.021633,0.0021489,0.064149,0.36797,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN,0.975684783597362
GSE29618_PRE_VS_DAY7_FLU_VAC...4,SET,174,0.022177,0.0021487,0.065774,0.36799,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP,0.975684783597362
GOBP_POSITIVE_REGULATION_OF_...342,SET,136,0.025302,0.0021695,0.075071,0.36804,GOBP_POSITIVE_REGULATION_OF_HORMONE_SECRETION,0.975684783597362
MODULE_249,SET,21,0.056426,0.0019072,0.16742,0.36805,MODULE_249,0.975684783597362
GOBP_REGULATION_OF_HYALURONA...,SET,8,0.099703,0.0020807,0.29596,0.36811,GOBP_REGULATION_OF_HYALURONAN_BIOSYNTHETIC_PROCESS,0.975684783597362
REACTOME_TP53_REGULATES_TRAN...8,SET,14,0.075988,0.0020975,0.22558,0.36812,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST,0.975684783597362
MODULE_62,SET,67,0.029684,0.0017898,0.088127,0.36812,MODULE_62,0.975684783597362
GOBP_POSITIVE_REGULATION_OF_...79,SET,28,0.057358,0.0022382,0.17028,0.36812,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.975684783597362
GOMF_ICOSANOID_TRANSMEMBRANE...,SET,13,0.085144,0.0022648,0.2528,0.36814,GOMF_ICOSANOID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.975684783597362
HEBERT_MATRISOME_TNBC_BRAIN_...1,SET,23,0.064579,0.0022842,0.19179,0.36816,HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS,0.975684783597362
WP_SEROTONIN_AND_ANXIETY,SET,15,0.082547,0.0023584,0.24518,0.36818,WP_SEROTONIN_AND_ANXIETY,0.975684783597362
REACTOME_RESOLUTION_OF_D_LOO...2,SET,25,0.056069,0.0020675,0.16657,0.36821,REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA,0.975684783597362
GOBP_NUCLEOTIDE_SALVAGE,SET,16,0.07419,0.0021891,0.22048,0.36825,GOBP_NUCLEOTIDE_SALVAGE,0.975684783597362
GOMF_MANNOSIDASE_ACTIVITY,SET,15,0.076005,0.0021715,0.22589,0.36826,GOMF_MANNOSIDASE_ACTIVITY,0.975684783597362
GOMF_MEMBRANE_INSERTASE_ACTI...,SET,14,0.068187,0.0018821,0.20265,0.36826,GOMF_MEMBRANE_INSERTASE_ACTIVITY,0.975684783597362
HNF4ALPHA_Q6,SET,236,0.018451,0.0020784,0.054857,0.3683,HNF4ALPHA_Q6,0.975684783597362
GSE3982_EFF_MEMORY_VS_CENT_M...2,SET,174,0.021638,0.0020964,0.064409,0.36846,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP,0.975684783597362
GOBP_REGULATION_OF_CALCIUM_I...2,SET,29,0.050627,0.0020104,0.15071,0.36847,GOBP_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.975684783597362
MIR4709_3P,SET,148,0.023616,0.0021117,0.070337,0.36853,MIR4709_3P,0.975684783597362
LET_7F_2_3P,SET,371,0.01475,0.0020755,0.043961,0.36861,LET_7F_2_3P,0.975684783597362
MIR4680_5P,SET,58,0.036741,0.0020617,0.10952,0.36863,MIR4680_5P,0.975684783597362
TONKS_TARGETS_OF_RUNX1_RUNX1...9,SET,42,0.043622,0.002084,0.13005,0.36865,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,0.975684783597362
HOEK_PBMC_INACTIVATED_INFLUE...5,SET,16,0.070616,0.0020837,0.2106,0.3687,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_DN,0.975684783597362
GOCC_PRP19_COMPLEX,SET,14,0.068505,0.0018909,0.2044,0.36876,GOCC_PRP19_COMPLEX,0.975684783597362
SIRNA_EIF4GI_DN,SET,84,0.032104,0.0021665,0.095816,0.36879,SIRNA_EIF4GI_DN,0.975684783597362
HP_ABNORMAL_AORTIC_VALVE_MOR...,SET,151,0.023456,0.0021184,0.070018,0.36882,HP_ABNORMAL_AORTIC_VALVE_MORPHOLOGY,0.975684783597362
HATADA_METHYLATED_IN_LUNG_CA...1,SET,31,0.055397,0.0022743,0.16539,0.36884,HATADA_METHYLATED_IN_LUNG_CANCER_DN,0.975684783597362
VERHAAK_AML_WITH_NPM1_MUTATE...2,SET,168,0.023807,0.0022668,0.071101,0.36888,VERHAAK_AML_WITH_NPM1_MUTATED_UP,0.975684783597362
HMGB2_TARGET_GENES,SET,412,0.01413,0.0020928,0.042212,0.36891,HMGB2_TARGET_GENES,0.975684783597362
WP_ACUTE_VIRAL_MYOCARDITIS,SET,82,0.032692,0.0021798,0.09772,0.36899,WP_ACUTE_VIRAL_MYOCARDITIS,0.975684783597362
NAKAMURA_CANCER_MICROENVIRON...1,SET,40,0.040184,0.0018735,0.12014,0.36901,NAKAMURA_CANCER_MICROENVIRONMENT_DN,0.975684783597362
GAUTAM_EYE_IRIS_CILIARY_BODY...3,SET,316,0.015196,0.0019763,0.045438,0.36903,GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS,0.975684783597362
GOBP_REGULATION_OF_CELL_SIZE,SET,156,0.022771,0.00209,0.068099,0.36905,GOBP_REGULATION_OF_CELL_SIZE,0.975684783597362
GOBP_GONADAL_MESODERM_DEVELO...,SET,2,0.20584,0.0021482,0.61567,0.36906,GOBP_GONADAL_MESODERM_DEVELOPMENT,0.975684783597362
HP_RENAL_HYPOPLASIA_APLASIA,SET,298,0.01626,0.0020546,0.04864,0.36908,HP_RENAL_HYPOPLASIA_APLASIA,0.975684783597362
MIR3620_5P,SET,49,0.037282,0.0019234,0.11155,0.36911,MIR3620_5P,0.975684783597362
GOBP_DNA_STRAND_ELONGATION_I...,SET,14,0.065291,0.0018022,0.19535,0.36911,GOBP_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION,0.975684783597362
REACTOME_REGULATION_OF_SIGNA...2,SET,9,0.092962,0.0020576,0.27817,0.36912,REACTOME_REGULATION_OF_SIGNALING_BY_NODAL,0.975684783597362
REACTOME_L1CAM_INTERACTIONS,SET,108,0.028613,0.002188,0.085673,0.3692,REACTOME_L1CAM_INTERACTIONS,0.975684783597362
GOBP_NEGATIVE_REGULATION_OF_...117,SET,9,0.091389,0.0020228,0.27372,0.36924,GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.975684783597362
GOBP_REGULATION_OF_ACTIN_FIL...4,SET,135,0.023995,0.0020499,0.071867,0.36924,GOBP_REGULATION_OF_ACTIN_FILAMENT_LENGTH,0.975684783597362
NABA_ECM_REGULATORS,SET,229,0.020428,0.0022671,0.061188,0.36925,NABA_ECM_REGULATORS,0.975684783597362
REACTOME_LGI_ADAM_INTERACTIO...,SET,14,0.076221,0.0021039,0.22832,0.36925,REACTOME_LGI_ADAM_INTERACTIONS,0.975684783597362
GAUTAM_EYE_IRIS_CILIARY_BODY...4,SET,83,0.031154,0.0020899,0.09338,0.36933,GAUTAM_EYE_IRIS_CILIARY_BODY_COL9A1_HIGH_CILIARY_BODY_CELLS,0.975684783597362
GSE19888_ADENOSINE_A3R_ACT_V...2,SET,166,0.020434,0.0019341,0.061257,0.36935,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP,0.975684783597362
HP_FLAT_FOREHEAD,SET,15,0.072408,0.0020688,0.21717,0.36941,HP_FLAT_FOREHEAD,0.975684783597362
LASTOWSKA_NEUROBLASTOMA_COPY...2,SET,169,0.0231,0.002206,0.069289,0.36942,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,0.975684783597362
HP_ABNORMAL_NASOLACRIMAL_SYS...,SET,63,0.034538,0.0020197,0.10362,0.36945,HP_ABNORMAL_NASOLACRIMAL_SYSTEM_MORPHOLOGY,0.975684783597362
HP_LONG_PALPEBRAL_FISSURE,SET,62,0.032639,0.0018934,0.097917,0.36945,HP_LONG_PALPEBRAL_FISSURE,0.975684783597362
GOBP_CD40_SIGNALING_PATHWAY,SET,13,0.070261,0.0018689,0.21086,0.36949,GOBP_CD40_SIGNALING_PATHWAY,0.975684783597362
GOBP_COPII_COATED_VESICLE_CA...,SET,18,0.062092,0.0019432,0.18635,0.36949,GOBP_COPII_COATED_VESICLE_CARGO_LOADING,0.975684783597362
HP_ABNORMAL_BOWMAN_CAPSULE_M...,SET,9,0.094594,0.0020938,0.28389,0.36949,HP_ABNORMAL_BOWMAN_CAPSULE_MORPHOLOGY,0.975684783597362
GSE21927_SPLEEN_VS_4T1_TUMOR...2,SET,162,0.022622,0.0021156,0.06791,0.36952,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,0.975684783597362
GOMF_UBIQUITIN_BINDING,SET,94,0.028601,0.0020412,0.085883,0.36956,GOMF_UBIQUITIN_BINDING,0.975684783597362
GSE12366_PLASMA_CELL_VS_NAIV...2,SET,165,0.022422,0.0021159,0.067355,0.36961,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP,0.975684783597362
GSE2405_HEAT_KILLED_LYSATE_V...3,SET,182,0.019661,0.0019477,0.05906,0.36961,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,0.975684783597362
REACTOME_ACTIVATED_PKN1_STIM...,SET,6,0.11917,0.0021539,0.35801,0.36962,REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3,0.975684783597362
REACTOME_PRESYNAPTIC_DEPOLAR...,SET,11,0.090982,0.0022262,0.27334,0.36963,REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING,0.975684783597362
REACTOME_DERMATAN_SULFATE_BI...,SET,10,0.080315,0.0018738,0.24138,0.36967,REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS,0.975684783597362
INAMURA_LUNG_CANCER_SCC_SUBT...,SET,12,0.070213,0.0017944,0.21105,0.36969,INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP,0.975684783597362
GOBP_REGULATION_OF_GENE_SILE...,SET,25,0.056946,0.0020999,0.1712,0.36971,GOBP_REGULATION_OF_GENE_SILENCING_BY_REGULATORY_NCRNA,0.975684783597362
GOBP_RIBOSOME_DISASSEMBLY,SET,32,0.045119,0.0018819,0.13566,0.36972,GOBP_RIBOSOME_DISASSEMBLY,0.975684783597362
TONKS_TARGETS_OF_RUNX1_RUNX1...4,SET,47,0.042253,0.002135,0.12705,0.36973,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,0.975684783597362
GOCC_VOLTAGE_GATED_CALCIUM_C...,SET,41,0.0458,0.0021619,0.13771,0.36973,GOCC_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,0.975684783597362
chr1q22,SET,43,0.070336,0.0033998,0.21151,0.36974,chr1q22,0.975684783597362
MIR520G_3P_MIR520H,SET,182,0.02049,0.0020299,0.061622,0.36975,MIR520G_3P_MIR520H,0.975684783597362
GSE18893_CTRL_VS_TNF_TREATED...7,SET,179,0.02059,0.0020231,0.061927,0.36976,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN,0.975684783597362
HP_BRONCHIAL_WALL_THICKENING,SET,6,0.13971,0.0025252,0.42041,0.36982,HP_BRONCHIAL_WALL_THICKENING,0.975684783597362
GSE26343_WT_VS_NFAT5_KO_MACR...3,SET,189,0.020465,0.0020656,0.061587,0.36983,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_UP,0.975684783597362
GOBP_REGULATION_OF_PROTEIN_S...3,SET,285,0.016128,0.0019937,0.048549,0.36987,GOBP_REGULATION_OF_PROTEIN_STABILITY,0.975684783597362
GSE45365_HEALTHY_VS_MCMV_INF...7,SET,181,0.021363,0.0021106,0.064308,0.36987,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_DN,0.975684783597362
GOBP_REGULATION_OF_HYDROLASE...,SET,641,0.01177,0.0021604,0.035431,0.36988,GOBP_REGULATION_OF_HYDROLASE_ACTIVITY,0.975684783597362
WP_ESTROGEN_METABOLISM_WP5276,SET,23,0.060199,0.0021293,0.18126,0.3699,WP_ESTROGEN_METABOLISM_WP5276,0.975684783597362
HP_FOOT_ACROOSTEOLYSIS,SET,7,0.10846,0.0021173,0.32658,0.3699,HP_FOOT_ACROOSTEOLYSIS,0.975684783597362
REACTOME_RHO_GTPASES_ACTIVAT...6,SET,19,0.063569,0.0020439,0.19141,0.36991,REACTOME_RHO_GTPASES_ACTIVATE_PAKS,0.975684783597362
REACTOME_EPHB_MEDIATED_FORWA...,SET,41,0.042607,0.0020111,0.1283,0.36992,REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,0.975684783597362
GSE22025_UNTREATED_VS_PROGES...2,SET,181,0.020991,0.0020739,0.063229,0.36995,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP,0.975684783597362
GOBP_PROTEIN_LOCALIZATION_TO...39,SET,296,0.015899,0.0020023,0.047894,0.36996,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.975684783597362
GSE14699_NAIVE_VS_ACT_CD8_TC...2,SET,174,0.022083,0.0021395,0.066524,0.36996,GSE14699_NAIVE_VS_ACT_CD8_TCELL_UP,0.975684783597362
GOBP_MATURATION_OF_SSU_RRNA_...,SET,30,0.049815,0.0020119,0.15012,0.37001,GOBP_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.975684783597362
GOCC_CANONICAL_INFLAMMASOME_...,SET,16,0.078863,0.002327,0.23767,0.37001,GOCC_CANONICAL_INFLAMMASOME_COMPLEX,0.975684783597362
GOMF_PHOSPHOLIPID_BINDING,SET,444,0.013577,0.0020856,0.040916,0.37001,GOMF_PHOSPHOLIPID_BINDING,0.975684783597362
GOBP_GLUCOCORTICOID_SECRETION,SET,11,0.084372,0.0020645,0.25429,0.37003,GOBP_GLUCOCORTICOID_SECRETION,0.975684783597362
HAY_BONE_MARROW_CD34_POS_ERP,SET,8,0.10303,0.0021501,0.31062,0.37006,HAY_BONE_MARROW_CD34_POS_ERP,0.975684783597362
ZNF2_TARGET_GENES,SET,940,0.0092956,0.0020487,0.028027,0.37007,ZNF2_TARGET_GENES,0.975684783597362
GOBP_5_PHOSPHORIBOSE_1_DIPHO...,SET,4,0.12465,0.0018397,0.37589,0.37009,GOBP_5_PHOSPHORIBOSE_1_DIPHOSPHATE_METABOLIC_PROCESS,0.975684783597362
MORF_BNIP1,SET,174,0.020619,0.0019977,0.062193,0.37012,MORF_BNIP1,0.975684783597362
BLANCO_MELO_BRONCHIAL_EPITHE...2,SET,577,0.012417,0.0021662,0.037465,0.37017,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP,0.975684783597362
YAO_HOXA10_TARGETS_VIA_PROGE...2,SET,75,0.033649,0.0021462,0.10157,0.37022,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,0.975684783597362
HP_SUPERNUMERARY_TOOTH,SET,44,0.043673,0.0021353,0.13183,0.37022,HP_SUPERNUMERARY_TOOTH,0.975684783597362
GSE40274_CTRL_VS_FOXP3_AND_S...1,SET,138,0.023945,0.0020681,0.072278,0.37022,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.975684783597362
GOBP_NEGATIVE_REGULATION_OF_...143,SET,21,0.06625,0.0022392,0.20003,0.37025,GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,0.975684783597362
HP_PROGRESSIVE_NEUROLOGIC_DE...,SET,62,0.033424,0.001939,0.10092,0.37025,HP_PROGRESSIVE_NEUROLOGIC_DETERIORATION,0.975684783597362
GOBP_OXYGEN_TRANSPORT,SET,11,0.10356,0.002534,0.31273,0.37027,GOBP_OXYGEN_TRANSPORT,0.975684783597362
GSE1432_6H_VS_24H_IFNG_MICRO...1,SET,179,0.019977,0.0019628,0.060342,0.3703,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,0.975684783597362
chr4q27,SET,14,0.11021,0.0030422,0.33299,0.37033,chr4q27,0.975684783597362
GSE30962_ACUTE_VS_CHRONIC_LC...3,SET,185,0.021358,0.0021331,0.064532,0.37033,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN,0.975684783597362
WP_MIRNA_REGULATION_OF_P53_P...,SET,24,0.058799,0.0021244,0.17766,0.37034,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,0.975684783597362
GOBP_CELLULAR_RESPONSE_TO_CA...4,SET,49,0.040279,0.002078,0.12171,0.37035,GOBP_CELLULAR_RESPONSE_TO_CAMP,0.975684783597362
REACTOME_CYTOCHROME_P450_ARR...,SET,63,0.039056,0.0022838,0.11804,0.37037,REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE,0.975684783597362
REACTOME_CLEC7A_INFLAMMASOME...,SET,5,0.12835,0.0021177,0.38821,0.37047,REACTOME_CLEC7A_INFLAMMASOME_PATHWAY,0.975874249658936
HOEK_NK_CELL_2011_2012_TIV_7...,SET,14,0.074877,0.0020668,0.22657,0.37052,HOEK_NK_CELL_2011_2012_TIV_7D_VS_0DY_ADULT_7D_DN,0.975884370263716
MIR93_5P,SET,570,0.011965,0.0020752,0.036208,0.37053,MIR93_5P,0.975884370263716
GOCC_CUL4B_RING_E3_UBIQUITIN...,SET,5,0.11903,0.001964,0.3604,0.37059,GOCC_CUL4B_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.975915563790365
GOBP_BRANCHED_CHAIN_AMINO_AC...1,SET,5,0.13813,0.0022791,0.41842,0.37065,GOBP_BRANCHED_CHAIN_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.975915563790365
HP_ABNORMAL_SACROILIAC_JOINT...,SET,6,0.13488,0.0024378,0.40863,0.37067,HP_ABNORMAL_SACROILIAC_JOINT_MORPHOLOGY,0.975915563790365
REACTOME_SEMA3A_PLEXIN_REPUL...,SET,13,0.081272,0.0021618,0.24635,0.37074,REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION,0.975915563790365
MATTIOLI_MULTIPLE_MYELOMA_SU...,SET,10,0.1015,0.0023681,0.3079,0.37083,MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS,0.975915563790365
GOBP_POSITIVE_REGULATION_OF_...75,SET,13,0.078132,0.0020783,0.23701,0.37083,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.975915563790365
GSE46606_UNSTIM_VS_CD40L_IL2...10,SET,187,0.019378,0.0019457,0.058799,0.37086,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,0.975915563790365
REACTOME_SIGNALING_BY_FGFR4,SET,39,0.044012,0.0020263,0.13356,0.37088,REACTOME_SIGNALING_BY_FGFR4,0.975915563790365
GSE17721_LPS_VS_POLYIC_4H_BM...1,SET,173,0.019607,0.0018943,0.059519,0.37092,GSE17721_LPS_VS_POLYIC_4H_BMDC_DN,0.975915563790365
WP_ONCOSTATIN_M_SIGNALING,SET,63,0.038403,0.0022457,0.11662,0.37097,WP_ONCOSTATIN_M_SIGNALING,0.975915563790365
GOBP_PROTEIN_MONOUBIQUITINAT...,SET,42,0.039965,0.0019092,0.12139,0.37099,GOBP_PROTEIN_MONOUBIQUITINATION,0.975915563790365
HALLMARK_MTORC1_SIGNALING,SET,184,0.019973,0.0019894,0.060681,0.37102,HALLMARK_MTORC1_SIGNALING,0.975915563790365
HP_GENERALIZED_HYPERTRICHOSIS,SET,8,0.10135,0.0021151,0.30794,0.37103,HP_GENERALIZED_HYPERTRICHOSIS,0.975915563790365
HP_RECURRENT_NEISSERIAL_INFE...,SET,7,0.10883,0.0021245,0.33066,0.37103,HP_RECURRENT_NEISSERIAL_INFECTIONS,0.975915563790365
GSE41176_UNSTIM_VS_ANTI_IGM_...11,SET,174,0.021494,0.0020825,0.065314,0.37105,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN,0.975915563790365
REACTOME_EXTENSION_OF_TELOME...,SET,48,0.03693,0.0018857,0.11223,0.37106,REACTOME_EXTENSION_OF_TELOMERES,0.975915563790365
KEGG_MEDICUS_REFERENCE_C9ORF...,SET,8,0.10046,0.0020964,0.30532,0.37107,KEGG_MEDICUS_REFERENCE_C9ORF72_MEDIATED_AUTOPHAGY_INITIATION,0.975915563790365
HP_ABNORMAL_PREPUTIUM_MORPHO...,SET,30,0.047535,0.0019199,0.14449,0.37108,HP_ABNORMAL_PREPUTIUM_MORPHOLOGY,0.975915563790365
MIR1184,SET,151,0.021878,0.0019759,0.066514,0.37111,MIR1184,0.975915563790365
GOBP_ALDITOL_PHOSPHATE_METAB...,SET,9,0.10325,0.0022854,0.31399,0.37114,GOBP_ALDITOL_PHOSPHATE_METABOLIC_PROCESS,0.975915563790365
GOMF_GAMMA_TUBULIN_BINDING,SET,28,0.052052,0.0020311,0.15829,0.37114,GOMF_GAMMA_TUBULIN_BINDING,0.975915563790365
MIR3199,SET,41,0.041979,0.0019815,0.12768,0.37116,MIR3199,0.975915563790365
HP_ABNORMAL_FRONTAL_BONE_MOR...,SET,365,0.014071,0.0019642,0.04281,0.37119,HP_ABNORMAL_FRONTAL_BONE_MORPHOLOGY,0.975915563790365
GOCC_NEUROTRANSMITTER_RECEPT...,SET,43,0.046358,0.0022408,0.14115,0.37129,GOCC_NEUROTRANSMITTER_RECEPTOR_COMPLEX,0.975915563790365
GOBP_MUSCLE_CONTRACTION,SET,328,0.015848,0.0020991,0.048255,0.3713,GOBP_MUSCLE_CONTRACTION,0.975915563790365
GOBP_VESICLE_MEDIATED_TRANSP...2,SET,44,0.041044,0.0020068,0.12497,0.3713,GOBP_VESICLE_MEDIATED_TRANSPORT_BETWEEN_ENDOSOMAL_COMPARTMENTS,0.975915563790365
GSE32901_TH1_VS_TH17_ENRICHE...2,SET,160,0.021261,0.0019761,0.064739,0.3713,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP,0.975915563790365
HP_UPPER_AIRWAY_OBSTRUCTION,SET,15,0.076745,0.0021927,0.23373,0.37133,HP_UPPER_AIRWAY_OBSTRUCTION,0.975920610254083
GSE7568_CTRL_VS_24H_TGFB_TRE...2,SET,180,0.020214,0.0019916,0.061616,0.37143,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,0.97610961436673
HP_NEONATAL_ALLOIMMUNE_THROM...,SET,14,0.072615,0.0020044,0.22143,0.37148,HP_NEONATAL_ALLOIMMUNE_THROMBOCYTOPENIA,0.976167200967791
IKEDA_MIR1_TARGETS_UP,SET,53,0.039034,0.0020942,0.1191,0.37155,IKEDA_MIR1_TARGETS_UP,0.976208141962422
GOBP_GERM_CELL_MIGRATION,SET,9,0.10484,0.0023206,0.31996,0.37158,GOBP_GERM_CELL_MIGRATION,0.976208141962422
GOMF_RNA_ENDONUCLEASE_ACTIVI...3,SET,27,0.055074,0.0021104,0.16811,0.37161,GOMF_RNA_ENDONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,0.976208141962422
GSE25123_WT_VS_PPARG_KO_MACR...6,SET,149,0.022613,0.0020288,0.069061,0.37167,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,0.976208141962422
HP_DECREASED_CIRCULATING_FRE...1,SET,5,0.10474,0.0017281,0.31995,0.3717,HP_DECREASED_CIRCULATING_FREE_T3,0.976208141962422
REACTOME_NICOTINATE_METABOLI...,SET,29,0.05065,0.0020114,0.15481,0.37177,REACTOME_NICOTINATE_METABOLISM,0.976208141962422
GSE22886_IGM_MEMORY_BCELL_VS...4,SET,180,0.02042,0.0020118,0.062419,0.37178,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,0.976208141962422
WHITFIELD_CELL_CYCLE_S,SET,128,0.024043,0.0020004,0.073501,0.37179,WHITFIELD_CELL_CYCLE_S,0.976208141962422
GSE17974_CTRL_VS_ACT_IL4_AND...17,SET,169,0.020549,0.0019624,0.06284,0.37183,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN,0.976208141962422
GSE17974_0.5H_VS_72H_UNTREAT...2,SET,160,0.02141,0.0019899,0.065546,0.37197,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.976208141962422
GOCC_NUCLEAR_MEMBRANE,SET,282,0.016302,0.0020048,0.049922,0.372,GOCC_NUCLEAR_MEMBRANE,0.976208141962422
MIR630,SET,71,0.032159,0.0019959,0.098482,0.37201,MIR630,0.976208141962422
HP_ABNORMALITY_OF_THE_MIDDLE...1,SET,543,0.012027,0.0020374,0.036838,0.37204,HP_ABNORMALITY_OF_THE_MIDDLE_EAR,0.976208141962422
GOBP_PROTEIN_DEGLUTAMYLATION,SET,7,0.11048,0.0021567,0.33854,0.37209,GOBP_PROTEIN_DEGLUTAMYLATION,0.976208141962422
MIR6764_5P,SET,213,0.019244,0.0020607,0.058996,0.37214,MIR6764_5P,0.976208141962422
MORF_CASP10,SET,109,0.025736,0.001977,0.078914,0.37217,MORF_CASP10,0.976208141962422
GOMF_SEMAPHORIN_RECEPTOR_BIN...,SET,23,0.059366,0.0020998,0.18211,0.37222,GOMF_SEMAPHORIN_RECEPTOR_BINDING,0.976208141962422
GOMF_RRNA_ADENINE_METHYLTRAN...,SET,7,0.088892,0.0017353,0.27283,0.37228,GOMF_RRNA_ADENINE_METHYLTRANSFERASE_ACTIVITY,0.976208141962422
HP_MICROCEPHALIC_SPERM_HEAD,SET,2,0.21357,0.0022289,0.65553,0.37229,HP_MICROCEPHALIC_SPERM_HEAD,0.976208141962422
GSE35543_IN_VIVO_NTREG_VS_CO...1,SET,179,0.021116,0.0020748,0.064819,0.3723,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN,0.976208141962422
MZF1_01,SET,222,0.018107,0.0019789,0.055599,0.37234,MZF1_01,0.976208141962422
CGCAAAA_MIR450,SET,9,0.090222,0.001997,0.2773,0.37245,CGCAAAA_MIR450,0.976208141962422
GOBP_PROTEIN_FOLDING,SET,200,0.018297,0.0018992,0.056237,0.37246,GOBP_PROTEIN_FOLDING,0.976208141962422
GOBP_CELLULAR_RESPONSE_TO_ES...2,SET,18,0.063259,0.0019797,0.19445,0.37247,GOBP_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS,0.976208141962422
GSE43863_LY6C_INT_CXCR5POS_V...2,SET,181,0.021442,0.0021184,0.065932,0.37251,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.976208141962422
GOBP_NEGATIVE_REGULATION_OF_...172,SET,7,0.10294,0.0020096,0.31677,0.3726,GOBP_NEGATIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,0.976208141962422
MIR1291,SET,97,0.028185,0.0020431,0.086739,0.37262,MIR1291,0.976208141962422
WP_NEUROINFLAMMATION,SET,11,0.095357,0.0023333,0.29352,0.37264,WP_NEUROINFLAMMATION,0.976208141962422
GOCC_MIB_COMPLEX,SET,9,0.085212,0.0018861,0.26228,0.37264,GOCC_MIB_COMPLEX,0.976208141962422
GOBP_MYOBLAST_DIFFERENTIATION,SET,108,0.026324,0.002013,0.081049,0.37267,GOBP_MYOBLAST_DIFFERENTIATION,0.976208141962422
GOBP_INSULIN_PROCESSING,SET,7,0.10562,0.0020619,0.32525,0.37269,GOBP_INSULIN_PROCESSING,0.976208141962422
GSE22601_DOUBLE_NEGATIVE_VS_...8,SET,172,0.019713,0.001899,0.060704,0.37269,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP,0.976208141962422
GOBP_OLEFINIC_COMPOUND_BIOSY...,SET,26,0.05514,0.0020735,0.16982,0.37271,GOBP_OLEFINIC_COMPOUND_BIOSYNTHETIC_PROCESS,0.976208141962422
HP_ABNORMAL_UPPER_LIMB_EPIPH...,SET,54,0.038249,0.0020713,0.11783,0.37274,HP_ABNORMAL_UPPER_LIMB_EPIPHYSIS_MORPHOLOGY,0.976208141962422
HP_INCREASED_CIRCULATING_IGA...,SET,26,0.053335,0.0020056,0.16431,0.37275,HP_INCREASED_CIRCULATING_IGA_LEVEL,0.976208141962422
MANNO_MIDBRAIN_NEUROTYPES_HN...2,SET,262,0.018019,0.0021371,0.055527,0.37278,MANNO_MIDBRAIN_NEUROTYPES_HNBM,0.976208141962422
ATGGYGGA_UNKNOWN,SET,85,0.029333,0.0019912,0.090403,0.37279,ATGGYGGA_UNKNOWN,0.976208141962422
HP_DEPRESSED_NASAL_BRIDGE,SET,527,0.011786,0.0019679,0.036328,0.3728,HP_DEPRESSED_NASAL_BRIDGE,0.976208141962422
MIR4445_3P,SET,9,0.083758,0.0018539,0.25824,0.37284,MIR4445_3P,0.976208141962422
GSE43863_TH1_VS_LY6C_LOW_CXC...2,SET,179,0.019521,0.001918,0.060194,0.37285,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.976208141962422
HP_STAPES_ANKYLOSIS,SET,6,0.11821,0.0021365,0.36457,0.37288,HP_STAPES_ANKYLOSIS,0.976208141962422
GSE23505_UNTREATED_VS_4DAY_I...1,SET,178,0.020828,0.0020408,0.064239,0.37288,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,0.976208141962422
GSE26030_TH1_VS_TH17_DAY5_PO...1,SET,182,0.020389,0.0020198,0.062892,0.3729,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN,0.976208141962422
MIR10396A_3P_MIR10396B_3P,SET,4,0.16475,0.0024314,0.50826,0.37292,MIR10396A_3P_MIR10396B_3P,0.976208141962422
HP_DELUSION,SET,28,0.053341,0.0020814,0.16457,0.37292,HP_DELUSION,0.976208141962422
MIR138_1_3P,SET,79,0.029852,0.0019539,0.092142,0.37298,MIR138_1_3P,0.976208141962422
GOBP_DETECTION_OF_MOLECULE_O...,SET,12,0.085351,0.0021813,0.2635,0.373,GOBP_DETECTION_OF_MOLECULE_OF_BACTERIAL_ORIGIN,0.976208141962422
XU_HGF_TARGETS_REPRESSED_BY_...1,SET,81,0.029628,0.0019635,0.091486,0.37303,XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,0.976208141962422
HAY_BONE_MARROW_PLASMA_CELL,SET,85,0.030041,0.0020393,0.092804,0.37308,HAY_BONE_MARROW_PLASMA_CELL,0.976208141962422
HP_HYPERPLASIA_OF_MIDFACE,SET,4,0.17246,0.0025452,0.53282,0.37309,HP_HYPERPLASIA_OF_MIDFACE,0.976208141962422
WP_OSTEOBLAST_SIGNALING,SET,13,0.083413,0.0022187,0.25774,0.37311,WP_OSTEOBLAST_SIGNALING,0.976208141962422
HP_ABNORMAL_BASOPHIL_MORPHOL...,SET,8,0.10101,0.0021079,0.31218,0.37314,HP_ABNORMAL_BASOPHIL_MORPHOLOGY,0.976208141962422
HP_NEVUS_SEBACEOUS,SET,5,0.10669,0.0017604,0.32975,0.37314,HP_NEVUS_SEBACEOUS,0.976208141962422
GOCC_ATP_BINDING_CASSETTE_AB...,SET,6,0.11556,0.0020887,0.35721,0.37315,GOCC_ATP_BINDING_CASSETTE_ABC_TRANSPORTER_COMPLEX,0.976208141962422
WEBER_METHYLATED_ICP_IN_FIBR...,SET,16,0.073514,0.0021692,0.2273,0.37319,WEBER_METHYLATED_ICP_IN_FIBROBLAST,0.976208141962422
GOBP_HIS_PURKINJE_SYSTEM_DEV...,SET,7,0.12873,0.002513,0.39814,0.37323,GOBP_HIS_PURKINJE_SYSTEM_DEVELOPMENT,0.976208141962422
GOBP_PROTON_TRANSPORTING_V_T...,SET,6,0.11021,0.001992,0.34094,0.37325,GOBP_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY,0.976208141962422
GOMF_FERROUS_IRON_TRANSMEMBR...,SET,5,0.12883,0.0021257,0.39927,0.37348,GOMF_FERROUS_IRON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.976208141962422
REACTOME_OTHER_SEMAPHORIN_IN...,SET,18,0.070694,0.0022124,0.21917,0.37352,REACTOME_OTHER_SEMAPHORIN_INTERACTIONS,0.976208141962422
GOBP_REGULATION_OF_CHONDROCY...2,SET,47,0.042938,0.0021696,0.13312,0.37352,GOBP_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,0.976208141962422
GSE28737_BCL6_HET_VS_BCL6_KO...4,SET,184,0.020707,0.0020625,0.064216,0.37355,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,0.976208141962422
ZHENG_CORD_BLOOD_C7_PUTATIVE...,SET,81,0.030566,0.0020257,0.094785,0.37355,ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1,0.976208141962422
HP_TOE_DEFORMITY,SET,112,0.02561,0.0019941,0.079426,0.37356,HP_TOE_DEFORMITY,0.976208141962422
SAGIV_CD24_TARGETS_DN,SET,43,0.040781,0.0019712,0.12651,0.37359,SAGIV_CD24_TARGETS_DN,0.976208141962422
VART_KSHV_INFECTION_ANGIOGEN...2,SET,152,0.02379,0.0021556,0.073806,0.3736,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,0.976208141962422
DANG_MYC_TARGETS_UP,SET,118,0.02428,0.0019402,0.075333,0.37361,DANG_MYC_TARGETS_UP,0.976208141962422
GOBP_POSITIVE_REGULATION_OF_...400,SET,27,0.055971,0.0021448,0.17369,0.37363,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.976208141962422
MIR6770_5P,SET,170,0.02054,0.0019672,0.063745,0.37365,MIR6770_5P,0.976208141962422
KEGG_GLYCOSYLPHOSPHATIDYLINO...,SET,24,0.049713,0.0017961,0.15434,0.37369,KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS,0.976208141962422
MIR4768_3P,SET,174,0.019879,0.001926,0.061746,0.37375,MIR4768_3P,0.976208141962422
GSE43955_TGFB_IL6_VS_TGFB_IL...1,SET,176,0.0217,0.0021144,0.067423,0.37378,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,0.976208141962422
REACTOME_DEFECTIVE_B4GALT7_C...,SET,17,0.066405,0.0020196,0.20633,0.37379,REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE,0.976208141962422
GOMF_CYSTEINE_TYPE_ENDOPEPTI...1,SET,5,0.12192,0.0020116,0.37882,0.37379,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY,0.976208141962422
BUSSLINGER_DUODENAL_DIFFEREN...,SET,266,0.01638,0.0019573,0.050899,0.3738,BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS,0.976208141962422
GOBP_POSITIVE_REGULATION_OF_...808,SET,8,0.095227,0.0019873,0.29594,0.37381,GOBP_POSITIVE_REGULATION_OF_T_CELL_TOLERANCE_INDUCTION,0.976208141962422
WP_MICROGLIA_PATHOGEN_PHAGOC...,SET,37,0.046517,0.0020861,0.1446,0.37384,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,0.976208141962422
HP_ARTERIAL_THROMBOSIS,SET,29,0.051842,0.0020587,0.16127,0.37393,HP_ARTERIAL_THROMBOSIS,0.976208141962422
DACOSTA_ERCC3_ALLELE_XPCS_VS...1,SET,31,0.047267,0.0019405,0.14714,0.37402,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,0.976208141962422
GOMF_SODIUM_ION_BINDING,SET,8,0.093252,0.0019461,0.29031,0.37402,GOMF_SODIUM_ION_BINDING,0.976208141962422
WP_NUCLEOTIDE_EXCISION_REPAI...,SET,55,0.031002,0.0016942,0.096513,0.37403,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,0.976208141962422
GOBP_CELL_PROJECTION_ORGANIZ...,SET,1455,0.0074977,0.0020253,0.023343,0.37403,GOBP_CELL_PROJECTION_ORGANIZATION,0.976208141962422
HP_SHORTENING_OF_ALL_DISTAL_...,SET,12,0.069493,0.001776,0.21635,0.37403,HP_SHORTENING_OF_ALL_DISTAL_PHALANGES_OF_THE_FINGERS,0.976208141962422
ELVIDGE_HYPOXIA_BY_DMOG_DN,SET,52,0.036602,0.0019451,0.11396,0.37404,ELVIDGE_HYPOXIA_BY_DMOG_DN,0.976208141962422
SETLUR_PROSTATE_CANCER_TMPRS...2,SET,66,0.033178,0.0019856,0.10332,0.37406,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,0.976208141962422
HP_OCULAR_FLUTTER,SET,5,0.13443,0.0022181,0.41863,0.37406,HP_OCULAR_FLUTTER,0.976208141962422
MIR25_3P,SET,379,0.014175,0.0020155,0.044161,0.37411,MIR25_3P,0.976208141962422
HP_HYPERMETROPIA,SET,240,0.01781,0.0020228,0.055531,0.37421,HP_HYPERMETROPIA,0.976208141962422
HP_RENAL_MAGNESIUM_WASTING,SET,7,0.10014,0.0019549,0.31225,0.37422,HP_RENAL_MAGNESIUM_WASTING,0.976208141962422
GCAAAAA_MIR129,SET,171,0.020766,0.0019947,0.064785,0.37428,GCAAAAA_MIR129,0.976208141962422
GSE21379_TFH_VS_NON_TFH_SAP_...1,SET,172,0.020814,0.0020051,0.064963,0.37433,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN,0.976208141962422
SPZ1_01,SET,216,0.01834,0.0019775,0.057245,0.37434,SPZ1_01,0.976208141962422
HP_TRIANGULAR_MOUTH,SET,19,0.055463,0.0017832,0.17315,0.37437,HP_TRIANGULAR_MOUTH,0.976208141962422
GSE3982_MAC_VS_NEUTROPHIL_LP...2,SET,173,0.020339,0.001965,0.063528,0.37442,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP,0.976208141962422
REACTOME_RND1_GTPASE_CYCLE,SET,41,0.041982,0.0019816,0.13119,0.37448,REACTOME_RND1_GTPASE_CYCLE,0.976208141962422
MIKKELSEN_PARTIALLY_REPROGRA...,SET,9,0.09787,0.0021663,0.30614,0.3746,MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,0.976208141962422
MIR518C_5P,SET,175,0.020712,0.0020124,0.064805,0.37464,MIR518C_5P,0.976208141962422
GSE22886_NAIVE_TCELL_VS_NKCE...1,SET,181,0.019157,0.0018926,0.05994,0.37464,GSE22886_NAIVE_TCELL_VS_NKCELL_DN,0.976208141962422
INGRAM_SHH_TARGETS_UP,SET,113,0.02769,0.0021656,0.086656,0.37466,INGRAM_SHH_TARGETS_UP,0.976208141962422
GEISS_RESPONSE_TO_DSRNA_UP,SET,37,0.043195,0.0019371,0.13524,0.37472,GEISS_RESPONSE_TO_DSRNA_UP,0.976208141962422
GOMF_PRERIBOSOME_BINDING,SET,6,0.11983,0.0021657,0.37526,0.37475,GOMF_PRERIBOSOME_BINDING,0.976208141962422
CHIARETTI_T_ALL_REFRACTORY_T...,SET,25,0.053052,0.0019563,0.16619,0.37478,CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,0.976208141962422
GOBP_POSITIVE_REGULATION_OF_...40,SET,6,0.1206,0.0021797,0.37777,0.37478,GOBP_POSITIVE_REGULATION_OF_ARTERY_MORPHOGENESIS,0.976208141962422
GOBP_REGULATION_OF_ARTERY_MO...,SET,6,0.1206,0.0021797,0.37777,0.37478,GOBP_REGULATION_OF_ARTERY_MORPHOGENESIS,0.976208141962422
KIM_WT1_TARGETS_12HR_DN,SET,202,0.018486,0.0019283,0.057917,0.37479,KIM_WT1_TARGETS_12HR_DN,0.976208141962422
HUANG_DASATINIB_RESISTANCE_DN,SET,66,0.03517,0.0021048,0.11029,0.37491,HUANG_DASATINIB_RESISTANCE_DN,0.976208141962422
GOBP_CONVERGENT_EXTENSION_IN...3,SET,5,0.12881,0.0021253,0.40415,0.37498,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_ORGANOGENESIS,0.976208141962422
HP_JUVENILE_CATARACT,SET,10,0.076653,0.0017884,0.24057,0.37501,HP_JUVENILE_CATARACT,0.976208141962422
WAKABAYASHI_ADIPOGENESIS_PPA...5,SET,132,0.022572,0.001907,0.070852,0.37502,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,0.976208141962422
HP_GLOMERULONEPHRITIS,SET,86,0.029148,0.0019902,0.091508,0.37504,HP_GLOMERULONEPHRITIS,0.976208141962422
GOBP_DEOXYRIBONUCLEOSIDE_MON...2,SET,14,0.077783,0.002147,0.2443,0.37509,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.976208141962422
HP_VASCULAR_CALCIFICATION,SET,31,0.049973,0.0020517,0.15702,0.37514,HP_VASCULAR_CALCIFICATION,0.976208141962422
GSE28726_NAIVE_CD4_TCELL_VS_...3,SET,173,0.019969,0.0019292,0.062748,0.37515,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN,0.976208141962422
GSE13887_ACT_CD4_VS_NO_TREAT...1,SET,119,0.025385,0.002037,0.079795,0.3752,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN,0.976208141962422
GOBP_MITOTIC_SISTER_CHROMATI...2,SET,3,0.20831,0.0026625,0.65516,0.37526,GOBP_MITOTIC_SISTER_CHROMATID_COHESION_CENTROMERIC,0.976208141962422
GOMF_NUCLEAR_VITAMIN_D_RECEP...,SET,13,0.0683,0.0018167,0.21484,0.37528,GOMF_NUCLEAR_VITAMIN_D_RECEPTOR_BINDING,0.976208141962422
GSE31082_DN_VS_CD8_SP_THYMOC...1,SET,188,0.019103,0.001923,0.060116,0.37533,GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN,0.976208141962422
PID_IL12_STAT4_PATHWAY,SET,32,0.048359,0.0020171,0.15221,0.37535,PID_IL12_STAT4_PATHWAY,0.976208141962422
REACTOME_UPTAKE_AND_ACTIONS_...,SET,28,0.050751,0.0019804,0.15977,0.37538,REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,0.976208141962422
MIR887_3P,SET,5,0.12774,0.0021076,0.40213,0.37538,MIR887_3P,0.976208141962422
GSE16385_ROSIGLITAZONE_IL4_V...2,SET,184,0.01947,0.0019392,0.061297,0.37539,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP,0.976208141962422
GOMF_SUGAR_TRANSMEMBRANE_TRA...,SET,25,0.055544,0.0020481,0.17489,0.3754,GOMF_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.976208141962422
MODULE_129,SET,203,0.019744,0.0020646,0.062173,0.37541,MODULE_129,0.976208141962422
GSE10147_IL3_VS_IL3_AND_CPG_...2,SET,132,0.023275,0.0019663,0.073299,0.37542,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP,0.976208141962422
HP_WIDE_MOUTH,SET,188,0.019197,0.0019326,0.06046,0.37543,HP_WIDE_MOUTH,0.976208141962422
MIR190B_5P,SET,104,0.02701,0.002027,0.085088,0.37546,MIR190B_5P,0.976208141962422
GSE41978_ID2_KO_AND_BIM_KO_V...1,SET,177,0.020077,0.0019617,0.063247,0.37546,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.976208141962422
YU_MYC_TARGETS_UP,SET,41,0.042225,0.0019931,0.13309,0.37552,YU_MYC_TARGETS_UP,0.976208141962422
CLASPER_LYMPHATIC_VESSELS_DU...2,SET,18,0.067536,0.0021135,0.21287,0.37553,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,0.976208141962422
REACTOME_TRANSPORT_OF_INORGA...,SET,103,0.027487,0.002053,0.086641,0.37553,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,0.976208141962422
GOCC_TRNA_SPLICING_LIGASE_CO...,SET,7,0.10346,0.0020198,0.32616,0.37554,GOCC_TRNA_SPLICING_LIGASE_COMPLEX,0.976208141962422
HOEK_NK_CELL_2011_2012_TIV_3...,SET,208,0.019701,0.002085,0.062149,0.37562,HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN,0.976208141962422
GOMF_HISTONE_H3K9ME_H3K9ME2_...,SET,4,0.11456,0.0016907,0.36144,0.37564,GOMF_HISTONE_H3K9ME_H3K9ME2_DEMETHYLASE_ACTIVITY,0.976208141962422
HP_DECREASED_ACTIVITY_OF_MIT...5,SET,60,0.030876,0.0017621,0.097418,0.37564,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_IV,0.976208141962422
HP_PUNCTATE_CATARACT,SET,14,0.073894,0.0020397,0.23317,0.37566,HP_PUNCTATE_CATARACT,0.976208141962422
ACCATTT_MIR522,SET,144,0.021974,0.0019383,0.069345,0.37567,ACCATTT_MIR522,0.976208141962422
HP_APLASIA_HYPOPLASIA_AFFECT...3,SET,418,0.013149,0.0019613,0.041501,0.37568,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_EYE,0.976208141962422
GOBP_REGULATION_OF_MEMBRANE_...3,SET,4,0.15162,0.0022377,0.47858,0.37569,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.976208141962422
HP_RENAL_CORTICAL_MICROCYSTS,SET,4,0.12904,0.0019044,0.4073,0.37569,HP_RENAL_CORTICAL_MICROCYSTS,0.976208141962422
chr10q21,SET,41,0.077826,0.0036735,0.24566,0.3757,chr10q21,0.976208141962422
WP_HOSTPATHOGEN_INTERACTION_...3,SET,30,0.049167,0.0019858,0.15521,0.37571,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,0.976208141962422
SMID_BREAST_CANCER_LUMINAL_A...1,SET,16,0.064392,0.0019,0.2033,0.37573,SMID_BREAST_CANCER_LUMINAL_A_DN,0.976208141962422
HP_SUBUNGUAL_HYPERKERATOSIS,SET,6,0.11094,0.0020052,0.35028,0.37573,HP_SUBUNGUAL_HYPERKERATOSIS,0.976208141962422
GSE29164_CD8_TCELL_VS_CD8_TC...3,SET,162,0.021064,0.0019698,0.066526,0.37576,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,0.976208141962422
GSE17721_LPS_VS_GARDIQUIMOD_...11,SET,190,0.018827,0.0019053,0.059463,0.37577,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_DN,0.976208141962422
GOBP_FOREBRAIN_NEURON_DIFFER...,SET,40,0.047949,0.0022356,0.15146,0.37578,GOBP_FOREBRAIN_NEURON_DIFFERENTIATION,0.976208141962422
REACTOME_CARNITINE_METABOLISM,SET,13,0.071743,0.0019083,0.22668,0.37582,REACTOME_CARNITINE_METABOLISM,0.976208141962422
GOBP_NON_CANONICAL_WNT_SIGNA...,SET,68,0.034467,0.0020937,0.10895,0.37587,GOBP_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.976208141962422
GSE41978_ID2_KO_VS_BIM_KO_KL...1,SET,180,0.019813,0.0019521,0.062641,0.37589,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.976208141962422
HP_CEREBELLAR_VERMIS_ATROPHY,SET,49,0.037306,0.0019247,0.11795,0.3759,HP_CEREBELLAR_VERMIS_ATROPHY,0.976208141962422
MANNE_COVID19_COMBINED_COHOR...1,SET,196,0.020719,0.0021292,0.065538,0.37595,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,0.976208141962422
GSE14769_20MIN_VS_360MIN_LPS...2,SET,177,0.019075,0.0018638,0.060351,0.37598,GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP,0.976208141962422
BARRIER_CANCER_RELAPSE_TUMOR...2,SET,15,0.067783,0.0019366,0.21454,0.37602,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP,0.976208141962422
GOBP_MEMBRANE_BIOGENESIS,SET,60,0.033321,0.0019017,0.10552,0.37608,GOBP_MEMBRANE_BIOGENESIS,0.976208141962422
HP_FRAGMENTED_ELASTIC_FIBERS...,SET,9,0.087428,0.0019352,0.27688,0.37609,HP_FRAGMENTED_ELASTIC_FIBERS_IN_THE_DERMIS,0.976208141962422
GSE14026_TH1_VS_TH17_UP,SET,178,0.019858,0.0019457,0.062885,0.37609,GSE14026_TH1_VS_TH17_UP,0.976208141962422
GOBP_REGULATION_OF_KERATINOC...1,SET,35,0.049831,0.0021736,0.15783,0.37611,GOBP_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,0.976208141962422
KENNEDY_PBMC_DRYVAX_AGE_18_5...,SET,11,0.089796,0.0021972,0.28446,0.37613,KENNEDY_PBMC_DRYVAX_AGE_18_50YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_UP,0.976208141962422
REACTOME_REGULATION_OF_TBK1_...1,SET,13,0.080004,0.0021281,0.25346,0.37614,REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7,0.976208141962422
WP_MITOCHONDRIAL_COMPLEX_I_A...,SET,45,0.03317,0.0016401,0.10509,0.37614,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,0.976208141962422
GSE13484_12H_VS_3H_YF17D_VAC...2,SET,174,0.020031,0.0019407,0.063477,0.37617,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,0.976208141962422
HP_SPARSE_BODY_HAIR,SET,57,0.038018,0.002115,0.12055,0.37624,HP_SPARSE_BODY_HAIR,0.976208141962422
HP_ABNORMALITY_OF_THE_ANKLE,SET,159,0.021464,0.0019887,0.068062,0.37625,HP_ABNORMALITY_OF_THE_ANKLE,0.976208141962422
REACTOME_TRANS_GOLGI_NETWORK...,SET,65,0.030607,0.0018179,0.097068,0.37626,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,0.976208141962422
GSE2770_UNTREATED_VS_TGFB_AN...6,SET,175,0.018981,0.0018442,0.060203,0.37628,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.976208141962422
KIM_LRRC3B_TARGETS,SET,29,0.048404,0.0019221,0.15354,0.37629,KIM_LRRC3B_TARGETS,0.976208141962422
XIE_ST_HSC_S1PR3_OE_UP,SET,175,0.021923,0.00213,0.069558,0.37632,XIE_ST_HSC_S1PR3_OE_UP,0.976208141962422
GRAHAM_CML_QUIESCENT_VS_CML_...2,SET,23,0.066147,0.0023397,0.20992,0.37634,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,0.976208141962422
WP_IL10_ANTIINFLAMMATORY_SIG...,SET,12,0.074097,0.0018937,0.23516,0.37635,WP_IL10_ANTIINFLAMMATORY_SIGNALING,0.976208141962422
GSE21380_TFH_VS_GERMINAL_CEN...1,SET,179,0.018656,0.001833,0.059227,0.37639,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,0.976208141962422
HP_ABNORMALITY_OF_THE_PANCRE...,SET,282,0.01604,0.0019725,0.050928,0.3764,HP_ABNORMALITY_OF_THE_PANCREAS,0.976208141962422
HP_HAMARTOMATOUS_POLYPOSIS,SET,14,0.064313,0.0017752,0.2042,0.3764,HP_HAMARTOMATOUS_POLYPOSIS,0.976208141962422
GOBP_REGULATION_OF_RESPONSE_...14,SET,160,0.021868,0.0020325,0.06946,0.37645,GOBP_REGULATION_OF_RESPONSE_TO_WOUNDING,0.976208141962422
GSE16385_UNTREATED_VS_12H_RO...2,SET,183,0.01995,0.0019817,0.063375,0.37646,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,0.976208141962422
GSE25147_UNSTIM_VS_HELIOBACT...1,SET,148,0.023073,0.0020631,0.073293,0.37646,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_DN,0.976208141962422
GOBP_REGULATION_OF_VENTRICUL...2,SET,7,0.12231,0.0023878,0.38862,0.37648,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION,0.976208141962422
FOXO1_02,SET,233,0.017954,0.0020096,0.057051,0.3765,FOXO1_02,0.976208141962422
LEE_SP4_THYMOCYTE,SET,15,0.072647,0.0020756,0.23089,0.37652,LEE_SP4_THYMOCYTE,0.976208141962422
HE_LIM_SUN_FETAL_LUNG_C7_MFN...,SET,17,0.067676,0.0020583,0.21512,0.37654,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,0.976208141962422
GSE31082_DP_VS_CD4_SP_THYMOC...1,SET,176,0.019673,0.0019169,0.062553,0.37657,GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN,0.976208141962422
MIR3614_3P,SET,58,0.033399,0.0018742,0.1062,0.37658,MIR3614_3P,0.976208141962422
KEGG_MEDICUS_REFERENCE_NOTCH...4,SET,13,0.075931,0.0020197,0.24154,0.37662,KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY,0.976208141962422
HP_LARYNGOMALACIA,SET,77,0.030148,0.0019482,0.09593,0.37666,HP_LARYNGOMALACIA,0.976208141962422
GSE17301_CTRL_VS_48H_IFNA2_S...2,SET,182,0.019595,0.0019412,0.062356,0.37667,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP,0.976208141962422
GOCC_PERICENTRIC_HETEROCHROM...,SET,27,0.051022,0.0019551,0.16241,0.3767,GOCC_PERICENTRIC_HETEROCHROMATIN,0.976208141962422
DELPUECH_FOXO3_TARGETS_UP,SET,61,0.035959,0.0020692,0.11447,0.37671,DELPUECH_FOXO3_TARGETS_UP,0.976208141962422
GOBP_ORGANELLE_MEMBRANE_FUSI...,SET,114,0.023432,0.0018406,0.074599,0.37672,GOBP_ORGANELLE_MEMBRANE_FUSION,0.976208141962422
GSE29949_CD8_NEG_DC_SPLEEN_V...4,SET,167,0.020791,0.0019738,0.066244,0.37682,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP,0.976275089312295
KEGG_MEDICUS_REFERENCE_EGF_E...1,SET,21,0.051368,0.0017362,0.1637,0.37684,KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY,0.976275089312295
GSE12392_WT_VS_IFNB_KO_CD8A_...3,SET,183,0.019745,0.0019614,0.062943,0.37688,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_DN,0.976275089312295
GOBP_REGULATION_OF_NATURAL_K...5,SET,49,0.040675,0.0020984,0.12969,0.3769,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.976275089312295
TAVAZOIE_METASTASIS,SET,87,0.028704,0.0019711,0.091657,0.37708,TAVAZOIE_METASTASIS,0.976275089312295
MIR3186_5P,SET,2,0.16538,0.001726,0.52825,0.37711,MIR3186_5P,0.976275089312295
GOBP_MITOTIC_NUCLEAR_DIVISION,SET,265,0.01582,0.0018868,0.050533,0.37712,GOBP_MITOTIC_NUCLEAR_DIVISION,0.976275089312295
FORTSCHEGGER_PHF8_TARGETS_UP,SET,230,0.017533,0.00195,0.056012,0.37713,FORTSCHEGGER_PHF8_TARGETS_UP,0.976275089312295
KEGG_ENDOCYTOSIS,SET,174,0.019932,0.0019311,0.06368,0.37714,KEGG_ENDOCYTOSIS,0.976275089312295
MIR4529_3P,SET,43,0.040091,0.0019379,0.12811,0.37716,MIR4529_3P,0.976275089312295
GOCC_LIPOPOLYSACCHARIDE_RECE...,SET,5,0.13163,0.0021718,0.4206,0.37716,GOCC_LIPOPOLYSACCHARIDE_RECEPTOR_COMPLEX,0.976275089312295
GOBP_ENDOTHELIAL_CELL_APOPTO...,SET,55,0.038097,0.0020819,0.12179,0.37722,GOBP_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.976275089312295
GOBP_NEGATIVE_REGULATION_OF_...659,SET,11,0.078367,0.0019176,0.25058,0.37724,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.976275089312295
GOBP_RNA_TEMPLATED_DNA_BIOSY...,SET,66,0.02967,0.0017757,0.094878,0.37725,GOBP_RNA_TEMPLATED_DNA_BIOSYNTHETIC_PROCESS,0.976275089312295
HP_PRELINGUAL_SENSORINEURAL_...,SET,11,0.086133,0.0021076,0.27546,0.37726,HP_PRELINGUAL_SENSORINEURAL_HEARING_IMPAIRMENT,0.976275089312295
MIR4691_5P,SET,119,0.02376,0.0019066,0.076001,0.37728,MIR4691_5P,0.976275089312295
GOBP_REGULATION_OF_NUCLEOTID...3,SET,22,0.056756,0.0019634,0.18163,0.37734,GOBP_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.976275089312295
GOBP_TYPE_II_INTERFERON_PROD...,SET,107,0.028021,0.0021328,0.089673,0.37734,GOBP_TYPE_II_INTERFERON_PRODUCTION,0.976275089312295
KEGG_HUNTINGTONS_DISEASE,SET,153,0.019447,0.0017678,0.062238,0.37735,KEGG_HUNTINGTONS_DISEASE,0.976275089312295
KEGG_MEDICUS_REFERENCE_MICRO...4,SET,20,0.05967,0.0019683,0.19098,0.37735,KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY,0.976275089312295
GOBP_POSITIVE_REGULATION_OF_...531,SET,8,0.10028,0.0020928,0.32101,0.37737,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION,0.976275089312295
GSE29618_PDC_VS_MDC_DN,SET,183,0.019972,0.0019839,0.063946,0.3774,GSE29618_PDC_VS_MDC_DN,0.976275089312295
GOBP_NEGATIVE_REGULATION_OF_...515,SET,5,0.12392,0.0020446,0.39683,0.37742,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,0.976275089312295
GOBP_PRIMARY_MIRNA_PROCESSING,SET,18,0.054259,0.001698,0.17376,0.37742,GOBP_PRIMARY_MIRNA_PROCESSING,0.976275089312295
HP_RECURRENT_JOINT_DISLOCATI...,SET,10,0.086104,0.0020089,0.27583,0.37746,HP_RECURRENT_JOINT_DISLOCATION,0.976293670509483
GOBP_GLUCOSYLCERAMIDE_CATABO...,SET,4,0.14716,0.0021718,0.47156,0.37749,GOBP_GLUCOSYLCERAMIDE_CATABOLIC_PROCESS,0.976293670509483
HE_LIM_SUN_FETAL_LUNG_C4_NKT...1,SET,8,0.1023,0.0021349,0.328,0.37756,HE_LIM_SUN_FETAL_LUNG_C4_NKT1_CELL,0.976293670509483
MIR422A,SET,37,0.040664,0.0018236,0.13039,0.37757,MIR422A,0.976293670509483
GOBP_POSITIVE_REGULATION_OF_...817,SET,92,0.027593,0.0019483,0.088479,0.37758,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.976293670509483
HP_SMALL_INTESTINAL_POLYPOSIS,SET,5,0.10505,0.0017332,0.33693,0.37761,HP_SMALL_INTESTINAL_POLYPOSIS,0.976293670509483
GSE27786_LIN_NEG_VS_BCELL_DN,SET,182,0.018399,0.0018227,0.059045,0.37767,GSE27786_LIN_NEG_VS_BCELL_DN,0.976293670509483
SENESE_HDAC1_TARGETS_UP,SET,398,0.013217,0.0019247,0.042419,0.37768,SENESE_HDAC1_TARGETS_UP,0.976293670509483
GOBP_T_CELL_CHEMOTAXIS,SET,24,0.055595,0.0020087,0.17843,0.37768,GOBP_T_CELL_CHEMOTAXIS,0.976293670509483
GOBP_POSITIVE_REGULATION_OF_...117,SET,305,0.016078,0.002055,0.051649,0.37779,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION,0.976359106427193
chr14q11,SET,91,0.056413,0.0039616,0.18126,0.37781,chr14q11,0.976359106427193
MIR1257,SET,88,0.028103,0.0019409,0.090343,0.37788,MIR1257,0.976359106427193
GSE3982_EOSINOPHIL_VS_CENT_M...1,SET,178,0.019116,0.0018731,0.06148,0.37793,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.976359106427193
MEISSNER_BRAIN_HCP_WITH_H3K4...2,SET,54,0.037724,0.0020428,0.12135,0.37795,MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3,0.976359106427193
chr17p12,SET,22,0.090141,0.0031183,0.29,0.37797,chr17p12,0.976359106427193
KEGG_MEDICUS_VARIANT_MUTATIO...33,SET,13,0.07586,0.0020178,0.24429,0.37808,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM,0.976359106427193
MISIAK_ANAPLASTIC_THYROID_CA...2,SET,44,0.041186,0.0020138,0.13275,0.37818,MISIAK_ANAPLASTIC_THYROID_CARCINOMA_UP,0.976359106427193
GOMF_L_ASCORBIC_ACID_BINDING,SET,20,0.056866,0.0018758,0.1833,0.37819,GOMF_L_ASCORBIC_ACID_BINDING,0.976359106427193
GOBP_MAST_CELL_MIGRATION,SET,14,0.076433,0.0021098,0.2464,0.3782,GOBP_MAST_CELL_MIGRATION,0.976359106427193
GOMF_PLUS_END_DIRECTED_MICRO...,SET,17,0.062377,0.0018971,0.20111,0.37822,GOMF_PLUS_END_DIRECTED_MICROTUBULE_MOTOR_ACTIVITY,0.976359106427193
IIZUKA_LIVER_CANCER_EARLY_RE...,SET,11,0.085607,0.0020947,0.27603,0.37823,IIZUKA_LIVER_CANCER_EARLY_RECURRENCE,0.976359106427193
KEGG_MEDICUS_PATHOGEN_SALMON...8,SET,19,0.051831,0.0016664,0.16712,0.37823,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY,0.976359106427193
MIR627_3P,SET,423,0.013084,0.0019629,0.04219,0.37824,MIR627_3P,0.976359106427193
GSE21670_UNTREATED_VS_IL6_TR...3,SET,180,0.018933,0.0018654,0.061058,0.37825,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.976359106427193
GSE1740_MCSF_VS_MCSF_AND_IFN...2,SET,161,0.02081,0.0019401,0.067146,0.37831,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP,0.976359106427193
MORF_GNB1,SET,273,0.015038,0.00182,0.048526,0.37832,MORF_GNB1,0.976359106427193
GOCC_CYCLIN_DEPENDENT_PROTEI...,SET,51,0.032609,0.0017162,0.10523,0.37832,GOCC_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,0.976359106427193
REACTOME_ZINC_TRANSPORTERS,SET,15,0.063173,0.0018049,0.20395,0.37838,REACTOME_ZINC_TRANSPORTERS,0.976359106427193
GOBP_ATRIAL_CARDIAC_MUSCLE_C...2,SET,16,0.071199,0.0021008,0.22987,0.37839,GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_COMMUNICATION,0.976359106427193
MIR4762_3P,SET,242,0.017031,0.0019424,0.054997,0.3784,MIR4762_3P,0.976359106427193
GSE19374_UNINF_VS_LISTERIA_I...2,SET,177,0.019522,0.0019074,0.063036,0.3784,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP,0.976359106427193
HP_BILATERAL_COXA_VALGA,SET,13,0.084569,0.0022495,0.2732,0.37845,HP_BILATERAL_COXA_VALGA,0.976359106427193
HP_3_METHYLGLUTACONIC_ACIDUR...,SET,17,0.062811,0.0019104,0.20294,0.37847,HP_3_METHYLGLUTACONIC_ACIDURIA,0.976359106427193
KEGG_MEDICUS_REFERENCE_ACTIV...1,SET,16,0.059354,0.0017513,0.19179,0.37848,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119,0.976359106427193
GSE10147_IL3_VS_IL3_AND_HIVP...2,SET,151,0.020196,0.001824,0.06526,0.37848,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP,0.976359106427193
GOBP_SEROTONIN_SECRETION,SET,9,0.089456,0.0019801,0.28911,0.3785,GOBP_SEROTONIN_SECRETION,0.976359106427193
HP_ABNORMAL_CLITORIS_MORPHOL...,SET,81,0.030442,0.0020175,0.09838,0.3785,HP_ABNORMAL_CLITORIS_MORPHOLOGY,0.976359106427193
GOBP_REGULATION_OF_WOUND_HEA...1,SET,125,0.024219,0.0019915,0.078285,0.37852,GOBP_REGULATION_OF_WOUND_HEALING,0.976359106427193
GNF2_CENPF,SET,57,0.035031,0.0019488,0.1133,0.37859,GNF2_CENPF,0.976391116299755
BOYLAN_MULTIPLE_MYELOMA_PCA1...1,SET,8,0.098904,0.002064,0.3199,0.3786,BOYLAN_MULTIPLE_MYELOMA_PCA1_DN,0.976391116299755
GSE25088_CTRL_VS_ROSIGLITAZO...2,SET,183,0.019472,0.0019342,0.063,0.37863,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.976391116299755
GOBP_NEGATIVE_REGULATION_OF_...198,SET,6,0.10986,0.0019857,0.3557,0.37871,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_CALCIUM_ION_CONCENTRATION,0.976391116299755
GSE14386_UNTREATED_VS_IFNA_T...2,SET,126,0.024367,0.0020116,0.078901,0.37873,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP,0.976391116299755
PARK_HSC_VS_MULTIPOTENT_PROG...2,SET,16,0.068133,0.0020104,0.22076,0.3788,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP,0.976391116299755
GSE43955_10H_VS_30H_ACT_CD4_...3,SET,182,0.019407,0.0019225,0.062881,0.37881,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.976391116299755
MOOTHA_TCA,SET,14,0.059765,0.0016497,0.19378,0.37889,MOOTHA_TCA,0.976391116299755
WP_DNA_IRDAMAGE_AND_CELLULAR...,SET,74,0.02634,0.0016688,0.085408,0.37889,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,0.976391116299755
KEGG_MEDICUS_REFERENCE_CITRA...1,SET,8,0.090284,0.0018841,0.29281,0.37892,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_FIRST_CARBON_OXIDATION,0.976391116299755
REACTOME_ESTROGEN_STIMULATED...,SET,6,0.096945,0.0017522,0.31445,0.37893,REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ,0.976391116299755
SMAD_Q6,SET,232,0.017498,0.0019545,0.056773,0.37896,SMAD_Q6,0.976391116299755
REACTOME_FLT3_SIGNALING_IN_D...,SET,27,0.047568,0.0018227,0.15435,0.37897,REACTOME_FLT3_SIGNALING_IN_DISEASE,0.976391116299755
MIR6780A_3P,SET,138,0.022215,0.0019187,0.072104,0.379,MIR6780A_3P,0.976391116299755
GOMF_P53_BINDING,SET,64,0.03198,0.0018848,0.10379,0.379,GOMF_P53_BINDING,0.976391116299755
GSE42021_TCONV_PLN_VS_CD24LO...1,SET,179,0.019129,0.0018795,0.062085,0.379,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_DN,0.976391116299755
GOBP_COMPARTMENT_PATTERN_SPE...,SET,5,0.12212,0.0020149,0.39638,0.37901,GOBP_COMPARTMENT_PATTERN_SPECIFICATION,0.976391116299755
REACTOME_REGULATION_OF_ENDOG...3,SET,37,0.041936,0.0018806,0.13616,0.37905,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS,0.976410755835495
ZHONG_RESPONSE_TO_AZACITIDIN...2,SET,150,0.020928,0.0018838,0.067973,0.37909,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,0.976410755835495
HMGIY_Q6,SET,237,0.017777,0.0020066,0.057758,0.37913,HMGIY_Q6,0.976410755835495
HP_AUTOPHAGIC_VACUOLES,SET,8,0.092218,0.0019245,0.29963,0.37913,HP_AUTOPHAGIC_VACUOLES,0.976410755835495
GOBP_HEAD_MORPHOGENESIS,SET,35,0.04433,0.0019336,0.14407,0.37916,GOBP_HEAD_MORPHOGENESIS,0.976415663900415
GOBP_REGULATION_OF_NEURON_PR...2,SET,402,0.013434,0.0019659,0.043688,0.37923,GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,0.976430383732128
CUI_DEVELOPING_HEART_C1_5TH_...,SET,73,0.030656,0.0019291,0.099694,0.37923,CUI_DEVELOPING_HEART_C1_5TH_WEEK_CARDIAC_CELLS,0.976430383732128
GOMF_MAP_KINASE_KINASE_ACTIV...,SET,15,0.068007,0.001943,0.22119,0.37925,GOMF_MAP_KINASE_KINASE_ACTIVITY,0.976430383732128
DESCARTES_FETAL_LIVER_VASCUL...,SET,102,0.027635,0.002054,0.090041,0.37946,DESCARTES_FETAL_LIVER_VASCULAR_ENDOTHELIAL_CELLS,0.976630901033973
FINAK_BREAST_CANCER_SDPP_SIG...,SET,20,0.066191,0.0021834,0.21575,0.3795,FINAK_BREAST_CANCER_SDPP_SIGNATURE,0.976630901033973
GOMF_CHONDROITIN_SULFOTRANSF...,SET,5,0.10616,0.0017516,0.34607,0.37952,GOMF_CHONDROITIN_SULFOTRANSFERASE_ACTIVITY,0.976630901033973
GOBP_PYRIMIDINE_RIBONUCLEOSI...1,SET,7,0.090094,0.0017588,0.29408,0.37967,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.976630901033973
GOBP_MATERNAL_PROCESS_INVOLV...1,SET,52,0.036565,0.0019431,0.11937,0.37968,GOBP_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,0.976630901033973
GSE2405_0H_VS_6H_A_PHAGOCYTO...1,SET,170,0.020395,0.0019534,0.066607,0.37973,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.976630901033973
WP_TRANSSULFURATION_PATHWAY,SET,9,0.10196,0.0022569,0.33314,0.37978,WP_TRANSSULFURATION_PATHWAY,0.976630901033973
GOBP_CAVEOLA_ASSEMBLY,SET,6,0.11407,0.0020618,0.37271,0.37978,GOBP_CAVEOLA_ASSEMBLY,0.976630901033973
GOBP_REGULATION_OF_ENDOCRINE...,SET,39,0.045786,0.0021079,0.1496,0.37978,GOBP_REGULATION_OF_ENDOCRINE_PROCESS,0.976630901033973
HE_LIM_SUN_FETAL_LUNG_C0_INT...2,SET,9,0.095916,0.002123,0.31341,0.37979,HE_LIM_SUN_FETAL_LUNG_C0_INTERM_FIBROBLAST,0.976630901033973
WP_FATTY_ACID_OMEGAOXIDATION,SET,15,0.073975,0.0021135,0.24176,0.37981,WP_FATTY_ACID_OMEGAOXIDATION,0.976630901033973
GSE3982_DC_VS_TH1_UP,SET,186,0.019208,0.0019235,0.06278,0.37982,GSE3982_DC_VS_TH1_UP,0.976630901033973
MIR4451,SET,132,0.022609,0.0019101,0.073905,0.37984,MIR4451,0.976630901033973
HP_INFANTILE_MUSCULAR_HYPOTO...,SET,177,0.019445,0.0018999,0.063603,0.37991,HP_INFANTILE_MUSCULAR_HYPOTONIA,0.976630901033973
MIR4518,SET,81,0.027501,0.0018226,0.090028,0.38,MIR4518,0.976630901033973
MIR1539,SET,5,0.11481,0.0018943,0.37585,0.38001,MIR1539,0.976630901033973
GOBP_REGULATION_OF_SULFUR_ME...,SET,12,0.081636,0.0020863,0.26728,0.38002,GOBP_REGULATION_OF_SULFUR_METABOLIC_PROCESS,0.976630901033973
GOBP_ZINC_ION_TRANSPORT,SET,29,0.044882,0.0017823,0.14695,0.38002,GOBP_ZINC_ION_TRANSPORT,0.976630901033973
AREB6_03,SET,242,0.017145,0.0019553,0.056184,0.38013,AREB6_03,0.976630901033973
GOBP_DEVELOPMENT_OF_SECONDAR...1,SET,6,0.12197,0.0022045,0.3997,0.38013,GOBP_DEVELOPMENT_OF_SECONDARY_FEMALE_SEXUAL_CHARACTERISTICS,0.976630901033973
DESCARTES_MAIN_FETAL_CORNEAL...,SET,219,0.01707,0.0018532,0.055955,0.38016,DESCARTES_MAIN_FETAL_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS,0.976630901033973
REACTOME_N_GLYCAN_ANTENNAE_E...1,SET,15,0.074472,0.0021277,0.24413,0.38017,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION,0.976630901033973
HP_ABNORMAL_MIDDLE_PHALANX_M...,SET,58,0.03485,0.0019556,0.11425,0.38017,HP_ABNORMAL_MIDDLE_PHALANX_MORPHOLOGY_OF_THE_HAND,0.976630901033973
SANSOM_APC_MYC_TARGETS,SET,223,0.016385,0.0017948,0.053729,0.3802,SANSOM_APC_MYC_TARGETS,0.976630901033973
WP_ESTROGEN_METABOLISM_WP697,SET,14,0.077714,0.0021451,0.25486,0.38021,WP_ESTROGEN_METABOLISM_WP697,0.976630901033973
GOBP_POSITIVE_REGULATION_OF_...354,SET,137,0.023821,0.0020499,0.078139,0.38024,GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,0.976630901033973
GOBP_PEPTIDYL_LYSINE_OXIDATI...,SET,5,0.13037,0.002151,0.42767,0.38025,GOBP_PEPTIDYL_LYSINE_OXIDATION,0.976630901033973
GOMF_PROTEIN_LYSINE_6_OXIDAS...,SET,5,0.13037,0.002151,0.42767,0.38025,GOMF_PROTEIN_LYSINE_6_OXIDASE_ACTIVITY,0.976630901033973
GSE26156_DOUBLE_POSITIVE_VS_...1,SET,184,0.018419,0.0018346,0.060439,0.38028,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.976630901033973
GAZDA_DIAMOND_BLACKFAN_ANEMI...5,SET,55,0.031562,0.0017248,0.1036,0.38032,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,0.976630901033973
GOBP_PYRIMIDINE_CONTAINING_C...4,SET,7,0.098736,0.0019275,0.32419,0.38035,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_SALVAGE,0.976630901033973
HP_ELEVATED_URINARY_MONOCARB...,SET,11,0.075563,0.001849,0.24818,0.38039,HP_ELEVATED_URINARY_MONOCARBOXYLIC_ACID_LEVEL,0.976630901033973
HP_ABNORMALITY_OF_BLOOD_CIRC...,SET,333,0.014198,0.0018946,0.046638,0.3804,HP_ABNORMALITY_OF_BLOOD_CIRCULATION,0.976630901033973
WIEDERSCHAIN_TARGETS_OF_BMI1...,SET,55,0.037757,0.0020634,0.12403,0.38041,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,0.976630901033973
GAVISH_3CA_METAPROGRAM_EPITH...20,SET,48,0.037553,0.0019175,0.12337,0.38042,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_3,0.976630901033973
GAUTAM_EYE_IRIS_CILIARY_BODY...14,SET,11,0.081522,0.0019948,0.26782,0.38042,GAUTAM_EYE_IRIS_CILIARY_BODY_RIBOSOMAL_GENES_HIGH_FIBROBLASTS,0.976630901033973
MORF_STK17A,SET,158,0.020399,0.0018841,0.067024,0.38043,MORF_STK17A,0.976630901033973
GSE37605_C57BL6_VS_NOD_FOXP3...2,SET,148,0.022089,0.0019752,0.07259,0.38045,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_UP,0.976630901033973
GOBP_STRIATED_MUSCLE_ATROPHY,SET,7,0.10125,0.0019766,0.33275,0.38046,GOBP_STRIATED_MUSCLE_ATROPHY,0.976630901033973
MIR378F,SET,36,0.040031,0.0017708,0.13157,0.38047,MIR378F,0.976630901033973
MIR30C_1_3P,SET,119,0.024559,0.0019707,0.080722,0.38048,MIR30C_1_3P,0.976630901033973
GOBP_THYROID_STIMULATING_HOR...,SET,6,0.11302,0.0020428,0.37164,0.38052,GOBP_THYROID_STIMULATING_HORMONE_SECRETING_CELL_DIFFERENTIATION,0.976661443024887
GSE19923_E2A_KO_VS_E2A_AND_H...2,SET,194,0.018196,0.0018605,0.059915,0.38068,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_UP,0.976829436048655
ZEILSTRA_CD44_TARGETS_UP,SET,8,0.099013,0.0020663,0.3262,0.38074,ZEILSTRA_CD44_TARGETS_UP,0.976829436048655
GYORFFY_DOXORUBICIN_RESISTAN...,SET,34,0.042982,0.0018479,0.14164,0.38077,GYORFFY_DOXORUBICIN_RESISTANCE,0.976829436048655
CUI_DEVELOPING_HEART_VALVAR_...,SET,126,0.024738,0.0020422,0.081531,0.38079,CUI_DEVELOPING_HEART_VALVAR_ENDOTHELIAL_CELL,0.976829436048655
HP_PRODUCTIVE_COUGH,SET,56,0.03291,0.0018147,0.10849,0.38081,HP_PRODUCTIVE_COUGH,0.976829436048655
GSE25146_UNSTIM_VS_HELIOBACT...2,SET,165,0.018643,0.0017594,0.061458,0.38081,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP,0.976829436048655
GOBP_HEAT_GENERATION,SET,18,0.069546,0.0021764,0.22927,0.38082,GOBP_HEAT_GENERATION,0.976829436048655
GOBP_POSITIVE_REGULATION_OF_...643,SET,4,0.13362,0.001972,0.44057,0.38084,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MONOUBIQUITINATION,0.976829436048655
GSE32034_LY6C_HIGH_VS_LOW_MO...1,SET,188,0.017771,0.001789,0.05861,0.38087,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN,0.976829436048655
GOCC_LATE_ENDOSOME_MEMBRANE,SET,153,0.020091,0.0018264,0.066269,0.38088,GOCC_LATE_ENDOSOME_MEMBRANE,0.976829436048655
GSE20366_TREG_VS_NAIVE_CD4_T...2,SET,186,0.01886,0.0018886,0.062231,0.38092,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP,0.976829436048655
HP_DIALEPTIC_SEIZURE,SET,221,0.017259,0.0018821,0.056956,0.38094,HP_DIALEPTIC_SEIZURE,0.976829436048655
GSE27786_NKTCELL_VS_NEUTROPH...1,SET,181,0.019168,0.0018937,0.06328,0.38098,GSE27786_NKTCELL_VS_NEUTROPHIL_DN,0.976829436048655
GOBP_MITOCHONDRIAL_TRANSMEMB...,SET,89,0.026468,0.0018383,0.087398,0.38101,GOBP_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT,0.976829436048655
GNF2_CDH11,SET,24,0.061576,0.0022248,0.20334,0.38102,GNF2_CDH11,0.976829436048655
MODULE_201,SET,48,0.038405,0.0019611,0.12685,0.38104,MODULE_201,0.976829436048655
GOBP_RESPONSE_TO_ZINC_ION_ST...,SET,8,0.082724,0.0017264,0.27352,0.38116,GOBP_RESPONSE_TO_ZINC_ION_STARVATION,0.976829436048655
GSE41176_WT_VS_TAK1_KO_ANTI_...7,SET,183,0.018646,0.0018522,0.061652,0.38116,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN,0.976829436048655
GOBP_RHOMBOMERE_DEVELOPMENT,SET,7,0.12106,0.0023633,0.40042,0.3812,GOBP_RHOMBOMERE_DEVELOPMENT,0.976829436048655
HP_HYPOCALCIURIA,SET,9,0.096496,0.0021359,0.31925,0.38123,HP_HYPOCALCIURIA,0.976829436048655
GOBP_REGULATION_OF_VENTRICUL...3,SET,22,0.055833,0.0019315,0.18473,0.38124,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.976829436048655
HP_THORACIC_AORTA_CALCIFICAT...,SET,5,0.12669,0.0020904,0.41919,0.38124,HP_THORACIC_AORTA_CALCIFICATION,0.976829436048655
GSE10325_LUPUS_CD4_TCELL_VS_...1,SET,166,0.021067,0.001994,0.069704,0.38124,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN,0.976829436048655
GOMF_BHLH_TRANSCRIPTION_FACT...,SET,31,0.046497,0.0019089,0.15387,0.38126,GOMF_BHLH_TRANSCRIPTION_FACTOR_BINDING,0.976829436048655
MIR1279,SET,167,0.020157,0.0019136,0.066724,0.38129,MIR1279,0.976834287925697
HP_INTERVERTEBRAL_DISK_DEGEN...,SET,6,0.11087,0.0020039,0.36713,0.38133,HP_INTERVERTEBRAL_DISK_DEGENERATION,0.976864756394192
WP_ETHER_LIPID_BIOSYNTHESIS,SET,19,0.059068,0.0018991,0.19573,0.38141,WP_ETHER_LIPID_BIOSYNTHESIS,0.976997682045991
GSE32164_RESTING_DIFFERENTIA...3,SET,188,0.0182,0.0018322,0.060322,0.38144,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN,0.977002520451028
GOBP_NUCLEAR_ENVELOPE_ORGANI...,SET,54,0.033911,0.0018363,0.11245,0.38149,GOBP_NUCLEAR_ENVELOPE_ORGANIZATION,0.977058581429624
GOBP_MODULATION_BY_SYMBIONT_...,SET,53,0.037094,0.00199,0.12304,0.38153,GOBP_MODULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST,0.977068247126437
GOBP_ORGANOPHOSPHATE_ESTER_T...,SET,141,0.021874,0.0019094,0.072567,0.38155,GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT,0.977068247126437
GCM_DFFA,SET,116,0.021368,0.0016931,0.070923,0.3816,GCM_DFFA,0.977124290871583
GSE17721_LPS_VS_CPG_6H_BMDC_...1,SET,180,0.018643,0.0018369,0.06192,0.38167,GSE17721_LPS_VS_CPG_6H_BMDC_DN,0.977185149171271
FULLER_PBMC_F_TULARENSIS_VAC...5,SET,54,0.037944,0.0020547,0.12602,0.38168,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP,0.977185149171271
HP_SUBDURAL_HEMORRHAGE,SET,12,0.0778,0.0019883,0.25861,0.38177,HP_SUBDURAL_HEMORRHAGE,0.97720443331615
CADWELL_ATG16L1_TARGETS_UP,SET,93,0.027317,0.0019392,0.090815,0.38178,CADWELL_ATG16L1_TARGETS_UP,0.97720443331615
GSE7831_1H_VS_4H_CPG_STIM_PD...1,SET,181,0.018136,0.0017917,0.060293,0.38179,GSE7831_1H_VS_4H_CPG_STIM_PDC_DN,0.97720443331615
REACTOME_NUCLEOTIDE_EXCISION...,SET,103,0.022574,0.001686,0.075059,0.3818,REACTOME_NUCLEOTIDE_EXCISION_REPAIR,0.97720443331615
GOMF_THIAMINE_PYROPHOSPHATE_...,SET,6,0.10302,0.001862,0.3429,0.38192,GOMF_THIAMINE_PYROPHOSPHATE_BINDING,0.977236936870728
BRUINS_UVC_RESPONSE_LATE,SET,1032,0.0078151,0.0018,0.026015,0.38194,BRUINS_UVC_RESPONSE_LATE,0.977236936870728
REACTOME_NEUROFASCIN_INTERAC...,SET,6,0.10316,0.0018645,0.34344,0.38195,REACTOME_NEUROFASCIN_INTERACTIONS,0.977236936870728
MODULE_315,SET,16,0.062143,0.0018336,0.20699,0.38201,MODULE_315,0.977236936870728
GOCC_NUCLEAR_PORE_CENTRAL_TR...,SET,5,0.10422,0.0017197,0.34729,0.38205,GOCC_NUCLEAR_PORE_CENTRAL_TRANSPORT_CHANNEL,0.977236936870728
HP_INTRAHEPATIC_BILE_DUCT_DI...,SET,3,0.14503,0.0018537,0.48343,0.38209,HP_INTRAHEPATIC_BILE_DUCT_DILATATION,0.977236936870728
GAVISH_3CA_METAPROGRAM_CD8_T...7,SET,48,0.03734,0.0019067,0.12452,0.38214,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_INTERFERON,0.977236936870728
HP_OLIGOZOOSPERMIA,SET,43,0.036979,0.0017875,0.12334,0.38216,HP_OLIGOZOOSPERMIA,0.977236936870728
REACTOME_ACYL_CHAIN_REMODELL...4,SET,16,0.066788,0.0019707,0.22279,0.38217,REACTOME_ACYL_CHAIN_REMODELLING_OF_PI,0.977236936870728
MIR3618,SET,88,0.027782,0.0019187,0.092677,0.38218,MIR3618,0.977236936870728
GOMF_NUCLEAR_RETINOIC_ACID_R...,SET,24,0.048491,0.001752,0.16176,0.38218,GOMF_NUCLEAR_RETINOIC_ACID_RECEPTOR_BINDING,0.977236936870728
GOBP_GERMINAL_CENTER_B_CELL_...,SET,8,0.10839,0.002262,0.36168,0.38221,GOBP_GERMINAL_CENTER_B_CELL_DIFFERENTIATION,0.977236936870728
GSE13484_3H_UNSTIM_VS_YF17D_...2,SET,185,0.017974,0.0017951,0.05998,0.38222,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,0.977236936870728
GOBP_ISOPRENOID_BIOSYNTHETIC...,SET,28,0.046881,0.0018294,0.15654,0.38229,GOBP_ISOPRENOID_BIOSYNTHETIC_PROCESS,0.977236936870728
GSE360_LOW_DOSE_B_MALAYI_VS_...1,SET,184,0.018651,0.0018577,0.062283,0.3823,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,0.977236936870728
RORA1_01,SET,217,0.017408,0.0018813,0.058138,0.38231,RORA1_01,0.977236936870728
GOBP_STEROID_CATABOLIC_PROCE...,SET,23,0.05444,0.0019256,0.18186,0.38234,GOBP_STEROID_CATABOLIC_PROCESS,0.977236936870728
HP_ABNORMAL_HAND_BONE_OSSIFI...,SET,34,0.042392,0.0018225,0.14166,0.38238,HP_ABNORMAL_HAND_BONE_OSSIFICATION,0.977236936870728
HP_MICROMELIA,SET,86,0.027423,0.0018724,0.091657,0.3824,HP_MICROMELIA,0.977236936870728
GSE25088_CTRL_VS_ROSIGLITAZO...3,SET,182,0.017987,0.0017819,0.060124,0.38241,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,0.977236936870728
GOBP_MITOCHONDRIAL_ADP_TRANS...,SET,3,0.13531,0.0017294,0.45234,0.38243,GOBP_MITOCHONDRIAL_ADP_TRANSMEMBRANE_TRANSPORT,0.977236936870728
MIR106A_5P,SET,596,0.010569,0.0018731,0.035341,0.38245,MIR106A_5P,0.977236936870728
GOBP_GTP_BIOSYNTHETIC_PROCESS,SET,10,0.081913,0.0019111,0.27394,0.38247,GOBP_GTP_BIOSYNTHETIC_PROCESS,0.977236936870728
GOBP_BUD_ELONGATION_INVOLVED...,SET,7,0.11025,0.0021523,0.36888,0.38252,GOBP_BUD_ELONGATION_INVOLVED_IN_LUNG_BRANCHING,0.977236936870728
MIR219A_2_3P,SET,64,0.031174,0.0018373,0.10431,0.38253,MIR219A_2_3P,0.977236936870728
MIR4320,SET,48,0.038223,0.0019518,0.12796,0.38259,MIR4320,0.977236936870728
GSE36078_WT_VS_IL1R_KO_LUNG_...1,SET,184,0.01929,0.0019214,0.064581,0.38259,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN,0.977236936870728
MIR103B,SET,36,0.040431,0.0017885,0.13537,0.3826,MIR103B,0.977236936870728
GOCC_R2TP_COMPLEX,SET,5,0.10181,0.0016798,0.34122,0.38271,GOCC_R2TP_COMPLEX,0.977325077002053
KANG_IMMORTALIZED_BY_TERT_DN,SET,95,0.027337,0.0019613,0.091682,0.38279,KANG_IMMORTALIZED_BY_TERT_DN,0.977325077002053
LOCKWOOD_AMPLIFIED_IN_LUNG_C...,SET,203,0.018849,0.001971,0.063227,0.38281,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,0.977325077002053
GOBP_PROTEIN_INSERTION_INTO_...6,SET,6,0.088139,0.001593,0.29565,0.38281,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE,0.977325077002053
HP_ABNORMAL_POSTERIOR_PITUIT...,SET,33,0.04179,0.0017701,0.14022,0.38284,HP_ABNORMAL_POSTERIOR_PITUITARY_MORPHOGENESIS,0.977325077002053
GOBP_NUCLEAR_EXPORT,SET,153,0.01894,0.0017217,0.063551,0.38285,GOBP_NUCLEAR_EXPORT,0.977325077002053
HP_INCREASED_ARM_SPAN,SET,7,0.08525,0.0016642,0.28616,0.38289,HP_INCREASED_ARM_SPAN,0.977325077002053
GOBP_DNA_MODIFICATION,SET,38,0.042171,0.0019165,0.14159,0.38292,GOBP_DNA_MODIFICATION,0.977325077002053
GOBP_PROTON_TRANSPORTING_TWO...,SET,11,0.07688,0.0018812,0.25819,0.38294,GOBP_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_ASSEMBLY,0.977325077002053
GOMF_MEDIUM_CHAIN_FATTY_ACID...,SET,9,0.09354,0.0020704,0.31424,0.38298,GOMF_MEDIUM_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,0.977325077002053
KEGG_MEDICUS_REFERENCE_GLYCO...4,SET,21,0.048871,0.0016518,0.1642,0.38299,KEGG_MEDICUS_REFERENCE_GLYCOLYSIS,0.977325077002053
HP_ABNORMALITY_OF_LIMB_BONE,SET,1523,0.0066744,0.0018408,0.022428,0.38301,HP_ABNORMALITY_OF_LIMB_BONE,0.977325077002053
LI_ESTROGENE_EARLY_E2_RESPON...2,SET,82,0.029472,0.0019652,0.09912,0.3831,LI_ESTROGENE_EARLY_E2_RESPONSE_UP,0.977325077002053
GOBP_CYCLOOXYGENASE_PATHWAY,SET,9,0.080387,0.0017793,0.27036,0.38311,GOBP_CYCLOOXYGENASE_PATHWAY,0.977325077002053
GOBP_ANTIMICROBIAL_HUMORAL_R...,SET,127,0.026468,0.0021937,0.08906,0.38316,GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE,0.977325077002053
MODULE_197,SET,169,0.019686,0.0018799,0.066245,0.38317,MODULE_197,0.977325077002053
REACTOME_SYNTHESIS_OF_IP3_AN...,SET,25,0.047758,0.0017611,0.16072,0.38318,REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL,0.977325077002053
MIR8052,SET,40,0.038677,0.0018033,0.13019,0.3832,MIR8052,0.977325077002053
HP_ABNORMAL_SIZE_OF_PITUITAR...,SET,27,0.047855,0.0018338,0.16111,0.38322,HP_ABNORMAL_SIZE_OF_PITUITARY_GLAND,0.977325077002053
HP_LARGE_CENTRAL_VISUAL_FIEL...,SET,13,0.070891,0.0018857,0.23866,0.38322,HP_LARGE_CENTRAL_VISUAL_FIELD_DEFECT,0.977325077002053
GOBP_POSITIVE_REGULATION_OF_...442,SET,5,0.11231,0.0018531,0.37812,0.38323,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_CHEMOTAXIS,0.977325077002053
BIOCARTA_CARM1_PATHWAY,SET,12,0.073307,0.0018735,0.24691,0.38328,BIOCARTA_CARM1_PATHWAY,0.977325077002053
HP_WIDOW_S_PEAK,SET,14,0.065658,0.0018123,0.22118,0.38329,HP_WIDOW_S_PEAK,0.977325077002053
MODULE_102,SET,16,0.060052,0.001772,0.20241,0.38335,MODULE_102,0.977325077002053
GSE7568_IL4_TGFB_DEXAMETHASO...2,SET,154,0.018807,0.0017151,0.063404,0.38338,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_UP,0.977325077002053
GSE19401_UNSTIM_VS_RETINOIC_...4,SET,183,0.018366,0.0018244,0.061935,0.38341,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,0.977325077002053
GOBP_MRNA_3_SPLICE_SITE_RECO...,SET,6,0.10251,0.0018527,0.34569,0.38342,GOBP_MRNA_3_SPLICE_SITE_RECOGNITION,0.977325077002053
GSE12845_IGD_POS_BLOOD_VS_NA...1,SET,187,0.017809,0.0017881,0.060068,0.38344,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,0.977325077002053
MODULE_287,SET,47,0.039656,0.0020038,0.13377,0.38345,MODULE_287,0.977325077002053
GSE16450_CTRL_VS_IFNA_6H_STI...1,SET,157,0.01996,0.0018378,0.067371,0.38351,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.977406324704847
HP_POSTERIOR_POLAR_CATARACT,SET,8,0.089868,0.0018755,0.30354,0.38359,HP_POSTERIOR_POLAR_CATARACT,0.977538528376595
GOBP_EARLY_ENDOSOME_TO_GOLGI...,SET,16,0.061306,0.001809,0.20713,0.38363,GOBP_EARLY_ENDOSOME_TO_GOLGI_TRANSPORT,0.977568784368355
MIR26A_2_3P,SET,66,0.030557,0.0018287,0.10333,0.38373,MIR26A_2_3P,0.977685002199091
REACTOME_TRNA_PROCESSING_IN_...2,SET,53,0.032763,0.0017577,0.11081,0.38374,REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS,0.977685002199091
AMIT_EGF_RESPONSE_40_HELA,SET,40,0.040837,0.001904,0.13814,0.38376,AMIT_EGF_RESPONSE_40_HELA,0.977685002199091
GOBP_STRESS_INDUCED_PREMATUR...,SET,7,0.079062,0.0015434,0.26772,0.38388,GOBP_STRESS_INDUCED_PREMATURE_SENESCENCE,0.977872834212841
GOBP_BIOLOGICAL_PHASE,SET,11,0.078221,0.001914,0.26491,0.38389,GOBP_BIOLOGICAL_PHASE,0.977872834212841
MAZR_01,SET,204,0.016611,0.0017411,0.056293,0.38397,MAZR_01,0.978004935873946
GSE12198_CTRL_VS_LOW_IL2_STI...1,SET,191,0.017263,0.0017515,0.058577,0.38411,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN,0.978257769230769
MIR185_3P,SET,137,0.021569,0.0018561,0.073215,0.38415,MIR185_3P,0.978257769230769
GOMF_ESTROGEN_RESPONSE_ELEME...,SET,10,0.088508,0.002065,0.30049,0.38417,GOMF_ESTROGEN_RESPONSE_ELEMENT_BINDING,0.978257769230769
GOBP_EPITHELIAL_CELL_DIFFERE...3,SET,10,0.088887,0.0020738,0.30182,0.38419,GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,0.978257769230769
chr1q23,SET,130,0.045659,0.0038283,0.15506,0.38421,chr1q23,0.978257769230769
MIR617,SET,57,0.031777,0.0017678,0.10804,0.38433,MIR617,0.978441222879684
HP_GONADAL_NEOPLASM,SET,100,0.024859,0.0018296,0.084662,0.38452,HP_GONADAL_NEOPLASM,0.978441222879684
GOBP_REGULATION_OF_POSTSYNAP...8,SET,5,0.12477,0.0020587,0.42496,0.38453,GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.978441222879684
GOBP_MITOTIC_SISTER_CHROMATI...3,SET,178,0.017861,0.00175,0.060839,0.38454,GOBP_MITOTIC_SISTER_CHROMATID_SEGREGATION,0.978441222879684
GSE1791_CTRL_VS_NEUROMEDINU_...1,SET,162,0.019934,0.0018642,0.0679,0.38454,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_DN,0.978441222879684
GOMF_HIGH_VOLTAGE_GATED_CALC...,SET,13,0.07352,0.0019556,0.2505,0.38458,GOMF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.978441222879684
GOMF_DNA_NUCLEASE_ACTIVITY,SET,59,0.030143,0.0017059,0.10272,0.38459,GOMF_DNA_NUCLEASE_ACTIVITY,0.978441222879684
FAN_OVARY_CL2_PUTATIVE_EARLY...,SET,82,0.028777,0.0019188,0.098079,0.38461,FAN_OVARY_CL2_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_1,0.978441222879684
LINDGREN_BLADDER_CANCER_CLUS...5,SET,343,0.014434,0.0019542,0.049209,0.38464,LINDGREN_BLADDER_CANCER_CLUSTER_2B,0.978441222879684
GOBP_NEGATIVE_REGULATION_OF_...400,SET,166,0.018717,0.0017716,0.063821,0.38466,GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,0.978441222879684
GOBP_PATTERN_SPECIFICATION_P...,SET,433,0.012995,0.0019719,0.044318,0.38468,GOBP_PATTERN_SPECIFICATION_PROCESS,0.978441222879684
GAUCHER_PBMC_YF_VAX_STAMARIL...2,SET,183,0.018589,0.0018465,0.063397,0.38468,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP,0.978441222879684
MIR561_3P,SET,437,0.012244,0.0018664,0.041766,0.3847,MIR561_3P,0.978441222879684
ZNF10_TARGET_GENES,SET,643,0.0096815,0.0017798,0.033024,0.3847,ZNF10_TARGET_GENES,0.978441222879684
KEGG_MEDICUS_PATHOGEN_ESCHER...4,SET,5,0.12499,0.0020622,0.42646,0.38473,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPJ_TO_IGG_FCGR_RAC_SIGNALING_PATHWAY,0.978441222879684
GOBP_NEURON_APOPTOTIC_PROCESS,SET,262,0.015574,0.0018471,0.053156,0.38477,GOBP_NEURON_APOPTOTIC_PROCESS,0.978441222879684
GOBP_LOCALIZATION_WITHIN_MEM...,SET,617,0.0099435,0.0017919,0.033947,0.3848,GOBP_LOCALIZATION_WITHIN_MEMBRANE,0.978441222879684
HP_ABNORMALITY_OF_THE_UPPER_...3,SET,442,0.011901,0.0018242,0.040643,0.38483,HP_ABNORMALITY_OF_THE_UPPER_RESPIRATORY_TRACT,0.978441222879684
COLLIS_PRKDC_SUBSTRATES,SET,15,0.060667,0.0017333,0.20722,0.38485,COLLIS_PRKDC_SUBSTRATES,0.978441222879684
HP_CUTANEOUS_ANERGY,SET,6,0.1094,0.0019773,0.37372,0.38487,HP_CUTANEOUS_ANERGY,0.978441222879684
FRIDMAN_IMMORTALIZATION_DN,SET,31,0.047011,0.00193,0.16063,0.38489,FRIDMAN_IMMORTALIZATION_DN,0.978441222879684
GOBP_INTRACELLULAR_IRON_ION_...,SET,60,0.032029,0.0018279,0.10947,0.38492,GOBP_INTRACELLULAR_IRON_ION_HOMEOSTASIS,0.978441222879684
GOCC_PRERIBOSOME,SET,94,0.023484,0.001676,0.080301,0.38497,GOCC_PRERIBOSOME,0.978441222879684
GOMF_ADP_D_RIBOSE_MODIFICATI...,SET,4,0.10753,0.0015869,0.3677,0.38498,GOMF_ADP_D_RIBOSE_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.978441222879684
GOCC_POSTSYNAPTIC_RECYCLING_...,SET,7,0.086264,0.001684,0.29509,0.38502,GOCC_POSTSYNAPTIC_RECYCLING_ENDOSOME,0.978441222879684
RPS14_DN.V1_DN,SET,167,0.018704,0.0017757,0.064,0.38505,RPS14_DN.V1_DN,0.978441222879684
GOBP_TUMOR_NECROSIS_FACTOR_S...,SET,161,0.020378,0.0018999,0.069763,0.3851,GOBP_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.978441222879684
GSE40274_GATA1_VS_FOXP3_AND_...2,SET,179,0.018172,0.0017855,0.062221,0.38512,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.978441222879684
HP_DEFORMED_SELLA_TURCICA,SET,18,0.052286,0.0016363,0.17905,0.38514,HP_DEFORMED_SELLA_TURCICA,0.978441222879684
DURANTE_ADULT_OLFACTORY_NEUR...5,SET,103,0.025513,0.0019055,0.087395,0.38517,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_DENDRITIC_CELLS,0.978441222879684
AGCACTT_MIR93_MIR302A_MIR302...,SET,318,0.013976,0.0018233,0.047905,0.38524,AGCACTT_MIR93_MIR302A_MIR302B_MIR302C_MIR302D_MIR372_MIR373_MIR520E_MIR520A_MIR526B_MIR520B_MIR520C_MIR520D,0.978441222879684
NIKOLSKY_BREAST_CANCER_11Q12...,SET,144,0.034094,0.0030075,0.1169,0.38528,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,0.978441222879684
FAN_EMBRYONIC_CTX_EX_1_EXCIT...,SET,5,0.10076,0.0016625,0.34559,0.38531,FAN_EMBRYONIC_CTX_EX_1_EXCITATORY_NEURON,0.978441222879684
HP_TALL_CHIN,SET,5,0.082934,0.0013684,0.28448,0.38533,HP_TALL_CHIN,0.978441222879684
GSE24634_IL4_VS_CTRL_TREATED...5,SET,183,0.018847,0.0018721,0.064656,0.38534,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN,0.978441222879684
GRAESSMANN_APOPTOSIS_BY_SERU...1,SET,215,0.016978,0.0018264,0.058253,0.38535,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,0.978441222879684
GSE10325_CD4_TCELL_VS_BCELL_...2,SET,175,0.018921,0.0018384,0.064915,0.38535,GSE10325_CD4_TCELL_VS_BCELL_UP,0.978441222879684
GOBP_PHOSPHOLIPID_TRANSPORT,SET,92,0.025589,0.0018068,0.087809,0.38537,GOBP_PHOSPHOLIPID_TRANSPORT,0.978441222879684
BIOCARTA_MEF2D_PATHWAY,SET,18,0.06088,0.0019052,0.20893,0.38538,BIOCARTA_MEF2D_PATHWAY,0.978441222879684
GSE27786_LIN_NEG_VS_NKTCELL_...2,SET,179,0.017317,0.0017014,0.059447,0.38541,GSE27786_LIN_NEG_VS_NKTCELL_UP,0.978445913075237
GILDEA_METASTASIS,SET,28,0.04773,0.0018625,0.16391,0.38545,GILDEA_METASTASIS,0.978448663843458
HP_ABNORMAL_CIRCULATING_ALPH...,SET,30,0.047418,0.0019151,0.16292,0.3855,HP_ABNORMAL_CIRCULATING_ALPHA_FETOPROTEIN_CONCENTRATION,0.978448663843458
MOREAUX_MULTIPLE_MYELOMA_BY_...2,SET,326,0.014151,0.0018688,0.048634,0.38554,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,0.978448663843458
HP_MACULAR_PURPURA,SET,78,0.028599,0.00186,0.09831,0.38556,HP_MACULAR_PURPURA,0.978448663843458
EFC_Q6,SET,242,0.015957,0.0018198,0.054855,0.38557,EFC_Q6,0.978448663843458
MILI_PSEUDOPODIA_HAPTOTAXIS_...2,SET,452,0.011231,0.0017403,0.038611,0.38558,MILI_PSEUDOPODIA_HAPTOTAXIS_UP,0.978448663843458
REACTOME_RHOA_GTPASE_CYCLE,SET,138,0.021188,0.0018299,0.072879,0.38563,REACTOME_RHOA_GTPASE_CYCLE,0.978486146415862
HP_ABNORMAL_SYNOVIAL_MEMBRAN...,SET,15,0.063983,0.001828,0.22025,0.38572,HP_ABNORMAL_SYNOVIAL_MEMBRANE_MORPHOLOGY,0.978486146415862
GOBP_VENTRICULAR_TRABECULA_M...,SET,14,0.076468,0.0021107,0.26325,0.38573,GOBP_VENTRICULAR_TRABECULA_MYOCARDIUM_MORPHOGENESIS,0.978486146415862
GOBP_REGULATION_OF_DOUBLE_ST...3,SET,18,0.053373,0.0016703,0.18383,0.38578,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.978486146415862
GSE17721_LPS_VS_CPG_24H_BMDC...1,SET,190,0.017329,0.0017536,0.059693,0.3858,GSE17721_LPS_VS_CPG_24H_BMDC_DN,0.978486146415862
MODULE_165,SET,77,0.030143,0.0019479,0.10388,0.38584,MODULE_165,0.978486146415862
HP_DILATATION_OF_THE_VENTRIC...,SET,9,0.077138,0.0017074,0.26596,0.3859,HP_DILATATION_OF_THE_VENTRICULAR_CAVITY,0.978486146415862
HALLMARK_TGF_BETA_SIGNALING,SET,52,0.034273,0.0018214,0.11819,0.38592,HALLMARK_TGF_BETA_SIGNALING,0.978486146415862
GSE5589_LPS_VS_LPS_AND_IL10_...3,SET,185,0.018625,0.00186,0.064233,0.38593,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_DN,0.978486146415862
HP_RHIZOMELIA,SET,59,0.033032,0.0018695,0.11397,0.38597,HP_RHIZOMELIA,0.978486146415862
NAKAMURA_ADIPOGENESIS_LATE_UP,SET,93,0.025295,0.0017957,0.087346,0.38606,NAKAMURA_ADIPOGENESIS_LATE_UP,0.978486146415862
GOBP_CALCIUM_ACTIVATED_PHOSP...,SET,5,0.11893,0.0019623,0.41084,0.38611,GOBP_CALCIUM_ACTIVATED_PHOSPHOLIPID_SCRAMBLING,0.978486146415862
HP_HYPOKALEMIA,SET,74,0.029312,0.0018571,0.10126,0.38611,HP_HYPOKALEMIA,0.978486146415862
HP_BIFID_UVULA,SET,139,0.020251,0.0017553,0.069987,0.38616,HP_BIFID_UVULA,0.978486146415862
HP_CORNEAL_NEOVASCULARIZATION,SET,23,0.057236,0.0020245,0.19782,0.38617,HP_CORNEAL_NEOVASCULARIZATION,0.978486146415862
GSE29164_DAY3_VS_DAY7_UNTREA...2,SET,163,0.018657,0.0017501,0.06451,0.38621,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP,0.978486146415862
GSE369_PRE_VS_POST_IL6_INJEC...6,SET,175,0.018802,0.0018268,0.065022,0.38623,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_UP,0.978486146415862
GOMF_SINGLE_STRANDED_DNA_5_3...,SET,5,0.084455,0.0013935,0.2921,0.38624,GOMF_SINGLE_STRANDED_DNA_5_3_DNA_EXONUCLEASE_ACTIVITY,0.978486146415862
GSE17721_LPS_VS_GARDIQUIMOD_...5,SET,180,0.018258,0.0017989,0.063168,0.38628,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN,0.978486146415862
ZNF816_TARGET_GENES,SET,419,0.012174,0.001818,0.04213,0.3863,ZNF816_TARGET_GENES,0.978486146415862
STANELLE_E2F1_TARGETS,SET,26,0.048336,0.0018176,0.16732,0.38633,STANELLE_E2F1_TARGETS,0.978486146415862
BIOCARTA_ETS_PATHWAY,SET,17,0.062882,0.0019125,0.21788,0.38644,BIOCARTA_ETS_PATHWAY,0.978486146415862
MIR5195_5P,SET,18,0.059569,0.0018642,0.20649,0.38649,MIR5195_5P,0.978486146415862
GSE26928_EFF_MEM_VS_CENTR_ME...2,SET,164,0.019259,0.001812,0.06679,0.38654,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP,0.978486146415862
GOBP_PURINE_CONTAINING_COMPO...3,SET,14,0.07114,0.0019637,0.24674,0.38655,GOBP_PURINE_CONTAINING_COMPOUND_SALVAGE,0.978486146415862
GSE16266_LPS_VS_HEATSHOCK_AN...2,SET,181,0.018851,0.0018624,0.065384,0.38656,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,0.978486146415862
VART_KSHV_INFECTION_ANGIOGEN...1,SET,124,0.023156,0.0018965,0.080327,0.38657,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,0.978486146415862
MIR6799_5P,SET,131,0.020598,0.0017336,0.071472,0.3866,MIR6799_5P,0.978486146415862
HP_ZONULAR_CATARACT,SET,47,0.036486,0.0018436,0.12661,0.38661,HP_ZONULAR_CATARACT,0.978486146415862
MIR3159,SET,84,0.027417,0.0018502,0.095167,0.38664,MIR3159,0.978486146415862
GSE40184_HEALTHY_VS_HCV_INFE...1,SET,187,0.017317,0.0017387,0.060111,0.38664,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN,0.978486146415862
GOBP_PROTEIN_TARGETING_TO_ME...,SET,107,0.02276,0.0017324,0.079018,0.38666,GOBP_PROTEIN_TARGETING_TO_MEMBRANE,0.978486146415862
REACTOME_ASPIRIN_ADME,SET,41,0.045919,0.0021675,0.15943,0.38667,REACTOME_ASPIRIN_ADME,0.978486146415862
GOCC_ASYMMETRIC_GLUTAMATERGI...,SET,13,0.071028,0.0018893,0.2466,0.38667,GOCC_ASYMMETRIC_GLUTAMATERGIC_EXCITATORY_SYNAPSE,0.978486146415862
GOBP_CELLULAR_RESPONSE_TO_CA...5,SET,137,0.02108,0.0018141,0.07323,0.38673,GOBP_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS,0.978486146415862
HP_INTELLECTUAL_DISABILITY_P...2,SET,31,0.038455,0.0015788,0.13362,0.38676,HP_INTELLECTUAL_DISABILITY_PROGRESSIVE,0.978486146415862
HP_MEMORY_IMPAIRMENT,SET,128,0.020664,0.0017193,0.07181,0.38676,HP_MEMORY_IMPAIRMENT,0.978486146415862
HP_APLASIA_HYPOPLASIA_OF_THE...6,SET,4,0.13782,0.002034,0.47906,0.38679,HP_APLASIA_HYPOPLASIA_OF_THE_4TH_FINGER,0.978486146415862
GOMF_PROTEIN_KINASE_ACTIVITY,SET,534,0.010536,0.0017704,0.03663,0.38682,GOMF_PROTEIN_KINASE_ACTIVITY,0.978486146415862
GSE15930_NAIVE_VS_72H_IN_VIT...5,SET,182,0.017813,0.0017646,0.061942,0.38684,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.978486146415862
FUNG_IL2_TARGETS_WITH_STAT5_...2,SET,9,0.089788,0.0019874,0.31229,0.38686,FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1,0.978486146415862
STEARMAN_TUMOR_FIELD_EFFECT_...,SET,34,0.042327,0.0018197,0.14726,0.38689,STEARMAN_TUMOR_FIELD_EFFECT_UP,0.978486146415862
GOBP_INTESTINAL_EPITHELIAL_C...3,SET,6,0.096038,0.0017358,0.3341,0.38689,GOBP_INTESTINAL_EPITHELIAL_CELL_MATURATION,0.978486146415862
GSE21033_CTRL_VS_POLYIC_STIM...1,SET,177,0.018135,0.001772,0.06312,0.38694,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_DN,0.978486146415862
GSE7509_UNSTIM_VS_FCGRIIB_ST...4,SET,150,0.018449,0.0016607,0.064241,0.38699,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP,0.978486146415862
GSE9601_UNTREATED_VS_PI3K_IN...1,SET,131,0.020645,0.0017376,0.071928,0.38705,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,0.978486146415862
HP_LIMB_DYSMETRIA,SET,14,0.06294,0.0017373,0.21943,0.38712,HP_LIMB_DYSMETRIA,0.978486146415862
WP_KLEEFSTRA_SYNDROME,SET,26,0.04623,0.0017384,0.16127,0.38719,WP_KLEEFSTRA_SYNDROME,0.978486146415862
DURANTE_ADULT_OLFACTORY_NEUR...15,SET,17,0.066221,0.0020141,0.23103,0.3872,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_HORIZONTAL_BASAL_CELLS,0.978486146415862
MIR5002_3P,SET,41,0.035957,0.0016972,0.12547,0.38722,MIR5002_3P,0.978486146415862
GTGCCTT_MIR506,SET,664,0.0094751,0.001769,0.033071,0.38725,GTGCCTT_MIR506,0.978486146415862
TCCAGAG_MIR518C,SET,137,0.022735,0.0019565,0.079356,0.38725,TCCAGAG_MIR518C,0.978486146415862
PITX1_TARGET_GENES,SET,290,0.014003,0.0017459,0.048893,0.38729,PITX1_TARGET_GENES,0.978486146415862
MARIADASON_RESPONSE_TO_CURCU...1,SET,22,0.047284,0.0016358,0.16511,0.3873,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5,0.978486146415862
HOXB6_TARGET_GENES,SET,514,0.010528,0.0017366,0.036764,0.3873,HOXB6_TARGET_GENES,0.978486146415862
MIR208A_3P,SET,38,0.039855,0.0018113,0.13929,0.38739,MIR208A_3P,0.978486146415862
GOBP_NEGATIVE_REGULATION_OF_...616,SET,34,0.041686,0.0017921,0.1457,0.3874,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.978486146415862
GOBP_REGULATION_OF_MULTICELL...2,SET,61,0.033705,0.0019395,0.11781,0.3874,GOBP_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.978486146415862
KEGG_MEDICUS_REFERENCE_SEROT...,SET,3,0.1501,0.0019185,0.5247,0.38741,KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM,0.978486146415862
HP_ABNORMAL_UPPER_MOTOR_NEUR...,SET,14,0.057117,0.0015766,0.19967,0.38742,HP_ABNORMAL_UPPER_MOTOR_NEURON_MORPHOLOGY,0.978486146415862
HP_MYOFIBRILLAR_MYOPATHY,SET,10,0.080316,0.0018739,0.2808,0.38743,HP_MYOFIBRILLAR_MYOPATHY,0.978486146415862
GOMF_EXTRACELLULAR_MATRIX_BI...,SET,60,0.033153,0.0018921,0.11592,0.38744,GOMF_EXTRACELLULAR_MATRIX_BINDING,0.978486146415862
GOBP_HINDLIMB_MORPHOGENESIS,SET,34,0.047046,0.0020226,0.16452,0.38745,GOBP_HINDLIMB_MORPHOGENESIS,0.978486146415862
GSE9006_TYPE_1_DIABETES_AT_D...1,SET,163,0.017993,0.0016877,0.06293,0.38747,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN,0.978486146415862
HP_ILEUS,SET,29,0.04513,0.0017921,0.15787,0.38749,HP_ILEUS,0.978486146415862
ZNF555_TARGET_GENES,SET,91,0.024084,0.0016913,0.084265,0.38751,ZNF555_TARGET_GENES,0.978486146415862
KEGG_MEDICUS_PATHOGEN_HPV_E6...2,SET,12,0.072658,0.0018569,0.25441,0.3876,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381,0.978486146415862
MIR8078,SET,28,0.045403,0.0017717,0.15899,0.3876,MIR8078,0.978486146415862
RYBP_TARGET_GENES,SET,1411,0.0068012,0.0018115,0.023815,0.3876,RYBP_TARGET_GENES,0.978486146415862
REACTOME_KILLING_MECHANISMS,SET,11,0.073882,0.0018078,0.25874,0.38762,REACTOME_KILLING_MECHANISMS,0.978486146415862
REACTOME_SUMOYLATION_OF_INTR...,SET,28,0.045095,0.0017597,0.15794,0.38763,REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS,0.978486146415862
GSE3982_DC_VS_MAC_LPS_STIM_DN,SET,173,0.018692,0.0018058,0.065473,0.38764,GSE3982_DC_VS_MAC_LPS_STIM_DN,0.978486146415862
HP_METRORRHAGIA,SET,15,0.065813,0.0018803,0.23055,0.38765,HP_METRORRHAGIA,0.978486146415862
BOYAULT_LIVER_CANCER_SUBCLAS...7,SET,27,0.05197,0.0019914,0.18225,0.38776,BOYAULT_LIVER_CANCER_SUBCLASS_G2,0.978604416563928
GSE2770_TGFB_AND_IL4_ACT_VS_...6,SET,177,0.017573,0.001717,0.061625,0.38776,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,0.978604416563928
MIR153_3P,SET,308,0.014196,0.0018231,0.049836,0.38788,MIR153_3P,0.978604416563928
GOMF_ATP_ADP_ANTIPORTER_ACTI...,SET,3,0.1346,0.0017204,0.47281,0.38794,GOMF_ATP_ADP_ANTIPORTER_ACTIVITY,0.978604416563928
MIR626,SET,51,0.035869,0.0018878,0.12601,0.38796,MIR626,0.978604416563928
LAIHO_COLORECTAL_CANCER_SERR...2,SET,103,0.022759,0.0016998,0.079972,0.38798,LAIHO_COLORECTAL_CANCER_SERRATED_UP,0.978604416563928
GSE3920_UNTREATED_VS_IFNG_TR...4,SET,156,0.019175,0.0017599,0.067379,0.38798,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP,0.978604416563928
HP_DECREASED_CIRCULATING_TER...,SET,6,0.10416,0.0018826,0.36616,0.38803,HP_DECREASED_CIRCULATING_TERMINAL_COMPLEMENT_COMPONENT_CONCENTRATION,0.978604416563928
HP_MATERNAL_HYPERTENSION,SET,7,0.0921,0.001798,0.32379,0.38804,HP_MATERNAL_HYPERTENSION,0.978604416563928
HP_ABNORMAL_UMBILICUS_MORPHO...,SET,265,0.014872,0.0017738,0.052299,0.38806,HP_ABNORMAL_UMBILICUS_MORPHOLOGY,0.978604416563928
GSE29949_CD8_POS_DC_SPLEEN_V...3,SET,175,0.018186,0.0017669,0.063961,0.38808,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,0.978604416563928
MORF_SOD1,SET,243,0.014163,0.0016186,0.049835,0.38813,MORF_SOD1,0.978604416563928
HP_ABNORMALITY_OF_NEUTROPHILS,SET,230,0.015506,0.0017245,0.054562,0.38814,HP_ABNORMALITY_OF_NEUTROPHILS,0.978604416563928
GOMF_OXYSTEROL_BINDING,SET,16,0.067828,0.0020014,0.23876,0.38817,GOMF_OXYSTEROL_BINDING,0.978604416563928
KUROZUMI_RESPONSE_TO_ONCOCYT...1,SET,41,0.040394,0.0019067,0.1422,0.38818,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,0.978604416563928
GSE12845_NAIVE_VS_PRE_GC_TON...1,SET,175,0.017421,0.0016926,0.06134,0.3882,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN,0.978604416563928
DESCARTES_FETAL_PANCREAS_ENS...1,SET,58,0.032855,0.0018437,0.11569,0.3882,DESCARTES_FETAL_PANCREAS_ENS_GLIA,0.978604416563928
GSE3982_BASOPHIL_VS_TH2_UP,SET,172,0.018384,0.0017709,0.064748,0.38823,GSE3982_BASOPHIL_VS_TH2_UP,0.978604416563928
GOBP_NEGATIVE_REGULATION_OF_...454,SET,35,0.040241,0.0017552,0.14175,0.38825,GOBP_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.978604416563928
RATTENBACHER_BOUND_BY_CELF1,SET,365,0.012443,0.0017369,0.043835,0.38826,RATTENBACHER_BOUND_BY_CELF1,0.978604416563928
MIR4533,SET,303,0.013483,0.0017178,0.047537,0.38834,MIR4533,0.978735076142132
REACTOME_KERATINIZATION,SET,183,0.024258,0.0024096,0.085617,0.38847,REACTOME_KERATINIZATION,0.97879527276679
GOBP_HYDROGEN_PEROXIDE_CATAB...,SET,26,0.050956,0.0019161,0.17991,0.3885,GOBP_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS,0.97879527276679
REACTOME_RSK_ACTIVATION,SET,5,0.11723,0.0019343,0.41393,0.38851,REACTOME_RSK_ACTIVATION,0.97879527276679
HP_ABNORMALITY_OF_HUMORAL_IM...,SET,280,0.014311,0.0017537,0.050528,0.38851,HP_ABNORMALITY_OF_HUMORAL_IMMUNITY,0.97879527276679
GOBP_CELLULAR_RESPONSE_TO_UV,SET,81,0.025298,0.0016765,0.089334,0.38852,GOBP_CELLULAR_RESPONSE_TO_UV,0.97879527276679
MIR6878_5P,SET,197,0.017563,0.0018095,0.062046,0.38856,MIR6878_5P,0.97879527276679
DESCARTES_MAIN_FETAL_MUC13_D...,SET,48,0.034722,0.001773,0.12271,0.38861,DESCARTES_MAIN_FETAL_MUC13_DMBT1_POSITIVE_CELLS,0.97879527276679
GOBP_INTERLEUKIN_2_PRODUCTION,SET,60,0.033379,0.001905,0.11801,0.38865,GOBP_INTERLEUKIN_2_PRODUCTION,0.97879527276679
SCHAEFFER_PROSTATE_DEVELOPME...3,SET,375,0.013518,0.0019121,0.047801,0.38866,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,0.97879527276679
REACTOME_BETA_OXIDATION_OF_V...,SET,10,0.076551,0.001786,0.2708,0.38871,REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS,0.97879527276679
HP_PERSISTENT_BLEEDING_AFTER...,SET,12,0.073861,0.0018876,0.26128,0.38871,HP_PERSISTENT_BLEEDING_AFTER_TRAUMA,0.97879527276679
HE_LIM_SUN_FETAL_LUNG_C2_DC2...,SET,49,0.035817,0.0018478,0.12671,0.38872,HE_LIM_SUN_FETAL_LUNG_C2_DC2_CELL,0.97879527276679
HP_WIDE_NOSE,SET,108,0.022544,0.0017239,0.079765,0.38873,HP_WIDE_NOSE,0.97879527276679
HP_ABNORMALITY_OF_CHROMOSOME...1,SET,13,0.072244,0.0019216,0.25584,0.38883,HP_ABNORMALITY_OF_CHROMOSOME_SEGREGATION,0.978944144887995
GOBP_ADAPTIVE_IMMUNE_MEMORY_...,SET,5,0.12445,0.0020535,0.44093,0.38888,GOBP_ADAPTIVE_IMMUNE_MEMORY_RESPONSE,0.978944144887995
GOBP_HEART_VALVE_MORPHOGENES...,SET,60,0.034027,0.001942,0.12063,0.38895,GOBP_HEART_VALVE_MORPHOGENESIS,0.978944144887995
GOBP_NUCLEOTIDE_SUGAR_BIOSYN...,SET,16,0.05554,0.0016388,0.19701,0.389,GOBP_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS,0.978944144887995
HP_TRIANGULAR_FACE,SET,145,0.019763,0.0017493,0.070099,0.389,HP_TRIANGULAR_FACE,0.978944144887995
GSE6875_TCONV_VS_TREG_DN,SET,186,0.017974,0.0017999,0.063763,0.38901,GSE6875_TCONV_VS_TREG_DN,0.978944144887995
HP_ABNORMALITY_OF_FIBRINOLYS...,SET,4,0.093611,0.0013815,0.33215,0.38904,HP_ABNORMALITY_OF_FIBRINOLYSIS,0.978944144887995
ZNF33A_TARGET_GENES,SET,175,0.017568,0.0017069,0.062367,0.38909,ZNF33A_TARGET_GENES,0.978944144887995
MODULE_212,SET,301,0.014024,0.0017808,0.049796,0.38911,MODULE_212,0.978944144887995
KAN_RESPONSE_TO_ARSENIC_TRIO...,SET,108,0.024964,0.001909,0.088661,0.38914,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,0.978944144887995
KEGG_VIRAL_MYOCARDITIS,SET,64,0.032662,0.001925,0.11604,0.38918,KEGG_VIRAL_MYOCARDITIS,0.978944144887995
HP_LOWER_EYELID_COLOBOMA,SET,10,0.067547,0.0015759,0.24002,0.3892,HP_LOWER_EYELID_COLOBOMA,0.978944144887995
GOBP_CERAMIDE_METABOLIC_PROC...,SET,99,0.024436,0.0017895,0.086873,0.38925,GOBP_CERAMIDE_METABOLIC_PROCESS,0.978944144887995
GOBP_POSITIVE_REGULATION_OF_...187,SET,26,0.046108,0.0017338,0.16393,0.38926,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.978944144887995
GSE5463_CTRL_VS_DEXAMETHASON...2,SET,187,0.01742,0.001749,0.061947,0.38928,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP,0.978944144887995
GAVIN_FOXP3_TARGETS_CLUSTER_...5,SET,82,0.026425,0.001762,0.094012,0.38933,GAVIN_FOXP3_TARGETS_CLUSTER_P7,0.978944144887995
PURWIN_A375_SOX10_TARGETS,SET,43,0.036084,0.0017442,0.12841,0.38935,PURWIN_A375_SOX10_TARGETS,0.978944144887995
GHO_ATF5_TARGETS_UP,SET,12,0.076394,0.0019524,0.27209,0.38945,GHO_ATF5_TARGETS_UP,0.978944144887995
GSE17721_LPS_VS_CPG_12H_BMDC...1,SET,177,0.017779,0.0017372,0.063377,0.38954,GSE17721_LPS_VS_CPG_12H_BMDC_DN,0.978944144887995
GOCC_NASCENT_POLYPEPTIDE_ASS...,SET,4,0.10137,0.001496,0.36154,0.38959,GOCC_NASCENT_POLYPEPTIDE_ASSOCIATED_COMPLEX,0.978944144887995
GOBP_CONDITIONED_PLACE_PREFE...,SET,5,0.10963,0.0018089,0.3911,0.38962,GOBP_CONDITIONED_PLACE_PREFERENCE,0.978944144887995
GROSS_HYPOXIA_VIA_ELK3_AND_H...2,SET,125,0.022244,0.0018291,0.07936,0.38963,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,0.978944144887995
GSE37605_TREG_VS_TCONV_C57BL...3,SET,136,0.019284,0.0016535,0.0688,0.38963,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_DN,0.978944144887995
HP_FETAL_AKINESIA_SEQUENCE,SET,32,0.041414,0.0017274,0.14786,0.38971,HP_FETAL_AKINESIA_SEQUENCE,0.978944144887995
MODULE_242,SET,187,0.017304,0.0017374,0.061806,0.38975,MODULE_242,0.978944144887995
HP_POOR_HEAD_CONTROL,SET,208,0.015642,0.0016554,0.055885,0.38978,HP_POOR_HEAD_CONTROL,0.978944144887995
HP_DECREASED_CIRCULATING_TOT...2,SET,8,0.090844,0.0018958,0.32471,0.38983,HP_DECREASED_CIRCULATING_TOTAL_IGG,0.978944144887995
MIR1912_5P,SET,73,0.028938,0.0018211,0.10346,0.38985,MIR1912_5P,0.978944144887995
REACTOME_CITRIC_ACID_CYCLE_T...,SET,32,0.036825,0.001536,0.13178,0.38995,REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE,0.978944144887995
GOMF_INWARD_RECTIFIER_POTASS...,SET,26,0.051543,0.0019382,0.18447,0.38997,GOMF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.978944144887995
HP_ABNORMALITY_OF_THE_HAMATE...,SET,9,0.081584,0.0018058,0.29216,0.39003,HP_ABNORMALITY_OF_THE_HAMATE_BONE,0.978944144887995
GRAHAM_NORMAL_QUIESCENT_VS_N...2,SET,54,0.034393,0.0018624,0.12318,0.39005,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,0.978944144887995
GOBP_SUPPRESSION_OF_VIRAL_RE...,SET,14,0.065633,0.0018117,0.23511,0.39006,GOBP_SUPPRESSION_OF_VIRAL_RELEASE_BY_HOST,0.978944144887995
GOBP_LATERAL_VENTRICLE_DEVEL...,SET,12,0.066026,0.0016874,0.23654,0.39007,GOBP_LATERAL_VENTRICLE_DEVELOPMENT,0.978944144887995
GOMF_OXIDOREDUCTASE_ACTIVITY...30,SET,7,0.09242,0.0018042,0.33114,0.39009,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR,0.978944144887995
HE_LIM_SUN_FETAL_LUNG_C3_AER...,SET,84,0.027716,0.0018704,0.099327,0.39011,HE_LIM_SUN_FETAL_LUNG_C3_AEROCYTE,0.978944144887995
GOBP_COPII_COATED_VESICLE_BU...,SET,42,0.035233,0.0016832,0.12629,0.39013,GOBP_COPII_COATED_VESICLE_BUDDING,0.978944144887995
MEISSNER_BRAIN_HCP_WITH_H3K2...,SET,251,0.016348,0.0018983,0.058607,0.39015,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,0.978944144887995
GOBP_PROTEIN_HISTIDYL_MODIFI...,SET,7,0.083552,0.0016311,0.29954,0.39015,GOBP_PROTEIN_HISTIDYL_MODIFICATION_TO_DIPHTHAMIDE,0.978944144887995
GSE17721_LPS_VS_GARDIQUIMOD_...9,SET,176,0.017009,0.0016573,0.060985,0.39016,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN,0.978944144887995
GOBP_PROTEIN_LOCALIZATION_TO...42,SET,15,0.059893,0.0017112,0.21489,0.39023,GOBP_PROTEIN_LOCALIZATION_TO_PHAGOPHORE_ASSEMBLY_SITE,0.978944144887995
HP_ABNORMAL_ENERGY_EXPENDITU...,SET,12,0.072237,0.0018461,0.25917,0.39023,HP_ABNORMAL_ENERGY_EXPENDITURE,0.978944144887995
MIR143_5P,SET,120,0.021869,0.0017622,0.078566,0.39037,MIR143_5P,0.978944144887995
GOMF_DNA_APURINIC_OR_APYRIMI...,SET,12,0.059261,0.0015145,0.21289,0.39037,GOMF_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY,0.978944144887995
GOBP_NOTOCHORD_MORPHOGENESIS,SET,6,0.10205,0.0018444,0.36679,0.39042,GOBP_NOTOCHORD_MORPHOGENESIS,0.978944144887995
HP_LARGE_EARLOBE,SET,28,0.043259,0.001688,0.15551,0.39044,HP_LARGE_EARLOBE,0.978944144887995
GSE37301_MULTIPOTENT_PROGENI...7,SET,169,0.018606,0.0017768,0.066895,0.39045,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN,0.978944144887995
ARGGGTTAA_UNKNOWN,SET,111,0.023242,0.0018017,0.08357,0.39046,ARGGGTTAA_UNKNOWN,0.978944144887995
HP_RETINAL_ARTERIAL_TORTUOSI...,SET,3,0.10481,0.0013396,0.37685,0.39046,HP_RETINAL_ARTERIAL_TORTUOSITY,0.978944144887995
GOCC_COATED_VESICLE_MEMBRANE,SET,184,0.017536,0.0017466,0.063059,0.39047,GOCC_COATED_VESICLE_MEMBRANE,0.978944144887995
GNF2_MSH6,SET,29,0.037052,0.0014714,0.13325,0.39048,GNF2_MSH6,0.978944144887995
GSE2770_IL12_AND_TGFB_VS_IL4...3,SET,162,0.0186,0.0017394,0.066913,0.39052,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.978944144887995
WP_KCNQ2RELATED_EPILEPSIES,SET,19,0.056845,0.0018277,0.20457,0.39055,WP_KCNQ2RELATED_EPILEPSIES,0.978944144887995
DESCARTES_FETAL_INTESTINE_ME...,SET,67,0.029361,0.0017704,0.10566,0.39055,DESCARTES_FETAL_INTESTINE_MESOTHELIAL_CELLS,0.978944144887995
GOMF_RNA_METHYLTRANSFERASE_A...,SET,53,0.028013,0.0015029,0.10086,0.3906,GOMF_RNA_METHYLTRANSFERASE_ACTIVITY,0.978944144887995
HP_OPTIC_NERVE_COMPRESSION,SET,14,0.064216,0.0017725,0.23119,0.3906,HP_OPTIC_NERVE_COMPRESSION,0.978944144887995
GOBP_REGULATION_OF_PEPTIDYL_...4,SET,106,0.023377,0.0017711,0.084191,0.39064,GOBP_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,0.978944144887995
GOBP_CIRCULATORY_SYSTEM_PROC...,SET,565,0.010665,0.0018418,0.038437,0.39071,GOBP_CIRCULATORY_SYSTEM_PROCESS,0.978944144887995
REACTOME_CYTOSOLIC_SULFONATI...,SET,21,0.054121,0.0018293,0.19509,0.39073,REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES,0.978944144887995
WP_OVERLAP_BETWEEN_SIGNAL_TR...,SET,51,0.032981,0.0017358,0.11892,0.39076,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,0.978944144887995
GSE24634_NAIVE_CD4_TCELL_VS_...3,SET,182,0.016661,0.0016506,0.060079,0.39077,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN,0.978944144887995
HP_ACUTE_INFECTIOUS_PNEUMONIA,SET,5,0.11325,0.0018686,0.40849,0.3908,HP_ACUTE_INFECTIOUS_PNEUMONIA,0.978944144887995
GOMF_NEUREGULIN_BINDING,SET,5,0.10813,0.0017842,0.39006,0.39081,GOMF_NEUREGULIN_BINDING,0.978944144887995
GSE14415_INDUCED_TREG_VS_FAI...2,SET,169,0.016559,0.0015813,0.059757,0.39085,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_UP,0.978944144887995
MIR380_5P,SET,42,0.038494,0.001839,0.13894,0.39087,MIR380_5P,0.978944144887995
HP_PERIVENTRICULAR_LEUKOMALA...,SET,38,0.03527,0.0016029,0.12733,0.39089,HP_PERIVENTRICULAR_LEUKOMALACIA,0.978944144887995
GOBP_REGULATION_OF_MOLECULAR...,SET,1741,0.0059454,0.0017418,0.021466,0.39091,GOBP_REGULATION_OF_MOLECULAR_FUNCTION,0.978944144887995
GOBP_PROTEIN_IMPORT_INTO_PER...2,SET,5,0.097365,0.0016065,0.35192,0.39102,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX_RECEPTOR_RECYCLING,0.978944144887995
GOBP_PRIMARY_AMINO_COMPOUND_...2,SET,13,0.061207,0.0016281,0.22126,0.39104,GOBP_PRIMARY_AMINO_COMPOUND_METABOLIC_PROCESS,0.978944144887995
HEIDENBLAD_AMPLICON_8Q24_UP,SET,35,0.036311,0.0015838,0.13129,0.39106,HEIDENBLAD_AMPLICON_8Q24_UP,0.978944144887995
GSE17721_CTRL_VS_PAM3CSK4_1H...2,SET,178,0.0163,0.0015971,0.058934,0.39106,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_UP,0.978944144887995
GOMF_CYCLIN_DEPENDENT_PROTEI...4,SET,45,0.032272,0.0015957,0.11673,0.39109,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY,0.978944144887995
GAO_ESOPHAGUS_25W_C3_FGFR1LO...,SET,43,0.034631,0.001674,0.12526,0.39109,GAO_ESOPHAGUS_25W_C3_FGFR1LOW_EPITHELIAL_CELLS,0.978944144887995
KIM_PTEN_TARGETS_DN,SET,4,0.10859,0.0016025,0.39276,0.3911,KIM_PTEN_TARGETS_DN,0.978944144887995
GOBP_REGULATION_OF_PHOSPHOLI...9,SET,14,0.060341,0.0016656,0.2183,0.39112,GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSPORT,0.978944144887995
HP_PRIMITIVE_REFLEX,SET,24,0.044661,0.0016136,0.1616,0.39113,HP_PRIMITIVE_REFLEX,0.978944144887995
GOCC_LUMENAL_SIDE_OF_MEMBRANE,SET,38,0.037735,0.0017149,0.13661,0.39119,GOCC_LUMENAL_SIDE_OF_MEMBRANE,0.978944144887995
GSE29614_CTRL_VS_TIV_FLU_VAC...1,SET,152,0.018908,0.0017132,0.068453,0.39119,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN,0.978944144887995
HP_HYPNOPOMPIC_HALLUCINATION,SET,6,0.10324,0.0018659,0.37379,0.3912,HP_HYPNOPOMPIC_HALLUCINATION,0.978944144887995
HP_ABNORMALITY_OF_THE_MIDDLE...4,SET,12,0.067534,0.0017259,0.24478,0.39131,HP_ABNORMALITY_OF_THE_MIDDLE_PHALANX_OF_THE_2ND_FINGER,0.978944144887995
GOBP_AMINO_ACID_ACTIVATION,SET,26,0.040511,0.0015234,0.14686,0.39134,GOBP_AMINO_ACID_ACTIVATION,0.978944144887995
GSE22886_NAIVE_CD4_TCELL_VS_...18,SET,181,0.016985,0.0016781,0.06158,0.39134,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP,0.978944144887995
MIR496,SET,95,0.024248,0.0017397,0.087938,0.39137,MIR496,0.978944144887995
GOBP_SIGNAL_TRANSDUCTION_INV...,SET,23,0.051171,0.00181,0.18564,0.39141,GOBP_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION,0.978944144887995
HP_URETHRAL_DIVERTICULUM,SET,4,0.12423,0.0018335,0.45069,0.39141,HP_URETHRAL_DIVERTICULUM,0.978944144887995
HP_ABNORMAL_BOWEL_SOUNDS,SET,8,0.068746,0.0014347,0.24941,0.39142,HP_ABNORMAL_BOWEL_SOUNDS,0.978944144887995
MIR20B_5P,SET,571,0.0099486,0.0017269,0.036117,0.39148,MIR20B_5P,0.978944144887995
GOBP_REGULATION_OF_CARDIAC_M...3,SET,7,0.073255,0.0014301,0.26598,0.3915,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_REGULATION_OF_CONTRACTION,0.978944144887995
GOMF_VASCULAR_ENDOTHELIAL_GR...1,SET,4,0.14608,0.0021559,0.53039,0.3915,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_BINDING,0.978944144887995
BIOCARTA_RELA_PATHWAY,SET,14,0.061373,0.001694,0.22291,0.39153,BIOCARTA_RELA_PATHWAY,0.978944144887995
HP_INTERMEDIATE_YOUNG_ADULT_...,SET,19,0.050358,0.0016191,0.18303,0.39161,HP_INTERMEDIATE_YOUNG_ADULT_ONSET,0.978944144887995
WP_IL6_SIGNALING,SET,42,0.038212,0.0018255,0.13892,0.39163,WP_IL6_SIGNALING,0.978944144887995
GOBP_NEGATIVE_REGULATION_OF_...164,SET,48,0.031002,0.0015831,0.11271,0.39164,GOBP_NEGATIVE_REGULATION_OF_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.978944144887995
HP_POOR_SPEECH,SET,167,0.017116,0.0016249,0.062235,0.39165,HP_POOR_SPEECH,0.978944144887995
MATSUMIYA_PBMC_MODIFIED_VACC...6,SET,9,0.079164,0.0017522,0.28799,0.3917,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_BCG_PRIMED_28DY_UP,0.978944144887995
CHYLA_CBFA2T3_TARGETS_DN,SET,212,0.015731,0.0016805,0.057229,0.39171,CHYLA_CBFA2T3_TARGETS_DN,0.978944144887995
MED16_TARGET_GENES,SET,19,0.05479,0.0017616,0.19937,0.39173,MED16_TARGET_GENES,0.978944144887995
KEGG_SYSTEMIC_LUPUS_ERYTHEMA...,SET,48,0.035294,0.0018022,0.12844,0.39174,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,0.978944144887995
GOBP_RNA_5_END_PROCESSING,SET,32,0.035081,0.0014633,0.12767,0.39174,GOBP_RNA_5_END_PROCESSING,0.978944144887995
GOBP_ENDOLYSOSOMAL_TOLL_LIKE...,SET,45,0.033751,0.0016688,0.12289,0.39179,GOBP_ENDOLYSOSOMAL_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.978944144887995
GOBP_TOLL_LIKE_RECEPTOR_2_SI...,SET,16,0.06054,0.0017863,0.22051,0.39184,GOBP_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.978944144887995
YAO_TEMPORAL_RESPONSE_TO_PRO...15,SET,71,0.030042,0.0018645,0.10949,0.3919,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,0.978944144887995
GSE20715_WT_VS_TLR4_KO_24H_O...1,SET,180,0.016485,0.0016242,0.060084,0.3919,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN,0.978944144887995
HP_ABNORMAL_HELIX_MORPHOLOGY,SET,151,0.018773,0.0016954,0.06844,0.39193,HP_ABNORMAL_HELIX_MORPHOLOGY,0.978944144887995
GSE7568_IL4_VS_IL4_AND_TGFB_...2,SET,151,0.018459,0.0016671,0.067328,0.39198,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP,0.978944144887995
PID_BETA_CATENIN_DEG_PATHWAY,SET,17,0.053126,0.0016158,0.19379,0.39199,PID_BETA_CATENIN_DEG_PATHWAY,0.978944144887995
GOBP_DETECTION_OF_STIMULUS_I...2,SET,27,0.045952,0.0017608,0.16767,0.39202,GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.978944144887995
GOBP_POSITIVE_REGULATION_OF_...232,SET,4,0.11648,0.001719,0.42502,0.39203,GOBP_POSITIVE_REGULATION_OF_ENAMEL_MINERALIZATION,0.978944144887995
HP_EXERCISE_INDUCED_MUSCLE_C...,SET,14,0.055801,0.0015403,0.20363,0.39203,HP_EXERCISE_INDUCED_MUSCLE_CRAMPS,0.978944144887995
GSE7568_IL4_VS_IL4_AND_DEXAM...1,SET,138,0.019178,0.0016564,0.069981,0.39203,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN,0.978944144887995
GOMF_MANGANESE_ION_TRANSMEMB...,SET,9,0.07525,0.0016656,0.2747,0.39207,GOMF_MANGANESE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.978944144887995
MIR6819_3P,SET,32,0.040852,0.0017039,0.14915,0.39208,MIR6819_3P,0.978944144887995
DESCARTES_FETAL_CEREBRUM_MEG...,SET,313,0.01314,0.0017009,0.047979,0.3921,DESCARTES_FETAL_CEREBRUM_MEGAKARYOCYTES,0.978944144887995
HP_UPPER_LIMB_PAIN,SET,8,0.084807,0.0017698,0.30973,0.39212,HP_UPPER_LIMB_PAIN,0.978944144887995
chr3q26,SET,61,0.060134,0.0034603,0.21965,0.39213,chr3q26,0.978944144887995
GSE32986_GMCSF_VS_GMCSF_AND_...3,SET,161,0.018025,0.0016805,0.065837,0.39213,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.978944144887995
GSE42021_CD24HI_VS_CD24LOW_T...2,SET,178,0.017688,0.0017331,0.064616,0.39214,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP,0.978944144887995
MORF_UNG,SET,65,0.025715,0.0015273,0.093968,0.39217,MORF_UNG,0.978944144887995
GSE23114_PERITONEAL_CAVITY_B...1,SET,183,0.016372,0.0016263,0.059834,0.39219,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN,0.978944144887995
GOCC_PHOSPHOLIPID_TRANSLOCAT...,SET,13,0.062772,0.0016697,0.22943,0.3922,GOCC_PHOSPHOLIPID_TRANSLOCATING_ATPASE_COMPLEX,0.978944144887995
HP_ABNORMAL_ATRIAL_ARRANGEME...,SET,41,0.034245,0.0016164,0.12521,0.39224,HP_ABNORMAL_ATRIAL_ARRANGEMENT,0.978944144887995
GOBP_RESPONSE_TO_DSRNA,SET,49,0.03548,0.0018304,0.12976,0.39226,GOBP_RESPONSE_TO_DSRNA,0.978944144887995
GOBP_GLIOGENESIS,SET,325,0.013472,0.0017764,0.049274,0.39227,GOBP_GLIOGENESIS,0.978944144887995
GOCC_PLATELET_DENSE_GRANULE,SET,19,0.051635,0.0016601,0.18889,0.39229,GOCC_PLATELET_DENSE_GRANULE,0.978944144887995
GOBP_REGULATION_OF_ANTIFUNGA...,SET,4,0.10218,0.001508,0.37387,0.39231,GOBP_REGULATION_OF_ANTIFUNGAL_INNATE_IMMUNE_RESPONSE,0.978944144887995
GOBP_RETINAL_BIPOLAR_NEURON_...,SET,7,0.088796,0.0017334,0.32501,0.39235,GOBP_RETINAL_BIPOLAR_NEURON_DIFFERENTIATION,0.978973670040922
POU3F2_02,SET,228,0.015588,0.0017262,0.057076,0.39239,POU3F2_02,0.979003190954774
GAUSSMANN_MLL_AF4_FUSION_TAR...9,SET,17,0.058954,0.001793,0.21594,0.39242,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,0.979007759672672
GSE36476_CTRL_VS_TSST_ACT_16...1,SET,181,0.016003,0.0015811,0.058662,0.3925,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN,0.979137058570198
KEGG_MEDICUS_REFERENCE_CRHR_...,SET,27,0.044305,0.0016977,0.16252,0.39258,KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.97914072036018
WP_ARACHIDONATE_EPOXYGENASE_...,SET,7,0.078274,0.001528,0.2872,0.3926,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,0.97914072036018
HP_NEOPLASM_OF_THE_GALLBLADD...,SET,6,0.097821,0.001768,0.35895,0.39261,HP_NEOPLASM_OF_THE_GALLBLADDER,0.97914072036018
WOOD_EBV_EBNA1_TARGETS_DN,SET,43,0.036007,0.0017405,0.13214,0.39262,WOOD_EBV_EBNA1_TARGETS_DN,0.97914072036018
REACTOME_RESPIRATORY_SYNCYTI...3,SET,16,0.051882,0.0015309,0.19053,0.3927,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION,0.97914072036018
GOCC_MICROVESICLE,SET,8,0.085299,0.0017801,0.31326,0.3927,GOCC_MICROVESICLE,0.97914072036018
DEBOSSCHER_NFKB_TARGETS_REPR...,SET,21,0.052772,0.0017837,0.19382,0.39271,DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS,0.97914072036018
GSE17721_POLYIC_VS_GARDIQUIM...12,SET,177,0.016809,0.0016424,0.061753,0.39273,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP,0.97914072036018
HP_ADENOCARCINOMA_OF_THE_INT...,SET,38,0.03412,0.0015506,0.12538,0.39276,HP_ADENOCARCINOMA_OF_THE_INTESTINES,0.97914072036018
REACTOME_RHO_GTPASES_ACTIVAT...3,SET,29,0.044756,0.0017773,0.16457,0.39283,REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS,0.97914072036018
GSE34515_CD16_NEG_MONOCYTE_V...1,SET,176,0.016388,0.0015967,0.060263,0.39284,GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN,0.97914072036018
HP_PROMINENCE_OF_THE_PREMAXI...,SET,7,0.079077,0.0015437,0.29125,0.393,HP_PROMINENCE_OF_THE_PREMAXILLA,0.97914072036018
GOBP_REGULATION_OF_NERVOUS_S...2,SET,107,0.023255,0.00177,0.08568,0.39304,GOBP_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,0.97914072036018
REACTOME_ADIPOGENESIS,SET,104,0.022023,0.0016527,0.081146,0.39305,REACTOME_ADIPOGENESIS,0.97914072036018
HP_CESSATION_OF_HEAD_GROWTH,SET,6,0.095561,0.0017272,0.35212,0.39305,HP_CESSATION_OF_HEAD_GROWTH,0.97914072036018
GSE17301_ACD3_ACD28_VS_ACD3_...4,SET,175,0.016916,0.0016436,0.06233,0.39305,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP,0.97914072036018
TRAVAGLINI_LUNG_BRONCHIAL_VE...2,SET,243,0.015246,0.0017423,0.05619,0.39307,TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_2_CELL,0.97914072036018
MILICIC_FAMILIAL_ADENOMATOUS...1,SET,9,0.083173,0.001841,0.30667,0.39311,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN,0.97914072036018
NFE2L3_TARGET_GENES,SET,10,0.06876,0.0016043,0.25351,0.39311,NFE2L3_TARGET_GENES,0.97914072036018
MIR580_3P,SET,190,0.01668,0.001688,0.061518,0.39314,MIR580_3P,0.97914072036018
HP_MULTIPLE_GASTRIC_POLYPS,SET,7,0.080075,0.0015632,0.29545,0.39319,HP_MULTIPLE_GASTRIC_POLYPS,0.97914072036018
GOBP_HEART_DEVELOPMENT,SET,557,0.010187,0.0017472,0.037598,0.39322,GOBP_HEART_DEVELOPMENT,0.97914072036018
GOBP_CATECHOL_CONTAINING_COM...2,SET,5,0.11841,0.0019538,0.43709,0.39323,GOBP_CATECHOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.97914072036018
ZFP37_TARGET_GENES,SET,4,0.13819,0.0020394,0.51062,0.39334,ZFP37_TARGET_GENES,0.97914072036018
GHO_ATF5_TARGETS_DN,SET,16,0.058554,0.0017277,0.2164,0.39336,GHO_ATF5_TARGETS_DN,0.97914072036018
GSE14308_TH1_VS_TH17_DN,SET,176,0.01632,0.0015901,0.060368,0.39345,GSE14308_TH1_VS_TH17_DN,0.97914072036018
GSE45365_HEALTHY_VS_MCMV_INF...5,SET,160,0.018083,0.0016807,0.066888,0.39345,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP,0.97914072036018
GSE25087_FETAL_VS_ADULT_TREG...1,SET,157,0.018349,0.0016895,0.067885,0.39347,GSE25087_FETAL_VS_ADULT_TREG_DN,0.97914072036018
ER_Q6_02,SET,234,0.015158,0.0017002,0.0561,0.39351,ER_Q6_02,0.97914072036018
PTEN_DN.V1_UP,SET,162,0.018664,0.0017454,0.069125,0.39358,PTEN_DN.V1_UP,0.97914072036018
GOBP_GLYCOSIDE_CATABOLIC_PRO...,SET,7,0.080288,0.0015674,0.2974,0.3936,GOBP_GLYCOSIDE_CATABOLIC_PROCESS,0.97914072036018
GOBP_RESPONSE_TO_TYPE_III_IN...,SET,11,0.078146,0.0019122,0.28966,0.39366,GOBP_RESPONSE_TO_TYPE_III_INTERFERON,0.97914072036018
TRAYNOR_RETT_SYNDROM_DN,SET,14,0.062997,0.0017389,0.23353,0.39367,TRAYNOR_RETT_SYNDROM_DN,0.97914072036018
UNTERMAN_IPF_VS_CTRL_CD8T_DN,SET,2,0.18888,0.0019712,0.70026,0.39369,UNTERMAN_IPF_VS_CTRL_CD8T_DN,0.97914072036018
KEGG_COLORECTAL_CANCER,SET,61,0.029173,0.0016787,0.10817,0.3937,KEGG_COLORECTAL_CANCER,0.97914072036018
TRAVAGLINI_LUNG_MYELOID_DEND...,SET,17,0.055646,0.0016924,0.20645,0.39376,TRAVAGLINI_LUNG_MYELOID_DENDRITIC_TYPE_1_CELL,0.97914072036018
WP_GLUCURONIDATION,SET,24,0.065544,0.0023681,0.24321,0.39377,WP_GLUCURONIDATION,0.97914072036018
GOBP_DEHYDROASCORBIC_ACID_TR...,SET,7,0.081358,0.0015883,0.30193,0.39379,GOBP_DEHYDROASCORBIC_ACID_TRANSPORT,0.97914072036018
HP_ABNORMAL_EPIDIDYMIS_MORPH...,SET,10,0.071429,0.0016665,0.26507,0.39379,HP_ABNORMAL_EPIDIDYMIS_MORPHOLOGY,0.97914072036018
GOBP_REGULATION_OF_CD8_POSIT...2,SET,8,0.081197,0.0016945,0.30137,0.3938,GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.97914072036018
GOBP_REGULATION_OF_APOPTOTIC...2,SET,9,0.076782,0.0016995,0.28513,0.39385,GOBP_REGULATION_OF_APOPTOTIC_DNA_FRAGMENTATION,0.97914072036018
GOBP_MEMBRANE_DEPOLARIZATION...3,SET,21,0.055869,0.0018884,0.20748,0.39386,GOBP_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.97914072036018
TONKS_TARGETS_OF_RUNX1_RUNX1...12,SET,9,0.082371,0.0018232,0.30593,0.39387,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN,0.97914072036018
GSE40274_CTRL_VS_FOXP3_AND_S...2,SET,150,0.018069,0.0016265,0.067106,0.39387,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.97914072036018
GSE25123_CTRL_VS_ROSIGLITAZO...3,SET,178,0.016758,0.001642,0.062246,0.39388,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,0.97914072036018
FOROUTAN_INTEGRATED_TGFB_EMT...2,SET,116,0.02215,0.001755,0.082285,0.3939,FOROUTAN_INTEGRATED_TGFB_EMT_UP,0.97914072036018
GSE19825_IL2RALOW_VS_IL2RAHI...1,SET,182,0.016561,0.0016406,0.061538,0.39392,GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,0.97914072036018
GSE27786_CD4_TCELL_VS_NKTCEL...2,SET,180,0.01604,0.0015803,0.05961,0.39394,GSE27786_CD4_TCELL_VS_NKTCELL_UP,0.97914072036018
GCM_TINF2,SET,38,0.032862,0.0014934,0.12222,0.39401,GCM_TINF2,0.97914072036018
TATA_01,SET,222,0.015834,0.0017305,0.05891,0.39405,TATA_01,0.97914072036018
HP_ABNORMALITY_OF_THE_THYROI...,SET,461,0.010768,0.0016847,0.040064,0.39405,HP_ABNORMALITY_OF_THE_THYROID_GLAND,0.97914072036018
GOBP_NEURON_PROJECTION_REGEN...,SET,55,0.0321,0.0017542,0.11947,0.39409,GOBP_NEURON_PROJECTION_REGENERATION,0.97914072036018
GOMF_TELOMERIC_DNA_BINDING,SET,37,0.035524,0.0015931,0.13221,0.39409,GOMF_TELOMERIC_DNA_BINDING,0.97914072036018
chr12q21,SET,59,0.054363,0.0030767,0.2024,0.39412,chr12q21,0.97914072036018
GSE39556_CD8A_DC_VS_NK_CELL_...4,SET,182,0.017016,0.0016857,0.06335,0.39412,GSE39556_CD8A_DC_VS_NK_CELL_UP,0.97914072036018
MIR342_5P,SET,57,0.029475,0.0016397,0.10974,0.39413,MIR342_5P,0.97914072036018
GOBP_PROTEIN_K29_LINKED_DEUB...,SET,4,0.10801,0.001594,0.40229,0.39417,GOBP_PROTEIN_K29_LINKED_DEUBIQUITINATION,0.97914072036018
HP_NEONATAL_BREATHING_DYSREG...,SET,5,0.078002,0.001287,0.29055,0.39417,HP_NEONATAL_BREATHING_DYSREGULATION,0.97914072036018
GSE360_L_DONOVANI_VS_L_MAJOR...3,SET,176,0.016808,0.0016377,0.062604,0.39417,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN,0.97914072036018
PID_NETRIN_PATHWAY,SET,32,0.040145,0.0016745,0.14959,0.39421,PID_NETRIN_PATHWAY,0.97914072036018
GOBP_TOXIN_METABOLIC_PROCESS,SET,15,0.058133,0.0016609,0.21663,0.39422,GOBP_TOXIN_METABOLIC_PROCESS,0.97914072036018
KEGG_MEDICUS_REFERENCE_TYPE_...1,SET,18,0.068359,0.0021393,0.25495,0.3943,KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,0.979208530399371
GSE19888_CTRL_VS_TCELL_MEMBR...1,SET,184,0.016923,0.0016856,0.063132,0.39433,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN,0.979208530399371
MORF_BUB3,SET,242,0.013293,0.001516,0.049598,0.39435,MORF_BUB3,0.979208530399371
WP_MACROPHAGE_MARKERS,SET,8,0.083839,0.0017496,0.31286,0.39436,WP_MACROPHAGE_MARKERS,0.979208530399371
GOBP_GLYCOSIDE_METABOLIC_PRO...,SET,19,0.056807,0.0018264,0.21223,0.39448,GOBP_GLYCOSIDE_METABOLIC_PROCESS,0.979333373596703
HP_NEURAL_TUBE_DEFECT,SET,271,0.013625,0.001643,0.050915,0.39451,HP_NEURAL_TUBE_DEFECT,0.979333373596703
HP_ABSENT_FOREARM_BONE,SET,24,0.046025,0.0016629,0.17201,0.39452,HP_ABSENT_FOREARM_BONE,0.979333373596703
HO_LIVER_CANCER_VASCULAR_INV...,SET,12,0.071218,0.0018201,0.26645,0.39463,HO_LIVER_CANCER_VASCULAR_INVASION,0.979333373596703
GOBP_COGNITION,SET,290,0.013691,0.0017069,0.051228,0.39464,GOBP_COGNITION,0.979333373596703
GOBP_L_PROLINE_BIOSYNTHETIC_...,SET,5,0.10215,0.0016854,0.38234,0.39467,GOBP_L_PROLINE_BIOSYNTHETIC_PROCESS,0.979333373596703
GOBP_MEIOTIC_ATTACHMENT_OF_T...,SET,2,0.11582,0.0012087,0.43371,0.39472,GOBP_MEIOTIC_ATTACHMENT_OF_TELOMERE_TO_NUCLEAR_ENVELOPE,0.979333373596703
GOBP_REGULATION_OF_DENDRITIC...1,SET,11,0.0689,0.0016859,0.25811,0.39476,GOBP_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,0.979333373596703
GOBP_NEGATIVE_REGULATION_OF_...589,SET,27,0.043812,0.0016788,0.16418,0.39479,GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.979333373596703
HP_EOSINOPHILIA,SET,52,0.031794,0.0016896,0.11914,0.39479,HP_EOSINOPHILIA,0.979333373596703
GSE19198_6H_VS_24H_IL21_TREA...2,SET,178,0.01729,0.0016941,0.064835,0.39486,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_UP,0.979333373596703
CAGNYGKNAAA_UNKNOWN,SET,70,0.027279,0.0016811,0.10232,0.39489,CAGNYGKNAAA_UNKNOWN,0.979333373596703
GSE12392_CD8A_POS_VS_NEG_SPL...4,SET,188,0.015768,0.0015873,0.059172,0.39494,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_UP,0.979333373596703
DESCARTES_FETAL_INTESTINE_EN...1,SET,46,0.036332,0.0018162,0.13634,0.39494,DESCARTES_FETAL_INTESTINE_ENS_GLIA,0.979333373596703
BLANCO_MELO_COVID19_SARS_COV...2,SET,68,0.028759,0.0017469,0.10796,0.39497,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,0.979333373596703
GOBP_DNA_DAMAGE_RESPONSE_SIG...3,SET,15,0.056993,0.0016283,0.21397,0.39498,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_RESULTING_IN_TRANSCRIPTION,0.979333373596703
GOMF_NEUROTRANSMITTER_RECEPT...3,SET,12,0.07078,0.0018089,0.26572,0.39498,GOMF_NEUROTRANSMITTER_RECEPTOR_REGULATOR_ACTIVITY,0.979333373596703
STOSSI_RESPONSE_TO_ESTRADIOL,SET,37,0.040213,0.0018033,0.151,0.395,STOSSI_RESPONSE_TO_ESTRADIOL,0.979333373596703
HE_LIM_SUN_FETAL_LUNG_C6_DEU...,SET,190,0.015452,0.0015637,0.058077,0.39509,HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL,0.979333373596703
GSE39110_UNTREATED_VS_IL2_TR...2,SET,182,0.016887,0.0016729,0.063473,0.3951,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP,0.979333373596703
GOBP_TOLL_SIGNALING_PATHWAY,SET,11,0.068446,0.0016748,0.25732,0.39512,GOBP_TOLL_SIGNALING_PATHWAY,0.979333373596703
REACTOME_MYOCLONIC_EPILEPSY_...,SET,8,0.078079,0.0016294,0.2936,0.39515,REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA,0.979333373596703
GOMF_RNA_2_O_METHYLTRANSFERA...,SET,6,0.079067,0.0014291,0.29753,0.39522,GOMF_RNA_2_O_METHYLTRANSFERASE_ACTIVITY,0.979333373596703
GOBP_REGULATION_OF_LYMPHOID_...,SET,12,0.063159,0.0016141,0.23774,0.39525,GOBP_REGULATION_OF_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION,0.979333373596703
GOBP_INTERCELLULAR_TRANSPORT,SET,10,0.076979,0.001796,0.28989,0.3953,GOBP_INTERCELLULAR_TRANSPORT,0.979333373596703
HP_CONGENITAL_SENSORINEURAL_...,SET,54,0.031628,0.0017127,0.11913,0.39532,HP_CONGENITAL_SENSORINEURAL_HEARING_IMPAIRMENT,0.979333373596703
MODULE_349,SET,17,0.058303,0.0017732,0.2197,0.39536,MODULE_349,0.979333373596703
HP_ERYTHROCYTE_INCLUSION_BOD...,SET,6,0.082381,0.001489,0.31042,0.39536,HP_ERYTHROCYTE_INCLUSION_BODIES,0.979333373596703
HP_ABNORMAL_HEART_SOUND,SET,39,0.037632,0.0017325,0.14189,0.39542,HP_ABNORMAL_HEART_SOUND,0.979333373596703
MIR5585_5P,SET,115,0.020868,0.0016463,0.078688,0.39543,MIR5585_5P,0.979333373596703
MODULE_471,SET,9,0.078871,0.0017458,0.2975,0.39546,MODULE_471,0.979333373596703
MIR6846_3P,SET,23,0.044404,0.0015706,0.16757,0.39551,MIR6846_3P,0.979333373596703
GOBP_MONOATOMIC_ION_TRANSPORT,SET,1104,0.0072077,0.0017134,0.027204,0.39552,GOBP_MONOATOMIC_ION_TRANSPORT,0.979333373596703
GSE18893_CTRL_VS_TNF_TREATED...8,SET,178,0.016951,0.0016609,0.063975,0.39552,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP,0.979333373596703
GOBP_TAURINE_METABOLIC_PROCE...,SET,9,0.084128,0.0018621,0.31758,0.39554,GOBP_TAURINE_METABOLIC_PROCESS,0.979333373596703
GSE17974_IL4_AND_ANTI_IL12_V...3,SET,168,0.017917,0.001706,0.067676,0.3956,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN,0.979333373596703
ZHONG_PFC_C2_THY1_POS_OPC,SET,22,0.051412,0.0017786,0.19427,0.39564,ZHONG_PFC_C2_THY1_POS_OPC,0.979333373596703
CUI_DEVELOPING_HEART_5TH_WEE...2,SET,64,0.029443,0.0017353,0.11126,0.39565,CUI_DEVELOPING_HEART_5TH_WEEK_VENTRICULAR_CARDIOMYOCYTE,0.979333373596703
HP_DEVIATION_OF_THE_2ND_FING...,SET,19,0.051228,0.0016471,0.19364,0.39568,HP_DEVIATION_OF_THE_2ND_FINGER,0.979333373596703
GOBP_MEMBRANE_DEPOLARIZATION...4,SET,5,0.10586,0.0017466,0.40027,0.39571,GOBP_MEMBRANE_DEPOLARIZATION_DURING_SA_NODE_CELL_ACTION_POTENTIAL,0.979333373596703
GSE11864_UNTREATED_VS_CSF1_I...2,SET,163,0.017259,0.0016189,0.065289,0.39576,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP,0.979333373596703
GOBP_SPHINGOMYELIN_BIOSYNTHE...,SET,11,0.063472,0.0015531,0.24017,0.39579,GOBP_SPHINGOMYELIN_BIOSYNTHETIC_PROCESS,0.979333373596703
MANNO_MIDBRAIN_NEUROTYPES_HP...2,SET,263,0.013954,0.0016581,0.05283,0.39584,MANNO_MIDBRAIN_NEUROTYPES_HPROGBP,0.979333373596703
GOCC_NUCLEAR_PERIPHERY,SET,139,0.018463,0.0016004,0.069915,0.39586,GOCC_NUCLEAR_PERIPHERY,0.979333373596703
WP_ACETAMINOPHEN_IN_ANALGESI...,SET,9,0.081938,0.0018136,0.31039,0.3959,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,0.979333373596703
GOCC_EXON_EXON_JUNCTION_COMP...,SET,16,0.05361,0.0015818,0.20313,0.39592,GOCC_EXON_EXON_JUNCTION_COMPLEX,0.979333373596703
GOBP_POSITIVE_REGULATION_OF_...658,SET,5,0.1114,0.0018381,0.42222,0.39595,GOBP_POSITIVE_REGULATION_OF_PYROPTOSIS,0.979333373596703
GOBP_POSITIVE_REGULATION_OF_...805,SET,32,0.04002,0.0016693,0.15169,0.39595,GOBP_POSITIVE_REGULATION_OF_T_CELL_MIGRATION,0.979333373596703
GSE27786_NKTCELL_VS_ERYTHROB...1,SET,186,0.01665,0.0016673,0.063111,0.39596,GSE27786_NKTCELL_VS_ERYTHROBLAST_DN,0.979333373596703
WP_CONTROL_OF_IMMUNE_TOLERAN...,SET,13,0.065286,0.0017366,0.24769,0.39605,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.979333373596703
GSE9037_CTRL_VS_LPS_1H_STIM_...4,SET,185,0.015706,0.0015685,0.059593,0.39606,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP,0.979333373596703
BIOCARTA_PEPI_PATHWAY,SET,8,0.082482,0.0017213,0.31297,0.39607,BIOCARTA_PEPI_PATHWAY,0.979333373596703
WP_PEROXIREDOXIN_2_INDUCED_O...,SET,8,0.079547,0.0016601,0.30184,0.39607,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,0.979333373596703
REACTOME_COPI_INDEPENDENT_GO...,SET,50,0.03224,0.0016801,0.12235,0.39608,REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,0.979333373596703
GCM_BMPR2,SET,78,0.024086,0.0015666,0.091405,0.39608,GCM_BMPR2,0.979333373596703
HP_SPONTANEOUS_PNEUMOTHORAX,SET,14,0.06553,0.0018088,0.24869,0.39609,HP_SPONTANEOUS_PNEUMOTHORAX,0.979333373596703
GNF2_CARD15,SET,62,0.029047,0.0016851,0.11028,0.39613,GNF2_CARD15,0.979333373596703
GOBP_HIGH_DENSITY_LIPOPROTEI...1,SET,11,0.057821,0.0014148,0.21954,0.39613,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY,0.979333373596703
HE_LIM_SUN_FETAL_LUNG_C0_LAT...2,SET,631,0.0092337,0.0016821,0.03506,0.39614,HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL,0.979333373596703
REACTOME_GLUTAMATE_AND_GLUTA...,SET,10,0.066951,0.001562,0.2544,0.39621,REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM,0.979333373596703
SATO_SILENCED_EPIGENETICALLY...,SET,39,0.035052,0.0016137,0.13321,0.39622,SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,0.979333373596703
MMS_MOUSE_LYMPH_HIGH_4HRS_UP,SET,28,0.041565,0.0016219,0.15798,0.39624,MMS_MOUSE_LYMPH_HIGH_4HRS_UP,0.979333373596703
GOBP_REGULATION_OF_MITOTIC_C...2,SET,311,0.012326,0.0015905,0.04685,0.39624,GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,0.979333373596703
HP_HYPERCHLOREMIC_ACIDOSIS,SET,13,0.059759,0.0015895,0.22728,0.3963,HP_HYPERCHLOREMIC_ACIDOSIS,0.979333373596703
HP_ABNORMAL_RENAL_ECHOGENICI...,SET,31,0.041356,0.0016979,0.15732,0.39632,HP_ABNORMAL_RENAL_ECHOGENICITY,0.979333373596703
E12_Q6,SET,245,0.014138,0.0016222,0.053799,0.39636,E12_Q6,0.979333373596703
HP_PES_CAVUS,SET,252,0.013943,0.0016222,0.053058,0.39636,HP_PES_CAVUS,0.979333373596703
GOBP_SKELETAL_MUSCLE_CELL_PR...,SET,23,0.043838,0.0015506,0.16684,0.39637,GOBP_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.979333373596703
GSE46606_DAY1_VS_DAY3_CD40L_...2,SET,155,0.018846,0.0017242,0.071749,0.39641,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP,0.979333373596703
BIOCARTA_NFAT_PATHWAY,SET,50,0.033028,0.0017212,0.12586,0.3965,BIOCARTA_NFAT_PATHWAY,0.979333373596703
GOMF_NUCLEOSOME_BINDING,SET,52,0.028358,0.001507,0.10807,0.3965,GOMF_NUCLEOSOME_BINDING,0.979333373596703
GSE17721_POLYIC_VS_CPG_0.5H_...2,SET,184,0.016092,0.0016028,0.061325,0.39651,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP,0.979333373596703
GSE27291_0H_VS_7D_STIM_GAMMA...1,SET,159,0.017275,0.0016006,0.065841,0.39652,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN,0.979333373596703
GOCC_PHOSPHORYLASE_KINASE_CO...,SET,3,0.10417,0.0013314,0.39707,0.39653,GOCC_PHOSPHORYLASE_KINASE_COMPLEX,0.979333373596703
HP_ABNORMALITY_OF_THE_UPPER_...2,SET,1520,0.0058819,0.0016208,0.022424,0.39654,HP_ABNORMALITY_OF_THE_UPPER_LIMB,0.979333373596703
MIR6806_5P,SET,63,0.027595,0.0016136,0.10522,0.39656,MIR6806_5P,0.979333373596703
WP_INTRAFLAGELLAR_TRANSPORT_...,SET,22,0.046455,0.0016071,0.17716,0.39658,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,0.979333373596703
GOBP_POSITIVE_REGULATION_OF_...235,SET,9,0.065564,0.0014512,0.25011,0.39661,GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.979337872113677
LUI_THYROID_CANCER_CLUSTER_3,SET,26,0.041381,0.0015561,0.1581,0.39677,LUI_THYROID_CANCER_CLUSTER_3,0.979528551166584
GSE43955_TH0_VS_TGFB_IL6_TH1...14,SET,183,0.016414,0.0016305,0.062737,0.3968,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP,0.979528551166584
HP_ABNORMAL_MORPHOLOGY_OF_UL...,SET,140,0.01915,0.0016658,0.073223,0.39685,HP_ABNORMAL_MORPHOLOGY_OF_ULNA,0.979528551166584
KEGG_MEDICUS_REFERENCE_COPII...,SET,12,0.05849,0.0014948,0.22392,0.39697,KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION,0.979528551166584
HP_ABNORMAL_PSYCHOTIC_PATTERN,SET,171,0.017408,0.0016722,0.066654,0.39698,HP_ABNORMAL_PSYCHOTIC_PATTERN,0.979528551166584
chr14q32,SET,129,0.038835,0.0032437,0.14875,0.39702,chr14q32,0.979528551166584
chr5q34,SET,12,0.093585,0.0023917,0.35853,0.39704,chr5q34,0.979528551166584
GSE1740_UNSTIM_VS_IFNA_STIMU...3,SET,166,0.016793,0.0015895,0.06434,0.39705,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN,0.979528551166584
HP_ABNORMAL_BLOOD_CHLORIDE_C...,SET,10,0.077296,0.0018034,0.29618,0.39706,HP_ABNORMAL_BLOOD_CHLORIDE_CONCENTRATION,0.979528551166584
MARTIN_NFKB_TARGETS_DN,SET,10,0.066159,0.0015436,0.25358,0.39708,MARTIN_NFKB_TARGETS_DN,0.979528551166584
GOBP_RESPIRATORY_BURST_INVOL...2,SET,9,0.074242,0.0016433,0.28454,0.39708,GOBP_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.979528551166584
GSE21033_3H_VS_12H_POLYIC_ST...2,SET,149,0.017292,0.0015514,0.066282,0.39709,GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP,0.979528551166584
NFAT_Q4_01,SET,243,0.014762,0.001687,0.056598,0.39712,NFAT_Q4_01,0.979528551166584
GOMF_PHOSPHATIDIC_ACID_BINDI...,SET,23,0.048589,0.0017186,0.18641,0.39718,GOMF_PHOSPHATIDIC_ACID_BINDING,0.979528551166584
KEGG_MEDICUS_REFERENCE_TLR7_...2,SET,15,0.068799,0.0019656,0.26397,0.39719,KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY,0.979528551166584
HP_NEOPLASM_OF_THE_TONGUE,SET,42,0.03176,0.0015173,0.12187,0.3972,HP_NEOPLASM_OF_THE_TONGUE,0.979528551166584
GSE25088_WT_VS_STAT6_KO_MACR...8,SET,165,0.01682,0.0015873,0.064571,0.39724,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP,0.979528551166584
GSE19888_ADENOSINE_A3R_ACT_V...5,SET,160,0.016406,0.0015248,0.062998,0.39727,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN,0.979528551166584
NAKAYA_PBMC_FLUMIST_AGE_18_5...1,SET,614,0.0087446,0.0015721,0.033582,0.39728,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN,0.979528551166584
HP_TYPE_1_MUSCLE_FIBER_PREDO...,SET,60,0.027122,0.0015479,0.10418,0.3973,HP_TYPE_1_MUSCLE_FIBER_PREDOMINANCE,0.979528551166584
HP_ABNORMAL_NASAL_BRIDGE_MOR...,SET,882,0.0074372,0.0015904,0.028582,0.39735,HP_ABNORMAL_NASAL_BRIDGE_MORPHOLOGY,0.979528551166584
CARDOSO_RESPONSE_TO_GAMMA_RA...,SET,11,0.062393,0.0015267,0.23979,0.39736,CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB,0.979528551166584
DI_MARTINO_MATRISOME_HIGHLY_...1,SET,26,0.044012,0.001655,0.16917,0.39737,DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC,0.979528551166584
GOBP_PROTEIN_CONTAINING_COMP...1,SET,1372,0.005923,0.0015574,0.022778,0.39742,GOBP_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.979528551166584
HP_BLEPHAROCHALASIS,SET,6,0.095643,0.0017287,0.3678,0.39742,HP_BLEPHAROCHALASIS,0.979528551166584
HP_CONICAL_INCISOR,SET,34,0.040286,0.001732,0.15492,0.39742,HP_CONICAL_INCISOR,0.979528551166584
REACTOME_DAP12_SIGNALING,SET,27,0.039801,0.0015251,0.1531,0.39745,REACTOME_DAP12_SIGNALING,0.97953302723018
WP_PHASE_I_BIOTRANSFORMATION...,SET,8,0.093225,0.0019455,0.35888,0.39752,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,0.979615903289847
VISALA_RESPONSE_TO_HEAT_SHOC...1,SET,12,0.063219,0.0016157,0.2434,0.39754,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN,0.979615903289847
MIR203B_3P,SET,88,0.023951,0.0016541,0.092313,0.39765,MIR203B_3P,0.97974803275202
TRAVAGLINI_LUNG_CD4_MEMORY_E...,SET,63,0.029697,0.0017366,0.11447,0.39765,TRAVAGLINI_LUNG_CD4_MEMORY_EFFECTOR_T_CELL,0.97974803275202
GOBP_GERMINAL_CENTER_FORMATI...,SET,13,0.061333,0.0016314,0.23665,0.39775,GOBP_GERMINAL_CENTER_FORMATION,0.979924948607075
HP_HYPERGLUTAMINEMIA,SET,8,0.067059,0.0013995,0.25917,0.39792,HP_HYPERGLUTAMINEMIA,0.980244948648082
MIR4491,SET,67,0.026119,0.0015749,0.10106,0.39803,MIR4491,0.980244948648082
GOBP_NEGATIVE_REGULATION_OF_...313,SET,7,0.088415,0.001726,0.34225,0.39808,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,0.980244948648082
GOBP_REGULATION_OF_UNSATURAT...,SET,10,0.064106,0.0014957,0.24819,0.39809,GOBP_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.980244948648082
GAUTAM_EYE_IRIS_CILIARY_BODY...16,SET,228,0.013976,0.0015477,0.054108,0.39809,GAUTAM_EYE_IRIS_CILIARY_BODY_SMOOTH_MUSCLE_CELLS,0.980244948648082
BIOCARTA_IL12_PATHWAY,SET,18,0.052242,0.0016349,0.20231,0.39812,BIOCARTA_IL12_PATHWAY,0.980244948648082
MARSON_FOXP3_TARGETS_DN,SET,48,0.034316,0.0017523,0.13293,0.39814,MARSON_FOXP3_TARGETS_DN,0.980244948648082
HP_HYPOHIDROSIS_OR_HYPERHIDR...,SET,210,0.015166,0.0016126,0.058792,0.39822,HP_HYPOHIDROSIS_OR_HYPERHIDROSIS,0.980244948648082
GOBP_NEGATIVE_REGULATION_OF_...391,SET,5,0.10679,0.0017621,0.41413,0.39825,GOBP_NEGATIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.980244948648082
HP_REDUCED_ANTIGEN_SPECIFIC_...,SET,8,0.072,0.0015026,0.27941,0.39833,HP_REDUCED_ANTIGEN_SPECIFIC_T_CELL_PROLIFERATION,0.980244948648082
GSE21546_UNSTIM_VS_ANTI_CD3_...1,SET,169,0.01563,0.0014926,0.060715,0.39842,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.980244948648082
OHASHI_AURKA_TARGETS,SET,5,0.094998,0.0015675,0.36929,0.3985,OHASHI_AURKA_TARGETS,0.980244948648082
GSE22601_DOUBLE_NEGATIVE_VS_...3,SET,165,0.017011,0.0016053,0.066182,0.39858,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.980244948648082
GSE17974_1.5H_VS_72H_IL4_AND...2,SET,172,0.016782,0.0016166,0.065303,0.3986,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,0.980244948648082
KEGG_MEDICUS_REFERENCE_REGUL...11,SET,6,0.078977,0.0014274,0.30735,0.39861,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1,0.980244948648082
REACTOME_IRON_UPTAKE_AND_TRA...,SET,53,0.031449,0.0016872,0.12246,0.39867,REACTOME_IRON_UPTAKE_AND_TRANSPORT,0.980244948648082
PEREZ_TP53_AND_TP63_TARGETS,SET,178,0.017273,0.0016924,0.067298,0.39872,PEREZ_TP53_AND_TP63_TARGETS,0.980244948648082
GAVISH_3CA_METAPROGRAM_FIBRO...16,SET,46,0.034604,0.0017298,0.13481,0.39872,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_METAL_RESPONSE,0.980244948648082
GOBP_REGULATION_OF_ACTION_PO...,SET,52,0.032113,0.0017065,0.12517,0.39876,GOBP_REGULATION_OF_ACTION_POTENTIAL,0.980244948648082
GSE16385_IFNG_TNF_VS_ROSIGLI...2,SET,160,0.016994,0.0015795,0.066281,0.39882,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.980244948648082
GOBP_NEGATIVE_REGULATION_OF_...329,SET,12,0.056244,0.0014374,0.21949,0.39888,GOBP_NEGATIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,0.980244948648082
GOBP_EPITHELIAL_CELL_DIFFERE...1,SET,681,0.0091671,0.0017324,0.035786,0.39891,GOBP_EPITHELIAL_CELL_DIFFERENTIATION,0.980244948648082
NAKAYAMA_SOFT_TISSUE_TUMORS_...3,SET,71,0.028119,0.0017452,0.10982,0.39896,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,0.980244948648082
HEBERT_MATRISOME_TNBC_BRAIN_...2,SET,9,0.078881,0.001746,0.30812,0.39897,HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED,0.980244948648082
GSE17721_LPS_VS_GARDIQUIMOD_...3,SET,180,0.015273,0.0015048,0.059689,0.39903,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_DN,0.980244948648082
KEGG_MEDICUS_PATHOGEN_EBV_EB...7,SET,10,0.067164,0.001567,0.26253,0.39904,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P53_MEDIATED_TRANSCRIPTION,0.980244948648082
GSE7348_UNSTIM_VS_TOLERIZED_...2,SET,147,0.016652,0.001484,0.06509,0.39904,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,0.980244948648082
CCAWYNNGAAR_UNKNOWN,SET,123,0.019967,0.0016288,0.078068,0.39907,CCAWYNNGAAR_UNKNOWN,0.980244948648082
GOBP_POSITIVE_REGULATION_OF_...181,SET,14,0.054581,0.0015066,0.21341,0.39907,GOBP_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.980244948648082
GSE22886_NAIVE_TCELL_VS_MONO...2,SET,177,0.015904,0.0015539,0.06219,0.39908,GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP,0.980244948648082
GOBP_MONOATOMIC_ANION_HOMEOS...,SET,20,0.04712,0.0015543,0.18429,0.3991,GOBP_MONOATOMIC_ANION_HOMEOSTASIS,0.980244948648082
HP_ABNORMALITY_OF_THE_LYMPHA...,SET,692,0.0082576,0.0015726,0.032301,0.39911,HP_ABNORMALITY_OF_THE_LYMPHATIC_SYSTEM,0.980244948648082
CHICAS_RB1_TARGETS_GROWING,SET,221,0.014809,0.0016149,0.057959,0.39917,CHICAS_RB1_TARGETS_GROWING,0.980244948648082
GOBP_REGULATION_OF_CELLULAR_...13,SET,70,0.025199,0.0015529,0.098646,0.39919,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.980244948648082
GSE10325_LUPUS_BCELL_VS_LUPU...1,SET,188,0.016542,0.0016652,0.064776,0.39922,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN,0.980244948648082
GSE12484_HEALTHY_VS_PERIDONT...1,SET,138,0.018178,0.00157,0.071218,0.39927,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN,0.980244948648082
GRAHAM_CML_QUIESCENT_VS_NORM...2,SET,49,0.034031,0.0017557,0.13334,0.39928,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,0.980244948648082
HP_TESTICULAR_ATROPHY,SET,9,0.064537,0.0014285,0.25289,0.39929,HP_TESTICULAR_ATROPHY,0.980244948648082
GOBP_BIOLOGICAL_PROCESS_INVO...5,SET,286,0.012958,0.0016046,0.050801,0.39933,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION,0.980244948648082
HE_LIM_SUN_FETAL_LUNG_C1_EAR...1,SET,32,0.044414,0.0018526,0.17415,0.39935,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_AIRWAY_PROGENITOR_CELL,0.980244948648082
GSE40274_CTRL_VS_FOXP3_AND_I...1,SET,147,0.016845,0.0015012,0.066068,0.39938,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.980244948648082
GSE45365_HEALTHY_VS_MCMV_INF...6,SET,154,0.016543,0.0015087,0.064887,0.39938,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP,0.980244948648082
REACTOME_UCH_PROTEINASES,SET,80,0.023128,0.0015233,0.090743,0.39941,REACTOME_UCH_PROTEINASES,0.980244948648082
MIR6866_3P,SET,66,0.026863,0.0016077,0.10547,0.39948,MIR6866_3P,0.980244948648082
WP_GLUCOSE_METABOLISM_IN_TRI...,SET,8,0.075319,0.0015718,0.29592,0.39955,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.980244948648082
GSE7509_UNSTIM_VS_FCGRIIB_ST...1,SET,159,0.01739,0.0016113,0.068345,0.39958,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN,0.980244948648082
GOMF_PALMITOYLTRANSFERASE_AC...,SET,35,0.035418,0.0015449,0.13925,0.39961,GOMF_PALMITOYLTRANSFERASE_ACTIVITY,0.980244948648082
GSE25146_UNSTIM_VS_HELIOBACT...1,SET,148,0.016951,0.0015157,0.066648,0.39962,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN,0.980244948648082
GOBP_REGULATION_OF_CELL_SUBS...1,SET,202,0.015459,0.0016125,0.06081,0.39966,GOBP_REGULATION_OF_CELL_SUBSTRATE_ADHESION,0.980244948648082
REACTOME_SIGNALING_BY_TGFBR3,SET,44,0.033683,0.0016469,0.13252,0.39969,REACTOME_SIGNALING_BY_TGFBR3,0.980244948648082
GSE40493_BCL6_KO_VS_WT_TREG_...2,SET,167,0.015922,0.0015116,0.062655,0.3997,GSE40493_BCL6_KO_VS_WT_TREG_UP,0.980244948648082
GSE41867_DAY6_VS_DAY15_LCMV_...2,SET,161,0.018301,0.0017062,0.072079,0.39979,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.980244948648082
WP_NETWORK_MAP_OF_SARSCOV2_S...,SET,203,0.015609,0.0016322,0.061509,0.39984,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,0.980244948648082
KEGG_MEDICUS_VARIANT_MUTATIO...88,SET,11,0.062783,0.0015362,0.24744,0.39986,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY,0.980244948648082
GOBP_POSITIVE_REGULATION_OF_...770,SET,17,0.049854,0.0015163,0.19662,0.39992,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.980244948648082
HP_GRAVES_DISEASE,SET,3,0.13315,0.0017019,0.52518,0.39993,HP_GRAVES_DISEASE,0.980244948648082
KEGG_TERPENOID_BACKBONE_BIOS...,SET,15,0.048254,0.0013787,0.19035,0.39994,KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS,0.980244948648082
GOCC_PLATELET_DENSE_TUBULAR_...2,SET,8,0.068919,0.0014383,0.27192,0.39996,GOCC_PLATELET_DENSE_TUBULAR_NETWORK_MEMBRANE,0.980244948648082
HP_FINGER_SYNDACTYLY,SET,177,0.016014,0.0015647,0.063202,0.39999,HP_FINGER_SYNDACTYLY,0.980244948648082
MATZUK_CENTRAL_FOR_FEMALE_FE...,SET,29,0.040172,0.0015953,0.15856,0.4,MATZUK_CENTRAL_FOR_FEMALE_FERTILITY,0.980244948648082
GOBP_PEPTIDE_METABOLIC_PROCE...,SET,72,0.025957,0.0016222,0.10249,0.40003,GOBP_PEPTIDE_METABOLIC_PROCESS,0.980244948648082
GOMF_ENZYME_SUBSTRATE_ADAPTO...,SET,65,0.02679,0.0015911,0.10581,0.40007,GOMF_ENZYME_SUBSTRATE_ADAPTOR_ACTIVITY,0.980244948648082
GOBP_REGULATION_OF_TELOMERE_...2,SET,94,0.020606,0.0014706,0.081464,0.40016,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE,0.980244948648082
GSE20727_CTRL_VS_ROS_INHIBIT...1,SET,180,0.015566,0.0015336,0.061546,0.40017,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_DN,0.980244948648082
WP_THYROID_STIMULATING_HORMO...,SET,66,0.028279,0.0016924,0.11182,0.40018,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,0.980244948648082
FAC1_01,SET,189,0.016515,0.0016669,0.065314,0.40019,FAC1_01,0.980244948648082
GOBP_REGULATION_OF_SOMITOGEN...,SET,6,0.094173,0.0017021,0.37256,0.40022,GOBP_REGULATION_OF_SOMITOGENESIS,0.980244948648082
HP_ANONYCHIA,SET,60,0.028237,0.0016115,0.11172,0.40023,HP_ANONYCHIA,0.980244948648082
HP_DECREASED_SERUM_LEPTIN,SET,11,0.068616,0.001679,0.27151,0.40024,HP_DECREASED_SERUM_LEPTIN,0.980244948648082
GSE29618_PRE_VS_DAY7_POST_LA...6,SET,182,0.015541,0.0015395,0.061494,0.40025,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP,0.980244948648082
GOBP_REGULATION_OF_LAMELLIPO...2,SET,11,0.061029,0.0014933,0.24164,0.40031,GOBP_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS,0.980244948648082
GSE17721_CTRL_VS_LPS_6H_BMDC...2,SET,178,0.01554,0.0015226,0.061529,0.40031,GSE17721_CTRL_VS_LPS_6H_BMDC_UP,0.980244948648082
GOBP_POSITIVE_REGULATION_OF_...648,SET,114,0.020352,0.0015987,0.080604,0.40033,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.980244948648082
HP_MEGAKARYOCYTE_DYSPLASIA,SET,4,0.10983,0.0016209,0.43502,0.40034,HP_MEGAKARYOCYTE_DYSPLASIA,0.980244948648082
MIR5000_3P,SET,89,0.023346,0.0016215,0.092492,0.40036,MIR5000_3P,0.980244948648082
REACTOME_SUMOYLATION_OF_DNA_...2,SET,15,0.054407,0.0015544,0.21557,0.40037,REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS,0.980244948648082
GSE19888_ADENOSINE_A3R_INH_P...3,SET,173,0.01498,0.0014472,0.059377,0.40041,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,0.980244948648082
GOMF_TRNA_GUANINE_METHYLTRAN...,SET,11,0.056292,0.0013774,0.22325,0.40047,GOMF_TRNA_GUANINE_METHYLTRANSFERASE_ACTIVITY,0.980244948648082
HP_COMPLEX_FEBRILE_SEIZURE,SET,15,0.053138,0.0015182,0.21077,0.40048,HP_COMPLEX_FEBRILE_SEIZURE,0.980244948648082
HP_IVORY_EPIPHYSES,SET,9,0.071152,0.0015749,0.28247,0.40056,HP_IVORY_EPIPHYSES,0.980244948648082
GSE18791_CTRL_VS_NEWCASTLE_V...17,SET,175,0.016795,0.0016318,0.066679,0.40057,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN,0.980244948648082
YORDY_RECIPROCAL_REGULATION_...2,SET,20,0.046966,0.0015492,0.18649,0.40059,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,0.980244948648082
REACTOME_SOMITOGENESIS,SET,52,0.026831,0.0014259,0.10659,0.40063,REACTOME_SOMITOGENESIS,0.980244948648082
GOBP_MICROGLIAL_CELL_PROLIFE...,SET,7,0.090771,0.001772,0.36063,0.40064,GOBP_MICROGLIAL_CELL_PROLIFERATION,0.980244948648082
AUNG_GASTRIC_CANCER,SET,47,0.029328,0.001482,0.11653,0.40065,AUNG_GASTRIC_CANCER,0.980244948648082
MIR6859_3P,SET,33,0.038865,0.0016462,0.15444,0.40066,MIR6859_3P,0.980244948648082
WP_MATRIX_METALLOPROTEINASES,SET,28,0.044206,0.001725,0.17576,0.40071,WP_MATRIX_METALLOPROTEINASES,0.980244948648082
GSE15930_STIM_VS_STIM_AND_TR...5,SET,181,0.016071,0.0015878,0.06396,0.4008,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN,0.980244948648082
HE_LIM_SUN_FETAL_LUNG_C2_CYC...,SET,1242,0.0058936,0.0014801,0.023453,0.4008,HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL,0.980244948648082
KEGG_MEDICUS_PATHOGEN_HIV_GP...3,SET,26,0.043122,0.0016216,0.17169,0.40084,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,0.980244948648082
HP_PLETHORA,SET,12,0.065182,0.0016658,0.25961,0.40088,HP_PLETHORA,0.980244948648082
LIU_OVARIAN_CANCER_TUMORS_AN...2,SET,1379,0.0065139,0.0017168,0.025959,0.40094,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_DN,0.980244948648082
GOBP_POSITIVE_REGULATION_OF_...775,SET,339,0.011623,0.0015646,0.04633,0.40096,GOBP_POSITIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,0.980244948648082
HP_HYPERGALACTOSEMIA,SET,6,0.085593,0.001547,0.3412,0.40096,HP_HYPERGALACTOSEMIA,0.980244948648082
DESCARTES_FETAL_MUSCLE_LYMPH...1,SET,56,0.031055,0.0017124,0.12379,0.40096,DESCARTES_FETAL_MUSCLE_LYMPHATIC_ENDOTHELIAL_CELLS,0.980244948648082
KEGG_MEDICUS_REFERENCE_TNFSF...,SET,5,0.10772,0.0017773,0.42949,0.40099,KEGG_MEDICUS_REFERENCE_TNFSF10_RIPK1_3_SIGNALING_PATHWAY,0.980244948648082
WP_REGULATION_OF_ACTIN_CYTOS...,SET,140,0.018499,0.0016091,0.073779,0.40101,WP_REGULATION_OF_ACTIN_CYTOSKELETON,0.980244948648082
NEWMAN_ERCC6_TARGETS_UP,SET,23,0.053377,0.001888,0.21297,0.40105,NEWMAN_ERCC6_TARGETS_UP,0.980244948648082
GOBP_MEGAKARYOCYTE_DIFFERENT...,SET,47,0.032671,0.0016509,0.13041,0.40109,GOBP_MEGAKARYOCYTE_DIFFERENTIATION,0.980244948648082
ZHENG_FOXP3_TARGETS_IN_T_LYM...1,SET,34,0.03773,0.0016221,0.15064,0.40111,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,0.980244948648082
QI_PLASMACYTOMA_UP,SET,245,0.014193,0.0016285,0.056681,0.40114,QI_PLASMACYTOMA_UP,0.980244948648082
GOBP_GLYCOSYL_COMPOUND_CATAB...,SET,31,0.042804,0.0017573,0.171,0.40117,GOBP_GLYCOSYL_COMPOUND_CATABOLIC_PROCESS,0.980244948648082
GOBP_C21_STEROID_HORMONE_BIO...,SET,19,0.052285,0.0016811,0.20889,0.40118,GOBP_C21_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.980244948648082
GOBP_LIPOPROTEIN_BIOSYNTHETI...,SET,90,0.021612,0.0015094,0.08635,0.40119,GOBP_LIPOPROTEIN_BIOSYNTHETIC_PROCESS,0.980244948648082
MODULE_262,SET,19,0.059405,0.00191,0.23738,0.4012,MODULE_262,0.980244948648082
SCHERER_PBMC_APSV_WETVAX_AGE...2,SET,57,0.028695,0.0015963,0.11479,0.40131,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_UP,0.980244948648082
GOMF_TESTOSTERONE_DEHYDROGEN...1,SET,7,0.071901,0.0014036,0.28798,0.40142,GOMF_TESTOSTERONE_DEHYDROGENASE_NADPLUS_ACTIVITY,0.980244948648082
GSE43863_DAY6_EFF_VS_DAY150_...5,SET,183,0.016429,0.0016319,0.065799,0.40142,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN,0.980244948648082
GSE17974_CTRL_VS_ACT_IL4_AND...6,SET,173,0.015874,0.0015336,0.063588,0.40143,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP,0.980244948648082
chr13q31,SET,9,0.09744,0.0021568,0.39085,0.40157,chr13q31,0.980244948648082
HP_ABNORMALITY_OF_DENTAL_ERU...,SET,209,0.01467,0.0015562,0.058864,0.4016,HP_ABNORMALITY_OF_DENTAL_ERUPTION,0.980244948648082
FOSTER_KDM1A_TARGETS_DN,SET,185,0.014647,0.0014629,0.058803,0.40165,FOSTER_KDM1A_TARGETS_DN,0.980244948648082
GOBP_POSITIVE_REGULATION_OF_...392,SET,15,0.0652,0.0018628,0.26178,0.40166,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,0.980244948648082
GSE41867_DAY6_VS_DAY15_LCMV_...3,SET,142,0.017796,0.001559,0.071466,0.40168,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.980244948648082
REACTOME_CELL_DEATH_SIGNALLI...,SET,67,0.026948,0.0016249,0.10823,0.40169,REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,0.980244948648082
GSE4748_CTRL_VS_LPS_STIM_DC_...1,SET,182,0.015814,0.0015667,0.063522,0.4017,GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN,0.980244948648082
GOMF_ATP_DEPENDENT_PEPTIDASE...,SET,7,0.065379,0.0012763,0.26266,0.40171,GOMF_ATP_DEPENDENT_PEPTIDASE_ACTIVITY,0.980244948648082
GOBP_SYNAPTIC_VESICLE_COATING,SET,5,0.088108,0.0014538,0.35402,0.40173,GOBP_SYNAPTIC_VESICLE_COATING,0.980244948648082
GSE4984_GALECTIN1_VS_VEHICLE...1,SET,176,0.014893,0.0014511,0.059854,0.40175,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN,0.980244948648082
GSE4811_CLASSSICALY_ACTIVATE...2,SET,174,0.015189,0.0014716,0.06107,0.40179,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_UP,0.980244948648082
GOBP_CELLULAR_RESPONSE_TO_GA...,SET,23,0.042156,0.0014911,0.1695,0.4018,GOBP_CELLULAR_RESPONSE_TO_GAMMA_RADIATION,0.980244948648082
GROSS_HYPOXIA_VIA_ELK3_ONLY_...2,SET,30,0.041006,0.0016562,0.16498,0.40185,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,0.980244948648082
HP_VENTRICULAR_SEPTAL_HYPERT...,SET,12,0.055972,0.0014304,0.2252,0.40186,HP_VENTRICULAR_SEPTAL_HYPERTROPHY,0.980244948648082
GOCC_RECEPTOR_COMPLEX,SET,382,0.011483,0.001639,0.046215,0.40189,GOCC_RECEPTOR_COMPLEX,0.980244948648082
HP_NEVUS,SET,153,0.016783,0.0015256,0.067545,0.40189,HP_NEVUS,0.980244948648082
BOYAULT_LIVER_CANCER_SUBCLAS...15,SET,19,0.049807,0.0016014,0.20052,0.40192,BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN,0.980244948648082
REACTOME_RETROGRADE_NEUROTRO...,SET,14,0.053885,0.0014874,0.21697,0.40193,REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING,0.980244948648082
HP_ABNORMAL_CIRCULATING_PHEN...,SET,9,0.074979,0.0016596,0.3019,0.40193,HP_ABNORMAL_CIRCULATING_PHENYLALANINE_CONCENTRATION,0.980244948648082
GOBP_BRANCHING_INVOLVED_IN_B...,SET,31,0.040697,0.0016708,0.16392,0.40196,GOBP_BRANCHING_INVOLVED_IN_BLOOD_VESSEL_MORPHOGENESIS,0.980244948648082
REACTOME_RECYCLING_PATHWAY_O...,SET,40,0.034209,0.0015949,0.13782,0.40199,REACTOME_RECYCLING_PATHWAY_OF_L1,0.980244948648082
RORA2_01,SET,134,0.018507,0.0015752,0.074561,0.40199,RORA2_01,0.980244948648082
GOBP_NLS_BEARING_PROTEIN_IMP...,SET,18,0.047141,0.0014753,0.18998,0.40201,GOBP_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS,0.980244948648082
GSE16450_IMMATURE_VS_MATURE_...1,SET,180,0.015216,0.0014992,0.061317,0.40201,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,0.980244948648082
GSE25123_IL4_VS_IL4_AND_ROSI...3,SET,170,0.016656,0.0015953,0.067142,0.40204,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,0.980244948648082
TRAVAGLINI_LUNG_PROXIMAL_CIL...,SET,1477,0.0054809,0.0014907,0.022096,0.40205,TRAVAGLINI_LUNG_PROXIMAL_CILIATED_CELL,0.980244948648082
CLAUS_PGR_POSITIVE_MENINGIOM...2,SET,8,0.06727,0.0014039,0.27131,0.40209,CLAUS_PGR_POSITIVE_MENINGIOMA_UP,0.980244948648082
HP_ABNORMALITY_OF_THE_HEPATI...,SET,84,0.022947,0.0015485,0.092561,0.4021,HP_ABNORMALITY_OF_THE_HEPATIC_VASCULATURE,0.980244948648082
HP_ADENOCARCINOMA_OF_THE_COL...,SET,30,0.035117,0.0014183,0.14166,0.40211,HP_ADENOCARCINOMA_OF_THE_COLON,0.980244948648082
REACTOME_G2_M_CHECKPOINTS,SET,125,0.017317,0.0014239,0.069881,0.40214,REACTOME_G2_M_CHECKPOINTS,0.980244948648082
REACTOME_ZINC_EFFLUX_AND_COM...,SET,5,0.094613,0.0015611,0.3818,0.40214,REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY,0.980244948648082
GOMF_TRANSITION_METAL_ION_TR...,SET,41,0.03081,0.0014543,0.12441,0.4022,GOMF_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.980244948648082
CHEMELLO_SOLEUS_VS_EDL_MYOFI...2,SET,16,0.051194,0.0015106,0.20686,0.40227,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP,0.980244948648082
WP_HEPATOCYTE_GROWTH_FACTOR_...,SET,33,0.037501,0.0015884,0.15154,0.40227,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,0.980244948648082
GOBP_SPERM_FLAGELLUM_ASSEMBLY,SET,42,0.030547,0.0014593,0.12347,0.4023,GOBP_SPERM_FLAGELLUM_ASSEMBLY,0.980244948648082
WP_TRANSCRIPTIONAL_CASCADE_R...,SET,12,0.070115,0.0017919,0.28348,0.40232,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,0.980244948648082
ZNF157_TARGET_GENES,SET,58,0.027466,0.0015413,0.11107,0.40234,ZNF157_TARGET_GENES,0.980244948648082
GSE42088_UNINF_VS_LEISHMANIA...6,SET,183,0.015516,0.0015413,0.062745,0.40234,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP,0.980244948648082
BIOCARTA_MRP_PATHWAY,SET,6,0.097742,0.0017666,0.39532,0.40236,BIOCARTA_MRP_PATHWAY,0.980244948648082
WP_ANGIOTENSIN_II_RECEPTOR_T...,SET,25,0.04286,0.0015804,0.17337,0.40237,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,0.980244948648082
MIR26A_1_3P,SET,66,0.025425,0.0015216,0.10289,0.40242,MIR26A_1_3P,0.980244948648082
HP_RIGHT_ATRIAL_ENLARGEMENT,SET,23,0.047151,0.0016678,0.19082,0.40242,HP_RIGHT_ATRIAL_ENLARGEMENT,0.980244948648082
MIR199A_3P_MIR199B_3P,SET,145,0.017128,0.0015161,0.069347,0.40246,MIR199A_3P_MIR199B_3P,0.980244948648082
HP_ABNORMAL_METACARPAL_EPIPH...,SET,16,0.053644,0.0015829,0.21721,0.40247,HP_ABNORMAL_METACARPAL_EPIPHYSIS_MORPHOLOGY,0.980244948648082
HOWLIN_PUBERTAL_MAMMARY_GLAND,SET,62,0.029498,0.0017112,0.11947,0.40249,HOWLIN_PUBERTAL_MAMMARY_GLAND,0.980244948648082
GOBP_REGULATION_OF_PENTOSE_P...,SET,6,0.085678,0.0015485,0.34716,0.40253,GOBP_REGULATION_OF_PENTOSE_PHOSPHATE_SHUNT,0.980244948648082
GOBP_REGULATION_OF_CARDIAC_M...6,SET,25,0.042943,0.0015835,0.17407,0.40257,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.980244948648082
HP_ABNORMAL_LYMPH_NODE_MORPH...,SET,227,0.01456,0.0016089,0.059054,0.40263,HP_ABNORMAL_LYMPH_NODE_MORPHOLOGY,0.980244948648082
WP_CHOLESTEROL_BIOSYNTHESIS_...1,SET,14,0.048765,0.001346,0.19782,0.40264,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,0.980244948648082
GSE17974_0H_VS_24H_IN_VITRO_...1,SET,178,0.014609,0.0014314,0.059268,0.40265,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN,0.980244948648082
GOBP_HYPOTHALAMUS_GONADOTROP...,SET,6,0.10037,0.0018141,0.40725,0.40266,GOBP_HYPOTHALAMUS_GONADOTROPHIN_RELEASING_HORMONE_NEURON_DIFFERENTIATION,0.980244948648082
MIR4504,SET,142,0.017743,0.0015543,0.072005,0.40268,MIR4504,0.980244948648082
MIKKELSEN_MEF_HCP_WITH_H3_UN...,SET,184,0.016041,0.0015977,0.065111,0.4027,MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,0.980244948648082
HP_JUVENILE_MYELOMONOCYTIC_L...,SET,18,0.045035,0.0014094,0.18283,0.40272,HP_JUVENILE_MYELOMONOCYTIC_LEUKEMIA,0.980244948648082
DESCARTES_FETAL_HEART_LYMPHO...,SET,86,0.024112,0.0016463,0.097934,0.40276,DESCARTES_FETAL_HEART_LYMPHOID_CELLS,0.980244948648082
SOBOLEV_PBMC_PANDEMRIX_AGE_1...2,SET,32,0.041217,0.0017192,0.16745,0.40278,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN,0.980244948648082
GOCC_BRAHMA_COMPLEX,SET,14,0.054468,0.0015035,0.22131,0.40279,GOCC_BRAHMA_COMPLEX,0.980244948648082
GOBP_ISOPRENOID_METABOLIC_PR...,SET,129,0.019178,0.0016018,0.077954,0.40284,GOBP_ISOPRENOID_METABOLIC_PROCESS,0.980244948648082
MIR5009_5P,SET,56,0.028573,0.0015756,0.11617,0.40286,MIR5009_5P,0.980244948648082
GSE360_T_GONDII_VS_M_TUBERCU...1,SET,184,0.01552,0.0015459,0.063116,0.40288,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN,0.980244948648082
GSE8835_HEALTHY_VS_CLL_CD8_T...1,SET,180,0.015486,0.0015258,0.063022,0.40295,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN,0.980244948648082
GSE25123_WT_VS_PPARG_KO_MACR...1,SET,177,0.015658,0.00153,0.063747,0.40299,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_DN,0.980244948648082
GSE18791_CTRL_VS_NEWCASTLE_V...12,SET,138,0.017741,0.0015322,0.072245,0.40301,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP,0.980244948648082
HP_JOINT_HEMORRHAGE,SET,14,0.053286,0.0014708,0.21701,0.40302,HP_JOINT_HEMORRHAGE,0.980244948648082
WP_MEVALONATE_PATHWAY,SET,7,0.062996,0.0012298,0.25659,0.40303,WP_MEVALONATE_PATHWAY,0.980244948648082
GOBP_NEGATIVE_REGULATION_OF_...334,SET,3,0.13437,0.0017174,0.54731,0.40303,GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.980244948648082
REACTOME_SIGNALING_BY_NODAL,SET,19,0.050148,0.0016124,0.2043,0.40305,REACTOME_SIGNALING_BY_NODAL,0.980244948648082
CTACTGT_MIR199A,SET,172,0.015494,0.0014926,0.063128,0.40306,CTACTGT_MIR199A,0.980244948648082
GSE44732_UNSTIM_VS_IL27_STIM...2,SET,175,0.015561,0.0015119,0.0634,0.40306,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP,0.980244948648082
GOMF_PORIN_ACTIVITY,SET,5,0.093932,0.0015499,0.38273,0.40307,GOMF_PORIN_ACTIVITY,0.980244948648082
GOBP_SOMATIC_STEM_CELL_DIVIS...,SET,11,0.068888,0.0016856,0.28084,0.40311,GOBP_SOMATIC_STEM_CELL_DIVISION,0.980244948648082
HP_GENERALIZED_MYOCLONIC_SEI...,SET,114,0.019413,0.0015249,0.079155,0.40313,HP_GENERALIZED_MYOCLONIC_SEIZURE,0.980244948648082
HP_APLASIA_HYPOPLASIA_OF_THE...31,SET,41,0.03108,0.001467,0.12673,0.40314,HP_APLASIA_HYPOPLASIA_OF_THE_EYELID,0.980244948648082
NIKOLSKY_BREAST_CANCER_22Q13...,SET,16,0.081716,0.0024112,0.3333,0.40316,NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON,0.980244948648082
TRAYNOR_RETT_SYNDROM_UP,SET,36,0.040657,0.0017985,0.16586,0.40318,TRAYNOR_RETT_SYNDROM_UP,0.980244948648082
GSE37301_CD4_TCELL_VS_RAG2_K...1,SET,165,0.015351,0.0014487,0.062622,0.40318,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN,0.980244948648082
GOBP_PROTEIN_INSERTION_INTO_...4,SET,4,0.079912,0.0011794,0.32606,0.4032,GOBP_PROTEIN_INSERTION_INTO_MEMBRANE_FROM_INNER_SIDE,0.980244948648082
GOMF_THIOREDOXIN_DEPENDENT_P...,SET,4,0.0919,0.0013563,0.3752,0.40325,GOMF_THIOREDOXIN_DEPENDENT_PEROXIREDOXIN_ACTIVITY,0.980244948648082
MIR326,SET,115,0.019852,0.0015662,0.081089,0.4033,MIR326,0.980244948648082
REACTOME_HISTIDINE_CATABOLISM,SET,7,0.082801,0.0016164,0.33826,0.40331,REACTOME_HISTIDINE_CATABOLISM,0.980244948648082
MIR4493,SET,88,0.021329,0.0014731,0.08714,0.40332,MIR4493,0.980244948648082
GOBP_ERROR_FREE_TRANSLESION_...,SET,5,0.062561,0.0010322,0.25562,0.40333,GOBP_ERROR_FREE_TRANSLESION_SYNTHESIS,0.980244948648082
GAVISH_3CA_MALIGNANT_METAPRO...35,SET,41,0.030114,0.0014214,0.12312,0.40338,GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN,0.980244948648082
HP_DEJA_VU_AURA,SET,7,0.07429,0.0014503,0.30369,0.40338,HP_DEJA_VU_AURA,0.980244948648082
GOMF_OXIDOREDUCTASE_ACTIVITY...7,SET,11,0.060227,0.0014737,0.24634,0.40343,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS,0.980244948648082
GSE24210_IL35_TREATED_VS_UNT...2,SET,173,0.015256,0.0014739,0.062399,0.40343,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP,0.980244948648082
HP_PECTORAL_MUSCLE_HYPOPLASI...,SET,7,0.078023,0.0015231,0.31936,0.4035,HP_PECTORAL_MUSCLE_HYPOPLASIA_APLASIA,0.980244948648082
GSE2706_UNSTIM_VS_2H_R848_DC...2,SET,172,0.01455,0.0014016,0.059583,0.40354,GSE2706_UNSTIM_VS_2H_R848_DC_UP,0.980244948648082
MIR106B_5P,SET,632,0.0083736,0.0015266,0.034298,0.40356,MIR106B_5P,0.980244948648082
KEGG_MEDICUS_REFERENCE_LPA_G...1,SET,12,0.058575,0.001497,0.23994,0.40357,KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,0.980244948648082
TRAVAGLINI_LUNG_PLATELET_MEG...,SET,513,0.0091349,0.0015054,0.037418,0.40357,TRAVAGLINI_LUNG_PLATELET_MEGAKARYOCYTE_CELL,0.980244948648082
WP_CHOLESTASIS,SET,19,0.052147,0.0016766,0.21364,0.40358,WP_CHOLESTASIS,0.980244948648082
MODULE_372,SET,20,0.044755,0.0014763,0.18346,0.40364,MODULE_372,0.980244948648082
GOMF_C_ACETYLTRANSFERASE_ACT...,SET,7,0.066671,0.0013015,0.27332,0.40364,GOMF_C_ACETYLTRANSFERASE_ACTIVITY,0.980244948648082
HP_ABNORMAL_ANATOMIC_LOCATIO...,SET,127,0.017033,0.0014117,0.069837,0.40366,HP_ABNORMAL_ANATOMIC_LOCATION_OF_THE_HEART,0.980244948648082
GARCIA_PINERES_PBMC_HPV_16_L...8,SET,237,0.014435,0.0016294,0.059199,0.40368,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP,0.980244948648082
GOBP_POSITIVE_REGULATION_OF_...146,SET,4,0.10918,0.0016114,0.44782,0.40369,GOBP_POSITIVE_REGULATION_OF_CENTRIOLE_ELONGATION,0.980244948648082
LEE_METASTASIS_AND_ALTERNATI...2,SET,65,0.025608,0.0015209,0.10508,0.40373,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,0.980273588794187
GSE21927_SPLENIC_C26GM_TUMOR...1,SET,162,0.015724,0.0014704,0.064566,0.4038,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_DN,0.980375061124694
MIR4796_3P,SET,224,0.013792,0.0015141,0.056687,0.40388,MIR4796_3P,0.980454032258064
REACTOME_CLASS_B_2_SECRETIN_...,SET,90,0.023554,0.001645,0.096824,0.4039,REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,0.980454032258064
HP_ELEVATED_URINARY_COLLAGEN...,SET,5,0.091603,0.0015114,0.37685,0.40398,HP_ELEVATED_URINARY_COLLAGEN_DEGRADATION_PRODUCTS,0.980454032258064
GSE17721_LPS_VS_CPG_6H_BMDC_...2,SET,175,0.015156,0.0014726,0.062357,0.40398,GSE17721_LPS_VS_CPG_6H_BMDC_UP,0.980454032258064
HP_ABNORMAL_EARLOBE_MORPHOLO...,SET,107,0.019973,0.0015203,0.082209,0.40402,HP_ABNORMAL_EARLOBE_MORPHOLOGY,0.980454032258064
GOCC_POSTSYNAPTIC_SPECIALIZA...2,SET,19,0.045416,0.0014602,0.18694,0.40403,GOCC_POSTSYNAPTIC_SPECIALIZATION_INTRACELLULAR_COMPONENT,0.980454032258064
GSE17721_CTRL_VS_GARDIQUIMOD...14,SET,185,0.014792,0.0014773,0.060887,0.40403,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_UP,0.980454032258064
GOBP_CITRATE_METABOLIC_PROCE...,SET,5,0.091055,0.0015024,0.37492,0.40406,GOBP_CITRATE_METABOLIC_PROCESS,0.980458374642184
BENITEZ_GBM_PROTEASOME_INHIB...,SET,45,0.031155,0.0015405,0.12834,0.4041,BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE,0.980486979893884
GOBP_REGULATION_OF_RESPONSE_...5,SET,983,0.0068516,0.0015423,0.028237,0.40414,GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,0.980515581151832
GOBP_BEHAVIORAL_RESPONSE_TO_...1,SET,16,0.052412,0.0015465,0.21609,0.40418,GOBP_BEHAVIORAL_RESPONSE_TO_COCAINE,0.980544178416864
FIGUEROA_AML_METHYLATION_CLU...1,SET,41,0.032515,0.0015347,0.1341,0.40421,FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,0.980548513296573
GOMF_XENOBIOTIC_TRANSMEMBRAN...,SET,32,0.039262,0.0016377,0.162,0.40425,GOMF_XENOBIOTIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.980577104271357
HP_OSTEOLYTIC_DEFECTS_OF_THE...,SET,5,0.08794,0.001451,0.36301,0.40429,HP_OSTEOLYTIC_DEFECTS_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,0.980598758110654
REACTOME_CREB_PHOSPHORYLATION,SET,6,0.097304,0.0017587,0.4018,0.40433,REACTOME_CREB_PHOSPHORYLATION,0.980598758110654
GOBP_POSITIVE_REGULATION_OF_...423,SET,4,0.090435,0.0013347,0.37356,0.40436,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_ANERGY,0.980598758110654
MIR4801,SET,242,0.0137,0.0015624,0.056606,0.40438,MIR4801,0.980598758110654
HP_ABDOMINAL_AORTIC_ANEURYSM,SET,22,0.047226,0.0016338,0.19518,0.4044,HP_ABDOMINAL_AORTIC_ANEURYSM,0.980598758110654
DITTMER_PTHLH_TARGETS_UP,SET,104,0.020083,0.0015072,0.083088,0.40451,DITTMER_PTHLH_TARGETS_UP,0.980797059439096
MIR4474_3P,SET,79,0.023714,0.0015521,0.098167,0.40456,MIR4474_3P,0.980805688476562
HP_LIMITATION_OF_JOINT_MOBIL...,SET,370,0.010839,0.001523,0.044871,0.40457,HP_LIMITATION_OF_JOINT_MOBILITY,0.980805688476562
GOBP_NEGATIVE_REGULATION_OF_...588,SET,24,0.042091,0.0015208,0.17444,0.40467,GOBP_NEGATIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,0.980873023839398
GSE360_DC_VS_MAC_B_MALAYI_LO...2,SET,177,0.014702,0.0014366,0.060947,0.40469,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP,0.980873023839398
REACTOME_TP53_REGULATES_TRAN...1,SET,20,0.044312,0.0014617,0.18375,0.40472,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN,0.980873023839398
GOMF_STEROID_HYDROXYLASE_ACT...,SET,26,0.04444,0.0016711,0.18434,0.40475,GOMF_STEROID_HYDROXYLASE_ACTIVITY,0.980873023839398
REACTOME_CIRCADIAN_CLOCK,SET,64,0.02603,0.0015341,0.108,0.40477,REACTOME_CIRCADIAN_CLOCK,0.980873023839398
GOBP_REGULATION_OF_NEURON_PR...3,SET,30,0.03958,0.0015986,0.16428,0.40481,GOBP_REGULATION_OF_NEURON_PROJECTION_REGENERATION,0.980873023839398
HAY_BONE_MARROW_CD34_POS_LMPP,SET,6,0.093794,0.0016952,0.38943,0.40484,HAY_BONE_MARROW_CD34_POS_LMPP,0.980873023839398
GOBP_REGULATION_OF_COAGULATI...,SET,72,0.02471,0.0015443,0.10265,0.40488,GOBP_REGULATION_OF_COAGULATION,0.980873023839398
GOCC_PAR_POLARITY_COMPLEX,SET,6,0.0896,0.0016194,0.3722,0.40488,GOCC_PAR_POLARITY_COMPLEX,0.980873023839398
GSE17721_CTRL_VS_PAM3CSK4_24...2,SET,185,0.01504,0.0015021,0.062476,0.40488,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_UP,0.980873023839398
GOBP_POSITIVE_REGULATION_OF_...647,SET,140,0.01765,0.0015353,0.073344,0.40492,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SECRETION,0.98088163507109
HP_CELIAC_DISEASE,SET,52,0.028448,0.0015118,0.11824,0.40494,HP_CELIAC_DISEASE,0.98088163507109
GOBP_OSTEOCLAST_FUSION,SET,6,0.086706,0.0015671,0.36062,0.405,GOBP_OSTEOCLAST_FUSION,0.980958603386996
MIR6775_5P,SET,4,0.11249,0.0016601,0.46804,0.40504,MIR6775_5P,0.98098712195122
HP_NEONATAL_ASPHYXIA,SET,12,0.059443,0.0015191,0.24749,0.40509,HP_NEONATAL_ASPHYXIA,0.98103985436555
GOBP_POSITIVE_REGULATION_OF_...462,SET,33,0.033442,0.0014165,0.13946,0.40525,GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.981108196040426
MARCHINI_TRABECTEDIN_RESISTA...1,SET,42,0.031722,0.0015154,0.13233,0.40527,MARCHINI_TRABECTEDIN_RESISTANCE_DN,0.981108196040426
GSE7852_LN_VS_THYMUS_TREG_UP,SET,182,0.015043,0.0014903,0.06275,0.40527,GSE7852_LN_VS_THYMUS_TREG_UP,0.981108196040426
GOBP_OXALATE_TRANSPORT,SET,11,0.060541,0.0014814,0.25255,0.40528,GOBP_OXALATE_TRANSPORT,0.981108196040426
GOMF_G_PROTEIN_COUPLED_AMINE...,SET,38,0.036482,0.001658,0.15225,0.40531,GOMF_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY,0.981108196040426
HP_ATLANTOAXIAL_INSTABILITY,SET,5,0.088166,0.0014547,0.3686,0.40548,HP_ATLANTOAXIAL_INSTABILITY,0.981108196040426
GOBP_REGULATION_OF_PHOSPHOLI...7,SET,27,0.036727,0.0014073,0.15358,0.4055,GOBP_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.981108196040426
GSE27092_WT_VS_HDAC7_PHOSPHO...2,SET,185,0.014928,0.0014909,0.062439,0.40552,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP,0.981108196040426
GOCC_EXOCYTIC_VESICLE,SET,217,0.014026,0.0015157,0.058669,0.40553,GOCC_EXOCYTIC_VESICLE,0.981108196040426
HP_HYPOPLASTIC_SACRUM,SET,6,0.078905,0.0014261,0.33009,0.40554,HP_HYPOPLASTIC_SACRUM,0.981108196040426
REACTOME_NEF_AND_SIGNAL_TRAN...,SET,8,0.072379,0.0015105,0.30283,0.40555,REACTOME_NEF_AND_SIGNAL_TRANSDUCTION,0.981108196040426
HP_ABNORMAL_3RD_FINGER_MORPH...,SET,24,0.043827,0.0015835,0.1834,0.40556,HP_ABNORMAL_3RD_FINGER_MORPHOLOGY,0.981108196040426
ESC_J1_UP_EARLY.V1_DN,SET,153,0.016382,0.0014892,0.068549,0.40556,ESC_J1_UP_EARLY.V1_DN,0.981108196040426
REACTOME_FCERI_MEDIATED_MAPK...,SET,32,0.03465,0.0014453,0.14503,0.40559,REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION,0.981108196040426
TGTATGA_MIR4853P,SET,146,0.016886,0.0014998,0.07068,0.40559,TGTATGA_MIR4853P,0.981108196040426
KEGG_MEDICUS_REFERENCE_CONDE...,SET,19,0.043438,0.0013966,0.18192,0.40564,KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING,0.981108196040426
MIR32_5P,SET,433,0.0098656,0.0014971,0.041328,0.40566,MIR32_5P,0.981108196040426
GOBP_METANEPHRIC_RENAL_VESIC...,SET,14,0.063468,0.0017519,0.26592,0.40568,GOBP_METANEPHRIC_RENAL_VESICLE_MORPHOGENESIS,0.981108196040426
HP_PROLONGED_NEONATAL_JAUNDI...,SET,63,0.024586,0.0014377,0.10303,0.4057,HP_PROLONGED_NEONATAL_JAUNDICE,0.981108196040426
WP_CANCER_IMMUNOTHERAPY_BY_P...,SET,22,0.045176,0.0015628,0.1894,0.40574,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,0.981108196040426
MIR5089_3P,SET,62,0.025104,0.0014563,0.10539,0.40587,MIR5089_3P,0.981108196040426
GSE26030_TH1_VS_TH17_RESTIMU...4,SET,185,0.014309,0.0014291,0.060078,0.40587,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_UP,0.981108196040426
CARRILLOREIXACH_HEPATOBLASTO...1,SET,971,0.00693,0.001551,0.029119,0.40595,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN,0.981108196040426
NKX25_02,SET,232,0.013888,0.0015512,0.05836,0.40595,NKX25_02,0.981108196040426
GOBP_TELOMERASE_HOLOENZYME_C...,SET,6,0.066459,0.0012012,0.27939,0.40599,GOBP_TELOMERASE_HOLOENZYME_COMPLEX_ASSEMBLY,0.981108196040426
GSE32255_UNSTIM_VS_4H_LPS_ST...2,SET,172,0.015666,0.0015091,0.065874,0.40601,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP,0.981108196040426
GAJATE_RESPONSE_TO_TRABECTED...1,SET,16,0.055158,0.0016275,0.2322,0.40612,GAJATE_RESPONSE_TO_TRABECTEDIN_DN,0.981108196040426
GOMF_PHOSPHATIDYLCHOLINE_STE...,SET,4,0.11409,0.0016838,0.48077,0.40621,GOMF_PHOSPHATIDYLCHOLINE_STEROL_O_ACYLTRANSFERASE_ACTIVATOR_ACTIVITY,0.981108196040426
HP_RECURRENT_GASTROENTERITIS,SET,12,0.055285,0.0014129,0.23306,0.40625,HP_RECURRENT_GASTROENTERITIS,0.981108196040426
MIR618,SET,59,0.025064,0.0014185,0.10571,0.40629,MIR618,0.981108196040426
GOMF_OXIDOREDUCTASE_ACTIVITY...12,SET,4,0.11522,0.0017005,0.48609,0.40631,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS_OXYGEN_AS_ACCEPTOR,0.981108196040426
KEGG_MEDICUS_REFERENCE_TSH_T...,SET,29,0.036667,0.0014561,0.15473,0.40634,KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY,0.981108196040426
HP_ESOPHAGEAL_VARIX,SET,39,0.034856,0.0016047,0.14713,0.40637,HP_ESOPHAGEAL_VARIX,0.981108196040426
GOBP_MICROGLIAL_CELL_MEDIATE...,SET,5,0.08682,0.0014325,0.36654,0.40638,GOBP_MICROGLIAL_CELL_MEDIATED_CYTOTOXICITY,0.981108196040426
GOBP_NEGATIVE_REGULATION_OF_...312,SET,6,0.10174,0.0018389,0.42955,0.40638,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,0.981108196040426
GOBP_POSITIVE_REGULATION_OF_...42,SET,12,0.064778,0.0016555,0.27354,0.4064,GOBP_POSITIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,0.981108196040426
HP_BACK_PAIN,SET,68,0.023929,0.0014535,0.10106,0.40642,HP_BACK_PAIN,0.981108196040426
BIOCARTA_PELP1_PATHWAY,SET,6,0.077793,0.001406,0.32875,0.40647,BIOCARTA_PELP1_PATHWAY,0.981108196040426
MODULE_101,SET,10,0.070584,0.0016468,0.29845,0.40652,MODULE_101,0.981108196040426
HP_ABNORMAL_PELVIC_GIRDLE_BO...,SET,548,0.0086366,0.0014696,0.036519,0.40652,HP_ABNORMAL_PELVIC_GIRDLE_BONE_MORPHOLOGY,0.981108196040426
HNF3_Q6,SET,165,0.01604,0.0015137,0.067855,0.40657,HNF3_Q6,0.981108196040426
chr17q21,SET,271,0.026827,0.0032351,0.11352,0.40659,chr17q21,0.981108196040426
GSE20152_SPHK1_KO_VS_HTNFA_O...1,SET,177,0.014165,0.001384,0.059941,0.4066,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN,0.981108196040426
GRAHAM_CML_DIVIDING_VS_NORMA...3,SET,77,0.024379,0.0015754,0.10326,0.40668,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,0.981108196040426
REACTOME_REGULATION_OF_TBK1_...2,SET,10,0.071926,0.0016781,0.30478,0.40672,REACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION,0.981108196040426
MIR4663,SET,61,0.025849,0.0014875,0.10954,0.40673,MIR4663,0.981108196040426
GOMF_5_3_DNA_HELICASE_ACTIVI...,SET,8,0.066032,0.001378,0.28003,0.40679,GOMF_5_3_DNA_HELICASE_ACTIVITY,0.981108196040426
GSE5503_PLN_DC_VS_SPLEEN_DC_...2,SET,186,0.014192,0.0014212,0.060196,0.40681,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.981108196040426
GOBP_PROTEIN_IMPORT_INTO_PER...1,SET,13,0.052494,0.0013963,0.22274,0.40684,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX,0.981108196040426
HP_INCREASED_CIRCULATING_LAC...1,SET,180,0.013489,0.001329,0.057232,0.40684,HP_INCREASED_CIRCULATING_LACTATE_CONCENTRATION,0.981108196040426
GSE36826_WT_VS_IL1R_KO_SKIN_...2,SET,176,0.015677,0.0015275,0.066542,0.40687,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN,0.981108196040426
HP_OSTEOCHONDRITIS_DISSECANS,SET,7,0.080347,0.0015685,0.34105,0.40688,HP_OSTEOCHONDRITIS_DISSECANS,0.981108196040426
GOBP_INTRINSIC_APOPTOTIC_SIG...8,SET,10,0.061309,0.0014304,0.26029,0.4069,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,0.981108196040426
HP_PURE_RED_CELL_APLASIA,SET,25,0.037617,0.0013871,0.15972,0.4069,HP_PURE_RED_CELL_APLASIA,0.981108196040426
GOBP_POSITIVE_REGULATION_OF_...239,SET,6,0.083732,0.0015134,0.35561,0.40693,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT,0.981108196040426
HP_MUSCLE_FIBER_SPLITTING,SET,19,0.043269,0.0013912,0.18381,0.40695,HP_MUSCLE_FIBER_SPLITTING,0.981108196040426
MIR4438,SET,61,0.025587,0.0014724,0.10871,0.40696,MIR4438,0.981108196040426
HP_ABNORMAL_CIRCULATING_PROG...,SET,6,0.077173,0.0013948,0.32799,0.40699,HP_ABNORMAL_CIRCULATING_PROGESTERONE_LEVEL,0.981108196040426
MIR92A_3P,SET,434,0.009693,0.0014725,0.041197,0.407,MIR92A_3P,0.981108196040426
HP_LACTOSE_INTOLERANCE,SET,5,0.09332,0.0015398,0.39684,0.40704,HP_LACTOSE_INTOLERANCE,0.981108196040426
KEGG_MEDICUS_ENV_FACTOR_E2_T...2,SET,15,0.051891,0.0014826,0.22076,0.40709,KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY,0.981108196040426
GOBP_CARNITINE_TRANSMEMBRANE...,SET,6,0.10481,0.0018943,0.44603,0.40711,GOBP_CARNITINE_TRANSMEMBRANE_TRANSPORT,0.981108196040426
GSE8685_IL15_ACT_IL2_STARVED...2,SET,149,0.016733,0.0015013,0.071231,0.40714,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.981108196040426
AAACCAC_MIR140,SET,98,0.019923,0.0014517,0.084881,0.40721,AAACCAC_MIR140,0.981108196040426
WIEMANN_TELOMERE_SHORTENING_...1,SET,5,0.073096,0.0012061,0.3115,0.40724,WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN,0.981108196040426
MIR4698,SET,572,0.0085654,0.0014881,0.036513,0.40727,MIR4698,0.981108196040426
MIR4742_3P,SET,201,0.014078,0.0014648,0.06002,0.40728,MIR4742_3P,0.981108196040426
GSE37534_UNTREATED_VS_ROSIGL...2,SET,177,0.014595,0.0014261,0.062234,0.40729,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.981108196040426
MORF_DDX11,SET,145,0.015445,0.0013671,0.065861,0.4073,MORF_DDX11,0.981108196040426
MORF_CTBP1,SET,155,0.014248,0.0013036,0.060777,0.40733,MORF_CTBP1,0.981108196040426
GOBP_NEGATIVE_REGULATION_OF_...200,SET,13,0.055419,0.0014741,0.23642,0.40733,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.981108196040426
YAUCH_HEDGEHOG_SIGNALING_PAR...2,SET,132,0.01811,0.00153,0.07731,0.4074,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,0.981108196040426
GSE34006_A2AR_KO_VS_A2AR_AGO...2,SET,190,0.014872,0.001505,0.06349,0.4074,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP,0.981108196040426
HP_LACRIMAL_DUCT_STENOSIS,SET,13,0.054407,0.0014472,0.23242,0.40746,HP_LACRIMAL_DUCT_STENOSIS,0.981108196040426
HP_REDUCED_PROGRESSIVE_SPERM...,SET,15,0.046012,0.0013146,0.19655,0.40746,HP_REDUCED_PROGRESSIVE_SPERM_MOTILITY,0.981108196040426
GSE7852_TREG_VS_TCONV_DN,SET,178,0.01509,0.0014785,0.064471,0.40747,GSE7852_TREG_VS_TCONV_DN,0.981108196040426
GOBP_REGULATION_OF_PROTEOLYS...1,SET,527,0.0088292,0.0014742,0.037725,0.40748,GOBP_REGULATION_OF_PROTEOLYSIS,0.981108196040426
GSE10500_ARTHRITIC_SYNOVIAL_...1,SET,125,0.017845,0.0014674,0.076284,0.40752,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN,0.981108196040426
BIOCARTA_ARENRF2_PATHWAY,SET,20,0.051868,0.0017109,0.22176,0.40754,BIOCARTA_ARENRF2_PATHWAY,0.981108196040426
GCM_NPM1,SET,104,0.018191,0.0013652,0.077791,0.40755,GCM_NPM1,0.981108196040426
HP_ABNORMALITY_OF_THE_EPIPHY...2,SET,6,0.087626,0.0015838,0.37472,0.40755,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_FEET,0.981108196040426
HP_PLEURAL_EFFUSION,SET,78,0.022597,0.0014697,0.096632,0.40756,HP_PLEURAL_EFFUSION,0.981108196040426
WIELAND_UP_BY_HBV_INFECTION,SET,93,0.021054,0.0014946,0.0901,0.40762,WIELAND_UP_BY_HBV_INFECTION,0.981108196040426
GSE45365_WT_VS_IFNAR_KO_CD11...3,SET,167,0.014541,0.0013805,0.062246,0.40764,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_UP,0.981108196040426
MIR3129_5P,SET,144,0.016204,0.0014294,0.069363,0.40765,MIR3129_5P,0.981108196040426
GOBP_PEPTIDE_TRANSPORT,SET,244,0.013099,0.0015,0.056085,0.40766,GOBP_PEPTIDE_TRANSPORT,0.981108196040426
WP_FRAGILE_X_SYNDROME,SET,117,0.017927,0.0014265,0.076759,0.40767,WP_FRAGILE_X_SYNDROME,0.981108196040426
MIR92B_3P,SET,431,0.009674,0.0014647,0.041424,0.40767,MIR92B_3P,0.981108196040426
HP_PRIMARY_PERITONEAL_CARCIN...,SET,13,0.057556,0.0015309,0.2465,0.40769,HP_PRIMARY_PERITONEAL_CARCINOMA,0.981108196040426
HP_ABNORMALITY_OF_THE_URINAR...,SET,988,0.0063172,0.0014254,0.027058,0.4077,HP_ABNORMALITY_OF_THE_URINARY_SYSTEM_PHYSIOLOGY,0.981108196040426
GSE45365_CTRL_VS_MCMV_INFECT...2,SET,180,0.014443,0.001423,0.061884,0.40773,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP,0.981108196040426
DESCARTES_MAIN_FETAL_SATELLI...,SET,44,0.029093,0.0014225,0.12466,0.40773,DESCARTES_MAIN_FETAL_SATELLITE_CELLS,0.981108196040426
HP_OVERLAPPING_TOE,SET,60,0.025161,0.0014359,0.10784,0.40776,HP_OVERLAPPING_TOE,0.981108196040426
PID_TCR_PATHWAY,SET,59,0.0243,0.0013753,0.10418,0.40778,PID_TCR_PATHWAY,0.981108196040426
MTOR_UP.N4.V1_DN,SET,155,0.015497,0.0014179,0.066448,0.4078,MTOR_UP.N4.V1_DN,0.981108196040426
CAO_BLOOD_FLUMIST_AGE_05_14Y...1,SET,8,0.060828,0.0012694,0.26105,0.40788,CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_DN,0.981188880813954
CHESLER_BRAIN_HIGHEST_GENETI...,SET,36,0.032776,0.0014499,0.14069,0.40789,CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE,0.981188880813954
HP_LOW_SET_POSTERIORLY_ROTAT...,SET,216,0.013267,0.0014305,0.057004,0.40799,HP_LOW_SET_POSTERIORLY_ROTATED_EARS,0.98122289360819
MODULE_252,SET,227,0.012635,0.0013962,0.054299,0.408,MODULE_252,0.98122289360819
GSE13547_CTRL_VS_ANTI_IGM_ST...1,SET,151,0.015649,0.0014133,0.067256,0.40801,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_DN,0.98122289360819
GOBP_PERIPHERAL_NERVOUS_SYST...5,SET,14,0.054276,0.0014982,0.23335,0.40804,GOBP_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,0.98122289360819
LIU_TARGETS_OF_VMYB_VS_CMYB_...2,SET,15,0.052503,0.0015,0.22591,0.40811,LIU_TARGETS_OF_VMYB_VS_CMYB_UP,0.98122289360819
GOCC_RNA_POLYMERASE_II_CORE_...,SET,13,0.051844,0.001379,0.2231,0.40812,GOCC_RNA_POLYMERASE_II_CORE_COMPLEX,0.98122289360819
HP_PROTRACTED_DIARRHEA,SET,13,0.053848,0.0014323,0.23172,0.40812,HP_PROTRACTED_DIARRHEA,0.98122289360819
GSE13485_CTRL_VS_DAY1_YF17D_...2,SET,179,0.013195,0.0012965,0.05679,0.40813,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP,0.98122289360819
HP_ACEPHALIC_SPERMATOZOA,SET,7,0.082693,0.0016143,0.3563,0.40824,HP_ACEPHALIC_SPERMATOZOA,0.981307749498582
chr7q31,SET,58,0.047674,0.0026752,0.20545,0.40825,chr7q31,0.981307749498582
TSENG_ADIPOGENIC_POTENTIAL_UP,SET,25,0.039283,0.0014485,0.16928,0.40825,TSENG_ADIPOGENIC_POTENTIAL_UP,0.981307749498582
BIOCARTA_VDR_PATHWAY,SET,24,0.036972,0.0013358,0.15939,0.40829,BIOCARTA_VDR_PATHWAY,0.981336026970954
GSE23114_WT_VS_SLE2C1_MOUSE_...2,SET,169,0.014711,0.0014049,0.063463,0.40835,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_UP,0.981412367747735
GSE13411_SWITCHED_MEMORY_BCE...1,SET,160,0.015751,0.0014639,0.068006,0.40842,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN,0.981512729912875
GOMF_TOXIC_SUBSTANCE_BINDING,SET,10,0.064311,0.0015004,0.27776,0.40845,GOMF_TOXIC_SUBSTANCE_BINDING,0.98151695706285
GOBP_NEGATIVE_REGULATION_OF_...580,SET,5,0.087191,0.0014386,0.37688,0.40852,GOBP_NEGATIVE_REGULATION_OF_SATELLITE_CELL_DIFFERENTIATION,0.981577685607632
MODULE_116,SET,13,0.053485,0.0014227,0.23122,0.40854,MODULE_116,0.981577685607632
PIONTEK_PKD1_TARGETS_UP,SET,39,0.030773,0.0014167,0.13307,0.40856,PIONTEK_PKD1_TARGETS_UP,0.981577685607632
GAVISH_3CA_METAPROGRAM_FIBRO...21,SET,45,0.030872,0.0015265,0.13368,0.40868,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PI16_POS,0.981754281863423
GOBP_POSITIVE_REGULATION_OF_...15,SET,10,0.060685,0.0014159,0.2628,0.40869,GOBP_POSITIVE_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.981754281863423
GOBP_THYROID_GLAND_DEVELOPME...,SET,30,0.036361,0.0014685,0.15759,0.40876,GOBP_THYROID_GLAND_DEVELOPMENT,0.981854571843251
MIR3671,SET,571,0.0083608,0.0014513,0.036249,0.40879,MIR3671,0.981858773324119
GOBP_REGULATION_OF_INTRINSIC...6,SET,8,0.066635,0.0013906,0.28965,0.40903,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,0.981884991736676
GSE3982_MAC_VS_NEUTROPHIL_UP,SET,181,0.01391,0.0013743,0.060468,0.40903,GSE3982_MAC_VS_NEUTROPHIL_UP,0.981884991736676
HEBERT_MATRISOME_TNBC_BONE_B...2,SET,7,0.077855,0.0015199,0.33848,0.40904,HEBERT_MATRISOME_TNBC_BONE_BRAIN_LUNG_LIVER_METASTASTASES_TUMOR_CELL_DERIVED,0.981884991736676
MODULE_362,SET,19,0.050732,0.0016311,0.22059,0.40905,MODULE_362,0.981884991736676
HP_ABNORMAL_CAPILLARY_PHYSIO...,SET,8,0.071082,0.0014834,0.3095,0.40918,HP_ABNORMAL_CAPILLARY_PHYSIOLOGY,0.981884991736676
GOBP_CELLULAR_RESPONSE_TO_KE...,SET,97,0.020647,0.0014967,0.089959,0.40924,GOBP_CELLULAR_RESPONSE_TO_KETONE,0.981884991736676
ZAMORA_NOS2_TARGETS_UP,SET,51,0.026339,0.0013862,0.11479,0.40926,ZAMORA_NOS2_TARGETS_UP,0.981884991736676
LINDGREN_BLADDER_CANCER_CLUS...6,SET,205,0.013249,0.0013922,0.057753,0.40927,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,0.981884991736676
PANGAS_TUMOR_SUPPRESSION_BY_...2,SET,118,0.018423,0.0014722,0.080331,0.4093,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,0.981884991736676
DESCARTES_MAIN_FETAL_EXCITAT...,SET,5,0.097991,0.0016168,0.42725,0.4093,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,0.981884991736676
GAVISH_3CA_MALIGNANT_METAPRO...15,SET,36,0.029909,0.001323,0.13043,0.40931,GAVISH_3CA_MALIGNANT_METAPROGRAM_24_CILIA,0.981884991736676
NUYTTEN_NIPP1_TARGETS_DN,SET,766,0.0071078,0.0014212,0.031009,0.40935,NUYTTEN_NIPP1_TARGETS_DN,0.981884991736676
MIR371B_3P,SET,36,0.033638,0.001488,0.14675,0.40935,MIR371B_3P,0.981884991736676
GSE2770_IL12_AND_TGFB_VS_IL4...6,SET,178,0.013771,0.0013494,0.060095,0.40937,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.981884991736676
GOBP_LYMPH_VESSEL_DEVELOPMENT,SET,29,0.037692,0.0014968,0.1645,0.40939,GOBP_LYMPH_VESSEL_DEVELOPMENT,0.981884991736676
GOBP_PIGMENT_GRANULE_LOCALIZ...,SET,23,0.040821,0.0014439,0.17818,0.4094,GOBP_PIGMENT_GRANULE_LOCALIZATION,0.981884991736676
HP_MYELOID_LEUKEMIA,SET,30,0.034997,0.0014135,0.15283,0.40944,HP_MYELOID_LEUKEMIA,0.981884991736676
REACTOME_SENSORY_PERCEPTION_...2,SET,45,0.032322,0.0015982,0.14118,0.40946,REACTOME_SENSORY_PERCEPTION_OF_TASTE,0.981884991736676
KEGG_MEDICUS_REFERENCE_TCR_P...,SET,19,0.043606,0.001402,0.19054,0.40949,KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY,0.981884991736676
GSE1925_CTRL_VS_IFNG_PRIMED_...3,SET,115,0.018493,0.0014589,0.080822,0.40951,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_DN,0.981884991736676
GSE21670_UNTREATED_VS_IL6_TR...4,SET,167,0.015249,0.0014477,0.066647,0.40951,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.981884991736676
GOBP_REGULATION_OF_SPINDLE_O...,SET,46,0.02604,0.0013018,0.11383,0.40953,GOBP_REGULATION_OF_SPINDLE_ORGANIZATION,0.981884991736676
ZNF512B_TARGET_GENES,SET,176,0.015254,0.0014862,0.066692,0.40955,ZNF512B_TARGET_GENES,0.981884991736676
BIOCARTA_NFKB_PATHWAY,SET,20,0.044511,0.0014683,0.19465,0.40956,BIOCARTA_NFKB_PATHWAY,0.981884991736676
GSE17974_IL4_AND_ANTI_IL12_V...14,SET,164,0.014515,0.0013656,0.063492,0.40959,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP,0.981884991736676
JIANG_AGING_HYPOTHALAMUS_UP,SET,39,0.029696,0.0013671,0.12994,0.40961,JIANG_AGING_HYPOTHALAMUS_UP,0.981884991736676
LOPEZ_MESOTHELIOMA_SURVIVAL_...4,SET,12,0.054292,0.0013875,0.23755,0.40961,LOPEZ_MESOTHELIOMA_SURVIVAL_UP,0.981884991736676
GOBP_REGULATION_OF_ATP_DEPEN...,SET,58,0.024834,0.0013936,0.10866,0.40961,GOBP_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.981884991736676
MIR6796_3P,SET,55,0.026248,0.0014344,0.11489,0.40965,MIR6796_3P,0.981884991736676
HP_MALFORMATION_OF_THE_HEPAT...,SET,8,0.055956,0.0011677,0.245,0.40967,HP_MALFORMATION_OF_THE_HEPATIC_DUCTAL_PLATE,0.981884991736676
GOBP_NEGATIVE_REGULATION_OF_...318,SET,32,0.032714,0.0013645,0.14325,0.40968,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,0.981884991736676
LI_PBMC_ZOSTAVAX_AGE_25_40_A...1,SET,7,0.067403,0.0013158,0.29539,0.40975,LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_79YO_1DY_UP,0.981884991736676
GOBP_CELLULAR_RESPONSE_TO_TE...2,SET,8,0.061186,0.0012769,0.26828,0.4098,GOBP_CELLULAR_RESPONSE_TO_TESTOSTERONE_STIMULUS,0.981884991736676
GOBP_TRNA_THREONYLCARBAMOYLA...1,SET,13,0.047042,0.0012513,0.20633,0.40983,GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_METABOLIC_PROCESS,0.981884991736676
REACTOME_REGULATION_OF_RAS_B...,SET,64,0.02177,0.001283,0.095564,0.4099,REACTOME_REGULATION_OF_RAS_BY_GAPS,0.981884991736676
GOMF_FATTY_ACID_TRANSMEMBRAN...,SET,18,0.044915,0.0014056,0.19732,0.40997,GOMF_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.981884991736676
MIR4658,SET,44,0.031222,0.0015266,0.13722,0.41,MIR4658,0.981884991736676
HP_MALIGNANT_HYPERTHERMIA,SET,25,0.03817,0.0014075,0.16774,0.41,HP_MALIGNANT_HYPERTHERMIA,0.981884991736676
PID_HEDGEHOG_GLI_PATHWAY,SET,46,0.028316,0.0014155,0.12448,0.41003,PID_HEDGEHOG_GLI_PATHWAY,0.981884991736676
GOBP_PROSTATE_GLAND_GROWTH,SET,10,0.072605,0.0016939,0.31919,0.41003,GOBP_PROSTATE_GLAND_GROWTH,0.981884991736676
GOBP_RETROGRADE_TRANS_SYNAPT...2,SET,5,0.093028,0.0015349,0.40906,0.41005,GOBP_RETROGRADE_TRANS_SYNAPTIC_SIGNALING_BY_LIPID,0.981884991736676
GSE2706_UNSTIM_VS_8H_R848_DC...1,SET,174,0.015793,0.0015301,0.0695,0.41012,GSE2706_UNSTIM_VS_8H_R848_DC_DN,0.981884991736676
GOMF_CYCLOHYDROLASE_ACTIVITY,SET,5,0.087965,0.0014514,0.38719,0.41014,GOMF_CYCLOHYDROLASE_ACTIVITY,0.981884991736676
REACTOME_TRNA_AMINOACYLATION,SET,24,0.035314,0.0012759,0.15548,0.41016,REACTOME_TRNA_AMINOACYLATION,0.981884991736676
WP_TRANSCRIPTION_FACTORS_REG...,SET,8,0.060831,0.0012695,0.26782,0.41016,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,0.981884991736676
GOBP_ENDOCARDIAL_CUSHION_FUS...,SET,4,0.11595,0.0017112,0.51065,0.41019,GOBP_ENDOCARDIAL_CUSHION_FUSION,0.981884991736676
GSE41867_NAIVE_VS_DAY8_LCMV_...6,SET,181,0.013208,0.0013049,0.05818,0.41021,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,0.981884991736676
HP_ABSENT_THUMB,SET,51,0.025282,0.0013306,0.11141,0.41024,HP_ABSENT_THUMB,0.981884991736676
HP_DECREASED_CIRCULATING_IRO...,SET,5,0.07113,0.0011736,0.31345,0.41024,HP_DECREASED_CIRCULATING_IRON_CONCENTRATION,0.981884991736676
SNF5_DN.V1_DN,SET,136,0.017569,0.0015064,0.077429,0.41025,SNF5_DN.V1_DN,0.981884991736676
WILSON_PROTEASES_AT_TUMOR_BO...2,SET,20,0.038568,0.0012722,0.17001,0.41027,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP,0.981884991736676
HP_ALVEOLAR_RHABDOMYOSARCOMA,SET,5,0.099103,0.0016352,0.43685,0.41027,HP_ALVEOLAR_RHABDOMYOSARCOMA,0.981884991736676
HP_ABNORMAL_MORPHOLOGY_OF_MY...,SET,19,0.043968,0.0014137,0.19424,0.41046,HP_ABNORMAL_MORPHOLOGY_OF_MYOCARDIAL_TRABECULAE,0.982232530120482
GTCAACC_MIR3805P,SET,20,0.046462,0.0015326,0.20534,0.4105,GTCAACC_MIR3805P,0.982232530120482
GOBP_REGULATION_OF_TOLERANCE...,SET,17,0.04976,0.0015134,0.21992,0.4105,GOBP_REGULATION_OF_TOLERANCE_INDUCTION,0.982232530120482
GOMF_LNCRNA_BINDING,SET,17,0.040585,0.0012344,0.17967,0.41065,GOMF_LNCRNA_BINDING,0.98233338150289
GSE23568_CTRL_TRANSDUCED_VS_...1,SET,187,0.013283,0.0013337,0.058809,0.41065,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN,0.98233338150289
REACTOME_NPAS4_REGULATES_EXP...,SET,20,0.046541,0.0015352,0.20609,0.41067,REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES,0.98233338150289
GOBP_HEART_PROCESS,SET,240,0.013124,0.0014906,0.058132,0.41069,GOBP_HEART_PROCESS,0.98233338150289
GOBP_NEGATIVE_REGULATION_OF_...218,SET,8,0.064404,0.001344,0.28532,0.41071,GOBP_NEGATIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,0.98233338150289
HP_ABNORMAL_CEREBROSPINAL_FL...,SET,531,0.0080305,0.0013458,0.035581,0.41072,HP_ABNORMAL_CEREBROSPINAL_FLUID_MORPHOLOGY,0.98233338150289
GOMF_CALCIUM_CHANNEL_INHIBIT...,SET,12,0.058387,0.0014922,0.25876,0.41074,GOMF_CALCIUM_CHANNEL_INHIBITOR_ACTIVITY,0.98233338150289
GOMF_G_QUADRUPLEX_RNA_BINDING,SET,6,0.07348,0.0013281,0.32606,0.41085,GOMF_G_QUADRUPLEX_RNA_BINDING,0.982445617776555
GOBP_CYTOSKELETON_DEPENDENT_...2,SET,180,0.014014,0.0013808,0.062207,0.41088,GOBP_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT,0.982445617776555
LIN_APC_TARGETS,SET,63,0.023612,0.0013807,0.10482,0.41089,LIN_APC_TARGETS,0.982445617776555
HP_ABNORMAL_CIRCULATING_DEHY...,SET,15,0.050658,0.0014473,0.22492,0.4109,HP_ABNORMAL_CIRCULATING_DEHYDROEPIANDROSTERONE_CONCENTRATION,0.982445617776555
WP_LTF_DANGER_SIGNAL_RESPONS...,SET,18,0.048732,0.0015251,0.21646,0.41094,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,0.982473667194057
GOBP_REGULATION_OF_PROTEIN_T...3,SET,400,0.0095955,0.0014008,0.042681,0.41106,GOBP_REGULATION_OF_PROTEIN_TRANSPORT,0.982625373134328
GSE29618_PRE_VS_DAY7_FLU_VAC...5,SET,180,0.013381,0.0013184,0.059514,0.41106,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN,0.982625373134328
GOBP_THYMOCYTE_APOPTOTIC_PRO...,SET,19,0.045091,0.0014498,0.20068,0.41111,GOBP_THYMOCYTE_APOPTOTIC_PROCESS,0.982633816060398
GOMF_ICOSANOID_RECEPTOR_ACTI...,SET,14,0.052349,0.001445,0.23309,0.41115,GOMF_ICOSANOID_RECEPTOR_ACTIVITY,0.982633816060398
TGANTCA_AP1_C,SET,1018,0.0062666,0.0014341,0.027906,0.41116,TGANTCA_AP1_C,0.982633816060398
GSE5589_LPS_AND_IL10_VS_LPS_...5,SET,184,0.014152,0.0014096,0.063044,0.4112,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.982633816060398
GOBP_NEGATIVE_REGULATION_OF_...57,SET,6,0.089163,0.0016115,0.39729,0.41121,GOBP_NEGATIVE_REGULATION_OF_B_CELL_DIFFERENTIATION,0.982633816060398
LEE_AGING_CEREBELLUM_DN,SET,66,0.024172,0.0014466,0.10774,0.41125,LEE_AGING_CEREBELLUM_DN,0.982633816060398
HP_ABNORMAL_VENTRICULAR_SEPT...,SET,429,0.0090547,0.0013678,0.040411,0.41135,HP_ABNORMAL_VENTRICULAR_SEPTUM_MORPHOLOGY,0.982633816060398
KRAS.600.LUNG.BREAST_UP.V1_UP,SET,248,0.013115,0.0015139,0.058549,0.41138,KRAS.600.LUNG.BREAST_UP.V1_UP,0.982633816060398
HP_PHONIC_TICS,SET,5,0.080526,0.0013287,0.35983,0.41146,HP_PHONIC_TICS,0.982633816060398
RELA_DN.V1_UP,SET,136,0.016444,0.00141,0.073502,0.41149,RELA_DN.V1_UP,0.982633816060398
GSE4142_PLASMA_CELL_VS_GC_BC...2,SET,181,0.013261,0.0013101,0.059277,0.41149,GSE4142_PLASMA_CELL_VS_GC_BCELL_UP,0.982633816060398
GOBP_MACROPHAGE_CYTOKINE_PRO...,SET,35,0.033153,0.0014461,0.14821,0.4115,GOBP_MACROPHAGE_CYTOKINE_PRODUCTION,0.982633816060398
GOBP_PH_REDUCTION,SET,6,0.085896,0.0015525,0.38424,0.41156,GOBP_PH_REDUCTION,0.982633816060398
HP_ABNORMAL_CD4_CD8_RATIO,SET,17,0.045881,0.0013954,0.20536,0.41161,HP_ABNORMAL_CD4_CD8_RATIO,0.982633816060398
chr5p12,SET,12,0.091333,0.0023341,0.4089,0.41163,chr5p12,0.982633816060398
MORF_EIF4A2,SET,128,0.015555,0.0012942,0.069685,0.41168,MORF_EIF4A2,0.982633816060398
GOBP_NEGATIVE_REGULATION_OF_...185,SET,3,0.10947,0.0013992,0.4904,0.41168,GOBP_NEGATIVE_REGULATION_OF_DNA_CATABOLIC_PROCESS,0.982633816060398
RANKIN_ANGIOGENIC_TARGETS_OF...1,SET,8,0.079191,0.0016526,0.35489,0.41171,RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN,0.982633816060398
GOBP_NEUTRAL_LIPID_BIOSYNTHE...,SET,45,0.026855,0.0013278,0.12034,0.41171,GOBP_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS,0.982633816060398
GOBP_OUTFLOW_TRACT_MORPHOGEN...,SET,75,0.025032,0.0015965,0.11219,0.41172,GOBP_OUTFLOW_TRACT_MORPHOGENESIS,0.982633816060398
GOBP_MANCHETTE_ASSEMBLY,SET,8,0.060263,0.0012576,0.27019,0.41175,GOBP_MANCHETTE_ASSEMBLY,0.982633816060398
GOCC_CONTRACTILE_RING,SET,11,0.048668,0.0011909,0.21819,0.41175,GOCC_CONTRACTILE_RING,0.982633816060398
HUANG_FOXA2_TARGETS_DN,SET,35,0.032592,0.0014216,0.14619,0.41179,HUANG_FOXA2_TARGETS_DN,0.982633816060398
GOBP_PYRAMIDAL_NEURON_DEVELO...,SET,9,0.064017,0.001417,0.28715,0.41179,GOBP_PYRAMIDAL_NEURON_DEVELOPMENT,0.982633816060398
HP_PIERRE_ROBIN_SEQUENCE,SET,25,0.03784,0.0013953,0.16974,0.4118,HP_PIERRE_ROBIN_SEQUENCE,0.982633816060398
GOBP_MULTICELLULAR_ORGANISM_...,SET,136,0.016827,0.0014428,0.07549,0.41181,GOBP_MULTICELLULAR_ORGANISM_GROWTH,0.982633816060398
HP_JOINT_CONTRACTURE_OF_THE_...3,SET,237,0.012536,0.001415,0.056272,0.41186,HP_JOINT_CONTRACTURE_OF_THE_HAND,0.982633816060398
WP_VITAMIN_B12_METABOLISM,SET,48,0.028588,0.0014598,0.12839,0.4119,WP_VITAMIN_B12_METABOLISM,0.982633816060398
BILBAN_B_CLL_LPL_DN,SET,37,0.03176,0.0014243,0.14268,0.41193,BILBAN_B_CLL_LPL_DN,0.982633816060398
HP_FINGER_SYMPHALANGISM,SET,11,0.0605,0.0014804,0.27181,0.41193,HP_FINGER_SYMPHALANGISM,0.982633816060398
GOBP_POSITIVE_REGULATION_OF_...572,SET,61,0.023469,0.0013505,0.10545,0.41194,GOBP_POSITIVE_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.982633816060398
HP_CONE_CONE_ROD_DYSTROPHY,SET,52,0.025903,0.0013766,0.11647,0.412,HP_CONE_CONE_ROD_DYSTROPHY,0.982646171001167
GOCC_PHAGOCYTIC_VESICLE,SET,126,0.016515,0.0013634,0.074276,0.41203,GOCC_PHAGOCYTIC_VESICLE,0.982646171001167
HP_OXYCEPHALY,SET,7,0.070115,0.0013688,0.31535,0.41203,HP_OXYCEPHALY,0.982646171001167
MIKKELSEN_MEF_LCP_WITH_H3K27...,SET,61,0.025424,0.001463,0.11445,0.4121,MIKKELSEN_MEF_LCP_WITH_H3K27ME3,0.982681615179122
GOMF_GLYCOLIPID_BINDING,SET,28,0.034152,0.0013326,0.15376,0.41211,GOMF_GLYCOLIPID_BINDING,0.982681615179122
MIR3684,SET,30,0.034886,0.001409,0.15715,0.41216,MIR3684,0.982681615179122
REACTOME_COMMON_PATHWAY_OF_F...,SET,21,0.043985,0.0014867,0.19825,0.41221,REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION,0.982681615179122
GOBP_EOSINOPHIL_MIGRATION,SET,28,0.042943,0.0016757,0.19366,0.41226,GOBP_EOSINOPHIL_MIGRATION,0.982681615179122
HP_ECLAMPSIA,SET,7,0.076843,0.0015001,0.34661,0.41228,HP_ECLAMPSIA,0.982681615179122
HP_SHORTENING_OF_ALL_PHALANG...,SET,6,0.069648,0.0012588,0.31463,0.41241,HP_SHORTENING_OF_ALL_PHALANGES_OF_THE_TOES,0.982681615179122
MIR3692_3P,SET,261,0.011864,0.0014045,0.053624,0.41245,MIR3692_3P,0.982681615179122
MIR548M,SET,172,0.01406,0.0013544,0.063563,0.41247,MIR548M,0.982681615179122
HP_APLASTIC_ANEMIA,SET,24,0.037204,0.0013442,0.1682,0.41247,HP_APLASTIC_ANEMIA,0.982681615179122
GSE7509_FCGRIIB_VS_TNFA_IL1B...2,SET,157,0.01389,0.0012789,0.062806,0.41248,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,0.982681615179122
JI_RESPONSE_TO_FSH_UP,SET,57,0.023572,0.0013113,0.10666,0.41254,JI_RESPONSE_TO_FSH_UP,0.982681615179122
HP_APLASIA_OF_THE_2ND_FINGER,SET,4,0.093318,0.0013772,0.42224,0.41254,HP_APLASIA_OF_THE_2ND_FINGER,0.982681615179122
REACTOME_HOMOLOGOUS_DNA_PAIR...,SET,41,0.028337,0.0013376,0.12825,0.41257,REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,0.982681615179122
GOBP_DISRUPTION_OF_ANATOMICA...,SET,81,0.022798,0.0015109,0.10319,0.41257,GOBP_DISRUPTION_OF_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM,0.982681615179122
GSE22045_TREG_VS_TCONV_UP,SET,153,0.015085,0.0013713,0.068285,0.41258,GSE22045_TREG_VS_TCONV_UP,0.982681615179122
GSE17721_0.5H_VS_8H_CPG_BMDC...2,SET,188,0.013178,0.0013266,0.059688,0.41263,GSE17721_0.5H_VS_8H_CPG_BMDC_UP,0.982681615179122
GOBP_CELLULAR_RESPONSE_TO_RE...2,SET,136,0.016327,0.0014,0.073988,0.41267,GOBP_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,0.982681615179122
chr7q11,SET,71,0.040686,0.0025251,0.18437,0.41268,chr7q11,0.982681615179122
DODD_NASOPHARYNGEAL_CARCINOM...1,SET,1481,0.0050768,0.0013825,0.023017,0.41272,DODD_NASOPHARYNGEAL_CARCINOMA_DN,0.982681615179122
GOBP_REGULATION_OF_SYSTEMIC_...3,SET,6,0.086898,0.0015706,0.39401,0.41272,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_ENDOTHELIN,0.982681615179122
WENDT_COHESIN_TARGETS_UP,SET,31,0.034751,0.0014267,0.15757,0.41273,WENDT_COHESIN_TARGETS_UP,0.982681615179122
YAO_HOXA10_TARGETS_VIA_PROGE...1,SET,18,0.051267,0.0016044,0.23247,0.41273,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN,0.982681615179122
HP_CALF_MUSCLE_PSEUDOHYPERTR...,SET,15,0.046733,0.0013352,0.21192,0.41273,HP_CALF_MUSCLE_PSEUDOHYPERTROPHY,0.982681615179122
GOBP_NEGATIVE_REGULATION_OF_...108,SET,351,0.0098324,0.0013464,0.044602,0.41276,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE,0.982681615179122
VALK_AML_WITH_FLT3_ITD,SET,36,0.033457,0.00148,0.15181,0.41278,VALK_AML_WITH_FLT3_ITD,0.982681615179122
VILLANUEVA_LIVER_CANCER_KRT1...2,SET,152,0.014494,0.0013133,0.065796,0.41283,VILLANUEVA_LIVER_CANCER_KRT19_UP,0.982733332191781
BONOME_OVARIAN_CANCER_POOR_S...2,SET,28,0.036092,0.0014083,0.16392,0.41287,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP,0.982761238956236
GOBP_NEGATIVE_REGULATION_OF_...567,SET,9,0.067428,0.0014925,0.30653,0.41295,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,0.982797339769926
WP_FOLATE_METABOLISM,SET,66,0.023827,0.001426,0.10834,0.41296,WP_FOLATE_METABOLISM,0.982797339769926
GOBP_POSITIVE_REGULATION_OF_...755,SET,5,0.088934,0.0014674,0.40441,0.41297,GOBP_POSITIVE_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,0.982797339769926
GOBP_ALDEHYDE_CATABOLIC_PROC...,SET,13,0.048804,0.0012981,0.22207,0.41303,GOBP_ALDEHYDE_CATABOLIC_PROCESS,0.982872827798699
PLASARI_NFIC_TARGETS_BASAL_DN,SET,20,0.047156,0.0015555,0.21483,0.41313,PLASARI_NFIC_TARGETS_BASAL_DN,0.982956479326397
VANASSE_BCL2_TARGETS_DN,SET,53,0.024029,0.0012892,0.10947,0.41313,VANASSE_BCL2_TARGETS_DN,0.982956479326397
GOBP_NEGATIVE_REGULATION_OF_...59,SET,15,0.052856,0.0015101,0.24086,0.41315,GOBP_NEGATIVE_REGULATION_OF_B_CELL_PROLIFERATION,0.982956479326397
MIR548AZ_5P,SET,393,0.0097274,0.0014078,0.04435,0.4132,MIR548AZ_5P,0.982988439425051
RORA_TARGET_GENES,SET,214,0.012332,0.0013236,0.056241,0.41322,RORA_TARGET_GENES,0.982988439425051
NABA_MATRISOME_HIGHLY_METAST...2,SET,26,0.034363,0.0012922,0.15682,0.41328,NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED,0.98304417601971
GSE17322_CD103_POS_VS_CD11B_...2,SET,176,0.01386,0.0013505,0.063269,0.4133,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP,0.98304417601971
GOBP_REGULATION_OF_BILE_ACID...2,SET,14,0.05466,0.0015088,0.24961,0.41334,GOBP_REGULATION_OF_BILE_ACID_METABOLIC_PROCESS,0.983072038595771
GOBP_MICROTUBULE_ANCHORING_A...,SET,13,0.045209,0.0012025,0.20667,0.41342,GOBP_MICROTUBULE_ANCHORING_AT_MICROTUBULE_ORGANIZING_CENTER,0.983127752309271
GOBP_PLATELET_MORPHOGENESIS,SET,23,0.034444,0.0012183,0.15745,0.41342,GOBP_PLATELET_MORPHOGENESIS,0.983127752309271
GSE13887_ACT_CD4_VS_NO_TREAT...2,SET,116,0.017321,0.0013724,0.079249,0.4135,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP,0.983250718390804
GOBP_POSITIVE_REGULATION_OF_...191,SET,167,0.014235,0.0013514,0.065169,0.41355,GOBP_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,0.983282620741551
GOBP_NEGATIVE_REGULATION_OF_...698,SET,22,0.042735,0.0014784,0.19569,0.41357,GOBP_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL,0.983282620741551
chr3q25,SET,61,0.044712,0.0025729,0.20494,0.41365,chr3q25,0.983390432077665
HP_ABSENCE_OF_RENAL_CORTICOM...,SET,6,0.088772,0.0016045,0.40742,0.41376,HP_ABSENCE_OF_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,0.983390432077665
GARGALOVIC_RESPONSE_TO_OXIDI...20,SET,10,0.064078,0.001495,0.29429,0.41382,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,0.983390432077665
ZF5_01,SET,226,0.012063,0.0013301,0.055407,0.41382,ZF5_01,0.983390432077665
HP_EMG_POSITIVE_SHARP_WAVES,SET,9,0.067627,0.0014969,0.31059,0.41382,HP_EMG_POSITIVE_SHARP_WAVES,0.983390432077665
MIR548U,SET,142,0.016057,0.0014066,0.073758,0.41384,MIR548U,0.983390432077665
MIR6856_5P,SET,93,0.019007,0.0013493,0.087326,0.41385,MIR6856_5P,0.983390432077665
IRF1_01,SET,225,0.012813,0.0014097,0.058878,0.41386,IRF1_01,0.983390432077665
GNF2_BNIP3L,SET,61,0.023069,0.0013275,0.10601,0.41387,GNF2_BNIP3L,0.983390432077665
GOBP_NEGATIVE_REGULATION_OF_...546,SET,21,0.042392,0.0014328,0.19491,0.41391,GOBP_NEGATIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.983418242411813
MIR214_3P,SET,222,0.011839,0.0012939,0.054469,0.41397,MIR214_3P,0.983493564153394
MIR6501_3P,SET,132,0.01614,0.0013635,0.074339,0.41406,MIR6501_3P,0.983494069012641
GOCC_MITOCHONDRIAL_ENVELOPE,SET,685,0.0068522,0.0012986,0.031562,0.41406,GOCC_MITOCHONDRIAL_ENVELOPE,0.983494069012641
REACTOME_DISASSEMBLY_OF_THE_...,SET,29,0.035059,0.0013922,0.16153,0.41409,REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE,0.983494069012641
HP_MYELOPATHY,SET,13,0.0501,0.0013326,0.23086,0.4141,HP_MYELOPATHY,0.983494069012641
HP_OPTIC_NEUROPATHY,SET,46,0.025083,0.0012539,0.11562,0.41413,HP_OPTIC_NEUROPATHY,0.983494069012641
GOMF_NARROW_PORE_CHANNEL_ACT...,SET,19,0.044475,0.00143,0.20505,0.41414,GOMF_NARROW_PORE_CHANNEL_ACTIVITY,0.983494069012641
HP_SALIVARY_GLAND_NEOPLASM,SET,12,0.046138,0.0011791,0.21292,0.41423,HP_SALIVARY_GLAND_NEOPLASM,0.983637893264178
MIR6745,SET,85,0.019665,0.0013349,0.090914,0.41438,MIR6745,0.983637893264178
E2F1_Q6,SET,207,0.012367,0.0013057,0.057176,0.41438,E2F1_Q6,0.983637893264178
GSE18281_SUBCAPSULAR_CORTICA...2,SET,189,0.012915,0.0013036,0.059715,0.41438,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,0.983637893264178
GOMF_CHEMOKINE_ACTIVITY,SET,45,0.033364,0.0016497,0.15431,0.41441,GOMF_CHEMOKINE_ACTIVITY,0.983637893264178
KEGG_MEDICUS_REFERENCE_LYSOS...,SET,10,0.054342,0.0012679,0.25137,0.41443,KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE,0.983637893264178
GOBP_REGULATION_OF_HYPERSENS...,SET,9,0.061338,0.0013577,0.28377,0.41443,GOBP_REGULATION_OF_HYPERSENSITIVITY,0.983637893264178
HP_RENAL_DYSPLASIA,SET,62,0.023204,0.0013461,0.10743,0.4145,HP_RENAL_DYSPLASIA,0.983637893264178
GOBP_MICROVILLUS_ASSEMBLY,SET,19,0.046101,0.0014822,0.21346,0.41451,GOBP_MICROVILLUS_ASSEMBLY,0.983637893264178
GOTZMANN_EPITHELIAL_TO_MESEN...1,SET,192,0.013184,0.0013411,0.061053,0.41452,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,0.983637893264178
GOBP_ESTABLISHMENT_OF_GOLGI_...,SET,6,0.079161,0.0014308,0.36671,0.41455,GOBP_ESTABLISHMENT_OF_GOLGI_LOCALIZATION,0.983637893264178
GOMF_RNA_POLYMERASE_II_CTD_H...1,SET,10,0.053524,0.0012488,0.24807,0.41459,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_KINASE_ACTIVITY,0.983637893264178
GOBP_REGULATION_OF_CHEMOKINE...,SET,9,0.060444,0.0013379,0.28018,0.4146,GOBP_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,0.983637893264178
HP_FRONTAL_BALDING,SET,13,0.049046,0.0013046,0.22736,0.4146,HP_FRONTAL_BALDING,0.983637893264178
HP_LEUKOPENIA,SET,129,0.015725,0.0013134,0.072928,0.41464,HP_LEUKOPENIA,0.983637893264178
GSE411_UNSTIM_VS_400MIN_IL6_...3,SET,175,0.013733,0.0013343,0.063701,0.41466,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,0.983637893264178
GOBP_RESPONSE_TO_ALKALOID,SET,97,0.018723,0.0013572,0.086879,0.41469,GOBP_RESPONSE_TO_ALKALOID,0.983637893264178
GSE19198_1H_VS_24H_IL21_TREA...2,SET,179,0.013984,0.001374,0.064906,0.41471,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP,0.983637893264178
GOMF_ANTIPORTER_ACTIVITY,SET,126,0.015893,0.001312,0.073858,0.41482,GOMF_ANTIPORTER_ACTIVITY,0.983831656885492
MODULE_488,SET,29,0.037664,0.0014957,0.17512,0.41486,MODULE_488,0.983859385875128
HP_INTESTINAL_BLEEDING,SET,6,0.07411,0.0013395,0.34482,0.41491,HP_INTESTINAL_BLEEDING,0.983897219776498
GOMF_STRUCTURAL_CONSTITUENT_...5,SET,9,0.06629,0.0014673,0.30868,0.41498,GOMF_STRUCTURAL_CONSTITUENT_OF_MYELIN_SHEATH,0.983897219776498
SENESE_HDAC3_TARGETS_UP,SET,437,0.0088664,0.0013515,0.041291,0.41499,SENESE_HDAC3_TARGETS_UP,0.983897219776498
GOBP_DICARBOXYLIC_ACID_METAB...,SET,89,0.018682,0.0012975,0.087051,0.41504,GOBP_DICARBOXYLIC_ACID_METABOLIC_PROCESS,0.983897219776498
HP_DELAYED_PROXIMAL_FEMORAL_...,SET,16,0.044269,0.0013062,0.2063,0.41505,HP_DELAYED_PROXIMAL_FEMORAL_EPIPHYSEAL_OSSIFICATION,0.983897219776498
MIR569,SET,69,0.022073,0.0013506,0.10298,0.41515,MIR569,0.983897219776498
GOBP_ADIPOSE_TISSUE_DEVELOPM...,SET,55,0.024242,0.0013248,0.11318,0.4152,GOBP_ADIPOSE_TISSUE_DEVELOPMENT,0.983897219776498
GSE7400_CTRL_VS_CSF3_IN_VIVO...1,SET,175,0.013463,0.0013081,0.062872,0.41522,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN,0.983897219776498
GOBP_ACTIVATION_OF_CYSTEINE_...3,SET,5,0.06682,0.0011025,0.3121,0.41524,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS_BY_CYTOCHROME_C,0.983897219776498
GOBP_ENDOCARDIAL_CELL_DIFFER...,SET,6,0.083619,0.0015113,0.39112,0.41535,GOBP_ENDOCARDIAL_CELL_DIFFERENTIATION,0.983897219776498
SP1_01,SET,214,0.012199,0.0013093,0.057087,0.41539,SP1_01,0.983897219776498
DNMT1_TARGET_GENES,SET,173,0.013426,0.0012971,0.062892,0.41548,DNMT1_TARGET_GENES,0.983897219776498
GOBP_POSITIVE_REGULATION_OF_...167,SET,28,0.031371,0.0012241,0.14698,0.4155,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEPARATION,0.983897219776498
GOBP_REGULATION_OF_B_CELL_DI...,SET,31,0.032857,0.0013489,0.15396,0.4155,GOBP_REGULATION_OF_B_CELL_DIFFERENTIATION,0.983897219776498
LAKE_ADULT_KIDNEY_C24_ENDOTH...,SET,144,0.015985,0.0014101,0.07495,0.41556,LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR,0.983897219776498
HP_SCLERODACTYLY,SET,5,0.084187,0.0013891,0.39479,0.41557,HP_SCLERODACTYLY,0.983897219776498
PR_01,SET,134,0.015846,0.0013487,0.074316,0.41558,PR_01,0.983897219776498
GOMF_CADHERIN_BINDING_INVOLV...,SET,18,0.047237,0.0014783,0.22156,0.41558,GOMF_CADHERIN_BINDING_INVOLVED_IN_CELL_CELL_ADHESION,0.983897219776498
HP_PRIMARY_HYPOTHYROIDISM,SET,6,0.061453,0.0011107,0.28847,0.41565,HP_PRIMARY_HYPOTHYROIDISM,0.983897219776498
GAUSSMANN_MLL_AF4_FUSION_TAR...10,SET,90,0.019863,0.0013872,0.093301,0.41571,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,0.983897219776498
GOBP_ORGANELLE_TRANSPORT_ALO...,SET,79,0.02002,0.0013104,0.094054,0.41572,GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,0.983897219776498
HP_ABNORMAL_CIRCULATING_ANTI...,SET,8,0.054023,0.0011274,0.25392,0.41576,HP_ABNORMAL_CIRCULATING_ANTIMULLERIAN_HORMONE_CONCENTRATION,0.983897219776498
GSE17721_CTRL_VS_PAM3CSK4_4H...2,SET,182,0.012799,0.001268,0.060198,0.41581,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_UP,0.983897219776498
HE_LIM_SUN_FETAL_LUNG_C5_LAT...,SET,25,0.038005,0.0014014,0.17882,0.41585,HE_LIM_SUN_FETAL_LUNG_C5_LATE_PRO_B_CELL,0.983897219776498
GOBP_PROTEIN_HEXAMERIZATION,SET,8,0.060116,0.0012546,0.28291,0.41586,GOBP_PROTEIN_HEXAMERIZATION,0.983897219776498
GAO_SMALL_INTESTINE_24W_C4_E...,SET,87,0.019907,0.001367,0.093694,0.41587,GAO_SMALL_INTESTINE_24W_C4_ENTEROCYTE_PROGENITOR_SUBTYPE_2,0.983897219776498
BLANCO_MELO_COVID19_SARS_COV...12,SET,139,0.015964,0.0013837,0.075147,0.41589,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,0.983897219776498
MIR1283,SET,435,0.0088678,0.0013487,0.041752,0.4159,MIR1283,0.983897219776498
GSE36095_WT_VS_HDAC9_KO_TREG...1,SET,109,0.01727,0.0013266,0.081311,0.4159,GSE36095_WT_VS_HDAC9_KO_TREG_DN,0.983897219776498
TRAVAGLINI_LUNG_CILIATED_CELL,SET,953,0.0058138,0.0012897,0.027381,0.41593,TRAVAGLINI_LUNG_CILIATED_CELL,0.983897219776498
HP_ABNORMALITY_OF_THE_FOOT_M...,SET,11,0.057631,0.0014102,0.27149,0.41595,HP_ABNORMALITY_OF_THE_FOOT_MUSCULATURE,0.983897219776498
BAUS_TFF2_TARGETS_DN,SET,11,0.055382,0.0013552,0.26097,0.41597,BAUS_TFF2_TARGETS_DN,0.983897219776498
GOCC_MICOS_COMPLEX,SET,5,0.074008,0.0012211,0.34876,0.41597,GOCC_MICOS_COMPLEX,0.983897219776498
GSE3982_DC_VS_NEUTROPHIL_DN,SET,171,0.013414,0.0012885,0.06322,0.41598,GSE3982_DC_VS_NEUTROPHIL_DN,0.983897219776498
HP_HYPOPIGMENTED_MACULE,SET,24,0.034372,0.0012419,0.16207,0.41602,HP_HYPOPIGMENTED_MACULE,0.983897219776498
HP_FEMALE_INFERTILITY,SET,69,0.02052,0.0012555,0.096796,0.41606,HP_FEMALE_INFERTILITY,0.983897219776498
HP_FATIGABLE_WEAKNESS_OF_BUL...,SET,52,0.023616,0.001255,0.11143,0.41608,HP_FATIGABLE_WEAKNESS_OF_BULBAR_MUSCLES,0.983897219776498
MIR378A_3P_MIR378C_MIR378D_M...,SET,38,0.027346,0.0012428,0.12905,0.41609,MIR378A_3P_MIR378C_MIR378D_MIR378I,0.983897219776498
HP_ABNORMALLY_OSSIFIED_VERTE...,SET,19,0.041679,0.0013401,0.19681,0.41614,HP_ABNORMALLY_OSSIFIED_VERTEBRAE,0.983897219776498
REACTOME_POLO_LIKE_KINASE_ME...,SET,16,0.040458,0.0011938,0.19121,0.41622,REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS,0.983897219776498
GOMF_CCR3_CHEMOKINE_RECEPTOR...,SET,4,0.093169,0.001375,0.44064,0.41627,GOMF_CCR3_CHEMOKINE_RECEPTOR_BINDING,0.983897219776498
GSE12003_MIR223_KO_VS_WT_BM_...1,SET,187,0.013299,0.0013352,0.062904,0.41628,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN,0.983897219776498
GOBP_BLOOD_VESSEL_MATURATION,SET,8,0.066906,0.0013963,0.31649,0.41629,GOBP_BLOOD_VESSEL_MATURATION,0.983897219776498
GOBP_DETERMINATION_OF_DORSAL...,SET,10,0.061564,0.0014364,0.29126,0.4163,GOBP_DETERMINATION_OF_DORSAL_VENTRAL_ASYMMETRY,0.983897219776498
MIR454_5P,SET,21,0.03902,0.0013188,0.18466,0.41632,MIR454_5P,0.983897219776498
GSE37416_CTRL_VS_48H_F_TULAR...1,SET,167,0.012868,0.0012217,0.060899,0.41632,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.983897219776498
MANNO_MIDBRAIN_NEUROTYPES_HP...5,SET,269,0.011365,0.0013655,0.053795,0.41634,MANNO_MIDBRAIN_NEUROTYPES_HPROGM,0.983897219776498
KEGG_MEDICUS_PATHOGEN_HCMV_U...7,SET,30,0.03255,0.0013146,0.15415,0.41638,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,0.983897219776498
REACTOME_GLUCOSE_METABOLISM,SET,77,0.018727,0.0012102,0.088715,0.41641,REACTOME_GLUCOSE_METABOLISM,0.983897219776498
GOBP_LATE_ENDOSOME_TO_LYSOSO...,SET,21,0.037645,0.0012724,0.17842,0.41645,GOBP_LATE_ENDOSOME_TO_LYSOSOME_TRANSPORT,0.983897219776498
GOBP_DOUBLE_STRAND_BREAK_REP...2,SET,7,0.06381,0.0012457,0.30258,0.41649,GOBP_DOUBLE_STRAND_BREAK_REPAIR_INVOLVED_IN_MEIOTIC_RECOMBINATION,0.983897219776498
GOBP_REGULATION_OF_GLUCOCORT...2,SET,11,0.051638,0.0012635,0.24488,0.4165,GOBP_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS,0.983897219776498
MIR4712_5P,SET,92,0.018937,0.0013371,0.08982,0.41651,MIR4712_5P,0.983897219776498
GOBP_REGULATION_OF_INTRACELL...5,SET,61,0.021843,0.0012569,0.10362,0.41652,GOBP_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.983897219776498
HP_ERUPTION_FAILURE,SET,16,0.04412,0.0013019,0.20929,0.41652,HP_ERUPTION_FAILURE,0.983897219776498
MIR6766_5P,SET,225,0.012075,0.0013284,0.057305,0.41656,MIR6766_5P,0.983897219776498
GSE25087_TREG_VS_TCONV_FETUS...1,SET,162,0.013897,0.0012996,0.065969,0.41658,GSE25087_TREG_VS_TCONV_FETUS_DN,0.983897219776498
GCM_IL6ST,SET,52,0.023466,0.001247,0.11143,0.4166,GCM_IL6ST,0.983897219776498
GOBP_PREPULSE_INHIBITION,SET,13,0.051606,0.0013727,0.24506,0.41661,GOBP_PREPULSE_INHIBITION,0.983897219776498
REACTOME_SIGNALING_BY_NTRK2_...,SET,25,0.032939,0.0012146,0.1566,0.4167,REACTOME_SIGNALING_BY_NTRK2_TRKB,0.983897219776498
HP_CONE_SHAPED_EPIPHYSIS,SET,72,0.020699,0.0012937,0.098407,0.4167,HP_CONE_SHAPED_EPIPHYSIS,0.983897219776498
HU_ANGIOGENESIS_DN,SET,32,0.028873,0.0012043,0.13732,0.41673,HU_ANGIOGENESIS_DN,0.983897219776498
ZHOU_CELL_CYCLE_GENES_IN_IR_...1,SET,116,0.016024,0.0012696,0.076204,0.41673,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR,0.983897219776498
PID_ATM_PATHWAY,SET,29,0.029458,0.0011698,0.14017,0.41677,PID_ATM_PATHWAY,0.983897219776498
GOBP_CARDIAC_VASCULAR_SMOOTH...,SET,8,0.07015,0.001464,0.33399,0.41682,GOBP_CARDIAC_VASCULAR_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.983897219776498
REACTOME_SMAD2_SMAD3_SMAD4_H...,SET,35,0.029032,0.0012664,0.13828,0.41685,REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,0.983897219776498
GSE24574_BCL6_HIGH_TFH_VS_TF...2,SET,176,0.01338,0.0013037,0.063758,0.41689,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_UP,0.983897219776498
REACTOME_ZINC_INFLUX_INTO_CE...,SET,10,0.050616,0.0011809,0.24124,0.41691,REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY,0.983897219776498
MEF2_Q6_01,SET,221,0.01237,0.001349,0.058963,0.41691,MEF2_Q6_01,0.983897219776498
HP_FOCAL_T2_HYPERINTENSE_THA...,SET,14,0.043531,0.0012016,0.20757,0.41695,HP_FOCAL_T2_HYPERINTENSE_THALAMIC_LESION,0.983897219776498
HP_J_SHAPED_SELLA_TURCICA,SET,12,0.048782,0.0012467,0.23277,0.417,HP_J_SHAPED_SELLA_TURCICA,0.983897219776498
GOBP_REGULATION_OF_TRANSPORT...,SET,194,0.013357,0.0013656,0.06378,0.41706,GOBP_REGULATION_OF_TRANSPORTER_ACTIVITY,0.983897219776498
GOBP_POSITIVE_REGULATION_OF_...698,SET,1621,0.0047087,0.0013359,0.022498,0.41711,GOBP_POSITIVE_REGULATION_OF_SIGNALING,0.983897219776498
GSE37532_VISCERAL_ADIPOSE_TI...5,SET,85,0.020554,0.0013953,0.098205,0.41711,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN,0.983897219776498
GSE16266_CTRL_VS_HEATSHOCK_A...2,SET,173,0.012886,0.0012449,0.061639,0.41721,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,0.983897219776498
GSE27786_LSK_VS_NEUTROPHIL_DN,SET,180,0.012918,0.0012727,0.061891,0.41733,GSE27786_LSK_VS_NEUTROPHIL_DN,0.983897219776498
SOX15_TARGET_GENES,SET,3,0.10707,0.0013685,0.51324,0.41737,SOX15_TARGET_GENES,0.983897219776498
WP_RAS_SIGNALING,SET,174,0.013557,0.0013135,0.064997,0.41739,WP_RAS_SIGNALING,0.983897219776498
GOBP_NEGATIVE_REGULATION_OF_...638,SET,18,0.038496,0.0012047,0.18464,0.41742,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.983897219776498
LOPEZ_MESOTHELIOMA_SURVIVAL_...5,SET,7,0.0653,0.0012748,0.31327,0.41744,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN,0.983897219776498
LY_AGING_MIDDLE_DN,SET,15,0.042351,0.00121,0.2032,0.41745,LY_AGING_MIDDLE_DN,0.983897219776498
GOBP_ACTIVATED_T_CELL_PROLIF...,SET,42,0.02942,0.0014055,0.14125,0.4175,GOBP_ACTIVATED_T_CELL_PROLIFERATION,0.983897219776498
HP_DEEP_PLANTAR_CREASES,SET,19,0.040431,0.0012999,0.19418,0.41753,HP_DEEP_PLANTAR_CREASES,0.983897219776498
GOCC_DENDRITIC_SHAFT,SET,39,0.028887,0.0013299,0.13875,0.41754,GOCC_DENDRITIC_SHAFT,0.983897219776498
GSE7852_LN_VS_THYMUS_TCONV_DN,SET,187,0.012609,0.001266,0.06056,0.41754,GSE7852_LN_VS_THYMUS_TCONV_DN,0.983897219776498
GSE12845_IGD_NEG_BLOOD_VS_PR...1,SET,182,0.01244,0.0012324,0.059774,0.41757,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,0.983897219776498
REACTOME_PENTOSE_PHOSPHATE_P...,SET,12,0.053689,0.0013721,0.25808,0.4176,REACTOME_PENTOSE_PHOSPHATE_PATHWAY,0.983897219776498
MIR548AV_5P_MIR548K,SET,267,0.010814,0.0012946,0.051988,0.41761,MIR548AV_5P_MIR548K,0.983897219776498
GSE5589_LPS_AND_IL10_VS_LPS_...1,SET,177,0.013072,0.0012772,0.06284,0.41761,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,0.983897219776498
LI_PBMC_MENACTRA_AGE_18_45YO...8,SET,15,0.049882,0.0014252,0.23992,0.41765,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE,0.983897219776498
GSE17974_CTRL_VS_ACT_IL4_AND...4,SET,159,0.014431,0.0013371,0.069433,0.41768,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP,0.983897219776498
MIR7853_5P,SET,198,0.012556,0.0012969,0.060432,0.4177,MIR7853_5P,0.983897219776498
CEBP_Q2_01,SET,239,0.01185,0.0013431,0.057035,0.41771,CEBP_Q2_01,0.983897219776498
HP_YELLOW_BROWN_DISCOLORATIO...,SET,14,0.04746,0.00131,0.22845,0.41771,HP_YELLOW_BROWN_DISCOLORATION_OF_THE_TEETH,0.983897219776498
GOBP_ESTABLISHMENT_OF_TISSUE...,SET,35,0.031576,0.0013773,0.15206,0.41775,GOBP_ESTABLISHMENT_OF_TISSUE_POLARITY,0.983897219776498
HP_EXANTHEM,SET,20,0.039229,0.001294,0.18892,0.41775,HP_EXANTHEM,0.983897219776498
HP_EUNUCHOID_HABITUS,SET,21,0.041108,0.0013894,0.19803,0.41778,HP_EUNUCHOID_HABITUS,0.983897219776498
LI_PBMC_MENOMUNE_A_C_Y_W_135...2,SET,27,0.0364,0.0013948,0.17553,0.41786,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_UP,0.983897219776498
GOBP_NEGATIVE_REGULATION_OF_...351,SET,24,0.034026,0.0012294,0.16409,0.41787,GOBP_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT,0.983897219776498
PID_IL2_PI3K_PATHWAY,SET,33,0.030668,0.001299,0.14797,0.41791,PID_IL2_PI3K_PATHWAY,0.983897219776498
TSAI_RESPONSE_TO_RADIATION_T...,SET,28,0.037191,0.0014512,0.17948,0.41792,TSAI_RESPONSE_TO_RADIATION_THERAPY,0.983897219776498
GOMF_CATALYTIC_ACTIVITY_ACTI...3,SET,16,0.037872,0.0011175,0.18279,0.41793,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_RRNA,0.983897219776498
SCHUHMACHER_MYC_TARGETS_DN,SET,7,0.066376,0.0012958,0.3204,0.41794,SCHUHMACHER_MYC_TARGETS_DN,0.983897219776498
DAZARD_UV_RESPONSE_CLUSTER_G2,SET,25,0.037701,0.0013902,0.18203,0.41796,DAZARD_UV_RESPONSE_CLUSTER_G2,0.983897219776498
STAT1_01,SET,62,0.021695,0.0012585,0.10474,0.41796,STAT1_01,0.983897219776498
GSE12963_ENV_NEF_VS_ENV_NEF_...2,SET,117,0.015398,0.0012252,0.074345,0.41796,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.983897219776498
LEE_NEURAL_CREST_STEM_CELL_DN,SET,103,0.018878,0.0014099,0.091155,0.41797,LEE_NEURAL_CREST_STEM_CELL_DN,0.983897219776498
GOBP_TRIPARTITE_REGIONAL_SUB...,SET,17,0.046651,0.0014188,0.22527,0.41797,GOBP_TRIPARTITE_REGIONAL_SUBDIVISION,0.983897219776498
TONKS_TARGETS_OF_RUNX1_RUNX1...2,SET,143,0.015707,0.0013807,0.075863,0.41799,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,0.983897219776498
TCCCRNNRTGC_UNKNOWN,SET,189,0.012296,0.0012411,0.059389,0.41799,TCCCRNNRTGC_UNKNOWN,0.983897219776498
MIR7844_5P,SET,139,0.01496,0.0012967,0.072416,0.41817,MIR7844_5P,0.984071519286631
OISHI_CHOLANGIOMA_STEM_CELL_...1,SET,253,0.011472,0.0013374,0.055556,0.4182,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,0.984071519286631
MIR519D_3P,SET,567,0.0074914,0.001296,0.036296,0.41824,MIR519D_3P,0.984071519286631
GSE3982_BASOPHIL_VS_CENT_MEM...2,SET,176,0.013114,0.0012777,0.063553,0.41826,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,0.984071519286631
GOMF_PROTEIN_SERINE_THREONIN...2,SET,392,0.0086161,0.0012454,0.041796,0.41834,GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.984071519286631
GOMF_HEMOGLOBIN_ALPHA_BINDING,SET,4,0.12061,0.00178,0.58527,0.41837,GOMF_HEMOGLOBIN_ALPHA_BINDING,0.984071519286631
WP_GENES_ASSOCIATED_WITH_THE...,SET,17,0.046485,0.0014138,0.2257,0.41841,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,0.984071519286631
GOCC_CYTOPLASMIC_DYNEIN_COMP...,SET,16,0.042177,0.0012445,0.20481,0.41842,GOCC_CYTOPLASMIC_DYNEIN_COMPLEX,0.984071519286631
GSE39152_CD103_NEG_VS_POS_ME...1,SET,186,0.012508,0.0012526,0.060744,0.41843,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN,0.984071519286631
REACTOME_ADENYLATE_CYCLASE_A...,SET,10,0.058498,0.0013648,0.28414,0.41844,REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY,0.984071519286631
REACTOME_INCRETIN_SYNTHESIS_...,SET,23,0.036977,0.0013079,0.17962,0.41845,REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION,0.984071519286631
GOBP_ARP2_3_COMPLEX_MEDIATED...,SET,33,0.02694,0.0011411,0.13094,0.4185,GOBP_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.984071519286631
GOMF_DIACYLGLYCEROL_O_ACYLTR...,SET,5,0.085077,0.0014037,0.4135,0.4185,GOMF_DIACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.984071519286631
GOMF_OXALATE_TRANSMEMBRANE_T...,SET,9,0.056979,0.0012612,0.27727,0.41859,GOMF_OXALATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.984071519286631
PRDM5_TARGET_GENES,SET,79,0.019337,0.0012656,0.094102,0.4186,PRDM5_TARGET_GENES,0.984071519286631
WALLACE_PROSTATE_CANCER_DN,SET,5,0.086963,0.0014349,0.42326,0.41861,WALLACE_PROSTATE_CANCER_DN,0.984071519286631
MIR4746_5P,SET,8,0.055781,0.0011641,0.27158,0.41863,MIR4746_5P,0.984071519286631
GOBP_REGULATION_OF_GLYCOGEN_...2,SET,6,0.071245,0.0012877,0.34707,0.41868,GOBP_REGULATION_OF_GLYCOGEN_CATABOLIC_PROCESS,0.984071519286631
MANNO_MIDBRAIN_NEUROTYPES_HE...,SET,803,0.006591,0.0013479,0.032113,0.41869,MANNO_MIDBRAIN_NEUROTYPES_HENDO,0.984071519286631
ZNF292_TARGET_GENES,SET,21,0.035755,0.0012085,0.17423,0.4187,ZNF292_TARGET_GENES,0.984071519286631
DESCARTES_MAIN_FETAL_GOBLET_...,SET,37,0.032223,0.0014451,0.15703,0.41871,DESCARTES_MAIN_FETAL_GOBLET_CELLS,0.984071519286631
MORF_PDPK1,SET,65,0.020508,0.001218,0.099976,0.41874,MORF_PDPK1,0.984071519286631
MIR378A_5P,SET,120,0.016448,0.0013253,0.080258,0.41881,MIR378A_5P,0.984071519286631
HP_RED_GREEN_DYSCHROMATOPSIA,SET,8,0.064586,0.0013478,0.31513,0.41881,HP_RED_GREEN_DYSCHROMATOPSIA,0.984071519286631
GOCC_PIP_BODY,SET,5,0.063608,0.0010495,0.31042,0.41882,GOCC_PIP_BODY,0.984071519286631
MORF_PPP2R5B,SET,156,0.013802,0.0012668,0.067387,0.41886,MORF_PPP2R5B,0.984071519286631
GSE3982_DC_VS_BASOPHIL_UP,SET,182,0.013115,0.0012993,0.064042,0.41887,GSE3982_DC_VS_BASOPHIL_UP,0.984071519286631
DAVICIONI_TARGETS_OF_PAX_FOX...1,SET,62,0.023919,0.0013876,0.11686,0.41891,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,0.984071519286631
GOBP_GUANINE_NUCLEOTIDE_TRAN...,SET,11,0.057959,0.0014182,0.28325,0.41893,GOBP_GUANINE_NUCLEOTIDE_TRANSPORT,0.984071519286631
GSE16385_ROSIGLITAZONE_IL4_V...5,SET,182,0.012555,0.0012437,0.061392,0.41898,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN,0.984071519286631
ABRAHAM_ALPC_VS_MULTIPLE_MYE...1,SET,20,0.038696,0.0012764,0.18927,0.419,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,0.984071519286631
GOBP_REGULATION_OF_REGULATOR...,SET,15,0.043493,0.0012426,0.21278,0.41902,GOBP_REGULATION_OF_REGULATORY_NCRNA_PROCESSING,0.984071519286631
GOBP_NEGATIVE_REGULATION_OF_...511,SET,6,0.067058,0.001212,0.32811,0.41903,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION,0.984071519286631
MCBRYAN_PUBERTAL_BREAST_6_7W...2,SET,177,0.012576,0.0012288,0.061568,0.41908,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,0.984071519286631
GOBP_SURFACTANT_HOMEOSTASIS,SET,20,0.039055,0.0012883,0.19131,0.41912,GOBP_SURFACTANT_HOMEOSTASIS,0.984071519286631
GOBP_CALCIUM_ION_EXPORT_ACRO...,SET,9,0.064244,0.001422,0.31476,0.41914,GOBP_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.984071519286631
GOBP_REGULATION_OF_TRANSMEMB...1,SET,247,0.011525,0.0013277,0.056467,0.41914,GOBP_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.984071519286631
HP_HIP_DISLOCATION,SET,226,0.011259,0.0012414,0.055169,0.41914,HP_HIP_DISLOCATION,0.984071519286631
GOBP_CELL_MIGRATION_INVOLVED...2,SET,19,0.045645,0.0014676,0.22392,0.41924,GOBP_CELL_MIGRATION_INVOLVED_IN_HEART_DEVELOPMENT,0.984103411621786
GOBP_POLYOL_TRANSMEMBRANE_TR...,SET,10,0.063165,0.0014737,0.30988,0.41924,GOBP_POLYOL_TRANSMEMBRANE_TRANSPORT,0.984103411621786
GOCC_CYTOPLASMIC_SIDE_OF_ROU...,SET,4,0.072045,0.0010633,0.35357,0.41927,GOCC_CYTOPLASMIC_SIDE_OF_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,0.984103411621786
GOBP_POSITIVE_REGULATION_OF_...219,SET,65,0.02037,0.0012098,0.10003,0.41932,GOBP_POSITIVE_REGULATION_OF_DNA_RECOMBINATION,0.984103411621786
GOBP_POSITIVE_REGULATION_OF_...637,SET,91,0.017328,0.0012169,0.085142,0.41936,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.984103411621786
HP_BULL_S_EYE_MACULOPATHY,SET,9,0.062642,0.0013865,0.30777,0.41936,HP_BULL_S_EYE_MACULOPATHY,0.984103411621786
MIR378E,SET,37,0.026489,0.0011879,0.13019,0.41939,MIR378E,0.984103411621786
AIZARANI_LIVER_C7_EPCAM_POS_...,SET,206,0.012781,0.0013461,0.06283,0.41941,AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2,0.984103411621786
MODULE_421,SET,15,0.043917,0.0012547,0.21603,0.41945,MODULE_421,0.984103411621786
HP_ABNORMALITY_OF_THE_LOWER_...,SET,739,0.0063182,0.0012418,0.031102,0.41951,HP_ABNORMALITY_OF_THE_LOWER_URINARY_TRACT,0.984103411621786
AIZARANI_LIVER_C13_LSECS_2,SET,255,0.011738,0.0013736,0.057777,0.41951,AIZARANI_LIVER_C13_LSECS_2,0.984103411621786
GOBP_DOUBLE_STRAND_BREAK_REP...6,SET,58,0.019964,0.0011203,0.098291,0.41952,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.984103411621786
LE_NEURONAL_DIFFERENTIATION_...2,SET,17,0.039819,0.0012111,0.19607,0.41954,LE_NEURONAL_DIFFERENTIATION_UP,0.984103411621786
GSE2405_HEAT_KILLED_LYSATE_V...4,SET,186,0.012991,0.0013009,0.063979,0.41955,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,0.984103411621786
YOSHIMURA_MAPK8_TARGETS_UP,SET,1186,0.0053559,0.0013165,0.026389,0.41958,YOSHIMURA_MAPK8_TARGETS_UP,0.984107362667027
REACTOME_TRIGLYCERIDE_CATABO...,SET,23,0.036796,0.0013015,0.18152,0.41968,REACTOME_TRIGLYCERIDE_CATABOLISM,0.984232520242915
GOBP_POSITIVE_REGULATION_OF_...604,SET,497,0.0078738,0.0012778,0.038848,0.41969,GOBP_POSITIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH,0.984232520242915
REACTOME_ERYTHROPOIETIN_ACTI...3,SET,14,0.044468,0.0012274,0.2197,0.4198,REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS,0.984311082647971
GOBP_GANGLIOSIDE_CATABOLIC_P...,SET,7,0.070159,0.0013696,0.34693,0.41987,GOBP_GANGLIOSIDE_CATABOLIC_PROCESS,0.984311082647971
GOBP_T_CELL_DIFFERENTIATION_...1,SET,79,0.020759,0.0013587,0.10265,0.41987,GOBP_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,0.984311082647971
JOHANSSON_GLIOMAGENESIS_BY_P...1,SET,21,0.038314,0.001295,0.18953,0.4199,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,0.984311082647971
GOBP_NEGATIVE_REGULATION_OF_...171,SET,7,0.069273,0.0013523,0.34295,0.41996,GOBP_NEGATIVE_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.984311082647971
WP_NAD_METABOLISM,SET,15,0.042749,0.0012214,0.2117,0.41999,WP_NAD_METABOLISM,0.984311082647971
GOBP_POSITIVE_REGULATION_OF_...677,SET,61,0.021337,0.0012278,0.10568,0.41999,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,0.984311082647971
MIR7851_3P,SET,52,0.024025,0.0012767,0.11905,0.42004,MIR7851_3P,0.984311082647971
GOBP_REGULATION_OF_SPONTANEO...,SET,5,0.077071,0.0012717,0.38191,0.42004,GOBP_REGULATION_OF_SPONTANEOUS_SYNAPTIC_TRANSMISSION,0.984311082647971
PETRETTO_HEART_MASS_QTL_CIS_...1,SET,24,0.03371,0.001218,0.16709,0.42006,PETRETTO_HEART_MASS_QTL_CIS_DN,0.984311082647971
FLETCHER_PBMC_BCG_10W_INFANT...3,SET,163,0.014154,0.0013277,0.070167,0.42007,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN,0.984311082647971
REACTOME_GAMMA_CARBOXYLATION...1,SET,51,0.023118,0.0012167,0.11463,0.42009,REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION,0.984311082647971
HP_PLATYSPONDYLY,SET,108,0.016293,0.0012459,0.080801,0.4201,HP_PLATYSPONDYLY,0.984311082647971
HP_EEG_WITH_GENERALIZED_SLOW...1,SET,32,0.029512,0.001231,0.1464,0.42012,HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY,0.984311082647971
GOBP_PURINE_RIBONUCLEOTIDE_S...,SET,7,0.068705,0.0013412,0.34096,0.42015,GOBP_PURINE_RIBONUCLEOTIDE_SALVAGE,0.984315015166835
GOCC_CCR4_NOT_COMPLEX,SET,15,0.042119,0.0012034,0.20919,0.42022,GOCC_CCR4_NOT_COMPLEX,0.984358089622641
GOBP_DNA_DOUBLE_STRAND_BREAK...,SET,19,0.03711,0.0011932,0.18435,0.42023,GOBP_DNA_DOUBLE_STRAND_BREAK_PROCESSING,0.984358089622641
HP_CARPAL_BONE_HYPOPLASIA,SET,11,0.045183,0.0011056,0.22463,0.42029,HP_CARPAL_BONE_HYPOPLASIA,0.984358089622641
KEGG_MEDICUS_REFERENCE_CXCR4...5,SET,26,0.034744,0.0013065,0.17277,0.42031,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,0.984358089622641
GOBP_CELLULAR_RESPONSE_TO_XE...,SET,187,0.013413,0.0013467,0.066696,0.42031,GOBP_CELLULAR_RESPONSE_TO_XENOBIOTIC_STIMULUS,0.984358089622641
HP_CRUMPLED_LONG_BONES,SET,6,0.064479,0.0011654,0.32073,0.42034,HP_CRUMPLED_LONG_BONES,0.984362017384273
ACEVEDO_LIVER_CANCER_WITH_H3...1,SET,141,0.015496,0.0013527,0.077165,0.42042,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,0.984440346684618
GSE22527_ANTI_CD3_INVIVO_VS_...1,SET,178,0.011767,0.001153,0.058616,0.42045,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN,0.984440346684618
GSE37533_UNTREATED_VS_PIOGLI...6,SET,129,0.014854,0.0012407,0.074055,0.42052,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP,0.984440346684618
TANG_SENESCENCE_TP53_TARGETS...1,SET,51,0.024972,0.0013143,0.12454,0.42054,TANG_SENESCENCE_TP53_TARGETS_DN,0.984440346684618
HP_FEVER,SET,372,0.0089519,0.0012612,0.044652,0.42055,HP_FEVER,0.984440346684618
GOBP_POSITIVE_REGULATION_OF_...601,SET,18,0.039648,0.0012408,0.19779,0.42056,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.984440346684618
WP_NUCLEOTIDE_EXCISION_REPAIR,SET,41,0.022662,0.0010697,0.11311,0.42061,WP_NUCLEOTIDE_EXCISION_REPAIR,0.984440346684618
CCATCCA_MIR432,SET,50,0.024033,0.0012525,0.12003,0.42065,CCATCCA_MIR432,0.984440346684618
HP_TRIPHALANGEAL_THUMB,SET,64,0.020223,0.0011919,0.10102,0.42067,HP_TRIPHALANGEAL_THUMB,0.984440346684618
WP_ZINC_HOMEOSTASIS,SET,36,0.028096,0.0012429,0.14045,0.42072,WP_ZINC_HOMEOSTASIS,0.984440346684618
GERHOLD_ADIPOGENESIS_DN,SET,58,0.022276,0.00125,0.11138,0.42074,GERHOLD_ADIPOGENESIS_DN,0.984440346684618
AP2_Q6_01,SET,247,0.010581,0.001219,0.052911,0.42075,AP2_Q6_01,0.984440346684618
GOBP_PLASMA_MEMBRANE_TO_ENDO...,SET,8,0.060534,0.0012633,0.30274,0.42076,GOBP_PLASMA_MEMBRANE_TO_ENDOSOME_TRANSPORT,0.984440346684618
GOBP_NEGATIVE_REGULATION_OF_...110,SET,59,0.020411,0.0011552,0.10209,0.42077,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.984440346684618
GOCC_INNER_MITOCHONDRIAL_MEM...,SET,113,0.01424,0.0011137,0.071279,0.42083,GOCC_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,0.984475491317809
MIR515_3P,SET,61,0.021572,0.0012413,0.10801,0.42085,MIR515_3P,0.984475491317809
GOBP_RESOLUTION_OF_DNA_RECOM...,SET,6,0.060654,0.0010963,0.30378,0.42087,GOBP_RESOLUTION_OF_DNA_RECOMBINATION_INTERMEDIATES,0.984475491317809
GSE40274_CTRL_VS_FOXP3_AND_L...1,SET,147,0.013613,0.0012131,0.068205,0.4209,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.984479406420351
HP_ENDOCARDIAL_FIBROSIS,SET,6,0.073909,0.0013358,0.37076,0.421,HP_ENDOCARDIAL_FIBROSIS,0.984631459426726
ILK_TARGET_GENES,SET,15,0.040286,0.001151,0.20223,0.42105,ILK_TARGET_GENES,0.984631459426726
GOBP_DICARBOXYLIC_ACID_BIOSY...,SET,12,0.052274,0.0013359,0.26239,0.42105,GOBP_DICARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,0.984631459426726
HP_NARROW_PALM,SET,13,0.050009,0.0013302,0.25136,0.42115,HP_NARROW_PALM,0.984643267486394
KYNG_ENVIRONMENTAL_STRESS_RE...7,SET,12,0.049364,0.0012616,0.24822,0.42118,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,0.984643267486394
GSE42724_NAIVE_VS_MEMORY_BCE...2,SET,184,0.011984,0.0011936,0.060283,0.42121,GSE42724_NAIVE_VS_MEMORY_BCELL_UP,0.984643267486394
HP_ORTHOSTATIC_HYPOTENSION_D...,SET,15,0.046559,0.0013302,0.23438,0.42127,HP_ORTHOSTATIC_HYPOTENSION_DUE_TO_AUTONOMIC_DYSFUNCTION,0.984643267486394
PARENT_MTOR_SIGNALING_DN,SET,41,0.026413,0.0012467,0.13302,0.4213,PARENT_MTOR_SIGNALING_DN,0.984643267486394
GOBP_REGULATED_EXOCYTOSIS,SET,210,0.011512,0.0012241,0.057973,0.4213,GOBP_REGULATED_EXOCYTOSIS,0.984643267486394
ZHENG_IL22_SIGNALING_DN,SET,34,0.028978,0.0012458,0.14605,0.42136,ZHENG_IL22_SIGNALING_DN,0.984643267486394
WANG_RESPONSE_TO_BEXAROTENE_...1,SET,28,0.032945,0.0012855,0.16606,0.42137,WANG_RESPONSE_TO_BEXAROTENE_DN,0.984643267486394
GOCC_DERLIN_1_RETROTRANSLOCA...,SET,7,0.056675,0.0011064,0.28572,0.42138,GOCC_DERLIN_1_RETROTRANSLOCATION_COMPLEX,0.984643267486394
GOBP_POSITIVE_REGULATION_OF_...134,SET,55,0.023601,0.0012898,0.119,0.4214,GOBP_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION,0.984643267486394
GOBP_PURINE_NUCLEOSIDE_METAB...,SET,24,0.038093,0.0013763,0.19209,0.42141,GOBP_PURINE_NUCLEOSIDE_METABOLIC_PROCESS,0.984643267486394
GOMF_TESTOSTERONE_17_BETA_DE...,SET,9,0.054414,0.0012044,0.27466,0.42148,GOMF_TESTOSTERONE_17_BETA_DEHYDROGENASE_NADPPLUS_ACTIVITY,0.984643267486394
GOBP_PHOSPHATIDYLETHANOLAMIN...1,SET,7,0.068377,0.0013348,0.34517,0.42149,GOBP_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING,0.984643267486394
HALLMARK_INFLAMMATORY_RESPON...,SET,190,0.013158,0.0013315,0.066419,0.42149,HALLMARK_INFLAMMATORY_RESPONSE,0.984643267486394
GOBP_STEROL_BIOSYNTHETIC_PRO...,SET,53,0.021879,0.0011738,0.11047,0.4215,GOBP_STEROL_BIOSYNTHETIC_PROCESS,0.984643267486394
KEGG_MEDICUS_REFERENCE_TYPE_...2,SET,20,0.04277,0.0014108,0.21603,0.42153,KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY,0.984643267486394
GOMF_NEUROPEPTIDE_BINDING,SET,28,0.037222,0.0014525,0.18806,0.42155,GOMF_NEUROPEPTIDE_BINDING,0.984643267486394
HP_POLYMORPHIC_VENTRICULAR_T...,SET,6,0.078216,0.0014137,0.39549,0.42161,HP_POLYMORPHIC_VENTRICULAR_TACHYCARDIA,0.984643267486394
BARRIER_COLON_CANCER_RECURRE...2,SET,37,0.026965,0.0012092,0.13638,0.42163,BARRIER_COLON_CANCER_RECURRENCE_UP,0.984643267486394
ATF6_TARGET_GENES,SET,864,0.0057615,0.00122,0.029139,0.42163,ATF6_TARGET_GENES,0.984643267486394
GOBP_REGULATION_OF_DOPAMINE_...2,SET,24,0.037363,0.0013499,0.189,0.42165,GOBP_REGULATION_OF_DOPAMINE_SECRETION,0.984643267486394
WP_CHOLESTEROL_SYNTHESIS_DIS...,SET,17,0.036797,0.0011192,0.18622,0.42168,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,0.984647164740661
HP_PLEURITIS,SET,26,0.035817,0.0013469,0.18138,0.42173,HP_PLEURITIS,0.984654957678355
HP_PROTRUDING_EAR,SET,168,0.012611,0.0012008,0.06387,0.42174,HP_PROTRUDING_EAR,0.984654957678355
MIR5695,SET,87,0.017898,0.0012291,0.09069,0.42178,MIR5695,0.9846627485223
SANSOM_APC_TARGETS_REQUIRE_M...,SET,210,0.010864,0.0011552,0.055068,0.4218,SANSOM_APC_TARGETS_REQUIRE_MYC,0.9846627485223
HP_TENTED_UPPER_LIP_VERMILION,SET,101,0.015908,0.0011766,0.080659,0.42183,HP_TENTED_UPPER_LIP_VERMILION,0.984666643159379
HP_TALIPES_VALGUS,SET,17,0.042674,0.0012979,0.21653,0.42188,HP_TALIPES_VALGUS,0.984717219610477
ZNF843_TARGET_GENES,SET,675,0.0065596,0.0012344,0.033304,0.42193,ZNF843_TARGET_GENES,0.984717229004561
HP_SUPRAVENTRICULAR_TACHYCAR...,SET,51,0.025159,0.0013241,0.12776,0.42195,HP_SUPRAVENTRICULAR_TACHYCARDIA,0.984717229004561
GCM_RAB10,SET,162,0.01217,0.0011381,0.061834,0.42199,GCM_RAB10,0.984717229004561
BIOCARTA_CELLCYCLE_PATHWAY,SET,23,0.033237,0.0011756,0.16895,0.42202,BIOCARTA_CELLCYCLE_PATHWAY,0.984717229004561
GOBP_PHOSPHATIDYLSERINE_META...,SET,22,0.036173,0.0012514,0.18403,0.42209,GOBP_PHOSPHATIDYLSERINE_METABOLIC_PROCESS,0.984717229004561
GSE10240_CTRL_VS_IL17_AND_IL...2,SET,182,0.011561,0.0011453,0.058822,0.42209,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.984717229004561
HP_BRADYCARDIA,SET,90,0.017737,0.0012388,0.090288,0.42213,HP_BRADYCARDIA,0.984717229004561
MIR4657,SET,66,0.02018,0.0012077,0.10278,0.42217,MIR4657,0.984717229004561
GOMF_HISTONE_H3_KINASE_ACTIV...,SET,10,0.051907,0.001211,0.2644,0.42218,GOMF_HISTONE_H3_KINASE_ACTIVITY,0.984717229004561
GOBP_POSITIVE_REGULATION_OF_...81,SET,13,0.050333,0.0013388,0.25644,0.4222,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,0.984717229004561
GOCC_WNT_SIGNALOSOME,SET,13,0.049185,0.0013083,0.2507,0.42223,GOCC_WNT_SIGNALOSOME,0.984717229004561
FOXC1_TARGET_GENES,SET,59,0.022152,0.0012537,0.11293,0.42225,FOXC1_TARGET_GENES,0.984717229004561
HP_BILE_DUCT_PROLIFERATION,SET,18,0.035572,0.0011132,0.18148,0.4223,HP_BILE_DUCT_PROLIFERATION,0.984717229004561
GARGALOVIC_RESPONSE_TO_OXIDI...15,SET,30,0.033599,0.001357,0.17148,0.42233,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN,0.984717229004561
HP_WOLFF_PARKINSON_WHITE_SYN...,SET,15,0.040105,0.0011458,0.2047,0.42234,HP_WOLFF_PARKINSON_WHITE_SYNDROME,0.984717229004561
GOBP_PROTEIN_LOCALIZATION_TO...40,SET,866,0.0055557,0.0011778,0.028362,0.42235,GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE,0.984717229004561
GSE36392_TYPE_2_MYELOID_VS_M...2,SET,183,0.012953,0.0012867,0.066154,0.42238,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP,0.984717229004561
HP_ABNORMAL_PERIPHERAL_MYELI...,SET,92,0.016817,0.0011874,0.085898,0.42239,HP_ABNORMAL_PERIPHERAL_MYELINATION,0.984717229004561
GOBP_POSITIVE_REGULATION_OF_...357,SET,81,0.018587,0.0012318,0.095066,0.42249,GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION,0.984825995842275
GOMF_POLY_A_BINDING,SET,21,0.036724,0.0012412,0.18786,0.42251,GOMF_POLY_A_BINDING,0.984825995842275
GSE22611_UNSTIM_VS_6H_MDP_ST...3,SET,180,0.012115,0.0011937,0.062004,0.42254,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.984825995842275
HP_ABNORMAL_RENAL_MORPHOLOGY,SET,983,0.0054037,0.0012164,0.027656,0.42255,HP_ABNORMAL_RENAL_MORPHOLOGY,0.984825995842275
LANDIS_ERBB2_BREAST_TUMORS_6...1,SET,36,0.029589,0.0013089,0.15156,0.42261,LANDIS_ERBB2_BREAST_TUMORS_65_DN,0.984899788774894
BIOCARTA_RARRXR_PATHWAY,SET,7,0.055865,0.0010906,0.28626,0.42264,BIOCARTA_RARRXR_PATHWAY,0.984903660989674
HP_ABNORMALITY_OF_THE_PHILTR...,SET,621,0.006559,0.0011857,0.033633,0.42269,HP_ABNORMALITY_OF_THE_PHILTRUM,0.9849385734397
MIR373_3P,SET,295,0.009597,0.0012067,0.049231,0.42272,MIR373_3P,0.9849385734397
GOBP_CELLULAR_RESPONSE_TO_NI...4,SET,6,0.058678,0.0010606,0.30106,0.42274,GOBP_CELLULAR_RESPONSE_TO_NITROSATIVE_STRESS,0.9849385734397
REACTOME_CASPASE_ACTIVATION_...2,SET,9,0.052828,0.0011693,0.27128,0.4228,REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND,0.984946310074402
GSE13887_RESTING_VS_ACT_CD4_...1,SET,116,0.014825,0.0011747,0.076132,0.4228,GSE13887_RESTING_VS_ACT_CD4_TCELL_DN,0.984946310074402
GOBP_GLANDULAR_EPITHELIAL_CE...2,SET,68,0.021695,0.0013178,0.11149,0.42286,GOBP_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION,0.985020060321716
GENTILE_UV_HIGH_DOSE_UP,SET,17,0.044156,0.001343,0.22705,0.4229,GENTILE_UV_HIGH_DOSE_UP,0.985031645781679
GSE17974_0H_VS_48H_IN_VITRO_...2,SET,164,0.013113,0.0012337,0.067457,0.42294,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP,0.985031645781679
GOBP_ISOCITRATE_METABOLIC_PR...,SET,5,0.072548,0.001197,0.37327,0.42295,GOBP_ISOCITRATE_METABOLIC_PROCESS,0.985031645781679
LEE_TARGETS_OF_PTCH1_AND_SUF...2,SET,51,0.022933,0.0012069,0.11813,0.42304,LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,0.985140219066122
HP_OPEN_OPERCULUM,SET,6,0.068024,0.0012295,0.35058,0.42308,HP_OPEN_OPERCULUM,0.985140219066122
ZMYND11_TARGET_GENES,SET,34,0.028148,0.0012101,0.1451,0.42309,ZMYND11_TARGET_GENES,0.985140219066122
MIR373_5P,SET,852,0.0057219,0.0012036,0.029502,0.42311,MIR373_5P,0.985140219066122
JIANG_MELANOMA_TRM2_CD8,SET,127,0.015806,0.00131,0.08157,0.42318,JIANG_MELANOMA_TRM2_CD8,0.985237198553055
HP_ABNORMAL_PUBIC_BONE_MORPH...,SET,39,0.0267,0.0012292,0.13793,0.42326,HP_ABNORMAL_PUBIC_BONE_MORPHOLOGY,0.985341347119052
GOBP_FOLLICLE_STIMULATING_HO...,SET,8,0.066493,0.0013876,0.34389,0.42334,GOBP_FOLLICLE_STIMULATING_HORMONE_SECRETION,0.985341347119052
GOBP_DETECTION_OF_CALCIUM_ION,SET,13,0.04659,0.0012392,0.24098,0.42335,GOBP_DETECTION_OF_CALCIUM_ION,0.985341347119052
HP_ANODONTIA,SET,13,0.04467,0.0011882,0.23129,0.42343,HP_ANODONTIA,0.985341347119052
HP_KNEE_JOINT_HYPERMOBILITY,SET,5,0.083645,0.0013801,0.4331,0.42343,HP_KNEE_JOINT_HYPERMOBILITY,0.985341347119052
SMID_BREAST_CANCER_NORMAL_LI...2,SET,422,0.0085331,0.0012787,0.044209,0.42347,SMID_BREAST_CANCER_NORMAL_LIKE_UP,0.985341347119052
HP_FOCAL_CORTICAL_DYSPLASIA_...,SET,5,0.077689,0.0012819,0.40255,0.42348,HP_FOCAL_CORTICAL_DYSPLASIA_TYPE_II,0.985341347119052
KEGG_MEDICUS_REFERENCE_TSC1_...,SET,11,0.047914,0.0011724,0.24834,0.42351,KEGG_MEDICUS_REFERENCE_TSC1_2_MTORC1_SIGNALING_PATHWAY,0.985341347119052
GOBP_REGULATION_OF_EXTRACELL...2,SET,9,0.063649,0.0014088,0.32997,0.42352,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_CONSTITUENT_SECRETION,0.985341347119052
HP_OVERWEIGHT,SET,42,0.024468,0.0011689,0.12694,0.42358,HP_OVERWEIGHT,0.985341347119052
GOMF_ACETYLCHOLINE_RECEPTOR_...3,SET,7,0.073602,0.0014368,0.38201,0.42361,GOMF_ACETYLCHOLINE_RECEPTOR_INHIBITOR_ACTIVITY,0.985341347119052
GNF2_ITGB2,SET,51,0.022534,0.0011859,0.11697,0.42362,GNF2_ITGB2,0.985341347119052
GOBP_NEGATIVE_REGULATION_OF_...126,SET,8,0.060564,0.0012639,0.3144,0.42362,GOBP_NEGATIVE_REGULATION_OF_CELL_SIZE,0.985341347119052
HP_EXERCISE_INDUCED_RHABDOMY...,SET,6,0.054382,0.00098291,0.28233,0.42363,HP_EXERCISE_INDUCED_RHABDOMYOLYSIS,0.985341347119052
PASTURAL_RIZ1_TARGETS_DN,SET,5,0.079479,0.0013114,0.41271,0.42365,PASTURAL_RIZ1_TARGETS_DN,0.985341347119052
KEGG_MEDICUS_REFERENCE_MDM2_...2,SET,11,0.04725,0.0011562,0.24545,0.42368,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00536,0.985345182012848
REACTOME_DUAL_INCISION_IN_TC...,SET,60,0.018397,0.00105,0.095732,0.4238,REACTOME_DUAL_INCISION_IN_TC_NER,0.985538879967884
BYSTRYKH_HEMATOPOIESIS_STEM_...5,SET,8,0.058593,0.0012228,0.30494,0.42382,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA,0.985538879967884
STEIN_ESR1_TARGETS,SET,77,0.019171,0.0012389,0.09994,0.42394,STEIN_ESR1_TARGETS,0.985603061769616
RAY_TARGETS_OF_P210_BCR_ABL_...2,SET,12,0.052495,0.0013416,0.2738,0.42398,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP,0.985603061769616
GOMF_PHOSPHATIDYLINOSITOL_3_...3,SET,35,0.027152,0.0011843,0.14166,0.424,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING,0.985603061769616
HP_ABNORMALITY_OF_THE_FOREHE...,SET,1026,0.0050531,0.0011607,0.026383,0.42406,HP_ABNORMALITY_OF_THE_FOREHEAD,0.985603061769616
GSE28737_WT_VS_BCL6_HET_FOLL...1,SET,178,0.011932,0.0011691,0.062301,0.42406,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_DN,0.985603061769616
GOCC_SYNAPTIC_VESICLE_MEMBRA...,SET,124,0.014889,0.0012195,0.077792,0.42411,GOCC_SYNAPTIC_VESICLE_MEMBRANE,0.985603061769616
HP_ABNORMALITY_OF_THE_ANTERI...1,SET,6,0.058812,0.001063,0.30733,0.42412,HP_ABNORMALITY_OF_THE_ANTERIOR_COMMISSURE,0.985603061769616
GOBP_ACTIN_FILAMENT_NETWORK_...,SET,6,0.072107,0.0013033,0.37697,0.42415,GOBP_ACTIN_FILAMENT_NETWORK_FORMATION,0.985603061769616
MIR3189_5P,SET,47,0.021933,0.0011083,0.11477,0.42422,MIR3189_5P,0.985603061769616
GOBP_ELASTIN_METABOLIC_PROCE...,SET,7,0.071658,0.0013989,0.37495,0.42422,GOBP_ELASTIN_METABOLIC_PROCESS,0.985603061769616
GOBP_PROLINE_METABOLIC_PROCE...,SET,9,0.057789,0.0012791,0.3026,0.42427,GOBP_PROLINE_METABOLIC_PROCESS,0.985603061769616
HP_SKELETAL_MYOPATHY,SET,9,0.045256,0.0010017,0.23699,0.42428,HP_SKELETAL_MYOPATHY,0.985603061769616
OVSYANNIKOVA_PBMC_FLUARIX_AG...7,SET,6,0.062574,0.001131,0.32775,0.42429,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_DN,0.985603061769616
MIR7159_3P,SET,199,0.011491,0.0011897,0.060188,0.4243,MIR7159_3P,0.985603061769616
WP_TRYPTOPHAN_CATABOLISM_LEA...,SET,16,0.041586,0.0012271,0.21801,0.42436,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,0.985603061769616
GOBP_NEGATIVE_REGULATION_OF_...395,SET,27,0.0311,0.0011917,0.16308,0.42438,GOBP_NEGATIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS,0.985603061769616
GSE14308_TH17_VS_NATURAL_TRE...2,SET,180,0.011845,0.001167,0.062125,0.4244,GSE14308_TH17_VS_NATURAL_TREG_UP,0.985603061769616
MIR105_3P,SET,4,0.10028,0.00148,0.5267,0.4245,MIR105_3P,0.985603061769616
GOBP_NEGATIVE_REGULATION_OF_...487,SET,53,0.021591,0.0011583,0.11345,0.42453,GOBP_NEGATIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,0.985603061769616
HP_HELICOBACTER_PYLORI_INFEC...,SET,4,0.080974,0.001195,0.4256,0.42455,HP_HELICOBACTER_PYLORI_INFECTION,0.985603061769616
KAECH_NAIVE_VS_DAY15_EFF_CD8...2,SET,177,0.011732,0.0011463,0.061657,0.42455,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP,0.985603061769616
MCCOLLUM_GELDANAMYCIN_RESIST...1,SET,7,0.06297,0.0012293,0.33098,0.42456,MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN,0.985603061769616
CAO_BLOOD_FLUMIST_AGE_05_14Y...5,SET,7,0.056814,0.0011091,0.29878,0.42459,CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_DN,0.985603061769616
GSE17721_LPS_VS_POLYIC_8H_BM...1,SET,177,0.011675,0.0011407,0.061403,0.4246,GSE17721_LPS_VS_POLYIC_8H_BMDC_DN,0.985603061769616
HP_ABNORMAL_EPIPHYSIS_MORPHO...2,SET,36,0.026933,0.0011914,0.14166,0.42461,HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY_OF_THE_PHALANGES_OF_THE_HAND,0.985603061769616
KIM_GERMINAL_CENTER_T_HELPER...2,SET,57,0.022955,0.001277,0.12079,0.42464,KIM_GERMINAL_CENTER_T_HELPER_UP,0.985603061769616
GSE8835_HEALTHY_VS_CLL_CD4_T...1,SET,174,0.011949,0.0011577,0.062887,0.42465,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN,0.985603061769616
REACTOME_RUNX1_REGULATES_GEN...,SET,35,0.027256,0.0011889,0.14348,0.42467,REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION,0.985603061769616
WP_ADIPOGENESIS,SET,125,0.015338,0.0012612,0.080743,0.42467,WP_ADIPOGENESIS,0.985603061769616
HP_ABNORMAL_CORNEAL_STROMA_M...,SET,95,0.016626,0.0011928,0.087556,0.4247,HP_ABNORMAL_CORNEAL_STROMA_MORPHOLOGY,0.98560687099359
SCHLOSSER_SERUM_RESPONSE_DN,SET,635,0.0063054,0.0011521,0.033219,0.42473,SCHLOSSER_SERUM_RESPONSE_DN,0.985610679708887
GSE26669_CTRL_VS_COSTIM_BLOC...1,SET,174,0.012237,0.0011855,0.064505,0.42477,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN,0.985637691948191
GOCC_ELASTIC_FIBER,SET,4,0.084948,0.0012537,0.44797,0.4248,GOCC_ELASTIC_FIBER,0.985641498097336
HP_FUNCTIONAL_ABNORMALITY_OF...4,SET,330,0.0086438,0.0011484,0.045632,0.42488,HP_FUNCTIONAL_ABNORMALITY_OF_THE_MIDDLE_EAR,0.985679913902423
ROVERSI_GLIOMA_COPY_NUMBER_DN,SET,51,0.027475,0.001446,0.14513,0.42493,ROVERSI_GLIOMA_COPY_NUMBER_DN,0.985679913902423
GOBP_PROTEIN_HOMOTETRAMERIZA...,SET,60,0.020815,0.0011879,0.10995,0.42493,GOBP_PROTEIN_HOMOTETRAMERIZATION,0.985679913902423
GOCC_VACUOLE,SET,773,0.0057546,0.0011556,0.030399,0.42493,GOCC_VACUOLE,0.985679913902423
GSE411_WT_VS_SOCS3_KO_MACROP...6,SET,177,0.01185,0.0011579,0.062633,0.42497,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP,0.985702718660351
MIR3194_3P,SET,90,0.016276,0.0011367,0.086083,0.42502,MIR3194_3P,0.985702718660351
GOBP_REGULATION_OF_PRO_B_CEL...,SET,8,0.060152,0.0012553,0.31817,0.42503,GOBP_REGULATION_OF_PRO_B_CELL_DIFFERENTIATION,0.985702718660351
GOMF_PHOSPHODIESTERASE_I_ACT...,SET,5,0.07035,0.0011608,0.37237,0.42508,GOMF_PHOSPHODIESTERASE_I_ACTIVITY,0.985702718660351
HP_TACHYPNEA,SET,88,0.016045,0.0011081,0.084946,0.42509,HP_TACHYPNEA,0.985702718660351
GOCC_CLATHRIN_COATED_ENDOCYT...2,SET,66,0.021292,0.0012743,0.11276,0.42511,GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE,0.985702718660351
HP_ABNORMAL_CORONARY_ARTERY_...1,SET,67,0.020163,0.0012157,0.10684,0.42516,HP_ABNORMAL_CORONARY_ARTERY_MORPHOLOGY,0.985709134519288
HP_MACROCEPHALY_AT_BIRTH,SET,8,0.0596,0.0012438,0.3161,0.42522,HP_MACROCEPHALY_AT_BIRTH,0.985709134519288
chr7p12,SET,18,0.065366,0.0020456,0.34683,0.42526,chr7p12,0.985709134519288
GOBP_NEGATIVE_REGULATION_OF_...646,SET,6,0.071555,0.0012933,0.38,0.42532,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.985709134519288
GSE8921_UNSTIM_VS_TLR1_2_STI...5,SET,183,0.011629,0.0011552,0.06178,0.42535,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN,0.985709134519288
GOBP_MITOCHONDRIAL_ELECTRON_...1,SET,16,0.036474,0.0010762,0.1938,0.42536,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_CYTOCHROME_C_TO_OXYGEN,0.985709134519288
HE_LIM_SUN_FETAL_LUNG_C0_INT...1,SET,62,0.022246,0.0012905,0.11825,0.42539,HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE,0.985709134519288
GOBP_CELL_PROLIFERATION_IN_F...,SET,25,0.034668,0.0012784,0.18433,0.42541,GOBP_CELL_PROLIFERATION_IN_FOREBRAIN,0.985709134519288
GOBP_T_HELPER_1_TYPE_IMMUNE_...,SET,45,0.026336,0.0013022,0.14006,0.42543,GOBP_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.985709134519288
NIKOLSKY_BREAST_CANCER_15Q26...,SET,17,0.058072,0.0017662,0.30927,0.42553,NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,0.985709134519288
HP_BROAD_METACARPALS,SET,17,0.041957,0.0012761,0.22349,0.42554,HP_BROAD_METACARPALS,0.985709134519288
HP_ABNORMAL_CIRCULATING_CALC...,SET,46,0.022482,0.0011239,0.11981,0.42558,HP_ABNORMAL_CIRCULATING_CALCIUM_PHOSPHATE_REGULATING_HORMONE_CONCENTRATION,0.985709134519288
BYSTRYKH_HEMATOPOIESIS_STEM_...4,SET,8,0.050349,0.0010507,0.26838,0.42559,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1,0.985709134519288
MIR2116_5P,SET,133,0.013272,0.0011255,0.070743,0.42559,MIR2116_5P,0.985709134519288
HP_HOFFMANN_SIGN,SET,9,0.047365,0.0010484,0.25257,0.42562,HP_HOFFMANN_SIGN,0.985709134519288
GSE23505_IL6_IL1_VS_IL6_IL1_...3,SET,169,0.011222,0.0010717,0.059857,0.42564,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,0.985709134519288
GOBP_NERVOUS_SYSTEM_PROCESS_...,SET,10,0.051719,0.0012067,0.27592,0.42566,GOBP_NERVOUS_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.985709134519288
CUI_DEVELOPING_HEART_VASCULA...,SET,178,0.012587,0.0012333,0.067153,0.42566,CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL,0.985709134519288
HP_DYSPAREUNIA,SET,34,0.028941,0.0012442,0.15445,0.42568,HP_DYSPAREUNIA,0.985709134519288
GSE26928_EFF_MEMORY_VS_CXCR5...1,SET,164,0.012311,0.0011583,0.065696,0.42568,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,0.985709134519288
GSE26928_CENTR_MEMORY_VS_CXC...2,SET,159,0.012284,0.0011382,0.065591,0.42572,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,0.985736082611592
GOBP_SIGNAL_TRANSDUCTION_BY_...,SET,158,0.012355,0.0011412,0.06605,0.42581,GOBP_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.985739468602251
GOBP_GLOMERULAR_ENDOTHELIUM_...,SET,4,0.095979,0.0014165,0.5132,0.42582,GOBP_GLOMERULAR_ENDOTHELIUM_DEVELOPMENT,0.985739468602251
GSE360_T_GONDII_VS_B_MALAYI_...1,SET,186,0.011551,0.0011567,0.06176,0.42582,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.985739468602251
GSE4748_CTRL_VS_LPS_AND_CYAN...2,SET,180,0.011786,0.0011612,0.063043,0.42585,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.985739468602251
HP_VASCULITIS_IN_THE_SKIN,SET,7,0.054718,0.0010682,0.29286,0.42589,HP_VASCULITIS_IN_THE_SKIN,0.985739468602251
GOBP_AXONEMAL_DYNEIN_COMPLEX...,SET,26,0.0281,0.0010567,0.15043,0.42591,GOBP_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY,0.985739468602251
GSE21063_CTRL_VS_ANTI_IGM_ST...6,SET,139,0.014269,0.0012368,0.076398,0.42592,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP,0.985739468602251
GOBP_NEGATIVE_REGULATION_OF_...598,SET,31,0.02599,0.001067,0.13935,0.42602,GOBP_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.985905253695565
GSE23321_CD8_STEM_CELL_MEMOR...2,SET,174,0.012348,0.0011964,0.066247,0.42607,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP,0.985912809587217
GOBP_GLYCEROLIPID_BIOSYNTHET...,SET,226,0.010111,0.0011148,0.054252,0.42608,GOBP_GLYCEROLIPID_BIOSYNTHETIC_PROCESS,0.985912809587217
WP_TCELL_RECEPTOR_SIGNALING,SET,87,0.017121,0.0011758,0.091941,0.42614,WP_TCELL_RECEPTOR_SIGNALING,0.985924139652533
FOROUTAN_PRODRANK_TGFB_EMT_UP,SET,178,0.012324,0.0012076,0.066195,0.42615,FOROUTAN_PRODRANK_TGFB_EMT_UP,0.985924139652533
GOMF_TRANSCRIPTION_COREGULAT...1,SET,451,0.0070954,0.0010983,0.038119,0.42617,GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY,0.985924139652533
GOMF_R_SMAD_BINDING,SET,25,0.030965,0.0011418,0.16659,0.42627,GOMF_R_SMAD_BINDING,0.986035520361991
GOBP_RIBOFLAVIN_TRANSPORT,SET,6,0.067521,0.0012204,0.36349,0.42632,GOBP_RIBOFLAVIN_TRANSPORT,0.986035520361991
GOMF_RIBOFLAVIN_TRANSMEMBRAN...,SET,6,0.067521,0.0012204,0.36349,0.42632,GOMF_RIBOFLAVIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.986035520361991
GOBP_POSITIVE_REGULATION_OF_...399,SET,23,0.033693,0.0011918,0.18146,0.42635,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.986035520361991
REACTOME_DNA_REPAIR,SET,264,0.0086799,0.0010333,0.046757,0.42636,REACTOME_DNA_REPAIR,0.986035520361991
GOBP_ENDOTHELIUM_DEVELOPMENT,SET,129,0.014654,0.001224,0.078977,0.4264,GOBP_ENDOTHELIUM_DEVELOPMENT,0.98606241266884
GOMF_BH_DOMAIN_BINDING,SET,10,0.051045,0.0011909,0.27521,0.42643,GOMF_BH_DOMAIN_BINDING,0.98606617764471
REACTOME_G_ALPHA_Z_SIGNALLIN...,SET,48,0.023556,0.0012028,0.12715,0.42651,REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS,0.986166188797233
WP_APOE_AND_MIR146_IN_INFLAM...,SET,6,0.064115,0.0011588,0.34616,0.42653,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.986166188797233
IBRAHIM_NRF3_DOWN,SET,13,0.038179,0.0010155,0.20661,0.4267,IBRAHIM_NRF3_DOWN,0.986400468781169
GOMF_RIBONUCLEOPROTEIN_COMPL...,SET,142,0.012255,0.0010735,0.066354,0.42674,GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING,0.986400468781169
GOMF_ORGANIC_ACID_BINDING,SET,188,0.012112,0.0012193,0.06562,0.42678,GOMF_ORGANIC_ACID_BINDING,0.986400468781169
HP_ROTARY_NYSTAGMUS,SET,21,0.033638,0.001137,0.18229,0.4268,HP_ROTARY_NYSTAGMUS,0.986400468781169
chr17q25,SET,176,0.02295,0.0022361,0.12442,0.42683,chr17q25,0.986400468781169
KRISHNAN_FURIN_TARGETS_UP,SET,8,0.059685,0.0012456,0.32358,0.42683,KRISHNAN_FURIN_TARGETS_UP,0.986400468781169
WP_DDX1_AS_A_REGULATORY_COMP...,SET,6,0.056604,0.0010231,0.30687,0.42683,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,0.986400468781169
HP_RENAL_CORTICAL_CYSTS,SET,16,0.037293,0.0011004,0.20227,0.42686,HP_RENAL_CORTICAL_CYSTS,0.986404208776596
GSE20500_RETINOIC_ACID_VS_RA...2,SET,182,0.011835,0.0011725,0.064241,0.42692,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,0.986477268798617
KAYO_CALORIE_RESTRICTION_MUS...1,SET,77,0.016393,0.0010594,0.08902,0.42695,KAYO_CALORIE_RESTRICTION_MUSCLE_DN,0.986481003191065
RICKMAN_TUMOR_DIFFERENTIATED...6,SET,212,0.01025,0.0010951,0.055684,0.42698,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,0.986484737087017
HP_DEVIATION_OF_THE_4TH_TOE,SET,4,0.089059,0.0013144,0.48417,0.42703,HP_DEVIATION_OF_THE_4TH_TOE,0.98653467495347
THRAP3_TARGET_GENES,SET,19,0.038127,0.0012259,0.20741,0.42708,THRAP3_TARGET_GENES,0.986584606181456
GOBP_MEIOTIC_CELL_CYCLE_PROC...2,SET,6,0.064764,0.0011706,0.35277,0.42717,GOBP_MEIOTIC_CELL_CYCLE_PROCESS_INVOLVED_IN_OOCYTE_MATURATION,0.986586847522911
CHIANG_LIVER_CANCER_SUBCLASS...5,SET,24,0.03431,0.0012396,0.18696,0.4272,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN,0.986586847522911
GOCC_H4_H2A_HISTONE_ACETYLTR...,SET,26,0.029552,0.0011113,0.16114,0.42725,GOCC_H4_H2A_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.986586847522911
GOBP_REVERSIBLE_DIFFERENTIAT...,SET,5,0.077409,0.0012772,0.42241,0.4273,GOBP_REVERSIBLE_DIFFERENTIATION,0.986586847522911
NAKAYA_MONOCYTE_FLUARIX_FLUV...2,SET,74,0.017681,0.0011202,0.096518,0.42733,NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.986586847522911
KEGG_ADIPOCYTOKINE_SIGNALING...,SET,63,0.019681,0.0011509,0.10746,0.42734,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,0.986586847522911
GOBP_NEGATIVE_REGULATION_OF_...595,SET,20,0.038784,0.0012793,0.2118,0.42735,GOBP_NEGATIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.986586847522911
MORF_SP3,SET,75,0.016457,0.0010497,0.08988,0.42736,MORF_SP3,0.986586847522911
MIR4253,SET,45,0.024225,0.0011978,0.13231,0.42737,MIR4253,0.986586847522911
HP_ANENCEPHALY,SET,37,0.023174,0.0010392,0.1266,0.42738,HP_ANENCEPHALY,0.986586847522911
GSE21546_SAP1A_KO_VS_SAP1A_K...4,SET,175,0.011222,0.0010903,0.061348,0.42743,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.986586847522911
DESCARTES_FETAL_LUNG_MEGAKAR...,SET,133,0.013981,0.0011856,0.076444,0.42744,DESCARTES_FETAL_LUNG_MEGAKARYOCYTES,0.986586847522911
HP_APLASIA_HYPOPLASIA_OF_THE...41,SET,51,0.022305,0.0011739,0.12197,0.42745,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANGES_OF_THE_HAND,0.986586847522911
MIR3158_5P,SET,154,0.012227,0.0011151,0.066956,0.42755,MIR3158_5P,0.986708890880127
GOBP_REGULATION_OF_FILOPODIU...,SET,41,0.02621,0.0012371,0.14359,0.42758,GOBP_REGULATION_OF_FILOPODIUM_ASSEMBLY,0.986708890880127
MIR4306,SET,428,0.0075935,0.0011458,0.041632,0.42764,MIR4306,0.986708890880127
GSE37416_0H_VS_3H_F_TULARENS...1,SET,182,0.011191,0.0011087,0.06139,0.42767,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.986708890880127
GOBP_GAMMA_AMINOBUTYRIC_ACID...4,SET,13,0.045933,0.0012218,0.25205,0.4277,GOBP_GAMMA_AMINOBUTYRIC_ACID_SECRETION,0.986708890880127
GOBP_FUSED_ANTRUM_STAGE,SET,6,0.069645,0.0012588,0.3822,0.42771,GOBP_FUSED_ANTRUM_STAGE,0.986708890880127
GOBP_REGULATION_OF_MACROPHAG...5,SET,23,0.034513,0.0012207,0.1894,0.42771,GOBP_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,0.986708890880127
GSE40274_CTRL_VS_GATA1_TRANS...2,SET,128,0.013219,0.0010999,0.072569,0.42773,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.986708890880127
MIR6792_3P,SET,117,0.013918,0.0011075,0.076485,0.4278,MIR6792_3P,0.986804871573638
GOBP_LUNG_GROWTH,SET,5,0.084391,0.0013924,0.46451,0.42792,GOBP_LUNG_GROWTH,0.987016166710911
GOMF_CYCLIC_NUCLEOTIDE_ACTIV...,SET,10,0.049495,0.0011548,0.27259,0.42796,GOMF_CYCLIC_NUCLEOTIDE_ACTIVATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.987042922556241
GSE43955_1H_VS_20H_ACT_CD4_T...1,SET,182,0.011518,0.001141,0.06348,0.42801,GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN,0.987073362749652
HP_PERIVENTRICULAR_WHITE_MAT...,SET,29,0.028496,0.0011316,0.1571,0.42803,HP_PERIVENTRICULAR_WHITE_MATTER_HYPERINTENSITIES,0.987073362749652
GOBP_CELLULAR_RESPONSE_TO_AC...2,SET,79,0.017224,0.0011273,0.095048,0.4281,GOBP_CELLULAR_RESPONSE_TO_ACID_CHEMICAL,0.987088033112583
HP_VISUAL_HALLUCINATION,SET,21,0.031476,0.0010639,0.17379,0.42814,HP_VISUAL_HALLUCINATION,0.987088033112583
GSE17721_CTRL_VS_POLYIC_2H_B...1,SET,188,0.011203,0.0011278,0.061883,0.42817,GSE17721_CTRL_VS_POLYIC_2H_BMDC_DN,0.987088033112583
MOREIRA_RESPONSE_TO_TSA_UP,SET,25,0.03013,0.001111,0.16654,0.42822,MOREIRA_RESPONSE_TO_TSA_UP,0.987088033112583
HALLMARK_KRAS_SIGNALING_UP,SET,186,0.012102,0.0012119,0.066896,0.42822,HALLMARK_KRAS_SIGNALING_UP,0.987088033112583
ODONNELL_TFRC_TARGETS_DN,SET,116,0.013432,0.0010643,0.074261,0.42823,ODONNELL_TFRC_TARGETS_DN,0.987088033112583
GOBP_NOREPINEPHRINE_BIOSYNTH...,SET,6,0.071209,0.001287,0.39373,0.42824,GOBP_NOREPINEPHRINE_BIOSYNTHETIC_PROCESS,0.987088033112583
KATSANOU_ELAVL1_TARGETS_DN,SET,133,0.013705,0.0011622,0.075816,0.42828,KATSANOU_ELAVL1_TARGETS_DN,0.987088033112583
REACTOME_FORMATION_OF_THE_AN...,SET,9,0.056496,0.0012505,0.31322,0.42843,REACTOME_FORMATION_OF_THE_ANTERIOR_NEURAL_PLATE,0.987088033112583
HP_ASYMMETRY_OF_THE_THORAX,SET,6,0.059199,0.00107,0.3282,0.42843,HP_ASYMMETRY_OF_THE_THORAX,0.987088033112583
ZNF320_TARGET_GENES,SET,1228,0.004498,0.0011237,0.024953,0.42848,ZNF320_TARGET_GENES,0.987088033112583
GSE43863_TFH_VS_LY6C_LOW_CXC...2,SET,184,0.011617,0.0011571,0.064466,0.4285,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.987088033112583
HP_PERIPHERAL_OPACIFICATION_...,SET,15,0.038913,0.0011118,0.21605,0.42853,HP_PERIPHERAL_OPACIFICATION_OF_THE_CORNEA,0.987088033112583
GOMF_ENOYL_COA_HYDRATASE_ACT...,SET,11,0.049632,0.0012144,0.27562,0.42855,GOMF_ENOYL_COA_HYDRATASE_ACTIVITY,0.987088033112583
HAHTOLA_MYCOSIS_FUNGOIDES_DN,SET,13,0.04457,0.0011855,0.24756,0.42856,HAHTOLA_MYCOSIS_FUNGOIDES_DN,0.987088033112583
ZHANG_GATA6_TARGETS_UP,SET,12,0.04663,0.0011917,0.25899,0.42856,ZHANG_GATA6_TARGETS_UP,0.987088033112583
chr9q22,SET,72,0.030966,0.0019353,0.17203,0.42857,chr9q22,0.987088033112583
HP_OCULOGYRIC_CRISIS,SET,12,0.044936,0.0011484,0.24975,0.42861,HP_OCULOGYRIC_CRISIS,0.987088033112583
REACTOME_SARS_COV_1_TARGETS_...,SET,16,0.039536,0.0011666,0.21982,0.42863,REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS,0.987088033112583
HP_ABNORMAL_JOINT_MORPHOLOGY,SET,1067,0.0047334,0.0011074,0.026347,0.42871,HP_ABNORMAL_JOINT_MORPHOLOGY,0.987088033112583
AGGTGCA_MIR500,SET,82,0.016585,0.0011059,0.092354,0.42874,AGGTGCA_MIR500,0.987088033112583
GOBP_ADENYLATE_CYCLASE_ACTIV...2,SET,9,0.052131,0.0011539,0.29055,0.4288,GOBP_ADENYLATE_CYCLASE_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.987088033112583
GSE17721_LPS_VS_CPG_16H_BMDC...1,SET,183,0.010411,0.0010342,0.058049,0.42883,GSE17721_LPS_VS_CPG_16H_BMDC_DN,0.987088033112583
GOBP_PROSTAGLANDIN_SECRETION,SET,18,0.042046,0.0013158,0.23447,0.42884,GOBP_PROSTAGLANDIN_SECRETION,0.987088033112583
HP_SMALL_HAND,SET,94,0.015927,0.0011366,0.088818,0.42885,HP_SMALL_HAND,0.987088033112583
HP_VAGINAL_ATRESIA,SET,18,0.040248,0.0012596,0.22447,0.42885,HP_VAGINAL_ATRESIA,0.987088033112583
HP_ABNORMALITY_OF_THE_ACOUST...,SET,4,0.081401,0.0012013,0.45405,0.42886,HP_ABNORMALITY_OF_THE_ACOUSTIC_REFLEX,0.987088033112583
HP_ABNORMAL_MIDDLE_EAR_REFLE...,SET,4,0.081401,0.0012013,0.45405,0.42886,HP_ABNORMAL_MIDDLE_EAR_REFLEXES,0.987088033112583
HP_FLEXION_CONTRACTURE_OF_DI...,SET,276,0.009279,0.0011291,0.051758,0.42886,HP_FLEXION_CONTRACTURE_OF_DIGIT,0.987088033112583
GOBP_MITOTIC_CELL_CYCLE_PROC...,SET,701,0.0056553,0.0010837,0.031586,0.42895,GOBP_MITOTIC_CELL_CYCLE_PROCESS,0.987182796054809
REACTOME_MATURATION_OF_TCA_E...,SET,19,0.030836,0.00099143,0.1724,0.42902,REACTOME_MATURATION_OF_TCA_ENZYMES_AND_REGULATION_OF_TCA_CYCLE,0.987182796054809
GSE37605_C57BL6_VS_NOD_FOXP3...7,SET,177,0.011269,0.0011011,0.063004,0.42902,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN,0.987182796054809
WP_CLOCKCONTROLLED_AUTOPHAGY...,SET,77,0.017927,0.0011585,0.10029,0.42907,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,0.987182796054809
GOBP_REGULATION_OF_GAMMA_AMI...,SET,8,0.058547,0.0012218,0.32759,0.42908,GOBP_REGULATION_OF_GAMMA_AMINOBUTYRIC_ACID_SECRETION,0.987182796054809
GOMF_OXIDOREDUCTASE_ACTIVITY...22,SET,4,0.083827,0.0012371,0.46914,0.42909,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_ASCORBATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.987182796054809
GOMF_EXTRACELLULARLY_ATP_GAT...,SET,7,0.062481,0.0012197,0.34973,0.4291,GOMF_EXTRACELLULARLY_ATP_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.987182796054809
GOBP_POTASSIUM_ION_HOMEOSTAS...,SET,34,0.026707,0.0011482,0.14959,0.42915,GOBP_POTASSIUM_ION_HOMEOSTASIS,0.987198924021388
HP_DEPRESSION,SET,380,0.0077615,0.001105,0.043548,0.42927,HP_DEPRESSION,0.987198924021388
HP_ABNORMALITY_OF_SKELETAL_M...1,SET,358,0.0078189,0.0010811,0.043899,0.42932,HP_ABNORMALITY_OF_SKELETAL_MATURATION,0.987198924021388
GSE411_100MIN_VS_400MIN_IL6_...4,SET,187,0.010446,0.0010488,0.058665,0.42934,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.987198924021388
HP_UVEAL_MELANOMA,SET,8,0.047167,0.00098432,0.26497,0.42936,HP_UVEAL_MELANOMA,0.987198924021388
GOBP_REGULATION_OF_ENDOTHELI...3,SET,34,0.02642,0.0011358,0.14846,0.42938,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,0.987198924021388
PID_FOXM1_PATHWAY,SET,39,0.024301,0.0011188,0.1366,0.4294,PID_FOXM1_PATHWAY,0.987198924021388
GSE34179_THPOK_KO_VS_WT_VA14...2,SET,187,0.010459,0.0010501,0.058787,0.4294,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP,0.987198924021388
REACTOME_TRNA_MODIFICATION_I...1,SET,7,0.046033,0.00089864,0.25894,0.42945,REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION,0.987198924021388
GSE43956_WT_VS_SGK1_KO_TH17_...1,SET,180,0.011477,0.0011308,0.064571,0.42946,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN,0.987198924021388
GOBP_REGULATION_OF_CD4_POSIT...3,SET,4,0.081469,0.0012023,0.4586,0.4295,GOBP_REGULATION_OF_CD4_POSITIVE_CD25_POSITIVE_ALPHA_BETA_REGULATORY_T_CELL_DIFFERENTIATION,0.987198924021388
HP_ABNORMAL_RIGHT_VENTRICLE_...,SET,61,0.01945,0.0011192,0.1095,0.42951,HP_ABNORMAL_RIGHT_VENTRICLE_MORPHOLOGY,0.987198924021388
MIR302B_5P,SET,187,0.011018,0.0011063,0.062115,0.42961,MIR302B_5P,0.987198924021388
HP_URIC_ACID_NEPHROLITHIASIS,SET,11,0.042292,0.0010349,0.2388,0.42971,HP_URIC_ACID_NEPHROLITHIASIS,0.987198924021388
SU_PANCREAS,SET,39,0.023475,0.0010807,0.1326,0.42974,SU_PANCREAS,0.987198924021388
GSE37301_HEMATOPOIETIC_STEM_...13,SET,159,0.012225,0.0011327,0.069083,0.42977,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN,0.987198924021388
GOBP_NEGATIVE_REGULATION_OF_...492,SET,272,0.0091888,0.0011101,0.051955,0.42981,GOBP_NEGATIVE_REGULATION_OF_PHOSPHORYLATION,0.987198924021388
GOBP_SATELLITE_CELL_ACTIVATI...,SET,6,0.054079,0.00097743,0.30588,0.42984,GOBP_SATELLITE_CELL_ACTIVATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.987198924021388
HP_ABNORMAL_INTONATION,SET,59,0.020133,0.0011394,0.11393,0.42987,HP_ABNORMAL_INTONATION,0.987198924021388
BIOCARTA_TUBBY_PATHWAY,SET,4,0.083873,0.0012378,0.4751,0.42994,BIOCARTA_TUBBY_PATHWAY,0.987198924021388
GOBP_NEGATIVE_REGULATION_OF_...183,SET,121,0.013473,0.0010901,0.076328,0.42994,GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.987198924021388
PID_CMYB_PATHWAY,SET,78,0.017406,0.001132,0.098613,0.42995,PID_CMYB_PATHWAY,0.987198924021388
HP_ASPIRATION_PNEUMONIA,SET,88,0.015151,0.0010464,0.085839,0.42995,HP_ASPIRATION_PNEUMONIA,0.987198924021388
HP_NUCHAL_RIGIDITY,SET,10,0.045058,0.0010512,0.2553,0.42996,HP_NUCHAL_RIGIDITY,0.987198924021388
GOBP_REGULATION_OF_LEUKOCYTE...2,SET,30,0.028779,0.0011623,0.16309,0.42997,GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.987198924021388
HE_LIM_SUN_FETAL_LUNG_C4_T_A...,SET,66,0.018955,0.0011344,0.10745,0.42998,HE_LIM_SUN_FETAL_LUNG_C4_T_ALPHA_BETA_ENTRY_CELL,0.987198924021388
HP_ABNORMALITY_IRIS_MORPHOLO...,SET,404,0.0075387,0.0011059,0.042745,0.43,HP_ABNORMALITY_IRIS_MORPHOLOGY,0.987198924021388
GOBP_PROTEIN_LOCALIZATION_TO...15,SET,11,0.039722,0.00097195,0.22525,0.43001,GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_MEMBRANE,0.987198924021388
TRAVAGLINI_LUNG_CLASSICAL_MO...,SET,248,0.0097521,0.0011257,0.055316,0.43003,TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL,0.987198924021388
GSE42021_TCONV_PLN_VS_CD24IN...1,SET,183,0.010753,0.0010682,0.061044,0.43009,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_DN,0.987198924021388
GOMF_O_ACETYLTRANSFERASE_ACT...,SET,9,0.052457,0.0011611,0.29783,0.4301,GOMF_O_ACETYLTRANSFERASE_ACTIVITY,0.987198924021388
GNF2_MLH1,SET,36,0.021783,0.00096359,0.12375,0.43014,GNF2_MLH1,0.987198924021388
HP_POSTNATAL_GROWTH_RETARDAT...,SET,219,0.009986,0.0010841,0.056741,0.43015,HP_POSTNATAL_GROWTH_RETARDATION,0.987198924021388
GSE40666_UNTREATED_VS_IFNA_S...6,SET,153,0.011943,0.0010857,0.067873,0.43016,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP,0.987198924021388
GSE17721_POLYIC_VS_CPG_6H_BM...1,SET,183,0.010471,0.0010401,0.059512,0.43017,GSE17721_POLYIC_VS_CPG_6H_BMDC_DN,0.987198924021388
HP_ABNORMAL_AORTIC_VALVE_PHY...,SET,148,0.0127,0.0011356,0.072209,0.4302,HP_ABNORMAL_AORTIC_VALVE_PHYSIOLOGY,0.987198924021388
REACTOME_CELLULAR_RESPONSE_T...5,SET,140,0.012307,0.0010706,0.070022,0.43024,REACTOME_CELLULAR_RESPONSE_TO_STARVATION,0.987198924021388
GOBP_CERAMIDE_1_PHOSPHATE_TR...,SET,5,0.056933,0.00093937,0.32401,0.43026,GOBP_CERAMIDE_1_PHOSPHATE_TRANSPORT,0.987198924021388
GOMF_CERAMIDE_1_PHOSPHATE_TR...,SET,5,0.056933,0.00093937,0.32401,0.43026,GOMF_CERAMIDE_1_PHOSPHATE_TRANSFER_ACTIVITY,0.987198924021388
GSE40068_BCL6_POS_VS_NEG_CXC...2,SET,186,0.010841,0.0010856,0.061702,0.43026,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_UP,0.987198924021388
JINESH_BLEBBISHIELD_TRANSFOR...2,SET,154,0.012811,0.0011683,0.072934,0.43029,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,0.987198924021388
GOBP_NEURONAL_DENSE_CORE_VES...,SET,7,0.062982,0.0012295,0.35863,0.4303,GOBP_NEURONAL_DENSE_CORE_VESICLE_EXOCYTOSIS,0.987198924021388
HP_JUVENILE_RHEUMATOID_ARTHR...,SET,5,0.065571,0.0010819,0.37379,0.43037,HP_JUVENILE_RHEUMATOID_ARTHRITIS,0.987252121972147
DESCARTES_FETAL_SPLEEN_MEGAK...,SET,88,0.016093,0.0011114,0.091744,0.43038,DESCARTES_FETAL_SPLEEN_MEGAKARYOCYTES,0.987252121972147
GOBP_DE_NOVO_PYRIMIDINE_NUCL...,SET,6,0.055434,0.0010019,0.31641,0.43046,GOBP_DE_NOVO_PYRIMIDINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,0.987328241932291
HP_MUSCLE_FIBER_ATROPHY,SET,61,0.017873,0.0010284,0.10203,0.43047,HP_MUSCLE_FIBER_ATROPHY,0.987328241932291
GOBP_REGULATION_OF_RIG_I_SIG...,SET,17,0.03324,0.001011,0.19014,0.43061,GOBP_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.987372017804154
ZNF34_TARGET_GENES,SET,213,0.0098707,0.001057,0.056517,0.43068,ZNF34_TARGET_GENES,0.987372017804154
GSE30083_SP1_VS_SP2_THYMOCYT...2,SET,178,0.011178,0.0010953,0.064012,0.43069,GSE30083_SP1_VS_SP2_THYMOCYTE_UP,0.987372017804154
MIR105_5P,SET,198,0.010549,0.0010896,0.060427,0.43071,MIR105_5P,0.987372017804154
GOMF_POTASSIUM_CHANNEL_ACTIV...2,SET,122,0.014617,0.0011876,0.083734,0.43071,GOMF_POTASSIUM_CHANNEL_ACTIVITY,0.987372017804154
HP_ADRENAL_HYPERPLASIA,SET,23,0.032834,0.0011614,0.18814,0.43073,HP_ADRENAL_HYPERPLASIA,0.987372017804154
GOMF_NADPH_BINDING,SET,16,0.034003,0.0010033,0.19488,0.43074,GOMF_NADPH_BINDING,0.987372017804154
GSE21927_BALBC_VS_C57BL6_MON...1,SET,148,0.011802,0.0010553,0.067667,0.43077,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_DN,0.987372017804154
HP_CHROMOSOMAL_BREAKAGE_INDU...2,SET,13,0.037181,0.00098898,0.21319,0.43078,HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_IONIZING_RADIATION,0.987372017804154
GOCC_EXTRINSIC_COMPONENT_OF_...10,SET,11,0.048148,0.0011781,0.27615,0.43079,GOCC_EXTRINSIC_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE,0.987372017804154
UNTERMAN_IPF_VS_CTRL_DC_UP,SET,4,0.066402,0.00097998,0.381,0.43082,UNTERMAN_IPF_VS_CTRL_DC_UP,0.987372017804154
HP_HYPOPLASTIC_ILIA,SET,47,0.021537,0.0010883,0.12359,0.43083,HP_HYPOPLASTIC_ILIA,0.987372017804154
ZNF136_TARGET_GENES,SET,5,0.064453,0.0010635,0.37035,0.43092,ZNF136_TARGET_GENES,0.987513161018067
GOBP_RESPONSE_TO_INTERLEUKIN...5,SET,17,0.039978,0.0012159,0.22984,0.43096,GOBP_RESPONSE_TO_INTERLEUKIN_17,0.987536671270718
HALLMARK_EPITHELIAL_MESENCHY...,SET,187,0.011821,0.0011869,0.068005,0.431,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.987536671270718
GSE15330_HSC_VS_PRO_BCELL_DN,SET,177,0.010351,0.0010114,0.059625,0.43109,GSE15330_HSC_VS_PRO_BCELL_DN,0.987536671270718
HP_ABNORMAL_AORTIC_VALVE_CUS...,SET,101,0.01515,0.0011205,0.087429,0.43122,HP_ABNORMAL_AORTIC_VALVE_CUSP_MORPHOLOGY,0.987536671270718
HP_GANGLIONEUROBLASTOMA,SET,7,0.065992,0.0012883,0.3812,0.43128,HP_GANGLIONEUROBLASTOMA,0.987536671270718
HP_ABNORMAL_HIP_JOINT_MORPHO...,SET,336,0.0079127,0.0010606,0.045729,0.43131,HP_ABNORMAL_HIP_JOINT_MORPHOLOGY,0.987536671270718
KEGG_ALPHA_LINOLENIC_ACID_ME...,SET,19,0.035415,0.0011387,0.20472,0.43133,KEGG_ALPHA_LINOLENIC_ACID_METABOLISM,0.987536671270718
GSE28726_NAIVE_CD4_TCELL_VS_...1,SET,184,0.010789,0.0010746,0.06237,0.43133,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN,0.987536671270718
WP_SARSCOV2_ALTERING_ANGIOGE...,SET,4,0.086555,0.0012774,0.50044,0.43134,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,0.987536671270718
HP_AREFLEXIA_OF_UPPER_LIMBS,SET,7,0.060902,0.0011889,0.35209,0.43134,HP_AREFLEXIA_OF_UPPER_LIMBS,0.987536671270718
GOMF_SHORT_CHAIN_CARBOXYLEST...,SET,6,0.058343,0.0010545,0.33734,0.43135,GOMF_SHORT_CHAIN_CARBOXYLESTERASE_ACTIVITY,0.987536671270718
HP_INCREASED_CIRCULATING_IGM...,SET,32,0.026634,0.0011109,0.15403,0.43136,HP_INCREASED_CIRCULATING_IGM_LEVEL,0.987536671270718
GSE360_HIGH_DOSE_B_MALAYI_VS...3,SET,178,0.011312,0.0011084,0.065491,0.43143,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,0.987536671270718
KEGG_MEDICUS_REFERENCE_RAD51...,SET,10,0.044119,0.0010293,0.25556,0.43147,KEGG_MEDICUS_REFERENCE_RAD51_DSDNA_DESTABILIZATION,0.987536671270718
GSE11864_CSF1_VS_CSF1_IFNG_I...2,SET,161,0.01113,0.0010377,0.064512,0.43151,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP,0.987536671270718
GSE16451_IMMATURE_VS_MATURE_...2,SET,181,0.010782,0.0010653,0.062518,0.43154,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.987536671270718
MIR6797_3P,SET,58,0.019461,0.0010921,0.11286,0.43155,MIR6797_3P,0.987536671270718
GOBP_BONE_TRABECULA_FORMATION,SET,11,0.044724,0.0010944,0.25951,0.43159,GOBP_BONE_TRABECULA_FORMATION,0.987536671270718
GOBP_MAMMARY_GLAND_EPITHELIA...2,SET,25,0.032649,0.0012039,0.18955,0.43163,GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,0.987536671270718
GSE22886_IGG_IGA_MEMORY_BCEL...3,SET,177,0.010901,0.0010652,0.063336,0.43167,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,0.987536671270718
WP_TYPE_2_PAPILLARY_RENAL_CE...,SET,31,0.025886,0.0010627,0.15042,0.43169,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,0.987536671270718
WP_DISRUPTION_OF_POSTSYNAPTI...,SET,29,0.027781,0.0011032,0.16147,0.4317,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,0.987536671270718
MODULE_514,SET,10,0.046398,0.0010825,0.26975,0.43172,MODULE_514,0.987536671270718
MURARO_PANCREAS_BETA_CELL,SET,858,0.0051499,0.0010869,0.029962,0.43177,MURARO_PANCREAS_BETA_CELL,0.987536671270718
HP_SHORT_FOOT,SET,111,0.014413,0.0011172,0.083875,0.43179,HP_SHORT_FOOT,0.987536671270718
MAML1_TARGET_GENES,SET,212,0.010236,0.0010935,0.059608,0.43183,MAML1_TARGET_GENES,0.987536671270718
GOCC_BRCA1_A_COMPLEX,SET,5,0.056173,0.00092684,0.32714,0.43183,GOCC_BRCA1_A_COMPLEX,0.987536671270718
GSE23114_WT_VS_SLE2C1_MOUSE_...3,SET,181,0.0106,0.0010472,0.061732,0.43184,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN,0.987536671270718
HP_INFERIOR_CEREBELLAR_VERMI...,SET,13,0.040382,0.0010741,0.23526,0.43186,HP_INFERIOR_CEREBELLAR_VERMIS_HYPOPLASIA,0.987536671270718
GSE43863_TH1_VS_LY6C_INT_CXC...4,SET,187,0.010499,0.0010542,0.061191,0.43188,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,0.987536671270718
WP_CELL_DIFFERENTIATION_INDEX,SET,12,0.045629,0.0011661,0.266,0.4319,WP_CELL_DIFFERENTIATION_INDEX,0.987536671270718
KEGG_MEDICUS_REFERENCE_FLCN_...,SET,13,0.037398,0.00099477,0.21808,0.43192,KEGG_MEDICUS_REFERENCE_FLCN_MTORC1_SIGNALING_PATHWAY,0.987536671270718
MIR8061,SET,150,0.011977,0.0010781,0.069896,0.43198,MIR8061,0.987536671270718
MIR1226_3P,SET,99,0.014506,0.0010623,0.084684,0.432,MIR1226_3P,0.987536671270718
CAR_TNFRSF25,SET,28,0.026965,0.0010522,0.15742,0.432,CAR_TNFRSF25,0.987536671270718
HP_ABNORMAL_FETAL_PULMONARY_...,SET,8,0.052751,0.0011009,0.30803,0.43201,HP_ABNORMAL_FETAL_PULMONARY_MORPHOLOGY,0.987536671270718
HP_HEPATIC_FIBROSIS,SET,134,0.011941,0.0010164,0.069726,0.43201,HP_HEPATIC_FIBROSIS,0.987536671270718
HP_JOINT_SUBLUXATION,SET,26,0.028192,0.0010601,0.16461,0.43201,HP_JOINT_SUBLUXATION,0.987536671270718
GOCC_PRESYNAPTIC_MEMBRANE,SET,159,0.012388,0.0011478,0.072395,0.43207,GOCC_PRESYNAPTIC_MEMBRANE,0.98760886879316
HP_REDUNDANT_NECK_SKIN,SET,28,0.025481,0.0009943,0.1493,0.43224,HP_REDUNDANT_NECK_SKIN,0.987713572132764
GOBP_ANDROGEN_METABOLIC_PROC...,SET,28,0.028782,0.0011231,0.16872,0.43227,GOBP_ANDROGEN_METABOLIC_PROCESS,0.987713572132764
GSE32128_INOS_DEPENDENT_VS_I...2,SET,186,0.010604,0.0010618,0.062156,0.43227,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP,0.987713572132764
GTF2E2_TARGET_GENES,SET,263,0.0088867,0.0010559,0.052097,0.43228,GTF2E2_TARGET_GENES,0.987713572132764
GOBP_HISTIDINE_METABOLIC_PRO...,SET,8,0.053697,0.0011206,0.31482,0.43228,GOBP_HISTIDINE_METABOLIC_PROCESS,0.987713572132764
GOBP_MITOCHONDRIAL_MEMBRANE_...,SET,98,0.013778,0.0010039,0.080788,0.43229,GOBP_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,0.987713572132764
BARIS_THYROID_CANCER_UP,SET,23,0.026785,0.0009474,0.15724,0.43237,BARIS_THYROID_CANCER_UP,0.987713572132764
GOBP_PLUS_END_DIRECTED_ORGAN...,SET,7,0.054415,0.0010623,0.31948,0.43238,GOBP_PLUS_END_DIRECTED_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,0.987713572132764
GOCC_MULTIVESICULAR_BODY_INT...,SET,5,0.07424,0.0012249,0.43604,0.4324,GOCC_MULTIVESICULAR_BODY_INTERNAL_VESICLE,0.987713572132764
GSE2770_UNTREATED_VS_TGFB_AN...4,SET,175,0.010353,0.0010059,0.060806,0.4324,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.987713572132764
HP_SENSORY_AXONAL_NEUROPATHY,SET,36,0.022886,0.0010124,0.13454,0.43247,HP_SENSORY_AXONAL_NEUROPATHY,0.98780854692429
GOMF_PROCOLLAGEN_PROLINE_DIO...,SET,8,0.041986,0.0008762,0.24703,0.43252,GOMF_PROCOLLAGEN_PROLINE_DIOXYGENASE_ACTIVITY,0.987856595283453
GOBP_TORC2_SIGNALING,SET,10,0.047363,0.001105,0.27889,0.43257,GOBP_TORC2_SIGNALING,0.987856595283453
HUMMERICH_SKIN_CANCER_PROGRE...2,SET,83,0.016641,0.0011163,0.098014,0.43259,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,0.987856595283453
HP_DYSURIA,SET,14,0.036482,0.001007,0.2151,0.43266,HP_DYSURIA,0.987856595283453
HP_ABNORMAL_MORPHOLOGY_OF_MU...,SET,4,0.062236,0.0009185,0.36708,0.43269,HP_ABNORMAL_MORPHOLOGY_OF_MUSCULATURE_OF_PHARYNX,0.987856595283453
HP_ABNORMAL_VOCAL_CORD_MORPH...,SET,4,0.062236,0.0009185,0.36708,0.43269,HP_ABNORMAL_VOCAL_CORD_MORPHOLOGY,0.987856595283453
GSE14413_UNSTIM_VS_IFNB_STIM...2,SET,110,0.013834,0.0010675,0.081598,0.43269,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_UP,0.987856595283453
GOBP_NEGATIVE_REGULATION_OF_...374,SET,139,0.012147,0.0010528,0.071701,0.43274,GOBP_NEGATIVE_REGULATION_OF_MAPK_CASCADE,0.987905852601156
GOBP_POSITIVE_REGULATION_OF_...746,SET,6,0.05454,0.00098576,0.32209,0.43277,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_FUSION_TO_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE,0.987909448275862
GOBP_REGULATION_OF_PROTEIN_L...14,SET,102,0.013748,0.0010219,0.081293,0.43285,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,0.988027173913044
GOBP_REGULATION_OF_HISTAMINE...,SET,6,0.059243,0.0010708,0.35125,0.43303,GOBP_REGULATION_OF_HISTAMINE_SECRETION_BY_MAST_CELL,0.988238371406065
LEIN_ASTROCYTE_MARKERS,SET,40,0.023212,0.0010823,0.13769,0.43306,LEIN_ASTROCYTE_MARKERS,0.988238371406065
HP_CALCIFICATION_OF_CARTILAGE,SET,11,0.046873,0.0011469,0.27802,0.43306,HP_CALCIFICATION_OF_CARTILAGE,0.988238371406065
GOBP_REGULATION_OF_PROTEIN_T...4,SET,39,0.02295,0.0010566,0.13628,0.43314,GOBP_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.988238371406065
HP_PSEUDOEPIPHYSES,SET,17,0.036592,0.0011129,0.2173,0.43314,HP_PSEUDOEPIPHYSES,0.988238371406065
REACTOME_ALPHA_LINOLENIC_OME...,SET,12,0.041096,0.0010503,0.24408,0.43315,REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM,0.988238371406065
GOCC_ENDOPLASMIC_RETICULUM_T...2,SET,4,0.065147,0.00096146,0.387,0.43316,GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_MEMBRANE,0.988238371406065
ZSCAN31_TARGET_GENES,SET,746,0.0052767,0.0010418,0.03135,0.43317,ZSCAN31_TARGET_GENES,0.988238371406065
GOBP_VIRAL_GENE_EXPRESSION,SET,98,0.013339,0.00097193,0.079308,0.43322,GOBP_VIRAL_GENE_EXPRESSION,0.988245513914413
TOMLINS_METASTASIS_UP,SET,14,0.039793,0.0010984,0.23665,0.43323,TOMLINS_METASTASIS_UP,0.988245513914413
HP_EXTRAPYRAMIDAL_MUSCULAR_R...,SET,13,0.039926,0.001062,0.23795,0.43337,HP_EXTRAPYRAMIDAL_MUSCULAR_RIGIDITY,0.988415870463941
GSE34156_TLR1_TLR2_LIGAND_VS...3,SET,147,0.011631,0.0010366,0.069313,0.43337,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,0.988415870463941
GSE26156_DOUBLE_POSITIVE_VS_...2,SET,178,0.010717,0.00105,0.063885,0.43339,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.988415870463941
WP_CYTOKINES_AND_INFLAMMATOR...,SET,25,0.030926,0.0011404,0.18446,0.43343,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,0.988442234251969
GOBP_RESPONSE_TO_GLUCAGON,SET,21,0.031593,0.0010678,0.18853,0.43346,GOBP_RESPONSE_TO_GLUCAGON,0.988445790958599
SLEBOS_HEAD_AND_NECK_CANCER_...,SET,66,0.016188,0.00096881,0.096704,0.43353,SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,0.988512578308536
GSE37605_C57BL6_VS_NOD_FOXP3...4,SET,109,0.014058,0.00108,0.084033,0.43357,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_UP,0.988512578308536
HALLMARK_CHOLESTEROL_HOMEOST...,SET,69,0.016423,0.0010048,0.098216,0.4336,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.988512578308536
KEGG_MEDICUS_PATHOGEN_EBV_EB...2,SET,7,0.052269,0.0010204,0.31284,0.43365,KEGG_MEDICUS_PATHOGEN_EBV_EBNA2_TO_RBP_JK_MEDIATED_TRANSCRIPTION,0.988512578308536
HP_DECREASED_SIZE_OF_NERVE_T...,SET,15,0.034475,0.00098497,0.20633,0.43365,HP_DECREASED_SIZE_OF_NERVE_TERMINALS,0.988512578308536
GOMF_METALLOPEPTIDASE_ACTIVI...,SET,173,0.011467,0.0011078,0.068715,0.43373,GOMF_METALLOPEPTIDASE_ACTIVITY,0.988512578308536
SMAD4_Q6,SET,222,0.0098157,0.0010728,0.058875,0.4338,SMAD4_Q6,0.988512578308536
GOBP_POSITIVE_REGULATION_OF_...384,SET,6,0.054546,0.00098586,0.32759,0.43388,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.988512578308536
GOBP_POSITIVE_REGULATION_OF_...252,SET,56,0.020892,0.0011521,0.12552,0.4339,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.988512578308536
GOBP_MYOTUBE_DIFFERENTIATION,SET,117,0.013444,0.0010697,0.080784,0.43392,GOBP_MYOTUBE_DIFFERENTIATION,0.988512578308536
GOBP_DENDRITE_SELF_AVOIDANCE,SET,14,0.044857,0.0012382,0.26963,0.43394,GOBP_DENDRITE_SELF_AVOIDANCE,0.988512578308536
GSE3982_MAST_CELL_VS_NEUTROP...2,SET,180,0.0095923,0.00094508,0.05766,0.43394,GSE3982_MAST_CELL_VS_NEUTROPHIL_UP,0.988512578308536
GOBP_DECIDUALIZATION,SET,24,0.029557,0.0010679,0.17773,0.43396,GOBP_DECIDUALIZATION,0.988512578308536
HP_ABNORMALITY_OF_THE_DISTAL...4,SET,34,0.023816,0.0010239,0.14322,0.43396,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER,0.988512578308536
REACTOME_TBC_RABGAPS,SET,40,0.020732,0.00096661,0.1248,0.43403,REACTOME_TBC_RABGAPS,0.988512578308536
GSE42021_CD24INT_TREG_VS_CD2...2,SET,177,0.0099458,0.0009718,0.059898,0.43406,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_UP,0.988512578308536
GOBP_REGULATION_OF_INOSITOL_...1,SET,4,0.073102,0.0010789,0.44049,0.4341,GOBP_REGULATION_OF_INOSITOL_1_4_5_TRISPHOSPHATE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.988512578308536
GOBP_CELLULAR_RESPONSE_TO_MI...,SET,12,0.044997,0.00115,0.27139,0.43416,GOBP_CELLULAR_RESPONSE_TO_MINERALOCORTICOID_STIMULUS,0.988512578308536
MIR144_3P,SET,451,0.0069032,0.0010685,0.041654,0.43419,MIR144_3P,0.988512578308536
HP_TARSAL_SYNOSTOSIS,SET,21,0.034181,0.0011553,0.20629,0.4342,HP_TARSAL_SYNOSTOSIS,0.988512578308536
GOBP_SEMICIRCULAR_CANAL_DEVE...,SET,9,0.052011,0.0011512,0.31407,0.43424,GOBP_SEMICIRCULAR_CANAL_DEVELOPMENT,0.988512578308536
GOBP_NEGATIVE_REGULATION_OF_...317,SET,2,0.09742,0.0010167,0.58855,0.43427,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,0.988512578308536
HP_ABNORMAL_5TH_FINGER_MORPH...,SET,435,0.0066308,0.0010085,0.040076,0.43429,HP_ABNORMAL_5TH_FINGER_MORPHOLOGY,0.988512578308536
KORKOLA_TERATOMA_UP,SET,13,0.041828,0.0011126,0.25284,0.4343,KORKOLA_TERATOMA_UP,0.988512578308536
KYNG_ENVIRONMENTAL_STRESS_RE...5,SET,28,0.025214,0.00098388,0.1526,0.43438,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,0.988512578308536
REACTOME_TELOMERE_C_STRAND_L...,SET,32,0.022353,0.00093234,0.1353,0.43439,REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS,0.988512578308536
GOBP_AMINOPHOSPHOLIPID_TRANS...2,SET,8,0.046707,0.00097472,0.28291,0.43444,GOBP_AMINOPHOSPHOLIPID_TRANSPORT,0.988512578308536
GOBP_POSITIVE_REGULATION_OF_...284,SET,8,0.049792,0.0010391,0.30161,0.43444,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.988512578308536
HP_HEMIMEGALENCEPHALY,SET,14,0.038459,0.0010616,0.23305,0.43446,HP_HEMIMEGALENCEPHALY,0.988512578308536
MTOR_UP.V1_UP,SET,155,0.010905,0.00099768,0.066077,0.43446,MTOR_UP.V1_UP,0.988512578308536
GOBP_REGULATION_OF_CARDIAC_M...9,SET,23,0.028894,0.001022,0.17511,0.43447,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,0.988512578308536
MIR2053,SET,159,0.011066,0.0010253,0.06708,0.43449,MIR2053,0.988512578308536
HP_OCULOMOTOR_APRAXIA,SET,102,0.012713,0.00094492,0.077067,0.43449,HP_OCULOMOTOR_APRAXIA,0.988512578308536
HP_CEREBRAL_WHITE_MATTER_ATR...,SET,56,0.01778,0.00098044,0.10789,0.43455,HP_CEREBRAL_WHITE_MATTER_ATROPHY,0.988512578308536
MIZUSHIMA_AUTOPHAGOSOME_FORM...,SET,12,0.035809,0.00091515,0.21744,0.4346,MIZUSHIMA_AUTOPHAGOSOME_FORMATION,0.988512578308536
GSE11367_CTRL_VS_IL17_TREATE...1,SET,101,0.014605,0.0010802,0.088723,0.43463,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_DN,0.988512578308536
GOBP_REGULATION_OF_PROTEIN_M...2,SET,1098,0.0043147,0.0010231,0.026216,0.43464,GOBP_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.988512578308536
LI_ESTROGENE_MCF7_E2_RESPONS...1,SET,35,0.026107,0.0011387,0.15873,0.43468,LI_ESTROGENE_MCF7_E2_RESPONSE_DN,0.988512578308536
GOBP_CHAPERONE_MEDIATED_PROT...2,SET,72,0.01497,0.00093559,0.091076,0.43472,GOBP_CHAPERONE_MEDIATED_PROTEIN_FOLDING,0.988512578308536
HP_ABNORMAL_RESPIRATORY_SYST...,SET,1271,0.0040291,0.0010227,0.024554,0.43483,HP_ABNORMAL_RESPIRATORY_SYSTEM_MORPHOLOGY,0.988512578308536
HP_SLOW_DECREASE_IN_VISUAL_A...,SET,24,0.027069,0.00097803,0.16498,0.43483,HP_SLOW_DECREASE_IN_VISUAL_ACUITY,0.988512578308536
HP_ELLIPTOCYTOSIS,SET,8,0.048069,0.0010032,0.29349,0.43495,HP_ELLIPTOCYTOSIS,0.988512578308536
GOBP_GMP_SALVAGE,SET,4,0.066821,0.00098616,0.40801,0.43496,GOBP_GMP_SALVAGE,0.988512578308536
GOBP_MITRAL_VALVE_DEVELOPMENT,SET,14,0.040392,0.0011149,0.24666,0.43496,GOBP_MITRAL_VALVE_DEVELOPMENT,0.988512578308536
GOBP_PIRNA_MEDIATED_RETROTRA...,SET,5,0.054829,0.00090467,0.33495,0.43499,GOBP_PIRNA_MEDIATED_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.988512578308536
ZNF362_TARGET_GENES,SET,488,0.0061404,0.00098766,0.037536,0.43503,ZNF362_TARGET_GENES,0.988512578308536
MARTORIATI_MDM4_TARGETS_NEUR...2,SET,150,0.011406,0.0010267,0.069733,0.43504,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,0.988512578308536
BIOCARTA_P53HYPOXIA_PATHWAY,SET,20,0.03042,0.0010034,0.18601,0.43505,BIOCARTA_P53HYPOXIA_PATHWAY,0.988512578308536
GOBP_ANTIFUNGAL_INNATE_IMMUN...,SET,14,0.034667,0.0009569,0.21198,0.43505,GOBP_ANTIFUNGAL_INNATE_IMMUNE_RESPONSE,0.988512578308536
HP_HAMSTRING_CONTRACTURES,SET,5,0.06303,0.00104,0.38564,0.43509,HP_HAMSTRING_CONTRACTURES,0.988512578308536
DESCARTES_FETAL_STOMACH_ENS_...1,SET,42,0.023309,0.0011135,0.14281,0.43518,DESCARTES_FETAL_STOMACH_ENS_GLIA,0.988512578308536
WP_CATABOLISM_OF_SKELETAL_MU...,SET,38,0.023073,0.0010486,0.14139,0.43519,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,0.988512578308536
HP_FULL_CHEEKS,SET,132,0.011328,0.00095701,0.069489,0.43525,HP_FULL_CHEEKS,0.988512578308536
GOBP_PHOTORECEPTOR_CELL_DEVE...,SET,49,0.020553,0.0010603,0.1261,0.43526,GOBP_PHOTORECEPTOR_CELL_DEVELOPMENT,0.988512578308536
BIOCARTA_RANKL_PATHWAY,SET,14,0.040383,0.0011147,0.24788,0.43529,BIOCARTA_RANKL_PATHWAY,0.988512578308536
GOBP_POSITIVE_REGULATION_OF_...419,SET,6,0.066473,0.0012014,0.40824,0.43533,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION,0.988512578308536
HP_ABNORMAL_CARDIAC_EXERCISE...,SET,19,0.032066,0.001031,0.19696,0.43534,HP_ABNORMAL_CARDIAC_EXERCISE_STRESS_TEST,0.988512578308536
GSE7852_THYMUS_VS_FAT_TCONV_...2,SET,178,0.01023,0.0010023,0.062843,0.43535,GSE7852_THYMUS_VS_FAT_TCONV_UP,0.988512578308536
BIOCARTA_DC_PATHWAY,SET,16,0.038601,0.001139,0.23732,0.4354,BIOCARTA_DC_PATHWAY,0.988512578308536
WP_MIRNA_REGULATION_OF_PROST...,SET,29,0.025478,0.0010118,0.15678,0.43545,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,0.988512578308536
KOBAYASHI_RESPONSE_TO_ROMIDE...,SET,19,0.034253,0.0011013,0.21091,0.4355,KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,0.988512578308536
GOBP_REGULATION_OF_ENDOTHELI...5,SET,5,0.068412,0.0011288,0.4215,0.43553,GOBP_REGULATION_OF_ENDOTHELIAL_TUBE_MORPHOGENESIS,0.988512578308536
HP_ABNORMAL_EYELASH_MORPHOLO...,SET,250,0.0087288,0.0010116,0.05378,0.43553,HP_ABNORMAL_EYELASH_MORPHOLOGY,0.988512578308536
KEGG_MEDICUS_REFERENCE_EP_NE...,SET,15,0.036323,0.0010378,0.22383,0.43554,KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY,0.988512578308536
HP_INCREASED_SENSITIVITY_TO_...,SET,12,0.036395,0.00093014,0.22425,0.43554,HP_INCREASED_SENSITIVITY_TO_IONIZING_RADIATION,0.988512578308536
BENPORATH_EED_TARGETS,SET,903,0.0052012,0.0011247,0.032067,0.43558,BENPORATH_EED_TARGETS,0.988512578308536
GOMF_2_ACYLGLYCEROL_O_ACYLTR...,SET,6,0.059922,0.001083,0.36946,0.43558,GOMF_2_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.988512578308536
DESCARTES_FETAL_PLACENTA_IGF...,SET,94,0.015091,0.001077,0.093054,0.43559,DESCARTES_FETAL_PLACENTA_IGFBP1_DKK1_POSITIVE_CELLS,0.988512578308536
HP_GASTROINTESTINAL_EOSINOPH...,SET,14,0.03813,0.0010525,0.23523,0.43562,HP_GASTROINTESTINAL_EOSINOPHILIA,0.988512578308536
GSE40666_STAT1_KO_VS_STAT4_K...2,SET,172,0.009575,0.00092239,0.059091,0.43564,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP,0.988512578308536
GOBP_NEGATIVE_REGULATION_OF_...122,SET,15,0.036383,0.0010395,0.22458,0.43565,GOBP_NEGATIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.988512578308536
GOBP_REGULATION_OF_PHOSPHOLI...3,SET,5,0.07138,0.0011778,0.44085,0.43569,GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.988512578308536
GOMF_MOLECULAR_ADAPTOR_ACTIV...,SET,1031,0.0042156,0.00097049,0.02605,0.43572,GOMF_MOLECULAR_ADAPTOR_ACTIVITY,0.988512578308536
GSE3039_ALPHABETA_CD8_TCELL_...3,SET,184,0.0097906,0.00097517,0.060498,0.43572,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_DN,0.988512578308536
GSE12505_WT_VS_E2_2_HET_PDC_...1,SET,142,0.011299,0.00098984,0.069848,0.43574,GSE12505_WT_VS_E2_2_HET_PDC_DN,0.988512578308536
GSE43863_TFH_VS_LY6C_INT_CXC...2,SET,182,0.0098858,0.00097934,0.061133,0.43577,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,0.988512578308536
GOBP_POSITIVE_REGULATION_OF_...587,SET,5,0.05999,0.00098983,0.37102,0.43578,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_TRANSLOCATION,0.988512578308536
DESCARTES_FETAL_MUSCLE_ERYTH...,SET,101,0.012976,0.00095978,0.080265,0.43578,DESCARTES_FETAL_MUSCLE_ERYTHROBLASTS,0.988512578308536
GSE17721_CTRL_VS_POLYIC_8H_B...1,SET,183,0.010075,0.0010008,0.062337,0.4358,GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN,0.988512578308536
NAKAYAMA_FRA2_TARGETS,SET,43,0.022538,0.0010894,0.13947,0.43581,NAKAYAMA_FRA2_TARGETS,0.988512578308536
HP_AUTOIMMUNE_ANTIBODY_POSIT...,SET,148,0.011539,0.0010318,0.07144,0.43584,HP_AUTOIMMUNE_ANTIBODY_POSITIVITY,0.988512578308536
GOBP_MITOCHONDRIAL_ATP_TRANS...,SET,6,0.060567,0.0010947,0.375,0.43585,GOBP_MITOCHONDRIAL_ATP_TRANSMEMBRANE_TRANSPORT,0.988512578308536
GOBP_REGULATION_OF_TUBE_SIZE,SET,139,0.012446,0.0010788,0.077068,0.43585,GOBP_REGULATION_OF_TUBE_SIZE,0.988512578308536
GOBP_REGULATION_OF_CELL_CELL...2,SET,19,0.029099,0.00093559,0.18059,0.43599,GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.988604659289458
GOBP_SNO_S_RNA_PROCESSING,SET,9,0.039229,0.00086831,0.24349,0.436,GOBP_SNO_S_RNA_PROCESSING,0.988604659289458
GOBP_EPIDERMAL_CELL_DIFFEREN...,SET,225,0.010174,0.0011193,0.063172,0.43603,GOBP_EPIDERMAL_CELL_DIFFERENTIATION,0.988604659289458
HP_ABNORMALITY_OF_THE_LEYDIG...,SET,12,0.038968,0.00099589,0.24256,0.43618,HP_ABNORMALITY_OF_THE_LEYDIG_CELLS,0.988604659289458
GOMF_MICROTUBULE_BINDING,SET,255,0.0083689,0.00097939,0.052117,0.43621,GOMF_MICROTUBULE_BINDING,0.988604659289458
REACTOME_RND3_GTPASE_CYCLE,SET,41,0.021146,0.00099813,0.13173,0.43624,REACTOME_RND3_GTPASE_CYCLE,0.988604659289458
MIR8055,SET,64,0.016868,0.00099414,0.10511,0.43625,MIR8055,0.988604659289458
GSE18893_TCONV_VS_TREG_2H_TN...2,SET,185,0.0097838,0.00097712,0.061021,0.43631,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP,0.988604659289458
GSE16385_IFNG_TNF_VS_UNSTIM_...2,SET,153,0.010522,0.00095653,0.065635,0.43632,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,0.988604659289458
ZHOU_INFLAMMATORY_RESPONSE_F...2,SET,425,0.0068544,0.0010307,0.042767,0.43633,ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP,0.988604659289458
REACTOME_INTERLEUKIN_6_FAMIL...,SET,24,0.027021,0.00097627,0.16859,0.43633,REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,0.988604659289458
REACTOME_TCR_SIGNALING,SET,108,0.012569,0.00096115,0.078447,0.43635,REACTOME_TCR_SIGNALING,0.988604659289458
HP_FRONTAL_CORTICAL_ATROPHY,SET,10,0.043026,0.0010038,0.26855,0.43636,HP_FRONTAL_CORTICAL_ATROPHY,0.988604659289458
GSE9037_CTRL_VS_LPS_1H_STIM_...1,SET,176,0.01008,0.0009821,0.062935,0.43638,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN,0.988604659289458
GOBP_COPPER_ION_TRANSMEMBRAN...,SET,7,0.046804,0.00091369,0.29241,0.43642,GOBP_COPPER_ION_TRANSMEMBRANE_TRANSPORT,0.988604659289458
MIR761,SET,209,0.0090255,0.00095744,0.056401,0.43643,MIR761,0.988604659289458
HP_BROAD_FACE,SET,15,0.03536,0.0010103,0.22109,0.43647,HP_BROAD_FACE,0.988604659289458
GOBP_CELLULAR_RESPONSE_TO_HY...3,SET,4,0.069595,0.0010271,0.43539,0.4365,GOBP_CELLULAR_RESPONSE_TO_HYPEROXIA,0.988604659289458
HILLION_HMGA1B_TARGETS,SET,78,0.015602,0.0010147,0.097671,0.43654,HILLION_HMGA1B_TARGETS,0.988604659289458
MIR4800_5P,SET,23,0.026768,0.00094681,0.16786,0.43665,MIR4800_5P,0.988604659289458
chr1p33,SET,28,0.041443,0.0016171,0.26001,0.43668,chr1p33,0.988604659289458
FUJIWARA_PARK2_HEPATOCYTE_PR...2,SET,12,0.044756,0.0011438,0.28088,0.4367,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP,0.988604659289458
GOBP_RESPONSE_TO_MUSCLE_INAC...,SET,9,0.048356,0.0010703,0.30348,0.4367,GOBP_RESPONSE_TO_MUSCLE_INACTIVITY,0.988604659289458
RODWELL_AGING_KIDNEY_NO_BLOO...1,SET,127,0.01242,0.0010294,0.077968,0.43672,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,0.988604659289458
GOMF_OXIDOREDUCTASE_ACTIVITY...17,SET,10,0.043318,0.0010107,0.27219,0.43678,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_OTHER_NITROGENOUS_COMPOUNDS_AS_DONORS,0.988604659289458
GSE16385_MONOCYTE_VS_12H_ROS...3,SET,187,0.0095041,0.00095425,0.059769,0.43683,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,0.988604659289458
HP_CALCIFICATION_OF_THE_AORTA,SET,21,0.030787,0.0010406,0.19368,0.43685,HP_CALCIFICATION_OF_THE_AORTA,0.988604659289458
GOBP_LIMB_BUD_FORMATION,SET,9,0.0479,0.0010602,0.30144,0.43687,GOBP_LIMB_BUD_FORMATION,0.988604659289458
GOBP_REGULATION_OF_HORMONE_L...,SET,511,0.0063335,0.0010418,0.039883,0.43691,GOBP_REGULATION_OF_HORMONE_LEVELS,0.988604659289458
REACTOME_ACTIVATION_OF_ANTER...,SET,60,0.01731,0.0009879,0.10902,0.43692,REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,0.988604659289458
GOBP_REGULATION_OF_T_CELL_ME...2,SET,10,0.050733,0.0011837,0.31967,0.43695,GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.988604659289458
GOBP_PROTEIN_LOCALIZATION_TO...34,SET,11,0.036115,0.00088369,0.22758,0.43696,GOBP_PROTEIN_LOCALIZATION_TO_NON_MOTILE_CILIUM,0.988604659289458
GOBP_REGULATION_OF_MONONUCLE...,SET,130,0.012071,0.0010121,0.076109,0.43699,GOBP_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,0.988604659289458
GOBP_CELLULAR_RESPONSE_TO_EP...,SET,11,0.041738,0.0010213,0.26323,0.43701,GOBP_CELLULAR_RESPONSE_TO_EPINEPHRINE_STIMULUS,0.988604659289458
GOBP_REGULATION_OF_BICELLULA...,SET,21,0.02942,0.0009944,0.18556,0.43701,GOBP_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,0.988604659289458
HP_EPISODIC_ATAXIA,SET,24,0.028594,0.0010331,0.18033,0.43701,HP_EPISODIC_ATAXIA,0.988604659289458
GSE18281_SUBCAPSULAR_VS_CENT...1,SET,187,0.0097762,0.00098157,0.061653,0.43701,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN,0.988604659289458
ZNF791_TARGET_GENES,SET,41,0.019592,0.0009248,0.12374,0.4371,ZNF791_TARGET_GENES,0.988604659289458
GSE46606_IRF4HIGH_VS_IRF4MID...4,SET,178,0.0092536,0.00090669,0.058475,0.43713,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.988604659289458
ZNF660_TARGET_GENES,SET,598,0.0055336,0.00098225,0.034991,0.43717,ZNF660_TARGET_GENES,0.988604659289458
REACTOME_POLYMERASE_SWITCHIN...,SET,24,0.024358,0.00088006,0.15406,0.43719,REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE,0.988604659289458
GSE18281_PERIMEDULLARY_CORTI...1,SET,170,0.010218,0.00097861,0.06464,0.4372,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,0.988604659289458
REACTOME_DISINHIBITION_OF_SN...,SET,5,0.052147,0.0008604,0.33047,0.43731,REACTOME_DISINHIBITION_OF_SNARE_FORMATION,0.988604659289458
WP_BMP_SIGNALING_IN_EYELID_D...,SET,19,0.035877,0.0011535,0.22743,0.43733,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,0.988604659289458
GOBP_MONOACYLGLYCEROL_CATABO...,SET,7,0.047591,0.00092905,0.30172,0.43734,GOBP_MONOACYLGLYCEROL_CATABOLIC_PROCESS,0.988604659289458
GOBP_CELLULAR_RESPONSE_TO_AB...,SET,307,0.0075564,0.00096889,0.047921,0.43735,GOBP_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS,0.988604659289458
GOMF_PROTEIN_TYROSINE_PHOSPH...,SET,89,0.013749,0.00095493,0.087345,0.43746,GOMF_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,0.988604659289458
GSE32986_UNSTIM_VS_GMCSF_STI...1,SET,180,0.0095393,0.00093987,0.060616,0.43748,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN,0.988604659289458
GOMF_MHC_CLASS_II_PROTEIN_BI...,SET,7,0.052663,0.0010281,0.33488,0.43752,GOMF_MHC_CLASS_II_PROTEIN_BINDING,0.988604659289458
PTEN_DN.V2_UP,SET,126,0.012619,0.0010417,0.080257,0.43753,PTEN_DN.V2_UP,0.988604659289458
GOMF_PDZ_DOMAIN_BINDING,SET,80,0.015519,0.0010221,0.098746,0.43756,GOMF_PDZ_DOMAIN_BINDING,0.988604659289458
GOBP_GLUCOCORTICOID_METABOLI...,SET,24,0.027608,0.0009975,0.17571,0.43757,GOBP_GLUCOCORTICOID_METABOLIC_PROCESS,0.988604659289458
MIR3926,SET,160,0.010312,0.00095846,0.065652,0.43759,MIR3926,0.988604659289458
HP_ABNORMALITY_OF_CANINE,SET,16,0.03438,0.0010144,0.21905,0.43764,HP_ABNORMALITY_OF_CANINE,0.988604659289458
MIR3192_5P,SET,142,0.011197,0.00098083,0.071362,0.43766,MIR3192_5P,0.988604659289458
GOBP_SEGMENTATION,SET,93,0.014506,0.0010298,0.092496,0.43769,GOBP_SEGMENTATION,0.988604659289458
CAGGGTC_MIR504,SET,69,0.015922,0.0009742,0.10153,0.4377,CAGGGTC_MIR504,0.988604659289458
GOBP_POSITIVE_REGULATION_OF_...582,SET,172,0.010811,0.0010414,0.068968,0.43772,GOBP_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,0.988604659289458
HP_NORMOCHROMIC_ANEMIA,SET,33,0.021125,0.00089477,0.13498,0.43782,HP_NORMOCHROMIC_ANEMIA,0.988604659289458
HP_ABNORMAL_FOVEAL_MORPHOLOG...,SET,6,0.057445,0.0010383,0.36719,0.43784,HP_ABNORMAL_FOVEAL_MORPHOLOGY_ON_MACULAR_OCT,0.988604659289458
GOBP_POSITIVE_REGULATION_OF_...45,SET,29,0.025162,0.0009992,0.16089,0.43786,GOBP_POSITIVE_REGULATION_OF_ATP_METABOLIC_PROCESS,0.988604659289458
WP_22Q112_COPY_NUMBER_VARIAT...,SET,105,0.014467,0.0010909,0.092512,0.43787,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,0.988604659289458
GOBP_REGULATION_OF_CELLULAR_...15,SET,13,0.037161,0.00098845,0.23771,0.43789,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,0.988604659289458
PARK_TRETINOIN_RESPONSE_AND_...2,SET,20,0.032285,0.0010649,0.20657,0.4379,PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,0.988604659289458
GOCC_FILOPODIUM,SET,92,0.014252,0.0010063,0.091182,0.4379,GOCC_FILOPODIUM,0.988604659289458
VALK_AML_WITH_T_8_21_TRANSLO...,SET,4,0.075569,0.0011153,0.48422,0.43799,VALK_AML_WITH_T_8_21_TRANSLOCATION,0.988604659289458
GSE10856_CTRL_VS_TNFRSF6B_IN...2,SET,157,0.010631,0.00097885,0.068121,0.43799,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP,0.988604659289458
GOBP_INTRACELLULAR_TRANSPORT...,SET,10,0.039912,0.00093118,0.25577,0.438,GOBP_INTRACELLULAR_TRANSPORT_OF_VIRUS,0.988604659289458
REACTOME_REDUCTION_OF_CYTOSO...,SET,11,0.038498,0.00094202,0.24675,0.43801,REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS,0.988604659289458
HP_MULTIPLE_SUTURE_CRANIOSYN...,SET,11,0.043367,0.0010612,0.27799,0.43802,HP_MULTIPLE_SUTURE_CRANIOSYNOSTOSIS,0.988604659289458
BIOCARTA_GABA_PATHWAY,SET,9,0.044328,0.00098116,0.28432,0.43805,BIOCARTA_GABA_PATHWAY,0.988604659289458
GOBP_REGULATION_OF_LIPID_MET...,SET,279,0.0080087,0.0009797,0.051437,0.43814,GOBP_REGULATION_OF_LIPID_METABOLIC_PROCESS,0.988604659289458
GSE7568_CTRL_VS_3H_TGFB_TREA...2,SET,139,0.011586,0.0010042,0.074451,0.43817,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,0.988604659289458
GOBP_URONIC_ACID_METABOLIC_P...,SET,24,0.038824,0.0014027,0.24955,0.43818,GOBP_URONIC_ACID_METABOLIC_PROCESS,0.988604659289458
HARALAMBIEVA_PBMC_FLUARIX_AG...7,SET,1111,0.0041573,0.00099122,0.026723,0.43819,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE,0.988604659289458
GTGTGAG_MIR342,SET,56,0.017136,0.00094492,0.11019,0.43821,GTGTGAG_MIR342,0.988604659289458
REACTOME_SEMA4D_INDUCED_CELL...,SET,20,0.029679,0.00097899,0.19091,0.43823,REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,0.988604659289458
HP_LOW_FRUSTRATION_TOLERANCE,SET,22,0.027914,0.00096567,0.17963,0.43825,HP_LOW_FRUSTRATION_TOLERANCE,0.988604659289458
GOBP_COLLAGEN_ACTIVATED_TYRO...,SET,9,0.045314,0.001003,0.29167,0.43827,GOBP_COLLAGEN_ACTIVATED_TYROSINE_KINASE_RECEPTOR_SIGNALING_PATHWAY,0.988604659289458
GSE17721_CTRL_VS_GARDIQUIMOD...10,SET,171,0.0098027,0.0009416,0.063202,0.43837,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP,0.988604659289458
GSE5589_LPS_VS_LPS_AND_IL10_...5,SET,181,0.0095496,0.00094346,0.061603,0.4384,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN,0.988604659289458
GOBP_POLY_A_PLUS_MRNA_EXPORT...,SET,18,0.026884,0.00084132,0.17369,0.4385,GOBP_POLY_A_PLUS_MRNA_EXPORT_FROM_NUCLEUS,0.988604659289458
GOBP_REGULATION_OF_VIRAL_PRO...,SET,154,0.010973,0.0010007,0.070903,0.4385,GOBP_REGULATION_OF_VIRAL_PROCESS,0.988604659289458
GOMF_INTERLEUKIN_6_RECEPTOR_...,SET,6,0.047481,0.00085818,0.30703,0.43855,GOMF_INTERLEUKIN_6_RECEPTOR_BINDING,0.988604659289458
HP_RECURRENT_SINUSITIS,SET,58,0.016861,0.00094617,0.10904,0.43856,HP_RECURRENT_SINUSITIS,0.988604659289458
REACTOME_UBIQUINOL_BIOSYNTHE...,SET,10,0.036781,0.00085814,0.23797,0.43858,REACTOME_UBIQUINOL_BIOSYNTHESIS,0.988604659289458
HP_SPINOCEREBELLAR_TRACT_DEG...,SET,8,0.046939,0.00097957,0.30365,0.43858,HP_SPINOCEREBELLAR_TRACT_DEGENERATION,0.988604659289458
GOBP_CITRULLINE_BIOSYNTHETIC...,SET,4,0.057065,0.00084218,0.36939,0.43862,GOBP_CITRULLINE_BIOSYNTHETIC_PROCESS,0.988604659289458
GSE360_L_DONOVANI_VS_T_GONDI...2,SET,183,0.0098439,0.00097784,0.063726,0.43862,GSE360_L_DONOVANI_VS_T_GONDII_DC_UP,0.988604659289458
GSE18791_CTRL_VS_NEWCASTLE_V...1,SET,170,0.010324,0.00098875,0.066899,0.43868,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN,0.988604659289458
BIOCARTA_ACH_PATHWAY,SET,14,0.036231,0.0010001,0.23492,0.43872,BIOCARTA_ACH_PATHWAY,0.988604659289458
DESCARTES_FETAL_THYMUS_THYMI...,SET,197,0.01007,0.0010374,0.065336,0.43876,DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS,0.988604659289458
GSE36527_CD69_NEG_VS_POS_TRE...1,SET,185,0.0090636,0.00090519,0.058829,0.43878,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_DN,0.988604659289458
DESCARTES_FETAL_THYMUS_ANTIG...,SET,152,0.011213,0.001016,0.07278,0.43878,DESCARTES_FETAL_THYMUS_ANTIGEN_PRESENTING_CELLS,0.988604659289458
GOBP_ECTODERM_DEVELOPMENT,SET,19,0.031279,0.0010057,0.20312,0.43881,GOBP_ECTODERM_DEVELOPMENT,0.988604659289458
WU_SILENCED_BY_METHYLATION_I...,SET,46,0.021072,0.0010534,0.1369,0.43884,WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,0.988604659289458
QUEREC_PBMC_YF_17D_VACCINE_A...1,SET,42,0.021414,0.001023,0.13913,0.43884,QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP,0.988604659289458
QUEREC_PBMC_YF_17D_VACCINE_A...2,SET,42,0.021414,0.001023,0.13913,0.43884,QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP,0.988604659289458
GOBP_GPI_ANCHOR_METABOLIC_PR...,SET,30,0.021158,0.00085453,0.13752,0.43886,GOBP_GPI_ANCHOR_METABOLIC_PROCESS,0.988604659289458
MIR6866_5P,SET,67,0.01597,0.00096295,0.10387,0.4389,MIR6866_5P,0.988604659289458
GOMF_SEQUENCE_SPECIFIC_MRNA_...,SET,11,0.033943,0.00083056,0.22109,0.43899,GOMF_SEQUENCE_SPECIFIC_MRNA_BINDING,0.988604659289458
GOCC_GLIAL_CELL_PROJECTION,SET,38,0.022646,0.0010292,0.14751,0.439,GOCC_GLIAL_CELL_PROJECTION,0.988604659289458
GSE15215_CD2_POS_VS_NEG_PDC_...1,SET,179,0.0090982,0.00089394,0.059285,0.43902,GSE15215_CD2_POS_VS_NEG_PDC_DN,0.988604659289458
GSE8621_LPS_STIM_VS_LPS_PRIM...1,SET,183,0.0096211,0.00095571,0.062691,0.43902,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.988604659289458
HP_ABNORMAL_CERVICAL_CURVATU...,SET,11,0.039249,0.0009604,0.25587,0.43904,HP_ABNORMAL_CERVICAL_CURVATURE,0.988604659289458
REACTOME_ACTIVATION_OF_NIMA_...,SET,7,0.046058,0.00089914,0.30029,0.43905,REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7,0.988604659289458
GSE24634_TEFF_VS_TCONV_DAY5_...1,SET,174,0.0098673,0.000956,0.064406,0.43912,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN,0.988604659289458
MIR302D_5P,SET,183,0.0096084,0.00095445,0.062757,0.43916,MIR302D_5P,0.988604659289458
GOBP_CRD_MEDIATED_MRNA_STABI...,SET,11,0.039607,0.00096916,0.25874,0.43917,GOBP_CRD_MEDIATED_MRNA_STABILIZATION,0.988604659289458
GOMF_5S_RRNA_BINDING,SET,8,0.04416,0.00092158,0.28851,0.43917,GOMF_5S_RRNA_BINDING,0.988604659289458
chr11p11,SET,62,0.034138,0.0019804,0.2231,0.43919,chr11p11,0.988604659289458
WP_PYRIMIDINE_METABOLISM,SET,75,0.014054,0.00089641,0.091897,0.43922,WP_PYRIMIDINE_METABOLISM,0.988604659289458
GSE411_WT_VS_SOCS3_KO_MACROP...5,SET,184,0.010064,0.0010024,0.065794,0.43922,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP,0.988604659289458
SENGUPTA_EBNA1_ANTICORRELATED,SET,126,0.011308,0.00093353,0.074038,0.4393,SENGUPTA_EBNA1_ANTICORRELATED,0.988604659289458
HP_ABNORMAL_FETAL_PHYSIOLOGY,SET,261,0.0081034,0.00095925,0.053059,0.43931,HP_ABNORMAL_FETAL_PHYSIOLOGY,0.988604659289458
HP_ABNORMAL_INTERNAL_GENITAL...,SET,467,0.0060443,0.00095162,0.039602,0.43935,HP_ABNORMAL_INTERNAL_GENITALIA,0.988604659289458
HELLER_HDAC_TARGETS_UP,SET,251,0.0080061,0.00092965,0.052469,0.43936,HELLER_HDAC_TARGETS_UP,0.988604659289458
chr4p15,SET,46,0.03847,0.0019231,0.25221,0.43938,chr4p15,0.988604659289458
MIR1246,SET,47,0.018545,0.00093709,0.1216,0.43939,MIR1246,0.988604659289458
GOCC_ATG12_ATG5_ATG16_COMPLEX,SET,6,0.060124,0.0010867,0.39419,0.43939,GOCC_ATG12_ATG5_ATG16_COMPLEX,0.988604659289458
GOMF_RNA_POLYMERASE_II_ACTIV...,SET,9,0.038943,0.00086198,0.25554,0.43944,GOMF_RNA_POLYMERASE_II_ACTIVITY,0.988604659289458
GOBP_T_CELL_ANTIGEN_PROCESSI...,SET,4,0.070725,0.0010438,0.4642,0.43945,GOBP_T_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,0.988604659289458
REACTOME_M_DECAY_DEGRADATION...,SET,31,0.022201,0.00091145,0.14573,0.43946,REACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS,0.988604659289458
GOBP_SYNAPTONEMAL_COMPLEX_OR...,SET,23,0.02513,0.00088888,0.16497,0.43946,GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION,0.988604659289458
HP_ORAL_MUCOSAL_BLISTERS,SET,13,0.036198,0.00096284,0.23773,0.43949,HP_ORAL_MUCOSAL_BLISTERS,0.988604659289458
HP_PANCREATIC_ADENOCARCINOMA,SET,35,0.021032,0.00091738,0.13815,0.4395,HP_PANCREATIC_ADENOCARCINOMA,0.988604659289458
MORF_SNRP70,SET,59,0.014469,0.00081886,0.095061,0.43951,MORF_SNRP70,0.988604659289458
MIR296_3P,SET,28,0.023784,0.00092807,0.15639,0.43956,MIR296_3P,0.988604659289458
HP_GENU_VARUM,SET,54,0.017762,0.00096184,0.11679,0.43956,HP_GENU_VARUM,0.988604659289458
GOBP_POSITIVE_REGULATION_OF_...341,SET,14,0.034691,0.00095757,0.22826,0.4396,GOBP_POSITIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS,0.988630645787498
AP1_Q4,SET,251,0.0081853,0.00095046,0.053882,0.43963,AP1_Q4,0.988634141054675
GOBP_NEGATIVE_REGULATION_OF_...421,SET,12,0.038118,0.00097415,0.25117,0.43969,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,0.988676049007564
GNF2_RFC4,SET,57,0.015329,0.00085277,0.10106,0.43972,GNF2_RFC4,0.988676049007564
GSE18281_CORTEX_VS_MEDULLA_T...1,SET,158,0.010216,0.00094363,0.067387,0.43975,GSE18281_CORTEX_VS_MEDULLA_THYMUS_DN,0.988676049007564
HP_HYPOPLASTIC_NIPPLES,SET,31,0.021205,0.00087055,0.13994,0.43978,HP_HYPOPLASTIC_NIPPLES,0.988676049007564
GOMF_WW_DOMAIN_BINDING,SET,21,0.026949,0.00091087,0.17802,0.43984,GOMF_WW_DOMAIN_BINDING,0.988676049007564
HP_RETINAL_PIGMENT_EPITHELIA...2,SET,39,0.020587,0.0009478,0.13603,0.43985,HP_RETINAL_PIGMENT_EPITHELIAL_MOTTLING,0.988676049007564
GOMF_NITRIC_OXIDE_SYNTHASE_R...,SET,7,0.047859,0.00093429,0.3164,0.43989,GOMF_NITRIC_OXIDE_SYNTHASE_REGULATOR_ACTIVITY,0.988676049007564
XU_AKT1_TARGETS_48HR,SET,9,0.043951,0.00097284,0.29072,0.43992,XU_AKT1_TARGETS_48HR,0.988676049007564
MODULE_497,SET,29,0.026096,0.0010363,0.17268,0.43994,MODULE_497,0.988676049007564
HP_EXERCISE_INTOLERANCE,SET,119,0.01172,0.00094043,0.077596,0.43998,HP_EXERCISE_INTOLERANCE,0.988676049007564
MIR4724_5P,SET,116,0.012197,0.00096638,0.080773,0.43999,MIR4724_5P,0.988676049007564
GSE2706_UNSTIM_VS_8H_LPS_AND...1,SET,173,0.010222,0.00098754,0.067698,0.43999,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN,0.988676049007564
HP_ABNORMAL_RETICULOCYTE_MOR...,SET,73,0.014417,0.00090724,0.095737,0.44015,HP_ABNORMAL_RETICULOCYTE_MORPHOLOGY,0.988850733583247
HE_LIM_SUN_FETAL_LUNG_C4_CD1...,SET,16,0.037204,0.0010978,0.24706,0.44015,HE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL,0.988850733583247
GOBP_PERIPHERAL_NERVOUS_SYST...3,SET,83,0.014229,0.00095453,0.094544,0.44018,GOBP_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT,0.988850733583247
GSE13738_RESTING_VS_BYSTANDE...2,SET,152,0.01014,0.00091875,0.067373,0.44019,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,0.988850733583247
REACTOME_SIGNALING_BY_MAPK_M...,SET,6,0.059018,0.0010667,0.39231,0.44021,REACTOME_SIGNALING_BY_MAPK_MUTANTS,0.988850733583247
GOCC_CYTOSOLIC_LARGE_RIBOSOM...,SET,50,0.017115,0.00089191,0.11383,0.44024,GOCC_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT,0.988854210560331
GGCAGTG_MIR3243P,SET,87,0.013239,0.00090918,0.088128,0.44029,GGCAGTG_MIR3243P,0.988902607599845
GOBP_CELL_CELL_ADHESION_MEDI...1,SET,48,0.019251,0.000983,0.12827,0.44035,GOBP_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.988942421991085
GOBP_TELOMERE_MAINTENANCE_VI...2,SET,9,0.039002,0.00086328,0.26015,0.44041,GOBP_TELOMERE_MAINTENANCE_VIA_SEMI_CONSERVATIVE_REPLICATION,0.988942421991085
GSE13484_UNSTIM_VS_3H_YF17D_...1,SET,179,0.0092828,0.00091207,0.061936,0.44043,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,0.988942421991085
GOBP_SCARNA_LOCALIZATION_TO_...,SET,4,0.048749,0.00071944,0.32534,0.44045,GOBP_SCARNA_LOCALIZATION_TO_CAJAL_BODY,0.988942421991085
GSE29618_BCELL_VS_MONOCYTE_DN,SET,179,0.0098782,0.00097057,0.065925,0.44045,GSE29618_BCELL_VS_MONOCYTE_DN,0.988942421991085
GOBP_MONOACYLGLYCEROL_METABO...,SET,14,0.033358,0.00092076,0.22279,0.44049,GOBP_MONOACYLGLYCEROL_METABOLIC_PROCESS,0.988968343023256
WP_OMEGA6FATTY_ACIDS_IN_SENE...,SET,55,0.017336,0.00094738,0.1159,0.44055,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,0.988975277741894
HP_ABNORMAL_LEUKOCYTE_ENZYME...,SET,6,0.051445,0.00092982,0.34392,0.44055,HP_ABNORMAL_LEUKOCYTE_ENZYME_CONCENTRATION_OR_ACTIVITY,0.988975277741894
HP_PROMINENT_EAR_HELIX,SET,6,0.057703,0.0010429,0.38603,0.44059,HP_PROMINENT_EAR_HELIX,0.989001191629529
GOMF_PROCOLLAGEN_PROLINE_4_D...,SET,5,0.041618,0.00068669,0.27861,0.44063,GOMF_PROCOLLAGEN_PROLINE_4_DIOXYGENASE_ACTIVITY,0.989027102169982
E2F3_UP.V1_DN,SET,131,0.01071,0.00090144,0.071764,0.44068,E2F3_UP.V1_DN,0.989034027508718
OUILLETTE_CLL_13Q14_DELETION...1,SET,47,0.018904,0.00095523,0.12668,0.44069,OUILLETTE_CLL_13Q14_DELETION_DN,0.989034027508718
GSE15733_BM_VS_SPLEEN_MEMORY...1,SET,176,0.0091897,0.00089541,0.061647,0.44075,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN,0.989104813714728
HP_ABNORMAL_URETER_MORPHOLOGY,SET,136,0.010605,0.0009093,0.07127,0.44086,HP_ABNORMAL_URETER_MORPHOLOGY,0.989268797210924
GOBP_TISSUE_REGENERATION,SET,69,0.015614,0.00095536,0.10498,0.44088,GOBP_TISSUE_REGENERATION,0.989268797210924
GSE22886_TH1_VS_TH2_48H_ACT_...2,SET,177,0.009797,0.00095725,0.065902,0.44091,GSE22886_TH1_VS_TH2_48H_ACT_UP,0.989272243382828
GSE4984_UNTREATED_VS_LPS_TRE...2,SET,144,0.01015,0.00089536,0.068391,0.44101,GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP,0.989432738364212
GOBP_NEGATIVE_REGULATION_OF_...488,SET,5,0.059379,0.00097975,0.40059,0.44108,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,0.989525910147173
GOBP_RESPONSE_TO_MISFOLDED_P...,SET,17,0.028085,0.00085417,0.18973,0.44116,GOBP_RESPONSE_TO_MISFOLDED_PROTEIN,0.98958105517909
JAZAG_TGFB1_SIGNALING_UP,SET,93,0.012236,0.00086865,0.08268,0.44117,JAZAG_TGFB1_SIGNALING_UP,0.98958105517909
ISHIDA_E2F_TARGETS,SET,50,0.016796,0.00087527,0.11352,0.44119,ISHIDA_E2F_TARGETS,0.98958105517909
DARWICHE_SQUAMOUS_CELL_CARCI...1,SET,164,0.0094576,0.00088983,0.064043,0.4413,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,0.989601016938278
GOMF_TRANSCRIPTION_COACTIVAT...1,SET,250,0.0075458,0.00087449,0.051145,0.44135,GOMF_TRANSCRIPTION_COACTIVATOR_ACTIVITY,0.989601016938278
GOBP_POSITIVE_REGULATION_OF_...434,SET,15,0.03303,0.00094369,0.22417,0.44143,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,0.989601016938278
GSE40274_FOXP3_VS_FOXP3_AND_...14,SET,116,0.012234,0.0009693,0.083045,0.44144,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.989601016938278
GOBP_NEGATIVE_REGULATION_OF_...520,SET,6,0.04917,0.00088869,0.33391,0.44147,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.989601016938278
MODULE_146,SET,96,0.013651,0.00098448,0.092904,0.44159,MODULE_146,0.989601016938278
GSE11864_CSF1_PAM3CYS_VS_CSF...2,SET,166,0.0098552,0.00093282,0.067071,0.44159,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.989601016938278
MIR1287_5P,SET,58,0.015568,0.00087363,0.106,0.44161,MIR1287_5P,0.989601016938278
GOBP_NEGATIVE_REGULATION_OF_...297,SET,83,0.013343,0.00089507,0.090856,0.44162,GOBP_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE,0.989601016938278
GTTGNYNNRGNAAC_UNKNOWN,SET,94,0.013133,0.00093729,0.089508,0.44167,GTTGNYNNRGNAAC_UNKNOWN,0.989601016938278
BAELDE_DIABETIC_NEPHROPATHY_...1,SET,401,0.0064058,0.00093627,0.043673,0.44169,BAELDE_DIABETIC_NEPHROPATHY_DN,0.989601016938278
GOBP_VIRAL_TRANSLATIONAL_TER...,SET,5,0.051196,0.00084472,0.34912,0.44171,GOBP_VIRAL_TRANSLATIONAL_TERMINATION_REINITIATION,0.989601016938278
KYNG_WERNER_SYNDROM_DN,SET,18,0.029718,0.00093001,0.2028,0.44175,KYNG_WERNER_SYNDROM_DN,0.989601016938278
KEGG_MEDICUS_VARIANT_MUTATIO...49,SET,17,0.028993,0.00088179,0.19784,0.44175,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM,0.989601016938278
HP_CHRONIC_HEPATITIS,SET,9,0.043295,0.00095831,0.29557,0.44177,HP_CHRONIC_HEPATITIS,0.989601016938278
HOEK_B_CELL_2011_2012_TIV_AD...5,SET,33,0.022423,0.00094975,0.15308,0.44177,HOEK_B_CELL_2011_2012_TIV_ADULT_7DY_UP,0.989601016938278
MISHRA_CARCINOMA_ASSOCIATED_...2,SET,22,0.026899,0.00093054,0.18406,0.44191,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,0.989601016938278
MIR371B_5P,SET,856,0.0042999,0.00090652,0.029431,0.44192,MIR371B_5P,0.989601016938278
GOBP_CARDIAC_ATRIUM_DEVELOPM...,SET,34,0.023954,0.0010299,0.16397,0.44193,GOBP_CARDIAC_ATRIUM_DEVELOPMENT,0.989601016938278
WP_EICOSANOID_METABOLISM_VIA...2,SET,9,0.041109,0.00090992,0.28146,0.44194,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,0.989601016938278
GSE37301_LYMPHOID_PRIMED_MPP...9,SET,170,0.0094386,0.000904,0.064672,0.44198,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN,0.989601016938278
MIR6823_5P,SET,64,0.015078,0.00088861,0.1034,0.44203,MIR6823_5P,0.989601016938278
REACTOME_TRANSPORT_OF_THE_SL...,SET,33,0.019245,0.00081513,0.13201,0.44205,REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA,0.989601016938278
MIR596,SET,29,0.022795,0.00090521,0.15639,0.44206,MIR596,0.989601016938278
GSE4142_PLASMA_CELL_VS_MEMOR...1,SET,183,0.0090854,0.0009025,0.062468,0.44218,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.989601016938278
WP_BILE_ACID_SYNTHESIS_AND_E...,SET,12,0.039989,0.001022,0.2752,0.44223,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,0.989601016938278
GOBP_NEGATIVE_REGULATION_OF_...450,SET,5,0.06476,0.0010685,0.4462,0.4423,GOBP_NEGATIVE_REGULATION_OF_NODAL_SIGNALING_PATHWAY,0.989601016938278
GSE10239_MEMORY_VS_DAY4.5_EF...1,SET,181,0.0088399,0.00087334,0.060938,0.44233,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN,0.989601016938278
NICK_RESPONSE_TO_PROC_TREATM...1,SET,23,0.023718,0.00083893,0.16362,0.44237,NICK_RESPONSE_TO_PROC_TREATMENT_DN,0.989601016938278
MIR5092,SET,6,0.045649,0.00082506,0.31491,0.44237,MIR5092,0.989601016938278
GSE3994_WT_VS_PAC1_KO_ACTIVA...2,SET,187,0.0093593,0.00093971,0.064563,0.44237,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP,0.989601016938278
MIR609,SET,30,0.021961,0.00088696,0.15152,0.44238,MIR609,0.989601016938278
GOMF_TELETHONIN_BINDING,SET,7,0.051721,0.0010097,0.35694,0.4424,GOMF_TELETHONIN_BINDING,0.989601016938278
GOBP_INCLUSION_BODY_ASSEMBLY,SET,22,0.026798,0.00092705,0.18497,0.44241,GOBP_INCLUSION_BODY_ASSEMBLY,0.989601016938278
MIR4482_5P,SET,32,0.021446,0.00089452,0.14806,0.44242,MIR4482_5P,0.989601016938278
TOMLINS_PROSTATE_CANCER_DN,SET,36,0.020771,0.00091882,0.14346,0.44244,TOMLINS_PROSTATE_CANCER_DN,0.989601016938278
HE_LIM_SUN_FETAL_LUNG_C1_SQU...,SET,230,0.0084708,0.00094211,0.058509,0.44244,HE_LIM_SUN_FETAL_LUNG_C1_SQUAMOUS_CELL,0.989601016938278
MIR4290,SET,62,0.01395,0.00080926,0.096364,0.44245,MIR4290,0.989601016938278
MIR143_3P_MIR4770,SET,187,0.0090468,0.00090833,0.06251,0.44246,MIR143_3P_MIR4770,0.989601016938278
chr16q12,SET,35,0.035125,0.0015321,0.24272,0.44247,chr16q12,0.989601016938278
GOBP_REGULATION_PROTEIN_CATA...,SET,4,0.048595,0.00071718,0.33592,0.44249,GOBP_REGULATION_PROTEIN_CATABOLIC_PROCESS_AT_SYNAPSE,0.989601016938278
REACTOME_PTK6_PROMOTES_HIF1A...,SET,6,0.053524,0.0009674,0.37024,0.44253,REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION,0.989601016938278
REACTOME_SIGNALING_BY_ALK,SET,26,0.024854,0.00093462,0.172,0.44255,REACTOME_SIGNALING_BY_ALK,0.989601016938278
KYNG_DNA_DAMAGE_UP,SET,188,0.0088375,0.00088966,0.061177,0.44257,KYNG_DNA_DAMAGE_UP,0.989601016938278
GSE9006_HEALTHY_VS_TYPE_2_DI...2,SET,176,0.0086013,0.00083807,0.05954,0.44257,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,0.989601016938278
GOBP_NEGATIVE_REGULATION_OF_...683,SET,16,0.032636,0.00096298,0.22653,0.44272,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,0.989601016938278
REACTOME_MTORC1_MEDIATED_SIG...,SET,23,0.024382,0.0008624,0.16944,0.44279,REACTOME_MTORC1_MEDIATED_SIGNALLING,0.989601016938278
GSE23984_CTRL_VS_HYPOCALEMIC...1,SET,168,0.0093486,0.00089014,0.06496,0.44279,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN,0.989601016938278
chr2p24,SET,26,0.039628,0.0014902,0.27546,0.44281,chr2p24,0.989601016938278
GOBP_RESPONSE_TO_WATER_DEPRI...,SET,5,0.04996,0.00082433,0.34732,0.44281,GOBP_RESPONSE_TO_WATER_DEPRIVATION,0.989601016938278
HP_ABNORMALITY_OF_BLOOD_AND_...,SET,1317,0.0034154,0.00088129,0.023744,0.44281,HP_ABNORMALITY_OF_BLOOD_AND_BLOOD_FORMING_TISSUES,0.989601016938278
GSE15735_CTRL_VS_HDAC_INHIBI...1,SET,185,0.0089123,0.00089007,0.061951,0.44281,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN,0.989601016938278
GOBP_PHOTOTRANSDUCTION,SET,40,0.01993,0.0009292,0.13862,0.44284,GOBP_PHOTOTRANSDUCTION,0.989601016938278
HP_HEMATOLOGICAL_NEOPLASM,SET,277,0.0072126,0.00087919,0.050229,0.44291,HP_HEMATOLOGICAL_NEOPLASM,0.989601016938278
MIR2110,SET,159,0.0093893,0.00086995,0.065439,0.44296,MIR2110,0.989601016938278
KIM_LIVER_CANCER_POOR_SURVIV...2,SET,21,0.026997,0.0009125,0.18821,0.44297,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,0.989601016938278
DYRK1A_TARGET_GENES,SET,599,0.0049425,0.00087803,0.034462,0.44298,DYRK1A_TARGET_GENES,0.989601016938278
GOBP_POSITIVE_REGULATION_OF_...815,SET,7,0.044882,0.00087618,0.31327,0.44304,GOBP_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,0.989601016938278
GOBP_REGULATION_OF_MONOATOMI...2,SET,13,0.034388,0.00091471,0.2401,0.44306,GOBP_REGULATION_OF_MONOATOMIC_ANION_TRANSPORT,0.989601016938278
GOBP_NEGATIVE_REGULATION_OF_...526,SET,11,0.041986,0.0010274,0.29375,0.44317,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,0.989601016938278
GOBP_POSITIVE_REGULATION_OF_...772,SET,7,0.049727,0.00097075,0.34796,0.44318,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NOTCH_RECEPTOR_TARGET,0.989601016938278
GOBP_NEGATIVE_REGULATION_OF_...244,SET,33,0.020736,0.00087828,0.14513,0.44319,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,0.989601016938278
HP_SMALL_JOINT_HYPERMOBILTY,SET,52,0.016919,0.00089913,0.11846,0.44321,HP_SMALL_JOINT_HYPERMOBILTY,0.989601016938278
GSE11924_TFH_VS_TH17_CD4_TCE...1,SET,180,0.008663,0.00085353,0.060688,0.44325,GSE11924_TFH_VS_TH17_CD4_TCELL_DN,0.989601016938278
GOBP_REGULATION_OF_GLYCOPROT...,SET,44,0.018176,0.00088872,0.12742,0.44328,GOBP_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,0.989601016938278
HP_LIMB_GIRDLE_MUSCLE_ATROPHY,SET,31,0.021725,0.0008919,0.15236,0.44331,HP_LIMB_GIRDLE_MUSCLE_ATROPHY,0.989601016938278
GOBP_BIOLOGICAL_PROCESS_INVO...4,SET,47,0.017886,0.00090377,0.12553,0.44335,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS,0.989601016938278
HP_CORNEAL_EROSION,SET,40,0.01968,0.00091755,0.13813,0.44335,HP_CORNEAL_EROSION,0.989601016938278
GSE17974_0H_VS_72H_IN_VITRO_...2,SET,162,0.0096994,0.00090705,0.068076,0.44335,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP,0.989601016938278
DESCARTES_FETAL_ADRENAL_VASC...,SET,110,0.012142,0.00093699,0.085211,0.44335,DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS,0.989601016938278
WP_PATHWAYS_OF_NUCLEIC_ACID_...,SET,13,0.031247,0.00083114,0.21944,0.44339,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,0.989601016938278
GOCC_CLATHRIN_COATED_ENDOCYT...1,SET,84,0.014262,0.00096245,0.10017,0.44339,GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE,0.989601016938278
GOBP_REGULATION_OF_PROTEIN_L...2,SET,9,0.043476,0.00096231,0.30555,0.44343,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,0.989601016938278
GSE24634_TREG_VS_TCONV_POST_...4,SET,181,0.0085228,0.00084202,0.059904,0.44343,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP,0.989601016938278
GSE26030_UNSTIM_VS_RESTIM_TH...7,SET,180,0.0089598,0.00088277,0.063025,0.44348,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_DN,0.989601016938278
GOBP_REGULATION_OF_COLLATERA...,SET,18,0.029881,0.00093512,0.21046,0.44355,GOBP_REGULATION_OF_COLLATERAL_SPROUTING,0.989601016938278
GOMF_NUCLEOSOMAL_DNA_BINDING,SET,24,0.022724,0.00082104,0.16022,0.44361,GOMF_NUCLEOSOMAL_DNA_BINDING,0.989601016938278
GSE21670_UNTREATED_VS_TGFB_I...3,SET,177,0.0086065,0.00084094,0.060688,0.44361,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.989601016938278
GOBP_GLYCEROPHOSPHOLIPID_BIO...,SET,190,0.008436,0.0008537,0.059502,0.44363,GOBP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.989601016938278
REACTOME_MRNA_DECAY_BY_3_TO_...,SET,12,0.028506,0.0007285,0.20112,0.44365,REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE,0.989601016938278
HBZ_TARGET_GENES,SET,836,0.0041959,0.00087472,0.029614,0.44366,HBZ_TARGET_GENES,0.989601016938278
GOBP_NEGATIVE_REGULATION_OF_...82,SET,26,0.024682,0.00092815,0.17423,0.44367,GOBP_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,0.989601016938278
HP_SPONDYLOLISTHESIS,SET,19,0.027724,0.00089136,0.1957,0.44367,HP_SPONDYLOLISTHESIS,0.989601016938278
REACTOME_NEF_MEDIATED_CD4_DO...,SET,9,0.038951,0.00086215,0.27507,0.4437,REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION,0.989601016938278
MIR3619_5P,SET,255,0.0072163,0.0008445,0.050964,0.4437,MIR3619_5P,0.989601016938278
USF_C,SET,262,0.0073348,0.0008699,0.051821,0.44372,USF_C,0.989601016938278
GOMF_TRANSFORMING_GROWTH_FAC...4,SET,26,0.025164,0.00094626,0.17777,0.44372,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.989601016938278
MIR3689D,SET,87,0.012485,0.00085734,0.088217,0.44373,MIR3689D,0.989601016938278
MIR3182,SET,238,0.0077485,0.00087645,0.054793,0.44377,MIR3182,0.989601016938278
DESCARTES_FETAL_LUNG_BRONCHI...,SET,48,0.019187,0.00097973,0.1357,0.44378,DESCARTES_FETAL_LUNG_BRONCHIOLAR_AND_ALVEOLAR_EPITHELIAL_CELLS,0.989601016938278
MIR10396B_5P,SET,19,0.028406,0.00091331,0.20095,0.44379,MIR10396B_5P,0.989601016938278
GARGALOVIC_RESPONSE_TO_OXIDI...5,SET,13,0.030232,0.00080414,0.21428,0.4439,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,0.98965051943055
NIKOLSKY_BREAST_CANCER_10Q22...,SET,8,0.054393,0.0011351,0.38583,0.44394,NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON,0.98965051943055
CHX10_01,SET,203,0.0088429,0.00092466,0.062734,0.44395,CHX10_01,0.98965051943055
GOMF_INTRACELLULARLY_CGMP_AC...,SET,6,0.048395,0.0008747,0.34356,0.44399,GOMF_INTRACELLULARLY_CGMP_ACTIVATED_CATION_CHANNEL_ACTIVITY,0.98965051943055
GOCC_REPLICATION_FORK,SET,69,0.013069,0.00079966,0.092848,0.44403,GOCC_REPLICATION_FORK,0.98965051943055
HP_SPONTANEOUS_HEMOLYTIC_CRI...,SET,7,0.040814,0.00079675,0.28995,0.44403,HP_SPONTANEOUS_HEMOLYTIC_CRISES,0.98965051943055
HUMMERICH_SKIN_CANCER_PROGRE...1,SET,89,0.012582,0.00087383,0.089401,0.44404,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,0.98965051943055
GOBP_POSITIVE_REGULATION_OF_...116,SET,2,0.096373,0.0010058,0.68477,0.44404,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MOLECULE_PRODUCTION,0.98965051943055
GSE17974_IL4_AND_ANTI_IL12_V...5,SET,139,0.010195,0.00088369,0.072533,0.44411,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN,0.989743061878807
HP_NEOPLASM_OF_THE_AUTONOMIC...,SET,10,0.043227,0.0010085,0.30783,0.44416,HP_NEOPLASM_OF_THE_AUTONOMIC_NERVOUS_SYSTEM,0.989772129255626
GOBP_NEGATIVE_REGULATION_OF_...469,SET,43,0.019995,0.00096648,0.14244,0.44418,GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.989772129255626
HP_ABNORMAL_RIGHT_VENTRICULA...,SET,19,0.029037,0.0009336,0.20697,0.44421,HP_ABNORMAL_RIGHT_VENTRICULAR_FUNCTION,0.989775519297346
MORF_RBBP8,SET,200,0.0082896,0.00086045,0.059226,0.44434,MORF_RBBP8,0.989974035503717
GSE339_CD8POS_VS_CD4CD8DN_DC...3,SET,184,0.0086003,0.00085662,0.061508,0.4444,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,0.989974035503717
WP_NONHOMOLOGOUS_END_JOINING,SET,10,0.030705,0.00071639,0.21965,0.44441,WP_NONHOMOLOGOUS_END_JOINING,0.989974035503717
MORF_RAB6A,SET,60,0.015229,0.00086915,0.10897,0.44443,MORF_RAB6A,0.989974035503717
GSE45365_NK_CELL_VS_CD8_TCEL...1,SET,144,0.010151,0.00089546,0.072664,0.44445,GSE45365_NK_CELL_VS_CD8_TCELL_DN,0.989974035503717
GOMF_OXIDOREDUCTASE_ACTIVITY...23,SET,42,0.020455,0.00097718,0.14647,0.44447,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.989974035503717
CHIARADONNA_NEOPLASTIC_TRANS...5,SET,130,0.010345,0.00086741,0.074218,0.44457,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,0.990133313040692
MIR3688_5P,SET,126,0.010747,0.00088724,0.077262,0.44469,MIR3688_5P,0.990337110726644
GSE43955_1H_VS_60H_ACT_CD4_T...2,SET,184,0.0086592,0.00086249,0.062324,0.44475,GSE43955_1H_VS_60H_ACT_CD4_TCELL_UP,0.990407269174089
NIKOLSKY_BREAST_CANCER_7P22_...,SET,37,0.034109,0.0015296,0.2458,0.44482,NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,0.990499686058432
REACTOME_SIGNALING_BY_FLT3_I...,SET,16,0.027957,0.00082491,0.20168,0.44488,REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,0.9905119392
GOBP_LIPOPROTEIN_CATABOLIC_P...,SET,14,0.031094,0.00085828,0.22447,0.44491,GOBP_LIPOPROTEIN_CATABOLIC_PROCESS,0.9905119392
BIOCARTA_VEGF_PATHWAY,SET,24,0.022678,0.00081936,0.16382,0.44495,BIOCARTA_VEGF_PATHWAY,0.9905119392
MORF_LTK,SET,137,0.010166,0.00087488,0.073476,0.44498,MORF_LTK,0.9905119392
HP_PAIN_IN_HEAD_AND_NECK_REG...,SET,40,0.018628,0.0008685,0.13472,0.44501,HP_PAIN_IN_HEAD_AND_NECK_REGION,0.9905119392
GNF2_SPRR1B,SET,23,0.027064,0.00095727,0.19576,0.44502,GNF2_SPRR1B,0.9905119392
GOMF_PROTEIN_SERINE_KINASE_A...,SET,334,0.0063162,0.0008441,0.045709,0.44505,GOMF_PROTEIN_SERINE_KINASE_ACTIVITY,0.9905119392
DAZARD_RESPONSE_TO_UV_NHEK_UP,SET,189,0.0085073,0.00085867,0.061584,0.44506,DAZARD_RESPONSE_TO_UV_NHEK_UP,0.9905119392
GSE17721_LPS_VS_CPG_1H_BMDC_...2,SET,180,0.0083129,0.00081903,0.060215,0.4451,GSE17721_LPS_VS_CPG_1H_BMDC_UP,0.9905119392
GOBP_DENDRITIC_TRANSPORT_OF_...,SET,5,0.049187,0.00081157,0.35694,0.4452,GOBP_DENDRITIC_TRANSPORT_OF_RIBONUCLEOPROTEIN_COMPLEX,0.9905119392
GOBP_MITOCHONDRIAL_GENE_EXPR...,SET,154,0.0087533,0.00079828,0.063555,0.44523,GOBP_MITOCHONDRIAL_GENE_EXPRESSION,0.9905119392
HP_HYDROMETROCOLPOS,SET,28,0.021901,0.0008546,0.15901,0.44523,HP_HYDROMETROCOLPOS,0.9905119392
REACTOME_VEGFR2_MEDIATED_VAS...,SET,26,0.023463,0.00088229,0.17046,0.44526,REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,0.9905119392
HP_RECURRENT_SINOPULMONARY_I...,SET,58,0.014782,0.00082951,0.10741,0.44527,HP_RECURRENT_SINOPULMONARY_INFECTIONS,0.9905119392
HP_ABNORMAL_MOTOR_NERVE_COND...,SET,60,0.014336,0.00081819,0.10421,0.44529,HP_ABNORMAL_MOTOR_NERVE_CONDUCTION_VELOCITY,0.9905119392
GOBP_REGULATION_OF_MAST_CELL...4,SET,25,0.02515,0.0009274,0.18285,0.4453,GOBP_REGULATION_OF_MAST_CELL_DEGRANULATION,0.9905119392
BOYAULT_LIVER_CANCER_SUBCLAS...11,SET,177,0.0083926,0.00082003,0.061025,0.44531,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,0.9905119392
MIR3677_5P,SET,24,0.022091,0.00079816,0.16078,0.44536,MIR3677_5P,0.9905597593754
EHLERS_ANEUPLOIDY_UP,SET,35,0.018236,0.00079542,0.13297,0.44546,EHLERS_ANEUPLOIDY_UP,0.990681355122324
HP_IMPAIRED_VIBRATORY_SENSAT...,SET,113,0.010532,0.00082367,0.077036,0.44563,HP_IMPAIRED_VIBRATORY_SENSATION,0.990681355122324
ZHOU_TNF_SIGNALING_4HR,SET,42,0.017159,0.00081973,0.12554,0.44564,ZHOU_TNF_SIGNALING_4HR,0.990681355122324
GSE11961_PLASMA_CELL_DAY7_VS...4,SET,175,0.0088013,0.00085514,0.064391,0.44564,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.990681355122324
GSE19401_RETINOIC_ACID_VS_RE...2,SET,176,0.0090449,0.00088129,0.066179,0.44565,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,0.990681355122324
GSE42088_UNINF_VS_LEISHMANIA...7,SET,169,0.0088907,0.00084903,0.065057,0.44565,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN,0.990681355122324
GOBP_NEGATIVE_REGULATION_OF_...289,SET,181,0.0088186,0.00087125,0.064535,0.44566,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE,0.990681355122324
GOBP_AMINO_ACID_BETAINE_META...,SET,16,0.029111,0.00085896,0.21312,0.44568,GOBP_AMINO_ACID_BETAINE_METABOLIC_PROCESS,0.990681355122324
GOBP_POSITIVE_REGULATION_OF_...670,SET,40,0.017965,0.00083761,0.1319,0.44583,GOBP_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.990681355122324
REACTOME_CROSSLINKING_OF_COL...,SET,16,0.032637,0.00096301,0.2398,0.44587,REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS,0.990681355122324
HP_ANGULAR_CHEILITIS,SET,11,0.038028,0.00093051,0.27941,0.44587,HP_ANGULAR_CHEILITIS,0.990681355122324
HP_POLYGENIC_INHERITANCE,SET,32,0.021223,0.00088521,0.15592,0.44587,HP_POLYGENIC_INHERITANCE,0.990681355122324
PAX3_TARGET_GENES,SET,1195,0.0034997,0.00086329,0.025753,0.44595,PAX3_TARGET_GENES,0.990681355122324
CHEBOTAEV_GR_TARGETS_UP,SET,76,0.013853,0.00088941,0.10198,0.44597,CHEBOTAEV_GR_TARGETS_UP,0.990681355122324
HOSHIDA_LIVER_CANCER_SUBCLAS...1,SET,216,0.0077828,0.00083916,0.057306,0.44599,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,0.990681355122324
MODULE_321,SET,107,0.011594,0.00088248,0.08538,0.44599,MODULE_321,0.990681355122324
GTGCCAA_MIR96,SET,276,0.0069932,0.00085093,0.051531,0.44603,GTGCCAA_MIR96,0.990681355122324
MIR6741_3P,SET,5,0.048639,0.00080254,0.35849,0.44604,MIR6741_3P,0.990681355122324
HALLMARK_MITOTIC_SPINDLE,SET,187,0.0079448,0.00079769,0.058608,0.44609,HALLMARK_MITOTIC_SPINDLE,0.990681355122324
GOBP_ESTABLISHMENT_OF_MITOTI...2,SET,40,0.018083,0.00084311,0.13353,0.44614,GOBP_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION,0.990681355122324
GSE22601_DOUBLE_NEGATIVE_VS_...7,SET,163,0.008943,0.00083887,0.066086,0.44618,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN,0.990681355122324
GOBP_ORGANIC_ACID_TRANSMEMBR...,SET,139,0.0098732,0.00085579,0.073072,0.44626,GOBP_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT,0.990681355122324
MIR188_5P,SET,65,0.014418,0.00085636,0.10673,0.44627,MIR188_5P,0.990681355122324
NOURUZI_NEPC_ASCL1_TARGETS,SET,124,0.011235,0.00092019,0.083182,0.44628,NOURUZI_NEPC_ASCL1_TARGETS,0.990681355122324
GOBP_REGULATION_OF_ACTIN_FIL...2,SET,341,0.0062072,0.00083802,0.045989,0.44632,GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS,0.990681355122324
HP_AORTIC_VALVE_CALCIFICATION,SET,8,0.043478,0.00090734,0.32231,0.44635,HP_AORTIC_VALVE_CALCIFICATION,0.990681355122324
HP_BRAIN_IMAGING_ABNORMALITY,SET,137,0.0095183,0.00081911,0.070567,0.44635,HP_BRAIN_IMAGING_ABNORMALITY,0.990681355122324
GAUCHER_PBMC_YF_VAX_STAMARIL...4,SET,53,0.015428,0.00082768,0.11437,0.44635,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_UP,0.990681355122324
GOCC_NUCLEAR_SPECK,SET,374,0.0055868,0.00078919,0.041424,0.44636,GOCC_NUCLEAR_SPECK,0.990681355122324
GSE41867_LCMV_ARMSTRONG_VS_C...1,SET,141,0.0095913,0.00083727,0.071122,0.44636,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_DN,0.990681355122324
GSE25088_WT_VS_STAT6_KO_MACR...7,SET,167,0.0080963,0.00076862,0.060064,0.44639,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,0.990681355122324
PID_CD8_TCR_PATHWAY,SET,51,0.015361,0.00080845,0.11402,0.44642,PID_CD8_TCR_PATHWAY,0.990681355122324
HP_SEVERE_SHORT_STATURE,SET,96,0.011504,0.00082969,0.085642,0.44657,HP_SEVERE_SHORT_STATURE,0.990681355122324
GSE22611_NOD2_TRANSDUCED_VS_...2,SET,166,0.0089515,0.00084729,0.066637,0.44657,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP,0.990681355122324
GOMF_CYTOCHROME_B5_REDUCTASE...,SET,6,0.042187,0.00076249,0.31415,0.44659,GOMF_CYTOCHROME_B5_REDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,0.990681355122324
GSE22935_UNSTIM_VS_12H_MBOVI...2,SET,181,0.0081111,0.00080135,0.060453,0.44663,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.990681355122324
GOMF_G_QUADRUPLEX_DNA_BINDING,SET,11,0.034399,0.00084172,0.25663,0.44668,GOMF_G_QUADRUPLEX_DNA_BINDING,0.990681355122324
MXD1_TARGET_GENES,SET,504,0.0050382,0.00082319,0.0376,0.4467,MXD1_TARGET_GENES,0.990681355122324
HP_ADENOCARCINOMA_OF_THE_SMA...,SET,9,0.033268,0.00073637,0.24836,0.44672,HP_ADENOCARCINOMA_OF_THE_SMALL_INTESTINE,0.990681355122324
GSE7831_UNSTIM_VS_CPG_STIM_P...3,SET,178,0.0084028,0.00082332,0.062756,0.44674,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_DN,0.990681355122324
GOMF_TRANSFERASE_ACTIVITY_TR...4,SET,822,0.0038906,0.00080455,0.029067,0.44676,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,0.990681355122324
GSE43955_10H_VS_60H_ACT_CD4_...1,SET,182,0.0086293,0.00085487,0.064466,0.44676,GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN,0.990681355122324
HP_AXILLARY_FRECKLING,SET,5,0.044802,0.00073923,0.33483,0.44678,HP_AXILLARY_FRECKLING,0.990681355122324
HP_NON_SMALL_CELL_LUNG_CARCI...,SET,22,0.022783,0.00078816,0.17027,0.44678,HP_NON_SMALL_CELL_LUNG_CARCINOMA,0.990681355122324
REACTOME_TIGHT_JUNCTION_INTE...,SET,27,0.024216,0.00092795,0.18106,0.4468,REACTOME_TIGHT_JUNCTION_INTERACTIONS,0.990681355122324
HP_PAPILLARY_RENAL_CELL_CARC...,SET,8,0.045048,0.00094012,0.33683,0.4468,HP_PAPILLARY_RENAL_CELL_CARCINOMA,0.990681355122324
GOBP_T_CELL_CYTOKINE_PRODUCT...,SET,36,0.019853,0.00087822,0.14848,0.44682,GOBP_T_CELL_CYTOKINE_PRODUCTION,0.990681355122324
MIR6509_3P,SET,123,0.010159,0.00082867,0.076018,0.44685,MIR6509_3P,0.990681355122324
MIR4653_3P,SET,47,0.016674,0.00084254,0.12491,0.4469,MIR4653_3P,0.990681355122324
GOBP_HORMONE_CATABOLIC_PROCE...,SET,12,0.034429,0.00087989,0.25811,0.44694,GOBP_HORMONE_CATABOLIC_PROCESS,0.990681355122324
GSE5589_UNSTIM_VS_180MIN_LPS...3,SET,182,0.0080387,0.00079636,0.060388,0.44705,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN,0.990681355122324
GSE4984_GALECTIN1_VS_LPS_STI...1,SET,156,0.0087988,0.00080757,0.066114,0.44706,GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN,0.990681355122324
GOBP_3_UTR_MEDIATED_MRNA_STA...,SET,19,0.026274,0.00084476,0.19745,0.44707,GOBP_3_UTR_MEDIATED_MRNA_STABILIZATION,0.990681355122324
MIR4646_3P,SET,54,0.015601,0.00084482,0.11728,0.44709,MIR4646_3P,0.990681355122324
GOBP_PROTON_TRANSMEMBRANE_TR...,SET,118,0.010298,0.00082288,0.077441,0.44711,GOBP_PROTON_TRANSMEMBRANE_TRANSPORT,0.990681355122324
GOBP_POSITIVE_REGULATION_OF_...672,SET,23,0.024835,0.00087842,0.1868,0.44712,GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.990681355122324
GOBP_SKELETAL_MUSCLE_TISSUE_...2,SET,36,0.019632,0.00086844,0.14767,0.44712,GOBP_SKELETAL_MUSCLE_TISSUE_REGENERATION,0.990681355122324
KEGG_RETINOL_METABOLISM,SET,60,0.018652,0.0010645,0.14041,0.44716,KEGG_RETINOL_METABOLISM,0.990681355122324
HP_ANTERIOR_PITUITARY_AGENES...,SET,10,0.03714,0.00086653,0.27957,0.44716,HP_ANTERIOR_PITUITARY_AGENESIS,0.990681355122324
GSE18791_CTRL_VS_NEWCASTLE_V...16,SET,182,0.0077906,0.00077178,0.058654,0.44717,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP,0.990681355122324
HOSHIDA_LIVER_CANCER_SUBCLAS...3,SET,241,0.0072153,0.0008212,0.054345,0.44719,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,0.990681355122324
HP_HYPERPIGMENTATION_OF_THE_...1,SET,6,0.048706,0.00088032,0.3669,0.4472,HP_HYPERPIGMENTATION_OF_THE_FUNDUS,0.990681355122324
GSE26890_CXCR1_NEG_VS_POS_EF...1,SET,176,0.0079859,0.00077811,0.06021,0.44724,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN,0.990681355122324
GOBP_POSITIVE_REGULATION_OF_...769,SET,1151,0.0033977,0.0008236,0.025641,0.44729,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.990681355122324
GSE14308_INDUCED_VS_NATURAL_...1,SET,182,0.0081802,0.00081038,0.061737,0.4473,GSE14308_INDUCED_VS_NATURAL_TREG_DN,0.990681355122324
HP_FLANK_PAIN,SET,14,0.02965,0.00081842,0.22404,0.44736,HP_FLANK_PAIN,0.990681355122324
MIR6849_3P,SET,68,0.013325,0.00080942,0.10071,0.44737,MIR6849_3P,0.990681355122324
GRAESSMANN_APOPTOSIS_BY_DOXO...2,SET,1054,0.0035253,0.00082003,0.026665,0.44741,GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP,0.990681355122324
KEGG_MEDICUS_PATHOGEN_SHIGEL...3,SET,9,0.039806,0.00088109,0.30109,0.44741,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,0.990681355122324
HP_ABSENT_EYEBROW,SET,31,0.021479,0.00088184,0.16248,0.44741,HP_ABSENT_EYEBROW,0.990681355122324
HP_ORTHOSTATIC_HYPOTENSION,SET,38,0.018841,0.00085625,0.14259,0.44744,HP_ORTHOSTATIC_HYPOTENSION,0.990684665859718
GOBP_EPITHELIAL_CELL_DIFFERE...2,SET,46,0.018518,0.00092571,0.14025,0.44748,GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.990694595541401
GOBP_DEOXYRIBONUCLEOSIDE_MON...1,SET,8,0.0374,0.00078049,0.28341,0.44751,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.990694595541401
REACTOME_REGULATED_PROTEOLYS...,SET,10,0.03227,0.0007529,0.24466,0.44753,REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR,0.990694595541401
GOBP_REGULATION_OF_CELL_COMM...1,SET,16,0.032304,0.00095319,0.24525,0.44761,GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,0.99072665414252
SHEDDEN_LUNG_CANCER_GOOD_SUR...1,SET,252,0.007256,0.00084421,0.055118,0.44763,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,0.99072665414252
GOBP_STRIATED_MUSCLE_CONTRAC...,SET,173,0.0086479,0.00083547,0.065693,0.44763,GOBP_STRIATED_MUSCLE_CONTRACTION,0.99072665414252
ZNF223_TARGET_GENES,SET,257,0.0067741,0.0007958,0.051488,0.44766,ZNF223_TARGET_GENES,0.990729960519613
GUTIERREZ_CHRONIC_LYMPHOCYTI...2,SET,11,0.035732,0.00087434,0.27211,0.44776,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,0.990755093799682
GOCC_CD40_RECEPTOR_COMPLEX,SET,11,0.029515,0.0007222,0.22481,0.44777,GOCC_CD40_RECEPTOR_COMPLEX,0.990755093799682
REACTOME_SYNTHESIS_OF_PA,SET,35,0.020983,0.00091525,0.15992,0.4478,REACTOME_SYNTHESIS_OF_PA,0.990755093799682
GSE4590_SMALL_VS_LARGE_PRE_B...2,SET,164,0.0086059,0.00080969,0.065772,0.44795,GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP,0.990755093799682
GENTILE_UV_RESPONSE_CLUSTER_...5,SET,33,0.019208,0.00081359,0.14686,0.44797,GENTILE_UV_RESPONSE_CLUSTER_D6,0.990755093799682
SPIRA_SMOKERS_LUNG_CANCER_UP,SET,36,0.018967,0.00083904,0.14509,0.44799,SPIRA_SMOKERS_LUNG_CANCER_UP,0.990755093799682
ZHAN_MULTIPLE_MYELOMA_MS_DN,SET,38,0.017112,0.00077768,0.13096,0.44802,ZHAN_MULTIPLE_MYELOMA_MS_DN,0.990755093799682
GOBP_REGULATION_OF_CELL_DIVI...,SET,171,0.0085401,0.00082031,0.065381,0.44804,GOBP_REGULATION_OF_CELL_DIVISION,0.990755093799682
GSE17721_PAM3CSK4_VS_CPG_0.5...2,SET,179,0.0080262,0.0007886,0.061462,0.44805,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP,0.990755093799682
MIR575,SET,49,0.014813,0.0007642,0.11345,0.44806,MIR575,0.990755093799682
GSE12845_IGD_POS_VS_NEG_BLOO...1,SET,171,0.0080976,0.00077781,0.062063,0.4481,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN,0.990755093799682
GOBP_MOTILE_CILIUM_ASSEMBLY,SET,64,0.012971,0.00076449,0.099472,0.44812,GOBP_MOTILE_CILIUM_ASSEMBLY,0.990755093799682
GOCC_PIGMENT_GRANULE,SET,106,0.010794,0.00081774,0.082766,0.44812,GOCC_PIGMENT_GRANULE,0.990755093799682
REACTOME_SYNTHESIS_OF_PIPS_A...4,SET,10,0.027322,0.00063744,0.20972,0.44817,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE,0.990755093799682
REACTOME_METABOLISM_OF_FAT_S...,SET,43,0.017899,0.00086518,0.1374,0.44818,REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,0.990755093799682
GSE39820_TGFBETA1_VS_TGFBETA...3,SET,179,0.0080741,0.00079331,0.06198,0.44818,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN,0.990755093799682
GSE3982_EOSINOPHIL_VS_DC_DN,SET,184,0.0081174,0.00080852,0.062332,0.44819,GSE3982_EOSINOPHIL_VS_DC_DN,0.990755093799682
HP_CHRONIC_FATIGUE,SET,24,0.024411,0.00088198,0.18746,0.4482,HP_CHRONIC_FATIGUE,0.990755093799682
GSE17721_PAM3CSK4_VS_GADIQUI...9,SET,186,0.0079007,0.00079116,0.060733,0.44825,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN,0.990755093799682
REACTOME_GLUCOCORTICOID_BIOS...,SET,10,0.038508,0.00089843,0.29614,0.44827,REACTOME_GLUCOCORTICOID_BIOSYNTHESIS,0.990755093799682
GOBP_CHROMOSOME_SEGREGATION,SET,383,0.0053594,0.00076593,0.041218,0.44827,GOBP_CHROMOSOME_SEGREGATION,0.990755093799682
REACTOME_TNF_RECEPTOR_SUPERF...,SET,16,0.029622,0.00087405,0.22793,0.4483,REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,0.990758393742846
GOBP_WNT_SIGNALING_PATHWAY,SET,415,0.0056397,0.00083824,0.043513,0.44844,GOBP_WNT_SIGNALING_PATHWAY,0.99093046130385
GOCC_PERINUCLEAR_THECA,SET,4,0.052059,0.0007683,0.40228,0.44852,GOCC_PERINUCLEAR_THECA,0.99093046130385
GOMF_ARRESTIN_FAMILY_PROTEIN...,SET,9,0.030651,0.00067843,0.23701,0.44855,GOMF_ARRESTIN_FAMILY_PROTEIN_BINDING,0.99093046130385
GSE30971_CTRL_VS_LPS_STIM_MA...3,SET,170,0.0078266,0.0007496,0.060519,0.44855,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN,0.99093046130385
MIR3143,SET,412,0.0054688,0.00080997,0.042293,0.44856,MIR3143,0.99093046130385
REACTOME_CDC6_ASSOCIATION_WI...,SET,8,0.03894,0.00081265,0.30154,0.44862,REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX,0.99093046130385
GSE26290_CTRL_VS_AKT_INHIBIT...1,SET,181,0.0082749,0.00081753,0.064089,0.44863,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,0.99093046130385
GOBP_SYMPATHETIC_GANGLION_DE...,SET,9,0.041261,0.0009133,0.31958,0.44864,GOBP_SYMPATHETIC_GANGLION_DEVELOPMENT,0.99093046130385
GOBP_PHOSPHATIDYLINOSITOL_BI...,SET,117,0.009456,0.00075243,0.073298,0.44868,GOBP_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,0.99093046130385
GSE37532_VISCERAL_ADIPOSE_TI...2,SET,148,0.0085155,0.00076144,0.066025,0.44869,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_UP,0.99093046130385
GOMF_INSULIN_LIKE_GROWTH_FAC...4,SET,16,0.030682,0.00090532,0.23793,0.4487,GOMF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_BINDING,0.99093046130385
HP_DUPLICATION_OF_RENAL_PELV...,SET,3,0.075219,0.0009614,0.58357,0.44872,HP_DUPLICATION_OF_RENAL_PELVIS,0.99093046130385
CALVET_IRINOTECAN_SENSITIVE_...3,SET,5,0.051495,0.00084965,0.40003,0.44879,CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP,0.990984476843911
BRACHAT_RESPONSE_TO_CISPLATIN,SET,20,0.024043,0.00079308,0.18686,0.44881,BRACHAT_RESPONSE_TO_CISPLATIN,0.990984476843911
GSE19888_CTRL_VS_A3R_ACT_TRE...2,SET,185,0.0080201,0.00080097,0.062349,0.44883,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP,0.990984476843911
REACTOME_SEROTONIN_NEUROTRAN...,SET,16,0.027313,0.00080592,0.21257,0.44888,REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE,0.990991040462428
HOWARD_NEUTROPHIL_INACT_MONO...3,SET,8,0.036904,0.00077015,0.28725,0.44889,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_DN,0.990991040462428
MIR323B_5P,SET,38,0.017233,0.00078316,0.13424,0.44893,MIR323B_5P,0.991016396722561
GOBP_POSITIVE_REGULATION_OF_...466,SET,9,0.037372,0.0008272,0.29179,0.44904,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_CALCIUM_ION_CONCENTRATION,0.991121061654708
GOBP_RENAL_WATER_ABSORPTION,SET,6,0.049096,0.00088737,0.38346,0.44906,GOBP_RENAL_WATER_ABSORPTION,0.991121061654708
GOUYER_TATI_TARGETS_UP,SET,10,0.038676,0.00090234,0.3024,0.44912,GOUYER_TATI_TARGETS_UP,0.991121061654708
GOBP_PYRIMIDINE_RIBONUCLEOSI...2,SET,11,0.030886,0.00075575,0.2415,0.44912,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.991121061654708
GOBP_REGULATION_OF_NATURAL_K...6,SET,12,0.035506,0.00090739,0.27764,0.44912,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION,0.991121061654708
SCHMAHL_PDGF_SIGNALING,SET,9,0.039898,0.00088312,0.31239,0.44919,SCHMAHL_PDGF_SIGNALING,0.991193800393626
GOBP_REGULATION_OF_DELAYED_R...,SET,15,0.030004,0.00085722,0.23501,0.44921,GOBP_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.991193800393626
MODULE_90,SET,3,0.049768,0.00063611,0.39056,0.4493,MODULE_90,0.991273996845426
GOBP_CELLULAR_RESPONSE_TO_ES...1,SET,36,0.018915,0.00083671,0.14859,0.44935,GOBP_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS,0.991273996845426
MIR4632_5P,SET,91,0.01137,0.00079843,0.089323,0.44936,MIR4632_5P,0.991273996845426
WP_LEUCINE_ISOLEUCINE_AND_VA...,SET,22,0.023266,0.00080486,0.18288,0.44938,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,0.991273996845426
TGCCAAR_NF1_Q6,SET,639,0.0044187,0.00080986,0.034764,0.44943,TGCCAAR_NF1_Q6,0.991273996845426
REACTOME_SIGNALING_BY_NUCLEA...,SET,225,0.0072671,0.00079952,0.057311,0.44955,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,0.991273996845426
GOBP_TRACHEA_CARTILAGE_DEVEL...,SET,7,0.041148,0.00080327,0.32471,0.44958,GOBP_TRACHEA_CARTILAGE_DEVELOPMENT,0.991273996845426
GOBP_PEROXISOMAL_TRANSPORT,SET,19,0.022394,0.00072001,0.17705,0.44968,GOBP_PEROXISOMAL_TRANSPORT,0.991273996845426
HP_APLASIA_INVOLVING_BONES_O...3,SET,15,0.027368,0.00078192,0.21672,0.44975,HP_APLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.991273996845426
MEF2D_TARGET_GENES,SET,474,0.0049141,0.00077931,0.038949,0.4498,MEF2D_TARGET_GENES,0.991273996845426
GSE41867_DAY6_EFFECTOR_VS_DA...4,SET,183,0.0077499,0.00076984,0.061438,0.44981,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.991273996845426
HP_MALAR_RASH,SET,29,0.020816,0.0008266,0.16508,0.44983,HP_MALAR_RASH,0.991273996845426
JOHNSTONE_PARVB_TARGETS_1_UP,SET,6,0.045537,0.00082304,0.36122,0.44984,JOHNSTONE_PARVB_TARGETS_1_UP,0.991273996845426
GSE26023_PHD3_KO_VS_WT_NEUTR...2,SET,171,0.0081864,0.00078634,0.064939,0.44984,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_UP,0.991273996845426
chr15q11,SET,8,0.049998,0.0010434,0.39672,0.44986,chr15q11,0.991273996845426
WP_MECHANOREGULATION_AND_PAT...,SET,44,0.016463,0.00080493,0.13073,0.44989,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,0.991273996845426
GSE2405_0H_VS_24H_A_PHAGOCYT...1,SET,183,0.0081969,0.00081424,0.065081,0.44989,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.991273996845426
FARMER_BREAST_CANCER_CLUSTER...8,SET,7,0.041703,0.00081411,0.33128,0.44991,FARMER_BREAST_CANCER_CLUSTER_8,0.991273996845426
MODULE_256,SET,54,0.01387,0.00075107,0.11018,0.44991,MODULE_256,0.991273996845426
GSE44955_MCSF_VS_MCSF_AND_IL...2,SET,175,0.0079896,0.00077628,0.063554,0.44998,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP,0.991273996845426
GOBP_NEGATIVE_REGULATION_OF_...288,SET,117,0.010425,0.00082955,0.083007,0.45003,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,0.991273996845426
HP_ALBUMINURIA,SET,22,0.021813,0.00075459,0.17369,0.45003,HP_ALBUMINURIA,0.991273996845426
HP_EXERCISE_INDUCED_MUSCLE_F...,SET,9,0.035085,0.00077658,0.27939,0.45003,HP_EXERCISE_INDUCED_MUSCLE_FATIGUE,0.991273996845426
chr18q12,SET,43,0.029433,0.0014227,0.23451,0.45006,chr18q12,0.991273996845426
GOBP_HOST_MEDIATED_REGULATIO...,SET,9,0.035415,0.00078388,0.28226,0.45008,GOBP_HOST_MEDIATED_REGULATION_OF_INTESTINAL_MICROBIOTA_COMPOSITION,0.991273996845426
GSE17974_IL4_AND_ANTI_IL12_V...11,SET,163,0.0084654,0.00079406,0.067506,0.4501,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN,0.991273996845426
HP_SEVERE_CYTOMEGALOVIRUS_IN...,SET,10,0.033292,0.00077673,0.2658,0.45016,HP_SEVERE_CYTOMEGALOVIRUS_INFECTION,0.991273996845426
GOBP_REGULATION_OF_SYNAPSE_P...,SET,6,0.046826,0.00084634,0.37388,0.45017,GOBP_REGULATION_OF_SYNAPSE_PRUNING,0.991273996845426
GOCC_MULTIVESICULAR_BODY_LUM...,SET,5,0.047144,0.00077786,0.3773,0.45028,GOCC_MULTIVESICULAR_BODY_LUMEN,0.991273996845426
TTF1_Q6,SET,239,0.0069883,0.00079209,0.055945,0.4503,TTF1_Q6,0.991273996845426
GSE9650_EXHAUSTED_VS_MEMORY_...1,SET,187,0.0075798,0.00076104,0.060698,0.45031,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN,0.991273996845426
GOBP_REGULATION_OF_MICROTUBU...7,SET,56,0.013228,0.0007294,0.10604,0.45037,GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION,0.991273996845426
HP_CALCIFIC_STIPPLING,SET,3,0.07393,0.00094493,0.59329,0.45042,HP_CALCIFIC_STIPPLING,0.991273996845426
DELACROIX_RAR_TARGETS_DN,SET,25,0.022342,0.00082386,0.1795,0.45047,DELACROIX_RAR_TARGETS_DN,0.991273996845426
GSE22611_NOD2_TRANSD_VS_CTRL...2,SET,163,0.0079913,0.00074959,0.064269,0.45052,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP,0.991273996845426
GSE29164_DAY3_VS_DAY7_CD8_TC...1,SET,187,0.0078745,0.00079063,0.063344,0.45053,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN,0.991273996845426
GSE21033_CTRL_VS_POLYIC_STIM...8,SET,179,0.0073112,0.00071835,0.058836,0.45055,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_UP,0.991273996845426
HP_INCREASED_CIRCULATING_ANT...,SET,93,0.010899,0.00077373,0.087723,0.45056,HP_INCREASED_CIRCULATING_ANTIBODY_LEVEL,0.991273996845426
GSE45365_CD8A_DC_VS_CD11B_DC...4,SET,151,0.0084835,0.00076616,0.068405,0.45065,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP,0.991273996845426
MIR134_5P,SET,68,0.012826,0.00077912,0.10354,0.45071,MIR134_5P,0.991273996845426
BUSSLINGER_DUODENAL_EARLY_IM...,SET,99,0.0107,0.00078357,0.086378,0.45071,BUSSLINGER_DUODENAL_EARLY_IMMATURE_ENTEROCYTES,0.991273996845426
DESCARTES_MAIN_FETAL_MESANGI...,SET,16,0.02844,0.00083919,0.22959,0.45071,DESCARTES_MAIN_FETAL_MESANGIAL_CELLS,0.991273996845426
HP_RENAL_INTERSTITIAL_FIBROS...,SET,6,0.038256,0.00069145,0.30901,0.45074,HP_RENAL_INTERSTITIAL_FIBROSIS,0.991273996845426
GOBP_INTERLEUKIN_5_MEDIATED_...,SET,6,0.046593,0.00084213,0.37646,0.45075,GOBP_INTERLEUKIN_5_MEDIATED_SIGNALING_PATHWAY,0.991273996845426
VALK_AML_CLUSTER_10,SET,28,0.020885,0.00081496,0.16886,0.45078,VALK_AML_CLUSTER_10,0.991273996845426
KEGG_MEDICUS_REFERENCE_EGF_E...11,SET,11,0.028896,0.00070707,0.23394,0.45085,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY,0.991273996845426
HP_EEG_WITH_FOCAL_SHARP_SLOW...,SET,12,0.029919,0.00076463,0.24235,0.45087,HP_EEG_WITH_FOCAL_SHARP_SLOW_WAVES,0.991273996845426
MIR2681_3P,SET,33,0.017637,0.00074704,0.14292,0.45089,MIR2681_3P,0.991273996845426
MODULE_528,SET,10,0.035215,0.00082161,0.28548,0.45091,MODULE_528,0.991273996845426
GOBP_NEGATIVE_REGULATION_OF_...635,SET,6,0.045491,0.00082221,0.369,0.45094,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.991273996845426
chr17q11,SET,76,0.025777,0.001655,0.20918,0.45096,chr17q11,0.991273996845426
GOMF_ACETYLESTERASE_ACTIVITY,SET,5,0.04432,0.00073128,0.36003,0.45101,GOMF_ACETYLESTERASE_ACTIVITY,0.991273996845426
GOBP_INOSINE_METABOLIC_PROCE...,SET,4,0.059945,0.00088468,0.48702,0.45102,GOBP_INOSINE_METABOLIC_PROCESS,0.991273996845426
REACTOME_SEROTONIN_RECEPTORS,SET,11,0.032724,0.00080074,0.26591,0.45103,REACTOME_SEROTONIN_RECEPTORS,0.991273996845426
GOMF_COA_TRANSFERASE_ACTIVITY,SET,5,0.048156,0.00079456,0.39163,0.45107,GOMF_COA_TRANSFERASE_ACTIVITY,0.991273996845426
HP_SHORT_MIDDLE_PHALANX_OF_T...1,SET,7,0.038353,0.00074872,0.3119,0.45107,HP_SHORT_MIDDLE_PHALANX_OF_THE_2ND_FINGER,0.991273996845426
MIR3127_3P,SET,95,0.010108,0.00072517,0.082227,0.45108,MIR3127_3P,0.991273996845426
chr20p12,SET,39,0.02784,0.0012817,0.22685,0.45116,chr20p12,0.991273996845426
PID_RHOA_PATHWAY,SET,42,0.01609,0.00076866,0.13112,0.45117,PID_RHOA_PATHWAY,0.991273996845426
HP_HYDRANENCEPHALY,SET,8,0.035825,0.00074764,0.29207,0.45119,HP_HYDRANENCEPHALY,0.991273996845426
HP_RECTOVAGINAL_FISTULA,SET,20,0.023099,0.00076194,0.18847,0.45123,HP_RECTOVAGINAL_FISTULA,0.991273996845426
DORN_ADENOVIRUS_INFECTION_48...2,SET,12,0.029622,0.00075703,0.24174,0.45124,DORN_ADENOVIRUS_INFECTION_48HR_UP,0.991273996845426
BROWNE_HCMV_INFECTION_24HR_DN,SET,131,0.0091431,0.00076953,0.074672,0.45127,BROWNE_HCMV_INFECTION_24HR_DN,0.991273996845426
MIR4759,SET,46,0.015216,0.00076064,0.12426,0.45127,MIR4759,0.991273996845426
GSE21670_UNTREATED_VS_TGFB_I...1,SET,160,0.0081368,0.00075625,0.066531,0.45133,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_DN,0.991273996845426
GOBP_REGULATION_OF_SODIUM_IO...1,SET,52,0.015277,0.00081186,0.12511,0.45141,GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,0.991273996845426
GSE557_CIITA_KO_VS_I_AB_KO_D...2,SET,180,0.0075165,0.00074057,0.061592,0.45144,GSE557_CIITA_KO_VS_I_AB_KO_DC_UP,0.991273996845426
HP_MUSCLE_FIBRILLATION,SET,58,0.013316,0.00074724,0.10916,0.45146,HP_MUSCLE_FIBRILLATION,0.991273996845426
HP_BILATERAL_PTOSIS,SET,63,0.012885,0.00075349,0.10575,0.45151,HP_BILATERAL_PTOSIS,0.991273996845426
AIGNER_ZEB1_TARGETS,SET,33,0.019405,0.00082193,0.15932,0.45153,AIGNER_ZEB1_TARGETS,0.991273996845426
HP_BRONCHOMALACIA,SET,23,0.020515,0.00072562,0.16845,0.45154,HP_BRONCHOMALACIA,0.991273996845426
GOBP_RESPONSE_TO_HYDROXYUREA,SET,9,0.034331,0.00075989,0.28211,0.45157,GOBP_RESPONSE_TO_HYDROXYUREA,0.991273996845426
HP_APLASIA_HYPOPLASIA_INVOLV...9,SET,119,0.0095533,0.00076659,0.078501,0.45157,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_METACARPAL_BONES,0.991273996845426
GOBP_DNA_LIGATION_INVOLVED_I...,SET,5,0.036546,0.00060299,0.30056,0.45161,GOBP_DNA_LIGATION_INVOLVED_IN_DNA_REPAIR,0.991273996845426
GOCC_3M_COMPLEX,SET,5,0.04197,0.0006925,0.34525,0.45162,GOCC_3M_COMPLEX,0.991273996845426
GSE45365_WT_VS_IFNAR_KO_CD11...2,SET,151,0.0087229,0.00078779,0.071764,0.45163,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN,0.991273996845426
HP_DECREASED_MEAN_CORPUSCULA...1,SET,5,0.054274,0.00089551,0.44665,0.45164,HP_DECREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,0.991273996845426
GOMF_PEPTIDYL_PROLINE_DIOXYG...,SET,12,0.025034,0.00063977,0.20609,0.45166,GOMF_PEPTIDYL_PROLINE_DIOXYGENASE_ACTIVITY,0.991273996845426
GOBP_L_ALPHA_AMINO_ACID_TRAN...,SET,66,0.013132,0.00078592,0.10815,0.45168,GOBP_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,0.991273996845426
DACOSTA_UV_RESPONSE_VIA_ERCC...1,SET,436,0.0049711,0.00075688,0.040952,0.45169,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,0.991273996845426
GSE9316_CD4_TCELL_BALBC_VS_T...1,SET,180,0.0078705,0.00077545,0.06485,0.4517,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN,0.991273996845426
GSE17721_PAM3CSK4_VS_GADIQUI...16,SET,179,0.0071737,0.00070484,0.059157,0.45174,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP,0.991273996845426
MODULE_438,SET,64,0.013145,0.00077472,0.10841,0.45175,MODULE_438,0.991273996845426
WP_EV_RELEASE_FROM_CARDIAC_C...,SET,7,0.043699,0.00085309,0.36121,0.45185,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,0.991273996845426
PPARA_02,SET,124,0.0087862,0.00071961,0.072627,0.45186,PPARA_02,0.991273996845426
HP_ABNORMAL_DENTAL_MORPHOLOGY,SET,255,0.0064859,0.00075902,0.053617,0.45186,HP_ABNORMAL_DENTAL_MORPHOLOGY,0.991273996845426
GOBP_NEGATIVE_REGULATION_OF_...476,SET,7,0.043246,0.00084424,0.35776,0.45189,GOBP_NEGATIVE_REGULATION_OF_P38MAPK_CASCADE,0.991273996845426
REACTOME_METABOLISM_OF_WATER...,SET,120,0.0090552,0.00072966,0.074917,0.4519,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,0.991273996845426
GOBP_NUCLEOBASE_CONTAINING_S...2,SET,28,0.022774,0.00088868,0.18845,0.45191,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_CATABOLIC_PROCESS,0.991273996845426
HP_RECURRENT_ENTEROVIRAL_INF...,SET,3,0.05878,0.00075129,0.4864,0.45191,HP_RECURRENT_ENTEROVIRAL_INFECTIONS,0.991273996845426
HP_ABNORMAL_BRONCHOALVEOLAR_...,SET,14,0.027402,0.00075636,0.22686,0.45193,HP_ABNORMAL_BRONCHOALVEOLAR_LAVAGE_FLUID_MORPHOLOGY,0.991273996845426
BIOCARTA_INTRINSIC_PATHWAY,SET,19,0.0258,0.0008295,0.21367,0.45195,BIOCARTA_INTRINSIC_PATHWAY,0.991273996845426
STAT4_01,SET,250,0.0065853,0.00076316,0.054549,0.45196,STAT4_01,0.991273996845426
WAMUNYOKOLI_OVARIAN_CANCER_L...1,SET,173,0.0079777,0.00077072,0.066134,0.45199,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,0.991273996845426
COATES_MACROPHAGE_M1_VS_M2_UP,SET,80,0.012003,0.00079054,0.09951,0.452,COATES_MACROPHAGE_M1_VS_M2_UP,0.991273996845426
GSE44649_NAIVE_VS_ACTIVATED_...1,SET,176,0.0072862,0.00070993,0.060439,0.45202,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,0.991273996845426
GOBP_POSITIVE_REGULATION_OF_...475,SET,7,0.041211,0.00080452,0.342,0.45204,GOBP_POSITIVE_REGULATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,0.991273996845426
GOBP_NATURAL_KILLER_CELL_PRO...,SET,14,0.030834,0.00085111,0.25593,0.45205,GOBP_NATURAL_KILLER_CELL_PROLIFERATION,0.991273996845426
REACTOME_HUR_ELAVL1_BINDS_AN...,SET,8,0.040567,0.00084658,0.33684,0.45207,REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA,0.991273996845426
GSE28726_NAIVE_VS_ACTIVATED_...2,SET,173,0.0077904,0.00075262,0.064771,0.45213,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP,0.991277998486568
DASU_IL6_SIGNALING_UP,SET,56,0.014068,0.00077575,0.11709,0.45218,DASU_IL6_SIGNALING_UP,0.991277998486568
LAU_APOPTOSIS_CDKN2A_DN,SET,5,0.041686,0.00068781,0.34703,0.45219,LAU_APOPTOSIS_CDKN2A_DN,0.991277998486568
HOLLERN_EMT_BREAST_TUMOR_UP,SET,128,0.0092359,0.00076845,0.07696,0.45224,HOLLERN_EMT_BREAST_TUMOR_UP,0.991277998486568
HP_ELONGATED_SUPERIOR_CEREBE...,SET,10,0.027382,0.00063884,0.22819,0.45224,HP_ELONGATED_SUPERIOR_CEREBELLAR_PEDUNCLE,0.991277998486568
HP_PARESTHESIA,SET,119,0.0091547,0.00073461,0.076305,0.45225,HP_PARESTHESIA,0.991277998486568
GOBP_POSITIVE_REGULATION_OF_...600,SET,32,0.018618,0.00077658,0.15532,0.45229,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,0.991277998486568
KEGG_MEDICUS_REFERENCE_PURIN...1,SET,11,0.030022,0.0007346,0.25048,0.4523,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_ADENINE_TO_AMP,0.991277998486568
WANG_RESPONSE_TO_FORSKOLIN_DN,SET,9,0.030824,0.00068228,0.25736,0.45233,WANG_RESPONSE_TO_FORSKOLIN_DN,0.991281237782963
ZNF513_TARGET_GENES,SET,614,0.0042021,0.00075546,0.035115,0.45237,ZNF513_TARGET_GENES,0.991306390290038
GOCC_ZONA_PELLUCIDA_RECEPTOR...,SET,8,0.028751,6e-04,0.24113,0.45254,GOCC_ZONA_PELLUCIDA_RECEPTOR_COMPLEX,0.991313832391714
WIZ_TARGET_GENES,SET,14,0.025492,0.00070363,0.21381,0.45255,WIZ_TARGET_GENES,0.991313832391714
HP_DISTAL_PERIPHERAL_SENSORY...,SET,6,0.037708,0.00068153,0.31656,0.45259,HP_DISTAL_PERIPHERAL_SENSORY_NEUROPATHY,0.991313832391714
REACTOME_METABOLISM_OF_NITRI...,SET,14,0.025783,0.00071167,0.2166,0.45263,REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION,0.991313832391714
REACTOME_PYRIMIDINE_SALVAGE,SET,10,0.031852,0.00074313,0.26767,0.45264,REACTOME_PYRIMIDINE_SALVAGE,0.991313832391714
ACEVEDO_LIVER_TUMOR_VS_NORMA...2,SET,753,0.0036213,0.00071815,0.030464,0.45269,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP,0.991313832391714
HU_GENOTOXIC_DAMAGE_24HR,SET,31,0.01675,0.00068768,0.14093,0.4527,HU_GENOTOXIC_DAMAGE_24HR,0.991313832391714
WANG_MLL_TARGETS,SET,273,0.0065158,0.00078858,0.054833,0.45271,WANG_MLL_TARGETS,0.991313832391714
REACTOME_PROGRAMMED_CELL_DEA...,SET,193,0.0069924,0.00071312,0.058907,0.45276,REACTOME_PROGRAMMED_CELL_DEATH,0.991313832391714
GOMF_DYNEIN_LIGHT_CHAIN_BIND...,SET,5,0.041989,0.00069281,0.3539,0.45278,GOMF_DYNEIN_LIGHT_CHAIN_BINDING,0.991313832391714
REACTOME_ENHANCED_BINDING_OF...,SET,7,0.041575,0.00081163,0.35099,0.45285,REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN,0.991313832391714
HP_APLASIA_HYPOPLASIA_INVOLV...13,SET,3,0.069108,0.0008833,0.58343,0.45286,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SHOULDER_MUSCULATURE,0.991313832391714
GSE6259_FLT3L_INDUCED_DEC205...3,SET,111,0.0098522,0.00076371,0.083204,0.45287,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN,0.991313832391714
GOBP_REGULATION_OF_STORE_OPE...2,SET,14,0.027867,0.00076921,0.23543,0.45289,GOBP_REGULATION_OF_STORE_OPERATED_CALCIUM_ENTRY,0.991313832391714
GOMF_BETA_N_ACETYLHEXOSAMINI...,SET,3,0.060437,0.00077247,0.51091,0.45292,GOMF_BETA_N_ACETYLHEXOSAMINIDASE_ACTIVITY,0.991313832391714
GOBP_NEGATIVE_REGULATION_OF_...508,SET,2,0.049192,0.00051338,0.41605,0.45294,GOBP_NEGATIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS,0.991313832391714
SCHLESINGER_METHYLATED_IN_CO...,SET,10,0.035312,0.00082386,0.29893,0.45298,SCHLESINGER_METHYLATED_IN_COLON_CANCER,0.991313832391714
KORKOLA_EMBRYONAL_CARCINOMA_...1,SET,9,0.038942,0.00086195,0.3297,0.45299,KORKOLA_EMBRYONAL_CARCINOMA_DN,0.991313832391714
WP_JAKSTAT_SIGNALING_IN_THE_...,SET,34,0.017863,0.00076797,0.15131,0.45301,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,0.991313832391714
HP_DIAPHYSEAL_UNDERTUBULATION,SET,13,0.02723,0.00072429,0.23085,0.45305,HP_DIAPHYSEAL_UNDERTUBULATION,0.991313832391714
GOBP_PROTEIN_DNA_COMPLEX_ASS...,SET,147,0.0077895,0.00069419,0.066076,0.45308,GOBP_PROTEIN_DNA_COMPLEX_ASSEMBLY,0.991313832391714
GOMF_5ALPHA_ANDROSTANE_3BETA...,SET,6,0.046232,0.0008356,0.39237,0.4531,GOMF_5ALPHA_ANDROSTANE_3BETA_17BETA_DIOL_DEHYDROGENASE_ACTIVITY,0.991313832391714
HP_INCREASED_CIRCULATING_THY...,SET,8,0.038747,0.00080861,0.3289,0.45311,HP_INCREASED_CIRCULATING_THYROGLOBULIN_CONCENTRATION,0.991313832391714
GOBP_CENP_A_CONTAINING_CHROM...,SET,9,0.036477,0.00080739,0.30992,0.45315,GOBP_CENP_A_CONTAINING_CHROMATIN_ASSEMBLY,0.991313832391714
HP_ABNORMALITY_OF_EXOCRINE_P...,SET,66,0.012375,0.0007406,0.10512,0.45315,HP_ABNORMALITY_OF_EXOCRINE_PANCREAS_PHYSIOLOGY,0.991313832391714
GSE37532_WT_VS_PPARG_KO_LN_T...3,SET,107,0.0099484,0.00075723,0.084604,0.4532,GSE37532_WT_VS_PPARG_KO_LN_TREG_DN,0.991313832391714
GSE11961_GERMINAL_CENTER_BCE...2,SET,179,0.0074309,0.00073012,0.063248,0.45324,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.991313832391714
GOCC_MYOSIN_COMPLEX,SET,55,0.014097,0.00077038,0.12007,0.45327,GOCC_MYOSIN_COMPLEX,0.991313832391714
PETRETTO_BLOOD_PRESSURE_DN,SET,7,0.039928,0.00077946,0.34022,0.45329,PETRETTO_BLOOD_PRESSURE_DN,0.991313832391714
ZNF436_TARGET_GENES,SET,409,0.0049909,0.00073655,0.042563,0.45333,ZNF436_TARGET_GENES,0.991313832391714
GNF2_RAN,SET,78,0.0099946,0.00065004,0.085341,0.45339,GNF2_RAN,0.991313832391714
REACTOME_CD28_DEPENDENT_VAV1...,SET,11,0.029003,0.00070969,0.24787,0.45343,REACTOME_CD28_DEPENDENT_VAV1_PATHWAY,0.991313832391714
GSE26727_WT_VS_KLF2_KO_LPS_S...1,SET,189,0.0070187,0.00070842,0.059982,0.45343,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_DN,0.991313832391714
REACTOME_WAX_AND_PLASMALOGEN...,SET,5,0.047541,0.00078442,0.40668,0.45347,REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS,0.991313832391714
GOBP_NEGATIVE_REGULATION_OF_...530,SET,35,0.016476,0.00071868,0.14101,0.45349,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.991313832391714
WP_TYPE_III_INTERFERON_SIGNA...,SET,10,0.030071,0.0007016,0.25746,0.45351,WP_TYPE_III_INTERFERON_SIGNALING,0.991313832391714
GOCC_GLYCOSYLPHOSPHATIDYLINO...,SET,6,0.040026,0.00072343,0.34266,0.45351,GOCC_GLYCOSYLPHOSPHATIDYLINOSITOL_N_ACETYLGLUCOSAMINYLTRANSFERASE_GPI_GNT_COMPLEX,0.991313832391714
AGGGCAG_MIR18A,SET,130,0.0090975,0.00076279,0.077903,0.45352,AGGGCAG_MIR18A,0.991313832391714
REACTOME_MAPK_FAMILY_SIGNALI...,SET,308,0.0056017,0.00071941,0.048001,0.45355,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,0.991313832391714
KEGG_MEDICUS_REFERENCE_ANGII...,SET,7,0.042056,0.000821,0.36056,0.45357,KEGG_MEDICUS_REFERENCE_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,0.991313832391714
GOBP_REGULATION_OF_DENDRITE_...1,SET,89,0.010584,0.00073508,0.090787,0.4536,GOBP_REGULATION_OF_DENDRITE_DEVELOPMENT,0.991313832391714
SUZUKI_RESPONSE_TO_TSA,SET,15,0.025929,0.00074082,0.22246,0.45361,SUZUKI_RESPONSE_TO_TSA,0.991313832391714
GSE26030_UNSTIM_VS_RESTIM_TH...5,SET,192,0.0069098,0.00070289,0.059366,0.45367,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN,0.991313832391714
UDAYAKUMAR_MED1_TARGETS_UP,SET,118,0.008782,0.00070176,0.075482,0.45369,UDAYAKUMAR_MED1_TARGETS_UP,0.991313832391714
GOBP_REGULATION_OF_BONE_MINE...2,SET,5,0.047108,0.00077726,0.40494,0.4537,GOBP_REGULATION_OF_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION,0.991313832391714
HP_GENERALIZED_HYPERPIGMENTA...,SET,37,0.015522,0.00069609,0.13348,0.45371,HP_GENERALIZED_HYPERPIGMENTATION,0.991313832391714
GOMF_DOUBLE_STRANDED_DNA_3_5...,SET,4,0.048485,0.00071556,0.41788,0.45382,GOMF_DOUBLE_STRANDED_DNA_3_5_DNA_EXONUCLEASE_ACTIVITY,0.991313832391714
HP_PROGRESSIVE_DISTAL_MUSCLE...,SET,14,0.025165,0.00069462,0.21697,0.45383,HP_PROGRESSIVE_DISTAL_MUSCLE_WEAKNESS,0.991313832391714
GSE3982_DC_VS_NEUTROPHIL_LPS...2,SET,176,0.0071174,0.00069349,0.061426,0.45388,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP,0.991313832391714
GOBP_POSITIVE_REGULATION_OF_...46,SET,11,0.026561,0.00064993,0.22957,0.45395,GOBP_POSITIVE_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.991313832391714
GOCC_GOLGI_APPARATUS_SUBCOMP...,SET,330,0.0052788,0.0007013,0.045665,0.45399,GOCC_GOLGI_APPARATUS_SUBCOMPARTMENT,0.991313832391714
GOMF_CYTOKINE_ACTIVITY,SET,217,0.0076942,0.0008315,0.066562,0.45399,GOMF_CYTOKINE_ACTIVITY,0.991313832391714
GSE3982_MAC_VS_BCELL_DN,SET,163,0.0072574,0.00068075,0.062785,0.45399,GSE3982_MAC_VS_BCELL_DN,0.991313832391714
ZSCAN18_TARGET_GENES,SET,33,0.017047,0.00072205,0.14754,0.45401,ZSCAN18_TARGET_GENES,0.991313832391714
CHUANG_OXIDATIVE_STRESS_RESP...1,SET,10,0.027046,0.000631,0.23453,0.4541,CHUANG_OXIDATIVE_STRESS_RESPONSE_DN,0.991313832391714
GOCC_TRANSPORTER_COMPLEX,SET,428,0.0049068,0.00074037,0.042579,0.45413,GOCC_TRANSPORTER_COMPLEX,0.991313832391714
ZHAN_MULTIPLE_MYELOMA_CD1_AN...2,SET,78,0.010617,0.00069052,0.092187,0.45416,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,0.991313832391714
GOCC_IGA_IMMUNOGLOBULIN_COMP...1,SET,2,0.073146,0.00076337,0.63515,0.45416,GOCC_IGA_IMMUNOGLOBULIN_COMPLEX,0.991313832391714
GOCC_IGA_IMMUNOGLOBULIN_COMP...2,SET,2,0.073146,0.00076337,0.63515,0.45416,GOCC_IGA_IMMUNOGLOBULIN_COMPLEX_CIRCULATING,0.991313832391714
GOBP_EXTRACELLULAR_MATRIX_CO...,SET,13,0.031276,0.00083192,0.27168,0.45418,GOBP_EXTRACELLULAR_MATRIX_CONSTITUENT_SECRETION,0.991313832391714
GOMF_ACID_PHOSPHATASE_ACTIVI...,SET,6,0.040175,0.00072612,0.3493,0.45422,GOMF_ACID_PHOSPHATASE_ACTIVITY,0.991313832391714
GSE1460_CD4_THYMOCYTE_VS_NAI...1,SET,174,0.0074535,0.00072213,0.064812,0.45422,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,0.991313832391714
MIR6125,SET,8,0.03654,0.00076255,0.31792,0.45425,MIR6125,0.991313832391714
WP_WNTBETACATENIN_SIGNALING_...2,SET,25,0.020923,0.00077154,0.18208,0.45426,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,0.991313832391714
HP_BLUE_NEVUS,SET,11,0.028612,0.00070012,0.24899,0.45426,HP_BLUE_NEVUS,0.991313832391714
MIR6069,SET,26,0.018338,0.00068957,0.15969,0.45429,MIR6069,0.991313832391714
GOBP_PHOSPHATIDYLINOSITOL_AC...,SET,6,0.046168,0.00083444,0.40208,0.45429,GOBP_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING,0.991313832391714
GSE360_CTRL_VS_T_GONDII_MAC_...1,SET,179,0.0070681,0.00069447,0.061603,0.45433,GSE360_CTRL_VS_T_GONDII_MAC_DN,0.991313832391714
BAKER_HEMATOPOIESIS_STAT3_TA...,SET,14,0.027775,0.00076667,0.24222,0.45435,BAKER_HEMATOPOIESIS_STAT3_TARGETS,0.991313832391714
HP_LARYNGEAL_CARCINOMA,SET,12,0.024192,0.00061826,0.21106,0.45437,HP_LARYNGEAL_CARCINOMA,0.991313832391714
MODULE_68,SET,26,0.02082,0.00078292,0.1818,0.45441,MODULE_68,0.9913363807492
GOMF_TYPE_2_FIBROBLAST_GROWT...,SET,5,0.052204,0.00086136,0.45663,0.45449,GOMF_TYPE_2_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,0.9913363807492
COLLER_MYC_TARGETS_DN,SET,4,0.049005,0.00072323,0.42888,0.45452,COLLER_MYC_TARGETS_DN,0.9913363807492
HP_DRUSEN,SET,25,0.020358,0.0007507,0.17827,0.45454,HP_DRUSEN,0.9913363807492
GOBP_LYMPHOCYTE_ANERGY,SET,7,0.035201,0.00068719,0.30843,0.45457,GOBP_LYMPHOCYTE_ANERGY,0.9913363807492
GENTILE_UV_LOW_DOSE_DN,SET,59,0.013472,0.00076245,0.11808,0.45458,GENTILE_UV_LOW_DOSE_DN,0.9913363807492
MIR376A_3P_MIR376B_3P,SET,133,0.0079992,0.00067834,0.07011,0.45458,MIR376A_3P_MIR376B_3P,0.9913363807492
KAECH_DAY8_EFF_VS_MEMORY_CD8...2,SET,183,0.006825,0.00067796,0.059897,0.45464,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP,0.991358909307577
HP_MONOTONIC_SPEECH,SET,8,0.037398,0.00078046,0.32857,0.45469,HP_MONOTONIC_SPEECH,0.991358909307577
MIR1258,SET,57,0.012901,0.0007177,0.11351,0.45476,MIR1258,0.991358909307577
GOBP_RESPONSE_TO_PROGESTERONE,SET,42,0.01489,0.00071132,0.13102,0.45476,GOBP_RESPONSE_TO_PROGESTERONE,0.991358909307577
GOBP_RESPONSE_TO_PROSTAGLAND...1,SET,31,0.019429,0.00079765,0.17094,0.45476,GOBP_RESPONSE_TO_PROSTAGLANDIN,0.991358909307577
HOFT_CD4_POSITIVE_ALPHA_BETA...3,SET,3,0.043463,0.00055552,0.38251,0.45477,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_DN,0.991358909307577
GOMF_GLUTAMATE_BINDING,SET,8,0.038275,0.00079875,0.33701,0.45479,GOMF_GLUTAMATE_BINDING,0.991358909307577
MODULE_120,SET,67,0.011669,0.00070358,0.10295,0.45488,MODULE_120,0.991396780362405
GOBP_REGULATION_OF_MYOBLAST_...1,SET,70,0.011493,0.00070829,0.1014,0.45488,GOBP_REGULATION_OF_MYOBLAST_DIFFERENTIATION,0.991396780362405
GOBP_NEGATIVE_REGULATION_OF_...500,SET,11,0.029788,0.00072888,0.26295,0.4549,GOBP_NEGATIVE_REGULATION_OF_POST_TRANSCRIPTIONAL_GENE_SILENCING,0.991396780362405
WP_KIT_RECEPTOR_SIGNALING,SET,56,0.013816,0.00076185,0.12204,0.45493,WP_KIT_RECEPTOR_SIGNALING,0.991396780362405
GOBP_POSTSYNAPTIC_DENSITY_PR...,SET,10,0.031419,0.00073303,0.2776,0.45495,GOBP_POSTSYNAPTIC_DENSITY_PROTEIN_95_CLUSTERING,0.991396780362405
HP_TIBIALIS_MUSCLE_WEAKNESS,SET,6,0.040808,0.00073757,0.36161,0.45507,HP_TIBIALIS_MUSCLE_WEAKNESS,0.991454606734593
KEGG_MEDICUS_REFERENCE_HORMO...,SET,17,0.025631,0.00077954,0.22729,0.45511,KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY,0.991454606734593
GOBP_REGULATION_OF_DNA_CATAB...,SET,10,0.030287,0.00070663,0.26858,0.45511,GOBP_REGULATION_OF_DNA_CATABOLIC_PROCESS,0.991454606734593
HP_ABNORMALITY_OF_THROMBOCYT...,SET,425,0.0046043,0.00069235,0.040862,0.45514,HP_ABNORMALITY_OF_THROMBOCYTES,0.991454606734593
GOBP_MECHANORECEPTOR_DIFFERE...,SET,65,0.012437,0.00073866,0.11057,0.45522,GOBP_MECHANORECEPTOR_DIFFERENTIATION,0.991454606734593
REACTOME_INTERACTIONS_OF_REV...,SET,35,0.014915,0.00065056,0.13269,0.45525,REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS,0.991454606734593
BIOCARTA_EPHA4_PATHWAY,SET,8,0.035343,0.00073757,0.31456,0.45527,BIOCARTA_EPHA4_PATHWAY,0.991454606734593
GSE37301_MULTIPOTENT_PROGENI...11,SET,184,0.0067493,0.00067225,0.060065,0.45527,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,0.991454606734593
DARWICHE_PAPILLOMA_RISK_LOW_...1,SET,152,0.0074624,0.00067615,0.066509,0.45533,DARWICHE_PAPILLOMA_RISK_LOW_DN,0.991454606734593
BIOCARTA_LECTIN_PATHWAY,SET,10,0.030048,0.00070105,0.26803,0.45537,BIOCARTA_LECTIN_PATHWAY,0.991454606734593
GOBP_POSITIVE_REGULATION_OF_...794,SET,18,0.023982,0.00075051,0.2139,0.45537,GOBP_POSITIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,0.991454606734593
GSE18281_SUBCAPSULAR_CORTICA...3,SET,172,0.0072464,0.00069806,0.064645,0.45537,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,0.991454606734593
GOBP_FATTY_ACID_BETA_OXIDATI...3,SET,12,0.02559,0.000654,0.22877,0.45547,GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_OXIDASE,0.991454606734593
GOMF_ACTIN_BINDING,SET,400,0.0047452,0.00069272,0.042443,0.45549,GOMF_ACTIN_BINDING,0.991454606734593
ODONNELL_TARGETS_OF_MYC_AND_...2,SET,68,0.011372,0.00069077,0.10176,0.45551,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,0.991454606734593
GAVISH_3CA_METAPROGRAM_FIBRO...13,SET,48,0.014604,0.00074571,0.13067,0.45551,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_HYPOXIA,0.991454606734593
GOBP_REGULATION_OF_SKELETAL_...11,SET,6,0.041853,0.00075645,0.37481,0.45555,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_GROWTH,0.991454606734593
GOBP_RIG_I_SIGNALING_PATHWAY,SET,22,0.019178,0.00066343,0.17202,0.45562,GOBP_RIG_I_SIGNALING_PATHWAY,0.991454606734593
GOBP_VESICLE_FUSION_TO_PLASM...,SET,23,0.018132,0.00064133,0.16269,0.45563,GOBP_VESICLE_FUSION_TO_PLASMA_MEMBRANE,0.991454606734593
GAUSSMANN_MLL_AF4_FUSION_TAR...12,SET,166,0.0076657,0.00072558,0.068853,0.45568,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,0.991454606734593
HALLMARK_UV_RESPONSE_UP,SET,149,0.0075492,0.00067729,0.06786,0.45571,HALLMARK_UV_RESPONSE_UP,0.991454606734593
GOBP_POSITIVE_REGULATION_OF_...565,SET,50,0.013754,0.00071675,0.12373,0.45574,GOBP_POSITIVE_REGULATION_OF_OSSIFICATION,0.991454606734593
AIZARANI_LIVER_C29_MVECS_2,SET,287,0.0060132,0.00074589,0.054098,0.45575,AIZARANI_LIVER_C29_MVECS_2,0.991454606734593
GOBP_BEHAVIORAL_RESPONSE_TO_...2,SET,9,0.035032,0.00077541,0.31535,0.45577,GOBP_BEHAVIORAL_RESPONSE_TO_ETHANOL,0.991454606734593
JIANG_MELANOMA_TRM9_CD8,SET,459,0.0043829,0.00068426,0.039485,0.45581,JIANG_MELANOMA_TRM9_CD8,0.991454606734593
GOBP_INTERLEUKIN_13_PRODUCTI...,SET,21,0.02061,0.00069663,0.18602,0.45589,GOBP_INTERLEUKIN_13_PRODUCTION,0.991454606734593
BARRIER_COLON_CANCER_RECURRE...1,SET,16,0.023112,0.00068197,0.20906,0.45598,BARRIER_COLON_CANCER_RECURRENCE_DN,0.991454606734593
GOBP_ORGANELLE_FUSION,SET,152,0.007262,0.00065799,0.065691,0.45599,GOBP_ORGANELLE_FUSION,0.991454606734593
REACTOME_SIGNAL_REGULATORY_P...,SET,14,0.026192,0.00072296,0.23706,0.45601,REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS,0.991454606734593
GOBP_REGULATION_OF_MICROVILL...1,SET,6,0.04241,0.00076651,0.38404,0.45604,GOBP_REGULATION_OF_MICROVILLUS_ASSEMBLY,0.991454606734593
HP_RECURRENT_INTRAPULMONARY_...,SET,7,0.043892,0.00085685,0.39759,0.45605,HP_RECURRENT_INTRAPULMONARY_HEMORRHAGE,0.991454606734593
GOBP_G_PROTEIN_COUPLED_RECEP...1,SET,9,0.029893,0.00066166,0.27091,0.45607,GOBP_G_PROTEIN_COUPLED_RECEPTOR_INTERNALIZATION,0.991454606734593
HALLMARK_G2M_CHECKPOINT,SET,181,0.0066742,0.00065938,0.060504,0.45608,HALLMARK_G2M_CHECKPOINT,0.991454606734593
GOMF_CARBONYL_REDUCTASE_NADP...,SET,9,0.03512,0.00077737,0.31845,0.45609,GOMF_CARBONYL_REDUCTASE_NADPH_ACTIVITY,0.991454606734593
TRAVAGLINI_LUNG_IGSF21_DENDR...,SET,43,0.016115,0.00077893,0.14624,0.45613,TRAVAGLINI_LUNG_IGSF21_DENDRITIC_CELL,0.991454606734593
GSE3982_NEUTROPHIL_VS_TH1_DN,SET,179,0.0066197,0.00065041,0.060145,0.45618,GSE3982_NEUTROPHIL_VS_TH1_DN,0.991454606734593
GSE26351_WNT_VS_BMP_PATHWAY_...2,SET,182,0.0068582,0.00067941,0.062326,0.45619,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,0.991454606734593
HP_LARYNGEAL_EDEMA,SET,4,0.051937,0.0007665,0.47227,0.45622,HP_LARYNGEAL_EDEMA,0.991454606734593
REACTOME_DEVELOPMENTAL_BIOLO...,SET,1245,0.00285,0.00071654,0.025983,0.45633,REACTOME_DEVELOPMENTAL_BIOLOGY,0.991454606734593
MIR25_5P,SET,6,0.041247,0.00074551,0.37604,0.45633,MIR25_5P,0.991454606734593
GOBP_NEGATIVE_REGULATION_OF_...582,SET,5,0.04229,0.00069778,0.38572,0.45635,GOBP_NEGATIVE_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,0.991454606734593
HP_SPOTTY_HYPOPIGMENTATION,SET,7,0.035423,0.00069151,0.32339,0.45639,HP_SPOTTY_HYPOPIGMENTATION,0.991454606734593
GSE17301_CTRL_VS_48H_ACD3_AC...4,SET,175,0.0068605,0.00066657,0.062657,0.45641,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP,0.991454606734593
WP_FOLLICLE_STIMULATING_HORM...,SET,26,0.018798,0.00070686,0.1721,0.45651,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,0.991454606734593
KEGG_MEDICUS_REFERENCE_AUTOP...6,SET,16,0.021613,0.00063772,0.198,0.45654,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1,0.991454606734593
HP_CONGENITAL_BILATERAL_HIP_...,SET,6,0.041355,0.00074745,0.37933,0.45659,HP_CONGENITAL_BILATERAL_HIP_DISLOCATION,0.991454606734593
BRACHAT_RESPONSE_TO_METHOTRE...1,SET,23,0.017993,0.00063641,0.16506,0.4566,BRACHAT_RESPONSE_TO_METHOTREXATE_DN,0.991454606734593
MIR4526,SET,94,0.009732,0.00069455,0.089324,0.45662,MIR4526,0.991454606734593
GOBP_STEROID_HORMONE_BIOSYNT...,SET,43,0.014508,0.00070128,0.1335,0.45673,GOBP_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.991454606734593
HP_RECURRENT_VIRAL_INFECTIONS,SET,54,0.012184,0.0006598,0.11213,0.45673,HP_RECURRENT_VIRAL_INFECTIONS,0.991454606734593
GSE5679_CTRL_VS_PPARG_LIGAND...4,SET,179,0.0063759,0.00062646,0.05877,0.4568,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP,0.991454606734593
MIR6775_3P,SET,69,0.011033,0.00067509,0.10171,0.45681,MIR6775_3P,0.991454606734593
HP_PROGRESSIVE_ENCEPHALOPATHY,SET,10,0.025854,0.00060321,0.23835,0.45681,HP_PROGRESSIVE_ENCEPHALOPATHY,0.991454606734593
GOBP_APOPTOTIC_PROCESS_INVOL...1,SET,37,0.015409,0.00069101,0.14236,0.4569,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.991454606734593
GOBP_POSITIVE_REGULATION_OF_...103,SET,5,0.040625,0.0006703,0.37531,0.4569,GOBP_POSITIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.991454606734593
JIANG_MELANOMA_TRM6_CD8,SET,122,0.0077746,0.00063163,0.071853,0.45692,JIANG_MELANOMA_TRM6_CD8,0.991454606734593
GSE11924_TFH_VS_TH17_CD4_TCE...2,SET,176,0.0064094,0.0006245,0.059296,0.45696,GSE11924_TFH_VS_TH17_CD4_TCELL_UP,0.991454606734593
ROSS_AML_WITH_CBFB_MYH11_FUS...,SET,45,0.014276,0.00070588,0.1323,0.45703,ROSS_AML_WITH_CBFB_MYH11_FUSION,0.991454606734593
GOBP_POSITIVE_REGULATION_OF_...487,SET,5,0.040685,0.0006713,0.37762,0.4571,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_EXTRAVASATION,0.991454606734593
DIAZ_CHRONIC_MYELOGENOUS_LEU...2,SET,1272,0.0025282,0.00064198,0.023505,0.45717,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP,0.991454606734593
REACTOME_NUCLEAR_EVENTS_MEDI...,SET,92,0.009191,0.00064896,0.085461,0.45718,REACTOME_NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,0.991454606734593
MORF_RBM8A,SET,77,0.010057,0.0006499,0.093517,0.45718,MORF_RBM8A,0.991454606734593
MORF_UBE2I,SET,216,0.0057009,0.00061468,0.053024,0.45719,MORF_UBE2I,0.991454606734593
LI_WILMS_TUMOR_VS_FETAL_KIDN...4,SET,25,0.018553,0.00068415,0.17265,0.45721,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,0.991454606734593
GOCC_CUL4_RING_E3_UBIQUITIN_...,SET,31,0.015882,0.00065203,0.14777,0.45721,GOCC_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.991454606734593
HP_URETHRAL_FISTULA,SET,4,0.037052,0.00054683,0.34486,0.45722,HP_URETHRAL_FISTULA,0.991454606734593
HP_URETHROVAGINAL_FISTULA,SET,4,0.037052,0.00054683,0.34486,0.45722,HP_URETHROVAGINAL_FISTULA,0.991454606734593
HP_RADIAL_HEAD_SUBLUXATION,SET,7,0.034764,0.00067865,0.32369,0.45724,HP_RADIAL_HEAD_SUBLUXATION,0.991454606734593
GSE21063_CTRL_VS_ANTI_IGM_ST...3,SET,149,0.007092,0.00063627,0.066076,0.45726,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_DN,0.991454606734593
GOMF_ANDROSTAN_3_ALPHA_17_BE...,SET,8,0.037354,0.00077954,0.34812,0.45728,GOMF_ANDROSTAN_3_ALPHA_17_BETA_DIOL_DEHYDROGENASE_ACTIVITY,0.991454606734593
GOMF_3_HYDROXYACYL_COA_DEHYD...2,SET,5,0.040216,0.00066355,0.37504,0.4573,GOMF_3_HYDROXYACYL_COA_DEHYDROGENASE_ACTIVITY,0.991454606734593
HP_LUMBAR_HYPERLORDOSIS,SET,82,0.0098431,0.00065633,0.091778,0.4573,HP_LUMBAR_HYPERLORDOSIS,0.991454606734593
HP_MEGALOBLASTIC_ANEMIA,SET,17,0.022572,0.00068651,0.21074,0.45735,HP_MEGALOBLASTIC_ANEMIA,0.991454606734593
GSE1460_INTRATHYMIC_T_PROGEN...4,SET,171,0.0069935,0.00067176,0.065283,0.45735,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP,0.991454606734593
MIR302A_3P_MIR302B_3P_MIR302...,SET,323,0.005056,0.00066467,0.047243,0.45739,MIR302A_3P_MIR302B_3P_MIR302C_3P_MIR302D_3P,0.991454606734593
TBP_01,SET,223,0.0062746,0.00068729,0.058631,0.45739,TBP_01,0.991454606734593
GOBP_POSITIVE_REGULATION_OF_...161,SET,8,0.033007,0.00068883,0.30875,0.45743,GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_PROLIFERATION,0.991454606734593
HP_SCHIZOPHRENIA,SET,61,0.012772,0.00073494,0.11945,0.45743,HP_SCHIZOPHRENIA,0.991454606734593
ARP1_01,SET,142,0.0073559,0.00064438,0.06882,0.45744,ARP1_01,0.991454606734593
MASRI_RESISTANCE_TO_TAMOXIFE...1,SET,16,0.024581,0.0007253,0.23045,0.45753,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,0.991454606734593
HP_SEVERE_PLATYSPONDYLY,SET,8,0.03147,0.00065674,0.29517,0.45755,HP_SEVERE_PLATYSPONDYLY,0.991454606734593
GSE21063_CTRL_VS_ANTI_IGM_ST...1,SET,183,0.0066631,0.00066188,0.062552,0.45759,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN,0.991454606734593
GOBP_POSITIVE_REGULATION_OF_...783,SET,185,0.0069139,0.0006905,0.065012,0.45765,GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,0.991454606734593
MIKKELSEN_MEF_ICP_WITH_H3K27...,SET,187,0.0067718,0.00067991,0.063724,0.45769,MIKKELSEN_MEF_ICP_WITH_H3K27ME3,0.991454606734593
MIR3975,SET,46,0.013835,0.00069162,0.1302,0.45769,MIR3975,0.991454606734593
HAY_BONE_MARROW_DENDRITIC_CE...,SET,167,0.0072418,0.0006875,0.068216,0.45773,HAY_BONE_MARROW_DENDRITIC_CELL,0.991454606734593
GOCC_PARANODAL_JUNCTION,SET,8,0.029449,0.00061458,0.27765,0.45777,GOCC_PARANODAL_JUNCTION,0.991454606734593
GSE23321_CD8_STEM_CELL_MEMOR...1,SET,159,0.0065324,0.00060525,0.061593,0.45777,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN,0.991454606734593
MIR591,SET,44,0.013545,0.00066229,0.12778,0.45779,MIR591,0.991454606734593
GSE17974_2H_VS_72H_UNTREATED...1,SET,164,0.0066681,0.00062737,0.062909,0.45779,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,0.991454606734593
GOBP_NEGATIVE_REGULATION_OF_...192,SET,22,0.018071,0.00062514,0.1705,0.4578,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.991454606734593
WP_MELATONIN_METABOLISM_AND_...,SET,30,0.016503,0.00066652,0.15577,0.45781,WP_MELATONIN_METABOLISM_AND_EFFECTS,0.991454606734593
MOTAMED_RESPONSE_TO_ANDROGEN...1,SET,6,0.03448,0.00062319,0.32586,0.45787,MOTAMED_RESPONSE_TO_ANDROGEN_DN,0.991454606734593
MYLLYKANGAS_AMPLIFICATION_HO...18,SET,12,0.026548,0.00067847,0.25094,0.45787,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8,0.991454606734593
BIOCARTA_EDG1_PATHWAY,SET,22,0.02005,0.00069363,0.18974,0.45792,BIOCARTA_EDG1_PATHWAY,0.991454606734593
GSE5542_IFNG_VS_IFNA_AND_IFN...1,SET,182,0.0065577,0.00064964,0.062145,0.45798,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.991454606734593
REACTOME_TRANSCRIPTIONAL_REG...8,SET,35,0.016062,0.00070058,0.15228,0.458,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,0.991454606734593
HP_PULMONARY_ARTERIOVENOUS_M...,SET,4,0.047587,0.00070231,0.45124,0.45801,HP_PULMONARY_ARTERIOVENOUS_MALFORMATION,0.991454606734593
FULLER_PBMC_F_TULARENSIS_VAC...8,SET,30,0.018036,0.00072845,0.17103,0.45801,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_DN,0.991454606734593
GAVISH_3CA_MALIGNANT_METAPRO...34,SET,36,0.013712,0.00060657,0.13021,0.45807,GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED,0.991454606734593
GOMF_ACTIVIN_RECEPTOR_ACTIVI...2,SET,5,0.048669,0.00080303,0.46247,0.45809,GOMF_ACTIVIN_RECEPTOR_ACTIVITY_TYPE_I,0.991454606734593
GSE22103_UNSTIM_VS_LPS_STIM_...1,SET,177,0.0066374,0.00064853,0.063069,0.45809,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN,0.991454606734593
MIR183_3P,SET,186,0.0065524,0.00065614,0.062305,0.45812,MIR183_3P,0.991454606734593
GOBP_LIPOPROTEIN_LOCALIZATION,SET,19,0.018867,0.0006066,0.17952,0.45815,GOBP_LIPOPROTEIN_LOCALIZATION,0.991454606734593
GSE10273_HIGH_VS_LOW_IL7_TRE...2,SET,171,0.0066169,0.00063559,0.062987,0.45817,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP,0.991454606734593
KORKOLA_SEMINOMA_DN,SET,8,0.037724,0.00078727,0.3592,0.45818,KORKOLA_SEMINOMA_DN,0.991454606734593
GSE40274_CTRL_VS_FOXP3_AND_E...2,SET,157,0.0071475,0.0006581,0.06811,0.45821,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.991454606734593
GOBP_REGULATION_OF_RESPONSE_...2,SET,158,0.0069442,0.0006414,0.06624,0.45825,GOBP_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,0.991454606734593
YRCCAKNNGNCGC_UNKNOWN,SET,60,0.011792,0.00067301,0.11252,0.45827,YRCCAKNNGNCGC_UNKNOWN,0.991454606734593
GSE11961_MEMORY_BCELL_DAY7_V...2,SET,180,0.006487,0.00063913,0.061982,0.45832,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.991454606734593
CCTGCTG_MIR214,SET,218,0.0057304,0.00062069,0.054786,0.45835,CCTGCTG_MIR214,0.991454606734593
GOBP_GLYCOSAMINOGLYCAN_CATAB...,SET,26,0.017303,0.00065064,0.16595,0.45848,GOBP_GLYCOSAMINOGLYCAN_CATABOLIC_PROCESS,0.991454606734593
HP_DEFORMED_TARSAL_BONES,SET,13,0.028538,0.0007591,0.27371,0.45848,HP_DEFORMED_TARSAL_BONES,0.991454606734593
GSE21063_WT_VS_NFATC1_KO_16H...1,SET,164,0.0073125,0.00068801,0.070149,0.45849,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_DN,0.991454606734593
GSE42724_B1_BCELL_VS_PLASMAB...2,SET,184,0.0061297,0.00061054,0.058822,0.4585,GSE42724_B1_BCELL_VS_PLASMABLAST_UP,0.991454606734593
GSE9988_ANTI_TREM1_VS_LOW_LP...2,SET,174,0.0067028,0.0006494,0.064313,0.4585,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP,0.991454606734593
TSUNODA_CISPLATIN_RESISTANCE...1,SET,43,0.013977,0.00067562,0.13424,0.45854,TSUNODA_CISPLATIN_RESISTANCE_DN,0.991454606734593
MIR6811_5P,SET,66,0.01117,0.00066851,0.10747,0.45861,MIR6811_5P,0.991454606734593
GOCC_ACETYLCHOLINE_GATED_CHA...,SET,16,0.024136,0.00071218,0.23233,0.45863,GOCC_ACETYLCHOLINE_GATED_CHANNEL_COMPLEX,0.991454606734593
HP_EPIPHYSEAL_DYSPLASIA,SET,28,0.016454,0.00064206,0.15837,0.45863,HP_EPIPHYSEAL_DYSPLASIA,0.991454606734593
HP_HYPERNATRIURIA,SET,9,0.032264,0.00071413,0.31138,0.45874,HP_HYPERNATRIURIA,0.991454606734593
HP_OSTEOSARCOMA,SET,32,0.014904,0.00062166,0.14389,0.45875,HP_OSTEOSARCOMA,0.991454606734593
GSE18281_PERIMEDULLARY_CORTI...4,SET,187,0.0063323,0.00063578,0.061125,0.45875,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,0.991454606734593
GSE3982_EOSINOPHIL_VS_NKCELL...2,SET,179,0.0065172,0.00064034,0.062922,0.45875,GSE3982_EOSINOPHIL_VS_NKCELL_UP,0.991454606734593
WP_TCA_CYCLE_AND_DEFICIENCY_...,SET,15,0.021981,0.00062801,0.2123,0.45877,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,0.991454606734593
GOMF_ACROSIN_BINDING,SET,5,0.036017,0.00059427,0.34834,0.45882,GOMF_ACROSIN_BINDING,0.991454606734593
GOBP_INTRACELLULAR_ZINC_ION_...,SET,34,0.016257,0.00069893,0.15726,0.45883,GOBP_INTRACELLULAR_ZINC_ION_HOMEOSTASIS,0.991454606734593
GSE40273_XBP1_KO_VS_WT_TREG_...1,SET,184,0.0065222,0.00064963,0.063085,0.45883,GSE40273_XBP1_KO_VS_WT_TREG_DN,0.991454606734593
MIR4719,SET,456,0.0041903,0.0006521,0.040542,0.45884,MIR4719,0.991454606734593
GOCC_COMMITMENT_COMPLEX,SET,5,0.027841,0.00045938,0.26935,0.45884,GOCC_COMMITMENT_COMPLEX,0.991454606734593
GOBP_MEIOTIC_CYTOKINESIS,SET,7,0.037815,0.00073821,0.36663,0.45893,GOBP_MEIOTIC_CYTOKINESIS,0.991454606734593
GOMF_CYCLIN_DEPENDENT_PROTEI...2,SET,14,0.020706,0.00057155,0.20089,0.45895,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,0.991454606734593
HP_FALLS,SET,38,0.014672,0.0006668,0.1424,0.45897,HP_FALLS,0.991454606734593
PID_RB_1PATHWAY,SET,60,0.011,0.0006278,0.10679,0.45898,PID_RB_1PATHWAY,0.991454606734593
HP_PAROXYSMAL_VENTRICULAR_TA...,SET,26,0.017103,0.00064314,0.16607,0.45899,HP_PAROXYSMAL_VENTRICULAR_TACHYCARDIA,0.991454606734593
RAPA_EARLY_UP.V1_DN,SET,168,0.0064863,0.0006176,0.062999,0.459,RAPA_EARLY_UP.V1_DN,0.991454606734593
GOCC_MYOSIN_FILAMENT,SET,24,0.019676,0.00071091,0.1913,0.45904,GOCC_MYOSIN_FILAMENT,0.991454606734593
HP_MUSCLE_STIFFNESS,SET,74,0.0095539,0.0006053,0.092922,0.45905,HP_MUSCLE_STIFFNESS,0.991454606734593
GOMF_G_PROTEIN_BETA_GAMMA_SU...,SET,21,0.019912,0.00067303,0.19367,0.45906,GOMF_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING,0.991454606734593
HP_LYMPHOPENIA,SET,163,0.0068659,0.00064403,0.066854,0.4591,HP_LYMPHOPENIA,0.991454606734593
GOBP_POSITIVE_REGULATION_OF_...555,SET,12,0.025962,0.00066349,0.25301,0.45914,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.991454606734593
GOBP_SMOOTH_MUSCLE_TISSUE_DE...,SET,24,0.018939,0.00068427,0.18458,0.45914,GOBP_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT,0.991454606734593
HE_LIM_SUN_FETAL_LUNG_C7_SST...,SET,333,0.0049151,0.00065589,0.047902,0.45914,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,0.991454606734593
HP_ABNORMAL_DESCEMET_MEMBRAN...,SET,14,0.025211,0.00069589,0.24579,0.45915,HP_ABNORMAL_DESCEMET_MEMBRANE_MORPHOLOGY,0.991454606734593
MULLIGHAN_MLL_SIGNATURE_2_UP,SET,388,0.0043046,0.00061911,0.041977,0.45916,MULLIGHAN_MLL_SIGNATURE_2_UP,0.991454606734593
MORF_HDAC1,SET,225,0.0053001,0.00058311,0.051681,0.45916,MORF_HDAC1,0.991454606734593
FRANCO_BLOOD_SANOFI_PASTEUR_...4,SET,20,0.018167,0.00059926,0.17719,0.45917,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_POSITIVE,0.991454606734593
KORKOLA_SEMINOMA_UP,SET,29,0.018916,0.00075116,0.18498,0.45928,KORKOLA_SEMINOMA_UP,0.991566988393023
HP_IMPAIRED_NEUTROPHIL_CHEMO...,SET,7,0.032307,0.00063068,0.31605,0.45929,HP_IMPAIRED_NEUTROPHIL_CHEMOTAXIS,0.991566988393023
MIR12132,SET,134,0.0071693,0.00061023,0.070185,0.45932,MIR12132,0.991566988393023
MODULE_272,SET,12,0.021467,0.00054862,0.21043,0.45937,MODULE_272,0.991566988393023
HP_SHORT_NOSE,SET,276,0.0051902,0.00063154,0.050892,0.45938,HP_SHORT_NOSE,0.991566988393023
TIAN_BHLHA15_TARGETS,SET,15,0.022158,0.00063307,0.21786,0.4595,TIAN_BHLHA15_TARGETS,0.991566988393023
PID_CD8_TCR_DOWNSTREAM_PATHW...,SET,61,0.011962,0.00068831,0.11761,0.4595,PID_CD8_TCR_DOWNSTREAM_PATHWAY,0.991566988393023
GOBP_NEGATIVE_REGULATION_OF_...428,SET,2,0.070584,0.00073663,0.69454,0.45953,GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_PROLIFERATION,0.991566988393023
GSE22527_ANTI_CD3_INVIVO_VS_...2,SET,176,0.0064751,0.0006309,0.063714,0.45953,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP,0.991566988393023
HP_FOOT_OLIGODACTYLY,SET,10,0.025662,0.00059873,0.25262,0.45954,HP_FOOT_OLIGODACTYLY,0.991566988393023
YANG_BREAST_CANCER_ESR1_BULK...2,SET,25,0.015251,0.00056235,0.15017,0.45956,YANG_BREAST_CANCER_ESR1_BULK_UP,0.991566988393023
GOBP_NEGATIVE_REGULATION_OF_...258,SET,17,0.021086,0.0006413,0.20775,0.45958,GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,0.991566988393023
GOMF_5_3_DNA_EXONUCLEASE_ACT...,SET,9,0.022679,0.00050198,0.22355,0.4596,GOMF_5_3_DNA_EXONUCLEASE_ACTIVITY,0.991566988393023
WP_PI3KAKT_SIGNALING,SET,322,0.0050385,0.00066137,0.049726,0.45965,WP_PI3KAKT_SIGNALING,0.991566988393023
HP_PARADOXICAL_INCREASED_COR...,SET,14,0.023421,0.00064648,0.23117,0.45965,HP_PARADOXICAL_INCREASED_CORTISOL_SECRETION_ON_DEXAMETHASONE_SUPPRESSION_TEST,0.991566988393023
GOBP_REGULATION_OF_VASCULAR_...5,SET,44,0.013787,0.00067412,0.13629,0.45971,GOBP_REGULATION_OF_VASCULAR_PERMEABILITY,0.991573328989015
GSE27786_CD4_TCELL_VS_MONO_M...2,SET,176,0.0059841,0.00058306,0.059148,0.45971,GSE27786_CD4_TCELL_VS_MONO_MAC_UP,0.991573328989015
GOMF_SIGNALING_RECEPTOR_INHI...,SET,27,0.016265,0.00062324,0.16142,0.45987,GOMF_SIGNALING_RECEPTOR_INHIBITOR_ACTIVITY,0.991598675640469
GOBP_REGULATION_OF_DNA_REPLI...,SET,117,0.0078571,0.0006252,0.078011,0.45989,GOBP_REGULATION_OF_DNA_REPLICATION,0.991598675640469
GOBP_POSITIVE_REGULATION_OF_...633,SET,6,0.034141,0.00061706,0.33905,0.4599,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CILIUM,0.991598675640469
MIR7113_5P,SET,136,0.0071977,0.00061716,0.071564,0.45994,MIR7113_5P,0.991598675640469
HP_ADRENAL_OVERACTIVITY,SET,49,0.013173,0.00067959,0.13096,0.45994,HP_ADRENAL_OVERACTIVITY,0.991598675640469
REACTOME_SIGNALING_BY_NOTCH3,SET,46,0.012489,0.00062433,0.12419,0.45995,REACTOME_SIGNALING_BY_NOTCH3,0.991598675640469
GOMF_PEPTIDASE_ACTIVITY,SET,534,0.0037676,0.0006331,0.037465,0.45995,GOMF_PEPTIDASE_ACTIVITY,0.991598675640469
HP_SYNOSTOSIS_INVOLVING_THE_...,SET,10,0.028118,0.00065603,0.27961,0.45995,HP_SYNOSTOSIS_INVOLVING_THE_ELBOW,0.991598675640469
GSE17721_0.5H_VS_12H_PAM3CSK...1,SET,184,0.0058905,0.00058671,0.058807,0.46011,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_DN,0.991842126155182
GOBP_AMIDE_TRANSPORT,SET,295,0.0051385,0.00064607,0.051313,0.46012,GOBP_AMIDE_TRANSPORT,0.991842126155182
HP_ACCELERATED_SKELETAL_MATU...,SET,63,0.010915,0.00063824,0.10909,0.46015,HP_ACCELERATED_SKELETAL_MATURATION,0.991845277226495
HP_FACIAL_ASYMMETRY,SET,128,0.0073764,0.00061373,0.074165,0.46039,HP_FACIAL_ASYMMETRY,0.992162700725401
REACTOME_REPRESSION_OF_WNT_T...,SET,13,0.024254,0.00064513,0.244,0.46041,REACTOME_REPRESSION_OF_WNT_TARGET_GENES,0.992162700725401
GOCC_MHC_CLASS_I_PROTEIN_COM...,SET,9,0.031145,0.00068937,0.3135,0.46043,GOCC_MHC_CLASS_I_PROTEIN_COMPLEX,0.992162700725401
HP_CALVARIAL_OSTEOSCLEROSIS,SET,7,0.031381,0.00061262,0.31585,0.46043,HP_CALVARIAL_OSTEOSCLEROSIS,0.992162700725401
GSE24210_IL35_TREATED_VS_UNT...1,SET,182,0.0063487,0.00062894,0.063915,0.46044,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN,0.992162700725401
MIR5571_5P,SET,149,0.0071105,0.00063793,0.07185,0.46058,MIR5571_5P,0.992223787307668
GSE3982_MAST_CELL_VS_MAC_UP,SET,175,0.0061355,0.00059613,0.06202,0.4606,GSE3982_MAST_CELL_VS_MAC_UP,0.992223787307668
WP_REGUCALCIN_IN_PROXIMAL_TU...,SET,30,0.014577,0.00058873,0.1476,0.46066,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,0.992223787307668
MIKKELSEN_MCV6_LCP_WITH_H3K2...,SET,24,0.017484,0.00063171,0.17705,0.46067,MIKKELSEN_MCV6_LCP_WITH_H3K27ME3,0.992223787307668
GSE46606_IRF4HIGH_VS_WT_CD40...3,SET,183,0.0060056,0.00059657,0.060836,0.46068,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.992223787307668
HP_DEMYELINATING_MOTOR_NEURO...,SET,5,0.041553,0.00068561,0.42147,0.46073,HP_DEMYELINATING_MOTOR_NEUROPATHY,0.992223787307668
GOCC_ORGANELLE_SUBCOMPARTMENT,SET,1359,0.0023513,0.00061556,0.023869,0.46076,GOCC_ORGANELLE_SUBCOMPARTMENT,0.992223787307668
GOBP_GLYCINE_METABOLIC_PROCE...,SET,12,0.022058,0.00056372,0.22392,0.46077,GOBP_GLYCINE_METABOLIC_PROCESS,0.992223787307668
SHEDDEN_LUNG_CANCER_POOR_SUR...,SET,416,0.004032,0.00059999,0.040952,0.46079,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,0.992223787307668
GOMF_CHOLINE_TRANSMEMBRANE_T...,SET,7,0.035342,0.00068993,0.35921,0.46081,GOMF_CHOLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.992223787307668
GOMF_DOUBLE_STRANDED_DNA_EXO...,SET,6,0.034817,0.00062929,0.35406,0.46083,GOMF_DOUBLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY,0.992223787307668
HP_ANGLE_CLOSURE_GLAUCOMA,SET,5,0.042582,0.00070259,0.43341,0.46087,HP_ANGLE_CLOSURE_GLAUCOMA,0.992223787307668
GAVISH_3CA_METAPROGRAM_MACRO...4,SET,46,0.013185,0.00065914,0.13447,0.46095,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_1,0.992223787307668
HP_ABNORMAL_LARYNX_MORPHOLOGY,SET,130,0.0073418,0.00061557,0.07493,0.46097,HP_ABNORMAL_LARYNX_MORPHOLOGY,0.992223787307668
MODULE_47,SET,208,0.0060756,0.00064298,0.06204,0.46099,MODULE_47,0.992223787307668
E2A_Q2,SET,220,0.0054971,0.00059811,0.056143,0.461,E2A_Q2,0.992223787307668
GOBP_CD4_POSITIVE_ALPHA_BETA...2,SET,19,0.019591,0.00062987,0.20022,0.46103,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_CYTOKINE_PRODUCTION,0.992223787307668
GOCC_POLAR_MICROTUBULE,SET,5,0.034946,0.0005766,0.35784,0.4611,GOCC_POLAR_MICROTUBULE,0.992223787307668
GSE2405_S_AUREUS_VS_A_PHAGOC...1,SET,189,0.0056985,0.00057517,0.058371,0.46112,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN,0.992223787307668
KEGG_PARKINSONS_DISEASE,SET,92,0.0075553,0.00053346,0.07748,0.46116,KEGG_PARKINSONS_DISEASE,0.992223787307668
MODULE_174,SET,89,0.009286,0.00064494,0.095481,0.46126,MODULE_174,0.992223787307668
MIR448,SET,327,0.0046146,0.00061033,0.047463,0.46127,MIR448,0.992223787307668
PID_DNA_PK_PATHWAY,SET,16,0.01686,0.00049747,0.17381,0.46136,PID_DNA_PK_PATHWAY,0.992223787307668
HP_CURLY_EYELASHES,SET,12,0.026612,0.0006801,0.27483,0.46143,HP_CURLY_EYELASHES,0.992223787307668
WP_SERINE_METABOLISM,SET,8,0.024243,0.00050593,0.25051,0.46145,WP_SERINE_METABOLISM,0.992223787307668
MIR365A_3P_MIR365B_3P,SET,106,0.0080192,0.00060754,0.082896,0.46147,MIR365A_3P_MIR365B_3P,0.992223787307668
FERRANDO_HOX11_NEIGHBORS,SET,22,0.018338,0.00063439,0.18968,0.46149,FERRANDO_HOX11_NEIGHBORS,0.992223787307668
DESCARTES_MAIN_FETAL_PARIETA...,SET,92,0.0082569,0.00058301,0.085434,0.4615,DESCARTES_MAIN_FETAL_PARIETAL_AND_CHIEF_CELLS,0.992223787307668
HOFFMAN_CLOCK_TARGETS_UP,SET,9,0.031212,0.00069085,0.32337,0.46155,HOFFMAN_CLOCK_TARGETS_UP,0.992223787307668
HP_ABNORMAL_UPPER_LIMB_BONE_...,SET,398,0.0041568,0.00060534,0.043069,0.46156,HP_ABNORMAL_UPPER_LIMB_BONE_MORPHOLOGY,0.992223787307668
GOBP_NEGATIVE_REGULATION_OF_...412,SET,20,0.01604,0.00052909,0.1664,0.4616,GOBP_NEGATIVE_REGULATION_OF_MRNA_PROCESSING,0.992223787307668
GOBP_REGULATION_OF_POSTSYNAP...1,SET,6,0.034094,0.00061622,0.35396,0.46163,GOBP_REGULATION_OF_POSTSYNAPSE_ASSEMBLY,0.992223787307668
GSE29164_CD8_TCELL_VS_CD8_TC...1,SET,184,0.006068,0.00060439,0.063051,0.46167,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,0.992223787307668
KIM_WT1_TARGETS_12HR_UP,SET,154,0.0067787,0.0006182,0.070471,0.46168,KIM_WT1_TARGETS_12HR_UP,0.992223787307668
GSE28130_ACTIVATED_VS_INDUCE...1,SET,171,0.0063613,0.00061103,0.066137,0.46169,GSE28130_ACTIVATED_VS_INDUCEED_TREG_DN,0.992223787307668
NGUYEN_NOTCH1_TARGETS_UP,SET,25,0.016696,0.00061567,0.17366,0.4617,NGUYEN_NOTCH1_TARGETS_UP,0.992223787307668
GOMF_CALCIUM_ION_BINDING,SET,660,0.003474,0.00064671,0.036129,0.4617,GOMF_CALCIUM_ION_BINDING,0.992223787307668
BIOCARTA_MHC_PATHWAY,SET,10,0.030527,0.00071223,0.3176,0.46171,BIOCARTA_MHC_PATHWAY,0.992223787307668
GOBP_CALCIUM_ION_HOMEOSTASIS,SET,302,0.0049859,0.00063416,0.051876,0.46172,GOBP_CALCIUM_ION_HOMEOSTASIS,0.992223787307668
SASSON_FSH_RESPONSE,SET,7,0.034071,0.00066513,0.3546,0.46173,SASSON_FSH_RESPONSE,0.992223787307668
MIR1915_5P,SET,42,0.013227,0.00063187,0.13765,0.46173,MIR1915_5P,0.992223787307668
STANHILL_HRAS_TRANSFROMATION...,SET,5,0.043107,0.00071125,0.44919,0.46177,STANHILL_HRAS_TRANSFROMATION_UP,0.992223787307668
REACTOME_FGFR3B_LIGAND_BINDI...,SET,7,0.036112,0.00070497,0.37645,0.46179,REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION,0.992223787307668
GOMF_ADENYLYLTRANSFERASE_ACT...,SET,21,0.017732,0.00059932,0.18511,0.46184,GOMF_ADENYLYLTRANSFERASE_ACTIVITY,0.992223787307668
GOBP_GABAERGIC_NEURON_DIFFER...,SET,18,0.02237,0.00070008,0.23368,0.46187,GOBP_GABAERGIC_NEURON_DIFFERENTIATION,0.992223787307668
GOBP_POSITIVE_REGULATION_OF_...401,SET,258,0.0054452,0.00064092,0.056883,0.46187,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION,0.992223787307668
HP_MYOKYMIA,SET,18,0.016763,0.0005246,0.17518,0.46188,HP_MYOKYMIA,0.992223787307668
GOBP_BONE_CELL_DEVELOPMENT,SET,18,0.020515,0.00064202,0.21468,0.46193,GOBP_BONE_CELL_DEVELOPMENT,0.992223787307668
GOBP_REGULATION_OF_TRANSCRIP...5,SET,29,0.015274,0.00060653,0.15984,0.46194,GOBP_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,0.992223787307668
GSE13493_DP_VS_CD8POS_THYMOC...2,SET,171,0.0060256,0.00057878,0.063137,0.46198,GSE13493_DP_VS_CD8POS_THYMOCYTE_UP,0.992223787307668
GSE17721_CTRL_VS_CPG_1H_BMDC...2,SET,186,0.0055935,0.00056012,0.058626,0.462,GSE17721_CTRL_VS_CPG_1H_BMDC_UP,0.992223787307668
GSE24972_WT_VS_IRF8_KO_MARGI...2,SET,174,0.0060899,0.00059003,0.063843,0.462,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP,0.992223787307668
GOBP_ARTERY_MORPHOGENESIS,SET,68,0.010798,0.00065594,0.11322,0.46201,GOBP_ARTERY_MORPHOGENESIS,0.992223787307668
GOBP_REGULATION_OF_THE_FORCE...1,SET,24,0.016977,0.0006134,0.178,0.46201,GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,0.992223787307668
DESCARTES_MAIN_FETAL_EPICARD...,SET,38,0.014442,0.00065633,0.15159,0.46205,DESCARTES_MAIN_FETAL_EPICARDIAL_FAT_CELLS,0.992248378027682
GSE17974_0H_VS_2H_IN_VITRO_A...1,SET,177,0.005757,0.00056251,0.060501,0.4621,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN,0.992254605832201
GOBP_ATTACHMENT_OF_GPI_ANCHO...,SET,6,0.027067,0.00048922,0.28458,0.46211,GOBP_ATTACHMENT_OF_GPI_ANCHOR_TO_PROTEIN,0.992254605832201
HP_FOCAL_ONSET_SEIZURE,SET,296,0.0046001,0.00057935,0.048399,0.46214,HP_FOCAL_ONSET_SEIZURE,0.992257719157349
GOBP_SENSORY_SYSTEM_DEVELOPM...,SET,383,0.0043695,0.00062446,0.046004,0.46217,GOBP_SENSORY_SYSTEM_DEVELOPMENT,0.99226083209785
GSE5589_LPS_VS_LPS_AND_IL10_...7,SET,185,0.0058263,0.00058188,0.061743,0.46241,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_DN,0.992261789746437
GOBP_REGULATION_OF_HUMORAL_I...1,SET,40,0.01388,0.00064713,0.14716,0.46243,GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.992261789746437
HE_PTEN_TARGETS_DN,SET,7,0.034318,0.00066994,0.36398,0.46244,HE_PTEN_TARGETS_DN,0.992261789746437
AAGWWRNYGGC_UNKNOWN,SET,111,0.0074047,0.00057399,0.078633,0.46249,AAGWWRNYGGC_UNKNOWN,0.992261789746437
HP_ATELECTASIS,SET,67,0.0099272,0.00059858,0.10542,0.46249,HP_ATELECTASIS,0.992261789746437
MIR149_3P,SET,396,0.0040229,0.0005844,0.042744,0.46251,MIR149_3P,0.992261789746437
ZNF274_TARGET_GENES,SET,743,0.0029362,0.00057859,0.031197,0.46251,ZNF274_TARGET_GENES,0.992261789746437
AIZARANI_LIVER_C17_HEPATOCYT...,SET,97,0.0086499,0.00062704,0.091941,0.46252,AIZARANI_LIVER_C17_HEPATOCYTES_3,0.992261789746437
GSE11961_FOLLICULAR_BCELL_VS...7,SET,178,0.0058922,0.00057733,0.062666,0.46255,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN,0.992261789746437
GOCC_NUCLEAR_LAMINA,SET,10,0.023375,0.00054536,0.24869,0.46256,GOCC_NUCLEAR_LAMINA,0.992261789746437
GSE13411_PLASMA_CELL_VS_MEMO...1,SET,175,0.0060157,0.00058449,0.064015,0.46257,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.992261789746437
GSE23505_UNTREATED_VS_4DAY_I...5,SET,184,0.0059208,0.00058974,0.063075,0.46261,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_DN,0.992261789746437
GOCC_PROTEIN_KINASE_COMPLEX,SET,135,0.0063026,0.00053844,0.067166,0.46262,GOCC_PROTEIN_KINASE_COMPLEX,0.992261789746437
GOMF_P_TYPE_CALCIUM_TRANSPOR...,SET,8,0.024868,0.00051898,0.2652,0.46265,GOMF_P_TYPE_CALCIUM_TRANSPORTER_ACTIVITY,0.992261789746437
HP_MUSCLE_FIBER_TUBULAR_INCL...,SET,7,0.029983,0.00058533,0.31976,0.46265,HP_MUSCLE_FIBER_TUBULAR_INCLUSIONS,0.992261789746437
HP_ABNORMAL_AMPLITUDE_OF_DAR...,SET,14,0.021906,0.00060468,0.23391,0.46269,HP_ABNORMAL_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM,0.992261789746437
MIR6851_5P,SET,94,0.007964,0.00056837,0.085059,0.4627,MIR6851_5P,0.992261789746437
HP_ABNORMAL_CIRCULATING_ALBU...,SET,108,0.0073744,0.00056391,0.078782,0.46271,HP_ABNORMAL_CIRCULATING_ALBUMIN_CONCENTRATION,0.992261789746437
GSE3039_NKT_CELL_VS_ALPHAALP...2,SET,185,0.0059932,0.00059854,0.064042,0.46272,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP,0.992261789746437
HP_PROGEROID_FACIAL_APPEARAN...,SET,29,0.013945,0.00055376,0.14918,0.46276,HP_PROGEROID_FACIAL_APPEARANCE,0.992261789746437
chr6p21,SET,271,0.01057,0.0012746,0.1131,0.46277,chr6p21,0.992261789746437
HP_MELANOCYTIC_NEVUS,SET,64,0.0089127,0.00052528,0.095467,0.46281,HP_MELANOCYTIC_NEVUS,0.992286338679827
WHITFIELD_CELL_CYCLE_M_G1,SET,115,0.0072359,0.00057086,0.077656,0.46288,WHITFIELD_CELL_CYCLE_M_G1,0.99233542746114
WP_REGULATORY_CIRCUITS_OF_ST...,SET,72,0.010216,0.0006385,0.10966,0.46289,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,0.99233542746114
HP_RHEUMATOID_ARTHRITIS,SET,20,0.018365,0.00060579,0.19748,0.46295,HP_RHEUMATOID_ARTHRITIS,0.992335714285714
HP_OCULAR_ANTERIOR_SEGMENT_D...,SET,273,0.004711,0.00057016,0.050759,0.46303,HP_OCULAR_ANTERIOR_SEGMENT_DYSGENESIS,0.992335714285714
GOBP_POSITIVE_REGULATION_OF_...790,SET,19,0.016927,0.00054423,0.18242,0.46304,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.992335714285714
GOMF_U6_SNRNA_BINDING,SET,14,0.017669,0.00048772,0.19043,0.46304,GOMF_U6_SNRNA_BINDING,0.992335714285714
GSE43863_DAY6_EFF_VS_DAY150_...2,SET,177,0.006009,0.00058714,0.064815,0.46307,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP,0.992335714285714
GOBP_ANTEROGRADE_AXONAL_TRAN...2,SET,6,0.031936,0.00057722,0.34459,0.46308,GOBP_ANTEROGRADE_AXONAL_TRANSPORT_OF_MITOCHONDRION,0.992335714285714
GOCC_TERTIARY_GRANULE,SET,147,0.006478,0.00057731,0.069922,0.46309,GOCC_TERTIARY_GRANULE,0.992335714285714
HP_GENERALIZED_HYPERKERATOSIS,SET,13,0.019026,0.00050609,0.20569,0.46315,HP_GENERALIZED_HYPERKERATOSIS,0.992345019109851
MIR4646_5P,SET,133,0.006713,0.00056927,0.072595,0.46316,MIR4646_5P,0.992345019109851
BRAUNE_GEIST_20_GENE_NOTCH_S...,SET,20,0.019168,0.00063228,0.20741,0.46318,BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER,0.992345019109851
GSE22886_NAIVE_BCELL_VS_NEUT...2,SET,171,0.0061307,0.00058889,0.06653,0.46329,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP,0.992382204016262
GOMF_TETRAPYRROLE_BINDING,SET,135,0.007269,0.000621,0.079041,0.46336,GOMF_TETRAPYRROLE_BINDING,0.992382204016262
GOBP_POSITIVE_REGULATION_OF_...128,SET,91,0.0087369,0.00061355,0.095027,0.46337,GOBP_POSITIVE_REGULATION_OF_CELL_DIVISION,0.992382204016262
GOBP_REGULATION_OF_LIPID_BIO...,SET,159,0.0062061,0.00057501,0.067507,0.46338,GOBP_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,0.992382204016262
GSE4590_PRE_BCELL_VS_VPREB_P...2,SET,140,0.0066871,0.00058169,0.072789,0.4634,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,0.992382204016262
MANN_RESPONSE_TO_AMIFOSTINE_...1,SET,9,0.022492,0.00049785,0.24503,0.46343,MANN_RESPONSE_TO_AMIFOSTINE_DN,0.992382204016262
chr5q35,SET,116,0.014559,0.0011535,0.15876,0.46347,chr5q35,0.992382204016262
GOBP_REGULATION_OF_LYMPHOCYT...1,SET,467,0.0037726,0.00059397,0.041157,0.46348,GOBP_REGULATION_OF_LYMPHOCYTE_ACTIVATION,0.992382204016262
GOCC_MICROTUBULE_ORGANIZING_...1,SET,779,0.0027231,0.00054888,0.029711,0.46349,GOCC_MICROTUBULE_ORGANIZING_CENTER,0.992382204016262
GNF2_CDC2,SET,58,0.010276,0.00057662,0.11221,0.46352,GNF2_CDC2,0.992382204016262
GOBP_TRANSFORMING_GROWTH_FAC...1,SET,11,0.026282,0.00064309,0.28705,0.46353,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.992382204016262
GOBP_REGULATION_OF_SPINDLE_A...,SET,32,0.012188,0.00050836,0.13316,0.46354,GOBP_REGULATION_OF_SPINDLE_ASSEMBLY,0.992382204016262
GSE40274_SATB1_VS_FOXP3_AND_...2,SET,155,0.0059176,0.00054141,0.064857,0.46365,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.992490986757796
GOBP_NEGATIVE_REGULATION_OF_...699,SET,51,0.011681,0.00061478,0.12806,0.46366,GOBP_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,0.992490986757796
GOBP_REGULATION_OF_CARDIAC_M...1,SET,10,0.026924,0.00062817,0.29543,0.46369,GOBP_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,0.992490986757796
DELLA_RESPONSE_TO_TSA_AND_BU...,SET,20,0.01707,0.00056307,0.18742,0.46372,DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,0.992490986757796
HP_ABNORMALITY_OF_THE_FEMALE...,SET,504,0.0034643,0.00056603,0.038104,0.46378,HP_ABNORMALITY_OF_THE_FEMALE_GENITALIA,0.992490986757796
MIR548AH_5P,SET,321,0.0043739,0.00057325,0.04818,0.46383,MIR548AH_5P,0.992490986757796
GOMF_HEXOSE_TRANSMEMBRANE_TR...,SET,21,0.018211,0.00061554,0.2006,0.46383,GOMF_HEXOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.992490986757796
GSE17721_0.5H_VS_4H_GARDIQUI...2,SET,172,0.0055134,0.00053112,0.060738,0.46384,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_UP,0.992490986757796
GOBP_NEGATIVE_REGULATION_OF_...514,SET,101,0.0073802,0.00054586,0.081471,0.46391,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.992490986757796
HP_VITREOUS_FLOATERS,SET,11,0.02384,0.00058335,0.26324,0.46392,HP_VITREOUS_FLOATERS,0.992490986757796
REACTOME_ANTIMICROBIAL_PEPTI...,SET,74,0.010953,0.00069396,0.12117,0.46399,REACTOME_ANTIMICROBIAL_PEPTIDES,0.992490986757796
GOBP_NATURAL_KILLER_CELL_CHE...,SET,10,0.027006,0.00063008,0.29918,0.46404,GOBP_NATURAL_KILLER_CELL_CHEMOTAXIS,0.992490986757796
MIR1263,SET,50,0.011323,0.00059006,0.12547,0.46405,MIR1263,0.992490986757796
GOBP_VESICLE_CARGO_LOADING,SET,31,0.013269,0.00054475,0.14705,0.46405,GOBP_VESICLE_CARGO_LOADING,0.992490986757796
GOBP_POSITIVE_REGULATION_OF_...742,SET,6,0.03501,0.00063277,0.38858,0.46411,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC,0.992490986757796
TGCTGAY_UNKNOWN,SET,483,0.0035452,0.00056739,0.039366,0.46412,TGCTGAY_UNKNOWN,0.992490986757796
GOBP_RESPONSE_TO_CAFFEINE,SET,14,0.019306,0.00053289,0.21464,0.46417,GOBP_RESPONSE_TO_CAFFEINE,0.992490986757796
CCCACAT_MIR2993P,SET,48,0.010471,0.00053469,0.11645,0.46418,CCCACAT_MIR2993P,0.992490986757796
BIOCARTA_EPONFKB_PATHWAY,SET,11,0.023229,0.00056839,0.25854,0.46421,BIOCARTA_EPONFKB_PATHWAY,0.992490986757796
HP_PSYCHOTIC_MENTATION,SET,15,0.017326,0.00049503,0.19289,0.46421,HP_PSYCHOTIC_MENTATION,0.992490986757796
OUYANG_PROSTATE_CANCER_MARKE...,SET,20,0.017384,0.00057342,0.19379,0.46426,OUYANG_PROSTATE_CANCER_MARKERS,0.992490986757796
WANG_BARRETTS_ESOPHAGUS_DN,SET,24,0.016769,0.00060588,0.18735,0.46434,WANG_BARRETTS_ESOPHAGUS_DN,0.992490986757796
GOBP_NEGATIVE_REGULATION_OF_...124,SET,157,0.0060598,0.00055795,0.067695,0.46434,GOBP_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.992490986757796
GOCC_CILIARY_TRANSITION_ZONE,SET,65,0.0086974,0.00051657,0.097203,0.46435,GOCC_CILIARY_TRANSITION_ZONE,0.992490986757796
GOBP_POSITIVE_REGULATION_OF_...443,SET,12,0.023229,0.00059365,0.26048,0.46447,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_DEGRANULATION,0.992490986757796
WP_TGFBETA_RECEPTOR_SIGNALING,SET,51,0.011502,0.00060532,0.12922,0.46454,WP_TGFBETA_RECEPTOR_SIGNALING,0.992490986757796
HP_MACRODONTIA_OF_PERMANENT_...,SET,12,0.02373,0.00060646,0.26664,0.46454,HP_MACRODONTIA_OF_PERMANENT_MAXILLARY_CENTRAL_INCISOR,0.992490986757796
WP_HORMONAL_CONTROL_OF_PUBER...,SET,5,0.036908,0.00060897,0.41475,0.46455,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,0.992490986757796
GOBP_REGULATION_OF_KINASE_AC...,SET,466,0.0035435,0.00055731,0.039847,0.46457,GOBP_REGULATION_OF_KINASE_ACTIVITY,0.992490986757796
DESCARTES_FETAL_INTESTINE_ST...,SET,33,0.014755,0.00062498,0.16592,0.46457,DESCARTES_FETAL_INTESTINE_STROMAL_CELLS,0.992490986757796
GOBP_NEGATIVE_REGULATION_OF_...243,SET,8,0.025963,0.00054182,0.29204,0.46458,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_MIGRATION,0.992490986757796
GOCC_SET1C_COMPASS_COMPLEX,SET,14,0.019303,0.00053281,0.21747,0.46464,GOCC_SET1C_COMPASS_COMPLEX,0.992490986757796
GSE339_EX_VIVO_VS_IN_CULTURE...3,SET,180,0.0054992,0.00054181,0.062029,0.46468,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN,0.992490986757796
GOMF_DEHYDROASCORBIC_ACID_TR...,SET,6,0.028733,0.00051933,0.32447,0.46472,GOMF_DEHYDROASCORBIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.992490986757796
WP_INTERLEUKIN1_INDUCED_ACTI...,SET,9,0.024217,0.00053602,0.27394,0.46478,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,0.992490986757796
HP_HYPOPLASIA_OF_THE_CORPUS_...,SET,391,0.00366,0.00052838,0.04151,0.46487,HP_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM,0.992490986757796
GSE7460_CTRL_VS_FOXP3_OVEREX...4,SET,181,0.0054742,0.00054083,0.062077,0.46487,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP,0.992490986757796
GOBP_DEPYRIMIDINATION,SET,8,0.025368,0.0005294,0.28778,0.46488,GOBP_DEPYRIMIDINATION,0.992490986757796
TCCATTKW_UNKNOWN,SET,217,0.0050785,0.00054882,0.057659,0.46491,TCCATTKW_UNKNOWN,0.992490986757796
GOBP_POSITIVE_REGULATION_OF_...473,SET,14,0.017399,0.00048027,0.1979,0.46497,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_TRANSLATION,0.992490986757796
BUSSLINGER_DUODENAL_PANETH_C...,SET,15,0.022466,0.00064187,0.25557,0.46498,BUSSLINGER_DUODENAL_PANETH_CELLS,0.992490986757796
ACEVEDO_LIVER_CANCER_DN,SET,490,0.0033981,0.00054766,0.038735,0.46505,ACEVEDO_LIVER_CANCER_DN,0.992490986757796
HP_GLOSSITIS,SET,10,0.02683,0.00062596,0.30627,0.4651,HP_GLOSSITIS,0.992490986757796
TORCHIA_TARGETS_OF_EWSR1_FLI...3,SET,17,0.019117,0.00058143,0.21887,0.4652,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP,0.992490986757796
GSE4984_UNTREATED_VS_LPS_TRE...1,SET,156,0.0058294,0.00053504,0.066734,0.4652,GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN,0.992490986757796
MIR8054,SET,268,0.0045167,0.00054169,0.051749,0.46522,MIR8054,0.992490986757796
GSE26030_UNSTIM_VS_RESTIM_TH...4,SET,166,0.0058827,0.00055682,0.067497,0.46527,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_UP,0.992490986757796
HOEK_PBMC_INACTIVATED_INFLUE...4,SET,6,0.029425,0.00053183,0.33761,0.46527,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_UP,0.992490986757796
GSE9601_NFKB_INHIBITOR_VS_PI...2,SET,177,0.0053763,0.00052531,0.061732,0.4653,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,0.992490986757796
RUTELLA_RESPONSE_TO_HGF_UP,SET,377,0.0039873,0.00056546,0.045797,0.46531,RUTELLA_RESPONSE_TO_HGF_UP,0.992490986757796
HP_HYPOVOLEMIC_SHOCK,SET,5,0.037398,0.00061705,0.42967,0.46532,HP_HYPOVOLEMIC_SHOCK,0.992490986757796
GOBP_REGULATION_OF_NMDA_RECE...,SET,14,0.019729,0.00054458,0.22673,0.46533,GOBP_REGULATION_OF_NMDA_RECEPTOR_ACTIVITY,0.992490986757796
BROWNE_HCMV_INFECTION_10HR_DN,SET,52,0.010612,0.00056393,0.12203,0.46535,BROWNE_HCMV_INFECTION_10HR_DN,0.992490986757796
REACTOME_PCP_CE_PATHWAY,SET,88,0.0073739,0.00050927,0.085059,0.46546,REACTOME_PCP_CE_PATHWAY,0.992490986757796
GOCC_EPSILON_DNA_POLYMERASE_...,SET,5,0.030148,0.00049744,0.34793,0.46548,GOCC_EPSILON_DNA_POLYMERASE_COMPLEX,0.992490986757796
HE_LIM_SUN_FETAL_LUNG_C2_ADC...2,SET,95,0.0080452,0.0005772,0.092943,0.46551,HE_LIM_SUN_FETAL_LUNG_C2_ADC_2_CELL,0.992490986757796
HP_ABNORMAL_B_CELL_SUBSET_DI...,SET,26,0.014906,0.00056054,0.17228,0.46553,HP_ABNORMAL_B_CELL_SUBSET_DISTRIBUTION,0.992490986757796
GOBP_POSITIVE_REGULATION_OF_...795,SET,70,0.0093865,0.00057846,0.10858,0.46556,GOBP_POSITIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION,0.992490986757796
GOBP_VACUOLAR_TRANSMEMBRANE_...,SET,8,0.024972,0.00052115,0.28999,0.46569,GOBP_VACUOLAR_TRANSMEMBRANE_TRANSPORT,0.992490986757796
HP_OVARIAN_NEOPLASM,SET,73,0.0082922,0.00052182,0.096299,0.46569,HP_OVARIAN_NEOPLASM,0.992490986757796
REACTOME_TYPE_I_HEMIDESMOSOM...,SET,11,0.021804,0.00053353,0.25353,0.46573,REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY,0.992490986757796
GOMF_C_X3_C_CHEMOKINE_BINDING,SET,5,0.034877,0.00057546,0.4056,0.46574,GOMF_C_X3_C_CHEMOKINE_BINDING,0.992490986757796
GOBP_BRANCH_ELONGATION_OF_AN...,SET,19,0.019085,0.00061363,0.22228,0.46579,GOBP_BRANCH_ELONGATION_OF_AN_EPITHELIUM,0.992490986757796
GOBP_REGULATION_OF_SECRETION,SET,559,0.0032033,0.00055035,0.037324,0.4658,GOBP_REGULATION_OF_SECRETION,0.992490986757796
GOBP_POSITIVE_REGULATION_OF_...703,SET,8,0.030114,0.00062845,0.35105,0.46582,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT,0.992490986757796
GSE17721_POLYIC_VS_PAM3CSK4_...11,SET,186,0.0053454,0.00053527,0.062304,0.46582,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_DN,0.992490986757796
HP_ABNORMAL_INTRAOCULAR_PRES...,SET,36,0.012661,0.00056009,0.14771,0.46585,HP_ABNORMAL_INTRAOCULAR_PRESSURE,0.992490986757796
SNRNP70_TARGET_GENES,SET,684,0.0027252,0.0005161,0.031817,0.46587,SNRNP70_TARGET_GENES,0.992490986757796
GSE16385_MONOCYTE_VS_12H_IL4...1,SET,187,0.0049048,0.00049246,0.057259,0.46587,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN,0.992490986757796
GOBP_TRNA_METHYLATION,SET,36,0.010898,0.00048211,0.12733,0.4659,GOBP_TRNA_METHYLATION,0.992490986757796
JNK_DN.V1_UP,SET,161,0.0058971,0.00054979,0.068947,0.46592,JNK_DN.V1_UP,0.992490986757796
GOCC_POSTSYNAPTIC_DENSITY_ME...,SET,94,0.0076272,0.00054433,0.089195,0.46593,GOCC_POSTSYNAPTIC_DENSITY_MEMBRANE,0.992490986757796
GOMF_ADP_BINDING,SET,32,0.012404,0.00051739,0.14534,0.46599,GOMF_ADP_BINDING,0.992490986757796
WP_TCELL_ANTIGEN_RECEPTOR_TC...,SET,59,0.0093583,0.00052964,0.10966,0.466,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,0.992490986757796
GOBP_REGULATION_OF_CORTISOL_...,SET,7,0.029546,0.00057679,0.34693,0.46607,GOBP_REGULATION_OF_CORTISOL_BIOSYNTHETIC_PROCESS,0.992490986757796
REACTOME_ROLE_OF_LAT2_NTAL_L...,SET,16,0.01785,0.0005267,0.20973,0.46609,REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION,0.992490986757796
GOBP_MITOCHONDRIAL_TRNA_PROC...,SET,12,0.017852,0.00045622,0.20979,0.46609,GOBP_MITOCHONDRIAL_TRNA_PROCESSING,0.992490986757796
GOBP_POSITIVE_REGULATION_OF_...509,SET,42,0.011093,0.00052993,0.13034,0.46609,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,0.992490986757796
GSE2770_UNTREATED_VS_IL12_TR...5,SET,178,0.0053385,0.00052308,0.062725,0.46609,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.992490986757796
HP_HIGH_NARROW_PALATE,SET,128,0.0061714,0.00051348,0.072624,0.46614,HP_HIGH_NARROW_PALATE,0.992490986757796
RICKMAN_HEAD_AND_NECK_CANCER...5,SET,75,0.0088286,0.0005631,0.10399,0.46617,RICKMAN_HEAD_AND_NECK_CANCER_E,0.992490986757796
WP_LIPID_METABOLISM_IN_SENES...,SET,20,0.016307,0.0005379,0.19215,0.46618,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,0.992490986757796
GOMF_RECEPTOR_ANTAGONIST_ACT...,SET,16,0.016431,0.00048483,0.19384,0.46622,GOMF_RECEPTOR_ANTAGONIST_ACTIVITY,0.992490986757796
REACTOME_NUCLEAR_IMPORT_OF_R...,SET,32,0.011904,0.00049651,0.14047,0.46623,REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN,0.992490986757796
GOBP_POLYKETIDE_METABOLIC_PR...,SET,10,0.028771,0.00067126,0.33955,0.46624,GOBP_POLYKETIDE_METABOLIC_PROCESS,0.992490986757796
GOBP_RESPONSE_TO_FRUCTOSE,SET,10,0.019625,0.00045788,0.2317,0.46625,GOBP_RESPONSE_TO_FRUCTOSE,0.992490986757796
GSE22935_UNSTIM_VS_12H_MBOVI...1,SET,183,0.0051102,0.00050762,0.060386,0.46628,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.992490986757796
GOBP_WYBUTOSINE_METABOLIC_PR...,SET,6,0.02953,0.00053373,0.34902,0.46629,GOBP_WYBUTOSINE_METABOLIC_PROCESS,0.992490986757796
GOMF_OXIDOREDUCTASE_ACTIVITY...33,SET,10,0.02195,0.00051212,0.25964,0.46631,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,0.992490986757796
HP_NORMOCYTIC_ANEMIA,SET,15,0.016889,0.00048254,0.2002,0.46638,HP_NORMOCYTIC_ANEMIA,0.992490986757796
GOBP_MALE_MEIOSIS_I,SET,25,0.013055,0.00048138,0.15475,0.46639,GOBP_MALE_MEIOSIS_I,0.992490986757796
HP_ELEVATED_CIRCULATING_CREA...,SET,265,0.0042347,0.00050505,0.050235,0.46641,HP_ELEVATED_CIRCULATING_CREATINE_KINASE_CONCENTRATION,0.992490986757796
RTTTNNNYTGGM_UNKNOWN,SET,141,0.0063607,0.00055525,0.075693,0.46652,RTTTNNNYTGGM_UNKNOWN,0.992490986757796
GOBP_ANDROGEN_CATABOLIC_PROC...,SET,5,0.031976,0.0005276,0.38126,0.46658,GOBP_ANDROGEN_CATABOLIC_PROCESS,0.992490986757796
GSE32423_CTRL_VS_IL7_IL4_MEM...1,SET,190,0.0048719,0.00049303,0.058121,0.4666,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,0.992490986757796
GSE36826_NORMAL_VS_STAPH_AUR...4,SET,175,0.0050882,0.00049438,0.060745,0.46662,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP,0.992490986757796
HP_ABSENT_FACIAL_HAIR,SET,33,0.013047,0.00055264,0.15584,0.46664,HP_ABSENT_FACIAL_HAIR,0.992490986757796
GSE20727_ROS_INH_VS_ROS_INH_...2,SET,177,0.0053584,0.00052356,0.064011,0.46664,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.992490986757796
GSE22140_HEALTHY_VS_ARTHRITI...4,SET,178,0.0052277,0.00051222,0.062443,0.46664,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP,0.992490986757796
GOMF_HISTONE_READER_ACTIVITY,SET,16,0.015465,0.00045634,0.18508,0.4667,GOMF_HISTONE_READER_ACTIVITY,0.992490986757796
GOBP_POSITIVE_REGULATION_OF_...735,SET,11,0.020174,0.00049365,0.24148,0.46671,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,0.992490986757796
MORI_PRE_BI_LYMPHOCYTE_DN,SET,71,0.0082057,0.00050928,0.09829,0.46673,MORI_PRE_BI_LYMPHOCYTE_DN,0.992490986757796
REACTOME_GENE_SILENCING_BY_R...,SET,77,0.0074334,0.00048036,0.089074,0.46675,REACTOME_GENE_SILENCING_BY_RNA,0.992490986757796
QI_PBMC_ZOSTAVAX_AGE_50_75YO...4,SET,266,0.0043767,0.00052296,0.052519,0.46679,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE,0.992490986757796
HP_ABNORMAL_SERUM_ESTRADIOL,SET,59,0.0090067,0.00050973,0.10813,0.46681,HP_ABNORMAL_SERUM_ESTRADIOL,0.992490986757796
GOMF_TRANSPORTER_INHIBITOR_A...,SET,38,0.011995,0.00054514,0.14406,0.46682,GOMF_TRANSPORTER_INHIBITOR_ACTIVITY,0.992490986757796
GARCIA_PINERES_PBMC_HPV_16_L...4,SET,305,0.0041705,0.00053303,0.050081,0.46682,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_UP,0.992490986757796
GSE339_CD4POS_VS_CD8POS_DC_I...1,SET,180,0.0050171,0.00049431,0.06027,0.46683,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN,0.992490986757796
YAO_TEMPORAL_RESPONSE_TO_PRO...17,SET,46,0.01033,0.00051642,0.12429,0.46688,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,0.992490986757796
GSE13229_IMM_VS_INTMATURE_NK...2,SET,180,0.0053186,0.00052401,0.064017,0.46689,GSE13229_IMM_VS_INTMATURE_NKCELL_UP,0.992490986757796
GSE6674_CPG_VS_PL2_3_STIM_BC...1,SET,175,0.0051953,0.00050478,0.06253,0.46689,GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN,0.992490986757796
GOBP_NEGATIVE_REGULATION_OF_...229,SET,5,0.034455,0.0005685,0.41587,0.46699,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,0.992490986757796
HP_DIFFUSE_ALVEOLAR_HEMORRHA...,SET,16,0.018216,0.0005375,0.21998,0.467,HP_DIFFUSE_ALVEOLAR_HEMORRHAGE,0.992490986757796
chr15q25,SET,58,0.014785,0.00082965,0.17884,0.46706,chr15q25,0.992490986757796
GOBP_TIGHT_JUNCTION_ORGANIZA...,SET,75,0.0083639,0.00053346,0.10118,0.46706,GOBP_TIGHT_JUNCTION_ORGANIZATION,0.992490986757796
GOMF_SECONDARY_ACTIVE_MONOCA...,SET,17,0.017164,0.00052203,0.20773,0.46707,GOMF_SECONDARY_ACTIVE_MONOCARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.992490986757796
HP_CONTRACTURE_OF_THE_DISTAL...,SET,6,0.031707,0.00057307,0.38364,0.46707,HP_CONTRACTURE_OF_THE_DISTAL_INTERPHALANGEAL_JOINT_OF_THE_FINGERS,0.992490986757796
HP_VEIN_OF_GALEN_ANEURYSMAL_...,SET,5,0.03059,0.00050473,0.37013,0.46707,HP_VEIN_OF_GALEN_ANEURYSMAL_MALFORMATION,0.992490986757796
GOBP_PROTEIN_DEUBIQUITINATIO...,SET,5,0.029798,0.00049166,0.36138,0.46714,GOBP_PROTEIN_DEUBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.992490986757796
HP_HIATUS_HERNIA,SET,32,0.011801,0.00049223,0.14312,0.46714,HP_HIATUS_HERNIA,0.992490986757796
KEGG_MEDICUS_REFERENCE_LESIO...,SET,12,0.015631,0.00039948,0.18964,0.46715,KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION,0.992490986757796
REACTOME_NF_KB_ACTIVATION_TH...,SET,11,0.019573,0.00047894,0.23756,0.46717,REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10,0.992490986757796
GSE21063_WT_VS_NFATC1_KO_BCE...1,SET,181,0.004874,0.00048153,0.059268,0.46723,GSE21063_WT_VS_NFATC1_KO_BCELL_DN,0.992490986757796
GSE29614_CTRL_VS_DAY7_TIV_FL...2,SET,145,0.0060472,0.00053527,0.073558,0.46724,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,0.992490986757796
GSE42021_CD24HI_VS_CD24INT_T...4,SET,180,0.0052003,0.00051237,0.063279,0.46725,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP,0.992490986757796
GOBP_TERTIARY_ALCOHOL_METABO...,SET,22,0.017131,0.00059264,0.2089,0.46732,GOBP_TERTIARY_ALCOHOL_METABOLIC_PROCESS,0.992490986757796
GOBP_VESICLE_TARGETING_TO_FR...,SET,31,0.011322,0.00046484,0.13816,0.46734,GOBP_VESICLE_TARGETING_TO_FROM_OR_WITHIN_GOLGI,0.992490986757796
GSE27241_CTRL_VS_DIGOXIN_TRE...2,SET,145,0.0058421,0.00051711,0.071349,0.46737,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,0.992490986757796
MODULE_346,SET,17,0.018148,0.00055196,0.22188,0.46741,MODULE_346,0.992490986757796
MIR6882_5P,SET,154,0.005558,0.00050688,0.068035,0.46745,MIR6882_5P,0.992490986757796
HP_ABNORMALITY_OF_THE_LIVER,SET,984,0.0022315,0.00050256,0.027325,0.46746,HP_ABNORMALITY_OF_THE_LIVER,0.992490986757796
MYLLYKANGAS_AMPLIFICATION_HO...3,SET,9,0.024695,0.00054662,0.30267,0.46749,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16,0.992490986757796
GOBP_LEUKOCYTE_ACTIVATION_IN...,SET,48,0.010817,0.00055232,0.13272,0.46752,GOBP_LEUKOCYTE_ACTIVATION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.992490986757796
WP_TAR_SYNDROME,SET,49,0.0099137,0.00051145,0.12169,0.46754,WP_TAR_SYNDROME,0.992490986757796
GSE37533_PPARG1_FOXP3_VS_PPA...2,SET,189,0.0052374,0.00052863,0.064294,0.46754,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.992490986757796
MIR939_3P,SET,138,0.0055891,0.00048272,0.068645,0.46755,MIR939_3P,0.992490986757796
MODULE_539,SET,15,0.018721,0.00053486,0.22987,0.46755,MODULE_539,0.992490986757796
WEI_MIR34A_TARGETS,SET,136,0.0060294,0.00051699,0.074162,0.4676,WEI_MIR34A_TARGETS,0.992490986757796
HP_ELEVATED_URINARY_DELTA_AM...,SET,5,0.03491,0.00057601,0.42984,0.46764,HP_ELEVATED_URINARY_DELTA_AMINOLEVULINIC_ACID,0.992490986757796
GOBP_MITOCHONDRIAL_PROTON_TR...,SET,5,0.032052,0.00052886,0.39531,0.46769,GOBP_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_ASSEMBLY,0.992490986757796
ZBTB18_TARGET_GENES,SET,670,0.0026442,0.0004958,0.032622,0.4677,ZBTB18_TARGET_GENES,0.992490986757796
GOBP_SHORT_CHAIN_FATTY_ACID_...2,SET,15,0.017373,0.00049636,0.21434,0.4677,GOBP_SHORT_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.992490986757796
HP_PRIMARY_MICROCEPHALY,SET,67,0.0076641,0.00046212,0.094595,0.46771,HP_PRIMARY_MICROCEPHALY,0.992490986757796
HP_ABNORMALITY_OF_JOINT_MOBI...,SET,1163,0.0020397,0.00049683,0.025183,0.46772,HP_ABNORMALITY_OF_JOINT_MOBILITY,0.992490986757796
GSE36476_YOUNG_VS_OLD_DONOR_...2,SET,174,0.0050898,0.00049313,0.062906,0.46776,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP,0.992490986757796
GOMF_CELL_CELL_ADHESION_MEDI...,SET,50,0.010741,0.00055975,0.13279,0.46777,GOMF_CELL_CELL_ADHESION_MEDIATOR_ACTIVITY,0.992490986757796
GOBP_EMBRYO_DEVELOPMENT_ENDI...,SET,642,0.0027617,0.0005073,0.034209,0.46783,GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING,0.992490986757796
WP_PROSTAGLANDIN_AND_LEUKOTR...1,SET,29,0.013374,0.00053111,0.1659,0.46787,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,0.992490986757796
REACTOME_DNA_REPLICATION_PRE...,SET,94,0.0062765,0.00044794,0.077945,0.46791,REACTOME_DNA_REPLICATION_PRE_INITIATION,0.992490986757796
GSE4142_NAIVE_VS_MEMORY_BCEL...2,SET,184,0.0052387,0.0005218,0.065063,0.46791,GSE4142_NAIVE_VS_MEMORY_BCELL_UP,0.992490986757796
GOCC_MEMBRANE_PROTEIN_COMPLEX,SET,1152,0.002085,0.0005056,0.025914,0.46794,GOCC_MEMBRANE_PROTEIN_COMPLEX,0.992490986757796
GOMF_TYPE_5_METABOTROPIC_GLU...,SET,6,0.029461,0.00053249,0.36617,0.46794,GOMF_TYPE_5_METABOTROPIC_GLUTAMATE_RECEPTOR_BINDING,0.992490986757796
GOBP_STEROID_BIOSYNTHETIC_PR...,SET,166,0.0053664,0.00050795,0.066742,0.46796,GOBP_STEROID_BIOSYNTHETIC_PROCESS,0.992490986757796
CASORELLI_ACUTE_PROMYELOCYTI...1,SET,590,0.0027367,0.00048264,0.034146,0.46806,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN,0.992642500610203
GSE37301_COMMON_LYMPHOID_PRO...3,SET,170,0.0052314,0.00050104,0.06554,0.46819,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,0.992857614863628
WP_TGIF_DISRUPTION_OF_SHH_SI...,SET,9,0.023273,0.00051513,0.29259,0.4683,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,0.992933396341463
MIR1233_5P,SET,94,0.0066629,0.00047552,0.083782,0.46831,MIR1233_5P,0.992933396341463
GSE13411_SWITCHED_MEMORY_BCE...2,SET,178,0.004958,0.0004858,0.062455,0.46836,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP,0.992933396341463
HATADA_METHYLATED_IN_LUNG_CA...2,SET,350,0.0037102,0.00050734,0.046741,0.46837,HATADA_METHYLATED_IN_LUNG_CANCER_UP,0.992933396341463
HE_LIM_SUN_FETAL_LUNG_C2_DC1...,SET,291,0.0039746,0.00049639,0.050148,0.46841,HE_LIM_SUN_FETAL_LUNG_C2_DC1_CELL,0.992933396341463
PARK_TRETINOIN_RESPONSE_AND_...1,SET,27,0.013437,0.00051489,0.16988,0.46848,PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,0.992933396341463
HP_INCREASED_BONE_MINERAL_DE...,SET,95,0.0070608,0.00050657,0.08929,0.46849,HP_INCREASED_BONE_MINERAL_DENSITY,0.992933396341463
MORF_TTN,SET,45,0.010187,0.00050368,0.12889,0.4685,MORF_TTN,0.992933396341463
WP_NF1_COPY_NUMBER_VARIATION...,SET,74,0.0084033,0.0005324,0.10638,0.46852,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,0.992933396341463
MODULE_245,SET,25,0.013323,0.00049128,0.16879,0.46854,MODULE_245,0.992933396341463
GOBP_SKELETAL_SYSTEM_DEVELOP...,SET,484,0.0032837,0.00052606,0.041599,0.46854,GOBP_SKELETAL_SYSTEM_DEVELOPMENT,0.992933396341463
GOBP_MICROTUBULE_POLYMERIZAT...2,SET,124,0.0055976,0.00045845,0.070991,0.46858,GOBP_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.9929576184379
HP_ABNORMAL_HUMERUS_MORPHOLO...,SET,14,0.017313,0.00047789,0.22004,0.46864,HP_ABNORMAL_HUMERUS_MORPHOLOGY,0.99296367737609
HP_CALCIFICATION_OF_FALX_CER...,SET,7,0.023436,0.00045751,0.2978,0.46864,HP_CALCIFICATION_OF_FALX_CEREBRI,0.99296367737609
MIR6876_3P,SET,49,0.010114,0.00052181,0.12878,0.4687,MIR6876_3P,0.992990920451082
MYLLYKANGAS_AMPLIFICATION_HO...13,SET,8,0.02553,0.00053279,0.3252,0.46871,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29,0.992990920451082
BYSTRYKH_HEMATOPOIESIS_STEM_...1,SET,64,0.0074494,0.00043904,0.095362,0.46887,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS,0.993169453924915
MIR96_5P,SET,414,0.003325,0.00049363,0.042571,0.46887,MIR96_5P,0.993169453924915
GOBP_REGULATION_OF_PROTEIN_M...1,SET,62,0.0080477,0.00046686,0.10307,0.46888,GOBP_REGULATION_OF_PROTEIN_MATURATION,0.993169453924915
HALLMARK_HEDGEHOG_SIGNALING,SET,33,0.012356,0.00052336,0.15841,0.46891,HALLMARK_HEDGEHOG_SIGNALING,0.993172469376562
GCM_HBP1,SET,63,0.0077566,0.00045357,0.099836,0.46904,GCM_HBP1,0.993387276051188
GSE17721_LPS_VS_PAM3CSK4_4H_...2,SET,189,0.0047865,0.00048312,0.061703,0.46908,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP,0.993411455730912
chr10p15,SET,30,0.018577,0.00075031,0.23971,0.46911,chr10p15,0.993414455885937
chr12q15,SET,23,0.023947,0.00084701,0.30932,0.46915,chr12q15,0.993438630963261
GOBP_NEURON_INTRINSIC_APOPTO...,SET,18,0.016129,0.00050477,0.20923,0.46928,GOBP_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS,0.993635181236674
GSE24142_EARLY_THYMIC_PROGEN...6,SET,188,0.0050723,0.00051062,0.065854,0.4693,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP,0.993635181236674
DESCARTES_FETAL_HEART_VISCER...,SET,73,0.0079293,0.00049898,0.10315,0.46936,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,0.993668289786223
GSE5542_IFNG_VS_IFNA_AND_IFN...4,SET,166,0.0048355,0.00045769,0.062985,0.4694,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.993668289786223
GSE33292_DN3_THYMOCYTE_VS_TC...2,SET,154,0.004786,0.00043647,0.062355,0.46941,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP,0.993668289786223
REACTOME_SIGNALING_BY_TGF_BE...1,SET,91,0.0064693,0.00045431,0.084345,0.46943,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,0.993668289786223
MIR4311,SET,325,0.0035507,0.00046819,0.046371,0.46948,MIR4311,0.99367425552646
GOBP_ESTABLISHMENT_OF_LEFT_R...,SET,5,0.025026,0.00041293,0.32689,0.46949,GOBP_ESTABLISHMENT_OF_LEFT_RIGHT_ASYMMETRY,0.99367425552646
HP_ABNORMAL_RETINAL_VASCULAR...,SET,226,0.0042929,0.00047333,0.056132,0.46952,HP_ABNORMAL_RETINAL_VASCULAR_MORPHOLOGY,0.993677237851662
GOCC_PERICENTRIOLAR_MATERIAL,SET,21,0.012293,0.00041551,0.16116,0.4696,GOCC_PERICENTRIOLAR_MATERIAL,0.993707342465753
GNF2_CASP1,SET,102,0.0064661,0.0004806,0.084786,0.46961,GNF2_CASP1,0.993707342465753
PAX3_B,SET,83,0.0076548,0.0005135,0.10043,0.46962,PAX3_B,0.993707342465753
GOBP_POST_TRANSCRIPTIONAL_RE...,SET,465,0.002956,0.00046442,0.038896,0.46971,GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION,0.993785696895922
GSE14769_40MIN_VS_360MIN_LPS...2,SET,179,0.0045731,0.00044932,0.060274,0.46976,GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP,0.993785696895922
GOMF_CELL_ADHESION_MEDIATOR_...,SET,63,0.008855,0.0005178,0.11678,0.46978,GOMF_CELL_ADHESION_MEDIATOR_ACTIVITY,0.993785696895922
GSE17721_PAM3CSK4_VS_GADIQUI...7,SET,178,0.0047373,0.00046418,0.062472,0.46978,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_DN,0.993785696895922
NR4A2_TARGET_GENES,SET,4,0.034426,0.00050807,0.45428,0.4698,NR4A2_TARGET_GENES,0.993785696895922
GOBP_REGULATION_OF_ANGIOTENS...,SET,8,0.024352,0.0005082,0.32196,0.46985,GOBP_REGULATION_OF_ANGIOTENSIN_LEVELS_IN_BLOOD,0.99380913347522
MORF_BRCA1,SET,242,0.0039345,0.00044871,0.052069,0.46988,MORF_BRCA1,0.99380913347522
GSE3982_NKCELL_VS_TH1_UP,SET,172,0.0050443,0.00048593,0.066955,0.46997,GSE3982_NKCELL_VS_TH1_UP,0.99380913347522
GOMF_PROTEIN_LYSINE_DEACETYL...,SET,21,0.013362,0.00045164,0.17748,0.46999,GOMF_PROTEIN_LYSINE_DEACETYLASE_ACTIVITY,0.99380913347522
P53_02,SET,228,0.00423,0.00046843,0.056212,0.47001,P53_02,0.99380913347522
HP_ULNAR_DEVIATION_OF_THE_WR...,SET,19,0.016641,0.00053504,0.22127,0.47002,HP_ULNAR_DEVIATION_OF_THE_WRIST,0.99380913347522
HP_SHORT_CLAVICLES,SET,29,0.01118,0.00044397,0.14879,0.47005,HP_SHORT_CLAVICLES,0.99380913347522
GSE22935_UNSTIM_VS_12H_MBOVI...4,SET,187,0.0047509,0.00047701,0.063226,0.47005,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.99380913347522
GOBP_NEGATIVE_REGULATION_OF_...189,SET,29,0.010975,0.00043584,0.1464,0.47012,GOBP_NEGATIVE_REGULATION_OF_DNA_REPAIR,0.99380913347522
GOBP_POSITIVE_REGULATION_OF_...574,SET,106,0.0063003,0.00047732,0.084139,0.47016,GOBP_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION,0.99380913347522
DESCARTES_FETAL_ADRENAL_MYEL...,SET,151,0.0055538,0.00050158,0.074227,0.47018,DESCARTES_FETAL_ADRENAL_MYELOID_CELLS,0.99380913347522
HP_ABNORMAL_OOCYTE_MORPHOLOGY,SET,6,0.024392,0.00044086,0.32627,0.4702,HP_ABNORMAL_OOCYTE_MORPHOLOGY,0.99380913347522
MIR6086,SET,49,0.0087725,0.00045258,0.11744,0.47023,MIR6086,0.99380913347522
HP_ABNORMAL_POSTURING,SET,5,0.025645,0.00042313,0.34339,0.47023,HP_ABNORMAL_POSTURING,0.99380913347522
AKT_UP_MTOR_DN.V1_DN,SET,173,0.0047333,0.00045728,0.063387,0.47024,AKT_UP_MTOR_DN.V1_DN,0.99380913347522
WP_CODEINE_AND_MORPHINE_META...,SET,14,0.017147,0.00047329,0.23069,0.47038,WP_CODEINE_AND_MORPHINE_METABOLISM,0.994014127659575
MODULE_474,SET,13,0.019597,0.00052125,0.26399,0.47041,MODULE_474,0.994014127659575
REACTOME_INWARDLY_RECTIFYING...,SET,35,0.011674,0.00050922,0.15757,0.47047,REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,0.994014127659575
GOBP_SCHWANN_CELL_MIGRATION,SET,5,0.03086,0.00050919,0.41659,0.47047,GOBP_SCHWANN_CELL_MIGRATION,0.994014127659575
HP_AUTOAMPUTATION_OF_DIGITS,SET,13,0.016799,0.00044685,0.22681,0.47048,HP_AUTOAMPUTATION_OF_DIGITS,0.994014127659575
BHATI_G2M_ARREST_BY_2METHOXY...2,SET,107,0.0060172,0.000458,0.081363,0.47052,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,0.994038210443134
REACTOME_RAB_GEFS_EXCHANGE_G...,SET,82,0.0067025,0.00044691,0.09079,0.47058,REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,0.9940470736599
GOMF_OLIGOSACCHARYL_TRANSFER...,SET,5,0.028441,0.00046927,0.38573,0.47061,GOMF_OLIGOSACCHARYL_TRANSFERASE_ACTIVITY,0.9940470736599
HP_SKIN_DIMPLE,SET,102,0.0065939,0.0004901,0.089429,0.47061,HP_SKIN_DIMPLE,0.9940470736599
HP_ABNORMAL_PERISTALSIS,SET,21,0.013276,0.00044871,0.1802,0.47064,HP_ABNORMAL_PERISTALSIS,0.994050027347311
GOBP_NEGATIVE_REGULATION_OF_...179,SET,82,0.0071703,0.00047811,0.097567,0.47071,GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,0.994137460500729
GOBP_REGULATION_OF_HEMOGLOBI...,SET,8,0.021374,0.00044605,0.29199,0.47082,GOBP_REGULATION_OF_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.994309357720119
GOMF_CCR2_CHEMOKINE_RECEPTOR...,SET,5,0.032206,0.0005314,0.44046,0.47086,GOMF_CCR2_CHEMOKINE_RECEPTOR_BINDING,0.994333412322275
KUROKAWA_LIVER_CANCER_EARLY_...1,SET,6,0.028045,0.0005069,0.38437,0.47092,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN,0.994363944815039
GOBP_NEGATIVE_REGULATION_OF_...344,SET,88,0.0071339,0.00049269,0.097942,0.47097,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.994363944815039
GOBP_RESPONSE_TO_ENDOGENOUS_...,SET,1522,0.001682,0.00046377,0.023183,0.47108,GOBP_RESPONSE_TO_ENDOGENOUS_STIMULUS,0.994363944815039
NIKOLSKY_BREAST_CANCER_19Q13...2,SET,7,0.0337,0.00065788,0.46477,0.4711,NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON,0.994363944815039
HP_SEVERE_EPSTEIN_BARR_VIRUS...,SET,4,0.034672,0.00051169,0.47828,0.47111,HP_SEVERE_EPSTEIN_BARR_VIRUS_INFECTION,0.994363944815039
GOCC_FILTRATION_DIAPHRAGM,SET,9,0.021967,0.00048622,0.30317,0.47112,GOCC_FILTRATION_DIAPHRAGM,0.994363944815039
GSE3982_CTRL_VS_LPS_4H_MAC_DN,SET,187,0.0045924,0.00046109,0.063406,0.47113,GSE3982_CTRL_VS_LPS_4H_MAC_DN,0.994363944815039
GOBP_NON_PROTEINOGENIC_AMINO...3,SET,68,0.0072321,0.00043931,0.1,0.47117,GOBP_NON_PROTEINOGENIC_AMINO_ACID_METABOLIC_PROCESS,0.994363944815039
WP_METHIONINE_METABOLISM_LEA...,SET,10,0.021568,0.00050319,0.29853,0.4712,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,0.994363944815039
DESCARTES_FETAL_KIDNEY_STROM...,SET,123,0.0058828,0.00047987,0.081546,0.47125,DESCARTES_FETAL_KIDNEY_STROMAL_CELLS,0.994363944815039
MIR4693_5P,SET,100,0.0061814,0.00045494,0.085727,0.47126,MIR4693_5P,0.994363944815039
DESCARTES_FETAL_CEREBELLUM_M...,SET,487,0.0029593,0.00047552,0.041086,0.47129,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,0.994363944815039
HP_OPTIC_NERVE_DYSPLASIA,SET,6,0.026765,0.00048375,0.37238,0.47135,HP_OPTIC_NERVE_DYSPLASIA,0.994363944815039
MODULE_239,SET,109,0.0056929,0.00043733,0.079373,0.47141,MODULE_239,0.994363944815039
GSE2405_HEAT_KILLED_LYSATE_V...1,SET,182,0.0044914,0.00044495,0.062626,0.47141,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,0.994363944815039
GSE6259_FLT3L_INDUCED_DEC205...6,SET,134,0.0051636,0.00043951,0.072057,0.47144,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP,0.994363944815039
GSE15330_LYMPHOID_MULTIPOTEN...5,SET,190,0.004339,0.0004391,0.060626,0.47147,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.994363944815039
HP_DACRYOCYSTITIS,SET,7,0.023179,0.0004525,0.32404,0.47149,HP_DACRYOCYSTITIS,0.994363944815039
GSE40273_XBP1_KO_VS_WT_TREG_...2,SET,185,0.0044403,0.00044345,0.062153,0.47152,GSE40273_XBP1_KO_VS_WT_TREG_UP,0.994363944815039
GOBP_SENSORY_PERCEPTION_OF_S...1,SET,331,0.0047223,0.0006283,0.066143,0.47154,GOBP_SENSORY_PERCEPTION_OF_SMELL,0.994363944815039
GOBP_POSITIVE_REGULATION_OF_...227,SET,80,0.0065477,0.00043126,0.091852,0.47159,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,0.994363944815039
GOBP_PHAGOCYTOSIS_RECOGNITION,SET,27,0.012898,0.00049424,0.18111,0.47161,GOBP_PHAGOCYTOSIS_RECOGNITION,0.994363944815039
HP_BRACHYDACTYLY,SET,337,0.0032622,0.00043788,0.045903,0.47167,HP_BRACHYDACTYLY,0.994363944815039
GSE21033_1H_VS_24H_POLYIC_ST...1,SET,152,0.0048188,0.00043663,0.067846,0.47169,GSE21033_1H_VS_24H_POLYIC_STIM_DC_DN,0.994363944815039
HP_ABNORMAL_CARDIAC_SEPTUM_M...,SET,657,0.0023423,0.00043508,0.032993,0.4717,HP_ABNORMAL_CARDIAC_SEPTUM_MORPHOLOGY,0.994363944815039
KEGG_MEDICUS_VARIANT_MUTATIO...75,SET,11,0.017494,0.00042807,0.24673,0.47174,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_P62_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,0.994363944815039
GOBP_FRUCTOSE_2_6_BISPHOSPHA...,SET,4,0.024458,0.00036095,0.34498,0.47174,GOBP_FRUCTOSE_2_6_BISPHOSPHATE_METABOLIC_PROCESS,0.994363944815039
GOMF_FRUCTOSE_2_6_BISPHOSPHA...,SET,4,0.024458,0.00036095,0.34498,0.47174,GOMF_FRUCTOSE_2_6_BISPHOSPHATE_2_PHOSPHATASE_ACTIVITY,0.994363944815039
HP_HASHIMOTO_THYROIDITIS,SET,15,0.015007,0.00042877,0.21166,0.47174,HP_HASHIMOTO_THYROIDITIS,0.994363944815039
KEGG_MEDICUS_REFERENCE_ERK_R...,SET,4,0.032234,0.00047571,0.45521,0.47177,KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING,0.994363944815039
MIR4732_5P,SET,18,0.013261,0.000415,0.1873,0.47178,MIR4732_5P,0.994363944815039
KEGG_MEDICUS_VARIANT_MUTATIO...26,SET,23,0.013495,0.00047734,0.19069,0.47179,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.994363944815039
GOCC_GUANYL_NUCLEOTIDE_EXCHA...,SET,22,0.012229,0.00042304,0.17308,0.47184,GOCC_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_COMPLEX,0.994399518159369
GOBP_CIRCULATORY_SYSTEM_DEVE...,SET,1046,0.0019585,0.00045394,0.027829,0.47195,GOBP_CIRCULATORY_SYSTEM_DEVELOPMENT,0.994399518159369
HP_WEBBED_NECK,SET,104,0.0056254,0.00042217,0.079967,0.47196,HP_WEBBED_NECK,0.994399518159369
JAZAERI_BREAST_CANCER_BRCA1_...1,SET,40,0.010118,0.00047176,0.1439,0.47197,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN,0.994399518159369
GOBP_POSITIVE_REGULATION_OF_...137,SET,32,0.0096083,0.00040077,0.13689,0.47202,GOBP_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS,0.994399518159369
HP_ABNORMAL_SIZE_OF_THE_PALP...,SET,259,0.0036469,0.00043007,0.052033,0.47206,HP_ABNORMAL_SIZE_OF_THE_PALPEBRAL_FISSURES,0.994399518159369
GOCC_CLATHRIN_COATED_VESICLE...,SET,123,0.0055717,0.0004545,0.079504,0.47207,GOCC_CLATHRIN_COATED_VESICLE_MEMBRANE,0.994399518159369
HP_BLEEDING_WITH_MINOR_OR_NO...,SET,7,0.023503,0.00045882,0.3362,0.47213,HP_BLEEDING_WITH_MINOR_OR_NO_TRAUMA,0.994399518159369
GSE360_DC_VS_MAC_B_MALAYI_LO...1,SET,175,0.004333,0.000421,0.062059,0.47217,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN,0.994399518159369
LI_ESTROGENE_MCF7_E2_RESPONS...2,SET,46,0.0091615,0.00045799,0.13126,0.47218,LI_ESTROGENE_MCF7_E2_RESPONSE_UP,0.994399518159369
MIR554,SET,16,0.014335,0.00042297,0.20555,0.4722,MIR554,0.994399518159369
HP_ABNORMAL_EOSINOPHIL_MORPH...,SET,65,0.0074281,0.00044118,0.10651,0.4722,HP_ABNORMAL_EOSINOPHIL_MORPHOLOGY,0.994399518159369
GOBP_POSITIVE_REGULATION_OF_...109,SET,13,0.015528,0.00041302,0.22314,0.47226,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPIRATION,0.994399518159369
MIR3130_5P,SET,49,0.0081982,0.00042295,0.11819,0.47235,MIR3130_5P,0.994399518159369
GSE18893_CTRL_VS_TNF_TREATED...3,SET,178,0.004184,0.00040996,0.060314,0.47235,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN,0.994399518159369
HP_RESPIRATORY_ARREST,SET,27,0.011377,0.00043597,0.16467,0.47246,HP_RESPIRATORY_ARREST,0.994399518159369
REACTOME_IMMUNOREGULATORY_IN...,SET,114,0.0060638,0.00047632,0.087791,0.47247,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,0.994399518159369
MEIS1AHOXA9_01,SET,107,0.0062036,0.00047219,0.089865,0.47248,MEIS1AHOXA9_01,0.994399518159369
GOBP_AMINO_ACID_BETAINE_TRAN...,SET,12,0.01948,0.00049783,0.28218,0.47248,GOBP_AMINO_ACID_BETAINE_TRANSPORT,0.994399518159369
HP_LOWER_EXTREMITY_JOINT_DIS...,SET,271,0.0035475,0.00042779,0.051384,0.47248,HP_LOWER_EXTREMITY_JOINT_DISLOCATION,0.994399518159369
THEODOROU_MAMMARY_TUMORIGENE...,SET,27,0.012998,0.00049806,0.18862,0.47253,THEODOROU_MAMMARY_TUMORIGENESIS,0.994399518159369
GOBP_ONCOGENE_INDUCED_CELL_S...,SET,6,0.02038,0.00036835,0.29591,0.47255,GOBP_ONCOGENE_INDUCED_CELL_SENESCENCE,0.994399518159369
MIR6790_5P,SET,46,0.0092508,0.00046245,0.1348,0.47264,MIR6790_5P,0.994399518159369
GOBP_ICOSANOID_BIOSYNTHETIC_...,SET,50,0.0080722,0.00042067,0.11765,0.47265,GOBP_ICOSANOID_BIOSYNTHETIC_PROCESS,0.994399518159369
PID_ANTHRAX_PATHWAY,SET,17,0.013985,0.00042534,0.20397,0.47267,PID_ANTHRAX_PATHWAY,0.994399518159369
HP_LEFT_VENTRICULAR_OUTFLOW_...,SET,8,0.023625,0.00049304,0.34477,0.47268,HP_LEFT_VENTRICULAR_OUTFLOW_TRACT_OBSTRUCTION,0.994399518159369
GSE9006_TYPE_1_DIABETES_AT_D...2,SET,182,0.0040661,0.00040281,0.059534,0.47277,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP,0.994399518159369
GNF2_ELAC2,SET,40,0.0081878,0.00038175,0.1199,0.47278,GNF2_ELAC2,0.994399518159369
GSE5589_IL6_KO_VS_IL10_KO_LP...5,SET,179,0.0043703,0.0004294,0.064177,0.47285,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.994399518159369
GOCC_NUCLEOTIDE_EXCISION_REP...,SET,11,0.013284,0.00032505,0.19522,0.47287,GOCC_NUCLEOTIDE_EXCISION_REPAIR_COMPLEX,0.994399518159369
ALCALAY_AML_BY_NPM1_LOCALIZA...2,SET,123,0.0054902,0.00044785,0.080691,0.47288,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,0.994399518159369
GOBP_ADENOSINE_METABOLIC_PRO...,SET,9,0.022051,0.00048808,0.32416,0.47288,GOBP_ADENOSINE_METABOLIC_PROCESS,0.994399518159369
GOBP_CELLULAR_RESPONSE_TO_NI...3,SET,11,0.017427,0.00042643,0.25613,0.47288,GOBP_CELLULAR_RESPONSE_TO_NITROGEN_LEVELS,0.994399518159369
GSE17721_CTRL_VS_POLYIC_4H_B...1,SET,183,0.0042138,0.00041858,0.061932,0.47288,GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN,0.994399518159369
GCM_ERBB2IP,SET,59,0.0072305,0.00040921,0.10634,0.4729,GCM_ERBB2IP,0.994399518159369
HP_ABNORMAL_PROSODY,SET,61,0.0076558,0.00044054,0.11296,0.47298,HP_ABNORMAL_PROSODY,0.994399518159369
HP_ABNORMALITY_OF_FLUID_REGU...,SET,705,0.0022474,0.00043185,0.033212,0.47302,HP_ABNORMALITY_OF_FLUID_REGULATION,0.994399518159369
GOBP_NERVE_DEVELOPMENT,SET,92,0.0063645,0.00044939,0.094262,0.47308,GOBP_NERVE_DEVELOPMENT,0.994399518159369
GCTCTTG_MIR335,SET,80,0.0060358,0.00039754,0.089427,0.47309,GCTCTTG_MIR335,0.994399518159369
GOBP_REGULATION_OF_NEUTROPHI...4,SET,4,0.030321,0.00044749,0.44913,0.47309,GOBP_REGULATION_OF_NEUTROPHIL_EXTRAVASATION,0.994399518159369
GOMF_CIS_TRANS_ISOMERASE_ACT...,SET,37,0.008491,0.00038078,0.12583,0.4731,GOMF_CIS_TRANS_ISOMERASE_ACTIVITY,0.994399518159369
MPHOSPH8_TARGET_GENES,SET,7,0.022101,0.00043144,0.32808,0.47315,MPHOSPH8_TARGET_GENES,0.994399518159369
GOBP_POSITIVE_REGULATION_OF_...420,SET,22,0.012391,0.00042866,0.18412,0.47317,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,0.994399518159369
GOCC_PLASMA_MEMBRANE_PROTEIN...,SET,566,0.0025862,0.00044701,0.03844,0.47318,GOCC_PLASMA_MEMBRANE_PROTEIN_COMPLEX,0.994399518159369
WP_REGULATION_OF_WNT_BCATENI...,SET,16,0.015311,0.00045178,0.22772,0.4732,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,0.994399518159369
WP_SEROTONIN_TRANSPORTER_ACT...,SET,10,0.017884,0.00041726,0.26597,0.4732,WP_SEROTONIN_TRANSPORTER_ACTIVITY,0.994399518159369
REACTOME_ATTACHMENT_OF_GPI_A...,SET,7,0.018326,0.00035776,0.27359,0.4733,REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR,0.994399518159369
HP_BLEPHAROPHIMOSIS,SET,111,0.0056033,0.00043435,0.083769,0.47333,HP_BLEPHAROPHIMOSIS,0.994399518159369
REACTOME_INTERLEUKIN_20_FAMI...,SET,26,0.012012,0.0004517,0.1796,0.47334,REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING,0.994399518159369
MIR196A_1_3P,SET,358,0.0030787,0.00042568,0.046092,0.47337,MIR196A_1_3P,0.994399518159369
GOBP_B_1_B_CELL_DIFFERENTIAT...,SET,5,0.027949,0.00046115,0.41861,0.47338,GOBP_B_1_B_CELL_DIFFERENTIATION,0.994399518159369
HP_HYPOINTENSITY_OF_CEREBRAL...,SET,12,0.016325,0.00041721,0.24483,0.47342,HP_HYPOINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI,0.994399518159369
VALK_AML_CLUSTER_8,SET,22,0.012274,0.00042461,0.18434,0.47346,VALK_AML_CLUSTER_8,0.994399518159369
GOMF_HSP90_PROTEIN_BINDING,SET,38,0.0087939,0.00039965,0.13208,0.47346,GOMF_HSP90_PROTEIN_BINDING,0.994399518159369
GOBP_PROTEIN_LOCALIZATION_TO...10,SET,62,0.0072039,0.00041791,0.10836,0.4735,GOBP_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,0.994399518159369
SRPK1_TARGET_GENES,SET,304,0.0031409,0.0004008,0.047306,0.47353,SRPK1_TARGET_GENES,0.994399518159369
GOBP_POINTED_END_ACTIN_FILAM...,SET,7,0.018303,0.00035731,0.27576,0.47354,GOBP_POINTED_END_ACTIN_FILAMENT_CAPPING,0.994399518159369
GOBP_NEGATIVE_REGULATION_OF_...320,SET,32,0.0098914,0.00041258,0.14947,0.47362,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.994399518159369
HP_ABNORMAL_EAR_MORPHOLOGY,SET,1420,0.0015155,0.00040484,0.023015,0.47375,HP_ABNORMAL_EAR_MORPHOLOGY,0.994399518159369
ANDERSEN_CHOLANGIOCARCINOMA_...1,SET,58,0.0075223,0.00042211,0.11434,0.47377,ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,0.994399518159369
WP_PHOTODYNAMIC_THERAPYINDUC...1,SET,48,0.0083248,0.00042509,0.12699,0.47387,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,0.994399518159369
STAT3_01,SET,21,0.011527,0.00038962,0.17591,0.47388,STAT3_01,0.994399518159369
chr2q37,SET,107,0.010202,0.0007765,0.15573,0.47389,chr2q37,0.994399518159369
GOMF_SPLICING_FACTOR_BINDING,SET,5,0.022536,0.00037184,0.34408,0.47389,GOMF_SPLICING_FACTOR_BINDING,0.994399518159369
FIGUEROA_AML_METHYLATION_CLU...6,SET,151,0.0046126,0.00041657,0.07053,0.47393,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,0.994399518159369
GOMF_PRENYLTRANSFERASE_ACTIV...,SET,16,0.012869,0.00037972,0.19717,0.47398,GOMF_PRENYLTRANSFERASE_ACTIVITY,0.994399518159369
GOMF_VITAMIN_BINDING,SET,133,0.0049046,0.00041591,0.07523,0.47401,GOMF_VITAMIN_BINDING,0.994399518159369
HP_RAPIDLY_PROGRESSIVE,SET,34,0.0090255,0.00038803,0.1385,0.47402,HP_RAPIDLY_PROGRESSIVE,0.994399518159369
HP_DECREASED_DISTAL_SENSORY_...,SET,9,0.019507,0.00043178,0.3002,0.47409,HP_DECREASED_DISTAL_SENSORY_NERVE_ACTION_POTENTIAL,0.994399518159369
HP_CARDIOVASCULAR_CALCIFICAT...,SET,36,0.0094627,0.00041859,0.14596,0.47416,HP_CARDIOVASCULAR_CALCIFICATION,0.994399518159369
HP_ABNORMAL_CIRCULATING_T4_C...,SET,24,0.011145,0.00040266,0.17201,0.47417,HP_ABNORMAL_CIRCULATING_T4_CONCENTRATION,0.994399518159369
NABA_MATRISOME_HIGHLY_METAST...1,SET,37,0.008587,0.00038509,0.13261,0.47419,NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER,0.994399518159369
HP_INCREASED_SERUM_TESTOSTER...,SET,10,0.018367,0.00042852,0.28496,0.4743,HP_INCREASED_SERUM_TESTOSTERONE_LEVEL,0.994399518159369
GOMF_PURINE_NUCLEOTIDE_BINDI...,SET,1797,0.0013239,0.00039339,0.020543,0.47431,GOMF_PURINE_NUCLEOTIDE_BINDING,0.994399518159369
ZHANG_BREAST_CANCER_PROGENIT...1,SET,131,0.0046911,0.00039483,0.072916,0.47435,ZHANG_BREAST_CANCER_PROGENITORS_DN,0.994399518159369
HP_STAGE_5_CHRONIC_KIDNEY_DI...,SET,124,0.0047106,0.00038581,0.07321,0.47435,HP_STAGE_5_CHRONIC_KIDNEY_DISEASE,0.994399518159369
HP_CHRONIC_RHINITIS,SET,49,0.0074482,0.00038425,0.11588,0.47438,HP_CHRONIC_RHINITIS,0.994399518159369
GSE13411_NAIVE_VS_IGM_MEMORY...1,SET,183,0.0039525,0.00039262,0.061536,0.47439,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN,0.994399518159369
HP_FAIR_HAIR,SET,17,0.013586,0.00041322,0.21159,0.4744,HP_FAIR_HAIR,0.994399518159369
GSE46606_DAY1_VS_DAY3_CD40L_...7,SET,179,0.003954,0.0003885,0.061625,0.47442,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN,0.994399518159369
GOBP_NEUTRAL_AMINO_ACID_TRAN...,SET,54,0.0075309,0.00040781,0.11744,0.47444,GOBP_NEUTRAL_AMINO_ACID_TRANSPORT,0.994399518159369
GSE2585_CTEC_VS_MTEC_THYMUS_...2,SET,176,0.0040078,0.0003905,0.062557,0.47446,GSE2585_CTEC_VS_MTEC_THYMUS_UP,0.994399518159369
GOBP_ATRIOVENTRICULAR_VALVE_...2,SET,8,0.021115,0.00044065,0.33032,0.47452,GOBP_ATRIOVENTRICULAR_VALVE_FORMATION,0.994399518159369
GSE7460_WT_VS_FOXP3_HET_ACT_...3,SET,176,0.0040302,0.00039268,0.063076,0.47453,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN,0.994399518159369
MILI_PSEUDOPODIA,SET,41,0.0080692,0.00038088,0.12655,0.47458,MILI_PSEUDOPODIA,0.994399518159369
GTGGGTGK_UNKNOWN,SET,264,0.0033821,0.00040262,0.053079,0.4746,GTGGGTGK_UNKNOWN,0.994399518159369
KEGG_T_CELL_RECEPTOR_SIGNALI...,SET,102,0.0053739,0.00039942,0.084423,0.47462,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.994399518159369
GSE13887_RESTING_VS_NO_TREAT...1,SET,93,0.0054781,0.00038888,0.086064,0.47462,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_DN,0.994399518159369
PTTG1_TARGET_GENES,SET,55,0.0070793,0.00038688,0.11122,0.47463,PTTG1_TARGET_GENES,0.994399518159369
GSE2585_THYMIC_DC_VS_THYMIC_...2,SET,158,0.0043206,0.00039907,0.068046,0.47469,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP,0.994399518159369
GOBP_LEUKOCYTE_CELL_CELL_ADH...,SET,384,0.0029715,0.00042521,0.04682,0.4747,GOBP_LEUKOCYTE_CELL_CELL_ADHESION,0.994399518159369
HP_SEVERE_FAILURE_TO_THRIVE,SET,16,0.0135,0.00039833,0.21295,0.47473,HP_SEVERE_FAILURE_TO_THRIVE,0.994399518159369
HP_SUBSTANTIA_NIGRA_GLIOSIS,SET,10,0.017324,0.00040418,0.27327,0.47473,HP_SUBSTANTIA_NIGRA_GLIOSIS,0.994399518159369
BIOCARTA_ERBB3_PATHWAY,SET,5,0.02779,0.00045854,0.4387,0.47475,BIOCARTA_ERBB3_PATHWAY,0.994399518159369
MASSARWEH_TAMOXIFEN_RESISTAN...2,SET,509,0.0024151,0.0003965,0.038159,0.47477,MASSARWEH_TAMOXIFEN_RESISTANCE_UP,0.994399518159369
KEGG_MEDICUS_VARIANT_MUTATIO...46,SET,7,0.024006,0.00046863,0.37929,0.47477,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_REST_MEDIATED_TRANSCRIPTIONAL_REPRESSION,0.994399518159369
HOLLEMAN_VINCRISTINE_RESISTA...1,SET,19,0.01216,0.00039097,0.19233,0.47479,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,0.994399518159369
HP_ACCESSORY_SPLEEN,SET,33,0.0082937,0.00035129,0.13116,0.47479,HP_ACCESSORY_SPLEEN,0.994399518159369
HP_CONGENITAL_LOCALIZED_ABSE...,SET,9,0.016343,0.00036173,0.25842,0.47479,HP_CONGENITAL_LOCALIZED_ABSENCE_OF_SKIN,0.994399518159369
WP_INSULIN_SIGNALING,SET,155,0.0042826,0.00039182,0.067762,0.4748,WP_INSULIN_SIGNALING,0.994399518159369
GOBP_POSITIVE_REGULATION_OF_...595,SET,12,0.017513,0.00044757,0.27729,0.47482,GOBP_POSITIVE_REGULATION_OF_PLATELET_AGGREGATION,0.994399518159369
GSE2770_TGFB_AND_IL4_ACT_VS_...1,SET,176,0.0039558,0.00038543,0.062646,0.47483,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,0.994399518159369
MIR500B_3P,SET,76,0.0062205,0.00039938,0.098691,0.47487,MIR500B_3P,0.994399518159369
HP_MIDFACE_RETRUSION,SET,253,0.0032702,0.00038122,0.051901,0.47488,HP_MIDFACE_RETRUSION,0.994399518159369
GSE2770_UNTREATED_VS_TGFB_AN...1,SET,177,0.0039976,0.0003906,0.063583,0.47493,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.994399518159369
GOBP_ELASTIN_CATABOLIC_PROCE...,SET,4,0.031165,0.00045995,0.49595,0.47495,GOBP_ELASTIN_CATABOLIC_PROCESS,0.994399518159369
KORKOLA_TERATOMA,SET,38,0.0090672,0.00041206,0.14434,0.47496,KORKOLA_TERATOMA,0.994399518159369
SANSOM_APC_TARGETS_DN,SET,333,0.0029748,0.00039697,0.047358,0.47496,SANSOM_APC_TARGETS_DN,0.994399518159369
GOBP_VESICLE_COATING,SET,37,0.0079949,0.00035853,0.12731,0.47496,GOBP_VESICLE_COATING,0.994399518159369
GSE43863_NAIVE_VS_MEMORY_TH1...2,SET,153,0.0043813,0.00039828,0.069851,0.47499,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP,0.994399518159369
GSE17721_LPS_VS_GARDIQUIMOD_...10,SET,183,0.0039711,0.00039447,0.063377,0.47502,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP,0.994399518159369
GSE7218_UNSTIM_VS_ANTIGEN_ST...3,SET,104,0.0051136,0.00038376,0.081622,0.47502,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_DN,0.994399518159369
MIR4769_3P,SET,97,0.0053467,0.00038759,0.085415,0.47504,MIR4769_3P,0.994399518159369
REACTOME_RUNX3_REGULATES_YAP...,SET,7,0.021951,0.00042851,0.35116,0.47508,REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION,0.994407641605971
WP_P38_MAPK_SIGNALING,SET,33,0.0091011,0.00038549,0.14605,0.47516,WP_P38_MAPK_SIGNALING,0.994407641605971
GOMF_FERRIC_IRON_BINDING,SET,8,0.020407,0.00042587,0.32768,0.47517,GOMF_FERRIC_IRON_BINDING,0.994407641605971
GOBP_REGULATION_OF_GLUTAMATE...1,SET,6,0.023098,0.00041747,0.3713,0.4752,GOBP_REGULATION_OF_GLUTAMATE_RECEPTOR_CLUSTERING,0.994407641605971
GOCC_RSC_TYPE_COMPLEX,SET,15,0.012186,0.00034816,0.19607,0.47522,GOCC_RSC_TYPE_COMPLEX,0.994407641605971
GOMF_CYTOKINE_BINDING,SET,130,0.0048346,0.00040536,0.077832,0.47524,GOMF_CYTOKINE_BINDING,0.994407641605971
GOBP_NK_T_CELL_DIFFERENTIATI...,SET,11,0.016605,0.00040631,0.26757,0.47526,GOBP_NK_T_CELL_DIFFERENTIATION,0.994407641605971
HP_DECREASED_CIRCULATING_GON...,SET,37,0.0085844,0.00038497,0.13862,0.47531,HP_DECREASED_CIRCULATING_GONADOTROPIN_CONCENTRATION,0.994407641605971
GOCC_GTPASE_ACTIVATOR_COMPLEX,SET,11,0.013376,0.00032731,0.21605,0.47532,GOCC_GTPASE_ACTIVATOR_COMPLEX,0.994407641605971
GSE23308_WT_VS_MINERALCORTIC...3,SET,189,0.0039993,0.00040366,0.064644,0.47533,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_DN,0.994407641605971
HP_RHABDOMYOLYSIS,SET,37,0.0079079,0.00035463,0.12867,0.4755,HP_RHABDOMYOLYSIS,0.994604600987
WANG_TARGETS_OF_MLL_CBP_FUSI...1,SET,38,0.0085103,0.00038676,0.13856,0.47551,WANG_TARGETS_OF_MLL_CBP_FUSION_DN,0.994604600987
HP_THIN_NAIL,SET,13,0.014001,0.00037243,0.22792,0.47551,HP_THIN_NAIL,0.994604600987
HP_ABNORMAL_TOENAIL_MORPHOLO...,SET,152,0.0041413,0.00037523,0.067644,0.47559,HP_ABNORMAL_TOENAIL_MORPHOLOGY,0.994650820707071
HP_RENAL_AMYLOIDOSIS,SET,11,0.015633,0.00038253,0.25538,0.47559,HP_RENAL_AMYLOIDOSIS,0.994650820707071
MODULE_371,SET,26,0.0099972,0.00037593,0.16354,0.47563,MODULE_371,0.994650820707071
REACTOME_NEGATIVE_REGULATION...4,SET,27,0.010153,0.00038904,0.16709,0.47577,REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING,0.994650820707071
REACTOME_PTK6_EXPRESSION,SET,5,0.02244,0.00037026,0.36929,0.47577,REACTOME_PTK6_EXPRESSION,0.994650820707071
GOBP_INDUCTION_OF_BACTERIAL_...,SET,5,0.027867,0.0004598,0.45848,0.47577,GOBP_INDUCTION_OF_BACTERIAL_AGGLUTINATION,0.994650820707071
MIR4284,SET,99,0.0050042,0.00036647,0.082377,0.47578,MIR4284,0.994650820707071
HOXB4_TARGET_GENES,SET,929,0.0016653,0.00036498,0.027418,0.47578,HOXB4_TARGET_GENES,0.994650820707071
GSE42724_MEMORY_BCELL_VS_PLA...2,SET,189,0.0037405,0.00037754,0.061635,0.4758,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP,0.994650820707071
GSE4748_CTRL_VS_CYANOBACTERI...2,SET,181,0.0036623,0.00036183,0.060544,0.47588,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_UP,0.994650820707071
HP_ABSENT_PHALANGEAL_CREASE,SET,15,0.014006,0.00040015,0.23156,0.47589,HP_ABSENT_PHALANGEAL_CREASE,0.994650820707071
GSE2770_UNTREATED_VS_IL12_TR...3,SET,180,0.0036359,0.00035823,0.060174,0.47591,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.994650820707071
MIR4276,SET,243,0.0032959,0.00037665,0.054656,0.47596,MIR4276,0.994650820707071
HP_ABNORMAL_CAUDATE_NUCLEUS_...,SET,19,0.01164,0.00037425,0.19304,0.47596,HP_ABNORMAL_CAUDATE_NUCLEUS_MORPHOLOGY,0.994650820707071
BIOCARTA_PPARG_PATHWAY,SET,8,0.020031,0.00041803,0.33235,0.47597,BIOCARTA_PPARG_PATHWAY,0.994650820707071
CART1_01,SET,201,0.0038137,0.00039684,0.063319,0.47599,CART1_01,0.994650820707071
MIR4659B_5P,SET,91,0.0052083,0.00036576,0.086901,0.4761,MIR4659B_5P,0.99480572587917
FAELT_B_CLL_WITH_VH3_21_DN,SET,44,0.0076793,0.00037547,0.12825,0.47613,FAELT_B_CLL_WITH_VH3_21_DN,0.99480572587917
GOBP_PROSTANOID_BIOSYNTHETIC...,SET,27,0.0096155,0.00036846,0.16074,0.47615,GOBP_PROSTANOID_BIOSYNTHETIC_PROCESS,0.99480572587917
REACTOME_INTERLEUKIN_1_FAMIL...,SET,143,0.0040474,0.0003558,0.068015,0.47627,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,0.994936818536996
GRE_C,SET,112,0.0048495,0.0003776,0.081496,0.47627,GRE_C,0.994936818536996
DESCARTES_FETAL_CEREBRUM_MIC...,SET,362,0.0028311,0.00039359,0.047669,0.47632,DESCARTES_FETAL_CEREBRUM_MICROGLIA,0.994981464118283
GSE37605_C57BL6_VS_NOD_FOXP3...3,SET,178,0.0037849,0.00037085,0.063914,0.47639,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN,0.995028966346154
HP_SLOW_SACCADIC_EYE_MOVEMEN...,SET,34,0.0080294,0.0003452,0.13568,0.4764,HP_SLOW_SACCADIC_EYE_MOVEMENTS,0.995028966346154
GNF2_AF1Q,SET,25,0.010403,0.0003836,0.17594,0.47643,GNF2_AF1Q,0.995031828015143
HP_DECREASED_TESTICULAR_SIZE,SET,148,0.0040947,0.00036614,0.069566,0.47653,HP_DECREASED_TESTICULAR_SIZE,0.995141963588295
WP_COPPER_HOMEOSTASIS,SET,49,0.0071922,0.00037105,0.12222,0.47654,WP_COPPER_HOMEOSTASIS,0.995141963588295
MORF_HEAB,SET,79,0.0052441,0.00034324,0.089284,0.47658,MORF_HEAB,0.995165699351118
GCNF_01,SET,67,0.0062092,0.0003744,0.1061,0.47667,GCNF_01,0.99523879615731
CREB_Q4,SET,236,0.003239,0.00036484,0.055449,0.47671,CREB_Q4,0.99523879615731
REACTOME_CREB1_PHOSPHORYLATI...2,SET,11,0.016415,0.00040167,0.28161,0.47676,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE,0.99523879615731
HP_MUSCLE_SPASM,SET,148,0.0039521,0.00035339,0.067892,0.47679,HP_MUSCLE_SPASM,0.99523879615731
GOBP_ESTABLISHMENT_OF_CENTRO...,SET,10,0.016862,0.0003934,0.29041,0.47685,GOBP_ESTABLISHMENT_OF_CENTROSOME_LOCALIZATION,0.99523879615731
GOBP_NEGATIVE_REGULATION_OF_...574,SET,7,0.015959,0.00031155,0.27516,0.47687,GOBP_NEGATIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.99523879615731
MANNO_MIDBRAIN_NEUROTYPES_HN...3,SET,287,0.0030629,0.00037993,0.052864,0.4769,MANNO_MIDBRAIN_NEUROTYPES_HNBML1,0.99523879615731
GOBP_INTERLEUKIN_1_ALPHA_PRO...,SET,8,0.02104,0.00043909,0.36337,0.47691,GOBP_INTERLEUKIN_1_ALPHA_PRODUCTION,0.99523879615731
GSE6259_33D1_POS_VS_DEC205_P...2,SET,159,0.0038915,0.00036056,0.067189,0.47691,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP,0.99523879615731
WP_PRIMARY_FOCAL_SEGMENTAL_G...,SET,70,0.006048,0.00037272,0.10449,0.47692,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,0.99523879615731
MIR6505_5P,SET,187,0.0036427,0.00036574,0.062961,0.47693,MIR6505_5P,0.99523879615731
MATZUK_IMPLANTATION_AND_UTER...,SET,18,0.012301,0.00038497,0.21298,0.47697,MATZUK_IMPLANTATION_AND_UTERINE,0.995262509005764
HALLMARK_PI3K_AKT_MTOR_SIGNA...,SET,102,0.0045763,0.00034014,0.079691,0.4771,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.995474004922855
GOBP_CELL_PROLIFERATION_IN_M...,SET,7,0.018719,0.00036542,0.32726,0.47719,GOBP_CELL_PROLIFERATION_IN_MIDBRAIN,0.9955524925015
GOMF_BETA_GALACTOSIDASE_ACTI...,SET,5,0.023117,0.00038142,0.40488,0.47723,GOMF_BETA_GALACTOSIDASE_ACTIVITY,0.9955524925015
IGLESIAS_E2F_TARGETS_UP,SET,135,0.0044256,0.00037808,0.077623,0.47727,IGLESIAS_E2F_TARGETS_UP,0.9955524925015
HP_PALMOPLANTAR_CUTIS_LAXA,SET,8,0.016511,0.00034457,0.2901,0.47731,HP_PALMOPLANTAR_CUTIS_LAXA,0.9955524925015
GOMF_LIGASE_ACTIVITY_FORMING...4,SET,38,0.0073707,0.00033497,0.12978,0.47735,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS,0.9955524925015
HARALAMBIEVA_PBMC_FLUARIX_AG...6,SET,14,0.015125,0.00041748,0.26653,0.47737,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_SIG_DIAB_OF_THE_YNG_POSITIVE,0.9955524925015
KEGG_MEDICUS_REFERENCE_IL10_...,SET,13,0.015624,0.00041559,0.27573,0.47741,KEGG_MEDICUS_REFERENCE_IL10_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.9955524925015
HORTON_SREBF_TARGETS,SET,24,0.0090338,0.00032639,0.15956,0.47743,HORTON_SREBF_TARGETS,0.9955524925015
GOBP_ENDOPLASMIC_RETICULUM_U...,SET,70,0.0055342,0.00034106,0.097815,0.47744,GOBP_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.9955524925015
MIR376B_5P_MIR376C_5P,SET,44,0.0073852,0.00036109,0.13068,0.47747,MIR376B_5P_MIR376C_5P,0.9955524925015
GSE6875_TCONV_VS_FOXP3_KO_TR...2,SET,179,0.003534,0.00034723,0.06255,0.47747,GSE6875_TCONV_VS_FOXP3_KO_TREG_UP,0.9955524925015
GOCC_MICROTUBULE_MINUS_END,SET,6,0.024887,0.00044982,0.44086,0.47749,GOCC_MICROTUBULE_MINUS_END,0.9955524925015
HP_ANTERIOR_UVEITIS,SET,15,0.012251,0.00035003,0.21722,0.47751,HP_ANTERIOR_UVEITIS,0.9955524925015
AGTGCGT_MIR521,SET,6,0.016647,0.00030088,0.29625,0.47759,AGTGCGT_MIR521,0.995659555515566
GSE14415_NATURAL_TREG_VS_TCO...2,SET,146,0.0040357,0.00035844,0.072032,0.47766,GSE14415_NATURAL_TREG_VS_TCONV_UP,0.995696169983218
AIYAR_COBRA1_TARGETS_DN,SET,27,0.009373,0.00035916,0.16747,0.47768,AIYAR_COBRA1_TARGETS_DN,0.995696169983218
HP_OSTEOPATHIA_STRIATA,SET,3,0.037432,0.00047843,0.67031,0.47773,HP_OSTEOPATHIA_STRIATA,0.995696169983218
MORF_RAN,SET,232,0.0028886,0.00032264,0.051889,0.4778,MORF_RAN,0.995696169983218
GOCC_LAMIN_FILAMENT,SET,5,0.019675,0.00032463,0.35339,0.4778,GOCC_LAMIN_FILAMENT,0.995696169983218
GOBP_PRIMARY_ALCOHOL_BIOSYNT...,SET,14,0.013392,0.00036964,0.24069,0.47782,GOBP_PRIMARY_ALCOHOL_BIOSYNTHETIC_PROCESS,0.995696169983218
REACTOME_THE_NLRP3_INFLAMMAS...,SET,14,0.011869,0.00032761,0.21404,0.47789,REACTOME_THE_NLRP3_INFLAMMASOME,0.995696169983218
GOBP_REGULATION_OF_GTPASE_AC...,SET,245,0.0031899,0.00036601,0.057523,0.47789,GOBP_REGULATION_OF_GTPASE_ACTIVITY,0.995696169983218
MIR6834_3P,SET,42,0.0070459,0.0003366,0.12721,0.47791,MIR6834_3P,0.995696169983218
MODULE_537,SET,17,0.011483,0.00034926,0.20774,0.47796,MODULE_537,0.995696169983218
HP_CAROTID_ARTERY_DILATATION,SET,23,0.010082,0.00035661,0.1826,0.47798,HP_CAROTID_ARTERY_DILATATION,0.995696169983218
GSE43955_TH0_VS_TGFB_IL6_TH1...10,SET,181,0.003396,0.00033551,0.061494,0.47798,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP,0.995696169983218
FULLER_PBMC_F_TULARENSIS_VAC...2,SET,7,0.017331,0.00033833,0.31379,0.47798,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_336HR_SUSTAINED_UP,0.995696169983218
REACTOME_SYNTHESIS_SECRETION...2,SET,20,0.010965,0.0003617,0.19934,0.47807,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1,0.995747924528302
GSE40277_GATA1_AND_SATB1_TRA...1,SET,180,0.0034632,0.00034121,0.063052,0.4781,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,0.995747924528302
MATSUDA_NATURAL_KILLER_DIFFE...,SET,437,0.0022499,0.00034295,0.040994,0.47812,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,0.995747924528302
GOBP_MAINTENANCE_OF_SISTER_C...,SET,8,0.016065,0.00033526,0.29274,0.47812,GOBP_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,0.995747924528302
GOCC_AXOLEMMA,SET,15,0.013839,0.0003954,0.25308,0.4782,GOCC_AXOLEMMA,0.995747924528302
THAKAR_PBMC_INACTIVATED_INFL...2,SET,158,0.0037194,0.00034354,0.068067,0.47821,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP,0.995747924528302
NEUROG3_TARGET_GENES,SET,15,0.011314,0.00032325,0.20722,0.47823,NEUROG3_TARGET_GENES,0.995747924528302
GAVISH_3CA_MALIGNANT_METAPRO...12,SET,38,0.0065566,0.00029797,0.1203,0.47827,GAVISH_3CA_MALIGNANT_METAPROGRAM_21_RESPIRATION,0.995747924528302
GOBP_POSITIVE_REGULATION_OF_...465,SET,52,0.0066742,0.00035468,0.12247,0.47827,GOBP_POSITIVE_REGULATION_OF_MIRNA_TRANSCRIPTION,0.995747924528302
GOMF_UBIQUITIN_PROTEIN_TRANS...3,SET,30,0.0087882,0.00035494,0.16147,0.4783,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_REGULATOR_ACTIVITY,0.995747924528302
GOBP_AMP_SALVAGE,SET,4,0.025295,0.00037331,0.46516,0.47832,GOBP_AMP_SALVAGE,0.995747924528302
GSE41867_NAIVE_VS_DAY6_LCMV_...2,SET,177,0.0033806,0.00033032,0.062474,0.47842,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.995774082381729
BIOCARTA_AHSP_PATHWAY,SET,9,0.014598,0.00032312,0.27015,0.47845,BIOCARTA_AHSP_PATHWAY,0.995774082381729
GOBP_ATRIAL_SEPTUM_DEVELOPME...,SET,21,0.011271,0.00038095,0.20856,0.47845,GOBP_ATRIAL_SEPTUM_DEVELOPMENT,0.995774082381729
HP_FINGER_CLINODACTYLY,SET,387,0.0023125,0.00033217,0.042843,0.47848,HP_FINGER_CLINODACTYLY,0.995774082381729
GOBP_CELLULAR_RESPONSE_TO_NI...2,SET,587,0.0019277,0.00033912,0.035742,0.47849,GOBP_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND,0.995774082381729
MIR17_5P,SET,580,0.0019256,0.00033679,0.03579,0.47855,MIR17_5P,0.995774082381729
GOMF_TOXIN_TRANSMEMBRANE_TRA...,SET,9,0.017032,0.000377,0.31725,0.47859,GOMF_TOXIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.995774082381729
GSE5960_TH1_VS_ANERGIC_TH1_UP,SET,183,0.0032284,0.0003207,0.060307,0.47865,GSE5960_TH1_VS_ANERGIC_TH1_UP,0.995774082381729
GSE43955_1H_VS_60H_ACT_CD4_T...1,SET,182,0.0034253,0.00033933,0.064082,0.47869,GSE43955_1H_VS_60H_ACT_CD4_TCELL_DN,0.995774082381729
GOBP_TRACHEA_MORPHOGENESIS,SET,11,0.01577,0.00038588,0.29519,0.4787,GOBP_TRACHEA_MORPHOGENESIS,0.995774082381729
GOBP_REGULATION_OF_CELLULAR_...10,SET,285,0.0027763,0.0003432,0.052099,0.47875,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,0.995774082381729
PTPRA_TARGET_GENES,SET,94,0.0046542,0.00033216,0.08745,0.47878,PTPRA_TARGET_GENES,0.995774082381729
ZBTB5_TARGET_GENES,SET,395,0.0023076,0.00033481,0.043366,0.47878,ZBTB5_TARGET_GENES,0.995774082381729
ZHOU_INFLAMMATORY_RESPONSE_L...3,SET,335,0.0025881,0.00034639,0.048698,0.47881,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,0.995774082381729
RODWELL_AGING_KIDNEY_NO_BLOO...2,SET,196,0.0033523,0.00034451,0.06321,0.47885,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,0.995774082381729
WP_PATHOGENESIS_OF_SARSCOV2_...,SET,18,0.011923,0.00037313,0.22502,0.47887,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,0.995774082381729
chr17q22,SET,42,0.011779,0.00056273,0.22349,0.47898,chr17q22,0.995774082381729
MIR4442,SET,4,0.022329,0.00032953,0.42376,0.47899,MIR4442,0.995774082381729
HP_DELAYED_ABILITY_TO_WALK,SET,253,0.0027324,0.00031852,0.052026,0.47906,HP_DELAYED_ABILITY_TO_WALK,0.995774082381729
GOBP_NEGATIVE_REGULATION_OF_...489,SET,4,0.025621,0.00037812,0.48819,0.47907,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.995774082381729
GOBP_NEGATIVE_REGULATION_OF_...490,SET,4,0.025621,0.00037812,0.48819,0.47907,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.995774082381729
HP_RENAL_TUBULAR_ACIDOSIS,SET,39,0.0070261,0.00032347,0.13386,0.47907,HP_RENAL_TUBULAR_ACIDOSIS,0.995774082381729
chr15q15,SET,86,0.010501,0.000717,0.20081,0.47915,chr15q15,0.995774082381729
MIR3161,SET,69,0.0056446,0.00034538,0.10808,0.47917,MIR3161,0.995774082381729
GOMF_CORECEPTOR_ACTIVITY,SET,52,0.0065872,0.00035006,0.12629,0.4792,GOMF_CORECEPTOR_ACTIVITY,0.995774082381729
GOMF_LIPID_BINDING,SET,787,0.0016416,0.0003325,0.031493,0.47921,GOMF_LIPID_BINDING,0.995774082381729
ROZANOV_MMP14_TARGETS_UP,SET,242,0.0029994,0.00034207,0.057608,0.47924,ROZANOV_MMP14_TARGETS_UP,0.995774082381729
ZNF433_TARGET_GENES,SET,46,0.0062301,0.00031144,0.11974,0.47925,ZNF433_TARGET_GENES,0.995774082381729
GOMF_OXIDOREDUCTASE_ACTIVITY...14,SET,10,0.012993,0.00030315,0.25004,0.47928,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_HEME_PROTEIN_AS_ACCEPTOR,0.995774082381729
GOBP_COLUMNAR_CUBOIDAL_EPITH...2,SET,119,0.0043587,0.00034976,0.084034,0.47932,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION,0.995774082381729
HP_TRICHORRHEXIS_NODOSA,SET,9,0.012933,0.00028627,0.24949,0.47933,HP_TRICHORRHEXIS_NODOSA,0.995774082381729
GOBP_MODULATION_BY_HOST_OF_V...1,SET,21,0.009562,0.00032319,0.18497,0.47939,GOBP_MODULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,0.995774082381729
HP_NARROW_FOREHEAD,SET,150,0.0034772,0.000313,0.067376,0.47942,HP_NARROW_FOREHEAD,0.995774082381729
KMT2D_TARGET_GENES,SET,584,0.0018196,0.00031932,0.035276,0.47943,KMT2D_TARGET_GENES,0.995774082381729
GOBP_REGULATION_OF_TRANSFERA...,SET,563,0.001858,0.00032033,0.036166,0.47951,GOBP_REGULATION_OF_TRANSFERASE_ACTIVITY,0.995774082381729
CHESLER_BRAIN_HIGHEST_EXPRES...,SET,34,0.0072352,0.00031106,0.14127,0.47958,CHESLER_BRAIN_HIGHEST_EXPRESSION,0.995774082381729
MIR154_5P,SET,61,0.0057552,0.00033117,0.11237,0.47958,MIR154_5P,0.995774082381729
GSE22886_NAIVE_CD4_TCELL_VS_...17,SET,185,0.0029933,0.00029895,0.058459,0.47958,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN,0.995774082381729
MODULE_382,SET,25,0.0095216,0.0003511,0.18632,0.47962,MODULE_382,0.995774082381729
GOBP_TOLERANCE_INDUCTION,SET,27,0.0089107,0.00034145,0.17449,0.47964,GOBP_TOLERANCE_INDUCTION,0.995774082381729
GOMF_RNA_POLYMERASE_III_GENE...,SET,12,0.0095296,0.00024354,0.18669,0.47964,GOMF_RNA_POLYMERASE_III_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.995774082381729
GSE36392_TYPE_2_MYELOID_VS_E...1,SET,176,0.0033021,0.00032174,0.064843,0.47969,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN,0.995774082381729
GOBP_POSITIVE_REGULATION_OF_...727,SET,23,0.009317,0.00032955,0.18301,0.4797,GOBP_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,0.995774082381729
HP_RECEPTIVE_LANGUAGE_DELAY,SET,13,0.011473,0.00030518,0.22533,0.4797,HP_RECEPTIVE_LANGUAGE_DELAY,0.995774082381729
WOTTON_RUNX_TARGETS_DN,SET,26,0.0092244,0.00034687,0.18136,0.47972,WOTTON_RUNX_TARGETS_DN,0.995774082381729
WP_RENINANGIOTENSINALDOSTERO...,SET,43,0.006527,0.00031549,0.12854,0.47975,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,0.995774082381729
CTGCAGY_UNKNOWN,SET,678,0.0017089,0.00032226,0.033712,0.47979,CTGCAGY_UNKNOWN,0.995774082381729
GOBP_RESPONSE_TO_SALT,SET,22,0.0095689,0.00033103,0.1893,0.47984,GOBP_RESPONSE_TO_SALT,0.995774082381729
HP_DYSTONIA,SET,461,0.0019377,0.00030316,0.038449,0.4799,HP_DYSTONIA,0.995774082381729
MATZUK_PREOVULATORY_FOLLICLE,SET,9,0.016405,0.00036311,0.32563,0.47991,MATZUK_PREOVULATORY_FOLLICLE,0.995774082381729
BANDRES_RESPONSE_TO_CARMUSTI...4,SET,18,0.0097053,0.00030373,0.19316,0.47996,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP,0.995774082381729
YATGNWAAT_OCT_C,SET,315,0.0025295,0.00032846,0.050451,0.48001,YATGNWAAT_OCT_C,0.995774082381729
FIGUEROA_AML_METHYLATION_CLU...14,SET,104,0.0042912,0.00032204,0.086187,0.48015,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,0.995774082381729
HP_ABSENT_HAIR,SET,55,0.0058956,0.00032219,0.11858,0.48017,HP_ABSENT_HAIR,0.995774082381729
MIR1229_3P,SET,75,0.0046,0.0002934,0.093025,0.48028,MIR1229_3P,0.995774082381729
MIR3659,SET,73,0.0049084,0.00030888,0.099528,0.48033,MIR3659,0.995774082381729
GOBP_MONOACYLGLYCEROL_BIOSYN...,SET,7,0.016295,0.00031811,0.33036,0.48033,GOBP_MONOACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.995774082381729
GSE9946_IMMATURE_VS_LISTERIA...2,SET,118,0.0038316,0.00030617,0.077682,0.48033,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP,0.995774082381729
GOBP_PURINE_NUCLEOSIDE_CATAB...,SET,7,0.017147,0.00033474,0.34865,0.48039,GOBP_PURINE_NUCLEOSIDE_CATABOLIC_PROCESS,0.995774082381729
REACTOME_HEDGEHOG_LIGAND_BIO...,SET,62,0.004671,0.00027097,0.095202,0.48043,REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,0.995774082381729
GOMF_ENZYME_ACTIVATOR_ACTIVI...,SET,540,0.0017922,0.0003028,0.036518,0.48043,GOMF_ENZYME_ACTIVATOR_ACTIVITY,0.995774082381729
WP_GLYOXYLATE_METABOLISM,SET,11,0.012688,0.00031047,0.25965,0.48051,WP_GLYOXYLATE_METABOLISM,0.995774082381729
WP_ATR_SIGNALING,SET,11,0.010964,0.00026828,0.22454,0.48053,WP_ATR_SIGNALING,0.995774082381729
HP_CAPILLARY_FRAGILITY,SET,6,0.017029,0.00030778,0.34968,0.48058,HP_CAPILLARY_FRAGILITY,0.995774082381729
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...7,SET,90,0.0043402,0.00030312,0.089303,0.48062,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN,0.995774082381729
HP_VEGETATIVE_STATE,SET,9,0.013023,0.00028826,0.26817,0.48063,HP_VEGETATIVE_STATE,0.995774082381729
HOEK_T_CELL_2011_2012_TIV_AD...1,SET,4,0.021126,0.00031178,0.43485,0.48063,HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_DN,0.995774082381729
FAN_OVARY_CL0_XBP1_SELK_HIGH...,SET,123,0.003605,0.00029407,0.074266,0.48064,FAN_OVARY_CL0_XBP1_SELK_HIGH_STROMAL_CELL,0.995774082381729
GOMF_NADPH_OXIDASE_H202_FORM...,SET,5,0.016037,0.0002646,0.33099,0.48068,GOMF_NADPH_OXIDASE_H202_FORMING_ACTIVITY,0.995774082381729
GOMF_PROTEIN_SERINE_THREONIN...3,SET,10,0.013711,0.0003199,0.28323,0.4807,GOMF_PROTEIN_SERINE_THREONINE_KINASE_BINDING,0.995774082381729
GOBP_VACUOLAR_PROTON_TRANSPO...,SET,5,0.017452,0.00028796,0.36106,0.48072,GOBP_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY,0.995774082381729
HP_ABNORMAL_FETAL_CARDIOVASC...,SET,46,0.0057913,0.00028951,0.12038,0.48082,HP_ABNORMAL_FETAL_CARDIOVASCULAR_MORPHOLOGY,0.995774082381729
GSE369_SOCS3_KO_VS_WT_LIVER_...1,SET,184,0.0028777,0.00028662,0.059818,0.48082,GSE369_SOCS3_KO_VS_WT_LIVER_DN,0.995774082381729
GOBP_EMBRYONIC_SKELETAL_SYST...1,SET,121,0.0041913,0.00033913,0.087214,0.48084,GOBP_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT,0.995774082381729
GOMF_CALCIUM_DEPENDENT_PROTE...3,SET,7,0.011955,0.00023338,0.2488,0.48084,GOMF_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.995774082381729
MARIADASON_RESPONSE_TO_BUTYR...3,SET,9,0.013528,0.00029944,0.28183,0.48086,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8,0.995774082381729
GSE27786_LSK_VS_BCELL_UP,SET,175,0.0029851,0.00029004,0.062348,0.48091,GSE27786_LSK_VS_BCELL_UP,0.995774082381729
GOBP_CHONDROCYTE_DIFFERENTIA...1,SET,107,0.0040652,0.00030942,0.085097,0.48095,GOBP_CHONDROCYTE_DIFFERENTIATION,0.995774082381729
GOBP_DENDRITIC_SPINE_MAINTEN...,SET,20,0.0092338,0.00030459,0.19348,0.48097,GOBP_DENDRITIC_SPINE_MAINTENANCE,0.995774082381729
GSE17721_CTRL_VS_LPS_4H_BMDC...1,SET,181,0.0029569,0.00029213,0.062188,0.48104,GSE17721_CTRL_VS_LPS_4H_BMDC_DN,0.995774082381729
SUZUKI_RESPONSE_TO_TSA_AND_D...2,SET,15,0.011358,0.00032449,0.239,0.48105,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B,0.995774082381729
HP_SLENDER_FINGER,SET,130,0.00348,0.00029179,0.073257,0.48106,HP_SLENDER_FINGER,0.995774082381729
GSE37301_LYMPHOID_PRIMED_MPP...7,SET,168,0.0030439,0.00028983,0.064295,0.48112,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN,0.995774082381729
GOMF_PRE_MIRNA_BINDING,SET,9,0.013199,0.00029216,0.27935,0.48116,GOMF_PRE_MIRNA_BINDING,0.995774082381729
DITTMER_PTHLH_TARGETS_DN,SET,69,0.0049687,0.00030402,0.10535,0.48119,DITTMER_PTHLH_TARGETS_DN,0.995774082381729
GSE24292_WT_VS_PPARG_KO_MACR...1,SET,178,0.0028924,0.0002834,0.06139,0.48121,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN,0.995774082381729
MORI_PLASMA_CELL_UP,SET,45,0.005903,0.00029188,0.12536,0.48122,MORI_PLASMA_CELL_UP,0.995774082381729
GSE37416_0H_VS_48H_F_TULAREN...2,SET,177,0.0029495,0.00028819,0.062676,0.48123,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.995774082381729
REACTOME_TFAP2A_ACTS_AS_A_TR...,SET,5,0.018869,0.00031133,0.40219,0.48129,REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION,0.995774082381729
GSE369_IFNG_KO_VS_WT_LIVER_UP,SET,179,0.0029546,0.0002903,0.062984,0.48129,GSE369_IFNG_KO_VS_WT_LIVER_UP,0.995774082381729
KEGG_MEDICUS_REFERENCE_REGUL...4,SET,4,0.016598,0.00024495,0.35413,0.48131,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_C1INH,0.995774082381729
REACTOME_EPHA_MEDIATED_GROWT...,SET,29,0.00787,0.00031252,0.16858,0.48138,REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE,0.995774082381729
HP_VERTICAL_NYSTAGMUS,SET,21,0.0082497,0.00027884,0.17683,0.48139,HP_VERTICAL_NYSTAGMUS,0.995774082381729
HP_INTESTINAL_LYMPHANGIECTAS...,SET,5,0.019321,0.0003188,0.41447,0.48141,HP_INTESTINAL_LYMPHANGIECTASIA,0.995774082381729
CARM1_TARGET_GENES,SET,8,0.014184,0.00029602,0.30512,0.48146,CARM1_TARGET_GENES,0.995774082381729
GAVISH_3CA_METAPROGRAM_ENDOT...2,SET,47,0.0061618,0.00031135,0.1328,0.4815,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_COAGULATION,0.995774082381729
GOBP_XENOBIOTIC_GLUCURONIDAT...,SET,6,0.022026,0.0003981,0.47509,0.48151,GOBP_XENOBIOTIC_GLUCURONIDATION,0.995774082381729
HP_ANOMIC_APHASIA,SET,6,0.015367,0.00027775,0.33149,0.48151,HP_ANOMIC_APHASIA,0.995774082381729
BILANGES_RAPAMYCIN_SENSITIVE...2,SET,59,0.0048459,0.00027425,0.10475,0.48155,BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,0.995774082381729
GSE7460_TCONV_VS_TREG_THYMUS...2,SET,182,0.0028781,0.00028512,0.062321,0.48158,GSE7460_TCONV_VS_TREG_THYMUS_UP,0.995774082381729
GOBP_DNA_LIGATION,SET,16,0.0083735,0.00024708,0.18221,0.48167,GOBP_DNA_LIGATION,0.995774082381729
LINDGREN_BLADDER_CANCER_CLUS...1,SET,348,0.0020955,0.00028575,0.045652,0.48169,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,0.995774082381729
GOBP_AGGRESSIVE_BEHAVIOR,SET,8,0.016306,0.00034029,0.35516,0.48169,GOBP_AGGRESSIVE_BEHAVIOR,0.995774082381729
GOCC_PRONUCLEUS,SET,12,0.01065,0.00027218,0.23192,0.48169,GOCC_PRONUCLEUS,0.995774082381729
GOCC_TRANS_GOLGI_NETWORK_TRA...2,SET,18,0.0087139,0.0002727,0.18998,0.48171,GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE_MEMBRANE,0.995774082381729
REACTOME_TRANSPORT_OF_FATTY_...,SET,8,0.013322,0.00027802,0.29062,0.48172,REACTOME_TRANSPORT_OF_FATTY_ACIDS,0.995774082381729
GSE36476_YOUNG_VS_OLD_DONOR_...6,SET,173,0.0029872,0.00028859,0.065199,0.48173,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP,0.995774082381729
TERAO_AOX4_TARGETS_HG_UP,SET,27,0.0072334,0.00027718,0.15796,0.48174,TERAO_AOX4_TARGETS_HG_UP,0.995774082381729
GOBP_LACRIMAL_GLAND_DEVELOPM...,SET,7,0.01656,0.00032329,0.36324,0.48182,GOBP_LACRIMAL_GLAND_DEVELOPMENT,0.995774082381729
GSE17721_CTRL_VS_LPS_6H_BMDC...1,SET,184,0.0028037,0.00027925,0.061506,0.48182,GSE17721_CTRL_VS_LPS_6H_BMDC_DN,0.995774082381729
BUSSLINGER_GASTRIC_G_CELLS,SET,88,0.004583,0.00031652,0.10078,0.48186,BUSSLINGER_GASTRIC_G_CELLS,0.995774082381729
HP_DISTAL_RENAL_TUBULAR_ACID...,SET,6,0.015833,0.00028617,0.34905,0.48191,HP_DISTAL_RENAL_TUBULAR_ACIDOSIS,0.995774082381729
GOBP_REGULATION_OF_EARLY_END...,SET,16,0.010132,0.00029896,0.22359,0.48193,GOBP_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,0.995774082381729
GOMF_DNA_BINDING_TRANSCRIPTI...1,SET,442,0.001888,0.00028939,0.04176,0.48197,GOMF_DNA_BINDING_TRANSCRIPTION_ACTIVATOR_ACTIVITY,0.995774082381729
GOBP_NEGATIVE_REGULATION_OF_...224,SET,3,0.022019,0.00028143,0.48731,0.48198,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,0.995774082381729
HP_GERM_CELL_NEOPLASIA,SET,40,0.0061935,0.00028876,0.13709,0.48198,HP_GERM_CELL_NEOPLASIA,0.995774082381729
HP_PANCREATIC_APLASIA,SET,6,0.015389,0.00027815,0.34056,0.48198,HP_PANCREATIC_APLASIA,0.995774082381729
GOBP_CELL_DIFFERENTIATION_IN...3,SET,21,0.0095765,0.00032368,0.2126,0.48204,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,0.995774082381729
NAKAYA_B_CELL_FLUMIST_AGE_18...2,SET,416,0.0018102,0.00026937,0.040193,0.48204,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP,0.995774082381729
GOBP_FATTY_ACID_OMEGA_OXIDAT...,SET,5,0.020555,0.00033915,0.45784,0.4821,GOBP_FATTY_ACID_OMEGA_OXIDATION,0.995774082381729
BIOCARTA_STEM_PATHWAY,SET,15,0.010291,0.00029402,0.22983,0.48214,BIOCARTA_STEM_PATHWAY,0.995774082381729
WP_NOTCH_SIGNALING_WP268,SET,45,0.0054678,0.00027036,0.12231,0.48217,WP_NOTCH_SIGNALING_WP268,0.995774082381729
WHITEHURST_PACLITAXEL_SENSIT...,SET,31,0.0062701,0.00025742,0.14045,0.4822,WHITEHURST_PACLITAXEL_SENSITIVITY,0.995774082381729
GOBP_MODULATION_OF_INHIBITOR...,SET,7,0.015873,0.00030986,0.35614,0.48223,GOBP_MODULATION_OF_INHIBITORY_POSTSYNAPTIC_POTENTIAL,0.995774082381729
HU_FETAL_RETINA_RPC,SET,97,0.004115,0.00029831,0.092519,0.48226,HU_FETAL_RETINA_RPC,0.995774082381729
MODULE_432,SET,13,0.0094883,0.00025238,0.21355,0.48228,MODULE_432,0.995774082381729
GOMF_PROTEIN_DEMETHYLASE_ACT...,SET,24,0.0066836,0.00024148,0.15073,0.48232,GOMF_PROTEIN_DEMETHYLASE_ACTIVITY,0.995774082381729
GSE26290_WT_VS_PDK1_KO_ANTI_...2,SET,169,0.0028928,0.00027625,0.065293,0.48233,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,0.995774082381729
COLDREN_GEFITINIB_RESISTANCE...2,SET,72,0.00424,0.00026499,0.095821,0.48235,COLDREN_GEFITINIB_RESISTANCE_UP,0.995774082381729
REACTOME_ETHANOL_OXIDATION,SET,12,0.012935,0.00033058,0.29261,0.48237,REACTOME_ETHANOL_OXIDATION,0.995774082381729
ZNF407_TARGET_GENES,SET,1551,0.00098833,0.00027485,0.022357,0.48237,ZNF407_TARGET_GENES,0.995774082381729
GSE22886_IGG_IGA_MEMORY_BCEL...4,SET,178,0.0027519,0.00026964,0.062297,0.48238,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,0.995774082381729
YANG_BREAST_CANCER_ESR1_DN,SET,21,0.0088349,0.00029862,0.20027,0.48241,YANG_BREAST_CANCER_ESR1_DN,0.995774082381729
GSE40274_LEF1_VS_FOXP3_AND_L...1,SET,173,0.0028401,0.00027438,0.064469,0.48243,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.995774082381729
MIR377_5P,SET,50,0.0051283,0.00026725,0.11651,0.48245,MIR377_5P,0.995774082381729
GSE29614_DAY3_VS_DAY7_TIV_FL...1,SET,158,0.0028834,0.00026632,0.065801,0.48252,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,0.995774082381729
FARDIN_HYPOXIA_9,SET,7,0.013444,0.00026245,0.30856,0.48262,FARDIN_HYPOXIA_9,0.995774082381729
HP_MACULAR_COLOBOMA,SET,10,0.012303,0.00028703,0.28247,0.48263,HP_MACULAR_COLOBOMA,0.995774082381729
SOBOLEV_PBMC_PANDEMRIX_AGE_1...3,SET,28,0.0071224,0.00027792,0.16447,0.48273,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_CORRELATED_WITH_AGE_1DY_POSITIVE,0.995774082381729
GOBP_FOREGUT_MORPHOGENESIS,SET,10,0.011807,0.00027548,0.27389,0.48281,GOBP_FOREGUT_MORPHOGENESIS,0.995774082381729
GOMF_NON_MEMBRANE_SPANNING_P...1,SET,43,0.0059575,0.00028797,0.13849,0.48284,GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.995774082381729
GSE40441_NRP1_POS_INDUCED_TR...1,SET,181,0.0025852,0.00025541,0.060281,0.4829,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN,0.995774082381729
GOCC_EUKARYOTIC_TRANSLATION_...4,SET,7,0.012201,0.00023818,0.28483,0.48292,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX_EIF3M,0.995774082381729
GOMF_SUMO_POLYMER_BINDING,SET,5,0.014594,0.00024079,0.34068,0.48292,GOMF_SUMO_POLYMER_BINDING,0.995774082381729
MANNO_MIDBRAIN_NEUROTYPES_HG...,SET,972,0.0012336,0.00027622,0.028897,0.48297,MANNO_MIDBRAIN_NEUROTYPES_HGABA,0.995774082381729
GAO_ESOPHAGUS_25W_C1_CILIATE...,SET,375,0.0018018,0.00025486,0.042346,0.48303,GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS,0.995774082381729
GRADE_COLON_AND_RECTAL_CANCE...1,SET,94,0.003766,0.00026877,0.088676,0.48306,GRADE_COLON_AND_RECTAL_CANCER_DN,0.995774082381729
MIR6777_3P,SET,45,0.0052747,0.00026081,0.12419,0.48306,MIR6777_3P,0.995774082381729
GOBP_DORSAL_VENTRAL_PATTERN_...,SET,88,0.0041544,0.00028692,0.098253,0.48314,GOBP_DORSAL_VENTRAL_PATTERN_FORMATION,0.995774082381729
HP_AXIAL_DYSTONIA,SET,15,0.0087828,0.00025093,0.20826,0.48318,HP_AXIAL_DYSTONIA,0.995774082381729
HP_DEVIATION_OF_THE_HAND_OR_...,SET,478,0.0016263,0.00025896,0.038656,0.48322,HP_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,0.995774082381729
HP_TENDON_RUPTURE,SET,5,0.016214,0.00026753,0.38562,0.48323,HP_TENDON_RUPTURE,0.995774082381729
GNF2_IGF1,SET,25,0.0072926,0.00026891,0.1738,0.48327,GNF2_IGF1,0.995774082381729
GSE5503_MLN_DC_VS_SPLEEN_DC_...1,SET,178,0.0025833,0.00025311,0.061657,0.48329,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.995774082381729
GOCC_ANAPHASE_PROMOTING_COMP...,SET,21,0.0069145,0.00023371,0.16511,0.4833,GOCC_ANAPHASE_PROMOTING_COMPLEX,0.995774082381729
GOBP_POSITIVE_REGULATION_OF_...824,SET,8,0.012027,0.00025098,0.28781,0.48333,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.995774082381729
HP_T_WAVE_INVERSION,SET,5,0.014969,0.00024699,0.35805,0.48333,HP_T_WAVE_INVERSION,0.995774082381729
TESAR_ALK_TARGETS_HUMAN_ES_5...1,SET,5,0.013962,0.00023038,0.33425,0.48334,TESAR_ALK_TARGETS_HUMAN_ES_5D_DN,0.995774082381729
GSE12198_NK_VS_NK_ACT_EXPANS...2,SET,182,0.0026798,0.00026547,0.064267,0.48337,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP,0.995774082381729
WEBER_METHYLATED_HCP_IN_FIBR...1,SET,38,0.005427,0.00024663,0.13031,0.48339,WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN,0.995774082381729
GSE16385_MONOCYTE_VS_MACROPH...2,SET,178,0.0025868,0.00025346,0.06211,0.48339,GSE16385_MONOCYTE_VS_MACROPHAGE_UP,0.995774082381729
MODULE_234,SET,53,0.0054579,0.00029281,0.13109,0.4834,MODULE_234,0.995774082381729
GOCC_CALYX_OF_HELD,SET,17,0.0089136,0.0002711,0.21419,0.4834,GOCC_CALYX_OF_HELD,0.995774082381729
KOHN_EMT_EPITHELIAL,SET,22,0.0078621,0.00027198,0.1891,0.48342,KOHN_EMT_EPITHELIAL,0.995774082381729
MIR1827,SET,359,0.0018541,0.00025671,0.044614,0.48343,MIR1827,0.995774082381729
LEE_METASTASIS_AND_RNA_PROCE...,SET,16,0.0077126,0.00022757,0.18607,0.48347,LEE_METASTASIS_AND_RNA_PROCESSING_UP,0.995774082381729
REACTOME_PURINERGIC_SIGNALIN...,SET,23,0.0068865,0.00024358,0.16643,0.4835,REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,0.995774082381729
HP_WEAKNESS_OF_LONG_FINGER_E...,SET,20,0.0073394,0.0002421,0.1774,0.4835,HP_WEAKNESS_OF_LONG_FINGER_EXTENSOR_MUSCLES,0.995774082381729
HP_INCREASED_CIRCULATING_PRO...,SET,26,0.0063025,0.000237,0.15284,0.48355,HP_INCREASED_CIRCULATING_PROLACTIN_CONCENTRATION,0.995774082381729
CAHOY_NEURONAL,SET,97,0.0038751,0.00028091,0.093956,0.48355,CAHOY_NEURONAL,0.995774082381729
KEGG_NUCLEOTIDE_EXCISION_REP...,SET,40,0.0046819,0.00021829,0.11378,0.48359,KEGG_NUCLEOTIDE_EXCISION_REPAIR,0.995774082381729
GOBP_REGULATION_OF_CELL_CYCL...4,SET,398,0.0016996,0.0002475,0.041303,0.48359,GOBP_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,0.995774082381729
MIR5088_3P,SET,121,0.0030709,0.00024847,0.074955,0.48366,MIR5088_3P,0.995774082381729
HP_HIGH_FREQUENCY_HEARING_IM...,SET,5,0.017589,0.00029021,0.43027,0.4837,HP_HIGH_FREQUENCY_HEARING_IMPAIRMENT,0.995774082381729
REACTOME_FORMATION_OF_APOPTO...,SET,10,0.010154,0.0002369,0.24876,0.48372,REACTOME_FORMATION_OF_APOPTOSOME,0.995774082381729
GOBP_ESTABLISHMENT_OF_PROTEI...5,SET,240,0.0021563,0.00024491,0.053005,0.48378,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.995774082381729
KEGG_MEDICUS_REFERENCE_BCR_P...1,SET,16,0.0084871,0.00025043,0.20893,0.4838,KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,0.995774082381729
HALLMARK_UV_RESPONSE_DN,SET,136,0.0032383,0.00027767,0.079796,0.48381,HALLMARK_UV_RESPONSE_DN,0.995774082381729
HP_ABNORMALITY_OF_THE_TESTIS...,SET,177,0.00255,0.00024916,0.063004,0.48386,HP_ABNORMALITY_OF_THE_TESTIS_SIZE,0.995774082381729
WP_GPCRS_CLASS_B_SECRETINLIKE,SET,22,0.0080532,0.00027859,0.19908,0.48387,WP_GPCRS_CLASS_B_SECRETINLIKE,0.995774082381729
GOCC_STEREOCILIUM_MEMBRANE,SET,5,0.015692,0.00025891,0.38814,0.48388,GOCC_STEREOCILIUM_MEMBRANE,0.995774082381729
GSE11057_NAIVE_VS_EFF_MEMORY...2,SET,165,0.002649,0.00024998,0.065688,0.48392,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,0.995774082381729
NAKAMURA_TUMOR_ZONE_PERIPHER...2,SET,249,0.0021079,0.0002438,0.052392,0.48395,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,0.995774082381729
CARRILLOREIXACH_HEPATOBLASTO...2,SET,18,0.0079759,0.00024961,0.19876,0.484,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPERMETHYLATED_AND_DN,0.995774082381729
MIR210_5P,SET,49,0.0047406,0.00024457,0.11819,0.484,MIR210_5P,0.995774082381729
HP_RETINAL_HEMORRHAGE,SET,25,0.007104,0.00026196,0.17756,0.48404,HP_RETINAL_HEMORRHAGE,0.995774082381729
STAT5A_02,SET,124,0.0030952,0.0002535,0.077383,0.48405,STAT5A_02,0.995774082381729
REACTOME_ACTIVATION_OF_BH3_O...,SET,30,0.0065244,0.00026351,0.16357,0.48409,REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS,0.995774082381729
HP_UVEAL_ECTROPION,SET,7,0.013056,0.00025488,0.32726,0.48409,HP_UVEAL_ECTROPION,0.995774082381729
SUZUKI_CTCFL_TARGETS_UP,SET,11,0.0097482,0.00023853,0.24465,0.48411,SUZUKI_CTCFL_TARGETS_UP,0.995774082381729
HIRSCH_CELLULAR_TRANSFORMATI...2,SET,227,0.0022428,0.00024783,0.056388,0.48414,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,0.995774082381729
MIR3115,SET,33,0.0054995,0.00023294,0.13835,0.48415,MIR3115,0.995774082381729
HP_UNCOMBABLE_HAIR,SET,4,0.019384,0.00028607,0.48785,0.48415,HP_UNCOMBABLE_HAIR,0.995774082381729
HP_PATELLAR_DISLOCATION,SET,56,0.0048108,0.00026528,0.12131,0.48418,HP_PATELLAR_DISLOCATION,0.995774082381729
GOBP_PHAGOLYSOSOME_ASSEMBLY,SET,17,0.0086806,0.00026401,0.21973,0.48424,GOBP_PHAGOLYSOSOME_ASSEMBLY,0.995774082381729
GOBP_METANEPHRIC_PART_OF_URE...,SET,6,0.015714,0.00028402,0.39947,0.48431,GOBP_METANEPHRIC_PART_OF_URETERIC_BUD_DEVELOPMENT,0.995774082381729
GAO_SMALL_INTESTINE_24W_C6_G...,SET,40,0.0050272,0.00023439,0.12803,0.48434,GAO_SMALL_INTESTINE_24W_C6_GOBLET_CELLS,0.995774082381729
BROWNE_HCMV_INFECTION_30MIN_...1,SET,126,0.0029758,0.00024567,0.07586,0.48435,BROWNE_HCMV_INFECTION_30MIN_DN,0.995774082381729
BACOLOD_RESISTANCE_TO_ALKYLA...2,SET,22,0.0075937,0.0002627,0.19404,0.48439,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,0.995774082381729
SIMBULAN_UV_RESPONSE_NORMAL_...1,SET,33,0.0061386,0.00026001,0.15692,0.4844,SIMBULAN_UV_RESPONSE_NORMAL_DN,0.995774082381729
GOBP_REGULATION_OF_PROTEIN_K...5,SET,18,0.0083395,0.00026099,0.21354,0.48442,GOBP_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING,0.995774082381729
CUI_DEVELOPING_HEART_C3_FIBR...,SET,103,0.0035859,0.00026782,0.091903,0.48444,CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL,0.995774082381729
HP_BROAD_FIRST_METATARSAL,SET,5,0.01509,0.00024898,0.38706,0.48445,HP_BROAD_FIRST_METATARSAL,0.995774082381729
HEBERT_MATRISOME_TNBC_BONE_M...1,SET,10,0.011591,0.00027043,0.29804,0.48449,HEBERT_MATRISOME_TNBC_BONE_METASTASIS,0.995774082381729
MIR6748_3P,SET,79,0.0037077,0.00024268,0.095437,0.48451,MIR6748_3P,0.995774082381729
DARWICHE_PAPILLOMA_RISK_HIGH...1,SET,163,0.0024873,0.00023331,0.064091,0.48452,DARWICHE_PAPILLOMA_RISK_HIGH_DN,0.995774082381729
GSE28449_WT_VS_LRF_KO_GERMIN...1,SET,171,0.0025481,0.00024476,0.066066,0.48462,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_DN,0.995774082381729
GOBP_ANTEROGRADE_DENDRITIC_T...1,SET,9,0.010612,0.00023489,0.27572,0.48465,GOBP_ANTEROGRADE_DENDRITIC_TRANSPORT,0.995774082381729
GOBP_CARDIOCYTE_DIFFERENTIAT...,SET,142,0.0028467,0.00024938,0.074439,0.48475,GOBP_CARDIOCYTE_DIFFERENTIATION,0.995774082381729
MIR652_3P,SET,4,0.018763,0.00027691,0.49161,0.48478,MIR652_3P,0.995774082381729
ZNF549_TARGET_GENES,SET,1015,0.0010158,0.00023213,0.026759,0.48486,ZNF549_TARGET_GENES,0.995774082381729
GSE21033_CTRL_VS_POLYIC_STIM...6,SET,142,0.0027271,0.0002389,0.071906,0.48487,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP,0.995774082381729
ASXL2_TARGET_GENES,SET,38,0.0050893,0.00023129,0.13436,0.48489,ASXL2_TARGET_GENES,0.995774082381729
GOBP_MEMBRANE_FUSION_INVOLVE...,SET,4,0.018071,0.0002667,0.4769,0.48489,GOBP_MEMBRANE_FUSION_INVOLVED_IN_VIRAL_ENTRY_INTO_HOST_CELL,0.995774082381729
HP_THYROID_CARCINOMA,SET,57,0.004193,0.00023326,0.11068,0.48489,HP_THYROID_CARCINOMA,0.995774082381729
GOBP_CORTISOL_METABOLIC_PROC...,SET,12,0.0099983,0.00025552,0.26441,0.48492,GOBP_CORTISOL_METABOLIC_PROCESS,0.995774082381729
GOCC_MRNA_CLEAVAGE_FACTOR_CO...,SET,22,0.0060233,0.00020837,0.15997,0.48498,GOCC_MRNA_CLEAVAGE_FACTOR_COMPLEX,0.995774082381729
MIR6802_5P,SET,22,0.0068134,0.0002357,0.1817,0.48504,MIR6802_5P,0.995774082381729
MIR6880_5P,SET,87,0.00341,0.00023417,0.090976,0.48505,MIR6880_5P,0.995774082381729
DING_LUNG_CANCER_BY_MUTATION...,SET,20,0.0074755,0.00024659,0.19975,0.48507,DING_LUNG_CANCER_BY_MUTATION_RATE,0.995774082381729
SETBP1_TARGET_GENES,SET,149,0.0025935,0.00023268,0.069287,0.48507,SETBP1_TARGET_GENES,0.995774082381729
LI_WILMS_TUMOR_ANAPLASTIC_UP,SET,17,0.0070968,0.00021584,0.19053,0.48514,LI_WILMS_TUMOR_ANAPLASTIC_UP,0.995774082381729
REACTOME_E2F_ENABLED_INHIBIT...,SET,9,0.010192,0.0002256,0.27468,0.4852,REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION,0.995774082381729
GAVISH_3CA_METAPROGRAM_CD8_T...4,SET,46,0.0046998,0.00023495,0.12674,0.48521,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_DYSFUNCTION,0.995774082381729
GOMF_ENZYME_INHIBITOR_ACTIVI...,SET,352,0.0017483,0.00023974,0.047154,0.48521,GOMF_ENZYME_INHIBITOR_ACTIVITY,0.995774082381729
CAVIN1_TARGET_GENES,SET,62,0.0038043,0.00022069,0.10288,0.48525,CAVIN1_TARGET_GENES,0.995774082381729
GOMF_COMPLEMENT_RECEPTOR_ACT...,SET,10,0.012784,0.00029826,0.34837,0.48536,GOMF_COMPLEMENT_RECEPTOR_ACTIVITY,0.995774082381729
GOBP_AMINOGLYCAN_CATABOLIC_P...,SET,32,0.0054822,0.00022867,0.15016,0.48544,GOBP_AMINOGLYCAN_CATABOLIC_PROCESS,0.995774082381729
GOBP_CHROMATIN_LOOPING,SET,10,0.0091886,0.00021438,0.2523,0.48547,GOBP_CHROMATIN_LOOPING,0.995774082381729
HP_CORTICAL_THICKENING_OF_LO...,SET,5,0.012691,0.0002094,0.34933,0.48551,HP_CORTICAL_THICKENING_OF_LONG_BONE_DIAPHYSES,0.995774082381729
HP_ABNORMAL_CERVICAL_SPINE_M...,SET,19,0.0074025,0.000238,0.20429,0.48555,HP_ABNORMAL_CERVICAL_SPINE_MORPHOLOGY,0.995774082381729
GAVISH_3CA_MALIGNANT_METAPRO...17,SET,38,0.0054817,0.00024912,0.15186,0.4856,GAVISH_3CA_MALIGNANT_METAPROGRAM_26_NPC_GLIOMA,0.995774082381729
DESCARTES_FETAL_PANCREAS_STR...,SET,16,0.0081269,0.0002398,0.22508,0.4856,DESCARTES_FETAL_PANCREAS_STROMAL_CELLS,0.995774082381729
WP_GLYCOLYSIS_IN_SENESCENCE,SET,9,0.0093792,0.0002076,0.2605,0.48564,WP_GLYCOLYSIS_IN_SENESCENCE,0.995774082381729
RAPA_EARLY_UP.V1_UP,SET,142,0.0026588,0.00023291,0.074065,0.48568,RAPA_EARLY_UP.V1_UP,0.995774082381729
GOBP_LOBAR_BRONCHUS_EPITHELI...,SET,5,0.015543,0.00025646,0.4331,0.48569,GOBP_LOBAR_BRONCHUS_EPITHELIUM_DEVELOPMENT,0.995774082381729
CIITA_TARGET_GENES,SET,973,0.00097928,0.00021938,0.027317,0.4857,CIITA_TARGET_GENES,0.995774082381729
REACTOME_FLT3_SIGNALING_BY_C...,SET,6,0.011447,0.00020689,0.31943,0.48571,REACTOME_FLT3_SIGNALING_BY_CBL_MUTANTS,0.995774082381729
GOMF_FIBRONECTIN_BINDING,SET,30,0.0062577,0.00025274,0.1749,0.48573,GOMF_FIBRONECTIN_BINDING,0.995774082381729
HP_ABNORMAL_LYMPHOCYTE_MORPH...,SET,221,0.0020501,0.00022357,0.057388,0.48575,HP_ABNORMAL_LYMPHOCYTE_MORPHOLOGY,0.995774082381729
GAO_STOMACH_24W_C2_TFF2POS_M...,SET,6,0.014457,0.0002613,0.40522,0.48577,GAO_STOMACH_24W_C2_TFF2POS_MULTIPOTENT_PROGENITOR,0.995774082381729
DORN_ADENOVIRUS_INFECTION_24...2,SET,11,0.0081978,0.00020059,0.23054,0.48582,DORN_ADENOVIRUS_INFECTION_24HR_UP,0.995774082381729
MORF_NOS2A,SET,263,0.0018728,0.00022252,0.052691,0.48582,MORF_NOS2A,0.995774082381729
HP_ANISOCORIA,SET,15,0.00776,0.00022171,0.21961,0.48591,HP_ANISOCORIA,0.995774082381729
BROWNE_HCMV_INFECTION_18HR_UP,SET,156,0.0023356,0.00021436,0.06648,0.48599,BROWNE_HCMV_INFECTION_18HR_UP,0.995774082381729
GOCC_ENZYME_ACTIVATOR_COMPLEX,SET,13,0.0069298,0.00018433,0.1973,0.48599,GOCC_ENZYME_ACTIVATOR_COMPLEX,0.995774082381729
GSE26912_TUMORICIDAL_VS_CTRL...2,SET,187,0.0022118,0.00022207,0.063011,0.486,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_UP,0.995774082381729
ETS_Q4,SET,227,0.001982,0.00021902,0.056511,0.48601,ETS_Q4,0.995774082381729
HP_DECREASED_CIRCULATING_IGE,SET,5,0.012924,0.00021325,0.36881,0.48602,HP_DECREASED_CIRCULATING_IGE,0.995774082381729
GOBP_SYNAPTIC_TRANSMISSION_D...,SET,27,0.0055147,0.00021132,0.15753,0.48604,GOBP_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,0.995774082381729
ONDER_CDH1_SIGNALING_VIA_CTN...,SET,79,0.0036357,0.00023797,0.10435,0.4861,ONDER_CDH1_SIGNALING_VIA_CTNNB1,0.995774082381729
MGGAAGTG_GABP_B,SET,698,0.0011087,0.00021202,0.031836,0.48611,MGGAAGTG_GABP_B,0.995774082381729
IRX3_TARGET_GENES,SET,44,0.004474,0.00021875,0.12862,0.48613,IRX3_TARGET_GENES,0.995774082381729
GOBP_REGULATION_OF_IRON_ION_...2,SET,6,0.011305,0.00020433,0.3255,0.48615,GOBP_REGULATION_OF_IRON_ION_TRANSPORT,0.995774082381729
CTAGGAA_MIR384,SET,56,0.0040592,0.00022383,0.11725,0.48619,CTAGGAA_MIR384,0.995774082381729
REACTOME_TELOMERE_MAINTENANCE,SET,61,0.0034524,0.00019866,0.09983,0.48621,REACTOME_TELOMERE_MAINTENANCE,0.995774082381729
GTAAGAT_MIR200A,SET,44,0.0044952,0.00021979,0.13,0.48621,GTAAGAT_MIR200A,0.995774082381729
HP_ABNORMAL_HEAD_BLOOD_VESSE...,SET,64,0.0039176,0.00023089,0.11351,0.48623,HP_ABNORMAL_HEAD_BLOOD_VESSEL_MORPHOLOGY,0.995774082381729
GOBP_ANTIGEN_PROCESSING_AND_...6,SET,36,0.0051929,0.00022971,0.15056,0.48624,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN,0.995774082381729
GSE3982_MAC_VS_NEUTROPHIL_LP...1,SET,166,0.0022863,0.0002164,0.066256,0.48624,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN,0.995774082381729
GOBP_RRNA_METHYLATION,SET,17,0.0059989,0.00018245,0.17497,0.48632,GOBP_RRNA_METHYLATION,0.995774082381729
SENGUPTA_NASOPHARYNGEAL_CARC...4,SET,362,0.0015964,0.00022193,0.046565,0.48633,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,0.995774082381729
GOCC_GTPASE_COMPLEX,SET,38,0.0047793,0.0002172,0.14035,0.48642,GOCC_GTPASE_COMPLEX,0.995774082381729
GAO_STOMACH_24W_C6_PIT_CELL,SET,12,0.0078394,0.00020035,0.23053,0.48644,GAO_STOMACH_24W_C6_PIT_CELL,0.995774082381729
GOMF_HISTONE_H3K36_TRIMETHYL...,SET,4,0.012226,0.00018044,0.36064,0.48648,GOMF_HISTONE_H3K36_TRIMETHYLTRANSFERASE_ACTIVITY,0.995774082381729
GOBP_POSITIVE_REGULATION_OF_...123,SET,31,0.005235,0.00021492,0.15457,0.48649,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.995774082381729
WP_EPO_RECEPTOR_SIGNALING,SET,26,0.0060276,0.00022666,0.17821,0.48651,WP_EPO_RECEPTOR_SIGNALING,0.995774082381729
HP_RENAL_ATROPHY,SET,7,0.01041,0.00020323,0.30892,0.48656,HP_RENAL_ATROPHY,0.995774082381729
GOBP_POSITIVE_REGULATION_OF_...158,SET,12,0.0082861,0.00021176,0.24736,0.48664,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.995774082381729
GOBP_CDP_DIACYLGLYCEROL_BIOS...,SET,11,0.0093067,0.00022773,0.27885,0.48669,GOBP_CDP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.995774082381729
GOBP_TERPENOID_CATABOLIC_PRO...,SET,7,0.011517,0.00022484,0.3458,0.48672,GOBP_TERPENOID_CATABOLIC_PROCESS,0.995774082381729
GOBP_TRANSFORMING_GROWTH_FAC...3,SET,31,0.0054055,0.00022192,0.16235,0.48672,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.995774082381729
GOBP_PROTEIN_N_LINKED_GLYCOS...1,SET,69,0.0032549,0.00019916,0.0979,0.48674,GOBP_PROTEIN_N_LINKED_GLYCOSYLATION,0.995774082381729
REACTOME_RESPIRATORY_ELECTRO...,SET,135,0.0021111,0.00018036,0.063544,0.48675,REACTOME_RESPIRATORY_ELECTRON_TRANSPORT,0.995774082381729
HP_TOENAIL_DYSPLASIA,SET,15,0.0080129,0.00022893,0.24253,0.48682,HP_TOENAIL_DYSPLASIA,0.995774082381729
GOBP_VACUOLAR_LOCALIZATION,SET,75,0.0032679,0.00020843,0.098955,0.48683,GOBP_VACUOLAR_LOCALIZATION,0.995774082381729
MIR4448,SET,61,0.0035861,0.00020636,0.10885,0.48686,MIR4448,0.995774082381729
GOBP_CEREBRAL_CORTEX_NEURON_...,SET,22,0.006633,0.00022946,0.20128,0.48686,GOBP_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION,0.995774082381729
WEST_ADRENOCORTICAL_TUMOR_MA...1,SET,18,0.0071795,0.00022468,0.21874,0.48691,WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN,0.995774082381729
DUTERTRE_ESTRADIOL_RESPONSE_...1,SET,475,0.0013569,0.00021541,0.041393,0.48692,DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN,0.995774082381729
GOCC_GBAF_COMPLEX,SET,12,0.0075055,0.00019181,0.2288,0.48692,GOCC_GBAF_COMPLEX,0.995774082381729
HP_ABNORMAL_SOFT_PALATE_MORP...,SET,224,0.0018075,0.00019842,0.055118,0.48692,HP_ABNORMAL_SOFT_PALATE_MORPHOLOGY,0.995774082381729
MIR6755_3P,SET,72,0.0033005,0.00020627,0.10082,0.48694,MIR6755_3P,0.995774082381729
REACTOME_GOLGI_ASSOCIATED_VE...,SET,50,0.0037399,0.0001949,0.11436,0.48696,REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,0.995774082381729
HP_MYOCLONIC_STATUS_EPILEPTI...,SET,5,0.013292,0.00021932,0.40679,0.48697,HP_MYOCLONIC_STATUS_EPILEPTICUS,0.995774082381729
GOBP_MACROPHAGE_ACTIVATION_I...,SET,19,0.0066311,0.0002132,0.20372,0.48702,GOBP_MACROPHAGE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.995774082381729
GOBP_GLOMERULAR_EPITHELIUM_D...,SET,25,0.0061704,0.00022753,0.18976,0.48703,GOBP_GLOMERULAR_EPITHELIUM_DEVELOPMENT,0.995774082381729
BIOCARTA_GSK3_PATHWAY,SET,19,0.0065802,0.00021156,0.20345,0.4871,BIOCARTA_GSK3_PATHWAY,0.995774082381729
HP_ABNORMAL_MALE_GERM_CELL_M...,SET,57,0.0035511,0.00019755,0.11009,0.48713,HP_ABNORMAL_MALE_GERM_CELL_MORPHOLOGY,0.995774082381729
GOBP_REGULATION_OF_POTASSIUM...1,SET,7,0.010537,0.0002057,0.32688,0.48714,GOBP_REGULATION_OF_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.995774082381729
GOBP_NEGATIVE_REGULATION_OF_...378,SET,5,0.012162,0.00020067,0.37819,0.48717,GOBP_NEGATIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,0.995774082381729
GOBP_OLIGOSACCHARIDE_CATABOL...,SET,16,0.0069724,0.00020573,0.21843,0.48727,GOBP_OLIGOSACCHARIDE_CATABOLIC_PROCESS,0.995774082381729
GSE37301_HEMATOPOIETIC_STEM_...12,SET,176,0.002051,0.00019984,0.064338,0.48728,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP,0.995774082381729
REACTOME_SUMOYLATION_OF_DNA_...1,SET,70,0.0030879,0.0001903,0.097665,0.48739,REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,0.995774082381729
GOBP_REGULATION_OF_PROTEIN_C...3,SET,13,0.006478,0.00017231,0.20631,0.48748,GOBP_REGULATION_OF_PROTEIN_COMPLEX_STABILITY,0.995774082381729
HP_APLASIA_CUTIS_CONGENITA_O...2,SET,6,0.010906,0.00019711,0.34762,0.48749,HP_APLASIA_CUTIS_CONGENITA_ON_TRUNK_OR_LIMBS,0.995774082381729
MCBRYAN_PUBERTAL_BREAST_3_4W...1,SET,32,0.0045635,0.00019035,0.14567,0.4875,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,0.995774082381729
MIR4503,SET,248,0.0017373,0.00020054,0.055789,0.48758,MIR4503,0.995774082381729
GSE39382_IL3_VS_IL3_IL33_TRE...2,SET,182,0.0018378,0.00018207,0.059127,0.4876,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_UP,0.995774082381729
HP_DEVIATION_OF_THE_4TH_FING...,SET,8,0.010269,0.0002143,0.33066,0.48761,HP_DEVIATION_OF_THE_4TH_FINGER,0.995774082381729
HE_LIM_SUN_FETAL_LUNG_C3_EAR...,SET,592,0.0010478,0.00018509,0.033852,0.48765,HE_LIM_SUN_FETAL_LUNG_C3_EARLY_CAP_CELL,0.995774082381729
HP_ABNORMAL_AMPLITUDE_OF_PAT...,SET,6,0.011339,0.00020495,0.36656,0.48766,HP_ABNORMAL_AMPLITUDE_OF_PATTERN_ELECTRORETINOGRAM,0.995774082381729
REACTOME_TRYPTOPHAN_CATABOLI...,SET,12,0.0078904,0.00020165,0.25605,0.48771,REACTOME_TRYPTOPHAN_CATABOLISM,0.995774082381729
GOBP_CGAS_STING_SIGNALING_PA...,SET,15,0.0059781,0.0001708,0.19405,0.48771,GOBP_CGAS_STING_SIGNALING_PATHWAY,0.995774082381729
CALVET_IRINOTECAN_SENSITIVE_...2,SET,5,0.011708,0.00019317,0.3804,0.48772,CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN,0.995774082381729
HP_MOTOR_AXONAL_NEUROPATHY,SET,34,0.0039689,0.00017063,0.12899,0.48773,HP_MOTOR_AXONAL_NEUROPATHY,0.995774082381729
GSE18281_PERIMEDULLARY_CORTI...2,SET,186,0.0018472,0.00018497,0.060087,0.48774,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,0.995774082381729
PEREZ_TP53_TARGETS,SET,1025,0.0008311,0.00019081,0.027125,0.48778,PEREZ_TP53_TARGETS,0.995774082381729
GOBP_POSITIVE_REGULATION_OF_...576,SET,79,0.0031306,0.0002049,0.10231,0.48779,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,0.995774082381729
FOURATI_BLOOD_TWINRIX_AGE_25...2,SET,407,0.0013088,0.00019269,0.042976,0.48785,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP,0.995774082381729
FLECHNER_BIOPSY_KIDNEY_TRANS...2,SET,509,0.001121,0.00018405,0.037091,0.48794,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,0.995774082381729
UNTERMAN_IPF_VS_CTRL_B_CELL_...,SET,27,0.0058154,0.00022284,0.19253,0.48795,UNTERMAN_IPF_VS_CTRL_B_CELL_DN,0.995774082381729
GOBP_NUCLEOSIDE_MONOPHOSPHAT...3,SET,69,0.0030613,0.00018731,0.1017,0.48799,GOBP_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.995774082381729
GOBP_REGULATION_OF_STRIATED_...2,SET,87,0.002768,0.00019009,0.092332,0.48804,GOBP_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,0.995774082381729
REACTOME_RAC3_GTPASE_CYCLE,SET,82,0.0029307,0.00019541,0.097928,0.48806,REACTOME_RAC3_GTPASE_CYCLE,0.995774082381729
GSE16522_ANTI_CD3CD28_STIM_V...1,SET,175,0.0018254,0.00017735,0.060985,0.48806,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN,0.995774082381729
GOBP_BRONCHIOLE_DEVELOPMENT,SET,6,0.011283,0.00020393,0.37735,0.48807,GOBP_BRONCHIOLE_DEVELOPMENT,0.995774082381729
P53_DN.V2_UP,SET,132,0.0023469,0.00019828,0.078594,0.48809,P53_DN.V2_UP,0.995774082381729
WANG_NEOPLASTIC_TRANSFORMATI...,SET,17,0.0073303,0.00022294,0.24737,0.48818,WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC,0.995774082381729
HP_EBSTEIN_ANOMALY_OF_THE_TR...,SET,5,0.012774,0.00021076,0.43116,0.48818,HP_EBSTEIN_ANOMALY_OF_THE_TRICUSPID_VALVE,0.995774082381729
REACTOME_BRANCHED_CHAIN_AMIN...,SET,20,0.005364,0.00017694,0.18109,0.48819,REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM,0.995774082381729
BENPORATH_ES_WITH_H3K27ME3,SET,1000,0.00089903,0.00020402,0.030635,0.48829,BENPORATH_ES_WITH_H3K27ME3,0.995774082381729
LUND_SILENCED_BY_METHYLATION,SET,14,0.0061337,0.00016931,0.20889,0.48829,LUND_SILENCED_BY_METHYLATION,0.995774082381729
GOBP_PROLACTIN_SECRETION,SET,5,0.012201,0.00020131,0.41662,0.48832,GOBP_PROLACTIN_SECRETION,0.995774082381729
GOBP_NEGATIVE_REGULATION_OF_...303,SET,17,0.0058635,0.00017833,0.20086,0.48836,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,0.995774082381729
HP_UNILATERAL_RENAL_HYPOPLAS...,SET,4,0.012458,0.00018385,0.42693,0.48836,HP_UNILATERAL_RENAL_HYPOPLASIA,0.995774082381729
MEBARKI_HCC_PROGENITOR_WNT_U...1,SET,107,0.0025676,0.00019544,0.088108,0.48838,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,0.995774082381729
GOBP_HOMEOSTASIS_OF_NUMBER_O...2,SET,33,0.0044278,0.00018754,0.15193,0.48838,GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE,0.995774082381729
MIR6754_3P,SET,87,0.0027032,0.00018564,0.09331,0.48844,MIR6754_3P,0.995774082381729
GOBP_POSITIVE_REGULATION_OF_...496,SET,30,0.0047304,0.00019105,0.16327,0.48844,GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.995774082381729
GOMF_CYSTEINE_TYPE_ENDOPEPTI...3,SET,12,0.0070003,0.0001789,0.24238,0.48848,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.995774082381729
HP_GENERALIZED_AMINOACIDURIA,SET,14,0.0067882,0.00018737,0.23503,0.48848,HP_GENERALIZED_AMINOACIDURIA,0.995774082381729
MIR514B_5P,SET,167,0.001872,0.00017772,0.064867,0.48849,MIR514B_5P,0.995774082381729
DESCARTES_FETAL_THYMUS_VASCU...,SET,112,0.0024891,0.00019381,0.086259,0.48849,DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS,0.995774082381729
GOBP_POSITIVE_REGULATION_OF_...340,SET,8,0.0089552,0.00018689,0.31083,0.48851,GOBP_POSITIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,0.995774082381729
REACTOME_RRNA_MODIFICATION_I...2,SET,51,0.0031284,0.00016465,0.1088,0.48853,REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,0.995774082381729
FAN_EMBRYONIC_CTX_NSC_1,SET,16,0.0065814,0.0001942,0.22879,0.48853,FAN_EMBRYONIC_CTX_NSC_1,0.995774082381729
GOBP_LEFT_RIGHT_AXIS_SPECIFI...,SET,12,0.0077289,0.00019752,0.2691,0.48854,GOBP_LEFT_RIGHT_AXIS_SPECIFICATION,0.995774082381729
KEGG_MEDICUS_REFERENCE_TRANS...1,SET,11,0.0068102,0.00016664,0.23761,0.48857,KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27,0.995774082381729
GOBP_INTRINSIC_APOPTOTIC_SIG...5,SET,58,0.0029977,0.00016822,0.10476,0.48859,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.995774082381729
GSE17721_CTRL_VS_GARDIQUIMOD...15,SET,184,0.0017494,0.00017424,0.061312,0.48862,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN,0.995774082381729
GSE22886_NAIVE_VS_IGM_MEMORY...2,SET,173,0.001835,0.00017728,0.064394,0.48863,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP,0.995774082381729
MIR4524A_5P,SET,221,0.0016387,0.0001787,0.057755,0.48868,MIR4524A_5P,0.995774082381729
MIR4524B_5P,SET,221,0.0016387,0.0001787,0.057755,0.48868,MIR4524B_5P,0.995774082381729
HP_VENTRICULAR_ESCAPE_RHYTHM,SET,8,0.0088158,0.00018398,0.31108,0.4887,HP_VENTRICULAR_ESCAPE_RHYTHM,0.995774082381729
GSE43863_TH1_VS_TFH_EFFECTOR...2,SET,187,0.0017873,0.00017946,0.063086,0.4887,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_UP,0.995774082381729
GOMF_BIOTIN_BINDING,SET,5,0.011447,0.00018887,0.40565,0.48874,GOMF_BIOTIN_BINDING,0.995774082381729
MIR320E,SET,60,0.0030506,0.0001741,0.10894,0.48883,MIR320E,0.995774082381729
MIR8082,SET,104,0.0022929,0.00017208,0.081971,0.48884,MIR8082,0.995774082381729
GSE360_HIGH_VS_LOW_DOSE_B_MA...3,SET,179,0.0017262,0.0001696,0.061713,0.48884,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN,0.995774082381729
GR_Q6,SET,234,0.0015768,0.00017687,0.05642,0.48885,GR_Q6,0.995774082381729
MIR4668_5P,SET,425,0.0011467,0.00017243,0.041219,0.4889,MIR4668_5P,0.995774082381729
SMIRNOV_CIRCULATING_ENDOTHEL...1,SET,5,0.010596,0.00017482,0.38109,0.48891,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN,0.995774082381729
GOBP_ER_OVERLOAD_RESPONSE,SET,10,0.0088071,0.00020548,0.31688,0.48891,GOBP_ER_OVERLOAD_RESPONSE,0.995774082381729
REACTOME_PD_1_SIGNALING,SET,18,0.00611,0.00019121,0.21994,0.48892,REACTOME_PD_1_SIGNALING,0.995774082381729
HP_SHORT_DIGIT,SET,523,0.0010197,0.00016963,0.036831,0.48896,HP_SHORT_DIGIT,0.995774082381729
HP_CRYPTORCHIDISM,SET,636,0.00092562,0.00016926,0.033576,0.489,HP_CRYPTORCHIDISM,0.995774082381729
REACTOME_MAPK_TARGETS_NUCLEA...,SET,29,0.0044812,0.00017795,0.16325,0.48905,REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,0.995774082381729
GATA1_01,SET,216,0.0016017,0.0001727,0.0586,0.4891,GATA1_01,0.995774082381729
GOBP_PYRIMIDINE_NUCLEOSIDE_D...1,SET,6,0.0083508,0.00015093,0.30564,0.4891,GOBP_PYRIMIDINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.995774082381729
GOBP_NEURAL_CREST_FORMATION,SET,15,0.0063483,0.00018137,0.23258,0.48911,GOBP_NEURAL_CREST_FORMATION,0.995774082381729
HP_BIPARIETAL_NARROWING,SET,60,0.0026429,0.00015083,0.097043,0.48914,HP_BIPARIETAL_NARROWING,0.995774082381729
GOBP_REGULATION_OF_MEMBRANE_...9,SET,24,0.0046786,0.00016904,0.17213,0.48916,GOBP_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.995774082381729
HP_MOTOR_DELAY,SET,852,0.00078507,0.00016514,0.028945,0.48918,HP_MOTOR_DELAY,0.995774082381729
LIU_IL13_MEMORY_MODEL_DN,SET,4,0.010016,0.00014783,0.36973,0.48919,LIU_IL13_MEMORY_MODEL_DN,0.995774082381729
REACTOME_PEROXISOMAL_LIPID_M...,SET,28,0.0041334,0.00016129,0.15248,0.48919,REACTOME_PEROXISOMAL_LIPID_METABOLISM,0.995774082381729
GOMF_PHOSPHOLIPASE_BINDING,SET,17,0.0056924,0.00017313,0.21054,0.48922,GOMF_PHOSPHOLIPASE_BINDING,0.995774082381729
MEBARKI_HCC_PROGENITOR_WNT_UP,SET,168,0.0018737,0.00017841,0.069679,0.48927,MEBARKI_HCC_PROGENITOR_WNT_UP,0.995774082381729
GOBP_REGULATION_OF_CYSTEINE_...4,SET,5,0.0094911,0.0001566,0.35469,0.48933,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,0.995774082381729
REACTOME_NFE2L2_REGULATING_T...,SET,11,0.0072892,0.00017836,0.27331,0.48936,REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES,0.995774082381729
MIR604,SET,13,0.0058744,0.00015625,0.22016,0.48936,MIR604,0.995774082381729
GSE33374_CD8_ALPHAALPHA_VS_A...2,SET,186,0.001658,0.00016603,0.062225,0.48937,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,0.995774082381729
GOMF_GAP_JUNCTION_CHANNEL_AC...3,SET,8,0.0084113,0.00017554,0.31774,0.48944,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY_INVOLVED_IN_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,0.995774082381729
WP_RESISTIN_AS_A_REGULATOR_O...,SET,32,0.0039047,0.00016287,0.14783,0.48946,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,0.995774082381729
KEGG_MEDICUS_ENV_FACTOR_ARSE...,SET,16,0.00494,0.00014576,0.18705,0.48947,KEGG_MEDICUS_ENV_FACTOR_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.995774082381729
GOBP_CELL_FATE_SPECIFICATION,SET,101,0.0023393,0.00017302,0.088651,0.48947,GOBP_CELL_FATE_SPECIFICATION,0.995774082381729
GOBP_SPERM_EGG_RECOGNITION,SET,49,0.0030796,0.00015888,0.11679,0.48948,GOBP_SPERM_EGG_RECOGNITION,0.995774082381729
WP_CLEAR_CELL_RENAL_CELL_CAR...,SET,80,0.0024595,0.00016199,0.093563,0.48951,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,0.995774082381729
MIR205_5P,SET,201,0.00157,0.00016337,0.060028,0.48957,MIR205_5P,0.995774082381729
HP_HYPOAUTOFLUORESCENT_RETIN...,SET,5,0.011862,0.00019572,0.45527,0.48961,HP_HYPOAUTOFLUORESCENT_RETINAL_LESION,0.995774082381729
DARWICHE_PAPILLOMA_RISK_HIGH...2,SET,137,0.0019157,0.00016486,0.073651,0.48962,DARWICHE_PAPILLOMA_RISK_HIGH_UP,0.995774082381729
GSE360_LOW_DOSE_B_MALAYI_VS_...3,SET,181,0.0015745,0.00015555,0.060482,0.48962,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,0.995774082381729
BILANGES_SERUM_RESPONSE_TRAN...,SET,29,0.0040045,0.00015902,0.15532,0.48972,BILANGES_SERUM_RESPONSE_TRANSLATION,0.995774082381729
DESCARTES_FETAL_EYE_RETINAL_...1,SET,63,0.0029448,0.0001722,0.11476,0.48976,DESCARTES_FETAL_EYE_RETINAL_PIGMENT_CELLS,0.995774082381729
MORF_ORC1L,SET,62,0.0025478,0.0001478,0.099711,0.48981,MORF_ORC1L,0.995774082381729
GOBP_NEUROMUSCULAR_PROCESS_C...2,SET,16,0.0052389,0.00015458,0.2051,0.48981,GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE,0.995774082381729
HP_NEONATAL_ONSET,SET,427,0.0010308,0.00015535,0.040332,0.48981,HP_NEONATAL_ONSET,0.995774082381729
HP_RECURRENT_INFECTION_OF_TH...,SET,35,0.0035519,0.00015493,0.13934,0.48983,HP_RECURRENT_INFECTION_OF_THE_GASTROINTESTINAL_TRACT,0.995774082381729
GOMF_COPPER_ION_TRANSMEMBRAN...,SET,6,0.008139,0.0001471,0.32019,0.48986,GOMF_COPPER_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.995774082381729
HP_CERVICAL_SUBLUXATION,SET,8,0.0074287,0.00015503,0.29237,0.48986,HP_CERVICAL_SUBLUXATION,0.995774082381729
GOBP_B_CELL_HOMEOSTASIS,SET,30,0.0041353,0.00016702,0.16337,0.4899,GOBP_B_CELL_HOMEOSTASIS,0.995774082381729
GAVISH_3CA_METAPROGRAM_EPITH...1,SET,48,0.0033535,0.00017124,0.13286,0.48993,GAVISH_3CA_METAPROGRAM_EPITHELIAL_ALVEOLAR,0.995774082381729
HP_ABNORMAL_MUSCULOSKELETAL_...,SET,1455,0.00057586,0.00015555,0.022803,0.48993,HP_ABNORMAL_MUSCULOSKELETAL_PHYSIOLOGY,0.995774082381729
GOBP_HEMATOPOIETIC_STEM_CELL...3,SET,9,0.0069352,0.00015351,0.2758,0.48997,GOBP_HEMATOPOIETIC_STEM_CELL_MIGRATION,0.995774082381729
HP_FLATTENED_FEMORAL_EPIPHYS...,SET,12,0.0060082,0.00015355,0.23935,0.48999,HP_FLATTENED_FEMORAL_EPIPHYSIS,0.995774082381729
HP_NOCTURNAL_HYPOVENTILATION,SET,15,0.0049478,0.00014136,0.19718,0.48999,HP_NOCTURNAL_HYPOVENTILATION,0.995774082381729
GSE2770_IL12_VS_IL4_TREATED_...4,SET,182,0.0014897,0.00014758,0.059452,0.49,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.995774082381729
LIU_SMARCA4_TARGETS,SET,43,0.0034715,0.0001678,0.1399,0.4901,LIU_SMARCA4_TARGETS,0.995774082381729
GOCC_NUCLEAR_OUTER_MEMBRANE_...,SET,1100,0.00065379,0.00015516,0.02639,0.49012,GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK,0.995774082381729
GOMF_DELAYED_RECTIFIER_POTAS...,SET,27,0.0046716,0.00017901,0.18905,0.49014,GOMF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.995774082381729
EBNA1BP2_TARGET_GENES,SET,290,0.0012138,0.00015134,0.049175,0.49015,EBNA1BP2_TARGET_GENES,0.995774082381729
CSR_LATE_UP.V1_UP,SET,154,0.0016641,0.00015176,0.067392,0.49015,CSR_LATE_UP.V1_UP,0.995774082381729
GOCC_MICROTUBULE_PLUS_END,SET,24,0.0040272,0.00014551,0.16424,0.49022,GOCC_MICROTUBULE_PLUS_END,0.995774082381729
AP2_Q3,SET,230,0.0013407,0.00014911,0.054714,0.49023,AP2_Q3,0.995774082381729
JIANG_MELANOMA_TRM11_CD8,SET,43,0.0033492,0.00016189,0.13694,0.49024,JIANG_MELANOMA_TRM11_CD8,0.995774082381729
REACTOME_GLYCOSPHINGOLIPID_M...,SET,50,0.0030127,0.000157,0.12324,0.49025,REACTOME_GLYCOSPHINGOLIPID_METABOLISM,0.995774082381729
HP_ABNORMALITY_OF_THE_KNEE,SET,371,0.0010908,0.00015348,0.044612,0.49025,HP_ABNORMALITY_OF_THE_KNEE,0.995774082381729
GOBP_NEGATIVE_REGULATION_OF_...254,SET,39,0.0034268,0.00015776,0.14032,0.49026,GOBP_NEGATIVE_REGULATION_OF_GLIOGENESIS,0.995774082381729
HP_EPISODIC_FLACCID_WEAKNESS,SET,5,0.01006,0.00016599,0.41342,0.49029,HP_EPISODIC_FLACCID_WEAKNESS,0.995774082381729
HORIUCHI_WTAP_TARGETS_DN,SET,284,0.001197,0.00014771,0.049281,0.49031,HORIUCHI_WTAP_TARGETS_DN,0.995774082381729
GSE19512_NAUTRAL_VS_INDUCED_...1,SET,173,0.001572,0.00015187,0.064844,0.49033,GSE19512_NAUTRAL_VS_INDUCED_TREG_DN,0.995774082381729
CHAUHAN_RESPONSE_TO_METHOXYE...2,SET,41,0.0028486,0.00013446,0.11812,0.49038,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,0.995774082381729
HNF1_C,SET,225,0.0014061,0.00015469,0.058529,0.49042,HNF1_C,0.995774082381729
GAUSSMANN_MLL_AF4_FUSION_TAR...3,SET,6,0.0089911,0.00016251,0.37534,0.49044,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN,0.995774082381729
SNIP1_TARGET_GENES,SET,593,0.00082525,0.00014589,0.034586,0.49048,SNIP1_TARGET_GENES,0.995774082381729
SAFFORD_T_LYMPHOCYTE_ANERGY,SET,85,0.002205,0.00014968,0.09251,0.49049,SAFFORD_T_LYMPHOCYTE_ANERGY,0.995774082381729
GOBP_REGULATION_OF_PRIMARY_M...,SET,5,0.0099522,0.00016421,0.41768,0.4905,GOBP_REGULATION_OF_PRIMARY_MIRNA_PROCESSING,0.995774082381729
ESC_V6.5_UP_EARLY.V1_UP,SET,154,0.0016212,0.00014785,0.068141,0.49051,ESC_V6.5_UP_EARLY.V1_UP,0.995774082381729
GOBP_MEMBRANE_REPOLARIZATION,SET,48,0.0030674,0.00015663,0.12901,0.49052,GOBP_MEMBRANE_REPOLARIZATION,0.995774082381729
GOBP_NEUROTROPHIN_TRK_RECEPT...,SET,24,0.0037811,0.00013661,0.15907,0.49052,GOBP_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,0.995774082381729
GOBP_SPONTANEOUS_SYNAPTIC_TR...,SET,13,0.0055152,0.0001467,0.23278,0.49055,GOBP_SPONTANEOUS_SYNAPTIC_TRANSMISSION,0.995774082381729
GOBP_NEGATIVE_REGULATION_OF_...35,SET,16,0.0049932,0.00014733,0.21133,0.49058,GOBP_NEGATIVE_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.995774082381729
GOBP_REGULATION_OF_GROWTH_HO...,SET,6,0.0089051,0.00016095,0.37705,0.49058,GOBP_REGULATION_OF_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.995774082381729
HP_ACUTE_ENCEPHALOPATHY,SET,10,0.0064921,0.00015147,0.27499,0.49058,HP_ACUTE_ENCEPHALOPATHY,0.995774082381729
HP_HYPOPIGMENTATION_OF_THE_S...,SET,179,0.001442,0.00014168,0.061504,0.49065,HP_HYPOPIGMENTATION_OF_THE_SKIN,0.995774082381729
GOBP_PROTEIN_LOCALIZATION_TO...43,SET,6,0.006696,0.00012102,0.2868,0.49069,GOBP_PROTEIN_LOCALIZATION_TO_PHOTORECEPTOR_OUTER_SEGMENT,0.995774082381729
REACTOME_SIGNALING_BY_PDGFR_...,SET,20,0.00427,0.00014085,0.18308,0.4907,REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE,0.995774082381729
REACTOME_BIOSYNTHESIS_OF_SPE...,SET,19,0.0047291,0.00015205,0.20302,0.49071,REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS,0.995774082381729
GSE29618_PDC_VS_MDC_DAY7_FLU...2,SET,173,0.0015314,0.00014794,0.065822,0.49072,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP,0.995774082381729
GOBP_SPHINGOLIPID_BIOSYNTHET...,SET,107,0.0019781,0.00015057,0.085496,0.49077,GOBP_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,0.995774082381729
HP_SUPERNUMERARY_SPLEENS,SET,81,0.0019754,0.00013092,0.085945,0.49083,HP_SUPERNUMERARY_SPLEENS,0.995774082381729
GOMF_RNA_POLYMERASE_CORE_ENZ...,SET,40,0.0030577,0.00014256,0.13384,0.49089,GOMF_RNA_POLYMERASE_CORE_ENZYME_BINDING,0.995774082381729
GOBP_POSITIVE_REGULATION_OF_...820,SET,7,0.0073818,0.00014411,0.32393,0.49091,GOBP_POSITIVE_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.995774082381729
GOBP_REGULATION_OF_THE_FORCE...2,SET,5,0.010209,0.00016845,0.44852,0.49092,GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION_BY_CHEMICAL_SIGNAL,0.995774082381729
RUBENSTEIN_SKELETAL_MUSCLE_E...,SET,123,0.0018755,0.00015299,0.082603,0.49094,RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS,0.995774082381729
GOBP_REGULATION_OF_T_CELL_CH...,SET,15,0.0048144,0.00013755,0.21248,0.49096,GOBP_REGULATION_OF_T_CELL_CHEMOTAXIS,0.995774082381729
GOBP_REGULATION_OF_ICOSANOID...,SET,21,0.0048267,0.00016314,0.21394,0.491,GOBP_REGULATION_OF_ICOSANOID_SECRETION,0.995774082381729
GOBP_CELLULAR_RESPONSE_TO_RA...,SET,161,0.0014419,0.00013443,0.063973,0.49101,GOBP_CELLULAR_RESPONSE_TO_RADIATION,0.995774082381729
HP_LIMB_UNDERGROWTH,SET,220,0.0012824,0.00013953,0.05716,0.49105,HP_LIMB_UNDERGROWTH,0.995774082381729
HP_STOMATITIS,SET,66,0.002451,0.00014669,0.10923,0.49105,HP_STOMATITIS,0.995774082381729
GOMF_VASCULAR_ENDOTHELIAL_GR...4,SET,12,0.0057369,0.00014661,0.25747,0.49111,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_BINDING,0.995774082381729
GOBP_NEGATIVE_REGULATION_OF_...482,SET,16,0.0049013,0.00014462,0.22018,0.49112,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,0.995774082381729
HP_RECURRENT_UPPER_AND_LOWER...,SET,14,0.0054215,0.00014965,0.24388,0.49113,HP_RECURRENT_UPPER_AND_LOWER_RESPIRATORY_TRACT_INFECTIONS,0.995774082381729
GOCC_SPERM_FIBROUS_SHEATH,SET,5,0.0090675,0.00014961,0.40848,0.49115,GOCC_SPERM_FIBROUS_SHEATH,0.995774082381729
MIR517A_3P_MIR517B_3P_MIR517...,SET,19,0.0041572,0.00013366,0.18758,0.49116,MIR517A_3P_MIR517B_3P_MIR517C_3P,0.995774082381729
HP_ABNORMAL_CIRCULATING_BILI...,SET,114,0.0017818,0.00013996,0.080502,0.49117,HP_ABNORMAL_CIRCULATING_BILIRUBIN_CONCENTRATION,0.995774082381729
YAMAZAKI_TCEB3_TARGETS_UP,SET,155,0.0015647,0.00014316,0.070921,0.4912,YAMAZAKI_TCEB3_TARGETS_UP,0.995774082381729
GSE28237_FOLLICULAR_VS_EARLY...1,SET,181,0.0013408,0.00013247,0.060928,0.49122,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN,0.995774082381729
KIM_MYC_AMPLIFICATION_TARGET...2,SET,170,0.0013949,0.0001336,0.0637,0.49126,KIM_MYC_AMPLIFICATION_TARGETS_UP,0.995774082381729
GOBP_POSTSYNAPTIC_SPECIALIZA...2,SET,45,0.0028747,0.00014214,0.13134,0.49127,GOBP_POSTSYNAPTIC_SPECIALIZATION_ORGANIZATION,0.995774082381729
GSE23114_PERITONEAL_CAVITY_B...3,SET,178,0.0013815,0.00013536,0.063672,0.49135,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP,0.995774082381729
MOOTHA_VOXPHOS,SET,68,0.0018944,0.00011507,0.087749,0.49139,MOOTHA_VOXPHOS,0.995774082381729
GOBP_ERYTHROCYTE_DEVELOPMENT,SET,38,0.0029034,0.00013195,0.13466,0.4914,GOBP_ERYTHROCYTE_DEVELOPMENT,0.995774082381729
WP_TGFBETA_RECEPTOR_SIGNALIN...,SET,55,0.0026548,0.00014508,0.12385,0.49145,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,0.995774082381729
HP_ABNORMAL_SPINAL_CORD_PHYS...,SET,7,0.0058151,0.00011352,0.27194,0.49147,HP_ABNORMAL_SPINAL_CORD_PHYSIOLOGY,0.995774082381729
GOBP_PROGESTERONE_BIOSYNTHET...,SET,5,0.0075172,0.00012403,0.35234,0.49149,GOBP_PROGESTERONE_BIOSYNTHETIC_PROCESS,0.995774082381729
GOBP_AMYLOID_BETA_CLEARANCE_...2,SET,7,0.0063178,0.00012334,0.29665,0.4915,GOBP_AMYLOID_BETA_CLEARANCE_BY_TRANSCYTOSIS,0.995774082381729
MIR3691_3P,SET,59,0.0021549,0.00012196,0.10119,0.49151,MIR3691_3P,0.995774082381729
GOBP_POSITIVE_REGULATION_OF_...435,SET,25,0.0036873,0.00013597,0.17416,0.49155,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_MIGRATION,0.995774082381729
GSE17186_BLOOD_VS_CORD_BLOOD...2,SET,187,0.0012889,0.00012941,0.060839,0.49155,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP,0.995774082381729
GOMF_PEPTIDASE_ACTIVATOR_ACT...1,SET,52,0.0023918,0.00012711,0.11311,0.49156,GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY,0.995774082381729
HP_ABNORMAL_EYELID_PHYSIOLOGY,SET,36,0.0028643,0.00012671,0.13637,0.49162,HP_ABNORMAL_EYELID_PHYSIOLOGY,0.995774082381729
KEGG_MEDICUS_REFERENCE_NODAL...,SET,8,0.0060005,0.00012522,0.28694,0.49166,KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY,0.995774082381729
GOBP_G0_TO_G1_TRANSITION,SET,36,0.0027038,0.00011961,0.13033,0.49172,GOBP_G0_TO_G1_TRANSITION,0.995774082381729
GOBP_TRIGEMINAL_NERVE_DEVELO...,SET,12,0.005955,0.00015219,0.28717,0.49173,GOBP_TRIGEMINAL_NERVE_DEVELOPMENT,0.995774082381729
BIOCARTA_TNFR2_PATHWAY,SET,15,0.0043061,0.00012303,0.20784,0.49174,BIOCARTA_TNFR2_PATHWAY,0.995774082381729
MIR449B_3P,SET,110,0.0017299,0.00013349,0.08356,0.49174,MIR449B_3P,0.995774082381729
GSE20198_IL12_VS_IL12_IL18_T...2,SET,175,0.0012539,0.00012183,0.060638,0.49175,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,0.995774082381729
GOBP_LUTEINIZATION,SET,11,0.0058248,0.00014253,0.28236,0.49177,GOBP_LUTEINIZATION,0.995774082381729
CAO_BLOOD_FLUZONE_AGE_05_14Y...1,SET,6,0.0066646,0.00012046,0.32699,0.49187,CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_DN,0.995835243611386
HP_CONTRACTURE_OF_THE_PROXIM...3,SET,5,0.0073702,0.00012161,0.3674,0.492,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_5TH_FINGER,0.995835243611386
GOBP_ENDOCRINE_PANCREAS_DEVE...,SET,42,0.0028283,0.00013512,0.14122,0.49201,GOBP_ENDOCRINE_PANCREAS_DEVELOPMENT,0.995835243611386
GOBP_SENSORY_PERCEPTION_OF_L...,SET,201,0.0012738,0.00013255,0.063661,0.49202,GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS,0.995835243611386
VALK_AML_CLUSTER_7,SET,25,0.0035054,0.00012926,0.17554,0.49203,VALK_AML_CLUSTER_7,0.995835243611386
KEGG_MEDICUS_ENV_FACTOR_NICO...1,SET,11,0.0050006,0.00012236,0.25064,0.49204,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY,0.995835243611386
ZHANG_ADIPOGENESIS_BY_BMP7,SET,14,0.004414,0.00012184,0.22173,0.49206,ZHANG_ADIPOGENESIS_BY_BMP7,0.995835243611386
GOCC_ROD_PHOTORECEPTOR_OUTER...,SET,7,0.0061062,0.0001192,0.30705,0.49207,GOCC_ROD_PHOTORECEPTOR_OUTER_SEGMENT,0.995835243611386
MIR5008_3P,SET,150,0.0014033,0.00012631,0.070795,0.49209,MIR5008_3P,0.995835243611386
GSE9509_10MIN_VS_30MIN_LPS_A...1,SET,142,0.001426,0.00012492,0.071964,0.4921,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.995835243611386
GOBP_GAMMA_AMINOBUTYRIC_ACID...6,SET,19,0.0042837,0.00013773,0.21697,0.49212,GOBP_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT,0.995835243611386
HP_DECREASED_CIRCULATING_ALD...,SET,18,0.0041152,0.00012879,0.2097,0.49217,HP_DECREASED_CIRCULATING_ALDOSTERONE_LEVEL,0.995835243611386
GOMF_XMP_5_NUCLEOSIDASE_ACTI...,SET,5,0.0086722,0.00014309,0.44426,0.49221,GOMF_XMP_5_NUCLEOSIDASE_ACTIVITY,0.995835243611386
RIGGI_EWING_SARCOMA_PROGENIT...1,SET,172,0.0013819,0.00013312,0.070868,0.49222,RIGGI_EWING_SARCOMA_PROGENITOR_DN,0.995835243611386
GSE27786_CD8_TCELL_VS_NKTCEL...2,SET,176,0.0011833,0.00011529,0.060764,0.49223,GSE27786_CD8_TCELL_VS_NKTCELL_UP,0.995835243611386
GOLDRATH_NAIVE_VS_MEMORY_CD8...1,SET,183,0.0012277,0.00012195,0.063543,0.49229,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.995877256065631
MIR10397_5P,SET,67,0.0018851,0.00011366,0.098586,0.49237,MIR10397_5P,0.995877256065631
MIR7849_3P,SET,105,0.0016227,0.00012236,0.084802,0.49237,MIR7849_3P,0.995877256065631
GSE17974_1.5H_VS_72H_IL4_AND...1,SET,165,0.0011413,0.0001077,0.060008,0.49241,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,0.995877256065631
XU_HGF_TARGETS_INDUCED_BY_AK...2,SET,13,0.0047987,0.00012764,0.25321,0.49244,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP,0.995877256065631
KEGG_MEDICUS_PATHOGEN_HPV_E7...1,SET,6,0.0058437,0.00010562,0.30963,0.49247,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_CELL_CYCLE_G1_S,0.995877256065631
GSE37534_UNTREATED_VS_ROSIGL...1,SET,182,0.0012135,0.00012022,0.06427,0.49247,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.995877256065631
GOBP_N_ACYLPHOSPHATIDYLETHAN...,SET,4,0.0080217,0.00011839,0.42567,0.49248,GOBP_N_ACYLPHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,0.995877256065631
REACTOME_SIGNALING_BY_PTK6,SET,53,0.0022319,0.00011974,0.11939,0.49254,REACTOME_SIGNALING_BY_PTK6,0.99594063881778
MIR6077,SET,220,0.0010518,0.00011444,0.056759,0.49261,MIR6077,0.995966291448517
HARALAMBIEVA_PBMC_M_M_R_II_A...6,SET,40,0.0027331,0.00012743,0.14754,0.49261,HARALAMBIEVA_PBMC_M_M_R_II_AGE_13_16YO_STIMULATED_VS_UNSTIMULATED_3_TO_7YR_POST_TOP_DEG_UP,0.995966291448517
FEKIR_HEPARG_SPHERE_VS_HEPAR...1,SET,34,0.0027954,0.00012018,0.1527,0.4927,FEKIR_HEPARG_SPHERE_VS_HEPARG_DN,0.996052585504886
FLOTHO_PEDIATRIC_ALL_THERAPY...1,SET,28,0.0030372,0.00011851,0.16614,0.49271,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN,0.996052585504886
GOBP_MICROTUBULE_BASED_PROTE...,SET,14,0.00417,0.0001151,0.22937,0.49275,GOBP_MICROTUBULE_BASED_PROTEIN_TRANSPORT,0.996075510382132
REACTOME_INTEGRATION_OF_PROV...,SET,9,0.0046299,0.00010248,0.25747,0.49283,REACTOME_INTEGRATION_OF_PROVIRUS,0.996152380952381
GOBP_CELLULAR_RESPONSE_TO_TO...2,SET,115,0.0014386,0.0001135,0.080941,0.49291,GOBP_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE,0.996152380952381
HOWARD_PBMC_INACT_MONOV_INFL...1,SET,27,0.0031958,0.00012246,0.1799,0.49291,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN,0.996152380952381
GOBP_POSITIVE_REGULATION_OF_...561,SET,83,0.0015935,0.0001069,0.090102,0.49294,GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,0.996152380952381
GOBP_HEME_A_METABOLIC_PROCESS,SET,10,0.0047183,0.00011008,0.26716,0.49295,GOBP_HEME_A_METABOLIC_PROCESS,0.996152380952381
REACTOME_DISSOLUTION_OF_FIBR...,SET,13,0.0040323,0.00010726,0.22837,0.49296,REACTOME_DISSOLUTION_OF_FIBRIN_CLOT,0.996152380952381
GOBP_RESPONSE_TO_TESTOSTERONE,SET,39,0.0022958,0.00010569,0.13237,0.49308,GOBP_RESPONSE_TO_TESTOSTERONE,0.99621169650122
HP_OCULAR_PAIN,SET,20,0.0033807,0.00011152,0.19562,0.49311,HP_OCULAR_PAIN,0.99621169650122
GSE8685_IL2_STARVED_VS_IL21_...1,SET,186,0.0010202,0.00010216,0.059268,0.49313,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,0.99621169650122
GOBP_NEGATIVE_REGULATION_OF_...308,SET,29,0.0026898,0.00010681,0.15637,0.49314,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,0.99621169650122
REACTOME_INTRINSIC_PATHWAY_O...,SET,20,0.0032493,0.00010718,0.18918,0.49315,REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,0.99621169650122
GOMF_SMALL_MOLECULE_SENSOR_A...,SET,44,0.0019812,9.6871e-05,0.11571,0.49317,GOMF_SMALL_MOLECULE_SENSOR_ACTIVITY,0.99621169650122
GOCC_ER_MEMBRANE_INSERTION_C...,SET,12,0.0040975,0.00010472,0.24017,0.49319,GOCC_ER_MEMBRANE_INSERTION_COMPLEX,0.99621169650122
GSE27786_BCELL_VS_NKTCELL_DN,SET,178,0.001072,0.00010504,0.063572,0.49327,GSE27786_BCELL_VS_NKTCELL_DN,0.996235974440895
GOCC_CKM_COMPLEX,SET,4,0.0054143,7.9906e-05,0.32308,0.49331,GOCC_CKM_COMPLEX,0.996235974440895
HP_ABNORMAL_INFERIOR_VENA_CA...,SET,42,0.0020156,9.6288e-05,0.12107,0.49336,HP_ABNORMAL_INFERIOR_VENA_CAVA_MORPHOLOGY,0.996235974440895
HP_HYPOCALCEMIA,SET,74,0.001677,0.00010625,0.10098,0.49338,HP_HYPOCALCEMIA,0.996235974440895
HP_RECURRENT_LOWER_RESPIRATO...,SET,212,0.00098766,0.00010551,0.05958,0.49339,HP_RECURRENT_LOWER_RESPIRATORY_TRACT_INFECTIONS,0.996235974440895
TTGCCAA_MIR182,SET,298,0.00084456,0.00010672,0.051129,0.49341,TTGCCAA_MIR182,0.996235974440895
KEGG_MEDICUS_ENV_FACTOR_E2_T...1,SET,7,0.0055986,0.00010929,0.34018,0.49343,KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,0.996235974440895
chr6p24,SET,31,0.0044321,0.00018196,0.26965,0.49344,chr6p24,0.996235974440895
HP_THORACIC_DYSPLASIA,SET,4,0.0059994,8.854e-05,0.3657,0.49346,HP_THORACIC_DYSPLASIA,0.996235974440895
WP_TRANSCRIPTIONAL_ACTIVATIO...,SET,15,0.0036864,0.00010532,0.22616,0.4935,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,0.996258858039033
SOGA_COLORECTAL_CANCER_MYC_UP,SET,76,0.0015052,9.6637e-05,0.093363,0.49357,SOGA_COLORECTAL_CANCER_MYC_UP,0.996304617261006
chr7q22,SET,121,0.0028627,0.00023163,0.17783,0.49358,chr7q22,0.996304617261006
RAMALHO_STEMNESS_UP,SET,180,0.00096025,9.4609e-05,0.060124,0.49363,RAMALHO_STEMNESS_UP,0.996347676984726
GSE13485_DAY1_VS_DAY3_YF17D_...1,SET,182,0.00094009,9.3131e-05,0.059597,0.49371,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN,0.996451280487805
GOBP_UBIQUITIN_DEPENDENT_PRO...2,SET,34,0.0020888,8.9802e-05,0.1334,0.49375,GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.996474144939318
REACTOME_VIRAL_MESSENGER_RNA...,SET,42,0.0019147,9.147e-05,0.12303,0.49379,REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS,0.996483301443729
REACTOME_HDR_THROUGH_SINGLE_...,SET,36,0.0021246,9.3983e-05,0.13713,0.49382,REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,0.996483301443729
MYLLYKANGAS_AMPLIFICATION_HO...9,SET,19,0.0029931,9.6232e-05,0.19703,0.49394,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,0.996483301443729
HP_ABNORMAL_ARM_SPAN,SET,11,0.0037284,9.1231e-05,0.2466,0.49397,HP_ABNORMAL_ARM_SPAN,0.996483301443729
HP_INCREASED_GLUTAMINE_FAMIL...,SET,5,0.0051833,8.5523e-05,0.34282,0.49397,HP_INCREASED_GLUTAMINE_FAMILY_AMINO_ACID_LEVEL_IN_URINE,0.996483301443729
GSE4748_LPS_VS_LPS_AND_CYANO...2,SET,170,0.00096479,9.2404e-05,0.063775,0.49397,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.996483301443729
MIR6729_5P,SET,8,0.003941,8.2245e-05,0.26443,0.49405,MIR6729_5P,0.996483301443729
GOBP_NEURONAL_STEM_CELL_POPU...,SET,25,0.0024273,8.9507e-05,0.16343,0.49407,GOBP_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE,0.996483301443729
GSE29164_DAY3_VS_DAY7_CD8_TC...2,SET,178,0.00090711,8.8881e-05,0.061127,0.49408,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP,0.996483301443729
GSE2770_TGFB_AND_IL4_VS_TGFB...4,SET,171,0.00084639,8.13e-05,0.058133,0.49419,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.996483301443729
GOBP_CHROMATIN_REMODELING,SET,516,0.00052215,8.6295e-05,0.035911,0.4942,GOBP_CHROMATIN_REMODELING,0.996483301443729
GOMF_OXIDOREDUCTASE_ACTIVITY...26,SET,9,0.0045266,0.00010019,0.31484,0.49426,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_OXIDATION_OF_A_PAIR_OF_DONORS_RESULTING_IN_THE_REDUCTION_OF_MOLECULAR_OXYGEN_TO_TWO_MOLECULES_OF_WATER,0.996483301443729
HP_RIGIDITY,SET,185,0.0008717,8.7057e-05,0.060553,0.49426,HP_RIGIDITY,0.996483301443729
GSE10325_CD4_TCELL_VS_LUPUS_...2,SET,182,0.00088266,8.7442e-05,0.061304,0.49426,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP,0.996483301443729
GSE19941_UNSTIM_VS_LPS_STIM_...1,SET,177,0.00090131,8.8066e-05,0.063089,0.4943,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN,0.996483301443729
MIR561_5P,SET,131,0.00103,8.6694e-05,0.072262,0.49431,MIR561_5P,0.996483301443729
ALTEMEIER_RESPONSE_TO_LPS_WI...,SET,112,0.0011876,9.2469e-05,0.083351,0.49432,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,0.996483301443729
WP_INTEGRINMEDIATED_CELL_ADH...,SET,95,0.0012645,9.0721e-05,0.089949,0.49439,WP_INTEGRINMEDIATED_CELL_ADHESION,0.996483301443729
HP_FOCAL_MYOCLONIC_SEIZURE,SET,18,0.0026607,8.3266e-05,0.19004,0.49441,HP_FOCAL_MYOCLONIC_SEIZURE,0.996483301443729
GOBP_POSITIVE_REGULATION_OF_...662,SET,66,0.0015407,9.2206e-05,0.11022,0.49442,GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,0.996483301443729
GOCC_SYNAPTIC_MEMBRANE,SET,369,0.00064994,9.1207e-05,0.046642,0.49444,GOCC_SYNAPTIC_MEMBRANE,0.996483301443729
HP_CLONIC_SEIZURE,SET,72,0.0014084,8.802e-05,0.1012,0.49445,HP_CLONIC_SEIZURE,0.996483301443729
MIR942_3P,SET,104,0.0011256,8.4476e-05,0.081461,0.49449,MIR942_3P,0.996483301443729
MIR10398_3P,SET,5,0.0056848,9.3799e-05,0.41208,0.4945,MIR10398_3P,0.996483301443729
EGR1_01,SET,240,0.00074858,8.5024e-05,0.054341,0.4945,EGR1_01,0.996483301443729
HP_PARKINSONISM_WITH_FAVORAB...,SET,22,0.0023684,8.1932e-05,0.17177,0.4945,HP_PARKINSONISM_WITH_FAVORABLE_RESPONSE_TO_DOPAMINERGIC_MEDICATION,0.996483301443729
KEGG_MEDICUS_REFERENCE_CLASS...,SET,4,0.0064572,9.5297e-05,0.48104,0.49465,KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,0.996579933924535
chr4q23,SET,18,0.0044216,0.00013837,0.33043,0.49466,chr4q23,0.996579933924535
TGFB_UP.V1_DN,SET,172,0.00087907,8.4683e-05,0.065634,0.49466,TGFB_UP.V1_DN,0.996579933924535
GSE5589_LPS_AND_IL10_VS_LPS_...3,SET,179,0.00084048,8.2581e-05,0.063127,0.49469,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,0.996579933924535
ZNF595_TARGET_GENES,SET,99,0.0011244,8.2338e-05,0.084716,0.49471,ZNF595_TARGET_GENES,0.996579933924535
GNF2_MCM4,SET,52,0.0014841,7.8869e-05,0.11219,0.49472,GNF2_MCM4,0.996579933924535
MODULE_111,SET,140,0.0009172,7.9784e-05,0.070183,0.49479,MODULE_111,0.996582367247669
LU_AGING_BRAIN_UP,SET,234,0.00075989,8.5237e-05,0.058558,0.49482,LU_AGING_BRAIN_UP,0.996582367247669
MSX2_TARGET_GENES,SET,15,0.0028066,8.0186e-05,0.21666,0.49483,MSX2_TARGET_GENES,0.996582367247669
GOCC_NLS_DEPENDENT_PROTEIN_N...,SET,10,0.0028964,6.7576e-05,0.22428,0.49485,GOCC_NLS_DEPENDENT_PROTEIN_NUCLEAR_IMPORT_COMPLEX,0.996582367247669
SA_FAS_SIGNALING,SET,9,0.0037311,8.2586e-05,0.29099,0.49488,SA_FAS_SIGNALING,0.996582367247669
GOBP_FRUCTOSE_1_6_BISPHOSPHA...,SET,9,0.0031342,6.9374e-05,0.24704,0.49494,GOBP_FRUCTOSE_1_6_BISPHOSPHATE_METABOLIC_PROCESS,0.996582367247669
GOBP_MESONEPHRIC_TUBULE_FORM...,SET,8,0.0042496,8.8685e-05,0.33772,0.49498,GOBP_MESONEPHRIC_TUBULE_FORMATION,0.996582367247669
HP_ANGIOFIBROMAS,SET,31,0.0016847,6.9167e-05,0.13503,0.49502,HP_ANGIOFIBROMAS,0.996582367247669
GOBP_NUCLEOSIDE_MONOPHOSPHAT...2,SET,18,0.0026823,8.3943e-05,0.21532,0.49503,GOBP_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.996582367247669
GOBP_REGULATION_OF_DENDRITE_...3,SET,57,0.0013652,7.595e-05,0.10969,0.49503,GOBP_REGULATION_OF_DENDRITE_MORPHOGENESIS,0.996582367247669
YTAAYNGCT_UNKNOWN,SET,130,0.00098331,8.2446e-05,0.079938,0.49509,YTAAYNGCT_UNKNOWN,0.996582367247669
REACTOME_MET_ACTIVATES_RAS_S...,SET,10,0.00295,6.8827e-05,0.24119,0.49512,REACTOME_MET_ACTIVATES_RAS_SIGNALING,0.996582367247669
GOBP_NEGATIVE_REGULATION_OF_...593,SET,6,0.0042237,7.6339e-05,0.34758,0.49515,GOBP_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,0.996582367247669
GSE14908_RESTING_VS_HDM_STIM...1,SET,185,0.00074253,7.4157e-05,0.061257,0.49516,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN,0.996582367247669
GOCC_U5_SNRNP,SET,19,0.0020813,6.6917e-05,0.17201,0.49517,GOCC_U5_SNRNP,0.996582367247669
YAATNANRNNNCAG_UNKNOWN,SET,61,0.0013135,7.5583e-05,0.10871,0.49518,YAATNANRNNNCAG_UNKNOWN,0.996582367247669
WP_TRANSCRIPTION_FACTOR_REGU...,SET,21,0.002568,8.6797e-05,0.2142,0.49522,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,0.996605159235669
GOBP_LIMBIC_SYSTEM_DEVELOPME...,SET,118,0.00096345,7.6988e-05,0.08154,0.49529,GOBP_LIMBIC_SYSTEM_DEVELOPMENT,0.996650735294118
GOBP_REGULATION_OF_CYTOPLASM...2,SET,101,0.00094864,7.0165e-05,0.080576,0.4953,GOBP_REGULATION_OF_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.996650735294118
HE_LIM_SUN_FETAL_LUNG_C4_ILC...3,SET,166,0.00080172,7.5885e-05,0.069179,0.49538,HE_LIM_SUN_FETAL_LUNG_C4_ILCP_CELL,0.996686824285218
MIR3074_3P,SET,79,0.0011253,7.3656e-05,0.097724,0.49541,MIR3074_3P,0.996686824285218
GOBP_LIVER_MORPHOGENESIS,SET,25,0.001934,7.1316e-05,0.16977,0.49546,GOBP_LIVER_MORPHOGENESIS,0.996686824285218
GOBP_SOMATOTROPIN_SECRETING_...,SET,5,0.0050338,8.3056e-05,0.44359,0.49547,GOBP_SOMATOTROPIN_SECRETING_CELL_DIFFERENTIATION,0.996686824285218
GOCC_CLUSTER_OF_ACTIN_BASED_...,SET,154,0.00077168,7.0375e-05,0.068177,0.49548,GOCC_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS,0.996686824285218
GOBP_REGULATION_OF_CATALYTIC...,SET,1226,0.00028676,7.1582e-05,0.02538,0.49549,GOBP_REGULATION_OF_CATALYTIC_ACTIVITY,0.996686824285218
MATTIOLI_MGUS_VS_PCL,SET,91,0.00097394,6.8395e-05,0.08771,0.49557,MATTIOLI_MGUS_VS_PCL,0.996790054401296
GSE3982_EFF_MEMORY_CD4_TCELL...3,SET,181,0.00066603,6.5801e-05,0.060714,0.49562,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN,0.99679801527601
GSE16385_MONOCYTE_VS_12H_IFN...2,SET,183,0.00067793,6.7342e-05,0.062177,0.49565,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,0.99679801527601
DESCARTES_FETAL_HEART_EPICAR...,SET,90,0.0010233,7.1466e-05,0.094034,0.49566,DESCARTES_FETAL_HEART_EPICARDIAL_FAT_CELLS,0.99679801527601
BUSSLINGER_DUODENAL_GOBLET_C...,SET,15,0.0027096,7.7414e-05,0.25087,0.49569,BUSSLINGER_DUODENAL_GOBLET_CELLS,0.996800668286756
HP_OPTIC_DISC_PALLOR,SET,216,0.00059524,6.418e-05,0.055609,0.49573,HP_OPTIC_DISC_PALLOR,0.99682342918306
MORF_ETV3,SET,60,0.0011395,6.5033e-05,0.10845,0.49581,MORF_ETV3,0.99688904894134
GSE11961_MARGINAL_ZONE_BCELL...5,SET,184,0.00063887,6.3634e-05,0.060991,0.49582,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN,0.99688904894134
GSE21360_PRIMARY_VS_QUATERNA...2,SET,157,0.00072938,6.7157e-05,0.071165,0.49591,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.997012324289929
GOBP_CELLULAR_RESPONSE_TO_OS...,SET,51,0.0011912,6.2695e-05,0.11805,0.49597,GOBP_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,0.997075274757057
MIR4519,SET,73,0.00096157,6.051e-05,0.096334,0.49602,MIR4519,0.997108000804968
HP_LABIAL_HYPERTROPHY,SET,7,0.003646,7.1176e-05,0.37193,0.49609,HP_LABIAL_HYPERTROPHY,0.997108000804968
GOBP_RNA_SURVEILLANCE,SET,17,0.0017631,5.3623e-05,0.18229,0.49614,GOBP_RNA_SURVEILLANCE,0.997108000804968
WP_CYSTEINE_AND_METHIONINE_C...,SET,13,0.0022781,6.0595e-05,0.23726,0.49617,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,0.997108000804968
GSE22140_HEALTHY_VS_ARTHRITI...1,SET,188,0.00060205,6.0608e-05,0.063408,0.49621,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN,0.997108000804968
GOBP_REGULATION_OF_NATURAL_K...2,SET,8,0.0031332,6.5386e-05,0.33142,0.49623,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS,0.997108000804968
HP_GLOMERULAR_DEPOSITS,SET,18,0.0017615,5.5127e-05,0.18927,0.49629,HP_GLOMERULAR_DEPOSITS,0.997108000804968
GOBP_POSITIVE_REGULATION_OF_...757,SET,11,0.0023232,5.6847e-05,0.25631,0.49638,GOBP_POSITIVE_REGULATION_OF_TISSUE_REMODELING,0.997108000804968
HP_PREMATURE_GRAYING_OF_HAIR,SET,46,0.0010933,5.4656e-05,0.12035,0.49638,HP_PREMATURE_GRAYING_OF_HAIR,0.997108000804968
MIR208B_5P,SET,232,0.00050173,5.6041e-05,0.055557,0.4964,MIR208B_5P,0.997108000804968
GOMF_MHC_CLASS_I_PROTEIN_BIN...,SET,15,0.0019574,5.5923e-05,0.21784,0.49642,GOMF_MHC_CLASS_I_PROTEIN_BINDING,0.997108000804968
GOBP_FAT_CELL_DIFFERENTIATION,SET,218,0.00053945,5.8431e-05,0.060257,0.49643,GOBP_FAT_CELL_DIFFERENTIATION,0.997108000804968
MIR4685_5P,SET,113,0.0006937,5.4253e-05,0.078208,0.49646,MIR4685_5P,0.997108000804968
NME2_TARGET_GENES,SET,53,0.0010504,5.6355e-05,0.11842,0.49646,NME2_TARGET_GENES,0.997108000804968
WP_NEPHROTIC_SYNDROME,SET,42,0.0011366,5.4299e-05,0.12905,0.49649,WP_NEPHROTIC_SYNDROME,0.997108000804968
HP_DEVELOPMENTAL_REGRESSION,SET,360,0.00038049,5.2754e-05,0.043773,0.49653,HP_DEVELOPMENTAL_REGRESSION,0.997108000804968
GSE39556_UNTREATED_VS_3H_POL...4,SET,178,0.00054317,5.3221e-05,0.062569,0.49654,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP,0.997108000804968
GSE39152_SPLEEN_CD103_NEG_VS...1,SET,188,0.00053227,5.3583e-05,0.062001,0.49658,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN,0.997108000804968
HP_APLASIA_HYPOPLASIA_OF_THE...8,SET,11,0.0021897,5.358e-05,0.25721,0.4966,HP_APLASIA_HYPOPLASIA_OF_THE_5TH_METACARPAL,0.997108000804968
GOBP_TRACHEA_DEVELOPMENT,SET,18,0.0018678,5.8452e-05,0.22014,0.49662,GOBP_TRACHEA_DEVELOPMENT,0.997108000804968
GSE13738_RESTING_VS_TCR_ACTI...2,SET,155,0.0005583,5.1079e-05,0.066529,0.49665,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP,0.997108000804968
WP_NEUROTRANSMITTER_DISORDERS,SET,9,0.0023961,5.3037e-05,0.29095,0.49671,WP_NEUROTRANSMITTER_DISORDERS,0.997108000804968
WP_DISORDERS_IN_KETOLYSIS,SET,5,0.0028122,4.64e-05,0.34157,0.49672,WP_DISORDERS_IN_KETOLYSIS,0.997108000804968
HP_SUBGLOTTIC_STENOSIS,SET,14,0.0018121,5.0018e-05,0.22272,0.49675,HP_SUBGLOTTIC_STENOSIS,0.997108000804968
HP_GAIT_DISTURBANCE,SET,1052,0.00020911,4.8598e-05,0.026403,0.49684,HP_GAIT_DISTURBANCE,0.997108000804968
GSE35543_IN_VITRO_ITREG_VS_C...2,SET,183,0.00048787,4.8462e-05,0.061663,0.49684,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP,0.997108000804968
REACTOME_NOTCH4_ACTIVATION_A...,SET,10,0.0020881,4.8718e-05,0.26481,0.49685,REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,0.997108000804968
GSE3982_DC_VS_NKCELL_UP,SET,181,0.00051693,5.107e-05,0.065391,0.49685,GSE3982_DC_VS_NKCELL_UP,0.997108000804968
MODULE_375,SET,85,0.00078095,5.3012e-05,0.099859,0.49688,MODULE_375,0.997108000804968
MIR4677_3P,SET,120,0.00059718,4.812e-05,0.077649,0.49693,MIR4677_3P,0.997108000804968
GOBP_INHIBITORY_SYNAPSE_ASSE...,SET,23,0.001602,5.6663e-05,0.20939,0.49695,GOBP_INHIBITORY_SYNAPSE_ASSEMBLY,0.997108000804968
STK33_DN,SET,237,0.00041909,4.7306e-05,0.055472,0.49699,STK33_DN,0.997108000804968
GOBP_REGULATION_OF_EXTRACELL...3,SET,13,0.0016054,4.2701e-05,0.21907,0.49708,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.997108000804968
GOBP_GLUCOSYLCERAMIDE_METABO...,SET,7,0.0024349,4.7534e-05,0.33445,0.4971,GOBP_GLUCOSYLCERAMIDE_METABOLIC_PROCESS,0.997108000804968
HP_REDUCED_NATURAL_KILLER_CE...2,SET,24,0.001184,4.2779e-05,0.16636,0.49716,HP_REDUCED_NATURAL_KILLER_CELL_COUNT,0.997108000804968
GAVISH_3CA_METAPROGRAM_EPITH...4,SET,35,0.00099007,4.3186e-05,0.13932,0.49717,GAVISH_3CA_METAPROGRAM_EPITHELIAL_CILIA,0.997108000804968
WP_CATALYTIC_CYCLE_OF_MAMMAL...,SET,5,0.0032824,5.4159e-05,0.46806,0.4972,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,0.997108000804968
GOMF_N_N_DIMETHYLANILINE_MON...,SET,5,0.0032824,5.4159e-05,0.46806,0.4972,GOMF_N_N_DIMETHYLANILINE_MONOOXYGENASE_ACTIVITY,0.997108000804968
GOBP_CHOLANGIOCYTE_PROLIFERA...,SET,4,0.0028239,4.1676e-05,0.40397,0.49721,GOBP_CHOLANGIOCYTE_PROLIFERATION,0.997108000804968
GOBP_POSITIVE_REGULATION_BY_...2,SET,19,0.0013324,4.284e-05,0.19114,0.49722,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS,0.997108000804968
GSE28726_ACT_CD4_TCELL_VS_AC...1,SET,177,0.00043604,4.2605e-05,0.06269,0.49723,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN,0.997108000804968
GOBP_REGULATION_OF_SKELETAL_...3,SET,18,0.0012688,3.9707e-05,0.18468,0.49726,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,0.997108000804968
HP_MULTIPLE_GLOMERULAR_CYSTS,SET,3,0.0033463,4.2771e-05,0.49977,0.49733,HP_MULTIPLE_GLOMERULAR_CYSTS,0.997108000804968
GRAHAM_CML_QUIESCENT_VS_NORM...1,SET,9,0.0020943,4.6356e-05,0.32115,0.4974,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN,0.997108000804968
GOCC_OTHER_ORGANISM_PART,SET,4,0.0030975,4.5714e-05,0.47503,0.4974,GOCC_OTHER_ORGANISM_PART,0.997108000804968
GOBP_INSULIN_LIKE_GROWTH_FAC...,SET,48,0.00082408,4.208e-05,0.12741,0.49742,GOBP_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.997108000804968
KYNG_NORMAL_AGING_DN,SET,16,0.0013829,4.0805e-05,0.21458,0.49743,KYNG_NORMAL_AGING_DN,0.997108000804968
HP_LIPOMATOUS_TUMOR,SET,42,0.00079005,3.7743e-05,0.12603,0.4975,HP_LIPOMATOUS_TUMOR,0.997108000804968
MIR4752,SET,74,0.00060011,3.8021e-05,0.096644,0.49752,MIR4752,0.997108000804968
HP_PERIPHERAL_HYPOMYELINATION,SET,9,0.0015531,3.4376e-05,0.25189,0.49754,HP_PERIPHERAL_HYPOMYELINATION,0.997108000804968
GOBP_NEURAL_CREST_CELL_MIGRA...,SET,6,0.0022581,4.0812e-05,0.36725,0.49755,GOBP_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,0.997108000804968
BIOCARTA_HCMV_PATHWAY,SET,17,0.001286,3.9113e-05,0.21879,0.49766,BIOCARTA_HCMV_PATHWAY,0.997108000804968
GSE5589_UNSTIM_VS_45MIN_LPS_...5,SET,182,0.00033863,3.3546e-05,0.058085,0.49767,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_DN,0.997108000804968
WP_NRF2ARE_REGULATION,SET,23,0.0010393,3.6762e-05,0.18041,0.4977,WP_NRF2ARE_REGULATION,0.997108000804968
GOBP_T_HELPER_1_CELL_DIFFERE...,SET,22,0.001114,3.8536e-05,0.19416,0.49771,GOBP_T_HELPER_1_CELL_DIFFERENTIATION,0.997108000804968
GOCC_EARLY_PHAGOSOME,SET,12,0.0013447,3.4366e-05,0.23601,0.49773,GOCC_EARLY_PHAGOSOME,0.997108000804968
GOCC_PML_BODY,SET,99,0.00046702,3.42e-05,0.083024,0.49776,GOCC_PML_BODY,0.997108000804968
MODULE_25,SET,13,0.0010731,2.8543e-05,0.192,0.49777,MODULE_25,0.997108000804968
DCA_UP.V1_DN,SET,165,0.00035266,3.3281e-05,0.064085,0.4978,DCA_UP.V1_DN,0.997108000804968
HP_ABNORMAL_CSF_CARBOXYLIC_A...,SET,24,0.00087653,3.1669e-05,0.16022,0.49782,HP_ABNORMAL_CSF_CARBOXYLIC_ACID_CONCENTRATION,0.997108000804968
WP_ETHANOL_METABOLISM_PRODUC...,SET,9,0.0016399,3.6298e-05,0.3024,0.49784,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,0.997108000804968
GSE22886_NAIVE_CD8_TCELL_VS_...5,SET,185,0.0003532,3.5274e-05,0.065313,0.49784,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN,0.997108000804968
YANAGISAWA_LUNG_CANCER_RECUR...,SET,6,0.0022546,4.075e-05,0.42567,0.49789,YANAGISAWA_LUNG_CANCER_RECURRENCE,0.997108000804968
STAT_01,SET,233,0.0002899,3.245e-05,0.056364,0.49795,STAT_01,0.997108000804968
MIR519E_3P,SET,60,0.00054332,3.1008e-05,0.10867,0.49801,MIR519E_3P,0.997108000804968
MIR6776_3P,SET,57,0.0005782,3.2166e-05,0.11696,0.49803,MIR6776_3P,0.997108000804968
HP_ABSENT_PALMAR_CREASE,SET,13,0.0011254,2.9935e-05,0.229,0.49804,HP_ABSENT_PALMAR_CREASE,0.997108000804968
GOBP_NEGATIVE_REGULATION_OF_...382,SET,9,0.0014455,3.1995e-05,0.29589,0.49805,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.997108000804968
GOBP_SEMAPHORIN_PLEXIN_SIGNA...,SET,42,0.00066624,3.1828e-05,0.13702,0.49806,GOBP_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY,0.997108000804968
GSE13547_CTRL_VS_ANTI_IGM_ST...4,SET,169,0.00032343,3.0887e-05,0.066725,0.49807,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP,0.997108000804968
GSE14415_ACT_TCONV_VS_ACT_NA...2,SET,158,0.00032834,3.0326e-05,0.067836,0.49807,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP,0.997108000804968
WP_CARDIAC_PROGENITOR_DIFFER...,SET,50,0.00059473,3.0993e-05,0.13268,0.49821,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,0.997108000804968
GSE45365_NK_CELL_VS_CD8_TCEL...4,SET,143,0.00030451,2.6768e-05,0.068954,0.49824,GSE45365_NK_CELL_VS_CD8_TCELL_UP,0.997108000804968
GOBP_ESTABLISHMENT_OF_CELL_P...,SET,145,0.00030835,2.7293e-05,0.070698,0.49826,GOBP_ESTABLISHMENT_OF_CELL_POLARITY,0.997108000804968
HP_ABNORMAL_MORPHOLOGY_OF_TH...9,SET,6,0.0012785,2.3108e-05,0.30316,0.49832,HP_ABNORMAL_MORPHOLOGY_OF_THE_PROXIMAL_PHALANX_OF_THE_HALLUX,0.997108000804968
BERENJENO_ROCK_SIGNALING_NOT...2,SET,28,0.00065878,2.5706e-05,0.15725,0.49833,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,0.997108000804968
GSE37533_PPARG2_FOXP3_VS_FOX...2,SET,172,0.00025265,2.4339e-05,0.060539,0.49834,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.997108000804968
MIR4637,SET,51,0.0004792,2.522e-05,0.11738,0.49837,MIR4637,0.997108000804968
HP_ABNORMALITY_OF_THYROID_PH...,SET,346,0.00018195,2.4741e-05,0.045932,0.49842,HP_ABNORMALITY_OF_THYROID_PHYSIOLOGY,0.997108000804968
WORSCHECH_TUMOR_REJECTION_DN,SET,8,0.0011472,2.394e-05,0.29853,0.49847,WORSCHECH_TUMOR_REJECTION_DN,0.997108000804968
GSE9509_LPS_VS_LPS_AND_IL10_...2,SET,187,0.00024833,2.4934e-05,0.065224,0.49848,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP,0.997108000804968
GSE37532_VISCERAL_ADIPOSE_TI...4,SET,156,0.0002347,2.1541e-05,0.063081,0.49852,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_UP,0.997108000804968
LHX3_TARGET_GENES,SET,18,0.00074051,2.3174e-05,0.20178,0.49854,LHX3_TARGET_GENES,0.997108000804968
HP_CEREBRAL_INFARCT,SET,35,0.00052681,2.2979e-05,0.145,0.49855,HP_CEREBRAL_INFARCT,0.997108000804968
GCM_Q2,SET,212,0.00020701,2.2115e-05,0.0579,0.49857,GCM_Q2,0.997108000804968
GOBP_POSITIVE_REGULATION_OF_...385,SET,7,0.0013078,2.5531e-05,0.36777,0.49858,GOBP_POSITIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.997108000804968
GOCC_SPINDLE_MICROTUBULE,SET,76,0.00031315,2.0105e-05,0.090269,0.49862,GOCC_SPINDLE_MICROTUBULE,0.997108000804968
GOMF_HISTONE_KINASE_ACTIVITY,SET,21,0.00060659,2.0503e-05,0.18253,0.49867,GOMF_HISTONE_KINASE_ACTIVITY,0.997108000804968
MODULE_9,SET,112,0.000253,1.9699e-05,0.077982,0.49871,MODULE_9,0.997108000804968
RAY_ALZHEIMERS_DISEASE,SET,13,0.0007485,1.991e-05,0.24375,0.49877,RAY_ALZHEIMERS_DISEASE,0.997108000804968
KEGG_MEDICUS_REFERENCE_CHRNA...,SET,6,0.0010112,1.8276e-05,0.3318,0.49878,KEGG_MEDICUS_REFERENCE_CHRNA7_E2F_SIGNALING_PATHWAY,0.997108000804968
HP_CHRONIC_HEMOLYTIC_ANEMIA,SET,5,0.0011636,1.92e-05,0.37909,0.49878,HP_CHRONIC_HEMOLYTIC_ANEMIA,0.997108000804968
GSE40685_TREG_VS_FOXP3_KO_TR...2,SET,171,0.00020038,1.9248e-05,0.06609,0.49879,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP,0.997108000804968
WP_2Q211_COPY_NUMBER_VARIATI...,SET,15,0.00077411,2.2117e-05,0.25772,0.4988,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,0.997108000804968
MODULE_191,SET,19,0.00069305,2.2283e-05,0.23204,0.49881,MODULE_191,0.997108000804968
GOBP_KERATINOCYTE_APOPTOTIC_...,SET,7,0.00095362,1.8616e-05,0.32071,0.49881,GOBP_KERATINOCYTE_APOPTOTIC_PROCESS,0.997108000804968
KYNG_RESPONSE_TO_H2O2_VIA_ER...3,SET,35,0.00040321,1.7588e-05,0.13817,0.49884,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,0.997108000804968
HP_UPPER_LIMB_HYPERTONIA,SET,9,0.00081957,1.8141e-05,0.28939,0.49887,HP_UPPER_LIMB_HYPERTONIA,0.997108000804968
GOBP_REGULATION_OF_BIOLOGICA...,SET,59,0.00033026,1.8691e-05,0.11754,0.49888,GOBP_REGULATION_OF_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION,0.997108000804968
GOBP_PYRIMIDINE_RIBONUCLEOTI...1,SET,21,0.00049386,1.6692e-05,0.17921,0.4989,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.997108000804968
GOBP_T_CELL_PROLIFERATION,SET,195,0.00016946,1.7371e-05,0.064291,0.49895,GOBP_T_CELL_PROLIFERATION,0.997108000804968
GOCC_BCL_2_FAMILY_PROTEIN_CO...,SET,10,0.00076569,1.7864e-05,0.2939,0.49896,GOCC_BCL_2_FAMILY_PROTEIN_COMPLEX,0.997108000804968
MIR6763_5P,SET,92,0.00021868,1.5441e-05,0.084359,0.49897,MIR6763_5P,0.997108000804968
HP_ABNORMAL_PATTERN_ELECTROR...,SET,7,0.00087575,1.7096e-05,0.33903,0.49897,HP_ABNORMAL_PATTERN_ELECTRORETINOGRAM,0.997108000804968
GOMF_HISTONE_H4K16_ACETYLTRA...,SET,8,0.00067284,1.4042e-05,0.27227,0.49901,GOMF_HISTONE_H4K16_ACETYLTRANSFERASE_ACTIVITY,0.997130601391364
GOBP_NEGATIVE_REGULATION_OF_...678,SET,65,0.00025569,1.5187e-05,0.11441,0.49911,GOBP_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION,0.997176728150319
GOCC_AMPHISOME,SET,13,0.00049395,1.3139e-05,0.22462,0.49912,GOCC_AMPHISOME,0.997176728150319
HP_ABNORMAL_FOOT_BONE_OSSIFI...,SET,9,0.00060141,1.3312e-05,0.27721,0.49913,HP_ABNORMAL_FOOT_BONE_OSSIFICATION,0.997176728150319
MARCHINI_TRABECTEDIN_RESISTA...2,SET,16,0.00043618,1.287e-05,0.21259,0.49918,MARCHINI_TRABECTEDIN_RESISTANCE_UP,0.997176728150319
GOBP_REGULATION_OF_CHAPERONE...,SET,8,0.00051161,1.0677e-05,0.26802,0.49924,GOBP_REGULATION_OF_CHAPERONE_MEDIATED_AUTOPHAGY,0.997176728150319
GOBP_ESCRT_COMPLEX_DISASSEMB...,SET,10,0.00041509,9.6844e-06,0.22978,0.49928,GOBP_ESCRT_COMPLEX_DISASSEMBLY,0.997176728150319
HP_MUSCULAR_VENTRICULAR_SEPT...,SET,22,0.00031451,1.088e-05,0.18296,0.49931,HP_MUSCULAR_VENTRICULAR_SEPTAL_DEFECT,0.997176728150319
HP_OPTIC_NERVE_GLIOMA,SET,5,0.00068541,1.1309e-05,0.39392,0.49931,HP_OPTIC_NERVE_GLIOMA,0.997176728150319
GSE17721_CTRL_VS_PAM3CSK4_6H...1,SET,181,0.00010501,1.0374e-05,0.061051,0.49931,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN,0.997176728150319
GOBP_NEGATIVE_REGULATION_OF_...687,SET,4,0.00080257,1.1845e-05,0.4727,0.49932,GOBP_NEGATIVE_REGULATION_OF_URINE_VOLUME,0.997176728150319
MARIADASON_REGULATED_BY_HIST...1,SET,37,0.00021502,9.6427e-06,0.14073,0.49939,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,0.997259219145024
GOBP_POSITIVE_REGULATION_OF_...188,SET,6,0.00047272,8.544e-06,0.33268,0.49943,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY,0.99726882282041
GAVISH_3CA_METAPROGRAM_EPITH...5,SET,47,0.00017351,8.7673e-06,0.13325,0.49948,GAVISH_3CA_METAPROGRAM_EPITHELIAL_COLON_RELATED,0.99726882282041
NFE2L1_TARGET_GENES,SET,1471,2.654e-05,7.2049e-06,0.022422,0.49953,NFE2L1_TARGET_GENES,0.99726882282041
GOBP_REGULATION_OF_POSTSYNAP...6,SET,83,0.00010622,7.1253e-06,0.092936,0.49954,GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_NEUROTRANSMITTER_RECEPTOR_LEVELS,0.99726882282041
MIR6849_5P,SET,28,0.00018319,7.1482e-06,0.1733,0.49958,MIR6849_5P,0.99726882282041
HP_ABNORMAL_LEUKOCYTE_COUNT,SET,435,4.2698e-05,6.4938e-06,0.040588,0.49958,HP_ABNORMAL_LEUKOCYTE_COUNT,0.99726882282041
GOBP_REGULATION_OF_CHRONIC_I...,SET,8,0.00025384,5.2974e-06,0.2926,0.49965,GOBP_REGULATION_OF_CHRONIC_INFLAMMATORY_RESPONSE,0.99726882282041
GSE22886_NAIVE_BCELL_VS_DC_DN,SET,188,5.1384e-05,5.1728e-06,0.059358,0.49965,GSE22886_NAIVE_BCELL_VS_DC_DN,0.99726882282041
KEGG_MEDICUS_PATHOGEN_HIV_GP...2,SET,17,0.00014317,4.3543e-06,0.19979,0.49971,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN,0.99726882282041
HP_HYPOPIGMENTED_SKIN_PATCHES,SET,105,5.8254e-05,4.3927e-06,0.079661,0.49971,HP_HYPOPIGMENTED_SKIN_PATCHES,0.99726882282041
BIOCARTA_IL5_PATHWAY,SET,9,0.00015314,3.3896e-06,0.30516,0.4998,BIOCARTA_IL5_PATHWAY,0.99726882282041
GOBP_CELLULAR_RESPONSE_TO_ET...1,SET,12,0.0001163,2.9723e-06,0.2381,0.49981,GOBP_CELLULAR_RESPONSE_TO_ETHANOL,0.99726882282041
HP_NEOPLASM,SET,880,1.3554e-05,2.8954e-06,0.028978,0.49981,HP_NEOPLASM,0.99726882282041
GOBP_VENTRICULAR_SYSTEM_DEVE...,SET,30,5.1173e-05,2.0668e-06,0.14652,0.49986,GOBP_VENTRICULAR_SYSTEM_DEVELOPMENT,0.99726882282041
HP_POINTED_CHIN,SET,118,2.6176e-05,2.0917e-06,0.079327,0.49987,HP_POINTED_CHIN,0.99726882282041
GOBP_POSITIVE_REGULATION_OF_...840,SET,22,4.2814e-05,1.4811e-06,0.16824,0.4999,GOBP_POSITIVE_REGULATION_OF_VIRAL_LIFE_CYCLE,0.99726882282041
HP_ABNORMAL_SUPERIOR_CEREBEL...,SET,12,4.4306e-05,1.1323e-06,0.2055,0.49991,HP_ABNORMAL_SUPERIOR_CEREBELLAR_PEDUNCLE_MORPHOLOGY,0.99726882282041
GOBP_REGULATION_OF_DEFENSE_R...3,SET,5,5.4933e-05,9.0638e-07,0.33543,0.49993,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_FUNGUS,0.99726882282041
MORI_LARGE_PRE_BII_LYMPHOCYT...1,SET,53,1.705e-05,9.1471e-07,0.12095,0.49994,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,0.99726882282041
HP_LATE_ONSET_PROXIMAL_MUSCL...,SET,6,-4.5904e-06,-8.2967e-08,0.37426,0.5,HP_LATE_ONSET_PROXIMAL_MUSCLE_WEAKNESS,0.997331267217631
HP_PROMINENT_DIGIT_PAD,SET,35,-1.6032e-05,-6.9927e-07,0.13842,0.50005,HP_PROMINENT_DIGIT_PAD,0.997373758967001
GOBP_SEPTUM_PRIMUM_DEVELOPME...,SET,4,-0.00016451,-2.4279e-06,0.47249,0.50014,GOBP_SEPTUM_PRIMUM_DEVELOPMENT,0.997430036125925
GSE17721_POLYIC_VS_CPG_8H_BM...2,SET,180,-2.8132e-05,-2.7717e-06,0.061553,0.50018,GSE17721_POLYIC_VS_CPG_8H_BMDC_UP,0.997430036125925
BOYAULT_LIVER_CANCER_SUBCLAS...5,SET,37,-7.1331e-05,-3.1988e-06,0.14148,0.5002,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,0.997430036125925
GSE13485_CTRL_VS_DAY7_YF17D_...1,SET,187,-3.3578e-05,-3.3714e-06,0.063474,0.50021,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN,0.997430036125925
GSE24102_GRANULOCYSTIC_MDSC_...2,SET,183,-4.7601e-05,-4.7285e-06,0.061883,0.50031,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP,0.997430036125925
HP_SHORTENED_PR_INTERVAL,SET,6,-0.00030309,-5.4781e-06,0.34455,0.50035,HP_SHORTENED_PR_INTERVAL,0.997430036125925
WONG_PROTEASOME_GENE_MODULE,SET,47,-0.00010579,-5.3453e-06,0.11502,0.50037,WONG_PROTEASOME_GENE_MODULE,0.997430036125925
MIR6820_3P,SET,88,-8.5436e-05,-5.9005e-06,0.090073,0.50038,MIR6820_3P,0.997430036125925
MIR5579_5P,SET,71,-0.00010655,-6.6131e-06,0.098168,0.50043,MIR5579_5P,0.997430036125925
GSE46606_IRF4_KO_VS_WT_UNSTI...2,SET,186,-6.6054e-05,-6.6145e-06,0.059891,0.50044,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP,0.997430036125925
ZHANG_RESPONSE_TO_CANTHARIDI...1,SET,60,-0.00011552,-6.5926e-06,0.099892,0.50046,ZHANG_RESPONSE_TO_CANTHARIDIN_DN,0.997430036125925
GSE22601_DOUBLE_NEGATIVE_VS_...1,SET,179,-7.0626e-05,-6.9393e-06,0.06066,0.50046,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.997430036125925
WP_BIOSYNTHESIS_AND_TURNOVER...,SET,8,-0.00035275,-7.3616e-06,0.30159,0.50047,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,0.997430036125925
GSE3982_MAST_CELL_VS_BCELL_UP,SET,180,-7.6925e-05,-7.5791e-06,0.064583,0.50048,GSE3982_MAST_CELL_VS_BCELL_UP,0.997430036125925
GOBP_ENDONUCLEOLYTIC_CLEAVAG...3,SET,16,-0.00027649,-8.1584e-06,0.20637,0.50053,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.997472485665138
GOBP_POSITIVE_REGULATION_OF_...836,SET,30,-0.00025533,-1.0312e-05,0.16985,0.5006,GOBP_POSITIVE_REGULATION_OF_VASOCONSTRICTION,0.997476662656814
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...3,SET,17,-0.00039381,-1.1977e-05,0.22391,0.5007,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_PROTEIN_COMPLEX,0.997476662656814
HP_ACRAL_OVERGROWTH,SET,3,-0.00072097,-9.215e-06,0.41058,0.5007,HP_ACRAL_OVERGROWTH,0.997476662656814
GSE6259_33D1_POS_VS_DEC205_P...1,SET,156,-0.00012047,-1.1058e-05,0.068716,0.5007,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN,0.997476662656814
GOMF_NEDD8_TRANSFERASE_ACTIV...,SET,7,-0.00048982,-9.5622e-06,0.27692,0.50071,GOMF_NEDD8_TRANSFERASE_ACTIVITY,0.997476662656814
MIR548AO_5P_MIR548AX,SET,152,-0.00013607,-1.2329e-05,0.070639,0.50077,MIR548AO_5P_MIR548AX,0.997476662656814
REACTOME_ACTIVATED_NTRK3_SIG...1,SET,6,-0.00073639,-1.331e-05,0.37724,0.50078,REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K,0.997476662656814
HP_SINGLE_LINEAGE_MYELODYSPL...,SET,5,-0.00071193,-1.1747e-05,0.34343,0.50083,HP_SINGLE_LINEAGE_MYELODYSPLASIA,0.997476662656814
WP_NCRNAS_INVOLVED_IN_STAT3_...,SET,13,-0.00054548,-1.4509e-05,0.24931,0.50087,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,0.997476662656814
HP_FUNDUS_ATROPHY,SET,3,-0.0014775,-1.8885e-05,0.66823,0.50088,HP_FUNDUS_ATROPHY,0.997476662656814
WP_4HYDROXYTAMOXIFEN_DEXAMET...,SET,25,-0.00041299,-1.5229e-05,0.18401,0.5009,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,0.997476662656814
MODULE_14,SET,13,-0.00059777,-1.59e-05,0.26496,0.5009,MODULE_14,0.997476662656814
GOBP_GASTRULATION_WITH_MOUTH...,SET,23,-0.00039739,-1.4056e-05,0.16892,0.50094,GOBP_GASTRULATION_WITH_MOUTH_FORMING_SECOND,0.997476662656814
DEMAGALHAES_AGING_UP,SET,48,-0.00029099,-1.4859e-05,0.12239,0.50095,DEMAGALHAES_AGING_UP,0.997476662656814
HP_APLASIA_HYPOPLASIA_INVOLV...16,SET,1045,-6.7042e-05,-1.5532e-05,0.026906,0.50099,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETON,0.997476662656814
GOBP_ESTABLISHMENT_OF_PROTEI...8,SET,18,-0.00047689,-1.4924e-05,0.19078,0.501,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PEROXISOME,0.997476662656814
HP_ARM_DYSTONIA,SET,12,-0.00058337,-1.4909e-05,0.2291,0.50102,HP_ARM_DYSTONIA,0.997476662656814
GOBP_NEGATIVE_REGULATION_OF_...385,SET,12,-0.0006819,-1.7427e-05,0.25093,0.50108,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_POTENTIAL,0.997501744086145
GOCC_GLYCOGEN_GRANULE,SET,6,-0.00088202,-1.5942e-05,0.32423,0.50109,GOCC_GLYCOGEN_GRANULE,0.997501744086145
ACACTCC_MIR122A,SET,68,-0.00028142,-1.7094e-05,0.096809,0.50116,ACACTCC_MIR122A,0.997583951890034
MORF_IKBKG,SET,121,-0.00022573,-1.8264e-05,0.071786,0.50125,MORF_IKBKG,0.997614174874027
HP_INCREASED_MUSCLE_GLYCOGEN...,SET,8,-0.00084774,-1.7692e-05,0.27162,0.50125,HP_INCREASED_MUSCLE_GLYCOGEN_CONTENT,0.997614174874027
GOCC_CIS_GOLGI_NETWORK_MEMBR...,SET,10,-0.00081352,-1.898e-05,0.25428,0.50128,GOCC_CIS_GOLGI_NETWORK_MEMBRANE,0.997614174874027
BIOCARTA_MCALPAIN_PATHWAY,SET,18,-0.00069556,-2.1768e-05,0.21495,0.50129,BIOCARTA_MCALPAIN_PATHWAY,0.997614174874027
GOMF_CALCIUM_CHANNEL_REGULAT...,SET,47,-0.00049179,-2.485e-05,0.13073,0.5015,GOMF_CALCIUM_CHANNEL_REGULATOR_ACTIVITY,0.997900475181771
MIR501_5P,SET,126,-0.00028573,-2.3589e-05,0.075738,0.50151,MIR501_5P,0.997900475181771
GOBP_SEROTONERGIC_NEURON_AXO...,SET,5,-0.0013591,-2.2424e-05,0.35687,0.50152,GOBP_SEROTONERGIC_NEURON_AXON_GUIDANCE,0.997900475181771
AGTCTTA_MIR499,SET,68,-0.00039788,-2.4169e-05,0.10031,0.50158,AGTCTTA_MIR499,0.997905598488751
GOMF_TOLL_LIKE_RECEPTOR_4_BI...,SET,5,-0.0013553,-2.2362e-05,0.34296,0.50158,GOMF_TOLL_LIKE_RECEPTOR_4_BINDING,0.997905598488751
HP_ABNORMAL_BASOPHIL_COUNT,SET,5,-0.0017559,-2.8972e-05,0.42651,0.50164,HP_ABNORMAL_BASOPHIL_COUNT,0.997930613588232
GSE17721_CTRL_VS_CPG_24H_BMD...1,SET,182,-0.00025272,-2.5036e-05,0.061134,0.50165,GSE17721_CTRL_VS_CPG_24H_BMDC_DN,0.997930613588232
MODULE_211,SET,11,-0.0013535,-3.3119e-05,0.31745,0.5017,MODULE_211,0.997972956730769
GOMF_CHROMO_SHADOW_DOMAIN_BI...,SET,5,-0.0014895,-2.4577e-05,0.3344,0.50178,GOMF_CHROMO_SHADOW_DOMAIN_BINDING,0.998074967092085
HP_ACCESSORY_ORAL_FRENULUM,SET,16,-0.00095311,-2.8123e-05,0.20889,0.50182,HP_ACCESSORY_ORAL_FRENULUM,0.99808771884655
LUCAS_HNF4A_TARGETS_DN,SET,7,-0.0015181,-2.9635e-05,0.31818,0.5019,LUCAS_HNF4A_TARGETS_DN,0.99808771884655
GOBP_OMEGA_HYDROXYLASE_P450_...,SET,11,-0.0013325,-3.2605e-05,0.27901,0.50191,GOBP_OMEGA_HYDROXYLASE_P450_PATHWAY,0.99808771884655
GOBP_REGULATION_OF_FOCAL_ADH...,SET,6,-0.0017595,-3.1801e-05,0.36534,0.50192,GOBP_REGULATION_OF_FOCAL_ADHESION_DISASSEMBLY,0.99808771884655
TBX1_TARGET_GENES,SET,166,-0.00030843,-2.9194e-05,0.063673,0.50193,TBX1_TARGET_GENES,0.99808771884655
MIR6740_3P,SET,146,-0.00035401,-3.1442e-05,0.070185,0.50201,MIR6740_3P,0.998152465675057
KEGG_MEDICUS_REFERENCE_PINK_...,SET,15,-0.001105,-3.1569e-05,0.21779,0.50202,KEGG_MEDICUS_REFERENCE_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,0.998152465675057
WP_FLUOROACETIC_ACID_TOXICITY,SET,6,-0.0015255,-2.7572e-05,0.28041,0.50217,WP_FLUOROACETIC_ACID_TOXICITY,0.998210027448962
SCHRAETS_MLL_TARGETS_UP,SET,29,-0.00096895,-3.8478e-05,0.17432,0.50222,SCHRAETS_MLL_TARGETS_UP,0.998210027448962
GOMF_NAD_DEPENDENT_PROTEIN_L...,SET,7,-0.0016818,-3.2832e-05,0.30257,0.50222,GOMF_NAD_DEPENDENT_PROTEIN_LYSINE_DEACETYLASE_ACTIVITY,0.998210027448962
MIR571,SET,61,-0.00060416,-3.4765e-05,0.10793,0.50223,MIR571,0.998210027448962
GOCC_PERINUCLEAR_REGION_OF_C...,SET,668,-0.00018424,-3.4496e-05,0.032844,0.50224,GOCC_PERINUCLEAR_REGION_OF_CYTOPLASM,0.998210027448962
MIR6733_3P,SET,128,-0.00044389,-3.6933e-05,0.078662,0.50225,MIR6733_3P,0.998210027448962
GNF2_FOS,SET,34,-0.00084908,-3.6504e-05,0.15078,0.50225,GNF2_FOS,0.998210027448962
SEAVEY_EPITHELIOID_HEMANGIOE...,SET,87,-0.00057101,-3.9212e-05,0.096499,0.50236,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,0.99830262
SHETH_LIVER_CANCER_VS_TXNIP_...1,SET,236,-0.00033236,-3.7438e-05,0.055223,0.5024,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,0.99830262
HP_ABNORMAL_MORPHOLOGY_OF_TH...4,SET,635,-0.00020668,-3.7765e-05,0.034038,0.50242,HP_ABNORMAL_MORPHOLOGY_OF_THE_GREAT_VESSELS,0.99830262
HP_ABNORMAL_PERITONEUM_MORPH...,SET,59,-0.00067843,-3.8396e-05,0.11117,0.50243,HP_ABNORMAL_PERITONEUM_MORPHOLOGY,0.99830262
GSE41867_DAY8_EFFECTOR_VS_DA...3,SET,185,-0.00037448,-3.7399e-05,0.059927,0.50249,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,0.99830262
GOBP_LONG_CHAIN_FATTY_ACID_B...,SET,25,-0.0011272,-4.1566e-05,0.17774,0.50253,GOBP_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.99830262
JIANG_HYPOXIA_VIA_VHL,SET,17,-0.001271,-3.8657e-05,0.19753,0.50257,JIANG_HYPOXIA_VIA_VHL,0.99830262
MANNO_MIDBRAIN_NEUROTYPES_BA...,SET,64,-0.00061513,-3.6254e-05,0.093705,0.50262,MANNO_MIDBRAIN_NEUROTYPES_BASAL,0.99830262
MATZUK_POSTIMPLANTATION_AND_...,SET,13,-0.0016308,-4.3379e-05,0.2475,0.50263,MATZUK_POSTIMPLANTATION_AND_POSTPARTUM,0.99830262
MANNO_MIDBRAIN_NEUROTYPES_HR...4,SET,296,-0.00034591,-4.3564e-05,0.052433,0.50263,MANNO_MIDBRAIN_NEUROTYPES_HRGL2C,0.99830262
HP_AMBIGUOUS_GENITALIA_FEMALE,SET,8,-0.0021015,-4.3856e-05,0.31535,0.50266,HP_AMBIGUOUS_GENITALIA_FEMALE,0.99830262
MIR3919,SET,278,-0.00034416,-4.2027e-05,0.051444,0.50267,MIR3919,0.99830262
GOBP_TOOTH_MINERALIZATION,SET,28,-0.0011104,-4.3329e-05,0.16604,0.50267,GOBP_TOOTH_MINERALIZATION,0.99830262
chr8q11,SET,19,-0.0022225,-7.1457e-05,0.32126,0.50276,chr8q11,0.99836726088447
KEGG_MEDICUS_PATHOGEN_HIV_GP...1,SET,12,-0.0016632,-4.2505e-05,0.24036,0.50276,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,0.99836726088447
GSE12198_LOW_IL2_STIM_NK_CEL...2,SET,183,-0.00041518,-4.1242e-05,0.058674,0.50282,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP,0.998429360681026
GSE2770_UNTREATED_VS_IL4_TRE...6,SET,187,-0.00042941,-4.3114e-05,0.05888,0.50291,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.99843897154864
GSE43863_TH1_VS_TFH_EFFECTOR...1,SET,173,-0.00046628,-4.5047e-05,0.063995,0.50291,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN,0.99843897154864
GOBP_NEGATIVE_REGULATION_OF_...203,SET,7,-0.0025015,-4.8833e-05,0.33777,0.50295,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,0.99843897154864
HE_LIM_SUN_FETAL_LUNG_C2_HSC...1,SET,1384,-0.00016838,-4.4452e-05,0.022743,0.50295,HE_LIM_SUN_FETAL_LUNG_C2_HSC_CELL,0.99843897154864
WU_ALZHEIMER_DISEASE_DN,SET,17,-0.0015574,-4.7367e-05,0.20762,0.50299,WU_ALZHEIMER_DISEASE_DN,0.99843897154864
KEGG_MEDICUS_REFERENCE_DEUBI...,SET,21,-0.0014298,-4.8327e-05,0.18888,0.50302,KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119,0.99843897154864
HP_BLURRED_VISION,SET,33,-0.001149,-4.8666e-05,0.15084,0.50304,HP_BLURRED_VISION,0.99843897154864
HE_LIM_SUN_FETAL_LUNG_C0_MYO...1,SET,46,-0.0011119,-5.5586e-05,0.14231,0.50312,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL,0.99843897154864
BIOCARTA_IL1R_PATHWAY,SET,30,-0.0013548,-5.472e-05,0.16662,0.50324,BIOCARTA_IL1R_PATHWAY,0.99843897154864
HOELZEL_NF1_TARGETS_DN,SET,99,-0.00077788,-5.6965e-05,0.095445,0.50325,HOELZEL_NF1_TARGETS_DN,0.99843897154864
chr2p13,SET,81,-0.0017484,-0.00011587,0.2138,0.50326,chr2p13,0.99843897154864
GOMF_CYCLIN_DEPENDENT_PROTEI...3,SET,12,-0.002108,-5.3874e-05,0.25538,0.50329,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,0.99843897154864
BIOCARTA_DREAM_PATHWAY,SET,13,-0.0023419,-6.2293e-05,0.27541,0.50339,BIOCARTA_DREAM_PATHWAY,0.99843897154864
GOMF_U1_SNRNA_BINDING,SET,8,-0.0021257,-4.436e-05,0.25023,0.50339,GOMF_U1_SNRNA_BINDING,0.99843897154864
HP_ANKLE_PAIN,SET,5,-0.0034478,-5.6889e-05,0.39809,0.50346,HP_ANKLE_PAIN,0.99843897154864
MODULE_495,SET,13,-0.0022664,-6.0285e-05,0.26062,0.50347,MODULE_495,0.99843897154864
GOBP_MEMBRANE_RAFT_ORGANIZAT...,SET,24,-0.0015528,-5.6104e-05,0.1752,0.50354,GOBP_MEMBRANE_RAFT_ORGANIZATION,0.99843897154864
MORF_CDH4,SET,115,-0.00072329,-5.7062e-05,0.080904,0.50357,MORF_CDH4,0.99843897154864
REACTOME_ANTIGEN_ACTIVATES_B...,SET,27,-0.001425,-5.4605e-05,0.15886,0.50358,REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS,0.99843897154864
GSE43955_1H_VS_20H_ACT_CD4_T...4,SET,184,-0.00058165,-5.7934e-05,0.06293,0.50369,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.99843897154864
MODULE_389,SET,196,-0.00055615,-5.7153e-05,0.059618,0.50372,MODULE_389,0.99843897154864
HP_ABNORMAL_LEFT_VENTRICULAR...,SET,26,-0.0016119,-6.0615e-05,0.17236,0.50373,HP_ABNORMAL_LEFT_VENTRICULAR_OUTFLOW_TRACT_MORPHOLOGY,0.99843897154864
NAKAYA_PBMC_FLUARIX_FLUVIRIN...8,SET,134,-0.00067306,-5.7289e-05,0.071805,0.50374,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_POSITIVE,0.99843897154864
GOMF_RNA_ENDONUCLEASE_ACTIVI...2,SET,5,-0.0032516,-5.3651e-05,0.34605,0.50375,GOMF_RNA_ENDONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS,0.99843897154864
MORF_CDK2,SET,67,-0.00086135,-5.1937e-05,0.091389,0.50376,MORF_CDK2,0.99843897154864
HAY_BONE_MARROW_NK_CELLS,SET,323,-0.00045672,-6.0041e-05,0.047908,0.5038,HAY_BONE_MARROW_NK_CELLS,0.99843897154864
HP_COLOBOMA,SET,207,-0.00056141,-5.9273e-05,0.058214,0.50385,HP_COLOBOMA,0.99843897154864
GOCC_MIGRASOME,SET,5,-0.0034626,-5.7132e-05,0.35812,0.50386,GOCC_MIGRASOME,0.99843897154864
GOBP_FEEDING_BEHAVIOR,SET,97,-0.00092559,-6.7097e-05,0.094831,0.50389,GOBP_FEEDING_BEHAVIOR,0.99843897154864
GOCC_PROTEASOME_REGULATORY_P...2,SET,7,-0.002794,-5.4544e-05,0.2868,0.50389,GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX,0.99843897154864
GSE39022_LN_VS_SPLEEN_DC_DN,SET,175,-0.000612,-5.9463e-05,0.062649,0.5039,GSE39022_LN_VS_SPLEEN_DC_DN,0.99843897154864
GOMF_GLYCINE_BINDING,SET,10,-0.0028391,-6.6238e-05,0.28999,0.50391,GOMF_GLYCINE_BINDING,0.99843897154864
SHIPP_DLBCL_VS_FOLLICULAR_LY...1,SET,36,-0.0013878,-6.139e-05,0.14119,0.50392,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,0.99843897154864
REACTOME_MITOCHONDRIAL_RNA_D...,SET,10,-0.0025179,-5.8745e-05,0.25157,0.50399,REACTOME_MITOCHONDRIAL_RNA_DEGRADATION,0.99843897154864
GOBP_NATURAL_KILLER_CELL_DEG...,SET,10,-0.0026296,-6.1352e-05,0.26011,0.50403,GOBP_NATURAL_KILLER_CELL_DEGRANULATION,0.99843897154864
MIR6832_5P,SET,74,-0.001018,-6.4496e-05,0.10023,0.50405,MIR6832_5P,0.99843897154864
REACTOME_APOPTOTIC_CLEAVAGE_...2,SET,11,-0.0028297,-6.9239e-05,0.27569,0.50409,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS,0.99843897154864
REACTOME_SOS_MEDIATED_SIGNAL...,SET,7,-0.0029959,-5.8485e-05,0.29182,0.5041,REACTOME_SOS_MEDIATED_SIGNALLING,0.99843897154864
MIR2276_3P,SET,109,-0.00085638,-6.5787e-05,0.083382,0.5041,MIR2276_3P,0.99843897154864
GOBP_RRNA_BASE_METHYLATION,SET,6,-0.0031869,-5.7601e-05,0.30834,0.50412,GOBP_RRNA_BASE_METHYLATION,0.99843897154864
WP_MESODERMAL_COMMITMENT_PAT...,SET,132,-0.00079973,-6.7564e-05,0.07723,0.50413,WP_MESODERMAL_COMMITMENT_PATHWAY,0.99843897154864
MODULE_332,SET,42,-0.0012847,-6.1371e-05,0.12251,0.50418,MODULE_332,0.99843897154864
GSE21380_NON_TFH_VS_TFH_CD4_...2,SET,183,-0.00066787,-6.6342e-05,0.063028,0.50423,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP,0.99843897154864
GSE20152_SPHK1_KO_VS_WT_HTNF...1,SET,180,-0.00062861,-6.1934e-05,0.058886,0.50426,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN,0.99843897154864
GOMF_INTERMEDIATE_FILAMENT_B...,SET,10,-0.0028,-6.5327e-05,0.26074,0.50428,GOMF_INTERMEDIATE_FILAMENT_BINDING,0.99843897154864
MYB_Q6,SET,228,-0.00060641,-6.7155e-05,0.056353,0.50429,MYB_Q6,0.99843897154864
HP_ABNORMAL_DISTAL_FEMORAL_M...,SET,5,-0.0042957,-7.0878e-05,0.39886,0.5043,HP_ABNORMAL_DISTAL_FEMORAL_METAPHYSIS_MORPHOLOGY,0.99843897154864
WATANABE_RECTAL_CANCER_RADIO...1,SET,89,-0.001004,-6.9729e-05,0.092333,0.50434,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,0.99843897154864
SHIN_B_CELL_LYMPHOMA_CLUSTER...8,SET,17,-0.0025164,-7.6535e-05,0.23053,0.50435,SHIN_B_CELL_LYMPHOMA_CLUSTER_9,0.99843897154864
MARTENS_BOUND_BY_PML_RARA_FU...,SET,410,-0.0004627,-6.8365e-05,0.042038,0.50439,MARTENS_BOUND_BY_PML_RARA_FUSION,0.99843897154864
GSE2405_HEAT_KILLED_VS_LIVE_...4,SET,178,-0.00064922,-6.3612e-05,0.058822,0.5044,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,0.99843897154864
GOBP_REGULATION_OF_CELL_GROW...2,SET,14,-0.0025271,-6.9755e-05,0.22812,0.50442,GOBP_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.99843897154864
GOBP_AMINO_ACID_IMPORT_ACROS...,SET,45,-0.0014763,-7.2995e-05,0.13132,0.50448,GOBP_AMINO_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99843897154864
SAMOLS_TARGETS_OF_KHSV_MIRNA...2,SET,8,-0.0038233,-7.9789e-05,0.33935,0.50449,SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP,0.99843897154864
GAO_LARGE_INTESTINE_24W_C11_...,SET,293,-0.00060492,-7.5804e-05,0.053141,0.50454,GAO_LARGE_INTESTINE_24W_C11_PANETH_LIKE_CELL,0.99843897154864
GSE6259_FLT3L_INDUCED_33D1_P...4,SET,159,-0.00075527,-6.9978e-05,0.065827,0.50458,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP,0.99843897154864
GSE6674_UNSTIM_VS_CPG_STIM_B...2,SET,131,-0.00083575,-7.0341e-05,0.072622,0.50459,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_UP,0.99843897154864
REACTOME_CLASS_I_MHC_MEDIATE...,SET,353,-0.00050671,-6.9579e-05,0.043475,0.50465,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,0.99843897154864
MIR4269,SET,190,-0.00072043,-7.2906e-05,0.061837,0.50465,MIR4269,0.99843897154864
REACTOME_ABACAVIR_ADME,SET,9,-0.0037792,-8.3651e-05,0.32305,0.50467,REACTOME_ABACAVIR_ADME,0.99843897154864
GSE14908_ATOPIC_VS_NONATOPIC...2,SET,177,-0.00071126,-6.9496e-05,0.060288,0.50471,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP,0.99843897154864
GSE14350_TREG_VS_TEFF_IN_IL2...2,SET,183,-0.00070675,-7.0205e-05,0.059676,0.50472,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP,0.99843897154864
GSE13493_DP_VS_CD4INTCD8POS_...1,SET,183,-0.00074624,-7.4128e-05,0.062057,0.5048,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN,0.99843897154864
CHEN_LVAD_SUPPORT_OF_FAILING...1,SET,42,-0.0016498,-7.8817e-05,0.13697,0.50481,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,0.99843897154864
HP_ABNORMAL_CIRCULATING_THYR...2,SET,31,-0.0018378,-7.5453e-05,0.15008,0.50489,HP_ABNORMAL_CIRCULATING_THYROID_HORMONE_CONCENTRATION,0.99843897154864
JONES_OVARY_NK_CELL,SET,79,-0.0012308,-8.0562e-05,0.10044,0.50489,JONES_OVARY_NK_CELL,0.99843897154864
GSE17301_ACD3_ACD28_VS_ACD3_...3,SET,183,-0.00081322,-8.0781e-05,0.06487,0.505,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN,0.99843897154864
HP_REDUCED_NUMBER_OF_CORNEAL...,SET,8,-0.0040557,-8.4639e-05,0.323,0.50501,HP_REDUCED_NUMBER_OF_CORNEAL_ENDOTHELIAL_CELLS,0.99843897154864
HP_REDUCED_SPERM_MOTILITY,SET,58,-0.001356,-7.6094e-05,0.10755,0.50503,HP_REDUCED_SPERM_MOTILITY,0.99843897154864
PAX4_01,SET,247,-0.00067641,-7.7924e-05,0.053333,0.50506,PAX4_01,0.99843897154864
GOBP_REGULATION_OF_TRIGLYCER...3,SET,37,-0.0017455,-7.8275e-05,0.13665,0.5051,GOBP_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.99843897154864
TCGA_GLIOBLASTOMA_COPY_NUMBE...2,SET,67,-0.0017245,-0.00010398,0.13361,0.50515,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,0.99843897154864
REACTOME_FORMATION_OF_THE_CO...,SET,120,-0.0012769,-0.00010289,0.098828,0.50515,REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,0.99843897154864
HP_FOCAL_SENSORY_SEIZURE,SET,15,-0.0027807,-7.9448e-05,0.21469,0.50517,HP_FOCAL_SENSORY_SEIZURE,0.99843897154864
YAGUE_PRETUMOR_DRUG_RESISTAN...1,SET,12,-0.0029523,-7.545e-05,0.22734,0.50518,YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,0.99843897154864
MIR6718_5P,SET,63,-0.0013749,-8.04e-05,0.10526,0.50521,MIR6718_5P,0.99843897154864
ASTON_MAJOR_DEPRESSIVE_DISOR...2,SET,42,-0.0017858,-8.5312e-05,0.1354,0.50526,ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,0.99843897154864
GSE45365_HEALTHY_VS_MCMV_INF...2,SET,184,-0.00079315,-7.9001e-05,0.059646,0.5053,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP,0.99843897154864
GOMF_HISTONE_H2AX_KINASE_ACT...,SET,5,-0.0046719,-7.7085e-05,0.35044,0.50532,GOMF_HISTONE_H2AX_KINASE_ACTIVITY,0.99843897154864
GOMF_DEAMINASE_ACTIVITY,SET,29,-0.0023518,-9.3391e-05,0.17587,0.50533,GOMF_DEAMINASE_ACTIVITY,0.99843897154864
ALK_DN.V1_DN,SET,129,-0.0010227,-8.5424e-05,0.076422,0.50534,ALK_DN.V1_DN,0.99843897154864
GOCC_SWR1_COMPLEX,SET,13,-0.0026268,-6.987e-05,0.19584,0.50535,GOCC_SWR1_COMPLEX,0.99843897154864
KEGG_MEDICUS_VARIANT_MUTATIO...61,SET,8,-0.0038135,-7.9584e-05,0.27993,0.50543,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.99843897154864
CACGTG_MYC_Q2,SET,931,-0.00038543,-8.4561e-05,0.028337,0.50543,CACGTG_MYC_Q2,0.99843897154864
GSE34156_UNTREATED_VS_24H_NO...1,SET,144,-0.00094328,-8.3208e-05,0.068654,0.50548,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.99843897154864
GOMF_ACTIVIN_RECEPTOR_ACTIVI...1,SET,9,-0.0041817,-9.2558e-05,0.30313,0.5055,GOMF_ACTIVIN_RECEPTOR_ACTIVITY,0.99843897154864
GOBP_NEGATIVE_REGULATION_OF_...352,SET,13,-0.0031081,-8.2672e-05,0.22453,0.50552,GOBP_NEGATIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,0.99843897154864
GOBP_T_CELL_MEDIATED_IMMUNE_...,SET,11,-0.0042294,-0.00010349,0.30438,0.50554,GOBP_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.99843897154864
GSE43955_1H_VS_42H_ACT_CD4_T...2,SET,180,-0.00084365,-8.3121e-05,0.060494,0.50556,GSE43955_1H_VS_42H_ACT_CD4_TCELL_UP,0.99843897154864
MIR889_5P,SET,110,-0.0011162,-8.6134e-05,0.079912,0.50557,MIR889_5P,0.99843897154864
HP_INFECTIOUS_ENCEPHALITIS,SET,39,-0.0019272,-8.8727e-05,0.13813,0.50557,HP_INFECTIOUS_ENCEPHALITIS,0.99843897154864
GSE6674_UNSTIM_VS_ANTI_IGM_A...1,SET,178,-0.00083652,-8.1964e-05,0.059665,0.50559,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,0.99843897154864
KYNG_DNA_DAMAGE_BY_4NQO_OR_G...,SET,15,-0.0029688,-8.482e-05,0.21,0.50564,KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION,0.99843897154864
DESCARTES_FETAL_HEART_VASCUL...,SET,16,-0.0031954,-9.4287e-05,0.22598,0.50564,DESCARTES_FETAL_HEART_VASCULAR_ENDOTHELIAL_CELLS,0.99843897154864
BUSSLINGER_GASTRIC_ANTRAL_ECS,SET,10,-0.0043628,-0.00010179,0.30578,0.50569,BUSSLINGER_GASTRIC_ANTRAL_ECS,0.99843897154864
WP_AMYOTROPHIC_LATERAL_SCLER...,SET,36,-0.0019273,-8.5256e-05,0.13419,0.50573,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,0.99843897154864
chr20q11,SET,118,-0.0029219,-0.00023348,0.20256,0.50575,chr20q11,0.99843897154864
GOBP_REGULATION_OF_BINDING,SET,204,-0.00084568,-8.8643e-05,0.058642,0.50575,GOBP_REGULATION_OF_BINDING,0.99843897154864
HOXA9_DN.V1_DN,SET,165,-0.00094501,-8.9181e-05,0.06556,0.50575,HOXA9_DN.V1_DN,0.99843897154864
FARMER_BREAST_CANCER_CLUSTER...6,SET,14,-0.0034329,-9.4758e-05,0.23769,0.50576,FARMER_BREAST_CANCER_CLUSTER_6,0.99843897154864
DR4_Q2,SET,226,-0.00080811,-8.9102e-05,0.055919,0.50577,DR4_Q2,0.99843897154864
HP_HYPOESTHESIA,SET,16,-0.0028111,-8.2947e-05,0.19175,0.50585,HP_HYPOESTHESIA,0.99843897154864
REACTOME_PLATELET_AGGREGATIO...,SET,39,-0.0020431,-9.4061e-05,0.13918,0.50586,REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,0.99843897154864
HP_BILATERAL_CLEFT_LIP,SET,12,-0.0041028,-0.00010485,0.27909,0.50586,HP_BILATERAL_CLEFT_LIP,0.99843897154864
GSE22886_NAIVE_BCELL_VS_MONO...1,SET,188,-0.00090395,-9.1e-05,0.061487,0.50586,GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN,0.99843897154864
GOCC_DENDRITE_MEMBRANE,SET,37,-0.0021023,-9.428e-05,0.14277,0.50587,GOCC_DENDRITE_MEMBRANE,0.99843897154864
GOBP_PROTEIN_TARGETING_TO_LY...,SET,29,-0.0023266,-9.2393e-05,0.15707,0.50591,GOBP_PROTEIN_TARGETING_TO_LYSOSOME,0.998446408558329
MIR92A_2_5P,SET,192,-0.00090564,-9.2125e-05,0.060176,0.506,MIR92A_2_5P,0.998446408558329
GSE13485_DAY3_VS_DAY21_YF17D...1,SET,139,-0.0011201,-9.7091e-05,0.073815,0.50605,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.998446408558329
GOBP_AUTONOMIC_NERVOUS_SYSTE...,SET,40,-0.0022205,-0.00010353,0.1449,0.50611,GOBP_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,0.998446408558329
WP_17Q12_COPY_NUMBER_VARIATI...,SET,84,-0.0026736,-0.00018042,0.17356,0.50615,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,0.998446408558329
HP_ROUND_FACE,SET,95,-0.0012828,-9.2033e-05,0.083041,0.50616,HP_ROUND_FACE,0.998446408558329
GSE9988_LPS_VS_LOW_LPS_MONOC...1,SET,147,-0.001079,-9.6161e-05,0.069829,0.50616,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN,0.998446408558329
GOBP_HAIR_FOLLICLE_PLACODE_F...,SET,4,-0.0056231,-8.2987e-05,0.36184,0.5062,GOBP_HAIR_FOLLICLE_PLACODE_FORMATION,0.998446408558329
GSE17186_CD21LOW_VS_CD21HIGH...1,SET,175,-0.00095289,-9.2583e-05,0.061204,0.50621,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.998446408558329
MIR376A_5P,SET,56,-0.0017829,-9.8314e-05,0.11364,0.50626,MIR376A_5P,0.998446408558329
GSE17721_PAM3CSK4_VS_CPG_24H...1,SET,182,-0.00096664,-9.5761e-05,0.061357,0.50628,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_DN,0.998446408558329
MIR10394_5P,SET,162,-0.0010528,-9.8458e-05,0.065952,0.50637,MIR10394_5P,0.998446408558329
LIAN_NEUTROPHIL_GRANULE_CONS...,SET,23,-0.0031739,-0.00011226,0.19788,0.5064,LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS,0.998446408558329
GOBP_POSITIVE_REGULATION_OF_...557,SET,34,-0.002432,-0.00010456,0.15137,0.50641,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,0.998446408558329
GOMF_ACTIVE_MONOATOMIC_ION_T...,SET,261,-0.00082674,-9.7866e-05,0.051431,0.50641,GOMF_ACTIVE_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.998446408558329
GOBP_VESICLE_BUDDING_FROM_ME...,SET,82,-0.0014394,-9.5975e-05,0.089499,0.50642,GOBP_VESICLE_BUDDING_FROM_MEMBRANE,0.998446408558329
HP_EYE_MOVEMENT_INDUCED_PAIN,SET,5,-0.0063089,-0.00010409,0.3911,0.50644,HP_EYE_MOVEMENT_INDUCED_PAIN,0.998446408558329
GOBP_DITERPENOID_METABOLIC_P...,SET,86,-0.0016287,-0.00011121,0.10041,0.50647,GOBP_DITERPENOID_METABOLIC_PROCESS,0.998446408558329
GOBP_INTRACELLULAR_SODIUM_IO...,SET,22,-0.0033867,-0.00011716,0.20841,0.50648,GOBP_INTRACELLULAR_SODIUM_ION_HOMEOSTASIS,0.998446408558329
GSE360_HIGH_DOSE_B_MALAYI_VS...1,SET,186,-0.0010207,-0.00010221,0.062667,0.5065,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,0.998446408558329
GSE2770_TGFB_AND_IL4_VS_IL4_...6,SET,162,-0.0010355,-9.6831e-05,0.062909,0.50657,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.998446408558329
chr6q26,SET,6,-0.0071927,-0.00013,0.43316,0.50662,chr6q26,0.998446408558329
GSE7852_TREG_VS_TCONV_THYMUS...1,SET,178,-0.0010407,-0.00010197,0.062679,0.50662,GSE7852_TREG_VS_TCONV_THYMUS_DN,0.998446408558329
GOBP_NEGATIVE_REGULATION_OF_...278,SET,10,-0.0048014,-0.00011202,0.28755,0.50666,GOBP_NEGATIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,0.998446408558329
GOBP_REGULATION_OF_TRIGLYCER...1,SET,18,-0.0030724,-9.6152e-05,0.18362,0.50668,GOBP_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.998446408558329
MIR6833_3P,SET,375,-0.00074017,-0.00010469,0.044158,0.50669,MIR6833_3P,0.998446408558329
KEGG_STEROID_BIOSYNTHESIS,SET,15,-0.0034407,-9.8302e-05,0.20487,0.5067,KEGG_STEROID_BIOSYNTHESIS,0.998446408558329
GOBP_REGULATION_OF_TOLL_LIKE...1,SET,11,-0.0044832,-0.0001097,0.2666,0.50671,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.998446408558329
GOTZMANN_EPITHELIAL_TO_MESEN...2,SET,65,-0.0018387,-0.00010921,0.10834,0.50677,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,0.998446408558329
GSE23925_LIGHT_ZONE_VS_NAIVE...2,SET,181,-0.0011106,-0.00010972,0.065085,0.50681,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP,0.998446408558329
GOBP_PROTEIN_LOCALIZATION_TO...9,SET,318,-0.0008106,-0.00010575,0.047441,0.50682,GOBP_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,0.998446408558329
SCHLESINGER_H3K27ME3_IN_NORM...,SET,26,-0.0035141,-0.00013214,0.20163,0.50695,SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER,0.998446408558329
GOBP_LIPOPOLYSACCHARIDE_MEDI...,SET,54,-0.0020528,-0.00011116,0.11776,0.50695,GOBP_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,0.998446408558329
MODULE_379,SET,178,-0.0011074,-0.00010851,0.063473,0.50696,MODULE_379,0.998446408558329
HP_DUPLICATION_OF_THUMB_PHAL...,SET,53,-0.0020202,-0.00010838,0.11281,0.50714,HP_DUPLICATION_OF_THUMB_PHALANX,0.998446408558329
GOBP_REGULATION_OF_HORMONE_B...,SET,23,-0.0033966,-0.00012014,0.18874,0.50718,GOBP_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,0.998446408558329
GOBP_HYPEROSMOTIC_SALINITY_R...,SET,10,-0.0052198,-0.00012178,0.28945,0.50719,GOBP_HYPEROSMOTIC_SALINITY_RESPONSE,0.998446408558329
GOBP_PLASMA_MEMBRANE_RAFT_AS...,SET,7,-0.0056514,-0.00011032,0.31344,0.50719,GOBP_PLASMA_MEMBRANE_RAFT_ASSEMBLY,0.998446408558329
MODULE_154,SET,67,-0.0019593,-0.00011814,0.10852,0.5072,MODULE_154,0.998446408558329
REACTOME_SYNTHESIS_OF_WYBUTO...,SET,6,-0.006159,-0.00011132,0.34054,0.50721,REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE,0.998446408558329
GAO_ESOPHAGUS_25W_C2_KRT6BPO...,SET,66,-0.0020334,-0.0001217,0.11221,0.50723,GAO_ESOPHAGUS_25W_C2_KRT6BPOS_SECRETORY_PROGENITOR_CELLS,0.998446408558329
GOBP_CARDIAC_MUSCLE_CELL_CON...,SET,78,-0.0018299,-0.00011901,0.10089,0.50724,GOBP_CARDIAC_MUSCLE_CELL_CONTRACTION,0.998446408558329
GOBP_FERTILIZATION,SET,183,-0.0011481,-0.00011405,0.063244,0.50724,GOBP_FERTILIZATION,0.998446408558329
GOBP_ENDOCRINE_PROCESS,SET,84,-0.0017953,-0.00012116,0.098807,0.50725,GOBP_ENDOCRINE_PROCESS,0.998446408558329
NABA_MATRISOME_POORLY_METAST...3,SET,35,-0.002592,-0.00011306,0.14241,0.50726,NABA_MATRISOME_POORLY_METASTATIC_MELANOMA,0.998446408558329
GSE43863_TH1_VS_TFH_MEMORY_C...1,SET,181,-0.0011572,-0.00011432,0.06296,0.50733,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN,0.998446408558329
REACTOME_COMPLEX_I_BIOGENESIS,SET,56,-0.0017917,-9.8795e-05,0.096978,0.50737,REACTOME_COMPLEX_I_BIOGENESIS,0.998446408558329
GOMF_MYOSIN_V_BINDING,SET,16,-0.0040918,-0.00012074,0.22107,0.50738,GOMF_MYOSIN_V_BINDING,0.998446408558329
GSE14386_UNTREATED_VS_IFNA_T...1,SET,149,-0.0013618,-0.00012218,0.073602,0.50738,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN,0.998446408558329
GOBP_CEREBELLAR_PURKINJE_CEL...2,SET,12,-0.0046428,-0.00011865,0.25019,0.5074,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_FORMATION,0.998446408558329
GOBP_CYTOLYSIS,SET,6,-0.0082831,-0.00014971,0.44631,0.5074,GOBP_CYTOLYSIS,0.998446408558329
HP_ABNORMALITY_OF_THE_MIDDLE...2,SET,19,-0.0038244,-0.00012296,0.20548,0.50742,HP_ABNORMALITY_OF_THE_MIDDLE_EAR_OSSICLES,0.998446408558329
GSE22886_NAIVE_VS_MEMORY_TCE...1,SET,183,-0.0011614,-0.00011537,0.06232,0.50743,GSE22886_NAIVE_VS_MEMORY_TCELL_DN,0.998446408558329
GSE5503_MLN_DC_VS_PLN_DC_ACT...2,SET,179,-0.0011513,-0.00011312,0.061462,0.50747,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.998446408558329
REACTOME_SUMOYLATION_OF_TRAN...2,SET,19,-0.0036026,-0.00011583,0.19163,0.5075,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS,0.998446408558329
WP_SPLICING_FACTOR_NOVA_REGU...,SET,41,-0.0024162,-0.00011405,0.12821,0.50752,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,0.998446408558329
GOBP_PHOSPHATIDYLETHANOLAMIN...2,SET,9,-0.0056682,-0.00012546,0.30066,0.50752,GOBP_PHOSPHATIDYLETHANOLAMINE_BIOSYNTHETIC_PROCESS,0.998446408558329
GSE3039_CD4_TCELL_VS_B1_BCEL...2,SET,184,-0.0011552,-0.00011506,0.061155,0.50754,GSE3039_CD4_TCELL_VS_B1_BCELL_UP,0.998446408558329
HP_AVASCULAR_NECROSIS,SET,83,-0.001816,-0.00012182,0.09446,0.50767,HP_AVASCULAR_NECROSIS,0.998452094995759
ALKBH3_TARGET_GENES,SET,353,-0.00084993,-0.00011671,0.044069,0.50769,ALKBH3_TARGET_GENES,0.998452094995759
STREICHER_LSM1_TARGETS_UP,SET,40,-0.0026256,-0.00012241,0.13464,0.50778,STREICHER_LSM1_TARGETS_UP,0.998452094995759
GOBP_EYE_PHOTORECEPTOR_CELL_...1,SET,36,-0.002923,-0.0001293,0.14953,0.5078,GOBP_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT,0.998452094995759
GSE41867_DAY8_EFFECTOR_VS_DA...1,SET,178,-0.0012189,-0.00011943,0.06213,0.50783,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.998452094995759
BIOCARTA_CB1R_PATHWAY,SET,7,-0.0062121,-0.00012127,0.315,0.50787,BIOCARTA_CB1R_PATHWAY,0.998452094995759
GSE40274_CTRL_VS_FOXP3_AND_X...1,SET,133,-0.001491,-0.00012644,0.075507,0.50788,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.998452094995759
HP_NARROW_FORAMEN_OBTURATORI...,SET,4,-0.0076649,-0.00011312,0.38772,0.50789,HP_NARROW_FORAMEN_OBTURATORIUM,0.998452094995759
SIX4_TARGET_GENES,SET,33,-0.0027207,-0.00011524,0.13715,0.50791,SIX4_TARGET_GENES,0.998452094995759
GOBP_POSITIVE_REGULATION_OF_...779,SET,22,-0.0032708,-0.00011315,0.16495,0.50791,GOBP_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,0.998452094995759
HADDAD_T_LYMPHOCYTE_AND_NK_P...2,SET,73,-0.0021095,-0.00013275,0.1062,0.50792,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,0.998452094995759
HP_ABNORMALITY_OF_PREMOLAR,SET,12,-0.0053187,-0.00013593,0.26722,0.50794,HP_ABNORMALITY_OF_PREMOLAR,0.998452094995759
MIR4474_5P,SET,44,-0.002649,-0.00012952,0.13272,0.50796,MIR4474_5P,0.998452094995759
GSE5542_IFNG_VS_IFNA_AND_IFN...2,SET,179,-0.0012048,-0.00011838,0.06032,0.50797,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.998452094995759
GAO_STOMACH_24W_C5_PUTATIVE_...,SET,51,-0.0024092,-0.0001268,0.1197,0.50803,GAO_STOMACH_24W_C5_PUTATIVE_PIT_CELL_PROGENITOR,0.998452094995759
HP_APLASIA_HYPOPLASIA_OF_THE...25,SET,7,-0.0073971,-0.0001444,0.36674,0.50805,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,0.998452094995759
GOBP_CARDIAC_ATRIUM_MORPHOGE...,SET,26,-0.003805,-0.00014308,0.18843,0.50806,GOBP_CARDIAC_ATRIUM_MORPHOGENESIS,0.998452094995759
GSE24574_BCL6_LOW_TFH_VS_NAI...1,SET,171,-0.0013359,-0.00012832,0.066114,0.50806,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_DN,0.998452094995759
WP_MITOCHONDRIAL_IMMUNE_RESP...,SET,23,-0.003454,-0.00012217,0.16883,0.50816,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.998528515713317
KEGG_MEDICUS_VARIANT_MUTATIO...2,SET,24,-0.0034998,-0.00012645,0.1699,0.50822,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.998528515713317
MIR7156_5P,SET,126,-0.0015858,-0.00013092,0.076853,0.50823,MIR7156_5P,0.998528515713317
GOBP_CELLULAR_RESPONSE_TO_UV...1,SET,10,-0.0065185,-0.00015208,0.31548,0.50824,GOBP_CELLULAR_RESPONSE_TO_UV_A,0.998528515713317
GOBP_TRNA_DECAY,SET,16,-0.0041044,-0.00012111,0.19775,0.50828,GOBP_TRNA_DECAY,0.998528515713317
WP_HIPPO_SIGNALING_REGULATION,SET,98,-0.0018903,-0.00013773,0.091002,0.50829,WP_HIPPO_SIGNALING_REGULATION,0.998528515713317
MIR2115_3P,SET,215,-0.0012249,-0.00013177,0.058852,0.5083,MIR2115_3P,0.998528515713317
DESCARTES_FETAL_SPLEEN_MESOT...,SET,177,-0.0014237,-0.00013911,0.066948,0.50848,DESCARTES_FETAL_SPLEEN_MESOTHELIAL_CELLS,0.99879876539722
REACTOME_HSF1_ACTIVATION,SET,28,-0.0033179,-0.00012947,0.15539,0.50852,REACTOME_HSF1_ACTIVATION,0.99879876539722
GSE1925_CTRL_VS_3H_IFNG_STIM...2,SET,155,-0.0014076,-0.00012878,0.065803,0.50853,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,0.99879876539722
HP_PROMINENT_UMBILICUS,SET,5,-0.0094757,-0.00015635,0.44161,0.50856,HP_PROMINENT_UMBILICUS,0.99879876539722
KEGG_MEDICUS_PATHOGEN_SALMON...9,SET,5,-0.0065128,-0.00010746,0.30201,0.5086,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SPVD_TO_TNF_NFKB_SIGNALING_PATHWAY,0.99879876539722
HP_CYSTIC_HYGROMA,SET,50,-0.0024476,-0.00012755,0.11334,0.50861,HP_CYSTIC_HYGROMA,0.99879876539722
TGTYNNNNNRGCARM_UNKNOWN,SET,79,-0.0021136,-0.00013834,0.096577,0.50873,TGTYNNNNNRGCARM_UNKNOWN,0.99894363877747
GOMF_UBIQUITIN_LIKE_PROTEIN_...8,SET,5,-0.0074002,-0.0001221,0.33749,0.50875,GOMF_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_ENDOPEPTIDASE_ACTIVITY,0.99894363877747
GSE17186_NAIVE_VS_CD21LOW_TR...4,SET,183,-0.0013958,-0.00013866,0.063482,0.50877,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP,0.99894363877747
GOMF_PHOSPHOLIPASE_ACTIVATOR...,SET,14,-0.0044397,-0.00012255,0.20041,0.50884,GOMF_PHOSPHOLIPASE_ACTIVATOR_ACTIVITY,0.998951160230352
MIR1205,SET,160,-0.0014816,-0.0001377,0.06649,0.50889,MIR1205,0.998951160230352
HP_ABNORMAL_CIRCULATING_LONG...,SET,16,-0.0045561,-0.00013444,0.20374,0.50892,HP_ABNORMAL_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION,0.998951160230352
MODULE_210,SET,26,-0.0039956,-0.00015025,0.17794,0.50896,MODULE_210,0.998951160230352
GSE41176_UNSTIM_VS_ANTI_IGM_...9,SET,175,-0.0013985,-0.00013588,0.062209,0.50897,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN,0.998951160230352
CP2_01,SET,238,-0.0012283,-0.00013894,0.054477,0.50899,CP2_01,0.998951160230352
GSE411_WT_VS_SOCS3_KO_MACROP...3,SET,186,-0.0013108,-0.00013126,0.058095,0.509,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_UP,0.998951160230352
GOMF_PRE_MRNA_3_SPLICE_SITE_...,SET,3,-0.010433,-0.00013335,0.4616,0.50902,GOMF_PRE_MRNA_3_SPLICE_SITE_BINDING,0.998951160230352
HP_GENERALIZED_AMYLOID_DEPOS...,SET,6,-0.0080159,-0.00014488,0.35383,0.50904,HP_GENERALIZED_AMYLOID_DEPOSITION,0.998951160230352
GOBP_PHOSPHATIDYLCHOLINE_ACY...,SET,13,-0.0053142,-0.00014135,0.23341,0.50908,GOBP_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING,0.998951160230352
GOBP_CARBOHYDRATE_IMPORT_ACR...,SET,5,-0.0098055,-0.00016179,0.43043,0.50909,GOBP_CARBOHYDRATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.998951160230352
REACTOME_SUMOYLATION,SET,163,-0.001487,-0.00013948,0.064683,0.50917,REACTOME_SUMOYLATION,0.998980746445498
GSE29617_DAY3_VS_DAY7_TIV_FL...1,SET,151,-0.0014807,-0.00013372,0.06442,0.50917,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,0.998980746445498
MIR4475,SET,58,-0.0025128,-0.00014101,0.10868,0.50922,MIR4475,0.998980746445498
REACTOME_INTERLEUKIN_2_SIGNA...,SET,11,-0.0063335,-0.00015497,0.27264,0.50927,REACTOME_INTERLEUKIN_2_SIGNALING,0.998980746445498
CACTTTG_MIR520G_MIR520H,SET,215,-0.0013788,-0.00014833,0.058989,0.50932,CACTTTG_MIR520G_MIR520H,0.998980746445498
GSE21927_SPLEEN_C57BL6_VS_EL...1,SET,184,-0.0013565,-0.00013511,0.058036,0.50932,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_DN,0.998980746445498
WP_PTF1A_RELATED_REGULATORY_...,SET,11,-0.0067531,-0.00016524,0.28825,0.50935,WP_PTF1A_RELATED_REGULATORY_PATHWAY,0.998980746445498
GSE24574_BCL6_HIGH_VS_LOW_TF...1,SET,181,-0.0014272,-0.000141,0.060848,0.50936,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN,0.998980746445498
GSE39152_CD103_NEG_VS_POS_ME...2,SET,185,-0.0014813,-0.00014794,0.062988,0.50938,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP,0.998980746445498
MODULE_155,SET,24,-0.003928,-0.00014192,0.16618,0.50943,MODULE_155,0.998980746445498
WP_AMPLIFICATION_AND_EXPANSI...,SET,17,-0.0053636,-0.00016313,0.2266,0.50944,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,0.998980746445498
GOBP_RIBONUCLEOSIDE_MONOPHOS...3,SET,52,-0.0027915,-0.00014834,0.11784,0.50945,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.998980746445498
WP_INVOLVEMENT_OF_SECRETASE_...,SET,16,-0.0053015,-0.00015643,0.2217,0.50954,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,0.999100857545839
GSE34156_UNTREATED_VS_6H_NOD...4,SET,159,-0.0015862,-0.00014697,0.06588,0.5096,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP,0.999162134717364
FLECHNER_PBL_KIDNEY_TRANSPLA...3,SET,50,-0.0027815,-0.00014495,0.11451,0.50969,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,0.999282222034185
MCCOLLUM_GELDANAMYCIN_RESIST...2,SET,9,-0.007366,-0.00016304,0.30185,0.50973,MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP,0.999304272901625
GOCC_MICROTUBULE_BUNDLE,SET,6,-0.0075612,-0.00013666,0.30793,0.50979,GOCC_MICROTUBULE_BUNDLE,0.999348367174281
GSE41867_DAY6_VS_DAY8_LCMV_C...1,SET,183,-0.0014362,-0.00014267,0.058397,0.50981,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.999348367174281
HP_CONE_SHAPED_EPIPHYSES_OF_...,SET,27,-0.0039223,-0.0001503,0.15764,0.50992,HP_CONE_SHAPED_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.99947280607937
GSE5099_MONOCYTE_VS_ALTERNAT...2,SET,143,-0.0017506,-0.00015389,0.070281,0.50994,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_UP,0.99947280607937
HP_CHRONIC_LYMPHATIC_LEUKEMIA,SET,14,-0.0055468,-0.00015311,0.22192,0.50997,HP_CHRONIC_LYMPHATIC_LEUKEMIA,0.99947280607937
BUSSLINGER_DUODENAL_TRANSIT_...,SET,162,-0.0016282,-0.00015226,0.064722,0.51003,BUSSLINGER_DUODENAL_TRANSIT_AMPLIFYING_CELLS,0.99947280607937
REACTOME_SCF_SKP2_MEDIATED_D...,SET,57,-0.0025369,-0.00014113,0.10077,0.51004,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,0.99947280607937
GOBP_NEURONAL_ION_CHANNEL_CL...,SET,12,-0.0061215,-0.00015644,0.24276,0.51006,GOBP_NEURONAL_ION_CHANNEL_CLUSTERING,0.99947280607937
GSE17721_0.5H_VS_8H_GARDIQUI...1,SET,184,-0.0015742,-0.00015679,0.061903,0.51014,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN,0.99947280607937
GOBP_BRANCHIOMOTOR_NEURON_AX...,SET,6,-0.0092588,-0.00016734,0.36372,0.51015,GOBP_BRANCHIOMOTOR_NEURON_AXON_GUIDANCE,0.99947280607937
GAUCHER_PBMC_YF_VAX_STAMARIL...8,SET,206,-0.0015449,-0.00016271,0.060667,0.51016,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP,0.99947280607937
GOBP_PROTEIN_DNA_COVALENT_CR...,SET,8,-0.0060548,-0.00012636,0.23748,0.51017,GOBP_PROTEIN_DNA_COVALENT_CROSS_LINKING_REPAIR,0.99947280607937
HP_HANDGRIP_MYOTONIA,SET,6,-0.0097381,-0.00017601,0.38054,0.51021,HP_HANDGRIP_MYOTONIA,0.99947280607937
RAMPON_ENRICHED_LEARNING_ENV...1,SET,10,-0.0074333,-0.00017343,0.28885,0.51027,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN,0.99947280607937
GOBP_REGULATION_OF_EOSINOPHI...,SET,5,-0.010613,-0.00017511,0.41241,0.51027,GOBP_REGULATION_OF_EOSINOPHIL_MIGRATION,0.99947280607937
GOBP_CHONDROBLAST_DIFFERENTI...,SET,4,-0.010335,-0.00015253,0.39843,0.51035,GOBP_CHONDROBLAST_DIFFERENTIATION,0.99947280607937
GOMF_TORC2_COMPLEX_BINDING,SET,4,-0.011566,-0.0001707,0.44409,0.51039,GOMF_TORC2_COMPLEX_BINDING,0.99947280607937
REACTOME_RAB_REGULATION_OF_T...,SET,111,-0.0020232,-0.00015683,0.07741,0.51043,REACTOME_RAB_REGULATION_OF_TRAFFICKING,0.99947280607937
GOBP_POSITIVE_REGULATION_OF_...306,SET,33,-0.0040891,-0.0001732,0.15553,0.51049,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT,0.99947280607937
GSE3691_CONVENTIONAL_VS_PLAS...1,SET,182,-0.0016542,-0.00016387,0.062851,0.5105,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN,0.99947280607937
MODULE_38,SET,422,-0.0011252,-0.00016862,0.042684,0.51052,MODULE_38,0.99947280607937
HP_GENETIC_ANTICIPATION,SET,8,-0.0071341,-0.00014888,0.27059,0.51052,HP_GENETIC_ANTICIPATION,0.99947280607937
HAY_BONE_MARROW_FOLLICULAR_B...,SET,125,-0.0021058,-0.00017316,0.079796,0.51053,HAY_BONE_MARROW_FOLLICULAR_B_CELL,0.99947280607937
GAVISH_3CA_METAPROGRAM_FIBRO...15,SET,44,-0.0039067,-0.00019101,0.14722,0.51059,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM,0.99947280607937
GOBP_MAINTENANCE_OF_POSTSYNA...,SET,8,-0.0078441,-0.0001637,0.29479,0.51061,GOBP_MAINTENANCE_OF_POSTSYNAPTIC_SPECIALIZATION_STRUCTURE,0.99947280607937
GOMF_LIPID_TRANSMEMBRANE_TRA...,SET,54,-0.0031449,-0.0001703,0.11824,0.51061,GOMF_LIPID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99947280607937
BLANCO_MELO_COVID19_SARS_COV...1,SET,90,-0.0024906,-0.00017395,0.093183,0.51066,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,0.99947280607937
HP_AIRWAY_HYPERRESPONSIVENESS,SET,8,-0.0084035,-0.00017537,0.3141,0.51067,HP_AIRWAY_HYPERRESPONSIVENESS,0.99947280607937
REACTOME_AQUAPORIN_MEDIATED_...,SET,50,-0.003502,-0.0001825,0.1308,0.51068,REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,0.99947280607937
HP_NEONATAL_DEATH,SET,82,-0.0023468,-0.00015648,0.0876,0.51069,HP_NEONATAL_DEATH,0.99947280607937
GOMF_POLY_A_SPECIFIC_RIBONUC...,SET,12,-0.0062549,-0.00015985,0.232,0.51075,GOMF_POLY_A_SPECIFIC_RIBONUCLEASE_ACTIVITY,0.99947280607937
GOMF_IRON_ION_TRANSMEMBRANE_...,SET,9,-0.0081492,-0.00018038,0.30134,0.51079,GOMF_IRON_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99947280607937
GSE5099_MONOCYTE_VS_CLASSICA...2,SET,174,-0.0016757,-0.00016235,0.061922,0.51079,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP,0.99947280607937
HP_AGANGLIONIC_MEGACOLON,SET,132,-0.001917,-0.00016195,0.070809,0.5108,HP_AGANGLIONIC_MEGACOLON,0.99947280607937
GSE24574_BCL6_LOW_TFH_VS_TCO...2,SET,168,-0.0018047,-0.00017184,0.066401,0.51084,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP,0.99947280607937
GOCC_OUTER_KINETOCHORE,SET,19,-0.0055832,-0.00017951,0.20509,0.51086,GOCC_OUTER_KINETOCHORE,0.99947280607937
HP_NEOPLASM_OF_THE_PANCREAS,SET,86,-0.0024824,-0.00016949,0.091047,0.51088,HP_NEOPLASM_OF_THE_PANCREAS,0.99947280607937
REACTOME_FORMATION_OF_SENESC...,SET,11,-0.0062752,-0.00015355,0.22928,0.51092,REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF,0.999494799054374
HP_ABNORMAL_GASTROINTESTINAL...2,SET,6,-0.010227,-0.00018484,0.37144,0.51098,HP_ABNORMAL_GASTROINTESTINAL_VASCULAR_MORPHOLOGY,0.999555912647042
GSE36891_POLYIC_TLR3_VS_PAM_...2,SET,140,-0.0021099,-0.00018354,0.076108,0.51106,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,0.999563521678322
GOBP_ENDOPLASMIC_RETICULUM_C...,SET,23,-0.0049739,-0.00017593,0.17896,0.51109,GOBP_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS,0.999563521678322
PID_IL8_CXCR1_PATHWAY,SET,27,-0.0045126,-0.00017292,0.16143,0.51115,PID_IL8_CXCR1_PATHWAY,0.999563521678322
ZBTB49_TARGET_GENES,SET,7,-0.0074151,-0.00014476,0.2653,0.51115,ZBTB49_TARGET_GENES,0.999563521678322
GOBP_OLIGOSACCHARIDE_BIOSYNT...,SET,29,-0.0047462,-0.00018847,0.16939,0.51118,GOBP_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS,0.999563521678322
HP_INCREASED_CIRCULATING_ACT...,SET,14,-0.0062951,-0.00017376,0.22459,0.51118,HP_INCREASED_CIRCULATING_ACTH_LEVEL,0.999563521678322
REACTOME_SODIUM_CALCIUM_EXCH...,SET,11,-0.0084545,-0.00020687,0.29987,0.51125,REACTOME_SODIUM_CALCIUM_EXCHANGERS,0.999563521678322
REACTOME_RHO_GTPASES_ACTIVAT...9,SET,19,-0.0056175,-0.00018061,0.19876,0.51127,REACTOME_RHO_GTPASES_ACTIVATE_ROCKS,0.999563521678322
NABA_CORE_MATRISOME,SET,252,-0.001643,-0.00019115,0.058049,0.51129,NABA_CORE_MATRISOME,0.999563521678322
GOBP_ANTIGEN_PROCESSING_AND_...12,SET,17,-0.0069539,-0.0002115,0.24472,0.51133,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_IB,0.999563521678322
GOBP_REGULATION_OF_INSULIN_R...,SET,65,-0.0029003,-0.00017226,0.10213,0.51133,GOBP_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY,0.999563521678322
GOBP_REGULATION_OF_EXOSOMAL_...,SET,18,-0.0053553,-0.00016759,0.1868,0.51144,GOBP_REGULATION_OF_EXOSOMAL_SECRETION,0.999563521678322
GOCC_NUCLEAR_INCLUSION_BODY,SET,11,-0.0057646,-0.00014106,0.20095,0.51144,GOCC_NUCLEAR_INCLUSION_BODY,0.999563521678322
PID_RET_PATHWAY,SET,39,-0.0039123,-0.00018012,0.13614,0.51146,PID_RET_PATHWAY,0.999563521678322
MIR4318,SET,100,-0.0024435,-0.00017983,0.084843,0.51149,MIR4318,0.999563521678322
RICKMAN_TUMOR_DIFFERENTIATED...1,SET,15,-0.0062798,-0.00017942,0.21653,0.51157,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN,0.999563521678322
HASLINGER_B_CLL_WITH_6Q21_DE...,SET,11,-0.006672,-0.00016326,0.22901,0.51162,HASLINGER_B_CLL_WITH_6Q21_DELETION,0.999563521678322
HE_LIM_SUN_FETAL_LUNG_C2_DC3...,SET,6,-0.0094545,-0.00017088,0.32377,0.51165,HE_LIM_SUN_FETAL_LUNG_C2_DC3_CELL,0.999563521678322
GOBP_PROTEIN_INSERTION_INTO_...5,SET,10,-0.0068594,-0.00016004,0.23244,0.51177,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_INNER_MEMBRANE,0.999563521678322
HP_SHORT_PALPEBRAL_FISSURE,SET,107,-0.0023685,-0.00018028,0.080118,0.51179,HP_SHORT_PALPEBRAL_FISSURE,0.999563521678322
GSE40274_CTRL_VS_FOXP3_AND_G...1,SET,135,-0.0021308,-0.00018204,0.072034,0.5118,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.999563521678322
GOBP_GLUTAMATE_CATABOLIC_PRO...,SET,7,-0.0096378,-0.00018815,0.32493,0.51183,GOBP_GLUTAMATE_CATABOLIC_PROCESS,0.999563521678322
HP_HYPERACTIVE_DEEP_TENDON_R...,SET,22,-0.0052358,-0.00018113,0.17575,0.51188,HP_HYPERACTIVE_DEEP_TENDON_REFLEXES,0.999563521678322
KEGG_MEDICUS_REFERENCE_PTH_P...,SET,15,-0.006918,-0.00019765,0.23196,0.5119,KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY,0.999563521678322
MIR6789_5P,SET,20,-0.005441,-0.00017948,0.18217,0.51191,MIR6789_5P,0.999563521678322
GOBP_ESTABLISHMENT_OF_PROTEI...10,SET,17,-0.0052035,-0.00015826,0.17432,0.51191,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE,0.999563521678322
HP_CHOREOATHETOSIS,SET,101,-0.0025403,-0.00018789,0.085063,0.51191,HP_CHOREOATHETOSIS,0.999563521678322
GSE42021_CD24LO_TREG_VS_CD24...1,SET,184,-0.0017569,-0.000175,0.058537,0.51197,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_DN,0.999563521678322
MIR4281,SET,18,-0.006507,-0.00020364,0.2167,0.51198,MIR4281,0.999563521678322
ZHAN_MULTIPLE_MYELOMA_SUBGRO...,SET,30,-0.0039319,-0.0001588,0.13079,0.51199,ZHAN_MULTIPLE_MYELOMA_SUBGROUPS,0.999563521678322
BENPORATH_SUZ12_TARGETS,SET,874,-0.00098661,-0.00021007,0.032588,0.51208,BENPORATH_SUZ12_TARGETS,0.999563521678322
GOBP_POSITIVE_REGULATION_BY_...3,SET,17,-0.00525,-0.00015968,0.17325,0.51209,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION,0.999563521678322
GOBP_NEGATIVE_REGULATION_OF_...556,SET,5,-0.012112,-0.00019984,0.39916,0.5121,GOBP_NEGATIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION,0.999563521678322
GSE24574_BCL6_HIGH_TFH_VS_TF...1,SET,185,-0.0019215,-0.00019191,0.063318,0.5121,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN,0.999563521678322
REACTOME_CLASS_C_3_METABOTRO...,SET,37,-0.0050837,-0.00022798,0.16662,0.51217,REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS,0.999563521678322
LANDIS_ERBB2_BREAST_PRENEOPL...1,SET,56,-0.0035361,-0.00019499,0.1158,0.51218,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,0.999563521678322
GOBP_BRANCHING_INVOLVED_IN_M...,SET,21,-0.0061343,-0.00020734,0.20078,0.51219,GOBP_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS,0.999563521678322
GROSS_HIF1A_TARGETS_DN,SET,21,-0.005616,-0.00018982,0.18347,0.51221,GROSS_HIF1A_TARGETS_DN,0.999563521678322
HP_ABNORMAL_FEAR_INDUCED_BEH...,SET,7,-0.0085952,-0.00016779,0.2796,0.51226,HP_ABNORMAL_FEAR_INDUCED_BEHAVIOR,0.999563521678322
GOMF_1_PHOSPHATIDYLINOSITOL_...5,SET,8,-0.0082573,-0.00017232,0.26838,0.51227,GOMF_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_ACTIVITY,0.999563521678322
GOBP_PROTEIN_K63_LINKED_UBIQ...,SET,64,-0.0030823,-0.00018166,0.1001,0.51228,GOBP_PROTEIN_K63_LINKED_UBIQUITINATION,0.999563521678322
BIOCARTA_LYM_PATHWAY,SET,13,-0.0078485,-0.00020876,0.25412,0.51232,BIOCARTA_LYM_PATHWAY,0.999563521678322
HP_BLADDER_NEOPLASM,SET,33,-0.0045094,-0.000191,0.14565,0.51235,HP_BLADDER_NEOPLASM,0.999563521678322
MIR3609,SET,324,-0.001489,-0.00019605,0.048058,0.51236,MIR3609,0.999563521678322
GOBP_GOLGI_DISASSEMBLY,SET,6,-0.0097867,-0.00017689,0.31476,0.5124,GOBP_GOLGI_DISASSEMBLY,0.999563521678322
MIR4709_5P,SET,94,-0.0028484,-0.00020329,0.091301,0.51244,MIR4709_5P,0.999563521678322
GOBP_PROTEIN_KINASE_C_SIGNAL...,SET,35,-0.0045953,-0.00020044,0.14714,0.51246,GOBP_PROTEIN_KINASE_C_SIGNALING,0.999563521678322
HP_ABNORMAL_LYMPHATIC_VESSEL...,SET,16,-0.0067169,-0.00019819,0.21456,0.51249,HP_ABNORMAL_LYMPHATIC_VESSEL_MORPHOLOGY,0.999563521678322
HP_NEURONAL_LOSS_IN_CENTRAL_...,SET,34,-0.0043012,-0.00018492,0.137,0.51252,HP_NEURONAL_LOSS_IN_CENTRAL_NERVOUS_SYSTEM,0.999563521678322
GOBP_DENDRITE_ARBORIZATION,SET,11,-0.008182,-0.00020021,0.25998,0.51255,GOBP_DENDRITE_ARBORIZATION,0.999563521678322
HP_PYRIDOXINE_RESPONSIVE_SID...,SET,22,-0.0052017,-0.00017995,0.16525,0.51256,HP_PYRIDOXINE_RESPONSIVE_SIDEROBLASTIC_ANEMIA,0.999563521678322
GNF2_CD1D,SET,38,-0.0044524,-0.00020234,0.14057,0.51263,GNF2_CD1D,0.999563521678322
HP_ABNORMAL_INCISOR_MORPHOLO...,SET,55,-0.0038122,-0.00020833,0.12032,0.51264,HP_ABNORMAL_INCISOR_MORPHOLOGY,0.999563521678322
GOBP_REGULATION_OF_MIRNA_TRA...,SET,72,-0.0032322,-0.00020201,0.10151,0.5127,GOBP_REGULATION_OF_MIRNA_TRANSCRIPTION,0.999563521678322
GSE27786_CD8_TCELL_VS_ERYTHR...2,SET,182,-0.0018532,-0.00018359,0.058028,0.51274,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP,0.999563521678322
GOCC_METHYLOSOME,SET,13,-0.006844,-0.00018204,0.21356,0.51278,GOCC_METHYLOSOME,0.999563521678322
HP_PERSONALITY_DISORDER,SET,16,-0.0066755,-0.00019697,0.20831,0.51278,HP_PERSONALITY_DISORDER,0.999563521678322
HOXA1_TARGET_GENES,SET,955,-0.00088449,-0.0001964,0.027535,0.51281,HOXA1_TARGET_GENES,0.999563521678322
GSE11057_PBMC_VS_MEM_CD4_TCE...1,SET,164,-0.002118,-0.00019927,0.065774,0.51284,GSE11057_PBMC_VS_MEM_CD4_TCELL_DN,0.999563521678322
EBAUER_TARGETS_OF_PAX3_FOXO1...2,SET,172,-0.0021528,-0.00020739,0.066807,0.51285,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,0.999563521678322
REACTOME_ZYGOTIC_GENOME_ACTI...,SET,13,-0.007549,-0.0002008,0.23391,0.51287,REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA,0.999563521678322
GOBP_ANTERIOR_COMMISSURE_MOR...,SET,7,-0.01197,-0.00023368,0.37077,0.51288,GOBP_ANTERIOR_COMMISSURE_MORPHOGENESIS,0.999563521678322
GSE3982_MAST_CELL_VS_EFF_MEM...2,SET,178,-0.0020691,-0.00020274,0.063981,0.5129,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP,0.999563521678322
HP_ABNORMAL_BLADDER_MORPHOLO...,SET,66,-0.0035276,-0.00021111,0.10899,0.51291,HP_ABNORMAL_BLADDER_MORPHOLOGY,0.999563521678322
HP_POSTERIOR_FOSSA_CYST,SET,15,-0.0069687,-0.0001991,0.21525,0.51291,HP_POSTERIOR_FOSSA_CYST,0.999563521678322
GOMF_CALCIUM_ACTIVATED_POTAS...,SET,13,-0.008562,-0.00022774,0.26293,0.51299,GOMF_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY,0.999563521678322
GNF2_RAD23A,SET,60,-0.0034929,-0.00019934,0.1072,0.513,GNF2_RAD23A,0.999563521678322
GSE32901_NAIVE_VS_TH17_ENRIC...1,SET,154,-0.0021753,-0.00019839,0.066743,0.513,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN,0.999563521678322
MIR4278,SET,31,-0.0049051,-0.00020138,0.14964,0.51307,MIR4278,0.999563521678322
TERAMOTO_OPN_TARGETS_CLUSTER...7,SET,8,-0.010054,-0.00020983,0.30584,0.51311,TERAMOTO_OPN_TARGETS_CLUSTER_8,0.999563521678322
GOBP_SYMPATHETIC_NERVOUS_SYS...,SET,21,-0.006815,-0.00023035,0.20546,0.51323,GOBP_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,0.999563521678322
HP_TORSION_DYSTONIA,SET,7,-0.0098623,-0.00019253,0.29644,0.51327,HP_TORSION_DYSTONIA,0.999563521678322
ZHOU_CELL_CYCLE_GENES_IN_IR_...2,SET,8,-0.0092186,-0.00019238,0.27666,0.51329,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR,0.999563521678322
USF_02,SET,237,-0.0017991,-0.00020307,0.053889,0.51332,USF_02,0.999563521678322
GOBP_EXCITATORY_SYNAPSE_ASSE...,SET,34,-0.0051284,-0.00022048,0.15353,0.51332,GOBP_EXCITATORY_SYNAPSE_ASSEMBLY,0.999563521678322
GOMF_PHOSPHATIDYLINOSITOL_4_...2,SET,75,-0.0033242,-0.00021202,0.099346,0.51335,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING,0.999563521678322
GOBP_PARACRINE_SIGNALING,SET,6,-0.012757,-0.00023056,0.37944,0.51341,GOBP_PARACRINE_SIGNALING,0.999563521678322
GSE19888_ADENOSINE_A3R_INH_V...3,SET,179,-0.0021489,-0.00021114,0.063876,0.51342,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN,0.999563521678322
GSE43863_NAIVE_VS_TH1_EFF_CD...2,SET,165,-0.0021906,-0.00020672,0.065038,0.51343,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP,0.999563521678322
ZHENG_FOXP3_TARGETS_IN_T_LYM...2,SET,12,-0.0079084,-0.00020211,0.23455,0.51345,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP,0.999563521678322
GSE33292_DN3_THYMOCYTE_VS_TC...4,SET,184,-0.0021303,-0.00021219,0.063191,0.51345,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP,0.999563521678322
GOBP_PYROPTOSIS,SET,33,-0.0050524,-0.000214,0.14977,0.51346,GOBP_PYROPTOSIS,0.999563521678322
GOBP_PARALLEL_ACTIN_FILAMENT...,SET,7,-0.01137,-0.00022196,0.33654,0.51348,GOBP_PARALLEL_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.999563521678322
GOBP_POSITIVE_REGULATION_OF_...687,SET,5,-0.014423,-0.00023798,0.42567,0.51351,GOBP_POSITIVE_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS,0.999563521678322
MIR6862_5P,SET,44,-0.0045752,-0.0002237,0.13481,0.51354,MIR6862_5P,0.999563521678322
GOBP_POSITIVE_REGULATION_OF_...50,SET,15,-0.0069471,-0.00019848,0.20462,0.51354,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.999563521678322
FULLER_PBMC_F_TULARENSIS_VAC...11,SET,57,-0.0042151,-0.00023449,0.12414,0.51354,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_UP,0.999563521678322
HP_THIN_SKIN,SET,83,-0.0030447,-0.00020425,0.089534,0.51356,HP_THIN_SKIN,0.999563521678322
HP_ABNORMALITY_OF_THE_EPIPHY...3,SET,5,-0.013793,-0.00022758,0.40057,0.51373,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,0.999563521678322
MIR1245B_5P,SET,53,-0.0038509,-0.0002066,0.11173,0.51375,MIR1245B_5P,0.999563521678322
GOBP_POSITIVE_REGULATION_OF_...518,SET,31,-0.0058944,-0.00024199,0.17097,0.51375,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.999563521678322
HALLMARK_KRAS_SIGNALING_DN,SET,175,-0.0022901,-0.00022251,0.066403,0.51376,HALLMARK_KRAS_SIGNALING_DN,0.999563521678322
GSE17721_POLYIC_VS_CPG_16H_B...1,SET,180,-0.002114,-0.00020829,0.061201,0.51378,GSE17721_POLYIC_VS_CPG_16H_BMDC_DN,0.999563521678322
GSE19888_CTRL_VS_A3R_ACTIVAT...1,SET,171,-0.0022638,-0.00021745,0.065538,0.51378,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_DN,0.999563521678322
TANAKA_METHYLATED_IN_ESOPHAG...,SET,97,-0.0035781,-0.00025938,0.10327,0.51382,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,0.999563521678322
GOBP_POSITIVE_REGULATION_OF_...588,SET,15,-0.0082872,-0.00023677,0.23904,0.51383,GOBP_POSITIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,0.999563521678322
MODULE_501,SET,15,-0.0075957,-0.00021701,0.21897,0.51384,MODULE_501,0.999563521678322
SCHLOSSER_MYC_TARGETS_AND_SE...1,SET,42,-0.0041043,-0.00019608,0.11769,0.51391,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,0.999563521678322
GOBP_REGULATION_OF_INTERLEUK...2,SET,4,-0.015735,-0.00023222,0.45107,0.51391,GOBP_REGULATION_OF_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY,0.999563521678322
GSE13547_2H_VS_12_H_ANTI_IGM...1,SET,165,-0.0021671,-0.00020451,0.062144,0.51391,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_DN,0.999563521678322
GOBP_UBIQUITIN_DEPENDENT_PRO...1,SET,12,-0.0081319,-0.00020782,0.2328,0.51393,GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY,0.999563521678322
GSE9988_LOW_LPS_VS_ANTI_TREM...1,SET,171,-0.0023206,-0.00022291,0.06623,0.51398,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,0.999563521678322
MIR2054,SET,148,-0.0025151,-0.00022489,0.071648,0.514,MIR2054,0.999563521678322
HNF6_Q6,SET,217,-0.0021435,-0.00023165,0.061051,0.514,HNF6_Q6,0.999563521678322
GOBP_TYROSINE_PHOSPHORYLATIO...,SET,74,-0.0035348,-0.00022395,0.10057,0.51402,GOBP_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.999563521678322
GOCC_CLATHRIN_SCULPTED_MONOA...,SET,5,-0.013505,-0.00022282,0.38271,0.51407,GOCC_CLATHRIN_SCULPTED_MONOAMINE_TRANSPORT_VESICLE,0.999563521678322
HP_GINGIVITIS,SET,29,-0.0055749,-0.00022138,0.15801,0.51407,HP_GINGIVITIS,0.999563521678322
HP_ABNORMAL_LACRIMAL_GLAND_M...,SET,9,-0.011066,-0.00024494,0.3132,0.51409,HP_ABNORMAL_LACRIMAL_GLAND_MORPHOLOGY,0.999563521678322
GSE339_CD4POS_VS_CD4CD8DN_DC...1,SET,179,-0.0022365,-0.00021975,0.062898,0.51418,GSE339_CD4POS_VS_CD4CD8DN_DC_DN,0.999582459913962
GSE5589_IL6_KO_VS_IL10_KO_LP...9,SET,180,-0.0022072,-0.00021746,0.061755,0.51426,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,0.999582459913962
HP_INFLAMMATION_OF_THE_LARGE...,SET,104,-0.0030436,-0.00022841,0.084873,0.5143,HP_INFLAMMATION_OF_THE_LARGE_INTESTINE,0.999582459913962
HP_ERYTHEMATOUS_PLAQUE,SET,13,-0.0074561,-0.00019833,0.20763,0.51432,HP_ERYTHEMATOUS_PLAQUE,0.999582459913962
SHETH_LIVER_CANCER_VS_TXNIP_...6,SET,51,-0.004317,-0.0002272,0.12018,0.51433,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,0.999582459913962
GSE25088_CTRL_VS_ROSIGLITAZO...1,SET,138,-0.0025321,-0.0002187,0.070471,0.51433,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.999582459913962
MIR12133,SET,352,-0.0016765,-0.00022989,0.046577,0.51436,MIR12133,0.999582459913962
BIOCARTA_ATRBRCA_PATHWAY,SET,21,-0.0059815,-0.00020217,0.16576,0.51439,BIOCARTA_ATRBRCA_PATHWAY,0.999582459913962
HP_HALLUX_VARUS,SET,5,-0.014164,-0.0002337,0.39192,0.51441,HP_HALLUX_VARUS,0.999582459913962
GSE411_UNSTIM_VS_400MIN_IL6_...4,SET,188,-0.0021727,-0.00021872,0.059985,0.51445,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.999582459913962
MARCINIAK_ER_STRESS_RESPONSE...,SET,20,-0.0069675,-0.00022983,0.19181,0.51449,MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,0.999582459913962
HP_ABNORMALITY_OF_OCULAR_ABD...,SET,11,-0.009424,-0.0002306,0.25862,0.51453,HP_ABNORMALITY_OF_OCULAR_ABDUCTION,0.999582459913962
SA_PROGRAMMED_CELL_DEATH,SET,12,-0.0089028,-0.00022752,0.24354,0.51458,SA_PROGRAMMED_CELL_DEATH,0.999582459913962
REACTOME_GLYCOGEN_SYNTHESIS,SET,12,-0.0088647,-0.00022655,0.24256,0.51458,REACTOME_GLYCOGEN_SYNTHESIS,0.999582459913962
GOBP_EXTRACELLULAR_VESICLE_B...,SET,24,-0.0060133,-0.00021726,0.16385,0.51464,GOBP_EXTRACELLULAR_VESICLE_BIOGENESIS,0.999582459913962
GSE24574_BCL6_LOW_TFH_VS_TCO...1,SET,179,-0.0022574,-0.0002218,0.061421,0.51466,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_DN,0.999582459913962
GOBP_POSITIVE_REGULATION_OF_...275,SET,13,-0.0086668,-0.00023053,0.23568,0.51467,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_OXIDATION,0.999582459913962
GOMF_MUSCLE_ALPHA_ACTININ_BI...,SET,15,-0.0085015,-0.00024289,0.23109,0.51467,GOMF_MUSCLE_ALPHA_ACTININ_BINDING,0.999582459913962
HP_ELEVATED_SERUM_11_DEOXYCO...,SET,9,-0.011423,-0.00025283,0.30911,0.51474,HP_ELEVATED_SERUM_11_DEOXYCORTISOL,0.999582459913962
MIR1266_5P,SET,83,-0.0032882,-0.00022058,0.088934,0.51475,MIR1266_5P,0.999582459913962
GOBP_POSITIVE_REGULATION_OF_...789,SET,7,-0.011518,-0.00022486,0.31108,0.51477,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_LIPASE_ACTIVITY,0.999582459913962
GOMF_GLYCOSAMINOGLYCAN_BINDI...,SET,225,-0.0022709,-0.00024984,0.061308,0.51477,GOMF_GLYCOSAMINOGLYCAN_BINDING,0.999582459913962
GSE21546_WT_VS_SAP1A_KO_AND_...2,SET,164,-0.0025205,-0.00023714,0.068024,0.51478,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.999582459913962
WP_MIR124_PREDICTED_INTERACT...,SET,6,-0.011387,-0.00020581,0.30699,0.51479,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,0.999582459913962
HP_ABNORMAL_BLOOD_SODIUM_CON...,SET,63,-0.0042166,-0.00024657,0.11324,0.51485,HP_ABNORMAL_BLOOD_SODIUM_CONCENTRATION,0.99958469678356
GSE43955_10H_VS_30H_ACT_CD4_...2,SET,183,-0.0023428,-0.00023272,0.062889,0.51486,GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP,0.99958469678356
GOMF_APOLIPOPROTEIN_A_I_BIND...,SET,5,-0.01377,-0.00022719,0.36836,0.51491,GOMF_APOLIPOPROTEIN_A_I_BINDING,0.99958469678356
SERVITJA_ISLET_HNF1A_TARGETS...2,SET,154,-0.0027486,-0.00025066,0.073422,0.51493,SERVITJA_ISLET_HNF1A_TARGETS_UP,0.99958469678356
HP_DYSPHAGIA,SET,465,-0.0014646,-0.00023011,0.039068,0.51495,HP_DYSPHAGIA,0.99958469678356
GOBP_REGULATION_OF_CILIUM_BE...1,SET,15,-0.0081087,-0.00023167,0.21593,0.51498,GOBP_REGULATION_OF_CILIUM_BEAT_FREQUENCY,0.99958469678356
GOBP_NEGATIVE_REGULATION_OF_...63,SET,4,-0.018567,-0.00027401,0.49256,0.51503,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.99958469678356
HP_ABNORMAL_NEUTROPHIL_COUNT,SET,196,-0.0022235,-0.0002285,0.059001,0.51503,HP_ABNORMAL_NEUTROPHIL_COUNT,0.99958469678356
HP_INTEROSSEUS_MUSCLE_ATROPHY,SET,4,-0.013683,-0.00020194,0.36266,0.51505,HP_INTEROSSEUS_MUSCLE_ATROPHY,0.99958469678356
MIR3118,SET,70,-0.0038979,-0.00024022,0.10232,0.51519,MIR3118,0.999727739936352
GSE40273_GATA1_KO_VS_WT_TREG...1,SET,183,-0.0023675,-0.00023517,0.06215,0.51519,GSE40273_GATA1_KO_VS_WT_TREG_DN,0.999727739936352
GSE11961_FOLLICULAR_BCELL_VS...5,SET,184,-0.0024044,-0.00023949,0.063045,0.51521,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN,0.999727739936352
MIR580_5P,SET,210,-0.0022183,-0.00023588,0.058051,0.51524,MIR580_5P,0.999730136221528
CHUNG_BLISTER_CYTOTOXICITY_DN,SET,40,-0.0051134,-0.0002384,0.13342,0.51529,CHUNG_BLISTER_CYTOTOXICITY_DN,0.999742113635095
GOBP_POTASSIUM_ION_IMPORT_AC...,SET,44,-0.0053458,-0.00026138,0.13904,0.51533,GOBP_POTASSIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.999742113635095
WP_GROWTH_FACTORS_AND_HORMON...,SET,26,-0.0062881,-0.00023645,0.1633,0.51536,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,0.999742113635095
GOBP_ACUTE_INFLAMMATORY_RESP...1,SET,99,-0.0035539,-0.00026025,0.092125,0.51539,GOBP_ACUTE_INFLAMMATORY_RESPONSE,0.999742113635095
GSE21063_CTRL_VS_ANTI_IGM_ST...7,SET,175,-0.0024031,-0.00023349,0.062274,0.51539,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN,0.999742113635095
GOCC_ESCRT_I_COMPLEX,SET,12,-0.0092681,-0.00023686,0.23913,0.51546,GOCC_ESCRT_I_COMPLEX,0.999807212182061
GOMF_MINOR_GROOVE_OF_ADENINE...,SET,8,-0.012264,-0.00025594,0.31526,0.51552,GOMF_MINOR_GROOVE_OF_ADENINE_THYMINE_RICH_DNA_BINDING,0.999807212182061
MIR4659A_5P,SET,73,-0.0038328,-0.00024119,0.09802,0.5156,MIR4659A_5P,0.999807212182061
HP_FATIGABLE_WEAKNESS_OF_SWA...,SET,37,-0.0051012,-0.00022876,0.13042,0.5156,HP_FATIGABLE_WEAKNESS_OF_SWALLOWING_MUSCLES,0.999807212182061
HP_TOE_CLINODACTYLY,SET,24,-0.0065963,-0.00023833,0.16864,0.5156,HP_TOE_CLINODACTYLY,0.999807212182061
TCTGGAC_MIR198,SET,78,-0.0037784,-0.00024575,0.096473,0.51562,TCTGGAC_MIR198,0.999807212182061
HP_LIMITED_HIP_MOVEMENT,SET,22,-0.0074795,-0.00025875,0.19063,0.51565,HP_LIMITED_HIP_MOVEMENT,0.999807212182061
AMIT_SERUM_RESPONSE_480_MCF1...,SET,32,-0.0055086,-0.00022977,0.13994,0.5157,AMIT_SERUM_RESPONSE_480_MCF10A,0.999807212182061
GSE21360_NAIVE_VS_QUATERNARY...1,SET,181,-0.002406,-0.0002377,0.061113,0.5157,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.999807212182061
REACTOME_CONSTITUTIVE_SIGNAL...1,SET,82,-0.0039439,-0.00026298,0.10005,0.51572,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,0.999807212182061
GOBP_COBALAMIN_METABOLIC_PRO...,SET,9,-0.011402,-0.00025238,0.28895,0.51574,GOBP_COBALAMIN_METABOLIC_PROCESS,0.999807212182061
GSE32986_UNSTIM_VS_GMCSF_AND...4,SET,180,-0.0023286,-0.00022942,0.058472,0.51588,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.99999
chr3q21,SET,62,-0.0071596,-0.00041534,0.17933,0.51592,chr3q21,0.99999
GOMF_QUATERNARY_AMMONIUM_GRO...1,SET,35,-0.0059012,-0.0002574,0.14726,0.51598,GOMF_QUATERNARY_AMMONIUM_GROUP_BINDING,0.99999
REACTOME_REGULATION_OF_GENE_...3,SET,8,-0.014018,-0.00029254,0.3486,0.51604,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS,0.99999
MIR6788_5P,SET,115,-0.0032995,-0.0002603,0.081871,0.51607,MIR6788_5P,0.99999
GSE36891_UNSTIM_VS_POLYIC_TL...2,SET,141,-0.0030553,-0.00026671,0.075806,0.51607,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP,0.99999
HP_MULTICYSTIC_KIDNEY_DYSPLA...,SET,82,-0.0036226,-0.00024155,0.089848,0.51608,HP_MULTICYSTIC_KIDNEY_DYSPLASIA,0.99999
ZNF165_TARGET_GENES,SET,67,-0.0040854,-0.00024634,0.10096,0.51614,ZNF165_TARGET_GENES,0.99999
GOBP_CELL_ADHESION,SET,1400,-0.0010204,-0.00027082,0.025116,0.5162,GOBP_CELL_ADHESION,0.99999
HP_MACULAR_DRUSEN,SET,5,-0.018222,-0.00030067,0.44847,0.51621,HP_MACULAR_DRUSEN,0.99999
GSE15767_MED_VS_SCS_MAC_LN_DN,SET,180,-0.0024745,-0.0002438,0.060851,0.51622,GSE15767_MED_VS_SCS_MAC_LN_DN,0.99999
HP_ADIPOSE_TISSUE_LOSS,SET,27,-0.0064627,-0.00024764,0.15885,0.51623,HP_ADIPOSE_TISSUE_LOSS,0.99999
HP_VENOUS_THROMBOSIS,SET,74,-0.0041558,-0.0002633,0.10197,0.51625,HP_VENOUS_THROMBOSIS,0.99999
KEGG_MEDICUS_REFERENCE_ADRB3...,SET,35,-0.0057489,-0.00025076,0.14088,0.51628,KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY,0.99999
HASLINGER_B_CLL_WITH_CHROMOS...,SET,20,-0.0075005,-0.00024741,0.18357,0.5163,HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,0.99999
GSE21546_WT_VS_SAP1A_KO_AND_...4,SET,184,-0.0025622,-0.0002552,0.062653,0.51631,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.99999
MIR4676_5P,SET,51,-0.0046369,-0.00024404,0.11184,0.51653,MIR4676_5P,0.99999
HP_EMG_CHRONIC_DENERVATION_S...,SET,25,-0.0064673,-0.00023848,0.15602,0.51653,HP_EMG_CHRONIC_DENERVATION_SIGNS,0.99999
GSE12845_IGD_POS_BLOOD_VS_PR...2,SET,169,-0.0026602,-0.00025404,0.064152,0.51654,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...12,SET,33,-0.0058779,-0.00024896,0.14142,0.51658,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,0.99999
SRF_Q5_01,SET,203,-0.0025354,-0.00026511,0.061002,0.51658,SRF_Q5_01,0.99999
GSE11961_FOLLICULAR_BCELL_VS...2,SET,186,-0.0024279,-0.00024312,0.058411,0.51658,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.99999
HALLMARK_INTERFERON_ALPHA_RE...,SET,93,-0.0036187,-0.00025689,0.087031,0.51658,HALLMARK_INTERFERON_ALPHA_RESPONSE,0.99999
GOCC_NEUROFILAMENT,SET,10,-0.012616,-0.00029434,0.30202,0.51666,GOCC_NEUROFILAMENT,0.99999
GOCC_NEURON_PROJECTION_MEMBR...,SET,56,-0.0048749,-0.00026881,0.11671,0.51666,GOCC_NEURON_PROJECTION_MEMBRANE,0.99999
HP_INCREASED_CIRCULATING_GON...,SET,75,-0.0040238,-0.00025664,0.096253,0.51667,HP_INCREASED_CIRCULATING_GONADOTROPIN_LEVEL,0.99999
GOBP_POSITIVE_REGULATION_OF_...542,SET,16,-0.010191,-0.0003007,0.24353,0.51669,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,0.99999
GNF2_SMC4L1,SET,80,-0.003777,-0.00024877,0.089967,0.51674,GNF2_SMC4L1,0.99999
GSE24671_CTRL_VS_SENDAI_VIRU...2,SET,146,-0.0029968,-0.00026617,0.071248,0.51677,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,0.99999
chr5q32,SET,44,-0.0099584,-0.00048691,0.23594,0.51683,chr5q32,0.99999
HP_SHALLOW_ACETABULAR_FOSSAE,SET,10,-0.010675,-0.00024907,0.25102,0.51696,HP_SHALLOW_ACETABULAR_FOSSAE,0.99999
HP_THICKENED_NUCHAL_SKIN_FOLD,SET,49,-0.0049053,-0.00025306,0.11469,0.51706,HP_THICKENED_NUCHAL_SKIN_FOLD,0.99999
GSE34217_MIR17_92_OVEREXPRES...1,SET,126,-0.0031212,-0.00025767,0.072862,0.51708,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN,0.99999
GOBP_INNER_EAR_RECEPTOR_CELL...1,SET,44,-0.0057496,-0.00028112,0.13413,0.5171,GOBP_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT,0.99999
REACTOME_ASSEMBLY_OF_ACTIVE_...,SET,16,-0.010005,-0.00029521,0.23238,0.51717,REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,0.99999
GOBP_REGULATION_OF_SKELETAL_...12,SET,7,-0.013948,-0.00027228,0.32391,0.51717,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION,0.99999
MIR711,SET,36,-0.0058659,-0.00025949,0.13613,0.51718,MIR711,0.99999
MIR4787_5P,SET,6,-0.015993,-0.00028905,0.37079,0.5172,MIR4787_5P,0.99999
GOBP_NUCLEAR_MIGRATION,SET,24,-0.0071301,-0.00025761,0.16533,0.5172,GOBP_NUCLEAR_MIGRATION,0.99999
GOBP_GOLGI_LUMEN_ACIDIFICATI...,SET,9,-0.012825,-0.00028388,0.29689,0.51723,GOBP_GOLGI_LUMEN_ACIDIFICATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...410,SET,24,-0.0077559,-0.00028022,0.17954,0.51723,GOBP_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,0.99999
HP_SNORING,SET,6,-0.014966,-0.00027049,0.34538,0.51728,HP_SNORING,0.99999
GSE6092_CTRL_VS_BORRELIA_BIR...2,SET,143,-0.0029027,-0.00025517,0.06701,0.51728,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP,0.99999
REACTOME_STING_MEDIATED_INDU...,SET,13,-0.008948,-0.00023801,0.20617,0.51731,REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES,0.99999
GOBP_REGULATION_OF_DNA_TOPOI...,SET,5,-0.01805,-0.00029783,0.4151,0.51734,GOBP_REGULATION_OF_DNA_TOPOISOMERASE_ATP_HYDROLYZING_ACTIVITY,0.99999
GOBP_BILE_ACID_METABOLIC_PRO...,SET,49,-0.0055032,-0.00028391,0.1265,0.51735,GOBP_BILE_ACID_METABOLIC_PROCESS,0.99999
CAO_BLOOD_FLUMIST_AGE_05_14Y...2,SET,7,-0.012968,-0.00025315,0.29816,0.51735,CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_UP,0.99999
GSE360_T_GONDII_VS_M_TUBERCU...4,SET,181,-0.0026991,-0.00026666,0.061972,0.51737,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP,0.99999
AZARE_NEOPLASTIC_TRANSFORMAT...1,SET,17,-0.0095337,-0.00028996,0.21867,0.51739,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN,0.99999
ZNF146_TARGET_GENES,SET,888,-0.0012535,-0.00026892,0.028733,0.5174,ZNF146_TARGET_GENES,0.99999
GOBP_PEPTIDYL_LYSINE_HYDROXY...,SET,8,-0.012912,-0.00026947,0.29542,0.51743,GOBP_PEPTIDYL_LYSINE_HYDROXYLATION,0.99999
GSE5679_RARA_AGONIST_AM580_V...2,SET,182,-0.0028206,-0.00027943,0.064372,0.51747,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP,0.99999
GSE21360_PRIMARY_VS_SECONDAR...1,SET,179,-0.0026841,-0.00026373,0.061254,0.51748,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN,0.99999
GSE21927_SPLENIC_C26GM_TUMOR...4,SET,135,-0.0031231,-0.00026681,0.071185,0.5175,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_UP,0.99999
MIR3688_3P,SET,368,-0.0019799,-0.00027747,0.045024,0.51754,MIR3688_3P,0.99999
HP_COLD_INDUCED_MUSCLE_CRAMPS,SET,6,-0.016533,-0.00029882,0.37598,0.51754,HP_COLD_INDUCED_MUSCLE_CRAMPS,0.99999
GSE40666_UNTREATED_VS_IFNA_S...8,SET,188,-0.0027574,-0.00027758,0.062642,0.51755,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_UP,0.99999
NAKAMURA_BRONCHIAL_AND_BRONC...,SET,5,-0.016772,-0.00027674,0.37984,0.51761,NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA,0.99999
HP_RENAL_CORTICOMEDULLARY_CY...,SET,8,-0.012814,-0.00026742,0.28997,0.51762,HP_RENAL_CORTICOMEDULLARY_CYSTS,0.99999
HP_ABNORMAL_SIZE_OF_THE_DENT...,SET,14,-0.010929,-0.00030167,0.24703,0.51764,HP_ABNORMAL_SIZE_OF_THE_DENTAL_ROOT,0.99999
NR1D1_TARGET_GENES,SET,88,-0.0038379,-0.00026506,0.086626,0.51767,NR1D1_TARGET_GENES,0.99999
HP_LARGE_PLACENTA,SET,6,-0.016374,-0.00029595,0.36964,0.51767,HP_LARGE_PLACENTA,0.99999
GOBP_SYNAPTIC_VESICLE_TRANSP...,SET,40,-0.0058044,-0.00027062,0.13081,0.5177,GOBP_SYNAPTIC_VESICLE_TRANSPORT,0.99999
GSE21379_TFH_VS_NON_TFH_CD4_...1,SET,176,-0.0029391,-0.00028637,0.066097,0.51773,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN,0.99999
HP_SPARSE_SCALP_HAIR,SET,127,-0.0032844,-0.00027221,0.073652,0.51778,HP_SPARSE_SCALP_HAIR,0.99999
GOBP_CYTOKINETIC_PROCESS,SET,46,-0.005338,-0.00026685,0.11945,0.51782,GOBP_CYTOKINETIC_PROCESS,0.99999
MODULE_263,SET,44,-0.0069437,-0.00033951,0.15529,0.51783,MODULE_263,0.99999
MIR196A_5P_MIR196B_5P,SET,85,-0.0039606,-0.00026885,0.088414,0.51786,MIR196A_5P_MIR196B_5P,0.99999
HUMMERICH_MALIGNANT_SKIN_TUM...1,SET,19,-0.0082643,-0.00026571,0.18405,0.51791,HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,0.99999
GOBP_GLUTAMATE_METABOLIC_PRO...,SET,32,-0.0067827,-0.00028291,0.14934,0.51811,GOBP_GLUTAMATE_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_LIP_MORPHOLOGY,SET,1049,-0.0012082,-0.00028041,0.026605,0.51811,HP_ABNORMAL_LIP_MORPHOLOGY,0.99999
KEGG_MEDICUS_VARIANT_LOSS_OF...2,SET,5,-0.01724,-0.00028445,0.37797,0.51819,KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_LONG_TERM...3,SET,45,-0.0058607,-0.00028979,0.12843,0.5182,GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,0.99999
HP_ABNORMALITY_OF_CARDIOVASC...,SET,494,-0.0017634,-0.00028533,0.03849,0.51827,HP_ABNORMALITY_OF_CARDIOVASCULAR_SYSTEM_ELECTROPHYSIOLOGY,0.99999
HP_RECURRENT_PHARYNGITIS,SET,7,-0.017765,-0.0003468,0.38489,0.51841,HP_RECURRENT_PHARYNGITIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...300,SET,6,-0.015498,-0.00028011,0.33491,0.51845,GOBP_NEGATIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,0.99999
GOBP_PROTEIN_DELIPIDATION,SET,4,-0.017711,-0.00026138,0.38282,0.51845,GOBP_PROTEIN_DELIPIDATION,0.99999
HP_ENURESIS_NOCTURNA,SET,10,-0.01274,-0.00029725,0.27537,0.51845,HP_ENURESIS_NOCTURNA,0.99999
MIR4662A_3P,SET,63,-0.0051427,-0.00030072,0.11109,0.51846,MIR4662A_3P,0.99999
REACTOME_REGULATION_OF_INSUL...1,SET,115,-0.0039454,-0.00031126,0.085204,0.51847,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,0.99999
KRAS.KIDNEY_UP.V1_UP,SET,127,-0.0038152,-0.00031621,0.082319,0.51848,KRAS.KIDNEY_UP.V1_UP,0.99999
GOBP_HISTAMINE_SECRETION,SET,12,-0.010683,-0.00027302,0.2298,0.51854,GOBP_HISTAMINE_SECRETION,0.99999
GOBP_POSITIVE_REGULATION_OF_...696,SET,13,-0.01147,-0.00030509,0.24668,0.51854,GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION,0.99999
GOBP_ANATOMICAL_STRUCTURE_FO...,SET,1096,-0.0012571,-0.00029782,0.026991,0.51857,GOBP_ANATOMICAL_STRUCTURE_FORMATION_INVOLVED_IN_MORPHOGENESIS,0.99999
GSE21546_UNSTIM_VS_ANTI_CD3_...3,SET,145,-0.0033734,-0.00029859,0.072262,0.51862,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_DN,0.99999
GOBERT_OLIGODENDROCYTE_DIFFE...1,SET,979,-0.0013072,-0.00029368,0.027955,0.51865,GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN,0.99999
GSE29614_CTRL_VS_TIV_FLU_VAC...2,SET,148,-0.0034157,-0.00030542,0.072771,0.51872,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP,0.99999
GOBP_PROTEIN_EXPORT_FROM_NUC...,SET,58,-0.0049802,-0.00027946,0.10584,0.51876,GOBP_PROTEIN_EXPORT_FROM_NUCLEUS,0.99999
MIR1299,SET,300,-0.0023662,-0.00029998,0.05001,0.51887,MIR1299,0.99999
GSE4748_CTRL_VS_CYANOBACTERI...4,SET,187,-0.0028214,-0.00028328,0.059543,0.5189,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.99999
YTTCCNNNGGAMR_UNKNOWN,SET,46,-0.0061586,-0.00030787,0.12961,0.51895,YTTCCNNNGGAMR_UNKNOWN,0.99999
GOCC_RNAI_EFFECTOR_COMPLEX,SET,15,-0.01098,-0.00031371,0.22961,0.51907,GOCC_RNAI_EFFECTOR_COMPLEX,0.99999
GOBP_PEPTIDYL_PROLINE_HYDROX...2,SET,8,-0.010837,-0.00022616,0.22601,0.51912,GOBP_PEPTIDYL_PROLINE_HYDROXYLATION_TO_4_HYDROXY_L_PROLINE,0.99999
GOMF_PEPTIDYL_PROLINE_4_DIOX...,SET,8,-0.010837,-0.00022616,0.22601,0.51912,GOMF_PEPTIDYL_PROLINE_4_DIOXYGENASE_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_GPCR_...2,SET,47,-0.0064608,-0.00032646,0.13424,0.51919,KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...2,SET,185,-0.0029772,-0.00029733,0.0617,0.51924,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.99999
REACTOME_ADORA2B_MEDIATED_AN...,SET,42,-0.0064656,-0.00030888,0.13387,0.51926,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,0.99999
SASSON_RESPONSE_TO_FORSKOLIN...2,SET,78,-0.0045694,-0.00029719,0.094498,0.51928,SASSON_RESPONSE_TO_FORSKOLIN_UP,0.99999
ELVIDGE_HYPOXIA_DN,SET,137,-0.0032833,-0.00028255,0.067836,0.5193,ELVIDGE_HYPOXIA_DN,0.99999
HP_GASTROINTESTINAL_OBSTRUCT...,SET,85,-0.0045215,-0.00030693,0.093234,0.51934,HP_GASTROINTESTINAL_OBSTRUCTION,0.99999
HP_HEINZ_BODIES,SET,2,-0.026939,-0.00028114,0.55431,0.51938,HP_HEINZ_BODIES,0.99999
MODULE_108,SET,52,-0.0066106,-0.0003513,0.13592,0.51939,MODULE_108,0.99999
HP_THORACIC_HYPOPLASIA,SET,130,-0.0036599,-0.00030686,0.075264,0.51939,HP_THORACIC_HYPOPLASIA,0.99999
GSE21927_UNTREATED_VS_GMCSF_...1,SET,163,-0.0032614,-0.00030592,0.066994,0.51941,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,0.99999
MIR6741_5P,SET,22,-0.0079679,-0.00027564,0.16357,0.51943,MIR6741_5P,0.99999
GOBP_SPINDLE_MIDZONE_ASSEMBLY,SET,13,-0.010526,-0.00027999,0.21556,0.51947,GOBP_SPINDLE_MIDZONE_ASSEMBLY,0.99999
GSE2770_UNTREATED_VS_IL4_TRE...2,SET,188,-0.0029551,-0.00029749,0.060488,0.51948,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
GOBP_B_CELL_DIFFERENTIATION,SET,139,-0.003782,-0.00032781,0.076841,0.51963,GOBP_B_CELL_DIFFERENTIATION,0.99999
WU_CELL_MIGRATION,SET,167,-0.0034407,-0.00032664,0.069806,0.51966,WU_CELL_MIGRATION,0.99999
REACTOME_RECEPTOR_TYPE_TYROS...,SET,16,-0.011155,-0.00032915,0.22581,0.5197,REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES,0.99999
HP_DEVIATION_OF_THE_5TH_TOE,SET,16,-0.01059,-0.00031249,0.2137,0.51976,HP_DEVIATION_OF_THE_5TH_TOE,0.99999
HP_MALE_HYPOGONADISM,SET,38,-0.0069052,-0.00031381,0.13934,0.51976,HP_MALE_HYPOGONADISM,0.99999
HP_DIFFICULTY_IN_TONGUE_MOVE...,SET,12,-0.012494,-0.0003193,0.25142,0.51982,HP_DIFFICULTY_IN_TONGUE_MOVEMENTS,0.99999
REACTOME_GRB7_EVENTS_IN_ERBB...,SET,5,-0.020482,-0.00033794,0.41184,0.51983,REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING,0.99999
MIR4478,SET,162,-0.0032842,-0.00030712,0.065965,0.51985,MIR4478,0.99999
HP_VISUAL_ACUITY_TEST_ABNORM...,SET,21,-0.0088179,-0.00029804,0.17708,0.51986,HP_VISUAL_ACUITY_TEST_ABNORMALITY,0.99999
BERTUCCI_MEDULLARY_VS_DUCTAL...1,SET,153,-0.003501,-0.00031825,0.070203,0.51989,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,0.99999
MORF_BCL2,SET,208,-0.0029051,-0.00030744,0.058253,0.51989,MORF_BCL2,0.99999
HP_ABNORMAL_IMMUNE_SYSTEM_MO...,SET,587,-0.0017711,-0.00031157,0.03526,0.52003,HP_ABNORMAL_IMMUNE_SYSTEM_MORPHOLOGY,0.99999
GUTIERREZ_MULTIPLE_MYELOMA_UP,SET,30,-0.007919,-0.00031984,0.15759,0.52004,GUTIERREZ_MULTIPLE_MYELOMA_UP,0.99999
BYSTRYKH_HEMATOPOIESIS_STEM_...8,SET,7,-0.018193,-0.00035515,0.36155,0.52007,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1,0.99999
HP_ABNORMAL_CELLULAR_COMPOSI...,SET,8,-0.016996,-0.00035469,0.33626,0.52016,HP_ABNORMAL_CELLULAR_COMPOSITION_OF_BRONCHOALVEOLAR_FLUID,0.99999
ONDER_CDH1_TARGETS_1_DN,SET,157,-0.003364,-0.00030973,0.0665,0.52017,ONDER_CDH1_TARGETS_1_DN,0.99999
GSE22033_UNTREATED_VS_MRL24_...1,SET,176,-0.0032478,-0.00031645,0.064226,0.52017,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN,0.99999
GOBP_AXON_DEVELOPMENT,SET,469,-0.0020931,-0.00033022,0.041357,0.52018,GOBP_AXON_DEVELOPMENT,0.99999
MIR6758_3P,SET,99,-0.0043814,-0.00032086,0.086446,0.52021,MIR6758_3P,0.99999
GOCC_CIS_GOLGI_NETWORK,SET,56,-0.0053243,-0.00029359,0.1049,0.52024,GOCC_CIS_GOLGI_NETWORK,0.99999
GOCC_P_BODY,SET,93,-0.0044395,-0.00031515,0.087448,0.52024,GOCC_P_BODY,0.99999
MORF_RPA1,SET,59,-0.0049782,-0.00028174,0.097745,0.52031,MORF_RPA1,0.99999
HP_POLYSPLENIA,SET,49,-0.0057753,-0.00029795,0.11326,0.52033,HP_POLYSPLENIA,0.99999
REACTOME_OPSINS,SET,7,-0.015463,-0.00030186,0.30321,0.52034,REACTOME_OPSINS,0.99999
HORIUCHI_WTAP_TARGETS_UP,SET,269,-0.0027178,-0.00032654,0.053218,0.52036,HORIUCHI_WTAP_TARGETS_UP,0.99999
HP_INCREASED_CIRCULATING_FRE...,SET,5,-0.016024,-0.0002644,0.3134,0.52039,HP_INCREASED_CIRCULATING_FREE_FATTY_ACID_LEVEL,0.99999
GOBP_POSITIVE_REGULATION_OF_...695,SET,297,-0.0025992,-0.00032789,0.050803,0.5204,GOBP_POSITIVE_REGULATION_OF_SECRETION,0.99999
DARWICHE_PAPILLOMA_RISK_LOW_...2,SET,148,-0.0036053,-0.00032238,0.070358,0.52043,DARWICHE_PAPILLOMA_RISK_LOW_UP,0.99999
GSE39820_CTRL_VS_TGFBETA3_IL...2,SET,177,-0.0031749,-0.00031022,0.06158,0.52056,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP,0.99999
GOBP_MIRNA_MEDIATED_GENE_SIL...2,SET,8,-0.014669,-0.00030613,0.28311,0.52066,GOBP_MIRNA_MEDIATED_GENE_SILENCING_BY_MRNA_DESTABILIZATION,0.99999
HP_ABNORMALITY_OF_THE_LARYNX,SET,192,-0.0031505,-0.00032048,0.060717,0.52069,HP_ABNORMALITY_OF_THE_LARYNX,0.99999
MIR5195_3P,SET,290,-0.0026011,-0.00032431,0.0501,0.5207,MIR5195_3P,0.99999
GOMF_RECEPTOR_TYROSINE_KINAS...,SET,75,-0.0048774,-0.00031109,0.093741,0.52075,GOMF_RECEPTOR_TYROSINE_KINASE_BINDING,0.99999
MIR1227_5P,SET,96,-0.0043045,-0.00031044,0.082521,0.5208,MIR1227_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...710,SET,33,-0.007703,-0.00032627,0.14719,0.52087,GOBP_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.99999
BROWNE_HCMV_INFECTION_4HR_DN,SET,227,-0.0028927,-0.00031964,0.055249,0.52088,BROWNE_HCMV_INFECTION_4HR_DN,0.99999
GOBP_ADULT_HEART_DEVELOPMENT,SET,13,-0.013072,-0.00034772,0.24965,0.52088,GOBP_ADULT_HEART_DEVELOPMENT,0.99999
CHEN_NEUROBLASTOMA_COPY_NUMB...,SET,48,-0.0074739,-0.00038164,0.1427,0.52089,CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,0.99999
HP_DILATATION_OF_THE_BLADDER,SET,11,-0.014536,-0.00035568,0.27663,0.52095,HP_DILATATION_OF_THE_BLADDER,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MYO...2,SET,78,-0.0055596,-0.00036159,0.10561,0.52099,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL,0.99999
NGUYEN_NOTCH1_TARGETS_DN,SET,78,-0.0049665,-0.00032302,0.094181,0.52103,NGUYEN_NOTCH1_TARGETS_DN,0.99999
MIR520F_5P,SET,182,-0.0033562,-0.00033249,0.063604,0.52104,MIR520F_5P,0.99999
MATSUMIYA_PBMC_MODIFIED_VACC...1,SET,60,-0.0061207,-0.00034932,0.11599,0.52104,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_2DY_UP,0.99999
GSE30971_2H_VS_4H_LPS_STIM_M...2,SET,160,-0.0034304,-0.00031883,0.064845,0.52109,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_UP,0.99999
GOBP_CARDIAC_EPITHELIAL_TO_M...,SET,36,-0.0082323,-0.00036416,0.15535,0.52113,GOBP_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.99999
GSE21927_HEALTHY_VS_TUMOROUS...1,SET,139,-0.0037897,-0.00032848,0.071442,0.52115,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_DN,0.99999
HP_ABNORMALITY_OF_THE_COMMON...,SET,61,-0.0059445,-0.00034206,0.11191,0.52118,HP_ABNORMALITY_OF_THE_COMMON_COAGULATION_PATHWAY,0.99999
GOBP_CELL_FATE_COMMITMENT,SET,268,-0.0029733,-0.00035659,0.055864,0.52122,GOBP_CELL_FATE_COMMITMENT,0.99999
RUTELLA_RESPONSE_TO_CSF2RB_A...2,SET,299,-0.0026963,-0.00034126,0.050607,0.52124,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,0.99999
HP_DILATATED_INTERNAL_AUDITO...,SET,3,-0.031729,-0.00040554,0.59538,0.52125,HP_DILATATED_INTERNAL_AUDITORY_CANAL,0.99999
GOBP_ODONTOGENESIS_OF_DENTIN...,SET,87,-0.0052803,-0.00036261,0.098641,0.52135,GOBP_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,0.99999
GSE27786_CD4_TCELL_VS_ERYTHT...1,SET,180,-0.0032062,-0.0003159,0.059785,0.52138,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN,0.99999
GNF2_CKS1B,SET,36,-0.0070619,-0.00031239,0.13111,0.52148,GNF2_CKS1B,0.99999
GOBP_POSITIVE_REGULATION_OF_...412,SET,109,-0.0044612,-0.00034271,0.082794,0.52149,GOBP_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,0.99999
GOBP_MESENCHYMAL_TO_EPITHELI...2,SET,11,-0.016351,-0.00040009,0.30272,0.52154,GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS,0.99999
CORDENONSI_YAP_CONSERVED_SIG...,SET,52,-0.006887,-0.00036599,0.12723,0.52158,CORDENONSI_YAP_CONSERVED_SIGNATURE,0.99999
MEISSNER_NPC_ICP_WITH_H3_UNM...,SET,20,-0.010987,-0.0003624,0.20182,0.52171,MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED,0.99999
GOMF_IGG_BINDING,SET,10,-0.017023,-0.00039716,0.3125,0.52172,GOMF_IGG_BINDING,0.99999
MIR501_3P_MIR502_3P,SET,65,-0.0059316,-0.0003523,0.10885,0.52173,MIR501_3P_MIR502_3P,0.99999
GOMF_HISTONE_H4K20_METHYLTRA...,SET,6,-0.018309,-0.00033091,0.33553,0.52176,GOMF_HISTONE_H4K20_METHYLTRANSFERASE_ACTIVITY,0.99999
GSE10240_IL17_VS_IL17_AND_IL...1,SET,187,-0.0034134,-0.00034271,0.062422,0.5218,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.99999
GSE22886_NEUTROPHIL_VS_DC_UP,SET,164,-0.0038182,-0.00035924,0.069745,0.52183,GSE22886_NEUTROPHIL_VS_DC_UP,0.99999
GOBP_CHAPERONE_COFACTOR_DEPE...,SET,30,-0.0077177,-0.00031171,0.14068,0.52187,GOBP_CHAPERONE_COFACTOR_DEPENDENT_PROTEIN_REFOLDING,0.99999
GSE39556_UNTREATED_VS_3H_POL...3,SET,179,-0.0035302,-0.00034685,0.064326,0.52188,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN,0.99999
GOCC_AXONEMAL_B_TUBULE_INNER...,SET,5,-0.019009,-0.00031364,0.34603,0.5219,GOCC_AXONEMAL_B_TUBULE_INNER_SHEATH,0.99999
REACTOME_SYNTHESIS_OF_5_EICO...,SET,9,-0.016856,-0.00037309,0.30668,0.52192,REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...9,SET,25,-0.0091914,-0.00033893,0.16659,0.522,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.99999
MIR4749_3P,SET,49,-0.0064029,-0.00033033,0.11575,0.52206,MIR4749_3P,0.99999
WP_G_PROTEIN_SIGNALING,SET,90,-0.0050502,-0.00035271,0.091117,0.5221,WP_G_PROTEIN_SIGNALING,0.99999
REACTOME_INLB_MEDIATED_ENTRY...,SET,13,-0.012854,-0.00034192,0.23172,0.52212,REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL,0.99999
GOBP_MYELOID_CELL_ACTIVATION...,SET,91,-0.0050435,-0.00035418,0.090767,0.52216,GOBP_MYELOID_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
KEGG_LYSINE_DEGRADATION,SET,37,-0.0071816,-0.00032206,0.12919,0.52217,KEGG_LYSINE_DEGRADATION,0.99999
HP_DIFFUSE_CEREBRAL_ATROPHY,SET,45,-0.0068103,-0.00033674,0.12232,0.5222,HP_DIFFUSE_CEREBRAL_ATROPHY,0.99999
KEGG_MEDICUS_REFERENCE_AVP_V...,SET,9,-0.017281,-0.0003825,0.31023,0.52221,KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY,0.99999
WP_FEMALE_STEROID_HORMONES_I...,SET,14,-0.011795,-0.00032559,0.21115,0.52227,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.99999
GSE25123_CTRL_VS_ROSIGLITAZO...4,SET,176,-0.0037344,-0.00036386,0.066845,0.52228,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,0.99999
GSE15330_MEGAKARYOCYTE_ERYTH...5,SET,178,-0.0033412,-0.00032738,0.059648,0.52234,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,0.99999
GOBP_RESPONSE_TO_ANTIBIOTIC,SET,36,-0.0077638,-0.00034344,0.13808,0.52242,GOBP_RESPONSE_TO_ANTIBIOTIC,0.99999
GOBP_STRIATUM_DEVELOPMENT,SET,20,-0.011168,-0.00036838,0.19852,0.52243,GOBP_STRIATUM_DEVELOPMENT,0.99999
HP_RECURRENT_FEVER,SET,85,-0.0052272,-0.00035483,0.092909,0.52243,HP_RECURRENT_FEVER,0.99999
PGF_UP.V1_DN,SET,169,-0.0036077,-0.00034452,0.064043,0.52246,PGF_UP.V1_DN,0.99999
MORF_XRCC5,SET,210,-0.002968,-0.00031559,0.052529,0.52253,MORF_XRCC5,0.99999
GOMF_MIRNA_BINDING,SET,28,-0.0079884,-0.00031172,0.14128,0.52255,GOMF_MIRNA_BINDING,0.99999
GOBP_LUNG_MORPHOGENESIS,SET,54,-0.0069485,-0.00037627,0.12258,0.5226,GOBP_LUNG_MORPHOGENESIS,0.99999
GOBP_CELL_FATE_COMMITMENT_IN...2,SET,11,-0.015589,-0.00038144,0.27488,0.52261,GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_PATTERN_SPECIFICATION,0.99999
MILI_PSEUDOPODIA_HAPTOTAXIS_...1,SET,631,-0.0019142,-0.0003487,0.033736,0.52262,MILI_PSEUDOPODIA_HAPTOTAXIS_DN,0.99999
GSE22611_UNSTIM_VS_2H_MDP_ST...3,SET,176,-0.0036036,-0.00035111,0.063528,0.52262,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.99999
GSE40666_NAIVE_VS_EFFECTOR_C...3,SET,179,-0.0035135,-0.00034522,0.061678,0.52271,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...7,SET,15,-0.011822,-0.00033778,0.20693,0.52278,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,0.99999
WANG_ESOPHAGUS_CANCER_PROGRE...,SET,9,-0.017323,-0.00038342,0.30287,0.5228,WANG_ESOPHAGUS_CANCER_PROGRESSION_UP,0.99999
REACTOME_THE_ACTIVATION_OF_A...,SET,8,-0.015924,-0.00033232,0.2782,0.52282,REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,0.99999
REACTOME_ABORTIVE_ELONGATION...,SET,23,-0.0088544,-0.00031319,0.1546,0.52284,REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT,0.99999
MIR4693_3P,SET,56,-0.0063097,-0.00034793,0.11004,0.52286,MIR4693_3P,0.99999
GSE37532_TREG_VS_TCONV_CD4_T...3,SET,149,-0.0037902,-0.00034004,0.066067,0.52287,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...16,SET,50,-0.0061556,-0.00032078,0.10701,0.52294,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR,0.99999
GSE18893_TCONV_VS_TREG_2H_CU...2,SET,174,-0.0035194,-0.00034098,0.061143,0.52295,GSE18893_TCONV_VS_TREG_2H_CULTURE_UP,0.99999
REACTOME_METABOLISM_OF_LIPIDS,SET,701,-0.0018819,-0.00036063,0.032648,0.52298,REACTOME_METABOLISM_OF_LIPIDS,0.99999
HP_WHITE_EYEBROW,SET,11,-0.016276,-0.00039827,0.28237,0.52298,HP_WHITE_EYEBROW,0.99999
HP_ABNORMAL_NEURON_MORPHOLOGY,SET,79,-0.0052394,-0.00034294,0.090729,0.52303,HP_ABNORMAL_NEURON_MORPHOLOGY,0.99999
GSE5679_CTRL_VS_PPARG_LIGAND...1,SET,177,-0.0037366,-0.0003651,0.064689,0.52303,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...319,SET,220,-0.0033854,-0.00036834,0.058589,0.52304,GOBP_POSITIVE_REGULATION_OF_GROWTH,0.99999
GSE13173_UNTREATED_VS_IL12_T...2,SET,113,-0.0046229,-0.00036155,0.079976,0.52305,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...8,SET,167,-0.0038559,-0.00036606,0.066607,0.52308,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP,0.99999
GSE17721_LPS_VS_PAM3CSK4_6H_...1,SET,182,-0.0034173,-0.00033854,0.058935,0.52312,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_DN,0.99999
HP_LIMITED_KNEE_EXTENSION,SET,17,-0.012884,-0.00039185,0.22214,0.52313,HP_LIMITED_KNEE_EXTENSION,0.99999
AAGCACT_MIR520F,SET,219,-0.0032763,-0.00035567,0.056324,0.52319,AAGCACT_MIR520F,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_M...1,SET,22,-0.011503,-0.00039793,0.1978,0.52319,GOBP_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS,0.99999
MIR4758_3P,SET,50,-0.0064307,-0.00033512,0.1104,0.52322,MIR4758_3P,0.99999
WGTTNNNNNAAA_UNKNOWN,SET,484,-0.0023603,-0.00037814,0.04053,0.52322,WGTTNNNNNAAA_UNKNOWN,0.99999
GOBP_PARAXIAL_MESODERM_DEVEL...,SET,17,-0.012087,-0.00036761,0.20741,0.52323,GOBP_PARAXIAL_MESODERM_DEVELOPMENT,0.99999
GOMF_PRIMARY_ACTIVE_TRANSMEM...,SET,143,-0.0039242,-0.00034496,0.067267,0.52326,GOMF_PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE11961_MARGINAL_ZONE_BCELL...8,SET,186,-0.0036805,-0.00036856,0.063095,0.52326,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP,0.99999
DESCARTES_MAIN_FETAL_CARDIOM...,SET,24,-0.010367,-0.00037457,0.17738,0.5233,DESCARTES_MAIN_FETAL_CARDIOMYOCYTES,0.99999
GSE11961_FOLLICULAR_BCELL_VS...9,SET,179,-0.0036349,-0.00035715,0.062136,0.52332,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_DN,0.99999
KEGG_MEDICUS_PATHOGEN_HCMV_G...2,SET,7,-0.01895,-0.00036993,0.32383,0.52333,KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY,0.99999
GOBP_PROTEIN_K6_LINKED_UBIQU...,SET,15,-0.012688,-0.00036251,0.21679,0.52334,GOBP_PROTEIN_K6_LINKED_UBIQUITINATION,0.99999
MIR2114_3P,SET,40,-0.007433,-0.00034656,0.12681,0.52337,MIR2114_3P,0.99999
GSE34006_UNTREATED_VS_A2AR_A...1,SET,182,-0.0037289,-0.0003694,0.063445,0.52343,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN,0.99999
HP_ABSENT_STERNAL_OSSIFICATI...,SET,5,-0.019093,-0.00031503,0.32464,0.52345,HP_ABSENT_STERNAL_OSSIFICATION,0.99999
HP_ABNORMAL_LOWER_LIMB_BONE_...,SET,671,-0.0019406,-0.00036415,0.032984,0.52346,HP_ABNORMAL_LOWER_LIMB_BONE_MORPHOLOGY,0.99999
GSE34515_CD16_NEG_VS_POS_MON...2,SET,181,-0.0037638,-0.00037185,0.063854,0.5235,GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP,0.99999
USF_Q6,SET,227,-0.0032354,-0.00035751,0.054773,0.52355,USF_Q6,0.99999
GOBP_PROTEIN_AUTO_ADP_RIBOSY...,SET,11,-0.015787,-0.00038628,0.26597,0.52367,GOBP_PROTEIN_AUTO_ADP_RIBOSYLATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...379,SET,952,-0.0017155,-0.00038037,0.028855,0.5237,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,0.99999
GSE21360_NAIVE_VS_PRIMARY_ME...1,SET,169,-0.0040296,-0.00038481,0.067728,0.52372,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN,0.99999
HP_ULNAR_DEVIATION_OF_THE_HA...2,SET,58,-0.0068861,-0.00038642,0.11559,0.52375,HP_ULNAR_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,0.99999
REACTOME_CRISTAE_FORMATION,SET,9,-0.015571,-0.00034465,0.25928,0.52394,REACTOME_CRISTAE_FORMATION,0.99999
GSE13306_TREG_VS_TCONV_UP,SET,187,-0.0036921,-0.0003707,0.061465,0.52395,GSE13306_TREG_VS_TCONV_UP,0.99999
HP_HYPERTROPHIC_NERVE_CHANGES,SET,6,-0.024259,-0.00043845,0.40329,0.52398,HP_HYPERTROPHIC_NERVE_CHANGES,0.99999
QIU_PBMC_HEPTATITIS_B_SURFAC...4,SET,14,-0.01435,-0.0003961,0.2382,0.52402,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_UP,0.99999
GOCC_IMMUNOGLOBULIN_COMPLEX_...,SET,3,-0.035808,-0.00045768,0.59222,0.52411,GOCC_IMMUNOGLOBULIN_COMPLEX_CIRCULATING,0.99999
GOBP_CRANIAL_SKELETAL_SYSTEM...,SET,67,-0.0067505,-0.00040703,0.11154,0.52413,GOBP_CRANIAL_SKELETAL_SYSTEM_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...10,SET,37,-0.0084636,-0.00037955,0.13972,0.52415,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,0.99999
GOBP_ERYTHROCYTE_MATURATION,SET,18,-0.011858,-0.00037109,0.1954,0.52419,GOBP_ERYTHROCYTE_MATURATION,0.99999
WP_GLYCEROPHOSPHOLIPID_BIOSY...,SET,27,-0.0098627,-0.00037793,0.16239,0.52422,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,0.99999
GOBP_OLEFINIC_COMPOUND_METAB...,SET,154,-0.0044351,-0.00040447,0.073012,0.52422,GOBP_OLEFINIC_COMPOUND_METABOLIC_PROCESS,0.99999
GSE14350_IL2RB_KO_VS_WT_TREG...1,SET,181,-0.0038229,-0.00037768,0.062925,0.52422,GSE14350_IL2RB_KO_VS_WT_TREG_DN,0.99999
MIR4264,SET,97,-0.0052322,-0.00037929,0.086073,0.52424,MIR4264,0.99999
GOBP_NUCLEAR_RNA_SURVEILLANCE,SET,14,-0.011772,-0.00032495,0.19344,0.52426,GOBP_NUCLEAR_RNA_SURVEILLANCE,0.99999
GSE13411_IGM_VS_SWITCHED_MEM...2,SET,173,-0.0039797,-0.00038447,0.065392,0.52426,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...8,SET,5,-0.020262,-0.00033432,0.33282,0.52427,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS_DISULFIDE_AS_ACCEPTOR,0.99999
MIR4793_3P,SET,68,-0.0063522,-0.00038585,0.10422,0.5243,MIR4793_3P,0.99999
GOBP_REGULATION_OF_B_CELL_PR...,SET,62,-0.0069227,-0.0004016,0.11351,0.52431,GOBP_REGULATION_OF_B_CELL_PROLIFERATION,0.99999
ZHENG_CORD_BLOOD_C3_MEGAKARY...,SET,89,-0.0053093,-0.00036875,0.086999,0.52433,ZHENG_CORD_BLOOD_C3_MEGAKARYOCYTE_ERYTHROID_PROGENITOR,0.99999
HP_CONGENITAL_GIANT_MELANOCY...,SET,5,-0.020363,-0.00033599,0.33292,0.52439,HP_CONGENITAL_GIANT_MELANOCYTIC_NEVUS,0.99999
HP_ABNORMAL_PERIVENTRICULAR_...,SET,116,-0.0045793,-0.00036283,0.074669,0.52445,HP_ABNORMAL_PERIVENTRICULAR_WHITE_MATTER_MORPHOLOGY,0.99999
REACTOME_ACYL_CHAIN_REMODELI...1,SET,5,-0.022897,-0.00037779,0.37298,0.52447,REACTOME_ACYL_CHAIN_REMODELING_OF_CL,0.99999
HP_ABNORMALITY_OF_THE_INNER_...,SET,79,-0.0057487,-0.00037627,0.093643,0.52448,HP_ABNORMALITY_OF_THE_INNER_EAR,0.99999
HP_MACULAR_DYSTROPHY,SET,18,-0.012662,-0.00039625,0.2061,0.52449,HP_MACULAR_DYSTROPHY,0.99999
MIR3116,SET,87,-0.0054584,-0.00037484,0.088732,0.52453,MIR3116,0.99999
GOBP_ATRIOVENTRICULAR_NODE_D...,SET,9,-0.018256,-0.00040409,0.2963,0.52456,GOBP_ATRIOVENTRICULAR_NODE_DEVELOPMENT,0.99999
STAT5B_01,SET,223,-0.0035959,-0.00039388,0.058257,0.52461,STAT5B_01,0.99999
MIR770_5P,SET,93,-0.0054461,-0.00038661,0.088124,0.52464,MIR770_5P,0.99999
WP_OVERVIEW_OF_PROINFLAMMATO...,SET,121,-0.0057333,-0.00046388,0.092454,0.52472,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...13,SET,75,-0.0056096,-0.00035779,0.090473,0.52472,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,0.99999
HP_NEOPLASM_OF_THE_MALE_EXTE...,SET,32,-0.010275,-0.00042858,0.16568,0.52473,HP_NEOPLASM_OF_THE_MALE_EXTERNAL_GENITALIA,0.99999
GSE29618_PRE_VS_DAY7_FLU_VAC...3,SET,178,-0.0037201,-0.0003645,0.059957,0.52474,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN,0.99999
GSE15330_HSC_VS_LYMPHOID_PRI...2,SET,177,-0.003841,-0.0003753,0.061371,0.52495,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_DN,0.99999
GOBP_REPLICATION_BORN_DOUBLE...,SET,6,-0.022242,-0.000402,0.35529,0.52496,GOBP_REPLICATION_BORN_DOUBLE_STRAND_BREAK_REPAIR_VIA_SISTER_CHROMATID_EXCHANGE,0.99999
PUJANA_BRCA_CENTERED_NETWORK,SET,110,-0.0046442,-0.00035839,0.074012,0.52502,PUJANA_BRCA_CENTERED_NETWORK,0.99999
MIR208A_5P,SET,228,-0.0035217,-0.00039,0.055964,0.52509,MIR208A_5P,0.99999
WP_CELL_CYCLE,SET,116,-0.0047757,-0.00037839,0.075867,0.5251,WP_CELL_CYCLE,0.99999
HP_PREMATURE_RUPTURE_OF_MEMB...,SET,15,-0.012196,-0.00034845,0.19356,0.52512,HP_PREMATURE_RUPTURE_OF_MEMBRANES,0.99999
JONES_OVARY_MACROPHAGE,SET,213,-0.0039172,-0.00041945,0.061977,0.5252,JONES_OVARY_MACROPHAGE,0.99999
CROMER_TUMORIGENESIS_DN,SET,46,-0.0082604,-0.00041294,0.13054,0.52523,CROMER_TUMORIGENESIS_DN,0.99999
MIR451A,SET,6,-0.023916,-0.00043226,0.3774,0.52526,MIR451A,0.99999
GOBP_MACROPHAGE_MIGRATION,SET,57,-0.0071649,-0.00039859,0.113,0.52528,GOBP_MACROPHAGE_MIGRATION,0.99999
GOBP_PROTEIN_RNA_COMPLEX_ORG...,SET,181,-0.0035343,-0.00034918,0.055731,0.52528,GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION,0.99999
REACTOME_DEFECTIVE_FACTOR_IX...,SET,7,-0.022452,-0.0004383,0.35365,0.52531,REACTOME_DEFECTIVE_FACTOR_IX_CAUSES_HEMOPHILIA_B,0.99999
GOBP_AMELOBLAST_DIFFERENTIAT...,SET,5,-0.029056,-0.00047942,0.45756,0.52532,GOBP_AMELOBLAST_DIFFERENTIATION,0.99999
HP_URINARY_RETENTION,SET,24,-0.011494,-0.00041529,0.18081,0.52534,HP_URINARY_RETENTION,0.99999
PAF1_TARGET_GENES,SET,55,-0.007224,-0.00039478,0.11341,0.52539,PAF1_TARGET_GENES,0.99999
GOBP_VASCULAR_ENDOTHELIAL_GR...2,SET,6,-0.026167,-0.00047294,0.41048,0.52541,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_SIGNALING_PATHWAY,0.99999
SCHMIDT_POR_TARGETS_IN_LIMB_...1,SET,8,-0.020246,-0.00042252,0.31704,0.52546,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN,0.99999
MIR7_1_3P,SET,593,-0.0023234,-0.00041076,0.036227,0.52557,MIR7_1_3P,0.99999
MIR3124_3P,SET,204,-0.0037287,-0.00039084,0.058039,0.52561,MIR3124_3P,0.99999
GOMF_1_PHOSPHATIDYLINOSITOL_...6,SET,15,-0.014061,-0.00040172,0.21864,0.52564,GOMF_1_PHOSPHATIDYLINOSITOL_BINDING,0.99999
GOBP_CENTRIOLE_CENTRIOLE_COH...,SET,14,-0.015153,-0.00041825,0.23535,0.52567,GOBP_CENTRIOLE_CENTRIOLE_COHESION,0.99999
HP_ABNORMAL_TONGUE_PHYSIOLOGY,SET,57,-0.0070494,-0.00039216,0.10947,0.52567,HP_ABNORMAL_TONGUE_PHYSIOLOGY,0.99999
HP_DIMINISHED_MOTIVATION,SET,563,-0.0022989,-0.00039633,0.035616,0.52573,HP_DIMINISHED_MOTIVATION,0.99999
KEGG_LYSOSOME,SET,113,-0.0050964,-0.00039858,0.078919,0.52574,KEGG_LYSOSOME,0.99999
DESCARTES_FETAL_HEART_LYMPHA...,SET,28,-0.011481,-0.00044801,0.17727,0.52582,DESCARTES_FETAL_HEART_LYMPHATIC_ENDOTHELIAL_CELLS,0.99999
GOBP_RNA_SECONDARY_STRUCTURE...,SET,8,-0.019073,-0.00039804,0.29388,0.52587,GOBP_RNA_SECONDARY_STRUCTURE_UNWINDING,0.99999
HP_ELEVATED_CIRCULATING_PHYT...,SET,14,-0.014485,-0.00039981,0.2228,0.52592,HP_ELEVATED_CIRCULATING_PHYTANIC_ACID_CONCENTRATION,0.99999
MIR3126_5P,SET,59,-0.0069276,-0.00039207,0.10644,0.52595,MIR3126_5P,0.99999
GOMF_PROTEIN_KINASE_A_BINDING,SET,49,-0.0076571,-0.00039504,0.11759,0.52596,GOMF_PROTEIN_KINASE_A_BINDING,0.99999
GOCC_CILIARY_BASE,SET,35,-0.0091289,-0.00039819,0.13987,0.52602,GOCC_CILIARY_BASE,0.99999
HP_LOSS_OF_EYELASHES,SET,4,-0.023057,-0.00034028,0.35322,0.52602,HP_LOSS_OF_EYELASHES,0.99999
XU_HGF_TARGETS_REPRESSED_BY_...2,SET,9,-0.018662,-0.00041306,0.28575,0.52603,XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP,0.99999
HP_PROLONGED_QT_INTERVAL,SET,45,-0.0085306,-0.0004218,0.13066,0.52603,HP_PROLONGED_QT_INTERVAL,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...9,SET,172,-0.0043802,-0.00042195,0.06709,0.52603,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN,0.99999
MODULE_20,SET,77,-0.0059791,-0.00038639,0.091539,0.52604,MODULE_20,0.99999
GOBP_POSITIVE_REGULATION_OF_...656,SET,115,-0.0050236,-0.00039632,0.076872,0.52605,GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_EPITHELIAL_CELL_FATE_CO...,SET,14,-0.016233,-0.00044809,0.24835,0.52606,GOBP_EPITHELIAL_CELL_FATE_COMMITMENT,0.99999
HEDVAT_ELF4_TARGETS_UP,SET,12,-0.018586,-0.00047499,0.28397,0.52609,HEDVAT_ELF4_TARGETS_UP,0.99999
GOCC_GOLGI_TRANS_CISTERNA,SET,9,-0.02028,-0.00044888,0.30946,0.52612,GOCC_GOLGI_TRANS_CISTERNA,0.99999
GOBP_REGULATION_OF_AUTOPHAGO...2,SET,15,-0.013424,-0.00038354,0.20479,0.52613,GOBP_REGULATION_OF_AUTOPHAGOSOME_MATURATION,0.99999
HP_ABNORMAL_PROXIMAL_PHALANX...,SET,27,-0.010823,-0.00041471,0.16513,0.52613,HP_ABNORMAL_PROXIMAL_PHALANX_MORPHOLOGY_OF_THE_HAND,0.99999
GSE21927_SPLEEN_VS_TUMOR_MON...2,SET,142,-0.0044599,-0.00039069,0.068022,0.52614,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_UP,0.99999
MORF_IL9,SET,86,-0.006058,-0.00041363,0.092369,0.52615,MORF_IL9,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...2,SET,9,-0.017739,-0.00039264,0.27027,0.52617,GOBP_PROTEIN_LOCALIZATION_TO_AXON,0.99999
GSE10325_CD4_TCELL_VS_BCELL_...1,SET,166,-0.0045545,-0.0004311,0.069368,0.52617,GSE10325_CD4_TCELL_VS_BCELL_DN,0.99999
REACTOME_RUNX1_REGULATES_TRA...2,SET,66,-0.0062121,-0.00037177,0.094566,0.52619,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,0.99999
GOBP_AUTOPHAGOSOME_LYSOSOME_...,SET,11,-0.015687,-0.00038385,0.2387,0.5262,GOBP_AUTOPHAGOSOME_LYSOSOME_FUSION,0.99999
DESCARTES_FETAL_PANCREAS_LYM...1,SET,41,-0.0093136,-0.00043962,0.14173,0.5262,DESCARTES_FETAL_PANCREAS_LYMPHATIC_ENDOTHELIAL_CELLS,0.99999
KEGG_MEDICUS_PATHOGEN_ESCHER...2,SET,17,-0.011451,-0.00034826,0.17415,0.52621,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY,0.99999
GSE360_L_MAJOR_VS_M_TUBERCUL...1,SET,168,-0.0043102,-0.0004104,0.065488,0.52624,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN,0.99999
GOBP_RECEPTOR_MEDIATED_ENDOC...1,SET,239,-0.0036126,-0.00040947,0.054824,0.52627,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.99999
HP_CENTROCECAL_SCOTOMA,SET,3,-0.025892,-0.00033094,0.39296,0.52627,HP_CENTROCECAL_SCOTOMA,0.99999
GOMF_LEUKOTRIENE_C4_GAMMA_GL...,SET,4,-0.028752,-0.00042433,0.43573,0.5263,GOMF_LEUKOTRIENE_C4_GAMMA_GLUTAMYL_TRANSFERASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...796,SET,18,-0.012714,-0.00039789,0.19254,0.52632,GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.99999
GTGACGY_E4F1_Q6,SET,589,-0.0022998,-0.00040524,0.034816,0.52633,GTGACGY_E4F1_Q6,0.99999
GOBP_RECEPTOR_LOCALIZATION_T...2,SET,56,-0.0076848,-0.00042376,0.11628,0.52635,GOBP_RECEPTOR_LOCALIZATION_TO_SYNAPSE,0.99999
WANG_LMO4_TARGETS_DN,SET,319,-0.0029373,-0.00038379,0.044384,0.52638,WANG_LMO4_TARGETS_DN,0.99999
MIR30C_2_3P,SET,117,-0.005358,-0.00042635,0.080964,0.52638,MIR30C_2_3P,0.99999
MIR6844,SET,306,-0.0032222,-0.00041249,0.048649,0.5264,MIR6844,0.99999
HP_HYPOPLASIA_OF_THE_EPIGLOT...,SET,9,-0.018885,-0.00041801,0.28505,0.52641,HP_HYPOPLASIA_OF_THE_EPIGLOTTIS,0.99999
GOBP_VACUOLE_ORGANIZATION,SET,212,-0.0037027,-0.00039557,0.055753,0.52648,GOBP_VACUOLE_ORGANIZATION,0.99999
GOCC_MEMBRANE_COAT,SET,93,-0.0054795,-0.00038898,0.082487,0.52648,GOCC_MEMBRANE_COAT,0.99999
HP_MACULE,SET,209,-0.0037022,-0.00039274,0.055504,0.52659,HP_MACULE,0.99999
GOBP_MICROAUTOPHAGY,SET,22,-0.011514,-0.00039831,0.17232,0.52664,GOBP_MICROAUTOPHAGY,0.99999
HP_ABNORMALITY_OF_THE_SUPRAO...,SET,87,-0.0062696,-0.00043055,0.093632,0.52669,HP_ABNORMALITY_OF_THE_SUPRAORBITAL_RIDGES,0.99999
HP_BIFID_URETER,SET,4,-0.026986,-0.00039827,0.4031,0.52669,HP_BIFID_URETER,0.99999
MIR548AO_3P,SET,17,-0.014495,-0.00044084,0.21628,0.52672,MIR548AO_3P,0.99999
DESCARTES_FETAL_MUSCLE_MYELO...,SET,106,-0.0057683,-0.00043702,0.086018,0.52673,DESCARTES_FETAL_MUSCLE_MYELOID_CELLS,0.99999
REACTOME_FBXW7_MUTANTS_AND_N...,SET,5,-0.022561,-0.00037226,0.33592,0.52677,REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER,0.99999
MOOTHA_GLYCOGEN_METABOLISM,SET,18,-0.012406,-0.00038825,0.18452,0.5268,MOOTHA_GLYCOGEN_METABOLISM,0.99999
GSE43863_TH1_VS_TFH_MEMORY_C...2,SET,179,-0.0041193,-0.00040474,0.061212,0.52683,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP,0.99999
IL15_UP.V1_UP,SET,164,-0.0044694,-0.00042051,0.066206,0.52691,IL15_UP.V1_UP,0.99999
GSE17974_0H_VS_6H_IN_VITRO_A...1,SET,178,-0.0040442,-0.00039626,0.059846,0.52694,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN,0.99999
MIR4432,SET,62,-0.0072313,-0.0004195,0.10674,0.52701,MIR4432,0.99999
FAN_OVARY_CL3_MATURE_CUMULUS...,SET,200,-0.0040699,-0.00042244,0.059975,0.52705,FAN_OVARY_CL3_MATURE_CUMULUS_GRANULOSA_CELL_1,0.99999
KEGG_CYTOKINE_CYTOKINE_RECEP...,SET,245,-0.0042488,-0.00048751,0.062601,0.52706,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,0.99999
GOCC_PROTEIN_PHOSPHATASE_4_C...,SET,3,-0.026645,-0.00034056,0.3919,0.5271,GOCC_PROTEIN_PHOSPHATASE_4_COMPLEX,0.99999
GSE20754_WT_VS_TCF1_KO_MEMOR...1,SET,179,-0.0043841,-0.00043075,0.064273,0.52719,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN,0.99999
GOBP_CARDIAC_CONDUCTION_SYST...,SET,36,-0.010787,-0.00047717,0.15811,0.5272,GOBP_CARDIAC_CONDUCTION_SYSTEM_DEVELOPMENT,0.99999
GSE7460_WT_VS_FOXP3_HET_ACT_...2,SET,186,-0.0042345,-0.00042403,0.061986,0.52723,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP,0.99999
REACTOME_SIGNALING_BY_WNT_IN...,SET,32,-0.010143,-0.00042309,0.14831,0.52726,REACTOME_SIGNALING_BY_WNT_IN_CANCER,0.99999
GSE12366_GC_VS_MEMORY_BCELL_...1,SET,180,-0.0042595,-0.00041967,0.062124,0.52733,GSE12366_GC_VS_MEMORY_BCELL_DN,0.99999
WU_HBX_TARGETS_2_DN,SET,14,-0.017031,-0.0004701,0.24757,0.52742,WU_HBX_TARGETS_2_DN,0.99999
GOBP_EXTRAEMBRYONIC_MEMBRANE...,SET,13,-0.018374,-0.00048874,0.26701,0.52743,GOBP_EXTRAEMBRYONIC_MEMBRANE_DEVELOPMENT,0.99999
CTAWWWATA_RSRFC4_Q2,SET,324,-0.0032974,-0.00043414,0.047898,0.52744,CTAWWWATA_RSRFC4_Q2,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...6,SET,127,-0.0055306,-0.00045838,0.080358,0.52744,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...2,SET,184,-0.0042276,-0.00042108,0.0614,0.52745,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP,0.99999
MIR514A_5P,SET,61,-0.0078831,-0.00045362,0.11417,0.52752,MIR514A_5P,0.99999
GSE15930_STIM_VS_STIM_AND_IL...2,SET,179,-0.0041189,-0.0004047,0.059564,0.52756,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP,0.99999
GOBP_LACTATION,SET,37,-0.0098071,-0.0004398,0.14156,0.52762,GOBP_LACTATION,0.99999
WP_ENTEROHEPATIC_CIRCULATION...,SET,12,-0.017422,-0.00044524,0.25119,0.52765,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,0.99999
GOBP_POLYSACCHARIDE_BIOSYNTH...,SET,60,-0.0075054,-0.00042834,0.10797,0.52771,GOBP_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,0.99999
BILANGES_SERUM_SENSITIVE_VIA...1,SET,20,-0.013468,-0.00044427,0.19369,0.52772,BILANGES_SERUM_SENSITIVE_VIA_TSC1,0.99999
ALONSO_METASTASIS_UP,SET,175,-0.004355,-0.00042314,0.062504,0.52777,ALONSO_METASTASIS_UP,0.99999
REACTOME_SPHINGOLIPID_METABO...,SET,95,-0.0061748,-0.00044301,0.088119,0.52793,REACTOME_SPHINGOLIPID_METABOLISM,0.99999
ZNF528_TARGET_GENES,SET,595,-0.0024352,-0.00043122,0.034722,0.52796,ZNF528_TARGET_GENES,0.99999
DOANE_BREAST_CANCER_ESR1_UP,SET,102,-0.0061957,-0.0004605,0.088104,0.52803,DOANE_BREAST_CANCER_ESR1_UP,0.99999
GOMF_RIBOSOME_BINDING,SET,87,-0.0060498,-0.00041545,0.086028,0.52803,GOMF_RIBOSOME_BINDING,0.99999
HP_VASCULITIS,SET,65,-0.0077352,-0.00045942,0.10976,0.52809,HP_VASCULITIS,0.99999
GOBP_T_CELL_LINEAGE_COMMITME...,SET,35,-0.01066,-0.00046495,0.15112,0.52812,GOBP_T_CELL_LINEAGE_COMMITMENT,0.99999
MIR4742_5P,SET,169,-0.0047799,-0.00045647,0.06738,0.52828,MIR4742_5P,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_INT...,SET,353,-0.0033914,-0.0004657,0.047788,0.52829,HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL,0.99999
MODULE_213,SET,74,-0.0072567,-0.00045976,0.10221,0.5283,MODULE_213,0.99999
GSE32164_ALTERNATIVELY_ACT_M...2,SET,178,-0.0043463,-0.00042586,0.061222,0.5283,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP,0.99999
HP_SUBEPIDERMAL_BLISTERING,SET,11,-0.017876,-0.00043742,0.25141,0.52834,HP_SUBEPIDERMAL_BLISTERING,0.99999
GSE17721_LPS_VS_PAM3CSK4_4H_...1,SET,188,-0.004024,-0.00040509,0.056602,0.52834,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_DN,0.99999
HP_OVERGROWTH,SET,37,-0.0095436,-0.00042798,0.13389,0.52841,HP_OVERGROWTH,0.99999
HMCES_TARGET_GENES,SET,6,-0.023244,-0.00042012,0.32564,0.52845,HMCES_TARGET_GENES,0.99999
GOBP_PLATELET_ACTIVATING_FAC...,SET,8,-0.020607,-0.00043004,0.28851,0.52847,GOBP_PLATELET_ACTIVATING_FACTOR_METABOLIC_PROCESS,0.99999
GSE5589_LPS_VS_LPS_AND_IL10_...4,SET,177,-0.0044554,-0.00043534,0.062378,0.52847,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...34,SET,12,-0.017867,-0.00045661,0.25008,0.52848,GOBP_NEGATIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...5,SET,171,-0.0046982,-0.00045128,0.065688,0.52851,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,0.99999
GSE17721_CTRL_VS_LPS_0.5H_BM...1,SET,182,-0.0045469,-0.00045045,0.063457,0.52856,GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN,0.99999
GOZGIT_ESR1_TARGETS_DN,SET,656,-0.0025654,-0.00047616,0.03578,0.52858,GOZGIT_ESR1_TARGETS_DN,0.99999
GOBP_LEUKOTRIENE_D4_BIOSYNTH...,SET,5,-0.028731,-0.00047406,0.40042,0.5286,GOBP_LEUKOTRIENE_D4_BIOSYNTHETIC_PROCESS,0.99999
GOMF_GLUTATHIONE_HYDROLASE_A...,SET,5,-0.028731,-0.00047406,0.40042,0.5286,GOMF_GLUTATHIONE_HYDROLASE_ACTIVITY,0.99999
HP_MULTIPLE_CAFE_AU_LAIT_SPO...,SET,61,-0.0071735,-0.00041279,0.099932,0.52861,HP_MULTIPLE_CAFE_AU_LAIT_SPOTS,0.99999
GSE19825_NAIVE_VS_IL2RAHIGH_...1,SET,179,-0.0043015,-0.00042264,0.059928,0.52861,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,0.99999
KYNG_ENVIRONMENTAL_STRESS_RE...2,SET,12,-0.017085,-0.00043663,0.23769,0.52865,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD,0.99999
HP_SECONDARY_MICROCEPHALY,SET,174,-0.0044686,-0.00043294,0.062138,0.52866,HP_SECONDARY_MICROCEPHALY,0.99999
WESTON_VEGFA_TARGETS_3HR,SET,59,-0.0085135,-0.00048182,0.11837,0.52867,WESTON_VEGFA_TARGETS_3HR,0.99999
WIERENGA_STAT5A_TARGETS_UP,SET,186,-0.0046918,-0.00046982,0.065234,0.52867,WIERENGA_STAT5A_TARGETS_UP,0.99999
REACTOME_METAL_SEQUESTRATION...,SET,6,-0.028815,-0.00052081,0.40064,0.52867,REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS,0.99999
HP_ERYTHEMA_NODOSUM,SET,7,-0.025661,-0.00050095,0.35564,0.52876,HP_ERYTHEMA_NODOSUM,0.99999
HP_SHAGREEN_PATCH,SET,5,-0.030063,-0.00049603,0.41636,0.52878,HP_SHAGREEN_PATCH,0.99999
MODULE_456,SET,102,-0.006215,-0.00046194,0.086053,0.52879,MODULE_456,0.99999
MIR3681_5P,SET,31,-0.011685,-0.00047974,0.16142,0.52885,MIR3681_5P,0.99999
APPEL_IMATINIB_RESPONSE,SET,28,-0.012252,-0.00047808,0.16844,0.52899,APPEL_IMATINIB_RESPONSE,0.99999
MIKKELSEN_DEDIFFERENTIATED_S...2,SET,6,-0.026448,-0.00047802,0.36357,0.52899,MIKKELSEN_DEDIFFERENTIATED_STATE_UP,0.99999
AAGCAAT_MIR137,SET,198,-0.0046149,-0.00047665,0.06337,0.52903,AAGCAAT_MIR137,0.99999
HP_UNILATERAL_RENAL_AGENESIS,SET,83,-0.0067172,-0.0004506,0.09214,0.52906,HP_UNILATERAL_RENAL_AGENESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...363,SET,36,-0.011595,-0.00051293,0.159,0.52907,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,0.99999
GOMF_PROTEIN_SEQUESTERING_AC...,SET,25,-0.012419,-0.00045796,0.17004,0.52911,GOMF_PROTEIN_SEQUESTERING_ACTIVITY,0.99999
HP_ABNORMALITY_OF_LOWER_LIMB...,SET,639,-0.0024668,-0.00045211,0.033708,0.52917,HP_ABNORMALITY_OF_LOWER_LIMB_JOINT,0.99999
GOCC_HOPS_COMPLEX,SET,14,-0.014431,-0.00039835,0.19656,0.52926,GOCC_HOPS_COMPLEX,0.99999
HP_ABNORMAL_BLOOD_MONOVALENT...,SET,140,-0.0054622,-0.00047514,0.074318,0.52929,HP_ABNORMAL_BLOOD_MONOVALENT_INORGANIC_CATION_CONCENTRATION,0.99999
HP_PANCREATIC_ISLET_CELL_ADE...,SET,9,-0.02216,-0.0004905,0.30123,0.52932,HP_PANCREATIC_ISLET_CELL_ADENOMA,0.99999
HP_SEVERELY_REDUCED_VISUAL_A...,SET,39,-0.010033,-0.00046192,0.13629,0.52934,HP_SEVERELY_REDUCED_VISUAL_ACUITY,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...1,SET,32,-0.010982,-0.00045806,0.14917,0.52934,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_BOWMANS_GLAND,0.99999
REACTOME_NRAGE_SIGNALS_DEATH...,SET,53,-0.0089252,-0.00047883,0.12106,0.52938,REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,0.99999
HP_INTERCOSTAL_MUSCLE_WEAKNE...,SET,9,-0.022807,-0.00050481,0.30841,0.52947,HP_INTERCOSTAL_MUSCLE_WEAKNESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...812,SET,6,-0.029916,-0.00054071,0.40445,0.52948,GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION,0.99999
HP_THORACOLUMBAR_KYPHOSCOLIO...,SET,6,-0.026611,-0.00048097,0.35927,0.52952,HP_THORACOLUMBAR_KYPHOSCOLIOSIS,0.99999
GOBP_INTRACILIARY_RETROGRADE...,SET,10,-0.018859,-0.00043999,0.25424,0.52956,GOBP_INTRACILIARY_RETROGRADE_TRANSPORT,0.99999
HP_ABNORMAL_LUNG_MORPHOLOGY,SET,1068,-0.0019743,-0.00046211,0.026596,0.52959,HP_ABNORMAL_LUNG_MORPHOLOGY,0.99999
GNF2_IL2RB,SET,41,-0.010561,-0.0004985,0.14218,0.52961,GNF2_IL2RB,0.99999
CAATGCA_MIR33,SET,88,-0.0065344,-0.00045129,0.087658,0.52971,CAATGCA_MIR33,0.99999
GSE1791_CTRL_VS_NEUROMEDINU_...6,SET,160,-0.0050226,-0.00046681,0.067389,0.52971,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP,0.99999
HP_FETAL_NECK_ANOMALY,SET,92,-0.0066742,-0.00047125,0.089492,0.52972,HP_FETAL_NECK_ANOMALY,0.99999
DICER1_TARGET_GENES,SET,52,-0.0088348,-0.0004695,0.11832,0.52976,DICER1_TARGET_GENES,0.99999
HP_ABNORMALITY_OF_CHROMOSOME...2,SET,49,-0.0083288,-0.00042969,0.11154,0.52976,HP_ABNORMALITY_OF_CHROMOSOME_STABILITY,0.99999
HP_HEPATIC_NECROSIS,SET,13,-0.016327,-0.00043429,0.21855,0.52978,HP_HEPATIC_NECROSIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...29,SET,29,-0.011683,-0.00046392,0.1563,0.52979,GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_ALV...,SET,7,-0.027692,-0.00054059,0.37055,0.52979,HE_LIM_SUN_FETAL_LUNG_C0_ALVEOLAR_FIBROBLAST,0.99999
GOBP_WATER_SOLUBLE_VITAMIN_M...,SET,58,-0.0080141,-0.00044971,0.1072,0.5298,GOBP_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS,0.99999
GSE13547_WT_VS_ZFX_KO_BCELL_...4,SET,158,-0.0050034,-0.00046214,0.06689,0.52981,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP,0.99999
BLANCO_MELO_COVID19_SARS_COV...11,SET,159,-0.0046876,-0.00043432,0.06266,0.52982,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN,0.99999
GOMF_REGULATORY_RNA_BINDING,SET,38,-0.0095022,-0.00043184,0.12689,0.52985,GOMF_REGULATORY_RNA_BINDING,0.99999
GOBP_SULFUR_COMPOUND_TRANSPO...,SET,60,-0.0083553,-0.00047684,0.11153,0.52986,GOBP_SULFUR_COMPOUND_TRANSPORT,0.99999
GOBP_MAST_CELL_ACTIVATION_IN...,SET,52,-0.0091297,-0.00048517,0.1218,0.52988,GOBP_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
GSE17974_0H_VS_72H_IN_VITRO_...1,SET,170,-0.0046016,-0.00044072,0.06132,0.52991,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN,0.99999
REACTOME_ROLE_OF_ABL_IN_ROBO...,SET,8,-0.020997,-0.00043818,0.27969,0.52992,REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING,0.99999
GOBP_PROTEIN_OXIDATION,SET,12,-0.019961,-0.00051012,0.26567,0.52995,GOBP_PROTEIN_OXIDATION,0.99999
GOMF_LIPASE_BINDING,SET,6,-0.028294,-0.00051138,0.37636,0.52996,GOMF_LIPASE_BINDING,0.99999
MIKKELSEN_IPS_LCP_WITH_H3K27...,SET,10,-0.018698,-0.00043624,0.24863,0.52997,MIKKELSEN_IPS_LCP_WITH_H3K27ME3,0.99999
GOMF_PROTEIN_PHOSPHATASE_2A_...,SET,26,-0.013195,-0.00049617,0.17546,0.52997,GOMF_PROTEIN_PHOSPHATASE_2A_BINDING,0.99999
MIR4773,SET,171,-0.0047681,-0.000458,0.063363,0.52999,MIR4773,0.99999
GSE12366_GC_VS_MEMORY_BCELL_...2,SET,174,-0.0046904,-0.00045443,0.062274,0.53002,GSE12366_GC_VS_MEMORY_BCELL_UP,0.99999
TGAGATT_MIR216,SET,101,-0.0063732,-0.00047138,0.084548,0.53004,TGAGATT_MIR216,0.99999
GOBP_DNA_TEMPLATED_TRANSCRIP...2,SET,175,-0.0046058,-0.0004475,0.061111,0.53004,GOBP_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.99999
MIR7158_5P,SET,63,-0.0080979,-0.00047353,0.10741,0.53005,MIR7158_5P,0.99999
BIOCARTA_BTG2_PATHWAY,SET,11,-0.017752,-0.00043436,0.23519,0.53008,BIOCARTA_BTG2_PATHWAY,0.99999
GSE29618_PRE_VS_DAY7_POST_TI...5,SET,172,-0.0044626,-0.0004299,0.058835,0.53023,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN,0.99999
GSE23568_ID3_TRANSDUCED_VS_I...2,SET,187,-0.0045691,-0.00045876,0.060205,0.53025,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP,0.99999
MODULE_366,SET,29,-0.011167,-0.00044346,0.14709,0.53026,MODULE_366,0.99999
GOBP_IRON_ION_TRANSMEMBRANE_...,SET,18,-0.015174,-0.00047487,0.19883,0.53042,GOBP_IRON_ION_TRANSMEMBRANE_TRANSPORT,0.99999
KEGG_ASCORBATE_AND_ALDARATE_...,SET,23,-0.017601,-0.00062255,0.23024,0.53047,KEGG_ASCORBATE_AND_ALDARATE_METABOLISM,0.99999
GOBP_REGULATION_OF_DNA_RECOM...,SET,112,-0.0056582,-0.00044057,0.073953,0.53049,GOBP_REGULATION_OF_DNA_RECOMBINATION,0.99999
GSE39110_UNTREATED_VS_IL2_TR...3,SET,186,-0.0050703,-0.00050772,0.0662,0.53052,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN,0.99999
PID_NECTIN_PATHWAY,SET,26,-0.013382,-0.00050321,0.17466,0.53054,PID_NECTIN_PATHWAY,0.99999
GOBP_REGULATION_OF_CELLULAR_...1,SET,12,-0.018056,-0.00046146,0.23557,0.53055,GOBP_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS,0.99999
GOBP_UV_DAMAGE_EXCISION_REPA...,SET,11,-0.015942,-0.00039008,0.20796,0.53055,GOBP_UV_DAMAGE_EXCISION_REPAIR,0.99999
GOMF_BETA_2_ADRENERGIC_RECEP...,SET,5,-0.029044,-0.00047922,0.37846,0.53059,GOMF_BETA_2_ADRENERGIC_RECEPTOR_BINDING,0.99999
HP_DEXAMETHASONE_SUPPRESSIBL...,SET,5,-0.03404,-0.00056164,0.44286,0.53063,HP_DEXAMETHASONE_SUPPRESSIBLE_PRIMARY_HYPERALDOSTERONISM,0.99999
MODULE_342,SET,194,-0.0048834,-0.00049931,0.063517,0.53064,MODULE_342,0.99999
MARTINEZ_RB1_AND_TP53_TARGET...2,SET,568,-0.002772,-0.00047995,0.036044,0.53065,MARTINEZ_RB1_AND_TP53_TARGETS_UP,0.99999
GOBP_RESPONSE_TO_LIPID,SET,853,-0.0023735,-0.00049955,0.03082,0.53069,GOBP_RESPONSE_TO_LIPID,0.99999
WP_DUAL_HIJACK_MODEL_OF_VIF_...,SET,5,-0.028643,-0.00047261,0.37142,0.53073,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...367,SET,8,-0.019808,-0.00041337,0.25596,0.53084,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_18_PRODUCTION,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_D...2,SET,9,-0.0204,-0.00045153,0.2636,0.53084,GOBP_PYRIMIDINE_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.99999
ZHENG_GLIOBLASTOMA_PLASTICIT...2,SET,227,-0.0045564,-0.00050348,0.05887,0.53085,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,0.99999
WP_MAP3K1_ROLE_IN_PROMOTING_...,SET,16,-0.017889,-0.00052785,0.23034,0.53095,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...187,SET,107,-0.0060129,-0.00045768,0.077414,0.53095,GOBP_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,0.99999
GOBP_BARBED_END_ACTIN_FILAME...,SET,21,-0.014125,-0.00047743,0.18162,0.531,GOBP_BARBED_END_ACTIN_FILAMENT_CAPPING,0.99999
REACTOME_PHYSIOLOGICAL_FACTO...,SET,14,-0.018515,-0.00051107,0.23755,0.53106,REACTOME_PHYSIOLOGICAL_FACTORS,0.99999
GOBP_INTERNEURON_MIGRATION,SET,13,-0.021814,-0.00058023,0.2799,0.53106,GOBP_INTERNEURON_MIGRATION,0.99999
HP_EYELID_COLOBOMA,SET,34,-0.01066,-0.00045829,0.13661,0.5311,HP_EYELID_COLOBOMA,0.99999
GOBP_REGULATION_OF_STEM_CELL...4,SET,79,-0.0077378,-0.00050646,0.098641,0.53126,GOBP_REGULATION_OF_STEM_CELL_PROLIFERATION,0.99999
HP_SMALL_SCROTUM,SET,51,-0.0096404,-0.00050737,0.12292,0.53126,HP_SMALL_SCROTUM,0.99999
HP_GLOSSOPTOSIS,SET,25,-0.01283,-0.00047311,0.1635,0.53127,HP_GLOSSOPTOSIS,0.99999
HP_CUTANEOUS_CYST,SET,21,-0.013811,-0.0004668,0.17576,0.53131,HP_CUTANEOUS_CYST,0.99999
GSE20715_0H_VS_6H_OZONE_TLR4...2,SET,178,-0.0049422,-0.00048424,0.062772,0.53138,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP,0.99999
GSE4748_CYANOBACTERIUM_LPSLI...1,SET,159,-0.0054428,-0.00050429,0.069009,0.53143,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,0.99999
GOBP_REGULATION_OF_DENDRITIC...3,SET,14,-0.018974,-0.00052373,0.24046,0.53145,GOBP_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,0.99999
GOCC_EXTERNAL_SIDE_OF_PLASMA...,SET,360,-0.0039515,-0.00054785,0.050071,0.53145,GOCC_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE,0.99999
CAFFAREL_RESPONSE_TO_THC_UP,SET,29,-0.011817,-0.00046926,0.14961,0.53148,CAFFAREL_RESPONSE_TO_THC_UP,0.99999
KEGG_MEDICUS_REFERENCE_CXCR4...1,SET,9,-0.024425,-0.00054062,0.30892,0.53151,KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...7,SET,4,-0.022925,-0.00033833,0.28881,0.53163,GOCC_EXTRINSIC_COMPONENT_OF_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...10,SET,7,-0.027453,-0.00053593,0.34513,0.5317,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN,0.99999
PID_AURORA_B_PATHWAY,SET,36,-0.010971,-0.00048531,0.13786,0.53171,PID_AURORA_B_PATHWAY,0.99999
REACTOME_VITAMIN_B2_RIBOFLAV...,SET,7,-0.025963,-0.00050684,0.32628,0.53171,REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...3,SET,178,-0.0050921,-0.00049893,0.06382,0.5318,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP,0.99999
KEGG_MEDICUS_REFERENCE_CXCR4...2,SET,12,-0.019498,-0.00049829,0.24389,0.53186,KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,0.99999
HP_CLINODACTYLY_OF_THE_2ND_F...,SET,8,-0.027321,-0.00057017,0.34166,0.53187,HP_CLINODACTYLY_OF_THE_2ND_FINGER,0.99999
MODULE_97,SET,88,-0.0069573,-0.0004805,0.086862,0.53192,MODULE_97,0.99999
CHANDRAN_METASTASIS_DN,SET,288,-0.004139,-0.0005143,0.051531,0.53201,CHANDRAN_METASTASIS_DN,0.99999
HP_HYPERNATREMIA,SET,8,-0.025631,-0.00053489,0.31911,0.53201,HP_HYPERNATREMIA,0.99999
HP_ABNORMAL_BASAL_GANGLIA_MR...,SET,35,-0.010895,-0.00047522,0.13561,0.53202,HP_ABNORMAL_BASAL_GANGLIA_MRI_SIGNAL_INTENSITY,0.99999
HP_ABNORMAL_PALMAR_DERMATOGL...,SET,226,-0.0043903,-0.00048408,0.054626,0.53203,HP_ABNORMAL_PALMAR_DERMATOGLYPHICS,0.99999
GOMF_PHOSPHATIDYLCHOLINE_TRA...2,SET,18,-0.016166,-0.00050592,0.20106,0.53204,GOMF_PHOSPHATIDYLCHOLINE_TRANSPORTER_ACTIVITY,0.99999
HP_OVERGROWTH_OF_EXTERNAL_GE...,SET,9,-0.026711,-0.00059124,0.33114,0.53215,HP_OVERGROWTH_OF_EXTERNAL_GENITALIA,0.99999
GSE22611_NOD2_TRANSD_VS_CTRL...4,SET,173,-0.0049257,-0.00047587,0.060946,0.53221,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP,0.99999
KANG_IMMORTALIZED_BY_TERT_UP,SET,82,-0.0079145,-0.00052773,0.09774,0.53227,KANG_IMMORTALIZED_BY_TERT_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...545,SET,14,-0.020476,-0.0005652,0.25254,0.53231,GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.99999
GOBP_SUBPALLIUM_DEVELOPMENT,SET,26,-0.014512,-0.0005457,0.17885,0.53233,GOBP_SUBPALLIUM_DEVELOPMENT,0.99999
GSE22025_UNTREATED_VS_TGFB1_...1,SET,174,-0.0052097,-0.00050475,0.064185,0.53234,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,0.99999
GSE3982_EFF_MEMORY_CD4_TCELL...6,SET,174,-0.0051641,-0.00050033,0.063586,0.53236,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP,0.99999
GOBP_REGULATION_OF_PROTEIN_D...4,SET,9,-0.020124,-0.00044544,0.24738,0.53242,GOBP_REGULATION_OF_PROTEIN_DEUBIQUITINATION,0.99999
REACTOME_MASTL_FACILITATES_M...,SET,10,-0.020643,-0.00048163,0.25352,0.53245,REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION,0.99999
GOCC_PYRUVATE_DEHYDROGENASE_...,SET,5,-0.034619,-0.00057121,0.42511,0.53245,GOCC_PYRUVATE_DEHYDROGENASE_COMPLEX,0.99999
REACTOME_NICOTINAMIDE_SALVAG...,SET,17,-0.016425,-0.00049954,0.20156,0.53247,REACTOME_NICOTINAMIDE_SALVAGING,0.99999
BIOCARTA_THELPER_PATHWAY,SET,12,-0.021863,-0.00055873,0.26825,0.53248,BIOCARTA_THELPER_PATHWAY,0.99999
ZNF597_TARGET_GENES,SET,606,-0.0027974,-0.00049975,0.034268,0.53253,ZNF597_TARGET_GENES,0.99999
GSE16522_ANTI_CD3CD28_STIM_V...2,SET,186,-0.0048895,-0.00048962,0.059901,0.53253,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP,0.99999
GSE36826_WT_VS_IL1R_KO_SKIN_...4,SET,179,-0.0052388,-0.00051473,0.06418,0.53253,GSE36826_WT_VS_IL1R_KO_SKIN_UP,0.99999
GOMF_BETA_GLUCOSIDASE_ACTIVI...,SET,5,-0.030992,-0.00051136,0.3792,0.53257,GOMF_BETA_GLUCOSIDASE_ACTIVITY,0.99999
HP_DUODENAL_ULCER,SET,12,-0.019778,-0.00050546,0.24174,0.5326,HP_DUODENAL_ULCER,0.99999
XU_RESPONSE_TO_TRETINOIN_UP,SET,13,-0.020588,-0.00054763,0.25129,0.53265,XU_RESPONSE_TO_TRETINOIN_UP,0.99999
GSE9006_1MONTH_VS_4MONTH_POS...1,SET,169,-0.0054299,-0.00051853,0.066241,0.53266,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN,0.99999
GSE17186_NAIVE_VS_CD21LOW_TR...3,SET,180,-0.0050831,-0.00050081,0.061939,0.5327,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN,0.99999
GSE9960_HEALTHY_VS_GRAM_NEG_...1,SET,163,-0.0052719,-0.00049452,0.064251,0.5327,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...445,SET,26,-0.013543,-0.00050928,0.16498,0.53271,GOBP_POSITIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.99999
GOBP_TYPE_B_PANCREATIC_CELL_...4,SET,23,-0.015571,-0.00055075,0.18952,0.53274,GOBP_TYPE_B_PANCREATIC_CELL_PROLIFERATION,0.99999
GSE5589_UNSTIM_VS_45MIN_LPS_...2,SET,182,-0.0050016,-0.00049548,0.060848,0.53275,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...294,SET,149,-0.0058858,-0.00052806,0.071599,0.53276,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,0.99999
WP_MOLYBDENUM_COFACTOR_MOCO_...,SET,6,-0.030298,-0.00054761,0.3684,0.53277,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...8,SET,187,-0.0050214,-0.00050417,0.060969,0.53282,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_UP,0.99999
WP_PATHOPHYSIOLOGICAL_ROLES_...,SET,15,-0.018814,-0.00053753,0.22827,0.53284,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,0.99999
RP58_01,SET,191,-0.0051901,-0.0005266,0.062914,0.53287,RP58_01,0.99999
GOBP_SMOOTH_MUSCLE_CONTRACTI...,SET,104,-0.0071708,-0.00053815,0.086905,0.53288,GOBP_SMOOTH_MUSCLE_CONTRACTION,0.99999
GOBP_T_CELL_EXTRAVASATION,SET,11,-0.022142,-0.00054179,0.26798,0.53292,GOBP_T_CELL_EXTRAVASATION,0.99999
REACTOME_TRANSPORT_OF_NUCLEO...1,SET,10,-0.021949,-0.00051209,0.2651,0.53299,REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE,0.99999
QI_PBMC_ZOSTAVAX_AGE_50_75YO...3,SET,158,-0.0052668,-0.00048646,0.063606,0.533,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGATIVE,0.99999
MYCMAX_B,SET,245,-0.0045159,-0.00051815,0.054455,0.53305,MYCMAX_B,0.99999
MATHEW_FANCONI_ANEMIA_GENES,SET,10,-0.019042,-0.00044426,0.22951,0.53306,MATHEW_FANCONI_ANEMIA_GENES,0.99999
GSE2405_0H_VS_1.5H_A_PHAGOCY...2,SET,188,-0.0052788,-0.00053142,0.063612,0.53307,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.99999
GOBP_INSULIN_SECRETION,SET,187,-0.0052502,-0.00052714,0.063235,0.53308,GOBP_INSULIN_SECRETION,0.99999
BAFNA_MUC4_TARGETS_UP,SET,3,-0.040693,-0.00052011,0.48994,0.5331,BAFNA_MUC4_TARGETS_UP,0.99999
HP_VOCAL_CORD_PARESIS,SET,14,-0.01929,-0.00053246,0.23218,0.53311,HP_VOCAL_CORD_PARESIS,0.99999
GOBP_LEUKOTRIENE_METABOLIC_P...,SET,29,-0.013914,-0.00055255,0.16728,0.53315,GOBP_LEUKOTRIENE_METABOLIC_PROCESS,0.99999
HOEBEKE_LYMPHOID_STEM_CELL_DN,SET,82,-0.0079983,-0.00053331,0.095996,0.5332,HOEBEKE_LYMPHOID_STEM_CELL_DN,0.99999
GSE8868_SPLEEN_VS_INTESTINE_...1,SET,178,-0.0051962,-0.00050914,0.062357,0.53321,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN,0.99999
GOBP_INTERLEUKIN_17_MEDIATED...,SET,11,-0.022969,-0.00056203,0.27472,0.53332,GOBP_INTERLEUKIN_17_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_GOLGI_TO_ENDOSOME_TRANS...,SET,15,-0.01602,-0.0004577,0.19111,0.5334,GOBP_GOLGI_TO_ENDOSOME_TRANSPORT,0.99999
AGTCTAG_MIR151,SET,20,-0.015723,-0.00051863,0.18747,0.53342,AGTCTAG_MIR151,0.99999
HP_UNSTEADY_GAIT,SET,169,-0.0053817,-0.00051393,0.064159,0.53342,HP_UNSTEADY_GAIT,0.99999
MORF_MYL3,SET,63,-0.0091549,-0.00053534,0.10911,0.53343,MORF_MYL3,0.99999
MIR363_5P,SET,65,-0.0087451,-0.0005194,0.10422,0.53344,MIR363_5P,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...78,SET,27,-0.01267,-0.00048551,0.15069,0.5335,HP_APLASIA_HYPOPLASIA_OF_THE_UVULA,0.99999
GOBP_DISTAL_TUBULE_DEVELOPME...,SET,11,-0.023897,-0.00058474,0.28396,0.53353,GOBP_DISTAL_TUBULE_DEVELOPMENT,0.99999
REACTOME_ACYL_CHAIN_REMODELI...2,SET,5,-0.033636,-0.00055498,0.39917,0.53358,REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG,0.99999
MIR3617_5P,SET,232,-0.0046675,-0.00052134,0.055283,0.53364,MIR3617_5P,0.99999
MIR323A_3P,SET,206,-0.0049968,-0.00052629,0.059048,0.53372,MIR323A_3P,0.99999
GOBP_TYPE_B_PANCREATIC_CELL_...3,SET,27,-0.014804,-0.00056729,0.17492,0.53372,GOBP_TYPE_B_PANCREATIC_CELL_DIFFERENTIATION,0.99999
REACTOME_INTERLEUKIN_3_INTER...,SET,43,-0.011528,-0.00055724,0.13621,0.53373,REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,0.99999
DAZARD_UV_RESPONSE_CLUSTER_G3,SET,13,-0.019809,-0.00052689,0.23383,0.53376,DAZARD_UV_RESPONSE_CLUSTER_G3,0.99999
MIR4308,SET,133,-0.0061965,-0.00052547,0.073128,0.53376,MIR4308,0.99999
HP_EPIRETINAL_MEMBRANE,SET,12,-0.021308,-0.00054455,0.25096,0.53383,HP_EPIRETINAL_MEMBRANE,0.99999
ALX4_TARGET_GENES,SET,23,-0.015927,-0.00056335,0.1875,0.53385,ALX4_TARGET_GENES,0.99999
GOMF_SIGNAL_RECOGNITION_PART...,SET,7,-0.021956,-0.00042862,0.25826,0.53387,GOMF_SIGNAL_RECOGNITION_PARTICLE_BINDING,0.99999
REACTOME_PEPTIDE_HORMONE_MET...,SET,81,-0.0083225,-0.00055156,0.097678,0.53395,REACTOME_PEPTIDE_HORMONE_METABOLISM,0.99999
GSE26669_CD4_VS_CD8_TCELL_IN...1,SET,189,-0.0053492,-0.00053991,0.062746,0.53397,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN,0.99999
KAECH_DAY15_EFF_VS_MEMORY_CD...2,SET,186,-0.0052783,-0.00052855,0.061883,0.53399,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP,0.99999
GSE12845_IGD_NEG_BLOOD_VS_DA...1,SET,182,-0.0049724,-0.0004926,0.058167,0.53406,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.99999
GSE16451_CTRL_VS_WEST_EQUINE...1,SET,177,-0.0052196,-0.00051001,0.061028,0.53408,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,0.99999
HP_NEPHRONOPHTHISIS,SET,35,-0.011742,-0.00051215,0.13722,0.53409,HP_NEPHRONOPHTHISIS,0.99999
GSE3039_CD4_TCELL_VS_ALPHABE...2,SET,174,-0.0054928,-0.00053218,0.064081,0.53415,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP,0.99999
GSE40443_INDUCED_VS_TOTAL_TR...1,SET,179,-0.0054008,-0.00053065,0.063015,0.53415,GSE40443_INDUCED_VS_TOTAL_TREG_DN,0.99999
REACTOME_SPHINGOLIPID_CATABO...,SET,9,-0.022637,-0.00050106,0.26406,0.53416,REACTOME_SPHINGOLIPID_CATABOLISM,0.99999
TASOR_TARGET_GENES,SET,209,-0.0050805,-0.00053895,0.059257,0.53416,TASOR_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...449,SET,38,-0.011374,-0.0005169,0.13241,0.53423,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PERMEABILITY,0.99999
PEART_HDAC_PROLIFERATION_CLU...1,SET,68,-0.008575,-0.00052088,0.099487,0.53434,PEART_HDAC_PROLIFERATION_CLUSTER_DN,0.99999
GOBP_HEART_FORMATION,SET,31,-0.014725,-0.00060453,0.17087,0.53434,GOBP_HEART_FORMATION,0.99999
GSE7831_CPG_VS_INFLUENZA_STI...4,SET,175,-0.005519,-0.00053623,0.064015,0.53435,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_UP,0.99999
GSE29618_LAIV_VS_TIV_FLU_VAC...4,SET,179,-0.0055425,-0.00054458,0.064244,0.53437,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP,0.99999
XU_GH1_EXOGENOUS_TARGETS_DN,SET,90,-0.0075559,-0.00052771,0.087572,0.53438,XU_GH1_EXOGENOUS_TARGETS_DN,0.99999
GOCC_OXIDOREDUCTASE_COMPLEX,SET,102,-0.0064267,-0.00047767,0.074447,0.5344,GOCC_OXIDOREDUCTASE_COMPLEX,0.99999
SRF_Q4,SET,202,-0.0053066,-0.00055353,0.061435,0.53442,SRF_Q4,0.99999
WP_GLYCEROLIPIDS_AND_GLYCERO...,SET,21,-0.01585,-0.00053573,0.18333,0.53445,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,0.99999
GSE34515_CD16_NEG_VS_POS_MON...1,SET,163,-0.0055819,-0.00052359,0.064515,0.53447,GSE34515_CD16_NEG_VS_POS_MONOCYTE_DN,0.99999
GSE17721_12H_VS_24H_PAM3CSK4...2,SET,180,-0.0053267,-0.00052481,0.0615,0.53451,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_UP,0.99999
GOBP_DNA_STRAND_ELONGATION,SET,35,-0.011826,-0.00051584,0.13652,0.53452,GOBP_DNA_STRAND_ELONGATION,0.99999
GOMF_COENZYME_A_DIPHOSPHATAS...,SET,5,-0.031266,-0.00051588,0.36088,0.53452,GOMF_COENZYME_A_DIPHOSPHATASE_ACTIVITY,0.99999
HFH3_01,SET,176,-0.0056765,-0.00055309,0.065455,0.53455,HFH3_01,0.99999
REACTOME_GLYCOGEN_STORAGE_DI...,SET,13,-0.02013,-0.00053545,0.23207,0.53456,REACTOME_GLYCOGEN_STORAGE_DISEASES,0.99999
WP_MBDNF_AND_PROBDNF_REGULAT...,SET,35,-0.013953,-0.00060859,0.16086,0.53456,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,0.99999
GOBP_SYNAPTIC_VESICLE_ENDOSO...,SET,8,-0.024554,-0.00051242,0.28273,0.5346,GOBP_SYNAPTIC_VESICLE_ENDOSOMAL_PROCESSING,0.99999
MODULE_118,SET,366,-0.0039164,-0.00054741,0.045014,0.53467,MODULE_118,0.99999
KYNG_NORMAL_AGING_UP,SET,13,-0.019987,-0.00053164,0.22961,0.53468,KYNG_NORMAL_AGING_UP,0.99999
ASTIER_INTEGRIN_SIGNALING,SET,54,-0.010663,-0.00057743,0.12241,0.53471,ASTIER_INTEGRIN_SIGNALING,0.99999
REACTOME_INTERLEUKIN_10_SIGN...,SET,43,-0.012514,-0.0006049,0.14362,0.53472,REACTOME_INTERLEUKIN_10_SIGNALING,0.99999
GOBP_RESPONSE_TO_XENOBIOTIC_...,SET,417,-0.0037794,-0.00056306,0.043354,0.53473,GOBP_RESPONSE_TO_XENOBIOTIC_STIMULUS,0.99999
WP_CAMKK2_PATHWAY,SET,32,-0.013423,-0.0005599,0.15364,0.53481,WP_CAMKK2_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...457,SET,14,-0.017709,-0.00048881,0.20262,0.53482,GOBP_POSITIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE,0.99999
GOMF_INTRACILIARY_TRANSPORT_...,SET,2,-0.04898,-0.00051117,0.55976,0.53486,GOMF_INTRACILIARY_TRANSPORT_PARTICLE_B_BINDING,0.99999
GOBP_REGULATION_OF_PROTEOLYS...2,SET,196,-0.0052211,-0.00053655,0.059648,0.53487,GOBP_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_M...2,SET,14,-0.018558,-0.00051226,0.21182,0.53491,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_MRNA_3_END_PROCESSING,SET,36,-0.011116,-0.00049174,0.12671,0.53495,GOBP_MRNA_3_END_PROCESSING,0.99999
GSE37301_MULTIPOTENT_PROGENI...3,SET,186,-0.005241,-0.00052482,0.059734,0.53496,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN,0.99999
MIR3663_3P,SET,134,-0.0061768,-0.00052575,0.070356,0.53498,MIR3663_3P,0.99999
CCANNAGRKGGC_UNKNOWN,SET,106,-0.0071364,-0.00054066,0.081256,0.53499,CCANNAGRKGGC_UNKNOWN,0.99999
GOMF_TUMOR_NECROSIS_FACTOR_R...2,SET,28,-0.014967,-0.00058405,0.17038,0.535,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...202,SET,4,-0.04154,-0.00061305,0.47247,0.53503,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,0.99999
SEKI_INFLAMMATORY_RESPONSE_L...2,SET,72,-0.00974,-0.00060873,0.11072,0.53505,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,0.99999
GOBP_SENSORY_ORGAN_MORPHOGEN...,SET,261,-0.0049297,-0.00058356,0.056037,0.53505,GOBP_SENSORY_ORGAN_MORPHOGENESIS,0.99999
HP_ABDOMINAL_COLIC,SET,5,-0.0377,-0.00062204,0.42762,0.53513,HP_ABDOMINAL_COLIC,0.99999
GOCC_NUCLEAR_RNA_EXPORT_FACT...,SET,2,-0.040294,-0.00042051,0.45645,0.53517,GOCC_NUCLEAR_RNA_EXPORT_FACTOR_COMPLEX,0.99999
HP_DEPRESSED_NASAL_RIDGE,SET,112,-0.0069481,-0.000541,0.07872,0.53517,HP_DEPRESSED_NASAL_RIDGE,0.99999
GOCC_INCLUSION_BODY,SET,66,-0.0086853,-0.00051979,0.098321,0.53519,GOCC_INCLUSION_BODY,0.99999
GSE6674_UNSTIM_VS_PL2_3_STIM...1,SET,152,-0.0057674,-0.00052258,0.065187,0.53525,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_DN,0.99999
GOCC_CUL4A_RING_E3_UBIQUITIN...,SET,12,-0.021756,-0.00055602,0.24574,0.53527,GOCC_CUL4A_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.99999
LAKE_ADULT_KIDNEY_C5_PROXIMA...,SET,359,-0.0040397,-0.00055932,0.045595,0.5353,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,0.99999
DASU_IL6_SIGNALING_SCAR_UP,SET,30,-0.01379,-0.00055695,0.15558,0.53531,DASU_IL6_SIGNALING_SCAR_UP,0.99999
TAXCREB_02,SET,25,-0.015021,-0.0005539,0.16922,0.53537,TAXCREB_02,0.99999
GSE25088_CTRL_VS_IL4_AND_ROS...1,SET,170,-0.0057341,-0.00054919,0.064553,0.53539,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.99999
GSE9960_HEALTHY_VS_GRAM_POS_...2,SET,165,-0.0054563,-0.00051491,0.061249,0.53549,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_UP,0.99999
GSE1112_OT1_VS_HY_CD8AB_THYM...1,SET,177,-0.0054718,-0.00053464,0.061272,0.53558,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_DN,0.99999
GSE360_DC_VS_MAC_B_MALAYI_HI...2,SET,181,-0.0054717,-0.00054058,0.061266,0.53558,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...4,SET,37,-0.012423,-0.00055712,0.13903,0.5356,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_UP,0.99999
GSE15330_WT_VS_IKAROS_KO_GRA...1,SET,185,-0.005522,-0.00055148,0.061779,0.53561,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.99999
DESCARTES_MAIN_FETAL_SMOOTH_...,SET,37,-0.012697,-0.00056939,0.14205,0.53561,DESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS,0.99999
GOBP_FUCOSE_CATABOLIC_PROCESS,SET,9,-0.029439,-0.00065162,0.32907,0.53564,GOBP_FUCOSE_CATABOLIC_PROCESS,0.99999
HP_ABNORMAL_INTERNAL_CAROTID...,SET,10,-0.026388,-0.00061567,0.29448,0.5357,HP_ABNORMAL_INTERNAL_CAROTID_ARTERY_MORPHOLOGY,0.99999
GSE39152_BRAIN_VS_SPLEEN_CD1...1,SET,186,-0.0053854,-0.00053928,0.060045,0.53573,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN,0.99999
REACTOME_NEUROTRANSMITTER_RE...2,SET,47,-0.01224,-0.0006185,0.1363,0.53578,REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE,0.99999
GOBP_REGULATION_OF_DENDRITIC...2,SET,10,-0.025235,-0.00058875,0.28089,0.53579,GOBP_REGULATION_OF_DENDRITIC_CELL_CHEMOTAXIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...269,SET,47,-0.011932,-0.00060291,0.13271,0.53582,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GSE3982_BCELL_VS_EFF_MEMORY_...2,SET,171,-0.0056632,-0.00054398,0.062944,0.53584,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...776,SET,4,-0.043795,-0.00064634,0.48623,0.53588,GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.99999
REACTOME_ROLE_OF_PHOSPHOLIPI...,SET,23,-0.01595,-0.00056415,0.17671,0.53596,REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS,0.99999
MIR33B_3P,SET,60,-0.0098078,-0.00055974,0.1086,0.53598,MIR33B_3P,0.99999
GOZGIT_ESR1_TARGETS_UP,SET,130,-0.0069309,-0.00058113,0.07673,0.53599,GOZGIT_ESR1_TARGETS_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...21,SET,28,-0.014717,-0.00057426,0.16262,0.53605,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...85,SET,28,-0.014717,-0.00057426,0.16262,0.53605,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY,0.99999
GOBP_ESTABLISHMENT_OF_SPINDL...,SET,42,-0.011705,-0.00055917,0.12918,0.5361,GOBP_ESTABLISHMENT_OF_SPINDLE_ORIENTATION,0.99999
TRAVAGLINI_LUNG_MYOFIBROBLAS...,SET,60,-0.010712,-0.00061135,0.11784,0.53622,TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL,0.99999
GOMF_PLATELET_DERIVED_GROWTH...1,SET,11,-0.02715,-0.00066435,0.29846,0.53624,GOMF_PLATELET_DERIVED_GROWTH_FACTOR_BINDING,0.99999
HP_ABNORMAL_CIRCULATING_FREE...3,SET,7,-0.025639,-0.00050052,0.28177,0.53625,HP_ABNORMAL_CIRCULATING_FREE_T4_CONCENTRATION,0.99999
HP_ANGIOID_STREAKS_OF_THE_FU...,SET,10,-0.02287,-0.00053357,0.2512,0.53627,HP_ANGIOID_STREAKS_OF_THE_FUNDUS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...72,SET,5,-0.031459,-0.00051907,0.34545,0.53628,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ERBB4_TO_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,0.99999
DESCARTES_FETAL_MUSCLE_SKELE...,SET,181,-0.0058183,-0.00057482,0.063887,0.53628,DESCARTES_FETAL_MUSCLE_SKELETAL_MUSCLE_CELLS,0.99999
GOBP_N_TERMINAL_PROTEIN_AMIN...2,SET,24,-0.015163,-0.00054786,0.16633,0.53632,GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,0.99999
GOBP_INTRACELLULAR_GLUCOSE_H...,SET,142,-0.0066106,-0.0005791,0.072472,0.53634,GOBP_INTRACELLULAR_GLUCOSE_HOMEOSTASIS,0.99999
MORF_PPP2R5E,SET,72,-0.0081461,-0.00050911,0.089214,0.53638,MORF_PPP2R5E,0.99999
HP_DELAYED_MYELINATION,SET,245,-0.0047358,-0.00054339,0.051845,0.53639,HP_DELAYED_MYELINATION,0.99999
HP_MALIGNANT_GASTROINTESTINA...,SET,70,-0.0089508,-0.00055161,0.097985,0.53639,HP_MALIGNANT_GASTROINTESTINAL_TRACT_TUMORS,0.99999
GOBP_AORTA_SMOOTH_MUSCLE_TIS...,SET,4,-0.038666,-0.00057065,0.42274,0.53644,GOBP_AORTA_SMOOTH_MUSCLE_TISSUE_MORPHOGENESIS,0.99999
MIR6841_3P,SET,49,-0.010653,-0.00054961,0.11636,0.53647,MIR6841_3P,0.99999
GOBP_REGULATION_OF_MACROPHAG...1,SET,54,-0.011373,-0.00061585,0.12424,0.53647,GOBP_REGULATION_OF_MACROPHAGE_ACTIVATION,0.99999
TATTATA_MIR374,SET,265,-0.0049928,-0.00059547,0.054501,0.53649,TATTATA_MIR374,0.99999
GSE23568_CTRL_VS_ID3_TRANSDU...1,SET,178,-0.0055785,-0.00054659,0.06084,0.53653,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_DN,0.99999
GOBP_GLUTATHIONE_CATABOLIC_P...,SET,7,-0.029436,-0.00057464,0.32064,0.53657,GOBP_GLUTATHIONE_CATABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...497,SET,17,-0.020833,-0.00063361,0.22697,0.53657,GOBP_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION,0.99999
GOBP_REGULATION_OF_CELL_COMM...2,SET,12,-0.025793,-0.00065917,0.28096,0.53657,GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION,0.99999
MODULE_22,SET,31,-0.011565,-0.00047478,0.12586,0.5366,MODULE_22,0.99999
DESCARTES_MAIN_FETAL_IGFBP1_...,SET,128,-0.0070935,-0.0005902,0.0771,0.53665,DESCARTES_MAIN_FETAL_IGFBP1_DKK1_POSITIVE_CELLS,0.99999
GOBP_METANEPHRIC_MESENCHYMAL...,SET,5,-0.040619,-0.00067021,0.44103,0.53669,GOBP_METANEPHRIC_MESENCHYMAL_CELL_DIFFERENTIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...335,SET,5,-0.033492,-0.00055261,0.36297,0.53676,GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.99999
GSE40273_EOS_KO_VS_WT_TREG_UP,SET,181,-0.0057052,-0.00056365,0.061825,0.53676,GSE40273_EOS_KO_VS_WT_TREG_UP,0.99999
GOBP_PRO_B_CELL_DIFFERENTIAT...,SET,12,-0.023356,-0.00059691,0.25302,0.53677,GOBP_PRO_B_CELL_DIFFERENTIATION,0.99999
SANA_TNF_SIGNALING_DN,SET,74,-0.0094761,-0.00060037,0.10261,0.53679,SANA_TNF_SIGNALING_DN,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...14,SET,26,-0.018034,-0.00067815,0.19523,0.5368,BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,0.99999
HP_INCREASED_MEGAKARYOCYTE_C...,SET,7,-0.027929,-0.00054523,0.30221,0.53682,HP_INCREASED_MEGAKARYOCYTE_COUNT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...274,SET,7,-0.028032,-0.00054723,0.30319,0.53683,GOBP_NEGATIVE_REGULATION_OF_HEPATOCYTE_APOPTOTIC_PROCESS,0.99999
HP_PARONYCHIA,SET,16,-0.020382,-0.00060141,0.22029,0.53686,HP_PARONYCHIA,0.99999
REACTOME_IRF3_MEDIATED_INDUC...,SET,11,-0.020023,-0.00048994,0.21615,0.5369,REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN,0.99999
MIR4650_3P,SET,119,-0.0073722,-0.00059157,0.079585,0.5369,MIR4650_3P,0.99999
GOBP_COCHLEA_DEVELOPMENT,SET,48,-0.012201,-0.00062301,0.1317,0.5369,GOBP_COCHLEA_DEVELOPMENT,0.99999
GOBP_PLASMA_MEMBRANE_RAFT_OR...,SET,11,-0.023931,-0.00058558,0.2583,0.53691,GOBP_PLASMA_MEMBRANE_RAFT_ORGANIZATION,0.99999
GOBP_TYPE_B_PANCREATIC_CELL_...1,SET,10,-0.028063,-0.00065475,0.30166,0.53706,GOBP_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS,0.99999
HP_HISTIOCYTOSIS,SET,6,-0.033894,-0.00061261,0.36437,0.53706,HP_HISTIOCYTOSIS,0.99999
GOMF_CARBOHYDRATE_DERIVATIVE...,SET,54,-0.011211,-0.0006071,0.12048,0.53707,GOMF_CARBOHYDRATE_DERIVATIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE37533_UNTREATED_VS_PIOGLI...5,SET,144,-0.0063,-0.00055573,0.067614,0.53712,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN,0.99999
MATZUK_MALE_REPRODUCTION_SER...,SET,25,-0.016238,-0.00059877,0.17423,0.53713,MATZUK_MALE_REPRODUCTION_SERTOLI,0.99999
GOMF_HISTONE_DECROTONYLASE_A...,SET,4,-0.037899,-0.00055932,0.40624,0.53716,GOMF_HISTONE_DECROTONYLASE_ACTIVITY,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...4,SET,183,-0.0058224,-0.00057837,0.062413,0.53716,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP,0.99999
GOBP_REGULATION_OF_MEIOTIC_N...,SET,32,-0.013888,-0.00057927,0.14874,0.53719,GOBP_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.99999
WP_DEVELOPMENT_OF_PULMONARY_...,SET,13,-0.022007,-0.00058536,0.23561,0.53721,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,0.99999
NABA_SECRETED_FACTORS,SET,318,-0.005128,-0.00066899,0.054831,0.53726,NABA_SECRETED_FACTORS,0.99999
SRY_01,SET,210,-0.0056062,-0.00059612,0.059918,0.53727,SRY_01,0.99999
GOBP_INTERLEUKIN_4_MEDIATED_...,SET,9,-0.02505,-0.00055447,0.26773,0.53727,GOBP_INTERLEUKIN_4_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_CELLULAR_...6,SET,121,-0.0071859,-0.00058142,0.076786,0.53728,GOBP_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS,0.99999
HP_STATUS_EPILEPTICUS,SET,182,-0.0058828,-0.00058279,0.062831,0.5373,HP_STATUS_EPILEPTICUS,0.99999
HP_ABNORMALITY_OF_LENS_SHAPE,SET,15,-0.02119,-0.00060542,0.22584,0.53738,HP_ABNORMALITY_OF_LENS_SHAPE,0.99999
GSE23321_CENTRAL_VS_EFFECTOR...2,SET,181,-0.0059261,-0.00058547,0.063088,0.53742,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,0.99999
RNTCANNRNNYNATTW_UNKNOWN,SET,58,-0.010772,-0.00060446,0.11453,0.53747,RNTCANNRNNYNATTW_UNKNOWN,0.99999
GOBP_SPHINGOSINE_1_PHOSPHATE...,SET,15,-0.021224,-0.00060638,0.22495,0.53758,GOBP_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_VERTEBRAL_CLEFTING,SET,35,-0.013513,-0.0005894,0.14303,0.53763,HP_VERTEBRAL_CLEFTING,0.99999
GOBP_POSITIVE_REGULATION_OF_...58,SET,48,-0.012118,-0.00061879,0.12822,0.53765,GOBP_POSITIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.99999
GOBP_CYCLIC_GMP_AMP_TRANSMEM...,SET,8,-0.031101,-0.00064904,0.32895,0.53766,GOBP_CYCLIC_GMP_AMP_TRANSMEMBRANE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOCC_DENDRITIC_GROWTH_CONE,SET,7,-0.02754,-0.00053764,0.29128,0.53766,GOCC_DENDRITIC_GROWTH_CONE,0.99999
REACTOME_SPHINGOLIPID_DE_NOV...,SET,36,-0.013371,-0.0005915,0.14138,0.53767,REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS,0.99999
MIR9_3P,SET,308,-0.0046173,-0.00059298,0.04875,0.53773,MIR9_3P,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...49,SET,71,-0.009725,-0.00060357,0.10259,0.53776,GOBP_PROTEIN_LOCALIZATION_TO_SYNAPSE,0.99999
GSE24634_IL4_VS_CTRL_TREATED...2,SET,174,-0.0062633,-0.00060683,0.065938,0.53784,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP,0.99999
TTGGGAG_MIR150,SET,82,-0.0086105,-0.00057414,0.090611,0.53785,TTGGGAG_MIR150,0.99999
HP_RECTAL_FISTULA,SET,23,-0.016707,-0.00059093,0.17579,0.53786,HP_RECTAL_FISTULA,0.99999
GOBP_REGULATION_OF_ATRIAL_CA...2,SET,5,-0.037434,-0.00061765,0.39375,0.53787,GOBP_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.99999
GSE40274_CTRL_VS_FOXP3_AND_L...2,SET,153,-0.0068852,-0.00062589,0.072424,0.53787,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...133,SET,70,-0.011244,-0.00069292,0.11802,0.53795,GOBP_POSITIVE_REGULATION_OF_CELL_KILLING,0.99999
GOCC_OUTER_MEMBRANE,SET,207,-0.0054846,-0.00057906,0.057529,0.53798,GOCC_OUTER_MEMBRANE,0.99999
GOBP_CELLULAR_RESPONSE_TO_TO...1,SET,95,-0.0080623,-0.00057842,0.084533,0.53799,GOBP_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,0.99999
HP_ABNORMAL_CIRCULATING_GONA...,SET,110,-0.0076485,-0.00059023,0.080017,0.53807,HP_ABNORMAL_CIRCULATING_GONADOTROPIN_CONCENTRATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...504,SET,9,-0.028475,-0.00063028,0.29773,0.5381,GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.99999
NAKAYA_MYELOID_DENDRITIC_CEL...4,SET,337,-0.0042934,-0.0005763,0.044824,0.53815,NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP,0.99999
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...6,SET,113,-0.0076828,-0.00060085,0.080203,0.53816,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GTE_200_VS_LTE_200_1DY_UP,0.99999
WAKASUGI_HAVE_ZNF143_BINDING...,SET,51,-0.0094169,-0.00049561,0.098188,0.5382,WAKASUGI_HAVE_ZNF143_BINDING_SITES,0.99999
HP_INTRAMUSCULAR_HEMATOMA,SET,7,-0.03212,-0.00062703,0.33448,0.53825,HP_INTRAMUSCULAR_HEMATOMA,0.99999
GSE1112_HY_CD8AB_VS_HY_CD8AA...2,SET,160,-0.0064243,-0.00059709,0.06686,0.53827,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,0.99999
GSE32423_IL7_VS_IL7_IL4_MEMO...2,SET,188,-0.0058084,-0.00058473,0.060415,0.5383,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,0.99999
UNTERMAN_IPF_VS_CTRL_NK_CELL...1,SET,8,-0.032042,-0.00066868,0.33301,0.53833,UNTERMAN_IPF_VS_CTRL_NK_CELL_DN,0.99999
GOBP_PHOSPHATIDYLINOSITOL_ME...2,SET,147,-0.0063219,-0.00056339,0.065695,0.53833,GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS,0.99999
LAKE_ADULT_KIDNEY_C21_COLLEC...,SET,98,-0.0087474,-0.00063736,0.090871,0.53834,LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B,0.99999
RAHMAN_TP53_TARGETS_PHOSPHOR...,SET,19,-0.017754,-0.00057081,0.18428,0.53838,RAHMAN_TP53_TARGETS_PHOSPHORYLATED,0.99999
GSE7764_NKCELL_VS_SPLENOCYTE...2,SET,184,-0.0061966,-0.0006172,0.064263,0.53841,GSE7764_NKCELL_VS_SPLENOCYTE_UP,0.99999
REACTOME_NEGATIVE_REGULATION...8,SET,19,-0.018809,-0.00060474,0.19484,0.53845,REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,0.99999
MIR197_3P,SET,90,-0.0083002,-0.00057969,0.085995,0.53845,MIR197_3P,0.99999
GSE339_CD4POS_VS_CD4CD8DN_DC...3,SET,185,-0.0058983,-0.00058907,0.061033,0.53849,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,0.99999
GNF2_HAT1,SET,45,-0.011776,-0.00058227,0.12173,0.53853,GNF2_HAT1,0.99999
HP_CONSTIPATION,SET,388,-0.0042335,-0.00060888,0.043744,0.53855,HP_CONSTIPATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...480,SET,17,-0.01827,-0.00055568,0.18869,0.53857,GOBP_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION,0.99999
TOOKER_GEMCITABINE_RESISTANC...2,SET,73,-0.0096758,-0.00060889,0.099879,0.53859,TOOKER_GEMCITABINE_RESISTANCE_UP,0.99999
WP_CELLULAR_PROTEOSTASIS,SET,5,-0.02834,-0.00046761,0.29248,0.5386,WP_CELLULAR_PROTEOSTASIS,0.99999
MIR139_5P,SET,145,-0.0068647,-0.00060762,0.070721,0.53866,MIR139_5P,0.99999
chr5p15,SET,52,-0.019779,-0.0010511,0.20354,0.53871,chr5p15,0.99999
MIR3929,SET,73,-0.0094114,-0.00059225,0.096758,0.53874,MIR3929,0.99999
KEGG_VIBRIO_CHOLERAE_INFECTI...,SET,50,-0.012161,-0.00063376,0.12486,0.53879,KEGG_VIBRIO_CHOLERAE_INFECTION,0.99999
MODULE_308,SET,63,-0.0099878,-0.00058404,0.10241,0.53884,MODULE_308,0.99999
REACTOME_DOWNSTREAM_SIGNAL_T...,SET,29,-0.015096,-0.00059947,0.15466,0.53888,REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...413,SET,23,-0.018389,-0.00065043,0.18823,0.53891,GOBP_POSITIVE_REGULATION_OF_LIPID_STORAGE,0.99999
SP3_Q3,SET,211,-0.0057095,-0.00060853,0.058416,0.53893,SP3_Q3,0.99999
KEGG_MEDICUS_PATHOGEN_HPV_E5...1,SET,6,-0.038721,-0.00069984,0.39588,0.53896,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.99999
KEGG_MEDICUS_PATHOGEN_KSHV_M...1,SET,6,-0.038721,-0.00069984,0.39588,0.53896,KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.99999
MIR216B_5P,SET,85,-0.0090172,-0.00061211,0.092175,0.53896,MIR216B_5P,0.99999
GSE16385_UNTREATED_VS_12H_RO...5,SET,165,-0.0064569,-0.00060933,0.06595,0.539,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,0.99999
GOBP_APICAL_JUNCTION_ASSEMBLY,SET,71,-0.010184,-0.00063208,0.10392,0.53903,GOBP_APICAL_JUNCTION_ASSEMBLY,0.99999
MIR142_5P,SET,315,-0.0046504,-0.00060387,0.047435,0.53905,MIR142_5P,0.99999
GOBP_ADP_TRANSPORT,SET,10,-0.02732,-0.0006374,0.2784,0.53908,GOBP_ADP_TRANSPORT,0.99999
REACTOME_OTHER_INTERLEUKIN_S...,SET,24,-0.017022,-0.00061503,0.1734,0.5391,REACTOME_OTHER_INTERLEUKIN_SIGNALING,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...24,SET,43,-0.013132,-0.00063476,0.13358,0.53916,GAVISH_3CA_MALIGNANT_METAPROGRAM_32_SKIN_PIGMENTATION,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...7,SET,414,-0.0039278,-0.00058312,0.039905,0.5392,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE,0.99999
MIR6854_3P,SET,10,-0.029033,-0.00067736,0.29494,0.53921,MIR6854_3P,0.99999
GOBP_APOPTOTIC_PROCESS_IN_BO...,SET,5,-0.040629,-0.00067038,0.41252,0.53923,GOBP_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL,0.99999
RICHERT_PBMC_HIV_LIPO_5_AGE_...1,SET,8,-0.045079,-0.00094075,0.45754,0.53924,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_0W_14W_METALLOTHIONEIN_SUBSET_UP,0.99999
GOBP_G2_MI_TRANSITION_OF_MEI...,SET,6,-0.029437,-0.00053204,0.29828,0.53931,GOBP_G2_MI_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.99999
GOBP_COPPER_ION_IMPORT,SET,6,-0.03223,-0.00058253,0.32646,0.53932,GOBP_COPPER_ION_IMPORT,0.99999
GOBP_RIBOSOMAL_LARGE_SUBUNIT...1,SET,19,-0.017318,-0.00055681,0.17531,0.53935,GOBP_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY,0.99999
GOBP_SALIVA_SECRETION,SET,13,-0.025887,-0.00068858,0.26181,0.53938,GOBP_SALIVA_SECRETION,0.99999
MIR6868_3P,SET,241,-0.0055405,-0.00063058,0.055949,0.53944,MIR6868_3P,0.99999
HP_ABNORMAL_BLOOD_VESSEL_MOR...,SET,854,-0.0029394,-0.00061901,0.029653,0.53948,HP_ABNORMAL_BLOOD_VESSEL_MORPHOLOGY,0.99999
GOBP_PROTEIN_INSERTION_INTO_...2,SET,9,-0.026192,-0.00057973,0.26412,0.5395,GOBP_PROTEIN_INSERTION_INTO_ER_MEMBRANE_BY_STOP_TRANSFER_MEMBRANE_ANCHOR_SEQUENCE,0.99999
chr17p11,SET,61,-0.018465,-0.0010625,0.1861,0.53952,chr17p11,0.99999
GSE21063_3H_VS_16H_ANTI_IGM_...1,SET,168,-0.0060156,-0.00057278,0.060625,0.53952,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN,0.99999
GSE28737_FOLLICULAR_VS_MARGI...4,SET,185,-0.0057243,-0.00057169,0.057695,0.53952,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_UP,0.99999
GSE15659_NAIVE_CD4_TCELL_VS_...4,SET,160,-0.006354,-0.00059055,0.06398,0.53955,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,0.99999
GOBP_RESPONSE_TO_IMMOBILIZAT...,SET,25,-0.016135,-0.00059496,0.16217,0.53963,GOBP_RESPONSE_TO_IMMOBILIZATION_STRESS,0.99999
DARWICHE_SQUAMOUS_CELL_CARCI...2,SET,136,-0.0073532,-0.0006305,0.07388,0.53964,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,0.99999
HP_INCREASED_INTRAMYOCELLULA...,SET,18,-0.019925,-0.00062354,0.2002,0.53964,HP_INCREASED_INTRAMYOCELLULAR_LIPID_DROPLETS,0.99999
HP_ELEVATED_CIRCULATING_GLUT...,SET,6,-0.034371,-0.00062123,0.3448,0.5397,HP_ELEVATED_CIRCULATING_GLUTARIC_ACID_CONCENTRATION,0.99999
LY_AGING_MIDDLE_UP,SET,14,-0.026019,-0.00071819,0.26086,0.53972,LY_AGING_MIDDLE_UP,0.99999
GSE39820_TGFBETA1_IL6_VS_TGF...2,SET,185,-0.0060009,-0.00059932,0.060178,0.53972,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP,0.99999
MIR4515,SET,38,-0.014194,-0.00064505,0.1423,0.53973,MIR4515,0.99999
GOCC_ASTER,SET,10,-0.027165,-0.00063379,0.2722,0.53975,GOCC_ASTER,0.99999
GOMF_SULFURIC_ESTER_HYDROLAS...,SET,11,-0.026969,-0.0006599,0.26988,0.5398,GOMF_SULFURIC_ESTER_HYDROLASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_POSTSYNAP...3,SET,9,-0.028903,-0.00063975,0.28916,0.53981,GOBP_REGULATION_OF_POSTSYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.99999
HOXC13_TARGET_GENES,SET,95,-0.0084758,-0.00060809,0.084699,0.53985,HOXC13_TARGET_GENES,0.99999
MIR4633_5P,SET,38,-0.014456,-0.00065697,0.14439,0.53987,MIR4633_5P,0.99999
GOBP_NOREPINEPHRINE_UPTAKE,SET,8,-0.035974,-0.00075075,0.3593,0.53988,GOBP_NOREPINEPHRINE_UPTAKE,0.99999
GOBP_ATRIAL_SEPTUM_MORPHOGEN...,SET,13,-0.026569,-0.00070673,0.26513,0.53991,GOBP_ATRIAL_SEPTUM_MORPHOGENESIS,0.99999
HP_ABNORMAL_ANKLE_PHYSIOLOGY,SET,54,-0.011306,-0.00061226,0.11271,0.53995,HP_ABNORMAL_ANKLE_PHYSIOLOGY,0.99999
ZNF134_TARGET_GENES,SET,843,-0.0028965,-0.00060623,0.028866,0.53996,ZNF134_TARGET_GENES,0.99999
MIR4700_3P,SET,86,-0.0092713,-0.00063303,0.092255,0.54002,MIR4700_3P,0.99999
MIR487B_3P,SET,9,-0.029843,-0.00066055,0.29664,0.54007,MIR487B_3P,0.99999
GOBP_INTRACELLULAR_SPHINGOLI...,SET,5,-0.031345,-0.00051719,0.31153,0.54007,GOBP_INTRACELLULAR_SPHINGOLIPID_HOMEOSTASIS,0.99999
TURASHVILI_BREAST_NORMAL_DUC...1,SET,5,-0.036494,-0.00060214,0.36264,0.54008,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN,0.99999
HP_PRIMARY_CONGENITAL_GLAUCO...,SET,6,-0.036253,-0.00065525,0.36021,0.54008,HP_PRIMARY_CONGENITAL_GLAUCOMA,0.99999
GOBP_PROCESS_UTILIZING_AUTOP...,SET,541,-0.003545,-0.00059948,0.035152,0.54016,GOBP_PROCESS_UTILIZING_AUTOPHAGIC_MECHANISM,0.99999
GOBP_REGULATION_OF_PHOSPHOLI...8,SET,6,-0.035108,-0.00063454,0.34742,0.54025,GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSLOCATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...138,SET,852,-0.0031115,-0.00065452,0.030783,0.54026,GOBP_POSITIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION,0.99999
KEGG_HEDGEHOG_SIGNALING_PATH...,SET,54,-0.012184,-0.0006598,0.12032,0.54033,KEGG_HEDGEHOG_SIGNALING_PATHWAY,0.99999
PID_INTEGRIN_A4B1_PATHWAY,SET,32,-0.015151,-0.00063196,0.14955,0.54035,PID_INTEGRIN_A4B1_PATHWAY,0.99999
GSE2706_LPS_VS_R848_AND_LPS_...2,SET,146,-0.0069283,-0.00061535,0.068362,0.54036,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP,0.99999
RUIZ_TNC_TARGETS_UP,SET,137,-0.0080208,-0.00069025,0.079117,0.54037,RUIZ_TNC_TARGETS_UP,0.99999
GOBP_ASPARAGINE_METABOLIC_PR...,SET,5,-0.035512,-0.00058594,0.34972,0.54044,GOBP_ASPARAGINE_METABOLIC_PROCESS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...29,SET,607,-0.0035464,-0.00063407,0.03491,0.54046,HP_APLASIA_HYPOPLASIA_OF_THE_EXTREMITIES,0.99999
SCIBETTA_KDM5B_TARGETS_DN,SET,75,-0.0097437,-0.00062147,0.095792,0.54051,SCIBETTA_KDM5B_TARGETS_DN,0.99999
GSE14000_TRANSLATED_RNA_VS_M...4,SET,174,-0.0061094,-0.00059191,0.060032,0.54053,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP,0.99999
GOMF_MONOCARBOXYLIC_ACID_TRA...,SET,67,-0.010866,-0.0006552,0.10673,0.54055,GOMF_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_ABNORMAL_PROPORTION_OF_CD...1,SET,26,-0.016732,-0.0006292,0.1642,0.54058,HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_HELPER_T_CELLS,0.99999
GOBP_INTRACELLULAR_MONOATOMI...,SET,10,-0.029197,-0.0006812,0.28638,0.5406,GOBP_INTRACELLULAR_MONOATOMIC_ANION_HOMEOSTASIS,0.99999
GSE26928_NAIVE_VS_EFF_MEMORY...2,SET,156,-0.0068267,-0.00062658,0.06695,0.54061,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
ANDERSON_BLOOD_CN54GP140_ADJ...9,SET,5,-0.045874,-0.00075691,0.44863,0.54072,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_HIGH_IGM_RESPONDERS_3DY_7D_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_BI...,SET,232,-0.006021,-0.00067252,0.058732,0.54083,GOBP_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS,0.99999
GSE34006_WT_VS_A2AR_KO_TREG_...2,SET,183,-0.0064625,-0.00064195,0.062966,0.54087,GSE34006_WT_VS_A2AR_KO_TREG_UP,0.99999
MIKKELSEN_MEF_LCP_WITH_H3K4M...,SET,112,-0.008349,-0.00065008,0.081143,0.54097,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,0.99999
REACTOME_SUMOYLATION_OF_DNA_...3,SET,43,-0.012422,-0.00060046,0.12066,0.541,REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS,0.99999
GOCC_AXON,SET,601,-0.0037375,-0.00066504,0.036264,0.54104,GOCC_AXON,0.99999
KEGG_GLYCOSPHINGOLIPID_BIOSY...2,SET,13,-0.024893,-0.00066214,0.24104,0.54113,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES,0.99999
GSE37301_COMMON_LYMPHOID_PRO...6,SET,177,-0.0064944,-0.00063457,0.062824,0.54117,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP,0.99999
GSE43863_NAIVE_VS_MEMORY_TH1...1,SET,139,-0.0072612,-0.00062938,0.070087,0.54126,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_DN,0.99999
DUNNE_TARGETS_OF_AML1_MTG8_F...2,SET,49,-0.013156,-0.00067872,0.12671,0.54135,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,0.99999
GSE34205_HEALTHY_VS_FLU_INF_...1,SET,174,-0.0068427,-0.00066296,0.065876,0.54136,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN,0.99999
MIR548A_5P,SET,444,-0.0042026,-0.00064557,0.04045,0.54137,MIR548A_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...292,SET,12,-0.027474,-0.00070214,0.26441,0.54138,GOBP_NEGATIVE_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,0.99999
chr13q21,SET,11,-0.042423,-0.0010381,0.40804,0.5414,chr13q21,0.99999
HP_RECURRENT_PNEUMONIA,SET,113,-0.0082659,-0.00064646,0.07944,0.54144,HP_RECURRENT_PNEUMONIA,0.99999
MNX1_TARGET_GENES,SET,8,-0.031258,-0.00065233,0.30026,0.54146,MNX1_TARGET_GENES,0.99999
ERCC8_TARGET_GENES,SET,7,-0.034136,-0.00066639,0.3272,0.54155,ERCC8_TARGET_GENES,0.99999
GOMF_PHOSPHATIDYLINOSITOL_3_...12,SET,11,-0.026119,-0.00063911,0.25034,0.54155,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATORY_SUBUNIT_BINDING,0.99999
GOBP_NEUROMUSCULAR_SYNAPTIC_...,SET,26,-0.017811,-0.00066975,0.17057,0.54158,GOBP_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION,0.99999
GOMF_PHOSPHATIDYLINOSITOL_3_...13,SET,10,-0.026224,-0.00061183,0.25116,0.54158,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY,0.99999
GOMF_NUCLEOSIDE_TRIPHOSPHATA...,SET,445,-0.0041664,-0.00064071,0.039851,0.54163,GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY,0.99999
HP_SHOULDER_GIRDLE_MUSCLE_AT...,SET,13,-0.025843,-0.00068741,0.2469,0.54168,HP_SHOULDER_GIRDLE_MUSCLE_ATROPHY,0.99999
GLI4_TARGET_GENES,SET,663,-0.0034257,-0.0006391,0.032721,0.54169,GLI4_TARGET_GENES,0.99999
GOBP_CELL_SURFACE_RECEPTOR_S...2,SET,166,-0.0072827,-0.00068933,0.06955,0.5417,GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.99999
GSE37301_HEMATOPOIETIC_STEM_...10,SET,185,-0.0064607,-0.00064523,0.061677,0.54171,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP,0.99999
HP_AGENESIS_OF_MAXILLARY_INC...,SET,15,-0.023858,-0.00068165,0.22768,0.54173,HP_AGENESIS_OF_MAXILLARY_INCISOR,0.99999
LI_CYTIDINE_ANALOG_PATHWAY,SET,17,-0.021527,-0.00065474,0.20534,0.54175,LI_CYTIDINE_ANALOG_PATHWAY,0.99999
MIR641,SET,232,-0.0057798,-0.00064557,0.055122,0.54175,MIR641,0.99999
MIR4302,SET,115,-0.0081945,-0.00064648,0.078089,0.54179,MIR4302,0.99999
MIR549A_3P,SET,69,-0.010975,-0.0006715,0.10425,0.54192,MIR549A_3P,0.99999
GSE37301_HEMATOPOIETIC_STEM_...1,SET,118,-0.0086281,-0.00068946,0.081833,0.54198,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_DN,0.99999
HP_ABNORMAL_UMBILICAL_STUMP_...,SET,8,-0.034411,-0.00071812,0.32596,0.54204,HP_ABNORMAL_UMBILICAL_STUMP_BLEEDING,0.99999
IGARASHI_ATF4_TARGETS_UP,SET,4,-0.05949,-0.00087797,0.56186,0.54216,IGARASHI_ATF4_TARGETS_UP,0.99999
GOBP_REGULATION_OF_TRANSLATI...4,SET,76,-0.009396,-0.00060325,0.08866,0.5422,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION,0.99999
KONDO_PROSTATE_CANCER_WITH_H...,SET,178,-0.00733,-0.00071821,0.069132,0.54222,KONDO_PROSTATE_CANCER_WITH_H3K27ME3,0.99999
HP_THYROTOXICOSIS_WITH_DIFFU...,SET,4,-0.049378,-0.00072873,0.46437,0.54234,HP_THYROTOXICOSIS_WITH_DIFFUSE_GOITER,0.99999
HP_GENERALIZED_LYMPHADENOPAT...,SET,9,-0.032827,-0.00072661,0.30862,0.54235,HP_GENERALIZED_LYMPHADENOPATHY,0.99999
GOBP_CEREBRAL_CORTEX_GABAERG...3,SET,4,-0.050993,-0.00075257,0.47923,0.54237,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_MIGRATION,0.99999
MORF_RRM1,SET,89,-0.0086611,-0.00060154,0.081275,0.54243,MORF_RRM1,0.99999
GOMF_TOLL_LIKE_RECEPTOR_BIND...,SET,14,-0.025758,-0.00071099,0.24133,0.5425,GOMF_TOLL_LIKE_RECEPTOR_BINDING,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...6,SET,106,-0.0087259,-0.00066108,0.081684,0.54254,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,0.99999
HP_NEONATAL_SHORT_LIMB_SHORT...,SET,13,-0.026566,-0.00070663,0.24865,0.54254,HP_NEONATAL_SHORT_LIMB_SHORT_STATURE,0.99999
PID_AP1_PATHWAY,SET,68,-0.011379,-0.00069117,0.10629,0.54263,PID_AP1_PATHWAY,0.99999
HP_VERTEBRAL_FUSION,SET,63,-0.011242,-0.00065737,0.10487,0.54268,HP_VERTEBRAL_FUSION,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...1,SET,6,-0.040636,-0.00073445,0.37857,0.54274,GOBP_PROTEIN_LOCALIZATION_TO_ADHERENS_JUNCTION,0.99999
HP_GASTROPARESIS,SET,30,-0.015359,-0.00062033,0.1429,0.54279,HP_GASTROPARESIS,0.99999
GSE14908_RESTING_VS_HDM_STIM...4,SET,186,-0.0065568,-0.00065658,0.061004,0.5428,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP,0.99999
ZHONG_PFC_C2_SOX5_BCL11B_POS...,SET,24,-0.020365,-0.00073579,0.18923,0.54285,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,0.99999
GAO_SMALL_INTESTINE_24W_C3_E...,SET,41,-0.013554,-0.00063978,0.12555,0.54298,GAO_SMALL_INTESTINE_24W_C3_ENTEROCYTE_PROGENITOR_SUBTYPE_1,0.99999
CRX_NRL_DN.V1_UP,SET,131,-0.0079959,-0.00067297,0.074057,0.54299,CRX_NRL_DN.V1_UP,0.99999
REACTOME_SEMA4D_IN_SEMAPHORI...,SET,24,-0.018816,-0.00067985,0.17424,0.543,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,0.99999
GOBP_FACULTATIVE_HETEROCHROM...,SET,37,-0.014724,-0.0006603,0.13633,0.543,GOBP_FACULTATIVE_HETEROCHROMATIN_FORMATION,0.99999
GOMF_PROTEIN_TRANSPORTER_ACT...,SET,36,-0.015326,-0.00067798,0.14167,0.54307,GOMF_PROTEIN_TRANSPORTER_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...283,SET,6,-0.035806,-0.00064715,0.33072,0.54311,GOBP_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH,0.99999
GSE19888_CTRL_VS_A3R_ACTIVAT...2,SET,179,-0.006162,-0.00060544,0.056863,0.54315,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP,0.99999
WP_IL2_SIGNALING,SET,41,-0.015037,-0.00070977,0.13861,0.54319,WP_IL2_SIGNALING,0.99999
MODULE_233,SET,21,-0.01825,-0.00061683,0.16824,0.54319,MODULE_233,0.99999
GOMF_SUPERCOILED_DNA_BINDING,SET,6,-0.035467,-0.00064104,0.32694,0.54319,GOMF_SUPERCOILED_DNA_BINDING,0.99999
REACTOME_SIGNALING_BY_PDGF,SET,57,-0.012526,-0.00069683,0.11541,0.54321,REACTOME_SIGNALING_BY_PDGF,0.99999
GOBP_NEGATIVE_REGULATION_OF_...672,SET,45,-0.014283,-0.00070621,0.13159,0.54322,GOBP_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION,0.99999
GOMF_DAMAGED_DNA_BINDING,SET,71,-0.0093704,-0.00058156,0.086104,0.54333,GOMF_DAMAGED_DNA_BINDING,0.99999
GSE40666_WT_VS_STAT4_KO_CD8_...4,SET,174,-0.006879,-0.00066648,0.063213,0.54333,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.99999
GSE4590_PRE_BCELL_VS_VPREB_P...1,SET,147,-0.0071653,-0.00063856,0.06584,0.54333,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.99999
MODULE_107,SET,73,-0.011156,-0.00070205,0.10202,0.54354,MODULE_107,0.99999
HP_X_LINKED_INHERITANCE,SET,11,-0.026689,-0.00065306,0.24376,0.54359,HP_X_LINKED_INHERITANCE,0.99999
WP_RETINOL_METABOLISM,SET,15,-0.024822,-0.00070919,0.22646,0.54364,WP_RETINOL_METABOLISM,0.99999
GOBP_REGULATION_OF_TELOMERAS...,SET,43,-0.01365,-0.00065979,0.12452,0.54364,GOBP_REGULATION_OF_TELOMERASE_ACTIVITY,0.99999
GOBP_CARBOHYDRATE_DERIVATIVE...3,SET,965,-0.0030487,-0.00068031,0.027795,0.54367,GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS,0.99999
GOMF_MOLYBDOPTERIN_COFACTOR_...,SET,4,-0.048533,-0.00071627,0.4425,0.54367,GOMF_MOLYBDOPTERIN_COFACTOR_BINDING,0.99999
GOBP_ACUTE_INFLAMMATORY_RESP...2,SET,23,-0.021309,-0.0007537,0.19417,0.54369,GOBP_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.99999
GOBP_EXOCYST_LOCALIZATION,SET,5,-0.042402,-0.00069963,0.38628,0.5437,GOBP_EXOCYST_LOCALIZATION,0.99999
HP_CENTRAL_APNEA,SET,37,-0.014688,-0.00065867,0.13381,0.5437,HP_CENTRAL_APNEA,0.99999
WP_INTERACTIONS_BETWEEN_LOXL...,SET,17,-0.021374,-0.00065008,0.19469,0.54371,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,0.99999
ATGTTTC_MIR494,SET,142,-0.007987,-0.00069967,0.072421,0.54391,ATGTTTC_MIR494,0.99999
SIG_INSULIN_RECEPTOR_PATHWAY...,SET,48,-0.0139,-0.00070976,0.12597,0.54393,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,0.99999
HP_IMPAIRED_OCULAR_ABDUCTION,SET,4,-0.05438,-0.00080255,0.49286,0.54393,HP_IMPAIRED_OCULAR_ABDUCTION,0.99999
GOMF_INTERLEUKIN_1_BINDING,SET,8,-0.033931,-0.00070811,0.30704,0.544,GOMF_INTERLEUKIN_1_BINDING,0.99999
GSE19941_LPS_VS_LPS_AND_IL10...1,SET,137,-0.0083853,-0.00072161,0.075849,0.54401,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.99999
GOMF_L_GLUTAMINE_TRANSMEMBRA...,SET,8,-0.035811,-0.00074733,0.32319,0.54411,GOMF_L_GLUTAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
PAX8_01,SET,33,-0.016859,-0.0007141,0.15205,0.54414,PAX8_01,0.99999
MIR412_3P,SET,66,-0.011991,-0.0007176,0.10812,0.54415,MIR412_3P,0.99999
GOBP_SNRNA_TRANSPORT,SET,5,-0.035879,-0.000592,0.3234,0.54417,GOBP_SNRNA_TRANSPORT,0.99999
GSE6092_B_BURGDOFERI_VS_B_BU...2,SET,160,-0.0074434,-0.0006918,0.06709,0.54417,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP,0.99999
MODULE_61,SET,47,-0.013481,-0.00068119,0.12145,0.54419,MODULE_61,0.99999
GOBP_REGULATION_OF_CELLULAR_...3,SET,897,-0.003159,-0.00068097,0.028441,0.54422,GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,0.99999
GSE21546_UNSTIM_VS_ANTI_CD3_...2,SET,163,-0.0075346,-0.00070676,0.067819,0.54423,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.99999
DARWICHE_PAPILLOMA_PROGRESSI...,SET,72,-0.011084,-0.0006927,0.099714,0.54425,DARWICHE_PAPILLOMA_PROGRESSION_RISK,0.99999
CLAUS_PGR_POSITIVE_MENINGIOM...1,SET,12,-0.031218,-0.00079783,0.28074,0.54427,CLAUS_PGR_POSITIVE_MENINGIOMA_DN,0.99999
MALIK_REPRESSED_BY_ESTROGEN,SET,13,-0.027765,-0.00073854,0.24927,0.54434,MALIK_REPRESSED_BY_ESTROGEN,0.99999
HP_NEUROGENIC_BLADDER,SET,65,-0.010976,-0.00065192,0.098552,0.54434,HP_NEUROGENIC_BLADDER,0.99999
ATGCACG_MIR517B,SET,18,-0.023455,-0.00073402,0.21021,0.54442,ATGCACG_MIR517B,0.99999
MIR532_5P,SET,68,-0.011491,-0.00069798,0.10297,0.54443,MIR532_5P,0.99999
GOCC_SERINE_TYPE_PEPTIDASE_C...,SET,13,-0.028125,-0.00074811,0.25202,0.54443,GOCC_SERINE_TYPE_PEPTIDASE_COMPLEX,0.99999
PARK_HSC_VS_MULTIPOTENT_PROG...1,SET,14,-0.024942,-0.00068845,0.22321,0.54448,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,0.99999
REACTOME_EICOSANOID_LIGAND_B...,SET,14,-0.026065,-0.00071947,0.23301,0.54453,REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS,0.99999
GOMF_TRANSFERASE_ACTIVITY_TR...2,SET,25,-0.019804,-0.00073026,0.17698,0.54455,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS,0.99999
REACTOME_POST_TRANSLATIONAL_...1,SET,87,-0.010433,-0.00071647,0.092908,0.54471,REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,0.99999
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...5,SET,125,-0.0088223,-0.00072545,0.078537,0.54472,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_UP,0.99999
MODULE_451,SET,30,-0.016869,-0.00068132,0.15005,0.54475,MODULE_451,0.99999
GOBP_CARDIAC_MUSCLE_CELL_MEM...,SET,36,-0.016479,-0.00072897,0.14643,0.5448,GOBP_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...6,SET,6,-0.035247,-0.00063706,0.31298,0.54483,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYDROGEN_PEROXIDE,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...1,SET,282,-0.0054487,-0.00067005,0.048306,0.5449,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOBP_LABYRINTHINE_LAYER_MORP...,SET,20,-0.023153,-0.00076373,0.20523,0.54491,GOBP_LABYRINTHINE_LAYER_MORPHOGENESIS,0.99999
GOBP_REGULATION_OF_MIRNA_MET...,SET,81,-0.010597,-0.00070229,0.09393,0.54491,GOBP_REGULATION_OF_MIRNA_METABOLIC_PROCESS,0.99999
HP_SHIELD_CHEST,SET,14,-0.023474,-0.00064795,0.208,0.54493,HP_SHIELD_CHEST,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...3,SET,42,-0.016117,-0.00076997,0.14275,0.54495,GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1,0.99999
GOBP_POSITIVE_REGULATION_OF_...793,SET,104,-0.0097426,-0.00073115,0.086234,0.54498,GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.99999
GSE23505_UNTREATED_VS_4DAY_I...2,SET,185,-0.0070176,-0.00070086,0.062093,0.54499,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_MODIFICAT...1,SET,4,-0.052116,-0.00076915,0.46098,0.54501,GOBP_REGULATION_OF_MODIFICATION_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.99999
GOBP_TRANSCYTOSIS,SET,21,-0.020931,-0.00070747,0.18512,0.54501,GOBP_TRANSCYTOSIS,0.99999
HP_CHOLANGIOCARCINOMA,SET,8,-0.034374,-0.00071734,0.30403,0.54501,HP_CHOLANGIOCARCINOMA,0.99999
GSE2585_CD80_HIGH_VS_LOW_AIR...1,SET,183,-0.0071431,-0.00070956,0.063139,0.54504,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN,0.99999
MIR6863,SET,8,-0.033435,-0.00069776,0.29547,0.54505,MIR6863,0.99999
MIR132_3P,SET,173,-0.0072045,-0.00069602,0.063633,0.54507,MIR132_3P,0.99999
HP_VASCULAR_SKIN_ABNORMALITY,SET,513,-0.0041999,-0.00069214,0.037064,0.54511,HP_VASCULAR_SKIN_ABNORMALITY,0.99999
MODULE_358,SET,71,-0.011318,-0.00070241,0.099836,0.54513,MODULE_358,0.99999
HP_CHILLS,SET,18,-0.021996,-0.00068837,0.19376,0.54519,HP_CHILLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...389,SET,89,-0.010423,-0.00072394,0.091763,0.54522,GOBP_POSITIVE_REGULATION_OF_JNK_CASCADE,0.99999
GSE3982_NEUTROPHIL_VS_BCELL_...1,SET,182,-0.006761,-0.00066978,0.059498,0.54523,GSE3982_NEUTROPHIL_VS_BCELL_DN,0.99999
HP_RETINOPATHY_OF_PREMATURITY,SET,4,-0.04243,-0.0006262,0.37322,0.54526,HP_RETINOPATHY_OF_PREMATURITY,0.99999
KEGG_NOTCH_SIGNALING_PATHWAY,SET,46,-0.013518,-0.00067576,0.11885,0.54528,KEGG_NOTCH_SIGNALING_PATHWAY,0.99999
MIR1245B_3P,SET,129,-0.0082791,-0.00069151,0.072741,0.54531,MIR1245B_3P,0.99999
GOBP_VESICLE_LOCALIZATION,SET,202,-0.0064976,-0.00067777,0.057047,0.54534,GOBP_VESICLE_LOCALIZATION,0.99999
HP_CSF_LYMPHOCYTIC_PLEIOCYTO...,SET,18,-0.020963,-0.00065603,0.18406,0.54534,HP_CSF_LYMPHOCYTIC_PLEIOCYTOSIS,0.99999
GSE36078_UNTREATED_VS_AD5_IN...1,SET,183,-0.0068287,-0.00067833,0.059947,0.54535,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN,0.99999
GOBP_PROGRAMMED_CELL_DEATH_I...2,SET,12,-0.027831,-0.00071125,0.24417,0.54537,GOBP_PROGRAMMED_CELL_DEATH_IN_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,0.99999
MIR204_3P,SET,128,-0.0084797,-0.00070553,0.07432,0.54542,MIR204_3P,0.99999
RYAN_MANTLE_CELL_LYMPHOMA_NO...,SET,143,-0.0087414,-0.00076842,0.076334,0.54558,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,0.99999
DESCARTES_MAIN_FETAL_BRONCHI...,SET,34,-0.018194,-0.00078221,0.15888,0.54559,DESCARTES_MAIN_FETAL_BRONCHIOLAR_AND_ALVEOLAR_EPITHELIAL_CELLS,0.99999
WP_SMC1SMC3_ROLE_IN_DNA_DAMA...,SET,9,-0.031404,-0.00069512,0.27409,0.54561,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,0.99999
HP_ABNORMAL_CIRCULATING_FREE...1,SET,9,-0.029917,-0.0006622,0.26107,0.54562,HP_ABNORMAL_CIRCULATING_FREE_FATTY_ACID_CONCENTRATION,0.99999
LI_ESTROGENE_NON_MCF7_T47D_E...2,SET,15,-0.024327,-0.00069505,0.2122,0.54564,LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_UP,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...12,SET,95,-0.0093137,-0.00066821,0.081183,0.54567,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME,0.99999
HP_DIABETES_INSIPIDUS,SET,53,-0.013594,-0.00072931,0.11845,0.54569,HP_DIABETES_INSIPIDUS,0.99999
HP_NEOPLASM_BY_HISTOLOGY,SET,331,-0.0052608,-0.00069995,0.04583,0.54569,HP_NEOPLASM_BY_HISTOLOGY,0.99999
WP_INITIATION_OF_TRANSCRIPTI...,SET,31,-0.01618,-0.00066428,0.14091,0.54571,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,0.99999
GOBP_POSITIVE_REGULATION_OF_...659,SET,10,-0.02969,-0.00069271,0.25853,0.54571,GOBP_POSITIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GOBP_SULFUR_AMINO_ACID_CATAB...,SET,9,-0.033441,-0.0007402,0.29118,0.54572,GOBP_SULFUR_AMINO_ACID_CATABOLIC_PROCESS,0.99999
MIR6817_5P,SET,98,-0.0097725,-0.00071205,0.085054,0.54574,MIR6817_5P,0.99999
WP_DISORDERS_OF_FRUCTOSE_MET...,SET,12,-0.024808,-0.00063401,0.2158,0.54576,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,0.99999
GSE23925_DARK_ZONE_VS_NAIVE_...1,SET,188,-0.0070766,-0.0007124,0.061535,0.54578,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN,0.99999
GOBP_PROTEIN_TARGETING_TO_VA...1,SET,44,-0.014241,-0.00069631,0.12378,0.5458,GOBP_PROTEIN_TARGETING_TO_VACUOLE,0.99999
NIKOLSKY_BREAST_CANCER_7P15_...,SET,11,-0.046653,-0.0011416,0.40518,0.54583,NIKOLSKY_BREAST_CANCER_7P15_AMPLICON,0.99999
HP_ABNORMAL_SPERM_TAIL_MORPH...,SET,36,-0.015543,-0.00068755,0.135,0.54583,HP_ABNORMAL_SPERM_TAIL_MORPHOLOGY,0.99999
GOBP_MEMORY,SET,117,-0.0091101,-0.0007249,0.079007,0.5459,GOBP_MEMORY,0.99999
MASRI_RESISTANCE_TO_TAMOXIFE...2,SET,15,-0.026298,-0.00075136,0.2277,0.54597,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP,0.99999
HP_MICROCORNEA,SET,111,-0.0091566,-0.00070979,0.079276,0.54598,HP_MICROCORNEA,0.99999
GOMF_GALACTOSIDASE_ACTIVITY,SET,6,-0.038261,-0.00069154,0.33086,0.54603,GOMF_GALACTOSIDASE_ACTIVITY,0.99999
ZHONG_PFC_MAJOR_TYPES_NPCS,SET,126,-0.0087114,-0.00071917,0.075223,0.5461,ZHONG_PFC_MAJOR_TYPES_NPCS,0.99999
HP_GIANT_CELL_HEPATITIS,SET,5,-0.044447,-0.00073336,0.38318,0.54617,HP_GIANT_CELL_HEPATITIS,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...6,SET,15,-0.022992,-0.0006569,0.19814,0.54619,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP,0.99999
GOBP_TYPE_2_IMMUNE_RESPONSE,SET,41,-0.016403,-0.00077423,0.14123,0.54623,GOBP_TYPE_2_IMMUNE_RESPONSE,0.99999
HP_LIMITED_NECK_RANGE_OF_MOT...,SET,8,-0.039915,-0.00083299,0.34353,0.54625,HP_LIMITED_NECK_RANGE_OF_MOTION,0.99999
MIR3164,SET,93,-0.010163,-0.00072143,0.087385,0.54629,MIR3164,0.99999
GOMF_METHYL_CPG_BINDING,SET,25,-0.019005,-0.00070079,0.16298,0.54641,GOMF_METHYL_CPG_BINDING,0.99999
HP_MOTOR_TICS,SET,11,-0.027905,-0.00068281,0.23932,0.54641,HP_MOTOR_TICS,0.99999
CAO_BLOOD_FLUZONE_AGE_05_14Y...5,SET,6,-0.043208,-0.00078095,0.37058,0.54641,CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_DN,0.99999
MODULE_221,SET,29,-0.016745,-0.00066495,0.14352,0.54644,MODULE_221,0.99999
GOMF_ICOSANOID_BINDING,SET,7,-0.038172,-0.00074519,0.32691,0.54648,GOMF_ICOSANOID_BINDING,0.99999
XU_RESPONSE_TO_TRETINOIN_DN,SET,10,-0.033062,-0.00077137,0.28287,0.54652,XU_RESPONSE_TO_TRETINOIN_DN,0.99999
REACTOME_MITOPHAGY,SET,34,-0.016132,-0.00069355,0.13797,0.54654,REACTOME_MITOPHAGY,0.99999
HP_ABNORMAL_CORONARY_ARTERY_...2,SET,6,-0.039298,-0.00071027,0.33587,0.54657,HP_ABNORMAL_CORONARY_ARTERY_ORIGIN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...604,SET,12,-0.03194,-0.00081626,0.27251,0.54665,GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,0.99999
WP_EPAC1_AND_PKA_REDUCTION_O...,SET,8,-0.036649,-0.00076482,0.31254,0.54667,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,0.99999
MIR3682_3P,SET,72,-0.011644,-0.0007277,0.099278,0.54668,MIR3682_3P,0.99999
GOMF_MONOCARBOXYLATE_SODIUM_...,SET,13,-0.026997,-0.00071811,0.23021,0.54668,GOMF_MONOCARBOXYLATE_SODIUM_SYMPORTER_ACTIVITY,0.99999
WORSCHECH_TUMOR_REJECTION_UP,SET,58,-0.013574,-0.00076173,0.11571,0.54669,WORSCHECH_TUMOR_REJECTION_UP,0.99999
NFE2_01,SET,237,-0.0064472,-0.00072774,0.054882,0.54676,NFE2_01,0.99999
CREB3L4_TARGET_GENES,SET,1159,-0.0029546,-0.00071851,0.02514,0.54678,CREB3L4_TARGET_GENES,0.99999
NAKAYA_PLASMACYTOID_DENDRITI...3,SET,804,-0.0035797,-0.0007325,0.030415,0.54685,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN,0.99999
GOBP_GMP_BIOSYNTHETIC_PROCESS,SET,13,-0.02729,-0.00072589,0.23145,0.54693,GOBP_GMP_BIOSYNTHETIC_PROCESS,0.99999
GSE8621_UNSTIM_VS_LPS_STIM_M...2,SET,182,-0.0073437,-0.00072751,0.062248,0.54696,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,0.99999
HP_AGENESIS_OF_PERMANENT_TEE...,SET,19,-0.022907,-0.0007365,0.19368,0.54707,HP_AGENESIS_OF_PERMANENT_TEETH,0.99999
REACTOME_RUNX1_AND_FOXP3_CON...,SET,9,-0.035878,-0.00079414,0.30322,0.54709,REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS,0.99999
ZNF418_TARGET_GENES,SET,26,-0.02041,-0.00076748,0.17229,0.54715,ZNF418_TARGET_GENES,0.99999
VERHAAK_GLIOBLASTOMA_NEURAL,SET,112,-0.0094868,-0.00073867,0.080032,0.54718,VERHAAK_GLIOBLASTOMA_NEURAL,0.99999
DESCARTES_MAIN_FETAL_STC2_TL...,SET,16,-0.027593,-0.00081419,0.23268,0.5472,DESCARTES_MAIN_FETAL_STC2_TLX1_POSITIVE_CELLS,0.99999
HP_ANEMIC_PALLOR,SET,14,-0.025881,-0.00071437,0.21815,0.54722,HP_ANEMIC_PALLOR,0.99999
GOCC_GABA_ERGIC_SYNAPSE,SET,69,-0.013385,-0.00081899,0.11278,0.54724,GOCC_GABA_ERGIC_SYNAPSE,0.99999
GSE19941_UNSTIM_VS_LPS_AND_I...4,SET,157,-0.0080313,-0.00073947,0.06761,0.54728,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...9,SET,15,-0.025223,-0.00072063,0.21196,0.54736,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY,0.99999
REACTOME_APOPTOTIC_EXECUTION...,SET,43,-0.015163,-0.00073293,0.12744,0.54736,REACTOME_APOPTOTIC_EXECUTION_PHASE,0.99999
GAO_LARGE_INTESTINE_24W_C4_P...,SET,5,-0.046264,-0.00076334,0.38871,0.54737,GAO_LARGE_INTESTINE_24W_C4_PROM1LOW_PROGENITOR,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...3,SET,9,-0.034344,-0.00076017,0.2885,0.54738,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY,0.99999
GSE3039_ALPHAALPHA_CD8_TCELL...2,SET,189,-0.0070637,-0.00071296,0.059101,0.54757,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_UP,0.99999
GOCC_PRESYNAPTIC_CYTOSKELETON,SET,10,-0.03672,-0.00085672,0.3071,0.54759,GOCC_PRESYNAPTIC_CYTOSKELETON,0.99999
PID_P38_ALPHA_BETA_DOWNSTREA...,SET,37,-0.017063,-0.00076519,0.14262,0.54761,PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...750,SET,29,-0.017805,-0.00070706,0.14882,0.54761,GOBP_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY,0.99999
HP_ANTINUCLEAR_ANTIBODY_POSI...,SET,62,-0.01368,-0.0007936,0.11427,0.54764,HP_ANTINUCLEAR_ANTIBODY_POSITIVITY,0.99999
HP_BONE_MARROW_HYPERCELLULAR...,SET,28,-0.020455,-0.00079817,0.17061,0.54772,HP_BONE_MARROW_HYPERCELLULARITY,0.99999
MIR195_3P,SET,206,-0.0072041,-0.00075878,0.06006,0.54774,MIR195_3P,0.99999
MIR3679_3P,SET,145,-0.008339,-0.00073813,0.069525,0.54774,MIR3679_3P,0.99999
GSE9960_GRAM_POS_VS_GRAM_NEG...2,SET,178,-0.0073687,-0.000722,0.061418,0.54775,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,0.99999
GSE36476_CTRL_VS_TSST_ACT_40...1,SET,181,-0.0069726,-0.00068887,0.0581,0.54776,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN,0.99999
GSE6259_DEC205_POS_DC_VS_CD4...1,SET,181,-0.0072155,-0.00071287,0.060047,0.54782,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN,0.99999
GNF2_XRCC5,SET,65,-0.011434,-0.00067913,0.09509,0.54786,GNF2_XRCC5,0.99999
HP_ABNORMAL_MUSCLE_TISSUE_ME...,SET,45,-0.014391,-0.00071158,0.11964,0.54787,HP_ABNORMAL_MUSCLE_TISSUE_METABOLITE_CONCENTRATION,0.99999
GOBP_RESPONSE_TO_ACID_CHEMIC...,SET,119,-0.0093944,-0.00075385,0.078067,0.54789,GOBP_RESPONSE_TO_ACID_CHEMICAL,0.99999
MIR3912_3P,SET,5,-0.041989,-0.00069281,0.3487,0.54792,MIR3912_3P,0.99999
GOBP_HORMONE_TRANSPORT,SET,304,-0.0060882,-0.00077688,0.050561,0.54792,GOBP_HORMONE_TRANSPORT,0.99999
HP_ABSENT_TIBIA,SET,5,-0.0509,-0.00083984,0.42246,0.54795,HP_ABSENT_TIBIA,0.99999
GOBP_PROTEIN_ACTIVATION_CASC...,SET,18,-0.028318,-0.00088623,0.23485,0.54799,GOBP_PROTEIN_ACTIVATION_CASCADE,0.99999
HP_RETROCOLLIS,SET,8,-0.032496,-0.00067815,0.26908,0.54806,HP_RETROCOLLIS,0.99999
MIR6507_3P,SET,112,-0.0095974,-0.00074728,0.079365,0.54812,MIR6507_3P,0.99999
NEUROD2_TARGET_GENES,SET,5,-0.044734,-0.0007381,0.36989,0.54813,NEUROD2_TARGET_GENES,0.99999
BERENJENO_TRANSFORMED_BY_RHO...5,SET,8,-0.042527,-0.0008875,0.35127,0.54818,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP,0.99999
GOMF_ACETYLCHOLINE_GATED_MON...,SET,16,-0.027859,-0.00082204,0.23007,0.54819,GOMF_ACETYLCHOLINE_GATED_MONOATOMIC_CATION_SELECTIVE_CHANNEL_ACTIVITY,0.99999
GOBP_HYPOTHALAMUS_CELL_DIFFE...,SET,11,-0.036667,-0.0008972,0.30276,0.5482,GOBP_HYPOTHALAMUS_CELL_DIFFERENTIATION,0.99999
HP_PERSISTENT_HEAD_LAG,SET,25,-0.018878,-0.00069612,0.15582,0.54821,HP_PERSISTENT_HEAD_LAG,0.99999
GOBP_TRABECULA_FORMATION,SET,27,-0.020714,-0.00079374,0.17096,0.54822,GOBP_TRABECULA_FORMATION,0.99999
HP_TETRAPLEGIA,SET,31,-0.017363,-0.00071286,0.14325,0.54824,HP_TETRAPLEGIA,0.99999
TRAVAGLINI_LUNG_PROXIMAL_BAS...,SET,556,-0.0043647,-0.00074793,0.03599,0.54826,TRAVAGLINI_LUNG_PROXIMAL_BASAL_CELL,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...10,SET,4,-0.060616,-0.00089459,0.49965,0.54828,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_MUSCULATURE_OF_THE_EXTREMITIES,0.99999
KEGG_LONG_TERM_POTENTIATION,SET,66,-0.012288,-0.00073538,0.10117,0.54833,KEGG_LONG_TERM_POTENTIATION,0.99999
GATA3_01,SET,219,-0.0071678,-0.00077813,0.059,0.54835,GATA3_01,0.99999
APRELIKOVA_BRCA1_TARGETS,SET,42,-0.014971,-0.00071521,0.12321,0.54836,APRELIKOVA_BRCA1_TARGETS,0.99999
WP_THYMIC_STROMAL_LYMPHOPOIE...,SET,44,-0.016658,-0.0008145,0.13696,0.5484,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...22,SET,9,-0.031797,-0.0007038,0.26145,0.5484,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.99999
GSE12707_AT16L1_HYPOMORPH_VS...1,SET,113,-0.0095059,-0.00074344,0.077999,0.5485,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_DN,0.99999
chr9q32,SET,31,-0.030326,-0.001245,0.24876,0.54852,chr9q32,0.99999
HP_ABNORMALITY_OF_LOWER_EYEL...,SET,5,-0.046116,-0.00076091,0.37786,0.54857,HP_ABNORMALITY_OF_LOWER_EYELASHES,0.99999
GOCC_SEX_CHROMOSOME,SET,26,-0.018385,-0.00069133,0.15045,0.54863,GOCC_SEX_CHROMOSOME,0.99999
GOMF_AMINOACYLASE_ACTIVITY,SET,4,-0.052693,-0.00077766,0.43111,0.54864,GOMF_AMINOACYLASE_ACTIVITY,0.99999
HP_ABNORMAL_TUBULAR_BASEMENT...,SET,5,-0.042676,-0.00070414,0.34869,0.5487,HP_ABNORMAL_TUBULAR_BASEMENT_MEMBRANE_MORPHOLOGY,0.99999
GOBP_CELLULAR_RESPONSE_TO_AR...,SET,16,-0.02575,-0.00075979,0.21038,0.54871,GOBP_CELLULAR_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,0.99999
MIR6756_3P,SET,92,-0.010264,-0.0007247,0.08383,0.54872,MIR6756_3P,0.99999
HOEK_T_CELL_2011_2012_TIV_AD...2,SET,8,-0.036094,-0.00075325,0.29434,0.5488,HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_UP,0.99999
MIR221_5P,SET,74,-0.012136,-0.00076887,0.098893,0.54883,MIR221_5P,0.99999
RICKMAN_HEAD_AND_NECK_CANCER...6,SET,50,-0.015694,-0.00081786,0.12787,0.54884,RICKMAN_HEAD_AND_NECK_CANCER_F,0.99999
GSE17721_CTRL_VS_LPS_24H_BMD...1,SET,184,-0.0074939,-0.00074642,0.061051,0.54885,GSE17721_CTRL_VS_LPS_24H_BMDC_DN,0.99999
HP_DEVIATED_NASAL_SEPTUM,SET,6,-0.043316,-0.0007829,0.35278,0.54886,HP_DEVIATED_NASAL_SEPTUM,0.99999
MIR2114_5P,SET,31,-0.018504,-0.00075968,0.15047,0.54893,MIR2114_5P,0.99999
HP_SIRENOMELIA,SET,11,-0.033376,-0.00081669,0.27138,0.54894,HP_SIRENOMELIA,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...19,SET,13,-0.032692,-0.00086957,0.26567,0.54897,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN,0.99999
HP_DIFFUSE_WHITE_MATTER_ABNO...,SET,29,-0.018457,-0.00073293,0.14997,0.54897,HP_DIFFUSE_WHITE_MATTER_ABNORMALITIES,0.99999
GOBP_KERATAN_SULFATE_METABOL...,SET,18,-0.025196,-0.0007885,0.2047,0.54898,GOBP_KERATAN_SULFATE_METABOLIC_PROCESS,0.99999
REACTOME_TRANSPORT_OF_SMALL_...,SET,684,-0.0040984,-0.00077617,0.033282,0.549,REACTOME_TRANSPORT_OF_SMALL_MOLECULES,0.99999
GOCC_BARR_BODY,SET,2,-0.085897,-0.00089643,0.69674,0.54906,GOCC_BARR_BODY,0.99999
GOMF_ALDOSE_REDUCTASE_NADPH_...,SET,12,-0.03885,-0.00099287,0.31512,0.54906,GOMF_ALDOSE_REDUCTASE_NADPH_ACTIVITY,0.99999
GOBP_DIGESTIVE_TRACT_MORPHOG...,SET,48,-0.016164,-0.00082538,0.13109,0.54907,GOBP_DIGESTIVE_TRACT_MORPHOGENESIS,0.99999
GSE8835_CD4_VS_CD8_TCELL_UP,SET,179,-0.0075549,-0.0007423,0.06127,0.54907,GSE8835_CD4_VS_CD8_TCELL_UP,0.99999
MONTERO_THYROID_CANCER_POOR_...2,SET,12,-0.032742,-0.00083676,0.26544,0.54908,MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP,0.99999
REACTOME_MITOCHONDRIAL_FATTY...3,SET,6,-0.039948,-0.00072203,0.32374,0.5491,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS,0.99999
SIG_REGULATION_OF_THE_ACTIN_...,SET,30,-0.018353,-0.00074126,0.14868,0.54912,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,0.99999
WP_NAD_BIOSYNTHESIS_II_FROM_...,SET,8,-0.036647,-0.00076479,0.29686,0.54912,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,0.99999
GSE40274_CTRL_VS_FOXP3_AND_G...2,SET,125,-0.0093231,-0.00076662,0.075484,0.54915,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_BLOOD_VES...,SET,7,-0.035455,-0.00069214,0.28673,0.54921,GOBP_REGULATION_OF_BLOOD_VESSEL_REMODELING,0.99999
GOBP_SKELETAL_SYSTEM_MORPHOG...,SET,218,-0.0076481,-0.0008284,0.06174,0.54929,GOBP_SKELETAL_SYSTEM_MORPHOGENESIS,0.99999
GSE18281_CORTICAL_VS_MEDULLA...1,SET,169,-0.0081158,-0.00077503,0.065503,0.5493,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN,0.99999
GSE37416_0H_VS_24H_F_TULAREN...2,SET,166,-0.0079169,-0.00074936,0.063848,0.54934,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
NABA_MATRISOME_HGSOC_OMENTAL...,SET,57,-0.014663,-0.00081569,0.11822,0.54935,NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS,0.99999
MIR345_3P,SET,199,-0.0074163,-0.00076789,0.059789,0.54936,MIR345_3P,0.99999
GSE360_CTRL_VS_M_TUBERCULOSI...2,SET,184,-0.0078007,-0.00077697,0.062866,0.54937,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP,0.99999
REACTOME_REGULATION_OF_RUNX1...,SET,17,-0.025476,-0.00077482,0.20517,0.54941,REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY,0.99999
HP_NEUROFIBROMA,SET,19,-0.021696,-0.00069757,0.17469,0.54942,HP_NEUROFIBROMA,0.99999
HP_APNEIC_EPISODES_PRECIPITA...,SET,11,-0.030392,-0.00074367,0.24435,0.54949,HP_APNEIC_EPISODES_PRECIPITATED_BY_ILLNESS_FATIGUE_STRESS,0.99999
HP_MITOCHONDRIAL_RESPIRATORY...,SET,10,-0.032392,-0.00075574,0.26028,0.54952,HP_MITOCHONDRIAL_RESPIRATORY_CHAIN_DEFECTS,0.99999
GSE12001_MIR223_KO_VS_WT_NEU...1,SET,178,-0.0076032,-0.00074497,0.061082,0.54953,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN,0.99999
MATZUK_STEROIDOGENESIS,SET,6,-0.047996,-0.00086749,0.38533,0.54956,MATZUK_STEROIDOGENESIS,0.99999
WP_HEMATOPOIETIC_STEM_CELL_G...,SET,19,-0.025629,-0.00082401,0.20537,0.54966,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,0.99999
WP_VITAMIN_K_METABOLISM_AND_...,SET,12,-0.028322,-0.0007238,0.22681,0.54969,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...332,SET,5,-0.05602,-0.00092432,0.4486,0.54969,GOBP_NEGATIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,0.99999
GOCC_POSTSYNAPTIC_SPECIALIZA...3,SET,121,-0.010043,-0.00081259,0.080418,0.54969,GOCC_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,0.99999
HP_ABNORMAL_PULMONARY_THORAC...,SET,131,-0.0095879,-0.00080697,0.076744,0.54971,HP_ABNORMAL_PULMONARY_THORACIC_IMAGING_FINDING,0.99999
GOBP_AMMONIUM_HOMEOSTASIS,SET,5,-0.059259,-0.00097775,0.47327,0.54982,GOBP_AMMONIUM_HOMEOSTASIS,0.99999
GSE7460_TREG_VS_TCONV_ACT_UP,SET,175,-0.008257,-0.00080226,0.065893,0.54986,GSE7460_TREG_VS_TCONV_ACT_UP,0.99999
GOCC_INTERCHROMATIN_GRANULE,SET,5,-0.047079,-0.00077679,0.37564,0.54987,GOCC_INTERCHROMATIN_GRANULE,0.99999
HP_FIRST_DEGREE_ATRIOVENTRIC...,SET,42,-0.017087,-0.00081627,0.13603,0.54998,HP_FIRST_DEGREE_ATRIOVENTRICULAR_BLOCK,0.99999
GOCC_AXONEMAL_A_TUBULE_INNER...,SET,9,-0.039337,-0.0008707,0.31305,0.55,GOCC_AXONEMAL_A_TUBULE_INNER_SHEATH,0.99999
WELCSH_BRCA1_TARGETS_DN,SET,125,-0.0087873,-0.00072257,0.069908,0.55001,WELCSH_BRCA1_TARGETS_DN,0.99999
RECHTIEN_PBMC_RVSV_ZEBOV_AGE...,SET,10,-0.036531,-0.00085231,0.29059,0.55002,RECHTIEN_PBMC_RVSV_ZEBOV_AGE_18_55YO_1DY_UP,0.99999
KEGG_P53_SIGNALING_PATHWAY,SET,66,-0.012825,-0.00076753,0.10196,0.55005,KEGG_P53_SIGNALING_PATHWAY,0.99999
GOBP_PROTEIN_DESUMOYLATION,SET,9,-0.032522,-0.00071986,0.25824,0.55011,GOBP_PROTEIN_DESUMOYLATION,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...2,SET,172,-0.0078468,-0.0007559,0.062067,0.5503,GSE22886_NAIVE_CD8_TCELL_VS_DC_UP,0.99999
HP_NAIL_PITS,SET,9,-0.036549,-0.00080899,0.28883,0.55035,HP_NAIL_PITS,0.99999
GOBP_REGULATION_OF_INWARD_RE...,SET,4,-0.058467,-0.00086287,0.46159,0.5504,GOBP_REGULATION_OF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.99999
HP_SCARRING,SET,88,-0.01157,-0.00079909,0.091293,0.55043,HP_SCARRING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...540,SET,5,-0.049383,-0.00081481,0.38951,0.55044,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION,0.99999
MIR656_5P,SET,32,-0.018627,-0.00077697,0.1468,0.55049,MIR656_5P,0.99999
GOMF_TUBULIN_BINDING,SET,346,-0.0056315,-0.00076574,0.044336,0.55054,GOMF_TUBULIN_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...702,SET,6,-0.043922,-0.00079385,0.3456,0.55056,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOBP_RENAL_WATER_HOMEOSTASIS,SET,24,-0.024233,-0.00087554,0.19064,0.55057,GOBP_RENAL_WATER_HOMEOSTASIS,0.99999
YEGNASUBRAMANIAN_PROSTATE_CA...,SET,100,-0.010851,-0.00079862,0.085302,0.55061,YEGNASUBRAMANIAN_PROSTATE_CANCER,0.99999
HP_ABNORMAL_CIRCULATING_PORP...,SET,8,-0.036597,-0.00076374,0.28758,0.55063,HP_ABNORMAL_CIRCULATING_PORPHYRIN_CONCENTRATION,0.99999
LI_ESTROGENE_T47D_E2_RESPONS...2,SET,56,-0.015448,-0.00085182,0.12134,0.55065,LI_ESTROGENE_T47D_E2_RESPONSE_UP,0.99999
GOMF_CARNITINE_TRANSMEMBRANE...,SET,5,-0.063753,-0.0010519,0.50055,0.55067,GOMF_CARNITINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_GAMMA_DELTA_T_CELL_ACTI...,SET,23,-0.022509,-0.00079615,0.17654,0.55073,GOBP_GAMMA_DELTA_T_CELL_ACTIVATION,0.99999
MIR4293,SET,99,-0.010972,-0.00080348,0.086022,0.55075,MIR4293,0.99999
chr6p11,SET,2,-0.081619,-0.00085179,0.63973,0.55076,chr6p11,0.99999
REACTOME_INOSITOL_PHOSPHATE_...,SET,45,-0.01479,-0.00073131,0.11586,0.55079,REACTOME_INOSITOL_PHOSPHATE_METABOLISM,0.99999
LEF1_Q6,SET,241,-0.007342,-0.00083561,0.057497,0.5508,LEF1_Q6,0.99999
FIGUEROA_AML_METHYLATION_CLU...13,SET,4,-0.064043,-0.00094517,0.50119,0.55084,FIGUEROA_AML_METHYLATION_CLUSTER_7_DN,0.99999
GSE37416_CTRL_VS_24H_F_TULAR...1,SET,176,-0.0076897,-0.00074925,0.060174,0.55084,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
chr15q23,SET,33,-0.029531,-0.0012508,0.23044,0.55098,chr15q23,0.99999
GSE1112_OT1_VS_HY_CD8AB_THYM...2,SET,180,-0.0078603,-0.00077444,0.061346,0.55098,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_UP,0.99999
GOBP_INTERLEUKIN_18_PRODUCTI...,SET,12,-0.028909,-0.0007388,0.22552,0.551,GOBP_INTERLEUKIN_18_PRODUCTION,0.99999
MIR6872_3P,SET,61,-0.014035,-0.00080759,0.10935,0.55106,MIR6872_3P,0.99999
GSE37533_PPARG1_FOXP3_VS_FOX...4,SET,184,-0.007766,-0.00077352,0.060515,0.55106,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,0.99999
GOBP_GLYCOSYL_COMPOUND_BIOSY...,SET,21,-0.024339,-0.00082264,0.18914,0.55119,GOBP_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...11,SET,14,-0.02874,-0.0007933,0.22317,0.55123,GOBP_RESPONSE_TO_INTERLEUKIN_7,0.99999
HP_2_HYDROXYGLUTARATE_ACIDUR...,SET,5,-0.050423,-0.00083197,0.39151,0.55124,HP_2_HYDROXYGLUTARATE_ACIDURIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...460,SET,23,-0.021669,-0.00076645,0.16821,0.55125,GOBP_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.99999
HP_ABNORMAL_ANTITRAGUS_MORPH...,SET,10,-0.034857,-0.00081324,0.27048,0.55127,HP_ABNORMAL_ANTITRAGUS_MORPHOLOGY,0.99999
REACTOME_RRNA_PROCESSING_IN_...,SET,6,-0.045522,-0.00082278,0.35265,0.55135,REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION,0.99999
REACTOME_CHROMATIN_MODIFICAT...,SET,7,-0.040387,-0.00078843,0.31282,0.55136,REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT,0.99999
REACTOME_NEGATIVE_REGULATION...13,SET,116,-0.010486,-0.00083085,0.081138,0.55142,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,0.99999
HP_ABNORMAL_MALE_REPRODUCTIV...,SET,283,-0.0064701,-0.00079705,0.050017,0.55146,HP_ABNORMAL_MALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,0.99999
GOCC_CLEAVAGE_FURROW,SET,50,-0.015584,-0.00081215,0.12043,0.55148,GOCC_CLEAVAGE_FURROW,0.99999
REACTOME_PROTEIN_HYDROXYLATI...,SET,17,-0.024817,-0.00075478,0.19166,0.55151,REACTOME_PROTEIN_HYDROXYLATION,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...3,SET,59,-0.013779,-0.00077985,0.10626,0.55159,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,0.99999
REACTOME_CYTOSOLIC_TRNA_AMIN...,SET,6,-0.03579,-0.00064687,0.27586,0.55161,REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,0.99999
GNF2_HMMR,SET,47,-0.016488,-0.00083312,0.12709,0.55161,GNF2_HMMR,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...5,SET,21,-0.026082,-0.00088155,0.20106,0.55161,GOBP_PROTEIN_LOCALIZATION_TO_CELL_CELL_JUNCTION,0.99999
GSE29618_BCELL_VS_MONOCYTE_D...1,SET,185,-0.0085178,-0.00085068,0.065653,0.55161,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN,0.99999
GOMF_EXONUCLEASE_ACTIVITY,SET,82,-0.010837,-0.00072261,0.083502,0.55163,GOMF_EXONUCLEASE_ACTIVITY,0.99999
UEDA_CENTRAL_CLOCK,SET,79,-0.012378,-0.00081014,0.09532,0.55166,UEDA_CENTRAL_CLOCK,0.99999
GOCC_ENDOPLASMIC_RETICULUM_C...,SET,11,-0.029866,-0.0007308,0.22983,0.5517,GOCC_ENDOPLASMIC_RETICULUM_CHAPERONE_COMPLEX,0.99999
GOCC_AXONEMAL_OUTER_DOUBLET,SET,14,-0.030167,-0.00083269,0.23207,0.55171,GOCC_AXONEMAL_OUTER_DOUBLET,0.99999
GSE30971_WBP7_HET_VS_KO_MACR...3,SET,173,-0.0082886,-0.00080075,0.063755,0.55172,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_DN,0.99999
HP_EARLY_SATIETY,SET,6,-0.040981,-0.0007407,0.3151,0.55174,HP_EARLY_SATIETY,0.99999
GOBP_DE_NOVO_PROTEIN_FOLDING,SET,39,-0.016441,-0.00075691,0.12636,0.55176,GOBP_DE_NOVO_PROTEIN_FOLDING,0.99999
MODULE_8,SET,394,-0.0054679,-0.00079234,0.042018,0.55177,MODULE_8,0.99999
HP_ABNORMAL_RESPONSE_TO_GLUC...,SET,4,-0.061416,-0.00090639,0.4719,0.55177,HP_ABNORMAL_RESPONSE_TO_GLUCAGON_STIMULATION_TEST,0.99999
MODULE_412,SET,13,-0.033593,-0.00089356,0.25803,0.55179,MODULE_412,0.99999
GOBP_POSITIVE_REGULATION_OF_...293,SET,6,-0.052244,-0.00094426,0.40129,0.55179,GOBP_POSITIVE_REGULATION_OF_GAP_JUNCTION_ASSEMBLY,0.99999
REACTOME_TRISTETRAPROLIN_TTP...,SET,16,-0.02501,-0.00073795,0.19203,0.55181,REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,0.99999
GSE6259_CD4_TCELL_VS_CD8_TCE...1,SET,165,-0.0081399,-0.00076817,0.062475,0.55183,GSE6259_CD4_TCELL_VS_CD8_TCELL_DN,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...6,SET,177,-0.0082278,-0.00080393,0.063145,0.55183,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP,0.99999
GOBP_REGULATION_OF_TYPE_2_IM...,SET,34,-0.019999,-0.00085981,0.15347,0.55184,GOBP_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,0.99999
GOBP_NUCLEOTIDE_SUGAR_METABO...,SET,34,-0.016922,-0.00072753,0.12976,0.55188,GOBP_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS,0.99999
GSE21774_CD62L_POS_CD56_BRIG...1,SET,173,-0.0085266,-0.00082375,0.065365,0.55189,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,0.99999
HP_SYMPHALANGISM_OF_MIDDLE_P...1,SET,4,-0.06374,-0.00094069,0.48857,0.5519,HP_SYMPHALANGISM_OF_MIDDLE_PHALANX_OF_5TH_FINGER,0.99999
GSE17721_LPS_VS_CPG_0.5H_BMD...1,SET,179,-0.0081105,-0.00079689,0.062133,0.55193,GSE17721_LPS_VS_CPG_0.5H_BMDC_DN,0.99999
GSE13306_LAMINA_PROPRIA_VS_S...2,SET,182,-0.0081513,-0.00080751,0.062427,0.55194,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP,0.99999
GALLUZZI_PERMEABILIZE_MITOCH...,SET,39,-0.018748,-0.00086315,0.14356,0.55195,GALLUZZI_PERMEABILIZE_MITOCHONDRIA,0.99999
GOBP_MEMBRANOUS_SEPTUM_MORPH...,SET,6,-0.054881,-0.00099192,0.42001,0.55198,GOBP_MEMBRANOUS_SEPTUM_MORPHOGENESIS,0.99999
KRAS.600.LUNG.BREAST_UP.V1_DN,SET,253,-0.0072103,-0.00084053,0.055182,0.55198,KRAS.600.LUNG.BREAST_UP.V1_DN,0.99999
TURJANSKI_MAPK1_AND_MAPK2_TA...,SET,11,-0.036921,-0.00090343,0.28232,0.55202,TURJANSKI_MAPK1_AND_MAPK2_TARGETS,0.99999
GSE17721_CTRL_VS_CPG_6H_BMDC...1,SET,178,-0.0080718,-0.00079089,0.061727,0.55202,GSE17721_CTRL_VS_CPG_6H_BMDC_DN,0.99999
PID_CXCR3_PATHWAY,SET,42,-0.017541,-0.000838,0.13404,0.55206,PID_CXCR3_PATHWAY,0.99999
REACTOME_FRUCTOSE_CATABOLISM,SET,5,-0.03845,-0.00063442,0.29378,0.55206,REACTOME_FRUCTOSE_CATABOLISM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...602,SET,44,-0.017601,-0.0008606,0.13444,0.55208,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.99999
GOMF_NUCLEASE_INHIBITOR_ACTI...,SET,6,-0.040915,-0.0007395,0.31223,0.55213,GOMF_NUCLEASE_INHIBITOR_ACTIVITY,0.99999
MORF_DNMT1,SET,104,-0.0099965,-0.00075021,0.076236,0.55216,MORF_DNMT1,0.99999
GSE19923_E2A_KO_VS_HEB_AND_E...2,SET,180,-0.0083747,-0.00082512,0.063812,0.55221,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.99999
GSE2405_HEAT_KILLED_LYSATE_V...2,SET,188,-0.0085377,-0.00085948,0.065044,0.55221,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,0.99999
GOBP_SEQUESTERING_OF_ACTIN_M...,SET,6,-0.046179,-0.00083465,0.35161,0.55224,GOBP_SEQUESTERING_OF_ACTIN_MONOMERS,0.99999
GOBP_GLYCOPROTEIN_CATABOLIC_...,SET,31,-0.021949,-0.00090112,0.16704,0.55227,GOBP_GLYCOPROTEIN_CATABOLIC_PROCESS,0.99999
GNF2_TNFRSF1B,SET,58,-0.014795,-0.00083025,0.11257,0.55229,GNF2_TNFRSF1B,0.99999
GSE46606_IRF4MID_VS_WT_CD40L...2,SET,171,-0.0081832,-0.00078604,0.06221,0.55233,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.99999
GSE20366_TREG_VS_NAIVE_CD4_T...6,SET,181,-0.0084015,-0.00083003,0.063851,0.55234,GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_CELL_FATE...2,SET,23,-0.023327,-0.00082508,0.17726,0.55235,GOBP_REGULATION_OF_CELL_FATE_SPECIFICATION,0.99999
ATF6_01,SET,118,-0.0098477,-0.00078692,0.074786,0.55238,ATF6_01,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...8,SET,28,-0.021507,-0.00083923,0.16323,0.55241,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,0.99999
MIR5590_3P,SET,318,-0.006229,-0.00081262,0.047173,0.55252,MIR5590_3P,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...8,SET,184,-0.0084437,-0.00084102,0.063858,0.5526,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP,0.99999
GSE24210_IL35_TREATED_VS_RES...2,SET,178,-0.0086445,-0.00084701,0.065319,0.55264,GSE24210_IL35_TREATED_VS_RESTING_TREG_UP,0.99999
GSE24634_NAIVE_CD4_TCELL_VS_...8,SET,181,-0.007856,-0.00077615,0.059302,0.55269,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP,0.99999
SESTO_RESPONSE_TO_UV_C8,SET,66,-0.014529,-0.00086951,0.10956,0.55275,SESTO_RESPONSE_TO_UV_C8,0.99999
GOBP_PRIMITIVE_HEMOPOIESIS,SET,8,-0.042596,-0.00088893,0.32122,0.55275,GOBP_PRIMITIVE_HEMOPOIESIS,0.99999
GOMF_PROTEIN_GERANYLGERANYLT...,SET,4,-0.049941,-0.00073705,0.3764,0.55278,GOMF_PROTEIN_GERANYLGERANYLTRANSFERASE_ACTIVITY,0.99999
GOBP_GLUCOSE_CATABOLIC_PROCE...,SET,21,-0.022431,-0.00075815,0.169,0.55279,GOBP_GLUCOSE_CATABOLIC_PROCESS,0.99999
GOBP_RENAL_SYSTEM_PROCESS,SET,117,-0.011098,-0.00088307,0.083509,0.55286,GOBP_RENAL_SYSTEM_PROCESS,0.99999
GSE3039_NKT_CELL_VS_ALPHAALP...1,SET,188,-0.0082927,-0.00083482,0.062252,0.55299,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_DN,0.99999
CHOP_01,SET,207,-0.0080901,-0.00085414,0.060669,0.55304,CHOP_01,0.99999
GOBP_CILIUM_DISASSEMBLY,SET,5,-0.047725,-0.00078745,0.35782,0.55305,GOBP_CILIUM_DISASSEMBLY,0.99999
RUTELLA_RESPONSE_TO_HGF_VS_C...1,SET,223,-0.0077579,-0.00084975,0.058158,0.55306,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,0.99999
HP_TRANSPOSITION_OF_THE_GREA...,SET,68,-0.013236,-0.00080399,0.099175,0.55308,HP_TRANSPOSITION_OF_THE_GREAT_ARTERIES,0.99999
KEGG_VASCULAR_SMOOTH_MUSCLE_...,SET,109,-0.011175,-0.00085844,0.083671,0.55312,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,0.99999
WGGAATGY_TEF1_Q6,SET,329,-0.0064517,-0.00085585,0.048284,0.55315,WGGAATGY_TEF1_Q6,0.99999
GSE42088_UNINF_VS_LEISHMANIA...3,SET,178,-0.0086373,-0.0008463,0.064626,0.55316,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN,0.99999
HP_ABNORMAL_CIRCULATING_ADRE...,SET,42,-0.017029,-0.00081353,0.12728,0.55322,HP_ABNORMAL_CIRCULATING_ADRENOCORTICOTROPIN_CONCENTRATION,0.99999
GSE2770_IL12_AND_TGFB_ACT_VS...6,SET,171,-0.0087875,-0.00084408,0.065677,0.55322,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP,0.99999
DESCARTES_FETAL_HEART_MYELOI...,SET,104,-0.011578,-0.00086892,0.086538,0.55322,DESCARTES_FETAL_HEART_MYELOID_CELLS,0.99999
SARRIO_EPITHELIAL_MESENCHYMA...1,SET,133,-0.010322,-0.00087533,0.077123,0.55324,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,0.99999
GOBP_REGULATION_OF_T_HELPER_...6,SET,12,-0.034075,-0.00087084,0.25453,0.55325,GOBP_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,0.99999
GOBP_RETINA_LAYER_FORMATION,SET,22,-0.026651,-0.00092196,0.19907,0.55325,GOBP_RETINA_LAYER_FORMATION,0.99999
GSE21927_SPLEEN_VS_C26GM_TUM...1,SET,162,-0.0087657,-0.00081973,0.065414,0.5533,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN,0.99999
HP_LISSENCEPHALY,SET,166,-0.0086868,-0.00082223,0.064802,0.55332,HP_LISSENCEPHALY,0.99999
GSE17721_12H_VS_24H_PAM3CSK4...1,SET,185,-0.0081043,-0.00080938,0.060459,0.55332,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_DN,0.99999
HP_ANTERIOR_PLAGIOCEPHALY,SET,5,-0.056701,-0.00093556,0.42261,0.55336,HP_ANTERIOR_PLAGIOCEPHALY,0.99999
MIR3935,SET,70,-0.013256,-0.00081691,0.098691,0.55342,MIR3935,0.99999
ACTAYRNNNCCCR_UNKNOWN,SET,411,-0.0055504,-0.00082107,0.041326,0.55342,ACTAYRNNNCCCR_UNKNOWN,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...33,SET,50,-0.017932,-0.00093448,0.13321,0.55354,GAVISH_3CA_MALIGNANT_METAPROGRAM_40_PDAC_RELATED,0.99999
MAYBURD_RESPONSE_TO_L663536_...2,SET,22,-0.022465,-0.00077716,0.16682,0.55356,MAYBURD_RESPONSE_TO_L663536_UP,0.99999
GOBP_CARDIAC_PACEMAKER_CELL_...2,SET,11,-0.037905,-0.00092751,0.28148,0.55356,GOBP_CARDIAC_PACEMAKER_CELL_DIFFERENTIATION,0.99999
GOBP_FATTY_ACID_DERIVATIVE_C...,SET,17,-0.027132,-0.00082519,0.20148,0.55356,GOBP_FATTY_ACID_DERIVATIVE_CATABOLIC_PROCESS,0.99999
GOMF_PEPTIDOGLYCAN_IMMUNE_RE...,SET,5,-0.05707,-0.00094163,0.42369,0.55357,GOMF_PEPTIDOGLYCAN_IMMUNE_RECEPTOR_ACTIVITY,0.99999
HP_TAPERED_DISTAL_PHALANGES_...,SET,6,-0.054096,-0.00097774,0.40164,0.55357,HP_TAPERED_DISTAL_PHALANGES_OF_FINGER,0.99999
GSE14350_TREG_VS_TEFF_UP,SET,181,-0.008221,-0.00081221,0.061025,0.55358,GSE14350_TREG_VS_TEFF_UP,0.99999
GSE5589_WT_VS_IL6_KO_LPS_STI...4,SET,172,-0.0083538,-0.00080474,0.062011,0.55358,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP,0.99999
HP_GASTROINTESTINAL_ARTERIOV...,SET,4,-0.068832,-0.0010158,0.51063,0.55361,HP_GASTROINTESTINAL_ARTERIOVENOUS_MALFORMATION,0.99999
REACTOME_RSV_HOST_INTERACTIO...,SET,84,-0.012674,-0.00085531,0.094003,0.55363,REACTOME_RSV_HOST_INTERACTIONS,0.99999
GSE24492_LYVE_NEG_VS_POS_MAC...2,SET,168,-0.0084296,-0.00080264,0.062518,0.55363,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP,0.99999
GSE32034_UNTREATED_VS_ROSIGL...2,SET,178,-0.00872,-0.00085441,0.064612,0.55368,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP,0.99999
FLECHNER_PBL_KIDNEY_TRANSPLA...1,SET,37,-0.018696,-0.00083842,0.13845,0.55371,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,0.99999
ACEVEDO_NORMAL_TISSUE_ADJACE...1,SET,320,-0.0063213,-0.00082721,0.046792,0.55373,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...13,SET,43,-0.019645,-0.00094956,0.14538,0.55374,GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC,0.99999
KEGG_CELL_CYCLE,SET,120,-0.010136,-0.00081675,0.074996,0.55375,KEGG_CELL_CYCLE,0.99999
HP_PERONEAL_MUSCLE_ATROPHY,SET,10,-0.039659,-0.00092529,0.29345,0.55375,HP_PERONEAL_MUSCLE_ATROPHY,0.99999
HP_SHORT_THUMB,SET,104,-0.011221,-0.00084208,0.083019,0.55376,HP_SHORT_THUMB,0.99999
HP_KETOTIC_HYPOGLYCEMIA,SET,12,-0.034102,-0.00087153,0.25212,0.5538,HP_KETOTIC_HYPOGLYCEMIA,0.99999
MIR4273,SET,94,-0.011805,-0.00084246,0.087245,0.55381,MIR4273,0.99999
GSE360_T_GONDII_VS_B_MALAYI_...8,SET,174,-0.0084844,-0.00082202,0.06266,0.55385,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.99999
chr16q22,SET,105,-0.022947,-0.0017303,0.16942,0.55387,chr16q22,0.99999
FOXQ1_TARGET_GENES,SET,34,-0.02114,-0.00090886,0.15586,0.55395,FOXQ1_TARGET_GENES,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...38,SET,10,-0.035372,-0.00082526,0.26074,0.55395,HP_APLASIA_HYPOPLASIA_OF_THE_INNER_EAR,0.99999
GOBP_RNA_DECAPPING,SET,17,-0.026971,-0.00082028,0.19878,0.55396,GOBP_RNA_DECAPPING,0.99999
GOBP_CHITIN_METABOLIC_PROCESS,SET,6,-0.04786,-0.00086502,0.35252,0.55399,GOBP_CHITIN_METABOLIC_PROCESS,0.99999
GOMF_CHITINASE_ACTIVITY,SET,6,-0.04786,-0.00086502,0.35252,0.55399,GOMF_CHITINASE_ACTIVITY,0.99999
GSE24142_DN2_VS_DN3_THYMOCYT...6,SET,184,-0.0085205,-0.00084867,0.062771,0.55399,GSE24142_DN2_VS_DN3_THYMOCYTE_UP,0.99999
GOCC_AP_TYPE_MEMBRANE_COAT_A...,SET,39,-0.017339,-0.00079826,0.12767,0.55401,GOCC_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX,0.99999
GSE21927_SPLEEN_MONOCYTE_VS_...2,SET,151,-0.0087323,-0.00078863,0.064297,0.55401,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_UP,0.99999
GOCC_EXTERNAL_ENCAPSULATING_...,SET,518,-0.0054664,-0.00090512,0.04021,0.55407,GOCC_EXTERNAL_ENCAPSULATING_STRUCTURE,0.99999
MORF_PRKACA,SET,109,-0.010812,-0.00083057,0.079513,0.55408,MORF_PRKACA,0.99999
GTCAGGA_MIR378,SET,50,-0.016087,-0.00083836,0.11817,0.55414,GTCAGGA_MIR378,0.99999
SETLUR_PROSTATE_CANCER_TMPRS...1,SET,16,-0.029904,-0.00088238,0.21943,0.5542,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN,0.99999
AACATTC_MIR4093P,SET,137,-0.0099597,-0.0008571,0.073057,0.55422,AACATTC_MIR4093P,0.99999
GOBP_VITAMIN_D3_METABOLIC_PR...,SET,7,-0.038862,-0.00075865,0.28467,0.55429,GOBP_VITAMIN_D3_METABOLIC_PROCESS,0.99999
HP_HIP_SUBLUXATION,SET,19,-0.026304,-0.0008457,0.19263,0.55431,HP_HIP_SUBLUXATION,0.99999
MORF_RAB11A,SET,51,-0.013978,-0.00073567,0.10234,0.55432,MORF_RAB11A,0.99999
GOBP_SENSORY_PERCEPTION_OF_C...,SET,403,-0.0078188,-0.0011456,0.057229,0.55434,GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS,0.99999
FAN_OVARY_CL16_LYMPHATIC_END...,SET,206,-0.0085007,-0.00089534,0.062212,0.55434,FAN_OVARY_CL16_LYMPHATIC_ENDOTHELIAL_CELL,0.99999
WP_ROBO4_AND_VEGF_SIGNALING_...,SET,6,-0.050039,-0.00090442,0.36599,0.55437,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,0.99999
CDPCR3HD_01,SET,213,-0.0082912,-0.00088782,0.060652,0.55437,CDPCR3HD_01,0.99999
GOMF_CYSTEINE_TYPE_ENDOPEPTI...2,SET,80,-0.012846,-0.00084612,0.093961,0.55437,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.99999
REACTOME_INTERLEUKIN_RECEPTO...,SET,23,-0.025795,-0.00091238,0.18862,0.55439,REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING,0.99999
GOBP_CELLULAR_RESPONSE_TO_VI...1,SET,70,-0.01481,-0.0009127,0.10808,0.5545,GOBP_CELLULAR_RESPONSE_TO_VIRUS,0.99999
FUJIWARA_PARK2_IN_LIVER_CANC...1,SET,5,-0.056336,-0.00092954,0.41038,0.55459,FUJIWARA_PARK2_IN_LIVER_CANCER_DN,0.99999
REACTOME_OXIDATIVE_STRESS_IN...,SET,61,-0.015326,-0.00088192,0.11157,0.55463,REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,0.99999
HP_DYSARTHRIA,SET,537,-0.0048736,-0.00082119,0.035481,0.55463,HP_DYSARTHRIA,0.99999
MATSUMIYA_BLOOD_MODIFIED_VAC...2,SET,13,-0.029721,-0.00079056,0.2163,0.55464,MATSUMIYA_BLOOD_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...821,SET,12,-0.03551,-0.0009075,0.25825,0.55468,GOBP_POSITIVE_REGULATION_OF_URINE_VOLUME,0.99999
GOBP_MYOTUBE_DIFFERENTIATION...,SET,7,-0.050272,-0.00098139,0.36555,0.55469,GOBP_MYOTUBE_DIFFERENTIATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.99999
GOMF_VITAMIN_TRANSMEMBRANE_T...,SET,33,-0.020536,-0.00086982,0.14933,0.55469,GOMF_VITAMIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_MACROMOLECULE_DEACYLATI...,SET,53,-0.015137,-0.00081207,0.1099,0.55477,GOBP_MACROMOLECULE_DEACYLATION,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...2,SET,181,-0.0085355,-0.00084327,0.061928,0.55481,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP,0.99999
MIR625_5P,SET,190,-0.0085064,-0.00086083,0.061676,0.55485,MIR625_5P,0.99999
GATA_Q6,SET,177,-0.0091563,-0.00089465,0.06638,0.55485,GATA_Q6,0.99999
GOBP_EMBRYONIC_PLACENTA_MORP...,SET,24,-0.025318,-0.00091475,0.18341,0.55489,GOBP_EMBRYONIC_PLACENTA_MORPHOGENESIS,0.99999
GOMF_OLEATE_TRANSMEMBRANE_TR...,SET,6,-0.048103,-0.00086942,0.34849,0.55489,GOMF_OLEATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_NADP_METABOLIC_PROCESS,SET,40,-0.018821,-0.00087751,0.13628,0.55492,GOBP_NADP_METABOLIC_PROCESS,0.99999
GSE22935_WT_VS_MYD88_KO_MACR...2,SET,188,-0.0084006,-0.00084568,0.060816,0.55493,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP,0.99999
GOBP_DETOXIFICATION,SET,129,-0.010746,-0.00089753,0.077657,0.55503,GOBP_DETOXIFICATION,0.99999
CUI_TCF21_TARGETS_2_UP,SET,390,-0.0060406,-0.00087096,0.043643,0.55504,CUI_TCF21_TARGETS_2_UP,0.99999
HP_CSF_PLEOCYTOSIS,SET,23,-0.023246,-0.00082222,0.16792,0.55505,HP_CSF_PLEOCYTOSIS,0.99999
GSE12003_MIR223_KO_VS_WT_BM_...4,SET,105,-0.011415,-0.00086075,0.082427,0.55507,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_UP,0.99999
HP_ABNORMAL_FULL_FIELD_ELECT...,SET,55,-0.017039,-0.00093116,0.12297,0.5551,HP_ABNORMAL_FULL_FIELD_ELECTRORETINOGRAM,0.99999
WP_HEPATITIS_B_INFECTION,SET,141,-0.010135,-0.0008847,0.073044,0.55517,WP_HEPATITIS_B_INFECTION,0.99999
GOBP_REGULATION_OF_CALCIDIOL...,SET,7,-0.046076,-0.00089949,0.33213,0.55517,GOBP_REGULATION_OF_CALCIDIOL_1_MONOOXYGENASE_ACTIVITY,0.99999
CHIARETTI_ACUTE_LYMPHOBLASTI...,SET,63,-0.013727,-0.00080272,0.098903,0.55519,CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,0.99999
SIG_BCR_SIGNALING_PATHWAY,SET,45,-0.017302,-0.00085551,0.12462,0.55521,SIG_BCR_SIGNALING_PATHWAY,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...2,SET,42,-0.018923,-0.00090398,0.13626,0.55522,GAVISH_3CA_METAPROGRAM_EPITHELIAL_ANDROGEN_PROSTATE,0.99999
MIR1537_5P,SET,109,-0.01132,-0.00086962,0.081496,0.55524,MIR1537_5P,0.99999
SAFB2_TARGET_GENES,SET,614,-0.0048279,-0.00086798,0.034746,0.55525,SAFB2_TARGET_GENES,0.99999
GOBP_DETECTION_OF_BIOTIC_STI...,SET,33,-0.020818,-0.00088177,0.14978,0.55527,GOBP_DETECTION_OF_BIOTIC_STIMULUS,0.99999
WP_CALCIUM_MEDIATED_TCELL_AP...,SET,20,-0.026339,-0.00086883,0.18926,0.55534,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.99999
GOBP_RESPONSE_TO_BACTERIUM,SET,611,-0.0051853,-0.00093003,0.037248,0.55536,GOBP_RESPONSE_TO_BACTERIUM,0.99999
GOBP_NEUROTRANSMITTER_REUPTA...,SET,33,-0.022009,-0.00093224,0.15798,0.5554,GOBP_NEUROTRANSMITTER_REUPTAKE,0.99999
MIR4530,SET,133,-0.01033,-0.000876,0.074062,0.55546,MIR4530,0.99999
GOBP_REGULATION_OF_EPITHELIA...5,SET,334,-0.006793,-0.00090783,0.04871,0.55546,GOBP_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,0.99999
HP_HYPERCHOLESTEROLEMIA,SET,69,-0.015257,-0.0009335,0.10925,0.55553,HP_HYPERCHOLESTEROLEMIA,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...60,SET,39,-0.016763,-0.00077173,0.12001,0.55554,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...6,SET,142,-0.0099231,-0.00086927,0.071034,0.55555,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,0.99999
GOMF_PHOSPHOLIPID_TRANSPORTE...,SET,58,-0.015468,-0.00086796,0.11071,0.55556,GOMF_PHOSPHOLIPID_TRANSPORTER_ACTIVITY,0.99999
GOBP_CALCIUM_INDEPENDENT_CEL...,SET,22,-0.028069,-0.00097101,0.2006,0.55564,GOBP_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,0.99999
RODRIGUES_THYROID_CARCINOMA_...5,SET,586,-0.0048519,-0.00085284,0.034671,0.55565,RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP,0.99999
WP_OMEGA9_FATTY_ACID_SYNTHES...,SET,13,-0.036388,-0.00096788,0.25997,0.55566,WP_OMEGA9_FATTY_ACID_SYNTHESIS,0.99999
GSE33425_CD161_HIGH_VS_NEG_C...1,SET,178,-0.0091217,-0.00089376,0.065082,0.55573,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN,0.99999
GSE2128_CTRL_VS_MIMETOPE_NEG...2,SET,158,-0.0094932,-0.00087683,0.067711,0.55575,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_UP,0.99999
CREB3L2_TARGET_GENES,SET,115,-0.011357,-0.00089602,0.080995,0.55576,CREB3L2_TARGET_GENES,0.99999
GOBP_ANTIBACTERIAL_INNATE_IM...,SET,8,-0.042965,-0.00089664,0.30614,0.55581,GOBP_ANTIBACTERIAL_INNATE_IMMUNE_RESPONSE,0.99999
GSE39820_TGFBETA1_IL6_VS_TGF...1,SET,181,-0.0086001,-0.00084965,0.061266,0.55582,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN,0.99999
GOBP_T_CELL_ACTIVATION_INVOL...,SET,115,-0.012108,-0.00095521,0.086097,0.55592,GOBP_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
HE_LIM_SUN_FETAL_LUNG_C5_DEL...,SET,3,-0.071562,-0.00091466,0.50808,0.556,HE_LIM_SUN_FETAL_LUNG_C5_DELTA_SMALL_PRE_B_CELL,0.99999
MIR4780,SET,38,-0.019892,-0.00090401,0.14122,0.55601,MIR4780,0.99999
GOBP_REGULATION_OF_HYDROGEN_...2,SET,9,-0.039629,-0.00087716,0.28116,0.55604,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH,0.99999
GOBP_CELL_COMMUNICATION_BY_E...2,SET,26,-0.02531,-0.00095176,0.1791,0.55619,GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION,0.99999
NGFIC_01,SET,223,-0.0078558,-0.00086048,0.055565,0.55621,NGFIC_01,0.99999
GOCC_PROTEIN_PHOSPHATASE_TYP...2,SET,16,-0.029732,-0.00087729,0.21021,0.55624,GOCC_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX,0.99999
HP_ABNORMAL_REFLEX,SET,1088,-0.003628,-0.00085659,0.025644,0.55625,HP_ABNORMAL_REFLEX,0.99999
MORF_PPP1CA,SET,145,-0.0089627,-0.00079333,0.06334,0.55626,MORF_PPP1CA,0.99999
GOBP_REGULATION_OF_CELL_CELL...1,SET,461,-0.0059599,-0.00093244,0.042099,0.55629,GOBP_REGULATION_OF_CELL_CELL_ADHESION,0.99999
MENON_FETAL_KIDNEY_5_PROXIMA...,SET,88,-0.01313,-0.00090683,0.092724,0.5563,MENON_FETAL_KIDNEY_5_PROXIMAL_TUBULE_CELLS,0.99999
GOCC_VACUOLAR_PROTON_TRANSPO...,SET,8,-0.037039,-0.00077296,0.26147,0.55632,GOCC_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN,0.99999
HP_HERPES_SIMPLEX_ENCEPHALIT...,SET,9,-0.038817,-0.0008592,0.27397,0.55633,HP_HERPES_SIMPLEX_ENCEPHALITIS,0.99999
GOCC_EGG_COAT,SET,5,-0.046596,-0.00076882,0.3288,0.55635,GOCC_EGG_COAT,0.99999
MIR4283,SET,185,-0.0086834,-0.00086722,0.061262,0.55636,MIR4283,0.99999
SESTO_RESPONSE_TO_UV_C4,SET,20,-0.025242,-0.00083263,0.17805,0.55637,SESTO_RESPONSE_TO_UV_C4,0.99999
GOMF_CALCIUM_INDEPENDENT_PHO...,SET,9,-0.038043,-0.00084205,0.26834,0.55637,GOMF_CALCIUM_INDEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY,0.99999
HP_ABNORMAL_ATRIOVENTRICULAR...1,SET,87,-0.013053,-0.0008964,0.092031,0.55639,HP_ABNORMAL_ATRIOVENTRICULAR_CONDUCTION,0.99999
HP_PARAPLEGIA,SET,126,-0.010826,-0.00089373,0.076336,0.55639,HP_PARAPLEGIA,0.99999
GSE25088_IL4_VS_IL4_AND_ROSI...3,SET,178,-0.0089888,-0.00088075,0.063351,0.55642,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,0.99999
GUTIERREZ_WALDENSTROEMS_MACR...3,SET,10,-0.04141,-0.00096614,0.29096,0.55659,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2,0.99999
GOCC_PLASMA_MEMBRANE_RAFT,SET,106,-0.012079,-0.00091509,0.084761,0.55666,GOCC_PLASMA_MEMBRANE_RAFT,0.99999
GOMF_CHROMATIN_BINDING,SET,522,-0.0052085,-0.00086563,0.036517,0.55671,GOMF_CHROMATIN_BINDING,0.99999
HP_STEREOTYPICAL_BODY_ROCKING,SET,6,-0.044138,-0.00079776,0.30945,0.55671,HP_STEREOTYPICAL_BODY_ROCKING,0.99999
GALLUZZI_PREVENT_MITOCHONDIA...,SET,14,-0.034931,-0.00096419,0.24475,0.55674,GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,0.99999
KIM_GERMINAL_CENTER_T_HELPER...1,SET,12,-0.040236,-0.0010283,0.28194,0.55674,KIM_GERMINAL_CENTER_T_HELPER_DN,0.99999
WP_CYTOPLASMIC_RIBOSOMAL_PRO...,SET,78,-0.013112,-0.00085278,0.091827,0.55677,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,0.99999
GOMF_RNA_DNA_HYBRID_RIBONUCL...,SET,6,-0.05075,-0.00091725,0.35542,0.55677,GOMF_RNA_DNA_HYBRID_RIBONUCLEASE_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_NUCLE...2,SET,11,-0.038803,-0.00094948,0.27168,0.55679,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_RETROGRAD...1,SET,12,-0.031559,-0.00080653,0.22085,0.55681,GOBP_REGULATION_OF_RETROGRADE_PROTEIN_TRANSPORT_ER_TO_CYTOSOL,0.99999
NAISHIRO_CTNNB1_TARGETS_WITH...,SET,8,-0.047125,-0.00098344,0.32974,0.55682,NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF,0.99999
GSE41867_NAIVE_VS_DAY6_LCMV_...1,SET,187,-0.0089414,-0.00089775,0.062486,0.55689,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.99999
TEF_Q6,SET,235,-0.0083451,-0.00093803,0.058275,0.55693,TEF_Q6,0.99999
GOBP_POSITIVE_REGULATION_OF_...722,SET,22,-0.026289,-0.00090945,0.18315,0.55707,GOBP_POSITIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS,0.99999
HP_ABNORMALITY_OF_PERIPHERAL...,SET,129,-0.01026,-0.00085697,0.07148,0.55707,HP_ABNORMALITY_OF_PERIPHERAL_NERVE_CONDUCTION,0.99999
GAVIN_FOXP3_TARGETS_CLUSTER_...1,SET,72,-0.014466,-0.00090412,0.10067,0.55713,GAVIN_FOXP3_TARGETS_CLUSTER_P2,0.99999
GOBP_ANGIOGENESIS_INVOLVED_I...2,SET,27,-0.02476,-0.00094877,0.17222,0.55716,GOBP_ANGIOGENESIS_INVOLVED_IN_WOUND_HEALING,0.99999
GOCC_NEURONAL_DENSE_CORE_VES...1,SET,25,-0.027593,-0.0010175,0.19191,0.55716,GOCC_NEURONAL_DENSE_CORE_VESICLE,0.99999
GSE36476_CTRL_VS_TSST_ACT_40...4,SET,177,-0.0091427,-0.00089332,0.063576,0.55717,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP,0.99999
SS18_SSX1_FUSION_UNIPROT_Q8I...,SET,311,-0.0073603,-0.00094977,0.051174,0.55718,SS18_SSX1_FUSION_UNIPROT_Q8IZH1_UNREVIEWED_TARGET_GENES,0.99999
GOBP_LUNG_ASSOCIATED_MESENCH...,SET,9,-0.044696,-0.00098932,0.31077,0.55718,GOBP_LUNG_ASSOCIATED_MESENCHYME_DEVELOPMENT,0.99999
MIR6835_5P,SET,30,-0.020764,-0.00083865,0.14425,0.55723,MIR6835_5P,0.99999
KEGG_MEDICUS_REFERENCE_BMP_S...1,SET,20,-0.028525,-0.00094092,0.19811,0.55724,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY,0.99999
HP_DECREASED_DLCO,SET,22,-0.024853,-0.00085976,0.17261,0.55724,HP_DECREASED_DLCO,0.99999
GOBP_NEGATIVE_REGULATION_OF_...417,SET,57,-0.016152,-0.00089855,0.11214,0.55726,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...10,SET,50,-0.019029,-0.00099168,0.13207,0.55728,GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...1,SET,236,-0.0080575,-0.00090761,0.055892,0.55731,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_FEET,0.99999
HP_PULMONARY_EMBOLISM,SET,35,-0.021025,-0.00091709,0.14549,0.55745,HP_PULMONARY_EMBOLISM,0.99999
REACTOME_HCMV_EARLY_EVENTS,SET,68,-0.014862,-0.00090276,0.10283,0.55746,REACTOME_HCMV_EARLY_EVENTS,0.99999
GSE9601_UNTREATED_VS_PI3K_IN...2,SET,156,-0.009513,-0.00087313,0.065824,0.55746,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,0.99999
FISCHER_DIRECT_P53_TARGETS_M...,SET,290,-0.0069956,-0.0008722,0.048361,0.55751,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,0.99999
HP_ABNORMAL_CIRCULATING_APOL...,SET,8,-0.044767,-0.00093424,0.30876,0.55764,HP_ABNORMAL_CIRCULATING_APOLIPOPROTEIN_CONCENTRATION,0.99999
HP_THYROID_DEFECT_IN_OXIDATI...,SET,6,-0.049997,-0.00090365,0.3447,0.55766,HP_THYROID_DEFECT_IN_OXIDATION_AND_ORGANIFICATION_OF_IODIDE,0.99999
GAVIN_FOXP3_TARGETS_CLUSTER_...2,SET,147,-0.01029,-0.000917,0.070807,0.55777,GAVIN_FOXP3_TARGETS_CLUSTER_P3,0.99999
HP_DECREASED_CERVICAL_SPINE_...2,SET,11,-0.034227,-0.0008375,0.23535,0.55781,HP_DECREASED_CERVICAL_SPINE_MOBILITY,0.99999
GOBP_DORSAL_VENTRAL_AXIS_SPE...,SET,14,-0.036128,-0.00099724,0.24818,0.55787,GOBP_DORSAL_VENTRAL_AXIS_SPECIFICATION,0.99999
GOBP_PINOCYTOSIS,SET,20,-0.024957,-0.00082322,0.17138,0.55789,GOBP_PINOCYTOSIS,0.99999
REACTOME_CELLULAR_RESPONSE_T...3,SET,70,-0.013395,-0.00082548,0.091967,0.5579,REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,0.99999
BURTON_ADIPOGENESIS_12,SET,28,-0.022492,-0.00087767,0.15428,0.55795,BURTON_ADIPOGENESIS_12,0.99999
HP_ABNORMAL_PATTERN_OF_RESPI...,SET,677,-0.0048117,-0.00090676,0.032978,0.558,HP_ABNORMAL_PATTERN_OF_RESPIRATION,0.99999
HP_IRIS_ATROPHY,SET,8,-0.052081,-0.0010869,0.35685,0.55802,HP_IRIS_ATROPHY,0.99999
REACTOME_PEROXISOMAL_PROTEIN...,SET,60,-0.015947,-0.00091009,0.10923,0.55804,REACTOME_PEROXISOMAL_PROTEIN_IMPORT,0.99999
ZHONG_SECRETOME_OF_LUNG_CANC...1,SET,63,-0.01583,-0.00092569,0.10841,0.55805,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,0.99999
GOCC_CILIARY_TRANSITION_FIBER,SET,8,-0.042995,-0.00089726,0.29434,0.55807,GOCC_CILIARY_TRANSITION_FIBER,0.99999
GSE2770_IL12_AND_TGFB_ACT_VS...5,SET,180,-0.008884,-0.0008753,0.060793,0.55809,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN,0.99999
GOBP_SCHWANN_CELL_DIFFERENTI...,SET,47,-0.018036,-0.00091134,0.12341,0.5581,GOBP_SCHWANN_CELL_DIFFERENTIATION,0.99999
GOMF_ACYLGLYCEROL_LIPASE_ACT...,SET,15,-0.030736,-0.00087815,0.21028,0.5581,GOMF_ACYLGLYCEROL_LIPASE_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_COHES...3,SET,14,-0.033025,-0.00091158,0.22591,0.55811,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE,0.99999
MIR6809_5P,SET,125,-0.011014,-0.00090564,0.075262,0.55817,MIR6809_5P,0.99999
HP_RECTAL_POLYPOSIS,SET,5,-0.057083,-0.00094186,0.38979,0.55821,HP_RECTAL_POLYPOSIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...635,SET,98,-0.0123,-0.0008962,0.083977,0.55822,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.99999
GOBP_CHORIONIC_TROPHOBLAST_C...2,SET,5,-0.055566,-0.00091682,0.37902,0.55828,GOBP_CHORIONIC_TROPHOBLAST_CELL_PROLIFERATION,0.99999
GOBP_HYPOTHALAMUS_CELL_MIGRA...,SET,6,-0.05974,-0.0010798,0.40739,0.55829,GOBP_HYPOTHALAMUS_CELL_MIGRATION,0.99999
ZHAN_MULTIPLE_MYELOMA_CD1_UP,SET,40,-0.02051,-0.00095625,0.13978,0.55832,ZHAN_MULTIPLE_MYELOMA_CD1_UP,0.99999
MIR4436B_5P,SET,121,-0.011794,-0.00095425,0.080374,0.55833,MIR4436B_5P,0.99999
GOMF_I_SMAD_BINDING,SET,16,-0.034244,-0.0010104,0.2333,0.55835,GOMF_I_SMAD_BINDING,0.99999
GOBP_MITOTIC_SPINDLE_ORGANIZ...,SET,124,-0.010515,-0.00086122,0.071506,0.55845,GOBP_MITOTIC_SPINDLE_ORGANIZATION,0.99999
HOEK_MONOCYTE_2011_2012_TIV_...4,SET,2,-0.10811,-0.0011282,0.73517,0.55845,HOEK_MONOCYTE_2011_2012_TIV_ADULT_3DY_UP,0.99999
GAVIN_FOXP3_TARGETS_CLUSTER_...4,SET,84,-0.014118,-0.00095275,0.095986,0.55847,GAVIN_FOXP3_TARGETS_CLUSTER_P6,0.99999
SEMENZA_HIF1_TARGETS,SET,32,-0.02322,-0.00096852,0.15777,0.5585,SEMENZA_HIF1_TARGETS,0.99999
LEE_CALORIE_RESTRICTION_NEOC...1,SET,59,-0.015208,-0.0008607,0.1033,0.55852,LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...38,SET,82,-0.013328,-0.00088871,0.090528,0.55852,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY,0.99999
GSE6674_UNSTIM_VS_ANTI_IGM_A...2,SET,185,-0.0089009,-0.00088894,0.06044,0.55854,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,0.99999
MIR5681A,SET,135,-0.010427,-0.00089081,0.070667,0.55865,MIR5681A,0.99999
REACTOME_GLUTATHIONE_SYNTHES...,SET,12,-0.033986,-0.00086856,0.23032,0.55866,REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING,0.99999
SMID_BREAST_CANCER_RELAPSE_I...5,SET,10,-0.037494,-0.00087478,0.25402,0.55867,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN,0.99999
OVOL3_TARGET_GENES,SET,392,-0.006142,-0.0008878,0.04161,0.55867,OVOL3_TARGET_GENES,0.99999
MORF_LCAT,SET,118,-0.011883,-0.00094951,0.080498,0.55867,MORF_LCAT,0.99999
GOMF_SMALL_PROTEIN_ACTIVATIN...,SET,5,-0.044749,-0.00073834,0.30303,0.5587,GOMF_SMALL_PROTEIN_ACTIVATING_ENZYME_BINDING,0.99999
BIOCARTA_WNT_PATHWAY,SET,23,-0.027545,-0.00097428,0.18646,0.55872,BIOCARTA_WNT_PATHWAY,0.99999
HP_INABILITY_TO_WALK,SET,327,-0.0067238,-0.00088928,0.045514,0.55872,HP_INABILITY_TO_WALK,0.99999
GOBP_GLUTATHIONE_TRANSMEMBRA...,SET,8,-0.045362,-0.00094666,0.30674,0.55878,GOBP_GLUTATHIONE_TRANSMEMBRANE_TRANSPORT,0.99999
WP_KENNEDY_PATHWAY_FROM_SPHI...,SET,13,-0.033901,-0.00090175,0.22923,0.55879,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,0.99999
GOBP_2_OXOGLUTARATE_METABOLI...,SET,16,-0.030271,-0.00089319,0.20468,0.55879,GOBP_2_OXOGLUTARATE_METABOLIC_PROCESS,0.99999
GOBP_GLUTATHIONE_METABOLIC_P...,SET,46,-0.019105,-0.00095509,0.12908,0.55883,GOBP_GLUTATHIONE_METABOLIC_PROCESS,0.99999
MIR6742_3P,SET,94,-0.012624,-0.00090096,0.085237,0.55887,MIR6742_3P,0.99999
CEBP_Q3,SET,218,-0.0089633,-0.00097086,0.060467,0.55892,CEBP_Q3,0.99999
GNF2_SMC2L1,SET,32,-0.022406,-0.00093459,0.15114,0.55892,GNF2_SMC2L1,0.99999
MARKS_HDAC_TARGETS_UP,SET,20,-0.029484,-0.00097257,0.19886,0.55893,MARKS_HDAC_TARGETS_UP,0.99999
MIR4534,SET,146,-0.010224,-0.00090809,0.068921,0.55896,MIR4534,0.99999
GSE1791_CTRL_VS_NEUROMEDINU_...3,SET,141,-0.010998,-0.00096002,0.074127,0.55897,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN,0.99999
GSE1740_MCSF_VS_MCSF_AND_IFN...4,SET,184,-0.0091137,-0.00090776,0.061416,0.55898,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP,0.99999
BIOCARTA_CHEMICAL_PATHWAY,SET,18,-0.029714,-0.00092989,0.20021,0.55899,BIOCARTA_CHEMICAL_PATHWAY,0.99999
GSE360_L_DONOVANI_VS_M_TUBER...2,SET,177,-0.0093158,-0.00091023,0.062726,0.55903,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP,0.99999
GOMF_LIPASE_ACTIVATOR_ACTIVI...,SET,18,-0.027465,-0.00085951,0.18491,0.55904,GOMF_LIPASE_ACTIVATOR_ACTIVITY,0.99999
GSE20715_0H_VS_48H_OZONE_TLR...2,SET,186,-0.0093171,-0.00093299,0.062716,0.55905,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP,0.99999
MIR5193,SET,158,-0.010143,-0.00093684,0.068265,0.55906,MIR5193,0.99999
KEGG_MEDICUS_REFERENCE_NOTCH...3,SET,10,-0.035869,-0.00083685,0.24133,0.55908,KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION,0.99999
WP_HEDGEHOG_SIGNALING_WP4249,SET,41,-0.020075,-0.00094757,0.13505,0.55908,WP_HEDGEHOG_SIGNALING_WP4249,0.99999
MIR4291,SET,351,-0.0066158,-0.00090594,0.04451,0.55908,MIR4291,0.99999
GOBP_NUCLEAR_TRANSCRIBED_MRN...4,SET,35,-0.01988,-0.00086712,0.13349,0.55919,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,0.99999
MIR4458,SET,318,-0.0072433,-0.00094494,0.048632,0.5592,MIR4458,0.99999
GSE33424_CD161_INT_VS_NEG_CD...1,SET,181,-0.0092224,-0.00091113,0.061877,0.55924,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN,0.99999
WP_SARSCOV2_B117_VARIANT_ANT...,SET,7,-0.044696,-0.00087254,0.29976,0.55926,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,0.99999
GSE27786_NKCELL_VS_NKTCELL_UP,SET,187,-0.0091153,-0.00091521,0.061067,0.55933,GSE27786_NKCELL_VS_NKTCELL_UP,0.99999
GCM_DDX5,SET,59,-0.015353,-0.00086893,0.10284,0.55934,GCM_DDX5,0.99999
JINESH_BLEBBISHIELD_TRANSFOR...1,SET,247,-0.0078506,-0.0009044,0.052556,0.55937,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,0.99999
GOMF_CYSTEINE_TYPE_ENDOPEPTI...8,SET,37,-0.020581,-0.00092295,0.13778,0.55937,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.99999
GSE36392_TYPE_2_MYELOID_VS_E...2,SET,177,-0.0091339,-0.00089247,0.061147,0.55937,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP,0.99999
TAGHAVI_NEOPLASTIC_TRANSFORM...,SET,11,-0.031885,-0.0007802,0.21341,0.55938,TAGHAVI_NEOPLASTIC_TRANSFORMATION,0.99999
GOBP_EPITHELIAL_CELL_APOPTOT...,SET,128,-0.011725,-0.00097558,0.07848,0.55938,GOBP_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_EMBRYONIC_ORGAN_MORPHOG...,SET,281,-0.0080444,-0.00098753,0.053816,0.55941,GOBP_EMBRYONIC_ORGAN_MORPHOGENESIS,0.99999
HOEK_NK_CELL_2011_2012_TIV_A...2,SET,12,-0.035304,-0.00090225,0.23613,0.55942,HOEK_NK_CELL_2011_2012_TIV_ADULT_3DY_UP,0.99999
GOBP_PROTEIN_K63_LINKED_DEUB...,SET,21,-0.025591,-0.00086498,0.17115,0.55943,GOBP_PROTEIN_K63_LINKED_DEUBIQUITINATION,0.99999
REACTOME_REELIN_SIGNALLING_P...,SET,4,-0.067735,-0.00099965,0.45212,0.55954,REACTOME_REELIN_SIGNALLING_PATHWAY,0.99999
GSE40274_CTRL_VS_XBP1_TRANSD...2,SET,156,-0.01044,-0.00095817,0.069556,0.55965,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GOBP_BLASTOCYST_GROWTH,SET,21,-0.026181,-0.00088492,0.17434,0.55969,GOBP_BLASTOCYST_GROWTH,0.99999
SCHERER_PBMC_YF_VAX_AGE_18_4...3,SET,17,-0.031963,-0.00097211,0.21281,0.55969,SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_DN,0.99999
GOCC_GPI_ANCHOR_TRANSAMIDASE...,SET,5,-0.047198,-0.00077876,0.31415,0.55971,GOCC_GPI_ANCHOR_TRANSAMIDASE_COMPLEX,0.99999
chr1q21,SET,161,-0.022039,-0.0020547,0.14668,0.55972,chr1q21,0.99999
DESCARTES_FETAL_EYE_STROMAL_...,SET,81,-0.015259,-0.0010113,0.10151,0.55975,DESCARTES_FETAL_EYE_STROMAL_CELLS,0.99999
S8_01,SET,230,-0.0089483,-0.00099522,0.059498,0.55977,S8_01,0.99999
GSE27786_LSK_VS_MONO_MAC_UP,SET,174,-0.0092629,-0.00089744,0.06154,0.55982,GSE27786_LSK_VS_MONO_MAC_UP,0.99999
MIR199B_5P,SET,164,-0.009508,-0.00089457,0.063153,0.55984,MIR199B_5P,0.99999
MIR3171,SET,73,-0.013628,-0.00085762,0.09044,0.55989,MIR3171,0.99999
HP_LOWER_LIMB_HYPERTONIA,SET,32,-0.021157,-0.00088248,0.14022,0.55997,HP_LOWER_LIMB_HYPERTONIA,0.99999
HP_UNEXPLAINED_FEVERS,SET,18,-0.029912,-0.00093609,0.19823,0.55997,HP_UNEXPLAINED_FEVERS,0.99999
HP_FALCIFORM_RETINAL_FOLD,SET,5,-0.058081,-0.00095833,0.38465,0.56001,HP_FALCIFORM_RETINAL_FOLD,0.99999
GSE21927_BALBC_VS_C57BL6_MON...2,SET,153,-0.01043,-0.00094812,0.068907,0.56015,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_UP,0.99999
GSE27786_LIN_NEG_VS_NKTCELL_...1,SET,184,-0.008901,-0.00088657,0.058813,0.56015,GSE27786_LIN_NEG_VS_NKTCELL_DN,0.99999
GOBP_SYNAPTIC_VESICLE_PRIMING,SET,19,-0.026074,-0.00083832,0.1722,0.56017,GOBP_SYNAPTIC_VESICLE_PRIMING,0.99999
GOBP_PHAGOSOME_LYSOSOME_FUSI...,SET,13,-0.037093,-0.00098666,0.24483,0.56021,GOBP_PHAGOSOME_LYSOSOME_FUSION,0.99999
REACTOME_FACTORS_INVOLVED_IN...,SET,144,-0.011165,-0.0009849,0.07367,0.56023,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,0.99999
MIR514A_3P_MIR514B_3P,SET,101,-0.012624,-0.0009337,0.083239,0.56027,MIR514A_3P_MIR514B_3P,0.99999
GSE19198_CTRL_VS_IL21_TREATE...4,SET,183,-0.010023,-0.00099561,0.066054,0.5603,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_UP,0.99999
GOCC_TRANSCRIPTION_EXPORT_CO...2,SET,4,-0.061131,-0.00090219,0.40278,0.56032,GOCC_TRANSCRIPTION_EXPORT_COMPLEX_2,0.99999
GOBP_BIOLOGICAL_PROCESS_INVO...1,SET,190,-0.0096064,-0.00097214,0.063278,0.56033,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_HOST,0.99999
REACTOME_SUMOYLATION_OF_SUMO...,SET,33,-0.020898,-0.00088514,0.13763,0.56034,REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS,0.99999
DI_MARTINO_MATRISOME_HIGHLY_...2,SET,17,-0.032231,-0.00098027,0.21224,0.56035,DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED,0.99999
GOCC_B_WICH_COMPLEX,SET,7,-0.045622,-0.00089062,0.30028,0.56038,GOCC_B_WICH_COMPLEX,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_ACT...,SET,46,-0.019251,-0.00096235,0.12651,0.56047,HE_LIM_SUN_FETAL_LUNG_C4_ACTIVATED_NK_CELL,0.99999
WP_DEGRADATION_PATHWAY_OF_SP...,SET,15,-0.037422,-0.0010692,0.2457,0.56053,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,0.99999
GOBP_N_TERMINAL_PEPTIDYL_MET...,SET,5,-0.04957,-0.00081789,0.32543,0.56053,GOBP_N_TERMINAL_PEPTIDYL_METHIONINE_ACETYLATION,0.99999
HP_GALACTOSURIA,SET,4,-0.058527,-0.00086375,0.38418,0.56054,HP_GALACTOSURIA,0.99999
REACTOME_PHASE_4_RESTING_MEM...,SET,19,-0.031267,-0.0010053,0.20522,0.56055,REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL,0.99999
GOBP_MEMBRANE_DEPOLARIZATION,SET,85,-0.01515,-0.0010284,0.099441,0.56055,GOBP_MEMBRANE_DEPOLARIZATION,0.99999
GSE37301_MULTIPOTENT_PROGENI...12,SET,182,-0.0093222,-0.00092352,0.061188,0.56055,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.99999
HP_IMPAIRED_DISTAL_TACTILE_S...,SET,18,-0.027759,-0.00086872,0.18197,0.56062,HP_IMPAIRED_DISTAL_TACTILE_SENSATION,0.99999
GSE2706_R848_VS_LPS_2H_STIM_...1,SET,145,-0.010815,-0.00095726,0.070891,0.56062,GSE2706_R848_VS_LPS_2H_STIM_DC_DN,0.99999
GOMF_SULFUR_COMPOUND_TRANSME...,SET,59,-0.016848,-0.00095349,0.11038,0.56066,GOMF_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_ABNORMAL_THALAMIC_MRI_SIG...,SET,32,-0.020811,-0.00086803,0.13634,0.56066,HP_ABNORMAL_THALAMIC_MRI_SIGNAL_INTENSITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...363,SET,54,-0.018494,-0.0010015,0.12115,0.56067,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,0.99999
chr14q21,SET,33,-0.036639,-0.0015519,0.23989,0.56069,chr14q21,0.99999
GOBP_APOPTOTIC_PROCESS,SET,1728,-0.0032542,-0.00095017,0.021296,0.56072,GOBP_APOPTOTIC_PROCESS,0.99999
GOBP_RETICULOPHAGY,SET,17,-0.030276,-0.00092081,0.19813,0.56072,GOBP_RETICULOPHAGY,0.99999
HP_LACK_OF_SKIN_ELASTICITY,SET,56,-0.017595,-0.00097021,0.11513,0.56073,HP_LACK_OF_SKIN_ELASTICITY,0.99999
HP_SHORT_NAIL,SET,13,-0.034655,-0.0009218,0.22653,0.56079,HP_SHORT_NAIL,0.99999
MIR3064_3P,SET,154,-0.010752,-0.00098054,0.070183,0.56088,MIR3064_3P,0.99999
MIR4268,SET,54,-0.018356,-0.00099401,0.11978,0.5609,MIR4268,0.99999
MIR495_3P,SET,639,-0.0053144,-0.00097402,0.034633,0.56098,MIR495_3P,0.99999
GSE19198_1H_VS_6H_IL21_TREAT...1,SET,186,-0.0096117,-0.00096249,0.062633,0.56098,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN,0.99999
MORF_PPP2R4,SET,44,-0.018521,-0.00090557,0.12068,0.56099,MORF_PPP2R4,0.99999
REACTOME_BETA_OXIDATION_OF_P...,SET,9,-0.039185,-0.00086732,0.25522,0.56101,REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA,0.99999
HP_MYDRIASIS,SET,16,-0.032299,-0.00095305,0.21036,0.56102,HP_MYDRIASIS,0.99999
HP_INCREASED_C_PEPTIDE_LEVEL,SET,13,-0.041478,-0.0011033,0.27008,0.56103,HP_INCREASED_C_PEPTIDE_LEVEL,0.99999
GSE2770_TGFB_AND_IL4_VS_IL4_...1,SET,178,-0.009773,-0.00095758,0.063602,0.56106,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.99999
GCM_CASP2,SET,26,-0.024424,-0.00091842,0.1588,0.56112,GCM_CASP2,0.99999
BLANCO_MELO_COVID19_SARS_COV...3,SET,370,-0.0068943,-0.00096878,0.044789,0.56117,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,0.99999
MIR3133,SET,447,-0.0062946,-0.00097012,0.040892,0.56117,MIR3133,0.99999
HP_PERIPHERAL_DEMYELINATION,SET,40,-0.02047,-0.00095439,0.1329,0.5612,HP_PERIPHERAL_DEMYELINATION,0.99999
LIANG_HEMATOPOIESIS_STEM_CEL...5,SET,36,-0.022131,-0.00097901,0.14367,0.56121,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,0.99999
HP_LAMBDOIDAL_CRANIOSYNOSTOS...,SET,15,-0.030323,-0.00086635,0.19684,0.56121,HP_LAMBDOIDAL_CRANIOSYNOSTOSIS,0.99999
GOBP_DNA_DAMAGE_RESPONSE_SIG...1,SET,66,-0.016084,-0.00096259,0.1044,0.56122,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.99999
HP_ACROPARESTHESIA,SET,9,-0.047603,-0.0010537,0.30885,0.56124,HP_ACROPARESTHESIA,0.99999
MODULE_150,SET,12,-0.031679,-0.00080959,0.20544,0.56127,MODULE_150,0.99999
HP_LIMITED_KNEE_FLEXION,SET,4,-0.065938,-0.00097312,0.42739,0.5613,HP_LIMITED_KNEE_FLEXION,0.99999
GNF2_DAP3,SET,105,-0.011605,-0.00087508,0.075182,0.56134,GNF2_DAP3,0.99999
AMIT_EGF_RESPONSE_480_HELA,SET,154,-0.010656,-0.00097179,0.068971,0.56139,AMIT_EGF_RESPONSE_480_HELA,0.99999
GOMF_GLUTATHIONE_TRANSMEMBRA...,SET,7,-0.049745,-0.00097111,0.322,0.56139,GOMF_GLUTATHIONE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...339,SET,17,-0.034317,-0.0010437,0.22206,0.56141,GOBP_POSITIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,0.99999
KEGG_MEDICUS_REFERENCE_HEDGE...2,SET,6,-0.057014,-0.0010305,0.36875,0.56144,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_HH_LIGAND_SECRETION,0.99999
GSE24634_TREG_VS_TCONV_POST_...8,SET,177,-0.0093667,-0.00091521,0.060581,0.56144,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...393,SET,13,-0.035603,-0.00094701,0.23009,0.56148,GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION,0.99999
HP_ABNORMAL_URINE_SODIUM_CON...,SET,16,-0.033196,-0.00097952,0.2145,0.56149,HP_ABNORMAL_URINE_SODIUM_CONCENTRATION,0.99999
HP_EXUDATIVE_VITREORETINOPAT...,SET,7,-0.042317,-0.0008261,0.27327,0.56153,HP_EXUDATIVE_VITREORETINOPATHY,0.99999
GSE22886_NAIVE_BCELL_VS_NEUT...1,SET,178,-0.010247,-0.001004,0.066173,0.56153,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...6,SET,143,-0.011569,-0.001017,0.074692,0.56154,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP,0.99999
GSE27786_LIN_NEG_VS_BCELL_UP,SET,185,-0.0095963,-0.00095839,0.061933,0.56157,GSE27786_LIN_NEG_VS_BCELL_UP,0.99999
GOBP_REGULATION_OF_FAT_CELL_...1,SET,121,-0.01275,-0.0010317,0.082253,0.56159,GOBP_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_CATION_CH...,SET,86,-0.015249,-0.0010411,0.098326,0.56162,GOBP_REGULATION_OF_CATION_CHANNEL_ACTIVITY,0.99999
HP_MITRAL_ATRESIA,SET,11,-0.044735,-0.0010946,0.28824,0.56167,HP_MITRAL_ATRESIA,0.99999
DACOSTA_UV_RESPONSE_VIA_ERCC...8,SET,22,-0.027025,-0.00093492,0.17408,0.56169,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,0.99999
GOBP_SPINDLE_LOCALIZATION,SET,61,-0.01691,-0.00097305,0.10892,0.56169,GOBP_SPINDLE_LOCALIZATION,0.99999
HP_EUTHYROID_GOITER,SET,4,-0.068265,-0.0010075,0.43972,0.56169,HP_EUTHYROID_GOITER,0.99999
OSMAN_BLOOD_CHAD63_KH_AGE_18...2,SET,1574,-0.0035672,-0.00099868,0.022975,0.56169,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP,0.99999
HP_ABNORMAL_BONE_STRUCTURE,SET,737,-0.0048773,-0.00095736,0.031408,0.5617,HP_ABNORMAL_BONE_STRUCTURE,0.99999
GOBP_CARDIAC_VENTRICLE_FORMA...,SET,7,-0.058831,-0.0011485,0.37871,0.56172,GOBP_CARDIAC_VENTRICLE_FORMATION,0.99999
CREIGHTON_ENDOCRINE_THERAPY_...3,SET,650,-0.0055127,-0.0010187,0.035481,0.56173,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...29,SET,9,-0.045723,-0.0010121,0.29421,0.56175,GOBP_PROTEIN_LOCALIZATION_TO_MEMBRANE_RAFT,0.99999
GAANYNYGACNY_UNKNOWN,SET,65,-0.01636,-0.00097169,0.10525,0.56176,GAANYNYGACNY_UNKNOWN,0.99999
MIR7154_3P,SET,56,-0.017387,-0.00095876,0.11182,0.56178,MIR7154_3P,0.99999
GOBP_SKELETAL_MUSCLE_SATELLI...2,SET,11,-0.037143,-0.00090885,0.2389,0.56178,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_DIFFERENTIATION,0.99999
GOBP_SMOOTH_MUSCLE_CELL_MATR...,SET,6,-0.044285,-0.00080041,0.28478,0.56179,GOBP_SMOOTH_MUSCLE_CELL_MATRIX_ADHESION,0.99999
GOBP_GLIAL_CELL_PROLIFERATION,SET,52,-0.01906,-0.0010129,0.12246,0.56184,GOBP_GLIAL_CELL_PROLIFERATION,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...68,SET,22,-0.027615,-0.00095531,0.1774,0.56185,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.99999
CARRILLOREIXACH_HEPATOBLASTO...4,SET,735,-0.0050317,-0.00098637,0.032296,0.5619,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP,0.99999
GSE20500_CTRL_VS_RARA_ANTAGO...1,SET,180,-0.0092905,-0.00091535,0.059618,0.56192,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,0.99999
IIZUKA_LIVER_CANCER_PROGRESS...6,SET,13,-0.036132,-0.00096108,0.23176,0.56194,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,0.99999
WP_TUMOR_SUPPRESSOR_ACTIVITY...,SET,29,-0.024285,-0.00096437,0.15578,0.56194,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,0.99999
GSE26290_WT_VS_PDK1_KO_ANTI_...1,SET,169,-0.0093415,-0.00089208,0.059924,0.56194,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,0.99999
RYAAAKNNNNNNTTGW_UNKNOWN,SET,74,-0.016003,-0.0010139,0.1026,0.56197,RYAAAKNNNNNNTTGW_UNKNOWN,0.99999
LAMB3_TARGET_GENES,SET,5,-0.057509,-0.00094889,0.36862,0.56199,LAMB3_TARGET_GENES,0.99999
AMIT_EGF_RESPONSE_60_HELA,SET,42,-0.020456,-0.00097723,0.13108,0.56201,AMIT_EGF_RESPONSE_60_HELA,0.99999
GOBP_AMINO_ACID_TRANSMEMBRAN...,SET,94,-0.014318,-0.0010218,0.091485,0.56218,GOBP_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,0.99999
KEGG_MEDICUS_REFERENCE_GF_RT...1,SET,81,-0.01641,-0.0010875,0.10476,0.56223,KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY,0.99999
HP_SHORT_CHIN,SET,56,-0.017525,-0.00096636,0.11189,0.56223,HP_SHORT_CHIN,0.99999
WP_DRUG_INDUCTION_OF_BILE_AC...,SET,17,-0.032737,-0.00099567,0.20899,0.56224,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...6,SET,166,-0.010554,-0.00099901,0.067333,0.56228,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,0.99999
WP_ENDOCHONDRAL_OSSIFICATION,SET,63,-0.017741,-0.0010374,0.1129,0.56243,WP_ENDOCHONDRAL_OSSIFICATION,0.99999
WP_ENDOCHONDRAL_OSSIFICATION...,SET,63,-0.017741,-0.0010374,0.1129,0.56243,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,0.99999
HP_ABNORMAL_RESPIRATORY_MOTI...,SET,29,-0.023271,-0.00092412,0.14795,0.56249,HP_ABNORMAL_RESPIRATORY_MOTILE_CILIUM_PHYSIOLOGY,0.99999
SABATES_COLORECTAL_ADENOMA_DN,SET,260,-0.0089049,-0.0010521,0.056603,0.5625,SABATES_COLORECTAL_ADENOMA_DN,0.99999
REACTOME_RUNX3_REGULATES_BCL...,SET,5,-0.066073,-0.0010902,0.42,0.5625,REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION,0.99999
GOBP_REGULATION_OF_MICROTUBU...2,SET,235,-0.0081954,-0.00092121,0.052077,0.56252,GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS,0.99999
GOBP_STABILIZATION_OF_MEMBRA...,SET,17,-0.033678,-0.0010243,0.21401,0.56252,GOBP_STABILIZATION_OF_MEMBRANE_POTENTIAL,0.99999
GSE25677_MPL_VS_MPL_AND_R848...1,SET,118,-0.011915,-0.00095211,0.075693,0.56254,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN,0.99999
GOMF_SPHINGOLIPID_BINDING,SET,25,-0.026276,-0.00096891,0.16687,0.56256,GOMF_SPHINGOLIPID_BINDING,0.99999
HP_ABNORMAL_TRACHEAL_MORPHOL...,SET,150,-0.010948,-0.00098546,0.06947,0.56261,HP_ABNORMAL_TRACHEAL_MORPHOLOGY,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...6,SET,47,-0.019005,-0.00096033,0.12058,0.56262,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_HEAT_SHOCK,0.99999
HP_RECURRENT_APHTHOUS_STOMAT...,SET,44,-0.02055,-0.0010048,0.13038,0.56262,HP_RECURRENT_APHTHOUS_STOMATITIS,0.99999
MALONEY_RESPONSE_TO_17AAG_UP,SET,37,-0.022626,-0.0010147,0.14354,0.56263,MALONEY_RESPONSE_TO_17AAG_UP,0.99999
WP_PURINERGIC_SIGNALING,SET,29,-0.025563,-0.0010151,0.16213,0.56264,WP_PURINERGIC_SIGNALING,0.99999
ZWANG_DOWN_BY_2ND_EGF_PULSE,SET,210,-0.0088853,-0.00094479,0.05629,0.56271,ZWANG_DOWN_BY_2ND_EGF_PULSE,0.99999
MIR3145_3P,SET,206,-0.0094286,-0.00099308,0.05973,0.56271,MIR3145_3P,0.99999
GOBP_MOTOR_NEURON_AXON_GUIDA...,SET,23,-0.029808,-0.0010543,0.18875,0.56274,GOBP_MOTOR_NEURON_AXON_GUIDANCE,0.99999
PID_FAK_PATHWAY,SET,57,-0.017261,-0.00096026,0.10923,0.56278,PID_FAK_PATHWAY,0.99999
CUI_DEVELOPING_HEART_COMPACT...2,SET,58,-0.019285,-0.0010822,0.12205,0.56278,CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE,0.99999
GOBP_NATURAL_KILLER_CELL_DIF...,SET,24,-0.030182,-0.0010905,0.19095,0.5628,GOBP_NATURAL_KILLER_CELL_DIFFERENTIATION,0.99999
HP_SUTURAL_CATARACT,SET,7,-0.047593,-0.0009291,0.30104,0.56281,HP_SUTURAL_CATARACT,0.99999
GOBP_REGULATION_OF_TOLL_LIKE...3,SET,28,-0.024604,-0.00096009,0.15561,0.56282,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.99999
GSE17974_0.5H_VS_72H_IL4_AND...2,SET,178,-0.0097902,-0.00095926,0.061914,0.56282,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,0.99999
GSE1460_CORD_VS_ADULT_BLOOD_...1,SET,175,-0.0098558,-0.0009576,0.062298,0.56285,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN,0.99999
GOCC_MITOTIC_SPINDLE_MICROTU...,SET,13,-0.029593,-0.00078716,0.18702,0.56286,GOCC_MITOTIC_SPINDLE_MICROTUBULE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...239,SET,13,-0.033097,-0.00088035,0.20915,0.56287,GOBP_NEGATIVE_REGULATION_OF_FIBRINOLYSIS,0.99999
HOFFMANN_SMALL_PRE_BII_TO_IM...2,SET,62,-0.0181,-0.00105,0.11436,0.56288,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,0.99999
ISHIKAWA_STING_SIGNALING,SET,10,-0.039611,-0.00092416,0.25024,0.56288,ISHIKAWA_STING_SIGNALING,0.99999
DESCARTES_MAIN_FETAL_ISLET_E...,SET,51,-0.019994,-0.0010523,0.12632,0.56288,DESCARTES_MAIN_FETAL_ISLET_ENDOCRINE_CELLS,0.99999
GOCC_MICROBODY_LUMEN,SET,50,-0.01913,-0.00099692,0.12083,0.5629,GOCC_MICROBODY_LUMEN,0.99999
GSE8515_CTRL_VS_IL6_4H_STIM_...2,SET,179,-0.0098427,-0.00096709,0.062166,0.5629,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP,0.99999
GOBP_PARKIN_MEDIATED_STIMULA...,SET,4,-0.074154,-0.0010944,0.46818,0.56292,GOBP_PARKIN_MEDIATED_STIMULATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,0.99999
chr4q12,SET,33,-0.042074,-0.0017821,0.26537,0.56299,chr4q12,0.99999
PTF1BETA_Q6,SET,213,-0.009306,-0.00099648,0.058681,0.563,PTF1BETA_Q6,0.99999
COWLING_MYCN_TARGETS,SET,38,-0.022834,-0.0010377,0.14396,0.56301,COWLING_MYCN_TARGETS,0.99999
HP_SERTOLI_CELL_NEOPLASM,SET,5,-0.062766,-0.0010356,0.39563,0.56303,HP_SERTOLI_CELL_NEOPLASM,0.99999
HP_COLOR_VISION_DEFECT,SET,133,-0.011934,-0.001012,0.075186,0.56306,HP_COLOR_VISION_DEFECT,0.99999
HP_PROMINENT_NOSE,SET,86,-0.014073,-0.00096087,0.088606,0.5631,HP_PROMINENT_NOSE,0.99999
HP_ANTI_THYROID_ANTIBODY_POS...,SET,10,-0.042045,-0.00098094,0.26464,0.56312,HP_ANTI_THYROID_ANTIBODY_POSITIVITY,0.99999
GOBP_RRNA_CATABOLIC_PROCESS,SET,12,-0.032667,-0.00083486,0.20558,0.56313,GOBP_RRNA_CATABOLIC_PROCESS,0.99999
JAZAG_TGFB1_SIGNALING_VIA_SM...1,SET,59,-0.017084,-0.00096688,0.10736,0.56322,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...67,SET,21,-0.029458,-0.00099567,0.18499,0.56326,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
PHB2_TARGET_GENES,SET,149,-0.010685,-0.00095867,0.067037,0.56332,PHB2_TARGET_GENES,0.99999
FUJII_YBX1_TARGETS_UP,SET,36,-0.022314,-0.0009871,0.13993,0.56335,FUJII_YBX1_TARGETS_UP,0.99999
MIR199A_5P,SET,165,-0.01006,-0.00094938,0.06302,0.56341,MIR199A_5P,0.99999
GOBP_SPERMATID_NUCLEUS_DIFFE...,SET,22,-0.028323,-0.00097981,0.1774,0.56342,GOBP_SPERMATID_NUCLEUS_DIFFERENTIATION,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...7,SET,174,-0.0099947,-0.00096834,0.062585,0.56344,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
GCM_SMO,SET,58,-0.0166,-0.00093153,0.10393,0.56345,GCM_SMO,0.99999
GOBP_REGULATION_OF_INTRINSIC...5,SET,3,-0.064805,-0.0008283,0.4054,0.5635,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYDROGEN_PEROXIDE,0.99999
REACTOME_FOXO_MEDIATED_TRANS...4,SET,28,-0.02701,-0.0010539,0.16885,0.56354,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,0.99999
HALLMARK_ADIPOGENESIS,SET,186,-0.0096127,-0.00096259,0.060097,0.56354,HALLMARK_ADIPOGENESIS,0.99999
REACTOME_CARBOXYTERMINAL_POS...,SET,41,-0.022172,-0.0010466,0.1386,0.56355,REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN,0.99999
REACTOME_RUNX1_REGULATES_EXP...,SET,5,-0.062558,-0.0010322,0.39099,0.56356,REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS,0.99999
HP_HYPERPIGMENTATION_IN_SUN_...,SET,7,-0.041007,-0.00080052,0.25607,0.56361,HP_HYPERPIGMENTATION_IN_SUN_EXPOSED_AREAS,0.99999
PLASARI_TGFB1_TARGETS_1HR_UP,SET,33,-0.026071,-0.0011043,0.16275,0.56363,PLASARI_TGFB1_TARGETS_1HR_UP,0.99999
BROWNE_HCMV_INFECTION_20HR_UP,SET,213,-0.0090451,-0.00096854,0.056454,0.56364,BROWNE_HCMV_INFECTION_20HR_UP,0.99999
AHRARNT_02,SET,14,-0.035949,-0.0009923,0.22424,0.56368,AHRARNT_02,0.99999
GOBP_POSITIVE_REGULATION_OF_...627,SET,9,-0.049313,-0.0010915,0.30764,0.56368,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING,0.99999
KORKOLA_EMBRYONAL_CARCINOMA_...2,SET,28,-0.027893,-0.0010884,0.17393,0.5637,KORKOLA_EMBRYONAL_CARCINOMA_UP,0.99999
HP_MUCOSAL_TELANGIECTASIAE,SET,36,-0.020105,-0.00088936,0.12536,0.5637,HP_MUCOSAL_TELANGIECTASIAE,0.99999
GOBP_OXYGEN_METABOLIC_PROCESS,SET,6,-0.053141,-0.00096047,0.33122,0.56373,GOBP_OXYGEN_METABOLIC_PROCESS,0.99999
KORKOLA_CHORIOCARCINOMA,SET,5,-0.066375,-0.0010952,0.41364,0.56374,KORKOLA_CHORIOCARCINOMA,0.99999
HP_ABNORMAL_ILIAC_WING_MORPH...,SET,53,-0.018548,-0.0009951,0.1156,0.56374,HP_ABNORMAL_ILIAC_WING_MORPHOLOGY,0.99999
GSE27786_CD8_TCELL_VS_NEUTRO...1,SET,179,-0.0097446,-0.00095745,0.060708,0.56376,GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN,0.99999
KAAB_FAILED_HEART_ATRIUM_UP,SET,32,-0.02364,-0.00098604,0.14721,0.56379,KAAB_FAILED_HEART_ATRIUM_UP,0.99999
HP_BOWED_HUMERUS,SET,7,-0.053569,-0.0010458,0.33308,0.56389,HP_BOWED_HUMERUS,0.99999
GSE27786_NKTCELL_VS_NEUTROPH...2,SET,175,-0.0099415,-0.00096593,0.061777,0.56392,GSE27786_NKTCELL_VS_NEUTROPHIL_UP,0.99999
MIR16_2_3P,SET,205,-0.0096844,-0.0010176,0.060177,0.56393,MIR16_2_3P,0.99999
BIOCARTA_CFTR_PATHWAY,SET,10,-0.046261,-0.0010793,0.28739,0.56394,BIOCARTA_CFTR_PATHWAY,0.99999
GOBP_CELL_MORPHOGENESIS_INVO...,SET,534,-0.0062237,-0.0010458,0.038613,0.56402,GOBP_CELL_MORPHOGENESIS_INVOLVED_IN_NEURON_DIFFERENTIATION,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...9,SET,164,-0.0106,-0.00099732,0.065664,0.56412,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN,0.99999
GOBP_PLATELET_DERIVED_GROWTH...2,SET,14,-0.038583,-0.001065,0.23887,0.56416,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY,0.99999
GOBP_MULTINUCLEAR_OSTEOCLAST...,SET,8,-0.051213,-0.0010688,0.31667,0.56424,GOBP_MULTINUCLEAR_OSTEOCLAST_DIFFERENTIATION,0.99999
KEGG_MEDICUS_PATHOGEN_SHIGEL...2,SET,10,-0.044474,-0.0010376,0.27491,0.56426,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,0.99999
REACTOME_PHOSPHORYLATION_OF_...1,SET,6,-0.050774,-0.00091769,0.31379,0.56427,REACTOME_PHOSPHORYLATION_OF_EMI1,0.99999
GOBP_RESPONSE_TO_PEPTIDE_HOR...,SET,405,-0.0069669,-0.0010232,0.043028,0.56431,GOBP_RESPONSE_TO_PEPTIDE_HORMONE,0.99999
GSE13547_CTRL_VS_ANTI_IGM_ST...2,SET,174,-0.010017,-0.0009705,0.061859,0.56432,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP,0.99999
GOBP_PROTEIN_SIDE_CHAIN_DEGL...,SET,5,-0.066869,-0.0011033,0.41272,0.56435,GOBP_PROTEIN_SIDE_CHAIN_DEGLUTAMYLATION,0.99999
HP_ABSENT_OR_MINIMALLY_OSSIF...,SET,11,-0.04091,-0.001001,0.25252,0.56435,HP_ABSENT_OR_MINIMALLY_OSSIFIED_VERTEBRAL_BODIES,0.99999
GSE28783_CTRL_ANTI_MIR_VS_UN...1,SET,182,-0.010345,-0.0010248,0.063853,0.56435,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,0.99999
MAGRANGEAS_MULTIPLE_MYELOMA_...4,SET,38,-0.023696,-0.0010769,0.14622,0.56437,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,0.99999
HP_EEG_WITH_GENERALIZED_POLY...,SET,6,-0.05782,-0.001045,0.35661,0.5644,HP_EEG_WITH_GENERALIZED_POLYSPIKES,0.99999
GSE411_UNSTIM_VS_400MIN_IL6_...2,SET,183,-0.0098826,-0.00098169,0.060954,0.5644,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_UP,0.99999
MODULE_42,SET,24,-0.022863,-0.00082606,0.14085,0.56447,MODULE_42,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...10,SET,186,-0.0092794,-0.00092922,0.057112,0.56453,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP,0.99999
GOBP_REGULATION_OF_RNA_POLYM...2,SET,6,-0.055268,-0.00099892,0.34006,0.56455,GOBP_REGULATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY,0.99999
HP_VENTRICULAR_TACHYCARDIA,SET,62,-0.01807,-0.0010483,0.11117,0.56456,HP_VENTRICULAR_TACHYCARDIA,0.99999
MIR548T_5P,SET,389,-0.0072454,-0.0010434,0.044563,0.56458,MIR548T_5P,0.99999
DESCARTES_FETAL_HEART_CARDIO...,SET,6,-0.06002,-0.0010848,0.36914,0.56458,DESCARTES_FETAL_HEART_CARDIOMYOCYTES,0.99999
GOBP_PYRIMIDINE_NUCLEOTIDE_C...,SET,21,-0.030588,-0.0010339,0.18789,0.56466,GOBP_PYRIMIDINE_NUCLEOTIDE_CATABOLIC_PROCESS,0.99999
WP_COMPLEMENTMEDIATED_INFLAM...,SET,10,-0.04589,-0.0010707,0.28176,0.56469,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,0.99999
GOBP_PURINE_RIBONUCLEOSIDE_C...,SET,5,-0.067557,-0.0011147,0.41479,0.56469,GOBP_PURINE_RIBONUCLEOSIDE_CATABOLIC_PROCESS,0.99999
MIR3649,SET,18,-0.03314,-0.0010371,0.20336,0.56472,MIR3649,0.99999
NAKAYA_PBMC_FLUAD_MALE_AGE_1...3,SET,17,-0.03726,-0.0011332,0.22842,0.56479,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_MA...1,SET,13,-0.043681,-0.0011619,0.26773,0.5648,GOBP_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS,0.99999
GOBP_CHOLESTEROL_STORAGE,SET,23,-0.030066,-0.0010635,0.18427,0.56481,GOBP_CHOLESTEROL_STORAGE,0.99999
GSE11057_NAIVE_VS_CENT_MEMOR...2,SET,153,-0.011222,-0.0010201,0.068746,0.56483,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
WP_CCL18_SIGNALING,SET,33,-0.026317,-0.0011147,0.16116,0.56486,WP_CCL18_SIGNALING,0.99999
GSE16385_MONOCYTE_VS_12H_ROS...4,SET,173,-0.01003,-0.00096897,0.061407,0.56487,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,0.99999
KEGG_MEDICUS_REFERENCE_GF_RT...3,SET,87,-0.016254,-0.0011162,0.099435,0.56492,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY,0.99999
GOCC_PRERIBOSOME_LARGE_SUBUN...,SET,18,-0.029567,-0.00092531,0.18086,0.56493,GOCC_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR,0.99999
GOCC_RIBONUCLEOPROTEIN_COMPL...,SET,619,-0.0052295,-0.00094387,0.031966,0.56497,GOCC_RIBONUCLEOPROTEIN_COMPLEX,0.99999
HP_NARROW_INTERNAL_AUDITORY_...,SET,15,-0.037206,-0.001063,0.22737,0.56499,HP_NARROW_INTERNAL_AUDITORY_CANAL,0.99999
MIR4446_3P,SET,56,-0.017989,-0.00099193,0.10987,0.56503,MIR4446_3P,0.99999
GOBP_SPINDLE_ASSEMBLY,SET,119,-0.011729,-0.00094117,0.071593,0.56507,GOBP_SPINDLE_ASSEMBLY,0.99999
GOBP_SULFATE_TRANSPORT,SET,16,-0.034843,-0.0010281,0.21256,0.5651,GOBP_SULFATE_TRANSPORT,0.99999
GSE7852_LN_VS_THYMUS_TREG_DN,SET,179,-0.01049,-0.0010307,0.063993,0.5651,GSE7852_LN_VS_THYMUS_TREG_DN,0.99999
REACTOME_FORMATION_OF_TC_NER...,SET,48,-0.017681,-0.00090282,0.10785,0.56511,REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX,0.99999
GOMF_GDP_BINDING,SET,70,-0.016637,-0.0010253,0.10141,0.56516,GOMF_GDP_BINDING,0.99999
GOLDRATH_ANTIGEN_RESPONSE,SET,322,-0.0077867,-0.0010221,0.047442,0.56519,GOLDRATH_ANTIGEN_RESPONSE,0.99999
GOBP_MODULATION_BY_HOST_OF_V...3,SET,3,-0.075649,-0.00096689,0.46078,0.5652,GOBP_MODULATION_BY_HOST_OF_VIRAL_RNA_GENOME_REPLICATION,0.99999
TUOMISTO_TUMOR_SUPPRESSION_B...1,SET,19,-0.032826,-0.0010554,0.1996,0.56531,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN,0.99999
GOBP_IRE1_MEDIATED_UNFOLDED_...,SET,20,-0.031969,-0.0010545,0.19432,0.56534,GOBP_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.99999
DACOSTA_LOW_DOSE_UV_RESPONSE...1,SET,8,-0.048714,-0.0010166,0.29607,0.56535,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN,0.99999
GSE7548_NAIVE_VS_DAY7_PCC_IM...2,SET,184,-0.0097004,-0.0009662,0.058905,0.5654,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP,0.99999
HP_CONNECTIVE_TISSUE_NEVI,SET,6,-0.062671,-0.0011327,0.38053,0.56541,HP_CONNECTIVE_TISSUE_NEVI,0.99999
HP_ABSENT_TESTIS,SET,24,-0.026154,-0.00094494,0.15872,0.56544,HP_ABSENT_TESTIS,0.99999
HP_EXOSTOSES,SET,18,-0.034199,-0.0010703,0.20739,0.56549,HP_EXOSTOSES,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...6,SET,42,-0.023982,-0.0011457,0.14528,0.56556,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_4,0.99999
GNF2_CCNA2,SET,64,-0.017562,-0.001035,0.10637,0.56556,GNF2_CCNA2,0.99999
DESCARTES_FETAL_EYE_SMOOTH_M...,SET,53,-0.018892,-0.0010135,0.11442,0.56557,DESCARTES_FETAL_EYE_SMOOTH_MUSCLE_CELLS,0.99999
MIR4494,SET,52,-0.019018,-0.0010107,0.11517,0.56558,MIR4494,0.99999
GOBP_VITAMIN_BIOSYNTHETIC_PR...,SET,24,-0.029368,-0.0010611,0.1778,0.5656,GOBP_VITAMIN_BIOSYNTHETIC_PROCESS,0.99999
GSE22886_CD8_VS_CD4_NAIVE_TC...2,SET,176,-0.010057,-0.00097988,0.060791,0.5657,GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP,0.99999
REACTOME_PROCESSING_OF_INTRO...,SET,19,-0.027123,-0.00087206,0.16392,0.56571,REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS,0.99999
MIR4433B_5P,SET,51,-0.020812,-0.0010953,0.12569,0.56576,MIR4433B_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...333,SET,155,-0.011482,-0.0010505,0.069318,0.56578,GOBP_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY,0.99999
GOMF_PHOSPHATASE_ACTIVITY,SET,231,-0.0087827,-0.0009789,0.052986,0.56582,GOMF_PHOSPHATASE_ACTIVITY,0.99999
HP_ABNORMAL_CORNEAL_ENDOTHEL...,SET,18,-0.035565,-0.001113,0.21451,0.56584,HP_ABNORMAL_CORNEAL_ENDOTHELIUM_MORPHOLOGY,0.99999
HP_HYPERINTENSITY_OF_CEREBRA...,SET,72,-0.017057,-0.0010661,0.10287,0.56585,HP_HYPERINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...16,SET,180,-0.010488,-0.0010334,0.063227,0.56587,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP,0.99999
MIR1271_5P,SET,355,-0.0076962,-0.0010597,0.046382,0.56589,MIR1271_5P,0.99999
GSE36826_WT_VS_IL1R_KO_SKIN_...1,SET,170,-0.010524,-0.0010079,0.063385,0.56593,GSE36826_WT_VS_IL1R_KO_SKIN_DN,0.99999
GOBP_FOAM_CELL_DIFFERENTIATI...,SET,37,-0.024747,-0.0011098,0.14905,0.56594,GOBP_FOAM_CELL_DIFFERENTIATION,0.99999
GOBP_POSTSYNAPSE_TO_NUCLEUS_...,SET,6,-0.041592,-0.00075174,0.25042,0.56596,GOBP_POSTSYNAPSE_TO_NUCLEUS_SIGNALING_PATHWAY,0.99999
GOCC_COATED_VESICLE,SET,291,-0.0083649,-0.0010447,0.050356,0.56597,GOCC_COATED_VESICLE,0.99999
HEIDENBLAD_AMPLIFIED_IN_PANC...,SET,53,-0.019804,-0.0010625,0.1192,0.56598,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,0.99999
GOBP_CELL_VOLUME_HOMEOSTASIS,SET,34,-0.023466,-0.0010089,0.14122,0.56599,GOBP_CELL_VOLUME_HOMEOSTASIS,0.99999
KEGG_ARACHIDONIC_ACID_METABO...,SET,58,-0.020384,-0.0011438,0.12265,0.566,KEGG_ARACHIDONIC_ACID_METABOLISM,0.99999
REACTOME_ADRENALINE_NORADREN...,SET,28,-0.028143,-0.0010982,0.16929,0.56602,REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION,0.99999
GOBP_RETINAL_CONE_CELL_DEVEL...,SET,11,-0.046774,-0.0011445,0.28103,0.56609,GOBP_RETINAL_CONE_CELL_DEVELOPMENT,0.99999
PHESSE_TARGETS_OF_APC_AND_MB...2,SET,15,-0.0386,-0.0011028,0.23187,0.56611,PHESSE_TARGETS_OF_APC_AND_MBD2_UP,0.99999
KIM_GLIS2_TARGETS_DN,SET,6,-0.054296,-0.00098135,0.32611,0.56612,KIM_GLIS2_TARGETS_DN,0.99999
MODULE_325,SET,53,-0.019253,-0.0010329,0.11563,0.56612,MODULE_325,0.99999
GOCC_PERICHROMATIN_FIBRILS,SET,6,-0.059314,-0.001072,0.35597,0.56617,GOCC_PERICHROMATIN_FIBRILS,0.99999
REACTOME_CONDENSATION_OF_PRO...2,SET,11,-0.040052,-0.00098005,0.24033,0.56618,REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES,0.99999
MODULE_214,SET,26,-0.029596,-0.0011129,0.17753,0.5662,MODULE_214,0.99999
GOMF_CCR_CHEMOKINE_RECEPTOR_...,SET,38,-0.028075,-0.0012759,0.16839,0.56621,GOMF_CCR_CHEMOKINE_RECEPTOR_BINDING,0.99999
CAHOY_OLIGODENDROCUTIC,SET,88,-0.015301,-0.0010568,0.091708,0.56625,CAHOY_OLIGODENDROCUTIC,0.99999
WP_2Q37_COPY_NUMBER_VARIATIO...,SET,124,-0.016455,-0.0013477,0.098599,0.56627,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,0.99999
MIR369_3P,SET,276,-0.008669,-0.0010548,0.05193,0.56629,MIR369_3P,0.99999
LI_PBMC_MENOMUNE_A_C_Y_W_135...4,SET,41,-0.02388,-0.0011272,0.14304,0.56629,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_POSITIVE,0.99999
GOCC_NEURONAL_RIBONUCLEOPROT...,SET,3,-0.076758,-0.00098107,0.45973,0.5663,GOCC_NEURONAL_RIBONUCLEOPROTEIN_GRANULE,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...49,SET,100,-0.013408,-0.00098679,0.0803,0.5663,HP_APLASIA_HYPOPLASIA_OF_THE_OPTIC_NERVE,0.99999
MIR135A_3P,SET,33,-0.024905,-0.0010549,0.14909,0.56633,MIR135A_3P,0.99999
GSE6090_UNSTIM_VS_DC_SIGN_ST...2,SET,153,-0.010497,-0.0009542,0.062783,0.56639,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP,0.99999
HP_GENERALIZED_TONIC_SEIZURE,SET,50,-0.019817,-0.0010327,0.11844,0.56643,HP_GENERALIZED_TONIC_SEIZURE,0.99999
ZHAN_EARLY_DIFFERENTIATION_G...2,SET,7,-0.05309,-0.0010364,0.31714,0.56647,ZHAN_EARLY_DIFFERENTIATION_GENES_UP,0.99999
MORF_CASP2,SET,89,-0.014249,-0.00098966,0.0851,0.56649,MORF_CASP2,0.99999
GOBP_PROTEIN_PALMITOYLATION,SET,28,-0.025879,-0.0010098,0.15439,0.56656,GOBP_PROTEIN_PALMITOYLATION,0.99999
REACTOME_SARS_COV_2_TARGETS_...1,SET,12,-0.043217,-0.0011045,0.25773,0.56658,REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS,0.99999
GOBP_GLOMERULAR_EPITHELIAL_C...,SET,12,-0.043174,-0.0011034,0.25749,0.56658,GOBP_GLOMERULAR_EPITHELIAL_CELL_DEVELOPMENT,0.99999
HP_LYMPHANGIECTASIS,SET,10,-0.045619,-0.0010643,0.27172,0.56666,HP_LYMPHANGIECTASIS,0.99999
SANA_RESPONSE_TO_IFNG_DN,SET,79,-0.016296,-0.0010666,0.09703,0.56669,SANA_RESPONSE_TO_IFNG_DN,0.99999
GSE2405_S_AUREUS_VS_A_PHAGOC...2,SET,182,-0.010995,-0.0010893,0.065452,0.5667,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP,0.99999
GOMF_MHC_CLASS_I_PROTEIN_COM...,SET,5,-0.054994,-0.00090739,0.32726,0.56672,GOMF_MHC_CLASS_I_PROTEIN_COMPLEX_BINDING,0.99999
NUNODA_RESPONSE_TO_DASATINIB...2,SET,29,-0.025735,-0.0010219,0.15296,0.5668,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,0.99999
BOSCO_INTERFERON_INDUCED_ANT...,SET,72,-0.016613,-0.0010383,0.098704,0.56683,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,0.99999
HP_NREM_PARASOMNIA,SET,16,-0.037251,-0.0010992,0.22124,0.56685,HP_NREM_PARASOMNIA,0.99999
GSE19923_WT_VS_E2A_KO_DP_THY...1,SET,176,-0.010422,-0.0010155,0.061886,0.56687,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_DN,0.99999
GOBP_RECEPTOR_METABOLIC_PROC...,SET,66,-0.016852,-0.0010085,0.1,0.56691,GOBP_RECEPTOR_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_TESTOSTER...,SET,6,-0.064815,-0.0011715,0.38431,0.56696,GOBP_REGULATION_OF_TESTOSTERONE_BIOSYNTHETIC_PROCESS,0.99999
HP_PERIPHERAL_ARTERIAL_STENO...,SET,30,-0.028202,-0.001139,0.16715,0.56699,HP_PERIPHERAL_ARTERIAL_STENOSIS,0.99999
GSE11961_MARGINAL_ZONE_BCELL...9,SET,176,-0.010526,-0.0010256,0.062359,0.56702,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN,0.99999
REACTOME_BETA_OXIDATION_OF_H...,SET,5,-0.059112,-0.00097533,0.35013,0.56703,REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA,0.99999
GSE3039_ALPHABETA_CD8_TCELL_...1,SET,179,-0.010413,-0.0010231,0.061668,0.56704,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_DN,0.99999
GOCC_POSTSYNAPTIC_ENDOSOME,SET,13,-0.038242,-0.0010172,0.22646,0.56705,GOCC_POSTSYNAPTIC_ENDOSOME,0.99999
MIR1255A_MIR1255B_5P,SET,65,-0.017556,-0.0010427,0.10394,0.56706,MIR1255A_MIR1255B_5P,0.99999
HP_DEVIATION_OF_THE_3RD_FING...,SET,10,-0.045788,-0.0010683,0.27081,0.56713,HP_DEVIATION_OF_THE_3RD_FINGER,0.99999
WP_RELATIONSHIP_BETWEEN_INFL...,SET,25,-0.029295,-0.0010802,0.17323,0.56714,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,0.99999
GOBP_TOLERANCE_INDUCTION_TO_...,SET,5,-0.068731,-0.0011341,0.40616,0.56719,GOBP_TOLERANCE_INDUCTION_TO_SELF_ANTIGEN,0.99999
HP_MYOSITIS,SET,34,-0.024072,-0.0010349,0.14226,0.56719,HP_MYOSITIS,0.99999
HEN1_02,SET,184,-0.010322,-0.0010281,0.060986,0.5672,HEN1_02,0.99999
MIR4664_5P,SET,76,-0.01611,-0.0010343,0.09517,0.56721,MIR4664_5P,0.99999
GSE7764_IL15_TREATED_VS_CTRL...1,SET,180,-0.010913,-0.0010752,0.064469,0.56721,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN,0.99999
MODULE_418,SET,56,-0.018889,-0.0010416,0.1115,0.56726,MODULE_418,0.99999
GSE37416_CTRL_VS_0H_F_TULARE...2,SET,147,-0.011285,-0.0010057,0.06662,0.56726,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
ZNF445_TARGET_GENES,SET,7,-0.056346,-0.0011,0.33251,0.56728,ZNF445_TARGET_GENES,0.99999
MORF_NF1,SET,160,-0.011103,-0.0010319,0.065504,0.5673,MORF_NF1,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HN...4,SET,413,-0.0076291,-0.0011313,0.044939,0.5674,MANNO_MIDBRAIN_NEUROTYPES_HNBML5,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...59,SET,11,-0.041752,-0.0010216,0.24577,0.56745,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY,0.99999
GSE22432_MULTIPOTENT_PROGENI...3,SET,177,-0.010256,-0.0010021,0.060356,0.56747,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_DN,0.99999
GSE14308_TH17_VS_NAIVE_CD4_T...1,SET,182,-0.010454,-0.0010356,0.061443,0.56755,GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN,0.99999
HERNANDEZ_ABERRANT_MITOSIS_B...2,SET,65,-0.018681,-0.0011095,0.10969,0.56761,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,0.99999
GOMF_URIDYLYLTRANSFERASE_ACT...,SET,5,-0.053741,-0.00088671,0.31528,0.56767,GOMF_URIDYLYLTRANSFERASE_ACTIVITY,0.99999
MIR6511B_5P,SET,66,-0.018264,-0.001093,0.10713,0.56768,MIR6511B_5P,0.99999
GSE3982_EOSINOPHIL_VS_TH2_DN,SET,179,-0.010642,-0.0010456,0.062353,0.56776,GSE3982_EOSINOPHIL_VS_TH2_DN,0.99999
GOBP_DOPAMINE_TRANSPORT,SET,43,-0.022679,-0.0010962,0.13281,0.56779,GOBP_DOPAMINE_TRANSPORT,0.99999
GSE25088_CTRL_VS_IL4_AND_ROS...3,SET,152,-0.011478,-0.00104,0.067114,0.5679,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,0.99999
GSE29949_MICROGLIA_VS_DC_BRA...2,SET,185,-0.010628,-0.0010614,0.062,0.56805,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...432,SET,10,-0.044076,-0.0010283,0.25704,0.56807,GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,0.99999
GSE3982_CTRL_VS_PMA_STIM_EOS...2,SET,173,-0.010709,-0.0010346,0.062408,0.56812,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP,0.99999
GOMF_PHOSPHOSERINE_RESIDUE_B...,SET,10,-0.046328,-0.0010809,0.26978,0.56817,GOMF_PHOSPHOSERINE_RESIDUE_BINDING,0.99999
TGCTGCT_MIR15A_MIR16_MIR15B_...,SET,554,-0.0061528,-0.0010525,0.035821,0.56819,TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497,0.99999
WP_GENES_TARGETED_BY_MIRNAS_...,SET,11,-0.047651,-0.001166,0.27719,0.56824,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,0.99999
GOBP_CARDIAC_MUSCLE_CELL_ACT...2,SET,57,-0.02158,-0.0012005,0.12553,0.56825,GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_CONTRACTION,0.99999
IIZUKA_LIVER_CANCER_PROGRESS...2,SET,12,-0.043916,-0.0011223,0.2552,0.56831,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,0.99999
GSE19923_WT_VS_HEB_KO_DP_THY...1,SET,180,-0.010457,-0.0010303,0.060738,0.56835,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_DN,0.99999
MIR2276_5P,SET,63,-0.018872,-0.0011036,0.1096,0.56836,MIR2276_5P,0.99999
MIR10401_5P,SET,73,-0.017222,-0.0010838,0.099976,0.56838,MIR10401_5P,0.99999
GSE4142_GC_BCELL_VS_MEMORY_B...2,SET,182,-0.010731,-0.0010631,0.062275,0.56841,GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP,0.99999
GOBP_BLOOD_VESSEL_ENDOTHELIA...3,SET,23,-0.033689,-0.0011916,0.19537,0.56845,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.99999
FUJIWARA_PARK2_IN_LIVER_CANC...2,SET,8,-0.053059,-0.0011073,0.30727,0.56855,FUJIWARA_PARK2_IN_LIVER_CANCER_UP,0.99999
HP_ENLARGED_KIDNEY,SET,41,-0.022324,-0.0010537,0.1292,0.56859,HP_ENLARGED_KIDNEY,0.99999
GOBP_METHYLGLYOXAL_METABOLIC...,SET,4,-0.058592,-0.00086471,0.33899,0.56861,GOBP_METHYLGLYOXAL_METABOLIC_PROCESS,0.99999
GOBP_PROXIMAL_DISTAL_PATTERN...2,SET,5,-0.080281,-0.0013246,0.46439,0.56862,GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION_INVOLVED_IN_NEPHRON_DEVELOPMENT,0.99999
GOBP_XMP_METABOLIC_PROCESS,SET,7,-0.054289,-0.0010598,0.31406,0.56862,GOBP_XMP_METABOLIC_PROCESS,0.99999
GOMF_LIGASE_ACTIVITY_FORMING...1,SET,7,-0.054011,-0.0010544,0.31246,0.56862,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_CARBON_BONDS,0.99999
VISALA_RESPONSE_TO_HEAT_SHOC...2,SET,14,-0.035951,-0.00099234,0.20791,0.56864,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,0.99999
HP_CONGENITAL_FIBROSIS_OF_EX...,SET,6,-0.057472,-0.0010387,0.33229,0.56866,HP_CONGENITAL_FIBROSIS_OF_EXTRAOCULAR_MUSCLES,0.99999
GSE5589_WT_VS_IL10_KO_LPS_AN...6,SET,177,-0.010841,-0.0010593,0.062672,0.56867,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.99999
HP_ABNORMALITY_OF_CARTILAGE_...,SET,14,-0.039595,-0.0010929,0.22878,0.5687,HP_ABNORMALITY_OF_CARTILAGE_OF_EXTERNAL_EAR,0.99999
REACTOME_SYNTHESIS_OF_PIPS_A...1,SET,15,-0.030531,-0.0008723,0.17634,0.56873,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE,0.99999
DORSEY_GAB2_TARGETS,SET,27,-0.030479,-0.0011679,0.17582,0.56881,DORSEY_GAB2_TARGETS,0.99999
HP_CORNEAL_SCARRING,SET,19,-0.032493,-0.0010447,0.18743,0.56882,HP_CORNEAL_SCARRING,0.99999
MODULE_45,SET,527,-0.0066755,-0.0011146,0.038452,0.56891,MODULE_45,0.99999
HP_BRAIN_NEOPLASM,SET,16,-0.033296,-0.00098245,0.19181,0.56891,HP_BRAIN_NEOPLASM,0.99999
REACTOME_SIGNALING_BY_FGFR2_...1,SET,19,-0.030984,-0.00099619,0.1784,0.56894,REACTOME_SIGNALING_BY_FGFR2_IIIA_TM,0.99999
GOBP_BILE_ACID_AND_BILE_SALT...,SET,29,-0.028105,-0.0011161,0.16166,0.56901,GOBP_BILE_ACID_AND_BILE_SALT_TRANSPORT,0.99999
GOBP_REGULATION_OF_RESPONSE_...8,SET,16,-0.037685,-0.001112,0.2167,0.56903,GOBP_REGULATION_OF_RESPONSE_TO_OSMOTIC_STRESS,0.99999
REACTOME_GPCR_LIGAND_BINDING,SET,426,-0.0080642,-0.001214,0.04635,0.56906,REACTOME_GPCR_LIGAND_BINDING,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...22,SET,50,-0.022558,-0.0011756,0.12965,0.56906,GAVISH_3CA_METAPROGRAM_EPITHELIAL_SECRETED,0.99999
chr3p24,SET,30,-0.046784,-0.0018895,0.26875,0.5691,chr3p24,0.99999
JIANG_AGING_CEREBRAL_CORTEX_...2,SET,31,-0.027414,-0.0011255,0.15743,0.56912,JIANG_AGING_CEREBRAL_CORTEX_UP,0.99999
HP_PSEUDOEPIPHYSES_OF_THE_PH...,SET,5,-0.075417,-0.0012444,0.43287,0.56915,HP_PSEUDOEPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.99999
GOBP_POSITIVE_REGULATION_OF_...415,SET,10,-0.047681,-0.0011124,0.27359,0.56918,GOBP_POSITIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,0.99999
ACTWSNACTNY_UNKNOWN,SET,96,-0.013721,-0.00098957,0.078695,0.56921,ACTWSNACTNY_UNKNOWN,0.99999
GOBP_GLUTAMINE_FAMILY_AMINO_...1,SET,14,-0.037153,-0.0010255,0.21309,0.56921,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.99999
MIR4798_3P,SET,10,-0.038162,-0.00089036,0.21883,0.56922,MIR4798_3P,0.99999
GOCC_PERINEURONAL_NET,SET,10,-0.046671,-0.0010889,0.26748,0.56925,GOCC_PERINEURONAL_NET,0.99999
GSE1460_CD4_THYMOCYTE_VS_THY...1,SET,174,-0.011586,-0.0011225,0.066393,0.56926,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...14,SET,172,-0.011414,-0.0010995,0.065395,0.56928,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP,0.99999
HP_ABNORMAL_FEMORAL_NECK_HEA...,SET,180,-0.010985,-0.0010823,0.062917,0.5693,HP_ABNORMAL_FEMORAL_NECK_HEAD_MORPHOLOGY,0.99999
MIR3059_3P,SET,47,-0.019497,-0.00098516,0.11165,0.56931,MIR3059_3P,0.99999
GOBP_PHOSPHATE_ION_TRANSMEMB...,SET,14,-0.040321,-0.001113,0.23078,0.56935,GOBP_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORT,0.99999
MDM2_TARGET_GENES,SET,9,-0.043013,-0.00095207,0.24609,0.56937,MDM2_TARGET_GENES,0.99999
STARK_PREFRONTAL_CORTEX_22Q1...1,SET,448,-0.0066543,-0.0010267,0.03805,0.56941,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN,0.99999
GOBP_REPLICATIVE_SENESCENCE,SET,16,-0.03344,-0.00098672,0.19124,0.56941,GOBP_REPLICATIVE_SENESCENCE,0.99999
HP_ABNORMAL_CIRCULATING_METH...,SET,15,-0.039354,-0.0011244,0.22499,0.56943,HP_ABNORMAL_CIRCULATING_METHIONINE_CONCENTRATION,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...8,SET,12,-0.0402,-0.0010274,0.22977,0.56944,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CYCLE,0.99999
BIOCARTA_KREB_PATHWAY,SET,8,-0.055254,-0.0011531,0.31569,0.56947,BIOCARTA_KREB_PATHWAY,0.99999
PATEL_SKIN_OF_BODY_ZOSTAVAX_...3,SET,96,-0.015552,-0.0011216,0.088837,0.56949,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_UP,0.99999
GOMF_CUPROUS_ION_BINDING,SET,8,-0.049185,-0.0010264,0.2808,0.56952,GOMF_CUPROUS_ION_BINDING,0.99999
KEGG_MEDICUS_REFERENCE_CCR2_...,SET,30,-0.026937,-0.0010879,0.15376,0.56953,KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,0.99999
MIR455_5P,SET,82,-0.015959,-0.0010641,0.091078,0.56955,MIR455_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...331,SET,21,-0.035457,-0.0011984,0.20234,0.56955,GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION,0.99999
GOBP_ODONTOBLAST_DIFFERENTIA...,SET,16,-0.041738,-0.0012316,0.23818,0.56955,GOBP_ODONTOBLAST_DIFFERENTIATION,0.99999
GOBP_RESPONSE_TO_RETINOIC_AC...,SET,101,-0.015792,-0.001168,0.090074,0.56958,GOBP_RESPONSE_TO_RETINOIC_ACID,0.99999
GOBP_TRANSCRIPTION_DEPENDENT...,SET,7,-0.055207,-0.0010777,0.31491,0.56958,GOBP_TRANSCRIPTION_DEPENDENT_TETHERING_OF_RNA_POLYMERASE_II_GENE_DNA_AT_NUCLEAR_PERIPHERY,0.99999
HP_INCREASED_FEMALE_LIBIDO,SET,18,-0.037295,-0.0011671,0.21273,0.56958,HP_INCREASED_FEMALE_LIBIDO,0.99999
HARRIS_BRAIN_CANCER_PROGENIT...,SET,37,-0.025179,-0.0011292,0.14358,0.5696,HARRIS_BRAIN_CANCER_PROGENITORS,0.99999
TSENG_IRS1_TARGETS_UP,SET,94,-0.015514,-0.0011072,0.088463,0.56961,TSENG_IRS1_TARGETS_UP,0.99999
CTCAAGA_MIR526B,SET,61,-0.018524,-0.0010659,0.1056,0.56962,CTCAAGA_MIR526B,0.99999
CHARAFE_BREAST_CANCER_LUMINA...2,SET,340,-0.0082872,-0.0011172,0.047221,0.56965,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,0.99999
HP_ABNORMALITY_OF_MOUTH_SIZE,SET,373,-0.0077483,-0.0010931,0.044151,0.56965,HP_ABNORMALITY_OF_MOUTH_SIZE,0.99999
MIR671_5P,SET,117,-0.013617,-0.0010836,0.07752,0.56972,MIR671_5P,0.99999
GSE7764_NKCELL_VS_SPLENOCYTE...1,SET,189,-0.01068,-0.0010779,0.060746,0.56978,GSE7764_NKCELL_VS_SPLENOCYTE_DN,0.99999
GOBP_RESPONSE_TO_LEPTIN,SET,21,-0.03402,-0.0011499,0.19344,0.5698,GOBP_RESPONSE_TO_LEPTIN,0.99999
MIR5704,SET,47,-0.021137,-0.001068,0.12017,0.56981,MIR5704,0.99999
GOBP_MINERALOCORTICOID_BIOSY...,SET,12,-0.049618,-0.0012681,0.28202,0.56983,GOBP_MINERALOCORTICOID_BIOSYNTHETIC_PROCESS,0.99999
KEGG_RNA_DEGRADATION,SET,49,-0.020017,-0.0010327,0.11375,0.56984,KEGG_RNA_DEGRADATION,0.99999
HP_LONG_FOOT,SET,22,-0.028823,-0.00099712,0.16361,0.56992,HP_LONG_FOOT,0.99999
GSE10422_WT_VS_BAFF_TRANSGEN...2,SET,157,-0.011416,-0.0010511,0.064803,0.56992,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP,0.99999
SMID_BREAST_CANCER_RELAPSE_I...10,SET,6,-0.062825,-0.0011355,0.35639,0.56996,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP,0.99999
GOBP_RETINA_VASCULATURE_DEVE...,SET,18,-0.034798,-0.001089,0.19732,0.56999,GOBP_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.99999
HP_ABNORMALITY_OF_THE_MENSTR...,SET,290,-0.0087129,-0.0010863,0.049409,0.56999,HP_ABNORMALITY_OF_THE_MENSTRUAL_CYCLE,0.99999
GOMF_BICARBONATE_TRANSMEMBRA...,SET,31,-0.025843,-0.001061,0.14652,0.57,GOMF_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE3920_IFNB_VS_IFNG_TREATED...1,SET,158,-0.011162,-0.001031,0.063251,0.57004,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.99999
DAZARD_UV_RESPONSE_CLUSTER_G1,SET,53,-0.020272,-0.0010876,0.11477,0.5701,DAZARD_UV_RESPONSE_CLUSTER_G1,0.99999
GOBP_MAINTENANCE_OF_CENTROSO...,SET,5,-0.054549,-0.00090004,0.30877,0.57011,GOBP_MAINTENANCE_OF_CENTROSOME_LOCATION,0.99999
chr12q23,SET,68,-0.033894,-0.0020589,0.19174,0.57015,chr12q23,0.99999
MIR1244,SET,86,-0.015833,-0.001081,0.089498,0.57021,MIR1244,0.99999
GOMF_CHEMOKINE_RECEPTOR_BIND...,SET,60,-0.022748,-0.0012983,0.12859,0.57021,GOMF_CHEMOKINE_RECEPTOR_BINDING,0.99999
KEGG_MEDICUS_REFERENCE_HEME_...,SET,8,-0.049796,-0.0010392,0.28139,0.57023,KEGG_MEDICUS_REFERENCE_HEME_BIOSYNTHESIS,0.99999
WP_HEMESYNTHESIS_DEFECTS_AND...,SET,8,-0.049796,-0.0010392,0.28139,0.57023,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,0.99999
WP_HEME_BIOSYNTHESIS,SET,8,-0.049796,-0.0010392,0.28139,0.57023,WP_HEME_BIOSYNTHESIS,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...4,SET,181,-0.010759,-0.0010629,0.060798,0.57023,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP,0.99999
GOBP_MITOTIC_G2_DNA_DAMAGE_C...,SET,29,-0.024457,-0.00097119,0.13795,0.57036,GOBP_MITOTIC_G2_DNA_DAMAGE_CHECKPOINT_SIGNALING,0.99999
GOMF_ACETYL_COA_C_ACYLTRANSF...,SET,7,-0.048968,-0.00095595,0.27612,0.57038,GOMF_ACETYL_COA_C_ACYLTRANSFERASE_ACTIVITY,0.99999
GSE24671_CTRL_VS_BAKIMULC_IN...1,SET,151,-0.0128,-0.001156,0.072137,0.57042,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN,0.99999
WP_COVID19_THROMBOSIS_AND_AN...,SET,7,-0.070885,-0.0013838,0.39923,0.57046,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,0.99999
ZZZ3_TARGET_GENES,SET,233,-0.0095725,-0.0010715,0.053911,0.57046,ZZZ3_TARGET_GENES,0.99999
GOCC_ENDOCYTIC_VESICLE,SET,314,-0.0088031,-0.0011413,0.049579,0.57046,GOCC_ENDOCYTIC_VESICLE,0.99999
GOBP_POSITIVE_REGULATION_OF_...272,SET,9,-0.048812,-0.0010804,0.27473,0.57051,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,0.99999
HP_CORNEAL_GUTTATA,SET,6,-0.061293,-0.0011078,0.34496,0.57051,HP_CORNEAL_GUTTATA,0.99999
GSE17721_0.5H_VS_12H_CPG_BMD...2,SET,181,-0.010943,-0.0010812,0.061577,0.57053,GSE17721_0.5H_VS_12H_CPG_BMDC_UP,0.99999
GSE9878_CTRL_VS_EBF_TRANSDUC...1,SET,180,-0.010402,-0.0010249,0.058494,0.57057,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN,0.99999
MIR6874_5P,SET,35,-0.026892,-0.001173,0.15112,0.57062,MIR6874_5P,0.99999
LHX9_TARGET_GENES,SET,1163,-0.0046055,-0.0011218,0.025865,0.57066,LHX9_TARGET_GENES,0.99999
MIR153_5P,SET,950,-0.0051182,-0.0011337,0.028731,0.57069,MIR153_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...220,SET,7,-0.054974,-0.0010732,0.30851,0.57071,GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.99999
GOBP_SODIUM_ION_HOMEOSTASIS,SET,46,-0.02489,-0.0012443,0.13963,0.57074,GOBP_SODIUM_ION_HOMEOSTASIS,0.99999
REACTOME_REMOVAL_OF_AMINOTER...,SET,8,-0.056074,-0.0011702,0.3145,0.57075,REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS,0.99999
MATZUK_SPERMATID_DIFFERENTIA...,SET,35,-0.025694,-0.0011207,0.14404,0.57079,MATZUK_SPERMATID_DIFFERENTIATION,0.99999
MIR3064_5P,SET,133,-0.012946,-0.0010978,0.072566,0.57079,MIR3064_5P,0.99999
HP_DELAYED_CNS_MYELINATION,SET,171,-0.011183,-0.0010742,0.062684,0.57079,HP_DELAYED_CNS_MYELINATION,0.99999
GSE14415_NATURAL_TREG_VS_FOX...2,SET,140,-0.012467,-0.0010845,0.069855,0.57082,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP,0.99999
REACTOME_METABOLISM_OF_RNA,SET,646,-0.0054987,-0.0010131,0.030804,0.57084,REACTOME_METABOLISM_OF_RNA,0.99999
HP_AMAUROSIS_FUGAX,SET,40,-0.02266,-0.0010565,0.12694,0.57084,HP_AMAUROSIS_FUGAX,0.99999
MODULE_540,SET,10,-0.054477,-0.001271,0.30512,0.57085,MODULE_540,0.99999
ZHONG_PFC_C2_UNKNOWN_NPC,SET,72,-0.01692,-0.0010575,0.094711,0.57089,ZHONG_PFC_C2_UNKNOWN_NPC,0.99999
WP_IL19_SIGNALING,SET,28,-0.029556,-0.0011533,0.16539,0.57091,WP_IL19_SIGNALING,0.99999
GOBP_MITOTIC_CYTOKINESIS,SET,88,-0.015109,-0.0010435,0.084433,0.57101,GOBP_MITOTIC_CYTOKINESIS,0.99999
GOBP_CELLULAR_RESPONSE_TO_OR...1,SET,483,-0.0071443,-0.0011434,0.039904,0.57104,GOBP_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,0.99999
GSE26488_WT_VS_HDAC7_DELTAP_...2,SET,184,-0.011744,-0.0011697,0.065601,0.57104,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_UP,0.99999
HP_DELAYED_UMBILICAL_CORD_SE...,SET,5,-0.083184,-0.0013725,0.46457,0.57105,HP_DELAYED_UMBILICAL_CORD_SEPARATION,0.99999
HP_NEUTROPENIA_IN_PRESENCE_O...,SET,21,-0.033213,-0.0011226,0.18551,0.57105,HP_NEUTROPENIA_IN_PRESENCE_OF_ANTI_NEUTROPIL_ANTIBODIES,0.99999
GCM_CHUK,SET,69,-0.017338,-0.0010608,0.09674,0.57112,GCM_CHUK,0.99999
HP_FLATTENED_EPIPHYSIS,SET,22,-0.031444,-0.0010878,0.17538,0.57114,HP_FLATTENED_EPIPHYSIS,0.99999
GOBP_ENDOSOMAL_TRANSPORT,SET,255,-0.0091157,-0.0010668,0.0508,0.5712,GOBP_ENDOSOMAL_TRANSPORT,0.99999
GOBP_INORGANIC_ION_HOMEOSTAS...,SET,488,-0.0073328,-0.0011795,0.040813,0.57129,GOBP_INORGANIC_ION_HOMEOSTASIS,0.99999
HERNANDEZ_MITOTIC_ARREST_BY_...2,SET,23,-0.035564,-0.0012579,0.19784,0.57133,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,0.99999
HP_ABNORMAL_CIRCULATING_PROL...,SET,19,-0.031818,-0.001023,0.17685,0.57139,HP_ABNORMAL_CIRCULATING_PROLINE_CONCENTRATION,0.99999
HP_ABNORMAL_CLAVICLE_MORPHOL...,SET,94,-0.015321,-0.0010934,0.085131,0.57141,HP_ABNORMAL_CLAVICLE_MORPHOLOGY,0.99999
MIR3085_3P,SET,132,-0.013049,-0.0011024,0.072497,0.57142,MIR3085_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...202,SET,17,-0.036164,-0.0010999,0.20086,0.57144,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,0.99999
WP_COMPLEMENT_SYSTEM_IN_NEUR...,SET,95,-0.016464,-0.0011812,0.09143,0.57145,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...13,SET,183,-0.0112,-0.0011125,0.062183,0.57147,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_DN,0.99999
GSE7460_TREG_VS_TCONV_ACT_WI...1,SET,179,-0.011167,-0.0010972,0.061998,0.57147,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN,0.99999
KEGG_MEDICUS_REFERENCE_KEAP1...,SET,20,-0.041725,-0.0013763,0.23142,0.57154,KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY,0.99999
MIR6875_5P,SET,62,-0.018776,-0.0010892,0.1039,0.5717,MIR6875_5P,0.99999
GSE14908_RESTING_VS_HDM_STIM...2,SET,177,-0.01072,-0.0010474,0.059314,0.57171,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP,0.99999
GSE22611_UNSTIM_VS_6H_MDP_ST...4,SET,176,-0.011334,-0.0011043,0.062681,0.57174,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.99999
GOCC_SPECTRIN,SET,9,-0.0486,-0.0010757,0.26867,0.57177,GOCC_SPECTRIN,0.99999
GUENTHER_GROWTH_SPHERICAL_VS...2,SET,20,-0.038123,-0.0012575,0.21068,0.5718,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP,0.99999
MIR6802_3P,SET,36,-0.024578,-0.0010872,0.13572,0.57185,MIR6802_3P,0.99999
HP_FOCAL_IMPAIRED_AWARENESS_...,SET,113,-0.014566,-0.0011392,0.08044,0.57185,HP_FOCAL_IMPAIRED_AWARENESS_SEIZURE,0.99999
GSE5503_LIVER_DC_VS_SPLEEN_D...2,SET,182,-0.011475,-0.0011367,0.063341,0.57188,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.99999
GSE30083_SP1_VS_SP4_THYMOCYT...2,SET,180,-0.011218,-0.0011053,0.061915,0.57189,GSE30083_SP1_VS_SP4_THYMOCYTE_UP,0.99999
MORF_PSMF1,SET,159,-0.011467,-0.0010625,0.063271,0.57191,MORF_PSMF1,0.99999
GSE29618_PRE_VS_DAY7_POST_TI...4,SET,179,-0.011256,-0.0011059,0.062104,0.57191,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP,0.99999
REACTOME_ESTROGEN_BIOSYNTHES...,SET,6,-0.058444,-0.0010563,0.32236,0.57193,REACTOME_ESTROGEN_BIOSYNTHESIS,0.99999
GHANDHI_DIRECT_IRRADIATION_UP,SET,97,-0.016879,-0.0012236,0.093076,0.57195,GHANDHI_DIRECT_IRRADIATION_UP,0.99999
REACTOME_METHIONINE_SALVAGE_...,SET,6,-0.07241,-0.0013087,0.39927,0.57196,REACTOME_METHIONINE_SALVAGE_PATHWAY,0.99999
MIR7_2_3P,SET,591,-0.0065871,-0.0011626,0.036304,0.57199,MIR7_2_3P,0.99999
MODULE_77,SET,27,-0.024976,-0.00095706,0.13765,0.57199,MODULE_77,0.99999
REACTOME_ABC_TRANSPORTER_DIS...,SET,74,-0.01652,-0.0010467,0.090965,0.57206,REACTOME_ABC_TRANSPORTER_DISORDERS,0.99999
RREB1_01,SET,191,-0.010954,-0.0011114,0.060276,0.57211,RREB1_01,0.99999
GOBP_POSITIVE_REGULATION_OF_...697,SET,8,-0.058802,-0.0012271,0.32349,0.57212,GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.99999
BUSSLINGER_DUODENAL_K_CELLS,SET,17,-0.038995,-0.001186,0.21444,0.57215,BUSSLINGER_DUODENAL_K_CELLS,0.99999
GOBP_REGULATION_OF_MICROTUBU...8,SET,85,-0.015562,-0.0010564,0.085523,0.57219,GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.99999
KEGG_MEDICUS_REFERENCE_AMH_S...,SET,9,-0.051375,-0.0011372,0.28228,0.57221,KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY,0.99999
GSE2706_2H_VS_8H_R848_STIM_D...2,SET,172,-0.011676,-0.0011248,0.064131,0.57223,GSE2706_2H_VS_8H_R848_STIM_DC_UP,0.99999
REACTOME_METABOLIC_DISORDERS...,SET,32,-0.027806,-0.0011598,0.1527,0.57224,REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES,0.99999
GOMF_MODIFICATION_DEPENDENT_...,SET,156,-0.011175,-0.0010257,0.061348,0.57227,GOMF_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.99999
LOPEZ_MBD_TARGETS_IMPRINTED_...,SET,3,-0.071358,-0.00091205,0.39107,0.57239,LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED,0.99999
GOCC_MICROBODY,SET,132,-0.01319,-0.0011143,0.072137,0.57254,GOCC_MICROBODY,0.99999
MIR6504_5P,SET,128,-0.013471,-0.0011208,0.073611,0.5726,MIR6504_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...743,SET,15,-0.040459,-0.0011559,0.22102,0.57262,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,0.99999
GOCC_TRICARBOXYLIC_ACID_CYCL...,SET,18,-0.031124,-0.00097401,0.16998,0.57264,GOCC_TRICARBOXYLIC_ACID_CYCLE_HETEROMERIC_ENZYME_COMPLEX,0.99999
GSE17301_CTRL_VS_48H_ACD3_AC...6,SET,177,-0.0114,-0.0011139,0.062256,0.57265,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP,0.99999
GSE37301_PRO_BCELL_VS_RAG2_K...1,SET,169,-0.012198,-0.0011649,0.066534,0.57273,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN,0.99999
HP_SACROCOCCYGEAL_TERATOMA,SET,5,-0.065928,-0.0010878,0.35933,0.57279,HP_SACROCOCCYGEAL_TERATOMA,0.99999
GOBP_CELLULAR_RESPONSE_TO_AL...4,SET,36,-0.026545,-0.0011743,0.14456,0.57284,GOBP_CELLULAR_RESPONSE_TO_ALKALOID,0.99999
HP_HIGH_PITCHED_CRY,SET,5,-0.062222,-0.0010266,0.33886,0.57284,HP_HIGH_PITCHED_CRY,0.99999
GSE11864_CSF1_IFNG_VS_CSF1_I...2,SET,174,-0.011676,-0.0011313,0.063527,0.57292,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.99999
TBX3_TARGET_GENES,SET,627,-0.0062448,-0.0011341,0.03397,0.57293,TBX3_TARGET_GENES,0.99999
chr10q25,SET,51,-0.038065,-0.0020034,0.20703,0.57294,chr10q25,0.99999
GOMF_CHONDROITIN_SULFATE_BIN...,SET,9,-0.055504,-0.0012285,0.30181,0.57295,GOMF_CHONDROITIN_SULFATE_BINDING,0.99999
REACTOME_NOREPINEPHRINE_NEUR...,SET,16,-0.04098,-0.0012092,0.22265,0.57301,REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE,0.99999
MODULE_57,SET,55,-0.019932,-0.0010892,0.10829,0.57302,MODULE_57,0.99999
GSE9960_HEALTHY_VS_GRAM_POS_...1,SET,166,-0.012102,-0.0011455,0.065696,0.57307,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN,0.99999
HP_CAUDATE_ATROPHY,SET,11,-0.049337,-0.0012072,0.2678,0.57308,HP_CAUDATE_ATROPHY,0.99999
HP_PARIETAL_CORTICAL_ATROPHY,SET,8,-0.053598,-0.0011185,0.29076,0.57313,HP_PARIETAL_CORTICAL_ATROPHY,0.99999
GSE17721_ALL_VS_24H_PAM3CSK4...1,SET,174,-0.011434,-0.0011078,0.061985,0.57317,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_DN,0.99999
GSE37533_PPARG1_FOXP3_VS_FOX...2,SET,188,-0.010856,-0.0010928,0.058853,0.57317,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.99999
GOBP_SYMBIONT_ENTRY_INTO_HOST,SET,154,-0.013168,-0.0012009,0.07138,0.57318,GOBP_SYMBIONT_ENTRY_INTO_HOST,0.99999
HP_SPONDYLOMETAPHYSEAL_DYSPL...,SET,8,-0.054733,-0.0011422,0.2967,0.57318,HP_SPONDYLOMETAPHYSEAL_DYSPLASIA,0.99999
REACTOME_TRANSCRIPTIONAL_ACT...1,SET,50,-0.022318,-0.001163,0.12085,0.57326,REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,0.99999
KEGG_MEDICUS_REFERENCE_BMP_S...2,SET,14,-0.045506,-0.0012561,0.24635,0.57327,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY_BMP_ANTAGONIST,0.99999
GOBP_CELLULAR_HYPEROSMOTIC_R...,SET,19,-0.035692,-0.0011476,0.19312,0.57331,GOBP_CELLULAR_HYPEROSMOTIC_RESPONSE,0.99999
HP_DYSGENESIS_OF_THE_BASAL_G...,SET,5,-0.06686,-0.0011032,0.36178,0.57331,HP_DYSGENESIS_OF_THE_BASAL_GANGLIA,0.99999
GOCC_CYTOPLASMIC_SIDE_OF_MEM...,SET,186,-0.011444,-0.001146,0.061914,0.57332,GOCC_CYTOPLASMIC_SIDE_OF_MEMBRANE,0.99999
HP_DECREASED_CERVICAL_SPINE_...1,SET,5,-0.073166,-0.0012072,0.3958,0.57333,HP_DECREASED_CERVICAL_SPINE_FLEXION_DUE_TO_CONTRACTURES_OF_POSTERIOR_CERVICAL_MUSCLES,0.99999
HP_SELF_BITING,SET,8,-0.055947,-0.0011676,0.30263,0.57333,HP_SELF_BITING,0.99999
MIR4427,SET,211,-0.01095,-0.0011671,0.059218,0.57335,MIR4427,0.99999
HP_SPERMATOGENESIS_MATURATIO...,SET,11,-0.043517,-0.0010648,0.23534,0.57335,HP_SPERMATOGENESIS_MATURATION_ARREST,0.99999
MODULE_2,SET,347,-0.0090805,-0.0012365,0.049089,0.57338,MODULE_2,0.99999
GSE2770_TGFB_AND_IL4_VS_IL4_...5,SET,171,-0.011575,-0.0011118,0.06254,0.57342,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
GSE32164_RESTING_DIFFERENTIA...4,SET,181,-0.011849,-0.0011706,0.064009,0.57343,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP,0.99999
GSE10325_CD4_TCELL_VS_LUPUS_...1,SET,178,-0.012178,-0.0011932,0.065748,0.57347,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN,0.99999
GOBP_RESPONSE_TO_PROSTAGLAND...3,SET,23,-0.035728,-0.0012637,0.19272,0.57354,GOBP_RESPONSE_TO_PROSTAGLANDIN_E,0.99999
ESC_J1_UP_LATE.V1_DN,SET,150,-0.012692,-0.0011425,0.068458,0.57354,ESC_J1_UP_LATE.V1_DN,0.99999
GOBP_HAIR_FOLLICLE_MATURATION,SET,15,-0.041165,-0.0011761,0.22197,0.57356,GOBP_HAIR_FOLLICLE_MATURATION,0.99999
ERWIN_COHEN_BLOOD_TC_83_AGE_...,SET,108,-0.01573,-0.0012028,0.084815,0.57356,ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP,0.99999
HP_REDUCED_BLOOD_FOLATE_CONC...,SET,4,-0.083681,-0.001235,0.4511,0.57358,HP_REDUCED_BLOOD_FOLATE_CONCENTRATION,0.99999
MIR548AQ_5P,SET,445,-0.0075163,-0.0011559,0.040485,0.57364,MIR548AQ_5P,0.99999
BENPORATH_PROLIFERATION,SET,135,-0.013263,-0.0011331,0.071371,0.57371,BENPORATH_PROLIFERATION,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...16,SET,5,-0.078095,-0.0012886,0.42025,0.57371,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN,0.99999
JIANG_MELANOMA_TRM_HIGH_SURV...,SET,19,-0.036853,-0.0011849,0.19828,0.57372,JIANG_MELANOMA_TRM_HIGH_SURVIVAL_22_GENE_SIGNATURE,0.99999
HP_ABNORMAL_FOVEAL_MORPHOLOGY,SET,45,-0.025386,-0.0012552,0.13652,0.57376,HP_ABNORMAL_FOVEAL_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_MICROTUBU...3,SET,7,-0.05262,-0.0010272,0.28293,0.57377,GOBP_REGULATION_OF_MICROTUBULE_BINDING,0.99999
FAN_EMBRYONIC_CTX_BIG_GROUPS...1,SET,341,-0.0092634,-0.0012506,0.049808,0.57377,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL,0.99999
WALLACE_JAK2_TARGETS_UP,SET,19,-0.032023,-0.0010296,0.17209,0.57381,WALLACE_JAK2_TARGETS_UP,0.99999
GOBP_T_FOLLICULAR_HELPER_CEL...,SET,7,-0.059108,-0.0011539,0.31756,0.57383,GOBP_T_FOLLICULAR_HELPER_CELL_DIFFERENTIATION,0.99999
GOBP_RESPONSE_TO_EPINEPHRINE,SET,14,-0.044022,-0.0012151,0.23644,0.57385,GOBP_RESPONSE_TO_EPINEPHRINE,0.99999
HP_ABNORMAL_URINE_POTASSIUM_...,SET,16,-0.042437,-0.0012522,0.2279,0.57386,HP_ABNORMAL_URINE_POTASSIUM_CONCENTRATION,0.99999
HP_SHORT_MIDDLE_PHALANX_OF_T...2,SET,5,-0.077182,-0.0012735,0.4144,0.57387,HP_SHORT_MIDDLE_PHALANX_OF_TOE,0.99999
MA_MYELOID_DIFFERENTIATION_UP,SET,37,-0.026014,-0.0011666,0.13963,0.5739,MA_MYELOID_DIFFERENTIATION_UP,0.99999
PID_HIF1_TFPATHWAY,SET,64,-0.020646,-0.0012168,0.11076,0.57393,PID_HIF1_TFPATHWAY,0.99999
GLI1_UP.V1_UP,SET,21,-0.034471,-0.0011651,0.18487,0.57396,GLI1_UP.V1_UP,0.99999
KINSEY_TARGETS_OF_EWSR1_FLII...1,SET,299,-0.0093755,-0.0011866,0.050268,0.57398,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,0.99999
chr16p13,SET,209,-0.022212,-0.0023562,0.11892,0.57408,chr16p13,0.99999
GSE41867_MEMORY_VS_EXHAUSTED...2,SET,186,-0.011606,-0.0011622,0.06211,0.57412,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP,0.99999
GOBP_BASIC_AMINO_ACID_TRANSP...,SET,20,-0.036911,-0.0012176,0.1975,0.57413,GOBP_BASIC_AMINO_ACID_TRANSPORT,0.99999
NKX62_Q2,SET,220,-0.011296,-0.0012291,0.06042,0.57415,NKX62_Q2,0.99999
HP_ANOSMIA,SET,47,-0.024647,-0.0012454,0.13184,0.57415,HP_ANOSMIA,0.99999
HP_STEPPAGE_GAIT,SET,49,-0.021853,-0.0011274,0.11688,0.57416,HP_STEPPAGE_GAIT,0.99999
MIR410_5P,SET,38,-0.024415,-0.0011096,0.13055,0.57417,MIR410_5P,0.99999
GSE2770_IL12_VS_IL4_TREATED_...1,SET,151,-0.013144,-0.0011871,0.070282,0.57418,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.99999
REACTOME_HEDGEHOG_ON_STATE,SET,82,-0.016085,-0.0010725,0.085965,0.57421,REACTOME_HEDGEHOG_ON_STATE,0.99999
GOBP_FERMENTATION,SET,3,-0.090938,-0.0011623,0.48594,0.57422,GOBP_FERMENTATION,0.99999
MIR3177_3P,SET,8,-0.062481,-0.0013039,0.3338,0.57424,MIR3177_3P,0.99999
GOCC_SWI_SNF_SUPERFAMILY_TYP...,SET,88,-0.015434,-0.0010659,0.082442,0.57425,GOCC_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX,0.99999
GOMF_ORGANIC_ACID_SODIUM_SYM...,SET,32,-0.029081,-0.001213,0.15531,0.57426,GOMF_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY,0.99999
HP_DARK_URINE,SET,9,-0.051228,-0.0011339,0.27353,0.57428,HP_DARK_URINE,0.99999
GOBP_LIPID_HYDROXYLATION,SET,7,-0.064209,-0.0012535,0.34264,0.57432,GOBP_LIPID_HYDROXYLATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...321,SET,183,-0.012564,-0.0012481,0.06704,0.57433,GOBP_POSITIVE_REGULATION_OF_GTPASE_ACTIVITY,0.99999
HP_SENILE_PLAQUES,SET,10,-0.049949,-0.0011654,0.26646,0.57435,HP_SENILE_PLAQUES,0.99999
GOBP_POSITIVE_REGULATION_OF_...828,SET,17,-0.037604,-0.0011437,0.20054,0.57437,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.99999
BIOCARTA_RNA_PATHWAY,SET,10,-0.049694,-0.0011594,0.26497,0.57438,BIOCARTA_RNA_PATHWAY,0.99999
HP_NECROTIZING_ENTEROCOLITIS,SET,6,-0.061886,-0.0011185,0.32999,0.57438,HP_NECROTIZING_ENTEROCOLITIS,0.99999
MODULE_11,SET,494,-0.0075433,-0.0012205,0.040192,0.57444,MODULE_11,0.99999
HP_SPLANCHNIC_VEIN_THROMBOSIS,SET,22,-0.035797,-0.0012384,0.19069,0.57445,HP_SPLANCHNIC_VEIN_THROMBOSIS,0.99999
MIR767_3P,SET,115,-0.015953,-0.0012586,0.084958,0.57447,MIR767_3P,0.99999
GOBP_ANTIFUNGAL_HUMORAL_RESP...,SET,4,-0.087627,-0.0012932,0.46629,0.57453,GOBP_ANTIFUNGAL_HUMORAL_RESPONSE,0.99999
GOBP_REGULATION_OF_CHOLESTER...4,SET,17,-0.038979,-0.0011855,0.20719,0.57461,GOBP_REGULATION_OF_CHOLESTEROL_STORAGE,0.99999
REACTOME_HDR_THROUGH_MMEJ_AL...,SET,11,-0.044129,-0.0010798,0.23452,0.57463,REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ,0.99999
GOBP_REGULATION_OF_DNA_DAMAG...3,SET,6,-0.063685,-0.0011511,0.33841,0.57464,GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR,0.99999
TAATTA_CHX10_01,SET,730,-0.0063071,-0.0012323,0.033497,0.57467,TAATTA_CHX10_01,0.99999
TAKEDA_TARGETS_OF_NUP98_HOXA...7,SET,42,-0.025896,-0.0012371,0.13737,0.57476,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,0.99999
HP_SHORT_TOE,SET,89,-0.016817,-0.001168,0.089168,0.57479,HP_SHORT_TOE,0.99999
GSE11057_PBMC_VS_MEM_CD4_TCE...2,SET,178,-0.012607,-0.0012353,0.066838,0.5748,GSE11057_PBMC_VS_MEM_CD4_TCELL_UP,0.99999
MOOTHA_MITOCHONDRIA,SET,396,-0.0078956,-0.001147,0.041858,0.57481,MOOTHA_MITOCHONDRIA,0.99999
MIR744_3P,SET,55,-0.020828,-0.0011382,0.11036,0.57484,MIR744_3P,0.99999
ALONSO_METASTASIS_EMT_UP,SET,32,-0.028449,-0.0011866,0.15067,0.57488,ALONSO_METASTASIS_EMT_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...176,SET,11,-0.05238,-0.0012817,0.27731,0.57491,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,0.99999
GSE41867_DAY8_EFFECTOR_VS_DA...4,SET,186,-0.01099,-0.0011005,0.058175,0.57492,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.99999
GSE5589_LPS_VS_LPS_AND_IL6_S...4,SET,172,-0.01222,-0.0011772,0.064679,0.57493,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,0.99999
KEGG_MEDICUS_REFERENCE_DERMA...,SET,7,-0.060856,-0.001188,0.32182,0.57499,KEGG_MEDICUS_REFERENCE_DERMATAN_SULFATE_DEGRADATION,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...12,SET,25,-0.034759,-0.0012817,0.18381,0.57499,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL,0.99999
HP_ABNORMAL_BLOOD_GAS_LEVEL,SET,44,-0.024767,-0.001211,0.13097,0.575,HP_ABNORMAL_BLOOD_GAS_LEVEL,0.99999
OZEN_MIR125B1_TARGETS,SET,22,-0.033974,-0.0011753,0.17956,0.57503,OZEN_MIR125B1_TARGETS,0.99999
REACTOME_PI_METABOLISM,SET,77,-0.017198,-0.0011114,0.090896,0.57503,REACTOME_PI_METABOLISM,0.99999
HP_FOCAL_DYSTONIA,SET,122,-0.013861,-0.0011261,0.07326,0.57503,HP_FOCAL_DYSTONIA,0.99999
GOBP_CERAMIDE_BIOSYNTHETIC_P...,SET,66,-0.020109,-0.0012035,0.10622,0.57508,GOBP_CERAMIDE_BIOSYNTHETIC_PROCESS,0.99999
REACTOME_TRANSCRIPTIONAL_REG...13,SET,28,-0.033616,-0.0013117,0.17743,0.57513,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,0.99999
GOMF_NADH_DEHYDROGENASE_UBIQ...,SET,33,-0.023231,-0.00098399,0.12261,0.57514,GOMF_NADH_DEHYDROGENASE_UBIQUINONE_ACTIVITY,0.99999
HP_SEBORRHEIC_DERMATITIS,SET,22,-0.034749,-0.0012021,0.1834,0.57514,HP_SEBORRHEIC_DERMATITIS,0.99999
IVANOVA_HEMATOPOIESIS_STEM_C...4,SET,18,-0.034517,-0.0010802,0.18157,0.57539,IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM,0.99999
DESCARTES_MAIN_FETAL_ADRENOC...,SET,62,-0.020966,-0.0012163,0.11026,0.5754,DESCARTES_MAIN_FETAL_ADRENOCORTICAL_CELLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...395,SET,273,-0.0099185,-0.0012004,0.052145,0.57543,GOBP_POSITIVE_REGULATION_OF_KINASE_ACTIVITY,0.99999
GOBP_ESTABLISHMENT_OF_ENDOTH...2,SET,13,-0.047853,-0.0012729,0.25142,0.57548,GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_INTESTINAL_BARRIER,0.99999
MODULE_158,SET,41,-0.024063,-0.0011358,0.12625,0.57558,MODULE_158,0.99999
GSE6674_ANTI_IGM_VS_ANTI_IGM...1,SET,177,-0.011778,-0.0011508,0.061792,0.57558,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,0.99999
CTIP_DN.V1_DN,SET,114,-0.015535,-0.0012203,0.081485,0.5756,CTIP_DN.V1_DN,0.99999
GOMF_EXCITATORY_EXTRACELLULA...,SET,34,-0.030436,-0.0013085,0.1596,0.57562,GOMF_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.99999
MCGOWAN_RSP6_TARGETS_UP,SET,20,-0.038233,-0.0012611,0.20042,0.57564,MCGOWAN_RSP6_TARGETS_UP,0.99999
GOMF_MICROTUBULE_PLUS_END_BI...,SET,21,-0.032344,-0.0010932,0.16948,0.57567,GOMF_MICROTUBULE_PLUS_END_BINDING,0.99999
GOBP_RESPONSE_TO_VASOPRESSIN,SET,8,-0.05965,-0.0012448,0.31249,0.57569,GOBP_RESPONSE_TO_VASOPRESSIN,0.99999
MIKKELSEN_NPC_ICP_WITH_H3K27...,SET,11,-0.056085,-0.0013724,0.29377,0.5757,MIKKELSEN_NPC_ICP_WITH_H3K27ME3,0.99999
GSE4142_NAIVE_BCELL_VS_PLASM...2,SET,175,-0.01178,-0.0011446,0.06169,0.57572,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_UP,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...7,SET,181,-0.011661,-0.0011521,0.061036,0.57576,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN,0.99999
REACTOME_COPI_DEPENDENT_GOLG...,SET,95,-0.015552,-0.0011158,0.08134,0.57581,REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,0.99999
HP_ABNORMALITY_OF_THUMB_PHAL...,SET,171,-0.012221,-0.0011739,0.063916,0.57582,HP_ABNORMALITY_OF_THUMB_PHALANX,0.99999
GOBP_RESPONSE_TO_HEPARIN,SET,6,-0.079364,-0.0014344,0.41499,0.57583,GOBP_RESPONSE_TO_HEPARIN,0.99999
GSE40685_NAIVE_CD4_TCELL_VS_...2,SET,186,-0.011723,-0.0011739,0.061276,0.57586,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_UP,0.99999
GOMF_ERBB_3_CLASS_RECEPTOR_B...,SET,5,-0.074071,-0.0012222,0.38695,0.5759,GOMF_ERBB_3_CLASS_RECEPTOR_BINDING,0.99999
GOBP_REGULATION_OF_REGULATED...,SET,104,-0.015667,-0.0011758,0.08183,0.57591,GOBP_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.99999
HP_TRUNCAL_ATAXIA,SET,66,-0.019342,-0.0011575,0.10103,0.57591,HP_TRUNCAL_ATAXIA,0.99999
KONG_E2F3_TARGETS,SET,90,-0.01719,-0.0012005,0.089748,0.57594,KONG_E2F3_TARGETS,0.99999
GOBP_RNA_METHYLATION,SET,66,-0.017685,-0.0010584,0.092325,0.57595,GOBP_RNA_METHYLATION,0.99999
KEGG_MEDICUS_PATHOGEN_KSHV_V...6,SET,29,-0.031962,-0.0012692,0.16678,0.57599,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY,0.99999
REACTOME_REGULATION_OF_NPAS4...2,SET,5,-0.076673,-0.0012651,0.39991,0.57602,REACTOME_REGULATION_OF_NPAS4_GENE_TRANSCRIPTION,0.99999
HP_ABNORMAL_ISOHEMAGGLUTININ...,SET,7,-0.069469,-0.0013561,0.36235,0.57602,HP_ABNORMAL_ISOHEMAGGLUTININ_LEVEL,0.99999
HP_ELEVATED_CIRCULATING_ALDO...,SET,6,-0.058827,-0.0010632,0.30682,0.57602,HP_ELEVATED_CIRCULATING_ALDOLASE_CONCENTRATION,0.99999
DESCARTES_FETAL_HEART_ERYTHR...,SET,242,-0.009695,-0.0011057,0.050541,0.57606,DESCARTES_FETAL_HEART_ERYTHROBLASTS,0.99999
DESCARTES_FETAL_LUNG_SQUAMOU...,SET,176,-0.013107,-0.0012771,0.068328,0.57606,DESCARTES_FETAL_LUNG_SQUAMOUS_EPITHELIAL_CELLS,0.99999
GOBP_GOLGI_TO_VACUOLE_TRANSP...,SET,20,-0.033919,-0.0011188,0.17668,0.57612,GOBP_GOLGI_TO_VACUOLE_TRANSPORT,0.99999
HP_ABNORMAL_VISUAL_FIELD_TEST,SET,20,-0.033956,-0.0011201,0.17683,0.57614,HP_ABNORMAL_VISUAL_FIELD_TEST,0.99999
GSE3400_UNTREATED_VS_IFNB_TR...2,SET,167,-0.01236,-0.0011734,0.064236,0.57629,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_UP,0.99999
GOCC_CELL_BODY_FIBER,SET,8,-0.061827,-0.0012903,0.32127,0.5763,GOCC_CELL_BODY_FIBER,0.99999
GOCC_LATE_ENDOSOME,SET,278,-0.0097362,-0.0011889,0.050591,0.5763,GOCC_LATE_ENDOSOME,0.99999
GCM_CSNK2B,SET,85,-0.015864,-0.0010769,0.082388,0.57634,GCM_CSNK2B,0.99999
HP_CEREBRAL_ARTERIOVENOUS_MA...,SET,7,-0.059289,-0.0011574,0.30792,0.57634,HP_CEREBRAL_ARTERIOVENOUS_MALFORMATION,0.99999
BIOCARTA_VIP_PATHWAY,SET,26,-0.033915,-0.0012753,0.17609,0.57636,BIOCARTA_VIP_PATHWAY,0.99999
REACTOME_XENOBIOTICS,SET,23,-0.037054,-0.0013106,0.19232,0.57639,REACTOME_XENOBIOTICS,0.99999
GOMF_DNA_DIRECTED_DNA_POLYME...,SET,22,-0.026569,-0.00091913,0.1377,0.5765,GOMF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,0.99999
PID_RAC1_REG_PATHWAY,SET,36,-0.027215,-0.0012039,0.14079,0.57664,PID_RAC1_REG_PATHWAY,0.99999
GOBP_NEUROPEPTIDE_SIGNALING_...,SET,92,-0.018613,-0.0013143,0.096245,0.57668,GOBP_NEUROPEPTIDE_SIGNALING_PATHWAY,0.99999
GOMF_INOSITOL_1_3_4_5_6_PENT...,SET,5,-0.058278,-0.00096158,0.30124,0.5767,GOMF_INOSITOL_1_3_4_5_6_PENTAKISPHOSPHATE_KINASE_ACTIVITY,0.99999
ZHAN_MULTIPLE_MYELOMA_MF_UP,SET,40,-0.025475,-0.0011877,0.13162,0.57673,ZHAN_MULTIPLE_MYELOMA_MF_UP,0.99999
ROY_WOUND_BLOOD_VESSEL_UP,SET,45,-0.024939,-0.0012331,0.12882,0.57675,ROY_WOUND_BLOOD_VESSEL_UP,0.99999
HP_SKIN_PLAQUE,SET,41,-0.025181,-0.0011886,0.13007,0.57675,HP_SKIN_PLAQUE,0.99999
GSE19941_LPS_VS_LPS_AND_IL10...4,SET,183,-0.012174,-0.0012093,0.062875,0.57676,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.99999
HP_ABNORMALITY_OF_THE_CERVIC...,SET,375,-0.0084195,-0.0011909,0.043473,0.57678,HP_ABNORMALITY_OF_THE_CERVICAL_SPINE,0.99999
GSE24210_RESTING_TREG_VS_TCO...2,SET,179,-0.011994,-0.0011784,0.061877,0.57684,GSE24210_RESTING_TREG_VS_TCONV_UP,0.99999
GOBP_HEXOSE_PHOSPHATE_TRANSP...,SET,6,-0.066641,-0.0012045,0.34369,0.57687,GOBP_HEXOSE_PHOSPHATE_TRANSPORT,0.99999
GOBP_VIRAL_GENOME_REPLICATION,SET,117,-0.015547,-0.0012371,0.080146,0.5769,GOBP_VIRAL_GENOME_REPLICATION,0.99999
GOBP_CEREBRAL_CORTEX_GABAERG...2,SET,9,-0.063931,-0.0014151,0.32937,0.57695,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DIFFERENTIATION,0.99999
HP_FEEDING_DIFFICULTIES_IN_I...,SET,509,-0.007189,-0.0011802,0.037024,0.57698,HP_FEEDING_DIFFICULTIES_IN_INFANCY,0.99999
GOBP_TRIGLYCERIDE_BIOSYNTHET...,SET,37,-0.0264,-0.0011839,0.13594,0.57699,GOBP_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.99999
HP_OLIGOARTHRITIS,SET,12,-0.050045,-0.001279,0.25769,0.57699,HP_OLIGOARTHRITIS,0.99999
GOBP_MEMBRANE_FUSION,SET,166,-0.012436,-0.0011771,0.064026,0.577,GOBP_MEMBRANE_FUSION,0.99999
GOBP_REGULATION_OF_FATTY_ACI...2,SET,39,-0.024861,-0.0011446,0.12801,0.577,GOBP_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.99999
HP_PROGRESSIVE_LANGUAGE_DETE...,SET,11,-0.04969,-0.0012159,0.25567,0.57705,HP_PROGRESSIVE_LANGUAGE_DETERIORATION,0.99999
HP_COMMUNICATING_HYDROCEPHAL...,SET,21,-0.034342,-0.0011608,0.17649,0.57714,HP_COMMUNICATING_HYDROCEPHALUS,0.99999
HP_METAPHYSEAL_SCLEROSIS,SET,12,-0.0517,-0.0013213,0.26568,0.57714,HP_METAPHYSEAL_SCLEROSIS,0.99999
GOCC_PROTON_TRANSPORTING_TWO...3,SET,10,-0.047018,-0.001097,0.24147,0.57719,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_PROTON_TRANSPORTING_DOMAIN,0.99999
GOCC_PROTON_TRANSPORTING_V_T...2,SET,10,-0.047018,-0.001097,0.24147,0.57719,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN,0.99999
MIR6749_3P,SET,100,-0.016526,-0.0012162,0.084858,0.5772,MIR6749_3P,0.99999
PGF_UP.V1_UP,SET,167,-0.013025,-0.0012365,0.066884,0.5772,PGF_UP.V1_UP,0.99999
GSE17721_0.5H_VS_24H_LPS_BMD...2,SET,182,-0.012392,-0.0012276,0.063611,0.57722,GSE17721_0.5H_VS_24H_LPS_BMDC_UP,0.99999
HP_KETOSIS,SET,60,-0.021102,-0.0012043,0.10829,0.57725,HP_KETOSIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...668,SET,14,-0.043113,-0.00119,0.22086,0.57738,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_RECYCLING,0.99999
HP_PROSTATITIS,SET,6,-0.083412,-0.0015076,0.42713,0.57741,HP_PROSTATITIS,0.99999
MIR8069,SET,57,-0.022467,-0.0012499,0.11496,0.57747,MIR8069,0.99999
GOBP_REGULATION_OF_LIPOPOLYS...,SET,27,-0.031696,-0.0012145,0.16218,0.57747,GOBP_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,0.99999
REACTOME_SIGNALING_BY_PDGFRA...,SET,12,-0.046131,-0.001179,0.23563,0.57761,REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS,0.99999
HP_ABNORMAL_RENAL_PELVIS_MOR...,SET,244,-0.010496,-0.0012019,0.053573,0.57766,HP_ABNORMAL_RENAL_PELVIS_MORPHOLOGY,0.99999
GSE22611_MUTANT_NOD2_TRANSDU...2,SET,170,-0.012364,-0.0011842,0.063084,0.57769,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP,0.99999
GOBP_DE_NOVO_NAD_BIOSYNTHETI...,SET,8,-0.063342,-0.0013219,0.32306,0.57772,GOBP_DE_NOVO_NAD_BIOSYNTHETIC_PROCESS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...67,SET,25,-0.032794,-0.0012092,0.16721,0.57774,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.99999
GOBP_PEPTIDYL_GLUTAMIC_ACID_...,SET,25,-0.033751,-0.0012446,0.1721,0.57774,GOBP_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION,0.99999
MIR4437,SET,96,-0.016797,-0.0012114,0.085493,0.57788,MIR4437,0.99999
GOBP_POST_GOLGI_VESICLE_MEDI...,SET,103,-0.015403,-0.0011504,0.078371,0.57791,GOBP_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.99999
GSE7460_TCONV_VS_TREG_LN_DN,SET,181,-0.012724,-0.0012571,0.064726,0.57792,GSE7460_TCONV_VS_TREG_LN_DN,0.99999
GSE5589_WT_VS_IL6_KO_LPS_AND...4,SET,175,-0.012251,-0.0011903,0.062294,0.57795,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.99999
GOBP_RESPONSE_TO_CORTICOTROP...,SET,5,-0.085458,-0.00141,0.43431,0.57799,GOBP_RESPONSE_TO_CORTICOTROPIN_RELEASING_HORMONE,0.99999
GOBP_CORPUS_CALLOSUM_DEVELOP...,SET,25,-0.036784,-0.0013564,0.18692,0.578,GOBP_CORPUS_CALLOSUM_DEVELOPMENT,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...5,SET,180,-0.012242,-0.0012062,0.062202,0.57801,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_DN,0.99999
SRF_C,SET,198,-0.011762,-0.0012148,0.059747,0.57803,SRF_C,0.99999
HP_EQUINUS_CALCANEUS,SET,8,-0.06347,-0.0013246,0.32232,0.57805,HP_EQUINUS_CALCANEUS,0.99999
GOBP_REGULATION_OF_PLASMA_ME...2,SET,6,-0.072663,-0.0013133,0.36895,0.57806,GOBP_REGULATION_OF_PLASMA_MEMBRANE_REPAIR,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_AIR...,SET,20,-0.041389,-0.0013653,0.21016,0.57806,HE_LIM_SUN_FETAL_LUNG_C0_AIRWAY_FIBROBLAST,0.99999
WU_APOPTOSIS_BY_CDKN1A_VIA_T...,SET,50,-0.022804,-0.0011884,0.11567,0.57814,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,0.99999
WP_INTERACTIONS_OF_NATURAL_K...,SET,28,-0.033691,-0.0013146,0.17087,0.57815,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,0.99999
MIR598_5P,SET,4,-0.084079,-0.0012409,0.42625,0.57818,MIR598_5P,0.99999
GSE15215_CD2_POS_VS_NEG_PDC_...2,SET,181,-0.012183,-0.0012036,0.061702,0.57826,GSE15215_CD2_POS_VS_NEG_PDC_UP,0.99999
HP_ABNORMAL_CIRCULATING_FREE...2,SET,7,-0.05748,-0.0011221,0.29104,0.57828,HP_ABNORMAL_CIRCULATING_FREE_T3_CONCENTRATION,0.99999
REACTOME_REGULATION_OF_MITF_...3,SET,15,-0.046856,-0.0013387,0.23723,0.57829,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_LYSOSOME_BIOGENESIS_AND_AUTOPHAGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...353,SET,18,-0.038488,-0.0012045,0.19482,0.5783,GOBP_POSITIVE_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...11,SET,23,-0.03623,-0.0012815,0.18338,0.57831,GOMF_STRUCTURAL_CONSTITUENT_OF_SYNAPSE,0.99999
QI_HYPOXIA_TARGETS_OF_HIF1A_...,SET,32,-0.029141,-0.0012155,0.14747,0.57832,QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,0.99999
GOBP_SENSORY_PERCEPTION_OF_T...1,SET,65,-0.022936,-0.0013623,0.11604,0.57834,GOBP_SENSORY_PERCEPTION_OF_TASTE,0.99999
GSE2770_TGFB_AND_IL4_ACT_VS_...2,SET,163,-0.012711,-0.0011923,0.064253,0.57841,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,0.99999
HP_SYMPTOMATIC_SEIZURES,SET,35,-0.029781,-0.001299,0.15047,0.57844,HP_SYMPTOMATIC_SEIZURES,0.99999
REACTOME_FREE_FATTY_ACID_REC...,SET,4,-0.099913,-0.0014745,0.50472,0.57846,REACTOME_FREE_FATTY_ACID_RECEPTORS,0.99999
GSE9037_CTRL_VS_LPS_4H_STIM_...1,SET,183,-0.011806,-0.0011728,0.059597,0.57852,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN,0.99999
GOMF_CALCIUM_SENSITIVE_GUANY...,SET,5,-0.078611,-0.0012971,0.39659,0.57856,GOMF_CALCIUM_SENSITIVE_GUANYLATE_CYCLASE_ACTIVATOR_ACTIVITY,0.99999
AMIT_EGF_RESPONSE_20_HELA,SET,10,-0.05452,-0.001272,0.27494,0.57859,AMIT_EGF_RESPONSE_20_HELA,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_LAT...1,SET,22,-0.041118,-0.0014224,0.20734,0.5786,HE_LIM_SUN_FETAL_LUNG_C1_LATE_AIRWAY_PROGENITOR_CELL,0.99999
GOBP_MACROMOLECULE_METHYLATI...,SET,104,-0.014827,-0.0011127,0.074721,0.57864,GOBP_MACROMOLECULE_METHYLATION,0.99999
GOBP_REGULATION_OF_DNA_DAMAG...2,SET,33,-0.029756,-0.0012604,0.14992,0.57866,GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...651,SET,21,-0.030459,-0.0010295,0.15329,0.57875,GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,0.99999
GOMF_EPHRIN_RECEPTOR_ACTIVITY,SET,18,-0.044194,-0.001383,0.22231,0.57879,GOMF_EPHRIN_RECEPTOR_ACTIVITY,0.99999
AIZARANI_LIVER_C24_EPCAM_POS...,SET,174,-0.013719,-0.0013292,0.068981,0.57882,AIZARANI_LIVER_C24_EPCAM_POS_BILE_DUCT_CELLS_3,0.99999
WP_AXON_GUIDANCE,SET,69,-0.021698,-0.0013276,0.10895,0.57892,WP_AXON_GUIDANCE,0.99999
GSE34156_NOD2_LIGAND_VS_NOD2...4,SET,161,-0.01234,-0.0011504,0.061959,0.57893,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,0.99999
GTCTTCC_MIR7,SET,155,-0.013607,-0.0012449,0.068313,0.57894,GTCTTCC_MIR7,0.99999
GSE34515_CD16_POS_MONOCYTE_V...2,SET,188,-0.012294,-0.0012376,0.061699,0.57897,GSE34515_CD16_POS_MONOCYTE_VS_DC_UP,0.99999
GSE37301_PRO_BCELL_VS_RAG2_K...2,SET,164,-0.013195,-0.0012415,0.066213,0.57898,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_UP,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...2,SET,183,-0.012359,-0.0012276,0.062015,0.57898,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP,0.99999
GSE12845_IGD_NEG_BLOOD_VS_NA...2,SET,173,-0.012315,-0.0011898,0.061716,0.57908,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,0.99999
GOBP_LOCOMOTORY_BEHAVIOR,SET,193,-0.012455,-0.0012702,0.062404,0.5791,GOBP_LOCOMOTORY_BEHAVIOR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...446,SET,5,-0.086344,-0.0014247,0.43246,0.57912,GOBP_NEGATIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,0.99999
REACTOME_MRNA_CAPPING,SET,28,-0.027282,-0.0010646,0.13663,0.57913,REACTOME_MRNA_CAPPING,0.99999
GOBP_POSITIVE_REGULATION_OF_...217,SET,271,-0.009836,-0.0011861,0.04925,0.57915,GOBP_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,0.99999
DESCARTES_FETAL_HEART_MEGAKA...,SET,80,-0.02009,-0.0013232,0.10059,0.57915,DESCARTES_FETAL_HEART_MEGAKARYOCYTES,0.99999
HP_ABNORMAL_NUMBER_OF_VERTEB...,SET,3,-0.089478,-0.0011436,0.44793,0.57916,HP_ABNORMAL_NUMBER_OF_VERTEBRAE,0.99999
CAGCTTT_MIR320,SET,220,-0.01161,-0.0012632,0.058096,0.5792,CAGCTTT_MIR320,0.99999
MIR4781_3P,SET,35,-0.027538,-0.0012011,0.13778,0.57921,MIR4781_3P,0.99999
HP_MILIA,SET,16,-0.043759,-0.0012912,0.21887,0.57923,HP_MILIA,0.99999
HP_LEFT_VENTRICULAR_DIASTOLI...,SET,7,-0.064138,-0.0012521,0.32075,0.57924,HP_LEFT_VENTRICULAR_DIASTOLIC_DYSFUNCTION,0.99999
GSE17721_LPS_VS_PAM3CSK4_2H_...2,SET,184,-0.012782,-0.0012731,0.063916,0.57925,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP,0.99999
HP_ABNORMALITY_OF_THE_PHARYNX,SET,197,-0.012051,-0.0012416,0.060246,0.57927,HP_ABNORMALITY_OF_THE_PHARYNX,0.99999
GOBP_DNA_REPAIR,SET,530,-0.0068717,-0.0011505,0.034336,0.57931,GOBP_DNA_REPAIR,0.99999
GOBP_REGULATION_OF_CHROMOSOM...3,SET,125,-0.014558,-0.0011971,0.072737,0.57932,GOBP_REGULATION_OF_CHROMOSOME_SEGREGATION,0.99999
HP_TAPERED_SPERM_HEAD,SET,7,-0.068859,-0.0013442,0.34395,0.57934,HP_TAPERED_SPERM_HEAD,0.99999
MIR1323,SET,285,-0.010218,-0.0012631,0.051029,0.57935,MIR1323,0.99999
PID_NOTCH_PATHWAY,SET,56,-0.02144,-0.0011822,0.10702,0.57939,PID_NOTCH_PATHWAY,0.99999
WDHD1_TARGET_GENES,SET,148,-0.013874,-0.0012405,0.069205,0.57944,WDHD1_TARGET_GENES,0.99999
MIR7151_3P,SET,250,-0.010603,-0.0012288,0.052887,0.57945,MIR7151_3P,0.99999
GOBP_RESPONSE_TO_HYDROSTATIC...,SET,7,-0.067009,-0.0013081,0.33406,0.57949,GOBP_RESPONSE_TO_HYDROSTATIC_PRESSURE,0.99999
ATAAGCT_MIR21,SET,111,-0.015933,-0.0012351,0.079412,0.57951,ATAAGCT_MIR21,0.99999
MIR1306_5P,SET,45,-0.024414,-0.0012072,0.12164,0.57954,MIR1306_5P,0.99999
GOBP_VASCULOGENESIS,SET,79,-0.020029,-0.0013109,0.099731,0.57958,GOBP_VASCULOGENESIS,0.99999
GSE22611_NOD2_VS_MUTANT_NOD2...1,SET,158,-0.013125,-0.0012123,0.06534,0.5796,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...300,SET,11,-0.056463,-0.0013816,0.28097,0.57963,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_MIGRATION,0.99999
CYCLIN_D1_KE_.V1_DN,SET,179,-0.012712,-0.001249,0.063254,0.57964,CYCLIN_D1_KE_.V1_DN,0.99999
TAATGTG_MIR323,SET,148,-0.013799,-0.0012338,0.06864,0.57966,TAATGTG_MIR323,0.99999
HP_ABNORMAL_ENDOMETRIUM_MORP...,SET,28,-0.027834,-0.0010861,0.13844,0.57967,HP_ABNORMAL_ENDOMETRIUM_MORPHOLOGY,0.99999
GOCC_KINESIN_COMPLEX,SET,47,-0.023071,-0.0011658,0.11474,0.57968,GOCC_KINESIN_COMPLEX,0.99999
GSE26343_UNSTIM_VS_LPS_STIM_...1,SET,182,-0.012158,-0.0012045,0.060442,0.57971,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.99999
MIR6793_5P,SET,56,-0.023533,-0.0012977,0.11695,0.57974,MIR6793_5P,0.99999
MIR3150B_3P,SET,137,-0.014678,-0.0012631,0.072855,0.57983,MIR3150B_3P,0.99999
MORF_MYST2,SET,60,-0.019657,-0.0011218,0.097504,0.57988,MORF_MYST2,0.99999
GSE17721_12H_VS_24H_CPG_BMDC...2,SET,186,-0.012362,-0.0012379,0.061296,0.57992,GSE17721_12H_VS_24H_CPG_BMDC_UP,0.99999
GOBP_EPITHELIAL_CELL_PROLIFE...1,SET,407,-0.0089343,-0.0013154,0.04428,0.57995,GOBP_EPITHELIAL_CELL_PROLIFERATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...478,SET,43,-0.02818,-0.0013621,0.13965,0.57996,GOBP_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...441,SET,9,-0.062483,-0.001383,0.3096,0.57997,GOBP_NEGATIVE_REGULATION_OF_NEURON_MIGRATION,0.99999
HP_ABNORMAL_ESOPHAGUS_PHYSIO...,SET,773,-0.0062017,-0.0012454,0.03073,0.57997,HP_ABNORMAL_ESOPHAGUS_PHYSIOLOGY,0.99999
HP_SQUARE_FACE,SET,11,-0.056955,-0.0013936,0.28216,0.57998,HP_SQUARE_FACE,0.99999
ZNF596_TARGET_GENES,SET,485,-0.0079528,-0.0012754,0.039368,0.58005,ZNF596_TARGET_GENES,0.99999
HP_TESSIER_CLEFT,SET,17,-0.040696,-0.0012377,0.20143,0.58005,HP_TESSIER_CLEFT,0.99999
GSE29614_CTRL_VS_DAY3_TIV_FL...1,SET,138,-0.015207,-0.0013134,0.07524,0.58008,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN,0.99999
GOBP_RESPONSE_TO_SELENIUM_ION,SET,5,-0.066101,-0.0010907,0.32695,0.58011,GOBP_RESPONSE_TO_SELENIUM_ION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...676,SET,30,-0.033692,-0.0013608,0.1666,0.58013,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,0.99999
GOBP_REGULATION_OF_HAIR_CYCLE,SET,28,-0.033326,-0.0013004,0.1648,0.58013,GOBP_REGULATION_OF_HAIR_CYCLE,0.99999
MIR513C_5P,SET,164,-0.013153,-0.0012375,0.065012,0.58017,MIR513C_5P,0.99999
REACTOME_CYP2E1_REACTIONS,SET,11,-0.055744,-0.001364,0.27546,0.58018,REACTOME_CYP2E1_REACTIONS,0.99999
GSE41867_LCMV_ARMSTRONG_VS_C...3,SET,186,-0.011887,-0.0011904,0.058676,0.58027,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_DN,0.99999
GOMF_FIBROBLAST_GROWTH_FACTO...2,SET,5,-0.083837,-0.0013833,0.41361,0.58031,GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_ACTIVITY,0.99999
CYCLIN_D1_UP.V1_UP,SET,169,-0.013342,-0.0012741,0.065789,0.58035,CYCLIN_D1_UP.V1_UP,0.99999
HP_LEFT_VENTRICULAR_NONCOMPA...,SET,9,-0.06284,-0.0013909,0.30978,0.58037,HP_LEFT_VENTRICULAR_NONCOMPACTION_CARDIOMYOPATHY,0.99999
GOBP_REGULATION_OF_VASCULAR_...1,SET,2,-0.13073,-0.0013643,0.64443,0.58038,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEDIFFERENTIATION,0.99999
GSE17721_CTRL_VS_LPS_1H_BMDC...1,SET,181,-0.013029,-0.0012872,0.064124,0.5805,GSE17721_CTRL_VS_LPS_1H_BMDC_DN,0.99999
HP_PTERYGIUM,SET,45,-0.024581,-0.0012154,0.12097,0.58051,HP_PTERYGIUM,0.99999
HP_PERMANENT_ATRIAL_FIBRILLA...,SET,9,-0.06005,-0.0013292,0.29525,0.58058,HP_PERMANENT_ATRIAL_FIBRILLATION,0.99999
REACTOME_TRIGLYCERIDE_METABO...,SET,35,-0.030488,-0.0013298,0.14973,0.58067,REACTOME_TRIGLYCERIDE_METABOLISM,0.99999
GOBP_REGULATION_OF_CELL_CYCL...2,SET,172,-0.013041,-0.0012563,0.064048,0.58067,GOBP_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,0.99999
GOMF_SYNDECAN_BINDING,SET,5,-0.086319,-0.0014242,0.42389,0.58068,GOMF_SYNDECAN_BINDING,0.99999
GOCC_COLLAGEN_CONTAINING_EXT...,SET,391,-0.009351,-0.00135,0.045901,0.58071,GOCC_COLLAGEN_CONTAINING_EXTRACELLULAR_MATRIX,0.99999
GSE4748_CTRL_VS_LPS_AND_CYAN...1,SET,189,-0.012899,-0.0013019,0.063266,0.58078,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,0.99999
GOBP_BONE_MORPHOGENESIS,SET,96,-0.018805,-0.0013562,0.092164,0.58084,GOBP_BONE_MORPHOGENESIS,0.99999
GSE39382_IL3_VS_IL3_IL33_TRE...1,SET,177,-0.013284,-0.0012979,0.065096,0.58085,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...641,SET,1110,-0.0053339,-0.0012712,0.026129,0.58087,GOBP_POSITIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS,0.99999
GOBP_CELL_FATE_SPECIFICATION...,SET,7,-0.066124,-0.0012909,0.32387,0.58089,GOBP_CELL_FATE_SPECIFICATION_INVOLVED_IN_PATTERN_SPECIFICATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_EAR...1,SET,71,-0.02036,-0.0012636,0.099724,0.58089,HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST,0.99999
MIR5582_5P,SET,357,-0.009256,-0.001278,0.04533,0.5809,MIR5582_5P,0.99999
BIOCARTA_BAD_PATHWAY,SET,24,-0.038993,-0.0014088,0.1909,0.58092,BIOCARTA_BAD_PATHWAY,0.99999
GOBP_MEDIUM_CHAIN_FATTY_ACID...2,SET,5,-0.069394,-0.001145,0.3396,0.58095,GOBP_MEDIUM_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.99999
GSE14308_NAIVE_CD4_TCELL_VS_...4,SET,177,-0.012561,-0.0012274,0.061474,0.58095,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP,0.99999
GOBP_MICROTUBULE_ANCHORING,SET,21,-0.034777,-0.0011755,0.17019,0.58096,GOBP_MICROTUBULE_ANCHORING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...660,SET,5,-0.074466,-0.0012287,0.36424,0.581,GOBP_NEGATIVE_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION,0.99999
HP_GENU_VALGUM,SET,139,-0.014858,-0.0012878,0.072648,0.58102,HP_GENU_VALGUM,0.99999
HP_SOCIAL_AND_OCCUPATIONAL_D...,SET,14,-0.047928,-0.001323,0.23436,0.58102,HP_SOCIAL_AND_OCCUPATIONAL_DETERIORATION,0.99999
GOCC_TRANSCRIPTION_FACTOR_AP...,SET,5,-0.090276,-0.0014895,0.44137,0.58103,GOCC_TRANSCRIPTION_FACTOR_AP_1_COMPLEX,0.99999
GOCC_NUCLEOCYTOPLASMIC_TRANS...,SET,12,-0.042622,-0.0010893,0.20818,0.58111,GOCC_NUCLEOCYTOPLASMIC_TRANSPORT_COMPLEX,0.99999
GSE1925_CTRL_VS_3H_IFNG_STIM...3,SET,177,-0.013729,-0.0013414,0.067052,0.58112,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN,0.99999
HP_ABNORMAL_RAPID_EYE_MOVEME...,SET,13,-0.051619,-0.001373,0.25205,0.58113,HP_ABNORMAL_RAPID_EYE_MOVEMENT_SLEEP,0.99999
HP_DYSPNEA,SET,432,-0.0085037,-0.0012889,0.041509,0.58116,HP_DYSPNEA,0.99999
GOBP_REGULATION_OF_PRESYNAPT...2,SET,28,-0.035997,-0.0014047,0.17564,0.58119,GOBP_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.99999
GSE40274_CTRL_VS_FOXP3_AND_H...2,SET,187,-0.012556,-0.0012607,0.061256,0.58121,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
REACTOME_N_GLYCAN_TRIMMING_A...,SET,5,-0.095178,-0.0015704,0.46403,0.58126,REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI,0.99999
HP_CROHN_S_DISEASE,SET,13,-0.058123,-0.001546,0.28302,0.58136,HP_CROHN_S_DISEASE,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...8,SET,176,-0.013352,-0.001301,0.065013,0.58136,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,0.99999
NATSUME_RESPONSE_TO_INTERFER...1,SET,51,-0.024434,-0.0012859,0.11896,0.58137,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,0.99999
HP_PROGRESSIVE_PROXIMAL_MUSC...,SET,21,-0.038055,-0.0012862,0.18524,0.58138,HP_PROGRESSIVE_PROXIMAL_MUSCLE_WEAKNESS,0.99999
HP_ABNORMAL_EYELID_MORPHOLOGY,SET,1179,-0.0051322,-0.0012581,0.024959,0.58146,HP_ABNORMAL_EYELID_MORPHOLOGY,0.99999
MIR1193,SET,32,-0.029934,-0.0012486,0.14552,0.58149,MIR1193,0.99999
EVI1_01,SET,14,-0.046897,-0.0012945,0.22794,0.5815,EVI1_01,0.99999
GOBP_OSTEOBLAST_PROLIFERATION,SET,32,-0.032165,-0.0013416,0.1563,0.58152,GOBP_OSTEOBLAST_PROLIFERATION,0.99999
LET_7D_5P,SET,316,-0.010044,-0.0013063,0.048798,0.58154,LET_7D_5P,0.99999
GSE11961_UNSTIM_VS_ANTI_IGM_...2,SET,182,-0.012854,-0.0012734,0.062418,0.58158,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_UP,0.99999
HAHTOLA_MYCOSIS_FUNGOIDES_UP,SET,14,-0.047698,-0.0013166,0.23157,0.58159,HAHTOLA_MYCOSIS_FUNGOIDES_UP,0.99999
SA_TRKA_RECEPTOR,SET,16,-0.041217,-0.0012162,0.20011,0.58159,SA_TRKA_RECEPTOR,0.99999
PBX1_01,SET,233,-0.011944,-0.0013369,0.057987,0.58159,PBX1_01,0.99999
REACTOME_PHASE_I_FUNCTIONALI...,SET,99,-0.019221,-0.0014076,0.093313,0.5816,REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,0.99999
WP_MRNA_PROTEIN_AND_METABOLI...,SET,7,-0.064835,-0.0012657,0.31465,0.58162,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,0.99999
HP_ABNORMAL_UVEA_MORPHOLOGY,SET,522,-0.0078219,-0.0013,0.037965,0.58162,HP_ABNORMAL_UVEA_MORPHOLOGY,0.99999
HP_WRITER_S_CRAMP,SET,18,-0.038911,-0.0012177,0.18882,0.58163,HP_WRITER_S_CRAMP,0.99999
PHONG_TNF_RESPONSE_NOT_VIA_P...,SET,323,-0.010297,-0.0013537,0.049958,0.58165,PHONG_TNF_RESPONSE_NOT_VIA_P38,0.99999
HP_ABNORMAL_HALLUX_PHALANX_M...,SET,37,-0.027728,-0.0012435,0.13451,0.58166,HP_ABNORMAL_HALLUX_PHALANX_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...706,SET,5,-0.077017,-0.0012708,0.37354,0.58167,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION,0.99999
KUMAMOTO_RESPONSE_TO_NUTLIN_...1,SET,9,-0.049862,-0.0011037,0.24178,0.58169,KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN,0.99999
HP_MALAR_PROMINENCE,SET,5,-0.07307,-0.0012056,0.35435,0.58169,HP_MALAR_PROMINENCE,0.99999
GOMF_GROWTH_FACTOR_BINDING,SET,126,-0.016825,-0.001389,0.08153,0.58175,GOMF_GROWTH_FACTOR_BINDING,0.99999
HP_FLEXION_CONTRACTURE_OF_TH...,SET,4,-0.10141,-0.0014966,0.49125,0.58177,HP_FLEXION_CONTRACTURE_OF_THE_2ND_FINGER,0.99999
HP_SUPERNUMERARY_MAXILLARY_I...,SET,3,-0.11671,-0.0014918,0.56496,0.58183,HP_SUPERNUMERARY_MAXILLARY_INCISOR,0.99999
DESCARTES_FETAL_LIVER_MYELOI...,SET,170,-0.014615,-0.0013998,0.070707,0.58188,DESCARTES_FETAL_LIVER_MYELOID_CELLS,0.99999
PID_CONE_PATHWAY,SET,20,-0.040271,-0.0013284,0.19477,0.5819,PID_CONE_PATHWAY,0.99999
GSE7852_TREG_VS_TCONV_THYMUS...2,SET,181,-0.01307,-0.0012913,0.063196,0.58192,GSE7852_TREG_VS_TCONV_THYMUS_UP,0.99999
MCCLUNG_CREB1_TARGETS_UP,SET,91,-0.019898,-0.0013973,0.09618,0.58195,MCCLUNG_CREB1_TARGETS_UP,0.99999
GOMF_TUMOR_NECROSIS_FACTOR_R...1,SET,9,-0.065493,-0.0014496,0.31648,0.58197,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_ACTIVITY,0.99999
HP_ABNORMAL_VAGINA_MORPHOLOGY,SET,111,-0.017094,-0.0013251,0.082547,0.58203,HP_ABNORMAL_VAGINA_MORPHOLOGY,0.99999
GSE17721_PAM3CSK4_VS_CPG_6H_...2,SET,177,-0.012217,-0.0011937,0.058985,0.58204,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_UP,0.99999
GSE7460_TCONV_VS_TREG_LN_UP,SET,184,-0.013406,-0.0013353,0.064677,0.5821,GSE7460_TCONV_VS_TREG_LN_UP,0.99999
HP_CRYPTOPHTHALMOS,SET,5,-0.092815,-0.0015314,0.44755,0.58214,HP_CRYPTOPHTHALMOS,0.99999
HP_UNUSUAL_INFECTION_BY_ANAT...,SET,95,-0.018368,-0.0013178,0.088556,0.58216,HP_UNUSUAL_INFECTION_BY_ANATOMICAL_SITE,0.99999
ABBUD_LIF_SIGNALING_1_DN,SET,21,-0.043604,-0.0014738,0.21015,0.58219,ABBUD_LIF_SIGNALING_1_DN,0.99999
ZNF514_TARGET_GENES,SET,7,-0.068672,-0.0013406,0.33093,0.58219,ZNF514_TARGET_GENES,0.99999
HP_ABNORMAL_CIRCULATING_DICA...,SET,139,-0.014956,-0.0012963,0.072067,0.5822,HP_ABNORMAL_CIRCULATING_DICARBOXYLIC_ACID_CONCENTRATION,0.99999
GSE23505_IL6_IL1_IL23_VS_IL6...1,SET,179,-0.012514,-0.0012295,0.060298,0.5822,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,0.99999
GSE45365_WT_VS_IFNAR_KO_BCEL...3,SET,150,-0.013793,-0.0012416,0.066467,0.5822,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP,0.99999
MIR498_3P,SET,196,-0.012668,-0.0013019,0.061027,0.58222,MIR498_3P,0.99999
HP_ABNORMAL_COCHLEA_MORPHOLO...,SET,27,-0.032349,-0.0012396,0.15582,0.58223,HP_ABNORMAL_COCHLEA_MORPHOLOGY,0.99999
MIR655_5P,SET,75,-0.021063,-0.0013434,0.10142,0.58226,MIR655_5P,0.99999
GOBP_NUCLEOBASE_CONTAINING_S...1,SET,15,-0.046766,-0.0013361,0.22512,0.58228,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMALITY_OF_HAIR_TEXTU...,SET,157,-0.013842,-0.0012745,0.066586,0.58234,HP_ABNORMALITY_OF_HAIR_TEXTURE,0.99999
REACTOME_ESR_MEDIATED_SIGNAL...,SET,157,-0.014151,-0.001303,0.068045,0.58237,REACTOME_ESR_MEDIATED_SIGNALING,0.99999
HP_BROAD_LONG_BONES,SET,128,-0.015727,-0.0013086,0.075581,0.58242,HP_BROAD_LONG_BONES,0.99999
GOBP_HEMATOPOIETIC_OR_LYMPHO...,SET,96,-0.018189,-0.0013117,0.087373,0.58245,GOBP_HEMATOPOIETIC_OR_LYMPHOID_ORGAN_DEVELOPMENT,0.99999
chr10q24,SET,109,-0.033765,-0.0025938,0.16194,0.58258,chr10q24,0.99999
HP_ASTROCYTOSIS,SET,21,-0.039576,-0.0013377,0.18978,0.58259,HP_ASTROCYTOSIS,0.99999
GOCC_CILIARY_TIP,SET,40,-0.027562,-0.001285,0.13213,0.58262,GOCC_CILIARY_TIP,0.99999
GOBP_REGULATION_OF_MUSCLE_OR...,SET,23,-0.042653,-0.0015087,0.20445,0.58263,GOBP_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT,0.99999
GOBP_AXON_EXTENSION,SET,93,-0.018366,-0.0013038,0.088024,0.58264,GOBP_AXON_EXTENSION,0.99999
HP_OLIGOHYDRAMNIOS,SET,166,-0.013407,-0.001269,0.064231,0.58267,HP_OLIGOHYDRAMNIOS,0.99999
HP_EARLY_YOUNG_ADULT_ONSET,SET,57,-0.023014,-0.0012803,0.11018,0.58272,HP_EARLY_YOUNG_ADULT_ONSET,0.99999
PID_IGF1_PATHWAY,SET,28,-0.034516,-0.0013469,0.16516,0.58277,PID_IGF1_PATHWAY,0.99999
MORF_RFC4,SET,132,-0.014486,-0.0012238,0.069283,0.58281,MORF_RFC4,0.99999
GOBP_REGULATION_OF_MEMBRANE_...7,SET,61,-0.022242,-0.0012799,0.10631,0.58286,GOBP_REGULATION_OF_MEMBRANE_PERMEABILITY,0.99999
HP_ABNORMALITY_OF_THE_MITOCH...,SET,190,-0.011767,-0.0011908,0.056244,0.58286,HP_ABNORMALITY_OF_THE_MITOCHONDRION,0.99999
GSE25088_WT_VS_STAT6_KO_MACR...6,SET,180,-0.012823,-0.0012634,0.061217,0.58296,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,0.99999
YAP1_UP,SET,40,-0.026889,-0.0012537,0.12833,0.58298,YAP1_UP,0.99999
GSE15750_WT_VS_TRAF6KO_DAY10...2,SET,175,-0.013178,-0.0012804,0.062844,0.58305,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP,0.99999
MOROSETTI_FACIOSCAPULOHUMERA...2,SET,19,-0.04096,-0.0013169,0.19519,0.5831,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP,0.99999
GOCC_FILAMENTOUS_ACTIN,SET,30,-0.031248,-0.0012621,0.14885,0.58314,GOCC_FILAMENTOUS_ACTIN,0.99999
JOHANSSON_BRAIN_CANCER_EARLY...2,SET,6,-0.068182,-0.0012323,0.32463,0.58318,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP,0.99999
HOXA9_DN.V1_UP,SET,172,-0.014103,-0.0013586,0.067131,0.5832,HOXA9_DN.V1_UP,0.99999
GOBP_PYRIMIDINE_NUCLEOBASE_B...,SET,7,-0.060535,-0.0011817,0.2881,0.58321,GOBP_PYRIMIDINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,0.99999
MOTAMED_RESPONSE_TO_ANDROGEN...2,SET,4,-0.10223,-0.0015087,0.48641,0.58323,MOTAMED_RESPONSE_TO_ANDROGEN_UP,0.99999
ZHAN_MULTIPLE_MYELOMA_LB_DN,SET,35,-0.029722,-0.0012964,0.14125,0.58333,ZHAN_MULTIPLE_MYELOMA_LB_DN,0.99999
HP_ABNORMAL_LUMBAR_SPINE_MOR...,SET,26,-0.036462,-0.0013711,0.17324,0.58335,HP_ABNORMAL_LUMBAR_SPINE_MORPHOLOGY,0.99999
GOBP_GAP_JUNCTION_MEDIATED_I...,SET,6,-0.086162,-0.0015573,0.40928,0.58337,GOBP_GAP_JUNCTION_MEDIATED_INTERCELLULAR_TRANSPORT,0.99999
HP_OCCIPITAL_MENINGOCELE,SET,7,-0.070086,-0.0013682,0.33272,0.58342,HP_OCCIPITAL_MENINGOCELE,0.99999
HP_HEMERALOPIA,SET,8,-0.066952,-0.0013972,0.31768,0.58346,HP_HEMERALOPIA,0.99999
CHICAS_RB1_TARGETS_LOW_SERUM,SET,74,-0.02041,-0.0012931,0.096762,0.58353,CHICAS_RB1_TARGETS_LOW_SERUM,0.99999
GOBP_ERBB3_SIGNALING_PATHWAY,SET,10,-0.059502,-0.0013882,0.28205,0.58354,GOBP_ERBB3_SIGNALING_PATHWAY,0.99999
HP_FACIAL_DIPLEGIA,SET,39,-0.027674,-0.0012741,0.13109,0.5836,HP_FACIAL_DIPLEGIA,0.99999
CHENG_RESPONSE_TO_NICKEL_ACE...,SET,40,-0.025339,-0.0011814,0.11981,0.58375,CHENG_RESPONSE_TO_NICKEL_ACETATE,0.99999
HP_TEMPOROMANDIBULAR_JOINT_A...,SET,4,-0.080709,-0.0011911,0.38095,0.58389,HP_TEMPOROMANDIBULAR_JOINT_ANKYLOSIS,0.99999
REACTOME_DISEASES_ASSOCIATED...4,SET,61,-0.024994,-0.0014383,0.11793,0.58392,REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS,0.99999
CREB_Q4_01,SET,191,-0.013139,-0.0013331,0.06198,0.58394,CREB_Q4_01,0.99999
GSE17580_TREG_VS_TEFF_S_MANS...2,SET,180,-0.013485,-0.0013286,0.063571,0.58399,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP,0.99999
CACTGTG_MIR128A_MIR128B,SET,306,-0.010313,-0.0013202,0.048597,0.58403,CACTGTG_MIR128A_MIR128B,0.99999
HP_CUTANEOUS_SYNDACTYLY_OF_T...,SET,25,-0.03589,-0.0013234,0.16911,0.58403,HP_CUTANEOUS_SYNDACTYLY_OF_TOES,0.99999
HP_IMPAIRMENT_IN_PERSONALITY...,SET,199,-0.012565,-0.001301,0.059137,0.58413,HP_IMPAIRMENT_IN_PERSONALITY_FUNCTIONING,0.99999
WP_OVARIAN_INFERTILITY,SET,38,-0.029647,-0.0013473,0.1395,0.58415,WP_OVARIAN_INFERTILITY,0.99999
HP_ABNORMAL_EUSTACHIAN_TUBE_...,SET,4,-0.11506,-0.0016981,0.5412,0.58418,HP_ABNORMAL_EUSTACHIAN_TUBE_MORPHOLOGY,0.99999
PCGF1_TARGET_GENES,SET,456,-0.0087245,-0.0013577,0.041009,0.58424,PCGF1_TARGET_GENES,0.99999
ZHONG_SECRETOME_OF_LUNG_CANC...2,SET,122,-0.015674,-0.0012734,0.073658,0.58425,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,0.99999
MIR3155A_MIR3155B,SET,71,-0.020637,-0.0012808,0.096895,0.58433,MIR3155A_MIR3155B,0.99999
GOBP_RIBOFLAVIN_METABOLIC_PR...,SET,5,-0.081637,-0.001347,0.38317,0.58436,GOBP_RIBOFLAVIN_METABOLIC_PROCESS,0.99999
GOCC_RNA_POLYMERASE_I_TRANSC...,SET,5,-0.072877,-0.0012024,0.34194,0.58438,GOCC_RNA_POLYMERASE_I_TRANSCRIPTION_REGULATOR_COMPLEX,0.99999
GOCC_RNA_POLYMERASE_TRANSCRI...,SET,5,-0.072877,-0.0012024,0.34194,0.58438,GOCC_RNA_POLYMERASE_TRANSCRIPTION_FACTOR_SL1_COMPLEX,0.99999
HP_DYSKINESIA,SET,172,-0.013433,-0.001294,0.06302,0.58439,HP_DYSKINESIA,0.99999
ESC_J1_UP_LATE.V1_UP,SET,162,-0.014869,-0.0013905,0.069753,0.5844,ESC_J1_UP_LATE.V1_UP,0.99999
GSE2706_2H_VS_8H_R848_AND_LP...1,SET,177,-0.013835,-0.0013518,0.064893,0.58441,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN,0.99999
GOBP_PROTEASOME_ASSEMBLY,SET,11,-0.04898,-0.0011985,0.2297,0.58443,GOBP_PROTEASOME_ASSEMBLY,0.99999
HP_METAPHYSEAL_STRIATIONS,SET,11,-0.060609,-0.001483,0.28419,0.58444,HP_METAPHYSEAL_STRIATIONS,0.99999
GOBP_SNORNA_LOCALIZATION,SET,6,-0.067972,-0.0012285,0.31867,0.58445,GOBP_SNORNA_LOCALIZATION,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...8,SET,9,-0.05703,-0.0012623,0.26716,0.58452,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PI3P_SYNTHESIS_BY_PI3KC3_C1,0.99999
HP_SCLERODERMA,SET,11,-0.055225,-0.0013513,0.25862,0.58454,HP_SCLERODERMA,0.99999
GSE27670_CTRL_VS_LMP1_TRANSD...1,SET,183,-0.013341,-0.0013252,0.062481,0.58454,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN,0.99999
GSE14308_TH1_VS_NATURAL_TREG...2,SET,176,-0.013013,-0.0012679,0.060937,0.58455,GSE14308_TH1_VS_NATURAL_TREG_UP,0.99999
HP_RADIOULNAR_SYNOSTOSIS,SET,68,-0.022536,-0.0013689,0.10552,0.58456,HP_RADIOULNAR_SYNOSTOSIS,0.99999
GSE360_T_GONDII_VS_B_MALAYI_...6,SET,174,-0.014154,-0.0013713,0.066237,0.5846,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP,0.99999
MIR140_3P,SET,129,-0.015547,-0.0012986,0.072749,0.58461,MIR140_3P,0.99999
MIR377_3P,SET,216,-0.012083,-0.0013028,0.05653,0.58462,MIR377_3P,0.99999
MIR218_1_3P,SET,84,-0.02016,-0.0013605,0.094262,0.58468,MIR218_1_3P,0.99999
GOMF_GROWTH_FACTOR_RECEPTOR_...,SET,132,-0.016408,-0.0013862,0.076667,0.58473,GOMF_GROWTH_FACTOR_RECEPTOR_BINDING,0.99999
GENTILE_RESPONSE_CLUSTER_D3,SET,51,-0.024985,-0.001315,0.1167,0.58476,GENTILE_RESPONSE_CLUSTER_D3,0.99999
HP_ABNORMAL_LUNG_DEVELOPMENT,SET,208,-0.012596,-0.0013331,0.058794,0.58482,HP_ABNORMAL_LUNG_DEVELOPMENT,0.99999
REACTOME_APOBEC3G_MEDIATED_R...,SET,5,-0.082899,-0.0013678,0.3869,0.58483,REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION,0.99999
REACTOME_COMPLEX_III_ASSEMBLY,SET,22,-0.034566,-0.0011958,0.16128,0.58485,REACTOME_COMPLEX_III_ASSEMBLY,0.99999
GOMF_CHEMOATTRACTANT_ACTIVITY,SET,32,-0.033275,-0.0013879,0.15525,0.58485,GOMF_CHEMOATTRACTANT_ACTIVITY,0.99999
GOMF_PROTEIN_CYSTEINE_S_STEA...,SET,6,-0.069646,-0.0012588,0.32488,0.58487,GOMF_PROTEIN_CYSTEINE_S_STEAROYLTRANSFERASE_ACTIVITY,0.99999
SASSON_RESPONSE_TO_GONADOTRO...1,SET,85,-0.019236,-0.0013057,0.089717,0.58488,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,0.99999
HP_SENSORY_SEEKING,SET,24,-0.037016,-0.0013374,0.17261,0.5849,HP_SENSORY_SEEKING,0.99999
GOBP_G1_TO_G0_TRANSITION,SET,18,-0.039787,-0.0012451,0.18549,0.58492,GOBP_G1_TO_G0_TRANSITION,0.99999
GOBP_REGULATION_OF_ENDOSOME_...2,SET,9,-0.061974,-0.0013717,0.28878,0.58496,GOBP_REGULATION_OF_ENDOSOME_SIZE,0.99999
HP_IRREGULAR_ILIAC_CREST,SET,6,-0.078825,-0.0014247,0.36728,0.58497,HP_IRREGULAR_ILIAC_CREST,0.99999
REACTOME_INFECTIOUS_DISEASE,SET,888,-0.00589,-0.0012636,0.027435,0.58499,REACTOME_INFECTIOUS_DISEASE,0.99999
chr3q22,SET,54,-0.048926,-0.0026494,0.22787,0.585,chr3q22,0.99999
GOBP_NEGATIVE_REGULATION_OF_...130,SET,7,-0.067212,-0.0013121,0.31299,0.58501,GOBP_NEGATIVE_REGULATION_OF_CENTRIOLE_REPLICATION,0.99999
HOUSTIS_ROS,SET,34,-0.033472,-0.001439,0.15584,0.58503,HOUSTIS_ROS,0.99999
HUPER_BREAST_BASAL_VS_LUMINA...1,SET,54,-0.027966,-0.0015144,0.13012,0.58509,HUPER_BREAST_BASAL_VS_LUMINAL_DN,0.99999
MIR7978,SET,78,-0.019906,-0.0012947,0.092558,0.58514,MIR7978,0.99999
HP_EPISCLERITIS,SET,4,-0.10439,-0.0015406,0.48504,0.5852,HP_EPISCLERITIS,0.99999
WP_CELL_LINEAGE_MAP_FOR_NEUR...,SET,122,-0.017692,-0.0014374,0.082192,0.58521,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,0.99999
GSE15324_NAIVE_VS_ACTIVATED_...1,SET,183,-0.013202,-0.0013115,0.061335,0.58521,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,0.99999
GSE45365_WT_VS_IFNAR_KO_BCEL...1,SET,149,-0.015038,-0.0013491,0.069846,0.58523,GSE45365_WT_VS_IFNAR_KO_BCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...437,SET,11,-0.057453,-0.0014058,0.26683,0.58524,GOBP_NEGATIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,0.99999
CHEN_PDGF_TARGETS,SET,18,-0.047796,-0.0014958,0.22191,0.58527,CHEN_PDGF_TARGETS,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...44,SET,260,-0.011266,-0.0013312,0.052294,0.58529,GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,0.99999
AMIT_EGF_RESPONSE_60_MCF10A,SET,36,-0.031658,-0.0014004,0.14688,0.58532,AMIT_EGF_RESPONSE_60_MCF10A,0.99999
PID_HES_HEY_PATHWAY,SET,45,-0.028051,-0.001387,0.13016,0.58532,PID_HES_HEY_PATHWAY,0.99999
GSE360_CTRL_VS_B_MALAYI_HIGH...2,SET,173,-0.013383,-0.001293,0.062094,0.58532,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP,0.99999
GOBP_REGULATION_OF_TELOMERE_...1,SET,26,-0.032932,-0.0012384,0.15278,0.58533,GOBP_REGULATION_OF_TELOMERE_CAPPING,0.99999
HP_MUSCLE_FLACCIDITY,SET,13,-0.054237,-0.0014427,0.2516,0.58534,HP_MUSCLE_FLACCIDITY,0.99999
REACTOME_FCGR_ACTIVATION,SET,12,-0.054773,-0.0013998,0.25388,0.5854,REACTOME_FCGR_ACTIVATION,0.99999
GOBP_MUSCLE_TISSUE_DEVELOPME...,SET,398,-0.0095418,-0.0013895,0.044231,0.5854,GOBP_MUSCLE_TISSUE_DEVELOPMENT,0.99999
MIR4640_3P,SET,14,-0.046684,-0.0012886,0.21634,0.58542,MIR4640_3P,0.99999
GOBP_NOSE_DEVELOPMENT,SET,15,-0.048804,-0.0013944,0.22603,0.58547,GOBP_NOSE_DEVELOPMENT,0.99999
RICHERT_PBMC_HIV_LIPO_5_AGE_...3,SET,5,-0.084786,-0.0013989,0.3925,0.58551,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_SIGNIFICANT_VARIATION_UP,0.99999
REACTOME_ACYL_CHAIN_REMODELL...5,SET,20,-0.044527,-0.0014688,0.206,0.58556,REACTOME_ACYL_CHAIN_REMODELLING_OF_PS,0.99999
HOUNKPE_HOUSEKEEPING_GENES,SET,1052,-0.005353,-0.0012441,0.024762,0.58558,HOUNKPE_HOUSEKEEPING_GENES,0.99999
MIR6770_3P,SET,4,-0.080368,-0.0011861,0.37171,0.58559,MIR6770_3P,0.99999
chr6q21,SET,46,-0.04675,-0.0023371,0.2162,0.5856,chr6q21,0.99999
GSE32986_UNSTIM_VS_CURDLAN_L...1,SET,176,-0.013605,-0.0013257,0.062904,0.58562,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_DN,0.99999
REACTOME_EXPORT_OF_VIRAL_RIB...,SET,31,-0.031122,-0.0012777,0.14387,0.58563,REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS,0.99999
GOBP_CMP_METABOLIC_PROCESS,SET,8,-0.067401,-0.0014066,0.31133,0.5857,GOBP_CMP_METABOLIC_PROCESS,0.99999
GOBP_DEVELOPMENTAL_PIGMENTAT...,SET,45,-0.029067,-0.0014372,0.13423,0.58571,GOBP_DEVELOPMENTAL_PIGMENTATION,0.99999
GSE360_DC_VS_MAC_L_DONOVANI_...2,SET,188,-0.013567,-0.0013658,0.062629,0.58575,GSE360_DC_VS_MAC_L_DONOVANI_UP,0.99999
GOBP_REGULATION_OF_ORGANELLE...3,SET,8,-0.066582,-0.0013895,0.30709,0.58582,GOBP_REGULATION_OF_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,0.99999
REACTOME_HDACS_DEACETYLATE_H...,SET,29,-0.031405,-0.0012471,0.14482,0.58584,REACTOME_HDACS_DEACETYLATE_HISTONES,0.99999
GOCC_NUCLEAR_OUTER_MEMBRANE,SET,26,-0.033875,-0.0012738,0.15616,0.58586,GOCC_NUCLEAR_OUTER_MEMBRANE,0.99999
GOMF_PURINE_NUCLEOTIDE_TRANS...,SET,25,-0.039923,-0.0014721,0.18402,0.58587,GOMF_PURINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...11,SET,162,-0.014161,-0.0013242,0.065251,0.5859,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN,0.99999
GOBP_HEART_TRABECULA_FORMATI...,SET,15,-0.050563,-0.0014446,0.23293,0.58592,GOBP_HEART_TRABECULA_FORMATION,0.99999
HP_WRIST_HYPERMOBILITY,SET,7,-0.078522,-0.0015329,0.36163,0.58595,HP_WRIST_HYPERMOBILITY,0.99999
ISSAEVA_MLL2_TARGETS,SET,52,-0.027285,-0.00145,0.12561,0.58598,ISSAEVA_MLL2_TARGETS,0.99999
GOBP_REGULATION_OF_RELAXATIO...2,SET,13,-0.055603,-0.001479,0.25599,0.58598,GOBP_REGULATION_OF_RELAXATION_OF_MUSCLE,0.99999
GSE12392_CD8A_POS_VS_NEG_SPL...2,SET,189,-0.013159,-0.0013282,0.060555,0.58601,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP,0.99999
GCM_CSNK1A1,SET,35,-0.026693,-0.0011643,0.1228,0.58604,GCM_CSNK1A1,0.99999
GOBP_PHAGOCYTOSIS,SET,221,-0.012826,-0.0013986,0.059001,0.58604,GOBP_PHAGOCYTOSIS,0.99999
GOBP_CYTOPLASM_ORGANIZATION,SET,15,-0.048357,-0.0013816,0.22245,0.58605,GOBP_CYTOPLASM_ORGANIZATION,0.99999
KEGG_MEDICUS_REFERENCE_GATOR...,SET,13,-0.049847,-0.0013259,0.22914,0.5861,KEGG_MEDICUS_REFERENCE_GATOR1_MTORC1_SIGNALING_PATHWAY,0.99999
GOBP_COMPLEMENT_ACTIVATION,SET,46,-0.031683,-0.0015838,0.14561,0.58612,GOBP_COMPLEMENT_ACTIVATION,0.99999
HP_CHRONIC_GASTRITIS,SET,2,-0.12933,-0.0013497,0.59438,0.58612,HP_CHRONIC_GASTRITIS,0.99999
GOBP_REPRODUCTIVE_BEHAVIOR,SET,44,-0.031009,-0.0015162,0.1425,0.58613,GOBP_REPRODUCTIVE_BEHAVIOR,0.99999
GOBP_DIACYLGLYCEROL_METABOLI...,SET,25,-0.035044,-0.0012922,0.16079,0.58626,GOBP_DIACYLGLYCEROL_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_PARIETAL_BONE_MO...,SET,28,-0.032488,-0.0012677,0.14906,0.58627,HP_ABNORMAL_PARIETAL_BONE_MORPHOLOGY,0.99999
WP_MIRNA_TARGETS_IN_ECM_AND_...,SET,22,-0.042542,-0.0014717,0.19513,0.58629,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,0.99999
MODULE_571,SET,14,-0.050712,-0.0013998,0.23254,0.58631,MODULE_571,0.99999
HP_ABNORMAL_ERYTHROCYTE_PHYS...,SET,15,-0.050147,-0.0014327,0.22997,0.58631,HP_ABNORMAL_ERYTHROCYTE_PHYSIOLOGY,0.99999
HP_MICROPENIS,SET,226,-0.012247,-0.0013504,0.05612,0.58637,HP_MICROPENIS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...51,SET,9,-0.053437,-0.0011828,0.24467,0.58644,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.99999
GOMF_PHOSPHATIDYLCHOLINE_BIN...,SET,27,-0.036807,-0.0014104,0.16842,0.5865,GOMF_PHOSPHATIDYLCHOLINE_BINDING,0.99999
GSE11924_TH1_VS_TH2_CD4_TCEL...1,SET,178,-0.014005,-0.0013723,0.06406,0.58653,GSE11924_TH1_VS_TH2_CD4_TCELL_DN,0.99999
GSE34392_ST2_KO_VS_WT_DAY8_L...1,SET,187,-0.014351,-0.0014409,0.065639,0.58653,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,0.99999
REACTOME_CELLULAR_RESPONSES_...,SET,700,-0.0069308,-0.0013272,0.031692,0.58655,REACTOME_CELLULAR_RESPONSES_TO_STIMULI,0.99999
MIR4460,SET,78,-0.020624,-0.0013413,0.094314,0.58655,MIR4460,0.99999
GATA1_03,SET,218,-0.012831,-0.0013898,0.058662,0.58657,GATA1_03,0.99999
GSE2706_2H_VS_8H_R848_STIM_D...1,SET,166,-0.014315,-0.001355,0.06545,0.58657,GSE2706_2H_VS_8H_R848_STIM_DC_DN,0.99999
PID_VEGF_VEGFR_PATHWAY,SET,9,-0.068649,-0.0015195,0.3138,0.58658,PID_VEGF_VEGFR_PATHWAY,0.99999
HP_SOMNAMBULISM,SET,7,-0.071595,-0.0013976,0.32723,0.58659,HP_SOMNAMBULISM,0.99999
MIR4315,SET,3,-0.10582,-0.0013526,0.4835,0.58662,MIR4315,0.99999
GOBP_NEPHRON_DEVELOPMENT,SET,150,-0.016397,-0.0014759,0.074882,0.58666,GOBP_NEPHRON_DEVELOPMENT,0.99999
GOCC_PHAGOPHORE_ASSEMBLY_SITE,SET,35,-0.030978,-0.0013512,0.14143,0.58669,GOCC_PHAGOPHORE_ASSEMBLY_SITE,0.99999
HALLMARK_PANCREAS_BETA_CELLS,SET,38,-0.03339,-0.0015174,0.15244,0.58669,HALLMARK_PANCREAS_BETA_CELLS,0.99999
HP_PONTOCEREBELLAR_ATROPHY,SET,8,-0.056093,-0.0011706,0.2559,0.58675,HP_PONTOCEREBELLAR_ATROPHY,0.99999
GOBP_POSITIVE_REGULATION_BY_...4,SET,13,-0.050913,-0.0013542,0.23194,0.58687,GOBP_POSITIVE_REGULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST,0.99999
REACTOME_O_GLYCOSYLATION_OF_...,SET,36,-0.034124,-0.0015095,0.15544,0.58688,REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS,0.99999
GSE5679_PPARG_LIGAND_ROSIGLI...4,SET,178,-0.013924,-0.0013643,0.063431,0.58688,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,0.99999
GSE36888_STAT5_AB_KNOCKIN_VS...4,SET,169,-0.014712,-0.001405,0.066997,0.58691,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP,0.99999
ZNF592_TARGET_GENES,SET,1471,-0.0049703,-0.0013493,0.022616,0.58697,ZNF592_TARGET_GENES,0.99999
ZNF101_TARGET_GENES,SET,360,-0.0097382,-0.0013502,0.044282,0.58703,ZNF101_TARGET_GENES,0.99999
GOBP_REGULATION_OF_RECEPTOR_...5,SET,16,-0.04373,-0.0012903,0.19859,0.58714,GOBP_REGULATION_OF_RECEPTOR_LOCALIZATION_TO_SYNAPSE,0.99999
HP_ABNORMALITY_OF_THE_PUBIC_...,SET,52,-0.025712,-0.0013664,0.11676,0.58715,HP_ABNORMALITY_OF_THE_PUBIC_HAIR,0.99999
GOBP_REGULATION_OF_PLATELET_...1,SET,50,-0.029341,-0.0015291,0.1332,0.58718,GOBP_REGULATION_OF_PLATELET_ACTIVATION,0.99999
GOBP_SYNAPTIC_MEMBRANE_ADHES...,SET,26,-0.041252,-0.0015512,0.18711,0.58725,GOBP_SYNAPTIC_MEMBRANE_ADHESION,0.99999
GSE27786_BCELL_VS_CD8_TCELL_...1,SET,180,-0.013702,-0.00135,0.062125,0.58728,GSE27786_BCELL_VS_CD8_TCELL_DN,0.99999
WP_CHOLESTEROL_BIOSYNTHESIS_...3,SET,5,-0.07306,-0.0012055,0.33122,0.58729,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,0.99999
TCF11MAFG_01,SET,182,-0.014045,-0.0013914,0.063665,0.5873,TCF11MAFG_01,0.99999
HP_SPIDER_HEMANGIOMA,SET,5,-0.082217,-0.0013566,0.37258,0.58732,HP_SPIDER_HEMANGIOMA,0.99999
HP_ABNORMAL_LIMB_EPIPHYSIS_M...,SET,120,-0.017167,-0.0013833,0.077786,0.58733,HP_ABNORMAL_LIMB_EPIPHYSIS_MORPHOLOGY,0.99999
GSE24634_TREG_VS_TCONV_POST_...6,SET,179,-0.013577,-0.001334,0.06151,0.58734,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP,0.99999
BEIER_GLIOMA_STEM_CELL_UP,SET,35,-0.034183,-0.001491,0.15485,0.58735,BEIER_GLIOMA_STEM_CELL_UP,0.99999
GSE11864_CSF1_VS_CSF1_IFNG_I...1,SET,168,-0.014123,-0.0013448,0.063968,0.58737,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN,0.99999
GSE26351_UNSTIM_VS_BMP_PATHW...2,SET,173,-0.013893,-0.0013422,0.062865,0.58745,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...36,SET,32,-0.034164,-0.001425,0.15458,0.58746,HP_APLASIA_HYPOPLASIA_OF_THE_HALLUX,0.99999
MIR4778_5P,SET,161,-0.014559,-0.0013573,0.065867,0.58747,MIR4778_5P,0.99999
HP_ABNORMAL_TARSAL_OSSIFICAT...,SET,8,-0.06572,-0.0013715,0.29732,0.58747,HP_ABNORMAL_TARSAL_OSSIFICATION,0.99999
PLASARI_TGFB1_TARGETS_1HR_DN,SET,4,-0.10782,-0.0015913,0.4877,0.58749,PLASARI_TGFB1_TARGETS_1HR_DN,0.99999
HP_ABNORMAL_MACROSCOPIC_URIN...,SET,47,-0.026471,-0.0013376,0.11971,0.5875,HP_ABNORMAL_MACROSCOPIC_URINE_APPEARANCE,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...20,SET,27,-0.039654,-0.0015195,0.17925,0.58754,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_COLUMNAR_CELLS,0.99999
HP_ABNORMALITY_OF_THE_GALLBL...,SET,99,-0.019226,-0.001408,0.086828,0.58762,HP_ABNORMALITY_OF_THE_GALLBLADDER,0.99999
REACTOME_RET_SIGNALING,SET,40,-0.029699,-0.0013847,0.13408,0.58765,REACTOME_RET_SIGNALING,0.99999
HP_ANTINEUTROPHIL_ANTIBODY_P...,SET,42,-0.028205,-0.0013474,0.12726,0.5877,HP_ANTINEUTROPHIL_ANTIBODY_POSITIVITY,0.99999
HP_ABNORMAL_T_CELL_SUBSET_DI...,SET,69,-0.022679,-0.0013876,0.10226,0.58775,HP_ABNORMAL_T_CELL_SUBSET_DISTRIBUTION,0.99999
PID_FANCONI_PATHWAY,SET,40,-0.026803,-0.0012497,0.12085,0.58776,PID_FANCONI_PATHWAY,0.99999
MIR378J,SET,70,-0.023579,-0.0014531,0.10625,0.58781,MIR378J,0.99999
HP_ABSENT_AXILLARY_HAIR,SET,11,-0.058825,-0.0014394,0.26487,0.58788,HP_ABSENT_AXILLARY_HAIR,0.99999
PID_P38_MK2_PATHWAY,SET,21,-0.045097,-0.0015243,0.20301,0.5879,PID_P38_MK2_PATHWAY,0.99999
GSE13484_UNSTIM_VS_3H_YF17D_...2,SET,179,-0.012867,-0.0012643,0.057911,0.58792,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,0.99999
chr12p12,SET,49,-0.046541,-0.0024011,0.20942,0.58793,chr12p12,0.99999
MSX1_TARGET_GENES,SET,167,-0.014599,-0.0013859,0.065652,0.58798,MSX1_TARGET_GENES,0.99999
GSE42021_TCONV_PLN_VS_TREG_P...1,SET,181,-0.014552,-0.0014377,0.065391,0.58805,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_DN,0.99999
GOBP_FOREBRAIN_GENERATION_OF...,SET,50,-0.029634,-0.0015443,0.13312,0.58808,GOBP_FOREBRAIN_GENERATION_OF_NEURONS,0.99999
HP_INTRACTABLE_DIARRHEA,SET,6,-0.086485,-0.0015631,0.38846,0.58809,HP_INTRACTABLE_DIARRHEA,0.99999
GOMF_BENZODIAZEPINE_RECEPTOR...,SET,9,-0.078347,-0.0017342,0.3517,0.58814,GOMF_BENZODIAZEPINE_RECEPTOR_ACTIVITY,0.99999
ZHONG_PFC_C9_ORG_OTHER,SET,71,-0.024678,-0.0015316,0.11073,0.58818,ZHONG_PFC_C9_ORG_OTHER,0.99999
HP_PRENATAL_MOVEMENT_ABNORMA...,SET,211,-0.01342,-0.0014303,0.060145,0.58828,HP_PRENATAL_MOVEMENT_ABNORMALITY,0.99999
HP_ABNORMALITY_OF_VISUAL_EVO...,SET,63,-0.023536,-0.0013763,0.10548,0.58829,HP_ABNORMALITY_OF_VISUAL_EVOKED_POTENTIALS,0.99999
WONG_MITOCHONDRIA_GENE_MODULE,SET,190,-0.012753,-0.0012906,0.057086,0.58839,WONG_MITOCHONDRIA_GENE_MODULE,0.99999
KEGG_PORPHYRIN_AND_CHLOROPHY...,SET,35,-0.037371,-0.0016301,0.16721,0.58842,KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM,0.99999
GSE27786_LSK_VS_NKCELL_DN,SET,182,-0.014114,-0.0013982,0.063142,0.58843,GSE27786_LSK_VS_NKCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...759,SET,6,-0.077778,-0.0014058,0.34796,0.58844,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.99999
GSE40068_CXCR5POS_BCL6POS_TF...2,SET,177,-0.013334,-0.0013028,0.059641,0.58845,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP,0.99999
GOBP_AXIS_SPECIFICATION,SET,87,-0.021757,-0.0014941,0.097244,0.58852,GOBP_AXIS_SPECIFICATION,0.99999
HP_DECREASED_HIP_ABDUCTION,SET,7,-0.072702,-0.0014193,0.32484,0.58854,HP_DECREASED_HIP_ABDUCTION,0.99999
GSE10094_LCMV_VS_LISTERIA_IN...1,SET,178,-0.014116,-0.0013831,0.063071,0.58855,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN,0.99999
GOBP_CARTILAGE_CONDENSATION,SET,18,-0.049728,-0.0015563,0.22205,0.5886,GOBP_CARTILAGE_CONDENSATION,0.99999
REACTOME_COPI_MEDIATED_ANTER...,SET,99,-0.018256,-0.0013369,0.081419,0.58871,REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,0.99999
GOBP_RESPONSE_TO_VITAMIN_A,SET,15,-0.051305,-0.0014658,0.22881,0.58871,GOBP_RESPONSE_TO_VITAMIN_A,0.99999
GSE3982_BCELL_VS_CENT_MEMORY...1,SET,175,-0.014617,-0.0014202,0.065183,0.58871,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
GSE34515_CD16_NEG_MONOCYTE_V...2,SET,180,-0.014413,-0.0014201,0.064231,0.58878,GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP,0.99999
EVI1_03,SET,54,-0.026122,-0.0014145,0.11637,0.5888,EVI1_03,0.99999
HAY_BONE_MARROW_CD34_POS_EO_...,SET,15,-0.053019,-0.0015148,0.23608,0.58884,HAY_BONE_MARROW_CD34_POS_EO_B_MAST,0.99999
QI_PBMC_ZOSTAVAX_AGE_50_75YO...8,SET,13,-0.051019,-0.0013571,0.22716,0.58885,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_EXPANSION_AND_CONTRACTION_1D_NOT_INFORMATIVE_OF_LONG_TERM_RESPONSES_POSITIVE,0.99999
BIOCARTA_MITR_PATHWAY,SET,5,-0.091889,-0.0015161,0.40871,0.58894,BIOCARTA_MITR_PATHWAY,0.99999
HP_NEURODEGENERATION,SET,76,-0.020498,-0.0013161,0.091162,0.58895,HP_NEURODEGENERATION,0.99999
HP_PATCHY_HYPOPIGMENTATION_O...,SET,21,-0.046386,-0.0015678,0.20623,0.58898,HP_PATCHY_HYPOPIGMENTATION_OF_HAIR,0.99999
MIR676_3P,SET,47,-0.027427,-0.0013859,0.12179,0.58909,MIR676_3P,0.99999
REACTOME_VOLTAGE_GATED_POTAS...,SET,42,-0.033592,-0.0016048,0.14909,0.58913,REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS,0.99999
KRAS.LUNG.BREAST_UP.V1_DN,SET,129,-0.017566,-0.0014672,0.077963,0.58913,KRAS.LUNG.BREAST_UP.V1_DN,0.99999
REACTOME_MITOCHONDRIAL_FATTY...2,SET,11,-0.050654,-0.0012395,0.22456,0.58923,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS,0.99999
GSE37301_HEMATOPOIETIC_STEM_...3,SET,186,-0.014734,-0.0014754,0.065292,0.58926,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN,0.99999
HP_ACETABULAR_DYSPLASIA,SET,23,-0.037136,-0.0013135,0.16442,0.58935,HP_ACETABULAR_DYSPLASIA,0.99999
HP_APLASIA_HYPOPLASIA_AFFECT...4,SET,140,-0.015835,-0.0013775,0.070102,0.58935,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_FUNDUS,0.99999
FOURATI_BLOOD_TWINRIX_AGE_25...1,SET,598,-0.0079789,-0.0014163,0.035267,0.58949,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN,0.99999
HP_PROGRESSIVE_EXTRAPYRAMIDA...,SET,8,-0.065905,-0.0013754,0.29123,0.58951,HP_PROGRESSIVE_EXTRAPYRAMIDAL_MOVEMENT_DISORDER,0.99999
GOCC_PROTEASOME_CORE_COMPLEX...1,SET,8,-0.058429,-0.0012194,0.25793,0.5896,GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX,0.99999
REACTOME_INTRAFLAGELLAR_TRAN...,SET,44,-0.029888,-0.0014613,0.1319,0.58963,REACTOME_INTRAFLAGELLAR_TRANSPORT,0.99999
HP_TETANY,SET,21,-0.04548,-0.0015372,0.20071,0.58963,HP_TETANY,0.99999
GOBP_CORTICOTROPIN_SECRETION,SET,6,-0.086534,-0.001564,0.38167,0.58968,GOBP_CORTICOTROPIN_SECRETION,0.99999
GOBP_HISTONE_MRNA_CATABOLIC_...,SET,11,-0.048903,-0.0011966,0.21566,0.5897,GOBP_HISTONE_MRNA_CATABOLIC_PROCESS,0.99999
MORF_AP2M1,SET,194,-0.0125,-0.0012781,0.055082,0.58976,MORF_AP2M1,0.99999
GSE2405_S_AUREUS_VS_UNTREATE...2,SET,173,-0.013356,-0.0012903,0.058853,0.58976,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP,0.99999
HP_LONG_EYELASHES,SET,115,-0.017379,-0.0013711,0.076568,0.58978,HP_LONG_EYELASHES,0.99999
HP_LARGE_POSTERIOR_FONTANELLE,SET,17,-0.046749,-0.0014218,0.20563,0.58992,HP_LARGE_POSTERIOR_FONTANELLE,0.99999
GOBP_INTESTINAL_EPITHELIAL_C...1,SET,16,-0.051198,-0.0015107,0.22513,0.58995,GOBP_INTESTINAL_EPITHELIAL_CELL_DEVELOPMENT,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...14,SET,183,-0.013886,-0.0013794,0.061035,0.58998,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_UP,0.99999
GOBP_HORMONE_METABOLIC_PROCE...,SET,228,-0.013883,-0.0015374,0.06102,0.58999,GOBP_HORMONE_METABOLIC_PROCESS,0.99999
MIR370_3P,SET,88,-0.02001,-0.001382,0.087893,0.59004,MIR370_3P,0.99999
GOBP_VENTRICULAR_CARDIAC_MUS...4,SET,27,-0.038374,-0.0014704,0.16854,0.59005,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.99999
GOBP_MODULATION_OF_PROCESS_O...,SET,14,-0.055527,-0.0015327,0.24372,0.59011,GOBP_MODULATION_OF_PROCESS_OF_ANOTHER_ORGANISM,0.99999
GOMF_ZINC_ION_BINDING,SET,757,-0.0070764,-0.0014069,0.031056,0.59012,GOMF_ZINC_ION_BINDING,0.99999
HP_PERIPHERAL_NEUROPATHY,SET,407,-0.0093215,-0.0013724,0.040911,0.59012,HP_PERIPHERAL_NEUROPATHY,0.99999
GOBP_POSTSYNAPTIC_SPECIALIZA...1,SET,29,-0.037237,-0.0014787,0.16338,0.59014,GOBP_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY,0.99999
KEGG_ARRHYTHMOGENIC_RIGHT_VE...,SET,70,-0.024322,-0.0014989,0.10671,0.59015,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,0.99999
WP_ARRHYTHMOGENIC_RIGHT_VENT...,SET,70,-0.024322,-0.0014989,0.10671,0.59015,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,0.99999
GOBP_ADENYLATE_CYCLASE_INHIB...5,SET,7,-0.085996,-0.0016788,0.37709,0.59019,GOBP_ADENYLATE_CYCLASE_INHIBITING_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...7,SET,47,-0.030477,-0.00154,0.1336,0.59022,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_2,0.99999
GOBP_REGULATION_OF_ASTROCYTE...1,SET,5,-0.096184,-0.001587,0.42167,0.59022,GOBP_REGULATION_OF_ASTROCYTE_ACTIVATION,0.99999
GOMF_KINASE_REGULATOR_ACTIVI...,SET,253,-0.012078,-0.0014079,0.052944,0.59022,GOMF_KINASE_REGULATOR_ACTIVITY,0.99999
AP1FJ_Q2,SET,248,-0.012587,-0.0014529,0.055164,0.59024,AP1FJ_Q2,0.99999
HP_DEVELOPMENTAL_GLAUCOMA,SET,64,-0.02417,-0.0014245,0.10592,0.59025,HP_DEVELOPMENTAL_GLAUCOMA,0.99999
MIR4671_5P,SET,7,-0.083294,-0.001626,0.36489,0.59028,MIR4671_5P,0.99999
GAO_SMALL_INTESTINE_24W_C1_T...,SET,8,-0.063244,-0.0013198,0.27702,0.59029,GAO_SMALL_INTESTINE_24W_C1_TUFT_PROGENITOR,0.99999
HP_CLOVERLEAF_SKULL,SET,8,-0.063958,-0.0013347,0.28005,0.59032,HP_CLOVERLEAF_SKULL,0.99999
MIR586,SET,256,-0.01231,-0.0014433,0.053876,0.59036,MIR586,0.99999
MYOGENIN_Q6,SET,245,-0.012429,-0.0014261,0.054395,0.59037,MYOGENIN_Q6,0.99999
KAYO_AGING_MUSCLE_DN,SET,106,-0.017479,-0.0013242,0.076486,0.59038,KAYO_AGING_MUSCLE_DN,0.99999
GOBP_REGULATION_OF_LIPID_KIN...,SET,8,-0.064382,-0.0013436,0.28162,0.59041,GOBP_REGULATION_OF_LIPID_KINASE_ACTIVITY,0.99999
DESCARTES_MAIN_FETAL_CILIATE...,SET,450,-0.0087182,-0.001348,0.038127,0.59043,DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS,0.99999
GSE26488_CTRL_VS_PEPTIDE_INJ...4,SET,148,-0.015789,-0.0014118,0.069041,0.59044,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...469,SET,4,-0.084763,-0.0012509,0.37061,0.59045,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FUSION,0.99999
chr11q12,SET,178,-0.032927,-0.0032263,0.14395,0.59046,chr11q12,0.99999
GSE24142_DN2_VS_DN3_THYMOCYT...4,SET,184,-0.014358,-0.0014301,0.062745,0.5905,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN,0.99999
DESCARTES_FETAL_LIVER_MEGAKA...,SET,113,-0.019127,-0.0014959,0.083587,0.5905,DESCARTES_FETAL_LIVER_MEGAKARYOCYTES,0.99999
HP_ABNORMAL_TESTIS_MORPHOLOGY,SET,832,-0.0067555,-0.0014051,0.029512,0.59053,HP_ABNORMAL_TESTIS_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_RAS_PROTE...,SET,46,-0.029872,-0.0014933,0.13044,0.59057,GOBP_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GSE339_EX_VIVO_VS_IN_CULTURE...2,SET,180,-0.013952,-0.0013747,0.06091,0.59059,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...86,SET,28,-0.038309,-0.0014948,0.16722,0.5906,GOBP_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...3,SET,20,-0.050094,-0.0016524,0.21863,0.59061,GOMF_STRUCTURAL_CONSTITUENT_OF_EYE_LENS,0.99999
GOMF_PHOSPHATIDYLETHANOLAMIN...1,SET,16,-0.046738,-0.0013791,0.20397,0.59062,GOMF_PHOSPHATIDYLETHANOLAMINE_BINDING,0.99999
GOBP_MACROPINOCYTOSIS,SET,8,-0.066258,-0.0013827,0.28912,0.59063,GOBP_MACROPINOCYTOSIS,0.99999
MIR3936,SET,30,-0.033768,-0.0013639,0.14733,0.59064,MIR3936,0.99999
WP_MIR5093P_ALTERATION_OF_YA...,SET,17,-0.053444,-0.0016255,0.23313,0.59066,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,0.99999
HSF4_TARGET_GENES,SET,5,-0.080994,-0.0013364,0.3533,0.59066,HSF4_TARGET_GENES,0.99999
HP_ABNORMAL_DERMATOGLYPHICS,SET,270,-0.011535,-0.0013884,0.050313,0.59067,HP_ABNORMAL_DERMATOGLYPHICS,0.99999
GOMF_TRANSPORTER_REGULATOR_A...,SET,141,-0.016951,-0.0014798,0.073928,0.59068,GOMF_TRANSPORTER_REGULATOR_ACTIVITY,0.99999
REACTOME_MATERNAL_TO_ZYGOTIC...,SET,58,-0.024665,-0.0013841,0.10753,0.59071,REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT,0.99999
MIR6833_5P,SET,119,-0.018183,-0.0014591,0.079266,0.59072,MIR6833_5P,0.99999
MIR299_5P,SET,134,-0.017377,-0.0014791,0.075735,0.59074,MIR299_5P,0.99999
GOBP_RESPONSE_TO_THYROID_HOR...,SET,22,-0.0449,-0.0015533,0.19567,0.59075,GOBP_RESPONSE_TO_THYROID_HORMONE,0.99999
HP_DUPLICATION_INVOLVING_BON...,SET,122,-0.017246,-0.0014011,0.075131,0.59077,HP_DUPLICATION_INVOLVING_BONES_OF_THE_FEET,0.99999
RODWELL_AGING_KIDNEY_DN,SET,124,-0.018001,-0.0014743,0.078418,0.59078,RODWELL_AGING_KIDNEY_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...463,SET,58,-0.026119,-0.0014657,0.11379,0.59078,GOBP_POSITIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS,0.99999
HP_ST_SEGMENT_ELEVATION,SET,24,-0.039451,-0.0014254,0.17176,0.59083,HP_ST_SEGMENT_ELEVATION,0.99999
GSE7768_OVA_ALONE_VS_OVA_WIT...4,SET,164,-0.014629,-0.0013764,0.063689,0.59083,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,0.99999
GSE19825_NAIVE_VS_DAY3_EFF_C...2,SET,177,-0.015218,-0.0014869,0.066215,0.59089,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP,0.99999
GSE14000_TRANSLATED_RNA_VS_M...2,SET,146,-0.016092,-0.0014292,0.069987,0.59092,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP,0.99999
REACTOME_CYTOSOLIC_IRON_SULF...,SET,10,-0.054347,-0.001268,0.2363,0.59095,REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY,0.99999
GSE12198_CTRL_VS_HIGH_IL2_ST...2,SET,180,-0.014362,-0.001415,0.062429,0.59097,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP,0.99999
NABA_MATRISOME_MULTIPLE_MYEL...,SET,9,-0.074923,-0.0016584,0.32565,0.59098,NABA_MATRISOME_MULTIPLE_MYELOMA,0.99999
chr13q13,SET,31,-0.061791,-0.0025368,0.26826,0.59108,chr13q13,0.99999
HP_THICK_UPPER_LIP_VERMILION,SET,20,-0.045553,-0.0015026,0.19776,0.59109,HP_THICK_UPPER_LIP_VERMILION,0.99999
MORF_XPC,SET,53,-0.023704,-0.0012717,0.10288,0.59111,MORF_XPC,0.99999
GOBP_PIECEMEAL_MICROAUTOPHAG...,SET,17,-0.046401,-0.0014113,0.20125,0.59117,GOBP_PIECEMEAL_MICROAUTOPHAGY_OF_THE_NUCLEUS,0.99999
HP_ABSENT_SPERM_FLAGELLA,SET,23,-0.037929,-0.0013416,0.16448,0.59119,HP_ABSENT_SPERM_FLAGELLA,0.99999
REACTOME_SWITCHING_OF_ORIGIN...,SET,88,-0.018949,-0.0013087,0.082164,0.5912,REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,0.99999
MIR511_3P,SET,154,-0.015505,-0.001414,0.06718,0.59126,MIR511_3P,0.99999
GOBP_HETEROCHROMATIN_ORGANIZ...,SET,13,-0.050455,-0.0013421,0.2186,0.59127,GOBP_HETEROCHROMATIN_ORGANIZATION,0.99999
LAKE_ADULT_KIDNEY_C11_THIN_A...,SET,158,-0.015922,-0.0014706,0.068977,0.59127,LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB,0.99999
MIR145_5P,SET,285,-0.011708,-0.0014473,0.050684,0.59134,MIR145_5P,0.99999
GOBP_T_CELL_TOLERANCE_INDUCT...,SET,14,-0.054737,-0.0015109,0.23691,0.59136,GOBP_T_CELL_TOLERANCE_INDUCTION,0.99999
GOBP_CELLULAR_RESPONSE_TO_MU...,SET,8,-0.056859,-0.0011866,0.24599,0.5914,GOBP_CELLULAR_RESPONSE_TO_MURAMYL_DIPEPTIDE,0.99999
MIR587,SET,338,-0.010971,-0.0014748,0.04743,0.59146,MIR587,0.99999
REACTOME_COMPLEX_IV_ASSEMBLY,SET,41,-0.026745,-0.0012624,0.11551,0.59155,REACTOME_COMPLEX_IV_ASSEMBLY,0.99999
GOBP_MATING_BEHAVIOR,SET,36,-0.036098,-0.0015969,0.1559,0.59155,GOBP_MATING_BEHAVIOR,0.99999
GOMF_UBIQUITIN_LIKE_LIGASE_S...,SET,53,-0.027263,-0.0014626,0.11771,0.59158,GOMF_UBIQUITIN_LIKE_LIGASE_SUBSTRATE_ADAPTOR_ACTIVITY,0.99999
LAKE_ADULT_KIDNEY_C27_VASCUL...,SET,145,-0.017579,-0.001556,0.075863,0.59162,LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES,0.99999
LASTOWSKA_NEUROBLASTOMA_COPY...1,SET,731,-0.008429,-0.001648,0.036371,0.59163,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN,0.99999
GOBP_REGULATION_OF_SMOOTH_MU...2,SET,34,-0.032938,-0.0014161,0.14213,0.59163,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.99999
HP_ABNORMAL_CSF_PYRUVATE_FAM...,SET,5,-0.092615,-0.0015281,0.39962,0.59163,HP_ABNORMAL_CSF_PYRUVATE_FAMILY_AMINO_ACID_CONCENTRATION,0.99999
MIR6780B_3P,SET,56,-0.026174,-0.0014433,0.11293,0.59164,MIR6780B_3P,0.99999
GSE2585_THYMIC_DC_VS_MTEC_DN,SET,177,-0.014807,-0.0014468,0.063861,0.59168,GSE2585_THYMIC_DC_VS_MTEC_DN,0.99999
GOBP_RECEPTOR_MEDIATED_VIRIO...,SET,5,-0.10246,-0.0016905,0.44173,0.59171,GOBP_RECEPTOR_MEDIATED_VIRION_ATTACHMENT_TO_HOST_CELL,0.99999
GOBP_POSITIVE_REGULATION_OF_...720,SET,8,-0.060973,-0.0012724,0.26282,0.59173,GOBP_POSITIVE_REGULATION_OF_SPINDLE_ASSEMBLY,0.99999
BIOCARTA_IL2_PATHWAY,SET,20,-0.046191,-0.0015237,0.19904,0.59176,BIOCARTA_IL2_PATHWAY,0.99999
WUNDER_INFLAMMATORY_RESPONSE...2,SET,59,-0.026394,-0.0014938,0.1137,0.59178,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...131,SET,11,-0.060462,-0.0014795,0.26046,0.59178,GOBP_NEGATIVE_REGULATION_OF_CENTROSOME_DUPLICATION,0.99999
LIN_NPAS4_TARGETS_DN,SET,65,-0.025548,-0.0015174,0.10995,0.59187,LIN_NPAS4_TARGETS_DN,0.99999
GSE24634_TEFF_VS_TCONV_DAY3_...2,SET,183,-0.01403,-0.0013937,0.060382,0.59187,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP,0.99999
WU_HBX_TARGETS_3_UP,SET,18,-0.048439,-0.0015159,0.20844,0.59188,WU_HBX_TARGETS_3_UP,0.99999
MODULE_298,SET,26,-0.041833,-0.0015731,0.17983,0.59197,MODULE_298,0.99999
GOBP_TAIL_ANCHORED_MEMBRANE_...,SET,12,-0.049384,-0.0012621,0.21227,0.59198,GOBP_TAIL_ANCHORED_MEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE,0.99999
HP_FETAL_ULTRASOUND_SOFT_MAR...,SET,104,-0.018534,-0.0013909,0.079656,0.59199,HP_FETAL_ULTRASOUND_SOFT_MARKER,0.99999
MIR520D_3P,SET,303,-0.011276,-0.0014365,0.048449,0.59201,MIR520D_3P,0.99999
GOMF_BIS_5_ADENOSYL_PENTAPHO...,SET,3,-0.14192,-0.0018139,0.60982,0.59201,GOMF_BIS_5_ADENOSYL_PENTAPHOSPHATASE_ACTIVITY,0.99999
GOBP_INSULIN_SECRETION_INVOL...,SET,59,-0.025162,-0.001424,0.10809,0.59203,GOBP_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.99999
HP_VITRITIS,SET,2,-0.12696,-0.001325,0.54541,0.59203,HP_VITRITIS,0.99999
MIR4740_5P,SET,61,-0.028325,-0.0016299,0.12156,0.59212,MIR4740_5P,0.99999
GOCC_NUCLEAR_BODY,SET,747,-0.0069256,-0.0013682,0.02971,0.59216,GOCC_NUCLEAR_BODY,0.99999
ZNF680_TARGET_GENES,SET,614,-0.007858,-0.0014127,0.033671,0.59226,ZNF680_TARGET_GENES,0.99999
GSE15750_DAY6_VS_DAY10_EFF_C...2,SET,179,-0.013888,-0.0013646,0.059482,0.59231,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP,0.99999
HP_INCREASED_HEPATIC_ECHOGEN...,SET,5,-0.091003,-0.0015015,0.38965,0.59233,HP_INCREASED_HEPATIC_ECHOGENICITY,0.99999
MIR890,SET,88,-0.021381,-0.0014767,0.091512,0.59237,MIR890,0.99999
HP_ABNORMAL_DENTAL_PULP_MORP...,SET,50,-0.027826,-0.0014501,0.11909,0.59237,HP_ABNORMAL_DENTAL_PULP_MORPHOLOGY,0.99999
GOBP_COLLAGEN_ACTIVATED_SIGN...,SET,13,-0.058433,-0.0015543,0.25005,0.59238,GOBP_COLLAGEN_ACTIVATED_SIGNALING_PATHWAY,0.99999
GOBP_PROSTAGLANDIN_TRANSPORT,SET,29,-0.041523,-0.0016489,0.17761,0.59243,GOBP_PROSTAGLANDIN_TRANSPORT,0.99999
WATANABE_COLON_CANCER_MSI_VS...1,SET,53,-0.028476,-0.0015277,0.12175,0.59246,WATANABE_COLON_CANCER_MSI_VS_MSS_DN,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...5,SET,12,-0.057351,-0.0014657,0.24518,0.59247,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_LC3_II_FORMATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...246,SET,57,-0.029453,-0.0016385,0.12584,0.59253,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
WONG_ENDOMETRIAL_CANCER_LATE,SET,7,-0.085577,-0.0016706,0.36538,0.59259,WONG_ENDOMETRIAL_CANCER_LATE,0.99999
GOBP_CEREBRAL_CORTEX_GABAERG...1,SET,5,-0.09756,-0.0016097,0.41655,0.59259,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DEVELOPMENT,0.99999
NOUSHMEHR_GBM_SOMATIC_MUTATED,SET,9,-0.074821,-0.0016561,0.31934,0.59262,NOUSHMEHR_GBM_SOMATIC_MUTATED,0.99999
MIR4736,SET,100,-0.019681,-0.0014485,0.083991,0.59263,MIR4736,0.99999
GSE46606_IRF4MID_VS_WT_CD40L...1,SET,185,-0.015693,-0.0015673,0.066898,0.59273,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.99999
MIR4727_5P,SET,103,-0.019851,-0.0014826,0.084567,0.59279,MIR4727_5P,0.99999
YAUCH_HEDGEHOG_SIGNALING_PAR...1,SET,237,-0.013258,-0.0014966,0.05647,0.59281,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,0.99999
REACTOME_CELLULAR_RESPONSE_T...4,SET,6,-0.068447,-0.0012371,0.29152,0.59281,REACTOME_CELLULAR_RESPONSE_TO_MITOCHONDRIAL_STRESS,0.99999
GSE15330_HSC_VS_LYMPHOID_PRI...1,SET,164,-0.015917,-0.0014976,0.067791,0.59282,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,0.99999
GSE30971_2H_VS_4H_LPS_STIM_M...1,SET,152,-0.016776,-0.00152,0.071437,0.59283,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN,0.99999
BIOCARTA_P38MAPK_PATHWAY,SET,35,-0.033481,-0.0014604,0.1425,0.59288,BIOCARTA_P38MAPK_PATHWAY,0.99999
GSE42088_UNINF_VS_LEISHMANIA...2,SET,183,-0.014588,-0.0014491,0.062075,0.5929,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP,0.99999
GSE18804_SPLEEN_MACROPHAGE_V...6,SET,170,-0.015336,-0.0014689,0.065219,0.59295,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...19,SET,46,-0.031315,-0.0015655,0.13312,0.59299,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_2,0.99999
GOBP_SUBSTANTIA_NIGRA_DEVELO...,SET,37,-0.030755,-0.0013792,0.13074,0.59299,GOBP_SUBSTANTIA_NIGRA_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_BLOOD_VOL...,SET,5,-0.10314,-0.0017018,0.438,0.59308,GOBP_REGULATION_OF_BLOOD_VOLUME_BY_RENIN_ANGIOTENSIN,0.99999
REACTOME_SIGNALING_BY_FLT3_F...,SET,19,-0.04467,-0.0014362,0.18955,0.59315,REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,0.99999
HP_RECURRENT_OPPORTUNISTIC_I...,SET,9,-0.067975,-0.0015046,0.28845,0.59315,HP_RECURRENT_OPPORTUNISTIC_INFECTIONS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...62,SET,44,-0.032675,-0.0015976,0.13864,0.59316,HP_APLASIA_HYPOPLASIA_OF_THE_RETINA,0.99999
GOMF_NUCLEOBASE_CONTAINING_C...2,SET,52,-0.028538,-0.0015165,0.12104,0.5932,GOMF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
REACTOME_FATTY_ACID_METABOLI...,SET,167,-0.015539,-0.0014752,0.065896,0.59321,REACTOME_FATTY_ACID_METABOLISM,0.99999
GOBP_CORNIFICATION,SET,9,-0.071245,-0.001577,0.30195,0.59326,GOBP_CORNIFICATION,0.99999
KENNY_CTNNB1_TARGETS_UP,SET,47,-0.029219,-0.0014764,0.12379,0.5933,KENNY_CTNNB1_TARGETS_UP,0.99999
MIR3977,SET,139,-0.016555,-0.001435,0.070138,0.5933,MIR3977,0.99999
GOBP_CARTILAGE_DEVELOPMENT,SET,187,-0.015108,-0.0015169,0.064004,0.5933,GOBP_CARTILAGE_DEVELOPMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...442,SET,113,-0.018879,-0.0014765,0.079962,0.59332,GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,0.99999
GOMF_PASSIVE_TRANSMEMBRANE_T...,SET,453,-0.010148,-0.0015742,0.042979,0.59333,GOMF_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOCC_NATA_COMPLEX,SET,4,-0.10453,-0.0015427,0.44262,0.59334,GOCC_NATA_COMPLEX,0.99999
MIR3121_3P,SET,590,-0.0083421,-0.0014712,0.03531,0.59338,MIR3121_3P,0.99999
MIR3059_5P,SET,274,-0.012023,-0.0014577,0.050877,0.59341,MIR3059_5P,0.99999
GSE40068_BCL6_POS_VS_NEG_CXC...1,SET,178,-0.015005,-0.0014702,0.063493,0.59341,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN,0.99999
GOCC_LEADING_EDGE_MEMBRANE,SET,170,-0.015323,-0.0014676,0.064818,0.59344,GOCC_LEADING_EDGE_MEMBRANE,0.99999
GOMF_ACYLGLYCEROL_O_ACYLTRAN...,SET,24,-0.042506,-0.0015358,0.17979,0.59345,GOMF_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...4,SET,162,-0.015917,-0.0014885,0.067319,0.59345,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP,0.99999
GOBP_MAINTENANCE_OF_LOCATION,SET,310,-0.011732,-0.0015114,0.049587,0.59351,GOBP_MAINTENANCE_OF_LOCATION,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...7,SET,4,-0.092006,-0.0013578,0.38887,0.59351,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CORTICOSPINAL_TRACTS,0.99999
GOMF_7SK_SNRNA_BINDING,SET,9,-0.052942,-0.0011718,0.22374,0.59352,GOMF_7SK_SNRNA_BINDING,0.99999
GOMF_GTPASE_ACTIVITY,SET,287,-0.012139,-0.0015058,0.051303,0.59352,GOMF_GTPASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...238,SET,13,-0.060437,-0.0016076,0.25532,0.59356,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,0.99999
GSE22935_UNSTIM_VS_24H_MBOVI...2,SET,189,-0.014632,-0.0014768,0.061811,0.59356,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.99999
GOBP_B_CELL_PROLIFERATION,SET,96,-0.022597,-0.0016296,0.095312,0.5937,GOBP_B_CELL_PROLIFERATION,0.99999
HP_ABNORMAL_TEMPORAL_LOBE_MO...,SET,125,-0.017958,-0.0014767,0.075736,0.59371,HP_ABNORMAL_TEMPORAL_LOBE_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...111,SET,272,-0.011795,-0.0014249,0.049742,0.59372,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS,0.99999
FAN_EMBRYONIC_CTX_BIG_GROUPS...3,SET,430,-0.0098717,-0.0014929,0.041625,0.59373,FAN_EMBRYONIC_CTX_BIG_GROUPS_CAJAL_RETZIUS,0.99999
HP_ABNORMAL_FEMUR_MORPHOLOGY,SET,270,-0.012139,-0.0014612,0.05118,0.59374,HP_ABNORMAL_FEMUR_MORPHOLOGY,0.99999
HP_ABNORMAL_PELVIS_BONE_OSSI...,SET,15,-0.050822,-0.001452,0.21416,0.59379,HP_ABNORMAL_PELVIS_BONE_OSSIFICATION,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...7,SET,171,-0.016711,-0.0016052,0.070411,0.5938,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN,0.99999
WP_DNA_REPAIR_PATHWAYS_FULL_...,SET,109,-0.016251,-0.0012484,0.068459,0.59382,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,0.99999
E4F1_Q6,SET,255,-0.012607,-0.0014753,0.053101,0.59383,E4F1_Q6,0.99999
HU_FETAL_RETINA_HORIZONTAL,SET,34,-0.036692,-0.0015775,0.15452,0.59385,HU_FETAL_RETINA_HORIZONTAL,0.99999
ATGCTGC_MIR103_MIR107,SET,197,-0.013941,-0.0014363,0.058702,0.59386,ATGCTGC_MIR103_MIR107,0.99999
GOBP_REGULATION_OF_PROTEIN_L...8,SET,10,-0.058193,-0.0013577,0.24496,0.59389,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CILIUM,0.99999
QI_PLASMACYTOMA_DN,SET,92,-0.02025,-0.0014298,0.085201,0.59393,QI_PLASMACYTOMA_DN,0.99999
HP_TRANSIENT_HYPERPHENYLALAN...,SET,5,-0.096107,-0.0015857,0.40435,0.59393,HP_TRANSIENT_HYPERPHENYLALANINEMIA,0.99999
NIKOLSKY_BREAST_CANCER_16P13...,SET,101,-0.034574,-0.0025572,0.14546,0.59394,NIKOLSKY_BREAST_CANCER_16P13_AMPLICON,0.99999
GOBP_POSITIVE_REGULATION_OF_...29,SET,33,-0.037891,-0.0016049,0.15924,0.59404,GOBP_POSITIVE_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS,0.99999
MIR6778_5P,SET,97,-0.019578,-0.0014192,0.082264,0.59405,MIR6778_5P,0.99999
HOXA13_TARGET_GENES,SET,39,-0.031292,-0.0014406,0.13148,0.59406,HOXA13_TARGET_GENES,0.99999
JISON_SICKLE_CELL_DISEASE_DN,SET,167,-0.015199,-0.0014429,0.063826,0.59411,JISON_SICKLE_CELL_DISEASE_DN,0.99999
GOCC_DEUTEROSOME,SET,5,-0.074368,-0.001227,0.31219,0.59414,GOCC_DEUTEROSOME,0.99999
GOMF_ELECTRON_TRANSFER_ACTIV...,SET,96,-0.018667,-0.0013462,0.078363,0.59414,GOMF_ELECTRON_TRANSFER_ACTIVITY,0.99999
GSE21927_SPLENIC_C26GM_TUMOR...2,SET,151,-0.015918,-0.0014376,0.066803,0.59417,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_UP,0.99999
HP_ABNORMAL_FEMORAL_TORSION,SET,9,-0.062569,-0.0013849,0.2625,0.5942,HP_ABNORMAL_FEMORAL_TORSION,0.99999
GOCC_CELL_BODY,SET,507,-0.0092306,-0.0015125,0.038722,0.59421,GOCC_CELL_BODY,0.99999
HP_ABSENT_HYPOPLASTIC_PARANA...,SET,5,-0.096905,-0.0015989,0.40649,0.59421,HP_ABSENT_HYPOPLASTIC_PARANASAL_SINUSES,0.99999
GOBP_INTERLEUKIN_10_PRODUCTI...,SET,51,-0.031603,-0.0016633,0.13255,0.59422,GOBP_INTERLEUKIN_10_PRODUCTION,0.99999
DESCARTES_FETAL_LIVER_LYMPHO...,SET,90,-0.022839,-0.0015951,0.09575,0.59426,DESCARTES_FETAL_LIVER_LYMPHOID_CELLS,0.99999
GOMF_MAP_KINASE_PHOSPHATASE_...,SET,13,-0.05855,-0.0015574,0.2451,0.5944,GOMF_MAP_KINASE_PHOSPHATASE_ACTIVITY,0.99999
HP_PURSED_LIPS,SET,4,-0.11492,-0.0016961,0.48094,0.59443,HP_PURSED_LIPS,0.99999
HP_ANTI_ACETYLCHOLINE_RECEPT...,SET,21,-0.042796,-0.0014465,0.17904,0.59446,HP_ANTI_ACETYLCHOLINE_RECEPTOR_ANTIBODY_POSITIVITY,0.99999
HP_NAIL_DYSTROPHY,SET,125,-0.01851,-0.001522,0.077425,0.59447,HP_NAIL_DYSTROPHY,0.99999
VANDESLUIS_COMMD1_TARGETS_GR...3,SET,70,-0.02355,-0.0014513,0.098399,0.59457,VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,0.99999
GOBP_REGULATION_OF_SKELETAL_...8,SET,10,-0.076551,-0.001786,0.3197,0.59462,GOBP_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT,0.99999
GOBP_AUDITORY_RECEPTOR_CELL_...1,SET,24,-0.042429,-0.001533,0.17716,0.59464,GOBP_AUDITORY_RECEPTOR_CELL_DEVELOPMENT,0.99999
MIR6819_5P,SET,75,-0.022444,-0.0014315,0.093692,0.59466,MIR6819_5P,0.99999
GSE26559_TCF1_KO_VS_WT_LIN_N...2,SET,182,-0.015136,-0.0014995,0.063155,0.5947,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP,0.99999
GSE37301_MULTIPOTENT_PROGENI...1,SET,176,-0.014729,-0.0014352,0.061443,0.59473,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN,0.99999
WEIGEL_OXIDATIVE_STRESS_BY_H...1,SET,31,-0.034274,-0.0014071,0.14289,0.59478,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,0.99999
GOBP_RESPONSE_TO_GONADOTROPI...,SET,5,-0.087187,-0.0014386,0.36337,0.59481,GOBP_RESPONSE_TO_GONADOTROPIN_RELEASING_HORMONE,0.99999
chr20p11,SET,52,-0.059181,-0.003145,0.24663,0.59482,chr20p11,0.99999
GOBP_PEPTIDYL_L_CYSTEINE_S_P...,SET,21,-0.044108,-0.0014908,0.18365,0.5949,GOBP_PEPTIDYL_L_CYSTEINE_S_PALMITOYLATION,0.99999
HP_SUPERNUMERARY_BONES_OF_TH...,SET,23,-0.040883,-0.001446,0.17017,0.59493,HP_SUPERNUMERARY_BONES_OF_THE_AXIAL_SKELETON,0.99999
GSE36891_POLYIC_TLR3_VS_PAM_...1,SET,146,-0.016289,-0.0014467,0.067802,0.59493,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,0.99999
GOCC_FEMALE_GERM_CELL_NUCLEUS,SET,14,-0.054625,-0.0015078,0.22702,0.59507,GOCC_FEMALE_GERM_CELL_NUCLEUS,0.99999
GOBP_ALPHA_LINOLENIC_ACID_ME...,SET,9,-0.065759,-0.0014555,0.27317,0.59511,GOBP_ALPHA_LINOLENIC_ACID_METABOLIC_PROCESS,0.99999
BIOCARTA_RHODOPSIN_PATHWAY,SET,8,-0.068565,-0.0014309,0.28482,0.59512,BIOCARTA_RHODOPSIN_PATHWAY,0.99999
GOBP_CUT_METABOLIC_PROCESS,SET,5,-0.080985,-0.0013362,0.33633,0.59514,GOBP_CUT_METABOLIC_PROCESS,0.99999
ZHONG_PFC_C3_HOPX_POS_OPC,SET,7,-0.076951,-0.0015022,0.31953,0.59515,ZHONG_PFC_C3_HOPX_POS_OPC,0.99999
HP_CUTANEOUS_MELANOMA,SET,19,-0.039524,-0.0012708,0.1641,0.59516,HP_CUTANEOUS_MELANOMA,0.99999
HP_PERIPHERAL_ARTERIOVENOUS_...,SET,7,-0.077653,-0.0015159,0.32235,0.59518,HP_PERIPHERAL_ARTERIOVENOUS_FISTULA,0.99999
HJURP_TARGET_GENES,SET,27,-0.037283,-0.0014287,0.15473,0.59521,HJURP_TARGET_GENES,0.99999
REACTOME_ENDOSOMAL_VACUOLAR_...,SET,11,-0.069452,-0.0016994,0.28814,0.59523,REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY,0.99999
GOBP_GLUCOSE_IMPORT,SET,68,-0.02569,-0.0015605,0.10656,0.59526,GOBP_GLUCOSE_IMPORT,0.99999
GOCC_MHC_PROTEIN_COMPLEX,SET,21,-0.052941,-0.0017894,0.21959,0.59526,GOCC_MHC_PROTEIN_COMPLEX,0.99999
HP_PULMONARY_HYPOPLASIA,SET,121,-0.018507,-0.0014975,0.076704,0.59533,HP_PULMONARY_HYPOPLASIA,0.99999
GOMF_SPHINGOLIPID_TRANSFER_A...,SET,7,-0.070573,-0.0013777,0.29248,0.59534,GOMF_SPHINGOLIPID_TRANSFER_ACTIVITY,0.99999
GOBP_REGULATION_OF_DEFENSE_R...1,SET,727,-0.0078237,-0.0015257,0.032393,0.59543,GOBP_REGULATION_OF_DEFENSE_RESPONSE,0.99999
GOMF_LIGAND_GATED_CHANNEL_AC...,SET,177,-0.016374,-0.0015999,0.067751,0.59548,GOMF_LIGAND_GATED_CHANNEL_ACTIVITY,0.99999
GSE2128_C57BL6_VS_NOD_THYMOC...2,SET,181,-0.015224,-0.0015041,0.062974,0.59551,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_DN,0.99999
MIR106A_3P,SET,99,-0.021408,-0.0015677,0.088526,0.59554,MIR106A_3P,0.99999
MODULE_330,SET,27,-0.04146,-0.0015887,0.17144,0.59554,MODULE_330,0.99999
GOMF_LRR_DOMAIN_BINDING,SET,15,-0.049683,-0.0014195,0.20542,0.59556,GOMF_LRR_DOMAIN_BINDING,0.99999
RAMASWAMY_METASTASIS_DN,SET,51,-0.027096,-0.0014261,0.11198,0.5956,RAMASWAMY_METASTASIS_DN,0.99999
HP_ANOREXIA,SET,107,-0.020742,-0.0015788,0.08571,0.59561,HP_ANOREXIA,0.99999
KEGG_ASTHMA,SET,25,-0.04581,-0.0016892,0.18926,0.59563,KEGG_ASTHMA,0.99999
HP_PULMONARY_EDEMA,SET,25,-0.042293,-0.0015595,0.1747,0.59564,HP_PULMONARY_EDEMA,0.99999
HP_INAPPROPRIATE_ANTIDIURETI...,SET,8,-0.066571,-0.0013893,0.27498,0.59565,HP_INAPPROPRIATE_ANTIDIURETIC_HORMONE_SECRETION,0.99999
WP_COHESIN_COMPLEX_CORNELIA_...,SET,27,-0.037773,-0.0014474,0.15591,0.59572,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,0.99999
HP_PARTIAL_ABSENCE_OF_THUMB,SET,9,-0.064042,-0.0014175,0.26426,0.59574,HP_PARTIAL_ABSENCE_OF_THUMB,0.99999
GOBP_NEGATIVE_REGULATION_OF_...471,SET,5,-0.1025,-0.0016913,0.42227,0.5959,GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DEVELOPMENT,0.99999
KEGG_MEDICUS_PATHOGEN_SALMON...6,SET,5,-0.076877,-0.0012685,0.31642,0.59598,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOG_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...708,SET,69,-0.025718,-0.0015736,0.10586,0.59598,GOBP_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...737,SET,5,-0.098066,-0.0016181,0.4029,0.59615,GOBP_POSITIVE_REGULATION_OF_SULFUR_METABOLIC_PROCESS,0.99999
MIR543,SET,295,-0.012114,-0.0015231,0.049747,0.59619,MIR543,0.99999
GOBP_RIBONUCLEOSIDE_MONOPHOS...2,SET,14,-0.059799,-0.0016506,0.24553,0.59621,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.99999
HP_PAROXYSMAL_BURSTS_OF_LAUG...,SET,9,-0.066467,-0.0014712,0.2729,0.59621,HP_PAROXYSMAL_BURSTS_OF_LAUGHTER,0.99999
HP_EXTERNAL_GENITAL_HYPOPLAS...,SET,436,-0.0099366,-0.0015129,0.040775,0.59626,HP_EXTERNAL_GENITAL_HYPOPLASIA,0.99999
GSE26495_PD1HIGH_VS_PD1LOW_C...1,SET,148,-0.016763,-0.0014989,0.068782,0.59627,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN,0.99999
HHEX_TARGET_GENES,SET,824,-0.007171,-0.0014847,0.029395,0.59636,HHEX_TARGET_GENES,0.99999
GSE17721_POLYIC_VS_CPG_2H_BM...2,SET,182,-0.014612,-0.0014475,0.059896,0.59636,GSE17721_POLYIC_VS_CPG_2H_BMDC_UP,0.99999
HP_LYMPHOCYTOSIS,SET,22,-0.043377,-0.0015006,0.17777,0.59639,HP_LYMPHOCYTOSIS,0.99999
GOBP_PLASMA_MEMBRANE_FUSION,SET,25,-0.045187,-0.0016662,0.18512,0.59642,GOBP_PLASMA_MEMBRANE_FUSION,0.99999
GOMF_S_ACYLTRANSFERASE_ACTIV...,SET,28,-0.036306,-0.0014167,0.14874,0.59642,GOMF_S_ACYLTRANSFERASE_ACTIVITY,0.99999
GOBP_DTTP_METABOLIC_PROCESS,SET,5,-0.095101,-0.0015691,0.38932,0.59649,GOBP_DTTP_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_CENTRIOLE...,SET,22,-0.042537,-0.0014715,0.17396,0.59659,GOBP_REGULATION_OF_CENTRIOLE_REPLICATION,0.99999
OHGUCHI_LIVER_HNF4A_TARGETS_...2,SET,45,-0.032048,-0.0015846,0.13105,0.5966,OHGUCHI_LIVER_HNF4A_TARGETS_UP,0.99999
GSE25088_CTRL_VS_IL4_STIM_ST...2,SET,156,-0.01694,-0.0015548,0.069249,0.59662,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_ART...,SET,259,-0.013698,-0.0016154,0.055998,0.59662,HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL,0.99999
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...1,SET,84,-0.022908,-0.0015459,0.093578,0.59669,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_ADDNL_EXON_LVL_UP,0.99999
ZHENG_CORD_BLOOD_C1_PUTATIVE...,SET,92,-0.023153,-0.0016348,0.094572,0.5967,ZHENG_CORD_BLOOD_C1_PUTATIVE_MEGAKARYOCYTE_PROGENITOR,0.99999
GAUTSCHI_SRC_SIGNALING,SET,8,-0.077999,-0.0016278,0.31858,0.59671,GAUTSCHI_SRC_SIGNALING,0.99999
HP_CERVICAL_C2_C3_VERTEBRAL_...,SET,11,-0.060503,-0.0014805,0.24704,0.59674,HP_CERVICAL_C2_C3_VERTEBRAL_FUSION,0.99999
GOBP_SMOOTH_MUSCLE_ADAPTATION,SET,4,-0.1242,-0.0018329,0.50694,0.59677,GOBP_SMOOTH_MUSCLE_ADAPTATION,0.99999
GOMF_CYSTEINE_TYPE_PEPTIDASE...,SET,145,-0.016157,-0.0014302,0.065933,0.59679,GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY,0.99999
DESCARTES_MAIN_FETAL_MEGAKAR...,SET,155,-0.016953,-0.001551,0.069157,0.59682,DESCARTES_MAIN_FETAL_MEGAKARYOCYTES,0.99999
HP_IRIS_COLOBOMA,SET,150,-0.016675,-0.001501,0.068004,0.59685,HP_IRIS_COLOBOMA,0.99999
HARALAMBIEVA_PBMC_FLUARIX_AG...3,SET,8,-0.072762,-0.0015185,0.29673,0.59685,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_NEGATIVE,0.99999
REACTOME_SUMOYLATION_OF_CHRO...,SET,53,-0.027332,-0.0014664,0.11143,0.59688,REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...65,SET,28,-0.038973,-0.0015208,0.15881,0.59693,HP_APLASIA_HYPOPLASIA_OF_THE_SCAPULAE,0.99999
GSE14000_UNSTIM_VS_16H_LPS_D...3,SET,180,-0.01546,-0.0015232,0.062984,0.59695,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_COL...,SET,65,-0.028245,-0.0016776,0.11506,0.59696,HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL,0.99999
HNF4_Q6,SET,244,-0.013083,-0.0014981,0.053256,0.59703,HNF4_Q6,0.99999
HP_UPPER_LIMB_UNDERGROWTH,SET,78,-0.022554,-0.0014669,0.091779,0.59706,HP_UPPER_LIMB_UNDERGROWTH,0.99999
GOBP_PHOSPHORYLATION,SET,1255,-0.0061191,-0.0015441,0.024894,0.59708,GOBP_PHOSPHORYLATION,0.99999
CADWELL_ATG16L1_TARGETS_DN,SET,61,-0.024658,-0.0014189,0.10027,0.59712,CADWELL_ATG16L1_TARGETS_DN,0.99999
MIR1290,SET,241,-0.013424,-0.0015278,0.054592,0.59712,MIR1290,0.99999
HP_WHITE_LESION_OF_THE_ORAL_...,SET,26,-0.043057,-0.0016191,0.17508,0.59713,HP_WHITE_LESION_OF_THE_ORAL_MUCOSA,0.99999
GSE6875_TCONV_VS_FOXP3_KO_TR...1,SET,177,-0.014969,-0.0014626,0.060857,0.59715,GSE6875_TCONV_VS_FOXP3_KO_TREG_DN,0.99999
GOCC_MICROTUBULE_END,SET,33,-0.036415,-0.0015424,0.14789,0.59725,GOCC_MICROTUBULE_END,0.99999
HP_MULTIPLE_JOINT_CONTRACTUR...,SET,57,-0.025225,-0.0014033,0.10239,0.5973,HP_MULTIPLE_JOINT_CONTRACTURES,0.99999
WANG_BARRETTS_ESOPHAGUS_AND_...2,SET,24,-0.046005,-0.0016622,0.18668,0.59733,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,0.99999
BIOCARTA_IL22BP_PATHWAY,SET,9,-0.088868,-0.001967,0.36057,0.59734,BIOCARTA_IL22BP_PATHWAY,0.99999
GOBP_ENDONUCLEOLYTIC_CLEAVAG...1,SET,7,-0.075019,-0.0014645,0.30415,0.59741,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_IN_5_ETS_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.99999
chr9p22,SET,20,-0.093066,-0.0030699,0.37723,0.59743,chr9p22,0.99999
HP_ABNORMAL_PATELLA_MORPHOLO...,SET,91,-0.023274,-0.0016344,0.094341,0.59743,HP_ABNORMAL_PATELLA_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...608,SET,69,-0.024718,-0.0015124,0.10018,0.59744,GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_RELEASE_OF_CYTOCHROME_C...,SET,52,-0.029982,-0.0015933,0.12148,0.59747,GOBP_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.99999
GSE37301_MULTIPOTENT_PROGENI...5,SET,188,-0.015019,-0.0015119,0.060845,0.59748,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,0.99999
BIOCARTA_EOSINOPHILS_PATHWAY,SET,7,-0.075459,-0.0014731,0.30568,0.59749,BIOCARTA_EOSINOPHILS_PATHWAY,0.99999
GOBP_GALACTOSE_CATABOLIC_PRO...2,SET,5,-0.087153,-0.001438,0.35297,0.59751,GOBP_GALACTOSE_CATABOLIC_PROCESS_VIA_UDP_GALACTOSE,0.99999
GSE36888_UNTREATED_VS_IL2_TR...10,SET,177,-0.01524,-0.0014891,0.061725,0.59751,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP,0.99999
REACTOME_ACTIVATED_NTRK2_SIG...2,SET,11,-0.055453,-0.0013569,0.22435,0.59761,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3,0.99999
GSE5589_WT_VS_IL6_KO_LPS_AND...2,SET,91,-0.022279,-0.0015645,0.090125,0.59762,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.99999
GOBP_REGULATION_OF_CELL_SUBS...2,SET,65,-0.025879,-0.001537,0.10467,0.59764,GOBP_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.99999
GSE5455_HEALTHY_VS_TUMOR_BEA...4,SET,178,-0.015778,-0.0015459,0.063811,0.59764,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP,0.99999
MCBRYAN_PUBERTAL_BREAST_6_7W...1,SET,71,-0.02548,-0.0015814,0.10287,0.59781,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,0.99999
HP_SMALL_FOR_GESTATIONAL_AGE,SET,226,-0.01378,-0.0015194,0.055603,0.59786,HP_SMALL_FOR_GESTATIONAL_AGE,0.99999
WANG_THOC1_TARGETS_UP,SET,5,-0.099029,-0.001634,0.39935,0.59792,WANG_THOC1_TARGETS_UP,0.99999
HP_ABNORMAL_SEVENTH_CRANIAL_...,SET,167,-0.015828,-0.0015027,0.063811,0.59795,HP_ABNORMAL_SEVENTH_CRANIAL_PHYSIOLOGY,0.99999
GOCC_OXOGLUTARATE_DEHYDROGEN...,SET,11,-0.054212,-0.0013265,0.21841,0.59801,GOCC_OXOGLUTARATE_DEHYDROGENASE_COMPLEX,0.99999
GOBP_POSITIVE_REGULATION_OF_...253,SET,7,-0.075908,-0.0014819,0.30578,0.59803,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TUBE_FORMATION,0.99999
DASU_IL6_SIGNALING_DN,SET,6,-0.093994,-0.0016988,0.37833,0.5981,DASU_IL6_SIGNALING_DN,0.99999
HP_ACIDEMIA,SET,22,-0.043086,-0.0014905,0.17342,0.5981,HP_ACIDEMIA,0.99999
BARRIER_CANCER_RELAPSE_NORMA...2,SET,29,-0.037248,-0.0014792,0.14983,0.59817,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,0.99999
HP_ABNORMAL_OSSIFICATION_OF_...,SET,10,-0.066975,-0.0015626,0.26916,0.59825,HP_ABNORMAL_OSSIFICATION_OF_THE_PUBIC_BONE,0.99999
FAN_OVARY_CL12_T_LYMPHOCYTE_...,SET,138,-0.017863,-0.0015428,0.071786,0.59825,FAN_OVARY_CL12_T_LYMPHOCYTE_NK_CELL_2,0.99999
REACTOME_TRANSCRIPTIONAL_REG...2,SET,57,-0.029154,-0.0016219,0.11714,0.59828,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...13,SET,153,-0.01777,-0.0016154,0.071396,0.59828,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN,0.99999
GOBP_RENAL_VESICLE_DEVELOPME...,SET,18,-0.056838,-0.0017788,0.22817,0.59836,GOBP_RENAL_VESICLE_DEVELOPMENT,0.99999
SVIL_TARGET_GENES,SET,10,-0.072749,-0.0016973,0.29199,0.59838,SVIL_TARGET_GENES,0.99999
HP_ENLARGED_JOINTS,SET,12,-0.057385,-0.0014666,0.2303,0.59838,HP_ENLARGED_JOINTS,0.99999
HP_POLYCLONAL_ELEVATION_OF_I...,SET,6,-0.076997,-0.0013917,0.30845,0.59856,HP_POLYCLONAL_ELEVATION_OF_IGM,0.99999
HP_DECREASED_CIRCULATING_TOT...1,SET,7,-0.088483,-0.0017273,0.35434,0.59859,HP_DECREASED_CIRCULATING_TOTAL_IGA,0.99999
WP_AEROBIC_GLYCOLYSIS,SET,10,-0.05249,-0.0012246,0.21017,0.59861,WP_AEROBIC_GLYCOLYSIS,0.99999
HP_NASOGASTRIC_TUBE_FEEDING,SET,34,-0.03482,-0.001497,0.13932,0.59868,HP_NASOGASTRIC_TUBE_FEEDING,0.99999
GOMF_TRANSLATION_INITIATION_...1,SET,43,-0.030081,-0.001454,0.12034,0.59869,GOMF_TRANSLATION_INITIATION_FACTOR_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...665,SET,6,-0.099711,-0.0018022,0.39867,0.59875,GOBP_NEGATIVE_REGULATION_OF_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS,0.99999
MIR4704_3P,SET,124,-0.019179,-0.0015708,0.076626,0.59882,MIR4704_3P,0.99999
GSE2770_TGFB_AND_IL4_ACT_VS_...4,SET,184,-0.015266,-0.0015206,0.060893,0.59898,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,0.99999
MIR219B_5P,SET,41,-0.032276,-0.0015235,0.12872,0.59899,MIR219B_5P,0.99999
GOBP_LEUKOCYTE_PROLIFERATION,SET,323,-0.012662,-0.0016646,0.050479,0.59903,GOBP_LEUKOCYTE_PROLIFERATION,0.99999
CTTTGCA_MIR527,SET,215,-0.014425,-0.0015518,0.057495,0.59905,CTTTGCA_MIR527,0.99999
GOBP_POSITIVE_REGULATION_OF_...516,SET,25,-0.046832,-0.0017269,0.18661,0.59908,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.99999
GOMF_ADENYLATE_CYCLASE_REGUL...,SET,8,-0.076066,-0.0015874,0.30304,0.5991,GOMF_ADENYLATE_CYCLASE_REGULATOR_ACTIVITY,0.99999
HP_ABNORMALITY_OF_THE_OUTER_...,SET,1117,-0.0064347,-0.0015381,0.025611,0.59919,HP_ABNORMALITY_OF_THE_OUTER_EAR,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...3,SET,179,-0.015828,-0.0015552,0.062993,0.59919,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.99999
GOBP_RESPONSE_TO_NEMATODE,SET,7,-0.086339,-0.0016855,0.34359,0.5992,GOBP_RESPONSE_TO_NEMATODE,0.99999
HP_CONCENTRIC_HYPERTROPHIC_C...,SET,7,-0.089789,-0.0017528,0.35729,0.59921,HP_CONCENTRIC_HYPERTROPHIC_CARDIOMYOPATHY,0.99999
HP_GLANDULAR_HYPOSPADIAS,SET,4,-0.099809,-0.001473,0.39715,0.59921,HP_GLANDULAR_HYPOSPADIAS,0.99999
GOCC_SEMAPHORIN_RECEPTOR_COM...,SET,11,-0.070736,-0.0017309,0.28137,0.59925,GOCC_SEMAPHORIN_RECEPTOR_COMPLEX,0.99999
GOBP_PROTEOLYSIS,SET,1452,-0.0057989,-0.0015649,0.023055,0.59929,GOBP_PROTEOLYSIS,0.99999
HOWLIN_CITED1_TARGETS_1_DN,SET,36,-0.039013,-0.0017258,0.15504,0.59934,HOWLIN_CITED1_TARGETS_1_DN,0.99999
HP_PATENT_DUCTUS_ARTERIOSUS,SET,334,-0.011644,-0.0015562,0.046244,0.5994,HP_PATENT_DUCTUS_ARTERIOSUS,0.99999
GOBP_MAINTENANCE_OF_ANIMAL_O...,SET,5,-0.1,-0.00165,0.39701,0.59943,GOBP_MAINTENANCE_OF_ANIMAL_ORGAN_IDENTITY,0.99999
GOBP_UBIQUITIN_INDEPENDENT_P...,SET,5,-0.096012,-0.0015842,0.38102,0.59947,GOBP_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.99999
HP_PERINUCLEAR_ANTINEUTROPHI...,SET,6,-0.076404,-0.0013809,0.30302,0.59953,HP_PERINUCLEAR_ANTINEUTROPHIL_ANTIBODY_POSITIVITY,0.99999
GOBP_ENTEROENDOCRINE_CELL_DI...,SET,33,-0.040046,-0.0016962,0.1587,0.59961,GOBP_ENTEROENDOCRINE_CELL_DIFFERENTIATION,0.99999
GOBP_GLUTATHIONE_TRANSPORT,SET,9,-0.074318,-0.001645,0.29449,0.59962,GOBP_GLUTATHIONE_TRANSPORT,0.99999
EPPERT_CE_HSC_LSC,SET,36,-0.03888,-0.0017199,0.15404,0.59964,EPPERT_CE_HSC_LSC,0.99999
HP_METAMORPHOPSIA,SET,17,-0.053691,-0.001633,0.21266,0.59966,HP_METAMORPHOPSIA,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HP...4,SET,298,-0.012515,-0.0015814,0.049565,0.59967,MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM,0.99999
GOBP_L_AMINO_ACID_TRANSPORT,SET,88,-0.023585,-0.0016289,0.093401,0.59968,GOBP_L_AMINO_ACID_TRANSPORT,0.99999
STEARMAN_LUNG_CANCER_EARLY_V...2,SET,118,-0.018545,-0.0014819,0.073419,0.59971,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,0.99999
GOMF_3_5_EXONUCLEASE_ACTIVITY,SET,56,-0.025429,-0.0014022,0.10064,0.59973,GOMF_3_5_EXONUCLEASE_ACTIVITY,0.99999
ZHANG_ANTIVIRAL_RESPONSE_TO_...1,SET,43,-0.03483,-0.0016836,0.13778,0.59979,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,0.99999
REACTOME_SHC_MEDIATED_CASCAD...3,SET,19,-0.048886,-0.0015718,0.19327,0.59984,REACTOME_SHC_MEDIATED_CASCADE_FGFR4,0.99999
GOBP_MAMMARY_GLAND_BRANCHING...,SET,6,-0.10251,-0.0018527,0.40496,0.59991,GOBP_MAMMARY_GLAND_BRANCHING_INVOLVED_IN_PREGNANCY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...107,SET,9,-0.071732,-0.0015877,0.28334,0.59993,GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.99999
MIR5094,SET,85,-0.023484,-0.0015941,0.092751,0.59994,MIR5094,0.99999
HP_SHORT_RIBS,SET,58,-0.027106,-0.0015211,0.10705,0.59994,HP_SHORT_RIBS,0.99999
WP_8P231_COPY_NUMBER_VARIATI...,SET,51,-0.039817,-0.0020955,0.1572,0.59998,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,0.99999
ZSCAN5DP_TARGET_GENES,SET,1192,-0.006345,-0.0015633,0.025035,0.60004,ZSCAN5DP_TARGET_GENES,0.99999
CRX_Q4,SET,247,-0.014157,-0.0016309,0.055811,0.60012,CRX_Q4,0.99999
GOMF_SUMO_LIGASE_ACTIVITY,SET,12,-0.062793,-0.0016048,0.24753,0.60013,GOMF_SUMO_LIGASE_ACTIVITY,0.99999
GSE17974_0.5H_VS_72H_UNTREAT...1,SET,172,-0.015109,-0.0014555,0.059548,0.60015,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...17,SET,43,-0.030953,-0.0014962,0.12195,0.60018,HP_APLASIA_HYPOPLASIA_OF_THE_CLAVICLES,0.99999
UNTERMAN_IPF_VS_CTRL_NK_CELL...2,SET,2,-0.12469,-0.0013013,0.49092,0.60025,UNTERMAN_IPF_VS_CTRL_NK_CELL_UP,0.99999
MOLENAAR_TARGETS_OF_CCND1_AN...2,SET,58,-0.026611,-0.0014933,0.10461,0.60039,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,0.99999
MODULE_327,SET,21,-0.047613,-0.0016093,0.1871,0.60044,MODULE_327,0.99999
GOBP_RETINAL_ROD_CELL_DEVELO...,SET,10,-0.070375,-0.0016419,0.27642,0.60048,GOBP_RETINAL_ROD_CELL_DEVELOPMENT,0.99999
ZMYM2_TARGET_GENES,SET,109,-0.020719,-0.0015916,0.081355,0.60051,ZMYM2_TARGET_GENES,0.99999
DING_LUNG_CANCER_MUTATED_SIG...,SET,25,-0.042997,-0.0015855,0.16878,0.60054,DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY,0.99999
MARTORIATI_MDM4_TARGETS_FETA...1,SET,466,-0.0099335,-0.0015623,0.038977,0.60058,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN,0.99999
GSE11961_GERMINAL_CENTER_BCE...3,SET,184,-0.016435,-0.001637,0.064392,0.60073,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,0.99999
GOBP_CELL_PROLIFERATION_INVO...3,SET,9,-0.087471,-0.0019361,0.3426,0.60076,GOBP_CELL_PROLIFERATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,0.99999
WP_OCTADECANOID_FORMATION_FR...,SET,12,-0.067735,-0.0017311,0.26513,0.60082,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,0.99999
GOBP_REGULATION_OF_PROTEIN_D...1,SET,25,-0.039092,-0.0014415,0.15283,0.60094,GOBP_REGULATION_OF_PROTEIN_DEACETYLATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...556,SET,20,-0.049932,-0.0016471,0.19512,0.60099,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,0.99999
REACTOME_PURINE_RIBONUCLEOSI...,SET,9,-0.071939,-0.0015923,0.28104,0.60101,REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS,0.99999
HP_EXUDATIVE_RETINAL_DETACHM...,SET,5,-0.11714,-0.0019328,0.4576,0.60102,HP_EXUDATIVE_RETINAL_DETACHMENT,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...11,SET,61,-0.027506,-0.0015828,0.10735,0.60111,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE,0.99999
GSE27786_LSK_VS_ERYTHROBLAST...2,SET,178,-0.015615,-0.00153,0.060939,0.60111,GSE27786_LSK_VS_ERYTHROBLAST_UP,0.99999
HP_METAPHYSEAL_DYSPLASIA,SET,31,-0.039007,-0.0016014,0.15222,0.60112,HP_METAPHYSEAL_DYSPLASIA,0.99999
NFAT_Q6,SET,217,-0.015437,-0.0016682,0.060238,0.60113,NFAT_Q6,0.99999
GOMF_APOLIPOPROTEIN_BINDING,SET,17,-0.054647,-0.001662,0.21322,0.60113,GOMF_APOLIPOPROTEIN_BINDING,0.99999
GNF2_PTPN4,SET,45,-0.032872,-0.0016254,0.1282,0.60118,GNF2_PTPN4,0.99999
GOBP_POST_EMBRYONIC_ANIMAL_M...,SET,4,-0.10812,-0.0015957,0.42159,0.6012,GOBP_POST_EMBRYONIC_ANIMAL_MORPHOGENESIS,0.99999
MATZUK_SPERMATOGONIA,SET,25,-0.045168,-0.0016656,0.17608,0.60122,MATZUK_SPERMATOGONIA,0.99999
GSE360_L_DONOVANI_VS_L_MAJOR...2,SET,181,-0.016036,-0.0015843,0.06251,0.60123,GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP,0.99999
SRC_UP.V1_UP,SET,148,-0.017956,-0.0016056,0.069981,0.60125,SRC_UP.V1_UP,0.99999
HP_DECREASED_CIRCULATING_AND...,SET,62,-0.028552,-0.0016563,0.11125,0.60127,HP_DECREASED_CIRCULATING_ANDROGEN_CONCENTRATION,0.99999
MIR6801_3P,SET,48,-0.032014,-0.0016347,0.12469,0.60132,MIR6801_3P,0.99999
AIZARANI_LIVER_C11_HEPATOCYT...,SET,274,-0.014039,-0.0017021,0.054677,0.60132,AIZARANI_LIVER_C11_HEPATOCYTES_1,0.99999
GSE12003_4D_VS_8D_CULTURE_BM...1,SET,127,-0.018277,-0.0015148,0.071158,0.60135,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN,0.99999
PID_IL5_PATHWAY,SET,14,-0.060343,-0.0016656,0.2349,0.60137,PID_IL5_PATHWAY,0.99999
GOBP_VIRAL_LIFE_CYCLE,SET,297,-0.013065,-0.0016482,0.050857,0.60137,GOBP_VIRAL_LIFE_CYCLE,0.99999
GOMF_NUCLEAR_RETINOID_X_RECE...,SET,17,-0.052459,-0.0015955,0.20418,0.60138,GOMF_NUCLEAR_RETINOID_X_RECEPTOR_BINDING,0.99999
GOBP_REGULATION_OF_ORGAN_GRO...,SET,80,-0.026169,-0.0017236,0.10184,0.60139,GOBP_REGULATION_OF_ORGAN_GROWTH,0.99999
GOBP_PRIMARY_ALCOHOL_CATABOL...,SET,13,-0.067966,-0.0018078,0.26433,0.60146,GOBP_PRIMARY_ALCOHOL_CATABOLIC_PROCESS,0.99999
HP_HOLOPROSENCEPHALY,SET,69,-0.024525,-0.0015006,0.095357,0.60148,HP_HOLOPROSENCEPHALY,0.99999
GOBP_ENTERIC_NERVOUS_SYSTEM_...,SET,11,-0.069795,-0.0017078,0.2713,0.60151,GOBP_ENTERIC_NERVOUS_SYSTEM_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_PROGRAMME...1,SET,1346,-0.0061551,-0.0016043,0.023927,0.60151,GOBP_REGULATION_OF_PROGRAMMED_CELL_DEATH,0.99999
GCM_NUMA1,SET,51,-0.026616,-0.0014008,0.10342,0.60155,GCM_NUMA1,0.99999
GOBP_CELL_DIFFERENTIATION_IN...2,SET,53,-0.033557,-0.0018003,0.13034,0.60158,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
ERWIN_COHEN_PBMC_TC_83_AGE_1...1,SET,36,-0.043044,-0.0019041,0.16719,0.60158,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,0.99999
GOBP_MICTURITION,SET,8,-0.080075,-0.0016711,0.311,0.60159,GOBP_MICTURITION,0.99999
GOBP_OVARIAN_FOLLICLE_DEVELO...,SET,55,-0.030097,-0.0016448,0.11681,0.60166,GOBP_OVARIAN_FOLLICLE_DEVELOPMENT,0.99999
REACTOME_OLFACTORY_SIGNALING...,SET,316,-0.017538,-0.0022809,0.068056,0.60168,REACTOME_OLFACTORY_SIGNALING_PATHWAY,0.99999
ABDELMOHSEN_ELAVL4_TARGETS,SET,15,-0.060588,-0.001731,0.23494,0.60175,ABDELMOHSEN_ELAVL4_TARGETS,0.99999
GOMF_SMAD_BINDING,SET,74,-0.026196,-0.0016597,0.10146,0.60186,GOMF_SMAD_BINDING,0.99999
MIR4713_3P,SET,37,-0.03694,-0.0016566,0.14304,0.60189,MIR4713_3P,0.99999
ZHAN_V2_LATE_DIFFERENTIATION...,SET,36,-0.037058,-0.0016393,0.14349,0.6019,ZHAN_V2_LATE_DIFFERENTIATION_GENES,0.99999
PKCA_DN.V1_UP,SET,143,-0.018079,-0.0015892,0.069994,0.60191,PKCA_DN.V1_UP,0.99999
SATO_SILENCED_BY_DEACETYLATI...,SET,36,-0.038684,-0.0017112,0.14965,0.60199,SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,0.99999
GSE5589_WT_VS_IL6_KO_LPS_AND...1,SET,134,-0.018491,-0.0015739,0.071429,0.60213,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.99999
HOEK_NEUTROPHIL_2011_2012_TI...3,SET,7,-0.098557,-0.001924,0.3805,0.60219,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_3DY_DN,0.99999
HP_CURLY_HAIR,SET,30,-0.037911,-0.0015312,0.14632,0.60222,HP_CURLY_HAIR,0.99999
GSE21927_SPLEEN_MONOCYTE_VS_...1,SET,166,-0.016969,-0.0016062,0.065491,0.60222,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_DN,0.99999
KEGG_MEDICUS_REFERENCE_TRAPP...,SET,8,-0.072502,-0.001513,0.27967,0.60227,KEGG_MEDICUS_REFERENCE_TRAPPI_RAB1_SIGNALING_PATHWAY,0.99999
GSE11924_TFH_VS_TH1_CD4_TCEL...2,SET,185,-0.015582,-0.0015562,0.060102,0.60228,GSE11924_TFH_VS_TH1_CD4_TCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...579,SET,9,-0.081007,-0.001793,0.31244,0.60229,GOBP_NEGATIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...287,SET,25,-0.047624,-0.0017561,0.18368,0.60229,GOBP_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,0.99999
HOEK_PBMC_INACTIVATED_INFLUE...1,SET,8,-0.067458,-0.0014078,0.26008,0.60233,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_DN,0.99999
CREB_02,SET,232,-0.014194,-0.0015854,0.054709,0.60235,CREB_02,0.99999
MOOTHA_HUMAN_MITODB_6_2002,SET,381,-0.010968,-0.0015635,0.042274,0.60236,MOOTHA_HUMAN_MITODB_6_2002,0.99999
DESCARTES_FETAL_PANCREAS_VAS...,SET,54,-0.032455,-0.0017575,0.12509,0.60236,DESCARTES_FETAL_PANCREAS_VASCULAR_ENDOTHELIAL_CELLS,0.99999
HP_THICK_CORPUS_CALLOSUM,SET,15,-0.052938,-0.0015125,0.204,0.60237,HP_THICK_CORPUS_CALLOSUM,0.99999
GSE360_DC_VS_MAC_B_MALAYI_HI...1,SET,181,-0.016084,-0.0015891,0.061987,0.60237,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...1,SET,185,-0.016184,-0.0016163,0.062344,0.60241,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN,0.99999
REACTOME_TRANSFERRIN_ENDOCYT...,SET,29,-0.043143,-0.0017132,0.16618,0.60242,REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING,0.99999
GOBP_POSITIVE_REGULATION_OF_...524,SET,37,-0.038708,-0.0017359,0.14908,0.60243,GOBP_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,0.99999
AIZARANI_LIVER_C10_MVECS_1,SET,244,-0.015567,-0.0017826,0.059953,0.60243,AIZARANI_LIVER_C10_MVECS_1,0.99999
BENPORATH_SOX2_TARGETS,SET,663,-0.00863,-0.00161,0.03322,0.60248,BENPORATH_SOX2_TARGETS,0.99999
GOMF_HISTONE_H4_ACETYLTRANSF...,SET,21,-0.043173,-0.0014592,0.16619,0.60249,GOMF_HISTONE_H4_ACETYLTRANSFERASE_ACTIVITY,0.99999
HP_HYDROURETER,SET,65,-0.02784,-0.0016535,0.10715,0.6025,HP_HYDROURETER,0.99999
MODULE_21,SET,9,-0.067653,-0.0014975,0.26033,0.60252,MODULE_21,0.99999
MODULE_56,SET,9,-0.067653,-0.0014975,0.26033,0.60252,MODULE_56,0.99999
GOBP_REGULATION_OF_INTRACELL...6,SET,242,-0.01372,-0.0015647,0.052762,0.60258,GOBP_REGULATION_OF_INTRACELLULAR_TRANSPORT,0.99999
MEF2_02,SET,201,-0.015829,-0.0016471,0.060842,0.60263,MEF2_02,0.99999
LAIHO_COLORECTAL_CANCER_SERR...1,SET,67,-0.025892,-0.0015612,0.099487,0.60266,LAIHO_COLORECTAL_CANCER_SERRATED_DN,0.99999
HP_ULCERATIVE_COLITIS,SET,13,-0.06507,-0.0017308,0.25,0.60267,HP_ULCERATIVE_COLITIS,0.99999
GOCC_DENSE_BODY,SET,5,-0.10322,-0.0017031,0.39651,0.60269,GOCC_DENSE_BODY,0.99999
MACAEVA_PBMC_RESPONSE_TO_IR,SET,90,-0.022778,-0.0015908,0.087453,0.60274,MACAEVA_PBMC_RESPONSE_TO_IR,0.99999
GOBP_CRANIAL_NERVE_FORMATION,SET,10,-0.084628,-0.0019745,0.3249,0.60275,GOBP_CRANIAL_NERVE_FORMATION,0.99999
ZNF746_TARGET_GENES,SET,55,-0.028814,-0.0015746,0.11059,0.60277,ZNF746_TARGET_GENES,0.99999
GOBP_REGULATION_OF_MITOCHOND...16,SET,136,-0.019034,-0.0016321,0.073059,0.60277,GOBP_REGULATION_OF_MITOCHONDRION_ORGANIZATION,0.99999
REACTOME_SIGNALING_BY_KIT_IN...,SET,20,-0.052062,-0.0017173,0.19977,0.6028,REACTOME_SIGNALING_BY_KIT_IN_DISEASE,0.99999
GOMF_ADENOSINE_DEAMINASE_ACT...,SET,12,-0.063354,-0.0016191,0.24309,0.6028,GOMF_ADENOSINE_DEAMINASE_ACTIVITY,0.99999
HP_RENAL_NECROSIS,SET,5,-0.096044,-0.0015847,0.36844,0.60283,HP_RENAL_NECROSIS,0.99999
HAHTOLA_MYCOSIS_FUNGOIDES_CD...1,SET,101,-0.021242,-0.0015711,0.081481,0.60284,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,0.99999
REACTOME_AMINO_ACIDS_REGULAT...,SET,49,-0.031812,-0.0016412,0.12186,0.60297,REACTOME_AMINO_ACIDS_REGULATE_MTORC1,0.99999
GOBP_POSITIVE_REGULATION_OF_...9,SET,7,-0.075106,-0.0014662,0.28773,0.60297,GOBP_POSITIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...115,SET,20,-0.051768,-0.0017076,0.19809,0.60308,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.99999
HP_ABNORMAL_CIRCULATING_CHOL...,SET,138,-0.0194,-0.0016755,0.074225,0.60309,HP_ABNORMAL_CIRCULATING_CHOLESTEROL_CONCENTRATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...324,SET,12,-0.069122,-0.0017665,0.26437,0.60313,GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,0.99999
GOCC_POSTSYNAPTIC_MEMBRANE,SET,257,-0.014771,-0.0017353,0.05648,0.60315,GOCC_POSTSYNAPTIC_MEMBRANE,0.99999
GOBP_NEURAL_CREST_CELL_FATE_...,SET,6,-0.10624,-0.0019201,0.40614,0.60317,GOBP_NEURAL_CREST_CELL_FATE_COMMITMENT,0.99999
MIR5682,SET,205,-0.01577,-0.001657,0.060285,0.60318,MIR5682,0.99999
HP_BUDD_CHIARI_SYNDROME,SET,7,-0.090427,-0.0017653,0.34559,0.60321,HP_BUDD_CHIARI_SYNDROME,0.99999
GOBP_REGULATION_OF_CALCIUM_I...7,SET,57,-0.030417,-0.0016921,0.11619,0.60325,GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOMF_INTERLEUKIN_2_RECEPTOR_...,SET,5,-0.089229,-0.0014723,0.34084,0.60326,GOMF_INTERLEUKIN_2_RECEPTOR_BINDING,0.99999
DESCARTES_MAIN_FETAL_SQUAMOU...,SET,94,-0.024554,-0.0017524,0.093763,0.60329,DESCARTES_MAIN_FETAL_SQUAMOUS_EPITHELIAL_CELLS,0.99999
GOBP_NEURON_PROJECTION_ORGAN...,SET,85,-0.023968,-0.001627,0.091485,0.60333,GOBP_NEURON_PROJECTION_ORGANIZATION,0.99999
GOMF_TRANSMEMBRANE_RECEPTOR_...2,SET,16,-0.055957,-0.0016511,0.21318,0.60353,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY,0.99999
GOCC_TRANSLATION_PREINITIATI...,SET,15,-0.052311,-0.0014945,0.1992,0.60357,GOCC_TRANSLATION_PREINITIATION_COMPLEX,0.99999
WP_MITOCHONDRIAL_COMPLEX_II_...,SET,8,-0.063668,-0.0013287,0.24219,0.60368,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,0.99999
GSE6269_E_COLI_VS_STREP_PNEU...1,SET,153,-0.017993,-0.0016357,0.068442,0.60368,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN,0.99999
REACTOME_DISEASES_OF_MITOTIC...,SET,36,-0.035007,-0.0015486,0.13315,0.60369,REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,0.99999
REACTOME_METABOLISM_OF_COFAC...,SET,22,-0.043554,-0.0015067,0.16566,0.60369,REACTOME_METABOLISM_OF_COFACTORS,0.99999
MIR1468_3P,SET,589,-0.0094238,-0.0016606,0.035845,0.60369,MIR1468_3P,0.99999
GROSS_HYPOXIA_VIA_ELK3_AND_H...1,SET,98,-0.022249,-0.0016211,0.084536,0.6038,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_X_...,SET,11,-0.058993,-0.0014435,0.22412,0.60381,GOBP_CELLULAR_RESPONSE_TO_X_RAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...675,SET,5,-0.12056,-0.0019892,0.45785,0.60385,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.99999
GOMF_TUMOR_NECROSIS_FACTOR_B...,SET,6,-0.082279,-0.0014871,0.3123,0.6039,GOMF_TUMOR_NECROSIS_FACTOR_BINDING,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...1,SET,174,-0.017224,-0.0016687,0.065349,0.60394,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN,0.99999
GOBP_DIPEPTIDE_TRANSMEMBRANE...,SET,8,-0.077434,-0.001616,0.29365,0.60399,GOBP_DIPEPTIDE_TRANSMEMBRANE_TRANSPORT,0.99999
GSE14000_UNSTIM_VS_4H_LPS_DC...4,SET,173,-0.015911,-0.0015371,0.06033,0.604,GSE14000_UNSTIM_VS_4H_LPS_DC_UP,0.99999
HP_EPILEPTIC_ENCEPHALOPATHY,SET,105,-0.022206,-0.0016744,0.084154,0.60406,HP_EPILEPTIC_ENCEPHALOPATHY,0.99999
GSE39820_CTRL_VS_TGFBETA1_IL...2,SET,181,-0.017128,-0.0016922,0.064893,0.60409,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP,0.99999
DESCARTES_FETAL_CEREBRUM_INH...,SET,32,-0.045822,-0.0019113,0.17351,0.60414,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,0.99999
GOBP_OLIGOPEPTIDE_TRANSPORT,SET,18,-0.05368,-0.0016799,0.20317,0.60419,GOBP_OLIGOPEPTIDE_TRANSPORT,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...17,SET,7,-0.098672,-0.0019263,0.37342,0.6042,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP,0.99999
MIR583,SET,156,-0.01793,-0.0016457,0.067857,0.6042,MIR583,0.99999
WCAANNNYCAG_UNKNOWN,SET,228,-0.015129,-0.0016754,0.057235,0.60424,WCAANNNYCAG_UNKNOWN,0.99999
GOBP_REGULATION_OF_MITOCHOND...7,SET,29,-0.037679,-0.0014962,0.1425,0.60427,GOBP_REGULATION_OF_MITOCHONDRIAL_GENE_EXPRESSION,0.99999
GOBP_SUBSTRATE_INDEPENDENT_T...,SET,9,-0.088108,-0.0019502,0.33298,0.60434,GOBP_SUBSTRATE_INDEPENDENT_TELENCEPHALIC_TANGENTIAL_MIGRATION,0.99999
ZHAN_MULTIPLE_MYELOMA_CD2_UP,SET,42,-0.036933,-0.0017644,0.13954,0.60437,ZHAN_MULTIPLE_MYELOMA_CD2_UP,0.99999
GOBP_ACTIN_FILAMENT_ORGANIZA...,SET,412,-0.01122,-0.0016617,0.042376,0.6044,GOBP_ACTIN_FILAMENT_ORGANIZATION,0.99999
MIR3529_5P,SET,32,-0.04082,-0.0017026,0.15408,0.60447,MIR3529_5P,0.99999
GOBP_REGULATION_OF_INCLUSION...,SET,17,-0.055534,-0.001689,0.20961,0.60447,GOBP_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,0.99999
KYNG_WERNER_SYNDROM_UP,SET,11,-0.065519,-0.0016032,0.24726,0.60449,KYNG_WERNER_SYNDROM_UP,0.99999
GOBP_RESPONSE_TO_TYPE_II_INT...,SET,112,-0.021789,-0.0016966,0.082199,0.60452,GOBP_RESPONSE_TO_TYPE_II_INTERFERON,0.99999
REACTOME_DEFECTIVE_CFTR_CAUS...,SET,58,-0.026098,-0.0014645,0.098433,0.60454,REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,0.99999
PID_TNF_PATHWAY,SET,43,-0.031706,-0.0015326,0.11958,0.60455,PID_TNF_PATHWAY,0.99999
GOBP_MAST_CELL_ACTIVATION,SET,64,-0.029249,-0.0017238,0.1103,0.60456,GOBP_MAST_CELL_ACTIVATION,0.99999
HP_VISUALLY_INDUCED_SEIZURE,SET,15,-0.062108,-0.0017745,0.2342,0.60457,HP_VISUALLY_INDUCED_SEIZURE,0.99999
MORF_GPX4,SET,47,-0.03089,-0.0015609,0.11647,0.60458,MORF_GPX4,0.99999
GOBP_POSITIVE_REGULATION_OF_...228,SET,38,-0.035774,-0.0016258,0.13483,0.60462,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,0.99999
HP_ABNORMAL_LIVER_PARENCHYMA...,SET,10,-0.065602,-0.0015306,0.24724,0.60462,HP_ABNORMAL_LIVER_PARENCHYMA_MORPHOLOGY,0.99999
GSE22601_CD4_SINGLE_POSITIVE...2,SET,181,-0.015704,-0.0015515,0.059163,0.60466,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
HP_ABNORMAL_SKIN_ADNEXA_MORP...,SET,1292,-0.0063412,-0.0016218,0.023883,0.60469,HP_ABNORMAL_SKIN_ADNEXA_MORPHOLOGY,0.99999
GOCC_TRANS_GOLGI_NETWORK,SET,228,-0.014565,-0.001613,0.054854,0.6047,GOCC_TRANS_GOLGI_NETWORK,0.99999
SWEET_KRAS_ONCOGENIC_SIGNATU...,SET,82,-0.024744,-0.0016499,0.093156,0.60473,SWEET_KRAS_ONCOGENIC_SIGNATURE,0.99999
HP_INTRA_ORAL_HYPERPIGMENTAT...,SET,7,-0.088215,-0.0017221,0.33212,0.60473,HP_INTRA_ORAL_HYPERPIGMENTATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...264,SET,72,-0.025994,-0.0016245,0.097827,0.60477,GOBP_POSITIVE_REGULATION_OF_EXOCYTOSIS,0.99999
GSE7460_CD8_TCELL_VS_TREG_AC...1,SET,179,-0.01598,-0.0015701,0.060088,0.60486,GSE7460_CD8_TCELL_VS_TREG_ACT_DN,0.99999
ENK_UV_RESPONSE_KERATINOCYTE...2,SET,469,-0.010205,-0.0016101,0.038345,0.60493,ENK_UV_RESPONSE_KERATINOCYTE_UP,0.99999
GOBP_PHOTORECEPTOR_CELL_DIFF...,SET,63,-0.029885,-0.0017475,0.11225,0.60497,GOBP_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.99999
MIR6858_3P,SET,41,-0.036607,-0.0017279,0.13747,0.60499,MIR6858_3P,0.99999
MIR98_3P,SET,667,-0.0088277,-0.0016517,0.033152,0.60499,MIR98_3P,0.99999
HARALAMBIEVA_PBMC_M_M_R_II_A...1,SET,639,-0.0094865,-0.0017387,0.035626,0.60499,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN,0.99999
GSE15330_WT_VS_IKAROS_KO_LYM...1,SET,179,-0.016165,-0.0015883,0.060671,0.60505,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN,0.99999
PID_ALK2_PATHWAY,SET,10,-0.072686,-0.0016958,0.27278,0.60506,PID_ALK2_PATHWAY,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...3,SET,43,-0.034864,-0.0016852,0.13073,0.60514,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_DYSFUNCTION,0.99999
GOCC_PLATELET_ALPHA_GRANULE_...2,SET,16,-0.062634,-0.0018481,0.23477,0.60518,GOCC_PLATELET_ALPHA_GRANULE_MEMBRANE,0.99999
CHEN_HOXA5_TARGETS_6HR_DN,SET,4,-0.11283,-0.0016651,0.4228,0.60521,CHEN_HOXA5_TARGETS_6HR_DN,0.99999
GOBP_REGULATION_OF_GLIAL_CEL...4,SET,36,-0.038441,-0.0017005,0.14405,0.60521,GOBP_REGULATION_OF_GLIAL_CELL_PROLIFERATION,0.99999
GOCC_INTEGRIN_COMPLEX,SET,29,-0.044338,-0.0017607,0.16614,0.60521,GOCC_INTEGRIN_COMPLEX,0.99999
HP_ABSENT_INNER_AND_OUTER_DY...,SET,3,-0.11937,-0.0015256,0.44727,0.60522,HP_ABSENT_INNER_AND_OUTER_DYNEIN_ARMS,0.99999
GOBP_GLIAL_CELL_ACTIVATION,SET,53,-0.033501,-0.0017973,0.12551,0.60523,GOBP_GLIAL_CELL_ACTIVATION,0.99999
NIKOLSKY_BREAST_CANCER_1Q32_...,SET,13,-0.08886,-0.0023636,0.33261,0.60532,NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,0.99999
PID_E2F_PATHWAY,SET,70,-0.02532,-0.0015604,0.094716,0.60539,PID_E2F_PATHWAY,0.99999
ERWIN_COHEN_BLOOD_VACCINE_TC...2,SET,26,-0.046904,-0.0017638,0.17541,0.60542,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_DN,0.99999
HP_HYPERCOAGULABILITY,SET,15,-0.060602,-0.0017314,0.22651,0.60547,HP_HYPERCOAGULABILITY,0.99999
FOSTER_TOLERANT_MACROPHAGE_DN,SET,382,-0.012188,-0.0017396,0.045553,0.60548,FOSTER_TOLERANT_MACROPHAGE_DN,0.99999
WP_ELECTRON_TRANSPORT_CHAIN_...,SET,69,-0.023303,-0.0014259,0.087079,0.6055,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...9,SET,184,-0.016794,-0.0016728,0.062754,0.6055,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_DN,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...1,SET,4,-0.16036,-0.0023666,0.5985,0.60562,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR,0.99999
REACTOME_SEMAPHORIN_INTERACT...,SET,61,-0.029819,-0.0017159,0.11128,0.60563,REACTOME_SEMAPHORIN_INTERACTIONS,0.99999
GSE21927_UNTREATED_VS_GMCSF_...2,SET,166,-0.017821,-0.0016868,0.066491,0.60566,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,0.99999
KEGG_MEDICUS_PATHOGEN_ARSENI...,SET,6,-0.071772,-0.0012972,0.2676,0.60573,KEGG_MEDICUS_PATHOGEN_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,0.99999
REACTOME_MITOCHONDRIAL_FATTY...1,SET,35,-0.036538,-0.0015937,0.13623,0.60573,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION,0.99999
GOBP_HISTAMINE_TRANSPORT,SET,15,-0.057314,-0.0016375,0.21369,0.60573,GOBP_HISTAMINE_TRANSPORT,0.99999
GSE37605_NOD_VS_C57BL6_IRES_...1,SET,143,-0.019076,-0.0016769,0.071103,0.60576,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN,0.99999
HP_COMMON_ATRIUM,SET,8,-0.077177,-0.0016106,0.28759,0.60579,HP_COMMON_ATRIUM,0.99999
REACTOME_TP53_REGULATES_TRAN...3,SET,48,-0.031229,-0.0015946,0.11633,0.60582,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,0.99999
MIR802,SET,121,-0.021005,-0.0016995,0.078248,0.60582,MIR802,0.99999
GOBP_PEPTIDYL_PROLINE_HYDROX...1,SET,11,-0.057198,-0.0013996,0.21307,0.60582,GOBP_PEPTIDYL_PROLINE_HYDROXYLATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...431,SET,18,-0.054156,-0.0016948,0.2017,0.60584,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.99999
LE_SKI_TARGETS_UP,SET,17,-0.057307,-0.0017429,0.21339,0.60586,LE_SKI_TARGETS_UP,0.99999
HP_INCREASED_HEPATOCELLULAR_...,SET,3,-0.11393,-0.0014562,0.42424,0.60586,HP_INCREASED_HEPATOCELLULAR_LIPID_DROPLETS,0.99999
REACTOME_FORMATION_OF_THE_EA...,SET,32,-0.033878,-0.0014131,0.12613,0.60588,REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX,0.99999
HP_ABNORMAL_ODONTOID_PROCESS...,SET,28,-0.041506,-0.0016196,0.15444,0.60594,HP_ABNORMAL_ODONTOID_PROCESS_MORPHOLOGY,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...15,SET,12,-0.063944,-0.0016342,0.23791,0.60595,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_OXYGEN_AS_ACCEPTOR,0.99999
HP_SMOOTH_TONGUE,SET,5,-0.11074,-0.0018272,0.41198,0.60596,HP_SMOOTH_TONGUE,0.99999
FAN_EMBRYONIC_CTX_BRAIN_ENDO...1,SET,402,-0.012147,-0.0017776,0.04514,0.60607,FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1,0.99999
GOBP_MICROTUBULE_ORGANIZING_...1,SET,30,-0.039931,-0.0016128,0.14838,0.60608,GOBP_MICROTUBULE_ORGANIZING_CENTER_LOCALIZATION,0.99999
GSE15930_STIM_VS_STIM_AND_IF...5,SET,181,-0.016115,-0.0015921,0.059867,0.6061,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN,0.99999
GSE37416_CTRL_VS_3H_F_TULARE...2,SET,168,-0.016693,-0.0015895,0.061997,0.60613,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
WP_MODULATION_OF_PI3KAKTMTOR...,SET,14,-0.066865,-0.0018456,0.2483,0.60614,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,0.99999
DESCARTES_FETAL_CEREBRUM_VAS...,SET,436,-0.011784,-0.0017942,0.043752,0.60616,DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...3,SET,43,-0.038767,-0.0018739,0.14393,0.60617,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CYTOTOXIC,0.99999
GOBP_AUTOPHAGOSOME_ORGANIZAT...,SET,112,-0.020363,-0.0015855,0.075565,0.60622,GOBP_AUTOPHAGOSOME_ORGANIZATION,0.99999
GOCC_SYNAPSE,SET,1365,-0.0065115,-0.0017081,0.024155,0.60625,GOCC_SYNAPSE,0.99999
GSE43863_NAIVE_VS_MEMORY_LY6...1,SET,184,-0.015931,-0.0015868,0.059071,0.6063,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_DN,0.99999
GOBP_CELL_CYCLE_G1_S_PHASE_T...,SET,222,-0.015277,-0.0016697,0.056641,0.60631,GOBP_CELL_CYCLE_G1_S_PHASE_TRANSITION,0.99999
GOBP_POSITIVE_REGULATION_OF_...112,SET,11,-0.07,-0.0017128,0.25927,0.60641,GOBP_POSITIVE_REGULATION_OF_CELLULAR_SENESCENCE,0.99999
DARWICHE_SKIN_TUMOR_PROMOTER...1,SET,174,-0.017018,-0.0016488,0.063019,0.60643,DARWICHE_SKIN_TUMOR_PROMOTER_DN,0.99999
MODULE_328,SET,13,-0.062113,-0.0016521,0.22998,0.60645,MODULE_328,0.99999
MIR3120_5P,SET,77,-0.026026,-0.0016819,0.096345,0.60647,MIR3120_5P,0.99999
GOBP_SINGLE_FERTILIZATION,SET,150,-0.018936,-0.0017046,0.070091,0.60648,GOBP_SINGLE_FERTILIZATION,0.99999
KEGG_PENTOSE_AND_GLUCURONATE...,SET,26,-0.058222,-0.0021894,0.21537,0.60655,KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS,0.99999
HP_PROXIMAL_RENAL_TUBULAR_AC...,SET,10,-0.066218,-0.0015449,0.24493,0.60656,HP_PROXIMAL_RENAL_TUBULAR_ACIDOSIS,0.99999
STAT5A_03,SET,233,-0.015584,-0.0017443,0.057623,0.60659,STAT5A_03,0.99999
HP_INTRAUTERINE_GROWTH_RETAR...,SET,547,-0.0095777,-0.0016283,0.035416,0.60659,HP_INTRAUTERINE_GROWTH_RETARDATION,0.99999
GOBP_COP9_SIGNALOSOME_ASSEMB...,SET,5,-0.10517,-0.0017352,0.38882,0.6066,GOBP_COP9_SIGNALOSOME_ASSEMBLY,0.99999
MIR122B_3P,SET,124,-0.021033,-0.0017226,0.077734,0.60664,MIR122B_3P,0.99999
MIR548AN,SET,438,-0.011165,-0.0017037,0.041262,0.60664,MIR548AN,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...11,SET,174,-0.016175,-0.0015671,0.059775,0.60665,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN,0.99999
HP_ABNORMAL_TEMPER_TANTRUMS,SET,29,-0.041186,-0.0016355,0.15219,0.60666,HP_ABNORMAL_TEMPER_TANTRUMS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...63,SET,116,-0.020415,-0.0016175,0.075422,0.60668,HP_APLASIA_HYPOPLASIA_OF_THE_RIBS,0.99999
HP_CAESARIAN_SECTION,SET,13,-0.066491,-0.0017686,0.24559,0.6067,HP_CAESARIAN_SECTION,0.99999
GOBP_PERICENTRIC_HETEROCHROM...,SET,3,-0.14929,-0.0019081,0.55137,0.60671,GOBP_PERICENTRIC_HETEROCHROMATIN_FORMATION,0.99999
GSE39110_DAY3_VS_DAY6_POST_I...3,SET,178,-0.016707,-0.001637,0.061681,0.60675,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN,0.99999
CONRAD_STEM_CELL,SET,35,-0.041232,-0.0017985,0.15208,0.60685,CONRAD_STEM_CELL,0.99999
MIR548AV_3P,SET,162,-0.018009,-0.0016841,0.066358,0.60695,MIR548AV_3P,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...8,SET,176,-0.017253,-0.0016811,0.063578,0.60695,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_UP,0.99999
chr4q21,SET,60,-0.05263,-0.0030036,0.19389,0.60697,chr4q21,0.99999
MIR4487,SET,73,-0.027184,-0.0017106,0.10012,0.607,MIR4487,0.99999
GOBP_IMP_SALVAGE,SET,4,-0.12194,-0.0017996,0.44907,0.60701,GOBP_IMP_SALVAGE,0.99999
HP_VAGINAL_FISTULA,SET,25,-0.044931,-0.0016568,0.16537,0.60707,HP_VAGINAL_FISTULA,0.99999
NAKAYAMA_SOFT_TISSUE_TUMORS_...2,SET,69,-0.029516,-0.001806,0.10856,0.60715,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,0.99999
NUFIP1_TARGET_GENES,SET,39,-0.03683,-0.0016956,0.13546,0.60715,NUFIP1_TARGET_GENES,0.99999
GSE15930_NAIVE_VS_72H_IN_VIT...6,SET,185,-0.016035,-0.0016014,0.058966,0.60716,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,0.99999
GOBP_INTERLEUKIN_33_MEDIATED...,SET,7,-0.089894,-0.0017549,0.33035,0.60723,GOBP_INTERLEUKIN_33_MEDIATED_SIGNALING_PATHWAY,0.99999
JI_CARCINOGENESIS_BY_KRAS_AN...2,SET,12,-0.064369,-0.001645,0.23641,0.60729,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP,0.99999
GOBP_REGULATION_OF_ALDOSTERO...,SET,8,-0.089626,-0.0018704,0.32908,0.60732,GOBP_REGULATION_OF_ALDOSTERONE_METABOLIC_PROCESS,0.99999
REACTOME_NUCLEAR_ENVELOPE_BR...,SET,50,-0.031157,-0.0016237,0.11437,0.60735,REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN,0.99999
REACTOME_HDMS_DEMETHYLATE_HI...,SET,17,-0.046213,-0.0014055,0.16959,0.60738,REACTOME_HDMS_DEMETHYLATE_HISTONES,0.99999
GSE40274_EOS_VS_FOXP3_AND_EO...2,SET,135,-0.018618,-0.0015905,0.068289,0.60743,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
BIOCARTA_ERYTH_PATHWAY,SET,15,-0.06543,-0.0018694,0.23998,0.60744,BIOCARTA_ERYTH_PATHWAY,0.99999
MIR193A_5P,SET,36,-0.038827,-0.0017176,0.1424,0.60744,MIR193A_5P,0.99999
GOCC_NUCLEAR_PROTEIN_CONTAIN...,SET,1120,-0.0066456,-0.0015905,0.024372,0.60744,GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX,0.99999
GSE5589_WT_VS_IL6_KO_LPS_AND...5,SET,178,-0.017387,-0.0017036,0.063684,0.60758,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.99999
MIR4667_3P,SET,117,-0.020968,-0.0016684,0.076792,0.60759,MIR4667_3P,0.99999
MODULE_86,SET,42,-0.034698,-0.0016576,0.12707,0.6076,MODULE_86,0.99999
TOYOTA_TARGETS_OF_MIR34B_AND...,SET,399,-0.010918,-0.0015919,0.039968,0.60763,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,0.99999
GOBP_NEGATIVE_REGULATION_OF_...475,SET,14,-0.066719,-0.0018416,0.24419,0.60766,GOBP_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_NUCLEOCYT...,SET,108,-0.021916,-0.0016759,0.08021,0.60766,GOBP_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.99999
WP_IRON_METABOLISM_DISORDERS,SET,15,-0.063138,-0.0018039,0.23096,0.60772,WP_IRON_METABOLISM_DISORDERS,0.99999
GOBP_POSITIVE_REGULATION_OF_...476,SET,116,-0.020902,-0.0016561,0.076448,0.60773,GOBP_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,0.99999
NAKAMURA_TUMOR_ZONE_PERIPHER...1,SET,549,-0.010064,-0.0017141,0.036807,0.60774,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN,0.99999
GOMF_PEROXISOME_TARGETING_SE...,SET,3,-0.12997,-0.0016613,0.47529,0.60775,GOMF_PEROXISOME_TARGETING_SEQUENCE_BINDING,0.99999
HP_DESMOID_TUMORS,SET,6,-0.097652,-0.001765,0.35704,0.60777,HP_DESMOID_TUMORS,0.99999
GOBP_NATURAL_KILLER_CELL_ACT...2,SET,29,-0.049749,-0.0019756,0.18186,0.60779,GOBP_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
GOBP_U4_SNRNA_3_END_PROCESSI...,SET,7,-0.071634,-0.0013984,0.26183,0.6078,GOBP_U4_SNRNA_3_END_PROCESSING,0.99999
MORF_TNFRSF6,SET,146,-0.019568,-0.001738,0.071511,0.60782,MORF_TNFRSF6,0.99999
GOMF_AMP_ACTIVATED_PROTEIN_K...,SET,8,-0.082096,-0.0017133,0.29988,0.60787,GOMF_AMP_ACTIVATED_PROTEIN_KINASE_ACTIVITY,0.99999
GOBP_PRENYLATION,SET,10,-0.069479,-0.001621,0.25361,0.60794,GOBP_PRENYLATION,0.99999
HP_ACUTE_LYMPHOBLASTIC_LEUKE...,SET,40,-0.036156,-0.0016858,0.13198,0.60794,HP_ACUTE_LYMPHOBLASTIC_LEUKEMIA,0.99999
DESCARTES_FETAL_INTESTINE_IN...,SET,208,-0.016774,-0.0017752,0.061222,0.60795,DESCARTES_FETAL_INTESTINE_INTESTINAL_EPITHELIAL_CELLS,0.99999
GOBP_REGULATION_OF_PROTEIN_C...5,SET,110,-0.021201,-0.0016361,0.07735,0.60799,GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.99999
MIR26B_3P,SET,95,-0.022655,-0.0016254,0.082649,0.608,MIR26B_3P,0.99999
MIR5186,SET,31,-0.040989,-0.0016828,0.14942,0.60808,MIR5186,0.99999
WP_OSTEOBLAST_DIFFERENTIATIO...,SET,116,-0.023679,-0.0018761,0.086243,0.60817,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,0.99999
HP_NUMEROUS_NEVI,SET,11,-0.069581,-0.0017026,0.25343,0.60817,HP_NUMEROUS_NEVI,0.99999
SRPK2_TARGET_GENES,SET,47,-0.03373,-0.0017044,0.12279,0.60822,SRPK2_TARGET_GENES,0.99999
GOMF_TRANSCRIPTION_COREPRESS...2,SET,42,-0.035624,-0.0017019,0.12955,0.60833,GOMF_TRANSCRIPTION_COREPRESSOR_BINDING,0.99999
GOBP_PLASMA_MEMBRANE_ORGANIZ...,SET,149,-0.0192,-0.0017226,0.069813,0.60835,GOBP_PLASMA_MEMBRANE_ORGANIZATION,0.99999
GSE12392_CD8A_POS_VS_NEG_SPL...3,SET,188,-0.016327,-0.0016436,0.059362,0.60835,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN,0.99999
GSE41978_WT_VS_BIM_KO_KLRG1_...2,SET,184,-0.01657,-0.0016504,0.060251,0.60835,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.99999
ELF2_TARGET_GENES,SET,1229,-0.0067722,-0.0016924,0.024619,0.60837,ELF2_TARGET_GENES,0.99999
GOBP_REGULATION_OF_OXIDATIVE...2,SET,37,-0.035479,-0.0015911,0.12898,0.60837,GOBP_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
MIR12123,SET,429,-0.011387,-0.0017201,0.04139,0.60838,MIR12123,0.99999
MIR11401,SET,7,-0.093208,-0.0018196,0.33873,0.6084,MIR11401,0.99999
GOBP_POSITIVE_REGULATION_OF_...798,SET,61,-0.03048,-0.0017539,0.11072,0.60845,GOBP_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.99999
GOBP_REGULATION_OF_CYTOPLASM...4,SET,7,-0.072669,-0.0014186,0.26381,0.60852,GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATIONAL_INITIATION,0.99999
NELSON_RESPONSE_TO_ANDROGEN_...2,SET,75,-0.028413,-0.0018122,0.10312,0.60855,NELSON_RESPONSE_TO_ANDROGEN_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...818,SET,9,-0.072008,-0.0015939,0.26097,0.6087,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,0.99999
HP_ABNORMAL_BLOOD_ZINC_CONCE...,SET,6,-0.088723,-0.0016036,0.32145,0.60873,HP_ABNORMAL_BLOOD_ZINC_CONCENTRATION,0.99999
HP_HYPOPLASTIC_FEMALE_EXTERN...,SET,55,-0.03277,-0.0017909,0.11869,0.60877,HP_HYPOPLASTIC_FEMALE_EXTERNAL_GENITALIA,0.99999
GSE15324_ELF4_KO_VS_WT_ACTIV...1,SET,180,-0.017041,-0.001679,0.061717,0.60877,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN,0.99999
GSE16451_IMMATURE_VS_MATURE_...1,SET,180,-0.016664,-0.0016419,0.060338,0.60879,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,0.99999
HP_RENAL_STEATOSIS,SET,9,-0.08954,-0.0019819,0.32415,0.60881,HP_RENAL_STEATOSIS,0.99999
REACTOME_SIGNALING_BY_GPCR,SET,652,-0.010076,-0.0018647,0.036475,0.60882,REACTOME_SIGNALING_BY_GPCR,0.99999
GOMF_PHOSPHOFRUCTOKINASE_ACT...,SET,6,-0.074907,-0.0013539,0.27115,0.60882,GOMF_PHOSPHOFRUCTOKINASE_ACTIVITY,0.99999
HP_HYPERGRANULOSIS,SET,20,-0.051438,-0.0016967,0.18619,0.60882,HP_HYPERGRANULOSIS,0.99999
GSE40274_CTRL_VS_HELIOS_TRAN...2,SET,146,-0.019948,-0.0017717,0.072211,0.60882,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
REACTOME_SIGNALING_BY_FGFR3,SET,38,-0.037324,-0.0016962,0.13507,0.60885,REACTOME_SIGNALING_BY_FGFR3,0.99999
GOBP_MITOTIC_RECOMBINATION,SET,24,-0.041816,-0.0015108,0.15117,0.60896,GOBP_MITOTIC_RECOMBINATION,0.99999
HP_MITTEN_DEFORMITY,SET,9,-0.079398,-0.0017574,0.28703,0.60896,HP_MITTEN_DEFORMITY,0.99999
GENTILE_UV_RESPONSE_CLUSTER_...1,SET,17,-0.057461,-0.0017476,0.2077,0.60897,GENTILE_UV_RESPONSE_CLUSTER_D1,0.99999
KEGG_MEDICUS_REFERENCE_N_GLY...1,SET,16,-0.059656,-0.0017603,0.21544,0.60907,KEGG_MEDICUS_REFERENCE_N_GLYCAN_BIOSYNTHESIS,0.99999
HP_ABNORMAL_BLOOD_ION_CONCEN...,SET,321,-0.013406,-0.0017571,0.048399,0.60911,HP_ABNORMAL_BLOOD_ION_CONCENTRATION,0.99999
ULE_SPLICING_VIA_NOVA2,SET,42,-0.035961,-0.0017179,0.12979,0.60913,ULE_SPLICING_VIA_NOVA2,0.99999
KEGG_MEDICUS_REFERENCE_OKAZA...,SET,11,-0.062166,-0.0015211,0.22438,0.60913,KEGG_MEDICUS_REFERENCE_OKAZAKI_FRAGMENT_MATURATION,0.99999
MIR10A_5P_MIR10B_5P,SET,99,-0.024422,-0.0017885,0.088046,0.60925,MIR10A_5P_MIR10B_5P,0.99999
GOBP_REGULATION_OF_INTESTINA...1,SET,11,-0.072538,-0.0017749,0.26153,0.60925,GOBP_REGULATION_OF_INTESTINAL_ABSORPTION,0.99999
HP_FACIAL_SHAPE_DEFORMATION,SET,14,-0.070407,-0.0019434,0.2536,0.60935,HP_FACIAL_SHAPE_DEFORMATION,0.99999
GSE43863_NAIVE_VS_LY6C_INT_C...2,SET,160,-0.018499,-0.0017193,0.06663,0.60935,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP,0.99999
HP_SEVERE_GLOBAL_DEVELOPMENT...,SET,197,-0.016346,-0.001684,0.058837,0.60942,HP_SEVERE_GLOBAL_DEVELOPMENTAL_DELAY,0.99999
GSE2770_IL12_AND_TGFB_ACT_VS...1,SET,167,-0.018376,-0.0017445,0.06613,0.60945,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN,0.99999
GSE6259_DEC205_POS_DC_VS_CD4...2,SET,180,-0.017094,-0.0016842,0.061516,0.60945,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_UP,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...8,SET,49,-0.033833,-0.0017455,0.1217,0.60949,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_STRESS_HSP,0.99999
WP_AEROBIC_GLYCOLYSIS_AUGMEN...,SET,11,-0.056166,-0.0013743,0.20202,0.6095,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,0.99999
GSE21678_WT_VS_FOXO1_FOXO3_K...2,SET,161,-0.019115,-0.0017821,0.06868,0.60961,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_UP,0.99999
GAUTAM_EYE_CHOROID_SCLERA_ME...,SET,136,-0.018994,-0.0016286,0.068241,0.60962,GAUTAM_EYE_CHOROID_SCLERA_MELANOCYTES,0.99999
REACTOME_CHL1_INTERACTIONS,SET,8,-0.099394,-0.0020743,0.35704,0.60964,REACTOME_CHL1_INTERACTIONS,0.99999
HP_WEAKNESS_OF_THE_INTRINSIC...,SET,24,-0.044586,-0.0016109,0.16012,0.60966,HP_WEAKNESS_OF_THE_INTRINSIC_HAND_MUSCLES,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...8,SET,45,-0.041251,-0.0020397,0.14812,0.60968,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_7,0.99999
GOBP_PERK_MEDIATED_UNFOLDED_...,SET,20,-0.054082,-0.001784,0.1942,0.60968,GOBP_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.99999
GOBP_MAINTENANCE_OF_LOCATION...,SET,209,-0.01659,-0.0017599,0.059567,0.60969,GOBP_MAINTENANCE_OF_LOCATION_IN_CELL,0.99999
MIR8065,SET,134,-0.019285,-0.0016414,0.069219,0.60972,MIR8065,0.99999
GSE30083_SP2_VS_SP4_THYMOCYT...1,SET,186,-0.01751,-0.0017535,0.062838,0.60975,GSE30083_SP2_VS_SP4_THYMOCYTE_DN,0.99999
GOBP_PHOSPHOLIPID_BIOSYNTHET...,SET,230,-0.015021,-0.0016706,0.053897,0.60976,GOBP_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...8,SET,143,-0.020322,-0.0017865,0.072863,0.60984,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...470,SET,34,-0.038905,-0.0016726,0.13946,0.60986,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,0.99999
HP_INFLEXIBLE_ADHERENCE_TO_R...,SET,2,-0.17337,-0.0018094,0.62152,0.60986,HP_INFLEXIBLE_ADHERENCE_TO_ROUTINES,0.99999
REACTOME_TRANSPORT_OF_ORGANI...,SET,10,-0.086461,-0.0020172,0.30976,0.60992,REACTOME_TRANSPORT_OF_ORGANIC_ANIONS,0.99999
HP_LEWY_BODIES,SET,25,-0.047149,-0.0017386,0.16889,0.60994,HP_LEWY_BODIES,0.99999
GSE3565_DUSP1_VS_WT_SPLENOCY...4,SET,148,-0.020856,-0.0018649,0.074695,0.60996,GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP,0.99999
REACTOME_TRANSCRIPTION_COUPL...,SET,73,-0.024132,-0.0015186,0.086371,0.61003,REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...8,SET,40,-0.037226,-0.0017356,0.13322,0.61004,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_FEMORAL_HEAD_AND_NECK,0.99999
GOBP_NEGATIVE_REGULATION_OF_...132,SET,5,-0.082612,-0.0013631,0.29558,0.61006,GOBP_NEGATIVE_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...12,SET,66,-0.029082,-0.0017405,0.10405,0.61007,HP_APLASIA_HYPOPLASIA_OF_THE_BREASTS,0.99999
HP_PANCREATIC_ENDOCRINE_TUMOR,SET,13,-0.070644,-0.0018791,0.25274,0.61007,HP_PANCREATIC_ENDOCRINE_TUMOR,0.99999
YAMAZAKI_TCEB3_TARGETS_DN,SET,179,-0.0177,-0.0017391,0.063312,0.61009,YAMAZAKI_TCEB3_TARGETS_DN,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...6,SET,31,-0.046989,-0.0019291,0.16806,0.6101,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_DN,0.99999
GOBP_REGULATION_OF_PHOSPHORU...,SET,1027,-0.0076786,-0.0017645,0.027457,0.61013,GOBP_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,0.99999
HP_INCREASED_SUSCEPTIBILITY_...,SET,212,-0.016196,-0.0017303,0.05784,0.61027,HP_INCREASED_SUSCEPTIBILITY_TO_FRACTURES,0.99999
GSE27786_CD4_VS_CD8_TCELL_UP,SET,188,-0.01706,-0.0017174,0.060905,0.6103,GSE27786_CD4_VS_CD8_TCELL_UP,0.99999
HP_EXSTROPHY,SET,6,-0.10083,-0.0018225,0.35979,0.61036,HP_EXSTROPHY,0.99999
GOBP_RESPONSE_TO_REDOX_STATE,SET,12,-0.068075,-0.0017398,0.24288,0.61037,GOBP_RESPONSE_TO_REDOX_STATE,0.99999
SPIRA_SMOKERS_LUNG_CANCER_DN,SET,14,-0.06176,-0.0017047,0.22032,0.61038,SPIRA_SMOKERS_LUNG_CANCER_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...102,SET,196,-0.018022,-0.001852,0.064276,0.6104,GOBP_NEGATIVE_REGULATION_OF_CELL_ACTIVATION,0.99999
HP_MICRONODULAR_CIRRHOSIS,SET,21,-0.049686,-0.0016794,0.17705,0.6105,HP_MICRONODULAR_CIRRHOSIS,0.99999
GOCC_HISTONE_DEACETYLASE_COM...,SET,73,-0.025537,-0.001607,0.090925,0.61059,GOCC_HISTONE_DEACETYLASE_COMPLEX,0.99999
HP_ABNORMAL_BRAINSTEM_MORPHO...,SET,249,-0.014383,-0.0016636,0.0512,0.61061,HP_ABNORMAL_BRAINSTEM_MORPHOLOGY,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_SCG...,SET,522,-0.010639,-0.0017681,0.037859,0.61065,HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL,0.99999
GOBP_SERINE_PHOSPHORYLATION_...,SET,19,-0.065164,-0.0020951,0.23183,0.61068,GOBP_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.99999
MIR499B_5P,SET,86,-0.02575,-0.0017582,0.091588,0.6107,MIR499B_5P,0.99999
GOBP_EAR_MORPHOGENESIS,SET,117,-0.023309,-0.0018548,0.082863,0.61076,GOBP_EAR_MORPHOGENESIS,0.99999
GAUCHER_PBMC_YF_VAX_STAMARIL...6,SET,26,-0.049009,-0.0018429,0.17416,0.6108,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_UP,0.99999
GOBP_CADMIUM_ION_TRANSMEMBRA...,SET,6,-0.10362,-0.0018729,0.36808,0.61084,GOBP_CADMIUM_ION_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_RESPONSE_TO_X_RAY,SET,26,-0.041796,-0.0015717,0.14846,0.61085,GOBP_RESPONSE_TO_X_RAY,0.99999
GOBP_REGULATION_OF_MEGAKARYO...,SET,22,-0.0531,-0.001837,0.1885,0.61091,GOBP_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_RAC_PROTE...,SET,23,-0.049886,-0.0017645,0.17709,0.61091,GOBP_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GSE5503_LIVER_DC_VS_SPLEEN_D...1,SET,173,-0.017184,-0.0016602,0.060957,0.61099,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.99999
MIR12128,SET,129,-0.021503,-0.001796,0.07626,0.61102,MIR12128,0.99999
GOBP_REGULATION_OF_P38MAPK_C...,SET,41,-0.040307,-0.0019025,0.14287,0.61107,GOBP_REGULATION_OF_P38MAPK_CASCADE,0.99999
ZNF169_TARGET_GENES,SET,35,-0.037007,-0.0016142,0.13113,0.61111,ZNF169_TARGET_GENES,0.99999
GSE21927_SPLEEN_C57BL6_VS_EL...2,SET,178,-0.017413,-0.0017061,0.061701,0.61111,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP,0.99999
GSE3039_NKT_CELL_VS_B2_BCELL...2,SET,190,-0.018107,-0.0018324,0.064159,0.61111,GSE3039_NKT_CELL_VS_B2_BCELL_UP,0.99999
HP_ANKLE_CLONUS,SET,44,-0.034347,-0.0016794,0.12169,0.61112,HP_ANKLE_CLONUS,0.99999
AMIT_EGF_RESPONSE_480_MCF10A,SET,42,-0.037286,-0.0017813,0.13205,0.61116,AMIT_EGF_RESPONSE_480_MCF10A,0.99999
TCCCCAC_MIR491,SET,58,-0.029519,-0.0016565,0.10455,0.61116,TCCCCAC_MIR491,0.99999
GOBP_L_ARGININE_IMPORT_ACROS...,SET,4,-0.14523,-0.0021434,0.51409,0.61122,GOBP_L_ARGININE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
WENG_POR_TARGETS_LIVER_DN,SET,22,-0.057878,-0.0020022,0.20478,0.61127,WENG_POR_TARGETS_LIVER_DN,0.99999
HP_ABNORMAL_URINE_CHLORIDE_C...,SET,5,-0.12316,-0.0020322,0.43549,0.61134,HP_ABNORMAL_URINE_CHLORIDE_CONCENTRATION,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...8,SET,9,-0.07807,-0.001728,0.27589,0.6114,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22,0.99999
BUSSLINGER_DUODENAL_I_CELLS,SET,14,-0.064104,-0.0017694,0.22647,0.61143,BUSSLINGER_DUODENAL_I_CELLS,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...1,SET,187,-0.017956,-0.0018029,0.063393,0.6115,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_DN,0.99999
chr3p12,SET,7,-0.12672,-0.0024737,0.4473,0.61152,chr3p12,0.99999
HP_ABNORMAL_EMOTION,SET,598,-0.0097955,-0.0017388,0.034575,0.61153,HP_ABNORMAL_EMOTION,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...7,SET,53,-0.03556,-0.0019078,0.1255,0.61155,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,0.99999
MIR205_3P,SET,359,-0.012853,-0.0017796,0.045341,0.61159,MIR205_3P,0.99999
MEF2_04,SET,23,-0.04923,-0.0017413,0.17366,0.61159,MEF2_04,0.99999
GSE27786_BCELL_VS_NKCELL_UP,SET,180,-0.017179,-0.0016926,0.060599,0.6116,GSE27786_BCELL_VS_NKCELL_UP,0.99999
REACTOME_ARACHIDONIC_ACID_ME...,SET,56,-0.033617,-0.0018537,0.11854,0.61164,REACTOME_ARACHIDONIC_ACID_METABOLISM,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...7,SET,180,-0.018099,-0.0017832,0.063808,0.61166,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,0.99999
HP_HYPOCHROMIC_ANEMIA,SET,51,-0.033108,-0.0017425,0.11671,0.61167,HP_HYPOCHROMIC_ANEMIA,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...8,SET,128,-0.022293,-0.0018548,0.078575,0.61168,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,0.99999
GOBP_EYE_PHOTORECEPTOR_CELL_...2,SET,49,-0.035867,-0.0018504,0.12633,0.61176,GOBP_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.99999
GOBP_NUCLEAR_PORE_COMPLEX_AS...,SET,11,-0.066463,-0.0016263,0.23402,0.6118,GOBP_NUCLEAR_PORE_COMPLEX_ASSEMBLY,0.99999
GSE16697_CD4_TCELL_VS_TFH_CD...1,SET,183,-0.017794,-0.0017676,0.062571,0.61194,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN,0.99999
HP_PARTIAL_DUPLICATION_OF_TH...2,SET,38,-0.03669,-0.0016674,0.12899,0.61197,HP_PARTIAL_DUPLICATION_OF_THE_PHALANX_OF_HAND,0.99999
GOBP_REGULATION_OF_MACROPHAG...4,SET,31,-0.046803,-0.0019215,0.16451,0.61198,GOBP_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,0.99999
HP_EEG_WITH_POLYSPIKE_WAVE_C...,SET,46,-0.036762,-0.0018377,0.12922,0.61198,HP_EEG_WITH_POLYSPIKE_WAVE_COMPLEXES,0.99999
MIR4662A_5P,SET,81,-0.026136,-0.0017321,0.091818,0.61204,MIR4662A_5P,0.99999
GSE2770_UNTREATED_VS_ACT_CD4...3,SET,164,-0.019056,-0.0017929,0.066944,0.61205,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN,0.99999
GOBP_REGULATION_OF_ESTABLISH...3,SET,11,-0.05771,-0.0014121,0.20263,0.6121,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME,0.99999
GOBP_CHIASMA_ASSEMBLY,SET,6,-0.081075,-0.0014654,0.28463,0.61212,GOBP_CHIASMA_ASSEMBLY,0.99999
HP_YOUNG_ADULT_ONSET,SET,512,-0.010562,-0.001739,0.037076,0.61213,HP_YOUNG_ADULT_ONSET,0.99999
HOEK_NEUTROPHIL_2011_2012_TI...2,SET,28,-0.05324,-0.0020775,0.18678,0.61219,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_UP,0.99999
NIKOLSKY_BREAST_CANCER_7Q21_...,SET,72,-0.051251,-0.0032031,0.17975,0.61222,NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,0.99999
HP_ELEVATED_BRONCHOALVEOLAR_...,SET,6,-0.11767,-0.0021269,0.41269,0.61223,HP_ELEVATED_BRONCHOALVEOLAR_LAVAGE_FLUID_NEUTROPHIL_PROPORTION,0.99999
HP_LIMITED_EXTRAOCULAR_MOVEM...,SET,14,-0.061242,-0.0016904,0.21475,0.61224,HP_LIMITED_EXTRAOCULAR_MOVEMENTS,0.99999
GSE17721_LPS_VS_PAM3CSK4_16H...1,SET,182,-0.018106,-0.0017937,0.063484,0.61225,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN,0.99999
ACATTCC_MIR1_MIR206,SET,279,-0.014355,-0.0017561,0.050303,0.61232,ACATTCC_MIR1_MIR206,0.99999
GOBP_REGULATION_OF_CYTOKINET...,SET,7,-0.093715,-0.0018295,0.32819,0.61239,GOBP_REGULATION_OF_CYTOKINETIC_PROCESS,0.99999
GSE26030_UNSTIM_VS_RESTIM_TH...1,SET,178,-0.017889,-0.0017528,0.062643,0.61239,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN,0.99999
GSE28737_WT_VS_BCL6_KO_FOLLI...1,SET,182,-0.017617,-0.0017453,0.061683,0.61241,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_DN,0.99999
HP_PAST_MEDICAL_HISTORY,SET,156,-0.019738,-0.0018117,0.069099,0.61243,HP_PAST_MEDICAL_HISTORY,0.99999
GSE14699_DELETIONAL_TOLERANC...2,SET,169,-0.018818,-0.001797,0.065863,0.61245,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,0.99999
HP_ABNORMAL_VENTRICULAR_AXIS,SET,5,-0.11674,-0.0019262,0.40857,0.61246,HP_ABNORMAL_VENTRICULAR_AXIS,0.99999
HP_UPPER_LIMB_ASYMMETRY,SET,10,-0.082822,-0.0019323,0.28979,0.61248,HP_UPPER_LIMB_ASYMMETRY,0.99999
JIANG_CORE_DUPLICON_GENES,SET,4,-0.10645,-0.001571,0.37217,0.61257,JIANG_CORE_DUPLICON_GENES,0.99999
MIR4802_3P,SET,153,-0.021187,-0.001926,0.074076,0.61257,MIR4802_3P,0.99999
UNTERMAN_PROGRESSIVE_VS_STAB...1,SET,4,-0.14213,-0.0020976,0.49678,0.6126,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_B_CELL_DN,0.99999
GOBP_GAS_TRANSPORT,SET,18,-0.067713,-0.0021191,0.23664,0.61261,GOBP_GAS_TRANSPORT,0.99999
GOBP_REGULATION_OF_DEOXYRIBO...,SET,10,-0.07752,-0.0018086,0.27086,0.61264,GOBP_REGULATION_OF_DEOXYRIBONUCLEASE_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_DISAS...,SET,16,-0.057195,-0.0016876,0.19981,0.61265,KEGG_MEDICUS_REFERENCE_DISASSEMBLY_OF_MCC,0.99999
HP_INCREASED_OVERBITE,SET,8,-0.08873,-0.0018517,0.30996,0.61266,HP_INCREASED_OVERBITE,0.99999
GOMF_ARYL_HYDROCARBON_RECEPT...,SET,7,-0.069866,-0.0013639,0.24405,0.61267,GOMF_ARYL_HYDROCARBON_RECEPTOR_BINDING,0.99999
GSE25088_CTRL_VS_ROSIGLITAZO...4,SET,159,-0.018927,-0.0017537,0.06609,0.61271,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,0.99999
DESCARTES_FETAL_CEREBELLUM_P...,SET,43,-0.040402,-0.0019529,0.14108,0.61271,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,0.99999
GOBP_POLYSACCHARIDE_CATABOLI...,SET,26,-0.047061,-0.0017697,0.1643,0.61273,GOBP_POLYSACCHARIDE_CATABOLIC_PROCESS,0.99999
HP_ABNORMALITY_OF_THE_ORBITA...,SET,1409,-0.0065754,-0.0017502,0.022944,0.61278,HP_ABNORMALITY_OF_THE_ORBITAL_REGION,0.99999
HP_LOW_APGAR_SCORE,SET,9,-0.090316,-0.0019991,0.31517,0.61278,HP_LOW_APGAR_SCORE,0.99999
GOBP_MITOTIC_SPINDLE_ELONGAT...,SET,11,-0.077173,-0.0018883,0.26926,0.61279,GOBP_MITOTIC_SPINDLE_ELONGATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...444,SET,5,-0.08733,-0.0014409,0.30459,0.61283,GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION,0.99999
GOMF_RNA_POLYMERASE_II_C_TER...,SET,10,-0.065492,-0.001528,0.22839,0.61285,GOMF_RNA_POLYMERASE_II_C_TERMINAL_DOMAIN_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...328,SET,34,-0.039096,-0.0016808,0.13615,0.613,GOBP_NEGATIVE_REGULATION_OF_JNK_CASCADE,0.99999
GSE21033_CTRL_VS_POLYIC_STIM...2,SET,144,-0.020253,-0.0017866,0.070527,0.61301,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_UP,0.99999
GOBP_REGULATION_OF_MAMMARY_G...,SET,14,-0.069136,-0.0019083,0.24071,0.61303,GOBP_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,0.99999
HP_VENOUS_INSUFFICIENCY,SET,35,-0.043361,-0.0018914,0.15092,0.61306,HP_VENOUS_INSUFFICIENCY,0.99999
GOBP_REGULATION_OF_LONG_TERM...2,SET,12,-0.083123,-0.0021243,0.28929,0.61307,GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION,0.99999
GOBP_DENDRITE_EXTENSION,SET,32,-0.044216,-0.0018443,0.15385,0.61309,GOBP_DENDRITE_EXTENSION,0.99999
HOEGERKORP_CD44_TARGETS_DIRE...1,SET,10,-0.083973,-0.0019592,0.29213,0.61312,HOEGERKORP_CD44_TARGETS_DIRECT_DN,0.99999
MODULE_267,SET,14,-0.063207,-0.0017447,0.21987,0.61312,MODULE_267,0.99999
HP_ABNORMAL_GASTRIC_MUCOSA_M...,SET,39,-0.040689,-0.0018733,0.14154,0.61312,HP_ABNORMAL_GASTRIC_MUCOSA_MORPHOLOGY,0.99999
GOBP_PROGESTERONE_RECEPTOR_S...,SET,10,-0.0764,-0.0017825,0.26575,0.61313,GOBP_PROGESTERONE_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_PARACENTRAL_SCOTOMA,SET,7,-0.10168,-0.001985,0.3536,0.61316,HP_PARACENTRAL_SCOTOMA,0.99999
MIR520A_3P,SET,304,-0.013922,-0.0017765,0.048401,0.61319,MIR520A_3P,0.99999
KEGG_MEDICUS_REFERENCE_IGF_I...1,SET,13,-0.070358,-0.0018715,0.24454,0.61322,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY,0.99999
REACTOME_RUNX3_REGULATES_P14...,SET,10,-0.070467,-0.0016441,0.2449,0.61322,REACTOME_RUNX3_REGULATES_P14_ARF,0.99999
MIR146B_3P,SET,62,-0.031708,-0.0018394,0.11011,0.61331,MIR146B_3P,0.99999
HP_AUTOIMMUNITY,SET,264,-0.015363,-0.0018289,0.053337,0.61334,HP_AUTOIMMUNITY,0.99999
GOBP_REGULATION_OF_CALCIUM_I...9,SET,18,-0.061305,-0.0019185,0.21275,0.61339,GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,0.99999
REACTOME_G_BETA_GAMMA_SIGNAL...1,SET,19,-0.057354,-0.001844,0.1989,0.61346,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42,0.99999
HP_CHIN_WITH_HORIZONTAL_CREA...,SET,8,-0.09964,-0.0020794,0.34554,0.61346,HP_CHIN_WITH_HORIZONTAL_CREASE,0.99999
GOBP_REGULATION_OF_AGGREPHAGY,SET,7,-0.091659,-0.0017893,0.31784,0.61347,GOBP_REGULATION_OF_AGGREPHAGY,0.99999
TEF1_Q6,SET,209,-0.017439,-0.00185,0.060428,0.61355,TEF1_Q6,0.99999
GSE37563_WT_VS_CTLA4_KO_CD4_...1,SET,168,-0.017895,-0.0017039,0.062005,0.61356,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_DN,0.99999
HALLMARK_WNT_BETA_CATENIN_SI...,SET,41,-0.037199,-0.0017559,0.12881,0.61362,HALLMARK_WNT_BETA_CATENIN_SIGNALING,0.99999
MODULE_560,SET,10,-0.071341,-0.0016645,0.24692,0.61368,MODULE_560,0.99999
ACTGTAG_MIR139,SET,109,-0.023944,-0.0018393,0.082847,0.61371,ACTGTAG_MIR139,0.99999
GOBP_FOREBRAIN_VENTRICULAR_Z...,SET,5,-0.12064,-0.0019906,0.41744,0.61371,GOBP_FOREBRAIN_VENTRICULAR_ZONE_PROGENITOR_CELL_DIVISION,0.99999
KEGG_MEDICUS_REFERENCE_SPIND...,SET,20,-0.054038,-0.0017825,0.18691,0.61375,KEGG_MEDICUS_REFERENCE_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...13,SET,142,-0.020573,-0.0018022,0.071153,0.61376,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN,0.99999
HP_VISCERAL_ANGIOMATOSIS,SET,15,-0.065169,-0.0018619,0.22533,0.61379,HP_VISCERAL_ANGIOMATOSIS,0.99999
GOBP_DNA_REPLICATION_DEPENDE...,SET,6,-0.088645,-0.0016022,0.30641,0.61382,GOBP_DNA_REPLICATION_DEPENDENT_CHROMATIN_ASSEMBLY,0.99999
GOBP_REGULATION_OF_CYTOSKELE...,SET,463,-0.011284,-0.0017691,0.038973,0.61391,GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION,0.99999
GOBP_SARCOPLASMIC_RETICULUM_...,SET,38,-0.039804,-0.0018089,0.13744,0.61394,GOBP_SARCOPLASMIC_RETICULUM_CALCIUM_ION_TRANSPORT,0.99999
HP_ABNORMAL_MITOCHONDRIAL_NU...,SET,6,-0.082536,-0.0014918,0.28494,0.61396,HP_ABNORMAL_MITOCHONDRIAL_NUMBER,0.99999
PETRETTO_CARDIAC_HYPERTROPHY,SET,32,-0.04359,-0.0018182,0.15045,0.61399,PETRETTO_CARDIAC_HYPERTROPHY,0.99999
HP_ABNORMAL_LOWER_LIMB_METAP...,SET,20,-0.051808,-0.001709,0.17882,0.61399,HP_ABNORMAL_LOWER_LIMB_METAPHYSIS_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...309,SET,6,-0.089355,-0.001615,0.30835,0.61401,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...500,SET,46,-0.037343,-0.0018668,0.12886,0.61401,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...125,SET,239,-0.016028,-0.0018167,0.055277,0.61407,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS,0.99999
GOBP_REGULATORY_T_CELL_DIFFE...,SET,35,-0.041873,-0.0018264,0.1444,0.61409,GOBP_REGULATORY_T_CELL_DIFFERENTIATION,0.99999
REACTOME_SYNTHESIS_SECRETION...1,SET,18,-0.05922,-0.0018533,0.20418,0.6141,REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN,0.99999
REACTOME_ADAPTIVE_IMMUNE_SYS...,SET,707,-0.0093387,-0.0017969,0.032192,0.61412,REACTOME_ADAPTIVE_IMMUNE_SYSTEM,0.99999
HP_SEVERE_INFECTION,SET,61,-0.031224,-0.0017967,0.10761,0.61415,HP_SEVERE_INFECTION,0.99999
GOMF_AMINO_ACID_TRANSMEMBRAN...,SET,91,-0.027155,-0.0019069,0.093546,0.6142,GOMF_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MORF_PSMC1,SET,170,-0.017025,-0.0016306,0.058647,0.61421,MORF_PSMC1,0.99999
GOBP_CELLULAR_RESPONSE_TO_LE...2,SET,17,-0.061545,-0.0018718,0.21198,0.61422,GOBP_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS,0.99999
HP_ABNORMALITY_OF_THE_INTERN...,SET,19,-0.060486,-0.0019447,0.20829,0.61424,HP_ABNORMALITY_OF_THE_INTERNAL_AUDITORY_CANAL,0.99999
HP_TRACHEAL_STENOSIS,SET,25,-0.048498,-0.0017883,0.16701,0.61424,HP_TRACHEAL_STENOSIS,0.99999
MODULE_284,SET,40,-0.038286,-0.0017851,0.1318,0.61428,MODULE_284,0.99999
GOBP_INNER_DYNEIN_ARM_ASSEMB...,SET,11,-0.065297,-0.0015978,0.22473,0.6143,GOBP_INNER_DYNEIN_ARM_ASSEMBLY,0.99999
DNMT3A_TARGET_GENES,SET,489,-0.011031,-0.001776,0.037964,0.61431,DNMT3A_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...519,SET,10,-0.069546,-0.0016226,0.23925,0.61435,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,0.99999
GNF2_ANP32B,SET,34,-0.040079,-0.0017231,0.13779,0.61442,GNF2_ANP32B,0.99999
HOFMANN_MYELODYSPLASTIC_SYND...5,SET,20,-0.05149,-0.0016985,0.17702,0.61443,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,0.99999
SCHEIDEREIT_IKK_TARGETS,SET,17,-0.065706,-0.0019984,0.22583,0.61446,SCHEIDEREIT_IKK_TARGETS,0.99999
REACTOME_ORGANIC_CATION_ANIO...,SET,15,-0.067197,-0.0019198,0.23094,0.61446,REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT,0.99999
GOMF_DISORDERED_DOMAIN_SPECI...,SET,27,-0.046878,-0.0017963,0.16109,0.61447,GOMF_DISORDERED_DOMAIN_SPECIFIC_BINDING,0.99999
HP_ABNORMAL_NUMBER_OF_ERYTHR...,SET,42,-0.035702,-0.0017056,0.12269,0.61447,HP_ABNORMAL_NUMBER_OF_ERYTHROID_PRECURSORS,0.99999
MIR5694,SET,49,-0.03522,-0.001817,0.12095,0.61455,MIR5694,0.99999
GSE3982_CTRL_VS_IGE_STIM_MAS...1,SET,180,-0.01794,-0.0017676,0.061544,0.61467,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN,0.99999
GOBP_MUSCLE_ORGAN_MORPHOGENE...,SET,76,-0.030826,-0.0019791,0.10573,0.61469,GOBP_MUSCLE_ORGAN_MORPHOGENESIS,0.99999
MODULE_55,SET,758,-0.0094895,-0.0018879,0.032535,0.61473,MODULE_55,0.99999
GOMF_METAL_ION_SEQUESTERING_...,SET,5,-0.11796,-0.0019464,0.40434,0.61476,GOMF_METAL_ION_SEQUESTERING_ACTIVITY,0.99999
AIYAR_COBRA1_TARGETS_UP,SET,36,-0.042199,-0.0018667,0.14463,0.61477,AIYAR_COBRA1_TARGETS_UP,0.99999
GOBP_PHOSPHATIDYLCHOLINE_BIO...,SET,26,-0.047661,-0.0017922,0.16328,0.61481,GOBP_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,0.99999
REACTOME_CYCLIN_A_B1_B2_ASSO...,SET,24,-0.046519,-0.0016808,0.15928,0.61487,REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,0.99999
GSE27786_LSK_VS_NEUTROPHIL_UP,SET,172,-0.017494,-0.0016852,0.05988,0.61491,GSE27786_LSK_VS_NEUTROPHIL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...409,SET,77,-0.028036,-0.0018117,0.095903,0.61498,GOBP_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,0.99999
REACTOME_INFLAMMASOMES,SET,19,-0.053521,-0.0017208,0.18293,0.61507,REACTOME_INFLAMMASOMES,0.99999
GOBP_CD8_POSITIVE_ALPHA_BETA...2,SET,15,-0.066256,-0.001893,0.22643,0.61509,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
HP_ABNORMALITY_OF_IMMUNE_SYS...,SET,1559,-0.0065059,-0.0018135,0.022232,0.6151,HP_ABNORMALITY_OF_IMMUNE_SYSTEM_PHYSIOLOGY,0.99999
GOCC_MALE_GERM_CELL_NUCLEUS,SET,48,-0.032933,-0.0016816,0.11248,0.61515,GOCC_MALE_GERM_CELL_NUCLEUS,0.99999
LEE_AGING_NEOCORTEX_UP,SET,72,-0.030167,-0.0018854,0.1029,0.6153,LEE_AGING_NEOCORTEX_UP,0.99999
HOLLEMAN_DAUNORUBICIN_B_ALL_...2,SET,10,-0.076413,-0.0017828,0.26063,0.61531,HOLLEMAN_DAUNORUBICIN_B_ALL_UP,0.99999
RASHI_RESPONSE_TO_IONIZING_R...4,SET,45,-0.037253,-0.001842,0.12703,0.61533,RASHI_RESPONSE_TO_IONIZING_RADIATION_4,0.99999
MIR3151_3P,SET,39,-0.036603,-0.0016852,0.12481,0.61534,MIR3151_3P,0.99999
MORF_FOSL1,SET,371,-0.013035,-0.001834,0.044439,0.61536,MORF_FOSL1,0.99999
GOBP_CATECHOLAMINE_UPTAKE_IN...,SET,11,-0.075581,-0.0018494,0.25764,0.61538,GOBP_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION,0.99999
HP_ABNORMAL_CENTRAL_SENSORY_...,SET,12,-0.066169,-0.0016911,0.22553,0.61539,HP_ABNORMAL_CENTRAL_SENSORY_FUNCTION,0.99999
CUI_DEVELOPING_HEART_ENDOCAR...,SET,50,-0.037807,-0.0019702,0.12886,0.61539,CUI_DEVELOPING_HEART_ENDOCARDIAL_CELL,0.99999
HP_AXONAL_DEGENERATION,SET,20,-0.052647,-0.0017366,0.1794,0.61541,HP_AXONAL_DEGENERATION,0.99999
HP_FOCAL_AWARE_SEIZURE,SET,26,-0.050116,-0.0018845,0.17074,0.61544,HP_FOCAL_AWARE_SEIZURE,0.99999
GSE15930_STIM_VS_STIM_AND_TR...3,SET,190,-0.017518,-0.0017727,0.059655,0.61549,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN,0.99999
GOBP_TRANSEPITHELIAL_TRANSPO...,SET,35,-0.045433,-0.0019817,0.15468,0.61551,GOBP_TRANSEPITHELIAL_TRANSPORT,0.99999
HP_PELVIC_GIRDLE_AMYOTROPHY,SET,3,-0.11139,-0.0014237,0.37918,0.61553,HP_PELVIC_GIRDLE_AMYOTROPHY,0.99999
GSE6875_TCONV_VS_TREG_UP,SET,180,-0.01815,-0.0017882,0.06177,0.61555,GSE6875_TCONV_VS_TREG_UP,0.99999
HP_ABNORMAL_PROLACTIN_LEVEL,SET,26,-0.047828,-0.0017985,0.1627,0.6156,HP_ABNORMAL_PROLACTIN_LEVEL,0.99999
MOROSETTI_FACIOSCAPULOHUMERA...1,SET,12,-0.072723,-0.0018585,0.24737,0.61561,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN,0.99999
MIR4317,SET,88,-0.025939,-0.0017915,0.088208,0.61565,MIR4317,0.99999
GOBP_POSITIVE_REGULATION_OF_...263,SET,4,-0.11001,-0.0016236,0.37353,0.61582,GOBP_POSITIVE_REGULATION_OF_EXIT_FROM_MITOSIS,0.99999
GSE19772_HCMV_INFL_VS_HCMV_I...2,SET,187,-0.018208,-0.0018281,0.061816,0.61583,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_LI...2,SET,557,-0.011055,-0.001896,0.03752,0.61586,GOBP_CELLULAR_RESPONSE_TO_LIPID,0.99999
REICHERT_MITOSIS_LIN9_TARGETS,SET,25,-0.047058,-0.0017353,0.15968,0.61589,REICHERT_MITOSIS_LIN9_TARGETS,0.99999
GOCC_DENDRITE_TERMINUS,SET,11,-0.071668,-0.0017536,0.24319,0.61589,GOCC_DENDRITE_TERMINUS,0.99999
GOMF_CYSTEINE_TYPE_ENDOPEPTI...5,SET,5,-0.11195,-0.0018471,0.37963,0.61596,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,0.99999
GOBP_REGULATION_OF_MACROPHAG...7,SET,42,-0.039213,-0.0018733,0.13292,0.616,GOBP_REGULATION_OF_MACROPHAGE_MIGRATION,0.99999
HP_VARICOSE_VEINS,SET,29,-0.049342,-0.0019594,0.16713,0.61609,HP_VARICOSE_VEINS,0.99999
GOBP_SPINDLE_ELONGATION,SET,13,-0.072467,-0.0019276,0.24543,0.6161,GOBP_SPINDLE_ELONGATION,0.99999
DELACROIX_RAR_BOUND_ES,SET,410,-0.01258,-0.0018587,0.04256,0.61622,DELACROIX_RAR_BOUND_ES,0.99999
GOBP_REGULATION_OF_MYELOID_C...1,SET,29,-0.045706,-0.001815,0.15461,0.61624,GOBP_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.99999
HP_ABNORMAL_BASAL_GANGLIA_MO...,SET,158,-0.019269,-0.0017798,0.065183,0.61624,HP_ABNORMAL_BASAL_GANGLIA_MORPHOLOGY,0.99999
WP_CALORIC_RESTRICTION_AND_A...,SET,8,-0.090166,-0.0018817,0.30491,0.61627,WP_CALORIC_RESTRICTION_AND_AGING,0.99999
GOBP_REGULATION_OF_FIBRINOLY...,SET,18,-0.055274,-0.0017298,0.18691,0.61628,GOBP_REGULATION_OF_FIBRINOLYSIS,0.99999
MIR653_3P,SET,121,-0.022544,-0.0018241,0.07622,0.6163,MIR653_3P,0.99999
GOBP_ATRIAL_CARDIAC_MUSCLE_T...1,SET,20,-0.06417,-0.0021167,0.21692,0.61631,GOBP_ATRIAL_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.99999
AIZARANI_LIVER_C32_MVECS_3,SET,121,-0.02438,-0.0019726,0.082417,0.61631,AIZARANI_LIVER_C32_MVECS_3,0.99999
GSE11864_UNTREATED_VS_CSF1_I...6,SET,166,-0.019045,-0.0018027,0.06438,0.61632,GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP,0.99999
chr13q22,SET,14,-0.11469,-0.0031658,0.38762,0.61634,chr13q22,0.99999
HP_LIP_TELANGIECTASIA,SET,5,-0.10682,-0.0017625,0.36092,0.61637,HP_LIP_TELANGIECTASIA,0.99999
HP_UPGAZE_PALSY,SET,11,-0.076059,-0.0018611,0.25687,0.61642,HP_UPGAZE_PALSY,0.99999
HP_OVARIAN_CARCINOMA,SET,14,-0.069814,-0.0019271,0.23574,0.61644,HP_OVARIAN_CARCINOMA,0.99999
HP_RHABDOMYOMA,SET,5,-0.12531,-0.0020676,0.42316,0.61644,HP_RHABDOMYOMA,0.99999
TNCATNTCCYR_UNKNOWN,SET,119,-0.022746,-0.0018253,0.076772,0.61649,TNCATNTCCYR_UNKNOWN,0.99999
MIR4772_3P,SET,82,-0.028941,-0.0019298,0.097664,0.61651,MIR4772_3P,0.99999
HP_TENDON_XANTHOMATOSIS,SET,14,-0.07608,-0.0021,0.25661,0.61657,HP_TENDON_XANTHOMATOSIS,0.99999
MIR4444,SET,5,-0.10388,-0.0017141,0.35024,0.61662,MIR4444,0.99999
HP_SKELETAL_DYSPLASIA,SET,169,-0.019191,-0.0018326,0.0647,0.61662,HP_SKELETAL_DYSPLASIA,0.99999
MORF_HDAC2,SET,248,-0.014665,-0.0016929,0.049417,0.61668,MORF_HDAC2,0.99999
GOBP_DETECTION_OF_ABIOTIC_ST...,SET,130,-0.022863,-0.0019169,0.076966,0.61678,GOBP_DETECTION_OF_ABIOTIC_STIMULUS,0.99999
HP_CHRONIC_MYELOGENOUS_LEUKE...,SET,9,-0.084239,-0.0018646,0.28351,0.61681,HP_CHRONIC_MYELOGENOUS_LEUKEMIA,0.99999
REACTOME_PLATELET_ADHESION_T...,SET,15,-0.068645,-0.0019612,0.23101,0.61682,REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,0.99999
MIR4324,SET,238,-0.016376,-0.0018524,0.055096,0.61685,MIR4324,0.99999
GOBP_GLOSSOPHARYNGEAL_NERVE_...,SET,5,-0.094514,-0.0015595,0.31796,0.61686,GOBP_GLOSSOPHARYNGEAL_NERVE_DEVELOPMENT,0.99999
BRUECKNER_TARGETS_OF_MIRLET7...1,SET,72,-0.03173,-0.001983,0.10674,0.61687,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,0.99999
WP_SECRETION_OF_HYDROCHLORIC...,SET,5,-0.11889,-0.0019617,0.39993,0.61687,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,0.99999
MITSIADES_RESPONSE_TO_APLIDI...1,SET,229,-0.016142,-0.0017914,0.054255,0.61696,MITSIADES_RESPONSE_TO_APLIDIN_DN,0.99999
BENPORATH_OCT4_TARGETS,SET,258,-0.016014,-0.0018849,0.053802,0.61701,BENPORATH_OCT4_TARGETS,0.99999
BIOCARTA_TSP1_PATHWAY,SET,7,-0.10508,-0.0020513,0.35304,0.61701,BIOCARTA_TSP1_PATHWAY,0.99999
HP_ABNORMAL_NECK_PHYSIOLOGY,SET,29,-0.049077,-0.0019489,0.16485,0.61703,HP_ABNORMAL_NECK_PHYSIOLOGY,0.99999
WP_SIGNAL_TRANSDUCTION_THROU...,SET,32,-0.047145,-0.0019665,0.15814,0.61719,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,0.99999
GSE7219_WT_VS_NIK_NFKB2_KO_L...1,SET,184,-0.019058,-0.0018983,0.063905,0.61723,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_DN,0.99999
GOBP_PROTEIN_POLY_ADP_RIBOSY...,SET,10,-0.072873,-0.0017002,0.2443,0.61726,GOBP_PROTEIN_POLY_ADP_RIBOSYLATION,0.99999
GOBP_REGULATION_OF_ANATOMICA...1,SET,750,-0.0096176,-0.0019037,0.032224,0.61732,GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_MORPHOGENESIS,0.99999
MIR1288_3P,SET,36,-0.042195,-0.0018665,0.14137,0.61733,MIR1288_3P,0.99999
GOMF_BMP_BINDING,SET,18,-0.062935,-0.0019695,0.21082,0.61735,GOMF_BMP_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...416,SET,41,-0.040191,-0.0018971,0.1346,0.61737,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
REACTOME_TRAFFICKING_OF_GLUR...,SET,15,-0.067843,-0.0019383,0.22705,0.61746,REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...58,SET,6,-0.1168,-0.0021111,0.3907,0.61751,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_PERK_ATF4_SIGNALING_PATHWAY,0.99999
REACTOME_TRANSCRIPTIONAL_ACT...2,SET,48,-0.034781,-0.001776,0.11634,0.61751,REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,0.99999
HP_ABNORMAL_PULMONARY_VEIN_M...,SET,66,-0.02999,-0.0017948,0.10026,0.61757,HP_ABNORMAL_PULMONARY_VEIN_MORPHOLOGY,0.99999
KEGG_MEDICUS_REFERENCE_FANCO...,SET,12,-0.061279,-0.0015661,0.20484,0.61759,KEGG_MEDICUS_REFERENCE_FANCONI_ANEMIA_PATHWAY,0.99999
GOCC_CLATHRIN_VESICLE_COAT,SET,32,-0.044905,-0.001873,0.1501,0.61759,GOCC_CLATHRIN_VESICLE_COAT,0.99999
HP_IMPAIRED_TACTILE_SENSATION,SET,32,-0.042229,-0.0017614,0.14115,0.61759,HP_IMPAIRED_TACTILE_SENSATION,0.99999
GSE29618_LAIV_VS_TIV_FLU_VAC...2,SET,166,-0.019604,-0.0018556,0.065521,0.61761,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP,0.99999
GSE36888_STAT5_AB_KNOCKIN_VS...2,SET,182,-0.018363,-0.0018192,0.06137,0.61761,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP,0.99999
GOBP_HEART_TRABECULA_MORPHOG...,SET,31,-0.050146,-0.0020587,0.16757,0.61763,GOBP_HEART_TRABECULA_MORPHOGENESIS,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...7,SET,176,-0.018699,-0.0018219,0.062477,0.61764,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_DN,0.99999
GOMF_GUANYLATE_CYCLASE_REGUL...,SET,7,-0.10745,-0.0020976,0.35888,0.61768,GOMF_GUANYLATE_CYCLASE_REGULATOR_ACTIVITY,0.99999
GEISS_RESPONSE_TO_DSRNA_DN,SET,15,-0.058299,-0.0016656,0.19461,0.61775,GEISS_RESPONSE_TO_DSRNA_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...684,SET,33,-0.046456,-0.0019677,0.15507,0.61775,GOBP_POSITIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...8,SET,184,-0.018222,-0.001815,0.060803,0.61779,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,0.99999
GOBP_LENS_FIBER_CELL_DIFFERE...,SET,34,-0.046742,-0.0020095,0.1559,0.61784,GOBP_LENS_FIBER_CELL_DIFFERENTIATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...631,SET,18,-0.055761,-0.001745,0.18597,0.61785,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,0.99999
GOBP_PEPTIDOGLYCAN_METABOLIC...,SET,6,-0.11183,-0.0020213,0.3729,0.61787,GOBP_PEPTIDOGLYCAN_METABOLIC_PROCESS,0.99999
HOEK_T_CELL_2011_2012_TIV_AD...4,SET,9,-0.084302,-0.001866,0.28107,0.61788,HOEK_T_CELL_2011_2012_TIV_ADULT_3DY_UP,0.99999
GOBP_ZYMOGEN_ACTIVATION,SET,51,-0.03571,-0.0018794,0.119,0.61794,GOBP_ZYMOGEN_ACTIVATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...458,SET,7,-0.090712,-0.0017709,0.30228,0.61795,GOBP_NEGATIVE_REGULATION_OF_NUCLEASE_ACTIVITY,0.99999
GOCC_AXONAL_GROWTH_CONE,SET,23,-0.053145,-0.0018798,0.17706,0.61797,GOCC_AXONAL_GROWTH_CONE,0.99999
REACTOME_PKMTS_METHYLATE_HIS...,SET,36,-0.038994,-0.0017249,0.12986,0.61801,REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES,0.99999
HP_DECREASED_THALAMIC_VOLUME,SET,9,-0.077986,-0.0017262,0.25949,0.61811,HP_DECREASED_THALAMIC_VOLUME,0.99999
HP_LACTIC_ACIDOSIS,SET,149,-0.019681,-0.0017657,0.065481,0.61812,HP_LACTIC_ACIDOSIS,0.99999
GAUTAM_EYE_CHOROID_SCLERA_CH...,SET,128,-0.02185,-0.001818,0.072688,0.61814,GAUTAM_EYE_CHOROID_SCLERA_CHOROID_ENDOTHELIAL_CELLS,0.99999
GOBP_SPINAL_CORD_OLIGODENDRO...,SET,5,-0.13793,-0.0022758,0.45877,0.61816,GOBP_SPINAL_CORD_OLIGODENDROCYTE_CELL_DIFFERENTIATION,0.99999
GOBP_ACTIN_FILAMENT_BUNDLE_O...,SET,152,-0.020867,-0.0018907,0.069332,0.61828,GOBP_ACTIN_FILAMENT_BUNDLE_ORGANIZATION,0.99999
MIR520B_3P_MIR520C_3P_MIR520...,SET,302,-0.014669,-0.0018658,0.048719,0.61833,MIR520B_3P_MIR520C_3P_MIR520E_3P,0.99999
PATIL_LIVER_CANCER,SET,585,-0.010391,-0.001825,0.0345,0.61836,PATIL_LIVER_CANCER,0.99999
HP_DECREASED_ADIPOSE_TISSUE,SET,43,-0.038967,-0.0018835,0.12938,0.61836,HP_DECREASED_ADIPOSE_TISSUE,0.99999
MODULE_125,SET,42,-0.037644,-0.0017983,0.12491,0.61843,MODULE_125,0.99999
GOBP_CEREBRAL_CORTEX_TANGENT...,SET,5,-0.12893,-0.0021273,0.42782,0.61843,GOBP_CEREBRAL_CORTEX_TANGENTIAL_MIGRATION,0.99999
HP_DISTAL_ARTHROGRYPOSIS,SET,24,-0.05112,-0.001847,0.1695,0.61852,HP_DISTAL_ARTHROGRYPOSIS,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...6,SET,174,-0.019309,-0.0018708,0.064002,0.61856,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_UP,0.99999
MORF_CSNK2B,SET,251,-0.014899,-0.0017301,0.049364,0.6186,MORF_CSNK2B,0.99999
GSE21033_CTRL_VS_POLYIC_STIM...3,SET,175,-0.019031,-0.0018491,0.063018,0.61867,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN,0.99999
GOBP_REGULATION_OF_FC_RECEPT...,SET,10,-0.080887,-0.0018872,0.2678,0.61869,GOBP_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.99999
GOBP_REDUCTION_OF_FOOD_INTAK...,SET,6,-0.10786,-0.0019495,0.35701,0.61872,GOBP_REDUCTION_OF_FOOD_INTAKE_IN_RESPONSE_TO_DIETARY_EXCESS,0.99999
HP_AUDITORY_HALLUCINATION,SET,16,-0.060147,-0.0017747,0.19907,0.61872,HP_AUDITORY_HALLUCINATION,0.99999
GOBP_TRANSLATIONAL_INITIATION,SET,106,-0.02232,-0.001691,0.073874,0.61873,GOBP_TRANSLATIONAL_INITIATION,0.99999
MIR4441,SET,271,-0.015425,-0.0018601,0.051043,0.61875,MIR4441,0.99999
MIR12113,SET,83,-0.028707,-0.0019257,0.094945,0.61881,MIR12113,0.99999
HP_HEMIPLEGIA_HEMIPARESIS,SET,192,-0.01836,-0.0018676,0.060715,0.61882,HP_HEMIPLEGIA_HEMIPARESIS,0.99999
GOBP_REACTIVE_OXYGEN_SPECIES...1,SET,45,-0.037142,-0.0018365,0.12274,0.6189,GOBP_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...33,SET,4,-0.12584,-0.0018572,0.41576,0.61893,GOBP_PROTEIN_LOCALIZATION_TO_MOTILE_CILIUM,0.99999
GSE2706_UNSTIM_VS_2H_LPS_AND...2,SET,162,-0.018884,-0.0017659,0.062373,0.61896,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP,0.99999
KEGG_MEDICUS_REFERENCE_VGCC_...,SET,20,-0.057522,-0.0018974,0.18998,0.61897,KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY,0.99999
HP_DEEP_PHILTRUM,SET,63,-0.031254,-0.0018276,0.1032,0.619,HP_DEEP_PHILTRUM,0.99999
GOBP_POSITIVE_REGULATION_OF_...96,SET,4,-0.12378,-0.0018268,0.40857,0.61904,GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,0.99999
GCM_ING1,SET,61,-0.0277,-0.0015939,0.091425,0.61905,GCM_ING1,0.99999
HP_POLYURIA,SET,35,-0.044611,-0.0019459,0.14724,0.61905,HP_POLYURIA,0.99999
MIR3690,SET,52,-0.035594,-0.0018915,0.11744,0.61908,MIR3690,0.99999
GSE42724_NAIVE_VS_B1_BCELL_UP,SET,182,-0.018307,-0.0018136,0.060397,0.6191,GSE42724_NAIVE_VS_B1_BCELL_UP,0.99999
MIR4258,SET,5,-0.11994,-0.0019791,0.39566,0.61911,MIR4258,0.99999
PAX5_02,SET,16,-0.060319,-0.0017798,0.19895,0.61913,PAX5_02,0.99999
MIR4676_3P,SET,189,-0.018372,-0.0018543,0.060582,0.61915,MIR4676_3P,0.99999
HP_FIBROUS_TISSUE_NEOPLASM,SET,78,-0.028102,-0.0018277,0.092668,0.61915,HP_FIBROUS_TISSUE_NEOPLASM,0.99999
GLINSKY_CANCER_DEATH_UP,SET,5,-0.097133,-0.0016027,0.32008,0.61923,GLINSKY_CANCER_DEATH_UP,0.99999
MIR1302,SET,63,-0.030219,-0.0017671,0.099571,0.61924,MIR1302,0.99999
GSE360_L_DONOVANI_VS_B_MALAY...3,SET,187,-0.017951,-0.0018024,0.059151,0.61924,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.99999
GOBP_NEURAL_PRECURSOR_CELL_P...,SET,157,-0.021296,-0.0019608,0.07016,0.61926,GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.99999
GOMF_LYASE_ACTIVITY,SET,179,-0.019481,-0.0019141,0.064168,0.61928,GOMF_LYASE_ACTIVITY,0.99999
LINDGREN_BLADDER_CANCER_CLUS...4,SET,8,-0.088423,-0.0018453,0.29093,0.61941,LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP,0.99999
KEGG_MEDICUS_REFERENCE_ANXA2...,SET,5,-0.12527,-0.002067,0.41211,0.61942,KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON,0.99999
GOMF_LYSOPHOSPHATIDIC_ACID_R...,SET,4,-0.11981,-0.0017682,0.39416,0.61943,GOMF_LYSOPHOSPHATIDIC_ACID_RECEPTOR_ACTIVITY,0.99999
GOCC_PRESYNAPTIC_CYTOSOL,SET,12,-0.073473,-0.0018777,0.24162,0.61947,GOCC_PRESYNAPTIC_CYTOSOL,0.99999
CTGAGCC_MIR24,SET,201,-0.017758,-0.0018478,0.058379,0.61951,CTGAGCC_MIR24,0.99999
HP_CUTANEOUS_SYNDACTYLY,SET,64,-0.031101,-0.001833,0.10221,0.61954,HP_CUTANEOUS_SYNDACTYLY,0.99999
GSE14000_UNSTIM_VS_4H_LPS_DC...1,SET,179,-0.019789,-0.0019443,0.065028,0.61955,GSE14000_UNSTIM_VS_4H_LPS_DC_DN,0.99999
KEGG_MEDICUS_VARIANT_SCRAPIE...4,SET,16,-0.063711,-0.0018799,0.20929,0.61959,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...666,SET,38,-0.046213,-0.0021002,0.15179,0.61961,GOBP_NEGATIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION,0.99999
HP_ABNORMAL_MYOCARDIUM_MORPH...,SET,511,-0.011256,-0.0018515,0.036944,0.61969,HP_ABNORMAL_MYOCARDIUM_MORPHOLOGY,0.99999
HALLMARK_NOTCH_SIGNALING,SET,31,-0.045661,-0.0018746,0.14978,0.61976,HALLMARK_NOTCH_SIGNALING,0.99999
ATOH8_TARGET_GENES,SET,38,-0.041366,-0.0018799,0.13564,0.6198,ATOH8_TARGET_GENES,0.99999
YAMASHITA_METHYLATED_IN_PROS...,SET,59,-0.035577,-0.0020135,0.1166,0.61986,YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,0.99999
GOBP_ORGANELLE_LOCALIZATION,SET,556,-0.01077,-0.0018456,0.035283,0.61991,GOBP_ORGANELLE_LOCALIZATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...147,SET,8,-0.085224,-0.0017785,0.27912,0.61994,GOBP_POSITIVE_REGULATION_OF_CENTRIOLE_REPLICATION,0.99999
DESCARTES_FETAL_STOMACH_PARI...,SET,36,-0.045937,-0.0020321,0.15036,0.62001,DESCARTES_FETAL_STOMACH_PARIETAL_AND_CHIEF_CELLS,0.99999
BILBAN_B_CLL_LPL_UP,SET,55,-0.034782,-0.0019008,0.1138,0.62006,BILBAN_B_CLL_LPL_UP,0.99999
HP_ABNORMAL_3RD_FINGER_PHALA...,SET,6,-0.11973,-0.002164,0.39169,0.62007,HP_ABNORMAL_3RD_FINGER_PHALANX_MORPHOLOGY,0.99999
GSE39152_BRAIN_VS_SPLEEN_CD1...2,SET,179,-0.019252,-0.0018916,0.062966,0.6201,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP,0.99999
REACTOME_NUCLEOTIDE_LIKE_PUR...,SET,13,-0.076655,-0.002039,0.25064,0.62013,REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS,0.99999
HP_URETEROCELE,SET,25,-0.05488,-0.0020237,0.17934,0.6202,HP_URETEROCELE,0.99999
HP_CENTRAL_OPACIFICATION_OF_...,SET,21,-0.064274,-0.0021724,0.20998,0.62023,HP_CENTRAL_OPACIFICATION_OF_THE_CORNEA,0.99999
chr1q43,SET,21,-0.09506,-0.003213,0.31053,0.62024,chr1q43,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...4,SET,11,-0.088684,-0.00217,0.28972,0.62024,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION,0.99999
MIR4436A,SET,77,-0.03094,-0.0019994,0.10099,0.62033,MIR4436A,0.99999
GSE18804_SPLEEN_MACROPHAGE_V...5,SET,173,-0.02019,-0.0019505,0.065898,0.62034,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN,0.99999
GSE36392_EOSINOPHIL_VS_MAC_I...2,SET,176,-0.019838,-0.001933,0.064712,0.62041,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP,0.99999
KEGG_OTHER_GLYCAN_DEGRADATION,SET,15,-0.070898,-0.0020256,0.23125,0.62042,KEGG_OTHER_GLYCAN_DEGRADATION,0.99999
MIR605_5P,SET,125,-0.024022,-0.0019753,0.078354,0.62042,MIR605_5P,0.99999
GSE21380_NON_TFH_VS_GERMINAL...2,SET,176,-0.019707,-0.0019202,0.064226,0.62051,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,0.99999
HP_GUSTATORY_LACRIMATION,SET,4,-0.1497,-0.0022094,0.48779,0.62054,HP_GUSTATORY_LACRIMATION,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...4,SET,176,-0.017613,-0.0017161,0.057381,0.62055,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_UP,0.99999
HP_ACUTE_RHABDOMYOLYSIS,SET,5,-0.10968,-0.0018097,0.35724,0.62058,HP_ACUTE_RHABDOMYOLYSIS,0.99999
JAERVINEN_AMPLIFIED_IN_LARYN...,SET,39,-0.041048,-0.0018898,0.13367,0.62061,JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER,0.99999
GSE1566_WT_VS_EZH2_KO_LN_TCE...1,SET,178,-0.019355,-0.0018964,0.063018,0.62063,GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN,0.99999
KEGG_MEDICUS_REFERENCE_CCR_C...,SET,31,-0.050817,-0.0020863,0.1654,0.62066,KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY,0.99999
HP_FRACTURES_OF_THE_LONG_BON...,SET,12,-0.064699,-0.0016535,0.21055,0.62068,HP_FRACTURES_OF_THE_LONG_BONES,0.99999
BIOCARTA_SKP2E2F_PATHWAY,SET,10,-0.079244,-0.0018488,0.25778,0.62073,BIOCARTA_SKP2E2F_PATHWAY,0.99999
GOLUB_ALL_VS_AML_DN,SET,22,-0.059565,-0.0020606,0.19375,0.62074,GOLUB_ALL_VS_AML_DN,0.99999
HP_FIBROSARCOMA,SET,9,-0.093404,-0.0020674,0.30381,0.62074,HP_FIBROSARCOMA,0.99999
HP_HYPOPLASIA_OF_THE_OLFACTO...,SET,6,-0.11697,-0.0021142,0.38036,0.62078,HP_HYPOPLASIA_OF_THE_OLFACTORY_BULB,0.99999
GOBP_RESPONSE_TO_OSMOTIC_STR...,SET,78,-0.029412,-0.0019129,0.095611,0.62081,GOBP_RESPONSE_TO_OSMOTIC_STRESS,0.99999
HP_INCREASED_CEREBRAL_LIPOFU...,SET,11,-0.075658,-0.0018513,0.24593,0.62082,HP_INCREASED_CEREBRAL_LIPOFUSCIN,0.99999
GOBP_PROTEIN_AUTOPROCESSING,SET,26,-0.049817,-0.0018733,0.1619,0.62084,GOBP_PROTEIN_AUTOPROCESSING,0.99999
WP_NOTCH_SIGNALING_WP61,SET,58,-0.033056,-0.0018549,0.10742,0.62085,WP_NOTCH_SIGNALING_WP61,0.99999
HP_FEMALE_REPRODUCTIVE_SYSTE...,SET,70,-0.029785,-0.0018355,0.096773,0.62087,HP_FEMALE_REPRODUCTIVE_SYSTEM_NEOPLASM,0.99999
GOCC_FICOLIN_1_RICH_GRANULE_...2,SET,52,-0.036761,-0.0019536,0.11939,0.62092,GOCC_FICOLIN_1_RICH_GRANULE_MEMBRANE,0.99999
GOBP_BOX_C_D_SNORNP_ASSEMBLY,SET,8,-0.085122,-0.0017764,0.27631,0.62098,GOBP_BOX_C_D_SNORNP_ASSEMBLY,0.99999
GOCC_RADIAL_SPOKE,SET,12,-0.060173,-0.0015378,0.19533,0.62098,GOCC_RADIAL_SPOKE,0.99999
GOBP_POSITIVE_REGULATION_OF_...634,SET,8,-0.098194,-0.0020492,0.31865,0.62102,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...40,SET,45,-0.038745,-0.0019157,0.12571,0.62103,GAVISH_3CA_MALIGNANT_METAPROGRAM_METAPROGRAM_6_HYPOXIA,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...4,SET,8,-0.092571,-0.0019319,0.30031,0.62105,GOBP_CELLULAR_RESPONSE_TO_INSULIN_LIKE_GROWTH_FACTOR_STIMULUS,0.99999
SESTO_RESPONSE_TO_UV_C6,SET,36,-0.045106,-0.0019953,0.14629,0.62108,SESTO_RESPONSE_TO_UV_C6,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_C...,SET,15,-0.086989,-0.0024853,0.282,0.62113,GOBP_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS,0.99999
chr6p12,SET,59,-0.061636,-0.0034883,0.19979,0.62115,chr6p12,0.99999
HP_GRANULOMA,SET,6,-0.11293,-0.0020411,0.36594,0.62118,HP_GRANULOMA,0.99999
GOBP_CARDIAC_LEFT_VENTRICLE_...,SET,16,-0.06981,-0.0020599,0.22621,0.62119,GOBP_CARDIAC_LEFT_VENTRICLE_MORPHOGENESIS,0.99999
MIKKELSEN_ES_LCP_WITH_H3K4ME3,SET,132,-0.022732,-0.0019204,0.073602,0.62128,MIKKELSEN_ES_LCP_WITH_H3K4ME3,0.99999
GOBP_NON_PROTEINOGENIC_AMINO...2,SET,14,-0.075504,-0.0020841,0.24445,0.62129,GOBP_NON_PROTEINOGENIC_AMINO_ACID_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_PROTEIN_L...9,SET,12,-0.072974,-0.0018649,0.23605,0.62139,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_ENDOSOME,0.99999
SENGUPTA_NASOPHARYNGEAL_CARC...1,SET,293,-0.015199,-0.0019046,0.049156,0.62141,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,0.99999
ZERBINI_RESPONSE_TO_SULINDAC...2,SET,9,-0.10281,-0.0022757,0.33242,0.62145,ZERBINI_RESPONSE_TO_SULINDAC_UP,0.99999
BOHN_PRIMARY_IMMUNODEFICIENC...2,SET,44,-0.04186,-0.0020467,0.1353,0.62148,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP,0.99999
SATO_SILENCED_BY_METHYLATION...1,SET,368,-0.014294,-0.0020032,0.046181,0.62153,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,0.99999
GOBP_REGULATION_OF_SKELETAL_...5,SET,16,-0.06291,-0.0018563,0.20322,0.62155,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION,0.99999
GOBP_INTERNEURON_MIGRATION_F...,SET,6,-0.13033,-0.0023557,0.42101,0.62156,GOBP_INTERNEURON_MIGRATION_FROM_THE_SUBPALLIUM_TO_THE_CORTEX,0.99999
HP_ABNORMAL_URINARY_PURINE_L...,SET,7,-0.12065,-0.0023553,0.38954,0.62161,HP_ABNORMAL_URINARY_PURINE_LEVEL,0.99999
GOBP_REGULATION_OF_MESENCHYM...3,SET,7,-0.1166,-0.0022763,0.37639,0.62164,GOBP_REGULATION_OF_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS,0.99999
MODULE_182,SET,89,-0.026892,-0.0018678,0.0868,0.62165,MODULE_182,0.99999
ZNF708_TARGET_GENES,SET,72,-0.029637,-0.0018522,0.095639,0.62167,ZNF708_TARGET_GENES,0.99999
MIR3142,SET,49,-0.035835,-0.0018487,0.11561,0.6217,MIR3142,0.99999
GOBP_HAIR_CYCLE_PHASE,SET,9,-0.090552,-0.0020043,0.29203,0.62175,GOBP_HAIR_CYCLE_PHASE,0.99999
MIR4750_3P,SET,36,-0.041463,-0.0018342,0.13369,0.62177,MIR4750_3P,0.99999
GOMF_SNORNA_BINDING,SET,28,-0.045751,-0.0017852,0.14747,0.6218,GOMF_SNORNA_BINDING,0.99999
HP_HYPOPLASTIC_DERMOEPIDERMA...,SET,7,-0.10684,-0.0020856,0.34419,0.62187,HP_HYPOPLASTIC_DERMOEPIDERMAL_HEMIDESMOSOMES,0.99999
GSE45365_BCELL_VS_CD8_TCELL_...2,SET,149,-0.022254,-0.0019965,0.071676,0.6219,GSE45365_BCELL_VS_CD8_TCELL_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...30,SET,6,-0.11897,-0.0021503,0.38309,0.62193,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_IRE1A_JNK_SIGNALING_PATHWAY,0.99999
TEAD2_TARGET_GENES,SET,1171,-0.0079051,-0.0019316,0.025439,0.622,TEAD2_TARGET_GENES,0.99999
GOBP_SOMATIC_STEM_CELL_POPUL...,SET,61,-0.034711,-0.0019974,0.11166,0.62204,GOBP_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.99999
HALLMARK_FATTY_ACID_METABOLI...,SET,145,-0.021211,-0.0018775,0.068238,0.62204,HALLMARK_FATTY_ACID_METABOLISM,0.99999
GOMF_CYCLOSPORIN_A_BINDING,SET,17,-0.057732,-0.0017559,0.1856,0.62212,GOMF_CYCLOSPORIN_A_BINDING,0.99999
GOMF_MRNA_3_UTR_AU_RICH_REGI...,SET,28,-0.047249,-0.0018437,0.15186,0.62214,GOMF_MRNA_3_UTR_AU_RICH_REGION_BINDING,0.99999
OCT_Q6,SET,217,-0.018815,-0.0020333,0.060467,0.62216,OCT_Q6,0.99999
GSE21927_HEALTHY_VS_TUMOROUS...2,SET,167,-0.020177,-0.0019155,0.064779,0.62228,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP,0.99999
GOCC_H4_HISTONE_ACETYLTRANSF...,SET,37,-0.04047,-0.0018149,0.1299,0.6223,GOCC_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.99999
HP_DISTAL_UPPER_LIMB_AMYOTRO...,SET,58,-0.033889,-0.0019017,0.10877,0.62232,HP_DISTAL_UPPER_LIMB_AMYOTROPHY,0.99999
GSE32901_NAIVE_VS_TH17_ENRIC...2,SET,137,-0.02222,-0.0019122,0.071316,0.62232,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP,0.99999
HP_DUODENAL_ADENOCARCINOMA,SET,7,-0.084794,-0.0016553,0.27212,0.62233,HP_DUODENAL_ADENOCARCINOMA,0.99999
REACTOME_CGMP_EFFECTS,SET,15,-0.072548,-0.0020727,0.23278,0.62235,REACTOME_CGMP_EFFECTS,0.99999
GOCC_TRANSCRIPTION_FACTOR_TF...1,SET,5,-0.10233,-0.0016884,0.32828,0.62237,GOCC_TRANSCRIPTION_FACTOR_TFIIA_COMPLEX,0.99999
GOBP_POST_TRANSLATIONAL_PROT...1,SET,870,-0.0088075,-0.0018712,0.02825,0.62239,GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.99999
HP_RENAL_SODIUM_WASTING,SET,7,-0.092205,-0.0018,0.29574,0.62239,HP_RENAL_SODIUM_WASTING,0.99999
GSE29618_PDC_VS_MDC_DAY7_FLU...1,SET,179,-0.020322,-0.0019967,0.065167,0.62242,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN,0.99999
GOBP_INTERFERON_MEDIATED_SIG...,SET,98,-0.027788,-0.0020247,0.089098,0.62243,GOBP_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_STORE_OPE...1,SET,5,-0.10593,-0.0017478,0.33965,0.62243,GOBP_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
KRIEG_HYPOXIA_VIA_KDM3A,SET,46,-0.040896,-0.0020444,0.13108,0.62247,KRIEG_HYPOXIA_VIA_KDM3A,0.99999
WP_RETINOBLASTOMA_GENE_IN_CA...,SET,81,-0.027568,-0.001827,0.088357,0.62248,WP_RETINOBLASTOMA_GENE_IN_CANCER,0.99999
GOBP_RNA_CATABOLIC_PROCESS,SET,264,-0.015533,-0.0018491,0.049774,0.6225,GOBP_RNA_CATABOLIC_PROCESS,0.99999
MIR548BB_5P,SET,447,-0.012591,-0.0019405,0.040325,0.62257,MIR548BB_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...777,SET,16,-0.069306,-0.002045,0.22196,0.62257,GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.99999
MCBRYAN_PUBERTAL_BREAST_4_5W...2,SET,242,-0.018213,-0.0020771,0.058283,0.62266,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,0.99999
GOBP_ORGANISM_EMERGENCE_FROM...,SET,22,-0.052419,-0.0018134,0.16775,0.62267,GOBP_ORGANISM_EMERGENCE_FROM_PROTECTIVE_STRUCTURE,0.99999
MARIADASON_RESPONSE_TO_BUTYR...1,SET,6,-0.12493,-0.002258,0.39973,0.62268,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1,0.99999
REACTOME_POST_CHAPERONIN_TUB...,SET,21,-0.054829,-0.0018532,0.17544,0.62268,REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,0.99999
HP_INCREASED_URINARY_POTASSI...,SET,9,-0.093698,-0.0020739,0.29978,0.62269,HP_INCREASED_URINARY_POTASSIUM,0.99999
GOMF_MOLECULAR_FUNCTION_INHI...,SET,454,-0.013039,-0.0020249,0.041693,0.62276,GOMF_MOLECULAR_FUNCTION_INHIBITOR_ACTIVITY,0.99999
GSE26343_WT_VS_NFAT5_KO_MACR...2,SET,176,-0.019583,-0.0019081,0.062616,0.62276,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN,0.99999
GSE11057_EFF_MEM_VS_CENT_MEM...2,SET,169,-0.020783,-0.0019847,0.066443,0.62278,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP,0.99999
HP_MIGRAINE,SET,120,-0.024406,-0.0019666,0.078021,0.62279,HP_MIGRAINE,0.99999
REACTOME_DEFECTIVE_CHST14_CA...,SET,7,-0.089116,-0.0017397,0.28448,0.62296,REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE,0.99999
ODONNELL_TARGETS_OF_MYC_AND_...1,SET,42,-0.038271,-0.0018283,0.12212,0.623,ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,0.99999
JIANG_HYPOXIA_NORMAL,SET,189,-0.01869,-0.0018865,0.059636,0.62301,JIANG_HYPOXIA_NORMAL,0.99999
SHIN_B_CELL_LYMPHOMA_CLUSTER...7,SET,36,-0.042913,-0.0018983,0.13692,0.62301,SHIN_B_CELL_LYMPHOMA_CLUSTER_8,0.99999
HP_CHRONIC_LEUKEMIA,SET,23,-0.054673,-0.0019338,0.17442,0.62303,HP_CHRONIC_LEUKEMIA,0.99999
XU_CREBBP_TARGETS_DN,SET,35,-0.041461,-0.0018085,0.13226,0.62304,XU_CREBBP_TARGETS_DN,0.99999
GSE17186_NAIVE_VS_CD21LOW_TR...2,SET,175,-0.018923,-0.0018385,0.060357,0.62305,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP,0.99999
GOCC_BASAL_PART_OF_CELL,SET,297,-0.016131,-0.002035,0.051426,0.62312,GOCC_BASAL_PART_OF_CELL,0.99999
GOBP_REGULATION_OF_DOUBLE_ST...1,SET,119,-0.022819,-0.0018311,0.072735,0.62313,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,0.99999
GSE21360_NAIVE_VS_SECONDARY_...1,SET,156,-0.021584,-0.001981,0.068761,0.6232,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN,0.99999
GOBP_MICROGLIAL_CELL_ACTIVAT...,SET,5,-0.12654,-0.0020878,0.403,0.62323,GOBP_MICROGLIAL_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
HP_EPIBLEPHARON,SET,6,-0.10653,-0.0019255,0.33928,0.62324,HP_EPIBLEPHARON,0.99999
KEGG_MEDICUS_REFERENCE_MAGI_...,SET,6,-0.1046,-0.0018906,0.33307,0.62326,KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY,0.99999
GOMF_HISTONE_H4K20_MONOMETHY...,SET,3,-0.17846,-0.002281,0.56822,0.62326,GOMF_HISTONE_H4K20_MONOMETHYLTRANSFERASE_ACTIVITY,0.99999
GOBP_CALCIUM_ION_TRANSPORT_I...,SET,28,-0.054283,-0.0021182,0.17283,0.62327,GOBP_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,0.99999
HP_ABNORMALITY_OF_THE_NAIL,SET,449,-0.012691,-0.0019602,0.040402,0.62329,HP_ABNORMALITY_OF_THE_NAIL,0.99999
GSE23505_IL6_IL1_VS_IL6_IL1_...2,SET,178,-0.019526,-0.0019132,0.062145,0.62332,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,0.99999
GENTILE_UV_RESPONSE_CLUSTER_...3,SET,52,-0.036169,-0.0019221,0.11508,0.62335,GENTILE_UV_RESPONSE_CLUSTER_D4,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...22,SET,32,-0.049658,-0.0020713,0.15798,0.62336,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_HORIZONTAL_BASAL_CELLS,0.99999
GOCC_ALPHA_KETOACID_DEHYDROG...,SET,15,-0.062318,-0.0017805,0.19825,0.62337,GOCC_ALPHA_KETOACID_DEHYDROGENASE_COMPLEX,0.99999
HP_ABNORMALITIES_OF_PLACENTA...,SET,103,-0.026842,-0.0020048,0.085392,0.62337,HP_ABNORMALITIES_OF_PLACENTA_OR_UMBILICAL_CORD,0.99999
GOMF_ORGANOPHOSPHATE_ESTER_T...,SET,35,-0.048336,-0.0021083,0.15367,0.62344,GOMF_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...4,SET,48,-0.043537,-0.0022231,0.13838,0.62347,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_2,0.99999
NAKAJIMA_MAST_CELL,SET,40,-0.044654,-0.0020819,0.14192,0.62348,NAKAJIMA_MAST_CELL,0.99999
MIR3150A_3P,SET,85,-0.027463,-0.0018642,0.087226,0.62356,MIR3150A_3P,0.99999
WP_HEART_DEVELOPMENT,SET,42,-0.045854,-0.0021906,0.14563,0.62357,WP_HEART_DEVELOPMENT,0.99999
GSE24574_BCL6_LOW_TFH_VS_NAI...2,SET,178,-0.019684,-0.0019287,0.062511,0.62358,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_UP,0.99999
MORF_RAC1,SET,186,-0.018187,-0.0018212,0.057724,0.62365,MORF_RAC1,0.99999
GOCC_MRNA_EDITING_COMPLEX,SET,5,-0.11935,-0.0019693,0.37875,0.62367,GOCC_MRNA_EDITING_COMPLEX,0.99999
KASLER_HDAC7_TARGETS_1_UP,SET,179,-0.019718,-0.0019374,0.062542,0.62372,KASLER_HDAC7_TARGETS_1_UP,0.99999
HP_MILD_PROTEINURIA,SET,4,-0.12067,-0.0017809,0.38263,0.62376,HP_MILD_PROTEINURIA,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...78,SET,7,-0.092376,-0.0018033,0.29277,0.62382,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01048,0.99999
MIR6742_5P,SET,40,-0.041364,-0.0019285,0.13107,0.62384,MIR6742_5P,0.99999
ZNF410_TARGET_GENES,SET,488,-0.011969,-0.0019251,0.037926,0.62384,ZNF410_TARGET_GENES,0.99999
GOMF_UBIQUITIN_LIKE_PROTEIN_...6,SET,93,-0.024731,-0.0017556,0.07833,0.62389,GOMF_UBIQUITIN_LIKE_PROTEIN_PEPTIDASE_ACTIVITY,0.99999
GOCC_MITOCHONDRIA_ASSOCIATED...,SET,18,-0.059047,-0.0018479,0.18695,0.62393,GOCC_MITOCHONDRIA_ASSOCIATED_ENDOPLASMIC_RETICULUM_MEMBRANE_CONTACT_SITE,0.99999
GOCC_OLIGOSACCHARYLTRANSFERA...,SET,13,-0.073262,-0.0019487,0.23187,0.62398,GOCC_OLIGOSACCHARYLTRANSFERASE_COMPLEX,0.99999
KEGG_MEDICUS_REFERENCE_CA2_P...1,SET,6,-0.11114,-0.0020088,0.35172,0.62399,KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY,0.99999
BANDRES_RESPONSE_TO_CARMUSTI...7,SET,28,-0.052221,-0.0020377,0.16524,0.62401,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,0.99999
WANG_CLIM2_TARGETS_UP,SET,214,-0.018005,-0.0019325,0.056971,0.62401,WANG_CLIM2_TARGETS_UP,0.99999
HP_MACROVESICULAR_HEPATIC_ST...,SET,15,-0.059751,-0.0017071,0.18907,0.62401,HP_MACROVESICULAR_HEPATIC_STEATOSIS,0.99999
SHETH_LIVER_CANCER_VS_TXNIP_...4,SET,258,-0.016848,-0.001983,0.053296,0.62404,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,0.99999
GSE22886_NAIVE_VS_MEMORY_TCE...2,SET,175,-0.019525,-0.0018971,0.061758,0.62405,GSE22886_NAIVE_VS_MEMORY_TCELL_UP,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...2,SET,183,-0.01967,-0.0019539,0.062214,0.62406,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
HP_OCULOMOTOR_NERVE_PALSY,SET,27,-0.049569,-0.0018994,0.15662,0.62418,HP_OCULOMOTOR_NERVE_PALSY,0.99999
GOMF_QUINONE_BINDING,SET,14,-0.061519,-0.0016981,0.19435,0.6242,GOMF_QUINONE_BINDING,0.99999
HP_MULTIPLE_EXOSTOSES,SET,7,-0.10712,-0.0020912,0.33835,0.62422,HP_MULTIPLE_EXOSTOSES,0.99999
GSE29949_CD8_NEG_DC_SPLEEN_V...5,SET,176,-0.020042,-0.0019528,0.063277,0.62428,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,0.99999
MIR361_3P,SET,81,-0.02985,-0.0019782,0.094207,0.62432,MIR361_3P,0.99999
REACTOME_DEFECTIVE_CHSY1_CAU...,SET,7,-0.090909,-0.0017747,0.28689,0.62433,REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS,0.99999
GSE6674_UNSTIM_VS_ANTI_IGM_S...2,SET,149,-0.020553,-0.0018439,0.064858,0.62433,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_UP,0.99999
GOBP_INTERMEDIATE_FILAMENT_B...2,SET,7,-0.11316,-0.002209,0.35708,0.62434,GOBP_INTERMEDIATE_FILAMENT_BUNDLE_ASSEMBLY,0.99999
ZNF548_TARGET_GENES,SET,45,-0.041702,-0.002062,0.13154,0.62439,ZNF548_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...441,SET,5,-0.11482,-0.0018946,0.36216,0.62439,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION,0.99999
MCGOWAN_RSP6_TARGETS_DN,SET,4,-0.13306,-0.0019637,0.41963,0.62441,MCGOWAN_RSP6_TARGETS_DN,0.99999
GSE26488_CTRL_VS_PEPTIDE_INJ...1,SET,177,-0.020249,-0.0019785,0.06386,0.62441,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_DN,0.99999
GOBP_LIPID_DIGESTION,SET,20,-0.06888,-0.0022721,0.2172,0.62442,GOBP_LIPID_DIGESTION,0.99999
MODULE_491,SET,68,-0.032263,-0.0019598,0.10171,0.62445,MODULE_491,0.99999
GSE37301_LYMPHOID_PRIMED_MPP...5,SET,178,-0.019121,-0.0018735,0.060279,0.62445,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN,0.99999
MARSON_FOXP3_CORE_DIRECT_TAR...,SET,17,-0.073469,-0.0022345,0.2316,0.62446,MARSON_FOXP3_CORE_DIRECT_TARGETS,0.99999
ETS2_B,SET,256,-0.016843,-0.0019749,0.053078,0.6245,ETS2_B,0.99999
GOBP_XENOBIOTIC_METABOLIC_PR...,SET,120,-0.027186,-0.0021906,0.085671,0.6245,GOBP_XENOBIOTIC_METABOLIC_PROCESS,0.99999
GSE40274_CTRL_VS_FOXP3_AND_I...2,SET,146,-0.022488,-0.0019973,0.07087,0.6245,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GSE5589_LPS_VS_LPS_AND_IL10_...12,SET,183,-0.019909,-0.0019777,0.062724,0.62453,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_PRO...1,SET,258,-0.016336,-0.0019227,0.051463,0.62454,HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL,0.99999
GSE36078_UNTREATED_VS_AD5_T4...4,SET,179,-0.019591,-0.0019249,0.061707,0.62456,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP,0.99999
HP_DISTURBED_PERCEPTION_WITH...,SET,33,-0.042685,-0.001808,0.13443,0.62458,HP_DISTURBED_PERCEPTION_WITH_A_STIMULUS,0.99999
CAGCACT_MIR5123P,SET,141,-0.02413,-0.0021064,0.075971,0.62461,CAGCACT_MIR5123P,0.99999
HP_ABNORMAL_CIRCULATING_ASPA...,SET,22,-0.060858,-0.0021053,0.1916,0.62462,HP_ABNORMAL_CIRCULATING_ASPARTATE_FAMILY_AMINO_ACID_CONCENTRATION,0.99999
HP_ADRENAL_HYPOPLASIA,SET,28,-0.050333,-0.001964,0.15835,0.6247,HP_ADRENAL_HYPOPLASIA,0.99999
GSE16451_CTRL_VS_WEST_EQUINE...2,SET,178,-0.020531,-0.0020116,0.064593,0.6247,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...213,SET,6,-0.10986,-0.0019857,0.34558,0.62472,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,0.99999
PID_AR_TF_PATHWAY,SET,49,-0.037414,-0.0019302,0.11764,0.62477,PID_AR_TF_PATHWAY,0.99999
LI_PBMC_MENACTRA_AGE_18_45YO...7,SET,34,-0.052413,-0.0022534,0.16478,0.62478,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE,0.99999
GOMF_GATED_CHANNEL_ACTIVITY,SET,301,-0.016698,-0.0021203,0.052488,0.6248,GOMF_GATED_CHANNEL_ACTIVITY,0.99999
GOMF_NERVE_GROWTH_FACTOR_BIN...,SET,5,-0.13462,-0.0022212,0.42308,0.62483,GOMF_NERVE_GROWTH_FACTOR_BINDING,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...29,SET,47,-0.039214,-0.0019815,0.12318,0.62489,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS,0.99999
CREB3_TARGET_GENES,SET,389,-0.01348,-0.0019412,0.042331,0.62493,CREB3_TARGET_GENES,0.99999
GOBP_LYMPHOCYTE_APOPTOTIC_PR...,SET,77,-0.031498,-0.0020355,0.098874,0.62497,GOBP_LYMPHOCYTE_APOPTOTIC_PROCESS,0.99999
GSE43957_UNTREATED_VS_NACL_T...1,SET,181,-0.019999,-0.0019758,0.062768,0.62499,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,0.99999
HOWARD_DENDRITIC_CELL_INACT_...1,SET,39,-0.045539,-0.0020966,0.14293,0.62499,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_PRO...3,SET,273,-0.017482,-0.0021157,0.054868,0.62499,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL,0.99999
GOBP_RNA_CAPPING,SET,13,-0.061396,-0.0016331,0.19264,0.62502,GOBP_RNA_CAPPING,0.99999
GOMF_HYDROLASE_ACTIVITY_ACTI...7,SET,677,-0.010239,-0.0019295,0.032118,0.62506,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS,0.99999
GOBP_LEPTIN_MEDIATED_SIGNALI...,SET,10,-0.085843,-0.0020028,0.26923,0.62507,GOBP_LEPTIN_MEDIATED_SIGNALING_PATHWAY,0.99999
WANG_LSD1_TARGETS_UP,SET,21,-0.062843,-0.0021241,0.19707,0.62509,WANG_LSD1_TARGETS_UP,0.99999
GOBP_RETROGRADE_NEURONAL_DEN...,SET,4,-0.13843,-0.0020429,0.43394,0.62513,GOBP_RETROGRADE_NEURONAL_DENSE_CORE_VESICLE_TRANSPORT,0.99999
GOBP_CYTOPLASMIC_TRANSLATION,SET,142,-0.021093,-0.0018478,0.06612,0.62514,GOBP_CYTOPLASMIC_TRANSLATION,0.99999
GOMF_SNRNA_BINDING,SET,44,-0.033733,-0.0016493,0.10571,0.62517,GOMF_SNRNA_BINDING,0.99999
HP_FUNCTIONAL_ABNORMALITY_OF...2,SET,1079,-0.0084395,-0.0019849,0.02644,0.62521,HP_FUNCTIONAL_ABNORMALITY_OF_THE_GASTROINTESTINAL_TRACT,0.99999
GOCC_PROTEASOME_COMPLEX,SET,60,-0.031115,-0.0017758,0.097457,0.62524,GOCC_PROTEASOME_COMPLEX,0.99999
GOMF_NAD_P_H_DEHYDROGENASE_Q...,SET,5,-0.12303,-0.0020299,0.38533,0.62524,GOMF_NAD_P_H_DEHYDROGENASE_QUINONE_ACTIVITY,0.99999
GOBP_REGULATION_OF_AMACRINE_...,SET,6,-0.12053,-0.0021784,0.37728,0.62531,GOBP_REGULATION_OF_AMACRINE_CELL_DIFFERENTIATION,0.99999
GSE26669_CD4_VS_CD8_TCELL_IN...2,SET,181,-0.019886,-0.0019646,0.06222,0.62536,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP,0.99999
MIR9985,SET,570,-0.011713,-0.0020315,0.036636,0.62541,MIR9985,0.99999
SCIAN_CELL_CYCLE_TARGETS_OF_...1,SET,22,-0.057061,-0.001974,0.17845,0.62542,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...140,SET,5,-0.1403,-0.0023149,0.43874,0.62543,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS,0.99999
MIR487A_5P,SET,94,-0.025896,-0.0018482,0.080973,0.62544,MIR487A_5P,0.99999
MIR487B_5P,SET,94,-0.025896,-0.0018482,0.080973,0.62544,MIR487B_5P,0.99999
GOBP_CAVEOLIN_MEDIATED_ENDOC...,SET,11,-0.080563,-0.0019713,0.25188,0.62546,GOBP_CAVEOLIN_MEDIATED_ENDOCYTOSIS,0.99999
GSE21546_WT_VS_SAP1A_KO_ANTI...1,SET,183,-0.019619,-0.0019489,0.061298,0.62554,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.99999
HP_CHOROID_PLEXUS_CARCINOMA,SET,5,-0.11429,-0.0018857,0.35704,0.62555,HP_CHOROID_PLEXUS_CARCINOMA,0.99999
MIR4778_3P,SET,230,-0.018371,-0.0020432,0.057389,0.62556,MIR4778_3P,0.99999
ANASTASSIOU_MULTICANCER_INVA...,SET,61,-0.03652,-0.0021015,0.11407,0.62557,ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,0.99999
HP_ABNORMAL_PROPORTION_OF_ME...,SET,5,-0.12718,-0.0020984,0.39713,0.62561,HP_ABNORMAL_PROPORTION_OF_MEMORY_T_CELLS,0.99999
HP_BONE_FRACTURE,SET,21,-0.052568,-0.0017768,0.16405,0.62568,HP_BONE_FRACTURE,0.99999
REACTOME_HDL_REMODELING,SET,8,-0.097567,-0.0020361,0.30436,0.62573,REACTOME_HDL_REMODELING,0.99999
GSE9960_HEALTHY_VS_SEPSIS_PB...1,SET,139,-0.023296,-0.0020193,0.072643,0.62578,GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN,0.99999
GSE37605_FOXP3_FUSION_GFP_VS...3,SET,151,-0.022815,-0.0020605,0.071029,0.62597,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN,0.99999
GOBP_FIBRINOLYSIS,SET,27,-0.051499,-0.0019734,0.16032,0.62598,GOBP_FIBRINOLYSIS,0.99999
GOBP_ARF_PROTEIN_SIGNAL_TRAN...,SET,21,-0.057169,-0.0019323,0.17794,0.626,GOBP_ARF_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
WP_ESTRADIOL_REGULATION_IN_P...,SET,5,-0.12886,-0.0021262,0.40102,0.62602,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,0.99999
GSE40274_EOS_VS_FOXP3_AND_EO...1,SET,108,-0.027163,-0.0020771,0.084535,0.62602,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
HP_OLIGOMENORRHEA,SET,37,-0.042114,-0.0018886,0.13105,0.62603,HP_OLIGOMENORRHEA,0.99999
GOCC_GOLGI_MEDIAL_CISTERNA,SET,11,-0.088151,-0.002157,0.27425,0.62605,GOCC_GOLGI_MEDIAL_CISTERNA,0.99999
GOBP_POSITIVE_REGULATION_OF_...756,SET,5,-0.12104,-0.0019972,0.37648,0.62609,GOBP_POSITIVE_REGULATION_OF_THYROID_HORMONE_GENERATION,0.99999
YAMASHITA_LIVER_CANCER_WITH_...1,SET,14,-0.070808,-0.0019545,0.22021,0.6261,YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN,0.99999
MIR942_5P,SET,194,-0.019319,-0.0019753,0.06007,0.62612,MIR942_5P,0.99999
HP_LOW_PLASMA_CITRULLINE,SET,5,-0.1075,-0.0017738,0.33422,0.62614,HP_LOW_PLASMA_CITRULLINE,0.99999
GOBP_PLACENTA_DEVELOPMENT,SET,142,-0.023611,-0.0020683,0.073398,0.62615,GOBP_PLACENTA_DEVELOPMENT,0.99999
GOBP_POSITIVE_CHEMOTAXIS,SET,60,-0.037257,-0.0021263,0.11575,0.62623,GOBP_POSITIVE_CHEMOTAXIS,0.99999
GOBP_MESENCHYMAL_CELL_DIFFER...2,SET,6,-0.13146,-0.002376,0.40836,0.62624,GOBP_MESENCHYMAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
REACTOME_GERM_LAYER_FORMATIO...,SET,15,-0.070836,-0.0020238,0.22003,0.62625,REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION,0.99999
MIR5009_3P,SET,155,-0.022697,-0.0020766,0.070499,0.62625,MIR5009_3P,0.99999
GOBP_EOSINOPHIL_MEDIATED_IMM...,SET,8,-0.087912,-0.0018346,0.27284,0.62635,GOBP_EOSINOPHIL_MEDIATED_IMMUNITY,0.99999
GOBP_TELENCEPHALON_REGIONALI...,SET,13,-0.093639,-0.0024907,0.29061,0.62635,GOBP_TELENCEPHALON_REGIONALIZATION,0.99999
GSE33513_TCF7_KO_VS_HET_EARL...2,SET,178,-0.021048,-0.0020623,0.065297,0.6264,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP,0.99999
GOBP_MOTOR_NEURON_MIGRATION,SET,12,-0.093812,-0.0023975,0.29096,0.62643,GOBP_MOTOR_NEURON_MIGRATION,0.99999
HP_ASCITES,SET,125,-0.024948,-0.0020515,0.077379,0.62643,HP_ASCITES,0.99999
REACTOME_STIMULI_SENSING_CHA...,SET,99,-0.028103,-0.002058,0.087154,0.62644,REACTOME_STIMULI_SENSING_CHANNELS,0.99999
GSE9509_10MIN_VS_30MIN_LPS_S...2,SET,174,-0.019985,-0.0019363,0.06198,0.62644,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_UP,0.99999
DALESSIO_TSA_RESPONSE,SET,19,-0.071212,-0.0022896,0.22075,0.6265,DALESSIO_TSA_RESPONSE,0.99999
KEGG_PYRIMIDINE_METABOLISM,SET,90,-0.027478,-0.0019191,0.085172,0.62651,KEGG_PYRIMIDINE_METABOLISM,0.99999
GSE3982_BCELL_VS_TH2_DN,SET,173,-0.020317,-0.0019628,0.062971,0.62652,GSE3982_BCELL_VS_TH2_DN,0.99999
KCCGNSWTTT_UNKNOWN,SET,96,-0.026792,-0.0019322,0.083027,0.62653,KCCGNSWTTT_UNKNOWN,0.99999
GOBP_GLUCOSE_IMPORT_IN_RESPO...,SET,5,-0.12081,-0.0019933,0.37434,0.62655,GOBP_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS,0.99999
GOBP_VASCULAR_ENDOTHELIAL_GR...3,SET,53,-0.039082,-0.0020967,0.1211,0.62655,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
REACTOME_AUF1_HNRNP_D0_BINDS...,SET,52,-0.034851,-0.0018521,0.10798,0.62656,REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,0.99999
GOBP_HEMOGLOBIN_BIOSYNTHETIC...,SET,13,-0.076441,-0.0020333,0.23684,0.62656,GOBP_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.99999
GOBP_HINDGUT_DEVELOPMENT,SET,8,-0.1156,-0.0024125,0.35807,0.62659,GOBP_HINDGUT_DEVELOPMENT,0.99999
HP_PIGMENTARY_RETINOPATHY,SET,163,-0.020877,-0.0019583,0.064664,0.62659,HP_PIGMENTARY_RETINOPATHY,0.99999
GOMF_G_PROTEIN_COUPLED_ADENO...,SET,5,-0.12432,-0.0020513,0.38506,0.6266,GOMF_G_PROTEIN_COUPLED_ADENOSINE_RECEPTOR_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...118,SET,28,-0.052159,-0.0020353,0.16152,0.62662,GOBP_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...658,SET,5,-0.11698,-0.0019301,0.36218,0.62664,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,0.99999
WP_TRANSLATION_FACTORS,SET,44,-0.036965,-0.0018074,0.11443,0.62667,WP_TRANSLATION_FACTORS,0.99999
HP_MACROORCHIDISM,SET,10,-0.090212,-0.0021047,0.27922,0.62668,HP_MACROORCHIDISM,0.99999
MODULE_357,SET,72,-0.033999,-0.0021249,0.10523,0.62669,MODULE_357,0.99999
GOBP_REGULATION_OF_NUCLEASE_...,SET,21,-0.061202,-0.0020686,0.18938,0.62671,GOBP_REGULATION_OF_NUCLEASE_ACTIVITY,0.99999
GOBP_MEIOTIC_SPINDLE_ASSEMBLY,SET,10,-0.092544,-0.0021591,0.28636,0.62672,GOBP_MEIOTIC_SPINDLE_ASSEMBLY,0.99999
HP_SUDDEN_LOSS_OF_VISUAL_ACU...,SET,5,-0.1107,-0.0018266,0.34255,0.62672,HP_SUDDEN_LOSS_OF_VISUAL_ACUITY,0.99999
CARRILLOREIXACH_MRS3_VS_LOWE...2,SET,38,-0.042085,-0.0019126,0.13016,0.62677,CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_UP,0.99999
MIR4727_3P,SET,31,-0.050299,-0.002065,0.15544,0.62688,MIR4727_3P,0.99999
MIR5003_5P,SET,177,-0.021131,-0.0020647,0.065297,0.62688,MIR5003_5P,0.99999
GSE30962_PRIMARY_VS_SECONDAR...2,SET,183,-0.019625,-0.0019494,0.060644,0.62688,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP,0.99999
RASHI_RESPONSE_TO_IONIZING_R...2,SET,116,-0.026233,-0.0020785,0.081058,0.62689,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,0.99999
MIR6511A_3P_MIR6511B_3P,SET,55,-0.035283,-0.0019282,0.10901,0.6269,MIR6511A_3P_MIR6511B_3P,0.99999
HP_ABNORMAL_MACROPHAGE_MORPH...,SET,41,-0.047977,-0.0022646,0.14816,0.62696,HP_ABNORMAL_MACROPHAGE_MORPHOLOGY,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...9,SET,188,-0.019973,-0.0020106,0.061665,0.62699,GSE22886_NAIVE_CD4_TCELL_VS_DC_DN,0.99999
GOCC_RNA_POLYMERASE_II_TRANS...1,SET,233,-0.017308,-0.0019373,0.05341,0.62705,GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATOR_COMPLEX,0.99999
GOBP_IMMATURE_T_CELL_PROLIFE...,SET,11,-0.089221,-0.0021832,0.27529,0.62706,GOBP_IMMATURE_T_CELL_PROLIFERATION,0.99999
GOBP_RESPONSE_TO_ETHER,SET,15,-0.071895,-0.0020541,0.2218,0.62709,GOBP_RESPONSE_TO_ETHER,0.99999
MIR6734_5P,SET,63,-0.033145,-0.0019382,0.10219,0.62716,MIR6734_5P,0.99999
HP_SMALL_BASAL_GANGLIA,SET,13,-0.071234,-0.0018948,0.21962,0.62716,HP_SMALL_BASAL_GANGLIA,0.99999
GSE14350_TREG_VS_TEFF_IN_IL2...1,SET,183,-0.019972,-0.0019839,0.061578,0.62716,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN,0.99999
MIR4648,SET,37,-0.042643,-0.0019123,0.13146,0.62718,MIR4648,0.99999
CONCANNON_APOPTOSIS_BY_EPOXO...1,SET,146,-0.023725,-0.0021071,0.073123,0.6272,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,0.99999
HP_GLIOMA,SET,48,-0.037243,-0.0019017,0.11479,0.6272,HP_GLIOMA,0.99999
GSE40274_CTRL_VS_FOXP3_AND_H...1,SET,171,-0.020486,-0.0019678,0.063113,0.62725,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
HP_ABNORMAL_EYEBROW_MORPHOLO...,SET,580,-0.011237,-0.0019653,0.034608,0.62729,HP_ABNORMAL_EYEBROW_MORPHOLOGY,0.99999
LANDIS_ERBB2_BREAST_TUMORS_6...2,SET,22,-0.063098,-0.0021828,0.19416,0.6274,LANDIS_ERBB2_BREAST_TUMORS_65_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...551,SET,28,-0.04995,-0.0019491,0.15369,0.62741,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.99999
HASLINGER_B_CLL_WITH_11Q23_D...,SET,20,-0.056229,-0.0018548,0.17286,0.62751,HASLINGER_B_CLL_WITH_11Q23_DELETION,0.99999
HP_SEPSIS,SET,106,-0.027732,-0.002101,0.08523,0.62755,HP_SEPSIS,0.99999
GSE43955_TGFB_IL6_VS_TGFB_IL...2,SET,185,-0.019381,-0.0019356,0.059561,0.62756,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,0.99999
REACTOME_BETA_OXIDATION_OF_O...,SET,5,-0.11539,-0.001904,0.3546,0.62757,REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA,0.99999
KANNAN_TP53_TARGETS_UP,SET,55,-0.035876,-0.0019606,0.11022,0.62759,KANNAN_TP53_TARGETS_UP,0.99999
GSE33162_HDAC3_KO_VS_HDAC3_K...3,SET,176,-0.020498,-0.0019972,0.062972,0.6276,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_DN,0.99999
GOBP_SECRETORY_GRANULE_LOCAL...,SET,22,-0.061084,-0.0021131,0.18761,0.62763,GOBP_SECRETORY_GRANULE_LOCALIZATION,0.99999
HMGA1_TARGET_GENES,SET,703,-0.010529,-0.0020205,0.032333,0.62765,HMGA1_TARGET_GENES,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...6,SET,20,-0.067579,-0.0022292,0.20752,0.62766,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN,0.99999
HP_OLIGODACTYLY,SET,24,-0.057185,-0.0020661,0.17549,0.62773,HP_OLIGODACTYLY,0.99999
HP_STRIDOR,SET,45,-0.039844,-0.0019701,0.12227,0.62773,HP_STRIDOR,0.99999
GSE40274_CTRL_VS_HELIOS_TRAN...1,SET,162,-0.021016,-0.0019653,0.064489,0.62774,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
MIR3913_3P,SET,73,-0.033115,-0.0020839,0.1016,0.62776,MIR3913_3P,0.99999
HP_THYROID_AGENESIS,SET,7,-0.11543,-0.0022533,0.35393,0.62783,HP_THYROID_AGENESIS,0.99999
TOMIDA_METASTASIS_UP,SET,23,-0.057444,-0.0020318,0.17613,0.62784,TOMIDA_METASTASIS_UP,0.99999
GOMF_NUCLEOTIDE_TRANSMEMBRAN...,SET,29,-0.05536,-0.0021984,0.16974,0.62784,GOMF_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MODULE_227,SET,14,-0.073866,-0.0020389,0.22637,0.6279,MODULE_227,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...7,SET,178,-0.020557,-0.0020143,0.06299,0.62792,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,0.99999
GOBP_VERY_LONG_CHAIN_FATTY_A...2,SET,6,-0.094317,-0.0017047,0.28897,0.62793,GOBP_VERY_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.99999
GOBP_CARBOHYDRATE_PHOSPHORYL...,SET,21,-0.051813,-0.0017513,0.15874,0.62794,GOBP_CARBOHYDRATE_PHOSPHORYLATION,0.99999
MIR889_3P,SET,214,-0.019029,-0.0020424,0.058294,0.62795,MIR889_3P,0.99999
GSE36891_UNSTIM_VS_PAM_TLR2_...2,SET,173,-0.021329,-0.0020606,0.065341,0.62795,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,0.99999
MIR498_5P,SET,216,-0.019528,-0.0021056,0.059821,0.62796,MIR498_5P,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...12,SET,155,-0.022969,-0.0021015,0.070311,0.62805,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP,0.99999
FIGUEROA_AML_METHYLATION_CLU...8,SET,99,-0.028521,-0.0020886,0.08728,0.62808,FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,0.99999
MIR6839_3P,SET,146,-0.023176,-0.0020584,0.07092,0.62808,MIR6839_3P,0.99999
GOCC_GROWTH_FACTOR_COMPLEX,SET,8,-0.11586,-0.002418,0.35436,0.62815,GOCC_GROWTH_FACTOR_COMPLEX,0.99999
LET_7A_3P,SET,665,-0.010865,-0.0020299,0.03319,0.6283,LET_7A_3P,0.99999
GOBP_TRAIL_ACTIVATED_APOPTOT...,SET,9,-0.088212,-0.0019525,0.26946,0.6283,GOBP_TRAIL_ACTIVATED_APOPTOTIC_SIGNALING_PATHWAY,0.99999
LE_NEURONAL_DIFFERENTIATION_...1,SET,18,-0.058031,-0.0018161,0.17726,0.62831,LE_NEURONAL_DIFFERENTIATION_DN,0.99999
LET_7F_1_3P,SET,663,-0.010888,-0.0020313,0.033251,0.62833,LET_7F_1_3P,0.99999
GSE36476_CTRL_VS_TSST_ACT_40...3,SET,181,-0.019435,-0.0019201,0.059357,0.62833,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...14,SET,27,-0.04616,-0.0017688,0.14096,0.62835,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION,0.99999
GOBP_REGULATION_OF_PHOSPHATE...,SET,7,-0.1105,-0.0021571,0.33734,0.62838,GOBP_REGULATION_OF_PHOSPHATE_TRANSPORT,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_PRO...4,SET,204,-0.020353,-0.0021333,0.062107,0.62843,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_3_CELL,0.99999
HP_CARDIAC_VALVE_CALCIFICATI...,SET,11,-0.092862,-0.0022722,0.28328,0.62847,HP_CARDIAC_VALVE_CALCIFICATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...709,SET,126,-0.025512,-0.0021062,0.077817,0.62849,GOBP_POSITIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,0.99999
HP_SLENDER_LONG_BONES_WITH_N...,SET,5,-0.10946,-0.0018061,0.33387,0.62849,HP_SLENDER_LONG_BONES_WITH_NARROW_DIAPHYSES,0.99999
VALK_AML_WITH_11Q23_REARRANG...,SET,16,-0.07226,-0.0021322,0.22036,0.62851,VALK_AML_WITH_11Q23_REARRANGED,0.99999
MENSE_HYPOXIA_UP,SET,89,-0.02854,-0.0019822,0.087032,0.62852,MENSE_HYPOXIA_UP,0.99999
GOBP_RIBOSOMAL_LARGE_SUBUNIT...3,SET,7,-0.097046,-0.0018945,0.29584,0.62856,GOBP_RIBOSOMAL_LARGE_SUBUNIT_EXPORT_FROM_NUCLEUS,0.99999
GATA4_Q3,SET,224,-0.019564,-0.0021476,0.059606,0.62862,GATA4_Q3,0.99999
GOBP_REGULATION_OF_TOLL_LIKE...2,SET,14,-0.067867,-0.0018733,0.20671,0.62866,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.99999
HP_AORTIC_TORTUOSITY,SET,6,-0.12842,-0.0023211,0.39081,0.62877,HP_AORTIC_TORTUOSITY,0.99999
HP_RECURRENT_THROMBOPHLEBITIS,SET,6,-0.097848,-0.0017685,0.29773,0.62879,HP_RECURRENT_THROMBOPHLEBITIS,0.99999
PASINI_SUZ12_TARGETS_DN,SET,289,-0.017098,-0.0021281,0.052013,0.62881,PASINI_SUZ12_TARGETS_DN,0.99999
HP_DECREASED_VIGILANCE,SET,9,-0.091914,-0.0020345,0.27949,0.62887,HP_DECREASED_VIGILANCE,0.99999
SIG_PIP3_SIGNALING_IN_CARDIA...,SET,62,-0.037856,-0.0021961,0.11502,0.62896,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,0.99999
IIZUKA_LIVER_CANCER_PROGRESS...4,SET,23,-0.05604,-0.0019822,0.17027,0.62897,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,0.99999
GOBP_APOPTOTIC_MITOCHONDRIAL...,SET,94,-0.028998,-0.0020695,0.088094,0.62899,GOBP_APOPTOTIC_MITOCHONDRIAL_CHANGES,0.99999
GOBP_METANEPHROS_DEVELOPMENT,SET,86,-0.033441,-0.0022833,0.10156,0.62902,GOBP_METANEPHROS_DEVELOPMENT,0.99999
REACTOME_ERYTHROCYTES_TAKE_U...1,SET,11,-0.087658,-0.0021449,0.26616,0.62905,REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN,0.99999
GOBP_REGULATION_OF_CYTOPLASM...1,SET,7,-0.10141,-0.0019798,0.30792,0.62906,GOBP_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY,0.99999
NCOA2_TARGET_GENES,SET,380,-0.014718,-0.0020953,0.044658,0.62913,NCOA2_TARGET_GENES,0.99999
MIR452_3P,SET,118,-0.027019,-0.002159,0.081976,0.62914,MIR452_3P,0.99999
CAFFAREL_RESPONSE_TO_THC_8HR...4,SET,13,-0.075357,-0.0020044,0.22854,0.6292,CAFFAREL_RESPONSE_TO_THC_8HR_5_UP,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...8,SET,46,-0.044062,-0.0022027,0.13361,0.62922,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_6,0.99999
P53_DN.V2_DN,SET,134,-0.024432,-0.0020796,0.07406,0.62926,P53_DN.V2_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...629,SET,6,-0.12662,-0.0022886,0.38379,0.62927,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,0.99999
HP_COMPLETE_OR_NEAR_COMPLETE...2,SET,5,-0.11528,-0.0019021,0.34943,0.62927,HP_COMPLETE_OR_NEAR_COMPLETE_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_UNCONJUGATED_PNEUMOCOCCUS_VACCINE,0.99999
GSE360_L_DONOVANI_VS_B_MALAY...4,SET,175,-0.021338,-0.0020733,0.064674,0.62927,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...649,SET,11,-0.06961,-0.0017033,0.21092,0.62931,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SUMOYLATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...207,SET,1215,-0.0085587,-0.0021276,0.025929,0.62933,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS,0.99999
REACTOME_TRANSPORT_OF_VITAMI...,SET,38,-0.044506,-0.0020226,0.13474,0.62941,REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...9,SET,174,-0.022188,-0.0021497,0.067172,0.62942,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN,0.99999
REACTOME_INSULIN_RECEPTOR_RE...,SET,28,-0.055327,-0.0021589,0.16747,0.62944,REACTOME_INSULIN_RECEPTOR_RECYCLING,0.99999
REACTOME_TNF_SIGNALING,SET,51,-0.036458,-0.0019188,0.11034,0.62946,REACTOME_TNF_SIGNALING,0.99999
VALK_AML_CLUSTER_9,SET,32,-0.051971,-0.0021677,0.15723,0.6295,VALK_AML_CLUSTER_9,0.99999
MIR1251_5P,SET,23,-0.052709,-0.0018644,0.15946,0.6295,MIR1251_5P,0.99999
GSE21033_CTRL_VS_POLYIC_STIM...7,SET,178,-0.019595,-0.00192,0.059258,0.62955,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN,0.99999
ZNF454_TARGET_GENES,SET,11,-0.084725,-0.0020731,0.2561,0.62961,ZNF454_TARGET_GENES,0.99999
MIR4422,SET,416,-0.014186,-0.002111,0.042877,0.62962,MIR4422,0.99999
CHIN_BREAST_CANCER_COPY_NUMB...2,SET,27,-0.056246,-0.0021553,0.16996,0.62965,CHIN_BREAST_CANCER_COPY_NUMBER_UP,0.99999
ATCMNTCCGY_UNKNOWN,SET,47,-0.039582,-0.002,0.11961,0.62965,ATCMNTCCGY_UNKNOWN,0.99999
REACTOME_STABILIZATION_OF_P53,SET,53,-0.034726,-0.001863,0.10492,0.62967,REACTOME_STABILIZATION_OF_P53,0.99999
GOCC_GLYCINERGIC_SYNAPSE,SET,7,-0.11092,-0.0021653,0.3351,0.62967,GOCC_GLYCINERGIC_SYNAPSE,0.99999
GSE43955_1H_VS_10H_ACT_CD4_T...2,SET,185,-0.019799,-0.0019773,0.059821,0.62967,GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP,0.99999
REACTOME_DOWNSTREAM_SIGNALIN...5,SET,26,-0.052507,-0.0019745,0.15855,0.62974,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4,0.99999
GSE41978_ID2_KO_AND_BIM_KO_V...2,SET,174,-0.021455,-0.0020787,0.064769,0.62977,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.99999
GOBP_DEVELOPMENTAL_INDUCTION,SET,30,-0.055361,-0.002236,0.16706,0.62982,GOBP_DEVELOPMENTAL_INDUCTION,0.99999
PID_EPHRINB_REV_PATHWAY,SET,29,-0.055376,-0.002199,0.16704,0.62987,PID_EPHRINB_REV_PATHWAY,0.99999
LET_7B_3P,SET,662,-0.011024,-0.0020552,0.033253,0.62987,LET_7B_3P,0.99999
REACTOME_REGULATION_OF_CDH11...3,SET,9,-0.096385,-0.0021334,0.2904,0.63002,REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS,0.99999
RAAGNYNNCTTY_UNKNOWN,SET,135,-0.025873,-0.0022103,0.077944,0.63003,RAAGNYNNCTTY_UNKNOWN,0.99999
GSE7218_UNSTIM_VS_ANTIGEN_ST...1,SET,156,-0.023445,-0.0021519,0.070547,0.63018,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN,0.99999
REACTOME_G1_S_SPECIFIC_TRANS...,SET,28,-0.048178,-0.00188,0.14494,0.63021,REACTOME_G1_S_SPECIFIC_TRANSCRIPTION,0.99999
GOCC_AXONEMAL_MICROTUBULE,SET,26,-0.051512,-0.001937,0.1549,0.63026,GOCC_AXONEMAL_MICROTUBULE,0.99999
HP_DECREASED_CIRCULATING_FOL...,SET,30,-0.050089,-0.002023,0.15062,0.63027,HP_DECREASED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_CONCENTRATION,0.99999
GOBP_EPITHELIAL_CELL_PROLIFE...4,SET,5,-0.14271,-0.0023546,0.42902,0.63029,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...436,SET,3,-0.21872,-0.0027956,0.65736,0.63033,GOBP_POSITIVE_REGULATION_OF_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,0.99999
GOBP_SPINDLE_ASSEMBLY_INVOLV...,SET,8,-0.10117,-0.0021114,0.30407,0.63033,GOBP_SPINDLE_ASSEMBLY_INVOLVED_IN_FEMALE_MEIOSIS,0.99999
GOBP_PYRIMIDINE_DEOXYRIBONUC...3,SET,6,-0.12131,-0.0021925,0.36455,0.63034,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.99999
GOMF_TITIN_BINDING,SET,13,-0.073729,-0.0019611,0.22154,0.63035,GOMF_TITIN_BINDING,0.99999
GSE18281_MEDULLARY_THYMOCYTE...1,SET,167,-0.02125,-0.0020174,0.063833,0.63039,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN,0.99999
WP_LACTATE_SHUTTLE_IN_GLIAL_...,SET,12,-0.086076,-0.0021998,0.25854,0.63041,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,0.99999
IL2_UP.V1_UP,SET,159,-0.022803,-0.0021127,0.068469,0.63045,IL2_UP.V1_UP,0.99999
WANG_SMARCE1_TARGETS_UP,SET,258,-0.018993,-0.0022355,0.057002,0.63051,WANG_SMARCE1_TARGETS_UP,0.99999
GOBP_ETHER_METABOLIC_PROCESS,SET,24,-0.060048,-0.0021696,0.18019,0.63052,GOBP_ETHER_METABOLIC_PROCESS,0.99999
GSE5589_WT_VS_IL10_KO_LPS_ST...4,SET,179,-0.020468,-0.0020111,0.061419,0.63053,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,0.99999
KEGG_PENTOSE_PHOSPHATE_PATHW...,SET,22,-0.056696,-0.0019613,0.17006,0.63057,KEGG_PENTOSE_PHOSPHATE_PATHWAY,0.99999
MIR33A_3P,SET,393,-0.014236,-0.0020603,0.042699,0.63058,MIR33A_3P,0.99999
CTTTGA_LEF1_Q2,SET,1088,-0.0092126,-0.0021751,0.027633,0.63058,CTTTGA_LEF1_Q2,0.99999
WP_GASTRIC_CANCER_NETWORK_2,SET,30,-0.053157,-0.0021469,0.15943,0.63059,WP_GASTRIC_CANCER_NETWORK_2,0.99999
GOBP_VACUOLAR_TRANSPORT,SET,161,-0.021637,-0.0020172,0.064887,0.6306,GOBP_VACUOLAR_TRANSPORT,0.99999
GSE32986_UNSTIM_VS_GMCSF_AND...3,SET,174,-0.02104,-0.0020385,0.063076,0.63064,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.99999
MIR4708_3P,SET,91,-0.029041,-0.0020394,0.087059,0.63065,MIR4708_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...594,SET,5,-0.11755,-0.0019395,0.3524,0.63065,GOBP_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.99999
MENON_FETAL_KIDNEY_7_LOOPOF_...,SET,209,-0.018788,-0.0019931,0.056249,0.63081,MENON_FETAL_KIDNEY_7_LOOPOF_HENLE_CELLS_DISTAL,0.99999
BIOCARTA_G1_PATHWAY,SET,28,-0.052305,-0.002041,0.15656,0.63084,BIOCARTA_G1_PATHWAY,0.99999
HP_DIFFUSE_OPTIC_DISC_PALLOR,SET,14,-0.076755,-0.0021186,0.22968,0.63088,HP_DIFFUSE_OPTIC_DISC_PALLOR,0.99999
GOBP_REGULATION_OF_CYTOPLASM...3,SET,32,-0.046883,-0.0019555,0.14026,0.63091,GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATION,0.99999
GOCC_PRERIBOSOME_SMALL_SUBUN...,SET,14,-0.068291,-0.001885,0.20426,0.63093,GOCC_PRERIBOSOME_SMALL_SUBUNIT_PRECURSOR,0.99999
LIU_VMYB_TARGETS_UP,SET,110,-0.027333,-0.0021093,0.08174,0.63096,LIU_VMYB_TARGETS_UP,0.99999
MIR3191_5P,SET,147,-0.023803,-0.0021213,0.071172,0.63098,MIR3191_5P,0.99999
GOBP_STRESS_GRANULE_ASSEMBLY,SET,32,-0.048298,-0.0020145,0.1444,0.63099,GOBP_STRESS_GRANULE_ASSEMBLY,0.99999
HELLEBREKERS_SILENCED_DURING...,SET,71,-0.035508,-0.0022038,0.10614,0.63101,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,0.99999
JAK2_DN.V1_UP,SET,158,-0.02425,-0.0022398,0.072483,0.63102,JAK2_DN.V1_UP,0.99999
GSE46468_LUNG_INNATE_LYMPHOI...2,SET,164,-0.020467,-0.0019257,0.061147,0.63108,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_REACTIVE_...2,SET,130,-0.025027,-0.0020984,0.074744,0.63112,GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...8,SET,13,-0.078024,-0.0020754,0.23297,0.63115,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY,0.99999
HP_INCREASED_INFLAMMATORY_RE...,SET,1101,-0.0087384,-0.0020747,0.02609,0.63116,HP_INCREASED_INFLAMMATORY_RESPONSE,0.99999
FIGUEROA_AML_METHYLATION_CLU...10,SET,12,-0.078959,-0.0020179,0.23562,0.63123,FIGUEROA_AML_METHYLATION_CLUSTER_5_UP,0.99999
GSE11961_PLASMA_CELL_DAY7_VS...1,SET,187,-0.01989,-0.001997,0.059349,0.63124,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.99999
GOBP_MIRNA_METABOLIC_PROCESS,SET,92,-0.029403,-0.0020761,0.087644,0.63137,GOBP_MIRNA_METABOLIC_PROCESS,0.99999
GSE27786_LIN_NEG_VS_CD4_TCEL...2,SET,180,-0.020162,-0.0019864,0.060091,0.63138,GSE27786_LIN_NEG_VS_CD4_TCELL_UP,0.99999
REACTOME_CLASS_A_1_RHODOPSIN...,SET,299,-0.018527,-0.0023449,0.055188,0.63145,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,0.99999
GOBP_CEREBELLAR_CORTEX_FORMA...,SET,22,-0.06306,-0.0021815,0.18785,0.63145,GOBP_CEREBELLAR_CORTEX_FORMATION,0.99999
RUBENSTEIN_SKELETAL_MUSCLE_S...1,SET,264,-0.017224,-0.0020504,0.051305,0.63145,RUBENSTEIN_SKELETAL_MUSCLE_SATELLITE_CELLS,0.99999
MCCABE_HOXC6_TARGETS_CANCER_...1,SET,19,-0.063154,-0.0020305,0.1881,0.63147,MCCABE_HOXC6_TARGETS_CANCER_DN,0.99999
HP_SQUARED_ILIAC_BONES,SET,11,-0.083532,-0.0020439,0.24875,0.63149,HP_SQUARED_ILIAC_BONES,0.99999
MIYAGAWA_TARGETS_OF_EWSR1_ET...2,SET,239,-0.020269,-0.0022974,0.060353,0.6315,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,0.99999
WANG_METASTASIS_OF_BREAST_CA...2,SET,29,-0.054017,-0.002145,0.16083,0.63151,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,0.99999
GOMF_ORGANIC_ACID_TRANSMEMBR...,SET,174,-0.022211,-0.0021519,0.066106,0.63156,GOMF_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE22432_MULTIPOTENT_PROGENI...4,SET,187,-0.020649,-0.0020732,0.061453,0.63156,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_UP,0.99999
GOBP_REGULATION_OF_PHOSPHORY...,SET,888,-0.0099237,-0.002129,0.029527,0.63159,GOBP_REGULATION_OF_PHOSPHORYLATION,0.99999
WP_GLIOBLASTOMA_SIGNALING,SET,80,-0.032005,-0.002108,0.095219,0.63161,WP_GLIOBLASTOMA_SIGNALING,0.99999
HP_UNCONTROLLED_EYE_MOVEMENTS,SET,8,-0.11768,-0.0024559,0.35011,0.63161,HP_UNCONTROLLED_EYE_MOVEMENTS,0.99999
HP_PILI_CANALICULI,SET,5,-0.14921,-0.002462,0.44363,0.63169,HP_PILI_CANALICULI,0.99999
MIR132_5P,SET,8,-0.10046,-0.0020966,0.29859,0.63174,MIR132_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...625,SET,230,-0.018931,-0.0021055,0.056234,0.63181,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY,0.99999
HP_HYPOCHOLESTEROLEMIA,SET,17,-0.068047,-0.0020696,0.20208,0.63184,HP_HYPOCHOLESTEROLEMIA,0.99999
WP_HIPPOMERLIN_SIGNALING_DYS...,SET,113,-0.028757,-0.002249,0.085355,0.63191,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,0.99999
CHEOK_RESPONSE_TO_MERCAPTOPU...6,SET,11,-0.079881,-0.0019546,0.23707,0.63192,CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,0.99999
REACTOME_PHOSPHATE_BOND_HYDR...1,SET,8,-0.091374,-0.0019069,0.27118,0.63192,REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS,0.99999
HP_EAR_PAIN,SET,15,-0.069222,-0.0019777,0.20543,0.63192,HP_EAR_PAIN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...673,SET,9,-0.095248,-0.0021083,0.28259,0.63196,GOBP_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,0.99999
WALLACE_PROSTATE_CANCER_RACE...2,SET,256,-0.019333,-0.0022669,0.057352,0.63197,WALLACE_PROSTATE_CANCER_RACE_UP,0.99999
BIOCARTA_TOB1_PATHWAY,SET,19,-0.068758,-0.0022107,0.20393,0.632,BIOCARTA_TOB1_PATHWAY,0.99999
BLANCO_MELO_RESPIRATORY_SYNC...1,SET,103,-0.02843,-0.0021234,0.0843,0.63203,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,0.99999
ELK1_01,SET,253,-0.017693,-0.0020625,0.052456,0.63205,ELK1_01,0.99999
GOBP_NUCLEAR_PORE_ORGANIZATI...,SET,15,-0.067952,-0.0019414,0.20134,0.63213,GOBP_NUCLEAR_PORE_ORGANIZATION,0.99999
HP_EXPRESSIVE_APHASIA,SET,11,-0.086361,-0.0021132,0.2558,0.63217,HP_EXPRESSIVE_APHASIA,0.99999
HP_UPPER_LIMB_AMYOTROPHY,SET,70,-0.03412,-0.0021027,0.10106,0.63217,HP_UPPER_LIMB_AMYOTROPHY,0.99999
GOBP_POSITIVE_REGULATION_OF_...66,SET,40,-0.047862,-0.0022315,0.14174,0.63219,GOBP_POSITIVE_REGULATION_OF_BONE_MINERALIZATION,0.99999
GSE2770_IL4_ACT_VS_ACT_CD4_T...4,SET,178,-0.021289,-0.002086,0.063047,0.63219,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,0.99999
GOBP_REGULATION_OF_APOPTOTIC...5,SET,347,-0.015339,-0.0020887,0.045422,0.63221,GOBP_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOCC_KAINATE_SELECTIVE_GLUTA...,SET,5,-0.13471,-0.0022227,0.39867,0.63228,GOCC_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX,0.99999
GOMF_KAINATE_SELECTIVE_GLUTA...,SET,5,-0.13471,-0.0022227,0.39867,0.63228,GOMF_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_RTK_P...,SET,53,-0.04259,-0.0022849,0.12602,0.6323,KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY,0.99999
GOCC_CLATHRIN_ADAPTOR_COMPLEX,SET,25,-0.054903,-0.0020245,0.16233,0.6324,GOCC_CLATHRIN_ADAPTOR_COMPLEX,0.99999
GOBP_APOPTOTIC_CHROMOSOME_CO...,SET,6,-0.11687,-0.0021123,0.34546,0.63243,GOBP_APOPTOTIC_CHROMOSOME_CONDENSATION,0.99999
HP_BILATERAL_TONIC_CLONIC_SE...3,SET,41,-0.048347,-0.0022821,0.14286,0.63247,HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_GENERALIZED_ONSET,0.99999
HP_KETOACIDOSIS,SET,35,-0.048646,-0.0021219,0.14376,0.63247,HP_KETOACIDOSIS,0.99999
GOMF_PROTEIN_TYROSINE_KINASE...3,SET,117,-0.026132,-0.0020794,0.077208,0.63249,GOMF_PROTEIN_TYROSINE_KINASE_BINDING,0.99999
ATAACCT_MIR154,SET,59,-0.034789,-0.0019689,0.10278,0.6325,ATAACCT_MIR154,0.99999
GSE22611_NOD2_VS_CTRL_TRANSD...1,SET,185,-0.020182,-0.0020156,0.059585,0.63258,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,0.99999
KEGG_MEDICUS_REFERENCE_MANNO...1,SET,3,-0.16325,-0.0020866,0.48195,0.63259,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_FKTN_TO_LARGE,0.99999
GOBP_ORGANONITROGEN_COMPOUND...1,SET,1501,-0.0076036,-0.0020833,0.022443,0.63261,GOBP_ORGANONITROGEN_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_RECEPTOR_...3,SET,14,-0.078291,-0.002161,0.23105,0.63264,GOBP_REGULATION_OF_RECEPTOR_CLUSTERING,0.99999
HP_THICK_CEREBRAL_CORTEX,SET,9,-0.099618,-0.002205,0.29393,0.63266,HP_THICK_CEREBRAL_CORTEX,0.99999
MIR3529_3P,SET,493,-0.013198,-0.0021335,0.038932,0.6327,MIR3529_3P,0.99999
HP_ABNORMAL_GALLBLADDER_MORP...,SET,84,-0.031826,-0.0021478,0.093878,0.6327,HP_ABNORMAL_GALLBLADDER_MORPHOLOGY,0.99999
HARALAMBIEVA_PBMC_FLUARIX_AG...4,SET,15,-0.08142,-0.0023262,0.24017,0.6327,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_POSITIVE,0.99999
MIR4728_5P,SET,516,-0.012674,-0.0020946,0.03738,0.63272,MIR4728_5P,0.99999
GOBP_REGULATION_OF_EPIDERMIS...,SET,58,-0.039708,-0.0022282,0.11709,0.63274,GOBP_REGULATION_OF_EPIDERMIS_DEVELOPMENT,0.99999
STK33_NOMO_UP,SET,262,-0.01848,-0.0021918,0.054476,0.63278,STK33_NOMO_UP,0.99999
GOBP_REGULATION_OF_NUCLEOTID...6,SET,80,-0.031488,-0.002074,0.092808,0.6328,GOBP_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,0.99999
MAGRANGEAS_MULTIPLE_MYELOMA_...2,SET,16,-0.072572,-0.0021414,0.21388,0.63281,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP,0.99999
REACTOME_MRNA_SPLICING_MINOR...,SET,48,-0.036107,-0.0018437,0.10635,0.63288,REACTOME_MRNA_SPLICING_MINOR_PATHWAY,0.99999
MORF_MBD4,SET,75,-0.029677,-0.0018928,0.087416,0.63288,MORF_MBD4,0.99999
GOBP_REGULATION_OF_MYELOID_D...,SET,4,-0.16383,-0.0024179,0.48251,0.6329,GOBP_REGULATION_OF_MYELOID_DENDRITIC_CELL_ACTIVATION,0.99999
GSE2770_TGFB_AND_IL4_VS_TGFB...2,SET,139,-0.025061,-0.0021722,0.073794,0.63292,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
PARENT_MTOR_SIGNALING_UP,SET,504,-0.012332,-0.0020149,0.036301,0.63296,PARENT_MTOR_SIGNALING_UP,0.99999
GCM_APEX1,SET,102,-0.025934,-0.0019276,0.076342,0.63296,GCM_APEX1,0.99999
GSE14769_UNSTIM_VS_80MIN_LPS...2,SET,182,-0.020122,-0.0019934,0.059206,0.63302,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP,0.99999
GOBP_REGULATION_OF_PROTEIN_A...4,SET,4,-0.14857,-0.0021926,0.43707,0.63304,GOBP_REGULATION_OF_PROTEIN_AUTOUBIQUITINATION,0.99999
HP_ABNORMAL_SEMICIRCULAR_CAN...,SET,21,-0.057985,-0.0019599,0.17058,0.63304,HP_ABNORMAL_SEMICIRCULAR_CANAL_MORPHOLOGY,0.99999
GOBP_RESPONSE_TO_ABIOTIC_STI...,SET,1024,-0.0092671,-0.0021266,0.027256,0.63307,GOBP_RESPONSE_TO_ABIOTIC_STIMULUS,0.99999
GOBP_PUTRESCINE_BIOSYNTHETIC...,SET,5,-0.11454,-0.0018899,0.33654,0.6332,GOBP_PUTRESCINE_BIOSYNTHETIC_PROCESS,0.99999
GOMF_LIPOTEICHOIC_ACID_BINDI...,SET,5,-0.13178,-0.0021744,0.38719,0.6332,GOMF_LIPOTEICHOIC_ACID_BINDING,0.99999
GOBP_THYROID_HORMONE_GENERAT...,SET,22,-0.064057,-0.002216,0.18819,0.63321,GOBP_THYROID_HORMONE_GENERATION,0.99999
GNF2_DDX5,SET,58,-0.034345,-0.0019273,0.10088,0.63324,GNF2_DDX5,0.99999
MIR4453,SET,24,-0.063775,-0.0023042,0.18724,0.6333,MIR4453,0.99999
MEF2_03,SET,204,-0.020832,-0.0021835,0.061136,0.63335,MEF2_03,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...12,SET,35,-0.05561,-0.0024256,0.16316,0.63338,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MONOCYTES,0.99999
AACTTT_UNKNOWN,SET,1694,-0.0076546,-0.0022152,0.022433,0.63353,AACTTT_UNKNOWN,0.99999
GOBP_CEREBRAL_CORTEX_REGIONA...,SET,7,-0.13326,-0.0026014,0.39036,0.63359,GOBP_CEREBRAL_CORTEX_REGIONALIZATION,0.99999
MIR493_5P,SET,431,-0.014342,-0.0021714,0.042005,0.63361,MIR493_5P,0.99999
GOBP_MEMBRANE_ORGANIZATION,SET,721,-0.010795,-0.0020967,0.031608,0.63364,GOBP_MEMBRANE_ORGANIZATION,0.99999
MEISSNER_NPC_HCP_WITH_H3K4ME...2,SET,140,-0.025825,-0.0022464,0.075571,0.63372,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.99999
HP_JERKY_OCULAR_PURSUIT_MOVE...,SET,8,-0.088936,-0.001856,0.26018,0.63376,HP_JERKY_OCULAR_PURSUIT_MOVEMENTS,0.99999
GOBP_BRANCHED_CHAIN_AMINO_AC...3,SET,27,-0.054976,-0.0021066,0.16081,0.63378,GOBP_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS,0.99999
GOBP_PEPTIDYL_PROLINE_MODIFI...,SET,29,-0.046988,-0.0018659,0.13744,0.63378,GOBP_PEPTIDYL_PROLINE_MODIFICATION,0.99999
HP_IMPAIRED_LYMPHOCYTE_TRANS...,SET,10,-0.091946,-0.0021452,0.26886,0.63381,HP_IMPAIRED_LYMPHOCYTE_TRANSFORMATION_WITH_PHYTOHEMAGGLUTININ,0.99999
GOBP_NEURON_MIGRATION,SET,166,-0.02379,-0.0022517,0.069553,0.63383,GOBP_NEURON_MIGRATION,0.99999
GAO_SMALL_INTESTINE_24W_C2_P...,SET,17,-0.072078,-0.0021922,0.21062,0.6339,GAO_SMALL_INTESTINE_24W_C2_PROCRPOS_PROGENITOR,0.99999
ZNF529_TARGET_GENES,SET,33,-0.045863,-0.0019426,0.13399,0.63393,ZNF529_TARGET_GENES,0.99999
GOBP_PURINE_DEOXYRIBONUCLEOS...2,SET,6,-0.12515,-0.0022621,0.36566,0.63393,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.99999
HP_DEEP_SET_NAILS,SET,6,-0.10454,-0.0018894,0.30542,0.63393,HP_DEEP_SET_NAILS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...150,SET,51,-0.042305,-0.0022265,0.12358,0.63394,GOBP_NEGATIVE_REGULATION_OF_COAGULATION,0.99999
HP_APLASIA_OF_THE_PROXIMAL_P...,SET,9,-0.090888,-0.0020118,0.26552,0.63394,HP_APLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,0.99999
GOBP_IN_UTERO_EMBRYONIC_DEVE...,SET,378,-0.014672,-0.0020834,0.042857,0.63395,GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...237,SET,16,-0.0736,-0.0021717,0.21498,0.63396,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.99999
SMIRNOV_RESPONSE_TO_IR_2HR_DN,SET,51,-0.041585,-0.0021886,0.12143,0.634,SMIRNOV_RESPONSE_TO_IR_2HR_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...597,SET,95,-0.029276,-0.0021004,0.085461,0.63404,GOBP_NEGATIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,0.99999
GSE7768_OVA_ALONE_VS_OVA_WIT...2,SET,155,-0.022646,-0.0020719,0.06607,0.63411,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,0.99999
HP_ELEVATED_TOTAL_SERUM_TRYP...,SET,6,-0.11607,-0.0020979,0.33852,0.63415,HP_ELEVATED_TOTAL_SERUM_TRYPTASE,0.99999
PETROVA_PROX1_TARGETS_UP,SET,25,-0.05928,-0.0021859,0.17285,0.63418,PETROVA_PROX1_TARGETS_UP,0.99999
GOBP_DETECTION_OF_TEMPERATUR...2,SET,19,-0.068125,-0.0021903,0.19861,0.63421,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.99999
GOBP_PERIPHERAL_NERVOUS_SYST...1,SET,28,-0.0546,-0.0021306,0.15916,0.63421,GOBP_PERIPHERAL_NERVOUS_SYSTEM_AXON_ENSHEATHMENT,0.99999
GSE13485_DAY3_VS_DAY7_YF17D_...1,SET,175,-0.022413,-0.0021777,0.065306,0.63428,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN,0.99999
REACTOME_FORMATION_OF_WDR5_C...,SET,37,-0.043263,-0.0019401,0.12603,0.6343,REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,0.99999
THAKAR_PBMC_INACTIVATED_INFL...11,SET,97,-0.028359,-0.0020558,0.082584,0.63435,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_UP,0.99999
REACTOME_REPLACEMENT_OF_PROT...,SET,6,-0.12341,-0.0022306,0.35935,0.63436,REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS,0.99999
REACTOME_RHOBTB2_GTPASE_CYCLE,SET,22,-0.055293,-0.0019128,0.161,0.63436,REACTOME_RHOBTB2_GTPASE_CYCLE,0.99999
BIOCARTA_IFNA_PATHWAY,SET,9,-0.09771,-0.0021628,0.2844,0.63441,BIOCARTA_IFNA_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...22,SET,6,-0.11978,-0.0021649,0.34863,0.63441,GOBP_POSITIVE_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.99999
HP_LONG_CLAVICLES,SET,13,-0.082472,-0.0021937,0.23997,0.63445,HP_LONG_CLAVICLES,0.99999
DESCARTES_FETAL_HEART_ENDOCA...,SET,29,-0.059088,-0.0023464,0.17193,0.63445,DESCARTES_FETAL_HEART_ENDOCARDIAL_CELLS,0.99999
CRGAARNNNNCGA_UNKNOWN,SET,39,-0.046386,-0.0021355,0.13496,0.63447,CRGAARNNNNCGA_UNKNOWN,0.99999
HP_FLARED_NOSTRILS,SET,6,-0.1165,-0.0021056,0.33874,0.63454,HP_FLARED_NOSTRILS,0.99999
GOBP_OLFACTORY_LOBE_DEVELOPM...,SET,36,-0.054569,-0.0024139,0.15865,0.63456,GOBP_OLFACTORY_LOBE_DEVELOPMENT,0.99999
HP_POLYHYDRAMNIOS,SET,263,-0.017852,-0.0021213,0.051876,0.63462,HP_POLYHYDRAMNIOS,0.99999
MIR5584_3P,SET,124,-0.026949,-0.0022071,0.078307,0.63463,MIR5584_3P,0.99999
HECKER_IFNB1_TARGETS,SET,88,-0.034357,-0.0023728,0.099814,0.63465,HECKER_IFNB1_TARGETS,0.99999
VANGURP_PANCREATIC_DELTA_CELL,SET,73,-0.037805,-0.002379,0.10983,0.63465,VANGURP_PANCREATIC_DELTA_CELL,0.99999
HP_BONE_CYST,SET,27,-0.054279,-0.0020799,0.15769,0.63466,HP_BONE_CYST,0.99999
GOBP_DENDRITIC_CELL_ANTIGEN_...,SET,13,-0.079001,-0.0021014,0.22941,0.63471,GOBP_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,0.99999
GOBP_PROTEIN_MODIFICATION_BY...2,SET,91,-0.027702,-0.0019454,0.080443,0.63471,GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL,0.99999
HP_DYSTROPHIC_TOENAIL,SET,19,-0.067973,-0.0021855,0.19728,0.63478,HP_DYSTROPHIC_TOENAIL,0.99999
GSE46606_IRF4HIGH_VS_IRF4MID...3,SET,181,-0.022163,-0.0021896,0.064288,0.63485,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.99999
GOBP_REGULATION_OF_SODIUM_IO...3,SET,76,-0.03558,-0.0022843,0.10319,0.63488,GOBP_REGULATION_OF_SODIUM_ION_TRANSPORT,0.99999
WP_POSTCOVID_NEUROINFLAMMATI...,SET,20,-0.071637,-0.002363,0.20769,0.63492,WP_POSTCOVID_NEUROINFLAMMATION,0.99999
GSE339_EX_VIVO_VS_IN_CULTURE...5,SET,187,-0.021878,-0.0021966,0.0634,0.63498,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN,0.99999
GOBP_HIPPOCAMPUS_DEVELOPMENT,SET,90,-0.031535,-0.0022024,0.091369,0.635,GOBP_HIPPOCAMPUS_DEVELOPMENT,0.99999
HP_POROKERATOSIS,SET,7,-0.10278,-0.0020065,0.29772,0.63504,HP_POROKERATOSIS,0.99999
GOBP_OTIC_VESICLE_MORPHOGENE...,SET,10,-0.085671,-0.0019988,0.2481,0.63506,GOBP_OTIC_VESICLE_MORPHOGENESIS,0.99999
GSE17721_0.5H_VS_8H_CPG_BMDC...1,SET,183,-0.020883,-0.0020744,0.060467,0.63508,GSE17721_0.5H_VS_8H_CPG_BMDC_DN,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HS...,SET,389,-0.015922,-0.0022929,0.046104,0.63508,MANNO_MIDBRAIN_NEUROTYPES_HSERT,0.99999
GOBP_L_AMINO_ACID_METABOLIC_...,SET,161,-0.022723,-0.0021185,0.065768,0.63514,GOBP_L_AMINO_ACID_METABOLIC_PROCESS,0.99999
GSE26488_WT_VS_VP16_TRANSGEN...1,SET,150,-0.025027,-0.0022528,0.072418,0.63517,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,0.99999
GOBP_REGULATION_OF_RELAXATIO...1,SET,6,-0.11934,-0.0021569,0.34531,0.63518,GOBP_REGULATION_OF_RELAXATION_OF_CARDIAC_MUSCLE,0.99999
GOMF_DESUMOYLASE_ACTIVITY,SET,7,-0.10084,-0.0019686,0.29144,0.63533,GOMF_DESUMOYLASE_ACTIVITY,0.99999
GSE2770_IL12_AND_TGFB_VS_IL4...2,SET,179,-0.021306,-0.0020934,0.061536,0.63541,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
chr15q14,SET,23,-0.10892,-0.0038527,0.31447,0.63547,chr15q14,0.99999
GSE14000_UNSTIM_VS_4H_LPS_DC...2,SET,178,-0.023074,-0.0022608,0.066597,0.6355,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN,0.99999
HP_HYPOARGININEMIA,SET,6,-0.10154,-0.0018352,0.29301,0.63553,HP_HYPOARGININEMIA,0.99999
GSE36078_UNTREATED_VS_AD5_T4...1,SET,181,-0.022031,-0.0021765,0.063572,0.63553,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_DN,0.99999
REACTOME_SIGNALING_BY_VEGF,SET,101,-0.029416,-0.0021757,0.084848,0.63558,REACTOME_SIGNALING_BY_VEGF,0.99999
GOMF_CYTOSKELETAL_PROTEIN_BI...,SET,909,-0.0097744,-0.0021203,0.028193,0.63559,GOMF_CYTOSKELETAL_PROTEIN_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...23,SET,10,-0.083895,-0.0019574,0.24193,0.63562,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.99999
GSE17721_CTRL_VS_CPG_4H_BMDC...1,SET,179,-0.021737,-0.0021357,0.062662,0.63566,GSE17721_CTRL_VS_CPG_4H_BMDC_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...276,SET,23,-0.069267,-0.00245,0.19966,0.63567,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_TRANSPORT,0.99999
GSE27786_LIN_NEG_VS_CD4_TCEL...1,SET,181,-0.021018,-0.0020765,0.06057,0.6357,GSE27786_LIN_NEG_VS_CD4_TCELL_DN,0.99999
HP_RECURRENT_STREPTOCOCCAL_I...,SET,3,-0.16299,-0.0020832,0.46947,0.63577,HP_RECURRENT_STREPTOCOCCAL_INFECTIONS,0.99999
MODULE_123,SET,232,-0.020022,-0.0022364,0.057651,0.63582,MODULE_123,0.99999
BENPORATH_NOS_TARGETS,SET,160,-0.024039,-0.0022342,0.069178,0.63589,BENPORATH_NOS_TARGETS,0.99999
ELVIDGE_HIF2A_TARGETS_UP,SET,6,-0.12139,-0.0021941,0.34909,0.63598,ELVIDGE_HIF2A_TARGETS_UP,0.99999
REACTOME_SIGNALING_BY_FGFR1,SET,50,-0.042281,-0.0022034,0.12156,0.63601,REACTOME_SIGNALING_BY_FGFR1,0.99999
HP_CONGENITAL_HEMOLYTIC_ANEM...,SET,8,-0.10783,-0.0022504,0.30991,0.63606,HP_CONGENITAL_HEMOLYTIC_ANEMIA,0.99999
GOBP_SPLICEOSOMAL_COMPLEX_AS...,SET,68,-0.030646,-0.0018615,0.088064,0.63608,GOBP_SPLICEOSOMAL_COMPLEX_ASSEMBLY,0.99999
MIR539_5P,SET,341,-0.016437,-0.0022192,0.047184,0.63622,MIR539_5P,0.99999
GOBP_BONE_TRABECULA_MORPHOGE...,SET,14,-0.081528,-0.0022504,0.23402,0.63622,GOBP_BONE_TRABECULA_MORPHOGENESIS,0.99999
GOBP_INNER_EAR_MORPHOGENESIS,SET,98,-0.031413,-0.0022888,0.090155,0.63624,GOBP_INNER_EAR_MORPHOGENESIS,0.99999
PAX2_01,SET,49,-0.040281,-0.0020781,0.11558,0.63627,PAX2_01,0.99999
HP_ABNORMAL_INTESTINE_MORPHO...,SET,675,-0.011415,-0.002148,0.032748,0.63629,HP_ABNORMAL_INTESTINE_MORPHOLOGY,0.99999
GOBP_CAP_DEPENDENT_TRANSLATI...,SET,7,-0.08844,-0.0017265,0.2537,0.6363,GOBP_CAP_DEPENDENT_TRANSLATIONAL_INITIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...73,SET,52,-0.040246,-0.0021388,0.11545,0.6363,GOBP_NEGATIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.99999
MIR4476,SET,202,-0.020998,-0.0021903,0.060226,0.63632,MIR4476,0.99999
GOBP_CONVERGENT_EXTENSION,SET,15,-0.08168,-0.0023337,0.23422,0.63635,GOBP_CONVERGENT_EXTENSION,0.99999
HP_REDUCED_CIRCULATING_PROLA...,SET,20,-0.062101,-0.0020485,0.17809,0.63635,HP_REDUCED_CIRCULATING_PROLACTIN_CONCENTRATION,0.99999
MIR6839_5P,SET,88,-0.033235,-0.0022954,0.095273,0.6364,MIR6839_5P,0.99999
GSE9316_CD4_TCELL_BALBC_VS_T...2,SET,178,-0.021688,-0.002125,0.062144,0.63645,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_UP,0.99999
GSE15930_NAIVE_VS_72H_IN_VIT...1,SET,182,-0.021284,-0.0021085,0.060973,0.63648,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN,0.99999
MIR4703_3P,SET,37,-0.04819,-0.0021611,0.13793,0.63659,MIR4703_3P,0.99999
HP_DECREASED_CIRCULATING_COM...4,SET,3,-0.20168,-0.0025778,0.57728,0.63659,HP_DECREASED_CIRCULATING_COMPLEMENT_FACTOR_I_CONCENTRATION,0.99999
chr4q33,SET,5,-0.18646,-0.0030765,0.53344,0.63666,chr4q33,0.99999
GOMF_ENDODEOXYRIBONUCLEASE_A...,SET,11,-0.085762,-0.0020985,0.24531,0.63668,GOMF_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,0.99999
BURTON_ADIPOGENESIS_10,SET,26,-0.057251,-0.0021529,0.16375,0.63669,BURTON_ADIPOGENESIS_10,0.99999
GSE15930_STIM_VS_STIM_AND_IL...5,SET,174,-0.022305,-0.002161,0.06378,0.63672,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN,0.99999
RIEGE_DELTANP63_DIRECT_TARGE...,SET,130,-0.026096,-0.002188,0.074607,0.63674,RIEGE_DELTANP63_DIRECT_TARGETS_UP,0.99999
HP_ABNORMAL_QT_INTERVAL,SET,55,-0.041615,-0.0022742,0.11898,0.63674,HP_ABNORMAL_QT_INTERVAL,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...11,SET,5,-0.13431,-0.0022161,0.38399,0.63675,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3,0.99999
REACTOME_MET_ACTIVATES_PTPN11,SET,5,-0.12359,-0.0020392,0.35333,0.63675,REACTOME_MET_ACTIVATES_PTPN11,0.99999
SHETH_LIVER_CANCER_VS_TXNIP_...3,SET,69,-0.035425,-0.0021676,0.10126,0.63677,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,0.99999
GSE10239_NAIVE_VS_MEMORY_CD8...1,SET,181,-0.02147,-0.0021212,0.06136,0.63679,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.99999
REACTOME_COHESIN_LOADING_ONT...,SET,7,-0.11973,-0.0023373,0.34216,0.6368,REACTOME_COHESIN_LOADING_ONTO_CHROMATIN,0.99999
ZNF257_TARGET_GENES,SET,446,-0.013801,-0.0021247,0.039436,0.63681,ZNF257_TARGET_GENES,0.99999
GSE360_L_DONOVANI_VS_M_TUBER...4,SET,184,-0.022314,-0.0022226,0.063738,0.63686,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP,0.99999
BILD_SRC_ONCOGENIC_SIGNATURE,SET,55,-0.037285,-0.0020376,0.10645,0.63693,BILD_SRC_ONCOGENIC_SIGNATURE,0.99999
GOBP_CARDIAC_MUSCLE_CELL_FAT...,SET,7,-0.12858,-0.00251,0.36708,0.63693,GOBP_CARDIAC_MUSCLE_CELL_FATE_COMMITMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...669,SET,9,-0.085728,-0.0018975,0.24475,0.63693,GOBP_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,0.99999
REACTOME_POU5F1_OCT4_SOX2_NA...2,SET,9,-0.10917,-0.0024164,0.31153,0.63699,REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION,0.99999
HP_APLASTIC_HYPOPLASTIC_LACR...,SET,8,-0.11854,-0.0024739,0.33826,0.637,HP_APLASTIC_HYPOPLASTIC_LACRIMAL_GLANDS,0.99999
REACTOME_ASYMMETRIC_LOCALIZA...,SET,61,-0.03526,-0.002029,0.1006,0.63702,REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,0.99999
HP_ACRAL_BLISTERING,SET,9,-0.094445,-0.0020905,0.26931,0.63709,HP_ACRAL_BLISTERING,0.99999
HP_EROSION_OF_ORAL_MUCOSA,SET,89,-0.032377,-0.0022487,0.092304,0.63712,HP_EROSION_OF_ORAL_MUCOSA,0.99999
WP_TGFB_SMAD_SIGNALING,SET,11,-0.10437,-0.0025538,0.29748,0.63714,WP_TGFB_SMAD_SIGNALING,0.99999
GSE9509_LPS_VS_LPS_AND_IL10_...1,SET,178,-0.021092,-0.0020666,0.06012,0.63714,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_DN,0.99999
HP_GENERALIZED_CEREBRAL_ATRO...,SET,11,-0.086112,-0.0021071,0.24539,0.63718,HP_GENERALIZED_CEREBRAL_ATROPHY_HYPOPLASIA,0.99999
WP_15Q112_COPY_NUMBER_VARIAT...,SET,4,-0.14708,-0.0021706,0.41902,0.6372,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GOBP_SEQUESTERING_OF_METAL_I...,SET,9,-0.10087,-0.0022326,0.28738,0.6372,GOBP_SEQUESTERING_OF_METAL_ION,0.99999
GOCC_EQUATORIAL_MICROTUBULE_...,SET,4,-0.14708,-0.0021706,0.41902,0.6372,GOCC_EQUATORIAL_MICROTUBULE_ORGANIZING_CENTER,0.99999
HP_INCREASED_PULMONARY_VASCU...,SET,13,-0.093677,-0.0024917,0.26685,0.63722,HP_INCREASED_PULMONARY_VASCULAR_RESISTANCE,0.99999
GSE39820_IL1B_IL6_VS_IL1B_IL...1,SET,179,-0.022388,-0.0021997,0.063776,0.63722,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN,0.99999
GOBP_GRANULOCYTE_ACTIVATION,SET,45,-0.043848,-0.0021681,0.12485,0.63728,GOBP_GRANULOCYTE_ACTIVATION,0.99999
GSE34217_MIR17_92_OVEREXPRES...2,SET,122,-0.027012,-0.0021945,0.076868,0.63736,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_UP,0.99999
MODULE_105,SET,188,-0.021054,-0.0021195,0.059895,0.6374,MODULE_105,0.99999
GSE38696_LIGHT_ZONE_VS_DARK_...2,SET,165,-0.021923,-0.0020689,0.062335,0.63747,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,0.99999
GOBP_REGULATION_OF_STEROID_M...,SET,90,-0.03282,-0.0022921,0.093305,0.63748,GOBP_REGULATION_OF_STEROID_METABOLIC_PROCESS,0.99999
DESCARTES_FETAL_LUNG_NEUROEN...,SET,76,-0.037238,-0.0023908,0.10586,0.6375,DESCARTES_FETAL_LUNG_NEUROENDOCRINE_CELLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...390,SET,27,-0.057774,-0.0022138,0.1642,0.63752,GOBP_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,0.99999
GOBP_TRANSITION_BETWEEN_FAST...,SET,7,-0.10608,-0.0020709,0.30148,0.63753,GOBP_TRANSITION_BETWEEN_FAST_AND_SLOW_FIBER,0.99999
HP_PROMINENT_CRUS_OF_HELIX,SET,5,-0.13983,-0.0023071,0.39739,0.63753,HP_PROMINENT_CRUS_OF_HELIX,0.99999
GOMF_DNA_ENDONUCLEASE_ACTIVI...2,SET,9,-0.095386,-0.0021113,0.27105,0.63755,GOMF_DNA_ENDONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS,0.99999
GOBP_PROTOPORPHYRINOGEN_IX_M...,SET,10,-0.0878,-0.0020485,0.24944,0.63757,GOBP_PROTOPORPHYRINOGEN_IX_METABOLIC_PROCESS,0.99999
GOBP_ADULT_LOCOMOTORY_BEHAVI...,SET,79,-0.034091,-0.0022314,0.096852,0.63758,GOBP_ADULT_LOCOMOTORY_BEHAVIOR,0.99999
GOBP_AXIS_ELONGATION,SET,28,-0.06338,-0.0024731,0.18006,0.63758,GOBP_AXIS_ELONGATION,0.99999
CHESLER_BRAIN_QTL_TRANS,SET,6,-0.12714,-0.0022979,0.3611,0.63761,CHESLER_BRAIN_QTL_TRANS,0.99999
BIOCARTA_PML_PATHWAY,SET,17,-0.06961,-0.0021171,0.19769,0.63762,BIOCARTA_PML_PATHWAY,0.99999
GOBP_BRADYKININ_CATABOLIC_PR...,SET,7,-0.1199,-0.0023407,0.3405,0.63763,GOBP_BRADYKININ_CATABOLIC_PROCESS,0.99999
HP_ABNORMAL_CIRCULATING_ALDO...2,SET,10,-0.098832,-0.0023058,0.28045,0.63773,HP_ABNORMAL_CIRCULATING_ALDOSTERONE,0.99999
HP_ABNORMALITY_OF_THE_GLENOI...,SET,6,-0.12802,-0.0023138,0.36316,0.63777,HP_ABNORMALITY_OF_THE_GLENOID_FOSSA,0.99999
HP_IMPAIRED_MASTICATION,SET,41,-0.047919,-0.0022619,0.1359,0.6378,HP_IMPAIRED_MASTICATION,0.99999
HP_CONFUSIONAL_AROUSAL,SET,9,-0.10572,-0.0023401,0.29977,0.63784,HP_CONFUSIONAL_AROUSAL,0.99999
MIR4784,SET,138,-0.025586,-0.0022098,0.072536,0.63785,MIR4784,0.99999
GSE26290_CTRL_VS_AKT_INHIBIT...2,SET,174,-0.023725,-0.0022986,0.067249,0.63788,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,0.99999
HP_PULMONARY_FIBROSIS,SET,68,-0.035394,-0.00215,0.1003,0.6379,HP_PULMONARY_FIBROSIS,0.99999
REACTOME_APC_C_CDC20_MEDIATE...,SET,22,-0.059028,-0.002042,0.16724,0.63793,REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,0.99999
SKP2_TARGET_GENES,SET,50,-0.040674,-0.0021196,0.11525,0.63793,SKP2_TARGET_GENES,0.99999
BECKER_TAMOXIFEN_RESISTANCE_...2,SET,51,-0.042663,-0.0022453,0.12084,0.63797,BECKER_TAMOXIFEN_RESISTANCE_UP,0.99999
HP_CHILDHOOD_ONSET,SET,774,-0.010823,-0.0021749,0.030648,0.63801,HP_CHILDHOOD_ONSET,0.99999
GOCC_NF_KAPPAB_COMPLEX,SET,4,-0.15307,-0.0022591,0.43324,0.63807,GOCC_NF_KAPPAB_COMPLEX,0.99999
HP_ABNORMAL_CIRCULATING_PROT...1,SET,101,-0.029068,-0.00215,0.082271,0.63808,HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_CONCENTRATION,0.99999
TAKAYAMA_BOUND_BY_AR,SET,10,-0.096099,-0.0022421,0.27196,0.63809,TAKAYAMA_BOUND_BY_AR,0.99999
GSE23308_WT_VS_MINERALCORTIC...1,SET,174,-0.022408,-0.002171,0.063401,0.63811,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_DN,0.99999
HP_RETINAL_PIGMENT_EPITHELIA...1,SET,36,-0.046712,-0.0020664,0.13209,0.63819,HP_RETINAL_PIGMENT_EPITHELIAL_ATROPHY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...679,SET,22,-0.062627,-0.0021665,0.17707,0.63821,GOBP_NEGATIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_INCREASED_NUMBER_OF_SKIN_...,SET,6,-0.10918,-0.0019732,0.30848,0.63829,HP_INCREASED_NUMBER_OF_SKIN_FOLDS,0.99999
HP_ABNORMALITY_OF_PRIMARY_TE...,SET,70,-0.035356,-0.0021789,0.099889,0.63831,HP_ABNORMALITY_OF_PRIMARY_TEETH,0.99999
GSE10240_CTRL_VS_IL17_STIM_P...2,SET,177,-0.022625,-0.0022107,0.063919,0.63831,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.99999
HP_ABNORMAL_TEMPORAL_BONE_MO...,SET,4,-0.18522,-0.0027336,0.52327,0.63832,HP_ABNORMAL_TEMPORAL_BONE_MORPHOLOGY,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...3,SET,5,-0.14487,-0.0023904,0.40915,0.63836,HP_APLASIA_HYPOPLASIA_OF_THE_2ND_METACARPAL,0.99999
MIR4680_3P,SET,228,-0.019859,-0.0021992,0.056069,0.6384,MIR4680_3P,0.99999
MIR3667_5P,SET,53,-0.041891,-0.0022474,0.11826,0.63841,MIR3667_5P,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...5,SET,185,-0.021618,-0.002159,0.061022,0.63843,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN,0.99999
MEBARKI_HCC_PROGENITOR_WNT_U...4,SET,21,-0.066402,-0.0022444,0.18735,0.63849,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...1,SET,10,-0.093906,-0.0021909,0.2647,0.63862,GOBP_CELLULAR_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,0.99999
GOCC_NSL_COMPLEX,SET,9,-0.087415,-0.0019349,0.2464,0.63862,GOCC_NSL_COMPLEX,0.99999
GOBP_ERBB_SIGNALING_PATHWAY,SET,121,-0.026745,-0.002164,0.075379,0.63863,GOBP_ERBB_SIGNALING_PATHWAY,0.99999
HP_CHRONIC_CSF_LYMPHOCYTOSIS,SET,8,-0.09609,-0.0020053,0.27082,0.63863,HP_CHRONIC_CSF_LYMPHOCYTOSIS,0.99999
HP_OPTIC_DISC_HYPOPLASIA,SET,16,-0.072269,-0.0021324,0.20357,0.63871,HP_OPTIC_DISC_HYPOPLASIA,0.99999
GOBP_REGULATION_OF_JUN_KINAS...,SET,39,-0.04689,-0.0021588,0.13205,0.63874,GOBP_REGULATION_OF_JUN_KINASE_ACTIVITY,0.99999
GSE30962_PRIMARY_VS_SECONDAR...3,SET,176,-0.023671,-0.0023064,0.066651,0.63876,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN,0.99999
CHAMP1_TARGET_GENES,SET,145,-0.02432,-0.0021527,0.068449,0.63882,CHAMP1_TARGET_GENES,0.99999
GOCC_SMAD_PROTEIN_COMPLEX,SET,9,-0.10563,-0.002338,0.29726,0.63883,GOCC_SMAD_PROTEIN_COMPLEX,0.99999
GOBP_BONE_MINERALIZATION_INV...,SET,11,-0.094921,-0.0023226,0.26704,0.63887,GOBP_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION,0.99999
GSE32034_LY6C_HIGH_VS_LOW_RO...1,SET,182,-0.022668,-0.0022456,0.063772,0.63887,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_DN,0.99999
GOBP_REGULATION_OF_GLUCONEOG...,SET,43,-0.04456,-0.0021539,0.12534,0.6389,GOBP_REGULATION_OF_GLUCONEOGENESIS,0.99999
BIOCARTA_ACTINY_PATHWAY,SET,11,-0.075747,-0.0018535,0.21296,0.63896,BIOCARTA_ACTINY_PATHWAY,0.99999
TRAVAGLINI_LUNG_CD8_NAIVE_T_...,SET,131,-0.027669,-0.0023288,0.077781,0.63898,TRAVAGLINI_LUNG_CD8_NAIVE_T_CELL,0.99999
REACTOME_NONCANONICAL_ACTIVA...,SET,7,-0.1121,-0.0021883,0.31508,0.63899,REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3,0.99999
GOCC_CYTOPLASMIC_SIDE_OF_LYS...,SET,9,-0.095418,-0.002112,0.26798,0.6391,GOCC_CYTOPLASMIC_SIDE_OF_LYSOSOMAL_MEMBRANE,0.99999
HP_DELAYED_MENARCHE,SET,23,-0.056119,-0.001985,0.15759,0.63912,HP_DELAYED_MENARCHE,0.99999
HP_SCHISTOCYTOSIS,SET,10,-0.093033,-0.0021705,0.26115,0.63917,HP_SCHISTOCYTOSIS,0.99999
HP_REDUCED_RENAL_CORTICOMEDU...,SET,14,-0.076633,-0.0021153,0.21508,0.63919,HP_REDUCED_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,0.99999
WP_ERBB_SIGNALING,SET,86,-0.033024,-0.0022548,0.092672,0.63921,WP_ERBB_SIGNALING,0.99999
CIC_TARGET_GENES,SET,376,-0.015336,-0.002172,0.043033,0.63922,CIC_TARGET_GENES,0.99999
GOBP_QUATERNARY_AMMONIUM_GRO...,SET,16,-0.08471,-0.0024995,0.23752,0.63932,GOBP_QUATERNARY_AMMONIUM_GROUP_TRANSPORT,0.99999
KASLER_HDAC7_TARGETS_2_UP,SET,5,-0.17414,-0.0028732,0.48812,0.63936,KASLER_HDAC7_TARGETS_2_UP,0.99999
REACTOME_ALPHA_OXIDATION_OF_...,SET,6,-0.11159,-0.0020168,0.31279,0.63936,REACTOME_ALPHA_OXIDATION_OF_PHYTANATE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...570,SET,7,-0.096296,-0.0018799,0.2698,0.63942,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,0.99999
GOBP_FATTY_ACID_TRANSMEMBRAN...,SET,19,-0.065701,-0.0021124,0.18407,0.63943,GOBP_FATTY_ACID_TRANSMEMBRANE_TRANSPORT,0.99999
WP_NAD_METABOLISM_IN_ONCOGEN...,SET,22,-0.061475,-0.0021267,0.1722,0.63946,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,0.99999
MODULE_333,SET,27,-0.054229,-0.002078,0.1518,0.63954,MODULE_333,0.99999
GOBP_SPERMATID_DIFFERENTIATI...,SET,190,-0.021401,-0.0021657,0.059897,0.63956,GOBP_SPERMATID_DIFFERENTIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...4,SET,8,-0.094064,-0.001963,0.26325,0.63957,GOBP_NEGATIVE_REGULATION_OF_ACTIN_NUCLEATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...525,SET,8,-0.11547,-0.0024098,0.32307,0.63961,GOBP_POSITIVE_REGULATION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_SKELETAL_...7,SET,4,-0.15855,-0.0023399,0.44312,0.63975,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION_BY_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION,0.99999
HENDRICKS_SMARCA4_TARGETS_DN,SET,41,-0.051778,-0.002444,0.1447,0.63976,HENDRICKS_SMARCA4_TARGETS_DN,0.99999
GOBP_SPERM_MITOCHONDRIAL_SHE...,SET,6,-0.12845,-0.0023216,0.35889,0.63979,GOBP_SPERM_MITOCHONDRIAL_SHEATH_ASSEMBLY,0.99999
GSE7218_UNSTIM_VS_ANTIGEN_ST...4,SET,109,-0.02861,-0.0021978,0.079885,0.63988,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_UP,0.99999
LIU_OVARIAN_CANCER_TUMORS_AN...3,SET,74,-0.034362,-0.0021771,0.095886,0.63996,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP,0.99999
GOBP_REGULATION_OF_MEMBRANE_...1,SET,41,-0.051775,-0.0024439,0.14446,0.63998,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.99999
GSE22443_NAIVE_VS_ACT_AND_IL...1,SET,185,-0.022229,-0.00222,0.062018,0.63998,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN,0.99999
GSE32034_LY6C_HIGH_VS_LOW_MO...2,SET,181,-0.02319,-0.0022911,0.064691,0.64,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_UP,0.99999
HP_ABNORMAL_PROXIMAL_FEMORAL...,SET,8,-0.098722,-0.0020602,0.27535,0.64002,HP_ABNORMAL_PROXIMAL_FEMORAL_METAPHYSIS_MORPHOLOGY,0.99999
CAO_BLOOD_FLUZONE_AGE_05_14Y...4,SET,7,-0.11529,-0.0022507,0.32156,0.64003,CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_UP,0.99999
MIR7112_5P,SET,7,-0.10289,-0.0020086,0.28691,0.64006,MIR7112_5P,0.99999
HP_HYPERORALITY,SET,15,-0.078058,-0.0022302,0.21764,0.64007,HP_HYPERORALITY,0.99999
MIR101_2_5P,SET,6,-0.1149,-0.0020768,0.32036,0.64008,MIR101_2_5P,0.99999
GOBP_NEUROBLAST_MIGRATION,SET,6,-0.14096,-0.0025477,0.39295,0.6401,GOBP_NEUROBLAST_MIGRATION,0.99999
NABA_BASEMENT_MEMBRANES,SET,37,-0.05353,-0.0024006,0.14918,0.64014,NABA_BASEMENT_MEMBRANES,0.99999
GOBP_BEHAVIOR,SET,611,-0.012967,-0.0023257,0.036133,0.64015,GOBP_BEHAVIOR,0.99999
HP_BRUSHFIELD_SPOTS,SET,12,-0.082468,-0.0021076,0.22978,0.64016,HP_BRUSHFIELD_SPOTS,0.99999
GSE3039_CD4_TCELL_VS_B2_BCEL...1,SET,181,-0.022711,-0.0022437,0.063272,0.64018,GSE3039_CD4_TCELL_VS_B2_BCELL_DN,0.99999
GSE7852_THYMUS_VS_FAT_TREG_DN,SET,178,-0.02286,-0.0022398,0.063678,0.6402,GSE7852_THYMUS_VS_FAT_TREG_DN,0.99999
GOBP_PURINE_NUCLEOSIDE_BIOSY...,SET,9,-0.10891,-0.0024106,0.30328,0.64023,GOBP_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,0.99999
GOCC_NUCLEAR_CYCLIN_DEPENDEN...,SET,13,-0.065614,-0.0017453,0.18272,0.64024,GOCC_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,0.99999
GOBP_POSITIVE_REGULATION_OF_...336,SET,14,-0.086232,-0.0023802,0.24011,0.64025,GOBP_POSITIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,0.99999
HP_ABNORMAL_BREATH_SOUND,SET,112,-0.028142,-0.0021912,0.078352,0.64027,HP_ABNORMAL_BREATH_SOUND,0.99999
GSE9878_CTRL_VS_EBF_TRANSDUC...2,SET,189,-0.022038,-0.0022244,0.06133,0.64033,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP,0.99999
HP_HYPOPLASTIC_VERTEBRAL_BOD...,SET,17,-0.073382,-0.0022319,0.20419,0.64035,HP_HYPOPLASTIC_VERTEBRAL_BODIES,0.99999
MCM2_TARGET_GENES,SET,75,-0.033823,-0.0021573,0.094084,0.64039,MCM2_TARGET_GENES,0.99999
GOBP_ANTIBACTERIAL_PEPTIDE_P...,SET,10,-0.10701,-0.0024968,0.29756,0.64044,GOBP_ANTIBACTERIAL_PEPTIDE_PRODUCTION,0.99999
WEST_ADRENOCORTICAL_TUMOR_UP,SET,280,-0.017863,-0.002189,0.049666,0.64045,WEST_ADRENOCORTICAL_TUMOR_UP,0.99999
HP_PERIPHERAL_EDEMA,SET,12,-0.091652,-0.0023423,0.25482,0.64045,HP_PERIPHERAL_EDEMA,0.99999
MODULE_184,SET,28,-0.052709,-0.0020568,0.14652,0.64048,MODULE_184,0.99999
GOBP_EAR_DEVELOPMENT,SET,209,-0.02228,-0.0023635,0.061921,0.64051,GOBP_EAR_DEVELOPMENT,0.99999
GOBP_RESPONSE_TO_INACTIVITY,SET,12,-0.095003,-0.0024279,0.26402,0.64051,GOBP_RESPONSE_TO_INACTIVITY,0.99999
GOBP_REGULATION_OF_T_CELL_AC...1,SET,357,-0.017219,-0.0023775,0.047847,0.64053,GOBP_REGULATION_OF_T_CELL_ACTIVATION,0.99999
HP_MYOCLONIC_SPASMS,SET,29,-0.054863,-0.0021786,0.15239,0.64058,HP_MYOCLONIC_SPASMS,0.99999
GSE3691_IFN_PRODUCING_KILLER...1,SET,177,-0.022471,-0.0021956,0.062412,0.64059,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...192,SET,155,-0.027253,-0.0024934,0.075686,0.6406,GOBP_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_AT1...,SET,37,-0.052358,-0.002348,0.14537,0.64064,HE_LIM_SUN_FETAL_LUNG_C1_AT1_CELL,0.99999
MIR3134,SET,59,-0.039434,-0.0022318,0.10948,0.64065,MIR3134,0.99999
HP_FREQUENT_FALLS,SET,117,-0.027919,-0.0022215,0.077502,0.64066,HP_FREQUENT_FALLS,0.99999
HP_BROAD_PHALANGES_OF_THE_HA...,SET,94,-0.031564,-0.0022527,0.087556,0.64076,HP_BROAD_PHALANGES_OF_THE_HAND,0.99999
MIR6505_3P,SET,87,-0.03222,-0.0022126,0.089362,0.64078,MIR6505_3P,0.99999
GOBP_EYE_MORPHOGENESIS,SET,155,-0.026048,-0.0023831,0.07223,0.64081,GOBP_EYE_MORPHOGENESIS,0.99999
REACTOME_FRUCTOSE_METABOLISM,SET,7,-0.097099,-0.0018955,0.26919,0.64084,REACTOME_FRUCTOSE_METABOLISM,0.99999
GSE17721_LPS_VS_CPG_4H_BMDC_...1,SET,171,-0.022171,-0.0021297,0.061427,0.64093,GSE17721_LPS_VS_CPG_4H_BMDC_DN,0.99999
JAIN_NFKB_SIGNALING,SET,68,-0.034981,-0.0021249,0.096892,0.64096,JAIN_NFKB_SIGNALING,0.99999
GOBP_4_HYDROXYPROLINE_METABO...,SET,12,-0.074421,-0.0019019,0.20604,0.64102,GOBP_4_HYDROXYPROLINE_METABOLIC_PROCESS,0.99999
HP_FLATTENED_FEMORAL_HEAD,SET,6,-0.11153,-0.0020157,0.30875,0.64103,HP_FLATTENED_FEMORAL_HEAD,0.99999
HP_GENERALIZED_ONSET_MOTOR_S...,SET,158,-0.024381,-0.0022519,0.067483,0.64106,HP_GENERALIZED_ONSET_MOTOR_SEIZURE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...649,SET,118,-0.026784,-0.0021403,0.074105,0.64111,GOBP_NEGATIVE_REGULATION_OF_TRANSLATION,0.99999
GSE3720_UNSTIM_VS_PMA_STIM_V...3,SET,173,-0.02245,-0.0021688,0.06211,0.64111,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...2,SET,15,-0.090122,-0.0025749,0.24933,0.64112,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CIRCULATORY_RENIN_ANGIOTENSIN,0.99999
DACOSTA_UV_RESPONSE_VIA_ERCC...3,SET,808,-0.010924,-0.0022406,0.030203,0.6412,DACOSTA_UV_RESPONSE_VIA_ERCC3_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...327,SET,5,-0.14227,-0.0023475,0.39319,0.64126,GOBP_NEGATIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.99999
GOMF_MICROTUBULE_MINUS_END_B...,SET,12,-0.082976,-0.0021206,0.22926,0.6413,GOMF_MICROTUBULE_MINUS_END_BINDING,0.99999
GOBP_MITOTIC_CYTOKINETIC_PRO...,SET,31,-0.053247,-0.0021861,0.14706,0.64135,GOBP_MITOTIC_CYTOKINETIC_PROCESS,0.99999
HP_FLAT_OCCIPUT,SET,52,-0.040917,-0.0021744,0.11298,0.64138,HP_FLAT_OCCIPUT,0.99999
GSE17721_LPS_VS_PAM3CSK4_6H_...2,SET,186,-0.022405,-0.0022436,0.061866,0.64138,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP,0.99999
BECKER_TAMOXIFEN_RESISTANCE_...1,SET,49,-0.044639,-0.0023029,0.12323,0.64141,BECKER_TAMOXIFEN_RESISTANCE_DN,0.99999
HP_DECREASED_CIRCULATING_COP...,SET,6,-0.13315,-0.0024066,0.3675,0.64144,HP_DECREASED_CIRCULATING_COPPER_CONCENTRATION,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...4,SET,125,-0.027868,-0.0022915,0.076897,0.64147,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,0.99999
INGRAM_SHH_TARGETS_DN,SET,57,-0.041664,-0.0023178,0.11495,0.64149,INGRAM_SHH_TARGETS_DN,0.99999
GOBP_T_HELPER_2_CELL_CYTOKIN...,SET,13,-0.093935,-0.0024986,0.25912,0.64152,GOBP_T_HELPER_2_CELL_CYTOKINE_PRODUCTION,0.99999
TGANNYRGCA_TCF11MAFG_01,SET,269,-0.01908,-0.0022924,0.052623,0.64154,TGANNYRGCA_TCF11MAFG_01,0.99999
SIX1_TARGET_GENES,SET,292,-0.0185,-0.0023143,0.051007,0.64158,SIX1_TARGET_GENES,0.99999
HP_ERYTHROMELALGIA,SET,7,-0.1164,-0.0022724,0.32093,0.64158,HP_ERYTHROMELALGIA,0.99999
GSE28726_NAIVE_CD4_TCELL_VS_...4,SET,183,-0.021612,-0.0021468,0.059571,0.64162,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP,0.99999
REACTOME_NUCLEAR_PORE_COMPLE...,SET,34,-0.048861,-0.0021007,0.13464,0.64166,REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY,0.99999
GOBP_EPIDIDYMIS_DEVELOPMENT,SET,3,-0.20702,-0.002646,0.57036,0.64168,GOBP_EPIDIDYMIS_DEVELOPMENT,0.99999
HP_RECURRENT_SPONTANEOUS_ABO...,SET,11,-0.094318,-0.0023079,0.25978,0.64172,HP_RECURRENT_SPONTANEOUS_ABORTION,0.99999
GOMF_PROTEOGLYCAN_BINDING,SET,34,-0.058272,-0.0025052,0.16049,0.64173,GOMF_PROTEOGLYCAN_BINDING,0.99999
GOBP_MAINTENANCE_OF_LENS_TRA...,SET,7,-0.13559,-0.002647,0.37342,0.64174,GOBP_MAINTENANCE_OF_LENS_TRANSPARENCY,0.99999
HP_ABNORMAL_EXTERNAL_NOSE_MO...,SET,789,-0.010775,-0.0021851,0.029661,0.6418,HP_ABNORMAL_EXTERNAL_NOSE_MORPHOLOGY,0.99999
HP_GLOBOZOOSPERMIA,SET,6,-0.13906,-0.0025134,0.38281,0.6418,HP_GLOBOZOOSPERMIA,0.99999
GSE19923_HEB_KO_VS_HEB_AND_E...2,SET,177,-0.022763,-0.0022241,0.06262,0.64188,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.99999
GOBP_ATP_EXPORT,SET,6,-0.14739,-0.0026639,0.40532,0.64193,GOBP_ATP_EXPORT,0.99999
GOBP_REGULATION_OF_SALIVA_SE...,SET,7,-0.15332,-0.0029931,0.42158,0.64195,GOBP_REGULATION_OF_SALIVA_SECRETION,0.99999
GOBP_FACE_MORPHOGENESIS,SET,30,-0.057609,-0.0023268,0.15838,0.64197,GOBP_FACE_MORPHOGENESIS,0.99999
HP_ABNORMAL_LONG_BONE_MORPHO...,SET,686,-0.011808,-0.0022393,0.032462,0.64197,HP_ABNORMAL_LONG_BONE_MORPHOLOGY,0.99999
HALLMARK_COMPLEMENT,SET,191,-0.022967,-0.0023302,0.063132,0.64199,HALLMARK_COMPLEMENT,0.99999
GOMF_SPHINGOSINE_1_PHOSPHATE...1,SET,2,-0.22968,-0.002397,0.6313,0.642,GOMF_SPHINGOSINE_1_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.99999
GSE43955_10H_VS_60H_ACT_CD4_...3,SET,184,-0.023497,-0.0023403,0.064567,0.64204,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.99999
HP_FRONTAL_LOBE_DEMENTIA,SET,18,-0.068112,-0.0021316,0.18705,0.64212,HP_FRONTAL_LOBE_DEMENTIA,0.99999
HP_ABSENCE_OF_LYMPH_NODE_GER...,SET,5,-0.15466,-0.0025519,0.42444,0.64222,HP_ABSENCE_OF_LYMPH_NODE_GERMINAL_CENTER,0.99999
DAIRKEE_CANCER_PRONE_RESPONS...1,SET,50,-0.040443,-0.0021076,0.11093,0.64228,DAIRKEE_CANCER_PRONE_RESPONSE_BPA,0.99999
GSE10325_CD4_TCELL_VS_MYELOI...2,SET,179,-0.023071,-0.0022668,0.063285,0.64228,GSE10325_CD4_TCELL_VS_MYELOID_UP,0.99999
GOBP_CD4_POSITIVE_CD25_POSIT...,SET,7,-0.13484,-0.0026324,0.36979,0.64231,GOBP_CD4_POSITIVE_CD25_POSITIVE_ALPHA_BETA_REGULATORY_T_CELL_DIFFERENTIATION,0.99999
HP_HYPERPIGMENTATION_OF_THE_...2,SET,289,-0.01742,-0.0021682,0.047769,0.64232,HP_HYPERPIGMENTATION_OF_THE_SKIN,0.99999
GRAESSMANN_APOPTOSIS_BY_DOXO...1,SET,1594,-0.0078237,-0.0022029,0.021445,0.64238,GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN,0.99999
IGLV5_37_TARGET_GENES,SET,473,-0.01475,-0.0023367,0.040428,0.64239,IGLV5_37_TARGET_GENES,0.99999
MIR5589_3P,SET,149,-0.026129,-0.0023442,0.071594,0.64243,MIR5589_3P,0.99999
HP_NEONATAL_RESPIRATORY_DIST...,SET,136,-0.026165,-0.0022435,0.071694,0.64243,HP_NEONATAL_RESPIRATORY_DISTRESS,0.99999
MIR8060,SET,91,-0.031845,-0.0022363,0.087239,0.64246,MIR8060,0.99999
AIZARANI_LIVER_C39_EPCAM_POS...,SET,177,-0.024505,-0.0023943,0.067117,0.64248,AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4,0.99999
REACTOME_REGULATION_OF_MITF_...4,SET,41,-0.04774,-0.0022534,0.13075,0.64249,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,0.99999
GOBP_REGULATION_OF_SIGNAL_TR...,SET,95,-0.031344,-0.0022487,0.085846,0.64249,GOBP_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.99999
HALLMARK_XENOBIOTIC_METABOLI...,SET,192,-0.022754,-0.0023146,0.062274,0.64259,HALLMARK_XENOBIOTIC_METABOLISM,0.99999
GSE411_UNSTIM_VS_100MIN_IL6_...1,SET,186,-0.021778,-0.0021808,0.059597,0.6426,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN,0.99999
HP_PORENCEPHALIC_CYST,SET,30,-0.054076,-0.0021841,0.14798,0.64261,HP_PORENCEPHALIC_CYST,0.99999
GOBP_NEGATIVE_REGULATION_OF_...703,SET,5,-0.14657,-0.0024183,0.40104,0.64262,GOBP_NEGATIVE_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...612,SET,26,-0.064599,-0.0024292,0.1767,0.64266,GOBP_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,0.99999
HP_SIDEROBLASTIC_ANEMIA,SET,32,-0.050295,-0.0020978,0.13752,0.64272,HP_SIDEROBLASTIC_ANEMIA,0.99999
GSE22229_UNTREATED_VS_IMMUNO...2,SET,171,-0.023871,-0.0022929,0.065241,0.64277,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP,0.99999
GSE42021_TREG_PLN_VS_CD24HI_...1,SET,183,-0.021395,-0.0021253,0.058475,0.64277,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_DN,0.99999
REACTOME_SIGNALING_BY_NOTCH4,SET,77,-0.032268,-0.0020852,0.088161,0.64282,REACTOME_SIGNALING_BY_NOTCH4,0.99999
GOBP_REGULATION_OF_GROWTH_RA...,SET,5,-0.14147,-0.0023343,0.38642,0.64286,GOBP_REGULATION_OF_GROWTH_RATE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...87,SET,30,-0.059928,-0.0024204,0.16366,0.64288,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
GOBP_FLAVONOID_METABOLIC_PRO...,SET,11,-0.11701,-0.0028631,0.31935,0.64296,GOBP_FLAVONOID_METABOLIC_PROCESS,0.99999
REACTOME_G_ALPHA_12_13_SIGNA...,SET,74,-0.037887,-0.0024004,0.10337,0.64301,REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,0.99999
HP_PRURITUS,SET,140,-0.026495,-0.0023047,0.072257,0.64307,HP_PRURITUS,0.99999
GOBP_REGULATION_OF_CELLULAR_...2,SET,413,-0.015132,-0.0022438,0.041263,0.64308,GOBP_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.99999
HP_EEG_WITH_FOCAL_SHARP_WAVES,SET,10,-0.097802,-0.0022818,0.26662,0.64312,HP_EEG_WITH_FOCAL_SHARP_WAVES,0.99999
GOBP_REACTIVE_OXYGEN_SPECIES...2,SET,201,-0.022528,-0.0023441,0.061394,0.64317,GOBP_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_LABIA_MORPHOLOGY,SET,72,-0.03893,-0.002433,0.10608,0.64319,HP_ABNORMAL_LABIA_MORPHOLOGY,0.99999
MIR34A_5P,SET,283,-0.017964,-0.002213,0.04894,0.64321,MIR34A_5P,0.99999
GOMF_TRANSMEMBRANE_TRANSPORT...,SET,125,-0.028713,-0.002361,0.078192,0.64327,GOMF_TRANSMEMBRANE_TRANSPORTER_BINDING,0.99999
GOBP_ANDROGEN_RECEPTOR_SIGNA...,SET,43,-0.045124,-0.0021811,0.12283,0.64332,GOBP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_LOCOMOTOR_RHYTHM,SET,16,-0.082158,-0.0024242,0.22364,0.64333,GOBP_LOCOMOTOR_RHYTHM,0.99999
HP_ANISOPOIKILOCYTOSIS,SET,9,-0.11179,-0.0024744,0.30409,0.64342,HP_ANISOPOIKILOCYTOSIS,0.99999
MIR6785_5P,SET,469,-0.01444,-0.0022782,0.039271,0.64345,MIR6785_5P,0.99999
CTACTAG_MIR325,SET,13,-0.080124,-0.0021312,0.21771,0.64357,CTACTAG_MIR325,0.99999
GOBP_REGULATION_OF_URINE_VOL...,SET,19,-0.076573,-0.0024619,0.20805,0.64358,GOBP_REGULATION_OF_URINE_VOLUME,0.99999
NFE2L2.V2,SET,396,-0.016701,-0.0024261,0.045376,0.64358,NFE2L2.V2,0.99999
GSE6674_ANTI_IGM_VS_ANTI_IGM...2,SET,183,-0.02237,-0.0022221,0.060766,0.64361,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,0.99999
MIR6715B_5P,SET,200,-0.02199,-0.0022826,0.059725,0.64363,MIR6715B_5P,0.99999
GOBP_REGULATION_OF_CELL_ADHE...1,SET,738,-0.012119,-0.0023804,0.032912,0.64365,GOBP_REGULATION_OF_CELL_ADHESION,0.99999
HP_JERKY_HEAD_MOVEMENTS,SET,11,-0.10322,-0.0025256,0.28026,0.64367,HP_JERKY_HEAD_MOVEMENTS,0.99999
HP_PHOTOSENSITIVE_TONIC_CLON...,SET,12,-0.099353,-0.0025391,0.26976,0.64367,HP_PHOTOSENSITIVE_TONIC_CLONIC_SEIZURE,0.99999
GSE11961_MARGINAL_ZONE_BCELL...2,SET,179,-0.02178,-0.00214,0.059138,0.64367,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.99999
GOMF_ACETYLGLUCOSAMINYLTRANS...,SET,40,-0.054437,-0.0025381,0.14778,0.6437,GOMF_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,0.99999
GOCC_BASEMENT_MEMBRANE,SET,85,-0.035056,-0.0023797,0.095156,0.64371,GOCC_BASEMENT_MEMBRANE,0.99999
GOBP_AMINE_CATABOLIC_PROCESS,SET,14,-0.09399,-0.0025944,0.25507,0.64374,GOBP_AMINE_CATABOLIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_ACTIV...3,SET,8,-0.11585,-0.0024176,0.31438,0.64375,KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY,0.99999
HP_IMPAIRED_OCULAR_ADDUCTION,SET,9,-0.10622,-0.002351,0.28803,0.64385,HP_IMPAIRED_OCULAR_ADDUCTION,0.99999
GSE20727_CTRL_VS_ROS_INH_AND...2,SET,167,-0.023647,-0.002245,0.064069,0.64397,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.99999
MIR4716_5P,SET,107,-0.029653,-0.0022571,0.080242,0.64414,MIR4716_5P,0.99999
AIZARANI_LIVER_C31_KUPFFER_C...,SET,107,-0.030431,-0.0023163,0.082345,0.64414,AIZARANI_LIVER_C31_KUPFFER_CELLS_5,0.99999
WP_MITOCHONDRIAL_FATTY_ACID_...1,SET,18,-0.070028,-0.0021915,0.18948,0.64415,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,0.99999
HP_ABNORMAL_DISTAL_PHALANX_M...,SET,146,-0.026159,-0.0023234,0.070769,0.64417,HP_ABNORMAL_DISTAL_PHALANX_MORPHOLOGY_OF_FINGER,0.99999
GSE11864_CSF1_VS_CSF1_IFNG_P...2,SET,167,-0.022745,-0.0021593,0.061534,0.64417,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.99999
GOMF_QUATERNARY_AMMONIUM_GRO...2,SET,13,-0.099485,-0.0026462,0.26912,0.64418,GOMF_QUATERNARY_AMMONIUM_GROUP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE32901_TH1_VS_TH17_ENRICHE...1,SET,142,-0.02587,-0.0022663,0.069984,0.64418,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN,0.99999
NFY_C,SET,212,-0.021825,-0.0023316,0.059029,0.64421,NFY_C,0.99999
GSE17721_0.5H_VS_24H_CPG_BMD...1,SET,188,-0.023678,-0.0023837,0.064012,0.64427,GSE17721_0.5H_VS_24H_CPG_BMDC_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...43,SET,11,-0.080257,-0.0019638,0.21687,0.64433,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_III,0.99999
HP_HORIZONTAL_EYEBROW,SET,32,-0.055025,-0.0022951,0.14869,0.64433,HP_HORIZONTAL_EYEBROW,0.99999
GOBP_EMBRYO_IMPLANTATION,SET,50,-0.045242,-0.0023577,0.12214,0.64446,GOBP_EMBRYO_IMPLANTATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...674,SET,85,-0.034716,-0.0023566,0.093724,0.64446,GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,0.99999
MIR6857_5P,SET,72,-0.035742,-0.0022338,0.096407,0.64458,MIR6857_5P,0.99999
HP_NONPROGRESSIVE_CEREBELLAR...,SET,8,-0.11818,-0.0024663,0.31877,0.64458,HP_NONPROGRESSIVE_CEREBELLAR_ATAXIA,0.99999
MIR6508_5P,SET,300,-0.017894,-0.0022686,0.048265,0.64459,MIR6508_5P,0.99999
GOBP_CRISTAE_FORMATION,SET,15,-0.082341,-0.0023525,0.22206,0.64461,GOBP_CRISTAE_FORMATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...175,SET,6,-0.14327,-0.0025894,0.38635,0.64461,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,0.99999
HP_ABNORMALITY_OF_THE_EXTRAO...,SET,11,-0.079542,-0.0019463,0.21442,0.64467,HP_ABNORMALITY_OF_THE_EXTRAOCULAR_MUSCLES,0.99999
MIR4694_3P,SET,281,-0.019088,-0.0023432,0.05145,0.64468,MIR4694_3P,0.99999
GOBP_ASCENDING_AORTA_DEVELOP...,SET,5,-0.1598,-0.0026366,0.43072,0.64468,GOBP_ASCENDING_AORTA_DEVELOPMENT,0.99999
GSE17721_0.5H_VS_4H_PAM3CSK4...2,SET,181,-0.023217,-0.0022938,0.062557,0.64473,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_UP,0.99999
MODULE_164,SET,58,-0.042703,-0.0023963,0.11504,0.64475,MODULE_164,0.99999
RFX7_TARGET_GENES,SET,402,-0.015562,-0.0022773,0.041897,0.64484,RFX7_TARGET_GENES,0.99999
GOBP_REGULATION_OF_INTERLEUK...1,SET,9,-0.099756,-0.002208,0.26858,0.64484,GOBP_REGULATION_OF_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,0.99999
MIR3945,SET,34,-0.052171,-0.002243,0.14041,0.64489,MIR3945,0.99999
REACTOME_RIPK1_MEDIATED_REGU...,SET,28,-0.055864,-0.0021799,0.15034,0.6449,REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS,0.99999
GOBP_RENAL_SYSTEM_VASCULATUR...2,SET,8,-0.12691,-0.0026485,0.34151,0.64491,GOBP_RENAL_SYSTEM_VASCULATURE_MORPHOGENESIS,0.99999
GSE24972_MARGINAL_ZONE_BCELL...4,SET,171,-0.023804,-0.0022865,0.064042,0.64494,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP,0.99999
GSE27241_WT_VS_RORGT_KO_TH17...1,SET,152,-0.023801,-0.0021566,0.06403,0.64495,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_DN,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...11,SET,48,-0.04853,-0.0024781,0.13039,0.64512,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_1,0.99999
MIR6812_5P,SET,62,-0.038338,-0.0022241,0.103,0.64513,MIR6812_5P,0.99999
GOMF_INSULIN_RECEPTOR_SUBSTR...,SET,13,-0.087812,-0.0023357,0.23591,0.64514,GOMF_INSULIN_RECEPTOR_SUBSTRATE_BINDING,0.99999
GSE10463_CD40L_AND_VA347_VS_...1,SET,147,-0.025556,-0.0022775,0.06865,0.64515,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN,0.99999
HP_MARCUS_GUNN_JAW_WINKING_S...,SET,10,-0.106,-0.0024731,0.28473,0.64516,HP_MARCUS_GUNN_JAW_WINKING_SYNKINESIS,0.99999
GOMF_LEUCINE_ZIPPER_DOMAIN_B...,SET,10,-0.10596,-0.0024721,0.28459,0.64517,GOMF_LEUCINE_ZIPPER_DOMAIN_BINDING,0.99999
HP_SKIN_RASH,SET,147,-0.026671,-0.0023769,0.071614,0.64521,HP_SKIN_RASH,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...1,SET,185,-0.022491,-0.0022462,0.060387,0.64522,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN,0.99999
PID_RETINOIC_ACID_PATHWAY,SET,30,-0.05666,-0.0022884,0.1521,0.64524,PID_RETINOIC_ACID_PATHWAY,0.99999
GOMF_P_TYPE_POTASSIUM_TRANSM...,SET,8,-0.12684,-0.0026471,0.34046,0.64526,GOMF_P_TYPE_POTASSIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
CERVERA_SDHB_TARGETS_1_DN,SET,34,-0.056454,-0.0024271,0.15149,0.6453,CERVERA_SDHB_TARGETS_1_DN,0.99999
GOBP_REGULATION_OF_T_CELL_EX...,SET,5,-0.14299,-0.0023593,0.38368,0.64531,GOBP_REGULATION_OF_T_CELL_EXTRAVASATION,0.99999
HOWLIN_CITED1_TARGETS_1_UP,SET,31,-0.058759,-0.0024123,0.15765,0.64532,HOWLIN_CITED1_TARGETS_1_UP,0.99999
MIR130A_3P,SET,356,-0.016865,-0.0023254,0.045239,0.64534,MIR130A_3P,0.99999
GOBP_SPLICEOSOMAL_TRI_SNRNP_...,SET,15,-0.066731,-0.0019065,0.17899,0.64535,GOBP_SPLICEOSOMAL_TRI_SNRNP_COMPLEX_ASSEMBLY,0.99999
GOBP_GALACTOSE_METABOLIC_PRO...,SET,9,-0.098909,-0.0021893,0.26526,0.64538,GOBP_GALACTOSE_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...577,SET,23,-0.058424,-0.0020665,0.15668,0.64538,GOBP_NEGATIVE_REGULATION_OF_RNA_SPLICING,0.99999
MIR503_5P,SET,95,-0.032656,-0.0023429,0.087572,0.64539,MIR503_5P,0.99999
HP_NEOPLASM_OF_THE_BREAST,SET,95,-0.03088,-0.0022155,0.082811,0.64539,HP_NEOPLASM_OF_THE_BREAST,0.99999
HP_ALVEOLAR_CELL_CARCINOMA,SET,17,-0.075551,-0.0022978,0.20253,0.64544,HP_ALVEOLAR_CELL_CARCINOMA,0.99999
CEBPA_01,SET,223,-0.021917,-0.0024007,0.058724,0.64551,CEBPA_01,0.99999
GSE20500_RETINOIC_ACID_VS_RA...1,SET,175,-0.024444,-0.002375,0.065492,0.64551,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...10,SET,175,-0.022851,-0.0022203,0.061227,0.64551,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,0.99999
MIR92B_5P,SET,8,-0.10405,-0.0021713,0.27872,0.64554,MIR92B_5P,0.99999
GOBP_PRONEPHROS_DEVELOPMENT,SET,9,-0.1046,-0.0023152,0.27997,0.64565,GOBP_PRONEPHROS_DEVELOPMENT,0.99999
GSE37534_PIOGLITAZONE_VS_ROS...2,SET,174,-0.022042,-0.0021355,0.058997,0.64565,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,0.99999
MIR342_3P,SET,111,-0.029253,-0.0022676,0.078293,0.64566,MIR342_3P,0.99999
HP_DECREASED_SERUM_ZINC,SET,4,-0.13489,-0.0019907,0.36096,0.64568,HP_DECREASED_SERUM_ZINC,0.99999
GOBP_POSITIVE_REGULATION_OF_...107,SET,15,-0.080803,-0.0023086,0.21614,0.64574,GOBP_POSITIVE_REGULATION_OF_CELLULAR_EXTRAVASATION,0.99999
GOBP_DEOXYRIBONUCLEOTIDE_BIO...,SET,14,-0.08301,-0.0022913,0.22189,0.64584,GOBP_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
FAN_EMBRYONIC_CTX_MICROGLIA_3,SET,19,-0.081878,-0.0026325,0.21866,0.64596,FAN_EMBRYONIC_CTX_MICROGLIA_3,0.99999
GSE45365_CD8A_DC_VS_CD11B_DC...1,SET,173,-0.023944,-0.0023132,0.063944,0.64597,GSE45365_CD8A_DC_VS_CD11B_DC_DN,0.99999
HP_ABNORMAL_CIRCULATING_LIPI...,SET,288,-0.018938,-0.0023532,0.05057,0.64598,HP_ABNORMAL_CIRCULATING_LIPID_CONCENTRATION,0.99999
HP_EPIDERMAL_NEVUS,SET,11,-0.085788,-0.0020992,0.22907,0.64599,HP_EPIDERMAL_NEVUS,0.99999
GSE17301_ACD3_ACD28_VS_ACD3_...2,SET,170,-0.023315,-0.002233,0.062236,0.64603,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP,0.99999
HP_ABNORMAL_VENA_CAVA_MORPHO...,SET,68,-0.037213,-0.0022604,0.099307,0.64606,HP_ABNORMAL_VENA_CAVA_MORPHOLOGY,0.99999
GSE10273_LOW_IL7_VS_HIGH_IL7...1,SET,178,-0.022804,-0.0022344,0.06082,0.64615,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...5,SET,177,-0.022496,-0.0021981,0.059974,0.6462,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_DN,0.99999
HP_ABNORMAL_CALVARIA_MORPHOL...,SET,859,-0.010805,-0.0022818,0.028806,0.64621,HP_ABNORMAL_CALVARIA_MORPHOLOGY,0.99999
REACTOME_MOLYBDENUM_COFACTOR...,SET,6,-0.14679,-0.0026531,0.39093,0.64635,REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS,0.99999
GOBP_PROSTHETIC_GROUP_METABO...,SET,6,-0.14679,-0.0026531,0.39093,0.64635,GOBP_PROSTHETIC_GROUP_METABOLIC_PROCESS,0.99999
NUYTTEN_EZH2_TARGETS_UP,SET,942,-0.010829,-0.0023892,0.028839,0.64636,NUYTTEN_EZH2_TARGETS_UP,0.99999
GSE15735_CTRL_VS_HDAC_INHIBI...4,SET,177,-0.024497,-0.0023936,0.065231,0.64637,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP,0.99999
MIR4768_5P,SET,302,-0.018498,-0.0023528,0.049228,0.64645,MIR4768_5P,0.99999
HP_BROAD_RIBS,SET,24,-0.06788,-0.0024525,0.18065,0.64645,HP_BROAD_RIBS,0.99999
NR5A1_TARGET_GENES,SET,11,-0.094444,-0.002311,0.25132,0.64646,NR5A1_TARGET_GENES,0.99999
HP_GASTROSTOMY_TUBE_FEEDING_...,SET,93,-0.031117,-0.002209,0.082791,0.64648,HP_GASTROSTOMY_TUBE_FEEDING_IN_INFANCY,0.99999
HAHTOLA_CTCL_CUTANEOUS,SET,21,-0.064403,-0.0021768,0.17132,0.64651,HAHTOLA_CTCL_CUTANEOUS,0.99999
GOCC_PHOTORECEPTOR_CONNECTIN...,SET,37,-0.050262,-0.002254,0.13367,0.64654,GOCC_PHOTORECEPTOR_CONNECTING_CILIUM,0.99999
WILLIAMS_ESR2_TARGETS_DN,SET,10,-0.10815,-0.0025232,0.28756,0.64657,WILLIAMS_ESR2_TARGETS_DN,0.99999
HP_INCREASED_BODY_MASS_INDEX,SET,4,-0.15639,-0.0023081,0.41584,0.64657,HP_INCREASED_BODY_MASS_INDEX,0.99999
GRAHAM_NORMAL_QUIESCENT_VS_N...1,SET,84,-0.032701,-0.0022068,0.086922,0.64662,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,0.99999
GOCC_CYTOLYTIC_GRANULE,SET,14,-0.097723,-0.0026974,0.25973,0.64663,GOCC_CYTOLYTIC_GRANULE,0.99999
GSE7348_UNSTIM_VS_TOLERIZED_...1,SET,144,-0.026302,-0.0023201,0.069839,0.64677,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,0.99999
chr1q25,SET,73,-0.078261,-0.0049249,0.20775,0.6468,chr1q25,0.99999
GOBP_RNA_SPLICING_VIA_ENDONU...,SET,13,-0.091537,-0.0024348,0.24298,0.64681,GOBP_RNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...785,SET,772,-0.011876,-0.0023835,0.031522,0.64682,GOBP_POSITIVE_REGULATION_OF_TRANSPORT,0.99999
HP_ABNORMAL_SHAPE_OF_THE_PAL...,SET,51,-0.043436,-0.002286,0.11528,0.64683,HP_ABNORMAL_SHAPE_OF_THE_PALPEBRAL_FISSURE,0.99999
GOCC_ENDOLYSOSOME,SET,26,-0.061238,-0.0023028,0.1625,0.64685,GOCC_ENDOLYSOSOME,0.99999
GOCC_COLLAGEN_TRIMER,SET,83,-0.039314,-0.0026373,0.10432,0.64686,GOCC_COLLAGEN_TRIMER,0.99999
GSE41867_DAY6_EFFECTOR_VS_DA...2,SET,185,-0.023551,-0.002352,0.062482,0.64688,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,0.99999
HP_SICK_SINUS_SYNDROME,SET,27,-0.063982,-0.0024517,0.16971,0.64692,HP_SICK_SINUS_SYNDROME,0.99999
GOMF_LIPID_TRANSPORTER_ACTIV...,SET,156,-0.026557,-0.0024375,0.070424,0.64695,GOMF_LIPID_TRANSPORTER_ACTIVITY,0.99999
HP_STROKE_LIKE_EPISODE,SET,12,-0.09091,-0.0023233,0.24102,0.64698,HP_STROKE_LIKE_EPISODE,0.99999
GSE5589_LPS_VS_LPS_AND_IL6_S...1,SET,180,-0.02289,-0.0022552,0.060677,0.647,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,0.99999
REACTOME_CREB1_PHOSPHORYLATI...1,SET,25,-0.06729,-0.0024813,0.17831,0.64705,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING,0.99999
GOBP_REGULATION_OF_ATTACHMEN...2,SET,22,-0.063761,-0.0022058,0.16896,0.64705,GOBP_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.99999
GOBP_MITOCHONDRIAL_FUSION,SET,30,-0.056054,-0.0022639,0.1485,0.64708,GOBP_MITOCHONDRIAL_FUSION,0.99999
GOMF_PHOSPHOLIPID_SCRAMBLASE...,SET,15,-0.090482,-0.0025851,0.23953,0.64719,GOMF_PHOSPHOLIPID_SCRAMBLASE_ACTIVITY,0.99999
GOBP_BLASTOCYST_DEVELOPMENT,SET,110,-0.029659,-0.0022888,0.078502,0.64721,GOBP_BLASTOCYST_DEVELOPMENT,0.99999
WP_1P36_COPY_NUMBER_VARIATIO...,SET,89,-0.040483,-0.0028117,0.10712,0.64725,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GOMF_MITOGEN_ACTIVATED_PROTE...2,SET,10,-0.10096,-0.0023556,0.2671,0.64729,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING,0.99999
REACTOME_DISEASES_OF_GLYCOSY...,SET,130,-0.027963,-0.0023446,0.073948,0.64734,REACTOME_DISEASES_OF_GLYCOSYLATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...548,SET,6,-0.11105,-0.0020071,0.2936,0.64737,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION,0.99999
MIR7108_5P,SET,43,-0.048838,-0.0023607,0.1291,0.6474,MIR7108_5P,0.99999
ANDERSEN_CHOLANGIOCARCINOMA_...2,SET,171,-0.025593,-0.0024583,0.06763,0.64744,ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,0.99999
GOBP_VASCULAR_ENDOTHELIAL_CE...,SET,25,-0.063105,-0.002327,0.16676,0.64744,GOBP_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.99999
MIR552_3P,SET,53,-0.043103,-0.0023124,0.11389,0.64745,MIR552_3P,0.99999
KEGG_PROTEASOME,SET,43,-0.043581,-0.0021066,0.11506,0.64756,KEGG_PROTEASOME,0.99999
GOBP_CELLULAR_RESPONSE_TO_L_...2,SET,11,-0.094957,-0.0023235,0.25065,0.64759,GOBP_CELLULAR_RESPONSE_TO_L_LEUCINE,0.99999
GOBP_REGULATION_OF_MAP_KINAS...,SET,122,-0.029149,-0.0023681,0.076902,0.64767,GOBP_REGULATION_OF_MAP_KINASE_ACTIVITY,0.99999
JU_AGING_TERC_TARGETS_UP,SET,6,-0.13375,-0.0024175,0.35278,0.6477,JU_AGING_TERC_TARGETS_UP,0.99999
NAGY_PCAF_COMPONENTS_HUMAN,SET,9,-0.097179,-0.002151,0.25631,0.64771,NAGY_PCAF_COMPONENTS_HUMAN,0.99999
CARRILLOREIXACH_HEPATOBLASTO...3,SET,156,-0.027388,-0.0025137,0.072218,0.64774,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP,0.99999
GOBP_GOLGI_VESICLE_TRANSPORT,SET,281,-0.018335,-0.0022508,0.048336,0.64777,GOBP_GOLGI_VESICLE_TRANSPORT,0.99999
GOCC_AP_3_ADAPTOR_COMPLEX,SET,11,-0.090004,-0.0022023,0.23725,0.64779,GOCC_AP_3_ADAPTOR_COMPLEX,0.99999
GOBP_NADH_DEHYDROGENASE_COMP...,SET,48,-0.040102,-0.0020477,0.1057,0.6478,GOBP_NADH_DEHYDROGENASE_COMPLEX_ASSEMBLY,0.99999
GOBP_REGULATION_OF_MRNA_CATA...,SET,170,-0.024058,-0.0023042,0.063401,0.64782,GOBP_REGULATION_OF_MRNA_CATABOLIC_PROCESS,0.99999
HP_ABNORMALITY_OF_THE_ACHILL...,SET,50,-0.04663,-0.00243,0.12288,0.64783,HP_ABNORMALITY_OF_THE_ACHILLES_TENDON,0.99999
GSE27241_WT_CTRL_VS_DIGOXIN_...1,SET,161,-0.024184,-0.0022547,0.063704,0.64789,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,0.99999
WP_NEURODEGENERATION_WITH_BR...,SET,41,-0.047131,-0.0022247,0.12408,0.64797,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,0.99999
GSE19888_ADENOSINE_A3R_INH_V...2,SET,173,-0.023889,-0.0023079,0.062889,0.64797,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP,0.99999
GSE5589_LPS_VS_LPS_AND_IL6_S...3,SET,188,-0.023216,-0.0023372,0.061121,0.64797,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,0.99999
MIR4643,SET,197,-0.023109,-0.0023808,0.060823,0.648,MIR4643,0.99999
WP_PURINE_METABOLISM_AND_REL...,SET,20,-0.073762,-0.0024331,0.19402,0.64809,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...394,SET,33,-0.051865,-0.0021968,0.13641,0.64811,GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,0.99999
GSE25677_R848_VS_MPL_AND_R84...2,SET,134,-0.027368,-0.0023295,0.071969,0.64813,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_UP,0.99999
HP_HYPERKERATOSIS,SET,212,-0.021926,-0.0023424,0.057637,0.64818,HP_HYPERKERATOSIS,0.99999
KEGG_FATTY_ACID_METABOLISM,SET,41,-0.049245,-0.0023244,0.12943,0.64821,KEGG_FATTY_ACID_METABOLISM,0.99999
HAHTOLA_MYCOSIS_FUNGOIDES_SK...2,SET,163,-0.024634,-0.0023107,0.064739,0.64822,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,0.99999
HP_RETINAL_TELANGIECTASIA,SET,14,-0.079152,-0.0021848,0.20797,0.64825,HP_RETINAL_TELANGIECTASIA,0.99999
MIR5690,SET,110,-0.031686,-0.0024452,0.083248,0.64826,MIR5690,0.99999
GSE9988_ANTI_TREM1_VS_ANTI_T...2,SET,181,-0.022518,-0.0022247,0.059143,0.6483,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,0.99999
GCAAGAC_MIR431,SET,43,-0.050929,-0.0024618,0.13374,0.64832,GCAAGAC_MIR431,0.99999
GOCC_CLATHRIN_COATED_VESICLE,SET,200,-0.023834,-0.0024739,0.06259,0.64832,GOCC_CLATHRIN_COATED_VESICLE,0.99999
chr4q28,SET,19,-0.12372,-0.0039778,0.3248,0.64836,chr4q28,0.99999
REACTOME_AMPK_INHIBITS_CHREB...,SET,8,-0.11731,-0.0024482,0.30791,0.64839,REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY,0.99999
GOBP_ENDOMEMBRANE_SYSTEM_ORG...,SET,531,-0.013838,-0.002319,0.036317,0.64841,GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION,0.99999
GOMF_LAMININ_1_BINDING,SET,7,-0.14206,-0.0027732,0.37274,0.64844,GOMF_LAMININ_1_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...211,SET,62,-0.042886,-0.0024879,0.11252,0.64845,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.99999
HP_NEOPLASM_OF_THE_ADRENAL_C...,SET,26,-0.068443,-0.0025737,0.17955,0.64847,HP_NEOPLASM_OF_THE_ADRENAL_CORTEX,0.99999
REACTOME_INACTIVATION_OF_CDC...,SET,8,-0.11867,-0.0024766,0.31128,0.64848,REACTOME_INACTIVATION_OF_CDC42_AND_RAC1,0.99999
GOBP_RESPONSE_TO_DEXAMETHASO...,SET,42,-0.053185,-0.0025408,0.1395,0.64849,GOBP_RESPONSE_TO_DEXAMETHASONE,0.99999
HP_ABSENT_CIRCULATING_B_CELLS,SET,6,-0.14441,-0.0026101,0.37865,0.64854,HP_ABSENT_CIRCULATING_B_CELLS,0.99999
WP_MARKERS_OF_KIDNEY_CELL_LI...,SET,57,-0.046252,-0.002573,0.12123,0.64858,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,0.99999
HP_IMMUNE_DYSREGULATION,SET,10,-0.098021,-0.0022869,0.25693,0.64859,HP_IMMUNE_DYSREGULATION,0.99999
MIR6728_5P,SET,66,-0.038111,-0.0022809,0.09988,0.64861,MIR6728_5P,0.99999
HP_AUTOAMPUTATION,SET,15,-0.081566,-0.0023304,0.21376,0.64861,HP_AUTOAMPUTATION,0.99999
GOBP_AUTOPHAGOSOME_MEMBRANE_...,SET,7,-0.095897,-0.0018721,0.25129,0.64863,GOBP_AUTOPHAGOSOME_MEMBRANE_DOCKING,0.99999
HP_ABNORMAL_GROWTH_HORMONE_L...,SET,25,-0.064368,-0.0023736,0.16863,0.64866,HP_ABNORMAL_GROWTH_HORMONE_LEVEL,0.99999
GOMF_DEATH_RECEPTOR_ACTIVITY,SET,12,-0.10502,-0.0026839,0.27501,0.64872,GOMF_DEATH_RECEPTOR_ACTIVITY,0.99999
GOBP_INNER_MITOCHONDRIAL_MEM...,SET,35,-0.050561,-0.0022054,0.13238,0.64874,GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,0.99999
GSE37416_12H_VS_48H_F_TULARE...1,SET,148,-0.026731,-0.0023903,0.069968,0.64878,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
GSE2405_0H_VS_3H_A_PHAGOCYTO...1,SET,163,-0.026744,-0.0025086,0.07,0.64879,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.99999
HP_ABNORMAL_HYPNAGOGIA,SET,8,-0.12152,-0.0025361,0.31806,0.6488,HP_ABNORMAL_HYPNAGOGIA,0.99999
GOCC_CLATHRIN_COAT,SET,48,-0.045318,-0.0023141,0.11858,0.64883,GOCC_CLATHRIN_COAT,0.99999
GSE36095_WT_VS_HDAC9_KO_TREG...2,SET,165,-0.025048,-0.0023638,0.065533,0.64885,GSE36095_WT_VS_HDAC9_KO_TREG_UP,0.99999
ZNF623_TARGET_GENES,SET,335,-0.01742,-0.0023314,0.045569,0.64887,ZNF623_TARGET_GENES,0.99999
HP_ABNORMAL_HEPATIC_ECHOGENI...,SET,7,-0.13186,-0.0025741,0.34494,0.64887,HP_ABNORMAL_HEPATIC_ECHOGENICITY,0.99999
GOBP_REGULATION_OF_FEMALE_RE...,SET,8,-0.12976,-0.0027079,0.33917,0.64898,GOBP_REGULATION_OF_FEMALE_RECEPTIVITY,0.99999
HP_SEPTO_OPTIC_DYSPLASIA,SET,18,-0.079568,-0.0024901,0.20789,0.64904,HP_SEPTO_OPTIC_DYSPLASIA,0.99999
WP_S1P_RECEPTOR_SIGNAL_TRANS...,SET,25,-0.063718,-0.0023496,0.16644,0.64908,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,0.99999
GSE9037_WT_VS_IRAK4_KO_LPS_4...2,SET,183,-0.023425,-0.002327,0.061188,0.64908,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...536,SET,63,-0.041869,-0.0024483,0.10936,0.64909,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION,0.99999
MIR6757_5P,SET,53,-0.041678,-0.002236,0.10878,0.64918,MIR6757_5P,0.99999
HP_CNS_DEMYELINATION,SET,45,-0.048041,-0.0023754,0.12534,0.64925,HP_CNS_DEMYELINATION,0.99999
HP_INVERTED_NIPPLES,SET,44,-0.044942,-0.0021974,0.1172,0.64931,HP_INVERTED_NIPPLES,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...3,SET,37,-0.051795,-0.0023227,0.13508,0.64931,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_DN,0.99999
WP_SEBALEIC_ACID_FORMATION_A...,SET,5,-0.15381,-0.0025378,0.40088,0.64939,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,0.99999
REACTOME_AMINE_LIGAND_BINDIN...,SET,40,-0.057687,-0.0026896,0.15033,0.64941,REACTOME_AMINE_LIGAND_BINDING_RECEPTORS,0.99999
GOBP_CORTISOL_SECRETION,SET,5,-0.13542,-0.0022344,0.3529,0.64941,GOBP_CORTISOL_SECRETION,0.99999
GSE36476_CTRL_VS_TSST_ACT_72...1,SET,181,-0.022756,-0.0022482,0.059293,0.64943,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN,0.99999
HP_ABNORMAL_MUSCLE_FIBER_ALP...,SET,9,-0.10398,-0.0023016,0.2709,0.64945,HP_ABNORMAL_MUSCLE_FIBER_ALPHA_DYSTROGLYCAN,0.99999
NKX2_8_TARGET_GENES,SET,31,-0.063239,-0.0025963,0.16474,0.64946,NKX2_8_TARGET_GENES,0.99999
MORF_MAP2K7,SET,157,-0.026832,-0.0024705,0.069894,0.64947,MORF_MAP2K7,0.99999
HOFMANN_CELL_LYMPHOMA_DN,SET,37,-0.050352,-0.002258,0.13107,0.64956,HOFMANN_CELL_LYMPHOMA_DN,0.99999
REACTOME_CHOLESTEROL_BIOSYNT...,SET,24,-0.05756,-0.0020797,0.14981,0.64959,REACTOME_CHOLESTEROL_BIOSYNTHESIS,0.99999
GOBP_REGULATION_OF_INSULIN_L...,SET,20,-0.082395,-0.0027179,0.21434,0.64966,GOBP_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE34156_UNTREATED_VS_6H_NOD...3,SET,166,-0.025306,-0.0023953,0.065819,0.64969,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN,0.99999
BIOCARTA_41BB_PATHWAY,SET,18,-0.072994,-0.0022844,0.18983,0.6497,BIOCARTA_41BB_PATHWAY,0.99999
WP_BARDETBIEDL_SYNDROME,SET,76,-0.035438,-0.0022753,0.092141,0.64973,WP_BARDETBIEDL_SYNDROME,0.99999
MIR548AP_5P_MIR548J_5P,SET,442,-0.015586,-0.002389,0.040527,0.64973,MIR548AP_5P_MIR548J_5P,0.99999
HP_ABNORMAL_CIRCULATING_IGE_...,SET,44,-0.04728,-0.0023117,0.12293,0.64974,HP_ABNORMAL_CIRCULATING_IGE_LEVEL,0.99999
ZNF493_TARGET_GENES,SET,6,-0.13316,-0.0024068,0.3462,0.64975,ZNF493_TARGET_GENES,0.99999
HP_NON_PERIODIC_RECURRENT_FE...,SET,11,-0.098375,-0.0024071,0.25573,0.64976,HP_NON_PERIODIC_RECURRENT_FEVER,0.99999
GSE29614_CTRL_VS_DAY3_TIV_FL...2,SET,151,-0.026648,-0.0024066,0.06924,0.64983,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP,0.99999
GSE28737_WT_VS_BCL6_HET_MARG...1,SET,179,-0.023588,-0.0023176,0.061281,0.64985,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN,0.99999
GOMF_CYCLASE_REGULATOR_ACTIV...,SET,15,-0.089133,-0.0025466,0.23154,0.64986,GOMF_CYCLASE_REGULATOR_ACTIVITY,0.99999
HP_APLASIA_OF_THE_SEMICIRCUL...,SET,16,-0.074191,-0.0021891,0.19271,0.64987,HP_APLASIA_OF_THE_SEMICIRCULAR_CANAL,0.99999
GSE42088_2H_VS_24H_LEISHMANI...2,SET,176,-0.024381,-0.0023756,0.063331,0.64987,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP,0.99999
GOBP_RESPONSE_TO_MUSCLE_ACTI...,SET,24,-0.074,-0.0026737,0.19219,0.64989,GOBP_RESPONSE_TO_MUSCLE_ACTIVITY,0.99999
TTTTGAG_MIR373,SET,212,-0.02219,-0.0023706,0.057625,0.6499,TTTTGAG_MIR373,0.99999
GSE39110_UNTREATED_VS_IL2_TR...4,SET,182,-0.024454,-0.0024226,0.063511,0.6499,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP,0.99999
YNTTTNNNANGCARM_UNKNOWN,SET,63,-0.044475,-0.0026007,0.11547,0.64994,YNTTTNNNANGCARM_UNKNOWN,0.99999
HP_EEG_WITH_GENERALIZED_SLOW...2,SET,9,-0.10765,-0.0023827,0.27949,0.64994,HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY_GRADE_4,0.99999
GOBP_NEGATIVE_REGULATION_OF_...41,SET,28,-0.05963,-0.0023268,0.1548,0.64996,GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...8,SET,184,-0.024492,-0.0024395,0.063554,0.65002,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN,0.99999
GNF2_H2AFX,SET,29,-0.063021,-0.0025026,0.16352,0.65003,GNF2_H2AFX,0.99999
REACTOME_ER_TO_GOLGI_ANTEROG...,SET,150,-0.025696,-0.002313,0.066653,0.65007,REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,0.99999
GOBP_REGULATION_OF_OSTEOBLAS...1,SET,116,-0.032551,-0.0025791,0.084433,0.65007,GOBP_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.99999
GSE36476_CTRL_VS_TSST_ACT_16...4,SET,173,-0.024866,-0.0024023,0.0645,0.65007,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP,0.99999
HP_ABNORMAL_PREIMPLANTATION_...,SET,6,-0.10872,-0.001965,0.28188,0.65014,HP_ABNORMAL_PREIMPLANTATION_EMBRYONIC_DEVELOPMENT,0.99999
MIR632,SET,56,-0.044079,-0.0024306,0.11426,0.65016,MIR632,0.99999
GOBP_OPSONIZATION,SET,15,-0.10059,-0.002874,0.26071,0.65019,GOBP_OPSONIZATION,0.99999
GSE24142_ADULT_VS_FETAL_DN2_...2,SET,186,-0.02478,-0.0024814,0.064219,0.6502,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP,0.99999
GOMF_OUTWARD_RECTIFIER_POTAS...,SET,26,-0.067295,-0.0025306,0.17439,0.65021,GOMF_OUTWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.99999
GOMF_MYRISTOYLTRANSFERASE_AC...,SET,10,-0.089429,-0.0020865,0.23165,0.65027,GOMF_MYRISTOYLTRANSFERASE_ACTIVITY,0.99999
REACTOME_REGULATION_OF_PTEN_...3,SET,9,-0.11168,-0.002472,0.28921,0.65031,REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION,0.99999
GOBP_MODULATION_OF_MICROTUBU...,SET,4,-0.15915,-0.0023487,0.41205,0.65034,GOBP_MODULATION_OF_MICROTUBULE_CYTOSKELETON_INVOLVED_IN_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION,0.99999
GSE1740_MCSF_VS_MCSF_AND_IFN...1,SET,172,-0.024027,-0.0023146,0.062208,0.65034,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN,0.99999
GSE7831_1H_VS_4H_INFLUENZA_S...2,SET,182,-0.024203,-0.0023977,0.062665,0.65034,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_UP,0.99999
GOCC_SARCOPLASMIC_RETICULUM_...2,SET,42,-0.048627,-0.0023231,0.12588,0.65036,GOCC_SARCOPLASMIC_RETICULUM_MEMBRANE,0.99999
GOMF_NERVE_GROWTH_FACTOR_REC...,SET,4,-0.19475,-0.0028741,0.50406,0.65038,GOMF_NERVE_GROWTH_FACTOR_RECEPTOR_BINDING,0.99999
GOBP_MRNA_METHYLGUANOSINE_CA...,SET,14,-0.081485,-0.0022492,0.21081,0.65044,GOBP_MRNA_METHYLGUANOSINE_CAP_DECAPPING,0.99999
HP_ABNORMAL_SKULL_BASE_MORPH...,SET,205,-0.022133,-0.0023256,0.057259,0.65045,HP_ABNORMAL_SKULL_BASE_MORPHOLOGY,0.99999
KEGG_MEDICUS_REFERENCE_CA2_E...2,SET,5,-0.14427,-0.0023804,0.37311,0.6505,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_STORE_OPERATED_CA2_CHANNEL,0.99999
RICKMAN_TUMOR_DIFFERENTIATED...4,SET,97,-0.033184,-0.0024056,0.085788,0.65055,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...453,SET,25,-0.075667,-0.0027902,0.19559,0.65057,GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.99999
HP_ABNORMAL_LEUKOCYTE_PHYSIO...,SET,263,-0.020117,-0.0023903,0.052,0.65057,HP_ABNORMAL_LEUKOCYTE_PHYSIOLOGY,0.99999
GOBP_MULTICELLULAR_ORGANISMA...4,SET,33,-0.063371,-0.0026842,0.16379,0.65059,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_WATER_HOMEOSTASIS,0.99999
KEGG_MEDICUS_REFERENCE_N_GLY...2,SET,11,-0.095059,-0.002326,0.24562,0.65062,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST,0.99999
HP_ADULT_ONSET,SET,776,-0.01182,-0.002378,0.030535,0.65065,HP_ADULT_ONSET,0.99999
GOBP_ADENOSINE_TO_INOSINE_ED...,SET,6,-0.14717,-0.00266,0.37992,0.65076,GOBP_ADENOSINE_TO_INOSINE_EDITING,0.99999
HP_FAVORABLE_RESPONSE_OF_WEA...,SET,4,-0.17378,-0.0025647,0.44861,0.65076,HP_FAVORABLE_RESPONSE_OF_WEAKNESS_TO_ACETYLCHOLINE_ESTERASE_INHIBITORS,0.99999
GOMF_NUCLEOTIDE_RECEPTOR_ACT...,SET,17,-0.094352,-0.0028696,0.24349,0.65081,GOMF_NUCLEOTIDE_RECEPTOR_ACTIVITY,0.99999
HP_FUNCTIONAL_ABNORMALITY_OF...3,SET,919,-0.010857,-0.0023674,0.028007,0.65086,HP_FUNCTIONAL_ABNORMALITY_OF_THE_INNER_EAR,0.99999
CHANG_POU5F1_TARGETS_UP,SET,13,-0.099539,-0.0026477,0.25674,0.65088,CHANG_POU5F1_TARGETS_UP,0.99999
GOMF_DOUBLE_STRANDED_RNA_ADE...,SET,6,-0.14744,-0.0026649,0.38025,0.6509,GOMF_DOUBLE_STRANDED_RNA_ADENOSINE_DEAMINASE_ACTIVITY,0.99999
HP_ABNORMAL_CIRCULATING_ANDR...2,SET,11,-0.10436,-0.0025535,0.26897,0.65098,HP_ABNORMAL_CIRCULATING_ANDROSTENEDIONE_CONCENTRATION,0.99999
MIR552_5P,SET,175,-0.02494,-0.0024232,0.064282,0.65099,MIR552_5P,0.99999
HP_METHYLMALONIC_ACIDEMIA,SET,13,-0.085104,-0.0022637,0.21933,0.65099,HP_METHYLMALONIC_ACIDEMIA,0.99999
FIRESTEIN_CTNNB1_PATHWAY_AND...,SET,6,-0.1529,-0.0027636,0.39404,0.65101,FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION,0.99999
GOMF_PHOSPHOLIPASE_C_ACTIVITY,SET,29,-0.059109,-0.0023473,0.15231,0.65102,GOMF_PHOSPHOLIPASE_C_ACTIVITY,0.99999
MIR548AR_5P,SET,450,-0.01563,-0.0024167,0.040267,0.65105,MIR548AR_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...732,SET,7,-0.095331,-0.001861,0.24554,0.65108,GOBP_POSITIVE_REGULATION_OF_STRESS_GRANULE_ASSEMBLY,0.99999
MIR372_3P,SET,304,-0.018801,-0.002399,0.048415,0.65111,MIR372_3P,0.99999
GSE37301_CD4_TCELL_VS_RAG2_K...2,SET,146,-0.027996,-0.0024865,0.072068,0.65116,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_UP,0.99999
MIKKELSEN_IPS_HCP_WITH_H3_UN...,SET,77,-0.039445,-0.002549,0.10154,0.65117,MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,0.99999
HP_OMPHALOCELE,SET,67,-0.040358,-0.0024335,0.10386,0.6512,HP_OMPHALOCELE,0.99999
GOBP_REGULATION_OF_ENDODERMA...,SET,6,-0.16239,-0.002935,0.41787,0.65121,GOBP_REGULATION_OF_ENDODERMAL_CELL_DIFFERENTIATION,0.99999
GOBP_FACIAL_NERVE_STRUCTURAL...,SET,8,-0.12986,-0.0027101,0.33415,0.65122,GOBP_FACIAL_NERVE_STRUCTURAL_ORGANIZATION,0.99999
VERNOCHET_ADIPOGENESIS,SET,18,-0.088275,-0.0027626,0.22706,0.65128,VERNOCHET_ADIPOGENESIS,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...9,SET,179,-0.023164,-0.002276,0.059571,0.6513,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_DN,0.99999
MIKKELSEN_NPC_HCP_WITH_H3K4M...,SET,202,-0.025274,-0.0026363,0.064984,0.65133,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.99999
KEGG_MEDICUS_REFERENCE_GPCR_...1,SET,31,-0.060806,-0.0024964,0.15633,0.65134,KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY,0.99999
MIR7152_5P,SET,223,-0.022759,-0.0024929,0.058517,0.65134,MIR7152_5P,0.99999
GSE1112_OT1_CD8AB_VS_HY_CD8A...2,SET,132,-0.028855,-0.0024378,0.07419,0.65134,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...197,SET,63,-0.039241,-0.0022946,0.10088,0.65135,GOBP_NEGATIVE_REGULATION_OF_ENDOCYTOSIS,0.99999
HP_PREMATURE_ADRENARCHE,SET,10,-0.11628,-0.0027129,0.29887,0.65139,HP_PREMATURE_ADRENARCHE,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...4,SET,38,-0.050575,-0.0022984,0.12996,0.65142,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,0.99999
GSE6259_FLT3L_INDUCED_DEC205...1,SET,149,-0.025733,-0.0023087,0.066109,0.65145,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN,0.99999
HP_EMG_NEUROPATHIC_CHANGES,SET,48,-0.044525,-0.0022736,0.11437,0.65147,HP_EMG_NEUROPATHIC_CHANGES,0.99999
REACTOME_NUCLEOTIDE_SALVAGE,SET,21,-0.07312,-0.0024715,0.18777,0.65152,REACTOME_NUCLEOTIDE_SALVAGE,0.99999
CTCNANGTGNY_UNKNOWN,SET,74,-0.036521,-0.0023138,0.093776,0.65152,CTCNANGTGNY_UNKNOWN,0.99999
GSE29618_PDC_VS_MDC_UP,SET,173,-0.02536,-0.0024501,0.065102,0.65156,GSE29618_PDC_VS_MDC_UP,0.99999
SCHMIDT_POR_TARGETS_IN_LIMB_...2,SET,26,-0.057857,-0.0021756,0.14842,0.65167,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP,0.99999
GOCC_GERM_CELL_NUCLEUS,SET,62,-0.039341,-0.0022822,0.10089,0.6517,GOCC_GERM_CELL_NUCLEUS,0.99999
GOBP_REGULATION_OF_ENTRY_OF_...,SET,7,-0.11953,-0.0023334,0.30647,0.65173,GOBP_REGULATION_OF_ENTRY_OF_BACTERIUM_INTO_HOST_CELL,0.99999
GOMF_COBALAMIN_BINDING,SET,8,-0.11317,-0.0023618,0.29017,0.65174,GOMF_COBALAMIN_BINDING,0.99999
GOMF_C2H2_ZINC_FINGER_DOMAIN...,SET,12,-0.096761,-0.0024729,0.24804,0.65177,GOMF_C2H2_ZINC_FINGER_DOMAIN_BINDING,0.99999
DING_LUNG_CANCER_MUTATED_REC...,SET,6,-0.12887,-0.0023292,0.3303,0.65179,DING_LUNG_CANCER_MUTATED_RECURRENTLY,0.99999
CUI_TCF21_TARGETS_UP,SET,35,-0.05991,-0.0026132,0.1535,0.65184,CUI_TCF21_TARGETS_UP,0.99999
HP_ABNORMALITY_OF_THE_VERTEB...2,SET,35,-0.059211,-0.0025827,0.1517,0.65184,HP_ABNORMALITY_OF_THE_VERTEBRAL_ENDPLATES,0.99999
WP_3Q29_COPY_NUMBER_VARIATIO...,SET,57,-0.049099,-0.0027314,0.12574,0.6519,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,0.99999
MIR4804_3P,SET,79,-0.037765,-0.0024718,0.096715,0.65191,MIR4804_3P,0.99999
GOCC_RECYCLING_ENDOSOME,SET,187,-0.023401,-0.0023495,0.05992,0.65193,GOCC_RECYCLING_ENDOSOME,0.99999
HP_CHROMOSOMAL_BREAKAGE_INDU...1,SET,16,-0.075688,-0.0022333,0.19379,0.65194,HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_CROSSLINKING_AGENTS,0.99999
MIR3920,SET,123,-0.030324,-0.0024736,0.07763,0.65196,MIR3920,0.99999
GOBP_PODOSOME_ASSEMBLY,SET,21,-0.072197,-0.0024402,0.18472,0.65204,GOBP_PODOSOME_ASSEMBLY,0.99999
GOMF_VIRION_BINDING,SET,9,-0.11655,-0.0025798,0.29812,0.65208,GOMF_VIRION_BINDING,0.99999
WP_MEASLES_VIRUS_INFECTION,SET,123,-0.03186,-0.0025989,0.081489,0.65209,WP_MEASLES_VIRUS_INFECTION,0.99999
GOBP_PERIPHERAL_NERVOUS_SYST...2,SET,8,-0.13898,-0.0029003,0.35539,0.65212,GOBP_PERIPHERAL_NERVOUS_SYSTEM_AXON_REGENERATION,0.99999
HP_DISTAL_SYMPHALANGISM,SET,6,-0.13405,-0.0024227,0.34274,0.65214,HP_DISTAL_SYMPHALANGISM,0.99999
GOCC_CHECKPOINT_CLAMP_COMPLEX,SET,5,-0.15189,-0.0025062,0.38822,0.65219,GOCC_CHECKPOINT_CLAMP_COMPLEX,0.99999
HP_HYPOCHLOREMIA,SET,6,-0.15707,-0.0028389,0.40141,0.65221,HP_HYPOCHLOREMIA,0.99999
GOBP_CELL_FATE_COMMITMENT_IN...1,SET,31,-0.06198,-0.0025446,0.15835,0.65225,GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER,0.99999
MIR660_3P,SET,91,-0.033946,-0.0023839,0.086724,0.65226,MIR660_3P,0.99999
GOMF_CYTIDINE_DEAMINASE_ACTI...,SET,10,-0.14312,-0.0033392,0.36561,0.65227,GOMF_CYTIDINE_DEAMINASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...199,SET,6,-0.13127,-0.0023726,0.33526,0.6523,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,0.99999
GOBP_GANGLIOSIDE_BIOSYNTHETI...2,SET,6,-0.1252,-0.0022629,0.31974,0.65231,GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS_VIA_LACTOSYLCERAMIDE,0.99999
GOBP_REGULATION_OF_VENTRICUL...1,SET,12,-0.10672,-0.0027274,0.27254,0.65231,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.99999
WP_ALLOGRAFT_REJECTION,SET,82,-0.040326,-0.0026889,0.10297,0.65233,WP_ALLOGRAFT_REJECTION,0.99999
HP_THORACOLUMBAR_KYPHOSIS,SET,18,-0.082614,-0.0025854,0.21088,0.65238,HP_THORACOLUMBAR_KYPHOSIS,0.99999
REACTOME_MRNA_EDITING_C_TO_U...,SET,7,-0.12229,-0.0023874,0.31212,0.6524,REACTOME_MRNA_EDITING_C_TO_U_CONVERSION,0.99999
GOMF_CALCIUM_DEPENDENT_PROTE...1,SET,74,-0.043774,-0.0027734,0.11168,0.65245,GOMF_CALCIUM_DEPENDENT_PROTEIN_BINDING,0.99999
HP_HEMIPLEGIA,SET,33,-0.06131,-0.0025969,0.15639,0.65248,HP_HEMIPLEGIA,0.99999
HP_ABNORMALITY_OF_THE_AMNIOT...,SET,418,-0.015949,-0.0023789,0.040681,0.65249,HP_ABNORMALITY_OF_THE_AMNIOTIC_FLUID,0.99999
LIANG_HEMATOPOIESIS_STEM_CEL...4,SET,33,-0.055874,-0.0023666,0.14248,0.65253,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,0.99999
FERRANDO_LYL1_NEIGHBORS,SET,15,-0.095912,-0.0027403,0.24448,0.65258,FERRANDO_LYL1_NEIGHBORS,0.99999
GOBP_REGULATION_OF_T_HELPER_...4,SET,11,-0.11208,-0.0027425,0.28568,0.65259,GOBP_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...549,SET,9,-0.10479,-0.0023194,0.26707,0.6526,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_BINDING,0.99999
GSE2770_IL12_AND_TGFB_ACT_VS...2,SET,174,-0.024144,-0.0023392,0.061525,0.65262,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP,0.99999
HP_PARKINSONISM,SET,123,-0.028956,-0.002362,0.073775,0.65265,HP_PARKINSONISM,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...7,SET,182,-0.024377,-0.0024149,0.062087,0.6527,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_DN,0.99999
KEGG_MEDICUS_REFERENCE_CXCR_...1,SET,27,-0.06539,-0.0025057,0.16644,0.65279,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY,0.99999
SIMBULAN_UV_RESPONSE_NORMAL_...2,SET,9,-0.11732,-0.0025969,0.29854,0.65284,SIMBULAN_UV_RESPONSE_NORMAL_UP,0.99999
AACTGAC_MIR223,SET,90,-0.035456,-0.0024762,0.090208,0.65285,AACTGAC_MIR223,0.99999
REACTOME_BIOTIN_TRANSPORT_AN...,SET,10,-0.095492,-0.0022279,0.24284,0.65293,REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM,0.99999
GOBP_NUCLEOTIDE_EXCISION_REP...1,SET,80,-0.032922,-0.0021684,0.083713,0.65294,GOBP_NUCLEOTIDE_EXCISION_REPAIR,0.99999
AGGAAGC_MIR5163P,SET,113,-0.032248,-0.002522,0.081992,0.65295,AGGAAGC_MIR5163P,0.99999
HP_POLAR_CATARACT,SET,15,-0.089807,-0.0025658,0.22829,0.65298,HP_POLAR_CATARACT,0.99999
TDRD3_TARGET_GENES,SET,3,-0.17476,-0.0022337,0.44423,0.65299,TDRD3_TARGET_GENES,0.99999
MIR1272,SET,80,-0.035723,-0.0023529,0.090791,0.65301,MIR1272,0.99999
GOBP_PURINE_DEOXYRIBONUCLEOS...3,SET,11,-0.10265,-0.0025119,0.26084,0.65304,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.99999
GOCC_MLL1_2_COMPLEX,SET,29,-0.053947,-0.0021423,0.13703,0.65309,GOCC_MLL1_2_COMPLEX,0.99999
GSE21670_UNTREATED_VS_TGFB_I...4,SET,180,-0.024229,-0.0023872,0.061488,0.65323,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.99999
ZHOU_TNF_SIGNALING_30MIN,SET,42,-0.047351,-0.0022621,0.12015,0.65324,ZHOU_TNF_SIGNALING_30MIN,0.99999
GOBP_MESENCHYMAL_STEM_CELL_M...,SET,6,-0.15865,-0.0028675,0.40255,0.65325,GOBP_MESENCHYMAL_STEM_CELL_MAINTENANCE_INVOLVED_IN_NEPHRON_MORPHOGENESIS,0.99999
MIR548AS_5P,SET,442,-0.015969,-0.0024477,0.040517,0.65326,MIR548AS_5P,0.99999
HP_MYOTONIA,SET,28,-0.064972,-0.0025353,0.16484,0.65327,HP_MYOTONIA,0.99999
GSE27786_LSK_VS_BCELL_DN,SET,182,-0.024329,-0.0024102,0.06172,0.65327,GSE27786_LSK_VS_BCELL_DN,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...4,SET,404,-0.01752,-0.0025701,0.044418,0.65337,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,0.99999
HP_PERICARDIAL_EFFUSION,SET,39,-0.053145,-0.0024467,0.13471,0.6534,HP_PERICARDIAL_EFFUSION,0.99999
REACTOME_ERCC6_CSB_AND_EHMT2...,SET,15,-0.081397,-0.0023256,0.20621,0.65348,REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION,0.99999
GSE35435_RESTING_VS_IL4_TREA...2,SET,175,-0.023799,-0.0023123,0.060292,0.65348,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP,0.99999
GSE41867_NAIVE_VS_DAY15_LCMV...1,SET,178,-0.024376,-0.0023884,0.061751,0.65348,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.99999
MODULE_92,SET,143,-0.031836,-0.0027986,0.080626,0.65352,MODULE_92,0.99999
MODULE_7,SET,214,-0.02271,-0.0024374,0.057503,0.65355,MODULE_7,0.99999
GOBP_NEGATIVE_REGULATION_OF_...299,SET,9,-0.12405,-0.0027457,0.31404,0.65358,GOBP_NEGATIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.99999
CUI_TCF21_TARGETS_2_DN,SET,762,-0.012802,-0.0025533,0.03239,0.65367,CUI_TCF21_TARGETS_2_DN,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...9,SET,8,-0.096452,-0.0020129,0.24399,0.65369,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_DIPHENOLS_AND_RELATED_SUBSTANCES_AS_DONORS,0.99999
GOBP_DETECTION_OF_LIGHT_STIM...1,SET,58,-0.045592,-0.0025584,0.11531,0.65371,GOBP_DETECTION_OF_LIGHT_STIMULUS,0.99999
GOBP_REGULATION_OF_MONOCYTE_...3,SET,6,-0.13838,-0.0025011,0.34993,0.65374,GOBP_REGULATION_OF_MONOCYTE_EXTRAVASATION,0.99999
GSE22140_HEALTHY_VS_ARTHRITI...3,SET,183,-0.024251,-0.0024089,0.061322,0.65375,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN,0.99999
TCTGATA_MIR361,SET,79,-0.036999,-0.0024217,0.09354,0.65378,TCTGATA_MIR361,0.99999
GOBP_ICOSANOID_CATABOLIC_PRO...,SET,9,-0.10887,-0.0024098,0.27514,0.65383,GOBP_ICOSANOID_CATABOLIC_PROCESS,0.99999
GSE2706_R848_VS_LPS_8H_STIM_...2,SET,141,-0.028396,-0.0024788,0.071751,0.65386,GSE2706_R848_VS_LPS_8H_STIM_DC_UP,0.99999
REACTOME_SYNTHESIS_OF_PI,SET,5,-0.14541,-0.0023993,0.36739,0.65387,REACTOME_SYNTHESIS_OF_PI,0.99999
HP_ABNORMAL_URINE_MAGNESIUM_...,SET,9,-0.11284,-0.0024975,0.28507,0.65388,HP_ABNORMAL_URINE_MAGNESIUM_CONCENTRATION,0.99999
GOBP_LYSOSOMAL_TRANSPORT,SET,126,-0.029484,-0.002434,0.074466,0.65392,GOBP_LYSOSOMAL_TRANSPORT,0.99999
GOBP_POSITIVE_REGULATION_OF_...446,SET,17,-0.08363,-0.0025435,0.21104,0.65405,GOBP_POSITIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.99999
HP_CLOSED_NEURAL_TUBE_DEFECT,SET,67,-0.041897,-0.0025263,0.10568,0.65411,HP_CLOSED_NEURAL_TUBE_DEFECT,0.99999
HP_SHAWL_SCROTUM,SET,18,-0.078836,-0.0024672,0.19886,0.65411,HP_SHAWL_SCROTUM,0.99999
GSE21670_TGFB_VS_TGFB_AND_IL...2,SET,181,-0.025,-0.0024699,0.063054,0.65413,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,0.99999
GOMF_VASCULAR_ENDOTHELIAL_GR...3,SET,7,-0.14978,-0.002924,0.37761,0.65419,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_ACTIVITY,0.99999
GOBP_CATECHOL_CONTAINING_COM...3,SET,46,-0.053746,-0.0026868,0.13547,0.65422,GOBP_CATECHOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...16,SET,58,-0.043605,-0.0024469,0.1099,0.65423,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,0.99999
GOBP_HINDBRAIN_TANGENTIAL_CE...,SET,5,-0.14405,-0.0023769,0.36283,0.65432,GOBP_HINDBRAIN_TANGENTIAL_CELL_MIGRATION,0.99999
GOMF_FRUCTOSE_TRANSMEMBRANE_...,SET,8,-0.1181,-0.0024647,0.29742,0.65435,GOMF_FRUCTOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MORI_LARGE_PRE_BII_LYMPHOCYT...2,SET,81,-0.036944,-0.0024484,0.093019,0.65438,MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,0.99999
GOMF_PROTEIN_ARGININE_OMEGA_...1,SET,7,-0.1268,-0.0024753,0.31925,0.65438,GOMF_PROTEIN_ARGININE_OMEGA_N_ASYMMETRIC_METHYLTRANSFERASE_ACTIVITY,0.99999
HP_ABNORMALITY_OF_THE_PROXIM...2,SET,7,-0.12282,-0.0023977,0.30924,0.65438,HP_ABNORMALITY_OF_THE_PROXIMAL_PHALANX_OF_THE_THUMB,0.99999
GOMF_O_METHYLTRANSFERASE_ACT...,SET,17,-0.071106,-0.0021626,0.17902,0.65439,GOMF_O_METHYLTRANSFERASE_ACTIVITY,0.99999
HP_INTESTINAL_CARCINOID,SET,6,-0.11886,-0.0021482,0.29917,0.65442,HP_INTESTINAL_CARCINOID,0.99999
HP_BOWING_OF_THE_LEGS,SET,217,-0.02325,-0.0025126,0.058514,0.65444,HP_BOWING_OF_THE_LEGS,0.99999
KIM_PTEN_TARGETS_UP,SET,17,-0.077409,-0.0023543,0.19478,0.65447,KIM_PTEN_TARGETS_UP,0.99999
MULLIGHAN_NPM1_SIGNATURE_3_DN,SET,143,-0.027716,-0.0024364,0.069724,0.6545,MULLIGHAN_NPM1_SIGNATURE_3_DN,0.99999
NKX6_1_TARGET_GENES,SET,23,-0.068218,-0.0024129,0.17162,0.6545,NKX6_1_TARGET_GENES,0.99999
GOMF_CYTOKINE_RECEPTOR_BINDI...,SET,247,-0.022981,-0.0026475,0.0578,0.65453,GOMF_CYTOKINE_RECEPTOR_BINDING,0.99999
GSE11973_MIR223_KOVS_WT_BONE...1,SET,154,-0.026361,-0.002404,0.066247,0.65465,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_DN,0.99999
GOBP_ACTOMYOSIN_CONTRACTILE_...,SET,10,-0.1006,-0.002347,0.25279,0.65466,GOBP_ACTOMYOSIN_CONTRACTILE_RING_ORGANIZATION,0.99999
WP_THYROXINE_THYROID_HORMONE...,SET,23,-0.072595,-0.0025677,0.18227,0.65479,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,0.99999
MIR98_5P,SET,361,-0.018146,-0.0025193,0.045557,0.6548,MIR98_5P,0.99999
HP_ABNORMAL_CIRCULATING_PROT...2,SET,58,-0.041721,-0.0023412,0.10471,0.65485,HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_CONCENTRATION,0.99999
BENPORATH_CYCLING_GENES,SET,589,-0.013598,-0.002396,0.034119,0.65488,BENPORATH_CYCLING_GENES,0.99999
GOBP_OTIC_VESICLE_DEVELOPMENT,SET,14,-0.086061,-0.0023755,0.21595,0.65488,GOBP_OTIC_VESICLE_DEVELOPMENT,0.99999
GOBP_AUTOPHAGY_OF_PEROXISOME,SET,13,-0.095518,-0.0025407,0.23957,0.65494,GOBP_AUTOPHAGY_OF_PEROXISOME,0.99999
STAMBOLSKY_BOUND_BY_MUTATED_...,SET,13,-0.095092,-0.0025294,0.23847,0.65496,STAMBOLSKY_BOUND_BY_MUTATED_TP53,0.99999
MIR4539,SET,67,-0.041721,-0.0025156,0.10459,0.65501,MIR4539,0.99999
HP_HYPOPLASTIC_HELICES,SET,10,-0.11541,-0.0026927,0.28927,0.65504,HP_HYPOPLASTIC_HELICES,0.99999
HOLLMANN_APOPTOSIS_VIA_CD40_...2,SET,184,-0.025449,-0.0025348,0.06378,0.65505,HOLLMANN_APOPTOSIS_VIA_CD40_UP,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...26,SET,186,-0.023726,-0.0023759,0.059449,0.65509,HP_APLASIA_HYPOPLASIA_OF_THE_EAR,0.99999
HOEK_MYELOID_DENDRITIC_CELL_...6,SET,20,-0.087111,-0.0028734,0.21826,0.65509,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_UP,0.99999
TATA_C,SET,259,-0.02197,-0.0025909,0.055023,0.65516,TATA_C,0.99999
GOBP_AGGREPHAGY,SET,16,-0.076908,-0.0022693,0.1926,0.65517,GOBP_AGGREPHAGY,0.99999
GOBP_VESTIBULOCOCHLEAR_NERVE...3,SET,7,-0.15506,-0.003027,0.38828,0.65518,GOBP_VESTIBULOCOCHLEAR_NERVE_MORPHOGENESIS,0.99999
REACTOME_RAC2_GTPASE_CYCLE,SET,78,-0.040131,-0.0026101,0.10047,0.6552,REACTOME_RAC2_GTPASE_CYCLE,0.99999
REACTOME_DOWNREGULATION_OF_E...3,SET,8,-0.10976,-0.0022906,0.2748,0.65521,REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...1,SET,180,-0.02393,-0.0023577,0.059906,0.65522,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...15,SET,180,-0.024111,-0.0023756,0.060351,0.65524,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN,0.99999
MIR512_3P,SET,94,-0.034689,-0.0024756,0.08682,0.65525,MIR512_3P,0.99999
KEGG_METABOLISM_OF_XENOBIOTI...,SET,65,-0.056619,-0.0033628,0.14168,0.65528,KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450,0.99999
GOBP_ANIMAL_ORGAN_REGENERATI...,SET,61,-0.044329,-0.0025508,0.11093,0.65528,GOBP_ANIMAL_ORGAN_REGENERATION,0.99999
GOMF_GABA_RECEPTOR_ACTIVITY,SET,19,-0.096496,-0.0031025,0.24141,0.65531,GOMF_GABA_RECEPTOR_ACTIVITY,0.99999
MIR320A_5P,SET,98,-0.034376,-0.0025047,0.085998,0.65532,MIR320A_5P,0.99999
GOBP_NEURON_FATE_COMMITMENT,SET,67,-0.046656,-0.0028132,0.11668,0.65537,GOBP_NEURON_FATE_COMMITMENT,0.99999
GOCC_INTERSTITIAL_MATRIX,SET,11,-0.11943,-0.0029224,0.29868,0.65537,GOCC_INTERSTITIAL_MATRIX,0.99999
GNF2_MMP1,SET,32,-0.069374,-0.0028936,0.17344,0.65542,GNF2_MMP1,0.99999
chr8p22,SET,20,-0.13516,-0.0044584,0.33782,0.65545,chr8p22,0.99999
GOBP_PURINE_NUCLEOSIDE_MONOP...1,SET,18,-0.080004,-0.0025037,0.19992,0.65548,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_CELL_CYCLE_G2_M_PHASE_T...,SET,139,-0.028333,-0.0024558,0.070782,0.65552,GOBP_CELL_CYCLE_G2_M_PHASE_TRANSITION,0.99999
GOBP_LOW_DENSITY_LIPOPROTEIN...3,SET,5,-0.16282,-0.0026864,0.40665,0.65556,GOBP_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_PARTICLE_METABOLIC_PROCESS,0.99999
HP_HAMMERTOE,SET,52,-0.0467,-0.0024817,0.11663,0.65557,HP_HAMMERTOE,0.99999
GOBP_REGULATION_OF_CELLULAR_...17,SET,460,-0.01532,-0.0023943,0.038259,0.65558,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_STRESS,0.99999
MINGUEZ_LIVER_CANCER_VASCULA...1,SET,21,-0.078303,-0.0026466,0.19553,0.65559,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,0.99999
GOBP_MONOCARBOXYLIC_ACID_MET...,SET,587,-0.014479,-0.0025471,0.036147,0.65562,GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS,0.99999
RAFFEL_VEGFA_TARGETS_UP,SET,9,-0.11822,-0.0026168,0.29509,0.65565,RAFFEL_VEGFA_TARGETS_UP,0.99999
MIR6830_3P,SET,191,-0.026221,-0.0026604,0.065444,0.65566,MIR6830_3P,0.99999
MIR3658,SET,734,-0.01281,-0.0025095,0.03195,0.65576,MIR3658,0.99999
GOCC_SPERM_CONNECTING_PIECE,SET,11,-0.106,-0.0025937,0.2643,0.65581,GOCC_SPERM_CONNECTING_PIECE,0.99999
GOBP_MESENCHYMAL_TO_EPITHELI...1,SET,18,-0.093319,-0.0029204,0.23265,0.65583,GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION,0.99999
GOCC_TERMINAL_BOUTON,SET,43,-0.053338,-0.0025782,0.13295,0.65586,GOCC_TERMINAL_BOUTON,0.99999
chr14q31,SET,15,-0.14497,-0.0041419,0.36133,0.65587,chr14q31,0.99999
GOBP_HEPATOCYTE_GROWTH_FACTO...,SET,11,-0.10619,-0.0025984,0.26459,0.65591,GOBP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_ADAPTATION_OF_...,SET,12,-0.096743,-0.0024724,0.24104,0.65592,GOBP_NEGATIVE_ADAPTATION_OF_SIGNALING_PATHWAY,0.99999
WP_MITOCHONDRIAL_LONG_CHAIN_...,SET,16,-0.085563,-0.0025247,0.21303,0.65602,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,0.99999
GOBP_EPITHELIUM_DEVELOPMENT,SET,1134,-0.011014,-0.0026513,0.027388,0.65621,GOBP_EPITHELIUM_DEVELOPMENT,0.99999
GOBP_PROTEIN_LINEAR_POLYUBIQ...,SET,3,-0.17874,-0.0022846,0.44441,0.65623,GOBP_PROTEIN_LINEAR_POLYUBIQUITINATION,0.99999
ANDERSON_BLOOD_CN54GP140_ADJ...5,SET,53,-0.044064,-0.002364,0.10948,0.65633,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_DN,0.99999
JIANG_MELANOMA_TRM10_LAMINA_...,SET,79,-0.042881,-0.0028067,0.10649,0.6564,JIANG_MELANOMA_TRM10_LAMINA_PROPRIA,0.99999
GSE17721_0.5H_VS_24H_PAM3CSK...1,SET,186,-0.023843,-0.0023876,0.059213,0.6564,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN,0.99999
DOANE_RESPONSE_TO_ANDROGEN_UP,SET,162,-0.026326,-0.0024619,0.06536,0.65645,DOANE_RESPONSE_TO_ANDROGEN_UP,0.99999
GOBP_CENTRIOLE_ASSEMBLY,SET,45,-0.048081,-0.0023774,0.11929,0.65654,GOBP_CENTRIOLE_ASSEMBLY,0.99999
GOBP_REVERSE_CHOLESTEROL_TRA...,SET,15,-0.09531,-0.0027231,0.23629,0.65666,GOBP_REVERSE_CHOLESTEROL_TRANSPORT,0.99999
CHIBA_RESPONSE_TO_TSA,SET,37,-0.055689,-0.0024974,0.13805,0.65667,CHIBA_RESPONSE_TO_TSA,0.99999
WP_VITAMIN_B12_DISORDERS,SET,11,-0.099954,-0.0024458,0.24774,0.65669,WP_VITAMIN_B12_DISORDERS,0.99999
HP_NEOPLASM_OF_THE_LARYNX,SET,18,-0.074306,-0.0023254,0.18416,0.6567,HP_NEOPLASM_OF_THE_LARYNX,0.99999
GOBP_POSITIVE_REGULATION_OF_...657,SET,12,-0.098433,-0.0025156,0.24381,0.65679,GOBP_POSITIVE_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY,0.99999
GSE24634_TEFF_VS_TCONV_DAY7_...2,SET,181,-0.024356,-0.0024063,0.060329,0.65679,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP,0.99999
GOBP_FOLIC_ACID_CONTAINING_C...2,SET,5,-0.13052,-0.0021535,0.32324,0.65681,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
GOBP_SINOATRIAL_NODE_DEVELOP...,SET,12,-0.11317,-0.0028922,0.28025,0.65683,GOBP_SINOATRIAL_NODE_DEVELOPMENT,0.99999
KEGG_LONG_TERM_DEPRESSION,SET,66,-0.043618,-0.0026104,0.10795,0.65691,KEGG_LONG_TERM_DEPRESSION,0.99999
GOBP_LIPID_GLYCOSYLATION,SET,11,-0.10623,-0.0025994,0.26291,0.65692,GOBP_LIPID_GLYCOSYLATION,0.99999
HP_BASAL_GANGLIA_CYSTS,SET,6,-0.12266,-0.0022169,0.30348,0.65695,HP_BASAL_GANGLIA_CYSTS,0.99999
GSE1448_CTRL_VS_ANTI_VALPHA2...1,SET,181,-0.025061,-0.0024759,0.062004,0.65696,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN,0.99999
GOBP_VIRAL_PROCESS,SET,396,-0.01749,-0.0025408,0.043269,0.65697,GOBP_VIRAL_PROCESS,0.99999
GSE16450_CTRL_VS_IFNA_12H_ST...3,SET,188,-0.023838,-0.0023997,0.05897,0.65698,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...530,SET,15,-0.085402,-0.00244,0.21125,0.65699,GOBP_POSITIVE_REGULATION_OF_NEURON_MIGRATION,0.99999
REACTOME_DIGESTION_OF_DIETAR...2,SET,6,-0.18132,-0.0032772,0.44833,0.65705,REACTOME_DIGESTION_OF_DIETARY_LIPID,0.99999
MIR328_3P,SET,39,-0.057273,-0.0026368,0.14162,0.65705,MIR328_3P,0.99999
GAUTAM_EYE_CHOROID_SCLERA_AC...,SET,104,-0.032331,-0.0024264,0.079937,0.65706,GAUTAM_EYE_CHOROID_SCLERA_ACTIVATED_T_CELLS,0.99999
LEE_LIVER_CANCER_ACOX1_UP,SET,62,-0.048088,-0.0027896,0.11886,0.6571,LEE_LIVER_CANCER_ACOX1_UP,0.99999
GSE14908_ATOPIC_VS_NONATOPIC...3,SET,180,-0.023922,-0.0023569,0.059089,0.6572,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN,0.99999
LIAO_METASTASIS,SET,476,-0.015333,-0.0024366,0.037871,0.65721,LIAO_METASTASIS,0.99999
BUSSLINGER_ESOPHAGEAL_EARLY_...,SET,74,-0.040096,-0.0025404,0.098941,0.65735,BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS,0.99999
GOCC_PROCENTRIOLE_REPLICATIO...,SET,6,-0.11683,-0.0021117,0.28828,0.65736,GOCC_PROCENTRIOLE_REPLICATION_COMPLEX,0.99999
BIOCARTA_MALATEX_PATHWAY,SET,7,-0.12961,-0.0025303,0.31971,0.65741,BIOCARTA_MALATEX_PATHWAY,0.99999
PID_ALK1_PATHWAY,SET,24,-0.06956,-0.0025132,0.17157,0.65742,PID_ALK1_PATHWAY,0.99999
GOBP_TRANSCRIPTION_ELONGATIO...1,SET,6,-0.14972,-0.002706,0.36927,0.65742,GOBP_TRANSCRIPTION_ELONGATION_BY_RNA_POLYMERASE_I,0.99999
GOMF_PHOSPHATASE_REGULATOR_A...,SET,92,-0.035104,-0.0024786,0.08655,0.65748,GOMF_PHOSPHATASE_REGULATOR_ACTIVITY,0.99999
GSE33424_CD161_HIGH_VS_INT_C...1,SET,184,-0.024909,-0.002481,0.061409,0.65749,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN,0.99999
GNF2_RRM1,SET,85,-0.035504,-0.0024101,0.087519,0.65751,GNF2_RRM1,0.99999
GSE12845_NAIVE_VS_DARKZONE_G...1,SET,176,-0.024093,-0.0023475,0.059391,0.65751,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.99999
HP_CHOANAL_ATRESIA,SET,107,-0.032026,-0.0024377,0.078935,0.65752,HP_CHOANAL_ATRESIA,0.99999
AIZARANI_LIVER_C6_KUPFFER_CE...,SET,203,-0.025569,-0.0026736,0.063017,0.65753,AIZARANI_LIVER_C6_KUPFFER_CELLS_2,0.99999
GSE37416_CTRL_VS_3H_F_TULARE...1,SET,176,-0.02532,-0.0024671,0.062364,0.65763,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
GSE17721_CTRL_VS_LPS_24H_BMD...2,SET,187,-0.024468,-0.0024566,0.060242,0.65768,GSE17721_CTRL_VS_LPS_24H_BMDC_UP,0.99999
GSE39110_DAY3_VS_DAY6_POST_I...4,SET,183,-0.024672,-0.0024508,0.060738,0.6577,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP,0.99999
NRF2_01,SET,249,-0.019999,-0.0023131,0.049232,0.65771,NRF2_01,0.99999
MCMURRAY_TP53_HRAS_COOPERATI...2,SET,26,-0.073645,-0.0027693,0.18128,0.65772,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,0.99999
HASLINGER_B_CLL_WITH_MUTATED...,SET,16,-0.089669,-0.0026459,0.22067,0.65776,HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,0.99999
WP_KETOGENESIS_AND_KETOLYSIS,SET,8,-0.13355,-0.002787,0.32844,0.65785,WP_KETOGENESIS_AND_KETOLYSIS,0.99999
HP_ABNORMAL_ATRIOVENTRICULAR...2,SET,14,-0.095019,-0.0026228,0.23366,0.65787,HP_ABNORMAL_ATRIOVENTRICULAR_CONNECTION,0.99999
YY1_02,SET,228,-0.022079,-0.0024451,0.054287,0.65789,YY1_02,0.99999
GSE14415_INDUCED_TREG_VS_TCO...1,SET,146,-0.028338,-0.0025168,0.069674,0.65789,GSE14415_INDUCED_TREG_VS_TCONV_DN,0.99999
GSE36826_NORMAL_VS_STAPH_AUR...2,SET,187,-0.025545,-0.0025648,0.06277,0.65798,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP,0.99999
GSE22886_UNSTIM_VS_IL15_STIM...2,SET,171,-0.025882,-0.002486,0.063589,0.658,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP,0.99999
GOMF_3_5_RNA_HELICASE_ACTIVI...,SET,5,-0.20922,-0.0034521,0.51392,0.65803,GOMF_3_5_RNA_HELICASE_ACTIVITY,0.99999
ITO_PTTG1_TARGETS_DN,SET,9,-0.11482,-0.0025414,0.282,0.65805,ITO_PTTG1_TARGETS_DN,0.99999
REACTOME_INTERLEUKIN_37_SIGN...,SET,19,-0.06988,-0.0022468,0.17163,0.65805,REACTOME_INTERLEUKIN_37_SIGNALING,0.99999
GOBP_SPERM_MOTILITY,SET,122,-0.029751,-0.0024171,0.073073,0.65805,GOBP_SPERM_MOTILITY,0.99999
GOMF_LONG_CHAIN_FATTY_ACID_T...,SET,15,-0.086584,-0.0024738,0.21259,0.6581,GOMF_LONG_CHAIN_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE37301_HEMATOPOIETIC_STEM_...5,SET,162,-0.027662,-0.0025869,0.067913,0.65811,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN,0.99999
GSE2770_TGFB_AND_IL4_VS_IL12...6,SET,184,-0.02464,-0.0024542,0.060488,0.65812,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.99999
GOBP_LONG_CHAIN_FATTY_ACYL_C...2,SET,24,-0.076718,-0.0027719,0.18832,0.65813,GOBP_LONG_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS,0.99999
GOBP_ICOSANOID_METABOLIC_PRO...,SET,110,-0.033954,-0.0026202,0.083333,0.65816,GOBP_ICOSANOID_METABOLIC_PROCESS,0.99999
GOBP_CEREBELLAR_PURKINJE_CEL...1,SET,23,-0.068738,-0.0024313,0.16861,0.65824,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT,0.99999
MIR7107_3P,SET,49,-0.050813,-0.0026215,0.12458,0.65832,MIR7107_3P,0.99999
GOBP_RRNA_3_END_PROCESSING,SET,10,-0.091929,-0.0021448,0.22538,0.65832,GOBP_RRNA_3_END_PROCESSING,0.99999
GSE9601_NFKB_INHIBITOR_VS_PI...1,SET,185,-0.026919,-0.0026884,0.065981,0.65835,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,0.99999
GOMF_PROSTANOID_RECEPTOR_ACT...,SET,11,-0.11854,-0.0029006,0.29052,0.65837,GOMF_PROSTANOID_RECEPTOR_ACTIVITY,0.99999
GOBP_NEUROINFLAMMATORY_RESPO...,SET,75,-0.043467,-0.0027724,0.10649,0.65843,GOBP_NEUROINFLAMMATORY_RESPONSE,0.99999
GOBP_REGULATION_OF_LIPOPHAGY,SET,5,-0.16027,-0.0026444,0.39223,0.65858,GOBP_REGULATION_OF_LIPOPHAGY,0.99999
HP_NASAL_CONGESTION,SET,47,-0.048527,-0.002452,0.11876,0.65859,HP_NASAL_CONGESTION,0.99999
DORSAM_HOXA9_TARGETS_DN,SET,30,-0.064156,-0.0025912,0.15697,0.65863,DORSAM_HOXA9_TARGETS_DN,0.99999
SENGUPTA_NASOPHARYNGEAL_CARC...3,SET,146,-0.030524,-0.002711,0.074669,0.65865,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,0.99999
MIR550A_3_5P_MIR550A_5P,SET,67,-0.043846,-0.0026438,0.10726,0.65865,MIR550A_3_5P_MIR550A_5P,0.99999
KEGG_MEDICUS_REFERENCE_CA2_C...3,SET,11,-0.11189,-0.0027377,0.2736,0.6587,KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY,0.99999
MODULE_205,SET,276,-0.021347,-0.0025975,0.052202,0.6587,MODULE_205,0.99999
KEGG_MEDICUS_REFERENCE_IFN_R...,SET,28,-0.076539,-0.0029866,0.18715,0.65872,KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY,0.99999
HP_MACROTIA,SET,219,-0.022809,-0.0024762,0.055768,0.65873,HP_MACROTIA,0.99999
MIR8064,SET,73,-0.041355,-0.0026024,0.10109,0.65876,MIR8064,0.99999
HP_ATOPIC_DERMATITIS,SET,35,-0.059741,-0.0026058,0.14602,0.65878,HP_ATOPIC_DERMATITIS,0.99999
BIOCARTA_EIF2_PATHWAY,SET,9,-0.11201,-0.0024792,0.27373,0.6588,BIOCARTA_EIF2_PATHWAY,0.99999
HP_ADVANCED_OSSIFICATION_OF_...,SET,10,-0.10288,-0.0024004,0.2514,0.65881,HP_ADVANCED_OSSIFICATION_OF_CARPAL_BONES,0.99999
GOCC_MITOCHONDRIAL_RESPIRATO...,SET,12,-0.087692,-0.0022411,0.21427,0.65882,GOCC_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III,0.99999
GSE13762_CTRL_VS_125_VITAMIN...3,SET,119,-0.031915,-0.002561,0.077962,0.65886,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN,0.99999
GOMF_AMIDINE_LYASE_ACTIVITY,SET,7,-0.13019,-0.0025415,0.31792,0.65891,GOMF_AMIDINE_LYASE_ACTIVITY,0.99999
GOBP_INTRACILIARY_ANTEROGRAD...,SET,15,-0.089124,-0.0025463,0.21758,0.65896,GOBP_INTRACILIARY_ANTEROGRADE_TRANSPORT,0.99999
GOBP_CARDIAC_MUSCLE_CELL_ACT...1,SET,77,-0.042454,-0.0027435,0.10363,0.65898,GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.99999
MIR516A_5P,SET,6,-0.14333,-0.0025905,0.3498,0.659,MIR516A_5P,0.99999
LEE_BMP2_TARGETS_UP,SET,698,-0.013865,-0.0026515,0.033832,0.65903,LEE_BMP2_TARGETS_UP,0.99999
HP_EPILEPTIC_SPASM,SET,167,-0.026741,-0.0025386,0.065243,0.65904,HP_EPILEPTIC_SPASM,0.99999
GCM_CALM1,SET,98,-0.033509,-0.0024416,0.081754,0.65905,GCM_CALM1,0.99999
GOBP_DOUBLE_STRAND_BREAK_REP...8,SET,8,-0.096987,-0.002024,0.2366,0.65906,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_SYNTHESIS_DEPENDENT_STRAND_ANNEALING,0.99999
WP_15Q11Q13_COPY_NUMBER_VARI...,SET,48,-0.051465,-0.002628,0.12555,0.65907,WP_15Q11Q13_COPY_NUMBER_VARIATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...492,SET,125,-0.029612,-0.0024349,0.072224,0.65909,GOBP_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,0.99999
HP_EYE_OF_THE_TIGER_ANOMALY_...,SET,9,-0.10738,-0.0023767,0.26191,0.65909,HP_EYE_OF_THE_TIGER_ANOMALY_OF_GLOBUS_PALLIDUS,0.99999
GOBP_PARAXIAL_MESODERM_FORMA...,SET,6,-0.15877,-0.0028696,0.38709,0.65915,GOBP_PARAXIAL_MESODERM_FORMATION,0.99999
MIR454_3P,SET,386,-0.017663,-0.0025339,0.043062,0.65916,MIR454_3P,0.99999
HP_HEPATIC_VEIN_THROMBOSIS,SET,9,-0.11417,-0.0025271,0.27822,0.65922,HP_HEPATIC_VEIN_THROMBOSIS,0.99999
MIR4797_5P,SET,105,-0.032342,-0.0024387,0.07878,0.65929,MIR4797_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...505,SET,43,-0.056557,-0.0027338,0.13774,0.65932,GOBP_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_CYC...2,SET,809,-0.011892,-0.0024406,0.028961,0.65932,HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL,0.99999
GOBP_REGULATION_OF_INTRACELL...2,SET,9,-0.11047,-0.0024451,0.26898,0.65935,GOBP_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,0.99999
GOBP_PYRUVATE_FAMILY_AMINO_A...2,SET,12,-0.097988,-0.0025042,0.23854,0.65938,GOBP_PYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.99999
BIOCARTA_RAN_PATHWAY,SET,5,-0.13706,-0.0022614,0.33356,0.65942,BIOCARTA_RAN_PATHWAY,0.99999
GSE2770_TGFB_AND_IL4_VS_IL4_...4,SET,177,-0.025411,-0.0024829,0.061825,0.65947,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_VEN...,SET,76,-0.041222,-0.0026466,0.10027,0.65951,HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL,0.99999
HP_HYPERLIPIDEMIA,SET,136,-0.030821,-0.0026428,0.074963,0.65952,HP_HYPERLIPIDEMIA,0.99999
SA_G2_AND_M_PHASES,SET,8,-0.09944,-0.0020752,0.24179,0.65956,SA_G2_AND_M_PHASES,0.99999
HP_ELEVATED_CIRCULATING_ALAN...,SET,69,-0.039286,-0.0024038,0.09552,0.65957,HP_ELEVATED_CIRCULATING_ALANINE_AMINOTRANSFERASE_CONCENTRATION,0.99999
LUI_THYROID_CANCER_PAX8_PPAR...2,SET,44,-0.049427,-0.0024167,0.12016,0.65959,LUI_THYROID_CANCER_PAX8_PPARG_UP,0.99999
GOMF_MODIFIED_AMINO_ACID_BIN...,SET,91,-0.038358,-0.0026937,0.093228,0.65962,GOMF_MODIFIED_AMINO_ACID_BINDING,0.99999
GOBP_REGULATION_OF_SKELETAL_...4,SET,14,-0.09072,-0.0025041,0.22042,0.65967,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.99999
GATA1_02,SET,218,-0.024196,-0.0026208,0.058769,0.65972,GATA1_02,0.99999
HP_ULNAR_DEVIATION_OF_THE_2N...,SET,7,-0.11878,-0.0023188,0.28826,0.65985,HP_ULNAR_DEVIATION_OF_THE_2ND_FINGER,0.99999
GOBP_DNA_DEAMINATION,SET,11,-0.1167,-0.0028555,0.28316,0.65987,GOBP_DNA_DEAMINATION,0.99999
GOCC_PROTEIN_COMPLEX_INVOLVE...3,SET,17,-0.082081,-0.0024964,0.19918,0.65987,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_MATRIX_ADHESION,0.99999
DESCARTES_FETAL_LUNG_CSH1_CS...,SET,180,-0.025541,-0.0025164,0.061977,0.65987,DESCARTES_FETAL_LUNG_CSH1_CSH2_POSITIVE_CELLS,0.99999
TBPL1_TARGET_GENES,SET,135,-0.030155,-0.0025762,0.07316,0.65989,TBPL1_TARGET_GENES,0.99999
HP_WIDENED_SUBARACHNOID_SPACE,SET,28,-0.062848,-0.0024524,0.15244,0.65993,HP_WIDENED_SUBARACHNOID_SPACE,0.99999
BUSSLINGER_GASTRIC_CHIEF_CEL...,SET,51,-0.050942,-0.0026811,0.12346,0.66005,BUSSLINGER_GASTRIC_CHIEF_CELLS,0.99999
GSE6681_DELETED_FOXP3_VS_WT_...1,SET,176,-0.025968,-0.0025302,0.062927,0.66007,GSE6681_DELETED_FOXP3_VS_WT_TREG_DN,0.99999
HP_CEREBRAL_VENOUS_THROMBOSIS,SET,8,-0.10789,-0.0022516,0.26143,0.66008,HP_CEREBRAL_VENOUS_THROMBOSIS,0.99999
GOBP_REGULATION_OF_GAMMA_DEL...1,SET,11,-0.10714,-0.0026216,0.25955,0.66011,GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION,0.99999
REACTOME_VEGF_LIGAND_RECEPTO...,SET,7,-0.14535,-0.0028374,0.35195,0.66018,REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS,0.99999
GOBP_GAMMA_DELTA_T_CELL_DIFF...,SET,13,-0.094846,-0.0025228,0.2296,0.66023,GOBP_GAMMA_DELTA_T_CELL_DIFFERENTIATION,0.99999
HP_ABNORMAL_BONE_MARROW_CELL...,SET,199,-0.024396,-0.002526,0.059041,0.66027,HP_ABNORMAL_BONE_MARROW_CELL_MORPHOLOGY,0.99999
GSE37301_GRANULOCYTE_MONOCYT...1,SET,182,-0.024827,-0.0024595,0.060082,0.66027,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,0.99999
GSE3982_DC_VS_TH1_DN,SET,177,-0.025079,-0.0024504,0.060686,0.66029,GSE3982_DC_VS_TH1_DN,0.99999
GOBP_CHEMOREPULSION_OF_AXON,SET,6,-0.15026,-0.0027158,0.36355,0.6603,GOBP_CHEMOREPULSION_OF_AXON,0.99999
GSE10273_HIGH_IL7_VS_HIGH_IL...1,SET,174,-0.02595,-0.0025141,0.062778,0.66032,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,0.99999
REACTOME_CROSS_PRESENTATION_...2,SET,47,-0.045067,-0.0022772,0.10901,0.66034,REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES,0.99999
BCAT_GDS748_DN,SET,40,-0.053181,-0.0024795,0.12862,0.66036,BCAT_GDS748_DN,0.99999
GOBP_RESPONSE_TO_HYDROGEN_PE...,SET,89,-0.037601,-0.0026115,0.090923,0.66039,GOBP_RESPONSE_TO_HYDROGEN_PEROXIDE,0.99999
REACTOME_NRIF_SIGNALS_CELL_D...,SET,14,-0.10008,-0.0027624,0.24198,0.66041,REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS,0.99999
MIKKELSEN_IPS_LCP_WITH_H3K4M...1,SET,157,-0.028025,-0.0025804,0.067751,0.66043,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,0.99999
REACTOME_BETA_OXIDATION_OF_B...,SET,5,-0.15152,-0.0025001,0.36628,0.66044,REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA,0.99999
MIR544A,SET,202,-0.024667,-0.002573,0.059628,0.66045,MIR544A,0.99999
GOMF_RNA_POLYMERASE_BINDING,SET,56,-0.046891,-0.0025857,0.11332,0.66048,GOMF_RNA_POLYMERASE_BINDING,0.99999
GSE17721_0.5H_VS_8H_POLYIC_B...1,SET,184,-0.026213,-0.0026109,0.063347,0.66048,GSE17721_0.5H_VS_8H_POLYIC_BMDC_DN,0.99999
HP_LIMB_ATAXIA,SET,82,-0.037359,-0.0024911,0.090273,0.6605,HP_LIMB_ATAXIA,0.99999
HP_ABNORMAL_BRAINSTEM_WHITE_...,SET,15,-0.079293,-0.0022654,0.1916,0.66051,HP_ABNORMAL_BRAINSTEM_WHITE_MATTER_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...235,SET,5,-0.17,-0.0028049,0.41074,0.66052,GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_PROLIFERATION,0.99999
GNF2_HDAC1,SET,99,-0.031804,-0.002329,0.076825,0.66055,GNF2_HDAC1,0.99999
KEGG_MEDICUS_PATHOGEN_EBV_LM...3,SET,5,-0.16699,-0.0027552,0.40334,0.66056,KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_CANONICAL_WNT_SIGNALING...,SET,287,-0.021828,-0.0027076,0.052715,0.66058,GOBP_CANONICAL_WNT_SIGNALING_PATHWAY,0.99999
GOMF_LYSOPHOSPHOLIPID_ACYLTR...,SET,18,-0.089108,-0.0027886,0.21519,0.66059,GOMF_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_LOCOMOTIO...,SET,5,-0.21161,-0.0034916,0.51089,0.66064,GOBP_REGULATION_OF_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR,0.99999
MIR6739_5P,SET,243,-0.022353,-0.0025545,0.05396,0.66066,MIR6739_5P,0.99999
GSE2770_TGFB_AND_IL4_VS_TGFB...5,SET,174,-0.026565,-0.0025738,0.064099,0.66072,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
HP_VENTRICULAR_HYPERTROPHY,SET,138,-0.027925,-0.0024118,0.067367,0.66075,HP_VENTRICULAR_HYPERTROPHY,0.99999
GUO_HEX_TARGETS_DN,SET,60,-0.04348,-0.0024815,0.10487,0.66078,GUO_HEX_TARGETS_DN,0.99999
HP_PUBERTY_AND_GONADAL_DISOR...,SET,561,-0.014817,-0.0025501,0.035686,0.661,HP_PUBERTY_AND_GONADAL_DISORDERS,0.99999
GSE13493_CD4INTCD8POS_VS_CD8...1,SET,182,-0.025042,-0.0024808,0.060305,0.66102,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN,0.99999
AEBP2_TARGET_GENES,SET,990,-0.011261,-0.0025434,0.027114,0.66104,AEBP2_TARGET_GENES,0.99999
TAAYNRNNTCC_UNKNOWN,SET,159,-0.028309,-0.0026229,0.068149,0.66107,TAAYNRNNTCC_UNKNOWN,0.99999
HP_POSTEXERTIONAL_SYMPTOM_EX...,SET,14,-0.09245,-0.0025519,0.22256,0.66107,HP_POSTEXERTIONAL_SYMPTOM_EXACERBATION,0.99999
GOBP_REGULATION_OF_PHOSPHOLI...5,SET,14,-0.094048,-0.002596,0.22616,0.66124,GOBP_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.99999
MORF_SMC1L1,SET,54,-0.042095,-0.0022795,0.10122,0.66125,MORF_SMC1L1,0.99999
GOMF_PHOSPHOLIPASE_A2_ACTIVI...,SET,28,-0.066603,-0.0025989,0.16013,0.66127,GOMF_PHOSPHOLIPASE_A2_ACTIVITY,0.99999
MIR892C_3P,SET,189,-0.02514,-0.0025375,0.060433,0.66129,MIR892C_3P,0.99999
GSE17721_CTRL_VS_PAM3CSK4_24...1,SET,180,-0.025859,-0.0025478,0.062163,0.66129,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_DN,0.99999
REACTOME_MITF_M_DEPENDENT_GE...,SET,91,-0.036977,-0.0025967,0.088864,0.66133,REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION,0.99999
PRDM4_TARGET_GENES,SET,467,-0.01656,-0.0026072,0.039798,0.66133,PRDM4_TARGET_GENES,0.99999
WILLIAMS_ESR1_TARGETS_UP,SET,25,-0.073743,-0.0027192,0.17718,0.66136,WILLIAMS_ESR1_TARGETS_UP,0.99999
WEST_ADRENOCORTICAL_CARCINOM...2,SET,16,-0.088869,-0.0026222,0.21352,0.66137,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP,0.99999
HP_ABNORMAL_CIRCULATING_SEX_...,SET,108,-0.033981,-0.0025985,0.081641,0.66137,HP_ABNORMAL_CIRCULATING_SEX_HORMONE_CONCENTRATION,0.99999
HP_AGENESIS_OF_INCISOR,SET,31,-0.066898,-0.0027465,0.16067,0.66143,HP_AGENESIS_OF_INCISOR,0.99999
GOBP_SKELETAL_MUSCLE_CELL_DI...,SET,72,-0.041642,-0.0026025,0.099997,0.66145,GOBP_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,0.99999
GSE6092_B_BURGDOFERI_VS_B_BU...1,SET,170,-0.026704,-0.0025576,0.06412,0.66146,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN,0.99999
GSE22886_NAIVE_BCELL_VS_MONO...2,SET,161,-0.028254,-0.0026341,0.067816,0.66152,GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP,0.99999
REACTOME_NEGATIVE_REGULATION...3,SET,32,-0.065697,-0.0027403,0.15767,0.66154,REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING,0.99999
HP_SUBCORTICAL_WHITE_MATTER_...,SET,3,-0.18761,-0.0023979,0.45018,0.66156,HP_SUBCORTICAL_WHITE_MATTER_CALCIFICATIONS,0.99999
WP_ANDROGEN_RECEPTOR_SIGNALI...,SET,83,-0.037781,-0.0025344,0.090651,0.66157,WP_ANDROGEN_RECEPTOR_SIGNALING,0.99999
GOCC_CUL5_RING_UBIQUITIN_LIG...,SET,8,-0.12766,-0.0026642,0.30627,0.6616,GOCC_CUL5_RING_UBIQUITIN_LIGASE_COMPLEX,0.99999
REACTOME_PHASE_II_CONJUGATIO...,SET,99,-0.041071,-0.0030077,0.098514,0.66162,REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,0.99999
HP_POSTERIOR_BLEPHARITIS,SET,5,-0.14049,-0.002318,0.33699,0.66162,HP_POSTERIOR_BLEPHARITIS,0.99999
GOBP_RESPONSE_TO_TYPE_I_INTE...,SET,79,-0.041789,-0.0027352,0.10013,0.66179,GOBP_RESPONSE_TO_TYPE_I_INTERFERON,0.99999
GOBP_CHROMOSOME_CONDENSATION,SET,31,-0.061141,-0.0025101,0.14643,0.66186,GOBP_CHROMOSOME_CONDENSATION,0.99999
GOBP_VESICLE_TARGETING_ROUGH...,SET,24,-0.068947,-0.0024911,0.16512,0.66186,GOBP_VESICLE_TARGETING_ROUGH_ER_TO_CIS_GOLGI,0.99999
GOCC_CELL_CELL_JUNCTION,SET,471,-0.017006,-0.0026886,0.040728,0.66186,GOCC_CELL_CELL_JUNCTION,0.99999
HP_ABNORMALITY_OF_OCULAR_SMO...,SET,64,-0.039774,-0.0023442,0.095242,0.66188,HP_ABNORMALITY_OF_OCULAR_SMOOTH_PURSUIT,0.99999
CEBPGAMMA_Q6,SET,233,-0.023897,-0.0026748,0.057212,0.66191,CEBPGAMMA_Q6,0.99999
GOBP_GLYCEROL_3_PHOSPHATE_ME...,SET,7,-0.15464,-0.0030189,0.37008,0.66198,GOBP_GLYCEROL_3_PHOSPHATE_METABOLIC_PROCESS,0.99999
GOMF_ENZYME_REGULATOR_ACTIVI...,SET,1187,-0.010585,-0.0026029,0.025328,0.66199,GOMF_ENZYME_REGULATOR_ACTIVITY,0.99999
GSE1925_3H_VS_24H_IFNG_STIM_...4,SET,170,-0.026928,-0.002579,0.064427,0.66201,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP,0.99999
GSE37319_WT_VS_RC3H1_KO_CD44...2,SET,130,-0.031874,-0.0026725,0.076258,0.66201,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP,0.99999
MIR548AD_5P_MIR548AE_5P_MIR5...,SET,445,-0.016886,-0.0025968,0.040393,0.66204,MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P,0.99999
GSE29615_DAY3_VS_DAY7_LAIV_F...1,SET,162,-0.02779,-0.0025988,0.066469,0.66206,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,0.99999
SEKI_INFLAMMATORY_RESPONSE_L...1,SET,20,-0.087144,-0.0028745,0.20842,0.66207,SEKI_INFLAMMATORY_RESPONSE_LPS_DN,0.99999
MORF_CTSB,SET,156,-0.029426,-0.0027008,0.070352,0.66212,MORF_CTSB,0.99999
GOCC_SM_LIKE_PROTEIN_FAMILY_...,SET,77,-0.034306,-0.002217,0.082014,0.66213,GOCC_SM_LIKE_PROTEIN_FAMILY_COMPLEX,0.99999
HP_INTERMITTENT_HYPERVENTILA...,SET,3,-0.2258,-0.0028861,0.53983,0.66213,HP_INTERMITTENT_HYPERVENTILATION,0.99999
GOBP_DETERMINATION_OF_ADULT_...,SET,31,-0.062659,-0.0025725,0.14967,0.66226,GOBP_DETERMINATION_OF_ADULT_LIFESPAN,0.99999
KEGG_MEDICUS_REFERENCE_TSH_D...,SET,12,-0.098456,-0.0025162,0.23516,0.66227,KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...4,SET,169,-0.02796,-0.0026701,0.066783,0.66227,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP,0.99999
DESCARTES_MAIN_FETAL_SCHWANN...,SET,37,-0.058572,-0.0026267,0.13985,0.66232,DESCARTES_MAIN_FETAL_SCHWANN_CELLS,0.99999
TBK1.DN.48HRS_DN,SET,46,-0.053357,-0.0026673,0.12736,0.66237,TBK1.DN.48HRS_DN,0.99999
GSE34205_RSV_VS_FLU_INF_INFA...1,SET,175,-0.026901,-0.0026137,0.064179,0.66244,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN,0.99999
GSE8921_UNSTIM_VS_TLR1_2_STI...4,SET,177,-0.027327,-0.0026701,0.065187,0.66246,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP,0.99999
KEGG_MEDICUS_REFERENCE_BMP_H...1,SET,11,-0.10506,-0.0025706,0.25052,0.66252,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY,0.99999
GOBP_PROTEIN_TARGETING_TO_PE...,SET,9,-0.10773,-0.0023845,0.25685,0.66254,GOBP_PROTEIN_TARGETING_TO_PEROXISOME,0.99999
GSE19941_UNSTIM_VS_LPS_AND_I...2,SET,185,-0.02708,-0.0027045,0.064565,0.66254,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.99999
GSE45837_WT_VS_GFI1_KO_PDC_UP,SET,164,-0.026864,-0.0025276,0.064054,0.66254,GSE45837_WT_VS_GFI1_KO_PDC_UP,0.99999
GSE9316_IL6_KO_VS_IFNG_KO_IN...2,SET,184,-0.026284,-0.0026179,0.06267,0.66254,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_UP,0.99999
GOBP_REGULATION_OF_SIGNALING...,SET,88,-0.03946,-0.0027253,0.094066,0.66257,GOBP_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,0.99999
SERVITJA_LIVER_HNF1A_TARGETS...2,SET,132,-0.031751,-0.0026825,0.075619,0.66271,SERVITJA_LIVER_HNF1A_TARGETS_UP,0.99999
HP_NON_OBSTRUCTIVE_AZOOSPERM...,SET,48,-0.05098,-0.0026032,0.12141,0.66272,HP_NON_OBSTRUCTIVE_AZOOSPERMIA,0.99999
ELVIDGE_HIF1A_AND_HIF2A_TARG...2,SET,37,-0.055194,-0.0024752,0.13142,0.66275,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP,0.99999
HP_INCREASED_CIRCULATING_IGE...,SET,39,-0.05473,-0.0025197,0.1303,0.66277,HP_INCREASED_CIRCULATING_IGE_LEVEL,0.99999
MODULE_492,SET,16,-0.091077,-0.0026874,0.21665,0.6629,MODULE_492,0.99999
REACTOME_RAS_ACTIVATION_UPON...,SET,19,-0.083517,-0.0026852,0.19865,0.66291,REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR,0.99999
MIR3944_5P,SET,103,-0.034279,-0.0025602,0.081531,0.66292,MIR3944_5P,0.99999
GOBP_RIBOSOMAL_LARGE_SUBUNIT...2,SET,60,-0.042526,-0.002427,0.1011,0.66299,GOBP_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS,0.99999
GOBP_UDP_GLUCOSE_METABOLIC_P...,SET,6,-0.11427,-0.0020653,0.27162,0.66301,GOBP_UDP_GLUCOSE_METABOLIC_PROCESS,0.99999
REACTOME_PLATELET_SENSITIZAT...,SET,16,-0.08845,-0.0026099,0.21019,0.66305,REACTOME_PLATELET_SENSITIZATION_BY_LDL,0.99999
REACTOME_INTERACTIONS_OF_VPR...,SET,33,-0.057105,-0.0024188,0.13568,0.66308,REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS,0.99999
GOBP_ENUCLEATE_ERYTHROCYTE_D...2,SET,12,-0.108,-0.0027602,0.25655,0.66311,GOBP_ENUCLEATE_ERYTHROCYTE_DIFFERENTIATION,0.99999
GOBP_RENAL_CONTROL_OF_PERIPH...,SET,4,-0.16963,-0.0025034,0.40282,0.66316,GOBP_RENAL_CONTROL_OF_PERIPHERAL_VASCULAR_RESISTANCE_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
GOBP_ARGININE_METABOLIC_PROC...,SET,17,-0.086179,-0.0026211,0.20457,0.66322,GOBP_ARGININE_METABOLIC_PROCESS,0.99999
MATZUK_OVULATION,SET,15,-0.099267,-0.0028361,0.23542,0.66336,MATZUK_OVULATION,0.99999
GSE36392_EOSINOPHIL_VS_NEUTR...2,SET,183,-0.026018,-0.0025845,0.06169,0.66339,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,0.99999
GSE41087_WT_VS_FOXP3_MUT_ANT...1,SET,173,-0.025457,-0.0024594,0.060323,0.66349,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...11,SET,12,-0.09997,-0.0025549,0.23681,0.66354,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION,0.99999
HP_HYPOKALEMIC_METABOLIC_ALK...,SET,9,-0.12544,-0.0027765,0.29695,0.66364,HP_HYPOKALEMIC_METABOLIC_ALKALOSIS,0.99999
GOBP_RESPONSE_TO_MACROPHAGE_...,SET,16,-0.10002,-0.0029512,0.23673,0.66367,GOBP_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR,0.99999
REACTOME_G2_PHASE,SET,5,-0.16309,-0.0026909,0.38592,0.6637,REACTOME_G2_PHASE,0.99999
TTCCGTT_MIR191,SET,28,-0.064983,-0.0025357,0.15373,0.66374,TTCCGTT_MIR191,0.99999
PID_LYMPH_ANGIOGENESIS_PATHW...,SET,24,-0.077391,-0.0027962,0.18307,0.66376,PID_LYMPH_ANGIOGENESIS_PATHWAY,0.99999
MIR510_5P,SET,59,-0.044534,-0.0025204,0.10533,0.66377,MIR510_5P,0.99999
TCCGTCC_MIR184,SET,12,-0.11462,-0.0029293,0.2711,0.66378,TCCGTCC_MIR184,0.99999
GOMF_GTP_DEPENDENT_PROTEIN_B...,SET,20,-0.086836,-0.0028644,0.20538,0.66378,GOMF_GTP_DEPENDENT_PROTEIN_BINDING,0.99999
GSE15330_LYMPHOID_MULTIPOTEN...10,SET,182,-0.025987,-0.0025744,0.061462,0.66378,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...407,SET,13,-0.10174,-0.0027062,0.24059,0.6638,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING,0.99999
GOBP_N_TERMINAL_PROTEIN_AMIN...1,SET,13,-0.097344,-0.0025893,0.23017,0.66382,GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_ACETYLATION,0.99999
KEGG_MEDICUS_ENV_FACTOR_NNK_...1,SET,9,-0.10808,-0.0023922,0.25538,0.66392,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_CHRNA7_E2F_SIGNALING_PATHWAY,0.99999
TACAATC_MIR508,SET,58,-0.047464,-0.0026635,0.11216,0.66392,TACAATC_MIR508,0.99999
GOMF_SOLUTE_INORGANIC_ANION_...,SET,31,-0.064091,-0.0026312,0.15145,0.66392,GOMF_SOLUTE_INORGANIC_ANION_ANTIPORTER_ACTIVITY,0.99999
WP_METHYLATION_PATHWAYS,SET,9,-0.12965,-0.0028698,0.30631,0.66395,WP_METHYLATION_PATHWAYS,0.99999
GSE6674_PL2_3_VS_ANTI_IGM_AN...2,SET,178,-0.025966,-0.0025442,0.061333,0.66398,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...33,SET,3,-0.22038,-0.0028167,0.52049,0.664,GOBP_NEGATIVE_REGULATION_OF_ASTROCYTE_ACTIVATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...294,SET,5,-0.1545,-0.0025492,0.3649,0.664,GOBP_POSITIVE_REGULATION_OF_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION,0.99999
GOBP_RESPONSE_TO_UV_C,SET,12,-0.098783,-0.0025246,0.23316,0.6641,GOBP_RESPONSE_TO_UV_C,0.99999
ZNF776_TARGET_GENES,SET,6,-0.12122,-0.002191,0.2861,0.66411,ZNF776_TARGET_GENES,0.99999
WP_IMMUNE_INFILTRATION_IN_PA...,SET,38,-0.061629,-0.0028008,0.14541,0.66415,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,0.99999
MIR202_3P,SET,229,-0.023986,-0.0026619,0.056592,0.66415,MIR202_3P,0.99999
GSE1432_1H_VS_6H_IFNG_MICROG...1,SET,179,-0.026676,-0.0026211,0.06293,0.66418,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,0.99999
GUENTHER_GROWTH_SPHERICAL_VS...1,SET,24,-0.076669,-0.0027701,0.18085,0.66419,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,0.99999
GOBP_CELLULAR_HYPOTONIC_RESP...,SET,11,-0.11408,-0.0027914,0.26908,0.6642,GOBP_CELLULAR_HYPOTONIC_RESPONSE,0.99999
SMITH_TERT_TARGETS_DN,SET,83,-0.041088,-0.0027563,0.096908,0.66421,SMITH_TERT_TARGETS_DN,0.99999
GOBP_REGULATION_OF_GLUCOSE_M...,SET,88,-0.038583,-0.0026647,0.090983,0.66424,GOBP_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...228,SET,28,-0.064243,-0.0025068,0.15148,0.66425,GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.99999
GOMF_COLLAGEN_RECEPTOR_ACTIV...,SET,6,-0.13873,-0.0025074,0.32711,0.66426,GOMF_COLLAGEN_RECEPTOR_ACTIVITY,0.99999
GSE33292_WT_VS_TCF1_KO_DN3_T...1,SET,189,-0.024686,-0.0024917,0.058193,0.66429,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN,0.99999
LI_ESTROGENE_LATE_E2_RESPONS...1,SET,71,-0.045555,-0.0028273,0.10736,0.66432,LI_ESTROGENE_LATE_E2_RESPONSE_DN,0.99999
MORF_FBL,SET,125,-0.029366,-0.0024147,0.069203,0.66434,MORF_FBL,0.99999
GCM_USP6,SET,67,-0.038988,-0.0023508,0.091865,0.66436,GCM_USP6,0.99999
GOBP_BRANCHED_CHAIN_AMINO_AC...2,SET,21,-0.074517,-0.0025187,0.17558,0.66437,GOBP_BRANCHED_CHAIN_AMINO_ACID_CATABOLIC_PROCESS,0.99999
GOCC_OMEGASOME,SET,4,-0.13959,-0.0020601,0.32881,0.66441,GOCC_OMEGASOME,0.99999
COLLER_MYC_TARGETS_UP,SET,23,-0.076572,-0.0027084,0.18036,0.66442,COLLER_MYC_TARGETS_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...516,SET,129,-0.031121,-0.0025994,0.073304,0.66442,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.99999
HP_ABNORMAL_EPIPHYSIS_MORPHO...1,SET,246,-0.023047,-0.0026498,0.054284,0.66442,HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY,0.99999
GOBP_FOREBRAIN_REGIONALIZATI...,SET,23,-0.087279,-0.0030871,0.20548,0.66449,GOBP_FOREBRAIN_REGIONALIZATION,0.99999
DODD_NASOPHARYNGEAL_CARCINOM...2,SET,1245,-0.010317,-0.002594,0.024285,0.66453,DODD_NASOPHARYNGEAL_CARCINOMA_UP,0.99999
JONES_OVARY_GRANULOSA,SET,69,-0.044526,-0.0027244,0.10478,0.66455,JONES_OVARY_GRANULOSA,0.99999
GOCC_FC_RECEPTOR_COMPLEX,SET,5,-0.18005,-0.0029707,0.42359,0.6646,GOCC_FC_RECEPTOR_COMPLEX,0.99999
GOBP_PHENOTYPIC_SWITCHING,SET,7,-0.14491,-0.0028289,0.34087,0.66462,GOBP_PHENOTYPIC_SWITCHING,0.99999
GOCC_INO80_TYPE_COMPLEX,SET,27,-0.063905,-0.0024488,0.15033,0.66462,GOCC_INO80_TYPE_COMPLEX,0.99999
GOBP_POSITIVE_REGULATION_OF_...127,SET,807,-0.01347,-0.0027612,0.031671,0.66469,GOBP_POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION,0.99999
REACTOME_SIGNALING_BY_HEDGEH...,SET,144,-0.028304,-0.0024967,0.066545,0.6647,REACTOME_SIGNALING_BY_HEDGEHOG,0.99999
GSE2706_LPS_VS_R848_AND_LPS_...1,SET,128,-0.032976,-0.0027437,0.077527,0.66471,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN,0.99999
HP_HYPOPLASIA_OF_PENIS,SET,340,-0.01982,-0.0026721,0.046591,0.66473,HP_HYPOPLASIA_OF_PENIS,0.99999
MIR7160_3P,SET,27,-0.070151,-0.0026881,0.16487,0.66476,MIR7160_3P,0.99999
GOMF_OSMOSENSOR_ACTIVITY,SET,5,-0.17639,-0.0029103,0.41439,0.66482,GOMF_OSMOSENSOR_ACTIVITY,0.99999
GSE38681_WT_VS_LYL1_KO_LYMPH...1,SET,191,-0.026647,-0.0027036,0.062601,0.66482,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...10,SET,176,-0.02596,-0.0025294,0.060951,0.66491,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP,0.99999
KIM_ALL_DISORDERS_CALB1_CORR...2,SET,497,-0.016124,-0.0026167,0.037856,0.66492,KIM_ALL_DISORDERS_CALB1_CORR_UP,0.99999
MIR6771_3P,SET,89,-0.038292,-0.0026595,0.089889,0.66494,MIR6771_3P,0.99999
HOSHIDA_LIVER_CANCER_SUBCLAS...2,SET,108,-0.033101,-0.0025312,0.077683,0.66498,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,0.99999
GOCC_BRUSH_BORDER_MEMBRANE,SET,55,-0.046746,-0.0025546,0.1097,0.66499,GOCC_BRUSH_BORDER_MEMBRANE,0.99999
CASTELLANO_HRAS_TARGETS_DN,SET,4,-0.16937,-0.0024996,0.3974,0.66501,CASTELLANO_HRAS_TARGETS_DN,0.99999
LOPEZ_MESOTELIOMA_SURVIVAL_T...2,SET,10,-0.11751,-0.0027416,0.2756,0.66508,LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP,0.99999
GOBP_PIGMENT_CELL_DIFFERENTI...,SET,34,-0.066797,-0.0028717,0.15666,0.66508,GOBP_PIGMENT_CELL_DIFFERENTIATION,0.99999
WP_TRIACYLGLYCERIDE_SYNTHESIS,SET,20,-0.087711,-0.0028932,0.20566,0.66512,WP_TRIACYLGLYCERIDE_SYNTHESIS,0.99999
GOCC_KINOCILIUM,SET,10,-0.11943,-0.0027864,0.27982,0.66524,GOCC_KINOCILIUM,0.99999
REACTOME_PKA_ACTIVATION_IN_G...,SET,17,-0.093053,-0.0028301,0.21795,0.66529,REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...409,SET,7,-0.14581,-0.0028464,0.34143,0.66533,GOBP_NEGATIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,0.99999
GOCC_APOLIPOPROTEIN_B_MRNA_E...,SET,4,-0.19316,-0.0028507,0.45226,0.66534,GOCC_APOLIPOPROTEIN_B_MRNA_EDITING_ENZYME_COMPLEX,0.99999
GSE30962_PRIMARY_VS_SECONDAR...1,SET,180,-0.027018,-0.0026619,0.063259,0.66534,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN,0.99999
GOBP_SYNAPTIC_VESICLE_RECYCL...2,SET,4,-0.15738,-0.0023227,0.36842,0.66537,GOBP_SYNAPTIC_VESICLE_RECYCLING_VIA_ENDOSOME,0.99999
GOCC_CYTOPLASMIC_SIDE_OF_PLA...,SET,152,-0.02974,-0.0026947,0.069568,0.66549,GOCC_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,0.99999
SA_MMP_CYTOKINE_CONNECTION,SET,15,-0.10302,-0.0029434,0.24091,0.66554,SA_MMP_CYTOKINE_CONNECTION,0.99999
GOBP_HYPOTONIC_RESPONSE,SET,13,-0.10591,-0.0028172,0.24763,0.66557,GOBP_HYPOTONIC_RESPONSE,0.99999
GOCC_FLEMMING_BODY,SET,34,-0.061839,-0.0026586,0.14457,0.66558,GOCC_FLEMMING_BODY,0.99999
FAN_EMBRYONIC_CTX_BIG_GROUPS...6,SET,8,-0.15195,-0.003171,0.35524,0.66558,FAN_EMBRYONIC_CTX_BIG_GROUPS_INHIBITORY,0.99999
LAU_APOPTOSIS_CDKN2A_UP,SET,55,-0.04583,-0.0025046,0.10713,0.6656,LAU_APOPTOSIS_CDKN2A_UP,0.99999
chr21q22,SET,149,-0.058529,-0.0052511,0.1368,0.66562,chr21q22,0.99999
GRAESSMANN_RESPONSE_TO_MC_AN...2,SET,565,-0.015256,-0.0026348,0.035655,0.66563,GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP,0.99999
HP_INCREASED_CORNEAL_THICKNE...,SET,5,-0.18796,-0.0031012,0.43918,0.66566,HP_INCREASED_CORNEAL_THICKNESS,0.99999
GCACTTT_MIR175P_MIR20A_MIR10...,SET,545,-0.015733,-0.00267,0.036758,0.66568,GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D,0.99999
GOCC_MATRIX_SIDE_OF_MITOCHON...,SET,5,-0.15911,-0.0026253,0.37166,0.66571,GOCC_MATRIX_SIDE_OF_MITOCHONDRIAL_INNER_MEMBRANE,0.99999
BIOCARTA_PCAF_PATHWAY,SET,13,-0.092564,-0.0024621,0.2162,0.66572,BIOCARTA_PCAF_PATHWAY,0.99999
CHARAFE_BREAST_CANCER_LUMINA...4,SET,400,-0.018571,-0.0027111,0.043361,0.66578,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,0.99999
HP_THICKENED_HELICES,SET,43,-0.051009,-0.0024656,0.11909,0.66579,HP_THICKENED_HELICES,0.99999
HP_SPONTANEOUS_HEMATOMAS,SET,18,-0.097758,-0.0030593,0.22818,0.66583,HP_SPONTANEOUS_HEMATOMAS,0.99999
GOBP_CELLULAR_HOMEOSTASIS,SET,746,-0.013781,-0.0027208,0.032145,0.66593,GOBP_CELLULAR_HOMEOSTASIS,0.99999
MIR876_5P,SET,123,-0.033673,-0.0027468,0.078528,0.66597,MIR876_5P,0.99999
GOBP_CLUSTERING_OF_VOLTAGE_G...,SET,6,-0.14586,-0.0026363,0.3401,0.66599,GOBP_CLUSTERING_OF_VOLTAGE_GATED_SODIUM_CHANNELS,0.99999
GOBP_L_CYSTINE_TRANSPORT,SET,6,-0.14503,-0.0026213,0.33814,0.666,GOBP_L_CYSTINE_TRANSPORT,0.99999
GOBP_NITRIC_OXIDE_SYNTHASE_B...,SET,18,-0.098554,-0.0030842,0.22978,0.666,GOBP_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,0.99999
WP_MIRNA_REGULATION_OF_DNA_D...,SET,67,-0.04115,-0.0024812,0.095908,0.66606,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,0.99999
WILLIAMS_ESR1_TARGETS_DN,SET,6,-0.14169,-0.002561,0.33016,0.6661,WILLIAMS_ESR1_TARGETS_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...49,SET,147,-0.029554,-0.0026338,0.068849,0.66613,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY,0.99999
REACTOME_PYRIMIDINE_CATABOLI...,SET,12,-0.11006,-0.0028126,0.25634,0.66615,REACTOME_PYRIMIDINE_CATABOLISM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...682,SET,5,-0.18743,-0.0030925,0.43659,0.66615,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,0.99999
GOBP_POLY_A_DEPENDENT_SNORNA...,SET,6,-0.12484,-0.0022564,0.29079,0.66615,GOBP_POLY_A_DEPENDENT_SNORNA_3_END_PROCESSING,0.99999
GOBP_MEMBRANE_RAFT_ASSEMBLY,SET,11,-0.10534,-0.0025775,0.24534,0.66616,GOBP_MEMBRANE_RAFT_ASSEMBLY,0.99999
KAT5_TARGET_GENES,SET,707,-0.013456,-0.0025892,0.031334,0.6662,KAT5_TARGET_GENES,0.99999
GOBP_PLASMA_MEMBRANE_TUBULAT...,SET,18,-0.079245,-0.00248,0.18444,0.66628,GOBP_PLASMA_MEMBRANE_TUBULATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...551,SET,6,-0.14824,-0.0026793,0.34487,0.66634,GOBP_POSITIVE_REGULATION_OF_NUCLEASE_ACTIVITY,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_NEU...,SET,58,-0.050043,-0.0028081,0.11639,0.66638,HE_LIM_SUN_FETAL_LUNG_C2_NEUTROPHIL_CELL,0.99999
HP_PITUITARY_GROWTH_HORMONE_...,SET,16,-0.084689,-0.0024989,0.19687,0.66646,HP_PITUITARY_GROWTH_HORMONE_CELL_ADENOMA,0.99999
MIR4294,SET,69,-0.043613,-0.0026685,0.10136,0.66649,MIR4294,0.99999
GOBP_DNA_DEMETHYLATION,SET,18,-0.10026,-0.0031377,0.233,0.66651,GOBP_DNA_DEMETHYLATION,0.99999
MIR4538,SET,25,-0.078682,-0.0029013,0.18276,0.66658,MIR4538,0.99999
GOBP_REGULATION_OF_CARBOHYDR...2,SET,58,-0.045187,-0.0025357,0.10492,0.66665,GOBP_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS,0.99999
MIR4325,SET,244,-0.02359,-0.0027012,0.054765,0.66667,MIR4325,0.99999
GCCNNNWTAAR_UNKNOWN,SET,132,-0.032166,-0.0027175,0.074659,0.6667,GCCNNNWTAAR_UNKNOWN,0.99999
RORIE_TARGETS_OF_EWSR1_FLI1_...1,SET,25,-0.080884,-0.0029825,0.18769,0.66675,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,0.99999
GOBP_POSTSYNAPTIC_DENSITY_AS...,SET,24,-0.07898,-0.0028536,0.18327,0.66675,GOBP_POSTSYNAPTIC_DENSITY_ASSEMBLY,0.99999
KAMIKUBO_MYELOID_MN1_NETWORK,SET,18,-0.088423,-0.0027672,0.20512,0.6668,KAMIKUBO_MYELOID_MN1_NETWORK,0.99999
MEL18_DN.V1_UP,SET,133,-0.034176,-0.0028981,0.079271,0.66681,MEL18_DN.V1_UP,0.99999
HP_ABNORMAL_CHOROID_MORPHOLO...,SET,169,-0.028415,-0.0027135,0.065903,0.66682,HP_ABNORMAL_CHOROID_MORPHOLOGY,0.99999
HP_SLOWLY_PROGRESSIVE,SET,141,-0.030112,-0.0026286,0.069835,0.66683,HP_SLOWLY_PROGRESSIVE,0.99999
RIZ_ERYTHROID_DIFFERENTIATIO...1,SET,32,-0.070827,-0.0029542,0.16421,0.66688,RIZ_ERYTHROID_DIFFERENTIATION_12HR,0.99999
GOBP_ACTION_POTENTIAL,SET,158,-0.031522,-0.0029115,0.073085,0.66688,GOBP_ACTION_POTENTIAL,0.99999
AIZARANI_LIVER_C14_HEPATOCYT...,SET,208,-0.027308,-0.00289,0.063305,0.66689,AIZARANI_LIVER_C14_HEPATOCYTES_2,0.99999
MIR6828_5P,SET,159,-0.028555,-0.0026457,0.066189,0.66691,MIR6828_5P,0.99999
GOMF_PROTEASE_BINDING,SET,126,-0.0323,-0.0026665,0.074863,0.66693,GOMF_PROTEASE_BINDING,0.99999
HP_HYPOTHALAMIC_HYPOTHYROIDI...,SET,12,-0.097331,-0.0024874,0.22558,0.66693,HP_HYPOTHALAMIC_HYPOTHYROIDISM,0.99999
REACTOME_REGULATION_OF_GLUCO...,SET,30,-0.062017,-0.0025048,0.14373,0.66694,REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN,0.99999
HP_NONCOMPACTION_CARDIOMYOPA...,SET,15,-0.096449,-0.0027556,0.22353,0.66694,HP_NONCOMPACTION_CARDIOMYOPATHY,0.99999
GSE411_100MIN_VS_400MIN_IL6_...1,SET,182,-0.025005,-0.0024772,0.057952,0.66694,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_DN,0.99999
THAKAR_PBMC_INACTIVATED_INFL...3,SET,66,-0.044638,-0.0026715,0.10346,0.66694,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN,0.99999
GOBP_SPHINGOLIPID_METABOLIC_...,SET,158,-0.030423,-0.00281,0.070502,0.66695,GOBP_SPHINGOLIPID_METABOLIC_PROCESS,0.99999
ERWIN_COHEN_BLOOD_VACCINE_TC...4,SET,71,-0.044888,-0.0027859,0.10402,0.66696,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_UP,0.99999
HP_ABNORMAL_EPIDERMAL_MORPHO...,SET,87,-0.038436,-0.0026395,0.089013,0.66705,HP_ABNORMAL_EPIDERMAL_MORPHOLOGY,0.99999
GOMF_AP_2_ADAPTOR_COMPLEX_BI...,SET,10,-0.11177,-0.0026076,0.2588,0.66708,GOMF_AP_2_ADAPTOR_COMPLEX_BINDING,0.99999
GOBP_NADPH_REGENERATION,SET,21,-0.081613,-0.0027585,0.18896,0.66709,GOBP_NADPH_REGENERATION,0.99999
HP_CERVICAL_CORD_COMPRESSION,SET,6,-0.14949,-0.0027019,0.34604,0.66713,HP_CERVICAL_CORD_COMPRESSION,0.99999
GOMF_MYOSIN_BINDING,SET,69,-0.043151,-0.0026403,0.099874,0.66715,GOMF_MYOSIN_BINDING,0.99999
BRUINS_UVC_RESPONSE_MIDDLE,SET,92,-0.035597,-0.0025134,0.082379,0.66717,BRUINS_UVC_RESPONSE_MIDDLE,0.99999
MIR3680_3P,SET,491,-0.017583,-0.0028365,0.040672,0.66724,MIR3680_3P,0.99999
MIR764,SET,46,-0.049199,-0.0024595,0.11379,0.66726,MIR764,0.99999
WP_CYTOKINECYTOKINE_RECEPTOR...,SET,241,-0.026797,-0.0030498,0.061973,0.66727,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,0.99999
WP_TRANSLATION_INHIBITORS_IN...,SET,45,-0.055919,-0.0027649,0.12932,0.66728,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,0.99999
GOBP_FREE_UBIQUITIN_CHAIN_PO...,SET,8,-0.13672,-0.0028532,0.31617,0.66728,GOBP_FREE_UBIQUITIN_CHAIN_POLYMERIZATION,0.99999
REACTOME_DEGRADATION_OF_GLI1...,SET,57,-0.04276,-0.0023788,0.098862,0.66732,REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,0.99999
GOBP_ACTIN_FILAMENT_DEPOLYME...,SET,54,-0.047949,-0.0025965,0.11086,0.66732,GOBP_ACTIN_FILAMENT_DEPOLYMERIZATION,0.99999
GOMF_INTRACELLULARLY_CAMP_AC...,SET,8,-0.12687,-0.0026476,0.29327,0.66734,GOMF_INTRACELLULARLY_CAMP_ACTIVATED_CATION_CHANNEL_ACTIVITY,0.99999
GOBP_CARDIAC_SEPTUM_DEVELOPM...,SET,104,-0.03844,-0.0028848,0.088817,0.66742,GOBP_CARDIAC_SEPTUM_DEVELOPMENT,0.99999
LET_7F_5P,SET,362,-0.019645,-0.0027311,0.04538,0.66745,LET_7F_5P,0.99999
GOCC_MITOCHONDRIAL_INTERMEMB...,SET,5,-0.13998,-0.0023096,0.32325,0.6675,GOCC_MITOCHONDRIAL_INTERMEMBRANE_SPACE_PROTEIN_TRANSPORTER_COMPLEX,0.99999
GSE3920_UNTREATED_VS_IFNB_TR...1,SET,157,-0.028531,-0.002627,0.065888,0.6675,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,0.99999
GOMF_INTEGRIN_BINDING_INVOLV...,SET,5,-0.17817,-0.0029398,0.41143,0.66751,GOMF_INTEGRIN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION,0.99999
HP_NARROW_PALATE,SET,164,-0.028047,-0.0026389,0.064766,0.66751,HP_NARROW_PALATE,0.99999
HP_HEMIFACIAL_SPASM,SET,12,-0.093378,-0.0023864,0.2156,0.66753,HP_HEMIFACIAL_SPASM,0.99999
HP_LOWER_LIMB_HYPERREFLEXIA,SET,71,-0.041478,-0.0025743,0.095766,0.66753,HP_LOWER_LIMB_HYPERREFLEXIA,0.99999
MIR4764_3P,SET,62,-0.045623,-0.0026467,0.1053,0.66758,MIR4764_3P,0.99999
GSE13522_WT_VS_IFNG_KO_SKING...2,SET,107,-0.036035,-0.0027428,0.083159,0.66761,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,0.99999
MIR5580_5P,SET,109,-0.035347,-0.0027154,0.081554,0.66764,MIR5580_5P,0.99999
GOBP_RENAL_WATER_TRANSPORT,SET,9,-0.13441,-0.0029751,0.31006,0.66767,GOBP_RENAL_WATER_TRANSPORT,0.99999
GOBP_HEMOGLOBIN_METABOLIC_PR...,SET,17,-0.088891,-0.0027035,0.20502,0.6677,GOBP_HEMOGLOBIN_METABOLIC_PROCESS,0.99999
MIR4521,SET,67,-0.046855,-0.0028252,0.10805,0.66773,MIR4521,0.99999
AFP1_Q6,SET,237,-0.025319,-0.002858,0.058379,0.66775,AFP1_Q6,0.99999
GOBP_REGULATION_OF_VITAMIN_D...1,SET,7,-0.14449,-0.0028208,0.3331,0.66777,GOBP_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_NUCLEAR_T...3,SET,13,-0.095878,-0.0025503,0.22097,0.66781,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,0.99999
MIR1915_3P,SET,156,-0.029867,-0.0027413,0.068811,0.66787,MIR1915_3P,0.99999
GOMF_CAMP_DEPENDENT_PROTEIN_...3,SET,12,-0.10278,-0.0026266,0.23664,0.66797,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_REGULATOR_ACTIVITY,0.99999
REACTOME_BIOLOGICAL_OXIDATIO...,SET,204,-0.029316,-0.0030729,0.06747,0.66804,REACTOME_BIOLOGICAL_OXIDATIONS,0.99999
ZWANG_EGF_PERSISTENTLY_DN,SET,56,-0.044615,-0.0024602,0.10259,0.66818,ZWANG_EGF_PERSISTENTLY_DN,0.99999
GSE22432_CDC_VS_COMMON_DC_PR...1,SET,184,-0.026574,-0.0026469,0.061085,0.66823,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_DN,0.99999
MIR3667_3P,SET,136,-0.032187,-0.0027599,0.073973,0.66826,MIR3667_3P,0.99999
GOMF_PROTEIN_GLUTAMIC_ACID_L...,SET,9,-0.12991,-0.0028754,0.29853,0.66827,GOMF_PROTEIN_GLUTAMIC_ACID_LIGASE_ACTIVITY,0.99999
MIR548AK_MIR548AM_5P_MIR548C...,SET,444,-0.017601,-0.0027037,0.040445,0.66828,MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P,0.99999
MIR548O_5P_MIR548W,SET,444,-0.017601,-0.0027037,0.040445,0.66828,MIR548O_5P_MIR548W,0.99999
GOBP_CELLULAR_RESPONSE_TO_PE...3,SET,5,-0.15681,-0.0025874,0.36031,0.66829,GOBP_CELLULAR_RESPONSE_TO_PEPTIDOGLYCAN,0.99999
HP_ABNORMALITY_OF_SUBCUTANEO...,SET,60,-0.048297,-0.0027564,0.11091,0.66838,HP_ABNORMALITY_OF_SUBCUTANEOUS_FAT_TISSUE,0.99999
HP_SHORTENED_QT_INTERVAL,SET,13,-0.11165,-0.0029699,0.25642,0.66838,HP_SHORTENED_QT_INTERVAL,0.99999
KAECH_NAIVE_VS_DAY8_EFF_CD8_...1,SET,184,-0.026939,-0.0026832,0.061858,0.66839,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN,0.99999
GOBP_INTERLEUKIN_23_PRODUCTI...,SET,10,-0.12406,-0.0028945,0.28483,0.66842,GOBP_INTERLEUKIN_23_PRODUCTION,0.99999
GOCC_TERTIARY_GRANULE_LUMEN,SET,50,-0.054471,-0.0028386,0.12494,0.66857,GOCC_TERTIARY_GRANULE_LUMEN,0.99999
GOBP_CATECHOL_CONTAINING_COM...1,SET,20,-0.088982,-0.0029352,0.20404,0.66861,GOBP_CATECHOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
GOCC_ATPASE_DEPENDENT_TRANSM...,SET,24,-0.081228,-0.0029348,0.18625,0.66862,GOCC_ATPASE_DEPENDENT_TRANSMEMBRANE_TRANSPORT_COMPLEX,0.99999
MIR7_5P,SET,241,-0.023957,-0.0027266,0.054923,0.66865,MIR7_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...457,SET,7,-0.13591,-0.0026532,0.31147,0.66871,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,0.99999
GSE13306_TREG_RA_VS_TCONV_RA...2,SET,192,-0.026203,-0.0026655,0.060048,0.66871,GSE13306_TREG_RA_VS_TCONV_RA_UP,0.99999
HP_PREGNANCY_EXPOSURE,SET,5,-0.1703,-0.0028098,0.39023,0.66872,HP_PREGNANCY_EXPOSURE,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...1,SET,7,-0.15478,-0.0030215,0.3546,0.66876,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.99999
HP_DECREASED_CIRCULATING_ACT...,SET,28,-0.066133,-0.0025806,0.1515,0.66877,HP_DECREASED_CIRCULATING_ACTH_CONCENTRATION,0.99999
GOMF_OMEGA_PEPTIDASE_ACTIVITY,SET,12,-0.11274,-0.0028811,0.2582,0.66881,GOMF_OMEGA_PEPTIDASE_ACTIVITY,0.99999
GOBP_INTEGRATED_STRESS_RESPO...,SET,44,-0.057001,-0.002787,0.13053,0.66883,GOBP_INTEGRATED_STRESS_RESPONSE_SIGNALING,0.99999
MIR8083,SET,49,-0.052532,-0.0027101,0.12029,0.66884,MIR8083,0.99999
GOMF_MICROFIBRIL_BINDING,SET,6,-0.18006,-0.0032545,0.41225,0.66886,GOMF_MICROFIBRIL_BINDING,0.99999
GSE1432_CTRL_VS_IFNG_6H_MICR...2,SET,183,-0.026484,-0.0026308,0.060607,0.66893,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...204,SET,35,-0.066655,-0.0029074,0.15246,0.66901,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,0.99999
GOCC_PHAGOCYTIC_VESICLE_MEMB...,SET,67,-0.044666,-0.0026932,0.10216,0.66902,GOCC_PHAGOCYTIC_VESICLE_MEMBRANE,0.99999
GOCC_SERINE_TYPE_ENDOPEPTIDA...,SET,11,-0.11838,-0.0028968,0.27077,0.66902,GOCC_SERINE_TYPE_ENDOPEPTIDASE_COMPLEX,0.99999
BRF2_TARGET_GENES,SET,7,-0.14072,-0.0027471,0.32179,0.66905,BRF2_TARGET_GENES,0.99999
HP_BROAD_FINGER,SET,113,-0.034369,-0.0026879,0.078588,0.66906,HP_BROAD_FINGER,0.99999
WOO_LIVER_CANCER_RECURRENCE_...2,SET,97,-0.037779,-0.0027387,0.086383,0.66907,WOO_LIVER_CANCER_RECURRENCE_UP,0.99999
GSE369_PRE_VS_POST_IL6_INJEC...1,SET,176,-0.027414,-0.0026711,0.062664,0.66911,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN,0.99999
REACTOME_PROTEIN_LOCALIZATION,SET,143,-0.029592,-0.0026013,0.067639,0.66912,REACTOME_PROTEIN_LOCALIZATION,0.99999
HP_ECTOPIA_PUPILLAE,SET,21,-0.088593,-0.0029944,0.20246,0.66915,HP_ECTOPIA_PUPILLAE,0.99999
GSE3203_INFLUENZA_INF_VS_IFN...2,SET,184,-0.027901,-0.002779,0.063764,0.66915,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP,0.99999
GSE14308_TH1_VS_NAIVE_CD4_TC...1,SET,176,-0.027471,-0.0026766,0.062765,0.66919,GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN,0.99999
HP_ABNORMALITY_OF_THE_PERIUN...,SET,20,-0.086519,-0.0028539,0.19756,0.66928,HP_ABNORMALITY_OF_THE_PERIUNGUAL_REGION,0.99999
GOBP_POSITIVE_REGULATION_OF_...597,SET,10,-0.12017,-0.0028037,0.27439,0.66929,GOBP_POSITIVE_REGULATION_OF_PODOSOME_ASSEMBLY,0.99999
HP_DECREASED_CIRCULATING_FRE...2,SET,4,-0.16038,-0.0023669,0.36612,0.66932,HP_DECREASED_CIRCULATING_FREE_T4_CONCENTRATION,0.99999
GSE14413_UNSTIM_VS_IFNB_STIM...3,SET,124,-0.031977,-0.002619,0.072998,0.66932,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_DN,0.99999
GSE22025_UNTREATED_VS_TGFB1_...3,SET,184,-0.027806,-0.0027696,0.063479,0.66932,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN,0.99999
HP_ALOPECIA,SET,218,-0.025697,-0.0027833,0.058653,0.66934,HP_ALOPECIA,0.99999
KRISHNAN_FURIN_TARGETS_DN,SET,9,-0.099376,-0.0021996,0.22682,0.66935,KRISHNAN_FURIN_TARGETS_DN,0.99999
MIR4520_3P,SET,81,-0.041606,-0.0027574,0.094953,0.66937,MIR4520_3P,0.99999
HP_PARATHYROID_ADENOMA,SET,15,-0.10472,-0.002992,0.23887,0.66945,HP_PARATHYROID_ADENOMA,0.99999
GOBP_REGULATION_OF_RESPONSE_...11,SET,1248,-0.010747,-0.002705,0.02451,0.66948,GOBP_REGULATION_OF_RESPONSE_TO_STRESS,0.99999
KEGG_MEDICUS_REFERENCE_NAD_B...,SET,12,-0.11412,-0.0029164,0.26016,0.66954,KEGG_MEDICUS_REFERENCE_NAD_BIOSYNTHESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...765,SET,47,-0.050886,-0.0025713,0.116,0.66956,GOBP_POSITIVE_REGULATION_OF_TORC1_SIGNALING,0.99999
MEISSNER_NPC_HCP_WITH_H3_UNM...,SET,487,-0.017632,-0.0028333,0.040189,0.66957,MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED,0.99999
GOBP_NEGATIVE_REGULATION_OF_...607,SET,12,-0.11318,-0.0028926,0.25798,0.66957,GOBP_NEGATIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS,0.99999
HAHTOLA_SEZARY_SYNDROM_UP,SET,83,-0.040822,-0.0027385,0.093017,0.66962,HAHTOLA_SEZARY_SYNDROM_UP,0.99999
KEGG_MEDICUS_REFERENCE_FSHR_...,SET,16,-0.099912,-0.0029481,0.22759,0.66966,KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY,0.99999
MIR370_5P,SET,67,-0.045028,-0.0027151,0.10257,0.66966,MIR370_5P,0.99999
GSE28726_NAIVE_VS_ACTIVATED_...3,SET,187,-0.026947,-0.0027056,0.061385,0.66966,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN,0.99999
GOBP_EXTRACELLULAR_REGULATIO...,SET,12,-0.11632,-0.0029727,0.26494,0.66968,GOBP_EXTRACELLULAR_REGULATION_OF_SIGNAL_TRANSDUCTION,0.99999
GSE26669_CD4_VS_CD8_TCELL_IN...4,SET,184,-0.026996,-0.0026889,0.061482,0.6697,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...182,SET,120,-0.033943,-0.0027351,0.077266,0.66977,GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.99999
HP_FETAL_POLYURIA,SET,11,-0.11904,-0.0029129,0.27095,0.66979,HP_FETAL_POLYURIA,0.99999
MIR4729,SET,642,-0.015004,-0.0027561,0.034141,0.66984,MIR4729,0.99999
GOBP_POSITIVE_REGULATION_OF_...837,SET,10,-0.11909,-0.0027785,0.27098,0.66984,GOBP_POSITIVE_REGULATION_OF_VESICLE_FUSION,0.99999
HP_INCREASED_CIRCULATING_LAC...2,SET,73,-0.044539,-0.0028028,0.10132,0.66988,HP_INCREASED_CIRCULATING_LACTATE_DEHYDROGENASE_CONCENTRATION,0.99999
GOMF_CHROMATIN_PROTEIN_ADAPT...,SET,24,-0.068602,-0.0024786,0.15604,0.6699,GOMF_CHROMATIN_PROTEIN_ADAPTOR_ACTIVITY,0.99999
GOBP_REGULATION_OF_CDC42_PRO...,SET,7,-0.16255,-0.0031732,0.36962,0.66995,GOBP_REGULATION_OF_CDC42_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GOMF_CAMP_RESPONSE_ELEMENT_B...1,SET,12,-0.10743,-0.0027455,0.24426,0.66996,GOMF_CAMP_RESPONSE_ELEMENT_BINDING,0.99999
PID_RHOA_REG_PATHWAY,SET,42,-0.057732,-0.002758,0.13123,0.67,PID_RHOA_REG_PATHWAY,0.99999
GOBP_MULTI_PASS_TRANSMEMBRAN...,SET,8,-0.15794,-0.0032961,0.359,0.67001,GOBP_MULTI_PASS_TRANSMEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE,0.99999
GOCC_MULTI_PASS_TRANSLOCON_C...,SET,8,-0.15794,-0.0032961,0.359,0.67001,GOCC_MULTI_PASS_TRANSLOCON_COMPLEX,0.99999
GSE33292_WT_VS_TCF1_KO_DN3_T...2,SET,175,-0.028628,-0.0027816,0.065064,0.67003,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP,0.99999
LOPEZ_MESOTHELIOMA_SURVIVAL_...2,SET,11,-0.12518,-0.003063,0.28448,0.67004,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN,0.99999
GOBP_MACROAUTOPHAGY,SET,325,-0.019739,-0.0026028,0.044853,0.67006,GOBP_MACROAUTOPHAGY,0.99999
REACTOME_HDL_CLEARANCE,SET,5,-0.16295,-0.0026886,0.37024,0.67007,REACTOME_HDL_CLEARANCE,0.99999
GOCC_PRESYNAPTIC_ACTIVE_ZONE...2,SET,30,-0.071371,-0.0028826,0.16216,0.67008,GOCC_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE,0.99999
GSE16385_ROSIGLITAZONE_VS_UN...2,SET,178,-0.029065,-0.0028479,0.066019,0.67012,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP,0.99999
GCM_MAPK10,SET,73,-0.045471,-0.0028615,0.10328,0.67013,GCM_MAPK10,0.99999
BIOCARTA_NPP1_PATHWAY,SET,8,-0.14345,-0.0029938,0.32577,0.67016,BIOCARTA_NPP1_PATHWAY,0.99999
GOMF_DEATH_DOMAIN_BINDING,SET,10,-0.12911,-0.0030124,0.29319,0.67017,GOMF_DEATH_DOMAIN_BINDING,0.99999
HP_COLON_CANCER,SET,40,-0.057516,-0.0026816,0.13059,0.67019,HP_COLON_CANCER,0.99999
GSE22935_UNSTIM_VS_24H_MBOVI...1,SET,180,-0.028936,-0.0028509,0.065689,0.67021,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.99999
GOBP_REGULATION_OF_DIGESTIVE...,SET,38,-0.062477,-0.0028393,0.14178,0.67026,GOBP_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,0.99999
GOBP_NUCLEOBASE_CONTAINING_S...3,SET,8,-0.13621,-0.0028426,0.30896,0.67035,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION,0.99999
OISHI_CHOLANGIOMA_STEM_CELL_...2,SET,324,-0.020194,-0.0026588,0.045795,0.67038,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,0.99999
ZHOU_INFLAMMATORY_RESPONSE_L...1,SET,323,-0.020295,-0.0026681,0.046026,0.67038,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,0.99999
HP_ABNORMAL_OPTIC_CHIASM_MOR...,SET,6,-0.17897,-0.0032348,0.40581,0.6704,HP_ABNORMAL_OPTIC_CHIASM_MORPHOLOGY,0.99999
TTGGAGA_MIR5155P_MIR519E,SET,123,-0.032995,-0.0026915,0.07478,0.67047,TTGGAGA_MIR5155P_MIR519E,0.99999
SESTO_RESPONSE_TO_UV_C0,SET,98,-0.036266,-0.0026424,0.082177,0.67051,SESTO_RESPONSE_TO_UV_C0,0.99999
MORF_PTEN,SET,77,-0.039559,-0.0025564,0.089633,0.67052,MORF_PTEN,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...28,SET,53,-0.050902,-0.0027308,0.11532,0.67053,GOBP_PROTEIN_LOCALIZATION_TO_LYSOSOME,0.99999
GOBP_NEGATIVE_REGULATION_OF_...262,SET,8,-0.15914,-0.0033211,0.36053,0.67054,GOBP_NEGATIVE_REGULATION_OF_GONADOTROPIN_SECRETION,0.99999
HP_FACIAL_TICS,SET,14,-0.10374,-0.0028634,0.23495,0.67058,HP_FACIAL_TICS,0.99999
chr9p21,SET,42,-0.099117,-0.0047351,0.22438,0.67065,chr9p21,0.99999
GOBP_VENTRAL_SPINAL_CORD_INT...,SET,13,-0.11417,-0.0030368,0.25836,0.67071,GOBP_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION,0.99999
chr8q12,SET,27,-0.13309,-0.0050998,0.30117,0.67072,chr8q12,0.99999
REACTOME_APC_CDC20_MEDIATED_...,SET,24,-0.07416,-0.0026794,0.16779,0.67074,REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A,0.99999
HP_HYPOPLASIA_OF_THE_BLADDER,SET,5,-0.1662,-0.0027423,0.37594,0.67078,HP_HYPOPLASIA_OF_THE_BLADDER,0.99999
KEGG_MEDICUS_REFERENCE_HYDRO...,SET,8,-0.13356,-0.0027874,0.30212,0.67079,KEGG_MEDICUS_REFERENCE_HYDROLYSIS_OF_SPHINGOMYELIN,0.99999
REACTOME_COLLAGEN_FORMATION,SET,88,-0.043109,-0.0029773,0.097503,0.6708,REACTOME_COLLAGEN_FORMATION,0.99999
HP_MYOPIC_ASTIGMATISM,SET,6,-0.14904,-0.0026939,0.33694,0.67088,HP_MYOPIC_ASTIGMATISM,0.99999
MIR3665,SET,73,-0.043101,-0.0027123,0.097373,0.67098,MIR3665,0.99999
GSE3982_MAST_CELL_VS_BCELL_DN,SET,161,-0.029462,-0.0027467,0.066527,0.67106,GSE3982_MAST_CELL_VS_BCELL_DN,0.99999
GSE339_CD8POS_VS_CD4CD8DN_DC...4,SET,184,-0.026858,-0.0026751,0.060644,0.67107,GSE339_CD8POS_VS_CD4CD8DN_DC_UP,0.99999
GOBP_OTIC_VESICLE_FORMATION,SET,8,-0.1212,-0.0025293,0.27364,0.67108,GOBP_OTIC_VESICLE_FORMATION,0.99999
GNF2_BUB1B,SET,49,-0.049912,-0.002575,0.11268,0.67109,GNF2_BUB1B,0.99999
ODONNELL_METASTASIS_UP,SET,70,-0.047869,-0.00295,0.10806,0.67111,ODONNELL_METASTASIS_UP,0.99999
GOCC_CYTOPLASMIC_REGION,SET,251,-0.022833,-0.0026513,0.051541,0.67112,GOCC_CYTOPLASMIC_REGION,0.99999
MIR133A_5P,SET,122,-0.033511,-0.0027225,0.075636,0.67114,MIR133A_5P,0.99999
POMEROY_MEDULLOBLASTOMA_DESM...1,SET,52,-0.053771,-0.0028575,0.12132,0.6712,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,0.99999
MODULE_291,SET,61,-0.051159,-0.0029438,0.11537,0.67127,MODULE_291,0.99999
GSE37532_VISCERAL_ADIPOSE_TI...7,SET,139,-0.030787,-0.0026686,0.069424,0.67128,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN,0.99999
GOBP_REGULATORY_NCRNA_PROCES...,SET,65,-0.043604,-0.0025898,0.098301,0.67132,GOBP_REGULATORY_NCRNA_PROCESSING,0.99999
FARMER_BREAST_CANCER_APOCRIN...1,SET,297,-0.0224,-0.0028258,0.050493,0.67134,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,0.99999
GOBP_CAMP_PKA_SIGNAL_TRANSDU...,SET,5,-0.17925,-0.0029576,0.40396,0.67138,GOBP_CAMP_PKA_SIGNAL_TRANSDUCTION,0.99999
GSE40666_UNTREATED_VS_IFNA_S...7,SET,176,-0.028338,-0.0027611,0.063862,0.67138,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN,0.99999
GSE24574_BCL6_HIGH_TFH_VS_NA...2,SET,179,-0.027666,-0.0027183,0.062335,0.67141,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_UP,0.99999
REACTOME_ION_HOMEOSTASIS,SET,52,-0.05308,-0.0028208,0.11959,0.67143,REACTOME_ION_HOMEOSTASIS,0.99999
ZSCAN26_TARGET_GENES,SET,4,-0.20814,-0.0030718,0.46853,0.67157,ZSCAN26_TARGET_GENES,0.99999
GOBP_MITOCHONDRIAL_DEPOLARIZ...,SET,21,-0.086756,-0.0029323,0.19526,0.67159,GOBP_MITOCHONDRIAL_DEPOLARIZATION,0.99999
MIR548AH_3P_MIR548AM_3P,SET,715,-0.014323,-0.0027709,0.032234,0.67161,MIR548AH_3P_MIR548AM_3P,0.99999
MIR7975,SET,37,-0.059564,-0.0026712,0.13398,0.67169,MIR7975,0.99999
MORF_DEAF1,SET,46,-0.052307,-0.0026148,0.11765,0.67169,MORF_DEAF1,0.99999
MIR6753_3P,SET,50,-0.054997,-0.002866,0.12361,0.67181,MIR6753_3P,0.99999
MIR5689,SET,137,-0.033367,-0.0028714,0.074938,0.67193,MIR5689,0.99999
MIR1298_5P,SET,40,-0.055632,-0.0025938,0.12494,0.67194,MIR1298_5P,0.99999
REACTOME_OPIOID_SIGNALLING,SET,88,-0.041245,-0.0028485,0.092571,0.67204,REACTOME_OPIOID_SIGNALLING,0.99999
THUM_MIR21_TARGETS_HEART_DIS...2,SET,16,-0.10806,-0.0031884,0.24246,0.67208,THUM_MIR21_TARGETS_HEART_DISEASE_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_EL...,SET,10,-0.11696,-0.0027287,0.26242,0.67208,GOBP_CELLULAR_RESPONSE_TO_ELECTRICAL_STIMULUS,0.99999
MIR6874_3P,SET,70,-0.044218,-0.002725,0.099185,0.67213,MIR6874_3P,0.99999
MODULE_486,SET,85,-0.038198,-0.0025929,0.085675,0.67214,MODULE_486,0.99999
HP_NEOPLASM_OF_THE_GASTROINT...,SET,285,-0.022521,-0.002784,0.050516,0.67214,HP_NEOPLASM_OF_THE_GASTROINTESTINAL_TRACT,0.99999
MELLMAN_TUT1_TARGETS_UP,SET,19,-0.08553,-0.0027499,0.19182,0.67216,MELLMAN_TUT1_TARGETS_UP,0.99999
chr10q26,SET,91,-0.074856,-0.0052568,0.16787,0.67217,chr10q26,0.99999
GOBP_REGULATION_OF_RESPIRATO...3,SET,22,-0.082526,-0.0028549,0.18497,0.67226,GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE,0.99999
GOBP_REGULATION_OF_RELEASE_O...1,SET,41,-0.06071,-0.0028656,0.13605,0.67228,GOBP_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.99999
REACTOME_BETA_OXIDATION_OF_L...,SET,5,-0.15717,-0.0025933,0.3522,0.67229,REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA,0.99999
HP_ABLEPHARON,SET,5,-0.17418,-0.0028739,0.39023,0.67233,HP_ABLEPHARON,0.99999
GOCC_CELL_DIVISION_SITE,SET,58,-0.049682,-0.0027879,0.11129,0.67234,GOCC_CELL_DIVISION_SITE,0.99999
GOMF_HYDROLASE_ACTIVITY_ACTI...4,SET,32,-0.073494,-0.0030655,0.16463,0.67235,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES,0.99999
GRABARCZYK_BCL11B_TARGETS_DN,SET,56,-0.05207,-0.0028713,0.11662,0.67238,GRABARCZYK_BCL11B_TARGETS_DN,0.99999
GOMF_KINASE_ACTIVATOR_ACTIVI...,SET,130,-0.032835,-0.0027531,0.073539,0.67238,GOMF_KINASE_ACTIVATOR_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...304,SET,7,-0.15514,-0.0030285,0.3474,0.6724,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,0.99999
WP_ENTEROCYTE_CHOLESTEROL_ME...,SET,34,-0.059997,-0.0025794,0.13432,0.67244,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.99999
GOBP_REGULATION_OF_LYSOSOME_...2,SET,4,-0.19938,-0.0029425,0.44631,0.67246,GOBP_REGULATION_OF_LYSOSOME_SIZE,0.99999
GOCC_BORC_COMPLEX,SET,4,-0.19938,-0.0029425,0.44631,0.67246,GOCC_BORC_COMPLEX,0.99999
HP_POSTERIOR_UVEITIS,SET,5,-0.17775,-0.0029329,0.3979,0.67246,HP_POSTERIOR_UVEITIS,0.99999
chr18q11,SET,27,-0.15646,-0.0059952,0.35013,0.67251,chr18q11,0.99999
GOMF_CORE_PROMOTER_SEQUENCE_...,SET,35,-0.062162,-0.0027114,0.13909,0.67253,GOMF_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,0.99999
MIR4499,SET,103,-0.038035,-0.0028408,0.085103,0.67254,MIR4499,0.99999
MURARO_PANCREAS_DELTA_CELL,SET,222,-0.027932,-0.0030527,0.062485,0.67257,MURARO_PANCREAS_DELTA_CELL,0.99999
GOMF_CXCR3_CHEMOKINE_RECEPTO...,SET,5,-0.21248,-0.0035058,0.47521,0.6726,GOMF_CXCR3_CHEMOKINE_RECEPTOR_BINDING,0.99999
HP_ABNORMAL_SPINAL_MENINGEAL...,SET,22,-0.085591,-0.002961,0.1914,0.67263,HP_ABNORMAL_SPINAL_MENINGEAL_MORPHOLOGY,0.99999
WP_HOSTPATHOGEN_INTERACTION_...2,SET,18,-0.091701,-0.0028698,0.20502,0.67266,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,0.99999
GOBP_MUSCLE_CELL_PROLIFERATI...,SET,188,-0.028801,-0.0028994,0.064391,0.67266,GOBP_MUSCLE_CELL_PROLIFERATION,0.99999
WP_TRYPTOPHAN_METABOLISM,SET,29,-0.075555,-0.0030003,0.16887,0.67271,WP_TRYPTOPHAN_METABOLISM,0.99999
GOBP_PHOSPHATIDIC_ACID_METAB...,SET,35,-0.066997,-0.0029223,0.14972,0.67274,GOBP_PHOSPHATIDIC_ACID_METABOLIC_PROCESS,0.99999
GSE17721_LPS_VS_PAM3CSK4_1H_...2,SET,175,-0.026905,-0.0026141,0.060115,0.67276,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_UP,0.99999
HOLLERN_SOLID_NODULAR_BREAST...1,SET,29,-0.077537,-0.003079,0.17314,0.67286,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN,0.99999
GOBP_CARDIAC_MUSCLE_TISSUE_M...,SET,58,-0.053659,-0.003011,0.11982,0.67286,GOBP_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,0.99999
LHX4_TARGET_GENES,SET,5,-0.15148,-0.0024993,0.33818,0.67289,LHX4_TARGET_GENES,0.99999
GOBP_EMBRYONIC_PROCESS_INVOL...,SET,6,-0.15749,-0.0028465,0.3516,0.67289,GOBP_EMBRYONIC_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,0.99999
WP_IL26_SIGNALING,SET,44,-0.063196,-0.0030899,0.14108,0.6729,WP_IL26_SIGNALING,0.99999
HP_ABNORMAL_NASAL_DORSUM_MOR...,SET,228,-0.024222,-0.0026823,0.054062,0.67293,HP_ABNORMAL_NASAL_DORSUM_MORPHOLOGY,0.99999
KEGG_MEDICUS_ENV_FACTOR_DCE_...,SET,15,-0.12904,-0.0036869,0.28795,0.67297,KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS,0.99999
STEARMAN_LUNG_CANCER_EARLY_V...1,SET,55,-0.052606,-0.0028749,0.11738,0.67298,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,0.99999
GOBP_EXIT_FROM_MITOSIS,SET,29,-0.06571,-0.0026094,0.14659,0.67301,GOBP_EXIT_FROM_MITOSIS,0.99999
XU_HGF_SIGNALING_NOT_VIA_AKT...1,SET,18,-0.091034,-0.0028489,0.20299,0.67309,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN,0.99999
GOBP_VITAMIN_K_METABOLIC_PRO...,SET,11,-0.10918,-0.0026716,0.24345,0.67309,GOBP_VITAMIN_K_METABOLIC_PROCESS,0.99999
GOMF_VOLTAGE_GATED_POTASSIUM...1,SET,96,-0.042948,-0.0030973,0.095761,0.6731,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.99999
HP_MODERATE_ALBUMINURIA,SET,10,-0.12723,-0.0029683,0.28368,0.6731,HP_MODERATE_ALBUMINURIA,0.99999
HP_PITUITARY_ADENOMA,SET,51,-0.050264,-0.0026454,0.11207,0.6731,HP_PITUITARY_ADENOMA,0.99999
GOCC_CHROMOSOME_PASSENGER_CO...,SET,6,-0.15576,-0.0028151,0.34715,0.67316,GOCC_CHROMOSOME_PASSENGER_COMPLEX,0.99999
REACTOME_REGULATION_OF_LOCAL...,SET,11,-0.11515,-0.0028177,0.25656,0.67322,REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS,0.99999
GOBP_RADIAL_GLIAL_CELL_DIFFE...,SET,14,-0.11212,-0.0030947,0.24978,0.67323,GOBP_RADIAL_GLIAL_CELL_DIFFERENTIATION,0.99999
WP_ATM_SIGNALING,SET,36,-0.055994,-0.002477,0.12474,0.67324,WP_ATM_SIGNALING,0.99999
GSE22935_UNSTIM_VS_12H_MBOVI...3,SET,181,-0.027702,-0.0027369,0.061709,0.67325,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.99999
GOBP_CELL_CELL_ADHESION_VIA_...,SET,259,-0.02903,-0.0034234,0.064625,0.67335,GOBP_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,0.99999
GSE8835_HEALTHY_VS_CLL_CD8_T...2,SET,183,-0.027763,-0.0027579,0.061802,0.67336,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP,0.99999
MIR550B_2_5P,SET,46,-0.054907,-0.0027448,0.12222,0.67337,MIR550B_2_5P,0.99999
GSE5542_UNTREATED_VS_IFNA_AN...2,SET,179,-0.026948,-0.0026477,0.059986,0.67337,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.99999
HP_WIDE_INTERMAMILLARY_DISTA...,SET,103,-0.036245,-0.0027071,0.08067,0.67339,HP_WIDE_INTERMAMILLARY_DISTANCE,0.99999
ERWIN_COHEN_PBMC_TC_83_AGE_1...3,SET,16,-0.10193,-0.0030077,0.22687,0.67339,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,0.99999
GOCC_SARCOPLASMIC_RETICULUM,SET,73,-0.043653,-0.002747,0.097142,0.67342,GOCC_SARCOPLASMIC_RETICULUM,0.99999
MATZUK_MATERNAL_EFFECT,SET,7,-0.14285,-0.0027887,0.31766,0.67353,MATZUK_MATERNAL_EFFECT,0.99999
CEBALLOS_TARGETS_OF_TP53_AND...1,SET,29,-0.069108,-0.0027443,0.15367,0.67354,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,0.99999
GSE22033_UNTREATED_VS_ROSIGL...2,SET,182,-0.026496,-0.0026249,0.058912,0.67356,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...549,SET,59,-0.052624,-0.0029783,0.11695,0.67363,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION,0.99999
REACTOME_MHC_CLASS_II_ANTIGE...,SET,117,-0.035418,-0.0028182,0.07867,0.67372,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,0.99999
MIR8075,SET,90,-0.042458,-0.0029653,0.094281,0.67376,MIR8075,0.99999
GOBP_NEGATIVE_REGULATION_OF_...15,SET,42,-0.062059,-0.0029647,0.1378,0.67377,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...64,SET,16,-0.094392,-0.0027852,0.20959,0.67377,HP_APLASIA_HYPOPLASIA_OF_THE_SACRUM,0.99999
BRACHAT_RESPONSE_TO_CAMPTOTH...2,SET,19,-0.079147,-0.0025447,0.17572,0.67379,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,0.99999
WP_BIOTIN_METABOLISM_INCLUDI...,SET,9,-0.12535,-0.0027745,0.27826,0.67381,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,0.99999
GSE30083_SP2_VS_SP3_THYMOCYT...2,SET,185,-0.029864,-0.0029826,0.066293,0.67382,GSE30083_SP2_VS_SP3_THYMOCYTE_UP,0.99999
REACTOME_PHOSPHOLIPID_METABO...,SET,189,-0.027693,-0.0027951,0.061465,0.67384,REACTOME_PHOSPHOLIPID_METABOLISM,0.99999
GOCC_MANCHETTE,SET,20,-0.086641,-0.0028579,0.19229,0.67385,GOCC_MANCHETTE,0.99999
GOBP_MEMBRANE_LIPID_METABOLI...,SET,203,-0.027034,-0.0028269,0.059985,0.67389,GOBP_MEMBRANE_LIPID_METABOLIC_PROCESS,0.99999
GSE12198_CTRL_VS_LOW_IL2_STI...2,SET,181,-0.027107,-0.0026781,0.060142,0.6739,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP,0.99999
CAFFAREL_RESPONSE_TO_THC_24H...2,SET,8,-0.11814,-0.0024654,0.26202,0.67396,CAFFAREL_RESPONSE_TO_THC_24HR_3_UP,0.99999
GOBP_GLOMERULUS_VASCULATURE_...,SET,6,-0.17794,-0.0032162,0.3946,0.67398,GOBP_GLOMERULUS_VASCULATURE_MORPHOGENESIS,0.99999
LE_EGR2_TARGETS_UP,SET,103,-0.037296,-0.0027856,0.082704,0.67399,LE_EGR2_TARGETS_UP,0.99999
REACTOME_PHOSPHOLIPASE_C_MED...3,SET,14,-0.10987,-0.0030327,0.24357,0.67403,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...4,SET,58,-0.052923,-0.0029698,0.1173,0.67407,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_CD8_T_CELLS,0.99999
GCM_RBM8A,SET,70,-0.041797,-0.0025759,0.092574,0.67418,GCM_RBM8A,0.99999
CIZ_01,SET,216,-0.026942,-0.002905,0.059631,0.6743,CIZ_01,0.99999
HP_ANHIDROSIS,SET,29,-0.076424,-0.0030349,0.16915,0.6743,HP_ANHIDROSIS,0.99999
GCM_RAP2A,SET,33,-0.066197,-0.0028039,0.1465,0.67431,GCM_RAP2A,0.99999
HP_ABNORMAL_GASTROINTESTINAL...1,SET,87,-0.040358,-0.0027715,0.089317,0.67431,HP_ABNORMAL_GASTROINTESTINAL_MOTILITY,0.99999
WRN_TARGET_GENES,SET,10,-0.13169,-0.0030723,0.29135,0.67436,WRN_TARGET_GENES,0.99999
TSAI_DNAJB4_TARGETS_DN,SET,6,-0.15305,-0.0027662,0.33857,0.67438,TSAI_DNAJB4_TARGETS_DN,0.99999
GOBP_REGULATION_OF_GLUTAMINE...,SET,6,-0.16386,-0.0029617,0.3625,0.67438,GOBP_REGULATION_OF_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.99999
GOCC_AP_1_ADAPTOR_COMPLEX,SET,10,-0.11716,-0.0027335,0.25913,0.67441,GOCC_AP_1_ADAPTOR_COMPLEX,0.99999
GOMF_GDP_PHOSPHATASE_ACTIVITY,SET,10,-0.11325,-0.0026421,0.25043,0.67443,GOMF_GDP_PHOSPHATASE_ACTIVITY,0.99999
GOBP_MESENCHYMAL_EPITHELIAL_...,SET,9,-0.14273,-0.0031593,0.31561,0.67445,GOBP_MESENCHYMAL_EPITHELIAL_CELL_SIGNALING,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...9,SET,45,-0.062357,-0.0030833,0.13788,0.67446,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_7,0.99999
HP_HYPERACTIVE_RENIN_ANGIOTE...,SET,8,-0.15504,-0.0032355,0.34268,0.67451,HP_HYPERACTIVE_RENIN_ANGIOTENSIN_SYSTEM,0.99999
GOBP_MRNA_SPLICE_SITE_RECOGN...,SET,30,-0.064497,-0.0026049,0.14254,0.67453,GOBP_MRNA_SPLICE_SITE_RECOGNITION,0.99999
GSE13887_RESTING_VS_ACT_CD4_...2,SET,94,-0.038426,-0.0027424,0.084916,0.67455,GSE13887_RESTING_VS_ACT_CD4_TCELL_UP,0.99999
HP_ABNORMAL_MAST_CELL_MORPHO...,SET,8,-0.13588,-0.0028357,0.30024,0.67457,HP_ABNORMAL_MAST_CELL_MORPHOLOGY,0.99999
MIR27A_3P_MIR27B_3P,SET,570,-0.016577,-0.0028751,0.036623,0.67459,MIR27A_3P_MIR27B_3P,0.99999
MORF_FRK,SET,98,-0.039383,-0.0028695,0.08701,0.67459,MORF_FRK,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...7,SET,12,-0.10821,-0.0027653,0.239,0.67463,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_7DY_TOP_100_DEG_EX_VIVO_DN,0.99999
GOBP_PROTEIN_PEPTIDYL_PROLYL...,SET,17,-0.088031,-0.0026774,0.19442,0.67464,GOBP_PROTEIN_PEPTIDYL_PROLYL_ISOMERIZATION,0.99999
REACTOME_TGFBR3_EXPRESSION,SET,25,-0.080722,-0.0029766,0.17827,0.67465,REACTOME_TGFBR3_EXPRESSION,0.99999
GOMF_CLASS_I_DNA_APURINIC_OR...,SET,8,-0.11801,-0.0024627,0.26061,0.67465,GOMF_CLASS_I_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY,0.99999
HP_INTRINSIC_HAND_MUSCLE_ATR...,SET,24,-0.082399,-0.0029771,0.18196,0.67466,HP_INTRINSIC_HAND_MUSCLE_ATROPHY,0.99999
GSE36888_STAT5_AB_KNOCKIN_VS...3,SET,186,-0.028519,-0.0028558,0.06297,0.67468,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN,0.99999
GOBP_REGULATION_OF_LIPOPROTE...1,SET,10,-0.12421,-0.0028979,0.27424,0.67469,GOBP_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY,0.99999
BONOME_OVARIAN_CANCER_POOR_S...1,SET,19,-0.077416,-0.0024891,0.1709,0.67472,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN,0.99999
GOMF_POLYUBIQUITIN_MODIFICAT...,SET,45,-0.048777,-0.0024118,0.10761,0.67481,GOMF_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.99999
MIR4804_5P,SET,8,-0.12999,-0.0027127,0.28677,0.67483,MIR4804_5P,0.99999
REACTOME_INTERACTION_BETWEEN...,SET,30,-0.076621,-0.0030946,0.16902,0.67484,REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS,0.99999
HP_HYPOGONADOTROPIC_HYPOGONA...,SET,146,-0.031933,-0.0028362,0.070436,0.67485,HP_HYPOGONADOTROPIC_HYPOGONADISM,0.99999
GOBP_RESPONSE_TO_GROWTH_HORM...,SET,35,-0.06977,-0.0030433,0.15383,0.67492,GOBP_RESPONSE_TO_GROWTH_HORMONE,0.99999
GOBP_REGULATION_OF_JNK_CASCA...,SET,131,-0.033676,-0.0028344,0.074244,0.67493,GOBP_REGULATION_OF_JNK_CASCADE,0.99999
GSE9509_LPS_VS_LPS_AND_IL10_...3,SET,173,-0.028418,-0.0027454,0.062648,0.67494,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_DN,0.99999
NOUZOVA_METHYLATED_IN_APL,SET,57,-0.055303,-0.0030766,0.12189,0.67498,NOUZOVA_METHYLATED_IN_APL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...645,SET,185,-0.028668,-0.0028631,0.063181,0.67499,GOBP_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,0.99999
MIR9718,SET,95,-0.041865,-0.0030036,0.092264,0.675,MIR9718,0.99999
GOBP_RESPIRATORY_CHAIN_COMPL...1,SET,8,-0.13092,-0.0027322,0.28851,0.675,GOBP_RESPIRATORY_CHAIN_COMPLEX_III_ASSEMBLY,0.99999
GOBP_CATECHOLAMINE_UPTAKE,SET,17,-0.096698,-0.002941,0.21303,0.67505,GOBP_CATECHOLAMINE_UPTAKE,0.99999
RASHI_NFKB1_TARGETS,SET,16,-0.10367,-0.0030591,0.22826,0.67515,RASHI_NFKB1_TARGETS,0.99999
MIR182_3P,SET,61,-0.050994,-0.0029343,0.11225,0.67518,MIR182_3P,0.99999
GOMF_NADPLUS_PROTEIN_CYSTEIN...,SET,6,-0.15838,-0.0028626,0.34864,0.67518,GOMF_NADPLUS_PROTEIN_CYSTEINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.99999
MIR6837_3P,SET,101,-0.036905,-0.0027296,0.081237,0.67519,MIR6837_3P,0.99999
GOBP_CELLULAR_RESPONSE_TO_FL...,SET,19,-0.09488,-0.0030505,0.20886,0.67519,GOBP_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS,0.99999
HP_SPASTIC_TETRAPARESIS,SET,59,-0.049552,-0.0028044,0.10905,0.67522,HP_SPASTIC_TETRAPARESIS,0.99999
MODULE_124,SET,92,-0.036884,-0.0026043,0.081162,0.67524,MODULE_124,0.99999
GOCC_G_PROTEIN_COUPLED_RECEP...2,SET,7,-0.1564,-0.0030531,0.3441,0.67527,GOCC_G_PROTEIN_COUPLED_RECEPTOR_DIMERIC_COMPLEX,0.99999
GOBP_POSITIVE_REGULATION_OF_...98,SET,41,-0.066118,-0.0031209,0.14546,0.67528,GOBP_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,0.99999
HP_ABNORMAL_IRIS_PIGMENTATION,SET,131,-0.035555,-0.0029925,0.078199,0.67533,HP_ABNORMAL_IRIS_PIGMENTATION,0.99999
GSE23568_CTRL_VS_ID3_TRANSDU...2,SET,183,-0.027578,-0.0027395,0.060653,0.67533,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP,0.99999
MIR379_5P,SET,41,-0.062658,-0.0029576,0.13779,0.67534,MIR379_5P,0.99999
HP_ABNORMAL_ILIUM_MORPHOLOGY,SET,85,-0.041427,-0.0028121,0.091091,0.67537,HP_ABNORMAL_ILIUM_MORPHOLOGY,0.99999
MIR4251,SET,353,-0.021259,-0.0029192,0.04674,0.67539,MIR4251,0.99999
GOBP_REGULATION_OF_DNA_METHY...,SET,14,-0.097937,-0.0027033,0.21532,0.67539,GOBP_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,0.99999
MIR8070,SET,116,-0.037899,-0.0030028,0.083308,0.67542,MIR8070,0.99999
HP_BICORONAL_SYNOSTOSIS,SET,9,-0.11615,-0.002571,0.25529,0.67544,HP_BICORONAL_SYNOSTOSIS,0.99999
PPAR_DR1_Q2,SET,235,-0.024592,-0.0027643,0.054028,0.6755,PPAR_DR1_Q2,0.99999
GOBP_DOUBLE_STRAND_BREAK_REP...7,SET,6,-0.14948,-0.0027018,0.32821,0.6756,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_SINGLE_STRAND_ANNEALING,0.99999
HP_ABNORMAL_DRINKING_BEHAVIOR,SET,50,-0.05686,-0.0029631,0.12484,0.6756,HP_ABNORMAL_DRINKING_BEHAVIOR,0.99999
GOBP_DNA_METHYLATION_DEPENDE...,SET,30,-0.070583,-0.0028507,0.15497,0.67561,GOBP_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,0.99999
GOBP_RELAXATION_OF_CARDIAC_M...,SET,17,-0.097274,-0.0029585,0.21358,0.67561,GOBP_RELAXATION_OF_CARDIAC_MUSCLE,0.99999
GSE360_CTRL_VS_B_MALAYI_LOW_...3,SET,179,-0.027653,-0.002717,0.060713,0.67561,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...372,SET,7,-0.17176,-0.0033531,0.3771,0.67562,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,0.99999
MIR520E_5P,SET,147,-0.032377,-0.0028854,0.071055,0.67568,MIR520E_5P,0.99999
GOMF_ARACHIDONIC_ACID_MONOOX...,SET,18,-0.10576,-0.0033099,0.232,0.67576,GOMF_ARACHIDONIC_ACID_MONOOXYGENASE_ACTIVITY,0.99999
HP_DISSEMINATED_INTRAVASCULA...,SET,25,-0.077567,-0.0028602,0.17015,0.67576,HP_DISSEMINATED_INTRAVASCULAR_COAGULATION,0.99999
WP_CEREBRAL_ORGANIC_ACIDURIA...,SET,8,-0.12642,-0.0026383,0.27719,0.67583,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,0.99999
RB_DN.V1_UP,SET,111,-0.034841,-0.0027008,0.076392,0.67583,RB_DN.V1_UP,0.99999
GSE27241_WT_VS_RORGT_KO_TH17...4,SET,138,-0.032166,-0.0027781,0.070522,0.67584,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP,0.99999
GOBP_ATRIOVENTRICULAR_VALVE_...1,SET,29,-0.079371,-0.0031519,0.17396,0.6759,GOBP_ATRIOVENTRICULAR_VALVE_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_OVARIAN_F...,SET,6,-0.14148,-0.0025571,0.31007,0.6759,GOBP_REGULATION_OF_OVARIAN_FOLLICLE_DEVELOPMENT,0.99999
GSE34156_NOD2_LIGAND_VS_NOD2...3,SET,181,-0.028846,-0.0028499,0.063207,0.67594,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...2,SET,32,-0.070203,-0.0029282,0.1538,0.67597,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,0.99999
GOBP_MRNA_EXPORT_FROM_NUCLEUS,SET,60,-0.044565,-0.0025434,0.097627,0.67597,GOBP_MRNA_EXPORT_FROM_NUCLEUS,0.99999
GOMF_GALACTOSYLCERAMIDASE_AC...,SET,4,-0.18181,-0.0026831,0.39824,0.67599,GOMF_GALACTOSYLCERAMIDASE_ACTIVITY,0.99999
URS_ADIPOCYTE_DIFFERENTIATIO...2,SET,64,-0.048593,-0.0028639,0.1064,0.67606,URS_ADIPOCYTE_DIFFERENTIATION_UP,0.99999
GOBP_MITOCHONDRIAL_RNA_METAB...,SET,50,-0.050399,-0.0026264,0.11034,0.67607,GOBP_MITOCHONDRIAL_RNA_METABOLIC_PROCESS,0.99999
MIR548AB,SET,444,-0.018484,-0.0028394,0.040459,0.67611,MIR548AB,0.99999
GOCC_PLASMA_MEMBRANE_SIGNALI...,SET,180,-0.030727,-0.0030274,0.067247,0.67614,GOCC_PLASMA_MEMBRANE_SIGNALING_RECEPTOR_COMPLEX,0.99999
MIR6865_3P,SET,41,-0.057402,-0.0027095,0.12558,0.67619,MIR6865_3P,0.99999
GOBP_OLIGOSACCHARIDE_METABOL...,SET,63,-0.050321,-0.0029425,0.11006,0.67624,GOBP_OLIGOSACCHARIDE_METABOLIC_PROCESS,0.99999
HP_SPONDYLOLYSIS,SET,5,-0.16344,-0.0026967,0.35732,0.67631,HP_SPONDYLOLYSIS,0.99999
GOBP_RECEPTOR_RECYCLING,SET,43,-0.056908,-0.0027507,0.12439,0.67634,GOBP_RECEPTOR_RECYCLING,0.99999
GOBP_SPINDLE_ORGANIZATION,SET,184,-0.026756,-0.002665,0.058482,0.67635,GOBP_SPINDLE_ORGANIZATION,0.99999
GSE12845_IGD_POS_BLOOD_VS_PR...1,SET,186,-0.027535,-0.0027573,0.060113,0.67654,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,0.99999
HP_HYPOGLYCEMIC_COMA,SET,20,-0.087864,-0.0028983,0.19176,0.67659,HP_HYPOGLYCEMIC_COMA,0.99999
MIR3146,SET,44,-0.058713,-0.0028707,0.12812,0.67661,MIR3146,0.99999
GOBP_REGULATION_OF_AUTOPHAGY,SET,333,-0.020887,-0.0027872,0.045568,0.67665,GOBP_REGULATION_OF_AUTOPHAGY,0.99999
PUJANA_BRCA2_PCC_NETWORK,SET,394,-0.018538,-0.0026863,0.040436,0.67668,PUJANA_BRCA2_PCC_NETWORK,0.99999
HP_TUBE_FEEDING,SET,186,-0.027811,-0.0027849,0.060664,0.67668,HP_TUBE_FEEDING,0.99999
BIOCARTA_PLK3_PATHWAY,SET,8,-0.11711,-0.002444,0.25542,0.6767,BIOCARTA_PLK3_PATHWAY,0.99999
HP_ABNORMALITY_OF_THE_FIRST_...,SET,11,-0.11417,-0.0027937,0.24898,0.67672,HP_ABNORMALITY_OF_THE_FIRST_METATARSAL_BONE,0.99999
MIR1289,SET,52,-0.056795,-0.0030182,0.12385,0.67673,MIR1289,0.99999
GOBP_MYOBLAST_FATE_COMMITMENT,SET,6,-0.17933,-0.0032413,0.39105,0.67673,GOBP_MYOBLAST_FATE_COMMITMENT,0.99999
GSE11961_MARGINAL_ZONE_BCELL...4,SET,180,-0.028763,-0.0028339,0.062713,0.67675,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,0.99999
WANG_CISPLATIN_RESPONSE_AND_...1,SET,207,-0.026197,-0.0027658,0.057117,0.67676,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,0.99999
KEGG_MEDICUS_REFERENCE_CA2_C...1,SET,19,-0.086423,-0.0027787,0.18832,0.67685,KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY,0.99999
GOMF_PROTEIN_KINASE_A_CATALY...,SET,14,-0.10238,-0.0028259,0.22309,0.67685,GOMF_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING,0.99999
SMCHD1_TARGET_GENES,SET,30,-0.073887,-0.0029842,0.16099,0.67687,SMCHD1_TARGET_GENES,0.99999
GOBP_REGULATION_OF_HEMATOPOI...1,SET,41,-0.057224,-0.0027011,0.12468,0.67687,GOBP_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,0.99999
REACTOME_ROS_AND_RNS_PRODUCT...,SET,33,-0.07307,-0.003095,0.15918,0.67689,REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES,0.99999
MIR6734_3P,SET,134,-0.033606,-0.0028604,0.073205,0.6769,MIR6734_3P,0.99999
GSE17721_PAM3CSK4_VS_CPG_2H_...1,SET,181,-0.027392,-0.0027063,0.059604,0.67708,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN,0.99999
HP_VESTIBULAR_HYPOFUNCTION,SET,15,-0.10858,-0.0031022,0.2361,0.6772,HP_VESTIBULAR_HYPOFUNCTION,0.99999
GOBP_ACETATE_ESTER_METABOLIC...,SET,6,-0.16249,-0.0029369,0.35327,0.67723,GOBP_ACETATE_ESTER_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_RENAL_CORTICOMED...,SET,21,-0.085277,-0.0028823,0.18537,0.67726,HP_ABNORMAL_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,0.99999
RYTTCCTG_ETS2_B,SET,1007,-0.012905,-0.0029381,0.028048,0.67727,RYTTCCTG_ETS2_B,0.99999
GOBP_POSITIVE_REGULATION_OF_...234,SET,142,-0.033977,-0.0029764,0.073844,0.67728,GOBP_POSITIVE_REGULATION_OF_ENDOCYTOSIS,0.99999
GSE36888_STAT5_AB_KNOCKIN_VS...5,SET,181,-0.028592,-0.0028247,0.062139,0.67728,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN,0.99999
GOBP_AMYLOID_PRECURSOR_PROTE...1,SET,13,-0.10342,-0.0027508,0.22464,0.67737,GOBP_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS,0.99999
GOMF_TRANSLATION_REGULATOR_A...1,SET,115,-0.033547,-0.0026466,0.072834,0.67746,GOMF_TRANSLATION_REGULATOR_ACTIVITY,0.99999
GOBP_REGULATION_OF_CELL_POPU...,SET,1515,-0.010755,-0.0029591,0.023346,0.67748,GOBP_REGULATION_OF_CELL_POPULATION_PROLIFERATION,0.99999
GSE41867_NAIVE_VS_DAY15_LCMV...4,SET,145,-0.032965,-0.0029179,0.071557,0.67748,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_UP,0.99999
GOBP_PANCREATIC_A_CELL_DIFFE...,SET,10,-0.15152,-0.0035352,0.32888,0.6775,GOBP_PANCREATIC_A_CELL_DIFFERENTIATION,0.99999
GOBP_CELL_AGGREGATION,SET,22,-0.092648,-0.0032051,0.20108,0.67751,GOBP_CELL_AGGREGATION,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOSI...3,SET,15,-0.096428,-0.002755,0.20926,0.67753,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.99999
GOCC_PROTON_TRANSPORTING_V_T...3,SET,12,-0.13355,-0.003413,0.2897,0.67759,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_V1_DOMAIN,0.99999
BIERIE_INFLAMMATORY_RESPONSE...,SET,5,-0.21785,-0.0035945,0.47252,0.67761,BIERIE_INFLAMMATORY_RESPONSE_TGFB1,0.99999
GOBP_INTERLEUKIN_4_PRODUCTION,SET,29,-0.078749,-0.0031272,0.1708,0.67762,GOBP_INTERLEUKIN_4_PRODUCTION,0.99999
REACTOME_NOTCH4_INTRACELLULA...,SET,19,-0.085311,-0.0027429,0.18502,0.67763,REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.99999
GNF2_TTK,SET,39,-0.060087,-0.0027663,0.1303,0.67764,GNF2_TTK,0.99999
LI_ESTROGENE_LATE_E2_RESPONS...2,SET,52,-0.057143,-0.0030367,0.12387,0.67771,LI_ESTROGENE_LATE_E2_RESPONSE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...520,SET,5,-0.18198,-0.0030026,0.39448,0.67771,GOBP_POSITIVE_REGULATION_OF_NECROPTOTIC_PROCESS,0.99999
REACTOME_PLASMA_LIPOPROTEIN_...1,SET,14,-0.099576,-0.0027485,0.2157,0.67783,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY,0.99999
GSE22025_UNTREATED_VS_PROGES...1,SET,184,-0.029481,-0.0029364,0.063827,0.67791,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN,0.99999
BOQUEST_STEM_CELL_CULTURED_V...2,SET,383,-0.02177,-0.0031113,0.047124,0.67795,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,0.99999
STAMBOLSKY_RESPONSE_TO_VITAM...2,SET,75,-0.045992,-0.0029334,0.099529,0.67799,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,0.99999
GSE46242_CTRL_VS_EGR2_DELETE...4,SET,168,-0.028749,-0.0027373,0.062199,0.67803,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_UP,0.99999
FRASOR_RESPONSE_TO_ESTRADIOL...1,SET,69,-0.049641,-0.0030374,0.10738,0.67807,FRASOR_RESPONSE_TO_ESTRADIOL_DN,0.99999
HP_SUBMUCOUS_CLEFT_PALATE,SET,70,-0.045329,-0.0027935,0.098042,0.67808,HP_SUBMUCOUS_CLEFT_PALATE,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...7,SET,182,-0.027835,-0.0027575,0.0602,0.67809,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN,0.99999
WP_METABOLIC_REPROGRAMMING_I...2,SET,41,-0.059721,-0.0028189,0.12913,0.67813,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,0.99999
GOBP_PROTEIN_CONTAINING_COMP...2,SET,231,-0.024279,-0.0027061,0.052492,0.67815,GOBP_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.99999
GOBP_REGULATION_OF_POLYSACCH...1,SET,33,-0.068389,-0.0028967,0.14781,0.6782,GOBP_REGULATION_OF_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,0.99999
WP_MONOAMINE_GPCRS,SET,32,-0.074622,-0.0031125,0.16126,0.67823,WP_MONOAMINE_GPCRS,0.99999
GOMF_ACYL_COA_BINDING,SET,18,-0.090771,-0.0028407,0.19613,0.67824,GOMF_ACYL_COA_BINDING,0.99999
HP_LOWER_LIMB_SPASTICITY,SET,189,-0.027245,-0.00275,0.05886,0.67827,HP_LOWER_LIMB_SPASTICITY,0.99999
TOMLINS_PROSTATE_CANCER_UP,SET,36,-0.062773,-0.0027768,0.1356,0.67828,TOMLINS_PROSTATE_CANCER_UP,0.99999
GOBP_INTERLEUKIN_21_PRODUCTI...,SET,2,-0.29812,-0.0031112,0.64392,0.6783,GOBP_INTERLEUKIN_21_PRODUCTION,0.99999
GOBP_REGULATION_OF_GLUCOSYLC...,SET,2,-0.32026,-0.0033423,0.69168,0.67832,GOBP_REGULATION_OF_GLUCOSYLCERAMIDE_CATABOLIC_PROCESS,0.99999
OZANNE_AP1_TARGETS_UP,SET,14,-0.099842,-0.0027559,0.21552,0.67841,OZANNE_AP1_TARGETS_UP,0.99999
GOCC_INTRACELLULAR_CYCLIC_NU...,SET,5,-0.16899,-0.0027883,0.36468,0.67845,GOCC_INTRACELLULAR_CYCLIC_NUCLEOTIDE_ACTIVATED_CATION_CHANNEL_COMPLEX,0.99999
NFKBIA_TARGET_GENES,SET,964,-0.013037,-0.0029077,0.028129,0.67848,NFKBIA_TARGET_GENES,0.99999
GSE29618_MONOCYTE_VS_MDC_UP,SET,186,-0.030119,-0.0030161,0.064976,0.67851,GSE29618_MONOCYTE_VS_MDC_UP,0.99999
WP_BONE_MORPHOGENIC_PROTEIN_...,SET,11,-0.11856,-0.0029011,0.25577,0.67852,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,0.99999
GSE5542_UNTREATED_VS_IFNG_TR...3,SET,180,-0.029778,-0.0029339,0.06422,0.67856,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.99999
GOMF_MDM2_MDM4_FAMILY_PROTEI...,SET,10,-0.13098,-0.0030559,0.28243,0.67859,GOMF_MDM2_MDM4_FAMILY_PROTEIN_BINDING,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...11,SET,182,-0.027802,-0.0027542,0.059926,0.67865,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN,0.99999
NAKAYA_B_CELL_FLUARIX_FLUVIR...2,SET,321,-0.020575,-0.0026966,0.044348,0.67865,NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...6,SET,145,-0.029633,-0.0026229,0.06387,0.67866,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,0.99999
REACTOME_PI5P_REGULATES_TP53...,SET,8,-0.14463,-0.0030182,0.31168,0.67868,REACTOME_PI5P_REGULATES_TP53_ACETYLATION,0.99999
GOBP_GOLGI_LOCALIZATION,SET,12,-0.10715,-0.0027384,0.23086,0.67873,GOBP_GOLGI_LOCALIZATION,0.99999
WP_EDA_SIGNALING_IN_HAIR_FOL...,SET,11,-0.11428,-0.0027963,0.24616,0.67876,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,0.99999
GOCC_POLYPRENYL_DIPHOSPHATE_...,SET,10,-0.1142,-0.0026644,0.24598,0.67877,GOCC_POLYPRENYL_DIPHOSPHATE_SYNTHASE_COMPLEX,0.99999
GSE3565_DUSP1_VS_WT_SPLENOCY...3,SET,141,-0.032002,-0.0027936,0.068891,0.67887,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_UP,0.99999
WP_INTERACTIONS_BETWEEN_IMMU...,SET,24,-0.086212,-0.0031149,0.18555,0.6789,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,0.99999
GOBP_CELLULAR_MODIFIED_AMINO...2,SET,29,-0.072363,-0.0028736,0.15571,0.67894,GOBP_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_EXOCYTOSIS,SET,155,-0.031538,-0.0028854,0.067848,0.67897,GOBP_REGULATION_OF_EXOCYTOSIS,0.99999
GOBP_REGULATION_OF_PHAGOCYTO...,SET,90,-0.044434,-0.0031033,0.095575,0.679,GOBP_REGULATION_OF_PHAGOCYTOSIS,0.99999
WP_CANCER_IMMUNOTHERAPY_BY_C...,SET,12,-0.11961,-0.0030568,0.25718,0.67906,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,0.99999
HP_LOWER_LIMB_METAPHYSEAL_IR...,SET,9,-0.12557,-0.0027793,0.26995,0.67908,HP_LOWER_LIMB_METAPHYSEAL_IRREGULARITY,0.99999
RIGGINS_TAMOXIFEN_RESISTANCE...1,SET,202,-0.029681,-0.003096,0.063775,0.67918,RIGGINS_TAMOXIFEN_RESISTANCE_DN,0.99999
GSE25123_CTRL_VS_IL4_STIM_MA...2,SET,177,-0.029067,-0.0028401,0.06244,0.67922,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_UP,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...16,SET,186,-0.029467,-0.0029508,0.063286,0.67925,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP,0.99999
HP_CEREBELLAR_ATROPHY,SET,393,-0.018929,-0.0027395,0.040651,0.67926,HP_CEREBELLAR_ATROPHY,0.99999
REACTOME_TGF_BETA_RECEPTOR_S...2,SET,15,-0.11151,-0.003186,0.23942,0.6793,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.99999
GOBP_RESPONSE_TO_INSECTICIDE,SET,6,-0.17898,-0.0032349,0.38424,0.67932,GOBP_RESPONSE_TO_INSECTICIDE,0.99999
GSE42088_UNINF_VS_LEISHMANIA...8,SET,183,-0.030448,-0.0030245,0.06536,0.67933,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...193,SET,8,-0.1607,-0.0033536,0.34495,0.67934,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.99999
GSE360_CTRL_VS_L_MAJOR_DC_UP,SET,180,-0.028488,-0.0028068,0.061137,0.67938,GSE360_CTRL_VS_L_MAJOR_DC_UP,0.99999
GSE29618_PRE_VS_DAY7_POST_TI...7,SET,175,-0.028016,-0.0027221,0.060119,0.67939,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN,0.99999
HP_AMYOTROPHIC_LATERAL_SCLER...,SET,48,-0.052556,-0.0026837,0.11276,0.67942,HP_AMYOTROPHIC_LATERAL_SCLEROSIS,0.99999
GOBP_G_PROTEIN_COUPLED_PURIN...2,SET,10,-0.12907,-0.0030114,0.27692,0.67943,GOBP_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY,0.99999
REACTOME_SIGNALING_BY_LRP5_M...,SET,6,-0.14076,-0.002544,0.30195,0.67944,REACTOME_SIGNALING_BY_LRP5_MUTANTS,0.99999
GSE10211_UV_INACT_SENDAI_VS_...2,SET,141,-0.033279,-0.002905,0.071387,0.67945,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP,0.99999
REACTOME_SYNTHESIS_OF_PE,SET,12,-0.12049,-0.0030793,0.25844,0.67947,REACTOME_SYNTHESIS_OF_PE,0.99999
GOBP_HEPATOCYTE_DIFFERENTIAT...,SET,13,-0.11319,-0.0030107,0.24272,0.67951,GOBP_HEPATOCYTE_DIFFERENTIATION,0.99999
GSE16385_IFNG_TNF_VS_UNSTIM_...1,SET,179,-0.029162,-0.0028653,0.062525,0.67954,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,0.99999
GSE27786_LSK_VS_NKTCELL_UP,SET,174,-0.029256,-0.0028345,0.062719,0.67955,GSE27786_LSK_VS_NKTCELL_UP,0.99999
GOCC_ER_UBIQUITIN_LIGASE_COM...,SET,4,-0.20457,-0.003019,0.43842,0.6796,GOCC_ER_UBIQUITIN_LIGASE_COMPLEX,0.99999
GNF2_PA2G4,SET,75,-0.040977,-0.0026136,0.08782,0.67961,GNF2_PA2G4,0.99999
GTAAACC_MIR2995P,SET,42,-0.062351,-0.0029787,0.13358,0.67966,GTAAACC_MIR2995P,0.99999
GOBP_REGULATION_OF_DNA_METAB...,SET,447,-0.018031,-0.0027789,0.038621,0.67971,GOBP_REGULATION_OF_DNA_METABOLIC_PROCESS,0.99999
MORF_PTPN9,SET,51,-0.051453,-0.002708,0.11018,0.67974,MORF_PTPN9,0.99999
HP_ABNORMAL_ERYTHROCYTE_ENZY...,SET,37,-0.059015,-0.0026465,0.12637,0.67975,HP_ABNORMAL_ERYTHROCYTE_ENZYME_CONCENTRATION_OR_ACTIVITY,0.99999
chr6q22,SET,54,-0.1029,-0.005572,0.22031,0.67977,chr6q22,0.99999
GOBP_PRIMITIVE_STREAK_FORMAT...,SET,8,-0.14796,-0.0030877,0.31679,0.67977,GOBP_PRIMITIVE_STREAK_FORMATION,0.99999
SESTO_RESPONSE_TO_UV_C2,SET,50,-0.052718,-0.0027473,0.11284,0.67981,SESTO_RESPONSE_TO_UV_C2,0.99999
HP_VIRAL_HEPATITIS,SET,13,-0.11277,-0.0029995,0.24137,0.67982,HP_VIRAL_HEPATITIS,0.99999
GSE15930_NAIVE_VS_48H_IN_VIT...4,SET,183,-0.028758,-0.0028567,0.061555,0.67982,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,0.99999
MIR302E,SET,444,-0.018864,-0.0028977,0.040368,0.67985,MIR302E,0.99999
MODULE_400,SET,18,-0.097256,-0.0030436,0.20813,0.67985,MODULE_400,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...34,SET,26,-0.0751,-0.002824,0.16065,0.67991,HP_APLASIA_HYPOPLASIA_OF_THE_FIBULA,0.99999
GOBP_POSITIVE_REGULATION_OF_...571,SET,26,-0.082802,-0.0031137,0.17712,0.67992,GOBP_POSITIVE_REGULATION_OF_P38MAPK_CASCADE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...557,SET,6,-0.19586,-0.00354,0.41888,0.67995,GOBP_NEGATIVE_REGULATION_OF_RELAXATION_OF_MUSCLE,0.99999
GOBP_DISTAL_CONVOLUTED_TUBUL...,SET,4,-0.22853,-0.0033727,0.48873,0.67996,GOBP_DISTAL_CONVOLUTED_TUBULE_DEVELOPMENT,0.99999
HP_ABNORMAL_URETER_PHYSIOLOGY,SET,213,-0.027023,-0.0028936,0.057776,0.68001,HP_ABNORMAL_URETER_PHYSIOLOGY,0.99999
MTOR_UP.N4.V1_UP,SET,175,-0.029471,-0.0028635,0.062958,0.68014,MTOR_UP.N4.V1_UP,0.99999
PID_HDAC_CLASSI_PATHWAY,SET,60,-0.050053,-0.0028566,0.10684,0.68028,PID_HDAC_CLASSI_PATHWAY,0.99999
GSE17580_TREG_VS_TEFF_S_MANS...1,SET,176,-0.03012,-0.0029348,0.064294,0.68028,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN,0.99999
HP_OPTIC_NERVE_MISROUTING,SET,5,-0.1935,-0.0031927,0.41295,0.68031,HP_OPTIC_NERVE_MISROUTING,0.99999
KEGG_O_GLYCAN_BIOSYNTHESIS,SET,27,-0.087102,-0.0033376,0.18584,0.68035,KEGG_O_GLYCAN_BIOSYNTHESIS,0.99999
GOBP_REGULATION_OF_SMALL_MOL...,SET,286,-0.023557,-0.0029171,0.05026,0.68036,GOBP_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,0.99999
MODULE_169,SET,89,-0.044938,-0.0031211,0.095869,0.68037,MODULE_169,0.99999
GSE16385_MONOCYTE_VS_12H_IL4...2,SET,175,-0.031154,-0.003027,0.066449,0.68041,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP,0.99999
MODULE_388,SET,16,-0.086718,-0.0025588,0.18492,0.68045,MODULE_388,0.99999
GOBP_MESENDODERM_DEVELOPMENT,SET,9,-0.13341,-0.0029529,0.28444,0.68047,GOBP_MESENDODERM_DEVELOPMENT,0.99999
HP_PLATYBASIA,SET,16,-0.1148,-0.0033873,0.24476,0.68047,HP_PLATYBASIA,0.99999
WP_MITOCHONDRIAL_BETAOXIDATI...,SET,8,-0.14181,-0.0029595,0.30208,0.68062,WP_MITOCHONDRIAL_BETAOXIDATION,0.99999
HP_ABNORMAL_THORAX_MORPHOLOGY,SET,783,-0.014398,-0.0029091,0.03067,0.68062,HP_ABNORMAL_THORAX_MORPHOLOGY,0.99999
LIU_CDX2_TARGETS_DN,SET,8,-0.15769,-0.0032908,0.33588,0.68063,LIU_CDX2_TARGETS_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...295,SET,5,-0.21632,-0.0035692,0.46075,0.68064,GOBP_POSITIVE_REGULATION_OF_GASTRULATION,0.99999
HP_DOWNSLANTED_PALPEBRAL_FIS...,SET,428,-0.019206,-0.002898,0.040902,0.68066,HP_DOWNSLANTED_PALPEBRAL_FISSURES,0.99999
MIR4529_5P,SET,45,-0.060744,-0.0030035,0.12932,0.68072,MIR4529_5P,0.99999
MIR3682_5P,SET,88,-0.042142,-0.0029105,0.089707,0.68074,MIR3682_5P,0.99999
GOBP_BLOOD_VESSEL_ENDOTHELIA...1,SET,11,-0.12807,-0.0031337,0.27261,0.68074,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_DIFFERENTIATION,0.99999
GSE22886_DC_VS_MONOCYTE_UP,SET,186,-0.028996,-0.0029036,0.061713,0.68077,GSE22886_DC_VS_MONOCYTE_UP,0.99999
GOBP_REGULATION_OF_RESPIRATO...4,SET,11,-0.12757,-0.0031216,0.27143,0.68082,GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE_BY_NERVOUS_SYSTEM_PROCESS,0.99999
HP_LATERAL_CLAVICLE_HOOK,SET,11,-0.11326,-0.0027713,0.24097,0.68082,HP_LATERAL_CLAVICLE_HOOK,0.99999
GSE2770_UNTREATED_VS_ACT_CD4...6,SET,180,-0.029122,-0.0028692,0.06196,0.68082,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP,0.99999
MIR642A_3P_MIR642B_3P,SET,126,-0.035116,-0.002899,0.074677,0.6809,MIR642A_3P_MIR642B_3P,0.99999
HP_GINGIVAL_RECESSION,SET,5,-0.16961,-0.0027985,0.3607,0.6809,HP_GINGIVAL_RECESSION,0.99999
GOBP_STEROL_METABOLIC_PROCESS,SET,138,-0.03374,-0.0029141,0.071744,0.68092,GOBP_STEROL_METABOLIC_PROCESS,0.99999
ANDERSON_BLOOD_CN54GP140_ADJ...3,SET,30,-0.065472,-0.0026443,0.13922,0.68092,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_DN,0.99999
GOBP_AMINO_ACID_TRANSPORT,SET,147,-0.034368,-0.0030628,0.073056,0.68098,GOBP_AMINO_ACID_TRANSPORT,0.99999
MIR3973,SET,233,-0.026191,-0.0029317,0.055666,0.681,MIR3973,0.99999
GOBP_MALONYL_COA_METABOLIC_P...,SET,6,-0.16236,-0.0029344,0.34506,0.681,GOBP_MALONYL_COA_METABOLIC_PROCESS,0.99999
HP_ESOPHAGEAL_ATRESIA,SET,25,-0.073919,-0.0027257,0.15707,0.68104,HP_ESOPHAGEAL_ATRESIA,0.99999
GSE36476_CTRL_VS_TSST_ACT_72...3,SET,179,-0.028571,-0.0028073,0.060711,0.68104,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN,0.99999
HP_ONYCHOGRYPOSIS_OF_TOENAILS,SET,7,-0.1456,-0.0028423,0.30936,0.68105,HP_ONYCHOGRYPOSIS_OF_TOENAILS,0.99999
REACTOME_APC_C_CDH1_MEDIATED...,SET,70,-0.042901,-0.0026438,0.091147,0.68106,REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,0.99999
GOBP_VITAMIN_METABOLIC_PROCE...,SET,109,-0.037568,-0.0028859,0.079796,0.6811,GOBP_VITAMIN_METABOLIC_PROCESS,0.99999
GSE360_CTRL_VS_B_MALAYI_LOW_...4,SET,181,-0.029162,-0.0028811,0.06194,0.68111,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.99999
GOCC_ACROSOMAL_VESICLE,SET,132,-0.03558,-0.0030059,0.075566,0.68112,GOCC_ACROSOMAL_VESICLE,0.99999
WP_EFFECT_OF_OMEGA3_PUFA_ON_...,SET,114,-0.038548,-0.003028,0.081854,0.68115,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,0.99999
HP_EXCESSIVE_DAYTIME_SOMNOLE...,SET,64,-0.048609,-0.0028648,0.10321,0.68116,HP_EXCESSIVE_DAYTIME_SOMNOLENCE,0.99999
HP_RETINAL_DYSPLASIA,SET,18,-0.088433,-0.0027675,0.18776,0.68117,HP_RETINAL_DYSPLASIA,0.99999
GSE17721_0.5H_VS_4H_PAM3CSK4...1,SET,191,-0.028959,-0.0029382,0.061487,0.68117,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN,0.99999
CCGNMNNTNACG_UNKNOWN,SET,74,-0.043382,-0.0027485,0.092107,0.68118,CCGNMNNTNACG_UNKNOWN,0.99999
GSE45365_NK_CELL_VS_BCELL_MC...1,SET,171,-0.031221,-0.0029989,0.06627,0.68122,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...561,SET,5,-0.18487,-0.0030503,0.39227,0.68127,GOBP_NEGATIVE_REGULATION_OF_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.99999
GSE36078_WT_VS_IL1R_KO_LUNG_...4,SET,181,-0.029332,-0.0028979,0.062221,0.68132,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_UP,0.99999
GSE22589_HIV_VS_HIV_AND_SIV_...2,SET,180,-0.028648,-0.0028225,0.060757,0.68136,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP,0.99999
GOCC_RESPIRATORY_CHAIN_COMPL...,SET,21,-0.084583,-0.0028589,0.17935,0.68139,GOCC_RESPIRATORY_CHAIN_COMPLEX_IV,0.99999
WP_10Q1121Q1123_COPY_NUMBER_...,SET,55,-0.052098,-0.0028471,0.11046,0.6814,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GSE12392_WT_VS_IFNB_KO_CD8A_...4,SET,176,-0.028604,-0.002787,0.060609,0.68151,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_UP,0.99999
GSE25147_UNSTIM_VS_HELIOBACT...2,SET,151,-0.031684,-0.0028615,0.06712,0.68155,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...213,SET,4,-0.18422,-0.0027188,0.39016,0.68159,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_CHECKPOINT,0.99999
ZHONG_PFC_C3_ASTROCYTE,SET,338,-0.022086,-0.0029689,0.046774,0.6816,ZHONG_PFC_C3_ASTROCYTE,0.99999
MIR6737_5P,SET,72,-0.044988,-0.0028117,0.095246,0.68165,MIR6737_5P,0.99999
GOCC_SYNAPTOBREVIN_2_SNAP_25...,SET,5,-0.16743,-0.0027625,0.35447,0.68166,GOCC_SYNAPTOBREVIN_2_SNAP_25_SYNTAXIN_1A_COMPLEX,0.99999
GRUETZMANN_PANCREATIC_CANCER...1,SET,182,-0.029769,-0.0029491,0.063005,0.68171,GRUETZMANN_PANCREATIC_CANCER_DN,0.99999
KEGG_NICOTINATE_AND_NICOTINA...,SET,24,-0.086241,-0.0031159,0.18249,0.68174,KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM,0.99999
HP_ABNORMALITY_OF_THE_DISTAL...2,SET,5,-0.17071,-0.0028167,0.36121,0.68175,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_2ND_FINGER,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...17,SET,67,-0.046654,-0.0028131,0.09871,0.68176,GOBP_PROTEIN_LOCALIZATION_TO_CILIUM,0.99999
MODULE_23,SET,517,-0.018077,-0.0029903,0.038233,0.68182,MODULE_23,0.99999
WORSCHECH_TUMOR_EVASION_AND_...1,SET,14,-0.11139,-0.0030746,0.23552,0.68187,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN,0.99999
KEGG_MEDICUS_PATHOGEN_ESCHER...7,SET,4,-0.20493,-0.0030244,0.43326,0.68188,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,0.99999
GCM_FANCL,SET,21,-0.076565,-0.0025879,0.16183,0.68193,GCM_FANCL,0.99999
HP_STEREOTYPIC_WHOLE_BODY_MO...,SET,8,-0.12759,-0.0026626,0.26968,0.68193,HP_STEREOTYPIC_WHOLE_BODY_MOVEMENTS,0.99999
GSE20366_EX_VIVO_VS_HOMEOSTA...2,SET,180,-0.028298,-0.0027881,0.059813,0.68193,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP,0.99999
HP_YELLOW_WHITE_LESIONS_OF_T...2,SET,55,-0.054363,-0.0029709,0.1149,0.68194,HP_YELLOW_WHITE_LESIONS_OF_THE_RETINA,0.99999
RAMPON_ENRICHED_LEARNING_ENV...2,SET,14,-0.10102,-0.0027885,0.21351,0.68195,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP,0.99999
GOBP_CELL_JUNCTION_ASSEMBLY,SET,421,-0.020759,-0.0031071,0.04387,0.68196,GOBP_CELL_JUNCTION_ASSEMBLY,0.99999
REACTOME_REGULATION_OF_GENE_...1,SET,11,-0.12234,-0.0029934,0.25846,0.68201,REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR,0.99999
GSE11864_UNTREATED_VS_CSF1_P...1,SET,176,-0.028273,-0.0027548,0.059722,0.68204,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN,0.99999
HP_TRICUSPID_ATRESIA,SET,11,-0.14594,-0.0035711,0.30821,0.68208,HP_TRICUSPID_ATRESIA,0.99999
GOBP_RESPONSE_TO_ZINC_ION,SET,44,-0.063364,-0.0030981,0.13378,0.68212,GOBP_RESPONSE_TO_ZINC_ION,0.99999
BIOCARTA_TEL_PATHWAY,SET,17,-0.09608,-0.0029222,0.2028,0.68216,BIOCARTA_TEL_PATHWAY,0.99999
MIR15B_3P,SET,73,-0.047641,-0.002998,0.10054,0.6822,MIR15B_3P,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...2,SET,62,-0.05589,-0.0032423,0.11794,0.68221,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,0.99999
GSE23568_ID3_TRANSDUCED_VS_I...1,SET,182,-0.029475,-0.00292,0.062196,0.68221,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN,0.99999
GSE26030_UNSTIM_VS_RESTIM_TH...3,SET,174,-0.030825,-0.0029865,0.065043,0.68222,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_DN,0.99999
MIR2277_3P,SET,15,-0.10312,-0.0029461,0.21756,0.68223,MIR2277_3P,0.99999
MIR142_3P,SET,162,-0.032527,-0.0030418,0.068608,0.68228,MIR142_3P,0.99999
HP_PERSISTENCE_OF_PRIMARY_TE...,SET,22,-0.082713,-0.0028614,0.17445,0.6823,HP_PERSISTENCE_OF_PRIMARY_TEETH,0.99999
REACTOME_REGULATION_OF_MRNA_...,SET,83,-0.041629,-0.0027926,0.087779,0.68234,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,0.99999
GOBP_LIPID_PHOSPHORYLATION,SET,10,-0.12018,-0.0028039,0.25335,0.68238,GOBP_LIPID_PHOSPHORYLATION,0.99999
GOMF_ATP_DEPENDENT_DIACYLGLY...,SET,10,-0.12018,-0.0028039,0.25335,0.68238,GOMF_ATP_DEPENDENT_DIACYLGLYCEROL_KINASE_ACTIVITY,0.99999
GOBP_SMOOTH_MUSCLE_CELL_DIFF...,SET,59,-0.055166,-0.0031221,0.11628,0.6824,GOBP_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.99999
HAHTOLA_SEZARY_SYNDROM_DN,SET,38,-0.066188,-0.003008,0.1395,0.68241,HAHTOLA_SEZARY_SYNDROM_DN,0.99999
GSE24574_BCL6_HIGH_TFH_VS_TC...1,SET,188,-0.030267,-0.0030469,0.063776,0.68245,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN,0.99999
MIR6515_5P,SET,79,-0.04408,-0.0028852,0.092877,0.68246,MIR6515_5P,0.99999
GOBP_MESENCHYMAL_CELL_APOPTO...,SET,15,-0.12041,-0.0034403,0.25371,0.68246,GOBP_MESENCHYMAL_CELL_APOPTOTIC_PROCESS,0.99999
MIR548I,SET,442,-0.019191,-0.0029416,0.040433,0.68248,MIR548I,0.99999
GSE11924_TH2_VS_TH17_CD4_TCE...2,SET,178,-0.030132,-0.0029524,0.063477,0.68249,GSE11924_TH2_VS_TH17_CD4_TCELL_UP,0.99999
HP_DECREASED_CIRCULATING_ADE...,SET,7,-0.15519,-0.0030295,0.32682,0.68254,HP_DECREASED_CIRCULATING_ADENOSYLCOBALAMIN_CONCENTRATION,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...1,SET,1551,-0.01034,-0.0028756,0.021773,0.68257,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.99999
LINDSTEDT_DENDRITIC_CELL_MAT...4,SET,60,-0.05355,-0.0030562,0.11275,0.68258,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,0.99999
GSE6674_CPG_VS_CPG_AND_ANTI_...2,SET,176,-0.028421,-0.0027692,0.059839,0.68259,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP,0.99999
MTOR_UP.V1_DN,SET,171,-0.03085,-0.0029633,0.064948,0.6826,MTOR_UP.V1_DN,0.99999
HP_ENLARGED_POSTERIOR_FOSSA,SET,163,-0.029504,-0.0027675,0.062095,0.68266,HP_ENLARGED_POSTERIOR_FOSSA,0.99999
REACTOME_ACTIVATION_OF_THE_T...,SET,11,-0.12624,-0.003089,0.26563,0.68269,REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS,0.99999
GSE14415_NATURAL_TREG_VS_TCO...1,SET,168,-0.030201,-0.0028757,0.063547,0.6827,GSE14415_NATURAL_TREG_VS_TCONV_DN,0.99999
NIKOLSKY_BREAST_CANCER_12Q24...,SET,14,-0.20158,-0.0055642,0.42412,0.68271,NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON,0.99999
GOCC_ARYL_HYDROCARBON_RECEPT...,SET,6,-0.13592,-0.0024567,0.28596,0.68272,GOCC_ARYL_HYDROCARBON_RECEPTOR_COMPLEX,0.99999
ABBUD_LIF_SIGNALING_2_UP,SET,13,-0.11733,-0.0031209,0.24679,0.68276,ABBUD_LIF_SIGNALING_2_UP,0.99999
KOINUMA_COLON_CANCER_MSI_UP,SET,16,-0.095531,-0.0028188,0.20088,0.6828,KOINUMA_COLON_CANCER_MSI_UP,0.99999
GSE37534_GW1929_VS_ROSIGLITA...1,SET,146,-0.032392,-0.002877,0.068075,0.6829,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,0.99999
GSE19888_CTRL_VS_T_CELL_MEMB...1,SET,186,-0.028748,-0.0028788,0.060396,0.68296,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN,0.99999
MIR135A_5P,SET,283,-0.024294,-0.0029928,0.051025,0.68301,MIR135A_5P,0.99999
BIOCARTA_PLC_PATHWAY,SET,9,-0.13692,-0.0030307,0.28754,0.68303,BIOCARTA_PLC_PATHWAY,0.99999
PUJANA_BRCA1_PCC_NETWORK,SET,1455,-0.010487,-0.0028328,0.022022,0.68304,PUJANA_BRCA1_PCC_NETWORK,0.99999
GOBP_FACIAL_NERVE_MORPHOGENE...,SET,9,-0.15092,-0.0033404,0.31689,0.68305,GOBP_FACIAL_NERVE_MORPHOGENESIS,0.99999
GOMF_OXO_ACID_LYASE_ACTIVITY,SET,7,-0.15491,-0.0030242,0.32527,0.68305,GOMF_OXO_ACID_LYASE_ACTIVITY,0.99999
GSE36888_UNTREATED_VS_IL2_TR...3,SET,173,-0.030105,-0.0029084,0.063191,0.68311,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN,0.99999
MIR548V,SET,124,-0.036416,-0.0029825,0.07642,0.68315,MIR548V,0.99999
HP_ABNORMAL_CIRCULATING_INTE...1,SET,23,-0.083938,-0.0029689,0.17615,0.68315,HP_ABNORMAL_CIRCULATING_INTERFERON_CONCENTRATION,0.99999
RICKMAN_HEAD_AND_NECK_CANCER...3,SET,101,-0.042809,-0.0031663,0.089826,0.68317,RICKMAN_HEAD_AND_NECK_CANCER_C,0.99999
SARTIPY_NORMAL_AT_INSULIN_RE...1,SET,17,-0.097288,-0.0029589,0.20413,0.68317,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN,0.99999
AAAGGAT_MIR501,SET,111,-0.038713,-0.0030009,0.081226,0.68318,AAAGGAT_MIR501,0.99999
MORF_BECN1,SET,96,-0.037217,-0.002684,0.078075,0.6832,MORF_BECN1,0.99999
GOCC_CATALYTIC_COMPLEX,SET,1516,-0.010272,-0.0028271,0.021547,0.68322,GOCC_CATALYTIC_COMPLEX,0.99999
HP_ABNORMAL_FEMORAL_NECK_MOR...,SET,139,-0.034261,-0.0029697,0.071866,0.68322,HP_ABNORMAL_FEMORAL_NECK_MORPHOLOGY,0.99999
GOMF_PROTEIN_BINDING_INVOLVE...,SET,12,-0.13012,-0.0033253,0.27284,0.68328,GOMF_PROTEIN_BINDING_INVOLVED_IN_HETEROTYPIC_CELL_CELL_ADHESION,0.99999
MIR223_5P,SET,138,-0.033636,-0.0029051,0.070515,0.68332,MIR223_5P,0.99999
HP_ABNORMAL_CORTICAL_GYRATION,SET,347,-0.021295,-0.0028997,0.044639,0.68333,HP_ABNORMAL_CORTICAL_GYRATION,0.99999
KEGG_MEDICUS_REFERENCE_PRL_J...,SET,5,-0.23738,-0.0039168,0.49741,0.6834,KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY,0.99999
GTGCCAT_MIR183,SET,159,-0.033377,-0.0030925,0.069933,0.68341,GTGCCAT_MIR183,0.99999
MIR3193,SET,7,-0.14156,-0.0027636,0.2966,0.68342,MIR3193,0.99999
MIR3120_3P,SET,320,-0.022778,-0.0029807,0.047692,0.68353,MIR3120_3P,0.99999
HP_BLOCK_VERTEBRAE,SET,5,-0.19218,-0.0031709,0.40237,0.68353,HP_BLOCK_VERTEBRAE,0.99999
GOBP_UTP_BIOSYNTHETIC_PROCESS,SET,9,-0.13889,-0.0030741,0.29075,0.68356,GOBP_UTP_BIOSYNTHETIC_PROCESS,0.99999
GSE42021_TREG_PLN_VS_CD24LO_...2,SET,171,-0.02986,-0.0028682,0.062507,0.68357,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_UP,0.99999
HP_DECREASED_SKULL_OSSIFICAT...,SET,38,-0.064862,-0.0029477,0.13577,0.68358,HP_DECREASED_SKULL_OSSIFICATION,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...70,SET,127,-0.036168,-0.0029976,0.0757,0.68359,HP_APLASIA_HYPOPLASIA_OF_THE_THUMB,0.99999
WP_CELLTYPE_DEPENDENT_SELECT...,SET,13,-0.12352,-0.0032857,0.25851,0.68361,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,0.99999
GSE42724_MEMORY_BCELL_VS_PLA...1,SET,175,-0.029501,-0.0028664,0.061741,0.68361,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN,0.99999
GOMF_ATP_TRANSMEMBRANE_TRANS...,SET,12,-0.1237,-0.0031613,0.25875,0.68369,GOMF_ATP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
REACTOME_RAB_GERANYLGERANYLA...,SET,57,-0.053914,-0.0029993,0.11275,0.68374,REACTOME_RAB_GERANYLGERANYLATION,0.99999
HP_NODULAR_REGENERATIVE_HYPE...,SET,5,-0.19602,-0.0032344,0.40986,0.68377,HP_NODULAR_REGENERATIVE_HYPERPLASIA_OF_LIVER,0.99999
GOBP_REGULATION_OF_UBIQUITIN...1,SET,149,-0.032703,-0.002934,0.068366,0.68379,GOBP_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
HP_CALCIUM_NEPHROLITHIASIS,SET,18,-0.090365,-0.002828,0.18887,0.68384,HP_CALCIUM_NEPHROLITHIASIS,0.99999
HP_CHROMOSOME_BREAKAGE,SET,36,-0.062692,-0.0027733,0.131,0.68387,HP_CHROMOSOME_BREAKAGE,0.99999
GOMF_PHOSPHOLIPASE_D_ACTIVITY,SET,6,-0.14791,-0.0026734,0.3088,0.68403,GOMF_PHOSPHOLIPASE_D_ACTIVITY,0.99999
HP_RHEGMATOGENOUS_RETINAL_DE...,SET,11,-0.12642,-0.0030934,0.2639,0.68404,HP_RHEGMATOGENOUS_RETINAL_DETACHMENT,0.99999
KEGG_TGF_BETA_SIGNALING_PATH...,SET,84,-0.044312,-0.0029903,0.092492,0.68406,KEGG_TGF_BETA_SIGNALING_PATHWAY,0.99999
MODULE_183,SET,62,-0.047351,-0.0027469,0.098812,0.6841,MODULE_183,0.99999
GAO_ESOPHAGUS_25W_C4_FGFR1HI...,SET,178,-0.02975,-0.002915,0.062083,0.6841,GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS,0.99999
GOBP_DCMP_CATABOLIC_PROCESS,SET,6,-0.17366,-0.0031388,0.3622,0.68419,GOBP_DCMP_CATABOLIC_PROCESS,0.99999
APPIERTO_RESPONSE_TO_FENRETI...1,SET,43,-0.05805,-0.0028059,0.12103,0.68425,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,0.99999
REACTOME_TRANSCRIPTIONAL_REG...7,SET,45,-0.057392,-0.0028378,0.11966,0.68425,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,0.99999
HP_GLOBAL_BRAIN_ATROPHY,SET,58,-0.051868,-0.0029106,0.1081,0.68432,HP_GLOBAL_BRAIN_ATROPHY,0.99999
GOMF_AMIDE_BINDING,SET,230,-0.027803,-0.0030922,0.057936,0.68435,GOMF_AMIDE_BINDING,0.99999
MIR127_5P,SET,80,-0.046936,-0.0030914,0.097786,0.68438,MIR127_5P,0.99999
GATGKMRGCG_UNKNOWN,SET,60,-0.052679,-0.0030065,0.10974,0.68439,GATGKMRGCG_UNKNOWN,0.99999
HP_DILATION_OF_VIRCHOW_ROBIN...,SET,13,-0.11715,-0.0031161,0.24406,0.68439,HP_DILATION_OF_VIRCHOW_ROBIN_SPACES,0.99999
NIKOLSKY_BREAST_CANCER_8Q23_...,SET,144,-0.063629,-0.0056128,0.13254,0.68441,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,0.99999
GSE360_L_MAJOR_VS_B_MALAYI_H...2,SET,177,-0.03108,-0.0030368,0.064739,0.68442,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP,0.99999
NKX2_2_TARGET_GENES,SET,1062,-0.012481,-0.0029136,0.025996,0.68443,NKX2_2_TARGET_GENES,0.99999
HP_PERIVENTRICULAR_CYSTS,SET,12,-0.11807,-0.0030174,0.24587,0.68445,HP_PERIVENTRICULAR_CYSTS,0.99999
REACTOME_G1_S_DNA_DAMAGE_CHE...,SET,64,-0.045336,-0.0026719,0.094381,0.68451,REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,0.99999
HP_CORTICAL_MYOCLONUS,SET,14,-0.10963,-0.003026,0.22815,0.68456,HP_CORTICAL_MYOCLONUS,0.99999
HP_BICARBONATE_WASTING_RENAL...,SET,5,-0.1795,-0.0029617,0.37336,0.68466,HP_BICARBONATE_WASTING_RENAL_TUBULAR_ACIDOSIS,0.99999
REACTOME_CYTOCHROME_C_MEDIAT...,SET,12,-0.11204,-0.0028634,0.23301,0.68469,REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE,0.99999
GOBP_NEGATIVE_T_CELL_SELECTI...,SET,13,-0.12658,-0.0033669,0.26316,0.68474,GOBP_NEGATIVE_T_CELL_SELECTION,0.99999
KEGG_ONE_CARBON_POOL_BY_FOLA...,SET,17,-0.085543,-0.0026017,0.17784,0.68475,KEGG_ONE_CARBON_POOL_BY_FOLATE,0.99999
REACTOME_FORMATION_OF_THE_BE...,SET,31,-0.073346,-0.0030112,0.15248,0.68475,REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,0.99999
HP_ABNORMAL_CIRCULATING_ANDR...1,SET,89,-0.044097,-0.0030627,0.091662,0.68477,HP_ABNORMAL_CIRCULATING_ANDROGEN_LEVEL,0.99999
REACTOME_EPHRIN_SIGNALING,SET,17,-0.099111,-0.0030144,0.20595,0.68482,REACTOME_EPHRIN_SIGNALING,0.99999
RGTTAMWNATT_HNF1_01,SET,65,-0.053965,-0.0032052,0.11212,0.68485,RGTTAMWNATT_HNF1_01,0.99999
HP_CIGARETTE_PAPER_SCARS,SET,10,-0.1396,-0.003257,0.28999,0.68488,HP_CIGARETTE_PAPER_SCARS,0.99999
HALLMARK_IL6_JAK_STAT3_SIGNA...,SET,80,-0.048671,-0.0032057,0.10109,0.6849,HALLMARK_IL6_JAK_STAT3_SIGNALING,0.99999
WP_MULTIPLE_EPIPHYSEAL_DYSPL...,SET,6,-0.18328,-0.0033127,0.38064,0.68492,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,0.99999
GSE27786_CD8_TCELL_VS_NKCELL...1,SET,182,-0.030366,-0.0030082,0.063062,0.68492,GSE27786_CD8_TCELL_VS_NKCELL_DN,0.99999
CHEOK_RESPONSE_TO_MERCAPTOPU...4,SET,8,-0.1628,-0.0033975,0.33801,0.68497,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP,0.99999
HERNANDEZ_MITOTIC_ARREST_BY_...1,SET,35,-0.074706,-0.0032586,0.15509,0.68498,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,0.99999
GOBP_MODULATION_BY_HOST_OF_V...2,SET,42,-0.06323,-0.0030207,0.13127,0.68498,GOBP_MODULATION_BY_HOST_OF_VIRAL_PROCESS,0.99999
BUSSLINGER_GASTRIC_X_CELLS,SET,172,-0.032503,-0.0031311,0.067479,0.68498,BUSSLINGER_GASTRIC_X_CELLS,0.99999
GOMF_MANNOSYLTRANSFERASE_ACT...,SET,24,-0.078039,-0.0028196,0.162,0.68499,GOMF_MANNOSYLTRANSFERASE_ACTIVITY,0.99999
GOBP_SEROTONIN_TRANSPORT,SET,20,-0.10003,-0.0032996,0.20762,0.68502,GOBP_SEROTONIN_TRANSPORT,0.99999
GSE46025_WT_VS_FOXO1_KO_KLRG...1,SET,161,-0.030961,-0.0028865,0.064249,0.68506,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_DN,0.99999
AP1_Q6_01,SET,239,-0.026565,-0.0030111,0.055113,0.6851,AP1_Q6_01,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...12,SET,184,-0.027956,-0.0027845,0.057982,0.68515,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...814,SET,9,-0.14896,-0.0032972,0.30886,0.6852,GOBP_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_CYTOKINE_PRODUCTION,0.99999
DESCARTES_FETAL_CEREBELLUM_A...,SET,112,-0.042492,-0.0033086,0.088102,0.6852,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,0.99999
GOBP_POSITIVE_REGULATION_OF_...156,SET,8,-0.13819,-0.0028838,0.28647,0.68523,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS,0.99999
HP_RENAL_AGENESIS,SET,178,-0.029918,-0.0029315,0.062017,0.68524,HP_RENAL_AGENESIS,0.99999
GOCC_CILIARY_PLASM,SET,135,-0.033047,-0.0028233,0.0685,0.68525,GOCC_CILIARY_PLASM,0.99999
REACTOME_METABOLISM_OF_NUCLE...,SET,92,-0.0433,-0.0030573,0.089745,0.68526,REACTOME_METABOLISM_OF_NUCLEOTIDES,0.99999
GSE8685_IL2_STARVED_VS_IL2_A...2,SET,183,-0.029577,-0.0029381,0.061303,0.68526,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...532,SET,144,-0.034413,-0.0030356,0.0713,0.68533,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,0.99999
REACTOME_NCAM_SIGNALING_FOR_...,SET,62,-0.052875,-0.0030674,0.10952,0.68537,REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,0.99999
GSE17186_NAIVE_VS_CD21HIGH_T...2,SET,176,-0.028804,-0.0028065,0.059662,0.68537,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,0.99999
GOCC_CAVEOLA,SET,75,-0.048849,-0.0031156,0.10117,0.68539,GOCC_CAVEOLA,0.99999
GOBP_PHARYNGEAL_SYSTEM_DEVEL...,SET,29,-0.086066,-0.0034178,0.1782,0.68544,GOBP_PHARYNGEAL_SYSTEM_DEVELOPMENT,0.99999
MIR212_3P,SET,170,-0.030918,-0.0029612,0.063963,0.68558,MIR212_3P,0.99999
RICKMAN_METASTASIS_DN,SET,243,-0.026109,-0.0029837,0.054011,0.68559,RICKMAN_METASTASIS_DN,0.99999
KEGG_MEDICUS_REFERENCE_ANTIG...1,SET,11,-0.14448,-0.0035352,0.29889,0.68559,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES,0.99999
GOMF_TRANSITION_METAL_ION_BI...,SET,1008,-0.013318,-0.0030335,0.02755,0.68559,GOMF_TRANSITION_METAL_ION_BINDING,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...3,SET,182,-0.028454,-0.0028188,0.058858,0.6856,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN,0.99999
HP_MEDIASTINAL_LYMPHADENOPAT...,SET,23,-0.090043,-0.0031849,0.18625,0.68561,HP_MEDIASTINAL_LYMPHADENOPATHY,0.99999
REACTOME_HIV_ELONGATION_ARRE...,SET,29,-0.065845,-0.0026148,0.13619,0.68562,REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY,0.99999
GOMF_CARBON_OXYGEN_LYASE_ACT...,SET,69,-0.048327,-0.002957,0.099924,0.68567,GOMF_CARBON_OXYGEN_LYASE_ACTIVITY,0.99999
chr12q13,SET,248,-0.061948,-0.0071508,0.12805,0.68572,chr12q13,0.99999
GOBP_REGULATION_OF_ATP_METAB...,SET,63,-0.049614,-0.0029012,0.10256,0.68572,GOBP_REGULATION_OF_ATP_METABOLIC_PROCESS,0.99999
GOBP_CELL_CELL_SIGNALING_INV...,SET,30,-0.081672,-0.0032986,0.1688,0.68574,GOBP_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION,0.99999
GSE40493_BCL6_KO_VS_WT_TREG_...1,SET,94,-0.042502,-0.0030332,0.087842,0.68575,GSE40493_BCL6_KO_VS_WT_TREG_DN,0.99999
GSE5542_IFNG_VS_IFNA_TREATED...3,SET,172,-0.031916,-0.0030745,0.065942,0.6858,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,0.99999
GOCC_SCF_UBIQUITIN_LIGASE_CO...,SET,59,-0.054484,-0.0030835,0.11256,0.68582,GOCC_SCF_UBIQUITIN_LIGASE_COMPLEX,0.99999
HP_ABNORMALITY_OF_THE_STAPES,SET,13,-0.12367,-0.0032896,0.25538,0.6859,HP_ABNORMALITY_OF_THE_STAPES,0.99999
GOBP_PHOSPHATIDYLSERINE_ACYL...,SET,8,-0.16313,-0.0034043,0.33673,0.68596,GOBP_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING,0.99999
KEGG_MEDICUS_REFERENCE_HEDGE...1,SET,14,-0.10538,-0.0029086,0.21749,0.68598,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY,0.99999
GOBP_REPLACEMENT_OSSIFICATION,SET,28,-0.083618,-0.0032629,0.17256,0.68601,GOBP_REPLACEMENT_OSSIFICATION,0.99999
OHM_METHYLATED_IN_ADULT_CANC...,SET,26,-0.082456,-0.0031007,0.17012,0.68605,OHM_METHYLATED_IN_ADULT_CANCERS,0.99999
MIR7151_5P,SET,42,-0.064302,-0.0030719,0.13264,0.68608,MIR7151_5P,0.99999
REACTOME_DEGRADATION_OF_BETA...,SET,80,-0.043957,-0.0028952,0.090654,0.68612,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,0.99999
MIR224_3P,SET,160,-0.032145,-0.0029877,0.066287,0.68614,MIR224_3P,0.99999
HP_THICK_HAIR,SET,19,-0.088339,-0.0028403,0.18215,0.68615,HP_THICK_HAIR,0.99999
FOXO1_01,SET,220,-0.028775,-0.0031308,0.059326,0.68617,FOXO1_01,0.99999
GOBP_MYOBLAST_FUSION_INVOLVE...,SET,3,-0.27684,-0.0035383,0.57066,0.6862,GOBP_MYOBLAST_FUSION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.99999
LI_ESTROGENE_EARLY_E2_RESPON...1,SET,73,-0.05267,-0.0033144,0.10852,0.68629,LI_ESTROGENE_EARLY_E2_RESPONSE_DN,0.99999
REACTOME_GOLGI_TO_ER_RETROGR...,SET,129,-0.034417,-0.0028747,0.070888,0.68634,REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,0.99999
GOBP_REGULATION_OF_TUMOR_NEC...,SET,57,-0.054006,-0.0030044,0.11124,0.68634,GOBP_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.99999
RAY_TUMORIGENESIS_BY_ERBB2_C...2,SET,176,-0.030976,-0.0030182,0.063798,0.68635,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,0.99999
HP_CACHEXIA,SET,89,-0.040682,-0.0028255,0.083788,0.68635,HP_CACHEXIA,0.99999
GSE15930_NAIVE_VS_72H_IN_VIT...8,SET,185,-0.028909,-0.0028872,0.059518,0.68641,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP,0.99999
GOBP_REGULATION_OF_PROSTAGLA...,SET,14,-0.1285,-0.003547,0.26443,0.68649,GOBP_REGULATION_OF_PROSTAGLANDIN_SECRETION,0.99999
GSE27786_LSK_VS_LIN_NEG_CELL...2,SET,179,-0.03008,-0.0029555,0.061876,0.68656,GSE27786_LSK_VS_LIN_NEG_CELL_UP,0.99999
GSE29618_PRE_VS_DAY7_FLU_VAC...7,SET,177,-0.028704,-0.0028047,0.059045,0.68656,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN,0.99999
HP_MIDDLE_AGE_ONSET,SET,219,-0.02787,-0.0030256,0.057313,0.68661,HP_MIDDLE_AGE_ONSET,0.99999
GOBP_METANEPHRIC_NEPHRON_DEV...,SET,40,-0.07459,-0.0034777,0.15337,0.68664,GOBP_METANEPHRIC_NEPHRON_DEVELOPMENT,0.99999
REACTOME_RA_BIOSYNTHESIS_PAT...,SET,22,-0.095283,-0.0032962,0.1959,0.68665,REACTOME_RA_BIOSYNTHESIS_PATHWAY,0.99999
MORF_RAB3A,SET,77,-0.047097,-0.0030436,0.096833,0.68665,MORF_RAB3A,0.99999
GSE7460_TREG_VS_TCONV_ACT_WI...2,SET,175,-0.03222,-0.0031305,0.066227,0.68669,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP,0.99999
MIR4694_5P,SET,34,-0.07081,-0.0030443,0.14552,0.68673,MIR4694_5P,0.99999
REACTOME_DEFECTS_IN_COBALAMI...,SET,12,-0.11422,-0.0029191,0.23471,0.68675,REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM,0.99999
CREBP1_01,SET,156,-0.034107,-0.0031305,0.070074,0.68677,CREBP1_01,0.99999
GOBP_FRUCTOSE_METABOLIC_PROC...,SET,13,-0.094078,-0.0025024,0.19329,0.68677,GOBP_FRUCTOSE_METABOLIC_PROCESS,0.99999
GOMF_PROTEIN_SERINE_THREONIN...6,SET,11,-0.11194,-0.002739,0.22998,0.68677,GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_INHIBITOR_ACTIVITY,0.99999
HP_SHORT_PALM,SET,93,-0.041921,-0.0029759,0.086131,0.68677,HP_SHORT_PALM,0.99999
CEBPE_TARGET_GENES,SET,25,-0.098128,-0.0036184,0.20158,0.6868,CEBPE_TARGET_GENES,0.99999
GSE7509_DC_VS_MONOCYTE_UP,SET,181,-0.030185,-0.0029822,0.062004,0.68681,GSE7509_DC_VS_MONOCYTE_UP,0.99999
HP_APNEIC_EPISODES_IN_INFANCY,SET,9,-0.13538,-0.0029965,0.27805,0.68683,HP_APNEIC_EPISODES_IN_INFANCY,0.99999
LUI_THYROID_CANCER_CLUSTER_4,SET,10,-0.14854,-0.0034655,0.30502,0.68686,LUI_THYROID_CANCER_CLUSTER_4,0.99999
REACTOME_NEGATIVE_REGULATION...2,SET,31,-0.077111,-0.0031658,0.15832,0.68689,REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...16,SET,9,-0.14886,-0.0032949,0.30554,0.68694,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN,0.99999
REACTOME_NUCLEOTIDE_BIOSYNTH...,SET,12,-0.11735,-0.0029989,0.24076,0.68701,REACTOME_NUCLEOTIDE_BIOSYNTHESIS,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...13,SET,26,-0.077036,-0.0028968,0.15804,0.68703,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,0.99999
MIR676_5P,SET,141,-0.035737,-0.0031196,0.073303,0.68705,MIR676_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...622,SET,7,-0.14138,-0.0027601,0.29002,0.68705,GOBP_POSITIVE_REGULATION_OF_PROTEIN_GLYCOSYLATION,0.99999
GOBP_VITAMIN_E_METABOLIC_PRO...,SET,6,-0.16173,-0.0029231,0.3317,0.68707,GOBP_VITAMIN_E_METABOLIC_PROCESS,0.99999
HP_DYSPLASIA_OF_THE_FEMORAL_...,SET,5,-0.1777,-0.0029319,0.36439,0.6871,HP_DYSPLASIA_OF_THE_FEMORAL_HEAD,0.99999
HP_POOR_FINE_MOTOR_COORDINAT...,SET,64,-0.052738,-0.0031082,0.10809,0.68718,HP_POOR_FINE_MOTOR_COORDINATION,0.99999
GSE22103_UNSTIM_VS_GMCSF_AND...2,SET,185,-0.028743,-0.0028706,0.058908,0.6872,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...566,SET,62,-0.056312,-0.0032667,0.11538,0.68725,GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,0.99999
GOBP_ESTABLISHMENT_OF_ORGANE...,SET,436,-0.01945,-0.0029613,0.039847,0.68726,GOBP_ESTABLISHMENT_OF_ORGANELLE_LOCALIZATION,0.99999
chr1p12,SET,16,-0.16747,-0.0049415,0.343,0.68731,chr1p12,0.99999
GOBP_FORMATE_METABOLIC_PROCE...,SET,6,-0.1863,-0.0033673,0.38156,0.68732,GOBP_FORMATE_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_RNA_EXPOR...,SET,14,-0.10325,-0.00285,0.21146,0.68732,GOBP_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS,0.99999
GOBP_REGULATION_OF_MEMBRANE_...4,SET,15,-0.12141,-0.0034688,0.24862,0.68734,GOBP_REGULATION_OF_MEMBRANE_INVAGINATION,0.99999
GOBP_PYRIMIDINE_DEOXYRIBONUC...5,SET,23,-0.085679,-0.0030305,0.17542,0.68737,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,0.99999
HP_LIMITED_HIP_EXTENSION,SET,5,-0.20377,-0.0033621,0.41716,0.68739,HP_LIMITED_HIP_EXTENSION,0.99999
GOBP_REGULATION_OF_NEUROBLAS...,SET,51,-0.061922,-0.0032589,0.12674,0.68742,GOBP_REGULATION_OF_NEUROBLAST_PROLIFERATION,0.99999
GOMF_PRE_MRNA_INTRONIC_BINDI...,SET,13,-0.1022,-0.0027184,0.20916,0.68743,GOMF_PRE_MRNA_INTRONIC_BINDING,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...9,SET,58,-0.055141,-0.0030942,0.11284,0.68746,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,0.99999
HP_DECREASED_LACRIMATION,SET,26,-0.084214,-0.0031667,0.17233,0.68746,HP_DECREASED_LACRIMATION,0.99999
GOMF_PHOSPHATE_TRANSMEMBRANE...,SET,16,-0.10574,-0.0031201,0.21637,0.68747,GOMF_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_ABNORMALITY_OF_VITAMIN_K_...,SET,13,-0.12346,-0.003284,0.25259,0.6875,HP_ABNORMALITY_OF_VITAMIN_K_METABOLISM,0.99999
KEGG_MEDICUS_ENV_FACTOR_NNK_...4,SET,18,-0.098329,-0.0030772,0.20113,0.68753,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY,0.99999
GSE29615_CTRL_VS_DAY3_LAIV_I...2,SET,175,-0.031396,-0.0030504,0.064205,0.68757,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP,0.99999
MODULE_209,SET,81,-0.047305,-0.003135,0.09673,0.68759,MODULE_209,0.99999
PID_PI3KCI_AKT_PATHWAY,SET,34,-0.066586,-0.0028627,0.13604,0.68774,PID_PI3KCI_AKT_PATHWAY,0.99999
HP_PERIMEMBRANOUS_VENTRICULA...,SET,23,-0.091642,-0.0032414,0.18716,0.6878,HP_PERIMEMBRANOUS_VENTRICULAR_SEPTAL_DEFECT,0.99999
GOBP_MITOCHONDRIAL_PROTEIN_C...,SET,9,-0.12886,-0.0028522,0.26316,0.68781,GOBP_MITOCHONDRIAL_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_GLYCOLYTIC_PROCESS_THRO...1,SET,19,-0.086304,-0.0027748,0.1762,0.68786,GOBP_GLYCOLYTIC_PROCESS_THROUGH_FRUCTOSE_6_PHOSPHATE,0.99999
GCM_DENR,SET,49,-0.053674,-0.0027691,0.10956,0.6879,GCM_DENR,0.99999
HP_MACULAR_EDEMA,SET,32,-0.074263,-0.0030976,0.15158,0.6879,HP_MACULAR_EDEMA,0.99999
GARCIA_PINERES_PBMC_HPV_16_L...2,SET,21,-0.090302,-0.0030522,0.18432,0.6879,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE,0.99999
MIR5587_5P,SET,101,-0.040576,-0.0030011,0.082748,0.68806,MIR5587_5P,0.99999
GOCC_GABA_RECEPTOR_COMPLEX,SET,18,-0.12218,-0.0038236,0.24914,0.68807,GOCC_GABA_RECEPTOR_COMPLEX,0.99999
GSE27859_CD11C_INT_F480_HI_M...2,SET,159,-0.031554,-0.0029236,0.064333,0.6881,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_UP,0.99999
GSE15330_LYMPHOID_MULTIPOTEN...8,SET,181,-0.030385,-0.003002,0.061932,0.68815,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,0.99999
MIR6131,SET,89,-0.042619,-0.00296,0.086823,0.68824,MIR6131,0.99999
IKEDA_MIR30_TARGETS_UP,SET,110,-0.040645,-0.0031365,0.082795,0.68825,IKEDA_MIR30_TARGETS_UP,0.99999
GOMF_PROTEINASE_ACTIVATED_RE...,SET,5,-0.22172,-0.0036583,0.45162,0.68826,GOMF_PROTEINASE_ACTIVATED_RECEPTOR_ACTIVITY,0.99999
GOBP_ACINAR_CELL_DIFFERENTIA...,SET,5,-0.20892,-0.0034472,0.42548,0.68829,GOBP_ACINAR_CELL_DIFFERENTIATION,0.99999
HP_SCOTOMA,SET,69,-0.050796,-0.003108,0.10344,0.68831,HP_SCOTOMA,0.99999
MIR8085,SET,207,-0.029597,-0.0031248,0.060242,0.68839,MIR8085,0.99999
MIR376C_3P,SET,138,-0.03523,-0.0030427,0.071693,0.68842,MIR376C_3P,0.99999
ZNF740_TARGET_GENES,SET,1189,-0.012335,-0.0030357,0.025097,0.68846,ZNF740_TARGET_GENES,0.99999
GSE20198_UNTREATED_VS_IFNA_T...1,SET,174,-0.02966,-0.0028736,0.060343,0.68847,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,0.99999
GOBP_CELL_PROLIFERATION_IN_H...,SET,13,-0.11289,-0.0030028,0.22965,0.68848,GOBP_CELL_PROLIFERATION_IN_HINDBRAIN,0.99999
HP_SHORT_LONG_BONE,SET,238,-0.027068,-0.0030617,0.055064,0.68849,HP_SHORT_LONG_BONE,0.99999
WP_KININKALLIKREIN_PATHWAY,SET,7,-0.18903,-0.0036903,0.38445,0.68853,WP_KININKALLIKREIN_PATHWAY,0.99999
GOCC_CLATHRIN_COAT_OF_COATED...,SET,18,-0.09477,-0.0029658,0.19274,0.68853,GOCC_CLATHRIN_COAT_OF_COATED_PIT,0.99999
GOBP_REGULATION_OF_VESICLE_S...,SET,15,-0.11153,-0.0031866,0.22677,0.68858,GOBP_REGULATION_OF_VESICLE_SIZE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...168,SET,234,-0.02755,-0.0030902,0.056006,0.6886,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE,0.99999
CHEN_ETV5_TARGETS_SERTOLI,SET,24,-0.0976,-0.0035263,0.19839,0.68863,CHEN_ETV5_TARGETS_SERTOLI,0.99999
YKACATTT_UNKNOWN,SET,257,-0.026682,-0.0031345,0.054233,0.68863,YKACATTT_UNKNOWN,0.99999
GUTIERREZ_WALDENSTROEMS_MACR...2,SET,10,-0.14402,-0.0033601,0.29268,0.68866,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP,0.99999
GOMF_PHOSPHOTYROSINE_RESIDUE...,SET,45,-0.062936,-0.0031119,0.12789,0.68868,GOMF_PHOSPHOTYROSINE_RESIDUE_BINDING,0.99999
GOBP_RIBONUCLEOSIDE_CATABOLI...,SET,18,-0.12154,-0.0038035,0.24693,0.68871,GOBP_RIBONUCLEOSIDE_CATABOLIC_PROCESS,0.99999
HP_PYODERMA,SET,4,-0.24342,-0.0035924,0.4945,0.68873,HP_PYODERMA,0.99999
REACTOME_HIV_TRANSCRIPTION_E...,SET,38,-0.056377,-0.0025621,0.11452,0.68874,REACTOME_HIV_TRANSCRIPTION_ELONGATION,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...10,SET,186,-0.030043,-0.0030085,0.061026,0.68874,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...10,SET,16,-0.1065,-0.0031423,0.2163,0.68876,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,0.99999
GSE16385_ROSIGLITAZONE_IL4_V...3,SET,188,-0.030166,-0.0030368,0.061271,0.68876,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN,0.99999
HP_CHRONIC_NEUTROPENIA,SET,9,-0.12323,-0.0027277,0.25028,0.68877,HP_CHRONIC_NEUTROPENIA,0.99999
GOBP_INNERVATION,SET,26,-0.090588,-0.0034064,0.18394,0.68881,GOBP_INNERVATION,0.99999
GOMF_TRANSCRIPTION_COREPRESS...1,SET,173,-0.03063,-0.0029591,0.062181,0.68885,GOMF_TRANSCRIPTION_COREPRESSOR_ACTIVITY,0.99999
RHEIN_ALL_GLUCOCORTICOID_THE...1,SET,324,-0.022973,-0.0030247,0.046631,0.68887,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,0.99999
GOBP_PHENYLPROPANOID_METABOL...,SET,7,-0.16696,-0.0032594,0.33876,0.68894,GOBP_PHENYLPROPANOID_METABOLIC_PROCESS,0.99999
ERWIN_COHEN_PBMC_TC_83_AGE_1...4,SET,31,-0.084133,-0.0034541,0.17062,0.68903,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,0.99999
GATAAGR_GATA_C,SET,277,-0.025631,-0.0031243,0.051951,0.68912,GATAAGR_GATA_C,0.99999
MODULE_54,SET,236,-0.026797,-0.0030185,0.054316,0.68912,MODULE_54,0.99999
KEGG_PHOSPHATIDYLINOSITOL_SI...,SET,75,-0.046511,-0.0029666,0.09426,0.68914,KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM,0.99999
WP_11P112_COPY_NUMBER_VARIAT...,SET,52,-0.066597,-0.0035391,0.13496,0.68915,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GOBP_MICROTUBULE_CYTOSKELETO...2,SET,157,-0.031999,-0.0029463,0.064848,0.68915,GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION_INVOLVED_IN_MITOSIS,0.99999
HP_PROGRESSIVE_PTOSIS,SET,4,-0.18321,-0.0027039,0.37128,0.68915,HP_PROGRESSIVE_PTOSIS,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...3,SET,184,-0.030103,-0.0029983,0.061006,0.68915,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN,0.99999
GOCC_SPERM_MIDPIECE,SET,50,-0.062463,-0.0032551,0.12658,0.68916,GOCC_SPERM_MIDPIECE,0.99999
GOCC_SCAR_COMPLEX,SET,11,-0.11406,-0.002791,0.23105,0.68922,GOCC_SCAR_COMPLEX,0.99999
KEGG_DRUG_METABOLISM_CYTOCHR...,SET,65,-0.068274,-0.004055,0.13828,0.68925,KEGG_DRUG_METABOLISM_CYTOCHROME_P450,0.99999
HP_HYPERLYSINURIA,SET,5,-0.17392,-0.0028696,0.35219,0.68928,HP_HYPERLYSINURIA,0.99999
GOBP_REGULATION_OF_VITAMIN_D...2,SET,10,-0.12577,-0.0029343,0.25467,0.6893,GOBP_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_SACCADIC_EYE_MOV...,SET,84,-0.044056,-0.0029731,0.089198,0.68931,HP_ABNORMAL_SACCADIC_EYE_MOVEMENTS,0.99999
GOCC_NUCLEAR_INNER_MEMBRANE,SET,48,-0.05913,-0.0030193,0.11968,0.68937,GOCC_NUCLEAR_INNER_MEMBRANE,0.99999
HP_PROXIMAL_AMYOTROPHY,SET,48,-0.060907,-0.0031101,0.12327,0.68937,HP_PROXIMAL_AMYOTROPHY,0.99999
GOBP_GLYCINE_TRANSPORT,SET,14,-0.12059,-0.0033286,0.24401,0.68942,GOBP_GLYCINE_TRANSPORT,0.99999
HP_TELECANTHUS,SET,148,-0.034809,-0.0031126,0.070383,0.68954,HP_TELECANTHUS,0.99999
GSE17974_0H_VS_4H_IN_VITRO_A...1,SET,179,-0.029504,-0.0028989,0.059656,0.68954,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN,0.99999
HP_ABNORMAL_VESTIBULO_OCULAR...,SET,7,-0.15588,-0.003043,0.31517,0.68955,HP_ABNORMAL_VESTIBULO_OCULAR_REFLEX,0.99999
DING_LUNG_CANCER_MUTATED_FRE...,SET,12,-0.11329,-0.0028953,0.22905,0.68956,DING_LUNG_CANCER_MUTATED_FREQUENTLY,0.99999
GOMF_CYSTEINE_TYPE_EXOPEPTID...,SET,4,-0.20386,-0.0030086,0.41215,0.68956,GOMF_CYSTEINE_TYPE_EXOPEPTIDASE_ACTIVITY,0.99999
GSE17186_MEMORY_VS_CD21LOW_T...1,SET,178,-0.030372,-0.0029759,0.061407,0.68956,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN,0.99999
GOBP_RESPONSE_TO_HYDROPEROXI...,SET,19,-0.10018,-0.0032211,0.20251,0.6896,GOBP_RESPONSE_TO_HYDROPEROXIDE,0.99999
GCM_LTK,SET,40,-0.063145,-0.0029441,0.12763,0.68961,GCM_LTK,0.99999
WP_HOMOLOGOUS_RECOMBINATION,SET,12,-0.11359,-0.002903,0.22954,0.68965,WP_HOMOLOGOUS_RECOMBINATION,0.99999
GOBP_RECEPTOR_MEDIATED_ENDOC...2,SET,5,-0.20004,-0.0033006,0.40414,0.68969,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS_INVOLVED_IN_CHOLESTEROL_TRANSPORT,0.99999
HP_CAMPTODACTYLY_OF_TOE,SET,11,-0.13337,-0.0032633,0.26942,0.6897,HP_CAMPTODACTYLY_OF_TOE,0.99999
GOBP_POSITIVE_REGULATION_OF_...52,SET,31,-0.072885,-0.0029923,0.1472,0.68975,GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION,0.99999
MIR3960_MIR8072,SET,17,-0.19951,-0.0060679,0.40286,0.68978,MIR3960_MIR8072,0.99999
JONES_OVARY_OOCYTE,SET,64,-0.051485,-0.0030343,0.10394,0.68981,JONES_OVARY_OOCYTE,0.99999
WHITFIELD_CELL_CYCLE_G2,SET,152,-0.03277,-0.0029693,0.066136,0.68987,WHITFIELD_CELL_CYCLE_G2,0.99999
HP_SUPRANUCLEAR_OPHTHALMOPLE...,SET,4,-0.18715,-0.002762,0.37763,0.68991,HP_SUPRANUCLEAR_OPHTHALMOPLEGIA,0.99999
CHEN_LIVER_METABOLISM_QTL_CIS,SET,88,-0.049762,-0.0034368,0.10037,0.68997,CHEN_LIVER_METABOLISM_QTL_CIS,0.99999
GSE22432_MULTIPOTENT_VS_COMM...4,SET,178,-0.029963,-0.0029359,0.060437,0.68997,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP,0.99999
GOBP_VACUOLAR_ACIDIFICATION,SET,32,-0.076272,-0.0031813,0.15379,0.69003,GOBP_VACUOLAR_ACIDIFICATION,0.99999
GACAGGG_MIR339,SET,63,-0.050848,-0.0029734,0.10252,0.69004,GACAGGG_MIR339,0.99999
GSE9960_GRAM_NEG_VS_GRAM_NEG...1,SET,167,-0.030273,-0.0028739,0.061037,0.69004,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,0.99999
GSE28737_FOLLICULAR_VS_MARGI...3,SET,179,-0.031724,-0.003117,0.063946,0.69009,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN,0.99999
REACTOME_UPTAKE_AND_FUNCTION...1,SET,11,-0.1382,-0.0033815,0.27853,0.6901,REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...31,SET,59,-0.05057,-0.002862,0.1019,0.69014,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS,0.99999
GOCC_TRAMP_COMPLEX,SET,2,-0.25064,-0.0026157,0.505,0.69016,GOCC_TRAMP_COMPLEX,0.99999
REACTOME_MYOGENESIS,SET,28,-0.087947,-0.0034318,0.17714,0.69022,REACTOME_MYOGENESIS,0.99999
GOBP_RANDOM_INACTIVATION_OF_...,SET,6,-0.16921,-0.0030583,0.34081,0.69022,GOBP_RANDOM_INACTIVATION_OF_X_CHROMOSOME,0.99999
HP_NASAL_REGURGITATION,SET,13,-0.11515,-0.0030629,0.23189,0.69025,HP_NASAL_REGURGITATION,0.99999
GSE19941_IL10_KO_VS_IL10_KO_...2,SET,177,-0.032101,-0.0031365,0.064638,0.69027,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.99999
GOBP_LIPID_MODIFICATION,SET,168,-0.031252,-0.0029757,0.062925,0.69028,GOBP_LIPID_MODIFICATION,0.99999
GINESTIER_BREAST_CANCER_ZNF2...1,SET,303,-0.02245,-0.0028601,0.045191,0.69033,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,0.99999
HP_DECREASED_SPECIFIC_ANTIBO...3,SET,13,-0.12969,-0.0034497,0.26105,0.69033,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_PROTEIN_VACCINE,0.99999
REACTOME_ERYTHROPOIETIN_ACTI...4,SET,7,-0.19803,-0.003866,0.39858,0.69035,REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5,0.99999
GOCC_SIGNAL_RECOGNITION_PART...,SET,6,-0.13606,-0.0024592,0.27385,0.69035,GOCC_SIGNAL_RECOGNITION_PARTICLE,0.99999
REACTOME_LINOLEIC_ACID_LA_ME...,SET,7,-0.17142,-0.0033464,0.34494,0.69039,REACTOME_LINOLEIC_ACID_LA_METABOLISM,0.99999
HP_INTERMITTENT_EPISODES_OF_...,SET,13,-0.11968,-0.0031835,0.24079,0.69042,HP_INTERMITTENT_EPISODES_OF_RESPIRATORY_INSUFFICIENCY_DUE_TO_MUSCLE_WEAKNESS,0.99999
GSE25677_MPL_VS_R848_STIM_BC...1,SET,166,-0.032688,-0.0030941,0.065716,0.69055,GSE25677_MPL_VS_R848_STIM_BCELL_DN,0.99999
WIKMAN_ASBESTOS_LUNG_CANCER_...2,SET,15,-0.10516,-0.0030044,0.21138,0.69057,WIKMAN_ASBESTOS_LUNG_CANCER_UP,0.99999
GOBP_RESPONSE_TO_RAPAMYCIN,SET,4,-0.20717,-0.0030575,0.41641,0.69059,GOBP_RESPONSE_TO_RAPAMYCIN,0.99999
MIR4288,SET,144,-0.036014,-0.0031768,0.072369,0.69063,MIR4288,0.99999
MODULE_241,SET,69,-0.053822,-0.0032932,0.10812,0.69068,MODULE_241,0.99999
HP_LUMBAR_SCOLIOSIS,SET,15,-0.099986,-0.0028567,0.20085,0.69069,HP_LUMBAR_SCOLIOSIS,0.99999
OCT1_05,SET,222,-0.029951,-0.0032734,0.060146,0.69075,OCT1_05,0.99999
YAGI_AML_RELAPSE_PROGNOSIS,SET,33,-0.076436,-0.0032375,0.15348,0.69076,YAGI_AML_RELAPSE_PROGNOSIS,0.99999
GOMF_HISTONE_H3K36_METHYLTRA...,SET,11,-0.11407,-0.0027913,0.22906,0.69076,GOMF_HISTONE_H3K36_METHYLTRANSFERASE_ACTIVITY,0.99999
HP_ABNORMAL_CEREBRAL_CORTEX_...,SET,676,-0.016167,-0.0030444,0.032457,0.69079,HP_ABNORMAL_CEREBRAL_CORTEX_MORPHOLOGY,0.99999
GOBP_RESPONSE_TO_GROWTH_FACT...,SET,662,-0.017296,-0.0032244,0.034712,0.69085,GOBP_RESPONSE_TO_GROWTH_FACTOR,0.99999
REACTOME_ACTIVATION_OF_THE_A...,SET,10,-0.1423,-0.00332,0.28545,0.69093,REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS,0.99999
GSE26928_NAIVE_VS_CENT_MEMOR...1,SET,170,-0.031618,-0.0030283,0.063425,0.69094,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
REACTOME_SIGNALING_BY_HIPPO,SET,19,-0.10691,-0.0034374,0.21445,0.69095,REACTOME_SIGNALING_BY_HIPPO,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...9,SET,7,-0.14079,-0.0027485,0.28234,0.69099,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP,0.99999
E2F1_UP.V1_UP,SET,172,-0.030599,-0.0029476,0.061361,0.69099,E2F1_UP.V1_UP,0.99999
HP_ANISOCYTOSIS,SET,17,-0.10693,-0.0032522,0.21442,0.691,HP_ANISOCYTOSIS,0.99999
HP_BRAIN_STEM_COMPRESSION,SET,14,-0.10677,-0.0029472,0.21398,0.6911,HP_BRAIN_STEM_COMPRESSION,0.99999
GOBP_MITOCHONDRIAL_TRANSPORT,SET,163,-0.032044,-0.0030058,0.064202,0.69115,GOBP_MITOCHONDRIAL_TRANSPORT,0.99999
MODULE_91,SET,35,-0.062625,-0.0027316,0.12545,0.69118,MODULE_91,0.99999
GOBP_POSITIVE_REGULATION_OF_...550,SET,12,-0.11511,-0.0029418,0.23051,0.69124,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...11,SET,150,-0.034665,-0.0031204,0.069413,0.69125,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN,0.99999
GOBP_GLUCOCORTICOID_BIOSYNTH...,SET,16,-0.11918,-0.0035166,0.23859,0.69129,GOBP_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_CONNECTIV...,SET,5,-0.18394,-0.003035,0.36816,0.69132,GOBP_REGULATION_OF_CONNECTIVE_TISSUE_REPLACEMENT,0.99999
GOMF_HISTONE_H3K4_DEMETHYLAS...,SET,4,-0.20085,-0.0029642,0.40167,0.69147,GOMF_HISTONE_H3K4_DEMETHYLASE_ACTIVITY,0.99999
JAATINEN_HEMATOPOIETIC_STEM_...1,SET,208,-0.031694,-0.0033542,0.063382,0.69148,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,0.99999
GOBP_FIBROBLAST_PROLIFERATION,SET,105,-0.042153,-0.0031785,0.084296,0.69148,GOBP_FIBROBLAST_PROLIFERATION,0.99999
HP_OBSTRUCTIVE_AZOOSPERMIA,SET,27,-0.079395,-0.0030424,0.15877,0.69148,HP_OBSTRUCTIVE_AZOOSPERMIA,0.99999
PID_NEPHRIN_NEPH1_PATHWAY,SET,30,-0.075043,-0.0030309,0.15006,0.69149,PID_NEPHRIN_NEPH1_PATHWAY,0.99999
GSE25088_ROSIGLITAZONE_VS_IL...4,SET,165,-0.032251,-0.0030436,0.064479,0.69152,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,0.99999
GOBP_REGULATION_OF_HIGH_VOLT...,SET,8,-0.16463,-0.0034356,0.32894,0.69163,GOBP_REGULATION_OF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
BROWNE_HCMV_INFECTION_1HR_UP,SET,47,-0.06294,-0.0031803,0.12573,0.69167,BROWNE_HCMV_INFECTION_1HR_UP,0.99999
GSE42021_CD24INT_VS_CD24LOW_...3,SET,179,-0.032197,-0.0031635,0.064302,0.69171,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN,0.99999
GSE15659_CD45RA_NEG_CD4_TCEL...4,SET,154,-0.034913,-0.003184,0.069689,0.69181,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,0.99999
LENAOUR_DENDRITIC_CELL_MATUR...2,SET,108,-0.043501,-0.0033265,0.086783,0.6919,LENAOUR_DENDRITIC_CELL_MATURATION_UP,0.99999
WP_PATHWAYS_AFFECTED_IN_ADEN...,SET,56,-0.052619,-0.0029015,0.10497,0.69191,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,0.99999
HP_NEOPLASM_OF_THE_SKELETAL_...,SET,97,-0.041615,-0.0030168,0.082974,0.692,HP_NEOPLASM_OF_THE_SKELETAL_SYSTEM,0.99999
MORF_BUB1,SET,43,-0.062595,-0.0030256,0.1248,0.69201,MORF_BUB1,0.99999
GOBP_NUCLEOTIDE_SUGAR_TRANSM...,SET,12,-0.1144,-0.0029235,0.22803,0.69204,GOBP_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORT,0.99999
HP_ABNORMALITY_OF_THE_CALCAN...,SET,31,-0.082494,-0.0033868,0.16445,0.69204,HP_ABNORMALITY_OF_THE_CALCANEUS,0.99999
GOBP_REGULATION_OF_WOUND_HEA...2,SET,10,-0.1153,-0.00269,0.22981,0.69206,GOBP_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...178,SET,7,-0.17052,-0.0033289,0.33975,0.69213,GOBP_POSITIVE_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION,0.99999
PRAMOONJAGO_SOX4_TARGETS_UP,SET,48,-0.064119,-0.0032741,0.12775,0.69214,PRAMOONJAGO_SOX4_TARGETS_UP,0.99999
REACTOME_RUNX1_INTERACTS_WIT...,SET,36,-0.068978,-0.0030513,0.13742,0.69215,REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN,0.99999
GOBP_TRABECULA_MORPHOGENESIS,SET,46,-0.06783,-0.0033909,0.13512,0.69217,GOBP_TRABECULA_MORPHOGENESIS,0.99999
GSE5455_EX_VIVO_VS_POST_24H_...1,SET,180,-0.030731,-0.0030278,0.061192,0.69223,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN,0.99999
GOBP_STEROL_HOMEOSTASIS,SET,82,-0.047295,-0.0031536,0.094148,0.69229,GOBP_STEROL_HOMEOSTASIS,0.99999
GOCC_TRANSCRIPTION_FACTOR_TF...3,SET,11,-0.10108,-0.0024732,0.2012,0.69229,GOCC_TRANSCRIPTION_FACTOR_TFIIH_HOLO_COMPLEX,0.99999
GSE34205_HEALTHY_VS_RSV_INF_...1,SET,170,-0.033051,-0.0031655,0.065766,0.69236,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN,0.99999
KAT2A_TARGET_GENES,SET,901,-0.014404,-0.0031116,0.028661,0.69237,KAT2A_TARGET_GENES,0.99999
GOMF_POLY_ADP_D_RIBOSE_MODIF...,SET,2,-0.30574,-0.0031908,0.60834,0.69237,GOMF_POLY_ADP_D_RIBOSE_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.99999
LIANG_HEMATOPOIESIS_STEM_CEL...3,SET,15,-0.10094,-0.002884,0.20083,0.69239,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL,0.99999
GOBP_REGULATION_OF_ACUTE_INF...2,SET,13,-0.11862,-0.0031551,0.23594,0.69242,GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.99999
GSE27786_BCELL_VS_MONO_MAC_UP,SET,170,-0.031711,-0.0030372,0.063072,0.69244,GSE27786_BCELL_VS_MONO_MAC_UP,0.99999
GOBP_CARDIOLIPIN_ACYL_CHAIN_...,SET,5,-0.23453,-0.0038697,0.46639,0.69247,GOBP_CARDIOLIPIN_ACYL_CHAIN_REMODELING,0.99999
GOBP_PLATELET_DERIVED_GROWTH...3,SET,53,-0.061023,-0.0032738,0.12125,0.69261,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOCC_NUCLEAR_UBIQUITIN_LIGAS...,SET,42,-0.062142,-0.0029687,0.12344,0.69266,GOCC_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX,0.99999
HP_UTERUS_DIDELPHYS,SET,10,-0.13277,-0.0030976,0.26372,0.69267,HP_UTERUS_DIDELPHYS,0.99999
GOBP_MONOSACCHARIDE_CATABOLI...,SET,44,-0.05994,-0.0029307,0.11905,0.69268,GOBP_MONOSACCHARIDE_CATABOLIC_PROCESS,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...17,SET,44,-0.073201,-0.0035791,0.14537,0.6927,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II,0.99999
GSE3982_MAST_CELL_VS_CENT_ME...1,SET,163,-0.03193,-0.0029951,0.06341,0.69271,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
GSE9946_MATURE_STIMULATORY_V...4,SET,120,-0.038025,-0.003064,0.075471,0.69281,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.99999
GOBP_COBALAMIN_TRANSPORT,SET,8,-0.14972,-0.0031244,0.29713,0.69282,GOBP_COBALAMIN_TRANSPORT,0.99999
GOBP_REGULATION_OF_DNA_STRAN...,SET,17,-0.11043,-0.0033587,0.21906,0.69291,GOBP_REGULATION_OF_DNA_STRAND_ELONGATION,0.99999
RGAANNTTC_HSF1_01,SET,406,-0.021278,-0.0031288,0.042202,0.69293,RGAANNTTC_HSF1_01,0.99999
GOBP_VESICLE_MEDIATED_TRANSP...1,SET,1409,-0.011745,-0.0031263,0.023295,0.69294,GOBP_VESICLE_MEDIATED_TRANSPORT,0.99999
MIR6073,SET,95,-0.043464,-0.0031183,0.086183,0.69298,MIR6073,0.99999
HP_PUNDING,SET,6,-0.19993,-0.0036136,0.3964,0.69299,HP_PUNDING,0.99999
GOMF_ATPASE_COUPLED_ION_TRAN...,SET,22,-0.095902,-0.0033176,0.19007,0.69306,GOMF_ATPASE_COUPLED_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE360_L_MAJOR_VS_M_TUBERCUL...2,SET,167,-0.03312,-0.0031442,0.065612,0.69314,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP,0.99999
CCCAGAG_MIR326,SET,137,-0.036652,-0.0031542,0.072605,0.69315,CCCAGAG_MIR326,0.99999
GOBP_ORGANIC_ACID_BIOSYNTHET...,SET,301,-0.024987,-0.0031729,0.049496,0.69316,GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_RESPONSE_TO_ACTH...,SET,6,-0.18325,-0.0033121,0.363,0.69316,HP_ABNORMAL_RESPONSE_TO_ACTH_STIMULATION_TEST,0.99999
GOBP_RESPONSE_TO_FORSKOLIN,SET,13,-0.13473,-0.0035838,0.26687,0.69317,GOBP_RESPONSE_TO_FORSKOLIN,0.99999
GSE9037_WT_VS_IRAK4_KO_LPS_4...1,SET,187,-0.031456,-0.0031583,0.062296,0.6932,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN,0.99999
MIR627_5P,SET,36,-0.067621,-0.0029913,0.13389,0.69323,MIR627_5P,0.99999
HP_MESANGIAL_HYPERCELLULARITY,SET,5,-0.186,-0.003069,0.36829,0.69323,HP_MESANGIAL_HYPERCELLULARITY,0.99999
REACTOME_NR1H2_AND_NR1H3_MED...,SET,42,-0.064957,-0.0031031,0.12857,0.6933,REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,0.99999
HP_DECREASED_LDL_CHOLESTEROL...,SET,13,-0.11794,-0.0031371,0.23342,0.69331,HP_DECREASED_LDL_CHOLESTEROL_CONCENTRATION,0.99999
GOBP_L_AMINO_ACID_CATABOLIC_...,SET,60,-0.055505,-0.0031678,0.10985,0.69332,GOBP_L_AMINO_ACID_CATABOLIC_PROCESS,0.99999
LIU_BREAST_CANCER,SET,25,-0.081814,-0.0030168,0.1619,0.69334,LIU_BREAST_CANCER,0.99999
HP_PAROTITIS,SET,4,-0.22975,-0.0033907,0.45463,0.69334,HP_PAROTITIS,0.99999
LIAO_HAVE_SOX4_BINDING_SITES,SET,40,-0.063038,-0.0029391,0.12473,0.69335,LIAO_HAVE_SOX4_BINDING_SITES,0.99999
DESCARTES_MAIN_FETAL_ENS_GLIA,SET,11,-0.13086,-0.003202,0.25893,0.69335,DESCARTES_MAIN_FETAL_ENS_GLIA,0.99999
GOBP_SPROUTING_ANGIOGENESIS,SET,126,-0.04021,-0.0033195,0.079549,0.69338,GOBP_SPROUTING_ANGIOGENESIS,0.99999
GSE29618_MONOCYTE_VS_PDC_DN,SET,170,-0.032715,-0.0031333,0.064714,0.6934,GSE29618_MONOCYTE_VS_PDC_DN,0.99999
DESCARTES_MAIN_FETAL_AMACRIN...,SET,16,-0.11443,-0.0033764,0.22632,0.69343,DESCARTES_MAIN_FETAL_AMACRINE_CELLS,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...2,SET,180,-0.031703,-0.0031236,0.062692,0.69346,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP,0.99999
AATGGAG_MIR136,SET,68,-0.050761,-0.0030834,0.10037,0.69348,AATGGAG_MIR136,0.99999
HP_ABNORMAL_ERYTHROCYTE_SEDI...,SET,57,-0.060129,-0.003345,0.11888,0.6935,HP_ABNORMAL_ERYTHROCYTE_SEDIMENTATION_RATE,0.99999
HIRSCH_CELLULAR_TRANSFORMATI...1,SET,91,-0.044966,-0.0031578,0.088894,0.69351,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,0.99999
GOBP_MITOCHONDRIAL_ELECTRON_...4,SET,12,-0.109,-0.0027855,0.21542,0.69355,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_UBIQUINOL_TO_CYTOCHROME_C,0.99999
REACTOME_BETA_CATENIN_INDEPE...,SET,142,-0.034537,-0.0030255,0.06826,0.69356,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,0.99999
GOMF_HISTONE_H3K4ME_H3K4ME2_...,SET,2,-0.34582,-0.0036091,0.68349,0.69356,GOMF_HISTONE_H3K4ME_H3K4ME2_H3K4ME3_DEMETHYLASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...423,SET,17,-0.10188,-0.0030986,0.20128,0.69362,GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,0.99999
PRC2_SUZ12_UP.V1_UP,SET,165,-0.03368,-0.0031784,0.066541,0.69362,PRC2_SUZ12_UP.V1_UP,0.99999
GSE2585_CTEC_VS_THYMIC_DC_UP,SET,178,-0.032036,-0.003139,0.063293,0.69363,GSE2585_CTEC_VS_THYMIC_DC_UP,0.99999
HP_INCREASED_FECAL_PORPHYRIN,SET,4,-0.19002,-0.0028044,0.37507,0.69379,HP_INCREASED_FECAL_PORPHYRIN,0.99999
MIR6083,SET,236,-0.028808,-0.003245,0.056842,0.69386,MIR6083,0.99999
GSE31082_DN_VS_DP_THYMOCYTE_...2,SET,174,-0.03027,-0.0029327,0.059705,0.69392,GSE31082_DN_VS_DP_THYMOCYTE_UP,0.99999
GOBP_VASCULAR_ASSOCIATED_SMO...4,SET,26,-0.098907,-0.0037193,0.19507,0.69393,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,0.99999
HP_CONGENITAL_PTOSIS,SET,4,-0.21881,-0.0032293,0.43142,0.69399,HP_CONGENITAL_PTOSIS,0.99999
GSE42021_TCONV_PLN_VS_CD24LO...2,SET,182,-0.030741,-0.0030454,0.060603,0.69401,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_UP,0.99999
HP_ABNORMAL_CIRCULATING_VITA...1,SET,17,-0.10284,-0.0031278,0.20273,0.69402,HP_ABNORMAL_CIRCULATING_VITAMIN_A_CONCENTRATION,0.99999
GSE20715_0H_VS_24H_OZONE_TLR...1,SET,192,-0.031988,-0.0032539,0.063053,0.69403,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN,0.99999
MODULE_64,SET,490,-0.021254,-0.0034254,0.041887,0.69406,MODULE_64,0.99999
HP_SHORTENING_OF_ALL_MIDDLE_...,SET,6,-0.18681,-0.0033764,0.36816,0.69406,HP_SHORTENING_OF_ALL_MIDDLE_PHALANGES_OF_THE_FINGERS,0.99999
MIR421,SET,160,-0.033338,-0.0030985,0.065695,0.69408,MIR421,0.99999
MANNE_COVID19_ICU_VS_HEALTHY...2,SET,117,-0.038889,-0.0030944,0.076629,0.69409,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,0.99999
chr4q31,SET,62,-0.098492,-0.0057136,0.19406,0.6941,chr4q31,0.99999
GOBP_REGULATION_OF_CELL_JUNC...,SET,198,-0.032142,-0.0033197,0.063324,0.69412,GOBP_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,0.99999
HP_HEMATOCHEZIA,SET,20,-0.092537,-0.0030524,0.18228,0.69415,HP_HEMATOCHEZIA,0.99999
KANG_CISPLATIN_RESISTANCE_DN,SET,8,-0.14625,-0.0030522,0.28805,0.69418,KANG_CISPLATIN_RESISTANCE_DN,0.99999
WP_MITOCHONDRIAL_COMPLEX_III...,SET,15,-0.095885,-0.0027395,0.18884,0.69419,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...427,SET,23,-0.093694,-0.003314,0.18451,0.6942,GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...154,SET,67,-0.055396,-0.0033402,0.10907,0.69423,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,0.99999
HP_ADRENOCORTICAL_ABNORMALITY,SET,9,-0.14487,-0.0032066,0.28522,0.69424,HP_ADRENOCORTICAL_ABNORMALITY,0.99999
KEGG_MEDICUS_REFERENCE_CXCL1...,SET,18,-0.10278,-0.0032165,0.20231,0.69428,KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY,0.99999
HP_EEG_WITH_PHOTOPAROXYSMAL_...,SET,15,-0.11799,-0.0033711,0.23223,0.6943,HP_EEG_WITH_PHOTOPAROXYSMAL_RESPONSE,0.99999
REACTOME_VLDL_ASSEMBLY,SET,3,-0.19139,-0.0024462,0.37667,0.69431,REACTOME_VLDL_ASSEMBLY,0.99999
GOMF_GLUCOSE_SODIUM_SYMPORTE...,SET,7,-0.16608,-0.0032422,0.32682,0.69433,GOMF_GLUCOSE_SODIUM_SYMPORTER_ACTIVITY,0.99999
GSE36888_UNTREATED_VS_IL2_TR...6,SET,171,-0.033575,-0.003225,0.066065,0.69434,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_UP,0.99999
HOLLERN_SQUAMOUS_BREAST_TUMOR,SET,169,-0.0362,-0.003457,0.071119,0.69462,HOLLERN_SQUAMOUS_BREAST_TUMOR,0.99999
MIKKELSEN_MCV6_ICP_WITH_H3K4...,SET,30,-0.083225,-0.0033613,0.16351,0.69462,MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,0.99999
KEGG_MEDICUS_PATHOGEN_HCMV_U...6,SET,19,-0.097476,-0.003134,0.19149,0.69464,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,0.99999
GOBP_ADENYLATE_CYCLASE_MODUL...,SET,249,-0.029753,-0.0034413,0.058443,0.69465,GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
MIR888_3P,SET,105,-0.041175,-0.0031048,0.080854,0.69471,MIR888_3P,0.99999
GOBP_CELL_DIFFERENTIATION_IN...6,SET,47,-0.069413,-0.0035074,0.1363,0.69472,GOBP_CELL_DIFFERENTIATION_IN_SPINAL_CORD,0.99999
GOBP_REGENERATION,SET,180,-0.033317,-0.0032825,0.065417,0.69472,GOBP_REGENERATION,0.99999
STEIN_ESRRA_TARGETS_DN,SET,94,-0.042268,-0.0030166,0.082979,0.69475,STEIN_ESRRA_TARGETS_DN,0.99999
GOBP_REGULATION_OF_AUTOPHAGY...2,SET,10,-0.1503,-0.0035066,0.2948,0.69491,GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,0.99999
BIOCARTA_PLCE_PATHWAY,SET,11,-0.14297,-0.0034984,0.28035,0.69496,BIOCARTA_PLCE_PATHWAY,0.99999
HP_ANOMALOUS_TRICHROMACY,SET,9,-0.19238,-0.0042583,0.37725,0.69496,HP_ANOMALOUS_TRICHROMACY,0.99999
HP_TRITANOMALY,SET,9,-0.19238,-0.0042583,0.37725,0.69496,HP_TRITANOMALY,0.99999
GOBP_REGULATION_OF_SISTER_CH...1,SET,11,-0.14395,-0.0035224,0.28219,0.69501,GOBP_REGULATION_OF_SISTER_CHROMATID_COHESION,0.99999
REACTOME_MEIOTIC_RECOMBINATI...,SET,26,-0.079896,-0.0030044,0.15659,0.69505,REACTOME_MEIOTIC_RECOMBINATION,0.99999
HP_ABNORMAL_FRONTALIS_MUSCLE...,SET,10,-0.13813,-0.0032227,0.27066,0.69509,HP_ABNORMAL_FRONTALIS_MUSCLE_PHYSIOLOGY,0.99999
HP_EPISODIC_RESPIRATORY_DIST...,SET,10,-0.13813,-0.0032227,0.27066,0.69509,HP_EPISODIC_RESPIRATORY_DISTRESS,0.99999
TAAWWATAG_RSRFC4_Q2,SET,148,-0.035591,-0.0031825,0.069735,0.6951,TAAWWATAG_RSRFC4_Q2,0.99999
GSE32986_CURDLAN_LOWDOSE_VS_...2,SET,175,-0.031844,-0.003094,0.062394,0.6951,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,0.99999
WP_ROS_IN_COVID19_ENDOTHELIA...,SET,6,-0.19566,-0.0035363,0.38331,0.69512,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,0.99999
GOCC_PROTON_TRANSPORTING_V_T...1,SET,24,-0.091001,-0.0032879,0.17828,0.69512,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX,0.99999
GSE27859_CD11C_INT_F480_HI_M...1,SET,179,-0.031942,-0.0031384,0.062552,0.69519,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_DN,0.99999
REACTOME_ATTACHMENT_AND_ENTRY,SET,16,-0.11848,-0.0034958,0.232,0.69521,REACTOME_ATTACHMENT_AND_ENTRY,0.99999
CGGTGTG_MIR220,SET,5,-0.19867,-0.003278,0.38893,0.69525,CGGTGTG_MIR220,0.99999
POU6F1_01,SET,211,-0.031742,-0.0033831,0.062139,0.69526,POU6F1_01,0.99999
BASAKI_YBX1_TARGETS_DN,SET,350,-0.023599,-0.003227,0.046188,0.6953,BASAKI_YBX1_TARGETS_DN,0.99999
GOCC_EMC_COMPLEX,SET,8,-0.14363,-0.0029974,0.28109,0.69531,GOCC_EMC_COMPLEX,0.99999
HP_ANEMIA_OF_INADEQUATE_PROD...,SET,174,-0.031785,-0.0030795,0.062204,0.69531,HP_ANEMIA_OF_INADEQUATE_PRODUCTION,0.99999
MIR545_5P,SET,286,-0.025986,-0.0032179,0.050854,0.69532,MIR545_5P,0.99999
HP_IRON_DEFICIENCY_ANEMIA,SET,27,-0.082783,-0.0031721,0.162,0.69532,HP_IRON_DEFICIENCY_ANEMIA,0.99999
REACTOME_ELECTRIC_TRANSMISSI...,SET,4,-0.23623,-0.0034863,0.46217,0.69537,REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS,0.99999
OCT1_01,SET,227,-0.030489,-0.003369,0.059648,0.69537,OCT1_01,0.99999
BIOCARTA_CDC42RAC_PATHWAY,SET,8,-0.13987,-0.0029191,0.27354,0.69544,BIOCARTA_CDC42RAC_PATHWAY,0.99999
HP_ABNORMAL_DELAYED_HYPERSEN...,SET,10,-0.14098,-0.0032892,0.2757,0.69544,HP_ABNORMAL_DELAYED_HYPERSENSITIVITY_SKIN_TEST,0.99999
GOBP_NEGATIVE_REGULATION_OF_...3,SET,54,-0.057202,-0.0030976,0.11186,0.69545,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,0.99999
GSE21063_WT_VS_NFATC1_KO_3H_...2,SET,184,-0.030222,-0.0030102,0.0591,0.69545,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_UP,0.99999
GSE22935_WT_VS_MYD88_KO_MACR...6,SET,184,-0.0317,-0.0031574,0.06196,0.69554,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP,0.99999
HP_ABNORMALITY_OF_PULMONARY_...,SET,168,-0.033162,-0.0031575,0.064811,0.69556,HP_ABNORMALITY_OF_PULMONARY_CIRCULATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...265,SET,15,-0.10098,-0.002885,0.19731,0.69559,GOBP_POSITIVE_REGULATION_OF_EXOSOMAL_SECRETION,0.99999
WP_MICRORNA_NETWORK_ASSOCIAT...,SET,4,-0.2334,-0.0034446,0.4559,0.69565,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,0.99999
GSE26343_WT_VS_NFAT5_KO_MACR...1,SET,186,-0.032522,-0.0032567,0.063529,0.69565,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN,0.99999
KRAS.AMP.LUNG_UP.V1_DN,SET,120,-0.040608,-0.0032722,0.079298,0.69571,KRAS.AMP.LUNG_UP.V1_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...555,SET,21,-0.097806,-0.0033058,0.19098,0.69572,GOBP_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.99999
HP_HYPOPLASTIC_CERVICAL_VERT...,SET,6,-0.20359,-0.0036796,0.39748,0.69574,HP_HYPOPLASTIC_CERVICAL_VERTEBRAE,0.99999
HP_DIMINISHED_ABILITY_TO_CON...,SET,9,-0.12821,-0.0028379,0.25014,0.69587,HP_DIMINISHED_ABILITY_TO_CONCENTRATE,0.99999
FERRANDO_T_ALL_WITH_MLL_ENL_...1,SET,78,-0.048275,-0.0031398,0.094176,0.69588,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,0.99999
AREB6_02,SET,236,-0.028693,-0.0032321,0.055977,0.69588,AREB6_02,0.99999
DORN_ADENOVIRUS_INFECTION_48...1,SET,37,-0.066419,-0.0029786,0.12957,0.69589,DORN_ADENOVIRUS_INFECTION_48HR_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...79,SET,6,-0.16024,-0.0028963,0.31254,0.69592,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01050,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...32,SET,40,-0.061381,-0.0028618,0.11971,0.69593,GAVISH_3CA_MALIGNANT_METAPROGRAM_3_CELL_CYLCE_HMG_RICH,0.99999
HP_BARRETT_ESOPHAGUS,SET,6,-0.17978,-0.0032494,0.35061,0.69594,HP_BARRETT_ESOPHAGUS,0.99999
GOMF_INSULIN_LIKE_GROWTH_FAC...1,SET,18,-0.11659,-0.0036486,0.22735,0.69595,GOMF_INSULIN_LIKE_GROWTH_FACTOR_BINDING,0.99999
MIR621,SET,30,-0.081615,-0.0032963,0.15914,0.69597,MIR621,0.99999
GOBP_NEUROTRANSMITTER_UPTAKE,SET,43,-0.068299,-0.0033014,0.13316,0.69599,GOBP_NEUROTRANSMITTER_UPTAKE,0.99999
GOBP_REGULATION_OF_WNT_SIGNA...1,SET,301,-0.02625,-0.0033333,0.051175,0.696,GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY,0.99999
GSE36476_CTRL_VS_TSST_ACT_72...4,SET,175,-0.033012,-0.0032075,0.06434,0.69605,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP,0.99999
chr11q14,SET,48,-0.119,-0.0060764,0.23187,0.69609,chr11q14,0.99999
HP_INCREASED_CIRCULATING_INS...,SET,5,-0.17554,-0.0028964,0.342,0.69612,HP_INCREASED_CIRCULATING_INSULIN_LIKE_GROWTH_FACTOR_1_CONCENTRATION,0.99999
MATTIOLI_MULTIPLE_MYELOMA_WI...,SET,31,-0.084691,-0.003477,0.16497,0.69615,MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,0.99999
GOBP_BLASTODERM_SEGMENTATION,SET,22,-0.099845,-0.003454,0.19447,0.69616,GOBP_BLASTODERM_SEGMENTATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...566,SET,11,-0.13965,-0.0034171,0.27199,0.69617,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...9,SET,32,-0.074604,-0.0031118,0.14529,0.6962,HP_APLASIA_HYPOPLASIA_OF_THE_ABDOMINAL_WALL_MUSCULATURE,0.99999
GOBP_ANTIMICROBIAL_PEPTIDE_P...,SET,12,-0.14238,-0.0036388,0.2772,0.69624,GOBP_ANTIMICROBIAL_PEPTIDE_PRODUCTION,0.99999
HP_NON_MOTOR_SEIZURE,SET,174,-0.032847,-0.0031824,0.063938,0.69628,HP_NON_MOTOR_SEIZURE,0.99999
MIR4641,SET,60,-0.054579,-0.0031149,0.10623,0.6963,MIR4641,0.99999
RB_P130_DN.V1_UP,SET,117,-0.040136,-0.0031937,0.078108,0.69632,RB_P130_DN.V1_UP,0.99999
HP_CONICAL_TOOTH,SET,49,-0.066819,-0.0034472,0.12999,0.69638,HP_CONICAL_TOOTH,0.99999
BURTON_ADIPOGENESIS_11,SET,47,-0.065465,-0.0033079,0.12735,0.69639,BURTON_ADIPOGENESIS_11,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_LYM...,SET,345,-0.025027,-0.0033982,0.048683,0.6964,HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL,0.99999
MIR548Y,SET,451,-0.020696,-0.0032035,0.040255,0.69641,MIR548Y,0.99999
GOCC_CYTOSKELETON_OF_PRESYNA...,SET,8,-0.17006,-0.003549,0.33075,0.69643,GOCC_CYTOSKELETON_OF_PRESYNAPTIC_ACTIVE_ZONE,0.99999
KEGG_MEDICUS_REFERENCE_COHES...4,SET,6,-0.18988,-0.0034319,0.36928,0.69644,KEGG_MEDICUS_REFERENCE_COHESIN_LOADING,0.99999
BUSSLINGER_GASTRIC_REG3A_POS...,SET,40,-0.077162,-0.0035976,0.15006,0.69645,BUSSLINGER_GASTRIC_REG3A_POSITIVE_CELLS,0.99999
BYSTRYKH_SCP2_QTL,SET,6,-0.15343,-0.0027731,0.29827,0.69651,BYSTRYKH_SCP2_QTL,0.99999
HP_ABNORMAL_CIRCULATING_NON_...,SET,21,-0.087852,-0.0029694,0.17077,0.69653,HP_ABNORMAL_CIRCULATING_NON_PROTEINOGENIC_AMINO_ACID_CONCENTRATION,0.99999
HP_INCREASED_SERUM_ESTRADIOL,SET,8,-0.1548,-0.0032306,0.30089,0.69654,HP_INCREASED_SERUM_ESTRADIOL,0.99999
MIR7705,SET,45,-0.063566,-0.0031431,0.12349,0.69663,MIR7705,0.99999
GOBP_CEREBELLAR_CORTEX_DEVEL...,SET,46,-0.063636,-0.0031812,0.12363,0.69663,GOBP_CEREBELLAR_CORTEX_DEVELOPMENT,0.99999
MIR135B_5P,SET,282,-0.026327,-0.0032376,0.051137,0.69666,MIR135B_5P,0.99999
chr2q32,SET,41,-0.12697,-0.0059931,0.24651,0.69674,chr2q32,0.99999
PURBEY_TARGETS_OF_CTBP1_NOT_...1,SET,352,-0.023269,-0.0031907,0.045167,0.69678,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,0.99999
REACTOME_SENSING_OF_DNA_DOUB...,SET,5,-0.16932,-0.0027937,0.32837,0.69694,REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS,0.99999
GOBP_ACTIVATION_OF_CYSTEINE_...2,SET,68,-0.054332,-0.0033003,0.10536,0.69695,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.99999
HP_MOTOR_STEREOTYPY,SET,224,-0.028585,-0.0031379,0.055431,0.69696,HP_MOTOR_STEREOTYPY,0.99999
HP_DECREASED_METHYLMALONYL_C...,SET,5,-0.20061,-0.00331,0.38896,0.69699,HP_DECREASED_METHYLMALONYL_COA_MUTASE_ACTIVITY,0.99999
GOCC_CYTOPLASMIC_EXOSOME_RNA...,SET,15,-0.09117,-0.0026048,0.1767,0.69706,GOCC_CYTOPLASMIC_EXOSOME_RNASE_COMPLEX,0.99999
GSE2770_TGFB_AND_IL4_ACT_VS_...5,SET,174,-0.031331,-0.0030355,0.060721,0.69706,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,0.99999
GOBP_HEME_B_METABOLIC_PROCESS,SET,9,-0.13675,-0.0030268,0.26498,0.69709,GOBP_HEME_B_METABOLIC_PROCESS,0.99999
HP_GLUCOSE_INTOLERANCE,SET,420,-0.021624,-0.0032329,0.0419,0.6971,HP_GLUCOSE_INTOLERANCE,0.99999
GOBP_REGULATION_OF_TYPE_I_IN...,SET,40,-0.066878,-0.0031181,0.12958,0.69711,GOBP_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.99999
HP_HEMOPHAGOCYTOSIS,SET,19,-0.10988,-0.0035327,0.21282,0.69717,HP_HEMOPHAGOCYTOSIS,0.99999
ACACTAC_MIR1423P,SET,118,-0.04125,-0.0032962,0.07989,0.69718,ACACTAC_MIR1423P,0.99999
GOBP_URETERIC_BUD_FORMATION,SET,5,-0.21781,-0.0035938,0.42184,0.69719,GOBP_URETERIC_BUD_FORMATION,0.99999
ZNF16_TARGET_GENES,SET,66,-0.056526,-0.0033829,0.10944,0.69725,ZNF16_TARGET_GENES,0.99999
PARK_TRETINOIN_RESPONSE,SET,11,-0.14763,-0.0036123,0.28571,0.69732,PARK_TRETINOIN_RESPONSE,0.99999
GSE22886_CTRL_VS_LPS_24H_DC_...1,SET,176,-0.033784,-0.0032917,0.065363,0.69737,GSE22886_CTRL_VS_LPS_24H_DC_DN,0.99999
HP_NO_SOCIAL_INTERACTION,SET,5,-0.24507,-0.0040436,0.4741,0.69739,HP_NO_SOCIAL_INTERACTION,0.99999
GOBP_OLIGOSACCHARIDE_LIPID_I...,SET,20,-0.086811,-0.0028635,0.16793,0.6974,GOBP_OLIGOSACCHARIDE_LIPID_INTERMEDIATE_BIOSYNTHETIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_ELECT...2,SET,10,-0.11617,-0.0027104,0.22471,0.69741,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_III,0.99999
KEGG_RENIN_ANGIOTENSIN_SYSTEM,SET,15,-0.12668,-0.0036192,0.24499,0.69744,KEGG_RENIN_ANGIOTENSIN_SYSTEM,0.99999
GOBP_EMBRYONIC_DIGESTIVE_TRA...1,SET,33,-0.086067,-0.0036455,0.16642,0.69748,GOBP_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT,0.99999
HP_ABNORMAL_GLIAL_CELL_MORPH...,SET,143,-0.035421,-0.0031137,0.068489,0.69748,HP_ABNORMAL_GLIAL_CELL_MORPHOLOGY,0.99999
GOMF_GLYCOSPHINGOLIPID_BINDI...,SET,10,-0.13987,-0.0032633,0.27039,0.69752,GOMF_GLYCOSPHINGOLIPID_BINDING,0.99999
REACTOME_LOSS_OF_FUNCTION_OF...1,SET,11,-0.13506,-0.0033048,0.26106,0.69755,REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME,0.99999
GOBP_EMBRYONIC_SKELETAL_JOIN...1,SET,14,-0.1278,-0.0035277,0.24699,0.69757,GOBP_EMBRYONIC_SKELETAL_JOINT_DEVELOPMENT,0.99999
HP_WEAKNESS_DUE_TO_UPPER_MOT...,SET,426,-0.021024,-0.0031651,0.040623,0.69761,HP_WEAKNESS_DUE_TO_UPPER_MOTOR_NEURON_DYSFUNCTION,0.99999
FOXR2_TARGET_GENES,SET,168,-0.033374,-0.0031777,0.064469,0.69765,FOXR2_TARGET_GENES,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...11,SET,36,-0.068574,-0.0030334,0.13245,0.69767,GOBP_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.99999
GEORGES_TARGETS_OF_MIR192_AN...,SET,796,-0.015702,-0.0031977,0.030326,0.69769,GEORGES_TARGETS_OF_MIR192_AND_MIR215,0.99999
GOMF_PHOSPHATIDYLINOSITOL_3_...11,SET,4,-0.16776,-0.0024758,0.32399,0.69769,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_INHIBITOR_ACTIVITY,0.99999
HP_REGIONAL_ABNORMALITY_OF_S...,SET,469,-0.020183,-0.0031843,0.03898,0.69769,HP_REGIONAL_ABNORMALITY_OF_SKIN,0.99999
ERR1_Q2,SET,228,-0.02948,-0.0032647,0.05691,0.69777,ERR1_Q2,0.99999
GOBP_REGULATION_OF_FAT_CELL_...2,SET,10,-0.15183,-0.0035423,0.29309,0.69778,GOBP_REGULATION_OF_FAT_CELL_PROLIFERATION,0.99999
MIR6888_5P,SET,45,-0.069998,-0.0034611,0.13511,0.69779,MIR6888_5P,0.99999
GSE7460_CD8_TCELL_VS_TREG_AC...2,SET,179,-0.031752,-0.0031197,0.061282,0.69781,GSE7460_CD8_TCELL_VS_TREG_ACT_UP,0.99999
WP_2Q112_COPY_NUMBER_VARIATI...,SET,32,-0.1018,-0.004246,0.19646,0.69782,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,0.99999
REACTOME_RUNX1_REGULATES_TRA...4,SET,7,-0.1575,-0.0030746,0.30394,0.69783,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...80,SET,33,-0.076686,-0.0032481,0.14795,0.69787,HP_APLASIA_HYPOPLASIA_OF_THE_VERTEBRAE,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HRN,SET,300,-0.027262,-0.0034561,0.052601,0.69787,MANNO_MIDBRAIN_NEUROTYPES_HRN,0.99999
HUANG_DASATINIB_SENSITIVITY_...,SET,75,-0.054805,-0.0034955,0.10574,0.69788,HUANG_DASATINIB_SENSITIVITY_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...701,SET,6,-0.21777,-0.0039361,0.42013,0.69789,GOBP_POSITIVE_REGULATION_OF_SISTER_CHROMATID_COHESION,0.99999
HP_INCREASED_RED_BLOOD_CELL_...,SET,5,-0.17993,-0.0029688,0.3471,0.6979,HP_INCREASED_RED_BLOOD_CELL_MASS,0.99999
CASTELLANO_NRAS_TARGETS_DN,SET,13,-0.12661,-0.0033678,0.2442,0.69794,CASTELLANO_NRAS_TARGETS_DN,0.99999
GSE3982_NEUTROPHIL_VS_CENT_M...2,SET,188,-0.032039,-0.0032253,0.06179,0.69795,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
GOBP_UBIQUITIN_RECYCLING,SET,12,-0.12766,-0.0032626,0.24617,0.69797,GOBP_UBIQUITIN_RECYCLING,0.99999
GOBP_VENTRICULAR_CARDIAC_MUS...2,SET,10,-0.16246,-0.0037904,0.31326,0.69798,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.99999
MIR1238_3P,SET,30,-0.077765,-0.0031408,0.14992,0.69802,MIR1238_3P,0.99999
KONDO_COLON_CANCER_HCP_WITH_...1,SET,22,-0.095189,-0.003293,0.18348,0.69804,KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,0.99999
HP_DISTURBANCE_DURING_TRANSI...,SET,17,-0.11322,-0.0034434,0.2182,0.69807,HP_DISTURBANCE_DURING_TRANSITIONS_BETWEEN_SLEEP_AND_WAKE_STATES,0.99999
HP_ERRATIC_MYOCLONUS,SET,4,-0.18714,-0.0027619,0.36064,0.69809,HP_ERRATIC_MYOCLONUS,0.99999
GNF2_TDG,SET,33,-0.067601,-0.0028633,0.13025,0.69812,GNF2_TDG,0.99999
GSE23502_BM_VS_COLON_TUMOR_M...1,SET,181,-0.031853,-0.003147,0.061365,0.69815,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,0.99999
GSE27291_0H_VS_6H_STIM_GAMMA...1,SET,157,-0.034702,-0.0031951,0.066834,0.69819,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN,0.99999
IBRAHIM_NRF2_DOWN,SET,129,-0.038229,-0.0031931,0.073617,0.69822,IBRAHIM_NRF2_DOWN,0.99999
MOOTHA_FFA_OXYDATION,SET,22,-0.090535,-0.003132,0.17432,0.69824,MOOTHA_FFA_OXYDATION,0.99999
BIOCARTA_TCYTOTOXIC_PATHWAY,SET,12,-0.13881,-0.0035476,0.26716,0.69832,BIOCARTA_TCYTOTOXIC_PATHWAY,0.99999
GSE29164_UNTREATED_VS_CD8_TC...8,SET,187,-0.032089,-0.0032219,0.061758,0.69832,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_UP,0.99999
GSE17974_2.5H_VS_72H_IL4_AND...1,SET,176,-0.031156,-0.0030357,0.059958,0.69833,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,0.99999
GOBP_ER_NUCLEUS_SIGNALING_PA...,SET,44,-0.065306,-0.0031931,0.12565,0.69837,GOBP_ER_NUCLEUS_SIGNALING_PATHWAY,0.99999
HP_FEBRILE_SEIZURE_WITHIN_TH...,SET,123,-0.040181,-0.0032777,0.077293,0.69842,HP_FEBRILE_SEIZURE_WITHIN_THE_AGE_RANGE_OF_3_MONTHS_TO_6_YEARS,0.99999
GSE32901_TH1_VS_TH17_NEG_CD4...2,SET,114,-0.041245,-0.0032399,0.079327,0.69845,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP,0.99999
HP_TYPIFIED_BY_INCOMPLETE_PE...,SET,132,-0.038767,-0.0032752,0.074555,0.69846,HP_TYPIFIED_BY_INCOMPLETE_PENETRANCE,0.99999
SIMBULAN_PARP1_TARGETS_DN,SET,16,-0.10047,-0.0029646,0.19317,0.69851,SIMBULAN_PARP1_TARGETS_DN,0.99999
REACTOME_NEGATIVE_REGULATION...12,SET,15,-0.11466,-0.003276,0.22045,0.69851,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS,0.99999
GOBP_GLUCOSE_IMPORT_ACROSS_P...,SET,4,-0.24575,-0.0036268,0.47232,0.69857,GOBP_GLUCOSE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
HP_THICKENED_GLOMERULAR_BASE...,SET,9,-0.13977,-0.0030938,0.26864,0.69857,HP_THICKENED_GLOMERULAR_BASEMENT_MEMBRANE,0.99999
GOBP_GUANINE_METABOLIC_PROCE...,SET,4,-0.21053,-0.003107,0.40446,0.69864,GOBP_GUANINE_METABOLIC_PROCESS,0.99999
GSE24726_WT_VS_E2_2_KO_PDC_UP,SET,177,-0.032729,-0.0031979,0.062879,0.69864,GSE24726_WT_VS_E2_2_KO_PDC_UP,0.99999
GSE27786_NEUTROPHIL_VS_MONO_...1,SET,178,-0.031164,-0.0030535,0.05987,0.69865,GSE27786_NEUTROPHIL_VS_MONO_MAC_DN,0.99999
GOBP_REGULATION_OF_EXIT_FROM...,SET,16,-0.1099,-0.0032429,0.21112,0.69867,GOBP_REGULATION_OF_EXIT_FROM_MITOSIS,0.99999
GOMF_CTPASE_ACTIVITY,SET,5,-0.18529,-0.0030573,0.35593,0.69867,GOMF_CTPASE_ACTIVITY,0.99999
REACTOME_GLUCAGON_LIKE_PEPTI...,SET,42,-0.070676,-0.0033764,0.13574,0.6987,REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,0.99999
GSE4142_NAIVE_BCELL_VS_PLASM...1,SET,187,-0.031534,-0.0031662,0.06056,0.69871,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_DN,0.99999
chr2q23,SET,21,-0.18973,-0.0064129,0.36432,0.69874,chr2q23,0.99999
MIR4434,SET,148,-0.035434,-0.0031685,0.068013,0.69881,MIR4434,0.99999
HP_ABNORMALITY_OF_KREBS_CYCL...,SET,8,-0.15821,-0.0033016,0.30366,0.69881,HP_ABNORMALITY_OF_KREBS_CYCLE_METABOLISM,0.99999
NATSUME_RESPONSE_TO_INTERFER...2,SET,68,-0.055753,-0.0033867,0.10698,0.69887,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,0.99999
GOMF_PROTEIN_PHOSPHORYLATED_...,SET,57,-0.05956,-0.0033134,0.11428,0.69887,GOMF_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING,0.99999
WP_TNFALPHA_SIGNALING,SET,89,-0.044486,-0.0030897,0.085355,0.69888,WP_TNFALPHA_SIGNALING,0.99999
MIR149_5P,SET,133,-0.037094,-0.0031456,0.071164,0.6989,MIR149_5P,0.99999
GSE2405_0H_VS_6H_A_PHAGOCYTO...2,SET,171,-0.031581,-0.0030335,0.060586,0.6989,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.99999
MIR222_3P,SET,158,-0.036063,-0.0033309,0.069183,0.69891,MIR222_3P,0.99999
GOMF_HISTONE_H3K9ME2_H3K9ME3...,SET,5,-0.16654,-0.0027479,0.31949,0.69891,GOMF_HISTONE_H3K9ME2_H3K9ME3_DEMETHYLASE_ACTIVITY,0.99999
GSE20366_CD103_POS_VS_CD103_...1,SET,178,-0.032683,-0.0032024,0.062696,0.69892,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...10,SET,44,-0.07157,-0.0034993,0.13727,0.69894,GAVISH_3CA_METAPROGRAM_B_CELLS_PROGENITOR,0.99999
HP_ABNORMAL_CIRCULATING_PROT...3,SET,606,-0.017991,-0.003214,0.034487,0.69905,HP_ABNORMAL_CIRCULATING_PROTEIN_CONCENTRATION,0.99999
GOBP_VESICLE_TARGETING,SET,62,-0.050298,-0.0029179,0.09641,0.69906,GOBP_VESICLE_TARGETING,0.99999
HP_GLOMERULAR_SUBEPITHELIAL_...,SET,11,-0.12478,-0.0030532,0.23916,0.69907,HP_GLOMERULAR_SUBEPITHELIAL_DEPOSITS,0.99999
GSE23505_IL6_IL1_VS_IL6_IL1_...4,SET,186,-0.031745,-0.0031789,0.060844,0.69907,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,0.99999
BUSSLINGER_GASTRIC_TUFT_CELLS,SET,11,-0.15286,-0.0037403,0.29298,0.69907,BUSSLINGER_GASTRIC_TUFT_CELLS,0.99999
WANG_SMARCE1_TARGETS_DN,SET,322,-0.025052,-0.0032883,0.048012,0.69909,WANG_SMARCE1_TARGETS_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_WA...,SET,6,-0.19056,-0.0034442,0.36518,0.6991,GOBP_CELLULAR_RESPONSE_TO_WATER_STIMULUS,0.99999
GOBP_REGULATION_OF_HEART_RATE,SET,96,-0.048476,-0.003496,0.092891,0.69911,GOBP_REGULATION_OF_HEART_RATE,0.99999
MIR4517,SET,189,-0.032927,-0.0033235,0.063091,0.69913,MIR4517,0.99999
GNF2_PTX3,SET,34,-0.085781,-0.0036879,0.16436,0.69913,GNF2_PTX3,0.99999
MIR6730_3P,SET,74,-0.050886,-0.003224,0.097485,0.69916,MIR6730_3P,0.99999
GSE3982_MAST_CELL_VS_TH2_DN,SET,181,-0.031128,-0.0030753,0.059632,0.69916,GSE3982_MAST_CELL_VS_TH2_DN,0.99999
VERRECCHIA_RESPONSE_TO_TGFB1...5,SET,20,-0.10119,-0.003338,0.19377,0.69924,VERRECCHIA_RESPONSE_TO_TGFB1_C5,0.99999
HP_ABNORMALITY_OF_THE_COAGUL...,SET,136,-0.038216,-0.0032768,0.07318,0.69924,HP_ABNORMALITY_OF_THE_COAGULATION_CASCADE,0.99999
HP_SYNCOPE,SET,116,-0.043156,-0.0034193,0.082592,0.69934,HP_SYNCOPE,0.99999
HP_OSTEOCHONDROMA,SET,7,-0.18519,-0.0036152,0.3543,0.6994,HP_OSTEOCHONDROMA,0.99999
HP_UPPER_LIMB_SPASTICITY,SET,22,-0.094546,-0.0032707,0.18089,0.6994,HP_UPPER_LIMB_SPASTICITY,0.99999
WP_ACTIVATION_OF_NLRP3_INFLA...,SET,6,-0.16213,-0.0029303,0.31017,0.69941,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,0.99999
HP_PROMINENT_NASAL_BRIDGE,SET,202,-0.029455,-0.0030724,0.056335,0.69946,HP_PROMINENT_NASAL_BRIDGE,0.99999
GSE360_CTRL_VS_B_MALAYI_HIGH...3,SET,189,-0.030911,-0.0031199,0.059103,0.69951,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.99999
HP_PSEUDOEPIPHYSES_OF_THE_ME...,SET,8,-0.15806,-0.0032986,0.30221,0.69952,HP_PSEUDOEPIPHYSES_OF_THE_METACARPALS,0.99999
REACTOME_SYNTHESIS_OF_LEUKOT...,SET,21,-0.10867,-0.0036729,0.20776,0.69953,REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX,0.99999
GOBP_BEHAVIORAL_RESPONSE_TO_...3,SET,8,-0.18272,-0.0038132,0.3493,0.69954,GOBP_BEHAVIORAL_RESPONSE_TO_NICOTINE,0.99999
HMG20B_TARGET_GENES,SET,1493,-0.012042,-0.0032911,0.023015,0.69958,HMG20B_TARGET_GENES,0.99999
GIAROLA_SILVA_BLOOD_INFLUENZ...,SET,4,-0.24566,-0.0036256,0.46954,0.69958,GIAROLA_SILVA_BLOOD_INFLUENZA_A_AGE_21_51YO_3DY_UP,0.99999
GSE44649_WT_VS_MIR155_KO_ACT...2,SET,189,-0.032053,-0.0032352,0.061259,0.69959,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP,0.99999
GAUTAM_EYE_CORNEA_CONJUNCTIV...,SET,92,-0.047185,-0.0033317,0.090141,0.69967,GAUTAM_EYE_CORNEA_CONJUNCTIVAL_CELLS,0.99999
GOMF_CALCIUM_POTASSIUM_SODIU...,SET,5,-0.2433,-0.0040144,0.46464,0.69973,GOMF_CALCIUM_POTASSIUM_SODIUM_ANTIPORTER_ACTIVITY,0.99999
REACTOME_FGFR1_MUTANT_RECEPT...,SET,30,-0.090037,-0.0036364,0.1719,0.69978,REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,0.99999
HP_ABSENT_LACRIMAL_PUNCTUM,SET,6,-0.19259,-0.003481,0.36752,0.69987,HP_ABSENT_LACRIMAL_PUNCTUM,0.99999
GOBP_TRANSCRIPTION_ELONGATIO...2,SET,8,-0.13531,-0.0028238,0.25803,0.7,GOBP_TRANSCRIPTION_ELONGATION_COUPLED_CHROMATIN_REMODELING,0.99999
GSE20198_IL12_VS_IL12_IL18_T...1,SET,191,-0.031543,-0.0032003,0.060143,0.70002,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,0.99999
GOBP_CILIARY_NEUROTROPHIC_FA...,SET,5,-0.21588,-0.0035619,0.41154,0.70005,GOBP_CILIARY_NEUROTROPHIC_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.99999
HP_BASAL_GANGLIA_CALCIFICATI...,SET,36,-0.077185,-0.0034144,0.14713,0.70007,HP_BASAL_GANGLIA_CALCIFICATION,0.99999
GSE14908_ATOPIC_VS_NONATOPIC...1,SET,174,-0.032615,-0.0031599,0.062172,0.70007,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN,0.99999
REACTOME_GLUCAGON_TYPE_LIGAN...,SET,33,-0.081203,-0.0034395,0.15475,0.70011,REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS,0.99999
HP_ALACRIMA,SET,17,-0.10755,-0.003271,0.20495,0.70012,HP_ALACRIMA,0.99999
GOBP_REGULATION_OF_IRE1_MEDI...,SET,14,-0.12561,-0.0034672,0.23933,0.70015,GOBP_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.99999
BIOCARTA_CPSF_PATHWAY,SET,9,-0.13788,-0.0030519,0.2627,0.70016,BIOCARTA_CPSF_PATHWAY,0.99999
MCBRYAN_TERMINAL_END_BUD_UP,SET,12,-0.13841,-0.0035373,0.26369,0.70017,MCBRYAN_TERMINAL_END_BUD_UP,0.99999
GOBP_REGULATION_OF_ADENYLATE...2,SET,42,-0.07319,-0.0034965,0.13943,0.70017,GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,0.99999
GSE3720_VD1_VS_VD2_GAMMADELT...2,SET,171,-0.03332,-0.0032005,0.063464,0.70021,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP,0.99999
PPARG_01,SET,45,-0.064392,-0.0031839,0.12259,0.7003,PPARG_01,0.99999
GSE16697_CD4_TCELL_VS_TFH_CD...2,SET,179,-0.033904,-0.0033312,0.064528,0.70035,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_UP,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...7,SET,45,-0.068296,-0.0033769,0.12997,0.70037,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MES_GLYCOLYSIS,0.99999
MIR1225_5P,SET,25,-0.087775,-0.0032366,0.16699,0.70042,MIR1225_5P,0.99999
FARDIN_HYPOXIA_11,SET,28,-0.082066,-0.0032023,0.15612,0.70044,FARDIN_HYPOXIA_11,0.99999
REACTOME_ERYTHROPOIETIN_ACTI...2,SET,7,-0.17957,-0.0035055,0.34157,0.70045,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG,0.99999
GOCC_MITOCHONDRIAL_MATRIX,SET,448,-0.020268,-0.003127,0.038554,0.70045,GOCC_MITOCHONDRIAL_MATRIX,0.99999
HP_IMPAIRED_EXECUTIVE_FUNCTI...,SET,9,-0.1519,-0.0033623,0.28894,0.70045,HP_IMPAIRED_EXECUTIVE_FUNCTIONING,0.99999
GOBP_AORTA_DEVELOPMENT,SET,60,-0.061669,-0.0035195,0.11727,0.70051,GOBP_AORTA_DEVELOPMENT,0.99999
MIR186_3P,SET,131,-0.038538,-0.0032435,0.07327,0.70054,MIR186_3P,0.99999
DESCARTES_FETAL_ADRENAL_CSH1...,SET,146,-0.038795,-0.0034456,0.073757,0.70055,DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS,0.99999
BIOCARTA_CCR3_PATHWAY,SET,18,-0.11434,-0.0035784,0.21736,0.70057,BIOCARTA_CCR3_PATHWAY,0.99999
HP_CEREBRAL_CORTICAL_HEMIATR...,SET,5,-0.19641,-0.0032407,0.37336,0.70057,HP_CEREBRAL_CORTICAL_HEMIATROPHY,0.99999
LIU_SOX4_TARGETS_DN,SET,286,-0.02583,-0.0031985,0.049099,0.70058,LIU_SOX4_TARGETS_DN,0.99999
GOBP_PURINE_RIBONUCLEOSIDE_M...,SET,19,-0.11246,-0.0036158,0.21373,0.70061,GOBP_PURINE_RIBONUCLEOSIDE_METABOLIC_PROCESS,0.99999
HP_UNDETECTABLE_LIGHT_AND_DA...,SET,13,-0.13652,-0.0036313,0.2593,0.70072,HP_UNDETECTABLE_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM,0.99999
GOBP_VASCULATURE_DEVELOPMENT,SET,690,-0.018007,-0.0034245,0.034192,0.70077,GOBP_VASCULATURE_DEVELOPMENT,0.99999
GSE3982_MAC_VS_TH1_UP,SET,181,-0.033673,-0.0033267,0.063941,0.70077,GSE3982_MAC_VS_TH1_UP,0.99999
MORF_THPO,SET,109,-0.043945,-0.0033758,0.083438,0.70079,MORF_THPO,0.99999
GOBP_NUCLEOSIDE_BISPHOSPHATE...3,SET,111,-0.042654,-0.0033064,0.080965,0.70084,GOBP_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS,0.99999
DAZARD_UV_RESPONSE_CLUSTER_G6,SET,135,-0.038865,-0.0033203,0.073752,0.70089,DAZARD_UV_RESPONSE_CLUSTER_G6,0.99999
REACTOME_JOSEPHIN_DOMAIN_DUBS,SET,9,-0.14113,-0.0031237,0.2678,0.7009,REACTOME_JOSEPHIN_DOMAIN_DUBS,0.99999
GOMF_TRANSMEMBRANE_EPHRIN_RE...,SET,15,-0.13161,-0.0037603,0.24969,0.70094,GOMF_TRANSMEMBRANE_EPHRIN_RECEPTOR_ACTIVITY,0.99999
GSE12003_MIR223_KO_VS_WT_BM_...3,SET,125,-0.038936,-0.0032016,0.073863,0.70095,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_DN,0.99999
GOMF_NON_MEMBRANE_SPANNING_P...2,SET,10,-0.13542,-0.0031595,0.25681,0.70101,GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,0.99999
MIR1180_3P,SET,6,-0.19474,-0.0035197,0.36928,0.70102,MIR1180_3P,0.99999
GOBP_RESPONSE_TO_BILE_ACID,SET,7,-0.17755,-0.003466,0.33669,0.70102,GOBP_RESPONSE_TO_BILE_ACID,0.99999
GSE9037_CTRL_VS_LPS_1H_STIM_...2,SET,173,-0.03273,-0.003162,0.062064,0.70102,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP,0.99999
HP_TELANGIECTASIA_OF_THE_SKIN,SET,70,-0.049042,-0.0030223,0.092976,0.70107,HP_TELANGIECTASIA_OF_THE_SKIN,0.99999
GSE43863_TFH_VS_LY6C_INT_CXC...3,SET,178,-0.033635,-0.0032956,0.063753,0.7011,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,0.99999
GSE23114_PERITONEAL_CAVITY_B...2,SET,175,-0.033548,-0.0032596,0.063585,0.70111,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_DN,0.99999
MIR2052,SET,220,-0.029438,-0.003203,0.055776,0.70117,MIR2052,0.99999
GOBP_IRON_COORDINATION_ENTIT...,SET,11,-0.13942,-0.0034115,0.26414,0.70119,GOBP_IRON_COORDINATION_ENTITY_TRANSPORT,0.99999
HP_OPEN_NEURAL_TUBE_DEFECT,SET,134,-0.037647,-0.0032044,0.071317,0.70121,HP_OPEN_NEURAL_TUBE_DEFECT,0.99999
GSE26928_CENTR_MEMORY_VS_CXC...1,SET,158,-0.035121,-0.0032439,0.066531,0.70121,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,0.99999
KEGG_LIMONENE_AND_PINENE_DEG...,SET,9,-0.13369,-0.0029591,0.25323,0.70122,KEGG_LIMONENE_AND_PINENE_DEGRADATION,0.99999
REACTOME_RUNX3_REGULATES_NOT...,SET,13,-0.11657,-0.0031007,0.22081,0.70122,REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING,0.99999
GOMF_PHOSPHOPROTEIN_BINDING,SET,86,-0.04815,-0.0032876,0.091203,0.70123,GOMF_PHOSPHOPROTEIN_BINDING,0.99999
GSE14415_INDUCED_TREG_VS_TCO...2,SET,158,-0.034246,-0.0031631,0.064814,0.70138,GSE14415_INDUCED_TREG_VS_TCONV_UP,0.99999
WP_PROTEASOME_DEGRADATION,SET,56,-0.05486,-0.0030251,0.10376,0.7015,WP_PROTEASOME_DEGRADATION,0.99999
MIR518A_5P_MIR527,SET,237,-0.029689,-0.0033512,0.05615,0.70151,MIR518A_5P_MIR527,0.99999
WP_PENTOSE_PHOSPHATE_PATHWAY...,SET,7,-0.1754,-0.0034241,0.33167,0.70154,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,0.99999
GSE27859_DC_VS_CD11C_INT_F48...4,SET,184,-0.032572,-0.0032443,0.061591,0.70154,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP,0.99999
GSE3982_EOSINOPHIL_VS_BCELL_...2,SET,182,-0.034568,-0.0034245,0.065321,0.70166,GSE3982_EOSINOPHIL_VS_BCELL_UP,0.99999
GOMF_CHROMATIN_INSULATOR_SEQ...,SET,4,-0.19387,-0.0028612,0.36625,0.70171,GOMF_CHROMATIN_INSULATOR_SEQUENCE_BINDING,0.99999
GOMF_LONG_CHAIN_FATTY_ACID_C...,SET,14,-0.11511,-0.0031773,0.21746,0.70171,GOMF_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,0.99999
MEINHOLD_OVARIAN_CANCER_LOW_...2,SET,10,-0.15642,-0.0036495,0.29548,0.70173,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,0.99999
HOWARD_NK_CELL_INACT_MONOV_I...3,SET,66,-0.052876,-0.0031645,0.099799,0.70188,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.99999
MIR3925_5P,SET,141,-0.037947,-0.0033125,0.071617,0.70189,MIR3925_5P,0.99999
HP_PRIMARY_HYPERCORTISOLISM,SET,9,-0.1449,-0.0032073,0.27341,0.70193,HP_PRIMARY_HYPERCORTISOLISM,0.99999
GOBP_REGULATION_OF_ACTIN_NUC...,SET,27,-0.077286,-0.0029615,0.14581,0.70195,GOBP_REGULATION_OF_ACTIN_NUCLEATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...443,SET,16,-0.11775,-0.0034745,0.22208,0.70202,GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION,0.99999
GOBP_REGULATION_OF_GLUCOCORT...1,SET,9,-0.16509,-0.0036542,0.31134,0.70203,GOBP_REGULATION_OF_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS,0.99999
PID_INSULIN_PATHWAY,SET,44,-0.066466,-0.0032498,0.12533,0.70206,PID_INSULIN_PATHWAY,0.99999
HP_DUANE_ANOMALY,SET,22,-0.094842,-0.003281,0.17883,0.70207,HP_DUANE_ANOMALY,0.99999
WILSON_PROTEASES_AT_TUMOR_BO...1,SET,5,-0.22612,-0.0037309,0.42632,0.70208,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN,0.99999
GSE23321_EFFECTOR_MEMORY_VS_...2,SET,172,-0.034949,-0.0033667,0.06588,0.70211,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.99999
E2F2_TARGET_GENES,SET,1185,-0.013259,-0.003258,0.024981,0.70221,E2F2_TARGET_GENES,0.99999
HP_ABNORMAL_CARDIAC_VENTRICL...,SET,599,-0.018115,-0.0032182,0.034124,0.70224,HP_ABNORMAL_CARDIAC_VENTRICLE_MORPHOLOGY,0.99999
HP_ABNORMAL_CIRCULATING_HOMO...,SET,15,-0.11469,-0.0032769,0.21597,0.70231,HP_ABNORMAL_CIRCULATING_HOMOCYSTEINE_CONCENTRATION,0.99999
GOMF_KINESIN_BINDING,SET,39,-0.067992,-0.0031302,0.12802,0.70232,GOMF_KINESIN_BINDING,0.99999
REACTOME_APOPTOTIC_CLEAVAGE_...1,SET,35,-0.075425,-0.00329,0.14201,0.70233,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,0.99999
HP_REDUCED_FACTOR_VII_ACTIVI...,SET,5,-0.19298,-0.0031841,0.3633,0.70235,HP_REDUCED_FACTOR_VII_ACTIVITY,0.99999
PGM3_TARGET_GENES,SET,214,-0.029952,-0.0032147,0.056376,0.70239,PGM3_TARGET_GENES,0.99999
HP_THORACOLUMBAR_SCOLIOSIS,SET,37,-0.069405,-0.0031125,0.13055,0.70251,HP_THORACOLUMBAR_SCOLIOSIS,0.99999
HP_ABNORMALITY_OF_THE_FRONTA...,SET,184,-0.03197,-0.0031843,0.0601,0.70261,HP_ABNORMALITY_OF_THE_FRONTAL_HAIRLINE,0.99999
GSE40666_STAT1_KO_VS_STAT4_K...1,SET,139,-0.04011,-0.0034767,0.075405,0.70261,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_DN,0.99999
GOBP_INFLAMMATORY_RESPONSE_T...1,SET,70,-0.058299,-0.0035928,0.10959,0.70263,GOBP_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MES...1,SET,264,-0.029111,-0.0034655,0.054717,0.70265,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_1_CELL,0.99999
chr4q24,SET,24,-0.17047,-0.006159,0.32031,0.7027,chr4q24,0.99999
HP_ENCEPHALOCELE,SET,110,-0.041468,-0.0032,0.077899,0.70275,HP_ENCEPHALOCELE,0.99999
HP_PROTRUSIO_ACETABULI,SET,12,-0.13908,-0.0035544,0.26123,0.70278,HP_PROTRUSIO_ACETABULI,0.99999
GSE21927_SPLEEN_VS_TUMOR_MON...1,SET,168,-0.035013,-0.0033338,0.065738,0.70285,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN,0.99999
WP_NETRINUNC5B_SIGNALING,SET,48,-0.0673,-0.0034365,0.12635,0.70286,WP_NETRINUNC5B_SIGNALING,0.99999
HP_ABNORMAL_CIRCULATING_VITA...3,SET,19,-0.10393,-0.0033417,0.19513,0.70286,HP_ABNORMAL_CIRCULATING_VITAMIN_E_CONCENTRATION,0.99999
ZNF350_TARGET_GENES,SET,1153,-0.013529,-0.0032821,0.025396,0.70288,ZNF350_TARGET_GENES,0.99999
GOBP_REGULATION_OF_ELECTRON_...,SET,3,-0.24681,-0.0031546,0.46331,0.70288,GOBP_REGULATION_OF_ELECTRON_TRANSFER_ACTIVITY,0.99999
GSE7768_OVA_ALONE_VS_OVA_WIT...3,SET,148,-0.036097,-0.0032278,0.067736,0.70295,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,0.99999
GOBP_PATTERN_SPECIFICATION_I...,SET,8,-0.19451,-0.0040592,0.36489,0.703,GOBP_PATTERN_SPECIFICATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...16,SET,9,-0.15767,-0.00349,0.29574,0.70303,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBRAL_WHITE_MATTER,0.99999
HP_CEREBRAL_WHITE_MATTER_HYP...,SET,9,-0.15767,-0.00349,0.29574,0.70303,HP_CEREBRAL_WHITE_MATTER_HYPOPLASIA,0.99999
HP_ABNORMAL_URINE_ALPHA_KETO...,SET,14,-0.11808,-0.0032593,0.22146,0.70305,HP_ABNORMAL_URINE_ALPHA_KETOGLUTARATE_CONCENTRATION,0.99999
PID_P53_REGULATION_PATHWAY,SET,55,-0.059263,-0.0032387,0.11114,0.70306,PID_P53_REGULATION_PATHWAY,0.99999
REACTOME_ASPARAGINE_N_LINKED...,SET,291,-0.025788,-0.0032207,0.048353,0.7031,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...310,SET,35,-0.076848,-0.003352,0.14408,0.7031,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,0.99999
GOMF_CARBOHYDRATE_PHOSPHATAS...,SET,8,-0.1512,-0.0031554,0.28341,0.70315,GOMF_CARBOHYDRATE_PHOSPHATASE_ACTIVITY,0.99999
DESCARTES_FETAL_ADRENAL_STRO...,SET,122,-0.045167,-0.0036695,0.084606,0.70327,DESCARTES_FETAL_ADRENAL_STROMAL_CELLS,0.99999
GOBP_REGULATION_OF_STRIATED_...3,SET,18,-0.12233,-0.0038284,0.22912,0.7033,GOBP_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT,0.99999
GSE11924_TH2_VS_TH17_CD4_TCE...1,SET,184,-0.033166,-0.0033034,0.062106,0.70333,GSE11924_TH2_VS_TH17_CD4_TCELL_DN,0.99999
WP_NRXN1_DELETION_SYNDROME,SET,14,-0.12956,-0.0035762,0.24254,0.70339,WP_NRXN1_DELETION_SYNDROME,0.99999
VOIGT_PBMC_FLUARIX_AGE_50_74...,SET,18,-0.11242,-0.0035183,0.21046,0.70339,VOIGT_PBMC_FLUARIX_AGE_50_74YO_FEMALES_VS_MALES_0DY_TO_28D_UP,0.99999
GOBP_ACTOMYOSIN_STRUCTURE_OR...,SET,205,-0.031495,-0.0033093,0.058951,0.70341,GOBP_ACTOMYOSIN_STRUCTURE_ORGANIZATION,0.99999
SIG_IL4RECEPTOR_IN_B_LYPHOCY...,SET,27,-0.087242,-0.003343,0.16327,0.70345,SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,0.99999
REACTOME_SPERM_MOTILITY_AND_...,SET,9,-0.14106,-0.0031222,0.26395,0.70347,REACTOME_SPERM_MOTILITY_AND_TAXES,0.99999
GSE45365_NK_CELL_VS_CD8A_DC_...1,SET,181,-0.034837,-0.0034417,0.065186,0.70347,GSE45365_NK_CELL_VS_CD8A_DC_DN,0.99999
GSE45365_NK_CELL_VS_CD8A_DC_...2,SET,161,-0.03478,-0.0032425,0.065082,0.70347,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN,0.99999
HP_CERVICAL_NEOPLASM,SET,6,-0.21381,-0.0038644,0.40001,0.7035,HP_CERVICAL_NEOPLASM,0.99999
GOBP_HEPATICOBILIARY_SYSTEM_...,SET,141,-0.039127,-0.0034156,0.073179,0.70356,GOBP_HEPATICOBILIARY_SYSTEM_DEVELOPMENT,0.99999
GOCC_MICROTUBULE_CYTOSKELETON,SET,1223,-0.012789,-0.0031888,0.023919,0.70356,GOCC_MICROTUBULE_CYTOSKELETON,0.99999
REACTOME_GLYCEROPHOSPHOLIPID...1,SET,113,-0.044247,-0.0034604,0.08274,0.70359,REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,0.99999
GOMF_MITOGEN_ACTIVATED_PROTE...4,SET,7,-0.18911,-0.0036918,0.35363,0.70359,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_P38_BINDING,0.99999
GOBP_GAMMA_AMINOBUTYRIC_ACID...2,SET,5,-0.24331,-0.0040146,0.45498,0.7036,GOBP_GAMMA_AMINOBUTYRIC_ACID_IMPORT,0.99999
CHEMELLO_SOLEUS_VS_EDL_MYOFI...1,SET,5,-0.21667,-0.003575,0.40512,0.70361,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN,0.99999
REACTOME_INTERLEUKIN_21_SIGN...,SET,9,-0.17709,-0.0039197,0.33109,0.70362,REACTOME_INTERLEUKIN_21_SIGNALING,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HN...1,SET,619,-0.019638,-0.0035445,0.036717,0.70362,MANNO_MIDBRAIN_NEUROTYPES_HNBGABA,0.99999
MODULE_489,SET,26,-0.087259,-0.0032813,0.16311,0.70366,MODULE_489,0.99999
ZNF558_TARGET_GENES,SET,225,-0.029362,-0.0032304,0.054885,0.70367,ZNF558_TARGET_GENES,0.99999
MIR3140_5P,SET,121,-0.040644,-0.0032886,0.075969,0.70368,MIR3140_5P,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_GHR...1,SET,140,-0.040811,-0.0035501,0.076278,0.70368,HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NEUROENDOCRINE_CELL,0.99999
HP_ABNORMAL_THYROID_STIMULAT...,SET,39,-0.072885,-0.0033555,0.13622,0.7037,HP_ABNORMAL_THYROID_STIMULATING_HORMONE_LEVEL,0.99999
HP_NARROW_MOUTH,SET,208,-0.031928,-0.0033789,0.059652,0.70375,HP_NARROW_MOUTH,0.99999
ENGELMANN_CANCER_PROGENITORS...1,SET,58,-0.06056,-0.0033983,0.11314,0.70377,ENGELMANN_CANCER_PROGENITORS_DN,0.99999
GOBP_RESPONSE_TO_WATER,SET,13,-0.12478,-0.0033191,0.2331,0.70378,GOBP_RESPONSE_TO_WATER,0.99999
HP_WEAK_EXTRAOCULAR_MUSCLES,SET,12,-0.12032,-0.0030749,0.22472,0.70381,HP_WEAK_EXTRAOCULAR_MUSCLES,0.99999
chr16q23,SET,51,-0.10524,-0.0055389,0.19648,0.70389,chr16q23,0.99999
GREENBAUM_E2A_TARGETS_UP,SET,27,-0.085417,-0.0032731,0.15946,0.7039,GREENBAUM_E2A_TARGETS_UP,0.99999
GOBP_REGULATION_OF_ANTIGEN_P...1,SET,18,-0.10802,-0.0033806,0.20165,0.70391,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...314,SET,7,-0.19442,-0.0037954,0.36292,0.70392,GOBP_POSITIVE_REGULATION_OF_GONADOTROPIN_SECRETION,0.99999
GOBP_REGULATION_OF_ATTACHMEN...1,SET,9,-0.14335,-0.003173,0.26749,0.70399,GOBP_REGULATION_OF_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.99999
HP_NAIL_DYSPLASIA,SET,140,-0.038868,-0.003381,0.072522,0.704,HP_NAIL_DYSPLASIA,0.99999
MODULE_352,SET,17,-0.097059,-0.002952,0.18109,0.70401,MODULE_352,0.99999
GOMF_RISC_COMPLEX_BINDING,SET,4,-0.2265,-0.0033428,0.42256,0.70402,GOMF_RISC_COMPLEX_BINDING,0.99999
GSE24634_TEFF_VS_TCONV_DAY3_...1,SET,169,-0.035938,-0.0034319,0.067047,0.70402,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN,0.99999
MIR4540,SET,47,-0.065825,-0.0033261,0.12278,0.70406,MIR4540,0.99999
AMIT_SERUM_RESPONSE_40_MCF10A,SET,29,-0.094731,-0.0037618,0.17668,0.70408,AMIT_SERUM_RESPONSE_40_MCF10A,0.99999
GSE23308_CTRL_VS_CORTICOSTER...1,SET,186,-0.032512,-0.0032557,0.06063,0.7041,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN,0.99999
REACTOME_FATTY_ACIDS,SET,15,-0.13159,-0.0037597,0.24538,0.70412,REACTOME_FATTY_ACIDS,0.99999
DESCARTES_FETAL_SPLEEN_AFP_A...,SET,170,-0.036721,-0.003517,0.068471,0.70412,DESCARTES_FETAL_SPLEEN_AFP_ALB_POSITIVE_CELLS,0.99999
GOMF_METAL_ION_SENSOR_ACTIVI...,SET,8,-0.19172,-0.0040009,0.35733,0.7042,GOMF_METAL_ION_SENSOR_ACTIVITY,0.99999
GOBP_AXIAL_MESODERM_DEVELOPM...,SET,7,-0.14548,-0.0028401,0.27115,0.70421,GOBP_AXIAL_MESODERM_DEVELOPMENT,0.99999
REACTOME_TRANSPORT_OF_NUCLEO...2,SET,8,-0.14829,-0.0030947,0.27637,0.70422,REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS,0.99999
GOMF_RNA_POLYMERASE_I_ACTIVI...,SET,9,-0.13488,-0.0029854,0.25123,0.70431,GOMF_RNA_POLYMERASE_I_ACTIVITY,0.99999
HP_KELOIDS,SET,9,-0.14581,-0.0032273,0.27152,0.70437,HP_KELOIDS,0.99999
MIR4733_5P,SET,83,-0.049351,-0.0033106,0.091889,0.70439,MIR4733_5P,0.99999
chr8q21,SET,67,-0.10177,-0.0061367,0.18942,0.70446,chr8q21,0.99999
REACTOME_FCGR3A_MEDIATED_IL1...,SET,37,-0.078131,-0.0035038,0.14541,0.70447,REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,0.99999
chr6p22,SET,103,-0.072786,-0.0054362,0.13542,0.70452,chr6p22,0.99999
REACTOME_SIGNALING_BY_CTNNB1...,SET,14,-0.12029,-0.0033204,0.22371,0.70461,REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS,0.99999
GOMF_NADPLUS_PROTEIN_ADP_RIB...,SET,28,-0.083543,-0.0032599,0.15531,0.70467,GOMF_NADPLUS_PROTEIN_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_DNA_TEMPL...3,SET,94,-0.043646,-0.0031149,0.081127,0.70471,GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.99999
HP_NEOPLASM_OF_THE_PITUITARY...,SET,64,-0.053675,-0.0031634,0.099733,0.70477,HP_NEOPLASM_OF_THE_PITUITARY_GLAND,0.99999
GOMF_TRANSPORTER_ACTIVATOR_A...,SET,7,-0.17872,-0.003489,0.33207,0.70478,GOMF_TRANSPORTER_ACTIVATOR_ACTIVITY,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...12,SET,47,-0.062819,-0.0031742,0.11669,0.70482,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_2,0.99999
HP_CEREBRAL_VISUAL_IMPAIRMENT,SET,140,-0.036828,-0.0032035,0.068408,0.70483,HP_CEREBRAL_VISUAL_IMPAIRMENT,0.99999
GOBP_RESPONSE_TO_EPIDERMAL_G...,SET,42,-0.067812,-0.0032396,0.12595,0.70485,GOBP_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...162,SET,33,-0.086889,-0.0036803,0.16137,0.70486,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
GOMF_EXTRACELLULAR_MATRIX_PR...,SET,6,-0.21712,-0.0039242,0.40311,0.70492,GOMF_EXTRACELLULAR_MATRIX_PROTEIN_BINDING,0.99999
GOMF_SPECTRIN_BINDING,SET,26,-0.094469,-0.0035524,0.17538,0.70493,GOMF_SPECTRIN_BINDING,0.99999
REACTOME_METHYLATION,SET,14,-0.12334,-0.0034046,0.22896,0.70495,REACTOME_METHYLATION,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...8,SET,177,-0.03295,-0.0032195,0.061157,0.70498,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
WP_CIRCADIAN_RHYTHM_GENES,SET,190,-0.034647,-0.0035062,0.064297,0.705,WP_CIRCADIAN_RHYTHM_GENES,0.99999
GOCC_G_PROTEIN_COUPLED_RECEP...1,SET,11,-0.15107,-0.0036966,0.28036,0.705,GOCC_G_PROTEIN_COUPLED_RECEPTOR_COMPLEX,0.99999
KEGG_PROPANOATE_METABOLISM,SET,31,-0.080908,-0.0033217,0.15014,0.70501,KEGG_PROPANOATE_METABOLISM,0.99999
HP_TYPE_E_BRACHYDACTYLY,SET,5,-0.22362,-0.0036897,0.41498,0.70501,HP_TYPE_E_BRACHYDACTYLY,0.99999
JOSEPH_RESPONSE_TO_SODIUM_BU...1,SET,57,-0.06208,-0.0034536,0.11518,0.70505,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,0.99999
chr4p11,SET,8,-0.26117,-0.0054504,0.48451,0.70507,chr4p11,0.99999
GSE2706_R848_VS_R848_AND_LPS...3,SET,158,-0.038156,-0.0035242,0.070771,0.7051,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN,0.99999
HP_ABNORMALITY_OF_THE_PALPEB...,SET,738,-0.016752,-0.0032904,0.031066,0.70514,HP_ABNORMALITY_OF_THE_PALPEBRAL_FISSURES,0.99999
REACTOME_INITIATION_OF_NUCLE...,SET,18,-0.10272,-0.0032146,0.19047,0.70515,REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION,0.99999
GSE21360_NAIVE_VS_PRIMARY_ME...2,SET,157,-0.03714,-0.0034196,0.06885,0.7052,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_UP,0.99999
FARMER_BREAST_CANCER_CLUSTER...4,SET,18,-0.11779,-0.0036862,0.2183,0.70525,FARMER_BREAST_CANCER_CLUSTER_4,0.99999
KEGG_AMINO_SUGAR_AND_NUCLEOT...,SET,40,-0.066837,-0.0031162,0.12379,0.70538,KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,0.99999
GATA2_01,SET,99,-0.04667,-0.0034177,0.086427,0.70539,GATA2_01,0.99999
GOBP_REGULATION_OF_GROWTH,SET,526,-0.020613,-0.0034385,0.038172,0.7054,GOBP_REGULATION_OF_GROWTH,0.99999
WP_FOCAL_ADHESION_PI3KAKTMTO...,SET,288,-0.027967,-0.0034751,0.051788,0.70541,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,0.99999
GOMF_MOLECULAR_FUNCTION_ACTI...,SET,1018,-0.015162,-0.0034697,0.028076,0.70541,GOMF_MOLECULAR_FUNCTION_ACTIVATOR_ACTIVITY,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...1,SET,155,-0.03883,-0.0035526,0.071899,0.70542,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,0.99999
GOBP_ARGININE_BIOSYNTHETIC_P...,SET,4,-0.19978,-0.0029484,0.36993,0.70542,GOBP_ARGININE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_NUCLEAR_T...1,SET,21,-0.095738,-0.0032359,0.17724,0.70545,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.99999
GOCC_FILOPODIUM_MEMBRANE,SET,16,-0.11643,-0.0034354,0.21552,0.70547,GOCC_FILOPODIUM_MEMBRANE,0.99999
GOCC_MICROTUBULE,SET,416,-0.021609,-0.0032156,0.04,0.70548,GOCC_MICROTUBULE,0.99999
GOMF_BMP_RECEPTOR_BINDING,SET,10,-0.15207,-0.0035479,0.28148,0.70549,GOMF_BMP_RECEPTOR_BINDING,0.99999
GSE43863_TH1_VS_LY6C_LOW_CXC...1,SET,184,-0.032996,-0.0032865,0.061044,0.70558,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,0.99999
GOMF_UBIQUITIN_LIGASE_INHIBI...,SET,9,-0.16678,-0.0036916,0.30846,0.70564,GOMF_UBIQUITIN_LIGASE_INHIBITOR_ACTIVITY,0.99999
GOCC_TRANSFERASE_COMPLEX_TRA...,SET,263,-0.02619,-0.003112,0.048432,0.70566,GOCC_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,0.99999
LET_7I_5P,SET,362,-0.02455,-0.003413,0.045397,0.70567,LET_7I_5P,0.99999
GOBP_REGULATION_OF_SKELETAL_...9,SET,11,-0.13134,-0.0032138,0.24283,0.7057,GOBP_REGULATION_OF_SKELETAL_MUSCLE_SATELLITE_CELL_PROLIFERATION,0.99999
HP_ABNORMAL_RETINAL_NERVE_FI...,SET,5,-0.18864,-0.0031125,0.34867,0.70575,HP_ABNORMAL_RETINAL_NERVE_FIBER_LAYER_MORPHOLOGY,0.99999
HP_APHTHOUS_ULCER,SET,6,-0.21153,-0.0038232,0.39089,0.7058,HP_APHTHOUS_ULCER,0.99999
GOBP_VENTRICULAR_CARDIAC_MUS...3,SET,14,-0.13698,-0.0037811,0.25306,0.70585,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...11,SET,183,-0.033257,-0.0033036,0.061435,0.70586,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN,0.99999
GOBP_EMBRYONIC_SKELETAL_SYST...2,SET,89,-0.053346,-0.003705,0.09854,0.70587,GOBP_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS,0.99999
GOMF_COPPER_ION_BINDING,SET,57,-0.059696,-0.0033209,0.11021,0.70597,GOMF_COPPER_ION_BINDING,0.99999
GSE8685_IL2_STARVED_VS_IL2_A...1,SET,177,-0.033348,-0.0032584,0.061563,0.70598,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN,0.99999
REACTOME_P38MAPK_EVENTS,SET,13,-0.12941,-0.0034422,0.23885,0.70601,REACTOME_P38MAPK_EVENTS,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...6,SET,173,-0.035025,-0.0033838,0.064633,0.70606,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_UP,0.99999
GOMF_RECEPTOR_SIGNALING_PROT...,SET,3,-0.22691,-0.0029002,0.41866,0.70608,GOMF_RECEPTOR_SIGNALING_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,0.99999
BIOCARTA_TCRA_PATHWAY,SET,10,-0.14934,-0.0034843,0.27553,0.70609,BIOCARTA_TCRA_PATHWAY,0.99999
MIR1305,SET,460,-0.021853,-0.0034154,0.040318,0.7061,MIR1305,0.99999
HP_ABNORMALITY_OF_VENOUS_PHY...,SET,11,-0.14391,-0.0035214,0.26548,0.70611,HP_ABNORMALITY_OF_VENOUS_PHYSIOLOGY,0.99999
GSE29614_DAY3_VS_DAY7_TIV_FL...2,SET,143,-0.040129,-0.0035276,0.074032,0.70611,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,0.99999
GOBP_PYRUVATE_METABOLIC_PROC...,SET,109,-0.042199,-0.0032417,0.077842,0.70613,GOBP_PYRUVATE_METABOLIC_PROCESS,0.99999
HP_HIGH_HYPERMETROPIA,SET,70,-0.056963,-0.0035104,0.10507,0.70614,HP_HIGH_HYPERMETROPIA,0.99999
MIR7113_3P,SET,83,-0.047193,-0.0031658,0.087039,0.70616,MIR7113_3P,0.99999
GSE6259_FLT3L_INDUCED_VS_WT_...2,SET,165,-0.037094,-0.0035005,0.068408,0.70617,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_UP,0.99999
GOMF_OLFACTORY_RECEPTOR_ACTI...,SET,305,-0.038496,-0.0049202,0.070963,0.70626,GOMF_OLFACTORY_RECEPTOR_ACTIVITY,0.99999
HP_APLASIA_OF_THE_BLADDER,SET,5,-0.20852,-0.0034406,0.38438,0.70626,HP_APLASIA_OF_THE_BLADDER,0.99999
GOBP_NUCLEAR_TRANSPORT,SET,306,-0.024809,-0.0031759,0.045721,0.7063,GOBP_NUCLEAR_TRANSPORT,0.99999
GOBP_RESPONSE_TO_AXON_INJURY,SET,79,-0.053443,-0.003498,0.098427,0.70642,GOBP_RESPONSE_TO_AXON_INJURY,0.99999
GOBP_NUCLEAR_TRANSCRIBED_MRN...1,SET,108,-0.041329,-0.0031604,0.076094,0.70648,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS,0.99999
WAGSCHAL_EHMT2_TARGETS_UP,SET,10,-0.1523,-0.0035533,0.28012,0.70667,WAGSCHAL_EHMT2_TARGETS_UP,0.99999
REACTOME_CHK1_CHK2_CDS1_MEDI...,SET,13,-0.12303,-0.0032726,0.22629,0.70667,REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX,0.99999
MIR4790_5P,SET,13,-0.12521,-0.0033305,0.23027,0.70669,MIR4790_5P,0.99999
HP_HAND_TREMOR,SET,37,-0.074921,-0.0033598,0.13777,0.70671,HP_HAND_TREMOR,0.99999
HP_THIN_LOWER_LIP_VERMILION,SET,5,-0.23072,-0.0038068,0.42425,0.70671,HP_THIN_LOWER_LIP_VERMILION,0.99999
HP_EPISODIC_HYPOKALEMIA,SET,4,-0.2506,-0.0036983,0.46068,0.70676,HP_EPISODIC_HYPOKALEMIA,0.99999
GOBP_REGULATION_OF_DNA_BINDI...1,SET,66,-0.058195,-0.0034828,0.10698,0.70677,GOBP_REGULATION_OF_DNA_BINDING,0.99999
REACTOME_REGULATION_OF_MITF_...1,SET,18,-0.11777,-0.0036855,0.21642,0.70683,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS,0.99999
GSE369_SOCS3_KO_VS_IFNG_KO_L...2,SET,170,-0.036769,-0.0035216,0.067561,0.70686,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP,0.99999
PPARA_TARGET_GENES,SET,55,-0.057876,-0.0031629,0.10634,0.70687,PPARA_TARGET_GENES,0.99999
HP_EPIDIDYMITIS,SET,3,-0.28887,-0.0036922,0.53068,0.7069,HP_EPIDIDYMITIS,0.99999
REACTOME_REGULATION_OF_NPAS4...3,SET,9,-0.15633,-0.0034603,0.28709,0.70696,REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION,0.99999
PID_ERBB1_INTERNALIZATION_PA...,SET,40,-0.070016,-0.0032644,0.12846,0.70713,PID_ERBB1_INTERNALIZATION_PATHWAY,0.99999
GOBP_DGMP_METABOLIC_PROCESS,SET,6,-0.18899,-0.0034159,0.34657,0.70723,GOBP_DGMP_METABOLIC_PROCESS,0.99999
GOBP_SOMATIC_DIVERSIFICATION...2,SET,13,-0.1018,-0.0027077,0.18665,0.70726,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_SOMATIC_MUTATION,0.99999
GOBP_EYE_PIGMENTATION,SET,4,-0.22637,-0.0033408,0.41497,0.70729,GOBP_EYE_PIGMENTATION,0.99999
GOBP_UNSATURATED_FATTY_ACID_...2,SET,104,-0.047155,-0.0035389,0.086441,0.7073,GOBP_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS,0.99999
HP_BILATERAL_TALIPES_EQUINOV...,SET,43,-0.072475,-0.0035032,0.13281,0.70736,HP_BILATERAL_TALIPES_EQUINOVARUS,0.99999
GSE22025_PROGESTERONE_VS_TGF...1,SET,181,-0.035054,-0.0034632,0.06422,0.70741,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,0.99999
GOBP_REFLEX,SET,22,-0.099899,-0.0034559,0.183,0.70743,GOBP_REFLEX,0.99999
GOBP_VASCULAR_ASSOCIATED_SMO...5,SET,57,-0.065077,-0.0036203,0.11918,0.70747,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.99999
GOBP_GLUTAMINE_FAMILY_AMINO_...2,SET,24,-0.10054,-0.0036326,0.1841,0.7075,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,0.99999
GOBP_PROTEOLYSIS_INVOLVED_IN...,SET,696,-0.017086,-0.0032629,0.031285,0.70752,GOBP_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.99999
REACTOME_REGULATION_OF_RUNX2...,SET,69,-0.050682,-0.0031011,0.092759,0.7076,REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,0.99999
GOBP_REGULATION_OF_ORGANELLE...2,SET,1094,-0.014202,-0.0033619,0.025981,0.70769,GOBP_REGULATION_OF_ORGANELLE_ORGANIZATION,0.99999
HP_DIASTASIS_RECTI,SET,21,-0.096974,-0.0032777,0.17739,0.70769,HP_DIASTASIS_RECTI,0.99999
GSE37605_FOXP3_FUSION_GFP_VS...2,SET,174,-0.037065,-0.003591,0.067782,0.70774,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP,0.99999
GOBP_HIPPOCAMPAL_NEURON_APOP...,SET,6,-0.20863,-0.0037708,0.38146,0.70778,GOBP_HIPPOCAMPAL_NEURON_APOPTOTIC_PROCESS,0.99999
GSE45365_CTRL_VS_MCMV_INFECT...1,SET,172,-0.034546,-0.0033279,0.063164,0.70778,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN,0.99999
GOCC_PLATELET_DENSE_GRANULE_...1,SET,13,-0.12012,-0.003195,0.21962,0.70779,GOCC_PLATELET_DENSE_GRANULE_LUMEN,0.99999
GSE3982_BASOPHIL_VS_NKCELL_DN,SET,182,-0.034794,-0.0034469,0.063617,0.70779,GSE3982_BASOPHIL_VS_NKCELL_DN,0.99999
KEGG_MEDICUS_REFERENCE_LHCGR...,SET,16,-0.12484,-0.0036836,0.22824,0.7078,KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY,0.99999
HP_SPINAL_CORD_LESION,SET,41,-0.068114,-0.0032151,0.12452,0.70782,HP_SPINAL_CORD_LESION,0.99999
GOBP_CANNABINOID_SIGNALING_P...,SET,7,-0.19055,-0.0037198,0.34829,0.70784,GOBP_CANNABINOID_SIGNALING_PATHWAY,0.99999
GOBP_POLYPRENOL_METABOLIC_PR...,SET,23,-0.08721,-0.0030847,0.1594,0.70784,GOBP_POLYPRENOL_METABOLIC_PROCESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_PA...,SET,8,-0.17354,-0.0036216,0.31719,0.70785,GOBP_CELLULAR_RESPONSE_TO_PARATHYROID_HORMONE_STIMULUS,0.99999
HP_AXILLARY_PTERYGIUM,SET,9,-0.16224,-0.0035912,0.29653,0.70786,HP_AXILLARY_PTERYGIUM,0.99999
GOBP_TOOTH_ERUPTION,SET,5,-0.22472,-0.0037078,0.41047,0.70797,GOBP_TOOTH_ERUPTION,0.99999
GOMF_NEUTRAL_L_AMINO_ACID_TR...,SET,40,-0.076221,-0.0035537,0.1392,0.708,GOMF_NEUTRAL_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
WP_PROSTAGLANDIN_AND_LEUKOTR...2,SET,32,-0.085445,-0.003564,0.15586,0.70823,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,0.99999
MIR1248,SET,120,-0.043251,-0.0034851,0.078872,0.70828,MIR1248,0.99999
MIR6507_5P,SET,306,-0.027588,-0.0035317,0.050299,0.70831,MIR6507_5P,0.99999
MIR600,SET,129,-0.043223,-0.0036102,0.07879,0.70835,MIR600,0.99999
MORF_DCC,SET,99,-0.04827,-0.0035349,0.087993,0.70835,MORF_DCC,0.99999
GOCC_SIDE_OF_MEMBRANE,SET,659,-0.019765,-0.0036767,0.036027,0.70837,GOCC_SIDE_OF_MEMBRANE,0.99999
MIR449A,SET,280,-0.027019,-0.003311,0.049244,0.70838,MIR449A,0.99999
GSE8921_UNSTIM_VS_TLR1_2_STI...2,SET,183,-0.034705,-0.0034474,0.063238,0.70842,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP,0.99999
MIR1182,SET,28,-0.093719,-0.003657,0.17075,0.70845,MIR1182,0.99999
GOMF_L_GLUTAMATE_TRANSMEMBRA...,SET,14,-0.12777,-0.0035268,0.23278,0.70846,GOMF_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_HEART_FIELD_SPECIFICATI...,SET,17,-0.13666,-0.0041565,0.2488,0.7086,GOBP_HEART_FIELD_SPECIFICATION,0.99999
WP_OSTEOCLAST_SIGNALING,SET,16,-0.12035,-0.0035511,0.21907,0.70861,WP_OSTEOCLAST_SIGNALING,0.99999
JONES_OVARY_PERICYTE,SET,151,-0.039649,-0.0035808,0.072175,0.70861,JONES_OVARY_PERICYTE,0.99999
HP_PAROXYSMAL_SUPRAVENTRICUL...,SET,5,-0.22886,-0.0037761,0.41654,0.70864,HP_PAROXYSMAL_SUPRAVENTRICULAR_TACHYCARDIA,0.99999
HP_WIDENED_CEREBRAL_SUBARACH...,SET,3,-0.33034,-0.0042222,0.6011,0.70868,HP_WIDENED_CEREBRAL_SUBARACHNOID_SPACE,0.99999
GOBP_UROGENITAL_SYSTEM_DEVEL...,SET,64,-0.065143,-0.0038393,0.11852,0.70872,GOBP_UROGENITAL_SYSTEM_DEVELOPMENT,0.99999
HP_ABNORMAL_PUPIL_MORPHOLOGY,SET,66,-0.060578,-0.0036254,0.1102,0.70873,HP_ABNORMAL_PUPIL_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_BMP_SIGNA...,SET,93,-0.051591,-0.0036624,0.093838,0.70877,GOBP_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.99999
GSE21670_TGFB_VS_TGFB_AND_IL...4,SET,180,-0.034483,-0.0033974,0.062719,0.70877,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.99999
GSE40277_EOS_AND_LEF1_TRANSD...2,SET,175,-0.034982,-0.0033989,0.063623,0.70878,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,0.99999
GSE18893_CTRL_VS_TNF_TREATED...1,SET,177,-0.034991,-0.0034189,0.063635,0.70879,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN,0.99999
GSE22140_HEALTHY_VS_ARTHRITI...2,SET,175,-0.033616,-0.0032662,0.061121,0.70884,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP,0.99999
REACTOME_SYNTHESIS_OF_16_20_...,SET,9,-0.16232,-0.0035928,0.29511,0.70885,REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE,0.99999
MIR4252,SET,86,-0.051273,-0.0035008,0.093214,0.70885,MIR4252,0.99999
GOBP_ALDITOL_METABOLIC_PROCE...,SET,21,-0.10375,-0.0035068,0.18862,0.70886,GOBP_ALDITOL_METABOLIC_PROCESS,0.99999
GOCC_SCHAFFER_COLLATERAL_CA1...,SET,88,-0.051276,-0.0035413,0.093216,0.70886,GOCC_SCHAFFER_COLLATERAL_CA1_SYNAPSE,0.99999
REACTOME_REGULATION_OF_TP53_...2,SET,28,-0.086946,-0.0033927,0.15804,0.70889,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION,0.99999
GOCC_EUKARYOTIC_48S_PREINITI...,SET,13,-0.11632,-0.0030941,0.21136,0.70896,GOCC_EUKARYOTIC_48S_PREINITIATION_COMPLEX,0.99999
GOBP_NEGATIVE_REGULATION_OF_...664,SET,15,-0.12969,-0.0037054,0.23562,0.70898,GOBP_NEGATIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,0.99999
HP_ELEVATED_URINARY_3_HYDROX...,SET,5,-0.21055,-0.003474,0.38252,0.70898,HP_ELEVATED_URINARY_3_HYDROXYBUTYRIC_ACID,0.99999
GSE7509_UNSTIM_VS_TNFA_IL1B_...1,SET,80,-0.050501,-0.0033262,0.091748,0.70898,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,0.99999
WP_THERMOGENESIS,SET,105,-0.044615,-0.0033642,0.081043,0.70901,WP_THERMOGENESIS,0.99999
GSE37301_MULTIPOTENT_PROGENI...6,SET,180,-0.034271,-0.0033766,0.062255,0.70901,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,0.99999
MIR6511A_5P,SET,175,-0.035818,-0.0034801,0.065031,0.7091,MIR6511A_5P,0.99999
GOMF_TRANSLATION_FACTOR_ACTI...,SET,71,-0.050362,-0.0031256,0.091434,0.70911,GOMF_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING,0.99999
LI_AMPLIFIED_IN_LUNG_CANCER,SET,165,-0.036229,-0.0034189,0.065773,0.70912,LI_AMPLIFIED_IN_LUNG_CANCER,0.99999
HP_ABNORMALITY_OF_THE_DISTAL...6,SET,29,-0.083496,-0.0033157,0.15156,0.70915,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,0.99999
CACGTTT_MIR302A,SET,29,-0.084133,-0.003341,0.15268,0.7092,CACGTTT_MIR302A,0.99999
MIR522_3P,SET,159,-0.036575,-0.0033888,0.066362,0.70923,MIR522_3P,0.99999
GOBP_SENSORY_PERCEPTION_OF_U...,SET,7,-0.1615,-0.0031527,0.29302,0.70923,GOBP_SENSORY_PERCEPTION_OF_UMAMI_TASTE,0.99999
HP_INCREASED_LEVEL_OF_HIPPUR...,SET,5,-0.22177,-0.0036591,0.40237,0.70923,HP_INCREASED_LEVEL_OF_HIPPURIC_ACID_IN_URINE,0.99999
GOBP_REGULATION_OF_AMINO_ACI...1,SET,14,-0.13051,-0.0036025,0.23676,0.70927,GOBP_REGULATION_OF_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,0.99999
HP_ABNORMALITY_OF_HAND_JOINT...,SET,43,-0.07265,-0.0035117,0.13176,0.70931,HP_ABNORMALITY_OF_HAND_JOINT_MOBILITY,0.99999
PID_IL8_CXCR2_PATHWAY,SET,34,-0.080773,-0.0034726,0.14645,0.70936,PID_IL8_CXCR2_PATHWAY,0.99999
GSE10240_IL22_VS_IL22_AND_IL...2,SET,185,-0.033077,-0.0033035,0.059955,0.70942,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.99999
REACTOME_ASSEMBLY_OF_COLLAGE...,SET,59,-0.067,-0.0037919,0.12138,0.70952,REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,0.99999
PARK_HSC_MARKERS,SET,41,-0.071534,-0.0033765,0.12957,0.70955,PARK_HSC_MARKERS,0.99999
MIR628_5P,SET,75,-0.056838,-0.0036252,0.10295,0.70955,MIR628_5P,0.99999
KEGG_MEDICUS_REFERENCE_FGF_F...2,SET,33,-0.086704,-0.0036725,0.15704,0.70956,KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY,0.99999
GOBP_CELL_JUNCTION_DISASSEMB...,SET,27,-0.10316,-0.0039528,0.18683,0.70957,GOBP_CELL_JUNCTION_DISASSEMBLY,0.99999
GOCC_PROTON_TRANSPORTING_TWO...1,SET,26,-0.095054,-0.0035744,0.17216,0.70957,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX,0.99999
LIANG_HEMATOPOIESIS_STEM_CEL...2,SET,39,-0.074518,-0.0034307,0.1349,0.70966,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,0.99999
PID_LYSOPHOSPHOLIPID_PATHWAY,SET,63,-0.061048,-0.0035698,0.11051,0.70967,PID_LYSOPHOSPHOLIPID_PATHWAY,0.99999
HP_CRACKLES,SET,21,-0.10688,-0.0036126,0.19348,0.70967,HP_CRACKLES,0.99999
GOBP_REGULATION_OF_GLYCOGEN_...4,SET,4,-0.20828,-0.0030738,0.37693,0.70971,GOBP_REGULATION_OF_GLYCOGEN_STARCH_SYNTHASE_ACTIVITY,0.99999
GSE22033_UNTREATED_VS_ROSIGL...1,SET,176,-0.035095,-0.0034195,0.063499,0.70976,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN,0.99999
GOBP_PROTEIN_CONTAINING_COMP...3,SET,177,-0.03501,-0.0034208,0.063337,0.70978,GOBP_PROTEIN_CONTAINING_COMPLEX_LOCALIZATION,0.99999
HP_RETICULOCYTOSIS,SET,41,-0.073293,-0.0034596,0.13259,0.70979,HP_RETICULOCYTOSIS,0.99999
DESCARTES_FETAL_LIVER_HEPATO...,SET,378,-0.026153,-0.0037137,0.047312,0.70979,DESCARTES_FETAL_LIVER_HEPATOBLASTS,0.99999
BIOCARTA_MELANOCYTE_PATHWAY,SET,7,-0.20736,-0.0040481,0.37511,0.7098,BIOCARTA_MELANOCYTE_PATHWAY,0.99999
GOBP_MONOCYTE_EXTRAVASATION,SET,9,-0.16389,-0.0036276,0.29644,0.70982,GOBP_MONOCYTE_EXTRAVASATION,0.99999
HP_PANCYTOPENIA,SET,116,-0.042312,-0.0033525,0.076517,0.70986,HP_PANCYTOPENIA,0.99999
chr3p11,SET,7,-0.25253,-0.0049299,0.45666,0.70987,chr3p11,0.99999
GOBP_GENITALIA_DEVELOPMENT,SET,46,-0.07445,-0.0037218,0.1346,0.70991,GOBP_GENITALIA_DEVELOPMENT,0.99999
OLSSON_E2F3_TARGETS_DN,SET,33,-0.088227,-0.003737,0.1595,0.70992,OLSSON_E2F3_TARGETS_DN,0.99999
GOBP_RESPONSE_TO_PLATELET_DE...,SET,19,-0.11298,-0.0036324,0.2042,0.70995,GOBP_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR,0.99999
GSE3982_EOSINOPHIL_VS_NEUTRO...2,SET,179,-0.032383,-0.0031817,0.058532,0.70995,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP,0.99999
LIM_MAMMARY_STEM_CELL_UP,SET,429,-0.023966,-0.0036202,0.04331,0.70998,LIM_MAMMARY_STEM_CELL_UP,0.99999
AMIT_SERUM_RESPONSE_120_MCF1...,SET,63,-0.059984,-0.0035076,0.10837,0.71003,AMIT_SERUM_RESPONSE_120_MCF10A,0.99999
GSE46606_IRF4_KO_VS_WT_CD40L...3,SET,169,-0.034236,-0.0032694,0.061848,0.71005,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN,0.99999
GOBP_REGULATION_OF_LIPID_TRA...2,SET,4,-0.27316,-0.0040313,0.49339,0.71008,GOBP_REGULATION_OF_LIPID_TRANSPORTER_ACTIVITY,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...4,SET,38,-0.072178,-0.0032802,0.13037,0.71009,BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,0.99999
GOCC_SPINDLE_POLE,SET,162,-0.035941,-0.003361,0.064904,0.71012,GOCC_SPINDLE_POLE,0.99999
GSE5679_PPARG_LIGAND_ROSIGLI...1,SET,184,-0.033358,-0.0033226,0.060232,0.71015,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN,0.99999
HP_ABNORMALITY_OF_THE_THORAC...,SET,46,-0.070033,-0.003501,0.12641,0.71021,HP_ABNORMALITY_OF_THE_THORACIC_CAVITY,0.99999
GOBP_REGULATION_OF_CELL_MATR...,SET,115,-0.043856,-0.0034599,0.079151,0.71023,GOBP_REGULATION_OF_CELL_MATRIX_ADHESION,0.99999
GSE13485_DAY7_VS_DAY21_YF17D...1,SET,141,-0.040867,-0.0035675,0.073757,0.71023,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.99999
HP_ABNORMAL_HAIR_QUANTITY,SET,757,-0.017058,-0.0033914,0.030775,0.7103,HP_ABNORMAL_HAIR_QUANTITY,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...3,SET,16,-0.11207,-0.0033069,0.20218,0.71031,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN,0.99999
HP_ABNORMAL_ADIPOSE_TISSUE_M...,SET,214,-0.032003,-0.0034348,0.057724,0.71035,HP_ABNORMAL_ADIPOSE_TISSUE_MORPHOLOGY,0.99999
GOBP_PROTEIN_REPAIR,SET,7,-0.16253,-0.0031728,0.29302,0.71043,GOBP_PROTEIN_REPAIR,0.99999
KEGG_MEDICUS_REFERENCE_COHES...2,SET,15,-0.11423,-0.0032637,0.2059,0.71048,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_ANAPHASE,0.99999
HP_CHOLESTATIC_LIVER_DISEASE,SET,16,-0.12327,-0.0036373,0.22211,0.71055,HP_CHOLESTATIC_LIVER_DISEASE,0.99999
MODULE_402,SET,12,-0.1498,-0.0038283,0.26989,0.71056,MODULE_402,0.99999
TAXCREB_01,SET,121,-0.042387,-0.0034296,0.076349,0.71061,TAXCREB_01,0.99999
GOBP_REGULATION_OF_GASTRULAT...,SET,15,-0.10717,-0.003062,0.19304,0.71061,GOBP_REGULATION_OF_GASTRULATION,0.99999
GOMF_UBIQUINOL_CYTOCHROME_C_...,SET,5,-0.16214,-0.0026753,0.29187,0.71073,GOMF_UBIQUINOL_CYTOCHROME_C_REDUCTASE_ACTIVITY,0.99999
HP_ABNORMAL_UPPER_LIMB_METAP...,SET,15,-0.14056,-0.0040159,0.253,0.71074,HP_ABNORMAL_UPPER_LIMB_METAPHYSIS_MORPHOLOGY,0.99999
DESCARTES_MAIN_FETAL_CLC_IL5...,SET,151,-0.03653,-0.0032991,0.065742,0.71077,DESCARTES_MAIN_FETAL_CLC_IL5RA_POSITIVE_CELLS,0.99999
HP_B_LYMPHOCYTOPENIA,SET,53,-0.064869,-0.0034802,0.11674,0.71078,HP_B_LYMPHOCYTOPENIA,0.99999
MIR4669,SET,10,-0.1272,-0.0029678,0.2289,0.71079,MIR4669,0.99999
GSE3982_DC_VS_NEUTROPHIL_UP,SET,181,-0.034493,-0.0034078,0.062067,0.7108,GSE3982_DC_VS_NEUTROPHIL_UP,0.99999
GNF2_BUB1,SET,26,-0.088106,-0.0033131,0.15848,0.71087,GNF2_BUB1,0.99999
HP_FEMALE_SEXUAL_DYSFUNCTION,SET,61,-0.061703,-0.0035506,0.11097,0.7109,HP_FEMALE_SEXUAL_DYSFUNCTION,0.99999
HP_GENERALIZED_ICHTHYOSIS,SET,4,-0.22072,-0.0032575,0.39675,0.711,HP_GENERALIZED_ICHTHYOSIS,0.99999
GOBP_POSTSYNAPTIC_CYTOSKELET...,SET,17,-0.12238,-0.0037221,0.21993,0.71104,GOBP_POSTSYNAPTIC_CYTOSKELETON_ORGANIZATION,0.99999
MODULE_385,SET,27,-0.098721,-0.0037829,0.1774,0.71106,MODULE_385,0.99999
GOBP_REGULATION_OF_TRANSPORT,SET,1447,-0.013087,-0.0035262,0.023515,0.71108,GOBP_REGULATION_OF_TRANSPORT,0.99999
YANG_BREAST_CANCER_ESR1_LASE...2,SET,27,-0.087285,-0.0033447,0.15682,0.71109,YANG_BREAST_CANCER_ESR1_LASER_UP,0.99999
AAAYRNCTG_UNKNOWN,SET,323,-0.027103,-0.003563,0.048695,0.71109,AAAYRNCTG_UNKNOWN,0.99999
GOMF_DEAD_H_BOX_RNA_HELICASE...,SET,8,-0.18977,-0.0039603,0.34094,0.7111,GOMF_DEAD_H_BOX_RNA_HELICASE_BINDING,0.99999
MIR892B,SET,71,-0.057028,-0.0035394,0.10245,0.71111,MIR892B,0.99999
BIOCARTA_REELIN_PATHWAY,SET,7,-0.18666,-0.0036438,0.33517,0.7112,BIOCARTA_REELIN_PATHWAY,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_SCH...,SET,214,-0.031505,-0.0033814,0.056566,0.71122,HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL,0.99999
GSE15324_NAIVE_VS_ACTIVATED_...2,SET,171,-0.034996,-0.0033616,0.062802,0.71132,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,0.99999
GOBP_OSTEOBLAST_DEVELOPMENT,SET,16,-0.12166,-0.0035897,0.2183,0.71134,GOBP_OSTEOBLAST_DEVELOPMENT,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...7,SET,21,-0.099406,-0.0033599,0.17835,0.71136,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,0.99999
HP_EEG_WITH_BURST_SUPPRESSION,SET,56,-0.060332,-0.0033268,0.10816,0.7115,HP_EEG_WITH_BURST_SUPPRESSION,0.99999
GAUTAM_EYE_CORNEA_MONOCYTES,SET,218,-0.030641,-0.0033189,0.054933,0.7115,GAUTAM_EYE_CORNEA_MONOCYTES,0.99999
REACTOME_DIFFERENTIATION_OF_...,SET,37,-0.082627,-0.0037054,0.14812,0.71152,REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN,0.99999
MIR1282,SET,10,-0.14901,-0.0034766,0.26709,0.71154,MIR1282,0.99999
PIAS4_TARGET_GENES,SET,49,-0.066754,-0.0034439,0.11963,0.71157,PIAS4_TARGET_GENES,0.99999
LET_7D_3P,SET,8,-0.17998,-0.003756,0.32248,0.71161,LET_7D_3P,0.99999
GOMF_CHLORIDE_ION_BINDING,SET,9,-0.17756,-0.0039302,0.31814,0.71162,GOMF_CHLORIDE_ION_BINDING,0.99999
HP_CONSPICUOUSLY_HAPPY_DISPO...,SET,5,-0.27068,-0.0044662,0.48499,0.71162,HP_CONSPICUOUSLY_HAPPY_DISPOSITION,0.99999
KEGG_MEDICUS_REFERENCE_INACT...,SET,6,-0.16473,-0.0029773,0.29512,0.71164,KEGG_MEDICUS_REFERENCE_INACTIVATION_OF_CONDENSIN_I,0.99999
GOBP_TELOMERE_LOCALIZATION,SET,8,-0.14192,-0.0029618,0.25417,0.7117,GOBP_TELOMERE_LOCALIZATION,0.99999
GSE14413_UNSTIM_VS_IFNB_STIM...4,SET,129,-0.040068,-0.0033467,0.071744,0.71174,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP,0.99999
GOMF_ENDONUCLEASE_ACTIVITY_A...1,SET,15,-0.11569,-0.0033053,0.20714,0.71175,GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS,0.99999
HP_INTRACEREBRAL_PERIVENTRIC...,SET,6,-0.18291,-0.003306,0.32743,0.71179,HP_INTRACEREBRAL_PERIVENTRICULAR_CALCIFICATIONS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...456,SET,10,-0.15216,-0.0035501,0.27236,0.71181,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.99999
GOCC_CONDENSED_NUCLEAR_CHROM...,SET,70,-0.05345,-0.003294,0.095673,0.71181,GOCC_CONDENSED_NUCLEAR_CHROMOSOME,0.99999
GOBP_DOPAMINE_METABOLIC_PROC...,SET,33,-0.087095,-0.003689,0.15581,0.71191,GOBP_DOPAMINE_METABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...763,SET,6,-0.2049,-0.0037033,0.36653,0.71192,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.99999
HP_SEVERE_B_LYMPHOCYTOPENIA,SET,6,-0.17832,-0.003223,0.319,0.71192,HP_SEVERE_B_LYMPHOCYTOPENIA,0.99999
HP_OROFACIAL_DYSKINESIA,SET,24,-0.092507,-0.0033423,0.16546,0.71195,HP_OROFACIAL_DYSKINESIA,0.99999
GSE27859_MACROPHAGE_VS_CD11C...2,SET,158,-0.036022,-0.0033271,0.064425,0.71196,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,0.99999
REACTOME_REGULATION_OF_PTEN_...1,SET,57,-0.059248,-0.003296,0.10595,0.71198,REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION,0.99999
WU_HBX_TARGETS_3_DN,SET,13,-0.13849,-0.0036836,0.2476,0.71202,WU_HBX_TARGETS_3_DN,0.99999
REACTOME_CELLULAR_HEXOSE_TRA...,SET,18,-0.11371,-0.0035587,0.20328,0.71205,REACTOME_CELLULAR_HEXOSE_TRANSPORT,0.99999
MIR6080,SET,42,-0.074478,-0.003558,0.13314,0.71205,MIR6080,0.99999
GOBP_PROSTATE_GLANDULAR_ACIN...2,SET,6,-0.20284,-0.0036661,0.3626,0.71205,GOBP_PROSTATE_GLANDULAR_ACINUS_MORPHOGENESIS,0.99999
HP_IMPAIRED_MYOCARDIAL_CONTR...,SET,8,-0.18152,-0.0037881,0.32449,0.71205,HP_IMPAIRED_MYOCARDIAL_CONTRACTILITY,0.99999
GOBP_MICROTUBULE_ORGANIZING_...2,SET,143,-0.037393,-0.0032871,0.066841,0.71207,GOBP_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION,0.99999
GOBP_REGULATORY_NCRNA_MEDIAT...1,SET,112,-0.042229,-0.003288,0.075483,0.71207,GOBP_REGULATORY_NCRNA_MEDIATED_GENE_SILENCING,0.99999
GOBP_ENDOTHELIAL_CELL_ACTIVA...,SET,9,-0.17991,-0.0039821,0.32152,0.7121,GOBP_ENDOTHELIAL_CELL_ACTIVATION,0.99999
GSE37301_PRO_BCELL_VS_GRANUL...2,SET,132,-0.041568,-0.0035118,0.074239,0.71223,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.99999
WP_MET_IN_TYPE_1_PAPILLARY_R...,SET,53,-0.064818,-0.0034775,0.11576,0.71224,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,0.99999
KEGG_MEDICUS_PATHOGEN_YERSIN...2,SET,6,-0.21808,-0.0039415,0.38941,0.71226,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.99999
GARCIA_PINERES_PBMC_HPV_16_L...6,SET,20,-0.11213,-0.0036987,0.20014,0.71234,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE,0.99999
MODULE_178,SET,15,-0.13932,-0.0039805,0.24865,0.71236,MODULE_178,0.99999
NAKAMURA_ADIPOGENESIS_EARLY_...1,SET,33,-0.086926,-0.0036819,0.1551,0.71241,NAKAMURA_ADIPOGENESIS_EARLY_DN,0.99999
HP_BREAST_HYPOPLASIA,SET,42,-0.078002,-0.0037264,0.13916,0.71244,HP_BREAST_HYPOPLASIA,0.99999
GOBP_INFLAMMATORY_RESPONSE_T...2,SET,24,-0.10323,-0.0037298,0.18412,0.71249,GOBP_INFLAMMATORY_RESPONSE_TO_WOUNDING,0.99999
KEGG_MEDICUS_REFERENCE_STERO...,SET,5,-0.22613,-0.0037311,0.40328,0.7125,KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE,0.99999
HP_CLITORAL_HYPOPLASIA,SET,26,-0.09802,-0.0036859,0.17475,0.71257,HP_CLITORAL_HYPOPLASIA,0.99999
GSE3691_IFN_PRODUCING_KILLER...3,SET,176,-0.03543,-0.0034521,0.063161,0.71258,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN,0.99999
WP_IL1_SIGNALING,SET,52,-0.066642,-0.0035415,0.11879,0.7126,WP_IL1_SIGNALING,0.99999
GOBP_POSITIVE_REGULATION_OF_...842,SET,6,-0.16438,-0.002971,0.29282,0.71272,GOBP_POSITIVE_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...8,SET,178,-0.035857,-0.0035133,0.063876,0.71272,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP,0.99999
HP_CONGENITAL_STATIONARY_NIG...,SET,18,-0.11587,-0.0036262,0.2064,0.71273,HP_CONGENITAL_STATIONARY_NIGHT_BLINDNESS,0.99999
GOBP_SCF_DEPENDENT_PROTEASOM...,SET,43,-0.073238,-0.0035401,0.13044,0.71276,GOBP_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...642,SET,682,-0.018592,-0.003516,0.033111,0.71277,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.99999
GOBP_SUCCINATE_TRANSMEMBRANE...,SET,6,-0.19852,-0.0035882,0.35354,0.71278,GOBP_SUCCINATE_TRANSMEMBRANE_TRANSPORT,0.99999
GOMF_SUCCINATE_TRANSMEMBRANE...,SET,6,-0.19852,-0.0035882,0.35354,0.71278,GOMF_SUCCINATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE27786_LSK_VS_NKTCELL_DN,SET,173,-0.03436,-0.0033195,0.061163,0.71286,GSE27786_LSK_VS_NKTCELL_DN,0.99999
GOMF_DINUCLEOTIDE_PHOSPHATAS...,SET,7,-0.19795,-0.0038643,0.35231,0.71289,GOMF_DINUCLEOTIDE_PHOSPHATASE_ACTIVITY,0.99999
GSE17721_4_VS_24H_GARDIQUIMO...2,SET,179,-0.035347,-0.003473,0.062909,0.71289,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_UP,0.99999
KEGG_MEDICUS_VARIANT_ERBB2_O...2,SET,12,-0.1357,-0.0034679,0.2415,0.7129,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,0.99999
MIR4456,SET,119,-0.042265,-0.0033915,0.075207,0.71293,MIR4456,0.99999
GOBP_ENDOCARDIAL_CUSHION_DEV...,SET,52,-0.075241,-0.0039985,0.13388,0.71294,GOBP_ENDOCARDIAL_CUSHION_DEVELOPMENT,0.99999
HP_BILATERAL_CAMPTODACTYLY,SET,5,-0.19921,-0.0032869,0.35447,0.71294,HP_BILATERAL_CAMPTODACTYLY,0.99999
IWANAGA_CARCINOGENESIS_BY_KR...3,SET,169,-0.035674,-0.0034067,0.063474,0.71295,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,0.99999
REACTOME_CROSS_PRESENTATION_...1,SET,6,-0.20595,-0.0037223,0.36643,0.71295,REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES,0.99999
HP_UNILATERAL_CLEFT_PALATE,SET,18,-0.11818,-0.0036983,0.21024,0.71297,HP_UNILATERAL_CLEFT_PALATE,0.99999
MIR21_3P,SET,122,-0.04453,-0.0036178,0.079217,0.71298,MIR21_3P,0.99999
GOBP_CELLULAR_DEFENSE_RESPON...,SET,47,-0.072459,-0.0036613,0.1289,0.71299,GOBP_CELLULAR_DEFENSE_RESPONSE,0.99999
SOX10_TARGET_GENES,SET,205,-0.033216,-0.0034901,0.059069,0.71305,SOX10_TARGET_GENES,0.99999
WP_VITAMIN_B6DEPENDENT_AND_R...,SET,6,-0.19485,-0.0035217,0.34644,0.71308,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,0.99999
GOBP_DORSAL_VENTRAL_NEURAL_T...,SET,16,-0.11997,-0.00354,0.21328,0.71311,GOBP_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,0.99999
GOBP_REGULATION_OF_CENTROSOM...,SET,52,-0.062933,-0.0033444,0.11185,0.71316,GOBP_REGULATION_OF_CENTROSOME_CYCLE,0.99999
GOBP_ORGANIC_CATION_TRANSPORT,SET,108,-0.048832,-0.0037341,0.086779,0.71318,GOBP_ORGANIC_CATION_TRANSPORT,0.99999
HP_HEMIATROPHY,SET,4,-0.21739,-0.0032084,0.38623,0.71323,HP_HEMIATROPHY,0.99999
BIOCARTA_CTBP1_PATHWAY,SET,8,-0.14539,-0.0030342,0.2583,0.71324,BIOCARTA_CTBP1_PATHWAY,0.99999
GOBP_RETINOL_METABOLIC_PROCE...,SET,50,-0.072875,-0.0037977,0.12946,0.71325,GOBP_RETINOL_METABOLIC_PROCESS,0.99999
REACTOME_SIGNALING_BY_LEPTIN,SET,11,-0.1739,-0.0042552,0.3089,0.71327,REACTOME_SIGNALING_BY_LEPTIN,0.99999
GOBP_PURINERGIC_NUCLEOTIDE_R...,SET,27,-0.10307,-0.0039497,0.18308,0.71328,GOBP_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOMF_HISTONE_H3K9ME2_METHYLT...,SET,7,-0.16906,-0.0033003,0.30022,0.71331,GOMF_HISTONE_H3K9ME2_METHYLTRANSFERASE_ACTIVITY,0.99999
GOBP_CENTROSOME_SEPARATION,SET,16,-0.10912,-0.0032199,0.19377,0.71333,GOBP_CENTROSOME_SEPARATION,0.99999
GOBP_MITOCHONDRION_ENDOPLASM...,SET,7,-0.16345,-0.0031909,0.29016,0.71339,GOBP_MITOCHONDRION_ENDOPLASMIC_RETICULUM_MEMBRANE_TETHERING,0.99999
CHIARADONNA_NEOPLASTIC_TRANS...1,SET,135,-0.04113,-0.0035138,0.073002,0.71342,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,0.99999
GOBP_HEMATOPOIETIC_STEM_CELL...4,SET,5,-0.1899,-0.0031333,0.33704,0.71343,GOBP_HEMATOPOIETIC_STEM_CELL_MIGRATION_TO_BONE_MARROW,0.99999
GSE25123_WT_VS_PPARG_KO_MACR...2,SET,163,-0.036728,-0.0034452,0.065173,0.71347,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...1,SET,179,-0.035263,-0.0034648,0.062566,0.71349,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.99999
HP_ABDOMINAL_OBESITY,SET,24,-0.099221,-0.0035849,0.17604,0.7135,HP_ABDOMINAL_OBESITY,0.99999
HP_ORAL_CAVITY_BLEEDING,SET,19,-0.11849,-0.0038096,0.21018,0.71353,HP_ORAL_CAVITY_BLEEDING,0.99999
MIR3923,SET,45,-0.068177,-0.0033711,0.12091,0.71357,MIR3923,0.99999
HP_ACANTHOLYSIS,SET,10,-0.14792,-0.0034512,0.26228,0.71361,HP_ACANTHOLYSIS,0.99999
HP_BITEMPORAL_HEMIANOPIA,SET,16,-0.10797,-0.0031858,0.19141,0.71364,HP_BITEMPORAL_HEMIANOPIA,0.99999
MIKKELSEN_DEDIFFERENTIATED_S...1,SET,7,-0.20159,-0.0039354,0.35716,0.71377,MIKKELSEN_DEDIFFERENTIATED_STATE_DN,0.99999
MODULE_458,SET,31,-0.086792,-0.0035632,0.15376,0.71378,MODULE_458,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...3,SET,8,-0.17002,-0.0035481,0.30108,0.71385,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_CARDIAC_CHAMBER_DEVELOP...,SET,162,-0.040602,-0.0037969,0.071884,0.7139,GOBP_CARDIAC_CHAMBER_DEVELOPMENT,0.99999
GOBP_SERTOLI_CELL_PROLIFERAT...,SET,5,-0.22662,-0.0037392,0.40122,0.7139,GOBP_SERTOLI_CELL_PROLIFERATION,0.99999
HP_NEOPLASM_OF_THE_TRACHEOBR...,SET,19,-0.11,-0.0035368,0.19473,0.71392,HP_NEOPLASM_OF_THE_TRACHEOBRONCHIAL_SYSTEM,0.99999
GOMF_DNA_TOPOISOMERASE_ACTIV...,SET,7,-0.15605,-0.0030463,0.2762,0.71396,GOMF_DNA_TOPOISOMERASE_ACTIVITY,0.99999
GOBP_RNA_IMPORT_INTO_MITOCHO...,SET,5,-0.15871,-0.0026187,0.28081,0.71403,GOBP_RNA_IMPORT_INTO_MITOCHONDRION,0.99999
MIR6504_3P,SET,342,-0.026506,-0.0035836,0.046884,0.71408,MIR6504_3P,0.99999
GOCC_LIPID_DROPLET,SET,91,-0.050664,-0.0035579,0.089598,0.71412,GOCC_LIPID_DROPLET,0.99999
GOBP_PROTEIN_IMPORT_INTO_PER...3,SET,4,-0.22387,-0.0033039,0.39587,0.71413,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX_SUBSTRATE_RELEASE,0.99999
HP_CHRONIC_HEPATIC_FAILURE,SET,14,-0.11789,-0.003254,0.20843,0.71416,HP_CHRONIC_HEPATIC_FAILURE,0.99999
MIR664A_3P,SET,359,-0.02602,-0.0036027,0.045988,0.71424,MIR664A_3P,0.99999
VAN_DEN_BIGGELAAR_PBMC_PREVN...3,SET,102,-0.045486,-0.0033808,0.080385,0.71425,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP,0.99999
HP_ABNORMAL_ENCHONDRAL_OSSIF...,SET,126,-0.042609,-0.0035175,0.075282,0.71429,HP_ABNORMAL_ENCHONDRAL_OSSIFICATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...166,SET,27,-0.082782,-0.0031721,0.14624,0.71432,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,0.99999
GSE6259_FLT3L_INDUCED_33D1_P...6,SET,134,-0.041555,-0.003537,0.073412,0.71432,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_UP,0.99999
GSE14415_ACT_VS_CTRL_NATURAL...2,SET,157,-0.036905,-0.003398,0.065182,0.71436,GSE14415_ACT_VS_CTRL_NATURAL_TREG_UP,0.99999
HP_CERVICAL_RIBS,SET,10,-0.14012,-0.0032691,0.24745,0.71439,HP_CERVICAL_RIBS,0.99999
SCHERER_PBMC_YF_VAX_AGE_18_4...1,SET,221,-0.031242,-0.0034069,0.05517,0.7144,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN,0.99999
MIR6509_5P,SET,88,-0.051806,-0.0035779,0.091464,0.71444,MIR6509_5P,0.99999
MORF_RAD23B,SET,158,-0.034699,-0.0032049,0.061244,0.71449,MORF_RAD23B,0.99999
GOBP_NEGATIVE_REGULATION_OF_...539,SET,4,-0.24386,-0.0035989,0.43037,0.71451,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.99999
KRAS.PROSTATE_UP.V1_DN,SET,124,-0.045435,-0.0037212,0.080187,0.71451,KRAS.PROSTATE_UP.V1_DN,0.99999
WANG_RECURRENT_LIVER_CANCER_...2,SET,16,-0.1184,-0.0034936,0.20892,0.71455,WANG_RECURRENT_LIVER_CANCER_UP,0.99999
REACTOME_TRNA_PROCESSING_IN_...1,SET,3,-0.26464,-0.0033824,0.46695,0.71455,REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION,0.99999
HP_THIN_VERMILION_BORDER,SET,346,-0.025282,-0.0034378,0.044611,0.71455,HP_THIN_VERMILION_BORDER,0.99999
HP_PROPORTIONATE_TALL_STATURE,SET,14,-0.12395,-0.0034213,0.21858,0.71466,HP_PROPORTIONATE_TALL_STATURE,0.99999
GR_01,SET,183,-0.036196,-0.0035956,0.063823,0.71469,GR_01,0.99999
GSE32255_UNSTIM_VS_4H_LPS_ST...1,SET,140,-0.040181,-0.0034952,0.07084,0.71471,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_DN,0.99999
GOBP_REGULATION_OF_TRANSLATI...11,SET,8,-0.15574,-0.0032501,0.27455,0.71472,GOBP_REGULATION_OF_TRANSLATION_INITIATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.99999
REACTOME_COBALAMIN_CBL_VITAM...,SET,20,-0.10897,-0.0035944,0.19201,0.71482,REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM,0.99999
GOBP_REGULATION_OF_CELLULAR_...14,SET,6,-0.22078,-0.0039903,0.3888,0.71493,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS,0.99999
GOBP_POSITIVE_REGULATION_OF_...165,SET,99,-0.044856,-0.0032849,0.07897,0.71498,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...2,SET,9,-0.17357,-0.0038418,0.30553,0.71501,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15,0.99999
GSE28737_WT_VS_BCL6_KO_MARGI...1,SET,174,-0.035281,-0.0034183,0.062106,0.71501,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,0.99999
REACTOME_LRR_FLII_INTERACTIN...,SET,5,-0.1953,-0.0032223,0.34377,0.71502,REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION,0.99999
VAN_DEN_BIGGELAAR_PBMC_PREVN...1,SET,62,-0.062028,-0.0035983,0.10918,0.71502,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_8MO_UP,0.99999
REACTOME_NOTCH3_INTRACELLULA...,SET,24,-0.097463,-0.0035214,0.17155,0.71503,REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.99999
GOCC_ALVEOLAR_LAMELLAR_BODY,SET,8,-0.17409,-0.003633,0.30639,0.71504,GOCC_ALVEOLAR_LAMELLAR_BODY,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...4,SET,184,-0.036501,-0.0036356,0.064227,0.71508,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_UP,0.99999
GOBP_MONOCYTE_CHEMOTAXIS,SET,47,-0.074318,-0.0037553,0.13076,0.7151,GOBP_MONOCYTE_CHEMOTAXIS,0.99999
MIR4699_3P,SET,440,-0.023636,-0.0036148,0.041563,0.71521,MIR4699_3P,0.99999
GOCC_CARDIAC_MYOFIBRIL,SET,6,-0.20094,-0.0036318,0.35327,0.71525,GOCC_CARDIAC_MYOFIBRIL,0.99999
GSE14415_ACT_TCONV_VS_ACT_NA...1,SET,164,-0.038223,-0.0035963,0.067194,0.71526,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN,0.99999
CHIARADONNA_NEOPLASTIC_TRANS...2,SET,102,-0.04917,-0.0036547,0.086437,0.71527,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,0.99999
ATF2_S_UP.V1_DN,SET,168,-0.03833,-0.0036496,0.067373,0.71529,ATF2_S_UP.V1_DN,0.99999
GOBP_NEPHRON_TUBULE_FORMATION,SET,18,-0.129,-0.0040371,0.22668,0.71535,GOBP_NEPHRON_TUBULE_FORMATION,0.99999
GOBP_RESPONSE_TO_MOLECULE_OF...1,SET,326,-0.028338,-0.0037423,0.049777,0.71542,GOBP_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,0.99999
GOBP_ESTABLISHMENT_OF_SISTER...,SET,7,-0.22977,-0.0044855,0.40349,0.71547,GOBP_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,0.99999
MIR6720_5P,SET,123,-0.041977,-0.0034242,0.073697,0.71552,MIR6720_5P,0.99999
WP_G13_SIGNALING,SET,35,-0.081768,-0.0035666,0.14352,0.71557,WP_G13_SIGNALING,0.99999
HP_ABNORMAL_HEMATOCRIT,SET,11,-0.14365,-0.0035151,0.25211,0.71559,HP_ABNORMAL_HEMATOCRIT,0.99999
HP_CUTIS_MARMORATA,SET,60,-0.063294,-0.0036123,0.11106,0.71562,HP_CUTIS_MARMORATA,0.99999
GOCC_HFE_TRANSFERRIN_RECEPTO...,SET,7,-0.18472,-0.003606,0.32395,0.71572,GOCC_HFE_TRANSFERRIN_RECEPTOR_COMPLEX,0.99999
GOMF_SECONDARY_ACTIVE_SULFAT...,SET,11,-0.14684,-0.0035929,0.25743,0.71579,GOMF_SECONDARY_ACTIVE_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_PEPTIDYL_LYSINE_DEACETY...,SET,5,-0.21347,-0.0035222,0.37415,0.71584,GOBP_PEPTIDYL_LYSINE_DEACETYLATION,0.99999
GNF2_KPNB1,SET,65,-0.055175,-0.0032771,0.096681,0.71589,GNF2_KPNB1,0.99999
HP_PAROXYSMAL_DYSTONIA,SET,20,-0.1091,-0.0035989,0.19118,0.71589,HP_PAROXYSMAL_DYSTONIA,0.99999
GSE22025_TGFB1_VS_TGFB1_AND_...2,SET,179,-0.036175,-0.0035544,0.063387,0.7159,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.99999
MAX_01,SET,240,-0.030633,-0.0034793,0.053673,0.71591,MAX_01,0.99999
GOBP_TRANSLATIONAL_READTHROU...,SET,8,-0.18368,-0.0038333,0.32183,0.71591,GOBP_TRANSLATIONAL_READTHROUGH,0.99999
GOBP_BONE_GROWTH,SET,31,-0.08846,-0.0036317,0.15494,0.71598,GOBP_BONE_GROWTH,0.99999
GOMF_TBP_CLASS_PROTEIN_BINDI...,SET,23,-0.10373,-0.003669,0.18168,0.71598,GOMF_TBP_CLASS_PROTEIN_BINDING,0.99999
REACTOME_GLUTAMATE_NEUROTRAN...,SET,23,-0.10973,-0.0038814,0.19217,0.716,REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE,0.99999
GOBP_PROTEIN_DEPOLYMERIZATION,SET,108,-0.043929,-0.0033592,0.076934,0.716,GOBP_PROTEIN_DEPOLYMERIZATION,0.99999
KEGG_MEDICUS_REFERENCE_TGFA_...1,SET,9,-0.16561,-0.0036657,0.28997,0.71604,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY,0.99999
HP_TRACTIONAL_RETINAL_DETACH...,SET,7,-0.16348,-0.0031914,0.28623,0.71604,HP_TRACTIONAL_RETINAL_DETACHMENT,0.99999
WU_ALZHEIMER_DISEASE_UP,SET,9,-0.16357,-0.0036205,0.28635,0.71607,WU_ALZHEIMER_DISEASE_UP,0.99999
BIOCARTA_MAPK_PATHWAY,SET,79,-0.054196,-0.0035473,0.094879,0.71607,BIOCARTA_MAPK_PATHWAY,0.99999
GOMF_ORGANOPHOSPHATE_PHOSPHA...,SET,7,-0.18012,-0.0035162,0.3153,0.71608,GOMF_ORGANOPHOSPHATE_PHOSPHATE_ANTIPORTER_ACTIVITY,0.99999
GOBP_REGULATION_OF_ATRIAL_CA...1,SET,9,-0.19211,-0.0042522,0.33625,0.71611,GOBP_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION,0.99999
CASP8AP2_TARGET_GENES,SET,262,-0.029208,-0.003464,0.051116,0.71613,CASP8AP2_TARGET_GENES,0.99999
QIU_PBMC_HEPTATITIS_B_SURFAC...6,SET,13,-0.15213,-0.0040464,0.26612,0.71621,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_3DY_UP,0.99999
DESCARTES_FETAL_PLACENTA_LYM...,SET,114,-0.048403,-0.0038021,0.084646,0.71628,DESCARTES_FETAL_PLACENTA_LYMPHOID_CELLS,0.99999
GOBP_SPERM_EJACULATION,SET,6,-0.21581,-0.0039005,0.37729,0.71633,GOBP_SPERM_EJACULATION,0.99999
HP_MENINGOCELE,SET,53,-0.068074,-0.0036521,0.11901,0.71634,HP_MENINGOCELE,0.99999
GSE12505_WT_VS_E2_2_HET_PDC_...2,SET,119,-0.044691,-0.0035862,0.078108,0.71639,GSE12505_WT_VS_E2_2_HET_PDC_UP,0.99999
GOBP_SEQUESTERING_OF_EXTRACE...,SET,10,-0.17457,-0.0040729,0.30509,0.7164,GOBP_SEQUESTERING_OF_EXTRACELLULAR_LIGAND_FROM_RECEPTOR,0.99999
REACTOME_PROSTACYCLIN_SIGNAL...,SET,19,-0.11794,-0.003792,0.20607,0.71645,REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR,0.99999
HP_ABNORMAL_LOWER_MOTOR_NEUR...,SET,26,-0.086789,-0.0032636,0.15161,0.71649,HP_ABNORMAL_LOWER_MOTOR_NEURON_MORPHOLOGY,0.99999
CACCAGC_MIR138,SET,208,-0.03466,-0.0036681,0.06054,0.71651,CACCAGC_MIR138,0.99999
HP_ERYTHEMA,SET,106,-0.046612,-0.0035314,0.081409,0.71653,HP_ERYTHEMA,0.99999
TTTGTAG_MIR520D,SET,311,-0.028297,-0.0036515,0.049418,0.71654,TTTGTAG_MIR520D,0.99999
GOCC_MEIOTIC_SPINDLE,SET,12,-0.14849,-0.0037948,0.2593,0.71655,GOCC_MEIOTIC_SPINDLE,0.99999
FIGUEROA_AML_METHYLATION_CLU...4,SET,47,-0.071729,-0.0036244,0.12525,0.71657,FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...104,SET,205,-0.03368,-0.0035388,0.058789,0.71664,GOBP_POSITIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.99999
TAKAO_RESPONSE_TO_UVB_RADIAT...1,SET,87,-0.050639,-0.0034775,0.088354,0.71672,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,0.99999
REACTOME_GLUCONEOGENESIS,SET,21,-0.096473,-0.0032608,0.16828,0.71677,REACTOME_GLUCONEOGENESIS,0.99999
GOBP_REGULATION_OF_VASCULOGE...,SET,15,-0.12984,-0.0037096,0.22647,0.71678,GOBP_REGULATION_OF_VASCULOGENESIS,0.99999
HP_EURYBLEPHARON,SET,9,-0.16441,-0.003639,0.28671,0.71682,HP_EURYBLEPHARON,0.99999
SWEET_KRAS_TARGETS_UP,SET,74,-0.060954,-0.0038618,0.10629,0.71683,SWEET_KRAS_TARGETS_UP,0.99999
USF2_Q6,SET,246,-0.031924,-0.0036704,0.055657,0.71687,USF2_Q6,0.99999
NIKOLSKY_BREAST_CANCER_20Q12...,SET,136,-0.079478,-0.0068148,0.13855,0.71689,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,0.99999
HP_ABNORMAL_HAIR_PATTERN,SET,308,-0.027216,-0.0034952,0.047437,0.71692,HP_ABNORMAL_HAIR_PATTERN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...54,SET,14,-0.12401,-0.0034229,0.21612,0.71694,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.99999
HP_SMALL_INTESTINAL_DYSMOTIL...,SET,6,-0.16843,-0.0030442,0.29354,0.71694,HP_SMALL_INTESTINAL_DYSMOTILITY,0.99999
GSE28783_ANTI_MIR33_VS_CTRL_...2,SET,183,-0.037588,-0.0037338,0.065506,0.71695,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_UP,0.99999
HP_HYPERNASAL_SPEECH,SET,88,-0.052229,-0.0036071,0.091015,0.71696,HP_HYPERNASAL_SPEECH,0.99999
GOBP_SUBSTRATE_DEPENDENT_CEL...1,SET,23,-0.1036,-0.0036645,0.18053,0.71698,GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION,0.99999
GSE17721_0.5H_VS_8H_LPS_BMDC...2,SET,189,-0.03523,-0.0035559,0.061384,0.71699,GSE17721_0.5H_VS_8H_LPS_BMDC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...435,SET,14,-0.12791,-0.0035306,0.22283,0.71702,GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,0.99999
HP_HYPOSMIA,SET,49,-0.06895,-0.0035571,0.1201,0.71704,HP_HYPOSMIA,0.99999
REACTOME_LYSOSOME_VESICLE_BI...,SET,32,-0.082283,-0.0034321,0.14332,0.71705,REACTOME_LYSOSOME_VESICLE_BIOGENESIS,0.99999
REACTOME_FIBRONECTIN_MATRIX_...,SET,6,-0.22136,-0.0040008,0.3855,0.71708,REACTOME_FIBRONECTIN_MATRIX_FORMATION,0.99999
GGCNRNWCTTYS_UNKNOWN,SET,77,-0.054513,-0.0035228,0.094916,0.71712,GGCNRNWCTTYS_UNKNOWN,0.99999
GOBP_GROWTH,SET,818,-0.017781,-0.0036684,0.030957,0.71714,GOBP_GROWTH,0.99999
HP_TYPIFIED_BY_SOMATIC_MOSAI...,SET,162,-0.038931,-0.0036406,0.067774,0.71715,HP_TYPIFIED_BY_SOMATIC_MOSAICISM,0.99999
HP_NEOPLASM_OF_THE_PARATHYRO...,SET,18,-0.1214,-0.0037993,0.21133,0.71717,HP_NEOPLASM_OF_THE_PARATHYROID_GLAND,0.99999
WP_GNAQ_PATHWAYS_IN_PORTWINE...,SET,20,-0.11316,-0.0037327,0.19696,0.71719,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,0.99999
GSE27786_LIN_NEG_VS_MONO_MAC...1,SET,182,-0.034565,-0.0034242,0.060152,0.71722,GSE27786_LIN_NEG_VS_MONO_MAC_DN,0.99999
MODULE_297,SET,72,-0.059727,-0.0037328,0.10394,0.71723,MODULE_297,0.99999
HP_COLLECTIONISM,SET,10,-0.14434,-0.0033677,0.25119,0.71723,HP_COLLECTIONISM,0.99999
HP_ABNORMAL_CEREBRAL_VEIN_MO...,SET,8,-0.17218,-0.0035932,0.29962,0.71724,HP_ABNORMAL_CEREBRAL_VEIN_MORPHOLOGY,0.99999
REACTOME_ACETYLCHOLINE_BINDI...,SET,14,-0.14259,-0.003936,0.24808,0.71728,REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS,0.99999
GOBP_CARBON_DIOXIDE_TRANSPORT,SET,12,-0.16919,-0.0043238,0.29432,0.7173,GOBP_CARBON_DIOXIDE_TRANSPORT,0.99999
MIR548AE_3P_MIR548AQ_3P,SET,720,-0.018483,-0.0035875,0.032135,0.71741,MIR548AE_3P_MIR548AQ_3P,0.99999
REACTOME_SCF_BETA_TRCP_MEDIA...,SET,52,-0.060079,-0.0031927,0.10444,0.71743,REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,0.99999
NELSON_RESPONSE_TO_ANDROGEN_...1,SET,17,-0.13666,-0.0041565,0.23757,0.71744,NELSON_RESPONSE_TO_ANDROGEN_DN,0.99999
GSE11057_EFF_MEM_VS_CENT_MEM...1,SET,158,-0.038637,-0.0035687,0.067164,0.71744,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN,0.99999
HP_MICROTIA_THIRD_DEGREE,SET,10,-0.14956,-0.0034893,0.25992,0.71748,HP_MICROTIA_THIRD_DEGREE,0.99999
GOBP_CRANIAL_NERVE_MORPHOGEN...,SET,29,-0.098853,-0.0039255,0.17177,0.71752,GOBP_CRANIAL_NERVE_MORPHOGENESIS,0.99999
GOBP_LENS_FIBER_CELL_MORPHOG...,SET,6,-0.20866,-0.0037714,0.36256,0.71753,GOBP_LENS_FIBER_CELL_MORPHOGENESIS,0.99999
NFY_Q6_01,SET,230,-0.031777,-0.0035342,0.05519,0.71761,NFY_Q6_01,0.99999
HP_ANTERIOR_CHAMBER_SYNECHIAE,SET,27,-0.10343,-0.0039633,0.17963,0.71762,HP_ANTERIOR_CHAMBER_SYNECHIAE,0.99999
GSE17721_PAM3CSK4_VS_CPG_12H...1,SET,187,-0.034931,-0.0035072,0.060667,0.71762,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN,0.99999
GSE32423_IL7_VS_IL4_MEMORY_C...2,SET,182,-0.03443,-0.0034108,0.059789,0.71764,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP,0.99999
MAHADEVAN_IMATINIB_RESISTANC...2,SET,17,-0.13716,-0.0041716,0.238,0.71779,MAHADEVAN_IMATINIB_RESISTANCE_UP,0.99999
MIR4435,SET,79,-0.054404,-0.0035609,0.094393,0.71781,MIR4435,0.99999
GSE7460_CTRL_VS_FOXP3_OVEREX...1,SET,184,-0.036246,-0.0036102,0.062885,0.71782,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...215,SET,5,-0.21462,-0.0035412,0.37231,0.71784,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR,0.99999
MODULE_408,SET,18,-0.1192,-0.0037302,0.20673,0.71788,MODULE_408,0.99999
GSE24634_NAIVE_CD4_TCELL_VS_...5,SET,187,-0.033279,-0.0033413,0.057706,0.71792,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN,0.99999
GSE1432_CTRL_VS_IFNG_1H_MICR...2,SET,171,-0.035914,-0.0034497,0.06224,0.71804,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,0.99999
HP_ABNORMAL_RIB_OSSIFICATION,SET,8,-0.18392,-0.0038383,0.31867,0.71808,HP_ABNORMAL_RIB_OSSIFICATION,0.99999
IRX2_TARGET_GENES,SET,187,-0.034513,-0.0034652,0.059789,0.71811,IRX2_TARGET_GENES,0.99999
GOMF_CALCIUM_DEPENDENT_PHOSP...1,SET,17,-0.13084,-0.0039793,0.22665,0.71812,GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY,0.99999
WP_T_CELL_RECEPTOR_AND_COSTI...,SET,27,-0.097314,-0.003729,0.16854,0.71816,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,0.99999
GOBP_PHOSPHATIDYLINOSITOL_PH...,SET,59,-0.060327,-0.0034142,0.10447,0.71818,GOBP_PHOSPHATIDYLINOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
WP_MITOCHONDRIAL_FATTY_ACID_...2,SET,12,-0.15093,-0.0038573,0.26134,0.71821,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,0.99999
KEGG_MEDICUS_VARIANT_EGF_OVE...1,SET,8,-0.17269,-0.0036038,0.29885,0.71831,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,0.99999
MODULE_84,SET,488,-0.023349,-0.0037557,0.040404,0.71833,MODULE_84,0.99999
GOBP_REGULATION_OF_VESICLE_M...,SET,464,-0.022801,-0.0035786,0.039456,0.71833,GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT,0.99999
GOCC_EARLY_ENDOSOME_LUMEN,SET,5,-0.23338,-0.0038507,0.40379,0.71835,GOCC_EARLY_ENDOSOME_LUMEN,0.99999
VANTVEER_BREAST_CANCER_ESR1_...2,SET,136,-0.042472,-0.0036418,0.073428,0.71851,VANTVEER_BREAST_CANCER_ESR1_UP,0.99999
BOYLAN_MULTIPLE_MYELOMA_D_CL...2,SET,25,-0.10163,-0.0037476,0.17568,0.71854,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...392,SET,6,-0.21061,-0.0038066,0.36402,0.71856,GOBP_NEGATIVE_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,0.99999
MODULE_381,SET,11,-0.13737,-0.0033614,0.2374,0.71859,MODULE_381,0.99999
GOBP_ATP_BIOSYNTHETIC_PROCESS,SET,62,-0.053545,-0.0031062,0.092519,0.71862,GOBP_ATP_BIOSYNTHETIC_PROCESS,0.99999
GSE27786_BCELL_VS_CD4_TCELL_...2,SET,180,-0.035144,-0.0034626,0.060705,0.71868,GSE27786_BCELL_VS_CD4_TCELL_UP,0.99999
SUNG_METASTASIS_STROMA_UP,SET,102,-0.049473,-0.0036771,0.085445,0.7187,SUNG_METASTASIS_STROMA_UP,0.99999
GOCC_DNA_REPAIR_COMPLEX,SET,20,-0.092241,-0.0030427,0.15925,0.71878,GOCC_DNA_REPAIR_COMPLEX,0.99999
HP_ABNORMAL_PARATHYROID_MORP...,SET,22,-0.11181,-0.003868,0.19301,0.71881,HP_ABNORMAL_PARATHYROID_MORPHOLOGY,0.99999
GOBP_VITAMIN_CATABOLIC_PROCE...,SET,15,-0.12804,-0.0036583,0.22101,0.71882,GOBP_VITAMIN_CATABOLIC_PROCESS,0.99999
MIR8067,SET,250,-0.030279,-0.003509,0.052252,0.71886,MIR8067,0.99999
MIR6736_3P,SET,113,-0.047595,-0.0037223,0.082117,0.71891,MIR6736_3P,0.99999
GOMF_ALPHA_TUBULIN_BINDING,SET,35,-0.076009,-0.0033154,0.13113,0.71893,GOMF_ALPHA_TUBULIN_BINDING,0.99999
MODULE_88,SET,760,-0.018762,-0.0037373,0.032362,0.71896,MODULE_88,0.99999
GOCC_CILIUM,SET,635,-0.019381,-0.0035413,0.033429,0.71896,GOCC_CILIUM,0.99999
GSE15930_NAIVE_VS_72H_IN_VIT...4,SET,187,-0.034862,-0.0035003,0.060131,0.71896,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,0.99999
HP_ABDOMINAL_CRAMPS,SET,7,-0.16046,-0.0031324,0.27668,0.71901,HP_ABDOMINAL_CRAMPS,0.99999
MIR10399_3P,SET,8,-0.16965,-0.0035404,0.29251,0.71903,MIR10399_3P,0.99999
GOBP_SEROTONIN_UPTAKE,SET,12,-0.15076,-0.0038528,0.25991,0.71905,GOBP_SEROTONIN_UPTAKE,0.99999
HP_ULNAR_DEVIATION_OF_THE_HA...1,SET,27,-0.10007,-0.0038348,0.17251,0.71907,HP_ULNAR_DEVIATION_OF_THE_HAND,0.99999
HP_SARCOMA,SET,167,-0.037702,-0.0035792,0.064978,0.71912,HP_SARCOMA,0.99999
MIR4500,SET,465,-0.02347,-0.0036875,0.040446,0.71913,MIR4500,0.99999
MIR759,SET,65,-0.066869,-0.0039716,0.11523,0.71913,MIR759,0.99999
MIYAGAWA_TARGETS_OF_EWSR1_ET...1,SET,204,-0.037364,-0.0039165,0.064384,0.71915,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,0.99999
WP_PHOSPHOINOSITIDES_METABOL...,SET,43,-0.068661,-0.0033188,0.11831,0.71916,WP_PHOSPHOINOSITIDES_METABOLISM,0.99999
REACTOME_E3_UBIQUITIN_LIGASE...,SET,39,-0.074262,-0.0034189,0.12795,0.71917,REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS,0.99999
GSE22140_GERMFREE_VS_SPF_ART...2,SET,186,-0.035163,-0.0035212,0.060587,0.71917,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP,0.99999
HP_ABNORMALITY_OF_PANCREAS_P...,SET,147,-0.04179,-0.0037243,0.071989,0.71921,HP_ABNORMALITY_OF_PANCREAS_PHYSIOLOGY,0.99999
GSE8685_IL2_STARVED_VS_IL21_...2,SET,182,-0.035576,-0.0035244,0.061284,0.71921,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.99999
VILLANUEVA_LIVER_CANCER_KRT1...1,SET,55,-0.065834,-0.0035978,0.11339,0.71923,VILLANUEVA_LIVER_CANCER_KRT19_DN,0.99999
GSE22886_CD8_TCELL_VS_BCELL_...2,SET,183,-0.034515,-0.0034285,0.05941,0.71936,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_EAR...3,SET,123,-0.04199,-0.0034253,0.072268,0.71939,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_TIP_CELL,0.99999
GOBP_ENDOCARDIAL_CUSHION_FOR...,SET,30,-0.10292,-0.004157,0.17713,0.7194,GOBP_ENDOCARDIAL_CUSHION_FORMATION,0.99999
REACTOME_SENSORY_PROCESSING_...1,SET,69,-0.061451,-0.00376,0.10572,0.71947,REACTOME_SENSORY_PROCESSING_OF_SOUND,0.99999
GOMF_RRNA_CYTOSINE_METHYLTRA...,SET,4,-0.22271,-0.0032868,0.38315,0.71947,GOMF_RRNA_CYTOSINE_METHYLTRANSFERASE_ACTIVITY,0.99999
GSE20152_SPHK1_KO_VS_WT_HTNF...2,SET,179,-0.036443,-0.0035807,0.062691,0.71948,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP,0.99999
MIR6845_3P,SET,124,-0.044856,-0.0036738,0.07716,0.71949,MIR6845_3P,0.99999
HP_ABNORMAL_FLASH_VISUAL_EVO...,SET,13,-0.13555,-0.0036054,0.23313,0.71952,HP_ABNORMAL_FLASH_VISUAL_EVOKED_POTENTIALS,0.99999
BOYLAN_MULTIPLE_MYELOMA_D_UP,SET,82,-0.05492,-0.003662,0.094436,0.71956,BOYLAN_MULTIPLE_MYELOMA_D_UP,0.99999
GSE6674_PL2_3_VS_ANTI_IGM_AN...1,SET,179,-0.037313,-0.0036662,0.064158,0.71957,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,0.99999
GOBP_ACROSOME_REACTION,SET,39,-0.083412,-0.0038402,0.14342,0.71958,GOBP_ACROSOME_REACTION,0.99999
GSE13306_TREG_VS_TCONV_DN,SET,186,-0.034324,-0.0034372,0.058973,0.71972,GSE13306_TREG_VS_TCONV_DN,0.99999
GOBP_RELEASE_OF_SEQUESTERED_...,SET,34,-0.086572,-0.0037219,0.14874,0.71973,GOBP_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_ENDOPLASMIC_RETICULUM,0.99999
GOBP_NUCLEOSIDE_SALVAGE,SET,10,-0.16463,-0.003841,0.28278,0.71978,GOBP_NUCLEOSIDE_SALVAGE,0.99999
GSE16266_LPS_VS_HEATSHOCK_AN...1,SET,175,-0.036569,-0.0035531,0.062803,0.71981,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,0.99999
PR_02,SET,123,-0.044853,-0.0036588,0.077009,0.71986,PR_02,0.99999
MIR4677_5P,SET,233,-0.032589,-0.0036478,0.055951,0.71987,MIR4677_5P,0.99999
HP_HAND_MUSCLE_ATROPHY,SET,48,-0.069985,-0.0035736,0.12013,0.71991,HP_HAND_MUSCLE_ATROPHY,0.99999
HP_HYPOCALCEMIC_TETANY,SET,7,-0.18977,-0.0037046,0.32568,0.71994,HP_HYPOCALCEMIC_TETANY,0.99999
HP_ABNORMAL_ENZYME_ACTIVITY_...2,SET,7,-0.16096,-0.0031421,0.27622,0.71995,HP_ABNORMAL_ENZYME_ACTIVITY_IN_MUSCLE_TISSUE,0.99999
REACTOME_SYNTHESIS_OF_IP2_IP...,SET,13,-0.11394,-0.0030306,0.1955,0.71998,REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL,0.99999
REACTOME_DEACTIVATION_OF_THE...,SET,38,-0.080541,-0.0036602,0.13818,0.72,REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX,0.99999
HP_2_3_FINGER_SYNDACTYLY,SET,9,-0.1751,-0.0038757,0.3004,0.72001,HP_2_3_FINGER_SYNDACTYLY,0.99999
GOBP_REGULATION_OF_MACROPHAG...6,SET,5,-0.22494,-0.0037115,0.38587,0.72003,GOBP_REGULATION_OF_MACROPHAGE_FUSION,0.99999
GOCC_ENDOLYSOSOME_MEMBRANE,SET,17,-0.11807,-0.003591,0.20247,0.7201,GOCC_ENDOLYSOSOME_MEMBRANE,0.99999
HSF_Q6,SET,183,-0.036154,-0.0035914,0.061982,0.72015,HSF_Q6,0.99999
GOCC_DYNACTIN_COMPLEX,SET,8,-0.17308,-0.0036121,0.29671,0.72016,GOCC_DYNACTIN_COMPLEX,0.99999
HP_ABNORMAL_DENTATE_NUCLEUS_...,SET,12,-0.12709,-0.0032478,0.21786,0.72016,HP_ABNORMAL_DENTATE_NUCLEUS_MORPHOLOGY,0.99999
GSE11057_NAIVE_VS_EFF_MEMORY...1,SET,173,-0.037587,-0.0036312,0.064432,0.72017,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...255,SET,5,-0.25403,-0.0041915,0.43544,0.72018,GOBP_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_BCR_P...2,SET,7,-0.19299,-0.0037674,0.33075,0.72021,KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY,0.99999
GOBP_N_GLYCAN_PROCESSING,SET,17,-0.12132,-0.0036899,0.20792,0.72022,GOBP_N_GLYCAN_PROCESSING,0.99999
GOBP_REGULATION_OF_MYOBLAST_...2,SET,19,-0.11943,-0.00384,0.20468,0.72022,GOBP_REGULATION_OF_MYOBLAST_FUSION,0.99999
GOBP_POSITIVE_REGULATION_OF_...262,SET,14,-0.13751,-0.0037955,0.23563,0.72024,GOBP_POSITIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...713,SET,36,-0.091241,-0.0040361,0.15621,0.72042,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,0.99999
GOBP_REGULATION_OF_PODOSOME_...,SET,13,-0.13718,-0.003649,0.23486,0.72042,GOBP_REGULATION_OF_PODOSOME_ASSEMBLY,0.99999
REACTOME_TRAIL_SIGNALING,SET,8,-0.21285,-0.004442,0.3644,0.72043,REACTOME_TRAIL_SIGNALING,0.99999
CREBL2_TARGET_GENES,SET,7,-0.20978,-0.0040953,0.35901,0.72049,CREBL2_TARGET_GENES,0.99999
MORF_RAF1,SET,108,-0.042215,-0.0032281,0.072236,0.72052,MORF_RAF1,0.99999
GOBP_MITOTIC_CELL_CYCLE_PHAS...,SET,403,-0.02412,-0.003534,0.041271,0.72053,GOBP_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,0.99999
REACTOME_RESPONSE_OF_EIF2AK1...,SET,14,-0.13555,-0.0037415,0.23192,0.72054,REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,0.99999
GOBP_REGULATION_OF_INTESTINA...2,SET,9,-0.17042,-0.0037722,0.29149,0.72061,GOBP_REGULATION_OF_INTESTINAL_LIPID_ABSORPTION,0.99999
HP_ENTROPION,SET,20,-0.099804,-0.0032921,0.1707,0.72061,HP_ENTROPION,0.99999
GSE2770_IL12_AND_TGFB_VS_IL4...1,SET,173,-0.036334,-0.0035102,0.062141,0.72062,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.99999
GOMF_INSULIN_LIKE_GROWTH_FAC...2,SET,8,-0.20896,-0.0043609,0.35733,0.72065,GOMF_INSULIN_LIKE_GROWTH_FACTOR_II_BINDING,0.99999
MIR3180_MIR3180_3P,SET,20,-0.11643,-0.0038405,0.19909,0.72066,MIR3180_MIR3180_3P,0.99999
PIEPOLI_LGI1_TARGETS_DN,SET,12,-0.14988,-0.0038305,0.25627,0.72068,PIEPOLI_LGI1_TARGETS_DN,0.99999
GOBP_SMOOTH_MUSCLE_CELL_PROL...,SET,130,-0.045473,-0.0038127,0.077738,0.72071,GOBP_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.99999
ZNF581_TARGET_GENES,SET,266,-0.030268,-0.0036167,0.05173,0.72076,ZNF581_TARGET_GENES,0.99999
WP_PI3KAKTMTOR_SIGNALING_AND...,SET,31,-0.094949,-0.0038981,0.16226,0.72078,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,0.99999
GOBP_5S_CLASS_RRNA_TRANSCRIP...,SET,6,-0.15731,-0.0028433,0.26883,0.72078,GOBP_5S_CLASS_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.99999
GOCC_TRANSCRIPTION_FACTOR_TF...4,SET,6,-0.15731,-0.0028433,0.26883,0.72078,GOCC_TRANSCRIPTION_FACTOR_TFIIIC_COMPLEX,0.99999
GOMF_BASIC_AMINO_ACID_TRANSM...,SET,16,-0.13094,-0.0038637,0.22377,0.72078,GOMF_BASIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
CDC5L_TARGET_GENES,SET,225,-0.032755,-0.0036037,0.055952,0.72086,CDC5L_TARGET_GENES,0.99999
GSE14769_UNSTIM_VS_360MIN_LP...1,SET,192,-0.034813,-0.0035413,0.059464,0.72087,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN,0.99999
GOBP_CELL_COMMUNICATION_BY_E...1,SET,33,-0.092045,-0.0038987,0.15719,0.72091,GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,0.99999
BERTUCCI_INVASIVE_CARCINOMA_...2,SET,20,-0.1044,-0.0034438,0.17825,0.72096,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,0.99999
GOMF_GAP_JUNCTION_HEMI_CHANN...,SET,6,-0.23909,-0.0043213,0.40821,0.72096,GOMF_GAP_JUNCTION_HEMI_CHANNEL_ACTIVITY,0.99999
GOMF_OXIDOREDUCTION_DRIVEN_A...,SET,52,-0.057699,-0.0030662,0.09851,0.72096,GOMF_OXIDOREDUCTION_DRIVEN_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_LOW_ANTERIOR_HAIRLINE,SET,130,-0.041773,-0.0035025,0.071302,0.72101,HP_LOW_ANTERIOR_HAIRLINE,0.99999
DESCARTES_MAIN_FETAL_EXTRAVI...,SET,97,-0.052059,-0.0037738,0.088861,0.72101,DESCARTES_MAIN_FETAL_EXTRAVILLOUS_TROPHOBLASTS,0.99999
KIM_RESPONSE_TO_TSA_AND_DECI...2,SET,108,-0.046629,-0.0035657,0.079533,0.72116,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,0.99999
HP_HEREDITARY_NONPOLYPOSIS_C...,SET,32,-0.088337,-0.0036846,0.15067,0.72116,HP_HEREDITARY_NONPOLYPOSIS_COLORECTAL_CARCINOMA,0.99999
GOBP_RNA_3_END_PROCESSING,SET,76,-0.050162,-0.0032205,0.085519,0.72124,GOBP_RNA_3_END_PROCESSING,0.99999
TCCAGAT_MIR5165P,SET,96,-0.051441,-0.0037099,0.087697,0.72125,TCCAGAT_MIR5165P,0.99999
GOBP_DENDRITIC_SPINE_MORPHOG...,SET,54,-0.069105,-0.0037421,0.11781,0.72125,GOBP_DENDRITIC_SPINE_MORPHOGENESIS,0.99999
PID_IL1_PATHWAY,SET,32,-0.086258,-0.0035979,0.14703,0.72129,PID_IL1_PATHWAY,0.99999
GOBP_MACROPHAGE_DIFFERENTIAT...,SET,57,-0.070978,-0.0039485,0.12098,0.72129,GOBP_MACROPHAGE_DIFFERENTIATION,0.99999
OUELLET_OVARIAN_CANCER_INVAS...2,SET,104,-0.046231,-0.0034695,0.078783,0.72133,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,0.99999
GOBP_REGULATION_OF_MESONEPHR...,SET,4,-0.24687,-0.0036433,0.42068,0.72134,GOBP_REGULATION_OF_MESONEPHROS_DEVELOPMENT,0.99999
HP_SUPERNUMERARY_NIPPLE,SET,46,-0.068646,-0.0034316,0.11694,0.7214,HP_SUPERNUMERARY_NIPPLE,0.99999
GOBP_MICROVILLUS_ORGANIZATION,SET,27,-0.094799,-0.0036326,0.16147,0.72143,GOBP_MICROVILLUS_ORGANIZATION,0.99999
GOMF_7S_RNA_BINDING,SET,7,-0.15379,-0.0030023,0.26195,0.72143,GOMF_7S_RNA_BINDING,0.99999
SESTO_RESPONSE_TO_UV_C7,SET,64,-0.064742,-0.0038156,0.11025,0.72146,SESTO_RESPONSE_TO_UV_C7,0.99999
GOBP_DEVELOPMENT_OF_SECONDAR...2,SET,9,-0.19603,-0.004339,0.33383,0.72147,GOBP_DEVELOPMENT_OF_SECONDARY_SEXUAL_CHARACTERISTICS,0.99999
GOBP_EPIBOLY,SET,39,-0.073182,-0.0033692,0.12462,0.72147,GOBP_EPIBOLY,0.99999
HP_CYSTOID_MACULAR_EDEMA,SET,19,-0.11484,-0.0036922,0.19555,0.72148,HP_CYSTOID_MACULAR_EDEMA,0.99999
KEGG_MEDICUS_REFERENCE_EGF_E...5,SET,15,-0.13552,-0.003872,0.23077,0.72149,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY,0.99999
GOBP_PEPTIDYL_TYROSINE_DEPHO...1,SET,27,-0.095632,-0.0036645,0.16282,0.72151,GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...787,SET,12,-0.12791,-0.003269,0.21775,0.72154,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_ADV...,SET,62,-0.067853,-0.0039363,0.11549,0.72158,HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST,0.99999
PID_BETA_CATENIN_NUC_PATHWAY,SET,70,-0.061821,-0.0038099,0.10518,0.72165,PID_BETA_CATENIN_NUC_PATHWAY,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...4,SET,8,-0.17791,-0.0037128,0.30263,0.72169,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_PERIPHERAL_NERVOUS_SYST...4,SET,8,-0.17324,-0.0036154,0.29464,0.72173,GOBP_PERIPHERAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE,0.99999
KEGG_MEDICUS_REFERENCE_COHES...1,SET,4,-0.2212,-0.0032645,0.37614,0.72175,KEGG_MEDICUS_REFERENCE_COHESIN_ACETYLATION,0.99999
GOBP_REGULATION_OF_MITOCHOND...8,SET,48,-0.069124,-0.0035296,0.11753,0.72177,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...403,SET,21,-0.10554,-0.0035673,0.17941,0.72182,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,0.99999
GOBP_REGULATION_OF_CHLORIDE_...,SET,6,-0.18613,-0.0033641,0.31635,0.72186,GOBP_REGULATION_OF_CHLORIDE_TRANSPORT,0.99999
GOMF_G_PROTEIN_COUPLED_OPIOI...,SET,7,-0.19083,-0.0037254,0.32434,0.72186,GOMF_G_PROTEIN_COUPLED_OPIOID_RECEPTOR_ACTIVITY,0.99999
KANNAN_TP53_TARGETS_DN,SET,21,-0.11644,-0.0039357,0.19789,0.72187,KANNAN_TP53_TARGETS_DN,0.99999
LMX1B_TARGET_GENES,SET,20,-0.11537,-0.0038056,0.19598,0.72196,LMX1B_TARGET_GENES,0.99999
GOBP_CYTOPLASMIC_SEQUESTERIN...1,SET,4,-0.23469,-0.0034636,0.39861,0.72199,GOBP_CYTOPLASMIC_SEQUESTERING_OF_NF_KAPPAB,0.99999
HP_LOW_MOLECULAR_WEIGHT_PROT...,SET,5,-0.21864,-0.0036075,0.3713,0.72201,HP_LOW_MOLECULAR_WEIGHT_PROTEINURIA,0.99999
GOCC_NUCLEAR_PORE_NUCLEAR_BA...,SET,11,-0.14036,-0.0034345,0.23836,0.72202,GOCC_NUCLEAR_PORE_NUCLEAR_BASKET,0.99999
REACTOME_RHOV_GTPASE_CYCLE,SET,36,-0.076576,-0.0033874,0.13003,0.72204,REACTOME_RHOV_GTPASE_CYCLE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...547,SET,12,-0.12953,-0.0033103,0.21991,0.72207,GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,0.99999
MIR3678_5P,SET,13,-0.13063,-0.0034746,0.22176,0.72209,MIR3678_5P,0.99999
GOMF_ANDROGEN_BINDING,SET,4,-0.20833,-0.0030745,0.35353,0.72216,GOMF_ANDROGEN_BINDING,0.99999
REACTOME_PRESYNAPTIC_NICOTIN...,SET,12,-0.15858,-0.0040528,0.2691,0.72217,REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,0.99999
HP_ABNORMAL_ACETABULUM_MORPH...,SET,84,-0.052309,-0.00353,0.088757,0.72219,HP_ABNORMAL_ACETABULUM_MORPHOLOGY,0.99999
GOBP_ANTERIOR_POSTERIOR_AXIS...,SET,51,-0.074073,-0.0038984,0.12567,0.7222,GOBP_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...44,SET,5,-0.24345,-0.0040169,0.41289,0.72227,HP_APLASIA_HYPOPLASIA_OF_THE_MUSCULATURE_OF_THE_PELVIS,0.99999
HP_POSTERIOR_HELIX_PIT,SET,4,-0.26854,-0.0039631,0.4554,0.72229,HP_POSTERIOR_HELIX_PIT,0.99999
GSE30083_SP1_VS_SP3_THYMOCYT...1,SET,181,-0.036921,-0.0036477,0.062608,0.72231,GSE30083_SP1_VS_SP3_THYMOCYTE_DN,0.99999
GOBP_WOUND_HEALING,SET,398,-0.026055,-0.0037942,0.044179,0.72232,GOBP_WOUND_HEALING,0.99999
GOBP_CELL_CELL_ADHESION,SET,897,-0.018773,-0.0040468,0.031828,0.72234,GOBP_CELL_CELL_ADHESION,0.99999
GOMF_FATTY_ACYL_COA_SYNTHASE...,SET,6,-0.24742,-0.0044719,0.41949,0.72234,GOMF_FATTY_ACYL_COA_SYNTHASE_ACTIVITY,0.99999
GSE24634_NAIVE_CD4_TCELL_VS_...4,SET,172,-0.036639,-0.0035295,0.062118,0.72234,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP,0.99999
GOCC_ATPASE_COMPLEX,SET,117,-0.04374,-0.0034805,0.074143,0.72238,GOCC_ATPASE_COMPLEX,0.99999
MIR3154,SET,107,-0.046651,-0.0035509,0.079068,0.72241,MIR3154,0.99999
DESCARTES_MAIN_FETAL_INHIBIT...2,SET,4,-0.29716,-0.0043856,0.50364,0.72241,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,0.99999
HP_ANAL_STENOSIS,SET,30,-0.097144,-0.0039235,0.16463,0.72243,HP_ANAL_STENOSIS,0.99999
CAO_BLOOD_FLUMIST_AGE_05_14Y...4,SET,3,-0.26999,-0.0034508,0.45754,0.72243,CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_UP,0.99999
GOBP_DOLICHYL_DIPHOSPHATE_ME...,SET,4,-0.25557,-0.0037717,0.43306,0.72245,GOBP_DOLICHYL_DIPHOSPHATE_METABOLIC_PROCESS,0.99999
GSE22886_NAIVE_BCELL_VS_BM_P...1,SET,182,-0.036521,-0.0036179,0.061883,0.72245,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN,0.99999
MIR500B_5P,SET,51,-0.067953,-0.0035764,0.11506,0.7226,MIR500B_5P,0.99999
GNF2_BUB3,SET,26,-0.086425,-0.0032499,0.14634,0.7226,GNF2_BUB3,0.99999
GSE9650_EFFECTOR_VS_EXHAUSTE...2,SET,183,-0.035106,-0.0034873,0.059444,0.7226,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP,0.99999
KEGG_MEDICUS_REFERENCE_RORA_...,SET,5,-0.21479,-0.003544,0.36359,0.72266,KEGG_MEDICUS_REFERENCE_RORA_MEDIATED_TRANSCRIPTION,0.99999
GOMF_3_HYDROXYACYL_COA_DEHYD...1,SET,7,-0.23615,-0.00461,0.3997,0.72267,GOMF_3_HYDROXYACYL_COA_DEHYDRATASE_ACTIVITY,0.99999
GOBP_PUTRESCINE_METABOLIC_PR...,SET,7,-0.17751,-0.0034652,0.30027,0.72279,GOBP_PUTRESCINE_METABOLIC_PROCESS,0.99999
HP_SCAPULOPERONEAL_AMYOTROPHY,SET,5,-0.21512,-0.0035495,0.36388,0.7228,HP_SCAPULOPERONEAL_AMYOTROPHY,0.99999
HP_ABNORMALITY_OF_ACID_BASE_...,SET,378,-0.024493,-0.0034779,0.041428,0.72281,HP_ABNORMALITY_OF_ACID_BASE_HOMEOSTASIS,0.99999
BANDRES_RESPONSE_TO_CARMUSTI...1,SET,31,-0.09322,-0.0038271,0.15763,0.72286,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,0.99999
WP_PRADERWILLI_AND_ANGELMAN_...,SET,93,-0.05576,-0.0039583,0.094268,0.7229,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,0.99999
GSE37605_TREG_VS_TCONV_C57BL...1,SET,158,-0.040727,-0.0037617,0.068836,0.72295,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_DN,0.99999
GOCC_SMALL_NUCLEAR_RIBONUCLE...,SET,70,-0.050753,-0.0031278,0.085781,0.72296,GOCC_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX,0.99999
LINSLEY_MIR16_TARGETS,SET,193,-0.033993,-0.0034668,0.05745,0.72297,LINSLEY_MIR16_TARGETS,0.99999
WP_VITAMIN_D_METABOLISM,SET,10,-0.15556,-0.0036294,0.26291,0.72297,WP_VITAMIN_D_METABOLISM,0.99999
HP_DECREASED_BODY_WEIGHT,SET,1374,-0.013789,-0.0036282,0.023303,0.72298,HP_DECREASED_BODY_WEIGHT,0.99999
VERRECCHIA_RESPONSE_TO_TGFB1...4,SET,11,-0.16215,-0.0039677,0.27402,0.72299,VERRECCHIA_RESPONSE_TO_TGFB1_C4,0.99999
HP_NARROW_FOOT,SET,4,-0.25407,-0.0037497,0.42932,0.723,HP_NARROW_FOOT,0.99999
GOCC_AP_2_ADAPTOR_COMPLEX,SET,11,-0.15441,-0.0037783,0.26081,0.72309,GOCC_AP_2_ADAPTOR_COMPLEX,0.99999
HP_SYNKINESIS,SET,28,-0.10534,-0.0041107,0.17793,0.72309,HP_SYNKINESIS,0.99999
MIR11400,SET,8,-0.15434,-0.003221,0.26067,0.72311,MIR11400,0.99999
MANNE_COVID19_ICU_VS_HEALTHY...1,SET,134,-0.046457,-0.0039542,0.078441,0.72316,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,0.99999
MIR4799_3P,SET,78,-0.056313,-0.0036626,0.095073,0.72318,MIR4799_3P,0.99999
HP_BIPOLAR_AFFECTIVE_DISORDER,SET,24,-0.098046,-0.0035425,0.16551,0.7232,HP_BIPOLAR_AFFECTIVE_DISORDER,0.99999
HP_SOFT_TISSUE_NEOPLASM,SET,5,-0.24859,-0.0041016,0.41962,0.72321,HP_SOFT_TISSUE_NEOPLASM,0.99999
GOBP_REGULATION_OF_PRESYNAPT...1,SET,12,-0.15941,-0.004074,0.26907,0.72322,GOBP_REGULATION_OF_PRESYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.99999
HP_DEEPLY_SET_EYE,SET,216,-0.033271,-0.0035874,0.056141,0.72328,HP_DEEPLY_SET_EYE,0.99999
WP_FATTY_ACID_TRANSPORTERS,SET,17,-0.12773,-0.0038848,0.21541,0.72339,WP_FATTY_ACID_TRANSPORTERS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...707,SET,156,-0.041503,-0.0038093,0.069968,0.72346,GOBP_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,0.99999
GSE27786_BCELL_VS_NKTCELL_UP,SET,180,-0.035455,-0.0034932,0.05976,0.7235,GSE27786_BCELL_VS_NKTCELL_UP,0.99999
HP_ABNORMALITY_OF_ADRENAL_PH...,SET,131,-0.044498,-0.0037452,0.074999,0.72351,HP_ABNORMALITY_OF_ADRENAL_PHYSIOLOGY,0.99999
HP_OSTEOMALACIA,SET,22,-0.11072,-0.0038304,0.18661,0.72352,HP_OSTEOMALACIA,0.99999
GSE21546_SAP1A_KO_VS_SAP1A_K...3,SET,185,-0.034821,-0.0034776,0.058684,0.72353,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...17,SET,62,-0.062983,-0.0036538,0.10612,0.72358,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_VERTEBRAL_COLUMN,0.99999
HP_ABNORMAL_METATARSAL_MORPH...,SET,139,-0.043255,-0.0037492,0.072871,0.7236,HP_ABNORMAL_METATARSAL_MORPHOLOGY,0.99999
MIR5007_3P,SET,109,-0.049143,-0.0037752,0.082783,0.72362,MIR5007_3P,0.99999
GOBP_ACTIVATION_OF_TRANSMEMB...,SET,6,-0.18398,-0.0033252,0.30977,0.72371,GOBP_ACTIVATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.99999
LIU_OVARIAN_CANCER_TUMORS_AN...1,SET,33,-0.09789,-0.0041463,0.1648,0.72374,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN,0.99999
HP_ENCEPHALOPATHY,SET,276,-0.029409,-0.0035785,0.049503,0.72377,HP_ENCEPHALOPATHY,0.99999
MIR372_5P,SET,226,-0.033149,-0.003655,0.055793,0.72379,MIR372_5P,0.99999
GOBP_REGULATION_OF_CALCIUM_I...3,SET,5,-0.25764,-0.004251,0.43358,0.72381,GOBP_REGULATION_OF_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOBP_REGULATION_OF_THYROID_H...,SET,7,-0.19644,-0.0038349,0.33055,0.72384,GOBP_REGULATION_OF_THYROID_HORMONE_GENERATION,0.99999
DANG_REGULATED_BY_MYC_UP,SET,65,-0.061485,-0.0036518,0.10342,0.72391,DANG_REGULATED_BY_MYC_UP,0.99999
HP_HYPERPITUITARISM,SET,110,-0.046592,-0.0035955,0.078366,0.72392,HP_HYPERPITUITARISM,0.99999
SETD1A_TARGET_GENES,SET,1212,-0.014772,-0.0036679,0.024845,0.72393,SETD1A_TARGET_GENES,0.99999
GOMF_TRNA_SPECIFIC_ADENOSINE...,SET,8,-0.17825,-0.0037199,0.29974,0.72397,GOMF_TRNA_SPECIFIC_ADENOSINE_DEAMINASE_ACTIVITY,0.99999
PID_ARF6_PATHWAY,SET,35,-0.086019,-0.003752,0.14461,0.72403,PID_ARF6_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_HOMOL...2,SET,12,-0.13561,-0.0034657,0.22796,0.72404,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR,0.99999
GOBP_MOTOR_BEHAVIOR,SET,20,-0.10766,-0.0035514,0.1809,0.72413,GOBP_MOTOR_BEHAVIOR,0.99999
GSE37416_12H_VS_24H_F_TULARE...1,SET,166,-0.038311,-0.0036263,0.064355,0.72418,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.99999
GOBP_CALCIUM_ION_REGULATED_E...2,SET,21,-0.10937,-0.0036966,0.18371,0.72419,GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS_OF_NEUROTRANSMITTER,0.99999
GOBP_RETINAL_CONE_CELL_DIFFE...,SET,13,-0.15025,-0.0039964,0.25237,0.72419,GOBP_RETINAL_CONE_CELL_DIFFERENTIATION,0.99999
WP_ALPHA_6_BETA_4_SIGNALING,SET,33,-0.088942,-0.0037673,0.14934,0.72426,WP_ALPHA_6_BETA_4_SIGNALING,0.99999
PID_TRAIL_PATHWAY,SET,27,-0.098504,-0.0037746,0.16537,0.7243,PID_TRAIL_PATHWAY,0.99999
HP_LANGUAGE_IMPAIRMENT,SET,987,-0.01607,-0.0036244,0.026975,0.72433,HP_LANGUAGE_IMPAIRMENT,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...14,SET,25,-0.096322,-0.0035518,0.16167,0.72434,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,0.99999
GSE3982_EFF_MEMORY_VS_CENT_M...1,SET,172,-0.037601,-0.0036222,0.063111,0.72434,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
HP_GAZE_EVOKED_HORIZONTAL_NY...,SET,17,-0.12208,-0.003713,0.20487,0.72438,HP_GAZE_EVOKED_HORIZONTAL_NYSTAGMUS,0.99999
ENK_UV_RESPONSE_EPIDERMIS_DN,SET,481,-0.023679,-0.003782,0.03973,0.72441,ENK_UV_RESPONSE_EPIDERMIS_DN,0.99999
HP_RETINAL_PERFORATION,SET,10,-0.16327,-0.0038093,0.27392,0.72442,HP_RETINAL_PERFORATION,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...16,SET,151,-0.042559,-0.0038436,0.071392,0.72445,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP,0.99999
HP_DEGENERATION_OF_THE_STRIA...,SET,11,-0.14088,-0.0034472,0.23629,0.72448,HP_DEGENERATION_OF_THE_STRIATUM,0.99999
HP_RHINORRHEA,SET,7,-0.16389,-0.0031994,0.27488,0.72448,HP_RHINORRHEA,0.99999
GOBP_TRANSCRIPTION_PREINITIA...,SET,64,-0.058821,-0.0034667,0.09865,0.7245,GOBP_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY,0.99999
GOMF_C_ACYLTRANSFERASE_ACTIV...,SET,19,-0.11434,-0.0036762,0.19175,0.7245,GOMF_C_ACYLTRANSFERASE_ACTIVITY,0.99999
AGUIRRE_PANCREATIC_CANCER_CO...1,SET,221,-0.035867,-0.0039112,0.060148,0.72451,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...534,SET,68,-0.059723,-0.0036278,0.10015,0.72451,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,0.99999
GSE39556_UNTREATED_VS_3H_POL...2,SET,180,-0.039328,-0.0038749,0.065949,0.72452,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP,0.99999
DESCARTES_MAIN_FETAL_ENS_NEU...,SET,27,-0.10096,-0.0038686,0.16924,0.72459,DESCARTES_MAIN_FETAL_ENS_NEURONS,0.99999
GOBP_DENDRITIC_CELL_CHEMOTAX...,SET,24,-0.11134,-0.0040228,0.18663,0.7246,GOBP_DENDRITIC_CELL_CHEMOTAXIS,0.99999
HP_REDUCED_AMPLITUDE_OF_DARK...,SET,12,-0.14907,-0.0038096,0.24985,0.72461,HP_REDUCED_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM_A_WAVE,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...24,SET,35,-0.074011,-0.0032283,0.12404,0.72464,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
YAP1_DN,SET,37,-0.086764,-0.0038909,0.14541,0.72464,YAP1_DN,0.99999
GSE29615_DAY3_VS_DAY7_LAIV_F...2,SET,145,-0.041919,-0.0037104,0.070253,0.72464,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,0.99999
REACTOME_HIGHLY_SODIUM_PERME...,SET,7,-0.18135,-0.0035403,0.30381,0.72472,REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS,0.99999
GSE1925_3H_VS_24H_IFNG_STIM_...2,SET,187,-0.037333,-0.0037484,0.062537,0.72473,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,0.99999
MORF_EIF3S2,SET,220,-0.030827,-0.0033541,0.051634,0.72475,MORF_EIF3S2,0.99999
MANALO_HYPOXIA_UP,SET,184,-0.039585,-0.0039428,0.066275,0.72484,MANALO_HYPOXIA_UP,0.99999
GOCC_CENTRIOLAR_SUBDISTAL_AP...,SET,9,-0.18636,-0.0041249,0.31196,0.72487,GOCC_CENTRIOLAR_SUBDISTAL_APPENDAGE,0.99999
MIR5002_5P,SET,233,-0.033511,-0.003751,0.056085,0.72491,MIR5002_5P,0.99999
HP_INTUSSUSCEPTION,SET,10,-0.16327,-0.0038094,0.27321,0.72495,HP_INTUSSUSCEPTION,0.99999
HU_GENOTOXIN_ACTION_DIRECT_V...2,SET,37,-0.083819,-0.0037589,0.1402,0.72503,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,0.99999
MIR1273H_3P,SET,88,-0.05475,-0.0037813,0.091577,0.72503,MIR1273H_3P,0.99999
GOBP_ENDOTHELIN_RECEPTOR_SIG...,SET,10,-0.17635,-0.0041145,0.29495,0.72505,GOBP_ENDOTHELIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
MIKKELSEN_MEF_HCP_WITH_H3K27...,SET,557,-0.023656,-0.0040572,0.039558,0.72508,MIKKELSEN_MEF_HCP_WITH_H3K27ME3,0.99999
HP_SPLIT_FOOT,SET,6,-0.18656,-0.0033719,0.31194,0.7251,HP_SPLIT_FOOT,0.99999
GSE21927_SPLEEN_VS_TUMOR_MON...4,SET,156,-0.040678,-0.0037335,0.068013,0.7251,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_UP,0.99999
MEL18_DN.V1_DN,SET,134,-0.047911,-0.004078,0.080097,0.72513,MEL18_DN.V1_DN,0.99999
ONO_AML1_TARGETS_DN,SET,37,-0.092606,-0.0041529,0.15478,0.72518,ONO_AML1_TARGETS_DN,0.99999
ENK_UV_RESPONSE_KERATINOCYTE...1,SET,438,-0.023886,-0.003645,0.03992,0.7252,ENK_UV_RESPONSE_KERATINOCYTE_DN,0.99999
GOBP_REGULATION_OF_TRANSLATI...12,SET,11,-0.14525,-0.0035542,0.24271,0.72523,GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.99999
MIR519A_3P_MIR519B_3P,SET,374,-0.025671,-0.0036262,0.042885,0.72527,MIR519A_3P_MIR519B_3P,0.99999
GSE45365_BCELL_VS_CD8_TCELL_...1,SET,137,-0.043691,-0.0037599,0.07299,0.72527,GSE45365_BCELL_VS_CD8_TCELL_DN,0.99999
GOBP_MORPHOGENESIS_OF_AN_EPI...1,SET,13,-0.16328,-0.0043432,0.27275,0.72529,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_BUD,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...33,SET,62,-0.065332,-0.00379,0.10909,0.72537,HP_APLASIA_HYPOPLASIA_OF_THE_FEMUR,0.99999
HP_ABNORMALITY_OF_DENTAL_STR...,SET,315,-0.028369,-0.0036837,0.047366,0.72538,HP_ABNORMALITY_OF_DENTAL_STRUCTURE,0.99999
GSE35543_IN_VIVO_NTREG_VS_IN...2,SET,169,-0.04248,-0.0040567,0.070929,0.72538,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP,0.99999
GOBP_REGULATION_OF_VASCULAR_...4,SET,29,-0.095369,-0.0037872,0.15919,0.72544,GOBP_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOCC_LEWY_BODY,SET,7,-0.17722,-0.0034596,0.29575,0.72548,GOCC_LEWY_BODY,0.99999
GOCC_APICAL_PART_OF_CELL,SET,434,-0.025522,-0.0038771,0.04259,0.72549,GOCC_APICAL_PART_OF_CELL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...656,SET,57,-0.070946,-0.0039467,0.11839,0.7255,GOBP_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,0.99999
HP_ABNORMAL_FEMALE_EXTERNAL_...,SET,137,-0.045269,-0.0038957,0.075506,0.72559,HP_ABNORMAL_FEMALE_EXTERNAL_GENITALIA_MORPHOLOGY,0.99999
MIR602,SET,7,-0.15864,-0.0030968,0.26452,0.72565,MIR602,0.99999
GOBP_AZOLE_TRANSMEMBRANE_TRA...,SET,13,-0.14773,-0.0039295,0.24632,0.72566,GOBP_AZOLE_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_GLYCOSIDE_TRANSPORT,SET,5,-0.23533,-0.0038829,0.39237,0.72566,GOBP_GLYCOSIDE_TRANSPORT,0.99999
GSE24671_CTRL_VS_BAKIMULC_IN...2,SET,180,-0.037232,-0.0036683,0.062045,0.72577,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP,0.99999
GOMF_GTPASE_BINDING,SET,283,-0.029427,-0.0036251,0.049035,0.72578,GOMF_GTPASE_BINDING,0.99999
REACTOME_ATTENUATION_PHASE,SET,26,-0.098852,-0.0037172,0.16469,0.72582,REACTOME_ATTENUATION_PHASE,0.99999
FLETCHER_PBMC_BCG_10W_INFANT...4,SET,89,-0.06098,-0.0042352,0.1016,0.72582,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP,0.99999
CTCTATG_MIR368,SET,38,-0.084759,-0.003852,0.14117,0.72588,CTCTATG_MIR368,0.99999
GSE30971_CTRL_VS_LPS_STIM_MA...1,SET,173,-0.038891,-0.0037572,0.064771,0.72589,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN,0.99999
GOBP_SPINAL_CORD_PATTERNING,SET,18,-0.12362,-0.0038686,0.20586,0.7259,GOBP_SPINAL_CORD_PATTERNING,0.99999
GOBP_NUCLEOSIDE_MONOPHOSPHAT...4,SET,11,-0.14564,-0.0035637,0.24245,0.72598,GOBP_NUCLEOSIDE_MONOPHOSPHATE_PHOSPHORYLATION,0.99999
GSE37605_C57BL6_VS_NOD_FOXP3...1,SET,169,-0.038217,-0.0036496,0.063611,0.72601,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN,0.99999
HP_ABNORMAL_GALLBLADDER_PHYS...,SET,18,-0.11509,-0.0036018,0.19152,0.72605,HP_ABNORMAL_GALLBLADDER_PHYSIOLOGY,0.99999
HP_PURPURA,SET,116,-0.048742,-0.0038619,0.081099,0.72608,HP_PURPURA,0.99999
MIR1233_3P,SET,71,-0.066694,-0.0041393,0.11092,0.72617,MIR1233_3P,0.99999
REACTOME_INSULIN_PROCESSING,SET,23,-0.1058,-0.0037421,0.17589,0.72624,REACTOME_INSULIN_PROCESSING,0.99999
BIOCARTA_STATHMIN_PATHWAY,SET,20,-0.11492,-0.0037907,0.19103,0.72627,BIOCARTA_STATHMIN_PATHWAY,0.99999
PR_Q2,SET,239,-0.034173,-0.0038734,0.056798,0.7263,PR_Q2,0.99999
HP_ABNORMAL_CORTICAL_BONE_MO...,SET,77,-0.058525,-0.0037821,0.097257,0.72633,HP_ABNORMAL_CORTICAL_BONE_MORPHOLOGY,0.99999
MIR4713_5P,SET,140,-0.04243,-0.0036909,0.070498,0.72636,MIR4713_5P,0.99999
MIR5703,SET,150,-0.040667,-0.0036606,0.067561,0.72638,MIR5703,0.99999
GOBP_NEGATIVE_REGULATION_OF_...306,SET,3,-0.32535,-0.0041584,0.54053,0.72638,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_18_PRODUCTION,0.99999
GOBP_UTERUS_DEVELOPMENT,SET,25,-0.10427,-0.0038448,0.17321,0.7264,GOBP_UTERUS_DEVELOPMENT,0.99999
HP_BLIND_VAGINA,SET,2,-0.37086,-0.0038704,0.616,0.72642,HP_BLIND_VAGINA,0.99999
GOMF_ATP_DEPENDENT_PROTEIN_B...,SET,6,-0.20027,-0.0036197,0.33263,0.72644,GOMF_ATP_DEPENDENT_PROTEIN_BINDING,0.99999
MIR4684_3P,SET,114,-0.049987,-0.0039266,0.08302,0.72645,MIR4684_3P,0.99999
GOBP_DETOXIFICATION_OF_NITRO...,SET,2,-0.41498,-0.0043308,0.68919,0.72645,GOBP_DETOXIFICATION_OF_NITROGEN_COMPOUND,0.99999
GSE7568_IL4_VS_IL4_AND_DEXAM...2,SET,149,-0.038758,-0.0034773,0.064352,0.7265,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP,0.99999
GOBP_MACROPHAGE_INFLAMMATORY...,SET,6,-0.21639,-0.0039111,0.35923,0.72653,GOBP_MACROPHAGE_INFLAMMATORY_PROTEIN_1_ALPHA_PRODUCTION,0.99999
GOBP_SECONDARY_PALATE_DEVELO...,SET,26,-0.11324,-0.0042581,0.18798,0.72654,GOBP_SECONDARY_PALATE_DEVELOPMENT,0.99999
GSE43863_NAIVE_VS_TFH_CD4_EF...1,SET,149,-0.043537,-0.003906,0.072269,0.72655,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_DN,0.99999
GOCC_9PLUS0_MOTILE_CILIUM,SET,4,-0.2273,-0.0033545,0.37728,0.72656,GOCC_9PLUS0_MOTILE_CILIUM,0.99999
MIR6715A_3P,SET,148,-0.041933,-0.0037496,0.069594,0.72659,MIR6715A_3P,0.99999
REACTOME_GLUTATHIONE_CONJUGA...,SET,32,-0.098855,-0.0041233,0.16403,0.72663,REACTOME_GLUTATHIONE_CONJUGATION,0.99999
GOBP_SENSORY_PERCEPTION_OF_M...,SET,170,-0.040968,-0.0039237,0.067979,0.72663,GOBP_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS,0.99999
GOBP_INTRACELLULAR_TRANSPORT,SET,1225,-0.01436,-0.0035832,0.023826,0.72664,GOBP_INTRACELLULAR_TRANSPORT,0.99999
MIR3622A_3P_MIR3622B_3P,SET,90,-0.056814,-0.0039679,0.09425,0.72667,MIR3622A_3P_MIR3622B_3P,0.99999
HARALAMBIEVA_PBMC_M_M_R_II_A...2,SET,842,-0.019058,-0.0039866,0.031616,0.72667,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP,0.99999
WP_APOPTOSIS_MODULATION_AND_...,SET,84,-0.056484,-0.0038117,0.093695,0.72669,WP_APOPTOSIS_MODULATION_AND_SIGNALING,0.99999
GSE40277_EOS_AND_LEF1_TRANSD...1,SET,188,-0.036972,-0.003722,0.061313,0.72675,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,0.99999
WP_ARYL_HYDROCARBON_RECEPTOR...1,SET,46,-0.073364,-0.0036675,0.12162,0.72681,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,0.99999
HP_SQUAMOUS_CELL_CARCINOMA_O...,SET,22,-0.097552,-0.0033747,0.1617,0.72684,HP_SQUAMOUS_CELL_CARCINOMA_OF_THE_SKIN,0.99999
HP_HAND_CLENCHING,SET,27,-0.093178,-0.0035705,0.15444,0.72685,HP_HAND_CLENCHING,0.99999
REACTOME_ASSEMBLY_OF_THE_HIV...,SET,15,-0.12744,-0.0036411,0.21119,0.72689,REACTOME_ASSEMBLY_OF_THE_HIV_VIRION,0.99999
GSE22611_MUTANT_NOD2_VS_CTRL...2,SET,176,-0.037854,-0.0036883,0.06273,0.72689,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,0.99999
GOBP_EXECUTION_PHASE_OF_APOP...,SET,77,-0.058577,-0.0037854,0.097067,0.7269,GOBP_EXECUTION_PHASE_OF_APOPTOSIS,0.99999
ZHOU_INFLAMMATORY_RESPONSE_L...2,SET,387,-0.027107,-0.0038937,0.044915,0.72691,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,0.99999
REACTOME_PROSTANOID_LIGAND_R...,SET,9,-0.1934,-0.0042807,0.32033,0.72699,REACTOME_PROSTANOID_LIGAND_RECEPTORS,0.99999
BIOCARTA_BLYMPHOCYTE_PATHWAY,SET,10,-0.1875,-0.0043745,0.31054,0.727,BIOCARTA_BLYMPHOCYTE_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...591,SET,7,-0.18011,-0.0035161,0.29827,0.72702,GOBP_POSITIVE_REGULATION_OF_PINOCYTOSIS,0.99999
GSE7831_1H_VS_4H_CPG_STIM_PD...2,SET,179,-0.036465,-0.0035828,0.06038,0.72705,GSE7831_1H_VS_4H_CPG_STIM_PDC_UP,0.99999
GOCC_AUTOPHAGOSOME,SET,105,-0.047281,-0.0035652,0.078281,0.72707,GOCC_AUTOPHAGOSOME,0.99999
MIR1343_5P,SET,114,-0.047136,-0.0037026,0.078005,0.72716,MIR1343_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...373,SET,23,-0.11236,-0.0039743,0.18591,0.7272,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,0.99999
GOMF_1_PHOSPHATIDYLINOSITOL_...3,SET,7,-0.20611,-0.0040236,0.341,0.72721,GOMF_1_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_3_KINASE_ACTIVITY,0.99999
KEGG_GLUTATHIONE_METABOLISM,SET,45,-0.081127,-0.0040113,0.1341,0.7274,KEGG_GLUTATHIONE_METABOLISM,0.99999
HP_CELLULITIS,SET,44,-0.077821,-0.003805,0.12861,0.72744,HP_CELLULITIS,0.99999
GSE31082_DP_VS_CD8_SP_THYMOC...2,SET,180,-0.03681,-0.0036267,0.060827,0.72746,GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP,0.99999
MIR1250_3P,SET,457,-0.02454,-0.003823,0.040548,0.72747,MIR1250_3P,0.99999
HP_DERMATOCHALASIS,SET,8,-0.19336,-0.0040353,0.31945,0.7275,HP_DERMATOCHALASIS,0.99999
GOBP_PARANODAL_JUNCTION_ASSE...,SET,6,-0.22136,-0.0040008,0.36568,0.72752,GOBP_PARANODAL_JUNCTION_ASSEMBLY,0.99999
MIR4743_3P,SET,185,-0.037374,-0.0037326,0.061725,0.72757,MIR4743_3P,0.99999
GSE2124_CTRL_VS_LYMPHOTOXIN_...1,SET,178,-0.037511,-0.0036754,0.061939,0.72761,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_DN,0.99999
GOCC_PICLN_SM_PROTEIN_COMPLEX,SET,6,-0.17507,-0.0031642,0.28901,0.72765,GOCC_PICLN_SM_PROTEIN_COMPLEX,0.99999
PAL_PRMT5_TARGETS_DN,SET,27,-0.10749,-0.0041189,0.17743,0.72768,PAL_PRMT5_TARGETS_DN,0.99999
GOBP_ACTIVATION_OF_PROTEIN_K...3,SET,3,-0.3131,-0.0040019,0.5168,0.72769,GOBP_ACTIVATION_OF_PROTEIN_KINASE_C_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...651,SET,236,-0.03291,-0.0037071,0.05432,0.72769,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TRANSPORT,0.99999
GSE2770_UNTREATED_VS_IL4_TRE...4,SET,188,-0.036394,-0.0036637,0.06007,0.72769,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
TESAR_ALK_TARGETS_HUMAN_ES_4...,SET,4,-0.24822,-0.0036633,0.40959,0.72775,TESAR_ALK_TARGETS_HUMAN_ES_4D_DN,0.99999
MIR5093,SET,221,-0.034703,-0.0037843,0.05726,0.72776,MIR5093,0.99999
GOCC_PRE_SNORNP_COMPLEX,SET,7,-0.17614,-0.0034386,0.29059,0.72779,GOCC_PRE_SNORNP_COMPLEX,0.99999
HP_PSEUDOEPIPHYSES_OF_HAND_B...,SET,14,-0.143,-0.0039472,0.23591,0.72779,HP_PSEUDOEPIPHYSES_OF_HAND_BONES,0.99999
HOEK_MYELOID_DENDRITIC_CELL_...3,SET,16,-0.12095,-0.0035688,0.19952,0.72781,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_DN,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_M...3,SET,8,-0.18814,-0.0039262,0.31032,0.72783,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.99999
HP_ELEVATED_CIRCULATING_ACYL...,SET,17,-0.1159,-0.003525,0.19111,0.72789,HP_ELEVATED_CIRCULATING_ACYLCARNITINE_CONCENTRATION,0.99999
GOBP_EXCRETION,SET,28,-0.102,-0.00398,0.16816,0.72792,GOBP_EXCRETION,0.99999
GSE9988_ANTI_TREM1_AND_LPS_V...3,SET,186,-0.036953,-0.0037004,0.060908,0.72797,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN,0.99999
GSE16450_CTRL_VS_IFNA_6H_STI...4,SET,187,-0.037788,-0.003794,0.062268,0.72802,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,0.99999
GOBP_10_FORMYLTETRAHYDROFOLA...,SET,5,-0.2293,-0.0037834,0.37783,0.72803,GOBP_10_FORMYLTETRAHYDROFOLATE_METABOLIC_PROCESS,0.99999
MENON_FETAL_KIDNEY_9_ENDOTHE...,SET,91,-0.060326,-0.0042364,0.099366,0.72811,MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS,0.99999
REACTOME_RHOBTB_GTPASE_CYCLE,SET,34,-0.07863,-0.0033805,0.12951,0.72812,REACTOME_RHOBTB_GTPASE_CYCLE,0.99999
HP_AORTIC_ATHEROSCLEROTIC_LE...,SET,8,-0.20707,-0.0043213,0.34101,0.72814,HP_AORTIC_ATHEROSCLEROTIC_LESION,0.99999
GOBP_MALE_MATING_BEHAVIOR,SET,7,-0.22675,-0.0044265,0.37329,0.72821,GOBP_MALE_MATING_BEHAVIOR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...267,SET,55,-0.07274,-0.0039752,0.11976,0.72821,GOBP_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_TOLL_SIGN...,SET,5,-0.23509,-0.0038789,0.38701,0.72822,GOBP_REGULATION_OF_TOLL_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_FLT3L...2,SET,15,-0.12097,-0.0034563,0.19909,0.72828,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY,0.99999
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,SET,55,-0.069623,-0.0038048,0.11456,0.72831,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,0.99999
GCM_PPP1CC,SET,51,-0.061582,-0.003241,0.10132,0.72833,GCM_PPP1CC,0.99999
GOMF_CHITIN_BINDING,SET,8,-0.18571,-0.0038756,0.30552,0.72835,GOMF_CHITIN_BINDING,0.99999
GOBP_METANEPHRIC_TUBULE_FORM...,SET,6,-0.22701,-0.004103,0.37339,0.72839,GOBP_METANEPHRIC_TUBULE_FORMATION,0.99999
GOCC_ISWI_TYPE_COMPLEX,SET,12,-0.12893,-0.0032949,0.21191,0.72854,GOCC_ISWI_TYPE_COMPLEX,0.99999
HP_MACULAR_THICKENING,SET,38,-0.084973,-0.0038617,0.13962,0.7286,HP_MACULAR_THICKENING,0.99999
TAGCTTT_MIR9,SET,210,-0.035419,-0.0037662,0.058194,0.72861,TAGCTTT_MIR9,0.99999
GOBP_STRIATED_MUSCLE_CELL_DI...,SET,281,-0.031762,-0.0038992,0.052188,0.72861,GOBP_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOBP_FORMATION_OF_CYTOPLASMI...,SET,13,-0.12861,-0.0034208,0.21128,0.72864,GOBP_FORMATION_OF_CYTOPLASMIC_TRANSLATION_INITIATION_COMPLEX,0.99999
GOBP_REGULATION_OF_MYOFIBROB...,SET,6,-0.18844,-0.0034058,0.30955,0.72865,GOBP_REGULATION_OF_MYOFIBROBLAST_DIFFERENTIATION,0.99999
GOMF_CLATHRIN_LIGHT_CHAIN_BI...,SET,6,-0.18188,-0.0032874,0.29878,0.72865,GOMF_CLATHRIN_LIGHT_CHAIN_BINDING,0.99999
GOMF_U3_SNORNA_BINDING,SET,8,-0.17788,-0.0037122,0.29207,0.72874,GOMF_U3_SNORNA_BINDING,0.99999
MIR6842_3P,SET,112,-0.049793,-0.0038771,0.081757,0.72875,MIR6842_3P,0.99999
GOBP_REGULATION_OF_OSTEOBLAS...2,SET,26,-0.1102,-0.004144,0.18095,0.72875,GOBP_REGULATION_OF_OSTEOBLAST_PROLIFERATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...661,SET,5,-0.23207,-0.0038291,0.38075,0.7289,GOBP_NEGATIVE_REGULATION_OF_TUBULIN_DEACETYLATION,0.99999
GOBP_NUCLEOSIDE_DIPHOSPHATE_...3,SET,119,-0.044584,-0.0035776,0.073139,0.72893,GOBP_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.99999
GOCC_ALPHA_BETA_T_CELL_RECEP...,SET,4,-0.25389,-0.003747,0.4165,0.72893,GOCC_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX,0.99999
HP_HYPOPLASTIC_LABIA_MAJORA,SET,34,-0.089971,-0.003868,0.14759,0.72893,HP_HYPOPLASTIC_LABIA_MAJORA,0.99999
HP_SUBSARCOLEMMAL_ACCUMULATI...,SET,5,-0.17567,-0.0028985,0.28818,0.72893,HP_SUBSARCOLEMMAL_ACCUMULATIONS_OF_ABNORMALLY_SHAPED_MITOCHONDRIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...88,SET,20,-0.12285,-0.0040523,0.20152,0.72894,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
REACTOME_INTRINSIC_PATHWAY_F...,SET,52,-0.072806,-0.0038691,0.11942,0.72895,REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS,0.99999
HP_MIGRAINE_WITH_AURA,SET,12,-0.16231,-0.0041479,0.26623,0.72895,HP_MIGRAINE_WITH_AURA,0.99999
HP_EEG_WITH_SPIKE_WAVE_COMPL...2,SET,8,-0.20894,-0.0043603,0.34265,0.72899,HP_EEG_WITH_SPIKE_WAVE_COMPLEXES_2_5_3_5_HZ,0.99999
GSE5589_UNSTIM_VS_45MIN_LPS_...6,SET,183,-0.037492,-0.0037243,0.061455,0.72909,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_UP,0.99999
GSE15930_NAIVE_VS_72H_IN_VIT...2,SET,188,-0.03685,-0.0037097,0.060387,0.72914,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP,0.99999
HP_HYPERPLASIA_OF_THE_MAXILLA,SET,9,-0.19851,-0.004394,0.32525,0.72918,HP_HYPERPLASIA_OF_THE_MAXILLA,0.99999
MODY_HIPPOCAMPUS_POSTNATAL,SET,52,-0.069503,-0.0036935,0.11384,0.72924,MODY_HIPPOCAMPUS_POSTNATAL,0.99999
MIR211_5P,SET,346,-0.028035,-0.003812,0.045917,0.72925,MIR211_5P,0.99999
MIR4661_5P,SET,36,-0.081071,-0.0035863,0.13278,0.72926,MIR4661_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...8,SET,22,-0.1237,-0.0042794,0.20255,0.72931,GOBP_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,0.99999
HP_PROGRESSIVE_EXTERNAL_OPHT...,SET,20,-0.10301,-0.0033978,0.16864,0.72933,HP_PROGRESSIVE_EXTERNAL_OPHTHALMOPLEGIA,0.99999
HNF3B_01,SET,196,-0.038804,-0.0039878,0.063523,0.72935,HNF3B_01,0.99999
MIR4428,SET,114,-0.047384,-0.003722,0.077559,0.72938,MIR4428,0.99999
DURAND_STROMA_S_UP,SET,261,-0.034445,-0.0040774,0.056371,0.72941,DURAND_STROMA_S_UP,0.99999
GNF2_MAP2K3,SET,66,-0.063432,-0.0037962,0.10379,0.72944,GNF2_MAP2K3,0.99999
HP_FLARED_METAPHYSIS,SET,49,-0.071035,-0.0036647,0.11623,0.72945,HP_FLARED_METAPHYSIS,0.99999
REACTOME_PLATELET_HOMEOSTASIS,SET,81,-0.059706,-0.0039569,0.097661,0.72952,REACTOME_PLATELET_HOMEOSTASIS,0.99999
GOBP_PHOSPHOLIPASE_C_ACTIVAT...3,SET,107,-0.0543,-0.0041331,0.088802,0.72955,GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOMF_TRANSMEMBRANE_RECEPTOR_...7,SET,17,-0.12993,-0.0039516,0.21242,0.72961,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ADAPTOR_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_PYRIN...,SET,4,-0.21522,-0.0031763,0.35172,0.7297,KEGG_MEDICUS_REFERENCE_PYRIN_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
HP_METABOLIC_ALKALOSIS,SET,18,-0.13108,-0.0041021,0.2142,0.7297,HP_METABOLIC_ALKALOSIS,0.99999
LANDIS_BREAST_CANCER_PROGRES...2,SET,40,-0.082771,-0.0038591,0.13521,0.72978,LANDIS_BREAST_CANCER_PROGRESSION_UP,0.99999
HP_CUTANEOUS_AMYLOIDOSIS,SET,5,-0.23237,-0.0038341,0.37956,0.7298,HP_CUTANEOUS_AMYLOIDOSIS,0.99999
GCM_PRKCG,SET,55,-0.065216,-0.003564,0.10652,0.72981,GCM_PRKCG,0.99999
GOBP_SOMATIC_MOTOR_NEURON_DI...,SET,5,-0.23678,-0.0039069,0.38672,0.72982,GOBP_SOMATIC_MOTOR_NEURON_DIFFERENTIATION,0.99999
GOCC_ORGANELLE_ENVELOPE_LUMEN,SET,83,-0.056297,-0.0037765,0.09192,0.72988,GOCC_ORGANELLE_ENVELOPE_LUMEN,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...10,SET,184,-0.038678,-0.0038525,0.063149,0.72989,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP,0.99999
BURTON_ADIPOGENESIS_8,SET,70,-0.063284,-0.0039,0.1033,0.72993,BURTON_ADIPOGENESIS_8,0.99999
GSE29617_CTRL_VS_DAY3_TIV_FL...1,SET,178,-0.036775,-0.0036032,0.060019,0.72996,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN,0.99999
GOMF_DIPEPTIDYL_PEPTIDASE_AC...,SET,12,-0.14714,-0.0037605,0.24014,0.72997,GOMF_DIPEPTIDYL_PEPTIDASE_ACTIVITY,0.99999
DESERT_STEM_CELL_HEPATOCELLU...,SET,229,-0.034262,-0.0038024,0.055915,0.72998,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...375,SET,41,-0.079822,-0.0037677,0.13027,0.72998,GOBP_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,0.99999
GOBP_RESPONSE_TO_LEAD_ION,SET,19,-0.1261,-0.0040545,0.20578,0.72999,GOBP_RESPONSE_TO_LEAD_ION,0.99999
HP_LIPEMIA_RETINALIS,SET,3,-0.33251,-0.0042499,0.5425,0.73003,HP_LIPEMIA_RETINALIS,0.99999
STAT6_02,SET,239,-0.034831,-0.0039479,0.056802,0.73012,STAT6_02,0.99999
HP_INTERMITTENT_JAUNDICE,SET,9,-0.18064,-0.0039983,0.29456,0.73014,HP_INTERMITTENT_JAUNDICE,0.99999
GOBP_HYPEROSMOTIC_RESPONSE,SET,25,-0.10708,-0.0039486,0.17461,0.73015,GOBP_HYPEROSMOTIC_RESPONSE,0.99999
GSE13485_DAY3_VS_DAY21_YF17D...2,SET,176,-0.037916,-0.0036944,0.061822,0.73016,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.99999
HP_PERIORBITAL_FULLNESS,SET,34,-0.080357,-0.0034547,0.13099,0.73021,HP_PERIORBITAL_FULLNESS,0.99999
WP_FOXP3_IN_COVID19,SET,13,-0.1709,-0.0045458,0.27855,0.73023,WP_FOXP3_IN_COVID19,0.99999
GOBP_DIOL_BIOSYNTHETIC_PROCE...,SET,20,-0.11409,-0.0037635,0.18595,0.73024,GOBP_DIOL_BIOSYNTHETIC_PROCESS,0.99999
REACTOME_GLUCAGON_SIGNALING_...,SET,33,-0.094823,-0.0040164,0.15454,0.73025,REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,0.99999
NIKOLSKY_BREAST_CANCER_21Q22...,SET,15,-0.21556,-0.0061587,0.35116,0.73034,NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON,0.99999
PID_LIS1_PATHWAY,SET,27,-0.096842,-0.0037109,0.15776,0.73034,PID_LIS1_PATHWAY,0.99999
MIR576_3P,SET,58,-0.067441,-0.0037845,0.10985,0.73036,MIR576_3P,0.99999
HP_DYSPLASTIC_CORPUS_CALLOSUM,SET,40,-0.079148,-0.0036902,0.12892,0.73036,HP_DYSPLASTIC_CORPUS_CALLOSUM,0.99999
GOBP_SENSORY_PERCEPTION,SET,812,-0.021722,-0.0044659,0.035376,0.7304,GOBP_SENSORY_PERCEPTION,0.99999
GOBP_INDOLE_CONTAINING_COMPO...3,SET,22,-0.12142,-0.0042004,0.19769,0.73045,GOBP_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GOBP_METANEPHRIC_GLOMERULUS_...1,SET,16,-0.15066,-0.0044454,0.24528,0.73046,GOBP_METANEPHRIC_GLOMERULUS_DEVELOPMENT,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...3,SET,182,-0.038481,-0.0038122,0.062633,0.73052,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN,0.99999
GSE7459_UNTREATED_VS_IL6_TRE...1,SET,125,-0.047843,-0.0039341,0.07787,0.73052,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_DN,0.99999
GOBP_PYRUVATE_FAMILY_AMINO_A...1,SET,10,-0.15895,-0.0037086,0.2586,0.73061,GOBP_PYRUVATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,0.99999
GSE44649_NAIVE_VS_ACTIVATED_...2,SET,175,-0.035344,-0.0034341,0.057502,0.73061,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN,0.99999
KMCATNNWGGA_UNKNOWN,SET,87,-0.054117,-0.0037163,0.088027,0.73065,KMCATNNWGGA_UNKNOWN,0.99999
GCM_DLG1,SET,69,-0.059106,-0.0036165,0.096133,0.73067,GCM_DLG1,0.99999
GOBP_CELLULAR_RESPONSE_TO_MO...,SET,209,-0.037922,-0.0040228,0.061658,0.73073,GOBP_CELLULAR_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,0.99999
GOBP_POSITIVE_REGULATION_OF_...325,SET,5,-0.23714,-0.0039127,0.38547,0.73078,GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_MATURATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...562,SET,114,-0.047566,-0.0037364,0.077289,0.73086,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,0.99999
GCM_CSNK1D,SET,29,-0.09374,-0.0037225,0.1523,0.73088,GCM_CSNK1D,0.99999
GOBP_LUTEINIZING_HORMONE_SEC...,SET,11,-0.17283,-0.004229,0.28078,0.73089,GOBP_LUTEINIZING_HORMONE_SECRETION,0.99999
MIR6892_3P,SET,92,-0.054886,-0.0038754,0.089129,0.73099,MIR6892_3P,0.99999
GSE22611_NOD2_VS_CTRL_TRANSD...2,SET,174,-0.038607,-0.0037405,0.062689,0.731,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,0.99999
MIR3152_5P,SET,55,-0.066409,-0.0036292,0.10781,0.73104,MIR3152_5P,0.99999
WP_SYNAPTIC_SIGNALING_ASSOCI...,SET,50,-0.074918,-0.0039042,0.1216,0.73109,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...4,SET,178,-0.037689,-0.0036929,0.061173,0.73109,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,0.99999
ZHONG_PFC_C1_ASTROCYTE,SET,26,-0.099143,-0.0037281,0.1609,0.7311,ZHONG_PFC_C1_ASTROCYTE,0.99999
HP_SUBEPENDYMAL_CYSTS,SET,8,-0.17043,-0.0035566,0.27657,0.73112,HP_SUBEPENDYMAL_CYSTS,0.99999
GOBP_CELLULAR_RESPONSE_TO_PR...3,SET,20,-0.13272,-0.0043781,0.21537,0.73113,GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS,0.99999
REACTOME_TRANSCRIPTIONAL_REG...3,SET,32,-0.09789,-0.0040831,0.15884,0.73114,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4,0.99999
WP_ARSENIC_METABOLISM_AND_RE...,SET,9,-0.17587,-0.0038928,0.28533,0.73118,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,0.99999
REACTOME_METABOLISM_OF_AMINO...,SET,330,-0.027937,-0.0037116,0.045316,0.73121,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,0.99999
GOBP_POSITIVE_REGULATION_OF_...221,SET,40,-0.080203,-0.0037394,0.13008,0.73124,GOBP_POSITIVE_REGULATION_OF_DNA_REPLICATION,0.99999
GOBP_REGULATION_OF_SYNAPSE_A...,SET,105,-0.05564,-0.0041955,0.090235,0.73125,GOBP_REGULATION_OF_SYNAPSE_ASSEMBLY,0.99999
GOBP_SMOOTHENED_SIGNALING_PA...1,SET,129,-0.045136,-0.00377,0.073196,0.73126,GOBP_SMOOTHENED_SIGNALING_PATHWAY,0.99999
BIOCARTA_ATM_PATHWAY,SET,19,-0.11671,-0.0037523,0.18925,0.73127,BIOCARTA_ATM_PATHWAY,0.99999
HP_PSORIASIFORM_LESION,SET,3,-0.34614,-0.0044241,0.56131,0.73127,HP_PSORIASIFORM_LESION,0.99999
GTATGAT_MIR154_MIR487,SET,64,-0.067021,-0.00395,0.10867,0.73129,GTATGAT_MIR154_MIR487,0.99999
GOBP_DEADENYLATION_DEPENDENT...,SET,10,-0.15579,-0.0036348,0.2526,0.7313,GOBP_DEADENYLATION_DEPENDENT_DECAPPING_OF_NUCLEAR_TRANSCRIBED_MRNA,0.99999
HP_NONSPHEROCYTIC_HEMOLYTIC_...,SET,7,-0.16975,-0.0033137,0.27514,0.73136,HP_NONSPHEROCYTIC_HEMOLYTIC_ANEMIA,0.99999
GOCC_CATALYTIC_STEP_2_SPLICE...,SET,83,-0.050509,-0.0033883,0.081864,0.73138,GOCC_CATALYTIC_STEP_2_SPLICEOSOME,0.99999
GOBP_INTESTINAL_CHOLESTEROL_...,SET,17,-0.14365,-0.004369,0.23278,0.73141,GOBP_INTESTINAL_CHOLESTEROL_ABSORPTION,0.99999
YAMANAKA_GLIOBLASTOMA_SURVIV...1,SET,8,-0.17105,-0.0035697,0.27701,0.73154,YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN,0.99999
ARNT_01,SET,238,-0.033925,-0.0038373,0.054934,0.73156,ARNT_01,0.99999
GOBP_BRONCHUS_DEVELOPMENT,SET,11,-0.18014,-0.004408,0.2917,0.73156,GOBP_BRONCHUS_DEVELOPMENT,0.99999
GOCC_RNA_POLYMERASE_COMPLEX,SET,90,-0.05009,-0.0034983,0.081103,0.73158,GOCC_RNA_POLYMERASE_COMPLEX,0.99999
REACTOME_ACTIVATION_OF_AMPK_...,SET,26,-0.10611,-0.0039903,0.17178,0.73162,REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS,0.99999
KEGG_MEDICUS_REFERENCE_26S_P...,SET,37,-0.075727,-0.003396,0.12257,0.73165,KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...90,SET,37,-0.075727,-0.003396,0.12257,0.73165,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
GOBP_ASPARTATE_TRANSMEMBRANE...,SET,20,-0.11689,-0.0038556,0.18912,0.73173,GOBP_ASPARTATE_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...97,SET,41,-0.079044,-0.003731,0.12789,0.73173,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.99999
MIR4275,SET,139,-0.044575,-0.0038637,0.072102,0.73178,MIR4275,0.99999
HP_METAPHYSEAL_IRREGULARITY,SET,44,-0.078438,-0.0038351,0.12687,0.73179,HP_METAPHYSEAL_IRREGULARITY,0.99999
GOBP_CYSTEINE_CATABOLIC_PROC...,SET,3,-0.32525,-0.0041571,0.52604,0.73181,GOBP_CYSTEINE_CATABOLIC_PROCESS,0.99999
GOBP_SYNAPTIC_VESICLE_MATURA...,SET,21,-0.11935,-0.0040339,0.19301,0.73183,GOBP_SYNAPTIC_VESICLE_MATURATION,0.99999
GOBP_INTRACELLULAR_GLUTAMATE...,SET,6,-0.22377,-0.0040444,0.36185,0.73184,GOBP_INTRACELLULAR_GLUTAMATE_HOMEOSTASIS,0.99999
GSE25123_CTRL_VS_IL4_STIM_PP...2,SET,179,-0.037433,-0.003678,0.060512,0.73191,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP,0.99999
ELVIDGE_HIF1A_AND_HIF2A_TARG...1,SET,94,-0.054042,-0.0038568,0.087337,0.73196,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,0.99999
GOCC_SODIUM_POTASSIUM_EXCHAN...,SET,11,-0.17936,-0.0043887,0.28986,0.73196,GOCC_SODIUM_POTASSIUM_EXCHANGING_ATPASE_COMPLEX,0.99999
GOBP_LUNG_CELL_DIFFERENTIATI...,SET,29,-0.10249,-0.0040698,0.16561,0.73198,GOBP_LUNG_CELL_DIFFERENTIATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_ASP...,SET,105,-0.054717,-0.004126,0.088406,0.73201,HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE,0.99999
HP_SYMPHALANGISM_OF_MIDDLE_P...2,SET,5,-0.23944,-0.0039507,0.38684,0.73202,HP_SYMPHALANGISM_OF_MIDDLE_PHALANX_OF_FINGER,0.99999
GOBP_POSITIVE_REGULATION_OF_...244,SET,26,-0.10815,-0.0040668,0.17466,0.7321,GOBP_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,0.99999
REACTOME_TRANSLATION_OF_SARS...1,SET,28,-0.094339,-0.0036812,0.15229,0.73219,REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS,0.99999
GSE24142_DN2_VS_DN3_THYMOCYT...2,SET,173,-0.03978,-0.0038431,0.064216,0.73219,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP,0.99999
GSE20366_TREG_VS_TCONV_UP,SET,179,-0.039868,-0.0039172,0.064344,0.73224,GSE20366_TREG_VS_TCONV_UP,0.99999
REACTOME_SIGNALING_BY_FGFR4_...,SET,11,-0.13945,-0.0034121,0.22498,0.73231,REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE,0.99999
GOBP_NUCLEAR_MIGRATION_ALONG...,SET,5,-0.2263,-0.0037339,0.36503,0.73235,GOBP_NUCLEAR_MIGRATION_ALONG_MICROTUBULE,0.99999
MIR4639_3P,SET,66,-0.065953,-0.0039471,0.10637,0.73238,MIR4639_3P,0.99999
GOMF_G_PROTEIN_COUPLED_RECEP...2,SET,254,-0.035065,-0.0040956,0.056547,0.7324,GOMF_G_PROTEIN_COUPLED_RECEPTOR_BINDING,0.99999
MCM3_TARGET_GENES,SET,184,-0.0388,-0.0038646,0.062543,0.73249,MCM3_TARGET_GENES,0.99999
HP_PROMINENT_CALCANEUS,SET,9,-0.17686,-0.0039146,0.28501,0.73254,HP_PROMINENT_CALCANEUS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...692,SET,5,-0.26423,-0.0043598,0.42575,0.73257,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.99999
WP_NUCLEOTIDE_GPCRS,SET,9,-0.16819,-0.0037228,0.27094,0.73262,WP_NUCLEOTIDE_GPCRS,0.99999
GOBP_L_ASPARTATE_TRANSMEMBRA...,SET,11,-0.15696,-0.0038407,0.25285,0.73262,GOBP_L_ASPARTATE_TRANSMEMBRANE_TRANSPORT,0.99999
REACTOME_SIGNALING_BY_FGFR_I...,SET,61,-0.068062,-0.0039165,0.10964,0.73263,REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,0.99999
HP_ABNORMAL_METAPHYSIS_MORPH...,SET,204,-0.036415,-0.003817,0.058649,0.73267,HP_ABNORMAL_METAPHYSIS_MORPHOLOGY,0.99999
GOBP_GOLGI_TO_LYSOSOME_TRANS...,SET,12,-0.14002,-0.0035784,0.22549,0.73268,GOBP_GOLGI_TO_LYSOSOME_TRANSPORT,0.99999
HP_OLIVOPONTOCEREBELLAR_HYPO...,SET,12,-0.13544,-0.0034615,0.21809,0.73271,HP_OLIVOPONTOCEREBELLAR_HYPOPLASIA,0.99999
GOBP_UNSATURATED_FATTY_ACID_...1,SET,45,-0.079572,-0.0039345,0.12807,0.7328,GOBP_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.99999
MIR1271_3P,SET,65,-0.067993,-0.0040383,0.10943,0.73281,MIR1271_3P,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...15,SET,83,-0.056137,-0.0037658,0.090339,0.73283,GAUTAM_EYE_IRIS_CILIARY_BODY_SCHWANN_CELLS,0.99999
chr14q12,SET,52,-0.14346,-0.0076238,0.23084,0.73285,chr14q12,0.99999
GOBP_REGULATION_OF_LUNG_BLOO...,SET,3,-0.32004,-0.0040905,0.51493,0.73287,GOBP_REGULATION_OF_LUNG_BLOOD_PRESSURE,0.99999
REACTOME_REGULATION_OF_SIGNA...1,SET,21,-0.12294,-0.0041554,0.1977,0.73298,REACTOME_REGULATION_OF_SIGNALING_BY_CBL,0.99999
MODULE_41,SET,510,-0.02361,-0.0038798,0.037959,0.73302,MODULE_41,0.99999
HP_DEVELOPMENTAL_CATARACT,SET,109,-0.048773,-0.0037467,0.078407,0.73304,HP_DEVELOPMENTAL_CATARACT,0.99999
REACTOME_FORMATION_OF_PARAXI...,SET,63,-0.05998,-0.0035074,0.096419,0.73305,REACTOME_FORMATION_OF_PARAXIAL_MESODERM,0.99999
GOBP_PURINE_NUCLEOSIDE_MONOP...2,SET,10,-0.17745,-0.00414,0.2852,0.73308,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,0.99999
GSE16385_IFNG_TNF_VS_ROSIGLI...1,SET,143,-0.044425,-0.0039053,0.071405,0.73308,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.99999
MIR10524_5P,SET,79,-0.060461,-0.0039574,0.097162,0.73311,MIR10524_5P,0.99999
GSE37533_UNTREATED_VS_PIOGLI...3,SET,180,-0.038438,-0.0037871,0.061764,0.73313,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.99999
MIR6744_5P,SET,42,-0.083942,-0.0040101,0.13487,0.73315,MIR6744_5P,0.99999
GOBP_REGULATION_OF_VESICLE_F...,SET,22,-0.11495,-0.0039768,0.18469,0.73317,GOBP_REGULATION_OF_VESICLE_FUSION,0.99999
DLX4_TARGET_GENES,SET,686,-0.020063,-0.0038049,0.032221,0.73324,DLX4_TARGET_GENES,0.99999
LET_7G_5P,SET,361,-0.028306,-0.0039298,0.045457,0.73325,LET_7G_5P,0.99999
chr2p22,SET,40,-0.15672,-0.0073067,0.25165,0.73327,chr2p22,0.99999
MIR4761_5P,SET,62,-0.064485,-0.0037409,0.1035,0.73337,MIR4761_5P,0.99999
HP_HETEROCHROMIA_IRIDIS,SET,23,-0.1198,-0.0042373,0.19226,0.73338,HP_HETEROCHROMIA_IRIDIS,0.99999
GSE13522_CTRL_VS_T_CRUZI_Y_S...7,SET,128,-0.044447,-0.0036981,0.071334,0.73338,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN,0.99999
HP_ABNORMAL_CIRCULATING_META...,SET,1249,-0.01523,-0.0038348,0.02444,0.73341,HP_ABNORMAL_CIRCULATING_METABOLITE_CONCENTRATION,0.99999
GOCC_CELL_PROJECTION_MEMBRANE,SET,330,-0.028563,-0.0037946,0.045811,0.73351,GOCC_CELL_PROJECTION_MEMBRANE,0.99999
NABA_MATRISOME_POORLY_METAST...4,SET,23,-0.11228,-0.0039713,0.18007,0.73352,NABA_MATRISOME_POORLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED,0.99999
MIR6748_5P,SET,59,-0.069032,-0.0039069,0.11071,0.73352,MIR6748_5P,0.99999
GOCC_TRAPPII_PROTEIN_COMPLEX,SET,9,-0.16572,-0.003668,0.26577,0.73353,GOCC_TRAPPII_PROTEIN_COMPLEX,0.99999
REACTOME_TRANSPORT_TO_THE_GO...,SET,181,-0.038647,-0.0038182,0.061972,0.73356,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,0.99999
MIR4714_3P,SET,53,-0.072046,-0.0038652,0.11553,0.73356,MIR4714_3P,0.99999
GOBP_CELLULAR_KETONE_METABOL...,SET,196,-0.037819,-0.0038865,0.060637,0.73358,GOBP_CELLULAR_KETONE_METABOLIC_PROCESS,0.99999
GOCC_SPINDLE_POLE_CENTROSOME,SET,11,-0.15551,-0.0038052,0.24931,0.7336,GOCC_SPINDLE_POLE_CENTROSOME,0.99999
GOBP_MDA_5_SIGNALING_PATHWAY,SET,10,-0.13342,-0.0031128,0.21384,0.73366,GOBP_MDA_5_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_DNA_DEMET...,SET,4,-0.2473,-0.0036497,0.39632,0.73368,GOBP_REGULATION_OF_DNA_DEMETHYLATION,0.99999
HP_VERTEBRAL_WEDGING,SET,16,-0.12655,-0.0037342,0.20279,0.7337,HP_VERTEBRAL_WEDGING,0.99999
HP_CLUBBING_OF_TOES,SET,28,-0.09375,-0.0036582,0.15022,0.73372,HP_CLUBBING_OF_TOES,0.99999
REACTOME_SHC_MEDIATED_CASCAD...2,SET,17,-0.12585,-0.0038276,0.20164,0.73373,REACTOME_SHC_MEDIATED_CASCADE_FGFR3,0.99999
WP_GENETIC_CAUSES_OF_PORTOSI...,SET,30,-0.098979,-0.0039976,0.15858,0.73373,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,0.99999
GOBP_MICROTUBULE_CYTOSKELETO...1,SET,577,-0.021327,-0.0037207,0.034166,0.73375,GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION,0.99999
REACTOME_MATURATION_OF_SARS_...3,SET,5,-0.20827,-0.0034364,0.33356,0.73381,REACTOME_MATURATION_OF_SARS_COV_2_SPIKE_PROTEIN,0.99999
GOBP_RIBOSOME_ASSOCIATED_UBI...,SET,7,-0.14278,-0.0027873,0.22867,0.73381,GOBP_RIBOSOME_ASSOCIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...13,SET,15,-0.12784,-0.0036524,0.20469,0.73386,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4,0.99999
GOBP_RIBONUCLEOSIDE_DIPHOSPH...,SET,10,-0.16025,-0.0037389,0.25658,0.73387,GOBP_RIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
AMIT_SERUM_RESPONSE_240_MCF1...,SET,53,-0.07786,-0.0041771,0.12465,0.73389,AMIT_SERUM_RESPONSE_240_MCF10A,0.99999
PID_PLK1_PATHWAY,SET,42,-0.076465,-0.0036529,0.1224,0.73392,PID_PLK1_PATHWAY,0.99999
MODULE_172,SET,89,-0.057785,-0.0040133,0.092491,0.73393,MODULE_172,0.99999
FALVELLA_SMOKERS_WITH_LUNG_C...,SET,72,-0.064696,-0.0040433,0.10354,0.73396,FALVELLA_SMOKERS_WITH_LUNG_CANCER,0.99999
HP_ABNORMAL_SHOULDER_MORPHOL...,SET,79,-0.061311,-0.004013,0.098099,0.73401,HP_ABNORMAL_SHOULDER_MORPHOLOGY,0.99999
GSE26030_UNSTIM_VS_RESTIM_TH...8,SET,180,-0.0392,-0.0038622,0.06272,0.73401,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP,0.99999
GOBP_MARGINAL_ZONE_B_CELL_DI...,SET,7,-0.19989,-0.0039022,0.31981,0.73402,GOBP_MARGINAL_ZONE_B_CELL_DIFFERENTIATION,0.99999
HP_ENTRAPMENT_NEUROPATHY,SET,10,-0.16489,-0.003847,0.26379,0.73403,HP_ENTRAPMENT_NEUROPATHY,0.99999
GOMF_PH_DOMAIN_BINDING,SET,8,-0.18596,-0.0038807,0.29749,0.73404,GOMF_PH_DOMAIN_BINDING,0.99999
GOBP_MAINTENANCE_OF_GASTROIN...,SET,21,-0.12985,-0.004389,0.20756,0.73422,GOBP_MAINTENANCE_OF_GASTROINTESTINAL_EPITHELIUM,0.99999
GSE32986_UNSTIM_VS_CURDLAN_H...1,SET,174,-0.039557,-0.0038325,0.063194,0.73432,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,0.99999
MIR548AJ_5P_MIR548G_5P_MIR54...,SET,446,-0.025939,-0.0039934,0.041431,0.73436,MIR548AJ_5P_MIR548G_5P_MIR548X_5P,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...6,SET,180,-0.04242,-0.0041794,0.06774,0.73441,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP,0.99999
GOBP_HISTONE_MRNA_METABOLIC_...,SET,20,-0.098263,-0.0032413,0.1569,0.73443,GOBP_HISTONE_MRNA_METABOLIC_PROCESS,0.99999
GRAESSMANN_RESPONSE_TO_MC_AN...4,SET,200,-0.038093,-0.003954,0.060808,0.73449,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...738,SET,56,-0.078837,-0.0043472,0.12584,0.7345,GOBP_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,0.99999
GOBP_SKIN_MORPHOGENESIS,SET,13,-0.13922,-0.0037033,0.22219,0.73454,GOBP_SKIN_MORPHOGENESIS,0.99999
HP_ABNORMAL_ODONTOID_TISSUE_...,SET,207,-0.03721,-0.0039286,0.05938,0.73455,HP_ABNORMAL_ODONTOID_TISSUE_MORPHOLOGY,0.99999
GOBP_GLYCOSYLCERAMIDE_CATABO...,SET,6,-0.21629,-0.0039092,0.34513,0.73456,GOBP_GLYCOSYLCERAMIDE_CATABOLIC_PROCESS,0.99999
HP_LOW_SELF_ESTEEM,SET,10,-0.19413,-0.0045292,0.30978,0.73456,HP_LOW_SELF_ESTEEM,0.99999
GOBP_MULTICELLULAR_ORGANISMA...2,SET,757,-0.020399,-0.0040558,0.032545,0.7346,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS,0.99999
GOMF_BILE_ACID_BINDING,SET,10,-0.18941,-0.0044192,0.30215,0.73462,GOMF_BILE_ACID_BINDING,0.99999
GOBP_NONRIBOSOMAL_PEPTIDE_BI...,SET,17,-0.13091,-0.0039814,0.20881,0.73464,GOBP_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS,0.99999
GSE17721_LPS_VS_PAM3CSK4_8H_...1,SET,180,-0.037385,-0.0036834,0.059603,0.73475,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_DN,0.99999
REACTOME_SUMOYLATION_OF_IMMU...,SET,10,-0.16794,-0.0039181,0.26769,0.73478,REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS,0.99999
GOMF_APOLIPOPROTEIN_RECEPTOR...,SET,7,-0.19457,-0.0037983,0.31015,0.73478,GOMF_APOLIPOPROTEIN_RECEPTOR_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...845,SET,129,-0.050382,-0.0042082,0.080287,0.73484,GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_MEVAL...,SET,12,-0.13057,-0.0033368,0.20804,0.73486,KEGG_MEDICUS_REFERENCE_MEVALONATE_PATHWAY,0.99999
GOBP_AXONAL_TRANSPORT_OF_MIT...,SET,16,-0.13735,-0.0040528,0.21886,0.73486,GOBP_AXONAL_TRANSPORT_OF_MITOCHONDRION,0.99999
REACTOME_APOPTOSIS,SET,163,-0.040385,-0.0037881,0.064343,0.73488,REACTOME_APOPTOSIS,0.99999
LANDIS_ERBB2_BREAST_PRENEOPL...2,SET,17,-0.12483,-0.0037966,0.19883,0.73493,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,0.99999
GOCC_CRD_MEDIATED_MRNA_STABI...,SET,6,-0.21144,-0.0038215,0.33679,0.73493,GOCC_CRD_MEDIATED_MRNA_STABILITY_COMPLEX,0.99999
MIR6855_5P,SET,60,-0.067668,-0.0038619,0.10777,0.73495,MIR6855_5P,0.99999
HP_INCOORDINATION,SET,251,-0.033021,-0.0038343,0.052588,0.73497,HP_INCOORDINATION,0.99999
HP_ABNORMAL_CIRCULATING_LYSI...,SET,5,-0.28059,-0.0046297,0.44684,0.73498,HP_ABNORMAL_CIRCULATING_LYSINE_CONCENTRATION,0.99999
GOMF_PHOSPHATIDYLINOSITOL_KI...,SET,25,-0.10696,-0.0039439,0.17022,0.7351,GOMF_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY,0.99999
GSE27092_WT_VS_HDAC7_PHOSPHO...1,SET,186,-0.036961,-0.0037012,0.058815,0.73513,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN,0.99999
GOBP_CYTOKINE_MEDIATED_SIGNA...,SET,472,-0.026377,-0.0041743,0.041971,0.73514,GOBP_CYTOKINE_MEDIATED_SIGNALING_PATHWAY,0.99999
GSE17721_POLYIC_VS_CPG_24H_B...2,SET,188,-0.038393,-0.003865,0.061078,0.73519,GSE17721_POLYIC_VS_CPG_24H_BMDC_UP,0.99999
GOBP_REGULATION_OF_MORPHOGEN...2,SET,46,-0.084614,-0.0042299,0.13459,0.73522,GOBP_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,0.99999
GOBP_REGULATION_OF_HIPPOCAMP...,SET,5,-0.27193,-0.0044868,0.43244,0.73527,GOBP_REGULATION_OF_HIPPOCAMPAL_NEURON_APOPTOTIC_PROCESS,0.99999
MATSUMIYA_PBMC_MODIFIED_VACC...5,SET,26,-0.10696,-0.0040221,0.17004,0.73533,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_WILD_TYPE_MVA_6HR_UP,0.99999
CEBALLOS_TARGETS_OF_TP53_AND...2,SET,18,-0.13665,-0.0042764,0.21718,0.73539,CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,0.99999
HP_CONJUNCTIVAL_HAMARTOMA,SET,10,-0.14181,-0.0033085,0.22533,0.73543,HP_CONJUNCTIVAL_HAMARTOMA,0.99999
GOCC_INTRACILIARY_TRANSPORT_...3,SET,15,-0.15698,-0.0044849,0.24937,0.73548,GOCC_INTRACILIARY_TRANSPORT_PARTICLE_B,0.99999
GOBP_VITAMIN_D_BIOSYNTHETIC_...,SET,10,-0.1735,-0.004048,0.27559,0.73551,GOBP_VITAMIN_D_BIOSYNTHETIC_PROCESS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...81,SET,5,-0.21551,-0.0035559,0.34229,0.73553,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.99999
ZHENG_CORD_BLOOD_C5_SIMILAR_...,SET,53,-0.081576,-0.0043765,0.12956,0.73553,ZHENG_CORD_BLOOD_C5_SIMILAR_TO_HSC_C6_PUTATIVE_ALTERED_METABOLIC_STATE,0.99999
REACTOME_TRAF6_MEDIATED_IRF7...1,SET,26,-0.11099,-0.0041736,0.17624,0.73557,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION,0.99999
MIR7848_3P,SET,26,-0.1033,-0.0038845,0.16399,0.73561,MIR7848_3P,0.99999
GOCC_PWP2P_CONTAINING_SUBCOM...,SET,4,-0.23158,-0.0034178,0.36765,0.73562,GOCC_PWP2P_CONTAINING_SUBCOMPLEX_OF_90S_PRERIBOSOME,0.99999
GSE17721_4_VS_24H_GARDIQUIMO...1,SET,177,-0.038815,-0.0037926,0.061617,0.73563,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...307,SET,39,-0.086979,-0.0040044,0.13807,0.73564,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,0.99999
GOCC_ZYMOGEN_GRANULE,SET,18,-0.12721,-0.0039811,0.20192,0.73565,GOCC_ZYMOGEN_GRANULE,0.99999
REACTOME_CHROMATIN_MODIFYING...,SET,183,-0.036137,-0.0035897,0.057339,0.73573,REACTOME_CHROMATIN_MODIFYING_ENZYMES,0.99999
PID_ILK_PATHWAY,SET,44,-0.080385,-0.0039303,0.12753,0.73576,PID_ILK_PATHWAY,0.99999
BIOCARTA_INFLAM_PATHWAY,SET,25,-0.11609,-0.0042806,0.18416,0.73577,BIOCARTA_INFLAM_PATHWAY,0.99999
GOBP_TRANSITION_METAL_ION_TR...,SET,89,-0.05558,-0.0038602,0.08817,0.73577,GOBP_TRANSITION_METAL_ION_TRANSPORT,0.99999
HP_ABDOMINAL_DISTENTION,SET,139,-0.046149,-0.0040001,0.073203,0.73579,HP_ABDOMINAL_DISTENTION,0.99999
GOBP_MYELOID_CELL_APOPTOTIC_...,SET,36,-0.086526,-0.0038276,0.13724,0.7358,GOBP_MYELOID_CELL_APOPTOTIC_PROCESS,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...8,SET,182,-0.036765,-0.0036421,0.05831,0.73581,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,0.99999
GOMF_LIPOPROTEIN_LIPASE_ACTI...,SET,9,-0.21415,-0.00474,0.33964,0.73582,GOMF_LIPOPROTEIN_LIPASE_ACTIVITY,0.99999
HP_GASTROINTESTINAL_STROMA_T...,SET,19,-0.12272,-0.0039458,0.19463,0.73583,HP_GASTROINTESTINAL_STROMA_TUMOR,0.99999
KEGG_MEDICUS_REFERENCE_NALP1...,SET,4,-0.22314,-0.0032932,0.35386,0.73585,KEGG_MEDICUS_REFERENCE_NALP12_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
KEGG_NEUROTROPHIN_SIGNALING_...,SET,120,-0.049607,-0.0039972,0.078647,0.7359,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,0.99999
REACTOME_REGULATION_OF_IFNA_...,SET,22,-0.1339,-0.0046322,0.21228,0.7359,REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING,0.99999
GOBP_REGULATION_OF_POLYSACCH...2,SET,39,-0.085201,-0.0039225,0.13507,0.7359,GOBP_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS,0.99999
HP_ABSENCE_OF_PUBERTAL_DEVEL...,SET,30,-0.1044,-0.0042168,0.16551,0.73591,HP_ABSENCE_OF_PUBERTAL_DEVELOPMENT,0.99999
GSE45365_WT_VS_IFNAR_KO_BCEL...2,SET,153,-0.043452,-0.0039499,0.068873,0.73594,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...322,SET,4,-0.31208,-0.0046058,0.49452,0.736,GOBP_POSITIVE_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY,0.99999
GOCC_PROTON_TRANSPORTING_TWO...2,SET,13,-0.17315,-0.0046057,0.27437,0.73601,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_CATALYTIC_DOMAIN,0.99999
HP_CHOKING_EPISODES,SET,16,-0.1331,-0.0039272,0.21088,0.73602,HP_CHOKING_EPISODES,0.99999
HP_ABNORMAL_CIRCULATING_IRON...,SET,17,-0.12221,-0.0037168,0.19362,0.73603,HP_ABNORMAL_CIRCULATING_IRON_CONCENTRATION,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...1,SET,44,-0.08379,-0.0040968,0.13274,0.73605,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CELL_CYCLE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...173,SET,6,-0.2186,-0.003951,0.34628,0.73607,GOBP_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS,0.99999
SMID_BREAST_CANCER_LUMINAL_B...2,SET,155,-0.044599,-0.0040804,0.070635,0.73611,SMID_BREAST_CANCER_LUMINAL_B_UP,0.99999
GOMF_SUMO_BINDING,SET,16,-0.12054,-0.0035568,0.19089,0.73613,GOMF_SUMO_BINDING,0.99999
GSE12845_PRE_GC_VS_DARKZONE_...1,SET,176,-0.038968,-0.0037969,0.0617,0.73616,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.99999
GOBP_SULFUR_AMINO_ACID_TRANS...,SET,12,-0.15338,-0.0039198,0.24281,0.7362,GOBP_SULFUR_AMINO_ACID_TRANSPORT,0.99999
HP_AVASCULAR_NECROSIS_OF_THE...,SET,29,-0.099434,-0.0039486,0.15741,0.7362,HP_AVASCULAR_NECROSIS_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS,0.99999
GOBP_REGULATION_OF_BRANCHING...2,SET,5,-0.28361,-0.0046795,0.44893,0.73622,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...618,SET,13,-0.14449,-0.0038434,0.22867,0.73627,GOBP_NEGATIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.99999
GSE21670_TGFB_VS_IL6_TREATED...3,SET,185,-0.039737,-0.0039686,0.062887,0.73627,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.99999
REACTOME_DOWNSTREAM_SIGNALIN...4,SET,24,-0.10305,-0.0037233,0.16307,0.73629,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3,0.99999
REACTOME_MINERALOCORTICOID_B...,SET,6,-0.23923,-0.0043238,0.37853,0.7363,REACTOME_MINERALOCORTICOID_BIOSYNTHESIS,0.99999
HP_FRAGMENTED_EPIPHYSES,SET,5,-0.27598,-0.0045536,0.4366,0.73634,HP_FRAGMENTED_EPIPHYSES,0.99999
IWANAGA_CARCINOGENESIS_BY_KR...4,SET,158,-0.043166,-0.003987,0.068281,0.73636,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,0.99999
MIR4298,SET,50,-0.070353,-0.0036663,0.11129,0.73636,MIR4298,0.99999
CROONQUIST_IL6_DEPRIVATION_DN,SET,91,-0.053041,-0.0037249,0.083894,0.73638,CROONQUIST_IL6_DEPRIVATION_DN,0.99999
KLEIN_TARGETS_OF_BCR_ABL1_FU...,SET,40,-0.091207,-0.0042524,0.14425,0.73639,KLEIN_TARGETS_OF_BCR_ABL1_FUSION,0.99999
GOBP_REGULATION_OF_SMOOTHENE...,SET,79,-0.058246,-0.0038124,0.092113,0.73641,GOBP_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,0.99999
GOCC_ATAC_COMPLEX,SET,12,-0.1378,-0.0035216,0.21791,0.73642,GOCC_ATAC_COMPLEX,0.99999
KEGG_MEDICUS_REFERENCE_ITGA_...6,SET,29,-0.10085,-0.0040049,0.15944,0.73647,KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,0.99999
GOBP_PROTEIN_O_LINKED_GLYCOS...2,SET,8,-0.18373,-0.0038343,0.29047,0.73648,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION_VIA_SERINE,0.99999
MIR128_2_5P,SET,11,-0.18313,-0.0044809,0.28946,0.73651,MIR128_2_5P,0.99999
HP_APNEA,SET,213,-0.036121,-0.0038679,0.057097,0.73651,HP_APNEA,0.99999
GOBP_DICARBOXYLIC_ACID_CATAB...,SET,17,-0.12241,-0.0037231,0.19334,0.73668,GOBP_DICARBOXYLIC_ACID_CATABOLIC_PROCESS,0.99999
HP_INCREASED_LEFT_VENTRICULA...,SET,21,-0.1212,-0.0040964,0.1914,0.73669,HP_INCREASED_LEFT_VENTRICULAR_END_DIASTOLIC_VOLUME,0.99999
GOBP_REGULATION_OF_PROTEIN_D...3,SET,77,-0.057856,-0.0037388,0.091367,0.7367,GOBP_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,0.99999
GSE21033_CTRL_VS_POLYIC_STIM...10,SET,183,-0.039284,-0.0039023,0.062026,0.73674,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP,0.99999
GSE46143_CTRL_VS_LMP2A_TRANS...2,SET,181,-0.040036,-0.0039554,0.063214,0.73674,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP,0.99999
HP_CHORIOCARCINOMA,SET,8,-0.20679,-0.0043155,0.32649,0.73675,HP_CHORIOCARCINOMA,0.99999
NEMETH_INFLAMMATORY_RESPONSE...1,SET,28,-0.10557,-0.0041193,0.16666,0.73677,NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,0.99999
GSE25087_FETAL_VS_ADULT_TREG...2,SET,176,-0.039349,-0.003834,0.062113,0.73679,GSE25087_FETAL_VS_ADULT_TREG_UP,0.99999
GOBP_PROTON_MOTIVE_FORCE_DRI...,SET,43,-0.06747,-0.0032613,0.1065,0.73681,GOBP_PROTON_MOTIVE_FORCE_DRIVEN_ATP_SYNTHESIS,0.99999
GOBP_REGULATION_OF_PEPTIDASE...,SET,268,-0.034428,-0.0041289,0.054336,0.73683,GOBP_REGULATION_OF_PEPTIDASE_ACTIVITY,0.99999
HP_ABNORMAL_HEART_MORPHOLOGY,SET,1338,-0.014966,-0.00389,0.023617,0.73685,HP_ABNORMAL_HEART_MORPHOLOGY,0.99999
HP_CHIARI_TYPE_I_MALFORMATION,SET,41,-0.083869,-0.0039587,0.13235,0.73686,HP_CHIARI_TYPE_I_MALFORMATION,0.99999
GOBP_REGULATION_OF_SUPRAMOLE...,SET,335,-0.028626,-0.0038312,0.045156,0.73693,GOBP_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.99999
HP_SPONDYLOEPIPHYSEAL_DYSPLA...,SET,9,-0.18047,-0.0039946,0.28457,0.73702,HP_SPONDYLOEPIPHYSEAL_DYSPLASIA,0.99999
P53_DN.V1_UP,SET,178,-0.042683,-0.0041822,0.067286,0.73707,P53_DN.V1_UP,0.99999
GSE21360_PRIMARY_VS_TERTIARY...2,SET,185,-0.037583,-0.0037535,0.059243,0.73708,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,0.99999
chr1p13,SET,106,-0.10606,-0.0080352,0.16717,0.7371,chr1p13,0.99999
GCAAGGA_MIR502,SET,65,-0.063454,-0.0037687,0.10001,0.7371,GCAAGGA_MIR502,0.99999
SCHAEFFER_SOX9_TARGETS_IN_PR...2,SET,19,-0.13583,-0.0043671,0.21403,0.73716,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,0.99999
GOMF_BILE_ACID_TRANSMEMBRANE...,SET,20,-0.12526,-0.0041317,0.19736,0.73717,GOMF_BILE_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_INCREASED_URINARY_PORPHOB...,SET,5,-0.24717,-0.0040783,0.38943,0.73719,HP_INCREASED_URINARY_PORPHOBILINOGEN,0.99999
MIR519C_3P,SET,375,-0.027195,-0.0038466,0.042843,0.7372,MIR519C_3P,0.99999
HP_T_LYMPHOCYTOPENIA,SET,60,-0.068376,-0.0039023,0.1077,0.73725,HP_T_LYMPHOCYTOPENIA,0.99999
PANGAS_TUMOR_SUPPRESSION_BY_...1,SET,128,-0.04759,-0.0039596,0.074952,0.73726,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,0.99999
REACTOME_PROTEIN_REPAIR,SET,6,-0.22163,-0.0040058,0.349,0.73729,REACTOME_PROTEIN_REPAIR,0.99999
GOCC_CYTOCHROME_COMPLEX,SET,34,-0.085869,-0.0036917,0.13522,0.73729,GOCC_CYTOCHROME_COMPLEX,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...3,SET,47,-0.088589,-0.0044764,0.13949,0.73731,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...23,SET,6,-0.21113,-0.003816,0.33244,0.73731,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER,0.99999
GOBP_EPITHELIAL_TO_MESENCHYM...2,SET,18,-0.14429,-0.0045156,0.22714,0.73736,GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION,0.99999
MORF_SKP1A,SET,179,-0.036112,-0.0035481,0.056845,0.73737,MORF_SKP1A,0.99999
GOCC_PALMITOYLTRANSFERASE_CO...,SET,10,-0.1633,-0.00381,0.25704,0.73738,GOCC_PALMITOYLTRANSFERASE_COMPLEX,0.99999
GSE13306_TREG_VS_TCONV_LAMIN...1,SET,181,-0.038821,-0.0038354,0.061107,0.73738,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN,0.99999
HP_INTESTINAL_PERFORATION,SET,5,-0.213,-0.0035144,0.33519,0.73743,HP_INTESTINAL_PERFORATION,0.99999
GOBP_CELLULAR_RESPONSE_TO_AL...2,SET,16,-0.14051,-0.004146,0.22105,0.73749,GOBP_CELLULAR_RESPONSE_TO_ALDEHYDE,0.99999
GSE17322_CD103_POS_VS_CD11B_...1,SET,173,-0.039209,-0.003788,0.061681,0.7375,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_DN,0.99999
MIR2682_5P,SET,106,-0.053629,-0.004063,0.084362,0.73751,MIR2682_5P,0.99999
HP_LEFT_VENTRICULAR_HYPERTRO...,SET,87,-0.053105,-0.0036468,0.083528,0.73753,HP_LEFT_VENTRICULAR_HYPERTROPHY,0.99999
GOBP_REGULATION_OF_INTEGRIN_...3,SET,18,-0.14397,-0.0045055,0.22644,0.73754,GOBP_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_HAIR_CELL_DIFFERENTIATI...,SET,50,-0.078874,-0.0041104,0.12405,0.73755,GOBP_HAIR_CELL_DIFFERENTIATION,0.99999
GSE32986_GMCSF_VS_GMCSF_AND_...2,SET,182,-0.039775,-0.0039404,0.062552,0.73756,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.99999
GOBP_DOPAMINE_SECRETION,SET,29,-0.10498,-0.0041687,0.16509,0.73757,GOBP_DOPAMINE_SECRETION,0.99999
GSE3982_BASOPHIL_VS_EFF_MEMO...1,SET,172,-0.040182,-0.0038708,0.063184,0.73759,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.99999
MIR31_3P,SET,51,-0.076746,-0.0040391,0.12066,0.73763,MIR31_3P,0.99999
GOBP_SIALYLATION,SET,10,-0.18029,-0.0042064,0.28339,0.73767,GOBP_SIALYLATION,0.99999
GOBP_GONADOTROPIN_SECRETION,SET,17,-0.14367,-0.0043696,0.22577,0.73772,GOBP_GONADOTROPIN_SECRETION,0.99999
GOBP_REGULATION_OF_EXTRACELL...1,SET,20,-0.1158,-0.0038199,0.18191,0.7378,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,0.99999
GSE17186_NAIVE_VS_CD21HIGH_T...1,SET,178,-0.040338,-0.0039524,0.063357,0.73783,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.99999
GOBP_RECEPTOR_MEDIATED_ENDOC...3,SET,10,-0.18534,-0.0043241,0.29108,0.73784,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS_OF_VIRUS_BY_HOST_CELL,0.99999
GCNP_SHH_UP_EARLY.V1_UP,SET,156,-0.041389,-0.0037988,0.065006,0.73784,GCNP_SHH_UP_EARLY.V1_UP,0.99999
GOBP_ENTRAINMENT_OF_CIRCADIA...,SET,27,-0.10521,-0.0040317,0.16524,0.73785,GOBP_ENTRAINMENT_OF_CIRCADIAN_CLOCK,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...23,SET,22,-0.11754,-0.0040663,0.18448,0.73798,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,0.99999
GOBP_REGULATION_OF_SENSORY_P...,SET,13,-0.15546,-0.0041352,0.24398,0.738,GOBP_REGULATION_OF_SENSORY_PERCEPTION,0.99999
GOBP_REGULATION_OF_CEREBELLA...,SET,9,-0.1874,-0.004148,0.29409,0.73801,GOBP_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION,0.99999
REACTOME_RUNX1_REGULATES_TRA...3,SET,8,-0.18284,-0.0038157,0.28687,0.73805,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES,0.99999
REACTOME_ASSOCIATION_OF_TRIC...,SET,36,-0.079146,-0.0035011,0.12418,0.73806,REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS,0.99999
MIR635,SET,40,-0.088715,-0.0041363,0.13917,0.73808,MIR635,0.99999
GOBP_REGULATION_OF_GLOMERULA...,SET,9,-0.20766,-0.0045964,0.32568,0.73814,GOBP_REGULATION_OF_GLOMERULAR_FILTRATION,0.99999
REACTOME_ACTIVATION_OF_NOXA_...,SET,5,-0.27115,-0.0044739,0.4252,0.73816,REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA,0.99999
HP_CONGENITAL_ABNORMAL_HAIR_...,SET,272,-0.031698,-0.0038294,0.049695,0.73821,HP_CONGENITAL_ABNORMAL_HAIR_PATTERN,0.99999
GSE18148_CBFB_KO_VS_WT_TREG_...1,SET,174,-0.042697,-0.0041367,0.066922,0.73826,GSE18148_CBFB_KO_VS_WT_TREG_DN,0.99999
GSE20366_CD103_KLRG1_DP_VS_D...1,SET,173,-0.040361,-0.0038993,0.063262,0.73826,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN,0.99999
REACTOME_GLYCOGEN_BREAKDOWN_...,SET,11,-0.14246,-0.0034859,0.22329,0.73827,REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...243,SET,87,-0.058853,-0.0040415,0.092229,0.7383,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...3,SET,181,-0.039525,-0.0039049,0.061939,0.7383,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN,0.99999
GSE21379_WT_VS_SAP_KO_TFH_CD...2,SET,175,-0.041619,-0.0040437,0.065196,0.73838,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP,0.99999
GOMF_LIPID_PHOSPHATASE_ACTIV...,SET,7,-0.20664,-0.004034,0.3234,0.73857,GOMF_LIPID_PHOSPHATASE_ACTIVITY,0.99999
MIR3121_5P,SET,95,-0.057392,-0.0041175,0.089802,0.73861,MIR3121_5P,0.99999
NEBEN_AML_WITH_FLT3_OR_NRAS_...1,SET,12,-0.15839,-0.0040478,0.24782,0.73862,NEBEN_AML_WITH_FLT3_OR_NRAS_DN,0.99999
KEGG_PROGESTERONE_MEDIATED_O...,SET,79,-0.059356,-0.003885,0.09287,0.73863,KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,0.99999
GSE15659_RESTING_TREG_VS_NON...2,SET,160,-0.042415,-0.0039421,0.066359,0.73864,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP,0.99999
DORN_ADENOVIRUS_INFECTION_24...1,SET,38,-0.084709,-0.0038497,0.13252,0.73866,DORN_ADENOVIRUS_INFECTION_24HR_DN,0.99999
REACTOME_VIRAL_INFECTION_PAT...,SET,707,-0.019504,-0.0037529,0.030513,0.73866,REACTOME_VIRAL_INFECTION_PATHWAYS,0.99999
GOBP_CELL_MORPHOGENESIS,SET,895,-0.018979,-0.0040868,0.029686,0.73869,GOBP_CELL_MORPHOGENESIS,0.99999
MIR148B_5P,SET,70,-0.062923,-0.0038777,0.098396,0.73874,MIR148B_5P,0.99999
GSE33425_CD161_INT_VS_NEG_CD...1,SET,190,-0.039219,-0.0039689,0.061318,0.73878,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN,0.99999
chr7q34,SET,50,-0.1373,-0.0071551,0.21465,0.7388,chr7q34,0.99999
GSE12392_IFNAR_KO_VS_IFNB_KO...1,SET,185,-0.040999,-0.0040946,0.064094,0.7388,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN,0.99999
HP_CORONARY_ARTERY_STENOSIS,SET,6,-0.20953,-0.003787,0.32748,0.73885,HP_CORONARY_ARTERY_STENOSIS,0.99999
KEGG_MEDICUS_REFERENCE_MODIF...2,SET,5,-0.18986,-0.0031327,0.29673,0.73886,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_I_SUBUNITS,0.99999
GSE26030_UNSTIM_VS_RESTIM_TH...6,SET,183,-0.040675,-0.0040405,0.063567,0.73887,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP,0.99999
GOBP_AMINO_ACID_CATABOLIC_PR...,SET,94,-0.055511,-0.0039617,0.086726,0.73893,GOBP_AMINO_ACID_CATABOLIC_PROCESS,0.99999
HP_DECREASED_SPECIFIC_ANTIBO...1,SET,12,-0.15674,-0.0040057,0.24484,0.73897,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_POLYSACCHARIDE_VACCINE,0.99999
GSE5589_LPS_VS_LPS_AND_IL10_...8,SET,179,-0.040007,-0.0039308,0.062486,0.73899,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP,0.99999
KEGG_MEDICUS_REFERENCE_NLRP1...,SET,4,-0.22366,-0.0033009,0.34921,0.73907,KEGG_MEDICUS_REFERENCE_NLRP1_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
WP_CARDIAC_HYPERTROPHIC_RESP...,SET,53,-0.076469,-0.0041025,0.11937,0.7391,WP_CARDIAC_HYPERTROPHIC_RESPONSE,0.99999
GOBP_CLATHRIN_DEPENDENT_ENDO...,SET,47,-0.076944,-0.0038879,0.1201,0.73912,GOBP_CLATHRIN_DEPENDENT_ENDOCYTOSIS,0.99999
GOBP_REGULATION_OF_MUSCLE_CO...,SET,154,-0.044947,-0.004099,0.070151,0.73914,GOBP_REGULATION_OF_MUSCLE_CONTRACTION,0.99999
CUI_TCF21_TARGETS_DN,SET,30,-0.11447,-0.0046232,0.17862,0.73918,CUI_TCF21_TARGETS_DN,0.99999
ROZANOV_MMP14_CORRELATED,SET,10,-0.18469,-0.0043091,0.28816,0.73922,ROZANOV_MMP14_CORRELATED,0.99999
HP_NEONATAL_HYPERBILIRUBINEM...,SET,22,-0.118,-0.004082,0.18409,0.73922,HP_NEONATAL_HYPERBILIRUBINEMIA,0.99999
GSE27786_CD8_TCELL_VS_NKTCEL...1,SET,178,-0.040571,-0.0039752,0.063288,0.73925,GSE27786_CD8_TCELL_VS_NKTCELL_DN,0.99999
MIR6827_5P,SET,75,-0.0592,-0.0037758,0.092339,0.73927,MIR6827_5P,0.99999
MIR559,SET,497,-0.024576,-0.0039883,0.03833,0.73929,MIR559,0.99999
HP_OVERTUBULATED_LONG_BONES,SET,7,-0.2024,-0.0039512,0.31547,0.73942,HP_OVERTUBULATED_LONG_BONES,0.99999
HU_FETAL_RETINA_PHOTORECEPTOR,SET,65,-0.071683,-0.0042575,0.11173,0.73942,HU_FETAL_RETINA_PHOTORECEPTOR,0.99999
GOBP_LIPOPHAGY,SET,7,-0.20889,-0.0040778,0.32553,0.73945,GOBP_LIPOPHAGY,0.99999
HP_ARTERIAL_RUPTURE,SET,8,-0.20134,-0.0042018,0.31373,0.73948,HP_ARTERIAL_RUPTURE,0.99999
GOMF_VOLUME_SENSITIVE_ANION_...,SET,9,-0.19762,-0.0043742,0.30792,0.73949,GOMF_VOLUME_SENSITIVE_ANION_CHANNEL_ACTIVITY,0.99999
GOBP_KETONE_BODY_BIOSYNTHETI...,SET,6,-0.22628,-0.0040898,0.35255,0.7395,GOBP_KETONE_BODY_BIOSYNTHETIC_PROCESS,0.99999
MIR138_5P,SET,189,-0.039825,-0.0040197,0.062047,0.73951,MIR138_5P,0.99999
CHAF1B_TARGET_GENES,SET,719,-0.020903,-0.0040546,0.032565,0.73952,CHAF1B_TARGET_GENES,0.99999
GOMF_SYNTAXIN_1_BINDING,SET,19,-0.12379,-0.0039802,0.19279,0.7396,GOMF_SYNTAXIN_1_BINDING,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...3,SET,8,-0.18733,-0.0039094,0.29169,0.73963,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC,0.99999
GOBP_MUSCLE_STRUCTURE_DEVELO...,SET,639,-0.022281,-0.0040836,0.034686,0.73967,GOBP_MUSCLE_STRUCTURE_DEVELOPMENT,0.99999
KARLSSON_TGFB1_TARGETS_DN,SET,175,-0.040535,-0.0039385,0.063103,0.73968,KARLSSON_TGFB1_TARGETS_DN,0.99999
CDP_02,SET,96,-0.057752,-0.004165,0.089904,0.73968,CDP_02,0.99999
GOMF_5_N_7_METHYLGUANOSINE_5...,SET,9,-0.20421,-0.00452,0.3179,0.73968,GOMF_5_N_7_METHYLGUANOSINE_5_TRIPHOSPHO_MRNA_HYDROLASE_ACTIVITY,0.99999
TAATAAT_MIR126,SET,201,-0.041524,-0.0043208,0.064623,0.73974,TAATAAT_MIR126,0.99999
GOBP_REGULATION_OF_DOUBLE_ST...2,SET,68,-0.061243,-0.0037201,0.095311,0.73974,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,0.99999
GOBP_REGULATION_OF_NEUROTRAN...3,SET,72,-0.063803,-0.0039876,0.099298,0.73974,GOBP_REGULATION_OF_NEUROTRANSMITTER_SECRETION,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...9,SET,162,-0.042928,-0.0040144,0.066805,0.73975,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN,0.99999
GOBP_PENTOSE_PHOSPHATE_SHUNT...,SET,6,-0.21869,-0.0039526,0.34023,0.73981,GOBP_PENTOSE_PHOSPHATE_SHUNT_NON_OXIDATIVE_BRANCH,0.99999
SNAPC2_TARGET_GENES,SET,4,-0.18355,-0.0027088,0.28552,0.73983,SNAPC2_TARGET_GENES,0.99999
GOBP_NUCLEOTIDE_EXCISION_REP...2,SET,6,-0.16846,-0.0030448,0.26194,0.73993,GOBP_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING,0.99999
GOBP_PROTEIN_NITROSYLATION,SET,13,-0.15864,-0.0042198,0.24665,0.73994,GOBP_PROTEIN_NITROSYLATION,0.99999
HP_COILED_SPERM_FLAGELLA,SET,26,-0.10452,-0.0039305,0.1625,0.73996,HP_COILED_SPERM_FLAGELLA,0.99999
MORI_SMALL_PRE_BII_LYMPHOCYT...1,SET,73,-0.060187,-0.0037875,0.093554,0.73999,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_TH...1,SET,52,-0.072861,-0.003872,0.11323,0.74005,HP_ABNORMAL_MORPHOLOGY_OF_THE_ABDOMINAL_MUSCULATURE,0.99999
HP_ABNORMAL_URINARY_ELECTROL...,SET,104,-0.054742,-0.0041083,0.085065,0.74006,HP_ABNORMAL_URINARY_ELECTROLYTE_CONCENTRATION,0.99999
GOBP_EPIDERMAL_GROWTH_FACTOR...,SET,101,-0.053159,-0.0039318,0.082591,0.74009,GOBP_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GNF2_S100A4,SET,44,-0.082339,-0.0040259,0.12792,0.74011,GNF2_S100A4,0.99999
HP_GONADAL_DYSGENESIS,SET,28,-0.093855,-0.0036623,0.1458,0.74011,HP_GONADAL_DYSGENESIS,0.99999
GSE40666_NAIVE_VS_EFFECTOR_C...2,SET,177,-0.041495,-0.0040544,0.064418,0.74026,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,0.99999
GOBP_ECTODERMAL_PLACODE_DEVE...,SET,12,-0.15042,-0.0038442,0.23349,0.74028,GOBP_ECTODERMAL_PLACODE_DEVELOPMENT,0.99999
TRIP13_TARGET_GENES,SET,69,-0.064598,-0.0039526,0.10027,0.74029,TRIP13_TARGET_GENES,0.99999
GOBP_REGULATION_OF_GLUCOSE_I...,SET,52,-0.078692,-0.0041819,0.12211,0.74034,GOBP_REGULATION_OF_GLUCOSE_IMPORT,0.99999
HP_HEPATIC_FAILURE,SET,133,-0.046086,-0.0039081,0.071515,0.74035,HP_HEPATIC_FAILURE,0.99999
LEIN_MIDBRAIN_MARKERS,SET,68,-0.069088,-0.0041966,0.1072,0.74036,LEIN_MIDBRAIN_MARKERS,0.99999
MIR150_3P,SET,118,-0.049652,-0.0039676,0.07704,0.74037,MIR150_3P,0.99999
GSE41867_NAIVE_VS_DAY15_LCMV...3,SET,164,-0.040291,-0.0037908,0.062515,0.74037,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN,0.99999
GSE35825_IFNA_VS_IFNG_STIM_M...2,SET,154,-0.043909,-0.0040044,0.068122,0.74039,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP,0.99999
HP_CONJUNCTIVAL_HYPEREMIA,SET,5,-0.25976,-0.004286,0.40295,0.74042,HP_CONJUNCTIVAL_HYPEREMIA,0.99999
GOBP_FORMATION_OF_ANATOMICAL...,SET,6,-0.22293,-0.0040293,0.34552,0.7406,GOBP_FORMATION_OF_ANATOMICAL_BOUNDARY,0.99999
HP_LEUKOENCEPHALOPATHY,SET,190,-0.037224,-0.003767,0.05769,0.74061,HP_LEUKOENCEPHALOPATHY,0.99999
DESCARTES_FETAL_KIDNEY_MEGAK...,SET,103,-0.058205,-0.0043472,0.090206,0.74061,DESCARTES_FETAL_KIDNEY_MEGAKARYOCYTES,0.99999
WP_NSP1_FROM_SARSCOV2_INHIBI...,SET,12,-0.14498,-0.0037051,0.22461,0.74068,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,0.99999
REACTOME_SCAVENGING_BY_CLASS...2,SET,6,-0.25041,-0.0045259,0.38791,0.74071,REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS,0.99999
AGCGCTT_MIR518F_MIR518E_MIR5...,SET,16,-0.13413,-0.0039579,0.20778,0.74071,AGCGCTT_MIR518F_MIR518E_MIR518A,0.99999
GOBP_PYRIDINE_CONTAINING_COM...1,SET,30,-0.10235,-0.0041336,0.15853,0.74073,GOBP_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
MIR10399_5P,SET,332,-0.030887,-0.0041156,0.047835,0.74076,MIR10399_5P,0.99999
HAY_BONE_MARROW_CD34_POS_PRE...2,SET,96,-0.058805,-0.0042409,0.091051,0.7408,HAY_BONE_MARROW_CD34_POS_PRE_PC,0.99999
CHANG_IMMORTALIZED_BY_HPV31_...1,SET,58,-0.072009,-0.0040408,0.11147,0.74086,CHANG_IMMORTALIZED_BY_HPV31_DN,0.99999
GOCC_CYTOSOLIC_PROTEASOME_CO...,SET,5,-0.21167,-0.0034925,0.32766,0.74086,GOCC_CYTOSOLIC_PROTEASOME_COMPLEX,0.99999
GIAROLA_SILVA_BLOOD_PANDEMRI...2,SET,4,-0.23171,-0.0034196,0.35867,0.74086,GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_3DY_UP,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...15,SET,42,-0.088765,-0.0042405,0.1374,0.74087,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETAL_MUSCULATURE,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...7,SET,18,-0.13173,-0.0041224,0.20387,0.7409,GOMF_STRUCTURAL_CONSTITUENT_OF_POSTSYNAPSE,0.99999
GOBP_PROTEIN_TRANSPORT_INTO_...,SET,4,-0.27619,-0.0040761,0.42743,0.74091,GOBP_PROTEIN_TRANSPORT_INTO_MEMBRANE_RAFT,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...3,SET,48,-0.082016,-0.004188,0.12691,0.74093,GAVISH_3CA_METAPROGRAM_B_CELLS_GERMINAL_CENTER,0.99999
LMO2COM_01,SET,241,-0.036522,-0.0041567,0.056511,0.74095,LMO2COM_01,0.99999
GOBP_POSITIVE_REGULATION_OF_...673,SET,42,-0.092316,-0.0044102,0.14283,0.74097,GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,0.99999
GSE22432_PDC_VS_TGFB1_TREATE...2,SET,168,-0.039217,-0.0037341,0.060673,0.74097,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...266,SET,14,-0.13625,-0.0037607,0.21074,0.74102,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,0.99999
MODULE_320,SET,19,-0.12853,-0.0041325,0.19878,0.74105,MODULE_320,0.99999
GRANDVAUX_IRF3_TARGETS_UP,SET,13,-0.15747,-0.0041886,0.24353,0.74106,GRANDVAUX_IRF3_TARGETS_UP,0.99999
GSE21546_WT_VS_ELK1_KO_ANTI_...2,SET,183,-0.039858,-0.0039593,0.061639,0.74106,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.99999
DLX6_TARGET_GENES,SET,450,-0.024769,-0.0038298,0.038301,0.74108,DLX6_TARGET_GENES,0.99999
GOBP_PLACENTA_BLOOD_VESSEL_D...,SET,29,-0.1079,-0.0042847,0.16684,0.74109,GOBP_PLACENTA_BLOOD_VESSEL_DEVELOPMENT,0.99999
GOBP_TELOMERIC_D_LOOP_DISASS...,SET,7,-0.21307,-0.0041595,0.32945,0.7411,GOBP_TELOMERIC_D_LOOP_DISASSEMBLY,0.99999
GSE360_T_GONDII_VS_M_TUBERCU...2,SET,178,-0.041453,-0.0040617,0.064081,0.74114,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP,0.99999
HP_DELAYED_PUBIC_BONE_OSSIFI...,SET,7,-0.22192,-0.0043322,0.34304,0.74115,HP_DELAYED_PUBIC_BONE_OSSIFICATION,0.99999
HP_ARTHRALGIA_OF_THE_HIP,SET,8,-0.20222,-0.0042201,0.31257,0.74116,HP_ARTHRALGIA_OF_THE_HIP,0.99999
HP_SELECTIVE_TOOTH_AGENESIS,SET,40,-0.09515,-0.0044362,0.14707,0.74117,HP_SELECTIVE_TOOTH_AGENESIS,0.99999
GOMF_CYTOKINE_RECEPTOR_ACTIV...,SET,87,-0.065767,-0.0045164,0.10164,0.7412,GOMF_CYTOKINE_RECEPTOR_ACTIVITY,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...13,SET,189,-0.041521,-0.0041908,0.064143,0.74128,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN,0.99999
HP_ABNORMALITY_OF_THE_CRUS_O...,SET,10,-0.17326,-0.0040423,0.26765,0.74129,HP_ABNORMALITY_OF_THE_CRUS_OF_THE_HELIX,0.99999
GOBP_PERISTALSIS,SET,12,-0.18402,-0.0047029,0.28417,0.74136,GOBP_PERISTALSIS,0.99999
HP_PERIODIC_HYPOKALEMIC_PARE...,SET,7,-0.21735,-0.004243,0.33561,0.74138,HP_PERIODIC_HYPOKALEMIC_PARESIS,0.99999
GOBP_GLUTAMINE_TRANSPORT,SET,9,-0.19975,-0.0044214,0.30834,0.74144,GOBP_GLUTAMINE_TRANSPORT,0.99999
HP_EEG_WITH_SERIES_OF_FOCAL_...,SET,10,-0.17508,-0.0040848,0.27026,0.74144,HP_EEG_WITH_SERIES_OF_FOCAL_SPIKES,0.99999
GOCC_PRESYNAPTIC_ACTIVE_ZONE...1,SET,16,-0.14565,-0.0042975,0.22482,0.74145,GOCC_PRESYNAPTIC_ACTIVE_ZONE_CYTOPLASMIC_COMPONENT,0.99999
GOBP_FLAVONE_METABOLIC_PROCE...,SET,6,-0.22439,-0.0040556,0.34628,0.7415,GOBP_FLAVONE_METABOLIC_PROCESS,0.99999
JAEGER_METASTASIS_DN,SET,236,-0.03755,-0.0042297,0.057944,0.74151,JAEGER_METASTASIS_DN,0.99999
MODULE_350,SET,54,-0.071048,-0.0038473,0.10964,0.74151,MODULE_350,0.99999
REACTOME_PHOSPHORYLATION_OF_...2,SET,19,-0.11262,-0.003621,0.17379,0.74152,REACTOME_PHOSPHORYLATION_OF_THE_APC_C,0.99999
GSE14308_TH17_VS_INDUCED_TRE...1,SET,186,-0.037856,-0.0037908,0.058414,0.74152,GSE14308_TH17_VS_INDUCED_TREG_DN,0.99999
MIR4777_3P,SET,61,-0.068562,-0.0039453,0.10579,0.74153,MIR4777_3P,0.99999
GOCC_NUCLEOID,SET,41,-0.079407,-0.0037481,0.12253,0.74153,GOCC_NUCLEOID,0.99999
GIAROLA_SILVA_BLOOD_PANDEMRI...1,SET,5,-0.20978,-0.0034613,0.32358,0.7416,GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_30DY_UP,0.99999
LINDVALL_IMMORTALIZED_BY_TER...1,SET,64,-0.07215,-0.0042523,0.11128,0.74162,LINDVALL_IMMORTALIZED_BY_TERT_DN,0.99999
GOBP_EPITHELIAL_TUBE_BRANCHI...,SET,30,-0.10621,-0.0042896,0.16369,0.74178,GOBP_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,0.99999
WP_MIRNA_BIOGENESIS,SET,6,-0.20966,-0.0037894,0.32305,0.74182,WP_MIRNA_BIOGENESIS,0.99999
HELLER_SILENCED_BY_METHYLATI...1,SET,100,-0.059176,-0.0043552,0.091162,0.74187,HELLER_SILENCED_BY_METHYLATION_DN,0.99999
HP_PROMINENT_SUPERFICIAL_BLO...,SET,33,-0.09355,-0.0039624,0.14407,0.74193,HP_PROMINENT_SUPERFICIAL_BLOOD_VESSELS,0.99999
GOBP_PROTEIN_COMPLEX_OLIGOME...,SET,250,-0.035412,-0.0041038,0.054531,0.74195,GOBP_PROTEIN_COMPLEX_OLIGOMERIZATION,0.99999
GOBP_PURINE_RIBONUCLEOSIDE_S...,SET,6,-0.24758,-0.0044748,0.38112,0.74202,GOBP_PURINE_RIBONUCLEOSIDE_SALVAGE,0.99999
MIR4771,SET,48,-0.076867,-0.003925,0.11831,0.74206,MIR4771,0.99999
HP_RECURRENT_MYOGLOBINURIA,SET,5,-0.1998,-0.0032966,0.30744,0.74211,HP_RECURRENT_MYOGLOBINURIA,0.99999
GSE34156_NOD2_LIGAND_VS_TLR1...1,SET,155,-0.040456,-0.0037014,0.062246,0.74213,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,0.99999
HP_ABNORMAL_PULMONARY_INTERS...,SET,135,-0.046347,-0.0039595,0.071305,0.74214,HP_ABNORMAL_PULMONARY_INTERSTITIAL_MORPHOLOGY,0.99999
GSE14000_4H_VS_16H_LPS_DC_TR...1,SET,172,-0.039949,-0.0038484,0.061462,0.74214,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN,0.99999
REACTOME_LTC4_CYSLTR_MEDIATE...,SET,6,-0.22785,-0.0041182,0.35054,0.74215,REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION,0.99999
HP_AUTOIMMUNE_THROMBOCYTOPEN...,SET,43,-0.083195,-0.0040214,0.12799,0.74215,HP_AUTOIMMUNE_THROMBOCYTOPENIA,0.99999
HP_MULTIPLE_RIB_FRACTURES,SET,10,-0.19041,-0.0044425,0.29294,0.74215,HP_MULTIPLE_RIB_FRACTURES,0.99999
GOBP_RESPONSE_TO_STARVATION,SET,191,-0.039986,-0.004057,0.061514,0.74216,GOBP_RESPONSE_TO_STARVATION,0.99999
GSE2770_UNTREATED_VS_ACT_CD4...2,SET,180,-0.041779,-0.0041163,0.064269,0.74217,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP,0.99999
MIR935,SET,106,-0.054782,-0.0041504,0.084264,0.74219,MIR935,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...2,SET,154,-0.046468,-0.0042377,0.071454,0.74225,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,0.99999
REACTOME_RAF_ACTIVATION,SET,32,-0.094006,-0.003921,0.14455,0.74226,REACTOME_RAF_ACTIVATION,0.99999
HP_DEMYELINATING_PERIPHERAL_...,SET,49,-0.075961,-0.0039189,0.1168,0.74226,HP_DEMYELINATING_PERIPHERAL_NEUROPATHY,0.99999
SCGGAAGY_ELK1_02,SET,1125,-0.016279,-0.0039041,0.025031,0.74227,SCGGAAGY_ELK1_02,0.99999
GOBP_NEGATIVE_REGULATION_OF_...565,SET,363,-0.029295,-0.0040781,0.045034,0.74231,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,0.99999
GOBP_TRANSCRIPTION_INITIATIO...2,SET,142,-0.044067,-0.0038603,0.067744,0.74231,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_II_PROMOTER,0.99999
MIR12120,SET,164,-0.042615,-0.0040095,0.065507,0.74232,MIR12120,0.99999
GOBP_ANTRAL_OVARIAN_FOLLICLE...,SET,12,-0.16054,-0.0041029,0.24673,0.74237,GOBP_ANTRAL_OVARIAN_FOLLICLE_GROWTH,0.99999
GOMF_MECHANOSENSITIVE_MONOAT...1,SET,5,-0.22878,-0.0037747,0.35158,0.74238,GOMF_MECHANOSENSITIVE_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.99999
HP_LETHARGY,SET,191,-0.03842,-0.0038981,0.059029,0.74243,HP_LETHARGY,0.99999
GSE25088_ROSIGLITAZONE_VS_IL...2,SET,180,-0.039946,-0.0039357,0.06137,0.74244,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,0.99999
MIR103A_3P_MIR107,SET,234,-0.036348,-0.0040771,0.055839,0.74245,MIR103A_3P_MIR107,0.99999
GSE14415_FOXP3_KO_NATURAL_TR...1,SET,158,-0.044203,-0.0040828,0.06787,0.74257,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_DN,0.99999
WRNIP1_TARGET_GENES,SET,967,-0.017585,-0.0039278,0.026998,0.74258,WRNIP1_TARGET_GENES,0.99999
REACTOME_TRANSCRIPTIONAL_REG...5,SET,112,-0.049341,-0.0038419,0.075742,0.74261,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...19,SET,49,-0.083541,-0.0043099,0.12823,0.74263,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MYOFIBROBLASTS,0.99999
MIR5588_5P,SET,80,-0.061353,-0.004041,0.094164,0.74265,MIR5588_5P,0.99999
GOBP_RESPONSE_TO_ORGANIC_CYC...,SET,826,-0.019987,-0.0041428,0.030665,0.74272,GOBP_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,0.99999
MODULE_117,SET,651,-0.02346,-0.0043384,0.035992,0.74274,MODULE_117,0.99999
GSE27786_NKTCELL_VS_MONO_MAC...2,SET,175,-0.039915,-0.0038782,0.061236,0.74274,GSE27786_NKTCELL_VS_MONO_MAC_UP,0.99999
GOMF_1_ACYLGLYCEROPHOSPHOCHO...,SET,6,-0.25856,-0.0046733,0.39666,0.74275,GOMF_1_ACYLGLYCEROPHOSPHOCHOLINE_O_ACYLTRANSFERASE_ACTIVITY,0.99999
MIR12135,SET,185,-0.040076,-0.0040024,0.061469,0.74279,MIR12135,0.99999
GOCC_INNER_DYNEIN_ARM,SET,4,-0.23304,-0.0034392,0.35743,0.74279,GOCC_INNER_DYNEIN_ARM,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...46,SET,39,-0.090525,-0.0041676,0.13882,0.74282,GOBP_PROTEIN_LOCALIZATION_TO_POSTSYNAPSE,0.99999
HP_BIRTH_LENGTH_LESS_THAN_3R...,SET,13,-0.13973,-0.0037166,0.21427,0.74282,HP_BIRTH_LENGTH_LESS_THAN_3RD_PERCENTILE,0.99999
REACTOME_TRANSPORT_OF_MATURE...2,SET,74,-0.05662,-0.0035872,0.086814,0.74286,REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,0.99999
GOBP_POSITIVE_REGULATION_OF_...819,SET,18,-0.12427,-0.0038891,0.1905,0.7429,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,0.99999
GSE17721_PAM3CSK4_VS_CPG_1H_...1,SET,176,-0.040764,-0.0039719,0.062487,0.74291,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_DN,0.99999
TSAI_RESPONSE_TO_IONIZING_RA...,SET,142,-0.045111,-0.0039518,0.069147,0.74292,TSAI_RESPONSE_TO_IONIZING_RADIATION,0.99999
GOBP_L_GLUTAMATE_TRANSMEMBRA...,SET,29,-0.10405,-0.0041318,0.15949,0.74292,GOBP_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORT,0.99999
GSE10422_WT_VS_BAFF_TRANSGEN...1,SET,120,-0.051847,-0.0041777,0.079448,0.74298,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN,0.99999
ZHONG_PFC_C3_MICROGLIA,SET,431,-0.027114,-0.0041052,0.041549,0.74299,ZHONG_PFC_C3_MICROGLIA,0.99999
GSE3982_MAST_CELL_VS_TH1_DN,SET,172,-0.041484,-0.0039963,0.063566,0.743,GSE3982_MAST_CELL_VS_TH1_DN,0.99999
HP_CORONAL_CRANIOSYNOSTOSIS,SET,26,-0.099351,-0.003736,0.15222,0.74301,HP_CORONAL_CRANIOSYNOSTOSIS,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...1,SET,174,-0.042228,-0.0040912,0.064687,0.74305,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...580,SET,64,-0.075868,-0.0044714,0.11622,0.74306,GOBP_POSITIVE_REGULATION_OF_PHAGOCYTOSIS,0.99999
HP_ANASARCA,SET,9,-0.14978,-0.0033153,0.2294,0.74309,HP_ANASARCA,0.99999
GOBP_CARDIAC_SEPTUM_MORPHOGE...,SET,68,-0.075657,-0.0045957,0.11587,0.7431,GOBP_CARDIAC_SEPTUM_MORPHOGENESIS,0.99999
HP_IRIDOCYCLITIS,SET,10,-0.17034,-0.0039742,0.26088,0.7431,HP_IRIDOCYCLITIS,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_S10...,SET,32,-0.098981,-0.0041286,0.15156,0.74314,HE_LIM_SUN_FETAL_LUNG_C2_S100A12_HI_CLASSICAL_MONOCYTE,0.99999
REACTOME_SYNTHESIS_OF_12_EIC...,SET,7,-0.21241,-0.0041466,0.32522,0.74316,REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES,0.99999
GSE19772_CTRL_VS_HCMV_INF_MO...1,SET,184,-0.040081,-0.0039922,0.061364,0.74317,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,0.99999
GOBP_LIPOXIN_METABOLIC_PROCE...,SET,5,-0.27114,-0.0044738,0.4151,0.74318,GOBP_LIPOXIN_METABOLIC_PROCESS,0.99999
GOBP_RECOGNITION_OF_APOPTOTI...,SET,7,-0.22487,-0.0043899,0.34421,0.74321,GOBP_RECOGNITION_OF_APOPTOTIC_CELL,0.99999
GSE11864_CSF1_VS_CSF1_IFNG_P...1,SET,173,-0.040516,-0.0039142,0.062,0.74327,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.99999
GOBP_NAIL_DEVELOPMENT,SET,11,-0.1833,-0.0044852,0.28042,0.74333,GOBP_NAIL_DEVELOPMENT,0.99999
GSE7509_DC_VS_MONOCYTE_WITH_...2,SET,182,-0.040024,-0.003965,0.06123,0.74333,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...437,SET,6,-0.25434,-0.0045969,0.38903,0.74337,GOBP_POSITIVE_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,0.99999
LET_7B_5P,SET,362,-0.029666,-0.0041243,0.045369,0.74341,LET_7B_5P,0.99999
REACTOME_REGULATION_OF_TP53_...6,SET,36,-0.092676,-0.0040996,0.14172,0.74343,REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION,0.99999
HP_PULMONARY_ARTERIAL_HYPERT...,SET,130,-0.047455,-0.0039789,0.072565,0.74343,HP_PULMONARY_ARTERIAL_HYPERTENSION,0.99999
BIOCARTA_CK1_PATHWAY,SET,16,-0.14682,-0.0043322,0.22441,0.74352,BIOCARTA_CK1_PATHWAY,0.99999
CAIRO_PML_TARGETS_BOUND_BY_M...2,SET,22,-0.12034,-0.0041629,0.18391,0.74354,CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,0.99999
GSE29949_CD8_POS_DC_SPLEEN_V...2,SET,184,-0.040192,-0.0040033,0.061421,0.74356,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP,0.99999
HP_ABNORMALITY_OF_THE_PERIPH...,SET,405,-0.027172,-0.0039908,0.04151,0.74363,HP_ABNORMALITY_OF_THE_PERIPHERAL_NERVOUS_SYSTEM,0.99999
WP_HIF1A_AND_PPARG_REGULATIO...,SET,6,-0.25466,-0.0046028,0.38904,0.74364,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,0.99999
HNF4_01_B,SET,233,-0.035081,-0.0039267,0.05359,0.74364,HNF4_01_B,0.99999
HP_INTRA_EPIDERMAL_BLISTERING,SET,6,-0.20537,-0.0037119,0.31369,0.74367,HP_INTRA_EPIDERMAL_BLISTERING,0.99999
HP_BLINDNESS,SET,266,-0.033126,-0.0039582,0.05059,0.7437,HP_BLINDNESS,0.99999
KEGG_MEDICUS_REFERENCE_PDGF_...2,SET,17,-0.14506,-0.0044118,0.22148,0.74374,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY,0.99999
MIR760,SET,116,-0.049802,-0.003946,0.076029,0.74378,MIR760,0.99999
HP_PROMINENT_NASAL_TIP,SET,25,-0.11489,-0.0042365,0.17538,0.74379,HP_PROMINENT_NASAL_TIP,0.99999
REACTOME_TRIGLYCERIDE_BIOSYN...,SET,12,-0.17331,-0.0044291,0.26453,0.74381,REACTOME_TRIGLYCERIDE_BIOSYNTHESIS,0.99999
MIR126_5P,SET,405,-0.02819,-0.0041402,0.043026,0.74382,MIR126_5P,0.99999
GOMF_SERINE_TYPE_EXOPEPTIDAS...,SET,12,-0.15632,-0.0039949,0.23856,0.74385,GOMF_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY,0.99999
GSE17186_MEMORY_VS_CD21LOW_T...2,SET,176,-0.040007,-0.0038981,0.06103,0.74393,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_UP,0.99999
HP_DEPLETION_OF_MITOCHONDRIA...,SET,16,-0.12456,-0.0036754,0.19001,0.74394,HP_DEPLETION_OF_MITOCHONDRIAL_DNA_IN_MUSCLE_TISSUE,0.99999
BLANCO_MELO_COVID19_SARS_COV...4,SET,425,-0.027375,-0.0041164,0.041743,0.74402,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,0.99999
REACTOME_HS_GAG_DEGRADATION,SET,21,-0.1274,-0.004306,0.19425,0.74404,REACTOME_HS_GAG_DEGRADATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...194,SET,13,-0.16385,-0.0043584,0.24975,0.74411,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,0.99999
HP_LARGE_FORAMEN_MAGNUM,SET,5,-0.23631,-0.0038991,0.36003,0.7442,HP_LARGE_FORAMEN_MAGNUM,0.99999
MIR548J_3P,SET,717,-0.02114,-0.0040951,0.032206,0.74421,MIR548J_3P,0.99999
GOBP_VENTRICULAR_SEPTUM_DEVE...,SET,70,-0.071132,-0.0043836,0.10836,0.74422,GOBP_VENTRICULAR_SEPTUM_DEVELOPMENT,0.99999
HP_DECREASED_MUSCLE_MASS,SET,53,-0.075717,-0.0040622,0.11534,0.74423,HP_DECREASED_MUSCLE_MASS,0.99999
GSE43863_LY6C_INT_CXCR5POS_V...1,SET,180,-0.041968,-0.0041349,0.063928,0.74424,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,0.99999
MIR585_5P,SET,119,-0.0527,-0.0042289,0.080258,0.74429,MIR585_5P,0.99999
GOMF_HISTONE_H4K12_ACETYLTRA...,SET,12,-0.15142,-0.0038696,0.23059,0.74429,GOMF_HISTONE_H4K12_ACETYLTRANSFERASE_ACTIVITY,0.99999
GSE29164_UNTREATED_VS_CD8_TC...2,SET,173,-0.040972,-0.0039582,0.062394,0.74429,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,0.99999
KEGG_RENAL_CELL_CARCINOMA,SET,64,-0.070005,-0.0041258,0.1066,0.7443,KEGG_RENAL_CELL_CARCINOMA,0.99999
HP_CLONUS,SET,98,-0.054568,-0.0039759,0.083098,0.7443,HP_CLONUS,0.99999
GOBP_CARDIAC_SEPTUM_CELL_DIF...,SET,5,-0.26376,-0.0043519,0.40155,0.74435,GOBP_CARDIAC_SEPTUM_CELL_DIFFERENTIATION,0.99999
HP_ABNORMAL_NASOPHARYNX_MORP...,SET,159,-0.04411,-0.0040869,0.067156,0.74435,HP_ABNORMAL_NASOPHARYNX_MORPHOLOGY,0.99999
chr10p13,SET,28,-0.18569,-0.007246,0.2827,0.74436,chr10p13,0.99999
HP_HYPERURICEMIA,SET,23,-0.10983,-0.0038849,0.16721,0.74436,HP_HYPERURICEMIA,0.99999
KEGG_MEDICUS_ENV_FACTOR_PARA...,SET,5,-0.27946,-0.0046109,0.42536,0.7444,KEGG_MEDICUS_ENV_FACTOR_PARAQUAT_TO_FAS_JNK_SIGNALING_PATHWAY,0.99999
chr16q13,SET,25,-0.1761,-0.0064937,0.268,0.74444,chr16q13,0.99999
GOCC_RNA_POLYMERASE_I_COMPLEX,SET,10,-0.15952,-0.0037218,0.24275,0.74445,GOCC_RNA_POLYMERASE_I_COMPLEX,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...13,SET,182,-0.039671,-0.0039301,0.060357,0.74449,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN,0.99999
GOCC_AXON_HILLOCK,SET,7,-0.21244,-0.0041472,0.32314,0.74454,GOCC_AXON_HILLOCK,0.99999
GSE42088_UNINF_VS_LEISHMANIA...4,SET,184,-0.042396,-0.0042228,0.064488,0.74454,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...4,SET,48,-0.084807,-0.0043305,0.12899,0.74455,GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2,0.99999
REACTOME_REGULATION_OF_GENE_...2,SET,21,-0.13207,-0.0044639,0.20082,0.74461,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS,0.99999
KEGG_OXIDATIVE_PHOSPHORYLATI...,SET,96,-0.051679,-0.0037271,0.078558,0.74468,KEGG_OXIDATIVE_PHOSPHORYLATION,0.99999
MIR509_5P,SET,141,-0.046153,-0.0040289,0.070148,0.74471,MIR509_5P,0.99999
GSE17812_WT_VS_THPOK_KO_MEMO...2,SET,182,-0.040399,-0.0040021,0.061383,0.74477,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_UP,0.99999
HALLMARK_MYC_TARGETS_V2,SET,56,-0.069883,-0.0038535,0.10618,0.74478,HALLMARK_MYC_TARGETS_V2,0.99999
GOCC_DISTAL_AXON,SET,249,-0.036226,-0.00419,0.055032,0.74481,GOCC_DISTAL_AXON,0.99999
GSE28237_FOLLICULAR_VS_EARLY...2,SET,167,-0.040393,-0.0038347,0.061354,0.74484,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP,0.99999
GOBP_RENAL_RESPONSE_TO_BLOOD...,SET,7,-0.25733,-0.0050235,0.39083,0.74486,GOBP_RENAL_RESPONSE_TO_BLOOD_FLOW_INVOLVED_IN_CIRCULATORY_RENIN_ANGIOTENSIN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
VALK_AML_CLUSTER_6,SET,32,-0.10002,-0.004172,0.15191,0.74487,VALK_AML_CLUSTER_6,0.99999
GSE17721_LPS_VS_POLYIC_8H_BM...2,SET,180,-0.040107,-0.0039516,0.060905,0.74489,GSE17721_LPS_VS_POLYIC_8H_BMDC_UP,0.99999
MIR4795_5P,SET,62,-0.071457,-0.0041453,0.10849,0.74494,MIR4795_5P,0.99999
GOBP_REGULATION_OF_CHROMOSOM...2,SET,225,-0.035439,-0.003899,0.053786,0.74501,GOBP_REGULATION_OF_CHROMOSOME_ORGANIZATION,0.99999
GOBP_RESPONSE_TO_CYTOKINE,SET,857,-0.02034,-0.0042905,0.030868,0.74503,GOBP_RESPONSE_TO_CYTOKINE,0.99999
HP_PRIMARY_ADRENAL_INSUFFICI...,SET,55,-0.07406,-0.0040473,0.11239,0.74503,HP_PRIMARY_ADRENAL_INSUFFICIENCY,0.99999
GSE37532_TREG_VS_TCONV_CD4_T...4,SET,118,-0.054453,-0.0043513,0.082623,0.74507,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,0.99999
REACTOME_BUTYRATE_RESPONSE_F...,SET,16,-0.12512,-0.0036919,0.18983,0.74509,REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA,0.99999
GOBP_RESPONSE_TO_STEROL,SET,32,-0.10311,-0.0043008,0.15642,0.7451,GOBP_RESPONSE_TO_STEROL,0.99999
GOBP_POSITIVE_REGULATION_OF_...760,SET,8,-0.18504,-0.0038617,0.2807,0.74512,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.99999
GSE27291_6H_VS_7D_STIM_GAMMA...2,SET,176,-0.039426,-0.0038415,0.059797,0.74515,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_UP,0.99999
HP_INCREASED_NEURONAL_AUTOFL...,SET,9,-0.18494,-0.0040936,0.28049,0.74516,HP_INCREASED_NEURONAL_AUTOFLUORESCENT_LIPOPIGMENT,0.99999
GOCC_LSM2_8_COMPLEX,SET,7,-0.19587,-0.0038238,0.29706,0.74517,GOCC_LSM2_8_COMPLEX,0.99999
PID_TCR_JNK_PATHWAY,SET,14,-0.14989,-0.0041373,0.2273,0.74518,PID_TCR_JNK_PATHWAY,0.99999
REACTOME_CLASS_I_PEROXISOMAL...,SET,18,-0.11894,-0.0037223,0.18037,0.74518,REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT,0.99999
GOBP_PHENOL_CONTAINING_COMPO...2,SET,7,-0.24566,-0.0047957,0.37251,0.7452,GOBP_PHENOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
MOOTHA_PYR,SET,5,-0.30858,-0.0050915,0.46776,0.74527,MOOTHA_PYR,0.99999
GOBP_FRUCTOSE_TRANSMEMBRANE_...,SET,9,-0.18469,-0.0040881,0.2799,0.74532,GOBP_FRUCTOSE_TRANSMEMBRANE_TRANSPORT,0.99999
HP_RETINAL_FLECKS,SET,8,-0.21445,-0.0044753,0.32488,0.74539,HP_RETINAL_FLECKS,0.99999
GOBP_DNA_CATABOLIC_PROCESS,SET,27,-0.10681,-0.0040928,0.16179,0.74542,GOBP_DNA_CATABOLIC_PROCESS,0.99999
GCM_ANP32B,SET,31,-0.09569,-0.0039285,0.1449,0.74549,GCM_ANP32B,0.99999
GOCC_SPECTRIN_ASSOCIATED_CYT...,SET,9,-0.18972,-0.0041993,0.28725,0.74552,GOCC_SPECTRIN_ASSOCIATED_CYTOSKELETON,0.99999
GSE15750_DAY6_VS_DAY10_TRAF6...2,SET,180,-0.040205,-0.0039612,0.060869,0.74553,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP,0.99999
GOBP_AUTOPHAGOSOME_MATURATION,SET,60,-0.064137,-0.0036604,0.097095,0.74555,GOBP_AUTOPHAGOSOME_MATURATION,0.99999
GSE14308_TH2_VS_NAIVE_CD4_TC...2,SET,175,-0.040079,-0.0038942,0.060673,0.74555,GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP,0.99999
MIR4297,SET,161,-0.045305,-0.0042237,0.068581,0.74556,MIR4297,0.99999
KIM_LIVER_CANCER_POOR_SURVIV...1,SET,41,-0.08516,-0.0040197,0.12889,0.7456,KIM_LIVER_CANCER_POOR_SURVIVAL_DN,0.99999
HIPC_SIGNATURES_PROJECT_PBMC...2,SET,9,-0.18468,-0.0040878,0.27951,0.7456,HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_UP,0.99999
GOBP_EXPLORATION_BEHAVIOR,SET,28,-0.11056,-0.004314,0.16729,0.74565,GOBP_EXPLORATION_BEHAVIOR,0.99999
GSE7460_WT_VS_FOXP3_HET_ACT_...4,SET,183,-0.040974,-0.0040701,0.062,0.74565,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...2,SET,184,-0.041128,-0.0040965,0.062224,0.74568,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
REACTOME_TRANSPORT_OF_RCBL_W...,SET,8,-0.19805,-0.004133,0.29958,0.74571,REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...236,SET,5,-0.29241,-0.0048247,0.44227,0.74574,GOBP_NEGATIVE_REGULATION_OF_FEEDING_BEHAVIOR,0.99999
SENESE_HDAC2_TARGETS_UP,SET,106,-0.052363,-0.0039671,0.079191,0.74576,SENESE_HDAC2_TARGETS_UP,0.99999
GOBP_PRESYNAPTIC_MODULATION_...,SET,33,-0.10124,-0.0042882,0.1531,0.74578,GOBP_PRESYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION,0.99999
AIZARANI_LIVER_C33_STELLATE_...,SET,117,-0.056469,-0.0044933,0.085379,0.74582,AIZARANI_LIVER_C33_STELLATE_CELLS_2,0.99999
chr18q21,SET,76,-0.11989,-0.0076973,0.18122,0.74587,chr18q21,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...11,SET,41,-0.088672,-0.0041855,0.13403,0.74587,GAVISH_3CA_METAPROGRAM_B_CELLS_RESPIRATION,0.99999
GOBP_DUMP_METABOLIC_PROCESS,SET,7,-0.22614,-0.0044147,0.34182,0.74588,GOBP_DUMP_METABOLIC_PROCESS,0.99999
GOBP_MONOCARBOXYLIC_ACID_BIO...,SET,202,-0.039995,-0.0041719,0.060453,0.74588,GOBP_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,0.99999
MODULE_28,SET,31,-0.086406,-0.0035474,0.13059,0.7459,MODULE_28,0.99999
GOBP_POSITIVE_REGULATION_OF_...844,SET,9,-0.19028,-0.0042116,0.28754,0.74592,GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.99999
HP_COMPLETE_ATRIOVENTRICULAR...,SET,16,-0.12897,-0.0038054,0.19489,0.74592,HP_COMPLETE_ATRIOVENTRICULAR_CANAL_DEFECT,0.99999
HP_SMALL_NAIL,SET,157,-0.043861,-0.0040384,0.066274,0.74595,HP_SMALL_NAIL,0.99999
GSE13485_DAY1_VS_DAY21_YF17D...1,SET,165,-0.040028,-0.0037775,0.060476,0.74597,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.99999
SOBOLEV_T_CELL_PANDEMRIX_AGE...2,SET,21,-0.12041,-0.0040697,0.18191,0.74597,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_7DY_DN,0.99999
HP_ABNORMAL_HEMOGLOBIN,SET,65,-0.067995,-0.0040385,0.10272,0.746,HP_ABNORMAL_HEMOGLOBIN,0.99999
BUSSLINGER_GASTRIC_D_CELLS,SET,24,-0.12833,-0.0046365,0.19385,0.74601,BUSSLINGER_GASTRIC_D_CELLS,0.99999
IK2_01,SET,235,-0.037582,-0.0042244,0.056764,0.74603,IK2_01,0.99999
HP_SENSORY_NEUROPATHY,SET,88,-0.05701,-0.0039373,0.086068,0.74613,HP_SENSORY_NEUROPATHY,0.99999
LOPES_METHYLATED_IN_COLON_CA...1,SET,28,-0.10856,-0.0042363,0.1639,0.74614,LOPES_METHYLATED_IN_COLON_CANCER_DN,0.99999
ATF_B,SET,174,-0.042889,-0.0041553,0.064709,0.74626,ATF_B,0.99999
HP_HYPOREFLEXIA,SET,349,-0.02912,-0.0039765,0.043935,0.74627,HP_HYPOREFLEXIA,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...10,SET,47,-0.09043,-0.0045694,0.13643,0.74628,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_3,0.99999
GOMF_HEPARIN_BINDING,SET,159,-0.048667,-0.0045092,0.073412,0.74631,GOMF_HEPARIN_BINDING,0.99999
PUJANA_CHEK2_PCC_NETWORK,SET,694,-0.020374,-0.0038854,0.030729,0.74634,PUJANA_CHEK2_PCC_NETWORK,0.99999
SMID_BREAST_CANCER_RELAPSE_I...4,SET,34,-0.10561,-0.0045404,0.15928,0.74635,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,0.99999
HP_3_4_FINGER_CUTANEOUS_SYND...,SET,6,-0.264,-0.0047715,0.39812,0.74637,HP_3_4_FINGER_CUTANEOUS_SYNDACTYLY,0.99999
GOBP_SECONDARY_METABOLIC_PRO...,SET,55,-0.08046,-0.0043971,0.12133,0.74638,GOBP_SECONDARY_METABOLIC_PROCESS,0.99999
GSE21063_3H_VS_16H_ANTI_IGM_...4,SET,180,-0.040458,-0.0039862,0.060992,0.74644,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP,0.99999
MORI_MATURE_B_LYMPHOCYTE_DN,SET,69,-0.065381,-0.0040005,0.098557,0.74645,MORI_MATURE_B_LYMPHOCYTE_DN,0.99999
GOBP_P38MAPK_CASCADE,SET,53,-0.08228,-0.0044143,0.12403,0.74646,GOBP_P38MAPK_CASCADE,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...11,SET,31,-0.11058,-0.0045398,0.16667,0.74648,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,0.99999
MORF_DAP3,SET,175,-0.038148,-0.0037065,0.057497,0.74648,MORF_DAP3,0.99999
HP_STIFF_NECK,SET,5,-0.26727,-0.0044098,0.40276,0.74652,HP_STIFF_NECK,0.99999
MIR3162_5P,SET,67,-0.066017,-0.0039806,0.099446,0.7466,MIR3162_5P,0.99999
MIR10393_5P,SET,135,-0.048543,-0.0041471,0.073121,0.74661,MIR10393_5P,0.99999
PILON_KLF1_TARGETS_UP,SET,439,-0.02719,-0.0041537,0.040947,0.74665,PILON_KLF1_TARGETS_UP,0.99999
MIR29A_5P,SET,183,-0.041707,-0.004143,0.062794,0.74671,MIR29A_5P,0.99999
MIR6889_5P,SET,11,-0.1783,-0.0043629,0.26842,0.74673,MIR6889_5P,0.99999
WIERENGA_STAT5A_TARGETS_GROU...1,SET,117,-0.053427,-0.0042513,0.080429,0.74674,WIERENGA_STAT5A_TARGETS_GROUP1,0.99999
MIR6881_5P,SET,48,-0.081996,-0.0041869,0.12339,0.74682,MIR6881_5P,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...3,SET,44,-0.086105,-0.00421,0.12956,0.74683,GAVISH_3CA_METAPROGRAM_EPITHELIAL_CELL_CYCLE,0.99999
GOBP_POSITIVE_REGULATION_OF_...429,SET,79,-0.061457,-0.0040225,0.092471,0.74684,GOBP_POSITIVE_REGULATION_OF_MACROAUTOPHAGY,0.99999
HP_OCCIPITAL_ENCEPHALOCELE,SET,36,-0.090283,-0.0039938,0.13584,0.74685,HP_OCCIPITAL_ENCEPHALOCELE,0.99999
GOBP_MATURATION_OF_5_8S_RRNA,SET,33,-0.08733,-0.003699,0.13139,0.74686,GOBP_MATURATION_OF_5_8S_RRNA,0.99999
MODULE_128,SET,87,-0.063545,-0.0043638,0.095592,0.74689,MODULE_128,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...35,SET,7,-0.1913,-0.0037344,0.28778,0.74689,HP_APLASIA_HYPOPLASIA_OF_THE_GALLBLADDER,0.99999
CAIRO_HEPATOBLASTOMA_POOR_SU...,SET,12,-0.15231,-0.0038924,0.2291,0.74691,CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL,0.99999
TTTNNANAGCYR_UNKNOWN,SET,79,-0.06523,-0.0042695,0.098108,0.74693,TTTNNANAGCYR_UNKNOWN,0.99999
GOBP_REGULATION_OF_WNT_PROTE...,SET,5,-0.25962,-0.0042836,0.39047,0.74693,GOBP_REGULATION_OF_WNT_PROTEIN_SECRETION,0.99999
GOBP_WNT_PROTEIN_SECRETION,SET,5,-0.25962,-0.0042836,0.39047,0.74693,GOBP_WNT_PROTEIN_SECRETION,0.99999
GOBP_POSITIVE_REGULATION_OF_...841,SET,60,-0.068665,-0.0039188,0.10326,0.74696,GOBP_POSITIVE_REGULATION_OF_VIRAL_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...613,SET,9,-0.19127,-0.0042336,0.2876,0.74699,GOBP_NEGATIVE_REGULATION_OF_STEROL_TRANSPORT,0.99999
FRASOR_TAMOXIFEN_RESPONSE_UP,SET,44,-0.086356,-0.0042223,0.12981,0.74705,FRASOR_TAMOXIFEN_RESPONSE_UP,0.99999
GNF2_SERPINI2,SET,21,-0.13978,-0.0047246,0.21,0.74717,GNF2_SERPINI2,0.99999
ONDER_CDH1_TARGETS_2_UP,SET,225,-0.039838,-0.0043829,0.059838,0.74721,ONDER_CDH1_TARGETS_2_UP,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...30,SET,45,-0.082969,-0.0041024,0.12463,0.74721,GAVISH_3CA_MALIGNANT_METAPROGRAM_38_GLUTATHIONE,0.99999
GOBP_CARDIAC_FIBROBLAST_CELL...,SET,4,-0.27631,-0.0040779,0.41499,0.74723,GOBP_CARDIAC_FIBROBLAST_CELL_DIFFERENTIATION,0.99999
GSE21546_UNSTIM_VS_ANTI_CD3_...7,SET,132,-0.049928,-0.0042181,0.074961,0.74731,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_DN,0.99999
HP_DEATH_IN_INFANCY,SET,221,-0.03657,-0.0039879,0.054887,0.74738,HP_DEATH_IN_INFANCY,0.99999
GCM_BCL2L1,SET,33,-0.086176,-0.0036501,0.12933,0.7474,GCM_BCL2L1,0.99999
SYED_ESTRADIOL_RESPONSE,SET,15,-0.14166,-0.0040475,0.21257,0.74743,SYED_ESTRADIOL_RESPONSE,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...21,SET,12,-0.17388,-0.0044437,0.26087,0.74746,GOBP_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME,0.99999
GSE41087_WT_VS_FOXP3_MUT_ANT...2,SET,166,-0.043507,-0.0041181,0.065266,0.74749,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,0.99999
HP_BILATERAL_SINGLE_TRANSVER...,SET,55,-0.077237,-0.0042209,0.11585,0.74751,HP_BILATERAL_SINGLE_TRANSVERSE_PALMAR_CREASES,0.99999
GOBP_SYNAPTIC_VESICLE_EXOCYT...,SET,90,-0.057435,-0.0040113,0.086144,0.74752,GOBP_SYNAPTIC_VESICLE_EXOCYTOSIS,0.99999
GSE29617_CTRL_VS_TIV_FLU_VAC...1,SET,171,-0.040776,-0.0039167,0.061151,0.74755,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN,0.99999
GOCC_CELL_POLE,SET,9,-0.18771,-0.0041548,0.28146,0.74758,GOCC_CELL_POLE,0.99999
GOBP_INTERLEUKIN_2_MEDIATED_...,SET,8,-0.22656,-0.004728,0.33965,0.74762,GOBP_INTERLEUKIN_2_MEDIATED_SIGNALING_PATHWAY,0.99999
GOMF_UBIQUITIN_UBIQUITIN_LIG...,SET,13,-0.13518,-0.0035958,0.20265,0.74763,GOMF_UBIQUITIN_UBIQUITIN_LIGASE_ACTIVITY,0.99999
HP_LOW_GRADE_FEVER,SET,11,-0.18348,-0.0044897,0.27506,0.74763,HP_LOW_GRADE_FEVER,0.99999
GOBP_LABYRINTHINE_LAYER_BLOO...,SET,18,-0.13736,-0.0042988,0.20587,0.74769,GOBP_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT,0.99999
GOMF_UNIPORTER_ACTIVITY,SET,9,-0.21943,-0.0048568,0.32885,0.74769,GOMF_UNIPORTER_ACTIVITY,0.99999
HP_IRON_ACCUMULATION_IN_BRAIN,SET,14,-0.13673,-0.0037742,0.20491,0.7477,HP_IRON_ACCUMULATION_IN_BRAIN,0.99999
GOBP_REGULATION_OF_SKELETAL_...1,SET,5,-0.23345,-0.0038518,0.34977,0.74775,GOBP_REGULATION_OF_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING,0.99999
HP_HYPOPLASIA_OF_THE_ODONTOI...,SET,22,-0.11688,-0.0040435,0.17512,0.74775,HP_HYPOPLASIA_OF_THE_ODONTOID_PROCESS,0.99999
HP_PTOSIS,SET,652,-0.02185,-0.0040438,0.032732,0.74779,HP_PTOSIS,0.99999
GOBP_GAMMA_AMINOBUTYRIC_ACID...5,SET,26,-0.12423,-0.0046717,0.18606,0.74784,GOBP_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY,0.99999
GSE21063_3H_VS_16H_ANTI_IGM_...2,SET,179,-0.043437,-0.0042678,0.065053,0.74784,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP,0.99999
GOBP_MEIOTIC_SISTER_CHROMATI...,SET,12,-0.17081,-0.0043652,0.25576,0.74788,GOBP_MEIOTIC_SISTER_CHROMATID_COHESION,0.99999
TERAMOTO_OPN_TARGETS_CLUSTER...1,SET,13,-0.15148,-0.0040292,0.22678,0.74792,TERAMOTO_OPN_TARGETS_CLUSTER_1,0.99999
GOBP_VESTIBULOCOCHLEAR_NERVE...1,SET,11,-0.19592,-0.0047941,0.29331,0.74792,GOBP_VESTIBULOCOCHLEAR_NERVE_DEVELOPMENT,0.99999
chr6p23,SET,7,-0.26474,-0.0051682,0.39622,0.74798,chr6p23,0.99999
GOBP_REGULATION_OF_MITOCHOND...12,SET,18,-0.13101,-0.0040999,0.19603,0.74803,GOBP_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GSE29949_MICROGLIA_BRAIN_VS_...2,SET,180,-0.042902,-0.004227,0.064189,0.74805,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,0.99999
REACTOME_KEAP1_NFE2L2_PATHWAY,SET,119,-0.050356,-0.0040408,0.075323,0.7481,REACTOME_KEAP1_NFE2L2_PATHWAY,0.99999
HP_ENDOCARDIAL_FIBROELASTOSIS,SET,7,-0.21619,-0.0042205,0.32335,0.74812,HP_ENDOCARDIAL_FIBROELASTOSIS,0.99999
GOBP_REGULATION_OF_CARTILAGE...,SET,62,-0.076141,-0.0044171,0.11385,0.74819,GOBP_REGULATION_OF_CARTILAGE_DEVELOPMENT,0.99999
GOBP_HEART_MORPHOGENESIS,SET,251,-0.038236,-0.0044399,0.057167,0.7482,GOBP_HEART_MORPHOGENESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...348,SET,5,-0.31042,-0.0051219,0.46406,0.74822,GOBP_POSITIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION,0.99999
MIR95_3P,SET,5,-0.27981,-0.0046167,0.41826,0.74824,MIR95_3P,0.99999
GOBP_SUCCINYL_COA_CATABOLIC_...,SET,6,-0.22567,-0.0040788,0.33734,0.74824,GOBP_SUCCINYL_COA_CATABOLIC_PROCESS,0.99999
HP_SECONDARY_AMENORRHEA,SET,62,-0.068399,-0.0039679,0.10225,0.74824,HP_SECONDARY_AMENORRHEA,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...8,SET,14,-0.13684,-0.0037772,0.20453,0.74826,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP,0.99999
MORF_RAB1A,SET,173,-0.039157,-0.003783,0.058519,0.74829,MORF_RAB1A,0.99999
GOMF_DENEDDYLASE_ACTIVITY,SET,6,-0.18805,-0.0033989,0.28104,0.74829,GOMF_DENEDDYLASE_ACTIVITY,0.99999
HP_VOLVULUS,SET,13,-0.15169,-0.004035,0.22671,0.74829,HP_VOLVULUS,0.99999
GSE29164_DAY3_VS_DAY7_CD8_TC...4,SET,181,-0.041227,-0.0040731,0.061579,0.74841,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP,0.99999
HP_ABNORMAL_FEMALE_REPRODUCT...,SET,354,-0.030093,-0.0041381,0.044941,0.74845,HP_ABNORMAL_FEMALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,0.99999
ZWANG_TRANSIENTLY_UP_BY_2ND_...,SET,1329,-0.016492,-0.0042735,0.024627,0.74847,ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY,0.99999
GSE40274_XBP1_VS_FOXP3_AND_X...2,SET,177,-0.042318,-0.0041349,0.063169,0.74854,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
PID_MYC_PATHWAY,SET,25,-0.11285,-0.0041612,0.16844,0.74855,PID_MYC_PATHWAY,0.99999
GOBP_SENSORY_PERCEPTION_OF_S...3,SET,7,-0.2032,-0.0039668,0.30326,0.74858,GOBP_SENSORY_PERCEPTION_OF_SWEET_TASTE,0.99999
GOBP_POSITIVE_REGULATION_OF_...331,SET,8,-0.18273,-0.0038135,0.27266,0.74862,GOBP_POSITIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,0.99999
HP_IRREGULARLY_SHAPED_SPERM_...,SET,11,-0.15158,-0.0037091,0.22618,0.74863,HP_IRREGULARLY_SHAPED_SPERM_TAIL,0.99999
WP_KISSPEPTINKISSPEPTIN_RECE...,SET,38,-0.093178,-0.0042346,0.13901,0.74866,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,0.99999
DEN_INTERACT_WITH_LCA5,SET,24,-0.12577,-0.0045442,0.18762,0.74868,DEN_INTERACT_WITH_LCA5,0.99999
SKIL_TARGET_GENES,SET,1478,-0.015491,-0.0042146,0.023109,0.74868,SKIL_TARGET_GENES,0.99999
FAN_EMBRYONIC_CTX_MICROGLIA_1,SET,137,-0.047532,-0.0040905,0.070905,0.74868,FAN_EMBRYONIC_CTX_MICROGLIA_1,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...65,SET,37,-0.07755,-0.0034777,0.11566,0.74873,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_TDP43_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,0.99999
HP_EMOTIONAL_LABILITY,SET,154,-0.044847,-0.0040899,0.066885,0.74873,HP_EMOTIONAL_LABILITY,0.99999
THAKAR_PBMC_INACTIVATED_INFL...8,SET,582,-0.022797,-0.0039938,0.033999,0.74873,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP,0.99999
GSE1925_CTRL_VS_3H_IFNG_STIM...4,SET,185,-0.040597,-0.0040544,0.060541,0.74875,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP,0.99999
BOYLAN_MULTIPLE_MYELOMA_PCA3...1,SET,63,-0.070884,-0.004145,0.1057,0.74876,BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,0.99999
NAKAMURA_ADIPOGENESIS_LATE_DN,SET,33,-0.10175,-0.0043099,0.15173,0.74877,NAKAMURA_ADIPOGENESIS_LATE_DN,0.99999
GERHOLD_RESPONSE_TO_TZD_DN,SET,11,-0.19904,-0.0048702,0.2966,0.7489,GERHOLD_RESPONSE_TO_TZD_DN,0.99999
REACTOME_METABOLISM_OF_POLYA...,SET,55,-0.066798,-0.0036504,0.099492,0.74901,REACTOME_METABOLISM_OF_POLYAMINES,0.99999
GSE29164_CD8_TCELL_VS_CD8_TC...2,SET,175,-0.041114,-0.0039946,0.06123,0.74903,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,0.99999
GOBP_ATP_SYNTHESIS_COUPLED_E...,SET,81,-0.054432,-0.0036074,0.081064,0.74904,GOBP_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT,0.99999
GOBP_CEREBELLAR_PURKINJE_CEL...3,SET,15,-0.14202,-0.0040577,0.21146,0.74908,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_MORPHOGENESIS,0.99999
GOCC_NADH_DEHYDROGENASE_COMP...,SET,40,-0.07535,-0.0035131,0.11219,0.74909,GOCC_NADH_DEHYDROGENASE_COMPLEX,0.99999
MARTINELLI_IMMATURE_NEUTROPH...1,SET,13,-0.18587,-0.0049439,0.27672,0.7491,MARTINELLI_IMMATURE_NEUTROPHIL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...132,SET,99,-0.061965,-0.0045377,0.092256,0.7491,GOBP_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,0.99999
HP_ADRENAL_INSUFFICIENCY,SET,93,-0.058829,-0.0041762,0.087581,0.74911,HP_ADRENAL_INSUFFICIENCY,0.99999
GSE15930_STIM_VS_STIM_AND_IL...3,SET,189,-0.044008,-0.0044419,0.065518,0.74911,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_DN,0.99999
HP_CLINODACTYLY_OF_THE_5TH_T...,SET,13,-0.16066,-0.0042736,0.23918,0.74912,HP_CLINODACTYLY_OF_THE_5TH_TOE,0.99999
LINDGREN_BLADDER_CANCER_CLUS...7,SET,288,-0.032843,-0.004081,0.048878,0.74919,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,0.99999
ZNF213_TARGET_GENES,SET,474,-0.025951,-0.0041155,0.038617,0.74921,ZNF213_TARGET_GENES,0.99999
GOBP_REGULATION_OF_INFLAMMAT...2,SET,39,-0.092452,-0.0042564,0.13757,0.74921,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.99999
GOBP_EPITHELIAL_CELL_PROLIFE...3,SET,10,-0.19264,-0.0044945,0.28662,0.74924,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,0.99999
GSE17721_0.5H_VS_4H_CPG_BMDC...2,SET,185,-0.039675,-0.0039624,0.059029,0.74924,GSE17721_0.5H_VS_4H_CPG_BMDC_UP,0.99999
HP_ABNORMAL_B_CELL_MORPHOLOGY,SET,90,-0.059907,-0.0041839,0.089122,0.74926,HP_ABNORMAL_B_CELL_MORPHOLOGY,0.99999
HP_ABNORMAL_PLACENTA_MORPHOL...,SET,33,-0.10648,-0.0045099,0.15836,0.74932,HP_ABNORMAL_PLACENTA_MORPHOLOGY,0.99999
CLIMENT_BREAST_CANCER_COPY_N...1,SET,8,-0.20208,-0.0042172,0.30044,0.7494,CLIMENT_BREAST_CANCER_COPY_NUMBER_DN,0.99999
GSE2706_2H_VS_8H_LPS_STIM_DC...1,SET,162,-0.045735,-0.0042769,0.067982,0.74944,GSE2706_2H_VS_8H_LPS_STIM_DC_DN,0.99999
MIR204_5P,SET,347,-0.030845,-0.0042001,0.045843,0.74947,MIR204_5P,0.99999
SOX11_TARGET_GENES,SET,35,-0.089706,-0.0039129,0.13331,0.7495,SOX11_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...232,SET,13,-0.1709,-0.0045457,0.25392,0.74954,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_OXIDATION,0.99999
GOBP_RETINA_VASCULATURE_MORP...,SET,9,-0.2013,-0.0044556,0.29902,0.74958,GOBP_RETINA_VASCULATURE_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.99999
SMID_BREAST_CANCER_RELAPSE_I...9,SET,22,-0.12145,-0.0042016,0.18039,0.74961,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN,0.99999
GSE8685_IL15_ACT_IL2_STARVED...1,SET,141,-0.047173,-0.004118,0.070064,0.74961,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,0.99999
MORF_G22P1,SET,152,-0.042038,-0.003809,0.06242,0.74967,MORF_G22P1,0.99999
REACTOME_INLA_MEDIATED_ENTRY...,SET,8,-0.20703,-0.0043205,0.30738,0.74969,REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS,0.99999
GSE4984_UNTREATED_VS_VEHICLE...2,SET,136,-0.048423,-0.004152,0.071894,0.74969,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP,0.99999
MORF_MAP2K2,SET,116,-0.048404,-0.0038352,0.071851,0.74973,MORF_MAP2K2,0.99999
ALFANO_MYC_TARGETS,SET,223,-0.03718,-0.0040725,0.055188,0.74974,ALFANO_MYC_TARGETS,0.99999
PID_ATF2_PATHWAY,SET,58,-0.078783,-0.0044209,0.11693,0.74977,PID_ATF2_PATHWAY,0.99999
GOBP_PROSTATE_GLANDULAR_ACIN...1,SET,10,-0.18862,-0.0044008,0.27985,0.74985,GOBP_PROSTATE_GLANDULAR_ACINUS_DEVELOPMENT,0.99999
MIR548AW,SET,539,-0.025099,-0.0042367,0.037233,0.74987,MIR548AW,0.99999
GOBP_LYMPHOID_PROGENITOR_CEL...,SET,24,-0.11711,-0.0042312,0.17373,0.74987,GOBP_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION,0.99999
KEGG_MEDICUS_REFERENCE_TYPE_...3,SET,20,-0.15679,-0.0051719,0.23259,0.74988,KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,0.99999
GOBP_FAT_SOLUBLE_VITAMIN_BIO...,SET,13,-0.16648,-0.0044282,0.24695,0.74988,GOBP_FAT_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS,0.99999
GOMF_SIALYLTRANSFERASE_ACTIV...,SET,21,-0.13204,-0.0044631,0.19586,0.74989,GOMF_SIALYLTRANSFERASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_EXTENT_OF...,SET,83,-0.062605,-0.0041997,0.092843,0.74994,GOBP_REGULATION_OF_EXTENT_OF_CELL_GROWTH,0.99999
HARALAMBIEVA_PBMC_FLUARIX_AG...2,SET,405,-0.027575,-0.00405,0.040891,0.74995,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_POSITIVE,0.99999
GOBP_ADULT_BEHAVIOR,SET,141,-0.049989,-0.0043638,0.074104,0.75002,GOBP_ADULT_BEHAVIOR,0.99999
GOCC_PEPTIDASE_INHIBITOR_COM...,SET,11,-0.16251,-0.0039764,0.24091,0.75002,GOCC_PEPTIDASE_INHIBITOR_COMPLEX,0.99999
HP_FLARED_ILIAC_WING,SET,16,-0.13784,-0.0040672,0.20434,0.75002,HP_FLARED_ILIAC_WING,0.99999
HP_ABNORMAL_METACARPOPHALANG...,SET,19,-0.13951,-0.0044854,0.20675,0.75008,HP_ABNORMAL_METACARPOPHALANGEAL_JOINT_MORPHOLOGY,0.99999
JACKSON_DNMT1_TARGETS_DN,SET,20,-0.13979,-0.004611,0.20715,0.75009,JACKSON_DNMT1_TARGETS_DN,0.99999
GSE35685_CD34POS_CD10NEG_CD6...2,SET,184,-0.040913,-0.0040751,0.060631,0.75009,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP,0.99999
GSE36392_EOSINOPHIL_VS_NEUTR...1,SET,179,-0.040737,-0.0040026,0.06037,0.75009,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,0.99999
GSE40274_CTRL_VS_LEF1_TRANSD...2,SET,155,-0.046304,-0.0042364,0.068606,0.75014,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
HP_GLIOSIS,SET,89,-0.059148,-0.004108,0.08763,0.75015,HP_GLIOSIS,0.99999
REACTOME_FATTY_ACYL_COA_BIOS...,SET,35,-0.1018,-0.0044402,0.15081,0.75017,REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,0.99999
ACEVEDO_LIVER_CANCER_UP,SET,861,-0.019366,-0.0040941,0.028685,0.7502,ACEVEDO_LIVER_CANCER_UP,0.99999
VANOEVELEN_MYOGENESIS_SIN3A_...,SET,207,-0.037458,-0.0039548,0.055476,0.75022,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,0.99999
WP_INTERFERONMEDIATED_SIGNAL...,SET,33,-0.12035,-0.0050974,0.17823,0.75023,WP_INTERFERONMEDIATED_SIGNALING,0.99999
MORF_WNT1,SET,93,-0.060217,-0.0042747,0.089154,0.75029,MORF_WNT1,0.99999
HP_DEATH_IN_ADOLESCENCE,SET,21,-0.1287,-0.0043501,0.19055,0.75029,HP_DEATH_IN_ADOLESCENCE,0.99999
ANDERSON_BLOOD_CN54GP140_ADJ...1,SET,77,-0.058864,-0.0038039,0.087144,0.75031,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN,0.99999
HP_ALEXIA,SET,7,-0.2032,-0.0039669,0.3008,0.75033,HP_ALEXIA,0.99999
FRASOR_RESPONSE_TO_ESTRADIOL...2,SET,33,-0.10173,-0.0043088,0.15051,0.75044,FRASOR_RESPONSE_TO_ESTRADIOL_UP,0.99999
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...8,SET,72,-0.069546,-0.0043465,0.1029,0.75044,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE,0.99999
GOBP_CRANIAL_NERVE_STRUCTURA...,SET,10,-0.20512,-0.0047857,0.30347,0.75045,GOBP_CRANIAL_NERVE_STRUCTURAL_ORGANIZATION,0.99999
GINESTIER_BREAST_CANCER_20Q1...2,SET,95,-0.058349,-0.0041862,0.086314,0.75048,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...3,SET,43,-0.090835,-0.0043906,0.13435,0.75051,GAVISH_3CA_METAPROGRAM_MACROPHAGES_LIPID_ASSOCIATED,0.99999
REACTOME_ALPHA_DEFENSINS,SET,6,-0.27153,-0.0049077,0.40159,0.75052,REACTOME_ALPHA_DEFENSINS,0.99999
GOMF_PROTEIN_KINASE_C_BINDING,SET,48,-0.087301,-0.0044578,0.1291,0.75055,GOMF_PROTEIN_KINASE_C_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...448,SET,10,-0.20187,-0.0047098,0.29848,0.75058,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.99999
REACTOME_DECTIN_1_MEDIATED_N...,SET,58,-0.067866,-0.0038083,0.10033,0.75062,REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,0.99999
GOCC_NLRP3_INFLAMMASOME_COMP...,SET,6,-0.22191,-0.0040108,0.32805,0.75062,GOCC_NLRP3_INFLAMMASOME_COMPLEX,0.99999
MODULE_72,SET,284,-0.033646,-0.004152,0.04973,0.75066,MODULE_72,0.99999
MATZUK_EARLY_ANTRAL_FOLLICLE,SET,12,-0.1828,-0.0046717,0.27017,0.75067,MATZUK_EARLY_ANTRAL_FOLLICLE,0.99999
GOMF_ATP_GATED_ION_CHANNEL_A...,SET,9,-0.19127,-0.0042336,0.28267,0.75068,GOMF_ATP_GATED_ION_CHANNEL_ACTIVITY,0.99999
REACTOME_VASOPRESSIN_REGULAT...,SET,42,-0.095107,-0.0045435,0.14054,0.7507,REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS,0.99999
GOBP_REGULATION_OF_FEEDING_B...,SET,25,-0.12969,-0.0047821,0.19163,0.75072,GOBP_REGULATION_OF_FEEDING_BEHAVIOR,0.99999
HP_GENERALIZED_NEONATAL_HYPO...,SET,18,-0.1211,-0.0037899,0.17894,0.75072,HP_GENERALIZED_NEONATAL_HYPOTONIA,0.99999
MZF1_TARGET_GENES,SET,1376,-0.016027,-0.0042199,0.023674,0.75079,MZF1_TARGET_GENES,0.99999
REACTOME_DCC_MEDIATED_ATTRAC...,SET,14,-0.14368,-0.0039658,0.21222,0.7508,REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...98,SET,3,-0.37522,-0.0047959,0.55422,0.7508,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,0.99999
GOBP_WOUND_HEALING_SPREADING...,SET,26,-0.10481,-0.0039414,0.15477,0.75087,GOBP_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,0.99999
GOBP_AMMONIUM_ION_METABOLIC_...,SET,22,-0.13684,-0.0047337,0.20204,0.75088,GOBP_AMMONIUM_ION_METABOLIC_PROCESS,0.99999
MIR12124,SET,289,-0.033092,-0.0041189,0.048858,0.75089,MIR12124,0.99999
GOMF_HYDROPEROXY_ICOSATETRAE...,SET,7,-0.23205,-0.0045301,0.34251,0.75096,GOMF_HYDROPEROXY_ICOSATETRAENOATE_DEHYDRATASE_ACTIVITY,0.99999
MIR8077,SET,61,-0.076971,-0.0044291,0.11359,0.75099,MIR8077,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...4,SET,179,-0.042004,-0.0041271,0.06197,0.75105,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP,0.99999
GSE36009_WT_VS_NLRP10_KO_DC_...2,SET,180,-0.039942,-0.0039353,0.058926,0.75106,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN,0.99999
MIR5701,SET,179,-0.043002,-0.0042251,0.063413,0.75115,MIR5701,0.99999
GOCC_MHC_CLASS_II_PROTEIN_CO...,SET,13,-0.19174,-0.0051001,0.28273,0.75117,GOCC_MHC_CLASS_II_PROTEIN_COMPLEX,0.99999
HP_CORNEAL_OPACITY,SET,246,-0.036845,-0.0042361,0.054327,0.75117,HP_CORNEAL_OPACITY,0.99999
HP_ANTERIOR_PITUITARY_HYPOPL...,SET,32,-0.10181,-0.0042467,0.15011,0.7512,HP_ANTERIOR_PITUITARY_HYPOPLASIA,0.99999
GOMF_TRNA_URIDINE_METHYLTRAN...,SET,3,-0.2677,-0.0034215,0.39463,0.75122,GOMF_TRNA_URIDINE_METHYLTRANSFERASE_ACTIVITY,0.99999
KRAS.AMP.LUNG_UP.V1_UP,SET,117,-0.055626,-0.0044263,0.08199,0.75125,KRAS.AMP.LUNG_UP.V1_UP,0.99999
HP_ATROPHY_DEGENERATION_AFFE...2,SET,750,-0.020445,-0.0040469,0.030127,0.75131,HP_ATROPHY_DEGENERATION_AFFECTING_THE_CENTRAL_NERVOUS_SYSTEM,0.99999
BIOCARTA_SALMONELLA_PATHWAY,SET,5,-0.20069,-0.0033113,0.29568,0.75134,BIOCARTA_SALMONELLA_PATHWAY,0.99999
HP_ABNORMAL_PUPILLARY_LIGHT_...,SET,28,-0.10942,-0.0042695,0.16121,0.75134,HP_ABNORMAL_PUPILLARY_LIGHT_REFLEX,0.99999
GOBP_REGULATION_OF_ACTIVIN_R...,SET,26,-0.1189,-0.0044712,0.17511,0.75143,GOBP_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE12003_4D_VS_8D_CULTURE_MI...1,SET,153,-0.046173,-0.0041972,0.067998,0.75144,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...2,SET,40,-0.085351,-0.0039794,0.12568,0.75147,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...605,SET,7,-0.22869,-0.0044644,0.33674,0.75147,GOBP_POSITIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.99999
GAVISH_3CA_METAPROGRAM_MACRO...1,SET,41,-0.091034,-0.004297,0.13402,0.75151,GAVISH_3CA_METAPROGRAM_MACROPHAGES_CELL_CYCLE,0.99999
GU_PDEF_TARGETS_DN,SET,37,-0.10399,-0.0046632,0.15303,0.75159,GU_PDEF_TARGETS_DN,0.99999
MATZUK_LUTEAL_GENES,SET,8,-0.20474,-0.0042727,0.3013,0.75159,MATZUK_LUTEAL_GENES,0.99999
HP_SCLEROTIC_VERTEBRAL_ENDPL...,SET,5,-0.28609,-0.0047205,0.42099,0.75161,HP_SCLEROTIC_VERTEBRAL_ENDPLATES,0.99999
HP_4_5_FINGER_SYNDACTYLY,SET,5,-0.28609,-0.0047205,0.42085,0.75168,HP_4_5_FINGER_SYNDACTYLY,0.99999
GOMF_POLY_PURINE_TRACT_BINDI...,SET,26,-0.11405,-0.0042888,0.16776,0.7517,GOMF_POLY_PURINE_TRACT_BINDING,0.99999
HP_COLITIS,SET,62,-0.074489,-0.0043212,0.10955,0.75173,HP_COLITIS,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...7,SET,188,-0.04011,-0.0040379,0.05898,0.75177,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN,0.99999
WNT_UP.V1_UP,SET,167,-0.045486,-0.0043182,0.066878,0.75178,WNT_UP.V1_UP,0.99999
GOMF_DNA_ENDONUCLEASE_ACTIVI...1,SET,38,-0.089262,-0.0040566,0.13123,0.7518,GOMF_DNA_ENDONUCLEASE_ACTIVITY,0.99999
LUI_TARGETS_OF_PAX8_PPARG_FU...,SET,32,-0.097118,-0.0040509,0.14278,0.75181,LUI_TARGETS_OF_PAX8_PPARG_FUSION,0.99999
WP_METABOLIC_REPROGRAMMING_I...1,SET,39,-0.085413,-0.0039323,0.12553,0.75187,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,0.99999
GOBP_MACROPHAGE_CHEMOTAXIS,SET,39,-0.090136,-0.0041497,0.13246,0.75189,GOBP_MACROPHAGE_CHEMOTAXIS,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...4,SET,23,-0.12691,-0.0044891,0.18638,0.75205,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,0.99999
GOBP_REACTIVE_GLIOSIS,SET,5,-0.28868,-0.0047632,0.42387,0.75208,GOBP_REACTIVE_GLIOSIS,0.99999
GSE11924_TFH_VS_TH1_CD4_TCEL...1,SET,174,-0.042929,-0.0041592,0.063033,0.75208,GSE11924_TFH_VS_TH1_CD4_TCELL_DN,0.99999
HP_ECTROPION,SET,58,-0.067809,-0.0038051,0.099554,0.7521,HP_ECTROPION,0.99999
MIR29B_1_5P,SET,155,-0.046265,-0.0042328,0.067917,0.75212,MIR29B_1_5P,0.99999
GOBP_ESTABLISHMENT_OF_LOCALI...,SET,1767,-0.013958,-0.0041164,0.020488,0.75215,GOBP_ESTABLISHMENT_OF_LOCALIZATION_IN_CELL,0.99999
GNF2_MLF1,SET,77,-0.065349,-0.004223,0.095911,0.75217,GNF2_MLF1,0.99999
GOBP_NEGATIVE_REGULATION_OF_...513,SET,62,-0.070277,-0.0040769,0.10314,0.75218,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_BINDING,0.99999
GSE3982_EOSINOPHIL_VS_NEUTRO...1,SET,170,-0.043724,-0.0041877,0.064169,0.75218,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOTI...2,SET,8,-0.21192,-0.0044226,0.31097,0.75221,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_CATABOLIC_PROCESS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...77,SET,37,-0.0788,-0.0035338,0.11562,0.75224,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,0.99999
HP_EXTRA_AXIAL_CEREBROSPINAL...,SET,14,-0.14445,-0.0039872,0.21193,0.75225,HP_EXTRA_AXIAL_CEREBROSPINAL_FLUID_ACCUMULATION,0.99999
GSE5589_UNSTIM_VS_180MIN_LPS...2,SET,183,-0.04132,-0.0041045,0.060621,0.75225,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,0.99999
BIOCARTA_PTC1_PATHWAY,SET,11,-0.15089,-0.0036921,0.22134,0.75228,BIOCARTA_PTC1_PATHWAY,0.99999
GOBP_REGULATION_OF_PIGMENTAT...,SET,17,-0.14313,-0.0043531,0.20995,0.75229,GOBP_REGULATION_OF_PIGMENTATION,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_M...4,SET,20,-0.12321,-0.0040642,0.18065,0.75238,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_CH...1,SET,286,-0.034391,-0.0042587,0.050422,0.7524,GOBP_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,0.99999
MIR10395_3P,SET,130,-0.04998,-0.0041906,0.073259,0.75245,MIR10395_3P,0.99999
GOBP_CELLULAR_RESPONSE_TO_CO...1,SET,10,-0.19185,-0.004476,0.28116,0.75248,GOBP_CELLULAR_RESPONSE_TO_COCAINE,0.99999
AIZARANI_LIVER_C3_NK_NKT_CEL...,SET,139,-0.050125,-0.0043447,0.073451,0.75251,AIZARANI_LIVER_C3_NK_NKT_CELLS_2,0.99999
GSE7852_TREG_VS_TCONV_FAT_UP,SET,183,-0.0431,-0.0042813,0.063152,0.75253,GSE7852_TREG_VS_TCONV_FAT_UP,0.99999
MENON_FETAL_KIDNEY_3_STROMAL...,SET,68,-0.074864,-0.0045475,0.10969,0.75254,MENON_FETAL_KIDNEY_3_STROMAL_CELLS,0.99999
RUAN_RESPONSE_TO_TROGLITAZON...1,SET,16,-0.15871,-0.0046831,0.23251,0.75257,RUAN_RESPONSE_TO_TROGLITAZONE_DN,0.99999
HP_SQUAMOUS_CELL_CARCINOMA,SET,62,-0.067956,-0.0039422,0.099554,0.75257,HP_SQUAMOUS_CELL_CARCINOMA,0.99999
GSE21927_C26GM_VS_4T1_TUMOR_...2,SET,175,-0.043675,-0.0042435,0.063981,0.75257,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,0.99999
GOBP_PHYSIOLOGICAL_CARDIAC_M...,SET,21,-0.1302,-0.0044007,0.1907,0.75261,GOBP_PHYSIOLOGICAL_CARDIAC_MUSCLE_HYPERTROPHY,0.99999
GOBP_POSITIVE_REGULATION_OF_...277,SET,61,-0.077843,-0.0044793,0.11401,0.75262,GOBP_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.99999
INGA_TP53_TARGETS,SET,16,-0.14031,-0.0041402,0.20546,0.75267,INGA_TP53_TARGETS,0.99999
SOGA_COLORECTAL_CANCER_MYC_DN,SET,69,-0.07111,-0.004351,0.10413,0.75267,SOGA_COLORECTAL_CANCER_MYC_DN,0.99999
FOXG1_TARGET_GENES,SET,476,-0.026332,-0.0041844,0.038557,0.75267,FOXG1_TARGET_GENES,0.99999
BROWNE_HCMV_INFECTION_18HR_DN,SET,167,-0.045018,-0.0042738,0.065911,0.75269,BROWNE_HCMV_INFECTION_18HR_DN,0.99999
HP_CHORIORETINAL_DEGENERATION,SET,48,-0.085828,-0.0043826,0.12566,0.7527,HP_CHORIORETINAL_DEGENERATION,0.99999
HP_MISSING_RIBS,SET,60,-0.071985,-0.0041083,0.10537,0.75274,HP_MISSING_RIBS,0.99999
TAL1ALPHAE47_01,SET,228,-0.040023,-0.0044321,0.058575,0.75278,TAL1ALPHAE47_01,0.99999
HP_ABNORMAL_CIRCULATING_ARGI...,SET,8,-0.18093,-0.0037759,0.26469,0.75287,HP_ABNORMAL_CIRCULATING_ARGININE_CONCENTRATION,0.99999
HP_PANCREATITIS,SET,71,-0.072501,-0.0044997,0.10606,0.75287,HP_PANCREATITIS,0.99999
GOBP_ANGIOGENESIS_INVOLVED_I...1,SET,5,-0.28808,-0.0047532,0.42132,0.75293,GOBP_ANGIOGENESIS_INVOLVED_IN_CORONARY_VASCULAR_MORPHOGENESIS,0.99999
GNF2_G22P1,SET,31,-0.095097,-0.0039042,0.13905,0.75298,GNF2_G22P1,0.99999
GOCC_X_CHROMOSOME,SET,6,-0.25936,-0.0046876,0.37922,0.75298,GOCC_X_CHROMOSOME,0.99999
GSE17721_LPS_VS_CPG_2H_BMDC_...2,SET,183,-0.043175,-0.0042888,0.06313,0.75298,GSE17721_LPS_VS_CPG_2H_BMDC_UP,0.99999
BIOCARTA_ARAP_PATHWAY,SET,17,-0.12488,-0.0037982,0.18255,0.75303,BIOCARTA_ARAP_PATHWAY,0.99999
REACTOME_SUMOYLATION_OF_UBIQ...,SET,37,-0.089869,-0.0040302,0.13135,0.75307,REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS,0.99999
GOBP_MEIOTIC_SPINDLE_ORGANIZ...,SET,16,-0.14777,-0.0043602,0.21596,0.75308,GOBP_MEIOTIC_SPINDLE_ORGANIZATION,0.99999
REACTOME_DOWNREGULATION_OF_E...1,SET,12,-0.17,-0.0043445,0.24842,0.7531,REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING,0.99999
GOBP_RESPONSE_TO_FUNGICIDE,SET,7,-0.19056,-0.00372,0.2784,0.75316,GOBP_RESPONSE_TO_FUNGICIDE,0.99999
HP_SEVERE_INTRAUTERINE_GROWT...,SET,13,-0.17027,-0.004529,0.2486,0.7533,HP_SEVERE_INTRAUTERINE_GROWTH_RETARDATION,0.99999
HP_VASCULAR_GRANULAR_OSMIOPH...,SET,12,-0.16568,-0.0042343,0.24185,0.75334,HP_VASCULAR_GRANULAR_OSMIOPHILIC_MATERIAL_DEPOSITION,0.99999
GOBP_GALACTOSE_CATABOLIC_PRO...1,SET,6,-0.2255,-0.0040758,0.32916,0.75335,GOBP_GALACTOSE_CATABOLIC_PROCESS,0.99999
MIR940,SET,164,-0.045229,-0.0042554,0.065995,0.75343,MIR940,0.99999
GOBP_AMEBOIDAL_TYPE_CELL_MIG...,SET,401,-0.030137,-0.0044048,0.043974,0.75343,GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION,0.99999
GOBP_REGULATION_OF_BRANCHING...3,SET,9,-0.19179,-0.0042451,0.27983,0.75344,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...5,SET,5,-0.26295,-0.0043387,0.38362,0.75347,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18,0.99999
FRANCO_BLOOD_SANOFI_PASTEUR_...7,SET,17,-0.14116,-0.0042932,0.20592,0.75348,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_3DY_POSITIVE,0.99999
GOCC_STEREOCILIA_ANKLE_LINK_...,SET,5,-0.272,-0.0044879,0.39674,0.75351,GOCC_STEREOCILIA_ANKLE_LINK_COMPLEX,0.99999
GOBP_AXONEME_ASSEMBLY,SET,70,-0.065941,-0.0040638,0.096179,0.75352,GOBP_AXONEME_ASSEMBLY,0.99999
HP_ABNORMALITY_OF_COAGULATION,SET,201,-0.040503,-0.0042145,0.059072,0.75353,HP_ABNORMALITY_OF_COAGULATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...623,SET,6,-0.26506,-0.0047907,0.38654,0.75355,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,0.99999
HP_ANTECUBITAL_PTERYGIUM,SET,7,-0.25071,-0.0048943,0.36554,0.7536,HP_ANTECUBITAL_PTERYGIUM,0.99999
HP_ABNORMAL_ULNAR_METAPHYSIS...,SET,10,-0.21678,-0.0050577,0.31603,0.75362,HP_ABNORMAL_ULNAR_METAPHYSIS_MORPHOLOGY,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...5,SET,166,-0.046043,-0.0043581,0.067125,0.75362,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN,0.99999
GOBP_RESPONSE_TO_MITOCHONDRI...,SET,16,-0.13676,-0.0040352,0.19928,0.75372,GOBP_RESPONSE_TO_MITOCHONDRIAL_DEPOLARISATION,0.99999
DESCARTES_FETAL_CEREBRUM_LIM...,SET,22,-0.13406,-0.0046375,0.1953,0.75376,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,0.99999
GOBP_ATRIAL_CARDIAC_MUSCLE_T...2,SET,5,-0.29472,-0.0048629,0.42938,0.75377,GOBP_ATRIAL_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,0.99999
HP_ATROPHY_DEGENERATION_INVO...1,SET,14,-0.16846,-0.00465,0.24543,0.75377,HP_ATROPHY_DEGENERATION_INVOLVING_THE_CAUDATE_NUCLEUS,0.99999
REACTOME_MET_ACTIVATES_RAP1_...,SET,11,-0.18821,-0.0046054,0.27415,0.75381,REACTOME_MET_ACTIVATES_RAP1_AND_RAC1,0.99999
WESTON_VEGFA_TARGETS,SET,85,-0.066369,-0.0045052,0.096659,0.75384,WESTON_VEGFA_TARGETS,0.99999
HP_OSTEOLYSIS,SET,72,-0.067561,-0.0042224,0.09838,0.75387,HP_OSTEOLYSIS,0.99999
GOBP_REGULATION_OF_PROTEASOM...1,SET,163,-0.044289,-0.0041544,0.064473,0.75394,GOBP_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_FIBROBLAS...1,SET,18,-0.13395,-0.004192,0.19496,0.75397,GOBP_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,0.99999
GCNP_SHH_UP_EARLY.V1_DN,SET,150,-0.047446,-0.0042709,0.069048,0.754,GCNP_SHH_UP_EARLY.V1_DN,0.99999
WP_EXRNA_MECHANISM_OF_ACTION...,SET,6,-0.21459,-0.0038785,0.31221,0.75405,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,0.99999
GOBP_DE_NOVO_CENTRIOLE_ASSEM...1,SET,5,-0.23354,-0.0038533,0.33977,0.75406,GOBP_DE_NOVO_CENTRIOLE_ASSEMBLY,0.99999
GSE20715_0H_VS_24H_OZONE_LUN...1,SET,189,-0.042806,-0.0043206,0.062276,0.75407,GSE20715_0H_VS_24H_OZONE_LUNG_DN,0.99999
PYEON_CANCER_HEAD_AND_NECK_V...2,SET,157,-0.046856,-0.0043142,0.068164,0.75408,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,0.99999
GOBP_NUCLEOSIDE_DIPHOSPHATE_...1,SET,13,-0.15667,-0.0041672,0.22792,0.75408,GOBP_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_EMBRYONIC_PATTERN_SPECI...,SET,63,-0.076214,-0.0044567,0.11087,0.75409,GOBP_EMBRYONIC_PATTERN_SPECIFICATION,0.99999
HP_ALOPECIA_TOTALIS,SET,13,-0.17961,-0.0047775,0.26123,0.75413,HP_ALOPECIA_TOTALIS,0.99999
HP_FEMORAL_HERNIA,SET,17,-0.15082,-0.004587,0.21929,0.7542,HP_FEMORAL_HERNIA,0.99999
KYNG_ENVIRONMENTAL_STRESS_RE...3,SET,33,-0.1013,-0.0042906,0.14727,0.75422,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,0.99999
ZFP3_TARGET_GENES,SET,286,-0.034303,-0.0042478,0.049868,0.75423,ZFP3_TARGET_GENES,0.99999
GOBP_MITOCHONDRIAL_RESPIRASO...,SET,7,-0.1867,-0.0036448,0.27127,0.75435,GOBP_MITOCHONDRIAL_RESPIRASOME_ASSEMBLY,0.99999
GOCC_LAMELLAR_BODY,SET,18,-0.14857,-0.0046496,0.21583,0.75439,GOCC_LAMELLAR_BODY,0.99999
GOBP_REGULATION_OF_INTRACELL...3,SET,139,-0.047378,-0.0041066,0.06882,0.7544,GOBP_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,0.99999
BENPORATH_ES_CORE_NINE_CORRE...,SET,94,-0.061529,-0.0043912,0.089349,0.75447,BENPORATH_ES_CORE_NINE_CORRELATED,0.99999
WP_SPHINGOLIPID_METABOLISM_O...,SET,23,-0.13144,-0.004649,0.19084,0.75449,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,0.99999
GSE35543_IN_VIVO_NTREG_VS_CO...2,SET,157,-0.045428,-0.0041827,0.06596,0.75449,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_UP,0.99999
REACTOME_NEPHRIN_FAMILY_INTE...,SET,21,-0.11994,-0.004054,0.17412,0.75453,REACTOME_NEPHRIN_FAMILY_INTERACTIONS,0.99999
GOBP_MACROPHAGE_FUSION,SET,6,-0.24836,-0.0044888,0.36055,0.75453,GOBP_MACROPHAGE_FUSION,0.99999
GOBP_EXTRACELLULAR_MATRIX_AS...,SET,43,-0.088781,-0.0042914,0.12888,0.75454,GOBP_EXTRACELLULAR_MATRIX_ASSEMBLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...337,SET,5,-0.29474,-0.0048632,0.42786,0.75454,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.99999
WP_EUKARYOTIC_TRANSCRIPTION_...,SET,41,-0.079586,-0.0037566,0.11552,0.75457,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,0.99999
GSE22229_RENAL_TRANSPLANT_VS...1,SET,178,-0.043895,-0.0043009,0.0637,0.75461,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN,0.99999
ZNF830_TARGET_GENES,SET,235,-0.037836,-0.004253,0.054902,0.75463,ZNF830_TARGET_GENES,0.99999
GSE29618_MONOCYTE_VS_PDC_DAY...1,SET,174,-0.043311,-0.0041962,0.062846,0.75463,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN,0.99999
GSE17721_4H_VS_24H_POLYIC_BM...2,SET,179,-0.042991,-0.0042241,0.062373,0.75467,GSE17721_4H_VS_24H_POLYIC_BMDC_UP,0.99999
GSE15330_HSC_VS_MEGAKARYOCYT...2,SET,176,-0.044597,-0.0043454,0.064695,0.75469,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,0.99999
GOBP_ANOIKIS,SET,31,-0.10863,-0.0044598,0.15757,0.75471,GOBP_ANOIKIS,0.99999
MODULE_340,SET,24,-0.1156,-0.0041767,0.16766,0.75473,MODULE_340,0.99999
MORF_PML,SET,133,-0.050208,-0.0042576,0.072816,0.75474,MORF_PML,0.99999
AR_Q6,SET,234,-0.038473,-0.0043155,0.055796,0.75475,AR_Q6,0.99999
GSE3982_EFF_MEMORY_CD4_TCELL...1,SET,172,-0.044189,-0.0042568,0.064078,0.75478,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN,0.99999
HP_ABSENT_FOVEAL_REFLEX,SET,14,-0.16128,-0.0044519,0.23385,0.7548,HP_ABSENT_FOVEAL_REFLEX,0.99999
GOBP_MESENCHYMAL_CELL_PROLIF...1,SET,42,-0.10298,-0.0049194,0.1493,0.75481,GOBP_MESENCHYMAL_CELL_PROLIFERATION,0.99999
MODULE_170,SET,89,-0.064985,-0.0045134,0.094189,0.75488,MODULE_170,0.99999
REACTOME_SIGNAL_AMPLIFICATION,SET,33,-0.10719,-0.00454,0.15533,0.75491,REACTOME_SIGNAL_AMPLIFICATION,0.99999
KAAB_HEART_ATRIUM_VS_VENTRIC...1,SET,240,-0.037268,-0.0042329,0.053993,0.75497,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,0.99999
MIR4720_5P,SET,79,-0.065208,-0.004268,0.094472,0.75497,MIR4720_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...827,SET,35,-0.108,-0.0047108,0.15646,0.75499,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.99999
MIR362_5P,SET,50,-0.080047,-0.0041715,0.11589,0.75512,MIR362_5P,0.99999
GOBP_VENTRAL_SPINAL_CORD_DEV...,SET,44,-0.094125,-0.0046022,0.13624,0.75518,GOBP_VENTRAL_SPINAL_CORD_DEVELOPMENT,0.99999
GOMF_L_ASPARTATE_TRANSMEMBRA...,SET,9,-0.18754,-0.0041511,0.27145,0.75518,GOMF_L_ASPARTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_OLIGODENDROCYTE_APOPTOT...,SET,5,-0.28756,-0.0047446,0.41619,0.75519,GOBP_OLIGODENDROCYTE_APOPTOTIC_PROCESS,0.99999
REACTOME_N_GLYCAN_ANTENNAE_E...2,SET,26,-0.12443,-0.0046792,0.18009,0.7552,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...7,SET,183,-0.043048,-0.0042762,0.062278,0.75528,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,0.99999
MODULE_253,SET,20,-0.1308,-0.0043144,0.18921,0.7553,MODULE_253,0.99999
HP_SINGLE_TRANSVERSE_PALMAR_...,SET,179,-0.042405,-0.0041665,0.061342,0.75531,HP_SINGLE_TRANSVERSE_PALMAR_CREASE,0.99999
GOBP_REGULATION_OF_POTASSIUM...2,SET,4,-0.32868,-0.0048507,0.47529,0.75538,GOBP_REGULATION_OF_POTASSIUM_ION_IMPORT,0.99999
GOBP_HEMATOPOIETIC_PROGENITO...,SET,128,-0.052504,-0.0043685,0.075885,0.75549,GOBP_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,0.99999
HP_COMPENSATORY_HEAD_POSTURE,SET,21,-0.1305,-0.0044107,0.18861,0.75549,HP_COMPENSATORY_HEAD_POSTURE,0.99999
HP_PROMINENT_COCCYX,SET,5,-0.29843,-0.004924,0.43125,0.75553,HP_PROMINENT_COCCYX,0.99999
GSE25088_WT_VS_STAT6_KO_MACR...1,SET,181,-0.043563,-0.0043038,0.062952,0.75553,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN,0.99999
GOBP_RESPONSE_TO_ESTRADIOL,SET,113,-0.056925,-0.004452,0.082247,0.75556,GOBP_RESPONSE_TO_ESTRADIOL,0.99999
KEGG_REGULATION_OF_AUTOPHAGY,SET,31,-0.12021,-0.0049353,0.17368,0.75558,KEGG_REGULATION_OF_AUTOPHAGY,0.99999
GOMF_ODORANT_BINDING,SET,95,-0.081109,-0.0058191,0.11717,0.7556,GOMF_ODORANT_BINDING,0.99999
GSE37416_0H_VS_6H_F_TULARENS...2,SET,166,-0.044896,-0.0042495,0.064857,0.7556,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
MIR4309,SET,40,-0.08612,-0.0040153,0.12438,0.75565,MIR4309,0.99999
HP_ABNORMAL_LIGHT_AND_DARK_A...,SET,35,-0.10618,-0.0046314,0.15335,0.75565,HP_ABNORMAL_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM,0.99999
DESCARTES_FETAL_CEREBRUM_EXC...,SET,13,-0.18324,-0.004874,0.26462,0.75567,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,0.99999
GSE11924_TFH_VS_TH2_CD4_TCEL...2,SET,183,-0.041036,-0.0040763,0.059252,0.7557,GSE11924_TFH_VS_TH2_CD4_TCELL_UP,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...2,SET,6,-0.23115,-0.0041778,0.33377,0.7557,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP,0.99999
HP_ECTOPIC_THYROID,SET,5,-0.29793,-0.0049158,0.43018,0.75571,HP_ECTOPIC_THYROID,0.99999
GOBP_POSITIVE_REGULATION_OF_...782,SET,95,-0.064087,-0.0045979,0.092481,0.75583,GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.99999
GOMF_PROTEIN_HORMONE_RECEPTO...,SET,18,-0.14906,-0.0046649,0.2151,0.75584,GOMF_PROTEIN_HORMONE_RECEPTOR_ACTIVITY,0.99999
GROSS_HYPOXIA_VIA_HIF1A_ONLY,SET,8,-0.22582,-0.0047126,0.32581,0.75587,GROSS_HYPOXIA_VIA_HIF1A_ONLY,0.99999
GOBP_VITAMIN_TRANSMEMBRANE_T...,SET,20,-0.12942,-0.0042691,0.1867,0.7559,GOBP_VITAMIN_TRANSMEMBRANE_TRANSPORT,0.99999
HP_ELEVATED_CIRCULATING_PARA...,SET,18,-0.15204,-0.004758,0.21931,0.75592,HP_ELEVATED_CIRCULATING_PARATHYROID_HORMONE_LEVEL,0.99999
MIR125A_3P,SET,68,-0.069436,-0.0042178,0.10015,0.75593,MIR125A_3P,0.99999
REACTOME_DNA_DAMAGE_REVERSAL,SET,8,-0.2022,-0.0042198,0.29164,0.75594,REACTOME_DNA_DAMAGE_REVERSAL,0.99999
GSE13547_CTRL_VS_ANTI_IGM_ST...5,SET,141,-0.050956,-0.0044482,0.073493,0.75595,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN,0.99999
MIR6811_3P,SET,55,-0.082157,-0.0044898,0.11849,0.75596,MIR6811_3P,0.99999
BUSSLINGER_DUODENAL_MATURE_E...,SET,237,-0.038157,-0.004307,0.05503,0.75596,BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES,0.99999
MIR301A_3P,SET,352,-0.031554,-0.0043268,0.045504,0.75598,MIR301A_3P,0.99999
REACTOME_INTERLEUKIN_1_PROCE...,SET,9,-0.18371,-0.0040664,0.2649,0.756,REACTOME_INTERLEUKIN_1_PROCESSING,0.99999
HP_ABNORMAL_LENGTH_OF_CORPUS...,SET,6,-0.25256,-0.0045649,0.36405,0.75608,HP_ABNORMAL_LENGTH_OF_CORPUS_CALLOSUM,0.99999
MIDORIKAWA_AMPLIFIED_IN_LIVE...,SET,51,-0.11984,-0.006307,0.17272,0.75609,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,0.99999
GOBP_REGULATION_OF_CARDIAC_M...7,SET,35,-0.1105,-0.00482,0.15924,0.75614,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.99999
GOBP_BONE_MARROW_DEVELOPMENT,SET,9,-0.20092,-0.0044473,0.28951,0.75616,GOBP_BONE_MARROW_DEVELOPMENT,0.99999
GOBP_MONOATOMIC_ION_HOMEOSTA...,SET,560,-0.025965,-0.0044649,0.037412,0.75616,GOBP_MONOATOMIC_ION_HOMEOSTASIS,0.99999
HP_GYNECOMASTIA,SET,91,-0.062059,-0.0043581,0.089407,0.75619,HP_GYNECOMASTIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...186,SET,12,-0.17966,-0.0045915,0.25881,0.75621,GOBP_NEGATIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.99999
HP_ABNORMAL_LEFT_VENTRICLE_M...,SET,111,-0.052351,-0.0040581,0.075412,0.75622,HP_ABNORMAL_LEFT_VENTRICLE_MORPHOLOGY,0.99999
GSE26928_EFF_MEM_VS_CENTR_ME...1,SET,146,-0.048776,-0.0043321,0.070261,0.75622,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN,0.99999
GSE30083_SP2_VS_SP4_THYMOCYT...2,SET,182,-0.045111,-0.004469,0.064983,0.75622,GSE30083_SP2_VS_SP4_THYMOCYTE_UP,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...5,SET,181,-0.042073,-0.0041566,0.060587,0.75628,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,0.99999
THUM_SYSTOLIC_HEART_FAILURE_...2,SET,366,-0.030867,-0.0043143,0.044444,0.75631,THUM_SYSTOLIC_HEART_FAILURE_UP,0.99999
GSE3982_BCELL_VS_BASOPHIL_DN,SET,176,-0.044542,-0.0043399,0.064116,0.75638,GSE3982_BCELL_VS_BASOPHIL_DN,0.99999
GSE43700_UNTREATED_VS_IL10_T...2,SET,184,-0.043665,-0.0043492,0.062846,0.7564,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...184,SET,30,-0.10238,-0.0041351,0.14734,0.75643,GOBP_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.99999
GOBP_ROOF_OF_MOUTH_DEVELOPME...,SET,89,-0.069584,-0.0048328,0.10014,0.75643,GOBP_ROOF_OF_MOUTH_DEVELOPMENT,0.99999
REACTOME_FORMATION_OF_LATERA...,SET,5,-0.27994,-0.0046189,0.40268,0.75652,REACTOME_FORMATION_OF_LATERAL_PLATE_MESODERM,0.99999
REACTOME_REGULATION_OF_CDH19...,SET,7,-0.245,-0.0047829,0.35243,0.75652,REACTOME_REGULATION_OF_CDH19_EXPRESSION_AND_FUNCTION,0.99999
PID_ER_NONGENOMIC_PATHWAY,SET,39,-0.090064,-0.0041464,0.12952,0.75657,PID_ER_NONGENOMIC_PATHWAY,0.99999
HP_TREMOR_BY_ANATOMICAL_SITE,SET,86,-0.064241,-0.0043863,0.092386,0.75658,HP_TREMOR_BY_ANATOMICAL_SITE,0.99999
HP_ABNORMAL_LIVER_METABOLITE...,SET,181,-0.042374,-0.0041864,0.06093,0.75661,HP_ABNORMAL_LIVER_METABOLITE_CONCENTRATION,0.99999
HP_ABNORMAL_CIRCULATING_IGM_...,SET,94,-0.061327,-0.0043768,0.088144,0.75671,HP_ABNORMAL_CIRCULATING_IGM_LEVEL,0.99999
PIT1_Q6,SET,202,-0.043634,-0.0045515,0.062694,0.75678,PIT1_Q6,0.99999
GSE28726_ACT_CD4_TCELL_VS_AC...3,SET,185,-0.042956,-0.00429,0.061719,0.75678,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN,0.99999
DESCARTES_FETAL_KIDNEY_METAN...,SET,110,-0.061557,-0.0047503,0.088426,0.75683,DESCARTES_FETAL_KIDNEY_METANEPHRIC_CELLS,0.99999
GOBP_MOLTING_CYCLE,SET,114,-0.059473,-0.0046717,0.085404,0.7569,GOBP_MOLTING_CYCLE,0.99999
GOBP_MITOCHONDRIAL_OUTER_MEM...,SET,26,-0.11069,-0.0041622,0.15893,0.75692,GOBP_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION,0.99999
HP_DECREASED_CIRCULATING_PRE...,SET,4,-0.33551,-0.0049516,0.48149,0.75704,HP_DECREASED_CIRCULATING_PREALBUMIN_CONCENTRATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...216,SET,28,-0.11139,-0.0043465,0.15983,0.75707,GOBP_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,0.99999
GOMF_G_PROTEIN_ACTIVITY,SET,46,-0.083535,-0.0041759,0.11986,0.75707,GOMF_G_PROTEIN_ACTIVITY,0.99999
MIR3606_5P,SET,141,-0.050764,-0.0044314,0.072838,0.75708,MIR3606_5P,0.99999
DESCARTES_FETAL_LIVER_STELLA...,SET,122,-0.060197,-0.0048906,0.086355,0.75712,DESCARTES_FETAL_LIVER_STELLATE_CELLS,0.99999
GOCC_GATOR2_COMPLEX,SET,8,-0.20744,-0.0043291,0.29748,0.75719,GOCC_GATOR2_COMPLEX,0.99999
TRAVAGLINI_LUNG_DIFFERENTIAT...,SET,148,-0.050509,-0.0045164,0.072434,0.75719,TRAVAGLINI_LUNG_DIFFERENTIATING_BASAL_CELL,0.99999
GOBP_ARGININE_CATABOLIC_PROC...,SET,9,-0.21777,-0.0048201,0.31228,0.7572,GOBP_ARGININE_CATABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...585,SET,9,-0.18467,-0.0040874,0.2648,0.75721,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_LUNG_LOBE_DEVELOPMENT,SET,7,-0.26318,-0.0051378,0.37734,0.75724,GOBP_LUNG_LOBE_DEVELOPMENT,0.99999
MIR499A_3P,SET,152,-0.050813,-0.0046041,0.072828,0.75732,MIR499A_3P,0.99999
MIR6893_3P,SET,86,-0.063429,-0.0043308,0.090906,0.75732,MIR6893_3P,0.99999
REACTOME_COLLAGEN_BIOSYNTHES...,SET,65,-0.078148,-0.0046415,0.112,0.75733,REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,0.99999
JAK2_DN.V1_DN,SET,116,-0.051668,-0.0040938,0.074043,0.75735,JAK2_DN.V1_DN,0.99999
GSE14000_UNSTIM_VS_16H_LPS_D...4,SET,169,-0.043698,-0.004173,0.062615,0.75737,GSE14000_UNSTIM_VS_16H_LPS_DC_UP,0.99999
GOBP_REGULATION_OF_MESENCHYM...1,SET,32,-0.11868,-0.0049501,0.17005,0.75738,GOBP_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.99999
MIR605_3P,SET,233,-0.038231,-0.0042793,0.054776,0.75739,MIR605_3P,0.99999
KEGG_MEDICUS_REFERENCE_MEMBR...,SET,9,-0.18919,-0.0041875,0.27103,0.75741,KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,0.99999
HP_TONGUE_FASCICULATIONS,SET,36,-0.09667,-0.0042763,0.13849,0.75742,HP_TONGUE_FASCICULATIONS,0.99999
HP_PETERS_ANOMALY,SET,18,-0.14203,-0.0044449,0.20345,0.75744,HP_PETERS_ANOMALY,0.99999
GSE3982_EOSINOPHIL_VS_BASOPH...2,SET,172,-0.044863,-0.0043218,0.064254,0.75747,GSE3982_EOSINOPHIL_VS_BASOPHIL_UP,0.99999
GSE21360_SECONDARY_VS_QUATER...2,SET,173,-0.048883,-0.0047226,0.070006,0.75749,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.99999
GSE10211_UV_INACT_SENDAI_VS_...1,SET,140,-0.049844,-0.0043358,0.071376,0.75751,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_MA...2,SET,7,-0.23385,-0.0045651,0.33482,0.75754,GOBP_CELLULAR_RESPONSE_TO_MAGNESIUM_ION,0.99999
REACTOME_SYNTHESIS_OF_EPOXY_...,SET,8,-0.20547,-0.0042879,0.29411,0.7576,REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET,0.99999
HP_DELAYED_BRAINSTEM_AUDITOR...,SET,3,-0.37496,-0.0047925,0.53669,0.75761,HP_DELAYED_BRAINSTEM_AUDITORY_EVOKED_RESPONSE_CONDUCTION_TIME,0.99999
GSE37301_HEMATOPOIETIC_STEM_...7,SET,154,-0.045917,-0.0041876,0.065709,0.75766,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_DN,0.99999
GSE557_WT_VS_CIITA_KO_DC_UP,SET,182,-0.040805,-0.0040424,0.058389,0.75767,GSE557_WT_VS_CIITA_KO_DC_UP,0.99999
USF_01,SET,229,-0.038309,-0.0042515,0.054812,0.75769,USF_01,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_LAT...2,SET,98,-0.063826,-0.0046505,0.091323,0.75769,HE_LIM_SUN_FETAL_LUNG_C1_LATE_BASAL_CELL,0.99999
MORF_MAP3K14,SET,106,-0.059175,-0.0044832,0.084657,0.75772,MORF_MAP3K14,0.99999
GOBP_PARATHYROID_GLAND_DEVEL...,SET,7,-0.21918,-0.0042787,0.31356,0.75772,GOBP_PARATHYROID_GLAND_DEVELOPMENT,0.99999
GOMF_ACETYLCHOLINE_BINDING,SET,10,-0.18114,-0.0042262,0.25908,0.75777,GOMF_ACETYLCHOLINE_BINDING,0.99999
MIR766_3P,SET,142,-0.050809,-0.0044509,0.072663,0.75779,MIR766_3P,0.99999
HP_ABNORMAL_BRONCHUS_PHYSIOL...,SET,20,-0.12282,-0.0040515,0.17566,0.75779,HP_ABNORMAL_BRONCHUS_PHYSIOLOGY,0.99999
GOBP_PROTEIN_DNA_COMPLEX_ORG...,SET,726,-0.021149,-0.0041215,0.030246,0.7578,GOBP_PROTEIN_DNA_COMPLEX_ORGANIZATION,0.99999
GOBP_MELANOSOME_ASSEMBLY,SET,18,-0.13866,-0.0043394,0.19828,0.75781,GOBP_MELANOSOME_ASSEMBLY,0.99999
GGARNTKYCCA_UNKNOWN,SET,70,-0.074756,-0.004607,0.1069,0.75782,GGARNTKYCCA_UNKNOWN,0.99999
MIR548O_3P,SET,250,-0.037964,-0.0043996,0.054281,0.75784,MIR548O_3P,0.99999
GOCC_GAMMA_DELTA_T_CELL_RECE...,SET,3,-0.34617,-0.0044245,0.49476,0.75793,GOCC_GAMMA_DELTA_T_CELL_RECEPTOR_COMPLEX,0.99999
GOBP_REGULATION_OF_AXON_GUID...,SET,11,-0.2045,-0.005004,0.29228,0.75794,GOBP_REGULATION_OF_AXON_GUIDANCE,0.99999
GOBP_EPIDERMIS_DEVELOPMENT,SET,356,-0.034355,-0.0047371,0.049091,0.75797,GOBP_EPIDERMIS_DEVELOPMENT,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...14,SET,172,-0.047119,-0.0045391,0.06732,0.75801,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP,0.99999
GSE40666_WT_VS_STAT1_KO_CD8_...1,SET,181,-0.043287,-0.0042766,0.061841,0.75802,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_DN,0.99999
GOBP_REGULATION_OF_UBIQUITIN...2,SET,18,-0.13605,-0.0042576,0.19432,0.75807,GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,0.99999
GOBP_STRIATED_MUSCLE_ADAPTAT...,SET,45,-0.091731,-0.0045357,0.13102,0.75807,GOBP_STRIATED_MUSCLE_ADAPTATION,0.99999
MODULE_235,SET,76,-0.06854,-0.0044005,0.097887,0.75809,MODULE_235,0.99999
HP_PUNCTATE_PALMOPLANTAR_HYP...,SET,6,-0.21544,-0.0038938,0.30766,0.75811,HP_PUNCTATE_PALMOPLANTAR_HYPERKERATOSIS,0.99999
KOKKINAKIS_METHIONINE_DEPRIV...2,SET,125,-0.05369,-0.0044149,0.076671,0.75812,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,0.99999
HP_HYPOTHALAMIC_GONADOTROPIN...,SET,20,-0.14551,-0.0047997,0.20773,0.75817,HP_HYPOTHALAMIC_GONADOTROPIN_RELEASING_HORMONE_DEFICIENCY,0.99999
GOBP_POSITIVE_REGULATION_OF_...250,SET,5,-0.30891,-0.0050969,0.44094,0.75821,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,0.99999
GOBP_RESPONSE_TO_PARATHYROID...,SET,10,-0.19804,-0.0046204,0.28268,0.75821,GOBP_RESPONSE_TO_PARATHYROID_HORMONE,0.99999
GOBP_MAMMARY_GLAND_DUCT_MORP...,SET,30,-0.11902,-0.0048071,0.16988,0.75823,GOBP_MAMMARY_GLAND_DUCT_MORPHOGENESIS,0.99999
HP_HYPOPLASIA_OF_THE_FEMORAL...,SET,5,-0.28813,-0.004754,0.41122,0.75824,HP_HYPOPLASIA_OF_THE_FEMORAL_HEAD,0.99999
GSE17721_0.5H_VS_4H_LPS_BMDC...2,SET,183,-0.041794,-0.0041516,0.05965,0.75824,GSE17721_0.5H_VS_4H_LPS_BMDC_UP,0.99999
MIR484,SET,81,-0.063993,-0.004241,0.091326,0.75825,MIR484,0.99999
GSE22589_HEALTHY_VS_HIV_INFE...1,SET,183,-0.043337,-0.0043049,0.06184,0.75828,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN,0.99999
MIR499B_3P,SET,153,-0.050885,-0.0046257,0.072608,0.75829,MIR499B_3P,0.99999
BROWNE_HCMV_INFECTION_14HR_DN,SET,257,-0.037063,-0.0043541,0.052879,0.75831,BROWNE_HCMV_INFECTION_14HR_DN,0.99999
BIOCARTA_CTLA4_PATHWAY,SET,17,-0.14554,-0.0044264,0.20765,0.75831,BIOCARTA_CTLA4_PATHWAY,0.99999
GOBP_UMP_CATABOLIC_PROCESS,SET,5,-0.27177,-0.0044841,0.38765,0.75837,GOBP_UMP_CATABOLIC_PROCESS,0.99999
HP_HYPERTRIGLYCERIDEMIA,SET,110,-0.058337,-0.0045018,0.083178,0.75845,HP_HYPERTRIGLYCERIDEMIA,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...23,SET,6,-0.18824,-0.0034023,0.26839,0.75847,GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM_EXIT_SITE,0.99999
MIR488_5P,SET,71,-0.069694,-0.0043255,0.099354,0.75849,MIR488_5P,0.99999
KEGG_ALZHEIMERS_DISEASE,SET,138,-0.045891,-0.0039636,0.065409,0.75853,KEGG_ALZHEIMERS_DISEASE,0.99999
GSE26495_NAIVE_VS_PD1LOW_CD8...1,SET,185,-0.044599,-0.0044541,0.063549,0.75859,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN,0.99999
HP_STRIAE_DISTENSAE,SET,33,-0.10446,-0.0044247,0.14884,0.75861,HP_STRIAE_DISTENSAE,0.99999
GSE2770_TGFB_AND_IL4_VS_IL12...5,SET,181,-0.041532,-0.0041032,0.059177,0.75861,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
HASLINGER_B_CLL_WITH_13Q14_D...,SET,23,-0.13228,-0.0046788,0.18846,0.75862,HASLINGER_B_CLL_WITH_13Q14_DELETION,0.99999
GSE35825_UNTREATED_VS_IFNG_S...1,SET,167,-0.044634,-0.0042373,0.06358,0.75866,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN,0.99999
DESCARTES_FETAL_LUNG_LYMPHAT...,SET,48,-0.090479,-0.0046201,0.12889,0.75866,DESCARTES_FETAL_LUNG_LYMPHATIC_ENDOTHELIAL_CELLS,0.99999
HP_INTRACELLULAR_ACCUMULATIO...,SET,13,-0.15854,-0.0042171,0.22583,0.75867,HP_INTRACELLULAR_ACCUMULATION_OF_AUTOFLUORESCENT_LIPOPIGMENT_STORAGE_MATERIAL,0.99999
GOBP_REGULATION_OF_HYDROGEN_...3,SET,17,-0.14109,-0.004291,0.20094,0.7587,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,0.99999
GOBP_VITAMIN_TRANSPORT,SET,48,-0.087606,-0.0044734,0.12475,0.75874,GOBP_VITAMIN_TRANSPORT,0.99999
GOBP_REGULATION_OF_BRANCHING...4,SET,17,-0.1557,-0.0047356,0.22168,0.75878,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS,0.99999
HP_INCREASED_LEVEL_OF_L_FUCO...,SET,16,-0.1473,-0.0043462,0.20969,0.75879,HP_INCREASED_LEVEL_OF_L_FUCOSE_IN_URINE,0.99999
MIR652_5P,SET,34,-0.09951,-0.0042781,0.14166,0.7588,MIR652_5P,0.99999
BASAKI_YBX1_TARGETS_UP,SET,261,-0.035825,-0.0042409,0.050993,0.75883,BASAKI_YBX1_TARGETS_UP,0.99999
HP_MICROPHTHALMIA,SET,239,-0.038224,-0.0043326,0.054406,0.75883,HP_MICROPHTHALMIA,0.99999
GYORFFY_MITOXANTRONE_RESISTA...,SET,32,-0.11333,-0.0047269,0.16128,0.75886,GYORFFY_MITOXANTRONE_RESISTANCE,0.99999
HP_ABNORMAL_METENCEPHALON_MO...,SET,887,-0.019695,-0.0042229,0.028029,0.75886,HP_ABNORMAL_METENCEPHALON_MORPHOLOGY,0.99999
HP_INTELLECTUAL_DISABILITY_S...,SET,312,-0.032645,-0.0042192,0.046455,0.75888,HP_INTELLECTUAL_DISABILITY_SEVERE,0.99999
DESCARTES_FETAL_INTESTINE_ER...,SET,132,-0.052582,-0.0044423,0.074803,0.75895,DESCARTES_FETAL_INTESTINE_ERYTHROBLASTS,0.99999
MIR147A,SET,57,-0.080367,-0.0044709,0.11431,0.75898,MIR147A,0.99999
HP_SENSORY_BEHAVIORAL_ABNORM...,SET,295,-0.034864,-0.0043835,0.049589,0.75898,HP_SENSORY_BEHAVIORAL_ABNORMALITY,0.99999
MIR5100,SET,84,-0.065751,-0.0044371,0.093518,0.75899,MIR5100,0.99999
AMIT_EGF_RESPONSE_120_HELA,SET,63,-0.074006,-0.0043276,0.10525,0.75902,AMIT_EGF_RESPONSE_120_HELA,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...9,SET,71,-0.074833,-0.0046444,0.10641,0.75904,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,0.99999
GSE27786_CD4_TCELL_VS_NKTCEL...1,SET,184,-0.042494,-0.0042326,0.060417,0.75908,GSE27786_CD4_TCELL_VS_NKTCELL_DN,0.99999
REACTOME_FRS_MEDIATED_FGFR4_...,SET,21,-0.12623,-0.0042665,0.17945,0.7591,REACTOME_FRS_MEDIATED_FGFR4_SIGNALING,0.99999
BIOCARTA_CACAM_PATHWAY,SET,9,-0.22925,-0.0050744,0.3259,0.75911,BIOCARTA_CACAM_PATHWAY,0.99999
HP_TONGUE_ATROPHY,SET,49,-0.081665,-0.0042131,0.11608,0.75912,HP_TONGUE_ATROPHY,0.99999
MCDOWELL_ACUTE_LUNG_INJURY_UP,SET,43,-0.095626,-0.0046223,0.1359,0.75916,MCDOWELL_ACUTE_LUNG_INJURY_UP,0.99999
GOBP_MATERNAL_PLACENTA_DEVEL...,SET,33,-0.10428,-0.004417,0.14821,0.75916,GOBP_MATERNAL_PLACENTA_DEVELOPMENT,0.99999
GOBP_NEPHRIC_DUCT_FORMATION,SET,5,-0.29772,-0.0049124,0.42312,0.75916,GOBP_NEPHRIC_DUCT_FORMATION,0.99999
GEORGES_CELL_CYCLE_MIR192_TA...,SET,58,-0.074539,-0.0041828,0.10592,0.7592,GEORGES_CELL_CYCLE_MIR192_TARGETS,0.99999
GSE37301_HEMATOPOIETIC_STEM_...11,SET,149,-0.045699,-0.0041,0.064922,0.75925,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_DN,0.99999
KEGG_OLFACTORY_TRANSDUCTION,SET,320,-0.045935,-0.006011,0.065252,0.75927,KEGG_OLFACTORY_TRANSDUCTION,0.99999
GOBP_MICROGLIAL_CELL_MIGRATI...,SET,8,-0.22953,-0.00479,0.32598,0.75931,GOBP_MICROGLIAL_CELL_MIGRATION,0.99999
DOANE_RESPONSE_TO_ANDROGEN_DN,SET,220,-0.040404,-0.0043961,0.057378,0.75933,DOANE_RESPONSE_TO_ANDROGEN_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...694,SET,16,-0.15699,-0.0046323,0.22291,0.75936,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_PERMEABILITY,0.99999
HP_SHORT_4TH_TOE,SET,5,-0.22347,-0.0036872,0.31725,0.7594,HP_SHORT_4TH_TOE,0.99999
REACTOME_RAP1_SIGNALLING,SET,16,-0.14985,-0.0044217,0.21265,0.7595,REACTOME_RAP1_SIGNALLING,0.99999
GSE6259_FLT3L_INDUCED_33D1_P...5,SET,129,-0.05217,-0.0043575,0.074027,0.75951,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_DN,0.99999
KEGG_MTOR_SIGNALING_PATHWAY,SET,49,-0.090863,-0.0046877,0.12892,0.75953,KEGG_MTOR_SIGNALING_PATHWAY,0.99999
GOBP_PHOSPHATIDYLGLYCEROL_BI...,SET,9,-0.2114,-0.0046793,0.29993,0.75954,GOBP_PHOSPHATIDYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...700,SET,26,-0.13027,-0.0048985,0.1848,0.75956,GOBP_NEGATIVE_REGULATION_OF_VIRAL_LIFE_CYCLE,0.99999
GOCC_PRESPLICEOSOME,SET,17,-0.14089,-0.0042849,0.19979,0.75965,GOCC_PRESPLICEOSOME,0.99999
HP_CHRONIC_NONINFECTIOUS_LYM...,SET,11,-0.17485,-0.0042785,0.24794,0.75966,HP_CHRONIC_NONINFECTIOUS_LYMPHADENOPATHY,0.99999
GOBP_VESTIBULOCOCHLEAR_NERVE...2,SET,5,-0.33067,-0.005456,0.46878,0.75971,GOBP_VESTIBULOCOCHLEAR_NERVE_FORMATION,0.99999
PID_INSULIN_GLUCOSE_PATHWAY,SET,26,-0.11502,-0.0043252,0.16303,0.75976,PID_INSULIN_GLUCOSE_PATHWAY,0.99999
GOBP_RESPONSE_TO_CATECHOLAMI...,SET,55,-0.084469,-0.0046161,0.11972,0.75977,GOBP_RESPONSE_TO_CATECHOLAMINE,0.99999
GSE20715_0H_VS_6H_OZONE_TLR4...1,SET,189,-0.043276,-0.004368,0.061328,0.75979,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN,0.99999
GOBP_RENAL_TUBULAR_SECRETION,SET,18,-0.14901,-0.0046632,0.21116,0.7598,GOBP_RENAL_TUBULAR_SECRETION,0.99999
GOBP_L_SERINE_CATABOLIC_PROC...,SET,3,-0.34231,-0.0043752,0.48503,0.75982,GOBP_L_SERINE_CATABOLIC_PROCESS,0.99999
HP_SINGLE_NARIS,SET,19,-0.13643,-0.0043866,0.19332,0.75982,HP_SINGLE_NARIS,0.99999
GSE39556_CD8A_DC_VS_NK_CELL_...1,SET,177,-0.046006,-0.0044952,0.065188,0.75982,GSE39556_CD8A_DC_VS_NK_CELL_DN,0.99999
GCM_RAD21,SET,32,-0.093546,-0.0039019,0.13253,0.75986,GCM_RAD21,0.99999
RTAAACA_FREAC2_01,SET,846,-0.021845,-0.0045798,0.030941,0.75991,RTAAACA_FREAC2_01,0.99999
REACTOME_DISORDERS_OF_TRANSM...,SET,166,-0.045094,-0.0042683,0.063864,0.75993,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,0.99999
GOBP_LENS_DEVELOPMENT_IN_CAM...,SET,79,-0.073926,-0.0048387,0.10468,0.75996,GOBP_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.99999
REACTOME_INITIAL_TRIGGERING_...,SET,17,-0.17171,-0.0052224,0.24311,0.75999,REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT,0.99999
BUCKANOVICH_T_LYMPHOCYTE_HOM...2,SET,18,-0.14626,-0.0045773,0.20708,0.76,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP,0.99999
MIR7854_3P,SET,99,-0.059411,-0.0043507,0.084113,0.76,MIR7854_3P,0.99999
BIOCARTA_MSP_PATHWAY,SET,6,-0.24963,-0.0045118,0.35334,0.76005,BIOCARTA_MSP_PATHWAY,0.99999
GOBP_MESENCHYMAL_CELL_DEVELO...,SET,6,-0.28512,-0.0051532,0.40351,0.76009,GOBP_MESENCHYMAL_CELL_DEVELOPMENT,0.99999
GOBP_DENDRITIC_CELL_MIGRATION,SET,31,-0.11722,-0.0048126,0.16586,0.76014,GOBP_DENDRITIC_CELL_MIGRATION,0.99999
KEGG_MEDICUS_REFERENCE_LPAR_...,SET,22,-0.13255,-0.0045854,0.18752,0.76017,KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...152,SET,5,-0.27195,-0.0044871,0.38459,0.76025,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_1_PRODUCTION,0.99999
HP_FAILURE_TO_THRIVE_SECONDA...,SET,6,-0.25782,-0.0046599,0.36461,0.76025,HP_FAILURE_TO_THRIVE_SECONDARY_TO_RECURRENT_INFECTIONS,0.99999
MIR6502_5P,SET,51,-0.083343,-0.0043864,0.11785,0.76028,MIR6502_5P,0.99999
HP_IRIDODONESIS,SET,4,-0.33859,-0.0049969,0.47863,0.76034,HP_IRIDODONESIS,0.99999
GOBP_BUNDLE_OF_HIS_CELL_TO_P...1,SET,15,-0.18274,-0.005221,0.25831,0.76035,GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_COMMUNICATION,0.99999
SU_THYMUS,SET,19,-0.15993,-0.005142,0.22603,0.76039,SU_THYMUS,0.99999
GOBP_PROTEIN_INSERTION_INTO_...3,SET,40,-0.092079,-0.0042931,0.13013,0.76039,GOBP_PROTEIN_INSERTION_INTO_MEMBRANE,0.99999
GSE25085_FETAL_LIVER_VS_FETA...2,SET,181,-0.041219,-0.0040723,0.058235,0.76046,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP,0.99999
DACOSTA_UV_RESPONSE_VIA_ERCC...2,SET,65,-0.072269,-0.0042923,0.10209,0.76048,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,0.99999
REACTOME_CA2_PATHWAY,SET,62,-0.076833,-0.0044572,0.10854,0.76048,REACTOME_CA2_PATHWAY,0.99999
GSE36476_YOUNG_VS_OLD_DONOR_...4,SET,176,-0.0464,-0.004521,0.065544,0.7605,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP,0.99999
GAVISH_3CA_METAPROGRAM_CD8_T...2,SET,42,-0.082474,-0.00394,0.11649,0.76053,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN,0.99999
JAEGER_METASTASIS_UP,SET,38,-0.099345,-0.0045148,0.14022,0.76067,JAEGER_METASTASIS_UP,0.99999
GSE21670_TGFB_VS_IL6_TREATED...1,SET,177,-0.042275,-0.0041306,0.059668,0.76068,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_DN,0.99999
GSE29949_MICROGLIA_BRAIN_VS_...5,SET,182,-0.043791,-0.0043382,0.061799,0.76071,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...190,SET,4,-0.24706,-0.0036461,0.3486,0.76075,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATIONAL_INITIATION,0.99999
GOCC_CATION_TRANSPORTING_ATP...,SET,18,-0.15468,-0.0048407,0.21825,0.76075,GOCC_CATION_TRANSPORTING_ATPASE_COMPLEX,0.99999
GOCC_IRON_SULFUR_CLUSTER_ASS...,SET,8,-0.22048,-0.0046011,0.31103,0.76079,GOCC_IRON_SULFUR_CLUSTER_ASSEMBLY_COMPLEX,0.99999
GOMF_DEUBIQUITINASE_ACTIVITY,SET,81,-0.059818,-0.0039643,0.084363,0.76085,GOMF_DEUBIQUITINASE_ACTIVITY,0.99999
GOBP_EXOCYTOSIS,SET,322,-0.033133,-0.0043491,0.046706,0.76095,GOBP_EXOCYTOSIS,0.99999
WP_ENERGY_METABOLISM,SET,47,-0.086731,-0.0043825,0.12225,0.76097,WP_ENERGY_METABOLISM,0.99999
chr10q23,SET,81,-0.12851,-0.0085169,0.18114,0.76098,chr10q23,0.99999
HP_LYMPHOMA,SET,112,-0.057141,-0.0044492,0.08052,0.76103,HP_LYMPHOMA,0.99999
GSE2826_XID_VS_BTK_KO_BCELL_...1,SET,185,-0.043954,-0.0043897,0.061931,0.76106,GSE2826_XID_VS_BTK_KO_BCELL_DN,0.99999
GOMF_RETINYL_PALMITATE_ESTER...,SET,6,-0.27461,-0.0049633,0.38678,0.76114,GOMF_RETINYL_PALMITATE_ESTERASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_FATTY_ACI...5,SET,31,-0.11855,-0.0048671,0.16696,0.76116,GOBP_REGULATION_OF_FATTY_ACID_TRANSPORT,0.99999
GTTAAAG_MIR302B,SET,63,-0.073354,-0.0042894,0.1033,0.76117,GTTAAAG_MIR302B,0.99999
ANDERSON_BLOOD_CN54GP140_ADJ...7,SET,6,-0.23,-0.004157,0.32391,0.76117,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_DN,0.99999
GOBP_CARDIAC_RIGHT_VENTRICLE...,SET,19,-0.15445,-0.004966,0.2175,0.76118,GOBP_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS,0.99999
CHEOK_RESPONSE_TO_MERCAPTOPU...1,SET,23,-0.12429,-0.0043962,0.17502,0.76119,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN,0.99999
REACTOME_GAMMA_CARBOXYLATION...2,SET,9,-0.20393,-0.0045138,0.28709,0.76124,REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,0.99999
GSE40655_FOXO1_KO_VS_WT_NTRE...2,SET,178,-0.042963,-0.0042096,0.060463,0.76132,GSE40655_FOXO1_KO_VS_WT_NTREG_UP,0.99999
GOBP_SRP_DEPENDENT_COTRANSLA...2,SET,3,-0.29183,-0.00373,0.41055,0.7614,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_SIGNAL_SEQUENCE_RECOGNITION,0.99999
HP_ABNORMAL_UPPER_LIP_MORPHO...,SET,814,-0.02119,-0.0043616,0.029807,0.76142,HP_ABNORMAL_UPPER_LIP_MORPHOLOGY,0.99999
GOBP_PROTEIN_CATABOLIC_PROCE...1,SET,909,-0.019805,-0.0042963,0.027851,0.76149,GOBP_PROTEIN_CATABOLIC_PROCESS,0.99999
CACCCBINDINGFACTOR_Q6,SET,242,-0.038803,-0.0044253,0.054562,0.76151,CACCCBINDINGFACTOR_Q6,0.99999
MIR3149,SET,130,-0.052639,-0.0044136,0.07396,0.76168,MIR3149,0.99999
GOBP_G_PROTEIN_COUPLED_PURIN...1,SET,10,-0.24094,-0.0056213,0.33853,0.76168,GOBP_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOMF_G_PROTEIN_COUPLED_PURIN...,SET,10,-0.24094,-0.0056213,0.33853,0.76168,GOMF_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY,0.99999
PHONG_TNF_RESPONSE_VIA_P38_P...,SET,155,-0.05206,-0.004763,0.073142,0.76169,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,0.99999
MODULE_322,SET,51,-0.079421,-0.0041799,0.11158,0.7617,MODULE_322,0.99999
GOBP_HIPPO_SIGNALING,SET,53,-0.089687,-0.0048116,0.126,0.7617,GOBP_HIPPO_SIGNALING,0.99999
GOBP_RESPONSE_TO_TOXIC_SUBST...,SET,225,-0.041594,-0.0045761,0.058421,0.76175,GOBP_RESPONSE_TO_TOXIC_SUBSTANCE,0.99999
HP_OSTEOCHONDROSIS,SET,12,-0.17859,-0.0045642,0.25085,0.76175,HP_OSTEOCHONDROSIS,0.99999
GOBP_SMAD_PROTEIN_SIGNAL_TRA...,SET,76,-0.076374,-0.0049034,0.10725,0.76179,GOBP_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
KEGG_MEDICUS_REFERENCE_ELECT...1,SET,36,-0.083294,-0.0036846,0.11691,0.76191,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_I,0.99999
GOBP_CARBOHYDRATE_METABOLIC_...,SET,516,-0.026323,-0.0043503,0.036938,0.76195,GOBP_CARBOHYDRATE_METABOLIC_PROCESS,0.99999
BLANCO_MELO_COVID19_SARS_COV...7,SET,16,-0.15,-0.004426,0.21046,0.76199,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_DN,0.99999
WUNDER_INFLAMMATORY_RESPONSE...1,SET,11,-0.18054,-0.0044175,0.25329,0.762,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN,0.99999
MIR3151_5P,SET,48,-0.079921,-0.004081,0.11213,0.762,MIR3151_5P,0.99999
GOBP_RIBONUCLEOSIDE_METABOLI...,SET,32,-0.12512,-0.0052191,0.1755,0.76206,GOBP_RIBONUCLEOSIDE_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...554,SET,22,-0.12039,-0.0041649,0.16881,0.76213,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.99999
GOCC_CATSPER_COMPLEX,SET,11,-0.1676,-0.0041009,0.235,0.76213,GOCC_CATSPER_COMPLEX,0.99999
HP_ABNORMAL_DERMOEPIDERMAL_J...,SET,12,-0.18542,-0.0047388,0.25998,0.76215,HP_ABNORMAL_DERMOEPIDERMAL_JUNCTION_MORPHOLOGY,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_PRO...1,SET,176,-0.049428,-0.004816,0.069295,0.76216,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_BASAL_CELL,0.99999
MIR1910_3P,SET,165,-0.047574,-0.0044895,0.066691,0.76218,MIR1910_3P,0.99999
NADLER_HYPERGLYCEMIA_AT_OBES...,SET,53,-0.087229,-0.0046798,0.12226,0.76222,NADLER_HYPERGLYCEMIA_AT_OBESITY,0.99999
HP_PHOTORECEPTOR_LAYER_LOSS_...,SET,5,-0.2469,-0.0040738,0.34604,0.76222,HP_PHOTORECEPTOR_LAYER_LOSS_ON_MACULAR_OCT,0.99999
HP_HYPERKETONEMIA,SET,4,-0.29818,-0.0044006,0.41788,0.76224,HP_HYPERKETONEMIA,0.99999
PID_THROMBIN_PAR1_PATHWAY,SET,42,-0.093635,-0.0044732,0.13118,0.76232,PID_THROMBIN_PAR1_PATHWAY,0.99999
chr2q31,SET,73,-0.12653,-0.0079622,0.17723,0.76235,chr2q31,0.99999
PID_TAP63_PATHWAY,SET,53,-0.082174,-0.0044086,0.1151,0.76236,PID_TAP63_PATHWAY,0.99999
GOBP_REGULATION_OF_CYSTEINE_...3,SET,11,-0.16605,-0.004063,0.23257,0.76237,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOMF_PROMOTER_SPECIFIC_CHROM...,SET,62,-0.073948,-0.0042898,0.10357,0.76237,GOMF_PROMOTER_SPECIFIC_CHROMATIN_BINDING,0.99999
REACTOME_PROTEIN_METHYLATION,SET,14,-0.16918,-0.0046698,0.23695,0.76238,REACTOME_PROTEIN_METHYLATION,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...3,SET,21,-0.14161,-0.0047864,0.19833,0.76239,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_CD4_T_CELLS,0.99999
PID_LKB1_PATHWAY,SET,45,-0.090818,-0.0044905,0.12714,0.76249,PID_LKB1_PATHWAY,0.99999
REACTOME_CELL_CELL_JUNCTION_...,SET,80,-0.074337,-0.0048961,0.10406,0.76249,REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,0.99999
GSE27434_WT_VS_DNMT1_KO_TREG...2,SET,182,-0.042232,-0.0041838,0.05912,0.76249,GSE27434_WT_VS_DNMT1_KO_TREG_UP,0.99999
MODULE_481,SET,81,-0.066963,-0.0044378,0.093732,0.76251,MODULE_481,0.99999
MODULE_544,SET,81,-0.066963,-0.0044378,0.093732,0.76251,MODULE_544,0.99999
HP_BONE_MARROW_MATURATION_AR...,SET,6,-0.24241,-0.0043813,0.33923,0.76256,HP_BONE_MARROW_MATURATION_ARREST,0.99999
GOBP_PROTEIN_MATURATION_BY_I...,SET,11,-0.18549,-0.0045388,0.25953,0.7626,GOBP_PROTEIN_MATURATION_BY_IRON_SULFUR_CLUSTER_TRANSFER,0.99999
GOBP_LIPID_BIOSYNTHETIC_PROC...,SET,668,-0.023624,-0.0044233,0.033049,0.76263,GOBP_LIPID_BIOSYNTHETIC_PROCESS,0.99999
ODONNELL_METASTASIS_DN,SET,23,-0.13928,-0.0049265,0.19485,0.76264,ODONNELL_METASTASIS_DN,0.99999
GOMF_PHOSPHATIDYLCHOLINE_FLI...,SET,5,-0.28078,-0.0046328,0.39276,0.76266,GOMF_PHOSPHATIDYLCHOLINE_FLIPPASE_ACTIVITY,0.99999
BIOCARTA_RANBP2_PATHWAY,SET,10,-0.19154,-0.0044687,0.26784,0.76272,BIOCARTA_RANBP2_PATHWAY,0.99999
MIR548AJ_3P_MIR548X_3P,SET,835,-0.02146,-0.0044712,0.030007,0.76274,MIR548AJ_3P_MIR548X_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...558,SET,18,-0.14253,-0.0044604,0.19928,0.76276,GOBP_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.99999
GSE22886_NEUTROPHIL_VS_MONOC...2,SET,169,-0.047849,-0.0045694,0.066898,0.76277,GSE22886_NEUTROPHIL_VS_MONOCYTE_UP,0.99999
TARTE_PLASMA_CELL_VS_B_LYMPH...2,SET,75,-0.069383,-0.0044254,0.096992,0.7628,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,0.99999
MYOGNF1_01,SET,41,-0.096578,-0.0045586,0.135,0.76282,MYOGNF1_01,0.99999
IWANAGA_E2F1_TARGETS_NOT_IND...,SET,6,-0.22041,-0.0039838,0.30808,0.76283,IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM,0.99999
GOBP_OVULATION,SET,16,-0.16779,-0.0049509,0.23444,0.76291,GOBP_OVULATION,0.99999
RYTGCNNRGNAAC_MIF1_01,SET,78,-0.06867,-0.0044663,0.095929,0.76295,RYTGCNNRGNAAC_MIF1_01,0.99999
MODULE_485,SET,49,-0.082199,-0.0042407,0.11483,0.76295,MODULE_485,0.99999
GOMF_MAP_KINASE_TYROSINE_SER...,SET,11,-0.19753,-0.0048334,0.27587,0.76301,GOMF_MAP_KINASE_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_CARDIAC_M...2,SET,27,-0.11999,-0.0045978,0.16757,0.76302,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.99999
GOBP_REGULATION_OF_VIRAL_GEN...,SET,80,-0.070643,-0.0046528,0.098631,0.76307,GOBP_REGULATION_OF_VIRAL_GENOME_REPLICATION,0.99999
HP_HYPOPLASTIC_AORTIC_ARCH,SET,11,-0.18106,-0.0044303,0.25277,0.76308,HP_HYPOPLASTIC_AORTIC_ARCH,0.99999
REACTOME_ACTIVATED_NTRK2_SIG...4,SET,7,-0.24464,-0.0047758,0.34154,0.76309,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K,0.99999
GOBP_CELLULAR_MODIFIED_AMINO...3,SET,175,-0.045245,-0.004396,0.063152,0.76314,GOBP_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS,0.99999
GAVIN_FOXP3_TARGETS_CLUSTER_...7,SET,91,-0.061465,-0.0043164,0.085761,0.76322,GAVIN_FOXP3_TARGETS_CLUSTER_T7,0.99999
GOBP_LEUKOCYTE_ADHESION_TO_V...,SET,47,-0.095436,-0.0048223,0.13312,0.76328,GOBP_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.99999
REACTOME_GP1B_IX_V_ACTIVATIO...,SET,11,-0.19908,-0.0048712,0.27761,0.76334,REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING,0.99999
WP_UDPDERIVED_SUGARS_SYNTHES...,SET,11,-0.18348,-0.0044896,0.25587,0.76334,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,0.99999
GSE1566_WT_VS_EZH2_KO_LN_TCE...2,SET,164,-0.048522,-0.0045652,0.06765,0.76339,GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP,0.99999
REACTOME_GLI_PROTEINS_BIND_P...,SET,7,-0.23878,-0.0046614,0.33281,0.76345,REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION,0.99999
GSE27670_CTRL_VS_LMP1_TRANSD...2,SET,181,-0.045034,-0.0044491,0.062767,0.76345,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_ET...2,SET,6,-0.2207,-0.003989,0.30757,0.76348,GOBP_CELLULAR_RESPONSE_TO_ETHER,0.99999
HP_ABNORMALITY_OF_EXTRAPYRAM...,SET,268,-0.036365,-0.0043612,0.050676,0.76349,HP_ABNORMALITY_OF_EXTRAPYRAMIDAL_MOTOR_FUNCTION,0.99999
RYTGCNWTGGNR_UNKNOWN,SET,100,-0.061559,-0.0045306,0.085775,0.76352,RYTGCNWTGGNR_UNKNOWN,0.99999
GOCC_INSULIN_RESPONSIVE_COMP...,SET,7,-0.21589,-0.0042145,0.30077,0.76355,GOCC_INSULIN_RESPONSIVE_COMPARTMENT,0.99999
IRF2_01,SET,118,-0.057179,-0.0045691,0.079651,0.76357,IRF2_01,0.99999
HP_ONYCHOLYSIS,SET,20,-0.13226,-0.0043627,0.18424,0.76357,HP_ONYCHOLYSIS,0.99999
HOXD11_TARGET_GENES,SET,117,-0.055491,-0.0044155,0.077283,0.76362,HOXD11_TARGET_GENES,0.99999
MIR5680,SET,425,-0.030753,-0.0046244,0.042829,0.76363,MIR5680,0.99999
DESCARTES_FETAL_INTESTINE_EN...2,SET,131,-0.057989,-0.0048807,0.080755,0.76364,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,0.99999
HP_RECURRENT_MENINGITIS,SET,3,-0.39443,-0.0050414,0.54923,0.76366,HP_RECURRENT_MENINGITIS,0.99999
GOBP_NUCLEOSIDE_BISPHOSPHATE...1,SET,51,-0.085044,-0.0044759,0.11841,0.76368,GOBP_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOCC_SITE_OF_POLARIZED_GROWTH,SET,153,-0.049002,-0.0044544,0.068227,0.76368,GOCC_SITE_OF_POLARIZED_GROWTH,0.99999
GOBP_RESPONSE_TO_ERYTHROPOIE...,SET,6,-0.29505,-0.0053328,0.41069,0.76375,GOBP_RESPONSE_TO_ERYTHROPOIETIN,0.99999
HP_GRANULAR_MACULAR_APPEARAN...,SET,8,-0.23836,-0.0049743,0.33165,0.76383,HP_GRANULAR_MACULAR_APPEARANCE,0.99999
KEGG_MEDICUS_PATHOGEN_SHIGEL...6,SET,5,-0.21603,-0.0035645,0.3005,0.7639,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGB1_TO_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,0.99999
chr9q34,SET,182,-0.080655,-0.0079902,0.11218,0.76392,chr9q34,0.99999
MIR3611,SET,135,-0.052504,-0.0044855,0.073001,0.76399,MIR3611,0.99999
HP_SPASTIC_PARAPARETIC_GAIT,SET,9,-0.22561,-0.0049938,0.31368,0.764,HP_SPASTIC_PARAPARETIC_GAIT,0.99999
HP_PRENATAL_DEATH,SET,61,-0.080684,-0.0046428,0.11217,0.76401,HP_PRENATAL_DEATH,0.99999
ZIRN_TRETINOIN_RESPONSE_DN,SET,5,-0.25566,-0.0042184,0.35542,0.76402,ZIRN_TRETINOIN_RESPONSE_DN,0.99999
WP_DNA_IRDOUBLE_STRAND_BREAK...,SET,52,-0.07672,-0.0040771,0.1066,0.76415,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,0.99999
GOBP_LEUKOTRIENE_D4_METABOLI...,SET,7,-0.23281,-0.0045449,0.32346,0.76416,GOBP_LEUKOTRIENE_D4_METABOLIC_PROCESS,0.99999
HOFMANN_MYELODYSPLASTIC_SYND...2,SET,8,-0.2217,-0.0046266,0.30797,0.76419,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...18,SET,182,-0.045772,-0.0045345,0.063579,0.76421,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP,0.99999
GSE8384_CTRL_VS_B_ABORTUS_4H...1,SET,177,-0.046412,-0.0045349,0.064457,0.76424,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...524,SET,192,-0.042894,-0.0043633,0.059563,0.76428,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION,0.99999
ROYLANCE_BREAST_CANCER_16Q_C...1,SET,24,-0.19021,-0.0068723,0.26406,0.76433,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN,0.99999
MIR3117_3P,SET,30,-0.11446,-0.0046227,0.15889,0.76434,MIR3117_3P,0.99999
NCX_01,SET,160,-0.049557,-0.0046059,0.068797,0.76434,NCX_01,0.99999
HP_PERIPORTAL_FIBROSIS,SET,10,-0.18401,-0.004293,0.25544,0.76434,HP_PERIPORTAL_FIBROSIS,0.99999
REACTOME_DEFECTS_IN_BIOTIN_B...,SET,8,-0.21118,-0.0044071,0.29315,0.76435,REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM,0.99999
PID_KIT_PATHWAY,SET,51,-0.092226,-0.0048538,0.12799,0.7644,PID_KIT_PATHWAY,0.99999
HP_ABNORMALITY_OF_THE_SUBUNG...,SET,11,-0.16683,-0.0040822,0.23153,0.7644,HP_ABNORMALITY_OF_THE_SUBUNGUAL_REGION,0.99999
HP_ABNORMAL_AUDITORY_CANAL_M...,SET,76,-0.068996,-0.0044298,0.095738,0.76444,HP_ABNORMAL_AUDITORY_CANAL_MORPHOLOGY,0.99999
GOCC_BASEMENT_MEMBRANE_COLLA...,SET,6,-0.26418,-0.0047749,0.36655,0.76446,GOCC_BASEMENT_MEMBRANE_COLLAGEN_TRIMER,0.99999
GGCAGCT_MIR22,SET,209,-0.041694,-0.004423,0.057843,0.76448,GGCAGCT_MIR22,0.99999
PID_INTEGRIN_A9B1_PATHWAY,SET,22,-0.13928,-0.0048183,0.19322,0.76449,PID_INTEGRIN_A9B1_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...739,SET,8,-0.20938,-0.0043695,0.29042,0.76452,GOBP_POSITIVE_REGULATION_OF_SYNAPSE_MATURATION,0.99999
SHIN_B_CELL_LYMPHOMA_CLUSTER...6,SET,27,-0.11334,-0.004343,0.15718,0.76456,SHIN_B_CELL_LYMPHOMA_CLUSTER_7,0.99999
HP_INCREASED_BODY_WEIGHT,SET,424,-0.030354,-0.004559,0.042087,0.7646,HP_INCREASED_BODY_WEIGHT,0.99999
GOBP_SA_NODE_CELL_TO_ATRIAL_...1,SET,11,-0.198,-0.0048449,0.27452,0.76462,GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_COMMUNICATION,0.99999
WP_RALA_DOWNSTREAM_REGULATED...,SET,12,-0.16412,-0.0041944,0.22755,0.76463,WP_RALA_DOWNSTREAM_REGULATED_GENES,0.99999
PID_VEGFR1_2_PATHWAY,SET,68,-0.073329,-0.0044543,0.10166,0.76464,PID_VEGFR1_2_PATHWAY,0.99999
WP_ALZHEIMERS_DISEASE,SET,247,-0.038075,-0.0043863,0.052785,0.76464,WP_ALZHEIMERS_DISEASE,0.99999
WP_ALZHEIMERS_DISEASE_AND_MI...,SET,247,-0.038075,-0.0043863,0.052785,0.76464,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,0.99999
GOMF_GLYCINE_TRANSMEMBRANE_T...,SET,9,-0.2108,-0.0046659,0.29222,0.76466,GOMF_GLYCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_CONGENITAL_THROMBOCYTOPEN...,SET,4,-0.26759,-0.0039492,0.37095,0.76466,HP_CONGENITAL_THROMBOCYTOPENIA,0.99999
GOMF_MONOATOMIC_CATION_BICAR...,SET,13,-0.15448,-0.004109,0.21412,0.76468,GOMF_MONOATOMIC_CATION_BICARBONATE_SYMPORTER_ACTIVITY,0.99999
GOBP_CELLULAR_RESPONSE_TO_OX...3,SET,1069,-0.019724,-0.0046185,0.027335,0.76471,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND,0.99999
GOMF_GALACTOSIDE_BINDING,SET,5,-0.30761,-0.0050755,0.42628,0.76473,GOMF_GALACTOSIDE_BINDING,0.99999
GSE17721_LPS_VS_PAM3CSK4_2H_...1,SET,178,-0.044104,-0.0043214,0.061118,0.76473,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_DN,0.99999
GSE26488_HDAC7_KO_VS_VP16_TR...1,SET,186,-0.044834,-0.0044896,0.062117,0.76478,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,0.99999
KEGG_HYPERTROPHIC_CARDIOMYOP...,SET,79,-0.071902,-0.0047062,0.099592,0.76484,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,0.99999
MIR7157_3P,SET,173,-0.047285,-0.0045682,0.065488,0.76486,MIR7157_3P,0.99999
GSE21360_SECONDARY_VS_TERTIA...1,SET,149,-0.048238,-0.0043278,0.066794,0.76491,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.99999
HP_INEFFECTIVE_ESOPHAGEAL_PE...,SET,14,-0.15974,-0.0044092,0.22116,0.76493,HP_INEFFECTIVE_ESOPHAGEAL_PERISTALSIS,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_FGF...,SET,45,-0.09226,-0.0045618,0.12772,0.76496,HE_LIM_SUN_FETAL_LUNG_C7_FGFBP2_POS_NEURAL_PROGENITOR_CELL,0.99999
MIR125B_5P,SET,296,-0.035434,-0.0044626,0.049045,0.76499,MIR125B_5P,0.99999
HP_ABNORMAL_NERVE_CONDUCTION...,SET,104,-0.057471,-0.004313,0.079546,0.765,HP_ABNORMAL_NERVE_CONDUCTION_VELOCITY,0.99999
HP_ABNORMAL_CELL_MORPHOLOGY,SET,42,-0.089029,-0.0042531,0.1232,0.76505,HP_ABNORMAL_CELL_MORPHOLOGY,0.99999
OKUMURA_INFLAMMATORY_RESPONS...,SET,156,-0.048519,-0.0044532,0.06713,0.76508,OKUMURA_INFLAMMATORY_RESPONSE_LPS,0.99999
GOBP_CEREBELLAR_GRANULAR_LAY...2,SET,6,-0.3141,-0.0056771,0.43452,0.76512,GOBP_CEREBELLAR_GRANULAR_LAYER_FORMATION,0.99999
HP_SWAN_NECK_LIKE_DEFORMITIE...,SET,8,-0.23056,-0.0048116,0.31894,0.76513,HP_SWAN_NECK_LIKE_DEFORMITIES_OF_THE_FINGERS,0.99999
GOMF_G_PROTEIN_COUPLED_GLUTA...2,SET,8,-0.22026,-0.0045966,0.30463,0.76517,GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_BINDING,0.99999
MIR6876_5P,SET,204,-0.043253,-0.0045338,0.059814,0.7652,MIR6876_5P,0.99999
MODULE_445,SET,11,-0.18714,-0.0045792,0.25875,0.76523,MODULE_445,0.99999
GOBP_TEMPERATURE_HOMEOSTASIS,SET,177,-0.047425,-0.0046338,0.065546,0.76532,GOBP_TEMPERATURE_HOMEOSTASIS,0.99999
MIR874_5P,SET,55,-0.077385,-0.004229,0.10695,0.76533,MIR874_5P,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...9,SET,5,-0.32444,-0.0053533,0.44838,0.76534,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_TNF_JNK_SIGNALING_PATHWAY,0.99999
HP_PROTUBERANT_ABDOMEN,SET,39,-0.099406,-0.0045765,0.13735,0.76538,HP_PROTUBERANT_ABDOMEN,0.99999
PID_IL4_2PATHWAY,SET,55,-0.085417,-0.0046679,0.11801,0.7654,PID_IL4_2PATHWAY,0.99999
GOBP_RESPONSE_TO_OXYGEN_CONT...,SET,1509,-0.01675,-0.0046004,0.023138,0.76544,GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND,0.99999
GOBP_NEGATIVE_REGULATION_OF_...39,SET,7,-0.2284,-0.0044588,0.31548,0.76545,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.99999
GOBP_FLAVONOID_GLUCURONIDATI...,SET,5,-0.59745,-0.0098578,0.82479,0.76558,GOBP_FLAVONOID_GLUCURONIDATION,0.99999
HP_ABNORMAL_FEMORAL_HEAD_MOR...,SET,87,-0.06579,-0.0045179,0.090814,0.7656,HP_ABNORMAL_FEMORAL_HEAD_MORPHOLOGY,0.99999
IIZUKA_LIVER_CANCER_PROGRESS...1,SET,23,-0.11309,-0.004,0.1561,0.76561,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN,0.99999
HP_U_SHAPED_UPPER_LIP_VERMIL...,SET,6,-0.20164,-0.0036445,0.27833,0.76561,HP_U_SHAPED_UPPER_LIP_VERMILION,0.99999
GOBP_REGULATION_OF_MITOCHOND...2,SET,17,-0.15531,-0.0047235,0.21435,0.76563,GOBP_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,0.99999
ACEVEDO_LIVER_CANCER_WITH_H3...3,SET,82,-0.066569,-0.0044387,0.091871,0.76564,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,0.99999
HP_MYOGLOBINURIA,SET,23,-0.11124,-0.0039345,0.15351,0.76565,HP_MYOGLOBINURIA,0.99999
GSE5542_UNTREATED_VS_IFNG_TR...4,SET,171,-0.046815,-0.0044968,0.064598,0.76568,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.99999
REACTOME_GLYCOGEN_METABOLISM,SET,21,-0.12651,-0.004276,0.17455,0.7657,REACTOME_GLYCOGEN_METABOLISM,0.99999
GOBP_POSITIVE_REGULATION_OF_...271,SET,12,-0.18695,-0.0047778,0.25794,0.76571,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.99999
EPPERT_HSC_R,SET,107,-0.06102,-0.0046446,0.08418,0.76573,EPPERT_HSC_R,0.99999
REACTOME_REGULATION_OF_CYTOS...,SET,7,-0.26896,-0.0052505,0.37104,0.76573,REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS,0.99999
GOBP_POSITIVE_REGULATION_OF_...416,SET,6,-0.25069,-0.0045309,0.34582,0.76574,GOBP_POSITIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
MEIS1_01,SET,225,-0.04076,-0.0044843,0.056225,0.76575,MEIS1_01,0.99999
REACTOME_BICARBONATE_TRANSPO...,SET,10,-0.18636,-0.0043479,0.25701,0.7658,REACTOME_BICARBONATE_TRANSPORTERS,0.99999
GOBP_REGULATION_OF_MICROTUBU...4,SET,148,-0.046359,-0.0041454,0.06393,0.76582,GOBP_REGULATION_OF_MICROTUBULE_CYTOSKELETON_ORGANIZATION,0.99999
HP_ABNORMAL_FOREARM_MORPHOLO...,SET,211,-0.04284,-0.004566,0.059073,0.76583,HP_ABNORMAL_FOREARM_MORPHOLOGY,0.99999
HP_HYPERMETRIC_SACCADES,SET,11,-0.17448,-0.0042694,0.24059,0.76584,HP_HYPERMETRIC_SACCADES,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...12,SET,184,-0.045881,-0.0045699,0.063266,0.76584,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_UP,0.99999
GSE27786_LSK_VS_NKCELL_UP,SET,177,-0.043581,-0.0042583,0.060087,0.76586,GSE27786_LSK_VS_NKCELL_UP,0.99999
GOCC_COLLAGEN_TYPE_IV_TRIMER,SET,4,-0.32667,-0.004821,0.45034,0.76589,GOCC_COLLAGEN_TYPE_IV_TRIMER,0.99999
GOMF_CARBOXYLIC_ESTER_HYDROL...,SET,138,-0.053853,-0.0046512,0.074218,0.76596,GOMF_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY,0.99999
WEBER_METHYLATED_HCP_IN_FIBR...2,SET,6,-0.25222,-0.0045586,0.34752,0.766,WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP,0.99999
CEBPB_01,SET,240,-0.040052,-0.0045491,0.055188,0.766,CEBPB_01,0.99999
GSE28726_NAIVE_VS_ACTIVATED_...1,SET,185,-0.044381,-0.0044324,0.061142,0.76603,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN,0.99999
HP_REDUCED_NATURAL_KILLER_CE...1,SET,11,-0.19427,-0.0047535,0.26756,0.7661,HP_REDUCED_NATURAL_KILLER_CELL_ACTIVITY,0.99999
GSE22886_TH1_VS_TH2_12H_ACT_...2,SET,180,-0.044327,-0.0043674,0.061045,0.76612,GSE22886_TH1_VS_TH2_12H_ACT_UP,0.99999
MIR5197_3P,SET,178,-0.04674,-0.0045797,0.064347,0.76619,MIR5197_3P,0.99999
GOBP_2FE_2S_CLUSTER_ASSEMBLY,SET,8,-0.22513,-0.0046982,0.30994,0.76619,GOBP_2FE_2S_CLUSTER_ASSEMBLY,0.99999
GOMF_NEUROPEPTIDE_Y_RECEPTOR...,SET,8,-0.26555,-0.0055417,0.36558,0.76619,GOMF_NEUROPEPTIDE_Y_RECEPTOR_ACTIVITY,0.99999
GOBP_INTRACELLULAR_AMINO_ACI...,SET,8,-0.22505,-0.0046965,0.30968,0.76629,GOBP_INTRACELLULAR_AMINO_ACID_HOMEOSTASIS,0.99999
GOBP_REGULATION_OF_GLYCOGEN_...1,SET,25,-0.12373,-0.0045625,0.17025,0.76631,GOBP_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS,0.99999
GOMF_TYPE_1_ANGIOTENSIN_RECE...,SET,6,-0.29708,-0.0053694,0.40874,0.76633,GOMF_TYPE_1_ANGIOTENSIN_RECEPTOR_BINDING,0.99999
GOBP_MAMMARY_GLAND_EPITHELIA...1,SET,17,-0.16222,-0.0049338,0.22316,0.76636,GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_CHROMOSOM...1,SET,11,-0.16299,-0.0039883,0.22421,0.76638,GOBP_REGULATION_OF_CHROMOSOME_CONDENSATION,0.99999
HP_FUSION_OF_THE_CEREBELLAR_...,SET,5,-0.22675,-0.0037414,0.31191,0.76638,HP_FUSION_OF_THE_CEREBELLAR_HEMISPHERES,0.99999
GSE13887_HEALTHY_VS_LUPUS_RE...1,SET,114,-0.057526,-0.0045188,0.079114,0.76642,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN,0.99999
GOBP_PROTEOGLYCAN_CATABOLIC_...,SET,9,-0.20671,-0.0045753,0.28421,0.76647,GOBP_PROTEOGLYCAN_CATABOLIC_PROCESS,0.99999
MARSON_FOXP3_TARGETS_STIMULA...1,SET,10,-0.18453,-0.0043052,0.25365,0.76653,MARSON_FOXP3_TARGETS_STIMULATED_DN,0.99999
REACTOME_REGULATION_OF_HSF1_...,SET,77,-0.067239,-0.0043452,0.092426,0.76653,REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,0.99999
WP_PLATELETMEDIATED_INTERACT...,SET,15,-0.16664,-0.004761,0.229,0.76659,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...247,SET,951,-0.020062,-0.0044459,0.027568,0.7666,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION,0.99999
GCM_ACTG1,SET,109,-0.056382,-0.0043313,0.077469,0.76663,GCM_ACTG1,0.99999
PECE_MAMMARY_STEM_CELL_DN,SET,122,-0.054847,-0.0044559,0.075334,0.7667,PECE_MAMMARY_STEM_CELL_DN,0.99999
GSE8515_IL1_VS_IL6_4H_STIM_M...1,SET,172,-0.046614,-0.0044905,0.064021,0.76672,GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN,0.99999
HP_ABNORMALITY_OF_FOVEAL_PIG...,SET,5,-0.33874,-0.0055892,0.46501,0.76683,HP_ABNORMALITY_OF_FOVEAL_PIGMENTATION,0.99999
HP_WEIGHT_LOSS,SET,351,-0.03297,-0.0045148,0.045259,0.76684,HP_WEIGHT_LOSS,0.99999
GOBP_CELLULAR_RESPONSE_TO_ST...1,SET,157,-0.049487,-0.0045565,0.067915,0.76689,GOBP_CELLULAR_RESPONSE_TO_STARVATION,0.99999
MORF_ERCC2,SET,98,-0.059214,-0.0043145,0.08125,0.76693,MORF_ERCC2,0.99999
HP_DECREASED_ACHILLES_REFLEX,SET,8,-0.21762,-0.0045415,0.29851,0.767,HP_DECREASED_ACHILLES_REFLEX,0.99999
GOBP_T_HELPER_2_CELL_DIFFERE...,SET,17,-0.15841,-0.0048179,0.21725,0.76705,GOBP_T_HELPER_2_CELL_DIFFERENTIATION,0.99999
GOCC_ELONGATOR_HOLOENZYME_CO...,SET,5,-0.27058,-0.0044645,0.37108,0.76705,GOCC_ELONGATOR_HOLOENZYME_COMPLEX,0.99999
GSE20366_TREG_VS_NAIVE_CD4_T...5,SET,178,-0.045198,-0.0044286,0.061949,0.76718,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP,0.99999
GOBP_HOMEOSTASIS_OF_NUMBER_O...1,SET,295,-0.036449,-0.0045828,0.049953,0.7672,GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS,0.99999
HP_LACK_OF_INSIGHT,SET,10,-0.17085,-0.0039861,0.23411,0.76723,HP_LACK_OF_INSIGHT,0.99999
HP_ABNORMALITY_OF_THE_DISTAL...5,SET,9,-0.20699,-0.0045816,0.28359,0.76727,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_HALLUX,0.99999
GOCC_INTRACILIARY_TRANSPORT_...1,SET,22,-0.13618,-0.0047109,0.18654,0.7673,GOCC_INTRACILIARY_TRANSPORT_PARTICLE,0.99999
MIR200C_5P,SET,58,-0.08304,-0.0046598,0.11375,0.76731,MIR200C_5P,0.99999
IPF1_Q4,SET,216,-0.044249,-0.0047711,0.060608,0.76733,IPF1_Q4,0.99999
GOBP_CARBOHYDRATE_HOMEOSTASIS,SET,229,-0.041824,-0.0046416,0.057285,0.76733,GOBP_CARBOHYDRATE_HOMEOSTASIS,0.99999
GOBP_REGULATION_OF_TYPE_B_PA...2,SET,11,-0.20131,-0.0049259,0.27571,0.76735,GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_PROLIFERATION,0.99999
GOMF_OLIGOPEPTIDE_BINDING,SET,10,-0.2021,-0.0047153,0.27676,0.76738,GOMF_OLIGOPEPTIDE_BINDING,0.99999
MORF_CNTN1,SET,91,-0.062005,-0.0043543,0.084903,0.76739,MORF_CNTN1,0.99999
HP_PROMINENT_INTERPHALANGEAL...,SET,6,-0.24665,-0.004458,0.33771,0.76741,HP_PROMINENT_INTERPHALANGEAL_JOINTS,0.99999
GOBP_MAINTENANCE_OF_APICAL_B...,SET,9,-0.23926,-0.0052958,0.32758,0.76742,GOBP_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY,0.99999
GSE19401_RETINOIC_ACID_VS_RE...1,SET,187,-0.042014,-0.0042184,0.057519,0.76744,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.99999
NAKAYA_PBMC_FLUARIX_FLUVIRIN...7,SET,423,-0.029321,-0.0043989,0.040137,0.76746,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...1,SET,43,-0.090954,-0.0043964,0.12449,0.76748,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN,0.99999
GSE13522_CTRL_VS_T_CRUZI_Y_S...1,SET,179,-0.047175,-0.0046351,0.064562,0.76751,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN,0.99999
GOBP_PHENOL_CONTAINING_COMPO...1,SET,44,-0.09892,-0.0048366,0.13538,0.76752,GOBP_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
GSE11864_CSF1_VS_CSF1_PAM3CY...2,SET,166,-0.046266,-0.0043792,0.063309,0.76754,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP,0.99999
GSE27786_BCELL_VS_NEUTROPHIL...2,SET,183,-0.042905,-0.004262,0.058708,0.76755,GSE27786_BCELL_VS_NEUTROPHIL_UP,0.99999
TONKS_TARGETS_OF_RUNX1_RUNX1...11,SET,14,-0.17749,-0.0048992,0.24281,0.7676,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP,0.99999
chr2p15,SET,15,-0.21142,-0.0060403,0.28905,0.76774,chr2p15,0.99999
RICKMAN_HEAD_AND_NECK_CANCER...1,SET,88,-0.071525,-0.0049398,0.097776,0.76776,RICKMAN_HEAD_AND_NECK_CANCER_A,0.99999
GOBP_REGULATION_OF_PROTEIN_B...,SET,111,-0.057537,-0.0044601,0.078649,0.76778,GOBP_REGULATION_OF_PROTEIN_BINDING,0.99999
GOBP_OTOLITH_DEVELOPMENT,SET,10,-0.20806,-0.0048543,0.28438,0.76779,GOBP_OTOLITH_DEVELOPMENT,0.99999
HP_PERIPHERAL_RETINAL_AVASCU...,SET,7,-0.24921,-0.004865,0.34061,0.7678,HP_PERIPHERAL_RETINAL_AVASCULARIZATION,0.99999
HP_INCREASED_THETA_FREQUENCY...,SET,10,-0.2063,-0.0048132,0.28194,0.76783,HP_INCREASED_THETA_FREQUENCY_ACTIVITY_IN_EEG,0.99999
GSE5542_IFNG_VS_IFNA_TREATED...2,SET,178,-0.043896,-0.004301,0.059977,0.76787,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,0.99999
MIR6760_3P,SET,96,-0.064115,-0.0046239,0.087603,0.76788,MIR6760_3P,0.99999
GALI_TP53_TARGETS_APOPTOTIC_...2,SET,8,-0.23787,-0.0049641,0.32499,0.76789,GALI_TP53_TARGETS_APOPTOTIC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...206,SET,24,-0.12433,-0.0044921,0.16984,0.76792,GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...278,SET,5,-0.298,-0.004917,0.40706,0.76793,GOBP_POSITIVE_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...510,SET,14,-0.16754,-0.0046246,0.22884,0.76795,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION,0.99999
LUI_THYROID_CANCER_CLUSTER_5,SET,14,-0.1606,-0.0044329,0.21931,0.768,LUI_THYROID_CANCER_CLUSTER_5,0.99999
ZHANG_RESPONSE_TO_IKK_INHIBI...1,SET,96,-0.066065,-0.0047645,0.090211,0.76801,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,0.99999
HP_SYRINGOMYELIA,SET,30,-0.10641,-0.0042975,0.14529,0.76802,HP_SYRINGOMYELIA,0.99999
GOMF_PROTEIN_CARBOXYL_O_METH...,SET,6,-0.2344,-0.0042366,0.32002,0.76805,GOMF_PROTEIN_CARBOXYL_O_METHYLTRANSFERASE_ACTIVITY,0.99999
RODRIGUES_THYROID_CARCINOMA_...2,SET,636,-0.024684,-0.0045137,0.033693,0.76809,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP,0.99999
HP_ANGIOSARCOMA,SET,5,-0.28157,-0.0046458,0.38426,0.76814,HP_ANGIOSARCOMA,0.99999
HP_IRREGULAR_VERTEBRAL_ENDPL...,SET,27,-0.12336,-0.0047272,0.16835,0.76815,HP_IRREGULAR_VERTEBRAL_ENDPLATES,0.99999
GSE39820_IL1B_IL6_VS_IL1B_IL...2,SET,181,-0.046249,-0.0045692,0.063114,0.76815,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP,0.99999
NCOA4_TARGET_GENES,SET,844,-0.021336,-0.0044681,0.029116,0.76816,NCOA4_TARGET_GENES,0.99999
HP_AMBLYOPIA,SET,99,-0.059905,-0.0043869,0.081719,0.76823,HP_AMBLYOPIA,0.99999
GOMF_DIACYLGLYCEROL_BINDING,SET,13,-0.17242,-0.0045862,0.23515,0.76828,GOMF_DIACYLGLYCEROL_BINDING,0.99999
HP_SMALL_EPIPHYSES,SET,20,-0.14598,-0.0048152,0.19908,0.76829,HP_SMALL_EPIPHYSES,0.99999
GSE6674_UNSTIM_VS_CPG_STIM_B...1,SET,145,-0.050026,-0.004428,0.068202,0.76837,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN,0.99999
GOBP_APOPTOTIC_DNA_FRAGMENTA...,SET,18,-0.14691,-0.0045975,0.20027,0.76839,GOBP_APOPTOTIC_DNA_FRAGMENTATION,0.99999
GOBP_REGULATION_OF_MITOTIC_N...,SET,116,-0.058226,-0.0046134,0.079373,0.76839,GOBP_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,0.99999
GOBP_REGULATION_OF_MICROTUBU...5,SET,25,-0.11065,-0.0040803,0.1508,0.76845,GOBP_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION,0.99999
GRAHAM_CML_DIVIDING_VS_NORMA...1,SET,9,-0.24881,-0.0055072,0.33906,0.76846,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN,0.99999
HNF1_Q6,SET,233,-0.04349,-0.004868,0.059249,0.76853,HNF1_Q6,0.99999
GSE8685_IL2_ACT_IL2_STARVED_...4,SET,161,-0.050786,-0.0047347,0.069189,0.76853,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...600,SET,15,-0.1553,-0.004437,0.21154,0.76856,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOCC_TRANSLOCON_COMPLEX,SET,5,-0.27505,-0.0045383,0.37465,0.76856,GOCC_TRANSLOCON_COMPLEX,0.99999
GOBP_REGULATION_OF_PROTEIN_E...2,SET,34,-0.10564,-0.0045419,0.14382,0.76869,GOBP_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.99999
GOBP_LONG_CHAIN_FATTY_ACID_M...,SET,102,-0.063771,-0.0047398,0.086798,0.76874,GOBP_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.99999
GOBP_MUSCLE_HYPERTROPHY_IN_R...,SET,24,-0.12651,-0.0045708,0.17214,0.7688,GOBP_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS,0.99999
ZHANG_RESPONSE_TO_IKK_INHIBI...2,SET,213,-0.044602,-0.004776,0.060686,0.76881,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,0.99999
GOBP_PYRIMIDINE_NUCLEOTIDE_B...,SET,28,-0.11443,-0.0044653,0.15566,0.76887,GOBP_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
CTCCAAG_MIR432,SET,74,-0.069768,-0.0044203,0.0949,0.76888,CTCCAAG_MIR432,0.99999
GSE3982_BASOPHIL_VS_EFF_MEMO...2,SET,184,-0.045629,-0.0045448,0.062059,0.7689,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...55,SET,22,-0.15028,-0.0051989,0.20436,0.76894,GOBP_POSITIVE_REGULATION_OF_BEHAVIOR,0.99999
NCOA6_TARGET_GENES,SET,275,-0.038116,-0.0046297,0.05183,0.76895,NCOA6_TARGET_GENES,0.99999
GOBP_REGULATION_OF_EPIDERMAL...,SET,15,-0.15189,-0.0043397,0.20654,0.76895,GOBP_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,0.99999
LET_7A_5P_LET_7C_5P_LET_7E_5P,SET,360,-0.033495,-0.0046439,0.045544,0.76896,LET_7A_5P_LET_7C_5P_LET_7E_5P,0.99999
GOBP_REGULATION_OF_SYNCYTIUM...,SET,27,-0.1229,-0.0047094,0.16709,0.76899,GOBP_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,0.99999
GOBP_EMBRYONIC_BRAIN_DEVELOP...,SET,15,-0.1706,-0.0048743,0.23192,0.76902,GOBP_EMBRYONIC_BRAIN_DEVELOPMENT,0.99999
MIR1914_3P,SET,23,-0.13512,-0.0047794,0.18362,0.76909,MIR1914_3P,0.99999
GOBP_GASTRIC_ACID_SECRETION,SET,13,-0.17064,-0.0045388,0.23188,0.76909,GOBP_GASTRIC_ACID_SECRETION,0.99999
REACTOME_MISCELLANEOUS_TRANS...,SET,21,-0.13919,-0.0047046,0.18911,0.76914,REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS,0.99999
HP_SANDAL_GAP,SET,87,-0.069205,-0.0047525,0.094025,0.76914,HP_SANDAL_GAP,0.99999
HP_SKEWFOOT,SET,6,-0.27615,-0.0049912,0.37516,0.76916,HP_SKEWFOOT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...494,SET,5,-0.21652,-0.0035725,0.29411,0.76919,GOBP_NEGATIVE_REGULATION_OF_PINOCYTOSIS,0.99999
GSE24634_IL4_VS_CTRL_TREATED...8,SET,177,-0.045028,-0.0043996,0.061163,0.76919,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP,0.99999
MIR5000_5P,SET,91,-0.064789,-0.0045498,0.088,0.7692,MIR5000_5P,0.99999
ACTGAAA_MIR30A3P_MIR30E3P,SET,180,-0.044912,-0.004425,0.060993,0.76924,ACTGAAA_MIR30A3P_MIR30E3P,0.99999
SMN1_SMN2_TARGET_GENES,SET,628,-0.0244,-0.0044347,0.03313,0.76928,SMN1_SMN2_TARGET_GENES,0.99999
HP_ADRENOCORTICOTROPIC_HORMO...1,SET,14,-0.16646,-0.0045949,0.22601,0.76929,HP_ADRENOCORTICOTROPIC_HORMONE_DEFICIENCY,0.99999
GOCC_PREFOLDIN_COMPLEX,SET,6,-0.20046,-0.0036231,0.27215,0.7693,GOCC_PREFOLDIN_COMPLEX,0.99999
GSE46606_IRF4MID_VS_WT_CD40L...3,SET,185,-0.043497,-0.0043441,0.059047,0.76933,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.99999
HP_ABNORMAL_CEREBELLAR_CORTE...,SET,4,-0.25208,-0.0037203,0.34216,0.76935,HP_ABNORMAL_CEREBELLAR_CORTEX_MORPHOLOGY,0.99999
GOBP_GDP_MANNOSE_METABOLIC_P...,SET,6,-0.18473,-0.0033389,0.25073,0.76936,GOBP_GDP_MANNOSE_METABOLIC_PROCESS,0.99999
ZEILSTRA_CD44_TARGETS_DN,SET,9,-0.1964,-0.0043472,0.2665,0.76942,ZEILSTRA_CD44_TARGETS_DN,0.99999
HP_FATIGABLE_WEAKNESS_OF_DIS...,SET,8,-0.20505,-0.0042791,0.27823,0.76942,HP_FATIGABLE_WEAKNESS_OF_DISTAL_LIMB_MUSCLES,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...21,SET,34,-0.099993,-0.0042989,0.13567,0.76944,GAVISH_3CA_METAPROGRAM_EPITHELIAL_RESPIRATION,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...13,SET,72,-0.079941,-0.0049961,0.10844,0.76948,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_NK_CELLS,0.99999
GSE1925_CTRL_VS_3H_IFNG_STIM...1,SET,181,-0.047458,-0.0046886,0.064377,0.76949,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,0.99999
HP_TYPE_II_DIABETES_MELLITUS,SET,191,-0.046432,-0.004711,0.062977,0.76952,HP_TYPE_II_DIABETES_MELLITUS,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_MYE...,SET,15,-0.17743,-0.0050693,0.24062,0.76955,HE_LIM_SUN_FETAL_LUNG_C2_MYELOCYTE_LIKE_CELL,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_OMD...,SET,323,-0.036988,-0.0048626,0.050156,0.76958,HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL,0.99999
PAX8_B,SET,91,-0.068949,-0.004842,0.093485,0.7696,PAX8_B,0.99999
GOBP_PYRIMIDINE_DEOXYRIBONUC...2,SET,11,-0.18778,-0.0045948,0.2546,0.7696,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.99999
REACTOME_REACTIONS_SPECIFIC_...,SET,10,-0.20639,-0.0048153,0.27981,0.76962,REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY,0.99999
DURCHDEWALD_SKIN_CARCINOGENE...1,SET,242,-0.040688,-0.0046403,0.055156,0.76964,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,0.99999
REACTOME_SIGNALING_BY_FGFR1_...,SET,37,-0.1061,-0.0047582,0.14381,0.76967,REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...445,SET,7,-0.20662,-0.0040336,0.27994,0.76977,GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.99999
HP_EOSINOPHILIC_INFILTRATION...,SET,10,-0.22251,-0.0051915,0.30146,0.76977,HP_EOSINOPHILIC_INFILTRATION_OF_THE_ESOPHAGUS,0.99999
MIR6827_3P,SET,72,-0.071415,-0.0044633,0.09675,0.76978,MIR6827_3P,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_TH...6,SET,82,-0.065989,-0.0044,0.089397,0.76978,HP_ABNORMAL_MORPHOLOGY_OF_THE_MUSCULATURE_OF_THE_NECK,0.99999
GOBP_REGULATION_OF_MITOTIC_R...,SET,6,-0.20894,-0.0037764,0.28306,0.76979,GOBP_REGULATION_OF_MITOTIC_RECOMBINATION,0.99999
KEGG_MEDICUS_REFERENCE_VALIN...,SET,8,-0.22292,-0.0046521,0.30195,0.76982,KEGG_MEDICUS_REFERENCE_VALINE_DEGRADATION,0.99999
HALLMARK_HYPOXIA,SET,178,-0.048335,-0.0047359,0.06547,0.76982,HALLMARK_HYPOXIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...537,SET,4,-0.23108,-0.0034103,0.31284,0.76994,GOBP_POSITIVE_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_LACRIMAL_DUCT_ATRESIA,SET,5,-0.32688,-0.0053934,0.44237,0.77002,HP_LACRIMAL_DUCT_ATRESIA,0.99999
SCIAN_INVERSED_TARGETS_OF_TP...2,SET,9,-0.21861,-0.0048388,0.29583,0.77003,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP,0.99999
PDGF_UP.V1_DN,SET,108,-0.062851,-0.0048061,0.085051,0.77004,PDGF_UP.V1_DN,0.99999
MODULE_299,SET,34,-0.099398,-0.0042733,0.1345,0.77005,MODULE_299,0.99999
GSE17721_CTRL_VS_CPG_8H_BMDC...2,SET,178,-0.044923,-0.0044016,0.060773,0.7701,GSE17721_CTRL_VS_CPG_8H_BMDC_UP,0.99999
KEGG_MEDICUS_REFERENCE_KERAT...,SET,5,-0.29516,-0.00487,0.39917,0.77017,KEGG_MEDICUS_REFERENCE_KERATAN_SULFATE_DEGRADATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...276,SET,21,-0.13876,-0.0046901,0.18766,0.77017,GOBP_NEGATIVE_REGULATION_OF_HIPPO_SIGNALING,0.99999
HP_DELAYED_ERUPTION_OF_PRIMA...,SET,14,-0.15345,-0.0042355,0.20752,0.77017,HP_DELAYED_ERUPTION_OF_PRIMARY_TEETH,0.99999
FRASOR_TAMOXIFEN_RESPONSE_DN,SET,10,-0.19405,-0.0045275,0.26241,0.77019,FRASOR_TAMOXIFEN_RESPONSE_DN,0.99999
GSE2935_UV_INACTIVATED_VS_LI...1,SET,162,-0.051917,-0.0048551,0.07019,0.77024,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN,0.99999
IVANOVA_HEMATOPOIESIS_INTERM...,SET,123,-0.053789,-0.0043877,0.072691,0.77034,IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,0.99999
HP_ABNORMAL_URINE_PH,SET,129,-0.055333,-0.0046217,0.074771,0.77035,HP_ABNORMAL_URINE_PH,0.99999
MIR509_3_5P,SET,140,-0.052085,-0.0045307,0.070381,0.77036,MIR509_3_5P,0.99999
KEGG_MEDICUS_REFERENCE_TLR3_...1,SET,9,-0.19967,-0.0044196,0.26976,0.7704,KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY,0.99999
HP_NEPHROCALCINOSIS,SET,86,-0.071723,-0.0048971,0.096896,0.77041,HP_NEPHROCALCINOSIS,0.99999
GSE24634_IL4_VS_CTRL_TREATED...6,SET,180,-0.048214,-0.0047503,0.065123,0.77045,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP,0.99999
MYB_Q3,SET,233,-0.040523,-0.0045359,0.054731,0.77047,MYB_Q3,0.99999
HP_ABNORMAL_VENOUS_MORPHOLOGY,SET,136,-0.053441,-0.0045823,0.072178,0.77047,HP_ABNORMAL_VENOUS_MORPHOLOGY,0.99999
HP_ANTERIOR_BEAKING_OF_LUMBA...,SET,5,-0.28266,-0.0046639,0.38173,0.77049,HP_ANTERIOR_BEAKING_OF_LUMBAR_VERTEBRAE,0.99999
HP_EXERCISE_INDUCED_MYOGLOBI...,SET,7,-0.18838,-0.0036775,0.25434,0.77055,HP_EXERCISE_INDUCED_MYOGLOBINURIA,0.99999
GOMF_DOUBLE_STRANDED_METHYLA...,SET,4,-0.29168,-0.0043048,0.39376,0.77058,GOMF_DOUBLE_STRANDED_METHYLATED_DNA_BINDING,0.99999
GSE37532_TREG_VS_TCONV_CD4_T...2,SET,181,-0.044424,-0.004389,0.059964,0.7706,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP,0.99999
GOMF_GAMMA_CATENIN_BINDING,SET,12,-0.18464,-0.0047187,0.24922,0.77061,GOMF_GAMMA_CATENIN_BINDING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...685,SET,9,-0.21571,-0.0047746,0.2911,0.77065,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,0.99999
GSE14769_UNSTIM_VS_40MIN_LPS...2,SET,178,-0.048421,-0.0047443,0.065345,0.77065,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP,0.99999
GOBP_CAMP_BIOSYNTHETIC_PROCE...,SET,10,-0.2098,-0.0048948,0.28311,0.77067,GOBP_CAMP_BIOSYNTHETIC_PROCESS,0.99999
GSE22229_RENAL_TRANSPLANT_VS...2,SET,183,-0.045155,-0.0044855,0.060933,0.77067,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP,0.99999
GOBP_REGULATION_OF_METAPHASE...,SET,14,-0.17014,-0.0046963,0.22955,0.7707,GOBP_REGULATION_OF_METAPHASE_PLATE_CONGRESSION,0.99999
MIR423_5P,SET,124,-0.052542,-0.0043033,0.070874,0.77076,MIR423_5P,0.99999
GAGCTGG_MIR337,SET,144,-0.050531,-0.0044574,0.068153,0.77078,GAGCTGG_MIR337,0.99999
HP_TYPICALLY_DE_NOVO,SET,11,-0.18367,-0.0044941,0.24771,0.77079,HP_TYPICALLY_DE_NOVO,0.99999
WANG_LSD1_TARGETS_DN,SET,34,-0.11391,-0.0048971,0.15362,0.7708,WANG_LSD1_TARGETS_DN,0.99999
GOMF_CCR6_CHEMOKINE_RECEPTOR...,SET,5,-0.33289,-0.0054926,0.44892,0.77081,GOMF_CCR6_CHEMOKINE_RECEPTOR_BINDING,0.99999
HP_TYPE_II_LISSENCEPHALY,SET,12,-0.16837,-0.004303,0.22706,0.77081,HP_TYPE_II_LISSENCEPHALY,0.99999
GOBP_TYPE_I_PNEUMOCYTE_DIFFE...,SET,8,-0.24402,-0.0050925,0.32904,0.77083,GOBP_TYPE_I_PNEUMOCYTE_DIFFERENTIATION,0.99999
REACTOME_NFE2L2_REGULATING_M...,SET,8,-0.2323,-0.0048479,0.31307,0.77095,REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES,0.99999
MIR329_3P,SET,106,-0.064741,-0.0049048,0.087237,0.77099,MIR329_3P,0.99999
HP_CENTRAL_HETEROCHROMIA,SET,6,-0.28819,-0.0052088,0.38833,0.77099,HP_CENTRAL_HETEROCHROMIA,0.99999
HP_RETINAL_EXUDATE,SET,8,-0.21557,-0.0044988,0.2904,0.77105,HP_RETINAL_EXUDATE,0.99999
GOMF_NAD_P_H_OXIDASE_H2O2_FO...,SET,8,-0.20245,-0.0042249,0.27269,0.77108,GOMF_NAD_P_H_OXIDASE_H2O2_FORMING_ACTIVITY,0.99999
MIR10527_5P,SET,531,-0.0285,-0.0047761,0.038382,0.77111,MIR10527_5P,0.99999
HOFMANN_MYELODYSPLASTIC_SYND...1,SET,20,-0.13481,-0.0044468,0.18154,0.77112,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,0.99999
ICHIBA_GRAFT_VERSUS_HOST_DIS...1,SET,51,-0.093811,-0.0049373,0.12633,0.77112,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,0.99999
MIR3184_5P,SET,120,-0.053409,-0.0043036,0.071922,0.77113,MIR3184_5P,0.99999
chr2q12,SET,24,-0.2161,-0.0078076,0.29095,0.77117,chr2q12,0.99999
GOMF_C_METHYLTRANSFERASE_ACT...,SET,6,-0.23095,-0.0041742,0.31095,0.77117,GOMF_C_METHYLTRANSFERASE_ACTIVITY,0.99999
chr20q13,SET,207,-0.099794,-0.010536,0.13436,0.77118,chr20q13,0.99999
GOBP_REGULATION_OF_HEPATOCYT...1,SET,8,-0.21495,-0.0044858,0.28931,0.77125,GOBP_REGULATION_OF_HEPATOCYTE_APOPTOTIC_PROCESS,0.99999
FOX_Q2,SET,191,-0.047121,-0.0047809,0.063417,0.77126,FOX_Q2,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...6,SET,7,-0.18753,-0.0036609,0.25239,0.77126,GOCC_EXTRINSIC_COMPONENT_OF_POSTSYNAPTIC_MEMBRANE,0.99999
GSE39110_UNTREATED_VS_IL2_TR...1,SET,182,-0.044912,-0.0044492,0.060442,0.77127,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_DN,0.99999
MIR562,SET,59,-0.079144,-0.0044792,0.10649,0.77132,MIR562,0.99999
GOBP_CELL_MOTILITY,SET,1577,-0.017056,-0.0047791,0.022941,0.7714,GOBP_CELL_MOTILITY,0.99999
QI_PBMC_ZOSTAVAX_AGE_50_75YO...7,SET,12,-0.19073,-0.0048743,0.25648,0.77144,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_1D_INFORMATIVE_OF_LONG_TERM_RESPONSES_NEGATIVE,0.99999
HP_ADRENOCORTICAL_ADENOMA,SET,9,-0.23096,-0.0051122,0.31054,0.77148,HP_ADRENOCORTICAL_ADENOMA,0.99999
MIR6737_3P,SET,172,-0.048828,-0.0047038,0.06565,0.77149,MIR6737_3P,0.99999
HP_DISTAL_JOINT_HYPERMOBILITY,SET,7,-0.26192,-0.0051131,0.35206,0.77154,HP_DISTAL_JOINT_HYPERMOBILITY,0.99999
MIR6841_5P,SET,32,-0.10946,-0.0045657,0.1471,0.77159,MIR6841_5P,0.99999
GOMF_GLYCEROPHOSPHODIESTER_P...,SET,4,-0.29425,-0.0043426,0.39539,0.77162,GOMF_GLYCEROPHOSPHODIESTER_PHOSPHODIESTERASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_NEUROTROP...,SET,9,-0.18397,-0.0040721,0.2472,0.77163,GOBP_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,0.99999
REACTOME_FGFRL1_MODULATION_O...,SET,13,-0.19551,-0.0052005,0.26269,0.77164,REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING,0.99999
GOBP_EMBRYONIC_MORPHOGENESIS,SET,573,-0.027801,-0.004834,0.037353,0.77164,GOBP_EMBRYONIC_MORPHOGENESIS,0.99999
GOBP_MORPHOGENESIS_OF_AN_EPI...3,SET,60,-0.078004,-0.0044518,0.10479,0.77168,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET,0.99999
GOBP_INTESTINAL_EPITHELIAL_C...2,SET,26,-0.12936,-0.0048644,0.17376,0.7717,GOBP_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
HP_MORTALITY_AGING,SET,399,-0.030548,-0.0044541,0.041033,0.7717,HP_MORTALITY_AGING,0.99999
GOBP_PROTEIN_METHYLATION,SET,40,-0.090865,-0.0042365,0.12204,0.77172,GOBP_PROTEIN_METHYLATION,0.99999
KEGG_MEDICUS_PATHOGEN_SHIGEL...5,SET,4,-0.2924,-0.0043154,0.39265,0.77176,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAH7.8_TO_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HO...1,SET,339,-0.036377,-0.004897,0.048847,0.77177,MANNO_MIDBRAIN_NEUROTYPES_HOMTN,0.99999
GOCC_STEREOCILIA_COUPLING_LI...,SET,7,-0.2592,-0.0050601,0.34798,0.77182,GOCC_STEREOCILIA_COUPLING_LINK,0.99999
HP_ABNORMAL_CEREBELLAR_VERMI...,SET,317,-0.034082,-0.0044395,0.045754,0.77183,HP_ABNORMAL_CEREBELLAR_VERMIS_MORPHOLOGY,0.99999
ZHONG_PFC_C8_UNKNOWN_NEUROD2...,SET,80,-0.074188,-0.0048863,0.099578,0.77187,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,0.99999
GOBP_BICARBONATE_TRANSPORT,SET,36,-0.1018,-0.0045034,0.13661,0.77192,GOBP_BICARBONATE_TRANSPORT,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...2,SET,49,-0.099069,-0.005111,0.13292,0.77195,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_10,0.99999
BOSCO_ALLERGEN_INDUCED_TH2_A...,SET,133,-0.057991,-0.0049177,0.077806,0.77196,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,0.99999
GOBP_REGULATION_OF_NATURAL_K...3,SET,13,-0.18352,-0.0048816,0.24616,0.77202,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION,0.99999
MODULE_63,SET,197,-0.048744,-0.0050218,0.065378,0.77203,MODULE_63,0.99999
HP_HYPERGONADOTROPIC_HYPOGON...,SET,54,-0.078792,-0.0042667,0.10567,0.77205,HP_HYPERGONADOTROPIC_HYPOGONADISM,0.99999
HP_ABNORMAL_BRAIN_EVOKED_POT...,SET,91,-0.065219,-0.00458,0.087439,0.77213,HP_ABNORMAL_BRAIN_EVOKED_POTENTIALS,0.99999
GOBP_POSITIVE_REGULATION_OF_...83,SET,7,-0.23412,-0.0045704,0.31381,0.77218,GOBP_POSITIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.99999
WARTERS_IR_RESPONSE_5GY,SET,44,-0.089974,-0.0043992,0.12057,0.77224,WARTERS_IR_RESPONSE_5GY,0.99999
HP_ANGIOKERATOMA,SET,5,-0.26476,-0.0043685,0.35469,0.7723,HP_ANGIOKERATOMA,0.99999
GOBP_PEPTIDYL_AMINO_ACID_MOD...,SET,762,-0.023152,-0.0046176,0.031014,0.77231,GOBP_PEPTIDYL_AMINO_ACID_MODIFICATION,0.99999
GTACTGT_MIR101,SET,233,-0.041813,-0.0046802,0.056007,0.77233,GTACTGT_MIR101,0.99999
HP_SLOW_PUPILLARY_LIGHT_RESP...,SET,17,-0.14654,-0.0044568,0.19625,0.77236,HP_SLOW_PUPILLARY_LIGHT_RESPONSE,0.99999
GSE22103_LPS_VS_GMCSF_AND_IF...1,SET,187,-0.044098,-0.0044276,0.059062,0.77236,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...325,SET,5,-0.25646,-0.0042316,0.34342,0.7724,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,0.99999
GOBP_RESPONSE_TO_AMPHETAMINE,SET,34,-0.11699,-0.0050297,0.15661,0.77247,GOBP_RESPONSE_TO_AMPHETAMINE,0.99999
GSE27786_BCELL_VS_CD4_TCELL_...1,SET,177,-0.047369,-0.0046284,0.063406,0.77249,GSE27786_BCELL_VS_CD4_TCELL_DN,0.99999
GOBP_STRIATED_MUSCLE_CELL_PR...,SET,67,-0.080211,-0.0048365,0.10734,0.77253,GOBP_STRIATED_MUSCLE_CELL_PROLIFERATION,0.99999
MIR664B_3P,SET,442,-0.031274,-0.0047935,0.041852,0.77254,MIR664B_3P,0.99999
GOBP_REGULATION_OF_APPETITE,SET,20,-0.15147,-0.0049963,0.20268,0.77256,GOBP_REGULATION_OF_APPETITE,0.99999
MIR11181_3P,SET,182,-0.047806,-0.004736,0.063963,0.77258,MIR11181_3P,0.99999
MIR564,SET,14,-0.17599,-0.0048579,0.23537,0.77268,MIR564,0.99999
HP_GENERALIZED_OSTEOPOROSIS,SET,17,-0.15383,-0.0046785,0.2057,0.77271,HP_GENERALIZED_OSTEOPOROSIS,0.99999
GOMF_RNA_EXONUCLEASE_ACTIVITY,SET,43,-0.08692,-0.0042014,0.11623,0.77272,GOMF_RNA_EXONUCLEASE_ACTIVITY,0.99999
GOCC_STEREOCILIUM_BASE,SET,7,-0.23966,-0.0046785,0.32039,0.77277,GOCC_STEREOCILIUM_BASE,0.99999
GOBP_NUCLEOSIDE_TRIPHOSPHATE...3,SET,220,-0.040162,-0.0043698,0.053685,0.7728,GOBP_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.99999
GOBP_NEURAL_TUBE_DEVELOPMENT,SET,151,-0.052242,-0.0047181,0.069818,0.77284,GOBP_NEURAL_TUBE_DEVELOPMENT,0.99999
REACTOME_FORMATION_OF_XYLULO...,SET,5,-0.29387,-0.0048487,0.39266,0.77288,REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE,0.99999
GOBP_GLUCURONATE_CATABOLIC_P...,SET,5,-0.29387,-0.0048487,0.39266,0.77288,GOBP_GLUCURONATE_CATABOLIC_PROCESS_TO_XYLULOSE_5_PHOSPHATE,0.99999
ATM_DN.V1_DN,SET,124,-0.059563,-0.0048783,0.079567,0.77294,ATM_DN.V1_DN,0.99999
HP_ABNORMALITY_OF_NAIL_COLOR,SET,17,-0.15527,-0.0047224,0.20741,0.77295,HP_ABNORMALITY_OF_NAIL_COLOR,0.99999
REACTOME_GLYCOSPHINGOLIPID_T...,SET,8,-0.20068,-0.004188,0.26806,0.77296,REACTOME_GLYCOSPHINGOLIPID_TRANSPORT,0.99999
HP_TICS,SET,22,-0.12405,-0.0042914,0.1657,0.77296,HP_TICS,0.99999
GSE2405_0H_VS_12H_A_PHAGOCYT...1,SET,178,-0.047403,-0.0046447,0.063309,0.77299,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.99999
GOBP_CONVERGENT_EXTENSION_IN...2,SET,9,-0.22217,-0.0049175,0.29662,0.77307,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_GASTRULATION,0.99999
GNF2_MATK,SET,23,-0.1274,-0.0045061,0.17007,0.77309,GNF2_MATK,0.99999
MIR128_1_5P,SET,12,-0.20835,-0.0053248,0.27802,0.77319,MIR128_1_5P,0.99999
GOBP_RENAL_SODIUM_EXCRETION,SET,11,-0.20463,-0.0050072,0.27306,0.77319,GOBP_RENAL_SODIUM_EXCRETION,0.99999
HP_INHERITANCE_QUALIFIER,SET,302,-0.037305,-0.0047448,0.049777,0.7732,HP_INHERITANCE_QUALIFIER,0.99999
GOBP_CARDIAC_CELL_FATE_COMMI...,SET,12,-0.21117,-0.0053967,0.28174,0.77322,GOBP_CARDIAC_CELL_FATE_COMMITMENT,0.99999
GOBP_T_CELL_APOPTOTIC_PROCESS,SET,56,-0.087175,-0.004807,0.1163,0.77324,GOBP_T_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_MITOCHONDRIAL_PROTEIN_P...,SET,12,-0.16796,-0.0042924,0.22405,0.77326,GOBP_MITOCHONDRIAL_PROTEIN_PROCESSING,0.99999
HP_TOXEMIA_OF_PREGNANCY,SET,24,-0.13728,-0.00496,0.18312,0.77327,HP_TOXEMIA_OF_PREGNANCY,0.99999
GSE13485_CTRL_VS_DAY7_YF17D_...2,SET,163,-0.048646,-0.004563,0.064889,0.77327,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...6,SET,184,-0.044421,-0.0044245,0.059224,0.77338,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.99999
REACTOME_ORGANIC_CATION_TRAN...,SET,10,-0.22774,-0.0053134,0.30351,0.77347,REACTOME_ORGANIC_CATION_TRANSPORT,0.99999
HP_LIMB_HYPERTONIA,SET,143,-0.051843,-0.0045573,0.069075,0.77353,HP_LIMB_HYPERTONIA,0.99999
GSE27786_BCELL_VS_NEUTROPHIL...1,SET,184,-0.046116,-0.0045933,0.061436,0.77356,GSE27786_BCELL_VS_NEUTROPHIL_DN,0.99999
MOHANKUMAR_HOXA1_TARGETS_DN,SET,151,-0.055348,-0.0049986,0.073732,0.77357,MOHANKUMAR_HOXA1_TARGETS_DN,0.99999
GOBP_RESPONSE_TO_VITAMIN_D,SET,35,-0.11644,-0.0050791,0.15509,0.77361,GOBP_RESPONSE_TO_VITAMIN_D,0.99999
HP_RECURRENT_OTITIS_MEDIA,SET,172,-0.049305,-0.0047497,0.065668,0.77362,HP_RECURRENT_OTITIS_MEDIA,0.99999
HP_ABNORMAL_SUBCUTANEOUS_FAT...,SET,8,-0.2206,-0.0046037,0.29377,0.77364,HP_ABNORMAL_SUBCUTANEOUS_FAT_TISSUE_DISTRIBUTION,0.99999
HP_METHYLMALONIC_ACIDURIA,SET,18,-0.14654,-0.0045858,0.19514,0.77364,HP_METHYLMALONIC_ACIDURIA,0.99999
MORF_IFNA1,SET,175,-0.04953,-0.0048124,0.065951,0.77367,MORF_IFNA1,0.99999
GOBP_REGULATION_OF_LOW_DENSI...,SET,15,-0.16784,-0.0047954,0.22345,0.77371,GOBP_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
TAVOR_CEBPA_TARGETS_UP,SET,47,-0.10142,-0.0051247,0.13496,0.77381,TAVOR_CEBPA_TARGETS_UP,0.99999
GOBP_PURINE_NUCLEOSIDE_MONOP...3,SET,38,-0.10443,-0.0047459,0.13896,0.77382,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.99999
BRUINS_UVC_RESPONSE_VIA_TP53...3,SET,85,-0.068263,-0.0046339,0.090831,0.77383,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,0.99999
GOMF_HISTAMINE_RECEPTOR_ACTI...,SET,6,-0.26124,-0.0047216,0.34759,0.77384,GOMF_HISTAMINE_RECEPTOR_ACTIVITY,0.99999
ATACCTC_MIR202,SET,168,-0.049575,-0.0047203,0.065952,0.77387,ATACCTC_MIR202,0.99999
GOMF_HORMONE_ACTIVITY,SET,111,-0.065009,-0.0050393,0.086482,0.77388,GOMF_HORMONE_ACTIVITY,0.99999
GOBP_REGULATION_OF_INNER_EAR...,SET,8,-0.23297,-0.0048619,0.3099,0.7739,GOBP_REGULATION_OF_INNER_EAR_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION,0.99999
GSE35825_IFNA_VS_IFNG_STIM_M...1,SET,178,-0.04536,-0.0044444,0.060328,0.77393,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...11,SET,52,-0.083518,-0.0044383,0.111,0.77409,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,0.99999
STAMBOLSKY_RESPONSE_TO_VITAM...1,SET,22,-0.13412,-0.0046397,0.17821,0.77415,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN,0.99999
KAECH_DAY8_EFF_VS_DAY15_EFF_...2,SET,176,-0.044852,-0.0043702,0.059594,0.77416,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP,0.99999
BERENJENO_TRANSFORMED_BY_RHO...1,SET,354,-0.034121,-0.0046918,0.04533,0.77418,BERENJENO_TRANSFORMED_BY_RHOA_DN,0.99999
FOXM1_01,SET,226,-0.043315,-0.0047759,0.05754,0.7742,FOXM1_01,0.99999
GAO_LARGE_INTESTINE_ADULT_CF...,SET,22,-0.14083,-0.0048719,0.18708,0.7742,GAO_LARGE_INTESTINE_ADULT_CF_GOBLET_CELL_SUBTYPE_1,0.99999
GRAHAM_CML_QUIESCENT_VS_CML_...1,SET,10,-0.22975,-0.0053603,0.30518,0.77422,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN,0.99999
MIR555,SET,39,-0.10221,-0.0047058,0.13573,0.77429,MIR555,0.99999
REACTOME_DEGRADATION_OF_AXIN,SET,52,-0.079354,-0.004217,0.10536,0.77432,REACTOME_DEGRADATION_OF_AXIN,0.99999
DESCARTES_MAIN_FETAL_CHROMAF...,SET,15,-0.15248,-0.0043563,0.20237,0.7744,DESCARTES_MAIN_FETAL_CHROMAFFIN_CELLS,0.99999
REACTOME_NEGATIVE_REGULATION...1,SET,10,-0.20983,-0.0048957,0.27843,0.77446,REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS,0.99999
GOMF_3_BETA_HYDROXY_DELTA5_S...,SET,5,-0.32103,-0.0052969,0.42594,0.77448,GOMF_3_BETA_HYDROXY_DELTA5_STEROID_DEHYDROGENASE_ACTIVITY,0.99999
MEISSNER_NPC_HCP_WITH_H3K27M...,SET,76,-0.081998,-0.0052645,0.10878,0.77452,MEISSNER_NPC_HCP_WITH_H3K27ME3,0.99999
HP_ABNORMAL_DURA_MATER_MORPH...,SET,23,-0.12785,-0.0045222,0.16955,0.77458,HP_ABNORMAL_DURA_MATER_MORPHOLOGY,0.99999
AIZARANI_LIVER_C12_NK_NKT_CE...,SET,43,-0.10289,-0.0049732,0.13643,0.7746,AIZARANI_LIVER_C12_NK_NKT_CELLS_4,0.99999
MIR625_3P,SET,45,-0.10153,-0.0050204,0.13463,0.77462,MIR625_3P,0.99999
GSE24142_ADULT_VS_FETAL_DN3_...2,SET,179,-0.048323,-0.0047479,0.064072,0.77463,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP,0.99999
GOBP_REGULATION_OF_CATABOLIC...,SET,914,-0.021147,-0.0045993,0.028034,0.77467,GOBP_REGULATION_OF_CATABOLIC_PROCESS,0.99999
GOBP_PROTEIN_DEUBIQUITINATION,SET,71,-0.069117,-0.0042897,0.09162,0.77469,GOBP_PROTEIN_DEUBIQUITINATION,0.99999
PPARGC1A_TARGET_GENES,SET,79,-0.069843,-0.0045714,0.092575,0.7747,PPARGC1A_TARGET_GENES,0.99999
GOBP_SPERM_DNA_CONDENSATION,SET,14,-0.16328,-0.004507,0.21643,0.7747,GOBP_SPERM_DNA_CONDENSATION,0.99999
GOCC_INTERCALATED_DISC,SET,50,-0.095898,-0.0049975,0.1271,0.77472,GOCC_INTERCALATED_DISC,0.99999
GSE9988_LPS_VS_LPS_AND_ANTI_...2,SET,177,-0.048741,-0.0047624,0.064587,0.77477,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP,0.99999
HP_BROAD_JAW,SET,5,-0.26025,-0.004294,0.34482,0.77479,HP_BROAD_JAW,0.99999
MIR12122,SET,193,-0.046563,-0.0047487,0.06169,0.77481,MIR12122,0.99999
GOBP_DETOXIFICATION_OF_COPPE...,SET,13,-0.2366,-0.0062934,0.31335,0.77489,GOBP_DETOXIFICATION_OF_COPPER_ION,0.99999
GOMF_NUCLEOSIDE_DIPHOSPHATE_...1,SET,17,-0.14778,-0.0044945,0.19571,0.77489,GOMF_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...607,SET,96,-0.062372,-0.0044982,0.082592,0.77493,GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.99999
GOCC_ASTROCYTE_PROJECTION,SET,21,-0.15371,-0.0051955,0.20354,0.77493,GOCC_ASTROCYTE_PROJECTION,0.99999
GSE16450_CTRL_VS_IFNA_6H_STI...2,SET,180,-0.048522,-0.0047806,0.064251,0.77493,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.99999
MIR6816_5P,SET,19,-0.15496,-0.0049822,0.20517,0.77495,MIR6816_5P,0.99999
MIR4733_3P,SET,66,-0.074578,-0.0044632,0.098729,0.77498,MIR4733_3P,0.99999
GOBP_CARBOHYDRATE_BIOSYNTHET...,SET,186,-0.046523,-0.0046587,0.061586,0.77499,GOBP_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,0.99999
GOMF_DOUBLE_STRANDED_TELOMER...,SET,9,-0.21132,-0.0046775,0.27975,0.77499,GOMF_DOUBLE_STRANDED_TELOMERIC_DNA_BINDING,0.99999
GSE5503_LIVER_DC_VS_PLN_DC_A...2,SET,182,-0.046628,-0.0046193,0.06172,0.77501,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.99999
GOMF_GLUTATHIONE_TRANSFERASE...,SET,23,-0.16045,-0.0056751,0.21235,0.77505,GOMF_GLUTATHIONE_TRANSFERASE_ACTIVITY,0.99999
HP_ENLARGED_TONSILS,SET,5,-0.26895,-0.0044377,0.35595,0.77505,HP_ENLARGED_TONSILS,0.99999
HP_UNDETECTABLE_ELECTRORETIN...,SET,33,-0.12006,-0.0050853,0.15889,0.77505,HP_UNDETECTABLE_ELECTRORETINOGRAM,0.99999
GSE2706_UNSTIM_VS_8H_R848_DC...2,SET,172,-0.048349,-0.0046576,0.063988,0.77505,GSE2706_UNSTIM_VS_8H_R848_DC_UP,0.99999
VDR_Q6,SET,236,-0.04193,-0.004723,0.055475,0.77512,VDR_Q6,0.99999
HP_EPIPHYSEAL_STIPPLING,SET,30,-0.1177,-0.0047536,0.15566,0.77521,HP_EPIPHYSEAL_STIPPLING,0.99999
GOBP_EXPORT_ACROSS_PLASMA_ME...,SET,65,-0.084942,-0.005045,0.11232,0.77525,GOBP_EXPORT_ACROSS_PLASMA_MEMBRANE,0.99999
MIR6804_5P,SET,66,-0.075606,-0.0045248,0.09995,0.7753,MIR6804_5P,0.99999
MIR12136,SET,903,-0.021997,-0.0047567,0.029075,0.77534,MIR12136,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_TH1...,SET,15,-0.1803,-0.0051512,0.23829,0.77536,HE_LIM_SUN_FETAL_LUNG_C4_TH17_CELL,0.99999
chr6q25,SET,67,-0.1664,-0.010033,0.2199,0.77537,chr6q25,0.99999
chr16q11,SET,7,-0.48816,-0.0095297,0.64502,0.77541,chr16q11,0.99999
GOBP_7_METHYLGUANOSINE_CAP_H...,SET,8,-0.19474,-0.0040641,0.25729,0.77544,GOBP_7_METHYLGUANOSINE_CAP_HYPERMETHYLATION,0.99999
HP_SOFT_TISSUE_SARCOMA,SET,124,-0.057109,-0.0046773,0.075449,0.77545,HP_SOFT_TISSUE_SARCOMA,0.99999
LEIN_CEREBELLUM_MARKERS,SET,76,-0.07771,-0.0049893,0.10266,0.77546,LEIN_CEREBELLUM_MARKERS,0.99999
GOBP_RESPONSE_TO_ALCOHOL,SET,244,-0.042731,-0.0048931,0.056442,0.77549,GOBP_RESPONSE_TO_ALCOHOL,0.99999
HP_POIKILODERMA,SET,23,-0.11882,-0.0042029,0.15695,0.77549,HP_POIKILODERMA,0.99999
HP_PEG_SHAPED_MAXILLARY_LATE...,SET,24,-0.1412,-0.0051016,0.18649,0.77551,HP_PEG_SHAPED_MAXILLARY_LATERAL_INCISORS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...36,SET,6,-0.25663,-0.0046383,0.3388,0.77561,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ATXN1_TO_RORA_MEDIATED_TRANSCRIPTION,0.99999
REACTOME_HEDGEHOG_OFF_STATE,SET,108,-0.05842,-0.0044673,0.077116,0.77564,REACTOME_HEDGEHOG_OFF_STATE,0.99999
HUPER_BREAST_BASAL_VS_LUMINA...2,SET,51,-0.095915,-0.005048,0.1266,0.77565,HUPER_BREAST_BASAL_VS_LUMINAL_UP,0.99999
ZNF41_TARGET_GENES,SET,171,-0.048804,-0.0046879,0.064416,0.77566,ZNF41_TARGET_GENES,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...10,SET,8,-0.22859,-0.0047705,0.30156,0.77578,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY,0.99999
HP_OCULAR_ALBINISM,SET,27,-0.12651,-0.0048476,0.16687,0.7758,HP_OCULAR_ALBINISM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...345,SET,10,-0.22381,-0.0052218,0.29521,0.77581,GOBP_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY,0.99999
GOBP_CELLULAR_RESPONSE_TO_GL...3,SET,43,-0.094296,-0.004558,0.12437,0.77582,GOBP_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION,0.99999
HP_PROGRESSIVE_PULMONARY_FUN...,SET,13,-0.16663,-0.0044324,0.21979,0.77582,HP_PROGRESSIVE_PULMONARY_FUNCTION_IMPAIRMENT,0.99999
HP_PULMONARY_CARCINOID_TUMOR,SET,8,-0.19945,-0.0041624,0.26297,0.77591,HP_PULMONARY_CARCINOID_TUMOR,0.99999
BLANCO_MELO_COVID19_SARS_COV...8,SET,302,-0.040229,-0.0051168,0.05303,0.77595,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,0.99999
GSE34156_UNTREATED_VS_6H_TLR...1,SET,163,-0.048196,-0.0045208,0.063529,0.77596,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.99999
chr20p13,SET,78,-0.14943,-0.0097185,0.19694,0.77599,chr20p13,0.99999
AP3_Q6,SET,228,-0.04494,-0.0049767,0.059223,0.77602,AP3_Q6,0.99999
MIR8062,SET,97,-0.063973,-0.0046375,0.084301,0.77603,MIR8062,0.99999
GOBP_LYSOSOMAL_LUMEN_ACIDIFI...,SET,20,-0.14871,-0.0049055,0.19593,0.77607,GOBP_LYSOSOMAL_LUMEN_ACIDIFICATION,0.99999
HP_DECREASED_CIRCULATING_COR...,SET,32,-0.10934,-0.0045608,0.14406,0.77607,HP_DECREASED_CIRCULATING_CORTISOL_LEVEL,0.99999
HP_NEOPLASIA_OF_THE_NASOPHAR...,SET,5,-0.27578,-0.0045503,0.36335,0.77607,HP_NEOPLASIA_OF_THE_NASOPHARYNX,0.99999
GOBP_GROWTH_PLATE_CARTILAGE_...3,SET,19,-0.14704,-0.0047275,0.1937,0.7761,GOBP_GROWTH_PLATE_CARTILAGE_DEVELOPMENT,0.99999
IVANOVA_HEMATOPOIESIS_MATURE...,SET,259,-0.039933,-0.0047092,0.052602,0.77611,IVANOVA_HEMATOPOIESIS_MATURE_CELL,0.99999
FAN_EMBRYONIC_CTX_ASTROCYTE_1,SET,73,-0.077877,-0.0049007,0.10259,0.77611,FAN_EMBRYONIC_CTX_ASTROCYTE_1,0.99999
chr11q24,SET,81,-0.14152,-0.0093791,0.18638,0.77617,chr11q24,0.99999
WESTON_VEGFA_TARGETS_12HR,SET,21,-0.15356,-0.0051903,0.2021,0.77632,WESTON_VEGFA_TARGETS_12HR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...249,SET,14,-0.17371,-0.0047949,0.2286,0.77633,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_VIA_CHROMOSOMAL_CPG_ISLAND_METHYLATION,0.99999
MIR151A_3P,SET,30,-0.12313,-0.0049731,0.16204,0.77634,MIR151A_3P,0.99999
HP_ADDICTIVE_BEHAVIOR,SET,29,-0.12434,-0.0049376,0.16359,0.77639,HP_ADDICTIVE_BEHAVIOR,0.99999
HP_DYSMETRIA,SET,158,-0.049745,-0.0045947,0.065447,0.77639,HP_DYSMETRIA,0.99999
GOBP_TROPHOBLAST_GIANT_CELL_...,SET,12,-0.21161,-0.0054081,0.27838,0.77641,GOBP_TROPHOBLAST_GIANT_CELL_DIFFERENTIATION,0.99999
HP_CURVILINEAR_INTRACELLULAR...,SET,11,-0.19536,-0.0047804,0.25701,0.77641,HP_CURVILINEAR_INTRACELLULAR_ACCUMULATION_OF_AUTOFLUORESCENT_LIPOPIGMENT_STORAGE_MATERIAL,0.99999
PLASARI_TGFB1_TARGETS_10HR_DN,SET,235,-0.045309,-0.005093,0.059596,0.77645,PLASARI_TGFB1_TARGETS_10HR_DN,0.99999
REACTOME_PROPIONYL_COA_CATAB...,SET,4,-0.36597,-0.0054011,0.48134,0.77647,REACTOME_PROPIONYL_COA_CATABOLISM,0.99999
LU_TUMOR_VASCULATURE_UP,SET,27,-0.12861,-0.0049283,0.16914,0.77649,LU_TUMOR_VASCULATURE_UP,0.99999
GOBP_CELL_SURFACE_RECEPTOR_P...2,SET,581,-0.027758,-0.0048589,0.036503,0.77649,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY,0.99999
REACTOME_IL_6_TYPE_CYTOKINE_...,SET,17,-0.15374,-0.0046758,0.20217,0.7765,REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,0.99999
HNF3ALPHA_Q6,SET,184,-0.048225,-0.0048034,0.063412,0.77652,HNF3ALPHA_Q6,0.99999
GSE11961_MARGINAL_ZONE_BCELL...10,SET,185,-0.045731,-0.0045672,0.060133,0.77652,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_UP,0.99999
KAUFFMANN_MELANOMA_RELAPSE_DN,SET,6,-0.25292,-0.0045714,0.3325,0.77657,KAUFFMANN_MELANOMA_RELAPSE_DN,0.99999
chr1q42,SET,83,-0.1396,-0.0093649,0.18348,0.77662,chr1q42,0.99999
REACTOME_VESICLE_MEDIATED_TR...,SET,631,-0.02541,-0.004629,0.033391,0.77667,REACTOME_VESICLE_MEDIATED_TRANSPORT,0.99999
DPPA3_TARGET_GENES,SET,16,-0.14474,-0.0042707,0.19018,0.77668,DPPA3_TARGET_GENES,0.99999
GOBP_RESPONSE_TO_NICOTINE,SET,51,-0.10135,-0.0053343,0.13314,0.77675,GOBP_RESPONSE_TO_NICOTINE,0.99999
GOBP_REGULATION_OF_BRANCHING...1,SET,6,-0.29517,-0.005335,0.38768,0.77678,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,0.99999
KEGG_VALINE_LEUCINE_AND_ISOL...1,SET,6,-0.25745,-0.0046531,0.33804,0.77684,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,0.99999
GSE9650_NAIVE_VS_MEMORY_CD8_...1,SET,181,-0.04847,-0.0047886,0.063637,0.77686,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.99999
HP_CONVEX_NASAL_RIDGE,SET,82,-0.066456,-0.0044312,0.087237,0.7769,HP_CONVEX_NASAL_RIDGE,0.99999
GOBP_CEREBELLAR_GRANULAR_LAY...3,SET,8,-0.28098,-0.0058638,0.36879,0.77693,GOBP_CEREBELLAR_GRANULAR_LAYER_MORPHOGENESIS,0.99999
GSE36392_TYPE_2_MYELOID_VS_N...2,SET,182,-0.046531,-0.0046097,0.061063,0.77697,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,0.99999
GOBP_PROTEIN_TARGETING_TO_VA...2,SET,5,-0.28029,-0.0046247,0.36772,0.77703,GOBP_PROTEIN_TARGETING_TO_VACUOLE_INVOLVED_IN_AUTOPHAGY,0.99999
GOBP_SPERM_CAPACITATION,SET,29,-0.12237,-0.0048595,0.16054,0.77703,GOBP_SPERM_CAPACITATION,0.99999
HP_ABNORMALITY_OF_IRON_HOMEO...,SET,23,-0.12781,-0.0045207,0.16768,0.77703,HP_ABNORMALITY_OF_IRON_HOMEOSTASIS,0.99999
GOBP_CELLULAR_RESPONSE_TO_ZI...,SET,20,-0.17063,-0.0056284,0.22385,0.77704,GOBP_CELLULAR_RESPONSE_TO_ZINC_ION,0.99999
GSE2770_IL12_AND_TGFB_ACT_VS...4,SET,178,-0.047844,-0.0046879,0.062766,0.77704,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP,0.99999
GSE17721_0.5H_VS_8H_POLYIC_B...2,SET,183,-0.044908,-0.004461,0.058907,0.77707,GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP,0.99999
GOBP_AMINE_BIOSYNTHETIC_PROC...,SET,35,-0.10803,-0.0047121,0.14165,0.77716,GOBP_AMINE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_OX...1,SET,225,-0.043062,-0.0047377,0.056458,0.77718,GOBP_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,0.99999
GOCC_CLATHRIN_COMPLEX,SET,8,-0.20408,-0.0042589,0.26757,0.77718,GOCC_CLATHRIN_COMPLEX,0.99999
GOBP_DEVELOPMENTAL_GROWTH,SET,586,-0.028095,-0.0049385,0.036822,0.77726,GOBP_DEVELOPMENTAL_GROWTH,0.99999
GOMF_PROFILIN_BINDING,SET,10,-0.20244,-0.0047232,0.26531,0.77728,GOMF_PROFILIN_BINDING,0.99999
KENNY_CTNNB1_TARGETS_DN,SET,49,-0.089997,-0.004643,0.11793,0.7773,KENNY_CTNNB1_TARGETS_DN,0.99999
KIM_ALL_DISORDERS_OLIGODENDR...1,SET,30,-0.10918,-0.0044097,0.14304,0.77734,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,0.99999
HP_ELEVATED_HEPATIC_IRON_CON...,SET,11,-0.20795,-0.0050884,0.27243,0.77736,HP_ELEVATED_HEPATIC_IRON_CONCENTRATION,0.99999
KIM_GASTRIC_CANCER_CHEMOSENS...,SET,86,-0.07001,-0.0047802,0.09171,0.77738,KIM_GASTRIC_CANCER_CHEMOSENSITIVITY,0.99999
GSE7852_THYMUS_VS_FAT_TREG_UP,SET,188,-0.044218,-0.0044514,0.057914,0.77742,GSE7852_THYMUS_VS_FAT_TREG_UP,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...2,SET,5,-0.25913,-0.0042755,0.33934,0.77745,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR_GRASP55,0.99999
GSE14415_TCONV_VS_FOXP3_KO_I...2,SET,151,-0.051383,-0.0046406,0.067285,0.77746,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP,0.99999
HOWARD_NK_CELL_INACT_MONOV_I...1,SET,19,-0.14838,-0.0047705,0.19427,0.77749,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.99999
WP_TNFRELATED_WEAK_INDUCER_O...,SET,41,-0.099209,-0.0046829,0.12982,0.77762,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,0.99999
MIR10526_3P,SET,105,-0.062405,-0.0047057,0.081663,0.77762,MIR10526_3P,0.99999
PID_AVB3_INTEGRIN_PATHWAY,SET,72,-0.078925,-0.0049326,0.10326,0.77765,PID_AVB3_INTEGRIN_PATHWAY,0.99999
GSE10239_MEMORY_VS_KLRG1INT_...1,SET,184,-0.046216,-0.0046033,0.060463,0.77767,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN,0.99999
GSE14908_RESTING_VS_HDM_STIM...3,SET,177,-0.047351,-0.0046266,0.061948,0.77767,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN,0.99999
HP_ABNORMAL_METAPHYSEAL_TRAB...,SET,21,-0.13612,-0.0046009,0.17805,0.77771,HP_ABNORMAL_METAPHYSEAL_TRABECULATION,0.99999
GOBP_CHEMOKINE_C_X_C_MOTIF_L...2,SET,6,-0.2724,-0.0049234,0.35619,0.77779,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_1_PRODUCTION,0.99999
GOBP_SKIN_DEVELOPMENT,SET,301,-0.041499,-0.0052696,0.054247,0.77786,GOBP_SKIN_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...484,SET,13,-0.20765,-0.0055233,0.2714,0.77789,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,0.99999
GOBP_REGULATION_OF_CELLULAR_...5,SET,37,-0.11057,-0.0049587,0.14451,0.7779,GOBP_REGULATION_OF_CELLULAR_EXTRAVASATION,0.99999
GOBP_EMBRYONIC_SKELETAL_JOIN...2,SET,10,-0.22764,-0.005311,0.2975,0.77791,GOBP_EMBRYONIC_SKELETAL_JOINT_MORPHOGENESIS,0.99999
GSE26023_PHD3_KO_VS_WT_NEUTR...1,SET,178,-0.046956,-0.0046009,0.061364,0.77792,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...705,SET,4,-0.34648,-0.0051134,0.45278,0.77793,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_GROWTH,0.99999
GSE3982_NEUTROPHIL_VS_BASOPH...1,SET,172,-0.047326,-0.0045591,0.061843,0.77794,GSE3982_NEUTROPHIL_VS_BASOPHIL_DN,0.99999
GOBP_REGULATION_OF_GAMMA_DEL...2,SET,9,-0.22206,-0.0049152,0.29013,0.77797,GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION,0.99999
GSE18281_CORTEX_VS_MEDULLA_T...2,SET,162,-0.049225,-0.0046033,0.064312,0.77798,GSE18281_CORTEX_VS_MEDULLA_THYMUS_UP,0.99999
H1_6_TARGET_GENES,SET,405,-0.032558,-0.0047818,0.042535,0.77799,H1_6_TARGET_GENES,0.99999
REACTOME_NCAM1_INTERACTIONS,SET,41,-0.1088,-0.0051354,0.14212,0.77801,REACTOME_NCAM1_INTERACTIONS,0.99999
GOBP_REGULATION_OF_CAVEOLIN_...,SET,6,-0.27263,-0.0049276,0.35598,0.77812,GOBP_REGULATION_OF_CAVEOLIN_MEDIATED_ENDOCYTOSIS,0.99999
GSE3982_BCELL_VS_EFF_MEMORY_...1,SET,177,-0.049641,-0.0048504,0.064815,0.77812,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN,0.99999
HP_ABNORMAL_T_CELL_MORPHOLOGY,SET,105,-0.063506,-0.0047887,0.082905,0.77816,HP_ABNORMAL_T_CELL_MORPHOLOGY,0.99999
SCHRAETS_MLL_TARGETS_DN,SET,32,-0.12686,-0.0052915,0.16559,0.77819,SCHRAETS_MLL_TARGETS_DN,0.99999
KEGG_MEDICUS_PATHOGEN_HIV_VP...1,SET,5,-0.3427,-0.0056544,0.44729,0.7782,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY,0.99999
GOBP_RESPONSE_TO_DIETARY_EXC...,SET,32,-0.12159,-0.0050718,0.15868,0.77823,GOBP_RESPONSE_TO_DIETARY_EXCESS,0.99999
GNF2_PPP6C,SET,35,-0.098106,-0.0042793,0.12801,0.77827,GNF2_PPP6C,0.99999
GOCC_COSTAMERE,SET,16,-0.16679,-0.0049216,0.21759,0.77832,GOCC_COSTAMERE,0.99999
HP_ABNORMALITY_OF_THE_ENDOCR...,SET,1248,-0.018651,-0.0046944,0.024329,0.77834,HP_ABNORMALITY_OF_THE_ENDOCRINE_SYSTEM,0.99999
HP_BLEPHARITIS,SET,42,-0.091999,-0.0043951,0.11994,0.77846,HP_BLEPHARITIS,0.99999
LOPEZ_EPITHELIOID_MESOTHELIO...,SET,15,-0.1609,-0.0045971,0.20974,0.7785,LOPEZ_EPITHELIOID_MESOTHELIOMA,0.99999
MASSARWEH_RESPONSE_TO_ESTRAD...,SET,59,-0.089658,-0.0050742,0.11687,0.77851,MASSARWEH_RESPONSE_TO_ESTRADIOL,0.99999
REACTOME_WNT_MEDIATED_ACTIVA...,SET,8,-0.23034,-0.0048071,0.30023,0.77852,REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_TH...3,SET,25,-0.11576,-0.0042686,0.15088,0.77853,HP_ABNORMAL_MORPHOLOGY_OF_THE_CONJUNCTIVAL_VASCULATURE,0.99999
GSE3982_MAST_CELL_VS_BASOPHI...2,SET,174,-0.049576,-0.0048032,0.064609,0.77855,GSE3982_MAST_CELL_VS_BASOPHIL_UP,0.99999
GOBP_OPTIC_NERVE_MORPHOGENES...,SET,6,-0.2878,-0.0052017,0.37503,0.77857,GOBP_OPTIC_NERVE_MORPHOGENESIS,0.99999
MIR371A_3P,SET,9,-0.22712,-0.0050271,0.29594,0.77858,MIR371A_3P,0.99999
GOBP_IRON_ION_TRANSPORT,SET,48,-0.096337,-0.0049192,0.12551,0.77862,GOBP_IRON_ION_TRANSPORT,0.99999
HP_INCREASED_CIRCULATING_COR...,SET,29,-0.12863,-0.0051082,0.16759,0.77862,HP_INCREASED_CIRCULATING_CORTISOL_LEVEL,0.99999
REACTOME_EVASION_BY_RSV_OF_H...,SET,28,-0.13603,-0.0053079,0.1772,0.77864,REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES,0.99999
REACTOME_TRP_CHANNELS,SET,27,-0.13208,-0.0050613,0.17196,0.77878,REACTOME_TRP_CHANNELS,0.99999
PAX8_TARGET_GENES,SET,65,-0.07474,-0.004439,0.097298,0.7788,PAX8_TARGET_GENES,0.99999
GGCNNMSMYNTTG_UNKNOWN,SET,69,-0.078696,-0.0048152,0.10242,0.77886,GGCNNMSMYNTTG_UNKNOWN,0.99999
MORF_SS18,SET,56,-0.07934,-0.004375,0.10326,0.77887,MORF_SS18,0.99999
GOBP_CELLULAR_RESPONSE_TO_TY...,SET,91,-0.06866,-0.0048217,0.089354,0.77887,GOBP_CELLULAR_RESPONSE_TO_TYPE_II_INTERFERON,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...15,SET,168,-0.047391,-0.0045124,0.061652,0.77896,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...1,SET,15,-0.14997,-0.0042847,0.19508,0.77897,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR,0.99999
GOBP_CRANIOFACIAL_SUTURE_MOR...,SET,19,-0.16517,-0.0053106,0.21486,0.77897,GOBP_CRANIOFACIAL_SUTURE_MORPHOGENESIS,0.99999
MIR32_3P,SET,306,-0.038097,-0.0048771,0.049549,0.77902,MIR32_3P,0.99999
GSE25085_FETAL_LIVER_VS_ADUL...1,SET,167,-0.046823,-0.0044451,0.060893,0.77903,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,0.99999
HP_SUICIDAL_IDEATION,SET,21,-0.13295,-0.0044938,0.17289,0.77905,HP_SUICIDAL_IDEATION,0.99999
HP_ATROPHY_DEGENERATION_AFFE...3,SET,591,-0.026137,-0.0046131,0.033984,0.77908,HP_ATROPHY_DEGENERATION_AFFECTING_THE_CEREBRUM,0.99999
TAKEDA_TARGETS_OF_NUP98_HOXA...1,SET,130,-0.06165,-0.0051691,0.080149,0.7791,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,0.99999
GOBP_RESPONSE_TO_GONADOTROPIN,SET,27,-0.13757,-0.0052715,0.17884,0.77912,GOBP_RESPONSE_TO_GONADOTROPIN,0.99999
GSE22886_CD8_TCELL_VS_BCELL_...1,SET,170,-0.049658,-0.004756,0.064554,0.77912,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN,0.99999
HP_COMA,SET,91,-0.066647,-0.0046803,0.086637,0.77913,HP_COMA,0.99999
GOBP_AMIDE_CATABOLIC_PROCESS,SET,16,-0.15819,-0.0046677,0.20563,0.77914,GOBP_AMIDE_CATABOLIC_PROCESS,0.99999
GOBP_POST_ANAL_TAIL_MORPHOGE...,SET,18,-0.15374,-0.0048114,0.19975,0.77925,GOBP_POST_ANAL_TAIL_MORPHOGENESIS,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...5,SET,34,-0.1129,-0.0048537,0.14667,0.77927,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,0.99999
GOBP_HETEROPHILIC_CELL_CELL_...,SET,45,-0.11012,-0.0054449,0.14305,0.77928,GOBP_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,0.99999
GOBP_POSITIVE_REGULATION_OF_...729,SET,4,-0.35135,-0.0051854,0.45644,0.77928,GOBP_POSITIVE_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...12,SET,143,-0.05372,-0.0047224,0.069778,0.77931,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_UP,0.99999
HP_ABNORMAL_STOOL_COMPOSITION,SET,18,-0.15491,-0.0048478,0.20113,0.7794,HP_ABNORMAL_STOOL_COMPOSITION,0.99999
KEGG_MEDICUS_VARIANT_SCRAPIE...1,SET,35,-0.095593,-0.0041696,0.12411,0.77942,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
HP_ABNORMAL_CIRCULATING_ORGA...,SET,655,-0.025527,-0.0047346,0.033131,0.77948,HP_ABNORMAL_CIRCULATING_ORGANIC_COMPOUND_CONCENTRATION,0.99999
GSE13522_WT_VS_IFNG_KO_SKING...1,SET,110,-0.061492,-0.0047453,0.079779,0.77957,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,0.99999
GOBP_RESPONSE_TO_ACTIVITY,SET,72,-0.079314,-0.004957,0.10289,0.77961,GOBP_RESPONSE_TO_ACTIVITY,0.99999
MIR6823_3P,SET,56,-0.083472,-0.0046028,0.10826,0.77965,MIR6823_3P,0.99999
GSE41867_NAIVE_VS_DAY8_LCMV_...3,SET,159,-0.049464,-0.004583,0.064138,0.7797,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.99999
GSE17721_CTRL_VS_CPG_1H_BMDC...1,SET,187,-0.047329,-0.004752,0.061341,0.77981,GSE17721_CTRL_VS_CPG_1H_BMDC_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...307,SET,2,-0.54889,-0.0057283,0.71135,0.77982,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION,0.99999
KEGG_MEDICUS_REFERENCE_INTRI...,SET,13,-0.18795,-0.0049994,0.24356,0.77985,KEGG_MEDICUS_REFERENCE_INTRINSIC_APOPTOTIC_PATHWAY,0.99999
GOBP_ARACHIDONIC_ACID_METABO...,SET,55,-0.092571,-0.0050589,0.11995,0.77987,GOBP_ARACHIDONIC_ACID_METABOLIC_PROCESS,0.99999
GSE25890_CTRL_VS_IL33_IL7_TR...2,SET,179,-0.047788,-0.0046953,0.061915,0.77989,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_UP,0.99999
GOBP_VITAMIN_D_RECEPTOR_SIGN...,SET,12,-0.18531,-0.0047358,0.24006,0.77991,GOBP_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,0.99999
BIOCARTA_FBW7_PATHWAY,SET,9,-0.20864,-0.0046182,0.27028,0.77992,BIOCARTA_FBW7_PATHWAY,0.99999
MODULE_157,SET,100,-0.063663,-0.0046855,0.082459,0.77996,MODULE_157,0.99999
MIR4659A_3P_MIR4659B_3P,SET,609,-0.026884,-0.0048142,0.034816,0.77999,MIR4659A_3P_MIR4659B_3P,0.99999
GSE44649_NAIVE_VS_ACTIVATED_...3,SET,176,-0.04729,-0.0046077,0.061243,0.77999,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP,0.99999
MIR6722_3P,SET,161,-0.051166,-0.0047702,0.066256,0.78001,MIR6722_3P,0.99999
GSE46242_TH1_VS_ANERGIC_TH1_...4,SET,166,-0.050622,-0.0047915,0.065544,0.78004,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_UP,0.99999
HP_EPISODIC_METABOLIC_ACIDOS...,SET,4,-0.37602,-0.0055495,0.48675,0.78009,HP_EPISODIC_METABOLIC_ACIDOSIS,0.99999
ZSCAN5B_TARGET_GENES,SET,48,-0.095995,-0.0049018,0.12426,0.7801,ZSCAN5B_TARGET_GENES,0.99999
MIR449B_5P,SET,237,-0.041678,-0.0047045,0.053947,0.78011,MIR449B_5P,0.99999
WP_CILIOPATHIES,SET,162,-0.049405,-0.0046202,0.063938,0.78015,WP_CILIOPATHIES,0.99999
GSE17721_0.5H_VS_12H_LPS_BMD...2,SET,174,-0.047067,-0.0045601,0.060905,0.78017,GSE17721_0.5H_VS_12H_LPS_BMDC_UP,0.99999
MIR103A_1_5P,SET,136,-0.056992,-0.0048867,0.073744,0.78018,MIR103A_1_5P,0.99999
HP_ACANTHOCYTOSIS,SET,10,-0.20254,-0.0047255,0.26195,0.7803,HP_ACANTHOCYTOSIS,0.99999
MIR301B_3P,SET,351,-0.035226,-0.0048236,0.045548,0.78034,MIR301B_3P,0.99999
KYNG_RESPONSE_TO_H2O2_VIA_ER...1,SET,17,-0.16896,-0.0051387,0.21846,0.78035,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,0.99999
HP_INFANTILE_AXIAL_HYPOTONIA,SET,42,-0.1023,-0.004887,0.13227,0.78035,HP_INFANTILE_AXIAL_HYPOTONIA,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...57,SET,38,-0.10549,-0.0047943,0.13636,0.78043,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_THUMB,0.99999
KEGG_MEDICUS_VARIANT_MLL_ENL...,SET,11,-0.22133,-0.0054157,0.28603,0.78047,KEGG_MEDICUS_VARIANT_MLL_ENL_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.99999
REACTOME_MICRORNA_MIRNA_BIOG...,SET,24,-0.12622,-0.0045605,0.16312,0.78047,REACTOME_MICRORNA_MIRNA_BIOGENESIS,0.99999
ZNF501_TARGET_GENES,SET,13,-0.18748,-0.0049868,0.24227,0.78048,ZNF501_TARGET_GENES,0.99999
WP_PHOSPHATIDYL_INOSITOL_PHO...,SET,40,-0.097277,-0.0045354,0.12568,0.78053,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,0.99999
GOBP_CELL_CYCLE_PHASE_TRANSI...,SET,495,-0.028902,-0.0046812,0.037336,0.78057,GOBP_CELL_CYCLE_PHASE_TRANSITION,0.99999
GOMF_ESTROGEN_16_ALPHA_HYDRO...,SET,8,-0.24697,-0.0051539,0.31901,0.78058,GOMF_ESTROGEN_16_ALPHA_HYDROXYLASE_ACTIVITY,0.99999
HP_EEG_WITH_ABNORMALLY_SLOW_...,SET,86,-0.069829,-0.0047678,0.090168,0.78066,HP_EEG_WITH_ABNORMALLY_SLOW_FREQUENCIES,0.99999
KOKKINAKIS_METHIONINE_DEPRIV...4,SET,113,-0.064068,-0.0050106,0.0827,0.78073,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,0.99999
GSE6259_BCELL_VS_CD8_TCELL_DN,SET,168,-0.051636,-0.0049166,0.066651,0.78074,GSE6259_BCELL_VS_CD8_TCELL_DN,0.99999
HP_ABNORMALITY_OF_GLYCOLIPID...,SET,9,-0.21061,-0.0046617,0.2718,0.78078,HP_ABNORMALITY_OF_GLYCOLIPID_METABOLISM,0.99999
REACTOME_RESOLUTION_OF_ABASI...,SET,37,-0.094527,-0.0042391,0.12195,0.78086,REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES,0.99999
ZNF561_TARGET_GENES,SET,689,-0.025178,-0.004785,0.032483,0.78086,ZNF561_TARGET_GENES,0.99999
GOBP_NITROGEN_COMPOUND_TRANS...,SET,1728,-0.016271,-0.004751,0.020991,0.78087,GOBP_NITROGEN_COMPOUND_TRANSPORT,0.99999
GSE4748_CTRL_VS_LPS_STIM_DC_...2,SET,183,-0.049166,-0.0048839,0.063425,0.78088,GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP,0.99999
REACTOME_TCF_DEPENDENT_SIGNA...,SET,165,-0.049827,-0.0047022,0.064262,0.78093,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,0.99999
GOBP_MACROMOLECULE_CATABOLIC...,SET,1245,-0.018545,-0.0046626,0.023913,0.78098,GOBP_MACROMOLECULE_CATABOLIC_PROCESS,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...5,SET,7,-0.28813,-0.0056247,0.37153,0.78098,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_EXTRACELLULAR_REGION,0.99999
GSE39556_CD8A_DC_VS_NK_CELL_...3,SET,179,-0.046058,-0.0045254,0.059389,0.78098,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP,0.99999
HP_ABNORMAL_CSF_GLUCOSE_CONC...,SET,6,-0.28407,-0.0051344,0.3662,0.78104,HP_ABNORMAL_CSF_GLUCOSE_CONCENTRATION,0.99999
GOBP_SODIUM_DEPENDENT_PHOSPH...,SET,12,-0.21218,-0.0054225,0.27349,0.78106,GOBP_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT,0.99999
HP_TIBIAL_TORSION,SET,20,-0.14424,-0.004758,0.18589,0.78111,HP_TIBIAL_TORSION,0.99999
HP_ABNORMAL_EKG,SET,120,-0.061914,-0.004989,0.079776,0.78115,HP_ABNORMAL_EKG,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...27,SET,11,-0.19209,-0.0047003,0.24748,0.78118,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.99999
GOCC_COP9_SIGNALOSOME,SET,31,-0.1117,-0.004586,0.14391,0.78118,GOCC_COP9_SIGNALOSOME,0.99999
BMI1_DN_MEL18_DN.V1_UP,SET,135,-0.061404,-0.0052459,0.07911,0.78118,BMI1_DN_MEL18_DN.V1_UP,0.99999
EVI1_06,SET,19,-0.14703,-0.0047273,0.18939,0.78122,EVI1_06,0.99999
MODULE_503,SET,103,-0.064332,-0.0048048,0.082849,0.78127,MODULE_503,0.99999
GOMF_L_ARGININE_TRANSMEMBRAN...,SET,11,-0.2265,-0.0055423,0.2917,0.78127,GOMF_L_ARGININE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE26343_WT_VS_NFAT5_KO_MACR...4,SET,181,-0.04607,-0.0045515,0.059331,0.78127,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP,0.99999
GOBP_NADH_METABOLIC_PROCESS,SET,28,-0.11437,-0.0044627,0.14724,0.78133,GOBP_NADH_METABOLIC_PROCESS,0.99999
GOBP_RESPONSE_TO_ETHANOL,SET,118,-0.062245,-0.0049739,0.080139,0.78133,GOBP_RESPONSE_TO_ETHANOL,0.99999
GSE17186_NAIVE_VS_CD21HIGH_T...4,SET,177,-0.049255,-0.0048127,0.063411,0.78135,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,0.99999
GOBP_RENAL_FILTRATION,SET,27,-0.14056,-0.0053862,0.18091,0.78141,GOBP_RENAL_FILTRATION,0.99999
GOBP_SNRNA_3_END_PROCESSING,SET,18,-0.13228,-0.0041396,0.17024,0.78142,GOBP_SNRNA_3_END_PROCESSING,0.99999
SMID_BREAST_CANCER_RELAPSE_I...3,SET,76,-0.07866,-0.0050503,0.10121,0.78147,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,0.99999
GOBP_REGULATION_OF_MEMBRANE_...11,SET,7,-0.2681,-0.0052338,0.34494,0.78149,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL,0.99999
HP_HEPATITIS,SET,82,-0.074296,-0.004954,0.095586,0.7815,HP_HEPATITIS,0.99999
GOMF_MANNOSE_BINDING,SET,22,-0.14512,-0.0050204,0.18666,0.78155,GOMF_MANNOSE_BINDING,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...8,SET,180,-0.047239,-0.0046543,0.060761,0.78155,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP,0.99999
HP_EPENDYMOMA,SET,19,-0.14927,-0.0047993,0.19199,0.78156,HP_EPENDYMOMA,0.99999
HP_ABNORMAL_HEMOGLOBIN_CONCE...,SET,17,-0.15615,-0.0047492,0.20081,0.78159,HP_ABNORMAL_HEMOGLOBIN_CONCENTRATION,0.99999
ZHONG_SECRETOME_OF_LUNG_CANC...3,SET,69,-0.07788,-0.0047652,0.10015,0.7816,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,0.99999
HP_ABNORMAL_URINARY_NUCLEOBA...,SET,11,-0.23532,-0.0057581,0.30259,0.78162,HP_ABNORMAL_URINARY_NUCLEOBASE_CONCENTRATION,0.99999
PID_RAC1_PATHWAY,SET,51,-0.08695,-0.0045762,0.11179,0.78166,PID_RAC1_PATHWAY,0.99999
GSE13547_WT_VS_ZFX_KO_BCELL_...1,SET,142,-0.05411,-0.0047401,0.069556,0.78169,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN,0.99999
GSE39916_B_CELL_SPLEEN_VS_PL...2,SET,180,-0.050167,-0.0049428,0.064483,0.78171,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP,0.99999
DESERT_PERIVENOUS_HEPATOCELL...,SET,143,-0.055338,-0.0048646,0.071112,0.78176,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.99999
HP_PALMAR_TELANGIECTASIA,SET,7,-0.26496,-0.0051726,0.34046,0.78179,HP_PALMAR_TELANGIECTASIA,0.99999
HESS_TARGETS_OF_HOXA9_AND_ME...2,SET,67,-0.080069,-0.0048279,0.10287,0.78182,HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,0.99999
MIR125A_5P,SET,298,-0.038028,-0.0048052,0.048854,0.78183,MIR125A_5P,0.99999
ROSS_ACUTE_MYELOID_LEUKEMIA_...,SET,77,-0.081388,-0.0052595,0.10454,0.78187,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,0.99999
GSE3337_CTRL_VS_4H_IFNG_IN_C...1,SET,187,-0.047879,-0.0048072,0.061498,0.78187,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN,0.99999
HP_CLASS_III_OBESITY,SET,5,-0.38371,-0.0063311,0.49284,0.78188,HP_CLASS_III_OBESITY,0.99999
HP_EXAGGERATED_STARTLE_RESPO...,SET,29,-0.12834,-0.0050965,0.16481,0.78192,HP_EXAGGERATED_STARTLE_RESPONSE,0.99999
GOBP_HORMONE_MEDIATED_APOPTO...,SET,5,-0.32352,-0.005338,0.41542,0.78194,GOBP_HORMONE_MEDIATED_APOPTOTIC_SIGNALING_PATHWAY,0.99999
DESCARTES_MAIN_FETAL_MESOTHE...,SET,22,-0.15168,-0.0052474,0.19474,0.78198,DESCARTES_MAIN_FETAL_MESOTHELIAL_CELLS,0.99999
REACTOME_ACTIVATION_OF_PUMA_...,SET,9,-0.23829,-0.0052743,0.30588,0.78201,REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA,0.99999
GROSS_ELK3_TARGETS_DN,SET,32,-0.12213,-0.005094,0.15673,0.78207,GROSS_ELK3_TARGETS_DN,0.99999
HOFMANN_MYELODYSPLASTIC_SYND...4,SET,20,-0.14673,-0.0048402,0.1883,0.78208,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,0.99999
HP_LONG_PENIS,SET,11,-0.20553,-0.0050291,0.26375,0.78208,HP_LONG_PENIS,0.99999
KEGG_PRIMARY_IMMUNODEFICIENCY,SET,30,-0.13261,-0.0053559,0.17016,0.7821,KEGG_PRIMARY_IMMUNODEFICIENCY,0.99999
GSE11961_PLASMA_CELL_DAY7_VS...2,SET,179,-0.04869,-0.004784,0.062477,0.7821,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.99999
GOBP_G_PROTEIN_COUPLED_OPIOI...,SET,11,-0.21185,-0.0051838,0.27183,0.78211,GOBP_G_PROTEIN_COUPLED_OPIOID_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE7509_UNSTIM_VS_FCGRIIB_ST...3,SET,150,-0.050861,-0.0045782,0.065257,0.78212,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN,0.99999
DEURIG_T_CELL_PROLYMPHOCYTIC...2,SET,310,-0.037154,-0.0047867,0.047669,0.78213,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,0.99999
LINDSTEDT_DENDRITIC_CELL_MAT...3,SET,60,-0.089341,-0.0050988,0.11461,0.78215,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,0.99999
GOBP_NEURAL_RETINA_DEVELOPME...,SET,79,-0.079433,-0.0051991,0.1019,0.78215,GOBP_NEURAL_RETINA_DEVELOPMENT,0.99999
REACTOME_TP53_REGULATES_TRAN...5,SET,12,-0.20336,-0.0051971,0.26088,0.78216,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS,0.99999
CTCTAGA_MIR526C_MIR518F_MIR5...,SET,48,-0.095357,-0.0048692,0.12231,0.78219,CTCTAGA_MIR526C_MIR518F_MIR526A,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...8,SET,8,-0.21422,-0.0044705,0.27477,0.78219,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_UP,0.99999
MIR3914,SET,50,-0.097805,-0.0050969,0.12542,0.78225,MIR3914,0.99999
SASAI_RESISTANCE_TO_NEOPLAST...,SET,45,-0.10548,-0.0052154,0.13524,0.78229,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,0.99999
HP_RIB_FUSION,SET,45,-0.099489,-0.0049193,0.12754,0.78231,HP_RIB_FUSION,0.99999
KEGG_TYROSINE_METABOLISM,SET,38,-0.11756,-0.0053427,0.1507,0.78233,KEGG_TYROSINE_METABOLISM,0.99999
MIKKELSEN_PLURIPOTENT_STATE_...1,SET,8,-0.27542,-0.0057477,0.353,0.78236,MIKKELSEN_PLURIPOTENT_STATE_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...38,SET,35,-0.096418,-0.0042056,0.12357,0.78238,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
MIR939_5P,SET,114,-0.061108,-0.0048001,0.078311,0.78239,MIR939_5P,0.99999
GOMF_CYSTEINE_TYPE_ENDOPEPTI...4,SET,6,-0.2827,-0.0051095,0.3622,0.78245,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.99999
HP_PALMOPLANTAR_ERYTHEMA,SET,5,-0.35292,-0.0058231,0.45211,0.78248,HP_PALMOPLANTAR_ERYTHEMA,0.99999
GSE22886_IGG_IGA_MEMORY_BCEL...1,SET,170,-0.048716,-0.0046658,0.062403,0.7825,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,0.99999
HP_PORTAL_INFLAMMATION,SET,4,-0.37914,-0.0055954,0.48563,0.78251,HP_PORTAL_INFLAMMATION,0.99999
ZNF547_TARGET_GENES,SET,263,-0.040961,-0.0048671,0.052462,0.78253,ZNF547_TARGET_GENES,0.99999
GOCC_U2_TYPE_CATALYTIC_STEP_...,SET,30,-0.10408,-0.0042035,0.13328,0.78256,GOCC_U2_TYPE_CATALYTIC_STEP_2_SPLICEOSOME,0.99999
chr2p25,SET,45,-0.17356,-0.0085815,0.22223,0.78258,chr2p25,0.99999
HP_INCREASED_SERUM_SEROTONIN,SET,9,-0.20005,-0.004428,0.25617,0.78258,HP_INCREASED_SERUM_SEROTONIN,0.99999
GOMF_HISTONE_H3K9_DEMETHYLAS...,SET,12,-0.1616,-0.0041298,0.2069,0.7826,GOMF_HISTONE_H3K9_DEMETHYLASE_ACTIVITY,0.99999
GSE7764_IL15_TREATED_VS_CTRL...2,SET,175,-0.046225,-0.0044912,0.059175,0.78264,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP,0.99999
GOMF_LIPID_KINASE_ACTIVITY,SET,39,-0.10348,-0.0047639,0.13246,0.78265,GOMF_LIPID_KINASE_ACTIVITY,0.99999
RICHERT_PBMC_HIV_LIPO_5_AGE_...4,SET,25,-0.14798,-0.0054565,0.18942,0.78266,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_TOP_FUNCTIONAL_NETWORK_UP,0.99999
MIR4732_3P,SET,81,-0.075203,-0.0049839,0.096255,0.78268,MIR4732_3P,0.99999
GOBP_PROTEIN_TRANSPORT,SET,1298,-0.018532,-0.00475,0.023716,0.78271,GOBP_PROTEIN_TRANSPORT,0.99999
KEGG_MEDICUS_REFERENCE_BMP_H...2,SET,6,-0.23896,-0.004319,0.3057,0.7828,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY_AUXILIARY_FACTOR,0.99999
GOBP_PROTEIN_MATURATION_BY_4...,SET,4,-0.41527,-0.0061287,0.53123,0.7828,GOBP_PROTEIN_MATURATION_BY_4FE_4S_CLUSTER_TRANSFER,0.99999
HP_HYPERPHOSPHATEMIA,SET,17,-0.16613,-0.0050527,0.21247,0.78286,HP_HYPERPHOSPHATEMIA,0.99999
FOSTER_TOLERANT_MACROPHAGE_UP,SET,151,-0.056492,-0.005102,0.072236,0.7829,FOSTER_TOLERANT_MACROPHAGE_UP,0.99999
MIR4536_5P,SET,41,-0.10149,-0.0047905,0.12978,0.7829,MIR4536_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...129,SET,5,-0.31381,-0.0051778,0.40127,0.7829,GOBP_NEGATIVE_REGULATION_OF_CELL_VOLUME,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...2,SET,40,-0.1053,-0.0049094,0.13463,0.78292,GAVISH_3CA_METAPROGRAM_B_CELLS_CELL_CYCLE,0.99999
GOBP_REGULATION_OF_VACUOLE_O...,SET,54,-0.087994,-0.004765,0.1125,0.78295,GOBP_REGULATION_OF_VACUOLE_ORGANIZATION,0.99999
ZHONG_PFC_C4_PTGDS_POS_OPC,SET,132,-0.059747,-0.0050477,0.076382,0.78295,ZHONG_PFC_C4_PTGDS_POS_OPC,0.99999
REACTOME_HOST_INTERACTIONS_O...,SET,121,-0.055276,-0.0044724,0.070637,0.78304,REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,0.99999
VANLOO_SP3_TARGETS_UP,SET,9,-0.23055,-0.0051031,0.29462,0.78305,VANLOO_SP3_TARGETS_UP,0.99999
GOBP_ENDOCARDIUM_DEVELOPMENT,SET,12,-0.21882,-0.0055923,0.27959,0.78307,GOBP_ENDOCARDIUM_DEVELOPMENT,0.99999
DESCARTES_FETAL_LUNG_CILIATE...,SET,360,-0.03399,-0.0047126,0.043431,0.78307,DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS,0.99999
SESTO_RESPONSE_TO_UV_C1,SET,68,-0.076862,-0.0046688,0.098181,0.78314,SESTO_RESPONSE_TO_UV_C1,0.99999
RFX1_01,SET,224,-0.044119,-0.0048432,0.05634,0.7832,RFX1_01,0.99999
SANSOM_APC_TARGETS,SET,191,-0.046878,-0.0047563,0.059863,0.78321,SANSOM_APC_TARGETS,0.99999
CYTAGCAAY_UNKNOWN,SET,135,-0.056132,-0.0047954,0.071641,0.78333,CYTAGCAAY_UNKNOWN,0.99999
GSE13485_DAY1_VS_DAY3_YF17D_...2,SET,141,-0.058448,-0.0051022,0.074593,0.78334,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP,0.99999
GOBP_OLIGODENDROCYTE_PROGENI...,SET,8,-0.26143,-0.0054558,0.33364,0.78335,GOBP_OLIGODENDROCYTE_PROGENITOR_PROLIFERATION,0.99999
DIRMEIER_LMP1_RESPONSE_LATE_...2,SET,53,-0.093545,-0.0050186,0.11935,0.78341,DIRMEIER_LMP1_RESPONSE_LATE_UP,0.99999
MEISSNER_NPC_ICP_WITH_H3K4ME3,SET,17,-0.14234,-0.0043292,0.18156,0.78347,MEISSNER_NPC_ICP_WITH_H3K4ME3,0.99999
BRCA1_DN.V1_DN,SET,115,-0.063509,-0.0050104,0.081001,0.78349,BRCA1_DN.V1_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...207,SET,12,-0.21364,-0.0054598,0.27245,0.78351,GOBP_NEGATIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,0.99999
GOCC_SMC5_SMC6_COMPLEX,SET,6,-0.28328,-0.0051201,0.36102,0.78367,GOCC_SMC5_SMC6_COMPLEX,0.99999
HP_MILD_HEARING_IMPAIRMENT,SET,7,-0.21662,-0.0042288,0.27601,0.78371,HP_MILD_HEARING_IMPAIRMENT,0.99999
HP_SHORT_SPERM_FLAGELLA,SET,27,-0.12288,-0.0047085,0.15657,0.78371,HP_SHORT_SPERM_FLAGELLA,0.99999
HP_HORIZONTAL_PENDULAR_NYSTA...,SET,7,-0.25132,-0.0049061,0.32021,0.78373,HP_HORIZONTAL_PENDULAR_NYSTAGMUS,0.99999
HP_ABNORMAL_CELLULAR_PHENOTY...,SET,573,-0.027031,-0.0047,0.034437,0.78375,HP_ABNORMAL_CELLULAR_PHENOTYPE,0.99999
JONES_TCOF1_TARGETS,SET,5,-0.29619,-0.004887,0.37729,0.78378,JONES_TCOF1_TARGETS,0.99999
HP_UNDETECTABLE_VISUAL_EVOKE...,SET,8,-0.21641,-0.0045162,0.27563,0.7838,HP_UNDETECTABLE_VISUAL_EVOKED_POTENTIALS,0.99999
HP_CONGENITAL_NYSTAGMUS,SET,19,-0.15663,-0.0050359,0.19946,0.78384,HP_CONGENITAL_NYSTAGMUS,0.99999
KUMAMOTO_RESPONSE_TO_NUTLIN_...2,SET,9,-0.20014,-0.00443,0.25486,0.78386,KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP,0.99999
BIOCARTA_DSP_PATHWAY,SET,8,-0.27313,-0.0056999,0.34778,0.78387,BIOCARTA_DSP_PATHWAY,0.99999
GOBP_REGULATION_OF_MAINTENAN...,SET,4,-0.43688,-0.0064475,0.55629,0.78387,GOBP_REGULATION_OF_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,0.99999
HP_GEOGRAPHIC_ATROPHY,SET,4,-0.31323,-0.0046228,0.39882,0.78389,HP_GEOGRAPHIC_ATROPHY,0.99999
TRAVAGLINI_LUNG_CAPILLARY_CE...,SET,14,-0.19495,-0.0053812,0.24822,0.78389,TRAVAGLINI_LUNG_CAPILLARY_CELL,0.99999
TRAVAGLINI_LUNG_BASAL_CELL,SET,174,-0.052375,-0.0050744,0.066663,0.78396,TRAVAGLINI_LUNG_BASAL_CELL,0.99999
HP_PULMONARY_ARTERY_DILATATI...,SET,12,-0.19158,-0.004896,0.24382,0.78398,HP_PULMONARY_ARTERY_DILATATION,0.99999
GOCC_PRESYNAPSE,SET,524,-0.030055,-0.0050043,0.038249,0.784,GOCC_PRESYNAPSE,0.99999
GOCC_APICOLATERAL_PLASMA_MEM...,SET,23,-0.15097,-0.0053398,0.19207,0.78406,GOCC_APICOLATERAL_PLASMA_MEMBRANE,0.99999
GSE24142_EARLY_THYMIC_PROGEN...5,SET,186,-0.05108,-0.005115,0.064987,0.78406,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP,0.99999
GSE411_WT_VS_SOCS3_KO_MACROP...2,SET,183,-0.045675,-0.0045371,0.0581,0.7841,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_DN,0.99999
GSE22611_MUTANT_NOD2_VS_CTRL...1,SET,160,-0.052519,-0.0048812,0.066776,0.7842,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,0.99999
GOBP_MRNA_MODIFICATION,SET,17,-0.13876,-0.0042203,0.17642,0.78421,GOBP_MRNA_MODIFICATION,0.99999
MIR221_3P,SET,161,-0.053816,-0.0050173,0.068423,0.78422,MIR221_3P,0.99999
HP_NON_MIDLINE_CLEFT_PALATE,SET,26,-0.13801,-0.0051898,0.17544,0.78426,HP_NON_MIDLINE_CLEFT_PALATE,0.99999
BAKKER_FOXO3_TARGETS_UP,SET,51,-0.092249,-0.0048551,0.11723,0.78432,BAKKER_FOXO3_TARGETS_UP,0.99999
GOCC_EUKARYOTIC_TRANSLATION_...3,SET,13,-0.16167,-0.0043003,0.20544,0.78433,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX,0.99999
GOBP_TETRAPYRROLE_METABOLIC_...,SET,57,-0.08611,-0.0047904,0.10942,0.78435,GOBP_TETRAPYRROLE_METABOLIC_PROCESS,0.99999
MIR9986,SET,148,-0.05592,-0.0050003,0.071045,0.78439,MIR9986,0.99999
FARMER_BREAST_CANCER_CLUSTER...1,SET,38,-0.12238,-0.0055618,0.15546,0.78443,FARMER_BREAST_CANCER_CLUSTER_1,0.99999
GSE22432_CONVENTIONAL_CDC_VS...2,SET,180,-0.04786,-0.0047154,0.060793,0.78443,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_UP,0.99999
HP_RECURRENT_SYSTEMIC_PYOGEN...,SET,5,-0.30289,-0.0049976,0.3847,0.78445,HP_RECURRENT_SYSTEMIC_PYOGENIC_INFECTIONS,0.99999
MIR4326,SET,78,-0.0797,-0.0051836,0.10122,0.78447,MIR4326,0.99999
HP_BIFID_EPIGLOTTIS,SET,5,-0.27202,-0.0044882,0.34547,0.78447,HP_BIFID_EPIGLOTTIS,0.99999
HOEGERKORP_CD44_TARGETS_DIRE...2,SET,24,-0.14136,-0.0051074,0.17951,0.7845,HOEGERKORP_CD44_TARGETS_DIRECT_UP,0.99999
MURARO_PANCREAS_ENDOTHELIAL_...,SET,337,-0.039396,-0.005288,0.050025,0.78451,MURARO_PANCREAS_ENDOTHELIAL_CELL,0.99999
GOCC_CORTICAL_ENDOPLASMIC_RE...,SET,5,-0.27855,-0.004596,0.35366,0.78453,GOCC_CORTICAL_ENDOPLASMIC_RETICULUM,0.99999
GOBP_POSITIVE_REGULATION_OF_...665,SET,9,-0.22216,-0.0049173,0.28205,0.78455,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_CLUSTERING,0.99999
WP_SARSCOV2_INNATE_IMMUNITY_...,SET,62,-0.086294,-0.0050061,0.10955,0.78456,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,0.99999
HP_UPLIFTED_EARLOBE,SET,20,-0.15316,-0.0050522,0.19443,0.78457,HP_UPLIFTED_EARLOBE,0.99999
GOBP_PROTEIN_K11_LINKED_DEUB...,SET,9,-0.18831,-0.0041681,0.239,0.78462,GOBP_PROTEIN_K11_LINKED_DEUBIQUITINATION,0.99999
HP_DECREASED_CIRCULATING_IGG...1,SET,7,-0.23966,-0.0046785,0.30408,0.78469,HP_DECREASED_CIRCULATING_IGG2_LEVEL,0.99999
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SET,104,-0.067749,-0.0050844,0.085939,0.78475,SMIRNOV_RESPONSE_TO_IR_6HR_DN,0.99999
GOBP_NUCLEAR_TRANSCRIBED_MRN...5,SET,29,-0.11981,-0.0047579,0.15198,0.78475,GOBP_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,0.99999
GSE20715_WT_VS_TLR4_KO_24H_O...2,SET,179,-0.050178,-0.0049302,0.063646,0.78476,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP,0.99999
MIR4295,SET,353,-0.035673,-0.0048985,0.045246,0.78477,MIR4295,0.99999
HP_FACIAL_MYOKYMIA,SET,7,-0.21963,-0.0042875,0.27856,0.78478,HP_FACIAL_MYOKYMIA,0.99999
WP_AUTOPHAGY_IN_PANCREATIC_D...,SET,18,-0.15654,-0.0048991,0.19851,0.78482,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,0.99999
GOBP_TELOMERE_CAPPING,SET,37,-0.099216,-0.0044494,0.12577,0.78491,GOBP_TELOMERE_CAPPING,0.99999
WP_GLYCOLYSIS_AND_GLUCONEOGE...,SET,38,-0.10217,-0.0046432,0.12949,0.78495,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,0.99999
GNF2_CYP2B6,SET,47,-0.093283,-0.0047135,0.11815,0.78509,GNF2_CYP2B6,0.99999
GOBP_ASPARTATE_FAMILY_AMINO_...2,SET,12,-0.18954,-0.0048439,0.24005,0.7851,GOBP_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,0.99999
WHITFIELD_CELL_CYCLE_G2_M,SET,183,-0.048703,-0.0048379,0.061679,0.78512,WHITFIELD_CELL_CYCLE_G2_M,0.99999
GOBP_DETECTION_OF_CHEMICAL_S...,SET,45,-0.11542,-0.0057072,0.14615,0.78517,GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE,0.99999
MIR5004_5P,SET,114,-0.061954,-0.0048666,0.078436,0.78519,MIR5004_5P,0.99999
GOBP_ZYGOTIC_DETERMINATION_O...,SET,6,-0.36627,-0.0066201,0.46366,0.78522,GOBP_ZYGOTIC_DETERMINATION_OF_ANTERIOR_POSTERIOR_AXIS_EMBRYO,0.99999
HP_ABNORMALITY_OF_THE_SENSE_...,SET,119,-0.060031,-0.0048172,0.075985,0.78524,HP_ABNORMALITY_OF_THE_SENSE_OF_SMELL,0.99999
KONDO_PROSTATE_CANCER_HCP_WI...,SET,87,-0.077511,-0.0053228,0.098075,0.78533,KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3,0.99999
REACTOME_SYNTHESIS_OF_KETONE...,SET,8,-0.25497,-0.0053211,0.32261,0.78533,REACTOME_SYNTHESIS_OF_KETONE_BODIES,0.99999
CHOW_RASSF1_TARGETS_DN,SET,28,-0.11814,-0.0046099,0.14945,0.78537,CHOW_RASSF1_TARGETS_DN,0.99999
RACCACAR_AML_Q6,SET,240,-0.043715,-0.0049651,0.055301,0.78537,RACCACAR_AML_Q6,0.99999
HP_CHORDEE,SET,13,-0.18572,-0.0049399,0.23494,0.78537,HP_CHORDEE,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...15,SET,5,-0.29457,-0.0048604,0.37261,0.78539,KEGG_MEDICUS_REFERENCE_REGULATION_OF_TNF_NFKB_SIGNALING_PATHWAY_LUBAC_MEDIATED_LINEAR_UBIQUITINATION,0.99999
GOBP_AMINOGLYCOSIDE_ANTIBIOT...,SET,10,-0.2705,-0.006311,0.34217,0.78539,GOBP_AMINOGLYCOSIDE_ANTIBIOTIC_METABOLIC_PROCESS,0.99999
HP_EEG_WITH_GENERALIZED_SHAR...,SET,8,-0.2423,-0.0050566,0.30644,0.78543,HP_EEG_WITH_GENERALIZED_SHARP_SLOW_WAVES,0.99999
GSE3039_ALPHAALPHA_VS_ALPHAB...2,SET,179,-0.049086,-0.0048229,0.062067,0.78548,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_UP,0.99999
WP_FLUOROPYRIMIDINE_ACTIVITY,SET,33,-0.11195,-0.0047417,0.14153,0.78551,WP_FLUOROPYRIMIDINE_ACTIVITY,0.99999
GSE5589_LPS_VS_LPS_AND_IL10_...11,SET,185,-0.047983,-0.0047921,0.060655,0.78554,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.99999
KEGG_ALANINE_ASPARTATE_AND_G...,SET,29,-0.12741,-0.0050597,0.16103,0.7856,KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,0.99999
HP_PITUITARY_HYPOTHYROIDISM,SET,35,-0.11008,-0.0048014,0.13911,0.78561,HP_PITUITARY_HYPOTHYROIDISM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...120,SET,32,-0.12496,-0.0052122,0.15791,0.78563,GOBP_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION,0.99999
GOMF_CYSTEINE_TYPE_ENDOPEPTI...6,SET,34,-0.13511,-0.0058085,0.17069,0.78567,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.99999
MIR3650,SET,49,-0.094291,-0.0048645,0.11912,0.78568,MIR3650,0.99999
HP_APLASIA_OF_METACARPAL_BON...,SET,12,-0.18962,-0.0048459,0.23954,0.78569,HP_APLASIA_OF_METACARPAL_BONES,0.99999
MORF_EIF3S6,SET,113,-0.05766,-0.0045095,0.072836,0.78571,MORF_EIF3S6,0.99999
REACTOME_NR1H3_NR1H2_REGULAT...,SET,32,-0.11377,-0.0047455,0.1437,0.78574,REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX,0.99999
GSE22033_WT_VS_PPARG_KO_MEF_...1,SET,180,-0.049963,-0.0049227,0.063093,0.78579,GSE22033_WT_VS_PPARG_KO_MEF_DN,0.99999
HP_PATHOLOGIC_FRACTURE,SET,57,-0.089243,-0.0049647,0.11269,0.7858,HP_PATHOLOGIC_FRACTURE,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...22,SET,75,-0.079152,-0.0050484,0.099933,0.78583,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...4,SET,177,-0.047029,-0.0045952,0.059358,0.7859,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP,0.99999
HP_LIMB_DYSTONIA,SET,74,-0.072884,-0.0046177,0.091986,0.78591,HP_LIMB_DYSTONIA,0.99999
HP_ABNORMAL_CIRCULATING_CREA...1,SET,10,-0.20074,-0.0046834,0.25334,0.78592,HP_ABNORMAL_CIRCULATING_CREATINE_CONCENTRATION,0.99999
REACTOME_KETONE_BODY_METABOL...,SET,10,-0.23295,-0.0054349,0.29389,0.786,REACTOME_KETONE_BODY_METABOLISM,0.99999
MIR650,SET,108,-0.064626,-0.0049419,0.081504,0.78608,MIR650,0.99999
GOMF_PHOSPHATIDYLCHOLINE_TRA...1,SET,5,-0.29602,-0.0048843,0.3733,0.7861,GOMF_PHOSPHATIDYLCHOLINE_TRANSFER_ACTIVITY,0.99999
RAMALHO_STEMNESS_DN,SET,65,-0.083717,-0.0049722,0.10555,0.78614,RAMALHO_STEMNESS_DN,0.99999
GSE5463_CTRL_VS_DEXAMETHASON...1,SET,177,-0.052511,-0.0051308,0.066209,0.78614,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN,0.99999
WP_SARS_CORONAVIRUS_AND_INNA...,SET,26,-0.14538,-0.0054669,0.18329,0.78616,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,0.99999
HP_COXA_VALGA,SET,82,-0.0759,-0.0050609,0.095665,0.78622,HP_COXA_VALGA,0.99999
GSE5679_CTRL_VS_PPARG_LIGAND...3,SET,181,-0.047998,-0.004742,0.06049,0.78624,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...194,SET,5,-0.28747,-0.0047432,0.36219,0.78632,GOBP_NEGATIVE_REGULATION_OF_DOPAMINE_SECRETION,0.99999
GSE17812_WT_VS_THPOK_KO_MEMO...1,SET,181,-0.051894,-0.0051269,0.065379,0.78632,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_DN,0.99999
REACTOME_PURINE_SALVAGE,SET,12,-0.20006,-0.0051128,0.25204,0.78633,REACTOME_PURINE_SALVAGE,0.99999
GOBP_ACTIN_MODIFICATION,SET,4,-0.32403,-0.0047821,0.4082,0.78634,GOBP_ACTIN_MODIFICATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...471,SET,6,-0.27146,-0.0049064,0.34197,0.78634,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,0.99999
GOBP_REGULATION_OF_NEURON_MI...,SET,43,-0.10894,-0.0052659,0.13724,0.78634,GOBP_REGULATION_OF_NEURON_MIGRATION,0.99999
HP_ABNORMAL_SKIN_MORPHOLOGY_...,SET,361,-0.035034,-0.0048639,0.044134,0.78634,HP_ABNORMAL_SKIN_MORPHOLOGY_OF_THE_PALM,0.99999
NFY_01,SET,230,-0.046116,-0.005129,0.058089,0.78636,NFY_01,0.99999
GSE15659_NONSUPPRESSIVE_TCEL...2,SET,161,-0.053187,-0.0049586,0.066982,0.78641,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP,0.99999
GOBP_BRANCHING_MORPHOGENESIS...1,SET,144,-0.059939,-0.0052873,0.075474,0.78644,GOBP_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE,0.99999
GSE41867_NAIVE_VS_DAY8_LCMV_...5,SET,179,-0.047476,-0.0046648,0.059778,0.78646,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,0.99999
GOBP_REGULATION_OF_ADHERENS_...,SET,5,-0.31372,-0.0051764,0.39498,0.78648,GOBP_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION,0.99999
FOURATI_BLOOD_TWINRIX_AGE_65...2,SET,5,-0.29564,-0.004878,0.37219,0.78649,FOURATI_BLOOD_TWINRIX_AGE_65_81YO_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_DN,0.99999
GOBP_PERICARDIUM_MORPHOGENES...,SET,8,-0.27145,-0.005665,0.34173,0.7865,GOBP_PERICARDIUM_MORPHOGENESIS,0.99999
HP_SHALLOW_ANTERIOR_CHAMBER,SET,17,-0.16527,-0.0050267,0.20806,0.78651,HP_SHALLOW_ANTERIOR_CHAMBER,0.99999
HP_EEG_WITH_MULTIFOCAL_SLOW_...,SET,49,-0.096164,-0.0049612,0.12104,0.78654,HP_EEG_WITH_MULTIFOCAL_SLOW_ACTIVITY,0.99999
KRAS.PROSTATE_UP.V1_UP,SET,122,-0.062682,-0.0050925,0.078892,0.78655,KRAS.PROSTATE_UP.V1_UP,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...9,SET,200,-0.04628,-0.0048038,0.058234,0.78661,GAUTAM_EYE_IRIS_CILIARY_BODY_MELANOCYTES,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...16,SET,8,-0.20695,-0.0043188,0.26039,0.78662,GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_TRANSITION_ZONE,0.99999
REACTOME_INDUCTION_OF_CELL_C...,SET,12,-0.20536,-0.0052482,0.25838,0.78663,REACTOME_INDUCTION_OF_CELL_CELL_FUSION,0.99999
AGCYRWTTC_UNKNOWN,SET,107,-0.064839,-0.0049353,0.08158,0.78663,AGCYRWTTC_UNKNOWN,0.99999
DESCARTES_FETAL_EYE_ASTROCYT...,SET,28,-0.14245,-0.0055587,0.17919,0.78668,DESCARTES_FETAL_EYE_ASTROCYTES,0.99999
MIR302C_5P,SET,524,-0.030232,-0.0050338,0.03802,0.78673,MIR302C_5P,0.99999
REACTOME_TRANSCRIPTIONAL_REG...6,SET,91,-0.065912,-0.0046287,0.082875,0.78678,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,0.99999
MIR4495,SET,435,-0.033529,-0.0050993,0.042157,0.78679,MIR4495,0.99999
GSE13411_NAIVE_VS_MEMORY_BCE...1,SET,181,-0.048969,-0.004838,0.061557,0.78683,GSE13411_NAIVE_VS_MEMORY_BCELL_DN,0.99999
HP_APPENDICULAR_SPASTICITY,SET,334,-0.036093,-0.0048235,0.045365,0.78686,HP_APPENDICULAR_SPASTICITY,0.99999
MIR3157_3P,SET,35,-0.11451,-0.0049948,0.14392,0.78688,MIR3157_3P,0.99999
MIR3190_3P,SET,109,-0.063297,-0.0048625,0.079554,0.78688,MIR3190_3P,0.99999
HP_CARCINOID_TUMOR,SET,12,-0.17732,-0.0045318,0.22284,0.78691,HP_CARCINOID_TUMOR,0.99999
GOMF_CYCLASE_ACTIVATOR_ACTIV...,SET,11,-0.22998,-0.0056273,0.28895,0.78695,GOMF_CYCLASE_ACTIVATOR_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...430,SET,25,-0.14713,-0.0054253,0.18485,0.78696,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_ACTIVATION,0.99999
WP_ADHD_AND_AUTISM_ASD_PATHW...,SET,342,-0.038688,-0.0052307,0.048597,0.787,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,0.99999
GOCC_PROTEIN_COMPLEX_INVOLVE...2,SET,5,-0.28238,-0.0046592,0.3547,0.78701,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_CELL_ADHESION,0.99999
MIR130B_3P,SET,358,-0.036014,-0.0049795,0.045219,0.7871,MIR130B_3P,0.99999
HP_SEGMENTAL_PERIPHERAL_DEMY...,SET,10,-0.21566,-0.0050315,0.27077,0.78711,HP_SEGMENTAL_PERIPHERAL_DEMYELINATION_REMYELINATION,0.99999
GSE25088_IL4_VS_IL4_AND_ROSI...2,SET,183,-0.04938,-0.0049051,0.062001,0.78711,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,0.99999
MIR6726_5P,SET,45,-0.092899,-0.0045934,0.11663,0.78713,MIR6726_5P,0.99999
MIR6865_5P,SET,55,-0.087918,-0.0048046,0.11037,0.78715,MIR6865_5P,0.99999
GOBP_ENZYME_LINKED_RECEPTOR_...,SET,890,-0.023877,-0.0051279,0.029974,0.78715,GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY,0.99999
GSE45365_CD8A_DC_VS_CD11B_DC...5,SET,149,-0.056137,-0.0050365,0.070471,0.78715,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP,0.99999
HP_ABNORMAL_PALM_MORPHOLOGY,SET,445,-0.031732,-0.0048797,0.039831,0.78717,HP_ABNORMAL_PALM_MORPHOLOGY,0.99999
HP_PREMATURE_ARTERIOSCLEROSIS,SET,8,-0.27485,-0.0057359,0.345,0.78717,HP_PREMATURE_ARTERIOSCLEROSIS,0.99999
REACTOME_PTK6_REGULATES_PROT...,SET,5,-0.3272,-0.0053988,0.41064,0.78721,REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING,0.99999
GOBP_PROTEIN_SUMOYLATION,SET,59,-0.083204,-0.0047089,0.10442,0.78722,GOBP_PROTEIN_SUMOYLATION,0.99999
GOMF_HYDROLASE_ACTIVITY_ACTI...9,SET,121,-0.064066,-0.0051837,0.080382,0.78728,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS,0.99999
REACTOME_ACYL_CHAIN_REMODELL...2,SET,23,-0.15191,-0.0053732,0.19057,0.78731,REACTOME_ACYL_CHAIN_REMODELLING_OF_PE,0.99999
GOBP_POSITIVE_REGULATION_OF_...149,SET,6,-0.31216,-0.005642,0.39159,0.78731,GOBP_POSITIVE_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION,0.99999
HP_PITUITARY_CORTICOTROPIC_C...,SET,11,-0.20208,-0.0049448,0.25351,0.78731,HP_PITUITARY_CORTICOTROPIC_CELL_ADENOMA,0.99999
VEGF_A_UP.V1_DN,SET,181,-0.048945,-0.0048355,0.0614,0.78731,VEGF_A_UP.V1_DN,0.99999
GSE29164_DAY3_VS_DAY7_UNTREA...1,SET,175,-0.051561,-0.0050097,0.064669,0.78736,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...655,SET,374,-0.035337,-0.0049916,0.044313,0.78739,GOBP_NEGATIVE_REGULATION_OF_TRANSPORT,0.99999
GOBP_REGULATION_OF_RESPIRATO...5,SET,14,-0.1929,-0.0053247,0.24185,0.78745,GOBP_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS,0.99999
GSE38681_WT_VS_LYL1_KO_LYMPH...2,SET,179,-0.048279,-0.0047436,0.060518,0.78749,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,0.99999
PID_MET_PATHWAY,SET,77,-0.075285,-0.0048651,0.094365,0.7875,PID_MET_PATHWAY,0.99999
GOMF_EXTRACELLULAR_MATRIX_ST...1,SET,152,-0.059088,-0.0053539,0.074044,0.78756,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT,0.99999
HP_URINARY_INCONTINENCE,SET,134,-0.057595,-0.0049023,0.07217,0.78757,HP_URINARY_INCONTINENCE,0.99999
MIR3153,SET,190,-0.049278,-0.0049868,0.061735,0.78762,MIR3153,0.99999
GOBP_NEGATIVE_REGULATION_OF_...388,SET,7,-0.29355,-0.0057306,0.36777,0.78762,GOBP_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,0.99999
GSE32986_GMCSF_AND_CURDLAN_L...1,SET,165,-0.05398,-0.0050941,0.067627,0.78762,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.99999
MATZUK_EMBRYONIC_GERM_CELL,SET,18,-0.17526,-0.0054848,0.21949,0.78771,MATZUK_EMBRYONIC_GERM_CELL,0.99999
GOMF_MODIFIED_AMINO_ACID_TRA...,SET,30,-0.12413,-0.0050133,0.15541,0.78776,GOMF_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...9,SET,144,-0.0593,-0.0052309,0.074238,0.78778,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...498,SET,11,-0.21801,-0.0053346,0.27291,0.7878,GOBP_NEGATIVE_REGULATION_OF_PLATELET_AGGREGATION,0.99999
GSE37534_UNTREATED_VS_GW1929...2,SET,183,-0.050553,-0.0050217,0.063278,0.78782,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.99999
REACTOME_ANTI_INFLAMMATORY_R...,SET,74,-0.079935,-0.0050644,0.1,0.78794,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,0.99999
MIR3934_3P,SET,90,-0.067263,-0.0046977,0.084122,0.78802,MIR3934_3P,0.99999
REACTOME_REGULATION_OF_KIT_S...,SET,15,-0.17815,-0.0050899,0.22279,0.78803,REACTOME_REGULATION_OF_KIT_SIGNALING,0.99999
HP_ABNORMAL_PLACENTAL_MEMBRA...,SET,13,-0.21308,-0.0056678,0.26648,0.78803,HP_ABNORMAL_PLACENTAL_MEMBRANE_MORPHOLOGY,0.99999
HP_ABNORMAL_FALLOPIAN_TUBE_M...,SET,21,-0.1447,-0.0048908,0.18095,0.78804,HP_ABNORMAL_FALLOPIAN_TUBE_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...220,SET,118,-0.060967,-0.0048718,0.076231,0.78807,GOBP_POSITIVE_REGULATION_OF_DNA_REPAIR,0.99999
GOMF_UBIQUITIN_LIGASE_COMPLE...,SET,6,-0.25222,-0.0045587,0.31535,0.78808,GOMF_UBIQUITIN_LIGASE_COMPLEX_SCAFFOLD_ACTIVITY,0.99999
GOBP_REGULATION_OF_FATTY_ACI...3,SET,80,-0.074792,-0.0049261,0.093505,0.7881,GOBP_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_TELOM...1,SET,3,-0.29072,-0.0037158,0.36329,0.78821,KEGG_MEDICUS_REFERENCE_TELOMERASE_RNA_MATURATION,0.99999
GOBP_ANTERIOR_HEAD_DEVELOPME...,SET,7,-0.28384,-0.005541,0.35467,0.78822,GOBP_ANTERIOR_HEAD_DEVELOPMENT,0.99999
HP_SLURRED_SPEECH,SET,45,-0.098379,-0.0048644,0.12291,0.78826,HP_SLURRED_SPEECH,0.99999
TCANNTGAY_SREBP1_01,SET,421,-0.03243,-0.004854,0.040506,0.78832,TCANNTGAY_SREBP1_01,0.99999
GROSS_HYPOXIA_VIA_HIF1A_UP,SET,75,-0.077497,-0.0049428,0.096789,0.78834,GROSS_HYPOXIA_VIA_HIF1A_UP,0.99999
WP_VALPROIC_ACID_PATHWAY,SET,11,-0.1952,-0.0047764,0.24377,0.78836,WP_VALPROIC_ACID_PATHWAY,0.99999
HP_PULMONARY_ARTERY_ANEURYSM,SET,7,-0.25432,-0.0049647,0.31751,0.78842,HP_PULMONARY_ARTERY_ANEURYSM,0.99999
HP_SACCADIC_SMOOTH_PURSUIT,SET,21,-0.13425,-0.0045376,0.1676,0.78843,HP_SACCADIC_SMOOTH_PURSUIT,0.99999
GCM_CBFB,SET,63,-0.078354,-0.0045818,0.097801,0.78847,GCM_CBFB,0.99999
GOBP_REGULATION_OF_APOPTOTIC...4,SET,4,-0.37327,-0.0055088,0.4659,0.78848,GOBP_REGULATION_OF_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL,0.99999
CUI_DEVELOPING_HEART_CORONAR...,SET,37,-0.12497,-0.0056044,0.15595,0.78853,CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL,0.99999
BPTF_TARGET_GENES,SET,885,-0.023689,-0.005074,0.029555,0.78858,BPTF_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...268,SET,5,-0.25473,-0.004203,0.31775,0.78862,GOBP_NEGATIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,0.99999
HP_EEG_WITH_PARIETAL_EPILEPT...,SET,4,-0.42996,-0.0063455,0.53628,0.78864,HP_EEG_WITH_PARIETAL_EPILEPTIFORM_DISCHARGES,0.99999
REACTOME_ACTIVATION_OF_RAC1_...,SET,7,-0.23792,-0.0046447,0.29669,0.78869,REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS,0.99999
RB_P130_DN.V1_DN,SET,119,-0.061322,-0.0049207,0.076469,0.78869,RB_P130_DN.V1_DN,0.99999
GOBP_MAPK_CASCADE,SET,684,-0.027057,-0.0051241,0.033722,0.78882,GOBP_MAPK_CASCADE,0.99999
GSE41867_DAY15_EFFECTOR_VS_D...3,SET,154,-0.052653,-0.0048018,0.065619,0.78883,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,0.99999
GSE17721_POLYIC_VS_CPG_2H_BM...1,SET,182,-0.050403,-0.0049933,0.062804,0.78888,GSE17721_POLYIC_VS_CPG_2H_BMDC_DN,0.99999
HP_CHERRY_RED_SPOT_OF_THE_MA...,SET,13,-0.18644,-0.0049592,0.23229,0.7889,HP_CHERRY_RED_SPOT_OF_THE_MACULA,0.99999
GSE23398_WT_VS_IL2_KO_CD4_TC...1,SET,180,-0.048224,-0.0047513,0.060083,0.7889,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_DN,0.99999
GCM_ERCC4,SET,25,-0.13014,-0.0047988,0.16213,0.78891,GCM_ERCC4,0.99999
GOBP_NEGATIVE_REGULATION_OF_...16,SET,25,-0.14413,-0.0053147,0.17951,0.78899,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.99999
GOBP_RESPONSE_TO_L_GLUTAMATE,SET,15,-0.16994,-0.0048552,0.21163,0.78901,GOBP_RESPONSE_TO_L_GLUTAMATE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...407,SET,30,-0.12294,-0.0049653,0.15304,0.78909,GOBP_NEGATIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,0.99999
MARTINEZ_RB1_TARGETS_UP,SET,643,-0.027217,-0.0050033,0.03387,0.78917,MARTINEZ_RB1_TARGETS_UP,0.99999
WP_10Q22Q23_COPY_NUMBER_VARI...,SET,55,-0.10112,-0.005526,0.12584,0.78917,WP_10Q22Q23_COPY_NUMBER_VARIATION,0.99999
MORF_CDC2L5,SET,134,-0.056453,-0.0048051,0.070247,0.78919,MORF_CDC2L5,0.99999
HP_ABNORMAL_THOUGHT_PATTERN,SET,63,-0.08268,-0.0048348,0.10288,0.7892,HP_ABNORMAL_THOUGHT_PATTERN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...11,SET,5,-0.32712,-0.0053974,0.40695,0.78925,GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE411_UNSTIM_VS_100MIN_IL6_...3,SET,186,-0.050863,-0.0050933,0.063266,0.78928,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,0.99999
GSE5589_IL6_KO_VS_IL10_KO_LP...4,SET,181,-0.051266,-0.0050649,0.063756,0.78933,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.99999
MIR489_3P,SET,69,-0.084171,-0.0051502,0.10467,0.78935,MIR489_3P,0.99999
MORF_USP5,SET,46,-0.089268,-0.0044625,0.111,0.78936,MORF_USP5,0.99999
REACTOME_COBALAMIN_CBL_METAB...,SET,6,-0.26559,-0.0048002,0.33022,0.78937,REACTOME_COBALAMIN_CBL_METABOLISM,0.99999
ZHANG_RESPONSE_TO_CANTHARIDI...2,SET,14,-0.18046,-0.0049813,0.22435,0.7894,ZHANG_RESPONSE_TO_CANTHARIDIN_UP,0.99999
GOBP_T_CELL_ACTIVATION_VIA_T...,SET,10,-0.22279,-0.0051979,0.27696,0.78942,GOBP_T_CELL_ACTIVATION_VIA_T_CELL_RECEPTOR_CONTACT_WITH_ANTIGEN_BOUND_TO_MHC_MOLECULE_ON_ANTIGEN_PRESENTING_CELL,0.99999
GOUYER_TUMOR_INVASIVENESS,SET,8,-0.27759,-0.0057931,0.34504,0.78945,GOUYER_TUMOR_INVASIVENESS,0.99999
HP_INCREASED_HEPATIC_GLYCOGE...,SET,11,-0.21677,-0.0053043,0.26941,0.78947,HP_INCREASED_HEPATIC_GLYCOGEN_CONTENT,0.99999
HP_METAPHYSEAL_CUPPING,SET,14,-0.1869,-0.005159,0.23226,0.7895,HP_METAPHYSEAL_CUPPING,0.99999
HP_ABNORMAL_LACRIMAL_PUNCTUM...,SET,8,-0.2411,-0.0050316,0.2996,0.78951,HP_ABNORMAL_LACRIMAL_PUNCTUM_MORPHOLOGY,0.99999
MIR1281,SET,9,-0.23691,-0.0052439,0.29436,0.78953,MIR1281,0.99999
GOBP_VOCALIZATION_BEHAVIOR,SET,15,-0.1892,-0.0054057,0.23486,0.78976,GOBP_VOCALIZATION_BEHAVIOR,0.99999
GOMF_N_ACETYLTRANSFERASE_ACT...,SET,61,-0.080334,-0.0046227,0.09972,0.78976,GOMF_N_ACETYLTRANSFERASE_ACTIVITY,0.99999
GSE7509_UNSTIM_VS_IFNA_STIM_...2,SET,169,-0.050248,-0.0047985,0.062372,0.78976,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP,0.99999
GCM_MAP4K4,SET,161,-0.051721,-0.0048219,0.06418,0.78983,GCM_MAP4K4,0.99999
HP_ABNORMALITY_OF_UPPER_LIP_...,SET,387,-0.034009,-0.0048851,0.042196,0.78986,HP_ABNORMALITY_OF_UPPER_LIP_VERMILLION,0.99999
GOMF_ACID_THIOL_LIGASE_ACTIV...,SET,29,-0.12708,-0.0050465,0.1576,0.78998,GOMF_ACID_THIOL_LIGASE_ACTIVITY,0.99999
GOMF_PROTON_CHANNEL_ACTIVITY,SET,9,-0.25866,-0.0057252,0.32056,0.79013,GOMF_PROTON_CHANNEL_ACTIVITY,0.99999
chr3q11,SET,20,-0.26009,-0.0085794,0.32231,0.79015,chr3q11,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...3,SET,170,-0.052492,-0.0050275,0.065051,0.79015,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN,0.99999
NAKAYA_MYELOID_DENDRITIC_CEL...1,SET,238,-0.041892,-0.0047384,0.051899,0.79021,NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.99999
HIPC_SIGNATURES_PROJECT_PBMC...1,SET,6,-0.25666,-0.0046389,0.31795,0.79023,HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_DOWN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...377,SET,5,-0.34886,-0.0057561,0.43215,0.79024,GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_DEGRANULATION,0.99999
HP_METATARSUS_ADDUCTUS,SET,44,-0.10187,-0.0049809,0.12618,0.79026,HP_METATARSUS_ADDUCTUS,0.99999
FXR_Q3,SET,102,-0.071066,-0.0052821,0.088008,0.7903,FXR_Q3,0.99999
BERNARD_PPAPDC1B_TARGETS_UP,SET,34,-0.1144,-0.0049184,0.14163,0.79038,BERNARD_PPAPDC1B_TARGETS_UP,0.99999
GOBP_MITOCHONDRIAL_RESPIRATO...,SET,82,-0.066646,-0.0044438,0.082445,0.79055,GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY,0.99999
GSE22432_CONVENTIONAL_CDC_VS...1,SET,185,-0.048803,-0.004874,0.060368,0.79057,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN,0.99999
GOMF_DYSTROGLYCAN_BINDING,SET,10,-0.2018,-0.0047083,0.24962,0.79058,GOMF_DYSTROGLYCAN_BINDING,0.99999
GOMF_SERINE_TYPE_CARBOXYPEPT...,SET,5,-0.27949,-0.0046114,0.34563,0.79063,GOMF_SERINE_TYPE_CARBOXYPEPTIDASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...464,SET,5,-0.28919,-0.0047716,0.35762,0.79064,GOBP_POSITIVE_REGULATION_OF_MIRNA_PROCESSING,0.99999
REACTOME_SLC_TRANSPORTER_DIS...,SET,92,-0.072208,-0.0050985,0.089276,0.79069,REACTOME_SLC_TRANSPORTER_DISORDERS,0.99999
REACTOME_INHIBITION_OF_THE_P...,SET,20,-0.14253,-0.0047015,0.17615,0.79077,REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS,0.99999
MIR6774_5P,SET,43,-0.10436,-0.0050445,0.12897,0.79079,MIR6774_5P,0.99999
NUMATA_CSF3_SIGNALING_VIA_ST...,SET,21,-0.15847,-0.0053562,0.1958,0.79083,NUMATA_CSF3_SIGNALING_VIA_STAT3,0.99999
MIR6512_3P,SET,122,-0.059838,-0.0048614,0.073899,0.79095,MIR6512_3P,0.99999
REACTOME_INTEGRATION_OF_ENER...,SET,106,-0.069732,-0.005283,0.086111,0.79096,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,0.99999
GOBP_DETECTION_OF_TEMPERATUR...3,SET,5,-0.33404,-0.0055117,0.41247,0.79098,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_THERMOCEPTION,0.99999
HP_PARAKERATOSIS,SET,30,-0.12728,-0.0051405,0.15715,0.79099,HP_PARAKERATOSIS,0.99999
HP_CHOROID_PLEXUS_CYST,SET,10,-0.23431,-0.0054666,0.28928,0.79102,HP_CHOROID_PLEXUS_CYST,0.99999
WIEMANN_TELOMERE_SHORTENING_...2,SET,9,-0.23858,-0.0052808,0.29452,0.79104,WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP,0.99999
GOBP_PROSTATE_GLAND_DEVELOPM...,SET,47,-0.11183,-0.0056508,0.13805,0.79105,GOBP_PROSTATE_GLAND_DEVELOPMENT,0.99999
MIR6893_5P,SET,163,-0.053405,-0.0050094,0.065915,0.79108,MIR6893_5P,0.99999
GOBP_MANNOSE_METABOLIC_PROCE...,SET,9,-0.19557,-0.0043288,0.24137,0.7911,GOBP_MANNOSE_METABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...552,SET,6,-0.30835,-0.0055731,0.38055,0.7911,GOBP_POSITIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.99999
GOBP_CYTOPLASMIC_TRANSLATION...2,SET,37,-0.095953,-0.004303,0.1184,0.79115,GOBP_CYTOPLASMIC_TRANSLATIONAL_INITIATION,0.99999
HP_RADIAL_DEVIATION_OF_THE_H...1,SET,8,-0.27403,-0.0057187,0.33797,0.79125,HP_RADIAL_DEVIATION_OF_THE_HAND,0.99999
GOBP_NEGATIVE_REGULATION_OF_...695,SET,4,-0.37691,-0.0055626,0.46487,0.79126,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_WOUND_HEALING,0.99999
REACTOME_FORMATION_OF_RNA_PO...,SET,52,-0.080323,-0.0042685,0.09905,0.79129,REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,0.99999
WP_PLURIPOTENT_STEM_CELL_DIF...,SET,46,-0.10925,-0.0054617,0.13473,0.79129,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,0.99999
NAKAYA_PBMC_FLUARIX_FLUVIRIN...3,SET,259,-0.044957,-0.0053016,0.055437,0.7913,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.99999
HP_DERMATAN_SULFATE_EXCRETIO...,SET,4,-0.30635,-0.0045212,0.37774,0.79131,HP_DERMATAN_SULFATE_EXCRETION_IN_URINE,0.99999
GSE13522_CTRL_VS_T_CRUZI_BRA...1,SET,181,-0.052447,-0.0051816,0.064659,0.79135,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN,0.99999
GUILLAUMOND_KLF10_TARGETS_UP,SET,48,-0.10012,-0.0051124,0.12342,0.79138,GUILLAUMOND_KLF10_TARGETS_UP,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...5,SET,179,-0.049948,-0.0049076,0.061539,0.79149,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_DN,0.99999
GOBP_LABYRINTHINE_LAYER_DEVE...,SET,42,-0.10936,-0.0052244,0.13473,0.7915,GOBP_LABYRINTHINE_LAYER_DEVELOPMENT,0.99999
BLANCO_MELO_MERS_COV_INFECTI...1,SET,30,-0.13307,-0.0053743,0.16391,0.79154,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...160,SET,20,-0.163,-0.0053769,0.20079,0.79154,GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,0.99999
SUBTIL_PROGESTIN_TARGETS,SET,31,-0.12127,-0.0049788,0.14937,0.79157,SUBTIL_PROGESTIN_TARGETS,0.99999
REACTOME_MITOCHONDRIAL_BIOGE...,SET,68,-0.083074,-0.0050462,0.10232,0.79157,REACTOME_MITOCHONDRIAL_BIOGENESIS,0.99999
GOBP_GLOMERULAR_BASEMENT_MEM...,SET,11,-0.20781,-0.005085,0.25596,0.79157,GOBP_GLOMERULAR_BASEMENT_MEMBRANE_DEVELOPMENT,0.99999
MIR103A_2_5P,SET,140,-0.058992,-0.0051316,0.072656,0.79158,MIR103A_2_5P,0.99999
GSE27786_CD4_TCELL_VS_ERYTHT...2,SET,182,-0.045903,-0.0045474,0.056521,0.79164,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP,0.99999
RICKMAN_TUMOR_DIFFERENTIATED...2,SET,111,-0.063799,-0.0049455,0.078548,0.79166,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,0.99999
GOBP_PYRIMIDINE_CONTAINING_C...1,SET,37,-0.11127,-0.00499,0.13698,0.79169,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
GSE11057_NAIVE_VS_MEMORY_CD4...1,SET,174,-0.05284,-0.0051194,0.065048,0.79169,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN,0.99999
REACTOME_RUNX3_REGULATES_CDK...,SET,7,-0.25102,-0.0049003,0.30895,0.79174,REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION,0.99999
MIR6862_3P,SET,26,-0.12133,-0.0045626,0.14932,0.79175,MIR6862_3P,0.99999
GOMF_TRNA_CYTIDINE_5_METHYLT...,SET,5,-0.2739,-0.0045193,0.337,0.79181,GOMF_TRNA_CYTIDINE_5_METHYLTRANSFERASE_ACTIVITY,0.99999
KEGG_MEDICUS_VARIANT_DUPLICA...1,SET,4,-0.43751,-0.0064569,0.5383,0.79182,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY,0.99999
GOBP_DNA_TEMPLATED_TRANSCRIP...1,SET,123,-0.058142,-0.0047428,0.071532,0.79183,GOBP_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.99999
GOCC_ENDOPLASMIC_RETICULUM_P...1,SET,8,-0.22316,-0.0046572,0.27455,0.79183,GOCC_ENDOPLASMIC_RETICULUM_PALMITOYLTRANSFERASE_COMPLEX,0.99999
HP_IMMOTILE_CILIA,SET,9,-0.23628,-0.00523,0.29063,0.79189,HP_IMMOTILE_CILIA,0.99999
DESCARTES_FETAL_EYE_LENS_FIB...,SET,58,-0.098937,-0.0055518,0.12169,0.79189,DESCARTES_FETAL_EYE_LENS_FIBRE_CELLS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...541,SET,18,-0.16059,-0.0050257,0.19751,0.79191,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.99999
VARELA_ZMPSTE24_TARGETS_DN,SET,35,-0.11861,-0.0051737,0.1458,0.79203,VARELA_ZMPSTE24_TARGETS_DN,0.99999
GOCC_INO80_COMPLEX,SET,16,-0.18138,-0.005352,0.22295,0.79204,GOCC_INO80_COMPLEX,0.99999
BLANCO_MELO_SARS_COV_1_INFEC...2,SET,11,-0.23398,-0.0057252,0.28749,0.79214,BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP,0.99999
GOBP_NEUROTRANSMITTER_LOADIN...,SET,7,-0.28108,-0.0054871,0.34534,0.79215,GOBP_NEUROTRANSMITTER_LOADING_INTO_SYNAPTIC_VESICLE,0.99999
GSE21033_1H_VS_12H_POLYIC_ST...2,SET,166,-0.053336,-0.0050484,0.065526,0.79216,GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP,0.99999
REACTOME_SIGNALING_BY_ERYTHR...,SET,25,-0.13977,-0.0051539,0.17168,0.7922,REACTOME_SIGNALING_BY_ERYTHROPOIETIN,0.99999
GOBP_DE_NOVO_CENTRIOLE_ASSEM...2,SET,4,-0.32067,-0.0047325,0.39383,0.79224,GOBP_DE_NOVO_CENTRIOLE_ASSEMBLY_INVOLVED_IN_MULTI_CILIATED_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
SHANK_TAL1_TARGETS_DN,SET,10,-0.23059,-0.0053798,0.28315,0.79227,SHANK_TAL1_TARGETS_DN,0.99999
HP_APLASIA_HYPOPLASIA_OF_MET...,SET,59,-0.091282,-0.0051661,0.11207,0.79232,HP_APLASIA_HYPOPLASIA_OF_METATARSAL_BONES,0.99999
HP_SUBVALVULAR_AORTIC_STENOS...,SET,21,-0.15437,-0.0052177,0.18951,0.79233,HP_SUBVALVULAR_AORTIC_STENOSIS,0.99999
GOBP_RESPONSE_TO_LIGHT_INTEN...,SET,15,-0.17698,-0.0050563,0.21719,0.79241,GOBP_RESPONSE_TO_LIGHT_INTENSITY,0.99999
GOBP_AMINO_ACID_METABOLIC_PR...,SET,255,-0.042704,-0.0049975,0.052401,0.79244,GOBP_AMINO_ACID_METABOLIC_PROCESS,0.99999
chr4q32,SET,38,-0.19333,-0.0087861,0.23716,0.79251,chr4q32,0.99999
GSE14415_INDUCED_VS_NATURAL_...2,SET,130,-0.058603,-0.0049136,0.071878,0.79255,GSE14415_INDUCED_VS_NATURAL_TREG_UP,0.99999
GSE7852_TREG_VS_TCONV_UP,SET,181,-0.053155,-0.0052515,0.065195,0.79255,GSE7852_TREG_VS_TCONV_UP,0.99999
BARRIER_CANCER_RELAPSE_NORMA...1,SET,27,-0.12717,-0.0048731,0.15597,0.79256,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,0.99999
VERRECCHIA_RESPONSE_TO_TGFB1...3,SET,14,-0.19073,-0.0052646,0.23392,0.79256,VERRECCHIA_RESPONSE_TO_TGFB1_C3,0.99999
GNF2_RAB7L1,SET,31,-0.12032,-0.0049398,0.14757,0.79256,GNF2_RAB7L1,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...18,SET,153,-0.058238,-0.0052941,0.071401,0.79264,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP,0.99999
HP_REDUCED_NUMBER_OF_INTRAHE...,SET,5,-0.34033,-0.0056154,0.41723,0.79266,HP_REDUCED_NUMBER_OF_INTRAHEPATIC_BILE_DUCTS,0.99999
GROSS_HYPOXIA_VIA_ELK3_ONLY_...1,SET,44,-0.10525,-0.0051459,0.12901,0.79269,GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,0.99999
HP_HYPOCHROMIA,SET,13,-0.19361,-0.0051499,0.2373,0.79271,HP_HYPOCHROMIA,0.99999
GSE20366_CD103_POS_VS_NEG_TR...1,SET,177,-0.050994,-0.0049826,0.062496,0.79273,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN,0.99999
HP_DEVIATION_OF_THE_THUMB,SET,41,-0.10371,-0.0048952,0.1271,0.79274,HP_DEVIATION_OF_THE_THUMB,0.99999
GSE27786_CD4_TCELL_VS_NEUTRO...2,SET,178,-0.050439,-0.0049421,0.061814,0.79274,GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP,0.99999
KEGG_LINOLEIC_ACID_METABOLISM,SET,29,-0.14488,-0.0057532,0.17754,0.79275,KEGG_LINOLEIC_ACID_METABOLISM,0.99999
GOCC_APICAL_CORTEX,SET,8,-0.22812,-0.0047606,0.27954,0.79276,GOCC_APICAL_CORTEX,0.99999
MIR3198,SET,42,-0.099983,-0.0047764,0.1225,0.7928,MIR3198,0.99999
HP_DRY_SKIN,SET,163,-0.052397,-0.0049149,0.064197,0.7928,HP_DRY_SKIN,0.99999
ATTCTTT_MIR186,SET,241,-0.045364,-0.005163,0.055577,0.79281,ATTCTTT_MIR186,0.99999
GSE22886_CD4_TCELL_VS_BCELL_...1,SET,170,-0.053109,-0.0050865,0.065059,0.79284,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN,0.99999
CAFFAREL_RESPONSE_TO_THC_8HR...3,SET,11,-0.1981,-0.0048472,0.24264,0.79287,CAFFAREL_RESPONSE_TO_THC_8HR_5_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...619,SET,4,-0.36369,-0.0053674,0.44544,0.79288,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEUBIQUITINATION,0.99999
GSE15930_NAIVE_VS_48H_IN_VIT...6,SET,187,-0.050114,-0.0050316,0.061371,0.79291,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,0.99999
HP_HYPOTELORISM,SET,114,-0.060801,-0.004776,0.074451,0.79293,HP_HYPOTELORISM,0.99999
GOCC_ENDOCYTIC_VESICLE_MEMBR...,SET,177,-0.054343,-0.0053098,0.066542,0.79294,GOCC_ENDOCYTIC_VESICLE_MEMBRANE,0.99999
HP_DECREASED_SPECIFIC_PNEUMO...,SET,7,-0.27373,-0.0053437,0.33514,0.79296,HP_DECREASED_SPECIFIC_PNEUMOCOCCAL_ANTIBODY_LEVEL,0.99999
MIR3156_3P,SET,86,-0.06897,-0.0047092,0.084426,0.79301,MIR3156_3P,0.99999
GOBP_L_GLUTAMINE_IMPORT_ACRO...,SET,4,-0.35553,-0.005247,0.4352,0.79301,GOBP_L_GLUTAMINE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
DESCARTES_FETAL_INTESTINE_LY...2,SET,129,-0.064978,-0.0054273,0.079511,0.79309,DESCARTES_FETAL_INTESTINE_LYMPHOID_CELLS,0.99999
HP_RECURRENT_FRACTURES,SET,124,-0.061821,-0.0050632,0.075647,0.7931,HP_RECURRENT_FRACTURES,0.99999
HP_FLAT_NASAL_ALAE,SET,8,-0.19576,-0.0040853,0.2395,0.79314,HP_FLAT_NASAL_ALAE,0.99999
GOMF_PROTEIN_LIPID_COMPLEX_B...,SET,27,-0.14731,-0.0056446,0.18019,0.79317,GOMF_PROTEIN_LIPID_COMPLEX_BINDING,0.99999
HP_INFANTILE_ONSET,SET,1171,-0.020538,-0.0050185,0.025117,0.79323,HP_INFANTILE_ONSET,0.99999
GSE7831_UNSTIM_VS_INFLUENZA_...2,SET,179,-0.049681,-0.0048814,0.060748,0.79327,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_UP,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...11,SET,9,-0.22439,-0.0049667,0.27434,0.79329,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25,0.99999
GOMF_SERINE_HYDROLASE_ACTIVI...,SET,182,-0.054939,-0.0054426,0.067162,0.79332,GOMF_SERINE_HYDROLASE_ACTIVITY,0.99999
HP_INSULIN_RESISTANT_DIABETE...,SET,38,-0.11545,-0.0052466,0.14113,0.79332,HP_INSULIN_RESISTANT_DIABETES_MELLITUS,0.99999
BURTON_ADIPOGENESIS_5,SET,100,-0.065123,-0.0047929,0.0796,0.79335,BURTON_ADIPOGENESIS_5,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...2,SET,173,-0.051172,-0.0049437,0.062545,0.79336,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP,0.99999
GOBP_MONOCYTE_AGGREGATION,SET,5,-0.37414,-0.0061733,0.45728,0.79337,GOBP_MONOCYTE_AGGREGATION,0.99999
HP_ATROPHY_DEGENERATION_AFFE...1,SET,36,-0.11789,-0.0052149,0.14408,0.79337,HP_ATROPHY_DEGENERATION_AFFECTING_THE_BRAINSTEM,0.99999
GSE2706_R848_VS_R848_AND_LPS...2,SET,148,-0.053581,-0.0047911,0.065479,0.7934,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP,0.99999
GSE11961_FOLLICULAR_BCELL_VS...11,SET,185,-0.048626,-0.0048563,0.05942,0.79341,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN,0.99999
GOMF_COA_LIGASE_ACTIVITY,SET,25,-0.14033,-0.0051747,0.17145,0.79346,GOMF_COA_LIGASE_ACTIVITY,0.99999
HP_OSTEOARTHRITIS_OF_THE_SMA...,SET,4,-0.37602,-0.0055493,0.45926,0.79353,HP_OSTEOARTHRITIS_OF_THE_SMALL_JOINTS_OF_THE_HAND,0.99999
GOMF_ALPHA_N_ACETYLNEURAMINA...,SET,6,-0.34652,-0.0062631,0.42319,0.79355,GOMF_ALPHA_N_ACETYLNEURAMINATE_ALPHA_2_8_SIALYLTRANSFERASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...223,SET,30,-0.13413,-0.0054174,0.1638,0.79357,GOBP_NEGATIVE_REGULATION_OF_EXOCYTOSIS,0.99999
MIR383_5P,SET,70,-0.0819,-0.0050473,0.10001,0.79358,MIR383_5P,0.99999
GOBP_DEVELOPMENTAL_CELL_GROW...,SET,198,-0.050657,-0.005232,0.061849,0.79361,GOBP_DEVELOPMENTAL_CELL_GROWTH,0.99999
BIOCARTA_CSK_PATHWAY,SET,18,-0.17079,-0.0053449,0.20849,0.79365,BIOCARTA_CSK_PATHWAY,0.99999
MIR656_3P,SET,358,-0.037329,-0.0051613,0.045568,0.79365,MIR656_3P,0.99999
REACTOME_ESTABLISHMENT_OF_SI...,SET,8,-0.25078,-0.0052335,0.30612,0.79366,REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,0.99999
GSE16522_ANTI_CD3CD28_STIM_V...4,SET,173,-0.051292,-0.0049553,0.062595,0.79372,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP,0.99999
WP_OLIGODENDROCYTE_SPECIFICA...,SET,29,-0.14006,-0.005562,0.1709,0.79376,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,0.99999
GOCC_GID_COMPLEX,SET,5,-0.29764,-0.004911,0.36317,0.79377,GOCC_GID_COMPLEX,0.99999
GOBP_REGULATION_OF_DEVELOPME...1,SET,271,-0.044581,-0.005376,0.054392,0.79378,GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH,0.99999
GOBP_GAP_JUNCTION_ASSEMBLY,SET,16,-0.20571,-0.0060697,0.25089,0.79386,GOBP_GAP_JUNCTION_ASSEMBLY,0.99999
GSE5542_UNTREATED_VS_IFNG_TR...1,SET,167,-0.05152,-0.0048911,0.062825,0.7939,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.99999
LOPES_METHYLATED_IN_COLON_CA...2,SET,27,-0.15044,-0.0057648,0.18341,0.79396,LOPES_METHYLATED_IN_COLON_CANCER_UP,0.99999
TERAMOTO_OPN_TARGETS_CLUSTER...3,SET,13,-0.16519,-0.0043939,0.20138,0.79396,TERAMOTO_OPN_TARGETS_CLUSTER_4,0.99999
HP_CLEFT_ALA_NASI,SET,4,-0.40952,-0.0060439,0.49922,0.79398,HP_CLEFT_ALA_NASI,0.99999
GOBP_COPULATION,SET,19,-0.17817,-0.0057286,0.21719,0.79399,GOBP_COPULATION,0.99999
HP_INCREASED_HEMATOCRIT,SET,9,-0.23143,-0.0051226,0.28201,0.79408,HP_INCREASED_HEMATOCRIT,0.99999
HP_ACUTE_PHASE_RESPONSE,SET,168,-0.05428,-0.0051683,0.066136,0.79409,HP_ACUTE_PHASE_RESPONSE,0.99999
MODULE_196,SET,22,-0.15019,-0.0051958,0.18295,0.79416,MODULE_196,0.99999
GOBP_BRANCHING_MORPHOGENESIS...2,SET,10,-0.24792,-0.0057841,0.30193,0.7942,GOBP_BRANCHING_MORPHOGENESIS_OF_A_NERVE,0.99999
HP_MECKEL_DIVERTICULUM,SET,25,-0.12953,-0.0047764,0.15773,0.79424,HP_MECKEL_DIVERTICULUM,0.99999
GGGGCCC_MIR296,SET,66,-0.081565,-0.0048814,0.099314,0.79425,GGGGCCC_MIR296,0.99999
HP_DIFFUSE_DEMYELINATION_OF_...,SET,8,-0.25556,-0.0053332,0.3111,0.7943,HP_DIFFUSE_DEMYELINATION_OF_THE_CEREBRAL_WHITE_MATTER,0.99999
GSE17186_MEMORY_VS_NAIVE_BCE...1,SET,183,-0.051483,-0.0051141,0.06266,0.79435,GSE17186_MEMORY_VS_NAIVE_BCELL_DN,0.99999
HP_PERIFOVEAL_RING_OF_HYPERA...,SET,15,-0.19369,-0.0055338,0.23572,0.79437,HP_PERIFOVEAL_RING_OF_HYPERAUTOFLUORESCENCE,0.99999
REACTOME_SMAC_XIAP_REGULATED...,SET,6,-0.23962,-0.0043308,0.2916,0.79438,REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE,0.99999
LYF1_01,SET,238,-0.046062,-0.0052102,0.056052,0.79439,LYF1_01,0.99999
HP_HYPOPLASTIC_HEART,SET,43,-0.11309,-0.0054666,0.1376,0.79443,HP_HYPOPLASTIC_HEART,0.99999
GSE22935_UNSTIM_VS_48H_MBOVI...2,SET,178,-0.052159,-0.0051106,0.063457,0.79444,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.99999
GOBP_DIRECT_OSSIFICATION,SET,7,-0.25083,-0.0048967,0.30514,0.79446,GOBP_DIRECT_OSSIFICATION,0.99999
REACTOME_ANTIGEN_PROCESSING_...2,SET,287,-0.039162,-0.0048578,0.047638,0.79448,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,0.99999
GOCC_MEMBRANE_MICRODOMAIN,SET,269,-0.043927,-0.0052778,0.053429,0.7945,GOCC_MEMBRANE_MICRODOMAIN,0.99999
MIR6837_5P,SET,116,-0.063852,-0.0050591,0.077648,0.79455,MIR6837_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...823,SET,23,-0.14297,-0.0050571,0.17387,0.79455,GOBP_POSITIVE_REGULATION_OF_VACUOLE_ORGANIZATION,0.99999
HP_ABNORMALITY_OF_THE_EPIPHY...1,SET,5,-0.30822,-0.0050856,0.37481,0.79455,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_DISTAL_PHALANX_OF_FINGER,0.99999
GOBP_THROMBOPOIETIN_MEDIATED...,SET,5,-0.29856,-0.0049262,0.36298,0.79461,GOBP_THROMBOPOIETIN_MEDIATED_SIGNALING_PATHWAY,0.99999
HP_LONG_NOSE,SET,32,-0.12092,-0.0050437,0.14699,0.79464,HP_LONG_NOSE,0.99999
MIR202_5P,SET,103,-0.068108,-0.0050868,0.082786,0.79465,MIR202_5P,0.99999
GOMF_DISACCHARIDE_BINDING,SET,5,-0.29644,-0.0048912,0.36032,0.79466,GOMF_DISACCHARIDE_BINDING,0.99999
FONTAINE_PAPILLARY_THYROID_C...1,SET,73,-0.084008,-0.0052865,0.10208,0.79473,FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,0.99999
SOBOLEV_T_CELL_PANDEMRIX_AGE...1,SET,23,-0.14544,-0.0051442,0.17672,0.79474,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_1DY_UP,0.99999
GOMF_LOW_DENSITY_LIPOPROTEIN...3,SET,22,-0.14398,-0.004981,0.17493,0.79476,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,0.99999
GSE2770_IL12_ACT_VS_ACT_CD4_...2,SET,167,-0.054332,-0.005158,0.065987,0.79485,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP,0.99999
GSE6092_IFNG_VS_IFNG_AND_B_B...2,SET,166,-0.054977,-0.0052037,0.066769,0.79485,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,0.99999
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SET,157,-0.054614,-0.0050285,0.066322,0.79487,SMIRNOV_RESPONSE_TO_IR_6HR_UP,0.99999
HP_PROMINENT_STERNUM,SET,12,-0.22546,-0.005762,0.27375,0.79491,HP_PROMINENT_STERNUM,0.99999
MIR6776_5P,SET,83,-0.073428,-0.0049257,0.089151,0.79492,MIR6776_5P,0.99999
FREAC3_01,SET,232,-0.047551,-0.0053113,0.057723,0.79496,FREAC3_01,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...9,SET,13,-0.20592,-0.0054772,0.24996,0.79497,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR,0.99999
HP_ABNORMAL_THORACIC_SPINE_M...,SET,94,-0.067676,-0.0048299,0.082138,0.79501,HP_ABNORMAL_THORACIC_SPINE_MORPHOLOGY,0.99999
MIR6825_5P,SET,379,-0.036845,-0.0052386,0.044709,0.79505,MIR6825_5P,0.99999
LASTOWSKA_COAMPLIFIED_WITH_M...,SET,35,-0.14081,-0.0061417,0.17083,0.79509,LASTOWSKA_COAMPLIFIED_WITH_MYCN,0.99999
GOBP_THORAX_AND_ANTERIOR_ABD...,SET,5,-0.43279,-0.0071409,0.52507,0.7951,GOBP_THORAX_AND_ANTERIOR_ABDOMEN_DETERMINATION,0.99999
HP_UPPER_EYELID_COLOBOMA,SET,9,-0.23665,-0.005238,0.28709,0.79511,HP_UPPER_EYELID_COLOBOMA,0.99999
GOMF_ACETYLTRANSFERASE_ACTIV...,SET,88,-0.068373,-0.0047221,0.082929,0.79516,GOMF_ACETYLTRANSFERASE_ACTIVITY,0.99999
GOMF_PEPTIDOGLYCAN_MURALYTIC...,SET,13,-0.21656,-0.0057604,0.26263,0.79519,GOMF_PEPTIDOGLYCAN_MURALYTIC_ACTIVITY,0.99999
WP_FAMILIAL_HYPERLIPIDEMIA_T...5,SET,14,-0.19463,-0.0053723,0.23601,0.79522,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,0.99999
GSE17721_4_VS_24H_CPG_BMDC_DN,SET,176,-0.050324,-0.0049034,0.061003,0.79529,GSE17721_4_VS_24H_CPG_BMDC_DN,0.99999
BORLAK_LIVER_CANCER_EGF_UP,SET,49,-0.10496,-0.005415,0.12722,0.79532,BORLAK_LIVER_CANCER_EGF_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...632,SET,23,-0.14006,-0.004954,0.16973,0.79537,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.99999
HP_SHORT_FIRST_METATARSAL,SET,4,-0.34894,-0.0051498,0.42283,0.79538,HP_SHORT_FIRST_METATARSAL,0.99999
HP_DECREASED_ACTIVITY_OF_THE...,SET,10,-0.2458,-0.0057347,0.2978,0.79541,HP_DECREASED_ACTIVITY_OF_THE_PYRUVATE_DEHYDROGENASE_COMPLEX,0.99999
HP_IMPAIRED_VIBRATION_SENSAT...1,SET,10,-0.19925,-0.0046486,0.2414,0.79542,HP_IMPAIRED_VIBRATION_SENSATION_AT_ANKLES,0.99999
GSE13485_DAY7_VS_DAY21_YF17D...2,SET,183,-0.052476,-0.0052127,0.063574,0.79543,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.99999
WP_PEPTIDE_GPCRS,SET,66,-0.098937,-0.0059211,0.11985,0.79544,WP_PEPTIDE_GPCRS,0.99999
BIOCARTA_HDAC_PATHWAY,SET,25,-0.14592,-0.0053808,0.17671,0.79552,BIOCARTA_HDAC_PATHWAY,0.99999
GOBP_LEUKOCYTE_DEGRANULATION,SET,75,-0.081118,-0.0051738,0.098226,0.79554,GOBP_LEUKOCYTE_DEGRANULATION,0.99999
GSE43863_DAY6_EFF_VS_DAY150_...4,SET,184,-0.0512,-0.0050997,0.061997,0.79555,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP,0.99999
MIR6861_3P,SET,45,-0.10185,-0.0050358,0.12324,0.79571,MIR6861_3P,0.99999
ID2_TARGET_GENES,SET,872,-0.024006,-0.0051057,0.02904,0.79577,ID2_TARGET_GENES,0.99999
KEGG_JAK_STAT_SIGNALING_PATH...,SET,139,-0.065343,-0.0056638,0.079045,0.79578,KEGG_JAK_STAT_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_PROTEIN_C...1,SET,317,-0.038591,-0.0050268,0.046672,0.79584,GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.99999
REACTOME_NITRIC_OXIDE_STIMUL...,SET,19,-0.17542,-0.0056402,0.2121,0.79589,REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE,0.99999
HP_CHILBLAINS,SET,10,-0.19958,-0.0046563,0.24131,0.79589,HP_CHILBLAINS,0.99999
VISALA_AGING_LYMPHOCYTE_DN,SET,16,-0.16439,-0.0048505,0.19875,0.7959,VISALA_AGING_LYMPHOCYTE_DN,0.99999
HP_NEOPLASM_OF_THE_RESPIRATO...,SET,74,-0.079919,-0.0050634,0.096621,0.79592,HP_NEOPLASM_OF_THE_RESPIRATORY_SYSTEM,0.99999
GOMF_PROTEIN_HETERODIMERIZAT...,SET,232,-0.047284,-0.0052814,0.057159,0.79594,GOMF_PROTEIN_HETERODIMERIZATION_ACTIVITY,0.99999
HP_TURRICEPHALY,SET,42,-0.10726,-0.0051242,0.12964,0.79599,HP_TURRICEPHALY,0.99999
MIR1203,SET,4,-0.33236,-0.004905,0.40146,0.79612,MIR1203,0.99999
GOBP_IMMUNOGLOBULIN_V_D_J_RE...,SET,7,-0.20912,-0.0040824,0.25259,0.79613,GOBP_IMMUNOGLOBULIN_V_D_J_RECOMBINATION,0.99999
HP_APLASIA_HYPOPLASIA_AFFECT...1,SET,814,-0.024957,-0.0051371,0.030145,0.79614,HP_APLASIA_HYPOPLASIA_AFFECTING_BONES_OF_THE_AXIAL_SKELETON,0.99999
GSE39110_DAY3_VS_DAY6_POST_I...2,SET,180,-0.052762,-0.0051984,0.063725,0.79615,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP,0.99999
HP_DOWNBEAT_NYSTAGMUS,SET,7,-0.25636,-0.0050046,0.30948,0.79626,HP_DOWNBEAT_NYSTAGMUS,0.99999
GOBP_CARDIAC_CONDUCTION,SET,91,-0.078323,-0.0055003,0.094542,0.79629,GOBP_CARDIAC_CONDUCTION,0.99999
GOBP_REGULATION_OF_LEUKOCYTE...5,SET,41,-0.10965,-0.0051755,0.13234,0.79631,GOBP_REGULATION_OF_LEUKOCYTE_DEGRANULATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...569,SET,8,-0.2653,-0.0055365,0.32008,0.7964,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,0.99999
MIR7157_5P,SET,194,-0.050304,-0.0051434,0.060678,0.79645,MIR7157_5P,0.99999
REACTOME_REGULATION_OF_TP53_...4,SET,17,-0.17846,-0.0054276,0.21522,0.79649,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION,0.99999
GOBP_RHYTHMIC_BEHAVIOR,SET,46,-0.11147,-0.0055726,0.13442,0.79653,GOBP_RHYTHMIC_BEHAVIOR,0.99999
REACTOME_IRF3_MEDIATED_ACTIV...,SET,5,-0.26066,-0.0043008,0.31428,0.79655,REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN,0.99999
MIR380_3P,SET,210,-0.048036,-0.0051077,0.057905,0.7966,MIR380_3P,0.99999
GSE23308_CTRL_VS_CORTICOSTER...2,SET,173,-0.051634,-0.0049884,0.062238,0.79662,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN,0.99999
KEGG_GRAFT_VERSUS_HOST_DISEA...,SET,33,-0.13787,-0.0058397,0.16611,0.79672,KEGG_GRAFT_VERSUS_HOST_DISEASE,0.99999
REACTOME_DEFECTS_IN_VITAMIN_...,SET,20,-0.1521,-0.0050171,0.18322,0.79677,REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...145,SET,4,-0.34373,-0.0050729,0.41406,0.79677,GOBP_NEGATIVE_REGULATION_OF_CHROMATIN_ORGANIZATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...275,SET,4,-0.34373,-0.0050729,0.41406,0.79677,GOBP_NEGATIVE_REGULATION_OF_HETEROCHROMATIN_FORMATION,0.99999
GSE2826_WT_VS_XID_BCELL_UP,SET,183,-0.050951,-0.0050612,0.061375,0.79677,GSE2826_WT_VS_XID_BCELL_UP,0.99999
MORF_MSH3,SET,225,-0.044964,-0.0049469,0.054155,0.79681,MORF_MSH3,0.99999
WEINBERGER_BLOOD_TWINRIX_AGE...2,SET,7,-0.28732,-0.0056091,0.34605,0.79681,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_HIGH_ANTI_HBS_CONC_AT_WEEK_30_PRIMARY_VACC_1DY_POSITIVE,0.99999
chr11p12,SET,6,-0.36453,-0.0065885,0.43893,0.79686,chr11p12,0.99999
REACTOME_LISTERIA_MONOCYTOGE...,SET,18,-0.16044,-0.005021,0.19319,0.79686,REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS,0.99999
GSE29617_CTRL_VS_DAY7_TIV_FL...1,SET,160,-0.053766,-0.0049971,0.064738,0.79687,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...36,SET,5,-0.37035,-0.0061107,0.44586,0.7969,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...37,SET,5,-0.37035,-0.0061107,0.44586,0.7969,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,0.99999
RADMACHER_AML_PROGNOSIS,SET,73,-0.086518,-0.0054445,0.10415,0.79692,RADMACHER_AML_PROGNOSIS,0.99999
HP_THICKENED_RIBS,SET,7,-0.27297,-0.0053288,0.32853,0.79697,HP_THICKENED_RIBS,0.99999
MIR30A_3P,SET,347,-0.037046,-0.0050444,0.044584,0.79698,MIR30A_3P,0.99999
GSE46242_TH1_VS_ANERGIC_TH1_...3,SET,169,-0.05268,-0.0050308,0.063402,0.79698,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_DN,0.99999
HU_FETAL_RETINA_BLOOD,SET,244,-0.046522,-0.0053272,0.055984,0.79701,HU_FETAL_RETINA_BLOOD,0.99999
PID_INTEGRIN5_PATHWAY,SET,16,-0.17265,-0.0050944,0.20773,0.79705,PID_INTEGRIN5_PATHWAY,0.99999
GOBP_REGULATION_OF_ORGANELLE...1,SET,231,-0.044542,-0.0049646,0.053589,0.79706,GOBP_REGULATION_OF_ORGANELLE_ASSEMBLY,0.99999
GSE41867_NAIVE_VS_DAY15_LCMV...6,SET,183,-0.049432,-0.0049104,0.059471,0.79706,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP,0.99999
GOBP_ESTABLISHMENT_OF_MEIOTI...,SET,6,-0.32789,-0.0059263,0.39446,0.79708,GOBP_ESTABLISHMENT_OF_MEIOTIC_SPINDLE_LOCALIZATION,0.99999
GSE20727_CTRL_VS_ROS_INHIBIT...2,SET,176,-0.050689,-0.0049389,0.060976,0.79709,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_UP,0.99999
GSE3039_ALPHAALPHA_VS_ALPHAB...1,SET,188,-0.053608,-0.0053967,0.064487,0.79709,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN,0.99999
MIR3943,SET,39,-0.11382,-0.00524,0.13691,0.7971,MIR3943,0.99999
REACTOME_NEDDYLATION,SET,227,-0.045235,-0.0049985,0.054406,0.79713,REACTOME_NEDDYLATION,0.99999
GSE14413_UNSTIM_VS_IFNB_STIM...5,SET,105,-0.068347,-0.0051537,0.082204,0.79713,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN,0.99999
CUI_DEVELOPING_HEART_5TH_WEE...1,SET,36,-0.1219,-0.0053924,0.14661,0.79713,CUI_DEVELOPING_HEART_5TH_WEEK_ATRIAL_CARDIOMYOCYTE,0.99999
MORF_AATF,SET,197,-0.045057,-0.004642,0.054187,0.79715,MORF_AATF,0.99999
MODULE_265,SET,25,-0.15435,-0.0056915,0.18561,0.79717,MODULE_265,0.99999
HERNANDEZ_MITOTIC_ARREST_BY_...3,SET,14,-0.17317,-0.0047799,0.20821,0.79721,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN,0.99999
GAO_LARGE_INTESTINE_24W_C7_G...,SET,16,-0.17938,-0.005293,0.21565,0.79724,GAO_LARGE_INTESTINE_24W_C7_GOBLET_PROGENITOR,0.99999
GOBP_DENSE_CORE_GRANULE_TRAN...,SET,10,-0.22246,-0.0051903,0.26743,0.79725,GOBP_DENSE_CORE_GRANULE_TRANSPORT,0.99999
GOBP_REGULATION_OF_SMALL_GTP...,SET,279,-0.043169,-0.0052809,0.051881,0.79731,GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.99999
MARSON_BOUND_BY_FOXP3_UNSTIM...,SET,1068,-0.022746,-0.0053239,0.027332,0.79735,MARSON_BOUND_BY_FOXP3_UNSTIMULATED,0.99999
GSE18281_SUBCAPSULAR_VS_CENT...2,SET,168,-0.053445,-0.0050889,0.064218,0.79736,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP,0.99999
chr3q28,SET,12,-0.34976,-0.0089385,0.4202,0.79739,chr3q28,0.99999
GOMF_STRUCTURAL_CONSTITUENT_...8,SET,7,-0.2824,-0.005513,0.33925,0.79741,GOMF_STRUCTURAL_CONSTITUENT_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.99999
GSE30962_ACUTE_VS_CHRONIC_LC...1,SET,185,-0.053185,-0.0053116,0.063885,0.79743,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN,0.99999
GSE16266_CTRL_VS_LPS_STIM_ME...2,SET,182,-0.055004,-0.005449,0.066055,0.79749,GSE16266_CTRL_VS_LPS_STIM_MEF_UP,0.99999
GSE25123_CTRL_VS_IL4_AND_ROS...1,SET,172,-0.051194,-0.0049316,0.061477,0.7975,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...203,SET,5,-0.31027,-0.0051194,0.37257,0.79751,GOBP_POSITIVE_REGULATION_OF_DEOXYRIBONUCLEASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_DENDRITE_...2,SET,24,-0.15902,-0.0057453,0.19094,0.79752,GOBP_REGULATION_OF_DENDRITE_EXTENSION,0.99999
HP_ABNORMALITY_OF_CORNEAL_TH...,SET,115,-0.065186,-0.0051427,0.078247,0.79759,HP_ABNORMALITY_OF_CORNEAL_THICKNESS,0.99999
BROWNE_HCMV_INFECTION_12HR_UP,SET,100,-0.070184,-0.0051654,0.08424,0.79761,BROWNE_HCMV_INFECTION_12HR_UP,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...3,SET,181,-0.050352,-0.0049746,0.060434,0.79762,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN,0.99999
DESCARTES_FETAL_MUSCLE_SATEL...,SET,41,-0.11482,-0.0054197,0.13781,0.79762,DESCARTES_FETAL_MUSCLE_SATELLITE_CELLS,0.99999
GOBP_REGULATION_OF_MITOCHOND...6,SET,12,-0.18169,-0.0046435,0.21805,0.79764,GOBP_REGULATION_OF_MITOCHONDRIAL_FUSION,0.99999
PID_AR_NONGENOMIC_PATHWAY,SET,30,-0.11981,-0.0048391,0.14379,0.79765,PID_AR_NONGENOMIC_PATHWAY,0.99999
WANG_TUMOR_INVASIVENESS_DN,SET,192,-0.050293,-0.005116,0.060351,0.79767,WANG_TUMOR_INVASIVENESS_DN,0.99999
AAGCCAT_MIR135A_MIR135B,SET,306,-0.041028,-0.0052522,0.049214,0.79776,AAGCCAT_MIR135A_MIR135B,0.99999
HP_TRUNCAL_OBESITY,SET,71,-0.082997,-0.0051511,0.099555,0.79776,HP_TRUNCAL_OBESITY,0.99999
MIR885_5P,SET,102,-0.067276,-0.0050004,0.080687,0.79779,MIR885_5P,0.99999
GOBP_REGULATION_OF_PROTEIN_C...2,SET,11,-0.23505,-0.0057514,0.2819,0.79779,GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,0.99999
GOBP_PORPHYRIN_CONTAINING_CO...,SET,48,-0.098537,-0.0050316,0.11818,0.7978,GOBP_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GSE14699_NAIVE_VS_DELETIONAL...2,SET,133,-0.061624,-0.0052258,0.073885,0.79787,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,0.99999
HP_GLIOBLASTOMA_MULTIFORME,SET,26,-0.12662,-0.0047615,0.15181,0.79788,HP_GLIOBLASTOMA_MULTIFORME,0.99999
GENTLES_LEUKEMIC_STEM_CELL_DN,SET,16,-0.181,-0.0053408,0.21699,0.7979,GENTLES_LEUKEMIC_STEM_CELL_DN,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...23,SET,48,-0.10974,-0.0056036,0.13155,0.79791,GAVISH_3CA_MALIGNANT_METAPROGRAM_31_ALVEOLAR,0.99999
WP_NICOTINE_METABOLISM_IN_LI...,SET,6,-0.36126,-0.0065295,0.43304,0.79792,WP_NICOTINE_METABOLISM_IN_LIVER_CELLS,0.99999
WP_EFFECT_OF_INTESTINAL_MICR...,SET,8,-0.25449,-0.005311,0.30505,0.79793,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...21,SET,48,-0.095623,-0.0048828,0.11458,0.79801,GAVISH_3CA_MALIGNANT_METAPROGRAM_2_CELL_CYCLE_G1_S,0.99999
GTGCAAT_MIR25_MIR32_MIR92_MI...,SET,281,-0.042436,-0.0052095,0.050838,0.79806,GTGCAAT_MIR25_MIR32_MIR92_MIR363_MIR367,0.99999
GOMF_FATTY_ACID_DERIVATIVE_B...,SET,18,-0.16421,-0.005139,0.19673,0.79806,GOMF_FATTY_ACID_DERIVATIVE_BINDING,0.99999
GOBP_SPHINGOLIPID_MEDIATED_S...,SET,17,-0.17696,-0.0053821,0.21193,0.79813,GOBP_SPHINGOLIPID_MEDIATED_SIGNALING_PATHWAY,0.99999
HP_SHORT_FEMUR,SET,25,-0.14727,-0.0054305,0.17637,0.79814,HP_SHORT_FEMUR,0.99999
REACTOME_ACTIVATION_OF_RAS_I...,SET,5,-0.28251,-0.0046613,0.33831,0.79815,REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS,0.99999
HP_INSOMNIA,SET,62,-0.09087,-0.0052715,0.10882,0.79815,HP_INSOMNIA,0.99999
GSE12845_NAIVE_VS_DARKZONE_G...2,SET,170,-0.054816,-0.00525,0.065642,0.79816,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.99999
MIR3942_3P,SET,299,-0.041156,-0.005209,0.049274,0.7982,MIR3942_3P,0.99999
HP_MILD_SHORT_STATURE,SET,18,-0.17634,-0.0055186,0.21109,0.79824,HP_MILD_SHORT_STATURE,0.99999
GOCC_MICROFIBRIL,SET,11,-0.21042,-0.0051488,0.25184,0.79828,GOCC_MICROFIBRIL,0.99999
GOBP_POSITIVE_REGULATION_OF_...337,SET,3,-0.36147,-0.0046201,0.43255,0.79832,GOBP_POSITIVE_REGULATION_OF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
WP_NANOPARTICLE_TRIGGERED_RE...,SET,12,-0.22224,-0.0056796,0.26591,0.79835,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,0.99999
GOMF_NODAL_BINDING,SET,2,-0.58303,-0.0060847,0.69761,0.79835,GOMF_NODAL_BINDING,0.99999
HP_TEMPERATURE_INSTABILITY,SET,34,-0.12194,-0.0052423,0.14588,0.79837,HP_TEMPERATURE_INSTABILITY,0.99999
HP_ARTERIOSCLEROSIS,SET,85,-0.080498,-0.0054644,0.0963,0.79839,HP_ARTERIOSCLEROSIS,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...6,SET,185,-0.052561,-0.0052494,0.062877,0.7984,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_UP,0.99999
LIN_SILENCED_BY_TUMOR_MICROE...,SET,96,-0.07763,-0.0055986,0.092841,0.79846,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,0.99999
GOMF_HISTONE_H4_DEMETHYLASE_...,SET,4,-0.33155,-0.0048931,0.39652,0.79846,GOMF_HISTONE_H4_DEMETHYLASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...401,SET,616,-0.029403,-0.0052945,0.035162,0.79847,GOBP_NEGATIVE_REGULATION_OF_MOLECULAR_FUNCTION,0.99999
ZNF184_TARGET_GENES,SET,1075,-0.021572,-0.0050646,0.025797,0.79848,ZNF184_TARGET_GENES,0.99999
chr7p13,SET,30,-0.23195,-0.0093682,0.27737,0.79849,chr7p13,0.99999
REACTOME_RUNX1_REGULATES_TRA...5,SET,5,-0.32227,-0.0053174,0.38532,0.79852,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING,0.99999
GOBP_IMPORT_INTO_NUCLEUS,SET,159,-0.053618,-0.0049679,0.064108,0.79852,GOBP_IMPORT_INTO_NUCLEUS,0.99999
SIRT3_TARGET_GENES,SET,38,-0.11479,-0.0052167,0.13724,0.79853,SIRT3_TARGET_GENES,0.99999
HAND1E47_01,SET,245,-0.047258,-0.0054224,0.056464,0.79868,HAND1E47_01,0.99999
REACTOME_INTERCONVERSION_OF_...,SET,28,-0.13823,-0.005394,0.16514,0.79871,REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES,0.99999
HP_METATARSUS_VALGUS,SET,19,-0.16131,-0.0051863,0.19271,0.79872,HP_METATARSUS_VALGUS,0.99999
DAIRKEE_CANCER_PRONE_RESPONS...2,SET,107,-0.067185,-0.0051138,0.08025,0.79875,DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,0.99999
KEGG_MEDICUS_PATHOGEN_HIV_TA...1,SET,8,-0.23508,-0.0049059,0.28079,0.79876,KEGG_MEDICUS_PATHOGEN_HIV_TAT_NEF_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.99999
GOBP_POSITIVE_REGULATION_OF_...93,SET,29,-0.14353,-0.0056998,0.17144,0.79877,GOBP_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,0.99999
GOBP_EMBRYONIC_ORGAN_DEVELOP...,SET,430,-0.036113,-0.0054614,0.043119,0.79884,GOBP_EMBRYONIC_ORGAN_DEVELOPMENT,0.99999
WP_ACETYLCHOLINE_SYNTHESIS,SET,5,-0.29918,-0.0049364,0.35716,0.79888,WP_ACETYLCHOLINE_SYNTHESIS,0.99999
HP_ELEVATED_CIRCULATING_ASPA...,SET,67,-0.084295,-0.0050828,0.1006,0.79895,HP_ELEVATED_CIRCULATING_ASPARTATE_AMINOTRANSFERASE_CONCENTRATION,0.99999
GOBP_PSEUDOPODIUM_ORGANIZATI...,SET,15,-0.18157,-0.0051876,0.21666,0.79899,GOBP_PSEUDOPODIUM_ORGANIZATION,0.99999
HP_INCREASED_PROPORTION_OF_C...,SET,6,-0.28124,-0.0050831,0.33551,0.79905,HP_INCREASED_PROPORTION_OF_CD25_MAST_CELLS,0.99999
MORF_ERH,SET,97,-0.066854,-0.0048463,0.079745,0.79908,MORF_ERH,0.99999
HP_ARTHRALGIA,SET,178,-0.055604,-0.0054482,0.06632,0.7991,HP_ARTHRALGIA,0.99999
MIR431_5P,SET,49,-0.094201,-0.0048599,0.11235,0.79911,MIR431_5P,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...28,SET,19,-0.17937,-0.0057672,0.21393,0.79911,GAVISH_3CA_MALIGNANT_METAPROGRAM_36_IG,0.99999
GOBP_POSITIVE_REGULATION_OF_...200,SET,35,-0.11851,-0.0051694,0.14134,0.79911,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,0.99999
MIR30D_3P,SET,350,-0.037247,-0.0050933,0.044416,0.79915,MIR30D_3P,0.99999
BRCA1_DN.V1_UP,SET,112,-0.070622,-0.0054989,0.084205,0.79917,BRCA1_DN.V1_UP,0.99999
GOBP_GRANULOCYTE_COLONY_STIM...1,SET,5,-0.3275,-0.0054036,0.39033,0.79926,GOBP_GRANULOCYTE_COLONY_STIMULATING_FACTOR_PRODUCTION,0.99999
FONTAINE_PAPILLARY_THYROID_C...2,SET,61,-0.094599,-0.0054436,0.11275,0.79927,FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_MID...,SET,50,-0.1082,-0.0056388,0.12895,0.79929,HE_LIM_SUN_FETAL_LUNG_C3_MID_CAP_CELL,0.99999
GSE41867_LCMV_ARMSTRONG_VS_C...2,SET,175,-0.051831,-0.005036,0.06176,0.79932,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP,0.99999
GSE39820_CTRL_VS_IL1B_IL6_CD...1,SET,182,-0.054058,-0.0053553,0.06441,0.79933,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN,0.99999
REN_MIF_TARGETS_DN,SET,4,-0.36721,-0.0054193,0.43748,0.79936,REN_MIF_TARGETS_DN,0.99999
HP_REDUCED_MUSCLE_FIBER_ALPH...,SET,8,-0.23556,-0.0049158,0.28063,0.79937,HP_REDUCED_MUSCLE_FIBER_ALPHA_DYSTROGLYCAN,0.99999
GSE23502_WT_VS_HDC_KO_MYELOI...4,SET,184,-0.052886,-0.0052676,0.063004,0.79937,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP,0.99999
ZHAN_VARIABLE_EARLY_DIFFEREN...1,SET,27,-0.12146,-0.0046542,0.14469,0.79938,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,0.99999
HP_LIMB_FASCICULATIONS,SET,6,-0.27948,-0.0050513,0.33293,0.79939,HP_LIMB_FASCICULATIONS,0.99999
REACTOME_CELL_JUNCTION_ORGAN...,SET,105,-0.075637,-0.0057034,0.090083,0.79944,REACTOME_CELL_JUNCTION_ORGANIZATION,0.99999
GOBP_CELL_CELL_JUNCTION_ASSE...,SET,146,-0.063148,-0.0056086,0.075209,0.79944,GOBP_CELL_CELL_JUNCTION_ASSEMBLY,0.99999
GOERING_BLOOD_HDL_CHOLESTERO...1,SET,8,-0.28485,-0.0059446,0.3392,0.79947,GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS,0.99999
HP_DEFICIT_IN_GRAMMAR,SET,9,-0.21103,-0.0046709,0.25127,0.79949,HP_DEFICIT_IN_GRAMMAR,0.99999
BMI1_DN.V1_UP,SET,137,-0.06467,-0.0055653,0.076995,0.79952,BMI1_DN.V1_UP,0.99999
GOBP_REGULATION_OF_EPITHELIA...3,SET,14,-0.22101,-0.0061006,0.26305,0.79959,GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
BLANCO_MELO_COVID19_SARS_COV...6,SET,70,-0.090885,-0.005601,0.10816,0.79962,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...480,SET,5,-0.30968,-0.0051096,0.36846,0.79967,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION,0.99999
GSE36888_UNTREATED_VS_IL2_TR...8,SET,169,-0.053774,-0.0051352,0.063974,0.7997,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...131,SET,4,-0.3856,-0.0056908,0.45873,0.79971,GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,0.99999
WP_PROLINE_AND_HYDROXYPROLIN...,SET,5,-0.3794,-0.00626,0.45132,0.79972,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,0.99999
MIR545_3P,SET,349,-0.039407,-0.0053811,0.046874,0.79974,MIR545_3P,0.99999
REACTOME_GLYCOSPHINGOLIPID_C...,SET,31,-0.12835,-0.0052694,0.1526,0.79985,REACTOME_GLYCOSPHINGOLIPID_CATABOLISM,0.99999
CAGTCAC_MIR134,SET,48,-0.10518,-0.0053707,0.12504,0.79986,CAGTCAC_MIR134,0.99999
GOMF_CAMP_RESPONSE_ELEMENT_B...2,SET,8,-0.25713,-0.0053661,0.30558,0.79995,GOMF_CAMP_RESPONSE_ELEMENT_BINDING_PROTEIN_BINDING,0.99999
GOBP_ATP_METABOLIC_PROCESS,SET,176,-0.049442,-0.0048174,0.058756,0.79996,GOBP_ATP_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...316,SET,13,-0.19796,-0.0052655,0.23522,0.79999,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOCC_CIA_COMPLEX,SET,2,-0.41353,-0.0043157,0.49132,0.80001,GOCC_CIA_COMPLEX,0.99999
GOBP_MODIFICATION_OF_POSTSYN...2,SET,21,-0.14623,-0.0049426,0.17371,0.80005,GOBP_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE,0.99999
GOMF_CARBOHYDRATE_KINASE_ACT...,SET,20,-0.13825,-0.0045605,0.16422,0.80007,GOMF_CARBOHYDRATE_KINASE_ACTIVITY,0.99999
HP_HYPERPIGMENTED_HYPOPIGMEN...,SET,5,-0.33389,-0.0055091,0.39659,0.80007,HP_HYPERPIGMENTED_HYPOPIGMENTED_MACULES,0.99999
GOBP_REGULATION_OF_CELLULAR_...11,SET,16,-0.18408,-0.0054315,0.21861,0.80011,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT,0.99999
GOCC_RUFFLE_MEMBRANE,SET,95,-0.071229,-0.0051103,0.084581,0.80014,GOCC_RUFFLE_MEMBRANE,0.99999
MIR6855_3P,SET,45,-0.10206,-0.0050464,0.12116,0.8002,MIR6855_3P,0.99999
MIR503_3P,SET,36,-0.12464,-0.0055136,0.14795,0.80022,MIR503_3P,0.99999
GOBP_MIDDLE_EAR_MORPHOGENESIS,SET,19,-0.18024,-0.005795,0.21394,0.80023,GOBP_MIDDLE_EAR_MORPHOGENESIS,0.99999
WP_COVID19_ADVERSE_OUTCOME_P...,SET,14,-0.20229,-0.0055838,0.24009,0.80026,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,0.99999
MIR526B_5P,SET,94,-0.073991,-0.0052805,0.087814,0.80026,MIR526B_5P,0.99999
GOBP_REGULATION_OF_HYDROGEN_...1,SET,7,-0.28024,-0.0054707,0.33258,0.80027,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS,0.99999
USF_Q6_01,SET,221,-0.046684,-0.0050908,0.05538,0.80037,USF_Q6_01,0.99999
GSE39110_DAY3_VS_DAY6_POST_I...1,SET,181,-0.052807,-0.0052171,0.062638,0.80039,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN,0.99999
GOCC_CELL_TRAILING_EDGE,SET,14,-0.18773,-0.0051819,0.22267,0.8004,GOCC_CELL_TRAILING_EDGE,0.99999
MIR8080,SET,127,-0.062867,-0.0052104,0.074566,0.80041,MIR8080,0.99999
GOBP_CELLULAR_RESPONSE_TO_RE...3,SET,63,-0.09553,-0.0055862,0.11328,0.80047,GOBP_CELLULAR_RESPONSE_TO_RETINOIC_ACID,0.99999
TAFAZZIN_TARGET_GENES,SET,367,-0.037339,-0.0052259,0.044272,0.80049,TAFAZZIN_TARGET_GENES,0.99999
GSE17721_CTRL_VS_CPG_4H_BMDC...2,SET,188,-0.050329,-0.0050666,0.059674,0.80049,GSE17721_CTRL_VS_CPG_4H_BMDC_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...636,SET,5,-0.35338,-0.0058306,0.41898,0.8005,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,0.99999
GOBP_REGULATION_OF_GLUTAMATE...4,SET,5,-0.33082,-0.0054584,0.39222,0.80051,GOBP_REGULATION_OF_GLUTAMATE_SECRETION_NEUROTRANSMISSION,0.99999
MIR320A_3P_MIR320B_MIR320C_M...,SET,276,-0.045151,-0.005494,0.053513,0.80059,MIR320A_3P_MIR320B_MIR320C_MIR320D,0.99999
GOBP_RAS_PROTEIN_SIGNAL_TRAN...,SET,116,-0.065334,-0.0051766,0.07743,0.8006,GOBP_RAS_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
HP_PROMINENT_SUPRAORBITAL_RI...,SET,33,-0.12607,-0.00534,0.14937,0.80066,HP_PROMINENT_SUPRAORBITAL_RIDGES,0.99999
LIU_TARGETS_OF_VMYB_VS_CMYB_...1,SET,38,-0.12121,-0.0055086,0.14354,0.80078,LIU_TARGETS_OF_VMYB_VS_CMYB_DN,0.99999
SCHERER_PBMC_APSV_WETVAX_AGE...4,SET,156,-0.059327,-0.0054452,0.070255,0.80079,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP,0.99999
GOCC_U6_SNRNP,SET,8,-0.22074,-0.0046066,0.26138,0.80081,GOCC_U6_SNRNP,0.99999
HP_ABNORMALITY_OF_REPRODUCTI...,SET,755,-0.026112,-0.005185,0.030916,0.80083,HP_ABNORMALITY_OF_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,0.99999
REACTOME_KSRP_KHSRP_BINDS_AN...,SET,16,-0.16221,-0.0047862,0.19198,0.80092,REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA,0.99999
HP_CERVICAL_SPINAL_CANAL_STE...,SET,9,-0.2561,-0.0056686,0.30309,0.80093,HP_CERVICAL_SPINAL_CANAL_STENOSIS,0.99999
TRAVAGLINI_LUNG_MACROPHAGE_C...,SET,189,-0.056604,-0.0057133,0.066973,0.80099,TRAVAGLINI_LUNG_MACROPHAGE_CELL,0.99999
GOBP_FATTY_ACID_BETA_OXIDATI...1,SET,70,-0.080252,-0.0049457,0.094942,0.80102,GOBP_FATTY_ACID_BETA_OXIDATION,0.99999
HP_HYPOKETOTIC_HYPOGLYCEMIA,SET,14,-0.18636,-0.0051441,0.22048,0.80102,HP_HYPOKETOTIC_HYPOGLYCEMIA,0.99999
SMID_BREAST_CANCER_BASAL_DN,SET,631,-0.029884,-0.0054439,0.035352,0.80103,SMID_BREAST_CANCER_BASAL_DN,0.99999
MIR4305,SET,50,-0.0994,-0.00518,0.11759,0.80103,MIR4305,0.99999
MIR636,SET,204,-0.052246,-0.0054764,0.061802,0.80105,MIR636,0.99999
GSE4142_PLASMA_CELL_VS_MEMOR...2,SET,176,-0.055751,-0.0054321,0.065933,0.8011,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP,0.99999
HP_WIDELY_SPACED_TEETH,SET,103,-0.069008,-0.0051541,0.081578,0.80119,HP_WIDELY_SPACED_TEETH,0.99999
GSE4811_CLASSSICALY_ACTIVATE...1,SET,176,-0.055433,-0.0054011,0.065528,0.8012,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_DN,0.99999
GSE37534_PIOGLITAZONE_VS_ROS...1,SET,144,-0.062282,-0.0054939,0.073618,0.80122,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,0.99999
GSE36078_UNTREATED_VS_AD5_IN...3,SET,175,-0.052683,-0.0051187,0.06226,0.80126,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_DN,0.99999
TRAVAGLINI_LUNG_SIGNALING_AL...,SET,67,-0.093937,-0.0056641,0.11102,0.80126,TRAVAGLINI_LUNG_SIGNALING_ALVEOLAR_EPITHELIAL_TYPE_2_CELL,0.99999
GOMF_ALPHA_1_4_GLUCOSIDASE_A...,SET,5,-0.32382,-0.005343,0.38267,0.80128,GOMF_ALPHA_1_4_GLUCOSIDASE_ACTIVITY,0.99999
HP_ABNORMALITY_OF_THE_SPLEEN,SET,555,-0.030525,-0.0052263,0.036068,0.80131,HP_ABNORMALITY_OF_THE_SPLEEN,0.99999
GOBP_CELL_CELL_JUNCTION_ORGA...,SET,199,-0.055032,-0.0056981,0.06499,0.80143,GOBP_CELL_CELL_JUNCTION_ORGANIZATION,0.99999
HP_RENAL_ANGIOMYOLIPOMA,SET,5,-0.29457,-0.0048603,0.34784,0.80145,HP_RENAL_ANGIOMYOLIPOMA,0.99999
GOMF_CARBOHYDRATE_BINDING,SET,248,-0.048238,-0.0055682,0.056959,0.80146,GOMF_CARBOHYDRATE_BINDING,0.99999
SCHUHMACHER_MYC_TARGETS_UP,SET,74,-0.08054,-0.0051027,0.095067,0.80155,SCHUHMACHER_MYC_TARGETS_UP,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...12,SET,152,-0.057125,-0.005176,0.067428,0.80155,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP,0.99999
GSE42724_MEMORY_VS_B1_BCELL_...1,SET,168,-0.055797,-0.0053128,0.065854,0.80158,GSE42724_MEMORY_VS_B1_BCELL_DN,0.99999
CHEOK_RESPONSE_TO_MERCAPTOPU...3,SET,17,-0.18915,-0.0057528,0.22321,0.80161,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN,0.99999
MIR483_3P,SET,49,-0.10494,-0.0054139,0.12381,0.80165,MIR483_3P,0.99999
MIR5004_3P,SET,124,-0.062453,-0.005115,0.073684,0.80166,MIR5004_3P,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...7,SET,168,-0.056426,-0.0053726,0.066571,0.80167,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN,0.99999
GOBP_REGULATION_OF_NUCLEOBAS...,SET,17,-0.16574,-0.0050407,0.1955,0.8017,GOBP_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.99999
REACTOME_APOPTOTIC_FACTOR_ME...,SET,17,-0.16828,-0.005118,0.1985,0.80171,REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...3,SET,9,-0.24586,-0.0054419,0.28986,0.80182,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR,0.99999
GOBP_LOOP_OF_HENLE_DEVELOPME...,SET,11,-0.23773,-0.0058169,0.28027,0.80183,GOBP_LOOP_OF_HENLE_DEVELOPMENT,0.99999
HP_IMPAIRED_GLUCOSE_TOLERANCE,SET,36,-0.12609,-0.0055777,0.14865,0.80184,HP_IMPAIRED_GLUCOSE_TOLERANCE,0.99999
GSE21360_TERTIARY_VS_QUATERN...1,SET,161,-0.059983,-0.0055922,0.070705,0.80187,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.99999
WHITESIDE_CISPLATIN_RESISTAN...2,SET,11,-0.21265,-0.0052033,0.25064,0.80189,WHITESIDE_CISPLATIN_RESISTANCE_UP,0.99999
GOMF_VERY_LONG_CHAIN_FATTY_A...,SET,9,-0.2326,-0.0051485,0.27416,0.80189,GOMF_VERY_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,0.99999
GAVIN_PDE3B_TARGETS,SET,20,-0.16102,-0.0053115,0.18973,0.80196,GAVIN_PDE3B_TARGETS,0.99999
GSE26488_WT_VS_HDAC7_KO_DOUB...2,SET,159,-0.05703,-0.005284,0.067196,0.80197,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,0.99999
HP_BLISTERING_BY_HISTOLOGICA...,SET,13,-0.18703,-0.0049748,0.22031,0.80203,HP_BLISTERING_BY_HISTOLOGICAL_LOCATION,0.99999
chr12q12,SET,24,-0.263,-0.0095021,0.30974,0.80208,chr12q12,0.99999
GNF2_TM4SF2,SET,23,-0.15741,-0.0055679,0.18533,0.80215,GNF2_TM4SF2,0.99999
GSE2706_R848_VS_LPS_8H_STIM_...1,SET,158,-0.059578,-0.0055029,0.070146,0.80215,GSE2706_R848_VS_LPS_8H_STIM_DC_DN,0.99999
CUI_DEVELOPING_HEART_RIGHT_V...,SET,20,-0.1472,-0.0048556,0.17331,0.80215,CUI_DEVELOPING_HEART_RIGHT_VENTRICULAR_CARDIOMYOCYTE,0.99999
GOBP_REGULATION_OF_ANTIBACTE...,SET,7,-0.29483,-0.0057556,0.34706,0.8022,GOBP_REGULATION_OF_ANTIBACTERIAL_PEPTIDE_PRODUCTION,0.99999
GOBP_REGULATION_OF_DENDRITIC...6,SET,41,-0.11558,-0.0054558,0.13603,0.80225,GOBP_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,0.99999
MIR5003_3P,SET,293,-0.042359,-0.005308,0.049844,0.80228,MIR5003_3P,0.99999
GOBP_PROTEIN_K48_LINKED_DEUB...,SET,22,-0.12987,-0.0044929,0.15282,0.80229,GOBP_PROTEIN_K48_LINKED_DEUBIQUITINATION,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...15,SET,178,-0.053018,-0.0051948,0.062386,0.80229,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN,0.99999
MIR9902,SET,259,-0.04488,-0.0052926,0.052806,0.8023,MIR9902,0.99999
GOBP_NEGATIVE_REGULATION_OF_...322,SET,96,-0.071014,-0.0051215,0.083548,0.80233,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GSE22432_MULTIPOTENT_VS_COMM...3,SET,175,-0.051091,-0.0049641,0.060108,0.80233,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_UP,0.99999
HP_ABNORMAL_MAXILLA_MORPHOLO...,SET,133,-0.062373,-0.0052893,0.073353,0.80242,HP_ABNORMAL_MAXILLA_MORPHOLOGY,0.99999
GOBP_MITOCHONDRIAL_TRANSLATI...2,SET,5,-0.27256,-0.0044972,0.32045,0.80249,GOBP_MITOCHONDRIAL_TRANSLATIONAL_ELONGATION,0.99999
GOMF_PURINE_RIBONUCLEOTIDE_T...,SET,20,-0.17583,-0.0057999,0.20671,0.8025,GOMF_PURINE_RIBONUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOCC_PERINUCLEAR_ENDOPLASMIC...,SET,19,-0.15969,-0.0051343,0.18773,0.80251,GOCC_PERINUCLEAR_ENDOPLASMIC_RETICULUM,0.99999
GOBP_APOPTOTIC_SIGNALING_PAT...,SET,558,-0.03053,-0.0052408,0.035871,0.80264,GOBP_APOPTOTIC_SIGNALING_PATHWAY,0.99999
chr5q21,SET,14,-0.29827,-0.008233,0.35041,0.80266,chr5q21,0.99999
GOMF_IODIDE_TRANSMEMBRANE_TR...,SET,5,-0.28212,-0.0046549,0.33143,0.80267,GOMF_IODIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_CARBOHYDRATE_CATABOLIC_...,SET,157,-0.05509,-0.0050723,0.064687,0.80279,GOBP_CARBOHYDRATE_CATABOLIC_PROCESS,0.99999
GOBP_CEREBELLAR_CORTEX_MORPH...,SET,32,-0.13047,-0.0054421,0.15319,0.80281,GOBP_CEREBELLAR_CORTEX_MORPHOGENESIS,0.99999
HP_IRREGULAR_DENTITION,SET,7,-0.27632,-0.0053943,0.32442,0.80281,HP_IRREGULAR_DENTITION,0.99999
MORF_BCL2L11,SET,161,-0.057716,-0.0053808,0.067752,0.80285,MORF_BCL2L11,0.99999
HP_THIN_CLAVICLES,SET,6,-0.28664,-0.0051808,0.33649,0.80285,HP_THIN_CLAVICLES,0.99999
HP_LOWER_LIMB_UNDERGROWTH,SET,14,-0.1929,-0.0053246,0.22637,0.80293,HP_LOWER_LIMB_UNDERGROWTH,0.99999
GOBP_OSTEOCLAST_PROLIFERATION,SET,11,-0.21944,-0.0053695,0.25741,0.80302,GOBP_OSTEOCLAST_PROLIFERATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...748,SET,22,-0.15302,-0.0052937,0.17948,0.80306,GOBP_POSITIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...149,SET,11,-0.23478,-0.0057448,0.27527,0.80314,GOBP_NEGATIVE_REGULATION_OF_CIRCADIAN_RHYTHM,0.99999
HP_PERSISTENT_OPEN_ANTERIOR_...,SET,7,-0.22913,-0.0044731,0.26865,0.80314,HP_PERSISTENT_OPEN_ANTERIOR_FONTANELLE,0.99999
BIOCARTA_IL4_PATHWAY,SET,10,-0.23473,-0.0054764,0.27517,0.80317,BIOCARTA_IL4_PATHWAY,0.99999
GOMF_EXONUCLEASE_ACTIVITY_AC...,SET,58,-0.084022,-0.0047149,0.098486,0.8032,GOMF_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,0.99999
HP_SECOND_DEGREE_ATRIOVENTRI...,SET,12,-0.20702,-0.0052907,0.24261,0.80325,HP_SECOND_DEGREE_ATRIOVENTRICULAR_BLOCK,0.99999
GSE25123_CTRL_VS_ROSIGLITAZO...1,SET,178,-0.054218,-0.0053124,0.06353,0.80328,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.99999
ASGHARZADEH_NEUROBLASTOMA_PO...,SET,37,-0.11759,-0.0052735,0.13777,0.80332,ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,0.99999
HP_KERATITIS,SET,70,-0.084239,-0.0051914,0.098679,0.80335,HP_KERATITIS,0.99999
MIR6794_3P,SET,77,-0.087654,-0.0056644,0.10267,0.80336,MIR6794_3P,0.99999
GOMF_5_3_EXONUCLEASE_ACTIVITY,SET,17,-0.1471,-0.0044738,0.17229,0.80338,GOMF_5_3_EXONUCLEASE_ACTIVITY,0.99999
GSE3982_EOSINOPHIL_VS_NKCELL...1,SET,171,-0.055311,-0.0053129,0.064769,0.80343,GSE3982_EOSINOPHIL_VS_NKCELL_DN,0.99999
GOCC_PROTEIN_COMPLEX_INVOLVE...1,SET,55,-0.099099,-0.0054156,0.11603,0.80347,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION,0.99999
HP_ALTERNATING_ESOTROPIA,SET,10,-0.22476,-0.005244,0.26313,0.80349,HP_ALTERNATING_ESOTROPIA,0.99999
HERNANDEZ_ABERRANT_MITOSIS_B...4,SET,18,-0.17424,-0.0054528,0.20396,0.80352,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,0.99999
PID_BMP_PATHWAY,SET,38,-0.12711,-0.0057767,0.14879,0.80352,PID_BMP_PATHWAY,0.99999
MIR3666,SET,353,-0.038788,-0.0053263,0.045401,0.80354,MIR3666,0.99999
SCHUETZ_BREAST_CANCER_DUCTAL...1,SET,78,-0.087538,-0.0056934,0.10245,0.80358,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,0.99999
GSE17721_LPS_VS_POLYIC_2H_BM...1,SET,190,-0.049829,-0.0050425,0.058309,0.8036,GSE17721_LPS_VS_POLYIC_2H_BMDC_DN,0.99999
GOCC_FACIT_COLLAGEN_TRIMER,SET,6,-0.3371,-0.0060928,0.39441,0.80363,GOCC_FACIT_COLLAGEN_TRIMER,0.99999
HP_JOINT_DISLOCATION,SET,330,-0.039928,-0.0053045,0.046714,0.80364,HP_JOINT_DISLOCATION,0.99999
HP_LARGE_FOR_GESTATIONAL_AGE,SET,49,-0.10207,-0.005266,0.11941,0.80367,HP_LARGE_FOR_GESTATIONAL_AGE,0.99999
IRF_Q6,SET,218,-0.049858,-0.0054004,0.058315,0.80371,IRF_Q6,0.99999
HP_CARDIAC_DIVERTICULUM,SET,20,-0.14459,-0.0047695,0.16903,0.80384,HP_CARDIAC_DIVERTICULUM,0.99999
YIH_RESPONSE_TO_ARSENITE_C1,SET,21,-0.15578,-0.0052653,0.18209,0.80385,YIH_RESPONSE_TO_ARSENITE_C1,0.99999
HP_ABNORMAL_TISSUE_METABOLIT...,SET,237,-0.045716,-0.0051603,0.05344,0.80385,HP_ABNORMAL_TISSUE_METABOLITE_CONCENTRATION,0.99999
VANDESLUIS_COMMD1_TARGETS_GR...4,SET,17,-0.19493,-0.0059285,0.22782,0.80389,VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN,0.99999
GOBP_RESPONSE_TO_NUTRIENT,SET,156,-0.060771,-0.0055778,0.071011,0.80394,GOBP_RESPONSE_TO_NUTRIENT,0.99999
HP_TETRAPLEGIA_TETRAPARESIS,SET,124,-0.063963,-0.0052387,0.074728,0.80398,HP_TETRAPLEGIA_TETRAPARESIS,0.99999
GOBP_RETROGRADE_TRANSPORT_EN...,SET,88,-0.071255,-0.0049212,0.083243,0.80399,GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,0.99999
HP_ABNORMALITY_OF_THE_POSTER...,SET,99,-0.06924,-0.0050705,0.080889,0.80399,HP_ABNORMALITY_OF_THE_POSTERIOR_HAIRLINE,0.99999
WP_TP53_NETWORK,SET,19,-0.18047,-0.0058026,0.21083,0.804,WP_TP53_NETWORK,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...6,SET,71,-0.093549,-0.005806,0.10928,0.80401,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS,0.99999
BANDRES_RESPONSE_TO_CARMUSTI...3,SET,148,-0.060225,-0.0053852,0.07035,0.80402,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...218,SET,9,-0.22542,-0.0049894,0.26324,0.80409,GOBP_POSITIVE_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...62,SET,50,-0.10534,-0.0054894,0.123,0.8041,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,0.99999
ALCALAY_AML_BY_NPM1_LOCALIZA...1,SET,168,-0.056128,-0.0053443,0.065507,0.80422,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,0.99999
HP_TRUNCAL_TITUBATION,SET,7,-0.28219,-0.0055088,0.32929,0.80426,HP_TRUNCAL_TITUBATION,0.99999
MODULE_576,SET,102,-0.071453,-0.0053108,0.083371,0.80428,MODULE_576,0.99999
LEE_LIVER_CANCER_CIPROFIBRAT...2,SET,57,-0.099349,-0.0055269,0.11592,0.80429,LEE_LIVER_CANCER_CIPROFIBRATE_UP,0.99999
HP_TRACHEOMALACIA,SET,43,-0.10737,-0.0051901,0.12527,0.80432,HP_TRACHEOMALACIA,0.99999
HP_RETINOPATHY,SET,127,-0.065593,-0.0054363,0.076502,0.80438,HP_RETINOPATHY,0.99999
MIR6831_3P,SET,55,-0.09181,-0.0050173,0.10707,0.8044,MIR6831_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...693,SET,10,-0.21387,-0.0049898,0.24936,0.80446,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
ONO_FOXP3_TARGETS_DN,SET,40,-0.11561,-0.0053904,0.13479,0.80447,ONO_FOXP3_TARGETS_DN,0.99999
ZERBINI_RESPONSE_TO_SULINDAC...1,SET,6,-0.24044,-0.0043458,0.28031,0.80448,ZERBINI_RESPONSE_TO_SULINDAC_DN,0.99999
WP_SEROTONIN_AND_ANXIETYRELA...,SET,12,-0.23921,-0.0061133,0.27888,0.80448,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,0.99999
HP_ABNORMAL_LIVER_MORPHOLOGY,SET,790,-0.026053,-0.0052865,0.030373,0.80448,HP_ABNORMAL_LIVER_MORPHOLOGY,0.99999
HP_NOCTURNAL_SEIZURES,SET,18,-0.18053,-0.0056498,0.21044,0.80452,HP_NOCTURNAL_SEIZURES,0.99999
GSE5589_WT_VS_IL10_KO_LPS_AN...1,SET,102,-0.074816,-0.0055608,0.087206,0.80453,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.99999
MIR95_5P,SET,606,-0.029652,-0.0052972,0.034559,0.80455,MIR95_5P,0.99999
GOMF_TRANSKETOLASE_OR_TRANSA...,SET,3,-0.41836,-0.0053472,0.48748,0.8046,GOMF_TRANSKETOLASE_OR_TRANSALDOLASE_ACTIVITY,0.99999
HP_ANAPHYLACTIC_SHOCK,SET,8,-0.25891,-0.0054033,0.3017,0.8046,HP_ANAPHYLACTIC_SHOCK,0.99999
PID_PTP1B_PATHWAY,SET,52,-0.10833,-0.0057569,0.12623,0.80461,PID_PTP1B_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...596,SET,50,-0.10502,-0.0054729,0.12236,0.80462,GOBP_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.99999
GOBP_MONOSACCHARIDE_BIOSYNTH...,SET,79,-0.078735,-0.0051535,0.091706,0.8047,GOBP_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS,0.99999
GSE16385_MONOCYTE_VS_12H_IFN...1,SET,174,-0.055848,-0.0054109,0.065049,0.8047,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOTI...3,SET,29,-0.13339,-0.0052969,0.15531,0.80478,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS,0.99999
BANDRES_RESPONSE_TO_CARMUSTI...8,SET,18,-0.1599,-0.005004,0.18618,0.80479,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,0.99999
GOBP_REGULATION_OF_PROTEIN_A...3,SET,34,-0.12601,-0.0054173,0.14666,0.80488,GOBP_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.99999
GSE3982_DC_VS_NKCELL_DN,SET,166,-0.055746,-0.0052766,0.064874,0.80491,GSE3982_DC_VS_NKCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...560,SET,6,-0.30667,-0.0055427,0.35686,0.80492,GOBP_NEGATIVE_REGULATION_OF_RESPIRATORY_BURST,0.99999
GOBP_CEREBELLAR_GRANULAR_LAY...1,SET,12,-0.22689,-0.0057986,0.26401,0.80493,GOBP_CEREBELLAR_GRANULAR_LAYER_DEVELOPMENT,0.99999
VALK_AML_CLUSTER_16,SET,21,-0.16579,-0.0056037,0.19287,0.80499,VALK_AML_CLUSTER_16,0.99999
MIR4724_3P,SET,78,-0.076988,-0.0050073,0.089563,0.80499,MIR4724_3P,0.99999
GOBP_METANEPHRIC_TUBULE_DEVE...,SET,23,-0.16924,-0.005986,0.19687,0.805,GOBP_METANEPHRIC_TUBULE_DEVELOPMENT,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...9,SET,177,-0.054494,-0.0053246,0.063385,0.80503,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN,0.99999
HP_HYPERVENTILATION,SET,26,-0.15556,-0.0058496,0.18093,0.80504,HP_HYPERVENTILATION,0.99999
WP_CILIARY_LANDSCAPE,SET,197,-0.04929,-0.0050781,0.057327,0.80505,WP_CILIARY_LANDSCAPE,0.99999
GOBP_CORTICOSTERONE_SECRETION,SET,5,-0.34945,-0.0057658,0.40643,0.80505,GOBP_CORTICOSTERONE_SECRETION,0.99999
HP_INCREASED_B_CELL_COUNT,SET,11,-0.23803,-0.0058244,0.27683,0.80505,HP_INCREASED_B_CELL_COUNT,0.99999
HP_ABNORMAL_PUPILLARY_FUNCTI...,SET,70,-0.090708,-0.0055901,0.10549,0.80506,HP_ABNORMAL_PUPILLARY_FUNCTION,0.99999
HP_BLOODY_DIARRHEA,SET,45,-0.10844,-0.0053618,0.12611,0.80506,HP_BLOODY_DIARRHEA,0.99999
HP_ALKALOSIS,SET,29,-0.13485,-0.0053548,0.1568,0.8051,HP_ALKALOSIS,0.99999
GSE11884_WT_VS_FURIN_KO_NAIV...1,SET,116,-0.06681,-0.0052935,0.077681,0.80511,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN,0.99999
HP_MULTIFOCAL_CEREBRAL_WHITE...,SET,15,-0.17616,-0.0050331,0.20479,0.80516,HP_MULTIFOCAL_CEREBRAL_WHITE_MATTER_ABNORMALITIES,0.99999
MIR15A_3P,SET,32,-0.12916,-0.0053875,0.15013,0.80519,MIR15A_3P,0.99999
HP_HYPERGLYCINURIA,SET,14,-0.20496,-0.0056575,0.23821,0.80522,HP_HYPERGLYCINURIA,0.99999
GOMF_PROTEIN_DOMAIN_SPECIFIC...,SET,599,-0.029309,-0.0052068,0.034059,0.80525,GOMF_PROTEIN_DOMAIN_SPECIFIC_BINDING,0.99999
GOBP_RAC_PROTEIN_SIGNAL_TRAN...,SET,44,-0.10789,-0.0052753,0.12535,0.8053,GOBP_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GOBP_PROTEIN_K27_LINKED_UBIQ...,SET,11,-0.21184,-0.0051836,0.2461,0.80532,GOBP_PROTEIN_K27_LINKED_UBIQUITINATION,0.99999
MIR6506_3P,SET,5,-0.27014,-0.0044573,0.31382,0.80533,MIR6506_3P,0.99999
CHEOK_RESPONSE_TO_HD_MTX_UP,SET,19,-0.17623,-0.0056662,0.20471,0.80535,CHEOK_RESPONSE_TO_HD_MTX_UP,0.99999
GOBP_CHEMICAL_SYNAPTIC_TRANS...,SET,104,-0.07434,-0.0055791,0.086351,0.80535,GOBP_CHEMICAL_SYNAPTIC_TRANSMISSION_POSTSYNAPTIC,0.99999
GSE3920_IFNA_VS_IFNG_TREATED...1,SET,153,-0.058475,-0.0053156,0.067923,0.80535,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.99999
GOBP_ISOPRENOID_CATABOLIC_PR...,SET,9,-0.26625,-0.0058933,0.30916,0.80543,GOBP_ISOPRENOID_CATABOLIC_PROCESS,0.99999
BUFFA_HYPOXIA_METAGENE,SET,44,-0.11104,-0.0054294,0.12892,0.80547,BUFFA_HYPOXIA_METAGENE,0.99999
MIR943,SET,47,-0.10923,-0.0055192,0.12678,0.80553,MIR943,0.99999
GOBP_PROTEIN_CATABOLIC_PROCE...2,SET,21,-0.17454,-0.0058994,0.20257,0.80555,GOBP_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,0.99999
HP_BLISTERING_BY_ANATOMICAL_...,SET,25,-0.14866,-0.0054818,0.17253,0.80555,HP_BLISTERING_BY_ANATOMICAL_LOCATION,0.99999
REACTOME_DEATH_RECEPTOR_SIGN...,SET,139,-0.062107,-0.0053833,0.072066,0.8056,REACTOME_DEATH_RECEPTOR_SIGNALING,0.99999
GOBP_ION_CHANNEL_MODULATING_...,SET,8,-0.27533,-0.0057458,0.31946,0.80561,GOBP_ION_CHANNEL_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE5455_HEALTHY_VS_TUMOR_BEA...3,SET,183,-0.055014,-0.0054648,0.063831,0.80561,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_DN,0.99999
REACTOME_EFFECTS_OF_PIP2_HYD...,SET,26,-0.14087,-0.0052973,0.16343,0.80564,REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS,0.99999
GOMF_PROTEIN_MEMBRANE_ADAPTO...,SET,32,-0.12118,-0.0050546,0.14058,0.80566,GOMF_PROTEIN_MEMBRANE_ADAPTOR_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...372,SET,33,-0.14066,-0.0059579,0.16316,0.80567,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,0.99999
GSE17721_CTRL_VS_POLYIC_1H_B...2,SET,176,-0.052153,-0.0050816,0.060484,0.80572,GSE17721_CTRL_VS_POLYIC_1H_BMDC_UP,0.99999
DESCARTES_FETAL_PANCREAS_CCL...,SET,43,-0.12293,-0.005942,0.14257,0.80572,DESCARTES_FETAL_PANCREAS_CCL19_CCL21_POSITIVE_CELLS,0.99999
chr15q22,SET,65,-0.17187,-0.010208,0.19929,0.80576,chr15q22,0.99999
GOBP_REGULATION_OF_NITRIC_OX...1,SET,6,-0.31897,-0.0057651,0.36981,0.8058,GOBP_REGULATION_OF_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION,0.99999
DESCARTES_FETAL_EYE_GANGLION...,SET,33,-0.13505,-0.0057203,0.15656,0.80582,DESCARTES_FETAL_EYE_GANGLION_CELLS,0.99999
HP_ABNORMALITY_OF_THE_TONGUE...,SET,3,-0.33009,-0.004219,0.38265,0.80583,HP_ABNORMALITY_OF_THE_TONGUE_MUSCLE,0.99999
GSE3920_UNTREATED_VS_IFNA_TR...2,SET,163,-0.05831,-0.0054696,0.067594,0.80583,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP,0.99999
GOBP_IMP_BIOSYNTHETIC_PROCESS,SET,10,-0.23265,-0.0054279,0.26967,0.80584,GOBP_IMP_BIOSYNTHETIC_PROCESS,0.99999
HP_SPEECH_ARTICULATION_DIFFI...,SET,29,-0.1446,-0.0057423,0.16761,0.80585,HP_SPEECH_ARTICULATION_DIFFICULTIES,0.99999
GSE32164_ALTERNATIVELY_ACT_M...1,SET,179,-0.052468,-0.0051552,0.060813,0.80586,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN,0.99999
HP_ABNORMAL_SALIVARY_GLAND_M...,SET,27,-0.13206,-0.0050603,0.15305,0.80588,HP_ABNORMAL_SALIVARY_GLAND_MORPHOLOGY,0.99999
CHANGOLKAR_H2AFY_TARGETS_UP,SET,42,-0.11593,-0.0055382,0.13434,0.80591,CHANGOLKAR_H2AFY_TARGETS_UP,0.99999
HP_CENTRAL_SLEEP_APNEA,SET,37,-0.12634,-0.0056658,0.14636,0.80599,HP_CENTRAL_SLEEP_APNEA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...26,SET,14,-0.18858,-0.0052053,0.21836,0.80609,GOBP_NEGATIVE_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_CIRCULATING_ALDO...1,SET,21,-0.14269,-0.0048228,0.16523,0.80609,HP_ABNORMAL_CIRCULATING_ALDOLASE_CONCENTRATION,0.99999
HP_OPISTHOTONUS,SET,47,-0.10311,-0.0052102,0.11938,0.80613,HP_OPISTHOTONUS,0.99999
GSE27241_CTRL_VS_DIGOXIN_TRE...3,SET,164,-0.056454,-0.0053116,0.065361,0.80613,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,0.99999
HP_GENERALIZED_HIRSUTISM,SET,86,-0.079086,-0.0053998,0.091535,0.8062,HP_GENERALIZED_HIRSUTISM,0.99999
GSE17721_CTRL_VS_LPS_0.5H_BM...2,SET,179,-0.055385,-0.0054418,0.064101,0.80621,GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP,0.99999
GOMF_GABA_A_RECEPTOR_ACTIVITY,SET,16,-0.22987,-0.0067826,0.26602,0.80622,GOMF_GABA_A_RECEPTOR_ACTIVITY,0.99999
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...3,SET,913,-0.025294,-0.0054983,0.02927,0.80625,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP,0.99999
CERIBELLI_PROMOTERS_INACTIVE...,SET,30,-0.13675,-0.005523,0.15823,0.80627,CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,0.99999
GOBP_PURINE_NUCLEOBASE_METAB...,SET,17,-0.17036,-0.0051812,0.19711,0.80627,GOBP_PURINE_NUCLEOBASE_METABOLIC_PROCESS,0.99999
MIR653_5P,SET,116,-0.066507,-0.0052695,0.076917,0.80638,MIR653_5P,0.99999
HP_MELANOMA,SET,74,-0.079742,-0.0050522,0.092217,0.8064,HP_MELANOMA,0.99999
DESCARTES_FETAL_ADRENAL_CHRO...,SET,75,-0.09396,-0.0059929,0.10865,0.80642,DESCARTES_FETAL_ADRENAL_CHROMAFFIN_CELLS,0.99999
HP_REDUCED_VISUAL_ACUITY,SET,518,-0.031947,-0.0052898,0.036941,0.80643,HP_REDUCED_VISUAL_ACUITY,0.99999
GSE1432_6H_VS_24H_IFNG_MICRO...2,SET,178,-0.05464,-0.0053537,0.063177,0.80644,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,0.99999
GOBP_MITOTIC_SISTER_CHROMATI...4,SET,60,-0.09223,-0.0052636,0.10663,0.80646,GOBP_MITOTIC_SISTER_CHROMATID_SEPARATION,0.99999
HP_ABNORMAL_CIRCULATING_LACT...,SET,90,-0.078402,-0.0054756,0.090623,0.80651,HP_ABNORMAL_CIRCULATING_LACTATE_DEHYDROGENASE_CONCENTRATION,0.99999
GOBP_GLUTAMATE_REUPTAKE,SET,6,-0.3454,-0.0062428,0.3991,0.8066,GOBP_GLUTAMATE_REUPTAKE,0.99999
HP_DECREASED_SERUM_INSULIN_L...,SET,21,-0.16219,-0.0054821,0.1874,0.80661,HP_DECREASED_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1,0.99999
HP_MUTISM,SET,46,-0.10253,-0.0051256,0.11846,0.80663,HP_MUTISM,0.99999
MIR6861_5P,SET,62,-0.090797,-0.0052672,0.10484,0.80676,MIR6861_5P,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...5,SET,172,-0.053039,-0.0051093,0.061235,0.80679,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_DN,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...16,SET,179,-0.054053,-0.005311,0.062404,0.8068,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...57,SET,37,-0.10064,-0.0045133,0.11614,0.80691,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,0.99999
MIR365A_5P,SET,30,-0.14279,-0.0057671,0.16477,0.80692,MIR365A_5P,0.99999
GSE22601_DOUBLE_POSITIVE_VS_...2,SET,167,-0.057156,-0.0054261,0.065951,0.80692,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
HP_OVOID_VERTEBRAL_BODIES,SET,34,-0.12837,-0.0055191,0.14813,0.80693,HP_OVOID_VERTEBRAL_BODIES,0.99999
REACTOME_SIGNALING_BY_LTK,SET,10,-0.22728,-0.0053027,0.26224,0.80694,REACTOME_SIGNALING_BY_LTK,0.99999
HP_RESPIRATORY_FAILURE_REQUI...,SET,29,-0.13268,-0.0052688,0.15307,0.80697,HP_RESPIRATORY_FAILURE_REQUIRING_ASSISTED_VENTILATION,0.99999
GCM_PFN1,SET,44,-0.10273,-0.0050231,0.11849,0.80703,GCM_PFN1,0.99999
DHIMAN_PBMC_ATTENUVAX_AGE_15...2,SET,44,-0.10776,-0.0052691,0.12429,0.80703,DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_OR...2,SET,1775,-0.018861,-0.0055736,0.021752,0.80704,GOBP_CELLULAR_RESPONSE_TO_ORGANIC_SUBSTANCE,0.99999
GOBP_CARDIAC_VENTRICLE_DEVEL...,SET,121,-0.072108,-0.0058343,0.083157,0.80706,GOBP_CARDIAC_VENTRICLE_DEVELOPMENT,0.99999
HP_ABNORMALITY_OF_DNA_REPAIR,SET,14,-0.1536,-0.0042398,0.17711,0.8071,HP_ABNORMALITY_OF_DNA_REPAIR,0.99999
CUI_DEVELOPING_HEART_C4_ENDO...,SET,135,-0.068502,-0.0058522,0.078961,0.80717,CUI_DEVELOPING_HEART_C4_ENDOTHELIAL_CELL,0.99999
GOBP_PYRIMIDINE_DEOXYRIBONUC...4,SET,6,-0.29104,-0.0052604,0.33547,0.80718,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
GSE1460_NAIVE_CD4_TCELL_ADUL...2,SET,170,-0.052297,-0.0050088,0.060274,0.8072,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP,0.99999
HP_ABNORMAL_PANCREAS_SIZE,SET,33,-0.13115,-0.0055552,0.15114,0.80724,HP_ABNORMAL_PANCREAS_SIZE,0.99999
HP_ABNORMAL_SEPTUM_PELLUCIDU...,SET,92,-0.073631,-0.005199,0.08485,0.80724,HP_ABNORMAL_SEPTUM_PELLUCIDUM_MORPHOLOGY,0.99999
GSE36392_TYPE_2_MYELOID_VS_M...1,SET,181,-0.050498,-0.004989,0.058188,0.80725,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN,0.99999
MIR4307,SET,389,-0.038389,-0.0055282,0.044227,0.8073,MIR4307,0.99999
GOCC_CHITOSOME,SET,20,-0.17513,-0.005777,0.20175,0.80731,GOCC_CHITOSOME,0.99999
chr6q13,SET,19,-0.25407,-0.0081689,0.29264,0.80735,chr6q13,0.99999
NKX3A_01,SET,205,-0.05467,-0.0057443,0.062971,0.80735,NKX3A_01,0.99999
REACTOME_MRNA_DECAY_BY_5_TO_...,SET,15,-0.18029,-0.0051509,0.20764,0.80738,REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE,0.99999
GOBP_CELLULAR_PIGMENTATION,SET,59,-0.097109,-0.0054959,0.11181,0.80743,GOBP_CELLULAR_PIGMENTATION,0.99999
GOBP_RESPONSE_TO_WOUNDING,SET,529,-0.033446,-0.0055947,0.038508,0.80744,GOBP_RESPONSE_TO_WOUNDING,0.99999
GENTILE_UV_RESPONSE_CLUSTER_...4,SET,35,-0.11824,-0.0051576,0.13608,0.80754,GENTILE_UV_RESPONSE_CLUSTER_D5,0.99999
TGAYRTCA_ATF3_Q6,SET,496,-0.034051,-0.0055205,0.03919,0.80754,TGAYRTCA_ATF3_Q6,0.99999
GOMF_PROTEIN_GLUTAMINE_GAMMA...,SET,9,-0.25597,-0.0056658,0.29458,0.80756,GOMF_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...553,SET,19,-0.15459,-0.0049704,0.17787,0.8076,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT,0.99999
chr11q22,SET,51,-0.19185,-0.010097,0.22074,0.80761,chr11q22,0.99999
REACTOME_SYNTHESIS_OF_VERY_L...,SET,23,-0.17125,-0.0060573,0.19703,0.80762,REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS,0.99999
GSE19772_HCMV_INFL_VS_HCMV_I...1,SET,181,-0.053082,-0.0052443,0.061068,0.80763,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,0.99999
MIR30E_3P,SET,348,-0.03874,-0.0052826,0.044554,0.80771,MIR30E_3P,0.99999
SMID_BREAST_CANCER_LUMINAL_A...2,SET,78,-0.087391,-0.0056838,0.1005,0.80772,SMID_BREAST_CANCER_LUMINAL_A_UP,0.99999
DESCARTES_FETAL_HEART_SATB2_...,SET,84,-0.092483,-0.0062411,0.10634,0.80775,DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS,0.99999
NR1I2_TARGET_GENES,SET,270,-0.043163,-0.0051956,0.049622,0.8078,NR1I2_TARGET_GENES,0.99999
GOCC_MANNOSYLTRANSFERASE_COM...,SET,4,-0.28147,-0.0041539,0.32354,0.80783,GOCC_MANNOSYLTRANSFERASE_COMPLEX,0.99999
GOMF_ACIDIC_AMINO_ACID_TRANS...,SET,18,-0.18043,-0.0056467,0.20733,0.80791,GOMF_ACIDIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_HYPERPROSTAGLANDINURIA,SET,6,-0.34752,-0.0062812,0.39923,0.80797,HP_HYPERPROSTAGLANDINURIA,0.99999
ZNF777_TARGET_GENES,SET,53,-0.10231,-0.0054887,0.1175,0.80803,ZNF777_TARGET_GENES,0.99999
GSE360_DC_VS_MAC_L_MAJOR_UP,SET,172,-0.0558,-0.0053753,0.064072,0.80809,GSE360_DC_VS_MAC_L_MAJOR_UP,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...15,SET,173,-0.056912,-0.0054982,0.065341,0.80812,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...774,SET,17,-0.18308,-0.0055682,0.21015,0.80817,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,0.99999
GSE32986_UNSTIM_VS_CURDLAN_H...2,SET,179,-0.052941,-0.0052017,0.060761,0.8082,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,0.99999
GOBP_MITOTIC_NUCLEAR_MEMBRAN...2,SET,10,-0.21275,-0.0049637,0.24415,0.80823,GOBP_MITOTIC_NUCLEAR_MEMBRANE_ORGANIZATION,0.99999
GOBP_THYROID_HORMONE_METABOL...,SET,28,-0.14855,-0.0057966,0.17047,0.80823,GOBP_THYROID_HORMONE_METABOLIC_PROCESS,0.99999
GSE21774_CD62L_POS_CD56_DIM_...1,SET,180,-0.054494,-0.005369,0.062531,0.80825,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,0.99999
SILIGAN_BOUND_BY_EWS_FLT1_FU...,SET,43,-0.11879,-0.0057418,0.13629,0.80828,SILIGAN_BOUND_BY_EWS_FLT1_FUSION,0.99999
HP_PATENT_DUCTUS_ARTERIOSUS_...,SET,5,-0.31761,-0.0052405,0.36437,0.8083,HP_PATENT_DUCTUS_ARTERIOSUS_AFTER_BIRTH_AT_TERM,0.99999
GSE39820_TGFBETA1_VS_TGFBETA...4,SET,184,-0.050915,-0.0050713,0.0584,0.80835,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP,0.99999
MIR28_3P,SET,46,-0.10088,-0.0050429,0.11568,0.8084,MIR28_3P,0.99999
GOBP_SKELETAL_MUSCLE_TISSUE_...1,SET,10,-0.24599,-0.0057392,0.28207,0.80841,GOBP_SKELETAL_MUSCLE_TISSUE_GROWTH,0.99999
MIR1294,SET,150,-0.061582,-0.0055433,0.070602,0.80846,MIR1294,0.99999
PID_INTEGRIN_CS_PATHWAY,SET,25,-0.15685,-0.0057837,0.17979,0.8085,PID_INTEGRIN_CS_PATHWAY,0.99999
GOBP_ELECTRON_TRANSPORT_CHAIN,SET,107,-0.063548,-0.004837,0.072829,0.80854,GOBP_ELECTRON_TRANSPORT_CHAIN,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...8,SET,161,-0.059116,-0.0055113,0.067742,0.80857,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,0.99999
chr5q15,SET,19,-0.26783,-0.0086111,0.30689,0.80859,chr5q15,0.99999
REACTOME_VITAMIN_B1_THIAMIN_...,SET,5,-0.30909,-0.0051,0.35415,0.8086,REACTOME_VITAMIN_B1_THIAMIN_METABOLISM,0.99999
GOBP_ADAPTIVE_THERMOGENESIS,SET,160,-0.059658,-0.0055447,0.068356,0.8086,GOBP_ADAPTIVE_THERMOGENESIS,0.99999
GOBP_THIAMINE_CONTAINING_COM...,SET,5,-0.30909,-0.0051,0.35415,0.8086,GOBP_THIAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GOBP_THIAMINE_DIPHOSPHATE_ME...,SET,5,-0.30909,-0.0051,0.35415,0.8086,GOBP_THIAMINE_DIPHOSPHATE_METABOLIC_PROCESS,0.99999
HP_RENAL_FANCONI_SYNDROME,SET,10,-0.23366,-0.0054515,0.26771,0.80861,HP_RENAL_FANCONI_SYNDROME,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...50,SET,81,-0.080431,-0.0053304,0.092149,0.80862,GOBP_PROTEIN_LOCALIZATION_TO_VACUOLE,0.99999
HP_POIKILOCYTOSIS,SET,49,-0.10512,-0.0054233,0.12043,0.80863,HP_POIKILOCYTOSIS,0.99999
GOBP_CARBOHYDRATE_DERIVATIVE...2,SET,249,-0.047439,-0.0054868,0.054343,0.80865,GOBP_CARBOHYDRATE_DERIVATIVE_CATABOLIC_PROCESS,0.99999
MIR584_3P,SET,96,-0.075232,-0.0054256,0.086161,0.8087,MIR584_3P,0.99999
MIR18A_5P_MIR18B_5P,SET,117,-0.068276,-0.0054328,0.078178,0.80875,MIR18A_5P_MIR18B_5P,0.99999
SEIDEN_MET_SIGNALING,SET,18,-0.14686,-0.0045961,0.16816,0.80876,SEIDEN_MET_SIGNALING,0.99999
BOQUEST_STEM_CELL_DN,SET,205,-0.057135,-0.0060033,0.065403,0.80882,BOQUEST_STEM_CELL_DN,0.99999
GSE36826_NORMAL_VS_STAPH_AUR...1,SET,183,-0.051962,-0.0051616,0.059477,0.80884,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN,0.99999
REACTOME_SENESCENCE_ASSOCIAT...,SET,49,-0.10644,-0.0054914,0.12181,0.80889,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,0.99999
WP_SENESCENCEASSOCIATED_SECR...,SET,49,-0.10644,-0.0054914,0.12181,0.80889,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,0.99999
GSE19825_NAIVE_VS_IL2RAHIGH_...2,SET,182,-0.056988,-0.0056456,0.065212,0.80891,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,0.99999
GOBP_ESTABLISHMENT_OR_MAINTE...5,SET,11,-0.25504,-0.0062406,0.29183,0.80892,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_TRANSMEMBRANE_ELECTROCHEMICAL_GRADIENT,0.99999
HP_THORACIC_PLATYSPONDYLY,SET,6,-0.26818,-0.0048471,0.30684,0.80893,HP_THORACIC_PLATYSPONDYLY,0.99999
KEGG_MEDICUS_REFERENCE_HEDGE...3,SET,9,-0.2605,-0.005766,0.29804,0.80895,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR,0.99999
GOBP_ODONTOGENESIS,SET,122,-0.073879,-0.0060021,0.084515,0.80898,GOBP_ODONTOGENESIS,0.99999
HP_ABNORMAL_ANTERIOR_CHAMBER...,SET,54,-0.10593,-0.0057362,0.12117,0.80899,HP_ABNORMAL_ANTERIOR_CHAMBER_MORPHOLOGY,0.99999
GSE14415_INDUCED_TREG_VS_FAI...1,SET,168,-0.058887,-0.005607,0.067346,0.80904,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN,0.99999
GOBP_NOTOCHORD_DEVELOPMENT,SET,16,-0.19546,-0.0057673,0.2235,0.80907,GOBP_NOTOCHORD_DEVELOPMENT,0.99999
GSE27670_BLIMP1_VS_LMP1_TRAN...1,SET,184,-0.053157,-0.0052946,0.060785,0.80907,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN,0.99999
GOBP_REGULATION_OF_LYASE_ACT...,SET,53,-0.10588,-0.0056804,0.12107,0.80908,GOBP_REGULATION_OF_LYASE_ACTIVITY,0.99999
MELLMAN_TUT1_TARGETS_DN,SET,45,-0.10617,-0.0052497,0.1214,0.80909,MELLMAN_TUT1_TARGETS_DN,0.99999
MIR6736_5P,SET,42,-0.10542,-0.0050361,0.12053,0.80911,MIR6736_5P,0.99999
NIKOLSKY_BREAST_CANCER_12Q13...,SET,42,-0.19584,-0.0093557,0.22389,0.80913,NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON,0.99999
HP_INCREASED_CIRCULATING_AND...,SET,17,-0.17734,-0.0053935,0.20271,0.80916,HP_INCREASED_CIRCULATING_ANDROGEN_CONCENTRATION,0.99999
COMP1_01,SET,103,-0.081849,-0.0061131,0.093543,0.8092,COMP1_01,0.99999
GOBP_DE_NOVO_AMP_BIOSYNTHETI...,SET,6,-0.29508,-0.0053332,0.33725,0.8092,GOBP_DE_NOVO_AMP_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_BRANCHING...5,SET,5,-0.37008,-0.0061062,0.42294,0.80921,GOBP_REGULATION_OF_BRANCHING_MORPHOGENESIS_OF_A_NERVE,0.99999
TRAVAGLINI_LUNG_MUCOUS_CELL,SET,116,-0.075999,-0.0060216,0.086852,0.80922,TRAVAGLINI_LUNG_MUCOUS_CELL,0.99999
CEBPZ_TARGET_GENES,SET,1238,-0.021435,-0.005375,0.024492,0.80925,CEBPZ_TARGET_GENES,0.99999
GSE6875_WT_VS_FOXP3_KO_TREG_...2,SET,177,-0.055174,-0.005391,0.063045,0.80925,GSE6875_WT_VS_FOXP3_KO_TREG_UP,0.99999
GOBP_BEHAVIORAL_RESPONSE_TO_...4,SET,19,-0.17667,-0.0056803,0.20187,0.80926,GOBP_BEHAVIORAL_RESPONSE_TO_PAIN,0.99999
GOMF_EXOPEPTIDASE_ACTIVITY,SET,95,-0.079411,-0.0056973,0.090737,0.80926,GOMF_EXOPEPTIDASE_ACTIVITY,0.99999
HP_HEMORRHAGE_OF_THE_EYE,SET,45,-0.11272,-0.0055734,0.12879,0.80926,HP_HEMORRHAGE_OF_THE_EYE,0.99999
WP_RIOK1_AND_RIOK2_IN_EGFR_A...,SET,15,-0.19877,-0.005679,0.2271,0.80928,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,0.99999
MIR1243,SET,56,-0.095107,-0.0052444,0.10865,0.8093,MIR1243,0.99999
HP_DECREASED_NUMBER_OF_PERIP...,SET,45,-0.11067,-0.0054723,0.12644,0.8093,HP_DECREASED_NUMBER_OF_PERIPHERAL_MYELINATED_NERVE_FIBERS,0.99999
GSE10325_LUPUS_CD4_TCELL_VS_...2,SET,175,-0.058039,-0.0056391,0.066301,0.80931,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP,0.99999
MIR6772_5P,SET,31,-0.12678,-0.0052048,0.14482,0.80932,MIR6772_5P,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...10,SET,179,-0.051906,-0.0051,0.059281,0.80937,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP,0.99999
ZNF510_TARGET_GENES,SET,36,-0.12138,-0.0053692,0.13859,0.80943,ZNF510_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...509,SET,44,-0.10586,-0.0051758,0.12087,0.80943,GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_DETERMINATION_OF_LEFT_R...,SET,10,-0.25441,-0.0059356,0.29047,0.80944,GOBP_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY_IN_LATERAL_MESODERM,0.99999
AHRR_TARGET_GENES,SET,1029,-0.023753,-0.0054634,0.027118,0.80946,AHRR_TARGET_GENES,0.99999
BIOCARTA_SM_PATHWAY,SET,13,-0.18697,-0.0049732,0.21336,0.80956,BIOCARTA_SM_PATHWAY,0.99999
ADCYAP1_TARGET_GENES,SET,7,-0.25326,-0.0049441,0.28902,0.80956,ADCYAP1_TARGET_GENES,0.99999
WP_HOSTPATHOGEN_INTERACTION_...1,SET,21,-0.17048,-0.0057621,0.1945,0.80962,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,0.99999
GOBP_MODIFICATION_OF_SYNAPTI...,SET,26,-0.13957,-0.0052484,0.1592,0.80966,GOBP_MODIFICATION_OF_SYNAPTIC_STRUCTURE,0.99999
HP_GASTROESOPHAGEAL_REFLUX,SET,434,-0.035987,-0.005467,0.041049,0.80966,HP_GASTROESOPHAGEAL_REFLUX,0.99999
WP_METASTATIC_BRAIN_TUMOR,SET,6,-0.33883,-0.006124,0.38649,0.80967,WP_METASTATIC_BRAIN_TUMOR,0.99999
HP_ANTERIORLY_PLACED_ANUS,SET,56,-0.098982,-0.0054581,0.1129,0.80969,HP_ANTERIORLY_PLACED_ANUS,0.99999
MIR4481,SET,121,-0.066988,-0.0054201,0.0764,0.8097,MIR4481,0.99999
GOBP_LATE_ENDOSOME_TO_GOLGI_...,SET,3,-0.49833,-0.0063693,0.56833,0.8097,GOBP_LATE_ENDOSOME_TO_GOLGI_TRANSPORT,0.99999
HP_GASTROINTESTINAL_INFLAMMA...,SET,150,-0.063025,-0.0056732,0.071839,0.80983,HP_GASTROINTESTINAL_INFLAMMATION,0.99999
HP_CENTRAL_ADRENAL_INSUFFICI...,SET,18,-0.16629,-0.0052042,0.18947,0.80993,HP_CENTRAL_ADRENAL_INSUFFICIENCY,0.99999
GOMF_DEOXYRIBONUCLEASE_I_ACT...,SET,4,-0.37885,-0.0055912,0.43163,0.80995,GOMF_DEOXYRIBONUCLEASE_I_ACTIVITY,0.99999
MCCLUNG_CREB1_TARGETS_DN,SET,51,-0.10496,-0.005524,0.11957,0.80997,MCCLUNG_CREB1_TARGETS_DN,0.99999
MODY_HIPPOCAMPUS_NEONATAL,SET,30,-0.14025,-0.0056645,0.15976,0.80999,MODY_HIPPOCAMPUS_NEONATAL,0.99999
REACTOME_TP53_REGULATES_TRAN...6,SET,57,-0.081778,-0.0045493,0.093133,0.81004,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES,0.99999
REACTOME_EARLY_PHASE_OF_HIV_...,SET,14,-0.18837,-0.0051994,0.21451,0.81006,REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE,0.99999
HP_HEPATOCELLULAR_CARCINOMA,SET,75,-0.08575,-0.0054692,0.097649,0.81006,HP_HEPATOCELLULAR_CARCINOMA,0.99999
GOBP_MAINTENANCE_OF_CELL_POL...,SET,15,-0.22107,-0.0063162,0.25172,0.81009,GOBP_MAINTENANCE_OF_CELL_POLARITY,0.99999
REACTOME_PRE_NOTCH_EXPRESSIO...,SET,48,-0.10035,-0.0051243,0.11423,0.81015,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,0.99999
GOBP_PROTEIN_DEACETYLATION,SET,37,-0.1134,-0.0050856,0.12909,0.81015,GOBP_PROTEIN_DEACETYLATION,0.99999
MIR3606_3P,SET,331,-0.04101,-0.0054564,0.046682,0.81016,MIR3606_3P,0.99999
PAX2_02,SET,241,-0.050324,-0.0057275,0.057284,0.81016,PAX2_02,0.99999
HP_ABNORMALITY_OF_THE_INTRIN...,SET,35,-0.11583,-0.0050525,0.13184,0.81018,HP_ABNORMALITY_OF_THE_INTRINSIC_PATHWAY,0.99999
MIR2681_5P,SET,146,-0.062231,-0.0055271,0.070824,0.8102,MIR2681_5P,0.99999
SPIELMAN_LYMPHOBLAST_EUROPEA...4,SET,429,-0.033919,-0.0051238,0.038592,0.81027,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,0.99999
GOBP_CELLULAR_COMPONENT_DISA...2,SET,31,-0.13383,-0.0054945,0.15227,0.81027,GOBP_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,0.99999
GOBP_POST_EMBRYONIC_EYE_MORP...,SET,7,-0.29946,-0.005846,0.34072,0.81027,GOBP_POST_EMBRYONIC_EYE_MORPHOGENESIS,0.99999
HP_ABNORMAL_CIRCULATING_AMIN...,SET,150,-0.059092,-0.0053192,0.067233,0.81027,HP_ABNORMAL_CIRCULATING_AMINO_ACID_CONCENTRATION,0.99999
MIR1301_5P,SET,50,-0.10407,-0.0054233,0.1184,0.81028,MIR1301_5P,0.99999
HP_PERSONALITY_CHANGES,SET,32,-0.12674,-0.0052865,0.14418,0.8103,HP_PERSONALITY_CHANGES,0.99999
HP_ABNORMAL_CONSUMPTION_BEHA...,SET,253,-0.048878,-0.0056979,0.055587,0.81038,HP_ABNORMAL_CONSUMPTION_BEHAVIOR,0.99999
GSE11884_WT_VS_FURIN_KO_NAIV...2,SET,121,-0.069606,-0.0056319,0.079153,0.8104,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_UP,0.99999
CTGYNNCTYTAA_UNKNOWN,SET,81,-0.084206,-0.0055806,0.095735,0.81045,CTGYNNCTYTAA_UNKNOWN,0.99999
ZNF22_TARGET_GENES,SET,820,-0.025485,-0.005264,0.028966,0.81051,ZNF22_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...781,SET,5,-0.3065,-0.0050571,0.34828,0.81057,GOBP_POSITIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,0.99999
HP_SYNOVIAL_LINING_HYPERPLAS...,SET,8,-0.28665,-0.0059821,0.32573,0.81057,HP_SYNOVIAL_LINING_HYPERPLASIA,0.99999
GOBP_DETECTION_OF_MECHANICAL...4,SET,13,-0.2231,-0.0059344,0.2535,0.81059,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SOUND,0.99999
GOBP_REGULATION_OF_GLYCOGEN_...3,SET,31,-0.13341,-0.0054771,0.15156,0.81064,GOBP_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,0.99999
LMNB2_TARGET_GENES,SET,31,-0.1256,-0.0051563,0.14264,0.81069,LMNB2_TARGET_GENES,0.99999
GOBP_IMP_CATABOLIC_PROCESS,SET,5,-0.35164,-0.005802,0.39938,0.81069,GOBP_IMP_CATABOLIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...10,SET,6,-0.25622,-0.0046309,0.29094,0.81074,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX,0.99999
GOBP_SECONDARY_METABOLITE_BI...,SET,24,-0.15852,-0.0057276,0.17999,0.81077,GOBP_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,0.99999
HP_SPERMATOCYTE_MATURATION_A...,SET,3,-0.47179,-0.0060302,0.53565,0.81078,HP_SPERMATOCYTE_MATURATION_ARREST,0.99999
GOBP_REGULATION_OF_HAIR_FOLL...,SET,20,-0.16644,-0.0054901,0.18895,0.81079,GOBP_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_ACTIN_FIL...5,SET,233,-0.048689,-0.0054499,0.055271,0.81081,GOBP_REGULATION_OF_ACTIN_FILAMENT_ORGANIZATION,0.99999
HP_ABNORMAL_CIRCULATING_HAPT...,SET,11,-0.21258,-0.0052017,0.24132,0.81081,HP_ABNORMAL_CIRCULATING_HAPTOGLOBIN_CONCENTRATION,0.99999
GSE411_100MIN_VS_400MIN_IL6_...2,SET,179,-0.05393,-0.0052989,0.061222,0.81081,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP,0.99999
GOBP_INTRACELLULAR_PH_ELEVAT...,SET,7,-0.27692,-0.0054059,0.31434,0.81082,GOBP_INTRACELLULAR_PH_ELEVATION,0.99999
VERHAAK_GLIOBLASTOMA_CLASSIC...,SET,152,-0.062729,-0.0056837,0.071203,0.81083,VERHAAK_GLIOBLASTOMA_CLASSICAL,0.99999
REACTOME_CONVERSION_FROM_APC...,SET,19,-0.15537,-0.0049954,0.17635,0.81084,REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE,0.99999
REACTOME_CELL_EXTRACELLULAR_...,SET,16,-0.20825,-0.0061447,0.23635,0.81086,REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,0.99999
LIANG_HEMATOPOIESIS_STEM_CEL...1,SET,37,-0.12456,-0.0055858,0.14133,0.81092,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...45,SET,219,-0.049354,-0.0053578,0.055996,0.81094,HP_APLASIA_HYPOPLASIA_OF_THE_NAILS,0.99999
HP_PALMAR_HYPERHIDROSIS,SET,15,-0.20662,-0.0059031,0.23441,0.81095,HP_PALMAR_HYPERHIDROSIS,0.99999
GOMF_LEUKOTRIENE_C4_SYNTHASE...,SET,5,-0.37083,-0.0061186,0.42066,0.81098,GOMF_LEUKOTRIENE_C4_SYNTHASE_ACTIVITY,0.99999
GOCC_U2_SNRNP,SET,22,-0.14191,-0.0049092,0.16093,0.81105,GOCC_U2_SNRNP,0.99999
HP_BONE_PAIN,SET,82,-0.086026,-0.0057361,0.09755,0.81107,HP_BONE_PAIN,0.99999
HP_HYPERSPLENISM,SET,20,-0.17287,-0.0057024,0.19601,0.8111,HP_HYPERSPLENISM,0.99999
KEGG_MEDICUS_PATHOGEN_SALMON...5,SET,9,-0.25949,-0.0057437,0.2941,0.81119,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOA_SIGNALING_PATHWAY,0.99999
GOMF_JUN_KINASE_BINDING,SET,11,-0.22771,-0.0055718,0.25807,0.8112,GOMF_JUN_KINASE_BINDING,0.99999
HP_INFANTILE_ENCEPHALOPATHY,SET,8,-0.26114,-0.0054498,0.29594,0.81122,HP_INFANTILE_ENCEPHALOPATHY,0.99999
DESCARTES_MAIN_FETAL_BIPOLAR...,SET,48,-0.11945,-0.0060993,0.13536,0.81122,DESCARTES_MAIN_FETAL_BIPOLAR_CELLS,0.99999
MUELLER_COMMON_TARGETS_OF_AM...1,SET,28,-0.14497,-0.005657,0.16428,0.81123,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...37,SET,25,-0.15056,-0.0055517,0.17053,0.81135,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS,0.99999
BLALOCK_ALZHEIMERS_DISEASE_I...1,SET,149,-0.058057,-0.0052087,0.065753,0.81136,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...2,SET,43,-0.10547,-0.005098,0.11945,0.81137,BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP,0.99999
GSE22886_NAIVE_TCELL_VS_MONO...1,SET,189,-0.0571,-0.0057633,0.064654,0.81142,GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN,0.99999
GOBP_PHOSPHOLIPID_HOMEOSTASIS,SET,17,-0.18376,-0.0055889,0.208,0.8115,GOBP_PHOSPHOLIPID_HOMEOSTASIS,0.99999
GOBP_PROTEIN_MODIFICATION_BY...1,SET,745,-0.026862,-0.0053,0.030404,0.81152,GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION,0.99999
GSE2826_XID_VS_BTK_KO_BCELL_...2,SET,186,-0.055322,-0.0055398,0.062612,0.81153,GSE2826_XID_VS_BTK_KO_BCELL_UP,0.99999
GOBP_GLOMERULUS_MORPHOGENESIS,SET,9,-0.28503,-0.0063089,0.32257,0.81154,GOBP_GLOMERULUS_MORPHOGENESIS,0.99999
GOBP_REGULATION_OF_CARDIAC_M...11,SET,5,-0.4139,-0.0068292,0.46836,0.81157,GOBP_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.99999
GOBP_ISOLEUCINE_METABOLIC_PR...,SET,6,-0.31261,-0.0056501,0.35372,0.81158,GOBP_ISOLEUCINE_METABOLIC_PROCESS,0.99999
GOBP_FATTY_ACYL_COA_METABOLI...,SET,37,-0.1288,-0.0057761,0.14573,0.8116,GOBP_FATTY_ACYL_COA_METABOLIC_PROCESS,0.99999
HP_POOR_GROSS_MOTOR_COORDINA...,SET,12,-0.22936,-0.0058618,0.25948,0.81163,HP_POOR_GROSS_MOTOR_COORDINATION,0.99999
HP_INCREASED_CIRCULATING_HEM...,SET,12,-0.21865,-0.0055878,0.2473,0.81168,HP_INCREASED_CIRCULATING_HEMOGLOBIN_CONCENTRATION,0.99999
GOBP_NEPHRIC_DUCT_MORPHOGENE...,SET,10,-0.27641,-0.0064489,0.31262,0.81169,GOBP_NEPHRIC_DUCT_MORPHOGENESIS,0.99999
GOCC_U2AF_COMPLEX,SET,3,-0.39741,-0.0050794,0.44947,0.81169,GOCC_U2AF_COMPLEX,0.99999
GOBP_MEMBRANE_FISSION,SET,44,-0.1037,-0.0050704,0.11727,0.81173,GOBP_MEMBRANE_FISSION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...167,SET,13,-0.22311,-0.0059346,0.25228,0.81174,GOBP_NEGATIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.99999
HP_PROXIMAL_HYPERREFLEXIA,SET,36,-0.11837,-0.005236,0.13385,0.81174,HP_PROXIMAL_HYPERREFLEXIA,0.99999
HP_ENTEROCOLITIS,SET,19,-0.16077,-0.0051689,0.18177,0.81177,HP_ENTEROCOLITIS,0.99999
REACTOME_NEPHRON_DEVELOPMENT,SET,12,-0.24065,-0.0061502,0.27207,0.81179,REACTOME_NEPHRON_DEVELOPMENT,0.99999
GCM_BNIP1,SET,67,-0.085231,-0.0051391,0.096352,0.8118,GCM_BNIP1,0.99999
HP_HYPOTHERMIA,SET,40,-0.1132,-0.0052779,0.12796,0.81182,HP_HYPOTHERMIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...150,SET,5,-0.33788,-0.0055749,0.38191,0.81184,GOBP_POSITIVE_REGULATION_OF_CGMP_MEDIATED_SIGNALING,0.99999
GOBP_REGULATION_OF_CORTICOTR...,SET,4,-0.39483,-0.005827,0.44626,0.81185,GOBP_REGULATION_OF_CORTICOTROPIN_SECRETION,0.99999
WP_LEUKOCYTEINTRINSIC_HIPPO_...,SET,30,-0.13981,-0.0056469,0.15802,0.81186,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,0.99999
REACTOME_CDC42_GTPASE_CYCLE,SET,142,-0.063509,-0.0055635,0.071774,0.81188,REACTOME_CDC42_GTPASE_CYCLE,0.99999
WP_MITOCHONDRIAL_GENE_EXPRES...,SET,18,-0.18957,-0.0059325,0.21422,0.8119,WP_MITOCHONDRIAL_GENE_EXPRESSION,0.99999
HP_ABNORMALITY_OF_SKIN_PIGME...,SET,434,-0.035401,-0.005378,0.040002,0.81191,HP_ABNORMALITY_OF_SKIN_PIGMENTATION,0.99999
GOMF_PHOSPHATASE_INHIBITOR_A...,SET,40,-0.11368,-0.0053002,0.12844,0.81193,GOMF_PHOSPHATASE_INHIBITOR_ACTIVITY,0.99999
GOMF_CILIARY_NEUROTROPHIC_FA...,SET,6,-0.29079,-0.0052558,0.32855,0.81194,GOMF_CILIARY_NEUROTROPHIC_FACTOR_RECEPTOR_BINDING,0.99999
GOBP_RESPONSE_TO_COBALT_ION,SET,9,-0.23892,-0.0052883,0.26992,0.81195,GOBP_RESPONSE_TO_COBALT_ION,0.99999
GSE40443_INDUCED_VS_TOTAL_TR...2,SET,180,-0.0557,-0.0054879,0.062929,0.81195,GSE40443_INDUCED_VS_TOTAL_TREG_UP,0.99999
REACTOME_CS_DS_DEGRADATION,SET,12,-0.19803,-0.0050609,0.22372,0.81196,REACTOME_CS_DS_DEGRADATION,0.99999
GOCC_PEPTIDASE_COMPLEX,SET,115,-0.063398,-0.0050016,0.07162,0.81197,GOCC_PEPTIDASE_COMPLEX,0.99999
MIR3657,SET,49,-0.10897,-0.0056221,0.12308,0.81202,MIR3657,0.99999
GOMF_MANGANESE_ION_BINDING,SET,61,-0.097998,-0.0056391,0.11068,0.81202,GOMF_MANGANESE_ION_BINDING,0.99999
GOCC_BETA_CATENIN_TCF_COMPLEX,SET,13,-0.21701,-0.0057724,0.24501,0.81212,GOCC_BETA_CATENIN_TCF_COMPLEX,0.99999
REACTOME_REGULATION_OF_GENE_...5,SET,15,-0.1873,-0.0053512,0.21144,0.81214,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS,0.99999
DESCARTES_FETAL_CEREBRUM_AST...,SET,141,-0.066276,-0.0057856,0.074811,0.81216,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,0.99999
GOCC_GOLGI_TRANSPORT_COMPLEX,SET,10,-0.23592,-0.0055041,0.26629,0.81217,GOCC_GOLGI_TRANSPORT_COMPLEX,0.99999
GOBP_REGULATION_OF_ENDOPLASM...2,SET,5,-0.31544,-0.0052047,0.3559,0.81227,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION,0.99999
MIR3152_3P,SET,76,-0.088729,-0.0056967,0.1001,0.81231,MIR3152_3P,0.99999
HP_ANTI_THYROGLOBULIN_ANTIBO...,SET,6,-0.33337,-0.0060254,0.376,0.81235,HP_ANTI_THYROGLOBULIN_ANTIBODY_POSITIVITY,0.99999
GOBP_REGULATION_OF_INTRACELL...4,SET,1634,-0.019601,-0.005581,0.022107,0.81236,GOBP_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,0.99999
KEGG_GLYCOLYSIS_GLUCONEOGENE...,SET,54,-0.10176,-0.0055103,0.11472,0.81246,KEGG_GLYCOLYSIS_GLUCONEOGENESIS,0.99999
KYNG_DNA_DAMAGE_BY_GAMMA_RAD...,SET,69,-0.091741,-0.0056134,0.1034,0.81252,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...544,SET,57,-0.094179,-0.0052392,0.10614,0.81253,GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.99999
HP_2_4_FINGER_SYNDACTYLY,SET,4,-0.34622,-0.0051096,0.39021,0.81253,HP_2_4_FINGER_SYNDACTYLY,0.99999
REACTOME_REGULATION_OF_NPAS4...1,SET,13,-0.21419,-0.0056973,0.24138,0.81255,REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION,0.99999
HP_CENTRAL_DIABETES_INSIPIDUS,SET,20,-0.17269,-0.0056963,0.19459,0.81258,HP_CENTRAL_DIABETES_INSIPIDUS,0.99999
GOBP_MUSCLE_CELL_DIFFERENTIA...,SET,376,-0.03954,-0.0056,0.044549,0.8126,GOBP_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOBP_AMACRINE_CELL_DIFFERENT...,SET,12,-0.24867,-0.0063552,0.2801,0.81267,GOBP_AMACRINE_CELL_DIFFERENTIATION,0.99999
GOMF_ARGININE_BINDING,SET,6,-0.33646,-0.0060811,0.37887,0.81274,GOMF_ARGININE_BINDING,0.99999
GSE360_L_MAJOR_VS_M_TUBERCUL...3,SET,166,-0.057599,-0.0054519,0.064858,0.81274,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN,0.99999
MIR3065_5P,SET,414,-0.036772,-0.005459,0.041401,0.81277,MIR3065_5P,0.99999
GOBP_GRANULOCYTE_COLONY_STIM...2,SET,5,-0.30172,-0.0049783,0.33969,0.81278,GOBP_GRANULOCYTE_COLONY_STIMULATING_FACTOR_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_NUCLEOTID...4,SET,49,-0.10231,-0.0052783,0.11517,0.81283,GOBP_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,0.99999
GOMF_CAMP_BINDING,SET,23,-0.15819,-0.0055952,0.17806,0.81283,GOMF_CAMP_BINDING,0.99999
HP_CHORIORETINAL_COLOBOMA,SET,40,-0.12254,-0.0057133,0.1379,0.81289,HP_CHORIORETINAL_COLOBOMA,0.99999
GOBP_NUCLEAR_TRANSCRIBED_MRN...2,SET,57,-0.096026,-0.005342,0.10806,0.8129,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,0.99999
HP_FOCAL_SENSORY_SEIZURE_WIT...,SET,6,-0.26455,-0.0047816,0.2977,0.8129,HP_FOCAL_SENSORY_SEIZURE_WITH_VISUAL_FEATURES,0.99999
GOCC_POSTSYNAPTIC_CYTOSOL,SET,13,-0.20811,-0.0055356,0.23418,0.81291,GOCC_POSTSYNAPTIC_CYTOSOL,0.99999
SOUCEK_MYC_TARGETS,SET,10,-0.2525,-0.0058911,0.28409,0.81294,SOUCEK_MYC_TARGETS,0.99999
RNCTGNYNRNCTGNY_UNKNOWN,SET,65,-0.09431,-0.0056014,0.10611,0.81294,RNCTGNYNRNCTGNY_UNKNOWN,0.99999
TERAMOTO_OPN_TARGETS_CLUSTER...2,SET,7,-0.22788,-0.0044486,0.25635,0.81298,TERAMOTO_OPN_TARGETS_CLUSTER_3,0.99999
MIR4701_3P,SET,46,-0.10373,-0.0051857,0.11668,0.813,MIR4701_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...124,SET,103,-0.072667,-0.0054273,0.081737,0.813,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,0.99999
GOBP_POSITIVE_REGULATION_OF_...715,SET,30,-0.14613,-0.0059021,0.16434,0.81305,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,0.99999
KRAS.LUNG.BREAST_UP.V1_UP,SET,126,-0.072515,-0.0059865,0.081534,0.8131,KRAS.LUNG.BREAST_UP.V1_UP,0.99999
MIR6851_3P,SET,53,-0.1013,-0.0054347,0.11389,0.81311,MIR6851_3P,0.99999
GSE15139_GMCSF_TREATED_VS_UN...1,SET,186,-0.053221,-0.0053295,0.059838,0.81311,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN,0.99999
GOBP_MONOATOMIC_ANION_TRANSP...,SET,159,-0.063015,-0.0058386,0.070846,0.81312,GOBP_MONOATOMIC_ANION_TRANSPORT,0.99999
GOBP_SEX_CHROMOSOME_DOSAGE_C...,SET,13,-0.20629,-0.0054871,0.23186,0.81319,GOBP_SEX_CHROMOSOME_DOSAGE_COMPENSATION,0.99999
GOMF_C4_DICARBOXYLATE_TRANSM...,SET,15,-0.19162,-0.0054747,0.21531,0.81326,GOMF_C4_DICARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_BY_...1,SET,10,-0.24698,-0.0057624,0.2775,0.81327,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,0.99999
GOBP_RESPONSE_TO_BMP,SET,147,-0.065003,-0.0057929,0.073034,0.81327,GOBP_RESPONSE_TO_BMP,0.99999
GOBP_RESPONSE_TO_IRON_ION,SET,27,-0.15179,-0.0058165,0.17052,0.8133,GOBP_RESPONSE_TO_IRON_ION,0.99999
GOBP_PRIMARY_ALCOHOL_METABOL...,SET,95,-0.082124,-0.0058919,0.092229,0.81338,GOBP_PRIMARY_ALCOHOL_METABOLIC_PROCESS,0.99999
PID_PI3KCI_PATHWAY,SET,47,-0.10923,-0.0055191,0.12262,0.81347,PID_PI3KCI_PATHWAY,0.99999
GOBP_REGULATION_OF_CYCLASE_A...,SET,51,-0.11329,-0.0059625,0.12718,0.81347,GOBP_REGULATION_OF_CYCLASE_ACTIVITY,0.99999
HP_PILOMATRIXOMA,SET,7,-0.29989,-0.0058543,0.33658,0.81353,HP_PILOMATRIXOMA,0.99999
MIR558,SET,106,-0.072757,-0.0055122,0.081609,0.81367,MIR558,0.99999
HP_ABNORMAL_VISUAL_FIXATION,SET,24,-0.15381,-0.0055573,0.17249,0.81372,HP_ABNORMAL_VISUAL_FIXATION,0.99999
HP_HEMIHYPERTROPHY,SET,14,-0.19032,-0.0052532,0.21343,0.81372,HP_HEMIHYPERTROPHY,0.99999
GSE40666_WT_VS_STAT1_KO_CD8_...2,SET,181,-0.057105,-0.0056417,0.064037,0.81373,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP,0.99999
MIR1247_5P,SET,4,-0.39285,-0.0057978,0.44047,0.81377,MIR1247_5P,0.99999
GOBP_MORPHOGENESIS_OF_AN_END...,SET,16,-0.19802,-0.005843,0.222,0.8138,GOBP_MORPHOGENESIS_OF_AN_ENDOTHELIUM,0.99999
GOBP_DIGESTIVE_SYSTEM_DEVELO...,SET,140,-0.067453,-0.0058676,0.075613,0.81382,GOBP_DIGESTIVE_SYSTEM_DEVELOPMENT,0.99999
GOBP_AMP_BIOSYNTHETIC_PROCESS,SET,10,-0.23119,-0.005394,0.2591,0.81388,GOBP_AMP_BIOSYNTHETIC_PROCESS,0.99999
MORF_PTPRR,SET,83,-0.085698,-0.0057488,0.096013,0.81395,MORF_PTPRR,0.99999
GOMF_AZOLE_TRANSMEMBRANE_TRA...,SET,12,-0.22682,-0.0057966,0.25408,0.81398,GOMF_AZOLE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
QI_PBMC_ZOSTAVAX_AGE_50_75YO...5,SET,107,-0.068158,-0.0051879,0.076339,0.81402,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_NEGATIVE,0.99999
LI_PROSTATE_CANCER_EPIGENETIC,SET,30,-0.13749,-0.0055529,0.15396,0.81406,LI_PROSTATE_CANCER_EPIGENETIC,0.99999
HP_TYPE_2_MUSCLE_FIBER_ATROP...,SET,16,-0.17591,-0.0051907,0.19698,0.81408,HP_TYPE_2_MUSCLE_FIBER_ATROPHY,0.99999
GOCC_SPLICEOSOMAL_TRI_SNRNP_...,SET,36,-0.10437,-0.0046169,0.11686,0.8141,GOCC_SPLICEOSOMAL_TRI_SNRNP_COMPLEX,0.99999
WP_OXIDATIVE_PHOSPHORYLATION,SET,35,-0.10775,-0.0047,0.12063,0.81413,WP_OXIDATIVE_PHOSPHORYLATION,0.99999
BUSSLINGER_DUODENAL_LATE_IMM...,SET,164,-0.060029,-0.0056479,0.067195,0.81416,BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...37,SET,4,-0.33476,-0.0049405,0.37464,0.81421,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION,0.99999
MIR4666A_3P,SET,502,-0.035082,-0.005721,0.039261,0.81422,MIR4666A_3P,0.99999
PID_CDC42_REG_PATHWAY,SET,25,-0.15016,-0.0055369,0.16802,0.81425,PID_CDC42_REG_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...638,SET,58,-0.09778,-0.0054869,0.10939,0.81429,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,0.99999
GSE1112_HY_CD8AB_VS_HY_CD8AA...1,SET,163,-0.060659,-0.0056899,0.067862,0.81429,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,0.99999
MARTINEZ_RESPONSE_TO_TRABECT...1,SET,45,-0.11339,-0.0056068,0.12682,0.81437,MARTINEZ_RESPONSE_TO_TRABECTEDIN,0.99999
MIR589_3P,SET,229,-0.050768,-0.0056342,0.056778,0.81437,MIR589_3P,0.99999
GSE41867_DAY6_EFFECTOR_VS_DA...3,SET,185,-0.053342,-0.0053273,0.059652,0.81439,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,0.99999
DR1_Q3,SET,229,-0.048845,-0.0054208,0.054606,0.81447,DR1_Q3,0.99999
REACTOME_CTLA4_INHIBITORY_SI...,SET,21,-0.16057,-0.0054272,0.17949,0.81448,REACTOME_CTLA4_INHIBITORY_SIGNALING,0.99999
GOBP_CELL_MOTILITY_INVOLVED_...,SET,5,-0.33093,-0.0054603,0.36994,0.81448,GOBP_CELL_MOTILITY_INVOLVED_IN_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION,0.99999
GOBP_VESICLE_MEDIATED_TRANSP...4,SET,138,-0.063611,-0.0054939,0.071109,0.81448,GOBP_VESICLE_MEDIATED_TRANSPORT_TO_THE_PLASMA_MEMBRANE,0.99999
REACTOME_RHO_GTPASE_CYCLE,SET,412,-0.036872,-0.0054609,0.041217,0.81449,REACTOME_RHO_GTPASE_CYCLE,0.99999
WP_OSX_AND_MIRNAS_IN_TOOTH_D...,SET,15,-0.21045,-0.0060128,0.23525,0.81449,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,0.99999
IGLESIAS_E2F_TARGETS_DN,SET,11,-0.23562,-0.0057654,0.26336,0.81451,IGLESIAS_E2F_TARGETS_DN,0.99999
GOCC_CYCLIN_CDK_POSITIVE_TRA...,SET,8,-0.20041,-0.0041823,0.22397,0.81454,GOCC_CYCLIN_CDK_POSITIVE_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,0.99999
GSE19941_UNSTIM_VS_LPS_AND_I...1,SET,184,-0.054378,-0.0054162,0.06077,0.81455,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.99999
WP_METHIONINE_DE_NOVO_AND_SA...,SET,21,-0.1774,-0.0059961,0.19816,0.81467,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,0.99999
HP_INCREASED_CONNECTIVE_TISS...,SET,24,-0.1487,-0.0053725,0.16608,0.81469,HP_INCREASED_CONNECTIVE_TISSUE,0.99999
HP_HYPOLIPOPROTEINEMIA,SET,57,-0.10176,-0.0056608,0.11363,0.81473,HP_HYPOLIPOPROTEINEMIA,0.99999
GOBP_REGULATION_OF_MODIFICAT...3,SET,12,-0.20168,-0.0051543,0.22518,0.81477,GOBP_REGULATION_OF_MODIFICATION_OF_SYNAPTIC_STRUCTURE,0.99999
IBRAHIM_NRF1_DOWN,SET,127,-0.068323,-0.0056626,0.076274,0.81481,IBRAHIM_NRF1_DOWN,0.99999
GOBP_TRNA_THREONYLCARBAMOYLA...2,SET,4,-0.29059,-0.0042886,0.32435,0.81485,GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_MODIFICATION,0.99999
GOCC_PSEUDOPODIUM,SET,16,-0.17767,-0.0052423,0.19829,0.81487,GOCC_PSEUDOPODIUM,0.99999
REACTOME_G_PROTEIN_ACTIVATION,SET,24,-0.16408,-0.0059282,0.1831,0.8149,REACTOME_G_PROTEIN_ACTIVATION,0.99999
GOBP_REGULATION_OF_PROTEIN_S...4,SET,20,-0.14816,-0.0048871,0.16528,0.81498,GOBP_REGULATION_OF_PROTEIN_SUMOYLATION,0.99999
GOBP_DEFINITIVE_HEMOPOIESIS,SET,18,-0.20461,-0.0064033,0.22824,0.81499,GOBP_DEFINITIVE_HEMOPOIESIS,0.99999
GOCC_VESICLE_COAT,SET,59,-0.093209,-0.0052752,0.10393,0.81509,GOCC_VESICLE_COAT,0.99999
GSE9960_GRAM_NEG_VS_GRAM_POS...1,SET,179,-0.054315,-0.0053366,0.060551,0.81514,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN,0.99999
MIR6869_5P,SET,37,-0.11829,-0.0053049,0.13187,0.81516,MIR6869_5P,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...91,SET,38,-0.10839,-0.0049259,0.12081,0.81519,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
GOBP_ORGANIC_ACID_METABOLIC_...,SET,855,-0.026897,-0.0056674,0.029975,0.81522,GOBP_ORGANIC_ACID_METABOLIC_PROCESS,0.99999
GSE1112_OT1_CD8AB_VS_HY_CD8A...1,SET,153,-0.059024,-0.0053655,0.065749,0.81532,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,0.99999
MIR3614_5P,SET,64,-0.096047,-0.0056607,0.10699,0.81533,MIR3614_5P,0.99999
GSE17721_LPS_VS_PAM3CSK4_8H_...2,SET,182,-0.055891,-0.0055369,0.062253,0.81535,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_UP,0.99999
chr8p12,SET,22,-0.29894,-0.010342,0.33292,0.81538,chr8p12,0.99999
GOBP_PIGMENTATION,SET,104,-0.076832,-0.005766,0.085533,0.81547,GOBP_PIGMENTATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_TM4...1,SET,51,-0.11234,-0.0059127,0.125,0.8156,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,0.99999
GOBP_OVULATION_FROM_OVARIAN_...,SET,9,-0.26692,-0.0059081,0.2969,0.81568,GOBP_OVULATION_FROM_OVARIAN_FOLLICLE,0.99999
PID_A6B1_A6B4_INTEGRIN_PATHW...,SET,46,-0.11338,-0.0056681,0.12611,0.8157,PID_A6B1_A6B4_INTEGRIN_PATHWAY,0.99999
GSE21927_SPLENIC_VS_TUMOR_MO...2,SET,163,-0.058608,-0.0054976,0.065179,0.81572,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...153,SET,9,-0.28296,-0.0062631,0.3146,0.81578,GOBP_NEGATIVE_REGULATION_OF_COLLATERAL_SPROUTING,0.99999
TFIIA_Q6,SET,231,-0.051512,-0.0057414,0.057267,0.8158,TFIIA_Q6,0.99999
DESCARTES_FETAL_HEART_CLC_IL...,SET,17,-0.19201,-0.0058397,0.21346,0.81581,DESCARTES_FETAL_HEART_CLC_IL5RA_POSITIVE_CELLS,0.99999
HP_MOLLUSCOID_PSEUDOTUMORS,SET,6,-0.34758,-0.0062822,0.38633,0.81585,HP_MOLLUSCOID_PSEUDOTUMORS,0.99999
HP_CEREBRAL_HYPOPLASIA,SET,53,-0.09947,-0.0053365,0.11055,0.81588,HP_CEREBRAL_HYPOPLASIA,0.99999
GOMF_GDP_DISSOCIATION_INHIBI...,SET,15,-0.18511,-0.0052886,0.2057,0.81591,GOMF_GDP_DISSOCIATION_INHIBITOR_ACTIVITY,0.99999
GOBP_CARDIAC_MUSCLE_CELL_DIF...,SET,112,-0.074172,-0.0057753,0.082419,0.81592,GOBP_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.99999
MIR519A_2_5P_MIR520B_5P,SET,190,-0.054087,-0.0054735,0.06009,0.81596,MIR519A_2_5P_MIR520B_5P,0.99999
GSE3982_DC_VS_BCELL_DN,SET,163,-0.058079,-0.0054479,0.064524,0.81596,GSE3982_DC_VS_BCELL_DN,0.99999
ADA2_TARGET_GENES,SET,753,-0.028139,-0.0055804,0.03126,0.81597,ADA2_TARGET_GENES,0.99999
GOBP_REGULATION_OF_RESPONSE_...3,SET,4,-0.35064,-0.0051749,0.38954,0.81597,GOBP_REGULATION_OF_RESPONSE_TO_DRUG,0.99999
GOBP_INHIBITORY_POSTSYNAPTIC...,SET,13,-0.22655,-0.0060262,0.25166,0.81599,GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL,0.99999
GSE5503_LIVER_DC_VS_MLN_DC_A...1,SET,176,-0.054634,-0.0053233,0.060672,0.81606,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.99999
WP_1Q211_COPY_NUMBER_VARIATI...,SET,23,-0.17784,-0.0062902,0.19745,0.8161,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...7,SET,140,-0.063464,-0.0055205,0.070465,0.8161,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...9,SET,48,-0.11888,-0.0060703,0.13198,0.81612,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_8,0.99999
MIR7855_5P,SET,70,-0.093857,-0.0057842,0.1042,0.81614,MIR7855_5P,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_CD8...,SET,46,-0.1177,-0.0058839,0.13062,0.81621,HE_LIM_SUN_FETAL_LUNG_C4_CD8_T_CELL,0.99999
WANG_RECURRENT_LIVER_CANCER_...1,SET,16,-0.20448,-0.0060335,0.22691,0.81624,WANG_RECURRENT_LIVER_CANCER_DN,0.99999
CAGCCTC_MIR4855P,SET,135,-0.063513,-0.005426,0.07048,0.81624,CAGCCTC_MIR4855P,0.99999
GSE23568_ID3_KO_VS_WT_CD8_TC...2,SET,173,-0.056369,-0.0054458,0.062534,0.81631,GSE23568_ID3_KO_VS_WT_CD8_TCELL_UP,0.99999
GSE15930_STIM_VS_STIM_AND_IL...4,SET,186,-0.053561,-0.0053635,0.059413,0.81633,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_UP,0.99999
REACTOME_SIGNALING_BY_NOTCH1...2,SET,52,-0.10162,-0.0054005,0.11271,0.81637,REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER,0.99999
HP_APLASIA_OF_THE_OVARY,SET,4,-0.30235,-0.0044621,0.33532,0.81638,HP_APLASIA_OF_THE_OVARY,0.99999
HP_TELANGIECTASIA,SET,136,-0.060366,-0.0051761,0.066943,0.8164,HP_TELANGIECTASIA,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...25,SET,7,-0.30241,-0.0059036,0.33533,0.81642,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_PTERIDINE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.99999
GSE14000_UNSTIM_VS_16H_LPS_D...2,SET,176,-0.059562,-0.0058034,0.066043,0.81643,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN,0.99999
WP_MAPK_CASCADE,SET,31,-0.13015,-0.0053431,0.14429,0.81646,WP_MAPK_CASCADE,0.99999
REACTOME_TELOMERE_C_STRAND_S...,SET,11,-0.19913,-0.0048724,0.22073,0.8165,REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION,0.99999
GOBP_MITOCHONDRIAL_ELECTRON_...2,SET,42,-0.099136,-0.004736,0.10989,0.8165,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE,0.99999
GOMF_ACID_AMINO_ACID_LIGASE_...,SET,22,-0.16524,-0.0057162,0.18314,0.81652,GOMF_ACID_AMINO_ACID_LIGASE_ACTIVITY,0.99999
GSE33425_CD161_INT_VS_NEG_CD...2,SET,187,-0.055942,-0.0056168,0.062003,0.81653,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP,0.99999
GOMF_TRANSFERASE_ACTIVITY_TR...1,SET,54,-0.10762,-0.0058277,0.11927,0.81655,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...10,SET,48,-0.11953,-0.0061035,0.13246,0.81658,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_9,0.99999
HP_APHASIA,SET,70,-0.09459,-0.0058293,0.1048,0.81661,HP_APHASIA,0.99999
HP_ABNORMALITY_OF_THE_PLANTA...,SET,159,-0.061963,-0.0057411,0.068634,0.81668,HP_ABNORMALITY_OF_THE_PLANTAR_SKIN_OF_FOOT,0.99999
HP_ABNORMAL_CIRCULATING_AROM...,SET,18,-0.19353,-0.0060564,0.21435,0.81669,HP_ABNORMAL_CIRCULATING_AROMATIC_AMINO_ACID_CONCENTRATION,0.99999
MIR4803,SET,411,-0.038909,-0.0057558,0.043093,0.81671,MIR4803,0.99999
GOMF_GUANYL_NUCLEOTIDE_EXCHA...,SET,215,-0.051318,-0.0055206,0.05683,0.81674,GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,0.99999
GOBP_VASODILATION,SET,44,-0.12862,-0.0062886,0.14241,0.81677,GOBP_VASODILATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...219,SET,117,-0.069815,-0.0055553,0.077297,0.81679,GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,0.99999
MIR5197_5P,SET,164,-0.059947,-0.0056402,0.06636,0.81683,MIR5197_5P,0.99999
GGAMTNNNNNTCCY_UNKNOWN,SET,107,-0.070868,-0.0053942,0.078444,0.81684,GGAMTNNNNNTCCY_UNKNOWN,0.99999
HP_ABNORMAL_CHOROID_PLEXUS_M...,SET,18,-0.18596,-0.0058196,0.20583,0.81686,HP_ABNORMAL_CHOROID_PLEXUS_MORPHOLOGY,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...6,SET,5,-0.35247,-0.0058157,0.39012,0.81687,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2,0.99999
GSE27786_LIN_NEG_VS_NKCELL_DN,SET,180,-0.054267,-0.0053467,0.060051,0.81691,GSE27786_LIN_NEG_VS_NKCELL_DN,0.99999
HNF4_DR1_Q3,SET,243,-0.048543,-0.0055474,0.053711,0.81694,HNF4_DR1_Q3,0.99999
MARIADASON_RESPONSE_TO_CURCU...2,SET,12,-0.20207,-0.0051642,0.22354,0.81699,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7,0.99999
GSE2128_CTRL_VS_MIMETOPE_NEG...1,SET,182,-0.054616,-0.0054106,0.060407,0.81703,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN,0.99999
HP_ABNORMALITY_OF_URINE_HOME...,SET,657,-0.030058,-0.0055832,0.033244,0.81704,HP_ABNORMALITY_OF_URINE_HOMEOSTASIS,0.99999
GSE13485_CTRL_VS_DAY21_YF17D...2,SET,177,-0.054778,-0.0053523,0.060576,0.81707,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_PRE...,SET,507,-0.033305,-0.0054573,0.036831,0.81707,HE_LIM_SUN_FETAL_LUNG_C2_PRE_PDC_DC5_CELL,0.99999
GSE5503_PLN_DC_VS_SPLEEN_DC_...1,SET,181,-0.055537,-0.0054869,0.061411,0.81709,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.99999
HP_ABNORMALITY_OF_URINE_CALC...,SET,63,-0.10311,-0.0060297,0.114,0.81714,HP_ABNORMALITY_OF_URINE_CALCIUM_CONCENTRATION,0.99999
GOCC_ENDOPEPTIDASE_COMPLEX,SET,84,-0.076336,-0.0051514,0.084385,0.81716,GOCC_ENDOPEPTIDASE_COMPLEX,0.99999
HP_ROUND_EAR,SET,7,-0.32782,-0.0063996,0.36238,0.81716,HP_ROUND_EAR,0.99999
CAAGGAT_MIR362,SET,59,-0.096766,-0.0054765,0.10697,0.81717,CAAGGAT_MIR362,0.99999
HP_PARAPLEGIA_PARAPARESIS,SET,181,-0.055049,-0.0054386,0.060838,0.81722,HP_PARAPLEGIA_PARAPARESIS,0.99999
CAMP_UP.V1_UP,SET,179,-0.054103,-0.0053159,0.05979,0.81723,CAMP_UP.V1_UP,0.99999
GOBP_CYTIDINE_TO_URIDINE_EDI...,SET,10,-0.32283,-0.0075319,0.35675,0.81724,GOBP_CYTIDINE_TO_URIDINE_EDITING,0.99999
GOBP_REGULATION_OF_MITOCHOND...4,SET,5,-0.30278,-0.0049957,0.33459,0.81724,GOBP_REGULATION_OF_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE,0.99999
HP_VELOPHARYNGEAL_INSUFFICIE...,SET,26,-0.14894,-0.0056006,0.16457,0.81726,HP_VELOPHARYNGEAL_INSUFFICIENCY,0.99999
ZHONG_PFC_MAJOR_TYPES_INTERN...,SET,13,-0.2357,-0.0062694,0.26045,0.81726,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,0.99999
GOMF_CXCR_CHEMOKINE_RECEPTOR...,SET,17,-0.22307,-0.0067845,0.24648,0.81727,GOMF_CXCR_CHEMOKINE_RECEPTOR_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...119,SET,6,-0.29756,-0.0053782,0.32877,0.81728,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.99999
GOBP_AMINOACYL_TRNA_METABOLI...,SET,8,-0.23617,-0.0049287,0.26092,0.8173,GOBP_AMINOACYL_TRNA_METABOLISM_INVOLVED_IN_TRANSLATIONAL_FIDELITY,0.99999
GOMF_AMINOACYL_TRNA_EDITING_...,SET,8,-0.23617,-0.0049287,0.26092,0.8173,GOMF_AMINOACYL_TRNA_EDITING_ACTIVITY,0.99999
REACTOME_EXTRACELLULAR_MATRI...,SET,285,-0.04843,-0.0059867,0.053499,0.81733,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,0.99999
REACTOME_TFAP2_AP_2_FAMILY_R...1,SET,5,-0.3577,-0.0059019,0.39514,0.81733,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS,0.99999
GSE23398_WT_VS_IL2_KO_CD4_TC...2,SET,180,-0.056936,-0.0056096,0.062895,0.81733,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP,0.99999
HP_COMBINED_IMMUNODEFICIENCY,SET,35,-0.13626,-0.0059436,0.1505,0.81737,HP_COMBINED_IMMUNODEFICIENCY,0.99999
GSE12392_WT_VS_IFNB_KO_CD8A_...1,SET,183,-0.057966,-0.0057581,0.064013,0.8174,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN,0.99999
MIR1262,SET,44,-0.1072,-0.0052417,0.11837,0.81743,MIR1262,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_MEG...,SET,615,-0.031977,-0.0057535,0.035299,0.8175,HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE,0.99999
KEGG_MEDICUS_REFERENCE_TETHE...,SET,9,-0.22638,-0.0050107,0.24988,0.81751,KEGG_MEDICUS_REFERENCE_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,0.99999
GCM_GSPT1,SET,153,-0.055282,-0.0050253,0.06101,0.81756,GCM_GSPT1,0.99999
HP_STIFF_SKIN,SET,6,-0.33032,-0.0059702,0.3645,0.81758,HP_STIFF_SKIN,0.99999
REACTOME_MECP2_REGULATES_TRA...2,SET,7,-0.34363,-0.0067082,0.37909,0.81765,REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS,0.99999
GSE19888_ADENOSINE_A3R_INH_V...7,SET,176,-0.057322,-0.0055852,0.063237,0.81765,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...311,SET,17,-0.20233,-0.0061536,0.22313,0.81773,GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,0.99999
HP_ABSENT_INNER_DYNEIN_ARMS,SET,7,-0.26922,-0.0052557,0.29688,0.81774,HP_ABSENT_INNER_DYNEIN_ARMS,0.99999
EGR3_01,SET,72,-0.091594,-0.0057244,0.10099,0.81777,EGR3_01,0.99999
GOBP_CELLULAR_RESPONSE_TO_HY...1,SET,63,-0.096883,-0.0056653,0.10681,0.81781,GOBP_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE,0.99999
GOBP_MULTICELLULAR_ORGANISMA...1,SET,75,-0.091667,-0.0058466,0.10106,0.81781,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_CHEMICAL_HOMEOSTASIS,0.99999
HP_INSULINOMA,SET,6,-0.31463,-0.0056866,0.34684,0.81782,HP_INSULINOMA,0.99999
GOBP_ENDOTHELIAL_CELL_PROLIF...,SET,146,-0.066013,-0.0058631,0.072769,0.81783,GOBP_ENDOTHELIAL_CELL_PROLIFERATION,0.99999
KAECH_NAIVE_VS_MEMORY_CD8_TC...1,SET,184,-0.057679,-0.005745,0.063572,0.81787,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN,0.99999
HP_SELF_INJURIOUS_BEHAVIOR,SET,166,-0.060009,-0.00568,0.066135,0.81789,HP_SELF_INJURIOUS_BEHAVIOR,0.99999
MODULE_367,SET,28,-0.1512,-0.0058998,0.16662,0.8179,MODULE_367,0.99999
KEGG_MEDICUS_PATHOGEN_KSHV_V...5,SET,24,-0.16301,-0.0058896,0.17963,0.81791,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,0.99999
MIR541_5P,SET,113,-0.071778,-0.0056136,0.079099,0.81791,MIR541_5P,0.99999
GOMF_ALCOHOL_BINDING,SET,85,-0.086143,-0.0058475,0.094907,0.81796,GOMF_ALCOHOL_BINDING,0.99999
GSE3720_UNSTIM_VS_LPS_STIM_V...1,SET,130,-0.069848,-0.0058565,0.076955,0.81796,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN,0.99999
HP_RHEUMATOID_FACTOR_POSITIVE,SET,18,-0.1846,-0.0057771,0.20335,0.818,HP_RHEUMATOID_FACTOR_POSITIVE,0.99999
GSE11057_NAIVE_VS_CENT_MEMOR...1,SET,183,-0.057714,-0.005733,0.063576,0.818,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
MIR6759_3P,SET,93,-0.082162,-0.0058326,0.0905,0.81802,MIR6759_3P,0.99999
TERF2_TARGET_GENES,SET,97,-0.077681,-0.0056312,0.085565,0.81802,TERF2_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...636,SET,11,-0.24256,-0.0059352,0.26717,0.81802,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,0.99999
WEIGEL_OXIDATIVE_STRESS_RESP...,SET,32,-0.13004,-0.0054242,0.14319,0.8181,WEIGEL_OXIDATIVE_STRESS_RESPONSE,0.99999
HP_INTESTINAL_PSEUDO_OBSTRUC...,SET,18,-0.16996,-0.005319,0.18714,0.81811,HP_INTESTINAL_PSEUDO_OBSTRUCTION,0.99999
MIR6731_5P,SET,206,-0.054493,-0.0057396,0.059995,0.81813,MIR6731_5P,0.99999
GAO_SMALL_INTESTINE_24W_C7_S...,SET,38,-0.12366,-0.00562,0.13615,0.81814,GAO_SMALL_INTESTINE_24W_C7_SECRETORY_PROGENITOR,0.99999
REACTOME_FGFR2_MUTANT_RECEPT...,SET,32,-0.13748,-0.0057344,0.15135,0.81815,REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION,0.99999
GOBP_DETECTION_OF_LIGHT_STIM...2,SET,19,-0.17914,-0.0057598,0.1972,0.81817,GOBP_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,0.99999
SCIBETTA_KDM5B_TARGETS_UP,SET,18,-0.16957,-0.0053066,0.18663,0.8182,SCIBETTA_KDM5B_TARGETS_UP,0.99999
GOBP_REGULATION_OF_CENTROMER...1,SET,4,-0.3698,-0.0054576,0.40698,0.81822,GOBP_REGULATION_OF_CENTROMERE_COMPLEX_ASSEMBLY,0.99999
WP_MIR517_RELATIONSHIP_WITH_...,SET,5,-0.30203,-0.0049835,0.33233,0.81827,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,0.99999
LTE2_UP.V1_UP,SET,178,-0.060371,-0.0059153,0.066425,0.81828,LTE2_UP.V1_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...528,SET,62,-0.10091,-0.0058538,0.11102,0.81829,GOBP_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.99999
GSE6259_33D1_POS_VS_DEC205_P...4,SET,173,-0.060235,-0.0058192,0.066272,0.81829,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP,0.99999
MIR5581_5P,SET,67,-0.094603,-0.0057043,0.10407,0.81832,MIR5581_5P,0.99999
GSE41867_DAY8_VS_DAY15_LCMV_...1,SET,133,-0.069883,-0.0059262,0.076875,0.81833,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.99999
HP_KNEE_PAIN,SET,15,-0.22847,-0.0065275,0.25132,0.81834,HP_KNEE_PAIN,0.99999
GSE21063_WT_VS_NFATC1_KO_BCE...2,SET,186,-0.055037,-0.0055113,0.060539,0.81835,GSE21063_WT_VS_NFATC1_KO_BCELL_UP,0.99999
HP_NEUROMUSCULAR_DYSPHAGIA,SET,11,-0.22606,-0.0055315,0.24862,0.81839,HP_NEUROMUSCULAR_DYSPHAGIA,0.99999
GOMF_S100_PROTEIN_BINDING,SET,14,-0.20633,-0.0056951,0.22681,0.81849,GOMF_S100_PROTEIN_BINDING,0.99999
HP_ABSENT_SEPTUM_PELLUCIDUM,SET,54,-0.099704,-0.0053991,0.10956,0.81859,HP_ABSENT_SEPTUM_PELLUCIDUM,0.99999
GOBP_MEMBRANE_REPOLARIZATION...1,SET,26,-0.16555,-0.0062252,0.1819,0.81861,GOBP_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...14,SET,8,-0.27693,-0.0057793,0.30426,0.81863,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY,0.99999
MIR137_3P,SET,482,-0.036475,-0.0058316,0.040074,0.81863,MIR137_3P,0.99999
HP_HYPOPROTEINEMIA,SET,18,-0.17721,-0.0055458,0.19468,0.81866,HP_HYPOPROTEINEMIA,0.99999
GOBP_ISOPENTENYL_DIPHOSPHATE...,SET,5,-0.30438,-0.0050222,0.33435,0.81868,GOBP_ISOPENTENYL_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
KEGG_FRUCTOSE_AND_MANNOSE_ME...,SET,28,-0.12481,-0.0048704,0.13709,0.81871,KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM,0.99999
SARTIPY_BLUNTED_BY_INSULIN_R...2,SET,18,-0.18536,-0.005801,0.20357,0.81873,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,0.99999
HP_VIRAL_ENCEPHALITIS,SET,11,-0.22398,-0.0054806,0.24598,0.81873,HP_VIRAL_ENCEPHALITIS,0.99999
TCOF1_TARGET_GENES,SET,12,-0.21956,-0.005611,0.24111,0.81874,TCOF1_TARGET_GENES,0.99999
REACTOME_CELL_CELL_COMMUNICA...,SET,139,-0.069459,-0.0060206,0.076263,0.81879,REACTOME_CELL_CELL_COMMUNICATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...280,SET,9,-0.27595,-0.006108,0.30299,0.81879,GOBP_POSITIVE_REGULATION_OF_FEEDING_BEHAVIOR,0.99999
HP_ABNORMAL_CORNEAL_EPITHELI...,SET,95,-0.077264,-0.0055433,0.084834,0.81879,HP_ABNORMAL_CORNEAL_EPITHELIUM_MORPHOLOGY,0.99999
KEGG_MEDICUS_REFERENCE_NLRP3...,SET,5,-0.30492,-0.0050312,0.33476,0.81881,KEGG_MEDICUS_REFERENCE_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
GSE10325_BCELL_VS_MYELOID_DN,SET,182,-0.058476,-0.005793,0.064172,0.81891,GSE10325_BCELL_VS_MYELOID_DN,0.99999
KEGG_MEDICUS_PATHOGEN_EBV_LM...2,SET,5,-0.34503,-0.0056929,0.37862,0.81892,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_PI3K_SIGNALING_PATHWAY,0.99999
MAHAJAN_RESPONSE_TO_IL1A_DN,SET,63,-0.09552,-0.0055856,0.10479,0.81898,MAHAJAN_RESPONSE_TO_IL1A_DN,0.99999
GSE18804_SPLEEN_MACROPHAGE_V...3,SET,174,-0.060094,-0.0058222,0.065915,0.81903,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN,0.99999
GSE22886_DAY0_VS_DAY1_MONOCY...2,SET,183,-0.058115,-0.0057729,0.063743,0.81903,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...630,SET,70,-0.091649,-0.0056481,0.10049,0.81912,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,0.99999
GSE9650_EFFECTOR_VS_EXHAUSTE...1,SET,177,-0.059367,-0.0058007,0.065091,0.81913,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN,0.99999
HP_INCREASED_CIRCULATING_VER...,SET,8,-0.29048,-0.006062,0.31843,0.81917,HP_INCREASED_CIRCULATING_VERY_LONG_CHAIN_FATTY_ACID_CONCENTRATION,0.99999
GOBP_MAMMARY_GLAND_EPITHELIU...,SET,67,-0.10296,-0.0062081,0.11285,0.81919,GOBP_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT,0.99999
HP_HYPOURICEMIA,SET,16,-0.19438,-0.0057355,0.213,0.81926,HP_HYPOURICEMIA,0.99999
GOBP_L_LEUCINE_METABOLIC_PRO...,SET,8,-0.2658,-0.005547,0.29126,0.81927,GOBP_L_LEUCINE_METABOLIC_PROCESS,0.99999
HP_JUVENILE_ASEPTIC_NECROSIS,SET,41,-0.12162,-0.0057406,0.13324,0.81932,HP_JUVENILE_ASEPTIC_NECROSIS,0.99999
BUSSLINGER_DUODENAL_EC_CELLS,SET,27,-0.16829,-0.0064488,0.18437,0.81932,BUSSLINGER_DUODENAL_EC_CELLS,0.99999
HP_EPIDERMAL_ACANTHOSIS,SET,49,-0.11155,-0.0057547,0.12219,0.81935,HP_EPIDERMAL_ACANTHOSIS,0.99999
GOMF_G_PROTEIN_BETA_SUBUNIT_...,SET,21,-0.18608,-0.0062895,0.20382,0.81936,GOMF_G_PROTEIN_BETA_SUBUNIT_BINDING,0.99999
MIR579_3P,SET,449,-0.03792,-0.0058569,0.041514,0.81949,MIR579_3P,0.99999
NAKAMURA_LUNG_CANCER_DIFFERE...,SET,12,-0.23116,-0.0059077,0.25303,0.81953,NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS,0.99999
WP_SRF_AND_MIRS_IN_SMOOTH_MU...,SET,10,-0.27092,-0.0063208,0.29653,0.81954,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,0.99999
GOMF_C_X_C_CHEMOKINE_RECEPTO...,SET,7,-0.29077,-0.0056763,0.31822,0.81957,GOMF_C_X_C_CHEMOKINE_RECEPTOR_ACTIVITY,0.99999
REACTOME_RUNX2_REGULATES_OST...,SET,21,-0.17821,-0.0060236,0.19501,0.8196,REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION,0.99999
SCIAN_INVERSED_TARGETS_OF_TP...1,SET,25,-0.14972,-0.0055209,0.16377,0.8197,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...6,SET,157,-0.05844,-0.0053808,0.06392,0.81971,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,0.99999
LHX2_TARGET_GENES,SET,1129,-0.023604,-0.0056702,0.025815,0.81972,LHX2_TARGET_GENES,0.99999
HP_MACULAR_HYPOPIGMENTATION,SET,5,-0.37688,-0.0062185,0.41207,0.81979,HP_MACULAR_HYPOPIGMENTATION,0.99999
MORF_IL16,SET,214,-0.052348,-0.0056184,0.057234,0.8198,MORF_IL16,0.99999
MIR12130,SET,29,-0.14244,-0.0056564,0.1556,0.82001,MIR12130,0.99999
GOBP_ORGAN_INDUCTION,SET,20,-0.1926,-0.0063532,0.21033,0.82009,GOBP_ORGAN_INDUCTION,0.99999
GSE43955_TH0_VS_TGFB_IL6_IL2...3,SET,187,-0.056173,-0.00564,0.061342,0.82009,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,0.99999
GOBP_STRIATED_MUSCLE_TISSUE_...,SET,239,-0.052948,-0.0060014,0.057819,0.8201,GOBP_STRIATED_MUSCLE_TISSUE_DEVELOPMENT,0.99999
ZNF354C_TARGET_GENES,SET,10,-0.23105,-0.0053906,0.2523,0.82011,ZNF354C_TARGET_GENES,0.99999
HP_HIGH_MYOPIA,SET,76,-0.092837,-0.0059604,0.10137,0.82012,HP_HIGH_MYOPIA,0.99999
HP_HIP_PAIN,SET,11,-0.22659,-0.0055445,0.24737,0.82016,HP_HIP_PAIN,0.99999
HP_PATCHY_PALMOPLANTAR_HYPER...,SET,6,-0.36442,-0.0065865,0.39759,0.82031,HP_PATCHY_PALMOPLANTAR_HYPERKERATOSIS,0.99999
TGTTTAC_MIR30A5P_MIR30C_MIR3...,SET,530,-0.034265,-0.0057369,0.03738,0.82034,TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P,0.99999
DESCARTES_FETAL_EYE_RETINAL_...2,SET,10,-0.2714,-0.0063319,0.29607,0.82034,DESCARTES_FETAL_EYE_RETINAL_PROGENITORS_AND_MULLER_GLIA,0.99999
WP_SYNTHESIS_OF_CERAMIDES_AN...,SET,22,-0.17346,-0.0060006,0.18921,0.82035,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,0.99999
GSE13229_IMM_VS_MATURE_NKCEL...1,SET,183,-0.05697,-0.0056591,0.062142,0.82036,GSE13229_IMM_VS_MATURE_NKCELL_DN,0.99999
GOMF_CELL_MATRIX_ADHESION_ME...,SET,8,-0.30304,-0.0063241,0.3304,0.82047,GOMF_CELL_MATRIX_ADHESION_MEDIATOR_ACTIVITY,0.99999
HP_UPPER_EXTREMITY_JOINT_DIS...,SET,81,-0.08522,-0.0056478,0.092913,0.82047,HP_UPPER_EXTREMITY_JOINT_DISLOCATION,0.99999
GOBP_CELLULAR_RESPONSE_TO_HE...,SET,59,-0.10041,-0.0056829,0.10947,0.8205,GOBP_CELLULAR_RESPONSE_TO_HEAT,0.99999
HP_PERIPHERAL_RETINAL_DEGENE...,SET,6,-0.34244,-0.0061893,0.37331,0.8205,HP_PERIPHERAL_RETINAL_DEGENERATION,0.99999
DESCARTES_MAIN_FETAL_TROPHOB...,SET,125,-0.071809,-0.0059048,0.078269,0.82055,DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS,0.99999
MIR647,SET,75,-0.087409,-0.0055751,0.09526,0.82058,MIR647,0.99999
REACTOME_RESPONSE_TO_METAL_I...,SET,14,-0.26577,-0.0073359,0.28959,0.82061,REACTOME_RESPONSE_TO_METAL_IONS,0.99999
GSE29618_LAIV_VS_TIV_FLU_VAC...8,SET,171,-0.055509,-0.0053319,0.060473,0.82066,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP,0.99999
GOBP_UDP_N_ACETYLGLUCOSAMINE...3,SET,5,-0.30487,-0.0050304,0.33202,0.82075,GOBP_UDP_N_ACETYLGLUCOSAMINE_TRANSMEMBRANE_TRANSPORT,0.99999
GOMF_UDP_N_ACETYLGLUCOSAMINE...,SET,5,-0.30487,-0.0050304,0.33202,0.82075,GOMF_UDP_N_ACETYLGLUCOSAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
CORRE_MULTIPLE_MYELOMA_DN,SET,52,-0.11465,-0.006093,0.12485,0.82077,CORRE_MULTIPLE_MYELOMA_DN,0.99999
GOMF_HORMONE_RECEPTOR_BINDING,SET,29,-0.15513,-0.0061603,0.16893,0.82077,GOMF_HORMONE_RECEPTOR_BINDING,0.99999
KEGG_MEDICUS_REFERENCE_MGLUR...1,SET,13,-0.21535,-0.0057282,0.23449,0.82078,KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY,0.99999
GOCC_U7_SNRNP,SET,7,-0.28409,-0.0055458,0.30934,0.82078,GOCC_U7_SNRNP,0.99999
PYEON_CANCER_HEAD_AND_NECK_V...1,SET,19,-0.18994,-0.0061069,0.20678,0.82083,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN,0.99999
GOMF_FRUCTOSE_6_PHOSPHATE_BI...,SET,4,-0.31591,-0.0046623,0.3439,0.82085,GOMF_FRUCTOSE_6_PHOSPHATE_BINDING,0.99999
HP_LARGE_FLESHY_EARS,SET,13,-0.23969,-0.0063756,0.26089,0.82088,HP_LARGE_FLESHY_EARS,0.99999
ZNF530_TARGET_GENES,SET,23,-0.17062,-0.0060349,0.18568,0.82092,ZNF530_TARGET_GENES,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MES...2,SET,265,-0.048587,-0.0057948,0.052875,0.82092,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL,0.99999
HP_DUPLICATION_OF_THE_DISTAL...1,SET,12,-0.22892,-0.0058503,0.2491,0.82093,HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_HAND,0.99999
SOX3_TARGET_GENES,SET,413,-0.038775,-0.0057496,0.042186,0.82098,SOX3_TARGET_GENES,0.99999
GSE4984_GALECTIN1_VS_VEHICLE...2,SET,164,-0.057585,-0.005418,0.062653,0.82098,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_UP,0.99999
MIR4672,SET,335,-0.043369,-0.0058043,0.047181,0.821,MIR4672,0.99999
HP_MALIGNANT_NEOPLASM_OF_THE...,SET,95,-0.077825,-0.0055835,0.084632,0.8211,HP_MALIGNANT_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM,0.99999
GGGNRMNNYCAT_UNKNOWN,SET,74,-0.088291,-0.0055938,0.095981,0.82117,GGGNRMNNYCAT_UNKNOWN,0.99999
GSE24634_NAIVE_CD4_TCELL_VS_...2,SET,168,-0.060206,-0.0057326,0.065429,0.82125,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP,0.99999
GSE23925_DARK_ZONE_VS_NAIVE_...2,SET,182,-0.055204,-0.0054689,0.059986,0.82128,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP,0.99999
MIR888_5P,SET,220,-0.052207,-0.0056803,0.056725,0.8213,MIR888_5P,0.99999
MIR3170,SET,46,-0.11227,-0.0056124,0.12193,0.82141,MIR3170,0.99999
GOBP_CELL_DIFFERENTIATION_IN...5,SET,20,-0.19187,-0.0063289,0.2083,0.8215,GOBP_CELL_DIFFERENTIATION_IN_HINDBRAIN,0.99999
KEGG_MEDICUS_VARIANT_MLL_AF4...,SET,25,-0.16339,-0.0060248,0.17733,0.82157,KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.99999
GSE22601_IMMATURE_CD4_SINGLE...6,SET,162,-0.064244,-0.0060079,0.06971,0.82162,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,0.99999
GCM_SUFU,SET,70,-0.083015,-0.005116,0.090075,0.82163,GCM_SUFU,0.99999
GCM_TPR,SET,29,-0.1311,-0.0052059,0.14222,0.82167,GCM_TPR,0.99999
LINDGREN_BLADDER_CANCER_CLUS...2,SET,104,-0.077569,-0.0058213,0.084141,0.8217,LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,0.99999
GSE24671_BAKIMULC_VS_SENDAI_...2,SET,182,-0.055176,-0.0054661,0.059848,0.82171,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,0.99999
HP_COMPULSIVE_BEHAVIORS,SET,137,-0.065617,-0.0056468,0.071169,0.82172,HP_COMPULSIVE_BEHAVIORS,0.99999
chr2q14,SET,65,-0.16126,-0.0095776,0.17489,0.82175,chr2q14,0.99999
GOBP_RESPONSE_TO_CARBOHYDRATE,SET,212,-0.053943,-0.0057627,0.058499,0.82176,GOBP_RESPONSE_TO_CARBOHYDRATE,0.99999
GOCC_IGM_IMMUNOGLOBULIN_COMP...,SET,3,-0.51297,-0.0065564,0.55629,0.82176,GOCC_IGM_IMMUNOGLOBULIN_COMPLEX,0.99999
GOMF_LIPOPOLYSACCHARIDE_IMMU...,SET,6,-0.30375,-0.0054901,0.3294,0.82176,GOMF_LIPOPOLYSACCHARIDE_IMMUNE_RECEPTOR_ACTIVITY,0.99999
GNF2_MAPT,SET,39,-0.1394,-0.0064179,0.15112,0.82184,GNF2_MAPT,0.99999
REACTOME_REGULATION_OF_INSUL...2,SET,77,-0.095433,-0.0061671,0.10345,0.82185,REACTOME_REGULATION_OF_INSULIN_SECRETION,0.99999
GOBP_PONS_DEVELOPMENT,SET,11,-0.23505,-0.0057513,0.25481,0.82185,GOBP_PONS_DEVELOPMENT,0.99999
HP_PALMOPLANTAR_BLISTERING,SET,11,-0.23858,-0.0058377,0.25863,0.82185,HP_PALMOPLANTAR_BLISTERING,0.99999
DAVIES_MULTIPLE_MYELOMA_VS_M...1,SET,23,-0.17472,-0.0061798,0.1894,0.82186,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,0.99999
chr8q24,SET,152,-0.13207,-0.011967,0.14316,0.82187,chr8q24,0.99999
GOBP_GLUCAN_BIOSYNTHETIC_PRO...,SET,40,-0.11953,-0.0055728,0.12956,0.82187,GOBP_GLUCAN_BIOSYNTHETIC_PROCESS,0.99999
GNF2_RFC3,SET,39,-0.1171,-0.0053913,0.1269,0.82193,GNF2_RFC3,0.99999
GOBP_REGULATION_OF_NAD_P_H_O...,SET,5,-0.34654,-0.0057178,0.37554,0.82193,GOBP_REGULATION_OF_NAD_P_H_OXIDASE_ACTIVITY,0.99999
GSE3982_EOSINOPHIL_VS_MAST_C...1,SET,174,-0.058216,-0.0056403,0.063086,0.82194,GSE3982_EOSINOPHIL_VS_MAST_CELL_DN,0.99999
GOBP_FAT_SOLUBLE_VITAMIN_CAT...,SET,12,-0.25292,-0.0064638,0.27406,0.82196,GOBP_FAT_SOLUBLE_VITAMIN_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...2,SET,193,-0.056679,-0.0057804,0.061412,0.82197,GOBP_REGULATION_OF_SYNAPTIC_PLASTICITY,0.99999
KIM_WT1_TARGETS_DN,SET,425,-0.037305,-0.0056095,0.040416,0.822,KIM_WT1_TARGETS_DN,0.99999
GOBP_REGULATION_OF_PROTEIN_E...1,SET,24,-0.14834,-0.0053597,0.1607,0.82202,GOBP_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,0.99999
ROY_WOUND_BLOOD_VESSEL_DN,SET,19,-0.18357,-0.0059019,0.19884,0.82204,ROY_WOUND_BLOOD_VESSEL_DN,0.99999
HP_FOCAL_CORTICAL_DYSPLASIA,SET,15,-0.19991,-0.0057115,0.21642,0.82217,HP_FOCAL_CORTICAL_DYSPLASIA,0.99999
KEGG_MEDICUS_REFERENCE_BMP15...,SET,6,-0.35056,-0.0063361,0.37951,0.82218,KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY,0.99999
HP_EPISODIC_VOMITING,SET,37,-0.11353,-0.0050912,0.12289,0.82221,HP_EPISODIC_VOMITING,0.99999
GOBP_DETECTION_OF_STIMULUS_I...1,SET,418,-0.051245,-0.0076434,0.055457,0.82226,GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,0.99999
GOBP_XYLULOSE_5_PHOSPHATE_ME...,SET,6,-0.3335,-0.0060276,0.36085,0.8223,GOBP_XYLULOSE_5_PHOSPHATE_METABOLIC_PROCESS,0.99999
HP_NEPHROLITHIASIS,SET,131,-0.071386,-0.0060082,0.077238,0.82231,HP_NEPHROLITHIASIS,0.99999
GOMF_METALLOCHAPERONE_ACTIVI...,SET,12,-0.20371,-0.0052061,0.22038,0.82235,GOMF_METALLOCHAPERONE_ACTIVITY,0.99999
HP_CIRRHOSIS,SET,146,-0.064529,-0.0057313,0.069798,0.82238,HP_CIRRHOSIS,0.99999
HP_PARTIAL_ATRIOVENTRICULAR_...,SET,5,-0.32566,-0.0053733,0.35226,0.82238,HP_PARTIAL_ATRIOVENTRICULAR_CANAL_DEFECT,0.99999
GOBP_GTP_METABOLIC_PROCESS,SET,22,-0.17277,-0.0059769,0.18681,0.82247,GOBP_GTP_METABOLIC_PROCESS,0.99999
GOBP_BASE_CONVERSION_OR_SUBS...,SET,16,-0.24056,-0.0070981,0.26009,0.82249,GOBP_BASE_CONVERSION_OR_SUBSTITUTION_EDITING,0.99999
GOCC_TORC1_COMPLEX,SET,6,-0.26401,-0.0047717,0.28544,0.82249,GOCC_TORC1_COMPLEX,0.99999
GNF2_TPT1,SET,34,-0.13156,-0.0056561,0.14218,0.8226,GNF2_TPT1,0.99999
GTTATAT_MIR410,SET,80,-0.088523,-0.0058305,0.095663,0.82261,GTTATAT_MIR410,0.99999
MATTIOLI_MGUS_VS_MULTIPLE_MY...,SET,13,-0.22717,-0.0060426,0.24547,0.82263,MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA,0.99999
GOMF_ALCOHOL_DEHYDROGENASE_N...1,SET,7,-0.49764,-0.0097148,0.53758,0.82269,GOMF_ALCOHOL_DEHYDROGENASE_NADPLUS_ACTIVITY_ZINC_DEPENDENT,0.99999
GSE42021_TREG_PLN_VS_CD24HI_...2,SET,184,-0.059565,-0.0059329,0.064317,0.8228,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP,0.99999
THAKAR_PBMC_INACTIVATED_INFL...1,SET,56,-0.10272,-0.0056639,0.11089,0.82284,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_DN,0.99999
GSE16450_IMMATURE_VS_MATURE_...2,SET,180,-0.058326,-0.0057466,0.062954,0.8229,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,0.99999
GOBP_MIRNA_PROCESSING,SET,40,-0.11598,-0.0054076,0.12516,0.82295,GOBP_MIRNA_PROCESSING,0.99999
PID_P38_MKK3_6PATHWAY,SET,26,-0.14905,-0.0056048,0.1608,0.82301,PID_P38_MKK3_6PATHWAY,0.99999
GOBP_DETECTION_OF_LIPOPOLYSA...,SET,5,-0.37106,-0.0061224,0.40031,0.82302,GOBP_DETECTION_OF_LIPOPOLYSACCHARIDE,0.99999
GOCC_PHOSPHATIDYLINOSITOL_3_...3,SET,8,-0.2694,-0.0056221,0.29062,0.82302,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_III,0.99999
GOBP_DNA_DAMAGE_RESPONSE_SIG...2,SET,19,-0.16831,-0.0054113,0.18153,0.82307,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_CELL_CYCLE_ARREST,0.99999
HP_X_LINKED_RECESSIVE_INHERI...,SET,10,-0.23612,-0.005509,0.25466,0.82309,HP_X_LINKED_RECESSIVE_INHERITANCE,0.99999
REACTOME_PEPTIDE_LIGAND_BIND...,SET,180,-0.067225,-0.0066234,0.072488,0.82313,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,0.99999
DESCARTES_MAIN_FETAL_SYMPATH...,SET,40,-0.13168,-0.0061396,0.14199,0.82315,DESCARTES_MAIN_FETAL_SYMPATHOBLASTS,0.99999
GOBP_TRICUSPID_VALVE_DEVELOP...,SET,7,-0.32934,-0.0064293,0.35506,0.82318,GOBP_TRICUSPID_VALVE_DEVELOPMENT,0.99999
GOMF_UBIQUITIN_LIKE_PROTEIN_...7,SET,19,-0.1526,-0.0049063,0.16451,0.82319,GOMF_UBIQUITIN_LIKE_PROTEIN_READER_ACTIVITY,0.99999
HP_PERSISTENT_PUPILLARY_MEMB...,SET,9,-0.28149,-0.0062307,0.30345,0.8232,HP_PERSISTENT_PUPILLARY_MEMBRANE,0.99999
ALCALA_APOPTOSIS,SET,80,-0.081883,-0.0053932,0.08826,0.82322,ALCALA_APOPTOSIS,0.99999
MEINHOLD_OVARIAN_CANCER_LOW_...1,SET,19,-0.18088,-0.0058156,0.19497,0.82322,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN,0.99999
KEGG_ERBB_SIGNALING_PATHWAY,SET,82,-0.087803,-0.0058546,0.094637,0.82323,KEGG_ERBB_SIGNALING_PATHWAY,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...1,SET,10,-0.23296,-0.0054352,0.25106,0.82326,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN,0.99999
LI_DCP2_BOUND_MRNA,SET,78,-0.080217,-0.0052172,0.086445,0.82328,LI_DCP2_BOUND_MRNA,0.99999
RYTAAWNNNTGAY_UNKNOWN,SET,55,-0.10687,-0.0058402,0.11516,0.82329,RYTAAWNNNTGAY_UNKNOWN,0.99999
GSE9960_GRAM_NEG_VS_GRAM_POS...2,SET,174,-0.058703,-0.0056875,0.063255,0.8233,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP,0.99999
HP_CUPPED_EAR,SET,57,-0.099031,-0.0055092,0.1067,0.82332,HP_CUPPED_EAR,0.99999
GOBP_PEPTIDYL_HISTIDINE_MODI...,SET,9,-0.22881,-0.0050646,0.24653,0.82333,GOBP_PEPTIDYL_HISTIDINE_MODIFICATION,0.99999
NFKB_C,SET,243,-0.050278,-0.0057457,0.054162,0.82337,NFKB_C,0.99999
GOMF_SH3_DOMAIN_BINDING,SET,111,-0.070965,-0.005501,0.07644,0.82339,GOMF_SH3_DOMAIN_BINDING,0.99999
HP_DECREASED_LIGHT_AND_DARK_...,SET,14,-0.21459,-0.0059232,0.2311,0.82343,HP_DECREASED_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM_AMPLITUDE,0.99999
GSE22601_DOUBLE_POSITIVE_VS_...4,SET,186,-0.05891,-0.0058992,0.063437,0.82346,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
NADERI_BREAST_CANCER_PROGNOS...1,SET,14,-0.23484,-0.0064821,0.25286,0.82348,NADERI_BREAST_CANCER_PROGNOSIS_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...498,SET,26,-0.14567,-0.0054777,0.15683,0.82351,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
HP_GENERALIZED_HYPOTONIA,SET,580,-0.032141,-0.0056215,0.034603,0.82351,HP_GENERALIZED_HYPOTONIA,0.99999
MEBARKI_HCC_PROGENITOR_FZD8C...1,SET,371,-0.042021,-0.0059126,0.045237,0.82353,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,0.99999
GSE339_CD4POS_VS_CD8POS_DC_UP,SET,183,-0.058824,-0.0058432,0.063323,0.82353,GSE339_CD4POS_VS_CD8POS_DC_UP,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...14,SET,44,-0.12675,-0.0061974,0.13644,0.82355,GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_1,0.99999
GOBP_NEGATIVE_REGULATION_OF_...138,SET,21,-0.18922,-0.0063954,0.20361,0.82363,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,0.99999
GSE40277_EOS_AND_LEF1_TRANSD...3,SET,181,-0.058401,-0.0057698,0.062842,0.82363,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN,0.99999
GOBP_MESONEPHROS_DEVELOPMENT,SET,97,-0.087174,-0.0063194,0.093762,0.82374,GOBP_MESONEPHROS_DEVELOPMENT,0.99999
GOMF_GUANYL_RIBONUCLEOTIDE_B...,SET,342,-0.043294,-0.0058534,0.046563,0.82375,GOMF_GUANYL_RIBONUCLEOTIDE_BINDING,0.99999
GOBP_CELLULAR_RESPONSE_TO_IR...,SET,7,-0.29763,-0.0058103,0.32003,0.82381,GOBP_CELLULAR_RESPONSE_TO_IRON_ION,0.99999
GOMF_OLIGOSACCHARIDE_BINDING,SET,17,-0.21721,-0.0066061,0.23352,0.82385,GOMF_OLIGOSACCHARIDE_BINDING,0.99999
MYCMAX_01,SET,235,-0.052043,-0.0058499,0.055941,0.82389,MYCMAX_01,0.99999
GOBP_REGULATION_OF_CHONDROCY...1,SET,4,-0.48009,-0.0070852,0.51606,0.82389,GOBP_REGULATION_OF_CHONDROCYTE_DEVELOPMENT,0.99999
GSE40666_UNTREATED_VS_IFNA_S...3,SET,177,-0.056443,-0.005515,0.06066,0.82393,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_DN,0.99999
REACTOME_RECYCLING_OF_EIF2_G...,SET,7,-0.25685,-0.0050141,0.27598,0.82398,REACTOME_RECYCLING_OF_EIF2_GDP,0.99999
GOBP_ALPHA_AMINO_ACID_METABO...,SET,194,-0.056061,-0.005732,0.060237,0.82398,GOBP_ALPHA_AMINO_ACID_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...343,SET,49,-0.11622,-0.005996,0.12488,0.82398,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,0.99999
HP_ABNORMALITY_OF_THE_DISTAL...3,SET,4,-0.43984,-0.0064913,0.47256,0.82401,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_3RD_FINGER,0.99999
GSE3982_EOSINOPHIL_VS_DC_UP,SET,173,-0.060553,-0.0058499,0.065056,0.82401,GSE3982_EOSINOPHIL_VS_DC_UP,0.99999
NIKOLSKY_BREAST_CANCER_19Q13...1,SET,21,-0.25509,-0.0086221,0.27397,0.8241,NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON,0.99999
HOLLERN_ADENOMYOEPITHELIAL_B...,SET,17,-0.18205,-0.005537,0.19546,0.82417,HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR,0.99999
GOBP_SUCCINYL_COA_METABOLIC_...,SET,9,-0.22785,-0.0050434,0.24458,0.82423,GOBP_SUCCINYL_COA_METABOLIC_PROCESS,0.99999
GSE22886_IGA_VS_IGM_MEMORY_B...2,SET,172,-0.060672,-0.0058447,0.065124,0.82423,GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP,0.99999
RANKIN_ANGIOGENIC_TARGETS_OF...2,SET,5,-0.31315,-0.0051668,0.33602,0.8243,RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP,0.99999
GOBP_RETROGRADE_TRANS_SYNAPT...1,SET,9,-0.29179,-0.0064587,0.31308,0.82433,GOBP_RETROGRADE_TRANS_SYNAPTIC_SIGNALING,0.99999
GSE26030_TH1_VS_TH17_DAY15_P...2,SET,181,-0.057434,-0.0056742,0.061614,0.82436,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_UP,0.99999
GOMF_INORGANIC_ANION_TRANSME...,SET,146,-0.068184,-0.0060559,0.07314,0.82439,GOMF_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOMF_CELL_ADHESION_MOLECULE_...,SET,501,-0.03578,-0.0058292,0.038375,0.82443,GOMF_CELL_ADHESION_MOLECULE_BINDING,0.99999
HP_WIDENED_CEREBELLAR_SUBARA...,SET,6,-0.33174,-0.0059959,0.35578,0.82443,HP_WIDENED_CEREBELLAR_SUBARACHNOID_SPACE,0.99999
HP_HIGHLY_ARCHED_EYEBROW,SET,177,-0.055675,-0.00544,0.059707,0.82445,HP_HIGHLY_ARCHED_EYEBROW,0.99999
GOBP_ACETYL_COA_BIOSYNTHETIC...1,SET,15,-0.20348,-0.0058136,0.2182,0.82447,GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS,0.99999
MORF_REV3L,SET,55,-0.096895,-0.0052952,0.10389,0.8245,MORF_REV3L,0.99999
HP_CHRONIC_PAIN,SET,6,-0.27497,-0.0049698,0.29481,0.82451,HP_CHRONIC_PAIN,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...3,SET,164,-0.059973,-0.0056427,0.064288,0.82455,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_THORAX,0.99999
GSE3720_LPS_VS_PMA_STIM_VD2_...2,SET,118,-0.071668,-0.0057269,0.076824,0.82455,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...14,SET,269,-0.045859,-0.0055099,0.049155,0.82457,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLAR_VERMIS,0.99999
GOBP_REGULATION_OF_RECEPTOR_...1,SET,13,-0.21593,-0.0057436,0.2314,0.82462,GOBP_REGULATION_OF_RECEPTOR_BINDING,0.99999
GSE13411_NAIVE_VS_IGM_MEMORY...2,SET,171,-0.060575,-0.0058185,0.064912,0.82463,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP,0.99999
MIR4314,SET,121,-0.070603,-0.0057126,0.075636,0.8247,MIR4314,0.99999
GSE22611_NOD2_VS_MUTANT_NOD2...2,SET,170,-0.058491,-0.005602,0.062652,0.82473,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.99999
REACTOME_FERTILIZATION,SET,26,-0.15187,-0.005711,0.16265,0.82477,REACTOME_FERTILIZATION,0.99999
REACTOME_MELANIN_BIOSYNTHESIS,SET,5,-0.41638,-0.0068702,0.44594,0.82477,REACTOME_MELANIN_BIOSYNTHESIS,0.99999
NAGASHIMA_NRG1_SIGNALING_DN,SET,50,-0.10595,-0.0055213,0.11346,0.82478,NAGASHIMA_NRG1_SIGNALING_DN,0.99999
HP_ABNORMAL_LDL_CHOLESTEROL_...,SET,41,-0.1286,-0.00607,0.13769,0.82483,HP_ABNORMAL_LDL_CHOLESTEROL_CONCENTRATION,0.99999
REACTOME_THE_ROLE_OF_NEF_IN_...,SET,27,-0.1477,-0.0056597,0.15814,0.82484,REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS,0.99999
GSE9037_CTRL_VS_LPS_4H_STIM_...2,SET,177,-0.059585,-0.005822,0.063789,0.82487,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP,0.99999
GOBP_PHOSPHATE_ION_TRANSPORT,SET,27,-0.16657,-0.0063827,0.1783,0.82489,GOBP_PHOSPHATE_ION_TRANSPORT,0.99999
GOBP_ENDOTHELIAL_CELL_CHEMOT...,SET,26,-0.16455,-0.0061876,0.17614,0.8249,GOBP_ENDOTHELIAL_CELL_CHEMOTAXIS,0.99999
HP_FEMALE_HYPOGONADISM,SET,28,-0.15441,-0.0060254,0.16524,0.82496,HP_FEMALE_HYPOGONADISM,0.99999
HP_NEOPLASM_OF_THE_LUNG,SET,60,-0.10242,-0.005845,0.1096,0.82497,HP_NEOPLASM_OF_THE_LUNG,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_APO...2,SET,433,-0.038011,-0.0057679,0.040674,0.82498,HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M2_MACROPHAGE_CELL,0.99999
NAKAYA_MONOCYTE_FLUARIX_FLUV...1,SET,86,-0.086303,-0.0058926,0.092334,0.82502,NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.99999
GOBP_DIPHOSPHOINOSITOL_POLYP...,SET,2,-0.75849,-0.0079157,0.81146,0.82503,GOBP_DIPHOSPHOINOSITOL_POLYPHOSPHATE_METABOLIC_PROCESS,0.99999
GOMF_ENDOPOLYPHOSPHATASE_ACT...,SET,2,-0.75849,-0.0079157,0.81146,0.82503,GOMF_ENDOPOLYPHOSPHATASE_ACTIVITY,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...10,SET,77,-0.096919,-0.0062631,0.10368,0.82504,GAUTAM_EYE_IRIS_CILIARY_BODY_MGP_HIGH_FIBROBLASTS,0.99999
GOBP_POSITIVE_REGULATION_OF_...358,SET,28,-0.14378,-0.0056103,0.1538,0.82505,GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,0.99999
HP_ANTERIOR_POLAR_CATARACT,SET,7,-0.32386,-0.0063224,0.34642,0.82507,HP_ANTERIOR_POLAR_CATARACT,0.99999
GOBP_POSITIVE_REGULATION_OF_...360,SET,11,-0.26478,-0.0064788,0.28321,0.82508,GOBP_POSITIVE_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.99999
HP_MOTOR_NEURON_ATROPHY,SET,61,-0.094987,-0.0054659,0.1016,0.82508,HP_MOTOR_NEURON_ATROPHY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...75,SET,47,-0.1061,-0.0053614,0.11348,0.82509,GOBP_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,0.99999
BUSSLINGER_DUODENAL_TUFT_CEL...,SET,70,-0.10495,-0.0064679,0.11225,0.8251,BUSSLINGER_DUODENAL_TUFT_CELLS,0.99999
GOBP_REGULATION_OF_GLIAL_CEL...3,SET,18,-0.20575,-0.0064388,0.22002,0.82513,GOBP_REGULATION_OF_GLIAL_CELL_MIGRATION,0.99999
WP_NONALCOHOLIC_FATTY_LIVER_...,SET,146,-0.060268,-0.0053528,0.064442,0.82516,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,0.99999
GOBP_HEME_TRANSPORT,SET,8,-0.28427,-0.0059323,0.30395,0.82516,GOBP_HEME_TRANSPORT,0.99999
GOMF_HEME_TRANSMEMBRANE_TRAN...,SET,8,-0.28427,-0.0059323,0.30395,0.82516,GOMF_HEME_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MIR34C_5P,SET,240,-0.050196,-0.0057012,0.053662,0.8252,MIR34C_5P,0.99999
WP_AMINO_ACID_TRANSPORT_DEFE...,SET,8,-0.27142,-0.0056642,0.29015,0.82521,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,0.99999
HP_INCREASED_CIRCULATING_IRO...,SET,11,-0.23767,-0.0058155,0.25406,0.82522,HP_INCREASED_CIRCULATING_IRON_CONCENTRATION,0.99999
WAKABAYASHI_ADIPOGENESIS_PPA...2,SET,598,-0.032796,-0.0058215,0.035057,0.82523,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D,0.99999
ZNF544_TARGET_GENES,SET,3,-0.3768,-0.004816,0.40274,0.82525,ZNF544_TARGET_GENES,0.99999
GOBP_NEUTROPHIL_HOMEOSTASIS,SET,19,-0.19274,-0.0061969,0.20598,0.82529,GOBP_NEUTROPHIL_HOMEOSTASIS,0.99999
GSE3203_HEALTHY_VS_INFLUENZA...1,SET,179,-0.059689,-0.0058647,0.063785,0.8253,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN,0.99999
GOBP_METANEPHRIC_TUBULE_MORP...,SET,10,-0.27078,-0.0063177,0.28935,0.82532,GOBP_METANEPHRIC_TUBULE_MORPHOGENESIS,0.99999
TURASHVILI_BREAST_LOBULAR_CA...4,SET,90,-0.086247,-0.0060235,0.092153,0.82533,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,0.99999
HP_PARTIAL_ABSENCE_OF_CEREBE...,SET,4,-0.34003,-0.0050182,0.36326,0.82537,HP_PARTIAL_ABSENCE_OF_CEREBELLAR_VERMIS,0.99999
GNF2_ESPL1,SET,35,-0.12768,-0.0055692,0.13639,0.82538,GNF2_ESPL1,0.99999
GOBP_APICAL_PROTEIN_LOCALIZA...,SET,14,-0.20242,-0.0055873,0.21624,0.82538,GOBP_APICAL_PROTEIN_LOCALIZATION,0.99999
REACTOME_PI_3K_CASCADE_FGFR4,SET,19,-0.18606,-0.0059822,0.19876,0.82539,REACTOME_PI_3K_CASCADE_FGFR4,0.99999
GOBP_REGULATION_OF_FATTY_ACI...1,SET,17,-0.1873,-0.0056966,0.20008,0.82539,GOBP_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,0.99999
HP_ENURESIS,SET,29,-0.15212,-0.0060407,0.16247,0.82544,HP_ENURESIS,0.99999
GOBP_REGULATION_OF_RENAL_SOD...,SET,7,-0.31189,-0.0060886,0.33304,0.82548,GOBP_REGULATION_OF_RENAL_SODIUM_EXCRETION,0.99999
GOBP_ACETYL_COA_BIOSYNTHETIC...2,SET,8,-0.296,-0.0061773,0.31599,0.82555,GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS_FROM_PYRUVATE,0.99999
GOBP_EXTRINSIC_APOPTOTIC_SIG...2,SET,79,-0.086788,-0.0056806,0.092635,0.82558,GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.99999
GOMF_ACYLTRANSFERASE_ACTIVIT...2,SET,199,-0.054223,-0.0056143,0.057869,0.82561,GOMF_ACYLTRANSFERASE_ACTIVITY_TRANSFERRING_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS,0.99999
GOBP_REGULATION_OF_CELL_MIGR...,SET,36,-0.13697,-0.0060589,0.14616,0.82564,GOBP_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.99999
HP_ABNORMALITY_OF_NEURONAL_M...,SET,424,-0.03747,-0.0056278,0.039985,0.82564,HP_ABNORMALITY_OF_NEURONAL_MIGRATION,0.99999
HP_ABNORMALITY_OF_PROTHROMBIN,SET,47,-0.12292,-0.0062109,0.13116,0.82565,HP_ABNORMALITY_OF_PROTHROMBIN,0.99999
REACTOME_TNFS_BIND_THEIR_PHY...,SET,27,-0.17249,-0.0066098,0.18406,0.82566,REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS,0.99999
GOBP_REGULATION_OF_ENDOTHELI...1,SET,19,-0.19982,-0.0064247,0.2132,0.82568,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,0.99999
chr5q12,SET,26,-0.26212,-0.0098566,0.27965,0.82569,chr5q12,0.99999
HP_ABNORMAL_CIRCULATING_ACYL...,SET,21,-0.16369,-0.0055326,0.17464,0.82569,HP_ABNORMAL_CIRCULATING_ACYLCARNITINE_CONCENTRATION,0.99999
HP_LIMBAL_DERMOID,SET,8,-0.27236,-0.0056839,0.29057,0.8257,HP_LIMBAL_DERMOID,0.99999
GATTGGY_NFY_Q6_01,SET,1023,-0.02557,-0.0058651,0.027275,0.82575,GATTGGY_NFY_Q6_01,0.99999
GOBP_MATURATION_OF_LSU_RRNA,SET,23,-0.14499,-0.0051285,0.15463,0.82579,GOBP_MATURATION_OF_LSU_RRNA,0.99999
TRAVAGLINI_LUNG_AIRWAY_SMOOT...,SET,156,-0.064697,-0.0059381,0.068986,0.82583,TRAVAGLINI_LUNG_AIRWAY_SMOOTH_MUSCLE_CELL,0.99999
MIR3147,SET,35,-0.14786,-0.0064494,0.15764,0.82586,MIR3147,0.99999
HP_EXCESSIVE_WRINKLING_OF_PA...,SET,11,-0.22784,-0.005575,0.2429,0.82587,HP_EXCESSIVE_WRINKLING_OF_PALMAR_SKIN,0.99999
MIR6752_3P,SET,131,-0.067261,-0.0056611,0.071691,0.82592,MIR6752_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...538,SET,7,-0.27042,-0.005279,0.28819,0.82595,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SUMOYLATION,0.99999
LE_SKI_TARGETS_DN,SET,6,-0.40009,-0.0072312,0.42638,0.82596,LE_SKI_TARGETS_DN,0.99999
MCCABE_HOXC6_TARGETS_CANCER_...2,SET,23,-0.17137,-0.0060616,0.1826,0.826,MCCABE_HOXC6_TARGETS_CANCER_UP,0.99999
AMIT_EGF_RESPONSE_240_HELA,SET,55,-0.10839,-0.0059233,0.11548,0.82603,AMIT_EGF_RESPONSE_240_HELA,0.99999
GSE13484_12H_UNSTIM_VS_YF17D...2,SET,177,-0.057987,-0.0056659,0.061773,0.82606,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,0.99999
KEGG_MEDICUS_VARIANT_EML4_AL...1,SET,5,-0.46883,-0.0077355,0.49928,0.82613,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY,0.99999
GSE39556_UNTREATED_VS_3H_POL...1,SET,184,-0.060469,-0.0060229,0.064383,0.82618,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN,0.99999
WP_PGK1_PKM2_KHKCKHKA_ACTING...,SET,10,-0.20447,-0.0047704,0.21765,0.82623,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,0.99999
HP_BROAD_ALVEOLAR_RIDGES,SET,12,-0.23678,-0.0060513,0.25204,0.82625,HP_BROAD_ALVEOLAR_RIDGES,0.99999
MIR4289,SET,63,-0.10184,-0.0059549,0.10837,0.8263,MIR4289,0.99999
GSE23505_UNTREATED_VS_4DAY_I...4,SET,182,-0.05807,-0.0057527,0.061788,0.82634,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,0.99999
GOBP_EXTERNAL_ENCAPSULATING_...,SET,306,-0.048213,-0.006172,0.051298,0.82635,GOBP_EXTERNAL_ENCAPSULATING_STRUCTURE_ORGANIZATION,0.99999
HP_PARIETAL_FORAMINA,SET,12,-0.2379,-0.0060799,0.25312,0.82635,HP_PARIETAL_FORAMINA,0.99999
GOBP_EOSINOPHIL_ACTIVATION,SET,8,-0.25954,-0.0054163,0.27611,0.82638,GOBP_EOSINOPHIL_ACTIVATION,0.99999
HP_CONGENITAL_MALFORMATION_O...1,SET,454,-0.037469,-0.0058185,0.039862,0.82638,HP_CONGENITAL_MALFORMATION_OF_THE_GREAT_ARTERIES,0.99999
GOCC_RPAP3_R2TP_PREFOLDIN_LI...,SET,9,-0.24881,-0.0055073,0.26468,0.8264,GOCC_RPAP3_R2TP_PREFOLDIN_LIKE_COMPLEX,0.99999
GSE24634_TREG_VS_TCONV_POST_...7,SET,186,-0.059593,-0.0059675,0.063387,0.82642,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN,0.99999
GSE8678_IL7R_LOW_VS_HIGH_EFF...2,SET,183,-0.058183,-0.0057796,0.061885,0.82643,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP,0.99999
GSE24142_DN2_VS_DN3_THYMOCYT...5,SET,179,-0.060025,-0.0058978,0.063824,0.82651,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP,0.99999
HP_ABNORMAL_LIVER_PHYSIOLOGY,SET,24,-0.16808,-0.0060729,0.17869,0.82654,HP_ABNORMAL_LIVER_PHYSIOLOGY,0.99999
GOBP_REGULATION_OF_TELOMERE_...3,SET,19,-0.17897,-0.0057541,0.19025,0.82657,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE,0.99999
HP_MIOSIS,SET,25,-0.17114,-0.0063106,0.18189,0.82661,HP_MIOSIS,0.99999
MIR4647_MIR4662B,SET,77,-0.089874,-0.0058079,0.095516,0.82662,MIR4647_MIR4662B,0.99999
HP_BOWING_OF_THE_ARM,SET,38,-0.13669,-0.0062122,0.14525,0.82667,HP_BOWING_OF_THE_ARM,0.99999
GSE41978_WT_VS_ID2_KO_KLRG1_...1,SET,190,-0.059451,-0.0060163,0.063161,0.82671,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.99999
GSE41978_KLRG1_HIGH_VS_LOW_E...2,SET,182,-0.060728,-0.006016,0.064512,0.82673,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP,0.99999
GOBP_REGULATION_OF_MITOCHOND...10,SET,62,-0.10263,-0.0059538,0.10902,0.82674,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,0.99999
DESCARTES_FETAL_HEART_STROMA...,SET,25,-0.17089,-0.0063013,0.1815,0.82677,DESCARTES_FETAL_HEART_STROMAL_CELLS,0.99999
HP_ABNORMAL_TENDON_MORPHOLOGY,SET,751,-0.029493,-0.0058415,0.031324,0.82678,HP_ABNORMAL_TENDON_MORPHOLOGY,0.99999
GSE17974_0H_VS_48H_IN_VITRO_...1,SET,173,-0.057354,-0.0055409,0.060906,0.82682,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN,0.99999
GOMF_HYDRO_LYASE_ACTIVITY,SET,52,-0.11369,-0.0060417,0.1207,0.82688,GOMF_HYDRO_LYASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_EXCITATOR...,SET,17,-0.19991,-0.00608,0.21217,0.82695,GOBP_REGULATION_OF_EXCITATORY_SYNAPSE_ASSEMBLY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...233,SET,7,-0.29318,-0.0057233,0.31109,0.82701,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_TRANSPORT,0.99999
GOBP_CLATHRIN_COAT_ASSEMBLY,SET,18,-0.18373,-0.0057497,0.19491,0.82706,GOBP_CLATHRIN_COAT_ASSEMBLY,0.99999
MIR4300,SET,57,-0.1016,-0.0056518,0.10777,0.82707,MIR4300,0.99999
HP_AQUEDUCTAL_STENOSIS,SET,21,-0.15257,-0.0051569,0.16185,0.82707,HP_AQUEDUCTAL_STENOSIS,0.99999
REACTOME_RNA_POLYMERASE_I_PR...,SET,27,-0.13028,-0.004992,0.13819,0.82708,REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE,0.99999
GOBP_SYNAPTIC_TRANSMISSION_G...3,SET,5,-0.36141,-0.0059633,0.38331,0.82712,GOBP_SYNAPTIC_TRANSMISSION_GLYCINERGIC,0.99999
HP_ABNORMAL_LIBIDO,SET,37,-0.1323,-0.0059329,0.1403,0.82714,HP_ABNORMAL_LIBIDO,0.99999
MANNO_MIDBRAIN_NEUROTYPES_HN...5,SET,197,-0.059253,-0.0061046,0.062835,0.82715,MANNO_MIDBRAIN_NEUROTYPES_HNPROG,0.99999
MIR187_5P,SET,163,-0.064148,-0.0060172,0.068019,0.82718,MIR187_5P,0.99999
GOBP_SNARE_COMPLEX_ASSEMBLY,SET,21,-0.16028,-0.0054175,0.16995,0.82718,GOBP_SNARE_COMPLEX_ASSEMBLY,0.99999
BIOCARTA_UCALPAIN_PATHWAY,SET,14,-0.21884,-0.0060405,0.23201,0.82721,BIOCARTA_UCALPAIN_PATHWAY,0.99999
GSE41176_WT_VS_TAK1_KO_UNSTI...1,SET,175,-0.060409,-0.0058694,0.064042,0.82722,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN,0.99999
HP_OPHTHALMOPARESIS,SET,244,-0.049117,-0.0056243,0.052066,0.82724,HP_OPHTHALMOPARESIS,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...8,SET,185,-0.058026,-0.0057951,0.061498,0.82729,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,0.99999
GOBP_BRANCHING_INVOLVED_IN_P...,SET,12,-0.25761,-0.0065837,0.27299,0.82732,GOBP_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS,0.99999
GSE27786_LSK_VS_ERYTHROBLAST...1,SET,178,-0.058552,-0.005737,0.062046,0.82733,GSE27786_LSK_VS_ERYTHROBLAST_DN,0.99999
VANTVEER_BREAST_CANCER_POOR_...,SET,44,-0.12436,-0.0060804,0.13175,0.82738,VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...321,SET,46,-0.11191,-0.0055943,0.11856,0.82738,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,0.99999
ZSCAN23_TARGET_GENES,SET,63,-0.10117,-0.0059158,0.10718,0.82739,ZSCAN23_TARGET_GENES,0.99999
GOBP_REGULATION_OF_T_CELL_PR...,SET,163,-0.068435,-0.0064193,0.072487,0.82743,GOBP_REGULATION_OF_T_CELL_PROLIFERATION,0.99999
HP_LOW_INSERTION_OF_COLUMELLA,SET,7,-0.28957,-0.0056528,0.30664,0.82749,HP_LOW_INSERTION_OF_COLUMELLA,0.99999
REACTOME_NEGATIVE_REGULATION...10,SET,51,-0.099535,-0.0052385,0.1054,0.8275,REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,0.99999
GOBP_COPPER_ION_HOMEOSTASIS,SET,18,-0.18701,-0.0058526,0.19799,0.82756,GOBP_COPPER_ION_HOMEOSTASIS,0.99999
MEISSNER_NPC_HCP_WITH_H3K4ME2,SET,447,-0.039878,-0.0061459,0.042212,0.82758,MEISSNER_NPC_HCP_WITH_H3K4ME2,0.99999
GOCC_GLYCOPROTEIN_COMPLEX,SET,21,-0.17938,-0.0060629,0.18984,0.82763,GOCC_GLYCOPROTEIN_COMPLEX,0.99999
TURASHVILI_BREAST_LOBULAR_CA...1,SET,81,-0.092879,-0.0061553,0.098296,0.82764,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,0.99999
HP_ABNORMAL_LABIA_MAJORA_MOR...,SET,40,-0.1269,-0.0059167,0.1343,0.82764,HP_ABNORMAL_LABIA_MAJORA_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_MEMBRANE_...12,SET,4,-0.42519,-0.0062751,0.44991,0.82768,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.99999
GOBP_REGULATION_OF_MEMBRANE_...13,SET,4,-0.42519,-0.0062751,0.44991,0.82768,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.99999
REACTOME_PCNA_DEPENDENT_LONG...,SET,21,-0.15425,-0.0052136,0.16317,0.82775,REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,0.99999
GOBP_INTRACELLULAR_PHOSPHATE...,SET,9,-0.31096,-0.006883,0.32892,0.82776,GOBP_INTRACELLULAR_PHOSPHATE_ION_HOMEOSTASIS,0.99999
GOBP_CONVERGENT_EXTENSION_IN...1,SET,5,-0.41674,-0.0068762,0.44075,0.8278,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_AXIS_ELONGATION,0.99999
REACTOME_DOPAMINE_NEUROTRANS...,SET,20,-0.18845,-0.0062163,0.19923,0.82789,REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE,0.99999
MIR4740_3P,SET,7,-0.3073,-0.0059989,0.32487,0.8279,MIR4740_3P,0.99999
REACTOME_TRIF_MEDIATED_PROGR...,SET,9,-0.27755,-0.0061434,0.2934,0.82791,REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH,0.99999
GOBP_REGULATION_OF_SMAD_PROT...,SET,59,-0.11674,-0.0066072,0.12341,0.82791,GOBP_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GSE15330_WT_VS_IKAROS_KO_GRA...2,SET,187,-0.058385,-0.0058621,0.061718,0.82792,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.99999
HP_SCARRING_ALOPECIA_OF_SCALP,SET,13,-0.2254,-0.0059953,0.23823,0.82795,HP_SCARRING_ALOPECIA_OF_SCALP,0.99999
KEGG_MEDICUS_REFERENCE_PDGF_...1,SET,13,-0.23128,-0.0061518,0.24434,0.82806,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY,0.99999
CROMER_METASTASIS_DN,SET,74,-0.093775,-0.0059413,0.099041,0.82813,CROMER_METASTASIS_DN,0.99999
MIR5187_5P,SET,97,-0.079557,-0.0057672,0.084025,0.82813,MIR5187_5P,0.99999
MIR6735_3P,SET,33,-0.13623,-0.00577,0.14388,0.82813,MIR6735_3P,0.99999
HP_PHALANGEAL_DISLOCATION,SET,7,-0.33908,-0.0066193,0.35812,0.82813,HP_PHALANGEAL_DISLOCATION,0.99999
GSE25677_MPL_VS_R848_STIM_BC...2,SET,161,-0.066415,-0.0061919,0.070146,0.82813,GSE25677_MPL_VS_R848_STIM_BCELL_UP,0.99999
GOBP_PARAXIAL_MESODERM_MORPH...,SET,9,-0.29584,-0.0065483,0.31244,0.82814,GOBP_PARAXIAL_MESODERM_MORPHOGENESIS,0.99999
GSE17721_CTRL_VS_LPS_4H_BMDC...2,SET,185,-0.055813,-0.0055741,0.058943,0.82815,GSE17721_CTRL_VS_LPS_4H_BMDC_UP,0.99999
GOBP_LONG_CHAIN_FATTY_ACID_C...,SET,8,-0.28688,-0.0059869,0.30293,0.82817,GOBP_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.99999
GSE19825_NAIVE_VS_DAY3_EFF_C...1,SET,181,-0.05401,-0.005336,0.057025,0.82821,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN,0.99999
GOBP_GENERAL_ADAPTATION_SYND...1,SET,6,-0.34392,-0.0062161,0.36297,0.82831,GOBP_GENERAL_ADAPTATION_SYNDROME,0.99999
GOMF_RNA_POLYMERASE_II_CTD_H...2,SET,17,-0.17899,-0.0054438,0.1889,0.82831,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_MODIFYING_ACTIVITY,0.99999
HP_DECREASED_ABSENT_ANKLE_RE...,SET,37,-0.12426,-0.0055724,0.13114,0.82831,HP_DECREASED_ABSENT_ANKLE_REFLEXES,0.99999
HP_MOTOR_POLYNEUROPATHY,SET,33,-0.13664,-0.0057875,0.1442,0.82833,HP_MOTOR_POLYNEUROPATHY,0.99999
MEBARKI_HCC_PROGENITOR_WNT_D...4,SET,13,-0.23014,-0.0061215,0.24285,0.82834,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_INDEPENDENT,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_PRO...5,SET,120,-0.079129,-0.0063761,0.083486,0.82838,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_PROGENITORS_CELL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...340,SET,20,-0.18684,-0.006163,0.19711,0.8284,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,0.99999
OHGUCHI_LIVER_HNF4A_TARGETS_...1,SET,153,-0.068267,-0.0062057,0.072016,0.82841,OHGUCHI_LIVER_HNF4A_TARGETS_DN,0.99999
EWSR1_TARGET_GENES,SET,769,-0.028917,-0.0057926,0.030499,0.82846,EWSR1_TARGET_GENES,0.99999
GOBP_REGULATION_OF_PINOCYTOS...,SET,12,-0.19856,-0.0050745,0.20941,0.82847,GOBP_REGULATION_OF_PINOCYTOSIS,0.99999
GOBP_REGULATION_OF_CARDIOBLA...,SET,5,-0.41304,-0.0068151,0.43557,0.8285,GOBP_REGULATION_OF_CARDIOBLAST_DIFFERENTIATION,0.99999
GSE29164_UNTREATED_VS_CD8_TC...5,SET,182,-0.059677,-0.005912,0.062929,0.82851,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN,0.99999
GOBP_INTRA_GOLGI_VESICLE_MED...,SET,32,-0.13198,-0.0055048,0.13913,0.82858,GOBP_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.99999
GOMF_ORGANIC_ANION_TRANSMEMB...,SET,253,-0.051974,-0.0060588,0.054787,0.82859,GOMF_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE360_T_GONDII_VS_B_MALAYI_...2,SET,175,-0.063309,-0.0061511,0.066716,0.82866,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP,0.99999
GSE6259_33D1_POS_DC_VS_CD8_T...1,SET,112,-0.075156,-0.0058519,0.0792,0.82867,GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...491,SET,98,-0.078863,-0.0057461,0.0831,0.82869,GOBP_POSITIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS,0.99999
HP_ABNORMALITY_OF_THE_BLADDER,SET,465,-0.037278,-0.0058568,0.039278,0.8287,HP_ABNORMALITY_OF_THE_BLADDER,0.99999
HP_ABNORMAL_HARD_PALATE_MORP...,SET,71,-0.093439,-0.0057992,0.098455,0.8287,HP_ABNORMAL_HARD_PALATE_MORPHOLOGY,0.99999
GSE2826_WT_VS_XID_BCELL_DN,SET,183,-0.061985,-0.0061573,0.065283,0.82881,GSE2826_WT_VS_XID_BCELL_DN,0.99999
ZHOU_INFLAMMATORY_RESPONSE_F...1,SET,250,-0.051231,-0.0059372,0.053953,0.82883,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,0.99999
VALK_AML_CLUSTER_15,SET,28,-0.16178,-0.0063127,0.17033,0.82888,VALK_AML_CLUSTER_15,0.99999
GOCC_MITOTIC_COHESIN_COMPLEX,SET,4,-0.52458,-0.0077419,0.55232,0.82888,GOCC_MITOTIC_COHESIN_COMPLEX,0.99999
REACTOME_PKA_MEDIATED_PHOSPH...1,SET,19,-0.20153,-0.0064794,0.21217,0.82889,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,0.99999
GSE20366_CD103_POS_VS_CD103_...2,SET,181,-0.058995,-0.0058285,0.06211,0.8289,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP,0.99999
REACTOME_SIGNALING_BY_MET,SET,76,-0.093679,-0.0060145,0.098609,0.82894,REACTOME_SIGNALING_BY_MET,0.99999
GOBP_NEGATIVE_REGULATION_OF_...49,SET,31,-0.1488,-0.0061088,0.15658,0.82902,GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,0.99999
GOBP_TUMOR_NECROSIS_FACTOR_M...,SET,104,-0.080092,-0.0060107,0.084276,0.82903,GOBP_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.99999
MIR340_5P,SET,707,-0.031058,-0.005976,0.032677,0.82906,MIR340_5P,0.99999
HP_LOSS_OF_CONSCIOUSNESS,SET,23,-0.17075,-0.0060394,0.17964,0.82906,HP_LOSS_OF_CONSCIOUSNESS,0.99999
KEGG_MEDICUS_REFERENCE_GNRH_...,SET,20,-0.18265,-0.0060248,0.19216,0.82907,KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY,0.99999
LAKE_ADULT_KIDNEY_C8_DECENDI...,SET,253,-0.050664,-0.0059061,0.053295,0.8291,LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...8,SET,25,-0.1822,-0.0067187,0.19164,0.82913,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,0.99999
MEISSNER_ES_ICP_WITH_H3K4ME3,SET,29,-0.14006,-0.0055617,0.1473,0.82914,MEISSNER_ES_ICP_WITH_H3K4ME3,0.99999
HP_ABNORMAL_LOWER_LIMB_EPIPH...,SET,84,-0.088609,-0.0059796,0.093191,0.82915,HP_ABNORMAL_LOWER_LIMB_EPIPHYSIS_MORPHOLOGY,0.99999
GSE360_L_MAJOR_VS_B_MALAYI_H...3,SET,183,-0.056571,-0.0056195,0.059486,0.82919,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.99999
GSE41867_DAY15_EFFECTOR_VS_D...4,SET,177,-0.061363,-0.0059957,0.064514,0.82923,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,0.99999
HP_SHORT_LOWER_LIMBS,SET,12,-0.22976,-0.0058718,0.24153,0.82926,HP_SHORT_LOWER_LIMBS,0.99999
REACTOME_SENSORY_PERCEPTION,SET,513,-0.044492,-0.0073322,0.046769,0.82927,REACTOME_SENSORY_PERCEPTION,0.99999
WP_TRANSCRIPTION_COFACTORS_S...,SET,17,-0.21803,-0.0066311,0.22917,0.82929,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,0.99999
LUCAS_HNF4A_TARGETS_UP,SET,53,-0.10658,-0.005718,0.11202,0.82932,LUCAS_HNF4A_TARGETS_UP,0.99999
GSE27786_CD8_TCELL_VS_ERYTHR...1,SET,182,-0.06036,-0.0059796,0.063432,0.82933,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN,0.99999
ZNF586_TARGET_GENES,SET,35,-0.12984,-0.0056634,0.13641,0.8294,ZNF586_TARGET_GENES,0.99999
HP_ABNORMALITY_OF_THE_PARATH...,SET,68,-0.10037,-0.0060966,0.10544,0.8294,HP_ABNORMALITY_OF_THE_PARATHYROID_GLAND,0.99999
GOBP_HRI_MEDIATED_SIGNALING,SET,5,-0.33696,-0.0055598,0.35396,0.82944,GOBP_HRI_MEDIATED_SIGNALING,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...9,SET,54,-0.10469,-0.0056689,0.10997,0.82944,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS,0.99999
HP_FASTING_HYPERINSULINEMIA,SET,9,-0.27806,-0.0061546,0.29203,0.82948,HP_FASTING_HYPERINSULINEMIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...371,SET,7,-0.34947,-0.0068223,0.36702,0.82949,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_23_PRODUCTION,0.99999
GOBP_SELF_PROTEOLYSIS,SET,12,-0.24316,-0.0062143,0.25534,0.82952,GOBP_SELF_PROTEOLYSIS,0.99999
HP_ABDOMINAL_MASS,SET,9,-0.33652,-0.0074486,0.35329,0.82958,HP_ABDOMINAL_MASS,0.99999
BIOCARTA_IL7_PATHWAY,SET,16,-0.20691,-0.0061054,0.2172,0.8296,BIOCARTA_IL7_PATHWAY,0.99999
HP_ODONTOGENIC_NEOPLASM,SET,6,-0.29238,-0.0052845,0.30692,0.8296,HP_ODONTOGENIC_NEOPLASM,0.99999
REACTOME_FLT3_SIGNALING,SET,37,-0.12842,-0.005759,0.13477,0.82967,REACTOME_FLT3_SIGNALING,0.99999
GOBP_REGULATION_OF_RECEPTOR_...6,SET,105,-0.077645,-0.0058548,0.081478,0.82969,GOBP_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.99999
GOBP_MUSCLE_CELL_MIGRATION,SET,80,-0.095155,-0.0062673,0.099831,0.82974,GOBP_MUSCLE_CELL_MIGRATION,0.99999
GSE22886_NAIVE_VS_IGG_IGA_ME...1,SET,173,-0.062644,-0.006052,0.065717,0.82976,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN,0.99999
GOBP_L_LYSINE_TRANSMEMBRANE_...,SET,6,-0.36165,-0.0065364,0.37936,0.82977,GOBP_L_LYSINE_TRANSMEMBRANE_TRANSPORT,0.99999
GOBP_ORNITHINE_TRANSPORT,SET,6,-0.36165,-0.0065364,0.37936,0.82977,GOBP_ORNITHINE_TRANSPORT,0.99999
GOCC_INTRACILIARY_TRANSPORT_...2,SET,8,-0.2507,-0.0052319,0.26299,0.82977,GOCC_INTRACILIARY_TRANSPORT_PARTICLE_A,0.99999
GOMF_L_LYSINE_TRANSMEMBRANE_...,SET,6,-0.36165,-0.0065364,0.37936,0.82977,GOMF_L_LYSINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...5,SET,14,-0.22681,-0.0062605,0.23789,0.82981,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,0.99999
REACTOME_BETA_CATENIN_PHOSPH...,SET,16,-0.20339,-0.0060015,0.21333,0.82981,REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE,0.99999
GOMF_INSULIN_LIKE_GROWTH_FAC...3,SET,13,-0.25329,-0.0067373,0.26562,0.82985,GOMF_INSULIN_LIKE_GROWTH_FACTOR_I_BINDING,0.99999
PROVENZANI_METASTASIS_UP,SET,169,-0.064688,-0.0061774,0.067827,0.82988,PROVENZANI_METASTASIS_UP,0.99999
KEGG_SPHINGOLIPID_METABOLISM,SET,34,-0.14611,-0.0062816,0.15319,0.8299,KEGG_SPHINGOLIPID_METABOLISM,0.99999
GOBP_PANCREAS_DEVELOPMENT,SET,74,-0.099805,-0.0063233,0.10464,0.8299,GOBP_PANCREAS_DEVELOPMENT,0.99999
GSE18281_SUBCAPSULAR_VS_PERI...2,SET,182,-0.0586,-0.0058052,0.061438,0.8299,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP,0.99999
GSE26351_WNT_VS_BMP_PATHWAY_...1,SET,176,-0.059044,-0.0057529,0.061904,0.8299,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,0.99999
GOBP_FOREBRAIN_DEVELOPMENT,SET,380,-0.04408,-0.0062755,0.046201,0.82998,GOBP_FOREBRAIN_DEVELOPMENT,0.99999
HP_ABNORMAL_SMALL_INTESTINE_...,SET,244,-0.051316,-0.0058761,0.053782,0.82999,HP_ABNORMAL_SMALL_INTESTINE_MORPHOLOGY,0.99999
GSE2770_TGFB_AND_IL4_VS_IL12...2,SET,172,-0.058963,-0.0056801,0.061794,0.83,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
GOBP_STEROID_METABOLIC_PROCE...,SET,299,-0.048738,-0.0061686,0.05107,0.83004,GOBP_STEROID_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...84,SET,384,-0.042384,-0.006065,0.044406,0.83007,GOBP_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY,0.99999
GOBP_EPITHELIAL_MESENCHYMAL_...,SET,5,-0.43278,-0.0071407,0.45325,0.83016,GOBP_EPITHELIAL_MESENCHYMAL_CELL_SIGNALING,0.99999
GOBP_POSITIVE_REGULATION_OF_...620,SET,12,-0.21443,-0.0054801,0.22456,0.83018,GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,0.99999
HP_ABNORMAL_URINARY_ORGANIC_...,SET,57,-0.10764,-0.0059879,0.11272,0.83018,HP_ABNORMAL_URINARY_ORGANIC_COMPOUND_LEVEL,0.99999
HP_ORTHOKERATOSIS,SET,18,-0.19548,-0.0061176,0.20469,0.83021,HP_ORTHOKERATOSIS,0.99999
GSE44955_MCSF_VS_MCSF_AND_IL...1,SET,180,-0.059869,-0.0058987,0.062685,0.83023,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN,0.99999
GNF2_SPINK1,SET,24,-0.18919,-0.0068357,0.19808,0.83024,GNF2_SPINK1,0.99999
HP_LACUNAR_STROKE,SET,6,-0.29951,-0.0054134,0.31356,0.83026,HP_LACUNAR_STROKE,0.99999
HP_EEG_WITH_SPIKE_WAVE_COMPL...1,SET,88,-0.089254,-0.0061642,0.093426,0.83029,HP_EEG_WITH_SPIKE_WAVE_COMPLEXES,0.99999
GOMF_NEUROLIGIN_FAMILY_PROTE...,SET,5,-0.34612,-0.0057108,0.36223,0.83033,GOMF_NEUROLIGIN_FAMILY_PROTEIN_BINDING,0.99999
GOCC_ZONULA_ADHERENS,SET,7,-0.32819,-0.0064069,0.3434,0.83039,GOCC_ZONULA_ADHERENS,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...26,SET,80,-0.098383,-0.0064799,0.10294,0.83039,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_VASCULAR_SMOOTH_MUSCLE_CELLS,0.99999
GOBP_RENAL_SYSTEM_DEVELOPMENT,SET,315,-0.049241,-0.0063941,0.05152,0.8304,GOBP_RENAL_SYSTEM_DEVELOPMENT,0.99999
MIR6767_3P,SET,24,-0.16182,-0.0058466,0.16928,0.83044,MIR6767_3P,0.99999
BRUINS_UVC_RESPONSE_VIA_TP53...4,SET,246,-0.052437,-0.0060288,0.054851,0.83046,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,0.99999
GOBP_TRANSCRIPTION_COUPLED_N...,SET,10,-0.22608,-0.0052748,0.23644,0.83051,GOBP_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR,0.99999
PARK_OSTEOBLAST_DIFFERENTIAT...2,SET,12,-0.25745,-0.0065795,0.26921,0.83054,PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP,0.99999
GSE13547_CTRL_VS_ANTI_IGM_ST...3,SET,149,-0.066928,-0.0060046,0.069985,0.83054,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN,0.99999
GSE12366_GC_BCELL_VS_PLASMA_...1,SET,162,-0.061999,-0.0057979,0.064828,0.83055,GSE12366_GC_BCELL_VS_PLASMA_CELL_DN,0.99999
MIR1268A_MIR1268B,SET,7,-0.33089,-0.0064596,0.34589,0.83062,MIR1268A_MIR1268B,0.99999
HP_INAPPROPRIATE_BEHAVIOR,SET,14,-0.20588,-0.0056828,0.2152,0.83062,HP_INAPPROPRIATE_BEHAVIOR,0.99999
HP_THROMBOPHLEBITIS,SET,10,-0.23251,-0.0054248,0.24293,0.83074,HP_THROMBOPHLEBITIS,0.99999
HP_PROGRESSIVE_MICROCEPHALY,SET,82,-0.086074,-0.0057393,0.089928,0.83075,HP_PROGRESSIVE_MICROCEPHALY,0.99999
REACTOME_INTEGRIN_CELL_SURFA...,SET,81,-0.096951,-0.0064252,0.10129,0.83076,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,0.99999
WP_DNA_DAMAGE_RESPONSE_ONLY_...,SET,108,-0.079227,-0.0060583,0.082765,0.83077,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,0.99999
HP_MULTIPLE_MITOCHONDRIAL_DN...,SET,9,-0.22511,-0.0049826,0.23514,0.83079,HP_MULTIPLE_MITOCHONDRIAL_DNA_DELETIONS,0.99999
GOCC_MCRD_MEDIATED_MRNA_STAB...,SET,5,-0.33694,-0.0055595,0.35194,0.83081,GOCC_MCRD_MEDIATED_MRNA_STABILITY_COMPLEX,0.99999
GOMF_INTERLEUKIN_1_RECEPTOR_...1,SET,6,-0.39639,-0.0071643,0.41401,0.83082,GOMF_INTERLEUKIN_1_RECEPTOR_ACTIVITY,0.99999
GGTGTGT_MIR329,SET,103,-0.087518,-0.0065365,0.091367,0.83093,GGTGTGT_MIR329,0.99999
ZNF329_TARGET_GENES,SET,439,-0.03846,-0.0058755,0.040151,0.83093,ZNF329_TARGET_GENES,0.99999
SMTTTTGT_UNKNOWN,SET,359,-0.044149,-0.0061127,0.04609,0.83093,SMTTTTGT_UNKNOWN,0.99999
GSE12392_WT_VS_IFNAR_KO_CD8A...1,SET,168,-0.06058,-0.0057682,0.063241,0.83094,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_DN,0.99999
GUO_TARGETS_OF_IRS1_AND_IRS2,SET,90,-0.081495,-0.0056916,0.085069,0.83096,GUO_TARGETS_OF_IRS1_AND_IRS2,0.99999
GOBP_ADHERENS_JUNCTION_ASSEM...,SET,13,-0.22464,-0.0059754,0.23449,0.83096,GOBP_ADHERENS_JUNCTION_ASSEMBLY,0.99999
GOBP_REGULATION_OF_CELL_PROJ...3,SET,11,-0.22513,-0.0055087,0.235,0.83096,GOBP_REGULATION_OF_CELL_PROJECTION_SIZE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...470,SET,12,-0.26348,-0.0067337,0.27492,0.83107,GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...697,SET,11,-0.26575,-0.0065027,0.27727,0.83108,GOBP_NEGATIVE_REGULATION_OF_VASOCONSTRICTION,0.99999
HP_MEGALENCEPHALY,SET,40,-0.13193,-0.0061513,0.13763,0.83111,HP_MEGALENCEPHALY,0.99999
WP_NEURAL_CREST_DIFFERENTIAT...,SET,94,-0.090067,-0.0064279,0.093936,0.83117,WP_NEURAL_CREST_DIFFERENTIATION,0.99999
WP_HIJACK_OF_UBIQUITINATION_...,SET,6,-0.31085,-0.0056183,0.32396,0.83134,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,0.99999
REACTOME_CASPASE_ACTIVATION_...3,SET,25,-0.16193,-0.0059712,0.16876,0.83135,REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY,0.99999
WP_WARBURG_EFFECT_MODULATED_...,SET,24,-0.16728,-0.0060439,0.17431,0.83138,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,0.99999
GSE37301_MULTIPOTENT_PROGENI...9,SET,162,-0.066365,-0.0062062,0.069135,0.83145,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_DN,0.99999
MIR6815_5P,SET,54,-0.10678,-0.0057823,0.11123,0.83146,MIR6815_5P,0.99999
BERNARD_PPAPDC1B_TARGETS_DN,SET,53,-0.11941,-0.0064061,0.12437,0.83148,BERNARD_PPAPDC1B_TARGETS_DN,0.99999
MIR6721_5P,SET,316,-0.045673,-0.00594,0.047574,0.83148,MIR6721_5P,0.99999
HP_LUMBAR_KYPHOSIS,SET,6,-0.32465,-0.0058678,0.33816,0.83148,HP_LUMBAR_KYPHOSIS,0.99999
HP_SUBRETINAL_FLUID,SET,9,-0.29126,-0.0064469,0.30333,0.83152,HP_SUBRETINAL_FLUID,0.99999
REACTOME_TRANSMISSION_ACROSS...,SET,252,-0.054502,-0.006341,0.056757,0.83153,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,0.99999
ZNF302_TARGET_GENES,SET,4,-0.32865,-0.0048503,0.34221,0.83156,ZNF302_TARGET_GENES,0.99999
HP_RESPONSE_TO_DRUGS_ACTING_...,SET,6,-0.3404,-0.0061524,0.35443,0.83157,HP_RESPONSE_TO_DRUGS_ACTING_ON_NEUROMUSCULAR_TRANSMISSION,0.99999
HP_ABNORMAL_AORTIC_ARCH_MORP...,SET,58,-0.10745,-0.0060297,0.11185,0.83163,HP_ABNORMAL_AORTIC_ARCH_MORPHOLOGY,0.99999
ZNF577_TARGET_GENES,SET,381,-0.042114,-0.0060032,0.043824,0.83171,ZNF577_TARGET_GENES,0.99999
GOBP_ENDOTHELIAL_CELL_FATE_C...,SET,8,-0.31852,-0.0066471,0.33144,0.83172,GOBP_ENDOTHELIAL_CELL_FATE_COMMITMENT,0.99999
GSE8621_LPS_PRIMED_UNSTIM_VS...1,SET,177,-0.057451,-0.0056135,0.05978,0.83172,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.99999
CHIBA_RESPONSE_TO_TSA_UP,SET,48,-0.12572,-0.0064197,0.13082,0.83173,CHIBA_RESPONSE_TO_TSA_UP,0.99999
GOBP_REGULATION_OF_PLATELET_...2,SET,29,-0.16666,-0.0066181,0.17339,0.83176,GOBP_REGULATION_OF_PLATELET_AGGREGATION,0.99999
MCMURRAY_TP53_HRAS_COOPERATI...1,SET,64,-0.11113,-0.0065494,0.1156,0.83179,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,0.99999
REACTOME_DIGESTION_AND_ABSOR...,SET,22,-0.19605,-0.0067822,0.20394,0.83179,REACTOME_DIGESTION_AND_ABSORPTION,0.99999
DE_YY1_TARGETS_UP,SET,17,-0.21553,-0.0065551,0.22417,0.83183,DE_YY1_TARGETS_UP,0.99999
MIR548BA,SET,159,-0.064343,-0.0059616,0.066911,0.83187,MIR548BA,0.99999
MODULE_426,SET,80,-0.09119,-0.0060061,0.094826,0.83188,MODULE_426,0.99999
DAVICIONI_MOLECULAR_ARMS_VS_...1,SET,166,-0.06774,-0.0064118,0.070434,0.83191,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,0.99999
FURUKAWA_DUSP6_TARGETS_PCI35...1,SET,71,-0.095911,-0.0059526,0.099718,0.83192,FURUKAWA_DUSP6_TARGETS_PCI35_DN,0.99999
GOBP_SPINAL_CORD_DEVELOPMENT,SET,93,-0.090686,-0.0064377,0.094285,0.83193,GOBP_SPINAL_CORD_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...467,SET,8,-0.31826,-0.0066417,0.33087,0.83194,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,0.99999
GOMF_1_4_ALPHA_OLIGOGLUCAN_P...,SET,5,-0.32239,-0.0053193,0.33514,0.83196,GOMF_1_4_ALPHA_OLIGOGLUCAN_PHOSPHORYLASE_ACTIVITY,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_EAR...2,SET,518,-0.037716,-0.0062449,0.039205,0.83197,HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL,0.99999
HP_PRIMARY_AMENORRHEA,SET,108,-0.079212,-0.0060572,0.082339,0.83198,HP_PRIMARY_AMENORRHEA,0.99999
GSE5455_EX_VIVO_VS_POST_24H_...2,SET,183,-0.057895,-0.005751,0.060165,0.83203,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_UP,0.99999
HP_EEG_WITH_FOCAL_SPIKES,SET,30,-0.15114,-0.0061044,0.15706,0.83204,HP_EEG_WITH_FOCAL_SPIKES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...691,SET,20,-0.18787,-0.006197,0.19521,0.83207,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.99999
GOBP_SYNAPSE_ASSEMBLY,SET,190,-0.064193,-0.0064962,0.066691,0.83211,GOBP_SYNAPSE_ASSEMBLY,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOSI...4,SET,13,-0.22175,-0.0058984,0.23032,0.83217,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GSE16385_UNTREATED_VS_12H_RO...3,SET,175,-0.062253,-0.0060485,0.064655,0.83218,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,0.99999
GSE21379_WT_VS_SAP_KO_TFH_CD...1,SET,178,-0.060978,-0.0059747,0.063325,0.8322,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN,0.99999
GOBP_REGULATION_OF_OSTEOCLAS...3,SET,6,-0.30801,-0.005567,0.31986,0.83221,GOBP_REGULATION_OF_OSTEOCLAST_PROLIFERATION,0.99999
GSE16522_MEMORY_VS_NAIVE_CD8...1,SET,180,-0.059929,-0.0059045,0.062233,0.83221,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.99999
GSE5679_PPARG_LIGAND_ROSIGLI...2,SET,181,-0.05807,-0.0057371,0.060301,0.83222,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_UP,0.99999
HP_RESTLESS_LEGS,SET,22,-0.17062,-0.0059024,0.17714,0.83227,HP_RESTLESS_LEGS,0.99999
BIOCARTA_AKAPCENTROSOME_PATH...,SET,14,-0.2084,-0.0057524,0.21632,0.83232,BIOCARTA_AKAPCENTROSOME_PATHWAY,0.99999
REACTOME_CHYLOMICRON_ASSEMBLY,SET,8,-0.28417,-0.0059303,0.29495,0.83233,REACTOME_CHYLOMICRON_ASSEMBLY,0.99999
GOBP_PEPTIDYL_SERINE_AUTOPHO...,SET,8,-0.2847,-0.0059414,0.29544,0.83238,GOBP_PEPTIDYL_SERINE_AUTOPHOSPHORYLATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...439,SET,428,-0.041398,-0.0062464,0.042952,0.83242,GOBP_POSITIVE_REGULATION_OF_MAPK_CASCADE,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...1,SET,11,-0.22448,-0.0054927,0.2329,0.83242,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS,0.99999
MIR452_5P,SET,197,-0.057105,-0.0058833,0.059243,0.83245,MIR452_5P,0.99999
MODULE_237,SET,54,-0.10744,-0.0058178,0.11146,0.83245,MODULE_237,0.99999
HP_IRREGULAR_ACETABULAR_ROOF,SET,6,-0.29935,-0.0054104,0.31052,0.83247,HP_IRREGULAR_ACETABULAR_ROOF,0.99999
GSE17721_CTRL_VS_POLYIC_6H_B...2,SET,174,-0.057922,-0.0056118,0.06005,0.83261,GSE17721_CTRL_VS_POLYIC_6H_BMDC_UP,0.99999
GOBP_EMBRYO_DEVELOPMENT,SET,1049,-0.026285,-0.0061005,0.027243,0.83267,GOBP_EMBRYO_DEVELOPMENT,0.99999
HP_DELAYED_EPIPHYSEAL_OSSIFI...,SET,37,-0.13727,-0.0061559,0.14227,0.83269,HP_DELAYED_EPIPHYSEAL_OSSIFICATION,0.99999
HP_HYDROPS_FETALIS,SET,115,-0.074282,-0.0058603,0.076978,0.83272,HP_HYDROPS_FETALIS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...32,SET,20,-0.17883,-0.005899,0.18531,0.83273,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.99999
GOBP_GENITALIA_MORPHOGENESIS,SET,11,-0.27875,-0.0068208,0.28884,0.83274,GOBP_GENITALIA_MORPHOGENESIS,0.99999
GOBP_REGULATION_OF_SECONDARY...2,SET,15,-0.21995,-0.0062841,0.22791,0.83274,GOBP_REGULATION_OF_SECONDARY_METABOLIC_PROCESS,0.99999
HP_GINGIVAL_FIBROMATOSIS,SET,22,-0.17875,-0.0061839,0.18521,0.83276,HP_GINGIVAL_FIBROMATOSIS,0.99999
GSE29949_MICROGLIA_BRAIN_VS_...1,SET,176,-0.061537,-0.0059959,0.063758,0.83277,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,0.99999
GOBP_RETINAL_CELL_APOPTOTIC_...,SET,6,-0.34187,-0.0061789,0.3541,0.83283,GOBP_RETINAL_CELL_APOPTOTIC_PROCESS,0.99999
GSE20151_CTRL_VS_FUSOBACT_NU...1,SET,174,-0.060089,-0.0058218,0.06223,0.83287,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...18,SET,11,-0.24784,-0.0060645,0.25667,0.83287,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PLASMA_CELLS,0.99999
ZNF664_TARGET_GENES,SET,764,-0.029538,-0.0058986,0.030588,0.83288,ZNF664_TARGET_GENES,0.99999
FOXO4_TARGET_GENES,SET,293,-0.045579,-0.0057117,0.0472,0.83289,FOXO4_TARGET_GENES,0.99999
HP_YELLOW_WHITE_LESIONS_OF_T...1,SET,16,-0.21099,-0.0062255,0.21839,0.83299,HP_YELLOW_WHITE_LESIONS_OF_THE_MACULA,0.99999
GSE46606_IRF4HIGH_VS_IRF4MID...1,SET,178,-0.061807,-0.006056,0.063965,0.83304,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.99999
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...9,SET,65,-0.093206,-0.0055358,0.096446,0.83307,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE,0.99999
FEVR_CTNNB1_TARGETS_UP,SET,635,-0.033559,-0.006132,0.034724,0.83308,FEVR_CTNNB1_TARGETS_UP,0.99999
REACTOME_P75NTR_REGULATES_AX...,SET,9,-0.30335,-0.0067144,0.31387,0.83309,REACTOME_P75NTR_REGULATES_AXONOGENESIS,0.99999
GOBP_OUTFLOW_TRACT_SEPTUM_MO...,SET,26,-0.18311,-0.0068856,0.18943,0.83313,GOBP_OUTFLOW_TRACT_SEPTUM_MORPHOGENESIS,0.99999
GSE31082_DN_VS_CD4_SP_THYMOC...2,SET,172,-0.057415,-0.0055309,0.059394,0.83314,GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP,0.99999
GSE15930_NAIVE_VS_24H_IN_VIT...4,SET,188,-0.058975,-0.005937,0.060994,0.8332,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,0.99999
GOBP_NEUROBLAST_DIFFERENTIAT...,SET,6,-0.41604,-0.0075196,0.43026,0.83321,GOBP_NEUROBLAST_DIFFERENTIATION,0.99999
HP_NON_MIDLINE_CLEFT_OF_THE_...,SET,34,-0.13604,-0.0058487,0.14068,0.83322,HP_NON_MIDLINE_CLEFT_OF_THE_UPPER_LIP,0.99999
CHEMNITZ_RESPONSE_TO_PROSTAG...2,SET,126,-0.069695,-0.0057537,0.07207,0.83323,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,0.99999
MORF_RAP1A,SET,133,-0.066604,-0.0056481,0.068868,0.83325,MORF_RAP1A,0.99999
GOCC_INTERCELLULAR_CANALICUL...,SET,6,-0.38094,-0.0068852,0.39389,0.83325,GOCC_INTERCELLULAR_CANALICULUS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...52,SET,30,-0.15385,-0.0062139,0.15909,0.83325,HP_APLASIA_HYPOPLASIA_OF_THE_PATELLA,0.99999
KEGG_MEDICUS_REFERENCE_ISOLE...,SET,9,-0.2607,-0.0057704,0.26954,0.83327,KEGG_MEDICUS_REFERENCE_ISOLEUCINE_DEGRADATION,0.99999
MIR4429,SET,275,-0.051844,-0.0062971,0.053587,0.83334,MIR4429,0.99999
TCATCTC_MIR143,SET,131,-0.070389,-0.0059243,0.072734,0.83341,TCATCTC_MIR143,0.99999
GOMF_AMINO_ACID_MONOATOMIC_C...1,SET,4,-0.34919,-0.0051534,0.36078,0.83343,GOMF_AMINO_ACID_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_TRH_T...,SET,12,-0.24609,-0.0062891,0.25423,0.83346,KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_CARBOHYDR...1,SET,88,-0.087261,-0.0060266,0.090148,0.83346,GOBP_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,0.99999
GSE2197_CPG_DNA_VS_UNTREATED...2,SET,177,-0.061208,-0.0059806,0.063229,0.83348,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP,0.99999
SMID_BREAST_CANCER_ERBB2_DN,SET,5,-0.40601,-0.006699,0.41937,0.83351,SMID_BREAST_CANCER_ERBB2_DN,0.99999
GSE360_CTRL_VS_T_GONDII_DC_UP,SET,177,-0.06255,-0.0061117,0.064605,0.83352,GSE360_CTRL_VS_T_GONDII_DC_UP,0.99999
GOMF_AP_1_ADAPTOR_COMPLEX_BI...,SET,5,-0.3342,-0.0055142,0.34513,0.83355,GOMF_AP_1_ADAPTOR_COMPLEX_BINDING,0.99999
BIOCARTA_RAS_PATHWAY,SET,20,-0.18721,-0.0061753,0.19328,0.83362,BIOCARTA_RAS_PATHWAY,0.99999
HP_LENTICONUS,SET,8,-0.29011,-0.0060543,0.29951,0.83362,HP_LENTICONUS,0.99999
MIR3612,SET,110,-0.0775,-0.0059806,0.079984,0.83371,MIR3612,0.99999
AUJLA_IL22_AND_IL17A_SIGNALI...,SET,10,-0.25615,-0.0059763,0.26435,0.83372,AUJLA_IL22_AND_IL17A_SIGNALING,0.99999
GOBP_TELOMERIC_LOOP_DISASSEM...,SET,9,-0.2559,-0.0056642,0.26408,0.83373,GOBP_TELOMERIC_LOOP_DISASSEMBLY,0.99999
GOBP_REGULATION_OF_PROTEIN_I...,SET,56,-0.10812,-0.0059617,0.11154,0.83379,GOBP_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,0.99999
GSE37532_WT_VS_PPARG_KO_VISC...4,SET,167,-0.061054,-0.0057961,0.062989,0.83379,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...1,SET,184,-0.055462,-0.0055242,0.057215,0.83381,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN,0.99999
GOBP_REGULATION_OF_MACROPHAG...3,SET,27,-0.15644,-0.0059948,0.16134,0.83389,GOBP_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.99999
HP_HIGH_ANTERIOR_HAIRLINE,SET,59,-0.1013,-0.0057332,0.10447,0.83389,HP_HIGH_ANTERIOR_HAIRLINE,0.99999
HP_ABNORMAL_T_CELL_PROLIFERA...,SET,14,-0.20258,-0.0055916,0.20888,0.83393,HP_ABNORMAL_T_CELL_PROLIFERATION,0.99999
GOBP_ENDODERM_DEVELOPMENT,SET,80,-0.097059,-0.0063927,0.10007,0.83394,GOBP_ENDODERM_DEVELOPMENT,0.99999
E2F1_UP.V1_DN,SET,176,-0.061343,-0.005977,0.063236,0.83399,E2F1_UP.V1_DN,0.99999
HP_REDUCED_C_PEPTIDE_LEVEL,SET,7,-0.33031,-0.0064481,0.34047,0.834,HP_REDUCED_C_PEPTIDE_LEVEL,0.99999
MIR4513,SET,46,-0.11678,-0.0058381,0.12035,0.83407,MIR4513,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...2,SET,175,-0.065517,-0.0063657,0.067498,0.83413,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN,0.99999
MIR140_5P,SET,82,-0.088693,-0.0059139,0.091359,0.83417,MIR140_5P,0.99999
MCCLUNG_DELTA_FOSB_TARGETS_2...,SET,43,-0.13574,-0.0065611,0.13981,0.83419,MCCLUNG_DELTA_FOSB_TARGETS_2WK,0.99999
REACTOME_MEMBRANE_TRAFFICKING,SET,596,-0.03317,-0.0058783,0.034163,0.8342,REACTOME_MEMBRANE_TRAFFICKING,0.99999
GOBP_REGULATION_OF_SISTER_CH...2,SET,101,-0.077829,-0.0057565,0.08015,0.83423,GOBP_REGULATION_OF_SISTER_CHROMATID_SEGREGATION,0.99999
GOCC_CARBOXY_TERMINAL_DOMAIN...,SET,19,-0.14529,-0.0046715,0.1496,0.83427,GOCC_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX,0.99999
GOMF_POLYPEPTIDE_N_ACETYLGAL...,SET,17,-0.22686,-0.0068996,0.23353,0.83432,GOMF_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,0.99999
chr5q31,SET,179,-0.14146,-0.013899,0.1456,0.83436,chr5q31,0.99999
KEGG_MEDICUS_VARIANT_DUPLICA...3,SET,14,-0.21032,-0.0058053,0.21647,0.83436,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY,0.99999
WP_GPR143_IN_MELANOCYTES_AND...,SET,29,-0.16318,-0.0064798,0.16792,0.83441,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...4,SET,33,-0.15453,-0.0065451,0.15901,0.83441,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE,0.99999
REACTOME_COOPERATION_OF_PDCL...,SET,38,-0.12982,-0.0058998,0.13359,0.83442,REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING,0.99999
GSE19941_IL10_KO_VS_IL10_KO_...3,SET,179,-0.060465,-0.005941,0.06222,0.83442,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_DN,0.99999
KEGG_MEDICUS_VARIANT_LOSS_OF...3,SET,6,-0.27827,-0.0050295,0.28624,0.83451,KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY,0.99999
HP_INSPIRATORY_STRIDOR,SET,14,-0.21999,-0.0060724,0.22629,0.83452,HP_INSPIRATORY_STRIDOR,0.99999
GSE6269_E_COLI_VS_STAPH_AURE...1,SET,162,-0.063996,-0.0059847,0.065824,0.83452,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN,0.99999
WP_LUNG_PATHOLOGY_OF_COVID19,SET,15,-0.21425,-0.0061213,0.22035,0.83454,WP_LUNG_PATHOLOGY_OF_COVID19,0.99999
GOBP_LATERAL_SPROUTING_FROM_...,SET,9,-0.32033,-0.0070903,0.32942,0.83457,GOBP_LATERAL_SPROUTING_FROM_AN_EPITHELIUM,0.99999
MODULE_222,SET,10,-0.26483,-0.0061787,0.27229,0.83462,MODULE_222,0.99999
CREIGHTON_ENDOCRINE_THERAPY_...5,SET,429,-0.040658,-0.0061417,0.041796,0.83466,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,0.99999
GOBP_REGULATION_OF_POSTSYNAP...5,SET,17,-0.21338,-0.0064899,0.21936,0.83466,GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ORGANIZATION,0.99999
GOBP_PEPTIDYL_CYSTEINE_MODIF...,SET,39,-0.13203,-0.0060787,0.1357,0.83472,GOBP_PEPTIDYL_CYSTEINE_MODIFICATION,0.99999
GOBP_PROSTATE_GLAND_MORPHOGE...,SET,26,-0.18629,-0.0070051,0.19145,0.83472,GOBP_PROSTATE_GLAND_MORPHOGENESIS,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...11,SET,179,-0.05903,-0.0057999,0.060662,0.83474,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN,0.99999
HP_FETAL_ANOMALY,SET,490,-0.037507,-0.0060449,0.038539,0.83477,HP_FETAL_ANOMALY,0.99999
GOBP_TUBULIN_DEACETYLATION,SET,18,-0.17208,-0.0053853,0.17681,0.83478,GOBP_TUBULIN_DEACETYLATION,0.99999
HP_MYOCLONIC_SEIZURE,SET,210,-0.05555,-0.0059068,0.057076,0.83478,HP_MYOCLONIC_SEIZURE,0.99999
GOMF_CARBON_NITROGEN_LYASE_A...,SET,13,-0.24444,-0.006502,0.25115,0.83479,GOMF_CARBON_NITROGEN_LYASE_ACTIVITY,0.99999
GOBP_NORADRENERGIC_NEURON_DI...,SET,9,-0.34117,-0.0075515,0.35051,0.8348,GOBP_NORADRENERGIC_NEURON_DIFFERENTIATION,0.99999
GOCC_DENDRITE_CYTOPLASM,SET,26,-0.15365,-0.0057777,0.15784,0.83482,GOCC_DENDRITE_CYTOPLASM,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_SMG...2,SET,650,-0.033329,-0.0061589,0.034212,0.83501,HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL,0.99999
HP_HIGHLY_ELEVATED_CREATINE_...,SET,6,-0.31374,-0.0056705,0.32188,0.83514,HP_HIGHLY_ELEVATED_CREATINE_KINASE,0.99999
WP_INSULIN_SIGNALING_IN_ADIP...1,SET,8,-0.30895,-0.0064474,0.31696,0.83515,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,0.99999
WP_INSULIN_SIGNALING_IN_ADIP...2,SET,8,-0.30895,-0.0064474,0.31696,0.83515,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,0.99999
HP_INCREASED_LDL_CHOLESTEROL...,SET,30,-0.16138,-0.0065177,0.16553,0.83518,HP_INCREASED_LDL_CHOLESTEROL_CONCENTRATION,0.99999
WP_UREA_CYCLE_AND_ASSOCIATED...,SET,23,-0.16594,-0.0058693,0.1702,0.8352,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,0.99999
REACTOME_MATURATION_OF_SARS_...2,SET,15,-0.18807,-0.0053733,0.19286,0.83526,REACTOME_MATURATION_OF_SARS_COV_2_NUCLEOPROTEIN,0.99999
GSE37534_GW1929_VS_ROSIGLITA...2,SET,149,-0.066055,-0.0059262,0.067728,0.83529,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,0.99999
GOMF_LYSOZYME_ACTIVITY,SET,9,-0.295,-0.0065297,0.30245,0.83531,GOMF_LYSOZYME_ACTIVITY,0.99999
HP_IMPAIRED_RENAL_CONCENTRAT...,SET,6,-0.32951,-0.0059556,0.33765,0.83544,HP_IMPAIRED_RENAL_CONCENTRATING_ABILITY,0.99999
GOBP_RETINAL_ROD_CELL_DIFFER...,SET,16,-0.20885,-0.0061624,0.21399,0.83545,GOBP_RETINAL_ROD_CELL_DIFFERENTIATION,0.99999
GOBP_MUSCLE_CELL_FATE_COMMIT...,SET,16,-0.2455,-0.0072438,0.25146,0.83553,GOBP_MUSCLE_CELL_FATE_COMMITMENT,0.99999
HP_CERVICAL_MYELOPATHY,SET,7,-0.32326,-0.0063105,0.3311,0.83554,HP_CERVICAL_MYELOPATHY,0.99999
HP_PERIPAPILLARY_CHORIORETIN...,SET,5,-0.40406,-0.0066669,0.41378,0.83559,HP_PERIPAPILLARY_CHORIORETINAL_ATROPHY,0.99999
TBK1.DN.48HRS_UP,SET,47,-0.11437,-0.0057789,0.11711,0.8356,TBK1.DN.48HRS_UP,0.99999
GOCC_TELOMERASE_HOLOENZYME_C...,SET,19,-0.1657,-0.0053276,0.16967,0.83561,GOCC_TELOMERASE_HOLOENZYME_COMPLEX,0.99999
GOBP_REGULATION_OF_ANTIMICRO...2,SET,9,-0.30852,-0.0068289,0.31587,0.83564,GOBP_REGULATION_OF_ANTIMICROBIAL_PEPTIDE_PRODUCTION,0.99999
WEST_ADRENOCORTICAL_CARCINOM...1,SET,22,-0.19386,-0.0067063,0.19847,0.83565,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,0.99999
HP_DIABETIC_KETOACIDOSIS,SET,19,-0.1998,-0.0064238,0.20455,0.83565,HP_DIABETIC_KETOACIDOSIS,0.99999
WP_MALE_INFERTILITY,SET,132,-0.069987,-0.0059128,0.071646,0.83567,WP_MALE_INFERTILITY,0.99999
GSE8921_UNSTIM_VS_TLR1_2_STI...3,SET,187,-0.059579,-0.0059819,0.060991,0.83567,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...692,SET,9,-0.31518,-0.0069764,0.3226,0.83571,GOBP_POSITIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.99999
GOMF_LIPOPROTEIN_PARTICLE_RE...2,SET,27,-0.15967,-0.0061183,0.16342,0.83571,GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,0.99999
HP_CHRONIC_LUNG_DISEASE,SET,39,-0.12635,-0.0058172,0.12929,0.83579,HP_CHRONIC_LUNG_DISEASE,0.99999
MIR5699_3P,SET,60,-0.10715,-0.0061151,0.10958,0.83592,MIR5699_3P,0.99999
GOBP_GLYCEROPHOSPHOLIPID_MET...,SET,276,-0.048915,-0.0059519,0.050023,0.83592,GOBP_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS,0.99999
GOBP_HINDBRAIN_DEVELOPMENT,SET,142,-0.07186,-0.006295,0.073453,0.83603,GOBP_HINDBRAIN_DEVELOPMENT,0.99999
WP_EPITHELIAL_TO_MESENCHYMAL...,SET,153,-0.071767,-0.0065239,0.07335,0.83606,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,0.99999
WP_FAMILIAL_PARTIAL_LIPODYST...,SET,30,-0.15756,-0.0063635,0.16102,0.83607,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,0.99999
GOBP_REGULATION_OF_T_CELL_AC...2,SET,6,-0.33016,-0.0059674,0.33744,0.83607,GOBP_REGULATION_OF_T_CELL_ACTIVATION_VIA_T_CELL_RECEPTOR_CONTACT_WITH_ANTIGEN_BOUND_TO_MHC_MOLECULE_ON_ANTIGEN_PRESENTING_CELL,0.99999
GTGTTGA_MIR505,SET,89,-0.086974,-0.0060406,0.088883,0.83608,GTGTTGA_MIR505,0.99999
HP_CLUBBING_OF_FINGERS,SET,37,-0.1392,-0.0062427,0.14224,0.83611,HP_CLUBBING_OF_FINGERS,0.99999
GOBP_REGULATION_OF_HEART_GRO...,SET,55,-0.12126,-0.0066269,0.12391,0.83612,GOBP_REGULATION_OF_HEART_GROWTH,0.99999
MIR6784_3P,SET,35,-0.12824,-0.0055937,0.13096,0.83626,MIR6784_3P,0.99999
GSE19198_CTRL_VS_IL21_TREATE...1,SET,182,-0.063812,-0.0063216,0.065166,0.83626,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_DN,0.99999
MIR8485,SET,922,-0.027842,-0.0060804,0.02843,0.83628,MIR8485,0.99999
GOCC_HIPPOCAMPAL_MOSSY_FIBER...,SET,41,-0.13396,-0.006323,0.13679,0.83628,GOCC_HIPPOCAMPAL_MOSSY_FIBER_TO_CA3_SYNAPSE,0.99999
GSE13485_PRE_VS_POST_YF17D_V...2,SET,167,-0.06289,-0.0059704,0.06422,0.83628,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP,0.99999
PID_RANBP2_PATHWAY,SET,11,-0.2527,-0.0061833,0.25793,0.83638,PID_RANBP2_PATHWAY,0.99999
GOBP_AIM2_INFLAMMASOME_COMPL...,SET,5,-0.30675,-0.0050612,0.31303,0.83643,GOBP_AIM2_INFLAMMASOME_COMPLEX_ASSEMBLY,0.99999
REACTOME_BIOSYNTHESIS_OF_THE...,SET,72,-0.092601,-0.0057873,0.094489,0.83645,REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,0.99999
MIR6890_5P,SET,18,-0.18551,-0.0058056,0.18928,0.83647,MIR6890_5P,0.99999
GSE14000_4H_VS_16H_LPS_DC_UP,SET,165,-0.064344,-0.0060721,0.06565,0.83648,GSE14000_4H_VS_16H_LPS_DC_UP,0.99999
MIR122_3P,SET,8,-0.27248,-0.0056864,0.27792,0.83656,MIR122_3P,0.99999
GOCC_HIGH_DENSITY_LIPOPROTEI...,SET,21,-0.19022,-0.0064293,0.194,0.83658,GOCC_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,0.99999
GOBP_L_KYNURENINE_METABOLIC_...,SET,5,-0.40599,-0.0066987,0.41401,0.8366,GOBP_L_KYNURENINE_METABOLIC_PROCESS,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...14,SET,189,-0.059731,-0.0060289,0.060886,0.8367,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_UP,0.99999
GOBP_IODIDE_TRANSPORT,SET,9,-0.24255,-0.0053686,0.24722,0.83672,GOBP_IODIDE_TRANSPORT,0.99999
GOBP_SIRNA_PROCESSING,SET,8,-0.30043,-0.0062697,0.30622,0.83672,GOBP_SIRNA_PROCESSING,0.99999
GOBP_PYRIMIDINE_CONTAINING_C...2,SET,41,-0.14496,-0.0068422,0.14774,0.83674,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
BENPORATH_MYC_TARGETS_WITH_E...,SET,200,-0.058377,-0.0060594,0.059494,0.83675,BENPORATH_MYC_TARGETS_WITH_EBOX,0.99999
MODULE_147,SET,101,-0.08038,-0.0059452,0.081915,0.83676,MODULE_147,0.99999
GOCC_SPERM_PRINCIPAL_PIECE,SET,29,-0.15216,-0.0060424,0.15507,0.83676,GOCC_SPERM_PRINCIPAL_PIECE,0.99999
GOCC_FLOTILLIN_COMPLEX,SET,9,-0.26433,-0.0058508,0.26933,0.8368,GOCC_FLOTILLIN_COMPLEX,0.99999
MIR610,SET,77,-0.098791,-0.0063841,0.10062,0.83691,MIR610,0.99999
GOBP_CELLULAR_RESPONSE_TO_IO...,SET,66,-0.097917,-0.00586,0.099726,0.83691,GOBP_CELLULAR_RESPONSE_TO_IONIZING_RADIATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MYO...3,SET,22,-0.19965,-0.0069068,0.2033,0.83696,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_3_CELL,0.99999
HAEGERSTRAND_RESPONSE_TO_IMA...,SET,9,-0.33304,-0.0073717,0.33911,0.83697,HAEGERSTRAND_RESPONSE_TO_IMATINIB,0.99999
BRF1_TARGET_GENES,SET,37,-0.13927,-0.0062457,0.14181,0.83697,BRF1_TARGET_GENES,0.99999
HP_KINKED_BRAINSTEM,SET,4,-0.36836,-0.0054363,0.37505,0.83698,HP_KINKED_BRAINSTEM,0.99999
HP_MENINGOENCEPHALOCELE,SET,4,-0.36836,-0.0054363,0.37505,0.83698,HP_MENINGOENCEPHALOCELE,0.99999
KEGG_MEDICUS_REFERENCE_AREG_...1,SET,11,-0.25404,-0.006216,0.25861,0.83702,KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY,0.99999
GOMF_NEUROPEPTIDE_RECEPTOR_B...,SET,29,-0.15796,-0.0062725,0.1608,0.83703,GOMF_NEUROPEPTIDE_RECEPTOR_BINDING,0.99999
GSE37301_COMMON_LYMPHOID_PRO...4,SET,177,-0.061049,-0.0059651,0.062121,0.83713,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,0.99999
CROONQUIST_NRAS_SIGNALING_UP,SET,32,-0.15388,-0.0064185,0.15657,0.83715,CROONQUIST_NRAS_SIGNALING_UP,0.99999
VERRECCHIA_RESPONSE_TO_TGFB1...6,SET,5,-0.37898,-0.006253,0.38558,0.83716,VERRECCHIA_RESPONSE_TO_TGFB1_C6,0.99999
KYNG_WERNER_SYNDROM_AND_NORM...2,SET,74,-0.091329,-0.0057863,0.092888,0.83724,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,0.99999
GSE43863_TFH_VS_LY6C_INT_CXC...4,SET,184,-0.063108,-0.0062858,0.064178,0.83727,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,0.99999
HP_INCREASED_LAXITY_OF_ANKLES,SET,5,-0.41301,-0.0068145,0.42,0.83728,HP_INCREASED_LAXITY_OF_ANKLES,0.99999
LUI_THYROID_CANCER_PAX8_PPAR...1,SET,44,-0.11749,-0.0057445,0.11946,0.8373,LUI_THYROID_CANCER_PAX8_PPARG_DN,0.99999
GOBP_REGULATION_OF_VOLTAGE_G...1,SET,21,-0.18981,-0.0064154,0.193,0.8373,GOBP_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
HP_DIPLOPIA,SET,85,-0.086928,-0.0059008,0.088359,0.83739,HP_DIPLOPIA,0.99999
MIKKELSEN_NPC_LCP_WITH_H3K4M...,SET,55,-0.1117,-0.0061042,0.11353,0.83741,MIKKELSEN_NPC_LCP_WITH_H3K4ME3,0.99999
GOBP_DENDRITE_MORPHOGENESIS,SET,131,-0.073524,-0.0061882,0.074728,0.83741,GOBP_DENDRITE_MORPHOGENESIS,0.99999
GOBP_THROMBIN_ACTIVATED_RECE...,SET,13,-0.255,-0.0067827,0.25912,0.83745,GOBP_THROMBIN_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_APLASIA_OF_THE_OLFACTORY_...,SET,13,-0.23352,-0.0062115,0.23731,0.83745,HP_APLASIA_OF_THE_OLFACTORY_BULB,0.99999
GSE6092_IFNG_VS_IFNG_AND_B_B...1,SET,160,-0.068364,-0.0063538,0.069472,0.83745,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,0.99999
CTTTAAR_UNKNOWN,SET,878,-0.02943,-0.0062799,0.029904,0.83747,CTTTAAR_UNKNOWN,0.99999
GSE8921_UNSTIM_VS_TLR1_2_STI...6,SET,186,-0.058218,-0.0058298,0.059151,0.83749,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP,0.99999
REACTOME_GPVI_MEDIATED_ACTIV...,SET,33,-0.15146,-0.0064153,0.15386,0.83753,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,0.99999
GOBP_GROWTH_HORMONE_RECEPTOR...,SET,10,-0.32852,-0.0076646,0.33371,0.83754,GOBP_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT,0.99999
KEGG_MEDICUS_REFERENCE_ARNO_...,SET,24,-0.15113,-0.0054603,0.15347,0.83762,KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,0.99999
MAF_Q6,SET,233,-0.056398,-0.0063128,0.05727,0.83763,MAF_Q6,0.99999
HP_INCREASED_JITTER_AT_SINGL...,SET,7,-0.34063,-0.0066496,0.34589,0.83763,HP_INCREASED_JITTER_AT_SINGLE_FIBER_EMG,0.99999
HP_MELENA,SET,21,-0.18548,-0.0062691,0.18831,0.83767,HP_MELENA,0.99999
DESCARTES_FETAL_EYE_PHOTOREC...,SET,29,-0.17214,-0.0068359,0.17477,0.83767,DESCARTES_FETAL_EYE_PHOTORECEPTOR_CELLS,0.99999
AACGGTT_MIR451,SET,9,-0.30475,-0.0067455,0.30933,0.83773,AACGGTT_MIR451,0.99999
IL2_UP.V1_DN,SET,159,-0.068153,-0.0063146,0.069178,0.83773,IL2_UP.V1_DN,0.99999
HP_PHOTOPHOBIA,SET,246,-0.053199,-0.0061164,0.053994,0.83775,HP_PHOTOPHOBIA,0.99999
GOCC_NMDA_SELECTIVE_GLUTAMAT...,SET,9,-0.29453,-0.0065192,0.29887,0.8378,GOCC_NMDA_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX,0.99999
ACCGAGC_MIR423,SET,5,-0.40859,-0.0067417,0.41441,0.83792,ACCGAGC_MIR423,0.99999
HP_CEREBELLAR_MALFORMATION,SET,219,-0.055253,-0.0059982,0.056038,0.83792,HP_CEREBELLAR_MALFORMATION,0.99999
HP_OBSESSIVE_COMPULSIVE_TRAIT,SET,36,-0.13697,-0.0060589,0.13889,0.83797,HP_OBSESSIVE_COMPULSIVE_TRAIT,0.99999
MIR125B_2_3P,SET,121,-0.07241,-0.0058588,0.073419,0.83799,MIR125B_2_3P,0.99999
WANG_LMO4_TARGETS_UP,SET,310,-0.046686,-0.0060148,0.047332,0.83801,WANG_LMO4_TARGETS_UP,0.99999
AAGTCCA_MIR422B_MIR422A,SET,63,-0.099792,-0.0058354,0.10117,0.83802,AAGTCCA_MIR422B_MIR422A,0.99999
GOBP_POSITIVE_REGULATION_OF_...16,SET,6,-0.36058,-0.0065172,0.36556,0.83802,GOBP_POSITIVE_REGULATION_OF_AGGREPHAGY,0.99999
HP_ACHOLIC_STOOLS,SET,8,-0.33755,-0.0070443,0.34219,0.83803,HP_ACHOLIC_STOOLS,0.99999
MIR4433A_5P,SET,43,-0.1265,-0.0061144,0.12822,0.83805,MIR4433A_5P,0.99999
GOBP_SENSORY_PERCEPTION_OF_B...,SET,43,-0.14952,-0.0072273,0.15157,0.83805,GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE,0.99999
HP_ABNORMAL_NIPPLE_MORPHOLOGY,SET,209,-0.05497,-0.0058313,0.055721,0.83805,HP_ABNORMAL_NIPPLE_MORPHOLOGY,0.99999
HP_DECREASED_CIRCULATING_VIT...1,SET,8,-0.34995,-0.0073031,0.35474,0.83805,HP_DECREASED_CIRCULATING_VITAMIN_B12_CONCENTRATION,0.99999
GSE27859_DC_VS_CD11C_INT_F48...2,SET,182,-0.058132,-0.005759,0.058909,0.83813,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,0.99999
GOCC_FIBRILLAR_CENTER,SET,134,-0.068461,-0.0058272,0.069368,0.83816,GOCC_FIBRILLAR_CENTER,0.99999
REACTOME_NEGATIVE_REGULATION...6,SET,14,-0.20605,-0.0056874,0.20874,0.8382,REACTOME_NEGATIVE_REGULATION_OF_FLT3,0.99999
HALLMARK_APICAL_JUNCTION,SET,183,-0.062683,-0.0062266,0.063494,0.83823,HALLMARK_APICAL_JUNCTION,0.99999
WP_DNA_DAMAGE_RESPONSE,SET,65,-0.09624,-0.005716,0.097456,0.8383,WP_DNA_DAMAGE_RESPONSE,0.99999
REACTOME_ANCHORING_FIBRIL_FO...,SET,13,-0.24142,-0.0064217,0.24442,0.83835,REACTOME_ANCHORING_FIBRIL_FORMATION,0.99999
GOMF_HYDROLASE_ACTIVITY_ACTI...3,SET,15,-0.21135,-0.0060385,0.21393,0.8384,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...523,SET,6,-0.33578,-0.006069,0.33985,0.83843,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY_BY_REGULATION_OF_PROTEIN_PHOSPHORYLATION,0.99999
WP_FAMILIAL_HYPERLIPIDEMIA_T...1,SET,16,-0.22031,-0.0065008,0.22293,0.83848,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...6,SET,45,-0.1311,-0.0064824,0.13265,0.8385,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1,0.99999
GOLDRATH_NAIVE_VS_EFF_CD8_TC...1,SET,180,-0.062087,-0.0061171,0.062807,0.83855,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN,0.99999
MIR6769A_5P,SET,43,-0.12596,-0.0060885,0.12741,0.83856,MIR6769A_5P,0.99999
STEIN_ESTROGEN_RESPONSE_NOT_...,SET,17,-0.22556,-0.0068603,0.22816,0.83857,STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA,0.99999
MORF_ARL3,SET,280,-0.050378,-0.0061735,0.05095,0.8386,MORF_ARL3,0.99999
GOBP_POSITIVE_REGULATION_OF_...590,SET,564,-0.036641,-0.0063225,0.037053,0.83864,GOBP_POSITIVE_REGULATION_OF_PHOSPHORYLATION,0.99999
GRUETZMANN_PANCREATIC_CANCER...2,SET,330,-0.046451,-0.0061711,0.046962,0.83869,GRUETZMANN_PANCREATIC_CANCER_UP,0.99999
KOHOUTEK_CCNT1_TARGETS,SET,47,-0.12741,-0.0064382,0.12881,0.8387,KOHOUTEK_CCNT1_TARGETS,0.99999
PID_GLYPICAN_1PATHWAY,SET,26,-0.17066,-0.0064173,0.17253,0.8387,PID_GLYPICAN_1PATHWAY,0.99999
GOBP_MULTICELLULAR_ORGANISMA...3,SET,24,-0.16612,-0.0060019,0.16793,0.83871,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_IRON_ION_HOMEOSTASIS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...10,SET,13,-0.24007,-0.0063857,0.24267,0.83873,HP_APLASIA_HYPOPLASIA_OF_THE_BLADDER,0.99999
MIR4323,SET,37,-0.13284,-0.0059573,0.13426,0.83876,MIR4323,0.99999
WEBER_METHYLATED_ICP_IN_SPER...2,SET,8,-0.32187,-0.0067171,0.32524,0.83881,WEBER_METHYLATED_ICP_IN_SPERM_UP,0.99999
REACTOME_MAPK6_MAPK4_SIGNALI...,SET,86,-0.086505,-0.0059064,0.087409,0.83882,REACTOME_MAPK6_MAPK4_SIGNALING,0.99999
REACTOME_PI3K_AKT_SIGNALING_...,SET,108,-0.083312,-0.0063708,0.084159,0.83889,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,0.99999
GOBP_LEUKOTRIENE_B4_METABOLI...,SET,5,-0.38091,-0.0062849,0.38477,0.8389,GOBP_LEUKOTRIENE_B4_METABOLIC_PROCESS,0.99999
HP_HYPOPLASIA_OF_THE_IRIS,SET,30,-0.16747,-0.0067637,0.16916,0.8389,HP_HYPOPLASIA_OF_THE_IRIS,0.99999
MIR504_3P,SET,130,-0.07021,-0.0058868,0.070895,0.83899,MIR504_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...560,SET,8,-0.35564,-0.0074218,0.35909,0.839,GOBP_POSITIVE_REGULATION_OF_OPSONIZATION,0.99999
GSE5542_IFNA_VS_IFNA_AND_IFN...3,SET,173,-0.060321,-0.0058276,0.060899,0.83903,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.99999
HP_FOOD_ALLERGY,SET,15,-0.22762,-0.0065032,0.22974,0.83909,HP_FOOD_ALLERGY,0.99999
GSE7852_LN_VS_FAT_TREG_DN,SET,181,-0.064422,-0.0063646,0.065021,0.8391,GSE7852_LN_VS_FAT_TREG_DN,0.99999
HP_LEIOMYOSARCOMA,SET,28,-0.16298,-0.0063598,0.16449,0.83911,HP_LEIOMYOSARCOMA,0.99999
chr4q22,SET,31,-0.28388,-0.011655,0.2865,0.83912,chr4q22,0.99999
GSE27786_CD8_TCELL_VS_NEUTRO...2,SET,175,-0.059864,-0.0058164,0.060409,0.83915,GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP,0.99999
chr2q24,SET,48,-0.23711,-0.012107,0.23924,0.83918,chr2q24,0.99999
MIR504_5P,SET,53,-0.11397,-0.0061144,0.11498,0.8392,MIR504_5P,0.99999
MODULE_73,SET,20,-0.21206,-0.0069949,0.21393,0.83921,MODULE_73,0.99999
GRAESSMANN_RESPONSE_TO_MC_AN...3,SET,76,-0.096639,-0.0062046,0.097486,0.83923,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,0.99999
GOMF_HEPARAN_SULFATE_PROTEOG...,SET,17,-0.23009,-0.0069979,0.23204,0.83929,GOMF_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING,0.99999
GSE45365_NK_CELL_VS_CD8_TCEL...2,SET,169,-0.065714,-0.0062755,0.066265,0.83932,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_DN,0.99999
HP_PALMOPLANTAR_HYPERKERATOS...,SET,120,-0.078973,-0.0063635,0.079626,0.83935,HP_PALMOPLANTAR_HYPERKERATOSIS,0.99999
LIU_CDX2_TARGETS_UP,SET,32,-0.15841,-0.0066073,0.15967,0.83942,LIU_CDX2_TARGETS_UP,0.99999
GOBP_RESPONSE_TO_CORTICOSTER...1,SET,146,-0.073766,-0.0065516,0.074343,0.83945,GOBP_RESPONSE_TO_CORTICOSTEROID,0.99999
GOBP_PROTEIN_HETEROTETRAMERI...,SET,15,-0.18997,-0.0054276,0.19144,0.83947,GOBP_PROTEIN_HETEROTETRAMERIZATION,0.99999
REACTOME_ACTIVATION_OF_KAINA...,SET,29,-0.16064,-0.0063791,0.16185,0.83951,REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING,0.99999
GSE17721_0.5H_VS_4H_LPS_BMDC...1,SET,184,-0.06175,-0.0061505,0.062217,0.83951,GSE17721_0.5H_VS_4H_LPS_BMDC_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...153,SET,11,-0.25979,-0.0063569,0.26174,0.83953,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,0.99999
HP_BROAD_NECK,SET,21,-0.17015,-0.005751,0.17136,0.83963,HP_BROAD_NECK,0.99999
NAKAYA_PBMC_FLUMIST_AGE_18_5...5,SET,10,-0.30829,-0.0071927,0.31044,0.83965,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_DN,0.99999
REACTOME_SLBP_DEPENDENT_PROC...,SET,11,-0.2123,-0.0051948,0.21372,0.83973,REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS,0.99999
MIR6768_5P,SET,186,-0.062487,-0.0062573,0.062904,0.83973,MIR6768_5P,0.99999
GOMF_SOLUTE_SODIUM_SYMPORTER...,SET,77,-0.10094,-0.006523,0.10159,0.83979,GOMF_SOLUTE_SODIUM_SYMPORTER_ACTIVITY,0.99999
BOGNI_TREATMENT_RELATED_MYEL...2,SET,25,-0.17073,-0.0062956,0.17179,0.83983,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,0.99999
REACTOME_DEFECTIVE_CHST3_CAU...,SET,7,-0.28468,-0.0055574,0.28646,0.83983,REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD,0.99999
GOBP_FLAVIN_CONTAINING_COMPO...,SET,6,-0.33571,-0.0060677,0.33782,0.83983,GOBP_FLAVIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_PINEAL_MORPHOLOGY,SET,10,-0.25586,-0.0059694,0.25746,0.83983,HP_ABNORMAL_PINEAL_MORPHOLOGY,0.99999
HP_ECTOPIC_ANUS,SET,72,-0.099822,-0.0062387,0.10044,0.83984,HP_ECTOPIC_ANUS,0.99999
GSE17721_0.5H_VS_24H_GARDIQU...2,SET,172,-0.06081,-0.005858,0.061183,0.83986,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_UP,0.99999
HP_FAILURE_TO_THRIVE,SET,956,-0.027529,-0.0061159,0.027687,0.83996,HP_FAILURE_TO_THRIVE,0.99999
GSE7596_AKT_TRANSD_VS_CTRL_C...2,SET,147,-0.068851,-0.0061358,0.069233,0.84,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP,0.99999
EVI1_04,SET,198,-0.063751,-0.0065845,0.064093,0.84004,EVI1_04,0.99999
GSE41867_NAIVE_VS_DAY8_LCMV_...4,SET,185,-0.05965,-0.0059573,0.059943,0.84015,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.99999
MIR4443,SET,155,-0.068787,-0.0062933,0.069091,0.84027,MIR4443,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...6,SET,5,-0.39409,-0.0065023,0.39567,0.84037,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_MITOCHONDRION,0.99999
GOBP_POSITIVE_REGULATION_OF_...694,SET,9,-0.28308,-0.0062658,0.28422,0.84037,GOBP_POSITIVE_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,0.99999
GOMF_DEUBIQUITINASE_ACTIVATO...,SET,7,-0.2743,-0.0053548,0.27539,0.84037,GOMF_DEUBIQUITINASE_ACTIVATOR_ACTIVITY,0.99999
HP_ABNORMAL_4TH_FINGER_MORPH...,SET,20,-0.20251,-0.0066798,0.20332,0.84037,HP_ABNORMAL_4TH_FINGER_MORPHOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...31,SET,5,-0.40855,-0.006741,0.41006,0.84044,GOBP_POSITIVE_REGULATION_OF_ANTIBACTERIAL_PEPTIDE_PRODUCTION,0.99999
HP_BIFID_NOSE,SET,11,-0.24381,-0.0059658,0.24472,0.84044,HP_BIFID_NOSE,0.99999
MIR6808_5P,SET,164,-0.065541,-0.0061665,0.06578,0.84046,MIR6808_5P,0.99999
GOMF_PROTEIN_TYROSINE_THREON...,SET,9,-0.32588,-0.0072131,0.32705,0.84047,GOMF_PROTEIN_TYROSINE_THREONINE_PHOSPHATASE_ACTIVITY,0.99999
GOBP_PYRIDINE_NUCLEOTIDE_BIO...,SET,27,-0.16487,-0.0063177,0.16546,0.84048,GOBP_PYRIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
MIR1267,SET,70,-0.098108,-0.0060461,0.098444,0.84051,MIR1267,0.99999
HP_ADRENOCORTICOTROPIC_HORMO...2,SET,4,-0.39613,-0.0058462,0.39746,0.84052,HP_ADRENOCORTICOTROPIC_HORMONE_EXCESS,0.99999
GOBP_INTESTINAL_STEM_CELL_HO...,SET,5,-0.36734,-0.006061,0.36847,0.84059,GOBP_INTESTINAL_STEM_CELL_HOMEOSTASIS,0.99999
GSE369_PRE_VS_POST_IL6_INJEC...3,SET,193,-0.059287,-0.0060464,0.059463,0.84062,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN,0.99999
MODULE_49,SET,249,-0.053675,-0.0062081,0.053822,0.84068,MODULE_49,0.99999
TGTTTGY_HNF3_Q6,SET,650,-0.034311,-0.0063404,0.034401,0.8407,TGTTTGY_HNF3_Q6,0.99999
GOBP_HEMATOPOIETIC_STEM_CELL...2,SET,19,-0.20627,-0.0066318,0.2068,0.84071,GOBP_HEMATOPOIETIC_STEM_CELL_HOMEOSTASIS,0.99999
REACTOME_HIGHLY_CALCIUM_PERM...2,SET,11,-0.30539,-0.0074726,0.30617,0.84072,REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,0.99999
GOBP_CELL_PROJECTION_MORPHOG...,SET,613,-0.03574,-0.0064205,0.03583,0.84073,GOBP_CELL_PROJECTION_MORPHOGENESIS,0.99999
MIR337_3P,SET,110,-0.080101,-0.0061813,0.080292,0.84076,MIR337_3P,0.99999
GOBP_REGULATION_OF_LEUKOCYTE...10,SET,18,-0.20947,-0.0065552,0.20995,0.84078,GOBP_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING,0.99999
HP_ABNORMALITY_OF_THE_VASCUL...,SET,336,-0.045748,-0.0061317,0.045853,0.84078,HP_ABNORMALITY_OF_THE_VASCULATURE_OF_THE_EYE,0.99999
GSE26890_CXCR1_NEG_VS_POS_EF...2,SET,180,-0.06328,-0.0062347,0.063416,0.84082,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP,0.99999
GOBP_KETONE_CATABOLIC_PROCESS,SET,12,-0.23348,-0.005967,0.23395,0.84086,GOBP_KETONE_CATABOLIC_PROCESS,0.99999
DESCARTES_FETAL_CEREBELLUM_O...,SET,68,-0.11241,-0.006828,0.11263,0.84086,DESCARTES_FETAL_CEREBELLUM_OLIGODENDROCYTES,0.99999
BOSCO_TH1_CYTOTOXIC_MODULE,SET,107,-0.087968,-0.0066957,0.088137,0.84087,BOSCO_TH1_CYTOTOXIC_MODULE,0.99999
HP_NONIMMUNE_HYDROPS_FETALIS,SET,58,-0.10314,-0.0057879,0.10334,0.84087,HP_NONIMMUNE_HYDROPS_FETALIS,0.99999
GSE6674_UNSTIM_VS_PL2_3_STIM...2,SET,132,-0.075584,-0.0063856,0.075722,0.8409,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP,0.99999
GOMF_ESTROGEN_2_HYDROXYLASE_...,SET,5,-0.419,-0.0069135,0.41973,0.84092,GOMF_ESTROGEN_2_HYDROXYLASE_ACTIVITY,0.99999
SNAPC4_TARGET_GENES,SET,60,-0.10618,-0.0060596,0.10633,0.84099,SNAPC4_TARGET_GENES,0.99999
HP_ABNORMALITY_OF_RETINAL_PI...,SET,283,-0.049535,-0.0061022,0.049586,0.84109,HP_ABNORMALITY_OF_RETINAL_PIGMENTATION,0.99999
ZHENG_FOXP3_TARGETS_IN_THYMU...2,SET,189,-0.066231,-0.0066849,0.066295,0.84111,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,0.99999
HP_TRANSIENT_GLOBAL_AMNESIA,SET,20,-0.18226,-0.0060122,0.18242,0.84113,HP_TRANSIENT_GLOBAL_AMNESIA,0.99999
GSE3982_NEUTROPHIL_VS_EFF_ME...1,SET,181,-0.058168,-0.0057467,0.058216,0.84114,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.99999
ZHOU_PANCREATIC_EXOCRINE_PRO...,SET,11,-0.29301,-0.0071697,0.29324,0.84115,ZHOU_PANCREATIC_EXOCRINE_PROGENITOR,0.99999
GOMF_METAL_DEPENDENT_DEUBIQU...,SET,11,-0.26696,-0.0065324,0.26704,0.84127,GOMF_METAL_DEPENDENT_DEUBIQUITINASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_POSTSYNAP...10,SET,15,-0.21821,-0.0062345,0.21826,0.84128,GOBP_REGULATION_OF_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY,0.99999
REACTOME_RUNX2_REGULATES_BON...,SET,28,-0.16927,-0.0066052,0.16931,0.84129,REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...406,SET,151,-0.073942,-0.0066779,0.073955,0.84129,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.99999
GOBP_REGULATION_OF_CELLULAR_...8,SET,7,-0.32233,-0.0062924,0.3224,0.84129,GOBP_REGULATION_OF_CELLULAR_PH_REDUCTION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...415,SET,9,-0.28678,-0.0063477,0.2868,0.84132,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ADAPTATION,0.99999
GOMF_SPHINGOSINE_N_ACYLTRANS...,SET,6,-0.35159,-0.0063547,0.35153,0.84138,GOMF_SPHINGOSINE_N_ACYLTRANSFERASE_ACTIVITY,0.99999
GOBP_SIGNAL_COMPLEX_ASSEMBLY,SET,8,-0.27522,-0.0057436,0.27516,0.84139,GOBP_SIGNAL_COMPLEX_ASSEMBLY,0.99999
HP_SPOTTY_HYPERPIGMENTATION,SET,9,-0.28213,-0.0062448,0.282,0.84145,HP_SPOTTY_HYPERPIGMENTATION,0.99999
GOBP_PEXOPHAGY,SET,5,-0.3726,-0.0061478,0.37229,0.84154,GOBP_PEXOPHAGY,0.99999
GSE30971_CTRL_VS_LPS_STIM_MA...4,SET,178,-0.063222,-0.0061946,0.063169,0.84154,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP,0.99999
GSE17721_LPS_VS_CPG_4H_BMDC_...2,SET,188,-0.061545,-0.0061956,0.061491,0.84155,GSE17721_LPS_VS_CPG_4H_BMDC_UP,0.99999
GOCC_CUTICULAR_PLATE,SET,8,-0.30371,-0.0063381,0.30343,0.84156,GOCC_CUTICULAR_PLATE,0.99999
HP_UTERINE_RUPTURE,SET,8,-0.34958,-0.0072953,0.34925,0.84156,HP_UTERINE_RUPTURE,0.99999
GOBP_REGULATION_OF_CARBOHYDR...3,SET,163,-0.065861,-0.0061779,0.065796,0.84158,GOBP_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,0.99999
HARALAMBIEVA_PBMC_FLUARIX_AG...8,SET,555,-0.033668,-0.0057643,0.033633,0.84159,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE,0.99999
HP_BROAD_DISTAL_PHALANX_OF_F...,SET,20,-0.1856,-0.0061223,0.18538,0.84163,HP_BROAD_DISTAL_PHALANX_OF_FINGER,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...1,SET,90,-0.093668,-0.0065418,0.09353,0.84169,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,0.99999
GGGYGTGNY_UNKNOWN,SET,598,-0.03467,-0.0061541,0.034618,0.8417,GGGYGTGNY_UNKNOWN,0.99999
MIR4725_5P,SET,52,-0.11626,-0.0061785,0.11608,0.84172,MIR4725_5P,0.99999
GOMF_FIBROBLAST_GROWTH_FACTO...1,SET,23,-0.17581,-0.0062187,0.1755,0.84177,GOMF_FIBROBLAST_GROWTH_FACTOR_BINDING,0.99999
GOCC_FIBRILLAR_COLLAGEN_TRIM...,SET,12,-0.26485,-0.0067687,0.26437,0.84178,GOCC_FIBRILLAR_COLLAGEN_TRIMER,0.99999
HP_RETROCEREBELLAR_CYST,SET,7,-0.28689,-0.0056006,0.28628,0.84185,HP_RETROCEREBELLAR_CYST,0.99999
MYOD_Q6_01,SET,237,-0.055026,-0.0062112,0.054908,0.84186,MYOD_Q6_01,0.99999
MACLACHLAN_BRCA1_TARGETS_UP,SET,19,-0.1895,-0.0060927,0.18908,0.84187,MACLACHLAN_BRCA1_TARGETS_UP,0.99999
WP_DISORDERS_OF_FOLATE_METAB...,SET,19,-0.17957,-0.0057736,0.17915,0.8419,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,0.99999
HP_MESOAXIAL_HAND_POLYDACTYLY,SET,10,-0.28189,-0.0065767,0.2812,0.84193,HP_MESOAXIAL_HAND_POLYDACTYLY,0.99999
DOUGLAS_BMI1_TARGETS_DN,SET,293,-0.049219,-0.0061677,0.049097,0.84194,DOUGLAS_BMI1_TARGETS_DN,0.99999
GSE3982_BCELL_VS_TH2_UP,SET,173,-0.063193,-0.006105,0.063035,0.84194,GSE3982_BCELL_VS_TH2_UP,0.99999
GOBP_B_CELL_LINEAGE_COMMITME...,SET,6,-0.31559,-0.005704,0.31479,0.84195,GOBP_B_CELL_LINEAGE_COMMITMENT,0.99999
GOBP_ARTERY_DEVELOPMENT,SET,99,-0.091553,-0.0067045,0.091319,0.84196,GOBP_ARTERY_DEVELOPMENT,0.99999
GOMF_PROTEIN_SERINE_THREONIN...1,SET,63,-0.10591,-0.0061933,0.10564,0.84197,GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,0.99999
GOBP_CELL_SUBSTRATE_JUNCTION...1,SET,8,-0.32682,-0.0068204,0.32591,0.84201,GOBP_CELL_SUBSTRATE_JUNCTION_DISASSEMBLY,0.99999
HP_INCREASED_ERYTHROCYTE_PRO...,SET,4,-0.42315,-0.0062449,0.4218,0.84211,HP_INCREASED_ERYTHROCYTE_PROTOPORPHYRIN_CONCENTRATION,0.99999
WP_LUNG_FIBROSIS,SET,59,-0.1172,-0.0066332,0.11682,0.84214,WP_LUNG_FIBROSIS,0.99999
REACTOME_METALLOTHIONEINS_BI...,SET,11,-0.39773,-0.009732,0.3964,0.84215,REACTOME_METALLOTHIONEINS_BIND_METALS,0.99999
MIR513A_5P,SET,346,-0.04684,-0.0063691,0.046679,0.84217,MIR513A_5P,0.99999
GOCC_INTEGRATOR_COMPLEX,SET,13,-0.21854,-0.005813,0.21779,0.84217,GOCC_INTEGRATOR_COMPLEX,0.99999
GSE29949_CD8_POS_DC_SPLEEN_V...4,SET,171,-0.064946,-0.0062383,0.064711,0.84221,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,0.99999
GOBP_MODIFICATION_DEPENDENT_...,SET,565,-0.03447,-0.0059528,0.034344,0.84222,GOBP_MODIFICATION_DEPENDENT_MACROMOLECULE_CATABOLIC_PROCESS,0.99999
MIR3085_5P,SET,33,-0.14382,-0.0060915,0.14324,0.8423,MIR3085_5P,0.99999
MIR6754_5P,SET,111,-0.078666,-0.006098,0.078355,0.8423,MIR6754_5P,0.99999
MIR4319,SET,404,-0.041863,-0.0061411,0.041678,0.84241,MIR4319,0.99999
HOLLMANN_APOPTOSIS_VIA_CD40_...1,SET,234,-0.056083,-0.0062908,0.055826,0.84245,HOLLMANN_APOPTOSIS_VIA_CD40_DN,0.99999
CC2D1A_TARGET_GENES,SET,1191,-0.025233,-0.0062146,0.025117,0.84246,CC2D1A_TARGET_GENES,0.99999
MIR5001_3P,SET,139,-0.070793,-0.0061362,0.070445,0.84253,MIR5001_3P,0.99999
GOBP_ACETYL_COA_METABOLIC_PR...,SET,30,-0.14983,-0.0060513,0.14909,0.84253,GOBP_ACETYL_COA_METABOLIC_PROCESS,0.99999
GOBP_D_AMINO_ACID_TRANSPORT,SET,6,-0.35896,-0.0064879,0.35717,0.84254,GOBP_D_AMINO_ACID_TRANSPORT,0.99999
TGFB_UP.V1_UP,SET,176,-0.068223,-0.0066474,0.067871,0.84259,TGFB_UP.V1_UP,0.99999
GOBP_SEQUESTERING_OF_BMP_IN_...,SET,4,-0.49076,-0.0072428,0.4882,0.8426,GOBP_SEQUESTERING_OF_BMP_IN_EXTRACELLULAR_MATRIX,0.99999
HP_ABNORMAL_GREATER_SCIATIC_...,SET,19,-0.20062,-0.0064502,0.19956,0.84262,HP_ABNORMAL_GREATER_SCIATIC_NOTCH_MORPHOLOGY,0.99999
GOBP_ORGAN_GROWTH,SET,151,-0.07312,-0.0066036,0.072726,0.84265,GOBP_ORGAN_GROWTH,0.99999
MIR1238_5P_MIR4758_5P,SET,43,-0.13093,-0.0063288,0.13022,0.84266,MIR1238_5P_MIR4758_5P,0.99999
PID_ECADHERIN_KERATINOCYTE_P...,SET,21,-0.17317,-0.0058529,0.1722,0.84269,PID_ECADHERIN_KERATINOCYTE_PATHWAY,0.99999
HP_INCREASED_ADIPOSE_TISSUE,SET,9,-0.27749,-0.0061421,0.27594,0.84269,HP_INCREASED_ADIPOSE_TISSUE,0.99999
GOMF_U4_SNRNA_BINDING,SET,5,-0.2708,-0.0044681,0.2692,0.84277,GOMF_U4_SNRNA_BINDING,0.99999
REACTOME_MATURATION_OF_SPIKE...,SET,35,-0.1413,-0.0061634,0.14042,0.84285,REACTOME_MATURATION_OF_SPIKE_PROTEIN,0.99999
HP_MULTINODULAR_GOITER,SET,5,-0.39149,-0.0064595,0.38901,0.84287,HP_MULTINODULAR_GOITER,0.99999
GOBP_REGULATION_OF_LEUKOCYTE...9,SET,246,-0.058521,-0.0067282,0.058146,0.84289,GOBP_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.99999
KEGG_MEDICUS_PATHOGEN_SALMON...3,SET,8,-0.26036,-0.0054334,0.25865,0.84293,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,0.99999
GOBP_RNA_PROCESSING,SET,831,-0.027834,-0.0057859,0.02765,0.84295,GOBP_RNA_PROCESSING,0.99999
DESCARTES_FETAL_INTESTINE_VA...,SET,38,-0.14799,-0.0067255,0.14699,0.84297,DESCARTES_FETAL_INTESTINE_VASCULAR_ENDOTHELIAL_CELLS,0.99999
GSE46606_IRF4_KO_VS_WT_UNSTI...1,SET,181,-0.066873,-0.0066068,0.066404,0.84304,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN,0.99999
DAVIES_MULTIPLE_MYELOMA_VS_M...2,SET,12,-0.21533,-0.0055032,0.21374,0.84313,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP,0.99999
GOBP_CAMERA_TYPE_EYE_PHOTORE...,SET,31,-0.15536,-0.0063784,0.1542,0.84316,GOBP_CAMERA_TYPE_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.99999
MIR371A_5P,SET,159,-0.066001,-0.0061152,0.0655,0.84318,MIR371A_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...522,SET,4,-0.40636,-0.0059971,0.40319,0.84323,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.99999
MODULE_215,SET,14,-0.26459,-0.0073035,0.26251,0.84325,MODULE_215,0.99999
BMI1_DN.V1_DN,SET,122,-0.083612,-0.0067929,0.082955,0.84325,BMI1_DN.V1_DN,0.99999
SU_PLACENTA,SET,23,-0.18381,-0.0065015,0.18234,0.84329,SU_PLACENTA,0.99999
YANG_BREAST_CANCER_ESR1_UP,SET,35,-0.14515,-0.0063312,0.14396,0.84332,YANG_BREAST_CANCER_ESR1_UP,0.99999
HP_SACCADIC_OSCILLATION,SET,20,-0.21555,-0.0071101,0.21374,0.84337,HP_SACCADIC_OSCILLATION,0.99999
REACTOME_PI3K_AKT_ACTIVATION,SET,9,-0.31186,-0.0069027,0.3092,0.84341,REACTOME_PI3K_AKT_ACTIVATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...330,SET,8,-0.34793,-0.0072609,0.34496,0.84341,GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,0.99999
MODULE_175,SET,52,-0.1217,-0.0064673,0.12066,0.84342,MODULE_175,0.99999
REACTOME_DAG_AND_IP3_SIGNALI...,SET,39,-0.14551,-0.006699,0.14423,0.84347,REACTOME_DAG_AND_IP3_SIGNALING,0.99999
GOCC_SYNAPSE_ASSOCIATED_EXTR...,SET,12,-0.24879,-0.0063582,0.2466,0.84348,GOCC_SYNAPSE_ASSOCIATED_EXTRACELLULAR_MATRIX,0.99999
MYCMAX_03,SET,230,-0.054657,-0.0060788,0.054167,0.84351,MYCMAX_03,0.99999
GAL_LEUKEMIC_STEM_CELL_DN,SET,212,-0.058639,-0.0062645,0.058104,0.84356,GAL_LEUKEMIC_STEM_CELL_DN,0.99999
CCAWWNAAGG_SRF_Q4,SET,77,-0.10286,-0.0066472,0.1019,0.84361,CCAWWNAAGG_SRF_Q4,0.99999
FOURNIER_ACINAR_DEVELOPMENT_...4,SET,22,-0.18467,-0.0063887,0.1829,0.84367,FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,0.99999
MIR5194,SET,33,-0.15475,-0.0065545,0.15321,0.84375,MIR5194,0.99999
YWATTWNNRGCT_UNKNOWN,SET,63,-0.11092,-0.0064859,0.1098,0.84379,YWATTWNNRGCT_UNKNOWN,0.99999
HP_IMPAIRMENT_OF_ACTIVITIES_...,SET,170,-0.065415,-0.0062652,0.064745,0.84383,HP_IMPAIRMENT_OF_ACTIVITIES_OF_DAILY_LIVING,0.99999
GSE37533_PPARG1_FOXP3_VS_FOX...3,SET,189,-0.063255,-0.0063845,0.062598,0.84386,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,0.99999
GOBP_BODY_MORPHOGENESIS,SET,45,-0.12249,-0.0060563,0.1212,0.84388,GOBP_BODY_MORPHOGENESIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...2,SET,11,-0.25109,-0.006144,0.24844,0.8439,GOBP_POSITIVE_REGULATION_OF_ACROSOME_REACTION,0.99999
GOMF_INORGANIC_DIPHOSPHATE_P...,SET,4,-0.48798,-0.0072017,0.48274,0.84395,GOMF_INORGANIC_DIPHOSPHATE_PHOSPHATASE_ACTIVITY,0.99999
MIR550B_3P,SET,49,-0.12406,-0.0064002,0.1227,0.844,MIR550B_3P,0.99999
REACTOME_PDH_COMPLEX_SYNTHES...,SET,4,-0.49196,-0.0072605,0.48649,0.84404,REACTOME_PDH_COMPLEX_SYNTHESIZES_ACETYL_COA_FROM_PYR,0.99999
GOMF_PYRUVATE_DEHYDROGENASE_...3,SET,4,-0.49196,-0.0072605,0.48649,0.84404,GOMF_PYRUVATE_DEHYDROGENASE_ACTIVITY,0.99999
REACTOME_MRNA_EDITING,SET,9,-0.28749,-0.0063633,0.28428,0.84405,REACTOME_MRNA_EDITING,0.99999
ZNF626_TARGET_GENES,SET,12,-0.23513,-0.0060091,0.23251,0.84405,ZNF626_TARGET_GENES,0.99999
chr10p11,SET,23,-0.29937,-0.010589,0.29598,0.84409,chr10p11,0.99999
GSE24726_WT_VS_E2_22_KO_PDC_...,SET,177,-0.062538,-0.0061105,0.061829,0.8441,GSE24726_WT_VS_E2_22_KO_PDC_DAY4_POST_DELETION_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...86,SET,72,-0.10495,-0.0065592,0.10374,0.84414,GOBP_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,0.99999
MIR6881_3P,SET,160,-0.066853,-0.0062134,0.066079,0.84415,MIR6881_3P,0.99999
MIR3168,SET,122,-0.075542,-0.0061372,0.074646,0.84422,MIR3168,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...2,SET,185,-0.061043,-0.0060964,0.060313,0.84425,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.99999
GSE22103_LPS_VS_GMCSF_AND_IF...2,SET,173,-0.061144,-0.005907,0.060411,0.84426,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,0.99999
REACTOME_ABERRANT_REGULATION...1,SET,19,-0.17517,-0.005632,0.17304,0.84429,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_EXIT_IN_CANCER_DUE_TO_RB1_DEFECTS,0.99999
GSE15733_BM_VS_SPLEEN_MEMORY...2,SET,175,-0.064988,-0.0063143,0.064198,0.8443,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP,0.99999
BIOCARTA_IL2RB_PATHWAY,SET,35,-0.15186,-0.0066239,0.14998,0.84435,BIOCARTA_IL2RB_PATHWAY,0.99999
GOBP_CELL_DIFFERENTIATION_IN...1,SET,24,-0.193,-0.0069733,0.19059,0.84438,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT,0.99999
REACTOME_DEPOLYMERIZATION_OF...,SET,14,-0.22171,-0.0061198,0.2189,0.84443,REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA,0.99999
MIR548AA_MIR548AP_3P_MIR548T...,SET,505,-0.038468,-0.0062914,0.037956,0.84458,MIR548AA_MIR548AP_3P_MIR548T_3P,0.99999
HP_LEUKONYCHIA,SET,14,-0.2307,-0.006368,0.22762,0.84459,HP_LEUKONYCHIA,0.99999
GSE7831_CPG_VS_INFLUENZA_STI...3,SET,177,-0.061783,-0.0060368,0.060951,0.84462,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_DN,0.99999
VANTVEER_BREAST_CANCER_BRCA1...1,SET,37,-0.14257,-0.0063937,0.14064,0.84464,VANTVEER_BREAST_CANCER_BRCA1_DN,0.99999
GSE37301_LYMPHOID_PRIMED_MPP...1,SET,176,-0.062175,-0.0060581,0.061333,0.84464,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_DN,0.99999
MIR4287,SET,115,-0.078827,-0.0062189,0.07774,0.8447,MIR4287,0.99999
REACTOME_G_ALPHA_I_SIGNALLIN...,SET,296,-0.055277,-0.0069617,0.054508,0.84473,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,0.99999
GSE7548_NAIVE_VS_DAY28_PCC_I...2,SET,186,-0.058399,-0.0058479,0.057581,0.84475,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,0.99999
WANG_ADIPOGENIC_GENES_REPRES...,SET,24,-0.174,-0.0062866,0.17149,0.84484,WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1,0.99999
GOBP_CHROMOSOME_SEPARATION,SET,78,-0.094786,-0.0061648,0.093415,0.84486,GOBP_CHROMOSOME_SEPARATION,0.99999
FAN_EMBRYONIC_CTX_BIG_GROUPS...5,SET,123,-0.08122,-0.0066254,0.080036,0.84489,FAN_EMBRYONIC_CTX_BIG_GROUPS_GLIAL,0.99999
PELLICCIOTTA_HDAC_IN_ANTIGEN...2,SET,60,-0.10106,-0.0057675,0.099549,0.84498,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,0.99999
NFMUE1_Q6,SET,217,-0.05739,-0.006202,0.056525,0.84501,NFMUE1_Q6,0.99999
GOMF_BICARBONATE_MONOATOMIC_...,SET,12,-0.24381,-0.0062308,0.24013,0.84501,GOMF_BICARBONATE_MONOATOMIC_ANION_ANTIPORTER_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_ITGA_...5,SET,27,-0.16317,-0.0062525,0.1607,0.84503,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,0.99999
GOMF_NEUROTRANSMITTER_RECEPT...1,SET,90,-0.099675,-0.0069613,0.098146,0.84508,GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.99999
GOBP_SEGMENT_SPECIFICATION,SET,15,-0.24231,-0.0069228,0.23854,0.84513,GOBP_SEGMENT_SPECIFICATION,0.99999
WP_EBOLA_VIRUS_INFECTION_IN_...,SET,122,-0.079753,-0.0064794,0.078502,0.84516,WP_EBOLA_VIRUS_INFECTION_IN_HOST,0.99999
GOMF_PHOSPHOLIPASE_A1_ACTIVI...,SET,13,-0.24151,-0.0064239,0.23767,0.84521,GOMF_PHOSPHOLIPASE_A1_ACTIVITY,0.99999
GOMF_NADPLUS_PROTEIN_LYSINE_...,SET,5,-0.38903,-0.0064188,0.38283,0.84522,GOMF_NADPLUS_PROTEIN_LYSINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.99999
GOCC_9PLUS0_NON_MOTILE_CILIUM,SET,114,-0.079081,-0.0062119,0.077809,0.84526,GOCC_9PLUS0_NON_MOTILE_CILIUM,0.99999
HP_ABSENT_BRAINSTEM_AUDITORY...,SET,9,-0.28907,-0.0063984,0.2844,0.84527,HP_ABSENT_BRAINSTEM_AUDITORY_RESPONSES,0.99999
LI_LUNG_CANCER,SET,40,-0.1316,-0.0061356,0.12947,0.84528,LI_LUNG_CANCER,0.99999
GOBP_TROPHOBLAST_CELL_MIGRAT...,SET,15,-0.22197,-0.0063419,0.21838,0.84529,GOBP_TROPHOBLAST_CELL_MIGRATION,0.99999
REACTOME_ACYL_CHAIN_REMODELL...3,SET,18,-0.21751,-0.0068071,0.21394,0.84534,REACTOME_ACYL_CHAIN_REMODELLING_OF_PG,0.99999
HP_MOTOR_SEIZURE,SET,367,-0.044747,-0.0062627,0.044011,0.84535,HP_MOTOR_SEIZURE,0.99999
DESCARTES_FETAL_PLACENTA_AFP...,SET,156,-0.073086,-0.0067081,0.071879,0.84537,DESCARTES_FETAL_PLACENTA_AFP_ALB_POSITIVE_CELLS,0.99999
GOCC_ENDOPLASMIC_RETICULUM_T...1,SET,24,-0.16301,-0.0058898,0.16031,0.84538,GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK,0.99999
HP_ERYTHROID_HYPERPLASIA,SET,14,-0.21121,-0.00583,0.20771,0.84539,HP_ERYTHROID_HYPERPLASIA,0.99999
HP_PULMONARY_ARTERY_HYPOPLAS...,SET,8,-0.33952,-0.0070854,0.33385,0.84541,HP_PULMONARY_ARTERY_HYPOPLASIA,0.99999
GOCC_SOMATODENDRITIC_COMPART...,SET,770,-0.032394,-0.0064933,0.031851,0.84543,GOCC_SOMATODENDRITIC_COMPARTMENT,0.99999
GOBP_GROWTH_PLATE_CARTILAGE_...1,SET,5,-0.44284,-0.0073067,0.43538,0.84545,GOBP_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...835,SET,11,-0.25949,-0.0063494,0.25512,0.84545,GOBP_POSITIVE_REGULATION_OF_VASCULOGENESIS,0.99999
HP_ABNORMALITY_OF_CIRCULATIN...2,SET,62,-0.1096,-0.0063581,0.10773,0.84551,HP_ABNORMALITY_OF_CIRCULATING_GLUCOCORTICOID_LEVEL,0.99999
WP_GPCRS_OTHER,SET,86,-0.10094,-0.006892,0.099211,0.84552,WP_GPCRS_OTHER,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...14,SET,174,-0.064963,-0.0062939,0.06385,0.84552,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.99999
HP_ABNORMAL_SERUM_INSULIN_LI...,SET,26,-0.16919,-0.0063623,0.16628,0.84554,HP_ABNORMAL_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1_LEVEL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...253,SET,16,-0.21336,-0.0062956,0.20968,0.84555,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION,0.99999
GOBP_SPHINGOMYELIN_METABOLIC...,SET,20,-0.18589,-0.0061318,0.18261,0.84565,GOBP_SPHINGOMYELIN_METABOLIC_PROCESS,0.99999
MIR3196,SET,19,-0.21139,-0.0067966,0.20765,0.84566,MIR3196,0.99999
MIR6733_5P,SET,240,-0.055291,-0.0062799,0.054312,0.84566,MIR6733_5P,0.99999
HP_MULTIFOCAL_SEIZURES,SET,16,-0.20324,-0.0059969,0.19964,0.84566,HP_MULTIFOCAL_SEIZURES,0.99999
MODULE_137,SET,492,-0.041296,-0.0066687,0.040561,0.84568,MODULE_137,0.99999
WP_IL5_SIGNALING,SET,38,-0.14582,-0.0066271,0.14322,0.84569,WP_IL5_SIGNALING,0.99999
HP_ABNORMAL_PULMONARY_VALVE_...1,SET,3,-0.53499,-0.0068378,0.52535,0.84573,HP_ABNORMAL_PULMONARY_VALVE_CUSP_MORPHOLOGY,0.99999
HP_EYELID_MYOCLONUS,SET,9,-0.2885,-0.0063857,0.28327,0.84576,HP_EYELID_MYOCLONUS,0.99999
REACTOME_DISEASES_OF_PROGRAM...,SET,42,-0.13112,-0.0062639,0.12873,0.84579,REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,0.99999
MIR1200,SET,301,-0.051377,-0.006524,0.050434,0.84582,MIR1200,0.99999
MIR6848_3P,SET,81,-0.10119,-0.006706,0.099311,0.84587,MIR6848_3P,0.99999
HP_PULMONARY_INTERSTITIAL_TH...,SET,7,-0.36443,-0.0071143,0.3576,0.84591,HP_PULMONARY_INTERSTITIAL_THICKENING,0.99999
HP_SYSTOLIC_HEART_MURMUR,SET,13,-0.27604,-0.0073424,0.27087,0.84591,HP_SYSTOLIC_HEART_MURMUR,0.99999
GOBP_LENS_MORPHOGENESIS_IN_C...,SET,19,-0.21469,-0.0069027,0.21066,0.84592,GOBP_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.99999
chr21q21,SET,25,-0.28201,-0.010399,0.27671,0.84593,chr21q21,0.99999
HP_ABNORMAL_URINE_PHOSPHATE_...,SET,26,-0.16576,-0.0062334,0.16261,0.84599,HP_ABNORMAL_URINE_PHOSPHATE_CONCENTRATION,0.99999
GOBP_RESPONSE_TO_ARSENIC_CON...,SET,30,-0.15469,-0.0062475,0.15174,0.846,GOBP_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,0.99999
KIM_ALL_DISORDERS_CALB1_CORR...1,SET,35,-0.15108,-0.0065897,0.14819,0.84601,KIM_ALL_DISORDERS_CALB1_CORR_DN,0.99999
GSE21379_TFH_VS_NON_TFH_CD4_...2,SET,178,-0.065303,-0.0063985,0.064052,0.84602,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP,0.99999
GOBP_PROTEIN_TO_MEMBRANE_DOC...,SET,5,-0.39944,-0.0065906,0.39176,0.84603,GOBP_PROTEIN_TO_MEMBRANE_DOCKING,0.99999
chr7p15,SET,40,-0.24139,-0.011254,0.23668,0.8461,chr7p15,0.99999
WP_MTHFR_DEFICIENCY,SET,22,-0.17604,-0.0060901,0.17257,0.84616,WP_MTHFR_DEFICIENCY,0.99999
GOMF_3_CHLOROALLYL_ALDEHYDE_...,SET,5,-0.3333,-0.0054994,0.32672,0.84616,GOMF_3_CHLOROALLYL_ALDEHYDE_DEHYDROGENASE_ACTIVITY,0.99999
MIR184,SET,7,-0.30343,-0.0059235,0.29742,0.84618,MIR184,0.99999
WP_GLP1_FROM_INTESTINE_AND_P...,SET,6,-0.40971,-0.0074051,0.40156,0.8462,WP_GLP1_FROM_INTESTINE_AND_PANCREAS_AND_ROLE_IN_GLUCOSE_HOMEOSTASIS,0.99999
GOBP_RESPONSE_TO_TEMPERATURE...,SET,160,-0.067919,-0.0063125,0.066568,0.8462,GOBP_RESPONSE_TO_TEMPERATURE_STIMULUS,0.99999
GOBP_INTRACELLULAR_PROTEIN_T...1,SET,29,-0.16046,-0.0063722,0.15726,0.84622,GOBP_INTRACELLULAR_PROTEIN_TRANSMEMBRANE_TRANSPORT,0.99999
HP_DUPLICATION_OF_THE_DISTAL...2,SET,6,-0.33237,-0.0060072,0.32568,0.84625,HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,0.99999
MIR6783_5P,SET,144,-0.07461,-0.0065815,0.073106,0.84627,MIR6783_5P,0.99999
KRAS.DF.V1_DN,SET,168,-0.068077,-0.0064821,0.066692,0.84631,KRAS.DF.V1_DN,0.99999
GSE34392_ST2_KO_VS_WT_DAY8_L...2,SET,182,-0.060972,-0.0060402,0.059726,0.84633,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_PR...2,SET,15,-0.24607,-0.0070303,0.241,0.84637,GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS,0.99999
HP_PROGRESSIVE_NIGHT_BLINDNE...,SET,85,-0.092548,-0.0062823,0.090632,0.8464,HP_PROGRESSIVE_NIGHT_BLINDNESS,0.99999
MIR513B_5P,SET,254,-0.054646,-0.0063827,0.053501,0.84646,MIR513B_5P,0.99999
HP_PATCHY_CHANGES_OF_BONE_MI...,SET,5,-0.38108,-0.0062877,0.37304,0.84649,HP_PATCHY_CHANGES_OF_BONE_MINERAL_DENSITY,0.99999
HP_PALMAR_HYPERLINEARITY,SET,6,-0.36097,-0.0065242,0.35325,0.84657,HP_PALMAR_HYPERLINEARITY,0.99999
GOBP_TELOMERE_MAINTENANCE_IN...,SET,30,-0.14974,-0.0060478,0.14653,0.84658,GOBP_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE,0.99999
HP_FACIAL_HYPEROSTOSIS,SET,4,-0.46985,-0.0069342,0.45975,0.8466,HP_FACIAL_HYPEROSTOSIS,0.99999
GOBP_XENOBIOTIC_CATABOLIC_PR...,SET,23,-0.1838,-0.0065011,0.17984,0.84661,GOBP_XENOBIOTIC_CATABOLIC_PROCESS,0.99999
HP_PHOTOPSIA,SET,90,-0.089777,-0.00627,0.087838,0.84662,HP_PHOTOPSIA,0.99999
HP_JOINT_SWELLING,SET,46,-0.13639,-0.0068182,0.13341,0.84669,HP_JOINT_SWELLING,0.99999
GOBP_MYOBLAST_FUSION,SET,44,-0.137,-0.0066983,0.13398,0.84672,GOBP_MYOBLAST_FUSION,0.99999
TRAVAGLINI_LUNG_ALVEOLAR_EPI...2,SET,126,-0.082411,-0.0068034,0.080593,0.84674,TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_2_CELL,0.99999
REACTOME_SEMA4D_MEDIATED_INH...,SET,8,-0.33476,-0.0069861,0.32727,0.84681,REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION,0.99999
GOBP_PROXIMAL_DISTAL_PATTERN...1,SET,34,-0.16697,-0.0071782,0.16321,0.84684,GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION,0.99999
MIR148A_5P,SET,102,-0.08576,-0.0063742,0.083816,0.84688,MIR148A_5P,0.99999
PAX6_01,SET,86,-0.098221,-0.0067064,0.095986,0.84691,PAX6_01,0.99999
MIR216B_3P,SET,115,-0.078517,-0.0061944,0.076721,0.84693,MIR216B_3P,0.99999
KEGG_MEDICUS_VARIANT_TGFA_OV...,SET,8,-0.30599,-0.0063858,0.29896,0.84696,KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,0.99999
GNF2_CCNA1,SET,56,-0.11744,-0.0064756,0.11473,0.84698,GNF2_CCNA1,0.99999
GSE20198_IL12_IL18_VS_IFNA_T...2,SET,186,-0.060906,-0.006099,0.0595,0.84699,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.99999
GOMF_CHLORIDE_TRANSMEMBRANE_...,SET,107,-0.088428,-0.0067307,0.086378,0.84701,GOMF_CHLORIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...290,SET,472,-0.04105,-0.0064965,0.040092,0.84705,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,0.99999
GOBP_SOFT_PALATE_DEVELOPMENT,SET,5,-0.45686,-0.0075381,0.44617,0.84707,GOBP_SOFT_PALATE_DEVELOPMENT,0.99999
ERWIN_COHEN_BLOOD_LIVE_VACCI...,SET,618,-0.035147,-0.0063387,0.034324,0.84707,ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP,0.99999
REACTOME_BASE_EXCISION_REPAI...,SET,17,-0.19604,-0.0059624,0.19144,0.84709,REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,0.99999
GSE19888_ADENOSINE_A3R_ACT_V...3,SET,182,-0.061156,-0.0060585,0.059712,0.84712,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN,0.99999
HALLMARK_ESTROGEN_RESPONSE_L...,SET,185,-0.066458,-0.0066372,0.064876,0.84716,HALLMARK_ESTROGEN_RESPONSE_LATE,0.99999
GSE27786_CD8_TCELL_VS_MONO_M...2,SET,171,-0.062796,-0.0060318,0.061299,0.84718,GSE27786_CD8_TCELL_VS_MONO_MAC_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_ADC...1,SET,151,-0.072306,-0.0065301,0.070566,0.84723,HE_LIM_SUN_FETAL_LUNG_C2_ADC_1_CELL,0.99999
EGFR_UP.V1_DN,SET,162,-0.068926,-0.0064457,0.067264,0.84724,EGFR_UP.V1_DN,0.99999
GOCC_SEH1_ASSOCIATED_COMPLEX,SET,12,-0.25974,-0.006638,0.25347,0.84725,GOCC_SEH1_ASSOCIATED_COMPLEX,0.99999
GSE15324_ELF4_KO_VS_WT_NAIVE...2,SET,181,-0.062842,-0.0062086,0.061314,0.84729,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP,0.99999
GOBP_PROTEIN_K48_LINKED_UBIQ...,SET,94,-0.086517,-0.0061745,0.084405,0.84732,GOBP_PROTEIN_K48_LINKED_UBIQUITINATION,0.99999
CERVERA_SDHB_TARGETS_1_UP,SET,111,-0.090131,-0.0069867,0.087923,0.84734,CERVERA_SDHB_TARGETS_1_UP,0.99999
WANG_RESPONSE_TO_BEXAROTENE_...2,SET,31,-0.14716,-0.0060417,0.14355,0.84735,WANG_RESPONSE_TO_BEXAROTENE_UP,0.99999
WP_PERTURBATIONS_TO_HOSTCELL...,SET,42,-0.12922,-0.0061733,0.12605,0.84735,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,0.99999
GOBP_LYSOSOMAL_PROTEIN_CATAB...,SET,18,-0.22329,-0.0069879,0.2178,0.84736,GOBP_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS,0.99999
REACTOME_RNA_POLYMERASE_II_T...2,SET,1234,-0.025734,-0.0064432,0.0251,0.84737,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION,0.99999
GSE37533_PPARG2_FOXP3_VS_FOX...3,SET,175,-0.065592,-0.006373,0.063976,0.84737,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,0.99999
GSE19401_UNSTIM_VS_RETINOIC_...1,SET,184,-0.064917,-0.006466,0.063317,0.84738,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.99999
NFY_Q6,SET,223,-0.059156,-0.0064796,0.057682,0.84744,NFY_Q6,0.99999
MIR485_3P,SET,207,-0.064125,-0.0067703,0.062522,0.84746,MIR485_3P,0.99999
GSE28737_WT_VS_BCL6_KO_MARGI...2,SET,178,-0.063647,-0.0062362,0.062049,0.84749,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,0.99999
DESCARTES_FETAL_LIVER_MESOTH...,SET,266,-0.057285,-0.0068449,0.055828,0.84757,DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS,0.99999
GOBP_VENTRICULAR_SEPTUM_MORP...,SET,40,-0.15655,-0.0072989,0.15256,0.84758,GOBP_VENTRICULAR_SEPTUM_MORPHOGENESIS,0.99999
GOBP_FORMATION_OF_EXTRACHROM...,SET,13,-0.21563,-0.0057357,0.21008,0.84765,GOBP_FORMATION_OF_EXTRACHROMOSOMAL_CIRCULAR_DNA,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...55,SET,35,-0.12731,-0.005553,0.12402,0.84766,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,0.99999
GSE43955_1H_VS_10H_ACT_CD4_T...4,SET,173,-0.067281,-0.0064999,0.065532,0.84771,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.99999
REACTOME_PLASMA_LIPOPROTEIN_...4,SET,30,-0.16351,-0.006604,0.15923,0.84776,REACTOME_PLASMA_LIPOPROTEIN_REMODELING,0.99999
GSE7852_LN_VS_FAT_TREG_UP,SET,181,-0.061121,-0.0060385,0.059512,0.84779,GSE7852_LN_VS_FAT_TREG_UP,0.99999
BOYLAN_MULTIPLE_MYELOMA_PCA1...2,SET,98,-0.09201,-0.0067041,0.089551,0.84789,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,0.99999
REACTOME_SIGNALING_BY_FGFR2_...2,SET,42,-0.1299,-0.0062057,0.12643,0.84789,REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE,0.99999
GOBP_BILE_ACID_SIGNALING_PAT...,SET,11,-0.27461,-0.0067195,0.26726,0.8479,GOBP_BILE_ACID_SIGNALING_PATHWAY,0.99999
GOMF_PYRIMIDINE_NUCLEOTIDE_S...,SET,10,-0.26345,-0.0061465,0.25637,0.84792,GOMF_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
DHIMAN_PBMC_ATTENUVAX_AGE_15...1,SET,17,-0.209,-0.0063566,0.20338,0.84793,DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_DN,0.99999
SCHAVOLT_TARGETS_OF_TP53_AND...,SET,15,-0.18811,-0.0053744,0.18302,0.84797,SCHAVOLT_TARGETS_OF_TP53_AND_TP63,0.99999
REACTOME_RND2_GTPASE_CYCLE,SET,40,-0.12977,-0.0060503,0.12623,0.84803,REACTOME_RND2_GTPASE_CYCLE,0.99999
HP_TOTAL_ANOMALOUS_PULMONARY...,SET,11,-0.23435,-0.0057343,0.22795,0.84803,HP_TOTAL_ANOMALOUS_PULMONARY_VENOUS_RETURN,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...10,SET,186,-0.061794,-0.0061879,0.060106,0.84804,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP,0.99999
HP_PERISYLVIAN_POLYMICROGYRIA,SET,32,-0.16133,-0.0067292,0.15688,0.84811,HP_PERISYLVIAN_POLYMICROGYRIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...780,SET,4,-0.38666,-0.0057065,0.37579,0.84824,GOBP_POSITIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.99999
MODULE_334,SET,146,-0.069765,-0.0061963,0.067799,0.84825,MODULE_334,0.99999
GSE22611_UNSTIM_VS_6H_MDP_ST...2,SET,178,-0.065175,-0.0063859,0.063326,0.8483,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.99999
DAZARD_UV_RESPONSE_CLUSTER_G...1,SET,21,-0.20396,-0.0068938,0.19817,0.84831,DAZARD_UV_RESPONSE_CLUSTER_G24,0.99999
WP_NEOVASCULARIZATION_PROCES...,SET,36,-0.16341,-0.0072285,0.15876,0.84832,WP_NEOVASCULARIZATION_PROCESSES,0.99999
HP_CEREBRAL_EDEMA,SET,28,-0.15886,-0.0061987,0.15434,0.84832,HP_CEREBRAL_EDEMA,0.99999
LIN_MELANOMA_COPY_NUMBER_DN,SET,38,-0.14299,-0.0064983,0.13892,0.84833,LIN_MELANOMA_COPY_NUMBER_DN,0.99999
CENPT_TARGET_GENES,SET,49,-0.1225,-0.0063197,0.11901,0.84833,CENPT_TARGET_GENES,0.99999
GOBP_REGULATION_OF_ACUTE_INF...1,SET,44,-0.13841,-0.0067674,0.13444,0.84838,GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...13,SET,181,-0.065936,-0.0065142,0.064044,0.84838,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_DN,0.99999
GOBP_PROTEIN_K29_LINKED_UBIQ...,SET,10,-0.27037,-0.006308,0.2626,0.84839,GOBP_PROTEIN_K29_LINKED_UBIQUITINATION,0.99999
MODULE_79,SET,89,-0.097638,-0.0067813,0.094827,0.8484,MODULE_79,0.99999
GOBP_METANEPHRIC_DISTAL_TUBU...,SET,6,-0.39106,-0.0070681,0.37958,0.84855,GOBP_METANEPHRIC_DISTAL_TUBULE_DEVELOPMENT,0.99999
GSE22443_IL2_VS_IL12_TREATED...1,SET,188,-0.061964,-0.0062379,0.060137,0.84858,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN,0.99999
MIR1226_5P,SET,40,-0.13953,-0.0065055,0.13539,0.84862,MIR1226_5P,0.99999
WEIGEL_OXIDATIVE_STRESS_BY_T...,SET,35,-0.14836,-0.0064712,0.14389,0.84874,WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,0.99999
MIR651_3P,SET,728,-0.033121,-0.006463,0.032122,0.84874,MIR651_3P,0.99999
HP_ABNORMAL_CIRCULATING_GLUT...1,SET,11,-0.23207,-0.0056786,0.22507,0.84875,HP_ABNORMAL_CIRCULATING_GLUTAMINE_CONCENTRATION,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...5,SET,426,-0.041194,-0.0062015,0.039942,0.84881,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,0.99999
HP_VENTRICULOMEGALY,SET,641,-0.034114,-0.0062618,0.033066,0.84889,HP_VENTRICULOMEGALY,0.99999
HP_ASPIRATION,SET,26,-0.16872,-0.0063444,0.16352,0.84891,HP_ASPIRATION,0.99999
CAIRO_HEPATOBLASTOMA_CLASSES...1,SET,194,-0.064728,-0.0066181,0.062731,0.84892,CAIRO_HEPATOBLASTOMA_CLASSES_DN,0.99999
GCM_MAX,SET,29,-0.15114,-0.0060017,0.14647,0.84892,GCM_MAX,0.99999
WP_FATTY_ACIDS_AND_LIPOPROTE...,SET,355,-0.046763,-0.0064391,0.045318,0.84893,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,0.99999
HP_WIDE_PUBIC_SYMPHYSIS,SET,7,-0.3636,-0.0070981,0.35234,0.84895,HP_WIDE_PUBIC_SYMPHYSIS,0.99999
HP_HYPERGLYCEMIA,SET,77,-0.098639,-0.0063743,0.095575,0.84897,HP_HYPERGLYCEMIA,0.99999
GOMF_DNA_POLYMERASE_ACTIVITY,SET,27,-0.13141,-0.0050355,0.1273,0.84902,GOMF_DNA_POLYMERASE_ACTIVITY,0.99999
HP_INCREASED_ASPARTATE_FAMIL...,SET,7,-0.32559,-0.0063561,0.31537,0.84905,HP_INCREASED_ASPARTATE_FAMILY_AMINO_ACID_LEVEL_IN_URINE,0.99999
GSE3982_NEUTROPHIL_VS_EFF_ME...2,SET,182,-0.063566,-0.0062972,0.061569,0.84906,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
HP_UPPER_EYELID_EDEMA,SET,6,-0.37436,-0.0067663,0.36247,0.84914,HP_UPPER_EYELID_EDEMA,0.99999
HP_NARROW_ILIAC_WING,SET,8,-0.28479,-0.0059433,0.27571,0.84917,HP_NARROW_ILIAC_WING,0.99999
HP_ALOBAR_HOLOPROSENCEPHALY,SET,6,-0.40616,-0.0073409,0.39313,0.84922,HP_ALOBAR_HOLOPROSENCEPHALY,0.99999
HP_ANOPHTHALMIA,SET,59,-0.10873,-0.0061537,0.10525,0.84922,HP_ANOPHTHALMIA,0.99999
HP_EXTRAPYRAMIDAL_DYSKINESIA,SET,6,-0.3941,-0.007123,0.38147,0.84922,HP_EXTRAPYRAMIDAL_DYSKINESIA,0.99999
GOBP_REGULATION_OF_MITOCHOND...3,SET,6,-0.32796,-0.0059276,0.31743,0.84923,GOBP_REGULATION_OF_MITOCHONDRIAL_DNA_METABOLIC_PROCESS,0.99999
BORCZUK_MALIGNANT_MESOTHELIO...2,SET,266,-0.050231,-0.006002,0.048617,0.84924,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,0.99999
REACTOME_TRAFFICKING_AND_PRO...,SET,11,-0.2791,-0.0068293,0.27011,0.84926,REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR,0.99999
GOBP_COMMON_MYELOID_PROGENIT...,SET,9,-0.28681,-0.0063483,0.27751,0.84931,GOBP_COMMON_MYELOID_PROGENITOR_CELL_PROLIFERATION,0.99999
TRAVAGLINI_LUNG_NATURAL_KILL...2,SET,30,-0.17953,-0.007251,0.17365,0.84939,TRAVAGLINI_LUNG_NATURAL_KILLER_T_CELL,0.99999
HP_CLAW_HAND_DEFORMITY,SET,8,-0.31869,-0.0066507,0.30821,0.84942,HP_CLAW_HAND_DEFORMITY,0.99999
RAGHAVACHARI_PLATELET_SPECIF...,SET,60,-0.11866,-0.006772,0.11476,0.84943,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,0.99999
GOBP_REGULATION_OF_MIRNA_CAT...,SET,4,-0.3715,-0.0054827,0.35928,0.84943,GOBP_REGULATION_OF_MIRNA_CATABOLIC_PROCESS,0.99999
WP_HEAD_AND_NECK_SQUAMOUS_CE...,SET,73,-0.10432,-0.0065649,0.10088,0.84945,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,0.99999
GOBP_GLUCOSE_6_PHOSPHATE_MET...,SET,26,-0.17352,-0.0065252,0.1678,0.84945,GOBP_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS,0.99999
RIGGINS_TAMOXIFEN_RESISTANCE...2,SET,53,-0.1291,-0.0069261,0.12483,0.84947,RIGGINS_TAMOXIFEN_RESISTANCE_UP,0.99999
KEGG_MEDICUS_ENV_FACTOR_TCDD...,SET,19,-0.23917,-0.0076898,0.23127,0.84947,KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...127,SET,53,-0.1225,-0.0065721,0.11845,0.84947,GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,0.99999
HP_IRREGULAR_CAPITAL_FEMORAL...,SET,4,-0.39108,-0.0057716,0.37815,0.84947,HP_IRREGULAR_CAPITAL_FEMORAL_EPIPHYSIS,0.99999
REACTOME_TELOMERE_EXTENSION_...,SET,22,-0.17519,-0.0060604,0.16937,0.8495,REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE,0.99999
MIR8087,SET,125,-0.077277,-0.0063544,0.07471,0.84951,MIR8087,0.99999
ZNF224_TARGET_GENES,SET,1078,-0.027122,-0.0063759,0.026219,0.84953,ZNF224_TARGET_GENES,0.99999
HP_PROXIMAL_RADIO_ULNAR_SYNO...,SET,6,-0.42444,-0.0076714,0.41029,0.84954,HP_PROXIMAL_RADIO_ULNAR_SYNOSTOSIS,0.99999
MURAKAMI_UV_RESPONSE_6HR_DN,SET,21,-0.19463,-0.0065785,0.18814,0.84955,MURAKAMI_UV_RESPONSE_6HR_DN,0.99999
GOBP_REGULATION_OF_OPSONIZAT...,SET,10,-0.33726,-0.0078686,0.32595,0.84958,GOBP_REGULATION_OF_OPSONIZATION,0.99999
GOBP_REGULATION_OF_T_CIRCLE_...,SET,5,-0.31718,-0.0052333,0.30652,0.8496,GOBP_REGULATION_OF_T_CIRCLE_FORMATION,0.99999
GSE37534_UNTREATED_VS_PIOGLI...2,SET,176,-0.063813,-0.0062177,0.061636,0.84974,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...631,SET,18,-0.19264,-0.0060286,0.18604,0.84977,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE,0.99999
NADELLA_PRKAR1A_TARGETS_UP,SET,9,-0.33149,-0.0073374,0.32004,0.84984,NADELLA_PRKAR1A_TARGETS_UP,0.99999
MIR4524B_3P,SET,65,-0.11229,-0.0066692,0.10841,0.84984,MIR4524B_3P,0.99999
MIR323A_5P,SET,39,-0.12867,-0.005924,0.12421,0.84987,MIR323A_5P,0.99999
WP_INFLAMMATORY_RESPONSE_PAT...,SET,28,-0.17638,-0.0068826,0.17023,0.84992,WP_INFLAMMATORY_RESPONSE_PATHWAY,0.99999
HP_GLYCOSURIA,SET,40,-0.13498,-0.0062931,0.13027,0.84993,HP_GLYCOSURIA,0.99999
HARALAMBIEVA_PBMC_M_M_R_II_A...5,SET,13,-0.27618,-0.0073462,0.26643,0.85003,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_LOW_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_UP,0.99999
GOBP_GLYCINE_BIOSYNTHETIC_PR...,SET,5,-0.38953,-0.0064271,0.37574,0.85006,GOBP_GLYCINE_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMAL_CIRCULATING_GLUT...2,SET,30,-0.14751,-0.0059576,0.14228,0.85007,HP_ABNORMAL_CIRCULATING_GLUTAMINE_FAMILY_AMINO_ACID_CONCENTRATION,0.99999
GOBP_REGULATION_OF_PROTEIN_F...,SET,9,-0.30228,-0.0066907,0.29152,0.85011,GOBP_REGULATION_OF_PROTEIN_FOLDING,0.99999
GOBP_REGULATION_OF_MITOTIC_C...3,SET,9,-0.2624,-0.005808,0.25303,0.85012,GOBP_REGULATION_OF_MITOTIC_CENTROSOME_SEPARATION,0.99999
DUNNE_TARGETS_OF_AML1_MTG8_F...1,SET,17,-0.21398,-0.0065079,0.20634,0.85013,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...661,SET,17,-0.22324,-0.0067895,0.21524,0.85016,GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,0.99999
GOBP_NEUROMUSCULAR_JUNCTION_...,SET,47,-0.12598,-0.0063659,0.12147,0.85017,GOBP_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,0.99999
HP_CAROTID_ARTERY_TORTUOSITY,SET,4,-0.46773,-0.0069028,0.45092,0.85019,HP_CAROTID_ARTERY_TORTUOSITY,0.99999
GSE8515_IL1_VS_IL6_4H_STIM_M...2,SET,176,-0.066182,-0.0064485,0.063789,0.85024,GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP,0.99999
GOBP_CELL_COMMUNICATION_INVO...,SET,55,-0.12979,-0.0070928,0.12509,0.85026,GOBP_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION,0.99999
GOBP_REGULATION_OF_MODIFICAT...2,SET,9,-0.26123,-0.0057822,0.25173,0.8503,GOBP_REGULATION_OF_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE,0.99999
GGGACCA_MIR133A_MIR133B,SET,184,-0.067264,-0.0066997,0.064803,0.85035,GGGACCA_MIR133A_MIR133B,0.99999
GOBP_CEREBRAL_CORTEX_RADIALL...,SET,33,-0.16484,-0.0069822,0.15881,0.85035,GOBP_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION,0.99999
GOMF_TYPE_I_INTERFERON_RECEP...,SET,13,-0.36961,-0.0098313,0.35608,0.85036,GOMF_TYPE_I_INTERFERON_RECEPTOR_BINDING,0.99999
HP_IMPAIRED_SMOOTH_PURSUIT,SET,38,-0.13069,-0.0059393,0.12591,0.85036,HP_IMPAIRED_SMOOTH_PURSUIT,0.99999
KEGG_MEDICUS_REFERENCE_TGF_B...,SET,8,-0.34837,-0.0072701,0.33559,0.85038,KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY,0.99999
MIR150_5P,SET,160,-0.066913,-0.006219,0.064452,0.8504,MIR150_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...245,SET,32,-0.16029,-0.0066859,0.15438,0.85043,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.99999
GSE32986_GMCSF_AND_CURDLAN_L...2,SET,178,-0.064203,-0.0062907,0.061834,0.85043,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.99999
GSE14415_INDUCED_TREG_VS_FOX...3,SET,161,-0.070917,-0.0066115,0.068297,0.85044,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...447,SET,5,-0.46697,-0.0077049,0.4497,0.85045,GOBP_POSITIVE_REGULATION_OF_MELANOCYTE_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_MRNA_EXPO...,SET,8,-0.2603,-0.0054323,0.25067,0.85046,GOBP_REGULATION_OF_MRNA_EXPORT_FROM_NUCLEUS,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...35,SET,17,-0.24185,-0.0073557,0.2329,0.85046,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS,0.99999
GOBP_C_X_C_CHEMOKINE_RECEPTO...,SET,5,-0.41937,-0.0069196,0.40376,0.85051,GOBP_C_X_C_CHEMOKINE_RECEPTOR_CXCR4_SIGNALING_PATHWAY,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_SPP...,SET,44,-0.13596,-0.0066478,0.1309,0.85051,HE_LIM_SUN_FETAL_LUNG_C2_SPP1_POS_MACROPHAGE_CELL,0.99999
GOBP_RECEPTOR_INTERNALIZATION,SET,120,-0.079837,-0.0064331,0.076853,0.85055,GOBP_RECEPTOR_INTERNALIZATION,0.99999
HP_ABNORMALITY_OF_THE_MUSCUL...4,SET,12,-0.26481,-0.0067677,0.25491,0.85056,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_ARM,0.99999
REACTOME_NEGATIVE_REGULATION...9,SET,20,-0.19949,-0.0065804,0.19202,0.85057,REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION,0.99999
WESTON_VEGFA_TARGETS_6HR,SET,43,-0.14225,-0.0068757,0.1369,0.85059,WESTON_VEGFA_TARGETS_6HR,0.99999
HP_BREAST_APLASIA,SET,16,-0.22446,-0.0066232,0.21596,0.85068,HP_BREAST_APLASIA,0.99999
GSE30962_ACUTE_VS_CHRONIC_LC...2,SET,176,-0.064188,-0.0062542,0.061755,0.85068,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP,0.99999
SMITH_LIVER_CANCER,SET,45,-0.13352,-0.0066018,0.12843,0.85073,SMITH_LIVER_CANCER,0.99999
TACTTGA_MIR26A_MIR26B,SET,273,-0.053613,-0.0064885,0.05156,0.85078,TACTTGA_MIR26A_MIR26B,0.99999
REACTOME_MRNA_SPLICING,SET,191,-0.056412,-0.0057236,0.054231,0.85087,REACTOME_MRNA_SPLICING,0.99999
STARK_HYPPOCAMPUS_22Q11_DELE...1,SET,19,-0.26063,-0.0083796,0.2505,0.85092,STARK_HYPPOCAMPUS_22Q11_DELETION_DN,0.99999
GOCC_CUL3_RING_UBIQUITIN_LIG...,SET,37,-0.14187,-0.0063624,0.13635,0.85095,GOCC_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX,0.99999
GOBP_CYTIDINE_METABOLIC_PROC...,SET,11,-0.35992,-0.0088069,0.34587,0.85097,GOBP_CYTIDINE_METABOLIC_PROCESS,0.99999
VALK_AML_CLUSTER_3,SET,27,-0.181,-0.0069359,0.17393,0.85098,VALK_AML_CLUSTER_3,0.99999
KEGG_GLYCEROPHOSPHOLIPID_MET...,SET,69,-0.10889,-0.0066625,0.10463,0.85098,KEGG_GLYCEROPHOSPHOLIPID_METABOLISM,0.99999
GSE360_CTRL_VS_B_MALAYI_LOW_...2,SET,180,-0.06658,-0.0065598,0.063977,0.85098,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP,0.99999
WANG_CLIM2_TARGETS_DN,SET,162,-0.063722,-0.0059591,0.06123,0.85099,WANG_CLIM2_TARGETS_DN,0.99999
GOCC_FASCIA_ADHERENS,SET,9,-0.33705,-0.0074604,0.32384,0.85101,GOCC_FASCIA_ADHERENS,0.99999
GOBP_REGULATION_OF_FEAR_RESP...,SET,8,-0.3522,-0.0073501,0.33837,0.85103,GOBP_REGULATION_OF_FEAR_RESPONSE,0.99999
GOBP_PROTEIN_LIPID_COMPLEX_A...,SET,26,-0.16836,-0.0063309,0.16171,0.85108,GOBP_PROTEIN_LIPID_COMPLEX_ASSEMBLY,0.99999
REACTOME_ACTIVATED_NTRK2_SIG...1,SET,6,-0.37339,-0.0067486,0.35857,0.85113,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5,0.99999
KEGG_MEDICUS_PATHOGEN_SHIGEL...7,SET,28,-0.15093,-0.0058896,0.14494,0.85114,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,0.99999
GSE17721_0.5H_VS_12H_GARDIQU...1,SET,189,-0.062789,-0.0063375,0.060293,0.85115,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN,0.99999
HP_ENLARGED_METAPHYSES,SET,5,-0.37625,-0.0062081,0.36125,0.85118,HP_ENLARGED_METAPHYSES,0.99999
HP_ABNORMALITY_OF_SKULL_OSSI...,SET,46,-0.12758,-0.0063777,0.12249,0.85119,HP_ABNORMALITY_OF_SKULL_OSSIFICATION,0.99999
GOBP_DEVELOPMENTAL_GROWTH_IN...,SET,211,-0.063508,-0.0067688,0.060969,0.8512,GOBP_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS,0.99999
HP_MICROCYTIC_ANEMIA,SET,37,-0.14799,-0.0066366,0.14207,0.85121,HP_MICROCYTIC_ANEMIA,0.99999
MIR1227_3P,SET,67,-0.1063,-0.0064096,0.10204,0.85124,MIR1227_3P,0.99999
GOBP_REGULATION_OF_ENDODEOXY...,SET,8,-0.32882,-0.0068622,0.31561,0.85125,GOBP_REGULATION_OF_ENDODEOXYRIBONUCLEASE_ACTIVITY,0.99999
HP_AMENORRHEA,SET,171,-0.067106,-0.0064458,0.064405,0.85127,HP_AMENORRHEA,0.99999
GOBP_ENDOCYTIC_RECYCLING,SET,74,-0.10286,-0.0065171,0.09872,0.85128,GOBP_ENDOCYTIC_RECYCLING,0.99999
GSE24726_WT_VS_E2_2_KO_PDC_D...2,SET,175,-0.065741,-0.0063875,0.063093,0.85128,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN,0.99999
XU_GH1_AUTOCRINE_TARGETS_UP,SET,158,-0.069949,-0.0064608,0.067129,0.85129,XU_GH1_AUTOCRINE_TARGETS_UP,0.99999
GOBP_REGULATION_OF_CATECHOLA...2,SET,8,-0.32409,-0.0067635,0.31093,0.85136,GOBP_REGULATION_OF_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION,0.99999
HP_RICKETS,SET,37,-0.15249,-0.0068382,0.14629,0.85136,HP_RICKETS,0.99999
WANG_BARRETTS_ESOPHAGUS_UP,SET,50,-0.13431,-0.0069995,0.12883,0.85143,WANG_BARRETTS_ESOPHAGUS_UP,0.99999
GOBP_REGULATION_OF_HEART_RAT...1,SET,39,-0.15397,-0.0070886,0.14766,0.85145,GOBP_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION,0.99999
GSE43700_UNTREATED_VS_IL10_T...1,SET,187,-0.064952,-0.0065215,0.062293,0.85145,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN,0.99999
GOBP_CALCITONIN_FAMILY_RECEP...,SET,7,-0.36176,-0.0070622,0.34694,0.85146,GOBP_CALCITONIN_FAMILY_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE15750_WT_VS_TRAF6KO_DAY6_...1,SET,185,-0.064387,-0.0064304,0.061724,0.85155,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN,0.99999
MIR6890_3P,SET,82,-0.09977,-0.0066525,0.095636,0.85157,MIR6890_3P,0.99999
GOMF_POLY_A_RNA_POLYMERASE_A...,SET,5,-0.42071,-0.0069416,0.40323,0.8516,GOMF_POLY_A_RNA_POLYMERASE_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...626,SET,10,-0.32096,-0.0074882,0.30758,0.85163,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,0.99999
PEDERSEN_METASTASIS_BY_ERBB2...6,SET,346,-0.04842,-0.0065839,0.046389,0.8517,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,0.99999
GOBP_NEGATIVE_REGULATION_OF_...74,SET,125,-0.081585,-0.0067087,0.078161,0.85171,GOBP_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,0.99999
REACTOME_PTK6_REGULATES_RHO_...,SET,14,-0.21707,-0.0059917,0.20793,0.85174,REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES,0.99999
HP_PREMATURE_OSTEOARTHRITIS,SET,9,-0.30761,-0.0068088,0.2946,0.85179,HP_PREMATURE_OSTEOARTHRITIS,0.99999
GSE40277_EOS_AND_LEF1_TRANSD...4,SET,179,-0.06538,-0.0064239,0.062597,0.85186,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP,0.99999
GSE24814_STAT5_KO_VS_WT_PRE_...2,SET,175,-0.069414,-0.0067444,0.06645,0.85189,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP,0.99999
GSE21670_UNTREATED_VS_TGFB_T...4,SET,181,-0.063111,-0.0062352,0.060414,0.8519,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP,0.99999
MIR4652_5P,SET,32,-0.15478,-0.0064559,0.14815,0.85192,MIR4652_5P,0.99999
GOBP_INDOLALKYLAMINE_METABOL...,SET,11,-0.29574,-0.0072366,0.28295,0.85203,GOBP_INDOLALKYLAMINE_METABOLIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_CORE_...,SET,27,-0.13552,-0.005193,0.12964,0.85207,KEGG_MEDICUS_REFERENCE_CORE_NER_REACTION,0.99999
GOCC_N_TERMINAL_PROTEIN_ACET...,SET,9,-0.26598,-0.0058873,0.25438,0.85212,GOCC_N_TERMINAL_PROTEIN_ACETYLTRANSFERASE_COMPLEX,0.99999
GOBP_HINDBRAIN_MORPHOGENESIS,SET,40,-0.14345,-0.0066884,0.13719,0.85213,GOBP_HINDBRAIN_MORPHOGENESIS,0.99999
GOBP_DOPAMINE_RECEPTOR_SIGNA...,SET,37,-0.15045,-0.0067468,0.14387,0.85214,GOBP_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.99999
WP_CONGENITAL_GENERALIZED_LI...,SET,16,-0.22536,-0.0066496,0.21542,0.85225,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,0.99999
BURTON_ADIPOGENESIS_PEAK_AT_...3,SET,42,-0.13044,-0.0062316,0.12468,0.85227,BURTON_ADIPOGENESIS_PEAK_AT_24HR,0.99999
IYENGAR_RESPONSE_TO_ADIPOCYT...,SET,10,-0.31612,-0.0073755,0.30213,0.85229,IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,0.99999
REACTOME_MITF_M_REGULATED_ME...,SET,124,-0.080073,-0.0065581,0.076526,0.85229,REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,0.99999
REACTOME_TRAFFICKING_OF_AMPA...,SET,29,-0.16821,-0.0066798,0.16075,0.85231,REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS,0.99999
TST1_01,SET,219,-0.063381,-0.0068806,0.060566,0.85232,TST1_01,0.99999
HP_ERYTHROID_DYSPLASIA,SET,4,-0.46361,-0.0068421,0.44303,0.85232,HP_ERYTHROID_DYSPLASIA,0.99999
GSE24634_TEFF_VS_TCONV_DAY5_...2,SET,188,-0.062601,-0.006302,0.05982,0.85233,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP,0.99999
GOBP_CAMP_MEDIATED_SIGNALING,SET,53,-0.12618,-0.0067693,0.12053,0.8524,GOBP_CAMP_MEDIATED_SIGNALING,0.99999
FONTAINE_FOLLICULAR_THYROID_...2,SET,70,-0.10228,-0.0063034,0.097704,0.85241,FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,0.99999
LI_WILMS_TUMOR_VS_FETAL_KIDN...1,SET,153,-0.070699,-0.0064268,0.06752,0.85246,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,0.99999
HP_RENAL_TUBULAR_DYSFUNCTION,SET,90,-0.088958,-0.0062129,0.084945,0.8525,HP_RENAL_TUBULAR_DYSFUNCTION,0.99999
MIR4262,SET,704,-0.034445,-0.0066142,0.03289,0.85251,MIR4262,0.99999
GOBP_REGULATION_OF_EPITHELIA...6,SET,7,-0.38785,-0.0075715,0.37029,0.85254,GOBP_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...169,SET,4,-0.39811,-0.0058754,0.38005,0.85256,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,0.99999
GOBP_SYNAPTIC_VESICLE_LUMEN_...,SET,15,-0.24288,-0.0069394,0.23187,0.85256,GOBP_SYNAPTIC_VESICLE_LUMEN_ACIDIFICATION,0.99999
GSE16522_MEMORY_VS_NAIVE_ANT...2,SET,172,-0.068588,-0.0066072,0.06547,0.85259,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP,0.99999
GOMF_POSTSYNAPTIC_NEUROTRANS...,SET,67,-0.11957,-0.0072097,0.11412,0.85262,GOMF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.99999
HP_AUTOIMMUNE_HEMOLYTIC_ANEM...,SET,39,-0.14505,-0.0066778,0.13839,0.8527,HP_AUTOIMMUNE_HEMOLYTIC_ANEMIA,0.99999
KEGG_MEDICUS_PATHOGEN_EBV_BA...,SET,7,-0.31954,-0.0062379,0.30484,0.85272,KEGG_MEDICUS_PATHOGEN_EBV_BARF1_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.99999
MIR5585_3P,SET,77,-0.10223,-0.0066063,0.097522,0.85274,MIR5585_3P,0.99999
WP_HOSTPATHOGEN_INTERACTION_...4,SET,35,-0.16771,-0.0073154,0.15995,0.85279,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,0.99999
GSE37532_VISCERAL_ADIPOSE_TI...8,SET,155,-0.06935,-0.0063448,0.066133,0.85282,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_UP,0.99999
GSE37301_HEMATOPOIETIC_STEM_...6,SET,149,-0.072627,-0.0065159,0.069233,0.85291,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP,0.99999
BROWNE_HCMV_INFECTION_2HR_DN,SET,47,-0.13414,-0.0067779,0.12785,0.85294,BROWNE_HCMV_INFECTION_2HR_DN,0.99999
REACTOME_ADP_SIGNALLING_THRO...1,SET,25,-0.19162,-0.0070658,0.18262,0.85297,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1,0.99999
MIR12127,SET,74,-0.10398,-0.0065878,0.099096,0.85297,MIR12127,0.99999
FERREIRA_EWINGS_SARCOMA_UNST...1,SET,86,-0.095133,-0.0064955,0.090623,0.85308,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,0.99999
GOBP_TELENCEPHALON_DEVELOPME...,SET,257,-0.05828,-0.0068466,0.055516,0.85308,GOBP_TELENCEPHALON_DEVELOPMENT,0.99999
WP_LIPID_METABOLISM_PATHWAY,SET,28,-0.15914,-0.0062099,0.15159,0.85309,WP_LIPID_METABOLISM_PATHWAY,0.99999
GOBP_CELL_ADHESION_MOLECULE_...,SET,11,-0.30032,-0.0073486,0.28596,0.85318,GOBP_CELL_ADHESION_MOLECULE_PRODUCTION,0.99999
HP_INCREASED_CIRCULATING_IGG...,SET,23,-0.1939,-0.0068584,0.18462,0.8532,HP_INCREASED_CIRCULATING_IGG_LEVEL,0.99999
GOMF_ALKALI_METAL_ION_BINDING,SET,19,-0.19696,-0.0063326,0.18751,0.85322,GOMF_ALKALI_METAL_ION_BINDING,0.99999
GOBP_REGULATION_OF_ENDOSOME_...3,SET,3,-0.45529,-0.0058192,0.43342,0.85324,GOBP_REGULATION_OF_ENDOSOME_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.99999
MURARO_PANCREAS_EPSILON_CELL,SET,42,-0.14596,-0.0069729,0.1389,0.85332,MURARO_PANCREAS_EPSILON_CELL,0.99999
MIR3169,SET,54,-0.12221,-0.0066176,0.11629,0.85333,MIR3169,0.99999
KAECH_DAY8_EFF_VS_DAY15_EFF_...1,SET,183,-0.065853,-0.0065415,0.062651,0.85339,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN,0.99999
BROWNE_HCMV_INFECTION_6HR_DN,SET,147,-0.072604,-0.0064703,0.069072,0.8534,BROWNE_HCMV_INFECTION_6HR_DN,0.99999
HP_ABNORMAL_URINE_CARBOHYDRA...,SET,37,-0.14077,-0.0063127,0.13391,0.85342,HP_ABNORMAL_URINE_CARBOHYDRATE_LEVEL,0.99999
REACTOME_TP53_REGULATES_TRAN...9,SET,18,-0.19125,-0.0059852,0.18191,0.85344,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST,0.99999
NAKAYA_PBMC_FLUARIX_FLUVIRIN...1,SET,377,-0.043921,-0.0062285,0.04176,0.85353,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN,0.99999
GOBP_ENDOPLASMIC_RETICULUM_L...,SET,9,-0.32782,-0.0072561,0.31166,0.85356,GOBP_ENDOPLASMIC_RETICULUM_LOCALIZATION,0.99999
FERREIRA_EWINGS_SARCOMA_UNST...2,SET,148,-0.067689,-0.0060526,0.064346,0.85358,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,0.99999
GOBP_ANTEROGRADE_NEURONAL_DE...,SET,6,-0.34989,-0.0063239,0.33261,0.85358,GOBP_ANTEROGRADE_NEURONAL_DENSE_CORE_VESICLE_TRANSPORT,0.99999
HP_CRANIOSYNOSTOSIS,SET,162,-0.068762,-0.0064303,0.065358,0.85361,HP_CRANIOSYNOSTOSIS,0.99999
GSE23925_LIGHT_ZONE_VS_DARK_...1,SET,187,-0.06391,-0.0064168,0.060745,0.85362,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,0.99999
GSE42021_CD24LO_TREG_VS_CD24...2,SET,184,-0.066293,-0.006603,0.063009,0.85362,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP,0.99999
GSE21546_WT_VS_SAP1A_KO_AND_...3,SET,183,-0.067607,-0.0067157,0.064255,0.85363,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.99999
GOBP_SA_NODE_CELL_TO_ATRIAL_...2,SET,9,-0.31974,-0.0070772,0.30384,0.85366,GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_SIGNALING,0.99999
GOBP_METANEPHROS_MORPHOGENES...,SET,30,-0.18589,-0.0075079,0.17659,0.85374,GOBP_METANEPHROS_MORPHOGENESIS,0.99999
HP_ENLARGEMENT_OF_THE_COSTOC...,SET,8,-0.33549,-0.0070014,0.31872,0.85374,HP_ENLARGEMENT_OF_THE_COSTOCHONDRAL_JUNCTION,0.99999
GOCC_ENDOLYSOSOME_LUMEN,SET,5,-0.45578,-0.0075202,0.43297,0.85375,GOCC_ENDOLYSOSOME_LUMEN,0.99999
REACTOME_TRANSCRIPTIONAL_AND...,SET,42,-0.14212,-0.0067894,0.135,0.85376,REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...535,SET,6,-0.36049,-0.0065155,0.34238,0.8538,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...602,SET,39,-0.15046,-0.006927,0.1429,0.8538,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,0.99999
GSE17721_POLYIC_VS_CPG_4H_BM...2,SET,180,-0.064913,-0.0063956,0.061648,0.85381,GSE17721_POLYIC_VS_CPG_4H_BMDC_UP,0.99999
LI_WILMS_TUMOR_ANAPLASTIC_DN,SET,5,-0.42353,-0.0069882,0.40219,0.85384,LI_WILMS_TUMOR_ANAPLASTIC_DN,0.99999
GSE26488_WT_VS_HDAC7_KO_DOUB...1,SET,157,-0.070949,-0.0065325,0.06735,0.85392,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...6,SET,46,-0.14238,-0.0071174,0.13513,0.85396,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_5,0.99999
GSE36891_UNSTIM_VS_PAM_TLR2_...1,SET,143,-0.072153,-0.0063427,0.068483,0.85396,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,0.99999
KEGG_BASE_EXCISION_REPAIR,SET,32,-0.14017,-0.0058466,0.13298,0.85406,KEGG_BASE_EXCISION_REPAIR,0.99999
REACTOME_PLASMA_LIPOPROTEIN_...3,SET,33,-0.15645,-0.0066267,0.14843,0.85406,REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,0.99999
ONO_AML1_TARGETS_UP,SET,23,-0.20382,-0.0072093,0.19336,0.85407,ONO_AML1_TARGETS_UP,0.99999
GSE17974_0H_VS_6H_IN_VITRO_A...2,SET,162,-0.070849,-0.0066255,0.06721,0.85408,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP,0.99999
DESCARTES_FETAL_THYMUS_THYMO...,SET,19,-0.22861,-0.0073502,0.21684,0.85412,DESCARTES_FETAL_THYMUS_THYMOCYTES,0.99999
GSE2770_IL12_ACT_VS_ACT_CD4_...1,SET,181,-0.063502,-0.0062737,0.060228,0.85413,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_DN,0.99999
GOBP_POLYAMINE_BIOSYNTHETIC_...,SET,12,-0.22437,-0.0057341,0.21279,0.85415,GOBP_POLYAMINE_BIOSYNTHETIC_PROCESS,0.99999
REACTOME_SYNTHESIS_OF_GDP_MA...,SET,5,-0.30036,-0.0049559,0.2848,0.8542,REACTOME_SYNTHESIS_OF_GDP_MANNOSE,0.99999
GOBP_ANTEROGRADE_DENDRITIC_T...2,SET,5,-0.44209,-0.0072944,0.41918,0.8542,GOBP_ANTEROGRADE_DENDRITIC_TRANSPORT_OF_NEUROTRANSMITTER_RECEPTOR_COMPLEX,0.99999
GNF2_CENPE,SET,38,-0.14529,-0.0066029,0.13776,0.85421,GNF2_CENPE,0.99999
MARTIN_INTERACT_WITH_HDAC,SET,37,-0.1361,-0.0061032,0.12902,0.85425,MARTIN_INTERACT_WITH_HDAC,0.99999
GSE3982_EFF_MEMORY_CD4_TCELL...4,SET,173,-0.06767,-0.0065376,0.064133,0.85431,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP,0.99999
MIR4753_5P,SET,156,-0.073266,-0.0067245,0.069428,0.85434,MIR4753_5P,0.99999
CAFFAREL_RESPONSE_TO_THC_24H...3,SET,44,-0.12814,-0.0062651,0.12142,0.85436,CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,0.99999
VANHARANTA_UTERINE_FIBROID_W...2,SET,57,-0.11427,-0.006357,0.10827,0.85438,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,0.99999
GOMF_LAMIN_BINDING,SET,16,-0.23224,-0.0068526,0.21994,0.85449,GOMF_LAMIN_BINDING,0.99999
GOBP_CXCL12_ACTIVATED_CXCR4_...,SET,4,-0.47573,-0.0070209,0.45041,0.85456,GOBP_CXCL12_ACTIVATED_CXCR4_SIGNALING_PATHWAY,0.99999
DORN_ADENOVIRUS_INFECTION_32...1,SET,36,-0.14064,-0.0062213,0.13312,0.85462,DORN_ADENOVIRUS_INFECTION_32HR_DN,0.99999
HP_PREMATURE_LOSS_OF_PRIMARY...,SET,19,-0.21589,-0.0069411,0.20431,0.85466,HP_PREMATURE_LOSS_OF_PRIMARY_TEETH,0.99999
REACTOME_PROCESSING_OF_CAPPE...1,SET,28,-0.14519,-0.0056656,0.13735,0.85476,REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA,0.99999
GOBP_ACYLGLYCEROL_HOMEOSTASIS,SET,35,-0.15157,-0.0066112,0.14325,0.85499,GOBP_ACYLGLYCEROL_HOMEOSTASIS,0.99999
GSE9650_NAIVE_VS_EFF_CD8_TCE...1,SET,188,-0.066791,-0.0067238,0.063115,0.85502,GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN,0.99999
MIR4425,SET,84,-0.094128,-0.006352,0.088938,0.85504,MIR4425,0.99999
TGCGCANK_UNKNOWN,SET,491,-0.039644,-0.0063957,0.037449,0.85511,TGCGCANK_UNKNOWN,0.99999
HP_ABNORMALITY_OF_DENTAL_COL...,SET,31,-0.15765,-0.0064721,0.14888,0.85517,HP_ABNORMALITY_OF_DENTAL_COLOR,0.99999
GOBP_NEGATIVE_REGULATION_OF_...384,SET,18,-0.20009,-0.0062617,0.18895,0.85518,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PERMEABILITY,0.99999
HP_INCREASED_PROTEINOGENIC_A...,SET,42,-0.1411,-0.0067409,0.13325,0.85519,HP_INCREASED_PROTEINOGENIC_AMINO_ACID_LEVEL_IN_URINE,0.99999
MIR362_3P,SET,107,-0.092482,-0.0070393,0.087307,0.85526,MIR362_3P,0.99999
HP_HYPOCALCEMIC_SEIZURES,SET,12,-0.26427,-0.0067538,0.24941,0.85532,HP_HYPOCALCEMIC_SEIZURES,0.99999
ZHONG_PFC_C1_MICROGLIA,SET,233,-0.055977,-0.0062656,0.052826,0.85534,ZHONG_PFC_C1_MICROGLIA,0.99999
MIR4433B_3P,SET,28,-0.17603,-0.0068687,0.16608,0.85539,MIR4433B_3P,0.99999
GSE16385_UNTREATED_VS_12H_RO...6,SET,142,-0.079763,-0.0069873,0.07525,0.85541,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,0.99999
GSE2706_R848_VS_LPS_2H_STIM_...2,SET,142,-0.076517,-0.006703,0.072189,0.85541,GSE2706_R848_VS_LPS_2H_STIM_DC_UP,0.99999
GSE5542_IFNA_VS_IFNA_AND_IFN...1,SET,182,-0.063962,-0.0063365,0.060346,0.85541,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.99999
QI_PBMC_ZOSTAVAX_AGE_50_75YO...6,SET,224,-0.060257,-0.0066148,0.056844,0.85543,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE,0.99999
VRTN_TARGET_GENES,SET,9,-0.29082,-0.006437,0.27434,0.85544,VRTN_TARGET_GENES,0.99999
GSE46606_DAY1_VS_DAY3_CD40L_...8,SET,183,-0.066193,-0.0065752,0.062417,0.85553,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP,0.99999
REACTOME_SYNTHESIS_OF_SUBSTR...,SET,58,-0.11306,-0.0063444,0.10661,0.85555,REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,0.99999
GOMF_GUANINE_NUCLEOTIDE_TRAN...,SET,5,-0.49442,-0.0081577,0.46616,0.85556,GOMF_GUANINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
SEF1_C,SET,5,-0.40767,-0.0067265,0.38435,0.85557,SEF1_C,0.99999
MIR4670_3P,SET,137,-0.07639,-0.0065738,0.072017,0.85558,MIR4670_3P,0.99999
TORCHIA_TARGETS_OF_EWSR1_FLI...2,SET,19,-0.2209,-0.0071024,0.20822,0.85562,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,0.99999
HP_ABNORMAL_VISUAL_ACCOMMODA...,SET,5,-0.38715,-0.0063879,0.36493,0.85562,HP_ABNORMAL_VISUAL_ACCOMMODATION,0.99999
KEGG_MEDICUS_ENV_FACTOR_NNK_...2,SET,11,-0.27119,-0.0066359,0.25556,0.85569,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339,0.99999
MISHRA_CARCINOMA_ASSOCIATED_...1,SET,20,-0.2161,-0.0071284,0.20363,0.8557,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,0.99999
HP_AGENESIS_OF_LATERAL_INCIS...,SET,23,-0.1955,-0.0069151,0.18421,0.85572,HP_AGENESIS_OF_LATERAL_INCISOR,0.99999
GOBP_CALCIUM_DEPENDENT_CELL_...,SET,47,-0.15151,-0.0076558,0.14276,0.85573,GOBP_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,0.99999
GSE3982_EOSINOPHIL_VS_BCELL_...1,SET,177,-0.065006,-0.0063517,0.061245,0.85574,GSE3982_EOSINOPHIL_VS_BCELL_DN,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_CD4...,SET,30,-0.17792,-0.0071858,0.16763,0.85574,HE_LIM_SUN_FETAL_LUNG_C4_CD4_T_CELL,0.99999
GOBP_RESPONSE_TO_GAMMA_RADIA...,SET,47,-0.12464,-0.006298,0.11742,0.85576,GOBP_RESPONSE_TO_GAMMA_RADIATION,0.99999
MULLIGHAN_NPM1_MUTATED_SIGNA...1,SET,110,-0.082405,-0.0063591,0.077627,0.85577,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,0.99999
MIR218_2_3P,SET,46,-0.13044,-0.0065206,0.12286,0.85581,MIR218_2_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...7,SET,16,-0.25305,-0.0074667,0.23834,0.85581,GOBP_NEGATIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
REACTOME_FRS_MEDIATED_FGFR3_...,SET,19,-0.19761,-0.0063534,0.18608,0.85586,REACTOME_FRS_MEDIATED_FGFR3_SIGNALING,0.99999
REACTOME_DOWNSTREAM_SIGNALIN...3,SET,29,-0.16388,-0.0065077,0.15431,0.85587,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2,0.99999
HP_CORTICAL_DYSPLASIA,SET,51,-0.1275,-0.0067104,0.12006,0.85587,HP_CORTICAL_DYSPLASIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...527,SET,6,-0.34651,-0.0062628,0.32623,0.85591,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...8,SET,135,-0.07906,-0.0067542,0.074422,0.85595,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP,0.99999
REACTOME_SIGNALING_BY_INSULI...,SET,79,-0.10394,-0.0068031,0.097835,0.85596,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,0.99999
GOMF_1_PHOSPHATIDYLINOSITOL_...2,SET,15,-0.26413,-0.0075465,0.24862,0.85597,GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY,0.99999
VALK_AML_CLUSTER_13,SET,29,-0.18058,-0.0071711,0.16996,0.85598,VALK_AML_CLUSTER_13,0.99999
FEV_TARGET_GENES,SET,1337,-0.025076,-0.0065157,0.023601,0.85599,FEV_TARGET_GENES,0.99999
HP_SLANTING_OF_THE_PALPEBRAL...,SET,622,-0.035684,-0.0064557,0.033578,0.85604,HP_SLANTING_OF_THE_PALPEBRAL_FISSURE,0.99999
GOBP_SEQUESTERING_OF_IRON_ION,SET,5,-0.43577,-0.00719,0.41002,0.85606,GOBP_SEQUESTERING_OF_IRON_ION,0.99999
KEGG_MEDICUS_REFERENCE_BLOCK...,SET,12,-0.24419,-0.0062407,0.22975,0.85607,KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2,0.99999
HOEK_NEUTROPHIL_2011_2012_TI...6,SET,17,-0.22748,-0.0069185,0.21398,0.85612,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_UP,0.99999
MIR4418,SET,118,-0.082231,-0.006571,0.077333,0.85618,MIR4418,0.99999
MAINA_VHL_TARGETS_UP,SET,10,-0.31357,-0.0073159,0.29488,0.85619,MAINA_VHL_TARGETS_UP,0.99999
GSE22601_DOUBLE_NEGATIVE_VS_...4,SET,163,-0.074203,-0.0069604,0.06978,0.85619,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
ZNF239_TARGET_GENES,SET,32,-0.16181,-0.0067492,0.15211,0.85627,ZNF239_TARGET_GENES,0.99999
HP_NEONATAL_INSULIN_DEPENDEN...,SET,20,-0.20337,-0.0067084,0.19117,0.85628,HP_NEONATAL_INSULIN_DEPENDENT_DIABETES_MELLITUS,0.99999
GOBP_PLATELET_AGGREGATION,SET,73,-0.11325,-0.0071266,0.10641,0.8564,GOBP_PLATELET_AGGREGATION,0.99999
HP_HEMIANOPIA,SET,37,-0.14391,-0.0064536,0.13514,0.85653,HP_HEMIANOPIA,0.99999
GSE15624_CTRL_VS_3H_HALOFUGI...1,SET,144,-0.070192,-0.0061917,0.065913,0.85654,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_DN,0.99999
BIOCARTA_IL17_PATHWAY,SET,15,-0.25938,-0.0074107,0.24353,0.85657,BIOCARTA_IL17_PATHWAY,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...20,SET,6,-0.36894,-0.0066683,0.34638,0.85659,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_ANOTHER_COMPOUND_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.99999
HP_UNICORONAL_SYNOSTOSIS,SET,7,-0.38935,-0.0076008,0.36552,0.8566,HP_UNICORONAL_SYNOSTOSIS,0.99999
SUMO1_TARGET_GENES,SET,803,-0.03216,-0.0065768,0.030191,0.85661,SUMO1_TARGET_GENES,0.99999
HP_WIDELY_SPACED_PRIMARY_TEE...,SET,5,-0.4048,-0.0066792,0.37999,0.85662,HP_WIDELY_SPACED_PRIMARY_TEETH,0.99999
TGATTTRY_GFI1_01,SET,263,-0.059761,-0.0071009,0.056095,0.85663,TGATTTRY_GFI1_01,0.99999
GSE20715_WT_VS_TLR4_KO_6H_OZ...2,SET,183,-0.06416,-0.0063734,0.060222,0.85664,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP,0.99999
GOBP_BROWN_FAT_CELL_DIFFEREN...,SET,50,-0.13115,-0.0068346,0.12309,0.85665,GOBP_BROWN_FAT_CELL_DIFFERENTIATION,0.99999
GOBP_CENTRAL_NERVOUS_SYSTEM_...1,SET,931,-0.031117,-0.0068269,0.029205,0.85666,GOBP_CENTRAL_NERVOUS_SYSTEM_DEVELOPMENT,0.99999
GOBP_CHORIO_ALLANTOIC_FUSION,SET,6,-0.40966,-0.0074042,0.38449,0.85666,GOBP_CHORIO_ALLANTOIC_FUSION,0.99999
GOBP_PROTEIN_HETEROOLIGOMERI...,SET,29,-0.15909,-0.0063176,0.14928,0.85672,GOBP_PROTEIN_HETEROOLIGOMERIZATION,0.99999
IVANOVA_HEMATOPOIESIS_LATE_P...,SET,466,-0.040086,-0.0063046,0.037609,0.85675,IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR,0.99999
MORF_ERCC4,SET,286,-0.053798,-0.0066618,0.050463,0.8568,MORF_ERCC4,0.99999
HP_DECREASED_CIRCULATING_VIT...2,SET,31,-0.15246,-0.0062592,0.14299,0.85684,HP_DECREASED_CIRCULATING_VITAMIN_D_CONCENTRATION,0.99999
WP_HUNGER_AND_SATIETY,SET,8,-0.32025,-0.0066833,0.30033,0.85686,WP_HUNGER_AND_SATIETY,0.99999
HP_ABNORMAL_HAIRSHAFT_MORPHO...,SET,25,-0.16731,-0.0061695,0.1569,0.85686,HP_ABNORMAL_HAIRSHAFT_MORPHOLOGY,0.99999
ZNF507_TARGET_GENES,SET,510,-0.03938,-0.0064714,0.036927,0.85688,ZNF507_TARGET_GENES,0.99999
GOBP_PARASYMPATHETIC_NERVOUS...,SET,17,-0.23265,-0.0070757,0.21812,0.85691,GOBP_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,0.99999
KEGG_MEDICUS_REFERENCE_ITGA_...1,SET,25,-0.19125,-0.0070522,0.1793,0.85692,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY,0.99999
GSE46025_WT_VS_FOXO1_KO_KLRG...2,SET,166,-0.067656,-0.0064038,0.063429,0.85692,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_UP,0.99999
TGASTMAGC_NFE2_01,SET,172,-0.067131,-0.0064669,0.062924,0.85698,TGASTMAGC_NFE2_01,0.99999
WP_PROXIMAL_TUBULE_TRANSPORT,SET,55,-0.12488,-0.0068245,0.11702,0.85704,WP_PROXIMAL_TUBULE_TRANSPORT,0.99999
TSENG_ADIPOGENIC_POTENTIAL_DN,SET,38,-0.1614,-0.0073351,0.15123,0.85707,TSENG_ADIPOGENIC_POTENTIAL_DN,0.99999
MIR499A_5P,SET,160,-0.072191,-0.0067096,0.067624,0.85713,MIR499A_5P,0.99999
GSE13485_CTRL_VS_DAY3_YF17D_...2,SET,151,-0.074559,-0.0067336,0.069838,0.85714,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP,0.99999
MIR4310,SET,262,-0.055447,-0.006576,0.051932,0.85716,MIR4310,0.99999
REACTOME_TETRAHYDROBIOPTERIN...,SET,10,-0.25913,-0.0060459,0.24261,0.85726,REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION,0.99999
BUSSLINGER_GASTRIC_PARIETAL_...,SET,220,-0.058549,-0.0063704,0.054805,0.8573,BUSSLINGER_GASTRIC_PARIETAL_CELLS,0.99999
HP_BUPHTHALMOS,SET,24,-0.20081,-0.0072553,0.18795,0.85733,HP_BUPHTHALMOS,0.99999
GOMF_ALPHA_CATENIN_BINDING,SET,10,-0.3051,-0.0071184,0.28544,0.85743,GOMF_ALPHA_CATENIN_BINDING,0.99999
HP_GENERALIZED_NON_CONVULSIV...,SET,16,-0.22101,-0.0065212,0.20676,0.85743,HP_GENERALIZED_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA,0.99999
GSE11961_MEMORY_BCELL_DAY40_...1,SET,178,-0.068275,-0.0066897,0.063868,0.85745,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.99999
MODULE_303,SET,27,-0.17846,-0.0068385,0.16692,0.85749,MODULE_303,0.99999
GOMF_MONOSACCHARIDE_BINDING,SET,69,-0.10571,-0.0064682,0.098854,0.85754,GOMF_MONOSACCHARIDE_BINDING,0.99999
HP_ABNORMAL_FINGERTIP_MORPHO...,SET,76,-0.10252,-0.0065822,0.095865,0.85755,HP_ABNORMAL_FINGERTIP_MORPHOLOGY,0.99999
MIR574_5P,SET,77,-0.10007,-0.0064666,0.093544,0.85762,MIR574_5P,0.99999
GCM_DPF2,SET,27,-0.15122,-0.0057947,0.1413,0.85773,GCM_DPF2,0.99999
GOBP_SKELETAL_MUSCLE_ADAPTAT...,SET,22,-0.20106,-0.0069555,0.18786,0.85774,GOBP_SKELETAL_MUSCLE_ADAPTATION,0.99999
HP_ABNORMAL_SCALP_MORPHOLOGY,SET,385,-0.045301,-0.0064907,0.04232,0.85778,HP_ABNORMAL_SCALP_MORPHOLOGY,0.99999
HP_HYDROCEPHALUS,SET,351,-0.046851,-0.0064156,0.043769,0.85778,HP_HYDROCEPHALUS,0.99999
HP_HEMATEMESIS,SET,17,-0.23674,-0.0072001,0.22112,0.85782,HP_HEMATEMESIS,0.99999
GOBP_RESPONSE_TO_L_LEUCINE,SET,14,-0.24824,-0.006852,0.23179,0.85789,GOBP_RESPONSE_TO_L_LEUCINE,0.99999
GOMF_COLLAGEN_BINDING_INVOLV...,SET,4,-0.51365,-0.0075806,0.47964,0.85789,GOMF_COLLAGEN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION,0.99999
GSE25087_FETAL_VS_ADULT_TCON...1,SET,156,-0.071247,-0.0065393,0.066518,0.85793,GSE25087_FETAL_VS_ADULT_TCONV_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...147,SET,49,-0.12567,-0.0064835,0.11732,0.85795,GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,0.99999
REACTOME_SARS_COV_2_MODULATE...1,SET,11,-0.23747,-0.0058108,0.22166,0.85798,REACTOME_SARS_COV_2_MODULATES_AUTOPHAGY,0.99999
GOBP_CELL_GROWTH,SET,427,-0.044615,-0.0067242,0.041636,0.85803,GOBP_CELL_GROWTH,0.99999
BIOCARTA_PRION_PATHWAY,SET,12,-0.25186,-0.0064367,0.23504,0.85804,BIOCARTA_PRION_PATHWAY,0.99999
GOBP_FOLATE_TRANSMEMBRANE_TR...,SET,5,-0.47222,-0.0077915,0.44067,0.85804,GOBP_FOLATE_TRANSMEMBRANE_TRANSPORT,0.99999
BLANCO_MELO_COVID19_SARS_COV...9,SET,14,-0.27312,-0.0075387,0.25486,0.85805,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...534,SET,17,-0.22972,-0.0069867,0.2143,0.85812,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION,0.99999
HP_CHRONIC_BRONCHITIS,SET,21,-0.18269,-0.0061748,0.17043,0.85812,HP_CHRONIC_BRONCHITIS,0.99999
HP_EEG_WITH_CENTROTEMPORAL_E...,SET,3,-0.57484,-0.0073473,0.5362,0.85815,HP_EEG_WITH_CENTROTEMPORAL_EPILEPTIFORM_DISCHARGES,0.99999
GSE1448_ANTI_VALPHA2_VS_VBET...2,SET,184,-0.066639,-0.0066374,0.062159,0.85815,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP,0.99999
GOMF_RETINOIC_ACID_4_HYDROXY...,SET,10,-0.29497,-0.006882,0.27511,0.85817,GOMF_RETINOIC_ACID_4_HYDROXYLASE_ACTIVITY,0.99999
GSE14308_TH2_VS_NATURAL_TREG...1,SET,180,-0.066876,-0.006589,0.062371,0.85818,GSE14308_TH2_VS_NATURAL_TREG_DN,0.99999
MIR490_3P,SET,40,-0.1409,-0.0065693,0.13137,0.85826,MIR490_3P,0.99999
GOBP_ENERGY_HOMEOSTASIS,SET,75,-0.10997,-0.007014,0.10252,0.85827,GOBP_ENERGY_HOMEOSTASIS,0.99999
GSE14000_UNSTIM_VS_4H_LPS_DC...3,SET,180,-0.065493,-0.0064528,0.061053,0.85829,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP,0.99999
HES2_TARGET_GENES,SET,1001,-0.029713,-0.0067459,0.027696,0.85831,HES2_TARGET_GENES,0.99999
GOBP_MITOCHONDRIAL_RNA_CATAB...,SET,6,-0.33658,-0.0060834,0.31375,0.85831,GOBP_MITOCHONDRIAL_RNA_CATABOLIC_PROCESS,0.99999
GOCC_GOLGI_ASSOCIATED_VESICLE,SET,85,-0.094718,-0.0064296,0.08829,0.85831,GOCC_GOLGI_ASSOCIATED_VESICLE,0.99999
REACTOME_VLDL_CLEARANCE,SET,4,-0.49446,-0.0072974,0.46076,0.85839,REACTOME_VLDL_CLEARANCE,0.99999
HP_ABNORMAL_CIRCULATING_NUCL...,SET,42,-0.1337,-0.0063871,0.12458,0.8584,HP_ABNORMAL_CIRCULATING_NUCLEOBASE_CONCENTRATION,0.99999
GSE20366_TREG_VS_NAIVE_CD4_T...1,SET,182,-0.06839,-0.0067751,0.063708,0.85847,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN,0.99999
SCHLOSSER_MYC_AND_SERUM_RESP...,SET,30,-0.15979,-0.0064538,0.14883,0.8585,SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY,0.99999
GOMF_C_PALMITOYLTRANSFERASE_...,SET,5,-0.44042,-0.0072668,0.41021,0.8585,GOMF_C_PALMITOYLTRANSFERASE_ACTIVITY,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...6,SET,172,-0.070226,-0.0067651,0.065397,0.85855,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP,0.99999
GOBP_REGULATION_OF_MOTOR_NEU...,SET,15,-0.2298,-0.0065655,0.21398,0.85857,GOBP_REGULATION_OF_MOTOR_NEURON_APOPTOTIC_PROCESS,0.99999
MORF_BAG5,SET,52,-0.11368,-0.0060414,0.10582,0.85864,MORF_BAG5,0.99999
HP_HYPOPLASIA_OF_THE_PRIMARY...,SET,7,-0.32838,-0.0064105,0.30564,0.85867,HP_HYPOPLASIA_OF_THE_PRIMARY_TEETH,0.99999
GCM_BECN1,SET,62,-0.10765,-0.0062449,0.10015,0.85878,GCM_BECN1,0.99999
GSE360_DC_VS_MAC_L_MAJOR_DN,SET,177,-0.066581,-0.0065056,0.061942,0.85878,GSE360_DC_VS_MAC_L_MAJOR_DN,0.99999
GOBP_DIACYLGLYCEROL_CATABOLI...,SET,5,-0.41014,-0.0067673,0.38155,0.85879,GOBP_DIACYLGLYCEROL_CATABOLIC_PROCESS,0.99999
GOMF_NADPLUS_NUCLEOTIDASE_CY...,SET,14,-0.32762,-0.0090431,0.30465,0.85889,GOMF_NADPLUS_NUCLEOTIDASE_CYCLIC_ADP_RIBOSE_GENERATING,0.99999
PID_CDC42_PATHWAY,SET,68,-0.11062,-0.0067192,0.10285,0.85891,PID_CDC42_PATHWAY,0.99999
GOBP_CIRCADIAN_SLEEP_WAKE_CY...2,SET,6,-0.40878,-0.0073882,0.38005,0.85893,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP,0.99999
HP_SHORT_PHALANX_OF_THE_THUMB,SET,29,-0.17722,-0.0070376,0.16475,0.85896,HP_SHORT_PHALANX_OF_THE_THUMB,0.99999
REACTOME_GASTRULATION,SET,118,-0.081671,-0.0065262,0.075915,0.85899,REACTOME_GASTRULATION,0.99999
HP_COLPOCEPHALY,SET,28,-0.16338,-0.0063754,0.15176,0.85915,HP_COLPOCEPHALY,0.99999
GSE21033_3H_VS_24H_POLYIC_ST...1,SET,108,-0.082694,-0.0063235,0.076801,0.85919,GSE21033_3H_VS_24H_POLYIC_STIM_DC_DN,0.99999
GOBP_MODIFICATION_OF_POSTSYN...1,SET,10,-0.28698,-0.0066956,0.26652,0.8592,GOBP_MODIFICATION_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.99999
HP_PULMONARY_INSUFFICIENCY,SET,24,-0.1846,-0.0066695,0.17143,0.8592,HP_PULMONARY_INSUFFICIENCY,0.99999
GOBP_DIADENOSINE_POLYPHOSPHA...1,SET,3,-0.59605,-0.0076183,0.55349,0.85923,GOBP_DIADENOSINE_POLYPHOSPHATE_CATABOLIC_PROCESS,0.99999
GOBP_DIADENOSINE_POLYPHOSPHA...2,SET,3,-0.59605,-0.0076183,0.55349,0.85923,GOBP_DIADENOSINE_POLYPHOSPHATE_METABOLIC_PROCESS,0.99999
REACTOME_SYNTHESIS_OF_PIPS_A...3,SET,16,-0.20915,-0.0061713,0.19421,0.85924,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE,0.99999
GSE24972_MARGINAL_ZONE_BCELL...2,SET,181,-0.067141,-0.0066332,0.062338,0.85926,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN,0.99999
HP_CYSTINURIA,SET,6,-0.4791,-0.0086593,0.4448,0.85928,HP_CYSTINURIA,0.99999
MIR516A_3P_MIR516B_3P,SET,160,-0.071586,-0.0066533,0.066455,0.8593,MIR516A_3P_MIR516B_3P,0.99999
REACTOME_ACTIVATION_OF_RAC1,SET,11,-0.26842,-0.0065679,0.24917,0.85931,REACTOME_ACTIVATION_OF_RAC1,0.99999
TOMIDA_LUNG_CANCER_POOR_SURV...,SET,5,-0.45682,-0.0075374,0.42401,0.85934,TOMIDA_LUNG_CANCER_POOR_SURVIVAL,0.99999
MIR3197,SET,5,-0.33939,-0.0055998,0.315,0.85935,MIR3197,0.99999
GOBP_NEGATIVE_REGULATION_OF_...72,SET,9,-0.29621,-0.0065563,0.2749,0.85936,GOBP_NEGATIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.99999
GOMF_LOW_DENSITY_LIPOPROTEIN...1,SET,16,-0.23935,-0.0070624,0.22212,0.85938,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,0.99999
HP_ANHYDRAMNIOS,SET,6,-0.36327,-0.0065658,0.3371,0.85939,HP_ANHYDRAMNIOS,0.99999
HP_ARTERIOVENOUS_MALFORMATION,SET,53,-0.12366,-0.0066341,0.11475,0.85939,HP_ARTERIOVENOUS_MALFORMATION,0.99999
MIR532_3P,SET,74,-0.10067,-0.0063784,0.093408,0.85943,MIR532_3P,0.99999
MIR4685_3P,SET,117,-0.082916,-0.0065977,0.076925,0.85945,MIR4685_3P,0.99999
HP_POLYMICROGYRIA,SET,179,-0.065908,-0.0064758,0.061135,0.85949,HP_POLYMICROGYRIA,0.99999
GSE20484_MCSG_VS_CXCL4_MONOC...2,SET,159,-0.071417,-0.006617,0.066244,0.8595,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_UP,0.99999
GOBP_REGULATION_OF_MUSCLE_CE...,SET,132,-0.079746,-0.0067373,0.073966,0.85951,GOBP_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOBP_RNA_SPLICING_VIA_TRANSE...,SET,269,-0.049893,-0.0059947,0.046275,0.85952,GOBP_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS,0.99999
LEE_NEURAL_CREST_STEM_CELL_UP,SET,139,-0.084882,-0.0073574,0.078723,0.85953,LEE_NEURAL_CREST_STEM_CELL_UP,0.99999
HP_REDUCED_DELAYED_HYPERSENS...,SET,4,-0.4407,-0.006504,0.40872,0.85953,HP_REDUCED_DELAYED_HYPERSENSITIVITY,0.99999
GOBP_REGULATION_OF_NUCLEAR_D...,SET,142,-0.077347,-0.0067757,0.07173,0.85954,GOBP_REGULATION_OF_NUCLEAR_DIVISION,0.99999
ROESSLER_LIVER_CANCER_METAST...1,SET,46,-0.13597,-0.0067971,0.12609,0.85955,ROESSLER_LIVER_CANCER_METASTASIS_DN,0.99999
HEIDENBLAD_AMPLICON_12P11_12...2,SET,33,-0.16307,-0.006907,0.15119,0.8596,HEIDENBLAD_AMPLICON_12P11_12_UP,0.99999
VEGF_A_UP.V1_UP,SET,176,-0.067931,-0.0066189,0.062973,0.85964,VEGF_A_UP.V1_UP,0.99999
HP_HYPOPLASIA_OF_THE_VENTRAL...,SET,6,-0.4086,-0.007385,0.37876,0.85965,HP_HYPOPLASIA_OF_THE_VENTRAL_PONS,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...3,SET,169,-0.071522,-0.0068301,0.066279,0.85972,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN,0.99999
HP_SHORT_FOURTH_METATARSAL,SET,15,-0.22145,-0.0063269,0.20519,0.85975,HP_SHORT_FOURTH_METATARSAL,0.99999
GOBP_ORGANIC_HYDROXY_COMPOUN...1,SET,224,-0.06159,-0.0067612,0.057049,0.85983,GOBP_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_AXON_EXTE...1,SET,68,-0.10895,-0.006618,0.10091,0.85985,GOBP_REGULATION_OF_AXON_EXTENSION,0.99999
GOBP_PROTEIN_TRANSPORT_TO_VA...,SET,15,-0.21304,-0.0060867,0.1973,0.85988,GOBP_PROTEIN_TRANSPORT_TO_VACUOLE_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.99999
MIR23A_3P_MIR23B_3P,SET,536,-0.040431,-0.0068064,0.037437,0.85992,MIR23A_3P_MIR23B_3P,0.99999
HP_METABOLIC_ACIDOSIS,SET,149,-0.070974,-0.0063676,0.065717,0.85992,HP_METABOLIC_ACIDOSIS,0.99999
DESCARTES_MAIN_FETAL_ENDOCAR...,SET,66,-0.11472,-0.0068654,0.10617,0.86003,DESCARTES_MAIN_FETAL_ENDOCARDIAL_CELLS,0.99999
SUPT20H_TARGET_GENES,SET,1112,-0.027619,-0.0065879,0.025557,0.86007,SUPT20H_TARGET_GENES,0.99999
HP_ABNORMAL_EPIPHYSEAL_OSSIF...,SET,70,-0.11104,-0.0068429,0.10274,0.8601,HP_ABNORMAL_EPIPHYSEAL_OSSIFICATION,0.99999
KEGG_MEDICUS_REFERENCE_CXCR4...4,SET,31,-0.1711,-0.0070245,0.15829,0.86012,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...464,SET,42,-0.13149,-0.0062815,0.12164,0.86012,GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,0.99999
GOCC_TRANSCRIPTION_ELONGATIO...,SET,45,-0.12319,-0.0060911,0.11396,0.86013,GOCC_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,0.99999
HP_CONGENITAL_ONSET,SET,951,-0.030153,-0.0066823,0.027893,0.86015,HP_CONGENITAL_ONSET,0.99999
KEGG_MEDICUS_REFERENCE_CCR5_...,SET,26,-0.17934,-0.006744,0.16585,0.86023,KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY,0.99999
GOBP_PHAGOSOME_MATURATION,SET,28,-0.18196,-0.0071003,0.16824,0.86027,GOBP_PHAGOSOME_MATURATION,0.99999
HP_UVEITIS,SET,47,-0.13932,-0.0070397,0.12879,0.86031,HP_UVEITIS,0.99999
SEMBA_FHIT_TARGETS_UP,SET,11,-0.27638,-0.0067629,0.25548,0.86033,SEMBA_FHIT_TARGETS_UP,0.99999
DESCARTES_FETAL_MUSCLE_SCHWA...,SET,101,-0.10039,-0.0074251,0.092791,0.86034,DESCARTES_FETAL_MUSCLE_SCHWANN_CELLS,0.99999
GOBP_REGULATION_OF_PROTEIN_K...3,SET,18,-0.22513,-0.0070453,0.20807,0.86036,GOBP_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,0.99999
GSE19941_UNSTIM_VS_LPS_AND_I...3,SET,174,-0.067598,-0.0065493,0.062473,0.86037,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.99999
SUH_COEXPRESSED_WITH_ID1_AND...,SET,18,-0.2225,-0.0069631,0.20562,0.86038,SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,0.99999
REACTOME_SIGNALING_BY_WNT,SET,260,-0.056551,-0.0066816,0.052249,0.86044,REACTOME_SIGNALING_BY_WNT,0.99999
GSE43863_NAIVE_VS_MEMORY_LY6...2,SET,174,-0.069406,-0.0067244,0.064125,0.86044,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_UP,0.99999
GOMF_VOLTAGE_GATED_POTASSIUM...2,SET,14,-0.26524,-0.0073214,0.24503,0.86048,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION,0.99999
GSE8921_UNSTIM_0H_VS_TLR1_2_...3,SET,184,-0.066502,-0.0066238,0.061427,0.8605,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN,0.99999
HP_CLINODACTYLY_OF_THE_3RD_F...,SET,6,-0.41572,-0.0075138,0.38395,0.86054,HP_CLINODACTYLY_OF_THE_3RD_FINGER,0.99999
GOMF_PRE_MRNA_BINDING,SET,36,-0.13593,-0.0060129,0.12552,0.86057,GOMF_PRE_MRNA_BINDING,0.99999
GSE16385_MONOCYTE_VS_MACROPH...1,SET,171,-0.069179,-0.006645,0.06387,0.86061,GSE16385_MONOCYTE_VS_MACROPHAGE_DN,0.99999
KEGG_ALLOGRAFT_REJECTION,SET,32,-0.18119,-0.0075577,0.16728,0.86062,KEGG_ALLOGRAFT_REJECTION,0.99999
GSE18281_SUBCAPSULAR_CORTICA...1,SET,167,-0.069712,-0.0066181,0.064361,0.86062,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,0.99999
MIR6853_3P,SET,186,-0.066978,-0.006707,0.061835,0.86063,MIR6853_3P,0.99999
GOBP_RESPONSE_TO_PAIN,SET,35,-0.16449,-0.0071747,0.15184,0.86066,GOBP_RESPONSE_TO_PAIN,0.99999
RIZKI_TUMOR_INVASIVENESS_3D_...2,SET,186,-0.066301,-0.0066392,0.061197,0.86068,RIZKI_TUMOR_INVASIVENESS_3D_UP,0.99999
GSE3982_MAST_CELL_VS_DC_UP,SET,161,-0.070508,-0.0065734,0.065076,0.8607,GSE3982_MAST_CELL_VS_DC_UP,0.99999
KYNG_DNA_DAMAGE_BY_4NQO,SET,33,-0.14864,-0.0062961,0.13718,0.86072,KYNG_DNA_DAMAGE_BY_4NQO,0.99999
MIR629_3P,SET,165,-0.072334,-0.0068262,0.066748,0.86074,MIR629_3P,0.99999
GOBP_REGULATION_OF_OPSIN_MED...,SET,8,-0.30215,-0.0063055,0.2788,0.86075,GOBP_REGULATION_OF_OPSIN_MEDIATED_SIGNALING_PATHWAY,0.99999
VERRECCHIA_DELAYED_RESPONSE_...,SET,36,-0.15867,-0.0070188,0.14639,0.86078,VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,0.99999
GOBP_NEGATIVE_REGULATION_OF_...346,SET,52,-0.12556,-0.0066726,0.11582,0.86083,GOBP_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...51,SET,52,-0.13258,-0.0070458,0.1223,0.86084,GOBP_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...310,SET,15,-0.25705,-0.0073442,0.23705,0.8609,GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS,0.99999
HP_PERSEVERATIVE_THOUGHT,SET,19,-0.20446,-0.0065736,0.18853,0.86091,HP_PERSEVERATIVE_THOUGHT,0.99999
HP_ANNULAR_PANCREAS,SET,25,-0.19033,-0.0070182,0.17548,0.86094,HP_ANNULAR_PANCREAS,0.99999
PAX6_TARGET_GENES,SET,692,-0.035554,-0.006771,0.032778,0.86096,PAX6_TARGET_GENES,0.99999
CDH4_TARGET_GENES,SET,56,-0.12633,-0.0069662,0.11645,0.86101,CDH4_TARGET_GENES,0.99999
GSE17974_0.5H_VS_72H_IL4_AND...1,SET,175,-0.06481,-0.006297,0.059734,0.86103,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...25,SET,25,-0.18393,-0.0067823,0.16951,0.86105,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_UNSPECIFIED,0.99999
GOBP_ORGANIC_ACID_CATABOLIC_...,SET,234,-0.059228,-0.0066436,0.05458,0.86107,GOBP_ORGANIC_ACID_CATABOLIC_PROCESS,0.99999
GOBP_CEREBRAL_CORTEX_CELL_MI...,SET,42,-0.15109,-0.0072179,0.13922,0.86108,GOBP_CEREBRAL_CORTEX_CELL_MIGRATION,0.99999
PSIP1_TARGET_GENES,SET,547,-0.038309,-0.006513,0.035299,0.86109,PSIP1_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...271,SET,5,-0.42106,-0.0069475,0.38793,0.86112,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,0.99999
ACCAAAG_MIR9,SET,467,-0.042709,-0.0067241,0.039343,0.86116,ACCAAAG_MIR9,0.99999
HP_FIBULAR_HYPOPLASIA,SET,22,-0.18612,-0.0064388,0.17141,0.86122,HP_FIBULAR_HYPOPLASIA,0.99999
GOBP_PRE_MIRNA_PROCESSING,SET,14,-0.24462,-0.0067522,0.22525,0.86126,GOBP_PRE_MIRNA_PROCESSING,0.99999
KEGG_CELL_ADHESION_MOLECULES...,SET,119,-0.092348,-0.0074104,0.085013,0.86131,KEGG_CELL_ADHESION_MOLECULES_CAMS,0.99999
MIR214_5P,SET,49,-0.1331,-0.0068668,0.12251,0.86135,MIR214_5P,0.99999
REACTOME_RUNX1_REGULATES_EST...,SET,6,-0.38493,-0.0069572,0.35423,0.8614,REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION,0.99999
KEGG_MEDICUS_PATHOGEN_HIV_VP...2,SET,8,-0.25773,-0.0053786,0.23715,0.86142,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M,0.99999
ELVIDGE_HIF1A_TARGETS_UP,SET,62,-0.10869,-0.0063051,0.1,0.86144,ELVIDGE_HIF1A_TARGETS_UP,0.99999
MORF_PTPN11,SET,93,-0.088045,-0.0062502,0.081007,0.86145,MORF_PTPN11,0.99999
GOBP_SYNAPTIC_SIGNALING_VIA_...,SET,6,-0.45293,-0.0081863,0.41667,0.86148,GOBP_SYNAPTIC_SIGNALING_VIA_NEUROPEPTIDE,0.99999
GOBP_CARDIAC_CHAMBER_MORPHOG...,SET,121,-0.093439,-0.0075602,0.085952,0.8615,GOBP_CARDIAC_CHAMBER_MORPHOGENESIS,0.99999
MORF_EIF4E,SET,79,-0.096254,-0.0063001,0.088523,0.86155,MORF_EIF4E,0.99999
HP_CRANIOFACIAL_HYPEROSTOSIS,SET,24,-0.17121,-0.0061858,0.15742,0.86159,HP_CRANIOFACIAL_HYPEROSTOSIS,0.99999
GSE15659_TREG_VS_TCONV_UP,SET,149,-0.074743,-0.0067057,0.068712,0.86164,GSE15659_TREG_VS_TCONV_UP,0.99999
HP_HEAD_TITUBATION,SET,18,-0.22474,-0.0070332,0.20657,0.86169,HP_HEAD_TITUBATION,0.99999
MODULE_168,SET,10,-0.31456,-0.007339,0.2891,0.86171,MODULE_168,0.99999
GOMF_MHC_CLASS_II_RECEPTOR_A...,SET,8,-0.37652,-0.0078577,0.34605,0.86171,GOMF_MHC_CLASS_II_RECEPTOR_ACTIVITY,0.99999
GOBP_LIPID_HOMEOSTASIS,SET,147,-0.075184,-0.0067003,0.069078,0.86178,GOBP_LIPID_HOMEOSTASIS,0.99999
KEGG_MEDICUS_REFERENCE_COPI_...,SET,23,-0.16581,-0.0058648,0.15234,0.86179,KEGG_MEDICUS_REFERENCE_COPI_VESICLE_FORMATION,0.99999
KEGG_UBIQUITIN_MEDIATED_PROT...,SET,119,-0.078405,-0.0062916,0.072012,0.86187,KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,0.99999
GSE18893_CTRL_VS_TNF_TREATED...2,SET,179,-0.067325,-0.0066149,0.061832,0.86188,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP,0.99999
GOBP_GLYCOLYTIC_PROCESS_THRO...2,SET,16,-0.20653,-0.0060941,0.18965,0.86191,GOBP_GLYCOLYTIC_PROCESS_THROUGH_GLUCOSE_6_PHOSPHATE,0.99999
GSE15330_WT_VS_IKAROS_KO_MEG...2,SET,179,-0.065097,-0.006396,0.059762,0.86197,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,0.99999
GSE18804_BRAIN_VS_COLON_TUMO...1,SET,174,-0.072268,-0.0070018,0.066348,0.86197,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN,0.99999
HU_FETAL_RETINA_AMACRINE,SET,57,-0.13731,-0.0076384,0.12606,0.86197,HU_FETAL_RETINA_AMACRINE,0.99999
CAO_BLOOD_FLUMIST_AGE_05_14Y...6,SET,7,-0.31473,-0.0061441,0.28888,0.86202,CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_UP,0.99999
HP_TRIGONOCEPHALY,SET,40,-0.14324,-0.0066783,0.13147,0.86203,HP_TRIGONOCEPHALY,0.99999
MIR7155_3P,SET,61,-0.10945,-0.0062979,0.10039,0.86217,MIR7155_3P,0.99999
GOMF_HYDROLASE_ACTIVITY_HYDR...2,SET,83,-0.10279,-0.0068952,0.094287,0.86217,GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS,0.99999
KEGG_MEDICUS_REFERENCE_BCR_B...,SET,14,-0.26551,-0.0073286,0.24353,0.86219,KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY,0.99999
GSE17721_CTRL_VS_POLYIC_0.5H...2,SET,180,-0.068119,-0.0067115,0.062479,0.86219,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP,0.99999
GOMF_DOLICHYL_PHOSPHATE_MANN...,SET,8,-0.28354,-0.0059172,0.26,0.86225,GOMF_DOLICHYL_PHOSPHATE_MANNOSE_PROTEIN_MANNOSYLTRANSFERASE_ACTIVITY,0.99999
GOMF_CALCITONIN_FAMILY_RECEP...,SET,6,-0.39526,-0.0071439,0.36244,0.86226,GOMF_CALCITONIN_FAMILY_RECEPTOR_ACTIVITY,0.99999
HP_FACIAL_TELANGIECTASIA,SET,15,-0.21423,-0.0061207,0.19642,0.86228,HP_FACIAL_TELANGIECTASIA,0.99999
GOBP_INTRACELLULAR_PROTEIN_T...2,SET,628,-0.035752,-0.0064979,0.032777,0.8623,GOBP_INTRACELLULAR_PROTEIN_TRANSPORT,0.99999
GOBP_TELENCEPHALON_GLIAL_CEL...,SET,25,-0.20014,-0.00738,0.18349,0.8623,GOBP_TELENCEPHALON_GLIAL_CELL_MIGRATION,0.99999
GOMF_TELOMERASE_INHIBITOR_AC...,SET,5,-0.41048,-0.0067728,0.37622,0.86237,GOMF_TELOMERASE_INHIBITOR_ACTIVITY,0.99999
GSE360_L_MAJOR_VS_B_MALAYI_H...1,SET,180,-0.067673,-0.0066675,0.062018,0.86239,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.99999
REACTOME_HIGHLY_CALCIUM_PERM...1,SET,9,-0.38047,-0.0084214,0.3486,0.86245,REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS,0.99999
MODULE_356,SET,140,-0.076264,-0.006634,0.069871,0.86246,MODULE_356,0.99999
HP_ABNORMAL_CNS_MYELINATION,SET,360,-0.045919,-0.0063664,0.042068,0.86247,HP_ABNORMAL_CNS_MYELINATION,0.99999
GOBP_POSTSYNAPSE_ORGANIZATION,SET,180,-0.069628,-0.0068602,0.063788,0.86248,GOBP_POSTSYNAPSE_ORGANIZATION,0.99999
GSE1460_DP_THYMOCYTE_VS_NAIV...4,SET,162,-0.069905,-0.0065372,0.064038,0.86249,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...20,SET,8,-0.32608,-0.006805,0.29868,0.86252,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_APO...1,SET,11,-0.28082,-0.0068714,0.25723,0.86252,HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M1_MACROPHAGE_CELL,0.99999
XIE_ST_HSC_S1PR3_OE_DN,SET,23,-0.20764,-0.0073442,0.19018,0.86253,XIE_ST_HSC_S1PR3_OE_DN,0.99999
MIR548E_5P,SET,659,-0.037021,-0.0068866,0.033907,0.86254,MIR548E_5P,0.99999
LY_AGING_OLD_UP,SET,7,-0.39822,-0.007774,0.36468,0.86257,LY_AGING_OLD_UP,0.99999
GSE11961_FOLLICULAR_BCELL_VS...8,SET,180,-0.06911,-0.0068091,0.063274,0.86262,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...370,SET,12,-0.28162,-0.0071972,0.25783,0.86264,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION,0.99999
GOBP_REGULATION_OF_MICROVILL...3,SET,13,-0.24297,-0.0064628,0.22243,0.86265,GOBP_REGULATION_OF_MICROVILLUS_ORGANIZATION,0.99999
GSE22611_UNSTIM_VS_2H_MDP_ST...4,SET,168,-0.070707,-0.0067324,0.06473,0.86265,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.99999
GOBP_EPIDERMIS_MORPHOGENESIS,SET,36,-0.17289,-0.0076482,0.15827,0.86266,GOBP_EPIDERMIS_MORPHOGENESIS,0.99999
GOBP_PROTEIN_AUTOPHOSPHORYLA...,SET,175,-0.071446,-0.0069417,0.065404,0.86266,GOBP_PROTEIN_AUTOPHOSPHORYLATION,0.99999
MIR1909_3P,SET,120,-0.083387,-0.0067192,0.076329,0.86268,MIR1909_3P,0.99999
KEGG_MEDICUS_REFERENCE_ITGA_...2,SET,29,-0.17886,-0.0071027,0.16371,0.86269,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY,0.99999
BILD_MYC_ONCOGENIC_SIGNATURE,SET,181,-0.06498,-0.0064198,0.059462,0.86275,BILD_MYC_ONCOGENIC_SIGNATURE,0.99999
KEGG_TYPE_I_DIABETES_MELLITUS,SET,39,-0.16919,-0.0077891,0.15479,0.86279,KEGG_TYPE_I_DIABETES_MELLITUS,0.99999
GOBP_PERICARDIUM_DEVELOPMENT,SET,18,-0.2366,-0.0074045,0.21644,0.86283,GOBP_PERICARDIUM_DEVELOPMENT,0.99999
GOCC_NEURON_PROJECTION,SET,1213,-0.028234,-0.0070132,0.025815,0.86296,GOCC_NEURON_PROJECTION,0.99999
GOBP_REGULATION_OF_FATTY_ACI...4,SET,31,-0.16742,-0.0068732,0.15304,0.863,GOBP_REGULATION_OF_FATTY_ACID_OXIDATION,0.99999
REACTOME_TP53_REGULATES_META...,SET,77,-0.10033,-0.0064836,0.091711,0.86301,REACTOME_TP53_REGULATES_METABOLIC_GENES,0.99999
RAX2_TARGET_GENES,SET,62,-0.12072,-0.0070029,0.11032,0.86308,RAX2_TARGET_GENES,0.99999
GOCC_TRIGLYCERIDE_RICH_PLASM...,SET,14,-0.28197,-0.0077831,0.25767,0.86308,GOCC_TRIGLYCERIDE_RICH_PLASMA_LIPOPROTEIN_PARTICLE,0.99999
GOBP_POSITIVE_REGULATION_OF_...485,SET,19,-0.21259,-0.0068352,0.19423,0.86313,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS,0.99999
GOMF_EXTRACELLULAR_LIGAND_GA...,SET,67,-0.12556,-0.0075712,0.11472,0.86313,GOMF_EXTRACELLULAR_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.99999
GOBP_MUSCLE_CELL_APOPTOTIC_P...,SET,76,-0.10536,-0.0067643,0.096255,0.86314,GOBP_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
MIR4423_3P,SET,116,-0.08738,-0.0069234,0.079829,0.86315,MIR4423_3P,0.99999
GOBP_MONOAMINE_TRANSPORT,SET,72,-0.11393,-0.0071203,0.10407,0.86318,GOBP_MONOAMINE_TRANSPORT,0.99999
GOBP_REGULATION_OF_VASCULATU...,SET,265,-0.059525,-0.0070993,0.054365,0.86322,GOBP_REGULATION_OF_VASCULATURE_DEVELOPMENT,0.99999
GATA6_01,SET,236,-0.064568,-0.007273,0.058964,0.86324,GATA6_01,0.99999
HP_INCREASED_WAIST_TO_HIP_RA...,SET,36,-0.16863,-0.0074597,0.154,0.86324,HP_INCREASED_WAIST_TO_HIP_RATIO,0.99999
GOBP_NONASSOCIATIVE_LEARNING,SET,6,-0.38368,-0.0069347,0.35024,0.86334,GOBP_NONASSOCIATIVE_LEARNING,0.99999
GOBP_REGULATION_OF_CLATHRIN_...,SET,16,-0.21667,-0.0063933,0.19778,0.86334,GOBP_REGULATION_OF_CLATHRIN_DEPENDENT_ENDOCYTOSIS,0.99999
DESCARTES_FETAL_CEREBRUM_SKO...,SET,48,-0.14502,-0.0074051,0.13236,0.86337,DESCARTES_FETAL_CEREBRUM_SKOR2_NPSR1_POSITIVE_CELLS,0.99999
GOBP_LONG_TERM_MEMORY,SET,36,-0.15901,-0.0070339,0.14512,0.86338,GOBP_LONG_TERM_MEMORY,0.99999
GOBP_REGULATION_OF_FOREBRAIN...,SET,5,-0.47603,-0.0078544,0.43445,0.86339,GOBP_REGULATION_OF_FOREBRAIN_NEURON_DIFFERENTIATION,0.99999
GOBP_CELLULAR_RESPONSE_TO_ST...4,SET,14,-0.2465,-0.006804,0.22491,0.86345,GOBP_CELLULAR_RESPONSE_TO_STEROL_DEPLETION,0.99999
GOBP_EXTRACELLULAR_TRANSPORT,SET,38,-0.13538,-0.0061524,0.12346,0.86356,GOBP_EXTRACELLULAR_TRANSPORT,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...5,SET,36,-0.14858,-0.0065727,0.13548,0.8636,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN,0.99999
GOBP_METANEPHRIC_NEPHRON_MOR...,SET,24,-0.21525,-0.0077772,0.19626,0.86362,GOBP_METANEPHRIC_NEPHRON_MORPHOGENESIS,0.99999
MIR4421,SET,49,-0.13105,-0.0067608,0.11945,0.86368,MIR4421,0.99999
HP_DECREASED_CIRCULATING_ANT...,SET,175,-0.069437,-0.0067466,0.063291,0.8637,HP_DECREASED_CIRCULATING_ANTIBODY_LEVEL,0.99999
GOBP_NEURAL_NUCLEUS_DEVELOPM...,SET,57,-0.1213,-0.0067481,0.11055,0.86373,GOBP_NEURAL_NUCLEUS_DEVELOPMENT,0.99999
HP_POSTERIOR_SYNECHIAE_OF_TH...,SET,10,-0.31419,-0.0073303,0.28629,0.86377,HP_POSTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER,0.99999
GSE12839_CTRL_VS_IL12_TREATE...1,SET,111,-0.087525,-0.0067847,0.079751,0.86378,GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN,0.99999
AFFAR_YY1_TARGETS_UP,SET,178,-0.070168,-0.0068752,0.063913,0.86386,AFFAR_YY1_TARGETS_UP,0.99999
HP_SUBCAPSULAR_CATARACT,SET,104,-0.089816,-0.0067404,0.081805,0.86387,HP_SUBCAPSULAR_CATARACT,0.99999
MIR23C,SET,538,-0.041037,-0.0069208,0.037375,0.86388,MIR23C,0.99999
GOBP_REGULATION_OF_VASOCONST...,SET,63,-0.12778,-0.0074718,0.11638,0.86388,GOBP_REGULATION_OF_VASOCONSTRICTION,0.99999
GOMF_ARACHIDONATE_COA_LIGASE...,SET,10,-0.29905,-0.0069772,0.27228,0.86396,GOMF_ARACHIDONATE_COA_LIGASE_ACTIVITY,0.99999
GOBP_NAD_METABOLIC_PROCESS,SET,57,-0.11872,-0.0066046,0.10809,0.86398,GOBP_NAD_METABOLIC_PROCESS,0.99999
NAKAYA_PLASMACYTOID_DENDRITI...2,SET,186,-0.066156,-0.0066247,0.06022,0.86401,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.99999
GOBP_PEPTIDE_BIOSYNTHETIC_PR...,SET,25,-0.19551,-0.0072094,0.17794,0.86405,GOBP_PEPTIDE_BIOSYNTHETIC_PROCESS,0.99999
HP_PICA,SET,8,-0.28541,-0.0059561,0.25971,0.8641,HP_PICA,0.99999
KEGG_MEDICUS_REFERENCE_IL2_F...,SET,20,-0.23397,-0.0077177,0.21285,0.86415,KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,0.99999
MIR7843_3P,SET,80,-0.10482,-0.0069041,0.095365,0.86415,MIR7843_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...94,SET,8,-0.33184,-0.0069252,0.30188,0.86416,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPIRATION,0.99999
WP_SLEEP_REGULATION,SET,38,-0.16974,-0.0077141,0.15441,0.86417,WP_SLEEP_REGULATION,0.99999
HP_ABNORMAL_SENSORY_NERVE_CO...,SET,24,-0.17916,-0.0064731,0.16298,0.86417,HP_ABNORMAL_SENSORY_NERVE_CONDUCTION_VELOCITY,0.99999
GSE13485_DAY1_VS_DAY21_YF17D...2,SET,160,-0.070575,-0.0065594,0.064198,0.86418,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP,0.99999
WP_NONCLASSICAL_ROLE_OF_VITA...,SET,6,-0.4252,-0.007685,0.38676,0.86419,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,0.99999
HP_DECREASED_SPECIFIC_ANTIBO...4,SET,29,-0.18484,-0.00734,0.1681,0.86424,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_VACCINATION,0.99999
MIR3615,SET,8,-0.35634,-0.0074364,0.32398,0.8643,MIR3615,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...28,SET,23,-0.21181,-0.007492,0.19258,0.8643,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN,0.99999
GOBP_PENILE_ERECTION,SET,7,-0.43479,-0.0084879,0.3953,0.86431,GOBP_PENILE_ERECTION,0.99999
REACTOME_ECM_PROTEOGLYCANS,SET,73,-0.11648,-0.0073302,0.10589,0.86433,REACTOME_ECM_PROTEOGLYCANS,0.99999
GOERING_BLOOD_HDL_CHOLESTERO...2,SET,12,-0.28234,-0.0072157,0.25666,0.86434,GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS,0.99999
HP_BRACHYTURRICEPHALY,SET,8,-0.34135,-0.0071236,0.3103,0.86434,HP_BRACHYTURRICEPHALY,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...12,SET,171,-0.069556,-0.0066812,0.06323,0.86434,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP,0.99999
MODULE_195,SET,138,-0.077609,-0.0067029,0.070545,0.86436,MODULE_195,0.99999
GOMF_C_C_CHEMOKINE_BINDING,SET,22,-0.22414,-0.007754,0.20374,0.86436,GOMF_C_C_CHEMOKINE_BINDING,0.99999
MORF_ANP32B,SET,178,-0.064478,-0.0063176,0.058605,0.86437,MORF_ANP32B,0.99999
HP_ABNORMAL_IMMUNE_SERUM_PRO...,SET,42,-0.14734,-0.0070389,0.13388,0.86444,HP_ABNORMAL_IMMUNE_SERUM_PROTEIN_PHYSIOLOGY,0.99999
GOBP_RENAL_SYSTEM_PROCESS_IN...1,SET,14,-0.26308,-0.0072618,0.23903,0.86446,GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_BLOOD_VOLUME,0.99999
GOBP_ENDOCARDIAL_CUSHION_MOR...,SET,42,-0.16533,-0.0078984,0.1502,0.86449,GOBP_ENDOCARDIAL_CUSHION_MORPHOGENESIS,0.99999
AMIT_SERUM_RESPONSE_20_MCF10A,SET,15,-0.25489,-0.0072824,0.23148,0.86457,AMIT_SERUM_RESPONSE_20_MCF10A,0.99999
HP_SENSORIMOTOR_NEUROPATHY,SET,73,-0.11056,-0.0069574,0.1004,0.86458,HP_SENSORIMOTOR_NEUROPATHY,0.99999
GSE21033_CTRL_VS_POLYIC_STIM...5,SET,137,-0.079585,-0.0068489,0.072271,0.86459,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_DN,0.99999
WP_SPHINGOLIPID_METABOLISM_I...1,SET,23,-0.20309,-0.0071834,0.1844,0.86462,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,0.99999
SCHLOSSER_MYC_TARGETS_AND_SE...2,SET,45,-0.13099,-0.0064771,0.11893,0.86464,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...550,SET,15,-0.22518,-0.0064336,0.20438,0.86471,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,0.99999
MORF_ATRX,SET,204,-0.061296,-0.006425,0.055618,0.86478,MORF_ATRX,0.99999
HP_PITUITARY_PROLACTIN_CELL_...,SET,7,-0.32754,-0.0063942,0.2972,0.86478,HP_PITUITARY_PROLACTIN_CELL_ADENOMA,0.99999
GSE29618_MONOCYTE_VS_PDC_UP,SET,185,-0.071492,-0.00714,0.064869,0.86478,GSE29618_MONOCYTE_VS_PDC_UP,0.99999
GOBP_MANNOSYLATION,SET,20,-0.20496,-0.0067607,0.18596,0.8648,GOBP_MANNOSYLATION,0.99999
ATATGCA_MIR448,SET,191,-0.073821,-0.0074899,0.066973,0.86481,ATATGCA_MIR448,0.99999
MODULE_447,SET,35,-0.15513,-0.0067664,0.14073,0.86482,MODULE_447,0.99999
HP_BONE_SPICULE_PIGMENTATION...,SET,101,-0.092075,-0.0068101,0.083531,0.86482,HP_BONE_SPICULE_PIGMENTATION_OF_THE_RETINA,0.99999
GOBP_VERY_LOW_DENSITY_LIPOPR...2,SET,3,-0.54269,-0.0069363,0.49228,0.86485,GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
YIH_RESPONSE_TO_ARSENITE_C2,SET,14,-0.23136,-0.0063862,0.20983,0.8649,YIH_RESPONSE_TO_ARSENITE_C2,0.99999
GOBP_CELL_CELL_SIGNALING,SET,1197,-0.028946,-0.0071457,0.02625,0.86491,GOBP_CELL_CELL_SIGNALING,0.99999
WP_CANONICAL_AND_NONCANONICA...2,SET,17,-0.24496,-0.0074503,0.22214,0.86492,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,0.99999
GSE20198_IL12_VS_IFNA_TREATE...1,SET,179,-0.068914,-0.0067711,0.062492,0.86493,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,0.99999
GOMF_ANGIOTENSIN_RECEPTOR_AC...,SET,4,-0.53694,-0.0079243,0.48678,0.86499,GOMF_ANGIOTENSIN_RECEPTOR_ACTIVITY,0.99999
HP_ABNORMALITY_OF_SPINAL_FAC...,SET,5,-0.45059,-0.0074346,0.40838,0.86506,HP_ABNORMALITY_OF_SPINAL_FACET_JOINT,0.99999
FRIDMAN_SENESCENCE_DN,SET,11,-0.26195,-0.0064098,0.23735,0.86512,FRIDMAN_SENESCENCE_DN,0.99999
MODULE_40,SET,81,-0.10516,-0.0069692,0.095283,0.86512,MODULE_40,0.99999
GOMF_MOLECULAR_TRANSDUCER_AC...,SET,1298,-0.030939,-0.0079302,0.028031,0.86514,GOMF_MOLECULAR_TRANSDUCER_ACTIVITY,0.99999
KRAS.300_UP.V1_DN,SET,125,-0.085441,-0.0070257,0.077402,0.86516,KRAS.300_UP.V1_DN,0.99999
MODULE_27,SET,333,-0.055088,-0.0073511,0.049904,0.86517,MODULE_27,0.99999
HP_ABNORMAL_TRABECULAR_BONE_...,SET,28,-0.17519,-0.0068362,0.1587,0.86518,HP_ABNORMAL_TRABECULAR_BONE_MORPHOLOGY,0.99999
GSE339_EX_VIVO_VS_IN_CULTURE...4,SET,185,-0.066451,-0.0066366,0.060195,0.86518,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP,0.99999
HP_ABNORMAL_MYELINATION,SET,539,-0.038509,-0.0065003,0.034882,0.86519,HP_ABNORMAL_MYELINATION,0.99999
KRAS.BREAST_UP.V1_DN,SET,124,-0.087595,-0.0071741,0.079335,0.86522,KRAS.BREAST_UP.V1_DN,0.99999
HP_SMALL_INTESTINAL_STENOSIS,SET,27,-0.1673,-0.0064109,0.15152,0.86523,HP_SMALL_INTESTINAL_STENOSIS,0.99999
HP_ABNORMALITY_OF_LIPOPROTEI...,SET,80,-0.10729,-0.0070664,0.097157,0.86525,HP_ABNORMALITY_OF_LIPOPROTEIN_CHOLESTEROL_CONCENTRATION,0.99999
GOBP_PHENOL_CONTAINING_COMPO...3,SET,103,-0.098963,-0.0073913,0.089613,0.86527,GOBP_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
MODULE_288,SET,34,-0.18896,-0.0081237,0.1711,0.86528,MODULE_288,0.99999
MIR1303,SET,189,-0.068447,-0.0069086,0.061966,0.86533,MIR1303,0.99999
GCM_RAN,SET,178,-0.066964,-0.0065613,0.060622,0.86533,GCM_RAN,0.99999
WP_MAMMARY_GLAND_DEVELOPMENT...1,SET,15,-0.25439,-0.0072682,0.23029,0.86534,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,0.99999
MIR3913_5P,SET,79,-0.10402,-0.0068087,0.094159,0.86536,MIR3913_5P,0.99999
REACTOME_REVERSIBLE_HYDRATIO...,SET,11,-0.30269,-0.0074065,0.27395,0.86539,REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE,0.99999
GOMF_NEUREXIN_FAMILY_PROTEIN...,SET,8,-0.33698,-0.0070324,0.30497,0.8654,GOMF_NEUREXIN_FAMILY_PROTEIN_BINDING,0.99999
MIR6820_5P,SET,11,-0.28175,-0.0068942,0.25497,0.86542,MIR6820_5P,0.99999
RIZ_ERYTHROID_DIFFERENTIATIO...3,SET,24,-0.20446,-0.0073873,0.185,0.86546,RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2,0.99999
HP_BEAKING_OF_VERTEBRAL_BODI...,SET,25,-0.17902,-0.0066012,0.16198,0.86546,HP_BEAKING_OF_VERTEBRAL_BODIES,0.99999
HOLLERN_SOLID_NODULAR_BREAST...2,SET,9,-0.35928,-0.0079524,0.32499,0.86552,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP,0.99999
GOBP_SPERM_AXONEME_ASSEMBLY,SET,26,-0.17732,-0.0066678,0.1604,0.86552,GOBP_SPERM_AXONEME_ASSEMBLY,0.99999
HP_11_PAIRS_OF_RIBS,SET,44,-0.13653,-0.0066755,0.12349,0.86553,HP_11_PAIRS_OF_RIBS,0.99999
HP_ABDUCENS_PALSY,SET,9,-0.32922,-0.007287,0.29777,0.86554,HP_ABDUCENS_PALSY,0.99999
MIR7162_5P,SET,162,-0.073188,-0.0068442,0.066181,0.8656,MIR7162_5P,0.99999
NOUZOVA_TRETINOIN_AND_H4_ACE...,SET,122,-0.079031,-0.0064207,0.071441,0.86568,NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,0.99999
TGACGTCA_ATF3_Q6,SET,210,-0.065734,-0.0069896,0.05941,0.86573,TGACGTCA_ATF3_Q6,0.99999
ALX4_01,SET,15,-0.26234,-0.0074952,0.23708,0.86575,ALX4_01,0.99999
GOCC_PRC1_COMPLEX,SET,17,-0.21954,-0.0066771,0.19836,0.86579,GOCC_PRC1_COMPLEX,0.99999
ZFP36L1_TARGET_GENES,SET,47,-0.13161,-0.0066502,0.11889,0.86584,ZFP36L1_TARGET_GENES,0.99999
RAG1_TARGET_GENES,SET,852,-0.03256,-0.0068491,0.02941,0.86587,RAG1_TARGET_GENES,0.99999
SP1_Q6_01,SET,229,-0.06002,-0.0066611,0.054204,0.86591,SP1_Q6_01,0.99999
GSE18203_CTRL_VS_INTRATUMORA...2,SET,187,-0.065881,-0.0066147,0.059498,0.86591,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP,0.99999
REACTOME_PLASMA_LIPOPROTEIN_...2,SET,67,-0.11504,-0.0069367,0.10389,0.86593,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,0.99999
HP_PROTRUDING_TONGUE,SET,38,-0.15082,-0.0068543,0.13613,0.86604,HP_PROTRUDING_TONGUE,0.99999
GOBP_POTASSIUM_ION_EXPORT_AC...,SET,18,-0.24378,-0.0076291,0.21999,0.86609,GOBP_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOMF_INTRAMOLECULAR_PHOSPHOT...,SET,10,-0.25758,-0.0060095,0.23244,0.86609,GOMF_INTRAMOLECULAR_PHOSPHOTRANSFERASE_ACTIVITY,0.99999
GOBP_ACTIVIN_RECEPTOR_SIGNAL...,SET,44,-0.15402,-0.0075308,0.13896,0.86614,GOBP_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_FAT_CELL_PROLIFERATION,SET,15,-0.26245,-0.0074984,0.23678,0.86615,GOBP_FAT_CELL_PROLIFERATION,0.99999
HOXC11_TARGET_GENES,SET,48,-0.1218,-0.0062193,0.10988,0.86616,HOXC11_TARGET_GENES,0.99999
WP_APOPTOSIS,SET,82,-0.10466,-0.0069787,0.094416,0.86617,WP_APOPTOSIS,0.99999
GOCC_TRAPP_COMPLEX,SET,14,-0.25083,-0.0069236,0.22624,0.86621,GOCC_TRAPP_COMPLEX,0.99999
GOBP_REGULATION_OF_ACTIN_FIL...3,SET,94,-0.097025,-0.0069244,0.087509,0.86622,GOBP_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.99999
GOBP_REGULATION_OF_SPROUTING...,SET,40,-0.15133,-0.0070555,0.13648,0.86622,GOBP_REGULATION_OF_SPROUTING_ANGIOGENESIS,0.99999
GSE2128_C57BL6_VS_NOD_THYMOC...1,SET,176,-0.067973,-0.006623,0.061303,0.86624,GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN,0.99999
GOBP_REGULATION_OF_CELL_CYCL...1,SET,41,-0.13744,-0.0064872,0.12392,0.8663,GOBP_REGULATION_OF_CELL_CYCLE_CHECKPOINT,0.99999
MIR93_3P,SET,106,-0.087844,-0.0066551,0.079192,0.86633,MIR93_3P,0.99999
HP_APLASIA_OF_THE_MUSCULATURE,SET,9,-0.33315,-0.007374,0.30014,0.86648,HP_APLASIA_OF_THE_MUSCULATURE,0.99999
HP_KERATOCONJUNCTIVITIS,SET,43,-0.14171,-0.0068498,0.12767,0.8665,HP_KERATOCONJUNCTIVITIS,0.99999
GOBP_POSITIVE_REGULATION_OF_...34,SET,7,-0.40092,-0.0078267,0.36114,0.86653,GOBP_POSITIVE_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE,0.99999
GOBP_CELLULAR_RESPONSE_TO_EX...1,SET,13,-0.24944,-0.006635,0.22465,0.86657,GOBP_CELLULAR_RESPONSE_TO_EXOGENOUS_DSRNA,0.99999
KEGG_MEDICUS_REFERENCE_CGAS_...,SET,13,-0.32276,-0.0085852,0.29065,0.86659,KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY,0.99999
MORF_UBE2N,SET,82,-0.091724,-0.006116,0.082601,0.86659,MORF_UBE2N,0.99999
GSE46242_CTRL_VS_EGR2_DELETE...1,SET,167,-0.074434,-0.0070664,0.067019,0.86663,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_DN,0.99999
GOBP_TENDON_DEVELOPMENT,SET,5,-0.48998,-0.0080845,0.44116,0.86664,GOBP_TENDON_DEVELOPMENT,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...4,SET,11,-0.32587,-0.0079738,0.29335,0.86668,GOBP_RESPONSE_TO_INTERLEUKIN_15,0.99999
MIR6765_5P,SET,7,-0.35727,-0.0069745,0.32151,0.86675,MIR6765_5P,0.99999
REACTOME_ION_CHANNEL_TRANSPO...,SET,170,-0.073862,-0.0070742,0.066468,0.86676,REACTOME_ION_CHANNEL_TRANSPORT,0.99999
GOBP_EMBRYONIC_PLACENTA_DEVE...,SET,83,-0.10791,-0.0072386,0.097072,0.86684,GOBP_EMBRYONIC_PLACENTA_DEVELOPMENT,0.99999
GOBP_ENDOCHONDRAL_BONE_MORPH...,SET,56,-0.13361,-0.0073673,0.12019,0.86684,GOBP_ENDOCHONDRAL_BONE_MORPHOGENESIS,0.99999
GSE411_UNSTIM_VS_100MIN_IL6_...2,SET,185,-0.069547,-0.0069457,0.062565,0.86684,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP,0.99999
GSE18791_UNSTIM_VS_NEWCATSLE...4,SET,175,-0.066397,-0.0064512,0.059723,0.86687,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP,0.99999
GOMF_MICROFILAMENT_MOTOR_ACT...,SET,37,-0.16309,-0.0073139,0.14669,0.86688,GOMF_MICROFILAMENT_MOTOR_ACTIVITY,0.99999
GOMF_TRANSLATION_REGULATOR_A...2,SET,91,-0.088516,-0.006216,0.07961,0.8669,GOMF_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING,0.99999
PRC2_EZH2_UP.V1_UP,SET,171,-0.076923,-0.0073888,0.069176,0.86692,PRC2_EZH2_UP.V1_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...667,SET,22,-0.20163,-0.0069752,0.18128,0.86698,GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,0.99999
HARALAMBIEVA_PBMC_TIV_AGE_50...1,SET,19,-0.21931,-0.0070512,0.19717,0.86698,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_28DY_NEGATIVE,0.99999
GOMF_KINASE_BINDING,SET,730,-0.035394,-0.0069158,0.031815,0.86704,GOMF_KINASE_BINDING,0.99999
HP_PRIMARY_HYPERPARATHYROIDI...,SET,13,-0.28499,-0.0075805,0.25616,0.86704,HP_PRIMARY_HYPERPARATHYROIDISM,0.99999
DUTERTRE_ESTRADIOL_RESPONSE_...3,SET,86,-0.11017,-0.0075223,0.099016,0.86706,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,0.99999
NFKAPPAB65_01,SET,228,-0.062948,-0.0069708,0.056576,0.86706,NFKAPPAB65_01,0.99999
GOBP_GLYCEROL_ETHER_METABOLI...,SET,19,-0.22167,-0.0071271,0.19922,0.86707,GOBP_GLYCEROL_ETHER_METABOLIC_PROCESS,0.99999
GSE36009_WT_VS_NLRP10_KO_DC_...4,SET,184,-0.068357,-0.0068086,0.06143,0.86709,GSE36009_WT_VS_NLRP10_KO_DC_UP,0.99999
GOBP_CIRCADIAN_SLEEP_WAKE_CY...1,SET,22,-0.21896,-0.0075749,0.19676,0.8671,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE,0.99999
GOBP_REGULATION_OF_EXTRINSIC...3,SET,45,-0.13399,-0.0066254,0.12041,0.8671,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,0.99999
PETROVA_ENDOTHELIUM_LYMPHATI...2,SET,125,-0.087317,-0.00718,0.078445,0.86716,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,0.99999
E4BP4_01,SET,194,-0.071241,-0.0072841,0.064002,0.86716,E4BP4_01,0.99999
GOBP_RESPONSE_TO_MERCURY_ION,SET,10,-0.2943,-0.0068664,0.26439,0.86716,GOBP_RESPONSE_TO_MERCURY_ION,0.99999
MODULE_35,SET,4,-0.43585,-0.0064323,0.39146,0.86722,MODULE_35,0.99999
GSE45881_CXCR6HI_VS_CXCR1LO_...2,SET,168,-0.06857,-0.0065289,0.061585,0.86723,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP,0.99999
GOBP_OSTEOBLAST_DIFFERENTIAT...,SET,209,-0.068177,-0.0072324,0.061225,0.86726,GOBP_OSTEOBLAST_DIFFERENTIATION,0.99999
BCAT.100_UP.V1_DN,SET,24,-0.19297,-0.0069721,0.17327,0.86729,BCAT.100_UP.V1_DN,0.99999
GOBP_RESPONSE_TO_STEROL_DEPL...,SET,15,-0.24319,-0.006948,0.21835,0.8673,GOBP_RESPONSE_TO_STEROL_DEPLETION,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...16,SET,184,-0.069876,-0.0069598,0.062739,0.8673,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_UP,0.99999
BIOCARTA_ACE2_PATHWAY,SET,9,-0.35368,-0.0078284,0.3175,0.86734,BIOCARTA_ACE2_PATHWAY,0.99999
GOBP_G1_TO_G0_TRANSITION_INV...,SET,6,-0.35696,-0.0064518,0.32043,0.86735,GOBP_G1_TO_G0_TRANSITION_INVOLVED_IN_CELL_DIFFERENTIATION,0.99999
GOBP_LIPID_IMPORT_INTO_CELL,SET,19,-0.21894,-0.0070392,0.19646,0.86744,GOBP_LIPID_IMPORT_INTO_CELL,0.99999
HP_OPEN_ANGLE_GLAUCOMA,SET,12,-0.30235,-0.007727,0.27131,0.86744,HP_OPEN_ANGLE_GLAUCOMA,0.99999
MIR198,SET,76,-0.1181,-0.0075827,0.10597,0.86746,MIR198,0.99999
GUCY1B1_TARGET_GENES,SET,517,-0.04155,-0.0068733,0.037273,0.86751,GUCY1B1_TARGET_GENES,0.99999
HP_ABNORMALITY_OF_THE_PYLORUS,SET,92,-0.10253,-0.0072395,0.091965,0.86754,HP_ABNORMALITY_OF_THE_PYLORUS,0.99999
MIR548P,SET,541,-0.04124,-0.0069738,0.03698,0.86761,MIR548P,0.99999
GOBP_REGULATION_OF_PROTEASOM...2,SET,113,-0.08598,-0.0067243,0.077097,0.86761,GOBP_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
BIOCARTA_G2_PATHWAY,SET,24,-0.17712,-0.0063994,0.15877,0.86769,BIOCARTA_G2_PATHWAY,0.99999
GOBP_PYRIMIDINE_NUCLEOBASE_M...,SET,20,-0.20512,-0.0067662,0.18387,0.86769,GOBP_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS,0.99999
GOMF_CADMIUM_ION_BINDING,SET,5,-0.45033,-0.0074303,0.40364,0.86771,GOMF_CADMIUM_ION_BINDING,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...5,SET,13,-0.27833,-0.0074034,0.24943,0.86775,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_DN,0.99999
FAN_EMBRYONIC_CTX_BRAIN_ENDO...2,SET,277,-0.0611,-0.0074479,0.054756,0.86775,FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2,0.99999
GOBP_CGMP_CATABOLIC_PROCESS,SET,5,-0.42809,-0.0070634,0.38359,0.86778,GOBP_CGMP_CATABOLIC_PROCESS,0.99999
HP_RETINAL_FOLD,SET,10,-0.30405,-0.0070938,0.27239,0.86783,HP_RETINAL_FOLD,0.99999
GSE20715_0H_VS_24H_OZONE_LUN...2,SET,183,-0.068165,-0.0067712,0.061063,0.86785,GSE20715_0H_VS_24H_OZONE_LUNG_UP,0.99999
YANG_BREAST_CANCER_ESR1_LASE...1,SET,42,-0.14537,-0.0069449,0.1302,0.8679,YANG_BREAST_CANCER_ESR1_LASER_DN,0.99999
HP_MYELOMENINGOCELE,SET,20,-0.22887,-0.0075495,0.20498,0.8679,HP_MYELOMENINGOCELE,0.99999
HP_HYPOPLASTIC_NASAL_BRIDGE,SET,5,-0.37275,-0.0061503,0.33381,0.86792,HP_HYPOPLASTIC_NASAL_BRIDGE,0.99999
HOFT_PBMC_TICE_BCG_RBCG_AG85...,SET,35,-0.16742,-0.0073025,0.14992,0.86793,HOFT_PBMC_TICE_BCG_RBCG_AG85A_AG85B_AGE_18_40YO_CORRELATED_WITH_WHOLE_BLOOD_BACTERICIDAL_ACTIVITY_NEGATIVE,0.99999
AAGGGAT_MIR188,SET,67,-0.11423,-0.0068879,0.10229,0.86795,AAGGGAT_MIR188,0.99999
DOANE_BREAST_CANCER_CLASSES_...2,SET,66,-0.11918,-0.0071327,0.10672,0.86796,DOANE_BREAST_CANCER_CLASSES_UP,0.99999
GOMF_DIPEPTIDASE_ACTIVITY,SET,17,-0.22439,-0.0068245,0.20088,0.868,GOMF_DIPEPTIDASE_ACTIVITY,0.99999
GSE32986_UNSTIM_VS_GMCSF_AND...2,SET,180,-0.067349,-0.0066356,0.060289,0.86802,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.99999
GOMF_INTRAMOLECULAR_TRANSFER...,SET,26,-0.16448,-0.006185,0.14722,0.86805,GOMF_INTRAMOLECULAR_TRANSFERASE_ACTIVITY,0.99999
BIOCARTA_BCELLSURVIVAL_PATHW...,SET,14,-0.27868,-0.0076923,0.24942,0.86806,BIOCARTA_BCELLSURVIVAL_PATHWAY,0.99999
GOBP_COMMA_SHAPED_BODY_MORPH...,SET,5,-0.52339,-0.0086359,0.46844,0.86806,GOBP_COMMA_SHAPED_BODY_MORPHOGENESIS,0.99999
GSE20366_EX_VIVO_VS_DEC205_C...1,SET,182,-0.069843,-0.0069191,0.062503,0.86809,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN,0.99999
HP_ABNORMAL_ILEUM_MORPHOLOGY,SET,33,-0.15915,-0.006741,0.1424,0.86812,HP_ABNORMAL_ILEUM_MORPHOLOGY,0.99999
GOBP_FATTY_ACID_ELONGATION,SET,13,-0.30068,-0.0079978,0.269,0.86816,GOBP_FATTY_ACID_ELONGATION,0.99999
GOBP_CDP_CHOLINE_PATHWAY,SET,6,-0.34549,-0.0062443,0.30907,0.86817,GOBP_CDP_CHOLINE_PATHWAY,0.99999
GOCC_PROTEASOME_ACCESSORY_CO...,SET,23,-0.17404,-0.006156,0.15563,0.86827,GOCC_PROTEASOME_ACCESSORY_COMPLEX,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...19,SET,646,-0.036542,-0.0067327,0.032672,0.86831,HP_APLASIA_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM,0.99999
GSE3982_CTRL_VS_LPS_4H_MAC_UP,SET,177,-0.066589,-0.0065064,0.059531,0.86833,GSE3982_CTRL_VS_LPS_4H_MAC_UP,0.99999
MIR1236_5P,SET,73,-0.10671,-0.0067151,0.095392,0.86835,MIR1236_5P,0.99999
MIR3136_5P,SET,69,-0.11851,-0.0072512,0.10593,0.86837,MIR3136_5P,0.99999
HP_GENERALIZED_ONSET_SEIZURE,SET,277,-0.05669,-0.0069103,0.05067,0.86838,HP_GENERALIZED_ONSET_SEIZURE,0.99999
QUEREC_MODEL_PBMC_YF_17D_VAC...2,SET,35,-0.15433,-0.0067317,0.13794,0.86838,QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45_7DY_PREDICTIVE,0.99999
GSE22601_IMMATURE_CD4_SINGLE...4,SET,184,-0.070853,-0.0070571,0.06332,0.86841,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,0.99999
GSE19888_CTRL_VS_A3R_INHIBIT...1,SET,168,-0.074833,-0.0071253,0.066872,0.86843,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN,0.99999
GOBP_NUCLEOSIDE_DIPHOSPHATE_...2,SET,96,-0.089863,-0.0064808,0.080291,0.86847,GOBP_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS,0.99999
GSE5142_CTRL_VS_HTERT_TRANSD...2,SET,188,-0.068026,-0.0068482,0.060779,0.86847,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP,0.99999
MODULE_324,SET,126,-0.094087,-0.0077673,0.084054,0.8685,MODULE_324,0.99999
MIR520A_5P,SET,146,-0.077548,-0.0068875,0.069276,0.86851,MIR520A_5P,0.99999
SOBOLEV_PBMC_PANDEMRIX_AGE_1...7,SET,4,-0.43278,-0.006387,0.38642,0.86863,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN,0.99999
GSE9509_10MIN_VS_30MIN_LPS_S...1,SET,171,-0.075121,-0.0072157,0.067056,0.86869,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN,0.99999
HP_PARTIAL_ANOMALOUS_PULMONA...,SET,6,-0.39399,-0.007121,0.35168,0.8687,HP_PARTIAL_ANOMALOUS_PULMONARY_VENOUS_RETURN,0.99999
HP_FUNCTIONAL_INTESTINAL_OBS...,SET,10,-0.31508,-0.0073512,0.28122,0.86873,HP_FUNCTIONAL_INTESTINAL_OBSTRUCTION,0.99999
GOMF_STEROID_HORMONE_BINDING,SET,6,-0.42579,-0.0076957,0.38,0.86874,GOMF_STEROID_HORMONE_BINDING,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...6,SET,180,-0.069799,-0.006877,0.062289,0.86876,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_UP,0.99999
HOSHIDA_LIVER_CANCER_LATE_RE...1,SET,63,-0.12044,-0.0070429,0.10747,0.86879,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...257,SET,12,-0.2709,-0.0069232,0.24167,0.86884,GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_IMPORT,0.99999
GSE25677_MPL_VS_MPL_AND_R848...2,SET,141,-0.077622,-0.006776,0.069235,0.86888,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP,0.99999
GOBP_LIPID_LOCALIZATION,SET,449,-0.046946,-0.007251,0.041867,0.86892,GOBP_LIPID_LOCALIZATION,0.99999
GOBP_EXTRACELLULAR_EXOSOME_A...,SET,7,-0.37748,-0.007369,0.33662,0.86893,GOBP_EXTRACELLULAR_EXOSOME_ASSEMBLY,0.99999
HP_RETINAL_VEIN_OCCLUSION,SET,6,-0.39721,-0.0071792,0.3542,0.86894,HP_RETINAL_VEIN_OCCLUSION,0.99999
GOCC_GOLGI_ASSOCIATED_VESICL...,SET,52,-0.12174,-0.0064693,0.10855,0.86895,GOCC_GOLGI_ASSOCIATED_VESICLE_MEMBRANE,0.99999
KEGG_MEDICUS_PATHOGEN_SHIGEL...1,SET,6,-0.43804,-0.0079171,0.39056,0.86897,KEGG_MEDICUS_PATHOGEN_SHIGELLA_FIMA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.99999
MIR3617_3P,SET,79,-0.10605,-0.006941,0.094535,0.86901,MIR3617_3P,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...10,SET,184,-0.069238,-0.0068963,0.061711,0.86905,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP,0.99999
GOBP_FAT_SOLUBLE_VITAMIN_MET...,SET,47,-0.14102,-0.0071255,0.12568,0.86907,GOBP_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS,0.99999
HP_THIN_UPPER_LIP_VERMILION,SET,263,-0.056939,-0.0067657,0.050744,0.86908,HP_THIN_UPPER_LIP_VERMILION,0.99999
HP_REMNANTS_OF_THE_HYALOID_V...,SET,9,-0.34215,-0.0075732,0.3049,0.8691,HP_REMNANTS_OF_THE_HYALOID_VASCULAR_SYSTEM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...581,SET,8,-0.30273,-0.0063176,0.26975,0.86912,GOBP_NEGATIVE_REGULATION_OF_SCHWANN_CELL_PROLIFERATION,0.99999
GOMF_SINGLE_STRANDED_DNA_END...,SET,10,-0.27003,-0.0063,0.24055,0.86917,GOMF_SINGLE_STRANDED_DNA_ENDODEOXYRIBONUCLEASE_ACTIVITY,0.99999
MORF_MT4,SET,234,-0.061179,-0.0068624,0.0545,0.86918,MORF_MT4,0.99999
GOMF_TRANSFORMING_GROWTH_FAC...3,SET,5,-0.48278,-0.0079658,0.43005,0.86919,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_ACTIVITY_TYPE_I,0.99999
BALDWIN_PRKCI_TARGETS_UP,SET,32,-0.18726,-0.0078106,0.16677,0.86925,BALDWIN_PRKCI_TARGETS_UP,0.99999
GOBP_MOLTING_CYCLE_PROCESS,SET,95,-0.10463,-0.0075069,0.093184,0.86925,GOBP_MOLTING_CYCLE_PROCESS,0.99999
TARTE_PLASMA_CELL_VS_PLASMAB...2,SET,350,-0.05365,-0.0073363,0.047774,0.86927,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,0.99999
GOBP_REGULATION_OF_PROTEIN_A...1,SET,17,-0.22079,-0.0067152,0.19659,0.86929,GOBP_REGULATION_OF_PROTEIN_ACETYLATION,0.99999
KEGG_MEDICUS_REFERENCE_TRANS...4,SET,5,-0.44532,-0.0073477,0.39644,0.86934,KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM,0.99999
MIR9983_3P,SET,423,-0.047307,-0.0070971,0.042109,0.86937,MIR9983_3P,0.99999
GOCC_DNA_RECOMBINASE_MEDIATO...,SET,7,-0.35282,-0.0068877,0.31397,0.86943,GOCC_DNA_RECOMBINASE_MEDIATOR_COMPLEX,0.99999
HP_FASTING_HYPOGLYCEMIA,SET,20,-0.22493,-0.0074194,0.20015,0.86944,HP_FASTING_HYPOGLYCEMIA,0.99999
GSE41978_WT_VS_BIM_KO_KLRG1_...1,SET,178,-0.071129,-0.0069694,0.063294,0.86944,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.99999
HP_ACROMICRIA,SET,8,-0.41038,-0.0085642,0.3651,0.86949,HP_ACROMICRIA,0.99999
HP_KNUCKLE_PAD,SET,7,-0.34771,-0.0067879,0.30933,0.8695,HP_KNUCKLE_PAD,0.99999
MIR642A_5P,SET,82,-0.10584,-0.0070576,0.094144,0.86955,MIR642A_5P,0.99999
RODRIGUES_NTN1_TARGETS_UP,SET,14,-0.27582,-0.0076134,0.24531,0.86957,RODRIGUES_NTN1_TARGETS_UP,0.99999
GOCC_NEURON_PROJECTION_TERMI...,SET,117,-0.092912,-0.0073931,0.082628,0.86958,GOCC_NEURON_PROJECTION_TERMINUS,0.99999
HP_SENSORY_ATAXIA,SET,14,-0.24152,-0.0066667,0.21477,0.86961,HP_SENSORY_ATAXIA,0.99999
MIR4761_3P,SET,46,-0.14439,-0.0072179,0.12838,0.86962,MIR4761_3P,0.99999
GOMF_PHOSPHOLIPID_TRANSFER_A...,SET,20,-0.19175,-0.006325,0.1705,0.86963,GOMF_PHOSPHOLIPID_TRANSFER_ACTIVITY,0.99999
HP_ABNORMAL_CIRCULATING_CITR...,SET,10,-0.29887,-0.0069729,0.26574,0.86963,HP_ABNORMAL_CIRCULATING_CITRULLINE_CONCENTRATION,0.99999
MIR936,SET,127,-0.083763,-0.0069422,0.074474,0.86964,MIR936,0.99999
MIR5591_5P,SET,59,-0.11981,-0.0067809,0.10647,0.86977,MIR5591_5P,0.99999
MIR6738_5P,SET,25,-0.19865,-0.0073253,0.17653,0.86977,MIR6738_5P,0.99999
GSE29164_DAY3_VS_DAY7_CD8_TC...3,SET,183,-0.069418,-0.0068957,0.061688,0.86977,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN,0.99999
GOBP_TORC1_SIGNALING,SET,92,-0.097326,-0.006872,0.086472,0.86981,GOBP_TORC1_SIGNALING,0.99999
GOBP_PYRIDINE_CONTAINING_COM...2,SET,91,-0.093566,-0.0065707,0.083067,0.86999,GOBP_PYRIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
GSE5542_IFNG_VS_IFNA_TREATED...1,SET,175,-0.073254,-0.0071174,0.06503,0.87001,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,0.99999
GOMF_TRANSCRIPTION_REGULATOR...3,SET,26,-0.20281,-0.0076263,0.18003,0.87002,GOMF_TRANSCRIPTION_REGULATOR_INHIBITOR_ACTIVITY,0.99999
GOBP_ENDOTHELIAL_CELL_MORPHO...,SET,9,-0.36234,-0.0080203,0.32163,0.87003,GOBP_ENDOTHELIAL_CELL_MORPHOGENESIS,0.99999
HP_ABNORMAL_RIB_CAGE_MORPHOL...,SET,339,-0.05231,-0.0070419,0.046432,0.87003,HP_ABNORMAL_RIB_CAGE_MORPHOLOGY,0.99999
KRAS.BREAST_UP.V1_UP,SET,118,-0.09603,-0.0076736,0.085237,0.87004,KRAS.BREAST_UP.V1_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...191,SET,10,-0.29001,-0.0067663,0.25739,0.87007,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.99999
HP_ABNORMAL_BLOOD_FOLATE_CON...,SET,10,-0.29811,-0.0069552,0.26455,0.87009,HP_ABNORMAL_BLOOD_FOLATE_CONCENTRATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_PRO...2,SET,96,-0.10773,-0.0077696,0.095598,0.87011,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_1_CELL,0.99999
MIR548F_5P,SET,446,-0.046497,-0.0071582,0.041251,0.87015,MIR548F_5P,0.99999
GSE20366_EX_VIVO_VS_HOMEOSTA...3,SET,179,-0.07178,-0.0070527,0.063683,0.87015,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN,0.99999
WP_GASTRIC_CANCER_NETWORK_1,SET,24,-0.20065,-0.0072496,0.17801,0.87016,WP_GASTRIC_CANCER_NETWORK_1,0.99999
HP_AMNIOTIC_CONSTRICTION_RING,SET,10,-0.34091,-0.0079537,0.30244,0.87016,HP_AMNIOTIC_CONSTRICTION_RING,0.99999
GOBP_RIBOSOMAL_SUBUNIT_EXPOR...,SET,15,-0.24265,-0.0069327,0.21518,0.87026,GOBP_RIBOSOMAL_SUBUNIT_EXPORT_FROM_NUCLEUS,0.99999
MIR934,SET,73,-0.11314,-0.00712,0.10031,0.87032,MIR934,0.99999
GOBP_WHITE_FAT_CELL_DIFFEREN...,SET,16,-0.24301,-0.0071706,0.21545,0.87032,GOBP_WHITE_FAT_CELL_DIFFERENTIATION,0.99999
GSE37301_PRO_BCELL_VS_CD4_TC...1,SET,150,-0.080117,-0.0072117,0.071008,0.87039,GSE37301_PRO_BCELL_VS_CD4_TCELL_DN,0.99999
HP_SLEEP_RELATED_BREATHING_D...,SET,148,-0.078582,-0.0070267,0.06964,0.87042,HP_SLEEP_RELATED_BREATHING_DISORDERS,0.99999
HP_LEUKOCORIA,SET,6,-0.36827,-0.0066561,0.32634,0.87044,HP_LEUKOCORIA,0.99999
BIOCARTA_ALK_PATHWAY,SET,34,-0.17458,-0.0075055,0.15467,0.87049,BIOCARTA_ALK_PATHWAY,0.99999
HP_HIP_OSTEOARTHRITIS,SET,17,-0.2601,-0.0079107,0.23042,0.8705,HP_HIP_OSTEOARTHRITIS,0.99999
GOBP_C4_DICARBOXYLATE_TRANSP...,SET,28,-0.18191,-0.0070985,0.16113,0.87054,GOBP_C4_DICARBOXYLATE_TRANSPORT,0.99999
PAX4_02,SET,217,-0.06756,-0.0073011,0.059833,0.87057,PAX4_02,0.99999
HP_MOTOR_DETERIORATION,SET,27,-0.17817,-0.0068272,0.15778,0.87059,HP_MOTOR_DETERIORATION,0.99999
GSE39820_CTRL_VS_TGFBETA1_IL...3,SET,179,-0.068619,-0.0067421,0.060764,0.8706,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN,0.99999
GSE43955_10H_VS_30H_ACT_CD4_...1,SET,185,-0.069295,-0.0069206,0.061362,0.8706,GSE43955_10H_VS_30H_ACT_CD4_TCELL_DN,0.99999
FAN_EMBRYONIC_CTX_BRAIN_MYEL...,SET,121,-0.0909,-0.0073548,0.080479,0.87064,FAN_EMBRYONIC_CTX_BRAIN_MYELOID,0.99999
GOBP_POSITIVE_REGULATION_OF_...839,SET,30,-0.1636,-0.0066077,0.14485,0.87065,GOBP_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,0.99999
WHITFIELD_CELL_CYCLE_LITERAT...,SET,44,-0.1287,-0.0062926,0.11393,0.87068,WHITFIELD_CELL_CYCLE_LITERATURE,0.99999
HP_TRICUSPID_STENOSIS,SET,6,-0.42631,-0.0077051,0.37737,0.87069,HP_TRICUSPID_STENOSIS,0.99999
GSE28237_EARLY_VS_LATE_GC_BC...1,SET,175,-0.069097,-0.0067135,0.061158,0.87072,GSE28237_EARLY_VS_LATE_GC_BCELL_DN,0.99999
SNACANNNYSYAGA_UNKNOWN,SET,79,-0.10306,-0.0067456,0.09119,0.87079,SNACANNNYSYAGA_UNKNOWN,0.99999
TOP2B_TARGET_GENES,SET,483,-0.044276,-0.0070861,0.039175,0.8708,TOP2B_TARGET_GENES,0.99999
GOBP_TANGENTIAL_MIGRATION_FR...,SET,7,-0.37174,-0.0072571,0.32889,0.87081,GOBP_TANGENTIAL_MIGRATION_FROM_THE_SUBVENTRICULAR_ZONE_TO_THE_OLFACTORY_BULB,0.99999
GOBP_NEGATIVE_REGULATION_OF_...105,SET,5,-0.46039,-0.0075963,0.4073,0.87082,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MOLECULE_PRODUCTION,0.99999
HEIDENBLAD_AMPLICON_12P11_12...1,SET,20,-0.21337,-0.0070384,0.18868,0.87094,HEIDENBLAD_AMPLICON_12P11_12_DN,0.99999
HP_FEMORAL_BOWING,SET,41,-0.15769,-0.0074432,0.13942,0.87097,HP_FEMORAL_BOWING,0.99999
DESCARTES_FETAL_KIDNEY_URETE...,SET,235,-0.067432,-0.0075797,0.059609,0.87101,DESCARTES_FETAL_KIDNEY_URETERIC_BUD_CELLS,0.99999
GOBP_FATTY_ACID_ELONGATION_S...,SET,8,-0.3826,-0.0079846,0.33821,0.87102,GOBP_FATTY_ACID_ELONGATION_SATURATED_FATTY_ACID,0.99999
HP_REDUCED_FACTOR_XI_ACTIVITY,SET,13,-0.23736,-0.0063135,0.2098,0.87104,HP_REDUCED_FACTOR_XI_ACTIVITY,0.99999
TRAVAGLINI_LUNG_NATURAL_KILL...1,SET,121,-0.093446,-0.0075608,0.082578,0.87109,TRAVAGLINI_LUNG_NATURAL_KILLER_CELL,0.99999
ISHIDA_TARGETS_OF_SYT_SSX_FU...,SET,6,-0.45236,-0.008176,0.39972,0.87111,ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS,0.99999
KEGG_MEDICUS_REFERENCE_IL1_I...1,SET,17,-0.25371,-0.0077163,0.22419,0.87111,KEGG_MEDICUS_REFERENCE_IL1_IL1R_JNK_SIGNALING_PATHWAY,0.99999
REACTOME_NEF_MEDIATES_DOWN_M...,SET,20,-0.20534,-0.0067734,0.18145,0.87111,REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS,0.99999
GOBP_POSITIVE_REGULATION_OF_...766,SET,65,-0.1158,-0.0068776,0.10227,0.87122,GOBP_POSITIVE_REGULATION_OF_TOR_SIGNALING,0.99999
GOBP_CIRCADIAN_RHYTHM,SET,192,-0.072009,-0.0073249,0.063596,0.87123,GOBP_CIRCADIAN_RHYTHM,0.99999
LIN_NPAS4_TARGETS_UP,SET,156,-0.073924,-0.0067849,0.065279,0.87126,LIN_NPAS4_TARGETS_UP,0.99999
TFEB_TARGET_GENES,SET,1068,-0.030177,-0.0070632,0.026646,0.87128,TFEB_TARGET_GENES,0.99999
HP_CHORIORETINAL_ATROPHY,SET,40,-0.15451,-0.007204,0.13643,0.8713,HP_CHORIORETINAL_ATROPHY,0.99999
HP_ABNORMAL_EATING_BEHAVIOR,SET,114,-0.092865,-0.0072947,0.081973,0.87136,HP_ABNORMAL_EATING_BEHAVIOR,0.99999
DESCARTES_FETAL_SPLEEN_LYMPH...,SET,93,-0.10565,-0.0074998,0.093257,0.87136,DESCARTES_FETAL_SPLEEN_LYMPHOID_CELLS,0.99999
GSE8685_IL2_STARVED_VS_IL15_...1,SET,178,-0.069998,-0.0068585,0.061773,0.87142,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,0.99999
REACTOME_RECEPTOR_MEDIATED_M...,SET,10,-0.28914,-0.0067459,0.25515,0.87143,REACTOME_RECEPTOR_MEDIATED_MITOPHAGY,0.99999
GOBP_MIRNA_MEDIATED_GENE_SIL...1,SET,18,-0.22383,-0.0070049,0.19752,0.87143,GOBP_MIRNA_MEDIATED_GENE_SILENCING_BY_INHIBITION_OF_TRANSLATION,0.99999
GSE6674_ANTI_IGM_VS_CPG_STIM...2,SET,180,-0.070951,-0.0069905,0.062604,0.87145,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP,0.99999
GSE6681_DELETED_FOXP3_VS_WT_...2,SET,174,-0.074174,-0.0071864,0.065447,0.87146,GSE6681_DELETED_FOXP3_VS_WT_TREG_UP,0.99999
GOCC_EXOCYST,SET,16,-0.23368,-0.0068951,0.20614,0.87151,GOCC_EXOCYST,0.99999
GSE36476_YOUNG_VS_OLD_DONOR_...1,SET,166,-0.074868,-0.0070865,0.066035,0.87154,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN,0.99999
HP_OVAL_FACE,SET,15,-0.24637,-0.0070389,0.21729,0.87156,HP_OVAL_FACE,0.99999
CROONQUIST_STROMAL_STIMULATI...1,SET,11,-0.30533,-0.0074712,0.26925,0.87159,CROONQUIST_STROMAL_STIMULATION_DN,0.99999
GOBP_DIGESTION,SET,127,-0.09161,-0.0075926,0.080782,0.8716,GOBP_DIGESTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...356,SET,10,-0.35339,-0.0082449,0.31157,0.87164,GOBP_POSITIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...686,SET,15,-0.23961,-0.0068458,0.21123,0.87167,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,0.99999
GSE40666_NAIVE_VS_EFFECTOR_C...1,SET,185,-0.07306,-0.0072965,0.064401,0.87169,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,0.99999
GSE2770_TGFB_AND_IL4_VS_IL12...3,SET,183,-0.06986,-0.0069395,0.061574,0.87171,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
GOBP_CHEMOKINE_PRODUCTION,SET,90,-0.10787,-0.0075338,0.095035,0.87182,GOBP_CHEMOKINE_PRODUCTION,0.99999
WP_HEDGEHOG_SIGNALING_WP47,SET,14,-0.23807,-0.0065713,0.20968,0.87188,WP_HEDGEHOG_SIGNALING_WP47,0.99999
HP_EXTERNAL_OPHTHALMOPLEGIA,SET,51,-0.12678,-0.0066724,0.11166,0.87189,HP_EXTERNAL_OPHTHALMOPLEGIA,0.99999
chr9p23,SET,4,-0.6186,-0.0091294,0.54454,0.87201,chr9p23,0.99999
GOBP_SENSORY_PERCEPTION_OF_T...2,SET,29,-0.18655,-0.0074079,0.16422,0.87201,GOBP_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS,0.99999
GOBP_DETECTION_OF_STIMULUS,SET,532,-0.052451,-0.0087978,0.046171,0.87202,GOBP_DETECTION_OF_STIMULUS,0.99999
TAANNYSGCG_UNKNOWN,SET,73,-0.11235,-0.0070703,0.098881,0.87207,TAANNYSGCG_UNKNOWN,0.99999
MIR6817_3P,SET,203,-0.069713,-0.0072896,0.061348,0.87209,MIR6817_3P,0.99999
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...1,SET,12,-0.33674,-0.0086059,0.2963,0.87211,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_II_PROTEIN_COMPLEX,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...8,SET,36,-0.16249,-0.0071879,0.14294,0.87218,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,0.99999
WP_AUTOPHAGY,SET,30,-0.16492,-0.0066609,0.14508,0.87218,WP_AUTOPHAGY,0.99999
GOBP_PYRIDINE_CONTAINING_COM...3,SET,158,-0.074133,-0.0068472,0.065204,0.87221,GOBP_PYRIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
HFH8_01,SET,191,-0.073081,-0.0074148,0.064272,0.87223,HFH8_01,0.99999
MIR6746_5P,SET,5,-0.44636,-0.0073649,0.39242,0.87232,MIR6746_5P,0.99999
REACTOME_RNA_POLYMERASE_I_TR...3,SET,26,-0.162,-0.0060918,0.14242,0.87233,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION,0.99999
FOXJ2_01,SET,168,-0.078221,-0.0074479,0.06876,0.87235,FOXJ2_01,0.99999
PURBEY_TARGETS_OF_CTBP1_AND_...1,SET,150,-0.077173,-0.0069468,0.067813,0.87244,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...356,SET,293,-0.058386,-0.0073164,0.051299,0.87246,GOBP_NEGATIVE_REGULATION_OF_LOCOMOTION,0.99999
HEBERT_MATRISOME_TNBC_LUNG_M...1,SET,20,-0.22044,-0.0072714,0.19366,0.87249,HEBERT_MATRISOME_TNBC_LUNG_METASTASIS,0.99999
OCT1_02,SET,187,-0.074257,-0.0074557,0.065234,0.8725,OCT1_02,0.99999
GOCC_CYTOSOLIC_REGION,SET,19,-0.21517,-0.0069181,0.18902,0.87251,GOCC_CYTOSOLIC_REGION,0.99999
SINGH_KRAS_DEPENDENCY_SIGNAT...,SET,19,-0.22952,-0.0073795,0.20156,0.87258,SINGH_KRAS_DEPENDENCY_SIGNATURE,0.99999
KEGG_MEDICUS_PATHOGEN_HIV_TA...2,SET,14,-0.34937,-0.0096434,0.30678,0.8726,KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY,0.99999
REACTOME_TRANSCRIPTIONAL_REG...10,SET,38,-0.1527,-0.0069397,0.13407,0.87264,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,0.99999
KANNAN_BLOOD_2012_2013_TIV_A...2,SET,190,-0.067881,-0.0068694,0.059593,0.87266,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MO_UP,0.99999
MIR3938,SET,68,-0.11162,-0.0067803,0.097961,0.87273,MIR3938,0.99999
REACTOME_RESOLUTION_OF_AP_SI...,SET,24,-0.17398,-0.0062859,0.15265,0.87279,REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY,0.99999
GSE12392_CD8A_POS_VS_NEG_SPL...1,SET,185,-0.069192,-0.0069103,0.06071,0.87279,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN,0.99999
MIR875_3P,SET,283,-0.058455,-0.007201,0.051283,0.87282,MIR875_3P,0.99999
GSE5542_UNTREATED_VS_IFNA_AN...3,SET,177,-0.07126,-0.0069628,0.062511,0.87284,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...3,SET,23,-0.16974,-0.0060038,0.14889,0.87285,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME,0.99999
GOBP_KIDNEY_MESENCHYME_DEVEL...,SET,15,-0.2836,-0.0081026,0.24871,0.8729,GOBP_KIDNEY_MESENCHYME_DEVELOPMENT,0.99999
HP_FRAGILE_SKIN,SET,34,-0.16992,-0.0073051,0.149,0.87292,HP_FRAGILE_SKIN,0.99999
GOBP_POSITIVE_REGULATION_OF_...240,SET,10,-0.34143,-0.0079659,0.29935,0.87296,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,0.99999
GSE26928_NAIVE_VS_CENT_MEMOR...2,SET,163,-0.072833,-0.0068318,0.063858,0.87296,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
KEGG_MEDICUS_REFERENCE_ANGIO...,SET,28,-0.18068,-0.0070505,0.15841,0.87298,KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.99999
GSE19888_NO_PRETREAT_VS_ADEN...2,SET,176,-0.070271,-0.0068469,0.061608,0.87298,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP,0.99999
GOBP_MYOFIBROBLAST_DIFFERENT...,SET,10,-0.28876,-0.006737,0.25313,0.873,GOBP_MYOFIBROBLAST_DIFFERENTIATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...589,SET,633,-0.039907,-0.0072808,0.034977,0.87304,GOBP_POSITIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,0.99999
GSE39916_B_CELL_SPLEEN_VS_PL...1,SET,179,-0.074585,-0.0073283,0.065372,0.87304,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN,0.99999
GOBP_REGULATION_OF_ANTIGEN_P...2,SET,5,-0.41872,-0.0069088,0.36696,0.87307,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,0.99999
BOCHKIS_FOXA2_TARGETS,SET,392,-0.048891,-0.0070671,0.042845,0.87308,BOCHKIS_FOXA2_TARGETS,0.99999
MIR6071,SET,155,-0.076344,-0.0069848,0.066888,0.87314,MIR6071,0.99999
AUTS2_TARGET_GENES,SET,487,-0.043979,-0.0070668,0.038529,0.87315,AUTS2_TARGET_GENES,0.99999
GSE3337_4H_VS_16H_IFNG_IN_CD...2,SET,186,-0.06811,-0.0068204,0.059664,0.87317,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP,0.99999
MOOTHA_ROS,SET,7,-0.41445,-0.0080907,0.36304,0.87318,MOOTHA_ROS,0.99999
GSE9988_LOW_LPS_VS_VEHICLE_T...1,SET,183,-0.068853,-0.0068395,0.060312,0.87318,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,0.99999
MIR4445_5P,SET,85,-0.10596,-0.007193,0.092813,0.8732,MIR4445_5P,0.99999
HP_DENTAL_ENAMEL_PITS,SET,8,-0.38936,-0.0081255,0.34103,0.8732,HP_DENTAL_ENAMEL_PITS,0.99999
HP_IRREGULAR_EPIPHYSES,SET,21,-0.20913,-0.0070686,0.18316,0.87322,HP_IRREGULAR_EPIPHYSES,0.99999
GOCC_MYELIN_SHEATH_ABAXONAL_...,SET,6,-0.37571,-0.0067906,0.32904,0.87323,GOCC_MYELIN_SHEATH_ABAXONAL_REGION,0.99999
WP_KYNURENINE_PATHWAY_AND_LI...,SET,24,-0.2097,-0.0075767,0.18364,0.87325,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,0.99999
HP_DECREASED_PROPORTION_OF_C...1,SET,9,-0.32706,-0.0072394,0.28638,0.87328,HP_DECREASED_PROPORTION_OF_CD3_POSITIVE_T_CELLS,0.99999
NOUSHMEHR_GBM_GERMLINE_MUTAT...,SET,7,-0.38771,-0.0075687,0.33944,0.87331,NOUSHMEHR_GBM_GERMLINE_MUTATED,0.99999
WP_ID_SIGNALING,SET,15,-0.23793,-0.0067979,0.20829,0.87333,WP_ID_SIGNALING,0.99999
GOBP_CELLULAR_RESPONSE_TO_AL...1,SET,96,-0.10468,-0.0075491,0.091631,0.87334,GOBP_CELLULAR_RESPONSE_TO_ALCOHOL,0.99999
MIR7112_3P,SET,87,-0.10627,-0.0072978,0.09297,0.87348,MIR7112_3P,0.99999
CREB_01,SET,241,-0.06283,-0.0071509,0.054968,0.87348,CREB_01,0.99999
GOMF_ALKALINE_PHOSPHATASE_AC...,SET,5,-0.52291,-0.0086279,0.4574,0.87352,GOMF_ALKALINE_PHOSPHATASE_ACTIVITY,0.99999
GSE9988_ANTI_TREM1_VS_CTRL_T...1,SET,188,-0.068296,-0.0068753,0.05974,0.87352,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN,0.99999
GOCC_SEX_CHROMATIN,SET,4,-0.39856,-0.0058821,0.34853,0.87359,GOCC_SEX_CHROMATIN,0.99999
REACTOME_NOSTRIN_MEDIATED_EN...,SET,5,-0.39031,-0.0064401,0.34126,0.87363,REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING,0.99999
MIR1470,SET,14,-0.24741,-0.0068292,0.2163,0.87364,MIR1470,0.99999
GAVIN_FOXP3_TARGETS_CLUSTER_...3,SET,92,-0.10721,-0.0075697,0.09372,0.87366,GAVIN_FOXP3_TARGETS_CLUSTER_P4,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...7,SET,185,-0.072135,-0.0072041,0.063059,0.87366,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,0.99999
MORI_EMU_MYC_LYMPHOMA_BY_ONS...1,SET,16,-0.23975,-0.0070742,0.20957,0.87368,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,0.99999
GOMF_CARGO_ADAPTOR_ACTIVITY,SET,20,-0.21563,-0.0071129,0.18849,0.87368,GOMF_CARGO_ADAPTOR_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_ITGA_...4,SET,22,-0.21695,-0.0075053,0.18962,0.87371,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,0.99999
WP_FATTY_ACID_BETAOXIDATION,SET,31,-0.17426,-0.0071543,0.15229,0.87374,WP_FATTY_ACID_BETAOXIDATION,0.99999
MIR365B_5P,SET,31,-0.18342,-0.0075304,0.16029,0.87375,MIR365B_5P,0.99999
GOBP_GLIAL_CELL_DERIVED_NEUR...,SET,15,-0.25429,-0.0072652,0.22201,0.87397,GOBP_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_METAPHYSEAL_WIDENING,SET,89,-0.10064,-0.0069897,0.087864,0.87397,HP_METAPHYSEAL_WIDENING,0.99999
KATSANOU_ELAVL1_TARGETS_UP,SET,154,-0.083123,-0.0075806,0.072539,0.87408,KATSANOU_ELAVL1_TARGETS_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...586,SET,11,-0.28389,-0.0069465,0.24772,0.8741,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.99999
GSE17721_CTRL_VS_CPG_12H_BMD...2,SET,183,-0.070896,-0.0070424,0.061858,0.87412,GSE17721_CTRL_VS_CPG_12H_BMDC_UP,0.99999
GSE25123_IL4_VS_IL4_AND_ROSI...4,SET,124,-0.083252,-0.0068185,0.072634,0.87413,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,0.99999
GOMF_BETA_GALACTOSIDE_CMP_AL...,SET,7,-0.31943,-0.0062357,0.27865,0.87416,GOMF_BETA_GALACTOSIDE_CMP_ALPHA_2_3_SIALYLTRANSFERASE_ACTIVITY,0.99999
GSE27896_HDAC6_KO_VS_WT_TREG...1,SET,150,-0.076977,-0.0069291,0.067139,0.87421,GSE27896_HDAC6_KO_VS_WT_TREG_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...611,SET,6,-0.4514,-0.0081586,0.39366,0.87423,GOBP_NEGATIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...734,SET,41,-0.16067,-0.0075838,0.14009,0.87427,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOMF_RETROMER_COMPLEX_BINDING,SET,6,-0.44989,-0.0081314,0.39224,0.8743,GOMF_RETROMER_COMPLEX_BINDING,0.99999
GOMF_PROTEASOME_ACTIVATING_A...,SET,6,-0.34712,-0.0062739,0.30261,0.87432,GOMF_PROTEASOME_ACTIVATING_ACTIVITY,0.99999
GOBP_CHEMOKINE_C_X_C_MOTIF_L...3,SET,18,-0.23923,-0.0074866,0.20853,0.87434,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,0.99999
HP_ABNORMAL_CIRCULATING_C_PE...,SET,26,-0.2015,-0.007577,0.17562,0.87437,HP_ABNORMAL_CIRCULATING_C_PEPTIDE_CONCENTRATION,0.99999
HAND1_TARGET_GENES,SET,361,-0.051718,-0.0071802,0.045073,0.87439,HAND1_TARGET_GENES,0.99999
GOBP_BLOOD_VESSEL_MORPHOGENE...,SET,578,-0.042866,-0.0074848,0.037352,0.87443,GOBP_BLOOD_VESSEL_MORPHOGENESIS,0.99999
GOBP_MODIFIED_AMINO_ACID_TRA...,SET,38,-0.16733,-0.0076045,0.14575,0.87452,GOBP_MODIFIED_AMINO_ACID_TRANSPORT,0.99999
GOBP_AMIDE_METABOLIC_PROCESS,SET,398,-0.050115,-0.007298,0.043649,0.87454,GOBP_AMIDE_METABOLIC_PROCESS,0.99999
GOBP_RESPONSE_TO_TUMOR_NECRO...,SET,213,-0.068007,-0.0072822,0.059224,0.87457,GOBP_RESPONSE_TO_TUMOR_NECROSIS_FACTOR,0.99999
GSE33162_HDAC3_KO_VS_HDAC3_K...4,SET,182,-0.068755,-0.0068112,0.059872,0.87458,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP,0.99999
ONO_FOXP3_TARGETS_UP,SET,21,-0.2386,-0.0080645,0.20771,0.87465,ONO_FOXP3_TARGETS_UP,0.99999
GOBP_MUSCLE_SYSTEM_PROCESS,SET,411,-0.049902,-0.007382,0.043442,0.87465,GOBP_MUSCLE_SYSTEM_PROCESS,0.99999
MIR330_5P,SET,169,-0.076229,-0.0072796,0.066356,0.87467,MIR330_5P,0.99999
HP_ABNORMAL_P_WAVE,SET,5,-0.49992,-0.0082485,0.43511,0.8747,HP_ABNORMAL_P_WAVE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...30,SET,5,-0.50695,-0.0083645,0.44121,0.87471,GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.99999
MIR6843_3P,SET,82,-0.11349,-0.0075673,0.098761,0.87474,MIR6843_3P,0.99999
HOSHIDA_LIVER_CANCER_LATE_RE...2,SET,56,-0.13279,-0.0073225,0.11552,0.87482,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,0.99999
BERENJENO_TRANSFORMED_BY_RHO...4,SET,25,-0.20009,-0.0073782,0.17404,0.87486,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,0.99999
REACTOME_LDL_CLEARANCE,SET,19,-0.22532,-0.0072444,0.19592,0.87494,REACTOME_LDL_CLEARANCE,0.99999
GSE42724_NAIVE_VS_MEMORY_BCE...1,SET,172,-0.074339,-0.0071612,0.064636,0.87494,GSE42724_NAIVE_VS_MEMORY_BCELL_DN,0.99999
GOBP_SMALL_MOLECULE_BIOSYNTH...,SET,536,-0.042028,-0.0070752,0.036541,0.87495,GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...296,SET,8,-0.34494,-0.0071985,0.29988,0.87497,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_WOUNDING,0.99999
HP_ABNORMAL_PERIPHERAL_NERVO...2,SET,151,-0.076275,-0.0068886,0.066311,0.87497,HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_PHYSIOLOGY,0.99999
GOBP_EPITHELIAL_CILIUM_MOVEM...,SET,9,-0.29321,-0.00649,0.25488,0.875,GOBP_EPITHELIAL_CILIUM_MOVEMENT_INVOLVED_IN_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY,0.99999
CAIRO_LIVER_DEVELOPMENT_UP,SET,145,-0.081597,-0.0072225,0.070927,0.87501,CAIRO_LIVER_DEVELOPMENT_UP,0.99999
HP_THIN_RIBS,SET,46,-0.14433,-0.0072154,0.12546,0.87501,HP_THIN_RIBS,0.99999
TUOMISTO_TUMOR_SUPPRESSION_B...2,SET,17,-0.26137,-0.0079492,0.22716,0.87504,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP,0.99999
OCT1_Q5_01,SET,224,-0.068444,-0.0075135,0.059475,0.87508,OCT1_Q5_01,0.99999
GOBP_N_TERMINAL_PROTEIN_LIPI...,SET,6,-0.40581,-0.0073346,0.35264,0.87508,GOBP_N_TERMINAL_PROTEIN_LIPIDATION,0.99999
GOMF_1_ALKYL_2_ACETYLGLYCERO...,SET,8,-0.30172,-0.0062967,0.26214,0.87513,GOMF_1_ALKYL_2_ACETYLGLYCEROPHOSPHOCHOLINE_ESTERASE_ACTIVITY,0.99999
KTGGYRSGAA_UNKNOWN,SET,68,-0.11574,-0.0070306,0.10055,0.87514,KTGGYRSGAA_UNKNOWN,0.99999
GOBP_INTESTINAL_ABSORPTION,SET,40,-0.16008,-0.0074638,0.13908,0.87514,GOBP_INTESTINAL_ABSORPTION,0.99999
KEGG_MEDICUS_REFERENCE_LPA_G...2,SET,8,-0.35999,-0.0075127,0.31273,0.87515,KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY,0.99999
LIU_IL13_MEMORY_MODEL_UP,SET,17,-0.23023,-0.0070021,0.19999,0.87516,LIU_IL13_MEMORY_MODEL_UP,0.99999
MODULE_257,SET,153,-0.072533,-0.0065935,0.062999,0.87519,MODULE_257,0.99999
SOX9_B1,SET,213,-0.06896,-0.0073842,0.05988,0.87526,SOX9_B1,0.99999
HP_MACULAR_HYPERPIGMENTATION,SET,6,-0.46498,-0.0084041,0.40374,0.87526,HP_MACULAR_HYPERPIGMENTATION,0.99999
CYCLIN_D1_KE_.V1_UP,SET,176,-0.071266,-0.0069439,0.061879,0.87527,CYCLIN_D1_KE_.V1_UP,0.99999
HP_SPLENOMEGALY,SET,429,-0.047856,-0.0072292,0.041544,0.87532,HP_SPLENOMEGALY,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...2,SET,17,-0.22503,-0.0068441,0.19535,0.87532,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP,0.99999
HP_MULTIPLE_LIPOMAS,SET,31,-0.1765,-0.0072463,0.15321,0.87534,HP_MULTIPLE_LIPOMAS,0.99999
MIR1537_3P,SET,9,-0.37691,-0.0083427,0.32716,0.87535,MIR1537_3P,0.99999
GOBP_ENDOSOME_TO_PLASMA_MEMB...,SET,14,-0.2695,-0.0074389,0.23392,0.87535,GOBP_ENDOSOME_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.99999
GOBP_ESTABLISHMENT_OF_MITOCH...2,SET,22,-0.21425,-0.0074117,0.18595,0.87536,GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION_MICROTUBULE_MEDIATED,0.99999
MATSUMIYA_PBMC_MODIFIED_VACC...3,SET,10,-0.33739,-0.0078716,0.29272,0.87546,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_LOW_VS_HIGH_RESPONDERS_2DY_GO_T_CELL_ACTIV_AND_CO_STIM_UP,0.99999
ROZANOV_MMP14_TARGETS_DN,SET,30,-0.19411,-0.0078397,0.16839,0.87548,ROZANOV_MMP14_TARGETS_DN,0.99999
HP_AGENESIS_OF_CORPUS_CALLOS...,SET,301,-0.054912,-0.0069729,0.047634,0.87549,HP_AGENESIS_OF_CORPUS_CALLOSUM,0.99999
GOBP_AEROBIC_RESPIRATION,SET,147,-0.072675,-0.0064767,0.06304,0.87551,GOBP_AEROBIC_RESPIRATION,0.99999
GOBP_INTERMEMBRANE_LIPID_TRA...,SET,28,-0.17312,-0.0067552,0.15011,0.87559,GOBP_INTERMEMBRANE_LIPID_TRANSFER,0.99999
GSE2770_IL12_VS_TGFB_AND_IL1...3,SET,184,-0.071341,-0.0071058,0.061861,0.87559,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
FONTAINE_THYROID_TUMOR_UNCER...2,SET,33,-0.17987,-0.0076187,0.15596,0.8756,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,0.99999
REACTOME_TRANSLATION_OF_SARS...2,SET,54,-0.12818,-0.006941,0.11114,0.8756,REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS,0.99999
HP_FRONTAL_HIRSUTISM,SET,8,-0.28901,-0.0060314,0.25059,0.8756,HP_FRONTAL_HIRSUTISM,0.99999
GSE9946_LISTERIA_INF_MATURE_...2,SET,122,-0.084577,-0.0068713,0.07332,0.87565,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.99999
GOBP_ENDODERM_FORMATION,SET,56,-0.13639,-0.0075211,0.11823,0.87567,GOBP_ENDODERM_FORMATION,0.99999
MODULE_82,SET,22,-0.17681,-0.0061165,0.1532,0.87576,MODULE_82,0.99999
GOBP_REGULATION_OF_KIDNEY_DE...,SET,31,-0.19395,-0.0079626,0.16806,0.87576,GOBP_REGULATION_OF_KIDNEY_DEVELOPMENT,0.99999
ZNF282_TARGET_GENES,SET,851,-0.033699,-0.0070848,0.029192,0.87582,ZNF282_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...206,SET,9,-0.36353,-0.0080465,0.31491,0.87582,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION,0.99999
MIR539_3P,SET,207,-0.072171,-0.0076197,0.06249,0.87593,MIR539_3P,0.99999
GOMF_TUMOR_NECROSIS_FACTOR_R...3,SET,46,-0.14508,-0.0072525,0.12561,0.87594,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING,0.99999
GOBP_NUCLEOBASE_CATABOLIC_PR...,SET,10,-0.32298,-0.0075355,0.27956,0.87601,GOBP_NUCLEOBASE_CATABOLIC_PROCESS,0.99999
HP_ABNORMALITY_OF_THE_CALF,SET,272,-0.060216,-0.0072746,0.052105,0.87608,HP_ABNORMALITY_OF_THE_CALF,0.99999
GSE37532_VISCERAL_ADIPOSE_TI...6,SET,112,-0.095624,-0.0074456,0.08273,0.87612,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_UP,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...9,SET,43,-0.15874,-0.0076729,0.13731,0.87616,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_T_REG,0.99999
WP_ALANINE_AND_ASPARTATE_MET...,SET,11,-0.28077,-0.0068701,0.24283,0.8762,WP_ALANINE_AND_ASPARTATE_METABOLISM,0.99999
GOBP_REGULATION_OF_DEFENSE_R...2,SET,18,-0.22599,-0.0070724,0.19545,0.8762,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,0.99999
KEGG_MEDICUS_REFERENCE_BASE_...3,SET,9,-0.26885,-0.0059509,0.23251,0.87622,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_NEIL_GLYCOSYLASE,0.99999
MORF_ARAF1,SET,70,-0.10799,-0.0066553,0.093381,0.87625,MORF_ARAF1,0.99999
GOBP_REGULATION_OF_MORPHOGEN...1,SET,59,-0.13466,-0.0076213,0.11644,0.87625,GOBP_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,0.99999
HP_ABNORMALITY_OF_THE_HUMERO...,SET,51,-0.13603,-0.0071594,0.11761,0.87628,HP_ABNORMALITY_OF_THE_HUMERORADIAL_JOINT,0.99999
MIR4715_3P,SET,67,-0.12235,-0.0073775,0.10578,0.87629,MIR4715_3P,0.99999
MODULE_110,SET,4,-0.39044,-0.0057622,0.33755,0.87629,MODULE_110,0.99999
GSE5542_IFNA_VS_IFNA_AND_IFN...4,SET,176,-0.069315,-0.0067537,0.059915,0.87633,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.99999
HP_REDUCED_CONSCIOUSNESS,SET,206,-0.067126,-0.0070701,0.058021,0.87634,HP_REDUCED_CONSCIOUSNESS,0.99999
GOBP_CARDIOBLAST_DIFFERENTIA...,SET,16,-0.27736,-0.0081839,0.23972,0.87636,GOBP_CARDIOBLAST_DIFFERENTIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...568,SET,1520,-0.026409,-0.0072771,0.022822,0.87639,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_STIMULUS,0.99999
REACTOME_RHO_GTPASES_ACTIVAT...8,SET,9,-0.32505,-0.0071948,0.28083,0.87645,REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS,0.99999
HP_SHORT_TELOMERE_LENGTH,SET,14,-0.25057,-0.0069164,0.21647,0.87647,HP_SHORT_TELOMERE_LENGTH,0.99999
HP_HYPOPLASIA_OF_THE_PONS,SET,82,-0.10248,-0.0068334,0.08847,0.87664,HP_HYPOPLASIA_OF_THE_PONS,0.99999
GSE16451_CTRL_VS_WEST_EQUINE...3,SET,182,-0.071721,-0.0071051,0.061913,0.87664,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...490,SET,32,-0.18035,-0.0075225,0.15569,0.87665,GOBP_POSITIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,0.99999
GOBP_MIRNA_CATABOLIC_PROCESS,SET,8,-0.32036,-0.0066856,0.27643,0.87674,GOBP_MIRNA_CATABOLIC_PROCESS,0.99999
GLI3_TARGET_GENES,SET,588,-0.04059,-0.0071465,0.035021,0.87677,GLI3_TARGET_GENES,0.99999
GOBP_AUTOPHAGIC_CELL_DEATH,SET,9,-0.3188,-0.0070564,0.27503,0.87679,GOBP_AUTOPHAGIC_CELL_DEATH,0.99999
TURJANSKI_MAPK14_TARGETS,SET,9,-0.34292,-0.0075904,0.29581,0.87682,TURJANSKI_MAPK14_TARGETS,0.99999
MUELLER_COMMON_TARGETS_OF_AM...2,SET,12,-0.31217,-0.0079779,0.26927,0.87683,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP,0.99999
GOBP_ADENYLATE_CYCLASE_INHIB...1,SET,5,-0.50103,-0.0082668,0.43213,0.87685,GOBP_ADENYLATE_CYCLASE_INHIBITING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOMF_MONOATOMIC_ANION_TRANSM...,SET,131,-0.090221,-0.0075935,0.077813,0.87686,GOMF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
YGTCCTTGR_UNKNOWN,SET,85,-0.10125,-0.0068728,0.087291,0.87694,YGTCCTTGR_UNKNOWN,0.99999
KEGG_MEDICUS_VARIANT_EML4_AL...2,SET,8,-0.3468,-0.0072373,0.29895,0.87698,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,0.99999
GCM_GSTA4,SET,57,-0.12348,-0.006869,0.10643,0.87701,GCM_GSTA4,0.99999
GOBP_FOLIC_ACID_CONTAINING_C...3,SET,27,-0.1728,-0.0066216,0.14891,0.87705,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
MYLLYKANGAS_AMPLIFICATION_HO...16,SET,6,-0.37654,-0.0068056,0.3244,0.87711,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6,0.99999
REACTOME_APC_C_MEDIATED_DEGR...,SET,84,-0.097665,-0.0065908,0.084145,0.87711,REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,0.99999
MODULE_78,SET,20,-0.21888,-0.00722,0.18855,0.87714,MODULE_78,0.99999
GOBP_POSITIVE_REGULATION_OF_...433,SET,18,-0.26399,-0.0082615,0.22735,0.8772,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_VERY_LOW_...1,SET,2,-0.64541,-0.0067356,0.55577,0.87723,GOBP_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
REACTOME_DISEASES_ASSOCIATED...5,SET,9,-0.39318,-0.0087028,0.33856,0.87724,REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM,0.99999
MODULE_277,SET,47,-0.13125,-0.0066322,0.11302,0.87724,MODULE_277,0.99999
GOBP_SPONTANEOUS_NEUROTRANSM...,SET,7,-0.34746,-0.006783,0.29917,0.87725,GOBP_SPONTANEOUS_NEUROTRANSMITTER_SECRETION,0.99999
LAKE_ADULT_KIDNEY_C26_MESANG...,SET,164,-0.080246,-0.00755,0.069088,0.87727,LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS,0.99999
MIR3074_5P,SET,136,-0.086172,-0.0073888,0.074178,0.87731,MIR3074_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...226,SET,6,-0.45908,-0.0082975,0.39518,0.87732,GOBP_POSITIVE_REGULATION_OF_DOPAMINE_SECRETION,0.99999
REACTOME_ERYTHROPOIETIN_ACTI...1,SET,12,-0.32518,-0.0083103,0.27989,0.87733,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,0.99999
CHANG_IMMORTALIZED_BY_HPV31_...2,SET,65,-0.12101,-0.0071869,0.10414,0.87736,CHANG_IMMORTALIZED_BY_HPV31_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...180,SET,35,-0.18361,-0.0080086,0.15802,0.87736,GOBP_POSITIVE_REGULATION_OF_CYCLASE_ACTIVITY,0.99999
CAR_IGFBP1,SET,55,-0.14378,-0.0078576,0.12372,0.87741,CAR_IGFBP1,0.99999
HP_FINGER_SWELLING,SET,4,-0.64528,-0.0095231,0.55522,0.87741,HP_FINGER_SWELLING,0.99999
GSE27670_BLIMP1_VS_LMP1_TRAN...2,SET,177,-0.074217,-0.0072517,0.063856,0.87742,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP,0.99999
HP_ABNORMAL_PONS_MORPHOLOGY,SET,105,-0.089368,-0.0067388,0.076877,0.87747,HP_ABNORMAL_PONS_MORPHOLOGY,0.99999
MODULE_354,SET,17,-0.26923,-0.0081884,0.23159,0.87748,MODULE_354,0.99999
CHICAS_RB1_TARGETS_CONFLUENT,SET,500,-0.046403,-0.0075524,0.039915,0.87749,CHICAS_RB1_TARGETS_CONFLUENT,0.99999
GOBP_JNK_CASCADE,SET,159,-0.078572,-0.00728,0.067568,0.87755,GOBP_JNK_CASCADE,0.99999
GOBP_REGULATION_OF_KIDNEY_SI...,SET,5,-0.4689,-0.0077367,0.40324,0.87755,GOBP_REGULATION_OF_KIDNEY_SIZE,0.99999
LE_EGR2_TARGETS_DN,SET,103,-0.097272,-0.007265,0.083631,0.8776,LE_EGR2_TARGETS_DN,0.99999
HP_APLASIA_HYPOPLASIA_INVOLV...2,SET,317,-0.056181,-0.0073179,0.048303,0.8776,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS,0.99999
GOBP_ALCOHOL_BIOSYNTHETIC_PR...,SET,125,-0.085535,-0.0070335,0.07352,0.87766,GOBP_ALCOHOL_BIOSYNTHETIC_PROCESS,0.99999
GSE25088_WT_VS_STAT6_KO_MACR...2,SET,178,-0.071991,-0.0070539,0.06187,0.8777,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN,0.99999
HP_PRECOCIOUS_ATHEROSCLEROSIS,SET,12,-0.30938,-0.0079065,0.26585,0.87772,HP_PRECOCIOUS_ATHEROSCLEROSIS,0.99999
HP_NAUSEA_AND_VOMITING,SET,487,-0.043967,-0.0070648,0.037773,0.87777,HP_NAUSEA_AND_VOMITING,0.99999
GOMF_PHOSPHOTRANSFERASE_ACTI...2,SET,7,-0.33971,-0.0066317,0.29185,0.87778,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_NITROGENOUS_GROUP_AS_ACCEPTOR,0.99999
MIR622,SET,74,-0.11188,-0.0070886,0.096107,0.87781,MIR622,0.99999
BROWNE_HCMV_INFECTION_24HR_UP,SET,134,-0.084587,-0.0071997,0.072654,0.87783,BROWNE_HCMV_INFECTION_24HR_UP,0.99999
GOBP_PROTEIN_O_LINKED_GLYCOS...3,SET,10,-0.34925,-0.0081484,0.29998,0.87783,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION_VIA_THREONINE,0.99999
GSE37416_0H_VS_3H_F_TULARENS...2,SET,178,-0.072022,-0.0070568,0.061862,0.87783,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.99999
HE_PTEN_TARGETS_UP,SET,18,-0.23344,-0.0073054,0.20032,0.87804,HE_PTEN_TARGETS_UP,0.99999
HP_EPIGASTRIC_PAIN,SET,11,-0.30893,-0.0075593,0.26511,0.87804,HP_EPIGASTRIC_PAIN,0.99999
GSE17721_LPS_VS_PAM3CSK4_0.5...1,SET,174,-0.073614,-0.0071322,0.063174,0.87804,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN,0.99999
MODULE_275,SET,15,-0.26263,-0.0075035,0.22532,0.8781,MODULE_275,0.99999
HP_ABNORMALLY_LARGE_GLOBE,SET,39,-0.16127,-0.0074247,0.13832,0.87817,HP_ABNORMALLY_LARGE_GLOBE,0.99999
MIR3175,SET,158,-0.075198,-0.0069456,0.064494,0.87818,MIR3175,0.99999
LEE_AGING_CEREBELLUM_UP,SET,77,-0.10919,-0.0070563,0.093645,0.87819,LEE_AGING_CEREBELLUM_UP,0.99999
REACTOME_MITOCHONDRIAL_PROTE...2,SET,53,-0.12539,-0.0067268,0.10751,0.87824,REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT,0.99999
GSE21546_UNSTIM_VS_ANTI_CD3_...8,SET,175,-0.077393,-0.0075196,0.066342,0.8783,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_UP,0.99999
GSE8921_UNSTIM_0H_VS_TLR1_2_...6,SET,174,-0.072279,-0.0070028,0.061942,0.87836,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP,0.99999
GOBP_REGULATION_OF_INFLAMMAT...3,SET,10,-0.32083,-0.0074852,0.27489,0.87841,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_WOUNDING,0.99999
REACTOME_RHOBTB1_GTPASE_CYCLE,SET,22,-0.18397,-0.0063644,0.15759,0.87847,REACTOME_RHOBTB1_GTPASE_CYCLE,0.99999
VANDESLUIS_NORMAL_EMBRYOS_UP,SET,5,-0.43506,-0.0071784,0.37265,0.87849,VANDESLUIS_NORMAL_EMBRYOS_UP,0.99999
HP_URETHRAL_STRICTURE,SET,16,-0.25047,-0.0073907,0.21452,0.87851,HP_URETHRAL_STRICTURE,0.99999
GOBP_REGULATION_OF_LIPOPROTE...3,SET,19,-0.22661,-0.0072859,0.19404,0.87856,GOBP_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
GOMF_HMG_BOX_DOMAIN_BINDING,SET,12,-0.27278,-0.0069713,0.23355,0.87859,GOMF_HMG_BOX_DOMAIN_BINDING,0.99999
GOBP_POST_EMBRYONIC_HEMOPOIE...,SET,5,-0.38369,-0.0063307,0.32837,0.87868,GOBP_POST_EMBRYONIC_HEMOPOIESIS,0.99999
GOBP_REGULATION_OF_CELL_GROW...1,SET,353,-0.053036,-0.0072827,0.045362,0.87882,GOBP_REGULATION_OF_CELL_GROWTH,0.99999
MULLIGHAN_NPM1_MUTATED_SIGNA...3,SET,65,-0.11288,-0.0067045,0.096539,0.87885,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,0.99999
HP_ABNORMAL_TRICUSPID_VALVE_...1,SET,35,-0.1834,-0.0079995,0.15684,0.87885,HP_ABNORMAL_TRICUSPID_VALVE_MORPHOLOGY,0.99999
MIR765,SET,256,-0.064621,-0.007577,0.055262,0.87886,MIR765,0.99999
GSE7831_UNSTIM_VS_INFLUENZA_...3,SET,181,-0.07218,-0.0071312,0.061721,0.87888,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN,0.99999
HP_EEG_WITH_CONTINUOUS_SLOW_...,SET,8,-0.32874,-0.0068605,0.28104,0.87894,HP_EEG_WITH_CONTINUOUS_SLOW_ACTIVITY,0.99999
REACTOME_HEME_SIGNALING,SET,45,-0.15239,-0.0075349,0.13025,0.87899,REACTOME_HEME_SIGNALING,0.99999
GSE33425_CD161_HIGH_VS_INT_C...1,SET,178,-0.073753,-0.0072265,0.063025,0.87904,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN,0.99999
GSE17186_NAIVE_VS_CD21HIGH_T...3,SET,179,-0.073949,-0.0072658,0.06319,0.87905,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,0.99999
FLECHNER_PBL_KIDNEY_TRANSPLA...2,SET,137,-0.081349,-0.0070006,0.069502,0.87908,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,0.99999
HP_ANTIPHOSPHOLIPID_ANTIBODY...,SET,16,-0.23942,-0.0070644,0.20453,0.87911,HP_ANTIPHOSPHOLIPID_ANTIBODY_POSITIVITY,0.99999
MIR181A_5P_MIR181B_5P,SET,555,-0.04307,-0.007374,0.036792,0.87912,MIR181A_5P_MIR181B_5P,0.99999
GOBP_MRNA_3_END_PROCESSING_B...,SET,6,-0.33872,-0.0061221,0.28934,0.87913,GOBP_MRNA_3_END_PROCESSING_BY_STEM_LOOP_BINDING_AND_CLEAVAGE,0.99999
HP_ULNAR_BOWING,SET,16,-0.28177,-0.0083142,0.24069,0.87913,HP_ULNAR_BOWING,0.99999
HP_ABNORMAL_AUDITORY_EVOKED_...,SET,22,-0.20861,-0.0072166,0.17816,0.87917,HP_ABNORMAL_AUDITORY_EVOKED_POTENTIALS,0.99999
HP_GLUCAGONOMA,SET,6,-0.40592,-0.0073367,0.34663,0.87921,HP_GLUCAGONOMA,0.99999
GSE5589_LPS_VS_LPS_AND_IL10_...1,SET,176,-0.074582,-0.0072669,0.063683,0.87922,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN,0.99999
HP_ABNORMAL_CIRCULATING_NITR...,SET,154,-0.076848,-0.0070084,0.065616,0.87923,HP_ABNORMAL_CIRCULATING_NITROGEN_COMPOUND_CONCENTRATION,0.99999
HP_MILD_MYOPIA,SET,4,-0.5865,-0.0086557,0.50076,0.87924,HP_MILD_MYOPIA,0.99999
DESCARTES_MAIN_FETAL_NEUROEN...,SET,27,-0.20346,-0.0077965,0.17372,0.87924,DESCARTES_MAIN_FETAL_NEUROENDOCRINE_CELLS,0.99999
GOBP_PROTEIN_TETRAMERIZATION,SET,91,-0.10172,-0.007143,0.086817,0.87931,GOBP_PROTEIN_TETRAMERIZATION,0.99999
GSE41867_NAIVE_VS_DAY6_LCMV_...3,SET,179,-0.072266,-0.0071004,0.061679,0.87932,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN,0.99999
MIR4745_5P,SET,79,-0.1115,-0.0072977,0.095114,0.87944,MIR4745_5P,0.99999
WP_HAIR_FOLLICLE_DEVELOPMENT...2,SET,31,-0.1985,-0.0081494,0.16932,0.87946,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,0.99999
HALLMARK_IL2_STAT5_SIGNALING,SET,187,-0.076372,-0.007668,0.065143,0.87947,HALLMARK_IL2_STAT5_SIGNALING,0.99999
GOBP_RESPONSE_TO_AMINE,SET,50,-0.14729,-0.0076758,0.12563,0.87949,GOBP_RESPONSE_TO_AMINE,0.99999
chr3p23,SET,3,-0.69191,-0.0088436,0.59008,0.87951,chr3p23,0.99999
GOBP_NEGATIVE_REGULATION_OF_...606,SET,4,-0.56724,-0.0083715,0.48366,0.87956,GOBP_NEGATIVE_REGULATION_OF_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.99999
GOBP_REGULATION_OF_PROGRAMME...2,SET,27,-0.18852,-0.007224,0.16073,0.87957,GOBP_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.99999
KYNG_DNA_DAMAGE_BY_UV,SET,51,-0.13945,-0.0073393,0.11888,0.8796,KYNG_DNA_DAMAGE_BY_UV,0.99999
GOBP_NEURAL_TUBE_FORMATION,SET,99,-0.098649,-0.0072242,0.08406,0.87971,GOBP_NEURAL_TUBE_FORMATION,0.99999
REACTOME_METABOLISM_OF_ANGIO...,SET,15,-0.30804,-0.0088009,0.2624,0.87978,REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS,0.99999
GSE6259_BCELL_VS_CD4_TCELL_DN,SET,166,-0.07505,-0.0071037,0.06392,0.87982,GSE6259_BCELL_VS_CD4_TCELL_DN,0.99999
GSE3982_DC_VS_NEUTROPHIL_LPS...1,SET,176,-0.076239,-0.0074284,0.06493,0.87983,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN,0.99999
GSE17721_12H_VS_24H_CPG_BMDC...1,SET,178,-0.07121,-0.0069773,0.060633,0.87988,GSE17721_12H_VS_24H_CPG_BMDC_DN,0.99999
HP_PRECOCIOUS_PUBERTY_IN_FEM...,SET,9,-0.34959,-0.0077379,0.29765,0.87989,HP_PRECOCIOUS_PUBERTY_IN_FEMALES,0.99999
GOBP_GLUTAMINE_FAMILY_AMINO_...3,SET,66,-0.1268,-0.0075883,0.10795,0.8799,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.99999
GSE21670_UNTREATED_VS_TGFB_T...2,SET,180,-0.076456,-0.0075329,0.065095,0.8799,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...40,SET,6,-0.37482,-0.0067745,0.31908,0.87993,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_AUTOPHAGY_VESICLE_NUCLEATION,0.99999
GOBP_MITOCHONDRIAL_DNA_REPAIR,SET,6,-0.3546,-0.0064091,0.30187,0.87994,GOBP_MITOCHONDRIAL_DNA_REPAIR,0.99999
REACTOME_RHO_GTPASES_ACTIVAT...4,SET,11,-0.27333,-0.0066881,0.23266,0.87995,REACTOME_RHO_GTPASES_ACTIVATE_KTN1,0.99999
CHOW_RASSF1_TARGETS_UP,SET,22,-0.19025,-0.0065816,0.16194,0.87996,CHOW_RASSF1_TARGETS_UP,0.99999
WILLERT_WNT_SIGNALING,SET,21,-0.20793,-0.007028,0.17698,0.87997,WILLERT_WNT_SIGNALING,0.99999
HP_PROLONGED_PARTIAL_THROMBO...,SET,30,-0.19093,-0.0077115,0.1625,0.87999,HP_PROLONGED_PARTIAL_THROMBOPLASTIN_TIME,0.99999
HP_DECREASED_CALVARIAL_OSSIF...,SET,17,-0.24551,-0.0074669,0.20885,0.8801,HP_DECREASED_CALVARIAL_OSSIFICATION,0.99999
GCM_ZNF198,SET,111,-0.088098,-0.0068291,0.074934,0.88013,GCM_ZNF198,0.99999
GSE339_CD4POS_VS_CD4CD8DN_DC...4,SET,187,-0.069802,-0.0070084,0.059367,0.88015,GSE339_CD4POS_VS_CD4CD8DN_DC_UP,0.99999
KEGG_MEDICUS_REFERENCE_LONG_...,SET,17,-0.20951,-0.0063719,0.17815,0.8802,KEGG_MEDICUS_REFERENCE_LONG_PATCH_BER,0.99999
HP_ARTERIOVENOUS_FISTULA,SET,10,-0.32728,-0.0076358,0.27826,0.88023,HP_ARTERIOVENOUS_FISTULA,0.99999
HP_NEUROPATHIC_SPINAL_ARTHRO...,SET,20,-0.20827,-0.0068702,0.17708,0.88023,HP_NEUROPATHIC_SPINAL_ARTHROPATHY,0.99999
KEGG_ADHERENS_JUNCTION,SET,66,-0.12385,-0.007412,0.10527,0.88028,KEGG_ADHERENS_JUNCTION,0.99999
MORF_MAGEA9,SET,376,-0.052542,-0.0074416,0.044656,0.88032,MORF_MAGEA9,0.99999
GOMF_INTRAMOLECULAR_OXIDORED...2,SET,5,-0.35943,-0.0059305,0.30545,0.88034,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_INTERCONVERTING_ALDOSES_AND_KETOSES,0.99999
GOBP_REGULATION_OF_SNARE_COM...,SET,13,-0.25783,-0.006858,0.2191,0.88035,GOBP_REGULATION_OF_SNARE_COMPLEX_ASSEMBLY,0.99999
MIR4779,SET,132,-0.086695,-0.0073243,0.073656,0.8804,MIR4779,0.99999
AIZARANI_LIVER_C5_NK_NKT_CEL...,SET,110,-0.099805,-0.0077019,0.084791,0.88041,AIZARANI_LIVER_C5_NK_NKT_CELLS_3,0.99999
GOBP_MESODERM_MORPHOGENESIS,SET,68,-0.12589,-0.0076469,0.10692,0.88047,GOBP_MESODERM_MORPHOGENESIS,0.99999
HP_HYPOPLASIA_OF_THE_FRONTAL...,SET,33,-0.15957,-0.006759,0.1355,0.88052,HP_HYPOPLASIA_OF_THE_FRONTAL_LOBES,0.99999
HP_DUPLICATION_OF_PHALANX_OF...,SET,12,-0.25558,-0.0065316,0.21695,0.8806,HP_DUPLICATION_OF_PHALANX_OF_TOE,0.99999
MIR1911_5P,SET,24,-0.19325,-0.006982,0.16403,0.88061,MIR1911_5P,0.99999
SETD7_TARGET_GENES,SET,718,-0.035986,-0.0069756,0.03054,0.88066,SETD7_TARGET_GENES,0.99999
HP_MULTIPLE_JOINT_DISLOCATION,SET,7,-0.36308,-0.0070879,0.30812,0.88066,HP_MULTIPLE_JOINT_DISLOCATION,0.99999
GSE3920_UNTREATED_VS_IFNB_TR...2,SET,183,-0.072833,-0.0072349,0.061806,0.88068,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,0.99999
FAN_EMBRYONIC_CTX_IN_5_INTER...,SET,5,-0.52882,-0.0087255,0.44871,0.8807,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,0.99999
GSE30083_SP2_VS_SP3_THYMOCYT...1,SET,183,-0.07442,-0.0073926,0.06314,0.88072,GSE30083_SP2_VS_SP3_THYMOCYTE_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...14,SET,28,-0.20747,-0.0080957,0.17602,0.88073,GOBP_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,0.99999
HP_ABNORMALITY_OF_VITAMIN_B1...,SET,30,-0.18524,-0.0074816,0.15715,0.88074,HP_ABNORMALITY_OF_VITAMIN_B12_METABOLISM,0.99999
GOBP_MESODERM_DEVELOPMENT,SET,117,-0.097003,-0.0077187,0.082258,0.88085,GOBP_MESODERM_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_POSTSYNAP...2,SET,99,-0.10165,-0.0074438,0.086176,0.8809,GOBP_REGULATION_OF_POSTSYNAPSE_ORGANIZATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...361,SET,151,-0.086304,-0.0077943,0.073165,0.88091,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION,0.99999
GSE13522_WT_VS_IFNAR_KO_SKIN...3,SET,152,-0.084799,-0.0076835,0.071887,0.88092,GSE13522_WT_VS_IFNAR_KO_SKIN_DN,0.99999
HP_ABNORMAL_NUMBER_OF_PERMAN...,SET,30,-0.18657,-0.0075353,0.15813,0.88096,HP_ABNORMAL_NUMBER_OF_PERMANENT_TEETH,0.99999
GSE11961_FOLLICULAR_BCELL_VS...10,SET,181,-0.071916,-0.007105,0.060955,0.88096,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP,0.99999
HP_POOR_COORDINATION,SET,32,-0.17437,-0.0072729,0.14777,0.881,HP_POOR_COORDINATION,0.99999
GOBP_CYTOPLASMIC_SEQUESTERIN...2,SET,13,-0.2616,-0.0069583,0.22165,0.88104,GOBP_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN,0.99999
TIAN_TNF_SIGNALING_VIA_NFKB,SET,24,-0.22668,-0.0081899,0.19205,0.88106,TIAN_TNF_SIGNALING_VIA_NFKB,0.99999
GSE5589_WT_VS_IL6_KO_LPS_STI...1,SET,129,-0.087715,-0.0073264,0.074284,0.88115,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_DN,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...7,SET,24,-0.19175,-0.0069279,0.16237,0.88118,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_NUCLEUS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...639,SET,43,-0.15491,-0.0074877,0.13117,0.88119,GOBP_NEGATIVE_REGULATION_OF_TORC1_SIGNALING,0.99999
GOBP_VESICLE_MEDIATED_TRANSP...3,SET,209,-0.069242,-0.0073453,0.058622,0.88122,GOBP_VESICLE_MEDIATED_TRANSPORT_IN_SYNAPSE,0.99999
GOBP_POLYSACCHARIDE_METABOLI...,SET,97,-0.10064,-0.0072952,0.085198,0.88123,GOBP_POLYSACCHARIDE_METABOLIC_PROCESS,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_CD5...,SET,5,-0.43645,-0.0072014,0.36939,0.8813,HE_LIM_SUN_FETAL_LUNG_C4_CD56BRIGHT_NK_CELL,0.99999
GOBP_MORPHOGENESIS_OF_EMBRYO...,SET,144,-0.085266,-0.0075214,0.072148,0.88136,GOBP_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM,0.99999
LEE_AGING_MUSCLE_UP,SET,34,-0.1786,-0.0076786,0.15111,0.88138,LEE_AGING_MUSCLE_UP,0.99999
MIR920,SET,47,-0.13606,-0.0068749,0.1151,0.88141,MIR920,0.99999
TTCYNRGAA_STAT5B_01,SET,300,-0.058754,-0.0074486,0.049687,0.88148,TTCYNRGAA_STAT5B_01,0.99999
GNF2_MKI67,SET,27,-0.19676,-0.0075396,0.16637,0.88153,GNF2_MKI67,0.99999
GOBP_FATTY_ACID_HOMEOSTASIS,SET,14,-0.25445,-0.0070235,0.21513,0.88154,GOBP_FATTY_ACID_HOMEOSTASIS,0.99999
GSE22886_NAIVE_CD8_TCELL_VS_...8,SET,173,-0.073709,-0.0071209,0.062309,0.88158,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP,0.99999
GSE42021_CD24INT_VS_CD24LOW_...1,SET,175,-0.077311,-0.0075116,0.065351,0.88159,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN,0.99999
HP_PATELLAR_HYPOPLASIA,SET,14,-0.28286,-0.0078078,0.23907,0.88162,HP_PATELLAR_HYPOPLASIA,0.99999
REACTOME_INTERLEUKIN_7_SIGNA...,SET,21,-0.22823,-0.0077141,0.19288,0.88164,REACTOME_INTERLEUKIN_7_SIGNALING,0.99999
HOEK_NEUTROPHIL_2011_2012_TI...1,SET,50,-0.14102,-0.0073491,0.11917,0.88166,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_DN,0.99999
REACTOME_ARYL_HYDROCARBON_RE...,SET,6,-0.32193,-0.0058185,0.27203,0.88167,REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING,0.99999
GOBP_ORGANIC_HYDROXY_COMPOUN...4,SET,251,-0.065249,-0.0075765,0.055128,0.8817,GOBP_ORGANIC_HYDROXY_COMPOUND_TRANSPORT,0.99999
GOBP_PROTEIN_INSERTION_INTO_...1,SET,25,-0.19417,-0.00716,0.16405,0.88171,GOBP_PROTEIN_INSERTION_INTO_ER_MEMBRANE,0.99999
HP_BASILAR_IMPRESSION,SET,5,-0.49472,-0.0081627,0.41793,0.88173,HP_BASILAR_IMPRESSION,0.99999
HP_ECTOPIC_CALCIFICATION,SET,209,-0.071092,-0.0075416,0.060054,0.88175,HP_ECTOPIC_CALCIFICATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...85,SET,95,-0.11033,-0.0079159,0.093198,0.88176,GOBP_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,0.99999
GSE24634_TEFF_VS_TCONV_DAY10...2,SET,183,-0.07353,-0.0073041,0.062109,0.88176,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP,0.99999
GOBP_MESONEPHRIC_DUCT_DEVELO...,SET,8,-0.36254,-0.0075659,0.3061,0.88186,GOBP_MESONEPHRIC_DUCT_DEVELOPMENT,0.99999
HP_PERIANAL_ABSCESS,SET,8,-0.37925,-0.0079147,0.32019,0.88188,HP_PERIANAL_ABSCESS,0.99999
ROESSLER_LIVER_CANCER_METAST...2,SET,100,-0.096918,-0.007133,0.081811,0.88192,ROESSLER_LIVER_CANCER_METASTASIS_UP,0.99999
HP_PRIMITIVE_NEUROECTODERMAL...,SET,68,-0.11976,-0.0072746,0.10109,0.88192,HP_PRIMITIVE_NEUROECTODERMAL_TUMOR,0.99999
NF1_Q6_01,SET,249,-0.065235,-0.0075452,0.055042,0.88202,NF1_Q6_01,0.99999
GSE2770_IL12_VS_IL4_TREATED_...5,SET,183,-0.070169,-0.0069703,0.059204,0.88202,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
HP_NEONATAL_HYPOGLYCEMIA,SET,42,-0.15657,-0.00748,0.1321,0.88203,HP_NEONATAL_HYPOGLYCEMIA,0.99999
DESCARTES_FETAL_PANCREAS_LYM...2,SET,112,-0.10165,-0.0079152,0.085761,0.88205,DESCARTES_FETAL_PANCREAS_LYMPHOID_CELLS,0.99999
GCM_MYST2,SET,159,-0.072546,-0.0067216,0.061185,0.88212,GCM_MYST2,0.99999
GOBP_REGULATION_OF_EXCRETION,SET,9,-0.35787,-0.0079212,0.30181,0.88213,GOBP_REGULATION_OF_EXCRETION,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...10,SET,51,-0.15246,-0.0080238,0.12852,0.88223,BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,0.99999
MYOD_Q6,SET,227,-0.06607,-0.0073007,0.055695,0.88223,MYOD_Q6,0.99999
GOMF_UBIQUITIN_PROTEIN_TRANS...2,SET,12,-0.31065,-0.0079392,0.26187,0.88224,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_INHIBITOR_ACTIVITY,0.99999
ARID5B_TARGET_GENES,SET,725,-0.037483,-0.0072998,0.031596,0.88225,ARID5B_TARGET_GENES,0.99999
MIR6750_3P,SET,62,-0.13311,-0.0077218,0.11217,0.88232,MIR6750_3P,0.99999
GSE23308_WT_VS_MINERALCORTIC...2,SET,175,-0.074384,-0.0072272,0.062675,0.88234,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_UP,0.99999
GOMF_PHOSPHORYLATION_DEPENDE...,SET,8,-0.38475,-0.0080293,0.32415,0.88237,GOMF_PHOSPHORYLATION_DEPENDENT_PROTEIN_BINDING,0.99999
GOBP_SIGNALING_RECEPTOR_LIGA...,SET,36,-0.17004,-0.0075219,0.14324,0.8824,GOBP_SIGNALING_RECEPTOR_LIGAND_PRECURSOR_PROCESSING,0.99999
GOBP_ALCOHOL_CATABOLIC_PROCE...,SET,31,-0.20026,-0.0082217,0.16865,0.88246,GOBP_ALCOHOL_CATABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...468,SET,19,-0.24791,-0.0079706,0.20871,0.88254,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FISSION,0.99999
GOBP_REGULATION_OF_HOMOPHILI...,SET,5,-0.46143,-0.0076135,0.38841,0.88258,GOBP_REGULATION_OF_HOMOPHILIC_CELL_ADHESION,0.99999
HP_BRONCHITIS,SET,62,-0.12745,-0.0073937,0.10727,0.8826,HP_BRONCHITIS,0.99999
WEBER_METHYLATED_LCP_IN_SPER...1,SET,6,-0.43276,-0.0078217,0.36399,0.88276,WEBER_METHYLATED_LCP_IN_SPERM_DN,0.99999
GOBP_DTMP_METABOLIC_PROCESS,SET,6,-0.37133,-0.0067114,0.31232,0.88276,GOBP_DTMP_METABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...291,SET,9,-0.36511,-0.0080814,0.30704,0.88279,GOBP_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION,0.99999
GOMF_LIGASE_ACTIVITY,SET,123,-0.087042,-0.0071002,0.073191,0.88282,GOMF_LIGASE_ACTIVITY,0.99999
GOBP_RNA_POLYMERASE_II_PREIN...,SET,52,-0.13007,-0.0069119,0.10936,0.88284,GOBP_RNA_POLYMERASE_II_PREINITIATION_COMPLEX_ASSEMBLY,0.99999
KEGG_MEDICUS_REFERENCE_EREG_...1,SET,11,-0.30749,-0.0075239,0.25849,0.88288,KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_KIDNEY_EPITHELIUM_DEVEL...,SET,143,-0.093042,-0.0081791,0.078212,0.88289,GOBP_KIDNEY_EPITHELIUM_DEVELOPMENT,0.99999
GSE24726_WT_VS_E2_2_KO_PDC_D...1,SET,186,-0.073488,-0.0073589,0.061774,0.88289,GSE24726_WT_VS_E2_2_KO_PDC_DAY4_POST_DELETION_UP,0.99999
MIR3188,SET,72,-0.11421,-0.0071381,0.095988,0.88294,MIR3188,0.99999
GSE5679_CTRL_VS_RARA_AGONIST...1,SET,180,-0.072403,-0.0071335,0.060851,0.88294,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN,0.99999
GOBP_MONOCARBOXYLIC_ACID_TRA...,SET,172,-0.081378,-0.0078393,0.068387,0.88296,GOBP_MONOCARBOXYLIC_ACID_TRANSPORT,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...12,SET,104,-0.10006,-0.0075094,0.084085,0.88297,GAUTAM_EYE_IRIS_CILIARY_BODY_PIGMENTED_CILIARY_BODY_CELLS,0.99999
MIR6769B_5P,SET,71,-0.11948,-0.0074156,0.10037,0.88305,MIR6769B_5P,0.99999
HP_ABNORMAL_URINE_METABOLITE...,SET,521,-0.043516,-0.0072255,0.036551,0.88308,HP_ABNORMAL_URINE_METABOLITE_LEVEL,0.99999
LAKE_ADULT_KIDNEY_C25_ENDOTH...,SET,37,-0.1844,-0.0082695,0.15488,0.88309,LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED,0.99999
GSE11961_MARGINAL_ZONE_BCELL...6,SET,181,-0.073393,-0.007251,0.061641,0.8831,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP,0.99999
MODULE_399,SET,49,-0.15173,-0.0078281,0.12742,0.88313,MODULE_399,0.99999
GOBP_INSEMINATION,SET,13,-0.30643,-0.0081507,0.25724,0.8832,GOBP_INSEMINATION,0.99999
GOBP_PALLIUM_DEVELOPMENT,SET,174,-0.079615,-0.0077136,0.066834,0.88321,GOBP_PALLIUM_DEVELOPMENT,0.99999
TRAVAGLINI_LUNG_PROLIFERATIN...3,SET,121,-0.089571,-0.0072473,0.075172,0.88327,TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL,0.99999
GSE6259_FLT3L_INDUCED_33D1_P...1,SET,176,-0.072083,-0.0070234,0.060482,0.88332,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN,0.99999
REACTOME_SENSORY_PROCESSING_...2,SET,49,-0.15164,-0.007823,0.12722,0.88335,REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,0.99999
MODULE_192,SET,99,-0.098072,-0.0071819,0.082268,0.88338,MODULE_192,0.99999
ZIM3_TARGET_GENES,SET,799,-0.03528,-0.0071977,0.029592,0.8834,ZIM3_TARGET_GENES,0.99999
GOBP_CELLULAR_EXTRAVASATION,SET,69,-0.13053,-0.0079868,0.10948,0.88341,GOBP_CELLULAR_EXTRAVASATION,0.99999
HP_AUTISM,SET,216,-0.070228,-0.0075721,0.05889,0.88346,HP_AUTISM,0.99999
GOBP_POSITIVE_REGULATION_OF_...740,SET,10,-0.29848,-0.0069639,0.25026,0.88349,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_PLASTICITY,0.99999
GOBP_FATTY_ACID_BIOSYNTHETIC...,SET,145,-0.083831,-0.0074202,0.070267,0.88356,GOBP_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.99999
MIR34B_3P,SET,98,-0.095475,-0.0069566,0.080017,0.88359,MIR34B_3P,0.99999
DESCARTES_MAIN_FETAL_HEPATOB...,SET,86,-0.10771,-0.0073542,0.090265,0.88361,DESCARTES_MAIN_FETAL_HEPATOBLASTS,0.99999
REACTOME_SIALIC_ACID_METABOL...,SET,33,-0.18124,-0.0076767,0.15187,0.88363,REACTOME_SIALIC_ACID_METABOLISM,0.99999
HP_POOR_MOTOR_COORDINATION,SET,77,-0.11592,-0.0074908,0.097135,0.88363,HP_POOR_MOTOR_COORDINATION,0.99999
SHEN_SMARCA2_TARGETS_DN,SET,265,-0.064214,-0.0076586,0.053804,0.88365,SHEN_SMARCA2_TARGETS_DN,0.99999
GOCC_U4_SNRNP,SET,10,-0.28349,-0.0066141,0.23751,0.88367,GOCC_U4_SNRNP,0.99999
GOBP_REGULATION_OF_SKELETAL_...10,SET,24,-0.20962,-0.0075736,0.1756,0.88369,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...111,SET,29,-0.18936,-0.0075195,0.15861,0.88373,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,0.99999
HP_SLEEP_WAKE_CYCLE_DISTURBA...,SET,35,-0.17547,-0.0076536,0.14694,0.88379,HP_SLEEP_WAKE_CYCLE_DISTURBANCE,0.99999
GOCC_CATENIN_COMPLEX,SET,31,-0.20983,-0.0086147,0.17569,0.88381,GOCC_CATENIN_COMPLEX,0.99999
HP_JOINT_CONTRACTURE_OF_THE_...1,SET,7,-0.39147,-0.0076422,0.32765,0.88391,HP_JOINT_CONTRACTURE_OF_THE_4TH_FINGER,0.99999
WILENSKY_RESPONSE_TO_DARAPLA...,SET,25,-0.19864,-0.0073246,0.1662,0.88399,WILENSKY_RESPONSE_TO_DARAPLADIB,0.99999
HAN_JNK_SINGALING_UP,SET,34,-0.18007,-0.0077415,0.15064,0.88402,HAN_JNK_SINGALING_UP,0.99999
GOBP_AMINO_ACID_BETAINE_BIOS...,SET,5,-0.50417,-0.0083187,0.42175,0.88403,GOBP_AMINO_ACID_BETAINE_BIOSYNTHETIC_PROCESS,0.99999
MODULE_4,SET,19,-0.20258,-0.0065134,0.16943,0.88409,MODULE_4,0.99999
GOBP_REGULATION_OF_STRESS_GR...,SET,11,-0.23647,-0.0057862,0.19776,0.8841,GOBP_REGULATION_OF_STRESS_GRANULE_ASSEMBLY,0.99999
GOCC_SECONDARY_LYSOSOME,SET,19,-0.22364,-0.0071903,0.18699,0.88414,GOCC_SECONDARY_LYSOSOME,0.99999
REACTOME_SYNTHESIS_OF_DOLICH...,SET,5,-0.47428,-0.0078255,0.3965,0.88418,REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE,0.99999
MIR6886_3P,SET,84,-0.1048,-0.007072,0.08761,0.88418,MIR6886_3P,0.99999
GOCC_U12_TYPE_SPLICEOSOMAL_C...,SET,24,-0.18237,-0.006589,0.15243,0.88422,GOCC_U12_TYPE_SPLICEOSOMAL_COMPLEX,0.99999
GSE32423_MEMORY_VS_NAIVE_CD8...1,SET,176,-0.076089,-0.0074138,0.063593,0.88424,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...721,SET,12,-0.26771,-0.0068418,0.22374,0.88425,GOBP_POSITIVE_REGULATION_OF_SPINDLE_CHECKPOINT,0.99999
GOBP_RESPONSE_TO_INORGANIC_S...,SET,469,-0.048164,-0.0075988,0.040251,0.88426,GOBP_RESPONSE_TO_INORGANIC_SUBSTANCE,0.99999
GOBP_TOLERANCE_INDUCTION_DEP...,SET,4,-0.55741,-0.0082264,0.46573,0.88431,GOBP_TOLERANCE_INDUCTION_DEPENDENT_UPON_IMMUNE_RESPONSE,0.99999
GOMF_HISTONE_H3_ACETYLTRANSF...,SET,15,-0.24529,-0.0070082,0.20495,0.88431,GOMF_HISTONE_H3_ACETYLTRANSFERASE_ACTIVITY,0.99999
GNF2_PTPRC,SET,59,-0.13115,-0.0074224,0.10956,0.88435,GNF2_PTPRC,0.99999
MIKHAYLOVA_OXIDATIVE_STRESS_...1,SET,6,-0.50017,-0.0090402,0.41779,0.88437,MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN,0.99999
GOBP_TYPE_III_INTERFERON_PRO...,SET,3,-0.53491,-0.0068369,0.44676,0.8844,GOBP_TYPE_III_INTERFERON_PRODUCTION,0.99999
GSE17721_CTRL_VS_POLYIC_0.5H...1,SET,187,-0.072164,-0.0072455,0.060267,0.88442,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_DN,0.99999
ER_Q6_01,SET,239,-0.065815,-0.0074598,0.054953,0.88447,ER_Q6_01,0.99999
GOBP_NEGATIVE_REGULATION_OF_...31,SET,213,-0.069202,-0.0074101,0.05778,0.88447,GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.99999
HP_HYPOGONADISM,SET,377,-0.051731,-0.0073361,0.043187,0.8845,HP_HYPOGONADISM,0.99999
GOBP_SMOOTH_MUSCLE_CELL_MIGR...,SET,67,-0.13293,-0.0080154,0.11092,0.88463,GOBP_SMOOTH_MUSCLE_CELL_MIGRATION,0.99999
ONDER_CDH1_TARGETS_3_UP,SET,15,-0.24994,-0.0071409,0.20853,0.88465,ONDER_CDH1_TARGETS_3_UP,0.99999
MIR3680_5P,SET,31,-0.16529,-0.006786,0.1379,0.88465,MIR3680_5P,0.99999
GOBP_TETRAPYRROLE_BIOSYNTHET...,SET,29,-0.17747,-0.0070475,0.14806,0.88466,GOBP_TETRAPYRROLE_BIOSYNTHETIC_PROCESS,0.99999
MIR548B_3P,SET,91,-0.10246,-0.0071954,0.085474,0.88468,MIR548B_3P,0.99999
HP_ABNORMAL_TRANSFERRIN_SATU...,SET,12,-0.28665,-0.0073257,0.23908,0.88472,HP_ABNORMAL_TRANSFERRIN_SATURATION,0.99999
GSE5503_MLN_DC_VS_SPLEEN_DC_...2,SET,178,-0.076561,-0.0075016,0.063849,0.88475,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.99999
GOBP_RESPONSE_TO_OZONE,SET,5,-0.51525,-0.0085016,0.42961,0.8848,GOBP_RESPONSE_TO_OZONE,0.99999
EIF4E_UP,SET,88,-0.10294,-0.0071094,0.085828,0.8848,EIF4E_UP,0.99999
GOMF_MECHANOSENSITIVE_MONOAT...2,SET,16,-0.26238,-0.007742,0.21873,0.88484,GOMF_MECHANOSENSITIVE_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.99999
GOMF_ACTIVIN_RECEPTOR_BINDING,SET,8,-0.36337,-0.0075831,0.3029,0.88485,GOMF_ACTIVIN_RECEPTOR_BINDING,0.99999
GOBP_CELL_SURFACE_RECEPTOR_P...3,SET,6,-0.38319,-0.0069259,0.31942,0.88486,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_PHOSPHATASE_SIGNALING_PATHWAY,0.99999
GOBP_METENCEPHALON_DEVELOPME...,SET,101,-0.10251,-0.0075821,0.085424,0.88493,GOBP_METENCEPHALON_DEVELOPMENT,0.99999
JECHLINGER_EPITHELIAL_TO_MES...1,SET,59,-0.1333,-0.0075442,0.11107,0.88496,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,0.99999
ERBB2_UP.V1_DN,SET,180,-0.073151,-0.0072072,0.060947,0.88497,ERBB2_UP.V1_DN,0.99999
GOBP_CELL_FATE_DETERMINATION,SET,40,-0.17918,-0.0083541,0.14927,0.88499,GOBP_CELL_FATE_DETERMINATION,0.99999
GSE22601_IMMATURE_CD4_SINGLE...5,SET,180,-0.075885,-0.0074766,0.063214,0.88501,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,0.99999
GSE41978_WT_VS_ID2_KO_AND_BI...2,SET,179,-0.071643,-0.0070392,0.05968,0.88501,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.99999
KEGG_MEDICUS_REFERENCE_PP2A_...,SET,18,-0.22498,-0.0070408,0.18736,0.88507,KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_CD80_...2,SET,21,-0.21271,-0.0071894,0.17713,0.88509,KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY,0.99999
GSE21670_IL6_VS_TGFB_AND_IL6...3,SET,178,-0.073601,-0.0072116,0.06129,0.88509,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.99999
GSE28237_FOLLICULAR_VS_LATE_...2,SET,180,-0.078964,-0.00778,0.065755,0.88509,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP,0.99999
GSE41978_WT_VS_ID2_KO_AND_BI...1,SET,179,-0.074266,-0.007297,0.061838,0.88511,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.99999
GOBP_PROTEIN_TRANSPORT_WITHI...,SET,6,-0.40893,-0.0073911,0.3405,0.88512,GOBP_PROTEIN_TRANSPORT_WITHIN_LIPID_BILAYER,0.99999
GOBP_DIOL_METABOLIC_PROCESS,SET,26,-0.20013,-0.0075257,0.16663,0.88513,GOBP_DIOL_METABOLIC_PROCESS,0.99999
GSE17721_CTRL_VS_LPS_12H_BMD...1,SET,182,-0.074138,-0.0073446,0.061725,0.88513,GSE17721_CTRL_VS_LPS_12H_BMDC_DN,0.99999
HP_ABSENCE_OF_SUBCUTANEOUS_F...,SET,13,-0.24751,-0.0065835,0.20605,0.88515,HP_ABSENCE_OF_SUBCUTANEOUS_FAT,0.99999
GOBP_INOSITOL_PHOSPHATE_META...,SET,38,-0.15998,-0.0072706,0.13318,0.88516,GOBP_INOSITOL_PHOSPHATE_METABOLIC_PROCESS,0.99999
ATAGGAA_MIR202,SET,95,-0.10626,-0.0076233,0.088445,0.88519,ATAGGAA_MIR202,0.99999
GOBP_NITRIC_OXIDE_CGMP_MEDIA...,SET,6,-0.47215,-0.0085336,0.39295,0.88522,GOBP_NITRIC_OXIDE_CGMP_MEDIATED_SIGNALING,0.99999
GOBP_TUBE_FORMATION,SET,144,-0.085635,-0.0075539,0.071256,0.88527,GOBP_TUBE_FORMATION,0.99999
GOBP_ORNITHINE_METABOLIC_PRO...,SET,9,-0.29057,-0.0064315,0.24172,0.88533,GOBP_ORNITHINE_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...32,SET,6,-0.38277,-0.0069182,0.31841,0.88534,GOBP_NEGATIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.99999
GSE3039_ALPHAALPHA_CD8_TCELL...4,SET,180,-0.075695,-0.0074579,0.062962,0.88536,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP,0.99999
CTTTGTA_MIR524,SET,397,-0.051406,-0.0074768,0.042755,0.88538,CTTTGTA_MIR524,0.99999
GOBP_EPITHELIAL_TUBE_FORMATI...,SET,131,-0.089149,-0.0075032,0.07412,0.88546,GOBP_EPITHELIAL_TUBE_FORMATION,0.99999
chr11q21,SET,28,-0.32454,-0.012664,0.26978,0.8855,chr11q21,0.99999
GOBP_UTP_METABOLIC_PROCESS,SET,11,-0.33396,-0.0081718,0.27759,0.88552,GOBP_UTP_METABOLIC_PROCESS,0.99999
GOBP_OXIDATIVE_PHOSPHORYLATI...,SET,105,-0.086403,-0.0065153,0.071805,0.88556,GOBP_OXIDATIVE_PHOSPHORYLATION,0.99999
GSE15659_RESTING_VS_ACTIVATE...2,SET,153,-0.081726,-0.0074291,0.067912,0.88558,GSE15659_RESTING_VS_ACTIVATED_TREG_UP,0.99999
GOBP_SODIUM_ION_EXPORT_ACROS...,SET,15,-0.29788,-0.0085106,0.24743,0.88567,GOBP_SODIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOBP_ORGANIC_ANION_TRANSPORT,SET,424,-0.051735,-0.0077704,0.042972,0.88568,GOBP_ORGANIC_ANION_TRANSPORT,0.99999
HP_METAPHYSEAL_CHONDRODYSPLA...,SET,10,-0.34769,-0.0081119,0.28875,0.88572,HP_METAPHYSEAL_CHONDRODYSPLASIA,0.99999
GOBP_REGULATION_OF_MITOCHOND...9,SET,36,-0.16191,-0.0071622,0.13445,0.88574,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.99999
HP_DECREASED_ACTIVITY_OF_MIT...4,SET,41,-0.14488,-0.0068386,0.12028,0.88579,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_III,0.99999
GSE29618_PRE_VS_DAY7_POST_TI...3,SET,177,-0.072118,-0.0070466,0.059868,0.88582,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN,0.99999
GOMF_PROTEIN_PRENYLTRANSFERA...,SET,6,-0.37822,-0.0068361,0.31394,0.88585,GOMF_PROTEIN_PRENYLTRANSFERASE_ACTIVITY,0.99999
WP_GPCRS_CLASS_C_METABOTROPI...,SET,15,-0.29378,-0.0083934,0.24383,0.88586,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,0.99999
GSE9239_CTRL_VS_TNF_INHIBITO...2,SET,175,-0.077161,-0.007497,0.06402,0.88594,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP,0.99999
GSE3039_NKT_CELL_VS_B2_BCELL...1,SET,185,-0.075584,-0.0075486,0.062709,0.88595,GSE3039_NKT_CELL_VS_B2_BCELL_DN,0.99999
chr2q21,SET,33,-0.36478,-0.015451,0.30261,0.88597,chr2q21,0.99999
HP_THIN_BONY_CORTEX,SET,18,-0.2489,-0.0077894,0.20649,0.88597,HP_THIN_BONY_CORTEX,0.99999
HP_DECREASED_CIRCULATING_IGG...2,SET,9,-0.32599,-0.0072155,0.27042,0.88598,HP_DECREASED_CIRCULATING_IGG_SUBCLASS_LEVEL,0.99999
HP_OROTICACIDURIA,SET,7,-0.3709,-0.0072407,0.30763,0.88602,HP_OROTICACIDURIA,0.99999
MEISSNER_BRAIN_HCP_WITH_H3K4...1,SET,16,-0.25868,-0.0076328,0.21453,0.88605,MEISSNER_BRAIN_HCP_WITH_H3K4ME2,0.99999
WP_TGFBETA_SIGNALING_IN_THYR...,SET,19,-0.23193,-0.0074569,0.19233,0.88606,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,0.99999
HP_MEDULLARY_NEPHROCALCINOSIS,SET,10,-0.34943,-0.0081526,0.28976,0.88607,HP_MEDULLARY_NEPHROCALCINOSIS,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...15,SET,14,-0.28762,-0.0079392,0.23849,0.88609,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,0.99999
GSE14415_FOXP3_KO_NATURAL_TR...2,SET,153,-0.081494,-0.0074081,0.067561,0.88613,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP,0.99999
GOBP_REGULATION_OF_GUANYL_NU...,SET,6,-0.44507,-0.0080442,0.36892,0.88616,GOBP_REGULATION_OF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,0.99999
GSE3565_CTRL_VS_LPS_INJECTED...4,SET,160,-0.084541,-0.0078574,0.070072,0.88618,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP,0.99999
MIR181D_5P,SET,554,-0.044401,-0.0075954,0.036799,0.8862,MIR181D_5P,0.99999
GOBP_REGULATION_OF_STEROID_H...1,SET,15,-0.29149,-0.0083281,0.24148,0.8863,GOBP_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,0.99999
GSE3720_UNSTIM_VS_LPS_STIM_V...2,SET,176,-0.076622,-0.0074657,0.063466,0.88633,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP,0.99999
HP_RETINAL_NEOVASCULARIZATION,SET,9,-0.36199,-0.0080123,0.2998,0.88636,HP_RETINAL_NEOVASCULARIZATION,0.99999
GOBP_RETROGRADE_VESICLE_MEDI...,SET,48,-0.13207,-0.0067436,0.10937,0.88637,GOBP_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ENDOPLASMIC_RETICULUM,0.99999
WP_BIOSYNTHESIS_AND_REGENERA...,SET,12,-0.28069,-0.0071735,0.23244,0.88639,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,0.99999
MIR379_3P_MIR411_3P,SET,173,-0.081165,-0.0078413,0.067213,0.88639,MIR379_3P_MIR411_3P,0.99999
GOBP_IMP_METABOLIC_PROCESS,SET,15,-0.26993,-0.0077121,0.2235,0.88642,GOBP_IMP_METABOLIC_PROCESS,0.99999
NAKAYA_B_CELL_FLUMIST_AGE_18...1,SET,346,-0.054286,-0.0073816,0.044945,0.88644,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN,0.99999
HP_ECTROPION_OF_LOWER_EYELIDS,SET,7,-0.30647,-0.0059829,0.25372,0.88645,HP_ECTROPION_OF_LOWER_EYELIDS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...615,SET,25,-0.21129,-0.0077913,0.17492,0.88646,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...68,SET,16,-0.24728,-0.0072965,0.20469,0.88648,HP_APLASIA_HYPOPLASIA_OF_THE_STERNUM,0.99999
GOBP_HEMATOPOIETIC_STEM_CELL...5,SET,31,-0.18013,-0.0073953,0.14909,0.88651,GOBP_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,0.99999
HP_ABSENT_SKIN_PIGMENTATION,SET,5,-0.50763,-0.0083758,0.42015,0.88651,HP_ABSENT_SKIN_PIGMENTATION,0.99999
REACTOME_RECOGNITION_AND_ASS...,SET,10,-0.30364,-0.0070842,0.2513,0.88652,REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE,0.99999
GOCC_SEC61_TRANSLOCON_COMPLEX,SET,4,-0.48219,-0.0071163,0.39908,0.88652,GOCC_SEC61_TRANSLOCON_COMPLEX,0.99999
REACTOME_FORMATION_OF_DEFINI...,SET,14,-0.29471,-0.0081348,0.24389,0.88654,REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM,0.99999
MIR7856_5P,SET,363,-0.054222,-0.0075482,0.044872,0.88654,MIR7856_5P,0.99999
GOBP_REGULATION_OF_DENDRITIC...4,SET,52,-0.14386,-0.0076448,0.11904,0.88657,GOBP_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,0.99999
GSE6259_33D1_POS_DC_VS_BCELL...1,SET,133,-0.086541,-0.0073387,0.071607,0.88657,GSE6259_33D1_POS_DC_VS_BCELL_DN,0.99999
GOMF_TRANSMEMBRANE_RECEPTOR_...4,SET,18,-0.24842,-0.0077743,0.20554,0.88658,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_BINDING,0.99999
HP_THYMOMA,SET,5,-0.4448,-0.0073391,0.36804,0.88658,HP_THYMOMA,0.99999
GSE9650_NAIVE_VS_EXHAUSTED_C...1,SET,176,-0.080059,-0.0078006,0.066227,0.88663,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...231,SET,32,-0.1786,-0.0074495,0.14772,0.88667,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_MACROAUTO...,SET,166,-0.077416,-0.0073276,0.064019,0.88671,GOBP_REGULATION_OF_MACROAUTOPHAGY,0.99999
GOBP_REGULATION_OF_REACTIVE_...1,SET,35,-0.1675,-0.0073063,0.1385,0.88675,GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,0.99999
HP_ABNORMALITY_OF_MULTIPLE_C...,SET,165,-0.077797,-0.0073417,0.064323,0.88675,HP_ABNORMALITY_OF_MULTIPLE_CELL_LINEAGES_IN_THE_BONE_MARROW,0.99999
GSE3039_CD4_TCELL_VS_ALPHAAL...2,SET,180,-0.076883,-0.0075749,0.063543,0.88684,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP,0.99999
GOMF_ADENYLATE_CYCLASE_BINDI...,SET,12,-0.31538,-0.0080599,0.26063,0.88686,GOMF_ADENYLATE_CYCLASE_BINDING,0.99999
HP_ABNORMALITY_OF_MACULAR_PI...,SET,35,-0.19045,-0.0083073,0.15738,0.88688,HP_ABNORMALITY_OF_MACULAR_PIGMENTATION,0.99999
KAZMIN_PBMC_P_FALCIPARUM_RTS...1,SET,39,-0.18079,-0.0083233,0.14937,0.88691,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE,0.99999
KEGG_GALACTOSE_METABOLISM,SET,24,-0.19593,-0.0070789,0.16188,0.88692,KEGG_GALACTOSE_METABOLISM,0.99999
WAMUNYOKOLI_OVARIAN_CANCER_G...1,SET,63,-0.13612,-0.0079594,0.11245,0.88695,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,0.99999
GOBP_FEMALE_GENITALIA_DEVELO...,SET,19,-0.25295,-0.0081329,0.20897,0.88695,GOBP_FEMALE_GENITALIA_DEVELOPMENT,0.99999
GSE6259_FLT3L_INDUCED_DEC205...4,SET,147,-0.078797,-0.0070222,0.065085,0.88698,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP,0.99999
GSE3691_IFN_PRODUCING_KILLER...4,SET,177,-0.075878,-0.007414,0.062636,0.88712,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP,0.99999
GOCC_MMXD_COMPLEX,SET,3,-0.4988,-0.0063754,0.41175,0.88713,GOCC_MMXD_COMPLEX,0.99999
MIR4707_5P,SET,9,-0.32835,-0.0072677,0.27102,0.88714,MIR4707_5P,0.99999
GSE11961_MARGINAL_ZONE_BCELL...7,SET,175,-0.080103,-0.0077828,0.066108,0.88718,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...57,SET,97,-0.10569,-0.0076618,0.087222,0.88719,GOBP_POSITIVE_REGULATION_OF_BINDING,0.99999
GOMF_LIGAND_GATED_MONOATOMIC...3,SET,15,-0.282,-0.0080569,0.23272,0.88719,GOMF_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY_INVOLVED_IN_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.99999
GOBP_REGULATION_OF_NEUROINFL...,SET,33,-0.19528,-0.0082713,0.16115,0.8872,GOBP_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,0.99999
KYNG_ENVIRONMENTAL_STRESS_RE...6,SET,23,-0.2034,-0.0071944,0.1678,0.88727,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,0.99999
GSE24142_ADULT_VS_FETAL_EARL...2,SET,183,-0.077062,-0.007655,0.063573,0.88727,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP,0.99999
KRAS.LUNG_UP.V1_DN,SET,128,-0.092807,-0.0077218,0.07656,0.88728,KRAS.LUNG_UP.V1_DN,0.99999
MIR4501,SET,73,-0.11601,-0.0073002,0.095692,0.88729,MIR4501,0.99999
GSE11961_FOLLICULAR_BCELL_VS...12,SET,184,-0.075435,-0.0075135,0.062223,0.8873,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP,0.99999
HP_ABNORMAL_SHAPE_OF_THE_RAD...,SET,24,-0.22348,-0.0080745,0.18432,0.88732,HP_ABNORMAL_SHAPE_OF_THE_RADIUS,0.99999
TSUDA_ALVEOLAR_SOFT_PART_SAR...,SET,10,-0.33634,-0.0078471,0.27736,0.88736,TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,0.99999
GOMF_PATTERN_RECOGNITION_REC...,SET,28,-0.19665,-0.0076736,0.16214,0.88739,GOMF_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY,0.99999
GOBP_ACTIVATION_OF_MEIOSIS,SET,5,-0.47362,-0.0078146,0.39047,0.88741,GOBP_ACTIVATION_OF_MEIOSIS,0.99999
BYSTRYKH_HEMATOPOIESIS_STEM_...7,SET,720,-0.038222,-0.007419,0.0315,0.8875,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS,0.99999
SUPT16H_TARGET_GENES,SET,1357,-0.02818,-0.0073726,0.023223,0.88752,SUPT16H_TARGET_GENES,0.99999
MIR449C_3P,SET,50,-0.13986,-0.0072883,0.11524,0.88755,MIR449C_3P,0.99999
GOCC_SUMO_LIGASE_COMPLEX,SET,10,-0.3335,-0.0077809,0.27479,0.88755,GOCC_SUMO_LIGASE_COMPLEX,0.99999
GSE32423_IL7_VS_IL4_MEMORY_C...1,SET,181,-0.073168,-0.0072287,0.060285,0.88756,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN,0.99999
MIR3670,SET,50,-0.14162,-0.0073801,0.11667,0.88758,MIR3670,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...44,SET,5,-0.48402,-0.0079863,0.39869,0.88763,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_EXTRINSIC_APOPTOTIC_PATHWAY,0.99999
MIR181C_5P,SET,556,-0.044632,-0.0076481,0.036756,0.88767,MIR181C_5P,0.99999
GOCC_POST_MRNA_RELEASE_SPLIC...,SET,10,-0.301,-0.0070226,0.24785,0.8877,GOCC_POST_MRNA_RELEASE_SPLICEOSOMAL_COMPLEX,0.99999
CDC73_TARGET_GENES,SET,479,-0.045005,-0.0071737,0.037056,0.88772,CDC73_TARGET_GENES,0.99999
HP_DILATED_CARDIOMYOPATHY,SET,139,-0.084756,-0.0073465,0.069784,0.88772,HP_DILATED_CARDIOMYOPATHY,0.99999
HP_IRIS_HYPOPIGMENTATION,SET,58,-0.14257,-0.0080001,0.11737,0.88774,HP_IRIS_HYPOPIGMENTATION,0.99999
GOBP_REGULATION_OF_SOMATIC_S...,SET,11,-0.31951,-0.007818,0.26302,0.88776,GOBP_REGULATION_OF_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...429,SET,4,-0.41539,-0.0061305,0.34185,0.88783,GOBP_NEGATIVE_REGULATION_OF_MYOFIBROBLAST_DIFFERENTIATION,0.99999
WHITEFORD_PEDIATRIC_CANCER_M...,SET,111,-0.097471,-0.0075556,0.080213,0.88784,WHITEFORD_PEDIATRIC_CANCER_MARKERS,0.99999
REACTOME_ENERGY_DEPENDENT_RE...,SET,28,-0.18339,-0.0071561,0.15091,0.88786,REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK,0.99999
GOBP_REGULATION_OF_UBIQUITIN...3,SET,35,-0.16878,-0.007362,0.13884,0.88793,GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,0.99999
REACTOME_TNFR1_MEDIATED_CERA...,SET,5,-0.42318,-0.0069824,0.34809,0.88795,REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...1,SET,47,-0.15614,-0.0078899,0.12843,0.88796,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1,0.99999
GOMF_NUCLEOTIDE_SUGAR_TRANSM...,SET,12,-0.28879,-0.0073805,0.23753,0.88796,GOMF_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
KEGG_INOSITOL_PHOSPHATE_META...,SET,52,-0.13535,-0.0071927,0.11131,0.88799,KEGG_INOSITOL_PHOSPHATE_METABOLISM,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_INT...,SET,243,-0.070005,-0.008,0.057571,0.88799,HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL,0.99999
GOBP_RRNA_5_END_PROCESSING,SET,5,-0.4291,-0.00708,0.35285,0.88802,GOBP_RRNA_5_END_PROCESSING,0.99999
GOCC_U1_SNRNP,SET,18,-0.21672,-0.0067822,0.17821,0.88802,GOCC_U1_SNRNP,0.99999
GOBP_L_ARGININE_TRANSMEMBRAN...,SET,13,-0.32381,-0.0086132,0.26626,0.88803,GOBP_L_ARGININE_TRANSMEMBRANE_TRANSPORT,0.99999
GSE360_HIGH_VS_LOW_DOSE_B_MA...1,SET,178,-0.076233,-0.0074695,0.062671,0.88808,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...627,SET,20,-0.22992,-0.0075841,0.18898,0.88811,GOBP_NEGATIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
KEGG_MEDICUS_REFERENCE_CXCR_...2,SET,26,-0.21166,-0.0079591,0.17397,0.88812,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,0.99999
WP_REGULATION_OF_SISTER_CHRO...,SET,13,-0.31656,-0.0084202,0.26018,0.88813,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,0.99999
YAMASHITA_LIVER_CANCER_STEM_...1,SET,69,-0.13372,-0.0081818,0.10988,0.88818,YAMASHITA_LIVER_CANCER_STEM_CELL_DN,0.99999
HP_CONFETTI_LIKE_HYPOPIGMENT...,SET,8,-0.36567,-0.0076311,0.30045,0.8882,HP_CONFETTI_LIKE_HYPOPIGMENTED_MACULES,0.99999
GOBP_REGULATION_OF_RESPONSE_...9,SET,27,-0.20199,-0.00774,0.16594,0.88823,GOBP_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,0.99999
DELYS_THYROID_CANCER_UP,SET,412,-0.052702,-0.0078055,0.043292,0.88826,DELYS_THYROID_CANCER_UP,0.99999
DELASERNA_MYOD_TARGETS_UP,SET,81,-0.11709,-0.0077596,0.096137,0.88836,DELASERNA_MYOD_TARGETS_UP,0.99999
chr1p21,SET,29,-0.32364,-0.012852,0.26571,0.88838,chr1p21,0.99999
MANN_RESPONSE_TO_AMIFOSTINE_...2,SET,19,-0.22046,-0.0070881,0.18097,0.88842,MANN_RESPONSE_TO_AMIFOSTINE_UP,0.99999
GOBP_RESPONSE_TO_ANGIOTENSIN,SET,38,-0.18466,-0.008392,0.15157,0.88844,GOBP_RESPONSE_TO_ANGIOTENSIN,0.99999
GOMF_INTRACELLULARLY_CALCIUM...,SET,20,-0.25052,-0.0082636,0.20563,0.88844,GOMF_INTRACELLULARLY_CALCIUM_GATED_CHLORIDE_CHANNEL_ACTIVITY,0.99999
STN1_TARGET_GENES,SET,8,-0.38395,-0.0080127,0.31512,0.88846,STN1_TARGET_GENES,0.99999
GSE11057_NAIVE_CD4_VS_PBMC_C...1,SET,186,-0.07501,-0.0075113,0.06156,0.88847,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN,0.99999
WP_MYOMETRIAL_RELAXATION_AND...,SET,153,-0.086419,-0.0078558,0.070908,0.88852,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,0.99999
GOBP_MESENCHYME_MORPHOGENESIS,SET,58,-0.15358,-0.0086183,0.12602,0.88852,GOBP_MESENCHYME_MORPHOGENESIS,0.99999
BANDRES_RESPONSE_TO_CARMUSTI...6,SET,12,-0.26349,-0.0067338,0.21615,0.88857,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP,0.99999
GOBP_FORMATION_OF_PRIMARY_GE...,SET,118,-0.10003,-0.0079934,0.082048,0.8886,GOBP_FORMATION_OF_PRIMARY_GERM_LAYER,0.99999
REACTOME_ARACHIDONATE_PRODUC...,SET,5,-0.45131,-0.0074465,0.37016,0.88861,REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG,0.99999
GNF2_CDC20,SET,52,-0.14361,-0.0076315,0.11775,0.88868,GNF2_CDC20,0.99999
GAO_LARGE_INTESTINE_24W_C2_M...,SET,104,-0.10867,-0.0081557,0.089086,0.88873,GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR,0.99999
GCM_NF2,SET,266,-0.058095,-0.0069417,0.047624,0.88874,GCM_NF2,0.99999
MODULE_100,SET,492,-0.049485,-0.0079912,0.040553,0.88881,MODULE_100,0.99999
GOMF_UBIQUITIN_SPECIFIC_PROT...,SET,14,-0.23788,-0.0065661,0.19492,0.88883,GOMF_UBIQUITIN_SPECIFIC_PROTEASE_BINDING,0.99999
GSE29618_PRE_VS_DAY7_FLU_VAC...6,SET,170,-0.080314,-0.0076922,0.065812,0.88883,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP,0.99999
GSE5503_LIVER_DC_VS_PLN_DC_A...1,SET,176,-0.072831,-0.0070963,0.059675,0.88885,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.99999
REACTOME_SHC_MEDIATED_CASCAD...1,SET,21,-0.2281,-0.0077098,0.18681,0.88895,REACTOME_SHC_MEDIATED_CASCADE_FGFR1,0.99999
HP_HYPERMETHIONINEMIA,SET,7,-0.44794,-0.0087446,0.36687,0.88895,HP_HYPERMETHIONINEMIA,0.99999
GOMF_ALPHA_GLUCOSIDASE_ACTIV...,SET,7,-0.38812,-0.0075768,0.31785,0.88897,GOMF_ALPHA_GLUCOSIDASE_ACTIVITY,0.99999
HP_ABNORMAL_ELECTRORETINOGRAM,SET,188,-0.076283,-0.0076793,0.062468,0.88898,HP_ABNORMAL_ELECTRORETINOGRAM,0.99999
ELF5_TARGET_GENES,SET,379,-0.053074,-0.0075462,0.043433,0.88913,ELF5_TARGET_GENES,0.99999
HP_ABNORMAL_FETAL_MORPHOLOGY,SET,265,-0.063564,-0.0075811,0.05201,0.88917,HP_ABNORMAL_FETAL_MORPHOLOGY,0.99999
BLANCO_MELO_MERS_COV_INFECTI...2,SET,230,-0.069086,-0.0076837,0.056526,0.88918,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,0.99999
GOMF_PHOSPHATIDYL_PHOSPHOLIP...,SET,11,-0.30935,-0.0075696,0.25311,0.88918,GOMF_PHOSPHATIDYL_PHOSPHOLIPASE_B_ACTIVITY,0.99999
GOBP_PROTEIN_RETENTION_IN_ER...,SET,8,-0.33594,-0.0070108,0.27483,0.88921,GOBP_PROTEIN_RETENTION_IN_ER_LUMEN,0.99999
ZHONG_PFC_C1_DLX5_POS_INTERN...,SET,6,-0.49996,-0.0090362,0.40899,0.88922,ZHONG_PFC_C1_DLX5_POS_INTERNEURON,0.99999
HP_ABNORMALITY_OF_THE_TEMPOR...,SET,18,-0.25707,-0.0080451,0.21027,0.88925,HP_ABNORMALITY_OF_THE_TEMPOROMANDIBULAR_JOINT,0.99999
LET_7I_3P,SET,5,-0.45297,-0.0074738,0.37046,0.88928,LET_7I_3P,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...10,SET,46,-0.16566,-0.0082812,0.13548,0.88928,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_1,0.99999
GOBP_DETECTION_OF_TEMPERATUR...1,SET,26,-0.21346,-0.008027,0.17458,0.88928,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS,0.99999
HP_PERIPHERAL_VISUAL_FIELD_L...,SET,92,-0.10731,-0.007577,0.087747,0.88932,HP_PERIPHERAL_VISUAL_FIELD_LOSS,0.99999
HP_LYMPH_NODE_HYPOPLASIA,SET,3,-0.65955,-0.00843,0.53925,0.88934,HP_LYMPH_NODE_HYPOPLASIA,0.99999
GSE3720_VD1_VS_VD2_GAMMADELT...3,SET,183,-0.072418,-0.0071936,0.059193,0.8894,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN,0.99999
GSE21063_CTRL_VS_ANTI_IGM_ST...10,SET,185,-0.077833,-0.0077732,0.063606,0.88945,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_UP,0.99999
GOBP_GASTRIC_MOTILITY,SET,5,-0.45924,-0.0075774,0.3753,0.88946,GOBP_GASTRIC_MOTILITY,0.99999
CREBP1CJUN_01,SET,237,-0.067889,-0.0076631,0.055462,0.88953,CREBP1CJUN_01,0.99999
GSE25677_R848_VS_MPL_AND_R84...1,SET,145,-0.08511,-0.0075335,0.069513,0.88959,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN,0.99999
GSE29949_MICROGLIA_BRAIN_VS_...3,SET,182,-0.080064,-0.0079316,0.065392,0.88959,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,0.99999
GOMF_P_TYPE_TRANSMEMBRANE_TR...,SET,22,-0.2143,-0.0074136,0.17501,0.88961,GOMF_P_TYPE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_RESPONSE_TO_LITHIUM_ION,SET,16,-0.26276,-0.0077534,0.21458,0.88962,GOBP_RESPONSE_TO_LITHIUM_ION,0.99999
GAO_LARGE_INTESTINE_ADULT_CJ...,SET,438,-0.053985,-0.0082379,0.044084,0.88962,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,0.99999
HP_ASTHMA,SET,149,-0.084752,-0.0076038,0.069208,0.88963,HP_ASTHMA,0.99999
HP_THUMB_CONTRACTURE,SET,4,-0.6036,-0.0089081,0.49287,0.88964,HP_THUMB_CONTRACTURE,0.99999
GOBP_REGULATION_OF_ANOIKIS,SET,22,-0.22418,-0.0077554,0.18305,0.88965,GOBP_REGULATION_OF_ANOIKIS,0.99999
MIR1285_5P,SET,60,-0.14097,-0.0080454,0.11508,0.88969,MIR1285_5P,0.99999
GOBP_FATTY_ACID_METABOLIC_PR...,SET,365,-0.055275,-0.0077156,0.045125,0.88969,GOBP_FATTY_ACID_METABOLIC_PROCESS,0.99999
GOBP_ORGANIC_CYCLIC_COMPOUND...,SET,558,-0.043705,-0.0075023,0.03568,0.88969,GOBP_ORGANIC_CYCLIC_COMPOUND_CATABOLIC_PROCESS,0.99999
KEGG_VALINE_LEUCINE_AND_ISOL...2,SET,42,-0.15418,-0.0073656,0.12582,0.88978,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,0.99999
GOMF_RNA_EXONUCLEASE_ACTIVIT...,SET,39,-0.14957,-0.0068859,0.12205,0.88979,GOMF_RNA_EXONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,0.99999
NADLER_OBESITY_UP,SET,58,-0.14459,-0.0081134,0.11796,0.88985,NADLER_OBESITY_UP,0.99999
BIOCARTA_ARF_PATHWAY,SET,17,-0.24782,-0.0075371,0.20214,0.88988,BIOCARTA_ARF_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...714,SET,79,-0.1226,-0.0080243,0.09999,0.88991,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,0.99999
MIR548AG,SET,158,-0.082145,-0.0075873,0.066994,0.88992,MIR548AG,0.99999
GOBP_DETECTION_OF_VISIBLE_LI...,SET,43,-0.16094,-0.0077791,0.13124,0.88995,GOBP_DETECTION_OF_VISIBLE_LIGHT,0.99999
GOBP_POSITIVE_REGULATION_OF_...290,SET,43,-0.15325,-0.0074077,0.12496,0.88996,GOBP_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE,0.99999
BROWNE_HCMV_INFECTION_12HR_DN,SET,88,-0.11653,-0.008048,0.095004,0.89,BROWNE_HCMV_INFECTION_12HR_DN,0.99999
MIR10226,SET,69,-0.1253,-0.0076667,0.10215,0.89,MIR10226,0.99999
AP1_Q2,SET,242,-0.067796,-0.0077318,0.055261,0.89005,AP1_Q2,0.99999
GSE3920_IFNA_VS_IFNB_TREATED...1,SET,151,-0.083392,-0.0075314,0.067967,0.89007,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,0.99999
GOMF_5_DEOXYRIBOSE_5_PHOSPHA...,SET,7,-0.2899,-0.0056593,0.23626,0.89008,GOMF_5_DEOXYRIBOSE_5_PHOSPHATE_LYASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...517,SET,70,-0.1162,-0.0071609,0.094687,0.89011,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.99999
GOBP_EPITHELIAL_CELL_PROLIFE...2,SET,10,-0.39057,-0.0091123,0.31821,0.89015,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,0.99999
REACTOME_SIGNALING_BY_SCF_KIT,SET,42,-0.16439,-0.0078534,0.13392,0.89018,REACTOME_SIGNALING_BY_SCF_KIT,0.99999
GOBP_LAYER_FORMATION_IN_CERE...,SET,13,-0.31507,-0.0083805,0.25666,0.89019,GOBP_LAYER_FORMATION_IN_CEREBRAL_CORTEX,0.99999
GOMF_VASOPRESSIN_RECEPTOR_AC...,SET,6,-0.46025,-0.0083187,0.37491,0.8902,GOMF_VASOPRESSIN_RECEPTOR_ACTIVITY,0.99999
KEGG_N_GLYCAN_BIOSYNTHESIS,SET,44,-0.14919,-0.0072944,0.12152,0.89021,KEGG_N_GLYCAN_BIOSYNTHESIS,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...1,SET,174,-0.077204,-0.0074799,0.062886,0.89021,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.99999
GOCC_STEREOCILIUM_BUNDLE,SET,59,-0.13864,-0.0078465,0.11289,0.89029,GOCC_STEREOCILIUM_BUNDLE,0.99999
GSE9006_1MONTH_VS_4MONTH_POS...2,SET,177,-0.078521,-0.0076722,0.063937,0.89029,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP,0.99999
GOBP_MEMBRANE_HYPERPOLARIZAT...,SET,11,-0.30232,-0.0073974,0.24612,0.89033,GOBP_MEMBRANE_HYPERPOLARIZATION,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...5,SET,97,-0.10976,-0.007957,0.089349,0.89036,GOCC_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE,0.99999
HP_CHORIORETINAL_DYSPLASIA,SET,14,-0.27181,-0.0075026,0.22124,0.89038,HP_CHORIORETINAL_DYSPLASIA,0.99999
MIR4735_3P,SET,107,-0.10014,-0.007622,0.08148,0.89045,MIR4735_3P,0.99999
HP_MYOPIA,SET,364,-0.054257,-0.0075633,0.044149,0.89045,HP_MYOPIA,0.99999
LEF1_UP.V1_DN,SET,166,-0.084094,-0.0079597,0.068421,0.89047,LEF1_UP.V1_DN,0.99999
HP_ASTIGMATISM,SET,196,-0.072141,-0.0074136,0.058692,0.89048,HP_ASTIGMATISM,0.99999
GOCC_ENDOPLASMIC_RETICULUM_E...,SET,28,-0.19208,-0.0074951,0.15626,0.8905,GOCC_ENDOPLASMIC_RETICULUM_EXIT_SITE,0.99999
GOBP_REGULATION_OF_RYANODINE...,SET,20,-0.26606,-0.0087764,0.21637,0.89058,GOBP_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.99999
GOBP_TUBE_LUMEN_CAVITATION,SET,4,-0.5821,-0.0085908,0.47339,0.89058,GOBP_TUBE_LUMEN_CAVITATION,0.99999
HP_INCREASED_CIRCULATING_INT...1,SET,20,-0.23569,-0.0077744,0.19165,0.8906,HP_INCREASED_CIRCULATING_INTERFERON_GAMMA_CONCENTRATION,0.99999
HOOI_ST7_TARGETS_UP,SET,84,-0.11476,-0.0077446,0.093294,0.89067,HOOI_ST7_TARGETS_UP,0.99999
GSE17186_BLOOD_VS_CORD_BLOOD...4,SET,189,-0.072944,-0.0073625,0.059283,0.89072,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP,0.99999
MIR410_3P,SET,297,-0.061289,-0.0077316,0.049806,0.89074,MIR410_3P,0.99999
KEGG_PURINE_METABOLISM,SET,144,-0.085209,-0.0075164,0.069214,0.89085,KEGG_PURINE_METABOLISM,0.99999
KAMMINGA_SENESCENCE,SET,38,-0.16617,-0.0075518,0.13497,0.89086,KAMMINGA_SENESCENCE,0.99999
GOCC_INTERPHOTORECEPTOR_MATR...,SET,5,-0.40797,-0.0067314,0.33135,0.89087,GOCC_INTERPHOTORECEPTOR_MATRIX,0.99999
HP_LARGE_FOREHEAD,SET,21,-0.22674,-0.0076637,0.18416,0.89087,HP_LARGE_FOREHEAD,0.99999
GOBP_REGULATION_OF_LYSOSOMAL...,SET,27,-0.19792,-0.0075839,0.16072,0.89091,GOBP_REGULATION_OF_LYSOSOMAL_LUMEN_PH,0.99999
WALLACE_PROSTATE_CANCER_RACE...1,SET,74,-0.11725,-0.0074284,0.09521,0.89092,WALLACE_PROSTATE_CANCER_RACE_DN,0.99999
HP_PARATHYROID_HYPERPLASIA,SET,10,-0.33848,-0.0078972,0.27485,0.89093,HP_PARATHYROID_HYPERPLASIA,0.99999
GSE21063_WT_VS_NFATC1_KO_3H_...1,SET,190,-0.077144,-0.0078068,0.062638,0.89094,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_DN,0.99999
RACTNNRTTTNC_UNKNOWN,SET,111,-0.09864,-0.0076463,0.080087,0.89096,RACTNNRTTTNC_UNKNOWN,0.99999
GOBP_FOLIC_ACID_METABOLIC_PR...,SET,13,-0.25046,-0.006662,0.20333,0.89098,GOBP_FOLIC_ACID_METABOLIC_PROCESS,0.99999
REACTOME_MATURATION_OF_SARS_...1,SET,11,-0.27585,-0.0067498,0.22389,0.89103,REACTOME_MATURATION_OF_SARS_COV_1_NUCLEOPROTEIN,0.99999
MIR3136_3P,SET,60,-0.12694,-0.0072446,0.10303,0.89103,MIR3136_3P,0.99999
MIR4786_3P,SET,149,-0.089758,-0.0080529,0.072852,0.89103,MIR4786_3P,0.99999
GOBP_BENZENE_CONTAINING_COMP...,SET,23,-0.23221,-0.0082133,0.18843,0.89108,GOBP_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GSE15750_WT_VS_TRAF6KO_DAY6_...2,SET,176,-0.074699,-0.0072784,0.060613,0.89109,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP,0.99999
GSE8515_CTRL_VS_IL1_4H_STIM_...1,SET,172,-0.077838,-0.0074984,0.06316,0.89109,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN,0.99999
HP_INFANTILE_SPASMS,SET,119,-0.095683,-0.007678,0.077638,0.8911,HP_INFANTILE_SPASMS,0.99999
GOBP_EXCITATORY_CHEMICAL_SYN...,SET,10,-0.35972,-0.0083926,0.29178,0.89117,GOBP_EXCITATORY_CHEMICAL_SYNAPTIC_TRANSMISSION,0.99999
MAHAJAN_RESPONSE_TO_IL1A_UP,SET,73,-0.12899,-0.0081174,0.10463,0.89118,MAHAJAN_RESPONSE_TO_IL1A_UP,0.99999
ROSS_LEUKEMIA_WITH_MLL_FUSIO...,SET,76,-0.12126,-0.0077854,0.098359,0.89118,ROSS_LEUKEMIA_WITH_MLL_FUSIONS,0.99999
GOMF_NUCLEOTIDASE_ACTIVITY,SET,13,-0.27003,-0.0071826,0.21899,0.89122,GOMF_NUCLEOTIDASE_ACTIVITY,0.99999
GOCC_PROTEIN_LIPID_COMPLEX,SET,33,-0.19557,-0.0082838,0.15854,0.89131,GOCC_PROTEIN_LIPID_COMPLEX,0.99999
LAKE_ADULT_KIDNEY_C28_INTERS...,SET,79,-0.12758,-0.0083505,0.10342,0.89133,LAKE_ADULT_KIDNEY_C28_INTERSTITIUM,0.99999
GOMF_TRIGLYCERIDE_LIPASE_ACT...,SET,24,-0.25167,-0.0090928,0.20399,0.89134,GOMF_TRIGLYCERIDE_LIPASE_ACTIVITY,0.99999
KRAS.KIDNEY_UP.V1_DN,SET,121,-0.10144,-0.008208,0.082225,0.89134,KRAS.KIDNEY_UP.V1_DN,0.99999
MAEKAWA_ATF2_TARGETS,SET,22,-0.22218,-0.0076861,0.18,0.89146,MAEKAWA_ATF2_TARGETS,0.99999
LEIN_LOCALIZED_TO_PROXIMAL_D...,SET,31,-0.19099,-0.0078413,0.15472,0.89147,LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES,0.99999
GRAHAM_CML_DIVIDING_VS_NORMA...4,SET,170,-0.079091,-0.007575,0.064057,0.89152,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,0.99999
GOBP_TUBULIN_COMPLEX_ASSEMBLY,SET,8,-0.28661,-0.0059812,0.23212,0.89153,GOBP_TUBULIN_COMPLEX_ASSEMBLY,0.99999
DESCARTES_FETAL_LUNG_VISCERA...,SET,168,-0.087696,-0.0083501,0.071002,0.8916,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,0.99999
GOBP_SYNCYTIUM_FORMATION,SET,60,-0.13762,-0.0078539,0.1114,0.89163,GOBP_SYNCYTIUM_FORMATION,0.99999
HP_HEMOGLOBINURIA,SET,8,-0.34777,-0.0072577,0.2815,0.89165,HP_HEMOGLOBINURIA,0.99999
REACTOME_REGULATION_OF_RUNX3...,SET,52,-0.13142,-0.006984,0.10637,0.89167,REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,0.99999
MIR1277_5P,SET,820,-0.037986,-0.0078462,0.030743,0.89168,MIR1277_5P,0.99999
GOCC_JUNCTIONAL_MEMBRANE_COM...,SET,6,-0.43652,-0.0078897,0.35325,0.89171,GOCC_JUNCTIONAL_MEMBRANE_COMPLEX,0.99999
HP_DISTICHIASIS,SET,8,-0.35893,-0.0074905,0.29043,0.89173,HP_DISTICHIASIS,0.99999
GOBP_STARTLE_RESPONSE,SET,25,-0.21563,-0.0079514,0.17448,0.89174,GOBP_STARTLE_RESPONSE,0.99999
WINTER_HYPOXIA_UP,SET,87,-0.10532,-0.0072329,0.085217,0.89175,WINTER_HYPOXIA_UP,0.99999
HP_ABNORMALITY_OF_THE_UTERUS,SET,225,-0.069315,-0.0076259,0.056076,0.89178,HP_ABNORMALITY_OF_THE_UTERUS,0.99999
PAX5_01,SET,138,-0.090924,-0.0078529,0.073552,0.8918,PAX5_01,0.99999
GOBP_INTRACELLULAR_POTASSIUM...,SET,15,-0.30296,-0.0086557,0.24504,0.89183,GOBP_INTRACELLULAR_POTASSIUM_ION_HOMEOSTASIS,0.99999
GSE22589_SIV_VS_HIV_AND_SIV_...2,SET,178,-0.078307,-0.0076727,0.063329,0.89186,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...472,SET,7,-0.35687,-0.0069668,0.28854,0.89191,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOBP_PYRIMIDINE_NUCLEOTIDE_M...,SET,49,-0.14839,-0.0076556,0.11997,0.89193,GOBP_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS,0.99999
REACTOME_REGULATION_OF_MECP2...,SET,29,-0.20292,-0.0080581,0.16404,0.89195,REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...345,SET,6,-0.46792,-0.0084573,0.37826,0.89196,GOBP_POSITIVE_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,0.99999
HOEK_MONOCYTE_2011_2012_TIV_...3,SET,4,-0.45464,-0.0067096,0.3675,0.89197,HOEK_MONOCYTE_2011_2012_TIV_ADULT_3DY_DN,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_PUL...1,SET,202,-0.07924,-0.0082655,0.064049,0.89198,HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NEUROENDOCRINE_CELL,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_HMO...,SET,22,-0.23335,-0.0080727,0.18862,0.89198,HE_LIM_SUN_FETAL_LUNG_C3_HMOX1_POS_PRIMITIVE_ERYTHROBLAST,0.99999
ONKEN_UVEAL_MELANOMA_UP,SET,718,-0.040031,-0.0077597,0.032354,0.892,ONKEN_UVEAL_MELANOMA_UP,0.99999
REACTOME_GLYCEROPHOSPHOLIPID...2,SET,7,-0.41656,-0.0081319,0.33665,0.89201,REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM,0.99999
GOBP_REGULATION_OF_ANDROGEN_...,SET,25,-0.19463,-0.0071767,0.15728,0.89203,GOBP_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,0.99999
GNF2_RTN1,SET,47,-0.16573,-0.0083743,0.13392,0.89205,GNF2_RTN1,0.99999
GOBP_MELANOCYTE_PROLIFERATION,SET,5,-0.48904,-0.008069,0.3951,0.89209,GOBP_MELANOCYTE_PROLIFERATION,0.99999
GOBP_REGULATION_OF_NEUTROPHI...5,SET,5,-0.47739,-0.0078769,0.38569,0.89209,GOBP_REGULATION_OF_NEUTROPHIL_MEDIATED_CYTOTOXICITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...381,SET,127,-0.089075,-0.0073825,0.071959,0.89211,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,0.99999
GOMF_ADRENERGIC_RECEPTOR_BIN...,SET,16,-0.27141,-0.0080085,0.21923,0.89214,GOMF_ADRENERGIC_RECEPTOR_BINDING,0.99999
COATES_MACROPHAGE_M1_VS_M2_DN,SET,75,-0.123,-0.0078452,0.099324,0.89221,COATES_MACROPHAGE_M1_VS_M2_DN,0.99999
chr14q22,SET,43,-0.33793,-0.016335,0.27284,0.89224,chr14q22,0.99999
GTATTAT_MIR3693P,SET,192,-0.080671,-0.0082061,0.065075,0.89244,GTATTAT_MIR3693P,0.99999
GOBP_MITOCHONDRIAL_DNA_METAB...,SET,21,-0.20615,-0.0069677,0.1663,0.89244,GOBP_MITOCHONDRIAL_DNA_METABOLIC_PROCESS,0.99999
GNF2_TNFSF10,SET,30,-0.18954,-0.0076553,0.15289,0.89246,GNF2_TNFSF10,0.99999
GOBP_NEGATIVE_REGULATION_OF_...245,SET,4,-0.57171,-0.0084375,0.46108,0.89249,GOBP_NEGATIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,0.99999
GOBP_HEPOXILIN_METABOLIC_PRO...,SET,7,-0.4688,-0.0091518,0.37805,0.89251,GOBP_HEPOXILIN_METABOLIC_PROCESS,0.99999
GSE21546_ELK1_KO_VS_SAP1A_KO...1,SET,187,-0.075859,-0.0076165,0.061175,0.89251,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.99999
JEON_SMAD6_TARGETS_UP,SET,23,-0.25122,-0.0088858,0.20256,0.89255,JEON_SMAD6_TARGETS_UP,0.99999
REPIN1_TARGET_GENES,SET,5,-0.52367,-0.0086404,0.4222,0.89256,REPIN1_TARGET_GENES,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...15,SET,174,-0.084503,-0.0081871,0.068119,0.8926,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN,0.99999
AAANWWTGC_UNKNOWN,SET,183,-0.079337,-0.0078809,0.063934,0.89267,AAANWWTGC_UNKNOWN,0.99999
STONER_ESOPHAGEAL_CARCINOGEN...1,SET,6,-0.41544,-0.0075086,0.33455,0.89283,STONER_ESOPHAGEAL_CARCINOGENESIS_DN,0.99999
GSE13493_DP_VS_CD8POS_THYMOC...1,SET,180,-0.074445,-0.0073347,0.05995,0.89283,GSE13493_DP_VS_CD8POS_THYMOCYTE_DN,0.99999
GSE37532_WT_VS_PPARG_KO_LN_T...4,SET,156,-0.079664,-0.0073118,0.064153,0.89283,GSE37532_WT_VS_PPARG_KO_LN_TREG_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...327,SET,23,-0.23512,-0.0083165,0.18932,0.89286,GOBP_POSITIVE_REGULATION_OF_HEART_RATE,0.99999
KAECH_DAY8_EFF_VS_MEMORY_CD8...1,SET,184,-0.076475,-0.0076172,0.061575,0.89287,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN,0.99999
GOBP_MICROTUBULE_DEPOLYMERIZ...,SET,41,-0.15241,-0.0071942,0.12269,0.89293,GOBP_MICROTUBULE_DEPOLYMERIZATION,0.99999
HP_ADRENOCORTICOTROPIN_DEFIC...,SET,6,-0.42028,-0.0075962,0.3383,0.89293,HP_ADRENOCORTICOTROPIN_DEFICIENT_ADRENAL_INSUFFICIENCY,0.99999
YBX3_TARGET_GENES,SET,52,-0.14222,-0.0075577,0.11448,0.89294,YBX3_TARGET_GENES,0.99999
GOBP_CEMENTUM_MINERALIZATION,SET,5,-0.50047,-0.0082577,0.40279,0.89297,GOBP_CEMENTUM_MINERALIZATION,0.99999
HP_LARGE_CAFE_AU_LAIT_MACULE...,SET,6,-0.42617,-0.0077025,0.34291,0.89302,HP_LARGE_CAFE_AU_LAIT_MACULES_WITH_IRREGULAR_MARGINS,0.99999
PID_MYC_ACTIV_PATHWAY,SET,77,-0.12204,-0.0078867,0.098198,0.89303,PID_MYC_ACTIV_PATHWAY,0.99999
GSE7831_UNSTIM_VS_INFLUENZA_...4,SET,184,-0.077636,-0.0077328,0.062457,0.89306,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_UP,0.99999
HP_ABNORMAL_URINARY_COLOR,SET,18,-0.23112,-0.007233,0.18593,0.89307,HP_ABNORMAL_URINARY_COLOR,0.99999
KEGG_MEDICUS_REFERENCE_NRG_E...,SET,11,-0.29609,-0.007245,0.23815,0.89311,KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,0.99999
GOCC_SAGA_TYPE_COMPLEX,SET,33,-0.15754,-0.0066727,0.12671,0.89311,GOCC_SAGA_TYPE_COMPLEX,0.99999
RUVBL1_TARGET_GENES,SET,126,-0.093724,-0.0077374,0.075371,0.89315,RUVBL1_TARGET_GENES,0.99999
MARIADASON_RESPONSE_TO_BUTYR...4,SET,16,-0.25889,-0.007639,0.20818,0.89317,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4,0.99999
MIR4267,SET,203,-0.073361,-0.007671,0.058982,0.8932,MIR4267,0.99999
GOCC_MICROVILLUS,SET,94,-0.10816,-0.0077191,0.086949,0.89323,GOCC_MICROVILLUS,0.99999
MIR548AI_MIR570_5P,SET,161,-0.082616,-0.0077023,0.066411,0.89324,MIR548AI_MIR570_5P,0.99999
REACTOME_SIGNALING_BY_MEMBRA...,SET,5,-0.45917,-0.0075762,0.36903,0.89329,REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB,0.99999
GOBP_REGULATION_OF_GAP_JUNCT...,SET,9,-0.4086,-0.0090442,0.32828,0.89336,GOBP_REGULATION_OF_GAP_JUNCTION_ASSEMBLY,0.99999
GOBP_REGULATION_OF_ANIMAL_OR...1,SET,26,-0.23371,-0.0087885,0.18771,0.89344,GOBP_REGULATION_OF_ANIMAL_ORGAN_FORMATION,0.99999
GOBP_PIGMENT_METABOLIC_PROCE...,SET,72,-0.12698,-0.007936,0.10198,0.89345,GOBP_PIGMENT_METABOLIC_PROCESS,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...10,SET,48,-0.17162,-0.0087634,0.13781,0.89348,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN,0.99999
PID_DELTA_NP63_PATHWAY,SET,43,-0.16556,-0.0080024,0.13293,0.8935,PID_DELTA_NP63_PATHWAY,0.99999
MIR4645_3P,SET,102,-0.10438,-0.0077584,0.083772,0.89362,MIR4645_3P,0.99999
GOBP_ENTRY_OF_BACTERIUM_INTO...,SET,9,-0.33134,-0.007334,0.26582,0.8937,GOBP_ENTRY_OF_BACTERIUM_INTO_HOST_CELL,0.99999
GOBP_NEGATIVE_REGULATION_OF_...543,SET,193,-0.077669,-0.007921,0.06231,0.8937,GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS,0.99999
GNF2_SERPINB5,SET,27,-0.21147,-0.0081035,0.16964,0.89372,GNF2_SERPINB5,0.99999
GOBP_REGULATION_OF_SKELETAL_...2,SET,11,-0.31256,-0.0076481,0.2507,0.89375,GOBP_REGULATION_OF_SKELETAL_MUSCLE_ADAPTATION,0.99999
GSE30962_ACUTE_VS_CHRONIC_LC...4,SET,180,-0.07726,-0.0076121,0.061964,0.89377,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP,0.99999
PAX4_04,SET,195,-0.078159,-0.0080118,0.062677,0.89379,PAX4_04,0.99999
BERENJENO_TRANSFORMED_BY_RHO...6,SET,496,-0.046054,-0.0074665,0.036929,0.89381,BERENJENO_TRANSFORMED_BY_RHOA_UP,0.99999
CTATGCA_MIR153,SET,203,-0.07521,-0.0078643,0.060281,0.89391,CTATGCA_MIR153,0.99999
HP_MITRAL_VALVE_CALCIFICATION,SET,7,-0.42321,-0.0082618,0.33918,0.89393,HP_MITRAL_VALVE_CALCIFICATION,0.99999
HP_SCANNING_SPEECH,SET,14,-0.30916,-0.0085336,0.24776,0.89395,HP_SCANNING_SPEECH,0.99999
LTE2_UP.V1_DN,SET,172,-0.085845,-0.0082696,0.068788,0.89397,LTE2_UP.V1_DN,0.99999
HP_BAND_KERATOPATHY,SET,14,-0.32068,-0.0088516,0.25684,0.89407,HP_BAND_KERATOPATHY,0.99999
GAVIN_FOXP3_TARGETS_CLUSTER_...6,SET,82,-0.11649,-0.0077673,0.093289,0.8941,GAVIN_FOXP3_TARGETS_CLUSTER_T4,0.99999
AGGAGTG_MIR483,SET,54,-0.1415,-0.0076623,0.1133,0.89415,AGGAGTG_MIR483,0.99999
GOBP_REGULATION_OF_STRIATED_...1,SET,78,-0.12372,-0.0080469,0.099052,0.89417,GOBP_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,0.99999
WP_BASE_EXCISION_REPAIR,SET,30,-0.16946,-0.0068443,0.13564,0.89423,WP_BASE_EXCISION_REPAIR,0.99999
GSE8515_CTRL_VS_IL6_4H_STIM_...1,SET,170,-0.08361,-0.0080079,0.066918,0.89424,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...8,SET,180,-0.079651,-0.0078477,0.063729,0.89432,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP,0.99999
BOYERINAS_ONCOFETAL_TARGETS_...,SET,10,-0.35046,-0.0081765,0.28038,0.89433,BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1,0.99999
WP_FGF23_SIGNALING_IN_HYPOPH...,SET,22,-0.24123,-0.0083452,0.193,0.89433,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,0.99999
HP_HYPERPARATHYROIDISM,SET,28,-0.20866,-0.0081421,0.16692,0.89435,HP_HYPERPARATHYROIDISM,0.99999
chr11p14,SET,21,-0.38947,-0.013164,0.31154,0.89437,chr11p14,0.99999
MIR6516_3P,SET,126,-0.094526,-0.0078036,0.075611,0.89437,MIR6516_3P,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_MID...2,SET,136,-0.098835,-0.0084746,0.079055,0.89438,HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL,0.99999
GSE2770_TGFB_AND_IL4_ACT_VS_...3,SET,179,-0.078856,-0.0077479,0.063064,0.89442,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,0.99999
MIR520F_3P,SET,184,-0.077177,-0.0076871,0.061712,0.89445,MIR520F_3P,0.99999
KEGG_MEDICUS_REFERENCE_TLR7_...1,SET,16,-0.33292,-0.0098233,0.2662,0.89446,KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY,0.99999
GOMF_CO_RECEPTOR_BINDING,SET,13,-0.2768,-0.0073626,0.22132,0.89447,GOMF_CO_RECEPTOR_BINDING,0.99999
GSE9650_EXHAUSTED_VS_MEMORY_...2,SET,182,-0.080932,-0.0080176,0.064701,0.8945,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP,0.99999
XU_GH1_EXOGENOUS_TARGETS_UP,SET,48,-0.15399,-0.007863,0.1231,0.89451,XU_GH1_EXOGENOUS_TARGETS_UP,0.99999
GOBP_L_LEUCINE_CATABOLIC_PRO...,SET,6,-0.41326,-0.0074693,0.33029,0.89456,GOBP_L_LEUCINE_CATABOLIC_PROCESS,0.99999
REACTOME_DOPAMINE_RECEPTORS,SET,5,-0.54803,-0.0090423,0.43799,0.89457,REACTOME_DOPAMINE_RECEPTORS,0.99999
GOMF_DOPAMINE_NEUROTRANSMITT...,SET,5,-0.54803,-0.0090423,0.43799,0.89457,GOMF_DOPAMINE_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.99999
SMID_BREAST_CANCER_NORMAL_LI...1,SET,6,-0.4661,-0.0084243,0.37249,0.89458,SMID_BREAST_CANCER_NORMAL_LIKE_DN,0.99999
GSE13522_WT_VS_IFNAR_KO_SKIN...2,SET,187,-0.08083,-0.0081157,0.064562,0.8947,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,0.99999
GSE37533_PPARG2_FOXP3_VS_FOX...4,SET,175,-0.077584,-0.0075381,0.061966,0.89471,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,0.99999
HP_POPLITEAL_PTERYGIUM,SET,8,-0.41196,-0.0085972,0.32903,0.89472,HP_POPLITEAL_PTERYGIUM,0.99999
GSE36476_YOUNG_VS_OLD_DONOR_...3,SET,179,-0.074545,-0.0073244,0.059539,0.89472,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN,0.99999
GOBP_CARDIOLIPIN_BIOSYNTHETI...,SET,7,-0.41575,-0.0081161,0.33197,0.89477,GOBP_CARDIOLIPIN_BIOSYNTHETIC_PROCESS,0.99999
HP_TITUBATION,SET,29,-0.20413,-0.0081063,0.16299,0.89478,HP_TITUBATION,0.99999
GSE38304_MYC_NEG_VS_POS_GC_B...1,SET,182,-0.080276,-0.0079526,0.064082,0.89484,GSE38304_MYC_NEG_VS_POS_GC_BCELL_DN,0.99999
IWANAGA_CARCINOGENESIS_BY_KR...2,SET,333,-0.058763,-0.0078416,0.046907,0.89485,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,0.99999
chr2q11,SET,69,-0.29528,-0.018067,0.23568,0.89487,chr2q11,0.99999
WEBER_METHYLATED_HCP_IN_SPER...1,SET,28,-0.19511,-0.0076135,0.15571,0.8949,WEBER_METHYLATED_HCP_IN_SPERM_DN,0.99999
GOMF_BMP_RECEPTOR_ACTIVITY,SET,7,-0.47026,-0.0091803,0.37528,0.8949,GOMF_BMP_RECEPTOR_ACTIVITY,0.99999
MORF_FSHR,SET,244,-0.06939,-0.0079458,0.055371,0.89492,MORF_FSHR,0.99999
REACTOME_G_PROTEIN_MEDIATED_...,SET,52,-0.15662,-0.0083233,0.12497,0.89493,REACTOME_G_PROTEIN_MEDIATED_EVENTS,0.99999
GSE15930_NAIVE_VS_24H_IN_VIT...2,SET,187,-0.076622,-0.0076931,0.061134,0.89495,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP,0.99999
MIR4723_3P,SET,76,-0.11962,-0.0076798,0.095434,0.89496,MIR4723_3P,0.99999
PHESSE_TARGETS_OF_APC_AND_MB...1,SET,9,-0.39806,-0.0088108,0.31752,0.89501,PHESSE_TARGETS_OF_APC_AND_MBD2_DN,0.99999
GOBP_FATTY_ACID_TRANSPORT,SET,114,-0.10574,-0.0083063,0.084348,0.89501,GOBP_FATTY_ACID_TRANSPORT,0.99999
REACTOME_COLLAGEN_DEGRADATION,SET,61,-0.1465,-0.0084302,0.11681,0.8951,REACTOME_COLLAGEN_DEGRADATION,0.99999
GSE21927_SPLEEN_VS_TUMOR_MON...3,SET,149,-0.088103,-0.0079043,0.070228,0.89517,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_DN,0.99999
WP_ENVELOPE_PROTEINS_AND_THE...,SET,43,-0.16801,-0.0081209,0.13391,0.89519,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...630,SET,31,-0.17216,-0.007068,0.13722,0.89519,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE,0.99999
HP_ABNORMAL_CEREBRAL_VENTRIC...,SET,816,-0.037165,-0.0076588,0.029618,0.89522,HP_ABNORMAL_CEREBRAL_VENTRICLE_MORPHOLOGY,0.99999
LI_PBMC_MENOMUNE_A_C_Y_W_135...3,SET,19,-0.2616,-0.008411,0.20842,0.89529,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_NEGATIVE,0.99999
HP_CENTRAL_HYPOTHYROIDISM,SET,63,-0.13553,-0.0079254,0.10797,0.89531,HP_CENTRAL_HYPOTHYROIDISM,0.99999
KEGG_STARCH_AND_SUCROSE_META...,SET,45,-0.17956,-0.0088783,0.14301,0.89535,KEGG_STARCH_AND_SUCROSE_METABOLISM,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...13,SET,10,-0.35782,-0.0083484,0.28496,0.89538,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN,0.99999
MIR24_1_5P_MIR24_2_5P,SET,42,-0.15846,-0.0075701,0.12617,0.89542,MIR24_1_5P_MIR24_2_5P,0.99999
HP_ABNORMAL_HAIR_WHORL,SET,27,-0.21705,-0.008317,0.17281,0.89543,HP_ABNORMAL_HAIR_WHORL,0.99999
HP_PROGRESSIVE_MACROCEPHALY,SET,7,-0.39487,-0.0077085,0.3144,0.89543,HP_PROGRESSIVE_MACROCEPHALY,0.99999
GSE10856_CTRL_VS_TNFRSF6B_IN...1,SET,164,-0.078126,-0.0073506,0.062198,0.89545,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN,0.99999
GSE21033_1H_VS_24H_POLYIC_ST...2,SET,154,-0.086375,-0.0078772,0.068766,0.89545,GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP,0.99999
MIR548AU_3P,SET,157,-0.083595,-0.0076969,0.066548,0.89546,MIR548AU_3P,0.99999
GOBP_CHLORIDE_TRANSPORT,SET,113,-0.10559,-0.0082581,0.084059,0.89546,GOBP_CHLORIDE_TRANSPORT,0.99999
NOTCH_DN.V1_DN,SET,161,-0.085824,-0.0080013,0.068324,0.89546,NOTCH_DN.V1_DN,0.99999
GSE19401_UNSTIM_VS_RETINOIC_...2,SET,177,-0.075291,-0.0073566,0.059922,0.89552,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...319,SET,509,-0.047465,-0.0077925,0.03777,0.89555,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,0.99999
GOBP_CARTILAGE_MORPHOGENESIS,SET,9,-0.41228,-0.0091256,0.32801,0.8956,GOBP_CARTILAGE_MORPHOGENESIS,0.99999
GOBP_RESPONSE_TO_CHEMOKINE,SET,91,-0.1309,-0.0091924,0.10414,0.89561,GOBP_RESPONSE_TO_CHEMOKINE,0.99999
GOBP_CELLULAR_RESPONSE_TO_HY...2,SET,9,-0.39327,-0.0087048,0.31283,0.89564,GOBP_CELLULAR_RESPONSE_TO_HYDROPEROXIDE,0.99999
chr15q12,SET,4,-0.64113,-0.0094619,0.50995,0.89566,chr15q12,0.99999
RAMJAUN_APOPTOSIS_BY_TGFB1_V...4,SET,10,-0.32179,-0.0075077,0.25594,0.89566,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...422,SET,35,-0.19216,-0.0083819,0.15281,0.89572,GOBP_POSITIVE_REGULATION_OF_LYASE_ACTIVITY,0.99999
ZNF711_TARGET_GENES,SET,1382,-0.029079,-0.0076718,0.023121,0.89574,ZNF711_TARGET_GENES,0.99999
HP_ABNORMALLY_LOW_PITCHED_VO...,SET,10,-0.32914,-0.0076792,0.2617,0.89574,HP_ABNORMALLY_LOW_PITCHED_VOICE,0.99999
GOBP_REGULATION_OF_TRANS_SYN...,SET,446,-0.052105,-0.0080216,0.041426,0.89576,GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...6,SET,9,-0.35295,-0.0078122,0.28055,0.89581,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY,0.99999
GSE9650_GP33_VS_GP276_LCMV_S...2,SET,179,-0.081431,-0.0080009,0.064726,0.89581,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP,0.99999
KEGG_MATURITY_ONSET_DIABETES...,SET,25,-0.23951,-0.0088318,0.19032,0.89588,KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,0.99999
MODULE_300,SET,33,-0.18404,-0.0077954,0.14622,0.89592,MODULE_300,0.99999
GSE32255_WT_VS_JMJD2D_KNOCKD...1,SET,129,-0.090606,-0.0075678,0.071977,0.89594,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,0.99999
GOBP_LONG_CHAIN_FATTY_ACYL_C...1,SET,18,-0.27559,-0.0086245,0.21892,0.89595,GOBP_LONG_CHAIN_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS,0.99999
GOBP_SCHWANN_CELL_PROLIFERAT...,SET,9,-0.31141,-0.0068929,0.24736,0.89597,GOBP_SCHWANN_CELL_PROLIFERATION,0.99999
LANDIS_ERBB2_BREAST_TUMORS_3...2,SET,140,-0.090335,-0.0078579,0.07173,0.89604,LANDIS_ERBB2_BREAST_TUMORS_324_UP,0.99999
HP_ATRIOVENTRICULAR_CANAL_DE...,SET,52,-0.13784,-0.0073253,0.10946,0.89604,HP_ATRIOVENTRICULAR_CANAL_DEFECT,0.99999
HP_DECEREBRATE_RIGIDITY,SET,5,-0.47083,-0.0077687,0.37377,0.8961,HP_DECEREBRATE_RIGIDITY,0.99999
GOBP_REGULATION_OF_ENDOCYTOS...,SET,266,-0.065732,-0.0078541,0.052178,0.89611,GOBP_REGULATION_OF_ENDOCYTOSIS,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...18,SET,69,-0.12264,-0.0075039,0.09735,0.89612,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,0.99999
REACTOME_TNFR2_NON_CANONICAL...,SET,94,-0.10764,-0.0076823,0.085446,0.89612,REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,0.99999
HP_DYSOSTOSIS_MULTIPLEX,SET,21,-0.21919,-0.0074084,0.17397,0.89615,HP_DYSOSTOSIS_MULTIPLEX,0.99999
MIR3662,SET,850,-0.037978,-0.0079799,0.03014,0.89616,MIR3662,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...71,SET,6,-0.41438,-0.0074896,0.32885,0.89617,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_DJ1_TO_FAS_JNK_SIGNALING_PATWHAY,0.99999
MIR6769B_3P,SET,76,-0.1203,-0.0077234,0.095449,0.89621,MIR6769B_3P,0.99999
GOBP_VESICLE_TRANSPORT_ALONG...1,SET,8,-0.34782,-0.0072586,0.27597,0.89621,GOBP_VESICLE_TRANSPORT_ALONG_ACTIN_FILAMENT,0.99999
GOCC_TRANSFERASE_COMPLEX,SET,758,-0.037228,-0.0074064,0.029535,0.89624,GOCC_TRANSFERASE_COMPLEX,0.99999
GOMF_N_ACYLTRANSFERASE_ACTIV...,SET,79,-0.11311,-0.0074031,0.089733,0.89624,GOMF_N_ACYLTRANSFERASE_ACTIVITY,0.99999
TUBG1_TARGET_GENES,SET,2,-0.49491,-0.005165,0.3926,0.89626,TUBG1_TARGET_GENES,0.99999
MIR4735_5P,SET,170,-0.081011,-0.0077589,0.064258,0.89629,MIR4735_5P,0.99999
GOMF_ALPHA_KETOGLUTARATE_TRA...,SET,6,-0.42107,-0.0076104,0.33398,0.89629,GOMF_ALPHA_KETOGLUTARATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE25123_CTRL_VS_IL4_AND_ROS...4,SET,177,-0.08189,-0.0080014,0.064953,0.89629,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,0.99999
REACTOME_FORMATION_OF_THE_NE...,SET,17,-0.29129,-0.0088594,0.23103,0.89631,REACTOME_FORMATION_OF_THE_NEPHRIC_DUCT,0.99999
GOLUB_ALL_VS_AML_UP,SET,24,-0.22213,-0.0080255,0.17614,0.89635,GOLUB_ALL_VS_AML_UP,0.99999
MIR670_5P,SET,230,-0.069818,-0.007765,0.055349,0.89641,MIR670_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...284,SET,5,-0.48512,-0.0080044,0.38458,0.89642,GOBP_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...241,SET,3,-0.68047,-0.0086973,0.53929,0.89648,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_PRODUCTION,0.99999
TRAVAGLINI_LUNG_LYMPHATIC_CE...,SET,191,-0.082917,-0.0084129,0.065699,0.89653,TRAVAGLINI_LUNG_LYMPHATIC_CELL,0.99999
HP_ELEVATED_URINARY_HOMOVANI...,SET,9,-0.41165,-0.0091115,0.3261,0.89657,HP_ELEVATED_URINARY_HOMOVANILLIC_ACID,0.99999
GOBP_APOPTOTIC_PROCESS_INVOL...3,SET,23,-0.25248,-0.0089302,0.19999,0.8966,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,0.99999
GOBP_CIRCADIAN_REGULATION_OF...,SET,61,-0.14065,-0.0080935,0.1114,0.89662,GOBP_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION,0.99999
LIU_LIVER_CANCER,SET,29,-0.19293,-0.0076616,0.1528,0.89663,LIU_LIVER_CANCER,0.99999
GOBP_PROTEIN_O_LINKED_MANNOS...,SET,14,-0.2674,-0.0073811,0.21176,0.89666,GOBP_PROTEIN_O_LINKED_MANNOSYLATION,0.99999
REACTOME_ADHERENS_JUNCTIONS_...,SET,51,-0.16365,-0.0086131,0.12959,0.89667,REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,0.99999
GOBP_POSITIVE_REGULATION_OF_...170,SET,16,-0.29225,-0.0086233,0.23138,0.89671,GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM,0.99999
KEGG_MEDICUS_REFERENCE_MANNO...2,SET,5,-0.39883,-0.0065805,0.31568,0.89676,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_POMT_TO_POMK,0.99999
GOBP_POSITIVE_REGULATION_OF_...749,SET,11,-0.32092,-0.0078525,0.254,0.89678,GOBP_POSITIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
GOMF_2_ACYLGLYCEROL_3_PHOSPH...,SET,8,-0.41178,-0.0085935,0.32591,0.89678,GOMF_2_ACYLGLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY,0.99999
GOBP_INDOLE_CONTAINING_COMPO...2,SET,9,-0.42051,-0.0093077,0.33281,0.89679,GOBP_INDOLE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
GOMF_MELANOCORTIN_RECEPTOR_A...,SET,6,-0.48918,-0.0088415,0.38711,0.89682,GOMF_MELANOCORTIN_RECEPTOR_ACTIVITY,0.99999
MIR331_5P,SET,66,-0.12662,-0.0075779,0.1002,0.89683,MIR331_5P,0.99999
MIR7161_3P,SET,77,-0.12174,-0.0078673,0.096329,0.89684,MIR7161_3P,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...14,SET,8,-0.39734,-0.0082921,0.31428,0.89693,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN,0.99999
MIR6832_3P,SET,233,-0.070758,-0.0079201,0.055926,0.8971,MIR6832_3P,0.99999
MIR212_5P,SET,86,-0.11486,-0.0078427,0.090761,0.89716,MIR212_5P,0.99999
GOBP_GLYCOLIPID_CATABOLIC_PR...,SET,20,-0.24617,-0.0081201,0.19451,0.89716,GOBP_GLYCOLIPID_CATABOLIC_PROCESS,0.99999
HP_ATTENUATION_OF_RETINAL_BL...,SET,118,-0.097889,-0.0078221,0.077324,0.89723,HP_ATTENUATION_OF_RETINAL_BLOOD_VESSELS,0.99999
HP_PLACENTAL_ABRUPTION,SET,4,-0.63878,-0.0094273,0.50444,0.89729,HP_PLACENTAL_ABRUPTION,0.99999
GOBP_GROWTH_HORMONE_SECRETION,SET,12,-0.32821,-0.008388,0.25912,0.89735,GOBP_GROWTH_HORMONE_SECRETION,0.99999
REACTOME_CELLULAR_SENESCENCE,SET,123,-0.094599,-0.0077167,0.074661,0.89742,REACTOME_CELLULAR_SENESCENCE,0.99999
GOBP_REGULATION_OF_OXIDATIVE...1,SET,19,-0.2338,-0.0075169,0.1845,0.89745,GOBP_REGULATION_OF_OXIDATIVE_PHOSPHORYLATION,0.99999
WP_ETHANOL_EFFECTS_ON_HISTON...,SET,29,-0.19224,-0.0076339,0.15169,0.89747,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,0.99999
HP_FEEDING_DIFFICULTIES,SET,1009,-0.03318,-0.0075613,0.026181,0.89747,HP_FEEDING_DIFFICULTIES,0.99999
REACTOME_INSULIN_RECEPTOR_SI...,SET,53,-0.15022,-0.008059,0.11848,0.89757,REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,0.99999
GSE8921_UNSTIM_0H_VS_TLR1_2_...1,SET,185,-0.077555,-0.0077455,0.061166,0.89758,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN,0.99999
ELVIDGE_HIF1A_TARGETS_DN,SET,81,-0.11782,-0.0078082,0.09292,0.89759,ELVIDGE_HIF1A_TARGETS_DN,0.99999
GSE17721_0.5H_VS_8H_PAM3CSK4...1,SET,185,-0.075133,-0.0075036,0.059253,0.89759,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_DN,0.99999
ZNF579_TARGET_GENES,SET,611,-0.043312,-0.0077685,0.034157,0.8976,ZNF579_TARGET_GENES,0.99999
HP_PALATE_FISTULA,SET,12,-0.33637,-0.0085965,0.26527,0.8976,HP_PALATE_FISTULA,0.99999
GOBP_POSITIVE_REGULATION_OF_...596,SET,5,-0.48493,-0.0080012,0.38237,0.89763,GOBP_POSITIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
NAKAYA_PBMC_FLUARIX_FLUVIRIN...6,SET,379,-0.055283,-0.0078602,0.043583,0.89767,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE,0.99999
MIR513A_3P_MIR513C_3P,SET,409,-0.053565,-0.007905,0.042222,0.89771,MIR513A_3P_MIR513C_3P,0.99999
WP_REGULATION_OF_APOPTOSIS_B...,SET,24,-0.2114,-0.0076379,0.16656,0.89781,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,0.99999
WANG_IMMORTALIZED_BY_HOXA9_A...1,SET,24,-0.23771,-0.0085887,0.18728,0.89782,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,0.99999
MIR6818_5P,SET,100,-0.11152,-0.0082073,0.087853,0.89783,MIR6818_5P,0.99999
MODULE_294,SET,18,-0.22472,-0.0070326,0.17702,0.89786,MODULE_294,0.99999
GOBP_MONOSACCHARIDE_METABOLI...,SET,226,-0.06911,-0.00762,0.054435,0.89788,GOBP_MONOSACCHARIDE_METABOLIC_PROCESS,0.99999
GOBP_LOBAR_BRONCHUS_DEVELOPM...,SET,6,-0.49947,-0.0090275,0.39331,0.89793,GOBP_LOBAR_BRONCHUS_DEVELOPMENT,0.99999
GSE36009_UNSTIM_VS_LPS_STIM_...1,SET,180,-0.076241,-0.0075117,0.060035,0.89794,GSE36009_UNSTIM_VS_LPS_STIM_DC_DN,0.99999
GOBP_TETRAHYDROFOLATE_METABO...,SET,17,-0.23332,-0.0070962,0.18369,0.89798,GOBP_TETRAHYDROFOLATE_METABOLIC_PROCESS,0.99999
WP_CELL_INTERACTIONS_OF_THE_...,SET,23,-0.25001,-0.0088432,0.19677,0.89805,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,0.99999
MIR877_5P,SET,75,-0.12282,-0.0078337,0.096662,0.89806,MIR877_5P,0.99999
GOCC_TORC2_COMPLEX,SET,9,-0.36922,-0.0081725,0.29057,0.89807,GOCC_TORC2_COMPLEX,0.99999
MIR4791,SET,58,-0.13702,-0.0076886,0.10781,0.89811,MIR4791,0.99999
HP_CERVICAL_SPINE_INSTABILITY,SET,8,-0.43594,-0.0090977,0.343,0.89812,HP_CERVICAL_SPINE_INSTABILITY,0.99999
GSE13762_CTRL_VS_125_VITAMIN...1,SET,120,-0.096096,-0.0077433,0.075608,0.89812,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN,0.99999
GSE5679_RARA_AGONIST_AM580_V...1,SET,181,-0.081437,-0.0080457,0.064055,0.89819,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN,0.99999
GOBP_DELAMINATION,SET,7,-0.36232,-0.0070731,0.28497,0.8982,GOBP_DELAMINATION,0.99999
GOBP_REGULATION_OF_AUTOPHAGO...1,SET,43,-0.15828,-0.007651,0.12448,0.89823,GOBP_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,0.99999
HAY_BONE_MARROW_CD8_T_CELL,SET,61,-0.14318,-0.008239,0.1126,0.89824,HAY_BONE_MARROW_CD8_T_CELL,0.99999
GOBP_CATECHOLAMINE_TRANSPORT,SET,61,-0.143,-0.0082288,0.11245,0.89825,GOBP_CATECHOLAMINE_TRANSPORT,0.99999
GOBP_MITOCHONDRION_ORGANIZAT...,SET,441,-0.049248,-0.0075401,0.038717,0.8983,GOBP_MITOCHONDRION_ORGANIZATION,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_T...1,SET,17,-0.25864,-0.0078663,0.20331,0.89833,GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
MODULE_76,SET,78,-0.13695,-0.0089073,0.10765,0.89834,MODULE_76,0.99999
GOBP_ACTIVATION_OF_NF_KAPPAB...,SET,10,-0.36225,-0.0084516,0.28467,0.89839,GOBP_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY,0.99999
GOMF_MORPHOGEN_ACTIVITY,SET,6,-0.45551,-0.008233,0.35789,0.89844,GOMF_MORPHOGEN_ACTIVITY,0.99999
GSE17721_CTRL_VS_POLYIC_8H_B...2,SET,177,-0.075357,-0.0073631,0.059208,0.89844,GSE17721_CTRL_VS_POLYIC_8H_BMDC_UP,0.99999
GSE16522_MEMORY_VS_NAIVE_CD8...2,SET,170,-0.077468,-0.0074196,0.060863,0.89845,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.99999
GOBP_ENDOPLASMIC_RETICULUM_M...,SET,11,-0.27049,-0.0066185,0.21248,0.89848,GOBP_ENDOPLASMIC_RETICULUM_MEMBRANE_ORGANIZATION,0.99999
GSE37605_TREG_VS_TCONV_NOD_F...1,SET,154,-0.087454,-0.0079755,0.068696,0.89849,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_DN,0.99999
BIOCARTA_CASPASE_PATHWAY,SET,21,-0.22785,-0.0077014,0.17896,0.89851,BIOCARTA_CASPASE_PATHWAY,0.99999
PID_THROMBIN_PAR4_PATHWAY,SET,15,-0.28949,-0.0082709,0.22727,0.89862,PID_THROMBIN_PAR4_PATHWAY,0.99999
GOMF_TFIID_CLASS_TRANSCRIPTI...,SET,10,-0.34287,-0.0079996,0.26918,0.89862,GOMF_TFIID_CLASS_TRANSCRIPTION_FACTOR_COMPLEX_BINDING,0.99999
BIOCARTA_CTL_PATHWAY,SET,13,-0.31412,-0.0083552,0.24659,0.89863,BIOCARTA_CTL_PATHWAY,0.99999
HP_TETRAPARESIS,SET,100,-0.10785,-0.0079379,0.08467,0.89863,HP_TETRAPARESIS,0.99999
PAX4_03,SET,234,-0.070757,-0.0079368,0.055523,0.89873,PAX4_03,0.99999
HP_THICK_EYEBROW,SET,134,-0.093076,-0.0079223,0.073021,0.89878,HP_THICK_EYEBROW,0.99999
GSE22886_TCELL_VS_BCELL_NAIV...1,SET,167,-0.086584,-0.0082198,0.06791,0.89883,GSE22886_TCELL_VS_BCELL_NAIVE_DN,0.99999
HP_SHORT_GREATER_SCIATIC_NOT...,SET,3,-0.69667,-0.0089043,0.54639,0.89884,HP_SHORT_GREATER_SCIATIC_NOTCH,0.99999
GOBP_POSITIVE_REGULATION_OF_...623,SET,39,-0.16861,-0.0077626,0.13224,0.89885,GOBP_POSITIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,0.99999
GARGALOVIC_RESPONSE_TO_OXIDI...17,SET,24,-0.23197,-0.0083813,0.18188,0.89891,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...369,SET,7,-0.36181,-0.0070631,0.28367,0.89892,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,0.99999
MIR5583_3P,SET,76,-0.12879,-0.0082685,0.10094,0.89899,MIR5583_3P,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...1,SET,45,-0.17025,-0.0084181,0.13343,0.89901,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CELL_CYCLE,0.99999
GSE32901_TH17_EMRICHED_VS_TH...2,SET,102,-0.11,-0.008176,0.086182,0.89908,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_UP,0.99999
GSE41867_NAIVE_VS_DAY15_LCMV...5,SET,177,-0.07668,-0.0074923,0.060071,0.8991,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN,0.99999
GENTILE_UV_RESPONSE_CLUSTER_...2,SET,37,-0.19098,-0.0085647,0.14961,0.89911,GENTILE_UV_RESPONSE_CLUSTER_D2,0.99999
GOBP_NEGATIVE_REGULATION_OF_...619,SET,136,-0.089174,-0.0076461,0.069852,0.89912,GOBP_NEGATIVE_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.99999
HP_THYROID_DYSGENESIS,SET,7,-0.46066,-0.0089928,0.36081,0.89914,HP_THYROID_DYSGENESIS,0.99999
HP_RENAL_HAMARTOMA,SET,7,-0.4088,-0.0079804,0.32016,0.89916,HP_RENAL_HAMARTOMA,0.99999
GSE2770_UNTREATED_VS_TGFB_AN...12,SET,183,-0.076903,-0.0076391,0.060229,0.89916,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP,0.99999
GSE40277_GATA1_AND_SATB1_TRA...2,SET,181,-0.078134,-0.0077193,0.061194,0.89916,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,0.99999
GGCAGAC_MIR346,SET,40,-0.17566,-0.0081897,0.13756,0.89917,GGCAGAC_MIR346,0.99999
GOBP_REGULATION_OF_PROSTATIC...,SET,5,-0.58115,-0.0095888,0.45509,0.89919,GOBP_REGULATION_OF_PROSTATIC_BUD_FORMATION,0.99999
HP_MACRODACTYLY,SET,4,-0.48133,-0.0071036,0.37685,0.89923,HP_MACRODACTYLY,0.99999
ZNF532_TARGET_GENES,SET,53,-0.14962,-0.0080271,0.11713,0.89926,ZNF532_TARGET_GENES,0.99999
MIR6506_5P,SET,93,-0.113,-0.0080221,0.088461,0.89927,MIR6506_5P,0.99999
GSE360_HIGH_VS_LOW_DOSE_B_MA...4,SET,177,-0.076869,-0.0075108,0.060169,0.89929,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP,0.99999
GSE30083_SP1_VS_SP2_THYMOCYT...1,SET,184,-0.082138,-0.0081812,0.06427,0.89937,GSE30083_SP1_VS_SP2_THYMOCYTE_DN,0.99999
ZNF416_TARGET_GENES,SET,4,-0.4914,-0.0072522,0.38442,0.89942,ZNF416_TARGET_GENES,0.99999
GOCC_CILIARY_MEMBRANE,SET,72,-0.12083,-0.0075514,0.094519,0.89942,GOCC_CILIARY_MEMBRANE,0.99999
HP_SPASTICITY,SET,776,-0.038092,-0.0076638,0.029798,0.89943,HP_SPASTICITY,0.99999
MIR5684,SET,35,-0.18481,-0.0080611,0.14448,0.89956,MIR5684,0.99999
GSE17721_LPS_VS_POLYIC_6H_BM...2,SET,182,-0.08199,-0.0081224,0.06409,0.89959,GSE17721_LPS_VS_POLYIC_6H_BMDC_UP,0.99999
REACTOME_G_ALPHA_S_SIGNALLIN...,SET,152,-0.094137,-0.0085296,0.07355,0.8997,REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,0.99999
GOMF_GUANYLYLTRANSFERASE_ACT...,SET,4,-0.49786,-0.0073475,0.38898,0.8997,GOMF_GUANYLYLTRANSFERASE_ACTIVITY,0.99999
GSE7509_FCGRIIB_VS_TNFA_IL1B...1,SET,131,-0.090892,-0.0076499,0.070983,0.8998,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...95,SET,92,-0.11839,-0.008359,0.092453,0.89981,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,0.99999
HP_ENTHESITIS,SET,10,-0.38964,-0.0090907,0.30423,0.89985,HP_ENTHESITIS,0.99999
HP_GONADOTROPIN_DEFICIENCY,SET,8,-0.41187,-0.0085953,0.32153,0.89989,HP_GONADOTROPIN_DEFICIENCY,0.99999
ACAWNRNSRCGG_UNKNOWN,SET,57,-0.13869,-0.0077153,0.10823,0.89996,ACAWNRNSRCGG_UNKNOWN,0.99999
GOBP_HEPARAN_SULFATE_PROTEOG...4,SET,8,-0.3809,-0.007949,0.2972,0.90001,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_CATABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_TRANSMISS...,SET,13,-0.31826,-0.0084656,0.24832,0.90002,GOBP_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...48,SET,6,-0.45798,-0.0082776,0.35729,0.90004,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY,0.99999
GOBP_NEPHRON_TUBULE_EPITHELI...,SET,13,-0.35386,-0.0094124,0.276,0.90008,GOBP_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
GOBP_RESPONSE_TO_IRON_II_ION,SET,6,-0.46056,-0.0083243,0.35919,0.90011,GOBP_RESPONSE_TO_IRON_II_ION,0.99999
HP_STUTTERING,SET,9,-0.35165,-0.0077836,0.27418,0.90017,HP_STUTTERING,0.99999
ZWANG_CLASS_1_TRANSIENTLY_IN...,SET,454,-0.052684,-0.0081813,0.041076,0.90018,ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF,0.99999
HP_ABNORMALITY_OF_THE_INCISOR,SET,93,-0.11206,-0.0079553,0.087364,0.9002,HP_ABNORMALITY_OF_THE_INCISOR,0.99999
GSE14308_TH2_VS_TH1_DN,SET,181,-0.078151,-0.007721,0.060915,0.90023,GSE14308_TH2_VS_TH1_DN,0.99999
GSE3982_DC_VS_TH2_DN,SET,178,-0.07822,-0.0076642,0.060959,0.90027,GSE3982_DC_VS_TH2_DN,0.99999
GOMF_ENDOPEPTIDASE_ACTIVATOR...,SET,17,-0.25721,-0.0078227,0.20037,0.90036,GOMF_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY,0.99999
GSE17721_CTRL_VS_LPS_2H_BMDC...2,SET,184,-0.07477,-0.0074473,0.058246,0.90036,GSE17721_CTRL_VS_LPS_2H_BMDC_UP,0.99999
GSE2770_IL4_ACT_VS_ACT_CD4_T...6,SET,171,-0.082247,-0.0079002,0.064061,0.9004,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,0.99999
GSE27786_NKTCELL_VS_MONO_MAC...1,SET,178,-0.082301,-0.008064,0.064102,0.9004,GSE27786_NKTCELL_VS_MONO_MAC_DN,0.99999
HP_VISUAL_AGNOSIA,SET,7,-0.35983,-0.0070246,0.28025,0.90041,HP_VISUAL_AGNOSIA,0.99999
KEGG_NITROGEN_METABOLISM,SET,21,-0.23882,-0.0080722,0.18588,0.90056,KEGG_NITROGEN_METABOLISM,0.99999
MODULE_465,SET,13,-0.31712,-0.0084351,0.24683,0.90056,MODULE_465,0.99999
REACTOME_CD163_MEDIATING_AN_...,SET,8,-0.38756,-0.0080879,0.30151,0.90066,REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...681,SET,8,-0.44076,-0.0091982,0.34281,0.90072,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.99999
GOBP_POSITIVE_REGULATION_OF_...159,SET,7,-0.45864,-0.0089534,0.35668,0.90074,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_STORAGE,0.99999
MIR4502,SET,68,-0.1269,-0.0077082,0.098683,0.90075,MIR4502,0.99999
GCM_DEAF1,SET,24,-0.20331,-0.0073456,0.1581,0.90076,GCM_DEAF1,0.99999
REACTOME_MEIOSIS,SET,56,-0.13788,-0.0076029,0.10721,0.90077,REACTOME_MEIOSIS,0.99999
GOBP_REGULATION_OF_BODY_FLUI...,SET,351,-0.061938,-0.0084815,0.048162,0.90077,GOBP_REGULATION_OF_BODY_FLUID_LEVELS,0.99999
KEGG_MEDICUS_REFERENCE_CDC25...,SET,9,-0.30386,-0.0067257,0.23623,0.90082,KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M,0.99999
GOBP_BASEMENT_MEMBRANE_ASSEM...,SET,9,-0.3234,-0.0071583,0.25141,0.90083,GOBP_BASEMENT_MEMBRANE_ASSEMBLY,0.99999
GOCC_OUTER_DENSE_FIBER,SET,4,-0.57952,-0.0085527,0.45042,0.90088,GOCC_OUTER_DENSE_FIBER,0.99999
GOBP_CELLULAR_RESPONSE_TO_DS...,SET,19,-0.25379,-0.0081597,0.19725,0.90089,GOBP_CELLULAR_RESPONSE_TO_DSRNA,0.99999
GSE42021_TREG_PLN_VS_TREG_PR...2,SET,175,-0.081868,-0.0079544,0.063625,0.9009,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP,0.99999
CARRILLOREIXACH_14Q32OVEREXP...,SET,2,-0.94352,-0.0098468,0.73311,0.90095,CARRILLOREIXACH_14Q32OVEREXPRESSION_IN_HEPATOBLASTOMA,0.99999
GSE1740_UNSTIM_VS_IFNA_STIMU...2,SET,154,-0.085151,-0.0077656,0.06616,0.90095,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_UP,0.99999
GSE37301_COMMON_LYMPHOID_PRO...2,SET,168,-0.080694,-0.0076834,0.062693,0.90097,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP,0.99999
CHOI_ATL_ACUTE_STAGE,SET,4,-0.56722,-0.0083711,0.44052,0.90105,CHOI_ATL_ACUTE_STAGE,0.99999
GOBP_CLEAVAGE_FURROW_FORMATI...,SET,7,-0.4716,-0.0092065,0.36626,0.90105,GOBP_CLEAVAGE_FURROW_FORMATION,0.99999
chr5p14,SET,5,-0.72436,-0.011952,0.56234,0.90114,chr5p14,0.99999
GOBP_METANEPHRIC_PROXIMAL_TU...,SET,5,-0.53791,-0.0088754,0.41753,0.90117,GOBP_METANEPHRIC_PROXIMAL_TUBULE_DEVELOPMENT,0.99999
GOBP_D_ASPARTATE_TRANSMEMBRA...,SET,5,-0.50122,-0.00827,0.38901,0.9012,GOBP_D_ASPARTATE_TRANSMEMBRANE_TRANSPORT,0.99999
MIR517_5P,SET,78,-0.12062,-0.007845,0.09361,0.90121,MIR517_5P,0.99999
GOCC_SAGA_COMPLEX,SET,21,-0.20156,-0.0068128,0.15642,0.90122,GOCC_SAGA_COMPLEX,0.99999
CAGGTCC_MIR492,SET,54,-0.14024,-0.0075943,0.10883,0.90124,CAGGTCC_MIR492,0.99999
GSE3982_MAST_CELL_VS_NEUTROP...1,SET,176,-0.082355,-0.0080243,0.063901,0.90125,GSE3982_MAST_CELL_VS_NEUTROPHIL_DN,0.99999
GOBP_CORNIFIED_ENVELOPE_ASSE...,SET,6,-0.40824,-0.0073785,0.31671,0.90129,GOBP_CORNIFIED_ENVELOPE_ASSEMBLY,0.99999
GOMF_DICARBOXYLIC_ACID_TRANS...,SET,30,-0.19672,-0.0079453,0.15257,0.90136,GOMF_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE5455_HEALTHY_VS_TUMOR_BEA...2,SET,176,-0.081656,-0.0079562,0.063327,0.90137,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_UP,0.99999
HP_MALNUTRITION,SET,41,-0.17371,-0.0081995,0.13467,0.90146,HP_MALNUTRITION,0.99999
REACTOME_VISUAL_PHOTOTRANSDU...,SET,88,-0.118,-0.0081496,0.091449,0.90153,REACTOME_VISUAL_PHOTOTRANSDUCTION,0.99999
HP_ATRESIA_OF_THE_EXTERNAL_A...,SET,45,-0.15977,-0.0079,0.12382,0.90153,HP_ATRESIA_OF_THE_EXTERNAL_AUDITORY_CANAL,0.99999
GOBP_REGULATION_OF_REMOVAL_O...,SET,6,-0.425,-0.0076815,0.32934,0.90155,GOBP_REGULATION_OF_REMOVAL_OF_SUPEROXIDE_RADICALS,0.99999
GSE30971_CTRL_VS_LPS_STIM_MA...5,SET,173,-0.082901,-0.008009,0.064234,0.90157,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_DN,0.99999
DOANE_BREAST_CANCER_CLASSES_...1,SET,32,-0.20909,-0.0087215,0.16197,0.90163,DOANE_BREAST_CANCER_CLASSES_DN,0.99999
NAM_FXYD5_TARGETS_DN,SET,17,-0.24951,-0.0075886,0.19325,0.90166,NAM_FXYD5_TARGETS_DN,0.99999
GOBP_INTRACELLULAR_SIGNALING...,SET,1727,-0.028168,-0.0082225,0.021817,0.90166,GOBP_INTRACELLULAR_SIGNALING_CASSETTE,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...10,SET,183,-0.076616,-0.0076106,0.059337,0.90167,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP,0.99999
CROONQUIST_NRAS_VS_STROMAL_S...2,SET,36,-0.17477,-0.0077312,0.13534,0.9017,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,0.99999
GOBP_MONOCARBOXYLIC_ACID_CAT...,SET,125,-0.095126,-0.0078221,0.073661,0.90171,GOBP_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS,0.99999
HP_BONE_MARROW_FOAM_CELLS,SET,5,-0.62225,-0.010267,0.48182,0.90172,HP_BONE_MARROW_FOAM_CELLS,0.99999
REACTOME_TRANSLOCATION_OF_SL...,SET,69,-0.12961,-0.0079305,0.10034,0.90177,REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_NKT...2,SET,8,-0.39731,-0.0082915,0.30758,0.90177,HE_LIM_SUN_FETAL_LUNG_C4_NKT2_CELL,0.99999
chr3p13,SET,10,-0.51492,-0.012014,0.39857,0.9018,chr3p13,0.99999
MEISSNER_BRAIN_ICP_WITH_H3K4...,SET,27,-0.19228,-0.0073679,0.14881,0.90183,MEISSNER_BRAIN_ICP_WITH_H3K4ME3,0.99999
MIR6126,SET,106,-0.10305,-0.007807,0.079747,0.90184,MIR6126,0.99999
BIOCARTA_P35ALZHEIMERS_PATHW...,SET,8,-0.4224,-0.0088152,0.32672,0.90196,BIOCARTA_P35ALZHEIMERS_PATHWAY,0.99999
HP_IMPAIRED_VISUOSPATIAL_CON...,SET,19,-0.2488,-0.0079993,0.19239,0.90202,HP_IMPAIRED_VISUOSPATIAL_CONSTRUCTIVE_COGNITION,0.99999
GSE5589_WT_VS_IL6_KO_LPS_STI...3,SET,182,-0.081654,-0.0080892,0.063135,0.90204,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...20,SET,47,-0.16385,-0.0082791,0.12666,0.90209,GAVISH_3CA_MALIGNANT_METAPROGRAM_29_NPC_OPC,0.99999
GOBP_NEGATIVE_REGULATION_OF_...93,SET,8,-0.41228,-0.0086039,0.31865,0.90213,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_EXTRAVASATION,0.99999
GOBP_MORPHOGENESIS_OF_A_BRAN...,SET,189,-0.085246,-0.0086042,0.06588,0.90215,GOBP_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,0.99999
REACTOME_SIGNALING_BY_NOTCH,SET,168,-0.079875,-0.0076054,0.061709,0.90223,REACTOME_SIGNALING_BY_NOTCH,0.99999
GOCC_SORTING_ENDOSOME,SET,6,-0.46177,-0.008346,0.35669,0.90226,GOCC_SORTING_ENDOSOME,0.99999
MIR340_3P,SET,44,-0.16012,-0.007829,0.12366,0.9023,MIR340_3P,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...13,SET,9,-0.33903,-0.0075043,0.26181,0.90233,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_LIPID_METABOLIC_PROCESS,SET,1263,-0.032277,-0.008169,0.024922,0.90235,GOBP_LIPID_METABOLIC_PROCESS,0.99999
HP_OPTIC_ATROPHY,SET,512,-0.047177,-0.0077673,0.036426,0.90236,HP_OPTIC_ATROPHY,0.99999
GOBP_PYRIMIDINE_CONTAINING_C...5,SET,16,-0.28569,-0.0084298,0.22054,0.9024,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT,0.99999
HP_TYPICAL_ABSENCE_SEIZURE,SET,37,-0.18547,-0.0083175,0.14318,0.9024,HP_TYPICAL_ABSENCE_SEIZURE,0.99999
PID_CASPASE_PATHWAY,SET,50,-0.15195,-0.0079185,0.11728,0.90244,PID_CASPASE_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...515,SET,8,-0.4009,-0.0083665,0.30938,0.90247,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION,0.99999
HP_HAPPY_DEMEANOR,SET,23,-0.27105,-0.0095873,0.20913,0.90252,HP_HAPPY_DEMEANOR,0.99999
HP_SECRETORY_DIARRHEA,SET,12,-0.2884,-0.0073705,0.2225,0.90254,HP_SECRETORY_DIARRHEA,0.99999
GSE13229_MATURE_VS_INTMATURE...1,SET,176,-0.08164,-0.0079546,0.06298,0.90255,GSE13229_MATURE_VS_INTMATURE_NKCELL_DN,0.99999
GAO_LARGE_INTESTINE_ADULT_CA...,SET,260,-0.07136,-0.0084313,0.055048,0.90256,GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS,0.99999
GOBP_FATTY_ACID_CATABOLIC_PR...,SET,101,-0.10366,-0.0076667,0.079952,0.90259,GOBP_FATTY_ACID_CATABOLIC_PROCESS,0.99999
GOBP_MACROPHAGE_COLONY_STIMU...1,SET,6,-0.45785,-0.0082753,0.35303,0.90266,GOBP_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,0.99999
GOBP_NEURON_CELLULAR_HOMEOST...,SET,58,-0.14174,-0.007954,0.10928,0.90268,GOBP_NEURON_CELLULAR_HOMEOSTASIS,0.99999
HP_ESODEVIATION,SET,200,-0.074564,-0.0077396,0.057479,0.90272,HP_ESODEVIATION,0.99999
GOBP_ASPARTATE_METABOLIC_PRO...,SET,6,-0.49115,-0.008877,0.37845,0.90281,GOBP_ASPARTATE_METABOLIC_PROCESS,0.99999
GSE1460_CD4_THYMOCYTE_VS_NAI...3,SET,176,-0.082065,-0.007996,0.063236,0.90281,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,0.99999
WP_GLYCOGEN_SYNTHESIS_AND_DE...,SET,35,-0.17705,-0.0077226,0.13639,0.90286,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,0.99999
GSE19923_WT_VS_HEB_KO_DP_THY...2,SET,183,-0.082183,-0.0081637,0.063302,0.9029,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP,0.99999
KEGG_APOPTOSIS,SET,81,-0.12344,-0.0081805,0.095071,0.90291,KEGG_APOPTOSIS,0.99999
KEGG_MEDICUS_VARIANT_BCR_ABL...1,SET,11,-0.32264,-0.0078947,0.24847,0.90293,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,0.99999
HP_PAPILLOMA,SET,46,-0.15053,-0.0075252,0.11589,0.90301,HP_PAPILLOMA,0.99999
ZHAN_MULTIPLE_MYELOMA_UP,SET,47,-0.14383,-0.0072679,0.11072,0.90304,ZHAN_MULTIPLE_MYELOMA_UP,0.99999
MIR541_3P,SET,94,-0.11227,-0.0080123,0.08641,0.90306,MIR541_3P,0.99999
GOBP_LUNG_EPITHELIUM_DEVELOP...,SET,45,-0.17394,-0.0086005,0.13387,0.90307,GOBP_LUNG_EPITHELIUM_DEVELOPMENT,0.99999
WU_APOPTOSIS_BY_CDKN1A_NOT_V...,SET,9,-0.32993,-0.0073028,0.25388,0.90311,WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53,0.99999
MIR6732_3P,SET,87,-0.11351,-0.0077947,0.087342,0.90312,MIR6732_3P,0.99999
GSE23114_PERITONEAL_CAVITY_B...4,SET,164,-0.085212,-0.0080173,0.065555,0.90317,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_UP,0.99999
GNF2_RRM2,SET,38,-0.17834,-0.0081047,0.13717,0.90322,GNF2_RRM2,0.99999
HP_ABNORMALITY_OF_PRENATAL_D...,SET,881,-0.037271,-0.007966,0.028666,0.90322,HP_ABNORMALITY_OF_PRENATAL_DEVELOPMENT_OR_BIRTH,0.99999
GOBP_GASTRULATION,SET,177,-0.084412,-0.0082478,0.064904,0.90329,GOBP_GASTRULATION,0.99999
GOMF_C_X_C_CHEMOKINE_BINDING,SET,4,-0.52133,-0.007694,0.40081,0.90331,GOMF_C_X_C_CHEMOKINE_BINDING,0.99999
GSE2770_UNTREATED_VS_IL4_TRE...3,SET,173,-0.078678,-0.007601,0.060485,0.90333,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
KEGG_MEDICUS_REFERENCE_CA2_E...1,SET,12,-0.33523,-0.0085674,0.25769,0.90335,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL,0.99999
GOBP_CELL_CELL_JUNCTION_DISA...,SET,5,-0.59769,-0.0098618,0.45943,0.90335,GOBP_CELL_CELL_JUNCTION_DISASSEMBLY,0.99999
LI_ESTROGENE_MID_E2_RESPONSE...2,SET,14,-0.3074,-0.0084849,0.23627,0.90336,LI_ESTROGENE_MID_E2_RESPONSE_UP,0.99999
VALK_AML_CLUSTER_5,SET,28,-0.1993,-0.0077768,0.15316,0.9034,VALK_AML_CLUSTER_5,0.99999
MIR181B_2_3P_MIR181B_3P,SET,188,-0.078572,-0.0079098,0.060383,0.9034,MIR181B_2_3P_MIR181B_3P,0.99999
GOBP_SULFUR_COMPOUND_CATABOL...,SET,40,-0.17424,-0.0081238,0.13391,0.9034,GOBP_SULFUR_COMPOUND_CATABOLIC_PROCESS,0.99999
BUSSLINGER_ESOPHAGEAL_LATE_S...,SET,130,-0.1047,-0.0087783,0.080458,0.90341,BUSSLINGER_ESOPHAGEAL_LATE_SUPRABASAL_CELLS,0.99999
GOBP_REGULATION_OF_METANEPHR...,SET,5,-0.58557,-0.0096617,0.44991,0.90345,GOBP_REGULATION_OF_METANEPHROS_DEVELOPMENT,0.99999
HP_PROMINENT_ANTITRAGUS,SET,6,-0.43447,-0.0078527,0.33383,0.90345,HP_PROMINENT_ANTITRAGUS,0.99999
GOBP_ORGANIC_ACID_TRANSPORT,SET,330,-0.064008,-0.0085037,0.049176,0.90347,GOBP_ORGANIC_ACID_TRANSPORT,0.99999
ZHAN_MULTIPLE_MYELOMA_CD2_DN,SET,44,-0.1705,-0.0083366,0.13096,0.90352,ZHAN_MULTIPLE_MYELOMA_CD2_DN,0.99999
REACTOME_INTRA_GOLGI_AND_RET...,SET,194,-0.076046,-0.0077754,0.058412,0.90352,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,0.99999
MORF_BMPR2,SET,47,-0.17976,-0.0090833,0.13808,0.90352,MORF_BMPR2,0.99999
GOBP_REGULATION_OF_MITOCHOND...13,SET,5,-0.4128,-0.0068111,0.31697,0.90359,GOBP_REGULATION_OF_MITOCHONDRIAL_RNA_CATABOLIC_PROCESS,0.99999
MIR4789_5P,SET,350,-0.058958,-0.0080621,0.045267,0.90361,MIR4789_5P,0.99999
GOMF_PHOSPHOLIPASE_INHIBITOR...,SET,11,-0.36506,-0.0089327,0.28029,0.90361,GOMF_PHOSPHOLIPASE_INHIBITOR_ACTIVITY,0.99999
GOBP_LIGAND_GATED_ION_CHANNE...,SET,30,-0.21877,-0.0088357,0.16793,0.90366,GOBP_LIGAND_GATED_ION_CHANNEL_SIGNALING_PATHWAY,0.99999
DESCARTES_FETAL_MUSCLE_STROM...,SET,65,-0.15241,-0.0090519,0.11696,0.90372,DESCARTES_FETAL_MUSCLE_STROMAL_CELLS,0.99999
REACTOME_ACTIVATION_OF_CASPA...,SET,5,-0.44387,-0.0073238,0.3406,0.90374,REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE,0.99999
REACTOME_G_BETA_GAMMA_SIGNAL...2,SET,25,-0.22998,-0.0084804,0.17648,0.90374,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA,0.99999
MIF1_01,SET,163,-0.086247,-0.0080901,0.066179,0.90375,MIF1_01,0.99999
GSE3982_MAC_VS_TH2_DN,SET,187,-0.075801,-0.0076107,0.058159,0.90376,GSE3982_MAC_VS_TH2_DN,0.99999
MIR6529_3P,SET,80,-0.12904,-0.0084988,0.099,0.90377,MIR6529_3P,0.99999
GOBP_RESPONSE_TO_FLUID_SHEAR...,SET,33,-0.20943,-0.0088706,0.16067,0.90378,GOBP_RESPONSE_TO_FLUID_SHEAR_STRESS,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...11,SET,44,-0.17097,-0.0083592,0.13115,0.9038,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CELL_CYCLE,0.99999
GOBP_XENOBIOTIC_EXPORT_FROM_...,SET,13,-0.28051,-0.0074613,0.21518,0.9038,GOBP_XENOBIOTIC_EXPORT_FROM_CELL,0.99999
GSE27786_BCELL_VS_MONO_MAC_DN,SET,180,-0.080575,-0.0079387,0.061794,0.90386,GSE27786_BCELL_VS_MONO_MAC_DN,0.99999
WP_HFE_EFFECT_ON_HEPCIDIN_PR...,SET,6,-0.43418,-0.0078475,0.33291,0.90391,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,0.99999
HP_COGNITIVE_IMPAIRMENT,SET,876,-0.037596,-0.0080136,0.028826,0.90391,HP_COGNITIVE_IMPAIRMENT,0.99999
REACTOME_SMALL_INTERFERING_R...,SET,9,-0.37561,-0.008314,0.28791,0.90398,REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS,0.99999
GOBP_REGULATION_OF_SYSTEM_PR...,SET,509,-0.052104,-0.0085542,0.039932,0.90401,GOBP_REGULATION_OF_SYSTEM_PROCESS,0.99999
HP_ADRENOCORTICAL_CARCINOMA,SET,17,-0.27764,-0.0084442,0.21278,0.90401,HP_ADRENOCORTICAL_CARCINOMA,0.99999
DESCARTES_MAIN_FETAL_CCL19_C...,SET,157,-0.088943,-0.0081893,0.068166,0.90401,DESCARTES_MAIN_FETAL_CCL19_CCL21_POSITIVE_CELLS,0.99999
PDGF_UP.V1_UP,SET,133,-0.09464,-0.0080255,0.072526,0.90403,PDGF_UP.V1_UP,0.99999
HP_ABNORMAL_CHORIORETINAL_MO...,SET,135,-0.095901,-0.008193,0.073486,0.90405,HP_ABNORMAL_CHORIORETINAL_MORPHOLOGY,0.99999
GOBP_NEURON_FATE_SPECIFICATI...,SET,32,-0.21185,-0.0088364,0.16229,0.90411,GOBP_NEURON_FATE_SPECIFICATION,0.99999
MIR6824_5P,SET,73,-0.14414,-0.0090703,0.11041,0.90412,MIR6824_5P,0.99999
GOBP_REGULATION_OF_G_PROTEIN...,SET,133,-0.098573,-0.0083591,0.0755,0.90415,GOBP_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
ROVERSI_GLIOMA_COPY_NUMBER_UP,SET,80,-0.14982,-0.0098677,0.11473,0.90418,ROVERSI_GLIOMA_COPY_NUMBER_UP,0.99999
GSE45365_WT_VS_IFNAR_KO_CD8A...3,SET,186,-0.078242,-0.0078349,0.059917,0.90419,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP,0.99999
GOMF_ALCOHOL_DEHYDROGENASE_N...3,SET,24,-0.26403,-0.0095396,0.20216,0.90423,GOMF_ALCOHOL_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.99999
MORF_GMPS,SET,40,-0.15502,-0.0072277,0.11868,0.90425,MORF_GMPS,0.99999
WP_SYNAPTIC_VESICLE_PATHWAY,SET,49,-0.15766,-0.0081337,0.12058,0.90448,WP_SYNAPTIC_VESICLE_PATHWAY,0.99999
GSE29949_DC_BRAIN_VS_MONOCYT...2,SET,176,-0.081013,-0.0078935,0.06195,0.90451,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.99999
HP_NEOPLASM_OF_THE_SKIN,SET,198,-0.075914,-0.0078407,0.058043,0.90454,HP_NEOPLASM_OF_THE_SKIN,0.99999
REACTOME_CDH11_HOMOTYPIC_AND...,SET,7,-0.46871,-0.00915,0.35832,0.90457,REACTOME_CDH11_HOMOTYPIC_AND_HETEROTYPIC_INTERACTIONS,0.99999
MIR1266_3P,SET,48,-0.15619,-0.0079756,0.11941,0.90457,MIR1266_3P,0.99999
GSE21360_NAIVE_VS_TERTIARY_M...2,SET,168,-0.084723,-0.008067,0.064768,0.90457,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_UP,0.99999
GOBP_FATTY_ACID_DERIVATIVE_M...,SET,68,-0.13812,-0.0083898,0.10558,0.90459,GOBP_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS,0.99999
HP_ORAL_PHARYNGEAL_DYSPHAGIA,SET,39,-0.17855,-0.0082201,0.13648,0.90459,HP_ORAL_PHARYNGEAL_DYSPHAGIA,0.99999
GOBP_RESPONSE_TO_IONIZING_RA...,SET,129,-0.091611,-0.0076518,0.070021,0.90461,GOBP_RESPONSE_TO_IONIZING_RADIATION,0.99999
GSE41867_DAY6_VS_DAY8_LCMV_A...2,SET,175,-0.082845,-0.0080493,0.063318,0.90462,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...387,SET,10,-0.41128,-0.0095955,0.31428,0.90466,GOBP_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_VESICLE_TETHERING_INVOL...,SET,9,-0.33698,-0.0074589,0.25751,0.90466,GOBP_VESICLE_TETHERING_INVOLVED_IN_EXOCYTOSIS,0.99999
GOBP_MITOCHONDRIAL_DNA_REPLI...,SET,13,-0.26914,-0.0071589,0.20565,0.90468,GOBP_MITOCHONDRIAL_DNA_REPLICATION,0.99999
HINATA_NFKB_TARGETS_FIBROBLA...,SET,79,-0.12671,-0.0082933,0.096809,0.90469,HINATA_NFKB_TARGETS_FIBROBLAST_UP,0.99999
GSE3982_DC_VS_MAC_DN,SET,178,-0.08487,-0.0083157,0.064839,0.90471,GSE3982_DC_VS_MAC_DN,0.99999
GOBP_RETINA_MORPHOGENESIS_IN...,SET,62,-0.14775,-0.0085709,0.11287,0.90472,GOBP_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...353,SET,4,-0.63569,-0.0093817,0.48561,0.90473,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...479,SET,44,-0.17779,-0.0086929,0.1358,0.90475,GOBP_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION,0.99999
SESTO_RESPONSE_TO_UV_C5,SET,46,-0.16749,-0.0083729,0.12789,0.90482,SESTO_RESPONSE_TO_UV_C5,0.99999
ZNF582_TARGET_GENES,SET,51,-0.15209,-0.0080044,0.11613,0.90483,ZNF582_TARGET_GENES,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...23,SET,16,-0.2742,-0.0080909,0.20937,0.90484,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.99999
GOMF_CHEMOKINE_BINDING,SET,29,-0.22787,-0.0090489,0.17399,0.90484,GOMF_CHEMOKINE_BINDING,0.99999
MORF_TFDP2,SET,211,-0.075181,-0.0080129,0.0574,0.90485,MORF_TFDP2,0.99999
GOCC_SARCOPLASM,SET,92,-0.11359,-0.0080203,0.086726,0.90485,GOCC_SARCOPLASM,0.99999
chr2q34,SET,15,-0.51532,-0.014723,0.39342,0.90487,chr2q34,0.99999
HP_SPASTIC_DIPLEGIA,SET,29,-0.2042,-0.008109,0.15586,0.90492,HP_SPASTIC_DIPLEGIA,0.99999
HP_WIDELY_PATENT_FONTANELLES...,SET,15,-0.30118,-0.0086049,0.22985,0.90495,HP_WIDELY_PATENT_FONTANELLES_AND_SUTURES,0.99999
HP_ABNORMAL_TISSUE_ENZYME_CO...,SET,55,-0.14328,-0.0078303,0.10933,0.90499,HP_ABNORMAL_TISSUE_ENZYME_CONCENTRATION_OR_ACTIVITY,0.99999
MIR4764_5P,SET,67,-0.13504,-0.0081424,0.10298,0.9051,MIR4764_5P,0.99999
HP_OLIVOPONTOCEREBELLAR_ATRO...,SET,6,-0.41024,-0.0074148,0.31286,0.90511,HP_OLIVOPONTOCEREBELLAR_ATROPHY,0.99999
HP_LONG_UPPER_LIP,SET,6,-0.53125,-0.0096018,0.40513,0.90512,HP_LONG_UPPER_LIP,0.99999
KEGG_MEDICUS_VARIANT_EGFR_OV...,SET,10,-0.34942,-0.0081523,0.26636,0.9052,KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,0.99999
HP_DELAYED_CRANIAL_SUTURE_CL...,SET,87,-0.11719,-0.0080476,0.089331,0.9052,HP_DELAYED_CRANIAL_SUTURE_CLOSURE,0.99999
GOMF_S_ADENOSYL_L_METHIONINE...,SET,16,-0.2647,-0.0078106,0.20173,0.90526,GOMF_S_ADENOSYL_L_METHIONINE_BINDING,0.99999
HP_EXTRAHEPATIC_CHOLESTASIS,SET,10,-0.37238,-0.008688,0.28371,0.90532,HP_EXTRAHEPATIC_CHOLESTASIS,0.99999
GOMF_PHOSPHORIC_ESTER_HYDROL...,SET,318,-0.059973,-0.007824,0.04569,0.90533,GOMF_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY,0.99999
REACTOME_ION_TRANSPORT_BY_P_...,SET,51,-0.15675,-0.0082499,0.11942,0.90534,REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,0.99999
WEST_ADRENOCORTICAL_TUMOR_MA...2,SET,22,-0.26378,-0.0091253,0.20089,0.9054,WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP,0.99999
HP_SEA_BLUE_HISTIOCYTOSIS,SET,4,-0.70145,-0.010352,0.53422,0.90541,HP_SEA_BLUE_HISTIOCYTOSIS,0.99999
GSE3982_MAST_CELL_VS_EFF_MEM...1,SET,171,-0.084438,-0.0081107,0.064305,0.90542,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN,0.99999
KEGG_ECM_RECEPTOR_INTERACTION,SET,82,-0.12798,-0.0085332,0.097451,0.90544,KEGG_ECM_RECEPTOR_INTERACTION,0.99999
BIOCARTA_DNAFRAGMENT_PATHWAY,SET,10,-0.41263,-0.009627,0.31417,0.90546,BIOCARTA_DNAFRAGMENT_PATHWAY,0.99999
GSE20727_CTRL_VS_H2O2_TREATE...1,SET,174,-0.081468,-0.0078931,0.062022,0.90549,GSE20727_CTRL_VS_H2O2_TREATED_DC_DN,0.99999
REACTOME_REGULATION_OF_BETA_...,SET,41,-0.17991,-0.0084919,0.13694,0.90552,REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT,0.99999
REACTOME_THROMBOXANE_SIGNALL...,SET,24,-0.24061,-0.0086933,0.18315,0.90552,REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR,0.99999
GOCC_ASTROCYTE_END_FOOT,SET,11,-0.36132,-0.0088412,0.275,0.90555,GOCC_ASTROCYTE_END_FOOT,0.99999
HP_THICKENED_EARS,SET,11,-0.34885,-0.0085361,0.26549,0.90557,HP_THICKENED_EARS,0.99999
REACTOME_GENERATION_OF_SECON...,SET,27,-0.22287,-0.0085403,0.16961,0.90558,REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES,0.99999
GSE7348_LPS_VS_TOLERIZED_AND...1,SET,157,-0.087203,-0.0080291,0.066348,0.90562,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,0.99999
HP_DEXTROTRANSPOSITION_OF_TH...,SET,5,-0.42191,-0.0069615,0.321,0.90563,HP_DEXTROTRANSPOSITION_OF_THE_GREAT_ARTERIES,0.99999
GSE13887_RESTING_VS_NO_TREAT...2,SET,113,-0.10971,-0.0085804,0.083467,0.90564,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP,0.99999
KEGG_BUTANOATE_METABOLISM,SET,31,-0.197,-0.0080879,0.14987,0.90565,KEGG_BUTANOATE_METABOLISM,0.99999
KANG_AR_TARGETS_UP,SET,16,-0.32272,-0.0095226,0.24546,0.90569,KANG_AR_TARGETS_UP,0.99999
REACTOME_SIGNALING_BY_NOTCH1,SET,68,-0.1298,-0.0078843,0.098721,0.9057,REACTOME_SIGNALING_BY_NOTCH1,0.99999
GOBP_PYRIMIDINE_CONTAINING_C...3,SET,80,-0.12893,-0.008492,0.098064,0.9057,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GOBP_SYNAPTIC_TRANSMISSION_G...1,SET,56,-0.15581,-0.0085919,0.11849,0.90574,GOBP_SYNAPTIC_TRANSMISSION_GABAERGIC,0.99999
GOBP_VERY_LONG_CHAIN_FATTY_A...3,SET,33,-0.20301,-0.0085988,0.15438,0.90574,GOBP_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.99999
GOBP_CARDIAC_MUSCLE_CELL_PRO...,SET,45,-0.18099,-0.0089493,0.13758,0.90582,GOBP_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.99999
GOMF_CAMP_DEPENDENT_PROTEIN_...1,SET,5,-0.41431,-0.006836,0.31487,0.90587,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
GNF2_CD7,SET,34,-0.20351,-0.0087492,0.15466,0.90588,GNF2_CD7,0.99999
GOBP_CDC42_PROTEIN_SIGNAL_TR...,SET,14,-0.34069,-0.009404,0.25889,0.9059,GOBP_CDC42_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GOCC_FICOLIN_1_RICH_GRANULE,SET,172,-0.084318,-0.0081226,0.06406,0.90594,GOCC_FICOLIN_1_RICH_GRANULE,0.99999
GOBP_REGULATION_OF_RECEPTOR_...4,SET,61,-0.14171,-0.0081542,0.10765,0.90596,GOBP_REGULATION_OF_RECEPTOR_INTERNALIZATION,0.99999
GOCC_RESPIRASOME,SET,82,-0.10627,-0.0070862,0.080736,0.90596,GOCC_RESPIRASOME,0.99999
GOCC_SUPER_ELONGATION_COMPLEX,SET,5,-0.43391,-0.0071594,0.3296,0.90598,GOCC_SUPER_ELONGATION_COMPLEX,0.99999
GAUTAM_EYE_IRIS_CILIARY_BODY...8,SET,99,-0.1175,-0.0086047,0.089239,0.90602,GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS,0.99999
GGGNNTTTCC_NFKB_Q6_01,SET,124,-0.10164,-0.0083241,0.077176,0.90606,GGGNNTTTCC_NFKB_Q6_01,0.99999
GOMF_CALCIUM_DEPENDENT_PROTE...2,SET,10,-0.35536,-0.0082909,0.26981,0.90608,GOMF_CALCIUM_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
GOBP_RETROGRADE_TRANSPORT_VE...,SET,9,-0.4061,-0.0089887,0.3083,0.90611,GOBP_RETROGRADE_TRANSPORT_VESICLE_RECYCLING_WITHIN_GOLGI,0.99999
GSE33162_UNTREATED_VS_4H_LPS...1,SET,182,-0.081634,-0.0080871,0.061971,0.90612,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...553,SET,61,-0.14223,-0.0081843,0.10795,0.90617,GOBP_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.99999
MIR6715B_3P,SET,116,-0.099919,-0.0079169,0.07583,0.90618,MIR6715B_3P,0.99999
GOMF_L_ORNITHINE_TRANSMEMBRA...,SET,4,-0.6655,-0.0098216,0.50502,0.9062,GOMF_L_ORNITHINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_HYPERACTIVE_PATELLAR_REFL...,SET,16,-0.24916,-0.007352,0.18902,0.90626,HP_HYPERACTIVE_PATELLAR_REFLEX,0.99999
GOBP_CYTOSOLIC_TRANSPORT,SET,123,-0.094473,-0.0077065,0.071656,0.90631,GOBP_CYTOSOLIC_TRANSPORT,0.99999
LEE_LIVER_CANCER_MYC_E2F1_UP,SET,55,-0.1628,-0.0088968,0.12348,0.90632,LEE_LIVER_CANCER_MYC_E2F1_UP,0.99999
GSE1925_CTRL_VS_IFNG_PRIMED_...5,SET,184,-0.08125,-0.0080927,0.061623,0.90632,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN,0.99999
REACTOME_DEFECTIVE_INTRINSIC...,SET,25,-0.2257,-0.0083226,0.17117,0.90634,REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,0.99999
BIOCARTA_GLEEVEC_PATHWAY,SET,23,-0.25225,-0.0089223,0.19128,0.90636,BIOCARTA_GLEEVEC_PATHWAY,0.99999
GOBP_CHONDROCYTE_HYPERTROPHY,SET,6,-0.54952,-0.0099321,0.41667,0.90638,GOBP_CHONDROCYTE_HYPERTROPHY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...259,SET,5,-0.56856,-0.0093811,0.43102,0.90643,GOBP_NEGATIVE_REGULATION_OF_GLUTAMATE_SECRETION,0.99999
GSE42021_CD24HI_VS_CD24LOW_T...3,SET,183,-0.084931,-0.0084367,0.064375,0.90646,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN,0.99999
GOCC_SPINDLE,SET,386,-0.054242,-0.0077816,0.041109,0.90648,GOCC_SPINDLE,0.99999
HOEK_B_CELL_2011_2012_TIV_AD...1,SET,5,-0.43628,-0.0071985,0.33066,0.90648,HOEK_B_CELL_2011_2012_TIV_ADULT_1DY_UP,0.99999
GOCC_PHOSPHATIDYLINOSITOL_3_...2,SET,9,-0.42842,-0.0094829,0.32463,0.90653,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_I,0.99999
CAFFAREL_RESPONSE_TO_THC_8HR...2,SET,5,-0.52112,-0.0085984,0.39465,0.90665,CAFFAREL_RESPONSE_TO_THC_8HR_3_UP,0.99999
GOBP_REGULATION_OF_CYCLIC_NU...,SET,6,-0.40214,-0.0072683,0.30454,0.90665,GOBP_REGULATION_OF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,0.99999
GGCKCATGS_UNKNOWN,SET,68,-0.13808,-0.0083872,0.10456,0.90667,GGCKCATGS_UNKNOWN,0.99999
HP_ABNORMAL_STOMACH_MORPHOLO...,SET,244,-0.072547,-0.0083074,0.054923,0.90672,HP_ABNORMAL_STOMACH_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...270,SET,14,-0.31913,-0.0088088,0.24153,0.90679,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,0.99999
SHIPP_DLBCL_CURED_VS_FATAL_DN,SET,38,-0.1805,-0.008203,0.13658,0.90684,SHIPP_DLBCL_CURED_VS_FATAL_DN,0.99999
GOCC_CALCITONIN_FAMILY_RECEP...,SET,5,-0.55392,-0.0091396,0.41911,0.90685,GOCC_CALCITONIN_FAMILY_RECEPTOR_COMPLEX,0.99999
GSE24574_BCL6_HIGH_TFH_VS_TC...2,SET,175,-0.086502,-0.0084046,0.065447,0.90686,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_UP,0.99999
GSE29615_CTRL_VS_LAIV_FLU_VA...1,SET,135,-0.094198,-0.0080475,0.07127,0.90686,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN,0.99999
GOBP_NEUROTRANSMITTER_RECEPT...3,SET,24,-0.24339,-0.0087938,0.18414,0.90687,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT,0.99999
GOBP_PURINE_CONTAINING_COMPO...1,SET,138,-0.092907,-0.0080242,0.070285,0.90688,GOBP_PURINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.99999
HP_ABNORMALITY_OF_RADIAL_EPI...,SET,5,-0.52608,-0.0086801,0.39798,0.90688,HP_ABNORMALITY_OF_RADIAL_EPIPHYSES,0.99999
DESCARTES_MAIN_FETAL_VISCERA...,SET,43,-0.17462,-0.0084405,0.1321,0.90689,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,0.99999
HP_DECREASED_CIRCULATING_TOT...3,SET,66,-0.13843,-0.0082844,0.10471,0.9069,HP_DECREASED_CIRCULATING_TOTAL_IGM,0.99999
GSE7768_OVA_WITH_LPS_VS_OVA_...1,SET,154,-0.089161,-0.0081312,0.067424,0.90697,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,0.99999
MIR4728_3P,SET,99,-0.11737,-0.0085954,0.088751,0.90699,MIR4728_3P,0.99999
HP_CARDIOMYOCYTE_HYPERTROPHY,SET,8,-0.39741,-0.0082936,0.3005,0.90699,HP_CARDIOMYOCYTE_HYPERTROPHY,0.99999
GOBP_MELANOCYTE_DIFFERENTIAT...,SET,23,-0.2574,-0.0091044,0.19457,0.90706,GOBP_MELANOCYTE_DIFFERENTIATION,0.99999
RUAN_RESPONSE_TO_TNF_TROGLIT...1,SET,35,-0.20213,-0.0088166,0.15278,0.90707,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,0.99999
HP_ABNORMAL_FUNDUS_MORPHOLOGY,SET,1213,-0.032586,-0.0080942,0.024624,0.90713,HP_ABNORMAL_FUNDUS_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...499,SET,12,-0.33149,-0.0084717,0.25047,0.90715,GOBP_NEGATIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_SPECIFIC_LEARNING_DISABIL...,SET,267,-0.068477,-0.0081974,0.051736,0.90717,HP_SPECIFIC_LEARNING_DISABILITY,0.99999
HP_HODGKIN_LYMPHOMA,SET,25,-0.21341,-0.0078694,0.16123,0.90718,HP_HODGKIN_LYMPHOMA,0.99999
WP_ENDOTHELIN_PATHWAYS,SET,31,-0.21468,-0.0088138,0.16217,0.90721,WP_ENDOTHELIN_PATHWAYS,0.99999
GOBP_POSITIVE_REGULATION_OF_...611,SET,46,-0.16969,-0.008483,0.12818,0.90721,GOBP_POSITIVE_REGULATION_OF_PROTEIN_BINDING,0.99999
MIR648,SET,47,-0.16877,-0.008528,0.12748,0.90723,MIR648,0.99999
GOBP_NEGATIVE_REGULATION_OF_...563,SET,79,-0.12303,-0.0080526,0.092928,0.90723,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,0.99999
MIR3127_5P,SET,49,-0.1597,-0.0082388,0.12061,0.90725,MIR3127_5P,0.99999
GOBP_ACYL_COA_METABOLIC_PROC...,SET,85,-0.12353,-0.0083855,0.093293,0.90726,GOBP_ACYL_COA_METABOLIC_PROCESS,0.99999
MIR4439,SET,66,-0.14472,-0.0086612,0.10929,0.90728,MIR4439,0.99999
TRAVAGLINI_LUNG_VEIN_CELL,SET,37,-0.19719,-0.0088429,0.1489,0.90729,TRAVAGLINI_LUNG_VEIN_CELL,0.99999
MIR129_5P,SET,336,-0.062613,-0.0083922,0.047277,0.9073,MIR129_5P,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_NON...,SET,16,-0.27194,-0.008024,0.20533,0.9073,HE_LIM_SUN_FETAL_LUNG_C2_NON_CLASSICAL_MONOCYTE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...349,SET,91,-0.11927,-0.0083759,0.090045,0.90734,GOBP_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,0.99999
MIR6777_5P,SET,5,-0.5432,-0.0089627,0.41003,0.90737,MIR6777_5P,0.99999
ALONSO_METASTASIS_DN,SET,23,-0.24569,-0.0086902,0.18544,0.90739,ALONSO_METASTASIS_DN,0.99999
GOBP_NUCLEOSIDE_PHOSPHATE_CA...,SET,165,-0.085077,-0.0080287,0.0642,0.90744,GOBP_NUCLEOSIDE_PHOSPHATE_CATABOLIC_PROCESS,0.99999
WP_NRP1TRIGGERED_SIGNALING_I...,SET,51,-0.16873,-0.0088801,0.12731,0.90746,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,0.99999
HP_VILLOUS_ATROPHY,SET,24,-0.20327,-0.0073443,0.15336,0.90747,HP_VILLOUS_ATROPHY,0.99999
WP_MAMMARY_GLAND_DEVELOPMENT...2,SET,10,-0.37758,-0.0088094,0.28487,0.90748,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,0.99999
GOMF_RIBOSOMAL_LARGE_SUBUNIT...,SET,12,-0.30507,-0.0077966,0.23016,0.90749,GOMF_RIBOSOMAL_LARGE_SUBUNIT_BINDING,0.99999
KEGG_MEDICUS_REFERENCE_TELOM...2,SET,16,-0.26039,-0.0076834,0.19643,0.90751,KEGG_MEDICUS_REFERENCE_TELOMERE_ELONGATION,0.99999
HP_HYPERPHENYLALANINEMIA,SET,6,-0.48321,-0.0087337,0.36446,0.90754,HP_HYPERPHENYLALANINEMIA,0.99999
MIR302F,SET,167,-0.089191,-0.0084673,0.067257,0.90759,MIR302F,0.99999
POU3F2_01,SET,96,-0.11816,-0.0085218,0.0891,0.9076,POU3F2_01,0.99999
GOBP_POSITIVE_REGULATION_OF_...209,SET,33,-0.20884,-0.0088459,0.15748,0.9076,GOBP_POSITIVE_REGULATION_OF_DNA_BINDING,0.99999
COLDREN_GEFITINIB_RESISTANCE...1,SET,205,-0.081811,-0.0085961,0.061677,0.90764,COLDREN_GEFITINIB_RESISTANCE_DN,0.99999
GSE17721_LPS_VS_PAM3CSK4_24H...1,SET,177,-0.082576,-0.0080684,0.062244,0.90768,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN,0.99999
AGTTCTC_MIR146A_MIR146B,SET,50,-0.15979,-0.008327,0.12041,0.90774,AGTTCTC_MIR146A_MIR146B,0.99999
GSE7509_UNSTIM_VS_FCGRIIB_ST...2,SET,167,-0.086274,-0.0081904,0.065001,0.90778,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP,0.99999
REACTOME_IRS_ACTIVATION,SET,5,-0.5906,-0.0097448,0.44497,0.90779,REACTOME_IRS_ACTIVATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_MID...1,SET,14,-0.33718,-0.0093071,0.25399,0.90783,HE_LIM_SUN_FETAL_LUNG_C1_MID_AIRWAY_PROGENITOR_CELL,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...9,SET,179,-0.082457,-0.0081018,0.062107,0.90785,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
GOBP_WNT_SIGNALING_PATHWAY_C...,SET,5,-0.61771,-0.010192,0.4652,0.90788,GOBP_WNT_SIGNALING_PATHWAY_CALCIUM_MODULATING_PATHWAY,0.99999
GOBP_REGULATION_OF_RECEPTOR_...7,SET,25,-0.21258,-0.0078387,0.16007,0.9079,GOBP_REGULATION_OF_RECEPTOR_RECYCLING,0.99999
HOEBEKE_LYMPHOID_STEM_CELL_UP,SET,86,-0.119,-0.0081248,0.089592,0.90793,HOEBEKE_LYMPHOID_STEM_CELL_UP,0.99999
REACTOME_POST_TRANSCRIPTIONA...,SET,7,-0.44812,-0.008748,0.33738,0.90794,REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS,0.99999
REACTOME_INTRA_GOLGI_TRAFFIC,SET,43,-0.17338,-0.0083808,0.13053,0.90795,REACTOME_INTRA_GOLGI_TRAFFIC,0.99999
MODULE_293,SET,10,-0.38969,-0.0090919,0.29338,0.90795,MODULE_293,0.99999
PDGF_ERK_DN.V1_DN,SET,135,-0.097615,-0.0083393,0.073484,0.90797,PDGF_ERK_DN.V1_DN,0.99999
MIR5581_3P,SET,117,-0.10327,-0.0082177,0.077708,0.90807,MIR5581_3P,0.99999
DER_IFN_BETA_RESPONSE_DN,SET,6,-0.45487,-0.0082213,0.34215,0.90814,DER_IFN_BETA_RESPONSE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...690,SET,10,-0.41019,-0.0095702,0.30848,0.90818,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...478,SET,112,-0.11562,-0.0090029,0.086948,0.9082,GOBP_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,0.99999
HP_DICARBOXYLIC_ACIDURIA,SET,64,-0.13777,-0.0081199,0.10361,0.9082,HP_DICARBOXYLIC_ACIDURIA,0.99999
HP_MATERNAL_DIABETES,SET,39,-0.18488,-0.0085116,0.13903,0.9082,HP_MATERNAL_DIABETES,0.99999
GSE19401_PLN_VS_PEYERS_PATCH...2,SET,171,-0.084487,-0.0081154,0.063526,0.90823,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_UP,0.99999
GSE35685_CD34POS_CD38NEG_VS_...2,SET,171,-0.084084,-0.0080767,0.063219,0.90824,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...1,SET,3,-0.70824,-0.0090522,0.53243,0.90826,GOBP_POSITIVE_REGULATION_OF_3_UTR_MEDIATED_MRNA_STABILIZATION,0.99999
ONDER_CDH1_TARGETS_3_DN,SET,55,-0.16637,-0.009092,0.12506,0.90828,ONDER_CDH1_TARGETS_3_DN,0.99999
TAKEDA_TARGETS_OF_NUP98_HOXA...3,SET,111,-0.11274,-0.0087394,0.084726,0.90834,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,0.99999
HP_MIGRAINE_WITHOUT_AURA,SET,7,-0.46533,-0.009084,0.34969,0.90835,HP_MIGRAINE_WITHOUT_AURA,0.99999
GOMF_ADENYLATE_CYCLASE_ACTIV...,SET,14,-0.31105,-0.0085858,0.23373,0.90837,GOMF_ADENYLATE_CYCLASE_ACTIVITY,0.99999
HP_DYSCHROMATOPSIA,SET,29,-0.21878,-0.0086879,0.16439,0.90837,HP_DYSCHROMATOPSIA,0.99999
HP_CONGENITAL_LARYNGEAL_STRI...,SET,7,-0.40782,-0.0079614,0.30642,0.90838,HP_CONGENITAL_LARYNGEAL_STRIDOR,0.99999
GOBP_REGULATION_OF_POSTSYNAP...7,SET,134,-0.10422,-0.0088707,0.078298,0.90841,GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,0.99999
HP_BRACHYCEPHALY,SET,216,-0.077278,-0.0083324,0.058032,0.90851,HP_BRACHYCEPHALY,0.99999
GSE2405_S_AUREUS_VS_UNTREATE...1,SET,180,-0.083228,-0.0082001,0.062481,0.90857,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN,0.99999
HP_BICORNUATE_UTERUS,SET,48,-0.16066,-0.008204,0.12061,0.90858,HP_BICORNUATE_UTERUS,0.99999
HP_SHORT_4TH_METACARPAL,SET,10,-0.38094,-0.0088878,0.28596,0.90858,HP_SHORT_4TH_METACARPAL,0.99999
KEGG_MEDICUS_REFERENCE_BASE_...2,SET,8,-0.32552,-0.0067933,0.24435,0.90859,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_MONOFUNCTIONAL_GLYCOSYLASE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...144,SET,3,-0.74284,-0.0094946,0.55759,0.9086,GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_PROLIFERATION,0.99999
GSE17721_LPS_VS_POLYIC_0.5H_...1,SET,182,-0.080478,-0.0079727,0.060402,0.90862,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_DN,0.99999
HP_ABNORMAL_CIRCULATING_CARB...2,SET,305,-0.063742,-0.0081468,0.047835,0.90865,HP_ABNORMAL_CIRCULATING_CARBOXYLIC_ACID_CONCENTRATION,0.99999
GSE29949_CD8_NEG_DC_SPLEEN_V...6,SET,184,-0.0831,-0.008277,0.062356,0.90867,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,0.99999
MIR9_5P,SET,436,-0.05488,-0.0083558,0.041179,0.90868,MIR9_5P,0.99999
CCTGTGA_MIR513,SET,116,-0.10487,-0.0083093,0.078676,0.90872,CCTGTGA_MIR513,0.99999
HP_CEREBELLAR_DYSPLASIA,SET,18,-0.26479,-0.0082868,0.19861,0.90877,HP_CEREBELLAR_DYSPLASIA,0.99999
HP_HYPOPHOSPHATEMIA,SET,41,-0.18595,-0.0087771,0.13944,0.90882,HP_HYPOPHOSPHATEMIA,0.99999
GOMF_AMMONIA_LYASE_ACTIVITY,SET,5,-0.56629,-0.0093437,0.42461,0.90884,GOMF_AMMONIA_LYASE_ACTIVITY,0.99999
GOLDRATH_IMMUNE_MEMORY,SET,61,-0.14873,-0.0085582,0.1115,0.90886,GOLDRATH_IMMUNE_MEMORY,0.99999
GOBP_POSITIVE_REGULATION_OF_...499,SET,66,-0.14183,-0.0084878,0.10633,0.90886,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...190,SET,22,-0.2457,-0.0084998,0.1842,0.90888,GOBP_NEGATIVE_REGULATION_OF_DNA_REPLICATION,0.99999
GSE19941_IL10_KO_VS_IL10_KO_...4,SET,181,-0.083947,-0.0082937,0.062933,0.90888,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_UP,0.99999
HP_IMPAIRED_T_CELL_FUNCTION,SET,28,-0.21847,-0.0085251,0.16372,0.90896,HP_IMPAIRED_T_CELL_FUNCTION,0.99999
GOBP_DIGESTIVE_SYSTEM_PROCESS,SET,102,-0.11747,-0.0087311,0.088015,0.909,GOBP_DIGESTIVE_SYSTEM_PROCESS,0.99999
GSE11924_TH1_VS_TH17_CD4_TCE...2,SET,182,-0.082938,-0.0082163,0.062142,0.909,GSE11924_TH1_VS_TH17_CD4_TCELL_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_CLU...,SET,64,-0.15331,-0.0090358,0.11485,0.90903,HE_LIM_SUN_FETAL_LUNG_C1_CLUB_CELL,0.99999
GOBP_DETECTION_OF_CELL_DENSI...,SET,8,-0.37122,-0.0077471,0.27807,0.90905,GOBP_DETECTION_OF_CELL_DENSITY,0.99999
GOCC_MITOTIC_SPINDLE,SET,167,-0.082196,-0.0078033,0.061571,0.90905,GOCC_MITOTIC_SPINDLE,0.99999
GSE17974_0H_VS_0.5H_IN_VITRO...1,SET,160,-0.085934,-0.0079869,0.064367,0.90906,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN,0.99999
REACTOME_MET_ACTIVATES_PI3K_...,SET,6,-0.48767,-0.0088142,0.36518,0.90912,REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING,0.99999
TURASHVILI_BREAST_CARCINOMA_...1,SET,3,-0.66289,-0.0084727,0.49637,0.90913,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN,0.99999
HP_MESOAXIAL_FOOT_POLYDACTYLY,SET,4,-0.65905,-0.0097264,0.4935,0.90913,HP_MESOAXIAL_FOOT_POLYDACTYLY,0.99999
MIR3184_3P,SET,66,-0.13149,-0.0078694,0.098443,0.90917,MIR3184_3P,0.99999
WP_BIOMARKERS_FOR_UREA_CYCLE...,SET,11,-0.34061,-0.0083345,0.25496,0.90921,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,0.99999
GOBP_VENTRICULAR_CARDIAC_MUS...6,SET,45,-0.1876,-0.0092762,0.14041,0.90924,GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,0.99999
HP_RETINOSCHISIS,SET,7,-0.52734,-0.010295,0.39462,0.90927,HP_RETINOSCHISIS,0.99999
BARRIER_CANCER_RELAPSE_TUMOR...1,SET,10,-0.3517,-0.0082056,0.26318,0.90928,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN,0.99999
GOCC_VARICOSITY,SET,8,-0.47996,-0.010016,0.35909,0.90932,GOCC_VARICOSITY,0.99999
GOBP_NUCLEOBASE_BIOSYNTHETIC...,SET,15,-0.27032,-0.0077232,0.2022,0.90937,GOBP_NUCLEOBASE_BIOSYNTHETIC_PROCESS,0.99999
MIR3941,SET,303,-0.064958,-0.0082754,0.048576,0.90942,MIR3941,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...38,SET,15,-0.27525,-0.0078641,0.20583,0.90943,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,0.99999
REACTOME_SIGNALING_BY_TYPE_1...,SET,52,-0.16036,-0.0085219,0.1199,0.90945,REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,0.99999
DACOSTA_UV_RESPONSE_VIA_ERCC...6,SET,287,-0.063709,-0.0079027,0.047629,0.90948,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,0.99999
KEGG_MEDICUS_REFERENCE_STRAD...,SET,8,-0.39432,-0.008229,0.29468,0.90956,KEGG_MEDICUS_REFERENCE_STRAD_STK11_TSC_SIGNALING_PATHWAY,0.99999
GOBP_METANEPHRIC_MESENCHYME_...,SET,13,-0.35296,-0.0093885,0.26376,0.90957,GOBP_METANEPHRIC_MESENCHYME_DEVELOPMENT,0.99999
GSE360_L_MAJOR_VS_T_GONDII_D...2,SET,177,-0.088592,-0.0086562,0.066203,0.90957,GSE360_L_MAJOR_VS_T_GONDII_DC_UP,0.99999
MODULE_43,SET,92,-0.11256,-0.007948,0.084104,0.90961,MODULE_43,0.99999
KEGG_MEDICUS_REFERENCE_CXCR4...3,SET,21,-0.24097,-0.0081447,0.18003,0.90962,KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_FETAL_SKIN_MORPH...,SET,14,-0.29718,-0.0082029,0.22195,0.9097,HP_ABNORMAL_FETAL_SKIN_MORPHOLOGY,0.99999
chr4q34,SET,19,-0.42436,-0.013644,0.31692,0.90971,chr4q34,0.99999
PID_FGF_PATHWAY,SET,54,-0.15363,-0.0083194,0.11473,0.90973,PID_FGF_PATHWAY,0.99999
GOBP_CELLULAR_RESPONSE_TO_LU...,SET,5,-0.53602,-0.0088442,0.40028,0.90973,GOBP_CELLULAR_RESPONSE_TO_LUTEINIZING_HORMONE_STIMULUS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...339,SET,129,-0.10635,-0.0088831,0.079414,0.90974,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...705,SET,8,-0.43882,-0.0091577,0.32758,0.9098,GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.99999
HP_MACULAR_SCAR,SET,5,-0.54621,-0.0090123,0.40753,0.90991,HP_MACULAR_SCAR,0.99999
GOBP_POSITIVE_REGULATION_OF_...92,SET,13,-0.31023,-0.0082518,0.23145,0.90992,GOBP_POSITIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.99999
KEGG_MEDICUS_REFERENCE_ITGA_...3,SET,22,-0.25544,-0.0088369,0.19054,0.90997,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY,0.99999
GSE31082_CD4_VS_CD8_SP_THYMO...2,SET,178,-0.084404,-0.0082701,0.062958,0.90997,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP,0.99999
REACTOME_CARDIOGENESIS,SET,24,-0.25029,-0.0090431,0.18668,0.90999,REACTOME_CARDIOGENESIS,0.99999
GOBP_PHOSPHOLIPASE_C_ACTIVAT...1,SET,8,-0.47694,-0.0099532,0.3557,0.91,GOBP_PHOSPHOLIPASE_C_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_PREMATURE_BIRTH,SET,151,-0.088975,-0.0080356,0.066361,0.91,HP_PREMATURE_BIRTH,0.99999
GOBP_POSITIVE_REGULATION_OF_...378,SET,89,-0.11239,-0.0078059,0.083819,0.91001,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,0.99999
HOEK_MYELOID_DENDRITIC_CELL_...1,SET,5,-0.50747,-0.0083732,0.37844,0.91002,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_DN,0.99999
MIR34B_5P,SET,120,-0.10613,-0.0085521,0.079127,0.91008,MIR34B_5P,0.99999
REACTOME_ESTROGEN_DEPENDENT_...1,SET,87,-0.11834,-0.0081266,0.088222,0.91009,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,0.99999
HP_HEAD_TREMOR,SET,39,-0.18231,-0.0083934,0.13591,0.9101,HP_HEAD_TREMOR,0.99999
NABA_MATRISOME_HIGHLY_METAST...3,SET,18,-0.28108,-0.0087963,0.20951,0.91013,NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA,0.99999
HP_FLARING_OF_RIB_CAGE,SET,7,-0.47303,-0.0092343,0.35254,0.91016,HP_FLARING_OF_RIB_CAGE,0.99999
HP_GLAUCOMA,SET,316,-0.065637,-0.0085364,0.048899,0.91024,HP_GLAUCOMA,0.99999
CCAWNWWNNNGGC_UNKNOWN,SET,75,-0.13055,-0.0083269,0.097236,0.9103,CCAWNWWNNNGGC_UNKNOWN,0.99999
HP_ABNORMAL_ABDOMEN_MORPHOLO...,SET,721,-0.04269,-0.0082918,0.031792,0.91032,HP_ABNORMAL_ABDOMEN_MORPHOLOGY,0.99999
BERGER_MBD2_TARGETS,SET,4,-0.67849,-0.010013,0.50525,0.91034,BERGER_MBD2_TARGETS,0.99999
GCM_CDH5,SET,31,-0.19344,-0.0079417,0.14404,0.91035,GCM_CDH5,0.99999
BIOCARTA_LDL_PATHWAY,SET,6,-0.54653,-0.0098781,0.40694,0.91036,BIOCARTA_LDL_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...583,SET,152,-0.09686,-0.0087764,0.072122,0.91036,GOBP_NEGATIVE_REGULATION_OF_SECRETION,0.99999
TSANG_PBMC_FLUVIRIN_PANDEMRI...,SET,65,-0.14665,-0.0087103,0.1092,0.91036,TSANG_PBMC_FLUVIRIN_PANDEMRIX_ADULT_CORR_WITH_CELL_FREQ_CD27HI_CD38HI_CD20_NEG_PLASMABLASTS_AND_CD38PLUS_OF_IGD_CD27PLUS_MEM_B_CELLS_7DY_POSITIVE,0.99999
MIR3928_5P,SET,94,-0.1211,-0.0086427,0.090148,0.91041,MIR3928_5P,0.99999
MIR5586_3P,SET,48,-0.16631,-0.0084922,0.1238,0.91041,MIR5586_3P,0.99999
GOBP_LYSINE_METABOLIC_PROCESS,SET,8,-0.35817,-0.0074746,0.26662,0.91042,GOBP_LYSINE_METABOLIC_PROCESS,0.99999
MIR192_3P,SET,95,-0.11936,-0.0085631,0.088819,0.91049,MIR192_3P,0.99999
GOBP_BASE_EXCISION_REPAIR,SET,41,-0.15262,-0.0072037,0.11356,0.9105,GOBP_BASE_EXCISION_REPAIR,0.99999
chr7p21,SET,35,-0.3053,-0.013317,0.22716,0.91052,chr7p21,0.99999
GOBP_SNRNA_PROCESSING,SET,22,-0.21408,-0.007406,0.15928,0.91053,GOBP_SNRNA_PROCESSING,0.99999
GENTILE_UV_RESPONSE_CLUSTER_...6,SET,30,-0.20913,-0.0084465,0.15558,0.91055,GENTILE_UV_RESPONSE_CLUSTER_D7,0.99999
GSE28783_ANTI_MIR33_VS_UNTRE...1,SET,177,-0.089,-0.0086962,0.066199,0.91059,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...4,SET,183,-0.087261,-0.0086681,0.064905,0.91059,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...170,SET,15,-0.28679,-0.0081937,0.2133,0.91061,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,0.99999
GOBP_RENAL_SYSTEM_PROCESS_IN...2,SET,24,-0.24832,-0.0089718,0.18468,0.91061,GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
KEGG_MEDICUS_REFERENCE_LECTI...1,SET,10,-0.45851,-0.010698,0.341,0.91062,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN,0.99999
HP_GLUTARIC_ACIDURIA,SET,7,-0.41898,-0.0081793,0.31148,0.9107,HP_GLUTARIC_ACIDURIA,0.99999
GOBP_ENDOPLASMIC_RETICULUM_P...,SET,5,-0.51968,-0.0085747,0.38629,0.91073,GOBP_ENDOPLASMIC_RETICULUM_PLASMA_MEMBRANE_TETHERING,0.99999
MIR654_5P,SET,95,-0.11569,-0.0083002,0.08599,0.91074,MIR654_5P,0.99999
GSE25123_IL4_VS_IL4_AND_ROSI...1,SET,177,-0.08287,-0.0080972,0.06159,0.91076,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.99999
GOBP_DETERMINATION_OF_DIGEST...,SET,6,-0.39278,-0.0070991,0.29191,0.91077,GOBP_DETERMINATION_OF_DIGESTIVE_TRACT_LEFT_RIGHT_ASYMMETRY,0.99999
CHANGOLKAR_H2AFY_TARGETS_DN,SET,35,-0.17853,-0.0077872,0.13267,0.91078,CHANGOLKAR_H2AFY_TARGETS_DN,0.99999
GSE3039_CD4_TCELL_VS_NKT_CEL...2,SET,182,-0.079207,-0.0078467,0.058862,0.91078,GSE3039_CD4_TCELL_VS_NKT_CELL_UP,0.99999
GOBP_REGULATION_OF_HEMATOPOI...2,SET,17,-0.25496,-0.0077545,0.18947,0.91079,GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,0.99999
GSE17974_0H_VS_12H_IN_VITRO_...2,SET,167,-0.08691,-0.0082508,0.064564,0.91086,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP,0.99999
WP_NANOPARTICLE_TRIGGERED_AU...,SET,22,-0.23319,-0.008067,0.1732,0.9109,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,0.99999
BIOCARTA_CHREBP_PATHWAY,SET,19,-0.25199,-0.0081018,0.18713,0.91094,BIOCARTA_CHREBP_PATHWAY,0.99999
GSE18791_CTRL_VS_NEWCASTLE_V...8,SET,181,-0.080837,-0.0079864,0.060029,0.91094,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP,0.99999
CHIN_BREAST_CANCER_COPY_NUMB...1,SET,12,-0.31267,-0.0079906,0.23216,0.91096,CHIN_BREAST_CANCER_COPY_NUMBER_DN,0.99999
GOMF_CYCLIC_NUCLEOTIDE_DEPEN...,SET,7,-0.38776,-0.0075697,0.28792,0.91096,GOMF_CYCLIC_NUCLEOTIDE_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
HP_SKULL_ASYMMETRY,SET,7,-0.4386,-0.0085622,0.32568,0.91096,HP_SKULL_ASYMMETRY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...28,SET,43,-0.1493,-0.0072166,0.11085,0.91097,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,0.99999
REACTOME_EPITHELIAL_MESENCHY...,SET,6,-0.42536,-0.007688,0.31582,0.91098,REACTOME_EPITHELIAL_MESENCHYMAL_TRANSITION_EMT_DURING_GASTRULATION,0.99999
MIR6768_3P,SET,127,-0.10308,-0.0085432,0.0765,0.91107,MIR6768_3P,0.99999
chr12q14,SET,32,-0.32608,-0.013601,0.24198,0.91108,chr12q14,0.99999
GOBP_U2_TYPE_PRESPLICEOSOME_...,SET,22,-0.21916,-0.0075816,0.16257,0.91117,GOBP_U2_TYPE_PRESPLICEOSOME_ASSEMBLY,0.99999
HP_HYPOVOLEMIA,SET,30,-0.2286,-0.0092328,0.16958,0.91117,HP_HYPOVOLEMIA,0.99999
HP_INVOLUNTARY_MOVEMENTS,SET,908,-0.037762,-0.0081871,0.028009,0.91119,HP_INVOLUNTARY_MOVEMENTS,0.99999
GOBP_NEUROTRANSMITTER_RECEPT...1,SET,33,-0.19956,-0.0084526,0.14801,0.9112,GOBP_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,0.99999
GOMF_NUCLEOTIDYLTRANSFERASE_...,SET,120,-0.095128,-0.0076653,0.070546,0.91124,GOMF_NUCLEOTIDYLTRANSFERASE_ACTIVITY,0.99999
THAKAR_PBMC_INACTIVATED_INFL...6,SET,377,-0.05791,-0.0082124,0.042943,0.91125,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP,0.99999
GSE32901_TH17_EMRICHED_VS_TH...1,SET,157,-0.087529,-0.0080591,0.064903,0.91126,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN,0.99999
GOBP_RESPONSE_TO_SYMBIONT,SET,6,-0.42954,-0.0077635,0.31849,0.91127,GOBP_RESPONSE_TO_SYMBIONT,0.99999
MIR6867_3P,SET,105,-0.1084,-0.0081736,0.080364,0.91129,MIR6867_3P,0.99999
HP_ANKLE_SWELLING,SET,12,-0.35924,-0.0091809,0.26633,0.9113,HP_ANKLE_SWELLING,0.99999
HP_DECREASED_CIRCULATING_CER...,SET,8,-0.3969,-0.0082829,0.29425,0.9113,HP_DECREASED_CIRCULATING_CERULOPLASMIN_CONCENTRATION,0.99999
HP_PARTIAL_DUPLICATION_OF_TH...1,SET,6,-0.44087,-0.0079684,0.32678,0.91135,HP_PARTIAL_DUPLICATION_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,0.99999
GCM_PTK2,SET,135,-0.09655,-0.0082484,0.071548,0.91139,GCM_PTK2,0.99999
GOBP_LOCOMOTION,SET,1124,-0.036829,-0.008829,0.027287,0.91144,GOBP_LOCOMOTION,0.99999
DESCARTES_MAIN_FETAL_RETINAL...2,SET,43,-0.17813,-0.0086102,0.13197,0.91145,DESCARTES_MAIN_FETAL_RETINAL_PROGENITORS_AND_MULLER_GLIA,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_PUL...2,SET,270,-0.073697,-0.0088709,0.054598,0.91145,HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL,0.99999
WP_NANOMATERIALINDUCED_INFLA...,SET,5,-0.46207,-0.0076241,0.34231,0.91146,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,0.99999
ELVIDGE_HYPOXIA_BY_DMOG_UP,SET,122,-0.10791,-0.0087665,0.079929,0.91149,ELVIDGE_HYPOXIA_BY_DMOG_UP,0.99999
GOCC_CYTOPLASMIC_UBIQUITIN_L...,SET,6,-0.47739,-0.0086284,0.35358,0.91151,GOCC_CYTOPLASMIC_UBIQUITIN_LIGASE_COMPLEX,0.99999
MORF_ATF2,SET,288,-0.06827,-0.0084829,0.050554,0.91155,MORF_ATF2,0.99999
HP_ABNORMALITY_OF_REFRACTION,SET,600,-0.046767,-0.0083149,0.034632,0.91155,HP_ABNORMALITY_OF_REFRACTION,0.99999
GOBP_KETONE_BODY_METABOLIC_P...,SET,10,-0.38832,-0.00906,0.28754,0.91156,GOBP_KETONE_BODY_METABOLIC_PROCESS,0.99999
HP_DECREASED_CD4_CD8_RATIO,SET,8,-0.39268,-0.0081948,0.29077,0.91156,HP_DECREASED_CD4_CD8_RATIO,0.99999
REACTOME_PI_3K_CASCADE_FGFR3,SET,17,-0.28078,-0.0085398,0.20789,0.91159,REACTOME_PI_3K_CASCADE_FGFR3,0.99999
HP_OTOSCLEROSIS,SET,6,-0.51447,-0.0092987,0.38087,0.91161,HP_OTOSCLEROSIS,0.99999
WP_P53_TRANSCRIPTIONAL_GENE_...,SET,89,-0.11494,-0.0079829,0.085081,0.91163,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,0.99999
HP_ASYMMETRIC_SEPTAL_HYPERTR...,SET,13,-0.33865,-0.0090078,0.25066,0.91164,HP_ASYMMETRIC_SEPTAL_HYPERTROPHY,0.99999
HP_KNEE_OSTEOARTHRITIS,SET,14,-0.3407,-0.0094043,0.25219,0.91164,HP_KNEE_OSTEOARTHRITIS,0.99999
JONES_OVARY_THECA,SET,42,-0.19872,-0.0094932,0.14707,0.91167,JONES_OVARY_THECA,0.99999
HP_ELEVATED_URINARY_VANILLYL...,SET,9,-0.46808,-0.010361,0.34636,0.91171,HP_ELEVATED_URINARY_VANILLYLMANDELIC_ACID,0.99999
GOBP_CELLULAR_RESPONSE_TO_PR...1,SET,6,-0.43967,-0.0079467,0.32533,0.91172,GOBP_CELLULAR_RESPONSE_TO_PROGESTERONE_STIMULUS,0.99999
chr17p13,SET,218,-0.18179,-0.01969,0.13449,0.91175,chr17p13,0.99999
REACTOME_MEIOTIC_SYNAPSIS,SET,31,-0.19484,-0.0079992,0.14415,0.91175,REACTOME_MEIOTIC_SYNAPSIS,0.99999
LI_ESTROGENE_META_E2_RESPONS...2,SET,61,-0.15654,-0.0090079,0.11581,0.91176,LI_ESTROGENE_META_E2_RESPONSE_UP,0.99999
HP_MIXED_DEMYELINATING_AND_A...,SET,3,-0.62783,-0.0080245,0.4643,0.91184,HP_MIXED_DEMYELINATING_AND_AXONAL_POLYNEUROPATHY,0.99999
GOBP_VENTRICULAR_CARDIAC_MUS...5,SET,60,-0.16575,-0.0094594,0.12251,0.91195,GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,0.99999
REACTOME_AKT_PHOSPHORYLATES_...2,SET,9,-0.35491,-0.0078558,0.26227,0.912,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS,0.99999
GSE13522_CTRL_VS_T_CRUZI_G_S...2,SET,186,-0.084123,-0.0084239,0.062162,0.91201,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP,0.99999
MOREAUX_MULTIPLE_MYELOMA_BY_...1,SET,153,-0.084065,-0.0076418,0.062098,0.91208,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,0.99999
GOCC_PHOTORECEPTOR_OUTER_SEG...2,SET,16,-0.25428,-0.0075031,0.18784,0.91208,GOCC_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE,0.99999
GOCC_PAM_COMPLEX_TIM23_ASSOC...,SET,5,-0.48135,-0.0079422,0.35529,0.91225,GOCC_PAM_COMPLEX_TIM23_ASSOCIATED_IMPORT_MOTOR,0.99999
GOBP_POSITIVE_REGULATION_OF_...621,SET,19,-0.25434,-0.0081774,0.18772,0.91227,GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,0.99999
HP_ABNORMALITY_OF_T_CELL_PHY...,SET,50,-0.16573,-0.0086369,0.12232,0.91228,HP_ABNORMALITY_OF_T_CELL_PHYSIOLOGY,0.99999
GOBP_ESTABLISHMENT_OF_MITOCH...1,SET,27,-0.23407,-0.0089695,0.17274,0.91229,GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION,0.99999
BIOCARTA_CTCF_PATHWAY,SET,24,-0.2641,-0.0095422,0.19484,0.91237,BIOCARTA_CTCF_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_LEUCI...,SET,7,-0.41641,-0.0081291,0.30718,0.91237,KEGG_MEDICUS_REFERENCE_LEUCINE_DEGRADATION,0.99999
GOBP_NEUROBLAST_PROLIFERATION,SET,78,-0.13426,-0.0087323,0.099037,0.91239,GOBP_NEUROBLAST_PROLIFERATION,0.99999
REACTOME_RUNX1_REGULATES_TRA...1,SET,6,-0.4373,-0.0079039,0.32243,0.91249,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING,0.99999
MIR193B_5P,SET,55,-0.15128,-0.0082673,0.11152,0.91253,MIR193B_5P,0.99999
GOBP_REGULATION_OF_TRANSLATI...3,SET,13,-0.27079,-0.0072028,0.19961,0.91253,GOBP_REGULATION_OF_TRANSLATIONAL_FIDELITY,0.99999
GOBP_RESPONSE_TO_LUTEINIZING...,SET,7,-0.43989,-0.0085873,0.32427,0.91253,GOBP_RESPONSE_TO_LUTEINIZING_HORMONE,0.99999
GOBP_REGULATION_OF_SREBP_SIG...,SET,6,-0.45338,-0.0081945,0.33418,0.91255,GOBP_REGULATION_OF_SREBP_SIGNALING_PATHWAY,0.99999
GSE22886_NEUTROPHIL_VS_DC_DN,SET,177,-0.082192,-0.0080309,0.060566,0.91261,GSE22886_NEUTROPHIL_VS_DC_DN,0.99999
TARTE_PLASMA_CELL_VS_PLASMAB...1,SET,276,-0.064749,-0.0078786,0.047711,0.91262,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,0.99999
HP_BILATERAL_SENSORINEURAL_H...,SET,60,-0.14807,-0.0084504,0.1091,0.91262,HP_BILATERAL_SENSORINEURAL_HEARING_IMPAIRMENT,0.99999
CREIGHTON_ENDOCRINE_THERAPY_...2,SET,366,-0.057113,-0.0079828,0.042082,0.91263,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,0.99999
WP_LEUKOTRIENE_METABOLIC_PAT...,SET,13,-0.3247,-0.0086367,0.23922,0.91265,WP_LEUKOTRIENE_METABOLIC_PATHWAY,0.99999
GCM_HMGA2,SET,107,-0.10675,-0.0081254,0.078617,0.91274,GCM_HMGA2,0.99999
ROSS_AML_WITH_MLL_FUSIONS,SET,68,-0.13873,-0.0084272,0.10217,0.91275,ROSS_AML_WITH_MLL_FUSIONS,0.99999
GOBP_EXOCYTIC_PROCESS,SET,75,-0.12548,-0.0080035,0.092391,0.91279,GOBP_EXOCYTIC_PROCESS,0.99999
HP_MUCOPOLYSACCHARIDURIA,SET,19,-0.24641,-0.0079224,0.18142,0.91279,HP_MUCOPOLYSACCHARIDURIA,0.99999
GOBP_REGULATION_OF_GONADOTRO...,SET,12,-0.38612,-0.009868,0.28419,0.91287,GOBP_REGULATION_OF_GONADOTROPIN_SECRETION,0.99999
GOMF_GLUCOSIDASE_ACTIVITY,SET,13,-0.30708,-0.0081681,0.22585,0.91303,GOMF_GLUCOSIDASE_ACTIVITY,0.99999
HP_ABNORMAL_CIRCULATING_SULF...,SET,23,-0.24534,-0.0086779,0.18039,0.91308,HP_ABNORMAL_CIRCULATING_SULFUR_AMINO_ACID_CONCENTRATION,0.99999
KEGG_MEDICUS_REFERENCE_GLYCO...2,SET,8,-0.39262,-0.0081936,0.28859,0.91315,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION,0.99999
MODULE_66,SET,500,-0.054598,-0.0088862,0.040129,0.91316,MODULE_66,0.99999
HP_BILATERAL_RENAL_AGENESIS,SET,10,-0.41188,-0.0096095,0.30273,0.91316,HP_BILATERAL_RENAL_AGENESIS,0.99999
MIR659_5P,SET,25,-0.24859,-0.0091665,0.1827,0.91317,MIR659_5P,0.99999
FINETTI_BREAST_CANCER_KINOME...2,SET,16,-0.30181,-0.0089054,0.22179,0.9132,FINETTI_BREAST_CANCER_KINOME_RED,0.99999
HP_TYPE_I_TRANSFERRIN_ISOFOR...,SET,17,-0.2264,-0.0068858,0.16637,0.9132,HP_TYPE_I_TRANSFERRIN_ISOFORM_PROFILE,0.99999
MIR3183,SET,75,-0.13052,-0.0083245,0.095907,0.91321,MIR3183,0.99999
GOBP_TOR_SIGNALING,SET,146,-0.093078,-0.0082669,0.068394,0.91322,GOBP_TOR_SIGNALING,0.99999
HP_VISUAL_FIXATION_INSTABILI...,SET,12,-0.32295,-0.0082534,0.23729,0.91323,HP_VISUAL_FIXATION_INSTABILITY,0.99999
GOCC_INTRACELLULAR_PROTEIN_C...,SET,806,-0.039327,-0.0080569,0.028885,0.91331,GOCC_INTRACELLULAR_PROTEIN_CONTAINING_COMPLEX,0.99999
GOBP_REGULATION_OF_RENAL_SYS...,SET,20,-0.28374,-0.0093593,0.20837,0.91335,GOBP_REGULATION_OF_RENAL_SYSTEM_PROCESS,0.99999
GOCC_FICOLIN_1_RICH_GRANULE_...1,SET,120,-0.1032,-0.008316,0.075788,0.91335,GOCC_FICOLIN_1_RICH_GRANULE_LUMEN,0.99999
HP_INFLAMMATORY_ABNORMALITY_...,SET,188,-0.084289,-0.0084853,0.061895,0.91336,HP_INFLAMMATORY_ABNORMALITY_OF_THE_EYE,0.99999
HP_REDUCED_PROTEIN_C_ACTIVITY,SET,10,-0.31409,-0.0073281,0.23064,0.91336,HP_REDUCED_PROTEIN_C_ACTIVITY,0.99999
GSE7852_LN_VS_FAT_TCONV_DN,SET,176,-0.090262,-0.0087947,0.066281,0.91336,GSE7852_LN_VS_FAT_TCONV_DN,0.99999
HP_EXOPHORIA,SET,6,-0.43199,-0.0078078,0.31719,0.91338,HP_EXOPHORIA,0.99999
YANG_BCL3_TARGETS_DN,SET,8,-0.42467,-0.0088624,0.31178,0.9134,YANG_BCL3_TARGETS_DN,0.99999
GSE13522_CTRL_VS_T_CRUZI_G_S...1,SET,121,-0.10491,-0.0084883,0.077012,0.91343,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN,0.99999
GSE22611_NOD2_TRANSD_VS_CTRL...3,SET,178,-0.088565,-0.0086778,0.065015,0.91343,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN,0.99999
HP_CALVARIAL_HYPEROSTOSIS,SET,10,-0.32838,-0.0076615,0.24103,0.91345,HP_CALVARIAL_HYPEROSTOSIS,0.99999
GOMF_ATPASE_COUPLED_MONOATOM...,SET,49,-0.16962,-0.0087508,0.1245,0.91346,GOMF_ATPASE_COUPLED_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
NAKAYAMA_SOFT_TISSUE_TUMORS_...4,SET,78,-0.13185,-0.0085754,0.096766,0.91348,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,0.99999
MIR4321,SET,4,-0.53934,-0.0079596,0.39576,0.91352,MIR4321,0.99999
HP_SECONDARY_GROWTH_HORMONE_...,SET,15,-0.26909,-0.0076881,0.19744,0.91353,HP_SECONDARY_GROWTH_HORMONE_DEFICIENCY,0.99999
GTGACTT_MIR224,SET,139,-0.09535,-0.0082648,0.069955,0.91355,GTGACTT_MIR224,0.99999
GOBP_DOPAMINERGIC_NEURON_AXO...,SET,6,-0.47447,-0.0085757,0.34809,0.91356,GOBP_DOPAMINERGIC_NEURON_AXON_GUIDANCE,0.99999
HP_GENERALIZED_EDEMA,SET,24,-0.21873,-0.0079027,0.16045,0.91358,HP_GENERALIZED_EDEMA,0.99999
HOEK_B_CELL_2011_2012_TIV_AD...2,SET,3,-0.68019,-0.0086938,0.49894,0.91359,HOEK_B_CELL_2011_2012_TIV_ADULT_3DY_DN,0.99999
GOCC_CULLIN_RING_UBIQUITIN_L...,SET,164,-0.089295,-0.0084014,0.06549,0.91363,GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX,0.99999
GOMF_CALMODULIN_DEPENDENT_PR...1,SET,24,-0.22183,-0.0080147,0.16267,0.91365,GOMF_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_PRO...2,SET,44,-0.17182,-0.008401,0.12598,0.91368,HE_LIM_SUN_FETAL_LUNG_C2_PROMYELOCYTE_LIKE_CELL,0.99999
MIR4795_3P,SET,629,-0.047247,-0.0085937,0.03464,0.9137,MIR4795_3P,0.99999
REACTOME_GAP_JUNCTION_DEGRAD...,SET,12,-0.33403,-0.0085367,0.24489,0.91371,REACTOME_GAP_JUNCTION_DEGRADATION,0.99999
ROAZ_01,SET,8,-0.36055,-0.0075243,0.26433,0.91371,ROAZ_01,0.99999
GOBP_MATURATION_OF_5_8S_RRNA...,SET,24,-0.20859,-0.0075366,0.15292,0.91372,GOBP_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.99999
GOBP_REGULATION_OF_NEUROTRAN...4,SET,88,-0.122,-0.0084256,0.089429,0.91374,GOBP_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.99999
GSE5589_UNSTIM_VS_180MIN_LPS...4,SET,180,-0.084393,-0.0083148,0.061854,0.91377,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP,0.99999
LEE_LIVER_CANCER_SURVIVAL_UP,SET,166,-0.090668,-0.008582,0.066437,0.91382,LEE_LIVER_CANCER_SURVIVAL_UP,0.99999
MODULE_414,SET,8,-0.47015,-0.0098115,0.3445,0.91382,MODULE_414,0.99999
WP_DIFFERENTIATION_OF_WHITE_...,SET,25,-0.25845,-0.0095303,0.18936,0.91384,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,0.99999
GOBP_REGULATION_OF_AEROBIC_R...,SET,27,-0.20688,-0.0079273,0.15158,0.91384,GOBP_REGULATION_OF_AEROBIC_RESPIRATION,0.99999
HP_SPINAL_CANAL_STENOSIS,SET,35,-0.19647,-0.0085696,0.14395,0.91384,HP_SPINAL_CANAL_STENOSIS,0.99999
HP_RECURRENT_MALADAPTIVE_BEH...,SET,960,-0.0383,-0.0085257,0.028058,0.91387,HP_RECURRENT_MALADAPTIVE_BEHAVIOR,0.99999
HP_ABNORMAL_LENS_MORPHOLOGY,SET,720,-0.043588,-0.0084605,0.031925,0.91391,HP_ABNORMAL_LENS_MORPHOLOGY,0.99999
HP_SPINAL_CORD_COMPRESSION,SET,34,-0.21096,-0.0090698,0.15452,0.91391,HP_SPINAL_CORD_COMPRESSION,0.99999
HP_ABNORMALITY_OF_THE_HYPOTH...1,SET,360,-0.059741,-0.0082827,0.043746,0.91396,HP_ABNORMALITY_OF_THE_HYPOTHALAMUS_PITUITARY_AXIS,0.99999
KEGG_MEDICUS_REFERENCE_N_GLY...4,SET,7,-0.30245,-0.0059043,0.22146,0.91398,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_GLC_6P_TO_MAN_P_DOL,0.99999
GSE27786_ERYTHROBLAST_VS_NEU...1,SET,176,-0.080372,-0.0078311,0.058846,0.91399,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN,0.99999
GOBP_T_CELL_PROLIFERATION_IN...,SET,5,-0.53896,-0.0088926,0.39457,0.91401,GOBP_T_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE,0.99999
ZHENG_FOXP3_TARGETS_DN,SET,6,-0.51909,-0.009382,0.38001,0.91402,ZHENG_FOXP3_TARGETS_DN,0.99999
HP_VENTRICULAR_FIBRILLATION,SET,52,-0.16294,-0.0086587,0.11927,0.91403,HP_VENTRICULAR_FIBRILLATION,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...8,SET,6,-0.50662,-0.0091566,0.37085,0.91404,GOCC_EXTRINSIC_COMPONENT_OF_PRESYNAPTIC_MEMBRANE,0.99999
BIOCARTA_CDC25_PATHWAY,SET,9,-0.3395,-0.0075147,0.24848,0.91407,BIOCARTA_CDC25_PATHWAY,0.99999
GSE3982_MAC_VS_NKCELL_DN,SET,177,-0.087746,-0.0085736,0.064222,0.91407,GSE3982_MAC_VS_NKCELL_DN,0.99999
MIR2115_5P,SET,123,-0.10456,-0.0085293,0.076513,0.91411,MIR2115_5P,0.99999
GOMF_INTERLEUKIN_1_RECEPTOR_...2,SET,17,-0.32414,-0.0098583,0.23719,0.91411,GOMF_INTERLEUKIN_1_RECEPTOR_BINDING,0.99999
HP_RHOMBENCEPHALOSYNAPSIS,SET,15,-0.29629,-0.0084651,0.21682,0.91411,HP_RHOMBENCEPHALOSYNAPSIS,0.99999
PID_CERAMIDE_PATHWAY,SET,43,-0.17833,-0.0086197,0.13048,0.91413,PID_CERAMIDE_PATHWAY,0.99999
TGIF_01,SET,229,-0.078195,-0.0086781,0.057208,0.91416,TGIF_01,0.99999
BIOCARTA_RACC_PATHWAY,SET,11,-0.39989,-0.0097849,0.29244,0.91425,BIOCARTA_RACC_PATHWAY,0.99999
MIR1321,SET,124,-0.10798,-0.0088434,0.078952,0.91427,MIR1321,0.99999
GSE39820_CTRL_VS_TGFBETA3_IL...3,SET,176,-0.08669,-0.0084466,0.063382,0.91429,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN,0.99999
GOBP_REGULATION_OF_DNA_REPAIR,SET,194,-0.0776,-0.0079343,0.056725,0.91434,GOBP_REGULATION_OF_DNA_REPAIR,0.99999
ZWANG_EGF_INTERVAL_UP,SET,76,-0.1351,-0.008674,0.09874,0.91437,ZWANG_EGF_INTERVAL_UP,0.99999
GOBP_RHODOPSIN_MEDIATED_SIGN...,SET,10,-0.34444,-0.008036,0.25172,0.91439,GOBP_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_CELLULAR_RESPONSE_TO_AN...1,SET,32,-0.22349,-0.009322,0.16332,0.9144,GOBP_CELLULAR_RESPONSE_TO_ANGIOTENSIN,0.99999
HP_TONIC_SEIZURE,SET,121,-0.10489,-0.008487,0.076641,0.91443,HP_TONIC_SEIZURE,0.99999
KEGG_MEDICUS_ENV_FACTOR_NNK_...3,SET,12,-0.3469,-0.0088655,0.25343,0.91446,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350,0.99999
MIR6798_3P,SET,34,-0.19256,-0.0082787,0.14066,0.9145,MIR6798_3P,0.99999
GSE21670_UNTREATED_VS_TGFB_T...1,SET,177,-0.088339,-0.0086315,0.064515,0.91453,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN,0.99999
GOBP_FATTY_ACID_ALPHA_OXIDAT...,SET,8,-0.43893,-0.00916,0.3205,0.91457,GOBP_FATTY_ACID_ALPHA_OXIDATION,0.99999
HP_WIDE_CRANIAL_SUTURES,SET,27,-0.22226,-0.0085166,0.16227,0.9146,HP_WIDE_CRANIAL_SUTURES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...48,SET,45,-0.17826,-0.0088143,0.13013,0.91463,GOBP_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE,0.99999
GSE12003_4D_VS_8D_CULTURE_MI...2,SET,133,-0.10467,-0.0088761,0.076406,0.91463,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP,0.99999
KINNEY_DNMT1_METHYLATION_TAR...,SET,14,-0.32961,-0.0090981,0.24056,0.91467,KINNEY_DNMT1_METHYLATION_TARGETS,0.99999
MAHADEVAN_IMATINIB_RESISTANC...1,SET,19,-0.31048,-0.0099826,0.22659,0.91468,MAHADEVAN_IMATINIB_RESISTANCE_DN,0.99999
GOBP_RESPONSE_TO_MAGNESIUM_I...,SET,20,-0.27558,-0.0090904,0.20111,0.91469,GOBP_RESPONSE_TO_MAGNESIUM_ION,0.99999
MIR550A_3P,SET,70,-0.14251,-0.0087827,0.10393,0.91483,MIR550A_3P,0.99999
GOMF_PEPTIDE_HORMONE_RECEPTO...,SET,19,-0.28316,-0.0091042,0.20647,0.91487,GOMF_PEPTIDE_HORMONE_RECEPTOR_BINDING,0.99999
GOBP_FEMALE_MEIOSIS_I,SET,9,-0.41445,-0.0091735,0.30217,0.91489,GOBP_FEMALE_MEIOSIS_I,0.99999
KANG_FLUOROURACIL_RESISTANCE...1,SET,16,-0.28604,-0.0084401,0.20854,0.9149,KANG_FLUOROURACIL_RESISTANCE_DN,0.99999
GOBP_CHONDROCYTE_DIFFERENTIA...2,SET,14,-0.3138,-0.0086617,0.22877,0.91491,GOBP_CHONDROCYTE_DIFFERENTIATION_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,0.99999
REACTOME_LATE_SARS_COV_2_INF...,SET,66,-0.13997,-0.0083765,0.102,0.915,REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS,0.99999
MIR557,SET,204,-0.081681,-0.0085618,0.059518,0.91502,MIR557,0.99999
MIR338_5P,SET,428,-0.058065,-0.0087613,0.042308,0.91503,MIR338_5P,0.99999
HP_TIBIAL_BOWING,SET,33,-0.21841,-0.0092512,0.15913,0.91505,HP_TIBIAL_BOWING,0.99999
GOBP_BLOOD_VESSEL_ENDOTHELIA...2,SET,108,-0.11532,-0.0088184,0.084007,0.91508,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,0.99999
GOCC_TRAPPIII_PROTEIN_COMPLEX,SET,10,-0.34262,-0.0079936,0.24957,0.91509,GOCC_TRAPPIII_PROTEIN_COMPLEX,0.99999
ZNF585B_TARGET_GENES,SET,96,-0.11685,-0.0084274,0.085114,0.9151,ZNF585B_TARGET_GENES,0.99999
REACTOME_INTERLEUKIN_36_PATH...,SET,7,-0.67971,-0.013269,0.49505,0.91512,REACTOME_INTERLEUKIN_36_PATHWAY,0.99999
GOBP_DETOXIFICATION_OF_INORG...,SET,20,-0.32418,-0.010693,0.23606,0.91516,GOBP_DETOXIFICATION_OF_INORGANIC_COMPOUND,0.99999
GOBP_NEGATIVE_REGULATION_OF_...628,SET,9,-0.41081,-0.009093,0.29912,0.91518,GOBP_NEGATIVE_REGULATION_OF_TELOMERASE_ACTIVITY,0.99999
GSE36826_WT_VS_IL1R_KO_SKIN_...3,SET,179,-0.080631,-0.0079223,0.058702,0.9152,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP,0.99999
VAN_DEN_BIGGELAAR_PBMC_PREVN...2,SET,4,-0.60542,-0.008935,0.4407,0.91523,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_DN,0.99999
MODULE_190,SET,8,-0.50469,-0.010532,0.36735,0.91525,MODULE_190,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...36,SET,14,-0.36667,-0.010121,0.26688,0.91526,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,0.99999
PID_HNF3A_PATHWAY,SET,42,-0.18844,-0.0090023,0.13714,0.91528,PID_HNF3A_PATHWAY,0.99999
GSE38697_LIGHT_ZONE_VS_DARK_...2,SET,154,-0.089059,-0.0081219,0.06481,0.9153,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,0.99999
THAKAR_PBMC_INACTIVATED_INFL...7,SET,546,-0.048327,-0.0082088,0.035168,0.9153,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN,0.99999
REACTOME_SYNDECAN_INTERACTIO...,SET,26,-0.23833,-0.008962,0.17337,0.91538,REACTOME_SYNDECAN_INTERACTIONS,0.99999
FAN_EMBRYONIC_CTX_OPC,SET,48,-0.18709,-0.0095536,0.13609,0.91538,FAN_EMBRYONIC_CTX_OPC,0.99999
DESERT_PERIPORTAL_HEPATOCELL...,SET,147,-0.096704,-0.008618,0.070327,0.91543,DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.99999
HP_ABNORMAL_VISUAL_ELECTROPH...,SET,233,-0.076546,-0.0085679,0.055667,0.91544,HP_ABNORMAL_VISUAL_ELECTROPHYSIOLOGY,0.99999
GOBP_EATING_BEHAVIOR,SET,37,-0.20911,-0.0093775,0.15205,0.91546,GOBP_EATING_BEHAVIOR,0.99999
GOMF_BILE_ACID_SODIUM_SYMPOR...,SET,5,-0.47687,-0.0078683,0.34676,0.91546,GOMF_BILE_ACID_SODIUM_SYMPORTER_ACTIVITY,0.99999
GOMF_STEROL_ESTERASE_ACTIVITY,SET,7,-0.44875,-0.0087603,0.32623,0.91551,GOMF_STEROL_ESTERASE_ACTIVITY,0.99999
GAVIN_IL2_RESPONSIVE_FOXP3_T...2,SET,15,-0.3537,-0.010105,0.25712,0.91552,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP,0.99999
QIU_PBMC_HEPTATITIS_B_SURFAC...3,SET,7,-0.46618,-0.0091006,0.33889,0.91552,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_DN,0.99999
GOBP_TRUNK_SEGMENTATION,SET,5,-0.53167,-0.0087724,0.38647,0.91553,GOBP_TRUNK_SEGMENTATION,0.99999
GOBP_CELLULAR_RESPONSE_TO_OX...2,SET,11,-0.36653,-0.0089686,0.26642,0.91554,GOBP_CELLULAR_RESPONSE_TO_OXIDISED_LOW_DENSITY_LIPOPROTEIN_PARTICLE_STIMULUS,0.99999
KANG_AR_TARGETS_DN,SET,18,-0.29073,-0.0090984,0.21131,0.91556,KANG_AR_TARGETS_DN,0.99999
REACTOME_CREATINE_METABOLISM,SET,10,-0.35717,-0.0083332,0.25954,0.9156,REACTOME_CREATINE_METABOLISM,0.99999
GSE6674_CPG_VS_PL2_3_STIM_BC...2,SET,171,-0.082248,-0.0079003,0.059767,0.9156,GSE6674_CPG_VS_PL2_3_STIM_BCELL_UP,0.99999
GSE2770_IL12_VS_TGFB_AND_IL1...6,SET,168,-0.089701,-0.008541,0.065175,0.91563,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.99999
MODULE_480,SET,82,-0.12512,-0.0083429,0.090904,0.91564,MODULE_480,0.99999
GSE37534_GW1929_VS_PIOGLITAZ...1,SET,179,-0.087379,-0.0085853,0.063483,0.91564,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,0.99999
GOBP_HEAD_DEVELOPMENT,SET,702,-0.046238,-0.0088666,0.033588,0.91568,GOBP_HEAD_DEVELOPMENT,0.99999
GOBP_POSITIVE_REGULATION_OF_...612,SET,178,-0.085938,-0.0084204,0.062425,0.91568,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.99999
LEE_LIVER_CANCER_ACOX1_DN,SET,61,-0.15233,-0.0087656,0.11065,0.91569,LEE_LIVER_CANCER_ACOX1_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...366,SET,31,-0.20166,-0.0082791,0.14648,0.91569,GOBP_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...230,SET,8,-0.42671,-0.0089051,0.30984,0.91577,GOBP_POSITIVE_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,0.99999
GOBP_AMP_METABOLIC_PROCESS,SET,20,-0.26538,-0.008754,0.19266,0.91581,GOBP_AMP_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...548,SET,36,-0.19483,-0.0086183,0.14143,0.91582,GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,0.99999
GCM_CRKL,SET,59,-0.14289,-0.0080869,0.10372,0.91583,GCM_CRKL,0.99999
GOBP_IONOTROPIC_GLUTAMATE_RE...,SET,21,-0.27788,-0.0093923,0.20171,0.91583,GOBP_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GSE10147_IL3_AND_HIVP17_VS_I...1,SET,134,-0.095695,-0.0081453,0.069462,0.91584,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN,0.99999
MODULE_12,SET,322,-0.07051,-0.0092552,0.051177,0.91585,MODULE_12,0.99999
GOBP_REGULATION_OF_MUSCLE_TI...,SET,42,-0.19295,-0.009218,0.14005,0.91585,GOBP_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,0.99999
GSE8515_CTRL_VS_IL1_4H_STIM_...2,SET,177,-0.085294,-0.008334,0.061907,0.91585,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP,0.99999
MIR548AR_3P,SET,512,-0.051857,-0.008538,0.037638,0.91586,MIR548AR_3P,0.99999
FLECHNER_BIOPSY_KIDNEY_TRANS...1,SET,23,-0.22378,-0.0079153,0.16239,0.9159,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,0.99999
FAN_EMBRYONIC_CTX_NSC_2,SET,215,-0.078125,-0.0084043,0.056692,0.9159,FAN_EMBRYONIC_CTX_NSC_2,0.99999
GOBP_CHOLESTEROL_IMPORT,SET,9,-0.42926,-0.0095013,0.31146,0.91592,GOBP_CHOLESTEROL_IMPORT,0.99999
WP_EFFECTS_OF_MFN2_MUTATION,SET,22,-0.25899,-0.0089596,0.18791,0.91594,WP_EFFECTS_OF_MFN2_MUTATION,0.99999
GOBP_REGULATION_OF_CAMP_MEDI...,SET,19,-0.26864,-0.0086373,0.1949,0.91594,GOBP_REGULATION_OF_CAMP_MEDIATED_SIGNALING,0.99999
GOBP_MATURATION_OF_LSU_RRNA_...,SET,16,-0.25424,-0.007502,0.18444,0.91596,GOBP_MATURATION_OF_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.99999
HP_VIRAL_INFECTION_INDUCED_R...,SET,9,-0.36653,-0.0081129,0.26589,0.91597,HP_VIRAL_INFECTION_INDUCED_RHABDOMYOLYSIS,0.99999
MIR2278,SET,95,-0.11966,-0.008585,0.086776,0.91604,MIR2278,0.99999
HP_AXIAL_HYPOTONIA,SET,288,-0.067871,-0.0084333,0.049215,0.91605,HP_AXIAL_HYPOTONIA,0.99999
MORF_TPR,SET,131,-0.092545,-0.007789,0.067101,0.91607,MORF_TPR,0.99999
GSE21927_SPLEEN_VS_4T1_TUMOR...1,SET,173,-0.086713,-0.0083773,0.062866,0.91609,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,0.99999
MIR891B,SET,115,-0.10475,-0.0082639,0.075934,0.91612,MIR891B,0.99999
SEMBA_FHIT_TARGETS_DN,SET,9,-0.39667,-0.0087799,0.28752,0.91613,SEMBA_FHIT_TARGETS_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...707,SET,38,-0.21104,-0.0095911,0.15298,0.91613,GOBP_POSITIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
GOBP_PIGMENT_GRANULE_ORGANIZ...,SET,36,-0.20019,-0.0088558,0.14509,0.91616,GOBP_PIGMENT_GRANULE_ORGANIZATION,0.99999
GSE7596_AKT_TRANSD_VS_CTRL_C...1,SET,109,-0.11347,-0.008717,0.082244,0.91616,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_DN,0.99999
HP_MILD_MICROCEPHALY,SET,17,-0.27535,-0.0083747,0.19954,0.91619,HP_MILD_MICROCEPHALY,0.99999
ZIRN_TRETINOIN_RESPONSE_UP,SET,16,-0.31696,-0.0093524,0.22965,0.91622,ZIRN_TRETINOIN_RESPONSE_UP,0.99999
CTIP_DN.V1_UP,SET,115,-0.11103,-0.0087593,0.080444,0.91623,CTIP_DN.V1_UP,0.99999
REACTOME_CASPASE_ACTIVATION_...1,SET,16,-0.29752,-0.0087789,0.21554,0.91625,REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND,0.99999
GOBP_NEGATIVE_REGULATION_OF_...106,SET,181,-0.091602,-0.0090499,0.066358,0.91626,GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION,0.99999
PID_IFNG_PATHWAY,SET,40,-0.18803,-0.0087666,0.1362,0.91627,PID_IFNG_PATHWAY,0.99999
HP_ANTERIOR_RIB_CUPPING,SET,15,-0.29745,-0.0084985,0.21548,0.91627,HP_ANTERIOR_RIB_CUPPING,0.99999
GOBP_EPITHELIAL_CELL_CELL_AD...,SET,16,-0.30177,-0.0089043,0.21859,0.91628,GOBP_EPITHELIAL_CELL_CELL_ADHESION,0.99999
GOBP_NEPHRON_MORPHOGENESIS,SET,75,-0.14657,-0.0093485,0.10617,0.91628,GOBP_NEPHRON_MORPHOGENESIS,0.99999
GSE17721_LPS_VS_POLYIC_1H_BM...1,SET,179,-0.083192,-0.008174,0.060259,0.91629,GSE17721_LPS_VS_POLYIC_1H_BMDC_DN,0.99999
GSE19923_WT_VS_E2A_KO_DP_THY...2,SET,181,-0.087085,-0.0086037,0.063078,0.91629,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_UP,0.99999
HP_PERSISTENT_EBV_VIREMIA,SET,12,-0.30678,-0.0078402,0.22218,0.91631,HP_PERSISTENT_EBV_VIREMIA,0.99999
GSE27786_LSK_VS_CD4_TCELL_DN,SET,177,-0.086339,-0.0084361,0.062531,0.91631,GSE27786_LSK_VS_CD4_TCELL_DN,0.99999
BONCI_TARGETS_OF_MIR15A_AND_...,SET,90,-0.121,-0.0084505,0.087623,0.91633,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,0.99999
HP_BIVENTRICULAR_HYPERTROPHY,SET,13,-0.30319,-0.0080646,0.21954,0.91635,HP_BIVENTRICULAR_HYPERTROPHY,0.99999
GSE36476_CTRL_VS_TSST_ACT_40...2,SET,178,-0.08827,-0.0086489,0.063896,0.91642,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP,0.99999
GOBP_REGULATION_OF_CANONICAL...,SET,233,-0.080055,-0.0089608,0.057948,0.91643,GOBP_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,0.99999
HP_WIDELY_SPACED_MAXILLARY_C...,SET,9,-0.34092,-0.0075461,0.24676,0.91644,HP_WIDELY_SPACED_MAXILLARY_CENTRAL_INCISORS,0.99999
FERRARI_RESPONSE_TO_FENRETIN...1,SET,5,-0.61615,-0.010166,0.44591,0.91647,FERRARI_RESPONSE_TO_FENRETINIDE_DN,0.99999
GOBP_L_GLUTAMATE_IMPORT,SET,39,-0.18951,-0.0087247,0.13715,0.91647,GOBP_L_GLUTAMATE_IMPORT,0.99999
GOCC_DYSTROPHIN_ASSOCIATED_G...,SET,17,-0.28412,-0.0086411,0.20561,0.91647,GOCC_DYSTROPHIN_ASSOCIATED_GLYCOPROTEIN_COMPLEX,0.99999
REACTOME_DOWNSTREAM_SIGNALIN...2,SET,31,-0.20723,-0.0085077,0.14996,0.91648,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1,0.99999
KEGG_MEDICUS_REFERENCE_DNA_D...,SET,6,-0.49633,-0.0089707,0.35916,0.9165,KEGG_MEDICUS_REFERENCE_DNA_DEGRADATION_BY_EXTRACELLULAR_ENDOLYSOSOMAL_DNASE,0.99999
GSE360_HIGH_VS_LOW_DOSE_B_MA...2,SET,179,-0.086826,-0.008531,0.062825,0.91651,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP,0.99999
CSR_EARLY_UP.V1_DN,SET,113,-0.10764,-0.0084179,0.07787,0.91654,CSR_EARLY_UP.V1_DN,0.99999
YCATTAA_UNKNOWN,SET,499,-0.055067,-0.0089539,0.039831,0.91658,YCATTAA_UNKNOWN,0.99999
SIG_CHEMOTAXIS,SET,39,-0.1779,-0.0081905,0.12867,0.91661,SIG_CHEMOTAXIS,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...9,SET,13,-0.28853,-0.0076746,0.20864,0.91664,GOCC_EXTRINSIC_COMPONENT_OF_SYNAPTIC_MEMBRANE,0.99999
GOCC_ACTIN_BASED_CELL_PROJEC...,SET,207,-0.083111,-0.0087747,0.060078,0.91672,GOCC_ACTIN_BASED_CELL_PROJECTION,0.99999
HFH4_01,SET,180,-0.090172,-0.0088842,0.065176,0.91674,HFH4_01,0.99999
REACTOME_CD28_DEPENDENT_PI3K...,SET,22,-0.2652,-0.0091743,0.19164,0.91678,REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING,0.99999
REACTOME_FORMATION_OF_THE_UR...,SET,19,-0.31133,-0.01001,0.22489,0.91687,REACTOME_FORMATION_OF_THE_URETERIC_BUD,0.99999
HP_ARTHROGRYPOSIS_MULTIPLEX_...,SET,122,-0.10369,-0.0084244,0.074895,0.91689,HP_ARTHROGRYPOSIS_MULTIPLEX_CONGENITA,0.99999
GSE14308_TH2_VS_INDUCED_TREG...2,SET,181,-0.088462,-0.0087397,0.063885,0.91692,GSE14308_TH2_VS_INDUCED_TREG_UP,0.99999
GRAHAM_CML_QUIESCENT_VS_NORM...4,SET,80,-0.13118,-0.0086401,0.094671,0.91706,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_LI...3,SET,32,-0.22013,-0.0091819,0.15887,0.91706,GOBP_CELLULAR_RESPONSE_TO_LIPOPROTEIN_PARTICLE_STIMULUS,0.99999
GOBP_PYRIMIDINE_DIMER_REPAIR,SET,9,-0.28934,-0.0064043,0.20882,0.91706,GOBP_PYRIMIDINE_DIMER_REPAIR,0.99999
GOBP_REGULATION_OF_CIRCADIAN...2,SET,5,-0.59329,-0.0097891,0.42817,0.91706,GOBP_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP,0.99999
GSE37532_VISCERAL_ADIPOSE_TI...3,SET,120,-0.10337,-0.0083297,0.074604,0.91706,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN,0.99999
HP_BROAD_CHIN,SET,8,-0.4876,-0.010176,0.35185,0.91709,HP_BROAD_CHIN,0.99999
GSE3039_NKT_CELL_VS_ALPHABET...2,SET,182,-0.082582,-0.0081811,0.05959,0.91709,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP,0.99999
GOBP_FLOOR_PLATE_DEVELOPMENT,SET,10,-0.3336,-0.0077831,0.24067,0.91714,GOBP_FLOOR_PLATE_DEVELOPMENT,0.99999
GOMF_OPSIN_BINDING,SET,4,-0.64222,-0.009478,0.46327,0.91716,GOMF_OPSIN_BINDING,0.99999
GTGCAAA_MIR507,SET,117,-0.11398,-0.0090694,0.082214,0.91717,GTGCAAA_MIR507,0.99999
GOBP_REGULATION_OF_PLATELET_...4,SET,8,-0.41489,-0.0086583,0.29927,0.91717,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_CEREBRAL_SUBCORT...,SET,1030,-0.036694,-0.0084435,0.026468,0.91717,HP_ABNORMAL_CEREBRAL_SUBCORTEX_MORPHOLOGY,0.99999
GOBP_PIGMENT_BIOSYNTHETIC_PR...,SET,49,-0.16578,-0.0085528,0.11957,0.91718,GOBP_PIGMENT_BIOSYNTHETIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...60,SET,33,-0.21354,-0.0090449,0.15401,0.9172,GOBP_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION,0.99999
GOMF_LIGAND_GATED_MONOATOMIC...1,SET,42,-0.20428,-0.0097588,0.14732,0.91721,GOMF_LIGAND_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.99999
GSE15930_NAIVE_VS_24H_IN_VIT...6,SET,187,-0.085476,-0.0085821,0.061645,0.91721,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...54,SET,4,-0.62179,-0.0091765,0.44837,0.91724,GOBP_NEGATIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,0.99999
REACTOME_TP53_REGULATES_TRAN...10,SET,13,-0.33034,-0.0087868,0.23818,0.91726,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN,0.99999
GOBP_SYNAPTIC_VESICLE_DOCKING,SET,9,-0.38026,-0.0084169,0.27414,0.91729,GOBP_SYNAPTIC_VESICLE_DOCKING,0.99999
HP_NEOPLASM_OF_THE_THYMUS,SET,7,-0.43945,-0.0085788,0.31681,0.91729,HP_NEOPLASM_OF_THE_THYMUS,0.99999
HP_ABNORMAL_NUMBER_OF_INCISO...,SET,51,-0.1628,-0.0085682,0.11736,0.9173,HP_ABNORMAL_NUMBER_OF_INCISORS,0.99999
LI_INDUCED_T_TO_NATURAL_KILL...2,SET,287,-0.070706,-0.0087705,0.05096,0.91734,LI_INDUCED_T_TO_NATURAL_KILLER_UP,0.99999
GOCC_UBIQUITIN_LIGASE_COMPLEX,SET,282,-0.068409,-0.0084125,0.049304,0.91734,GOCC_UBIQUITIN_LIGASE_COMPLEX,0.99999
GATA1_05,SET,260,-0.077117,-0.0091115,0.055579,0.91735,GATA1_05,0.99999
GSE14308_TH2_VS_TH17_DN,SET,184,-0.080685,-0.0080364,0.05814,0.91739,GSE14308_TH2_VS_TH17_DN,0.99999
ENK_UV_RESPONSE_EPIDERMIS_UP,SET,268,-0.071128,-0.0085304,0.051247,0.91742,ENK_UV_RESPONSE_EPIDERMIS_UP,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...7,SET,5,-0.57753,-0.0095291,0.41609,0.91742,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PACER_RUBCN_PI3KC3_C2,0.99999
HP_HYPERGASTRINEMIA,SET,6,-0.47632,-0.008609,0.34317,0.91742,HP_HYPERGASTRINEMIA,0.99999
HP_SYSTEMIC_LUPUS_ERYTHEMATO...,SET,29,-0.23086,-0.0091674,0.16622,0.91755,HP_SYSTEMIC_LUPUS_ERYTHEMATOSUS,0.99999
GOBP_PYRIMIDINE_NUCLEOSIDE_T...2,SET,22,-0.26036,-0.009007,0.18746,0.91756,GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...54,SET,5,-0.40928,-0.0067531,0.29462,0.9176,GOBP_POSITIVE_REGULATION_OF_BASEMENT_MEMBRANE_ASSEMBLY_INVOLVED_IN_EMBRYONIC_BODY_MORPHOGENESIS,0.99999
HP_BOWED_FOREARM_BONES,SET,31,-0.22712,-0.0093244,0.16349,0.9176,HP_BOWED_FOREARM_BONES,0.99999
GRAESSMANN_APOPTOSIS_BY_SERU...2,SET,509,-0.052003,-0.0085376,0.03743,0.91762,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP,0.99999
GOMF_ATP_ACTIVATED_INWARD_RE...,SET,6,-0.60124,-0.010867,0.43268,0.91766,GOMF_ATP_ACTIVATED_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.99999
LEE_CALORIE_RESTRICTION_MUSC...2,SET,36,-0.19933,-0.0088177,0.14339,0.91775,LEE_CALORIE_RESTRICTION_MUSCLE_UP,0.99999
MODULE_355,SET,29,-0.20348,-0.0080805,0.14637,0.91776,MODULE_355,0.99999
HP_CARIOUS_TEETH,SET,147,-0.098526,-0.0087805,0.070844,0.91784,HP_CARIOUS_TEETH,0.99999
LANG_MYB_FAMILY_TARGETS,SET,28,-0.22439,-0.008756,0.16132,0.91788,LANG_MYB_FAMILY_TARGETS,0.99999
CORONEL_RFX7_DIRECT_TARGETS_...,SET,39,-0.18636,-0.0085798,0.13396,0.9179,CORONEL_RFX7_DIRECT_TARGETS_UP,0.99999
HP_MANDIBULAR_APLASIA,SET,10,-0.38073,-0.0088829,0.27366,0.91792,HP_MANDIBULAR_APLASIA,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...2,SET,185,-0.082783,-0.0082676,0.059499,0.91793,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.99999
MIR4440,SET,5,-0.62613,-0.010331,0.44997,0.91795,MIR4440,0.99999
HP_PARATHYROID_CARCINOMA,SET,7,-0.47703,-0.0093124,0.34278,0.91797,HP_PARATHYROID_CARCINOMA,0.99999
PARK_APL_PATHOGENESIS_UP,SET,14,-0.33171,-0.0091561,0.23834,0.91799,PARK_APL_PATHOGENESIS_UP,0.99999
MIR4799_5P,SET,364,-0.062542,-0.0087181,0.044932,0.91802,MIR4799_5P,0.99999
GOBP_VENTRICULAR_CARDIAC_MUS...1,SET,33,-0.2235,-0.0094666,0.16055,0.91804,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.99999
GOBP_PHOSPHATIDYLGLYCEROL_AC...,SET,9,-0.43607,-0.0096522,0.31323,0.91806,GOBP_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING,0.99999
GOMF_HISTONE_METHYLTRANSFERA...2,SET,13,-0.28171,-0.0074932,0.20234,0.91807,GOMF_HISTONE_METHYLTRANSFERASE_BINDING,0.99999
HP_ABNORMAL_HEAD_MOVEMENTS,SET,33,-0.21532,-0.00912,0.15464,0.91809,HP_ABNORMAL_HEAD_MOVEMENTS,0.99999
ZHONG_PFC_C1_OPC,SET,218,-0.078958,-0.0085522,0.056704,0.9181,ZHONG_PFC_C1_OPC,0.99999
HP_NARROW_PALPEBRAL_FISSURE,SET,59,-0.14637,-0.0082839,0.10511,0.91811,HP_NARROW_PALPEBRAL_FISSURE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...230,SET,17,-0.26278,-0.0079922,0.18867,0.91815,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.99999
GOBP_PLATELET_DERIVED_GROWTH...1,SET,7,-0.48014,-0.0093731,0.34472,0.91816,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_ALPHA_SIGNALING_PATHWAY,0.99999
HP_CHRONIC_DIARRHEA,SET,93,-0.11949,-0.0084825,0.085776,0.91819,HP_CHRONIC_DIARRHEA,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...9,SET,71,-0.14004,-0.0086917,0.1005,0.91824,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,0.99999
GOBP_ENDOSOMAL_LUMEN_ACIDIFI...,SET,11,-0.37977,-0.0092926,0.27253,0.91826,GOBP_ENDOSOMAL_LUMEN_ACIDIFICATION,0.99999
GOMF_CORTICOTROPIN_RELEASING...,SET,5,-0.56383,-0.0093031,0.40457,0.91828,GOMF_CORTICOTROPIN_RELEASING_HORMONE_RECEPTOR_BINDING,0.99999
HP_BIRD_LIKE_FACIES,SET,13,-0.27867,-0.0074125,0.19991,0.91833,HP_BIRD_LIKE_FACIES,0.99999
GSE17721_CTRL_VS_PAM3CSK4_12...2,SET,181,-0.085968,-0.0084933,0.061669,0.91834,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP,0.99999
MODULE_410,SET,35,-0.21879,-0.0095433,0.15692,0.91837,MODULE_410,0.99999
WP_HIPPOCAMPAL_SYNAPTOGENESI...,SET,27,-0.26052,-0.0099827,0.18681,0.91841,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,0.99999
GSE21670_UNTREATED_VS_TGFB_I...2,SET,170,-0.089715,-0.0085925,0.064327,0.91843,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP,0.99999
REACTOME_MET_INTERACTS_WITH_...,SET,5,-0.61198,-0.010098,0.43878,0.91844,REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS,0.99999
GOMF_LYSINE_N_ACETYLTRANSFER...,SET,6,-0.47689,-0.0086193,0.34189,0.91846,GOMF_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY_ACTING_ON_ACETYL_PHOSPHATE_AS_DONOR,0.99999
PEPPER_CHRONIC_LYMPHOCYTIC_L...1,SET,21,-0.28057,-0.0094832,0.20112,0.91848,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,0.99999
GSE26030_TH1_VS_TH17_DAY15_P...1,SET,176,-0.09021,-0.0087897,0.064662,0.9185,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN,0.99999
NKX2_3_TARGET_GENES,SET,435,-0.056162,-0.0085415,0.040244,0.91857,NKX2_3_TARGET_GENES,0.99999
GOBP_CELLULAR_RESPONSE_TO_CH...2,SET,17,-0.29237,-0.0088923,0.20946,0.91861,GOBP_CELLULAR_RESPONSE_TO_CHOLESTEROL,0.99999
REACTOME_RNA_POLYMERASE_I_TR...1,SET,45,-0.15613,-0.0077201,0.11184,0.91864,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,0.99999
REACTOME_PROCESSIVE_SYNTHESI...1,SET,19,-0.24962,-0.0080256,0.17879,0.91865,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE,0.99999
GSE27241_CTRL_VS_DIGOXIN_TRE...4,SET,175,-0.085435,-0.0083009,0.061192,0.91866,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...12,SET,8,-0.37681,-0.0078638,0.26986,0.91868,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_PRIMING,0.99999
GOBP_REGULATION_OF_FIBROBLAS...2,SET,29,-0.23507,-0.0093347,0.16834,0.91869,GOBP_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
MIR6757_3P,SET,96,-0.11798,-0.0085089,0.084484,0.91871,MIR6757_3P,0.99999
MIR196A_3P,SET,115,-0.11113,-0.0087676,0.079567,0.91874,MIR196A_3P,0.99999
MIR449C_5P,SET,121,-0.1102,-0.0089168,0.078899,0.91875,MIR449C_5P,0.99999
chr16p12,SET,78,-0.24461,-0.015909,0.17511,0.91876,chr16p12,0.99999
GOMF_LIPASE_INHIBITOR_ACTIVI...,SET,14,-0.34592,-0.0095483,0.24764,0.91876,GOMF_LIPASE_INHIBITOR_ACTIVITY,0.99999
HP_PERIODIC_PARALYSIS,SET,9,-0.41394,-0.0091623,0.29633,0.91876,HP_PERIODIC_PARALYSIS,0.99999
GSE3982_CTRL_VS_LPS_48H_DC_UP,SET,183,-0.087831,-0.0087247,0.062878,0.91876,GSE3982_CTRL_VS_LPS_48H_DC_UP,0.99999
HP_PREMATURE_OVARIAN_INSUFFI...,SET,61,-0.14077,-0.0081006,0.10077,0.91877,HP_PREMATURE_OVARIAN_INSUFFICIENCY,0.99999
HP_CENTRAL_PRIMITIVE_NEUROEC...,SET,6,-0.5485,-0.0099137,0.39258,0.91881,HP_CENTRAL_PRIMITIVE_NEUROECTODERMAL_TUMOR,0.99999
WP_MEVALONATE_ARM_OF_CHOLEST...,SET,13,-0.27623,-0.0073475,0.19767,0.91885,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,0.99999
HP_ABNORMAL_MAGNESIUM_CONCEN...,SET,31,-0.22679,-0.0093108,0.16228,0.91886,HP_ABNORMAL_MAGNESIUM_CONCENTRATION,0.99999
HP_SPOKEN_WORD_RECOGNITION_D...,SET,8,-0.40114,-0.0083715,0.28703,0.91887,HP_SPOKEN_WORD_RECOGNITION_DEFICIT,0.99999
GSE15659_CD45RA_NEG_CD4_TCEL...2,SET,163,-0.091796,-0.0086106,0.065678,0.91888,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP,0.99999
GOMF_PYRUVATE_TRANSMEMBRANE_...,SET,5,-0.55039,-0.0090813,0.39376,0.9189,GOMF_PYRUVATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...12,SET,181,-0.082018,-0.008103,0.058674,0.91891,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP,0.99999
HP_ABNORMALITY_OF_FOLATE_MET...,SET,13,-0.33247,-0.0088435,0.23767,0.91907,HP_ABNORMALITY_OF_FOLATE_METABOLISM,0.99999
GOMF_PEPTIDE_RECEPTOR_ACTIVI...,SET,119,-0.12154,-0.0097528,0.086862,0.91912,GOMF_PEPTIDE_RECEPTOR_ACTIVITY,0.99999
YAO_TEMPORAL_RESPONSE_TO_PRO...1,SET,68,-0.14301,-0.0086868,0.10219,0.91914,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,0.99999
GOCC_PRESYNAPTIC_ENDOCYTIC_Z...,SET,9,-0.42043,-0.0093059,0.30042,0.91915,GOCC_PRESYNAPTIC_ENDOCYTIC_ZONE,0.99999
GAO_LARGE_INTESTINE_24W_C1_D...,SET,93,-0.1336,-0.0094843,0.09546,0.91917,GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR,0.99999
ACATATC_MIR190,SET,54,-0.17016,-0.0092146,0.12157,0.91919,ACATATC_MIR190,0.99999
GOBP_REGULATION_OF_MEMBRANE_...14,SET,5,-0.46873,-0.0077339,0.33487,0.91919,GOBP_REGULATION_OF_MEMBRANE_TUBULATION,0.99999
GSE3565_CTRL_VS_LPS_INJECTED...2,SET,166,-0.097356,-0.0092151,0.06953,0.91927,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP,0.99999
GOBP_L_GLUTAMATE_IMPORT_ACRO...,SET,17,-0.30294,-0.0092135,0.21631,0.91931,GOBP_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GSE12845_NAIVE_VS_PRE_GC_TON...2,SET,180,-0.08916,-0.0087845,0.06366,0.91932,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP,0.99999
GSE1925_CTRL_VS_IFNG_PRIMED_...4,SET,156,-0.089199,-0.008187,0.063689,0.91932,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP,0.99999
GU_PDEF_TARGETS_UP,SET,68,-0.157,-0.0095366,0.11205,0.91941,GU_PDEF_TARGETS_UP,0.99999
GOBP_DNA_TOPOLOGICAL_CHANGE,SET,9,-0.32604,-0.0072167,0.23264,0.91945,GOBP_DNA_TOPOLOGICAL_CHANGE,0.99999
MIR12116,SET,48,-0.15883,-0.0081104,0.11329,0.91953,MIR12116,0.99999
MOREAUX_B_LYMPHOCYTE_MATURAT...1,SET,69,-0.1283,-0.0078502,0.091493,0.91958,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN,0.99999
GOBP_REGULATION_OF_PHOSPHATI...1,SET,5,-0.57211,-0.0094397,0.40794,0.9196,GOBP_REGULATION_OF_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,0.99999
MIR5010_5P,SET,33,-0.20824,-0.0088203,0.14845,0.91964,MIR5010_5P,0.99999
PASINI_SUZ12_TARGETS_UP,SET,93,-0.12877,-0.0091411,0.091791,0.91966,PASINI_SUZ12_TARGETS_UP,0.99999
GOMF_PHEROMONE_RECEPTOR_ACTI...,SET,3,-0.7478,-0.009558,0.53304,0.91967,GOMF_PHEROMONE_RECEPTOR_ACTIVITY,0.99999
GOBP_CORPUS_CALLOSUM_MORPHOG...,SET,5,-0.60915,-0.010051,0.43411,0.91971,GOBP_CORPUS_CALLOSUM_MORPHOGENESIS,0.99999
GOMF_POLY_ADP_D_RIBOSE_BINDI...,SET,4,-0.47906,-0.0070701,0.34138,0.91973,GOMF_POLY_ADP_D_RIBOSE_BINDING,0.99999
GOBP_REGULATION_OF_INFLAMMAT...1,SET,357,-0.065851,-0.0090926,0.046903,0.91983,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE,0.99999
KEGG_MEDICUS_REFERENCE_TAC3_...,SET,10,-0.37238,-0.008688,0.26519,0.91986,KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY,0.99999
MIR510_3P,SET,337,-0.065634,-0.0088099,0.046742,0.91986,MIR510_3P,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...14,SET,5,-0.47627,-0.0078584,0.33907,0.91993,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_LRRK2_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.99999
PID_CXCR4_PATHWAY,SET,95,-0.12082,-0.0086682,0.086016,0.91993,PID_CXCR4_PATHWAY,0.99999
BIOCARTA_DICER_PATHWAY,SET,5,-0.56202,-0.0092732,0.40008,0.91994,BIOCARTA_DICER_PATHWAY,0.99999
MODULE_166,SET,48,-0.16335,-0.0083413,0.11628,0.91996,MODULE_166,0.99999
KEGG_MEDICUS_REFERENCE_GLYCO...3,SET,5,-0.51779,-0.0085434,0.36852,0.91999,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_,0.99999
GOBP_LOW_DENSITY_LIPOPROTEIN...1,SET,27,-0.24301,-0.0093119,0.17295,0.91999,GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
GOBP_RIBOSE_PHOSPHATE_BIOSYN...,SET,176,-0.084454,-0.0082288,0.060085,0.92007,GOBP_RIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_PE...1,SET,13,-0.35473,-0.0094356,0.25234,0.9201,GOBP_CELLULAR_RESPONSE_TO_PEPTIDE,0.99999
GOBP_DISACCHARIDE_METABOLIC_...,SET,11,-0.36326,-0.0088887,0.25836,0.92014,GOBP_DISACCHARIDE_METABOLIC_PROCESS,0.99999
PUJANA_BREAST_CANCER_WITH_BR...1,SET,8,-0.36501,-0.0076174,0.25957,0.92016,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN,0.99999
HP_HYPERTONIA,SET,975,-0.037851,-0.0084876,0.026917,0.92016,HP_HYPERTONIA,0.99999
HOLLEMAN_DAUNORUBICIN_ALL_UP,SET,6,-0.48432,-0.0087536,0.34431,0.92022,HOLLEMAN_DAUNORUBICIN_ALL_UP,0.99999
MIR4756_5P,SET,123,-0.11153,-0.0090976,0.079283,0.92023,MIR4756_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...108,SET,5,-0.52584,-0.0086762,0.37381,0.92023,GOBP_POSITIVE_REGULATION_OF_CELLULAR_PH_REDUCTION,0.99999
BIOCARTA_RB_PATHWAY,SET,13,-0.29279,-0.0077881,0.20812,0.92026,BIOCARTA_RB_PATHWAY,0.99999
GSE3982_CTRL_VS_PMA_STIM_EOS...1,SET,174,-0.092103,-0.0089234,0.065466,0.92026,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN,0.99999
REACTOME_LYSINE_CATABOLISM,SET,12,-0.31861,-0.0081425,0.22641,0.92031,REACTOME_LYSINE_CATABOLISM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...166,SET,135,-0.099882,-0.008533,0.070978,0.92031,GOBP_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,0.99999
GOBP_GLUCOSE_METABOLIC_PROCE...,SET,168,-0.090513,-0.0086183,0.064315,0.92033,GOBP_GLUCOSE_METABOLIC_PROCESS,0.99999
HP_ABSENCE_OF_THE_SACRUM,SET,8,-0.4224,-0.008815,0.30011,0.92034,HP_ABSENCE_OF_THE_SACRUM,0.99999
HP_PARASOMNIA,SET,37,-0.19804,-0.008881,0.1407,0.92036,HP_PARASOMNIA,0.99999
GOBP_RESPONSE_TO_VITAMIN_K,SET,4,-0.70171,-0.010356,0.49848,0.92038,GOBP_RESPONSE_TO_VITAMIN_K,0.99999
MIR3978,SET,228,-0.079773,-0.0088341,0.056653,0.92044,MIR3978,0.99999
GOBP_MUCOSA_ASSOCIATED_LYMPH...,SET,8,-0.45966,-0.0095927,0.32644,0.92044,GOBP_MUCOSA_ASSOCIATED_LYMPHOID_TISSUE_DEVELOPMENT,0.99999
MIR4420,SET,176,-0.087946,-0.0085691,0.062451,0.92046,MIR4420,0.99999
GSE13522_WT_VS_IFNG_KO_SKIN_...1,SET,108,-0.11747,-0.0089828,0.083415,0.92047,GSE13522_WT_VS_IFNG_KO_SKIN_DN,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...8,SET,40,-0.20699,-0.0096508,0.14697,0.92049,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL,0.99999
CREL_01,SET,240,-0.078335,-0.0088973,0.055605,0.92054,CREL_01,0.99999
HP_PANCREATIC_HYPOPLASIA,SET,24,-0.25672,-0.0092753,0.18223,0.92054,HP_PANCREATIC_HYPOPLASIA,0.99999
GOBP_POSITIVE_REGULATION_OF_...90,SET,23,-0.27692,-0.0097947,0.19649,0.92062,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.99999
GOBP_REGULATION_OF_HIGH_DENS...,SET,4,-0.5367,-0.0079208,0.38062,0.92073,GOBP_REGULATION_OF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
PRKDC_TARGET_GENES,SET,696,-0.045599,-0.0087081,0.032335,0.92075,PRKDC_TARGET_GENES,0.99999
MIKKELSEN_IPS_ICP_WITH_H3K27...,SET,54,-0.1645,-0.0089082,0.11664,0.92078,MIKKELSEN_IPS_ICP_WITH_H3K27ME3,0.99999
GOMF_FATTY_ACID_ELONGASE_ACT...,SET,7,-0.50313,-0.0098219,0.35667,0.92082,GOMF_FATTY_ACID_ELONGASE_ACTIVITY,0.99999
HP_THIN_CORPUS_CALLOSUM,SET,735,-0.043423,-0.0085123,0.03078,0.92083,HP_THIN_CORPUS_CALLOSUM,0.99999
GSE22886_UNSTIM_VS_STIM_MEMO...2,SET,178,-0.090215,-0.0088394,0.063949,0.92083,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP,0.99999
GOMF_VOLTAGE_GATED_MONOATOMI...1,SET,14,-0.30886,-0.0085252,0.2189,0.92086,GOMF_VOLTAGE_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.99999
HP_KETONURIA,SET,32,-0.20036,-0.008357,0.142,0.92086,HP_KETONURIA,0.99999
GOBP_NEUTRAL_LIPID_METABOLIC...,SET,119,-0.10949,-0.0087862,0.077601,0.92087,GOBP_NEUTRAL_LIPID_METABOLIC_PROCESS,0.99999
PID_AJDISS_2PATHWAY,SET,46,-0.18568,-0.009282,0.13158,0.92089,PID_AJDISS_2PATHWAY,0.99999
GOMF_POTASSIUM_CHANNEL_ACTIV...1,SET,5,-0.59393,-0.0097998,0.42085,0.92091,GOMF_POTASSIUM_CHANNEL_ACTIVATOR_ACTIVITY,0.99999
HP_CARDIAC_SHUNT,SET,14,-0.35012,-0.0096644,0.24808,0.92092,HP_CARDIAC_SHUNT,0.99999
REACTOME_CD28_CO_STIMULATION,SET,32,-0.21898,-0.0091336,0.15513,0.92095,REACTOME_CD28_CO_STIMULATION,0.99999
BEIER_GLIOMA_STEM_CELL_DN,SET,60,-0.15317,-0.0087416,0.10847,0.92103,BEIER_GLIOMA_STEM_CELL_DN,0.99999
LET_7C_3P,SET,537,-0.052406,-0.0088302,0.037111,0.92104,LET_7C_3P,0.99999
HP_INCREASED_INTERVERTEBRAL_...,SET,6,-0.49149,-0.0088832,0.34798,0.92108,HP_INCREASED_INTERVERTEBRAL_SPACE,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...5,SET,173,-0.086443,-0.0083512,0.061199,0.92109,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_UP,0.99999
TRAVAGLINI_LUNG_PERICYTE_CELL,SET,109,-0.12701,-0.0097569,0.0899,0.92113,TRAVAGLINI_LUNG_PERICYTE_CELL,0.99999
GOBP_HEMOSTASIS,SET,220,-0.085371,-0.0092887,0.060422,0.92115,GOBP_HEMOSTASIS,0.99999
GSE28237_EARLY_VS_LATE_GC_BC...2,SET,183,-0.091671,-0.0091061,0.064867,0.92119,GSE28237_EARLY_VS_LATE_GC_BCELL_UP,0.99999
MIR138_2_3P,SET,154,-0.10109,-0.0092193,0.07153,0.9212,MIR138_2_3P,0.99999
HP_POSTERIOR_PLAGIOCEPHALY,SET,7,-0.45801,-0.0089411,0.324,0.92126,HP_POSTERIOR_PLAGIOCEPHALY,0.99999
GSE29615_CTRL_VS_DAY7_LAIV_F...2,SET,153,-0.099282,-0.0090251,0.070227,0.92127,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...22,SET,65,-0.13902,-0.0082571,0.098332,0.92128,GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,0.99999
JNK_DN.V1_DN,SET,167,-0.098176,-0.0093204,0.06943,0.92132,JNK_DN.V1_DN,0.99999
AIZARANI_LIVER_C1_NK_NKT_CEL...,SET,136,-0.10892,-0.0093397,0.076999,0.9214,AIZARANI_LIVER_C1_NK_NKT_CELLS_1,0.99999
GNF2_ZAP70,SET,23,-0.24797,-0.0087709,0.17527,0.92143,GNF2_ZAP70,0.99999
MIR6128,SET,153,-0.098307,-0.0089365,0.06948,0.92144,MIR6128,0.99999
REACTOME_REGULATION_OF_ENDOG...4,SET,9,-0.33345,-0.0073808,0.23565,0.92146,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX,0.99999
GSE21774_CD62L_POS_CD56_BRIG...2,SET,173,-0.095459,-0.0092222,0.067448,0.9215,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,0.99999
REACTOME_TLR3_MEDIATED_TICAM...,SET,6,-0.54216,-0.0097991,0.38303,0.92153,REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH,0.99999
HP_PULMONARY_CYST,SET,26,-0.23453,-0.008819,0.16568,0.92154,HP_PULMONARY_CYST,0.99999
GOBP_CELLULAR_LIPID_METABOLI...,SET,921,-0.040598,-0.0088615,0.028678,0.92155,GOBP_CELLULAR_LIPID_METABOLIC_PROCESS,0.99999
MODULE_279,SET,122,-0.10457,-0.0084952,0.073862,0.92156,MODULE_279,0.99999
GSE41867_NAIVE_VS_EFFECTOR_C...1,SET,182,-0.080681,-0.0079927,0.056986,0.92158,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,0.99999
REACTOME_PTK6_REGULATES_RTKS...,SET,8,-0.4553,-0.0095016,0.32156,0.92159,REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1,0.99999
MODULE_36,SET,145,-0.093515,-0.0082774,0.066045,0.92159,MODULE_36,0.99999
JIANG_AGING_CEREBRAL_CORTEX_...1,SET,43,-0.18248,-0.0088203,0.12887,0.9216,JIANG_AGING_CEREBRAL_CORTEX_DN,0.99999
LIU_COMMON_CANCER_GENES,SET,59,-0.15052,-0.0085188,0.10629,0.92162,LIU_COMMON_CANCER_GENES,0.99999
HP_SCHIZENCEPHALY,SET,9,-0.46081,-0.0102,0.3254,0.92163,HP_SCHIZENCEPHALY,0.99999
MIR1296_3P,SET,34,-0.19608,-0.00843,0.13842,0.92169,MIR1296_3P,0.99999
CARRILLOREIXACH_MRS3_VS_LOWE...1,SET,144,-0.10811,-0.0095364,0.076313,0.9217,CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN,0.99999
GOBP_ENDOSOMAL_VESICLE_FUSION,SET,15,-0.27401,-0.0078285,0.19342,0.9217,GOBP_ENDOSOMAL_VESICLE_FUSION,0.99999
HP_HYPERSOMNIA,SET,15,-0.31361,-0.0089601,0.22134,0.92173,HP_HYPERSOMNIA,0.99999
GSE37301_GRANULOCYTE_MONOCYT...2,SET,165,-0.092302,-0.0087105,0.065141,0.92174,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.99999
MORF_MDM2,SET,248,-0.076867,-0.0088729,0.05424,0.92177,MORF_MDM2,0.99999
GOMF_NMDA_GLUTAMATE_RECEPTOR...,SET,7,-0.48226,-0.0094145,0.34031,0.92177,GOMF_NMDA_GLUTAMATE_RECEPTOR_ACTIVITY,0.99999
GSE11864_UNTREATED_VS_CSF1_I...1,SET,172,-0.087999,-0.0084772,0.062088,0.9218,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN,0.99999
GSE27786_LIN_NEG_VS_ERYTHROB...2,SET,182,-0.084692,-0.0083901,0.059745,0.92183,GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP,0.99999
WP_PENTOSE_PHOSPHATE_METABOL...,SET,6,-0.5106,-0.0092286,0.36018,0.92184,WP_PENTOSE_PHOSPHATE_METABOLISM,0.99999
GOMF_VITAMIN_D_BINDING,SET,6,-0.55943,-0.010111,0.39462,0.92184,GOMF_VITAMIN_D_BINDING,0.99999
NAKAYAMA_SOFT_TISSUE_TUMORS_...1,SET,66,-0.16201,-0.009696,0.11424,0.92192,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,0.99999
HP_ATROPHIC_GASTRITIS,SET,7,-0.40955,-0.0079952,0.28875,0.92195,HP_ATROPHIC_GASTRITIS,0.99999
MIR4789_3P,SET,305,-0.070796,-0.0090484,0.049911,0.92196,MIR4789_3P,0.99999
GOBP_REGULATION_OF_MICROVILL...2,SET,7,-0.38702,-0.0075553,0.27284,0.92196,GOBP_REGULATION_OF_MICROVILLUS_LENGTH,0.99999
CHIARADONNA_NEOPLASTIC_TRANS...3,SET,49,-0.17623,-0.009092,0.12424,0.92197,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...21,SET,15,-0.34283,-0.0097948,0.24168,0.92197,GOBP_NEGATIVE_REGULATION_OF_AMINO_ACID_TRANSPORT,0.99999
GOMF_GLUTAMATE_GATED_CALCIUM...,SET,7,-0.48438,-0.0094559,0.34142,0.922,GOMF_GLUTAMATE_GATED_CALCIUM_ION_CHANNEL_ACTIVITY,0.99999
GOMF_GLYCERALDEHYDE_3_PHOSPH...,SET,7,-0.41152,-0.0080337,0.29002,0.92204,GOMF_GLYCERALDEHYDE_3_PHOSPHATE_DEHYDROGENASE_NADPLUS_NON_PHOSPHORYLATING_ACTIVITY,0.99999
MIR3664_5P,SET,69,-0.14502,-0.0088734,0.10219,0.92206,MIR3664_5P,0.99999
GOBP_NUCLEOSIDE_TRIPHOSPHATE...1,SET,85,-0.11645,-0.0079046,0.082047,0.92208,GOBP_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
ERBB2_UP.V1_UP,SET,168,-0.095875,-0.0091288,0.067543,0.92211,ERBB2_UP.V1_UP,0.99999
REACTOME_REGULATION_OF_HOMOT...,SET,30,-0.23388,-0.009446,0.16472,0.92217,REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,0.99999
GOBP_PYRIMIDINE_RIBONUCLEOSI...5,SET,16,-0.31035,-0.0091574,0.21857,0.92217,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.99999
GOMF_VINCULIN_BINDING,SET,11,-0.3816,-0.0093373,0.26874,0.92218,GOMF_VINCULIN_BINDING,0.99999
GOBP_LEUKOTRIENE_CATABOLIC_P...,SET,6,-0.49465,-0.0089403,0.34832,0.9222,GOBP_LEUKOTRIENE_CATABOLIC_PROCESS,0.99999
GSE11864_UNTREATED_VS_CSF1_I...5,SET,163,-0.091433,-0.0085766,0.064385,0.9222,GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN,0.99999
GOBP_SECRETION,SET,898,-0.041702,-0.0089941,0.029352,0.9223,GOBP_SECRETION,0.99999
GSE15735_2H_VS_12H_HDAC_INHI...1,SET,189,-0.088144,-0.0088967,0.062028,0.92234,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...9,SET,185,-0.087322,-0.008721,0.061449,0.92234,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN,0.99999
KEGG_MEDICUS_REFERENCE_REGUL...3,SET,4,-0.64158,-0.0094686,0.45139,0.92238,KEGG_MEDICUS_REFERENCE_REGULATION_OF_EXTRINSIC_APOPTOTIC_PATHWAY_XIAP,0.99999
HP_CORONARY_ARTERY_ANEURYSM,SET,7,-0.53702,-0.010484,0.3778,0.9224,HP_CORONARY_ARTERY_ANEURYSM,0.99999
HP_ANTALGIC_GAIT,SET,9,-0.47199,-0.010447,0.33203,0.92241,HP_ANTALGIC_GAIT,0.99999
chr7q33,SET,24,-0.33979,-0.012277,0.23888,0.92254,chr7q33,0.99999
HP_HIRSUTISM,SET,195,-0.083498,-0.0085591,0.058687,0.92259,HP_HIRSUTISM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...637,SET,4,-0.63857,-0.0094241,0.44876,0.92262,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_MUSCLE_HY...,SET,53,-0.17866,-0.009585,0.12552,0.92267,GOBP_REGULATION_OF_MUSCLE_HYPERTROPHY,0.99999
MIR296_5P,SET,50,-0.16057,-0.0083679,0.1128,0.92269,MIR296_5P,0.99999
WONG_ENDMETRIUM_CANCER_UP,SET,24,-0.23697,-0.0085617,0.16642,0.92275,WONG_ENDMETRIUM_CANCER_UP,0.99999
GOBP_EMBRYONIC_CLEAVAGE,SET,8,-0.40352,-0.0084211,0.28335,0.92278,GOBP_EMBRYONIC_CLEAVAGE,0.99999
BYSTRYKH_HEMATOPOIESIS_STEM_...9,SET,26,-0.24546,-0.0092303,0.17234,0.92281,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,0.99999
WP_NEUROGENESIS_REGULATION_I...,SET,55,-0.17159,-0.0093771,0.12047,0.92281,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,0.99999
PRC1_BMI_UP.V1_UP,SET,162,-0.098312,-0.0091937,0.069025,0.92281,PRC1_BMI_UP.V1_UP,0.99999
GOBP_INOSITOL_PHOSPHATE_BIOS...,SET,26,-0.23092,-0.0086834,0.1621,0.92284,GOBP_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_PYRIMIDINE_NUCLEOBASE_C...,SET,8,-0.43706,-0.0091211,0.3068,0.92285,GOBP_PYRIMIDINE_NUCLEOBASE_CATABOLIC_PROCESS,0.99999
GSE37336_LY6C_POS_VS_NEG_NAI...2,SET,132,-0.10874,-0.0091871,0.076335,0.92285,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...252,SET,5,-0.58264,-0.0096134,0.40898,0.92286,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_MIGRATION,0.99999
GSE32986_UNSTIM_VS_GMCSF_AND...1,SET,168,-0.094525,-0.0090003,0.066351,0.92286,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.99999
REACTOME_DEFECTIVE_CSF2RB_CA...,SET,7,-0.54994,-0.010736,0.38598,0.92288,REACTOME_DEFECTIVE_CSF2RB_CAUSES_SMDP5,0.99999
GSE45739_UNSTIM_VS_ACD3_ACD2...1,SET,176,-0.094329,-0.009191,0.066196,0.92291,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN,0.99999
ATF2_UP.V1_UP,SET,171,-0.093132,-0.0089457,0.065344,0.92295,ATF2_UP.V1_UP,0.99999
HP_INCREASED_SKULL_OSSIFICAT...,SET,8,-0.40754,-0.008505,0.28593,0.92296,HP_INCREASED_SKULL_OSSIFICATION,0.99999
GOBP_MACROPHAGE_COLONY_STIMU...2,SET,7,-0.50548,-0.0098678,0.35462,0.92297,GOBP_MACROPHAGE_COLONY_STIMULATING_FACTOR_SIGNALING_PATHWAY,0.99999
REACTOME_DISEASES_ASSOCIATED...3,SET,19,-0.24736,-0.007953,0.17353,0.92298,REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS,0.99999
GSE8921_UNSTIM_0H_VS_TLR1_2_...8,SET,182,-0.088446,-0.008762,0.062031,0.92303,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_OX...4,SET,145,-0.09827,-0.0086983,0.068919,0.92304,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,0.99999
BIOCARTA_TNFR1_PATHWAY,SET,29,-0.2183,-0.0086688,0.15309,0.92305,BIOCARTA_TNFR1_PATHWAY,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...69,SET,6,-0.45078,-0.0081474,0.31613,0.92305,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATXN3_TO_AUTOPHAGY_VESICLE_NUCLEATION,0.99999
HP_ABNORMAL_RETINAL_MORPHOLO...,SET,845,-0.042305,-0.0088641,0.029665,0.92307,HP_ABNORMAL_RETINAL_MORPHOLOGY,0.99999
HP_MEDULLOBLASTOMA,SET,18,-0.26829,-0.008396,0.18812,0.92307,HP_MEDULLOBLASTOMA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...650,SET,4,-0.59178,-0.0087336,0.41486,0.92312,GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_ELONGATION,0.99999
HDAC8_TARGET_GENES,SET,126,-0.10744,-0.0088694,0.075307,0.92315,HDAC8_TARGET_GENES,0.99999
HP_ABNORMAL_RIB_MORPHOLOGY,SET,290,-0.07177,-0.0089483,0.050307,0.92315,HP_ABNORMAL_RIB_MORPHOLOGY,0.99999
BIOCARTA_AKAP95_PATHWAY,SET,11,-0.31927,-0.0078124,0.22377,0.92317,BIOCARTA_AKAP95_PATHWAY,0.99999
REACTOME_NFE2L2_REGULATING_E...,SET,5,-0.52584,-0.0086762,0.36851,0.92319,REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES,0.99999
GOBP_REGULATION_OF_HOMOTYPIC...,SET,36,-0.21951,-0.0097102,0.1538,0.92323,GOBP_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,0.99999
GNF2_CDH3,SET,26,-0.24601,-0.0092507,0.17235,0.92326,GNF2_CDH3,0.99999
GOBP_PURINE_NUCLEOSIDE_DIPHO...,SET,6,-0.52805,-0.0095441,0.3699,0.92328,GOBP_PURINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_LONG_CHAI...2,SET,7,-0.44108,-0.0086107,0.30884,0.92338,GOBP_REGULATION_OF_LONG_CHAIN_FATTY_ACID_IMPORT_INTO_CELL,0.99999
GOCC_LOW_DENSITY_LIPOPROTEIN...,SET,11,-0.36371,-0.0088997,0.25463,0.9234,GOCC_LOW_DENSITY_LIPOPROTEIN_PARTICLE,0.99999
NR2E3_TARGET_GENES,SET,8,-0.48612,-0.010145,0.34026,0.92344,NR2E3_TARGET_GENES,0.99999
GGGATGC_MIR3245P,SET,42,-0.17791,-0.008499,0.1245,0.92348,GGGATGC_MIR3245P,0.99999
GOMF_UBIQUITIN_LIKE_PROTEIN_...4,SET,332,-0.065272,-0.0086973,0.045668,0.92353,GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY,0.99999
JEON_SMAD6_TARGETS_DN,SET,19,-0.2697,-0.0086712,0.18862,0.92361,JEON_SMAD6_TARGETS_DN,0.99999
GOBP_SYNAPTIC_SIGNALING,SET,716,-0.047206,-0.0091383,0.033005,0.92367,GOBP_SYNAPTIC_SIGNALING,0.99999
MODULE_96,SET,36,-0.22175,-0.0098095,0.15503,0.92368,MODULE_96,0.99999
GSE17721_CTRL_VS_PAM3CSK4_4H...1,SET,187,-0.086766,-0.0087116,0.060658,0.92369,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN,0.99999
MIR1183,SET,112,-0.11534,-0.008981,0.080632,0.9237,MIR1183,0.99999
GNF2_DEK,SET,51,-0.15634,-0.0082282,0.10929,0.92371,GNF2_DEK,0.99999
SANA_TNF_SIGNALING_UP,SET,79,-0.14499,-0.0094899,0.10134,0.92373,SANA_TNF_SIGNALING_UP,0.99999
BIOCARTA_RAC1_PATHWAY,SET,21,-0.27532,-0.0093058,0.19239,0.92378,BIOCARTA_RAC1_PATHWAY,0.99999
KEGG_MEDICUS_REFERENCE_IGF2_...,SET,11,-0.37319,-0.0091317,0.26078,0.92379,KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY,0.99999
HP_NEOPLASM_OF_STRIATED_MUSC...,SET,29,-0.2327,-0.0092406,0.16258,0.92381,HP_NEOPLASM_OF_STRIATED_MUSCLE,0.99999
HP_TRACHEOBRONCHOMALACIA,SET,7,-0.40448,-0.0078962,0.28251,0.92388,HP_TRACHEOBRONCHOMALACIA,0.99999
REACTOME_ASSEMBLY_AND_CELL_S...,SET,39,-0.20824,-0.0095872,0.14543,0.9239,REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS,0.99999
GOCC_PERICILIARY_MEMBRANE_CO...,SET,4,-0.58257,-0.0085977,0.40681,0.92393,GOCC_PERICILIARY_MEMBRANE_COMPARTMENT,0.99999
HOFFMAN_CLOCK_TARGETS_DN,SET,10,-0.39492,-0.0092139,0.27572,0.92396,HOFFMAN_CLOCK_TARGETS_DN,0.99999
HP_LIMITED_PRONATION_SUPINAT...,SET,11,-0.42015,-0.010281,0.29334,0.92396,HP_LIMITED_PRONATION_SUPINATION_OF_FOREARM,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...5,SET,182,-0.083469,-0.0082689,0.058265,0.924,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN,0.99999
chr11q25,SET,13,-0.59332,-0.015782,0.41415,0.92401,chr11q25,0.99999
KEGG_SPLICEOSOME,SET,117,-0.098043,-0.0078014,0.068416,0.92407,KEGG_SPLICEOSOME,0.99999
GOBP_PROTEASOMAL_PROTEIN_CAT...,SET,481,-0.053301,-0.0085133,0.037195,0.92407,GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...103,SET,272,-0.076383,-0.0092277,0.053293,0.9241,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION,0.99999
GOCC_CUL2_RING_UBIQUITIN_LIG...,SET,20,-0.26723,-0.008815,0.18645,0.9241,GOCC_CUL2_RING_UBIQUITIN_LIGASE_COMPLEX,0.99999
MORF_MAGEA8,SET,226,-0.083071,-0.0091594,0.057942,0.92416,MORF_MAGEA8,0.99999
HP_VITREORETINOPATHY,SET,21,-0.2587,-0.008744,0.18044,0.92416,HP_VITREORETINOPATHY,0.99999
KEGG_NEUROACTIVE_LIGAND_RECE...,SET,252,-0.085345,-0.0099296,0.059513,0.92421,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,0.99999
ZNF618_TARGET_GENES,SET,1048,-0.03869,-0.0089757,0.026975,0.92424,ZNF618_TARGET_GENES,0.99999
HP_OPSOCLONUS,SET,14,-0.36702,-0.010131,0.25582,0.9243,HP_OPSOCLONUS,0.99999
GSE37301_LYMPHOID_PRIMED_MPP...8,SET,175,-0.086812,-0.0084347,0.06051,0.9243,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_UP,0.99999
RPS14_DN.V1_UP,SET,180,-0.093272,-0.0091896,0.065011,0.92431,RPS14_DN.V1_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...196,SET,14,-0.35393,-0.0097695,0.24667,0.92433,GOBP_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,0.99999
TURJANSKI_MAPK8_AND_MAPK9_TA...,SET,7,-0.41771,-0.0081543,0.29109,0.92434,TURJANSKI_MAPK8_AND_MAPK9_TARGETS,0.99999
GOBP_REGULATION_OF_ACROSOME_...,SET,18,-0.29984,-0.0093835,0.20895,0.92435,GOBP_REGULATION_OF_ACROSOME_REACTION,0.99999
GSE7568_CTRL_VS_3H_TGFB_TREA...1,SET,150,-0.098412,-0.0088586,0.068576,0.92436,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,0.99999
KEGG_MEDICUS_PATHOGEN_SALMON...4,SET,29,-0.20596,-0.0081787,0.1435,0.92438,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...205,SET,12,-0.33964,-0.00868,0.23665,0.92438,GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,0.99999
RB_P107_DN.V1_DN,SET,110,-0.1079,-0.0083265,0.075171,0.9244,RB_P107_DN.V1_DN,0.99999
GREGORY_SYNTHETIC_LETHAL_WIT...,SET,128,-0.10334,-0.0085981,0.071991,0.92441,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,0.99999
GOBP_EPITHELIAL_TUBE_MORPHOG...,SET,315,-0.070509,-0.0091557,0.049104,0.92448,GOBP_EPITHELIAL_TUBE_MORPHOGENESIS,0.99999
GOBP_LIPID_OXIDATION,SET,107,-0.1161,-0.0088371,0.080843,0.92451,GOBP_LIPID_OXIDATION,0.99999
HU_ANGIOGENESIS_UP,SET,20,-0.26637,-0.0087866,0.18545,0.92454,HU_ANGIOGENESIS_UP,0.99999
GSE42021_CD24HI_VS_CD24INT_T...2,SET,182,-0.08876,-0.0087931,0.06179,0.92456,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP,0.99999
GSE17721_LPS_VS_GARDIQUIMOD_...14,SET,177,-0.088711,-0.0086679,0.06174,0.92461,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_UP,0.99999
HOLLEMAN_PREDNISOLONE_RESIST...3,SET,9,-0.42004,-0.0092972,0.29225,0.92467,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,0.99999
GOMF_ADENOSINE_RECEPTOR_BIND...,SET,7,-0.4911,-0.009587,0.34164,0.9247,GOMF_ADENOSINE_RECEPTOR_BINDING,0.99999
GSE40184_HEALTHY_VS_HCV_INFE...2,SET,178,-0.089072,-0.0087275,0.061957,0.92472,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP,0.99999
MIR491_3P,SET,108,-0.11682,-0.008933,0.081253,0.92474,MIR491_3P,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...1,SET,12,-0.32555,-0.00832,0.22634,0.92482,GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ENDOPLASMIC_RETICULUM,0.99999
GTTNYYNNGGTNA_UNKNOWN,SET,80,-0.13377,-0.0088104,0.092944,0.92494,GTTNYYNNGGTNA_UNKNOWN,0.99999
MIR4506,SET,42,-0.17893,-0.0085479,0.1243,0.92499,MIR4506,0.99999
GOBP_INTRACELLULAR_OXYGEN_HO...,SET,6,-0.47758,-0.0086317,0.33162,0.92507,GOBP_INTRACELLULAR_OXYGEN_HOMEOSTASIS,0.99999
FREAC7_01,SET,173,-0.097371,-0.0094069,0.067611,0.92508,FREAC7_01,0.99999
HP_ILEAL_ATRESIA,SET,4,-0.63896,-0.0094299,0.44359,0.92511,HP_ILEAL_ATRESIA,0.99999
REACTOME_DEGRADATION_OF_THE_...,SET,132,-0.11443,-0.0096673,0.079436,0.92513,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,0.99999
GOBP_PROTEIN_N_LINKED_GLYCOS...2,SET,23,-0.25058,-0.0088632,0.17395,0.92513,GOBP_PROTEIN_N_LINKED_GLYCOSYLATION_VIA_ASPARAGINE,0.99999
ATCATGA_MIR433,SET,107,-0.11553,-0.0087939,0.080201,0.92514,ATCATGA_MIR433,0.99999
GSE19401_PAM2CSK4_VS_RETINOI...3,SET,175,-0.089899,-0.0087347,0.062401,0.92515,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,0.99999
GOMF_G_PROTEIN_COUPLED_CHEMO...,SET,24,-0.27828,-0.010054,0.19315,0.92516,GOMF_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY,0.99999
REACTOME_DNA_DAMAGE_TELOMERE...,SET,27,-0.21257,-0.0081455,0.14752,0.92519,REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,0.99999
GOBP_POSITIVE_REGULATION_OF_...741,SET,152,-0.10171,-0.009216,0.070579,0.92522,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,0.99999
AKT_UP.V1_UP,SET,149,-0.1007,-0.0090347,0.069872,0.92523,AKT_UP.V1_UP,0.99999
GOBP_LIPOXYGENASE_PATHWAY,SET,11,-0.41187,-0.010078,0.28571,0.92528,GOBP_LIPOXYGENASE_PATHWAY,0.99999
HP_UPPER_MOTOR_NEURON_DYSFUN...,SET,1034,-0.037721,-0.0086958,0.026166,0.92528,HP_UPPER_MOTOR_NEURON_DYSFUNCTION,0.99999
XU_HGF_TARGETS_INDUCED_BY_AK...1,SET,21,-0.29243,-0.0098841,0.20284,0.92529,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN,0.99999
VANDESLUIS_COMMD1_TARGETS_GR...2,SET,32,-0.24582,-0.010253,0.1705,0.9253,VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,0.99999
GOMF_SULFUR_COMPOUND_BINDING,SET,245,-0.083266,-0.009554,0.057747,0.92533,GOMF_SULFUR_COMPOUND_BINDING,0.99999
MIR335_3P,SET,786,-0.04545,-0.0092003,0.031513,0.92538,MIR335_3P,0.99999
WATANABE_ULCERATIVE_COLITIS_...2,SET,17,-0.30731,-0.0093466,0.21303,0.92542,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,0.99999
MIR4286,SET,79,-0.13239,-0.0086651,0.091754,0.92546,MIR4286,0.99999
MIR6792_5P,SET,113,-0.12149,-0.0095011,0.084184,0.92549,MIR6792_5P,0.99999
GOBP_ESTROUS_CYCLE,SET,16,-0.29546,-0.0087181,0.20473,0.9255,GOBP_ESTROUS_CYCLE,0.99999
GOBP_REGULATION_OF_RESPONSE_...10,SET,10,-0.3745,-0.0087375,0.25944,0.92555,GOBP_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,0.99999
MCCLUNG_COCAINE_REWARD_5D,SET,68,-0.14928,-0.0090678,0.1034,0.92557,MCCLUNG_COCAINE_REWARD_5D,0.99999
GOBP_NEGATIVE_REGULATION_OF_...592,SET,2,-0.88148,-0.0091994,0.61053,0.92559,GOBP_NEGATIVE_REGULATION_OF_SISTER_CHROMATID_COHESION,0.99999
MIR607,SET,872,-0.042809,-0.0091051,0.029647,0.92562,MIR607,0.99999
MODULE_427,SET,99,-0.11903,-0.0087169,0.082431,0.92563,MODULE_427,0.99999
HUTTMANN_B_CLL_POOR_SURVIVAL...2,SET,240,-0.08008,-0.0090954,0.055438,0.92569,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,0.99999
CATRRAGC_UNKNOWN,SET,122,-0.10901,-0.0088561,0.075452,0.92572,CATRRAGC_UNKNOWN,0.99999
HP_DERMOID_CYST,SET,6,-0.53091,-0.0095957,0.36739,0.92577,HP_DERMOID_CYST,0.99999
GOBP_POSITIVE_REGULATION_OF_...511,SET,11,-0.36005,-0.00881,0.24915,0.92578,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_PROLIFERATION,0.99999
GSE7348_UNSTIM_VS_LPS_STIM_M...1,SET,157,-0.10362,-0.0095411,0.07169,0.92583,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.99999
BIOCARTA_WNT_LRP6_PATHWAY,SET,6,-0.55207,-0.0099782,0.38181,0.92589,BIOCARTA_WNT_LRP6_PATHWAY,0.99999
GOBP_CENTROSOME_DUPLICATION,SET,71,-0.13747,-0.0085321,0.095079,0.92589,GOBP_CENTROSOME_DUPLICATION,0.99999
MIR5189_3P,SET,51,-0.17053,-0.0089749,0.11791,0.92594,MIR5189_3P,0.99999
HP_ABNORMAL_CIRCULATING_CERU...,SET,10,-0.38931,-0.0090829,0.26917,0.92595,HP_ABNORMAL_CIRCULATING_CERULOPLASMIN_CONCENTRATION,0.99999
GOBP_RIBONUCLEOPROTEIN_COMPL...2,SET,10,-0.34014,-0.0079359,0.23514,0.92598,GOBP_RIBONUCLEOPROTEIN_COMPLEX_LOCALIZATION,0.99999
GSE3982_MAC_VS_NEUTROPHIL_DN,SET,174,-0.093715,-0.0090796,0.064773,0.92602,GSE3982_MAC_VS_NEUTROPHIL_DN,0.99999
REACTOME_PHASE_1_INACTIVATIO...,SET,6,-0.49275,-0.008906,0.34039,0.92613,REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS,0.99999
MYF6_TARGET_GENES,SET,13,-0.33081,-0.0087993,0.22851,0.92614,MYF6_TARGET_GENES,0.99999
HP_GALACTORRHEA,SET,9,-0.39343,-0.0087082,0.27176,0.92614,HP_GALACTORRHEA,0.99999
GAGCCAG_MIR149,SET,130,-0.10211,-0.0085617,0.070526,0.92616,GAGCCAG_MIR149,0.99999
GOBP_NUCLEOBASE_METABOLIC_PR...,SET,36,-0.19635,-0.0086859,0.13562,0.92616,GOBP_NUCLEOBASE_METABOLIC_PROCESS,0.99999
GOMF_N_FORMYL_PEPTIDE_RECEPT...,SET,4,-0.78179,-0.011538,0.53983,0.92621,GOMF_N_FORMYL_PEPTIDE_RECEPTOR_ACTIVITY,0.99999
GOBP_REGULATION_OF_CRISTAE_F...,SET,5,-0.58277,-0.0096155,0.40239,0.92622,GOBP_REGULATION_OF_CRISTAE_FORMATION,0.99999
GOBP_RESPONSE_TO_METAL_ION,SET,322,-0.070412,-0.0092424,0.048608,0.92626,GOBP_RESPONSE_TO_METAL_ION,0.99999
GSE37532_TREG_VS_TCONV_PPARG...2,SET,180,-0.084237,-0.0082995,0.058146,0.92628,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP,0.99999
GOBP_KIDNEY_MORPHOGENESIS,SET,92,-0.13983,-0.0098732,0.096517,0.92629,GOBP_KIDNEY_MORPHOGENESIS,0.99999
GOMF_PROTEIN_FOLDING_CHAPERO...2,SET,125,-0.1056,-0.008683,0.072888,0.92629,GOMF_PROTEIN_FOLDING_CHAPERONE_BINDING,0.99999
GSE10147_IL3_AND_HIVP17_VS_I...2,SET,132,-0.11069,-0.0093516,0.07639,0.92633,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP,0.99999
GSE21360_PRIMARY_VS_SECONDAR...2,SET,176,-0.09189,-0.0089533,0.063397,0.92638,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP,0.99999
GSE7348_LPS_VS_TOLERIZED_AND...2,SET,170,-0.090563,-0.0086737,0.062476,0.9264,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,0.99999
SIGMAR1_TARGET_GENES,SET,9,-0.38892,-0.0086085,0.2683,0.92641,SIGMAR1_TARGET_GENES,0.99999
HP_TREMOR,SET,540,-0.052373,-0.0088486,0.036128,0.92641,HP_TREMOR,0.99999
WP_GLYCOSAMINOGLYCAN_DEGRADA...,SET,16,-0.31105,-0.0091781,0.2145,0.92648,WP_GLYCOSAMINOGLYCAN_DEGRADATION,0.99999
chr14q13,SET,22,-0.37065,-0.012822,0.25553,0.92654,chr14q13,0.99999
GOCC_LATERAL_PLASMA_MEMBRANE,SET,65,-0.15521,-0.0092183,0.10696,0.92661,GOCC_LATERAL_PLASMA_MEMBRANE,0.99999
KEGG_MEDICUS_REFERENCE_UREA_...,SET,5,-0.48392,-0.0079845,0.33347,0.92662,KEGG_MEDICUS_REFERENCE_UREA_CYCLE,0.99999
GOBP_CELLULAR_RESPONSE_TO_GO...,SET,17,-0.33871,-0.010301,0.23341,0.92662,GOBP_CELLULAR_RESPONSE_TO_GONADOTROPIN_STIMULUS,0.99999
HP_NARROW_NASAL_BRIDGE,SET,41,-0.19963,-0.009423,0.13756,0.92664,HP_NARROW_NASAL_BRIDGE,0.99999
GOBP_POSITIVE_REGULATION_OF_...177,SET,3,-0.70384,-0.008996,0.48491,0.92667,GOBP_POSITIVE_REGULATION_OF_CONNECTIVE_TISSUE_REPLACEMENT,0.99999
GOBP_LYMPHATIC_ENDOTHELIAL_C...,SET,8,-0.4303,-0.0089799,0.29642,0.92669,GOBP_LYMPHATIC_ENDOTHELIAL_CELL_DIFFERENTIATION,0.99999
GOBP_MAMMARY_GLAND_INVOLUTION,SET,8,-0.48648,-0.010152,0.33506,0.92673,GOBP_MAMMARY_GLAND_INVOLUTION,0.99999
GARCIA_PINERES_PBMC_HPV_16_L...3,SET,256,-0.076764,-0.0090008,0.052859,0.92678,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN,0.99999
GSE29618_PRE_VS_DAY7_POST_LA...3,SET,172,-0.093089,-0.0089675,0.064086,0.92682,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN,0.99999
ZNF37A_TARGET_GENES,SET,116,-0.11513,-0.0091218,0.079251,0.92684,ZNF37A_TARGET_GENES,0.99999
GOBP_REGULATION_OF_HEART_CON...,SET,190,-0.09516,-0.00963,0.065493,0.92688,GOBP_REGULATION_OF_HEART_CONTRACTION,0.99999
GOBP_RESPONSE_TO_GRANULOCYTE...,SET,9,-0.43358,-0.0095969,0.29839,0.92689,GOBP_RESPONSE_TO_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR,0.99999
GSE17721_CTRL_VS_CPG_2H_BMDC...2,SET,176,-0.090918,-0.0088587,0.062565,0.9269,GSE17721_CTRL_VS_CPG_2H_BMDC_UP,0.99999
WP_SARSCOV2_AND_ACE2_RECEPTO...,SET,6,-0.5885,-0.010637,0.40496,0.92691,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...9,SET,7,-0.47109,-0.0091965,0.32408,0.92697,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN,0.99999
HP_REDUCED_CEREBRAL_WHITE_MA...,SET,31,-0.22251,-0.0091352,0.15305,0.927,HP_REDUCED_CEREBRAL_WHITE_MATTER_VOLUME,0.99999
REACTOME_SPECIFICATION_OF_PR...,SET,11,-0.38743,-0.0094801,0.26633,0.92712,REACTOME_SPECIFICATION_OF_PRIMORDIAL_GERM_CELLS,0.99999
MIR3925_3P,SET,161,-0.097437,-0.009084,0.066975,0.92713,MIR3925_3P,0.99999
HP_ABNORMAL_SERUM_BILE_ACID_...,SET,25,-0.25623,-0.0094482,0.17612,0.92713,HP_ABNORMAL_SERUM_BILE_ACID_CONCENTRATION,0.99999
HOEK_NK_CELL_2011_2012_TIV_1...,SET,42,-0.20003,-0.0095558,0.13749,0.92713,HOEK_NK_CELL_2011_2012_TIV_1D_VS_0DY_ADULT_1D_DN,0.99999
HP_ABNORMAL_JEJUNUM_MORPHOLO...,SET,9,-0.4126,-0.0091326,0.2836,0.92714,HP_ABNORMAL_JEJUNUM_MORPHOLOGY,0.99999
HP_LENS_SUBLUXATION,SET,13,-0.35231,-0.0093713,0.24213,0.92716,HP_LENS_SUBLUXATION,0.99999
RASHI_RESPONSE_TO_IONIZING_R...3,SET,43,-0.17281,-0.008353,0.11876,0.92717,RASHI_RESPONSE_TO_IONIZING_RADIATION_3,0.99999
WP_ANGIOPOIETINLIKE_PROTEIN_...,SET,125,-0.11303,-0.0092945,0.077665,0.92721,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,0.99999
GSE2128_CTRL_VS_MIMETOPE_NEG...3,SET,164,-0.094958,-0.0089342,0.065239,0.92723,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN,0.99999
GOBP_HOMOPHILIC_CELL_ADHESIO...,SET,157,-0.13017,-0.011986,0.089429,0.92724,GOBP_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,0.99999
GOBP_RESPONSE_TO_PROTOZOAN,SET,27,-0.26276,-0.010069,0.18049,0.92727,GOBP_RESPONSE_TO_PROTOZOAN,0.99999
GSE14769_UNSTIM_VS_40MIN_LPS...1,SET,189,-0.091875,-0.0092733,0.063107,0.92728,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN,0.99999
HERNANDEZ_MITOTIC_ARREST_BY_...4,SET,53,-0.17083,-0.009165,0.11733,0.92729,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,0.99999
HP_NEOPLASM_OF_THE_STOMACH,SET,85,-0.13036,-0.0088492,0.089527,0.92731,HP_NEOPLASM_OF_THE_STOMACH,0.99999
KEGG_MEDICUS_REFERENCE_TBK1_...,SET,10,-0.37991,-0.0088638,0.26089,0.92733,KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION,0.99999
CATTTCA_MIR203,SET,259,-0.074636,-0.0088017,0.051253,0.92733,CATTTCA_MIR203,0.99999
GSE29164_UNTREATED_VS_CD8_TC...4,SET,172,-0.089758,-0.0086466,0.061633,0.92734,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,0.99999
GOCC_CORTICAL_CYTOSKELETON,SET,103,-0.11735,-0.0087644,0.080564,0.92737,GOCC_CORTICAL_CYTOSKELETON,0.99999
HP_MACULAR_HYPOPLASIA,SET,13,-0.36919,-0.0098202,0.25347,0.92737,HP_MACULAR_HYPOPLASIA,0.99999
GENTILE_UV_HIGH_DOSE_DN,SET,269,-0.075335,-0.0090515,0.051707,0.92743,GENTILE_UV_HIGH_DOSE_DN,0.99999
MORF_CAMK4,SET,253,-0.079273,-0.0092412,0.054404,0.92745,MORF_CAMK4,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...3,SET,196,-0.092684,-0.0095247,0.063608,0.92745,GOBP_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE,0.99999
HP_FOAM_CELLS,SET,11,-0.41348,-0.010117,0.28376,0.92745,HP_FOAM_CELLS,0.99999
HP_ABNORMAL_CONUS_TERMINALIS...,SET,29,-0.23105,-0.0091754,0.1585,0.92753,HP_ABNORMAL_CONUS_TERMINALIS_MORPHOLOGY,0.99999
GCM_NCAM1,SET,115,-0.11027,-0.0086992,0.075629,0.92757,GCM_NCAM1,0.99999
ZHAN_V1_LATE_DIFFERENTIATION...1,SET,11,-0.37495,-0.0091746,0.2571,0.92762,ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN,0.99999
HP_THICKENED_SKIN,SET,381,-0.063704,-0.0090809,0.043671,0.92767,HP_THICKENED_SKIN,0.99999
MIR412_5P,SET,5,-0.50656,-0.008358,0.34723,0.92769,MIR412_5P,0.99999
WALLACE_PROSTATE_CANCER_UP,SET,18,-0.29756,-0.0093123,0.20391,0.92775,WALLACE_PROSTATE_CANCER_UP,0.99999
REACTOME_SUMOYLATION_OF_TRAN...1,SET,41,-0.17915,-0.0084564,0.12277,0.92775,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,0.99999
GOBP_NITROGEN_CYCLE_METABOLI...,SET,12,-0.32925,-0.0084146,0.22557,0.9278,GOBP_NITROGEN_CYCLE_METABOLIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...601,SET,22,-0.28801,-0.0099636,0.19719,0.92793,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...410,SET,11,-0.3589,-0.0087819,0.24566,0.92797,GOBP_NEGATIVE_REGULATION_OF_MOTOR_NEURON_APOPTOTIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...663,SET,5,-0.58838,-0.0097081,0.40271,0.92799,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_BINDING,0.99999
GOBP_ICOSANOID_TRANSPORT,SET,64,-0.16921,-0.0099727,0.11581,0.928,GOBP_ICOSANOID_TRANSPORT,0.99999
HP_MISALIGNMENT_OF_INCISORS,SET,14,-0.29313,-0.008091,0.20061,0.92801,HP_MISALIGNMENT_OF_INCISORS,0.99999
MIR4777_5P,SET,101,-0.12734,-0.0094184,0.08713,0.92805,MIR4777_5P,0.99999
ZNF560_TARGET_GENES,SET,42,-0.18694,-0.0089306,0.12791,0.92806,ZNF560_TARGET_GENES,0.99999
HP_UPSLANTED_PALPEBRAL_FISSU...,SET,270,-0.072768,-0.0087591,0.049748,0.92822,HP_UPSLANTED_PALPEBRAL_FISSURE,0.99999
HP_HEPATOSPLENOMEGALY,SET,152,-0.099653,-0.0090294,0.068118,0.92825,HP_HEPATOSPLENOMEGALY,0.99999
KIM_TIAL1_TARGETS,SET,29,-0.23393,-0.0092895,0.15989,0.92827,KIM_TIAL1_TARGETS,0.99999
MIR3924,SET,306,-0.072762,-0.0093146,0.049731,0.92827,MIR3924,0.99999
GOMF_PHOSPHATIDYLSERINE_1_AC...,SET,6,-0.46491,-0.0084028,0.31776,0.92827,GOMF_PHOSPHATIDYLSERINE_1_ACYLHYDROLASE_ACTIVITY,0.99999
GOBP_ADIPONECTIN_ACTIVATED_S...,SET,7,-0.45249,-0.0088333,0.30926,0.92828,GOBP_ADIPONECTIN_ACTIVATED_SIGNALING_PATHWAY,0.99999
GSE43955_TH0_VS_TGFB_IL6_IL2...2,SET,182,-0.092225,-0.0091364,0.063033,0.92828,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,0.99999
GOBP_WALKING_BEHAVIOR,SET,34,-0.21581,-0.0092781,0.14745,0.92834,GOBP_WALKING_BEHAVIOR,0.99999
GOBP_POSITIVE_REGULATION_OF_...94,SET,483,-0.056256,-0.0090033,0.038414,0.92845,GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS,0.99999
ZHONG_PFC_C8_ORG_PROLIFERATI...,SET,57,-0.16921,-0.0094131,0.11554,0.92847,ZHONG_PFC_C8_ORG_PROLIFERATING,0.99999
REACTOME_ACETYLCHOLINE_REGUL...,SET,10,-0.42686,-0.009959,0.29142,0.9285,REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION,0.99999
HP_INCREASED_URINARY_NON_PRO...,SET,31,-0.23764,-0.0097563,0.16222,0.92852,HP_INCREASED_URINARY_NON_PROTEINOGENIC_AMINO_ACID_LEVEL,0.99999
ELVIDGE_HYPOXIA_UP,SET,155,-0.10172,-0.0093063,0.069422,0.92856,ELVIDGE_HYPOXIA_UP,0.99999
HP_PULMONARY_INTERSTITIAL_HI...,SET,21,-0.28065,-0.0094859,0.19155,0.92856,HP_PULMONARY_INTERSTITIAL_HIGH_RESOLUTION_COMPUTED_TOMOGRAPHY_ABNORMALITY,0.99999
HP_ABNORMALITY_OF_THE_RADIAL...,SET,46,-0.18199,-0.0090976,0.12419,0.92859,HP_ABNORMALITY_OF_THE_RADIAL_HEAD,0.99999
GSE19401_PAM2CSK4_VS_RETINOI...1,SET,178,-0.091282,-0.008944,0.062273,0.92864,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.99999
GOCC_BASAL_CORTEX,SET,5,-0.42463,-0.0070062,0.28967,0.92865,GOCC_BASAL_CORTEX,0.99999
MA_RAT_AGING_DN,SET,143,-0.10967,-0.0096404,0.074782,0.92873,MA_RAT_AGING_DN,0.99999
GOBP_REGULATION_OF_RETROGRAD...2,SET,5,-0.53295,-0.0087936,0.36337,0.92876,GOBP_REGULATION_OF_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,0.99999
CAO_BLOOD_FLUZONE_AGE_05_14Y...3,SET,7,-0.45588,-0.0088996,0.31082,0.92876,CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_DN,0.99999
HP_CLEFT_LIP,SET,175,-0.091824,-0.0089217,0.062582,0.92884,HP_CLEFT_LIP,0.99999
GSE16385_IFNG_TNF_VS_IL4_STI...3,SET,161,-0.097385,-0.0090791,0.066352,0.9289,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,0.99999
GSE8685_IL2_ACT_IL2_STARVED_...2,SET,181,-0.088606,-0.0087539,0.060368,0.92891,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,0.99999
GOBP_SECONDARY_HEART_FIELD_S...,SET,11,-0.4392,-0.010747,0.29921,0.92892,GOBP_SECONDARY_HEART_FIELD_SPECIFICATION,0.99999
HP_PROBOSCIS,SET,16,-0.3118,-0.0092004,0.21242,0.92892,HP_PROBOSCIS,0.99999
ATGCTGG_MIR338,SET,108,-0.11585,-0.0088587,0.078904,0.92897,ATGCTGG_MIR338,0.99999
GOBP_REGULATION_OF_ANTIGEN_P...3,SET,4,-0.65578,-0.0096782,0.44664,0.92897,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,0.99999
GOMF_PHOSPHATIDATE_PHOSPHATA...,SET,3,-0.7052,-0.0090135,0.48028,0.92898,GOMF_PHOSPHATIDATE_PHOSPHATASE_ACTIVITY,0.99999
HP_DELAYED_ABILITY_TO_STAND,SET,14,-0.33718,-0.0093071,0.22961,0.929,HP_DELAYED_ABILITY_TO_STAND,0.99999
GSE15659_CD45RA_NEG_CD4_TCEL...6,SET,158,-0.099622,-0.0092015,0.067843,0.929,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP,0.99999
MIR4536_3P,SET,19,-0.28734,-0.0092385,0.19557,0.92911,MIR4536_3P,0.99999
GOBP_ESTABLISHMENT_OF_MITOTI...1,SET,5,-0.68818,-0.011355,0.46837,0.92912,GOBP_ESTABLISHMENT_OF_MITOTIC_SISTER_CHROMATID_COHESION,0.99999
GALIE_TUMOR_STEMNESS_GENES,SET,6,-0.57632,-0.010416,0.39219,0.92914,GALIE_TUMOR_STEMNESS_GENES,0.99999
AP4_Q5,SET,235,-0.080357,-0.0090326,0.054667,0.9292,AP4_Q5,0.99999
REACTOME_CA_DEPENDENT_EVENTS,SET,35,-0.2303,-0.010045,0.15666,0.92922,REACTOME_CA_DEPENDENT_EVENTS,0.99999
GOBP_EQUILIBRIOCEPTION,SET,8,-0.51509,-0.01075,0.35033,0.92925,GOBP_EQUILIBRIOCEPTION,0.99999
GSE4535_BM_DERIVED_DC_VS_FOL...2,SET,178,-0.094915,-0.0093,0.064556,0.92925,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_UP,0.99999
GSE20152_HTNFA_OVERXPRESS_AN...2,SET,174,-0.094921,-0.0091964,0.064552,0.92927,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_UP,0.99999
GOBP_CARTILAGE_DEVELOPMENT_I...,SET,31,-0.22797,-0.0093592,0.15499,0.92933,GOBP_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,0.99999
GSE37301_HEMATOPOIETIC_STEM_...14,SET,155,-0.10099,-0.0092392,0.068651,0.92934,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP,0.99999
GSE37605_C57BL6_VS_NOD_FOXP3...8,SET,107,-0.12053,-0.0091744,0.081916,0.9294,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_UP,0.99999
CURSONS_NATURAL_KILLER_CELLS,SET,17,-0.32526,-0.0098926,0.22102,0.92944,CURSONS_NATURAL_KILLER_CELLS,0.99999
MIR1236_3P,SET,170,-0.095758,-0.0091713,0.065057,0.92947,MIR1236_3P,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...3,SET,7,-0.47733,-0.0093183,0.32427,0.92948,GOBP_PROTEIN_LOCALIZATION_TO_BASOLATERAL_PLASMA_MEMBRANE,0.99999
GOBP_VERY_LONG_CHAIN_FATTY_A...1,SET,13,-0.39591,-0.010531,0.26891,0.92951,GOBP_VERY_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.99999
SHIRAISHI_PLZF_TARGETS_UP,SET,9,-0.39643,-0.0087747,0.26923,0.92954,SHIRAISHI_PLZF_TARGETS_UP,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...7,SET,48,-0.19495,-0.0099548,0.13239,0.92956,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_5,0.99999
ARNT_02,SET,217,-0.081411,-0.008798,0.055278,0.92958,ARNT_02,0.99999
GSE11961_MEMORY_BCELL_DAY7_V...3,SET,179,-0.092194,-0.0090584,0.062597,0.92959,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.99999
GSE20366_EX_VIVO_VS_DEC205_C...2,SET,182,-0.092897,-0.009203,0.063072,0.9296,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN,0.99999
KEGG_ETHER_LIPID_METABOLISM,SET,30,-0.24006,-0.0096956,0.16297,0.92961,KEGG_ETHER_LIPID_METABOLISM,0.99999
MIR4512,SET,17,-0.30664,-0.0093262,0.20817,0.92962,MIR4512,0.99999
HP_ABNORMAL_CIRCULATING_FATT...2,SET,68,-0.1438,-0.0087347,0.097618,0.92962,HP_ABNORMAL_CIRCULATING_FATTY_ACID_CONCENTRATION,0.99999
GOBP_URETER_MORPHOGENESIS,SET,7,-0.43998,-0.0085892,0.29865,0.92965,GOBP_URETER_MORPHOGENESIS,0.99999
GOBP_METANEPHRIC_EPITHELIUM_...,SET,27,-0.26616,-0.010199,0.18061,0.92971,GOBP_METANEPHRIC_EPITHELIUM_DEVELOPMENT,0.99999
REACTOME_UNBLOCKING_OF_NMDA_...,SET,19,-0.30906,-0.0099369,0.2097,0.92973,REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION,0.99999
MODULE_440,SET,18,-0.29128,-0.0091157,0.19761,0.92975,MODULE_440,0.99999
GOBP_COLLECTING_DUCT_DEVELOP...,SET,15,-0.37438,-0.010696,0.25393,0.92979,GOBP_COLLECTING_DUCT_DEVELOPMENT,0.99999
GOBP_REGULATION_OF_DOPAMINE_...1,SET,11,-0.44398,-0.010864,0.30114,0.92979,GOBP_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...277,SET,13,-0.37881,-0.010076,0.25692,0.92981,GOBP_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,0.99999
GOBP_POSITIVE_REGULATION_OF_...173,SET,98,-0.13215,-0.0096288,0.089626,0.92981,GOBP_POSITIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS,0.99999
SARTIPY_BLUNTED_BY_INSULIN_R...1,SET,17,-0.33035,-0.010047,0.22402,0.92984,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,0.99999
HP_IRRITABILITY,SET,243,-0.078452,-0.0089653,0.053199,0.92984,HP_IRRITABILITY,0.99999
HEBERT_MATRISOME_TNBC_LUNG_M...2,SET,6,-0.44046,-0.0079609,0.29866,0.92986,HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED,0.99999
HP_PERITONEAL_ABSCESS,SET,11,-0.41273,-0.010099,0.27978,0.92991,HP_PERITONEAL_ABSCESS,0.99999
HENDRICKS_SMARCA4_TARGETS_UP,SET,51,-0.18446,-0.0097082,0.12502,0.92994,HENDRICKS_SMARCA4_TARGETS_UP,0.99999
REACTOME_SCAVENGING_BY_CLASS...1,SET,18,-0.3209,-0.010042,0.21747,0.92997,REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS,0.99999
MORF_PPP6C,SET,95,-0.11453,-0.008217,0.077615,0.92997,MORF_PPP6C,0.99999
GSE3982_MEMORY_CD4_TCELL_VS_...2,SET,172,-0.097987,-0.0094394,0.066402,0.92997,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP,0.99999
MORF_ITGA2,SET,47,-0.18536,-0.0093662,0.12561,0.92998,MORF_ITGA2,0.99999
GOMF_HEXOKINASE_ACTIVITY,SET,5,-0.62169,-0.010258,0.42125,0.92999,GOMF_HEXOKINASE_ACTIVITY,0.99999
HP_MILD_GLOBAL_DEVELOPMENTAL...,SET,70,-0.1502,-0.0092566,0.10178,0.92999,HP_MILD_GLOBAL_DEVELOPMENTAL_DELAY,0.99999
GSE17721_CTRL_VS_POLYIC_24H_...2,SET,177,-0.090069,-0.0088006,0.061031,0.92999,GSE17721_CTRL_VS_POLYIC_24H_BMDC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...506,SET,813,-0.044971,-0.0092512,0.030463,0.93005,GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH,0.99999
GSE360_L_DONOVANI_VS_L_MAJOR...4,SET,180,-0.09135,-0.0090003,0.06188,0.93005,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP,0.99999
GOCC_TOR_COMPLEX,SET,12,-0.33931,-0.0086716,0.22982,0.93007,GOCC_TOR_COMPLEX,0.99999
HP_HYPERINSULINEMIC_HYPOGLYC...,SET,25,-0.2492,-0.0091892,0.16879,0.93007,HP_HYPERINSULINEMIC_HYPOGLYCEMIA,0.99999
LI_ADIPOGENESIS_BY_ACTIVATED...,SET,18,-0.30549,-0.0095602,0.20683,0.93015,LI_ADIPOGENESIS_BY_ACTIVATED_PPARG,0.99999
GOBP_POSITIVE_REGULATION_OF_...791,SET,7,-0.46203,-0.0090196,0.31275,0.9302,GOBP_POSITIVE_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION,0.99999
GOBP_REGULATION_OF_NEURON_DI...,SET,176,-0.10304,-0.01004,0.069731,0.93025,GOBP_REGULATION_OF_NEURON_DIFFERENTIATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C3_GRI...,SET,113,-0.129,-0.010089,0.08728,0.93029,HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL,0.99999
GOBP_REGULATION_OF_PEPTIDYL_...1,SET,8,-0.45331,-0.0094602,0.30661,0.93035,GOBP_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...159,SET,5,-0.492,-0.0081179,0.33271,0.93039,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.99999
HP_THYROIDITIS,SET,45,-0.18633,-0.0092131,0.12598,0.93043,HP_THYROIDITIS,0.99999
KEGG_MEDICUS_REFERENCE_IRE1A...,SET,7,-0.48164,-0.0094025,0.32558,0.93047,KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY,0.99999
MURAKAMI_UV_RESPONSE_24HR,SET,20,-0.28209,-0.0093052,0.19067,0.93049,MURAKAMI_UV_RESPONSE_24HR,0.99999
HP_ABNORMALITY_OF_VITAMIN_B_...,SET,41,-0.19569,-0.009237,0.13225,0.93051,HP_ABNORMALITY_OF_VITAMIN_B_METABOLISM,0.99999
HP_INCREASED_CUP_TO_DISC_RAT...,SET,8,-0.50745,-0.01059,0.34293,0.93052,HP_INCREASED_CUP_TO_DISC_RATIO,0.99999
HP_METAPHYSEAL_SPURS,SET,7,-0.48001,-0.0093706,0.32434,0.93055,HP_METAPHYSEAL_SPURS,0.99999
GSE20500_CTRL_VS_RARA_ANTAGO...2,SET,182,-0.089131,-0.0088299,0.060219,0.93057,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...426,SET,10,-0.42744,-0.0099727,0.28873,0.93061,GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.99999
GOBP_POSITIVE_REGULATION_OF_...479,SET,6,-0.44333,-0.0080127,0.29937,0.93067,GOBP_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION,0.99999
HP_DYSCALCULIA,SET,22,-0.24437,-0.0084539,0.16499,0.9307,HP_DYSCALCULIA,0.99999
GOCC_LATERAL_PART_OF_CELL,SET,5,-0.5998,-0.0098966,0.40496,0.93071,GOCC_LATERAL_PART_OF_CELL,0.99999
MIR4654,SET,51,-0.17406,-0.0091607,0.11749,0.93075,MIR4654,0.99999
HOEGERKORP_CD44_TARGETS_TEMP...1,SET,23,-0.26776,-0.0094709,0.18071,0.93079,HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,0.99999
GOBP_CAMKK_AMPK_SIGNALING_CA...,SET,9,-0.42654,-0.0094412,0.28783,0.93081,GOBP_CAMKK_AMPK_SIGNALING_CASCADE,0.99999
REACTOME_RHOU_GTPASE_CYCLE,SET,37,-0.19497,-0.0087434,0.13153,0.93085,REACTOME_RHOU_GTPASE_CYCLE,0.99999
GSE27859_MACROPHAGE_VS_CD11C...1,SET,168,-0.092833,-0.0088392,0.062623,0.93088,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,0.99999
WP_AMINO_ACID_METABOLISM,SET,80,-0.14219,-0.0093655,0.095875,0.93097,WP_AMINO_ACID_METABOLISM,0.99999
GNF2_CCNB2,SET,53,-0.17244,-0.0092514,0.11625,0.93101,GNF2_CCNB2,0.99999
CAIRO_HEPATOBLASTOMA_UP,SET,189,-0.092292,-0.0093154,0.062211,0.93102,CAIRO_HEPATOBLASTOMA_UP,0.99999
GOBP_GLYCEROLIPID_METABOLIC_...,SET,354,-0.066534,-0.009149,0.044849,0.93102,GOBP_GLYCEROLIPID_METABOLIC_PROCESS,0.99999
REACTOME_RUNX2_REGULATES_GEN...,SET,8,-0.44512,-0.0092892,0.30003,0.93103,REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION,0.99999
MIR3144_5P,SET,46,-0.18856,-0.0094261,0.12709,0.93104,MIR3144_5P,0.99999
TAKEDA_TARGETS_OF_NUP98_HOXA...5,SET,28,-0.25295,-0.0098704,0.17042,0.93113,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,0.99999
GOBP_RIBOSOMAL_SMALL_SUBUNIT...3,SET,8,-0.49955,-0.010425,0.33651,0.93115,GOBP_RIBOSOMAL_SMALL_SUBUNIT_EXPORT_FROM_NUCLEUS,0.99999
HP_ABNORMAL_CONJUGATE_EYE_MO...,SET,1020,-0.039406,-0.0090262,0.026544,0.93116,HP_ABNORMAL_CONJUGATE_EYE_MOVEMENT,0.99999
GSE17721_0.5H_VS_24H_POLYIC_...1,SET,183,-0.088311,-0.0087724,0.059474,0.9312,GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN,0.99999
REACTOME_POTENTIAL_THERAPEUT...,SET,92,-0.12698,-0.008966,0.085507,0.93123,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,0.99999
MIR19A_3P,SET,592,-0.053671,-0.0094806,0.036137,0.93125,MIR19A_3P,0.99999
KEGG_MEDICUS_REFERENCE_LECTI...2,SET,8,-0.50173,-0.010471,0.33774,0.93129,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN,0.99999
GOBP_REGULATION_OF_MDA_5_SIG...,SET,6,-0.43071,-0.0077847,0.28992,0.9313,GOBP_REGULATION_OF_MDA_5_SIGNALING_PATHWAY,0.99999
HP_LOWER_LIMB_ASYMMETRY,SET,41,-0.20706,-0.0097734,0.13929,0.93141,HP_LOWER_LIMB_ASYMMETRY,0.99999
GOBP_REGULATION_OF_CELLULAR_...9,SET,42,-0.18653,-0.0089111,0.12546,0.93146,GOBP_REGULATION_OF_CELLULAR_RESPIRATION,0.99999
GOMF_GENERAL_TRANSCRIPTION_I...2,SET,50,-0.17388,-0.0090614,0.11694,0.93148,GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING,0.99999
GSE30083_SP3_VS_SP4_THYMOCYT...2,SET,179,-0.09809,-0.0096378,0.065934,0.93158,GSE30083_SP3_VS_SP4_THYMOCYTE_UP,0.99999
GOBP_SMALL_MOLECULE_CATABOLI...,SET,349,-0.067803,-0.0092586,0.045572,0.93159,GOBP_SMALL_MOLECULE_CATABOLIC_PROCESS,0.99999
GSE8921_3H_VS_24H_TLR1_2_STI...1,SET,184,-0.093393,-0.0093023,0.062769,0.9316,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN,0.99999
TGACAGNY_MEIS1_01,SET,766,-0.046734,-0.0093444,0.031406,0.93162,TGACAGNY_MEIS1_01,0.99999
GOBP_REGULATION_OF_GTP_BINDI...,SET,8,-0.47102,-0.0098298,0.31646,0.93167,GOBP_REGULATION_OF_GTP_BINDING,0.99999
HP_ABNORMAL_BLOOD_TRANSITION...,SET,37,-0.19925,-0.0089355,0.13386,0.93168,HP_ABNORMAL_BLOOD_TRANSITION_ELEMENT_CATION_CONCENTRATION,0.99999
THAKAR_PBMC_INACTIVATED_INFL...5,SET,785,-0.044211,-0.008944,0.029696,0.93172,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN,0.99999
YU_BAP1_TARGETS,SET,29,-0.22038,-0.0087514,0.14802,0.93173,YU_BAP1_TARGETS,0.99999
MIR1264,SET,109,-0.11583,-0.008898,0.077786,0.93176,MIR1264,0.99999
GSE27786_BCELL_VS_NKCELL_DN,SET,183,-0.090427,-0.0089826,0.060727,0.93176,GSE27786_BCELL_VS_NKCELL_DN,0.99999
GSE22886_NAIVE_TCELL_VS_NEUT...2,SET,175,-0.090589,-0.0088017,0.060832,0.93177,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP,0.99999
HP_RESPIRATORY_DISTRESS,SET,192,-0.090744,-0.0092307,0.060928,0.93179,HP_RESPIRATORY_DISTRESS,0.99999
GSE40666_UNTREATED_VS_IFNA_S...2,SET,147,-0.10579,-0.0094274,0.07102,0.93182,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_UP,0.99999
TURASHVILI_BREAST_LOBULAR_CA...2,SET,62,-0.17083,-0.0099102,0.11463,0.93192,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,0.99999
HP_ABNORMAL_QRS_COMPLEX,SET,9,-0.46783,-0.010355,0.31392,0.93192,HP_ABNORMAL_QRS_COMPLEX,0.99999
GSE25123_WT_VS_PPARG_KO_MACR...4,SET,182,-0.097115,-0.0096208,0.06516,0.93193,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN,0.99999
HP_ABNORMALITY_OF_SKIN_PHYSI...,SET,504,-0.05685,-0.0092888,0.038143,0.93194,HP_ABNORMALITY_OF_SKIN_PHYSIOLOGY,0.99999
GOBP_MAMMARY_GLAND_FORMATION,SET,7,-0.54075,-0.010556,0.36269,0.932,GOBP_MAMMARY_GLAND_FORMATION,0.99999
GSE24972_WT_VS_IRF8_KO_SPLEE...2,SET,180,-0.097009,-0.0095578,0.065068,0.932,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_UP,0.99999
REACTOME_CHEMOKINE_RECEPTORS...,SET,54,-0.20226,-0.010953,0.13564,0.93202,REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,0.99999
GOBP_POSITIVE_REGULATION_OF_...417,SET,547,-0.057929,-0.0098485,0.038847,0.93204,GOBP_POSITIVE_REGULATION_OF_LOCOMOTION,0.99999
GOMF_PEPTIDE_HORMONE_BINDING,SET,48,-0.20037,-0.010232,0.13436,0.93205,GOMF_PEPTIDE_HORMONE_BINDING,0.99999
MIR500A_5P,SET,140,-0.10624,-0.0092415,0.071237,0.93206,MIR500A_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...260,SET,6,-0.45468,-0.0082179,0.30486,0.93207,GOBP_NEGATIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,0.99999
GOBP_NEUROTRANSMITTER_TRANSP...,SET,194,-0.091113,-0.009316,0.061076,0.93212,GOBP_NEUROTRANSMITTER_TRANSPORT,0.99999
MIR6814_5P,SET,100,-0.12394,-0.0091219,0.083075,0.93213,MIR6814_5P,0.99999
GOBP_PURINE_CONTAINING_COMPO...2,SET,484,-0.056748,-0.0090913,0.038037,0.93213,GOBP_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
MIR1914_5P,SET,55,-0.1791,-0.0097875,0.12004,0.93214,MIR1914_5P,0.99999
GSE37563_WT_VS_CTLA4_KO_CD4_...2,SET,149,-0.10304,-0.0092443,0.069047,0.93218,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP,0.99999
GOMF_VOLTAGE_GATED_POTASSIUM...3,SET,11,-0.42611,-0.010426,0.28552,0.93219,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION,0.99999
GSE36888_UNTREATED_VS_IL2_TR...11,SET,174,-0.092834,-0.0089942,0.062204,0.93219,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN,0.99999
GSE12845_IGD_POS_BLOOD_VS_NA...2,SET,160,-0.093089,-0.0086518,0.062368,0.93221,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,0.99999
GSE13522_CTRL_VS_T_CRUZI_Y_S...4,SET,121,-0.10704,-0.0086609,0.07172,0.93221,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_UP,0.99999
GOBP_CELLULAR_CATABOLIC_PROC...,SET,1032,-0.039522,-0.0091026,0.026472,0.93226,GOBP_CELLULAR_CATABOLIC_PROCESS,0.99999
HP_MYOCLONUS,SET,321,-0.070667,-0.0092618,0.047333,0.93227,HP_MYOCLONUS,0.99999
REACTOME_CASPASE_MEDIATED_CL...,SET,12,-0.35139,-0.0089803,0.23535,0.93228,REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS,0.99999
TGCAAAC_MIR452,SET,86,-0.13996,-0.0095565,0.093742,0.93228,TGCAAAC_MIR452,0.99999
HP_UNILATERAL_CLEFT_LIP,SET,8,-0.37258,-0.0077754,0.24951,0.9323,HP_UNILATERAL_CLEFT_LIP,0.99999
GOBP_POSITIVE_REGULATION_OF_...309,SET,11,-0.41714,-0.010207,0.27928,0.93235,GOBP_POSITIVE_REGULATION_OF_GLUTAMATE_SECRETION,0.99999
NKX2_5_TARGET_GENES,SET,1229,-0.037435,-0.0093554,0.025062,0.93236,NKX2_5_TARGET_GENES,0.99999
HP_ANTERIOR_SUBCAPSULAR_CATA...,SET,6,-0.52957,-0.0095715,0.35454,0.93236,HP_ANTERIOR_SUBCAPSULAR_CATARACT,0.99999
MIR4751,SET,31,-0.21286,-0.0087391,0.14249,0.93238,MIR4751,0.99999
GSE22432_MULTIPOTENT_PROGENI...1,SET,183,-0.089356,-0.0088762,0.059815,0.93239,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN,0.99999
GSE3982_EOSINOPHIL_VS_EFF_ME...2,SET,173,-0.09272,-0.0089577,0.062044,0.93246,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,0.99999
MARZEC_IL2_SIGNALING_DN,SET,36,-0.20791,-0.0091973,0.13912,0.93247,MARZEC_IL2_SIGNALING_DN,0.99999
GOMF_ALDEHYDE_DEHYDROGENASE_...,SET,17,-0.29931,-0.0091032,0.20025,0.93249,GOMF_ALDEHYDE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.99999
WP_STEROL_REGULATORY_ELEMENT...,SET,67,-0.14506,-0.0087469,0.097025,0.93255,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,0.99999
GOBP_BLOOD_VESSEL_REMODELING,SET,40,-0.20195,-0.0094159,0.13505,0.93258,GOBP_BLOOD_VESSEL_REMODELING,0.99999
HP_ABNORMAL_CILIARY_BODY_MOR...,SET,6,-0.49498,-0.0089463,0.3309,0.93264,HP_ABNORMAL_CILIARY_BODY_MORPHOLOGY,0.99999
MIR654_3P,SET,71,-0.14859,-0.0092223,0.099303,0.93271,MIR654_3P,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MID...3,SET,849,-0.04508,-0.0094669,0.030127,0.93271,HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL,0.99999
REACTOME_SYNTHESIS_OF_PC,SET,27,-0.2395,-0.0091774,0.16002,0.93275,REACTOME_SYNTHESIS_OF_PC,0.99999
GOBP_REGULATION_OF_MEMBRANE_...8,SET,420,-0.066607,-0.0099579,0.044462,0.93293,GOBP_REGULATION_OF_MEMBRANE_POTENTIAL,0.99999
HP_JOINT_STIFFNESS,SET,177,-0.095886,-0.0093689,0.064007,0.93293,HP_JOINT_STIFFNESS,0.99999
GOBP_METANEPHRIC_LOOP_OF_HEN...,SET,5,-0.62358,-0.010289,0.41619,0.93297,GOBP_METANEPHRIC_LOOP_OF_HENLE_DEVELOPMENT,0.99999
RLF_TARGET_GENES,SET,268,-0.078789,-0.0094492,0.052576,0.933,RLF_TARGET_GENES,0.99999
GSE12366_NAIVE_VS_MEMORY_BCE...2,SET,162,-0.09896,-0.0092543,0.066024,0.93303,GSE12366_NAIVE_VS_MEMORY_BCELL_UP,0.99999
MIKKELSEN_IPS_ICP_WITH_H3K4M...,SET,116,-0.12582,-0.009969,0.083941,0.93304,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,0.99999
REACTOME_NEURONAL_SYSTEM,SET,384,-0.069468,-0.0099406,0.046345,0.93304,REACTOME_NEURONAL_SYSTEM,0.99999
GOCC_CHROMOSOME_TELOMERIC_RE...2,SET,12,-0.33861,-0.0086537,0.22591,0.93304,GOCC_CHROMOSOME_TELOMERIC_REPEAT_REGION,0.99999
MIR599,SET,81,-0.13935,-0.0092354,0.092956,0.93307,MIR599,0.99999
YOSHIMURA_MAPK8_TARGETS_DN,SET,350,-0.06765,-0.0092507,0.04512,0.9331,YOSHIMURA_MAPK8_TARGETS_DN,0.99999
WP_METABOLIC_EPILEPTIC_DISOR...,SET,80,-0.13577,-0.0089424,0.09055,0.9331,WP_METABOLIC_EPILEPTIC_DISORDERS,0.99999
MIR432_3P,SET,57,-0.16976,-0.0094436,0.11322,0.9331,MIR432_3P,0.99999
HP_HYPOPARATHYROIDISM,SET,28,-0.24486,-0.0095545,0.1633,0.93311,HP_HYPOPARATHYROIDISM,0.99999
HP_ABNORMAL_DIGESTIVE_SYSTEM...,SET,923,-0.042462,-0.0092781,0.028318,0.93312,HP_ABNORMAL_DIGESTIVE_SYSTEM_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_MICROGLIA...,SET,17,-0.32482,-0.0098792,0.21658,0.93315,GOBP_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,0.99999
GOBP_REGULATION_OF_PH,SET,95,-0.13107,-0.0094037,0.087392,0.93316,GOBP_REGULATION_OF_PH,0.99999
GOBP_HEPATOCYTE_APOPTOTIC_PR...,SET,19,-0.29156,-0.0093742,0.19436,0.9332,GOBP_HEPATOCYTE_APOPTOTIC_PROCESS,0.99999
HP_ABNORMAL_CIRCULATING_IGA_...,SET,95,-0.12951,-0.0092915,0.086317,0.93323,HP_ABNORMAL_CIRCULATING_IGA_LEVEL,0.99999
REACTOME_RNA_POLYMERASE_II_T...1,SET,71,-0.13363,-0.0082937,0.089051,0.93327,REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,0.99999
KIM_MYC_AMPLIFICATION_TARGET...1,SET,87,-0.14251,-0.0097865,0.094955,0.93329,KIM_MYC_AMPLIFICATION_TARGETS_DN,0.99999
HP_CORONAL_CLEFT_VERTEBRAE,SET,17,-0.30743,-0.0093502,0.2048,0.93333,HP_CORONAL_CLEFT_VERTEBRAE,0.99999
GOBP_LINOLEIC_ACID_METABOLIC...,SET,19,-0.30027,-0.0096541,0.19999,0.93336,GOBP_LINOLEIC_ACID_METABOLIC_PROCESS,0.99999
TGGNNNNNNKCCAR_UNKNOWN,SET,382,-0.066978,-0.0095599,0.044607,0.93338,TGGNNNNNNKCCAR_UNKNOWN,0.99999
MIR6755_5P,SET,32,-0.22057,-0.0092002,0.14689,0.93339,MIR6755_5P,0.99999
HP_ABNORMALITY_OF_THE_BREAST,SET,393,-0.061827,-0.0089481,0.041171,0.93341,HP_ABNORMALITY_OF_THE_BREAST,0.99999
GOBP_PLATELET_ACTIVATION,SET,130,-0.1195,-0.01002,0.079566,0.93343,GOBP_PLATELET_ACTIVATION,0.99999
GOBP_DENDRITE_DEVELOPMENT,SET,218,-0.087394,-0.009466,0.058186,0.93344,GOBP_DENDRITE_DEVELOPMENT,0.99999
GOBP_RESPONSE_TO_PEPTIDE,SET,20,-0.30163,-0.0099495,0.20081,0.93345,GOBP_RESPONSE_TO_PEPTIDE,0.99999
HUTTMANN_B_CLL_POOR_SURVIVAL...1,SET,57,-0.16993,-0.0094532,0.11312,0.93347,HUTTMANN_B_CLL_POOR_SURVIVAL_DN,0.99999
GSE13484_UNSTIM_VS_YF17D_VAC...2,SET,179,-0.088579,-0.0087032,0.058961,0.93348,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...81,SET,11,-0.39079,-0.0095623,0.26006,0.93353,GOBP_NEGATIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.99999
GOBP_LONG_CHAIN_FATTY_ACID_I...,SET,10,-0.40611,-0.0094751,0.2702,0.93357,GOBP_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOBP_POSITIVE_REGULATION_OF_...438,SET,5,-0.61096,-0.010081,0.4065,0.93357,GOBP_POSITIVE_REGULATION_OF_MAPKKK_CASCADE_BY_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_NAD_CATABOLIC_PROCESS,SET,16,-0.28998,-0.0085565,0.19291,0.9336,GOBP_NAD_CATABOLIC_PROCESS,0.99999
HP_ABNORMAL_OPTIC_NERVE_MORP...,SET,753,-0.04582,-0.0090868,0.030476,0.93363,HP_ABNORMAL_OPTIC_NERVE_MORPHOLOGY,0.99999
HP_AGGRESSIVE_BEHAVIOR,SET,242,-0.080111,-0.0091363,0.053281,0.93364,HP_AGGRESSIVE_BEHAVIOR,0.99999
GSE13411_NAIVE_VS_SWITCHED_M...2,SET,174,-0.097147,-0.0094121,0.06457,0.93377,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP,0.99999
HP_LARGE_ILIAC_WING,SET,3,-0.70313,-0.008987,0.46732,0.93378,HP_LARGE_ILIAC_WING,0.99999
DESCARTES_MAIN_FETAL_SYNCYTI...,SET,64,-0.16967,-0.0099996,0.11276,0.93378,DESCARTES_MAIN_FETAL_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS,0.99999
HP_SUBACUTE_PROGRESSIVE_VIRA...,SET,9,-0.42192,-0.009339,0.28036,0.93382,HP_SUBACUTE_PROGRESSIVE_VIRAL_HEPATITIS,0.99999
GAO_LARGE_INTESTINE_24W_C5_L...,SET,49,-0.19092,-0.0098497,0.12686,0.93382,GAO_LARGE_INTESTINE_24W_C5_LGR5POS_STEM_CELL,0.99999
LIM_MAMMARY_STEM_CELL_DN,SET,385,-0.064072,-0.0091802,0.042573,0.93383,LIM_MAMMARY_STEM_CELL_DN,0.99999
GOBP_MEMBRANE_TUBULATION,SET,4,-0.68637,-0.01013,0.45597,0.93387,GOBP_MEMBRANE_TUBULATION,0.99999
GOBP_FIBROBLAST_APOPTOTIC_PR...,SET,24,-0.25632,-0.009261,0.17023,0.93393,GOBP_FIBROBLAST_APOPTOTIC_PROCESS,0.99999
HP_RENAL_TUBULAR_ATROPHY,SET,18,-0.2851,-0.0089223,0.18926,0.93401,HP_RENAL_TUBULAR_ATROPHY,0.99999
HP_GENERALIZED_HYPERREFLEXIA,SET,10,-0.3268,-0.0076247,0.21694,0.93402,HP_GENERALIZED_HYPERREFLEXIA,0.99999
GSE1460_INTRATHYMIC_T_PROGEN...6,SET,178,-0.09231,-0.0090448,0.061269,0.93404,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.99999
GSE9960_GRAM_POS_VS_GRAM_NEG...1,SET,173,-0.1004,-0.0096995,0.066631,0.93406,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,0.99999
ZIC1_01,SET,234,-0.082598,-0.009265,0.054811,0.93408,ZIC1_01,0.99999
MIR6513_3P,SET,133,-0.11186,-0.0094861,0.074225,0.9341,MIR6513_3P,0.99999
GSE40274_FOXP3_VS_FOXP3_AND_...12,SET,176,-0.097206,-0.0094713,0.064484,0.93414,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
MIR633,SET,128,-0.10784,-0.0089729,0.071528,0.93418,MIR633,0.99999
GOBP_PEPTIDE_CROSS_LINKING,SET,26,-0.2534,-0.0095289,0.16806,0.93419,GOBP_PEPTIDE_CROSS_LINKING,0.99999
MIR8063,SET,362,-0.06695,-0.0093075,0.044396,0.93422,MIR8063,0.99999
MIR649,SET,62,-0.15343,-0.0089009,0.10171,0.93428,MIR649,0.99999
MIR6816_3P,SET,31,-0.21114,-0.0086685,0.13991,0.93436,MIR6816_3P,0.99999
HP_CRUMPLED_EAR,SET,5,-0.55449,-0.0091489,0.36737,0.93439,HP_CRUMPLED_EAR,0.99999
GSE22886_NEUTROPHIL_VS_MONOC...1,SET,176,-0.092441,-0.009007,0.061241,0.9344,GSE22886_NEUTROPHIL_VS_MONOCYTE_DN,0.99999
GSE3982_BCELL_VS_NKCELL_DN,SET,171,-0.10086,-0.0096881,0.066816,0.93441,GSE3982_BCELL_VS_NKCELL_DN,0.99999
ZNF214_TARGET_GENES,SET,12,-0.37998,-0.0097109,0.2517,0.93442,ZNF214_TARGET_GENES,0.99999
GSE13485_CTRL_VS_DAY21_YF17D...1,SET,129,-0.11258,-0.0094029,0.074562,0.93445,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.99999
MIR8056,SET,40,-0.19868,-0.0092634,0.13158,0.93447,MIR8056,0.99999
NF1_Q6,SET,240,-0.085061,-0.0096612,0.05633,0.93447,NF1_Q6,0.99999
GAO_LARGE_INTESTINE_24W_C8_G...,SET,38,-0.22629,-0.010284,0.14985,0.93448,GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL,0.99999
HP_LENS_LUXATION,SET,6,-0.57923,-0.010469,0.38351,0.93451,HP_LENS_LUXATION,0.99999
REACTOME_DIGESTION_OF_DIETAR...1,SET,7,-0.48545,-0.0094768,0.32139,0.93453,REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE,0.99999
BHATI_G2M_ARREST_BY_2METHOXY...1,SET,107,-0.12253,-0.0093266,0.081112,0.93455,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,0.99999
REACTOME_FRS_MEDIATED_FGFR2_...,SET,24,-0.26192,-0.0094633,0.17337,0.93456,REACTOME_FRS_MEDIATED_FGFR2_SIGNALING,0.99999
WP_FACTORS_AND_PATHWAYS_AFFE...,SET,36,-0.21448,-0.0094879,0.14197,0.93457,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,0.99999
OCT1_Q6,SET,229,-0.087109,-0.0096674,0.057659,0.93457,OCT1_Q6,0.99999
PECE_MAMMARY_STEM_CELL_UP,SET,120,-0.10996,-0.0088604,0.072778,0.93458,PECE_MAMMARY_STEM_CELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...24,SET,22,-0.29,-0.010032,0.19193,0.93459,GOBP_POSITIVE_REGULATION_OF_AMINO_ACID_TRANSPORT,0.99999
GOBP_ACTIVATION_OF_PROTEIN_K...1,SET,75,-0.14725,-0.0093921,0.097428,0.93465,GOBP_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,0.99999
OUELLET_CULTURED_OVARIAN_CAN...1,SET,30,-0.23727,-0.0095831,0.15698,0.93466,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...3,SET,171,-0.09425,-0.0090532,0.06234,0.93471,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,0.99999
chr5q14,SET,46,-0.31306,-0.01565,0.20699,0.93478,chr5q14,0.99999
REACTOME_HATS_ACETYLATE_HIST...,SET,71,-0.14071,-0.0087328,0.093,0.93485,REACTOME_HATS_ACETYLATE_HISTONES,0.99999
HP_HYPERLIPOPROTEINEMIA,SET,36,-0.2256,-0.0099798,0.14907,0.9349,HP_HYPERLIPOPROTEINEMIA,0.99999
WP_RAS_AND_BRADYKININ_PATHWA...,SET,27,-0.28039,-0.010744,0.18523,0.93494,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,0.99999
GOBP_REGULATION_OF_GUANYLATE...,SET,6,-0.5941,-0.010738,0.39235,0.935,GOBP_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY,0.99999
NAKAYA_PLASMACYTOID_DENDRITI...1,SET,168,-0.092698,-0.0088264,0.061208,0.93504,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.99999
HP_ABNORMAL_T_CELL_ACTIVATION,SET,5,-0.55982,-0.0092369,0.36946,0.93514,HP_ABNORMAL_T_CELL_ACTIVATION,0.99999
GSE29164_UNTREATED_VS_CD8_TC...6,SET,175,-0.092067,-0.0089453,0.060754,0.93516,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_UP,0.99999
REACTOME_AMINO_ACID_CONJUGAT...,SET,8,-0.65606,-0.013691,0.43277,0.93522,REACTOME_AMINO_ACID_CONJUGATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...708,SET,69,-0.15743,-0.0096329,0.10383,0.93527,GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING,0.99999
GOMF_NADPLUS_NUCLEOSIDASE_AC...,SET,9,-0.58784,-0.013011,0.38762,0.9353,GOMF_NADPLUS_NUCLEOSIDASE_ACTIVITY,0.99999
GGGCATT_MIR365,SET,100,-0.12722,-0.0093634,0.083884,0.93532,GGGCATT_MIR365,0.99999
GSE17721_LPS_VS_POLYIC_4H_BM...2,SET,184,-0.092527,-0.009216,0.061007,0.93532,GSE17721_LPS_VS_POLYIC_4H_BMDC_UP,0.99999
HP_ABNORMAL_TIBIA_MORPHOLOGY,SET,90,-0.14063,-0.0098218,0.092718,0.93533,HP_ABNORMAL_TIBIA_MORPHOLOGY,0.99999
ISRE_01,SET,226,-0.088374,-0.0097441,0.058259,0.93535,ISRE_01,0.99999
GSE17721_CTRL_VS_LPS_8H_BMDC...1,SET,184,-0.095065,-0.0094688,0.062668,0.93535,GSE17721_CTRL_VS_LPS_8H_BMDC_DN,0.99999
GSE22886_UNSTIM_VS_STIM_MEMO...1,SET,182,-0.087985,-0.0087163,0.057978,0.93543,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN,0.99999
GOBP_REGULATION_OF_POLYAMINE...,SET,5,-0.4935,-0.0081426,0.32515,0.93545,GOBP_REGULATION_OF_POLYAMINE_TRANSMEMBRANE_TRANSPORT,0.99999
GOMF_ORNITHINE_DECARBOXYLASE...,SET,5,-0.4935,-0.0081426,0.32515,0.93545,GOMF_ORNITHINE_DECARBOXYLASE_REGULATOR_ACTIVITY,0.99999
GOBP_PHOTOTRANSDUCTION_VISIB...,SET,16,-0.32121,-0.0094779,0.21155,0.93553,GOBP_PHOTOTRANSDUCTION_VISIBLE_LIGHT,0.99999
KEGG_MEDICUS_VARIANT_OLIGOME...,SET,13,-0.33642,-0.0089486,0.22155,0.93555,KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.99999
GOBP_ACTIN_FILAMENT_BASED_TR...,SET,10,-0.3741,-0.0087281,0.24634,0.93556,GOBP_ACTIN_FILAMENT_BASED_TRANSPORT,0.99999
GOCC_CYTOPLASMIC_MICROTUBULE,SET,81,-0.13904,-0.0092146,0.091558,0.93556,GOCC_CYTOPLASMIC_MICROTUBULE,0.99999
REACTOME_KIDNEY_DEVELOPMENT,SET,42,-0.22378,-0.010691,0.14734,0.93558,REACTOME_KIDNEY_DEVELOPMENT,0.99999
GOMF_K48_LINKED_POLYUBIQUITI...,SET,7,-0.48588,-0.0094852,0.31992,0.93558,GOMF_K48_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...8,SET,181,-0.099144,-0.009795,0.065277,0.93559,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP,0.99999
GNF2_JAK1,SET,30,-0.21824,-0.0088145,0.14368,0.93561,GNF2_JAK1,0.99999
JAZAERI_BREAST_CANCER_BRCA1_...2,SET,45,-0.17439,-0.0086229,0.11477,0.93567,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,0.99999
HP_ORGANIC_ACIDURIA,SET,112,-0.12236,-0.0095273,0.0805,0.93573,HP_ORGANIC_ACIDURIA,0.99999
GSE14415_NATURAL_TREG_VS_FOX...1,SET,144,-0.10524,-0.0092835,0.069228,0.93576,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN,0.99999
GOBP_REGULATION_OF_COPII_VES...,SET,5,-0.46418,-0.0076589,0.30526,0.93581,GOBP_REGULATION_OF_COPII_VESICLE_COATING,0.99999
GOMF_G_PROTEIN_COUPLED_RECEP...1,SET,696,-0.061389,-0.011724,0.040362,0.93586,GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY,0.99999
KOMMAGANI_TP63_GAMMA_TARGETS,SET,9,-0.41108,-0.009099,0.27024,0.93588,KOMMAGANI_TP63_GAMMA_TARGETS,0.99999
STREICHER_LSM1_TARGETS_DN,SET,18,-0.30525,-0.0095527,0.20067,0.93588,STREICHER_LSM1_TARGETS_DN,0.99999
TGCCTTA_MIR124A,SET,511,-0.057371,-0.0094368,0.037715,0.93588,TGCCTTA_MIR124A,0.99999
GSE20198_UNTREATED_VS_IL12_T...1,SET,182,-0.092064,-0.0091205,0.060521,0.93589,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN,0.99999
REACTOME_PHOSPHOLIPASE_C_MED...2,SET,17,-0.34848,-0.010599,0.22899,0.93596,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2,0.99999
REACTOME_METABOLISM_OF_FOLAT...,SET,16,-0.29319,-0.0086511,0.19261,0.93601,REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES,0.99999
WP_GENES_CONTROLLING_NEPHROG...,SET,41,-0.22469,-0.010606,0.1476,0.93603,WP_GENES_CONTROLLING_NEPHROGENESIS,0.99999
REACTOME_REGULATION_OF_NFE2L...,SET,8,-0.48009,-0.010019,0.31533,0.93605,REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION,0.99999
GSE5099_UNSTIM_VS_MCSF_TREAT...3,SET,173,-0.096063,-0.0092806,0.063096,0.93605,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN,0.99999
HP_PARTIAL_AGENESIS_OF_THE_C...,SET,46,-0.17912,-0.0089541,0.11762,0.93608,HP_PARTIAL_AGENESIS_OF_THE_CORPUS_CALLOSUM,0.99999
HP_ABNORMAL_UTERINE_CERVIX_M...,SET,11,-0.44975,-0.011005,0.2953,0.93612,HP_ABNORMAL_UTERINE_CERVIX_MORPHOLOGY,0.99999
HP_ABNORMALITY_OF_COORDINATI...,SET,1040,-0.040055,-0.009259,0.026296,0.93614,HP_ABNORMALITY_OF_COORDINATION,0.99999
GSE1925_CTRL_VS_24H_IFNG_STI...3,SET,174,-0.092078,-0.008921,0.060443,0.93616,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN,0.99999
HP_ASYMMETRIC_GROWTH,SET,58,-0.17331,-0.0097251,0.11376,0.93617,HP_ASYMMETRIC_GROWTH,0.99999
GOMF_PROTEIN_SERINE_THREONIN...7,SET,42,-0.20128,-0.0096158,0.13211,0.93618,GOMF_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY,0.99999
HP_GASTROINTESTINAL_ATRESIA,SET,75,-0.14507,-0.0092526,0.095196,0.93622,HP_GASTROINTESTINAL_ATRESIA,0.99999
GSE25123_WT_VS_PPARG_KO_MACR...7,SET,181,-0.095351,-0.0094203,0.06255,0.93629,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,0.99999
RAMJAUN_APOPTOSIS_BY_TGFB1_V...3,SET,10,-0.44043,-0.010276,0.2889,0.9363,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN,0.99999
GSE17721_CTRL_VS_POLYIC_4H_B...2,SET,183,-0.090254,-0.0089654,0.059174,0.93639,GSE17721_CTRL_VS_POLYIC_4H_BMDC_UP,0.99999
HP_SHORT_NASAL_BRIDGE,SET,5,-0.67255,-0.011097,0.44089,0.93642,HP_SHORT_NASAL_BRIDGE,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...5,SET,47,-0.20761,-0.010491,0.13606,0.93647,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3,0.99999
GOBP_POSITIVE_REGULATION_OF_...610,SET,21,-0.28782,-0.0097284,0.18862,0.93647,GOBP_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.99999
HP_ANISOMETROPIA,SET,4,-0.52109,-0.0076903,0.3415,0.93647,HP_ANISOMETROPIA,0.99999
REACTOME_REGULATION_OF_TP53_...3,SET,14,-0.34129,-0.0094204,0.22365,0.93649,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS,0.99999
GTAGGCA_MIR189,SET,25,-0.25363,-0.0093526,0.16617,0.93653,GTAGGCA_MIR189,0.99999
GOBP_POSITIVE_REGULATION_OF_...536,SET,5,-0.62341,-0.010286,0.40844,0.93653,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_UPTAKE,0.99999
HP_PARTIAL_ABSENCE_OF_SPECIF...2,SET,6,-0.56529,-0.010217,0.37035,0.93653,HP_PARTIAL_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_UNCONJUGATED_PNEUMOCOCCUS_VACCINE,0.99999
REACTOME_PHENYLALANINE_METAB...,SET,5,-0.66784,-0.011019,0.43745,0.93657,REACTOME_PHENYLALANINE_METABOLISM,0.99999
GOBP_MESODERMAL_CELL_FATE_CO...,SET,17,-0.31773,-0.0096634,0.2081,0.93658,GOBP_MESODERMAL_CELL_FATE_COMMITMENT,0.99999
GOCC_RISC_LOADING_COMPLEX,SET,8,-0.47528,-0.0099187,0.31129,0.93659,GOCC_RISC_LOADING_COMPLEX,0.99999
HP_EXODEVIATION,SET,104,-0.11984,-0.0089933,0.078485,0.93659,HP_EXODEVIATION,0.99999
HP_ABNORMAL_NASAL_CAVITY_MOR...,SET,16,-0.32983,-0.0097324,0.21595,0.93666,HP_ABNORMAL_NASAL_CAVITY_MORPHOLOGY,0.99999
HP_NEOPLASM_OF_THE_LIVER,SET,132,-0.11446,-0.0096703,0.074902,0.93676,HP_NEOPLASM_OF_THE_LIVER,0.99999
GOBP_NEGATIVE_REGULATION_OF_...414,SET,12,-0.44625,-0.011405,0.29187,0.93685,GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.99999
LEE_LIVER_CANCER_E2F1_UP,SET,60,-0.18983,-0.010834,0.12416,0.93686,LEE_LIVER_CANCER_E2F1_UP,0.99999
SYNCRIP_TARGET_GENES,SET,16,-0.31232,-0.0092155,0.20422,0.93689,SYNCRIP_TARGET_GENES,0.99999
PHONG_TNF_TARGETS_DN,SET,8,-0.48407,-0.010102,0.31647,0.93693,PHONG_TNF_TARGETS_DN,0.99999
GSE17721_CTRL_VS_PAM3CSK4_8H...2,SET,178,-0.093423,-0.0091538,0.061073,0.93695,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_UP,0.99999
KEGG_MEDICUS_REFERENCE_ICOSL...,SET,8,-0.47883,-0.0099928,0.313,0.93696,KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY,0.99999
HP_ABNORMALITY_OF_THE_FIFTH_...,SET,8,-0.50802,-0.010602,0.33208,0.93696,HP_ABNORMALITY_OF_THE_FIFTH_METATARSAL_BONE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...473,SET,25,-0.24067,-0.0088745,0.1573,0.93698,GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
HP_ABNORMALITY_OF_THE_CURVAT...,SET,305,-0.073093,-0.009342,0.047773,0.93698,HP_ABNORMALITY_OF_THE_CURVATURE_OF_THE_CORNEA,0.99999
REACTOME_HIV_INFECTION,SET,215,-0.079687,-0.0085724,0.052082,0.93699,REACTOME_HIV_INFECTION,0.99999
GOBP_ANIMAL_ORGAN_FORMATION,SET,64,-0.17754,-0.010463,0.11602,0.93701,GOBP_ANIMAL_ORGAN_FORMATION,0.99999
GOMF_RNA_DIRECTED_DNA_POLYME...,SET,6,-0.48265,-0.0087235,0.31542,0.93701,GOMF_RNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,0.99999
YOKOE_CANCER_TESTIS_ANTIGENS,SET,33,-0.21069,-0.0089242,0.13766,0.93705,YOKOE_CANCER_TESTIS_ANTIGENS,0.99999
HP_ABNORMAL_PORTAL_VENOUS_SY...,SET,13,-0.38066,-0.010125,0.24871,0.93705,HP_ABNORMAL_PORTAL_VENOUS_SYSTEM_MORPHOLOGY,0.99999
GOBP_RESPONSE_TO_STIMULUS_IN...,SET,13,-0.37405,-0.0099495,0.24434,0.93709,GOBP_RESPONSE_TO_STIMULUS_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION,0.99999
HP_INTRAHEPATIC_BILIARY_ATRE...,SET,7,-0.44712,-0.0087285,0.292,0.93713,HP_INTRAHEPATIC_BILIARY_ATRESIA,0.99999
GOBP_MESODERMAL_CELL_FATE_SP...,SET,13,-0.35834,-0.0095315,0.23396,0.93718,GOBP_MESODERMAL_CELL_FATE_SPECIFICATION,0.99999
MIR4525,SET,32,-0.23023,-0.0096031,0.1503,0.9372,MIR4525,0.99999
GOBP_G_PROTEIN_COUPLED_GLUTA...,SET,15,-0.34623,-0.0098921,0.226,0.93723,GOBP_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_LATE_ONSET,SET,122,-0.1179,-0.0095783,0.076956,0.93723,HP_LATE_ONSET,0.99999
chr12q22,SET,18,-0.51829,-0.01622,0.33821,0.93728,chr12q22,0.99999
REACTOME_LDL_REMODELING,SET,6,-0.46962,-0.008488,0.3064,0.93732,REACTOME_LDL_REMODELING,0.99999
GOBP_NEGATIVE_REGULATION_OF_...123,SET,640,-0.054608,-0.010016,0.035628,0.93732,GOBP_NEGATIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION,0.99999
PANAPASA_BLOOD_FLUENZ_AGE_03...1,SET,6,-0.49011,-0.0088582,0.31972,0.93734,PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_3DY_4DY_DN,0.99999
GSE16386_IL4_VS_IL4_AND_ROSI...1,SET,173,-0.097831,-0.0094514,0.063808,0.93738,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN,0.99999
GOBP_CELLULAR_RESPONSE_TO_VI...3,SET,19,-0.31094,-0.0099972,0.20275,0.93743,GOBP_CELLULAR_RESPONSE_TO_VITAMIN_D,0.99999
HP_CRANIAL_HYPEROSTOSIS,SET,40,-0.18815,-0.0087725,0.12268,0.93744,HP_CRANIAL_HYPEROSTOSIS,0.99999
MIR6806_3P,SET,94,-0.13787,-0.0098394,0.089891,0.93745,MIR6806_3P,0.99999
GOCC_PRESYNAPTIC_ACTIVE_ZONE,SET,73,-0.15886,-0.009997,0.10356,0.93749,GOCC_PRESYNAPTIC_ACTIVE_ZONE,0.99999
GSE29949_MICROGLIA_BRAIN_VS_...4,SET,180,-0.098146,-0.0096699,0.063977,0.93749,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,0.99999
HOWARD_MONOCYTE_INACT_MONOV_...1,SET,35,-0.23671,-0.010325,0.15428,0.9375,HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.99999
GOMF_SEMAPHORIN_RECEPTOR_ACT...,SET,10,-0.47366,-0.011051,0.3087,0.93752,GOMF_SEMAPHORIN_RECEPTOR_ACTIVITY,0.99999
MTF1_Q4,SET,221,-0.089193,-0.0097263,0.058116,0.93757,MTF1_Q4,0.99999
GOBP_RESPONSE_TO_L_ASCORBIC_...,SET,5,-0.64886,-0.010706,0.42271,0.9376,GOBP_RESPONSE_TO_L_ASCORBIC_ACID,0.99999
KAECH_NAIVE_VS_DAY15_EFF_CD8...1,SET,183,-0.097769,-0.0097119,0.063692,0.9376,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN,0.99999
MIR3646,SET,771,-0.048196,-0.0096666,0.031392,0.93763,MIR3646,0.99999
BIOCARTA_MITOCHONDRIA_PATHWAY,SET,17,-0.30561,-0.0092948,0.19905,0.93764,BIOCARTA_MITOCHONDRIA_PATHWAY,0.99999
GOBP_MITOTIC_DNA_REPLICATION...,SET,11,-0.34622,-0.0084718,0.22551,0.93764,GOBP_MITOTIC_DNA_REPLICATION_CHECKPOINT_SIGNALING,0.99999
GOBP_REGULATION_OF_SKELETAL_...6,SET,7,-0.45985,-0.0089771,0.29949,0.93765,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,0.99999
GOBP_REGULATION_OF_LOCOMOTION,SET,960,-0.045198,-0.010061,0.029435,0.93766,GOBP_REGULATION_OF_LOCOMOTION,0.99999
GOBP_ICOSANOID_SECRETION,SET,47,-0.20975,-0.010599,0.13656,0.93772,GOBP_ICOSANOID_SECRETION,0.99999
ZNF785_TARGET_GENES,SET,55,-0.16855,-0.009211,0.10972,0.93774,ZNF785_TARGET_GENES,0.99999
GLI1_TARGET_GENES,SET,421,-0.063659,-0.0095283,0.041435,0.93776,GLI1_TARGET_GENES,0.99999
KEGG_MEDICUS_VARIANT_BCL2_OV...,SET,7,-0.46852,-0.0091463,0.30481,0.93785,KEGG_MEDICUS_VARIANT_BCL2_OVEREXPRESSION_TO_INTRINSIC_APOPTOTIC_PATHWAY,0.99999
GSE3982_MAC_VS_EFF_MEMORY_CD...1,SET,173,-0.097478,-0.0094173,0.063414,0.93787,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN,0.99999
GOMF_CYCLIC_NUCLEOTIDE_BINDI...,SET,36,-0.21738,-0.0096162,0.14138,0.93791,GOMF_CYCLIC_NUCLEOTIDE_BINDING,0.99999
GOBP_CELLULAR_RESPONSE_TO_NU...1,SET,45,-0.20104,-0.0099405,0.13074,0.93793,GOBP_CELLULAR_RESPONSE_TO_NUTRIENT,0.99999
GOCC_DESMOSOME,SET,26,-0.2756,-0.010363,0.17921,0.93794,GOCC_DESMOSOME,0.99999
WP_ACE_INHIBITOR_PATHWAY,SET,14,-0.4116,-0.011361,0.26762,0.93797,WP_ACE_INHIBITOR_PATHWAY,0.99999
HP_TRICUSPID_VALVE_PROLAPSE,SET,10,-0.42262,-0.0098602,0.27478,0.93797,HP_TRICUSPID_VALVE_PROLAPSE,0.99999
GOBP_ADRENERGIC_RECEPTOR_SIG...,SET,30,-0.25264,-0.010204,0.16425,0.93799,GOBP_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,0.99999
KEGG_GLYCEROLIPID_METABOLISM,SET,41,-0.20468,-0.0096612,0.13306,0.938,KEGG_GLYCEROLIPID_METABOLISM,0.99999
MIR375_3P,SET,36,-0.21932,-0.0097019,0.14258,0.938,MIR375_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...134,SET,5,-0.64653,-0.010668,0.42025,0.93802,GOBP_NEGATIVE_REGULATION_OF_CGMP_MEDIATED_SIGNALING,0.99999
MIR507,SET,241,-0.084272,-0.0095912,0.054774,0.93803,MIR507,0.99999
GSE11057_CD4_CENT_MEM_VS_PBM...1,SET,175,-0.10131,-0.0098431,0.065836,0.93806,GSE11057_CD4_CENT_MEM_VS_PBMC_DN,0.99999
GOBP_TRICARBOXYLIC_ACID_TRAN...,SET,5,-0.57078,-0.0094178,0.37092,0.93807,GOBP_TRICARBOXYLIC_ACID_TRANSPORT,0.99999
MIR4712_3P,SET,57,-0.17699,-0.0098463,0.11498,0.93813,MIR4712_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...696,SET,88,-0.14666,-0.010129,0.095268,0.93815,GOBP_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,0.99999
WP_GLUCOCORTICOID_RECEPTOR_P...,SET,68,-0.16756,-0.010178,0.10882,0.93819,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,0.99999
GOBP_NEURON_PROJECTION_EXTEN...1,SET,148,-0.10929,-0.0097721,0.07097,0.9382,GOBP_NEURON_PROJECTION_EXTENSION,0.99999
GOBP_REGULATION_OF_TOLL_LIKE...5,SET,11,-0.41741,-0.010214,0.27104,0.93821,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_PAROTID_GLAND_MO...,SET,8,-0.45621,-0.0095206,0.29622,0.93822,HP_ABNORMAL_PAROTID_GLAND_MORPHOLOGY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...347,SET,25,-0.273,-0.010067,0.17717,0.93832,GOBP_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,0.99999
REACTOME_VXPX_CARGO_TARGETIN...,SET,20,-0.27029,-0.0089157,0.17527,0.93846,REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM,0.99999
YNGTTNNNATT_UNKNOWN,SET,339,-0.075872,-0.010214,0.049202,0.93846,YNGTTNNNATT_UNKNOWN,0.99999
GOBP_NITRIC_OXIDE_MEDIATED_S...,SET,18,-0.34089,-0.010668,0.22105,0.93847,GOBP_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION,0.99999
GOCC_MICROVILLUS_MEMBRANE,SET,29,-0.24774,-0.0098377,0.16064,0.93848,GOCC_MICROVILLUS_MEMBRANE,0.99999
LOPEZ_MESOTHELIOMA_SURVIVAL_...1,SET,10,-0.42196,-0.0098448,0.27357,0.93851,LOPEZ_MESOTHELIOMA_SURVIVAL_DN,0.99999
MIR3654,SET,43,-0.19033,-0.0092001,0.12334,0.93859,MIR3654,0.99999
MODULE_417,SET,20,-0.31503,-0.010392,0.20415,0.93859,MODULE_417,0.99999
GOBP_REGULATION_OF_PHOSPHATI...2,SET,9,-0.47998,-0.010624,0.31097,0.93864,GOBP_REGULATION_OF_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,0.99999
GOCC_T_CELL_RECEPTOR_COMPLEX,SET,15,-0.36097,-0.010313,0.23385,0.93865,GOCC_T_CELL_RECEPTOR_COMPLEX,0.99999
WP_CONVERSION_OF_ANGIOTENSIN...,SET,5,-0.72854,-0.012021,0.47189,0.93868,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,0.99999
GOBP_REGULATION_OF_CHROMATIN...2,SET,28,-0.22953,-0.0089565,0.14863,0.93873,GOBP_REGULATION_OF_CHROMATIN_ORGANIZATION,0.99999
GOBP_NITROGEN_UTILIZATION,SET,5,-0.57881,-0.0095503,0.37475,0.93876,GOBP_NITROGEN_UTILIZATION,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...18,SET,179,-0.094325,-0.0092678,0.061063,0.93878,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_UP,0.99999
GSE29618_MONOCYTE_VS_MDC_DAY...2,SET,189,-0.10073,-0.010167,0.065198,0.93881,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP,0.99999
MIR6875_3P,SET,361,-0.069613,-0.0096645,0.045057,0.93882,MIR6875_3P,0.99999
GSE22886_UNSTIM_VS_IL2_STIM_...2,SET,169,-0.097311,-0.0092929,0.062976,0.93884,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP,0.99999
REACTOME_ACYL_CHAIN_REMODELL...1,SET,25,-0.28331,-0.010447,0.18332,0.93887,REACTOME_ACYL_CHAIN_REMODELLING_OF_PC,0.99999
GSE28737_WT_VS_BCL6_KO_FOLLI...2,SET,180,-0.098563,-0.009711,0.063773,0.93888,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP,0.99999
GATA_C,SET,237,-0.087459,-0.0098721,0.056546,0.93902,GATA_C,0.99999
GOBP_REGULATION_OF_POSTSYNAP...4,SET,13,-0.37656,-0.010016,0.24341,0.93906,GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ASSEMBLY,0.99999
MODULE_236,SET,16,-0.3393,-0.010012,0.2193,0.93908,MODULE_236,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...17,SET,8,-0.48314,-0.010083,0.31219,0.93913,KEGG_MEDICUS_VARIANT_AMPLIFIED_REL_TO_TRANSCRIPTION,0.99999
GOBP_DENDRITIC_SPINE_DEVELOP...,SET,87,-0.1437,-0.009868,0.092832,0.93917,GOBP_DENDRITIC_SPINE_DEVELOPMENT,0.99999
GOCC_U2_TYPE_SPLICEOSOMAL_CO...,SET,86,-0.1211,-0.0082686,0.078224,0.9392,GOCC_U2_TYPE_SPLICEOSOMAL_COMPLEX,0.99999
KEGG_GLYCOSAMINOGLYCAN_DEGRA...,SET,20,-0.30234,-0.009973,0.19524,0.93925,KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,0.99999
CHIARETTI_T_ALL_RELAPSE_PROG...,SET,17,-0.33136,-0.010078,0.21393,0.93929,CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,0.99999
BIOCARTA_TCAPOPTOSIS_PATHWAY,SET,9,-0.4539,-0.010047,0.29303,0.9393,BIOCARTA_TCAPOPTOSIS_PATHWAY,0.99999
MIR3616_3P,SET,54,-0.17084,-0.0092512,0.11026,0.93935,MIR3616_3P,0.99999
GOBP_CARDIAC_MUSCLE_CELL_MYO...,SET,11,-0.44229,-0.010822,0.28543,0.93937,GOBP_CARDIAC_MUSCLE_CELL_MYOBLAST_DIFFERENTIATION,0.99999
GSE11961_MARGINAL_ZONE_BCELL...1,SET,188,-0.098365,-0.0099023,0.063479,0.93937,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,0.99999
HP_RECURRENT_BRONCHITIS,SET,33,-0.23222,-0.0098362,0.14985,0.93939,HP_RECURRENT_BRONCHITIS,0.99999
GOBP_PEPTIDYL_LYSINE_DIMETHY...,SET,4,-0.66454,-0.0098074,0.42877,0.93941,GOBP_PEPTIDYL_LYSINE_DIMETHYLATION,0.99999
GSE20727_DNFB_ALLERGEN_VS_RO...2,SET,163,-0.10396,-0.0097517,0.067068,0.93943,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.99999
LI_CISPLATIN_RESISTANCE_UP,SET,24,-0.29225,-0.010559,0.18849,0.93948,LI_CISPLATIN_RESISTANCE_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...77,SET,8,-0.45248,-0.0094429,0.29182,0.93948,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.99999
KEGG_MEDICUS_REFERENCE_BASE_...1,SET,8,-0.38969,-0.0081324,0.25127,0.93953,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_BIFUNCTIONAL_GLYCOSYLASE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...285,SET,171,-0.10429,-0.010018,0.067246,0.93953,GOBP_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY,0.99999
GSE35685_CD34POS_CD38NEG_VS_...3,SET,187,-0.096479,-0.0096868,0.062206,0.93953,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN,0.99999
GOBP_REGULATION_OF_MESODERMA...2,SET,6,-0.54936,-0.0099293,0.3542,0.93954,GOBP_REGULATION_OF_MESODERMAL_CELL_FATE_SPECIFICATION,0.99999
REACTOME_NEUROTRANSMITTER_RE...1,SET,191,-0.1001,-0.010156,0.064531,0.93956,REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,0.99999
PID_SYNDECAN_1_PATHWAY,SET,43,-0.20965,-0.010134,0.13514,0.93958,PID_SYNDECAN_1_PATHWAY,0.99999
GOBP_TRANSFERRIN_TRANSPORT,SET,10,-0.39852,-0.0092978,0.25689,0.93958,GOBP_TRANSFERRIN_TRANSPORT,0.99999
REACTOME_HIV_LIFE_CYCLE,SET,138,-0.1,-0.0086368,0.064442,0.93963,REACTOME_HIV_LIFE_CYCLE,0.99999
HP_ABNORMAL_BLOOD_PHOSPHATE_...,SET,58,-0.1807,-0.01014,0.11645,0.93963,HP_ABNORMAL_BLOOD_PHOSPHATE_CONCENTRATION,0.99999
GOBP_REGULATION_OF_ARP2_3_CO...,SET,18,-0.27407,-0.0085769,0.17658,0.93967,GOBP_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.99999
FOXD3_01,SET,179,-0.10161,-0.0099834,0.065454,0.9397,FOXD3_01,0.99999
GSE39820_TGFBETA3_IL6_VS_TGF...2,SET,181,-0.096018,-0.0094862,0.061837,0.93975,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP,0.99999
GSE21670_UNTREATED_VS_IL6_TR...2,SET,168,-0.096534,-0.0091916,0.062167,0.93976,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP,0.99999
GOBP_HINDBRAIN_MATURATION,SET,5,-0.58273,-0.0096149,0.37518,0.9398,GOBP_HINDBRAIN_MATURATION,0.99999
GSE7509_UNSTIM_VS_TNFA_IL1B_...2,SET,175,-0.094986,-0.0092289,0.061157,0.9398,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...391,SET,4,-0.64527,-0.009523,0.41543,0.93981,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_APOPTOTIC_PROCESS,0.99999
IL21_UP.V1_UP,SET,166,-0.1032,-0.0097682,0.066442,0.93981,IL21_UP.V1_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...684,SET,46,-0.17827,-0.0089119,0.11475,0.93984,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
GSE10240_IL22_VS_IL17_STIM_P...1,SET,174,-0.094253,-0.0091317,0.060671,0.93984,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.99999
PYEON_HPV_POSITIVE_TUMORS_UP,SET,81,-0.14094,-0.0093408,0.090654,0.93999,PYEON_HPV_POSITIVE_TUMORS_UP,0.99999
SMID_BREAST_CANCER_RELAPSE_I...2,SET,87,-0.14661,-0.010068,0.094296,0.93999,SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...640,SET,61,-0.1653,-0.0095119,0.10631,0.94,GOBP_NEGATIVE_REGULATION_OF_TOR_SIGNALING,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...1,SET,45,-0.20271,-0.010023,0.13035,0.94004,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_CELL_CYCLE,0.99999
GOBP_GENERAL_ADAPTATION_SYND...2,SET,5,-0.60266,-0.0099437,0.38753,0.94004,GOBP_GENERAL_ADAPTATION_SYNDROME_BEHAVIORAL_PROCESS,0.99999
HP_POSITIVE_BLOOD_INFECTIOUS...,SET,17,-0.30181,-0.0091793,0.19401,0.94009,HP_POSITIVE_BLOOD_INFECTIOUS_AGENT_TEST,0.99999
GOBP_POSITIVE_REGULATION_OF_...609,SET,11,-0.38198,-0.0093468,0.24553,0.94011,GOBP_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION,0.99999
GSE21678_WT_VS_FOXO1_FOXO3_K...1,SET,163,-0.096995,-0.0090982,0.062336,0.94014,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...451,SET,14,-0.3399,-0.0093821,0.21838,0.94019,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.99999
PID_AURORA_A_PATHWAY,SET,31,-0.22583,-0.0092714,0.14509,0.9402,PID_AURORA_A_PATHWAY,0.99999
MENON_FETAL_KIDNEY_0_CAP_MES...,SET,73,-0.14904,-0.0093787,0.095748,0.9402,MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS,0.99999
GOBP_TISSUE_MIGRATION,SET,294,-0.079997,-0.010041,0.05139,0.94022,GOBP_TISSUE_MIGRATION,0.99999
GGTAACC_MIR4095P,SET,28,-0.2469,-0.0096343,0.15852,0.94032,GGTAACC_MIR4095P,0.99999
GOBP_BASEMENT_MEMBRANE_ORGAN...,SET,37,-0.21804,-0.0097781,0.13998,0.94034,GOBP_BASEMENT_MEMBRANE_ORGANIZATION,0.99999
GSE6566_STRONG_VS_WEAK_DC_ST...2,SET,156,-0.10853,-0.0099608,0.069634,0.94044,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP,0.99999
GSE22342_CD11C_HIGH_VS_LOW_D...2,SET,174,-0.098689,-0.0095616,0.063292,0.94053,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP,0.99999
GOMF_GLUTAMATE_GATED_RECEPTO...,SET,15,-0.36693,-0.010483,0.23528,0.94055,GOMF_GLUTAMATE_GATED_RECEPTOR_ACTIVITY,0.99999
MIR1208,SET,119,-0.11957,-0.0095947,0.076661,0.94058,MIR1208,0.99999
HARALAMBIEVA_PBMC_DRYVAX_AGE...,SET,14,-0.38045,-0.010501,0.24387,0.94062,HARALAMBIEVA_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_9_TO_34MO_UP,0.99999
HP_HYPERREFLEXIA,SET,706,-0.04883,-0.0093891,0.031297,0.94064,HP_HYPERREFLEXIA,0.99999
BAKKER_FOXO3_TARGETS_DN,SET,157,-0.10146,-0.0093416,0.065019,0.94066,BAKKER_FOXO3_TARGETS_DN,0.99999
GSE15624_CTRL_VS_6H_HALOFUGI...1,SET,142,-0.10245,-0.0089744,0.065653,0.94066,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,0.99999
REACTOME_RUNX1_REGULATES_TRA...6,SET,5,-0.59815,-0.0098693,0.38331,0.94067,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...15,SET,459,-0.059423,-0.0092772,0.038072,0.94071,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLUM,0.99999
HP_VITILIGO,SET,22,-0.30057,-0.010398,0.19255,0.94072,HP_VITILIGO,0.99999
KEGG_AUTOIMMUNE_THYROID_DISE...,SET,44,-0.2324,-0.011363,0.14887,0.94073,KEGG_AUTOIMMUNE_THYROID_DISEASE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...483,SET,39,-0.20842,-0.0095954,0.13348,0.94078,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,0.99999
HDGF_TARGET_GENES,SET,717,-0.048906,-0.0094738,0.031308,0.94086,HDGF_TARGET_GENES,0.99999
GOCC_RIBBON_SYNAPSE,SET,15,-0.35616,-0.010176,0.22796,0.94089,GOCC_RIBBON_SYNAPSE,0.99999
HP_IMPOTENCE,SET,47,-0.19313,-0.0097585,0.1236,0.9409,HP_IMPOTENCE,0.99999
HP_MIDLINE_DEFECT_OF_THE_NOSE,SET,15,-0.33641,-0.0096114,0.2153,0.94091,HP_MIDLINE_DEFECT_OF_THE_NOSE,0.99999
GOBP_CELL_MIGRATION_INVOLVED...5,SET,51,-0.19242,-0.010127,0.12314,0.94092,GOBP_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.99999
GOCC_PERIKARYON,SET,131,-0.12061,-0.010151,0.077172,0.94094,GOCC_PERIKARYON,0.99999
GSE17721_0.5H_VS_24H_LPS_BMD...1,SET,183,-0.094516,-0.0093888,0.060479,0.94094,GSE17721_0.5H_VS_24H_LPS_BMDC_DN,0.99999
REACTOME_SYNTHESIS_OF_LIPOXI...,SET,6,-0.58032,-0.010489,0.37131,0.94095,REACTOME_SYNTHESIS_OF_LIPOXINS_LX,0.99999
DESCARTES_FETAL_STOMACH_CILI...,SET,225,-0.084472,-0.0092935,0.054037,0.94099,DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS,0.99999
REACTOME_REGULATION_OF_GENE_...4,SET,5,-0.65873,-0.010869,0.42133,0.94102,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS,0.99999
HP_PROGRESSIVE_VISUAL_LOSS,SET,92,-0.13543,-0.0095627,0.086618,0.94103,HP_PROGRESSIVE_VISUAL_LOSS,0.99999
KEGG_MEDICUS_REFERENCE_RELN_...,SET,15,-0.35207,-0.010059,0.22516,0.94104,KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY,0.99999
REACTOME_FGFR2C_LIGAND_BINDI...,SET,12,-0.4338,-0.011086,0.27743,0.94104,REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION,0.99999
GSE43955_TH0_VS_TGFB_IL6_TH1...13,SET,183,-0.102,-0.010132,0.065233,0.94104,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_DN,0.99999
GOBP_MAMMALIAN_OOGENESIS_STA...,SET,12,-0.41356,-0.010569,0.26443,0.94108,GOBP_MAMMALIAN_OOGENESIS_STAGE,0.99999
CROSBY_E2F4_TARGETS,SET,6,-0.49587,-0.0089624,0.31693,0.94115,CROSBY_E2F4_TARGETS,0.99999
GSE2770_IL12_VS_TGFB_AND_IL1...2,SET,114,-0.12507,-0.0098242,0.079905,0.94122,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
GOMF_JUN_KINASE_KINASE_KINAS...,SET,9,-0.46408,-0.010272,0.29636,0.94131,GOMF_JUN_KINASE_KINASE_KINASE_ACTIVITY,0.99999
HP_INTERRUPTED_AORTIC_ARCH,SET,18,-0.32076,-0.010038,0.20481,0.94133,HP_INTERRUPTED_AORTIC_ARCH,0.99999
ROETH_TERT_TARGETS_DN,SET,9,-0.46683,-0.010333,0.298,0.94138,ROETH_TERT_TARGETS_DN,0.99999
GOCC_NUCLEOTIDE_ACTIVATED_PR...,SET,10,-0.38295,-0.0089347,0.24445,0.94139,GOCC_NUCLEOTIDE_ACTIVATED_PROTEIN_KINASE_COMPLEX,0.99999
WP_7Q1123_COPY_NUMBER_VARIAT...,SET,86,-0.14553,-0.0099368,0.092882,0.94142,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...14,SET,181,-0.091142,-0.0090045,0.058164,0.94143,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP,0.99999
MORF_SUPT3H,SET,288,-0.080054,-0.0099472,0.051067,0.94151,MORF_SUPT3H,0.99999
GOBP_NORADRENERGIC_NEURON_DE...,SET,4,-0.78046,-0.011518,0.49781,0.94152,GOBP_NORADRENERGIC_NEURON_DEVELOPMENT,0.99999
HP_VAGINAL_NEOPLASM,SET,8,-0.58124,-0.01213,0.37072,0.94154,HP_VAGINAL_NEOPLASM,0.99999
GSE17186_BLOOD_VS_CORD_BLOOD...1,SET,182,-0.096198,-0.00953,0.06133,0.94161,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN,0.99999
GSE19888_ADENOSINE_A3R_INH_V...5,SET,177,-0.10446,-0.010207,0.06659,0.94163,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN,0.99999
HU_GENOTOXIN_ACTION_DIRECT_V...1,SET,45,-0.20034,-0.0099056,0.12769,0.94166,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,0.99999
GOCC_NON_MOTILE_CILIUM,SET,146,-0.10869,-0.0096538,0.06927,0.94168,GOCC_NON_MOTILE_CILIUM,0.99999
DESCARTES_FETAL_STOMACH_PDE1...,SET,20,-0.32492,-0.010718,0.20708,0.94168,DESCARTES_FETAL_STOMACH_PDE1C_ACSM3_POSITIVE_CELLS,0.99999
GOBP_PHOSPHATIDYLETHANOLAMIN...3,SET,23,-0.28195,-0.0099728,0.17964,0.94173,GOBP_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,0.99999
HP_CHONDROCALCINOSIS,SET,21,-0.32083,-0.010844,0.2044,0.94174,HP_CHONDROCALCINOSIS,0.99999
GOCC_CELL_CORTEX_REGION,SET,34,-0.21988,-0.009453,0.14004,0.94179,GOCC_CELL_CORTEX_REGION,0.99999
SENESE_HDAC1_TARGETS_DN,SET,220,-0.092436,-0.010057,0.058867,0.94181,SENESE_HDAC1_TARGETS_DN,0.99999
GOBP_REGULATION_OF_RESPONSE_...6,SET,15,-0.37093,-0.010598,0.2362,0.94183,GOBP_REGULATION_OF_RESPONSE_TO_FOOD,0.99999
KOHOUTEK_CCNT2_TARGETS,SET,54,-0.18027,-0.0097621,0.11477,0.94188,KOHOUTEK_CCNT2_TARGETS,0.99999
ZNF354B_TARGET_GENES,SET,161,-0.10317,-0.0096186,0.065668,0.94191,ZNF354B_TARGET_GENES,0.99999
GSE12003_MIR223_KO_VS_WT_BM_...2,SET,178,-0.099691,-0.0097679,0.063452,0.94191,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP,0.99999
HP_PARTIAL_ABSENCE_OF_SPECIF...1,SET,6,-0.56609,-0.010232,0.36018,0.94198,HP_PARTIAL_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_TETANUS_VACCINE,0.99999
GOBP_CHONDROCYTE_DEVELOPMENT,SET,29,-0.27202,-0.010802,0.17306,0.942,GOBP_CHONDROCYTE_DEVELOPMENT,0.99999
ONGUSAHA_BRCA1_TARGETS_DN,SET,11,-0.39154,-0.0095806,0.24908,0.94201,ONGUSAHA_BRCA1_TARGETS_DN,0.99999
GCM_TEC,SET,29,-0.23357,-0.0092752,0.14855,0.94206,GCM_TEC,0.99999
GOCC_90S_PRERIBOSOME,SET,23,-0.26334,-0.0093145,0.16748,0.94206,GOCC_90S_PRERIBOSOME,0.99999
GOBP_NEURON_DEVELOPMENT,SET,1052,-0.043443,-0.010096,0.027627,0.94207,GOBP_NEURON_DEVELOPMENT,0.99999
KUUSELO_PANCREATIC_CANCER_19...,SET,31,-0.35933,-0.014752,0.22848,0.94209,KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION,0.99999
GOMF_LIPID_TRANSFER_ACTIVITY,SET,49,-0.19163,-0.0098862,0.12182,0.94213,GOMF_LIPID_TRANSFER_ACTIVITY,0.99999
ASH1L_TARGET_GENES,SET,1137,-0.040986,-0.0098785,0.026055,0.94214,ASH1L_TARGET_GENES,0.99999
WP_EXTRACELLULAR_VESICLEMEDI...,SET,29,-0.24472,-0.0097178,0.15556,0.94215,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,0.99999
GOMF_PHOSPHATASE_ACTIVATOR_A...,SET,16,-0.33739,-0.0099552,0.21439,0.94221,GOMF_PHOSPHATASE_ACTIVATOR_ACTIVITY,0.99999
KEGG_MEDICUS_REFERENCE_BMP9_...,SET,8,-0.54944,-0.011466,0.34904,0.94226,KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY,0.99999
GOMF_CATALYTIC_ACTIVITY_ACTI...1,SET,22,-0.3261,-0.011281,0.20715,0.94228,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_GLYCOPROTEIN,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...7,SET,4,-0.77186,-0.011391,0.49009,0.94235,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_VASOPRESSIN,0.99999
MIR6738_3P,SET,137,-0.11088,-0.0095422,0.070392,0.94239,MIR6738_3P,0.99999
GOMF_COPPER_CHAPERONE_ACTIVI...,SET,6,-0.43031,-0.0077774,0.2731,0.94244,GOMF_COPPER_CHAPERONE_ACTIVITY,0.99999
WP_GDNFRET_SIGNALING_AXIS,SET,20,-0.35072,-0.011569,0.22256,0.94245,WP_GDNFRET_SIGNALING_AXIS,0.99999
GOBP_ACTIVATION_OF_CYSTEINE_...1,SET,13,-0.35353,-0.0094035,0.22432,0.94247,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.99999
GOCC_CD95_DEATH_INDUCING_SIG...,SET,6,-0.60473,-0.01093,0.38358,0.94254,GOCC_CD95_DEATH_INDUCING_SIGNALING_COMPLEX,0.99999
MIR130A_5P,SET,307,-0.080448,-0.010315,0.051022,0.94256,MIR130A_5P,0.99999
ZFP91_TARGET_GENES,SET,1121,-0.040541,-0.0097068,0.025712,0.94256,ZFP91_TARGET_GENES,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_ACT...,SET,520,-0.060247,-0.0099943,0.038184,0.94269,HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL,0.99999
GOBP_POSITIVE_REGULATION_OF_...231,SET,17,-0.34294,-0.01043,0.21726,0.94276,GOBP_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT,0.99999
ZHENG_RESPONSE_TO_ARSENITE_DN,SET,11,-0.36807,-0.0090065,0.23318,0.94277,ZHENG_RESPONSE_TO_ARSENITE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...295,SET,26,-0.26773,-0.010067,0.1696,0.94277,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...17,SET,183,-0.09702,-0.0096374,0.061458,0.94278,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN,0.99999
GSE40274_SATB1_VS_FOXP3_AND_...1,SET,105,-0.1324,-0.0099834,0.083866,0.94278,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
HP_TYPE_II_TRANSFERRIN_ISOFO...,SET,13,-0.37758,-0.010043,0.23917,0.94279,HP_TYPE_II_TRANSFERRIN_ISOFORM_PROFILE,0.99999
WP_UREA_CYCLE_AND_METABOLISM...,SET,18,-0.29443,-0.0092141,0.18648,0.9428,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,0.99999
HP_PROFOUND_SENSORINEURAL_HE...,SET,9,-0.47201,-0.010448,0.29898,0.9428,HP_PROFOUND_SENSORINEURAL_HEARING_IMPAIRMENT,0.99999
GAVISH_3CA_METAPROGRAM_CD4_T...2,SET,44,-0.22545,-0.011023,0.14273,0.94289,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CYTOTOXIC,0.99999
GOBP_REGULATION_OF_MITOTIC_S...1,SET,53,-0.1804,-0.0096781,0.11418,0.94293,GOBP_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION,0.99999
GOBP_I_KAPPAB_PHOSPHORYLATION,SET,13,-0.41555,-0.011053,0.263,0.94294,GOBP_I_KAPPAB_PHOSPHORYLATION,0.99999
REACTOME_CHOLINE_CATABOLISM,SET,6,-0.60385,-0.010914,0.38206,0.94299,REACTOME_CHOLINE_CATABOLISM,0.99999
HP_TOE_JOINT_CONTRACTURE,SET,27,-0.26412,-0.010121,0.16711,0.94299,HP_TOE_JOINT_CONTRACTURE,0.99999
HP_ABNORMAL_COLUMELLA_MORPHO...,SET,78,-0.14488,-0.0094227,0.091643,0.94304,HP_ABNORMAL_COLUMELLA_MORPHOLOGY,0.99999
GSE13306_RA_VS_UNTREATED_TCO...1,SET,179,-0.10229,-0.01005,0.064677,0.94311,GSE13306_RA_VS_UNTREATED_TCONV_DN,0.99999
HP_LONG_THORAX,SET,6,-0.57269,-0.010351,0.36207,0.94314,HP_LONG_THORAX,0.99999
GOMF_FILAMIN_BINDING,SET,12,-0.39664,-0.010137,0.25065,0.94321,GOMF_FILAMIN_BINDING,0.99999
GSE19401_NAIVE_VS_IMMUNIZED_...1,SET,181,-0.098627,-0.009744,0.062324,0.94322,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN,0.99999
BAKER_HEMATOPOESIS_STAT1_TAR...,SET,10,-0.40225,-0.0093849,0.25418,0.94323,BAKER_HEMATOPOESIS_STAT1_TARGETS,0.99999
GOBP_MONOCYTE_CHEMOTACTIC_PR...,SET,18,-0.36657,-0.011472,0.23151,0.94332,GOBP_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,0.99999
WP_FAMILIAL_HYPERLIPIDEMIA_T...2,SET,16,-0.33477,-0.009878,0.21138,0.94336,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,0.99999
HP_HYPOPHOSPHATEMIC_RICKETS,SET,18,-0.32622,-0.010209,0.20594,0.9434,HP_HYPOPHOSPHATEMIC_RICKETS,0.99999
GSE45365_WT_VS_IFNAR_KO_CD8A...2,SET,171,-0.10393,-0.0099825,0.065599,0.94342,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_DN,0.99999
GSE10500_ARTHRITIC_SYNOVIAL_...2,SET,135,-0.11371,-0.0097143,0.07177,0.94343,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...784,SET,5,-0.66267,-0.010934,0.41823,0.94345,GOBP_POSITIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,0.99999
GOBP_POSITIVE_REGULATION_OF_...699,SET,21,-0.29766,-0.010061,0.18784,0.94346,GOBP_POSITIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,0.99999
HP_RENAL_PHOSPHATE_WASTING,SET,11,-0.42293,-0.010349,0.26689,0.94347,HP_RENAL_PHOSPHATE_WASTING,0.99999
KEGG_MEDICUS_REFERENCE_HEPAR...2,SET,6,-0.52246,-0.009443,0.3296,0.94352,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_DEGRADATION,0.99999
REACTOME_DISEASES_OF_METABOL...,SET,227,-0.089573,-0.0098978,0.05651,0.94352,REACTOME_DISEASES_OF_METABOLISM,0.99999
ZIRN_TRETINOIN_RESPONSE_WT1_...2,SET,23,-0.30173,-0.010672,0.19031,0.94357,ZIRN_TRETINOIN_RESPONSE_WT1_UP,0.99999
GOMF_RECEPTOR_SERINE_THREONI...,SET,24,-0.29149,-0.010532,0.18381,0.9436,GOMF_RECEPTOR_SERINE_THREONINE_KINASE_BINDING,0.99999
NIKOLSKY_BREAST_CANCER_6P24_...,SET,21,-0.46893,-0.01585,0.29564,0.94364,NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON,0.99999
HP_PRURITIS_ON_HAND,SET,5,-0.61977,-0.010226,0.39073,0.94364,HP_PRURITIS_ON_HAND,0.99999
GOBP_RESPONSE_TO_COPPER_ION,SET,31,-0.26677,-0.010952,0.16817,0.94366,GOBP_RESPONSE_TO_COPPER_ION,0.99999
PID_HEDGEHOG_2PATHWAY,SET,21,-0.29391,-0.009934,0.18525,0.94369,PID_HEDGEHOG_2PATHWAY,0.99999
GSE40068_CXCR5NEG_BCL6NEG_CD...1,SET,183,-0.098011,-0.009736,0.061761,0.94373,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN,0.99999
GOCC_CASPASE_COMPLEX,SET,10,-0.3762,-0.0087771,0.23704,0.94374,GOCC_CASPASE_COMPLEX,0.99999
GCM_VAV1,SET,40,-0.18859,-0.008793,0.11883,0.94375,GCM_VAV1,0.99999
CAR_HPX,SET,69,-0.16865,-0.010319,0.10625,0.94376,CAR_HPX,0.99999
HP_PERIORBITAL_ECCHYMOSIS_WI...,SET,7,-0.61852,-0.012075,0.38963,0.94378,HP_PERIORBITAL_ECCHYMOSIS_WITH_TARSAL_PLATE_SPARING,0.99999
KEGG_MEDICUS_REFERENCE_KITLG...1,SET,11,-0.4096,-0.010023,0.25802,0.94379,KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY,0.99999
MEIS1BHOXA9_01,SET,127,-0.12833,-0.010636,0.080833,0.9438,MEIS1BHOXA9_01,0.99999
SHIN_B_CELL_LYMPHOMA_CLUSTER...1,SET,13,-0.37162,-0.0098849,0.23392,0.94392,SHIN_B_CELL_LYMPHOMA_CLUSTER_1,0.99999
GSE22935_UNSTIM_VS_24H_MBOVI...4,SET,191,-0.092678,-0.0094032,0.058339,0.94392,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.99999
MORF_EI24,SET,118,-0.11534,-0.0092169,0.072595,0.94395,MORF_EI24,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_BAS...,SET,100,-0.14095,-0.010373,0.088707,0.94395,HE_LIM_SUN_FETAL_LUNG_C2_BASOPHIL_CELL,0.99999
GCM_HDAC1,SET,35,-0.22138,-0.0096561,0.13932,0.94396,GCM_HDAC1,0.99999
GOBP_AMINE_TRANSPORT,SET,90,-0.15257,-0.010656,0.096021,0.94396,GOBP_AMINE_TRANSPORT,0.99999
GSE7219_UNSTIM_VS_LPS_AND_AN...1,SET,162,-0.10467,-0.0097882,0.065859,0.94399,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_DN,0.99999
GSE12198_CTRL_VS_HIGH_IL2_ST...1,SET,186,-0.094275,-0.0094405,0.059316,0.944,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN,0.99999
REACTOME_DISEASES_ASSOCIATED...2,SET,13,-0.31928,-0.0084926,0.20087,0.94402,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS,0.99999
MIR937_5P,SET,50,-0.19665,-0.010248,0.12369,0.94405,MIR937_5P,0.99999
GOBP_MORPHOGENESIS_OF_A_POLA...,SET,58,-0.18559,-0.010414,0.11672,0.94407,GOBP_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM,0.99999
HP_PERSISTENT_CMV_VIREMIA,SET,5,-0.61691,-0.010179,0.38794,0.9441,HP_PERSISTENT_CMV_VIREMIA,0.99999
GOBP_REGULATION_OF_GLUCAGON_...,SET,8,-0.45849,-0.0095682,0.28828,0.94412,GOBP_REGULATION_OF_GLUCAGON_SECRETION,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_RES...,SET,98,-0.14844,-0.010816,0.093326,0.94414,HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE,0.99999
FOXO4_01,SET,229,-0.092774,-0.010296,0.058301,0.94422,FOXO4_01,0.99999
KEGG_BASAL_TRANSCRIPTION_FAC...,SET,31,-0.21795,-0.0089481,0.13695,0.94424,KEGG_BASAL_TRANSCRIPTION_FACTORS,0.99999
GOMF_VOLTAGE_GATED_CHLORIDE_...,SET,9,-0.4268,-0.009447,0.26807,0.94431,GOMF_VOLTAGE_GATED_CHLORIDE_CHANNEL_ACTIVITY,0.99999
GOBP_ONE_CARBON_METABOLIC_PR...,SET,36,-0.2213,-0.0097894,0.13895,0.94437,GOBP_ONE_CARBON_METABOLIC_PROCESS,0.99999
MIR4772_5P,SET,48,-0.19487,-0.0099505,0.12235,0.94438,MIR4772_5P,0.99999
DER_IFN_ALPHA_RESPONSE_DN,SET,4,-0.72321,-0.010673,0.454,0.94441,DER_IFN_ALPHA_RESPONSE_DN,0.99999
GSE22033_WT_VS_PPARG_KO_MEF_...2,SET,173,-0.099108,-0.0095748,0.062199,0.94446,GSE22033_WT_VS_PPARG_KO_MEF_UP,0.99999
GOBP_CHEMOKINE_C_X_C_MOTIF_L...1,SET,6,-0.58466,-0.010567,0.36689,0.94447,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_12_SIGNALING_PATHWAY,0.99999
MIR16_5P,SET,532,-0.058181,-0.009759,0.036506,0.9445,MIR16_5P,0.99999
REACTOME_FRS_MEDIATED_FGFR1_...,SET,23,-0.27773,-0.0098233,0.17424,0.94451,REACTOME_FRS_MEDIATED_FGFR1_SIGNALING,0.99999
WP_IDO_METABOLIC_PATHWAY,SET,9,-0.50444,-0.011166,0.31647,0.94452,WP_IDO_METABOLIC_PATHWAY,0.99999
MIR758_3P,SET,112,-0.12395,-0.009651,0.077758,0.94453,MIR758_3P,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...13,SET,191,-0.093229,-0.0094591,0.058469,0.94458,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_DN,0.99999
HP_INTESTINAL_ATRESIA,SET,56,-0.18157,-0.010012,0.11387,0.94459,HP_INTESTINAL_ATRESIA,0.99999
REACTOME_PROTEIN_FOLDING,SET,92,-0.13186,-0.0093104,0.082688,0.9446,REACTOME_PROTEIN_FOLDING,0.99999
HP_ABNORMAL_FOURTH_VENTRICLE...,SET,132,-0.10895,-0.0092048,0.068321,0.9446,HP_ABNORMAL_FOURTH_VENTRICLE_MORPHOLOGY,0.99999
HP_DECREASED_HEAD_CIRCUMFERE...,SET,1163,-0.039402,-0.0095973,0.024706,0.94461,HP_DECREASED_HEAD_CIRCUMFERENCE,0.99999
HP_CARDIAC_ARREST,SET,146,-0.11788,-0.01047,0.073895,0.94466,HP_CARDIAC_ARREST,0.99999
GOBP_NEGATIVE_REGULATION_OF_...237,SET,8,-0.50416,-0.010521,0.31589,0.94475,GOBP_NEGATIVE_REGULATION_OF_FERROPTOSIS,0.99999
HP_SHOULDER_DISLOCATION,SET,16,-0.32296,-0.0095296,0.20231,0.94479,HP_SHOULDER_DISLOCATION,0.99999
GSE360_L_MAJOR_VS_B_MALAYI_L...1,SET,178,-0.098029,-0.0096051,0.061405,0.94479,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN,0.99999
GOMF_RNA_POLYMERASE_I_GENERA...,SET,3,-0.75864,-0.0096964,0.4752,0.9448,GOMF_RNA_POLYMERASE_I_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.99999
GOBP_RESPONSE_TO_PHEROMONE,SET,6,-0.54026,-0.0097647,0.33838,0.94481,GOBP_RESPONSE_TO_PHEROMONE,0.99999
HP_NON_HODGKIN_LYMPHOMA,SET,38,-0.22472,-0.010212,0.14074,0.94482,HP_NON_HODGKIN_LYMPHOMA,0.99999
PGBD5_TARGET_GENES,SET,14,-0.33838,-0.0093403,0.21192,0.94483,PGBD5_TARGET_GENES,0.99999
GOBP_DNA_REPLICATION_CHECKPO...,SET,20,-0.26333,-0.0086861,0.16491,0.94483,GOBP_DNA_REPLICATION_CHECKPOINT_SIGNALING,0.99999
GOBP_INORGANIC_ANION_TRANSPO...,SET,159,-0.11273,-0.010444,0.070592,0.94484,GOBP_INORGANIC_ANION_TRANSPORT,0.99999
REACTOME_DEFECTIVE_LFNG_CAUS...,SET,5,-0.63969,-0.010555,0.4005,0.94488,REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3,0.99999
GSE27786_LSK_VS_MONO_MAC_DN,SET,186,-0.099504,-0.0099641,0.062275,0.94495,GSE27786_LSK_VS_MONO_MAC_DN,0.99999
KEGG_MEDICUS_VARIANT_EWSR1_W...,SET,5,-0.65177,-0.010754,0.40779,0.94501,KEGG_MEDICUS_VARIANT_EWSR1_WT1_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...122,SET,54,-0.18234,-0.0098739,0.11408,0.94501,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,0.99999
ATCTTGC_MIR31,SET,70,-0.15416,-0.0095002,0.096442,0.94502,ATCTTGC_MIR31,0.99999
GOBP_S_SHAPED_BODY_MORPHOGEN...,SET,7,-0.61741,-0.012053,0.38607,0.9451,GOBP_S_SHAPED_BODY_MORPHOGENESIS,0.99999
GOBP_ALPHA_KETOGLUTARATE_TRA...,SET,7,-0.5053,-0.0098643,0.31589,0.94515,GOBP_ALPHA_KETOGLUTARATE_TRANSPORT,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...14,SET,3,-0.78386,-0.010019,0.49003,0.94515,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_TRANSPORT,0.99999
GOMF_GLYCINE_N_ACYLTRANSFERA...,SET,4,-0.9395,-0.013865,0.58731,0.94516,GOMF_GLYCINE_N_ACYLTRANSFERASE_ACTIVITY,0.99999
GOBP_VESICLE_TETHERING,SET,30,-0.2388,-0.0096447,0.14924,0.9452,GOBP_VESICLE_TETHERING,0.99999
GSE22886_NAIVE_CD4_TCELL_VS_...16,SET,176,-0.098091,-0.0095576,0.0613,0.94521,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...341,SET,12,-0.40322,-0.010305,0.25194,0.94524,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,0.99999
GOBP_NEUTRAL_LIPID_CATABOLIC...,SET,36,-0.23671,-0.010471,0.1479,0.94524,GOBP_NEUTRAL_LIPID_CATABOLIC_PROCESS,0.99999
REACTOME_VITAMINS,SET,6,-0.62202,-0.011243,0.38864,0.94525,REACTOME_VITAMINS,0.99999
GOMF_SODIUM_PHOSPHATE_SYMPOR...,SET,13,-0.4412,-0.011736,0.27552,0.94534,GOMF_SODIUM_PHOSPHATE_SYMPORTER_ACTIVITY,0.99999
BIDUS_METASTASIS_UP,SET,186,-0.094774,-0.0094904,0.059168,0.94539,BIDUS_METASTASIS_UP,0.99999
GSE26495_NAIVE_VS_PD1HIGH_CD...1,SET,181,-0.103,-0.010176,0.064301,0.94539,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN,0.99999
BOYLAN_MULTIPLE_MYELOMA_C_D_...1,SET,247,-0.091536,-0.010545,0.057124,0.94546,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,0.99999
MIR497_5P,SET,476,-0.061465,-0.0097674,0.038355,0.94547,MIR497_5P,0.99999
HP_PINEAL_CYST,SET,8,-0.45608,-0.009518,0.28459,0.94548,HP_PINEAL_CYST,0.99999
GSE45365_WT_VS_IFNAR_KO_CD11...4,SET,161,-0.10306,-0.0096086,0.064309,0.94548,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_UP,0.99999
REACTOME_CREB1_PHOSPHORYLATI...3,SET,8,-0.53689,-0.011204,0.33495,0.94551,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...165,SET,9,-0.43961,-0.0097305,0.27427,0.94551,GOBP_NEGATIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION,0.99999
HP_RETINAL_THINNING,SET,28,-0.26052,-0.010166,0.16252,0.94553,HP_RETINAL_THINNING,0.99999
MIR424_5P,SET,476,-0.061677,-0.0098011,0.038464,0.94558,MIR424_5P,0.99999
GOCC_LSM1_7_PAT1_COMPLEX,SET,5,-0.50278,-0.0082957,0.31347,0.94562,GOCC_LSM1_7_PAT1_COMPLEX,0.99999
WP_NGLYCAN_BIOSYNTHESIS,SET,53,-0.17279,-0.0092701,0.10773,0.94563,WP_NGLYCAN_BIOSYNTHESIS,0.99999
HP_FEMALE_PSEUDOHERMAPHRODIT...,SET,7,-0.58517,-0.011423,0.36468,0.9457,HP_FEMALE_PSEUDOHERMAPHRODITISM,0.99999
MIR483_5P,SET,7,-0.56016,-0.010935,0.34904,0.94573,MIR483_5P,0.99999
KEGG_GNRH_SIGNALING_PATHWAY,SET,98,-0.14315,-0.01043,0.089189,0.94575,KEGG_GNRH_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_SPACED_INCISORS,SET,12,-0.3496,-0.0089344,0.21782,0.94575,HP_ABNORMAL_SPACED_INCISORS,0.99999
HP_POOR_APPETITE,SET,47,-0.19211,-0.0097073,0.11969,0.94575,HP_POOR_APPETITE,0.99999
GTGGTGA_MIR197,SET,64,-0.16863,-0.0099384,0.10506,0.94576,GTGGTGA_MIR197,0.99999
REACTOME_COSTIMULATION_BY_TH...,SET,62,-0.182,-0.010558,0.11337,0.94579,REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,0.99999
GOBP_SRP_DEPENDENT_COTRANSLA...1,SET,16,-0.31417,-0.0092701,0.19568,0.94581,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.99999
MIR4739,SET,127,-0.12517,-0.010374,0.077942,0.94585,MIR4739,0.99999
GOBP_RESPONSE_TO_CADMIUM_ION,SET,55,-0.19642,-0.010734,0.12225,0.94593,GOBP_RESPONSE_TO_CADMIUM_ION,0.99999
WNT_UP.V1_DN,SET,160,-0.11339,-0.010538,0.070562,0.94596,WNT_UP.V1_DN,0.99999
TATCTGG_MIR488,SET,58,-0.18229,-0.010229,0.11342,0.94599,TATCTGG_MIR488,0.99999
GOMF_ADENYL_NUCLEOTIDE_EXCHA...,SET,15,-0.31533,-0.0090093,0.1962,0.94599,GOMF_ADENYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,0.99999
HP_COARSE_HAIR,SET,48,-0.1828,-0.0093341,0.1137,0.94605,HP_COARSE_HAIR,0.99999
HP_ANEMIA_DUE_TO_REDUCED_LIF...,SET,139,-0.11327,-0.0098178,0.070433,0.94609,HP_ANEMIA_DUE_TO_REDUCED_LIFE_SPAN_OF_RED_CELLS,0.99999
GSE32034_UNTREATED_VS_ROSIGL...4,SET,154,-0.10809,-0.0098579,0.067211,0.9461,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP,0.99999
HP_AMINOACIDURIA,SET,123,-0.1188,-0.0096909,0.073861,0.94612,HP_AMINOACIDURIA,0.99999
MODULE_401,SET,15,-0.39594,-0.011312,0.24612,0.94615,MODULE_401,0.99999
GOBP_EXTRINSIC_APOPTOTIC_SIG...1,SET,216,-0.094702,-0.010211,0.058868,0.94615,GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOBP_HIGH_DENSITY_LIPOPROTEI...3,SET,15,-0.37752,-0.010786,0.2346,0.9462,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,0.99999
GOBP_REGULATION_OF_CYSTEINE_...2,SET,146,-0.1141,-0.010134,0.070908,0.9462,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.99999
MIR4424,SET,109,-0.12942,-0.0099423,0.080425,0.94621,MIR4424,0.99999
GOMF_AMYLASE_ACTIVITY,SET,2,-1.0012,-0.010448,0.62214,0.94621,GOMF_AMYLASE_ACTIVITY,0.99999
GSE10240_CTRL_VS_IL17_AND_IL...1,SET,190,-0.094302,-0.0095431,0.058579,0.94627,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.99999
GSE22886_CD8_VS_CD4_NAIVE_TC...1,SET,175,-0.10258,-0.0099664,0.06372,0.94627,GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN,0.99999
GOBP_GLIAL_CELL_APOPTOTIC_PR...,SET,17,-0.32445,-0.0098677,0.20147,0.94633,GOBP_GLIAL_CELL_APOPTOTIC_PROCESS,0.99999
GOBP_DENTINOGENESIS,SET,6,-0.61797,-0.011169,0.38372,0.94634,GOBP_DENTINOGENESIS,0.99999
WP_15Q133_COPY_NUMBER_VARIAT...,SET,16,-0.31693,-0.0093517,0.19676,0.94638,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GSE34156_UNTREATED_VS_24H_NO...2,SET,154,-0.11165,-0.010182,0.069296,0.94642,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.99999
GOBP_VERY_LOW_DENSITY_LIPOPR...1,SET,10,-0.44233,-0.01032,0.27452,0.94643,GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY,0.99999
GOBP_CENTRAL_NERVOUS_SYSTEM_...2,SET,6,-0.5689,-0.010282,0.35291,0.94651,GOBP_CENTRAL_NERVOUS_SYSTEM_MATURATION,0.99999
REACTOME_LONG_TERM_POTENTIAT...,SET,22,-0.31297,-0.010827,0.19412,0.94654,REACTOME_LONG_TERM_POTENTIATION,0.99999
HP_ABULIA,SET,10,-0.42056,-0.009812,0.26069,0.94665,HP_ABULIA,0.99999
GOBP_SYNAPTIC_VESICLE_BUDDING,SET,12,-0.37627,-0.0096162,0.23322,0.94666,GOBP_SYNAPTIC_VESICLE_BUDDING,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...1,SET,45,-0.20561,-0.010166,0.12736,0.94677,BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,0.99999
MIR2392,SET,68,-0.16824,-0.01022,0.1042,0.94679,MIR2392,0.99999
GOCC_NURF_COMPLEX,SET,5,-0.53053,-0.0087536,0.32858,0.9468,GOCC_NURF_COMPLEX,0.99999
GOBP_LYMPHOCYTE_HOMEOSTASIS,SET,71,-0.16675,-0.010349,0.10326,0.94681,GOBP_LYMPHOCYTE_HOMEOSTASIS,0.99999
GOBP_REGULATION_OF_VASCULAR_...3,SET,8,-0.49653,-0.010362,0.30748,0.94682,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION,0.99999
GCM_RING1,SET,98,-0.13027,-0.0094918,0.080651,0.94686,GCM_RING1,0.99999
GOMF_SNRNP_BINDING,SET,9,-0.39939,-0.0088402,0.24721,0.9469,GOMF_SNRNP_BINDING,0.99999
GOBP_NEPHRON_EPITHELIUM_DEVE...,SET,113,-0.14177,-0.011087,0.087713,0.94698,GOBP_NEPHRON_EPITHELIUM_DEVELOPMENT,0.99999
HP_POSTERIOR_PHARYNGEAL_CLEFT,SET,12,-0.44452,-0.01136,0.27493,0.94704,HP_POSTERIOR_PHARYNGEAL_CLEFT,0.99999
MYC_UP.V1_UP,SET,159,-0.10365,-0.0096035,0.064102,0.94704,MYC_UP.V1_UP,0.99999
GOMF_MITOCHONDRIAL_RIBOSOME_...,SET,8,-0.46314,-0.0096652,0.28632,0.94711,GOMF_MITOCHONDRIAL_RIBOSOME_BINDING,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...45,SET,21,-0.29164,-0.0098575,0.18028,0.94713,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.99999
RNGTGGGC_UNKNOWN,SET,709,-0.052717,-0.010157,0.032585,0.94714,RNGTGGGC_UNKNOWN,0.99999
GSE43955_10H_VS_60H_ACT_CD4_...4,SET,180,-0.10025,-0.009877,0.06196,0.94716,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.99999
GOBP_GENERATION_OF_NEURONS,SET,1370,-0.039875,-0.010478,0.024641,0.94719,GOBP_GENERATION_OF_NEURONS,0.99999
GSE16385_IFNG_TNF_VS_IL4_STI...1,SET,150,-0.10892,-0.009804,0.067299,0.9472,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,0.99999
MIR3976,SET,104,-0.13152,-0.0098705,0.081199,0.94735,MIR3976,0.99999
GOBP_REGULATION_OF_CELLULAR_...16,SET,17,-0.34094,-0.01037,0.21048,0.94736,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...1,SET,181,-0.10138,-0.010016,0.062583,0.94737,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_DN,0.99999
HOSHIDA_LIVER_CANCER_SURVIVA...2,SET,71,-0.17037,-0.010574,0.10516,0.94738,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,0.99999
MIR4279,SET,198,-0.098002,-0.010122,0.060479,0.94742,MIR4279,0.99999
GOMF_1_PHOSPHATIDYLINOSITOL_...4,SET,7,-0.51926,-0.010137,0.32044,0.94742,GOMF_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_3_KINASE_ACTIVITY,0.99999
HP_ABNORMAL_MORPHOLOGY_OF_TH...8,SET,31,-0.25217,-0.010353,0.15557,0.94748,HP_ABNORMAL_MORPHOLOGY_OF_THE_OLFACTORY_BULB,0.99999
HP_CEREBRAL_DYSMYELINATION,SET,12,-0.35326,-0.009028,0.21788,0.94752,HP_CEREBRAL_DYSMYELINATION,0.99999
GOBP_TOLL_LIKE_RECEPTOR_9_SI...,SET,18,-0.32881,-0.01029,0.20274,0.94757,GOBP_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,0.99999
GOCC_CORVET_COMPLEX,SET,7,-0.44949,-0.0087748,0.27708,0.94762,GOCC_CORVET_COMPLEX,0.99999
MIR3692_5P,SET,128,-0.12147,-0.010107,0.074863,0.94765,MIR3692_5P,0.99999
GOBP_MESONEPHRIC_TUBULE_MORP...,SET,62,-0.18919,-0.010975,0.11659,0.94766,GOBP_MESONEPHRIC_TUBULE_MORPHOGENESIS,0.99999
GSE20366_EX_VIVO_VS_DEC205_C...4,SET,182,-0.097968,-0.0097053,0.060366,0.94768,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP,0.99999
HP_HYPERAMMONEMIA,SET,66,-0.15763,-0.0094336,0.097126,0.94769,HP_HYPERAMMONEMIA,0.99999
OSF2_Q6,SET,245,-0.08995,-0.010321,0.055406,0.94775,OSF2_Q6,0.99999
GSE40274_IRF4_VS_FOXP3_AND_I...2,SET,157,-0.10217,-0.0094072,0.06292,0.94778,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
GSE3982_MAC_VS_CENT_MEMORY_C...1,SET,167,-0.10242,-0.0097228,0.063056,0.94783,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN,0.99999
REACTOME_CD22_MEDIATED_BCR_R...,SET,4,-0.77062,-0.011373,0.47422,0.94791,REACTOME_CD22_MEDIATED_BCR_REGULATION,0.99999
HP_MECONIUM_STAINED_AMNIOTIC...,SET,8,-0.51112,-0.010667,0.31454,0.94791,HP_MECONIUM_STAINED_AMNIOTIC_FLUID,0.99999
HP_ABNORMALITY_OF_AMINO_ACID...,SET,7,-0.49632,-0.009689,0.30541,0.94792,HP_ABNORMALITY_OF_AMINO_ACID_METABOLISM,0.99999
GROSS_HYPOXIA_VIA_ELK3_UP,SET,192,-0.098127,-0.0099818,0.06038,0.94793,GROSS_HYPOXIA_VIA_ELK3_UP,0.99999
GOBP_REGULATION_OF_EXTRINSIC...2,SET,43,-0.21318,-0.010304,0.13115,0.94795,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,0.99999
GOMF_CYTIDYLYLTRANSFERASE_AC...,SET,8,-0.49979,-0.01043,0.30745,0.94798,GOMF_CYTIDYLYLTRANSFERASE_ACTIVITY,0.99999
HP_EPICANTHUS_INVERSUS,SET,13,-0.40288,-0.010716,0.24778,0.94801,HP_EPICANTHUS_INVERSUS,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...8,SET,6,-0.56033,-0.010127,0.34452,0.94806,GOBP_RESPONSE_TO_INTERLEUKIN_3,0.99999
GSE35685_CD34POS_CD38NEG_VS_...4,SET,181,-0.10223,-0.0101,0.062834,0.94812,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP,0.99999
MIR525_5P,SET,143,-0.11354,-0.0099807,0.069772,0.94815,MIR525_5P,0.99999
GSE22589_HIV_VS_HIV_AND_SIV_...1,SET,182,-0.097668,-0.0096756,0.060019,0.94815,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN,0.99999
GOBP_MITOCHONDRION_DISTRIBUT...,SET,18,-0.32864,-0.010285,0.20193,0.94818,GOBP_MITOCHONDRION_DISTRIBUTION,0.99999
GOBP_RECEPTOR_GUANYLYL_CYCLA...,SET,8,-0.48249,-0.010069,0.2964,0.94821,GOBP_RECEPTOR_GUANYLYL_CYCLASE_SIGNALING_PATHWAY,0.99999
REACTOME_RETROGRADE_TRANSPOR...,SET,46,-0.19414,-0.0097052,0.11925,0.94823,REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,0.99999
GOBP_ACTIVATION_OF_ADENYLATE...,SET,23,-0.32677,-0.011558,0.20066,0.94828,GOBP_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY,0.99999
GOCC_ACETYLTRANSFERASE_COMPL...,SET,89,-0.13355,-0.0092755,0.081974,0.94835,GOCC_ACETYLTRANSFERASE_COMPLEX,0.99999
GSE26727_WT_VS_KLF2_KO_LPS_S...2,SET,179,-0.10451,-0.010269,0.064152,0.94835,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP,0.99999
GOBP_REGULATION_OF_VERY_LOW_...2,SET,5,-0.72995,-0.012044,0.44791,0.94841,GOBP_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,0.99999
GSE15330_MEGAKARYOCYTE_ERYTH...4,SET,175,-0.10232,-0.0099417,0.062755,0.94849,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.99999
GSE9988_LPS_VS_CTRL_TREATED_...1,SET,189,-0.09496,-0.0095847,0.058233,0.94851,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN,0.99999
GOBP_INTEGRIN_BIOSYNTHETIC_P...,SET,4,-0.77738,-0.011473,0.47659,0.94856,GOBP_INTEGRIN_BIOSYNTHETIC_PROCESS,0.99999
MORF_PRKAG1,SET,203,-0.089565,-0.0093653,0.054902,0.94858,MORF_PRKAG1,0.99999
GOBP_NEGATIVE_REGULATION_OF_...571,SET,91,-0.14776,-0.010376,0.09055,0.94863,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,0.99999
GOBP_REGULATION_OF_LIPID_CAT...,SET,57,-0.1899,-0.010564,0.11635,0.94867,GOBP_REGULATION_OF_LIPID_CATABOLIC_PROCESS,0.99999
REACTOME_REGULATION_OF_TP53_...5,SET,87,-0.14153,-0.0097193,0.086701,0.94869,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,0.99999
MIR19B_3P,SET,594,-0.058858,-0.010414,0.036037,0.94879,MIR19B_3P,0.99999
GTGTCAA_MIR514,SET,55,-0.17099,-0.0093445,0.10467,0.94883,GTGTCAA_MIR514,0.99999
GSE3720_UNSTIM_VS_LPS_STIM_V...3,SET,129,-0.12333,-0.010301,0.075486,0.94884,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN,0.99999
HOEK_MYELOID_DENDRITIC_CELL_...4,SET,3,-0.95623,-0.012222,0.58527,0.94884,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_UP,0.99999
GOBP_EPOXYGENASE_P450_PATHWAY,SET,18,-0.3787,-0.011852,0.23173,0.94889,GOBP_EPOXYGENASE_P450_PATHWAY,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...22,SET,47,-0.22627,-0.011433,0.13845,0.9489,GAVISH_3CA_MALIGNANT_METAPROGRAM_30_PDAC_CLASSICAL,0.99999
GOBP_STRESS_FIBER_ASSEMBLY,SET,103,-0.13801,-0.010308,0.08444,0.9489,GOBP_STRESS_FIBER_ASSEMBLY,0.99999
HP_DECREASED_NUMBER_OF_LARGE...,SET,18,-0.29897,-0.0093563,0.18293,0.9489,HP_DECREASED_NUMBER_OF_LARGE_PERIPHERAL_MYELINATED_NERVE_FIBERS,0.99999
REACTOME_PRE_NOTCH_PROCESSIN...1,SET,18,-0.30494,-0.009543,0.18657,0.94891,REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,0.99999
HP_DYSLEXIA,SET,29,-0.25591,-0.010162,0.15657,0.94891,HP_DYSLEXIA,0.99999
GSE4984_UNTREATED_VS_VEHICLE...1,SET,153,-0.10809,-0.0098258,0.066132,0.94891,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN,0.99999
POU1F1_Q6,SET,218,-0.098643,-0.010684,0.060342,0.94894,POU1F1_Q6,0.99999
GSE13484_12H_UNSTIM_VS_YF17D...1,SET,177,-0.10564,-0.010322,0.064621,0.94894,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...13,SET,11,-0.46735,-0.011436,0.28585,0.94896,BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP,0.99999
GOBP_GROWTH_PLATE_CARTILAGE_...2,SET,9,-0.47183,-0.010444,0.28858,0.94897,GOBP_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DIFFERENTIATION,0.99999
HP_MYOFIBER_DISARRAY,SET,10,-0.40418,-0.0094299,0.24718,0.94898,HP_MYOFIBER_DISARRAY,0.99999
REACTOME_POSITIVE_EPIGENETIC...,SET,42,-0.19734,-0.0094277,0.12067,0.949,REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,0.99999
REACTOME_PHOSPHOLIPASE_C_MED...1,SET,16,-0.37779,-0.011147,0.231,0.94901,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1,0.99999
MODULE_173,SET,16,-0.37984,-0.011208,0.23225,0.94902,MODULE_173,0.99999
GOBP_POSITIVE_REGULATION_OF_...163,SET,12,-0.36441,-0.0093129,0.22274,0.94907,GOBP_POSITIVE_REGULATION_OF_CHROMATIN_ORGANIZATION,0.99999
GOBP_CELLULAR_RESPONSE_TO_L_...1,SET,6,-0.54796,-0.009904,0.33486,0.94911,GOBP_CELLULAR_RESPONSE_TO_L_GLUTAMATE,0.99999
CCAGGGG_MIR331,SET,83,-0.14545,-0.0097571,0.088877,0.94913,CCAGGGG_MIR331,0.99999
GOBP_POLYOL_BIOSYNTHETIC_PRO...,SET,58,-0.17544,-0.0098447,0.1072,0.94913,GOBP_POLYOL_BIOSYNTHETIC_PROCESS,0.99999
GSE32423_IL7_VS_IL7_IL4_NAIV...2,SET,172,-0.10799,-0.010403,0.065982,0.94915,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP,0.99999
KLEIN_PRIMARY_EFFUSION_LYMPH...2,SET,46,-0.19545,-0.0097704,0.1194,0.94917,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,0.99999
GOBP_ADENYLATE_CYCLASE_ACTIV...3,SET,162,-0.117,-0.010942,0.071477,0.94917,GOBP_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_NYCTALOPIA,SET,200,-0.098624,-0.010237,0.060231,0.94922,HP_NYCTALOPIA,0.99999
GOBP_GLUTAMATE_SECRETION_NEU...,SET,8,-0.50955,-0.010634,0.31116,0.94923,GOBP_GLUTAMATE_SECRETION_NEUROTRANSMISSION,0.99999
MODULE_65,SET,7,-0.51683,-0.010089,0.31561,0.94924,MODULE_65,0.99999
GSE41867_NAIVE_VS_DAY8_LCMV_...2,SET,179,-0.10202,-0.010024,0.062282,0.94928,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.99999
WEBER_METHYLATED_LCP_IN_FIBR...1,SET,9,-0.49799,-0.011023,0.30399,0.9493,WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN,0.99999
GOBP_UBIQUITIN_DEPENDENT_END...,SET,7,-0.50605,-0.0098789,0.30889,0.94931,GOBP_UBIQUITIN_DEPENDENT_ENDOCYTOSIS,0.99999
MIR3714,SET,404,-0.069719,-0.010227,0.04255,0.94933,MIR3714,0.99999
GOBP_NEGATIVE_REGULATION_OF_...610,SET,23,-0.31474,-0.011133,0.19204,0.94938,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,0.99999
GOBP_POST_CHAPERONIN_TUBULIN...,SET,6,-0.43701,-0.0078986,0.26656,0.94943,GOBP_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,0.99999
HP_IMMUNOLOGIC_HYPERSENSITIV...,SET,209,-0.096651,-0.010253,0.058955,0.94943,HP_IMMUNOLOGIC_HYPERSENSITIVITY,0.99999
MIKKELSEN_ES_ICP_WITH_H3K4ME3,SET,619,-0.055837,-0.010078,0.034053,0.94946,MIKKELSEN_ES_ICP_WITH_H3K4ME3,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...1,SET,28,-0.26179,-0.010215,0.15965,0.94946,HP_APLASIA_HYPOPLASIA_OF_THE_1ST_METACARPAL,0.99999
DAZARD_RESPONSE_TO_UV_SCC_UP,SET,88,-0.14382,-0.0099326,0.087663,0.94955,DAZARD_RESPONSE_TO_UV_SCC_UP,0.99999
KEGG_MEDICUS_PATHOGEN_SARS_C...1,SET,6,-0.68925,-0.012458,0.42011,0.94955,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_N_TO_LECTIN_PATHWAY_OF_COAGULATION_CASCADE,0.99999
GOBP_INORGANIC_ANION_TRANSME...,SET,120,-0.13295,-0.010713,0.081039,0.94955,GOBP_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORT,0.99999
GSE12845_IGD_POS_VS_NEG_BLOO...2,SET,169,-0.10226,-0.0097653,0.062329,0.94955,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP,0.99999
GSE30153_LUPUS_VS_HEALTHY_DO...2,SET,184,-0.10046,-0.010006,0.061215,0.9496,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...563,SET,44,-0.22985,-0.011238,0.14005,0.94961,GOBP_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,0.99999
GOBP_REGULATION_OF_EXTRINSIC...1,SET,145,-0.11677,-0.010336,0.071145,0.94963,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GSE40666_WT_VS_STAT4_KO_CD8_...1,SET,174,-0.099759,-0.0096652,0.060769,0.94965,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_DN,0.99999
MIR4695_3P,SET,70,-0.17154,-0.010572,0.10449,0.94967,MIR4695_3P,0.99999
GSE10239_MEMORY_VS_KLRG1HIGH...1,SET,182,-0.1012,-0.010026,0.061644,0.94967,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.99999
REACTOME_BASE_EXCISION_REPAIR,SET,44,-0.18565,-0.0090772,0.11305,0.94972,REACTOME_BASE_EXCISION_REPAIR,0.99999
AP2ALPHA_01,SET,221,-0.089903,-0.0098037,0.054743,0.94972,AP2ALPHA_01,0.99999
HP_HYDROXYPROLINURIA,SET,9,-0.55521,-0.012289,0.33798,0.94977,HP_HYDROXYPROLINURIA,0.99999
MIR6529_5P,SET,42,-0.21581,-0.01031,0.13136,0.94979,MIR6529_5P,0.99999
GOBP_MEMBRANE_REPOLARIZATION...3,SET,14,-0.40883,-0.011285,0.24879,0.94982,GOBP_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.99999
GOMF_U1_SNRNP_BINDING,SET,6,-0.45976,-0.0083097,0.27976,0.94984,GOMF_U1_SNRNP_BINDING,0.99999
GOMF_SODIUM_CHANNEL_REGULATO...,SET,38,-0.23307,-0.010592,0.14181,0.94985,GOMF_SODIUM_CHANNEL_REGULATOR_ACTIVITY,0.99999
HP_APLASTIC_CLAVICLE,SET,16,-0.31552,-0.0093099,0.19196,0.94986,HP_APLASTIC_CLAVICLE,0.99999
REACTOME_REGULATION_BY_C_FLIP,SET,11,-0.42691,-0.010446,0.25972,0.94987,REACTOME_REGULATION_BY_C_FLIP,0.99999
HP_3_METHYLGLUTARIC_ACIDURIA,SET,5,-0.57926,-0.0095576,0.3524,0.94988,HP_3_METHYLGLUTARIC_ACIDURIA,0.99999
GOMF_ALPHA_2A_ADRENERGIC_REC...,SET,4,-0.78224,-0.011544,0.47585,0.94989,GOMF_ALPHA_2A_ADRENERGIC_RECEPTOR_BINDING,0.99999
HP_FETAL_PYELECTASIS,SET,9,-0.4707,-0.010419,0.28633,0.9499,HP_FETAL_PYELECTASIS,0.99999
GNF2_RPA1,SET,25,-0.26032,-0.0095993,0.15828,0.94998,GNF2_RPA1,0.99999
HP_HYPOGLYCEMIA,SET,230,-0.090932,-0.010113,0.055257,0.95007,HP_HYPOGLYCEMIA,0.99999
GOBP_T_CELL_HOMEOSTASIS,SET,44,-0.21188,-0.01036,0.12874,0.95008,GOBP_T_CELL_HOMEOSTASIS,0.99999
BILANGES_SERUM_SENSITIVE_GEN...,SET,72,-0.16506,-0.010316,0.10029,0.95009,BILANGES_SERUM_SENSITIVE_GENES,0.99999
HP_ABNORMAL_HYPOTHALAMUS_PHY...,SET,49,-0.20344,-0.010496,0.1236,0.9501,HP_ABNORMAL_HYPOTHALAMUS_PHYSIOLOGY,0.99999
DESCARTES_MAIN_FETAL_DUCTAL_...,SET,50,-0.21209,-0.011053,0.12882,0.95016,DESCARTES_MAIN_FETAL_DUCTAL_CELLS,0.99999
HP_ABNORMAL_1ST_METACARPAL_M...,SET,31,-0.25064,-0.01029,0.15218,0.95021,HP_ABNORMAL_1ST_METACARPAL_MORPHOLOGY,0.99999
GOMF_CYSTEINE_TYPE_ENDOPEPTI...7,SET,18,-0.33599,-0.010515,0.20393,0.95027,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.99999
WP_HYPOTHETICAL_CRANIOFACIAL...,SET,7,-0.51863,-0.010124,0.31477,0.95028,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,0.99999
HP_ABSENT_DISTAL_PHALANGES,SET,6,-0.624,-0.011278,0.37873,0.95028,HP_ABSENT_DISTAL_PHALANGES,0.99999
CUI_DEVELOPING_HEART_LEFT_VE...,SET,37,-0.25649,-0.011502,0.15562,0.95033,CUI_DEVELOPING_HEART_LEFT_VENTRICULAR_CARDIOMYOCYTE,0.99999
GOBP_POSITIVE_REGULATION_OF_...225,SET,5,-0.76364,-0.0126,0.46328,0.95035,GOBP_POSITIVE_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_APATHY,SET,82,-0.15216,-0.010146,0.092305,0.95036,HP_APATHY,0.99999
LEE_LIVER_CANCER_DENA_UP,SET,56,-0.19849,-0.010945,0.12037,0.95041,LEE_LIVER_CANCER_DENA_UP,0.99999
MIR616_3P,SET,41,-0.22462,-0.010603,0.13618,0.95047,MIR616_3P,0.99999
GOBP_EMBRYONIC_DIGESTIVE_TRA...2,SET,17,-0.38004,-0.011559,0.23039,0.95048,GOBP_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS,0.99999
GSE19401_UNSTIM_VS_RETINOIC_...3,SET,168,-0.10668,-0.010158,0.064665,0.95049,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,0.99999
GSE360_CTRL_VS_L_DONOVANI_MA...2,SET,183,-0.10082,-0.010015,0.061109,0.9505,GSE360_CTRL_VS_L_DONOVANI_MAC_UP,0.99999
GOBP_MITOCHONDRIAL_FRAGMENTA...,SET,10,-0.49827,-0.011625,0.30164,0.95071,GOBP_MITOCHONDRIAL_FRAGMENTATION_INVOLVED_IN_APOPTOTIC_PROCESS,0.99999
GOBP_MITOCHONDRIAL_RNA_3_END...,SET,6,-0.54732,-0.0098923,0.33133,0.95071,GOBP_MITOCHONDRIAL_RNA_3_END_PROCESSING,0.99999
GOBP_POSITIVE_REGULATION_OF_...47,SET,18,-0.33033,-0.010338,0.19992,0.95075,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,0.99999
MATZUK_FERTILIZATION,SET,7,-0.51662,-0.010085,0.3126,0.95079,MATZUK_FERTILIZATION,0.99999
KEGG_MEDICUS_REFERENCE_TNF_J...,SET,16,-0.36087,-0.010648,0.21834,0.9508,KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY,0.99999
MIR944,SET,381,-0.072805,-0.010378,0.044042,0.95083,MIR944,0.99999
GSE28783_ANTI_MIR33_VS_CTRL_...1,SET,166,-0.11228,-0.010627,0.067917,0.95084,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN,0.99999
KEGG_TRYPTOPHAN_METABOLISM,SET,36,-0.23255,-0.010287,0.14066,0.95086,KEGG_TRYPTOPHAN_METABOLISM,0.99999
GOBP_LENS_FIBER_CELL_DEVELOP...,SET,14,-0.3869,-0.010679,0.23401,0.95086,GOBP_LENS_FIBER_CELL_DEVELOPMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...246,SET,4,-0.53921,-0.0079578,0.32606,0.9509,GOBP_NEGATIVE_REGULATION_OF_G0_TO_G1_TRANSITION,0.99999
REACTOME_NFE2L2_REGULATING_I...,SET,5,-0.66153,-0.010915,0.3999,0.95095,REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES,0.99999
GOBP_MESENCHYMAL_CELL_PROLIF...2,SET,6,-0.64755,-0.011704,0.39143,0.95096,GOBP_MESENCHYMAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_DEVELOPMENT,0.99999
HP_ABNORMALITY_OF_THE_PINEAL...,SET,14,-0.36994,-0.010211,0.22356,0.951,HP_ABNORMALITY_OF_THE_PINEAL_GLAND,0.99999
HP_DYSMETRIC_SACCADES,SET,15,-0.33771,-0.0096485,0.20405,0.95103,HP_DYSMETRIC_SACCADES,0.99999
REACTOME_B_WICH_COMPLEX_POSI...,SET,28,-0.24449,-0.0095403,0.14769,0.95107,REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,0.99999
GOBP_CELL_JUNCTION_ORGANIZAT...,SET,704,-0.055939,-0.010741,0.033792,0.95107,GOBP_CELL_JUNCTION_ORGANIZATION,0.99999
GSE2585_CD80_HIGH_VS_LOW_AIR...2,SET,176,-0.10786,-0.01051,0.065158,0.95107,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_UP,0.99999
GSE23502_WT_VS_HDC_KO_MYELOI...3,SET,173,-0.10994,-0.010621,0.066408,0.95108,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_DN,0.99999
GOMF_CADHERIN_BINDING,SET,302,-0.079548,-0.010118,0.04804,0.95112,GOMF_CADHERIN_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...535,SET,22,-0.31396,-0.010861,0.18954,0.95117,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,0.99999
GOBP_LEUKOCYTE_HOMEOSTASIS,SET,101,-0.1439,-0.010643,0.086869,0.95118,GOBP_LEUKOCYTE_HOMEOSTASIS,0.99999
chr1p32,SET,63,-0.31898,-0.018652,0.19252,0.95122,chr1p32,0.99999
SHIPP_DLBCL_CURED_VS_FATAL_UP,SET,36,-0.23811,-0.010533,0.14371,0.95122,SHIPP_DLBCL_CURED_VS_FATAL_UP,0.99999
GOBP_ESTABLISHMENT_OR_MAINTE...4,SET,22,-0.29439,-0.010184,0.17765,0.95124,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_MONOPOLAR_CELL_POLARITY,0.99999
GOBP_MAMMARY_GLAND_DEVELOPME...,SET,128,-0.13311,-0.011075,0.080305,0.95129,GOBP_MAMMARY_GLAND_DEVELOPMENT,0.99999
GOBP_PHOSPHATIDYLINOSITOL_3_...2,SET,21,-0.27308,-0.0092301,0.16473,0.95131,GOBP_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...212,SET,120,-0.13679,-0.011022,0.082491,0.95135,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,0.99999
MIR3911,SET,81,-0.15319,-0.010152,0.092376,0.95136,MIR3911,0.99999
MORF_PRKCA,SET,154,-0.11547,-0.01053,0.069622,0.95138,MORF_PRKCA,0.99999
MIR544B,SET,191,-0.099286,-0.010074,0.059856,0.95141,MIR544B,0.99999
GOBP_POSITIVE_REGULATION_OF_...136,SET,19,-0.33194,-0.010673,0.2001,0.95142,GOBP_POSITIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.99999
GOMF_CARBON_NITROGEN_LIGASE_...,SET,10,-0.40227,-0.0093854,0.2425,0.95142,GOMF_CARBON_NITROGEN_LIGASE_ACTIVITY_WITH_GLUTAMINE_AS_AMIDO_N_DONOR,0.99999
HP_ELEVATED_TRANSFERRIN_SATU...,SET,9,-0.44527,-0.0098558,0.26842,0.95142,HP_ELEVATED_TRANSFERRIN_SATURATION,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...2,SET,183,-0.10315,-0.010246,0.062143,0.95152,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_VAS...1,SET,117,-0.14181,-0.011284,0.085428,0.95154,HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL,0.99999
LI_WILMS_TUMOR,SET,22,-0.34104,-0.011798,0.20542,0.95156,LI_WILMS_TUMOR,0.99999
MIR20B_3P,SET,65,-0.16748,-0.0099471,0.10088,0.95156,MIR20B_3P,0.99999
KRASNOSELSKAYA_ILF3_TARGETS_...1,SET,43,-0.21134,-0.010215,0.12728,0.95158,KRASNOSELSKAYA_ILF3_TARGETS_DN,0.99999
DESCARTES_FETAL_ADRENAL_LYMP...,SET,131,-0.13129,-0.01105,0.079045,0.95163,DESCARTES_FETAL_ADRENAL_LYMPHOID_CELLS,0.99999
GOBP_ANIMAL_ORGAN_MORPHOGENE...,SET,953,-0.049242,-0.010924,0.029639,0.95168,GOBP_ANIMAL_ORGAN_MORPHOGENESIS,0.99999
REACTOME_RNA_POLYMERASE_I_TR...2,SET,42,-0.19219,-0.0091816,0.11566,0.9517,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION,0.99999
REACTOME_DIGESTION,SET,17,-0.39083,-0.011887,0.23519,0.95171,REACTOME_DIGESTION,0.99999
HP_PROGRESSIVE_CEREBELLAR_AT...,SET,57,-0.17777,-0.0098892,0.10695,0.95175,HP_PROGRESSIVE_CEREBELLAR_ATAXIA,0.99999
MIR147B_3P,SET,5,-0.67877,-0.011199,0.40829,0.95178,MIR147B_3P,0.99999
GOBP_PROXIMAL_TUBULE_DEVELOP...,SET,10,-0.46677,-0.01089,0.2807,0.95182,GOBP_PROXIMAL_TUBULE_DEVELOPMENT,0.99999
GOBP_NEUROGENESIS,SET,1593,-0.037956,-0.010684,0.022814,0.95191,GOBP_NEUROGENESIS,0.99999
GSE7568_IL4_VS_IL4_AND_TGFB_...1,SET,176,-0.10013,-0.0097559,0.060181,0.95191,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN,0.99999
CAFFAREL_RESPONSE_TO_THC_DN,SET,29,-0.23816,-0.0094576,0.14314,0.95192,CAFFAREL_RESPONSE_TO_THC_DN,0.99999
TMTCGCGANR_UNKNOWN,SET,148,-0.1109,-0.0099163,0.066648,0.95193,TMTCGCGANR_UNKNOWN,0.99999
ELK1_02,SET,235,-0.087738,-0.0098623,0.052715,0.95197,ELK1_02,0.99999
HEIDENBLAD_AMPLIFIED_IN_BONE...,SET,7,-0.61082,-0.011924,0.36693,0.952,HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER,0.99999
GOBP_POSITIVE_REGULATION_OF_...121,SET,17,-0.31691,-0.0096384,0.19033,0.95204,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_CHECKPOINT,0.99999
HP_CONSTRICTION_OF_PERIPHERA...,SET,126,-0.12573,-0.01038,0.075495,0.95208,HP_CONSTRICTION_OF_PERIPHERAL_VISUAL_FIELD,0.99999
HE_LIM_SUN_FETAL_LUNG_C2_PLA...,SET,316,-0.079367,-0.010322,0.047654,0.95208,HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL,0.99999
DESCARTES_FETAL_INTESTINE_SM...,SET,41,-0.22761,-0.010744,0.1366,0.95216,DESCARTES_FETAL_INTESTINE_SMOOTH_MUSCLE_CELLS,0.99999
HP_CHIN_WITH_H_SHAPED_CREASE,SET,4,-0.85157,-0.012568,0.51087,0.95222,HP_CHIN_WITH_H_SHAPED_CREASE,0.99999
GSE43955_1H_VS_20H_ACT_CD4_T...2,SET,184,-0.10526,-0.010485,0.063147,0.95223,GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP,0.99999
TURASHVILI_BREAST_LOBULAR_CA...3,SET,67,-0.17984,-0.010844,0.10787,0.95225,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,0.99999
GOBP_FOREBRAIN_RADIAL_GLIAL_...,SET,7,-0.56053,-0.010943,0.33617,0.95227,GOBP_FOREBRAIN_RADIAL_GLIAL_CELL_DIFFERENTIATION,0.99999
GOBP_METANEPHRIC_NEPHRON_TUB...2,SET,8,-0.5394,-0.011257,0.32346,0.95229,GOBP_METANEPHRIC_NEPHRON_TUBULE_MORPHOGENESIS,0.99999
WP_CORI_CYCLE,SET,13,-0.35593,-0.0094675,0.21344,0.9523,WP_CORI_CYCLE,0.99999
KOBAYASHI_EGFR_SIGNALING_6HR...2,SET,6,-0.56308,-0.010177,0.33759,0.95233,KOBAYASHI_EGFR_SIGNALING_6HR_UP,0.99999
GOBP_RESPONSE_TO_HEAT,SET,94,-0.14239,-0.010162,0.08536,0.95234,GOBP_RESPONSE_TO_HEAT,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...3,SET,46,-0.20574,-0.010285,0.1233,0.9524,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,0.99999
GCM_PSME1,SET,75,-0.15461,-0.0098614,0.092641,0.95243,GCM_PSME1,0.99999
GOBP_NEGATIVE_REGULATION_OF_...250,SET,10,-0.4564,-0.010648,0.27347,0.95243,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS,0.99999
HP_OSTEOARTHRITIS,SET,57,-0.19626,-0.010918,0.1176,0.95243,HP_OSTEOARTHRITIS,0.99999
MIR4520_2_3P,SET,111,-0.13697,-0.010618,0.082052,0.95246,MIR4520_2_3P,0.99999
MIR513B_3P,SET,144,-0.12266,-0.01082,0.073479,0.95246,MIR513B_3P,0.99999
GSE32986_CURDLAN_LOWDOSE_VS_...1,SET,190,-0.10606,-0.010733,0.063523,0.95249,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,0.99999
GOBP_PURINE_NUCLEOBASE_BIOSY...,SET,8,-0.47391,-0.00989,0.28383,0.9525,GOBP_PURINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_SYNAPSE_S...2,SET,230,-0.096103,-0.010688,0.057559,0.9525,GOBP_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY,0.99999
REACTOME_MTOR_SIGNALLING,SET,40,-0.2142,-0.0099869,0.12828,0.95251,REACTOME_MTOR_SIGNALLING,0.99999
GOBP_PLANAR_CELL_POLARITY_PA...1,SET,6,-0.68637,-0.012406,0.41093,0.95256,GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_AXIS_ELONGATION,0.99999
GOCC_NETWORK_FORMING_COLLAGE...,SET,6,-0.6147,-0.01111,0.36791,0.95261,GOCC_NETWORK_FORMING_COLLAGEN_TRIMER,0.99999
GSE46606_DAY1_VS_DAY3_CD40L_...6,SET,176,-0.10693,-0.010419,0.064,0.95261,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP,0.99999
GOMF_CYTOSKELETON_NUCLEAR_ME...,SET,5,-0.6006,-0.0099097,0.35946,0.95262,GOMF_CYTOSKELETON_NUCLEAR_MEMBRANE_ANCHOR_ACTIVITY,0.99999
GOBP_ANATOMICAL_STRUCTURE_AR...,SET,16,-0.3848,-0.011354,0.23028,0.95263,GOBP_ANATOMICAL_STRUCTURE_ARRANGEMENT,0.99999
GSE36009_WT_VS_NLRP10_KO_DC_...1,SET,187,-0.09902,-0.009942,0.059257,0.95263,GSE36009_WT_VS_NLRP10_KO_DC_DN,0.99999
GOBP_SPLEEN_DEVELOPMENT,SET,37,-0.23309,-0.010453,0.13946,0.95267,GOBP_SPLEEN_DEVELOPMENT,0.99999
REACTOME_MET_RECEPTOR_RECYCL...,SET,10,-0.46479,-0.010844,0.278,0.95272,REACTOME_MET_RECEPTOR_RECYCLING,0.99999
HP_ABNORMALITY_OF_THE_METOPI...,SET,80,-0.15257,-0.010049,0.091257,0.95272,HP_ABNORMALITY_OF_THE_METOPIC_SUTURE,0.99999
CDX2_Q5,SET,232,-0.10202,-0.011395,0.061003,0.95276,CDX2_Q5,0.99999
GOBP_REGULATION_OF_SPINDLE_C...,SET,22,-0.26669,-0.0092259,0.15942,0.95281,GOBP_REGULATION_OF_SPINDLE_CHECKPOINT,0.99999
HP_PORTAL_VEIN_THROMBOSIS,SET,11,-0.44987,-0.011008,0.26891,0.95282,HP_PORTAL_VEIN_THROMBOSIS,0.99999
BUCKANOVICH_T_LYMPHOCYTE_HOM...1,SET,19,-0.29942,-0.0096269,0.17895,0.95284,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN,0.99999
MIR3177_5P,SET,146,-0.11636,-0.010335,0.069548,0.95284,MIR3177_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...806,SET,93,-0.16186,-0.01149,0.096731,0.95285,GOBP_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION,0.99999
KEGG_MEDICUS_REFERENCE_NLRC4...,SET,4,-0.52609,-0.0077642,0.31441,0.95286,KEGG_MEDICUS_REFERENCE_NLRC4_INFLAMMASOME_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...89,SET,8,-0.46383,-0.0096797,0.27715,0.95288,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...531,SET,25,-0.26299,-0.0096976,0.1571,0.95292,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION,0.99999
GSE21927_UNTREATED_VS_GMCSF_...3,SET,153,-0.11469,-0.010426,0.068497,0.95297,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_DN,0.99999
HP_ACANTHOSIS_NIGRICANS,SET,57,-0.19523,-0.01086,0.11659,0.95298,HP_ACANTHOSIS_NIGRICANS,0.99999
PID_P53_DOWNSTREAM_PATHWAY,SET,134,-0.11786,-0.010032,0.070374,0.95301,PID_P53_DOWNSTREAM_PATHWAY,0.99999
GSE3039_CD4_TCELL_VS_NKT_CEL...1,SET,180,-0.10026,-0.0098783,0.059855,0.95303,GSE3039_CD4_TCELL_VS_NKT_CELL_DN,0.99999
WP_BIOMARKERS_FOR_PYRIMIDINE...,SET,15,-0.3528,-0.01008,0.21058,0.95306,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,0.99999
GSE21360_NAIVE_VS_QUATERNARY...2,SET,188,-0.10165,-0.010233,0.060671,0.95306,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.99999
HP_DEEP_VENOUS_THROMBOSIS,SET,17,-0.29647,-0.009017,0.17689,0.95313,HP_DEEP_VENOUS_THROMBOSIS,0.99999
TTCYRGAA_UNKNOWN,SET,300,-0.08241,-0.010448,0.049166,0.95314,TTCYRGAA_UNKNOWN,0.99999
AR_Q2,SET,115,-0.13509,-0.010657,0.080587,0.95315,AR_Q2,0.99999
MIR8081,SET,50,-0.19599,-0.010214,0.1169,0.95318,MIR8081,0.99999
GSE8384_CTRL_VS_B_ABORTUS_4H...2,SET,174,-0.10507,-0.01018,0.062668,0.95319,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP,0.99999
GSE27786_LIN_NEG_VS_NEUTROPH...2,SET,172,-0.10227,-0.0098516,0.060978,0.95323,GSE27786_LIN_NEG_VS_NEUTROPHIL_UP,0.99999
GSE4984_LPS_VS_VEHICLE_CTRL_...1,SET,177,-0.1077,-0.010523,0.064203,0.95326,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN,0.99999
P53_DN.V1_DN,SET,177,-0.11239,-0.010982,0.066973,0.95333,P53_DN.V1_DN,0.99999
GSE15624_CTRL_VS_6H_HALOFUGI...2,SET,123,-0.13159,-0.010734,0.0784,0.95337,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.99999
WINZEN_DEGRADED_VIA_KHSRP,SET,96,-0.16634,-0.011997,0.099087,0.95339,WINZEN_DEGRADED_VIA_KHSRP,0.99999
GOBP_MEMBRANE_LIPID_CATABOLI...,SET,44,-0.21672,-0.010596,0.1291,0.95339,GOBP_MEMBRANE_LIPID_CATABOLIC_PROCESS,0.99999
HP_HORNER_SYNDROME,SET,9,-0.57795,-0.012793,0.34413,0.95346,HP_HORNER_SYNDROME,0.99999
BIOCARTA_GCR_PATHWAY,SET,17,-0.36159,-0.010998,0.21526,0.95349,BIOCARTA_GCR_PATHWAY,0.99999
HP_ABNORMAL_CIRCULATING_ORNI...,SET,5,-0.59938,-0.0098896,0.35673,0.95353,HP_ABNORMAL_CIRCULATING_ORNITHINE_CONCENTRATION,0.99999
GOBP_RIGHTING_REFLEX,SET,8,-0.51213,-0.010688,0.30467,0.95361,GOBP_RIGHTING_REFLEX,0.99999
HNF4_01,SET,244,-0.089548,-0.010254,0.053263,0.95363,HNF4_01,0.99999
HP_CHOROIDEREMIA,SET,6,-0.66424,-0.012006,0.39506,0.95365,HP_CHOROIDEREMIA,0.99999
GSE37301_HEMATOPOIETIC_STEM_...4,SET,174,-0.10687,-0.010354,0.063547,0.95367,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.99999
GSE17721_CTRL_VS_CPG_6H_BMDC...2,SET,181,-0.1002,-0.0098992,0.05958,0.95368,GSE17721_CTRL_VS_CPG_6H_BMDC_UP,0.99999
MIR195_5P,SET,534,-0.061101,-0.010268,0.03633,0.95369,MIR195_5P,0.99999
GOBP_SPERMIDINE_TRANSPORT,SET,5,-0.75115,-0.012394,0.44645,0.95376,GOBP_SPERMIDINE_TRANSPORT,0.99999
CUI_DEVELOPING_HEART_SMOOTH_...,SET,41,-0.23552,-0.011117,0.13998,0.95376,CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL,0.99999
GOBP_REGULATION_OF_PROTEIN_L...12,SET,9,-0.42804,-0.0094743,0.25437,0.95378,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,0.99999
WP_NEUROINFLAMMATION_AND_GLU...,SET,135,-0.13134,-0.011221,0.078047,0.95379,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,0.99999
GOBP_NUCLEOBASE_CONTAINING_S...4,SET,582,-0.058329,-0.010219,0.034656,0.95381,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS,0.99999
AKL_HTLV1_INFECTION_DN,SET,61,-0.18655,-0.010735,0.1108,0.95387,AKL_HTLV1_INFECTION_DN,0.99999
CREIGHTON_AKT1_SIGNALING_VIA...1,SET,20,-0.29699,-0.0097965,0.17639,0.95387,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN,0.99999
GOBP_CYTOSOLIC_RIBOSOME_ASSE...,SET,7,-0.47693,-0.0093105,0.28323,0.95389,GOBP_CYTOSOLIC_RIBOSOME_ASSEMBLY,0.99999
GOBP_LONG_CHAIN_FATTY_ACID_T...,SET,64,-0.18303,-0.010787,0.10869,0.95389,GOBP_LONG_CHAIN_FATTY_ACID_TRANSPORT,0.99999
GOBP_TRYPTOPHAN_METABOLIC_PR...,SET,10,-0.51996,-0.012131,0.30878,0.95389,GOBP_TRYPTOPHAN_METABOLIC_PROCESS,0.99999
DESCARTES_MAIN_FETAL_PHOTORE...,SET,67,-0.18752,-0.011307,0.11133,0.95393,DESCARTES_MAIN_FETAL_PHOTORECEPTOR_CELLS,0.99999
HP_ABNORMALITY_OF_ALKALINE_P...,SET,120,-0.12985,-0.010463,0.077087,0.95395,HP_ABNORMALITY_OF_ALKALINE_PHOSPHATASE_LEVEL,0.99999
WP_SULINDAC_METABOLIC_PATHWAY,SET,5,-0.70259,-0.011593,0.41705,0.95396,WP_SULINDAC_METABOLIC_PATHWAY,0.99999
HP_ELEVATED_CIRCULATING_THYR...,SET,27,-0.2807,-0.010756,0.16663,0.95396,HP_ELEVATED_CIRCULATING_THYROID_STIMULATING_HORMONE_CONCENTRATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...128,SET,14,-0.39196,-0.010819,0.23264,0.95398,GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.99999
GOCC_MICROTUBULE_ORGANIZING_...2,SET,10,-0.44375,-0.010353,0.26338,0.95398,GOCC_MICROTUBULE_ORGANIZING_CENTER_ATTACHMENT_SITE,0.99999
GOBP_LUNG_ALVEOLUS_DEVELOPME...,SET,51,-0.21167,-0.01114,0.1256,0.95402,GOBP_LUNG_ALVEOLUS_DEVELOPMENT,0.99999
GAUSSMANN_MLL_AF4_FUSION_TAR...5,SET,20,-0.33826,-0.011158,0.20071,0.95403,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN,0.99999
HP_ABNORMAL_UTERUS_MORPHOLOGY,SET,138,-0.11746,-0.010145,0.069695,0.95403,HP_ABNORMAL_UTERUS_MORPHOLOGY,0.99999
MIR3122,SET,59,-0.1837,-0.010397,0.10899,0.95404,MIR3122,0.99999
GOBP_CELLULAR_RESPONSE_TO_CA...1,SET,33,-0.28943,-0.012259,0.17173,0.95404,GOBP_CELLULAR_RESPONSE_TO_CADMIUM_ION,0.99999
GSE40666_WT_VS_STAT1_KO_CD8_...3,SET,185,-0.10179,-0.010166,0.060388,0.95405,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.99999
GOBP_REGULATION_OF_BASEMENT_...,SET,11,-0.37713,-0.0092281,0.22365,0.95412,GOBP_REGULATION_OF_BASEMENT_MEMBRANE_ORGANIZATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...493,SET,6,-0.63892,-0.011548,0.37881,0.95416,GOBP_NEGATIVE_REGULATION_OF_PHOTORECEPTOR_CELL_DIFFERENTIATION,0.99999
GSE36078_WT_VS_IL1R_KO_LUNG_...2,SET,182,-0.10583,-0.010484,0.062742,0.95417,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_UP,0.99999
PID_RHODOPSIN_PATHWAY,SET,21,-0.2875,-0.0097173,0.17037,0.95423,PID_RHODOPSIN_PATHWAY,0.99999
GSE9960_HEALTHY_VS_SEPSIS_PB...2,SET,166,-0.10885,-0.010303,0.064503,0.95424,GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...73,SET,27,-0.27996,-0.010728,0.16586,0.95428,HP_APLASIA_HYPOPLASIA_OF_THE_TIBIA,0.99999
BIOCARTA_TALL1_PATHWAY,SET,15,-0.40219,-0.011491,0.23824,0.9543,BIOCARTA_TALL1_PATHWAY,0.99999
GSE17721_CTRL_VS_CPG_24H_BMD...2,SET,180,-0.10375,-0.010222,0.061452,0.95431,GSE17721_CTRL_VS_CPG_24H_BMDC_UP,0.99999
KEGG_MEDICUS_REFERENCE_P4_PR...1,SET,8,-0.49937,-0.010421,0.29567,0.95438,KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY,0.99999
KEGG_BETA_ALANINE_METABOLISM,SET,21,-0.31989,-0.010812,0.18936,0.95441,KEGG_BETA_ALANINE_METABOLISM,0.99999
GOBP_POSITIVE_REGULATION_OF_...97,SET,11,-0.48628,-0.011899,0.28785,0.95442,GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_SECRETION,0.99999
GOBP_REGULATION_OF_CGMP_MEDI...,SET,10,-0.4775,-0.011141,0.28263,0.95443,GOBP_REGULATION_OF_CGMP_MEDIATED_SIGNALING,0.99999
GOBP_MITOCHONDRION_LOCALIZAT...,SET,45,-0.21447,-0.010605,0.12689,0.9545,GOBP_MITOCHONDRION_LOCALIZATION,0.99999
DORN_ADENOVIRUS_INFECTION_12...2,SET,23,-0.27907,-0.0098709,0.1651,0.95451,DORN_ADENOVIRUS_INFECTION_12HR_UP,0.99999
MIR6750_5P,SET,63,-0.16842,-0.0098486,0.09963,0.95452,MIR6750_5P,0.99999
HP_HYDROXYPROLINEMIA,SET,5,-0.7794,-0.01286,0.46105,0.95452,HP_HYDROXYPROLINEMIA,0.99999
GOBP_ACYLGLYCEROL_TRANSPORT,SET,6,-0.54461,-0.0098433,0.32207,0.95457,GOBP_ACYLGLYCEROL_TRANSPORT,0.99999
GSE13547_CTRL_VS_ANTI_IGM_ST...6,SET,126,-0.12815,-0.010579,0.075779,0.95458,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...428,SET,4,-0.86632,-0.012785,0.51223,0.9546,GOBP_POSITIVE_REGULATION_OF_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS,0.99999
REACTOME_PRESYNAPTIC_FUNCTIO...,SET,21,-0.31964,-0.010804,0.18898,0.95461,REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS,0.99999
GOBP_POSITIVE_REGULATION_OF_...613,SET,5,-0.77308,-0.012756,0.457,0.95464,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,0.99999
GOBP_ADENYLATE_CYCLASE_INHIB...3,SET,9,-0.51258,-0.011346,0.30297,0.95465,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOMF_G_PROTEIN_COUPLED_GLUTA...1,SET,9,-0.51258,-0.011346,0.30297,0.95465,GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_ACTIVITY,0.99999
HP_LEFT_TO_RIGHT_SHUNT,SET,10,-0.49829,-0.011626,0.29453,0.95465,HP_LEFT_TO_RIGHT_SHUNT,0.99999
GOBP_INTESTINAL_LIPID_ABSORP...,SET,21,-0.3331,-0.011259,0.19686,0.95467,GOBP_INTESTINAL_LIPID_ABSORPTION,0.99999
MEF2C_TARGET_GENES,SET,1332,-0.04035,-0.010466,0.023838,0.95473,MEF2C_TARGET_GENES,0.99999
GNF2_CEBPA,SET,60,-0.17931,-0.010234,0.10593,0.95475,GNF2_CEBPA,0.99999
HP_ICHTHYOSIS,SET,123,-0.12811,-0.01045,0.075665,0.95477,HP_ICHTHYOSIS,0.99999
GSE4142_NAIVE_VS_MEMORY_BCEL...1,SET,189,-0.10218,-0.010314,0.060293,0.95493,GSE4142_NAIVE_VS_MEMORY_BCELL_DN,0.99999
GOCC_PRECATALYTIC_SPLICEOSOME,SET,48,-0.17731,-0.0090539,0.1046,0.95496,GOCC_PRECATALYTIC_SPLICEOSOME,0.99999
TING_SILENCED_BY_DICER,SET,26,-0.29438,-0.01107,0.17367,0.95497,TING_SILENCED_BY_DICER,0.99999
GSE20152_HTNFA_OVERXPRESS_AN...1,SET,173,-0.10482,-0.010126,0.061827,0.95499,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_DN,0.99999
HP_NON_CONVULSIVE_STATUS_EPI...,SET,18,-0.33667,-0.010536,0.19854,0.95502,HP_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA,0.99999
REACTOME_REGULATION_OF_CDH11...1,SET,10,-0.49398,-0.011525,0.29125,0.95506,REACTOME_REGULATION_OF_CDH11_FUNCTION,0.99999
PRC2_EED_DN.V1_UP,SET,172,-0.11192,-0.010781,0.065972,0.95509,PRC2_EED_DN.V1_UP,0.99999
GOBP_TRYPTOPHAN_CATABOLIC_PR...,SET,5,-0.77919,-0.012856,0.45925,0.95511,GOBP_TRYPTOPHAN_CATABOLIC_PROCESS_TO_KYNURENINE,0.99999
HP_PROFOUND_HEARING_IMPAIRME...,SET,10,-0.48274,-0.011263,0.28434,0.95521,HP_PROFOUND_HEARING_IMPAIRMENT,0.99999
GNF2_EGFR,SET,29,-0.29277,-0.011626,0.17242,0.95524,GNF2_EGFR,0.99999
GSE22886_IGM_MEMORY_BCELL_VS...2,SET,175,-0.1075,-0.010444,0.063305,0.95524,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,0.99999
BENPORATH_NANOG_TARGETS,SET,877,-0.049322,-0.010519,0.029046,0.95525,BENPORATH_NANOG_TARGETS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...466,SET,22,-0.32417,-0.011214,0.19086,0.95528,GOBP_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,0.99999
GOCC_EUKARYOTIC_TRANSLATION_...1,SET,5,-0.55715,-0.0091929,0.32803,0.95528,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2B_COMPLEX,0.99999
GSE37301_LYMPHOID_PRIMED_MPP...4,SET,187,-0.10323,-0.010365,0.060781,0.95528,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.99999
GOBP_FRUCTOSE_6_PHOSPHATE_ME...,SET,12,-0.40438,-0.010335,0.23807,0.95529,GOBP_FRUCTOSE_6_PHOSPHATE_METABOLIC_PROCESS,0.99999
HP_SHORT_1ST_METACARPAL,SET,21,-0.32705,-0.011054,0.19252,0.95531,HP_SHORT_1ST_METACARPAL,0.99999
REACTOME_BETA_DEFENSINS,SET,26,-0.39553,-0.014873,0.23274,0.95538,REACTOME_BETA_DEFENSINS,0.99999
GOBP_ESTABLISHMENT_OF_PROTEI...2,SET,5,-0.56055,-0.009249,0.32982,0.95539,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.99999
GOBP_MUSCLE_HYPERTROPHY,SET,84,-0.16496,-0.011132,0.09706,0.95539,GOBP_MUSCLE_HYPERTROPHY,0.99999
MIR1304_3P,SET,100,-0.14603,-0.010748,0.08591,0.95541,MIR1304_3P,0.99999
MIR6854_5P,SET,66,-0.17332,-0.010372,0.10196,0.95542,MIR6854_5P,0.99999
GOBP_RETINAL_CELL_PROGRAMMED...,SET,6,-0.6263,-0.01132,0.36843,0.95542,GOBP_RETINAL_CELL_PROGRAMMED_CELL_DEATH,0.99999
REACTOME_CONJUGATION_OF_BENZ...,SET,6,-0.79347,-0.014341,0.46673,0.95543,REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE,0.99999
GOCC_POSTSYNAPSE,SET,608,-0.06033,-0.010795,0.035482,0.95545,GOCC_POSTSYNAPSE,0.99999
HP_PERIVENTRICULAR_HETEROTOP...,SET,37,-0.21486,-0.0096352,0.12637,0.95545,HP_PERIVENTRICULAR_HETEROTOPIA,0.99999
HP_LOW_HANGING_COLUMELLA,SET,43,-0.20614,-0.0099643,0.12123,0.95547,HP_LOW_HANGING_COLUMELLA,0.99999
MIR1298_3P,SET,41,-0.22598,-0.010666,0.13284,0.95553,MIR1298_3P,0.99999
GOBP_RESPONSE_TO_VITAMIN,SET,85,-0.16827,-0.011422,0.098918,0.95553,GOBP_RESPONSE_TO_VITAMIN,0.99999
MIR3663_5P,SET,49,-0.20643,-0.01065,0.12134,0.95554,MIR3663_5P,0.99999
WYAAANNRNNNGCG_UNKNOWN,SET,63,-0.18306,-0.010705,0.10755,0.95562,WYAAANNRNNNGCG_UNKNOWN,0.99999
REACTOME_RUNX2_REGULATES_CHO...,SET,5,-0.6412,-0.01058,0.37669,0.95563,REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION,0.99999
GSE29618_PRE_VS_DAY7_FLU_VAC...1,SET,175,-0.10431,-0.010135,0.06128,0.95563,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN,0.99999
GOBP_GLUCAN_METABOLIC_PROCESS,SET,74,-0.16337,-0.010351,0.095971,0.95565,GOBP_GLUCAN_METABOLIC_PROCESS,0.99999
HP_NONKETOTIC_HYPOGLYCEMIA,SET,13,-0.37942,-0.010092,0.22286,0.95566,HP_NONKETOTIC_HYPOGLYCEMIA,0.99999
GOBP_REGULATION_OF_LONG_CHAI...1,SET,6,-0.58287,-0.010535,0.34235,0.95567,GOBP_REGULATION_OF_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
DESCARTES_FETAL_SPLEEN_STC2_...,SET,10,-0.48326,-0.011275,0.28377,0.95571,DESCARTES_FETAL_SPLEEN_STC2_TLX1_POSITIVE_CELLS,0.99999
GOBP_GLIAL_CELL_MIGRATION,SET,57,-0.21013,-0.01169,0.12338,0.95572,GOBP_GLIAL_CELL_MIGRATION,0.99999
GSE40068_CXCR5NEG_BCL6NEG_CD...2,SET,184,-0.10467,-0.010426,0.061456,0.95573,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_UP,0.99999
REACTOME_POST_TRANSLATIONAL_...2,SET,1289,-0.040654,-0.010387,0.023859,0.95579,REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.99999
GREB1_TARGET_GENES,SET,682,-0.056323,-0.010652,0.033056,0.95579,GREB1_TARGET_GENES,0.99999
GOBP_CELLULAR_RESPONSE_TO_UV...3,SET,4,-0.60917,-0.0089903,0.35748,0.95581,GOBP_CELLULAR_RESPONSE_TO_UV_C,0.99999
MIR5582_3P,SET,601,-0.060268,-0.010724,0.035364,0.95582,MIR5582_3P,0.99999
GCM_MSN,SET,23,-0.29496,-0.010433,0.17304,0.95586,GCM_MSN,0.99999
GSE40666_STAT1_KO_VS_STAT4_K...4,SET,167,-0.10142,-0.0096279,0.059486,0.95588,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.99999
GSE3565_DUSP1_VS_WT_SPLENOCY...2,SET,146,-0.12519,-0.011119,0.073428,0.95589,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_DN,0.99999
GOBP_REGULATION_OF_PROTEIN_L...6,SET,9,-0.41422,-0.0091686,0.24288,0.95594,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,0.99999
MIR222_5P,SET,174,-0.10693,-0.01036,0.062667,0.95602,MIR222_5P,0.99999
MORF_DDB1,SET,224,-0.08859,-0.0097251,0.051915,0.95603,MORF_DDB1,0.99999
GOBP_REGULATION_OF_SYNAPSE_S...1,SET,7,-0.5362,-0.010468,0.31423,0.95603,GOBP_REGULATION_OF_SYNAPSE_STRUCTURAL_PLASTICITY,0.99999
GOMF_BETA_CATENIN_BINDING,SET,98,-0.15248,-0.01111,0.089322,0.95609,GOMF_BETA_CATENIN_BINDING,0.99999
GOBP_ACID_SECRETION,SET,43,-0.22184,-0.010723,0.12994,0.9561,GOBP_ACID_SECRETION,0.99999
MIR6782_3P,SET,79,-0.1616,-0.010577,0.094646,0.95612,MIR6782_3P,0.99999
GOBP_CELLULAR_DETOXIFICATION...,SET,9,-0.48664,-0.010771,0.28493,0.95617,GOBP_CELLULAR_DETOXIFICATION_OF_ALDEHYDE,0.99999
GOMF_SHORT_CHAIN_FATTY_ACYL_...,SET,5,-0.60468,-0.009977,0.3537,0.95632,GOMF_SHORT_CHAIN_FATTY_ACYL_COA_DEHYDROGENASE_ACTIVITY,0.99999
HP_HEPARAN_SULFATE_EXCRETION...,SET,8,-0.46629,-0.009731,0.27268,0.95636,HP_HEPARAN_SULFATE_EXCRETION_IN_URINE,0.99999
GOBP_ADHERENS_JUNCTION_ORGAN...,SET,56,-0.20971,-0.011564,0.12263,0.95637,GOBP_ADHERENS_JUNCTION_ORGANIZATION,0.99999
PAL_PRMT5_TARGETS_UP,SET,186,-0.10136,-0.01015,0.059259,0.9564,PAL_PRMT5_TARGETS_UP,0.99999
BUSSLINGER_GASTRIC_OXYNTIC_E...,SET,74,-0.18148,-0.011498,0.1061,0.9564,BUSSLINGER_GASTRIC_OXYNTIC_ENTEROCHROMAFFIN_LIKE_CELLS,0.99999
GOBP_FIBROBLAST_GROWTH_FACTO...1,SET,7,-0.5825,-0.011371,0.34054,0.95641,GOBP_FIBROBLAST_GROWTH_FACTOR_PRODUCTION,0.99999
MIR147B_5P,SET,285,-0.086346,-0.010674,0.05047,0.95643,MIR147B_5P,0.99999
MORF_MLLT10,SET,268,-0.088929,-0.010665,0.051983,0.95643,MORF_MLLT10,0.99999
MIR4753_3P,SET,513,-0.065651,-0.010819,0.038372,0.95644,MIR4753_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...135,SET,5,-0.67099,-0.011071,0.39216,0.95645,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,0.99999
REACTOME_LOSS_OF_MECP2_BINDI...,SET,5,-0.59068,-0.0097461,0.34518,0.95647,REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX,0.99999
GOBP_SMALL_GTPASE_MEDIATED_S...,SET,461,-0.068652,-0.010741,0.04012,0.95647,GOBP_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,0.99999
REACTOME_TP53_REGULATES_TRAN...7,SET,19,-0.34203,-0.010997,0.19985,0.95649,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE,0.99999
WP_PYRIMIDINE_METABOLISM_AND...,SET,19,-0.32463,-0.010437,0.18966,0.9565,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,0.99999
chr1p31,SET,77,-0.31773,-0.020533,0.18562,0.95652,chr1p31,0.99999
MIR15A_5P,SET,535,-0.062169,-0.010456,0.03632,0.95652,MIR15A_5P,0.99999
WP_OXIDATIVE_DAMAGE_RESPONSE,SET,36,-0.23854,-0.010552,0.13934,0.95653,WP_OXIDATIVE_DAMAGE_RESPONSE,0.99999
MIR6838_5P,SET,489,-0.064889,-0.010448,0.037904,0.95654,MIR6838_5P,0.99999
GOBP_NEPHRIC_DUCT_DEVELOPMENT,SET,14,-0.41635,-0.011492,0.24316,0.95657,GOBP_NEPHRIC_DUCT_DEVELOPMENT,0.99999
GOBP_TRANS_SYNAPTIC_SIGNALIN...3,SET,7,-0.60562,-0.011823,0.35362,0.9566,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_TRANS_SYNAPTIC_COMPLEX,0.99999
MCLACHLAN_DENTAL_CARIES_DN,SET,70,-0.18225,-0.011231,0.10639,0.95663,MCLACHLAN_DENTAL_CARIES_DN,0.99999
CBX5_TARGET_GENES,SET,592,-0.060463,-0.01068,0.035297,0.95663,CBX5_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...28,SET,9,-0.50078,-0.011084,0.29235,0.95663,GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,0.99999
KEGG_MEDICUS_REFERENCE_TNF_R...,SET,7,-0.52645,-0.010277,0.30727,0.95666,KEGG_MEDICUS_REFERENCE_TNF_RIPK1_3_SIGNALING_PATHWAY,0.99999
MIR1206,SET,105,-0.14047,-0.010592,0.081979,0.95668,MIR1206,0.99999
GOBP_HEART_GROWTH,SET,76,-0.18031,-0.011576,0.10517,0.95677,GOBP_HEART_GROWTH,0.99999
GOBP_MITOCHONDRIAL_FISSION,SET,37,-0.25372,-0.011378,0.14798,0.95678,GOBP_MITOCHONDRIAL_FISSION,0.99999
GSE6092_UNSTIM_VS_IFNG_STIM_...2,SET,179,-0.10654,-0.010468,0.062124,0.95682,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,0.99999
REACTOME_IRS_MEDIATED_SIGNAL...,SET,47,-0.21631,-0.01093,0.12611,0.95684,REACTOME_IRS_MEDIATED_SIGNALLING,0.99999
GOMF_CARBONATE_DEHYDRATASE_A...,SET,14,-0.41213,-0.011376,0.24028,0.95684,GOMF_CARBONATE_DEHYDRATASE_ACTIVITY,0.99999
HAY_BONE_MARROW_CD34_POS_MKP,SET,54,-0.2142,-0.011599,0.12488,0.95684,HAY_BONE_MARROW_CD34_POS_MKP,0.99999
NR1H4_TARGET_GENES,SET,328,-0.080503,-0.010663,0.046932,0.95685,NR1H4_TARGET_GENES,0.99999
GOMF_RNA_POLYMERASE_II_CTD_H...3,SET,7,-0.49991,-0.0097591,0.29142,0.95686,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_PHOSPHATASE_ACTIVITY,0.99999
HP_ABNORMAL_CIRCULATING_INTE...3,SET,31,-0.27986,-0.011489,0.16312,0.95687,HP_ABNORMAL_CIRCULATING_INTERLEUKIN_CONCENTRATION,0.99999
REACTOME_PROCESSING_OF_CAPPE...2,SET,255,-0.080943,-0.0094725,0.047177,0.95689,REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,0.99999
GSE18893_TCONV_VS_TREG_2H_TN...1,SET,174,-0.11014,-0.010671,0.064187,0.95691,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN,0.99999
GSE27434_WT_VS_DNMT1_KO_TREG...1,SET,182,-0.11101,-0.010998,0.064694,0.95691,GSE27434_WT_VS_DNMT1_KO_TREG_DN,0.99999
GOMF_SUMO_TRANSFERASE_ACTIVI...,SET,24,-0.3087,-0.011153,0.17989,0.95692,GOMF_SUMO_TRANSFERASE_ACTIVITY,0.99999
MIR7974,SET,80,-0.16379,-0.010788,0.095392,0.957,MIR7974,0.99999
GOBP_MIGRACYTOSIS,SET,5,-0.77133,-0.012727,0.44923,0.957,GOBP_MIGRACYTOSIS,0.99999
GOBP_TELOMERE_MAINTENANCE_VI...1,SET,14,-0.35999,-0.0099366,0.20967,0.957,GOBP_TELOMERE_MAINTENANCE_VIA_RECOMBINATION,0.99999
CHUANG_OXIDATIVE_STRESS_RESP...2,SET,26,-0.29405,-0.011057,0.17123,0.95703,CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,0.99999
HP_OBSTRUCTIVE_SLEEP_APNEA,SET,72,-0.17333,-0.010833,0.10093,0.95703,HP_OBSTRUCTIVE_SLEEP_APNEA,0.99999
HP_ABNORMAL_OVARIAN_PHYSIOLO...,SET,87,-0.14919,-0.010245,0.086863,0.95705,HP_ABNORMAL_OVARIAN_PHYSIOLOGY,0.99999
HP_DECREASED_CIRCULATING_CAR...,SET,22,-0.28253,-0.0097739,0.16448,0.95706,HP_DECREASED_CIRCULATING_CARNITINE_CONCENTRATION,0.99999
HP_ABNORMALITY_OF_THE_PROTEI...,SET,13,-0.35203,-0.0093638,0.20493,0.95708,HP_ABNORMALITY_OF_THE_PROTEIN_C_ANTICOAGULANT_PATHWAY,0.99999
GRAHAM_CML_DIVIDING_VS_NORMA...2,SET,9,-0.49301,-0.010912,0.28697,0.95709,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP,0.99999
MIR3119,SET,341,-0.080371,-0.010851,0.046782,0.95709,MIR3119,0.99999
REACTOME_TNFR1_INDUCED_PROAP...,SET,23,-0.30159,-0.010667,0.17554,0.9571,REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING,0.99999
GSE14308_TH1_VS_INDUCED_TREG...2,SET,180,-0.10529,-0.010374,0.061287,0.9571,GSE14308_TH1_VS_INDUCED_TREG_UP,0.99999
FARMER_BREAST_CANCER_CLUSTER...7,SET,19,-0.32593,-0.010479,0.18969,0.95711,FARMER_BREAST_CANCER_CLUSTER_7,0.99999
FURUKAWA_DUSP6_TARGETS_PCI35...2,SET,61,-0.19807,-0.011398,0.11527,0.95713,FURUKAWA_DUSP6_TARGETS_PCI35_UP,0.99999
GSE3982_BASOPHIL_VS_TH1_UP,SET,179,-0.10723,-0.010536,0.062395,0.95715,GSE3982_BASOPHIL_VS_TH1_UP,0.99999
MIR502_5P,SET,68,-0.17499,-0.01063,0.10179,0.9572,MIR502_5P,0.99999
GOBP_PARENTAL_BEHAVIOR,SET,13,-0.47572,-0.012654,0.27669,0.95721,GOBP_PARENTAL_BEHAVIOR,0.99999
GOBP_KYNURENINE_METABOLIC_PR...,SET,9,-0.55363,-0.012254,0.322,0.95722,GOBP_KYNURENINE_METABOLIC_PROCESS,0.99999
MIR2113,SET,234,-0.096817,-0.01086,0.056302,0.95724,MIR2113,0.99999
NRL_DN.V1_UP,SET,130,-0.12748,-0.010689,0.074122,0.95726,NRL_DN.V1_UP,0.99999
HP_PROXIMAL_PLACEMENT_OF_THU...,SET,34,-0.24668,-0.010606,0.14342,0.95727,HP_PROXIMAL_PLACEMENT_OF_THUMB,0.99999
chr2p16,SET,35,-0.37679,-0.016435,0.21906,0.95728,chr2p16,0.99999
MIR7702,SET,50,-0.19594,-0.010211,0.11391,0.95728,MIR7702,0.99999
REACTOME_ACTIVATION_OF_PPARG...,SET,10,-0.46605,-0.010873,0.27085,0.95733,REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION,0.99999
MOREAUX_B_LYMPHOCYTE_MATURAT...2,SET,72,-0.18108,-0.011317,0.10523,0.95735,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,0.99999
HP_CYCLOPIA,SET,19,-0.32879,-0.010571,0.19101,0.95739,HP_CYCLOPIA,0.99999
HP_DYSTROPHIC_FINGERNAILS,SET,25,-0.27497,-0.010139,0.15974,0.95739,HP_DYSTROPHIC_FINGERNAILS,0.99999
THAKAR_PBMC_INACTIVATED_INFL...12,SET,5,-0.57649,-0.0095119,0.33478,0.95746,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_VS_21_30YO_0DY_UP,0.99999
HP_SHORT_STERNUM,SET,10,-0.4724,-0.011022,0.2743,0.95747,HP_SHORT_STERNUM,0.99999
ZHONG_RESPONSE_TO_AZACITIDIN...1,SET,58,-0.17635,-0.009896,0.1024,0.95748,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,0.99999
GOMF_GLUTAMATE_SODIUM_SYMPOR...,SET,5,-0.74503,-0.012293,0.43254,0.9575,GOMF_GLUTAMATE_SODIUM_SYMPORTER_ACTIVITY,0.99999
HP_MACRODONTIA,SET,27,-0.28145,-0.010785,0.16339,0.9575,HP_MACRODONTIA,0.99999
DESCARTES_FETAL_STOMACH_MUC1...,SET,81,-0.17142,-0.01136,0.099454,0.9576,DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS,0.99999
REACTOME_CELLULAR_RESPONSE_T...2,SET,95,-0.14209,-0.010194,0.082417,0.95764,REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,0.99999
GOBP_RESPONSE_TO_INTERLEUKIN...7,SET,9,-0.59257,-0.013116,0.3436,0.95769,GOBP_RESPONSE_TO_INTERLEUKIN_2,0.99999
GOBP_POSITIVE_REGULATION_OF_...394,SET,8,-0.5646,-0.011783,0.32731,0.95772,GOBP_POSITIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,0.99999
HP_SELF_MUTILATION,SET,39,-0.2288,-0.010534,0.1326,0.95777,HP_SELF_MUTILATION,0.99999
HP_FLUCTUATIONS_IN_CONSCIOUS...,SET,6,-0.67445,-0.01219,0.39059,0.95788,HP_FLUCTUATIONS_IN_CONSCIOUSNESS,0.99999
GOBP_MUSCLE_ATROPHY,SET,11,-0.42229,-0.010333,0.24448,0.95793,GOBP_MUSCLE_ATROPHY,0.99999
KEGG_MEDICUS_REFERENCE_ACH_C...1,SET,7,-0.52589,-0.010266,0.30442,0.95795,KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY,0.99999
HP_IMPULSIVITY,SET,128,-0.1319,-0.010975,0.076358,0.95795,HP_IMPULSIVITY,0.99999
GSE39820_TGFBETA1_VS_TGFBETA...2,SET,185,-0.10387,-0.010374,0.06013,0.95795,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP,0.99999
EN1_01,SET,98,-0.15527,-0.011313,0.089866,0.95798,EN1_01,0.99999
TONG_INTERACT_WITH_PTTG1,SET,51,-0.18979,-0.0099886,0.10979,0.95805,TONG_INTERACT_WITH_PTTG1,0.99999
GOBP_REGULATION_OF_L_GLUTAMA...,SET,8,-0.5121,-0.010687,0.29615,0.9581,GOBP_REGULATION_OF_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GSE16450_CTRL_VS_IFNA_6H_STI...3,SET,176,-0.10473,-0.010205,0.060564,0.95811,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,0.99999
HP_BULBAR_PALSY,SET,39,-0.21955,-0.010108,0.12694,0.95813,HP_BULBAR_PALSY,0.99999
GOCC_EXTRINSIC_COMPONENT_OF_...2,SET,167,-0.11894,-0.011292,0.068731,0.95822,GOCC_EXTRINSIC_COMPONENT_OF_MEMBRANE,0.99999
WP_STATIN_INHIBITION_OF_CHOL...,SET,26,-0.30199,-0.011356,0.17447,0.95826,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,0.99999
GOBP_REGULATION_OF_CELL_CHEM...,SET,5,-0.70454,-0.011625,0.40697,0.95828,GOBP_REGULATION_OF_CELL_CHEMOTAXIS_TO_FIBROBLAST_GROWTH_FACTOR,0.99999
GOBP_POSITIVE_REGULATION_OF_...68,SET,14,-0.39714,-0.010962,0.22937,0.95831,GOBP_POSITIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,0.99999
GOCC_TRANSCRIPTION_FACTOR_TF...5,SET,17,-0.30294,-0.0092136,0.17495,0.95832,GOCC_TRANSCRIPTION_FACTOR_TFTC_COMPLEX,0.99999
HP_ELEVATED_SERUM_ANION_GAP,SET,4,-0.74408,-0.010981,0.42971,0.95832,HP_ELEVATED_SERUM_ANION_GAP,0.99999
GSE17721_CTRL_VS_LPS_12H_BMD...2,SET,173,-0.10639,-0.010278,0.06143,0.95834,GSE17721_CTRL_VS_LPS_12H_BMDC_UP,0.99999
PEDERSEN_TARGETS_OF_611CTF_I...,SET,68,-0.19116,-0.011612,0.11037,0.95835,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,0.99999
HP_SOLITARY_MEDIAN_MAXILLARY...,SET,22,-0.28728,-0.0099383,0.16586,0.95836,HP_SOLITARY_MEDIAN_MAXILLARY_CENTRAL_INCISOR,0.99999
BIOCARTA_EFP_PATHWAY,SET,16,-0.34305,-0.010122,0.19804,0.95837,BIOCARTA_EFP_PATHWAY,0.99999
LI_PBMC_MENACTRA_AGE_18_45YO...6,SET,25,-0.32532,-0.011996,0.1878,0.95837,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_NEGATIVE,0.99999
BIOCARTA_MTA3_PATHWAY,SET,17,-0.3448,-0.010487,0.19905,0.95838,BIOCARTA_MTA3_PATHWAY,0.99999
ZNF677_TARGET_GENES,SET,128,-0.13186,-0.010971,0.076114,0.95839,ZNF677_TARGET_GENES,0.99999
GSE360_L_DONOVANI_VS_T_GONDI...3,SET,184,-0.10265,-0.010224,0.059244,0.95841,GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN,0.99999
HP_PLAGIOCEPHALY,SET,134,-0.12267,-0.010442,0.070792,0.95843,HP_PLAGIOCEPHALY,0.99999
DESCARTES_MAIN_FETAL_HEMATOP...,SET,38,-0.22117,-0.010051,0.12759,0.95848,DESCARTES_MAIN_FETAL_HEMATOPOIETIC_STEM_CELLS,0.99999
GOBP_NEUROTRANSMITTER_RECEPT...4,SET,9,-0.53177,-0.01177,0.30674,0.9585,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_ENDOSOME_TO_POSTSYNAPTIC_MEMBRANE,0.99999
HP_LICHENIFICATION,SET,15,-0.37439,-0.010697,0.21591,0.95854,HP_LICHENIFICATION,0.99999
MIR6798_5P,SET,41,-0.22502,-0.010621,0.1297,0.95862,MIR6798_5P,0.99999
GSE37532_WT_VS_PPARG_KO_VISC...1,SET,180,-0.10514,-0.010359,0.060593,0.95863,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN,0.99999
HP_VISUAL_FIELD_DEFECT,SET,256,-0.090779,-0.010644,0.05231,0.95866,HP_VISUAL_FIELD_DEFECT,0.99999
HP_ABNORMALITY_OF_TASTE_SENS...,SET,5,-0.66617,-0.010992,0.38382,0.95868,HP_ABNORMALITY_OF_TASTE_SENSATION,0.99999
HP_DELAYED_CLOSURE_OF_THE_AN...,SET,29,-0.25702,-0.010206,0.14806,0.9587,HP_DELAYED_CLOSURE_OF_THE_ANTERIOR_FONTANELLE,0.99999
GSE17974_CTRL_VS_ACT_IL4_AND...1,SET,167,-0.10732,-0.010189,0.061827,0.9587,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN,0.99999
REACTOME_TRANSCRIPTION_OF_TH...,SET,62,-0.1583,-0.0091832,0.091186,0.95871,REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME,0.99999
REACTOME_UREA_CYCLE,SET,9,-0.46559,-0.010306,0.26817,0.95873,REACTOME_UREA_CYCLE,0.99999
GOBP_PHOSPHATIDYLGLYCEROL_ME...,SET,32,-0.27692,-0.011551,0.15949,0.95874,GOBP_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_GHR...2,SET,376,-0.078191,-0.011074,0.045033,0.95874,HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL,0.99999
GOMF_NADPLUS_PROTEIN_ARGININ...,SET,6,-0.63004,-0.011387,0.36283,0.95875,GOMF_NADPLUS_PROTEIN_ARGININE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.99999
GSE22886_NAIVE_BCELL_VS_BLOO...1,SET,175,-0.10765,-0.01046,0.061968,0.95882,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN,0.99999
GOMF_UBIQUITIN_LIKE_PROTEIN_...2,SET,36,-0.24014,-0.010623,0.1382,0.95886,GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY,0.99999
HP_ABNORMAL_ERYTHROID_LINEAG...,SET,6,-0.62589,-0.011312,0.35998,0.95895,HP_ABNORMAL_ERYTHROID_LINEAGE_CELL_MORPHOLOGY,0.99999
GSE360_DC_VS_MAC_T_GONDII_DN,SET,180,-0.10995,-0.010833,0.06324,0.95895,GSE360_DC_VS_MAC_T_GONDII_DN,0.99999
FUJII_YBX1_TARGETS_DN,SET,183,-0.10672,-0.010601,0.061364,0.95898,FUJII_YBX1_TARGETS_DN,0.99999
GOCC_RIPOPTOSOME,SET,6,-0.72468,-0.013098,0.4165,0.95906,GOCC_RIPOPTOSOME,0.99999
HP_BILATERAL_MICROPHTHALMOS,SET,19,-0.31035,-0.0099784,0.17834,0.95908,HP_BILATERAL_MICROPHTHALMOS,0.99999
WP_NANOMATERIAL_INDUCED_APOP...,SET,19,-0.33088,-0.010638,0.19012,0.9591,WP_NANOMATERIAL_INDUCED_APOPTOSIS,0.99999
HP_CAPILLARY_HEMANGIOMA,SET,37,-0.25094,-0.011253,0.14417,0.95912,HP_CAPILLARY_HEMANGIOMA,0.99999
HOLLERN_MICROACINAR_BREAST_T...1,SET,14,-0.40392,-0.011149,0.23203,0.95913,HOLLERN_MICROACINAR_BREAST_TUMOR_DN,0.99999
HALLMARK_GLYCOLYSIS,SET,182,-0.1065,-0.01055,0.061164,0.95916,HALLMARK_GLYCOLYSIS,0.99999
BARX2_TARGET_GENES,SET,1489,-0.03905,-0.01066,0.022425,0.95918,BARX2_TARGET_GENES,0.99999
LEE_LIVER_CANCER_MYC_UP,SET,49,-0.20797,-0.010729,0.11942,0.95919,LEE_LIVER_CANCER_MYC_UP,0.99999
MIR15B_5P,SET,532,-0.063465,-0.010645,0.036444,0.95919,MIR15B_5P,0.99999
MORF_DAP,SET,69,-0.16405,-0.010038,0.094206,0.95919,MORF_DAP,0.99999
GSE41867_DAY6_VS_DAY15_LCMV_...4,SET,147,-0.12682,-0.011302,0.072801,0.95923,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.99999
GSE29617_CTRL_VS_DAY7_TIV_FL...2,SET,170,-0.12438,-0.011913,0.071399,0.95924,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,0.99999
MODULE_143,SET,12,-0.46573,-0.011903,0.26734,0.95925,MODULE_143,0.99999
GOBP_V_D_J_RECOMBINATION,SET,17,-0.31424,-0.0095572,0.18028,0.95933,GOBP_V_D_J_RECOMBINATION,0.99999
CAGTGTT_MIR141_MIR200A,SET,288,-0.086694,-0.010772,0.04973,0.95935,CAGTGTT_MIR141_MIR200A,0.99999
WP_BURN_WOUND_HEALING,SET,95,-0.1638,-0.011752,0.093958,0.95936,WP_BURN_WOUND_HEALING,0.99999
HP_DESQUAMATION_OF_SKIN_SOON...,SET,11,-0.44177,-0.01081,0.25331,0.95941,HP_DESQUAMATION_OF_SKIN_SOON_AFTER_BIRTH,0.99999
GOCC_DENDRITIC_SPINE_HEAD,SET,7,-0.58782,-0.011475,0.33703,0.95942,GOCC_DENDRITIC_SPINE_HEAD,0.99999
OLF1_01,SET,242,-0.095294,-0.010868,0.054612,0.95949,OLF1_01,0.99999
GOBP_MITOCHONDRIAL_GENOME_MA...,SET,29,-0.25549,-0.010146,0.14641,0.9595,GOBP_MITOCHONDRIAL_GENOME_MAINTENANCE,0.99999
GSE2585_THYMIC_MACROPHAGE_VS...1,SET,165,-0.11443,-0.010798,0.065576,0.9595,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_DN,0.99999
GOBP_SPERMIDINE_METABOLIC_PR...,SET,6,-0.53398,-0.0096511,0.30598,0.95951,GOBP_SPERMIDINE_METABOLIC_PROCESS,0.99999
HP_STATUS_EPILEPTICUS_WITHOU...,SET,24,-0.29518,-0.010665,0.16914,0.95951,HP_STATUS_EPILEPTICUS_WITHOUT_PROMINENT_MOTOR_SYMPTOMS,0.99999
BIOCARTA_AKAP13_PATHWAY,SET,11,-0.44654,-0.010926,0.25585,0.95952,BIOCARTA_AKAP13_PATHWAY,0.99999
HP_BRADYPHRENIA,SET,5,-0.58305,-0.0096202,0.33404,0.95954,HP_BRADYPHRENIA,0.99999
HP_HYPOLIPIDEMIA,SET,10,-0.46262,-0.010793,0.26496,0.95958,HP_HYPOLIPIDEMIA,0.99999
GOBP_LUNG_SECRETORY_CELL_DIF...,SET,11,-0.47212,-0.011552,0.27038,0.9596,GOBP_LUNG_SECRETORY_CELL_DIFFERENTIATION,0.99999
GOMF_LYSOPHOSPHOLIPASE_ACTIV...,SET,26,-0.28837,-0.010844,0.16514,0.9596,GOMF_LYSOPHOSPHOLIPASE_ACTIVITY,0.99999
HP_ASTERIXIS,SET,5,-0.7243,-0.011951,0.41474,0.95962,HP_ASTERIXIS,0.99999
HP_LONG_NASAL_BRIDGE,SET,4,-0.72638,-0.01072,0.41587,0.95964,HP_LONG_NASAL_BRIDGE,0.99999
DAZARD_RESPONSE_TO_UV_NHEK_DN,SET,283,-0.087944,-0.010834,0.050344,0.95966,DAZARD_RESPONSE_TO_UV_NHEK_DN,0.99999
GOBP_THERMOCEPTION,SET,8,-0.57063,-0.011909,0.32665,0.95967,GOBP_THERMOCEPTION,0.99999
GOCC_NEURON_TO_NEURON_SYNAPSE,SET,338,-0.082005,-0.011023,0.046932,0.9597,GOCC_NEURON_TO_NEURON_SYNAPSE,0.99999
GOBP_RESPONSE_TO_FOOD,SET,35,-0.26194,-0.011425,0.14987,0.95973,GOBP_RESPONSE_TO_FOOD,0.99999
GOCC_CELL_TIP,SET,7,-0.5702,-0.011131,0.32622,0.95975,GOCC_CELL_TIP,0.99999
BAHD1_TARGET_GENES,SET,18,-0.33161,-0.010378,0.18968,0.95978,BAHD1_TARGET_GENES,0.99999
GRASEMANN_RETINOBLASTOMA_WIT...,SET,14,-0.38535,-0.010637,0.22042,0.95979,GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION,0.99999
GOBP_REGULATION_OF_RESPONSE_...7,SET,29,-0.28438,-0.011293,0.16261,0.95983,GOBP_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS,0.99999
GOMF_SIALIC_ACID_BINDING,SET,20,-0.38866,-0.01282,0.22225,0.95983,GOMF_SIALIC_ACID_BINDING,0.99999
GOMF_SODIUM_CHANNEL_INHIBITO...,SET,8,-0.59631,-0.012444,0.34095,0.95984,GOMF_SODIUM_CHANNEL_INHIBITOR_ACTIVITY,0.99999
MIR3909,SET,68,-0.18114,-0.011003,0.10355,0.95986,MIR3909,0.99999
HP_ABNORMALITY_OF_SOMATOSENS...,SET,14,-0.40444,-0.011164,0.23111,0.95993,HP_ABNORMALITY_OF_SOMATOSENSORY_EVOKED_POTENTIALS,0.99999
HP_INCREASED_URINE_PROTEINOG...,SET,10,-0.42907,-0.010011,0.24509,0.95999,HP_INCREASED_URINE_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_LEVEL,0.99999
RSRFC4_01,SET,219,-0.10347,-0.011233,0.059084,0.96004,RSRFC4_01,0.99999
GOBP_NEURAL_PLATE_PATTERN_SP...,SET,7,-0.5838,-0.011397,0.33336,0.96004,GOBP_NEURAL_PLATE_PATTERN_SPECIFICATION,0.99999
GAO_SMALL_INTESTINE_24W_C9_E...,SET,42,-0.23916,-0.011425,0.13656,0.96004,GAO_SMALL_INTESTINE_24W_C9_ENTEROENDOCRINE_CELL,0.99999
WP_LEPTININSULIN_SIGNALING_O...,SET,16,-0.41721,-0.01231,0.23813,0.9601,WP_LEPTININSULIN_SIGNALING_OVERLAP,0.99999
HP_HYPOINSULINEMIA,SET,21,-0.33972,-0.011483,0.19392,0.9601,HP_HYPOINSULINEMIA,0.99999
MIR3201,SET,74,-0.16503,-0.010456,0.094183,0.96013,MIR3201,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...2,SET,5,-0.68694,-0.011334,0.39197,0.96015,GOBP_CELLULAR_RESPONSE_TO_INDOLE_3_METHANOL,0.99999
HP_ABNORMAL_COCCYX_MORPHOLOGY,SET,8,-0.60544,-0.012635,0.3454,0.96018,HP_ABNORMAL_COCCYX_MORPHOLOGY,0.99999
GOBP_REGULATION_OF_CYSTEINE_...1,SET,176,-0.11339,-0.011048,0.064668,0.96022,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.99999
GOCC_PHOTORECEPTOR_RIBBON_SY...,SET,9,-0.54099,-0.011974,0.30851,0.96024,GOCC_PHOTORECEPTOR_RIBBON_SYNAPSE,0.99999
GSE21927_EL4_VS_MCA203_TUMOR...1,SET,153,-0.11843,-0.010766,0.067522,0.96027,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_DN,0.99999
GOBP_SPINAL_CORD_MOTOR_NEURO...2,SET,27,-0.3007,-0.011523,0.17138,0.96033,GOBP_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION,0.99999
GSE9988_ANTI_TREM1_VS_VEHICL...1,SET,183,-0.10759,-0.010687,0.061314,0.96033,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN,0.99999
HP_ABNORMALITY_OF_THE_COSTOC...,SET,17,-0.38994,-0.01186,0.22218,0.96037,HP_ABNORMALITY_OF_THE_COSTOCHONDRAL_JUNCTION,0.99999
GSE39820_CTRL_VS_IL1B_IL6_IL...2,SET,180,-0.11034,-0.010872,0.062861,0.96039,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP,0.99999
WP_6Q16_COPY_NUMBER_VARIATION,SET,14,-0.4157,-0.011474,0.23681,0.9604,WP_6Q16_COPY_NUMBER_VARIATION,0.99999
GOBP_REGULATION_OF_INTEGRIN_...2,SET,3,-0.97386,-0.012447,0.55477,0.9604,GOBP_REGULATION_OF_INTEGRIN_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_BLOOD_CIR...,SET,240,-0.10294,-0.011692,0.058637,0.96041,GOBP_REGULATION_OF_BLOOD_CIRCULATION,0.99999
DUTTA_APOPTOSIS_VIA_NFKB,SET,32,-0.27153,-0.011326,0.15466,0.96042,DUTTA_APOPTOSIS_VIA_NFKB,0.99999
GOMF_SIRNA_BINDING,SET,7,-0.58869,-0.011492,0.33525,0.96044,GOMF_SIRNA_BINDING,0.99999
MIR491_5P,SET,97,-0.14705,-0.01066,0.083736,0.96046,MIR491_5P,0.99999
REACTOME_RHOF_GTPASE_CYCLE,SET,39,-0.24147,-0.011117,0.1375,0.96047,REACTOME_RHOF_GTPASE_CYCLE,0.99999
GOBP_ORGANONITROGEN_COMPOUND...2,SET,1305,-0.041928,-0.010773,0.023872,0.96048,GOBP_ORGANONITROGEN_COMPOUND_CATABOLIC_PROCESS,0.99999
FREAC4_01,SET,134,-0.13817,-0.01176,0.07863,0.96055,FREAC4_01,0.99999
BIOCARTA_FAS_PATHWAY,SET,30,-0.27522,-0.011116,0.15661,0.96056,BIOCARTA_FAS_PATHWAY,0.99999
HP_CHRONIC_CONSTIPATION,SET,90,-0.15525,-0.010842,0.088339,0.96056,HP_CHRONIC_CONSTIPATION,0.99999
GSE13485_DAY1_VS_DAY7_YF17D_...2,SET,140,-0.12971,-0.011283,0.073793,0.9606,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...208,SET,13,-0.39632,-0.010542,0.22545,0.96061,GOBP_POSITIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...629,SET,8,-0.43621,-0.0091033,0.24813,0.96062,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_CAPPING,0.99999
KEGG_MEDICUS_ENV_FACTOR_META...1,SET,8,-0.58041,-0.012113,0.32989,0.96074,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY,0.99999
GOBP_ENERGY_RESERVE_METABOLI...,SET,85,-0.16084,-0.010918,0.091396,0.96077,GOBP_ENERGY_RESERVE_METABOLIC_PROCESS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...64,SET,10,-0.43209,-0.010081,0.24552,0.96078,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,0.99999
GSE3982_DC_VS_CENT_MEMORY_CD...2,SET,186,-0.10956,-0.010971,0.062252,0.96078,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
LI_PBMC_MENACTRA_AGE_18_45YO...9,SET,53,-0.23258,-0.012478,0.13212,0.96082,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE,0.99999
MIR299_3P,SET,50,-0.20124,-0.010487,0.11431,0.96083,MIR299_3P,0.99999
GOBP_PHOSPHOLIPID_METABOLIC_...,SET,340,-0.079336,-0.010696,0.045064,0.96083,GOBP_PHOSPHOLIPID_METABOLIC_PROCESS,0.99999
GOBP_PROTEIN_REFOLDING,SET,24,-0.29669,-0.01072,0.16853,0.96083,GOBP_PROTEIN_REFOLDING,0.99999
REACTOME_CALCITONIN_LIKE_LIG...,SET,9,-0.57402,-0.012705,0.32603,0.96084,REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS,0.99999
MIR10398_5P,SET,70,-0.17488,-0.010777,0.099324,0.96085,MIR10398_5P,0.99999
HP_ANKYLOBLEPHARON,SET,13,-0.37091,-0.009866,0.21062,0.96088,HP_ANKYLOBLEPHARON,0.99999
HP_CONGENITAL_CONTRACTURE,SET,156,-0.11824,-0.010852,0.067116,0.96093,HP_CONGENITAL_CONTRACTURE,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_MES...3,SET,156,-0.12864,-0.011807,0.073006,0.96096,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL,0.99999
MIR433_5P,SET,7,-0.54402,-0.01062,0.30866,0.961,MIR433_5P,0.99999
BIOCARTA_CERAMIDE_PATHWAY,SET,20,-0.34383,-0.011342,0.19501,0.96105,BIOCARTA_CERAMIDE_PATHWAY,0.99999
LIU_TOPBP1_TARGETS,SET,12,-0.4469,-0.011421,0.25343,0.96108,LIU_TOPBP1_TARGETS,0.99999
GOBP_FATTY_ACYL_COA_BIOSYNTH...,SET,25,-0.31797,-0.011725,0.18032,0.96108,GOBP_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS,0.99999
GSE15659_TREG_VS_TCONV_DN,SET,149,-0.1249,-0.011205,0.070815,0.9611,GSE15659_TREG_VS_TCONV_DN,0.99999
BIOCARTA_GHRELIN_PATHWAY,SET,13,-0.49257,-0.013102,0.27923,0.96113,BIOCARTA_GHRELIN_PATHWAY,0.99999
BRCA2_TARGET_GENES,SET,1258,-0.043327,-0.010945,0.024559,0.96114,BRCA2_TARGET_GENES,0.99999
GOBP_POLYOL_CATABOLIC_PROCESS,SET,8,-0.60836,-0.012696,0.3448,0.96116,GOBP_POLYOL_CATABOLIC_PROCESS,0.99999
HP_AORTIC_VALVE_STENOSIS,SET,51,-0.21238,-0.011178,0.12036,0.96117,HP_AORTIC_VALVE_STENOSIS,0.99999
ATF2_S_UP.V1_UP,SET,174,-0.11957,-0.011585,0.067757,0.96118,ATF2_S_UP.V1_UP,0.99999
MIR6889_3P,SET,100,-0.15214,-0.011197,0.086201,0.9612,MIR6889_3P,0.99999
GAO_STOMACH_24W_C1_PROCRPOS_...,SET,37,-0.22946,-0.01029,0.12997,0.96126,GAO_STOMACH_24W_C1_PROCRPOS_MULTIPOTENT_PROGENITOR,0.99999
GOBP_ADP_BIOSYNTHETIC_PROCESS,SET,5,-0.76275,-0.012585,0.43199,0.96127,GOBP_ADP_BIOSYNTHETIC_PROCESS,0.99999
DESCARTES_MAIN_FETAL_THYMIC_...,SET,139,-0.12779,-0.011077,0.072376,0.96127,DESCARTES_MAIN_FETAL_THYMIC_EPITHELIAL_CELLS,0.99999
HP_FREQUENT_TEMPER_TANTRUMS,SET,8,-0.49858,-0.010405,0.28233,0.96129,HP_FREQUENT_TEMPER_TANTRUMS,0.99999
HOLLEMAN_PREDNISOLONE_RESIST...1,SET,11,-0.43415,-0.010623,0.24571,0.96137,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN,0.99999
GOBP_PLASMA_LIPOPROTEIN_PART...,SET,37,-0.25842,-0.011589,0.14625,0.96137,GOBP_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
KEGG_MEDICUS_REFERENCE_MGLUR...2,SET,20,-0.32642,-0.010767,0.1847,0.9614,KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.99999
NABA_MATRISOME_HIGHLY_METAST...4,SET,12,-0.44823,-0.011455,0.25361,0.96141,NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED,0.99999
GOBP_GLAND_DEVELOPMENT,SET,427,-0.076621,-0.011548,0.043342,0.96145,GOBP_GLAND_DEVELOPMENT,0.99999
GOCC_SEPTIN_CYTOSKELETON,SET,2,-0.95407,-0.0099569,0.5396,0.96147,GOCC_SEPTIN_CYTOSKELETON,0.99999
GSE7548_NAIVE_VS_DAY28_PCC_I...1,SET,172,-0.11522,-0.011099,0.065152,0.9615,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,0.99999
HP_ABNORMAL_BLISTERING_OF_TH...,SET,103,-0.15194,-0.011348,0.085906,0.96151,HP_ABNORMAL_BLISTERING_OF_THE_SKIN,0.99999
MIKKELSEN_ES_ICP_WITH_H3K27M...,SET,41,-0.24225,-0.011435,0.13696,0.96153,MIKKELSEN_ES_ICP_WITH_H3K27ME3,0.99999
chr17q23,SET,51,-0.35179,-0.018515,0.19886,0.96155,chr17q23,0.99999
GOBP_NEGATIVE_REGULATION_OF_...404,SET,5,-0.77854,-0.012846,0.44007,0.96155,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,0.99999
GOBP_OTOLITH_MORPHOGENESIS,SET,5,-0.71727,-0.011835,0.40539,0.96157,GOBP_OTOLITH_MORPHOGENESIS,0.99999
MIR3180_5P,SET,288,-0.08801,-0.010936,0.049739,0.96158,MIR3180_5P,0.99999
GOBP_REGULATION_OF_SARCOMERE...,SET,8,-0.52465,-0.010949,0.29648,0.96159,GOBP_REGULATION_OF_SARCOMERE_ORGANIZATION,0.99999
MIR615_3P,SET,6,-0.5858,-0.010588,0.33102,0.9616,MIR615_3P,0.99999
MCAATNNNNNGCG_UNKNOWN,SET,74,-0.18165,-0.011509,0.10265,0.9616,MCAATNNNNNGCG_UNKNOWN,0.99999
JI_RESPONSE_TO_FSH_DN,SET,49,-0.21095,-0.010883,0.11919,0.96162,JI_RESPONSE_TO_FSH_DN,0.99999
GOBP_MEMBRANE_DOCKING,SET,83,-0.15803,-0.010601,0.089267,0.96165,GOBP_MEMBRANE_DOCKING,0.99999
CACTGCC_MIR34A_MIR34C_MIR449,SET,258,-0.089916,-0.010583,0.050781,0.96168,CACTGCC_MIR34A_MIR34C_MIR449,0.99999
GOBP_PTERIDINE_CONTAINING_CO...2,SET,33,-0.24252,-0.010272,0.13697,0.96168,GOBP_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GOBP_ACETYLCHOLINE_SECRETION,SET,5,-0.64656,-0.010668,0.36512,0.9617,GOBP_ACETYLCHOLINE_SECRETION,0.99999
MORF_HAT1,SET,153,-0.10865,-0.0098766,0.06135,0.96171,MORF_HAT1,0.99999
GSE21670_TGFB_VS_IL6_TREATED...4,SET,188,-0.10963,-0.011036,0.061884,0.96175,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.99999
HP_INCOMPREHENSIBLE_SPEECH,SET,8,-0.48519,-0.010125,0.27382,0.96179,HP_INCOMPREHENSIBLE_SPEECH,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...24,SET,25,-0.28964,-0.01068,0.16341,0.96183,GOBP_PROTEIN_LOCALIZATION_TO_ENDOSOME,0.99999
GOBP_NEGATIVE_REGULATION_OF_...266,SET,17,-0.36985,-0.011249,0.20862,0.96186,GOBP_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY,0.99999
GOMF_CELL_ADHESIVE_PROTEIN_B...,SET,5,-0.78914,-0.013021,0.4451,0.96187,GOMF_CELL_ADHESIVE_PROTEIN_BINDING_INVOLVED_IN_BUNDLE_OF_HIS_CELL_PURKINJE_MYOCYTE_COMMUNICATION,0.99999
GOBP_POLYAMINE_METABOLIC_PRO...,SET,15,-0.34825,-0.0099498,0.19635,0.96193,GOBP_POLYAMINE_METABOLIC_PROCESS,0.99999
HP_CONGENITAL_ICHTHYOSIFORM_...,SET,27,-0.29891,-0.011454,0.16848,0.96197,HP_CONGENITAL_ICHTHYOSIFORM_ERYTHRODERMA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...242,SET,16,-0.41484,-0.012241,0.23381,0.96198,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
DESCARTES_FETAL_EYE_AMACRINE...,SET,7,-0.5667,-0.011063,0.31934,0.96201,DESCARTES_FETAL_EYE_AMACRINE_CELLS,0.99999
SILIGAN_TARGETS_OF_EWS_FLI1_...1,SET,17,-0.35898,-0.010918,0.20227,0.96203,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN,0.99999
GOCC_CELL_CELL_CONTACT_ZONE,SET,68,-0.18836,-0.011442,0.10611,0.96205,GOCC_CELL_CELL_CONTACT_ZONE,0.99999
GOBP_HIGH_DENSITY_LIPOPROTEI...2,SET,9,-0.50225,-0.011117,0.28288,0.96208,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
GOBP_REGULATION_OF_ACTOMYOSI...,SET,94,-0.1549,-0.011055,0.087221,0.96212,GOBP_REGULATION_OF_ACTOMYOSIN_STRUCTURE_ORGANIZATION,0.99999
GOBP_REGULATION_OF_APOPTOTIC...3,SET,11,-0.53134,-0.013001,0.29917,0.96213,GOBP_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.99999
TURASHVILI_BREAST_DUCTAL_CAR...4,SET,71,-0.1773,-0.011004,0.099821,0.96214,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,0.99999
GOMF_ADENYLATE_KINASE_ACTIVI...,SET,9,-0.51638,-0.01143,0.29067,0.96217,GOMF_ADENYLATE_KINASE_ACTIVITY,0.99999
GOBP_NEUROTRANSMITTER_SECRET...,SET,135,-0.12754,-0.010896,0.071784,0.96219,GOBP_NEUROTRANSMITTER_SECRETION,0.99999
GOBP_REGULATION_OF_GLIAL_CEL...1,SET,12,-0.44753,-0.011437,0.25186,0.9622,GOBP_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS,0.99999
HP_DROWSINESS,SET,52,-0.20243,-0.010757,0.11393,0.9622,HP_DROWSINESS,0.99999
DESCARTES_FETAL_STOMACH_STRO...,SET,42,-0.24978,-0.011933,0.14056,0.96221,DESCARTES_FETAL_STOMACH_STROMAL_CELLS,0.99999
WP_NOCGMPPKG_MEDIATED_NEUROP...,SET,41,-0.24034,-0.011345,0.13523,0.96223,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,0.99999
WILLIAMS_ESR2_TARGETS_UP,SET,25,-0.28607,-0.010549,0.16095,0.96224,WILLIAMS_ESR2_TARGETS_UP,0.99999
REACTOME_SODIUM_COUPLED_PHOS...,SET,5,-0.73773,-0.012172,0.41502,0.96225,REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS,0.99999
KIM_ALL_DISORDERS_DURATION_C...1,SET,131,-0.12187,-0.010257,0.068547,0.96228,KIM_ALL_DISORDERS_DURATION_CORR_DN,0.99999
GOBP_PROTEIN_ACYLATION,SET,83,-0.15722,-0.010547,0.088433,0.96228,GOBP_PROTEIN_ACYLATION,0.99999
MIR186_5P,SET,507,-0.067913,-0.011128,0.038189,0.96232,MIR186_5P,0.99999
REACTOME_ASPARTATE_AND_ASPAR...,SET,11,-0.44063,-0.010782,0.24773,0.96234,REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM,0.99999
GOBP_VITAMIN_D_METABOLIC_PRO...,SET,21,-0.32964,-0.011142,0.18534,0.96234,GOBP_VITAMIN_D_METABOLIC_PROCESS,0.99999
HP_INCREASED_FEMORAL_ANTEVER...,SET,4,-0.63803,-0.0094163,0.35867,0.96236,HP_INCREASED_FEMORAL_ANTEVERSION,0.99999
HP_ARTERIAL_DISSECTION,SET,12,-0.50041,-0.012789,0.28125,0.96239,HP_ARTERIAL_DISSECTION,0.99999
HP_ATONIC_SEIZURE,SET,87,-0.15946,-0.010951,0.08962,0.9624,HP_ATONIC_SEIZURE,0.99999
GOBP_REGULATION_OF_SMOOTH_MU...3,SET,56,-0.21011,-0.011586,0.11806,0.96243,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,0.99999
GAZDA_DIAMOND_BLACKFAN_ANEMI...4,SET,27,-0.28838,-0.01105,0.16203,0.96244,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...292,SET,7,-0.64385,-0.012569,0.36172,0.96245,GOBP_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_MUC...,SET,48,-0.2361,-0.012056,0.13264,0.96245,HE_LIM_SUN_FETAL_LUNG_C1_MUC5AC_POS_ASCL1_POS_PROGENITOR_CELL,0.99999
MIR466,SET,372,-0.078245,-0.011024,0.04394,0.96251,MIR466,0.99999
GOBP_MODULATION_BY_VIRUS_OF_...,SET,3,-0.86822,-0.011097,0.48758,0.96251,GOBP_MODULATION_BY_VIRUS_OF_HOST_PROCESS,0.99999
RSRFC4_Q2,SET,195,-0.11072,-0.011349,0.062168,0.96253,RSRFC4_Q2,0.99999
HP_SUBCORTICAL_CEREBRAL_ATRO...,SET,25,-0.30673,-0.011311,0.17223,0.96253,HP_SUBCORTICAL_CEREBRAL_ATROPHY,0.99999
MODULE_407,SET,13,-0.45993,-0.012234,0.25802,0.96266,MODULE_407,0.99999
HP_APRAXIA,SET,190,-0.10277,-0.0104,0.057653,0.96266,HP_APRAXIA,0.99999
HP_ABNORMALITY_OF_TIBIAL_EPI...,SET,4,-0.85566,-0.012628,0.47988,0.96271,HP_ABNORMALITY_OF_TIBIAL_EPIPHYSES,0.99999
GOBP_ANTIGEN_PROCESSING_AND_...13,SET,30,-0.31168,-0.012588,0.17478,0.96272,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,0.99999
HP_INTERSTITIAL_PNEUMONITIS,SET,15,-0.4082,-0.011663,0.22891,0.96272,HP_INTERSTITIAL_PNEUMONITIS,0.99999
HP_HYPERTYROSINEMIA,SET,6,-0.65942,-0.011918,0.36968,0.96276,HP_HYPERTYROSINEMIA,0.99999
GOBP_REGULATION_OF_MUSCLE_SY...,SET,215,-0.10775,-0.011591,0.060385,0.96281,GOBP_REGULATION_OF_MUSCLE_SYSTEM_PROCESS,0.99999
GOMF_FIBROBLAST_GROWTH_FACTO...3,SET,24,-0.34155,-0.01234,0.19141,0.96281,GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,0.99999
GOMF_SEQUENCE_SPECIFIC_SINGL...,SET,12,-0.38834,-0.0099247,0.21763,0.96281,GOMF_SEQUENCE_SPECIFIC_SINGLE_STRANDED_DNA_BINDING,0.99999
KORKOLA_CHORIOCARCINOMA_UP,SET,3,-0.97724,-0.01249,0.54763,0.96282,KORKOLA_CHORIOCARCINOMA_UP,0.99999
WP_INDUCTION_OF_AUTOPHAGY_AN...,SET,11,-0.43299,-0.010595,0.24264,0.96282,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,0.99999
GNF2_TIMP2,SET,39,-0.26578,-0.012236,0.14894,0.96282,GNF2_TIMP2,0.99999
GOBP_PHARYNGEAL_ARCH_ARTERY_...,SET,9,-0.56727,-0.012556,0.31782,0.96285,GOBP_PHARYNGEAL_ARCH_ARTERY_MORPHOGENESIS,0.99999
REACTOME_SIGNALING_BY_BMP,SET,28,-0.28978,-0.011308,0.16234,0.96286,REACTOME_SIGNALING_BY_BMP,0.99999
chr1p35,SET,77,-0.33814,-0.021852,0.18942,0.96288,chr1p35,0.99999
GOBP_CARDIOLIPIN_METABOLIC_P...,SET,13,-0.46218,-0.012294,0.25884,0.96291,GOBP_CARDIOLIPIN_METABOLIC_PROCESS,0.99999
GSE17721_0.5H_VS_24H_POLYIC_...2,SET,183,-0.10946,-0.010873,0.061285,0.96294,GSE17721_0.5H_VS_24H_POLYIC_BMDC_UP,0.99999
GSE20366_EX_VIVO_VS_HOMEOSTA...1,SET,182,-0.11453,-0.011346,0.064124,0.96294,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN,0.99999
IIZUKA_LIVER_CANCER_PROGRESS...7,SET,8,-0.49117,-0.01025,0.27496,0.96297,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN,0.99999
COLIN_PILOCYTIC_ASTROCYTOMA_...2,SET,33,-0.27918,-0.011825,0.15628,0.96298,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,0.99999
GSE21380_NON_TFH_VS_TFH_CD4_...1,SET,180,-0.11331,-0.011164,0.063407,0.96303,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...654,SET,5,-0.71903,-0.011864,0.40229,0.96305,GOBP_NEGATIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,0.99999
MURAKAMI_UV_RESPONSE_1HR_UP,SET,14,-0.3984,-0.010997,0.22289,0.96306,MURAKAMI_UV_RESPONSE_1HR_UP,0.99999
GOBP_PROSTATIC_BUD_FORMATION,SET,7,-0.69484,-0.013565,0.38866,0.96309,GOBP_PROSTATIC_BUD_FORMATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...146,SET,83,-0.15872,-0.010648,0.088754,0.96313,GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,0.99999
REACTOME_NEUREXINS_AND_NEURO...,SET,51,-0.21995,-0.011576,0.12298,0.96314,REACTOME_NEUREXINS_AND_NEUROLIGINS,0.99999
GOBP_FOREBRAIN_CELL_MIGRATION,SET,59,-0.2138,-0.0121,0.11953,0.96315,GOBP_FOREBRAIN_CELL_MIGRATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...205,SET,145,-0.1314,-0.011631,0.073442,0.9632,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,0.99999
GOBP_ESTABLISHMENT_OF_EPITHE...1,SET,16,-0.38093,-0.01124,0.21287,0.96322,GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY,0.99999
GOBP_REGULATION_OF_BILE_ACID...3,SET,5,-0.64939,-0.010715,0.36279,0.96326,GOBP_REGULATION_OF_BILE_ACID_SECRETION,0.99999
KHETCHOUMIAN_TRIM24_TARGETS_...1,SET,7,-0.61708,-0.012046,0.34473,0.96327,KHETCHOUMIAN_TRIM24_TARGETS_DN,0.99999
GOBP_BRANCHING_INVOLVED_IN_S...,SET,22,-0.33276,-0.011512,0.18586,0.96329,GOBP_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,0.99999
GOBP_CARDIAC_VENTRICLE_MORPH...,SET,68,-0.20497,-0.012451,0.11445,0.96334,GOBP_CARDIAC_VENTRICLE_MORPHOGENESIS,0.99999
GOBP_NAD_BIOSYNTHESIS_VIA_NI...,SET,9,-0.51771,-0.011459,0.28892,0.96342,GOBP_NAD_BIOSYNTHESIS_VIA_NICOTINAMIDE_RIBOSIDE_SALVAGE_PATHWAY,0.99999
GSE17721_CTRL_VS_CPG_12H_BMD...1,SET,184,-0.10993,-0.01095,0.06135,0.96342,GSE17721_CTRL_VS_CPG_12H_BMDC_DN,0.99999
GOBP_PYRUVATE_TRANSPORT,SET,7,-0.6157,-0.012019,0.34352,0.96345,GOBP_PYRUVATE_TRANSPORT,0.99999
GOBP_POSITIVE_REGULATION_OF_...151,SET,5,-0.68302,-0.01127,0.38105,0.96346,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,0.99999
HP_CHORIORETINAL_HYPOPIGMENT...,SET,10,-0.51277,-0.011963,0.28606,0.96346,HP_CHORIORETINAL_HYPOPIGMENTATION,0.99999
MORF_PPP5C,SET,87,-0.14805,-0.010167,0.08259,0.96348,MORF_PPP5C,0.99999
GSE17721_CTRL_VS_GARDIQUIMOD...4,SET,179,-0.11046,-0.010853,0.061578,0.96357,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_UP,0.99999
MIR6836_3P,SET,53,-0.20773,-0.011145,0.11579,0.96359,MIR6836_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...497,SET,4,-0.86919,-0.012828,0.48425,0.96366,GOBP_POSITIVE_REGULATION_OF_MUSCLE_ADAPTATION,0.99999
GOBP_REGULATION_OF_NITRIC_OX...3,SET,20,-0.34017,-0.011221,0.18951,0.96366,GOBP_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,0.99999
GSE17721_POLYIC_VS_CPG_4H_BM...1,SET,184,-0.11017,-0.010974,0.061372,0.96368,GSE17721_POLYIC_VS_CPG_4H_BMDC_DN,0.99999
JI_METASTASIS_REPRESSED_BY_S...,SET,24,-0.34696,-0.012536,0.19319,0.96374,JI_METASTASIS_REPRESSED_BY_STK11,0.99999
GSE12392_WT_VS_IFNB_KO_CD8A_...2,SET,185,-0.10843,-0.010829,0.06037,0.96375,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP,0.99999
GOMF_OPIOID_RECEPTOR_BINDING,SET,7,-0.64591,-0.012609,0.35959,0.96376,GOMF_OPIOID_RECEPTOR_BINDING,0.99999
HP_ABNORMAL_BLOOD_GLUCOSE_CO...,SET,285,-0.08929,-0.011038,0.049704,0.96378,HP_ABNORMAL_BLOOD_GLUCOSE_CONCENTRATION,0.99999
HP_STILLBIRTH,SET,28,-0.28867,-0.011264,0.16067,0.96379,HP_STILLBIRTH,0.99999
GOBP_ERYTHROSE_4_PHOSPHATE_P...,SET,17,-0.39789,-0.012102,0.22142,0.96382,GOBP_ERYTHROSE_4_PHOSPHATE_PHOSPHOENOLPYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.99999
HP_USUAL_INTERSTITIAL_PNEUMO...,SET,13,-0.42703,-0.011359,0.23765,0.96382,HP_USUAL_INTERSTITIAL_PNEUMONIA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...280,SET,64,-0.2044,-0.012046,0.11373,0.96385,GOBP_NEGATIVE_REGULATION_OF_HORMONE_SECRETION,0.99999
HP_FIBROADENOMA_OF_THE_BREAST,SET,11,-0.45821,-0.011212,0.2549,0.96387,HP_FIBROADENOMA_OF_THE_BREAST,0.99999
MIR6774_3P,SET,5,-0.81066,-0.013376,0.45094,0.96388,MIR6774_3P,0.99999
MODULE_106,SET,14,-0.43347,-0.011965,0.24109,0.9639,MODULE_106,0.99999
GSE1925_3H_VS_24H_IFNG_STIM_...1,SET,187,-0.10787,-0.010831,0.059991,0.96391,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,0.99999
REACTOME_REGULATION_OF_PTEN_...4,SET,65,-0.17107,-0.010161,0.095103,0.96397,REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,0.99999
GOCC_RNA_POLYMERASE_II_HOLOE...,SET,67,-0.1678,-0.010118,0.093281,0.96397,GOCC_RNA_POLYMERASE_II_HOLOENZYME,0.99999
PID_FAS_PATHWAY,SET,36,-0.26491,-0.011719,0.14725,0.96398,PID_FAS_PATHWAY,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...15,SET,182,-0.11413,-0.011306,0.063417,0.96404,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_DN,0.99999
BANG_VERTEPORFIN_ENDOMETRIAL...1,SET,13,-0.37996,-0.010107,0.2111,0.96405,BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_DN,0.99999
GOBP_REGULATION_OF_MITOCHOND...5,SET,27,-0.31123,-0.011926,0.17291,0.96406,GOBP_REGULATION_OF_MITOCHONDRIAL_FISSION,0.99999
WOO_LIVER_CANCER_RECURRENCE_...1,SET,74,-0.18041,-0.01143,0.10021,0.96408,WOO_LIVER_CANCER_RECURRENCE_DN,0.99999
MIR2355_3P,SET,97,-0.16094,-0.011667,0.089388,0.9641,MIR2355_3P,0.99999
GOCC_ORGANELLE_MEMBRANE_CONT...,SET,39,-0.23882,-0.010995,0.13259,0.96415,GOCC_ORGANELLE_MEMBRANE_CONTACT_SITE,0.99999
RICKMAN_HEAD_AND_NECK_CANCER...4,SET,30,-0.31729,-0.012815,0.17613,0.96418,RICKMAN_HEAD_AND_NECK_CANCER_D,0.99999
GOMF_MONOATOMIC_ANION_CHANNE...,SET,88,-0.17838,-0.01232,0.09899,0.96422,GOMF_MONOATOMIC_ANION_CHANNEL_ACTIVITY,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...4,SET,62,-0.1883,-0.010923,0.10447,0.96425,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_CELL,0.99999
KRAS.600_UP.V1_DN,SET,254,-0.10097,-0.011793,0.056013,0.96426,KRAS.600_UP.V1_DN,0.99999
GOMF_3_5_CYCLIC_AMP_PHOSPHOD...,SET,22,-0.3386,-0.011714,0.18782,0.96428,GOMF_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_ANTIMICRO...1,SET,11,-0.49373,-0.012081,0.27386,0.96429,GOBP_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE,0.99999
GSE8621_LPS_STIM_VS_LPS_PRIM...2,SET,185,-0.11336,-0.011322,0.062865,0.96432,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,0.99999
HP_DEATH_IN_CHILDHOOD,SET,111,-0.13825,-0.010717,0.076657,0.96434,HP_DEATH_IN_CHILDHOOD,0.99999
MIKI_COEXPRESSED_WITH_CYP19A1,SET,7,-0.57474,-0.01122,0.31854,0.9644,MIKI_COEXPRESSED_WITH_CYP19A1,0.99999
HP_ASYMMETRY_OF_SPINAL_FACET...,SET,4,-0.82996,-0.012249,0.45999,0.9644,HP_ASYMMETRY_OF_SPINAL_FACET_JOINTS,0.99999
DAZARD_UV_RESPONSE_CLUSTER_G5,SET,8,-0.41027,-0.008562,0.22733,0.96443,DAZARD_UV_RESPONSE_CLUSTER_G5,0.99999
GSE17721_0.5H_VS_24H_GARDIQU...1,SET,184,-0.10571,-0.010529,0.058569,0.96445,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_DN,0.99999
GOBP_REGULATION_OF_PLATELET_...3,SET,5,-0.69613,-0.011486,0.38564,0.96446,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_ALPHA_SIGNALING_PATHWAY,0.99999
GOBP_LOW_DENSITY_LIPOPROTEIN...2,SET,15,-0.4229,-0.012083,0.23427,0.96447,GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,0.99999
DESCARTES_FETAL_PANCREAS_DUC...,SET,96,-0.1671,-0.012051,0.092483,0.9646,DESCARTES_FETAL_PANCREAS_DUCTAL_CELLS,0.99999
GOBP_REGULATION_OF_PIGMENT_C...,SET,8,-0.62762,-0.013098,0.34731,0.96462,GOBP_REGULATION_OF_PIGMENT_CELL_DIFFERENTIATION,0.99999
MODULE_295,SET,19,-0.34241,-0.011009,0.18945,0.96464,MODULE_295,0.99999
REACTOME_TRANSCRIPTIONAL_REG...9,SET,337,-0.078753,-0.010571,0.043566,0.96466,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,0.99999
GOBP_INTERNAL_PROTEIN_AMINO_...,SET,10,-0.40512,-0.0094519,0.22409,0.96467,GOBP_INTERNAL_PROTEIN_AMINO_ACID_ACETYLATION,0.99999
GOBP_CGMP_MEDIATED_SIGNALING,SET,25,-0.31642,-0.011668,0.17502,0.96468,GOBP_CGMP_MEDIATED_SIGNALING,0.99999
GCM_SUPT4H1,SET,52,-0.19855,-0.010551,0.10977,0.96475,GCM_SUPT4H1,0.99999
GSE17186_MEMORY_VS_CD21HIGH_...1,SET,187,-0.11497,-0.011544,0.063562,0.96475,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,0.99999
GOCC_ADHERENS_JUNCTION,SET,170,-0.12347,-0.011826,0.068237,0.9648,GOCC_ADHERENS_JUNCTION,0.99999
HP_CONTRACTURE_OF_THE_PROXIM...2,SET,5,-0.6542,-0.010794,0.36153,0.96481,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_4TH_FINGER,0.99999
MIR2355_5P,SET,118,-0.1358,-0.010852,0.075021,0.96486,MIR2355_5P,0.99999
HP_ABNORMAL_CONJUNCTIVA_MORP...,SET,150,-0.12232,-0.011011,0.067568,0.96487,HP_ABNORMAL_CONJUNCTIVA_MORPHOLOGY,0.99999
chr19q13,SET,714,-0.13896,-0.026864,0.076725,0.96493,chr19q13,0.99999
REACTOME_PI_3K_CASCADE_FGFR2,SET,22,-0.34523,-0.011943,0.19059,0.96495,REACTOME_PI_3K_CASCADE_FGFR2,0.99999
HP_ALOPECIA_UNIVERSALIS,SET,11,-0.51212,-0.012531,0.28272,0.96495,HP_ALOPECIA_UNIVERSALIS,0.99999
MIR570_3P,SET,686,-0.059976,-0.011374,0.033109,0.96496,MIR570_3P,0.99999
HP_PROLONGED_QRS_COMPLEX,SET,6,-0.71444,-0.012913,0.39439,0.96496,HP_PROLONGED_QRS_COMPLEX,0.99999
GOBP_REGULATION_OF_CARDIOCYT...,SET,25,-0.30856,-0.011378,0.17031,0.96498,GOBP_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,0.99999
CUI_DEVELOPING_HEART_COMPACT...1,SET,15,-0.40653,-0.011615,0.22427,0.96505,CUI_DEVELOPING_HEART_COMPACT_ATRIAL_CARDIOMYOCYTE,0.99999
TERAO_AOX4_TARGETS_SKIN_DN,SET,17,-0.37789,-0.011493,0.20842,0.96508,TERAO_AOX4_TARGETS_SKIN_DN,0.99999
REACTOME_DEFENSINS,SET,32,-0.36578,-0.015257,0.20175,0.96508,REACTOME_DEFENSINS,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...5,SET,6,-0.77238,-0.01396,0.426,0.96508,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_NOREPINEPHRINE_EPINEPHRINE,0.99999
HP_CEREBELLAR_CYST,SET,138,-0.12336,-0.010654,0.06802,0.96512,HP_CEREBELLAR_CYST,0.99999
chr1q32,SET,139,-0.27974,-0.024248,0.15423,0.96514,chr1q32,0.99999
HP_SEVERE_PHOTOSENSITIVITY,SET,5,-0.5387,-0.0088885,0.29691,0.96518,HP_SEVERE_PHOTOSENSITIVITY,0.99999
GSE17721_CPG_VS_GARDIQUIMOD_...8,SET,190,-0.10796,-0.010925,0.0595,0.96518,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_UP,0.99999
GOMF_DIHYDROPYRIMIDINASE_ACT...,SET,6,-0.65843,-0.0119,0.36278,0.96523,GOMF_DIHYDROPYRIMIDINASE_ACTIVITY,0.99999
ZHAN_MULTIPLE_MYELOMA_CD1_VS...2,SET,60,-0.20514,-0.011708,0.11301,0.96524,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,0.99999
GOMF_CGMP_BINDING,SET,15,-0.39334,-0.011238,0.21659,0.96531,GOMF_CGMP_BINDING,0.99999
GOMF_PHOSPHOLIPASE_ACTIVITY,SET,101,-0.15212,-0.011251,0.083761,0.96531,GOMF_PHOSPHOLIPASE_ACTIVITY,0.99999
GAVIN_IL2_RESPONSIVE_FOXP3_T...1,SET,5,-0.6649,-0.010971,0.36601,0.96535,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN,0.99999
GOBP_MRNA_METABOLIC_PROCESS,SET,641,-0.056778,-0.010422,0.031255,0.96535,GOBP_MRNA_METABOLIC_PROCESS,0.99999
KUROZUMI_RESPONSE_TO_ONCOCYT...2,SET,20,-0.37415,-0.012342,0.20588,0.96541,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,0.99999
MIR4426,SET,133,-0.1345,-0.011406,0.074001,0.96543,MIR4426,0.99999
NUYTTEN_NIPP1_TARGETS_UP,SET,665,-0.060481,-0.0113,0.033259,0.9655,NUYTTEN_NIPP1_TARGETS_UP,0.99999
MIR9900,SET,40,-0.25439,-0.01186,0.13984,0.96554,MIR9900,0.99999
KEGG_MEDICUS_REFERENCE_FASLG...,SET,5,-0.74669,-0.01232,0.41039,0.96557,KEGG_MEDICUS_REFERENCE_FASLG_RIPK1_3_SIGNALING_PATHWAY,0.99999
GNF2_HPN,SET,127,-0.13775,-0.011416,0.075676,0.96563,GNF2_HPN,0.99999
HP_ABNORMAL_SEXUAL_BEHAVIOR,SET,7,-0.5556,-0.010846,0.30519,0.96565,HP_ABNORMAL_SEXUAL_BEHAVIOR,0.99999
SMAD3_Q6,SET,213,-0.10876,-0.011646,0.059718,0.96571,SMAD3_Q6,0.99999
MIR548F_3P,SET,434,-0.074441,-0.011309,0.040867,0.96573,MIR548F_3P,0.99999
EGR2_01,SET,179,-0.11564,-0.011362,0.063469,0.96577,EGR2_01,0.99999
DCA_UP.V1_UP,SET,161,-0.12428,-0.011587,0.068209,0.96577,DCA_UP.V1_UP,0.99999
GOBP_PROTEIN_TRIMERIZATION,SET,17,-0.37369,-0.011366,0.20495,0.96586,GOBP_PROTEIN_TRIMERIZATION,0.99999
GOCC_NEURON_SPINE,SET,167,-0.12358,-0.011732,0.067767,0.96588,GOCC_NEURON_SPINE,0.99999
KEGG_MEDICUS_REFERENCE_PKR_E...,SET,7,-0.53257,-0.010397,0.29198,0.96592,KEGG_MEDICUS_REFERENCE_PKR_EIF2ALPHA_SIGNALING_PATHWAY,0.99999
MIR2116_3P,SET,68,-0.18975,-0.011526,0.10403,0.96592,MIR2116_3P,0.99999
HP_ABNORMAL_FETAL_GENITOURIN...,SET,11,-0.47725,-0.011678,0.26162,0.96593,HP_ABNORMAL_FETAL_GENITOURINARY_SYSTEM_MORPHOLOGY,0.99999
GOBP_TRIGLYCERIDE_METABOLIC_...,SET,93,-0.1631,-0.011578,0.089364,0.966,GOBP_TRIGLYCERIDE_METABOLIC_PROCESS,0.99999
GOMF_CALCIUM_DEPENDENT_CYSTE...,SET,15,-0.41868,-0.011962,0.22923,0.9661,GOMF_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.99999
GOBP_RESPONSE_TO_AMINO_ACID_...,SET,50,-0.21644,-0.01128,0.11847,0.96614,GOBP_RESPONSE_TO_AMINO_ACID_STARVATION,0.99999
HU_FETAL_RETINA_BIPOLAR,SET,79,-0.18603,-0.012176,0.10181,0.96615,HU_FETAL_RETINA_BIPOLAR,0.99999
WP_PANCREATIC_CANCER_SUBTYPES,SET,46,-0.2524,-0.012617,0.13811,0.96618,WP_PANCREATIC_CANCER_SUBTYPES,0.99999
GOMF_VOLTAGE_GATED_SODIUM_CH...2,SET,5,-0.787,-0.012985,0.43064,0.96618,GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...50,SET,6,-0.66917,-0.012095,0.36605,0.96622,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM,0.99999
GOBP_POSITIVE_REGULATION_OF_...450,SET,11,-0.49939,-0.01222,0.27318,0.96622,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_POTENTIAL,0.99999
GOBP_POSITIVE_REGULATION_OF_...564,SET,41,-0.26382,-0.012453,0.14429,0.96624,GOBP_POSITIVE_REGULATION_OF_ORGAN_GROWTH,0.99999
HP_HYPOPLASTIC_ACETABULAE,SET,5,-0.73459,-0.01212,0.40177,0.96624,HP_HYPOPLASTIC_ACETABULAE,0.99999
GSE1791_CTRL_VS_NEUROMEDINU_...8,SET,175,-0.11554,-0.011226,0.063183,0.96626,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP,0.99999
WP_FAMILIAL_HYPERLIPIDEMIA_T...3,SET,12,-0.47307,-0.01209,0.25864,0.9663,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,0.99999
HP_PANHYPOPITUITARISM,SET,25,-0.29119,-0.010738,0.15916,0.96633,HP_PANHYPOPITUITARISM,0.99999
MIR548BC,SET,433,-0.074686,-0.011333,0.040814,0.96636,MIR548BC,0.99999
GOBP_SIGNAL_RELEASE,SET,456,-0.074977,-0.011668,0.040954,0.96642,GOBP_SIGNAL_RELEASE,0.99999
LEE_TARGETS_OF_PTCH1_AND_SUF...1,SET,80,-0.17771,-0.011705,0.097044,0.96646,LEE_TARGETS_OF_PTCH1_AND_SUFU_DN,0.99999
WATANABE_RECTAL_CANCER_RADIO...2,SET,96,-0.14393,-0.01038,0.078597,0.96646,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,0.99999
GSE5589_LPS_AND_IL10_VS_LPS_...6,SET,180,-0.10839,-0.010679,0.059174,0.96649,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,0.99999
GOBP_REGULATION_OF_SYNAPTIC_...6,SET,70,-0.19736,-0.012163,0.10773,0.96652,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,0.99999
HP_HYPERTRICHOSIS,SET,234,-0.098324,-0.011029,0.053668,0.96652,HP_HYPERTRICHOSIS,0.99999
REACTOME_LIPOPHAGY,SET,9,-0.4992,-0.011049,0.27238,0.96657,REACTOME_LIPOPHAGY,0.99999
BUSSLINGER_DUODENAL_BCHE_CEL...,SET,39,-0.26498,-0.012199,0.14456,0.96659,BUSSLINGER_DUODENAL_BCHE_CELLS,0.99999
GOBP_G_PROTEIN_COUPLED_RECEP...2,SET,1095,-0.055745,-0.013201,0.03039,0.96669,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOCC_HIPPOCAMPAL_MOSSY_FIBER,SET,6,-0.57477,-0.010388,0.31331,0.9667,GOCC_HIPPOCAMPAL_MOSSY_FIBER,0.99999
KAYO_AGING_MUSCLE_UP,SET,208,-0.10636,-0.011256,0.057972,0.96671,KAYO_AGING_MUSCLE_UP,0.99999
CDX1_TARGET_GENES,SET,35,-0.27292,-0.011904,0.14877,0.96671,CDX1_TARGET_GENES,0.99999
BAE_BRCA1_TARGETS_UP,SET,60,-0.19847,-0.011327,0.10818,0.96672,BAE_BRCA1_TARGETS_UP,0.99999
HP_MODERATE_GLOBAL_DEVELOPME...,SET,22,-0.31385,-0.010857,0.17106,0.96672,HP_MODERATE_GLOBAL_DEVELOPMENTAL_DELAY,0.99999
GOBP_REGULATION_OF_PEPTIDYL_...2,SET,10,-0.48933,-0.011417,0.26668,0.96673,GOBP_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION,0.99999
GOMF_LIGASE_ACTIVITY_FORMING...2,SET,45,-0.22636,-0.011192,0.12334,0.96675,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS,0.99999
HP_BONE_MARROW_HYPOCELLULARI...,SET,64,-0.18619,-0.010973,0.10143,0.96678,HP_BONE_MARROW_HYPOCELLULARITY,0.99999
SP1_Q4_01,SET,231,-0.10012,-0.011159,0.054508,0.96687,SP1_Q4_01,0.99999
GOMF_SULFUR_AMINO_ACID_TRANS...,SET,11,-0.44318,-0.010844,0.24124,0.96689,GOMF_SULFUR_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
GOBP_VENTRICULAR_COMPACT_MYO...,SET,7,-0.6535,-0.012758,0.35571,0.9669,GOBP_VENTRICULAR_COMPACT_MYOCARDIUM_MORPHOGENESIS,0.99999
BUSSLINGER_DUODENAL_MX_CELLS,SET,10,-0.49578,-0.011567,0.26984,0.96691,BUSSLINGER_DUODENAL_MX_CELLS,0.99999
HP_ORTHOKERATOTIC_HYPERKERAT...,SET,7,-0.58472,-0.011415,0.31821,0.96693,HP_ORTHOKERATOTIC_HYPERKERATOSIS,0.99999
GOBP_L_ASPARTATE_IMPORT_ACRO...,SET,6,-0.70177,-0.012684,0.38181,0.96696,GOBP_L_ASPARTATE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.99999
GOBP_POSTSYNAPTIC_NEUROTRANS...,SET,26,-0.29499,-0.011093,0.16047,0.96698,GOBP_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,0.99999
GSE3982_CTRL_VS_IGE_STIM_MAS...2,SET,183,-0.11171,-0.011097,0.06077,0.96698,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP,0.99999
MORF_DMPK,SET,153,-0.12683,-0.011529,0.068979,0.96701,MORF_DMPK,0.99999
NFKB_Q6_01,SET,221,-0.10448,-0.011393,0.056817,0.96703,NFKB_Q6_01,0.99999
GOMF_POTASSIUM_ION_BINDING,SET,13,-0.44128,-0.011738,0.23997,0.96703,GOMF_POTASSIUM_ION_BINDING,0.99999
MASSARWEH_TAMOXIFEN_RESISTAN...1,SET,212,-0.1117,-0.011933,0.060728,0.96706,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,0.99999
MIR556_3P,SET,129,-0.13444,-0.011229,0.073086,0.96707,MIR556_3P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...510,SET,33,-0.24818,-0.010512,0.13491,0.96708,GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
GOMF_HEPARAN_SULFATE_BINDING,SET,7,-0.61812,-0.012067,0.336,0.96708,GOMF_HEPARAN_SULFATE_BINDING,0.99999
REACTOME_HIV_TRANSCRIPTION_I...,SET,43,-0.20846,-0.010076,0.11329,0.96712,REACTOME_HIV_TRANSCRIPTION_INITIATION,0.99999
MIR3135A,SET,30,-0.27181,-0.010978,0.14768,0.96715,MIR3135A,0.99999
GGCACAT_MIR455,SET,54,-0.20662,-0.011189,0.11226,0.96715,GGCACAT_MIR455,0.99999
GOMF_RIBOSOMAL_PROTEIN_S6_KI...,SET,5,-0.65336,-0.01078,0.35494,0.96716,GOMF_RIBOSOMAL_PROTEIN_S6_KINASE_ACTIVITY,0.99999
BRUNO_HEMATOPOIESIS,SET,61,-0.20647,-0.011881,0.11214,0.96719,BRUNO_HEMATOPOIESIS,0.99999
GOBP_THIOESTER_BIOSYNTHETIC_...,SET,41,-0.25271,-0.011928,0.13726,0.96719,GOBP_THIOESTER_BIOSYNTHETIC_PROCESS,0.99999
GSE2770_UNTREATED_VS_IL12_TR...1,SET,172,-0.11364,-0.010947,0.061691,0.96726,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.99999
GOBP_FATTY_ACID_DERIVATIVE_B...,SET,43,-0.25486,-0.012319,0.13834,0.96728,GOBP_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_REGULATION_OF_LUTEINIZI...,SET,7,-0.66417,-0.012966,0.36045,0.9673,GOBP_REGULATION_OF_LUTEINIZING_HORMONE_SECRETION,0.99999
WIKMAN_ASBESTOS_LUNG_CANCER_...1,SET,28,-0.28696,-0.011197,0.15572,0.96731,WIKMAN_ASBESTOS_LUNG_CANCER_DN,0.99999
GOMF_POLY_G_BINDING,SET,7,-0.56025,-0.010937,0.304,0.96732,GOMF_POLY_G_BINDING,0.99999
GOCC_DEATH_INDUCING_SIGNALIN...,SET,9,-0.56528,-0.012512,0.30669,0.96734,GOCC_DEATH_INDUCING_SIGNALING_COMPLEX,0.99999
MIR17_3P,SET,121,-0.14397,-0.011649,0.078103,0.96735,MIR17_3P,0.99999
REACTOME_HSF1_DEPENDENT_TRAN...,SET,36,-0.26027,-0.011513,0.14117,0.96738,REACTOME_HSF1_DEPENDENT_TRANSACTIVATION,0.99999
GSE42021_TCONV_PLN_VS_TREG_P...2,SET,180,-0.11609,-0.011438,0.062956,0.9674,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...242,SET,96,-0.16455,-0.011867,0.089229,0.96741,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,0.99999
MIR4666A_5P,SET,226,-0.10341,-0.011402,0.05606,0.96745,MIR4666A_5P,0.99999
GOBP_NEURON_CELL_CELL_ADHESI...,SET,13,-0.46318,-0.01232,0.25103,0.96748,GOBP_NEURON_CELL_CELL_ADHESION,0.99999
WP_FAMILIAL_HYPERLIPIDEMIA_T...4,SET,21,-0.34013,-0.011496,0.18433,0.96749,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,0.99999
KIM_BIPOLAR_DISORDER_OLIGODE...2,SET,597,-0.061252,-0.010864,0.033192,0.9675,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP,0.99999
GOBP_EXPORT_FROM_CELL,SET,833,-0.056325,-0.011722,0.030516,0.96753,GOBP_EXPORT_FROM_CELL,0.99999
GOCC_AMINOACYL_TRNA_SYNTHETA...,SET,3,-0.7009,-0.0089584,0.37971,0.96754,GOCC_AMINOACYL_TRNA_SYNTHETASE_MULTIENZYME_COMPLEX,0.99999
REACTOME_PROTEIN_UBIQUITINAT...,SET,57,-0.2016,-0.011215,0.10915,0.96762,REACTOME_PROTEIN_UBIQUITINATION,0.99999
GOBP_REGULATION_OF_RHO_PROTE...,SET,79,-0.17823,-0.011666,0.096472,0.96765,GOBP_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
HP_TRANSIENT_NEONATAL_DIABET...,SET,15,-0.42033,-0.012009,0.22747,0.96768,HP_TRANSIENT_NEONATAL_DIABETES_MELLITUS,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...19,SET,11,-0.46399,-0.011353,0.25107,0.96769,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_MITOCHOND...14,SET,6,-0.56988,-0.0103,0.30839,0.96769,GOBP_REGULATION_OF_MITOCHONDRIAL_TRANSCRIPTION,0.99999
HP_UTERINE_PROLAPSE,SET,6,-0.73306,-0.013249,0.39654,0.96774,HP_UTERINE_PROLAPSE,0.99999
REACTOME_CHYLOMICRON_REMODEL...,SET,8,-0.70052,-0.014619,0.37875,0.9678,REACTOME_CHYLOMICRON_REMODELING,0.99999
ZHAN_MULTIPLE_MYELOMA_PR_UP,SET,41,-0.24389,-0.011512,0.13174,0.96793,ZHAN_MULTIPLE_MYELOMA_PR_UP,0.99999
GSE27291_0H_VS_6H_STIM_GAMMA...2,SET,152,-0.12264,-0.011112,0.066201,0.96802,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP,0.99999
COREBINDINGFACTOR_Q6,SET,247,-0.10266,-0.011827,0.055413,0.96803,COREBINDINGFACTOR_Q6,0.99999
HP_CONGENITAL_NONBULLOUS_ICH...,SET,20,-0.34875,-0.011504,0.18821,0.96805,HP_CONGENITAL_NONBULLOUS_ICHTHYOSIFORM_ERYTHRODERMA,0.99999
GOLDRATH_EFF_VS_MEMORY_CD8_T...2,SET,183,-0.11589,-0.011512,0.06254,0.96805,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP,0.99999
MIR5007_5P,SET,53,-0.21832,-0.011713,0.11774,0.96814,MIR5007_5P,0.99999
HP_ABNORMALITY_OF_HEPATOBILI...,SET,181,-0.11289,-0.011153,0.060877,0.96815,HP_ABNORMALITY_OF_HEPATOBILIARY_SYSTEM_PHYSIOLOGY,0.99999
HP_APLASIA_OF_THE_LEFT_HEMID...,SET,5,-0.79913,-0.013185,0.4309,0.96816,HP_APLASIA_OF_THE_LEFT_HEMIDIAPHRAGM,0.99999
HP_B_CELL_LYMPHOMA,SET,21,-0.36042,-0.012182,0.19433,0.96817,HP_B_CELL_LYMPHOMA,0.99999
GOBP_CARDIAC_MUSCLE_CELL_CAR...,SET,7,-0.68493,-0.013371,0.36913,0.96823,GOBP_CARDIAC_MUSCLE_CELL_CARDIAC_MUSCLE_CELL_ADHESION,0.99999
MIR18B_3P,SET,46,-0.22664,-0.01133,0.12213,0.96824,MIR18B_3P,0.99999
CHEN_LUNG_CANCER_SURVIVAL,SET,24,-0.30996,-0.011199,0.16702,0.96825,CHEN_LUNG_CANCER_SURVIVAL,0.99999
GNF2_CDKN1C,SET,25,-0.33681,-0.01242,0.18148,0.96826,GNF2_CDKN1C,0.99999
YAGI_AML_SURVIVAL,SET,108,-0.15049,-0.011508,0.081043,0.96833,YAGI_AML_SURVIVAL,0.99999
KEGG_MEDICUS_REFERENCE_BETA_...1,SET,11,-0.44183,-0.010811,0.23793,0.96834,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION,0.99999
GSE22025_TGFB1_VS_TGFB1_AND_...1,SET,180,-0.12171,-0.011991,0.065514,0.96839,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,0.99999
GSE17721_PAM3CSK4_VS_CPG_8H_...1,SET,183,-0.11414,-0.011338,0.061436,0.9684,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_DN,0.99999
TAKADA_GASTRIC_CANCER_COPY_N...2,SET,7,-0.59557,-0.011627,0.32051,0.96842,TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP,0.99999
HP_VERRUCAE,SET,25,-0.32122,-0.011845,0.17285,0.96843,HP_VERRUCAE,0.99999
GSE21670_STAT3_KO_VS_WT_CD4_...8,SET,174,-0.12056,-0.011681,0.064879,0.96843,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_UP,0.99999
GOBP_RIBOSE_PHOSPHATE_METABO...,SET,405,-0.07609,-0.011175,0.04094,0.96845,GOBP_RIBOSE_PHOSPHATE_METABOLIC_PROCESS,0.99999
HP_CLEFT_UPPER_LIP,SET,126,-0.13849,-0.011433,0.074513,0.96845,HP_CLEFT_UPPER_LIP,0.99999
GSE9946_MATURE_STIMULATORY_V...2,SET,117,-0.14085,-0.011208,0.075785,0.96845,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP,0.99999
TRAVAGLINI_LUNG_ARTERY_CELL,SET,124,-0.1528,-0.012515,0.082199,0.96847,TRAVAGLINI_LUNG_ARTERY_CELL,0.99999
ACTGCCT_MIR34B,SET,200,-0.1116,-0.011584,0.060034,0.96848,ACTGCCT_MIR34B,0.99999
GOBP_NEGATIVE_REGULATION_OF_...507,SET,16,-0.38064,-0.011232,0.20473,0.96849,GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,0.99999
FULLER_PBMC_F_TULARENSIS_VAC...4,SET,14,-0.39393,-0.010873,0.21188,0.96849,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_UP,0.99999
GSE13738_TCR_VS_BYSTANDER_AC...1,SET,169,-0.12018,-0.011477,0.064629,0.96852,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,0.99999
GSE5542_UNTREATED_VS_IFNA_TR...4,SET,172,-0.12305,-0.011854,0.066169,0.96852,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...624,SET,8,-0.62404,-0.013023,0.33556,0.96853,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,0.99999
MIR548A_3P,SET,431,-0.076215,-0.011539,0.040976,0.96855,MIR548A_3P,0.99999
HP_STOMACH_CANCER,SET,33,-0.27069,-0.011465,0.14547,0.9686,HP_STOMACH_CANCER,0.99999
HP_REDUCED_PANCREATIC_BETA_C...,SET,7,-0.71738,-0.014005,0.38536,0.96866,HP_REDUCED_PANCREATIC_BETA_CELLS,0.99999
GOMF_NEUROTRANSMITTER_RECEPT...2,SET,52,-0.2458,-0.013063,0.13201,0.96869,GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY_INVOLVED_IN_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,0.99999
HP_ARRHINENCEPHALY,SET,30,-0.26834,-0.010838,0.14411,0.96869,HP_ARRHINENCEPHALY,0.99999
GSE21546_WT_VS_SAP1A_KO_ANTI...2,SET,183,-0.11542,-0.011465,0.061978,0.96871,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.99999
MIR3200_5P,SET,58,-0.20831,-0.011689,0.11185,0.96872,MIR3200_5P,0.99999
GOBP_MORPHOGENESIS_OF_AN_EPI...4,SET,472,-0.075298,-0.011917,0.040431,0.96872,GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM,0.99999
HOXB7_TARGET_GENES,SET,24,-0.3214,-0.011612,0.17251,0.96876,HOXB7_TARGET_GENES,0.99999
GOBP_REGULATION_OF_DOPAMINER...,SET,9,-0.59527,-0.013176,0.31949,0.96877,GOBP_REGULATION_OF_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.99999
GSE34156_UNTREATED_VS_24H_TL...1,SET,160,-0.12016,-0.011168,0.064486,0.96878,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,0.99999
GOBP_REGULATION_OF_MONOCYTE_...1,SET,25,-0.32346,-0.011928,0.17359,0.96879,GOBP_REGULATION_OF_MONOCYTE_CHEMOTAXIS,0.99999
HINATA_NFKB_TARGETS_KERATINO...1,SET,22,-0.36842,-0.012745,0.1977,0.9688,HINATA_NFKB_TARGETS_KERATINOCYTE_DN,0.99999
GOBP_ANTIGEN_PROCESSING_AND_...8,SET,27,-0.34757,-0.013319,0.1865,0.96881,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_II,0.99999
HP_REDUCED_PROTEIN_S_ACTIVITY,SET,8,-0.44762,-0.0093414,0.24015,0.96883,HP_REDUCED_PROTEIN_S_ACTIVITY,0.99999
GOMF_MEMBRANE_POTENTIAL_DRIV...,SET,5,-0.81713,-0.013482,0.43816,0.96889,GOMF_MEMBRANE_POTENTIAL_DRIVEN_UNIPORTER_ACTIVITY,0.99999
REACTOME_INHIBITION_OF_DNA_R...,SET,19,-0.33426,-0.010747,0.17923,0.9689,REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE,0.99999
GOBP_SYNAPSE_ORGANIZATION,SET,448,-0.078559,-0.012121,0.042122,0.9689,GOBP_SYNAPSE_ORGANIZATION,0.99999
GSE20727_CTRL_VS_DNFB_ALLERG...2,SET,179,-0.11598,-0.011396,0.06219,0.9689,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP,0.99999
GOBP_TUBE_MORPHOGENESIS,SET,811,-0.058345,-0.011988,0.031274,0.96894,GOBP_TUBE_MORPHOGENESIS,0.99999
HP_BASAL_GANGLIA_GLIOSIS,SET,8,-0.60296,-0.012583,0.32303,0.96901,HP_BASAL_GANGLIA_GLIOSIS,0.99999
MODULE_153,SET,31,-0.28303,-0.01162,0.15162,0.96902,MODULE_153,0.99999
GOCC_INSULIN_LIKE_GROWTH_FAC...,SET,5,-0.81645,-0.013471,0.43721,0.96907,GOCC_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEIN_COMPLEX,0.99999
GAVISH_3CA_METAPROGRAM_FIBRO...3,SET,47,-0.26058,-0.013167,0.13953,0.96908,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2,0.99999
GSE19772_CTRL_VS_HCMV_INF_MO...2,SET,168,-0.11808,-0.011243,0.063222,0.96909,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,0.99999
GOCC_VESICLE_TETHERING_COMPL...,SET,62,-0.1893,-0.010982,0.10135,0.9691,GOCC_VESICLE_TETHERING_COMPLEX,0.99999
GAUTAM_EYE_CORNEA_CYTOTOXIC_...,SET,124,-0.13783,-0.011288,0.073779,0.96912,GAUTAM_EYE_CORNEA_CYTOTOXIC_T_CELLS,0.99999
HP_ABNORMAL_GLUCOSE_HOMEOSTA...,SET,622,-0.064365,-0.011644,0.034451,0.96913,HP_ABNORMAL_GLUCOSE_HOMEOSTASIS,0.99999
GOMF_AMP_BINDING,SET,15,-0.35582,-0.010166,0.19044,0.96914,GOMF_AMP_BINDING,0.99999
HP_OROMOTOR_APRAXIA,SET,24,-0.32413,-0.011711,0.17347,0.96914,HP_OROMOTOR_APRAXIA,0.99999
KEGG_MEDICUS_REFERENCE_ATR_P...,SET,8,-0.44663,-0.0093208,0.23903,0.96915,KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M,0.99999
GOBP_URETER_DEVELOPMENT,SET,17,-0.40059,-0.012183,0.21438,0.96915,GOBP_URETER_DEVELOPMENT,0.99999
HP_PERIPHERAL_CYANOSIS,SET,31,-0.27233,-0.01118,0.14573,0.96916,HP_PERIPHERAL_CYANOSIS,0.99999
HP_ABNORMAL_CIRCULATING_VITA...2,SET,24,-0.34054,-0.012304,0.18221,0.96918,HP_ABNORMAL_CIRCULATING_VITAMIN_B12_CONCENTRATION,0.99999
GSE360_T_GONDII_VS_B_MALAYI_...5,SET,181,-0.11696,-0.011555,0.06257,0.96919,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN,0.99999
MIR1322,SET,68,-0.21445,-0.013027,0.11467,0.96926,MIR1322,0.99999
WP_APOPTOSIS_MODULATION_BY_H...,SET,18,-0.37155,-0.011628,0.19864,0.96928,WP_APOPTOSIS_MODULATION_BY_HSP70,0.99999
CCTGAGT_MIR510,SET,35,-0.25743,-0.011229,0.13763,0.96928,CCTGAGT_MIR510,0.99999
GAZDA_DIAMOND_BLACKFAN_ANEMI...2,SET,23,-0.33304,-0.01178,0.17805,0.96929,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,0.99999
MIR6822_5P,SET,64,-0.18522,-0.010916,0.09902,0.96929,MIR6822_5P,0.99999
HP_SHORT_TIBIA,SET,23,-0.3286,-0.011623,0.17564,0.96931,HP_SHORT_TIBIA,0.99999
GOBP_TETRAHYDROFOLATE_BIOSYN...,SET,6,-0.56563,-0.010223,0.30232,0.96932,GOBP_TETRAHYDROFOLATE_BIOSYNTHETIC_PROCESS,0.99999
REACTOME_NEF_MEDIATED_DOWNRE...,SET,9,-0.47917,-0.010606,0.25608,0.96933,REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION,0.99999
HP_HEPATOMEGALY,SET,572,-0.066196,-0.0115,0.035373,0.96934,HP_HEPATOMEGALY,0.99999
MARTENS_TRETINOIN_RESPONSE_UP,SET,752,-0.063675,-0.01262,0.034025,0.96935,MARTENS_TRETINOIN_RESPONSE_UP,0.99999
GOMF_SULFATE_BINDING,SET,4,-0.8744,-0.012905,0.46723,0.96935,GOMF_SULFATE_BINDING,0.99999
HP_ABNORMAL_CORNEA_MORPHOLOGY,SET,639,-0.063119,-0.011568,0.033719,0.96938,HP_ABNORMAL_CORNEA_MORPHOLOGY,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...2,SET,6,-0.74745,-0.013509,0.39928,0.96939,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY,0.99999
HP_GERMINOMA,SET,12,-0.46966,-0.012003,0.25089,0.96939,HP_GERMINOMA,0.99999
YORDY_RECIPROCAL_REGULATION_...1,SET,63,-0.21904,-0.012808,0.11694,0.96947,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,0.99999
GOBP_MESODERMAL_CELL_DIFFERE...,SET,31,-0.2917,-0.011976,0.15572,0.96947,GOBP_MESODERMAL_CELL_DIFFERENTIATION,0.99999
GOBP_MYOBLAST_PROLIFERATION,SET,24,-0.3293,-0.011898,0.17578,0.96948,GOBP_MYOBLAST_PROLIFERATION,0.99999
GSE16385_ROSIGLITAZONE_IL4_V...6,SET,177,-0.12229,-0.011949,0.065264,0.96951,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP,0.99999
DESCARTES_MAIN_FETAL_ELF3_AG...,SET,127,-0.13095,-0.010853,0.069873,0.96954,DESCARTES_MAIN_FETAL_ELF3_AGBL2_POSITIVE_CELLS,0.99999
GSE37532_TREG_VS_TCONV_PPARG...3,SET,172,-0.1169,-0.011262,0.062352,0.96959,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...27,SET,18,-0.40859,-0.012787,0.21783,0.96965,GOBP_NEGATIVE_REGULATION_OF_ANOIKIS,0.99999
GOBP_RETINAL_BLOOD_VESSEL_MO...,SET,5,-0.70936,-0.011704,0.37816,0.96965,GOBP_RETINAL_BLOOD_VESSEL_MORPHOGENESIS,0.99999
GSE15750_DAY6_VS_DAY10_TRAF6...1,SET,183,-0.11202,-0.011128,0.05972,0.96965,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN,0.99999
GOBP_INTERNAL_PEPTIDYL_LYSIN...,SET,8,-0.45,-0.009391,0.23983,0.96968,GOBP_INTERNAL_PEPTIDYL_LYSINE_ACETYLATION,0.99999
GOBP_POSITIVE_REGULATION_OF_...460,SET,7,-0.63953,-0.012485,0.34085,0.96968,GOBP_POSITIVE_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,0.99999
GOBP_MUSCLE_ADAPTATION,SET,98,-0.16936,-0.01234,0.090257,0.96969,GOBP_MUSCLE_ADAPTATION,0.99999
WP_ALSTROM_SYNDROME,SET,30,-0.28179,-0.011381,0.15017,0.9697,WP_ALSTROM_SYNDROME,0.99999
HP_ABNORMAL_PITUITARY_GLAND_...,SET,304,-0.090663,-0.011569,0.048311,0.96971,HP_ABNORMAL_PITUITARY_GLAND_MORPHOLOGY,0.99999
HP_VISUAL_IMPAIRMENT,SET,993,-0.051118,-0.011562,0.027232,0.96974,HP_VISUAL_IMPAIRMENT,0.99999
HP_BASAL_CELL_CARCINOMA,SET,61,-0.18602,-0.010704,0.099091,0.96975,HP_BASAL_CELL_CARCINOMA,0.99999
HP_IRREGULAR_FEMORAL_EPIPHYS...,SET,8,-0.53405,-0.011145,0.28445,0.96976,HP_IRREGULAR_FEMORAL_EPIPHYSIS,0.99999
GSE43955_10H_VS_60H_ACT_CD4_...2,SET,177,-0.11813,-0.011542,0.062916,0.96977,GSE43955_10H_VS_60H_ACT_CD4_TCELL_UP,0.99999
GOBP_LATERAL_MESODERM_DEVELO...,SET,18,-0.41655,-0.013036,0.22184,0.96978,GOBP_LATERAL_MESODERM_DEVELOPMENT,0.99999
HP_SCALING_SKIN,SET,42,-0.24482,-0.011696,0.13037,0.96979,HP_SCALING_SKIN,0.99999
HP_PANHYPOGAMMAGLOBULINEMIA,SET,16,-0.37919,-0.011189,0.20181,0.96987,HP_PANHYPOGAMMAGLOBULINEMIA,0.99999
GSE5099_UNSTIM_VS_MCSF_TREAT...1,SET,186,-0.11219,-0.011234,0.059687,0.96991,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN,0.99999
MIR12121,SET,27,-0.32986,-0.01264,0.17548,0.96992,MIR12121,0.99999
GOBP_REGULATION_OF_PLASMA_ME...1,SET,16,-0.39767,-0.011734,0.21152,0.96994,GOBP_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION,0.99999
GOBP_RESPONSE_TO_VITAMIN_E,SET,9,-0.53368,-0.011813,0.28388,0.96994,GOBP_RESPONSE_TO_VITAMIN_E,0.99999
HP_MADELUNG_DEFORMITY,SET,4,-0.7742,-0.011426,0.41169,0.96997,HP_MADELUNG_DEFORMITY,0.99999
GCM_RAF1,SET,37,-0.23179,-0.010395,0.12325,0.96998,GCM_RAF1,0.99999
GOBP_REGULATION_OF_BROWN_FAT...,SET,22,-0.34751,-0.012022,0.18476,0.96999,GOBP_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,0.99999
HP_ABNORMAL_FIBULA_MORPHOLOGY,SET,51,-0.22658,-0.011925,0.12043,0.97003,HP_ABNORMAL_FIBULA_MORPHOLOGY,0.99999
HP_ABNORMAL_PROPORTION_OF_CL...,SET,17,-0.44619,-0.01357,0.23716,0.97003,HP_ABNORMAL_PROPORTION_OF_CLASS_SWITCHED_MEMORY_B_CELLS,0.99999
HP_ALLERGIC_RHINITIS,SET,10,-0.47194,-0.011011,0.25086,0.97003,HP_ALLERGIC_RHINITIS,0.99999
GOBP_RESPONSE_TO_CORTISOL,SET,6,-0.72325,-0.013072,0.38436,0.97005,GOBP_RESPONSE_TO_CORTISOL,0.99999
GSE41176_WT_VS_TAK1_KO_ANTI_...5,SET,176,-0.12099,-0.011789,0.064294,0.97006,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN,0.99999
GSE8685_IL2_STARVED_VS_IL15_...2,SET,181,-0.11848,-0.011706,0.062964,0.97006,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...21,SET,15,-0.42359,-0.012102,0.22504,0.9701,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_EPITHELIAL_CELLS,0.99999
RIZKI_TUMOR_INVASIVENESS_2D_...2,SET,60,-0.19957,-0.01139,0.10602,0.97011,RIZKI_TUMOR_INVASIVENESS_2D_UP,0.99999
BROWNE_HCMV_INFECTION_30MIN_...2,SET,47,-0.24545,-0.012402,0.13037,0.97012,BROWNE_HCMV_INFECTION_30MIN_UP,0.99999
GOBP_PARTURITION,SET,14,-0.42131,-0.011629,0.22375,0.97014,GOBP_PARTURITION,0.99999
THRA_TARGET_GENES,SET,66,-0.18406,-0.011015,0.097739,0.97015,THRA_TARGET_GENES,0.99999
GSE21774_CD56_BRIGHT_VS_DIM_...2,SET,176,-0.12537,-0.012216,0.066578,0.97015,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_VAS...2,SET,156,-0.13604,-0.012486,0.072219,0.97019,HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_2_CELL,0.99999
NABA_COLLAGENS,SET,42,-0.26895,-0.012849,0.14275,0.97022,NABA_COLLAGENS,0.99999
REACTOME_COLLAGEN_CHAIN_TRIM...,SET,42,-0.26895,-0.012849,0.14275,0.97022,REACTOME_COLLAGEN_CHAIN_TRIMERIZATION,0.99999
HP_NEURONAL_LOSS_IN_THE_CERE...,SET,12,-0.44481,-0.011368,0.23606,0.97023,HP_NEURONAL_LOSS_IN_THE_CEREBRAL_CORTEX,0.99999
TCTAGAG_MIR517,SET,41,-0.24939,-0.011771,0.13234,0.97024,TCTAGAG_MIR517,0.99999
GOBP_REGULATION_OF_HEMATOPOI...3,SET,14,-0.42544,-0.011743,0.2257,0.97028,GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,0.99999
GOMF_FOLIC_ACID_TRANSMEMBRAN...,SET,5,-0.82002,-0.01353,0.43498,0.97029,GOMF_FOLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
MIR4769_5P,SET,39,-0.25223,-0.011612,0.13379,0.9703,MIR4769_5P,0.99999
BREDEMEYER_RAG_SIGNALING_VIA...1,SET,38,-0.26327,-0.011964,0.13963,0.97031,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,0.99999
GOBP_REGULATION_OF_NEUTROPHI...1,SET,5,-0.78782,-0.012999,0.41778,0.97032,GOBP_REGULATION_OF_NEUTROPHIL_ACTIVATION,0.99999
HP_ABNORMAL_ANTERIOR_EYE_SEG...,SET,1152,-0.048154,-0.011677,0.025537,0.97032,HP_ABNORMAL_ANTERIOR_EYE_SEGMENT_MORPHOLOGY,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...4,SET,22,-0.37542,-0.012987,0.19905,0.97034,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,0.99999
WP_ECTODERM_DIFFERENTIATION,SET,121,-0.15722,-0.012721,0.083352,0.97036,WP_ECTODERM_DIFFERENTIATION,0.99999
HP_MULTIPLE_PULMONARY_CYSTS,SET,18,-0.38687,-0.012107,0.20505,0.97039,HP_MULTIPLE_PULMONARY_CYSTS,0.99999
HP_PULMONARY_OPACITY,SET,22,-0.35001,-0.012108,0.1855,0.9704,HP_PULMONARY_OPACITY,0.99999
ZHAN_V1_LATE_DIFFERENTIATION...2,SET,31,-0.28316,-0.011625,0.15005,0.97042,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,0.99999
BOYAULT_LIVER_CANCER_SUBCLAS...3,SET,14,-0.48339,-0.013343,0.25612,0.97044,BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN,0.99999
MIR518A_3P_MIR518B_MIR518C_3...,SET,8,-0.61143,-0.01276,0.32396,0.97044,MIR518A_3P_MIR518B_MIR518C_3P_MIR518D_3P_MIR518F_3P_MIR526A_3P,0.99999
PBXIP1_TARGET_GENES,SET,196,-0.11446,-0.011763,0.060633,0.97046,PBXIP1_TARGET_GENES,0.99999
ID1_TARGET_GENES,SET,1008,-0.050941,-0.011604,0.026975,0.97051,ID1_TARGET_GENES,0.99999
GOBP_PROTEIN_ACETYLATION,SET,49,-0.21461,-0.011072,0.11359,0.97057,GOBP_PROTEIN_ACETYLATION,0.99999
KIM_BIPOLAR_DISORDER_OLIGODE...1,SET,81,-0.17824,-0.011812,0.094307,0.97061,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,0.99999
GOBP_CELLULAR_SENESCENCE,SET,93,-0.16593,-0.011779,0.087771,0.97064,GOBP_CELLULAR_SENESCENCE,0.99999
HP_ABNORMALITY_OF_FUNDUS_PIG...,SET,39,-0.25333,-0.011663,0.13398,0.97066,HP_ABNORMALITY_OF_FUNDUS_PIGMENTATION,0.99999
HP_HOODED_EYELID,SET,6,-0.59276,-0.010714,0.31353,0.97066,HP_HOODED_EYELID,0.99999
HP_ELEVATED_CIRCULATING_GROW...,SET,15,-0.40176,-0.011479,0.21238,0.97073,HP_ELEVATED_CIRCULATING_GROWTH_HORMONE_CONCENTRATION,0.99999
HP_FRONTAL_UPSWEEP_OF_HAIR,SET,20,-0.3784,-0.012482,0.20002,0.97074,HP_FRONTAL_UPSWEEP_OF_HAIR,0.99999
GSE17974_2H_VS_72H_UNTREATED...2,SET,174,-0.11473,-0.011115,0.060634,0.97075,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.99999
HP_DYSGERMINOMA,SET,9,-0.51518,-0.011403,0.27212,0.97082,HP_DYSGERMINOMA,0.99999
GOCC_COMPLEX_OF_COLLAGEN_TRI...,SET,19,-0.37828,-0.012162,0.19976,0.97086,GOCC_COMPLEX_OF_COLLAGEN_TRIMERS,0.99999
GOCC_RNA_N6_METHYLADENOSINE_...,SET,8,-0.54395,-0.011352,0.28723,0.97087,GOCC_RNA_N6_METHYLADENOSINE_METHYLTRANSFERASE_COMPLEX,0.99999
GOBP_CATECHOLAMINE_SECRETION,SET,46,-0.24859,-0.012427,0.13117,0.97095,GOBP_CATECHOLAMINE_SECRETION,0.99999
GOBP_ESTABLISHMENT_OF_SKIN_B...,SET,33,-0.2893,-0.012254,0.15267,0.97095,GOBP_ESTABLISHMENT_OF_SKIN_BARRIER,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...4,SET,23,-0.33955,-0.01201,0.17913,0.97098,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP,0.99999
GOCC_POSTSYNAPTIC_SPECIALIZA...1,SET,324,-0.091257,-0.012015,0.04814,0.97099,GOCC_POSTSYNAPTIC_SPECIALIZATION,0.99999
HP_PROTEIN_AVOIDANCE,SET,5,-0.69417,-0.011454,0.36597,0.97106,HP_PROTEIN_AVOIDANCE,0.99999
chr3q24,SET,15,-0.65159,-0.018616,0.34351,0.97107,chr3q24,0.99999
SIG_CD40PATHWAYMAP,SET,33,-0.28356,-0.01201,0.14947,0.97109,SIG_CD40PATHWAYMAP,0.99999
GOMF_EXTRACELLULAR_MATRIX_ST...3,SET,42,-0.27175,-0.012982,0.14323,0.9711,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_TENSILE_STRENGTH,0.99999
HP_EPISPADIAS,SET,25,-0.31178,-0.011497,0.16431,0.97111,HP_EPISPADIAS,0.99999
MIR3174,SET,38,-0.27212,-0.012367,0.14336,0.97115,MIR3174,0.99999
GSE13522_WT_VS_IFNAR_KO_SKIN...1,SET,178,-0.11836,-0.011597,0.062345,0.97117,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,0.99999
GSE27786_CD4_TCELL_VS_NKCELL...2,SET,183,-0.11398,-0.011322,0.059987,0.97128,GSE27786_CD4_TCELL_VS_NKCELL_UP,0.99999
MIKKELSEN_ES_HCP_WITH_H3K27M...,SET,38,-0.28283,-0.012853,0.14884,0.97129,MIKKELSEN_ES_HCP_WITH_H3K27ME3,0.99999
GOBP_UV_PROTECTION,SET,11,-0.40297,-0.0098604,0.21198,0.97134,GOBP_UV_PROTECTION,0.99999
GOBP_GLYCEROPHOSPHOLIPID_CAT...,SET,33,-0.28722,-0.012165,0.15106,0.97137,GOBP_GLYCEROPHOSPHOLIPID_CATABOLIC_PROCESS,0.99999
GOBP_RESPONSE_TO_OXYGEN_GLUC...,SET,9,-0.51456,-0.01139,0.2706,0.97138,GOBP_RESPONSE_TO_OXYGEN_GLUCOSE_DEPRIVATION,0.99999
DESCARTES_FETAL_STOMACH_ENS_...2,SET,64,-0.2107,-0.012418,0.1108,0.97138,DESCARTES_FETAL_STOMACH_ENS_NEURONS,0.99999
HP_ECZEMATOID_DERMATITIS,SET,145,-0.13077,-0.011575,0.068762,0.9714,HP_ECZEMATOID_DERMATITIS,0.99999
HP_ZOLLINGER_ELLISON_SYNDROME,SET,9,-0.54394,-0.01204,0.28591,0.97144,HP_ZOLLINGER_ELLISON_SYNDROME,0.99999
MORF_CSNK1D,SET,65,-0.18568,-0.011028,0.097512,0.97155,MORF_CSNK1D,0.99999
PIONTEK_PKD1_TARGETS_DN,SET,15,-0.38784,-0.011081,0.20353,0.97164,PIONTEK_PKD1_TARGETS_DN,0.99999
REACTOME_PI_3K_CASCADE_FGFR1,SET,21,-0.36539,-0.01235,0.19174,0.97164,REACTOME_PI_3K_CASCADE_FGFR1,0.99999
MYBL1_TARGET_GENES,SET,353,-0.083003,-0.011398,0.043556,0.97165,MYBL1_TARGET_GENES,0.99999
HP_ELEVATED_URINARY_CARBOXYL...,SET,94,-0.1684,-0.012018,0.088361,0.97165,HP_ELEVATED_URINARY_CARBOXYLIC_ACID,0.99999
HP_CNS_HYPOMYELINATION,SET,79,-0.17182,-0.011246,0.090145,0.97167,HP_CNS_HYPOMYELINATION,0.99999
HP_CONTINUOUS_SPIKE_AND_WAVE...,SET,8,-0.61155,-0.012763,0.32083,0.97168,HP_CONTINUOUS_SPIKE_AND_WAVES_DURING_SLOW_SLEEP,0.99999
REACTOME_SYNAPTIC_ADHESION_L...,SET,19,-0.35388,-0.011378,0.18563,0.97169,REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES,0.99999
GOBP_MATERNAL_PROCESS_INVOLV...2,SET,5,-0.6224,-0.01027,0.32625,0.97178,GOBP_MATERNAL_PROCESS_INVOLVED_IN_PARTURITION,0.99999
HP_ABNORMAL_MACULAR_MORPHOLO...,SET,188,-0.12043,-0.012124,0.06313,0.97178,HP_ABNORMAL_MACULAR_MORPHOLOGY,0.99999
MIR5683,SET,217,-0.11231,-0.012137,0.058866,0.97179,MIR5683,0.99999
HP_DEFECTIVE_DNA_REPAIR_AFTE...,SET,10,-0.40428,-0.0094323,0.21189,0.97179,HP_DEFECTIVE_DNA_REPAIR_AFTER_ULTRAVIOLET_RADIATION_DAMAGE,0.99999
BIOCARTA_ASBCELL_PATHWAY,SET,10,-0.55941,-0.013052,0.29306,0.97185,BIOCARTA_ASBCELL_PATHWAY,0.99999
MIR31_5P,SET,129,-0.14298,-0.011943,0.074898,0.97186,MIR31_5P,0.99999
HP_ABNORMAL_FACTOR_IX_ACTIVI...,SET,5,-0.58656,-0.0096781,0.30706,0.97194,HP_ABNORMAL_FACTOR_IX_ACTIVITY,0.99999
GOMF_TRANSLATION_REPRESSOR_A...,SET,30,-0.26639,-0.010759,0.13945,0.97195,GOMF_TRANSLATION_REPRESSOR_ACTIVITY,0.99999
chr7q36,SET,76,-0.36587,-0.02349,0.19147,0.97198,chr7q36,0.99999
chr4p13,SET,12,-0.68392,-0.017479,0.35764,0.97208,chr4p13,0.99999
GOBP_REGULATION_OF_MESODERMA...1,SET,8,-0.61203,-0.012773,0.32002,0.97208,GOBP_REGULATION_OF_MESODERMAL_CELL_DIFFERENTIATION,0.99999
GOBP_PROTEIN_QUALITY_CONTROL...,SET,23,-0.2926,-0.010349,0.15288,0.97218,GOBP_PROTEIN_QUALITY_CONTROL_FOR_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEINS,0.99999
HP_VITREOUS_HEMORRHAGE,SET,16,-0.41221,-0.012163,0.21533,0.9722,HP_VITREOUS_HEMORRHAGE,0.99999
GSE7460_CTRL_VS_FOXP3_OVEREX...3,SET,173,-0.12039,-0.011631,0.062875,0.97223,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN,0.99999
AAGCACA_MIR218,SET,373,-0.088058,-0.012423,0.04597,0.97228,AAGCACA_MIR218,0.99999
HP_DEFORMED_RIB_CAGE,SET,7,-0.64011,-0.012496,0.33408,0.97231,HP_DEFORMED_RIB_CAGE,0.99999
GSE27859_DC_VS_CD11C_INT_F48...1,SET,143,-0.12758,-0.011216,0.06659,0.97231,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,0.99999
GOBP_APOPTOTIC_PROCESS_INVOL...2,SET,4,-1.0045,-0.014825,0.52403,0.97236,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_HEART_MORPHOGENESIS,0.99999
HP_HEPATOCELLULAR_ADENOMA,SET,17,-0.41474,-0.012614,0.21634,0.97238,HP_HEPATOCELLULAR_ADENOMA,0.99999
TRAVAGLINI_LUNG_PROLIFERATIN...1,SET,798,-0.0566,-0.011541,0.029519,0.9724,TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL,0.99999
GOBP_CYTOPLASMIC_TRANSLATION...1,SET,4,-0.65744,-0.0097027,0.34286,0.97241,GOBP_CYTOPLASMIC_TRANSLATIONAL_ELONGATION,0.99999
ZHOU_PANCREATIC_ENDOCRINE_PR...,SET,12,-0.5225,-0.013353,0.27236,0.97246,ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR,0.99999
MIR3918,SET,83,-0.16697,-0.011201,0.087017,0.97249,MIR3918,0.99999
GOMF_GLIAL_CELL_DERIVED_NEUR...,SET,5,-0.78555,-0.012961,0.40916,0.97256,GOMF_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_ACTIVITY,0.99999
GSE40666_UNTREATED_VS_IFNA_S...1,SET,174,-0.11479,-0.011122,0.059787,0.97256,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN,0.99999
REACTOME_RNA_POLYMERASE_II_T...3,SET,60,-0.18283,-0.010434,0.095221,0.97257,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,0.99999
HP_FACIAL_CAPILLARY_HEMANGIO...,SET,10,-0.54357,-0.012682,0.28305,0.97259,HP_FACIAL_CAPILLARY_HEMANGIOMA,0.99999
WP_ROLES_OF_CERAMIDES_IN_DEV...,SET,23,-0.3539,-0.012518,0.18423,0.97262,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,0.99999
GOBP_POSITIVE_REGULATION_OF_...17,SET,24,-0.34169,-0.012345,0.17787,0.97263,GOBP_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.99999
HP_DEHYDRATION,SET,99,-0.1713,-0.012544,0.089164,0.97264,HP_DEHYDRATION,0.99999
HP_INTELLECTUAL_DISABILITY_B...,SET,24,-0.33746,-0.012193,0.17565,0.97264,HP_INTELLECTUAL_DISABILITY_BORDERLINE,0.99999
GOBP_ACETATE_ESTER_TRANSPORT,SET,9,-0.53818,-0.011912,0.28002,0.97268,GOBP_ACETATE_ESTER_TRANSPORT,0.99999
GSE5542_UNTREATED_VS_IFNA_TR...2,SET,186,-0.11905,-0.011921,0.061942,0.97268,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,0.99999
GSE21360_NAIVE_VS_SECONDARY_...2,SET,172,-0.12783,-0.012314,0.066505,0.9727,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP,0.99999
GOBP_ALDITOL_CATABOLIC_PROCE...,SET,5,-0.82008,-0.013531,0.42651,0.97274,GOBP_ALDITOL_CATABOLIC_PROCESS,0.99999
GOBP_UREA_CYCLE,SET,10,-0.47242,-0.011022,0.24568,0.97274,GOBP_UREA_CYCLE,0.99999
STAT_Q6,SET,234,-0.10868,-0.012191,0.056519,0.97275,STAT_Q6,0.99999
HP_PATELLAR_APLASIA,SET,20,-0.37938,-0.012514,0.19728,0.97275,HP_PATELLAR_APLASIA,0.99999
HP_ABNORMAL_URINE_CARBOXYLIC...,SET,117,-0.15221,-0.012112,0.079146,0.97276,HP_ABNORMAL_URINE_CARBOXYLIC_ACID_LEVEL,0.99999
GOBP_HOMEOSTATIC_PROCESS,SET,1566,-0.044176,-0.012339,0.022968,0.97277,GOBP_HOMEOSTATIC_PROCESS,0.99999
GSE3982_MAC_VS_BASOPHIL_DN,SET,167,-0.12556,-0.01192,0.065269,0.9728,GSE3982_MAC_VS_BASOPHIL_DN,0.99999
HP_ELEVATED_HEMOGLOBIN_A1C,SET,26,-0.3377,-0.012699,0.17545,0.97286,HP_ELEVATED_HEMOGLOBIN_A1C,0.99999
GSE2770_UNTREATED_VS_IL12_TR...4,SET,179,-0.11983,-0.011774,0.062262,0.97286,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
GSE17721_0.5H_VS_8H_GARDIQUI...2,SET,174,-0.11643,-0.01128,0.060465,0.97291,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_UP,0.99999
PID_INTEGRIN4_PATHWAY,SET,11,-0.5144,-0.012587,0.26712,0.97292,PID_INTEGRIN4_PATHWAY,0.99999
GSE36476_CTRL_VS_TSST_ACT_16...2,SET,170,-0.12544,-0.012014,0.065133,0.97293,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP,0.99999
GOCC_PHOTORECEPTOR_DISC_MEMB...,SET,18,-0.35894,-0.011233,0.18634,0.97295,GOCC_PHOTORECEPTOR_DISC_MEMBRANE,0.99999
HP_BROAD_COLUMELLA,SET,12,-0.44548,-0.011385,0.23126,0.97296,HP_BROAD_COLUMELLA,0.99999
GOBP_CEREBRAL_CORTEX_DEVELOP...,SET,112,-0.16384,-0.012757,0.085005,0.97303,GOBP_CEREBRAL_CORTEX_DEVELOPMENT,0.99999
GOMF_CYCLASE_ACTIVITY,SET,17,-0.41018,-0.012475,0.21276,0.97306,GOMF_CYCLASE_ACTIVITY,0.99999
MIR1976,SET,79,-0.18303,-0.01198,0.094906,0.9731,MIR1976,0.99999
GCM_FANCC,SET,111,-0.14701,-0.011396,0.076212,0.97312,GCM_FANCC,0.99999
GOBP_INTESTINAL_EPITHELIAL_S...,SET,7,-0.68622,-0.013396,0.35576,0.97312,GOBP_INTESTINAL_EPITHELIAL_STRUCTURE_MAINTENANCE,0.99999
GOBP_RETINA_DEVELOPMENT_IN_C...,SET,155,-0.13766,-0.012595,0.07134,0.97317,GOBP_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.99999
ICSBP_Q6,SET,230,-0.11032,-0.01227,0.057165,0.97319,ICSBP_Q6,0.99999
GSE32423_MEMORY_VS_NAIVE_CD8...5,SET,182,-0.12009,-0.011897,0.062203,0.97323,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP,0.99999
MIR6826_3P,SET,93,-0.16072,-0.011409,0.08323,0.97325,MIR6826_3P,0.99999
GOBP_FOLIC_ACID_TRANSPORT,SET,10,-0.59967,-0.013991,0.31053,0.97326,GOBP_FOLIC_ACID_TRANSPORT,0.99999
GCM_AIP,SET,34,-0.26585,-0.01143,0.13763,0.97329,GCM_AIP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...43,SET,11,-0.55765,-0.013645,0.28868,0.9733,GOBP_NEGATIVE_REGULATION_OF_BEHAVIOR,0.99999
GOBP_GLUTAMATE_RECEPTOR_SIGN...,SET,48,-0.25636,-0.013091,0.13266,0.97334,GOBP_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,0.99999
MIR3130_3P,SET,45,-0.22771,-0.011259,0.11783,0.97335,MIR3130_3P,0.99999
MODULE_397,SET,110,-0.15192,-0.011723,0.07859,0.97337,MODULE_397,0.99999
HP_ESOPHAGITIS,SET,33,-0.30071,-0.012737,0.15551,0.97342,HP_ESOPHAGITIS,0.99999
RADAEVA_RESPONSE_TO_IFNA1_DN,SET,10,-0.60535,-0.014123,0.31298,0.97345,RADAEVA_RESPONSE_TO_IFNA1_DN,0.99999
GSE2770_TGFB_AND_IL4_VS_IL12...4,SET,173,-0.12024,-0.011616,0.062164,0.97345,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.99999
GOBP_REGULATION_OF_AMINO_ACI...2,SET,40,-0.2818,-0.013138,0.14568,0.97346,GOBP_REGULATION_OF_AMINO_ACID_TRANSPORT,0.99999
HP_ABNORMAL_CIRCULATING_HORM...,SET,434,-0.079366,-0.012057,0.041025,0.97347,HP_ABNORMAL_CIRCULATING_HORMONE_CONCENTRATION,0.99999
AGCGCAG_MIR191,SET,12,-0.46255,-0.011821,0.23907,0.97348,AGCGCAG_MIR191,0.99999
GOBP_PEPTIDYL_LYSINE_TRIMETH...,SET,5,-0.64306,-0.01061,0.33235,0.97349,GOBP_PEPTIDYL_LYSINE_TRIMETHYLATION,0.99999
GOBP_FERROPTOSIS,SET,9,-0.58245,-0.012892,0.301,0.9735,GOBP_FERROPTOSIS,0.99999
LIM_MAMMARY_LUMINAL_MATURE_DN,SET,89,-0.18856,-0.013096,0.097434,0.97351,LIM_MAMMARY_LUMINAL_MATURE_DN,0.99999
REACTOME_SIGNALING_BY_ACTIVA...,SET,11,-0.54404,-0.013312,0.28112,0.97351,REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1,0.99999
HP_ELEVATED_CIRCULATING_HEPA...,SET,324,-0.089427,-0.011774,0.046208,0.97352,HP_ELEVATED_CIRCULATING_HEPATIC_TRANSAMINASE_CONCENTRATION,0.99999
HP_SMALL_CEREBRAL_CORTEX,SET,8,-0.58087,-0.012122,0.30008,0.97354,HP_SMALL_CEREBRAL_CORTEX,0.99999
chr2q35,SET,64,-0.40147,-0.023661,0.20735,0.97357,chr2q35,0.99999
MIR1261,SET,76,-0.18306,-0.011753,0.09452,0.9736,MIR1261,0.99999
GOBP_CYCLIC_NUCLEOTIDE_CATAB...,SET,14,-0.43414,-0.011983,0.22408,0.97364,GOBP_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS,0.99999
HP_DIFFICULTY_STANDING,SET,28,-0.30575,-0.011931,0.15776,0.97368,HP_DIFFICULTY_STANDING,0.99999
GOBP_ARACHIDONIC_ACID_SECRET...,SET,31,-0.31558,-0.012956,0.16276,0.97373,GOBP_ARACHIDONIC_ACID_SECRETION,0.99999
GOBP_CELL_MIGRATION_IN_HINDB...,SET,16,-0.42728,-0.012608,0.22034,0.97375,GOBP_CELL_MIGRATION_IN_HINDBRAIN,0.99999
GSE40274_HELIOS_VS_FOXP3_AND...2,SET,182,-0.12289,-0.012174,0.063376,0.97375,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.99999
MIR181C_3P,SET,10,-0.44899,-0.010475,0.23148,0.97378,MIR181C_3P,0.99999
GOBP_LONG_TERM_SYNAPTIC_POTE...,SET,88,-0.17688,-0.012216,0.091194,0.97378,GOBP_LONG_TERM_SYNAPTIC_POTENTIATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...455,SET,61,-0.20339,-0.011703,0.10486,0.97378,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION,0.99999
GOBP_TRANSEPITHELIAL_CHLORID...,SET,8,-0.61124,-0.012756,0.31505,0.97381,GOBP_TRANSEPITHELIAL_CHLORIDE_TRANSPORT,0.99999
GOBP_REGULATION_OF_MYOBLAST_...3,SET,15,-0.42293,-0.012083,0.21797,0.97382,GOBP_REGULATION_OF_MYOBLAST_PROLIFERATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...227,SET,92,-0.1724,-0.012173,0.088833,0.97384,GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
GOBP_ADULT_FEEDING_BEHAVIOR,SET,9,-0.62563,-0.013848,0.32234,0.97386,GOBP_ADULT_FEEDING_BEHAVIOR,0.99999
GSE10273_HIGH_VS_LOW_IL7_TRE...1,SET,175,-0.1208,-0.011737,0.062206,0.97392,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN,0.99999
HP_DEFECTIVE_T_CELL_PROLIFER...,SET,7,-0.55107,-0.010758,0.28364,0.97397,HP_DEFECTIVE_T_CELL_PROLIFERATION,0.99999
GSE19888_ADENOSINE_A3R_INH_P...2,SET,170,-0.12738,-0.0122,0.065566,0.97397,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP,0.99999
GSE5099_MONOCYTE_VS_CLASSICA...1,SET,177,-0.11759,-0.011489,0.060514,0.97399,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...17,SET,7,-0.59387,-0.011593,0.30553,0.97403,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_BASOLATERAL_PROTEIN_SEC...,SET,5,-0.66914,-0.011041,0.34424,0.97403,GOBP_BASOLATERAL_PROTEIN_SECRETION,0.99999
GOBP_CYCLIC_NUCLEOTIDE_BIOSY...,SET,17,-0.41858,-0.012731,0.21534,0.97403,GOBP_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.99999
WP_2Q13_COPY_NUMBER_VARIATIO...,SET,57,-0.26876,-0.014951,0.13823,0.97406,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,0.99999
GOBP_NEGATIVE_REGULATION_OF_...709,SET,5,-0.56507,-0.0093235,0.29064,0.97406,GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,0.99999
GSE40274_CTRL_VS_FOXP3_AND_E...1,SET,148,-0.1319,-0.011794,0.067842,0.97406,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.99999
MIR769_5P,SET,46,-0.24109,-0.012052,0.12398,0.97408,MIR769_5P,0.99999
GOMF_GLUCOSE_BINDING,SET,9,-0.5798,-0.012834,0.29816,0.97408,GOMF_GLUCOSE_BINDING,0.99999
NOTCH3_TARGET_GENES,SET,1079,-0.052246,-0.012288,0.026859,0.97412,NOTCH3_TARGET_GENES,0.99999
GOCC_GATOR1_COMPLEX,SET,5,-0.81876,-0.013509,0.42088,0.97413,GOCC_GATOR1_COMPLEX,0.99999
GOBP_LEUKOCYTE_TETHERING_OR_...,SET,34,-0.30371,-0.013057,0.15607,0.97417,GOBP_LEUKOCYTE_TETHERING_OR_ROLLING,0.99999
GSE21670_TGFB_VS_TGFB_AND_IL...3,SET,184,-0.11408,-0.011363,0.058611,0.97419,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.99999
HP_ABNORMALITY_OF_ENDOCRINE_...,SET,28,-0.33432,-0.013046,0.1717,0.97423,HP_ABNORMALITY_OF_ENDOCRINE_PANCREAS_PHYSIOLOGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...693,SET,5,-0.76006,-0.012541,0.39034,0.97424,GOBP_POSITIVE_REGULATION_OF_SARCOMERE_ORGANIZATION,0.99999
KEGG_MEDICUS_REFERENCE_HGF_M...1,SET,10,-0.53811,-0.012555,0.27624,0.97428,KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY,0.99999
MIR4524A_3P,SET,200,-0.11698,-0.012142,0.060054,0.97428,MIR4524A_3P,0.99999
DESCARTES_FETAL_PLACENTA_TRO...,SET,66,-0.22442,-0.013431,0.1152,0.97429,DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS,0.99999
GOBP_REGULATION_OF_GENERATIO...,SET,121,-0.1436,-0.011619,0.073702,0.97431,GOBP_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,0.99999
GOBP_POSITIVE_REGULATION_OF_...279,SET,6,-0.79253,-0.014324,0.40669,0.97433,GOBP_POSITIVE_REGULATION_OF_FEAR_RESPONSE,0.99999
GOBP_INOSITOL_TRISPHOSPHATE_...2,SET,10,-0.58093,-0.013554,0.29807,0.97434,GOBP_INOSITOL_TRISPHOSPHATE_METABOLIC_PROCESS,0.99999
GOMF_HETEROTRIMERIC_G_PROTEI...,SET,5,-0.83224,-0.013732,0.42698,0.97435,GOMF_HETEROTRIMERIC_G_PROTEIN_BINDING,0.99999
GOBP_N_ACYLETHANOLAMINE_META...,SET,5,-0.67833,-0.011192,0.34776,0.97444,GOBP_N_ACYLETHANOLAMINE_METABOLIC_PROCESS,0.99999
HP_HYPEROSTOSIS,SET,47,-0.22708,-0.011474,0.1164,0.97446,HP_HYPEROSTOSIS,0.99999
BIOCARTA_D4GDI_PATHWAY,SET,12,-0.45323,-0.011583,0.23228,0.97448,BIOCARTA_D4GDI_PATHWAY,0.99999
HP_ABNORMAL_LARGE_INTESTINE_...2,SET,52,-0.23531,-0.012505,0.12058,0.97449,HP_ABNORMAL_LARGE_INTESTINE_PHYSIOLOGY,0.99999
GALI_TP53_TARGETS_APOPTOTIC_...1,SET,6,-0.57683,-0.010426,0.29554,0.97451,GALI_TP53_TARGETS_APOPTOTIC_DN,0.99999
TOMIDA_METASTASIS_DN,SET,11,-0.49419,-0.012092,0.25308,0.97456,TOMIDA_METASTASIS_DN,0.99999
TAKEDA_TARGETS_OF_NUP98_HOXA...8,SET,77,-0.19157,-0.01238,0.098086,0.97459,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP,0.99999
GOMF_MYOSIN_LIGHT_CHAIN_BIND...,SET,8,-0.55833,-0.011652,0.28583,0.9746,GOMF_MYOSIN_LIGHT_CHAIN_BINDING,0.99999
TFDP2_TARGET_GENES,SET,4,-0.68899,-0.010168,0.3526,0.97464,TFDP2_TARGET_GENES,0.99999
GOBP_RESPONSE_TO_ISCHEMIA,SET,62,-0.21763,-0.012625,0.11132,0.9747,GOBP_RESPONSE_TO_ISCHEMIA,0.99999
GSE3982_NEUTROPHIL_VS_BCELL_...2,SET,168,-0.13178,-0.012547,0.067381,0.97474,GSE3982_NEUTROPHIL_VS_BCELL_UP,0.99999
TGGTGCT_MIR29A_MIR29B_MIR29C,SET,470,-0.077322,-0.012212,0.039528,0.97477,TGGTGCT_MIR29A_MIR29B_MIR29C,0.99999
GOBP_NEGATIVE_REGULATION_OF_...125,SET,5,-0.78122,-0.01289,0.39937,0.97477,GOBP_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
GSE24102_GRANULOCYSTIC_MDSC_...1,SET,181,-0.11861,-0.011719,0.060635,0.97477,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN,0.99999
VERHAAK_GLIOBLASTOMA_PRONEUR...,SET,149,-0.14151,-0.012696,0.072333,0.97478,VERHAAK_GLIOBLASTOMA_PRONEURAL,0.99999
REACTOME_G2_M_DNA_REPLICATIO...,SET,5,-0.66367,-0.01095,0.33923,0.97478,REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT,0.99999
GOBP_REGULATION_OF_CELL_PROL...2,SET,6,-0.60716,-0.010974,0.31025,0.97482,GOBP_REGULATION_OF_CELL_PROLIFERATION_IN_BONE_MARROW,0.99999
MIR383_3P,SET,122,-0.1532,-0.012447,0.078245,0.97488,MIR383_3P,0.99999
HP_ABNORMAL_ENZYME_ACTIVITY_...1,SET,21,-0.36994,-0.012504,0.18892,0.97489,HP_ABNORMAL_ENZYME_ACTIVITY_IN_CULTURED_FIBROBLASTS,0.99999
HP_CUPPED_RIBS,SET,23,-0.34286,-0.012127,0.17509,0.97489,HP_CUPPED_RIBS,0.99999
GOBP_CELLULAR_RESPONSE_TO_CO...3,SET,22,-0.41814,-0.014465,0.21348,0.97491,GOBP_CELLULAR_RESPONSE_TO_COPPER_ION,0.99999
MIR8086,SET,21,-0.37859,-0.012796,0.19327,0.97493,MIR8086,0.99999
GOBP_CELLULAR_RESPONSE_TO_LE...3,SET,10,-0.48652,-0.011351,0.24819,0.97501,GOBP_CELLULAR_RESPONSE_TO_LEUCINE_STARVATION,0.99999
BIOCARTA_FEEDER_PATHWAY,SET,8,-0.47797,-0.0099747,0.24381,0.97502,BIOCARTA_FEEDER_PATHWAY,0.99999
SP1_Q2_01,SET,236,-0.10852,-0.012224,0.05535,0.97503,SP1_Q2_01,0.99999
GOBP_PEPTIDYL_THREONINE_MODI...,SET,100,-0.1685,-0.012401,0.085914,0.97507,GOBP_PEPTIDYL_THREONINE_MODIFICATION,0.99999
HP_LOCALIZED_HIRSUTISM,SET,17,-0.36989,-0.01125,0.18859,0.97507,HP_LOCALIZED_HIRSUTISM,0.99999
HE_LIM_SUN_FETAL_LUNG_C4_TRE...,SET,36,-0.31252,-0.013824,0.15933,0.97508,HE_LIM_SUN_FETAL_LUNG_C4_TREG_CELL,0.99999
GCM_PRKAG1,SET,44,-0.22619,-0.011059,0.11529,0.9751,GCM_PRKAG1,0.99999
HP_ABNORMALITY_OF_VITAMIN_D_...,SET,45,-0.24369,-0.012049,0.12422,0.9751,HP_ABNORMALITY_OF_VITAMIN_D_METABOLISM,0.99999
MIR548AZ_3P,SET,437,-0.079753,-0.012156,0.040644,0.97512,MIR548AZ_3P,0.99999
REACTOME_RNA_POLYMERASE_II_P...,SET,72,-0.16733,-0.010458,0.085267,0.97513,REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,0.99999
REACTOME_REPRODUCTION,SET,93,-0.1661,-0.011791,0.084612,0.97517,REACTOME_REPRODUCTION,0.99999
GOMF_CARBOXYPEPTIDASE_ACTIVI...,SET,42,-0.26733,-0.012771,0.13612,0.97523,GOMF_CARBOXYPEPTIDASE_ACTIVITY,0.99999
GOMF_MAP_KINASE_KINASE_KINAS...1,SET,22,-0.35718,-0.012356,0.18184,0.97524,GOMF_MAP_KINASE_KINASE_KINASE_ACTIVITY,0.99999
HP_CUTANEOUS_PHOTOSENSITIVITY,SET,94,-0.16299,-0.011632,0.082981,0.97524,HP_CUTANEOUS_PHOTOSENSITIVITY,0.99999
GAVISH_3CA_METAPROGRAM_EPITH...24,SET,44,-0.26649,-0.01303,0.13566,0.97525,GAVISH_3CA_METAPROGRAM_EPITHELIAL_V_ATPASE,0.99999
HP_BIFID_RIBS,SET,16,-0.40657,-0.011997,0.20695,0.97526,HP_BIFID_RIBS,0.99999
HP_ABNORMAL_NERVOUS_SYSTEM_E...,SET,610,-0.066808,-0.011973,0.034001,0.97528,HP_ABNORMAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY,0.99999
GOCC_CHYLOMICRON,SET,10,-0.62944,-0.014685,0.32019,0.97533,GOCC_CHYLOMICRON,0.99999
GOBP_CELLULAR_RESPIRATION,SET,189,-0.11149,-0.011254,0.056708,0.97535,GOBP_CELLULAR_RESPIRATION,0.99999
GSE14699_NAIVE_VS_DELETIONAL...1,SET,185,-0.12156,-0.01214,0.061828,0.97535,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,0.99999
GOBP_GROOMING_BEHAVIOR,SET,18,-0.44681,-0.013983,0.22712,0.97541,GOBP_GROOMING_BEHAVIOR,0.99999
MARTINEZ_RESPONSE_TO_TRABECT...3,SET,65,-0.2046,-0.012152,0.10398,0.97544,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,0.99999
GSE37532_WT_VS_PPARG_KO_LN_T...2,SET,181,-0.12137,-0.01199,0.061682,0.97544,GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...16,SET,47,-0.27117,-0.013702,0.13781,0.97545,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_MICROVILLAR_CELLS,0.99999
KEGG_MEDICUS_REFERENCE_FAS_J...,SET,7,-0.65072,-0.012703,0.33057,0.97549,KEGG_MEDICUS_REFERENCE_FAS_JNK_SIGNALING_PATHWAY,0.99999
GOBP_AROMATIC_AMINO_ACID_MET...,SET,29,-0.33096,-0.013143,0.16809,0.97551,GOBP_AROMATIC_AMINO_ACID_METABOLIC_PROCESS,0.99999
KUROKAWA_LIVER_CANCER_EARLY_...2,SET,12,-0.42486,-0.010858,0.21568,0.97557,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP,0.99999
JIANG_AGING_HYPOTHALAMUS_DN,SET,30,-0.29403,-0.011875,0.14921,0.97561,JIANG_AGING_HYPOTHALAMUS_DN,0.99999
GSE45365_NK_CELL_VS_CD11B_DC...4,SET,176,-0.12338,-0.012022,0.062602,0.97563,GSE45365_NK_CELL_VS_CD11B_DC_UP,0.99999
GOBP_REGULATION_OF_MELANOCYT...,SET,6,-0.80956,-0.014632,0.41058,0.97567,GOBP_REGULATION_OF_MELANOCYTE_DIFFERENTIATION,0.99999
GOMF_ATPASE_ACTIVATOR_ACTIVI...,SET,24,-0.32319,-0.011677,0.16392,0.97567,GOMF_ATPASE_ACTIVATOR_ACTIVITY,0.99999
HP_ABNORMAL_BRAIN_FDG_POSITR...,SET,22,-0.33162,-0.011472,0.16817,0.97568,HP_ABNORMAL_BRAIN_FDG_POSITRON_EMISSION_TOMOGRAPHY,0.99999
HP_ABNORMAL_CIRCULATING_COPP...,SET,11,-0.49149,-0.012026,0.24925,0.97568,HP_ABNORMAL_CIRCULATING_COPPER_CONCENTRATION,0.99999
HP_FACIAL_HEMANGIOMA,SET,19,-0.39405,-0.012669,0.19966,0.97578,HP_FACIAL_HEMANGIOMA,0.99999
KEGG_MEDICUS_REFERENCE_WEE1_...,SET,6,-0.54969,-0.0099352,0.27841,0.97582,KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M,0.99999
GSE22589_HEALTHY_VS_HIV_AND_...2,SET,182,-0.11585,-0.011477,0.058667,0.97584,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP,0.99999
GSE1791_CTRL_VS_NEUROMEDINU_...7,SET,175,-0.12281,-0.011932,0.062189,0.97585,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN,0.99999
GOMF_ACYLTRANSFERASE_ACTIVITY,SET,650,-0.064984,-0.012008,0.032904,0.97586,GOMF_ACYLTRANSFERASE_ACTIVITY,0.99999
HP_DECREASED_LIBIDO,SET,11,-0.46982,-0.011496,0.23789,0.97586,HP_DECREASED_LIBIDO,0.99999
GOBP_INOSITOL_METABOLIC_PROC...,SET,8,-0.50572,-0.010554,0.25601,0.97588,GOBP_INOSITOL_METABOLIC_PROCESS,0.99999
GOBP_TISSUE_MORPHOGENESIS,SET,576,-0.073102,-0.012743,0.037002,0.97589,GOBP_TISSUE_MORPHOGENESIS,0.99999
QI_HYPOXIA,SET,128,-0.14628,-0.012171,0.074041,0.9759,QI_HYPOXIA,0.99999
GOBP_SRP_DEPENDENT_COTRANSLA...3,SET,8,-0.58447,-0.012197,0.29581,0.97591,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_TRANSLOCATION,0.99999
VANTVEER_BREAST_CANCER_METAS...1,SET,96,-0.18075,-0.013035,0.091466,0.97592,VANTVEER_BREAST_CANCER_METASTASIS_DN,0.99999
MIR4509,SET,60,-0.21229,-0.012116,0.10742,0.97593,MIR4509,0.99999
BURTON_ADIPOGENESIS_4,SET,42,-0.24933,-0.011911,0.1261,0.97598,BURTON_ADIPOGENESIS_4,0.99999
GSE19941_IL10_KO_VS_IL10_KO_...6,SET,183,-0.12605,-0.012521,0.06373,0.97602,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...704,SET,18,-0.41919,-0.013118,0.21192,0.97603,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,0.99999
GOCC_BASAL_DENDRITE,SET,6,-0.76452,-0.013818,0.38641,0.97606,GOCC_BASAL_DENDRITE,0.99999
ZNF491_TARGET_GENES,SET,6,-0.61273,-0.011074,0.30964,0.97608,ZNF491_TARGET_GENES,0.99999
GOBP_NEGATIVE_REGULATION_OF_...116,SET,151,-0.13551,-0.012238,0.068464,0.9761,GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH,0.99999
HP_INERTIA,SET,4,-0.90808,-0.013402,0.45874,0.97611,HP_INERTIA,0.99999
GOCC_MPP7_DLG1_LIN7_COMPLEX,SET,5,-0.84568,-0.013954,0.42705,0.97616,GOCC_MPP7_DLG1_LIN7_COMPLEX,0.99999
BIOCARTA_SODD_PATHWAY,SET,10,-0.51492,-0.012014,0.25995,0.97619,BIOCARTA_SODD_PATHWAY,0.99999
GOBP_BILE_ACID_SECRETION,SET,10,-0.50359,-0.011749,0.25413,0.97623,GOBP_BILE_ACID_SECRETION,0.99999
YGACNNYACAR_UNKNOWN,SET,83,-0.18399,-0.012343,0.092833,0.97625,YGACNNYACAR_UNKNOWN,0.99999
GNF2_ATM,SET,25,-0.32404,-0.011949,0.1635,0.97625,GNF2_ATM,0.99999
HP_RED_EYE,SET,99,-0.16653,-0.012195,0.084004,0.97627,HP_RED_EYE,0.99999
GOMF_STEROL_TRANSFER_ACTIVITY,SET,23,-0.37902,-0.013406,0.19117,0.97629,GOMF_STEROL_TRANSFER_ACTIVITY,0.99999
HP_ABNORMAL_SPERM_AXONEME_MO...,SET,6,-0.71883,-0.012992,0.36256,0.97629,HP_ABNORMAL_SPERM_AXONEME_MORPHOLOGY,0.99999
GSE21546_UNSTIM_VS_ANTI_CD3_...5,SET,134,-0.15192,-0.012931,0.076617,0.9763,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.99999
HP_ABNORMAL_ORAL_GLUCOSE_TOL...,SET,15,-0.45152,-0.0129,0.22763,0.97634,HP_ABNORMAL_ORAL_GLUCOSE_TOLERANCE,0.99999
GSE34156_NOD2_LIGAND_VS_NOD2...1,SET,158,-0.12785,-0.011809,0.064453,0.97634,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,0.99999
TRAVAGLINI_LUNG_VASCULAR_SMO...,SET,57,-0.234,-0.013018,0.11796,0.97635,TRAVAGLINI_LUNG_VASCULAR_SMOOTH_MUSCLE_CELL,0.99999
AATGTGA_MIR23A_MIR23B,SET,381,-0.086055,-0.012267,0.043373,0.97637,AATGTGA_MIR23A_MIR23B,0.99999
MODULE_522,SET,30,-0.31988,-0.012919,0.16122,0.97637,MODULE_522,0.99999
GSE32034_UNTREATED_VS_ROSIGL...1,SET,176,-0.12339,-0.012022,0.062189,0.97637,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_DN,0.99999
REACTOME_G_PROTEIN_BETA_GAMM...,SET,30,-0.31288,-0.012637,0.15762,0.97642,REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING,0.99999
GSE2770_IL12_VS_TGFB_AND_IL1...5,SET,184,-0.11813,-0.011766,0.059476,0.97649,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.99999
HP_IMPAIRED_ANTIGEN_SPECIFIC...,SET,47,-0.25686,-0.012979,0.1293,0.9765,HP_IMPAIRED_ANTIGEN_SPECIFIC_RESPONSE,0.99999
GOBP_STEROL_TRANSPORT,SET,103,-0.16767,-0.012523,0.084384,0.97653,GOBP_STEROL_TRANSPORT,0.99999
GOBP_TRIGLYCERIDE_RICH_LIPOP...1,SET,4,-0.90638,-0.013377,0.45606,0.97655,GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
GOCC_CLATHRIN_COATED_PIT,SET,73,-0.19241,-0.012108,0.09682,0.97655,GOCC_CLATHRIN_COATED_PIT,0.99999
DESCARTES_FETAL_CEREBELLUM_G...,SET,26,-0.35761,-0.013447,0.17994,0.97655,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,0.99999
REACTOME_REGULATION_OF_TP53_...1,SET,152,-0.13322,-0.012071,0.067013,0.97658,REACTOME_REGULATION_OF_TP53_ACTIVITY,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...2,SET,42,-0.24389,-0.011651,0.12269,0.97658,GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE,0.99999
HP_SLEEP_ABNORMALITY,SET,504,-0.07547,-0.012331,0.037955,0.97661,HP_SLEEP_ABNORMALITY,0.99999
SREBP1_01,SET,140,-0.13551,-0.011788,0.068128,0.97665,SREBP1_01,0.99999
REACTOME_APEX1_INDEPENDENT_R...,SET,7,-0.48939,-0.0095538,0.24599,0.97667,REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY,0.99999
MIKKELSEN_ES_ICP_WITH_H3K4ME...,SET,126,-0.15942,-0.013161,0.080101,0.97671,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,0.99999
GOMF_CHLORIDE_CHANNEL_ACTIVI...,SET,72,-0.21686,-0.013553,0.10892,0.97676,GOMF_CHLORIDE_CHANNEL_ACTIVITY,0.99999
GSE27786_CD8_TCELL_VS_NKCELL...2,SET,187,-0.11928,-0.011976,0.059897,0.97677,GSE27786_CD8_TCELL_VS_NKCELL_UP,0.99999
REACTOME_CRMPS_IN_SEMA3A_SIG...,SET,15,-0.4634,-0.01324,0.23264,0.9768,REACTOME_CRMPS_IN_SEMA3A_SIGNALING,0.99999
GOMF_1_PHOSPHATIDYLINOSITOL_...1,SET,10,-0.55568,-0.012965,0.27898,0.9768,GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY,0.99999
PLASARI_TGFB1_SIGNALING_VIA_...3,SET,99,-0.17063,-0.012495,0.085646,0.97682,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,0.99999
GNF2_SNRK,SET,26,-0.32385,-0.012178,0.1625,0.97686,GNF2_SNRK,0.99999
GSE9037_WT_VS_IRAK4_KO_BMDM_...1,SET,179,-0.12483,-0.012265,0.062592,0.97694,GSE9037_WT_VS_IRAK4_KO_BMDM_DN,0.99999
KEGG_MEDICUS_REFERENCE_MLK_J...,SET,10,-0.55549,-0.01296,0.27851,0.97695,KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY,0.99999
HP_SUBCORTICAL_HETEROTOPIA,SET,11,-0.46289,-0.011327,0.232,0.97698,HP_SUBCORTICAL_HETEROTOPIA,0.99999
GSE19401_UNSTIM_VS_PAM2CSK4_...2,SET,175,-0.12505,-0.01215,0.062655,0.97702,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP,0.99999
GSE37301_MULTIPOTENT_PROGENI...10,SET,178,-0.12542,-0.012289,0.06284,0.97702,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP,0.99999
GSE3982_MAST_CELL_VS_NKCELL_...1,SET,179,-0.12714,-0.012492,0.06369,0.97704,GSE3982_MAST_CELL_VS_NKCELL_DN,0.99999
REACTOME_FGFR2B_LIGAND_BINDI...,SET,10,-0.61994,-0.014464,0.31032,0.97712,REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION,0.99999
KIM_MYCL1_AMPLIFICATION_TARG...2,SET,12,-0.53924,-0.013781,0.26985,0.97715,KIM_MYCL1_AMPLIFICATION_TARGETS_UP,0.99999
MIR8076,SET,116,-0.14702,-0.011649,0.073563,0.97716,MIR8076,0.99999
GOBP_VESICLE_DOCKING,SET,57,-0.22053,-0.012268,0.11035,0.97716,GOBP_VESICLE_DOCKING,0.99999
GOBP_THIAMINE_TRANSPORT,SET,8,-0.63362,-0.013223,0.31699,0.97718,GOBP_THIAMINE_TRANSPORT,0.99999
DESCARTES_MAIN_FETAL_MICROGL...,SET,121,-0.15982,-0.012931,0.079953,0.97718,DESCARTES_MAIN_FETAL_MICROGLIA,0.99999
REACTOME_FGFR2_LIGAND_BINDIN...,SET,19,-0.45846,-0.01474,0.2293,0.97721,REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION,0.99999
TBK1.DF_DN,SET,264,-0.1014,-0.012072,0.050713,0.97722,TBK1.DF_DN,0.99999
HP_HYPOPLASIA_OF_TEETH,SET,109,-0.15913,-0.012224,0.079505,0.97733,HP_HYPOPLASIA_OF_TEETH,0.99999
GOBP_REGULATION_OF_INOSITOL_...2,SET,15,-0.47849,-0.013671,0.23904,0.97734,GOBP_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_CD80_...1,SET,10,-0.53501,-0.012482,0.2672,0.97736,KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY,0.99999
CCCNNGGGAR_OLF1_01,SET,293,-0.10077,-0.012627,0.050316,0.97739,CCCNNGGGAR_OLF1_01,0.99999
SMITH_TERT_TARGETS_UP,SET,130,-0.14399,-0.012073,0.071877,0.97742,SMITH_TERT_TARGETS_UP,0.99999
HP_ABNORMAL_HEART_RATE_VARIA...,SET,22,-0.35685,-0.012345,0.17813,0.97742,HP_ABNORMAL_HEART_RATE_VARIABILITY,0.99999
GNF2_CD97,SET,36,-0.30349,-0.013425,0.15144,0.97746,GNF2_CD97,0.99999
SU_LIVER,SET,55,-0.24264,-0.01326,0.12103,0.9775,SU_LIVER,0.99999
HP_ABNORMAL_ERYTHROCYTE_MORP...,SET,599,-0.069247,-0.012302,0.034541,0.9775,HP_ABNORMAL_ERYTHROCYTE_MORPHOLOGY,0.99999
GSE3982_DC_VS_EFF_MEMORY_CD4...1,SET,162,-0.12507,-0.011696,0.062378,0.97751,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN,0.99999
MIR4692,SET,202,-0.11917,-0.012431,0.059426,0.97753,MIR4692,0.99999
GOBP_NEGATIVE_REGULATION_OF_...272,SET,3,-1.2285,-0.015702,0.6123,0.97758,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,0.99999
GOBP_PROTEIN_POLYUBIQUITINAT...,SET,251,-0.10361,-0.012031,0.051633,0.9776,GOBP_PROTEIN_POLYUBIQUITINATION,0.99999
KEGG_MEDICUS_VARIANT_DELETED...,SET,9,-0.55818,-0.012355,0.27813,0.97761,KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX,0.99999
GOBP_RESPIRATORY_SYSTEM_DEVE...,SET,209,-0.12267,-0.013013,0.061112,0.97763,GOBP_RESPIRATORY_SYSTEM_DEVELOPMENT,0.99999
GOBP_PHOSPHATE_ION_HOMEOSTAS...,SET,19,-0.4489,-0.014433,0.22343,0.97773,GOBP_PHOSPHATE_ION_HOMEOSTASIS,0.99999
GSE13547_2H_VS_12_H_ANTI_IGM...4,SET,153,-0.13516,-0.012287,0.067265,0.97774,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP,0.99999
MISSIAGLIA_REGULATED_BY_METH...1,SET,107,-0.15358,-0.01169,0.076424,0.97775,MISSIAGLIA_REGULATED_BY_METHYLATION_DN,0.99999
E2F_Q2,SET,170,-0.13219,-0.012661,0.065785,0.97775,E2F_Q2,0.99999
HP_RECURRENT_HYPOGLYCEMIA,SET,21,-0.3906,-0.013202,0.19416,0.97787,HP_RECURRENT_HYPOGLYCEMIA,0.99999
GSE360_L_MAJOR_VS_B_MALAYI_L...3,SET,176,-0.12159,-0.011848,0.060435,0.97788,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.99999
HP_FACIAL_GRIMACING,SET,10,-0.48605,-0.01134,0.24154,0.9779,HP_FACIAL_GRIMACING,0.99999
HP_DECREASED_MEAN_CORPUSCULA...2,SET,11,-0.46126,-0.011287,0.2292,0.97791,HP_DECREASED_MEAN_CORPUSCULAR_VOLUME,0.99999
HP_ERECTILE_DYSFUNCTION,SET,60,-0.22216,-0.012679,0.11036,0.97794,HP_ERECTILE_DYSFUNCTION,0.99999
GSE17721_LPS_VS_POLYIC_2H_BM...2,SET,187,-0.12815,-0.012866,0.063649,0.97795,GSE17721_LPS_VS_POLYIC_2H_BMDC_UP,0.99999
KEGG_MEDICUS_REFERENCE_CROSS...,SET,15,-0.44663,-0.012761,0.2218,0.97797,KEGG_MEDICUS_REFERENCE_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,0.99999
GOBP_SPECIFICATION_OF_ANIMAL...,SET,35,-0.32496,-0.014174,0.16136,0.97798,GOBP_SPECIFICATION_OF_ANIMAL_ORGAN_IDENTITY,0.99999
DESCARTES_FETAL_LUNG_STROMAL...,SET,37,-0.30199,-0.013543,0.14994,0.97799,DESCARTES_FETAL_LUNG_STROMAL_CELLS,0.99999
GOBP_L_PHENYLALANINE_METABOL...,SET,8,-0.66042,-0.013782,0.32788,0.978,GOBP_L_PHENYLALANINE_METABOLIC_PROCESS,0.99999
OHM_EMBRYONIC_CARCINOMA_UP,SET,6,-0.70054,-0.012662,0.34773,0.97802,OHM_EMBRYONIC_CARCINOMA_UP,0.99999
GOBP_POSITIVE_REGULATION_OF_...56,SET,8,-0.69217,-0.014445,0.34352,0.97804,GOBP_POSITIVE_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,0.99999
AML1_01,SET,251,-0.11182,-0.012984,0.055484,0.97806,AML1_01,0.99999
AML1_Q6,SET,251,-0.11182,-0.012984,0.055484,0.97806,AML1_Q6,0.99999
GSE31622_WT_VS_KLF3_KO_BCELL...1,SET,178,-0.13267,-0.013,0.065815,0.97808,GSE31622_WT_VS_KLF3_KO_BCELL_DN,0.99999
GOBP_TRIGLYCERIDE_RICH_LIPOP...2,SET,10,-0.5945,-0.01387,0.29491,0.97809,GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_REMODELING,0.99999
GOBP_REGULATION_OF_MONOOXYGE...,SET,32,-0.29891,-0.012468,0.14825,0.9781,GOBP_REGULATION_OF_MONOOXYGENASE_ACTIVITY,0.99999
GSE17721_CTRL_VS_POLYIC_1H_B...1,SET,180,-0.12936,-0.012745,0.064149,0.97812,GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN,0.99999
GOBP_PHOSPHAGEN_METABOLIC_PR...,SET,5,-0.65582,-0.010821,0.32515,0.97814,GOBP_PHOSPHAGEN_METABOLIC_PROCESS,0.99999
HP_ABNORMAL_SHARPEY_FIBER_MO...,SET,31,-0.3423,-0.014053,0.16967,0.97817,HP_ABNORMAL_SHARPEY_FIBER_MORPHOLOGY,0.99999
TAKEDA_TARGETS_OF_NUP98_HOXA...9,SET,176,-0.1359,-0.013241,0.067345,0.97819,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,0.99999
HP_RETINAL_DETACHMENT,SET,97,-0.17713,-0.012841,0.087784,0.97819,HP_RETINAL_DETACHMENT,0.99999
GSE34156_TLR1_TLR2_LIGAND_VS...4,SET,184,-0.13244,-0.013191,0.065633,0.97819,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,0.99999
MINGUEZ_LIVER_CANCER_VASCULA...2,SET,13,-0.42875,-0.011404,0.21232,0.97827,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP,0.99999
RPA1_TARGET_GENES,SET,38,-0.28175,-0.012804,0.13949,0.97829,RPA1_TARGET_GENES,0.99999
HP_POLYPHAGIA,SET,67,-0.22556,-0.013601,0.11162,0.97835,HP_POLYPHAGIA,0.99999
REACTOME_CHYLOMICRON_CLEARAN...,SET,4,-0.94907,-0.014007,0.46941,0.9784,REACTOME_CHYLOMICRON_CLEARANCE,0.99999
WP_DISORDERS_IN_KETONE_BODY_...,SET,5,-0.80402,-0.013266,0.3976,0.97841,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,0.99999
HP_ABNORMALITY_OF_CRANIAL_SU...,SET,338,-0.09262,-0.01245,0.045796,0.97843,HP_ABNORMALITY_OF_CRANIAL_SUTURES,0.99999
MIKKELSEN_ES_HCP_WITH_H3_UNM...,SET,55,-0.24687,-0.013491,0.12205,0.97845,MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED,0.99999
GOBP_RESPONSE_TO_DISACCHARIDE,SET,8,-0.56322,-0.011754,0.27834,0.97848,GOBP_RESPONSE_TO_DISACCHARIDE,0.99999
GOMF_NEUROPEPTIDE_ACTIVITY,SET,25,-0.36602,-0.013497,0.18088,0.97848,GOMF_NEUROPEPTIDE_ACTIVITY,0.99999
GSE17721_CTRL_VS_CPG_8H_BMDC...1,SET,187,-0.12469,-0.01252,0.061625,0.97848,GSE17721_CTRL_VS_CPG_8H_BMDC_DN,0.99999
GOBP_NEUROBLAST_DIVISION,SET,14,-0.46306,-0.012782,0.22883,0.97849,GOBP_NEUROBLAST_DIVISION,0.99999
HEN1_01,SET,182,-0.12655,-0.012537,0.062515,0.97852,HEN1_01,0.99999
MORF_PHB,SET,115,-0.14573,-0.011497,0.071942,0.97859,MORF_PHB,0.99999
HSIAO_LIVER_SPECIFIC_GENES,SET,225,-0.12045,-0.013252,0.059451,0.97861,HSIAO_LIVER_SPECIFIC_GENES,0.99999
GOBP_INTRACELLULAR_LIPID_TRA...,SET,44,-0.24729,-0.012091,0.12202,0.97864,GOBP_INTRACELLULAR_LIPID_TRANSPORT,0.99999
GOBP_SMALL_MOLECULE_METABOLI...,SET,1628,-0.044316,-0.012597,0.021863,0.97866,GOBP_SMALL_MOLECULE_METABOLIC_PROCESS,0.99999
GOMF_MITOGEN_ACTIVATED_PROTE...1,SET,29,-0.31316,-0.012436,0.15446,0.97868,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING,0.99999
GOBP_OVULATION_CYCLE_PROCESS,SET,49,-0.26518,-0.013681,0.13079,0.97869,GOBP_OVULATION_CYCLE_PROCESS,0.99999
HP_LARYNGEAL_STENOSIS,SET,14,-0.51785,-0.014294,0.25541,0.97869,HP_LARYNGEAL_STENOSIS,0.99999
HP_DISTURBANCE_OF_FACIAL_EXP...,SET,40,-0.27135,-0.012651,0.13381,0.97871,HP_DISTURBANCE_OF_FACIAL_EXPRESSION,0.99999
GOBP_SKIN_EPIDERMIS_DEVELOPM...,SET,127,-0.16325,-0.01353,0.080469,0.97875,GOBP_SKIN_EPIDERMIS_DEVELOPMENT,0.99999
LIM_MAMMARY_LUMINAL_MATURE_UP,SET,97,-0.18566,-0.013459,0.09147,0.9788,LIM_MAMMARY_LUMINAL_MATURE_UP,0.99999
GOBP_TERMINATION_OF_RNA_POLY...,SET,10,-0.56818,-0.013256,0.27992,0.9788,GOBP_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION,0.99999
GOMF_MAP_KINASE_SCAFFOLD_ACT...,SET,12,-0.50011,-0.012781,0.2463,0.97884,GOMF_MAP_KINASE_SCAFFOLD_ACTIVITY,0.99999
GOBP_REGULATION_OF_TRANSLATI...13,SET,20,-0.37555,-0.012388,0.18493,0.97885,GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,0.99999
HP_DECREASED_CIRCULATING_IGA...,SET,70,-0.20422,-0.012586,0.10057,0.97885,HP_DECREASED_CIRCULATING_IGA_LEVEL,0.99999
GSE22886_IGG_IGA_MEMORY_BCEL...2,SET,180,-0.13075,-0.012882,0.064384,0.97885,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,0.99999
GOBP_MITOCHONDRIAL_TRANSCRIP...,SET,19,-0.37443,-0.012038,0.18429,0.9789,GOBP_MITOCHONDRIAL_TRANSCRIPTION,0.99999
TURASHVILI_BREAST_DUCTAL_CAR...2,SET,42,-0.27575,-0.013173,0.1357,0.97892,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,0.99999
ACAGGGT_MIR10A_MIR10B,SET,111,-0.15717,-0.012183,0.07734,0.97892,ACAGGGT_MIR10A_MIR10B,0.99999
GOBP_CARDIAC_MUSCLE_MYOBLAST...,SET,3,-0.95004,-0.012143,0.46746,0.97893,GOBP_CARDIAC_MUSCLE_MYOBLAST_PROLIFERATION,0.99999
GOMF_HORMONE_BINDING,SET,88,-0.19368,-0.013376,0.095306,0.97893,GOMF_HORMONE_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...142,SET,5,-0.66449,-0.010964,0.32693,0.97894,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_IN_BONE_MARROW,0.99999
GOBP_REGULATION_OF_MITOCHOND...1,SET,6,-0.66851,-0.012083,0.32855,0.97905,GOBP_REGULATION_OF_MITOCHONDRIAL_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT,0.99999
REACTOME_MET_PROMOTES_CELL_M...,SET,41,-0.29003,-0.01369,0.14248,0.9791,REACTOME_MET_PROMOTES_CELL_MOTILITY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...573,SET,20,-0.37295,-0.012302,0.18319,0.97911,GOBP_NEGATIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
HP_LARYNGOTRACHEAL_STENOSIS,SET,5,-0.83404,-0.013762,0.40965,0.97912,HP_LARYNGOTRACHEAL_STENOSIS,0.99999
KEGG_ARGININE_AND_PROLINE_ME...,SET,47,-0.23004,-0.011624,0.11295,0.97915,KEGG_ARGININE_AND_PROLINE_METABOLISM,0.99999
HOEK_B_CELL_2011_2012_TIV_AD...3,SET,30,-0.30535,-0.012332,0.14988,0.97918,HOEK_B_CELL_2011_2012_TIV_ADULT_3DY_UP,0.99999
MIR7150,SET,121,-0.15273,-0.012358,0.074945,0.97921,MIR7150,0.99999
GOBP_NEURAL_PLATE_REGIONALIZ...,SET,5,-0.81507,-0.013448,0.39988,0.97923,GOBP_NEURAL_PLATE_REGIONALIZATION,0.99999
REACTOME_RUNX3_REGULATES_IMM...,SET,6,-0.75461,-0.013639,0.37014,0.97925,REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION,0.99999
HP_MORNING_MYOCLONIC_JERKS,SET,10,-0.6036,-0.014083,0.29594,0.9793,HP_MORNING_MYOCLONIC_JERKS,0.99999
GOBP_REGULATION_OF_NEUROTRAN...5,SET,17,-0.40997,-0.012469,0.20095,0.97932,GOBP_REGULATION_OF_NEUROTRANSMITTER_UPTAKE,0.99999
DESCARTES_FETAL_INTESTINE_LY...1,SET,26,-0.35653,-0.013407,0.17467,0.97938,DESCARTES_FETAL_INTESTINE_LYMPHATIC_ENDOTHELIAL_CELLS,0.99999
GOBP_ACTIVATION_INDUCED_CELL...,SET,8,-0.63901,-0.013336,0.31303,0.97939,GOBP_ACTIVATION_INDUCED_CELL_DEATH_OF_T_CELLS,0.99999
REACTOME_SODIUM_COUPLED_SULP...,SET,5,-0.85594,-0.014123,0.41918,0.97941,REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS,0.99999
YY1_01,SET,225,-0.11466,-0.012614,0.056145,0.97942,YY1_01,0.99999
GSE13306_TREG_VS_TCONV_SPLEE...2,SET,183,-0.13348,-0.013259,0.065324,0.97948,GSE13306_TREG_VS_TCONV_SPLEEN_UP,0.99999
GSE16450_CTRL_VS_IFNA_12H_ST...4,SET,180,-0.13008,-0.012816,0.063661,0.97948,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,0.99999
GOBP_ESTABLISHMENT_OF_EPITHE...2,SET,32,-0.31466,-0.013125,0.15398,0.97949,GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY,0.99999
HP_ABNORMAL_CIRCULATING_FATT...1,SET,39,-0.25698,-0.011831,0.12576,0.97949,HP_ABNORMAL_CIRCULATING_FATTY_ACID_ANION_CONCENTRATION,0.99999
NIKOLSKY_BREAST_CANCER_17P11...,SET,9,-0.7983,-0.01767,0.39051,0.97953,NIKOLSKY_BREAST_CANCER_17P11_AMPLICON,0.99999
KUMAR_AUTOPHAGY_NETWORK,SET,59,-0.22363,-0.012657,0.10939,0.97954,KUMAR_AUTOPHAGY_NETWORK,0.99999
REACTOME_FICOLINS_BIND_TO_RE...,SET,5,-0.88292,-0.014568,0.43185,0.97954,REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE,0.99999
REACTOME_OVARIAN_TUMOR_DOMAI...,SET,34,-0.27968,-0.012024,0.13678,0.97956,REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,0.99999
GOBP_POLARIZED_EPITHELIAL_CE...,SET,24,-0.3653,-0.013198,0.1786,0.97958,GOBP_POLARIZED_EPITHELIAL_CELL_DIFFERENTIATION,0.99999
GOBP_REGULATION_OF_PHOSPHOLI...6,SET,5,-0.88821,-0.014655,0.43416,0.9796,GOBP_REGULATION_OF_PHOSPHOLIPID_CATABOLIC_PROCESS,0.99999
GOMF_AMINOACYLTRANSFERASE_AC...,SET,443,-0.080792,-0.012397,0.03949,0.97961,GOMF_AMINOACYLTRANSFERASE_ACTIVITY,0.99999
GOBP_REGULATION_OF_HETEROCHR...,SET,18,-0.37275,-0.011665,0.18212,0.97965,GOBP_REGULATION_OF_HETEROCHROMATIN_FORMATION,0.99999
GOBP_REGULATION_OF_MUSCLE_AD...,SET,73,-0.21646,-0.013621,0.10575,0.97966,GOBP_REGULATION_OF_MUSCLE_ADAPTATION,0.99999
KEGG_MEDICUS_REFERENCE_KISS1...,SET,11,-0.55455,-0.013569,0.27086,0.97968,KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY,0.99999
WP_FAS_LIGAND_PATHWAY_AND_ST...,SET,42,-0.26799,-0.012803,0.13084,0.97973,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,0.99999
GSE2128_C57BL6_VS_NOD_CD4CD8...2,SET,175,-0.13118,-0.012745,0.064026,0.97975,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_UP,0.99999
REACTOME_UB_SPECIFIC_PROCESS...,SET,148,-0.13172,-0.011778,0.064252,0.97981,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,0.99999
MIR5696,SET,621,-0.071873,-0.012992,0.03503,0.97989,MIR5696,0.99999
MURAKAMI_UV_RESPONSE_6HR_UP,SET,31,-0.30767,-0.012631,0.14993,0.97991,MURAKAMI_UV_RESPONSE_6HR_UP,0.99999
LU_TUMOR_ENDOTHELIAL_MARKERS...2,SET,20,-0.40237,-0.013273,0.19606,0.97992,LU_TUMOR_ENDOTHELIAL_MARKERS_UP,0.99999
HP_LARGE_FONTANELLES,SET,151,-0.14269,-0.012887,0.069531,0.97992,HP_LARGE_FONTANELLES,0.99999
GOMF_GENERAL_TRANSCRIPTION_I...1,SET,46,-0.22307,-0.011151,0.10866,0.97995,GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.99999
GOBP_NUCLEOSIDE_PHOSPHATE_BI...,SET,232,-0.10981,-0.012265,0.053468,0.97999,GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GOBP_CELLULAR_RESPONSE_TO_ST...3,SET,22,-0.3869,-0.013384,0.18836,0.98,GOBP_CELLULAR_RESPONSE_TO_STEROL,0.99999
GSE9988_LOW_LPS_VS_CTRL_TREA...1,SET,187,-0.12215,-0.012264,0.059456,0.98003,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN,0.99999
GSE13547_WT_VS_ZFX_KO_BCELL_...6,SET,156,-0.14456,-0.013268,0.070352,0.98004,GSE13547_WT_VS_ZFX_KO_BCELL_UP,0.99999
HP_MALE_SEXUAL_DYSFUNCTION,SET,78,-0.19783,-0.012867,0.09627,0.98005,HP_MALE_SEXUAL_DYSFUNCTION,0.99999
HP_DECREASED_CIRCULATING_PAR...,SET,10,-0.58176,-0.013573,0.28304,0.98007,HP_DECREASED_CIRCULATING_PARATHYROID_HORMONE_LEVEL,0.99999
GCNP_SHH_UP_LATE.V1_DN,SET,159,-0.13758,-0.012747,0.066931,0.98008,GCNP_SHH_UP_LATE.V1_DN,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...7,SET,166,-0.14051,-0.0133,0.068353,0.98009,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...7,SET,183,-0.12878,-0.012793,0.062637,0.9801,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN,0.99999
GOMF_RNA_POLYMERASE_II_GENER...1,SET,35,-0.25965,-0.011326,0.12625,0.98013,GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,0.99999
GOCC_PHOTORECEPTOR_OUTER_SEG...1,SET,82,-0.1873,-0.012489,0.091045,0.98016,GOCC_PHOTORECEPTOR_OUTER_SEGMENT,0.99999
GOMF_POLYAMINE_TRANSMEMBRANE...,SET,10,-0.62213,-0.014515,0.30236,0.98018,GOMF_POLYAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
HP_ABNORMAL_DUODENUM_MORPHOL...,SET,81,-0.18897,-0.012523,0.091836,0.98018,HP_ABNORMAL_DUODENUM_MORPHOLOGY,0.99999
AMEF2_Q6,SET,229,-0.11851,-0.013152,0.057583,0.9802,AMEF2_Q6,0.99999
GCM_FCGR2B,SET,35,-0.27775,-0.012115,0.13496,0.9802,GCM_FCGR2B,0.99999
HP_ABNORMAL_CIRCULATING_FERR...,SET,47,-0.26042,-0.013159,0.12649,0.98024,HP_ABNORMAL_CIRCULATING_FERRITIN_CONCENTRATION,0.99999
DAVICIONI_RHABDOMYOSARCOMA_P...1,SET,13,-0.58854,-0.015655,0.28578,0.98027,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,0.99999
GSE29618_PRE_VS_DAY7_FLU_VAC...8,SET,175,-0.1297,-0.012602,0.062964,0.98029,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP,0.99999
MIR548E_3P,SET,433,-0.084106,-0.012763,0.040827,0.9803,MIR548E_3P,0.99999
PEDERSEN_METASTASIS_BY_ERBB2...5,SET,25,-0.39736,-0.014653,0.19286,0.98031,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,0.99999
COUP_DR1_Q6,SET,217,-0.11546,-0.012477,0.056039,0.98031,COUP_DR1_Q6,0.99999
GOMF_HSP70_PROTEIN_BINDING,SET,48,-0.2464,-0.012582,0.11959,0.98031,GOMF_HSP70_PROTEIN_BINDING,0.99999
MMEF2_Q6,SET,245,-0.11391,-0.01307,0.055269,0.98034,MMEF2_Q6,0.99999
GSE25087_TREG_VS_TCONV_ADULT...2,SET,174,-0.13664,-0.013239,0.066274,0.98038,GSE25087_TREG_VS_TCONV_ADULT_UP,0.99999
MIR3910,SET,365,-0.094407,-0.013178,0.045778,0.9804,MIR3910,0.99999
GOBP_POSITIVE_REGULATION_OF_...502,SET,21,-0.4146,-0.014013,0.20102,0.98041,GOBP_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,0.99999
GOBP_SIGNAL_TRANSDUCTION_IN_...1,SET,66,-0.21971,-0.013149,0.10647,0.98046,GOBP_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,0.99999
GOBP_ACTIVATION_OF_PROTEIN_K...2,SET,21,-0.38177,-0.012904,0.18495,0.98049,GOBP_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY,0.99999
GOCC_CHLORIDE_CHANNEL_COMPLEX,SET,49,-0.28176,-0.014536,0.1365,0.98049,GOCC_CHLORIDE_CHANNEL_COMPLEX,0.99999
GOBP_RESPONSE_TO_STILBENOID,SET,7,-0.83932,-0.016385,0.40659,0.9805,GOBP_RESPONSE_TO_STILBENOID,0.99999
KUMAR_PATHOGEN_LOAD_BY_MACRO...,SET,228,-0.11552,-0.012792,0.055942,0.98053,KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,0.99999
JAZAG_TGFB1_SIGNALING_DN,SET,32,-0.29219,-0.012187,0.14144,0.98057,JAZAG_TGFB1_SIGNALING_DN,0.99999
GOBP_MOTOR_NEURON_APOPTOTIC_...,SET,21,-0.37391,-0.012638,0.18086,0.98065,GOBP_MOTOR_NEURON_APOPTOTIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...320,SET,8,-0.72849,-0.015203,0.35234,0.98065,GOBP_POSITIVE_REGULATION_OF_GROWTH_HORMONE_SECRETION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...590,SET,34,-0.30731,-0.013212,0.14859,0.98068,GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,0.99999
GOBP_POSITIVE_REGULATION_OF_...326,SET,31,-0.35027,-0.01438,0.16937,0.98068,GOBP_POSITIVE_REGULATION_OF_HEART_GROWTH,0.99999
GAZDA_DIAMOND_BLACKFAN_ANEMI...6,SET,36,-0.30215,-0.013366,0.14605,0.98071,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,0.99999
HP_ANAL_ATRESIA,SET,111,-0.16585,-0.012856,0.080154,0.98073,HP_ANAL_ATRESIA,0.99999
GSE17721_0.5H_VS_8H_LPS_BMDC...1,SET,180,-0.12871,-0.012681,0.062166,0.98078,GSE17721_0.5H_VS_8H_LPS_BMDC_DN,0.99999
KYNG_ENVIRONMENTAL_STRESS_RE...8,SET,48,-0.24396,-0.012457,0.11781,0.9808,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,0.99999
SIG_PIP3_SIGNALING_IN_B_LYMP...,SET,34,-0.3082,-0.01325,0.14881,0.98082,SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,0.99999
GOBP_FATTY_ACID_BETA_OXIDATI...2,SET,11,-0.46221,-0.01131,0.22275,0.981,GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE,0.99999
MIR6800_3P,SET,27,-0.3498,-0.013404,0.16856,0.98101,MIR6800_3P,0.99999
GOBP_ASYMMETRIC_NEUROBLAST_D...,SET,5,-0.72622,-0.011982,0.34985,0.98104,GOBP_ASYMMETRIC_NEUROBLAST_DIVISION,0.99999
GOBP_CORONARY_VASCULATURE_DE...,SET,45,-0.27314,-0.013505,0.13152,0.98108,GOBP_CORONARY_VASCULATURE_DEVELOPMENT,0.99999
GOMF_FOLIC_ACID_BINDING,SET,12,-0.50964,-0.013025,0.24533,0.98111,GOMF_FOLIC_ACID_BINDING,0.99999
GOBP_RESPONSE_TO_NUTRIENT_LE...,SET,454,-0.085158,-0.013224,0.040986,0.98113,GOBP_RESPONSE_TO_NUTRIENT_LEVELS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...265,SET,200,-0.1279,-0.013275,0.061541,0.98115,GOBP_NEGATIVE_REGULATION_OF_GROWTH,0.99999
HP_ECTOPIA_LENTIS,SET,39,-0.30411,-0.014001,0.14633,0.98115,HP_ECTOPIA_LENTIS,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...7,SET,31,-0.33981,-0.013951,0.16352,0.98115,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_GLOBOSE_BASAL_CELLS,0.99999
HP_FLARED_LOWER_LIMB_METAPHY...,SET,5,-0.72684,-0.011993,0.34968,0.98116,HP_FLARED_LOWER_LIMB_METAPHYSIS,0.99999
GSE16450_IMMATURE_VS_MATURE_...6,SET,164,-0.13637,-0.012831,0.065571,0.98122,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,0.99999
CATTGTYY_SOX9_B1,SET,330,-0.098125,-0.013036,0.047167,0.98125,CATTGTYY_SOX9_B1,0.99999
GOBP_REGULATION_OF_PROTEIN_L...10,SET,4,-0.80473,-0.011876,0.38646,0.98134,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_LYSOSOME,0.99999
GOMF_ATPASE_REGULATOR_ACTIVI...,SET,45,-0.2464,-0.012183,0.11833,0.98134,GOMF_ATPASE_REGULATOR_ACTIVITY,0.99999
WP_SARSCOV2_AND_COVID19_PATH...,SET,8,-0.71054,-0.014828,0.34119,0.98135,WP_SARSCOV2_AND_COVID19_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...355,SET,9,-0.60498,-0.013391,0.29049,0.98135,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
HP_SMOOTH_PHILTRUM,SET,159,-0.13608,-0.012608,0.065327,0.98137,HP_SMOOTH_PHILTRUM,0.99999
HP_T_CELL_LYMPHOMA,SET,14,-0.45008,-0.012423,0.21605,0.98138,HP_T_CELL_LYMPHOMA,0.99999
GOMF_LIGASE_ACTIVITY_FORMING...5,SET,5,-0.71821,-0.01185,0.3444,0.98148,GOMF_LIGASE_ACTIVITY_FORMING_PHOSPHORIC_ESTER_BONDS,0.99999
GOBP_CIRCADIAN_SLEEP_WAKE_CY...3,SET,16,-0.47286,-0.013953,0.22671,0.98149,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP,0.99999
HP_LOW_ALKALINE_PHOSPHATASE,SET,10,-0.58669,-0.013688,0.28124,0.98151,HP_LOW_ALKALINE_PHOSPHATASE,0.99999
LIU_PROSTATE_CANCER_UP,SET,86,-0.19819,-0.013532,0.094995,0.98152,LIU_PROSTATE_CANCER_UP,0.99999
HP_URTICARIA,SET,49,-0.23892,-0.012326,0.11452,0.98152,HP_URTICARIA,0.99999
GSE26488_WT_VS_VP16_TRANSGEN...2,SET,181,-0.13234,-0.013075,0.063434,0.98152,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,0.99999
GOBP_PROTEIN_PROCESSING_INVO...,SET,7,-0.64825,-0.012655,0.31065,0.98154,GOBP_PROTEIN_PROCESSING_INVOLVED_IN_PROTEIN_TARGETING_TO_MITOCHONDRION,0.99999
GSE360_DC_VS_MAC_UP,SET,178,-0.13182,-0.012916,0.063166,0.98154,GSE360_DC_VS_MAC_UP,0.99999
REACTOME_FGFR1C_LIGAND_BINDI...,SET,13,-0.54201,-0.014417,0.25971,0.98155,REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION,0.99999
ZIC3_01,SET,235,-0.11675,-0.013124,0.055938,0.98156,ZIC3_01,0.99999
GNF2_MMP11,SET,36,-0.32157,-0.014225,0.154,0.9816,GNF2_MMP11,0.99999
HP_ANTI_SMOOTH_MUSCLE_ANTIBO...,SET,5,-0.70865,-0.011693,0.33934,0.98161,HP_ANTI_SMOOTH_MUSCLE_ANTIBODY_POSITIVITY,0.99999
NAKAYA_PBMC_FLUAD_MALE_AGE_1...2,SET,49,-0.27188,-0.014027,0.13016,0.98163,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN,0.99999
DESCARTES_FETAL_PANCREAS_ENS...2,SET,125,-0.16798,-0.013813,0.0804,0.98166,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,0.99999
REACTOME_CONSTITUTIVE_SIGNAL...2,SET,25,-0.33009,-0.012172,0.15794,0.98168,REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,0.99999
GOBP_NEGATIVE_REGULATION_OF_...405,SET,5,-0.8975,-0.014809,0.42923,0.98173,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS,0.99999
IBRAHIM_NRF3_UP,SET,5,-0.75365,-0.012435,0.36037,0.98174,IBRAHIM_NRF3_UP,0.99999
MIR11399,SET,68,-0.20791,-0.012629,0.09941,0.98175,MIR11399,0.99999
HP_PANCREATIC_ISLET_CELL_HYP...,SET,10,-0.65602,-0.015306,0.31358,0.98178,HP_PANCREATIC_ISLET_CELL_HYPERPLASIA,0.99999
MIR3137,SET,47,-0.27588,-0.01394,0.13184,0.9818,MIR3137,0.99999
GOCC_PROTEASOME_REGULATORY_P...1,SET,11,-0.42732,-0.010456,0.20419,0.98181,GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX,0.99999
PID_SMAD2_3NUCLEAR_PATHWAY,SET,75,-0.20818,-0.013278,0.099467,0.98182,PID_SMAD2_3NUCLEAR_PATHWAY,0.99999
GOMF_GUANYLATE_CYCLASE_ACTIV...,SET,5,-0.80419,-0.013269,0.38413,0.98184,GOMF_GUANYLATE_CYCLASE_ACTIVITY,0.99999
chr6q16,SET,24,-0.69853,-0.025238,0.33364,0.98185,chr6q16,0.99999
GOCC_TRANSCRIPTION_EXPORT_CO...1,SET,10,-0.43958,-0.010256,0.20989,0.98188,GOCC_TRANSCRIPTION_EXPORT_COMPLEX,0.99999
HP_RIDGED_NAIL,SET,20,-0.35412,-0.011681,0.16908,0.98188,HP_RIDGED_NAIL,0.99999
WARTERS_RESPONSE_TO_IR_SKIN,SET,70,-0.20784,-0.012809,0.099214,0.9819,WARTERS_RESPONSE_TO_IR_SKIN,0.99999
GOCC_PHOSPHATIDYLINOSITOL_3_...1,SET,29,-0.34556,-0.013723,0.16494,0.98191,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX,0.99999
GSE13762_CTRL_VS_125_VITAMIN...2,SET,131,-0.1547,-0.01302,0.073833,0.98192,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP,0.99999
GOMF_CALMODULIN_BINDING,SET,197,-0.12666,-0.01305,0.060446,0.98193,GOMF_CALMODULIN_BINDING,0.99999
HP_SUBCORTICAL_BAND_HETEROTO...,SET,10,-0.49988,-0.011663,0.23856,0.98193,HP_SUBCORTICAL_BAND_HETEROTOPIA,0.99999
GSE21380_NON_TFH_VS_GERMINAL...1,SET,184,-0.12596,-0.012546,0.060107,0.98194,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,0.99999
HP_THORACIC_KYPHOSIS,SET,43,-0.24616,-0.011899,0.11734,0.98203,HP_THORACIC_KYPHOSIS,0.99999
GOBP_SOMITE_SPECIFICATION,SET,4,-0.91626,-0.013522,0.4367,0.98205,GOBP_SOMITE_SPECIFICATION,0.99999
GSE34006_UNTREATED_VS_A2AR_A...2,SET,176,-0.12836,-0.012506,0.061165,0.98206,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_UP,0.99999
MORF_RAD51L3,SET,343,-0.09761,-0.013216,0.046505,0.98208,MORF_RAD51L3,0.99999
GOBP_NEGATIVE_REGULATION_OF_...662,SET,26,-0.34986,-0.013156,0.1667,0.98208,GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_CELLULAR_...12,SET,17,-0.40414,-0.012292,0.19246,0.98212,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA,0.99999
MIR346,SET,61,-0.22175,-0.01276,0.10555,0.98217,MIR346,0.99999
HP_CRYPTOZOOSPERMIA,SET,6,-0.70415,-0.012727,0.33509,0.98219,HP_CRYPTOZOOSPERMIA,0.99999
chr6q14,SET,36,-0.44905,-0.019864,0.21366,0.9822,chr6q14,0.99999
WP_GPCRS_CLASS_A_RHODOPSINLI...,SET,230,-0.13444,-0.014953,0.063897,0.98231,WP_GPCRS_CLASS_A_RHODOPSINLIKE,0.99999
GOBP_PHOSPHATIDYLCHOLINE_MET...,SET,67,-0.22033,-0.013285,0.10471,0.98231,GOBP_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,0.99999
GSE7460_CTRL_VS_TGFB_TREATED...5,SET,186,-0.13457,-0.013475,0.063952,0.98231,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN,0.99999
MIR519E_5P,SET,285,-0.1072,-0.013252,0.050902,0.98239,MIR519E_5P,0.99999
GOCC_CORNIFIED_ENVELOPE,SET,58,-0.27849,-0.015628,0.13222,0.9824,GOCC_CORNIFIED_ENVELOPE,0.99999
LINDSTEDT_DENDRITIC_CELL_MAT...2,SET,44,-0.29968,-0.014653,0.14226,0.98241,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,0.99999
GSE8921_UNSTIM_0H_VS_TLR1_2_...4,SET,171,-0.13974,-0.013423,0.066329,0.98242,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP,0.99999
MIR3156_5P,SET,61,-0.24452,-0.01407,0.11604,0.98244,MIR3156_5P,0.99999
WP_MRNA_PROCESSING,SET,116,-0.14878,-0.011788,0.07058,0.98248,WP_MRNA_PROCESSING,0.99999
HP_EEG_WITH_FRONTAL_EPILEPTI...,SET,5,-0.92126,-0.015201,0.43691,0.9825,HP_EEG_WITH_FRONTAL_EPILEPTIFORM_DISCHARGES,0.99999
GSE24972_WT_VS_IRF8_KO_MARGI...1,SET,181,-0.13195,-0.013037,0.062574,0.98251,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_DN,0.99999
BMI1_DN_MEL18_DN.V1_DN,SET,129,-0.16703,-0.013951,0.079197,0.98252,BMI1_DN_MEL18_DN.V1_DN,0.99999
GSE46606_UNSTIM_VS_CD40L_IL2...16,SET,168,-0.14147,-0.013471,0.067025,0.9826,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.99999
GSE2770_UNTREATED_VS_IL12_TR...2,SET,176,-0.13405,-0.013061,0.063468,0.98266,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,0.99999
MIR183_5P,SET,210,-0.12564,-0.01336,0.059477,0.98267,MIR183_5P,0.99999
GOBP_GRANZYME_MEDIATED_PROGR...,SET,8,-0.68291,-0.014252,0.32329,0.98267,GOBP_GRANZYME_MEDIATED_PROGRAMMED_CELL_DEATH_SIGNALING_PATHWAY,0.99999
NUTT_GBM_VS_AO_GLIOMA_DN,SET,44,-0.25282,-0.012361,0.11964,0.9827,NUTT_GBM_VS_AO_GLIOMA_DN,0.99999
KEGG_MEDICUS_REFERENCE_TYROS...,SET,5,-0.81109,-0.013383,0.38373,0.98272,KEGG_MEDICUS_REFERENCE_TYROSINE_DEGRADATION,0.99999
REACTOME_TYROSINE_CATABOLISM,SET,5,-0.81109,-0.013383,0.38373,0.98272,REACTOME_TYROSINE_CATABOLISM,0.99999
WP_TYROSINE_METABOLISM_AND_R...,SET,5,-0.81109,-0.013383,0.38373,0.98272,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,0.99999
GOBP_EXOCRINE_SYSTEM_DEVELOP...,SET,48,-0.26529,-0.013547,0.12549,0.98274,GOBP_EXOCRINE_SYSTEM_DEVELOPMENT,0.99999
GOBP_GLUTAMINE_METABOLIC_PRO...,SET,25,-0.35245,-0.012997,0.16668,0.98276,GOBP_GLUTAMINE_METABOLIC_PROCESS,0.99999
GOBP_ORGANIC_HYDROXY_COMPOUN...2,SET,50,-0.27367,-0.014261,0.12942,0.98276,GOBP_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS,0.99999
GOBP_VIRAL_PROTEIN_PROCESSING,SET,31,-0.3134,-0.012867,0.14818,0.98278,GOBP_VIRAL_PROTEIN_PROCESSING,0.99999
HP_ABNORMAL_MEAN_CORPUSCULAR...1,SET,16,-0.42053,-0.012409,0.19881,0.98279,HP_ABNORMAL_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,0.99999
GOCC_EARP_COMPLEX,SET,3,-0.89863,-0.011486,0.42475,0.98281,GOCC_EARP_COMPLEX,0.99999
CGGAARNGGCNG_UNKNOWN,SET,52,-0.23084,-0.012268,0.10908,0.98283,CGGAARNGGCNG_UNKNOWN,0.99999
SRC_UP.V1_DN,SET,147,-0.14797,-0.013187,0.069924,0.98283,SRC_UP.V1_DN,0.99999
GOBP_CHEMICAL_HOMEOSTASIS,SET,934,-0.061801,-0.01358,0.029193,0.98286,GOBP_CHEMICAL_HOMEOSTASIS,0.99999
REACTOME_DEUBIQUITINATION,SET,217,-0.1145,-0.012373,0.054082,0.98287,REACTOME_DEUBIQUITINATION,0.99999
ZNF23_TARGET_GENES,SET,13,-0.48952,-0.013021,0.23121,0.98287,ZNF23_TARGET_GENES,0.99999
GSE17721_CTRL_VS_POLYIC_6H_B...1,SET,189,-0.13209,-0.013333,0.062362,0.98291,GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN,0.99999
REACTOME_PTEN_REGULATION,SET,131,-0.14563,-0.012257,0.068735,0.98294,REACTOME_PTEN_REGULATION,0.99999
GFI1_01,SET,241,-0.1184,-0.013476,0.05584,0.98301,GFI1_01,0.99999
HP_ABNORMAL_VITREOUS_HUMOR_M...,SET,42,-0.27628,-0.013199,0.13019,0.98308,HP_ABNORMAL_VITREOUS_HUMOR_MORPHOLOGY,0.99999
GSE7768_OVA_ALONE_VS_OVA_WIT...1,SET,157,-0.14672,-0.013509,0.069105,0.98312,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,0.99999
GOBP_RESPONSE_TO_FIBROBLAST_...,SET,107,-0.18606,-0.014162,0.08761,0.98314,GOBP_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR,0.99999
HP_CENTRAL_NERVOUS_SYSTEM_CY...,SET,180,-0.12768,-0.012579,0.060117,0.98315,HP_CENTRAL_NERVOUS_SYSTEM_CYST,0.99999
GOBP_DETERMINATION_OF_LIVER_...,SET,5,-0.77744,-0.012828,0.366,0.98316,GOBP_DETERMINATION_OF_LIVER_LEFT_RIGHT_ASYMMETRY,0.99999
GOBP_POSITIVE_REGULATION_OF_...241,SET,4,-1.0069,-0.014861,0.47405,0.98316,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MATRIX_ADHESION_VIA_FIBRONECTIN,0.99999
BERTUCCI_INVASIVE_CARCINOMA_...1,SET,41,-0.29888,-0.014108,0.14069,0.98317,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,0.99999
HP_ABNORMAL_CIRCULATING_OSTE...,SET,8,-0.68518,-0.014299,0.32252,0.98318,HP_ABNORMAL_CIRCULATING_OSTEOCALCIN_LEVEL,0.99999
ZHONG_PFC_C3_UNKNOWN_INP,SET,36,-0.287,-0.012696,0.13507,0.98319,ZHONG_PFC_C3_UNKNOWN_INP,0.99999
chr15q21,SET,78,-0.36667,-0.023848,0.17254,0.9832,chr15q21,0.99999
MIR515_5P,SET,282,-0.1089,-0.013392,0.051246,0.9832,MIR515_5P,0.99999
REACTOME_RHOD_GTPASE_CYCLE,SET,48,-0.27198,-0.013888,0.12794,0.98323,REACTOME_RHOD_GTPASE_CYCLE,0.99999
KEGG_INTESTINAL_IMMUNE_NETWO...,SET,40,-0.3033,-0.014141,0.14266,0.98324,KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,0.99999
GOBP_CGMP_BIOSYNTHETIC_PROCE...,SET,7,-0.70557,-0.013774,0.3318,0.98326,GOBP_CGMP_BIOSYNTHETIC_PROCESS,0.99999
GOBP_BIOGENIC_AMINE_METABOLI...,SET,83,-0.20633,-0.013841,0.097016,0.98327,GOBP_BIOGENIC_AMINE_METABOLIC_PROCESS,0.99999
WP_13Q1212_COPY_NUMBER_VARIA...,SET,31,-0.33087,-0.013584,0.15556,0.98328,WP_13Q1212_COPY_NUMBER_VARIATION,0.99999
TERF1_TARGET_GENES,SET,214,-0.12383,-0.01329,0.058216,0.98329,TERF1_TARGET_GENES,0.99999
GSE2770_IL4_ACT_VS_ACT_CD4_T...3,SET,179,-0.13541,-0.013304,0.063655,0.98329,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,0.99999
DAVICIONI_PAX_FOXO1_SIGNATUR...1,SET,19,-0.46496,-0.014949,0.21842,0.98336,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,0.99999
FREDERICK_PRKCI_TARGETS,SET,9,-0.57621,-0.012754,0.27063,0.98337,FREDERICK_PRKCI_TARGETS,0.99999
MIR18A_3P,SET,82,-0.19113,-0.012744,0.089756,0.98338,MIR18A_3P,0.99999
MIR4301,SET,34,-0.28438,-0.012226,0.13355,0.98338,MIR4301,0.99999
GOCC_MESSENGER_RIBONUCLEOPRO...,SET,6,-0.64094,-0.011584,0.30078,0.98345,GOCC_MESSENGER_RIBONUCLEOPROTEIN_COMPLEX,0.99999
GNF2_TST,SET,99,-0.17824,-0.013052,0.083588,0.9835,GNF2_TST,0.99999
GOBP_TRIGLYCERIDE_CATABOLIC_...,SET,26,-0.38119,-0.014334,0.17873,0.98352,GOBP_TRIGLYCERIDE_CATABOLIC_PROCESS,0.99999
WANG_BARRETTS_ESOPHAGUS_AND_...1,SET,33,-0.31661,-0.01341,0.14842,0.98354,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN,0.99999
GSE17974_IL4_AND_ANTI_IL12_V...7,SET,163,-0.14861,-0.01394,0.069655,0.98355,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN,0.99999
REACTOME_VITAMIN_D_CALCIFERO...,SET,12,-0.55458,-0.014173,0.25991,0.98356,REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM,0.99999
GOBP_NEGATIVE_REGULATION_OF_...587,SET,1298,-0.052202,-0.01338,0.024459,0.98358,GOBP_NEGATIVE_REGULATION_OF_SIGNALING,0.99999
ZIC2_01,SET,228,-0.12137,-0.01344,0.056858,0.9836,ZIC2_01,0.99999
GOBP_ANGIOTENSIN_ACTIVATED_S...,SET,17,-0.47856,-0.014555,0.22419,0.9836,GOBP_ANGIOTENSIN_ACTIVATED_SIGNALING_PATHWAY,0.99999
GOBP_ETHANOLAMINE_CONTAINING...,SET,7,-0.66434,-0.012969,0.31105,0.98365,GOBP_ETHANOLAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.99999
GOBP_REGULATION_OF_CIRCADIAN...1,SET,105,-0.18187,-0.013714,0.085148,0.98365,GOBP_REGULATION_OF_CIRCADIAN_RHYTHM,0.99999
MIR508_5P,SET,86,-0.19892,-0.013582,0.093118,0.98366,MIR508_5P,0.99999
GNF2_KISS1,SET,43,-0.30181,-0.014588,0.14116,0.98374,GNF2_KISS1,0.99999
GOMF_BASAL_TRANSCRIPTION_MAC...,SET,56,-0.24041,-0.013257,0.1124,0.98377,GOMF_BASAL_TRANSCRIPTION_MACHINERY_BINDING,0.99999
WELCSH_BRCA1_TARGETS_UP,SET,180,-0.13283,-0.013087,0.062087,0.98379,WELCSH_BRCA1_TARGETS_UP,0.99999
HAY_BONE_MARROW_CD34_POS_MUL...,SET,17,-0.44841,-0.013638,0.20957,0.9838,HAY_BONE_MARROW_CD34_POS_MULTILIN,0.99999
GOBP_MAINTENANCE_OF_PROTEIN_...3,SET,81,-0.19952,-0.013223,0.093235,0.98381,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION,0.99999
MIR5001_5P,SET,159,-0.13631,-0.01263,0.063674,0.98385,MIR5001_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...92,SET,622,-0.072472,-0.013111,0.033842,0.98388,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION,0.99999
GOBP_REGULATION_OF_CELLULAR_...20,SET,41,-0.27162,-0.012821,0.12681,0.9839,GOBP_REGULATION_OF_CELLULAR_SENESCENCE,0.99999
REACTOME_TP53_REGULATES_TRAN...2,SET,12,-0.45301,-0.011577,0.21145,0.98391,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES,0.99999
GOBP_REGULATION_OF_GLUTAMATE...3,SET,19,-0.46424,-0.014926,0.21669,0.98391,GOBP_REGULATION_OF_GLUTAMATE_SECRETION,0.99999
REACTOME_PROTEIN_PROTEIN_INT...,SET,77,-0.21536,-0.013917,0.10052,0.98392,REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,0.99999
GOCC_DENDRITIC_TREE,SET,570,-0.078496,-0.013614,0.036634,0.98393,GOCC_DENDRITIC_TREE,0.99999
MODULE_135,SET,25,-0.38768,-0.014295,0.1809,0.98394,MODULE_135,0.99999
TTTGCAC_MIR19A_MIR19B,SET,466,-0.085359,-0.013425,0.039826,0.98395,TTTGCAC_MIR19A_MIR19B,0.99999
STARK_BRAIN_22Q11_DELETION,SET,10,-0.57198,-0.013345,0.2668,0.98397,STARK_BRAIN_22Q11_DELETION,0.99999
GSE4590_PRE_BCELL_VS_LARGE_P...2,SET,142,-0.16017,-0.014031,0.074683,0.984,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP,0.99999
MIR762,SET,163,-0.13354,-0.012527,0.062258,0.98402,MIR762,0.99999
MODULE_122,SET,129,-0.17376,-0.014514,0.081001,0.98402,MODULE_122,0.99999
GSE17721_POLYIC_VS_GARDIQUIM...6,SET,186,-0.13382,-0.0134,0.062374,0.98403,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP,0.99999
WANG_TNF_TARGETS,SET,24,-0.39097,-0.014126,0.18221,0.98404,WANG_TNF_TARGETS,0.99999
TTAYRTAA_E4BP4_01,SET,236,-0.12435,-0.014007,0.057956,0.98404,TTAYRTAA_E4BP4_01,0.99999
GOBP_VESICLE_MEDIATED_CHOLES...,SET,9,-0.6023,-0.013332,0.28067,0.98405,GOBP_VESICLE_MEDIATED_CHOLESTEROL_TRANSPORT,0.99999
MIR6883_3P,SET,50,-0.26425,-0.013771,0.12314,0.98406,MIR6883_3P,0.99999
GOMF_DYNEIN_COMPLEX_BINDING,SET,19,-0.40665,-0.013075,0.18948,0.98406,GOMF_DYNEIN_COMPLEX_BINDING,0.99999
FEKIR_HEPARG_SIDE_POP_VS_HEP...2,SET,77,-0.20004,-0.012927,0.093168,0.9841,FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP,0.99999
MEK_UP.V1_DN,SET,162,-0.14515,-0.013574,0.06758,0.98413,MEK_UP.V1_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...358,SET,8,-0.67374,-0.01406,0.31357,0.98416,GOBP_NEGATIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.99999
GOBP_REGULATION_OF_PLATELET_...5,SET,22,-0.38994,-0.01349,0.18145,0.98418,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
HP_ABNORMAL_RENAL_TUBULAR_RE...,SET,19,-0.43061,-0.013845,0.20034,0.98419,HP_ABNORMAL_RENAL_TUBULAR_RESORPTION,0.99999
WP_THYROID_HORMONES_PRODUCTI...,SET,90,-0.19202,-0.013411,0.089328,0.9842,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,0.99999
GOMF_METALLOEXOPEPTIDASE_ACT...,SET,63,-0.25441,-0.014877,0.11819,0.98432,GOMF_METALLOEXOPEPTIDASE_ACTIVITY,0.99999
HP_ABNORMAL_CIRCULATING_IGG_...,SET,107,-0.17499,-0.013319,0.081287,0.98432,HP_ABNORMAL_CIRCULATING_IGG_LEVEL,0.99999
GOBP_NEUTROPHIL_CLEARANCE,SET,6,-0.84644,-0.015299,0.39313,0.98434,GOBP_NEUTROPHIL_CLEARANCE,0.99999
GSE6092_UNSTIM_VS_IFNG_STIM_...3,SET,173,-0.13559,-0.0131,0.06296,0.98436,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN,0.99999
HP_DISINHIBITION,SET,539,-0.079381,-0.0134,0.036843,0.9844,HP_DISINHIBITION,0.99999
GOBP_NECROPTOTIC_PROCESS,SET,36,-0.30676,-0.01357,0.14229,0.98445,GOBP_NECROPTOTIC_PROCESS,0.99999
HP_OVERHANGING_NASAL_TIP,SET,7,-0.587,-0.011459,0.27196,0.98454,HP_OVERHANGING_NASAL_TIP,0.99999
GSE43863_NAIVE_VS_LY6C_LOW_C...2,SET,139,-0.15292,-0.013254,0.070825,0.98457,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_UP,0.99999
MIR203A_3P,SET,334,-0.10303,-0.013769,0.047707,0.98459,MIR203A_3P,0.99999
GOBP_LATERAL_MESODERM_MORPHO...,SET,5,-0.87527,-0.014442,0.40518,0.98461,GOBP_LATERAL_MESODERM_MORPHOGENESIS,0.99999
GOBP_PENTOSE_METABOLIC_PROCE...,SET,12,-0.51328,-0.013118,0.23757,0.98463,GOBP_PENTOSE_METABOLIC_PROCESS,0.99999
GOBP_RENAL_TUBULE_DEVELOPMENT,SET,96,-0.20513,-0.014794,0.094946,0.98463,GOBP_RENAL_TUBULE_DEVELOPMENT,0.99999
HP_RETINAL_NONATTACHMENT,SET,7,-0.7384,-0.014415,0.34172,0.98464,HP_RETINAL_NONATTACHMENT,0.99999
MIR338_3P,SET,132,-0.16438,-0.013888,0.076052,0.98466,MIR338_3P,0.99999
GOBP_MULTI_MULTICELLULAR_ORG...,SET,191,-0.13891,-0.014094,0.064268,0.98466,GOBP_MULTI_MULTICELLULAR_ORGANISM_PROCESS,0.99999
GOBP_RESPONSE_TO_INCREASED_O...,SET,23,-0.36353,-0.012858,0.16819,0.98466,GOBP_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,0.99999
GAVISH_3CA_METAPROGRAM_B_CEL...1,SET,41,-0.26143,-0.01234,0.12088,0.98471,GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1,0.99999
HP_POOR_SUCK,SET,126,-0.169,-0.013952,0.078106,0.98475,HP_POOR_SUCK,0.99999
GOMF_LIPASE_ACTIVITY,SET,127,-0.16604,-0.013762,0.076728,0.98476,GOMF_LIPASE_ACTIVITY,0.99999
KANG_GLIS3_TARGETS,SET,34,-0.34713,-0.014924,0.16039,0.98477,KANG_GLIS3_TARGETS,0.99999
SA_CASPASE_CASCADE,SET,18,-0.43621,-0.013651,0.20156,0.98477,SA_CASPASE_CASCADE,0.99999
HP_PSEUDOARTHROSIS,SET,8,-0.6415,-0.013387,0.2963,0.9848,HP_PSEUDOARTHROSIS,0.99999
GOBP_TUBE_DEVELOPMENT,SET,1009,-0.06104,-0.01391,0.028191,0.98481,GOBP_TUBE_DEVELOPMENT,0.99999
AP2REP_01,SET,156,-0.15071,-0.013833,0.069601,0.98482,AP2REP_01,0.99999
GOBP_ALCOHOL_METABOLIC_PROCE...,SET,332,-0.10163,-0.013542,0.046917,0.98484,GOBP_ALCOHOL_METABOLIC_PROCESS,0.99999
PATEL_SKIN_OF_BODY_ZOSTAVAX_...1,SET,25,-0.39501,-0.014566,0.18237,0.98484,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGED_POST_VACCINATION_VS_UNCHALLENGED_72HR_TOP_30_DEG_UP,0.99999
CSR_LATE_UP.V1_DN,SET,130,-0.17195,-0.014417,0.07935,0.98487,CSR_LATE_UP.V1_DN,0.99999
GOBP_INTRACELLULAR_PH_REDUCT...,SET,51,-0.26791,-0.0141,0.12357,0.98492,GOBP_INTRACELLULAR_PH_REDUCTION,0.99999
HP_PROLINURIA,SET,7,-0.72092,-0.014074,0.33244,0.98494,HP_PROLINURIA,0.99999
GOBP_RESPONSE_TO_HYPEROXIA,SET,17,-0.42303,-0.012866,0.19484,0.98503,GOBP_RESPONSE_TO_HYPEROXIA,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...6,SET,43,-0.31047,-0.015007,0.14299,0.98504,GAVISH_3CA_MALIGNANT_METAPROGRAM_15_EMT_4,0.99999
GOBP_RAP_PROTEIN_SIGNAL_TRAN...,SET,12,-0.58512,-0.014954,0.26948,0.98504,GOBP_RAP_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
KEGG_MEDICUS_REFERENCE_LECTI...3,SET,9,-0.66282,-0.014671,0.30519,0.98506,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,0.99999
HP_INVOLUNTARY_VOCALIZATION,SET,42,-0.26937,-0.012868,0.12402,0.98506,HP_INVOLUNTARY_VOCALIZATION,0.99999
BIOCARTA_CARM_ER_PATHWAY,SET,22,-0.37329,-0.012914,0.1717,0.98514,BIOCARTA_CARM_ER_PATHWAY,0.99999
BCL6B_TARGET_GENES,SET,129,-0.16523,-0.013801,0.075972,0.98517,BCL6B_TARGET_GENES,0.99999
GSE42021_CD24INT_TREG_VS_CD2...1,SET,178,-0.12884,-0.012624,0.059241,0.98517,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_DN,0.99999
MIR4498,SET,231,-0.12177,-0.013572,0.055979,0.98519,MIR4498,0.99999
MIR5089_5P,SET,103,-0.18049,-0.01348,0.082884,0.98528,MIR5089_5P,0.99999
GOBP_POSITIVE_REGULATION_OF_...304,SET,3,-1.1913,-0.015226,0.54695,0.98529,GOBP_POSITIVE_REGULATION_OF_GLOMERULUS_DEVELOPMENT,0.99999
SASAI_TARGETS_OF_CXCR6_AND_P...2,SET,12,-0.56487,-0.014436,0.25929,0.98531,SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...256,SET,15,-0.43342,-0.012383,0.19888,0.98534,GOBP_NEGATIVE_REGULATION_OF_GLUCONEOGENESIS,0.99999
GSE17721_CTRL_VS_LPS_2H_BMDC...1,SET,183,-0.13811,-0.013719,0.063358,0.98536,GSE17721_CTRL_VS_LPS_2H_BMDC_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...286,SET,6,-0.66854,-0.012083,0.30667,0.98537,GOBP_NEGATIVE_REGULATION_OF_HYPOXIA_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.99999
DER_IFN_GAMMA_RESPONSE_DN,SET,10,-0.63698,-0.014861,0.29213,0.98538,DER_IFN_GAMMA_RESPONSE_DN,0.99999
PID_SYNDECAN_4_PATHWAY,SET,31,-0.33986,-0.013953,0.15586,0.98539,PID_SYNDECAN_4_PATHWAY,0.99999
GSE13411_NAIVE_VS_MEMORY_BCE...2,SET,163,-0.14546,-0.013644,0.066705,0.98539,GSE13411_NAIVE_VS_MEMORY_BCELL_UP,0.99999
GOCC_COPI_VESICLE_COAT,SET,12,-0.44692,-0.011422,0.2049,0.98541,GOCC_COPI_VESICLE_COAT,0.99999
MIR6503_3P,SET,28,-0.33699,-0.01315,0.15443,0.98544,MIR6503_3P,0.99999
GSE2585_THYMIC_DC_VS_MTEC_UP,SET,172,-0.13814,-0.013308,0.063307,0.98544,GSE2585_THYMIC_DC_VS_MTEC_UP,0.99999
GOCC_APICAL_DENDRITE,SET,16,-0.46057,-0.01359,0.21097,0.98548,GOCC_APICAL_DENDRITE,0.99999
KEGG_MEDICUS_VARIANT_MUTATIO...15,SET,9,-0.62403,-0.013812,0.28574,0.98551,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_TRANSLATI...6,SET,15,-0.46786,-0.013367,0.2142,0.98552,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS,0.99999
HP_HYPOHIDROSIS,SET,64,-0.23891,-0.014081,0.10934,0.98555,HP_HYPOHIDROSIS,0.99999
KIM_ALL_DISORDERS_DURATION_C...2,SET,8,-0.56638,-0.01182,0.25918,0.98556,KIM_ALL_DISORDERS_DURATION_CORR_UP,0.99999
MIR4688,SET,44,-0.26601,-0.013007,0.12172,0.98556,MIR4688,0.99999
MIR5191,SET,27,-0.3602,-0.013803,0.16482,0.98556,MIR5191,0.99999
GSE9988_LPS_VS_VEHICLE_TREAT...1,SET,184,-0.1309,-0.013038,0.059833,0.98565,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,0.99999
GOCC_CALCIUM_AND_CALMODULIN_...,SET,5,-0.88995,-0.014684,0.4066,0.98569,GOCC_CALCIUM_AND_CALMODULIN_DEPENDENT_PROTEIN_KINASE_COMPLEX,0.99999
HP_REPETITIVE_COMPULSIVE_BEH...,SET,12,-0.5969,-0.015255,0.27268,0.98569,HP_REPETITIVE_COMPULSIVE_BEHAVIOR,0.99999
GOMF_SODIUM_BICARBONATE_SYMP...,SET,6,-0.68429,-0.012368,0.31259,0.9857,GOMF_SODIUM_BICARBONATE_SYMPORTER_ACTIVITY,0.99999
MIR619_5P,SET,130,-0.15984,-0.013402,0.072965,0.98575,MIR619_5P,0.99999
CDC5_01,SET,228,-0.12899,-0.014285,0.058875,0.98577,CDC5_01,0.99999
KEGG_MEDICUS_PATHOGEN_HIV_VP...3,SET,4,-0.80816,-0.011927,0.36873,0.98579,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_WEE1_CELL_CYCLE_G2M,0.99999
GSE18804_BRAIN_VS_COLON_TUMO...2,SET,144,-0.16114,-0.014214,0.073478,0.98584,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP,0.99999
GOMF_DEATH_RECEPTOR_BINDING,SET,19,-0.40424,-0.012997,0.1843,0.98585,GOMF_DEATH_RECEPTOR_BINDING,0.99999
PID_ARF6_TRAFFICKING_PATHWAY,SET,47,-0.27747,-0.014021,0.12637,0.98593,PID_ARF6_TRAFFICKING_PATHWAY,0.99999
GSE28449_WT_VS_LRF_KO_GERMIN...2,SET,174,-0.14571,-0.014117,0.066351,0.98595,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_UP,0.99999
MIR4496,SET,268,-0.11801,-0.014153,0.053733,0.98596,MIR4496,0.99999
GOBP_REGULATION_OF_ERBB_SIGN...,SET,65,-0.23114,-0.013728,0.10522,0.98597,GOBP_REGULATION_OF_ERBB_SIGNALING_PATHWAY,0.99999
HP_CLUBBING,SET,128,-0.15713,-0.013073,0.071517,0.98599,HP_CLUBBING,0.99999
GSE17721_CTRL_VS_PAM3CSK4_8H...1,SET,180,-0.13042,-0.01285,0.059334,0.98602,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN,0.99999
DURANTE_ADULT_OLFACTORY_NEUR...23,SET,28,-0.3957,-0.015441,0.18002,0.98602,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_SECRETORY_CELLS,0.99999
HP_ENLARGEMENT_OF_THE_ANKLES,SET,5,-0.90137,-0.014872,0.41,0.98604,HP_ENLARGEMENT_OF_THE_ANKLES,0.99999
GOMF_CYCLIC_NUCLEOTIDE_PHOSP...,SET,26,-0.37137,-0.013965,0.16888,0.98606,GOMF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,0.99999
HE_LIM_SUN_FETAL_LUNG_C0_PER...,SET,186,-0.14671,-0.014692,0.066717,0.98606,HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE,0.99999
HP_LYMPHOPROLIFERATIVE_DISOR...,SET,13,-0.50234,-0.013362,0.22832,0.98609,HP_LYMPHOPROLIFERATIVE_DISORDER,0.99999
NAGY_TFTC_COMPONENTS_HUMAN,SET,17,-0.3818,-0.011612,0.17353,0.9861,NAGY_TFTC_COMPONENTS_HUMAN,0.99999
PID_HDAC_CLASSII_PATHWAY,SET,30,-0.34227,-0.013824,0.15555,0.98611,PID_HDAC_CLASSII_PATHWAY,0.99999
GSE14308_TH1_VS_NAIVE_CD4_TC...2,SET,178,-0.13515,-0.013242,0.061407,0.98612,GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP,0.99999
HP_HETEROTROPIA,SET,234,-0.11754,-0.013184,0.0534,0.98613,HP_HETEROTROPIA,0.99999
KRCTCNNNNMANAGC_UNKNOWN,SET,14,-0.52321,-0.014442,0.23766,0.98614,KRCTCNNNNMANAGC_UNKNOWN,0.99999
ZNF707_TARGET_GENES,SET,35,-0.30186,-0.013167,0.13709,0.98616,ZNF707_TARGET_GENES,0.99999
GOBP_AROMATIC_AMINO_ACID_FAM...,SET,16,-0.52307,-0.015434,0.23736,0.98622,GOBP_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS,0.99999
GOBP_PROTEIN_LOCALIZATION_TO...37,SET,15,-0.44112,-0.012603,0.20014,0.98623,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,0.99999
GOBP_PROTEIN_CONTAINING_COMP...4,SET,34,-0.34916,-0.015011,0.15836,0.98626,GOBP_PROTEIN_CONTAINING_COMPLEX_REMODELING,0.99999
GOBP_POLYOL_METABOLIC_PROCESS,SET,95,-0.18957,-0.013601,0.085932,0.9863,GOBP_POLYOL_METABOLIC_PROCESS,0.99999
GSE32164_RESTING_DIFFERENTIA...1,SET,182,-0.14019,-0.013888,0.063537,0.98632,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN,0.99999
GOBP_ENDOTHELIAL_CELL_MATRIX...,SET,6,-0.8733,-0.015784,0.39571,0.98633,GOBP_ENDOTHELIAL_CELL_MATRIX_ADHESION,0.99999
GOBP_POSITIVE_REGULATION_OF_...88,SET,2,-1.4547,-0.015182,0.65912,0.98634,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,0.99999
REACTOME_CREATION_OF_C4_AND_...,SET,12,-0.65727,-0.016798,0.2977,0.98637,REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS,0.99999
REACTOME_MUCOPOLYSACCHARIDOS...,SET,10,-0.58125,-0.013561,0.26318,0.98639,REACTOME_MUCOPOLYSACCHARIDOSES,0.99999
MIKKELSEN_MCV6_ICP_WITH_H3K2...,SET,74,-0.23314,-0.014771,0.10551,0.98643,MIKKELSEN_MCV6_ICP_WITH_H3K27ME3,0.99999
GOMF_PHOSPHATIDYLINOSITOL_TR...1,SET,10,-0.52553,-0.012261,0.23779,0.98644,GOMF_PHOSPHATIDYLINOSITOL_TRANSFER_ACTIVITY,0.99999
GOCC_UNCONVENTIONAL_MYOSIN_C...,SET,9,-0.6045,-0.01338,0.27337,0.98649,GOCC_UNCONVENTIONAL_MYOSIN_COMPLEX,0.99999
GOBP_POSITIVE_REGULATION_OF_...570,SET,34,-0.31869,-0.013701,0.14406,0.98652,GOBP_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,0.99999
FAN_EMBRYONIC_CTX_OLIG,SET,671,-0.074694,-0.014016,0.033757,0.98653,FAN_EMBRYONIC_CTX_OLIG,0.99999
KEGG_MEDICUS_VARIANT_AMPLIFI...9,SET,9,-0.63535,-0.014063,0.28706,0.98656,KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY,0.99999
GOBP_REGULATION_OF_SYSTEMIC_...1,SET,84,-0.21319,-0.014387,0.096263,0.9866,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,0.99999
HP_SCLERAL_STAPHYLOMA,SET,9,-0.63603,-0.014078,0.28714,0.98662,HP_SCLERAL_STAPHYLOMA,0.99999
KEGG_MEDICUS_PATHOGEN_HTLV_1...3,SET,5,-0.72103,-0.011897,0.32546,0.98663,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_E47_MEDIATED_TRANSCRIPTION,0.99999
GOBP_HINDBRAIN_RADIAL_GLIA_G...,SET,8,-0.75449,-0.015746,0.34039,0.98667,GOBP_HINDBRAIN_RADIAL_GLIA_GUIDED_CELL_MIGRATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...36,SET,11,-0.52709,-0.012897,0.23778,0.98667,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,0.99999
GOBP_CYTOPLASMIC_SEQUESTERIN...3,SET,7,-0.6462,-0.012615,0.29144,0.98669,GOBP_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR,0.99999
HP_ABNORMAL_PROTEIN_GLYCOSYL...,SET,39,-0.27691,-0.012749,0.12483,0.98673,HP_ABNORMAL_PROTEIN_GLYCOSYLATION,0.99999
HP_FOOD_INTOLERANCE,SET,9,-0.54178,-0.011992,0.24422,0.98673,HP_FOOD_INTOLERANCE,0.99999
GSE16385_MONOCYTE_VS_12H_ROS...6,SET,171,-0.14544,-0.01397,0.065535,0.98676,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,0.99999
GOMF_PEPTIDE_LYSINE_N_ACETYL...,SET,43,-0.26051,-0.012592,0.11736,0.98678,GOMF_PEPTIDE_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY,0.99999
HP_PROMINENT_METOPIC_RIDGE,SET,57,-0.24589,-0.013679,0.11077,0.98678,HP_PROMINENT_METOPIC_RIDGE,0.99999
GOMF_THIAMINE_TRANSMEMBRANE_...,SET,7,-0.75683,-0.014775,0.34085,0.9868,GOMF_THIAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.99999
BRIDEAU_IMPRINTED_GENES,SET,59,-0.28983,-0.016403,0.13046,0.98684,BRIDEAU_IMPRINTED_GENES,0.99999
DESCARTES_FETAL_LUNG_VASCULA...,SET,43,-0.30786,-0.014881,0.1385,0.98688,DESCARTES_FETAL_LUNG_VASCULAR_ENDOTHELIAL_CELLS,0.99999
HP_DIFFUSE_PALMOPLANTAR_HYPE...,SET,10,-0.6033,-0.014076,0.27134,0.9869,HP_DIFFUSE_PALMOPLANTAR_HYPERKERATOSIS,0.99999
GOBP_PROTECTION_FROM_NON_HOM...,SET,9,-0.52367,-0.011591,0.23541,0.98694,GOBP_PROTECTION_FROM_NON_HOMOLOGOUS_END_JOINING_AT_TELOMERE,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...1,SET,7,-0.74742,-0.014591,0.33592,0.98695,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN,0.99999
HP_PERIVENTRICULAR_NODULAR_H...,SET,14,-0.45237,-0.012487,0.20296,0.98708,HP_PERIVENTRICULAR_NODULAR_HETEROTOPIA,0.99999
MODULE_493,SET,58,-0.24225,-0.013594,0.10864,0.98712,MODULE_493,0.99999
OVSYANNIKOVA_PBMC_FLUARIX_AG...6,SET,29,-0.32904,-0.013067,0.14755,0.98712,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_UP,0.99999
CTCAGGG_MIR125B_MIR125A,SET,303,-0.10723,-0.013661,0.048052,0.98717,CTCAGGG_MIR125B_MIR125A,0.99999
GOBP_DESMOSOME_ORGANIZATION,SET,9,-0.74197,-0.016423,0.33243,0.98718,GOBP_DESMOSOME_ORGANIZATION,0.99999
HP_DECREASED_SPECIFIC_ANTI_P...,SET,7,-0.76694,-0.014972,0.34366,0.98718,HP_DECREASED_SPECIFIC_ANTI_POLYSACCHARIDE_ANTIBODY_LEVEL,0.99999
HP_ANOTIA,SET,12,-0.5167,-0.013205,0.23139,0.98722,HP_ANOTIA,0.99999
GOBP_HEMATOPOIETIC_STEM_CELL...1,SET,36,-0.31181,-0.013793,0.1396,0.98724,GOBP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,0.99999
CATGTAA_MIR496,SET,161,-0.14613,-0.013624,0.065396,0.98727,CATGTAA_MIR496,0.99999
GOBP_REGULATION_OF_BLOOD_PRE...,SET,170,-0.15473,-0.014819,0.06922,0.98729,GOBP_REGULATION_OF_BLOOD_PRESSURE,0.99999
GOBP_POSITIVE_REGULATION_OF_...23,SET,38,-0.33461,-0.015206,0.14954,0.98737,GOBP_POSITIVE_REGULATION_OF_AMINE_TRANSPORT,0.99999
GSE17580_TREG_VS_TEFF_DN,SET,189,-0.13702,-0.01383,0.061226,0.98738,GSE17580_TREG_VS_TEFF_DN,0.99999
HE_LIM_SUN_FETAL_LUNG_C1_SMG...1,SET,347,-0.10965,-0.014931,0.048989,0.98739,HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL,0.99999
DING_LUNG_CANCER_EXPRESSION_...,SET,96,-0.1916,-0.013818,0.085565,0.98742,DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,0.99999
WP_UREA_CYCLE_AND_RELATED_DI...,SET,8,-0.63918,-0.013339,0.28535,0.98745,WP_UREA_CYCLE_AND_RELATED_DISEASES,0.99999
GOMF_TELOMERASE_ACTIVITY,SET,5,-0.7481,-0.012344,0.33392,0.98746,GOMF_TELOMERASE_ACTIVITY,0.99999
GOCC_LAMININ_COMPLEX,SET,9,-0.66564,-0.014734,0.29689,0.98751,GOCC_LAMININ_COMPLEX,0.99999
TRAVAGLINI_LUNG_CD8_MEMORY_E...,SET,26,-0.36792,-0.013835,0.16403,0.98754,TRAVAGLINI_LUNG_CD8_MEMORY_EFFECTOR_T_CELL,0.99999
MORF_PTPRB,SET,222,-0.12818,-0.014009,0.057128,0.98757,MORF_PTPRB,0.99999
HP_ABNORMALITY_OF_THE_EXTRIN...,SET,20,-0.36864,-0.01216,0.1643,0.98757,HP_ABNORMALITY_OF_THE_EXTRINSIC_PATHWAY,0.99999
RELA_DN.V1_DN,SET,119,-0.18244,-0.014639,0.081303,0.98757,RELA_DN.V1_DN,0.99999
GOBP_CAMP_CATABOLIC_PROCESS,SET,9,-0.64872,-0.014359,0.28904,0.98759,GOBP_CAMP_CATABOLIC_PROCESS,0.99999
MODULE_543,SET,14,-0.53159,-0.014673,0.23681,0.9876,MODULE_543,0.99999
TATAAA_TATA_01,SET,1142,-0.060615,-0.014639,0.026977,0.98767,TATAAA_TATA_01,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...13,SET,18,-0.48977,-0.015328,0.21798,0.98767,HP_APLASIA_HYPOPLASIA_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS,0.99999
GSE20152_SPHK1_KO_VS_HTNFA_O...2,SET,171,-0.13885,-0.013337,0.061794,0.98767,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP,0.99999
SERVITJA_LIVER_HNF1A_TARGETS...1,SET,152,-0.16129,-0.014614,0.071733,0.98772,SERVITJA_LIVER_HNF1A_TARGETS_DN,0.99999
GSE5142_HTERT_TRANSDUCED_VS_...1,SET,178,-0.14148,-0.013863,0.062896,0.98775,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN,0.99999
REACTOME_FGFR3_LIGAND_BINDIN...,SET,12,-0.62449,-0.01596,0.27758,0.98776,REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION,0.99999
ZNF133_TARGET_GENES,SET,175,-0.13945,-0.013549,0.061967,0.98778,ZNF133_TARGET_GENES,0.99999
GOBP_CELLULAR_RESPONSE_TO_NU...2,SET,223,-0.13013,-0.014253,0.057802,0.98781,GOBP_CELLULAR_RESPONSE_TO_NUTRIENT_LEVELS,0.99999
GOCC_TRANSCRIPTION_FACTOR_TF...2,SET,30,-0.2971,-0.011999,0.13196,0.98782,GOCC_TRANSCRIPTION_FACTOR_TFIID_COMPLEX,0.99999
REACTOME_NFE2L2_REGULATES_PE...,SET,7,-0.77351,-0.0151,0.34339,0.98785,REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES,0.99999
GOBP_SLEEP,SET,21,-0.4485,-0.015159,0.19908,0.98786,GOBP_SLEEP,0.99999
WP_DEVELOPMENT_OF_URETERIC_C...,SET,57,-0.28197,-0.015686,0.12514,0.98787,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,0.99999
REACTOME_ACTIVATION_OF_THE_P...1,SET,11,-0.51521,-0.012607,0.22858,0.9879,REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE,0.99999
HP_ABNORMAL_FETAL_CENTRAL_NE...,SET,5,-0.83192,-0.013726,0.36888,0.98793,HP_ABNORMAL_FETAL_CENTRAL_NERVOUS_SYSTEM_MORPHOLOGY,0.99999
PID_P38_ALPHA_BETA_PATHWAY,SET,29,-0.3587,-0.014244,0.15894,0.98798,PID_P38_ALPHA_BETA_PATHWAY,0.99999
HP_DIASTEMA,SET,22,-0.37173,-0.01286,0.1647,0.98799,HP_DIASTEMA,0.99999
GOBP_RHYTHMIC_PROCESS,SET,280,-0.11927,-0.014616,0.052838,0.988,GOBP_RHYTHMIC_PROCESS,0.99999
chr15q13,SET,18,-0.59354,-0.018575,0.26289,0.98801,chr15q13,0.99999
HP_OVARIAN_PAPILLARY_ADENOCA...,SET,6,-0.71482,-0.01292,0.31651,0.98803,HP_OVARIAN_PAPILLARY_ADENOCARCINOMA,0.99999
GOMF_EUKARYOTIC_TRANSLATION_...,SET,6,-0.77597,-0.014025,0.34329,0.98809,GOMF_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2ALPHA_KINASE_ACTIVITY,0.99999
GSE24081_CONTROLLER_VS_PROGR...1,SET,173,-0.14608,-0.014113,0.064617,0.9881,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN,0.99999
GOBP_POSITIVE_REGULATION_OF_...527,SET,14,-0.54643,-0.015083,0.24165,0.98812,GOBP_POSITIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,0.99999
GSE14308_TH2_VS_NAIVE_CD4_TC...1,SET,178,-0.13566,-0.013293,0.059979,0.98814,GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN,0.99999
OUELLET_CULTURED_OVARIAN_CAN...2,SET,60,-0.23986,-0.013689,0.10601,0.98816,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,0.99999
KEGG_MEDICUS_REFERENCE_CD40_...,SET,6,-0.78878,-0.014256,0.34847,0.98819,KEGG_MEDICUS_REFERENCE_CD40_NFKB_SIGNALING_PATHWAY,0.99999
MODULE_396,SET,9,-0.69475,-0.015378,0.30692,0.9882,MODULE_396,0.99999
DAVICIONI_MOLECULAR_ARMS_VS_...2,SET,301,-0.10951,-0.013906,0.048367,0.98821,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,0.99999
GCACCTT_MIR18A_MIR18B,SET,112,-0.18117,-0.014106,0.079967,0.98825,GCACCTT_MIR18A_MIR18B,0.99999
GOBP_COTRANSLATIONAL_PROTEIN...,SET,21,-0.40109,-0.013557,0.17705,0.98825,GOBP_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.99999
REACTOME_LECTIN_PATHWAY_OF_C...,SET,8,-0.78367,-0.016354,0.34586,0.98826,REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION,0.99999
GSE22886_TH1_VS_TH2_12H_ACT_...1,SET,178,-0.14188,-0.013902,0.062617,0.98826,GSE22886_TH1_VS_TH2_12H_ACT_DN,0.99999
HP_ATYPICAL_ABSENCE_SEIZURE,SET,31,-0.34927,-0.014339,0.15412,0.98828,HP_ATYPICAL_ABSENCE_SEIZURE,0.99999
GSE27859_MACROPHAGE_VS_DC_UP,SET,154,-0.15069,-0.013743,0.066481,0.98829,GSE27859_MACROPHAGE_VS_DC_UP,0.99999
GCM_SMARCD1,SET,90,-0.19294,-0.013475,0.085061,0.98834,GCM_SMARCD1,0.99999
HP_HYPOPIGMENTATION_OF_THE_F...,SET,22,-0.40908,-0.014152,0.18023,0.98838,HP_HYPOPIGMENTATION_OF_THE_FUNDUS,0.99999
HP_RIGHT_VENTRICULAR_CARDIOM...,SET,7,-0.83516,-0.016304,0.36796,0.98838,HP_RIGHT_VENTRICULAR_CARDIOMYOPATHY,0.99999
MIR141_3P,SET,369,-0.10304,-0.01446,0.045392,0.98839,MIR141_3P,0.99999
GOBP_TYROSINE_CATABOLIC_PROC...,SET,6,-0.8362,-0.015113,0.36828,0.98841,GOBP_TYROSINE_CATABOLIC_PROCESS,0.99999
GSE29615_CTRL_VS_LAIV_FLU_VA...2,SET,175,-0.15005,-0.014579,0.066069,0.98843,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP,0.99999
HP_WIDE_ANTERIOR_FONTANEL,SET,80,-0.21614,-0.014236,0.095143,0.98844,HP_WIDE_ANTERIOR_FONTANEL,0.99999
REACTOME_CONDENSATION_OF_PRO...1,SET,11,-0.4967,-0.012154,0.21864,0.98845,REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES,0.99999
HP_APLASIA_HYPOPLASIA_OF_THE...20,SET,5,-0.72963,-0.012039,0.3211,0.98846,HP_APLASIA_HYPOPLASIA_OF_THE_DIAPHRAGM,0.99999
GOBP_CHONDROCYTE_DEVELOPMENT...,SET,8,-0.76681,-0.016003,0.3374,0.98847,GOBP_CHONDROCYTE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,0.99999
GOBP_TETRAHYDROBIOPTERIN_MET...,SET,8,-0.62213,-0.012983,0.27367,0.98849,GOBP_TETRAHYDROBIOPTERIN_METABOLIC_PROCESS,0.99999
OSWALD_HEMATOPOIETIC_STEM_CE...1,SET,241,-0.12118,-0.013792,0.053281,0.98852,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,0.99999
MIR12117,SET,84,-0.19907,-0.013434,0.087527,0.98852,MIR12117,0.99999
GOCC_CELL_BODY_MEMBRANE,SET,32,-0.381,-0.015892,0.16745,0.98855,GOCC_CELL_BODY_MEMBRANE,0.99999
GSE32423_CTRL_VS_IL7_MEMORY_...1,SET,174,-0.14915,-0.014451,0.065544,0.98856,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN,0.99999
REACTOME_AKT_PHOSPHORYLATES_...1,SET,14,-0.45504,-0.01256,0.19993,0.98857,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,0.99999
GOBP_REGULATION_OF_PLASMA_LI...,SET,72,-0.23389,-0.014618,0.10275,0.98858,GOBP_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS,0.99999
GSE2770_IL4_ACT_VS_ACT_CD4_T...2,SET,177,-0.13973,-0.013653,0.061382,0.98858,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,0.99999
GOBP_RHO_PROTEIN_SIGNAL_TRAN...,SET,131,-0.17266,-0.014532,0.075823,0.9886,GOBP_RHO_PROTEIN_SIGNAL_TRANSDUCTION,0.99999
MIR487A_3P,SET,92,-0.20376,-0.014387,0.089453,0.98863,MIR487A_3P,0.99999
GSE3039_B2_VS_B1_BCELL_DN,SET,180,-0.13494,-0.013295,0.05924,0.98863,GSE3039_B2_VS_B1_BCELL_DN,0.99999
GOMF_METALLODIPEPTIDASE_ACTI...,SET,8,-0.71463,-0.014914,0.31356,0.98866,GOMF_METALLODIPEPTIDASE_ACTIVITY,0.99999
GOBP_PROTEIN_LIPID_COMPLEX_O...,SET,49,-0.28526,-0.014717,0.12508,0.98871,GOBP_PROTEIN_LIPID_COMPLEX_ORGANIZATION,0.99999
KEGG_MEDICUS_REFERENCE_AUTOP...4,SET,7,-0.64297,-0.012552,0.28185,0.98873,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_E3_UBIQUITIN_LIGASE_MALIN,0.99999
GOBP_REGULATION_OF_CARDIAC_M...4,SET,16,-0.45849,-0.013529,0.20096,0.98874,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,0.99999
GOBP_DETERMINATION_OF_PANCRE...,SET,4,-0.91334,-0.013479,0.40018,0.98876,GOBP_DETERMINATION_OF_PANCREATIC_LEFT_RIGHT_ASYMMETRY,0.99999
GOBP_FIBROBLAST_GROWTH_FACTO...2,SET,74,-0.24099,-0.015268,0.10558,0.98876,GOBP_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.99999
BIOCARTA_DEATH_PATHWAY,SET,28,-0.37496,-0.014631,0.16427,0.98877,BIOCARTA_DEATH_PATHWAY,0.99999
HP_INTERMITTENT_DIARRHEA,SET,21,-0.40545,-0.013704,0.17754,0.9888,HP_INTERMITTENT_DIARRHEA,0.99999
AAAYWAACM_HFH4_01,SET,224,-0.13435,-0.014749,0.058817,0.98882,AAAYWAACM_HFH4_01,0.99999
GOBP_NEGATIVE_REGULATION_OF_...96,SET,10,-0.58961,-0.013756,0.25806,0.98883,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA,0.99999
CHENG_IMPRINTED_BY_ESTRADIOL,SET,98,-0.20526,-0.014956,0.089822,0.98884,CHENG_IMPRINTED_BY_ESTRADIOL,0.99999
GOBP_RISC_COMPLEX_ASSEMBLY,SET,10,-0.64582,-0.015068,0.28257,0.98885,GOBP_RISC_COMPLEX_ASSEMBLY,0.99999
MIR4652_3P,SET,290,-0.11657,-0.014534,0.051001,0.98886,MIR4652_3P,0.99999
MIR3187_3P,SET,63,-0.24265,-0.014189,0.10614,0.98887,MIR3187_3P,0.99999
MIR4452,SET,148,-0.15889,-0.014207,0.069501,0.98887,MIR4452,0.99999
GOBP_OSMOSENSORY_SIGNALING_P...,SET,6,-0.72351,-0.013077,0.31648,0.98887,GOBP_OSMOSENSORY_SIGNALING_PATHWAY,0.99999
GSE16385_ROSIGLITAZONE_IL4_V...4,SET,178,-0.14399,-0.014109,0.062953,0.9889,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP,0.99999
HP_BURKITT_LYMPHOMA,SET,8,-0.7447,-0.015541,0.32552,0.98892,HP_BURKITT_LYMPHOMA,0.99999
WINNEPENNINCKX_MELANOMA_META...2,SET,151,-0.14801,-0.013367,0.064655,0.98896,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,0.99999
MODULE_373,SET,20,-0.43939,-0.014494,0.19195,0.98896,MODULE_373,0.99999
GOBP_OVULATION_CYCLE,SET,71,-0.24308,-0.015086,0.10618,0.98896,GOBP_OVULATION_CYCLE,0.99999
SAENZ_DETOX_PATHWAY_AND_CARC...,SET,14,-0.48024,-0.013256,0.20971,0.98898,SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN,0.99999
GOBP_MAMMARY_GLAND_MORPHOGEN...,SET,44,-0.32042,-0.015667,0.13989,0.989,GOBP_MAMMARY_GLAND_MORPHOGENESIS,0.99999
GOBP_NEUROTRANSMITTER_RECEPT...6,SET,15,-0.51732,-0.01478,0.22582,0.98901,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_TO_PLASMA_MEMBRANE,0.99999
GSE15330_LYMPHOID_MULTIPOTEN...9,SET,176,-0.14344,-0.013976,0.062606,0.98902,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_DN,0.99999
MODULE_141,SET,14,-0.58368,-0.016111,0.25461,0.98905,MODULE_141,0.99999
GOBP_VESICLE_DOCKING_INVOLVE...,SET,35,-0.31608,-0.013787,0.1379,0.98905,GOBP_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS,0.99999
HP_VOMITING,SET,301,-0.10981,-0.013943,0.047893,0.98906,HP_VOMITING,0.99999
GSE37533_PPARG1_FOXP3_VS_PPA...4,SET,164,-0.14466,-0.013611,0.063089,0.98907,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP,0.99999
SCHLOSSER_SERUM_RESPONSE_AUG...,SET,99,-0.17679,-0.012947,0.077036,0.98913,SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,0.99999
MIR200A_3P,SET,366,-0.10452,-0.014609,0.045529,0.98915,MIR200A_3P,0.99999
MIR4259,SET,23,-0.39834,-0.01409,0.17351,0.98915,MIR4259,0.99999
GOCC_COPI_COATED_VESICLE_MEM...,SET,17,-0.40945,-0.012453,0.17831,0.98916,GOCC_COPI_COATED_VESICLE_MEMBRANE,0.99999
GOMF_HEAT_SHOCK_PROTEIN_BIND...,SET,119,-0.17321,-0.013899,0.075432,0.98916,GOMF_HEAT_SHOCK_PROTEIN_BINDING,0.99999
PLASARI_TGFB1_SIGNALING_VIA_...2,SET,51,-0.28961,-0.015242,0.12612,0.98917,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,0.99999
GOBP_REGULATION_OF_I_KAPPAB_...,SET,7,-0.78102,-0.015247,0.33997,0.98919,GOBP_REGULATION_OF_I_KAPPAB_PHOSPHORYLATION,0.99999
KEGG_PHENYLALANINE_METABOLISM,SET,15,-0.56591,-0.016168,0.24615,0.98924,KEGG_PHENYLALANINE_METABOLISM,0.99999
REACTOME_ACTIVATION_OF_NMDA_...,SET,85,-0.21712,-0.014738,0.094444,0.98924,REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,0.99999
MIR4261,SET,387,-0.10056,-0.014445,0.043731,0.98926,MIR4261,0.99999
HP_ABNORMAL_HEMIDIAPHRAGM_MO...,SET,7,-0.81615,-0.015933,0.35452,0.98933,HP_ABNORMAL_HEMIDIAPHRAGM_MORPHOLOGY,0.99999
CAIRO_HEPATOBLASTOMA_DN,SET,243,-0.13032,-0.014892,0.056587,0.98935,CAIRO_HEPATOBLASTOMA_DN,0.99999
GOMF_GLUTAMATE_RECEPTOR_ACTI...,SET,25,-0.4228,-0.01559,0.18356,0.98936,GOMF_GLUTAMATE_RECEPTOR_ACTIVITY,0.99999
REACTOME_MET_ACTIVATES_PTK2_...,SET,30,-0.38525,-0.01556,0.16723,0.98937,REACTOME_MET_ACTIVATES_PTK2_SIGNALING,0.99999
KIM_ALL_DISORDERS_OLIGODENDR...2,SET,679,-0.072544,-0.01369,0.031469,0.98942,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP,0.99999
GNF2_ITGAL,SET,51,-0.27903,-0.014685,0.121,0.98944,GNF2_ITGAL,0.99999
chr5p13,SET,54,-0.52492,-0.028425,0.22757,0.98946,chr5p13,0.99999
GOMF_G_RICH_STRAND_TELOMERIC...,SET,10,-0.55757,-0.013009,0.24166,0.98947,GOMF_G_RICH_STRAND_TELOMERIC_DNA_BINDING,0.99999
WP_MAJOR_RECEPTORS_TARGETED_...,SET,16,-0.53223,-0.015705,0.23066,0.98948,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,0.99999
REACTOME_FGFR1B_LIGAND_BINDI...,SET,8,-0.7418,-0.015481,0.32133,0.98951,REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION,0.99999
GAVISH_3CA_METAPROGRAM_ENDOT...11,SET,50,-0.28328,-0.014762,0.1227,0.98952,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_2,0.99999
HP_GASTRITIS,SET,18,-0.45308,-0.014179,0.19618,0.98954,HP_GASTRITIS,0.99999
GSE39556_CD8A_DC_VS_NK_CELL_...2,SET,180,-0.14671,-0.014455,0.063503,0.98956,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN,0.99999
HP_ABNORMAL_GLYCOSYLATION,SET,44,-0.27413,-0.013403,0.11863,0.98957,HP_ABNORMAL_GLYCOSYLATION,0.99999
SAKAI_TUMOR_INFILTRATING_MON...2,SET,26,-0.39179,-0.014733,0.16946,0.9896,SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,0.99999
REACTOME_SURFACTANT_METABOLI...,SET,26,-0.41989,-0.015789,0.18162,0.9896,REACTOME_SURFACTANT_METABOLISM,0.99999
KEGG_MEDICUS_REFERENCE_CREAT...,SET,7,-0.67291,-0.013136,0.29079,0.98966,KEGG_MEDICUS_REFERENCE_CREATINE_PATHWAY,0.99999
GSE32423_MEMORY_VS_NAIVE_CD8...2,SET,177,-0.14362,-0.014033,0.062068,0.98966,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN,0.99999
GSE14000_4H_VS_16H_LPS_DC_DN,SET,161,-0.14574,-0.013587,0.062959,0.98968,GSE14000_4H_VS_16H_LPS_DC_DN,0.99999
HP_INTERICTAL_EEG_ABNORMALITY,SET,289,-0.11539,-0.014362,0.049802,0.98974,HP_INTERICTAL_EEG_ABNORMALITY,0.99999
GSE17721_0.5H_VS_4H_GARDIQUI...1,SET,185,-0.14144,-0.014126,0.060988,0.9898,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_DN,0.99999
GOBP_NEGATIVE_REGULATION_OF_...158,SET,42,-0.29934,-0.0143,0.12901,0.98983,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.99999
LIAN_LIPA_TARGETS_6M,SET,65,-0.26381,-0.015668,0.11366,0.98985,LIAN_LIPA_TARGETS_6M,0.99999
GOBP_MULTICELLULAR_ORGANISMA...7,SET,90,-0.2216,-0.015476,0.095469,0.98985,GOBP_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS,0.99999
MIR154_3P,SET,91,-0.20872,-0.014657,0.089818,0.98993,MIR154_3P,0.99999
GOCC_GARP_COMPLEX,SET,4,-0.83415,-0.012311,0.35891,0.98993,GOCC_GARP_COMPLEX,0.99999
GSE20198_UNTREATED_VS_IL12_I...2,SET,183,-0.14428,-0.014332,0.062027,0.98999,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,0.99999
GOMF_ALPHA_ADRENERGIC_RECEPT...,SET,6,-0.90537,-0.016364,0.38871,0.99007,GOMF_ALPHA_ADRENERGIC_RECEPTOR_ACTIVITY,0.99999
BIOCARTA_CELL2CELL_PATHWAY,SET,12,-0.58231,-0.014882,0.24983,0.99011,BIOCARTA_CELL2CELL_PATHWAY,0.99999
REACTOME_FGFR1_LIGAND_BINDIN...,SET,17,-0.54518,-0.016581,0.23384,0.99013,REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION,0.99999
REACTOME_LAMININ_INTERACTIONS,SET,28,-0.38461,-0.015008,0.16491,0.99015,REACTOME_LAMININ_INTERACTIONS,0.99999
GOBP_MRNA_PROCESSING,SET,423,-0.087187,-0.01308,0.037385,0.99015,GOBP_MRNA_PROCESSING,0.99999
REACTOME_FREE_FATTY_ACIDS_RE...,SET,10,-0.69184,-0.016141,0.29646,0.99019,REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION,0.99999
NAGY_STAGA_COMPONENTS_HUMAN,SET,13,-0.48613,-0.012931,0.20826,0.9902,NAGY_STAGA_COMPONENTS_HUMAN,0.99999
REACTOME_CAMK_IV_MEDIATED_PH...,SET,10,-0.70447,-0.016436,0.30184,0.9902,REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB,0.99999
HP_AGYRIA,SET,15,-0.4398,-0.012565,0.18839,0.99021,HP_AGYRIA,0.99999
MIR4748,SET,61,-0.24761,-0.014249,0.10602,0.99024,MIR4748,0.99999
GOBP_NEGATIVE_REGULATION_OF_...240,SET,7,-0.64322,-0.012557,0.27531,0.99026,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,0.99999
HNF1_01,SET,220,-0.14311,-0.015571,0.061208,0.9903,HNF1_01,0.99999
GNF2_IGFBP1,SET,30,-0.39366,-0.015899,0.16836,0.99031,GNF2_IGFBP1,0.99999
GOBP_RESPONSE_TO_INDOLE_3_ME...,SET,6,-0.82453,-0.014903,0.35248,0.99033,GOBP_RESPONSE_TO_INDOLE_3_METHANOL,0.99999
REACTOME_RHOH_GTPASE_CYCLE,SET,35,-0.33289,-0.01452,0.14223,0.99036,REACTOME_RHOH_GTPASE_CYCLE,0.99999
GOBP_METANEPHRIC_S_SHAPED_BO...,SET,5,-1.0575,-0.017448,0.45163,0.99039,GOBP_METANEPHRIC_S_SHAPED_BODY_MORPHOGENESIS,0.99999
GOBP_REGULATION_OF_ORGANIC_A...,SET,73,-0.25142,-0.015821,0.10734,0.99041,GOBP_REGULATION_OF_ORGANIC_ACID_TRANSPORT,0.99999
HP_ABNORMALITY_OF_VITAMIN_ME...,SET,94,-0.20379,-0.014544,0.086985,0.99043,HP_ABNORMALITY_OF_VITAMIN_METABOLISM,0.99999
HP_RETINAL_DYSTROPHY,SET,310,-0.11169,-0.01439,0.047646,0.99046,HP_RETINAL_DYSTROPHY,0.99999
GSE17721_CTRL_VS_POLYIC_24H_...1,SET,186,-0.14485,-0.014505,0.061785,0.99047,GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN,0.99999
GOBP_METANEPHRIC_COLLECTING_...,SET,10,-0.7193,-0.016782,0.30665,0.9905,GOBP_METANEPHRIC_COLLECTING_DUCT_DEVELOPMENT,0.99999
GOBP_PROTEASOME_MEDIATED_UBI...,SET,369,-0.099784,-0.014003,0.042537,0.9905,GOBP_PROTEASOME_MEDIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.99999
GSE13547_2H_VS_12_H_ANTI_IGM...2,SET,166,-0.15991,-0.015136,0.068173,0.9905,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP,0.99999
GOBP_EMBRYONIC_BODY_MORPHOGE...,SET,10,-0.52602,-0.012272,0.22408,0.99054,GOBP_EMBRYONIC_BODY_MORPHOGENESIS,0.99999
GOCC_CORTICAL_ACTIN_CYTOSKEL...,SET,72,-0.22589,-0.014118,0.096205,0.99056,GOCC_CORTICAL_ACTIN_CYTOSKELETON,0.99999
GOBP_INTRACELLULAR_DISTRIBUT...,SET,7,-0.78656,-0.015355,0.33489,0.99057,GOBP_INTRACELLULAR_DISTRIBUTION_OF_MITOCHONDRIA,0.99999
PEDERSEN_METASTASIS_BY_ERBB2...3,SET,99,-0.21202,-0.015526,0.090217,0.99061,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,0.99999
GCM_MYCL1,SET,23,-0.3761,-0.013303,0.16,0.99062,GCM_MYCL1,0.99999
REACTOME_FORMATION_OF_INTERM...,SET,7,-0.86414,-0.01687,0.36747,0.99065,REACTOME_FORMATION_OF_INTERMEDIATE_MESODERM,0.99999
GOBP_ORGANOPHOSPHATE_CATABOL...,SET,220,-0.13239,-0.014404,0.056294,0.99065,GOBP_ORGANOPHOSPHATE_CATABOLIC_PROCESS,0.99999
HP_ABNORMALITY_OF_THE_FONTAN...,SET,407,-0.09832,-0.014475,0.041787,0.99068,HP_ABNORMALITY_OF_THE_FONTANELLES_OR_CRANIAL_SUTURES,0.99999
HP_ELEVATED_TISSUE_NON_SPECI...,SET,17,-0.49647,-0.0151,0.21094,0.9907,HP_ELEVATED_TISSUE_NON_SPECIFIC_ALKALINE_PHOSPHATASE,0.99999
GSE1460_DP_THYMOCYTE_VS_NAIV...1,SET,175,-0.1509,-0.014661,0.064111,0.9907,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,0.99999
REACTOME_TP53_REGULATES_TRAN...4,SET,42,-0.29886,-0.014278,0.12693,0.99072,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES,0.99999
MIR6810_5P,SET,57,-0.25618,-0.014252,0.10881,0.99072,MIR6810_5P,0.99999
KUMAR_TARGETS_OF_MLL_AF9_FUS...,SET,367,-0.10719,-0.015003,0.045484,0.99078,KUMAR_TARGETS_OF_MLL_AF9_FUSION,0.99999
REACTOME_SYNTHESIS_OF_ACTIVE...,SET,26,-0.40245,-0.015134,0.17075,0.99078,REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES,0.99999
GOBP_NECROPTOTIC_SIGNALING_P...,SET,8,-0.74601,-0.015568,0.31649,0.99079,GOBP_NECROPTOTIC_SIGNALING_PATHWAY,0.99999
HP_ELEVATED_ALKALINE_PHOSPHA...,SET,13,-0.57575,-0.015315,0.24395,0.99086,HP_ELEVATED_ALKALINE_PHOSPHATASE_OF_BONE_ORIGIN,0.99999
HP_MEDIAN_CLEFT_UPPER_LIP,SET,32,-0.33878,-0.014131,0.14354,0.99086,HP_MEDIAN_CLEFT_UPPER_LIP,0.99999
GOBP_STRIATED_MUSCLE_CELL_AP...,SET,42,-0.30736,-0.014684,0.13019,0.99088,GOBP_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
HP_ROD_CONE_DYSTROPHY,SET,197,-0.13905,-0.014325,0.058894,0.99088,HP_ROD_CONE_DYSTROPHY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...397,SET,6,-0.79644,-0.014395,0.33722,0.9909,GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_FUSION,0.99999
WP_CHOLESTEROL_METABOLISM,SET,66,-0.24803,-0.014844,0.10497,0.99093,WP_CHOLESTEROL_METABOLISM,0.99999
REACTOME_INTRACELLULAR_SIGNA...,SET,300,-0.11388,-0.014438,0.048184,0.99094,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,0.99999
HP_ABNORMAL_VERTEBRAL_SEGMEN...,SET,8,-0.79372,-0.016564,0.33564,0.99097,HP_ABNORMAL_VERTEBRAL_SEGMENTATION_AND_FUSION,0.99999
GSE29164_UNTREATED_VS_CD8_TC...1,SET,183,-0.14095,-0.014001,0.059563,0.99101,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,0.99999
AKT_UP_MTOR_DN.V1_UP,SET,165,-0.15894,-0.014999,0.067119,0.99105,AKT_UP_MTOR_DN.V1_UP,0.99999
REACTOME_DISEASES_OF_CARBOHY...,SET,30,-0.34974,-0.014125,0.14766,0.99106,REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,0.99999
REACTOME_THE_PHOTOTRANSDUCTI...,SET,31,-0.33518,-0.013761,0.14146,0.99109,REACTOME_THE_PHOTOTRANSDUCTION_CASCADE,0.99999
HP_ABNORMALITY_OF_THE_ANUS,SET,197,-0.14258,-0.01469,0.060146,0.99112,HP_ABNORMALITY_OF_THE_ANUS,0.99999
HP_ABNORMAL_PROTEIN_O_LINKED...,SET,5,-0.79041,-0.013042,0.33325,0.99114,HP_ABNORMAL_PROTEIN_O_LINKED_GLYCOSYLATION,0.99999
HP_LOSS_OF_PURKINJE_CELLS_IN...,SET,5,-0.90424,-0.01492,0.38129,0.99114,HP_LOSS_OF_PURKINJE_CELLS_IN_THE_CEREBELLAR_VERMIS,0.99999
HP_ABNORMAL_INVOLUNTARY_EYE_...,SET,961,-0.065432,-0.014572,0.027569,0.99118,HP_ABNORMAL_INVOLUNTARY_EYE_MOVEMENTS,0.99999
DESCARTES_FETAL_STOMACH_VASC...,SET,28,-0.41829,-0.016322,0.17609,0.99123,DESCARTES_FETAL_STOMACH_VASCULAR_ENDOTHELIAL_CELLS,0.99999
GOBP_POSITIVE_REGULATION_OF_...255,SET,29,-0.37222,-0.014781,0.15666,0.99124,GOBP_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,0.99999
GOMF_HISTONE_DEACETYLASE_REG...,SET,5,-1.016,-0.016764,0.42753,0.99125,GOMF_HISTONE_DEACETYLASE_REGULATOR_ACTIVITY,0.99999
MODULE_337,SET,58,-0.2499,-0.014023,0.10513,0.99127,MODULE_337,0.99999
TURJANSKI_MAPK11_TARGETS,SET,4,-1.0193,-0.015044,0.42874,0.99128,TURJANSKI_MAPK11_TARGETS,0.99999
HP_ENAMEL_HYPOPLASIA,SET,90,-0.20932,-0.014619,0.088039,0.99128,HP_ENAMEL_HYPOPLASIA,0.99999
GOBP_BRUSH_BORDER_ASSEMBLY,SET,8,-0.62454,-0.013034,0.26243,0.99133,GOBP_BRUSH_BORDER_ASSEMBLY,0.99999
OSADA_ASCL1_TARGETS_DN,SET,23,-0.46109,-0.016309,0.19356,0.99139,OSADA_ASCL1_TARGETS_DN,0.99999
GSE17721_PAM3CSK4_VS_GADIQUI...1,SET,180,-0.14575,-0.01436,0.061156,0.99141,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN,0.99999
GSE3982_EOSINOPHIL_VS_CENT_M...2,SET,180,-0.15068,-0.014846,0.063232,0.99141,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,0.99999
MIR497_3P,SET,217,-0.13825,-0.01494,0.058006,0.99142,MIR497_3P,0.99999
WP_GPR40_PATHWAY,SET,15,-0.48848,-0.013956,0.20487,0.99144,WP_GPR40_PATHWAY,0.99999
MIR4464,SET,62,-0.24664,-0.014308,0.10343,0.99144,MIR4464,0.99999
MODULE_343,SET,24,-0.38009,-0.013733,0.1594,0.99144,MODULE_343,0.99999
WP_DRAVET_SYNDROME,SET,26,-0.43774,-0.01646,0.18341,0.99149,WP_DRAVET_SYNDROME,0.99999
GOBP_PROTEIN_AUTOUBIQUITINAT...,SET,67,-0.23731,-0.014309,0.099398,0.99151,GOBP_PROTEIN_AUTOUBIQUITINATION,0.99999
MIR218_5P,SET,384,-0.10737,-0.015364,0.044939,0.99155,MIR218_5P,0.99999
GSE16385_IL4_VS_ROSIGLITAZON...1,SET,157,-0.1567,-0.014428,0.065585,0.99155,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.99999
MIR1276,SET,163,-0.1599,-0.014999,0.066888,0.99158,MIR1276,0.99999
KYNG_DNA_DAMAGE_DN,SET,171,-0.1523,-0.014629,0.063702,0.99159,KYNG_DNA_DAMAGE_DN,0.99999
MIR219A_1_3P,SET,55,-0.26086,-0.014256,0.10904,0.99162,MIR219A_1_3P,0.99999
CCTNTMAGA_UNKNOWN,SET,120,-0.18612,-0.014997,0.077768,0.99165,CCTNTMAGA_UNKNOWN,0.99999
GOBP_AMIDE_BIOSYNTHETIC_PROC...,SET,144,-0.17427,-0.015372,0.072812,0.99165,GOBP_AMIDE_BIOSYNTHETIC_PROCESS,0.99999
GOMF_SIGNALING_ADAPTOR_ACTIV...,SET,109,-0.19504,-0.014983,0.081455,0.99167,GOMF_SIGNALING_ADAPTOR_ACTIVITY,0.99999
HP_FIBULAR_BOWING,SET,9,-0.73203,-0.016203,0.30575,0.99167,HP_FIBULAR_BOWING,0.99999
GOBP_REGULATION_OF_TRANSLATI...5,SET,12,-0.55906,-0.014288,0.23335,0.9917,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_BY_EIF2_ALPHA_PHOSPHORYLATION,0.99999
GOBP_ADENYLATE_CYCLASE_ACTIV...1,SET,23,-0.45875,-0.016226,0.19144,0.99171,GOBP_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,0.99999
GOBP_COMPLEMENT_ACTIVATION_L...,SET,10,-0.71287,-0.016632,0.29747,0.99172,GOBP_COMPLEMENT_ACTIVATION_LECTIN_PATHWAY,0.99999
ALPHACP1_01,SET,224,-0.13944,-0.015307,0.058163,0.99174,ALPHACP1_01,0.99999
KYNG_WERNER_SYNDROM_AND_NORM...1,SET,163,-0.14794,-0.013877,0.061687,0.99176,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,0.99999
GSE23321_CD8_STEM_CELL_MEMOR...4,SET,177,-0.1465,-0.014314,0.06105,0.99179,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,0.99999
GOBP_ENDOTHELIAL_CELL_MIGRAT...,SET,202,-0.14898,-0.01554,0.062032,0.99184,GOBP_ENDOTHELIAL_CELL_MIGRATION,0.99999
GOBP_VENTRAL_MIDLINE_DEVELOP...,SET,6,-0.89752,-0.016222,0.37366,0.99184,GOBP_VENTRAL_MIDLINE_DEVELOPMENT,0.99999
REACTOME_NOTCH1_INTRACELLULA...,SET,43,-0.30644,-0.014812,0.12757,0.99185,REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.99999
NFKB_Q6,SET,236,-0.13355,-0.015043,0.055546,0.99189,NFKB_Q6,0.99999
GOMF_SIGNALING_RECEPTOR_COMP...,SET,51,-0.27976,-0.014724,0.11624,0.99195,GOMF_SIGNALING_RECEPTOR_COMPLEX_ADAPTOR_ACTIVITY,0.99999
GSE3982_CENT_MEMORY_CD4_TCEL...1,SET,175,-0.15664,-0.015219,0.06507,0.99196,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN,0.99999
BIOCARTA_HSP27_PATHWAY,SET,14,-0.53182,-0.014679,0.22066,0.99202,BIOCARTA_HSP27_PATHWAY,0.99999
FISCHER_G2_M_CELL_CYCLE,SET,221,-0.13509,-0.014732,0.055999,0.99207,FISCHER_G2_M_CELL_CYCLE,0.99999
GOBP_HOMOTYPIC_CELL_CELL_ADH...,SET,94,-0.2236,-0.015958,0.09263,0.9921,GOBP_HOMOTYPIC_CELL_CELL_ADHESION,0.99999
GOMF_SH2_DOMAIN_BINDING,SET,39,-0.35269,-0.016237,0.14604,0.99213,GOMF_SH2_DOMAIN_BINDING,0.99999
GOBP_ORGANOPHOSPHATE_BIOSYNT...,SET,508,-0.088597,-0.014532,0.036677,0.99214,GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
NAKAMURA_CANCER_MICROENVIRON...2,SET,23,-0.45042,-0.015932,0.18635,0.99217,NAKAMURA_CANCER_MICROENVIRONMENT_UP,0.99999
REACTOME_P75NTR_NEGATIVELY_R...,SET,6,-0.80898,-0.014622,0.33454,0.9922,REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1,0.99999
GOMF_PRIMARY_AMINE_OXIDASE_A...,SET,7,-0.9821,-0.019172,0.40585,0.99223,GOMF_PRIMARY_AMINE_OXIDASE_ACTIVITY,0.99999
GSE36476_CTRL_VS_TSST_ACT_72...2,SET,174,-0.15724,-0.015235,0.064968,0.99224,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP,0.99999
KEGG_MEDICUS_REFERENCE_FGF_F...1,SET,30,-0.40548,-0.016377,0.16737,0.99229,KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY,0.99999
GOMF_METALLOCARBOXYPEPTIDASE...,SET,29,-0.4266,-0.01694,0.17607,0.99229,GOMF_METALLOCARBOXYPEPTIDASE_ACTIVITY,0.99999
HP_INCREASED_MEAN_CORPUSCULA...,SET,11,-0.53793,-0.013163,0.22202,0.9923,HP_INCREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,0.99999
GOBP_CO_TRANSCRIPTIONAL_RNA_...,SET,10,-0.55896,-0.013041,0.23065,0.99231,GOBP_CO_TRANSCRIPTIONAL_RNA_3_END_PROCESSING_CLEAVAGE_AND_POLYADENYLATION_PATHWAY,0.99999
GSE36891_UNSTIM_VS_POLYIC_TL...1,SET,178,-0.15086,-0.014782,0.062248,0.99231,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN,0.99999
MIR6882_3P,SET,106,-0.1968,-0.01491,0.081174,0.99233,MIR6882_3P,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...17,SET,180,-0.14335,-0.014124,0.059128,0.99233,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_DN,0.99999
WP_PROSURVIVAL_SIGNALING_OF_...,SET,15,-0.52647,-0.015042,0.21712,0.99234,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,0.99999
GRABARCZYK_BCL11B_TARGETS_UP,SET,68,-0.24928,-0.015142,0.10278,0.99235,GRABARCZYK_BCL11B_TARGETS_UP,0.99999
GSE3982_NEUTROPHIL_VS_BASOPH...2,SET,176,-0.14991,-0.014607,0.061785,0.99237,GSE3982_NEUTROPHIL_VS_BASOPHIL_UP,0.99999
GOBP_CELLULAR_RESPONSE_TO_AM...1,SET,5,-1.0264,-0.016935,0.42222,0.99247,GOBP_CELLULAR_RESPONSE_TO_AMMONIUM_ION,0.99999
GOBP_RESPONSE_TO_AMMONIUM_ION,SET,5,-1.0264,-0.016935,0.42222,0.99247,GOBP_RESPONSE_TO_AMMONIUM_ION,0.99999
DESCARTES_FETAL_MUSCLE_VASCU...,SET,63,-0.27991,-0.016368,0.11513,0.99247,DESCARTES_FETAL_MUSCLE_VASCULAR_ENDOTHELIAL_CELLS,0.99999
REACTOME_VASOPRESSIN_LIKE_RE...,SET,5,-1.094,-0.018051,0.44982,0.99249,REACTOME_VASOPRESSIN_LIKE_RECEPTORS,0.99999
WOTTON_RUNX_TARGETS_UP,SET,18,-0.48257,-0.015102,0.19837,0.9925,WOTTON_RUNX_TARGETS_UP,0.99999
GOBP_LONG_TERM_SYNAPTIC_DEPR...,SET,30,-0.41885,-0.016917,0.17205,0.99254,GOBP_LONG_TERM_SYNAPTIC_DEPRESSION,0.99999
HP_ABNORMALITY_OF_THE_ANTERI...2,SET,110,-0.19353,-0.014935,0.079486,0.99254,HP_ABNORMALITY_OF_THE_ANTERIOR_FONTANELLE,0.99999
GSE17721_CTRL_VS_PAM3CSK4_2H...2,SET,183,-0.14646,-0.014549,0.060135,0.99256,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_UP,0.99999
HP_PANNICULITIS,SET,25,-0.42717,-0.015752,0.1753,0.99259,HP_PANNICULITIS,0.99999
GOBP_REGULATION_OF_POSTSYNAP...9,SET,18,-0.47106,-0.014742,0.19316,0.99262,GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,0.99999
chr22q11,SET,98,-0.39029,-0.028437,0.16002,0.99263,chr22q11,0.99999
HP_SUBCUTANEOUS_LIPOMA,SET,7,-0.77932,-0.015214,0.31947,0.99264,HP_SUBCUTANEOUS_LIPOMA,0.99999
MIR505_3P,SET,98,-0.2063,-0.015031,0.084529,0.99266,MIR505_3P,0.99999
HP_INFRA_ORBITAL_CREASE,SET,7,-0.78917,-0.015406,0.3233,0.99267,HP_INFRA_ORBITAL_CREASE,0.99999
GOBP_NEGATIVE_REGULATION_OF_...622,SET,52,-0.30756,-0.016344,0.12594,0.99269,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,0.99999
GOBP_ORGANIC_HYDROXY_COMPOUN...3,SET,511,-0.094005,-0.015463,0.038494,0.99269,GOBP_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS,0.99999
BIOCARTA_BBCELL_PATHWAY,SET,6,-0.95207,-0.017208,0.38982,0.9927,BIOCARTA_BBCELL_PATHWAY,0.99999
WP_PHOSPHODIESTERASES_IN_NEU...,SET,52,-0.2995,-0.015916,0.12261,0.99271,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,0.99999
HP_ALLERGY,SET,35,-0.36417,-0.015885,0.14907,0.99271,HP_ALLERGY,0.99999
MIR4678,SET,100,-0.20761,-0.01528,0.084951,0.99273,MIR4678,0.99999
HP_FACIAL_HYPERTRICHOSIS,SET,174,-0.15176,-0.014703,0.062104,0.99273,HP_FACIAL_HYPERTRICHOSIS,0.99999
GOBP_CAMP_METABOLIC_PROCESS,SET,23,-0.45243,-0.016003,0.18508,0.99274,GOBP_CAMP_METABOLIC_PROCESS,0.99999
GSE41176_UNSTIM_VS_ANTI_IGM_...5,SET,170,-0.15012,-0.014378,0.061421,0.99274,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN,0.99999
GSE42724_NAIVE_BCELL_VS_PLAS...1,SET,179,-0.15648,-0.015375,0.064017,0.99274,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN,0.99999
HP_FOLLICULAR_HYPERPLASIA,SET,14,-0.5725,-0.015802,0.23416,0.99275,HP_FOLLICULAR_HYPERPLASIA,0.99999
HP_ACTION_TREMOR,SET,167,-0.15481,-0.014696,0.063223,0.99282,HP_ACTION_TREMOR,0.99999
HP_DECREASED_SERUM_CREATININE,SET,4,-1.0309,-0.015215,0.42095,0.99283,HP_DECREASED_SERUM_CREATININE,0.99999
MODULE_13,SET,470,-0.095474,-0.015078,0.03897,0.99285,MODULE_13,0.99999
GOCC_SYNAPTIC_CLEFT,SET,21,-0.48697,-0.016459,0.19871,0.99287,GOCC_SYNAPTIC_CLEFT,0.99999
IIZUKA_LIVER_CANCER_PROGRESS...8,SET,19,-0.52016,-0.016724,0.21205,0.99291,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,0.99999
GSE15930_STIM_VS_STIM_AND_TR...4,SET,185,-0.16091,-0.016071,0.065603,0.99291,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP,0.99999
GOMF_PEPTIDE_N_ACETYLTRANSFE...,SET,46,-0.28081,-0.014038,0.1143,0.99299,GOMF_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY,0.99999
PID_INTEGRIN1_PATHWAY,SET,63,-0.2787,-0.016297,0.1134,0.993,PID_INTEGRIN1_PATHWAY,0.99999
GOMF_PHOSPHORUS_OXYGEN_LYASE...,SET,20,-0.49665,-0.016383,0.20202,0.99302,GOMF_PHOSPHORUS_OXYGEN_LYASE_ACTIVITY,0.99999
HP_RETINAL_DEGENERATION,SET,260,-0.12712,-0.01502,0.051699,0.99303,HP_RETINAL_DEGENERATION,0.99999
GOCC_SHELTERIN_COMPLEX,SET,6,-0.77393,-0.013988,0.31459,0.99305,GOCC_SHELTERIN_COMPLEX,0.99999
HP_FRONTOTEMPORAL_CEREBRAL_A...,SET,14,-0.52321,-0.014442,0.21259,0.99307,HP_FRONTOTEMPORAL_CEREBRAL_ATROPHY,0.99999
YANAGIHARA_ESX1_TARGETS,SET,26,-0.40401,-0.015192,0.16408,0.99309,YANAGIHARA_ESX1_TARGETS,0.99999
REACTOME_NON_INTEGRIN_MEMBRA...,SET,55,-0.2949,-0.016116,0.11978,0.99309,REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,0.99999
GSE22886_CTRL_VS_LPS_24H_DC_...2,SET,178,-0.14543,-0.014249,0.059057,0.9931,GSE22886_CTRL_VS_LPS_24H_DC_UP,0.99999
HP_FRAGILE_NAILS,SET,23,-0.41698,-0.014749,0.16921,0.99313,HP_FRAGILE_NAILS,0.99999
GOBP_PEPTIDYL_LYSINE_MONOMET...,SET,7,-0.68043,-0.013283,0.27594,0.99316,GOBP_PEPTIDYL_LYSINE_MONOMETHYLATION,0.99999
GCGCTTT_MIR518B_MIR518C_MIR5...,SET,17,-0.45728,-0.013908,0.18537,0.99318,GCGCTTT_MIR518B_MIR518C_MIR518D,0.99999
HP_MACULAR_ATROPHY,SET,39,-0.348,-0.016021,0.14103,0.99319,HP_MACULAR_ATROPHY,0.99999
chr1q24,SET,54,-0.58297,-0.031569,0.23598,0.99325,chr1q24,0.99999
TTANTCA_UNKNOWN,SET,839,-0.077088,-0.016098,0.031174,0.99329,TTANTCA_UNKNOWN,0.99999
HP_COOMBS_POSITIVE_HEMOLYTIC...,SET,9,-0.70647,-0.015637,0.28566,0.9933,HP_COOMBS_POSITIVE_HEMOLYTIC_ANEMIA,0.99999
GOBP_CHEMOKINE_C_C_MOTIF_LIG...,SET,10,-0.67476,-0.015743,0.27277,0.99331,GOBP_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,0.99999
GSE3039_CD4_TCELL_VS_ALPHAAL...1,SET,178,-0.15471,-0.015159,0.062542,0.99331,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN,0.99999
MIR2117,SET,112,-0.19492,-0.015177,0.078775,0.99332,MIR2117,0.99999
HP_HYPOPITUITARISM,SET,159,-0.16656,-0.015432,0.067317,0.99332,HP_HYPOPITUITARISM,0.99999
GOMF_PHOSPHORIC_DIESTER_HYDR...,SET,86,-0.22024,-0.015038,0.088968,0.99334,GOMF_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY,0.99999
GSE2826_WT_VS_BTK_KO_BCELL_DN,SET,193,-0.15359,-0.015664,0.062043,0.99334,GSE2826_WT_VS_BTK_KO_BCELL_DN,0.99999
YAMASHITA_LIVER_CANCER_STEM_...2,SET,46,-0.33112,-0.016553,0.13367,0.99337,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,0.99999
GOCC_STEREOCILIUM_TIP,SET,17,-0.54369,-0.016536,0.21947,0.99338,GOCC_STEREOCILIUM_TIP,0.99999
HP_INCREASED_CIRCULATING_INT...2,SET,5,-0.96703,-0.015956,0.3901,0.99341,HP_INCREASED_CIRCULATING_INTERLEUKIN_18_CONCENTRATION,0.99999
GSE2770_TGFB_AND_IL4_VS_TGFB...3,SET,170,-0.15646,-0.014985,0.06311,0.99341,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.99999
GOBP_REGULATION_OF_EMBRYONIC...,SET,81,-0.2248,-0.014898,0.09063,0.99343,GOBP_REGULATION_OF_EMBRYONIC_DEVELOPMENT,0.99999
HP_ABNORMALITY_OF_VISION,SET,1184,-0.062219,-0.015282,0.025075,0.99345,HP_ABNORMALITY_OF_VISION,0.99999
MODULE_112,SET,237,-0.1497,-0.016897,0.060311,0.99346,MODULE_112,0.99999
GSE11961_MEMORY_BCELL_DAY40_...2,SET,182,-0.15154,-0.015012,0.061063,0.99346,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.99999
HP_ABNORMAL_RESPONSE_TO_ENDO...,SET,130,-0.18442,-0.015463,0.074252,0.99349,HP_ABNORMAL_RESPONSE_TO_ENDOCRINE_STIMULATION_TEST,0.99999
HP_ENLARGEMENT_OF_THE_WRISTS,SET,6,-0.93795,-0.016953,0.37765,0.99349,HP_ENLARGEMENT_OF_THE_WRISTS,0.99999
GOMF_SPHINGOMYELIN_PHOSPHODI...,SET,7,-0.78799,-0.015383,0.31711,0.99352,GOMF_SPHINGOMYELIN_PHOSPHODIESTERASE_ACTIVITY,0.99999
HP_CONCAVE_NAIL,SET,11,-0.582,-0.014241,0.23407,0.99354,HP_CONCAVE_NAIL,0.99999
REACTOME_DEFECTIVE_RIPK1_MED...,SET,7,-0.7734,-0.015098,0.31086,0.99357,REACTOME_DEFECTIVE_RIPK1_MEDIATED_REGULATED_NECROSIS,0.99999
HP_ABNORMAL_MEAN_CORPUSCULAR...2,SET,55,-0.26331,-0.01439,0.10578,0.99359,HP_ABNORMAL_MEAN_CORPUSCULAR_VOLUME,0.99999
GCM_MLL,SET,157,-0.15185,-0.013981,0.060982,0.99361,GCM_MLL,0.99999
HP_AUTISTIC_BEHAVIOR,SET,499,-0.094186,-0.015315,0.037826,0.99361,HP_AUTISTIC_BEHAVIOR,0.99999
MIR1_5P,SET,82,-0.23645,-0.015766,0.09493,0.99362,MIR1_5P,0.99999
WP_SILDENAFIL_TREATMENT,SET,19,-0.51328,-0.016503,0.20595,0.99365,WP_SILDENAFIL_TREATMENT,0.99999
GOBP_GLYCEROLIPID_CATABOLIC_...,SET,62,-0.27931,-0.016203,0.11203,0.99366,GOBP_GLYCEROLIPID_CATABOLIC_PROCESS,0.99999
MIR6731_3P,SET,68,-0.25533,-0.01551,0.10229,0.99372,MIR6731_3P,0.99999
GOBP_REGULATION_OF_ENDOTHELI...4,SET,153,-0.17688,-0.016079,0.070813,0.99375,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,0.99999
GOBP_FOLIC_ACID_CONTAINING_C...1,SET,8,-0.66963,-0.013974,0.26761,0.99382,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
GOBP_RESPONSE_TO_OXYGEN_LEVE...,SET,302,-0.12188,-0.015502,0.048677,0.99385,GOBP_RESPONSE_TO_OXYGEN_LEVELS,0.99999
GOCC_HISTONE_PRE_MRNA_3_END_...,SET,6,-0.7964,-0.014394,0.31795,0.99387,GOCC_HISTONE_PRE_MRNA_3_END_PROCESSING_COMPLEX,0.99999
HOEGERKORP_CD44_TARGETS_TEMP...2,SET,10,-0.70111,-0.016358,0.27962,0.99391,HOEGERKORP_CD44_TARGETS_TEMPORAL_UP,0.99999
GOBP_RNA_SPLICING,SET,396,-0.098478,-0.014306,0.039258,0.99393,GOBP_RNA_SPLICING,0.99999
HP_ABNORMALITY_OF_CENTRAL_NE...,SET,525,-0.09241,-0.015401,0.036842,0.99393,HP_ABNORMALITY_OF_CENTRAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY,0.99999
GOMF_CASPASE_BINDING,SET,12,-0.54624,-0.01396,0.21721,0.99404,GOMF_CASPASE_BINDING,0.99999
MODULE_176,SET,209,-0.16142,-0.017124,0.064141,0.99407,MODULE_176,0.99999
TRAVAGLINI_LUNG_NEUROENDOCRI...,SET,114,-0.21213,-0.016663,0.084282,0.99408,TRAVAGLINI_LUNG_NEUROENDOCRINE_CELL,0.99999
GOBP_NOREPINEPHRINE_TRANSPORT,SET,23,-0.50737,-0.017946,0.20144,0.99411,GOBP_NOREPINEPHRINE_TRANSPORT,0.99999
MODULE_278,SET,32,-0.36149,-0.015078,0.14347,0.99412,MODULE_278,0.99999
GOCC_PHOTORECEPTOR_INNER_SEG...,SET,65,-0.27272,-0.016198,0.10823,0.99413,GOCC_PHOTORECEPTOR_INNER_SEGMENT,0.99999
HP_ABNORMALITY_OF_FONTANELLES,SET,180,-0.15809,-0.015576,0.062708,0.99415,HP_ABNORMALITY_OF_FONTANELLES,0.99999
GOBP_CHOLINE_METABOLIC_PROCE...,SET,6,-0.97886,-0.017692,0.38807,0.99417,GOBP_CHOLINE_METABOLIC_PROCESS,0.99999
HOSHIDA_LIVER_CANCER_SURVIVA...1,SET,99,-0.20953,-0.015344,0.083006,0.9942,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,0.99999
GSE29618_LAIV_VS_TIV_FLU_VAC...1,SET,170,-0.15772,-0.015106,0.062484,0.9942,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN,0.99999
HP_GIANT_SOMATOSENSORY_EVOKE...,SET,5,-0.91683,-0.015127,0.36301,0.99422,HP_GIANT_SOMATOSENSORY_EVOKED_POTENTIALS,0.99999
GOMF_ADRENERGIC_RECEPTOR_ACT...,SET,10,-0.79521,-0.018553,0.31475,0.99423,GOMF_ADRENERGIC_RECEPTOR_ACTIVITY,0.99999
GOBP_FEAR_RESPONSE,SET,44,-0.3562,-0.017416,0.14089,0.99426,GOBP_FEAR_RESPONSE,0.99999
GCM_PTPRD,SET,53,-0.2975,-0.015961,0.11761,0.99429,GCM_PTPRD,0.99999
HP_ACUTE_PANCREATITIS,SET,6,-0.94745,-0.017124,0.3745,0.99429,HP_ACUTE_PANCREATITIS,0.99999
HP_ABNORMAL_LUNG_LOBATION,SET,37,-0.36798,-0.016502,0.14541,0.9943,HP_ABNORMAL_LUNG_LOBATION,0.99999
HP_EEG_WITH_GENERALIZED_EPIL...,SET,247,-0.13613,-0.015682,0.05374,0.99434,HP_EEG_WITH_GENERALIZED_EPILEPTIFORM_DISCHARGES,0.99999
HP_BILIARY_ATRESIA,SET,11,-0.62287,-0.015241,0.24585,0.99435,HP_BILIARY_ATRESIA,0.99999
HP_DECREASED_LYMPHOCYTE_APOP...,SET,6,-0.8097,-0.014635,0.31951,0.99436,HP_DECREASED_LYMPHOCYTE_APOPTOSIS,0.99999
GSE37533_PPARG1_FOXP3_VS_PPA...3,SET,173,-0.15921,-0.015381,0.062797,0.99438,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,0.99999
GSE37301_RAG2_KO_VS_RAG2_AND...2,SET,181,-0.15671,-0.015482,0.061775,0.9944,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP,0.99999
HP_POSTERIOR_STAPHYLOMA,SET,7,-0.89036,-0.017381,0.35087,0.99441,HP_POSTERIOR_STAPHYLOMA,0.99999
PKCA_DN.V1_DN,SET,140,-0.18544,-0.016131,0.073067,0.99442,PKCA_DN.V1_DN,0.99999
GSE43955_TH0_VS_TGFB_IL6_IL2...4,SET,184,-0.15657,-0.015595,0.061687,0.99442,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,0.99999
HP_HYPSARRHYTHMIA,SET,159,-0.17108,-0.015851,0.067385,0.99443,HP_HYPSARRHYTHMIA,0.99999
HP_BROAD_BASED_GAIT,SET,99,-0.21143,-0.015483,0.083258,0.99444,HP_BROAD_BASED_GAIT,0.99999
KEGG_FOLATE_BIOSYNTHESIS,SET,10,-0.66557,-0.015529,0.26205,0.99445,KEGG_FOLATE_BIOSYNTHESIS,0.99999
GSE19923_E2A_KO_VS_E2A_AND_H...1,SET,182,-0.16427,-0.016273,0.064654,0.99446,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN,0.99999
BIOCARTA_HIVNEF_PATHWAY,SET,54,-0.29107,-0.015762,0.11455,0.99447,BIOCARTA_HIVNEF_PATHWAY,0.99999
REACTOME_RHOQ_GTPASE_CYCLE,SET,57,-0.28382,-0.015789,0.1117,0.99447,REACTOME_RHOQ_GTPASE_CYCLE,0.99999
WTTGKCTG_UNKNOWN,SET,455,-0.10508,-0.016335,0.041342,0.99448,WTTGKCTG_UNKNOWN,0.99999
GOBP_POSITIVE_REGULATION_OF_...388,SET,6,-0.91829,-0.016597,0.36128,0.99448,GOBP_POSITIVE_REGULATION_OF_I_KAPPAB_PHOSPHORYLATION,0.99999
GOBP_ACIDIC_AMINO_ACID_TRANS...,SET,65,-0.28356,-0.016842,0.11154,0.99449,GOBP_ACIDIC_AMINO_ACID_TRANSPORT,0.99999
GSE17721_POLYIC_VS_PAM3CSK4_...16,SET,185,-0.15829,-0.015808,0.062257,0.99449,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP,0.99999
WP_GLYCOSYLATION_AND_RELATED...,SET,20,-0.40257,-0.013279,0.1582,0.99453,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,0.99999
HP_ABNORMAL_PROPORTION_OF_DO...,SET,6,-0.93123,-0.016831,0.36583,0.99454,HP_ABNORMAL_PROPORTION_OF_DOUBLE_NEGATIVE_ALPHA_BETA_REGULATORY_T_CELL,0.99999
GOBP_PHAGOSOME_ACIDIFICATION,SET,7,-0.9169,-0.017899,0.35998,0.99456,GOBP_PHAGOSOME_ACIDIFICATION,0.99999
PID_ECADHERIN_STABILIZATION_...,SET,39,-0.32985,-0.015186,0.12938,0.9946,PID_ECADHERIN_STABILIZATION_PATHWAY,0.99999
WP_SARSCOV2_MITOCHONDRIAL_CH...,SET,22,-0.46285,-0.016012,0.18147,0.99462,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,0.99999
MIR6762_3P,SET,115,-0.19287,-0.015216,0.075623,0.99462,MIR6762_3P,0.99999
HP_SKIN_EROSION,SET,26,-0.38881,-0.014621,0.15237,0.99464,HP_SKIN_EROSION,0.99999
HP_VISUAL_LOSS,SET,206,-0.15053,-0.015855,0.058967,0.99465,HP_VISUAL_LOSS,0.99999
GOCC_SPLICEOSOMAL_COMPLEX,SET,178,-0.14554,-0.01426,0.056987,0.99467,GOCC_SPLICEOSOMAL_COMPLEX,0.99999
GOBP_DNA_TEMPLATED_TRANSCRIP...3,SET,20,-0.52499,-0.017317,0.20546,0.99469,GOBP_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION,0.99999
GOBP_REGULATION_OF_OXIDOREDU...,SET,53,-0.29739,-0.015955,0.11638,0.99469,GOBP_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,0.99999
FAN_EMBRYONIC_CTX_EX_4_EXCIT...,SET,133,-0.189,-0.016027,0.07393,0.99471,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,0.99999
KIM_MYCN_AMPLIFICATION_TARGE...2,SET,79,-0.25269,-0.016539,0.098373,0.99489,KIM_MYCN_AMPLIFICATION_TARGETS_UP,0.99999
GOMF_STEROL_BINDING,SET,65,-0.28369,-0.016849,0.11015,0.99499,GOMF_STEROL_BINDING,0.99999
GSE1432_1H_VS_6H_IFNG_MICROG...2,SET,185,-0.15955,-0.015934,0.061958,0.99499,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,0.99999
CHIANG_LIVER_CANCER_SUBCLASS...6,SET,67,-0.26927,-0.016236,0.10451,0.995,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,0.99999
GNF2_LCAT,SET,118,-0.20113,-0.016072,0.078023,0.99502,GNF2_LCAT,0.99999
GOCC_AUTOLYSOSOME,SET,12,-0.61624,-0.015749,0.2391,0.99502,GOCC_AUTOLYSOSOME,0.99999
GOBP_NEGATIVE_REGULATION_OF_...552,SET,5,-0.98894,-0.016317,0.38344,0.99504,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_RECYCLING,0.99999
GOBP_BASE_EXCISION_REPAIR_GA...,SET,13,-0.45441,-0.012087,0.17612,0.99506,GOBP_BASE_EXCISION_REPAIR_GAP_FILLING,0.99999
HP_DUMBBELL_SHAPED_LONG_BONE,SET,7,-0.80288,-0.015674,0.31095,0.99508,HP_DUMBBELL_SHAPED_LONG_BONE,0.99999
RRCCGTTA_UNKNOWN,SET,79,-0.24253,-0.015874,0.093888,0.9951,RRCCGTTA_UNKNOWN,0.99999
HE_LIM_SUN_FETAL_LUNG_C7_KCN...,SET,95,-0.25054,-0.017975,0.096966,0.99511,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,0.99999
GOBP_SPHINGOMYELIN_CATABOLIC...,SET,8,-0.78092,-0.016297,0.30198,0.99514,GOBP_SPHINGOMYELIN_CATABOLIC_PROCESS,0.99999
GOBP_PEPTIDYL_LYSINE_METHYLA...,SET,14,-0.55153,-0.015224,0.21322,0.99515,GOBP_PEPTIDYL_LYSINE_METHYLATION,0.99999
MIR6514_3P,SET,67,-0.26817,-0.01617,0.1036,0.99518,MIR6514_3P,0.99999
GSE3720_LPS_VS_PMA_STIM_VD1_...2,SET,124,-0.19494,-0.015966,0.075295,0.99518,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,0.99999
GSE29618_PRE_VS_DAY7_POST_TI...1,SET,171,-0.15504,-0.014892,0.059829,0.99522,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN,0.99999
GNF2_HPX,SET,128,-0.19588,-0.016298,0.075553,0.99523,GNF2_HPX,0.99999
MIR4469,SET,104,-0.21468,-0.016111,0.082762,0.99525,MIR4469,0.99999
REACTOME_PHENYLALANINE_AND_T...,SET,10,-0.74883,-0.017471,0.28845,0.99528,REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM,0.99999
CHIBA_RESPONSE_TO_TSA_DN,SET,20,-0.48986,-0.016159,0.18866,0.99529,CHIBA_RESPONSE_TO_TSA_DN,0.99999
PID_CD40_PATHWAY,SET,30,-0.42168,-0.017031,0.16229,0.99531,PID_CD40_PATHWAY,0.99999
HP_LARYNGEAL_CLEFT,SET,6,-1.0978,-0.019841,0.42256,0.99531,HP_LARYNGEAL_CLEFT,0.99999
chr4q26,SET,15,-1.054,-0.030115,0.40562,0.99532,chr4q26,0.99999
WP_PI3KAKTMTOR_VITAMIN_D3_SI...,SET,20,-0.51474,-0.016979,0.19807,0.99532,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,0.99999
BIOCARTA_SHH_PATHWAY,SET,16,-0.5718,-0.016872,0.21995,0.99533,BIOCARTA_SHH_PATHWAY,0.99999
WP_NEURAL_CREST_CELL_MIGRATI...2,SET,40,-0.37776,-0.017613,0.14528,0.99534,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,0.99999
WP_HEREDITARY_LEIOMYOMATOSIS...,SET,18,-0.48583,-0.015204,0.18678,0.99535,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,0.99999
MIR3166,SET,103,-0.2265,-0.016917,0.086915,0.99542,MIR3166,0.99999
GSE23502_BM_VS_COLON_TUMOR_H...2,SET,178,-0.1693,-0.016589,0.064955,0.99542,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,0.99999
GOBP_PEPTIDYL_LYSINE_MODIFIC...,SET,127,-0.18682,-0.015483,0.071628,0.99544,GOBP_PEPTIDYL_LYSINE_MODIFICATION,0.99999
GOBP_PROTEIN_K11_LINKED_UBIQ...,SET,31,-0.36304,-0.014905,0.13921,0.99544,GOBP_PROTEIN_K11_LINKED_UBIQUITINATION,0.99999
WP_CREATINE_PATHWAY,SET,4,-1.2198,-0.018003,0.46758,0.99545,WP_CREATINE_PATHWAY,0.99999
MIR4794,SET,88,-0.24429,-0.016871,0.093647,0.99545,MIR4794,0.99999
DESCARTES_MAIN_FETAL_PDE1C_A...,SET,238,-0.13261,-0.014999,0.05083,0.99545,DESCARTES_MAIN_FETAL_PDE1C_ACSM3_POSITIVE_CELLS,0.99999
HP_THYROID_ADENOMA,SET,13,-0.6321,-0.016813,0.24198,0.9955,HP_THYROID_ADENOMA,0.99999
HP_SPEECH_APRAXIA,SET,28,-0.39218,-0.015303,0.15004,0.99552,HP_SPEECH_APRAXIA,0.99999
GSE17721_CTRL_VS_PAM3CSK4_6H...2,SET,178,-0.16495,-0.016162,0.063066,0.99554,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_UP,0.99999
KEGG_MEDICUS_REFERENCE_CASR_...,SET,7,-0.84544,-0.016504,0.32285,0.99558,KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY,0.99999
MIR892C_5P,SET,252,-0.14376,-0.016726,0.054884,0.99559,MIR892C_5P,0.99999
HP_CAUDAL_APPENDAGE,SET,6,-1.059,-0.01914,0.40374,0.99564,HP_CAUDAL_APPENDAGE,0.99999
KERLEY_RESPONSE_TO_CISPLATIN...1,SET,5,-0.97455,-0.01608,0.37135,0.99566,KERLEY_RESPONSE_TO_CISPLATIN_DN,0.99999
DESCARTES_MAIN_FETAL_LENS_FI...,SET,137,-0.1921,-0.016532,0.073197,0.99566,DESCARTES_MAIN_FETAL_LENS_FIBRE_CELLS,0.99999
GOBP_CELL_PROLIFERATION_IN_B...,SET,8,-0.74597,-0.015568,0.28388,0.9957,GOBP_CELL_PROLIFERATION_IN_BONE_MARROW,0.99999
HP_ATRIAL_FLUTTER,SET,17,-0.58068,-0.017661,0.22097,0.9957,HP_ATRIAL_FLUTTER,0.99999
GOBP_GLUTAMATE_SECRETION,SET,28,-0.46774,-0.018252,0.17791,0.99572,GOBP_GLUTAMATE_SECRETION,0.99999
MIR302A_5P,SET,175,-0.16904,-0.016424,0.064259,0.99573,MIR302A_5P,0.99999
GOBP_NEGATIVE_REGULATION_OF_...157,SET,55,-0.30363,-0.016593,0.11544,0.99573,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.99999
HP_ABNORMAL_CIRCULATING_INTE...2,SET,8,-0.84734,-0.017683,0.32217,0.99573,HP_ABNORMAL_CIRCULATING_INTERLEUKIN_10_CONCENTRATION,0.99999
GSE7218_IGM_VS_IGG_SIGNAL_TH...2,SET,176,-0.16332,-0.015913,0.062086,0.99573,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP,0.99999
ZHONG_PFC_C3_PROX1_CCK_POS_I...,SET,10,-0.84631,-0.019745,0.32179,0.99573,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,0.99999
WP_AMPACTIVATED_PROTEIN_KINA...,SET,67,-0.2697,-0.016262,0.10248,0.99575,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,0.99999
HP_SIMPLE_EAR,SET,19,-0.51686,-0.016618,0.19607,0.9958,HP_SIMPLE_EAR,0.99999
GSE17721_CTRL_VS_LPS_8H_BMDC...2,SET,179,-0.16528,-0.01624,0.062702,0.9958,GSE17721_CTRL_VS_LPS_8H_BMDC_UP,0.99999
GSE7460_FOXP3_MUT_VS_WT_ACT_...3,SET,184,-0.16372,-0.016307,0.062039,0.99584,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN,0.99999
MIR3689A_5P_MIR3689B_5P_MIR3...,SET,110,-0.21854,-0.016865,0.08279,0.99585,MIR3689A_5P_MIR3689B_5P_MIR3689E_MIR3689F,0.99999
GOMF_OXIDOREDUCTASE_ACTIVITY...34,SET,13,-0.54919,-0.014608,0.20798,0.99586,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_WITH_A_FLAVIN_AS_ACCEPTOR,0.99999
GOBP_CGMP_METABOLIC_PROCESS,SET,13,-0.642,-0.017077,0.24306,0.99587,GOBP_CGMP_METABOLIC_PROCESS,0.99999
GSE9988_ANTI_TREM1_AND_LPS_V...1,SET,185,-0.15493,-0.015473,0.058646,0.99587,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN,0.99999
GSE11864_CSF1_PAM3CYS_VS_CSF...1,SET,173,-0.17344,-0.016756,0.065647,0.99588,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.99999
WP_PTDINS45P2_IN_CYTOKINESIS...,SET,9,-0.74795,-0.016555,0.283,0.99589,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,0.99999
HMEF2_Q6,SET,129,-0.19961,-0.016672,0.075525,0.99589,HMEF2_Q6,0.99999
HP_MATURITY_ONSET_DIABETES_O...,SET,19,-0.53961,-0.017349,0.20416,0.99589,HP_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,0.99999
GSE12366_NAIVE_VS_MEMORY_BCE...1,SET,174,-0.17774,-0.017221,0.067114,0.99595,GSE12366_NAIVE_VS_MEMORY_BCELL_DN,0.99999
HP_ABNORMALITY_OF_CHORIORETI...,SET,12,-0.70017,-0.017894,0.26428,0.99596,HP_ABNORMALITY_OF_CHORIORETINAL_PIGMENTATION,0.99999
HP_SEPTATE_VAGINA,SET,10,-0.74224,-0.017317,0.2796,0.99603,HP_SEPTATE_VAGINA,0.99999
WP_METABOLIC_PATHWAY_OF_LDL_...,SET,15,-0.60002,-0.017143,0.2257,0.99607,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,0.99999
HP_ABNORMAL_LYMPHOCYTE_APOPT...,SET,8,-0.75723,-0.015803,0.28488,0.99607,HP_ABNORMAL_LYMPHOCYTE_APOPTOSIS,0.99999
GOBP_EMBRYONIC_RETINA_MORPHO...,SET,6,-1.0318,-0.018649,0.38797,0.99608,GOBP_EMBRYONIC_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,0.99999
GCM_SMARCC1,SET,32,-0.35794,-0.01493,0.13448,0.99611,GCM_SMARCC1,0.99999
GOCC_CELL_CORTEX,SET,288,-0.13182,-0.01638,0.049519,0.99611,GOCC_CELL_CORTEX,0.99999
HP_RETINAL_ATROPHY,SET,91,-0.22919,-0.016095,0.086076,0.99612,HP_RETINAL_ATROPHY,0.99999
MCBRYAN_PUBERTAL_TGFB1_TARGE...2,SET,156,-0.17946,-0.016471,0.067348,0.99614,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,0.99999
GOBP_REGULATION_OF_EPITHELIA...4,SET,212,-0.16025,-0.01712,0.060126,0.99615,GOBP_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.99999
MIR505_5P,SET,50,-0.30988,-0.016149,0.11601,0.99622,MIR505_5P,0.99999
STARK_PREFRONTAL_CORTEX_22Q1...2,SET,180,-0.16826,-0.016578,0.062929,0.99625,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,0.99999
GSE6092_UNSTIM_VS_IFNG_STIM_...1,SET,177,-0.17332,-0.016935,0.064739,0.99628,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,0.99999
GOBP_SPINAL_CORD_MOTOR_NEURO...1,SET,9,-0.76756,-0.016989,0.28657,0.9963,GOBP_SPINAL_CORD_MOTOR_NEURON_CELL_FATE_SPECIFICATION,0.99999
GOCC_GLUTAMATERGIC_SYNAPSE,SET,389,-0.11655,-0.016784,0.043459,0.99634,GOCC_GLUTAMATERGIC_SYNAPSE,0.99999
GOCC_COPI_COATED_VESICLE,SET,24,-0.42475,-0.015346,0.15826,0.99636,GOCC_COPI_COATED_VESICLE,0.99999
WP_LEPTIN_AND_ADIPONECTIN,SET,10,-0.678,-0.015818,0.25255,0.99637,WP_LEPTIN_AND_ADIPONECTIN,0.99999
HP_ABNORMAL_CIRCULATING_INSU...,SET,144,-0.19195,-0.016932,0.071434,0.99639,HP_ABNORMAL_CIRCULATING_INSULIN_CONCENTRATION,0.99999
MIR664A_5P,SET,65,-0.29452,-0.017493,0.10956,0.9964,MIR664A_5P,0.99999
HP_RACHITIC_ROSARY,SET,6,-1.0099,-0.018253,0.37557,0.99641,HP_RACHITIC_ROSARY,0.99999
GOBP_ENERGY_DERIVATION_BY_OX...,SET,277,-0.12963,-0.015801,0.048182,0.99643,GOBP_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS,0.99999
BYSTROEM_CORRELATED_WITH_IL5...1,SET,55,-0.30554,-0.016697,0.11349,0.99645,BYSTROEM_CORRELATED_WITH_IL5_DN,0.99999
MIR3185,SET,188,-0.16347,-0.016456,0.060695,0.99646,MIR3185,0.99999
MIR4492,SET,387,-0.11631,-0.016707,0.043149,0.99648,MIR4492,0.99999
HP_ABSENT_EPIPHYSES,SET,20,-0.55029,-0.018152,0.20414,0.99648,HP_ABSENT_EPIPHYSES,0.99999
GSE2770_TGFB_AND_IL4_VS_TGFB...6,SET,177,-0.17036,-0.016646,0.063216,0.99648,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.99999
AGUIRRE_PANCREATIC_CANCER_CO...2,SET,271,-0.14528,-0.01752,0.05388,0.99649,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,0.99999
GNF2_GSTM1,SET,102,-0.22282,-0.016561,0.082649,0.99649,GNF2_GSTM1,0.99999
GSE16266_CTRL_VS_LPS_STIM_ME...1,SET,178,-0.17351,-0.017001,0.064355,0.99649,GSE16266_CTRL_VS_LPS_STIM_MEF_DN,0.99999
LIAN_LIPA_TARGETS_3M,SET,52,-0.3402,-0.018079,0.12589,0.99656,LIAN_LIPA_TARGETS_3M,0.99999
GOBP_INTRACELLULAR_STEROL_TR...,SET,32,-0.40571,-0.016922,0.15008,0.99656,GOBP_INTRACELLULAR_STEROL_TRANSPORT,0.99999
LEE_CALORIE_RESTRICTION_MUSC...1,SET,40,-0.31579,-0.014723,0.11658,0.99662,LEE_CALORIE_RESTRICTION_MUSCLE_DN,0.99999
BDP1_TARGET_GENES,SET,1011,-0.071725,-0.016361,0.026473,0.99663,BDP1_TARGET_GENES,0.99999
HP_ABNORMAL_CIRCULATING_MONO...,SET,66,-0.27555,-0.016491,0.10158,0.99666,HP_ABNORMAL_CIRCULATING_MONOCARBOXYLIC_ACID_CONCENTRATION,0.99999
HP_RESPIRATORY_ALKALOSIS,SET,5,-0.9829,-0.016218,0.36239,0.99666,HP_RESPIRATORY_ALKALOSIS,0.99999
MIR634,SET,83,-0.24307,-0.016306,0.089494,0.99669,MIR634,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...6,SET,7,-0.86883,-0.016961,0.31994,0.99669,GOBP_CELLULAR_RESPONSE_TO_INTERFERON_ALPHA,0.99999
GOBP_POSITIVE_REGULATION_OF_...247,SET,6,-1.1197,-0.020238,0.4121,0.9967,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.99999
chr6q27,SET,25,-0.68146,-0.025128,0.25074,0.99671,chr6q27,0.99999
REACTOME_FATTY_ACIDS_BOUND_T...,SET,8,-0.87899,-0.018344,0.32334,0.99672,REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION,0.99999
GSE6674_CPG_VS_CPG_AND_ANTI_...1,SET,172,-0.18134,-0.017469,0.066658,0.99674,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_DN,0.99999
GSE29618_LAIV_VS_TIV_FLU_VAC...7,SET,173,-0.17636,-0.017038,0.064802,0.99675,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN,0.99999
MIR670_3P,SET,268,-0.14028,-0.016824,0.051514,0.99676,MIR670_3P,0.99999
MEF2_01,SET,137,-0.20326,-0.017492,0.074624,0.99677,MEF2_01,0.99999
HOFT_CD4_POSITIVE_ALPHA_BETA...8,SET,25,-0.44197,-0.016297,0.16227,0.99677,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_7DY_TOP_100_DEG_EX_VIVO_UP,0.99999
GOBP_REGULATION_OF_GLOMERULU...,SET,4,-1.3262,-0.019573,0.48623,0.99681,GOBP_REGULATION_OF_GLOMERULUS_DEVELOPMENT,0.99999
GOBP_GENERATION_OF_PRECURSOR...,SET,393,-0.11103,-0.016069,0.040666,0.99683,GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,0.99999
GOMF_THIOESTERASE_BINDING,SET,9,-0.67878,-0.015024,0.24864,0.99683,GOMF_THIOESTERASE_BINDING,0.99999
GOBP_PHOSPHATIDYLINOSITOL_ME...1,SET,23,-0.49212,-0.017407,0.18009,0.99685,GOBP_PHOSPHATIDYLINOSITOL_MEDIATED_SIGNALING,0.99999
MIR96_3P,SET,65,-0.27797,-0.016509,0.10164,0.99688,MIR96_3P,0.99999
GSE11864_UNTREATED_VS_CSF1_I...3,SET,164,-0.17302,-0.016279,0.063239,0.99689,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.99999
GOMF_MRNA_REGULATORY_ELEMENT...,SET,15,-0.4904,-0.014011,0.17916,0.9969,GOMF_MRNA_REGULATORY_ELEMENT_BINDING_TRANSLATION_REPRESSOR_ACTIVITY,0.99999
REACTOME_RHOJ_GTPASE_CYCLE,SET,50,-0.32924,-0.017158,0.12024,0.99691,REACTOME_RHOJ_GTPASE_CYCLE,0.99999
MODULE_134,SET,29,-0.49471,-0.019645,0.18055,0.99692,MODULE_134,0.99999
GOBP_POSITIVE_REGULATION_OF_...529,SET,85,-0.27821,-0.018886,0.10155,0.99692,GOBP_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION,0.99999
HP_SPARSE_BONE_TRABECULAE,SET,4,-1.2432,-0.018348,0.45329,0.99695,HP_SPARSE_BONE_TRABECULAE,0.99999
GOBP_PROGRAMMED_NECROTIC_CEL...,SET,47,-0.3318,-0.016766,0.12068,0.99701,GOBP_PROGRAMMED_NECROTIC_CELL_DEATH,0.99999
HOEK_MONOCYTE_2011_2012_TIV_...5,SET,9,-0.90632,-0.020061,0.32954,0.99702,HOEK_MONOCYTE_2011_2012_TIV_ADULT_7DY_DN,0.99999
GOBP_GLAND_MORPHOGENESIS,SET,121,-0.22547,-0.018243,0.081949,0.99703,GOBP_GLAND_MORPHOGENESIS,0.99999
BIOCARTA_LEPTIN_PATHWAY,SET,11,-0.66038,-0.016159,0.23987,0.99704,BIOCARTA_LEPTIN_PATHWAY,0.99999
GOBP_NEGATIVE_REGULATION_OF_...101,SET,21,-0.48433,-0.01637,0.17594,0.99704,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_SENESCENCE,0.99999
GOBP_POSITIVE_REGULATION_OF_...541,SET,13,-0.6133,-0.016313,0.22282,0.99704,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,0.99999
GSE45365_HEALTHY_VS_MCMV_INF...1,SET,167,-0.17675,-0.01678,0.064224,0.99704,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_DN,0.99999
GOBP_POLYAMINE_TRANSPORT,SET,16,-0.59688,-0.017612,0.21676,0.99705,GOBP_POLYAMINE_TRANSPORT,0.99999
HP_ERYTHRODERMA,SET,56,-0.30684,-0.01692,0.11135,0.99707,HP_ERYTHRODERMA,0.99999
GTF3C1_TARGET_GENES,SET,4,-1.1696,-0.017261,0.42405,0.99709,GTF3C1_TARGET_GENES,0.99999
GOMF_CATECHOLAMINE_BINDING,SET,12,-0.77094,-0.019702,0.27953,0.99709,GOMF_CATECHOLAMINE_BINDING,0.99999
GCM_UBE2N,SET,141,-0.18609,-0.016245,0.067337,0.99714,GCM_UBE2N,0.99999
GOBP_ENDOPLASMIC_RETICULUM_O...,SET,84,-0.2436,-0.016439,0.088135,0.99714,GOBP_ENDOPLASMIC_RETICULUM_ORGANIZATION,0.99999
HP_RECURRENT_BRONCHOPULMONAR...,SET,10,-0.60728,-0.014168,0.21962,0.99715,HP_RECURRENT_BRONCHOPULMONARY_INFECTIONS,0.99999
MIR8084,SET,213,-0.16673,-0.017853,0.060273,0.99716,MIR8084,0.99999
WP_T_CELL_MODULATION_IN_PANC...,SET,43,-0.37418,-0.018086,0.13522,0.99717,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,0.99999
MIKKELSEN_NPC_ICP_WITH_H3K4M...,SET,381,-0.11908,-0.016974,0.042988,0.99719,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,0.99999
HP_GRAY_MATTER_HETEROTOPIA,SET,111,-0.20483,-0.015877,0.073897,0.99721,HP_GRAY_MATTER_HETEROTOPIA,0.99999
GCM_BAG5,SET,34,-0.37422,-0.016089,0.13493,0.99722,GCM_BAG5,0.99999
GSE15330_WT_VS_IKAROS_KO_HSC...1,SET,184,-0.17409,-0.01734,0.062735,0.99724,GSE15330_WT_VS_IKAROS_KO_HSC_DN,0.99999
NFKAPPAB_01,SET,232,-0.15614,-0.01744,0.056232,0.99725,NFKAPPAB_01,0.99999
MIR3912_5P,SET,77,-0.27049,-0.01748,0.097306,0.99728,MIR3912_5P,0.99999
GOBP_PHOSPHOLIPID_CATABOLIC_...,SET,52,-0.33335,-0.017715,0.11978,0.9973,GOBP_PHOSPHOLIPID_CATABOLIC_PROCESS,0.99999
KEGG_MEDICUS_REFERENCE_EXTRI...,SET,10,-0.73291,-0.0171,0.26327,0.99731,KEGG_MEDICUS_REFERENCE_EXTRINSIC_APOPTOTIC_PATHWAY,0.99999
GSE21546_WT_VS_ELK1_KO_DP_TH...1,SET,179,-0.17272,-0.01697,0.062023,0.99732,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_DN,0.99999
HP_DUODENAL_ATRESIA,SET,39,-0.38688,-0.017812,0.1388,0.99734,HP_DUODENAL_ATRESIA,0.99999
GOMF_STEROID_BINDING,SET,102,-0.24408,-0.018141,0.08752,0.99735,GOMF_STEROID_BINDING,0.99999
MIR10522_5P,SET,215,-0.16046,-0.017262,0.057498,0.99737,MIR10522_5P,0.99999
SP1_Q6,SET,235,-0.15269,-0.017163,0.054622,0.99741,SP1_Q6,0.99999
MOLENAAR_TARGETS_OF_CCND1_AN...1,SET,50,-0.32474,-0.016923,0.11598,0.99744,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN,0.99999
HP_REDUCED_ATTENTION_REGULAT...,SET,439,-0.1144,-0.017477,0.040867,0.99744,HP_REDUCED_ATTENTION_REGULATION,0.99999
MIR4802_5P,SET,57,-0.31081,-0.017291,0.11095,0.99745,MIR4802_5P,0.99999
MIR6500_3P,SET,73,-0.26893,-0.016924,0.095937,0.99747,MIR6500_3P,0.99999
SQSTM1_TARGET_GENES,SET,30,-0.41249,-0.01666,0.14698,0.99749,SQSTM1_TARGET_GENES,0.99999
GOMF_CHOLESTEROL_BINDING,SET,51,-0.33897,-0.01784,0.12074,0.9975,GOMF_CHOLESTEROL_BINDING,0.99999
HP_ABNORMAL_ENZYME_CONCENTRA...,SET,637,-0.094445,-0.017284,0.033646,0.9975,HP_ABNORMAL_ENZYME_CONCENTRATION_OR_ACTIVITY,0.99999
REACTOME_NOTCH_HLH_TRANSCRIP...,SET,24,-0.46383,-0.016758,0.16518,0.99751,REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY,0.99999
GOMF_NUCLEAR_GLUCOCORTICOID_...,SET,12,-0.75642,-0.019331,0.26894,0.99754,GOMF_NUCLEAR_GLUCOCORTICOID_RECEPTOR_BINDING,0.99999
GSE29615_CTRL_VS_DAY7_LAIV_F...1,SET,130,-0.20378,-0.017086,0.072427,0.99755,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,0.99999
GSE46606_IRF4HIGH_VS_WT_CD40...4,SET,180,-0.17794,-0.017531,0.063241,0.99755,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.99999
GOBP_CALMODULIN_DEPENDENT_KI...,SET,12,-0.69955,-0.017878,0.24832,0.99757,GOBP_CALMODULIN_DEPENDENT_KINASE_SIGNALING_PATHWAY,0.99999
HP_DIFFUSE_CEREBELLAR_ATROPHY,SET,15,-0.53892,-0.015397,0.19135,0.99757,HP_DIFFUSE_CEREBELLAR_ATROPHY,0.99999
WP_NEURAL_CREST_CELL_MIGRATI...1,SET,37,-0.42039,-0.018852,0.14922,0.99758,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,0.99999
HP_LARYNGEAL_HYPOPLASIA,SET,8,-0.72951,-0.015224,0.25841,0.99762,HP_LARYNGEAL_HYPOPLASIA,0.99999
NADERI_BREAST_CANCER_PROGNOS...2,SET,47,-0.35366,-0.01787,0.12502,0.99766,NADERI_BREAST_CANCER_PROGNOSIS_UP,0.99999
DESCARTES_FETAL_PLACENTA_SYN...,SET,51,-0.34966,-0.018402,0.12321,0.99773,DESCARTES_FETAL_PLACENTA_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS,0.99999
GOBP_CELLULAR_RESPONSE_TO_IN...7,SET,24,-0.511,-0.018463,0.17983,0.99775,GOBP_CELLULAR_RESPONSE_TO_INTERFERON_BETA,0.99999
GOBP_NEGATIVE_REGULATION_OF_...465,SET,312,-0.13235,-0.017105,0.046578,0.99775,GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,0.99999
GOBP_INOSITOL_TRISPHOSPHATE_...1,SET,6,-1.0097,-0.018249,0.35493,0.99778,GOBP_INOSITOL_TRISPHOSPHATE_BIOSYNTHETIC_PROCESS,0.99999
GSE36009_UNSTIM_VS_LPS_STIM_...4,SET,181,-0.1799,-0.017773,0.063082,0.99782,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP,0.99999
DESCARTES_FETAL_PLACENTA_SMO...,SET,74,-0.30984,-0.019631,0.10862,0.99783,DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS,0.99999
HP_MACULAR_DEGENERATION,SET,87,-0.25854,-0.017755,0.090377,0.99788,HP_MACULAR_DEGENERATION,0.99999
WP_LIPID_PARTICLES_COMPOSITI...,SET,8,-0.92129,-0.019226,0.32203,0.99789,WP_LIPID_PARTICLES_COMPOSITION,0.99999
GOBP_CELLULAR_MODIFIED_AMINO...1,SET,42,-0.36502,-0.017438,0.12748,0.9979,GOBP_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.99999
MIR20A_3P,SET,173,-0.18245,-0.017626,0.063675,0.99791,MIR20A_3P,0.99999
MIR4514,SET,162,-0.1896,-0.017731,0.066154,0.99792,MIR4514,0.99999
GSE1925_CTRL_VS_24H_IFNG_STI...2,SET,184,-0.18386,-0.018313,0.0639,0.99799,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,0.99999
ZHENG_BOUND_BY_FOXP3,SET,456,-0.1213,-0.018878,0.042143,0.998,ZHENG_BOUND_BY_FOXP3,0.99999
GOCC_ENDOPLASMIC_RETICULUM_P...2,SET,9,-0.80739,-0.017871,0.28032,0.99801,GOCC_ENDOPLASMIC_RETICULUM_PLASMA_MEMBRANE_CONTACT_SITE,0.99999
GSE26928_NAIVE_VS_CXCR5_POS_...2,SET,155,-0.18565,-0.016985,0.064449,0.99801,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP,0.99999
MIR6743_5P,SET,35,-0.39023,-0.017021,0.13539,0.99802,MIR6743_5P,0.99999
GOBP_CRANIAL_SUTURE_MORPHOGE...,SET,9,-0.90249,-0.019976,0.31278,0.99804,GOBP_CRANIAL_SUTURE_MORPHOGENESIS,0.99999
GOBP_NEGATIVE_REGULATION_OF_...1,SET,27,-0.46232,-0.017716,0.16026,0.99804,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.99999
AP2GAMMA_01,SET,232,-0.15748,-0.01759,0.054528,0.99806,AP2GAMMA_01,0.99999
REACTOME_RELAXIN_RECEPTORS,SET,7,-1.0611,-0.020714,0.36718,0.99807,REACTOME_RELAXIN_RECEPTORS,0.99999
GSE9960_HEALTHY_VS_GRAM_NEG_...2,SET,148,-0.19821,-0.017724,0.068522,0.99809,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,0.99999
NAKAMURA_LUNG_CANCER,SET,8,-0.97693,-0.020388,0.33756,0.9981,NAKAMURA_LUNG_CANCER,0.99999
GOBP_AMINE_METABOLIC_PROCESS,SET,102,-0.25554,-0.018993,0.088263,0.9981,GOBP_AMINE_METABOLIC_PROCESS,0.99999
GNF2_CASP8,SET,24,-0.5377,-0.019427,0.18551,0.99812,GNF2_CASP8,0.99999
TGAATGT_MIR181A_MIR181B_MIR1...,SET,449,-0.12074,-0.018649,0.041644,0.99813,TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D,0.99999
GOBP_RESPONSE_TO_INTERFERON_...2,SET,30,-0.48071,-0.019415,0.16581,0.99813,GOBP_RESPONSE_TO_INTERFERON_BETA,0.99999
GOBP_TRANSFORMING_GROWTH_FAC...2,SET,8,-0.89775,-0.018735,0.30956,0.99813,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA2_PRODUCTION,0.99999
GOBP_POSITIVE_REGULATION_OF_...248,SET,140,-0.21507,-0.018709,0.074064,0.99815,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,0.99999
REACTOME_FASL_CD95L_SIGNALING,SET,5,-1.1712,-0.019324,0.40262,0.99818,REACTOME_FASL_CD95L_SIGNALING,0.99999
HP_LOW_SET_NIPPLES,SET,6,-0.78962,-0.014272,0.27153,0.99818,HP_LOW_SET_NIPPLES,0.99999
REACTOME_POLB_DEPENDENT_LONG...,SET,7,-0.76597,-0.014953,0.26317,0.99819,REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,0.99999
GOBP_VAGINA_DEVELOPMENT,SET,10,-0.8871,-0.020697,0.30478,0.99819,GOBP_VAGINA_DEVELOPMENT,0.99999
HP_DIARRHEA,SET,362,-0.13133,-0.018258,0.045133,0.99819,HP_DIARRHEA,0.99999
FOURNIER_ACINAR_DEVELOPMENT_...5,SET,10,-0.86113,-0.020091,0.29584,0.9982,FOURNIER_ACINAR_DEVELOPMENT_LATE_UP,0.99999
GOBP_SALIVARY_GLAND_DEVELOPM...,SET,36,-0.41083,-0.018173,0.14108,0.9982,GOBP_SALIVARY_GLAND_DEVELOPMENT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...20,SET,27,-0.52127,-0.019975,0.1784,0.99826,GOBP_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT,0.99999
HP_EEG_WITH_FRONTAL_FOCAL_SP...,SET,4,-1.5154,-0.022364,0.51837,0.99827,HP_EEG_WITH_FRONTAL_FOCAL_SPIKES,0.99999
FOXJ2_02,SET,214,-0.17465,-0.018745,0.059604,0.9983,FOXJ2_02,0.99999
GCTNWTTGK_UNKNOWN,SET,279,-0.15456,-0.018907,0.052701,0.99832,GCTNWTTGK_UNKNOWN,0.99999
GSE32423_MEMORY_VS_NAIVE_CD8...4,SET,178,-0.19662,-0.019266,0.067051,0.99832,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP,0.99999
GOBP_REGULATION_OF_BONE_DEVE...,SET,8,-0.88241,-0.018415,0.30063,0.99833,GOBP_REGULATION_OF_BONE_DEVELOPMENT,0.99999
GOMF_RNA_POLYMERASE_II_GENER...2,SET,21,-0.5025,-0.016984,0.17098,0.99835,GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING,0.99999
GOBP_POSITIVE_REGULATION_OF_...822,SET,8,-0.90792,-0.018947,0.30877,0.99836,GOBP_POSITIVE_REGULATION_OF_UTERINE_SMOOTH_MUSCLE_CONTRACTION,0.99999
MIR1843,SET,58,-0.32536,-0.018258,0.11019,0.99842,MIR1843,0.99999
MIR595,SET,57,-0.31902,-0.017747,0.10805,0.99842,MIR595,0.99999
GOBP_NEGATIVE_REGULATION_OF_...85,SET,13,-0.74051,-0.019697,0.2499,0.99848,GOBP_NEGATIVE_REGULATION_OF_CATECHOLAMINE_SECRETION,0.99999
HP_NUMEROUS_PIGMENTED_FRECKL...,SET,7,-0.817,-0.015949,0.27572,0.99848,HP_NUMEROUS_PIGMENTED_FRECKLES,0.99999
METTL14_TARGET_GENES,SET,109,-0.24044,-0.01847,0.080884,0.99852,METTL14_TARGET_GENES,0.99999
GOBP_BRAINSTEM_DEVELOPMENT,SET,7,-0.91507,-0.017864,0.30715,0.99855,GOBP_BRAINSTEM_DEVELOPMENT,0.99999
SCHAEFFER_SOX9_TARGETS_IN_PR...1,SET,44,-0.40777,-0.019938,0.13678,0.99856,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,0.99999
GOBP_CELLULAR_LIPID_CATABOLI...,SET,220,-0.1696,-0.018453,0.0569,0.99856,GOBP_CELLULAR_LIPID_CATABOLIC_PROCESS,0.99999
GOBP_POSITIVE_REGULATION_OF_...489,SET,23,-0.50496,-0.017861,0.16945,0.99856,GOBP_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,0.99999
GSE19401_PAM2CSK4_VS_RETINOI...2,SET,170,-0.18938,-0.018138,0.063395,0.99859,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,0.99999
MIR3927_3P,SET,94,-0.26506,-0.018917,0.088468,0.99863,MIR3927_3P,0.99999
GOBP_CELLULAR_RESPONSE_TO_VI...2,SET,27,-0.52996,-0.020307,0.17576,0.99871,GOBP_CELLULAR_RESPONSE_TO_VITAMIN,0.99999
PID_HIV_NEF_PATHWAY,SET,35,-0.42613,-0.018587,0.14114,0.99873,PID_HIV_NEF_PATHWAY,0.99999
GOBP_NOREPINEPHRINE_SECRETION,SET,14,-0.75724,-0.020902,0.25061,0.99874,GOBP_NOREPINEPHRINE_SECRETION,0.99999
WP_TARGET_OF_RAPAMYCIN_SIGNA...,SET,35,-0.43914,-0.019155,0.14487,0.99878,WP_TARGET_OF_RAPAMYCIN_SIGNALING,0.99999
MIKKELSEN_MEF_ICP_WITH_H3K4M...,SET,37,-0.44924,-0.020146,0.1481,0.99879,MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3,0.99999
REACTOME_ADRENOCEPTORS,SET,9,-1.0039,-0.022221,0.33071,0.9988,REACTOME_ADRENOCEPTORS,0.99999
MIR100_3P,SET,67,-0.30591,-0.018445,0.10078,0.9988,MIR100_3P,0.99999
HP_PORTAL_FIBROSIS,SET,15,-0.63252,-0.018072,0.20785,0.99883,HP_PORTAL_FIBROSIS,0.99999
GSE17721_CTRL_VS_POLYIC_2H_B...2,SET,177,-0.1857,-0.018145,0.06099,0.99883,GSE17721_CTRL_VS_POLYIC_2H_BMDC_UP,0.99999
WTGAAAT_UNKNOWN,SET,529,-0.11778,-0.019702,0.038573,0.99887,WTGAAAT_UNKNOWN,0.99999
HOXA7_TARGET_GENES,SET,95,-0.26407,-0.018946,0.086381,0.99888,HOXA7_TARGET_GENES,0.99999
GOBP_ZYMOGEN_INHIBITION,SET,7,-0.85972,-0.016783,0.28112,0.99888,GOBP_ZYMOGEN_INHIBITION,0.99999
HP_ATTENTION_DEFICIT_HYPERAC...,SET,349,-0.13859,-0.018925,0.045325,0.99888,HP_ATTENTION_DEFICIT_HYPERACTIVITY_DISORDER,0.99999
GSE40666_UNTREATED_VS_IFNA_S...5,SET,181,-0.19397,-0.019163,0.063413,0.99889,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN,0.99999
MIR6831_5P,SET,106,-0.25745,-0.019505,0.083696,0.99895,MIR6831_5P,0.99999
CTR9_TARGET_GENES,SET,46,-0.35134,-0.017564,0.11422,0.99895,CTR9_TARGET_GENES,0.99999
GOBP_POSITIVE_REGULATION_OF_...501,SET,25,-0.57585,-0.021234,0.18672,0.99898,GOBP_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,0.99999
GOBP_REGULATION_OF_MESODERM_...,SET,5,-1.2141,-0.020032,0.3916,0.99903,GOBP_REGULATION_OF_MESODERM_DEVELOPMENT,0.99999
HP_KINETIC_TREMOR,SET,90,-0.26199,-0.018298,0.084411,0.99904,HP_KINETIC_TREMOR,0.99999
HALLMARK_DNA_REPAIR,SET,136,-0.20545,-0.017617,0.065878,0.99909,HALLMARK_DNA_REPAIR,0.99999
GOBP_PHOSPHATIDYLCHOLINE_CAT...,SET,15,-0.68617,-0.019604,0.21982,0.9991,GOBP_PHOSPHATIDYLCHOLINE_CATABOLIC_PROCESS,0.99999
WP_PKCGAMMA_CALCIUM_SIGNALIN...,SET,21,-0.60341,-0.020395,0.19311,0.99911,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,0.99999
GOBP_DICARBOXYLIC_ACID_TRANS...,SET,99,-0.27942,-0.020462,0.089418,0.99911,GOBP_DICARBOXYLIC_ACID_TRANSPORT,0.99999
GOBP_LIPID_CATABOLIC_PROCESS,SET,322,-0.15065,-0.019774,0.047974,0.99915,GOBP_LIPID_CATABOLIC_PROCESS,0.99999
GOBP_PTERIDINE_CONTAINING_CO...1,SET,13,-0.68261,-0.018157,0.21717,0.99916,GOBP_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.99999
GSE14908_ATOPIC_VS_NONATOPIC...4,SET,176,-0.19424,-0.018925,0.061684,0.99918,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP,0.99999
GSE13306_TREG_RA_VS_TCONV_RA...1,SET,177,-0.20248,-0.019785,0.064196,0.99919,GSE13306_TREG_RA_VS_TCONV_RA_DN,0.99999
GSE12366_GC_VS_NAIVE_BCELL_UP,SET,178,-0.1943,-0.019038,0.061495,0.99921,GSE12366_GC_VS_NAIVE_BCELL_UP,0.99999
SCHAEFFER_PROSTATE_DEVELOPME...2,SET,102,-0.27287,-0.020281,0.086185,0.99923,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,0.99999
GOCC_THO_COMPLEX,SET,5,-1.0985,-0.018125,0.3469,0.99923,GOCC_THO_COMPLEX,0.99999
GSE5542_UNTREATED_VS_IFNG_TR...2,SET,184,-0.1999,-0.019911,0.062984,0.99925,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.99999
GOBP_NEGATIVE_REGULATION_OF_...8,SET,10,-0.89276,-0.020829,0.2809,0.99926,GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,0.99999
MIR4774_3P,SET,75,-0.31712,-0.020226,0.099463,0.99928,MIR4774_3P,0.99999
GOBP_ENDOPLASMIC_RETICULUM_T...4,SET,19,-0.60705,-0.019518,0.19057,0.99928,GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION,0.99999
GOBP_CYCLIC_NUCLEOTIDE_METAB...,SET,37,-0.45893,-0.020581,0.14365,0.9993,GOBP_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS,0.99999
GOBP_PEPTIDYL_LYSINE_ACETYLA...,SET,22,-0.51629,-0.017861,0.16105,0.99933,GOBP_PEPTIDYL_LYSINE_ACETYLATION,0.99999
HP_SPLIT_NAIL,SET,4,-1.0086,-0.014886,0.3135,0.99935,HP_SPLIT_NAIL,0.99999
HP_TIGER_TAIL_BANDING,SET,4,-1.0086,-0.014886,0.3135,0.99935,HP_TIGER_TAIL_BANDING,0.99999
GSE35543_IN_VIVO_NTREG_VS_IN...1,SET,144,-0.23267,-0.020524,0.072142,0.99937,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN,0.99999
HP_ABNORMAL_PERIOSTEUM_MORPH...,SET,8,-1.0907,-0.022763,0.33714,0.99939,HP_ABNORMAL_PERIOSTEUM_MORPHOLOGY,0.99999
GOBP_ORGANOPHOSPHATE_METABOL...,SET,900,-0.090946,-0.019636,0.028079,0.9994,GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS,0.99999
REACTOME_ACROSOME_REACTION_A...,SET,6,-1.2802,-0.023139,0.39367,0.99943,REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING,0.99999
PID_ECADHERIN_NASCENT_AJ_PAT...,SET,38,-0.45174,-0.02053,0.13791,0.99947,PID_ECADHERIN_NASCENT_AJ_PATHWAY,0.99999
MIR6124,SET,410,-0.13539,-0.020005,0.041331,0.99947,MIR6124,0.99999
GOBP_POSITIVE_REGULATION_OF_...575,SET,6,-1.1046,-0.019964,0.33553,0.9995,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION,0.99999
GOBP_SYNAPTIC_TRANSMISSION_G...2,SET,98,-0.29906,-0.02179,0.09062,0.99952,GOBP_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,0.99999
HP_ALOPECIA_OF_SCALP,SET,37,-0.4512,-0.020234,0.13635,0.99953,HP_ALOPECIA_OF_SCALP,0.99999
GABRIELY_MIR21_TARGETS,SET,261,-0.17373,-0.020565,0.052288,0.99955,GABRIELY_MIR21_TARGETS,0.99999
GOBP_ENDOPLASMIC_RETICULUM_T...3,SET,5,-1.1508,-0.018989,0.34319,0.9996,GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_FORMATION,0.99999
MIR1237_3P,SET,120,-0.26855,-0.02164,0.078987,0.99966,MIR1237_3P,0.99999
GOBP_RESPONSE_TO_INTERFERON_...1,SET,17,-0.70772,-0.021525,0.20787,0.99967,GOBP_RESPONSE_TO_INTERFERON_ALPHA,0.99999
HP_PULP_CALCIFICATION,SET,7,-1.279,-0.024968,0.37371,0.99969,HP_PULP_CALCIFICATION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...9,SET,4,-1.702,-0.025118,0.49434,0.99971,GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.99999
HP_ABNORMAL_METABOLISM,SET,146,-0.23344,-0.020733,0.06788,0.99971,HP_ABNORMAL_METABOLISM,0.99999
GOBP_INTRINSIC_APOPTOTIC_SIG...7,SET,9,-0.84665,-0.01874,0.24525,0.99972,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYPOXIA,0.99999
GSE25088_CTRL_VS_IL4_STIM_MA...2,SET,171,-0.23148,-0.022235,0.067096,0.99972,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP,0.99999
RAF_UP.V1_DN,SET,171,-0.24595,-0.023625,0.070983,0.99973,RAF_UP.V1_DN,0.99999
MIR548BB_3P,SET,541,-0.12745,-0.021553,0.036704,0.99974,MIR548BB_3P,0.99999
GOBP_POSITIVE_REGULATION_OF_...61,SET,30,-0.56906,-0.022983,0.16366,0.99975,GOBP_POSITIVE_REGULATION_OF_BLOOD_PRESSURE,0.99999
GOBP_TYPE_II_PNEUMOCYTE_DIFF...,SET,6,-1.2133,-0.02193,0.34364,0.99979,GOBP_TYPE_II_PNEUMOCYTE_DIFFERENTIATION,0.99999
MCRS1_TARGET_GENES,SET,33,-0.51942,-0.022001,0.14617,0.99981,MCRS1_TARGET_GENES,0.99999
MIR329_5P,SET,124,-0.25739,-0.02108,0.07227,0.99982,MIR329_5P,0.99999
KEGG_MEDICUS_PATHOGEN_HCMV_U...2,SET,6,-1.2568,-0.022716,0.35064,0.99983,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,0.99999
GOBP_POSITIVE_REGULATION_OF_...733,SET,12,-0.8549,-0.021848,0.23835,0.99983,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,0.99999
MIR548D_3P,SET,547,-0.13163,-0.022378,0.036541,0.99984,MIR548D_3P,0.99999
MIR548H_3P_MIR548Z,SET,547,-0.13285,-0.022587,0.036512,0.99986,MIR548H_3P_MIR548Z,0.99999
GAVISH_3CA_MALIGNANT_METAPRO...31,SET,42,-0.47806,-0.022838,0.13187,0.99986,GAVISH_3CA_MALIGNANT_METAPROGRAM_39_METAL_RESPONSE,0.99999
MIR548AC,SET,545,-0.13337,-0.022634,0.036571,0.99987,MIR548AC,0.99999
GOBP_UTERINE_SMOOTH_MUSCLE_C...,SET,10,-0.94181,-0.021973,0.25615,0.99988,GOBP_UTERINE_SMOOTH_MUSCLE_CONTRACTION,0.99999
GSE41978_ID2_KO_VS_ID2_KO_AN...2,SET,175,-0.24579,-0.023881,0.067073,0.99988,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.99999
SPIELMAN_LYMPHOBLAST_EUROPEA...1,SET,17,-0.83399,-0.025365,0.22282,0.99991,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,0.99999
MIR6499_3P,SET,111,-0.30652,-0.023761,0.080102,0.99993,MIR6499_3P,0.99999
MIR324_5P,SET,39,-0.5051,-0.023254,0.12819,0.99996,MIR324_5P,0.99999
PID_REELIN_PATHWAY,SET,28,-0.6789,-0.026491,0.16537,0.99998,PID_REELIN_PATHWAY,0.99999
GOBP_EPINEPHRINE_TRANSPORT,SET,11,-1.2004,-0.029373,0.29388,0.99998,GOBP_EPINEPHRINE_TRANSPORT,0.99999
GOBP_NEGATIVE_REGULATION_OF_...453,SET,6,-1.5933,-0.028798,0.38886,0.99998,GOBP_NEGATIVE_REGULATION_OF_NOREPINEPHRINE_SECRETION,0.99999
HP_ENLARGED_EPIPHYSES,SET,12,-0.97456,-0.024906,0.23576,0.99998,HP_ENLARGED_EPIPHYSES,0.99999
HP_HIGH_SERUM_CALCITRIOL,SET,5,-1.8135,-0.029922,0.44501,0.99998,HP_HIGH_SERUM_CALCITRIOL,0.99999
GOBP_EPINEPHRINE_SECRETION,SET,7,-1.5231,-0.029734,0.36272,0.99999,GOBP_EPINEPHRINE_SECRETION,0.99999
GOBP_NEGATIVE_REGULATION_OF_...208,SET,5,-1.766,-0.029138,0.41405,0.99999,GOBP_NEGATIVE_REGULATION_OF_EPINEPHRINE_SECRETION,0.99999
GOMF_EPINEPHRINE_BINDING,SET,6,-1.62,-0.029281,0.38516,0.99999,GOMF_EPINEPHRINE_BINDING,0.99999
